id|nct_id|result_group_id|ctgov_group_code|period|reason|count
796856|NCT03670537|2573731|P1|Overall Study|Protocol Violation|1
796857|NCT03648983|2573739|P1|Overall Study|Study was terminated due to PI departure|95
796858|NCT03585504|2573807|P2|Overall Study|Lost to Follow-up|29
796859|NCT03585504|2573808|P1|Overall Study|Lost to Follow-up|26
796860|NCT03582943|2573820|P2|Analyzed|Protocol Violation|1
796861|NCT03582943|2573821|P1|Analyzed|Protocol Violation|4
796862|NCT03582943|2573820|P2|Intervention and Follow up|Withdrawal by Subject|2
796863|NCT03582943|2573821|P1|Intervention and Follow up|Withdrawal by Subject|4
796864|NCT03582943|2573820|P2|Allocated to Groups|Withdrawal by Subject|1
796865|NCT03582943|2573821|P1|Allocated to Groups|Withdrawal by Subject|1
796866|NCT03578146|2573833|P6|Overall Study|Lost to Follow-up|1
796867|NCT03578146|2573834|P5|Overall Study|Lost to Follow-up|0
796868|NCT03578146|2573835|P4|Overall Study|Lost to Follow-up|0
796869|NCT03578146|2573836|P3|Overall Study|Lost to Follow-up|1
796870|NCT03578146|2573837|P2|Overall Study|Lost to Follow-up|1
796871|NCT03578146|2573838|P1|Overall Study|Lost to Follow-up|0
796872|NCT03578146|2573833|P6|Overall Study|Did Not Receive Treatment|2
796873|NCT03578146|2573834|P5|Overall Study|Did Not Receive Treatment|0
796874|NCT03578146|2573835|P4|Overall Study|Did Not Receive Treatment|0
796875|NCT03578146|2573836|P3|Overall Study|Did Not Receive Treatment|0
796876|NCT03578146|2573837|P2|Overall Study|Did Not Receive Treatment|0
796877|NCT03578146|2573838|P1|Overall Study|Did Not Receive Treatment|1
796878|NCT03551743|2573904|P4|Overall Study|Withdrawal by Subject|0
796879|NCT03551743|2573905|P3|Overall Study|Withdrawal by Subject|0
796880|NCT03551743|2573906|P2|Overall Study|Withdrawal by Subject|0
796881|NCT03551743|2573907|P1|Overall Study|Withdrawal by Subject|1
796882|NCT03551743|2573904|P4|Overall Study|Adverse Event|0
796883|NCT03551743|2573905|P3|Overall Study|Adverse Event|0
796884|NCT03551743|2573906|P2|Overall Study|Adverse Event|0
796885|NCT03551743|2573907|P1|Overall Study|Adverse Event|1
796886|NCT03551730|2573953|P4|Overall Study|Adverse Event|0
796887|NCT03551730|2573954|P3|Overall Study|Adverse Event|0
796888|NCT03551730|2573955|P2|Overall Study|Adverse Event|0
796889|NCT03551730|2573956|P1|Overall Study|Adverse Event|1
796890|NCT03549130|2573996|P2|Overall Study|Lost to Follow-up|1
796891|NCT03549130|2573997|P1|Overall Study|Lost to Follow-up|0
796892|NCT03549130|2573996|P2|Overall Study|Adverse Event|1
796893|NCT03549130|2573997|P1|Overall Study|Adverse Event|0
796894|NCT03549117|2574015|P2|Overall Study|Withdrawal by Subject|0
796895|NCT03549117|2574016|P1|Overall Study|Withdrawal by Subject|1
796896|NCT03494985|2574136|P4|Overall Study|Other (Not specified)|0
796897|NCT03494985|2574137|P3|Overall Study|Other (Not specified)|1
796898|NCT03494985|2574138|P2|Overall Study|Other (Not specified)|1
796899|NCT03494985|2574139|P1|Overall Study|Other (Not specified)|0
796900|NCT03494985|2574136|P4|Overall Study|Other (Withdrawal of consent)|5
796901|NCT03494985|2574137|P3|Overall Study|Other (Withdrawal of consent)|2
796902|NCT03494985|2574138|P2|Overall Study|Other (Withdrawal of consent)|3
796903|NCT03494985|2574139|P1|Overall Study|Other (Withdrawal of consent)|2
796904|NCT03494985|2574136|P4|Overall Study|Adverse Event|0
796905|NCT03494985|2574137|P3|Overall Study|Adverse Event|3
796906|NCT03494985|2574138|P2|Overall Study|Adverse Event|2
796907|NCT03494985|2574139|P1|Overall Study|Adverse Event|3
796908|NCT03489551|2574186|P1|Overall Study|Withdrawal by Subject|2
796909|NCT03489304|2574190|P1|Overall Study|Lost to Follow-up|4
796910|NCT03479216|2574198|P2|Overall Study|Physician Decision|3
796911|NCT03479216|2574199|P1|Overall Study|Physician Decision|2
796912|NCT03479216|2574198|P2|Overall Study|Withdrawal by Subject|2
796913|NCT03479216|2574199|P1|Overall Study|Withdrawal by Subject|3
796914|NCT03478891|2574220|P3|Overall Study|Lost to Follow-up|0
796915|NCT03478891|2574221|P2|Overall Study|Lost to Follow-up|0
796916|NCT03478891|2574222|P1|Overall Study|Lost to Follow-up|1
796917|NCT03478891|2574220|P3|Overall Study|Moved from area|1
796918|NCT03478891|2574221|P2|Overall Study|Moved from area|0
796919|NCT03478891|2574222|P1|Overall Study|Moved from area|0
796920|NCT03478891|2574220|P3|Overall Study|Still Active in Study|9
796921|NCT03478891|2574221|P2|Overall Study|Still Active in Study|5
796922|NCT03478891|2574222|P1|Overall Study|Still Active in Study|2
796923|NCT03478891|2574220|P3|Overall Study|Enrolled, but product never administered|1
796924|NCT03478891|2574221|P2|Overall Study|Enrolled, but product never administered|0
796925|NCT03478891|2574222|P1|Overall Study|Enrolled, but product never administered|0
796926|NCT03478644|2574238|P2|Phase 2|Lost to Follow-up|0
796927|NCT03478644|2574239|P1|Phase 2|Lost to Follow-up|1
796928|NCT03478644|2574238|P2|Phase 2|Withdrawal by Subject|1
796929|NCT03478644|2574239|P1|Phase 2|Withdrawal by Subject|2
796930|NCT03447821|2574254|P3|Overall Study|Lost to Follow-up|1
796931|NCT03447821|2574255|P2|Overall Study|Lost to Follow-up|0
796932|NCT03447821|2574256|P1|Overall Study|Lost to Follow-up|0
796933|NCT03447821|2574254|P3|Overall Study|Withdrawal by Subject|0
796934|NCT03447821|2574255|P2|Overall Study|Withdrawal by Subject|1
796935|NCT03447821|2574256|P1|Overall Study|Withdrawal by Subject|1
796936|NCT03447353|2574279|P1|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1
796937|NCT03447353|2574279|P1|Overall Study|Scheduling Conflicts|3
796938|NCT03447353|2574279|P1|Overall Study|Lost to Follow-up|4
796939|NCT03447353|2574279|P1|Overall Study|Failure at Screening Visit|2
796940|NCT03407430|2574327|P2|Washout|Protocol Violation|0
796941|NCT03407430|2574328|P1|Washout|Protocol Violation|1
796942|NCT03405818|2574360|P1|Overall Study|Lost to Follow-up|4
796943|NCT03405818|2574360|P1|Overall Study|Withdrawal by Subject|4
796944|NCT03365011|2574446|P2|Overall Study|Withdrawal by Subject|2
796945|NCT03365011|2574447|P1|Overall Study|Withdrawal by Subject|1
796946|NCT03364335|2574462|P5|Overall Study|Lost to Follow-up|11
796947|NCT03364335|2574463|P4|Overall Study|Lost to Follow-up|11
796948|NCT03364335|2574464|P3|Overall Study|Lost to Follow-up|10
796949|NCT03364335|2574465|P2|Overall Study|Lost to Follow-up|7
796950|NCT03364335|2574466|P1|Overall Study|Lost to Follow-up|7
796951|NCT03364335|2574462|P5|Overall Study|Adverse Event|0
796952|NCT03364335|2574463|P4|Overall Study|Adverse Event|2
796953|NCT03364335|2574464|P3|Overall Study|Adverse Event|1
796954|NCT03364335|2574465|P2|Overall Study|Adverse Event|4
796955|NCT03364335|2574466|P1|Overall Study|Adverse Event|3
796956|NCT03349099|2574605|P2|Overall Study|Stone migrated from the kidney|0
796957|NCT03349099|2574606|P1|Overall Study|Stone migrated from the kidney|1
796958|NCT03349099|2574605|P2|Overall Study|Physician Decision|4
796959|NCT03349099|2574606|P1|Overall Study|Physician Decision|3
796960|NCT03346759|2574618|P2|Second Menstrual Cycle|Lost to Follow-up|0
796961|NCT03346759|2574619|P1|Second Menstrual Cycle|Lost to Follow-up|1
796962|NCT03346759|2574618|P2|First Menstrual Cycle|Withdrawal by Subject|0
796963|NCT03346759|2574619|P1|First Menstrual Cycle|Withdrawal by Subject|1
796964|NCT03346759|2574618|P2|Enrollment to Baseline Data Collected|Lost to Follow-up|3
796965|NCT03346759|2574619|P1|Enrollment to Baseline Data Collected|Lost to Follow-up|2
796966|NCT03335566|2574655|P2|Overall Study|Other than specified above|2
796967|NCT03335566|2574656|P1|Overall Study|Other than specified above|1
796968|NCT03335566|2574655|P2|Overall Study|Protocol Violation|0
796969|NCT03335566|2574656|P1|Overall Study|Protocol Violation|1
796970|NCT03335566|2574655|P2|Overall Study|Technical Problems|0
796971|NCT03335566|2574656|P1|Overall Study|Technical Problems|1
796972|NCT03335566|2574655|P2|Overall Study|Lost to Follow-up|0
796973|NCT03335566|2574656|P1|Overall Study|Lost to Follow-up|1
796974|NCT03335566|2574655|P2|Overall Study|Adverse Event|1
796975|NCT03335566|2574656|P1|Overall Study|Adverse Event|0
796976|NCT03331315|2574670|P2|Overall Study|Physician Decision|14
796977|NCT03331315|2574671|P1|Overall Study|Physician Decision|18
796978|NCT03295201|2574736|P2|Overall Study|Hospital admission|1
796979|NCT03295201|2574737|P1|Overall Study|Hospital admission|0
796980|NCT03295201|2574736|P2|Overall Study|Lost to Follow-up|1
796981|NCT03295201|2574737|P1|Overall Study|Lost to Follow-up|1
796982|NCT03274453|2574857|P4|Overall Study|Surgery Cancelled|0
796983|NCT03274453|2574858|P3|Overall Study|Surgery Cancelled|0
796984|NCT03274453|2574859|P2|Overall Study|Surgery Cancelled|1
796985|NCT03274453|2574860|P1|Overall Study|Surgery Cancelled|0
796986|NCT03274453|2574857|P4|Overall Study|Physician Decision|3
796987|NCT03274453|2574858|P3|Overall Study|Physician Decision|0
796988|NCT03274453|2574859|P2|Overall Study|Physician Decision|0
796989|NCT03274453|2574860|P1|Overall Study|Physician Decision|2
796990|NCT03274453|2574857|P4|Overall Study|Lost to Follow-up|1
796991|NCT03274453|2574858|P3|Overall Study|Lost to Follow-up|4
796992|NCT03274453|2574859|P2|Overall Study|Lost to Follow-up|5
796993|NCT03274453|2574860|P1|Overall Study|Lost to Follow-up|2
796994|NCT03263806|2574887|P2|Overall Study|Study Termination|6
796995|NCT03263806|2574888|P1|Overall Study|Study Termination|5
796996|NCT03263806|2574887|P2|Overall Study|Withdrawal by Subject|1
796997|NCT03263806|2574888|P1|Overall Study|Withdrawal by Subject|0
796998|NCT03263806|2574887|P2|Overall Study|Elevated Troponin (failed screen)|0
796999|NCT03263806|2574888|P1|Overall Study|Elevated Troponin (failed screen)|1
797000|NCT03256552|2574900|P1|Overall Study|Withdrawal by Subject|2
797001|NCT03256552|2574900|P1|Overall Study|Adverse Event|1
797002|NCT03256552|2574900|P1|Overall Study|Physician Decision|1
797003|NCT03256552|2574900|P1|Overall Study|Protocol Violation|1
797004|NCT03255733|2574922|P1|Overall Study|Lost to Follow-up|4
797005|NCT03255655|2574929|P2|Overall Study|Lost to Follow-up|4
797006|NCT03255655|2574930|P1|Overall Study|Lost to Follow-up|7
797007|NCT03254602|2574938|P1|Overall Study|Lost to Follow-up|4
797008|NCT03254459|2574946|P2|Overall Study|Miscellaneous|1
797009|NCT03254459|2574947|P1|Overall Study|Miscellaneous|0
797010|NCT03254459|2574946|P2|Overall Study|Lost to Follow-up|1
797011|NCT03254459|2574947|P1|Overall Study|Lost to Follow-up|0
797012|NCT03254459|2574946|P2|Overall Study|Withdrawal by Subject Consent|1
797013|NCT03254459|2574947|P1|Overall Study|Withdrawal by Subject Consent|3
797014|NCT03254459|2574946|P2|Overall Study|Adverse Event|20
797015|NCT03254459|2574947|P1|Overall Study|Adverse Event|7
797016|NCT03238924|2574984|P2|Overall Study|Withdrawal by Subject|2
797017|NCT03238924|2574985|P1|Overall Study|Withdrawal by Subject|2
797018|NCT03238352|2574998|P3|Overall Study|Withdrawal by Subject|0
797019|NCT03238352|2574999|P2|Overall Study|Withdrawal by Subject|1
797020|NCT03238352|2575000|P1|Overall Study|Withdrawal by Subject|0
797021|NCT03238352|2574998|P3|Overall Study|Lost to Follow-up|1
797022|NCT03238352|2574999|P2|Overall Study|Lost to Follow-up|2
797023|NCT03238352|2575000|P1|Overall Study|Lost to Follow-up|0
797024|NCT03238001|2575011|P1|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4
797025|NCT03238001|2575011|P1|Visit 2 (Secondary Endpoint Cohort)|Study completion|1
797026|NCT03238001|2575011|P1|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3
797027|NCT03238001|2575011|P1|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3
797028|NCT03238001|2575011|P1|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2
797029|NCT03238001|2575011|P1|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16
797030|NCT03238001|2575011|P1|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2
797031|NCT03238001|2575011|P1|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2
797032|NCT03235115|2575056|P6|Omafilcon A|Lost to Follow-up|1
797033|NCT03235115|2575057|P5|Omafilcon A|Lost to Follow-up|0
797034|NCT03235115|2575058|P4|Omafilcon A|Lost to Follow-up|0
797035|NCT03235115|2575059|P3|Omafilcon A|Lost to Follow-up|0
797036|NCT03235115|2575060|P2|Omafilcon A|Lost to Follow-up|0
797037|NCT03235115|2575061|P1|Omafilcon A|Lost to Follow-up|0
797038|NCT03233009|2575081|P1|Overall Study|Lost to Follow-up|1
797039|NCT03231371|2575124|P1|Overall Study|chose or were ineligible to have MRI|12
797040|NCT03231371|2575124|P1|Overall Study|Withdrawal by Subject|1
797041|NCT03223662|2575134|P1|Overall Study|Study closure|1
797042|NCT03223662|2575134|P1|Overall Study|Physician Decision|1
797043|NCT03222141|2575144|P1|Overall Study|Lost to Follow-up|3
797044|NCT03222141|2575144|P1|Overall Study|Death|15
797045|NCT03218163|2575164|P1|Overall Study|Study termination|1
797046|NCT03217968|2575168|P1|Overall Study|Protocol Violation|6
797047|NCT03217968|2575168|P1|Overall Study|Lost to Follow-up|1
797048|NCT03217968|2575168|P1|Overall Study|Withdrawal by Subject|4
797049|NCT03198767|2575184|P7|Overall Study|Protocol Violation|0
797050|NCT03198767|2575185|P6|Overall Study|Protocol Violation|0
797051|NCT03198767|2575186|P5|Overall Study|Protocol Violation|0
797052|NCT03198767|2575187|P4|Overall Study|Protocol Violation|6
797053|NCT03198767|2575188|P3|Overall Study|Protocol Violation|0
797054|NCT03198767|2575189|P2|Overall Study|Protocol Violation|0
797055|NCT03198767|2575190|P1|Overall Study|Protocol Violation|0
797056|NCT03196635|2575335|P1|Overall Study|Withdrawal by Subject|1
797057|NCT03192306|2575355|P2|Overall Study|Protocol Violation|1
797058|NCT03192306|2575356|P1|Overall Study|Protocol Violation|1
797059|NCT03192306|2575355|P2|Overall Study|Lost to Follow-up|0
797060|NCT03192306|2575356|P1|Overall Study|Lost to Follow-up|1
797061|NCT03192306|2575355|P2|Overall Study|Withdrawal by Subject|1
797062|NCT03192306|2575356|P1|Overall Study|Withdrawal by Subject|1
797063|NCT03192306|2575355|P2|Overall Study|Did not treat cold sore during study|143
797064|NCT03192306|2575356|P1|Overall Study|Did not treat cold sore during study|149
797065|NCT03191552|2575377|P3|Overall Study|Undergone surgery (Progressive hip dyspl|0
797066|NCT03191552|2575378|P2|Overall Study|Undergone surgery (Progressive hip dyspl|1
797067|NCT03191552|2575379|P1|Overall Study|Undergone surgery (Progressive hip dyspl|0
797068|NCT03191552|2575377|P3|Overall Study|Lost to Follow-up|0
797069|NCT03191552|2575378|P2|Overall Study|Lost to Follow-up|0
797070|NCT03191552|2575379|P1|Overall Study|Lost to Follow-up|1
797071|NCT03184441|2575430|P1|Overall Study|Withdrawal by Subject|1
797072|NCT03184077|2575440|P2|Overall Study|Lost to Follow-up|21
797073|NCT03184077|2575441|P1|Overall Study|Lost to Follow-up|21
797074|NCT03180138|2575470|P3|Overall Study|Found to be >24 mon after randomization|3
797075|NCT03180138|2575471|P2|Overall Study|Found to be >24 mon after randomization|0
797076|NCT03180138|2575472|P1|Overall Study|Found to be >24 mon after randomization|3
797077|NCT03180138|2575470|P3|Overall Study|No prior immunization records|6
797078|NCT03180138|2575471|P2|Overall Study|No prior immunization records|0
797079|NCT03180138|2575472|P1|Overall Study|No prior immunization records|17
797080|NCT03180138|2575470|P3|Overall Study|Mobile-phone could not be verified|15
797081|NCT03180138|2575471|P2|Overall Study|Mobile-phone could not be verified|13
797082|NCT03180138|2575472|P1|Overall Study|Mobile-phone could not be verified|2
797083|NCT03166618|2575502|P2|Overall Study|Study was Terminated|1
797084|NCT03166618|2575503|P1|Overall Study|Study was Terminated|0
797085|NCT03151226|2575562|P1|Overall Study|not wear device correctly|1
797086|NCT03151226|2575562|P1|Overall Study|Withdrawal by Subject|2
797087|NCT03150485|2575566|P6|Overall Study|Unsatisfactory Lens Fitting|0
797088|NCT03150485|2575567|P5|Overall Study|Unsatisfactory Lens Fitting|0
797089|NCT03150485|2575568|P4|Overall Study|Unsatisfactory Lens Fitting|0
797090|NCT03150485|2575569|P3|Overall Study|Unsatisfactory Lens Fitting|0
797091|NCT03150485|2575570|P2|Overall Study|Unsatisfactory Lens Fitting|1
797092|NCT03150485|2575571|P1|Overall Study|Unsatisfactory Lens Fitting|0
797093|NCT03148756|2575588|P2|Overall Study|Study Terminated|1
797094|NCT03148756|2575589|P1|Overall Study|Study Terminated|0
797095|NCT03142932|2575630|P2|Overall Study|Lost to Follow-up|11
797096|NCT03142932|2575631|P1|Overall Study|Lost to Follow-up|2
797097|NCT03139552|2575677|P1|Overall Study|unable to attend tasting due to schedule|3
797098|NCT03134183|2575760|P2|Overall Study|Withdrawal by Subject|1
797099|NCT03134183|2575761|P1|Overall Study|Withdrawal by Subject|1
797100|NCT03133767|2575771|P2|Overall Study|Protocol Violation|1
797101|NCT03133767|2575772|P1|Overall Study|Protocol Violation|0
797102|NCT03133767|2575771|P2|Overall Study|Lost to Follow-up|24
797103|NCT03133767|2575772|P1|Overall Study|Lost to Follow-up|38
797104|NCT03128723|2575811|P1|Overall Study|Withdrawal by Subject|2
797105|NCT03128307|2575830|P1|Overall Study|Withdrawal by Subject|5
797106|NCT03128307|2575830|P1|Overall Study|Lost to Follow-up|29
797107|NCT03124784|2575877|P1|Overall Study|Computer/Equip Malfunction|1
797108|NCT03124784|2575877|P1|Overall Study|Adverse Event|1
797109|NCT03124381|2575895|P2|Overall Study|Non-Compliance with Study Treatment|0
797110|NCT03124381|2575896|P1|Overall Study|Non-Compliance with Study Treatment|1
797111|NCT03124381|2575895|P2|Overall Study|Adverse Event|1
797112|NCT03124381|2575896|P1|Overall Study|Adverse Event|1
797113|NCT03124381|2575895|P2|Overall Study|Protocol Violation|1
797114|NCT03124381|2575896|P1|Overall Study|Protocol Violation|0
797115|NCT03124381|2575895|P2|Overall Study|Withdrawal by Subject|3
797116|NCT03124381|2575896|P1|Overall Study|Withdrawal by Subject|6
797117|NCT03124381|2575895|P2|Overall Study|Lost to Follow-up|1
797118|NCT03124381|2575896|P1|Overall Study|Lost to Follow-up|1
797119|NCT03124199|2575986|P1|Overall Study|Lost to Follow-up|4
797120|NCT03123354|2576014|P1|Overall Study|Physician Decision|6
797121|NCT03118934|2576106|P6|Overall Study|Discontinued prior to exposure|0
797122|NCT03118934|2576107|P5|Overall Study|Discontinued prior to exposure|2
797123|NCT03118934|2576108|P4|Overall Study|Discontinued prior to exposure|1
797124|NCT03118934|2576109|P3|Overall Study|Discontinued prior to exposure|1
797125|NCT03118934|2576110|P2|Overall Study|Discontinued prior to exposure|1
797126|NCT03118934|2576111|P1|Overall Study|Discontinued prior to exposure|0
797127|NCT03118934|2576106|P6|Overall Study|Physician Decision|1
797128|NCT03118934|2576107|P5|Overall Study|Physician Decision|0
797129|NCT03118934|2576108|P4|Overall Study|Physician Decision|0
797130|NCT03118934|2576109|P3|Overall Study|Physician Decision|0
797131|NCT03118934|2576110|P2|Overall Study|Physician Decision|0
797132|NCT03118934|2576111|P1|Overall Study|Physician Decision|0
797133|NCT03118934|2576106|P6|Overall Study|Adverse Event|1
797134|NCT03118934|2576107|P5|Overall Study|Adverse Event|0
797135|NCT03118934|2576108|P4|Overall Study|Adverse Event|0
797136|NCT03118934|2576109|P3|Overall Study|Adverse Event|0
797137|NCT03118934|2576110|P2|Overall Study|Adverse Event|0
797138|NCT03118934|2576111|P1|Overall Study|Adverse Event|0
797139|NCT03118297|2576123|P2|Overall Study|Lost to Follow-up|2
797140|NCT03118297|2576124|P1|Overall Study|Lost to Follow-up|0
797141|NCT03110900|2576256|P2|Overall Study|Sponsor withdrew|1
797142|NCT03110900|2576257|P1|Overall Study|Sponsor withdrew|1
797143|NCT03101150|2576361|P2|Overall Study|Miscarriage|6
797144|NCT03101150|2576362|P1|Overall Study|Miscarriage|3
797145|NCT03101150|2576361|P2|Overall Study|Lost to Follow-up|4
797146|NCT03101150|2576362|P1|Overall Study|Lost to Follow-up|2
797147|NCT03099096|2576395|P1|Overall Study|Physician Decision|1
797148|NCT03099096|2576395|P1|Overall Study|Adverse Event|1
797149|NCT03097614|2576408|P1|Overall Study|Adverse Event|3
797150|NCT03097289|2576412|P1|Overall Study|Collected platelet product unusable|3
797151|NCT03097289|2576412|P1|Overall Study|Equipment failure|2
797152|NCT03097289|2576412|P1|Overall Study|Adverse Event|1
797153|NCT03091439|2576474|P2|Overall Study|Study Terminated by the Sponsor|0
797154|NCT03091439|2576475|P1|Overall Study|Study Terminated by the Sponsor|1
797155|NCT03086447|2576524|P2|Overall Study|Lens Discomfort|1
797156|NCT03086447|2576525|P1|Overall Study|Lens Discomfort|2
797157|NCT03086447|2576524|P2|Overall Study|Adverse Event|0
797158|NCT03086447|2576525|P1|Overall Study|Adverse Event|3
797159|NCT03086447|2576524|P2|Overall Study|Lost to Follow-up|1
797160|NCT03086447|2576525|P1|Overall Study|Lost to Follow-up|0
797161|NCT03086447|2576524|P2|Overall Study|Protocol Violation|4
797162|NCT03086447|2576525|P1|Overall Study|Protocol Violation|2
797163|NCT03086447|2576524|P2|Overall Study|Test Article No Longer Available|0
797164|NCT03086447|2576525|P1|Overall Study|Test Article No Longer Available|1
797165|NCT03086447|2576524|P2|Overall Study|Unsatisfactory Lens Fitting|1
797166|NCT03086447|2576525|P1|Overall Study|Unsatisfactory Lens Fitting|0
797167|NCT03086447|2576524|P2|Overall Study|Lens Damage|6
797168|NCT03086447|2576525|P1|Overall Study|Lens Damage|1
797169|NCT03086447|2576524|P2|Overall Study|Product quality complaint|1
797170|NCT03086447|2576525|P1|Overall Study|Product quality complaint|0
797171|NCT03086447|2576524|P2|Overall Study|Lost Lens|5
797172|NCT03086447|2576525|P1|Overall Study|Lost Lens|2
797173|NCT03086447|2576524|P2|Overall Study|No Longer Meets Eligibility Criteria|1
797174|NCT03086447|2576525|P1|Overall Study|No Longer Meets Eligibility Criteria|0
797175|NCT03083483|2576548|P3|Overall Study|technological issues|1
797176|NCT03083483|2576549|P2|Overall Study|technological issues|0
797177|NCT03083483|2576550|P1|Overall Study|technological issues|1
797178|NCT03083483|2576548|P3|Overall Study|Lost to Follow-up|1
797179|NCT03083483|2576549|P2|Overall Study|Lost to Follow-up|1
797180|NCT03083483|2576550|P1|Overall Study|Lost to Follow-up|2
797181|NCT03083483|2576548|P3|Overall Study|Adverse Event|1
797182|NCT03083483|2576549|P2|Overall Study|Adverse Event|1
797183|NCT03083483|2576550|P1|Overall Study|Adverse Event|1
797184|NCT03073798|2576573|P1|Overall Study|Withdrawal by Subject|1
797185|NCT03073798|2576573|P1|Overall Study|Adverse Event|1
797186|NCT03072875|2576584|P1|Overall Study|Lost to Follow-up|1
797187|NCT03072719|2576591|P2|Overall Study|Adverse Event|1
797188|NCT03072719|2576592|P1|Overall Study|Adverse Event|1
797189|NCT03070002|2576738|P1|Follow up for 2 Years|Death|1
797190|NCT03069313|2576744|P1|Overall Study|Adverse Event|5
797191|NCT03065933|2576756|P1|Overall Study|study terminated|5
797192|NCT03061331|2576778|P2|Washout Period (8 Weeks)|Adverse Event|1
797193|NCT03061331|2576779|P1|Washout Period (8 Weeks)|Adverse Event|2
797194|NCT03060512|2576787|P2|Overall Study|Non-compliance with study medication|2
797195|NCT03060512|2576788|P1|Overall Study|Non-compliance with study medication|1
797196|NCT03060512|2576787|P2|Overall Study|Withdrawal by Subject|0
797197|NCT03060512|2576788|P1|Overall Study|Withdrawal by Subject|1
797198|NCT03060512|2576787|P2|Overall Study|Lost to Follow-up|1
797199|NCT03060512|2576788|P1|Overall Study|Lost to Follow-up|1
797200|NCT03060512|2576787|P2|Overall Study|Adverse Event|6
797201|NCT03060512|2576788|P1|Overall Study|Adverse Event|4
797202|NCT03056352|2576831|P1|Overall Study|Lost to Follow-up|1
797203|NCT03055221|2576837|P1|Overall Study|Study terminated by Sponsor|3
797204|NCT03055221|2576837|P1|Overall Study|Physician Decision|1
797205|NCT03055221|2576837|P1|Overall Study|Death|6
797206|NCT03055221|2576837|P1|Overall Study|Withdrawal by Subject|4
797207|NCT03055221|2576837|P1|Overall Study|Adverse Event|2
797208|NCT03048058|2577042|P2|Overall Study|Withdrawal by Subject|4
797209|NCT03048058|2577043|P1|Overall Study|Withdrawal by Subject|0
797210|NCT03048058|2577042|P2|Overall Study|Lost to Follow-up|0
797211|NCT03048058|2577043|P1|Overall Study|Lost to Follow-up|4
797212|NCT03044431|2577118|P1|Overall Study|Lost to Follow-up|59
797213|NCT03037307|2577245|P6|Period 1|Did Not Meet Study Criteria|0
797214|NCT03037307|2577246|P5|Period 1|Did Not Meet Study Criteria|0
797215|NCT03037307|2577247|P4|Period 1|Did Not Meet Study Criteria|1
797216|NCT03037307|2577248|P3|Period 1|Did Not Meet Study Criteria|0
797217|NCT03037307|2577249|P2|Period 1|Did Not Meet Study Criteria|0
797218|NCT03037307|2577250|P1|Period 1|Did Not Meet Study Criteria|0
797219|NCT03035916|2577289|P3|Overall Study|Puncture failed|0
797220|NCT03035916|2577290|P2|Overall Study|Puncture failed|2
797221|NCT03035916|2577291|P1|Overall Study|Puncture failed|0
797222|NCT03034954|2577340|P2|Overall Study|Machine malfunction; did not reach 3 mA|0
797223|NCT03034954|2577341|P1|Overall Study|Machine malfunction; did not reach 3 mA|1
797224|NCT03031899|2577435|P1|Overall Study|lesion disappeared after stopping habit|1
797225|NCT03031899|2577435|P1|Overall Study|Protocol Violation|1
797226|NCT03031496|2577452|P2|Period 1|Withdrawal by Subject|2
797227|NCT03031496|2577453|P1|Period 1|Withdrawal by Subject|0
797228|NCT03031496|2577452|P2|Period 1|Adverse Event|0
797229|NCT03031496|2577453|P1|Period 1|Adverse Event|2
797230|NCT03029650|2577508|P2|Washout (1 Week)|Physician Decision|1
797231|NCT03029650|2577509|P1|Washout (1 Week)|Physician Decision|0
797232|NCT03029650|2577508|P2|Washout (1 Week)|Withdrawal by Subject|1
797233|NCT03029650|2577509|P1|Washout (1 Week)|Withdrawal by Subject|1
797234|NCT03028870|2577548|P4|Overall Study|Administrative|4
797235|NCT03028870|2577549|P3|Overall Study|Administrative|12
797236|NCT03028870|2577550|P2|Overall Study|Administrative|5
797237|NCT03028870|2577551|P1|Overall Study|Administrative|5
797238|NCT03028870|2577548|P4|Overall Study|Lack of Efficacy|0
797239|NCT03028870|2577549|P3|Overall Study|Lack of Efficacy|0
797240|NCT03028870|2577550|P2|Overall Study|Lack of Efficacy|0
797241|NCT03028870|2577551|P1|Overall Study|Lack of Efficacy|3
797242|NCT03028870|2577548|P4|Overall Study|Lost to Follow-up|0
797243|NCT03028870|2577549|P3|Overall Study|Lost to Follow-up|0
797244|NCT03028870|2577550|P2|Overall Study|Lost to Follow-up|0
797245|NCT03028870|2577551|P1|Overall Study|Lost to Follow-up|1
797246|NCT03028870|2577548|P4|Overall Study|Withdrawal by Subject|2
797247|NCT03028870|2577549|P3|Overall Study|Withdrawal by Subject|1
797248|NCT03028870|2577550|P2|Overall Study|Withdrawal by Subject|1
797249|NCT03028870|2577551|P1|Overall Study|Withdrawal by Subject|1
797250|NCT03028870|2577548|P4|Overall Study|Adverse Event|3
797251|NCT03028870|2577549|P3|Overall Study|Adverse Event|3
797252|NCT03028870|2577550|P2|Overall Study|Adverse Event|4
797253|NCT03028870|2577551|P1|Overall Study|Adverse Event|7
797254|NCT03026257|2577661|P6|Overall Study|Withdrawal by Subject|0
797255|NCT03026257|2577662|P5|Overall Study|Withdrawal by Subject|0
797256|NCT03026257|2577663|P4|Overall Study|Withdrawal by Subject|0
797257|NCT03026257|2577664|P3|Overall Study|Withdrawal by Subject|0
797258|NCT03026257|2577665|P2|Overall Study|Withdrawal by Subject|1
797259|NCT03026257|2577666|P1|Overall Study|Withdrawal by Subject|1
797260|NCT03026257|2577661|P6|Overall Study|Protocol Violation|0
797261|NCT03026257|2577662|P5|Overall Study|Protocol Violation|1
797262|NCT03026257|2577663|P4|Overall Study|Protocol Violation|1
797263|NCT03026257|2577664|P3|Overall Study|Protocol Violation|0
797264|NCT03026257|2577665|P2|Overall Study|Protocol Violation|0
797265|NCT03026257|2577666|P1|Overall Study|Protocol Violation|1
797266|NCT03026257|2577661|P6|Overall Study|Lost to Follow-up|0
797267|NCT03026257|2577662|P5|Overall Study|Lost to Follow-up|0
797268|NCT03026257|2577663|P4|Overall Study|Lost to Follow-up|0
797269|NCT03026257|2577664|P3|Overall Study|Lost to Follow-up|0
797270|NCT03026257|2577665|P2|Overall Study|Lost to Follow-up|0
797271|NCT03026257|2577666|P1|Overall Study|Lost to Follow-up|1
797272|NCT03026257|2577661|P6|Overall Study|Adverse Event|0
797273|NCT03026257|2577662|P5|Overall Study|Adverse Event|0
797274|NCT03026257|2577663|P4|Overall Study|Adverse Event|0
797275|NCT03026257|2577664|P3|Overall Study|Adverse Event|0
797276|NCT03026257|2577665|P2|Overall Study|Adverse Event|0
797277|NCT03026257|2577666|P1|Overall Study|Adverse Event|3
797278|NCT03024606|2577682|P2|Overall Study|Withdrawal by Subject|10
797279|NCT03024606|2577683|P1|Overall Study|Withdrawal by Subject|9
797280|NCT03023137|2577757|P2|Overall Study|Lost the baby in a car accident|0
797281|NCT03023137|2577758|P1|Overall Study|Lost the baby in a car accident|1
797282|NCT03023137|2577757|P2|Overall Study|Protocol Violation|4
797283|NCT03023137|2577758|P1|Overall Study|Protocol Violation|0
797284|NCT03023137|2577757|P2|Overall Study|Lost to Follow-up|1
797285|NCT03023137|2577758|P1|Overall Study|Lost to Follow-up|1
797286|NCT03023137|2577757|P2|Overall Study|Multiple pregnancy|4
797287|NCT03023137|2577758|P1|Overall Study|Multiple pregnancy|2
797288|NCT03022422|2577816|P6|Overall Study|3 subjects consented but not vaccinated|0
797289|NCT03022422|2577817|P5|Overall Study|3 subjects consented but not vaccinated|0
797290|NCT03022422|2577818|P4|Overall Study|3 subjects consented but not vaccinated|0
797291|NCT03022422|2577819|P3|Overall Study|3 subjects consented but not vaccinated|3
797292|NCT03022422|2577820|P2|Overall Study|3 subjects consented but not vaccinated|0
797293|NCT03022422|2577821|P1|Overall Study|3 subjects consented but not vaccinated|0
797294|NCT03021304|2577883|P1|Overall Study|Lack of Efficacy|1
797295|NCT03020576|2577890|P2|Overall Study|Withdrawal by Subject|2
797296|NCT03020576|2577891|P1|Overall Study|Withdrawal by Subject|1
797297|NCT03018106|2577978|P2|Overall Study|Lost to Follow-up|1
797298|NCT03018106|2577979|P1|Overall Study|Lost to Follow-up|0
797299|NCT03017612|2577987|P1|Overall Study|Adverse Event|2
797300|NCT03017235|2577997|P2|Overall Study|Cancer, emergency, allergy, active UTI|2
797301|NCT03017235|2577998|P1|Overall Study|Cancer, emergency, allergy, active UTI|4
797302|NCT03017235|2577997|P2|Overall Study|Protocol Violation|1
797303|NCT03017235|2577998|P1|Overall Study|Protocol Violation|2
797304|NCT03017235|2577997|P2|Overall Study|Adverse Event|1
797305|NCT03017235|2577998|P1|Overall Study|Adverse Event|0
797306|NCT03017235|2577997|P2|Overall Study|Lost to Follow-up|7
797307|NCT03017235|2577998|P1|Overall Study|Lost to Follow-up|2
797308|NCT03017235|2577997|P2|Overall Study|Withdrawal by Subject|3
797309|NCT03017235|2577998|P1|Overall Study|Withdrawal by Subject|4
797310|NCT03016078|2578059|P1|Overall Study|Protocol Violation|1
797311|NCT03016078|2578059|P1|Overall Study|Protocol Violation|1
797312|NCT03014674|2578073|P3|Overall Study|Withdrawal by Subject|0
797313|NCT03014674|2578074|P2|Overall Study|Withdrawal by Subject|0
797314|NCT03014674|2578075|P1|Overall Study|Withdrawal by Subject|1
797315|NCT03011099|2578139|P2|Overall Study|Withdrawal by Subject|2
797316|NCT03011099|2578140|P1|Overall Study|Withdrawal by Subject|0
797317|NCT03005067|2578175|P2|Overall Study|Protocol Violation|1
797318|NCT03005067|2578176|P1|Overall Study|Protocol Violation|0
797319|NCT03005067|2578175|P2|Overall Study|Other (reason not specified)|1
797320|NCT03005067|2578176|P1|Overall Study|Other (reason not specified)|3
797321|NCT03005067|2578175|P2|Overall Study|Adverse Event|3
797322|NCT03005067|2578176|P1|Overall Study|Adverse Event|4
797323|NCT03005067|2578175|P2|Overall Study|Withdrawal by Subject|2
797324|NCT03005067|2578176|P1|Overall Study|Withdrawal by Subject|3
797325|NCT03000452|2578371|P1|Follow-Up Period|Withdrawal by Subject|3
797326|NCT03000452|2578371|P1|Follow-Up Period|Death|3
797327|NCT03000452|2578371|P1|Follow-Up Period|Study Terminated by Sponsor|1
797328|NCT03000452|2578371|P1|Treatment Period|Miscellaneous|2
797329|NCT03000452|2578371|P1|Treatment Period|Physician Decision|1
797330|NCT03000452|2578371|P1|Treatment Period|Progressive Disease (PD)|14
797331|NCT03000452|2578371|P1|Treatment Period|Death|1
797332|NCT02992691|2578420|P1|Overall Study|Withdrawal by Subject|1
797333|NCT02992691|2578420|P1|Overall Study|Adverse Event|2
797334|NCT02990910|2578450|P2|Overall Study|Lack of Efficacy|10
797335|NCT02990910|2578451|P1|Overall Study|Lack of Efficacy|6
797336|NCT02988622|2578472|P1|Overall Study|Lost to Follow-up|17
797337|NCT02988219|2578507|P2|Overall Study|Withdrawal by Subject|2
797338|NCT02988219|2578508|P1|Overall Study|Withdrawal by Subject|0
797339|NCT02988219|2578507|P2|Overall Study|Lack of Efficacy|1
797340|NCT02988219|2578508|P1|Overall Study|Lack of Efficacy|1
797341|NCT02987205|2578528|P1|Overall Study|Withdrawal by Subject|3
797342|NCT02987205|2578528|P1|Overall Study|Adverse Event|1
797343|NCT02986854|2578556|P3|Overall Study|Lost to Follow-up|2
797344|NCT02986854|2578557|P2|Overall Study|Lost to Follow-up|11
797345|NCT02986854|2578558|P1|Overall Study|Lost to Follow-up|3
797346|NCT02986854|2578556|P3|Overall Study|Withdrawal by Subject|1
797347|NCT02986854|2578557|P2|Overall Study|Withdrawal by Subject|1
797348|NCT02986854|2578558|P1|Overall Study|Withdrawal by Subject|0
797349|NCT02986139|2578649|P2|Overall Study|Lost to Follow-up|1
797350|NCT02986139|2578650|P1|Overall Study|Lost to Follow-up|0
797351|NCT02986139|2578649|P2|Overall Study|Withdrawal by Subject|1
797352|NCT02986139|2578650|P1|Overall Study|Withdrawal by Subject|0
797353|NCT02986139|2578649|P2|Overall Study|Sponsor Decision|2
797354|NCT02986139|2578650|P1|Overall Study|Sponsor Decision|1
797355|NCT02984267|2578688|P2|Overall Study|Withdrawal by Subject|1
797356|NCT02984267|2578689|P1|Overall Study|Withdrawal by Subject|0
797357|NCT02984267|2578688|P2|Overall Study|Protocol Violation|0
797358|NCT02984267|2578689|P1|Overall Study|Protocol Violation|1
797359|NCT02982863|2578725|P5|Overall Study|Not eligible patients|492
797360|NCT02982863|2578726|P4|Overall Study|Not eligible patients|1400
797361|NCT02982863|2578727|P3|Overall Study|Not eligible patients|1852
797362|NCT02982863|2578728|P2|Overall Study|Not eligible patients|4261
797363|NCT02982863|2578729|P1|Overall Study|Not eligible patients|809
797364|NCT02982018|2578788|P2|Overall Study|Withdrawal by Subject|1
797365|NCT02982018|2578789|P1|Overall Study|Withdrawal by Subject|0
797366|NCT02982018|2578788|P2|Overall Study|Lens Discomfort|0
797367|NCT02982018|2578789|P1|Overall Study|Lens Discomfort|2
797368|NCT02982018|2578788|P2|Overall Study|Adverse Event|1
797369|NCT02982018|2578789|P1|Overall Study|Adverse Event|1
797370|NCT02982018|2578788|P2|Overall Study|Protocol Violation|1
797371|NCT02982018|2578789|P1|Overall Study|Protocol Violation|1
797372|NCT02982018|2578788|P2|Overall Study|Incorrect Lens Dispensed|0
797373|NCT02982018|2578789|P1|Overall Study|Incorrect Lens Dispensed|1
797374|NCT02978833|2578821|P2|Overall Study|Study terminated|1
797375|NCT02978833|2578822|P1|Overall Study|Study terminated|1
797376|NCT02977572|2578840|P2|Overall Study|Exclusion criterion|2
797377|NCT02977572|2578841|P1|Overall Study|Exclusion criterion|2
797378|NCT02977507|2578863|P1|Overall Study|Lost to Follow-up|1
797379|NCT02977507|2578863|P1|Overall Study|Protocol Deviation|1
797380|NCT02974543|2578887|P2|Overall Study|Withdrawal by Subject|0
797381|NCT02974543|2578888|P1|Overall Study|Withdrawal by Subject|1
797382|NCT02974140|2578908|P1|Overall Study|Study Terminated by Sponsor|36
797383|NCT02974140|2578908|P1|Overall Study|Lost to Follow-up|1
797384|NCT02974140|2578908|P1|Overall Study|Adverse Event|2
797385|NCT02974114|2578924|P3|Overall Study|Other (Not specified)|2
797386|NCT02974114|2578925|P2|Overall Study|Other (Not specified)|1
797387|NCT02974114|2578926|P1|Overall Study|Other (Not specified)|0
797388|NCT02973100|2578971|P4|Overall Study|Failed to attend Safety followup period|0
797389|NCT02973100|2578972|P3|Overall Study|Failed to attend Safety followup period|1
797390|NCT02973100|2578973|P2|Overall Study|Failed to attend Safety followup period|0
797391|NCT02973100|2578974|P1|Overall Study|Failed to attend Safety followup period|0
797392|NCT02973100|2578971|P4|Overall Study|Notification of change in address|1
797393|NCT02973100|2578972|P3|Overall Study|Notification of change in address|0
797394|NCT02973100|2578973|P2|Overall Study|Notification of change in address|0
797395|NCT02973100|2578974|P1|Overall Study|Notification of change in address|0
797396|NCT02973100|2578971|P4|Overall Study|Withdrawal by Subject|4
797397|NCT02973100|2578972|P3|Overall Study|Withdrawal by Subject|1
797398|NCT02973100|2578973|P2|Overall Study|Withdrawal by Subject|5
797399|NCT02973100|2578974|P1|Overall Study|Withdrawal by Subject|3
797400|NCT02973100|2578971|P4|Overall Study|Lost to Follow-up|0
797401|NCT02973100|2578972|P3|Overall Study|Lost to Follow-up|1
797402|NCT02973100|2578973|P2|Overall Study|Lost to Follow-up|1
797403|NCT02973100|2578974|P1|Overall Study|Lost to Follow-up|3
797404|NCT02973100|2578971|P4|Overall Study|Adverse Event|2
797405|NCT02973100|2578972|P3|Overall Study|Adverse Event|1
797406|NCT02973100|2578973|P2|Overall Study|Adverse Event|2
797407|NCT02973100|2578974|P1|Overall Study|Adverse Event|1
797408|NCT02972502|2579012|P2|Overall Study|Withdrawal by Subject|1
797409|NCT02972502|2579013|P1|Overall Study|Withdrawal by Subject|1
797410|NCT02972502|2579012|P2|Overall Study|Lost to Follow-up|1
797411|NCT02972502|2579013|P1|Overall Study|Lost to Follow-up|3
797412|NCT02971670|2579027|P4|Overall Study|Withdrawal by Subject|2
797413|NCT02971670|2579028|P3|Overall Study|Withdrawal by Subject|1
797414|NCT02971670|2579029|P2|Overall Study|Withdrawal by Subject|1
797415|NCT02971670|2579030|P1|Overall Study|Withdrawal by Subject|4
797416|NCT02971007|2579051|P3|Overall Study|Patient discontinued study drug|0
797417|NCT02971007|2579052|P2|Overall Study|Patient discontinued study drug|1
797418|NCT02971007|2579053|P1|Overall Study|Patient discontinued study drug|0
797419|NCT02971007|2579051|P3|Overall Study|Patient had yeast at Day 5 visit|0
797420|NCT02971007|2579052|P2|Overall Study|Patient had yeast at Day 5 visit|0
797421|NCT02971007|2579053|P1|Overall Study|Patient had yeast at Day 5 visit|1
797422|NCT02971007|2579051|P3|Overall Study|Withdrawal by Subject|0
797423|NCT02971007|2579052|P2|Overall Study|Withdrawal by Subject|1
797424|NCT02971007|2579053|P1|Overall Study|Withdrawal by Subject|0
797425|NCT02971007|2579051|P3|Overall Study|Lost to Follow-up|1
797426|NCT02971007|2579052|P2|Overall Study|Lost to Follow-up|1
797427|NCT02971007|2579053|P1|Overall Study|Lost to Follow-up|0
797428|NCT02971007|2579051|P3|Overall Study|Adverse Event|0
797429|NCT02971007|2579052|P2|Overall Study|Adverse Event|0
797430|NCT02971007|2579053|P1|Overall Study|Adverse Event|1
797431|NCT02969863|2579070|P6|Overall Study|Physician Decision|0
797432|NCT02969863|2579071|P5|Overall Study|Physician Decision|0
797433|NCT02969863|2579072|P4|Overall Study|Physician Decision|0
797434|NCT02969863|2579073|P3|Overall Study|Physician Decision|0
797435|NCT02969863|2579074|P2|Overall Study|Physician Decision|0
797436|NCT02969863|2579075|P1|Overall Study|Physician Decision|1
797437|NCT02968173|2579089|P1|Overall Study|Withdrawal by Subject|1
797438|NCT02966509|2579177|P2|End of Life Utilization and Cost 15month|Patient Still Alive|48
797439|NCT02966509|2579178|P1|End of Life Utilization and Cost 15month|Patient Still Alive|45
797440|NCT02966509|2579177|P2|End of Life Utilization and Cost 6 Month|Patient Still Alive|75
797441|NCT02966509|2579178|P1|End of Life Utilization and Cost 6 Month|Patient Still Alive|69
797442|NCT02966509|2579177|P2|6 Month Satisfaction Survey|Refused to Answer|11
797443|NCT02966509|2579178|P1|6 Month Satisfaction Survey|Refused to Answer|8
797444|NCT02966509|2579177|P2|6 Month Satisfaction Survey|Lost to Follow-up|1
797445|NCT02966509|2579178|P1|6 Month Satisfaction Survey|Lost to Follow-up|1
797446|NCT02966509|2579177|P2|6 Month Satisfaction Survey|Withdrawal by Subject|3
797447|NCT02966509|2579178|P1|6 Month Satisfaction Survey|Withdrawal by Subject|2
797448|NCT02966509|2579177|P2|6 Month Satisfaction Survey|Death|33
797449|NCT02966509|2579178|P1|6 Month Satisfaction Survey|Death|36
797450|NCT02966509|2579177|P2|6 Month Satisfaction Decision Survey|Refused to Answer|2
797451|NCT02966509|2579178|P1|6 Month Satisfaction Decision Survey|Refused to Answer|0
797452|NCT02966509|2579177|P2|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
797453|NCT02966509|2579178|P1|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
797454|NCT02966509|2579177|P2|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3
797455|NCT02966509|2579178|P1|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2
797456|NCT02966509|2579177|P2|6 Month Satisfaction Decision Survey|Death|25
797457|NCT02966509|2579178|P1|6 Month Satisfaction Decision Survey|Death|22
797458|NCT02966509|2579177|P2|Baseline Satisfaction Survey|Refused to Answer|2
797459|NCT02966509|2579178|P1|Baseline Satisfaction Survey|Refused to Answer|1
797460|NCT02966509|2579177|P2|Baseline Satisfaction Survey|Lost to Follow-up|1
797461|NCT02966509|2579178|P1|Baseline Satisfaction Survey|Lost to Follow-up|1
797462|NCT02966509|2579177|P2|Baseline Satisfaction Survey|Death|1
797463|NCT02966509|2579178|P1|Baseline Satisfaction Survey|Death|0
797464|NCT02966509|2579177|P2|Baseline Satisfaction Survey|Withdrawal by Subject|3
797465|NCT02966509|2579178|P1|Baseline Satisfaction Survey|Withdrawal by Subject|2
797466|NCT02966015|2579239|P2|Inclusion Visit|did not answer questionnaire|3
797467|NCT02966015|2579240|P1|Inclusion Visit|did not answer questionnaire|8
797468|NCT02966002|2579246|P1|Overall Study|Lost to Follow-up|1
797469|NCT02966002|2579246|P1|Overall Study|Adverse Event|1
797470|NCT02966002|2579246|P1|Overall Study|Withdrawal by Subject|2
797471|NCT02965846|2579256|P3|Overall Study|Participants not randomized|33
797472|NCT02965846|2579257|P2|Overall Study|Participants not randomized|0
797473|NCT02965846|2579258|P1|Overall Study|Participants not randomized|0
797474|NCT02965846|2579256|P3|Overall Study|Study Terminated By Sponsor|0
797475|NCT02965846|2579257|P2|Overall Study|Study Terminated By Sponsor|4
797476|NCT02965846|2579258|P1|Overall Study|Study Terminated By Sponsor|4
797477|NCT02965846|2579256|P3|Overall Study|Withdrawal by Subject|0
797478|NCT02965846|2579257|P2|Overall Study|Withdrawal by Subject|1
797479|NCT02965846|2579258|P1|Overall Study|Withdrawal by Subject|0
797480|NCT02965846|2579256|P3|Overall Study|Lost to Follow-up|0
797481|NCT02965846|2579257|P2|Overall Study|Lost to Follow-up|0
797482|NCT02965846|2579258|P1|Overall Study|Lost to Follow-up|1
797483|NCT02965833|2579266|P2|Period 2, Second 30 Days of Wear|Protocol Violation|0
797484|NCT02965833|2579267|P1|Period 2, Second 30 Days of Wear|Protocol Violation|2
797485|NCT02965833|2579266|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
797486|NCT02965833|2579267|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
797487|NCT02965833|2579266|P2|Period 1, First 30 Days of Wear|Protocol Violation|0
797488|NCT02965833|2579267|P1|Period 1, First 30 Days of Wear|Protocol Violation|1
797489|NCT02965833|2579266|P2|Period 1, First 30 Days of Wear|Lost to Follow-up|1
797490|NCT02965833|2579267|P1|Period 1, First 30 Days of Wear|Lost to Follow-up|1
797491|NCT02965833|2579266|P2|Period 1, First 30 Days of Wear|Adverse Event|1
797492|NCT02965833|2579267|P1|Period 1, First 30 Days of Wear|Adverse Event|0
797493|NCT02965820|2579273|P2|Period 2, Second 30 Days|Adverse Event|1
797494|NCT02965820|2579274|P1|Period 2, Second 30 Days|Adverse Event|1
797495|NCT02963701|2579292|P2|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0
797496|NCT02963701|2579293|P1|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1
797497|NCT02962882|2579323|P1|Overall Study|Transfer from ICU|32
797498|NCT02962882|2579323|P1|Overall Study|Withdrawal by Subject|2
797499|NCT02962882|2579323|P1|Overall Study|Adverse Event|2
797500|NCT02961244|2579334|P2|Overall Study|İnadequate data|2
797501|NCT02961244|2579335|P1|Overall Study|İnadequate data|0
797502|NCT02961244|2579334|P2|Overall Study|Lost to Follow-up|2
797503|NCT02961244|2579335|P1|Overall Study|Lost to Follow-up|0
797504|NCT02961244|2579334|P2|Overall Study|Surgery plan change after study approval|2
797505|NCT02961244|2579335|P1|Overall Study|Surgery plan change after study approval|0
797506|NCT02961244|2579334|P2|Overall Study|Withdrawal by Subject|2
797507|NCT02961244|2579335|P1|Overall Study|Withdrawal by Subject|1
797508|NCT02961244|2579334|P2|Overall Study|Protocol Violation|1
797509|NCT02961244|2579335|P1|Overall Study|Protocol Violation|0
797510|NCT02956837|2579460|P4|Overall Study|Lost to Follow-up|0
797511|NCT02956837|2579461|P3|Overall Study|Lost to Follow-up|2
797512|NCT02956837|2579462|P2|Overall Study|Lost to Follow-up|1
797513|NCT02956837|2579463|P1|Overall Study|Lost to Follow-up|0
797514|NCT02956837|2579460|P4|Overall Study|Withdrawal by Subject|3
797515|NCT02956837|2579461|P3|Overall Study|Withdrawal by Subject|0
797516|NCT02956837|2579462|P2|Overall Study|Withdrawal by Subject|1
797517|NCT02956837|2579463|P1|Overall Study|Withdrawal by Subject|0
797518|NCT02956837|2579460|P4|Overall Study|Serious Adverse Events|0
797519|NCT02956837|2579461|P3|Overall Study|Serious Adverse Events|0
797520|NCT02956837|2579462|P2|Overall Study|Serious Adverse Events|1
797521|NCT02956837|2579463|P1|Overall Study|Serious Adverse Events|0
797522|NCT02956460|2579555|P2|Lens 1|Lost to Follow-up|0
797523|NCT02956460|2579556|P1|Lens 1|Lost to Follow-up|1
797524|NCT02954601|2579586|P4|First Intervention (Five Days)|Withdrawal by Subject|0
797525|NCT02954601|2579587|P3|First Intervention (Five Days)|Withdrawal by Subject|1
797526|NCT02954601|2579588|P2|First Intervention (Five Days)|Withdrawal by Subject|0
797527|NCT02954601|2579589|P1|First Intervention (Five Days)|Withdrawal by Subject|0
797528|NCT02952261|2579619|P2|Overall Study|Protocol Violation|0
797529|NCT02952261|2579620|P1|Overall Study|Protocol Violation|1
797530|NCT02952261|2579619|P2|Overall Study|Withdrawal by Subject|5
797531|NCT02952261|2579620|P1|Overall Study|Withdrawal by Subject|4
797532|NCT02951767|2579648|P1|Overall Study|Lost to Follow-up|1
797533|NCT02951767|2579648|P1|Overall Study|Death|59
797534|NCT02951767|2579648|P1|Overall Study|Withdrawal by Subject|5
797535|NCT02951767|2579648|P1|Overall Study|Ongoing at data cutoff 04 July 2016|54
797536|NCT02948582|2579827|P6|Washout Period 4|Adverse Event|0
797537|NCT02948582|2579828|P5|Washout Period 4|Adverse Event|0
797538|NCT02948582|2579829|P4|Washout Period 4|Adverse Event|0
797539|NCT02948582|2579830|P3|Washout Period 4|Adverse Event|1
797540|NCT02948582|2579831|P2|Washout Period 4|Adverse Event|0
797541|NCT02948582|2579832|P1|Washout Period 4|Adverse Event|1
797542|NCT02948582|2579827|P6|Washout Period 2|personal reasons|0
797543|NCT02948582|2579828|P5|Washout Period 2|personal reasons|0
797544|NCT02948582|2579829|P4|Washout Period 2|personal reasons|1
797545|NCT02948582|2579830|P3|Washout Period 2|personal reasons|0
797546|NCT02948582|2579831|P2|Washout Period 2|personal reasons|0
797547|NCT02948582|2579832|P1|Washout Period 2|personal reasons|0
797548|NCT02948582|2579827|P6|Washout Period 2|Adverse Event|0
797549|NCT02948582|2579828|P5|Washout Period 2|Adverse Event|0
797550|NCT02948582|2579829|P4|Washout Period 2|Adverse Event|0
797551|NCT02948582|2579830|P3|Washout Period 2|Adverse Event|0
797552|NCT02948582|2579831|P2|Washout Period 2|Adverse Event|1
797553|NCT02948582|2579832|P1|Washout Period 2|Adverse Event|0
797554|NCT02948582|2579827|P6|Washout Period 1|Protocol Violation|1
797555|NCT02948582|2579828|P5|Washout Period 1|Protocol Violation|0
797556|NCT02948582|2579829|P4|Washout Period 1|Protocol Violation|0
797557|NCT02948582|2579830|P3|Washout Period 1|Protocol Violation|0
797558|NCT02948582|2579831|P2|Washout Period 1|Protocol Violation|0
797559|NCT02948582|2579832|P1|Washout Period 1|Protocol Violation|0
797560|NCT02948582|2579827|P6|Washout Period 1|Adverse Event|0
797561|NCT02948582|2579828|P5|Washout Period 1|Adverse Event|0
797562|NCT02948582|2579829|P4|Washout Period 1|Adverse Event|0
797563|NCT02948582|2579830|P3|Washout Period 1|Adverse Event|0
797564|NCT02948582|2579831|P2|Washout Period 1|Adverse Event|2
797565|NCT02948582|2579832|P1|Washout Period 1|Adverse Event|0
797566|NCT02947022|2579940|P1|Overall Study|Study Stopped|1
797567|NCT02945657|2579963|P1|Overall Study|Withdrawal by Parent/Guardian|3
797568|NCT02945657|2579963|P1|Overall Study|Adverse Event|1
797569|NCT02945254|2579982|P2|Overall Study|Withdrawal by Subject|0
797570|NCT02945254|2579983|P1|Overall Study|Withdrawal by Subject|1
797571|NCT02945254|2579982|P2|Overall Study|Lost to Follow-up|0
797572|NCT02945254|2579983|P1|Overall Study|Lost to Follow-up|1
797573|NCT02940522|2580088|P2|Overall Study|Withdrawal by Subject|0
797574|NCT02940522|2580089|P1|Overall Study|Withdrawal by Subject|1
797575|NCT02940522|2580088|P2|Overall Study|Lost to Follow-up|2
797576|NCT02940522|2580089|P1|Overall Study|Lost to Follow-up|1
797577|NCT02937870|2580138|P1|Overall Study|Protocol Deviation|2
797578|NCT02937870|2580138|P1|Overall Study|Adverse Event|1
797579|NCT02935894|2580182|P1|Overall Study|Subject dismissed|1
797580|NCT02932904|2580238|P4|Overall Study|Randomized But Not Treated|2
797581|NCT02932904|2580239|P3|Overall Study|Randomized But Not Treated|0
797582|NCT02932904|2580240|P2|Overall Study|Randomized But Not Treated|1
797583|NCT02932904|2580241|P1|Overall Study|Randomized But Not Treated|1
797584|NCT02932904|2580238|P4|Overall Study|Pretreatment Event/Adverse Event|3
797585|NCT02932904|2580239|P3|Overall Study|Pretreatment Event/Adverse Event|1
797586|NCT02932904|2580240|P2|Overall Study|Pretreatment Event/Adverse Event|5
797587|NCT02932904|2580241|P1|Overall Study|Pretreatment Event/Adverse Event|3
797588|NCT02932904|2580238|P4|Overall Study|Significant Protocol Deviation|1
797589|NCT02932904|2580239|P3|Overall Study|Significant Protocol Deviation|6
797590|NCT02932904|2580240|P2|Overall Study|Significant Protocol Deviation|3
797591|NCT02932904|2580241|P1|Overall Study|Significant Protocol Deviation|2
797592|NCT02932904|2580238|P4|Overall Study|Lost to Follow-up|0
797593|NCT02932904|2580239|P3|Overall Study|Lost to Follow-up|6
797594|NCT02932904|2580240|P2|Overall Study|Lost to Follow-up|3
797595|NCT02932904|2580241|P1|Overall Study|Lost to Follow-up|5
797596|NCT02932904|2580238|P4|Overall Study|Voluntary Withdrawal|2
797597|NCT02932904|2580239|P3|Overall Study|Voluntary Withdrawal|4
797598|NCT02932904|2580240|P2|Overall Study|Voluntary Withdrawal|1
797599|NCT02932904|2580241|P1|Overall Study|Voluntary Withdrawal|2
797600|NCT02932904|2580238|P4|Overall Study|Study Termination|0
797601|NCT02932904|2580239|P3|Overall Study|Study Termination|0
797602|NCT02932904|2580240|P2|Overall Study|Study Termination|1
797603|NCT02932904|2580241|P1|Overall Study|Study Termination|0
797604|NCT02932904|2580238|P4|Overall Study|Pregnancy|0
797605|NCT02932904|2580239|P3|Overall Study|Pregnancy|1
797606|NCT02932904|2580240|P2|Overall Study|Pregnancy|1
797607|NCT02932904|2580241|P1|Overall Study|Pregnancy|0
797608|NCT02932904|2580238|P4|Overall Study|Noncompliance with Study Drug|4
797609|NCT02932904|2580239|P3|Overall Study|Noncompliance with Study Drug|3
797610|NCT02932904|2580240|P2|Overall Study|Noncompliance with Study Drug|3
797611|NCT02932904|2580241|P1|Overall Study|Noncompliance with Study Drug|2
797612|NCT02932904|2580238|P4|Overall Study|Reason not Specified|2
797613|NCT02932904|2580239|P3|Overall Study|Reason not Specified|2
797614|NCT02932904|2580240|P2|Overall Study|Reason not Specified|0
797615|NCT02932904|2580241|P1|Overall Study|Reason not Specified|1
797616|NCT02927431|2580597|P3|Overall Study|Withdrawal by Subject|1
797617|NCT02927431|2580598|P2|Overall Study|Withdrawal by Subject|0
797618|NCT02927431|2580599|P1|Overall Study|Withdrawal by Subject|0
797619|NCT02926573|2580677|P2|Overall Study|Delirium|1
797620|NCT02926573|2580678|P1|Overall Study|Delirium|0
797621|NCT02926573|2580677|P2|Overall Study|Return to operating room|2
797622|NCT02926573|2580678|P1|Overall Study|Return to operating room|0
797623|NCT02926573|2580677|P2|Overall Study|Withdrawal by Subject|2
797624|NCT02926573|2580678|P1|Overall Study|Withdrawal by Subject|0
797625|NCT02926573|2580677|P2|Overall Study|Change to outpatient status|1
797626|NCT02926573|2580678|P1|Overall Study|Change to outpatient status|5
797627|NCT02926573|2580677|P2|Overall Study|Change in surgery plan|1
797628|NCT02926573|2580678|P1|Overall Study|Change in surgery plan|3
797629|NCT02926573|2580677|P2|Overall Study|Remain intubated|2
797630|NCT02926573|2580678|P1|Overall Study|Remain intubated|2
797631|NCT02926573|2580677|P2|Overall Study|Nausea|0
797632|NCT02926573|2580678|P1|Overall Study|Nausea|1
797633|NCT02923245|2580726|P2|Overall Study|ultrasound order was cancelled|1
797634|NCT02923245|2580727|P1|Overall Study|ultrasound order was cancelled|2
797635|NCT02921425|2580778|P1|Overall Study|Protocol Violation|9
797636|NCT02920957|2580848|P2|Second Intervention: 1 Month|Lost to Follow-up|1
797637|NCT02920957|2580849|P1|Second Intervention: 1 Month|Lost to Follow-up|0
797638|NCT02920957|2580848|P2|First Intervention : 1 Month|Adverse Event|0
797639|NCT02920957|2580849|P1|First Intervention : 1 Month|Adverse Event|1
797640|NCT02920957|2580848|P2|First Intervention : 1 Month|Lost to Follow-up|0
797641|NCT02920957|2580849|P1|First Intervention : 1 Month|Lost to Follow-up|1
797642|NCT02920957|2580848|P2|First Intervention : 1 Month|Withdrawal by Subject|0
797643|NCT02920957|2580849|P1|First Intervention : 1 Month|Withdrawal by Subject|2
797644|NCT02918071|2581041|P1|Overall Study|Lost to Follow-up|1
797645|NCT02918071|2581041|P1|Overall Study|Withdrawal by Subject|2
797646|NCT02915978|2581065|P3|Overall Study|Adverse Event|0
797647|NCT02915978|2581066|P2|Overall Study|Adverse Event|1
797648|NCT02915978|2581067|P1|Overall Study|Adverse Event|2
797649|NCT02915302|2581119|P2|Overall Study|Other|0
797650|NCT02915302|2581120|P1|Overall Study|Other|1
797651|NCT02915302|2581119|P2|Overall Study|Withdrawal by Subject|29
797652|NCT02915302|2581120|P1|Overall Study|Withdrawal by Subject|22
797653|NCT02915302|2581119|P2|Overall Study|Lost to Follow-up|22
797654|NCT02915302|2581120|P1|Overall Study|Lost to Follow-up|19
797655|NCT02915302|2581119|P2|Overall Study|Protocol Violation|27
797656|NCT02915302|2581120|P1|Overall Study|Protocol Violation|20
797657|NCT02915302|2581119|P2|Overall Study|Adverse Event|0
797658|NCT02915302|2581120|P1|Overall Study|Adverse Event|3
797659|NCT02914236|2581130|P1|Overall Study|Lost to Follow-up|1
797660|NCT02912650|2581142|P4|Overall Study|Adverse Event|0
797661|NCT02912650|2581143|P3|Overall Study|Adverse Event|1
797662|NCT02912650|2581144|P2|Overall Study|Adverse Event|0
797663|NCT02912650|2581145|P1|Overall Study|Adverse Event|0
797664|NCT02912650|2581142|P4|Overall Study|Withdrawal by Subject|5
797665|NCT02912650|2581143|P3|Overall Study|Withdrawal by Subject|1
797666|NCT02912650|2581144|P2|Overall Study|Withdrawal by Subject|0
797667|NCT02912650|2581145|P1|Overall Study|Withdrawal by Subject|1
797668|NCT02910739|2581242|P4|Overall Study|Adverse Event|0
797669|NCT02910739|2581243|P3|Overall Study|Adverse Event|0
797670|NCT02910739|2581244|P2|Overall Study|Adverse Event|0
797671|NCT02910739|2581245|P1|Overall Study|Adverse Event|1
797672|NCT02907892|2581301|P2|Overall Study|Lost to Follow-up|40
797673|NCT02907892|2581302|P1|Overall Study|Lost to Follow-up|27
797674|NCT02906917|2581320|P2|Intensification Period (Week 26-38)|Withdrawal by Subject|2
797675|NCT02906917|2581321|P1|Intensification Period (Week 26-38)|Withdrawal by Subject|3
797676|NCT02906917|2581320|P2|Intensification Period (Week 26-38)|Lost to Follow-up|1
797677|NCT02906917|2581321|P1|Intensification Period (Week 26-38)|Lost to Follow-up|3
797678|NCT02906917|2581320|P2|Intensification Period (Week 26-38)|Adverse Event|2
797679|NCT02906917|2581321|P1|Intensification Period (Week 26-38)|Adverse Event|0
797680|NCT02906917|2581320|P2|Intensification Period (Week 26-38)|Unclassified|2
797681|NCT02906917|2581321|P1|Intensification Period (Week 26-38)|Unclassified|3
797682|NCT02906917|2581320|P2|Initiation Period (Week 0-26)|Withdrawal by Subject|4
797683|NCT02906917|2581321|P1|Initiation Period (Week 0-26)|Withdrawal by Subject|3
797684|NCT02906917|2581320|P2|Initiation Period (Week 0-26)|Lost to Follow-up|4
797685|NCT02906917|2581321|P1|Initiation Period (Week 0-26)|Lost to Follow-up|1
797686|NCT02906917|2581320|P2|Initiation Period (Week 0-26)|Adverse Event|0
797687|NCT02906917|2581321|P1|Initiation Period (Week 0-26)|Adverse Event|1
797688|NCT02906917|2581320|P2|Initiation Period (Week 0-26)|Unclassified|3
797689|NCT02906917|2581321|P1|Initiation Period (Week 0-26)|Unclassified|1
797690|NCT02906358|2581382|P2|Overall Study|Lost to Follow-up|15
797691|NCT02906358|2581383|P1|Overall Study|Lost to Follow-up|12
797692|NCT02906358|2581382|P2|Overall Study|Withdrawal by Subject|7
797693|NCT02906358|2581383|P1|Overall Study|Withdrawal by Subject|10
797694|NCT02905825|2581411|P1|Overall Study|Device Malfunction|1
797695|NCT02905825|2581411|P1|Overall Study|Protocol Violation|11
797696|NCT02905331|2581419|P3|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
797697|NCT02905331|2581420|P2|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2
797698|NCT02905331|2581421|P1|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
797699|NCT02905331|2581419|P3|Active Treatment and Follow up (wk16-40)|Other|0
797700|NCT02905331|2581420|P2|Active Treatment and Follow up (wk16-40)|Other|6
797701|NCT02905331|2581421|P1|Active Treatment and Follow up (wk16-40)|Other|0
797702|NCT02905331|2581419|P3|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
797703|NCT02905331|2581420|P2|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1
797704|NCT02905331|2581421|P1|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
797705|NCT02905331|2581419|P3|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
797706|NCT02905331|2581420|P2|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
797707|NCT02905331|2581421|P1|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2
797708|NCT02905331|2581419|P3|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
797709|NCT02905331|2581420|P2|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
797710|NCT02905331|2581421|P1|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1
797711|NCT02903238|2581473|P1|Overall Study|Lost to Follow-up|4
797712|NCT02901054|2581504|P1|Overall Study|Withdrawal by Subject|3
797713|NCT02901054|2581504|P1|Overall Study|Physician Decision|1
797714|NCT02899338|2581510|P2|Overall Study|Withdrawal by Subject|0
797715|NCT02899338|2581511|P1|Overall Study|Withdrawal by Subject|2
797716|NCT02899338|2581510|P2|Overall Study|Adverse Event|2
797717|NCT02899338|2581511|P1|Overall Study|Adverse Event|1
797718|NCT02898116|2581523|P1|Overall Study|Progressive disease|1
797719|NCT02898116|2581523|P1|Overall Study|Adverse Event|1
797720|NCT02896296|2581539|P1|Overall Study|Relocation|1
797721|NCT02896296|2581539|P1|Overall Study|Incarceration|1
797722|NCT02896296|2581539|P1|Overall Study|Site closing|7
797723|NCT02896296|2581539|P1|Overall Study|Withdrawal by Subject|10
797724|NCT02896296|2581539|P1|Overall Study|Physician Decision|2
797725|NCT02896296|2581539|P1|Overall Study|Pregnancy|1
797726|NCT02896296|2581539|P1|Overall Study|Lost to Follow-up|19
797727|NCT02896296|2581539|P1|Overall Study|Adverse Event|1
797728|NCT02895347|2581547|P2|Overall Study|Withdrawal by Subject|1
797729|NCT02895347|2581548|P1|Overall Study|Withdrawal by Subject|3
797730|NCT02894840|2581561|P4|Overall Study|Lost to Follow-up|0
797731|NCT02894840|2581562|P3|Overall Study|Lost to Follow-up|3
797732|NCT02894840|2581563|P2|Overall Study|Lost to Follow-up|0
797733|NCT02894840|2581564|P1|Overall Study|Lost to Follow-up|1
797734|NCT02887989|2581635|P2|Overall Study|Death|0
797735|NCT02887989|2581636|P1|Overall Study|Death|1
797736|NCT02887989|2581635|P2|Overall Study|Withdrawal by Subject|11
797737|NCT02887989|2581636|P1|Overall Study|Withdrawal by Subject|8
797738|NCT02886715|2581649|P3|Overall Study|missing|2
797739|NCT02886715|2581650|P2|Overall Study|missing|2
797740|NCT02886715|2581651|P1|Overall Study|missing|7
797741|NCT02886715|2581649|P3|Overall Study|Withdrawal by Subject|5
797742|NCT02886715|2581650|P2|Overall Study|Withdrawal by Subject|18
797743|NCT02886715|2581651|P1|Overall Study|Withdrawal by Subject|20
797744|NCT02886715|2581649|P3|Overall Study|Protocol Violation|1
797745|NCT02886715|2581650|P2|Overall Study|Protocol Violation|2
797746|NCT02886715|2581651|P1|Overall Study|Protocol Violation|3
797747|NCT02886715|2581649|P3|Overall Study|Pregnancy|1
797748|NCT02886715|2581650|P2|Overall Study|Pregnancy|1
797749|NCT02886715|2581651|P1|Overall Study|Pregnancy|1
797750|NCT02886715|2581649|P3|Overall Study|Lost to Follow-up|10
797751|NCT02886715|2581650|P2|Overall Study|Lost to Follow-up|26
797752|NCT02886715|2581651|P1|Overall Study|Lost to Follow-up|29
797753|NCT02886715|2581649|P3|Overall Study|Lack of Efficacy|1
797754|NCT02886715|2581650|P2|Overall Study|Lack of Efficacy|2
797755|NCT02886715|2581651|P1|Overall Study|Lack of Efficacy|0
797756|NCT02886715|2581649|P3|Overall Study|Adverse Event|0
797757|NCT02886715|2581650|P2|Overall Study|Adverse Event|2
797758|NCT02886715|2581651|P1|Overall Study|Adverse Event|4
797759|NCT02886715|2581649|P3|Overall Study|Non-Compliance With Study Drug|0
797760|NCT02886715|2581650|P2|Overall Study|Non-Compliance With Study Drug|2
797761|NCT02886715|2581651|P1|Overall Study|Non-Compliance With Study Drug|0
797762|NCT02886702|2581668|P3|Overall Study|Administrative Reasons|1
797763|NCT02886702|2581669|P2|Overall Study|Administrative Reasons|0
797764|NCT02886702|2581670|P1|Overall Study|Administrative Reasons|0
797765|NCT02886702|2581668|P3|Overall Study|Adverse Event|3
797766|NCT02886702|2581669|P2|Overall Study|Adverse Event|9
797767|NCT02886702|2581670|P1|Overall Study|Adverse Event|4
797768|NCT02886702|2581668|P3|Overall Study|Lack of Efficacy|5
797769|NCT02886702|2581669|P2|Overall Study|Lack of Efficacy|4
797770|NCT02886702|2581670|P1|Overall Study|Lack of Efficacy|3
797771|NCT02886702|2581668|P3|Overall Study|Lost to Follow-up|8
797772|NCT02886702|2581669|P2|Overall Study|Lost to Follow-up|13
797773|NCT02886702|2581670|P1|Overall Study|Lost to Follow-up|11
797774|NCT02886702|2581668|P3|Overall Study|Non-Compliance With Study Drug|4
797775|NCT02886702|2581669|P2|Overall Study|Non-Compliance With Study Drug|1
797776|NCT02886702|2581670|P1|Overall Study|Non-Compliance With Study Drug|0
797777|NCT02886702|2581668|P3|Overall Study|Protocol Violation|1
797778|NCT02886702|2581669|P2|Overall Study|Protocol Violation|2
797779|NCT02886702|2581670|P1|Overall Study|Protocol Violation|2
797780|NCT02886702|2581668|P3|Overall Study|Significant Worsening of Condition|0
797781|NCT02886702|2581669|P2|Overall Study|Significant Worsening of Condition|1
797782|NCT02886702|2581670|P1|Overall Study|Significant Worsening of Condition|0
797783|NCT02886702|2581668|P3|Overall Study|Withdrawal by Subject|22
797784|NCT02886702|2581669|P2|Overall Study|Withdrawal by Subject|18
797785|NCT02886702|2581670|P1|Overall Study|Withdrawal by Subject|24
797786|NCT02886702|2581668|P3|Overall Study|Not Specified|9
797787|NCT02886702|2581669|P2|Overall Study|Not Specified|3
797788|NCT02886702|2581670|P1|Overall Study|Not Specified|4
797789|NCT02886338|2581684|P1|Overall Study|Withdrawal by Subject|1
797790|NCT02885181|2581692|P4|Overall Study|Withdrawal by Subject|1
797791|NCT02885181|2581693|P3|Overall Study|Withdrawal by Subject|0
797792|NCT02885181|2581694|P2|Overall Study|Withdrawal by Subject|0
797793|NCT02885181|2581695|P1|Overall Study|Withdrawal by Subject|0
797794|NCT02885181|2581692|P4|Overall Study|Adverse Event|1
797795|NCT02885181|2581693|P3|Overall Study|Adverse Event|0
797796|NCT02885181|2581694|P2|Overall Study|Adverse Event|0
797797|NCT02885181|2581695|P1|Overall Study|Adverse Event|0
797798|NCT02885181|2581692|P4|Overall Study|Investigator's Discretion|1
797799|NCT02885181|2581693|P3|Overall Study|Investigator's Discretion|0
797800|NCT02885181|2581694|P2|Overall Study|Investigator's Discretion|1
797801|NCT02885181|2581695|P1|Overall Study|Investigator's Discretion|0
797802|NCT02884089|2581749|P4|Follow-up Visit|Withdrawal by Subject|1
797803|NCT02884089|2581750|P3|Follow-up Visit|Withdrawal by Subject|0
797804|NCT02884089|2581751|P2|Follow-up Visit|Withdrawal by Subject|0
797805|NCT02884089|2581752|P1|Follow-up Visit|Withdrawal by Subject|1
797806|NCT02884089|2581749|P4|Period 4|Lost to Follow-up|0
797807|NCT02884089|2581750|P3|Period 4|Lost to Follow-up|0
797808|NCT02884089|2581751|P2|Period 4|Lost to Follow-up|0
797809|NCT02884089|2581752|P1|Period 4|Lost to Follow-up|1
797810|NCT02884089|2581749|P4|Period 4|Withdrawal by Subject|0
797811|NCT02884089|2581750|P3|Period 4|Withdrawal by Subject|0
797812|NCT02884089|2581751|P2|Period 4|Withdrawal by Subject|1
797813|NCT02884089|2581752|P1|Period 4|Withdrawal by Subject|0
797814|NCT02884089|2581749|P4|Washout Period 3|Lost to Follow-up|1
797815|NCT02884089|2581750|P3|Washout Period 3|Lost to Follow-up|0
797816|NCT02884089|2581751|P2|Washout Period 3|Lost to Follow-up|0
797817|NCT02884089|2581752|P1|Washout Period 3|Lost to Follow-up|0
797818|NCT02884089|2581749|P4|Washout Period 3|Withdrawal by Subject|0
797819|NCT02884089|2581750|P3|Washout Period 3|Withdrawal by Subject|1
797820|NCT02884089|2581751|P2|Washout Period 3|Withdrawal by Subject|0
797821|NCT02884089|2581752|P1|Washout Period 3|Withdrawal by Subject|0
797822|NCT02884089|2581749|P4|Period 3|Withdrawal by Subject|0
797823|NCT02884089|2581750|P3|Period 3|Withdrawal by Subject|1
797824|NCT02884089|2581751|P2|Period 3|Withdrawal by Subject|0
797825|NCT02884089|2581752|P1|Period 3|Withdrawal by Subject|0
797826|NCT02884089|2581749|P4|Period 2|Adverse Event|0
797827|NCT02884089|2581750|P3|Period 2|Adverse Event|0
797828|NCT02884089|2581751|P2|Period 2|Adverse Event|0
797829|NCT02884089|2581752|P1|Period 2|Adverse Event|1
797830|NCT02884089|2581749|P4|Washout Period 1|Withdrawal by Subject|0
797831|NCT02884089|2581750|P3|Washout Period 1|Withdrawal by Subject|0
797832|NCT02884089|2581751|P2|Washout Period 1|Withdrawal by Subject|1
797833|NCT02884089|2581752|P1|Washout Period 1|Withdrawal by Subject|0
797834|NCT02884089|2581749|P4|Washout Period 1|Lost to Follow-up|1
797835|NCT02884089|2581750|P3|Washout Period 1|Lost to Follow-up|0
797836|NCT02884089|2581751|P2|Washout Period 1|Lost to Follow-up|1
797837|NCT02884089|2581752|P1|Washout Period 1|Lost to Follow-up|0
797838|NCT02884089|2581749|P4|Period 1|Dosing error|0
797839|NCT02884089|2581750|P3|Period 1|Dosing error|0
797840|NCT02884089|2581751|P2|Period 1|Dosing error|2
797841|NCT02884089|2581752|P1|Period 1|Dosing error|2
797842|NCT02883244|2581768|P2|Overall Study|Lost to Follow-up|1
797843|NCT02883244|2581769|P1|Overall Study|Lost to Follow-up|0
797844|NCT02882152|2581787|P2|Overall Study|Lost to Follow-up|0
797845|NCT02882152|2581788|P1|Overall Study|Lost to Follow-up|1
797846|NCT02877927|2581905|P2|Overall Study|Missed EOT/PTE Visit|6
797847|NCT02877927|2581906|P1|Overall Study|Missed EOT/PTE Visit|5
797848|NCT02877927|2581905|P2|Overall Study|Physician Decision|1
797849|NCT02877927|2581906|P1|Overall Study|Physician Decision|0
797850|NCT02877927|2581905|P2|Overall Study|Withdrawal by Subject|12
797851|NCT02877927|2581906|P1|Overall Study|Withdrawal by Subject|11
797852|NCT02877927|2581905|P2|Overall Study|Lost to Follow-up|38
797853|NCT02877927|2581906|P1|Overall Study|Lost to Follow-up|37
797854|NCT02877927|2581905|P2|Overall Study|Adverse Event|0
797855|NCT02877927|2581906|P1|Overall Study|Adverse Event|1
797856|NCT02877082|2581935|P1|Overall Study|Trial was closed early|5
797857|NCT02875977|2581958|P2|Overall Study|Lost to Follow-up|29
797858|NCT02875977|2581959|P1|Overall Study|Lost to Follow-up|42
797859|NCT02875340|2581973|P1|Overall Study|Adverse Event|1
797860|NCT02875340|2581973|P1|Overall Study|Physician Decision|3
797861|NCT02875340|2581973|P1|Overall Study|Withdrawal by Subject|2
797862|NCT02875340|2581973|P1|Overall Study|Death|2
797863|NCT02873754|2582006|P1|Overall Study|Couldn't complete study procedures|1
797864|NCT02873754|2582006|P1|Overall Study|Lost to Follow-up|5
797865|NCT02873429|2582041|P2|16 Weeks|Lost to Follow-up|0
797866|NCT02873429|2582042|P1|16 Weeks|Lost to Follow-up|3
797867|NCT02873429|2582041|P2|16 Weeks|Completed 6-8 week, missed 16 week|2
797868|NCT02873429|2582042|P1|16 Weeks|Completed 6-8 week, missed 16 week|2
797869|NCT02873429|2582041|P2|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1
797870|NCT02873429|2582042|P1|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10
797871|NCT02871375|2582098|P2|Period 1, First 14 Days of Wear|Inclusion criteria not met|1
797872|NCT02871375|2582099|P1|Period 1, First 14 Days of Wear|Inclusion criteria not met|0
797873|NCT02868892|2582147|P1|Overall Study|Investigator left site and no follow-up|6
797874|NCT02865083|2582159|P2|Overall Study|Early Termination|1
797875|NCT02865083|2582160|P1|Overall Study|Early Termination|3
797876|NCT02864342|2582198|P2|Overall Study|Adverse Event|0
797877|NCT02864342|2582199|P1|Overall Study|Adverse Event|1
797878|NCT02864342|2582198|P2|Overall Study|Lost Device|0
797879|NCT02864342|2582199|P1|Overall Study|Lost Device|1
797880|NCT02864342|2582198|P2|Overall Study|Lost to Follow-up|5
797881|NCT02864342|2582199|P1|Overall Study|Lost to Follow-up|1
797882|NCT02864342|2582198|P2|Overall Study|Did Not Start Treatment with Symbicort|1
797883|NCT02864342|2582199|P1|Overall Study|Did Not Start Treatment with Symbicort|0
797884|NCT02864342|2582198|P2|Overall Study|Death|1
797885|NCT02864342|2582199|P1|Overall Study|Death|0
797886|NCT02864342|2582198|P2|Overall Study|Device Technology Issue|7
797887|NCT02864342|2582199|P1|Overall Study|Device Technology Issue|6
797888|NCT02864342|2582198|P2|Overall Study|Withdrawal by Subject|2
797889|NCT02864342|2582199|P1|Overall Study|Withdrawal by Subject|4
797890|NCT02864342|2582198|P2|Overall Study|Eligibility Criteria Deviation|3
797891|NCT02864342|2582199|P1|Overall Study|Eligibility Criteria Deviation|2
797892|NCT02862730|2582233|P7|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
797893|NCT02862730|2582234|P6|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
797894|NCT02862730|2582235|P5|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
797895|NCT02862730|2582236|P4|Third Intervention (84 Hours)|diagnosis of gastroparesis|1
797896|NCT02862730|2582237|P3|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
797897|NCT02862730|2582238|P2|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
797898|NCT02862730|2582239|P1|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
797899|NCT02862730|2582233|P7|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
797900|NCT02862730|2582234|P6|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
797901|NCT02862730|2582235|P5|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
797902|NCT02862730|2582236|P4|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
797903|NCT02862730|2582237|P3|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
797904|NCT02862730|2582238|P2|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
797905|NCT02862730|2582239|P1|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
797906|NCT02862730|2582233|P7|Second Intervention (84 Hours)|Withdrawal by Subject|0
797907|NCT02862730|2582234|P6|Second Intervention (84 Hours)|Withdrawal by Subject|0
797908|NCT02862730|2582235|P5|Second Intervention (84 Hours)|Withdrawal by Subject|0
797909|NCT02862730|2582236|P4|Second Intervention (84 Hours)|Withdrawal by Subject|0
797910|NCT02862730|2582237|P3|Second Intervention (84 Hours)|Withdrawal by Subject|0
797911|NCT02862730|2582238|P2|Second Intervention (84 Hours)|Withdrawal by Subject|0
797912|NCT02862730|2582239|P1|Second Intervention (84 Hours)|Withdrawal by Subject|1
797913|NCT02862730|2582233|P7|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
797914|NCT02862730|2582234|P6|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
797915|NCT02862730|2582235|P5|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
797916|NCT02862730|2582236|P4|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
797917|NCT02862730|2582237|P3|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1
797918|NCT02862730|2582238|P2|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
797919|NCT02862730|2582239|P1|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
797920|NCT02862600|2582294|P1|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7
797921|NCT02862600|2582294|P1|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1
797922|NCT02862600|2582294|P1|Period 1--Perhexiline-low Target Range|Protocol Violation|3
797923|NCT02862600|2582294|P1|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9
797924|NCT02862574|2582304|P3|Open-Label Treatment Period|Study Terminated by Sponsor|1
797925|NCT02862574|2582305|P2|Open-Label Treatment Period|Study Terminated by Sponsor|3
797926|NCT02862574|2582306|P1|Open-Label Treatment Period|Study Terminated by Sponsor|2
797927|NCT02862574|2582304|P3|Double-Blind Treatment Period|Study Terminated by Sponsor|4
797928|NCT02862574|2582305|P2|Double-Blind Treatment Period|Study Terminated by Sponsor|1
797929|NCT02862574|2582306|P1|Double-Blind Treatment Period|Study Terminated by Sponsor|3
797930|NCT02862574|2582304|P3|Double-Blind Treatment Period|Adverse Event|0
797931|NCT02862574|2582305|P2|Double-Blind Treatment Period|Adverse Event|1
797932|NCT02862574|2582306|P1|Double-Blind Treatment Period|Adverse Event|0
797933|NCT02862106|2582330|P2|Overall Study|Subjects moved to other city|0
797934|NCT02862106|2582331|P1|Overall Study|Subjects moved to other city|1
797935|NCT02862106|2582330|P2|Overall Study|Withdrawal by Subject|0
797936|NCT02862106|2582331|P1|Overall Study|Withdrawal by Subject|2
797937|NCT02862106|2582330|P2|Overall Study|Lost to Follow-up|5
797938|NCT02862106|2582331|P1|Overall Study|Lost to Follow-up|15
797939|NCT02862106|2582330|P2|Overall Study|Protocol Violation|1
797940|NCT02862106|2582331|P1|Overall Study|Protocol Violation|16
797941|NCT02862106|2582330|P2|Overall Study|Adverse Event|0
797942|NCT02862106|2582331|P1|Overall Study|Adverse Event|4
797943|NCT02861664|2582391|P2|Overall Study|Withdrawal of Consent|1
797944|NCT02861664|2582392|P1|Overall Study|Withdrawal of Consent|0
797945|NCT02856880|2582402|P1|Overall Study|Withdrawal of consent|1
797946|NCT02855541|2582426|P1|Overall Study|Withdrawal by Subject|2
797947|NCT02855541|2582426|P1|Overall Study|Change in health status|2
797948|NCT02855411|2582437|P1|Overall Study|Does not meet entrance criteria|14
797949|NCT02855411|2582437|P1|Overall Study|Study terminated by sponsor|21
797950|NCT02854527|2582478|P10|Overall Study|Lost to Follow-up|0
797951|NCT02854527|2582479|P9|Overall Study|Lost to Follow-up|0
797952|NCT02854527|2582480|P8|Overall Study|Lost to Follow-up|0
797953|NCT02854527|2582481|P7|Overall Study|Lost to Follow-up|0
797954|NCT02854527|2582482|P6|Overall Study|Lost to Follow-up|0
797955|NCT02854527|2582483|P5|Overall Study|Lost to Follow-up|0
797956|NCT02854527|2582484|P4|Overall Study|Lost to Follow-up|1
797957|NCT02854527|2582485|P3|Overall Study|Lost to Follow-up|0
797958|NCT02854527|2582486|P2|Overall Study|Lost to Follow-up|0
797959|NCT02854527|2582487|P1|Overall Study|Lost to Follow-up|0
797960|NCT02854527|2582478|P10|Overall Study|Adverse Event|0
797961|NCT02854527|2582479|P9|Overall Study|Adverse Event|0
797962|NCT02854527|2582480|P8|Overall Study|Adverse Event|0
797963|NCT02854527|2582481|P7|Overall Study|Adverse Event|0
797964|NCT02854527|2582482|P6|Overall Study|Adverse Event|0
797965|NCT02854527|2582483|P5|Overall Study|Adverse Event|1
797966|NCT02854527|2582484|P4|Overall Study|Adverse Event|0
797967|NCT02854527|2582485|P3|Overall Study|Adverse Event|0
797968|NCT02854527|2582486|P2|Overall Study|Adverse Event|0
797969|NCT02854527|2582487|P1|Overall Study|Adverse Event|0
797970|NCT02853435|2582521|P6|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
797971|NCT02853435|2582522|P5|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1
797972|NCT02853435|2582523|P4|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
797973|NCT02853435|2582524|P3|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
797974|NCT02853435|2582525|P2|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
797975|NCT02853435|2582526|P1|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
797976|NCT02852434|2582836|P2|Overall Study|Unsuccessful Dilator Procedure|0
797977|NCT02852434|2582837|P1|Overall Study|Unsuccessful Dilator Procedure|2
797978|NCT02852434|2582836|P2|Overall Study|Withdrawal by Subject|1
797979|NCT02852434|2582837|P1|Overall Study|Withdrawal by Subject|0
797980|NCT02852265|2582853|P2|3-month Follow-up|Lost to Follow-up|1
797981|NCT02852265|2582854|P1|3-month Follow-up|Lost to Follow-up|1
797982|NCT02849678|2582881|P2|Overall Study|Protocol Violation|6
797983|NCT02849678|2582882|P1|Overall Study|Protocol Violation|3
797984|NCT02847637|2582917|P4|Overall Study|First emicizumab dose delayed|0
797985|NCT02847637|2582918|P3|Overall Study|First emicizumab dose delayed|0
797986|NCT02847637|2582919|P2|Overall Study|First emicizumab dose delayed|0
797987|NCT02847637|2582920|P1|Overall Study|First emicizumab dose delayed|1
797988|NCT02847637|2582917|P4|Overall Study|Ongoing treatment with emicizumab|63
797989|NCT02847637|2582918|P3|Overall Study|Ongoing treatment with emicizumab|34
797990|NCT02847637|2582919|P2|Overall Study|Ongoing treatment with emicizumab|35
797991|NCT02847637|2582920|P1|Overall Study|Ongoing treatment with emicizumab|16
797992|NCT02847637|2582917|P4|Overall Study|Withdrew from treatment due to AE|0
797993|NCT02847637|2582918|P3|Overall Study|Withdrew from treatment due to AE|1
797994|NCT02847637|2582919|P2|Overall Study|Withdrew from treatment due to AE|0
797995|NCT02847637|2582920|P1|Overall Study|Withdrew from treatment due to AE|0
797996|NCT02847260|2583032|P1|Overall Study|Physician Decision|1
797997|NCT02847260|2583032|P1|Overall Study|Clinical Deterioration|1
797998|NCT02847260|2583032|P1|Overall Study|Withdrawal by Subject|2
797999|NCT02847260|2583032|P1|Overall Study|Adverse Event|3
798000|NCT02846558|2583083|P4|Overall Study|Lost to Follow-up|0
798001|NCT02846558|2583084|P3|Overall Study|Lost to Follow-up|0
798002|NCT02846558|2583085|P2|Overall Study|Lost to Follow-up|0
798003|NCT02846558|2583086|P1|Overall Study|Lost to Follow-up|2
798004|NCT02846558|2583083|P4|Overall Study|Withdrawal by Subject|2
798005|NCT02846558|2583084|P3|Overall Study|Withdrawal by Subject|2
798006|NCT02846558|2583085|P2|Overall Study|Withdrawal by Subject|4
798007|NCT02846558|2583086|P1|Overall Study|Withdrawal by Subject|5
798008|NCT02846558|2583083|P4|Overall Study|Adverse Event|0
798009|NCT02846558|2583084|P3|Overall Study|Adverse Event|0
798010|NCT02846558|2583085|P2|Overall Study|Adverse Event|0
798011|NCT02846558|2583086|P1|Overall Study|Adverse Event|1
798012|NCT02844543|2583138|P1|Overall Study|Did not meet eligibility criteria|1
798013|NCT02844543|2583138|P1|Overall Study|Withdrawal by Subject|4
798014|NCT02843659|2583148|P3|Overall Study|Adverse Event|0
798015|NCT02843659|2583149|P2|Overall Study|Adverse Event|1
798016|NCT02843659|2583150|P1|Overall Study|Adverse Event|0
798017|NCT02843659|2583148|P3|Overall Study|Administrative Reason by Sponsor|4
798018|NCT02843659|2583149|P2|Overall Study|Administrative Reason by Sponsor|5
798019|NCT02843659|2583150|P1|Overall Study|Administrative Reason by Sponsor|4
798020|NCT02843659|2583148|P3|Overall Study|Subject Withdrew Consent|1
798021|NCT02843659|2583149|P2|Overall Study|Subject Withdrew Consent|0
798022|NCT02843659|2583150|P1|Overall Study|Subject Withdrew Consent|0
798023|NCT02841787|2583218|P3|Overall Study|Withdrawal by Subject|0
798024|NCT02841787|2583219|P2|Overall Study|Withdrawal by Subject|4
798025|NCT02841787|2583220|P1|Overall Study|Withdrawal by Subject|1
798026|NCT02841787|2583218|P3|Overall Study|Symptoms dropped below threshold|0
798027|NCT02841787|2583219|P2|Overall Study|Symptoms dropped below threshold|0
798028|NCT02841787|2583220|P1|Overall Study|Symptoms dropped below threshold|1
798029|NCT02841787|2583218|P3|Overall Study|Lost to Follow-up|0
798030|NCT02841787|2583219|P2|Overall Study|Lost to Follow-up|0
798031|NCT02841787|2583220|P1|Overall Study|Lost to Follow-up|1
798032|NCT02840253|2583247|P1|Overall Study|Unsuccessful block|4
798033|NCT02838901|2583294|P2|Overall Study|Lost to Follow-up|1
798034|NCT02838901|2583295|P1|Overall Study|Lost to Follow-up|1
798035|NCT02838901|2583294|P2|Overall Study|Withdrawal by Subject|1
798036|NCT02838901|2583295|P1|Overall Study|Withdrawal by Subject|1
798037|NCT02837952|2583325|P2|Overall Study|Medication Error|0
798038|NCT02837952|2583326|P1|Overall Study|Medication Error|1
798039|NCT02837952|2583325|P2|Overall Study|Withdrawal by Subject|5
798040|NCT02837952|2583326|P1|Overall Study|Withdrawal by Subject|4
798041|NCT02837952|2583325|P2|Overall Study|Adverse Event|1
798042|NCT02837952|2583326|P1|Overall Study|Adverse Event|0
798043|NCT02836249|2583351|P2|Overall Study|Still on Study|55
798044|NCT02836249|2583352|P1|Overall Study|Still on Study|121
798045|NCT02836249|2583351|P2|Overall Study|Lost to Follow-up|1
798046|NCT02836249|2583352|P1|Overall Study|Lost to Follow-up|0
798047|NCT02836249|2583351|P2|Overall Study|Withdrew Consent|1
798048|NCT02836249|2583352|P1|Overall Study|Withdrew Consent|0
798049|NCT02836249|2583351|P2|Overall Study|Pregnancy|0
798050|NCT02836249|2583352|P1|Overall Study|Pregnancy|2
798051|NCT02836249|2583351|P2|Overall Study|Randomized but Never Treated|1
798052|NCT02836249|2583352|P1|Overall Study|Randomized but Never Treated|0
798053|NCT02836236|2583370|P2|Overall Study|Still on Study|49
798054|NCT02836236|2583371|P1|Overall Study|Still on Study|101
798055|NCT02836236|2583370|P2|Overall Study|Investigator's Discretion|0
798056|NCT02836236|2583371|P1|Overall Study|Investigator's Discretion|1
798057|NCT02836236|2583370|P2|Overall Study|Adverse Event|1
798058|NCT02836236|2583371|P1|Overall Study|Adverse Event|0
798059|NCT02836236|2583370|P2|Overall Study|Withdrew Consent|0
798060|NCT02836236|2583371|P1|Overall Study|Withdrew Consent|2
798061|NCT02836236|2583370|P2|Overall Study|Randomized but Never Treated|0
798062|NCT02836236|2583371|P1|Overall Study|Randomized but Never Treated|1
798063|NCT02832375|2583409|P2|Overall Study|Withdrawal of Consent|0
798064|NCT02832375|2583410|P1|Overall Study|Withdrawal of Consent|1
798065|NCT02832375|2583409|P2|Overall Study|Lost to Follow-up|0
798066|NCT02832375|2583410|P1|Overall Study|Lost to Follow-up|1
798067|NCT02831387|2583439|P2|Overall Study|Discontinued due to stock recovery|1
798068|NCT02831387|2583440|P1|Overall Study|Discontinued due to stock recovery|0
798069|NCT02831387|2583439|P2|Overall Study|Withdrawal by Subject|1
798070|NCT02831387|2583440|P1|Overall Study|Withdrawal by Subject|1
798071|NCT02829996|2583463|P5|Overall Study|Withdrawal by Subject|0
798072|NCT02829996|2583464|P4|Overall Study|Withdrawal by Subject|0
798073|NCT02829996|2583465|P3|Overall Study|Withdrawal by Subject|0
798074|NCT02829996|2583466|P2|Overall Study|Withdrawal by Subject|0
798075|NCT02829996|2583467|P1|Overall Study|Withdrawal by Subject|1
798076|NCT02829775|2583490|P1|Overall Study|Disease remission|1
798077|NCT02829775|2583490|P1|Overall Study|Withdrawal by Subject|3
798078|NCT02829775|2583490|P1|Overall Study|Death|1
798079|NCT02829138|2583566|P2|Overall Study|Withdrawal by Subject|0
798080|NCT02829138|2583567|P1|Overall Study|Withdrawal by Subject|1
798081|NCT02826421|2583605|P4|Overall Study|Reason not given|0
798082|NCT02826421|2583606|P3|Overall Study|Reason not given|1
798083|NCT02826421|2583607|P2|Overall Study|Reason not given|0
798084|NCT02826421|2583608|P1|Overall Study|Reason not given|1
798085|NCT02826421|2583605|P4|Overall Study|Withdrawal by Subject|1
798086|NCT02826421|2583606|P3|Overall Study|Withdrawal by Subject|1
798087|NCT02826421|2583607|P2|Overall Study|Withdrawal by Subject|3
798088|NCT02826421|2583608|P1|Overall Study|Withdrawal by Subject|1
798089|NCT02826421|2583605|P4|Overall Study|Adverse Event|1
798090|NCT02826421|2583606|P3|Overall Study|Adverse Event|0
798091|NCT02826421|2583607|P2|Overall Study|Adverse Event|0
798092|NCT02826421|2583608|P1|Overall Study|Adverse Event|1
798093|NCT02825550|2583620|P1|Overall Study|Physician Decision|1
798094|NCT02825251|2583628|P2|Overall Study|Unclassified|0
798095|NCT02825251|2583629|P1|Overall Study|Unclassified|2
798096|NCT02825251|2583628|P2|Overall Study|Withdrawal by Subject|4
798097|NCT02825251|2583629|P1|Overall Study|Withdrawal by Subject|1
798098|NCT02825251|2583628|P2|Overall Study|Lost to Follow-up|1
798099|NCT02825251|2583629|P1|Overall Study|Lost to Follow-up|0
798100|NCT02825251|2583628|P2|Overall Study|Adverse Event|1
798101|NCT02825251|2583629|P1|Overall Study|Adverse Event|0
798102|NCT02824562|2583832|P2|Overall Study|Death|1
798103|NCT02824562|2583833|P1|Overall Study|Death|0
798104|NCT02824562|2583832|P2|Overall Study|Lost to Follow-up|4
798105|NCT02824562|2583833|P1|Overall Study|Lost to Follow-up|3
798106|NCT02823964|2583840|P1|Overall Study|Withdrawal by Subject|1
798107|NCT02823964|2583840|P1|Overall Study|Lack of Efficacy|1
798108|NCT02823964|2583840|P1|Overall Study|Physician Decision|1
798109|NCT02823964|2583840|P1|Overall Study|Adverse Event|2
798110|NCT02823470|2583854|P2|Overall Study|Study terminated by sponsor|15
798111|NCT02823470|2583855|P1|Overall Study|Study terminated by sponsor|8
798112|NCT02823470|2583854|P2|Overall Study|Adverse Event|0
798113|NCT02823470|2583855|P1|Overall Study|Adverse Event|1
798114|NCT02822794|2583915|P2|Overall Study|Withdrew Consent|0
798115|NCT02822794|2583916|P1|Overall Study|Withdrew Consent|1
798116|NCT02816138|2584038|P1|Overall Study|Adverse Event|1
798117|NCT02815735|2584084|P2|Second Intervention (4 Weeks)|Protocol Violation|0
798118|NCT02815735|2584085|P1|Second Intervention (4 Weeks)|Protocol Violation|1
798119|NCT02815735|2584084|P2|First Intervention (4 Weeks)|Poor fitting characteristics|1
798120|NCT02815735|2584085|P1|First Intervention (4 Weeks)|Poor fitting characteristics|0
798121|NCT02815735|2584084|P2|First Intervention (4 Weeks)|Lost to Follow-up|0
798122|NCT02815735|2584085|P1|First Intervention (4 Weeks)|Lost to Follow-up|1
798123|NCT02815735|2584084|P2|First Intervention (4 Weeks)|Discomfort|0
798124|NCT02815735|2584085|P1|First Intervention (4 Weeks)|Discomfort|1
798125|NCT02815397|2584121|P1|Overall Study|Physician Decision|2
798126|NCT02814643|2584130|P2|Overall Study|Withdrawal by Subject|2
798127|NCT02814643|2584131|P1|Overall Study|Withdrawal by Subject|1
798128|NCT02814643|2584130|P2|Overall Study|Lost to Follow-up|1
798129|NCT02814643|2584131|P1|Overall Study|Lost to Follow-up|0
798130|NCT02809833|2584261|P1|Overall Study|Missing Information|52
798131|NCT02809833|2584261|P1|Overall Study|Not Specified|5
798132|NCT02809833|2584261|P1|Overall Study|Adverse Event (AE)|24
798133|NCT02809833|2584261|P1|Overall Study|Lost to Follow-up|35
798134|NCT02809833|2584261|P1|Overall Study|Withdrawal by Subject|34
798135|NCT02809833|2584261|P1|Overall Study|Noncompliance|1
798136|NCT02809833|2584261|P1|Overall Study|Remission/Treatment No Longer Needed|3
798137|NCT02809833|2584261|P1|Overall Study|Lack of Efficacy|89
798138|NCT02809833|2584261|P1|Overall Study|Intolerance|54
798139|NCT02809833|2584261|P1|Overall Study|Death|3
798140|NCT02806505|2584409|P2|Overall Study|Insufficient therapeutic response|4
798141|NCT02806505|2584410|P1|Overall Study|Insufficient therapeutic response|2
798142|NCT02806505|2584409|P2|Overall Study|Failure to return|1
798143|NCT02806505|2584410|P1|Overall Study|Failure to return|0
798144|NCT02806505|2584409|P2|Overall Study|Did not cooperate/refused treatment|3
798145|NCT02806505|2584410|P1|Overall Study|Did not cooperate/refused treatment|3
798146|NCT02806505|2584409|P2|Overall Study|Death|0
798147|NCT02806505|2584410|P1|Overall Study|Death|4
798148|NCT02806505|2584409|P2|Overall Study|Adverse event/intercurrent illness|3
798149|NCT02806505|2584410|P1|Overall Study|Adverse event/intercurrent illness|1
798150|NCT02805907|2584422|P2|Overall Study|Lost to Follow-up|3
798151|NCT02805907|2584423|P1|Overall Study|Lost to Follow-up|3
798152|NCT02802878|2584437|P2|Overall Study|Protocol Violation|0
798153|NCT02802878|2584438|P1|Overall Study|Protocol Violation|1
798154|NCT02802878|2584437|P2|Overall Study|Withdrawal by Subject|3
798155|NCT02802878|2584438|P1|Overall Study|Withdrawal by Subject|3
798156|NCT02802592|2584452|P1|Overall Study|Study terminated due to loss of funding|4
798157|NCT02801396|2584480|P6|Period 1|Withdrawal by Subject|0
798158|NCT02801396|2584481|P5|Period 1|Withdrawal by Subject|1
798159|NCT02801396|2584482|P4|Period 1|Withdrawal by Subject|0
798160|NCT02801396|2584483|P3|Period 1|Withdrawal by Subject|0
798161|NCT02801396|2584484|P2|Period 1|Withdrawal by Subject|0
798162|NCT02801396|2584485|P1|Period 1|Withdrawal by Subject|0
798163|NCT02799784|2584528|P2|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1
798164|NCT02799784|2584529|P1|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0
798165|NCT02799784|2584528|P2|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1
798166|NCT02799784|2584529|P1|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0
798167|NCT02799784|2584528|P2|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0
798168|NCT02799784|2584529|P1|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1
798169|NCT02799784|2584528|P2|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1
798170|NCT02799784|2584529|P1|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0
798171|NCT02799784|2584528|P2|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0
798172|NCT02799784|2584529|P1|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5
798173|NCT02799784|2584528|P2|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
798174|NCT02799784|2584529|P1|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
798175|NCT02799472|2584537|P2|Overall Study|Lost to Follow-up|1
798176|NCT02799472|2584538|P1|Overall Study|Lost to Follow-up|0
798177|NCT02799472|2584537|P2|Overall Study|Lack of Efficacy|0
798178|NCT02799472|2584538|P1|Overall Study|Lack of Efficacy|2
798179|NCT02799472|2584537|P2|Overall Study|Withdrawal by Subject|4
798180|NCT02799472|2584538|P1|Overall Study|Withdrawal by Subject|2
798181|NCT02799082|2584598|P2|Overall Study|Protocol Violation|1
798182|NCT02799082|2584599|P1|Overall Study|Protocol Violation|0
798183|NCT02799082|2584598|P2|Overall Study|Refused second PDT or withdraw consent|3
798184|NCT02799082|2584599|P1|Overall Study|Refused second PDT or withdraw consent|4
798185|NCT02799069|2584636|P3|Overall Study|Protocol Violation|2
798186|NCT02799069|2584637|P2|Overall Study|Protocol Violation|0
798187|NCT02799069|2584638|P1|Overall Study|Protocol Violation|1
798188|NCT02799069|2584636|P3|Overall Study|Withdrawal by Subject|3
798189|NCT02799069|2584637|P2|Overall Study|Withdrawal by Subject|4
798190|NCT02799069|2584638|P1|Overall Study|Withdrawal by Subject|4
798191|NCT02799069|2584636|P3|Overall Study|Lost to Follow-up|0
798192|NCT02799069|2584637|P2|Overall Study|Lost to Follow-up|1
798193|NCT02799069|2584638|P1|Overall Study|Lost to Follow-up|1
798194|NCT02799069|2584636|P3|Overall Study|Lack of Efficacy|0
798195|NCT02799069|2584637|P2|Overall Study|Lack of Efficacy|0
798196|NCT02799069|2584638|P1|Overall Study|Lack of Efficacy|2
798197|NCT02799069|2584636|P3|Overall Study|Adverse Event|2
798198|NCT02799069|2584637|P2|Overall Study|Adverse Event|2
798199|NCT02799069|2584638|P1|Overall Study|Adverse Event|0
798200|NCT02797522|2584779|P11|Overall Study|Study Terminated by Sponsor|1
798201|NCT02797522|2584780|P10|Overall Study|Study Terminated by Sponsor|4
798202|NCT02797522|2584781|P9|Overall Study|Study Terminated by Sponsor|2
798203|NCT02797522|2584782|P8|Overall Study|Study Terminated by Sponsor|4
798204|NCT02797522|2584783|P7|Overall Study|Study Terminated by Sponsor|0
798205|NCT02797522|2584784|P6|Overall Study|Study Terminated by Sponsor|0
798206|NCT02797522|2584785|P5|Overall Study|Study Terminated by Sponsor|0
798207|NCT02797522|2584786|P4|Overall Study|Study Terminated by Sponsor|0
798208|NCT02797522|2584787|P3|Overall Study|Study Terminated by Sponsor|0
798209|NCT02797522|2584788|P2|Overall Study|Study Terminated by Sponsor|0
798210|NCT02797522|2584789|P1|Overall Study|Study Terminated by Sponsor|0
798211|NCT02797132|2584895|P1|Part B (24 Weeks)|Adverse Event|3
798212|NCT02797132|2584895|P1|Part A (15 Days)|Adverse Event|1
798213|NCT02797080|2584947|P1|Overall Study|Withdrawal by Subject|1
798214|NCT02797080|2584947|P1|Overall Study|Lost to Follow-up|1
798215|NCT02796963|2584989|P4|Overall Study|Lost to Follow-up|72
798216|NCT02796963|2584990|P3|Overall Study|Lost to Follow-up|69
798217|NCT02796963|2584991|P2|Overall Study|Lost to Follow-up|76
798218|NCT02796963|2584992|P1|Overall Study|Lost to Follow-up|89
798219|NCT02796677|2585058|P4|Overall Study|Reason not mentioned|5
798220|NCT02796677|2585059|P3|Overall Study|Reason not mentioned|0
798221|NCT02796677|2585060|P2|Overall Study|Reason not mentioned|3
798222|NCT02796677|2585061|P1|Overall Study|Reason not mentioned|2
798223|NCT02796677|2585058|P4|Overall Study|Progressive disease|18
798224|NCT02796677|2585059|P3|Overall Study|Progressive disease|13
798225|NCT02796677|2585060|P2|Overall Study|Progressive disease|15
798226|NCT02796677|2585061|P1|Overall Study|Progressive disease|6
798227|NCT02796677|2585058|P4|Overall Study|Withdrawal by Subject|7
798228|NCT02796677|2585059|P3|Overall Study|Withdrawal by Subject|6
798229|NCT02796677|2585060|P2|Overall Study|Withdrawal by Subject|14
798230|NCT02796677|2585061|P1|Overall Study|Withdrawal by Subject|4
798231|NCT02796677|2585058|P4|Overall Study|Lack of Efficacy|20
798232|NCT02796677|2585059|P3|Overall Study|Lack of Efficacy|14
798233|NCT02796677|2585060|P2|Overall Study|Lack of Efficacy|9
798234|NCT02796677|2585061|P1|Overall Study|Lack of Efficacy|7
798235|NCT02796677|2585058|P4|Overall Study|Lost to Follow-up|2
798236|NCT02796677|2585059|P3|Overall Study|Lost to Follow-up|2
798237|NCT02796677|2585060|P2|Overall Study|Lost to Follow-up|5
798238|NCT02796677|2585061|P1|Overall Study|Lost to Follow-up|1
798239|NCT02796677|2585058|P4|Overall Study|Protocol Violation|8
798240|NCT02796677|2585059|P3|Overall Study|Protocol Violation|4
798241|NCT02796677|2585060|P2|Overall Study|Protocol Violation|5
798242|NCT02796677|2585061|P1|Overall Study|Protocol Violation|7
798243|NCT02796677|2585058|P4|Overall Study|Adverse Event|14
798244|NCT02796677|2585059|P3|Overall Study|Adverse Event|14
798245|NCT02796677|2585060|P2|Overall Study|Adverse Event|22
798246|NCT02796677|2585061|P1|Overall Study|Adverse Event|11
798247|NCT02796651|2585085|P1|Overall Study|Not specified|10
798248|NCT02796651|2585085|P1|Overall Study|Lack of Efficacy|1
798249|NCT02796651|2585085|P1|Overall Study|Protocol Violation|4
798250|NCT02796651|2585085|P1|Overall Study|Withdrawal by Subject|4
798251|NCT02796651|2585085|P1|Overall Study|Lost to Follow-up|1
798252|NCT02796651|2585085|P1|Overall Study|Adverse Event|6
798253|NCT02794974|2585158|P2|Overall Study|Physician Decision|1
798254|NCT02794974|2585159|P1|Overall Study|Physician Decision|0
798255|NCT02794870|2585175|P2|Overall Study|Withdrawal by Subject|0
798256|NCT02794870|2585176|P1|Overall Study|Withdrawal by Subject|2
798257|NCT02794480|2585212|P4|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
798258|NCT02794480|2585213|P3|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
798259|NCT02794480|2585214|P2|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
798260|NCT02794480|2585215|P1|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
798261|NCT02794480|2585212|P4|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1
798262|NCT02794480|2585213|P3|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
798263|NCT02794480|2585214|P2|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2
798264|NCT02794480|2585215|P1|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
798265|NCT02794480|2585212|P4|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2
798266|NCT02794480|2585213|P3|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
798267|NCT02794480|2585214|P2|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
798268|NCT02794480|2585215|P1|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
798269|NCT02794480|2585212|P4|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
798270|NCT02794480|2585213|P3|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1
798271|NCT02794480|2585214|P2|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
798272|NCT02794480|2585215|P1|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
798273|NCT02794480|2585212|P4|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
798274|NCT02794480|2585213|P3|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1
798275|NCT02794480|2585214|P2|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
798276|NCT02794480|2585215|P1|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
798277|NCT02793947|2585235|P2|Overall Study|Physician Decision|5
798278|NCT02793947|2585236|P1|Overall Study|Physician Decision|1
798279|NCT02793947|2585235|P2|Overall Study|Death|0
798280|NCT02793947|2585236|P1|Overall Study|Death|1
798281|NCT02793232|2585270|P9|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
798282|NCT02793232|2585271|P8|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
798283|NCT02793232|2585272|P7|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
798284|NCT02793232|2585273|P6|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
798285|NCT02793232|2585274|P5|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
798286|NCT02793232|2585275|P4|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
798287|NCT02793232|2585276|P3|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
798288|NCT02793232|2585277|P2|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
798289|NCT02793232|2585278|P1|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
798290|NCT02792062|2585537|P6|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
798291|NCT02792062|2585538|P5|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
798292|NCT02792062|2585539|P4|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
798293|NCT02792062|2585540|P3|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
798294|NCT02792062|2585541|P2|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
798295|NCT02792062|2585542|P1|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1
798296|NCT02791659|2585593|P2|Overall Study|Protocol Violation|1
798297|NCT02791659|2585594|P1|Overall Study|Protocol Violation|0
798298|NCT02791269|2585602|P2|Overall Study|Lost to Follow-up|1
798299|NCT02791269|2585603|P1|Overall Study|Lost to Follow-up|0
798300|NCT02788357|2585636|P2|Overall Study|Lost to Follow-up|0
798301|NCT02788357|2585637|P1|Overall Study|Lost to Follow-up|3
798302|NCT02786927|2585706|P1|Overall Study|Protocol Violation|4
798303|NCT02786927|2585706|P1|Overall Study|Adverse Event|1
798304|NCT02786004|2585729|P2|Overall Study|Withdrawal by Subject|1
798305|NCT02786004|2585730|P1|Overall Study|Withdrawal by Subject|0
798306|NCT02784106|2585827|P4|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
798307|NCT02784106|2585828|P3|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
798308|NCT02784106|2585829|P2|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
798309|NCT02784106|2585830|P1|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
798310|NCT02784106|2585827|P4|Open-Label Extension Period (26 Weeks)|Adverse Event|1
798311|NCT02784106|2585828|P3|Open-Label Extension Period (26 Weeks)|Adverse Event|2
798312|NCT02784106|2585829|P2|Open-Label Extension Period (26 Weeks)|Adverse Event|0
798313|NCT02784106|2585830|P1|Open-Label Extension Period (26 Weeks)|Adverse Event|0
798314|NCT02784106|2585827|P4|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
798315|NCT02784106|2585828|P3|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
798316|NCT02784106|2585829|P2|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
798317|NCT02784106|2585830|P1|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1
798318|NCT02784106|2585827|P4|Double-Blind Treatment Period (12 Weeks)|Not specified|0
798319|NCT02784106|2585828|P3|Double-Blind Treatment Period (12 Weeks)|Not specified|0
798320|NCT02784106|2585829|P2|Double-Blind Treatment Period (12 Weeks)|Not specified|0
798321|NCT02784106|2585830|P1|Double-Blind Treatment Period (12 Weeks)|Not specified|2
798322|NCT02784106|2585827|P4|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
798323|NCT02784106|2585828|P3|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
798324|NCT02784106|2585829|P2|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1
798325|NCT02784106|2585830|P1|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2
798326|NCT02784106|2585827|P4|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
798327|NCT02784106|2585828|P3|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
798328|NCT02784106|2585829|P2|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5
798329|NCT02784106|2585830|P1|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3
798330|NCT02782676|2585891|P2|Overall Study|Lost to Follow-up|1
798331|NCT02782676|2585892|P1|Overall Study|Lost to Follow-up|0
798332|NCT02782169|2585922|P2|Overall Study|Lost to Follow-up|2
798333|NCT02782169|2585923|P1|Overall Study|Lost to Follow-up|1
798334|NCT02781818|2585940|P3|Overall Study|Lost to Follow-up|1
798335|NCT02781818|2585941|P2|Overall Study|Lost to Follow-up|2
798336|NCT02781818|2585942|P1|Overall Study|Lost to Follow-up|4
798337|NCT02781558|2586008|P2|Overall Study|Adverse Event|0
798338|NCT02781558|2586009|P1|Overall Study|Adverse Event|1
798339|NCT02781558|2586008|P2|Overall Study|Lost to Follow-up|2
798340|NCT02781558|2586009|P1|Overall Study|Lost to Follow-up|2
798341|NCT02780700|2586073|P1|Overall Study|Progressive disease|1
798342|NCT02780167|2586146|P5|Overall Study|Other|2
798343|NCT02780167|2586147|P4|Overall Study|Other|1
798344|NCT02780167|2586148|P3|Overall Study|Other|3
798345|NCT02780167|2586149|P2|Overall Study|Other|0
798346|NCT02780167|2586150|P1|Overall Study|Other|0
798347|NCT02780167|2586146|P5|Overall Study|Withdrawal by Subject|4
798348|NCT02780167|2586147|P4|Overall Study|Withdrawal by Subject|3
798349|NCT02780167|2586148|P3|Overall Study|Withdrawal by Subject|4
798350|NCT02780167|2586149|P2|Overall Study|Withdrawal by Subject|4
798351|NCT02780167|2586150|P1|Overall Study|Withdrawal by Subject|6
798352|NCT02780167|2586146|P5|Overall Study|Protocol Violation|2
798353|NCT02780167|2586147|P4|Overall Study|Protocol Violation|1
798354|NCT02780167|2586148|P3|Overall Study|Protocol Violation|1
798355|NCT02780167|2586149|P2|Overall Study|Protocol Violation|5
798356|NCT02780167|2586150|P1|Overall Study|Protocol Violation|5
798357|NCT02780167|2586146|P5|Overall Study|No longer meets eligibility criteria|1
798358|NCT02780167|2586147|P4|Overall Study|No longer meets eligibility criteria|1
798359|NCT02780167|2586148|P3|Overall Study|No longer meets eligibility criteria|0
798360|NCT02780167|2586149|P2|Overall Study|No longer meets eligibility criteria|0
798361|NCT02780167|2586150|P1|Overall Study|No longer meets eligibility criteria|0
798362|NCT02780167|2586146|P5|Overall Study|Does not meet entrance criteria|0
798363|NCT02780167|2586147|P4|Overall Study|Does not meet entrance criteria|0
798364|NCT02780167|2586148|P3|Overall Study|Does not meet entrance criteria|1
798365|NCT02780167|2586149|P2|Overall Study|Does not meet entrance criteria|0
798366|NCT02780167|2586150|P1|Overall Study|Does not meet entrance criteria|0
798367|NCT02780167|2586146|P5|Overall Study|Lost to Follow-up|0
798368|NCT02780167|2586147|P4|Overall Study|Lost to Follow-up|0
798369|NCT02780167|2586148|P3|Overall Study|Lost to Follow-up|1
798370|NCT02780167|2586149|P2|Overall Study|Lost to Follow-up|0
798371|NCT02780167|2586150|P1|Overall Study|Lost to Follow-up|2
798372|NCT02780167|2586146|P5|Overall Study|Lack of Efficacy|0
798373|NCT02780167|2586147|P4|Overall Study|Lack of Efficacy|1
798374|NCT02780167|2586148|P3|Overall Study|Lack of Efficacy|6
798375|NCT02780167|2586149|P2|Overall Study|Lack of Efficacy|5
798376|NCT02780167|2586150|P1|Overall Study|Lack of Efficacy|6
798377|NCT02780167|2586146|P5|Overall Study|Adverse Event|8
798378|NCT02780167|2586147|P4|Overall Study|Adverse Event|12
798379|NCT02780167|2586148|P3|Overall Study|Adverse Event|8
798380|NCT02780167|2586149|P2|Overall Study|Adverse Event|8
798381|NCT02780167|2586150|P1|Overall Study|Adverse Event|9
798382|NCT02777242|2586319|P1|Overall Study|Withdrawal by Subject|1
798383|NCT02777242|2586319|P1|Overall Study|Sponsor's request|1
798384|NCT02777242|2586319|P1|Overall Study|Multiple|1
798385|NCT02777242|2586319|P1|Overall Study|Lost to Follow-up|1
798386|NCT02777242|2586319|P1|Overall Study|Other|2
798387|NCT02777125|2586325|P2|Overall Study|Protocol Violation|12
798388|NCT02777125|2586326|P1|Overall Study|Protocol Violation|8
798389|NCT02777125|2586325|P2|Overall Study|Assent form violation|23
798390|NCT02777125|2586326|P1|Overall Study|Assent form violation|21
798391|NCT02777125|2586325|P2|Overall Study|Consent form violation|12
798392|NCT02777125|2586326|P1|Overall Study|Consent form violation|14
798393|NCT02774278|2586379|P1|Overall Study|Protocol Violation|2
798394|NCT02774278|2586379|P1|Overall Study|Withdrawal by Subject|3
798395|NCT02774278|2586379|P1|Overall Study|Administrative reasons|6
798396|NCT02774278|2586379|P1|Overall Study|Refused treatment/did not cooperate|9
798397|NCT02774278|2586379|P1|Overall Study|Adverse event/intercurrent illness|16
798398|NCT02774278|2586379|P1|Overall Study|Death|29
798399|NCT02774278|2586379|P1|Overall Study|Lack of Efficacy|199
798400|NCT02773446|2586436|P6|First Admission|Lost to Follow-up|0
798401|NCT02773446|2586437|P5|First Admission|Lost to Follow-up|0
798402|NCT02773446|2586438|P4|First Admission|Lost to Follow-up|0
798403|NCT02773446|2586439|P3|First Admission|Lost to Follow-up|0
798404|NCT02773446|2586440|P2|First Admission|Lost to Follow-up|0
798405|NCT02773446|2586441|P1|First Admission|Lost to Follow-up|1
798406|NCT02773446|2586436|P6|First Admission|Withdrawal by Subject|0
798407|NCT02773446|2586437|P5|First Admission|Withdrawal by Subject|0
798408|NCT02773446|2586438|P4|First Admission|Withdrawal by Subject|1
798409|NCT02773446|2586439|P3|First Admission|Withdrawal by Subject|0
798410|NCT02773446|2586440|P2|First Admission|Withdrawal by Subject|0
798411|NCT02773446|2586441|P1|First Admission|Withdrawal by Subject|0
798412|NCT02773368|2586482|P2|Overall Study|Missing|1
798413|NCT02773368|2586483|P1|Overall Study|Missing|0
798414|NCT02773368|2586482|P2|Overall Study|Unclassified|1
798415|NCT02773368|2586483|P1|Overall Study|Unclassified|1
798416|NCT02773368|2586482|P2|Overall Study|Withdrawal by Subject|1
798417|NCT02773368|2586483|P1|Overall Study|Withdrawal by Subject|5
798418|NCT02773368|2586482|P2|Overall Study|Lost to Follow-up|1
798419|NCT02773368|2586483|P1|Overall Study|Lost to Follow-up|4
798420|NCT02771145|2586558|P1|Overall Study|Lost to Follow-up|1
798421|NCT02771145|2586558|P1|Overall Study|Adverse Event|3
798422|NCT02770248|2586612|P2|Overall Study|Randomized in error, prior to treatment|1
798423|NCT02770248|2586613|P1|Overall Study|Randomized in error, prior to treatment|0
798424|NCT02770248|2586612|P2|Overall Study|Adverse Event|1
798425|NCT02770248|2586613|P1|Overall Study|Adverse Event|0
798426|NCT02769858|2586625|P1|Overall Study|Withdrawal by Subject|2
798427|NCT02769247|2586651|P4|Overall Study|Physician Decision|0
798428|NCT02769247|2586652|P3|Overall Study|Physician Decision|0
798429|NCT02769247|2586653|P2|Overall Study|Physician Decision|0
798430|NCT02769247|2586654|P1|Overall Study|Physician Decision|1
798431|NCT02769247|2586651|P4|Overall Study|Protocol Violation|0
798432|NCT02769247|2586652|P3|Overall Study|Protocol Violation|1
798433|NCT02769247|2586653|P2|Overall Study|Protocol Violation|0
798434|NCT02769247|2586654|P1|Overall Study|Protocol Violation|0
798435|NCT02769247|2586651|P4|Overall Study|Withdrawal by Subject|1
798436|NCT02769247|2586652|P3|Overall Study|Withdrawal by Subject|0
798437|NCT02769247|2586653|P2|Overall Study|Withdrawal by Subject|0
798438|NCT02769247|2586654|P1|Overall Study|Withdrawal by Subject|1
798439|NCT02768194|2586692|P6|Period 3|Other (Reason not specified)|0
798440|NCT02768194|2586693|P5|Period 3|Other (Reason not specified)|0
798441|NCT02768194|2586694|P4|Period 3|Other (Reason not specified)|0
798442|NCT02768194|2586695|P3|Period 3|Other (Reason not specified)|0
798443|NCT02768194|2586696|P2|Period 3|Other (Reason not specified)|1
798444|NCT02768194|2586697|P1|Period 3|Other (Reason not specified)|0
798445|NCT02768194|2586692|P6|Period 2|Other (Reason not specified)|0
798446|NCT02768194|2586693|P5|Period 2|Other (Reason not specified)|0
798447|NCT02768194|2586694|P4|Period 2|Other (Reason not specified)|0
798448|NCT02768194|2586695|P3|Period 2|Other (Reason not specified)|0
798449|NCT02768194|2586696|P2|Period 2|Other (Reason not specified)|0
798450|NCT02768194|2586697|P1|Period 2|Other (Reason not specified)|1
798451|NCT02768194|2586692|P6|Period 1|Adverse Event|0
798452|NCT02768194|2586693|P5|Period 1|Adverse Event|0
798453|NCT02768194|2586694|P4|Period 1|Adverse Event|1
798454|NCT02768194|2586695|P3|Period 1|Adverse Event|0
798455|NCT02768194|2586696|P2|Period 1|Adverse Event|0
798456|NCT02768194|2586697|P1|Period 1|Adverse Event|0
798457|NCT02767765|2586714|P1|Overall Study|Withdrawal by Subject|1
798458|NCT02767765|2586714|P1|Overall Study|Non-Compliance|1
798459|NCT02767765|2586714|P1|Overall Study|Investigator decision|1
798460|NCT02767765|2586714|P1|Overall Study|Lost to Follow-up|2
798461|NCT02767765|2586714|P1|Overall Study|Insufficient response|1
798462|NCT02767765|2586714|P1|Overall Study|Death|1
798463|NCT02767765|2586714|P1|Overall Study|Adverse Event|4
798464|NCT02766400|2586725|P2|Overall Study|Withdrawal by Subject|0
798465|NCT02766400|2586726|P1|Overall Study|Withdrawal by Subject|1
798466|NCT02766400|2586725|P2|Overall Study|Death|2
798467|NCT02766400|2586726|P1|Overall Study|Death|1
798468|NCT02766283|2586732|P1|Overall Study|Lost to Follow-up|27
798469|NCT02764697|2586795|P1|Overall Study|Lack of Efficacy|3
798470|NCT02763189|2586802|P2|Overall Study|Device failure|2
798471|NCT02763189|2586803|P1|Overall Study|Device failure|0
798472|NCT02762370|2586813|P2|Overall Study|Protocol Violation|0
798473|NCT02762370|2586814|P1|Overall Study|Protocol Violation|1
798474|NCT02761733|2586836|P4|Overall Study|Cognitive Impairment|0
798475|NCT02761733|2586837|P3|Overall Study|Cognitive Impairment|1
798476|NCT02761733|2586838|P2|Overall Study|Cognitive Impairment|0
798477|NCT02761733|2586839|P1|Overall Study|Cognitive Impairment|5
798478|NCT02761733|2586836|P4|Overall Study|Discharged from Study Site|11
798479|NCT02761733|2586837|P3|Overall Study|Discharged from Study Site|25
798480|NCT02761733|2586838|P2|Overall Study|Discharged from Study Site|9
798481|NCT02761733|2586839|P1|Overall Study|Discharged from Study Site|10
798482|NCT02761733|2586836|P4|Overall Study|Withdrawal by Subject|0
798483|NCT02761733|2586837|P3|Overall Study|Withdrawal by Subject|0
798484|NCT02761733|2586838|P2|Overall Study|Withdrawal by Subject|0
798485|NCT02761733|2586839|P1|Overall Study|Withdrawal by Subject|2
798486|NCT02761733|2586836|P4|Overall Study|Physician Decision|0
798487|NCT02761733|2586837|P3|Overall Study|Physician Decision|0
798488|NCT02761733|2586838|P2|Overall Study|Physician Decision|0
798489|NCT02761733|2586839|P1|Overall Study|Physician Decision|4
798490|NCT02761733|2586836|P4|Overall Study|Lost to Follow-up|3
798491|NCT02761733|2586837|P3|Overall Study|Lost to Follow-up|0
798492|NCT02761733|2586838|P2|Overall Study|Lost to Follow-up|7
798493|NCT02761733|2586839|P1|Overall Study|Lost to Follow-up|6
798494|NCT02761733|2586836|P4|Overall Study|Death|1
798495|NCT02761733|2586837|P3|Overall Study|Death|1
798496|NCT02761733|2586838|P2|Overall Study|Death|5
798497|NCT02761733|2586839|P1|Overall Study|Death|3
798498|NCT02761642|2586869|P1|Overall Study|Reason Unspecified|21
798499|NCT02761642|2586869|P1|Overall Study|Physician Decision|1
798500|NCT02761642|2586869|P1|Overall Study|Lack of Efficacy|20
798501|NCT02761642|2586869|P1|Overall Study|Death|3
798502|NCT02761642|2586869|P1|Overall Study|Non-compliant|7
798503|NCT02761642|2586869|P1|Overall Study|Withdrawal by Subject|2
798504|NCT02761642|2586869|P1|Overall Study|Adverse Event|13
798505|NCT02761642|2586869|P1|Overall Study|Did not Receive Study Treatment|3
798506|NCT02761629|2586882|P2|Overall Study|Randomized But Not Treated|4
798507|NCT02761629|2586883|P1|Overall Study|Randomized But Not Treated|8
798508|NCT02761629|2586882|P2|Overall Study|Lost to Follow-up|1
798509|NCT02761629|2586883|P1|Overall Study|Lost to Follow-up|4
798510|NCT02761629|2586882|P2|Overall Study|Other|2
798511|NCT02761629|2586883|P1|Overall Study|Other|0
798512|NCT02761629|2586882|P2|Overall Study|Withdrawal by Subject|3
798513|NCT02761629|2586883|P1|Overall Study|Withdrawal by Subject|0
798514|NCT02761629|2586882|P2|Overall Study|Protocol Violation|2
798515|NCT02761629|2586883|P1|Overall Study|Protocol Violation|2
798516|NCT02761629|2586882|P2|Overall Study|Did not Cooperate/Refused Treatment|4
798517|NCT02761629|2586883|P1|Overall Study|Did not Cooperate/Refused Treatment|2
798518|NCT02761629|2586882|P2|Overall Study|Failure to Return|4
798519|NCT02761629|2586883|P1|Overall Study|Failure to Return|2
798520|NCT02761629|2586882|P2|Overall Study|Insufficient Therapeutic Response|7
798521|NCT02761629|2586883|P1|Overall Study|Insufficient Therapeutic Response|2
798522|NCT02761629|2586882|P2|Overall Study|Adverse Event/Intercurrent Illness|5
798523|NCT02761629|2586883|P1|Overall Study|Adverse Event/Intercurrent Illness|7
798524|NCT02760927|2586903|P1|Overall Study|Tube Slippage from Device|1
798525|NCT02760810|2586911|P1|Overall Study|Protocol Violation|1
798526|NCT02760654|2586919|P2|Overall Study|Withdrawal by Subject|3
798527|NCT02760654|2586920|P1|Overall Study|Withdrawal by Subject|4
798528|NCT02760654|2586919|P2|Overall Study|Lost to Follow-up|3
798529|NCT02760654|2586920|P1|Overall Study|Lost to Follow-up|3
798530|NCT02760602|2586946|P2|Overall Study|Terminated by sponsor|13
798531|NCT02760602|2586947|P1|Overall Study|Terminated by sponsor|12
798532|NCT02760602|2586946|P2|Overall Study|Withdrawal by Subject|0
798533|NCT02760602|2586947|P1|Overall Study|Withdrawal by Subject|1
798534|NCT02759692|2586996|P2|Period 2|Test article no longer available|1
798535|NCT02759692|2586997|P1|Period 2|Test article no longer available|0
798536|NCT02759692|2586996|P2|Period 2|Lost to Follow-up|0
798537|NCT02759692|2586997|P1|Period 2|Lost to Follow-up|1
798538|NCT02759692|2586996|P2|Period 1|Miss-Randomized|1
798539|NCT02759692|2586997|P1|Period 1|Miss-Randomized|1
798540|NCT02759692|2586996|P2|Period 1|No longer meets eligibility criteria.|0
798541|NCT02759692|2586997|P1|Period 1|No longer meets eligibility criteria.|1
798542|NCT02759692|2586996|P2|Period 1|Test article no longer available|1
798543|NCT02759692|2586997|P1|Period 1|Test article no longer available|1
798544|NCT02759562|2587015|P2|Open-Label Treatment Period|Study Terminated by Sponsor|2
798545|NCT02759562|2587016|P1|Open-Label Treatment Period|Study Terminated by Sponsor|1
798546|NCT02759562|2587015|P2|Open-Label Treatment Period|Withdrew Consent|0
798547|NCT02759562|2587016|P1|Open-Label Treatment Period|Withdrew Consent|1
798548|NCT02759471|2587029|P1|Overall Study|discomfort|2
798549|NCT02759315|2587044|P5|Overall Study|Study terminated prior to completion|1
798550|NCT02759315|2587045|P4|Overall Study|Study terminated prior to completion|0
798551|NCT02759315|2587046|P3|Overall Study|Study terminated prior to completion|5
798552|NCT02759315|2587047|P2|Overall Study|Study terminated prior to completion|0
798553|NCT02759315|2587048|P1|Overall Study|Study terminated prior to completion|2
798554|NCT02759315|2587044|P5|Overall Study|Protocol Violation|0
798555|NCT02759315|2587045|P4|Overall Study|Protocol Violation|0
798556|NCT02759315|2587046|P3|Overall Study|Protocol Violation|0
798557|NCT02759315|2587047|P2|Overall Study|Protocol Violation|1
798558|NCT02759315|2587048|P1|Overall Study|Protocol Violation|0
798559|NCT02759315|2587044|P5|Overall Study|Lost to Follow-up|0
798560|NCT02759315|2587045|P4|Overall Study|Lost to Follow-up|0
798561|NCT02759315|2587046|P3|Overall Study|Lost to Follow-up|4
798562|NCT02759315|2587047|P2|Overall Study|Lost to Follow-up|0
798563|NCT02759315|2587048|P1|Overall Study|Lost to Follow-up|2
798564|NCT02759315|2587044|P5|Overall Study|Death|0
798565|NCT02759315|2587045|P4|Overall Study|Death|0
798566|NCT02759315|2587046|P3|Overall Study|Death|1
798567|NCT02759315|2587047|P2|Overall Study|Death|0
798568|NCT02759315|2587048|P1|Overall Study|Death|0
798569|NCT02759315|2587044|P5|Overall Study|Adverse Event|0
798570|NCT02759315|2587045|P4|Overall Study|Adverse Event|1
798571|NCT02759315|2587046|P3|Overall Study|Adverse Event|0
798572|NCT02759315|2587047|P2|Overall Study|Adverse Event|0
798573|NCT02759315|2587048|P1|Overall Study|Adverse Event|0
798574|NCT02758613|2587096|P4|Treatment|Withdrawal by Subject|0
798575|NCT02758613|2587097|P3|Treatment|Withdrawal by Subject|1
798576|NCT02758613|2587098|P2|Treatment|Withdrawal by Subject|0
798577|NCT02758613|2587099|P1|Treatment|Withdrawal by Subject|1
798578|NCT02758613|2587096|P4|Treatment|Physician and Sponsor Decision|0
798579|NCT02758613|2587097|P3|Treatment|Physician and Sponsor Decision|0
798580|NCT02758613|2587098|P2|Treatment|Physician and Sponsor Decision|0
798581|NCT02758613|2587099|P1|Treatment|Physician and Sponsor Decision|1
798582|NCT02758171|2587126|P2|Wash-out|Other reason|0
798583|NCT02758171|2587127|P1|Wash-out|Other reason|1
798584|NCT02758171|2587126|P2|Wash-out|Withdrawal by Subject|0
798585|NCT02758171|2587127|P1|Wash-out|Withdrawal by Subject|1
798586|NCT02756637|2587183|P2|Overall Study|Did not complete curative therapy|0
798587|NCT02756637|2587184|P1|Overall Study|Did not complete curative therapy|33
798588|NCT02756637|2587183|P2|Overall Study|No available NLR value|44
798589|NCT02756637|2587184|P1|Overall Study|No available NLR value|44
798590|NCT02756637|2587183|P2|Overall Study|Not eligible for initial SWOG study|10
798591|NCT02756637|2587184|P1|Overall Study|Not eligible for initial SWOG study|10
798592|NCT02756338|2587216|P1|Overall Study|Device Replaced with Pacemaker|4
798593|NCT02756338|2587216|P1|Overall Study|Withdrawn by Investigator|1
798594|NCT02756078|2587225|P2|Period 2|Withdrawal by Subject|1
798595|NCT02756078|2587226|P1|Period 2|Withdrawal by Subject|3
798596|NCT02756078|2587225|P2|Period 2|Unsatisfactory Lens Fitting|1
798597|NCT02756078|2587226|P1|Period 2|Unsatisfactory Lens Fitting|0
798598|NCT02756078|2587225|P2|Period 2|Adverse Event|5
798599|NCT02756078|2587226|P1|Period 2|Adverse Event|3
798600|NCT02756078|2587225|P2|Period 1|Lens Discomfort|2
798601|NCT02756078|2587226|P1|Period 1|Lens Discomfort|2
798602|NCT02756078|2587225|P2|Period 1|Withdrawal by Subject|6
798603|NCT02756078|2587226|P1|Period 1|Withdrawal by Subject|6
798604|NCT02756078|2587225|P2|Period 1|Adverse Event|10
798605|NCT02756078|2587226|P1|Period 1|Adverse Event|1
798606|NCT02756078|2587225|P2|Period 1|Protocol Violation|1
798607|NCT02756078|2587226|P1|Period 1|Protocol Violation|0
798608|NCT02756078|2587225|P2|Period 1|Lost to Follow-up|2
798609|NCT02756078|2587226|P1|Period 1|Lost to Follow-up|0
798610|NCT02756078|2587225|P2|Period 1|Unsatisfactory Lens Fitting|1
798611|NCT02756078|2587226|P1|Period 1|Unsatisfactory Lens Fitting|0
798612|NCT02755805|2587251|P2|Overall Study|Withdrawal by Subject|2
798613|NCT02755805|2587252|P1|Overall Study|Withdrawal by Subject|0
798614|NCT02755805|2587251|P2|Overall Study|Refused assessments|0
798615|NCT02755805|2587252|P1|Overall Study|Refused assessments|1
798616|NCT02755805|2587251|P2|Overall Study|Lost to Follow-up|2
798617|NCT02755805|2587252|P1|Overall Study|Lost to Follow-up|1
798618|NCT02755090|2587266|P2|Overall Study|equipment malfunction|0
798619|NCT02755090|2587267|P1|Overall Study|equipment malfunction|1
798620|NCT02754492|2587279|P4|Overall Study|Venous access issues not resulting in AE|4
798621|NCT02754492|2587280|P3|Overall Study|Venous access issues not resulting in AE|0
798622|NCT02754492|2587281|P2|Overall Study|Venous access issues not resulting in AE|0
798623|NCT02754492|2587282|P1|Overall Study|Venous access issues not resulting in AE|0
798624|NCT02754492|2587279|P4|Overall Study|Adverse Event|13
798625|NCT02754492|2587280|P3|Overall Study|Adverse Event|0
798626|NCT02754492|2587281|P2|Overall Study|Adverse Event|0
798627|NCT02754492|2587282|P1|Overall Study|Adverse Event|0
798628|NCT02754492|2587279|P4|Overall Study|Equipment malfuntion|5
798629|NCT02754492|2587280|P3|Overall Study|Equipment malfuntion|2
798630|NCT02754492|2587281|P2|Overall Study|Equipment malfuntion|0
798631|NCT02754492|2587282|P1|Overall Study|Equipment malfuntion|0
798632|NCT02754492|2587279|P4|Overall Study|Withdrawal by Subject|0
798633|NCT02754492|2587280|P3|Overall Study|Withdrawal by Subject|0
798634|NCT02754492|2587281|P2|Overall Study|Withdrawal by Subject|0
798635|NCT02754492|2587282|P1|Overall Study|Withdrawal by Subject|2
798636|NCT02754492|2587279|P4|Overall Study|Protocol Violation|1
798637|NCT02754492|2587280|P3|Overall Study|Protocol Violation|0
798638|NCT02754492|2587281|P2|Overall Study|Protocol Violation|2
798639|NCT02754492|2587282|P1|Overall Study|Protocol Violation|2
798640|NCT02754440|2587298|P4|Overall Study|Subject issues not resulting in AE|12
798641|NCT02754440|2587299|P3|Overall Study|Subject issues not resulting in AE|0
798642|NCT02754440|2587300|P2|Overall Study|Subject issues not resulting in AE|0
798643|NCT02754440|2587301|P1|Overall Study|Subject issues not resulting in AE|0
798644|NCT02754440|2587298|P4|Overall Study|Equipment failure|7
798645|NCT02754440|2587299|P3|Overall Study|Equipment failure|5
798646|NCT02754440|2587300|P2|Overall Study|Equipment failure|5
798647|NCT02754440|2587301|P1|Overall Study|Equipment failure|0
798648|NCT02754440|2587298|P4|Overall Study|Withdrawal by Subject|1
798649|NCT02754440|2587299|P3|Overall Study|Withdrawal by Subject|0
798650|NCT02754440|2587300|P2|Overall Study|Withdrawal by Subject|0
798651|NCT02754440|2587301|P1|Overall Study|Withdrawal by Subject|0
798652|NCT02754440|2587298|P4|Overall Study|Adverse Event|9
798653|NCT02754440|2587299|P3|Overall Study|Adverse Event|0
798654|NCT02754440|2587300|P2|Overall Study|Adverse Event|1
798655|NCT02754440|2587301|P1|Overall Study|Adverse Event|3
798656|NCT02754440|2587298|P4|Overall Study|Protocol Violation|6
798657|NCT02754440|2587299|P3|Overall Study|Protocol Violation|2
798658|NCT02754440|2587300|P2|Overall Study|Protocol Violation|2
798659|NCT02754440|2587301|P1|Overall Study|Protocol Violation|3
798660|NCT02753075|2587383|P3|Overall Study|Physician Decision|0
798661|NCT02753075|2587384|P2|Overall Study|Physician Decision|1
798662|NCT02753075|2587385|P1|Overall Study|Physician Decision|3
798663|NCT02753075|2587383|P3|Overall Study|Withdrawal of Consent|3
798664|NCT02753075|2587384|P2|Overall Study|Withdrawal of Consent|1
798665|NCT02753075|2587385|P1|Overall Study|Withdrawal of Consent|1
798666|NCT02753075|2587383|P3|Overall Study|Lost to Follow-up|0
798667|NCT02753075|2587384|P2|Overall Study|Lost to Follow-up|0
798668|NCT02753075|2587385|P1|Overall Study|Lost to Follow-up|2
798669|NCT02753075|2587383|P3|Overall Study|Adverse Event|0
798670|NCT02753075|2587384|P2|Overall Study|Adverse Event|1
798671|NCT02753075|2587385|P1|Overall Study|Adverse Event|2
798672|NCT02752958|2587410|P1|Overall Study|Other (Reason not specified)|2
798673|NCT02752958|2587410|P1|Overall Study|Withdrawal by Subject|2
798674|NCT02752958|2587410|P1|Overall Study|Protocol Violation|1
798675|NCT02752958|2587410|P1|Overall Study|Lost to Follow-up|1
798676|NCT02752958|2587410|P1|Overall Study|Adverse Event|3
798677|NCT02752802|2587481|P2|Overall Study|Contrast Volume Not Collected|0
798678|NCT02752802|2587482|P1|Overall Study|Contrast Volume Not Collected|1
798679|NCT02752633|2587491|P1|Overall Study|Withdrawal by Subject|1
798680|NCT02751450|2587520|P2|Overall Study|Adverse Event|0
798681|NCT02751450|2587521|P1|Overall Study|Adverse Event|1
798682|NCT02751424|2587542|P9|Part 2|Adverse Event|0
798683|NCT02751424|2587543|P8|Part 2|Adverse Event|5
798684|NCT02751424|2587544|P7|Part 2|Adverse Event|0
798685|NCT02751424|2587545|P6|Part 2|Adverse Event|0
798686|NCT02751424|2587546|P5|Part 2|Adverse Event|0
798687|NCT02751424|2587547|P4|Part 2|Adverse Event|0
798688|NCT02751424|2587548|P3|Part 2|Adverse Event|0
798689|NCT02751424|2587549|P2|Part 2|Adverse Event|0
798690|NCT02751424|2587550|P1|Part 2|Adverse Event|0
798691|NCT02751320|2587693|P1|Overall Study|Withdrawal by Subject|1
798692|NCT02751320|2587693|P1|Overall Study|Adverse Event|2
798693|NCT02750943|2587731|P2|Overall Study|Withdrawal by Subject|7
798694|NCT02750943|2587732|P1|Overall Study|Withdrawal by Subject|5
798695|NCT02750943|2587731|P2|Overall Study|Lost to Follow-up|2
798696|NCT02750943|2587732|P1|Overall Study|Lost to Follow-up|1
798697|NCT02750930|2587746|P1|Overall Study|Study closed/terminated|8
798698|NCT02750813|2587758|P2|Period 1, First 14 Days of Wear|Reason not given|1
798699|NCT02750813|2587759|P1|Period 1, First 14 Days of Wear|Reason not given|0
798700|NCT02750813|2587758|P2|Period 1, First 14 Days of Wear|Withdrawal by Subject|0
798701|NCT02750813|2587759|P1|Period 1, First 14 Days of Wear|Withdrawal by Subject|1
798702|NCT02750709|2587768|P6|Treatment Period 1|Adverse Event|1
798703|NCT02750709|2587769|P5|Treatment Period 1|Adverse Event|0
798704|NCT02750709|2587770|P4|Treatment Period 1|Adverse Event|0
798705|NCT02750709|2587771|P3|Treatment Period 1|Adverse Event|0
798706|NCT02750709|2587772|P2|Treatment Period 1|Adverse Event|0
798707|NCT02750709|2587773|P1|Treatment Period 1|Adverse Event|0
798708|NCT02750501|2587815|P1|Overall Study|Non-compliant use of PERT|1
798709|NCT02750501|2587815|P1|Overall Study|G-tube came out|1
798710|NCT02750501|2587815|P1|Overall Study|Protocol Violation|1
798711|NCT02750501|2587815|P1|Overall Study|Physician Decision|1
798712|NCT02750501|2587815|P1|Overall Study|Adverse Event|4
798713|NCT02750345|2587827|P6|Intervention 1|Adverse Event|0
798714|NCT02750345|2587828|P5|Intervention 1|Adverse Event|1
798715|NCT02750345|2587829|P4|Intervention 1|Adverse Event|0
798716|NCT02750345|2587830|P3|Intervention 1|Adverse Event|0
798717|NCT02750345|2587831|P2|Intervention 1|Adverse Event|0
798718|NCT02750345|2587832|P1|Intervention 1|Adverse Event|0
798719|NCT02750332|2587858|P2|Treatment Period 1|Withdrawal by Subject|1
798720|NCT02750332|2587859|P1|Treatment Period 1|Withdrawal by Subject|0
798721|NCT02749370|2587918|P1|Overall Study|Lost to Follow-up|3
798722|NCT02749370|2587918|P1|Overall Study|Withdrawal by Subject|11
798723|NCT02748213|2588007|P2|Overall Study|Not Specified|29
798724|NCT02748213|2588008|P1|Overall Study|Not Specified|30
798725|NCT02748213|2588007|P2|Overall Study|Failure to Return|0
798726|NCT02748213|2588008|P1|Overall Study|Failure to Return|1
798727|NCT02748213|2588007|P2|Overall Study|Refused Treatment*|6
798728|NCT02748213|2588008|P1|Overall Study|Refused Treatment*|6
798729|NCT02748213|2588007|P2|Overall Study|Protocol Violation|4
798730|NCT02748213|2588008|P1|Overall Study|Protocol Violation|6
798731|NCT02748213|2588007|P2|Overall Study|Violation of Selection Criteria|0
798732|NCT02748213|2588008|P1|Overall Study|Violation of Selection Criteria|2
798733|NCT02748213|2588007|P2|Overall Study|Insufficient Therapeutic Response|57
798734|NCT02748213|2588008|P1|Overall Study|Insufficient Therapeutic Response|56
798735|NCT02748213|2588007|P2|Overall Study|Death|3
798736|NCT02748213|2588008|P1|Overall Study|Death|5
798737|NCT02748213|2588007|P2|Overall Study|Adverse Event or Intercurrent Illness|11
798738|NCT02748213|2588008|P1|Overall Study|Adverse Event or Intercurrent Illness|5
798739|NCT02748213|2588007|P2|Overall Study|Abnormal Laboratory Test|0
798740|NCT02748213|2588008|P1|Overall Study|Abnormal Laboratory Test|1
798741|NCT02748213|2588007|P2|Overall Study|Withdrawal Prior to Treatment|2
798742|NCT02748213|2588008|P1|Overall Study|Withdrawal Prior to Treatment|1
798743|NCT02746679|2588044|P2|Overall Study|Lost to Follow-up|6
798744|NCT02746679|2588045|P1|Overall Study|Lost to Follow-up|4
798745|NCT02745392|2588129|P4|Overall Study|Lost to Follow-up|0
798746|NCT02745392|2588130|P3|Overall Study|Lost to Follow-up|0
798747|NCT02745392|2588131|P2|Overall Study|Lost to Follow-up|1
798748|NCT02745392|2588132|P1|Overall Study|Lost to Follow-up|0
798749|NCT02744066|2588148|P2|Overall Study|Discharged from NICU prior to completion|4
798750|NCT02744066|2588149|P1|Overall Study|Discharged from NICU prior to completion|0
798751|NCT02744066|2588148|P2|Overall Study|Withdrawal by parent|1
798752|NCT02744066|2588149|P1|Overall Study|Withdrawal by parent|0
798753|NCT02743962|2588159|P2|Overall Study|Atrophic vaginitis diagnosed|0
798754|NCT02743962|2588160|P1|Overall Study|Atrophic vaginitis diagnosed|1
798755|NCT02743780|2588195|P5|Part 3 (7 Days)|Adverse Event|0
798756|NCT02743780|2588196|P4|Part 3 (7 Days)|Adverse Event|0
798757|NCT02743780|2588197|P3|Part 3 (7 Days)|Adverse Event|1
798758|NCT02743780|2588198|P2|Part 3 (7 Days)|Adverse Event|0
798759|NCT02743780|2588199|P1|Part 3 (7 Days)|Adverse Event|0
798760|NCT02743117|2588289|P2|Overall Study|Other|0
798761|NCT02743117|2588290|P1|Overall Study|Other|1
798762|NCT02743117|2588289|P2|Overall Study|Lost to Follow-up|1
798763|NCT02743117|2588290|P1|Overall Study|Lost to Follow-up|0
798764|NCT02742818|2588315|P2|Overall Study|Protocol Violation|1
798765|NCT02742818|2588316|P1|Overall Study|Protocol Violation|0
798766|NCT02742818|2588315|P2|Overall Study|Adverse Event|1
798767|NCT02742818|2588316|P1|Overall Study|Adverse Event|0
798768|NCT02742519|2588332|P3|Part 2 Open Label Period (32 Weeks)|Other|1
798769|NCT02742519|2588333|P2|Part 2 Open Label Period (32 Weeks)|Other|0
798770|NCT02742519|2588334|P1|Part 2 Open Label Period (32 Weeks)|Other|0
798771|NCT02742519|2588332|P3|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9
798772|NCT02742519|2588333|P2|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
798773|NCT02742519|2588334|P1|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
798774|NCT02742519|2588332|P3|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0
798775|NCT02742519|2588333|P2|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
798776|NCT02742519|2588334|P1|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
798777|NCT02742441|2588354|P2|Overall Study|Adverse Event|2
798778|NCT02742441|2588355|P1|Overall Study|Adverse Event|0
798779|NCT02742441|2588354|P2|Overall Study|Withdrawal by Subject|2
798780|NCT02742441|2588355|P1|Overall Study|Withdrawal by Subject|2
798781|NCT02742441|2588354|P2|Overall Study|Lost to Follow-up|4
798782|NCT02742441|2588355|P1|Overall Study|Lost to Follow-up|4
798783|NCT02741713|2588373|P2|Overall Study|Surgery type changed intra-operatively|1
798784|NCT02741713|2588374|P1|Overall Study|Surgery type changed intra-operatively|2
798785|NCT02741245|2588438|P5|Overall Study|Withdrawal by Subject|0
798786|NCT02741245|2588439|P4|Overall Study|Withdrawal by Subject|1
798787|NCT02741245|2588440|P3|Overall Study|Withdrawal by Subject|0
798788|NCT02741245|2588441|P2|Overall Study|Withdrawal by Subject|0
798789|NCT02741245|2588442|P1|Overall Study|Withdrawal by Subject|0
798790|NCT02741245|2588438|P5|Overall Study|Protocol Violation|0
798791|NCT02741245|2588439|P4|Overall Study|Protocol Violation|1
798792|NCT02741245|2588440|P3|Overall Study|Protocol Violation|0
798793|NCT02741245|2588441|P2|Overall Study|Protocol Violation|1
798794|NCT02741245|2588442|P1|Overall Study|Protocol Violation|0
798795|NCT02741245|2588438|P5|Overall Study|Adverse Event|2
798796|NCT02741245|2588439|P4|Overall Study|Adverse Event|2
798797|NCT02741245|2588440|P3|Overall Study|Adverse Event|0
798798|NCT02741245|2588441|P2|Overall Study|Adverse Event|0
798799|NCT02741245|2588442|P1|Overall Study|Adverse Event|0
798800|NCT02739997|2588544|P1|Overall Study|Withdrawal by Subject|1
798801|NCT02739997|2588544|P1|Overall Study|Death|1
798802|NCT02739984|2588558|P2|Overall Study|Lost to Follow-up|0
798803|NCT02739984|2588559|P1|Overall Study|Lost to Follow-up|3
798804|NCT02739984|2588558|P2|Overall Study|Death|1
798805|NCT02739984|2588559|P1|Overall Study|Death|0
798806|NCT02739984|2588558|P2|Overall Study|Withdrawal by Subject|1
798807|NCT02739984|2588559|P1|Overall Study|Withdrawal by Subject|1
798808|NCT02739984|2588558|P2|Overall Study|Sponsor Decision|0
798809|NCT02739984|2588559|P1|Overall Study|Sponsor Decision|1
798810|NCT02739594|2588618|P2|Overall Study|Not Specified|2
798811|NCT02739594|2588619|P1|Overall Study|Not Specified|6
798812|NCT02739594|2588618|P2|Overall Study|Elevated Serum Creatinine|1
798813|NCT02739594|2588619|P1|Overall Study|Elevated Serum Creatinine|0
798814|NCT02739594|2588618|P2|Overall Study|Lost to Follow-up|1
798815|NCT02739594|2588619|P1|Overall Study|Lost to Follow-up|0
798816|NCT02739594|2588618|P2|Overall Study|Withdrawal by Subject|1
798817|NCT02739594|2588619|P1|Overall Study|Withdrawal by Subject|1
798818|NCT02739594|2588618|P2|Overall Study|Administrative Reasons|3
798819|NCT02739594|2588619|P1|Overall Study|Administrative Reasons|1
798820|NCT02739594|2588618|P2|Overall Study|Renal Insufficiency|6
798821|NCT02739594|2588619|P1|Overall Study|Renal Insufficiency|4
798822|NCT02739594|2588618|P2|Overall Study|Death|2
798823|NCT02739594|2588619|P1|Overall Study|Death|4
798824|NCT02739594|2588618|P2|Overall Study|Protocol Violation|6
798825|NCT02739594|2588619|P1|Overall Study|Protocol Violation|5
798826|NCT02739594|2588618|P2|Overall Study|Violation of Eligibility Criteria|2
798827|NCT02739594|2588619|P1|Overall Study|Violation of Eligibility Criteria|1
798828|NCT02739594|2588618|P2|Overall Study|Undesired Event|4
798829|NCT02739594|2588619|P1|Overall Study|Undesired Event|3
798830|NCT02739321|2588651|P2|Overall Study|Withdrawal by Subject|2
798831|NCT02739321|2588652|P1|Overall Study|Withdrawal by Subject|1
798832|NCT02739321|2588651|P2|Overall Study|Lost to Follow-up|1
798833|NCT02739321|2588652|P1|Overall Study|Lost to Follow-up|1
798834|NCT02739321|2588651|P2|Overall Study|Lack of Efficacy|1
798835|NCT02739321|2588652|P1|Overall Study|Lack of Efficacy|1
798836|NCT02738333|2588715|P3|Overall Study|Lost to Follow-up|0
798837|NCT02738333|2588716|P2|Overall Study|Lost to Follow-up|0
798838|NCT02738333|2588717|P1|Overall Study|Lost to Follow-up|1
798839|NCT02738333|2588715|P3|Overall Study|Death|0
798840|NCT02738333|2588716|P2|Overall Study|Death|0
798841|NCT02738333|2588717|P1|Overall Study|Death|1
798842|NCT02738203|2588806|P2|Overall Study|Protocol Violation|1
798843|NCT02738203|2588807|P1|Overall Study|Protocol Violation|0
798844|NCT02738203|2588806|P2|Overall Study|Failed IUD Insertion|2
798845|NCT02738203|2588807|P1|Overall Study|Failed IUD Insertion|2
798846|NCT02738151|2588823|P2|Overall Study|Other than specified above|21
798847|NCT02738151|2588824|P1|Overall Study|Other than specified above|11
798848|NCT02738151|2588823|P2|Overall Study|Poor Compliance to Protocol|3
798849|NCT02738151|2588824|P1|Overall Study|Poor Compliance to Protocol|4
798850|NCT02738151|2588823|P2|Overall Study|Hypoglycemia|1
798851|NCT02738151|2588824|P1|Overall Study|Hypoglycemia|0
798852|NCT02738151|2588823|P2|Overall Study|Adverse Event|5
798853|NCT02738151|2588824|P1|Overall Study|Adverse Event|4
798854|NCT02738151|2588823|P2|Overall Study|Randomized but not treated|1
798855|NCT02738151|2588824|P1|Overall Study|Randomized but not treated|4
798856|NCT02738138|2588868|P2|Overall Study|Other - not further specified|0
798857|NCT02738138|2588869|P1|Overall Study|Other - not further specified|1
798858|NCT02738138|2588868|P2|Overall Study|Lost to Follow-up|0
798859|NCT02738138|2588869|P1|Overall Study|Lost to Follow-up|2
798860|NCT02738138|2588868|P2|Overall Study|Adverse Event|1
798861|NCT02738138|2588869|P1|Overall Study|Adverse Event|0
798862|NCT02737852|2588876|P1|Overall Study|Withdrawal by Subject|2
798863|NCT02737618|2588886|P1|Overall Study|Withdrawal by Subject|9
798864|NCT02737592|2588891|P1|Overall Study|Withdrawal by Subject|1
798865|NCT02736721|2588910|P1|Overall Study|Other|5
798866|NCT02736721|2588910|P1|Overall Study|Lost to Follow-up|3
798867|NCT02736721|2588910|P1|Overall Study|Adverse Event|8
798868|NCT02735200|2588932|P2|Overall Study|Withdrawal by Subject|0
798869|NCT02735200|2588933|P1|Overall Study|Withdrawal by Subject|8
798870|NCT02735200|2588932|P2|Overall Study|Lost to Follow-up|5
798871|NCT02735200|2588933|P1|Overall Study|Lost to Follow-up|0
798872|NCT02734810|2588981|P2|Overall Study|Lack of Efficacy|0
798873|NCT02734810|2588982|P1|Overall Study|Lack of Efficacy|1
798874|NCT02734810|2588981|P2|Overall Study|Adverse Event|0
798875|NCT02734810|2588982|P1|Overall Study|Adverse Event|1
798876|NCT02734212|2589023|P2|Overall Study|Lost to Follow-up|10
798877|NCT02734212|2589024|P1|Overall Study|Lost to Follow-up|5
798878|NCT02732639|2589067|P1|Overall Study|Lost to Follow-up|1
798879|NCT02732561|2589080|P2|Overall Study|Withdrawal by Subject|0
798880|NCT02732561|2589081|P1|Overall Study|Withdrawal by Subject|1
798881|NCT02732561|2589080|P2|Overall Study|Lost to Follow-up|1
798882|NCT02732561|2589081|P1|Overall Study|Lost to Follow-up|1
798883|NCT02732327|2589091|P2|Overall Study|Protocol Violation|1
798884|NCT02732327|2589092|P1|Overall Study|Protocol Violation|0
798885|NCT02732210|2589100|P2|Overall Study|Missing|8
798886|NCT02732210|2589101|P1|Overall Study|Missing|0
798887|NCT02732210|2589100|P2|Overall Study|Other|103
798888|NCT02732210|2589101|P1|Overall Study|Other|35
798889|NCT02732210|2589100|P2|Overall Study|Death|15
798890|NCT02732210|2589101|P1|Overall Study|Death|4
798891|NCT02732210|2589100|P2|Overall Study|Lost to Follow-up|57
798892|NCT02732210|2589101|P1|Overall Study|Lost to Follow-up|5
798893|NCT02732210|2589100|P2|Overall Study|Withdrawal by Subject|87
798894|NCT02732210|2589101|P1|Overall Study|Withdrawal by Subject|28
798895|NCT02732210|2589100|P2|Overall Study|Study Ended|13
798896|NCT02732210|2589101|P1|Overall Study|Study Ended|13
798897|NCT02732210|2589100|P2|Overall Study|Site Closed|11
798898|NCT02732210|2589101|P1|Overall Study|Site Closed|0
798899|NCT02731131|2589153|P2|Overall Study|Refused Therapy|1
798900|NCT02731131|2589154|P1|Overall Study|Refused Therapy|0
798901|NCT02731131|2589153|P2|Overall Study|Psychiatric Disorder|1
798902|NCT02731131|2589154|P1|Overall Study|Psychiatric Disorder|0
798903|NCT02730819|2589170|P1|Overall Study|Lost to Follow-up|9
798904|NCT02730728|2589179|P3|Overall Study|Lack of Efficacy|1
798905|NCT02730728|2589180|P2|Overall Study|Lack of Efficacy|1
798906|NCT02730728|2589181|P1|Overall Study|Lack of Efficacy|0
798907|NCT02730728|2589179|P3|Overall Study|Withdrawal by Subject|0
798908|NCT02730728|2589180|P2|Overall Study|Withdrawal by Subject|1
798909|NCT02730728|2589181|P1|Overall Study|Withdrawal by Subject|0
798910|NCT02730598|2589200|P2|Overall Study|Unrelated Injury affecting outcomes.|0
798911|NCT02730598|2589201|P1|Overall Study|Unrelated Injury affecting outcomes.|1
798912|NCT02730598|2589200|P2|Overall Study|Protocol Violation|1
798913|NCT02730598|2589201|P1|Overall Study|Protocol Violation|0
798914|NCT02730598|2589200|P2|Overall Study|Withdrawal by Subject|3
798915|NCT02730598|2589201|P1|Overall Study|Withdrawal by Subject|3
798916|NCT02730351|2589221|P2|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0
798917|NCT02730351|2589222|P1|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1
798918|NCT02730351|2589221|P2|Treatment Period 2 (2 Weeks)|Adverse Event|0
798919|NCT02730351|2589222|P1|Treatment Period 2 (2 Weeks)|Adverse Event|1
798920|NCT02730351|2589221|P2|Wash-out Period (2 Weeks)|Withdrawal by Subject|0
798921|NCT02730351|2589222|P1|Wash-out Period (2 Weeks)|Withdrawal by Subject|1
798922|NCT02730351|2589221|P2|Wash-out Period (2 Weeks)|Protocol Violation|1
798923|NCT02730351|2589222|P1|Wash-out Period (2 Weeks)|Protocol Violation|0
798924|NCT02730351|2589221|P2|Treatment Period 1 (2 Weeks)|Adverse Event|0
798925|NCT02730351|2589222|P1|Treatment Period 1 (2 Weeks)|Adverse Event|1
798926|NCT02729753|2589245|P2|Overall Study|Device Malfunction. No units in stock.|1
798927|NCT02729753|2589246|P1|Overall Study|Device Malfunction. No units in stock.|0
798928|NCT02728089|2589384|P1|Overall Study|Withdrawal by Subject|1
798929|NCT02728089|2589384|P1|Overall Study|Physician Decision|2
798930|NCT02726022|2589474|P1|Overall Study|Treatment Failure and Poor Compliance|1
798931|NCT02726022|2589474|P1|Overall Study|Poor Compliance|13
798932|NCT02726022|2589474|P1|Overall Study|Treatment Failure|8
798933|NCT02726022|2589474|P1|Overall Study|Adverse Event|14
798934|NCT02725788|2589485|P2|Overall Study|Protocol Violation|1
798935|NCT02725788|2589486|P1|Overall Study|Protocol Violation|0
798936|NCT02725788|2589485|P2|Overall Study|Lost to Follow-up|1
798937|NCT02725788|2589486|P1|Overall Study|Lost to Follow-up|1
798938|NCT02724644|2589494|P2|Overall Study|Administrative|0
798939|NCT02724644|2589495|P1|Overall Study|Administrative|1
798940|NCT02724644|2589494|P2|Overall Study|Withdrawal by Subject|1
798941|NCT02724644|2589495|P1|Overall Study|Withdrawal by Subject|7
798942|NCT02724644|2589494|P2|Overall Study|Lost to Follow-up|2
798943|NCT02724644|2589495|P1|Overall Study|Lost to Follow-up|6
798944|NCT02724644|2589494|P2|Overall Study|Adverse Event|1
798945|NCT02724644|2589495|P1|Overall Study|Adverse Event|7
798946|NCT02724111|2589529|P2|Overall Study|Protocol Violation|5
798947|NCT02724111|2589530|P1|Overall Study|Protocol Violation|2
798948|NCT02723201|2589553|P3|Second Intervention Period|Adverse Event|0
798949|NCT02723201|2589554|P2|Second Intervention Period|Adverse Event|0
798950|NCT02723201|2589555|P1|Second Intervention Period|Adverse Event|1
798951|NCT02723201|2589553|P3|Second Intervention Period|Protocol Violation|0
798952|NCT02723201|2589554|P2|Second Intervention Period|Protocol Violation|0
798953|NCT02723201|2589555|P1|Second Intervention Period|Protocol Violation|1
798954|NCT02723188|2589614|P3|Overall Study|Withdrawal by Subject|0
798955|NCT02723188|2589615|P2|Overall Study|Withdrawal by Subject|0
798956|NCT02723188|2589616|P1|Overall Study|Withdrawal by Subject|1
798957|NCT02723175|2589629|P2|Overall Study|Lost to 3 Month Follow Up|1
798958|NCT02723175|2589630|P1|Overall Study|Lost to 3 Month Follow Up|1
798959|NCT02723175|2589629|P2|Overall Study|Lost to 1 Month Follow Up|2
798960|NCT02723175|2589630|P1|Overall Study|Lost to 1 Month Follow Up|3
798961|NCT02722967|2589673|P3|Overall Study|Non-adherence of the patch to the skin|2
798962|NCT02722967|2589674|P2|Overall Study|Non-adherence of the patch to the skin|0
798963|NCT02722967|2589675|P1|Overall Study|Non-adherence of the patch to the skin|0
798964|NCT02722967|2589673|P3|Overall Study|Physician Decision|0
798965|NCT02722967|2589674|P2|Overall Study|Physician Decision|0
798966|NCT02722967|2589675|P1|Overall Study|Physician Decision|1
798967|NCT02722967|2589673|P3|Overall Study|Withdrawal by Subject|1
798968|NCT02722967|2589674|P2|Overall Study|Withdrawal by Subject|0
798969|NCT02722967|2589675|P1|Overall Study|Withdrawal by Subject|1
798970|NCT02722967|2589673|P3|Overall Study|Non-compliance with patch wearing|1
798971|NCT02722967|2589674|P2|Overall Study|Non-compliance with patch wearing|1
798972|NCT02722967|2589675|P1|Overall Study|Non-compliance with patch wearing|2
798973|NCT02722967|2589673|P3|Overall Study|Lost to Follow-up|0
798974|NCT02722967|2589674|P2|Overall Study|Lost to Follow-up|1
798975|NCT02722967|2589675|P1|Overall Study|Lost to Follow-up|0
798976|NCT02722967|2589673|P3|Overall Study|Adverse Event|0
798977|NCT02722967|2589674|P2|Overall Study|Adverse Event|0
798978|NCT02722967|2589675|P1|Overall Study|Adverse Event|1
798979|NCT02722278|2589707|P2|Overall Study|Site closure not study related|1
798980|NCT02722278|2589708|P1|Overall Study|Site closure not study related|0
798981|NCT02722278|2589707|P2|Overall Study|Subject declined after tx assignment|1
798982|NCT02722278|2589708|P1|Overall Study|Subject declined after tx assignment|0
798983|NCT02722278|2589707|P2|Overall Study|High PSA pre-study/ not eligible|1
798984|NCT02722278|2589708|P1|Overall Study|High PSA pre-study/ not eligible|0
798985|NCT02722278|2589707|P2|Overall Study|Protocol Violation|0
798986|NCT02722278|2589708|P1|Overall Study|Protocol Violation|1
798987|NCT02722278|2589707|P2|Overall Study|Lost to Follow-up|0
798988|NCT02722278|2589708|P1|Overall Study|Lost to Follow-up|2
798989|NCT02722278|2589707|P2|Overall Study|Adverse Event|1
798990|NCT02722278|2589708|P1|Overall Study|Adverse Event|4
798991|NCT02722278|2589707|P2|Overall Study|Withdrawal by Subject|3
798992|NCT02722278|2589708|P1|Overall Study|Withdrawal by Subject|5
798993|NCT02722044|2589732|P1|Overall Study|Did Not Meet Criteria at Week 14|1
798994|NCT02722044|2589732|P1|Overall Study|Withdrawal by Subject|1
798995|NCT02722044|2589732|P1|Overall Study|Physician Decision|1
798996|NCT02722044|2589732|P1|Overall Study|Adverse Event|2
798997|NCT02721875|2589761|P2|Overall Study|Progressive disease/relapse|0
798998|NCT02721875|2589762|P1|Overall Study|Progressive disease/relapse|1
798999|NCT02721147|2589813|P3|Overall Study|Lost to Follow-up|0
799000|NCT02721147|2589814|P2|Overall Study|Lost to Follow-up|0
799001|NCT02721147|2589815|P1|Overall Study|Lost to Follow-up|2
799002|NCT02720510|2589861|P2|Overall Study|Physician Decision|2
799003|NCT02720510|2589862|P1|Overall Study|Physician Decision|1
799004|NCT02720510|2589861|P2|Overall Study|Adverse Event|1
799005|NCT02720510|2589862|P1|Overall Study|Adverse Event|0
799006|NCT02720510|2589861|P2|Overall Study|Study Terminated by the sponsor|0
799007|NCT02720510|2589862|P1|Overall Study|Study Terminated by the sponsor|2
799008|NCT02720081|2589882|P2|Overall Study|Protocol Violation|1
799009|NCT02720081|2589883|P1|Overall Study|Protocol Violation|4
799010|NCT02720081|2589882|P2|Overall Study|Adverse Event|3
799011|NCT02720081|2589883|P1|Overall Study|Adverse Event|0
799012|NCT02718898|2589941|P2|Overall Study|Lost to Follow-up|0
799013|NCT02718898|2589942|P1|Overall Study|Lost to Follow-up|2
799014|NCT02718898|2589941|P2|Overall Study|Lack of Efficacy|0
799015|NCT02718898|2589942|P1|Overall Study|Lack of Efficacy|1
799016|NCT02718898|2589941|P2|Overall Study|Physician Decision|0
799017|NCT02718898|2589942|P1|Overall Study|Physician Decision|1
799018|NCT02718898|2589941|P2|Overall Study|Adverse Event|1
799019|NCT02718898|2589942|P1|Overall Study|Adverse Event|5
799020|NCT02717754|2590042|P6|Overall Study|Incorrect Infusion Duration|20
799021|NCT02717754|2590043|P5|Overall Study|Incorrect Infusion Duration|20
799022|NCT02717754|2590044|P4|Overall Study|Incorrect Infusion Duration|10
799023|NCT02717754|2590045|P3|Overall Study|Incorrect Infusion Duration|0
799024|NCT02717754|2590046|P2|Overall Study|Incorrect Infusion Duration|0
799025|NCT02717754|2590047|P1|Overall Study|Incorrect Infusion Duration|0
799026|NCT02716779|2590099|P3|Combination Therapy|Adverse Event|1
799027|NCT02716779|2590100|P2|Combination Therapy|Adverse Event|2
799028|NCT02716779|2590101|P1|Combination Therapy|Adverse Event|0
799029|NCT02716779|2590099|P3|Monotherapy|Adverse Event|1
799030|NCT02716779|2590100|P2|Monotherapy|Adverse Event|1
799031|NCT02716779|2590101|P1|Monotherapy|Adverse Event|0
799032|NCT02716298|2590174|P2|First Intervention (1 Month)|Lens discomfort|1
799033|NCT02716298|2590175|P1|First Intervention (1 Month)|Lens discomfort|1
799034|NCT02716194|2590193|P3|Period 1 - ADVATE|Withdrawal by Subject|0
799035|NCT02716194|2590194|P2|Period 1 - ADVATE|Withdrawal by Subject|1
799036|NCT02716194|2590195|P1|Period 1 - ADVATE|Withdrawal by Subject|1
799037|NCT02714062|2590285|P3|Overall Study|Protocol Violation|0
799038|NCT02714062|2590286|P2|Overall Study|Protocol Violation|1
799039|NCT02714062|2590287|P1|Overall Study|Protocol Violation|0
799040|NCT02714062|2590285|P3|Overall Study|Withdrawal by Subject|1
799041|NCT02714062|2590286|P2|Overall Study|Withdrawal by Subject|0
799042|NCT02714062|2590287|P1|Overall Study|Withdrawal by Subject|1
799043|NCT02714062|2590285|P3|Overall Study|Adverse Event|2
799044|NCT02714062|2590286|P2|Overall Study|Adverse Event|0
799045|NCT02714062|2590287|P1|Overall Study|Adverse Event|0
799046|NCT02713594|2590346|P2|Overall Study|Lost to Follow-up|374
799047|NCT02713594|2590347|P1|Overall Study|Lost to Follow-up|358
799048|NCT02713594|2590346|P2|Overall Study|Withdrawal by Subject|22
799049|NCT02713594|2590347|P1|Overall Study|Withdrawal by Subject|32
799050|NCT02712333|2590365|P2|First Period|Withdrawal by Subject|2
799051|NCT02712333|2590366|P1|First Period|Withdrawal by Subject|3
799052|NCT02712320|2590384|P1|Overall Study|Treating with the prohibited medications|2
799053|NCT02712320|2590384|P1|Overall Study|Transferred to another facility|1
799054|NCT02712320|2590384|P1|Overall Study|Withdrawal by Subject|1
799055|NCT02712320|2590384|P1|Overall Study|Lost to Follow-up|1
799056|NCT02712008|2590427|P8|From Week 12 up to Week 36|Withdrawal by Subject|2
799057|NCT02712008|2590428|P7|From Week 12 up to Week 36|Withdrawal by Subject|3
799058|NCT02712008|2590429|P6|From Week 12 up to Week 36|Withdrawal by Subject|0
799059|NCT02712008|2590430|P5|From Week 12 up to Week 36|Withdrawal by Subject|0
799060|NCT02712008|2590431|P4|From Week 12 up to Week 36|Withdrawal by Subject|0
799061|NCT02712008|2590432|P3|From Week 12 up to Week 36|Withdrawal by Subject|0
799062|NCT02712008|2590433|P2|From Week 12 up to Week 36|Withdrawal by Subject|0
799063|NCT02712008|2590434|P1|From Week 12 up to Week 36|Withdrawal by Subject|0
799064|NCT02712008|2590427|P8|From Week 12 up to Week 36|Physician Decision|0
799065|NCT02712008|2590428|P7|From Week 12 up to Week 36|Physician Decision|0
799066|NCT02712008|2590429|P6|From Week 12 up to Week 36|Physician Decision|0
799067|NCT02712008|2590430|P5|From Week 12 up to Week 36|Physician Decision|1
799068|NCT02712008|2590431|P4|From Week 12 up to Week 36|Physician Decision|1
799069|NCT02712008|2590432|P3|From Week 12 up to Week 36|Physician Decision|0
799070|NCT02712008|2590433|P2|From Week 12 up to Week 36|Physician Decision|0
799071|NCT02712008|2590434|P1|From Week 12 up to Week 36|Physician Decision|0
799072|NCT02712008|2590427|P8|From Week 12 up to Week 36|Lost to Follow-up|0
799073|NCT02712008|2590428|P7|From Week 12 up to Week 36|Lost to Follow-up|1
799074|NCT02712008|2590429|P6|From Week 12 up to Week 36|Lost to Follow-up|0
799075|NCT02712008|2590430|P5|From Week 12 up to Week 36|Lost to Follow-up|0
799076|NCT02712008|2590431|P4|From Week 12 up to Week 36|Lost to Follow-up|1
799077|NCT02712008|2590432|P3|From Week 12 up to Week 36|Lost to Follow-up|0
799078|NCT02712008|2590433|P2|From Week 12 up to Week 36|Lost to Follow-up|0
799079|NCT02712008|2590434|P1|From Week 12 up to Week 36|Lost to Follow-up|0
799080|NCT02712008|2590427|P8|From Week 12 up to Week 36|Death|0
799081|NCT02712008|2590428|P7|From Week 12 up to Week 36|Death|1
799082|NCT02712008|2590429|P6|From Week 12 up to Week 36|Death|0
799083|NCT02712008|2590430|P5|From Week 12 up to Week 36|Death|0
799084|NCT02712008|2590431|P4|From Week 12 up to Week 36|Death|0
799085|NCT02712008|2590432|P3|From Week 12 up to Week 36|Death|0
799086|NCT02712008|2590433|P2|From Week 12 up to Week 36|Death|0
799087|NCT02712008|2590434|P1|From Week 12 up to Week 36|Death|1
799088|NCT02712008|2590427|P8|From Week 12 up to Week 36|Adverse Event|2
799089|NCT02712008|2590428|P7|From Week 12 up to Week 36|Adverse Event|0
799090|NCT02712008|2590429|P6|From Week 12 up to Week 36|Adverse Event|0
799091|NCT02712008|2590430|P5|From Week 12 up to Week 36|Adverse Event|1
799092|NCT02712008|2590431|P4|From Week 12 up to Week 36|Adverse Event|0
799093|NCT02712008|2590432|P3|From Week 12 up to Week 36|Adverse Event|0
799094|NCT02712008|2590433|P2|From Week 12 up to Week 36|Adverse Event|0
799095|NCT02712008|2590434|P1|From Week 12 up to Week 36|Adverse Event|0
799096|NCT02712008|2590427|P8|Baseline (Day 1) up to Week 12|Other Unspecified|0
799097|NCT02712008|2590428|P7|Baseline (Day 1) up to Week 12|Other Unspecified|0
799098|NCT02712008|2590429|P6|Baseline (Day 1) up to Week 12|Other Unspecified|0
799099|NCT02712008|2590430|P5|Baseline (Day 1) up to Week 12|Other Unspecified|0
799100|NCT02712008|2590431|P4|Baseline (Day 1) up to Week 12|Other Unspecified|0
799101|NCT02712008|2590432|P3|Baseline (Day 1) up to Week 12|Other Unspecified|0
799102|NCT02712008|2590433|P2|Baseline (Day 1) up to Week 12|Other Unspecified|1
799103|NCT02712008|2590434|P1|Baseline (Day 1) up to Week 12|Other Unspecified|0
799104|NCT02712008|2590427|P8|Baseline (Day 1) up to Week 12|Protocol Violation|0
799105|NCT02712008|2590428|P7|Baseline (Day 1) up to Week 12|Protocol Violation|0
799106|NCT02712008|2590429|P6|Baseline (Day 1) up to Week 12|Protocol Violation|0
799107|NCT02712008|2590430|P5|Baseline (Day 1) up to Week 12|Protocol Violation|0
799108|NCT02712008|2590431|P4|Baseline (Day 1) up to Week 12|Protocol Violation|0
799109|NCT02712008|2590432|P3|Baseline (Day 1) up to Week 12|Protocol Violation|1
799110|NCT02712008|2590433|P2|Baseline (Day 1) up to Week 12|Protocol Violation|0
799111|NCT02712008|2590434|P1|Baseline (Day 1) up to Week 12|Protocol Violation|0
799112|NCT02712008|2590427|P8|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
799113|NCT02712008|2590428|P7|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
799114|NCT02712008|2590429|P6|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
799115|NCT02712008|2590430|P5|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
799116|NCT02712008|2590431|P4|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
799117|NCT02712008|2590432|P3|Baseline (Day 1) up to Week 12|Lost to Follow-up|2
799118|NCT02712008|2590433|P2|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
799119|NCT02712008|2590434|P1|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
799120|NCT02712008|2590427|P8|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
799121|NCT02712008|2590428|P7|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
799122|NCT02712008|2590429|P6|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
799123|NCT02712008|2590430|P5|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
799124|NCT02712008|2590431|P4|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
799125|NCT02712008|2590432|P3|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
799126|NCT02712008|2590433|P2|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2
799127|NCT02712008|2590434|P1|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
799128|NCT02712008|2590427|P8|Baseline (Day 1) up to Week 12|Death|0
799129|NCT02712008|2590428|P7|Baseline (Day 1) up to Week 12|Death|0
799130|NCT02712008|2590429|P6|Baseline (Day 1) up to Week 12|Death|0
799131|NCT02712008|2590430|P5|Baseline (Day 1) up to Week 12|Death|0
799132|NCT02712008|2590431|P4|Baseline (Day 1) up to Week 12|Death|0
799133|NCT02712008|2590432|P3|Baseline (Day 1) up to Week 12|Death|0
799134|NCT02712008|2590433|P2|Baseline (Day 1) up to Week 12|Death|0
799135|NCT02712008|2590434|P1|Baseline (Day 1) up to Week 12|Death|3
799136|NCT02711995|2590466|P1|Washout (90 Days)|Conflicting medication|1
799137|NCT02710292|2590541|P2|Period 1, First 10 Days of Wear|Withdrawal by Subject|2
799138|NCT02710292|2590542|P1|Period 1, First 10 Days of Wear|Withdrawal by Subject|1
799139|NCT02710292|2590541|P2|Period 1, First 10 Days of Wear|Adverse Event|1
799140|NCT02710292|2590542|P1|Period 1, First 10 Days of Wear|Adverse Event|0
799141|NCT02710136|2590551|P2|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0
799142|NCT02710136|2590552|P1|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1
799143|NCT02709577|2590577|P4|Overall Study|Withdrawal by Subject|0
799144|NCT02709577|2590578|P3|Overall Study|Withdrawal by Subject|2
799145|NCT02709577|2590579|P2|Overall Study|Withdrawal by Subject|3
799146|NCT02709577|2590580|P1|Overall Study|Withdrawal by Subject|2
799147|NCT02709577|2590577|P4|Overall Study|procedural complication|0
799148|NCT02709577|2590578|P3|Overall Study|procedural complication|0
799149|NCT02709577|2590579|P2|Overall Study|procedural complication|1
799150|NCT02709577|2590580|P1|Overall Study|procedural complication|0
799151|NCT02709577|2590577|P4|Overall Study|non-accommodating anatomy|0
799152|NCT02709577|2590578|P3|Overall Study|non-accommodating anatomy|0
799153|NCT02709577|2590579|P2|Overall Study|non-accommodating anatomy|1
799154|NCT02709577|2590580|P1|Overall Study|non-accommodating anatomy|0
799155|NCT02709538|2590595|P3|Overall Study|Other|5
799156|NCT02709538|2590596|P2|Overall Study|Other|7
799157|NCT02709538|2590597|P1|Overall Study|Other|16
799158|NCT02709538|2590595|P3|Overall Study|Withdrawal by Parent or Legal Guardian|0
799159|NCT02709538|2590596|P2|Overall Study|Withdrawal by Parent or Legal Guardian|0
799160|NCT02709538|2590597|P1|Overall Study|Withdrawal by Parent or Legal Guardian|1
799161|NCT02709538|2590595|P3|Overall Study|Protocol deviation|4
799162|NCT02709538|2590596|P2|Overall Study|Protocol deviation|4
799163|NCT02709538|2590597|P1|Overall Study|Protocol deviation|10
799164|NCT02709538|2590595|P3|Overall Study|Non-compliance with study drug|0
799165|NCT02709538|2590596|P2|Overall Study|Non-compliance with study drug|0
799166|NCT02709538|2590597|P1|Overall Study|Non-compliance with study drug|2
799167|NCT02709538|2590595|P3|Overall Study|Non-compliance with study procedures|0
799168|NCT02709538|2590596|P2|Overall Study|Non-compliance with study procedures|0
799169|NCT02709538|2590597|P1|Overall Study|Non-compliance with study procedures|5
799170|NCT02709538|2590595|P3|Overall Study|Withdrawal by Subject|4
799171|NCT02709538|2590596|P2|Overall Study|Withdrawal by Subject|7
799172|NCT02709538|2590597|P1|Overall Study|Withdrawal by Subject|40
799173|NCT02709538|2590595|P3|Overall Study|Physician Decision|0
799174|NCT02709538|2590596|P2|Overall Study|Physician Decision|0
799175|NCT02709538|2590597|P1|Overall Study|Physician Decision|1
799176|NCT02709538|2590595|P3|Overall Study|Lost to Follow-up|4
799177|NCT02709538|2590596|P2|Overall Study|Lost to Follow-up|8
799178|NCT02709538|2590597|P1|Overall Study|Lost to Follow-up|24
799179|NCT02709538|2590595|P3|Overall Study|Lack of Efficacy|0
799180|NCT02709538|2590596|P2|Overall Study|Lack of Efficacy|0
799181|NCT02709538|2590597|P1|Overall Study|Lack of Efficacy|1
799182|NCT02709538|2590595|P3|Overall Study|Adverse Event|3
799183|NCT02709538|2590596|P2|Overall Study|Adverse Event|2
799184|NCT02709538|2590597|P1|Overall Study|Adverse Event|13
799185|NCT02709096|2590607|P2|Overall Study|non-compliance|1
799186|NCT02709096|2590608|P1|Overall Study|non-compliance|1
799187|NCT02709083|2590614|P1|Overall Study|Original PI left institution|7
799188|NCT02708524|2590629|P4|Overall Study|Subject lost study lens|0
799189|NCT02708524|2590630|P3|Overall Study|Subject lost study lens|0
799190|NCT02708524|2590631|P2|Overall Study|Subject lost study lens|0
799191|NCT02708524|2590632|P1|Overall Study|Subject lost study lens|1
799192|NCT02708524|2590629|P4|Overall Study|Did not wear lens at final visit|0
799193|NCT02708524|2590630|P3|Overall Study|Did not wear lens at final visit|0
799194|NCT02708524|2590631|P2|Overall Study|Did not wear lens at final visit|1
799195|NCT02708524|2590632|P1|Overall Study|Did not wear lens at final visit|0
799196|NCT02708524|2590629|P4|Overall Study|Dispensed incorrect study lens|0
799197|NCT02708524|2590630|P3|Overall Study|Dispensed incorrect study lens|1
799198|NCT02708524|2590631|P2|Overall Study|Dispensed incorrect study lens|1
799199|NCT02708524|2590632|P1|Overall Study|Dispensed incorrect study lens|0
799200|NCT02708524|2590629|P4|Overall Study|Withdrawal by Subject|0
799201|NCT02708524|2590630|P3|Overall Study|Withdrawal by Subject|0
799202|NCT02708524|2590631|P2|Overall Study|Withdrawal by Subject|1
799203|NCT02708524|2590632|P1|Overall Study|Withdrawal by Subject|1
799204|NCT02708524|2590629|P4|Overall Study|Protocol Violation|0
799205|NCT02708524|2590630|P3|Overall Study|Protocol Violation|0
799206|NCT02708524|2590631|P2|Overall Study|Protocol Violation|1
799207|NCT02708524|2590632|P1|Overall Study|Protocol Violation|0
799208|NCT02708524|2590629|P4|Overall Study|Lost to Follow-up|0
799209|NCT02708524|2590630|P3|Overall Study|Lost to Follow-up|1
799210|NCT02708524|2590631|P2|Overall Study|Lost to Follow-up|1
799211|NCT02708524|2590632|P1|Overall Study|Lost to Follow-up|1
799212|NCT02708524|2590629|P4|Overall Study|Lens Discomfort|0
799213|NCT02708524|2590630|P3|Overall Study|Lens Discomfort|1
799214|NCT02708524|2590631|P2|Overall Study|Lens Discomfort|0
799215|NCT02708524|2590632|P1|Overall Study|Lens Discomfort|1
799216|NCT02708524|2590629|P4|Overall Study|Adverse Event|0
799217|NCT02708524|2590630|P3|Overall Study|Adverse Event|0
799218|NCT02708524|2590631|P2|Overall Study|Adverse Event|1
799219|NCT02708524|2590632|P1|Overall Study|Adverse Event|0
799220|NCT02708485|2590680|P2|Overall Study|Withdrawal by Subject|2
799221|NCT02708485|2590681|P1|Overall Study|Withdrawal by Subject|3
799222|NCT02708355|2590701|P3|Overall Study|Adverse Event|0
799223|NCT02708355|2590702|P2|Overall Study|Adverse Event|0
799224|NCT02708355|2590703|P1|Overall Study|Adverse Event|1
799225|NCT02708277|2590716|P2|Overall Study|Lost to Follow-up|4
799226|NCT02708277|2590717|P1|Overall Study|Lost to Follow-up|7
799227|NCT02708095|2590761|P3|Overall Study|Withdrawal by Subject|4
799228|NCT02708095|2590762|P2|Overall Study|Withdrawal by Subject|3
799229|NCT02708095|2590763|P1|Overall Study|Withdrawal by Subject|5
799230|NCT02708095|2590761|P3|Overall Study|Protocol Violation|1
799231|NCT02708095|2590762|P2|Overall Study|Protocol Violation|0
799232|NCT02708095|2590763|P1|Overall Study|Protocol Violation|0
799233|NCT02708095|2590761|P3|Overall Study|Physician Decision|2
799234|NCT02708095|2590762|P2|Overall Study|Physician Decision|3
799235|NCT02708095|2590763|P1|Overall Study|Physician Decision|2
799236|NCT02708095|2590761|P3|Overall Study|Lost to Follow-up|0
799237|NCT02708095|2590762|P2|Overall Study|Lost to Follow-up|0
799238|NCT02708095|2590763|P1|Overall Study|Lost to Follow-up|2
799239|NCT02708095|2590761|P3|Overall Study|Lack of Efficacy|0
799240|NCT02708095|2590762|P2|Overall Study|Lack of Efficacy|3
799241|NCT02708095|2590763|P1|Overall Study|Lack of Efficacy|9
799242|NCT02708095|2590761|P3|Overall Study|Adverse Event|11
799243|NCT02708095|2590762|P2|Overall Study|Adverse Event|10
799244|NCT02708095|2590763|P1|Overall Study|Adverse Event|4
799245|NCT02707952|2590788|P4|Overall Study|Withdrawal by Subject|0
799246|NCT02707952|2590789|P3|Overall Study|Withdrawal by Subject|2
799247|NCT02707952|2590790|P2|Overall Study|Withdrawal by Subject|1
799248|NCT02707952|2590791|P1|Overall Study|Withdrawal by Subject|0
799249|NCT02707952|2590788|P4|Overall Study|Lost to Follow-up|0
799250|NCT02707952|2590789|P3|Overall Study|Lost to Follow-up|0
799251|NCT02707952|2590790|P2|Overall Study|Lost to Follow-up|0
799252|NCT02707952|2590791|P1|Overall Study|Lost to Follow-up|1
799253|NCT02707952|2590788|P4|Overall Study|Adverse Event|0
799254|NCT02707952|2590789|P3|Overall Study|Adverse Event|0
799255|NCT02707952|2590790|P2|Overall Study|Adverse Event|0
799256|NCT02707952|2590791|P1|Overall Study|Adverse Event|1
799257|NCT02707640|2590812|P2|Overall Study|Sponsor Discretion|0
799258|NCT02707640|2590813|P1|Overall Study|Sponsor Discretion|1
799259|NCT02707640|2590812|P2|Overall Study|Participant's Personal Decision|2
799260|NCT02707640|2590813|P1|Overall Study|Participant's Personal Decision|1
799261|NCT02707640|2590812|P2|Overall Study|Withdrawal by Subject|1
799262|NCT02707640|2590813|P1|Overall Study|Withdrawal by Subject|0
799263|NCT02707640|2590812|P2|Overall Study|Physician Decision|0
799264|NCT02707640|2590813|P1|Overall Study|Physician Decision|2
799265|NCT02707640|2590812|P2|Overall Study|Death|2
799266|NCT02707640|2590813|P1|Overall Study|Death|1
799267|NCT02707640|2590812|P2|Overall Study|Adverse Event|2
799268|NCT02707640|2590813|P1|Overall Study|Adverse Event|4
799269|NCT02707601|2590833|P2|Overall Study|Participants Randomized but Not Treated|0
799270|NCT02707601|2590834|P1|Overall Study|Participants Randomized but Not Treated|2
799271|NCT02707601|2590833|P2|Overall Study|Lost to Follow-up|1
799272|NCT02707601|2590834|P1|Overall Study|Lost to Follow-up|1
799273|NCT02707601|2590833|P2|Overall Study|Withdrew Consent|1
799274|NCT02707601|2590834|P1|Overall Study|Withdrew Consent|0
799275|NCT02707601|2590833|P2|Overall Study|Investigator's Discretion|0
799276|NCT02707601|2590834|P1|Overall Study|Investigator's Discretion|1
799277|NCT02707601|2590833|P2|Overall Study|Lack of Efficacy|1
799278|NCT02707601|2590834|P1|Overall Study|Lack of Efficacy|0
799279|NCT02707601|2590833|P2|Overall Study|Death|1
799280|NCT02707601|2590834|P1|Overall Study|Death|0
799281|NCT02706834|2590864|P11|Overall Study|Other Reason Not Specified|0
799282|NCT02706834|2590865|P10|Overall Study|Other Reason Not Specified|0
799283|NCT02706834|2590866|P9|Overall Study|Other Reason Not Specified|0
799284|NCT02706834|2590867|P8|Overall Study|Other Reason Not Specified|0
799285|NCT02706834|2590868|P7|Overall Study|Other Reason Not Specified|0
799286|NCT02706834|2590869|P6|Overall Study|Other Reason Not Specified|0
799287|NCT02706834|2590870|P5|Overall Study|Other Reason Not Specified|1
799288|NCT02706834|2590871|P4|Overall Study|Other Reason Not Specified|0
799289|NCT02706834|2590872|P3|Overall Study|Other Reason Not Specified|0
799290|NCT02706834|2590873|P2|Overall Study|Other Reason Not Specified|0
799291|NCT02706834|2590874|P1|Overall Study|Other Reason Not Specified|1
799292|NCT02706834|2590864|P11|Overall Study|Voluntary Withdrawal|0
799293|NCT02706834|2590865|P10|Overall Study|Voluntary Withdrawal|1
799294|NCT02706834|2590866|P9|Overall Study|Voluntary Withdrawal|0
799295|NCT02706834|2590867|P8|Overall Study|Voluntary Withdrawal|0
799296|NCT02706834|2590868|P7|Overall Study|Voluntary Withdrawal|0
799297|NCT02706834|2590869|P6|Overall Study|Voluntary Withdrawal|0
799298|NCT02706834|2590870|P5|Overall Study|Voluntary Withdrawal|0
799299|NCT02706834|2590871|P4|Overall Study|Voluntary Withdrawal|0
799300|NCT02706834|2590872|P3|Overall Study|Voluntary Withdrawal|0
799301|NCT02706834|2590873|P2|Overall Study|Voluntary Withdrawal|0
799302|NCT02706834|2590874|P1|Overall Study|Voluntary Withdrawal|1
799303|NCT02706834|2590864|P11|Overall Study|Lost to Follow-up|0
799304|NCT02706834|2590865|P10|Overall Study|Lost to Follow-up|0
799305|NCT02706834|2590866|P9|Overall Study|Lost to Follow-up|0
799306|NCT02706834|2590867|P8|Overall Study|Lost to Follow-up|0
799307|NCT02706834|2590868|P7|Overall Study|Lost to Follow-up|0
799308|NCT02706834|2590869|P6|Overall Study|Lost to Follow-up|0
799309|NCT02706834|2590870|P5|Overall Study|Lost to Follow-up|0
799310|NCT02706834|2590871|P4|Overall Study|Lost to Follow-up|0
799311|NCT02706834|2590872|P3|Overall Study|Lost to Follow-up|1
799312|NCT02706834|2590873|P2|Overall Study|Lost to Follow-up|0
799313|NCT02706834|2590874|P1|Overall Study|Lost to Follow-up|0
799314|NCT02706834|2590864|P11|Overall Study|Pretreatment Event/Adverse Event|1
799315|NCT02706834|2590865|P10|Overall Study|Pretreatment Event/Adverse Event|0
799316|NCT02706834|2590866|P9|Overall Study|Pretreatment Event/Adverse Event|0
799317|NCT02706834|2590867|P8|Overall Study|Pretreatment Event/Adverse Event|0
799318|NCT02706834|2590868|P7|Overall Study|Pretreatment Event/Adverse Event|0
799319|NCT02706834|2590869|P6|Overall Study|Pretreatment Event/Adverse Event|0
799320|NCT02706834|2590870|P5|Overall Study|Pretreatment Event/Adverse Event|0
799321|NCT02706834|2590871|P4|Overall Study|Pretreatment Event/Adverse Event|0
799322|NCT02706834|2590872|P3|Overall Study|Pretreatment Event/Adverse Event|0
799323|NCT02706834|2590873|P2|Overall Study|Pretreatment Event/Adverse Event|1
799324|NCT02706834|2590874|P1|Overall Study|Pretreatment Event/Adverse Event|0
799325|NCT02706717|2591018|P2|Overall Study|Death|1
799326|NCT02706717|2591019|P1|Overall Study|Death|0
799327|NCT02706717|2591018|P2|Overall Study|Physician Decision|1
799328|NCT02706717|2591019|P1|Overall Study|Physician Decision|0
799329|NCT02706717|2591018|P2|Overall Study|Lost to Follow-up|1
799330|NCT02706717|2591019|P1|Overall Study|Lost to Follow-up|0
799331|NCT02706717|2591018|P2|Overall Study|Withdrawal by Subject|8
799332|NCT02706717|2591019|P1|Overall Study|Withdrawal by Subject|1
799333|NCT02706327|2591040|P3|Overall Study|Lost to Follow-up|2
799334|NCT02706327|2591041|P2|Overall Study|Lost to Follow-up|1
799335|NCT02706327|2591042|P1|Overall Study|Lost to Follow-up|1
799336|NCT02705716|2591094|P2|Overall Study|Withdrawal of Consent|1
799337|NCT02705716|2591095|P1|Overall Study|Withdrawal of Consent|1
799338|NCT02705716|2591094|P2|Overall Study|Protocol Violation|0
799339|NCT02705716|2591095|P1|Overall Study|Protocol Violation|3
799340|NCT02705716|2591094|P2|Overall Study|Adverse Event|1
799341|NCT02705716|2591095|P1|Overall Study|Adverse Event|0
799342|NCT02704689|2591159|P1|Overall Study|Study device not implanted|2
799343|NCT02704689|2591159|P1|Overall Study|Physician Decision|1
799344|NCT02702011|2591251|P4|Overall Study|Withdrawal by Subject|0
799345|NCT02702011|2591252|P3|Overall Study|Withdrawal by Subject|0
799346|NCT02702011|2591253|P2|Overall Study|Withdrawal by Subject|1
799347|NCT02702011|2591254|P1|Overall Study|Withdrawal by Subject|0
799348|NCT02701985|2591266|P2|Overall Study|Adverse Event|5
799349|NCT02701985|2591267|P1|Overall Study|Adverse Event|0
799350|NCT02701985|2591266|P2|Overall Study|Death|0
799351|NCT02701985|2591267|P1|Overall Study|Death|1
799352|NCT02701985|2591266|P2|Overall Study|Lost to Follow-up|0
799353|NCT02701985|2591267|P1|Overall Study|Lost to Follow-up|1
799354|NCT02701985|2591266|P2|Overall Study|Withdrawal by Subject|1
799355|NCT02701985|2591267|P1|Overall Study|Withdrawal by Subject|1
799356|NCT02701361|2591325|P3|Overall Study|incarceration|1
799357|NCT02701361|2591326|P2|Overall Study|incarceration|0
799358|NCT02701361|2591327|P1|Overall Study|incarceration|0
799359|NCT02701361|2591325|P3|Overall Study|timed out in rehab center|0
799360|NCT02701361|2591326|P2|Overall Study|timed out in rehab center|1
799361|NCT02701361|2591327|P1|Overall Study|timed out in rehab center|0
799362|NCT02701361|2591325|P3|Overall Study|Withdrawal by Subject|0
799363|NCT02701361|2591326|P2|Overall Study|Withdrawal by Subject|0
799364|NCT02701361|2591327|P1|Overall Study|Withdrawal by Subject|4
799365|NCT02701361|2591325|P3|Overall Study|Lost to Follow-up|1
799366|NCT02701361|2591326|P2|Overall Study|Lost to Follow-up|2
799367|NCT02701361|2591327|P1|Overall Study|Lost to Follow-up|5
799368|NCT02701296|2591368|P2|Overall Study|Incomplete Data|2
799369|NCT02701296|2591369|P1|Overall Study|Incomplete Data|0
799370|NCT02700997|2591419|P1|Overall Study|No CT measurement - pelvic calcification|1
799371|NCT02700997|2591419|P1|Overall Study|Did not undergo CT imaging|1
799372|NCT02699892|2591423|P1|Overall Study|Other|36
799373|NCT02699684|2591428|P2|Period 2, Second 30 Days of Wear|Adverse Event|0
799374|NCT02699684|2591429|P1|Period 2, Second 30 Days of Wear|Adverse Event|1
799375|NCT02699593|2591446|P2|Period 2|Torn Contact Lens|0
799376|NCT02699593|2591447|P1|Period 2|Torn Contact Lens|1
799377|NCT02699593|2591446|P2|Period 2|Lost Contact Lens|1
799378|NCT02699593|2591447|P1|Period 2|Lost Contact Lens|0
799379|NCT02699593|2591446|P2|Period 2|Adverse Event|1
799380|NCT02699593|2591447|P1|Period 2|Adverse Event|1
799381|NCT02699593|2591446|P2|Period 1|Adverse Event|1
799382|NCT02699593|2591447|P1|Period 1|Adverse Event|1
799383|NCT02699593|2591446|P2|Period 1|Withdrawal by Subject|1
799384|NCT02699593|2591447|P1|Period 1|Withdrawal by Subject|0
799385|NCT02699593|2591446|P2|Period 1|Protocol Violation|1
799386|NCT02699593|2591447|P1|Period 1|Protocol Violation|0
799387|NCT02699593|2591446|P2|Period 1|Torn Contact Len|3
799388|NCT02699593|2591447|P1|Period 1|Torn Contact Len|4
799389|NCT02699593|2591446|P2|Period 1|Unsatisfactory Visual Response|1
799390|NCT02699593|2591447|P1|Period 1|Unsatisfactory Visual Response|0
799391|NCT02698436|2591464|P2|Overall Study|Non-compliance with study regimen|0
799392|NCT02698436|2591465|P1|Overall Study|Non-compliance with study regimen|1
799393|NCT02698436|2591464|P2|Overall Study|Lost to Follow-up|4
799394|NCT02698436|2591465|P1|Overall Study|Lost to Follow-up|2
799395|NCT02698436|2591464|P2|Overall Study|Withdrawal by Subject|3
799396|NCT02698436|2591465|P1|Overall Study|Withdrawal by Subject|3
799397|NCT02698436|2591464|P2|Overall Study|Adverse Event|0
799398|NCT02698436|2591465|P1|Overall Study|Adverse Event|1
799399|NCT02698423|2591505|P2|Overall Study|Lost to Follow-up|24
799400|NCT02698423|2591506|P1|Overall Study|Lost to Follow-up|19
799401|NCT02698176|2591517|P4|Overall Study|Clinical progression|0
799402|NCT02698176|2591518|P3|Overall Study|Clinical progression|0
799403|NCT02698176|2591519|P2|Overall Study|Clinical progression|0
799404|NCT02698176|2591520|P1|Overall Study|Clinical progression|3
799405|NCT02698176|2591517|P4|Overall Study|Adverse Event|0
799406|NCT02698176|2591518|P3|Overall Study|Adverse Event|0
799407|NCT02698176|2591519|P2|Overall Study|Adverse Event|0
799408|NCT02698176|2591520|P1|Overall Study|Adverse Event|2
799409|NCT02698176|2591517|P4|Overall Study|Progressive disease|0
799410|NCT02698176|2591518|P3|Overall Study|Progressive disease|1
799411|NCT02698176|2591519|P2|Overall Study|Progressive disease|3
799412|NCT02698176|2591520|P1|Overall Study|Progressive disease|4
799413|NCT02696317|2591579|P2|Period 2, 10 Days of Wear|Withdrawal by Subject|0
799414|NCT02696317|2591580|P1|Period 2, 10 Days of Wear|Withdrawal by Subject|1
799415|NCT02696317|2591579|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|4
799416|NCT02696317|2591580|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|2
799417|NCT02696226|2591624|P4|Overall Study|Study terminated - lack of enrollment|0
799418|NCT02696226|2591625|P3|Overall Study|Study terminated - lack of enrollment|2
799419|NCT02696226|2591626|P2|Overall Study|Study terminated - lack of enrollment|0
799420|NCT02696226|2591627|P1|Overall Study|Study terminated - lack of enrollment|1
799421|NCT02694978|2591668|P2|Overall Study|Other-Withdrew prior to dosing|8
799422|NCT02694978|2591669|P1|Overall Study|Other-Withdrew prior to dosing|9
799423|NCT02694978|2591668|P2|Overall Study|Other-Personal reasons|3
799424|NCT02694978|2591669|P1|Overall Study|Other-Personal reasons|3
799425|NCT02694978|2591668|P2|Overall Study|Other-Protocol noncompliant|1
799426|NCT02694978|2591669|P1|Overall Study|Other-Protocol noncompliant|2
799427|NCT02694978|2591668|P2|Overall Study|Other-Unable to be reached|1
799428|NCT02694978|2591669|P1|Overall Study|Other-Unable to be reached|0
799429|NCT02694978|2591668|P2|Overall Study|Other-Investigator’s decision|0
799430|NCT02694978|2591669|P1|Overall Study|Other-Investigator’s decision|1
799431|NCT02694978|2591668|P2|Overall Study|Other-Decision of Participant|1
799432|NCT02694978|2591669|P1|Overall Study|Other-Decision of Participant|6
799433|NCT02694978|2591668|P2|Overall Study|Death|1
799434|NCT02694978|2591669|P1|Overall Study|Death|4
799435|NCT02694978|2591668|P2|Overall Study|Lost to Follow-up|17
799436|NCT02694978|2591669|P1|Overall Study|Lost to Follow-up|14
799437|NCT02694978|2591668|P2|Overall Study|Withdrawal by Subject|19
799438|NCT02694978|2591669|P1|Overall Study|Withdrawal by Subject|22
799439|NCT02694978|2591668|P2|Overall Study|Adverse Event|9
799440|NCT02694978|2591669|P1|Overall Study|Adverse Event|10
799441|NCT02694744|2591683|P2|Overall Study|Taking potassium supplement: exclusion 6|1
799442|NCT02694744|2591684|P1|Overall Study|Taking potassium supplement: exclusion 6|0
799443|NCT02694744|2591683|P2|Overall Study|Lost to Follow-up|0
799444|NCT02694744|2591684|P1|Overall Study|Lost to Follow-up|1
799445|NCT02694744|2591683|P2|Overall Study|Physician Decision|2
799446|NCT02694744|2591684|P1|Overall Study|Physician Decision|1
799447|NCT02694744|2591683|P2|Overall Study|Withdrawal by Subject|1
799448|NCT02694744|2591684|P1|Overall Study|Withdrawal by Subject|2
799449|NCT02694744|2591683|P2|Overall Study|Adverse Event|1
799450|NCT02694744|2591684|P1|Overall Study|Adverse Event|2
799451|NCT02694718|2591692|P1|Overall Study|Withdrawal by Subject|1
799452|NCT02694718|2591692|P1|Overall Study|Death|1
799453|NCT02694549|2591722|P1|Overall Study|screen failures|2
799454|NCT02694536|2591728|P1|Overall Study|Not Specified|22
799455|NCT02694536|2591728|P1|Overall Study|Death|8
799456|NCT02694536|2591728|P1|Overall Study|Withdrawal by Subject|8
799457|NCT02694536|2591728|P1|Overall Study|Study Drug-Related Adverse Event|1
799458|NCT02694536|2591728|P1|Overall Study|Lost to Follow-up|1
799459|NCT02694536|2591728|P1|Overall Study|Progressive Disease|40
799460|NCT02693002|2591799|P2|Overall Study|Withdrawal by Subject|0
799461|NCT02693002|2591800|P1|Overall Study|Withdrawal by Subject|1
799462|NCT02692703|2591821|P1|Overall Study|Not Specified|1
799463|NCT02692703|2591821|P1|Overall Study|Lost to Follow-up|1
799464|NCT02692560|2591829|P2|Overall Study|Withdrawal by Subject|6
799465|NCT02692560|2591830|P1|Overall Study|Withdrawal by Subject|0
799466|NCT02691702|2591879|P11|Overall Study|Protocol Violation|0
799467|NCT02691702|2591880|P10|Overall Study|Protocol Violation|2
799468|NCT02691702|2591881|P9|Overall Study|Protocol Violation|0
799469|NCT02691702|2591882|P8|Overall Study|Protocol Violation|0
799470|NCT02691702|2591883|P7|Overall Study|Protocol Violation|0
799471|NCT02691702|2591884|P6|Overall Study|Protocol Violation|0
799472|NCT02691702|2591885|P5|Overall Study|Protocol Violation|0
799473|NCT02691702|2591886|P4|Overall Study|Protocol Violation|0
799474|NCT02691702|2591887|P3|Overall Study|Protocol Violation|0
799475|NCT02691702|2591888|P2|Overall Study|Protocol Violation|0
799476|NCT02691702|2591889|P1|Overall Study|Protocol Violation|0
799477|NCT02691702|2591879|P11|Overall Study|not specified|0
799478|NCT02691702|2591880|P10|Overall Study|not specified|0
799479|NCT02691702|2591881|P9|Overall Study|not specified|1
799480|NCT02691702|2591882|P8|Overall Study|not specified|0
799481|NCT02691702|2591883|P7|Overall Study|not specified|1
799482|NCT02691702|2591884|P6|Overall Study|not specified|0
799483|NCT02691702|2591885|P5|Overall Study|not specified|0
799484|NCT02691702|2591886|P4|Overall Study|not specified|0
799485|NCT02691702|2591887|P3|Overall Study|not specified|0
799486|NCT02691702|2591888|P2|Overall Study|not specified|0
799487|NCT02691702|2591889|P1|Overall Study|not specified|0
799488|NCT02691702|2591879|P11|Overall Study|Withdrawal by Subject|0
799489|NCT02691702|2591880|P10|Overall Study|Withdrawal by Subject|0
799490|NCT02691702|2591881|P9|Overall Study|Withdrawal by Subject|0
799491|NCT02691702|2591882|P8|Overall Study|Withdrawal by Subject|0
799492|NCT02691702|2591883|P7|Overall Study|Withdrawal by Subject|2
799493|NCT02691702|2591884|P6|Overall Study|Withdrawal by Subject|1
799494|NCT02691702|2591885|P5|Overall Study|Withdrawal by Subject|0
799495|NCT02691702|2591886|P4|Overall Study|Withdrawal by Subject|0
799496|NCT02691702|2591887|P3|Overall Study|Withdrawal by Subject|0
799497|NCT02691702|2591888|P2|Overall Study|Withdrawal by Subject|1
799498|NCT02691702|2591889|P1|Overall Study|Withdrawal by Subject|1
799499|NCT02691702|2591879|P11|Overall Study|Lost to Follow-up|1
799500|NCT02691702|2591880|P10|Overall Study|Lost to Follow-up|0
799501|NCT02691702|2591881|P9|Overall Study|Lost to Follow-up|0
799502|NCT02691702|2591882|P8|Overall Study|Lost to Follow-up|0
799503|NCT02691702|2591883|P7|Overall Study|Lost to Follow-up|0
799504|NCT02691702|2591884|P6|Overall Study|Lost to Follow-up|2
799505|NCT02691702|2591885|P5|Overall Study|Lost to Follow-up|0
799506|NCT02691702|2591886|P4|Overall Study|Lost to Follow-up|0
799507|NCT02691702|2591887|P3|Overall Study|Lost to Follow-up|1
799508|NCT02691702|2591888|P2|Overall Study|Lost to Follow-up|0
799509|NCT02691702|2591889|P1|Overall Study|Lost to Follow-up|0
799510|NCT02691702|2591879|P11|Overall Study|Adverse Event|1
799511|NCT02691702|2591880|P10|Overall Study|Adverse Event|0
799512|NCT02691702|2591881|P9|Overall Study|Adverse Event|1
799513|NCT02691702|2591882|P8|Overall Study|Adverse Event|0
799514|NCT02691702|2591883|P7|Overall Study|Adverse Event|0
799515|NCT02691702|2591884|P6|Overall Study|Adverse Event|0
799516|NCT02691702|2591885|P5|Overall Study|Adverse Event|0
799517|NCT02691702|2591886|P4|Overall Study|Adverse Event|0
799518|NCT02691702|2591887|P3|Overall Study|Adverse Event|0
799519|NCT02691702|2591888|P2|Overall Study|Adverse Event|0
799520|NCT02691702|2591889|P1|Overall Study|Adverse Event|1
799521|NCT02691572|2592175|P2|Overall Study|Protocol Violation|1
799522|NCT02691572|2592176|P1|Overall Study|Protocol Violation|0
799523|NCT02691572|2592175|P2|Overall Study|Withdrawal by Subject|0
799524|NCT02691572|2592176|P1|Overall Study|Withdrawal by Subject|1
799525|NCT02691507|2592184|P2|Overall Study|Missed Visit 3|1
799526|NCT02691507|2592185|P1|Overall Study|Missed Visit 3|0
799527|NCT02690727|2592360|P2|Overall Study|Adverse Event|2
799528|NCT02690727|2592361|P1|Overall Study|Adverse Event|2
799529|NCT02689804|2592469|P2|Overall Study|Withdrawal by Subject|0
799530|NCT02689804|2592470|P1|Overall Study|Withdrawal by Subject|2
799531|NCT02689206|2592501|P5|Overall Study|Withdrawal by Subject|0
799532|NCT02689206|2592502|P4|Overall Study|Withdrawal by Subject|0
799533|NCT02689206|2592503|P3|Overall Study|Withdrawal by Subject|1
799534|NCT02689206|2592504|P2|Overall Study|Withdrawal by Subject|0
799535|NCT02689206|2592505|P1|Overall Study|Withdrawal by Subject|1
799536|NCT02689206|2592501|P5|Overall Study|Physician Decision|0
799537|NCT02689206|2592502|P4|Overall Study|Physician Decision|0
799538|NCT02689206|2592503|P3|Overall Study|Physician Decision|0
799539|NCT02689206|2592504|P2|Overall Study|Physician Decision|0
799540|NCT02689206|2592505|P1|Overall Study|Physician Decision|1
799541|NCT02689206|2592501|P5|Overall Study|Other: Reached stopping criteria|4
799542|NCT02689206|2592502|P4|Overall Study|Other: Reached stopping criteria|3
799543|NCT02689206|2592503|P3|Overall Study|Other: Reached stopping criteria|2
799544|NCT02689206|2592504|P2|Overall Study|Other: Reached stopping criteria|1
799545|NCT02689206|2592505|P1|Overall Study|Other: Reached stopping criteria|0
799546|NCT02689206|2592501|P5|Overall Study|Protocol Violation|2
799547|NCT02689206|2592502|P4|Overall Study|Protocol Violation|1
799548|NCT02689206|2592503|P3|Overall Study|Protocol Violation|0
799549|NCT02689206|2592504|P2|Overall Study|Protocol Violation|0
799550|NCT02689206|2592505|P1|Overall Study|Protocol Violation|1
799551|NCT02689206|2592501|P5|Overall Study|Adverse Event|2
799552|NCT02689206|2592502|P4|Overall Study|Adverse Event|0
799553|NCT02689206|2592503|P3|Overall Study|Adverse Event|1
799554|NCT02689206|2592504|P2|Overall Study|Adverse Event|0
799555|NCT02689206|2592505|P1|Overall Study|Adverse Event|0
799556|NCT02688933|2592711|P2|Overall Study|Lost to Follow-up|5
799557|NCT02688933|2592712|P1|Overall Study|Lost to Follow-up|1
799558|NCT02688933|2592711|P2|Overall Study|Other than Specified|25
799559|NCT02688933|2592712|P1|Overall Study|Other than Specified|14
799560|NCT02688933|2592711|P2|Overall Study|Hypoglycemia|0
799561|NCT02688933|2592712|P1|Overall Study|Hypoglycemia|2
799562|NCT02688933|2592711|P2|Overall Study|Poor compliance to protocol|4
799563|NCT02688933|2592712|P1|Overall Study|Poor compliance to protocol|7
799564|NCT02688933|2592711|P2|Overall Study|Lack of Efficacy|2
799565|NCT02688933|2592712|P1|Overall Study|Lack of Efficacy|2
799566|NCT02688933|2592711|P2|Overall Study|Adverse Event|1
799567|NCT02688933|2592712|P1|Overall Study|Adverse Event|3
799568|NCT02688153|2592734|P2|Overall Study|Conversion to Commercial Valve|0
799569|NCT02688153|2592735|P1|Overall Study|Conversion to Commercial Valve|3
799570|NCT02688153|2592734|P2|Overall Study|Valve Explant|0
799571|NCT02688153|2592735|P1|Overall Study|Valve Explant|1
799572|NCT02688153|2592734|P2|Overall Study|Withdrawal by Subject|2
799573|NCT02688153|2592735|P1|Overall Study|Withdrawal by Subject|4
799574|NCT02688153|2592734|P2|Overall Study|Death|5
799575|NCT02688153|2592735|P1|Overall Study|Death|7
799576|NCT02685488|2592826|P2|Overall Study|Withdrawal by Subject|1
799577|NCT02685488|2592827|P1|Overall Study|Withdrawal by Subject|0
799578|NCT02685202|2592841|P1|Overall Study|Lost to Follow-up|9
799579|NCT02683746|2592987|P2|Overall Study|Physician Decision|1
799580|NCT02683746|2592988|P1|Overall Study|Physician Decision|2
799581|NCT02683746|2592987|P2|Overall Study|Withdrawal by Subject|5
799582|NCT02683746|2592988|P1|Overall Study|Withdrawal by Subject|6
799583|NCT02683746|2592987|P2|Overall Study|Lost to Follow-up|6
799584|NCT02683746|2592988|P1|Overall Study|Lost to Follow-up|5
799585|NCT02683746|2592987|P2|Overall Study|Adverse Event|2
799586|NCT02683746|2592988|P1|Overall Study|Adverse Event|3
799587|NCT02683109|2593088|P2|Overall Study|Adverse Event|0
799588|NCT02683109|2593089|P1|Overall Study|Adverse Event|1
799589|NCT02681510|2593187|P1|Overall Study|Lost to Follow-up|9
799590|NCT02681510|2593187|P1|Overall Study|Withdrawal by Subject|1
799591|NCT02681094|2593217|P3|2 - Enrolled Participants Set|No treatment given|1
799592|NCT02681094|2593218|P2|2 - Enrolled Participants Set|No treatment given|1
799593|NCT02681094|2593219|P1|2 - Enrolled Participants Set|No treatment given|0
799594|NCT02681094|2593217|P3|2 - Enrolled Participants Set|Not specified|7
799595|NCT02681094|2593218|P2|2 - Enrolled Participants Set|Not specified|6
799596|NCT02681094|2593219|P1|2 - Enrolled Participants Set|Not specified|6
799597|NCT02681094|2593217|P3|2 - Enrolled Participants Set|Study specific discontinuation criteria|21
799598|NCT02681094|2593218|P2|2 - Enrolled Participants Set|Study specific discontinuation criteria|15
799599|NCT02681094|2593219|P1|2 - Enrolled Participants Set|Study specific discontinuation criteria|14
799600|NCT02681094|2593217|P3|2 - Enrolled Participants Set|Lack of therapeutic response|14
799601|NCT02681094|2593218|P2|2 - Enrolled Participants Set|Lack of therapeutic response|5
799602|NCT02681094|2593219|P1|2 - Enrolled Participants Set|Lack of therapeutic response|1
799603|NCT02681094|2593217|P3|2 - Enrolled Participants Set|Severe non-compliance to protocol|1
799604|NCT02681094|2593218|P2|2 - Enrolled Participants Set|Severe non-compliance to protocol|0
799605|NCT02681094|2593219|P1|2 - Enrolled Participants Set|Severe non-compliance to protocol|2
799606|NCT02681094|2593217|P3|2 - Enrolled Participants Set|Adverse Event|1
799607|NCT02681094|2593218|P2|2 - Enrolled Participants Set|Adverse Event|4
799608|NCT02681094|2593219|P1|2 - Enrolled Participants Set|Adverse Event|10
799609|NCT02681094|2593217|P3|2 - Enrolled Participants Set|Participant decision|9
799610|NCT02681094|2593218|P2|2 - Enrolled Participants Set|Participant decision|10
799611|NCT02681094|2593219|P1|2 - Enrolled Participants Set|Participant decision|7
799612|NCT02681094|2593217|P3|1 -Modified Enrolled Participants Set|No treatment given|1
799613|NCT02681094|2593218|P2|1 -Modified Enrolled Participants Set|No treatment given|1
799614|NCT02681094|2593219|P1|1 -Modified Enrolled Participants Set|No treatment given|0
799615|NCT02681094|2593217|P3|1 -Modified Enrolled Participants Set|Not specified|7
799616|NCT02681094|2593218|P2|1 -Modified Enrolled Participants Set|Not specified|6
799617|NCT02681094|2593219|P1|1 -Modified Enrolled Participants Set|Not specified|6
799618|NCT02681094|2593217|P3|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20
799619|NCT02681094|2593218|P2|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13
799620|NCT02681094|2593219|P1|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11
799621|NCT02681094|2593217|P3|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14
799622|NCT02681094|2593218|P2|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5
799623|NCT02681094|2593219|P1|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1
799624|NCT02681094|2593217|P3|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1
799625|NCT02681094|2593218|P2|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0
799626|NCT02681094|2593219|P1|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2
799627|NCT02681094|2593217|P3|1 -Modified Enrolled Participants Set|Adverse Event|1
799628|NCT02681094|2593218|P2|1 -Modified Enrolled Participants Set|Adverse Event|4
799629|NCT02681094|2593219|P1|1 -Modified Enrolled Participants Set|Adverse Event|10
799630|NCT02681094|2593217|P3|1 -Modified Enrolled Participants Set|Participant decision|9
799631|NCT02681094|2593218|P2|1 -Modified Enrolled Participants Set|Participant decision|10
799632|NCT02681094|2593219|P1|1 -Modified Enrolled Participants Set|Participant decision|7
799633|NCT02680847|2593238|P3|Overall Study|Adverse Event|1
799634|NCT02680847|2593239|P2|Overall Study|Adverse Event|0
799635|NCT02680847|2593240|P1|Overall Study|Adverse Event|0
799636|NCT02680847|2593238|P3|Overall Study|Lack of Efficacy|2
799637|NCT02680847|2593239|P2|Overall Study|Lack of Efficacy|0
799638|NCT02680847|2593240|P1|Overall Study|Lack of Efficacy|0
799639|NCT02680847|2593238|P3|Overall Study|Unwilling to participate in study|0
799640|NCT02680847|2593239|P2|Overall Study|Unwilling to participate in study|1
799641|NCT02680847|2593240|P1|Overall Study|Unwilling to participate in study|1
799642|NCT02680847|2593238|P3|Overall Study|No longer met eligibility criteria|0
799643|NCT02680847|2593239|P2|Overall Study|No longer met eligibility criteria|2
799644|NCT02680847|2593240|P1|Overall Study|No longer met eligibility criteria|2
799645|NCT02680847|2593238|P3|Overall Study|Other|0
799646|NCT02680847|2593239|P2|Overall Study|Other|0
799647|NCT02680847|2593240|P1|Overall Study|Other|2
799648|NCT02679729|2593310|P9|Overall Study|Participant decision|0
799649|NCT02679729|2593311|P8|Overall Study|Participant decision|0
799650|NCT02679729|2593312|P7|Overall Study|Participant decision|1
799651|NCT02679729|2593313|P6|Overall Study|Participant decision|0
799652|NCT02679729|2593314|P5|Overall Study|Participant decision|0
799653|NCT02679729|2593315|P4|Overall Study|Participant decision|0
799654|NCT02679729|2593316|P3|Overall Study|Participant decision|0
799655|NCT02679729|2593317|P2|Overall Study|Participant decision|1
799656|NCT02679729|2593318|P1|Overall Study|Participant decision|0
799657|NCT02679729|2593310|P9|Overall Study|Lost to Follow-up|0
799658|NCT02679729|2593311|P8|Overall Study|Lost to Follow-up|0
799659|NCT02679729|2593312|P7|Overall Study|Lost to Follow-up|0
799660|NCT02679729|2593313|P6|Overall Study|Lost to Follow-up|0
799661|NCT02679729|2593314|P5|Overall Study|Lost to Follow-up|1
799662|NCT02679729|2593315|P4|Overall Study|Lost to Follow-up|0
799663|NCT02679729|2593316|P3|Overall Study|Lost to Follow-up|0
799664|NCT02679729|2593317|P2|Overall Study|Lost to Follow-up|1
799665|NCT02679729|2593318|P1|Overall Study|Lost to Follow-up|0
799666|NCT02678923|2593430|P2|Overall Study|Did Not Return for Study Visits|0
799667|NCT02678923|2593431|P1|Overall Study|Did Not Return for Study Visits|1
799668|NCT02678923|2593430|P2|Overall Study|Lost to Follow-up|0
799669|NCT02678923|2593431|P1|Overall Study|Lost to Follow-up|1
799670|NCT02678923|2593430|P2|Overall Study|Withdrawal by Subject|2
799671|NCT02678923|2593431|P1|Overall Study|Withdrawal by Subject|3
799672|NCT02678923|2593430|P2|Overall Study|Protocol Deviation (Not Dosed)|3
799673|NCT02678923|2593431|P1|Overall Study|Protocol Deviation (Not Dosed)|1
799674|NCT02678676|2593447|P2|Overall Study|Unconfirmed for lost to follow-up|67
799675|NCT02678676|2593448|P1|Overall Study|Unconfirmed for lost to follow-up|85
799676|NCT02678676|2593447|P2|Overall Study|Lost to Follow-up|151
799677|NCT02678676|2593448|P1|Overall Study|Lost to Follow-up|171
799678|NCT02678676|2593447|P2|Overall Study|Withdrawal by Subject|5
799679|NCT02678676|2593448|P1|Overall Study|Withdrawal by Subject|13
799680|NCT02678676|2593447|P2|Overall Study|Death|649
799681|NCT02678676|2593448|P1|Overall Study|Death|619
799682|NCT02678286|2593458|P2|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
799683|NCT02678286|2593459|P1|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
799684|NCT02678286|2593458|P2|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2
799685|NCT02678286|2593459|P1|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3
799686|NCT02678286|2593458|P2|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0
799687|NCT02678286|2593459|P1|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1
799688|NCT02678286|2593458|P2|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1
799689|NCT02678286|2593459|P1|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0
799690|NCT02678286|2593458|P2|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1
799691|NCT02678286|2593459|P1|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2
799692|NCT02677844|2593508|P7|Period 3|Withdrawal by Subject|0
799693|NCT02677844|2593509|P6|Period 3|Withdrawal by Subject|0
799694|NCT02677844|2593510|P5|Period 3|Withdrawal by Subject|0
799695|NCT02677844|2593511|P4|Period 3|Withdrawal by Subject|1
799696|NCT02677844|2593512|P3|Period 3|Withdrawal by Subject|0
799697|NCT02677844|2593513|P2|Period 3|Withdrawal by Subject|0
799698|NCT02677844|2593514|P1|Period 3|Withdrawal by Subject|0
799699|NCT02675907|2593577|P2|Study Overall|Lost to Follow-up|2
799700|NCT02675907|2593578|P1|Study Overall|Lost to Follow-up|0
799701|NCT02675907|2593577|P2|Study Overall|Withdrawal by Subject|2
799702|NCT02675907|2593578|P1|Study Overall|Withdrawal by Subject|2
799703|NCT02675907|2593577|P2|Study Overall|Lack of Efficacy|0
799704|NCT02675907|2593578|P1|Study Overall|Lack of Efficacy|1
799705|NCT02675907|2593577|P2|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
799706|NCT02675907|2593578|P1|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
799707|NCT02675907|2593577|P2|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
799708|NCT02675907|2593578|P1|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
799709|NCT02675634|2593623|P6|Test Period 2|Adverse Event|1
799710|NCT02675634|2593624|P5|Test Period 2|Adverse Event|0
799711|NCT02675634|2593625|P4|Test Period 2|Adverse Event|0
799712|NCT02675634|2593626|P3|Test Period 2|Adverse Event|0
799713|NCT02675634|2593627|P2|Test Period 2|Adverse Event|0
799714|NCT02675634|2593628|P1|Test Period 2|Adverse Event|0
799715|NCT02675634|2593623|P6|Test Period 2|Lack of Efficacy|0
799716|NCT02675634|2593624|P5|Test Period 2|Lack of Efficacy|0
799717|NCT02675634|2593625|P4|Test Period 2|Lack of Efficacy|0
799718|NCT02675634|2593626|P3|Test Period 2|Lack of Efficacy|0
799719|NCT02675634|2593627|P2|Test Period 2|Lack of Efficacy|0
799720|NCT02675634|2593628|P1|Test Period 2|Lack of Efficacy|1
799721|NCT02675634|2593623|P6|Test Period 1|Device deficiency that did not lead to A|0
799722|NCT02675634|2593624|P5|Test Period 1|Device deficiency that did not lead to A|0
799723|NCT02675634|2593625|P4|Test Period 1|Device deficiency that did not lead to A|0
799724|NCT02675634|2593626|P3|Test Period 1|Device deficiency that did not lead to A|1
799725|NCT02675634|2593627|P2|Test Period 1|Device deficiency that did not lead to A|0
799726|NCT02675634|2593628|P1|Test Period 1|Device deficiency that did not lead to A|0
799727|NCT02675634|2593623|P6|Test Period 1|Adverse Event|0
799728|NCT02675634|2593624|P5|Test Period 1|Adverse Event|0
799729|NCT02675634|2593625|P4|Test Period 1|Adverse Event|1
799730|NCT02675634|2593626|P3|Test Period 1|Adverse Event|0
799731|NCT02675634|2593627|P2|Test Period 1|Adverse Event|1
799732|NCT02675634|2593628|P1|Test Period 1|Adverse Event|0
799733|NCT02675517|2593645|P1|Overall Study|Evaluable PF-10 questionnaire at visit1|151
799734|NCT02675517|2593645|P1|Overall Study|No evaluable PF-10 questionnaire at all|8
799735|NCT02674334|2593667|P2|Overall Study|NIRS not recording|0
799736|NCT02674334|2593668|P1|Overall Study|NIRS not recording|1
799737|NCT02674334|2593667|P2|Overall Study|participant difficulty breathing|0
799738|NCT02674334|2593668|P1|Overall Study|participant difficulty breathing|1
799739|NCT02674334|2593667|P2|Overall Study|Lost to Follow-up|3
799740|NCT02674334|2593668|P1|Overall Study|Lost to Follow-up|5
799741|NCT02673619|2593685|P4|Overall Study|Lack of Efficacy|0
799742|NCT02673619|2593686|P3|Overall Study|Lack of Efficacy|1
799743|NCT02673619|2593687|P2|Overall Study|Lack of Efficacy|0
799744|NCT02673619|2593688|P1|Overall Study|Lack of Efficacy|0
799745|NCT02673619|2593685|P4|Overall Study|Adverse Event|0
799746|NCT02673619|2593686|P3|Overall Study|Adverse Event|1
799747|NCT02673619|2593687|P2|Overall Study|Adverse Event|0
799748|NCT02673619|2593688|P1|Overall Study|Adverse Event|0
799749|NCT02673619|2593685|P4|Overall Study|Withdrawal by Subject|0
799750|NCT02673619|2593686|P3|Overall Study|Withdrawal by Subject|1
799751|NCT02673619|2593687|P2|Overall Study|Withdrawal by Subject|1
799752|NCT02673619|2593688|P1|Overall Study|Withdrawal by Subject|1
799753|NCT02673619|2593685|P4|Overall Study|Lost to Follow-up|0
799754|NCT02673619|2593686|P3|Overall Study|Lost to Follow-up|0
799755|NCT02673619|2593687|P2|Overall Study|Lost to Follow-up|0
799756|NCT02673619|2593688|P1|Overall Study|Lost to Follow-up|1
799757|NCT02673489|2593780|P2|Follow Up Period|Unable to return for follow-up|1
799758|NCT02673489|2593781|P1|Follow Up Period|Unable to return for follow-up|0
799759|NCT02673489|2593780|P2|Follow Up Period|Unable to return for week 24 follow-up|1
799760|NCT02673489|2593781|P1|Follow Up Period|Unable to return for week 24 follow-up|0
799761|NCT02673489|2593780|P2|Treatment Period|Adverse Event|1
799762|NCT02673489|2593781|P1|Treatment Period|Adverse Event|0
799763|NCT02673489|2593780|P2|Treatment Period|Participant was incarcerated|1
799764|NCT02673489|2593781|P1|Treatment Period|Participant was incarcerated|0
799765|NCT02673489|2593780|P2|Treatment Period|Participant moved to another province|0
799766|NCT02673489|2593781|P1|Treatment Period|Participant moved to another province|1
799767|NCT02673489|2593780|P2|Treatment Period|Participant request to discontinue|1
799768|NCT02673489|2593781|P1|Treatment Period|Participant request to discontinue|1
799769|NCT02673489|2593780|P2|Treatment Period|Lost to Follow-up|0
799770|NCT02673489|2593781|P1|Treatment Period|Lost to Follow-up|3
799771|NCT02672423|2593818|P10|Period 3|Physician Decision|0
799772|NCT02672423|2593819|P9|Period 3|Physician Decision|0
799773|NCT02672423|2593820|P8|Period 3|Physician Decision|0
799774|NCT02672423|2593821|P7|Period 3|Physician Decision|0
799775|NCT02672423|2593822|P6|Period 3|Physician Decision|1
799776|NCT02672423|2593823|P5|Period 3|Physician Decision|0
799777|NCT02672423|2593824|P4|Period 3|Physician Decision|0
799778|NCT02672423|2593825|P3|Period 3|Physician Decision|0
799779|NCT02672423|2593826|P2|Period 3|Physician Decision|0
799780|NCT02672423|2593827|P1|Period 3|Physician Decision|0
799781|NCT02672423|2593818|P10|Period 3|Withdrawal by Subject|0
799782|NCT02672423|2593819|P9|Period 3|Withdrawal by Subject|0
799783|NCT02672423|2593820|P8|Period 3|Withdrawal by Subject|1
799784|NCT02672423|2593821|P7|Period 3|Withdrawal by Subject|0
799785|NCT02672423|2593822|P6|Period 3|Withdrawal by Subject|0
799786|NCT02672423|2593823|P5|Period 3|Withdrawal by Subject|0
799787|NCT02672423|2593824|P4|Period 3|Withdrawal by Subject|0
799788|NCT02672423|2593825|P3|Period 3|Withdrawal by Subject|0
799789|NCT02672423|2593826|P2|Period 3|Withdrawal by Subject|0
799790|NCT02672423|2593827|P1|Period 3|Withdrawal by Subject|0
799791|NCT02672423|2593818|P10|Period 2|Withdrawal by Subject|0
799792|NCT02672423|2593819|P9|Period 2|Withdrawal by Subject|0
799793|NCT02672423|2593820|P8|Period 2|Withdrawal by Subject|0
799794|NCT02672423|2593821|P7|Period 2|Withdrawal by Subject|0
799795|NCT02672423|2593822|P6|Period 2|Withdrawal by Subject|0
799796|NCT02672423|2593823|P5|Period 2|Withdrawal by Subject|0
799797|NCT02672423|2593824|P4|Period 2|Withdrawal by Subject|0
799798|NCT02672423|2593825|P3|Period 2|Withdrawal by Subject|1
799799|NCT02672423|2593826|P2|Period 2|Withdrawal by Subject|0
799800|NCT02672423|2593827|P1|Period 2|Withdrawal by Subject|0
799801|NCT02672423|2593818|P10|Period 1|Adverse Event|0
799802|NCT02672423|2593819|P9|Period 1|Adverse Event|0
799803|NCT02672423|2593820|P8|Period 1|Adverse Event|0
799804|NCT02672423|2593821|P7|Period 1|Adverse Event|0
799805|NCT02672423|2593822|P6|Period 1|Adverse Event|0
799806|NCT02672423|2593823|P5|Period 1|Adverse Event|1
799807|NCT02672423|2593824|P4|Period 1|Adverse Event|0
799808|NCT02672423|2593825|P3|Period 1|Adverse Event|0
799809|NCT02672423|2593826|P2|Period 1|Adverse Event|0
799810|NCT02672423|2593827|P1|Period 1|Adverse Event|0
799811|NCT02671760|2593850|P3|Overall Study|Lost to Follow-up|0
799812|NCT02671760|2593851|P2|Overall Study|Lost to Follow-up|1
799813|NCT02671760|2593852|P1|Overall Study|Lost to Follow-up|0
799814|NCT02671461|2593881|P3|Follow-up|Administrative Reason by Sponsor|0
799815|NCT02671461|2593882|P2|Follow-up|Administrative Reason by Sponsor|1
799816|NCT02671461|2593883|P1|Follow-up|Administrative Reason by Sponsor|0
799817|NCT02671461|2593881|P3|Follow-up|Lost to Follow-up|1
799818|NCT02671461|2593882|P2|Follow-up|Lost to Follow-up|0
799819|NCT02671461|2593883|P1|Follow-up|Lost to Follow-up|0
799820|NCT02671461|2593881|P3|Follow-up|Withdrawal by Subject|0
799821|NCT02671461|2593882|P2|Follow-up|Withdrawal by Subject|0
799822|NCT02671461|2593883|P1|Follow-up|Withdrawal by Subject|1
799823|NCT02671461|2593881|P3|Treatment|Lost to Follow-up|0
799824|NCT02671461|2593882|P2|Treatment|Lost to Follow-up|0
799825|NCT02671461|2593883|P1|Treatment|Lost to Follow-up|1
799826|NCT02671461|2593881|P3|Treatment|Administrative Reason by Sponsor|4
799827|NCT02671461|2593882|P2|Treatment|Administrative Reason by Sponsor|3
799828|NCT02671461|2593883|P1|Treatment|Administrative Reason by Sponsor|1
799829|NCT02671461|2593881|P3|Treatment|Adverse Event|1
799830|NCT02671461|2593882|P2|Treatment|Adverse Event|0
799831|NCT02671461|2593883|P1|Treatment|Adverse Event|0
799832|NCT02671266|2593908|P2|Overall Study|Withdrawal by Subject|1
799833|NCT02671266|2593909|P1|Overall Study|Withdrawal by Subject|1
799834|NCT02670473|2593940|P1|Overall Study|Withdrawal by Subject|1
799835|NCT02669940|2593999|P2|Overall Study|Insufficient follow-up data|0
799836|NCT02669940|2594000|P1|Overall Study|Insufficient follow-up data|1
799837|NCT02669940|2593999|P2|Overall Study|Failure to return|3
799838|NCT02669940|2594000|P1|Overall Study|Failure to return|0
799839|NCT02669095|2594107|P2|Overall Study|Visit 5 assessments not completed|1
799840|NCT02669095|2594108|P1|Overall Study|Visit 5 assessments not completed|0
799841|NCT02669095|2594107|P2|Overall Study|Torn Lens|1
799842|NCT02669095|2594108|P1|Overall Study|Torn Lens|0
799843|NCT02669095|2594107|P2|Overall Study|Unsatisfactory Lens Fitting|1
799844|NCT02669095|2594108|P1|Overall Study|Unsatisfactory Lens Fitting|0
799845|NCT02669095|2594107|P2|Overall Study|Adverse Event|0
799846|NCT02669095|2594108|P1|Overall Study|Adverse Event|1
799847|NCT02669043|2594116|P1|Overall Study|Didn't meet I/E criteria|4
799848|NCT02668822|2594143|P2|Overall Study|Study Terminated by Sponsor|9
799849|NCT02668822|2594144|P1|Overall Study|Study Terminated by Sponsor|7
799850|NCT02668822|2594143|P2|Overall Study|Protocol Violation|0
799851|NCT02668822|2594144|P1|Overall Study|Protocol Violation|2
799852|NCT02668783|2594166|P2|Overall Study|Withdrawal by Subject|0
799853|NCT02668783|2594167|P1|Overall Study|Withdrawal by Subject|1
799854|NCT02668783|2594166|P2|Overall Study|Subject moved|0
799855|NCT02668783|2594167|P1|Overall Study|Subject moved|1
799856|NCT02668783|2594166|P2|Overall Study|Study terminated by sponsor|10
799857|NCT02668783|2594167|P1|Overall Study|Study terminated by sponsor|9
799858|NCT02668783|2594166|P2|Overall Study|Protocol Violation|1
799859|NCT02668783|2594167|P1|Overall Study|Protocol Violation|2
799860|NCT02668783|2594166|P2|Overall Study|Pregnancy|1
799861|NCT02668783|2594167|P1|Overall Study|Pregnancy|0
799862|NCT02668302|2594189|P2|Overall Study|Withdrawal by Subject|0
799863|NCT02668302|2594190|P1|Overall Study|Withdrawal by Subject|1
799864|NCT02667288|2594213|P1|Overall Study|Withdrawal by Subject|5
799865|NCT02667288|2594213|P1|Overall Study|Lost to Follow-up|3
799866|NCT02667288|2594213|P1|Overall Study|Protocol Violation|5
799867|NCT02667275|2594220|P2|Overall Study|Discontinued early without completing|1
799868|NCT02667275|2594221|P1|Overall Study|Discontinued early without completing|0
799869|NCT02667275|2594220|P2|Overall Study|Withdrawal by Subject|5
799870|NCT02667275|2594221|P1|Overall Study|Withdrawal by Subject|0
799871|NCT02667275|2594220|P2|Overall Study|Lost to Follow-up|2
799872|NCT02667275|2594221|P1|Overall Study|Lost to Follow-up|0
799873|NCT02667275|2594220|P2|Overall Study|Protocol Violation|7
799874|NCT02667275|2594221|P1|Overall Study|Protocol Violation|11
799875|NCT02667236|2594231|P2|Overall Study|Withdrawal by Subject|0
799876|NCT02667236|2594232|P1|Overall Study|Withdrawal by Subject|2
799877|NCT02667236|2594231|P2|Overall Study|Adverse Event|1
799878|NCT02667236|2594232|P1|Overall Study|Adverse Event|1
799879|NCT02666222|2594366|P1|Overall Study|Death|2
799880|NCT02665455|2594374|P1|Overall Study|Protocol Violation|1
799881|NCT02665455|2594374|P1|Overall Study|Adverse Event|1
799882|NCT02665455|2594374|P1|Overall Study|Lost to Follow-up|1
799883|NCT02665455|2594374|P1|Overall Study|Withdrawal by Subject|6
799884|NCT02665286|2594381|P3|Overall Study|Lost to Follow-up|1
799885|NCT02665286|2594382|P2|Overall Study|Lost to Follow-up|2
799886|NCT02665286|2594383|P1|Overall Study|Lost to Follow-up|3
799887|NCT02664415|2594473|P2|Overall Study|Adverse Event|0
799888|NCT02664415|2594474|P1|Overall Study|Adverse Event|1
799889|NCT02663687|2594529|P5|Overall Study|Other|0
799890|NCT02663687|2594530|P4|Overall Study|Other|0
799891|NCT02663687|2594531|P3|Overall Study|Other|1
799892|NCT02663687|2594532|P2|Overall Study|Other|0
799893|NCT02663687|2594533|P1|Overall Study|Other|1
799894|NCT02663687|2594529|P5|Overall Study|Adverse Event|0
799895|NCT02663687|2594530|P4|Overall Study|Adverse Event|0
799896|NCT02663687|2594531|P3|Overall Study|Adverse Event|0
799897|NCT02663687|2594532|P2|Overall Study|Adverse Event|0
799898|NCT02663687|2594533|P1|Overall Study|Adverse Event|1
799899|NCT02663453|2594587|P2|Overall Study|Withdrawal by Subject|0
799900|NCT02663453|2594588|P1|Overall Study|Withdrawal by Subject|1
799901|NCT02663453|2594587|P2|Overall Study|Death|4
799902|NCT02663453|2594588|P1|Overall Study|Death|4
799903|NCT02662764|2594631|P1|Overall Study|Patient discharged prior to 24 hrs|5
799904|NCT02662764|2594631|P1|Overall Study|Patient changed treatment|1
799905|NCT02662764|2594631|P1|Overall Study|Device failure|4
799906|NCT02662764|2594631|P1|Overall Study|Withdrawal by Subject|5
799907|NCT02662764|2594631|P1|Overall Study|Protocol Violation|1
799908|NCT02662764|2594631|P1|Overall Study|Lack of Efficacy|8
799909|NCT02662764|2594631|P1|Overall Study|Adverse Event|6
799910|NCT02662556|2594695|P1|Overall Study|Lack of Efficacy|4
799911|NCT02662556|2594695|P1|Overall Study|Adverse Event|4
799912|NCT02661594|2594727|P4|Overall Study|Protocol Violation|0
799913|NCT02661594|2594728|P3|Overall Study|Protocol Violation|1
799914|NCT02661594|2594729|P2|Overall Study|Protocol Violation|0
799915|NCT02661594|2594730|P1|Overall Study|Protocol Violation|1
799916|NCT02660242|2594740|P1|Glucagon Injection|Lost to Follow-up|1
799917|NCT02660242|2594740|P1|Glucose Tabs|Lost to Follow-up|1
799918|NCT02660229|2594796|P2|Overall Study|Withdrawal by Subject|1
799919|NCT02660229|2594797|P1|Overall Study|Withdrawal by Subject|0
799920|NCT02660229|2594796|P2|Overall Study|Adverse Event|0
799921|NCT02660229|2594797|P1|Overall Study|Adverse Event|2
799922|NCT02658149|2594857|P2|Overall Study|Physician Decision|0
799923|NCT02658149|2594858|P1|Overall Study|Physician Decision|1
799924|NCT02657031|2594903|P2|Overall Study|Adverse Event|2
799925|NCT02657031|2594904|P1|Overall Study|Adverse Event|1
799926|NCT02656173|2594946|P2|Overall Study|Miscellaneous|0
799927|NCT02656173|2594947|P1|Overall Study|Miscellaneous|2
799928|NCT02656173|2594946|P2|Overall Study|Protocol Violation|1
799929|NCT02656173|2594947|P1|Overall Study|Protocol Violation|0
799930|NCT02656173|2594946|P2|Overall Study|Withdrawal by Subject|3
799931|NCT02656173|2594947|P1|Overall Study|Withdrawal by Subject|1
799932|NCT02656173|2594946|P2|Overall Study|Adverse Event|5
799933|NCT02656173|2594947|P1|Overall Study|Adverse Event|7
799934|NCT02656173|2594946|P2|Overall Study|Deviation from the Eligible Criteria|2
799935|NCT02656173|2594947|P1|Overall Study|Deviation from the Eligible Criteria|3
799936|NCT02655666|2595019|P1|Overall Study|Sponsor stopped this clinical research.|12
799937|NCT02654145|2595036|P1|Overall Study|Withdrawal by Subject|5
799938|NCT02654145|2595036|P1|Overall Study|Protocol Violation|1
799939|NCT02654145|2595036|P1|Overall Study|Lack of Efficacy|1
799940|NCT02653625|2595078|P1|Overall Study|Suspected Drug Induced Liver Injury|1
799941|NCT02653625|2595078|P1|Overall Study|Protocol Violation|1
799942|NCT02653625|2595078|P1|Overall Study|Non-compliance with Study Drug|1
799943|NCT02653625|2595078|P1|Overall Study|Adverse Event|1
799944|NCT02653495|2595102|P2|Overall Study|Screening Failure|0
799945|NCT02653495|2595103|P1|Overall Study|Screening Failure|10
799946|NCT02653495|2595102|P2|Overall Study|Lost to Follow-up|0
799947|NCT02653495|2595103|P1|Overall Study|Lost to Follow-up|2
799948|NCT02652624|2595126|P2|Extension Phase|Lost to Follow-up|1
799949|NCT02652624|2595127|P1|Extension Phase|Lost to Follow-up|0
799950|NCT02652624|2595126|P2|Extension Phase|Still in Extension Phase of Study|227
799951|NCT02652624|2595127|P1|Extension Phase|Still in Extension Phase of Study|230
799952|NCT02652624|2595126|P2|Randomized Phase|Still in Randomized Phase of Study|3
799953|NCT02652624|2595127|P1|Randomized Phase|Still in Randomized Phase of Study|1
799954|NCT02652624|2595126|P2|Randomized Phase|Lost to Follow-up|1
799955|NCT02652624|2595127|P1|Randomized Phase|Lost to Follow-up|0
799956|NCT02652624|2595126|P2|Randomized Phase|Investigator's Discretion|2
799957|NCT02652624|2595127|P1|Randomized Phase|Investigator's Discretion|0
799958|NCT02652624|2595126|P2|Randomized Phase|Pregnancy|1
799959|NCT02652624|2595127|P1|Randomized Phase|Pregnancy|3
799960|NCT02652624|2595126|P2|Randomized Phase|Death|1
799961|NCT02652624|2595127|P1|Randomized Phase|Death|0
799962|NCT02652624|2595126|P2|Randomized Phase|Randomized but Not Treated|1
799963|NCT02652624|2595127|P1|Randomized Phase|Randomized but Not Treated|1
799964|NCT02652156|2595187|P3|Overall Study|Physician Decision|0
799965|NCT02652156|2595188|P2|Overall Study|Physician Decision|0
799966|NCT02652156|2595189|P1|Overall Study|Physician Decision|1
799967|NCT02651922|2595215|P1|Overall Study|due to exclusion criteria|2
799968|NCT02651467|2595235|P3|Overall Study|Other (Not specified)|2
799969|NCT02651467|2595236|P2|Overall Study|Other (Not specified)|0
799970|NCT02651467|2595237|P1|Overall Study|Other (Not specified)|1
799971|NCT02651467|2595235|P3|Overall Study|Withdrawal by Subject|2
799972|NCT02651467|2595236|P2|Overall Study|Withdrawal by Subject|0
799973|NCT02651467|2595237|P1|Overall Study|Withdrawal by Subject|0
799974|NCT02651194|2595256|P1|Overall Study|Not Specified|2
799975|NCT02651194|2595256|P1|Overall Study|Lost to Follow-up|3
799976|NCT02651155|2595264|P2|Overall Study|Voluntary Withdrawal|0
799977|NCT02651155|2595265|P1|Overall Study|Voluntary Withdrawal|5
799978|NCT02651155|2595264|P2|Overall Study|Pretreatment Event/Adverse Event|2
799979|NCT02651155|2595265|P1|Overall Study|Pretreatment Event/Adverse Event|1
799980|NCT02650128|2595409|P1|Overall Study|Death|2
799981|NCT02649634|2595418|P2|Overall Study|Lost to Follow-up|1
799982|NCT02649634|2595419|P1|Overall Study|Lost to Follow-up|0
799983|NCT02649634|2595418|P2|Overall Study|Withdrawal by Subject|5
799984|NCT02649634|2595419|P1|Overall Study|Withdrawal by Subject|3
799985|NCT02648438|2595526|P3|Overall Study|Withdrawal by Subject|0
799986|NCT02648438|2595527|P2|Overall Study|Withdrawal by Subject|1
799987|NCT02648438|2595528|P1|Overall Study|Withdrawal by Subject|1
799988|NCT02648438|2595526|P3|Overall Study|Protocol Violation|0
799989|NCT02648438|2595527|P2|Overall Study|Protocol Violation|0
799990|NCT02648438|2595528|P1|Overall Study|Protocol Violation|2
799991|NCT02648438|2595526|P3|Overall Study|Eligibility criteria not fulfilled|0
799992|NCT02648438|2595527|P2|Overall Study|Eligibility criteria not fulfilled|2
799993|NCT02648438|2595528|P1|Overall Study|Eligibility criteria not fulfilled|0
799994|NCT02648217|2595570|P2|Overall Study|Unclassified|0
799995|NCT02648217|2595571|P1|Overall Study|Unclassified|5
799996|NCT02648217|2595570|P2|Overall Study|Withdrawal by Subject|3
799997|NCT02648217|2595571|P1|Overall Study|Withdrawal by Subject|4
799998|NCT02648217|2595570|P2|Overall Study|Lost to Follow-up|1
799999|NCT02648217|2595571|P1|Overall Study|Lost to Follow-up|1
800000|NCT02648217|2595570|P2|Overall Study|Adverse Event|1
800001|NCT02648217|2595571|P1|Overall Study|Adverse Event|0
800002|NCT02648204|2595593|P4|Overall Study|Adverse Event|0
800003|NCT02648204|2595594|P3|Overall Study|Adverse Event|1
800004|NCT02648204|2595595|P2|Overall Study|Adverse Event|0
800005|NCT02648204|2595596|P1|Overall Study|Adverse Event|0
800006|NCT02648204|2595593|P4|Overall Study|Death|2
800007|NCT02648204|2595594|P3|Overall Study|Death|2
800008|NCT02648204|2595595|P2|Overall Study|Death|1
800009|NCT02648204|2595596|P1|Overall Study|Death|1
800010|NCT02648204|2595593|P4|Overall Study|Missing follow-up information|2
800011|NCT02648204|2595594|P3|Overall Study|Missing follow-up information|4
800012|NCT02648204|2595595|P2|Overall Study|Missing follow-up information|4
800013|NCT02648204|2595596|P1|Overall Study|Missing follow-up information|4
800014|NCT02648204|2595593|P4|Overall Study|Lost to Follow-up|6
800015|NCT02648204|2595594|P3|Overall Study|Lost to Follow-up|4
800016|NCT02648204|2595595|P2|Overall Study|Lost to Follow-up|8
800017|NCT02648204|2595596|P1|Overall Study|Lost to Follow-up|5
800018|NCT02648204|2595593|P4|Overall Study|Withdrawal by Subject|6
800019|NCT02648204|2595594|P3|Overall Study|Withdrawal by Subject|2
800020|NCT02648204|2595595|P2|Overall Study|Withdrawal by Subject|8
800021|NCT02648204|2595596|P1|Overall Study|Withdrawal by Subject|12
800022|NCT02647944|2595729|P2|Overall Study|Adverse Event|0
800023|NCT02647944|2595730|P1|Overall Study|Adverse Event|2
800024|NCT02647944|2595729|P2|Overall Study|Withdrawal by Subject|3
800025|NCT02647944|2595730|P1|Overall Study|Withdrawal by Subject|0
800026|NCT02647905|2595754|P1|Overall Study|Withdrawal by Subject|2
800027|NCT02647905|2595754|P1|Overall Study|Lost to Follow-up|1
800028|NCT02647645|2595761|P2|Overall Study|Lost to Follow-up|1
800029|NCT02647645|2595762|P1|Overall Study|Lost to Follow-up|2
800030|NCT02647320|2595777|P5|Overall Study|Disposition Missing Due to Fire at Site|4
800031|NCT02647320|2595778|P4|Overall Study|Disposition Missing Due to Fire at Site|3
800032|NCT02647320|2595779|P3|Overall Study|Disposition Missing Due to Fire at Site|4
800033|NCT02647320|2595780|P2|Overall Study|Disposition Missing Due to Fire at Site|3
800034|NCT02647320|2595781|P1|Overall Study|Disposition Missing Due to Fire at Site|2
800035|NCT02647320|2595777|P5|Overall Study|Lack of Efficacy|0
800036|NCT02647320|2595778|P4|Overall Study|Lack of Efficacy|1
800037|NCT02647320|2595779|P3|Overall Study|Lack of Efficacy|0
800038|NCT02647320|2595780|P2|Overall Study|Lack of Efficacy|0
800039|NCT02647320|2595781|P1|Overall Study|Lack of Efficacy|0
800040|NCT02647320|2595777|P5|Overall Study|Develop anemia|0
800041|NCT02647320|2595778|P4|Overall Study|Develop anemia|0
800042|NCT02647320|2595779|P3|Overall Study|Develop anemia|0
800043|NCT02647320|2595780|P2|Overall Study|Develop anemia|0
800044|NCT02647320|2595781|P1|Overall Study|Develop anemia|1
800045|NCT02647320|2595777|P5|Overall Study|Lost to Follow-up|0
800046|NCT02647320|2595778|P4|Overall Study|Lost to Follow-up|0
800047|NCT02647320|2595779|P3|Overall Study|Lost to Follow-up|0
800048|NCT02647320|2595780|P2|Overall Study|Lost to Follow-up|1
800049|NCT02647320|2595781|P1|Overall Study|Lost to Follow-up|1
800050|NCT02647320|2595777|P5|Overall Study|Reason not provided|2
800051|NCT02647320|2595778|P4|Overall Study|Reason not provided|0
800052|NCT02647320|2595779|P3|Overall Study|Reason not provided|1
800053|NCT02647320|2595780|P2|Overall Study|Reason not provided|0
800054|NCT02647320|2595781|P1|Overall Study|Reason not provided|0
800055|NCT02647320|2595777|P5|Overall Study|Study terminated by sponsor|2
800056|NCT02647320|2595778|P4|Overall Study|Study terminated by sponsor|1
800057|NCT02647320|2595779|P3|Overall Study|Study terminated by sponsor|1
800058|NCT02647320|2595780|P2|Overall Study|Study terminated by sponsor|1
800059|NCT02647320|2595781|P1|Overall Study|Study terminated by sponsor|1
800060|NCT02647320|2595777|P5|Overall Study|Persistent hyperglycemia|1
800061|NCT02647320|2595778|P4|Overall Study|Persistent hyperglycemia|1
800062|NCT02647320|2595779|P3|Overall Study|Persistent hyperglycemia|1
800063|NCT02647320|2595780|P2|Overall Study|Persistent hyperglycemia|1
800064|NCT02647320|2595781|P1|Overall Study|Persistent hyperglycemia|0
800065|NCT02647320|2595777|P5|Overall Study|Withdrawal by Subject|7
800066|NCT02647320|2595778|P4|Overall Study|Withdrawal by Subject|2
800067|NCT02647320|2595779|P3|Overall Study|Withdrawal by Subject|2
800068|NCT02647320|2595780|P2|Overall Study|Withdrawal by Subject|4
800069|NCT02647320|2595781|P1|Overall Study|Withdrawal by Subject|7
800070|NCT02647320|2595777|P5|Overall Study|Protocol Violation|0
800071|NCT02647320|2595778|P4|Overall Study|Protocol Violation|0
800072|NCT02647320|2595779|P3|Overall Study|Protocol Violation|3
800073|NCT02647320|2595780|P2|Overall Study|Protocol Violation|0
800074|NCT02647320|2595781|P1|Overall Study|Protocol Violation|0
800075|NCT02647320|2595777|P5|Overall Study|Adverse Event|1
800076|NCT02647320|2595778|P4|Overall Study|Adverse Event|2
800077|NCT02647320|2595779|P3|Overall Study|Adverse Event|3
800078|NCT02647320|2595780|P2|Overall Study|Adverse Event|1
800079|NCT02647320|2595781|P1|Overall Study|Adverse Event|0
800080|NCT02647281|2595872|P9|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1
800081|NCT02647281|2595873|P8|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
800082|NCT02647281|2595874|P7|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
800083|NCT02647281|2595875|P6|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
800084|NCT02647281|2595876|P5|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
800085|NCT02647281|2595877|P4|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
800086|NCT02647281|2595878|P3|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
800087|NCT02647281|2595879|P2|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
800088|NCT02647281|2595880|P1|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
800089|NCT02646124|2596071|P2|Overall Study|Lost to Follow-up|2
800090|NCT02646124|2596072|P1|Overall Study|Lost to Follow-up|0
800091|NCT02644356|2596249|P1|Overall Study|Withdrawal by Subject|2
800092|NCT02644122|2596259|P1|Overall Study|Withdrawal by Subject|1
800093|NCT02644109|2596269|P2|Overall Study|Adverse Event|4
800094|NCT02644109|2596270|P1|Overall Study|Adverse Event|0
800095|NCT02644096|2596278|P2|Overall Study|Withdrawal by Subject|25
800096|NCT02644096|2596279|P1|Overall Study|Withdrawal by Subject|28
800097|NCT02643394|2596313|P2|Overall Study|Protocol Violation|5
800098|NCT02643394|2596314|P1|Overall Study|Protocol Violation|4
800099|NCT02643251|2596324|P2|Overall Study|PI Decision to terminate patient|0
800100|NCT02643251|2596325|P1|Overall Study|PI Decision to terminate patient|1
800101|NCT02643251|2596324|P2|Overall Study|Protocol Violation|0
800102|NCT02643251|2596325|P1|Overall Study|Protocol Violation|1
800103|NCT02643251|2596324|P2|Overall Study|Lost to Follow-up|1
800104|NCT02643251|2596325|P1|Overall Study|Lost to Follow-up|4
800105|NCT02643251|2596324|P2|Overall Study|Withdrawal by Subject|0
800106|NCT02643251|2596325|P1|Overall Study|Withdrawal by Subject|2
800107|NCT02643251|2596324|P2|Overall Study|Adverse Event|1
800108|NCT02643251|2596325|P1|Overall Study|Adverse Event|3
800109|NCT02642679|2596411|P1|Overall Study|Physician Decision|1
800110|NCT02642679|2596411|P1|Overall Study|Physician Decision|1
800111|NCT02642679|2596411|P1|Overall Study|Withdrawal by Subject|1
800112|NCT02642432|2596452|P1|Overall Study|Not Specified|3
800113|NCT02642432|2596452|P1|Overall Study|Lost to Follow-up|2
800114|NCT02642432|2596452|P1|Overall Study|Withdrew Consent|1
800115|NCT02642432|2596452|P1|Overall Study|Adverse Event|2
800116|NCT02642159|2596460|P2|Overall Study|Other than specified above|3
800117|NCT02642159|2596461|P1|Overall Study|Other than specified above|10
800118|NCT02642159|2596460|P2|Overall Study|Poor compliance to study protocol|0
800119|NCT02642159|2596461|P1|Overall Study|Poor compliance to study protocol|1
800120|NCT02642159|2596460|P2|Overall Study|Withdrawal by Subject|1
800121|NCT02642159|2596461|P1|Overall Study|Withdrawal by Subject|9
800122|NCT02642159|2596460|P2|Overall Study|Adverse Event|4
800123|NCT02642159|2596461|P1|Overall Study|Adverse Event|10
800124|NCT02642159|2596460|P2|Overall Study|Randomized but not treated|0
800125|NCT02642159|2596461|P1|Overall Study|Randomized but not treated|1
800126|NCT02641379|2596690|P11|Overall Study|PCR positive|0
800127|NCT02641379|2596691|P10|Overall Study|PCR positive|0
800128|NCT02641379|2596692|P9|Overall Study|PCR positive|0
800129|NCT02641379|2596693|P8|Overall Study|PCR positive|0
800130|NCT02641379|2596694|P7|Overall Study|PCR positive|1
800131|NCT02641379|2596695|P6|Overall Study|PCR positive|0
800132|NCT02641379|2596696|P5|Overall Study|PCR positive|0
800133|NCT02641379|2596697|P4|Overall Study|PCR positive|0
800134|NCT02641379|2596698|P3|Overall Study|PCR positive|0
800135|NCT02641379|2596699|P2|Overall Study|PCR positive|0
800136|NCT02641379|2596700|P1|Overall Study|PCR positive|0
800137|NCT02641379|2596690|P11|Overall Study|Missing PCR result at Week 8|0
800138|NCT02641379|2596691|P10|Overall Study|Missing PCR result at Week 8|1
800139|NCT02641379|2596692|P9|Overall Study|Missing PCR result at Week 8|0
800140|NCT02641379|2596693|P8|Overall Study|Missing PCR result at Week 8|0
800141|NCT02641379|2596694|P7|Overall Study|Missing PCR result at Week 8|0
800142|NCT02641379|2596695|P6|Overall Study|Missing PCR result at Week 8|0
800143|NCT02641379|2596696|P5|Overall Study|Missing PCR result at Week 8|0
800144|NCT02641379|2596697|P4|Overall Study|Missing PCR result at Week 8|0
800145|NCT02641379|2596698|P3|Overall Study|Missing PCR result at Week 8|0
800146|NCT02641379|2596699|P2|Overall Study|Missing PCR result at Week 8|0
800147|NCT02641379|2596700|P1|Overall Study|Missing PCR result at Week 8|0
800148|NCT02641379|2596690|P11|Overall Study|Participant treated after Week 24|0
800149|NCT02641379|2596691|P10|Overall Study|Participant treated after Week 24|0
800150|NCT02641379|2596692|P9|Overall Study|Participant treated after Week 24|1
800151|NCT02641379|2596693|P8|Overall Study|Participant treated after Week 24|0
800152|NCT02641379|2596694|P7|Overall Study|Participant treated after Week 24|0
800153|NCT02641379|2596695|P6|Overall Study|Participant treated after Week 24|0
800154|NCT02641379|2596696|P5|Overall Study|Participant treated after Week 24|0
800155|NCT02641379|2596697|P4|Overall Study|Participant treated after Week 24|0
800156|NCT02641379|2596698|P3|Overall Study|Participant treated after Week 24|0
800157|NCT02641379|2596699|P2|Overall Study|Participant treated after Week 24|0
800158|NCT02641379|2596700|P1|Overall Study|Participant treated after Week 24|0
800159|NCT02641379|2596690|P11|Overall Study|Participant’s PCR high|0
800160|NCT02641379|2596691|P10|Overall Study|Participant’s PCR high|0
800161|NCT02641379|2596692|P9|Overall Study|Participant’s PCR high|0
800162|NCT02641379|2596693|P8|Overall Study|Participant’s PCR high|1
800163|NCT02641379|2596694|P7|Overall Study|Participant’s PCR high|0
800164|NCT02641379|2596695|P6|Overall Study|Participant’s PCR high|0
800165|NCT02641379|2596696|P5|Overall Study|Participant’s PCR high|0
800166|NCT02641379|2596697|P4|Overall Study|Participant’s PCR high|0
800167|NCT02641379|2596698|P3|Overall Study|Participant’s PCR high|0
800168|NCT02641379|2596699|P2|Overall Study|Participant’s PCR high|0
800169|NCT02641379|2596700|P1|Overall Study|Participant’s PCR high|0
800170|NCT02641379|2596690|P11|Overall Study|Negative PCR result|0
800171|NCT02641379|2596691|P10|Overall Study|Negative PCR result|1
800172|NCT02641379|2596692|P9|Overall Study|Negative PCR result|0
800173|NCT02641379|2596693|P8|Overall Study|Negative PCR result|0
800174|NCT02641379|2596694|P7|Overall Study|Negative PCR result|0
800175|NCT02641379|2596695|P6|Overall Study|Negative PCR result|0
800176|NCT02641379|2596696|P5|Overall Study|Negative PCR result|0
800177|NCT02641379|2596697|P4|Overall Study|Negative PCR result|0
800178|NCT02641379|2596698|P3|Overall Study|Negative PCR result|0
800179|NCT02641379|2596699|P2|Overall Study|Negative PCR result|0
800180|NCT02641379|2596700|P1|Overall Study|Negative PCR result|0
800181|NCT02641379|2596690|P11|Overall Study|No 2 Log drop at Week 12|1
800182|NCT02641379|2596691|P10|Overall Study|No 2 Log drop at Week 12|0
800183|NCT02641379|2596692|P9|Overall Study|No 2 Log drop at Week 12|0
800184|NCT02641379|2596693|P8|Overall Study|No 2 Log drop at Week 12|0
800185|NCT02641379|2596694|P7|Overall Study|No 2 Log drop at Week 12|0
800186|NCT02641379|2596695|P6|Overall Study|No 2 Log drop at Week 12|0
800187|NCT02641379|2596696|P5|Overall Study|No 2 Log drop at Week 12|0
800188|NCT02641379|2596697|P4|Overall Study|No 2 Log drop at Week 12|0
800189|NCT02641379|2596698|P3|Overall Study|No 2 Log drop at Week 12|0
800190|NCT02641379|2596699|P2|Overall Study|No 2 Log drop at Week 12|0
800191|NCT02641379|2596700|P1|Overall Study|No 2 Log drop at Week 12|0
800192|NCT02641379|2596690|P11|Overall Study|Non-response Week 12|0
800193|NCT02641379|2596691|P10|Overall Study|Non-response Week 12|0
800194|NCT02641379|2596692|P9|Overall Study|Non-response Week 12|0
800195|NCT02641379|2596693|P8|Overall Study|Non-response Week 12|1
800196|NCT02641379|2596694|P7|Overall Study|Non-response Week 12|0
800197|NCT02641379|2596695|P6|Overall Study|Non-response Week 12|0
800198|NCT02641379|2596696|P5|Overall Study|Non-response Week 12|0
800199|NCT02641379|2596697|P4|Overall Study|Non-response Week 12|0
800200|NCT02641379|2596698|P3|Overall Study|Non-response Week 12|0
800201|NCT02641379|2596699|P2|Overall Study|Non-response Week 12|0
800202|NCT02641379|2596700|P1|Overall Study|Non-response Week 12|0
800203|NCT02641379|2596690|P11|Overall Study|Participant showed weight reduction|0
800204|NCT02641379|2596691|P10|Overall Study|Participant showed weight reduction|0
800205|NCT02641379|2596692|P9|Overall Study|Participant showed weight reduction|0
800206|NCT02641379|2596693|P8|Overall Study|Participant showed weight reduction|1
800207|NCT02641379|2596694|P7|Overall Study|Participant showed weight reduction|0
800208|NCT02641379|2596695|P6|Overall Study|Participant showed weight reduction|0
800209|NCT02641379|2596696|P5|Overall Study|Participant showed weight reduction|0
800210|NCT02641379|2596697|P4|Overall Study|Participant showed weight reduction|0
800211|NCT02641379|2596698|P3|Overall Study|Participant showed weight reduction|0
800212|NCT02641379|2596699|P2|Overall Study|Participant showed weight reduction|0
800213|NCT02641379|2596700|P1|Overall Study|Participant showed weight reduction|0
800214|NCT02641379|2596690|P11|Overall Study|Source data not found|0
800215|NCT02641379|2596691|P10|Overall Study|Source data not found|0
800216|NCT02641379|2596692|P9|Overall Study|Source data not found|0
800217|NCT02641379|2596693|P8|Overall Study|Source data not found|0
800218|NCT02641379|2596694|P7|Overall Study|Source data not found|0
800219|NCT02641379|2596695|P6|Overall Study|Source data not found|1
800220|NCT02641379|2596696|P5|Overall Study|Source data not found|0
800221|NCT02641379|2596697|P4|Overall Study|Source data not found|0
800222|NCT02641379|2596698|P3|Overall Study|Source data not found|0
800223|NCT02641379|2596699|P2|Overall Study|Source data not found|0
800224|NCT02641379|2596700|P1|Overall Study|Source data not found|0
800225|NCT02641379|2596690|P11|Overall Study|Lost to Follow-up|0
800226|NCT02641379|2596691|P10|Overall Study|Lost to Follow-up|0
800227|NCT02641379|2596692|P9|Overall Study|Lost to Follow-up|1
800228|NCT02641379|2596693|P8|Overall Study|Lost to Follow-up|0
800229|NCT02641379|2596694|P7|Overall Study|Lost to Follow-up|0
800230|NCT02641379|2596695|P6|Overall Study|Lost to Follow-up|0
800231|NCT02641379|2596696|P5|Overall Study|Lost to Follow-up|0
800232|NCT02641379|2596697|P4|Overall Study|Lost to Follow-up|0
800233|NCT02641379|2596698|P3|Overall Study|Lost to Follow-up|0
800234|NCT02641379|2596699|P2|Overall Study|Lost to Follow-up|0
800235|NCT02641379|2596700|P1|Overall Study|Lost to Follow-up|0
800236|NCT02641379|2596690|P11|Overall Study|Participation in sili rescue study|0
800237|NCT02641379|2596691|P10|Overall Study|Participation in sili rescue study|0
800238|NCT02641379|2596692|P9|Overall Study|Participation in sili rescue study|0
800239|NCT02641379|2596693|P8|Overall Study|Participation in sili rescue study|0
800240|NCT02641379|2596694|P7|Overall Study|Participation in sili rescue study|0
800241|NCT02641379|2596695|P6|Overall Study|Participation in sili rescue study|1
800242|NCT02641379|2596696|P5|Overall Study|Participation in sili rescue study|0
800243|NCT02641379|2596697|P4|Overall Study|Participation in sili rescue study|0
800244|NCT02641379|2596698|P3|Overall Study|Participation in sili rescue study|0
800245|NCT02641379|2596699|P2|Overall Study|Participation in sili rescue study|0
800246|NCT02641379|2596700|P1|Overall Study|Participation in sili rescue study|0
800247|NCT02641379|2596690|P11|Overall Study|Protocol Violation|0
800248|NCT02641379|2596691|P10|Overall Study|Protocol Violation|0
800249|NCT02641379|2596692|P9|Overall Study|Protocol Violation|1
800250|NCT02641379|2596693|P8|Overall Study|Protocol Violation|0
800251|NCT02641379|2596694|P7|Overall Study|Protocol Violation|0
800252|NCT02641379|2596695|P6|Overall Study|Protocol Violation|0
800253|NCT02641379|2596696|P5|Overall Study|Protocol Violation|2
800254|NCT02641379|2596697|P4|Overall Study|Protocol Violation|0
800255|NCT02641379|2596698|P3|Overall Study|Protocol Violation|0
800256|NCT02641379|2596699|P2|Overall Study|Protocol Violation|0
800257|NCT02641379|2596700|P1|Overall Study|Protocol Violation|0
800258|NCT02641379|2596690|P11|Overall Study|Blood could not be drawn|0
800259|NCT02641379|2596691|P10|Overall Study|Blood could not be drawn|0
800260|NCT02641379|2596692|P9|Overall Study|Blood could not be drawn|0
800261|NCT02641379|2596693|P8|Overall Study|Blood could not be drawn|0
800262|NCT02641379|2596694|P7|Overall Study|Blood could not be drawn|0
800263|NCT02641379|2596695|P6|Overall Study|Blood could not be drawn|0
800264|NCT02641379|2596696|P5|Overall Study|Blood could not be drawn|1
800265|NCT02641379|2596697|P4|Overall Study|Blood could not be drawn|0
800266|NCT02641379|2596698|P3|Overall Study|Blood could not be drawn|0
800267|NCT02641379|2596699|P2|Overall Study|Blood could not be drawn|0
800268|NCT02641379|2596700|P1|Overall Study|Blood could not be drawn|0
800269|NCT02641379|2596690|P11|Overall Study|Baseline viral load unavailable|0
800270|NCT02641379|2596691|P10|Overall Study|Baseline viral load unavailable|0
800271|NCT02641379|2596692|P9|Overall Study|Baseline viral load unavailable|0
800272|NCT02641379|2596693|P8|Overall Study|Baseline viral load unavailable|0
800273|NCT02641379|2596694|P7|Overall Study|Baseline viral load unavailable|0
800274|NCT02641379|2596695|P6|Overall Study|Baseline viral load unavailable|0
800275|NCT02641379|2596696|P5|Overall Study|Baseline viral load unavailable|0
800276|NCT02641379|2596697|P4|Overall Study|Baseline viral load unavailable|1
800277|NCT02641379|2596698|P3|Overall Study|Baseline viral load unavailable|0
800278|NCT02641379|2596699|P2|Overall Study|Baseline viral load unavailable|0
800279|NCT02641379|2596700|P1|Overall Study|Baseline viral load unavailable|0
800280|NCT02641379|2596690|P11|Overall Study|Inclusion criteria not fulfilled|0
800281|NCT02641379|2596691|P10|Overall Study|Inclusion criteria not fulfilled|0
800282|NCT02641379|2596692|P9|Overall Study|Inclusion criteria not fulfilled|0
800283|NCT02641379|2596693|P8|Overall Study|Inclusion criteria not fulfilled|0
800284|NCT02641379|2596694|P7|Overall Study|Inclusion criteria not fulfilled|0
800285|NCT02641379|2596695|P6|Overall Study|Inclusion criteria not fulfilled|0
800286|NCT02641379|2596696|P5|Overall Study|Inclusion criteria not fulfilled|0
800287|NCT02641379|2596697|P4|Overall Study|Inclusion criteria not fulfilled|1
800288|NCT02641379|2596698|P3|Overall Study|Inclusion criteria not fulfilled|0
800289|NCT02641379|2596699|P2|Overall Study|Inclusion criteria not fulfilled|0
800290|NCT02641379|2596700|P1|Overall Study|Inclusion criteria not fulfilled|0
800291|NCT02641379|2596690|P11|Overall Study|PCR sample for Week 4 not drawn|0
800292|NCT02641379|2596691|P10|Overall Study|PCR sample for Week 4 not drawn|0
800293|NCT02641379|2596692|P9|Overall Study|PCR sample for Week 4 not drawn|0
800294|NCT02641379|2596693|P8|Overall Study|PCR sample for Week 4 not drawn|0
800295|NCT02641379|2596694|P7|Overall Study|PCR sample for Week 4 not drawn|0
800296|NCT02641379|2596695|P6|Overall Study|PCR sample for Week 4 not drawn|0
800297|NCT02641379|2596696|P5|Overall Study|PCR sample for Week 4 not drawn|0
800298|NCT02641379|2596697|P4|Overall Study|PCR sample for Week 4 not drawn|1
800299|NCT02641379|2596698|P3|Overall Study|PCR sample for Week 4 not drawn|0
800300|NCT02641379|2596699|P2|Overall Study|PCR sample for Week 4 not drawn|0
800301|NCT02641379|2596700|P1|Overall Study|PCR sample for Week 4 not drawn|0
800302|NCT02641379|2596690|P11|Overall Study|PCR positive at Week 28|0
800303|NCT02641379|2596691|P10|Overall Study|PCR positive at Week 28|0
800304|NCT02641379|2596692|P9|Overall Study|PCR positive at Week 28|0
800305|NCT02641379|2596693|P8|Overall Study|PCR positive at Week 28|0
800306|NCT02641379|2596694|P7|Overall Study|PCR positive at Week 28|0
800307|NCT02641379|2596695|P6|Overall Study|PCR positive at Week 28|0
800308|NCT02641379|2596696|P5|Overall Study|PCR positive at Week 28|0
800309|NCT02641379|2596697|P4|Overall Study|PCR positive at Week 28|0
800310|NCT02641379|2596698|P3|Overall Study|PCR positive at Week 28|1
800311|NCT02641379|2596699|P2|Overall Study|PCR positive at Week 28|0
800312|NCT02641379|2596700|P1|Overall Study|PCR positive at Week 28|0
800313|NCT02641379|2596690|P11|Overall Study|No PCR at baseline|0
800314|NCT02641379|2596691|P10|Overall Study|No PCR at baseline|0
800315|NCT02641379|2596692|P9|Overall Study|No PCR at baseline|0
800316|NCT02641379|2596693|P8|Overall Study|No PCR at baseline|0
800317|NCT02641379|2596694|P7|Overall Study|No PCR at baseline|0
800318|NCT02641379|2596695|P6|Overall Study|No PCR at baseline|0
800319|NCT02641379|2596696|P5|Overall Study|No PCR at baseline|0
800320|NCT02641379|2596697|P4|Overall Study|No PCR at baseline|0
800321|NCT02641379|2596698|P3|Overall Study|No PCR at baseline|1
800322|NCT02641379|2596699|P2|Overall Study|No PCR at baseline|0
800323|NCT02641379|2596700|P1|Overall Study|No PCR at baseline|0
800324|NCT02641379|2596690|P11|Overall Study|PCR not performed at Week 12|0
800325|NCT02641379|2596691|P10|Overall Study|PCR not performed at Week 12|0
800326|NCT02641379|2596692|P9|Overall Study|PCR not performed at Week 12|0
800327|NCT02641379|2596693|P8|Overall Study|PCR not performed at Week 12|0
800328|NCT02641379|2596694|P7|Overall Study|PCR not performed at Week 12|0
800329|NCT02641379|2596695|P6|Overall Study|PCR not performed at Week 12|0
800330|NCT02641379|2596696|P5|Overall Study|PCR not performed at Week 12|0
800331|NCT02641379|2596697|P4|Overall Study|PCR not performed at Week 12|0
800332|NCT02641379|2596698|P3|Overall Study|PCR not performed at Week 12|1
800333|NCT02641379|2596699|P2|Overall Study|PCR not performed at Week 12|0
800334|NCT02641379|2596700|P1|Overall Study|PCR not performed at Week 12|0
800335|NCT02641379|2596690|P11|Overall Study|PCR positive at Week 48|0
800336|NCT02641379|2596691|P10|Overall Study|PCR positive at Week 48|0
800337|NCT02641379|2596692|P9|Overall Study|PCR positive at Week 48|0
800338|NCT02641379|2596693|P8|Overall Study|PCR positive at Week 48|0
800339|NCT02641379|2596694|P7|Overall Study|PCR positive at Week 48|0
800340|NCT02641379|2596695|P6|Overall Study|PCR positive at Week 48|0
800341|NCT02641379|2596696|P5|Overall Study|PCR positive at Week 48|0
800342|NCT02641379|2596697|P4|Overall Study|PCR positive at Week 48|0
800343|NCT02641379|2596698|P3|Overall Study|PCR positive at Week 48|0
800344|NCT02641379|2596699|P2|Overall Study|PCR positive at Week 48|1
800345|NCT02641379|2596700|P1|Overall Study|PCR positive at Week 48|0
800346|NCT02641379|2596690|P11|Overall Study|PCR positive at Week 68|0
800347|NCT02641379|2596691|P10|Overall Study|PCR positive at Week 68|0
800348|NCT02641379|2596692|P9|Overall Study|PCR positive at Week 68|0
800349|NCT02641379|2596693|P8|Overall Study|PCR positive at Week 68|0
800350|NCT02641379|2596694|P7|Overall Study|PCR positive at Week 68|0
800351|NCT02641379|2596695|P6|Overall Study|PCR positive at Week 68|0
800352|NCT02641379|2596696|P5|Overall Study|PCR positive at Week 68|0
800353|NCT02641379|2596697|P4|Overall Study|PCR positive at Week 68|0
800354|NCT02641379|2596698|P3|Overall Study|PCR positive at Week 68|0
800355|NCT02641379|2596699|P2|Overall Study|PCR positive at Week 68|1
800356|NCT02641379|2596700|P1|Overall Study|PCR positive at Week 68|0
800357|NCT02641379|2596690|P11|Overall Study|Financial problems|0
800358|NCT02641379|2596691|P10|Overall Study|Financial problems|0
800359|NCT02641379|2596692|P9|Overall Study|Financial problems|0
800360|NCT02641379|2596693|P8|Overall Study|Financial problems|0
800361|NCT02641379|2596694|P7|Overall Study|Financial problems|0
800362|NCT02641379|2596695|P6|Overall Study|Financial problems|0
800363|NCT02641379|2596696|P5|Overall Study|Financial problems|0
800364|NCT02641379|2596697|P4|Overall Study|Financial problems|0
800365|NCT02641379|2596698|P3|Overall Study|Financial problems|0
800366|NCT02641379|2596699|P2|Overall Study|Financial problems|1
800367|NCT02641379|2596700|P1|Overall Study|Financial problems|0
800368|NCT02641379|2596690|P11|Overall Study|Therapy stopped due to misunderstanding|0
800369|NCT02641379|2596691|P10|Overall Study|Therapy stopped due to misunderstanding|0
800370|NCT02641379|2596692|P9|Overall Study|Therapy stopped due to misunderstanding|0
800371|NCT02641379|2596693|P8|Overall Study|Therapy stopped due to misunderstanding|0
800372|NCT02641379|2596694|P7|Overall Study|Therapy stopped due to misunderstanding|0
800373|NCT02641379|2596695|P6|Overall Study|Therapy stopped due to misunderstanding|0
800374|NCT02641379|2596696|P5|Overall Study|Therapy stopped due to misunderstanding|0
800375|NCT02641379|2596697|P4|Overall Study|Therapy stopped due to misunderstanding|0
800376|NCT02641379|2596698|P3|Overall Study|Therapy stopped due to misunderstanding|0
800377|NCT02641379|2596699|P2|Overall Study|Therapy stopped due to misunderstanding|0
800378|NCT02641379|2596700|P1|Overall Study|Therapy stopped due to misunderstanding|1
800379|NCT02641379|2596690|P11|Overall Study|Participant stopped study/treatment|0
800380|NCT02641379|2596691|P10|Overall Study|Participant stopped study/treatment|0
800381|NCT02641379|2596692|P9|Overall Study|Participant stopped study/treatment|1
800382|NCT02641379|2596693|P8|Overall Study|Participant stopped study/treatment|0
800383|NCT02641379|2596694|P7|Overall Study|Participant stopped study/treatment|2
800384|NCT02641379|2596695|P6|Overall Study|Participant stopped study/treatment|1
800385|NCT02641379|2596696|P5|Overall Study|Participant stopped study/treatment|0
800386|NCT02641379|2596697|P4|Overall Study|Participant stopped study/treatment|0
800387|NCT02641379|2596698|P3|Overall Study|Participant stopped study/treatment|1
800388|NCT02641379|2596699|P2|Overall Study|Participant stopped study/treatment|3
800389|NCT02641379|2596700|P1|Overall Study|Participant stopped study/treatment|1
800390|NCT02641379|2596690|P11|Overall Study|Participant showed relapse|0
800391|NCT02641379|2596691|P10|Overall Study|Participant showed relapse|0
800392|NCT02641379|2596692|P9|Overall Study|Participant showed relapse|0
800393|NCT02641379|2596693|P8|Overall Study|Participant showed relapse|0
800394|NCT02641379|2596694|P7|Overall Study|Participant showed relapse|1
800395|NCT02641379|2596695|P6|Overall Study|Participant showed relapse|0
800396|NCT02641379|2596696|P5|Overall Study|Participant showed relapse|0
800397|NCT02641379|2596697|P4|Overall Study|Participant showed relapse|0
800398|NCT02641379|2596698|P3|Overall Study|Participant showed relapse|0
800399|NCT02641379|2596699|P2|Overall Study|Participant showed relapse|0
800400|NCT02641379|2596700|P1|Overall Study|Participant showed relapse|1
800401|NCT02641379|2596690|P11|Overall Study|PCR positive at follow up 2|0
800402|NCT02641379|2596691|P10|Overall Study|PCR positive at follow up 2|0
800403|NCT02641379|2596692|P9|Overall Study|PCR positive at follow up 2|0
800404|NCT02641379|2596693|P8|Overall Study|PCR positive at follow up 2|0
800405|NCT02641379|2596694|P7|Overall Study|PCR positive at follow up 2|0
800406|NCT02641379|2596695|P6|Overall Study|PCR positive at follow up 2|0
800407|NCT02641379|2596696|P5|Overall Study|PCR positive at follow up 2|0
800408|NCT02641379|2596697|P4|Overall Study|PCR positive at follow up 2|0
800409|NCT02641379|2596698|P3|Overall Study|PCR positive at follow up 2|0
800410|NCT02641379|2596699|P2|Overall Study|PCR positive at follow up 2|0
800411|NCT02641379|2596700|P1|Overall Study|PCR positive at follow up 2|1
800412|NCT02641379|2596690|P11|Overall Study|PCR positive at Week 24|0
800413|NCT02641379|2596691|P10|Overall Study|PCR positive at Week 24|1
800414|NCT02641379|2596692|P9|Overall Study|PCR positive at Week 24|0
800415|NCT02641379|2596693|P8|Overall Study|PCR positive at Week 24|8
800416|NCT02641379|2596694|P7|Overall Study|PCR positive at Week 24|3
800417|NCT02641379|2596695|P6|Overall Study|PCR positive at Week 24|6
800418|NCT02641379|2596696|P5|Overall Study|PCR positive at Week 24|0
800419|NCT02641379|2596697|P4|Overall Study|PCR positive at Week 24|0
800420|NCT02641379|2596698|P3|Overall Study|PCR positive at Week 24|62
800421|NCT02641379|2596699|P2|Overall Study|PCR positive at Week 24|21
800422|NCT02641379|2596700|P1|Overall Study|PCR positive at Week 24|15
800423|NCT02641379|2596690|P11|Overall Study|Participant cannot be reached|1
800424|NCT02641379|2596691|P10|Overall Study|Participant cannot be reached|2
800425|NCT02641379|2596692|P9|Overall Study|Participant cannot be reached|0
800426|NCT02641379|2596693|P8|Overall Study|Participant cannot be reached|1
800427|NCT02641379|2596694|P7|Overall Study|Participant cannot be reached|0
800428|NCT02641379|2596695|P6|Overall Study|Participant cannot be reached|1
800429|NCT02641379|2596696|P5|Overall Study|Participant cannot be reached|2
800430|NCT02641379|2596697|P4|Overall Study|Participant cannot be reached|8
800431|NCT02641379|2596698|P3|Overall Study|Participant cannot be reached|0
800432|NCT02641379|2596699|P2|Overall Study|Participant cannot be reached|4
800433|NCT02641379|2596700|P1|Overall Study|Participant cannot be reached|4
800434|NCT02641379|2596690|P11|Overall Study|Participant’s compliance|1
800435|NCT02641379|2596691|P10|Overall Study|Participant’s compliance|1
800436|NCT02641379|2596692|P9|Overall Study|Participant’s compliance|1
800437|NCT02641379|2596693|P8|Overall Study|Participant’s compliance|0
800438|NCT02641379|2596694|P7|Overall Study|Participant’s compliance|0
800439|NCT02641379|2596695|P6|Overall Study|Participant’s compliance|2
800440|NCT02641379|2596696|P5|Overall Study|Participant’s compliance|0
800441|NCT02641379|2596697|P4|Overall Study|Participant’s compliance|1
800442|NCT02641379|2596698|P3|Overall Study|Participant’s compliance|0
800443|NCT02641379|2596699|P2|Overall Study|Participant’s compliance|1
800444|NCT02641379|2596700|P1|Overall Study|Participant’s compliance|0
800445|NCT02641379|2596690|P11|Overall Study|Participant unable to attend study visit|0
800446|NCT02641379|2596691|P10|Overall Study|Participant unable to attend study visit|2
800447|NCT02641379|2596692|P9|Overall Study|Participant unable to attend study visit|0
800448|NCT02641379|2596693|P8|Overall Study|Participant unable to attend study visit|1
800449|NCT02641379|2596694|P7|Overall Study|Participant unable to attend study visit|1
800450|NCT02641379|2596695|P6|Overall Study|Participant unable to attend study visit|1
800451|NCT02641379|2596696|P5|Overall Study|Participant unable to attend study visit|5
800452|NCT02641379|2596697|P4|Overall Study|Participant unable to attend study visit|2
800453|NCT02641379|2596698|P3|Overall Study|Participant unable to attend study visit|1
800454|NCT02641379|2596699|P2|Overall Study|Participant unable to attend study visit|10
800455|NCT02641379|2596700|P1|Overall Study|Participant unable to attend study visit|4
800456|NCT02641379|2596690|P11|Overall Study|Lack of Efficacy|0
800457|NCT02641379|2596691|P10|Overall Study|Lack of Efficacy|0
800458|NCT02641379|2596692|P9|Overall Study|Lack of Efficacy|0
800459|NCT02641379|2596693|P8|Overall Study|Lack of Efficacy|5
800460|NCT02641379|2596694|P7|Overall Study|Lack of Efficacy|0
800461|NCT02641379|2596695|P6|Overall Study|Lack of Efficacy|2
800462|NCT02641379|2596696|P5|Overall Study|Lack of Efficacy|0
800463|NCT02641379|2596697|P4|Overall Study|Lack of Efficacy|0
800464|NCT02641379|2596698|P3|Overall Study|Lack of Efficacy|2
800465|NCT02641379|2596699|P2|Overall Study|Lack of Efficacy|0
800466|NCT02641379|2596700|P1|Overall Study|Lack of Efficacy|0
800467|NCT02641379|2596690|P11|Overall Study|Adverse Event|5
800468|NCT02641379|2596691|P10|Overall Study|Adverse Event|1
800469|NCT02641379|2596692|P9|Overall Study|Adverse Event|1
800470|NCT02641379|2596693|P8|Overall Study|Adverse Event|0
800471|NCT02641379|2596694|P7|Overall Study|Adverse Event|5
800472|NCT02641379|2596695|P6|Overall Study|Adverse Event|1
800473|NCT02641379|2596696|P5|Overall Study|Adverse Event|5
800474|NCT02641379|2596697|P4|Overall Study|Adverse Event|2
800475|NCT02641379|2596698|P3|Overall Study|Adverse Event|2
800476|NCT02641379|2596699|P2|Overall Study|Adverse Event|8
800477|NCT02641379|2596700|P1|Overall Study|Adverse Event|7
800478|NCT02641379|2596690|P11|Overall Study|Withdrawal of informed consent|0
800479|NCT02641379|2596691|P10|Overall Study|Withdrawal of informed consent|0
800480|NCT02641379|2596692|P9|Overall Study|Withdrawal of informed consent|0
800481|NCT02641379|2596693|P8|Overall Study|Withdrawal of informed consent|1
800482|NCT02641379|2596694|P7|Overall Study|Withdrawal of informed consent|0
800483|NCT02641379|2596695|P6|Overall Study|Withdrawal of informed consent|0
800484|NCT02641379|2596696|P5|Overall Study|Withdrawal of informed consent|0
800485|NCT02641379|2596697|P4|Overall Study|Withdrawal of informed consent|0
800486|NCT02641379|2596698|P3|Overall Study|Withdrawal of informed consent|0
800487|NCT02641379|2596699|P2|Overall Study|Withdrawal of informed consent|1
800488|NCT02641379|2596700|P1|Overall Study|Withdrawal of informed consent|0
800489|NCT02641379|2596690|P11|Overall Study|Exclusion criterion during screening|0
800490|NCT02641379|2596691|P10|Overall Study|Exclusion criterion during screening|0
800491|NCT02641379|2596692|P9|Overall Study|Exclusion criterion during screening|0
800492|NCT02641379|2596693|P8|Overall Study|Exclusion criterion during screening|0
800493|NCT02641379|2596694|P7|Overall Study|Exclusion criterion during screening|0
800494|NCT02641379|2596695|P6|Overall Study|Exclusion criterion during screening|0
800495|NCT02641379|2596696|P5|Overall Study|Exclusion criterion during screening|2
800496|NCT02641379|2596697|P4|Overall Study|Exclusion criterion during screening|1
800497|NCT02641379|2596698|P3|Overall Study|Exclusion criterion during screening|0
800498|NCT02641379|2596699|P2|Overall Study|Exclusion criterion during screening|0
800499|NCT02641379|2596700|P1|Overall Study|Exclusion criterion during screening|1
800500|NCT02640547|2596774|P1|Overall Study|Miscellaneous|3
800501|NCT02640547|2596774|P1|Overall Study|Death|6
800502|NCT02640547|2596774|P1|Overall Study|Withdrawal by Subject|1
800503|NCT02640547|2596774|P1|Overall Study|Failure to Return|1
800504|NCT02640482|2596851|P2|Overall Study|Lost to Follow-up|0
800505|NCT02640482|2596852|P1|Overall Study|Lost to Follow-up|3
800506|NCT02640404|2596864|P2|Overall Study|Withdrawal by Subject|0
800507|NCT02640404|2596865|P1|Overall Study|Withdrawal by Subject|1
800508|NCT02640404|2596864|P2|Overall Study|Protocol Violation|0
800509|NCT02640404|2596865|P1|Overall Study|Protocol Violation|1
800510|NCT02640157|2596876|P3|Overall Study|Randomized in error; did not receive Tx|0
800511|NCT02640157|2596877|P2|Overall Study|Randomized in error; did not receive Tx|1
800512|NCT02640157|2596878|P1|Overall Study|Randomized in error; did not receive Tx|0
800513|NCT02640157|2596876|P3|Overall Study|Lost to Follow-up|7
800514|NCT02640157|2596877|P2|Overall Study|Lost to Follow-up|2
800515|NCT02640157|2596878|P1|Overall Study|Lost to Follow-up|9
800516|NCT02640157|2596876|P3|Overall Study|Withdrew consent|2
800517|NCT02640157|2596877|P2|Overall Study|Withdrew consent|0
800518|NCT02640157|2596878|P1|Overall Study|Withdrew consent|2
800519|NCT02640157|2596876|P3|Overall Study|Adverse Event|1
800520|NCT02640157|2596877|P2|Overall Study|Adverse Event|2
800521|NCT02640157|2596878|P1|Overall Study|Adverse Event|2
800522|NCT02640053|2596897|P2|Overall Study|Chemo regimen changed after 1st Rx|1
800523|NCT02640053|2596898|P1|Overall Study|Chemo regimen changed after 1st Rx|0
800524|NCT02640053|2596897|P2|Overall Study|Alternative Therapy|1
800525|NCT02640053|2596898|P1|Overall Study|Alternative Therapy|1
800526|NCT02640053|2596897|P2|Overall Study|Adverse Event|1
800527|NCT02640053|2596898|P1|Overall Study|Adverse Event|1
800528|NCT02640053|2596897|P2|Overall Study|Withdrawal by Subject|1
800529|NCT02640053|2596898|P1|Overall Study|Withdrawal by Subject|2
800530|NCT02639338|2597003|P2|Overall Study|Randomized but Not Treated|1
800531|NCT02639338|2597004|P1|Overall Study|Randomized but Not Treated|0
800532|NCT02639338|2597003|P2|Overall Study|Death|0
800533|NCT02639338|2597004|P1|Overall Study|Death|1
800534|NCT02639338|2597003|P2|Overall Study|Withdrew Consent|2
800535|NCT02639338|2597004|P1|Overall Study|Withdrew Consent|1
800536|NCT02639338|2597003|P2|Overall Study|Lost to Follow-up|2
800537|NCT02639338|2597004|P1|Overall Study|Lost to Follow-up|2
800538|NCT02639247|2597022|P2|Overall Study|Protocol Violation|0
800539|NCT02639247|2597023|P1|Overall Study|Protocol Violation|1
800540|NCT02639247|2597022|P2|Overall Study|Withdrew Consent|1
800541|NCT02639247|2597023|P1|Overall Study|Withdrew Consent|0
800542|NCT02639247|2597022|P2|Overall Study|Death|0
800543|NCT02639247|2597023|P1|Overall Study|Death|2
800544|NCT02639247|2597022|P2|Overall Study|Lost to Follow-up|1
800545|NCT02639247|2597023|P1|Overall Study|Lost to Follow-up|2
800546|NCT02639052|2597039|P1|Overall Study|Lost to Follow-up|1
800547|NCT02638493|2597056|P3|Overall Study|Inability to provide semen samples|0
800548|NCT02638493|2597057|P2|Overall Study|Inability to provide semen samples|0
800549|NCT02638493|2597058|P1|Overall Study|Inability to provide semen samples|2
800550|NCT02638259|2597089|P2|Treatment Period 2|Withdrawal by Subject|7
800551|NCT02638259|2597090|P1|Treatment Period 2|Withdrawal by Subject|1
800552|NCT02638259|2597089|P2|Treatment Period 2|Adverse Event|4
800553|NCT02638259|2597090|P1|Treatment Period 2|Adverse Event|5
800554|NCT02638259|2597089|P2|Treatment Period 1|Withdrawn per sponsor decision|2
800555|NCT02638259|2597090|P1|Treatment Period 1|Withdrawn per sponsor decision|0
800556|NCT02638259|2597089|P2|Treatment Period 1|Withdrawal by Subject|6
800557|NCT02638259|2597090|P1|Treatment Period 1|Withdrawal by Subject|4
800558|NCT02638259|2597089|P2|Treatment Period 1|Protocol Violation|3
800559|NCT02638259|2597090|P1|Treatment Period 1|Protocol Violation|0
800560|NCT02638259|2597089|P2|Treatment Period 1|Lack of Efficacy|1
800561|NCT02638259|2597090|P1|Treatment Period 1|Lack of Efficacy|0
800562|NCT02638259|2597089|P2|Treatment Period 1|Death|1
800563|NCT02638259|2597090|P1|Treatment Period 1|Death|0
800564|NCT02638259|2597089|P2|Treatment Period 1|Adverse Event|5
800565|NCT02638259|2597090|P1|Treatment Period 1|Adverse Event|1
800566|NCT02638129|2597166|P2|Overall Study|Study terminated|30
800567|NCT02638129|2597167|P1|Overall Study|Study terminated|28
800568|NCT02637323|2597340|P2|Overall Study|Protocol Violation|1
800569|NCT02637323|2597341|P1|Overall Study|Protocol Violation|0
800570|NCT02637323|2597340|P2|Overall Study|Lost to Follow-up|0
800571|NCT02637323|2597341|P1|Overall Study|Lost to Follow-up|2
800572|NCT02637063|2597352|P3|Overall Study|Withdrawal by Subject|3
800573|NCT02637063|2597353|P2|Overall Study|Withdrawal by Subject|2
800574|NCT02637063|2597354|P1|Overall Study|Withdrawal by Subject|2
800575|NCT02637063|2597352|P3|Overall Study|Lost to Follow-up|3
800576|NCT02637063|2597353|P2|Overall Study|Lost to Follow-up|2
800577|NCT02637063|2597354|P1|Overall Study|Lost to Follow-up|3
800578|NCT02637037|2597382|P2|Overall Study|Adverse Event|0
800579|NCT02637037|2597383|P1|Overall Study|Adverse Event|1
800580|NCT02637037|2597382|P2|Overall Study|Withdrawal by Subject|1
800581|NCT02637037|2597383|P1|Overall Study|Withdrawal by Subject|2
800582|NCT02637037|2597382|P2|Overall Study|Positive drug screen at admission|0
800583|NCT02637037|2597383|P1|Overall Study|Positive drug screen at admission|1
800584|NCT02636907|2597449|P1|Extension Phase|Lack of Efficacy|1
800585|NCT02636907|2597449|P1|Extension Phase|Lost to Follow-up|2
800586|NCT02636907|2597449|P1|Extension Phase|Physician Decision|1
800587|NCT02636907|2597449|P1|Extension Phase|Withdrawal by Subject|4
800588|NCT02636907|2597449|P1|Extension Phase|Adverse Event|2
800589|NCT02636907|2597449|P1|Autoinjector Assessment Period|Withdrawal by Subject|2
800590|NCT02636907|2597449|P1|Autoinjector Assessment Period|Adverse Event|2
800591|NCT02636595|2597458|P1|Overall Study|Not specified|1
800592|NCT02636595|2597458|P1|Overall Study|Lost to Follow-up|1
800593|NCT02635984|2597466|P2|Overall Study|Study Arm Closed|0
800594|NCT02635984|2597467|P1|Overall Study|Study Arm Closed|1
800595|NCT02635984|2597466|P2|Overall Study|Lost to Follow-up|4
800596|NCT02635984|2597467|P1|Overall Study|Lost to Follow-up|2
800597|NCT02635204|2597536|P2|Overall Study|Lost to Follow-up|1
800598|NCT02635204|2597537|P1|Overall Study|Lost to Follow-up|1
800599|NCT02635204|2597536|P2|Overall Study|Adverse Event|0
800600|NCT02635204|2597537|P1|Overall Study|Adverse Event|1
800601|NCT02634801|2597550|P3|Overall Study|Withdrawal by Subject|3
800602|NCT02634801|2597551|P2|Overall Study|Withdrawal by Subject|8
800603|NCT02634801|2597552|P1|Overall Study|Withdrawal by Subject|1
800604|NCT02634801|2597550|P3|Overall Study|Protocol Violation|1
800605|NCT02634801|2597551|P2|Overall Study|Protocol Violation|0
800606|NCT02634801|2597552|P1|Overall Study|Protocol Violation|0
800607|NCT02634801|2597550|P3|Overall Study|Lost to Follow-up|1
800608|NCT02634801|2597551|P2|Overall Study|Lost to Follow-up|1
800609|NCT02634801|2597552|P1|Overall Study|Lost to Follow-up|2
800610|NCT02634801|2597550|P3|Overall Study|Lack of Efficacy|0
800611|NCT02634801|2597551|P2|Overall Study|Lack of Efficacy|2
800612|NCT02634801|2597552|P1|Overall Study|Lack of Efficacy|0
800613|NCT02634801|2597550|P3|Overall Study|Adverse Event|0
800614|NCT02634801|2597551|P2|Overall Study|Adverse Event|20
800615|NCT02634801|2597552|P1|Overall Study|Adverse Event|2
800616|NCT02634788|2597648|P4|Overall Study|Withdrawal by Subject|0
800617|NCT02634788|2597649|P3|Overall Study|Withdrawal by Subject|1
800618|NCT02634788|2597650|P2|Overall Study|Withdrawal by Subject|1
800619|NCT02634788|2597651|P1|Overall Study|Withdrawal by Subject|0
800620|NCT02634788|2597648|P4|Overall Study|Lost to Follow-up|0
800621|NCT02634788|2597649|P3|Overall Study|Lost to Follow-up|0
800622|NCT02634788|2597650|P2|Overall Study|Lost to Follow-up|1
800623|NCT02634788|2597651|P1|Overall Study|Lost to Follow-up|0
800624|NCT02634788|2597648|P4|Overall Study|Lack of Efficacy|4
800625|NCT02634788|2597649|P3|Overall Study|Lack of Efficacy|1
800626|NCT02634788|2597650|P2|Overall Study|Lack of Efficacy|0
800627|NCT02634788|2597651|P1|Overall Study|Lack of Efficacy|4
800628|NCT02634788|2597648|P4|Overall Study|Adverse Event|1
800629|NCT02634788|2597649|P3|Overall Study|Adverse Event|3
800630|NCT02634788|2597650|P2|Overall Study|Adverse Event|8
800631|NCT02634788|2597651|P1|Overall Study|Adverse Event|0
800632|NCT02634580|2597721|P4|Overall Study|Subject Request|1
800633|NCT02634580|2597722|P3|Overall Study|Subject Request|1
800634|NCT02634580|2597723|P2|Overall Study|Subject Request|0
800635|NCT02634580|2597724|P1|Overall Study|Subject Request|1
800636|NCT02634346|2597781|P3|Overall Study|Protocol Violation|0
800637|NCT02634346|2597782|P2|Overall Study|Protocol Violation|1
800638|NCT02634346|2597783|P1|Overall Study|Protocol Violation|0
800639|NCT02634346|2597781|P3|Overall Study|Lost to Follow-up|0
800640|NCT02634346|2597782|P2|Overall Study|Lost to Follow-up|0
800641|NCT02634346|2597783|P1|Overall Study|Lost to Follow-up|1
800642|NCT02634346|2597781|P3|Overall Study|Lack of Efficacy|8
800643|NCT02634346|2597782|P2|Overall Study|Lack of Efficacy|2
800644|NCT02634346|2597783|P1|Overall Study|Lack of Efficacy|1
800645|NCT02634346|2597781|P3|Overall Study|Adverse Event|7
800646|NCT02634346|2597782|P2|Overall Study|Adverse Event|2
800647|NCT02634346|2597783|P1|Overall Study|Adverse Event|2
800648|NCT02634346|2597781|P3|Overall Study|Withdrawal by Subject|8
800649|NCT02634346|2597782|P2|Overall Study|Withdrawal by Subject|9
800650|NCT02634346|2597783|P1|Overall Study|Withdrawal by Subject|8
800651|NCT02634320|2597797|P1|Overall Study|Lack of Efficacy|2
800652|NCT02634320|2597797|P1|Overall Study|Withdrawal by Subject|5
800653|NCT02634320|2597797|P1|Overall Study|Protocol Violation|1
800654|NCT02634320|2597797|P1|Overall Study|Out of window for study visits|1
800655|NCT02634320|2597797|P1|Overall Study|Moved out of area|2
800656|NCT02634320|2597797|P1|Overall Study|Lost to Follow-up|3
800657|NCT02634320|2597797|P1|Overall Study|Adverse Event|2
800658|NCT02633787|2597920|P1|Overall Study|Withdrawal by Subject|1
800659|NCT02633215|2597932|P2|Overall Study|Lost to Follow-up|3
800660|NCT02633215|2597933|P1|Overall Study|Lost to Follow-up|2
800661|NCT02632838|2597945|P2|Overall Study|Lost to Follow-up|2
800662|NCT02632838|2597946|P1|Overall Study|Lost to Follow-up|0
800663|NCT02632838|2597945|P2|Overall Study|Withdrawal by Subject|0
800664|NCT02632838|2597946|P1|Overall Study|Withdrawal by Subject|3
800665|NCT02632110|2597986|P10|Overall Study|Withdrawal by Subject|1
800666|NCT02632110|2597987|P9|Overall Study|Withdrawal by Subject|1
800667|NCT02632110|2597988|P8|Overall Study|Withdrawal by Subject|3
800668|NCT02632110|2597989|P7|Overall Study|Withdrawal by Subject|3
800669|NCT02632110|2597990|P6|Overall Study|Withdrawal by Subject|1
800670|NCT02632110|2597991|P5|Overall Study|Withdrawal by Subject|1
800671|NCT02632110|2597992|P4|Overall Study|Withdrawal by Subject|0
800672|NCT02632110|2597993|P3|Overall Study|Withdrawal by Subject|0
800673|NCT02632110|2597994|P2|Overall Study|Withdrawal by Subject|1
800674|NCT02632110|2597995|P1|Overall Study|Withdrawal by Subject|1
800675|NCT02631551|2598466|P4|Overall Study|Other, specific reasons not collected|2
800676|NCT02631551|2598467|P3|Overall Study|Other, specific reasons not collected|2
800677|NCT02631551|2598468|P2|Overall Study|Other, specific reasons not collected|7
800678|NCT02631551|2598469|P1|Overall Study|Other, specific reasons not collected|5
800679|NCT02631551|2598466|P4|Overall Study|Non-compliance with study drug|0
800680|NCT02631551|2598467|P3|Overall Study|Non-compliance with study drug|0
800681|NCT02631551|2598468|P2|Overall Study|Non-compliance with study drug|0
800682|NCT02631551|2598469|P1|Overall Study|Non-compliance with study drug|1
800683|NCT02631551|2598466|P4|Overall Study|Non-compliance with study procedures|1
800684|NCT02631551|2598467|P3|Overall Study|Non-compliance with study procedures|1
800685|NCT02631551|2598468|P2|Overall Study|Non-compliance with study procedures|0
800686|NCT02631551|2598469|P1|Overall Study|Non-compliance with study procedures|0
800687|NCT02631551|2598466|P4|Overall Study|Protocol deviation|0
800688|NCT02631551|2598467|P3|Overall Study|Protocol deviation|3
800689|NCT02631551|2598468|P2|Overall Study|Protocol deviation|6
800690|NCT02631551|2598469|P1|Overall Study|Protocol deviation|3
800691|NCT02631551|2598466|P4|Overall Study|Withdrawal by Subject|5
800692|NCT02631551|2598467|P3|Overall Study|Withdrawal by Subject|0
800693|NCT02631551|2598468|P2|Overall Study|Withdrawal by Subject|2
800694|NCT02631551|2598469|P1|Overall Study|Withdrawal by Subject|2
800695|NCT02631551|2598466|P4|Overall Study|Lost to Follow-up|3
800696|NCT02631551|2598467|P3|Overall Study|Lost to Follow-up|0
800697|NCT02631551|2598468|P2|Overall Study|Lost to Follow-up|2
800698|NCT02631551|2598469|P1|Overall Study|Lost to Follow-up|1
800699|NCT02631551|2598466|P4|Overall Study|Lack of Efficacy|0
800700|NCT02631551|2598467|P3|Overall Study|Lack of Efficacy|1
800701|NCT02631551|2598468|P2|Overall Study|Lack of Efficacy|0
800702|NCT02631551|2598469|P1|Overall Study|Lack of Efficacy|0
800703|NCT02631551|2598466|P4|Overall Study|Adverse Event|0
800704|NCT02631551|2598467|P3|Overall Study|Adverse Event|4
800705|NCT02631551|2598468|P2|Overall Study|Adverse Event|2
800706|NCT02631551|2598469|P1|Overall Study|Adverse Event|1
800707|NCT02630563|2598505|P1|Overall Study|Administrative|1
800708|NCT02629861|2598517|P3|Overall Study|Pregnancy|0
800709|NCT02629861|2598518|P2|Overall Study|Pregnancy|1
800710|NCT02629861|2598519|P1|Overall Study|Pregnancy|2
800711|NCT02629861|2598517|P3|Overall Study|Not specified|0
800712|NCT02629861|2598518|P2|Overall Study|Not specified|1
800713|NCT02629861|2598519|P1|Overall Study|Not specified|1
800714|NCT02629861|2598517|P3|Overall Study|Lost to Follow-up|4
800715|NCT02629861|2598518|P2|Overall Study|Lost to Follow-up|9
800716|NCT02629861|2598519|P1|Overall Study|Lost to Follow-up|12
800717|NCT02629861|2598517|P3|Overall Study|Protocol Violation|7
800718|NCT02629861|2598518|P2|Overall Study|Protocol Violation|3
800719|NCT02629861|2598519|P1|Overall Study|Protocol Violation|2
800720|NCT02629861|2598517|P3|Overall Study|Withdrawal by Subject|13
800721|NCT02629861|2598518|P2|Overall Study|Withdrawal by Subject|8
800722|NCT02629861|2598519|P1|Overall Study|Withdrawal by Subject|5
800723|NCT02629861|2598517|P3|Overall Study|Adverse Event|4
800724|NCT02629861|2598518|P2|Overall Study|Adverse Event|5
800725|NCT02629861|2598519|P1|Overall Study|Adverse Event|7
800726|NCT02628938|2598599|P3|Overall Study|Failure to comply with the instructions|3
800727|NCT02628938|2598600|P2|Overall Study|Failure to comply with the instructions|0
800728|NCT02628938|2598601|P1|Overall Study|Failure to comply with the instructions|3
800729|NCT02628938|2598599|P3|Overall Study|Did not attend the follow up recall|1
800730|NCT02628938|2598600|P2|Overall Study|Did not attend the follow up recall|2
800731|NCT02628938|2598601|P1|Overall Study|Did not attend the follow up recall|2
800732|NCT02628418|2598617|P2|Overall Study|Lost to Follow-up|2
800733|NCT02628418|2598618|P1|Overall Study|Lost to Follow-up|1
800734|NCT02627144|2598693|P1|Overall Study|Other|17
800735|NCT02627144|2598693|P1|Overall Study|Enrolled, not treated|6
800736|NCT02627144|2598693|P1|Overall Study|Lost to Follow-up|8
800737|NCT02627144|2598693|P1|Overall Study|Administrative reasons|65
800738|NCT02627144|2598693|P1|Overall Study|Refusal of treatment / poor cooperation|38
800739|NCT02627144|2598693|P1|Overall Study|Death from other cause|8
800740|NCT02627144|2598693|P1|Overall Study|Death from cancer|20
800741|NCT02627144|2598693|P1|Overall Study|Cancer progression|171
800742|NCT02627144|2598693|P1|Overall Study|Serious adverse event|32
800743|NCT02626520|2598760|P2|Overall Study|Study terminated|1
800744|NCT02626520|2598761|P1|Overall Study|Study terminated|0
800745|NCT02626520|2598760|P2|Overall Study|Did not start protocol therapy|2
800746|NCT02626520|2598761|P1|Overall Study|Did not start protocol therapy|0
800747|NCT02626520|2598760|P2|Overall Study|Lack of Efficacy|2
800748|NCT02626520|2598761|P1|Overall Study|Lack of Efficacy|0
800749|NCT02626520|2598760|P2|Overall Study|Adverse Event|4
800750|NCT02626520|2598761|P1|Overall Study|Adverse Event|0
800751|NCT02626520|2598760|P2|Overall Study|Physician Decision|1
800752|NCT02626520|2598761|P1|Overall Study|Physician Decision|1
800753|NCT02625922|2598773|P2|Overall Study|Systolic blood pressure < 125 mmHg|1
800754|NCT02625922|2598774|P1|Overall Study|Systolic blood pressure < 125 mmHg|1
800755|NCT02625922|2598773|P2|Overall Study|Non-availability of IMP|1
800756|NCT02625922|2598774|P1|Overall Study|Non-availability of IMP|1
800757|NCT02625623|2598793|P2|Overall Study|Off-Treatment, but follow up ongoing|24
800758|NCT02625623|2598794|P1|Overall Study|Off-Treatment, but follow up ongoing|30
800759|NCT02625623|2598793|P2|Overall Study|Still on Treatment|10
800760|NCT02625623|2598794|P1|Overall Study|Still on Treatment|10
800761|NCT02625623|2598793|P2|Overall Study|Participants randomized but not treated|1
800762|NCT02625623|2598794|P1|Overall Study|Participants randomized but not treated|9
800763|NCT02625259|2598843|P5|First Intervention (Day 1)|Withdrawal by Subject|0
800764|NCT02625259|2598844|P4|First Intervention (Day 1)|Withdrawal by Subject|1
800765|NCT02625259|2598845|P3|First Intervention (Day 1)|Withdrawal by Subject|0
800766|NCT02625259|2598846|P2|First Intervention (Day 1)|Withdrawal by Subject|0
800767|NCT02625259|2598847|P1|First Intervention (Day 1)|Withdrawal by Subject|0
800768|NCT02625259|2598843|P5|First Intervention (Day 1)|Adverse Event|0
800769|NCT02625259|2598844|P4|First Intervention (Day 1)|Adverse Event|0
800770|NCT02625259|2598845|P3|First Intervention (Day 1)|Adverse Event|0
800771|NCT02625259|2598846|P2|First Intervention (Day 1)|Adverse Event|1
800772|NCT02625259|2598847|P1|First Intervention (Day 1)|Adverse Event|2
800773|NCT02625259|2598843|P5|First Intervention (Day 1)|Other|0
800774|NCT02625259|2598844|P4|First Intervention (Day 1)|Other|0
800775|NCT02625259|2598845|P3|First Intervention (Day 1)|Other|1
800776|NCT02625259|2598846|P2|First Intervention (Day 1)|Other|0
800777|NCT02625259|2598847|P1|First Intervention (Day 1)|Other|0
800778|NCT02625233|2598884|P2|Overall Study|Adverse Event|0
800779|NCT02625233|2598885|P1|Overall Study|Adverse Event|2
800780|NCT02625220|2598893|P1|Overall Study|Study discontinued at site|2
800781|NCT02625220|2598893|P1|Overall Study|Protocol Violation|1
800782|NCT02625220|2598893|P1|Overall Study|Lost to Follow-up|2
800783|NCT02625220|2598893|P1|Overall Study|Adverse Event|2
800784|NCT02624791|2598993|P6|Overall Study|Withdrawal by Subject|0
800785|NCT02624791|2598994|P5|Overall Study|Withdrawal by Subject|0
800786|NCT02624791|2598995|P4|Overall Study|Withdrawal by Subject|0
800787|NCT02624791|2598996|P3|Overall Study|Withdrawal by Subject|0
800788|NCT02624791|2598997|P2|Overall Study|Withdrawal by Subject|0
800789|NCT02624791|2598998|P1|Overall Study|Withdrawal by Subject|2
800790|NCT02623361|2599005|P2|Overall Study|Withdrawal by Subject|1
800791|NCT02623361|2599006|P1|Overall Study|Withdrawal by Subject|0
800792|NCT02623361|2599005|P2|Overall Study|Protocol Violation|1
800793|NCT02623361|2599006|P1|Overall Study|Protocol Violation|0
800794|NCT02622568|2599018|P2|Overall Study|Lost to Follow-up|5
800795|NCT02622568|2599019|P1|Overall Study|Lost to Follow-up|5
800796|NCT02622321|2599029|P4|Overall Study|Withdrawal by Subject|0
800797|NCT02622321|2599030|P3|Overall Study|Withdrawal by Subject|0
800798|NCT02622321|2599031|P2|Overall Study|Withdrawal by Subject|0
800799|NCT02622321|2599032|P1|Overall Study|Withdrawal by Subject|1
800800|NCT02622321|2599029|P4|Overall Study|Ongoing treatment with emicizumab|7
800801|NCT02622321|2599030|P3|Overall Study|Ongoing treatment with emicizumab|49
800802|NCT02622321|2599031|P2|Overall Study|Ongoing treatment with emicizumab|13
800803|NCT02622321|2599032|P1|Overall Study|Ongoing treatment with emicizumab|31
800804|NCT02622321|2599029|P4|Overall Study|Ongoing in safety follow-up|0
800805|NCT02622321|2599030|P3|Overall Study|Ongoing in safety follow-up|0
800806|NCT02622321|2599031|P2|Overall Study|Ongoing in safety follow-up|0
800807|NCT02622321|2599032|P1|Overall Study|Ongoing in safety follow-up|3
800808|NCT02622321|2599029|P4|Overall Study|Ongoing treatment with no emicizumab|0
800809|NCT02622321|2599030|P3|Overall Study|Ongoing treatment with no emicizumab|0
800810|NCT02622321|2599031|P2|Overall Study|Ongoing treatment with no emicizumab|5
800811|NCT02622321|2599032|P1|Overall Study|Ongoing treatment with no emicizumab|0
800812|NCT02621047|2599105|P3|Overall Study|Adverse Event|1
800813|NCT02621047|2599106|P2|Overall Study|Adverse Event|0
800814|NCT02621047|2599107|P1|Overall Study|Adverse Event|0
800815|NCT02621034|2599223|P3|Overall Study|Lost to Follow-up|5
800816|NCT02621034|2599224|P2|Overall Study|Lost to Follow-up|2
800817|NCT02621034|2599225|P1|Overall Study|Lost to Follow-up|3
800818|NCT02619812|2599251|P4|Overall Study|Withdrawal by Subject|2
800819|NCT02619812|2599252|P3|Overall Study|Withdrawal by Subject|1
800820|NCT02619812|2599253|P2|Overall Study|Withdrawal by Subject|0
800821|NCT02619812|2599254|P1|Overall Study|Withdrawal by Subject|0
800822|NCT02615990|2599503|P2|Overall Study|study terminated|1
800823|NCT02615990|2599504|P1|Overall Study|study terminated|1
800824|NCT02614183|2599660|P3|Post Treatment Follow-up Phase|Withdrawal by Subject|5
800825|NCT02614183|2599661|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|2
800826|NCT02614183|2599662|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|7
800827|NCT02614183|2599660|P3|Post Treatment Follow-up Phase|Protocol Violation|0
800828|NCT02614183|2599661|P2|Post Treatment Follow-up Phase|Protocol Violation|0
800829|NCT02614183|2599662|P1|Post Treatment Follow-up Phase|Protocol Violation|1
800830|NCT02614183|2599660|P3|Post Treatment Follow-up Phase|Physician Decision|2
800831|NCT02614183|2599661|P2|Post Treatment Follow-up Phase|Physician Decision|1
800832|NCT02614183|2599662|P1|Post Treatment Follow-up Phase|Physician Decision|5
800833|NCT02614183|2599660|P3|Post Treatment Follow-up Phase|Lost to Follow-up|5
800834|NCT02614183|2599661|P2|Post Treatment Follow-up Phase|Lost to Follow-up|3
800835|NCT02614183|2599662|P1|Post Treatment Follow-up Phase|Lost to Follow-up|5
800836|NCT02614183|2599660|P3|Double Blind Treatment Phase|Did not receive study drug|2
800837|NCT02614183|2599661|P2|Double Blind Treatment Phase|Did not receive study drug|1
800838|NCT02614183|2599662|P1|Double Blind Treatment Phase|Did not receive study drug|1
800839|NCT02614183|2599660|P3|Double Blind Treatment Phase|Withdrawal by Subject|16
800840|NCT02614183|2599661|P2|Double Blind Treatment Phase|Withdrawal by Subject|11
800841|NCT02614183|2599662|P1|Double Blind Treatment Phase|Withdrawal by Subject|33
800842|NCT02614183|2599660|P3|Double Blind Treatment Phase|Protocol Violation|2
800843|NCT02614183|2599661|P2|Double Blind Treatment Phase|Protocol Violation|2
800844|NCT02614183|2599662|P1|Double Blind Treatment Phase|Protocol Violation|2
800845|NCT02614183|2599660|P3|Double Blind Treatment Phase|Pregnancy|3
800846|NCT02614183|2599661|P2|Double Blind Treatment Phase|Pregnancy|1
800847|NCT02614183|2599662|P1|Double Blind Treatment Phase|Pregnancy|2
800848|NCT02614183|2599660|P3|Double Blind Treatment Phase|Physician Decision|2
800849|NCT02614183|2599661|P2|Double Blind Treatment Phase|Physician Decision|3
800850|NCT02614183|2599662|P1|Double Blind Treatment Phase|Physician Decision|7
800851|NCT02614183|2599660|P3|Double Blind Treatment Phase|Lost to Follow-up|5
800852|NCT02614183|2599661|P2|Double Blind Treatment Phase|Lost to Follow-up|9
800853|NCT02614183|2599662|P1|Double Blind Treatment Phase|Lost to Follow-up|18
800854|NCT02614183|2599660|P3|Double Blind Treatment Phase|Lack of Efficacy|2
800855|NCT02614183|2599661|P2|Double Blind Treatment Phase|Lack of Efficacy|1
800856|NCT02614183|2599662|P1|Double Blind Treatment Phase|Lack of Efficacy|10
800857|NCT02614183|2599660|P3|Double Blind Treatment Phase|Adverse Event|7
800858|NCT02614183|2599661|P2|Double Blind Treatment Phase|Adverse Event|9
800859|NCT02614183|2599662|P1|Double Blind Treatment Phase|Adverse Event|10
800860|NCT02614079|2599699|P1|Overall Study|Withdrawal by Subject|1
800861|NCT02613910|2599703|P1|Overall Study|Termination of study|1
800862|NCT02613871|2599752|P1|Overall Study|On Study|111
800863|NCT02613403|2599771|P5|Overall Study|Withdrawal by Subject|0
800864|NCT02613403|2599772|P4|Overall Study|Withdrawal by Subject|0
800865|NCT02613403|2599773|P3|Overall Study|Withdrawal by Subject|0
800866|NCT02613403|2599774|P2|Overall Study|Withdrawal by Subject|0
800867|NCT02613403|2599775|P1|Overall Study|Withdrawal by Subject|2
800868|NCT02613403|2599771|P5|Overall Study|Lost to Follow-up|0
800869|NCT02613403|2599772|P4|Overall Study|Lost to Follow-up|0
800870|NCT02613403|2599773|P3|Overall Study|Lost to Follow-up|0
800871|NCT02613403|2599774|P2|Overall Study|Lost to Follow-up|1
800872|NCT02613403|2599775|P1|Overall Study|Lost to Follow-up|0
800873|NCT02612610|2599821|P4|Overall Study|Cough Improvement|0
800874|NCT02612610|2599822|P3|Overall Study|Cough Improvement|1
800875|NCT02612610|2599823|P2|Overall Study|Cough Improvement|0
800876|NCT02612610|2599824|P1|Overall Study|Cough Improvement|0
800877|NCT02612610|2599821|P4|Overall Study|Noncompliance|0
800878|NCT02612610|2599822|P3|Overall Study|Noncompliance|0
800879|NCT02612610|2599823|P2|Overall Study|Noncompliance|0
800880|NCT02612610|2599824|P1|Overall Study|Noncompliance|1
800881|NCT02612610|2599821|P4|Overall Study|Physician Decision|0
800882|NCT02612610|2599822|P3|Overall Study|Physician Decision|0
800883|NCT02612610|2599823|P2|Overall Study|Physician Decision|1
800884|NCT02612610|2599824|P1|Overall Study|Physician Decision|0
800885|NCT02612610|2599821|P4|Overall Study|Lack of Efficacy|1
800886|NCT02612610|2599822|P3|Overall Study|Lack of Efficacy|0
800887|NCT02612610|2599823|P2|Overall Study|Lack of Efficacy|2
800888|NCT02612610|2599824|P1|Overall Study|Lack of Efficacy|1
800889|NCT02612610|2599821|P4|Overall Study|Protocol Violation|0
800890|NCT02612610|2599822|P3|Overall Study|Protocol Violation|1
800891|NCT02612610|2599823|P2|Overall Study|Protocol Violation|1
800892|NCT02612610|2599824|P1|Overall Study|Protocol Violation|0
800893|NCT02612610|2599821|P4|Overall Study|Lost to Follow-up|0
800894|NCT02612610|2599822|P3|Overall Study|Lost to Follow-up|0
800895|NCT02612610|2599823|P2|Overall Study|Lost to Follow-up|1
800896|NCT02612610|2599824|P1|Overall Study|Lost to Follow-up|0
800897|NCT02612610|2599821|P4|Overall Study|Adverse Event|10
800898|NCT02612610|2599822|P3|Overall Study|Adverse Event|3
800899|NCT02612610|2599823|P2|Overall Study|Adverse Event|2
800900|NCT02612610|2599824|P1|Overall Study|Adverse Event|2
800901|NCT02612610|2599821|P4|Overall Study|Withdrawal by Subject|2
800902|NCT02612610|2599822|P3|Overall Study|Withdrawal by Subject|0
800903|NCT02612610|2599823|P2|Overall Study|Withdrawal by Subject|1
800904|NCT02612610|2599824|P1|Overall Study|Withdrawal by Subject|1
800905|NCT02612285|2600066|P1|Overall Study|Withdrawal by Subject|1
800906|NCT02612077|2600070|P1|Overall Study|Unknown reason|2
800907|NCT02612077|2600070|P1|Overall Study|Disease Progression|3
800908|NCT02612077|2600070|P1|Overall Study|Enrollment in a Clinical Trial|1
800909|NCT02612077|2600070|P1|Overall Study|Moved or Changed Medical Team|23
800910|NCT02612077|2600070|P1|Overall Study|Death|377
800911|NCT02612077|2600070|P1|Overall Study|Lost to Follow-up|20
800912|NCT02612077|2600070|P1|Overall Study|Protocol Violation|28
800913|NCT02612077|2600070|P1|Overall Study|Withdrawal by Subject|9
800914|NCT02612077|2600070|P1|Overall Study|Adverse Event|3
800915|NCT02612064|2600082|P2|Overall Study|Not Specified|2
800916|NCT02612064|2600083|P1|Overall Study|Not Specified|0
800917|NCT02612064|2600082|P2|Overall Study|Withdrawal by Subject|1
800918|NCT02612064|2600083|P1|Overall Study|Withdrawal by Subject|1
800919|NCT02610842|2600121|P1|Overall Study|Lost to Follow-up|5
800920|NCT02610816|2600130|P4|Phase 2|Pregnancy|1
800921|NCT02610816|2600131|P3|Phase 2|Pregnancy|0
800922|NCT02610816|2600132|P2|Phase 2|Pregnancy|0
800923|NCT02610816|2600133|P1|Phase 2|Pregnancy|0
800924|NCT02610816|2600130|P4|Phase 2|Physician Decision|2
800925|NCT02610816|2600131|P3|Phase 2|Physician Decision|0
800926|NCT02610816|2600132|P2|Phase 2|Physician Decision|0
800927|NCT02610816|2600133|P1|Phase 2|Physician Decision|0
800928|NCT02610816|2600130|P4|Phase 2|Lost to Follow-up|0
800929|NCT02610816|2600131|P3|Phase 2|Lost to Follow-up|2
800930|NCT02610816|2600132|P2|Phase 2|Lost to Follow-up|0
800931|NCT02610816|2600133|P1|Phase 2|Lost to Follow-up|0
800932|NCT02610816|2600130|P4|Phase 2|Withdrawal by Subject|3
800933|NCT02610816|2600131|P3|Phase 2|Withdrawal by Subject|9
800934|NCT02610816|2600132|P2|Phase 2|Withdrawal by Subject|0
800935|NCT02610816|2600133|P1|Phase 2|Withdrawal by Subject|0
800936|NCT02610816|2600130|P4|Phase 1|Physician Decision|0
800937|NCT02610816|2600131|P3|Phase 1|Physician Decision|0
800938|NCT02610816|2600132|P2|Phase 1|Physician Decision|1
800939|NCT02610816|2600133|P1|Phase 1|Physician Decision|0
800940|NCT02610816|2600130|P4|Phase 1|Lost to Follow-up|0
800941|NCT02610816|2600131|P3|Phase 1|Lost to Follow-up|0
800942|NCT02610816|2600132|P2|Phase 1|Lost to Follow-up|1
800943|NCT02610816|2600133|P1|Phase 1|Lost to Follow-up|2
800944|NCT02610816|2600130|P4|Phase 1|Withdrawal by Subject|0
800945|NCT02610816|2600131|P3|Phase 1|Withdrawal by Subject|0
800946|NCT02610816|2600132|P2|Phase 1|Withdrawal by Subject|6
800947|NCT02610816|2600133|P1|Phase 1|Withdrawal by Subject|2
800948|NCT02609672|2600173|P2|Overall Study|Lost to Follow-up|1
800949|NCT02609672|2600174|P1|Overall Study|Lost to Follow-up|3
800950|NCT02609659|2600208|P1|Overall Study|Not Specified|1
800951|NCT02609659|2600208|P1|Overall Study|Lost to Follow-up|6
800952|NCT02609659|2600208|P1|Overall Study|Adverse Event|1
800953|NCT02609633|2600218|P2|Overall Study|Reason not Specified|1
800954|NCT02609633|2600219|P1|Overall Study|Reason not Specified|2
800955|NCT02609633|2600218|P2|Overall Study|Non-Compliant with Study Procedures|0
800956|NCT02609633|2600219|P1|Overall Study|Non-Compliant with Study Procedures|2
800957|NCT02609633|2600218|P2|Overall Study|Protocol Deviation|0
800958|NCT02609633|2600219|P1|Overall Study|Protocol Deviation|1
800959|NCT02609633|2600218|P2|Overall Study|Consent Withdrawn|1
800960|NCT02609633|2600219|P1|Overall Study|Consent Withdrawn|0
800961|NCT02609399|2600246|P2|Influenza Season 2016-2017|Found ineligible after randomization|0
800962|NCT02609399|2600247|P1|Influenza Season 2016-2017|Found ineligible after randomization|1
800963|NCT02609399|2600246|P2|Influenza Season 2016-2017|Lost to Follow-up|5
800964|NCT02609399|2600247|P1|Influenza Season 2016-2017|Lost to Follow-up|8
800965|NCT02609399|2600246|P2|Influenza Season 2015-2016|Lost to Follow-up|2
800966|NCT02609399|2600247|P1|Influenza Season 2015-2016|Lost to Follow-up|3
800967|NCT02609178|2600264|P6|First Crown|Withdrawal by Subject|0
800968|NCT02609178|2600265|P5|First Crown|Withdrawal by Subject|0
800969|NCT02609178|2600266|P4|First Crown|Withdrawal by Subject|1
800970|NCT02609178|2600267|P3|First Crown|Withdrawal by Subject|1
800971|NCT02609178|2600268|P2|First Crown|Withdrawal by Subject|0
800972|NCT02609178|2600269|P1|First Crown|Withdrawal by Subject|0
800973|NCT02607956|2600366|P2|Overall Study|Lost to Follow-up|5
800974|NCT02607956|2600367|P1|Overall Study|Lost to Follow-up|8
800975|NCT02607956|2600366|P2|Overall Study|Withdrawal by Subject|8
800976|NCT02607956|2600367|P1|Overall Study|Withdrawal by Subject|7
800977|NCT02607956|2600366|P2|Overall Study|Protocol Violation|1
800978|NCT02607956|2600367|P1|Overall Study|Protocol Violation|2
800979|NCT02607956|2600366|P2|Overall Study|Non-Compliance with Study Drug|1
800980|NCT02607956|2600367|P1|Overall Study|Non-Compliance with Study Drug|0
800981|NCT02607956|2600366|P2|Overall Study|Investigator's Decision|0
800982|NCT02607956|2600367|P1|Overall Study|Investigator's Decision|3
800983|NCT02607956|2600366|P2|Overall Study|Death|2
800984|NCT02607956|2600367|P1|Overall Study|Death|1
800985|NCT02607956|2600366|P2|Overall Study|Adverse Event|1
800986|NCT02607956|2600367|P1|Overall Study|Adverse Event|3
800987|NCT02607956|2600366|P2|Overall Study|Still on Study|307
800988|NCT02607956|2600367|P1|Overall Study|Still on Study|296
800989|NCT02607956|2600366|P2|Overall Study|Randomized and Never Treated|5
800990|NCT02607956|2600367|P1|Overall Study|Randomized and Never Treated|7
800991|NCT02607930|2600381|P2|Overall Study|Lost to Follow-up|6
800992|NCT02607930|2600382|P1|Overall Study|Lost to Follow-up|9
800993|NCT02607930|2600381|P2|Overall Study|Withdrawal by Subject|5
800994|NCT02607930|2600382|P1|Overall Study|Withdrawal by Subject|3
800995|NCT02607930|2600381|P2|Overall Study|Protocol Violation|0
800996|NCT02607930|2600382|P1|Overall Study|Protocol Violation|1
800997|NCT02607930|2600381|P2|Overall Study|Non-Compliance with Study Drug|0
800998|NCT02607930|2600382|P1|Overall Study|Non-Compliance with Study Drug|2
800999|NCT02607930|2600381|P2|Overall Study|Physician Decision|0
801000|NCT02607930|2600382|P1|Overall Study|Physician Decision|3
801001|NCT02607930|2600381|P2|Overall Study|Adverse Event|3
801002|NCT02607930|2600382|P1|Overall Study|Adverse Event|0
801003|NCT02607930|2600381|P2|Overall Study|Still in Study|301
801004|NCT02607930|2600382|P1|Overall Study|Still in Study|296
801005|NCT02607930|2600381|P2|Overall Study|Randomized and Never Treated|0
801006|NCT02607930|2600382|P1|Overall Study|Randomized and Never Treated|2
801007|NCT02607800|2600404|P2|Overall Study|Randomized/Enrolled but Not Treated|1
801008|NCT02607800|2600405|P1|Overall Study|Randomized/Enrolled but Not Treated|1
801009|NCT02607800|2600404|P2|Overall Study|Withdrew Consent|0
801010|NCT02607800|2600405|P1|Overall Study|Withdrew Consent|2
801011|NCT02607800|2600404|P2|Overall Study|Lost to Follow-up|10
801012|NCT02607800|2600405|P1|Overall Study|Lost to Follow-up|7
801013|NCT02607735|2600423|P3|Deferred Treatment Substudy|Withdrew Consent|1
801014|NCT02607735|2600424|P2|Deferred Treatment Substudy|Withdrew Consent|0
801015|NCT02607735|2600425|P1|Deferred Treatment Substudy|Withdrew Consent|0
801016|NCT02607735|2600423|P3|Deferred Treatment Substudy|Lost to Follow-up|4
801017|NCT02607735|2600424|P2|Deferred Treatment Substudy|Lost to Follow-up|0
801018|NCT02607735|2600425|P1|Deferred Treatment Substudy|Lost to Follow-up|0
801019|NCT02607735|2600423|P3|Primary Study|Withdrew Consent|0
801020|NCT02607735|2600424|P2|Primary Study|Withdrew Consent|0
801021|NCT02607735|2600425|P1|Primary Study|Withdrew Consent|2
801022|NCT02607735|2600423|P3|Primary Study|Lost to Follow-up|0
801023|NCT02607735|2600424|P2|Primary Study|Lost to Follow-up|0
801024|NCT02607735|2600425|P1|Primary Study|Lost to Follow-up|4
801025|NCT02607735|2600423|P3|Primary Study|Randomized but Never Treated|0
801026|NCT02607735|2600424|P2|Primary Study|Randomized but Never Treated|0
801027|NCT02607735|2600425|P1|Primary Study|Randomized but Never Treated|1
801028|NCT02606643|2600492|P2|Overall Study|did not meet inclusion criteria|3
801029|NCT02606643|2600493|P1|Overall Study|did not meet inclusion criteria|1
801030|NCT02606279|2600524|P2|Overall Study|Lost to Follow-up|1
801031|NCT02606279|2600525|P1|Overall Study|Lost to Follow-up|0
801032|NCT02605954|2600539|P2|Overall Study|Randomized but not treated|1
801033|NCT02605954|2600540|P1|Overall Study|Randomized but not treated|0
801034|NCT02605954|2600539|P2|Overall Study|Lost to Follow-up|0
801035|NCT02605954|2600540|P1|Overall Study|Lost to Follow-up|3
801036|NCT02605954|2600539|P2|Overall Study|Withdrew Consent|2
801037|NCT02605954|2600540|P1|Overall Study|Withdrew Consent|2
801038|NCT02605954|2600539|P2|Overall Study|Non-Compliance with Study Drug|0
801039|NCT02605954|2600540|P1|Overall Study|Non-Compliance with Study Drug|1
801040|NCT02605954|2600539|P2|Overall Study|Investigator's Discretion|0
801041|NCT02605954|2600540|P1|Overall Study|Investigator's Discretion|1
801042|NCT02605954|2600539|P2|Overall Study|Adverse Event|1
801043|NCT02605954|2600540|P1|Overall Study|Adverse Event|5
801044|NCT02605928|2600557|P1|Overall Study|Lack of Efficacy|5
801045|NCT02605928|2600557|P1|Overall Study|Model tuning phase|28
801046|NCT02605174|2600675|P7|Overall Study|Randomization Failure|30
801047|NCT02605174|2600676|P6|Overall Study|Randomization Failure|11
801048|NCT02605174|2600677|P5|Overall Study|Randomization Failure|16
801049|NCT02605174|2600678|P4|Overall Study|Randomization Failure|7
801050|NCT02605174|2600679|P3|Overall Study|Randomization Failure|20
801051|NCT02605174|2600680|P2|Overall Study|Randomization Failure|6
801052|NCT02605174|2600681|P1|Overall Study|Randomization Failure|22
801053|NCT02605174|2600675|P7|Overall Study|Physician Decision|3
801054|NCT02605174|2600676|P6|Overall Study|Physician Decision|0
801055|NCT02605174|2600677|P5|Overall Study|Physician Decision|0
801056|NCT02605174|2600678|P4|Overall Study|Physician Decision|0
801057|NCT02605174|2600679|P3|Overall Study|Physician Decision|0
801058|NCT02605174|2600680|P2|Overall Study|Physician Decision|0
801059|NCT02605174|2600681|P1|Overall Study|Physician Decision|2
801060|NCT02605174|2600675|P7|Overall Study|Withdrawal by Subject|15
801061|NCT02605174|2600676|P6|Overall Study|Withdrawal by Subject|4
801062|NCT02605174|2600677|P5|Overall Study|Withdrawal by Subject|6
801063|NCT02605174|2600678|P4|Overall Study|Withdrawal by Subject|11
801064|NCT02605174|2600679|P3|Overall Study|Withdrawal by Subject|14
801065|NCT02605174|2600680|P2|Overall Study|Withdrawal by Subject|6
801066|NCT02605174|2600681|P1|Overall Study|Withdrawal by Subject|9
801067|NCT02605174|2600675|P7|Overall Study|Pregnancy|0
801068|NCT02605174|2600676|P6|Overall Study|Pregnancy|0
801069|NCT02605174|2600677|P5|Overall Study|Pregnancy|0
801070|NCT02605174|2600678|P4|Overall Study|Pregnancy|2
801071|NCT02605174|2600679|P3|Overall Study|Pregnancy|0
801072|NCT02605174|2600680|P2|Overall Study|Pregnancy|0
801073|NCT02605174|2600681|P1|Overall Study|Pregnancy|1
801074|NCT02605174|2600675|P7|Overall Study|Protocol Violation|12
801075|NCT02605174|2600676|P6|Overall Study|Protocol Violation|7
801076|NCT02605174|2600677|P5|Overall Study|Protocol Violation|7
801077|NCT02605174|2600678|P4|Overall Study|Protocol Violation|6
801078|NCT02605174|2600679|P3|Overall Study|Protocol Violation|14
801079|NCT02605174|2600680|P2|Overall Study|Protocol Violation|4
801080|NCT02605174|2600681|P1|Overall Study|Protocol Violation|10
801081|NCT02605174|2600675|P7|Overall Study|Lost to Follow-up|29
801082|NCT02605174|2600676|P6|Overall Study|Lost to Follow-up|10
801083|NCT02605174|2600677|P5|Overall Study|Lost to Follow-up|20
801084|NCT02605174|2600678|P4|Overall Study|Lost to Follow-up|10
801085|NCT02605174|2600679|P3|Overall Study|Lost to Follow-up|27
801086|NCT02605174|2600680|P2|Overall Study|Lost to Follow-up|7
801087|NCT02605174|2600681|P1|Overall Study|Lost to Follow-up|20
801088|NCT02605174|2600675|P7|Overall Study|Adverse Event|0
801089|NCT02605174|2600676|P6|Overall Study|Adverse Event|0
801090|NCT02605174|2600677|P5|Overall Study|Adverse Event|4
801091|NCT02605174|2600678|P4|Overall Study|Adverse Event|0
801092|NCT02605174|2600679|P3|Overall Study|Adverse Event|1
801093|NCT02605174|2600680|P2|Overall Study|Adverse Event|0
801094|NCT02605174|2600681|P1|Overall Study|Adverse Event|0
801095|NCT02604589|2600744|P3|Overall Study|catheter dislodgement|1
801096|NCT02604589|2600745|P2|Overall Study|catheter dislodgement|0
801097|NCT02604589|2600746|P1|Overall Study|catheter dislodgement|0
801098|NCT02604550|2600774|P2|Overall Study|Incomplete data using paper journal|19
801099|NCT02604550|2600775|P1|Overall Study|Incomplete data using paper journal|18
801100|NCT02604550|2600774|P2|Overall Study|Withdrawal by Subject|1
801101|NCT02604550|2600775|P1|Overall Study|Withdrawal by Subject|0
801102|NCT02604550|2600774|P2|Overall Study|Lost to Follow-up|6
801103|NCT02604550|2600775|P1|Overall Study|Lost to Follow-up|7
801104|NCT02604407|2600802|P3|Overall Study|Other|4
801105|NCT02604407|2600803|P2|Overall Study|Other|1
801106|NCT02604407|2600804|P1|Overall Study|Other|3
801107|NCT02604407|2600802|P3|Overall Study|Lack of Efficacy|0
801108|NCT02604407|2600803|P2|Overall Study|Lack of Efficacy|0
801109|NCT02604407|2600804|P1|Overall Study|Lack of Efficacy|1
801110|NCT02604407|2600802|P3|Overall Study|Lost to Follow-up|2
801111|NCT02604407|2600803|P2|Overall Study|Lost to Follow-up|1
801112|NCT02604407|2600804|P1|Overall Study|Lost to Follow-up|2
801113|NCT02604407|2600802|P3|Overall Study|Withdrawal by Subject|5
801114|NCT02604407|2600803|P2|Overall Study|Withdrawal by Subject|3
801115|NCT02604407|2600804|P1|Overall Study|Withdrawal by Subject|3
801116|NCT02604407|2600802|P3|Overall Study|Protocol Violation|0
801117|NCT02604407|2600803|P2|Overall Study|Protocol Violation|0
801118|NCT02604407|2600804|P1|Overall Study|Protocol Violation|2
801119|NCT02604407|2600802|P3|Overall Study|Adverse Event|5
801120|NCT02604407|2600803|P2|Overall Study|Adverse Event|7
801121|NCT02604407|2600804|P1|Overall Study|Adverse Event|0
801122|NCT02604342|2600817|P2|Overall Study|Ongoing|25
801123|NCT02604342|2600818|P1|Overall Study|Ongoing|52
801124|NCT02604342|2600817|P2|Overall Study|Withdrawal by Subject|3
801125|NCT02604342|2600818|P1|Overall Study|Withdrawal by Subject|3
801126|NCT02604342|2600817|P2|Overall Study|Progression of disease|0
801127|NCT02604342|2600818|P1|Overall Study|Progression of disease|1
801128|NCT02604342|2600817|P2|Overall Study|Death|7
801129|NCT02604342|2600818|P1|Overall Study|Death|16
801130|NCT02604264|2600870|P2|Intervention|Didn't use CVC for at least 21 days|242
801131|NCT02604264|2600871|P1|Intervention|Didn't use CVC for at least 21 days|200
801132|NCT02604017|2600898|P2|Overall Study|Not Specified|0
801133|NCT02604017|2600899|P1|Overall Study|Not Specified|1
801134|NCT02604017|2600898|P2|Overall Study|Lost to Follow-up|6
801135|NCT02604017|2600899|P1|Overall Study|Lost to Follow-up|5
801136|NCT02604017|2600898|P2|Overall Study|Withdrew Consent|2
801137|NCT02604017|2600899|P1|Overall Study|Withdrew Consent|0
801138|NCT02603952|2600928|P4|Overall Study|Received oseltamivir by error|1
801139|NCT02603952|2600929|P3|Overall Study|Received oseltamivir by error|0
801140|NCT02603952|2600930|P2|Overall Study|Received oseltamivir by error|0
801141|NCT02603952|2600931|P1|Overall Study|Received oseltamivir by error|0
801142|NCT02603952|2600928|P4|Overall Study|Withdrawal by Subject|0
801143|NCT02603952|2600929|P3|Overall Study|Withdrawal by Subject|0
801144|NCT02603952|2600930|P2|Overall Study|Withdrawal by Subject|0
801145|NCT02603952|2600931|P1|Overall Study|Withdrawal by Subject|1
801146|NCT02603120|2600978|P2|Overall Study|Lost to Follow-up|2
801147|NCT02603120|2600979|P1|Overall Study|Lost to Follow-up|2
801148|NCT02603120|2600978|P2|Overall Study|Withdrew Consent|7
801149|NCT02603120|2600979|P1|Overall Study|Withdrew Consent|3
801150|NCT02603120|2600978|P2|Overall Study|Pregnancy|1
801151|NCT02603120|2600979|P1|Overall Study|Pregnancy|0
801152|NCT02603120|2600978|P2|Overall Study|Death|0
801153|NCT02603120|2600979|P1|Overall Study|Death|2
801154|NCT02603120|2600978|P2|Overall Study|Adverse Event|2
801155|NCT02603120|2600979|P1|Overall Study|Adverse Event|3
801156|NCT02603120|2600978|P2|Overall Study|Still in Study|269
801157|NCT02603120|2600979|P1|Overall Study|Still in Study|272
801158|NCT02603120|2600978|P2|Overall Study|Randomized but Never Treated|2
801159|NCT02603120|2600979|P1|Overall Study|Randomized but Never Treated|2
801160|NCT02603107|2600999|P2|Optional Extension Phase|Still in Study|213
801161|NCT02603107|2601000|P1|Optional Extension Phase|Still in Study|241
801162|NCT02603107|2600999|P2|Randomized Phase|Lost to Follow-up|3
801163|NCT02603107|2601000|P1|Randomized Phase|Lost to Follow-up|0
801164|NCT02603107|2600999|P2|Randomized Phase|Withdrew Consent|14
801165|NCT02603107|2601000|P1|Randomized Phase|Withdrew Consent|8
801166|NCT02603107|2600999|P2|Randomized Phase|Protocol Violation|0
801167|NCT02603107|2601000|P1|Randomized Phase|Protocol Violation|1
801168|NCT02603107|2600999|P2|Randomized Phase|Non-Compliance with Study Drug|1
801169|NCT02603107|2601000|P1|Randomized Phase|Non-Compliance with Study Drug|1
801170|NCT02603107|2600999|P2|Randomized Phase|Investigator's Discretion|1
801171|NCT02603107|2601000|P1|Randomized Phase|Investigator's Discretion|0
801172|NCT02603107|2600999|P2|Randomized Phase|Death|1
801173|NCT02603107|2601000|P1|Randomized Phase|Death|1
801174|NCT02603107|2600999|P2|Randomized Phase|Adverse Event|0
801175|NCT02603107|2601000|P1|Randomized Phase|Adverse Event|2
801176|NCT02603107|2600999|P2|Randomized Phase|Still in Study|27
801177|NCT02603107|2601000|P1|Randomized Phase|Still in Study|32
801178|NCT02603107|2600999|P2|Randomized Phase|Randomized and Never Treated|1
801179|NCT02603107|2601000|P1|Randomized Phase|Randomized and Never Treated|0
801180|NCT02601573|2601039|P5|Overall Study|Withdrawal by Subject|0
801181|NCT02601573|2601040|P4|Overall Study|Withdrawal by Subject|1
801182|NCT02601573|2601041|P3|Overall Study|Withdrawal by Subject|0
801183|NCT02601573|2601042|P2|Overall Study|Withdrawal by Subject|1
801184|NCT02601573|2601043|P1|Overall Study|Withdrawal by Subject|0
801185|NCT02601573|2601039|P5|Overall Study|Lost to Follow-up|2
801186|NCT02601573|2601040|P4|Overall Study|Lost to Follow-up|0
801187|NCT02601573|2601041|P3|Overall Study|Lost to Follow-up|1
801188|NCT02601573|2601042|P2|Overall Study|Lost to Follow-up|3
801189|NCT02601573|2601043|P1|Overall Study|Lost to Follow-up|0
801190|NCT02601560|2601078|P8|Overall Study|Other|0
801191|NCT02601560|2601079|P7|Overall Study|Other|1
801192|NCT02601560|2601080|P6|Overall Study|Other|0
801193|NCT02601560|2601081|P5|Overall Study|Other|0
801194|NCT02601560|2601082|P4|Overall Study|Other|0
801195|NCT02601560|2601083|P3|Overall Study|Other|0
801196|NCT02601560|2601084|P2|Overall Study|Other|0
801197|NCT02601560|2601085|P1|Overall Study|Other|0
801198|NCT02601300|2601267|P1|Extension Phase|Lack of Efficacy|10
801199|NCT02601300|2601267|P1|Extension Phase|Adverse Event|4
801200|NCT02601300|2601267|P1|Extension Phase|Withdrawal by Subject|3
801201|NCT02601300|2601267|P1|Induction Phase|Protocol Violation|1
801202|NCT02601300|2601267|P1|Induction Phase|Lack of Efficacy|2
801203|NCT02600871|2601282|P2|Overall Study|Lost to Follow-up|10
801204|NCT02600871|2601283|P1|Overall Study|Lost to Follow-up|13
801205|NCT02600845|2601293|P1|Overall Study|Consent Withdrawal|5
801206|NCT02600845|2601293|P1|Overall Study|Non-compliance with Study Procedures|10
801207|NCT02600845|2601293|P1|Overall Study|Reason Not Specified|3
801208|NCT02600819|2601308|P1|Overall Study|Still on Study|45
801209|NCT02600819|2601308|P1|Overall Study|Withdrew Consent|5
801210|NCT02600819|2601308|P1|Overall Study|Non-Compliance with Study Drug|1
801211|NCT02600819|2601308|P1|Overall Study|Investigator's Discretion|2
801212|NCT02600819|2601308|P1|Overall Study|Adverse Event|2
801213|NCT02600351|2601397|P4|Overall Study|Randomized but Not Treated|3
801214|NCT02600351|2601398|P3|Overall Study|Randomized but Not Treated|1
801215|NCT02600351|2601399|P2|Overall Study|Randomized but Not Treated|0
801216|NCT02600351|2601400|P1|Overall Study|Randomized but Not Treated|1
801217|NCT02600351|2601397|P4|Overall Study|Lost to Follow-up|0
801218|NCT02600351|2601398|P3|Overall Study|Lost to Follow-up|0
801219|NCT02600351|2601399|P2|Overall Study|Lost to Follow-up|0
801220|NCT02600351|2601400|P1|Overall Study|Lost to Follow-up|1
801221|NCT02600351|2601397|P4|Overall Study|Lack of Efficacy|2
801222|NCT02600351|2601398|P3|Overall Study|Lack of Efficacy|5
801223|NCT02600351|2601399|P2|Overall Study|Lack of Efficacy|0
801224|NCT02600351|2601400|P1|Overall Study|Lack of Efficacy|3
801225|NCT02599129|2601432|P2|Overall Study|Withdrawal by Subject|1
801226|NCT02599129|2601433|P1|Overall Study|Withdrawal by Subject|2
801227|NCT02599129|2601432|P2|Overall Study|Lost to Follow-up|0
801228|NCT02599129|2601433|P1|Overall Study|Lost to Follow-up|1
801229|NCT02599129|2601432|P2|Overall Study|Lack of Efficacy|2
801230|NCT02599129|2601433|P1|Overall Study|Lack of Efficacy|2
801231|NCT02598934|2601449|P2|Overall Study|Protocol Violation|2
801232|NCT02598934|2601450|P1|Overall Study|Protocol Violation|1
801233|NCT02598934|2601449|P2|Overall Study|Administrative|1
801234|NCT02598934|2601450|P1|Overall Study|Administrative|2
801235|NCT02598934|2601449|P2|Overall Study|Withdrawal by Subject|3
801236|NCT02598934|2601450|P1|Overall Study|Withdrawal by Subject|2
801237|NCT02598934|2601449|P2|Overall Study|Failure to Return|3
801238|NCT02598934|2601450|P1|Overall Study|Failure to Return|3
801239|NCT02598934|2601449|P2|Overall Study|Adverse Event|13
801240|NCT02598934|2601450|P1|Overall Study|Adverse Event|11
801241|NCT02598622|2601462|P2|Overall Study|Physician Decision|0
801242|NCT02598622|2601463|P1|Overall Study|Physician Decision|3
801243|NCT02598622|2601462|P2|Overall Study|Withdrawal by Subject|0
801244|NCT02598622|2601463|P1|Overall Study|Withdrawal by Subject|3
801245|NCT02598193|2601490|P1|Overall Study|Does not want to take Nintedanib|1
801246|NCT02598193|2601490|P1|Overall Study|Listed in active lung transplant list|1
801247|NCT02598193|2601490|P1|Overall Study|Withdrawal by Subject|1
801248|NCT02598193|2601490|P1|Overall Study|Adverse Event|13
801249|NCT02598128|2601498|P4|Period A: Days -7 to -1|Adverse Event|0
801250|NCT02598128|2601499|P3|Period A: Days -7 to -1|Adverse Event|0
801251|NCT02598128|2601500|P2|Period A: Days -7 to -1|Adverse Event|0
801252|NCT02598128|2601501|P1|Period A: Days -7 to -1|Adverse Event|1
801253|NCT02597855|2601524|P2|Overall Study|Lost to Follow-up|1
801254|NCT02597855|2601525|P1|Overall Study|Lost to Follow-up|2
801255|NCT02597049|2601574|P3|Overall Study|Noncompliant with Study Visits|0
801256|NCT02597049|2601575|P2|Overall Study|Noncompliant with Study Visits|0
801257|NCT02597049|2601576|P1|Overall Study|Noncompliant with Study Visits|1
801258|NCT02597049|2601574|P3|Overall Study|Death|0
801259|NCT02597049|2601575|P2|Overall Study|Death|0
801260|NCT02597049|2601576|P1|Overall Study|Death|2
801261|NCT02597049|2601574|P3|Overall Study|Adverse Event|0
801262|NCT02597049|2601575|P2|Overall Study|Adverse Event|0
801263|NCT02597049|2601576|P1|Overall Study|Adverse Event|2
801264|NCT02597049|2601574|P3|Overall Study|Withdrawal by Subject|1
801265|NCT02597049|2601575|P2|Overall Study|Withdrawal by Subject|2
801266|NCT02597049|2601576|P1|Overall Study|Withdrawal by Subject|2
801267|NCT02597049|2601574|P3|Overall Study|Lost to Follow-up|2
801268|NCT02597049|2601575|P2|Overall Study|Lost to Follow-up|3
801269|NCT02597049|2601576|P1|Overall Study|Lost to Follow-up|0
801270|NCT02596958|2601614|P1|Overall Study|Excluded Due to Second Line Treatment|9
801271|NCT02596958|2601614|P1|Overall Study|Missing|32
801272|NCT02596958|2601614|P1|Overall Study|Lost to Follow-up|33
801273|NCT02596958|2601614|P1|Overall Study|Administrative Reasons/Other|231
801274|NCT02596958|2601614|P1|Overall Study|Refusal of Treatment/Poor Cooperation|61
801275|NCT02596958|2601614|P1|Overall Study|Death From Other Cause|33
801276|NCT02596958|2601614|P1|Overall Study|Death From Cancer|112
801277|NCT02596958|2601614|P1|Overall Study|Cancer Progression|441
801278|NCT02596958|2601614|P1|Overall Study|Serious Adverse Drug Reactions|44
801279|NCT02596945|2601626|P1|Overall Study|Missing|1
801280|NCT02596945|2601626|P1|Overall Study|Withdrawal by Subject|1
801281|NCT02596945|2601626|P1|Overall Study|Other Erythropoietin stimulating agent|4
801282|NCT02596945|2601626|P1|Overall Study|Change to hemodialysis|15
801283|NCT02596945|2601626|P1|Overall Study|Other|32
801284|NCT02596945|2601626|P1|Overall Study|No documentation of study drug dosing|3
801285|NCT02596854|2601637|P1|Overall Study|Withdrawn|8
801286|NCT02596620|2601658|P2|Overall Study|Lost to Follow-up|1
801287|NCT02596620|2601659|P1|Overall Study|Lost to Follow-up|1
801288|NCT02596009|2601701|P6|Overall Study|Administrative problems|0
801289|NCT02596009|2601702|P5|Overall Study|Administrative problems|0
801290|NCT02596009|2601703|P4|Overall Study|Administrative problems|0
801291|NCT02596009|2601704|P3|Overall Study|Administrative problems|0
801292|NCT02596009|2601705|P2|Overall Study|Administrative problems|1
801293|NCT02596009|2601706|P1|Overall Study|Administrative problems|0
801294|NCT02595502|2601719|P2|Period 3|Received Incorrect Treatment at period 3|1
801295|NCT02595502|2601720|P1|Period 3|Received Incorrect Treatment at period 3|0
801296|NCT02595502|2601719|P2|Period 3|Lost to Follow-up|0
801297|NCT02595502|2601720|P1|Period 3|Lost to Follow-up|1
801298|NCT02595502|2601719|P2|Period 3|Protocol Violation|1
801299|NCT02595502|2601720|P1|Period 3|Protocol Violation|0
801300|NCT02595502|2601719|P2|Period 2|Received incorrect lens at Period 1|1
801301|NCT02595502|2601720|P1|Period 2|Received incorrect lens at Period 1|0
801302|NCT02595502|2601719|P2|Period 2|Adverse Event|1
801303|NCT02595502|2601720|P1|Period 2|Adverse Event|1
801304|NCT02595502|2601719|P2|Period 1|Lost to Follow-up|1
801305|NCT02595502|2601720|P1|Period 1|Lost to Follow-up|0
801306|NCT02595502|2601719|P2|Period 1|Withdrawal by Subject|0
801307|NCT02595502|2601720|P1|Period 1|Withdrawal by Subject|1
801308|NCT02595502|2601719|P2|Period 1|Adverse Event|1
801309|NCT02595502|2601720|P1|Period 1|Adverse Event|0
801310|NCT02595450|2601726|P1|Overall Study|Enrolled, but not treated|8
801311|NCT02595450|2601726|P1|Overall Study|Unspecified (only completed 1 cycle)|73
801312|NCT02595437|2601732|P1|Triferic Via IV|Withdrawal by Subject|1
801313|NCT02594163|2601780|P2|Follow-up Period|Physician Decision|1
801314|NCT02594163|2601781|P1|Follow-up Period|Physician Decision|0
801315|NCT02594163|2601780|P2|Follow-up Period|Progressive Disease|0
801316|NCT02594163|2601781|P1|Follow-up Period|Progressive Disease|2
801317|NCT02594163|2601780|P2|Follow-up Period|Adverse Event|1
801318|NCT02594163|2601781|P1|Follow-up Period|Adverse Event|0
801319|NCT02594163|2601780|P2|Follow-up Period|Death|5
801320|NCT02594163|2601781|P1|Follow-up Period|Death|2
801321|NCT02594163|2601780|P2|Follow-up Period|Lost to Follow-up|0
801322|NCT02594163|2601781|P1|Follow-up Period|Lost to Follow-up|1
801323|NCT02594163|2601780|P2|Follow-up Period|Study Termination by Sponsor|4
801324|NCT02594163|2601781|P1|Follow-up Period|Study Termination by Sponsor|6
801325|NCT02594163|2601780|P2|Follow-up Period|Withdrawal by Subject|1
801326|NCT02594163|2601781|P1|Follow-up Period|Withdrawal by Subject|0
801327|NCT02594163|2601780|P2|Treatment Period|Other, Non-AE|0
801328|NCT02594163|2601781|P1|Treatment Period|Other, Non-AE|1
801329|NCT02594163|2601780|P2|Treatment Period|Study termination by sponsor|1
801330|NCT02594163|2601781|P1|Treatment Period|Study termination by sponsor|2
801331|NCT02594163|2601780|P2|Treatment Period|Physician Decision|3
801332|NCT02594163|2601781|P1|Treatment Period|Physician Decision|1
801333|NCT02594163|2601780|P2|Treatment Period|Adverse Event|5
801334|NCT02594163|2601781|P1|Treatment Period|Adverse Event|1
801335|NCT02594163|2601780|P2|Treatment Period|Progressive disease|3
801336|NCT02594163|2601781|P1|Treatment Period|Progressive disease|2
801337|NCT02593773|2601806|P1|Overall Study|Death|1
801338|NCT02593773|2601806|P1|Overall Study|Study Terminated by Sponsor|31
801339|NCT02593773|2601806|P1|Overall Study|Voluntary Withdrawal|3
801340|NCT02591290|2601878|P1|Overall Study|Withdrawal by Subject|2
801341|NCT02591238|2601888|P4|Overall Study|personal circumstances|0
801342|NCT02591238|2601889|P3|Overall Study|personal circumstances|0
801343|NCT02591238|2601890|P2|Overall Study|personal circumstances|1
801344|NCT02591238|2601891|P1|Overall Study|personal circumstances|0
801345|NCT02591238|2601888|P4|Overall Study|personal circumstances|1
801346|NCT02591238|2601889|P3|Overall Study|personal circumstances|0
801347|NCT02591238|2601890|P2|Overall Study|personal circumstances|0
801348|NCT02591238|2601891|P1|Overall Study|personal circumstances|0
801349|NCT02591238|2601888|P4|Overall Study|influenza|1
801350|NCT02591238|2601889|P3|Overall Study|influenza|0
801351|NCT02591238|2601890|P2|Overall Study|influenza|0
801352|NCT02591238|2601891|P1|Overall Study|influenza|0
801353|NCT02591238|2601888|P4|Overall Study|Withdrawal by Subject|1
801354|NCT02591238|2601889|P3|Overall Study|Withdrawal by Subject|0
801355|NCT02591238|2601890|P2|Overall Study|Withdrawal by Subject|0
801356|NCT02591238|2601891|P1|Overall Study|Withdrawal by Subject|0
801357|NCT02591238|2601888|P4|Overall Study|Pregnancy|0
801358|NCT02591238|2601889|P3|Overall Study|Pregnancy|0
801359|NCT02591238|2601890|P2|Overall Study|Pregnancy|0
801360|NCT02591238|2601891|P1|Overall Study|Pregnancy|1
801361|NCT02590939|2601927|P2|Overall Study|Failed the nociceptive test|1
801362|NCT02590939|2601928|P1|Overall Study|Failed the nociceptive test|2
801363|NCT02590939|2601927|P2|Overall Study|Withdrawal by Subject|1
801364|NCT02590939|2601928|P1|Overall Study|Withdrawal by Subject|3
801365|NCT02590588|2601948|P1|Overall Study|Adverse Event|1
801366|NCT02590562|2601956|P1|Overall Study|Did Not Meet the Inclusion Criteria|6
801367|NCT02590003|2602015|P2|Overall Study|Death|2
801368|NCT02590003|2602016|P1|Overall Study|Death|1
801369|NCT02587819|2602063|P1|Overall Study|Lost to Follow-up|1
801370|NCT02587819|2602063|P1|Overall Study|Adverse Event|1
801371|NCT02587234|2602072|P2|Overall Study|Lost to Follow-up|2
801372|NCT02587234|2602073|P1|Overall Study|Lost to Follow-up|0
801373|NCT02587234|2602072|P2|Overall Study|Withdrawal by Subject|1
801374|NCT02587234|2602073|P1|Overall Study|Withdrawal by Subject|1
801375|NCT02586805|2602098|P4|Overall Study|Physician Decision|0
801376|NCT02586805|2602099|P3|Overall Study|Physician Decision|0
801377|NCT02586805|2602100|P2|Overall Study|Physician Decision|0
801378|NCT02586805|2602101|P1|Overall Study|Physician Decision|1
801379|NCT02586805|2602098|P4|Overall Study|Lost to Follow-up|0
801380|NCT02586805|2602099|P3|Overall Study|Lost to Follow-up|1
801381|NCT02586805|2602100|P2|Overall Study|Lost to Follow-up|0
801382|NCT02586805|2602101|P1|Overall Study|Lost to Follow-up|0
801383|NCT02586805|2602098|P4|Overall Study|Adverse Event|0
801384|NCT02586805|2602099|P3|Overall Study|Adverse Event|1
801385|NCT02586805|2602100|P2|Overall Study|Adverse Event|0
801386|NCT02586805|2602101|P1|Overall Study|Adverse Event|2
801387|NCT02586805|2602098|P4|Overall Study|Withdrawal by Subject|2
801388|NCT02586805|2602099|P3|Overall Study|Withdrawal by Subject|1
801389|NCT02586805|2602100|P2|Overall Study|Withdrawal by Subject|1
801390|NCT02586805|2602101|P1|Overall Study|Withdrawal by Subject|3
801391|NCT02586506|2602123|P1|Overall Study|Other Reason|2
801392|NCT02586506|2602123|P1|Overall Study|Lost to Follow-up|1
801393|NCT02586506|2602123|P1|Overall Study|Protocol Violation|6
801394|NCT02586493|2602129|P1|Overall Study|Withdrawal by Subject|1
801395|NCT02586493|2602129|P1|Overall Study|Lost to Follow-up|1
801396|NCT02586493|2602129|P1|Overall Study|Protocol Violation|6
801397|NCT02586493|2602129|P1|Overall Study|Adverse Event|4
801398|NCT02586415|2602137|P2|Overall Study|Lost to Follow-up|2
801399|NCT02586415|2602138|P1|Overall Study|Lost to Follow-up|1
801400|NCT02586415|2602137|P2|Overall Study|Death|23
801401|NCT02586415|2602138|P1|Overall Study|Death|13
801402|NCT02585999|2602146|P1|Overall Study|Protocol Violation|1
801403|NCT02585999|2602146|P1|Overall Study|Lost to Follow-up|1
801404|NCT02585778|2602173|P2|Overall Study|Other than specified above|2
801405|NCT02585778|2602174|P1|Overall Study|Other than specified above|6
801406|NCT02585778|2602173|P2|Overall Study|Randomized but not treated|2
801407|NCT02585778|2602174|P1|Overall Study|Randomized but not treated|1
801408|NCT02585778|2602173|P2|Overall Study|Death|1
801409|NCT02585778|2602174|P1|Overall Study|Death|0
801410|NCT02585778|2602173|P2|Overall Study|Poor compliance to study protocol|2
801411|NCT02585778|2602174|P1|Overall Study|Poor compliance to study protocol|0
801412|NCT02585778|2602173|P2|Overall Study|Participant did not wish to continue|4
801413|NCT02585778|2602174|P1|Overall Study|Participant did not wish to continue|9
801414|NCT02585778|2602173|P2|Overall Study|Adverse Event|4
801415|NCT02585778|2602174|P1|Overall Study|Adverse Event|17
801416|NCT02584959|2602296|P3|Period 2|Withdrawn from study|2
801417|NCT02584959|2602297|P2|Period 2|Withdrawn from study|1
801418|NCT02584959|2602298|P1|Period 2|Withdrawn from study|6
801419|NCT02584959|2602296|P3|Period 1|Withdrawn from study|0
801420|NCT02584959|2602297|P2|Period 1|Withdrawn from study|4
801421|NCT02584959|2602298|P1|Period 1|Withdrawn from study|3
801422|NCT02584660|2602405|P2|Overall Study|Other|1
801423|NCT02584660|2602406|P1|Overall Study|Other|0
801424|NCT02584660|2602405|P2|Overall Study|Withdrawal by Subject|2
801425|NCT02584660|2602406|P1|Overall Study|Withdrawal by Subject|0
801426|NCT02584660|2602405|P2|Overall Study|Protocol Violation|1
801427|NCT02584660|2602406|P1|Overall Study|Protocol Violation|0
801428|NCT02584660|2602405|P2|Overall Study|Lost to Follow-up|4
801429|NCT02584660|2602406|P1|Overall Study|Lost to Follow-up|3
801430|NCT02584660|2602405|P2|Overall Study|Adverse Event|0
801431|NCT02584660|2602406|P1|Overall Study|Adverse Event|4
801432|NCT02584504|2602425|P3|Open-label Treatment|Entered but not treated|1
801433|NCT02584504|2602426|P2|Open-label Treatment|Entered but not treated|1
801434|NCT02584504|2602427|P1|Open-label Treatment|Entered but not treated|0
801435|NCT02584504|2602425|P3|Open-label Treatment|Ongoing in the study|52
801436|NCT02584504|2602426|P2|Open-label Treatment|Ongoing in the study|49
801437|NCT02584504|2602427|P1|Open-label Treatment|Ongoing in the study|54
801438|NCT02584504|2602425|P3|Open-label Treatment|Adverse Event|0
801439|NCT02584504|2602426|P2|Open-label Treatment|Adverse Event|1
801440|NCT02584504|2602427|P1|Open-label Treatment|Adverse Event|0
801441|NCT02584504|2602425|P3|Open-label Treatment|Participant withdrew consent|2
801442|NCT02584504|2602426|P2|Open-label Treatment|Participant withdrew consent|0
801443|NCT02584504|2602427|P1|Open-label Treatment|Participant withdrew consent|0
801444|NCT02584504|2602425|P3|Double-blind Treatment|Family Matter|0
801445|NCT02584504|2602426|P2|Double-blind Treatment|Family Matter|1
801446|NCT02584504|2602427|P1|Double-blind Treatment|Family Matter|0
801447|NCT02584504|2602425|P3|Double-blind Treatment|Adverse Event|0
801448|NCT02584504|2602426|P2|Double-blind Treatment|Adverse Event|1
801449|NCT02584504|2602427|P1|Double-blind Treatment|Adverse Event|0
801450|NCT02584504|2602425|P3|Double-blind Treatment|Participant withdrew consent|1
801451|NCT02584504|2602426|P2|Double-blind Treatment|Participant withdrew consent|0
801452|NCT02584504|2602427|P1|Double-blind Treatment|Participant withdrew consent|0
801453|NCT02583425|2602478|P1|Treatment Period|Adverse Event|1
801454|NCT02583425|2602478|P1|Baseline|Did not meet continued criteria|5
801455|NCT02583425|2602478|P1|Screening|Did not meet entry criteria|12
801456|NCT02582983|2602489|P1|Overall Study|Adverse Event|1
801457|NCT02582983|2602489|P1|Overall Study|Withdrawal by Subject|2
801458|NCT02582983|2602489|P1|Overall Study|Death|3
801459|NCT02582684|2602504|P1|Overall Study|Found to be ineligible after enrollment|2
801460|NCT02582684|2602504|P1|Overall Study|Subject withdrew consent|1
801461|NCT02582684|2602504|P1|Overall Study|Subject not able to get to clinic|10
801462|NCT02582684|2602504|P1|Overall Study|Unable to contact subject/parent|4
801463|NCT02582632|2602523|P1|Overall Study|Not Specified|1
801464|NCT02582242|2602538|P2|Overall Study|Unclassified|1
801465|NCT02582242|2602539|P1|Overall Study|Unclassified|2
801466|NCT02582242|2602538|P2|Overall Study|Withdrawal by Subject|11
801467|NCT02582242|2602539|P1|Overall Study|Withdrawal by Subject|11
801468|NCT02582242|2602538|P2|Overall Study|Lost to Follow-up|1
801469|NCT02582242|2602539|P1|Overall Study|Lost to Follow-up|0
801470|NCT02582242|2602538|P2|Overall Study|Protocol Violation|1
801471|NCT02582242|2602539|P1|Overall Study|Protocol Violation|3
801472|NCT02582242|2602538|P2|Overall Study|Adverse Event|3
801473|NCT02582242|2602539|P1|Overall Study|Adverse Event|4
801474|NCT02581995|2602579|P1|Overall Study|Death|4
801475|NCT02581995|2602579|P1|Overall Study|Physician Decision|1
801476|NCT02581995|2602579|P1|Overall Study|Withdrawal by participant|12
801477|NCT02581995|2602579|P1|Overall Study|Lost to Follow-up|5
801478|NCT02581995|2602579|P1|Overall Study|Adverse Event|6
801479|NCT02581995|2602579|P1|Overall Study|Unspecified other|3
801480|NCT02581488|2602595|P2|Overall Study|Protocol Violation|4
801481|NCT02581488|2602596|P1|Overall Study|Protocol Violation|0
801482|NCT02581488|2602595|P2|Overall Study|Non-Compliance|0
801483|NCT02581488|2602596|P1|Overall Study|Non-Compliance|1
801484|NCT02581488|2602595|P2|Overall Study|Withdrawal by Subject|0
801485|NCT02581488|2602596|P1|Overall Study|Withdrawal by Subject|1
801486|NCT02581488|2602595|P2|Overall Study|Lost to Follow-up|0
801487|NCT02581488|2602596|P1|Overall Study|Lost to Follow-up|1
801488|NCT02581488|2602595|P2|Overall Study|Adverse Event|7
801489|NCT02581488|2602596|P1|Overall Study|Adverse Event|6
801490|NCT02581410|2602627|P2|End of Study Phase|Other-transfer of subject not completed|1
801491|NCT02581410|2602628|P1|End of Study Phase|Other-transfer of subject not completed|0
801492|NCT02581410|2602627|P2|End of Study Phase|Lost to Follow-up|2
801493|NCT02581410|2602628|P1|End of Study Phase|Lost to Follow-up|0
801494|NCT02581410|2602627|P2|End of Study Phase|Migrated/moved from study area|3
801495|NCT02581410|2602628|P1|End of Study Phase|Migrated/moved from study area|0
801496|NCT02581410|2602627|P2|End of Study Phase|Withdrawal by Subject|2
801497|NCT02581410|2602628|P1|End of Study Phase|Withdrawal by Subject|1
801498|NCT02581410|2602627|P2|End of Study Phase|Adverse Event|3
801499|NCT02581410|2602628|P1|End of Study Phase|Adverse Event|4
801500|NCT02581410|2602627|P2|Vaccination Phase|Migrated/moved from study area|1
801501|NCT02581410|2602628|P1|Vaccination Phase|Migrated/moved from study area|0
801502|NCT02581410|2602627|P2|Vaccination Phase|Withdrawal by Subject|1
801503|NCT02581410|2602628|P1|Vaccination Phase|Withdrawal by Subject|0
801504|NCT02581410|2602627|P2|Vaccination Phase|Adverse Event|1
801505|NCT02581410|2602628|P1|Vaccination Phase|Adverse Event|2
801506|NCT02581345|2602658|P4|Part 2: Week 17 to Week 47|Unspecified Reason|1
801507|NCT02581345|2602659|P3|Part 2: Week 17 to Week 47|Unspecified Reason|1
801508|NCT02581345|2602660|P2|Part 2: Week 17 to Week 47|Unspecified Reason|0
801509|NCT02581345|2602661|P1|Part 2: Week 17 to Week 47|Unspecified Reason|2
801510|NCT02581345|2602658|P4|Part 2: Week 17 to Week 47|Lost to Follow-up|1
801511|NCT02581345|2602659|P3|Part 2: Week 17 to Week 47|Lost to Follow-up|0
801512|NCT02581345|2602660|P2|Part 2: Week 17 to Week 47|Lost to Follow-up|0
801513|NCT02581345|2602661|P1|Part 2: Week 17 to Week 47|Lost to Follow-up|2
801514|NCT02581345|2602658|P4|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2
801515|NCT02581345|2602659|P3|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3
801516|NCT02581345|2602660|P2|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0
801517|NCT02581345|2602661|P1|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8
801518|NCT02581345|2602658|P4|Part 2: Week 17 to Week 47|Withdrawal by Subject|5
801519|NCT02581345|2602659|P3|Part 2: Week 17 to Week 47|Withdrawal by Subject|7
801520|NCT02581345|2602660|P2|Part 2: Week 17 to Week 47|Withdrawal by Subject|0
801521|NCT02581345|2602661|P1|Part 2: Week 17 to Week 47|Withdrawal by Subject|9
801522|NCT02581345|2602658|P4|Part 2: Week 17 to Week 47|Physician Decision|1
801523|NCT02581345|2602659|P3|Part 2: Week 17 to Week 47|Physician Decision|2
801524|NCT02581345|2602660|P2|Part 2: Week 17 to Week 47|Physician Decision|0
801525|NCT02581345|2602661|P1|Part 2: Week 17 to Week 47|Physician Decision|3
801526|NCT02581345|2602658|P4|Part 2: Week 17 to Week 47|Adverse Event|2
801527|NCT02581345|2602659|P3|Part 2: Week 17 to Week 47|Adverse Event|2
801528|NCT02581345|2602660|P2|Part 2: Week 17 to Week 47|Adverse Event|0
801529|NCT02581345|2602661|P1|Part 2: Week 17 to Week 47|Adverse Event|5
801530|NCT02581345|2602658|P4|Part 1: up to Week 16|Did Not Receive Treatment|0
801531|NCT02581345|2602659|P3|Part 1: up to Week 16|Did Not Receive Treatment|0
801532|NCT02581345|2602660|P2|Part 1: up to Week 16|Did Not Receive Treatment|1
801533|NCT02581345|2602661|P1|Part 1: up to Week 16|Did Not Receive Treatment|1
801534|NCT02581345|2602658|P4|Part 1: up to Week 16|Unspecified Reason|0
801535|NCT02581345|2602659|P3|Part 1: up to Week 16|Unspecified Reason|0
801536|NCT02581345|2602660|P2|Part 1: up to Week 16|Unspecified Reason|3
801537|NCT02581345|2602661|P1|Part 1: up to Week 16|Unspecified Reason|3
801538|NCT02581345|2602658|P4|Part 1: up to Week 16|Lost to Follow-up|0
801539|NCT02581345|2602659|P3|Part 1: up to Week 16|Lost to Follow-up|0
801540|NCT02581345|2602660|P2|Part 1: up to Week 16|Lost to Follow-up|0
801541|NCT02581345|2602661|P1|Part 1: up to Week 16|Lost to Follow-up|2
801542|NCT02581345|2602658|P4|Part 1: up to Week 16|Withdrawal by Subject|0
801543|NCT02581345|2602659|P3|Part 1: up to Week 16|Withdrawal by Subject|0
801544|NCT02581345|2602660|P2|Part 1: up to Week 16|Withdrawal by Subject|7
801545|NCT02581345|2602661|P1|Part 1: up to Week 16|Withdrawal by Subject|4
801546|NCT02581345|2602658|P4|Part 1: up to Week 16|Physician Decision|0
801547|NCT02581345|2602659|P3|Part 1: up to Week 16|Physician Decision|0
801548|NCT02581345|2602660|P2|Part 1: up to Week 16|Physician Decision|4
801549|NCT02581345|2602661|P1|Part 1: up to Week 16|Physician Decision|2
801550|NCT02581345|2602658|P4|Part 1: up to Week 16|Adverse Event|0
801551|NCT02581345|2602659|P3|Part 1: up to Week 16|Adverse Event|0
801552|NCT02581345|2602660|P2|Part 1: up to Week 16|Adverse Event|8
801553|NCT02581345|2602661|P1|Part 1: up to Week 16|Adverse Event|3
801554|NCT02580591|2602802|P4|Overall Study|Other than specified|2
801555|NCT02580591|2602803|P3|Overall Study|Other than specified|5
801556|NCT02580591|2602804|P2|Overall Study|Other than specified|2
801557|NCT02580591|2602805|P1|Overall Study|Other than specified|3
801558|NCT02580591|2602802|P4|Overall Study|Not treated|0
801559|NCT02580591|2602803|P3|Overall Study|Not treated|0
801560|NCT02580591|2602804|P2|Overall Study|Not treated|1
801561|NCT02580591|2602805|P1|Overall Study|Not treated|1
801562|NCT02580591|2602802|P4|Overall Study|Withdrawal by Subject|3
801563|NCT02580591|2602803|P3|Overall Study|Withdrawal by Subject|2
801564|NCT02580591|2602804|P2|Overall Study|Withdrawal by Subject|1
801565|NCT02580591|2602805|P1|Overall Study|Withdrawal by Subject|6
801566|NCT02580591|2602802|P4|Overall Study|Lost to Follow-up|1
801567|NCT02580591|2602803|P3|Overall Study|Lost to Follow-up|3
801568|NCT02580591|2602804|P2|Overall Study|Lost to Follow-up|3
801569|NCT02580591|2602805|P1|Overall Study|Lost to Follow-up|5
801570|NCT02580591|2602802|P4|Overall Study|Protocol Violation|1
801571|NCT02580591|2602803|P3|Overall Study|Protocol Violation|1
801572|NCT02580591|2602804|P2|Overall Study|Protocol Violation|2
801573|NCT02580591|2602805|P1|Overall Study|Protocol Violation|3
801574|NCT02580591|2602802|P4|Overall Study|Adverse Event|5
801575|NCT02580591|2602803|P3|Overall Study|Adverse Event|2
801576|NCT02580591|2602804|P2|Overall Study|Adverse Event|1
801577|NCT02580591|2602805|P1|Overall Study|Adverse Event|0
801578|NCT02580357|2602838|P3|Overall Study|Protocol Violation|0
801579|NCT02580357|2602839|P2|Overall Study|Protocol Violation|0
801580|NCT02580357|2602840|P1|Overall Study|Protocol Violation|1
801581|NCT02580357|2602838|P3|Overall Study|Lost to Follow-up|0
801582|NCT02580357|2602839|P2|Overall Study|Lost to Follow-up|0
801583|NCT02580357|2602840|P1|Overall Study|Lost to Follow-up|2
801584|NCT02580240|2602857|P2|Overall Study|Physician Decision|0
801585|NCT02580240|2602858|P1|Overall Study|Physician Decision|2
801586|NCT02579772|2602875|P2|Overall Study|flu-like illness, orthopedic trauma|1
801587|NCT02579772|2602876|P1|Overall Study|flu-like illness, orthopedic trauma|1
801588|NCT02579772|2602875|P2|Overall Study|Usage of additional antioxidants|0
801589|NCT02579772|2602876|P1|Overall Study|Usage of additional antioxidants|1
801590|NCT02579772|2602875|P2|Overall Study|Withdrawal by Subject|1
801591|NCT02579772|2602876|P1|Overall Study|Withdrawal by Subject|0
801592|NCT02579603|2602896|P2|Overall Study|Other than stated|0
801593|NCT02579603|2602897|P1|Overall Study|Other than stated|1
801594|NCT02579603|2602896|P2|Overall Study|Adverse Event|2
801595|NCT02579603|2602897|P1|Overall Study|Adverse Event|2
801596|NCT02579603|2602896|P2|Overall Study|Not treated|0
801597|NCT02579603|2602897|P1|Overall Study|Not treated|1
801598|NCT02578992|2602935|P2|Overall Study|equipment not available or malfunction|3
801599|NCT02578992|2602936|P1|Overall Study|equipment not available or malfunction|3
801600|NCT02578706|2602951|P3|Overall Study|Physician Decision|0
801601|NCT02578706|2602952|P2|Overall Study|Physician Decision|1
801602|NCT02578706|2602953|P1|Overall Study|Physician Decision|0
801603|NCT02578706|2602951|P3|Overall Study|Lost to Follow-up|0
801604|NCT02578706|2602952|P2|Overall Study|Lost to Follow-up|4
801605|NCT02578706|2602953|P1|Overall Study|Lost to Follow-up|0
801606|NCT02578706|2602951|P3|Overall Study|Withdrawal by Subject|0
801607|NCT02578706|2602952|P2|Overall Study|Withdrawal by Subject|0
801608|NCT02578706|2602953|P1|Overall Study|Withdrawal by Subject|1
801609|NCT02578680|2603032|P2|Overall Study|Ongoing in Study|96
801610|NCT02578680|2603033|P1|Overall Study|Ongoing in Study|276
801611|NCT02578680|2603032|P2|Overall Study|Withdrawal by Subject|5
801612|NCT02578680|2603033|P1|Overall Study|Withdrawal by Subject|8
801613|NCT02578680|2603032|P2|Overall Study|Withdrawal by Parent/Guardian|0
801614|NCT02578680|2603033|P1|Overall Study|Withdrawal by Parent/Guardian|1
801615|NCT02578680|2603032|P2|Overall Study|Protocol Violation|1
801616|NCT02578680|2603033|P1|Overall Study|Protocol Violation|1
801617|NCT02578680|2603032|P2|Overall Study|Death|104
801618|NCT02578680|2603033|P1|Overall Study|Death|124
801619|NCT02578316|2603049|P1|Extension Phase|Progression of disease|6
801620|NCT02578186|2603078|P2|Period 1 (First of Crossover)|Withdrawal by Subject|1
801621|NCT02578186|2603079|P1|Period 1 (First of Crossover)|Withdrawal by Subject|1
801622|NCT02578186|2603078|P2|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
801623|NCT02578186|2603079|P1|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
801624|NCT02577718|2603085|P1|Overall Study|Withdrawal by Subject|2
801625|NCT02577718|2603085|P1|Overall Study|Death|6
801626|NCT02577315|2603120|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
801627|NCT02577315|2603121|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
801628|NCT02577107|2603139|P2|Overall Study|Protocol deviation|1
801629|NCT02577107|2603140|P1|Overall Study|Protocol deviation|0
801630|NCT02577016|2603154|P2|Overall Study|Physician Decision|1
801631|NCT02577016|2603155|P1|Overall Study|Physician Decision|0
801632|NCT02577016|2603154|P2|Overall Study|Adverse Event|1
801633|NCT02577016|2603155|P1|Overall Study|Adverse Event|2
801634|NCT02577003|2603173|P2|Overall Study|Withdrawal by Subject|1
801635|NCT02577003|2603174|P1|Overall Study|Withdrawal by Subject|0
801636|NCT02577003|2603173|P2|Overall Study|Adverse Event|4
801637|NCT02577003|2603174|P1|Overall Study|Adverse Event|2
801638|NCT02576938|2603195|P3|Overall Study|Met Exclusion Criteria|0
801639|NCT02576938|2603196|P2|Overall Study|Met Exclusion Criteria|1
801640|NCT02576938|2603197|P1|Overall Study|Met Exclusion Criteria|0
801641|NCT02576938|2603195|P3|Overall Study|Physician Decision|0
801642|NCT02576938|2603196|P2|Overall Study|Physician Decision|1
801643|NCT02576938|2603197|P1|Overall Study|Physician Decision|0
801644|NCT02576938|2603195|P3|Overall Study|Lost to Follow-up|1
801645|NCT02576938|2603196|P2|Overall Study|Lost to Follow-up|0
801646|NCT02576938|2603197|P1|Overall Study|Lost to Follow-up|2
801647|NCT02576938|2603195|P3|Overall Study|Lack of Efficacy|0
801648|NCT02576938|2603196|P2|Overall Study|Lack of Efficacy|4
801649|NCT02576938|2603197|P1|Overall Study|Lack of Efficacy|9
801650|NCT02576938|2603195|P3|Overall Study|Withdrawal by Subject|4
801651|NCT02576938|2603196|P2|Overall Study|Withdrawal by Subject|2
801652|NCT02576938|2603197|P1|Overall Study|Withdrawal by Subject|3
801653|NCT02576938|2603195|P3|Overall Study|Protocol Violation|1
801654|NCT02576938|2603196|P2|Overall Study|Protocol Violation|1
801655|NCT02576938|2603197|P1|Overall Study|Protocol Violation|1
801656|NCT02576938|2603195|P3|Overall Study|Adverse Event|6
801657|NCT02576938|2603196|P2|Overall Study|Adverse Event|3
801658|NCT02576938|2603197|P1|Overall Study|Adverse Event|5
801659|NCT02576678|2603228|P3|Overall Study|Ongoing|10
801660|NCT02576678|2603229|P2|Overall Study|Ongoing|0
801661|NCT02576678|2603230|P1|Overall Study|Ongoing|0
801662|NCT02576678|2603228|P3|Overall Study|Miscellaneous|0
801663|NCT02576678|2603229|P2|Overall Study|Miscellaneous|0
801664|NCT02576678|2603230|P1|Overall Study|Miscellaneous|2
801665|NCT02576678|2603228|P3|Overall Study|Lost to Follow-up|1
801666|NCT02576678|2603229|P2|Overall Study|Lost to Follow-up|0
801667|NCT02576678|2603230|P1|Overall Study|Lost to Follow-up|0
801668|NCT02576678|2603228|P3|Overall Study|Withdrawal by Subject|2
801669|NCT02576678|2603229|P2|Overall Study|Withdrawal by Subject|1
801670|NCT02576678|2603230|P1|Overall Study|Withdrawal by Subject|3
801671|NCT02576678|2603228|P3|Overall Study|Adverse Event|2
801672|NCT02576678|2603229|P2|Overall Study|Adverse Event|0
801673|NCT02576678|2603230|P1|Overall Study|Adverse Event|0
801674|NCT02576639|2603267|P5|Overall Study|Physician Decision|1
801675|NCT02576639|2603268|P4|Overall Study|Physician Decision|0
801676|NCT02576639|2603269|P3|Overall Study|Physician Decision|0
801677|NCT02576639|2603270|P2|Overall Study|Physician Decision|0
801678|NCT02576639|2603271|P1|Overall Study|Physician Decision|0
801679|NCT02576639|2603267|P5|Overall Study|Adverse Event|2
801680|NCT02576639|2603268|P4|Overall Study|Adverse Event|1
801681|NCT02576639|2603269|P3|Overall Study|Adverse Event|1
801682|NCT02576639|2603270|P2|Overall Study|Adverse Event|0
801683|NCT02576639|2603271|P1|Overall Study|Adverse Event|1
801684|NCT02576639|2603267|P5|Overall Study|Withdrawal by Subject|1
801685|NCT02576639|2603268|P4|Overall Study|Withdrawal by Subject|0
801686|NCT02576639|2603269|P3|Overall Study|Withdrawal by Subject|1
801687|NCT02576639|2603270|P2|Overall Study|Withdrawal by Subject|2
801688|NCT02576639|2603271|P1|Overall Study|Withdrawal by Subject|1
801689|NCT02576587|2603330|P2|Follow up Period (Case Only)|Controls not eligible for followup|155
801690|NCT02576587|2603331|P1|Follow up Period (Case Only)|Controls not eligible for followup|0
801691|NCT02576587|2603330|P2|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0
801692|NCT02576587|2603331|P1|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92
801693|NCT02576587|2603330|P2|Follow up Period (Case Only)|Withdrawal by Subject|0
801694|NCT02576587|2603331|P1|Follow up Period (Case Only)|Withdrawal by Subject|25
801695|NCT02576587|2603330|P2|Baseline|Equipment failure|1
801696|NCT02576587|2603331|P1|Baseline|Equipment failure|0
801697|NCT02576535|2603349|P1|Overall Study|Withdrawal by Subject|2
801698|NCT02576145|2603373|P2|Overall Study|Tetanus Titers Decreased|1
801699|NCT02576145|2603374|P1|Overall Study|Tetanus Titers Decreased|0
801700|NCT02576145|2603373|P2|Overall Study|Acute rejection|0
801701|NCT02576145|2603374|P1|Overall Study|Acute rejection|1
801702|NCT02576145|2603373|P2|Overall Study|Withdrawal by Subject|0
801703|NCT02576145|2603374|P1|Overall Study|Withdrawal by Subject|1
801704|NCT02576145|2603373|P2|Overall Study|Adverse Event|0
801705|NCT02576145|2603374|P1|Overall Study|Adverse Event|1
801706|NCT02575911|2603416|P1|Overall Study|Lost to Follow-up|1
801707|NCT02575833|2603436|P2|Overall Study|Lost to Follow-up|0
801708|NCT02575833|2603437|P1|Overall Study|Lost to Follow-up|1
801709|NCT02575833|2603436|P2|Overall Study|Withdrawal by Subject|1
801710|NCT02575833|2603437|P1|Overall Study|Withdrawal by Subject|0
801711|NCT02574845|2603458|P6|Overall Study|Adverse Event|1
801712|NCT02574845|2603459|P5|Overall Study|Adverse Event|0
801713|NCT02574845|2603460|P4|Overall Study|Adverse Event|0
801714|NCT02574845|2603461|P3|Overall Study|Adverse Event|0
801715|NCT02574845|2603462|P2|Overall Study|Adverse Event|1
801716|NCT02574845|2603463|P1|Overall Study|Adverse Event|0
801717|NCT02574845|2603458|P6|Overall Study|Consent withdrawn further participation|0
801718|NCT02574845|2603459|P5|Overall Study|Consent withdrawn further participation|1
801719|NCT02574845|2603460|P4|Overall Study|Consent withdrawn further participation|0
801720|NCT02574845|2603461|P3|Overall Study|Consent withdrawn further participation|0
801721|NCT02574845|2603462|P2|Overall Study|Consent withdrawn further participation|0
801722|NCT02574845|2603463|P1|Overall Study|Consent withdrawn further participation|0
801723|NCT02574260|2603493|P1|Overall Study|Disease Progression|1
801724|NCT02574247|2603502|P3|Overall Study|Did not meet inclusion criteria|5
801725|NCT02574247|2603503|P2|Overall Study|Did not meet inclusion criteria|3
801726|NCT02574247|2603504|P1|Overall Study|Did not meet inclusion criteria|4
801727|NCT02574247|2603502|P3|Overall Study|Withdrawal by Subject|0
801728|NCT02574247|2603503|P2|Overall Study|Withdrawal by Subject|0
801729|NCT02574247|2603504|P1|Overall Study|Withdrawal by Subject|1
801730|NCT02573948|2603516|P1|Longitudinal Cohort|Incarcerated|25
801731|NCT02573948|2603516|P1|Longitudinal Cohort|Lost to Follow-up|22
801732|NCT02573948|2603516|P1|Longitudinal Cohort|Death|9
801733|NCT02573870|2603526|P2|Overall Study|Other: Fail to Meet Visit|2
801734|NCT02573870|2603527|P1|Overall Study|Other: Fail to Meet Visit|0
801735|NCT02573870|2603526|P2|Overall Study|Lost to Follow-up|1
801736|NCT02573870|2603527|P1|Overall Study|Lost to Follow-up|0
801737|NCT02573870|2603526|P2|Overall Study|Other: Reached defined stopping criteria|1
801738|NCT02573870|2603527|P1|Overall Study|Other: Reached defined stopping criteria|0
801739|NCT02573870|2603526|P2|Overall Study|Lack of Efficacy|1
801740|NCT02573870|2603527|P1|Overall Study|Lack of Efficacy|0
801741|NCT02573870|2603526|P2|Overall Study|Adverse Event|2
801742|NCT02573870|2603527|P1|Overall Study|Adverse Event|0
801743|NCT02573467|2603537|P4|Post-treatment Follow up Epoch|Technical problems|0
801744|NCT02573467|2603538|P3|Post-treatment Follow up Epoch|Technical problems|1
801745|NCT02573467|2603539|P2|Post-treatment Follow up Epoch|Technical problems|0
801746|NCT02573467|2603540|P1|Post-treatment Follow up Epoch|Technical problems|0
801747|NCT02573467|2603537|P4|Post-treatment Follow up Epoch|Withdrawal by Subject|2
801748|NCT02573467|2603538|P3|Post-treatment Follow up Epoch|Withdrawal by Subject|9
801749|NCT02573467|2603539|P2|Post-treatment Follow up Epoch|Withdrawal by Subject|4
801750|NCT02573467|2603540|P1|Post-treatment Follow up Epoch|Withdrawal by Subject|5
801751|NCT02573467|2603537|P4|Post-treatment Follow up Epoch|Death|1
801752|NCT02573467|2603538|P3|Post-treatment Follow up Epoch|Death|0
801753|NCT02573467|2603539|P2|Post-treatment Follow up Epoch|Death|1
801754|NCT02573467|2603540|P1|Post-treatment Follow up Epoch|Death|1
801755|NCT02573467|2603537|P4|Double-blind Treatment Epoch|Study Terminated by sponsor|55
801756|NCT02573467|2603538|P3|Double-blind Treatment Epoch|Study Terminated by sponsor|48
801757|NCT02573467|2603539|P2|Double-blind Treatment Epoch|Study Terminated by sponsor|51
801758|NCT02573467|2603540|P1|Double-blind Treatment Epoch|Study Terminated by sponsor|50
801759|NCT02573467|2603537|P4|Double-blind Treatment Epoch|Withdrawal by Subject|0
801760|NCT02573467|2603538|P3|Double-blind Treatment Epoch|Withdrawal by Subject|1
801761|NCT02573467|2603539|P2|Double-blind Treatment Epoch|Withdrawal by Subject|1
801762|NCT02573467|2603540|P1|Double-blind Treatment Epoch|Withdrawal by Subject|2
801763|NCT02573467|2603537|P4|Double-blind Treatment Epoch|Adverse Event|0
801764|NCT02573467|2603538|P3|Double-blind Treatment Epoch|Adverse Event|1
801765|NCT02573467|2603539|P2|Double-blind Treatment Epoch|Adverse Event|0
801766|NCT02573467|2603540|P1|Double-blind Treatment Epoch|Adverse Event|1
801767|NCT02573467|2603537|P4|Double-blind Treatment Epoch|Lack of Efficacy|0
801768|NCT02573467|2603538|P3|Double-blind Treatment Epoch|Lack of Efficacy|1
801769|NCT02573467|2603539|P2|Double-blind Treatment Epoch|Lack of Efficacy|0
801770|NCT02573467|2603540|P1|Double-blind Treatment Epoch|Lack of Efficacy|0
801771|NCT02573155|2603604|P2|Washout Between Treatment Period 4 and 5|Adverse Event|1
801772|NCT02573155|2603605|P1|Washout Between Treatment Period 4 and 5|Adverse Event|0
801773|NCT02573155|2603604|P2|Washout Between Treatment Period 3 and 4|Adverse Event|1
801774|NCT02573155|2603605|P1|Washout Between Treatment Period 3 and 4|Adverse Event|0
801775|NCT02573155|2603604|P2|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1
801776|NCT02573155|2603605|P1|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0
801777|NCT02573155|2603604|P2|Washout Between Treatment Period 2 and 3|Adverse Event|2
801778|NCT02573155|2603605|P1|Washout Between Treatment Period 2 and 3|Adverse Event|0
801779|NCT02573155|2603604|P2|Washout Between Treatment Period 2 and 3|Sponsor's decision|0
801780|NCT02573155|2603605|P1|Washout Between Treatment Period 2 and 3|Sponsor's decision|1
801781|NCT02573155|2603604|P2|Washout Between Treatment Period 1 and 2|Adverse Event|3
801782|NCT02573155|2603605|P1|Washout Between Treatment Period 1 and 2|Adverse Event|0
801783|NCT02573155|2603604|P2|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1
801784|NCT02573155|2603605|P1|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0
801785|NCT02573155|2603604|P2|Washout Between Treatment Period 1 and 2|Physician Decision|1
801786|NCT02573155|2603605|P1|Washout Between Treatment Period 1 and 2|Physician Decision|0
801787|NCT02572076|2603791|P1|Overall Study|Protocol Violation|1
801788|NCT02571244|2603832|P2|Overall Study|Unable to reach out post discharge|0
801789|NCT02571244|2603833|P1|Overall Study|Unable to reach out post discharge|3
801790|NCT02571244|2603832|P2|Overall Study|Lost to Follow-up|1
801791|NCT02571244|2603833|P1|Overall Study|Lost to Follow-up|0
801792|NCT02571049|2603878|P2|Randomization|No migraine attack|1
801793|NCT02571049|2603879|P1|Randomization|No migraine attack|0
801794|NCT02571049|2603878|P2|Screening|Did not meet entry criteria|2
801795|NCT02571049|2603879|P1|Screening|Did not meet entry criteria|2
801796|NCT02570165|2603967|P7|Overall Study|Withdrawal Request by GSK|0
801797|NCT02570165|2603968|P6|Overall Study|Withdrawal Request by GSK|0
801798|NCT02570165|2603969|P5|Overall Study|Withdrawal Request by GSK|0
801799|NCT02570165|2603970|P4|Overall Study|Withdrawal Request by GSK|0
801800|NCT02570165|2603971|P3|Overall Study|Withdrawal Request by GSK|2
801801|NCT02570165|2603972|P2|Overall Study|Withdrawal Request by GSK|0
801802|NCT02570165|2603973|P1|Overall Study|Withdrawal Request by GSK|0
801803|NCT02570165|2603967|P7|Overall Study|Par. did not Meet Continuation Criteria|0
801804|NCT02570165|2603968|P6|Overall Study|Par. did not Meet Continuation Criteria|1
801805|NCT02570165|2603969|P5|Overall Study|Par. did not Meet Continuation Criteria|0
801806|NCT02570165|2603970|P4|Overall Study|Par. did not Meet Continuation Criteria|0
801807|NCT02570165|2603971|P3|Overall Study|Par. did not Meet Continuation Criteria|0
801808|NCT02570165|2603972|P2|Overall Study|Par. did not Meet Continuation Criteria|0
801809|NCT02570165|2603973|P1|Overall Study|Par. did not Meet Continuation Criteria|0
801810|NCT02570165|2603967|P7|Overall Study|Withdrawal by Subject|0
801811|NCT02570165|2603968|P6|Overall Study|Withdrawal by Subject|0
801812|NCT02570165|2603969|P5|Overall Study|Withdrawal by Subject|1
801813|NCT02570165|2603970|P4|Overall Study|Withdrawal by Subject|2
801814|NCT02570165|2603971|P3|Overall Study|Withdrawal by Subject|0
801815|NCT02570165|2603972|P2|Overall Study|Withdrawal by Subject|0
801816|NCT02570165|2603973|P1|Overall Study|Withdrawal by Subject|0
801817|NCT02570165|2603967|P7|Overall Study|Physician Decision|0
801818|NCT02570165|2603968|P6|Overall Study|Physician Decision|0
801819|NCT02570165|2603969|P5|Overall Study|Physician Decision|0
801820|NCT02570165|2603970|P4|Overall Study|Physician Decision|0
801821|NCT02570165|2603971|P3|Overall Study|Physician Decision|0
801822|NCT02570165|2603972|P2|Overall Study|Physician Decision|1
801823|NCT02570165|2603973|P1|Overall Study|Physician Decision|0
801824|NCT02570165|2603967|P7|Overall Study|Lost to Follow-up|0
801825|NCT02570165|2603968|P6|Overall Study|Lost to Follow-up|0
801826|NCT02570165|2603969|P5|Overall Study|Lost to Follow-up|0
801827|NCT02570165|2603970|P4|Overall Study|Lost to Follow-up|1
801828|NCT02570165|2603971|P3|Overall Study|Lost to Follow-up|1
801829|NCT02570165|2603972|P2|Overall Study|Lost to Follow-up|0
801830|NCT02570165|2603973|P1|Overall Study|Lost to Follow-up|0
801831|NCT02570165|2603967|P7|Overall Study|Par. Reached Stopping Criteria|0
801832|NCT02570165|2603968|P6|Overall Study|Par. Reached Stopping Criteria|1
801833|NCT02570165|2603969|P5|Overall Study|Par. Reached Stopping Criteria|1
801834|NCT02570165|2603970|P4|Overall Study|Par. Reached Stopping Criteria|2
801835|NCT02570165|2603971|P3|Overall Study|Par. Reached Stopping Criteria|0
801836|NCT02570165|2603972|P2|Overall Study|Par. Reached Stopping Criteria|1
801837|NCT02570165|2603973|P1|Overall Study|Par. Reached Stopping Criteria|1
801838|NCT02570165|2603967|P7|Overall Study|Lack of Efficacy|0
801839|NCT02570165|2603968|P6|Overall Study|Lack of Efficacy|0
801840|NCT02570165|2603969|P5|Overall Study|Lack of Efficacy|4
801841|NCT02570165|2603970|P4|Overall Study|Lack of Efficacy|0
801842|NCT02570165|2603971|P3|Overall Study|Lack of Efficacy|0
801843|NCT02570165|2603972|P2|Overall Study|Lack of Efficacy|1
801844|NCT02570165|2603973|P1|Overall Study|Lack of Efficacy|0
801845|NCT02570165|2603967|P7|Overall Study|Adverse Event|0
801846|NCT02570165|2603968|P6|Overall Study|Adverse Event|0
801847|NCT02570165|2603969|P5|Overall Study|Adverse Event|0
801848|NCT02570165|2603970|P4|Overall Study|Adverse Event|0
801849|NCT02570165|2603971|P3|Overall Study|Adverse Event|2
801850|NCT02570165|2603972|P2|Overall Study|Adverse Event|0
801851|NCT02570165|2603973|P1|Overall Study|Adverse Event|1
801852|NCT02570126|2604013|P2|Overall Study|Withdrawal by Subject|7
801853|NCT02570126|2604014|P1|Overall Study|Withdrawal by Subject|3
801854|NCT02570126|2604013|P2|Overall Study|Protocol Violation|1
801855|NCT02570126|2604014|P1|Overall Study|Protocol Violation|0
801856|NCT02570126|2604013|P2|Overall Study|Violation Of Procedures GSK|1
801857|NCT02570126|2604014|P1|Overall Study|Violation Of Procedures GSK|0
801858|NCT02570126|2604013|P2|Overall Study|Unable To Arrange Visit 3|0
801859|NCT02570126|2604014|P1|Overall Study|Unable To Arrange Visit 3|1
801860|NCT02570126|2604013|P2|Overall Study|Lost to Follow-up|0
801861|NCT02570126|2604014|P1|Overall Study|Lost to Follow-up|2
801862|NCT02569996|2604049|P1|Overall Study|Unknown reason|1
801863|NCT02569996|2604049|P1|Overall Study|Complete remission|7
801864|NCT02569996|2604049|P1|Overall Study|Lost to Follow-up|5
801865|NCT02569996|2604049|P1|Overall Study|Withdrawal by Subject|5
801866|NCT02569996|2604049|P1|Overall Study|Non-compliance|9
801867|NCT02569996|2604049|P1|Overall Study|New anti-lymphoma treatment|1
801868|NCT02569996|2604049|P1|Overall Study|Progression of the disease|18
801869|NCT02569996|2604049|P1|Overall Study|Physician Decision|3
801870|NCT02569996|2604049|P1|Overall Study|Adverse Event|6
801871|NCT02569957|2604061|P2|Overall Study|Withdrawal by Subject|1
801872|NCT02569957|2604062|P1|Overall Study|Withdrawal by Subject|0
801873|NCT02569853|2604094|P2|Overall Study|Physician Decision|1
801874|NCT02569853|2604095|P1|Overall Study|Physician Decision|1
801875|NCT02569853|2604094|P2|Overall Study|Did not experience migraine attack|7
801876|NCT02569853|2604095|P1|Overall Study|Did not experience migraine attack|10
801877|NCT02569853|2604094|P2|Overall Study|Protocol Violation|1
801878|NCT02569853|2604095|P1|Overall Study|Protocol Violation|1
801879|NCT02569853|2604094|P2|Overall Study|Lost to Follow-up|3
801880|NCT02569853|2604095|P1|Overall Study|Lost to Follow-up|3
801881|NCT02569853|2604094|P2|Overall Study|Withdrawal by Subject|2
801882|NCT02569853|2604095|P1|Overall Study|Withdrawal by Subject|3
801883|NCT02569853|2604094|P2|Overall Study|Adverse Event|0
801884|NCT02569853|2604095|P1|Overall Study|Adverse Event|2
801885|NCT02569437|2604124|P2|Overall Study|Lost to Follow-up|14
801886|NCT02569437|2604125|P1|Overall Study|Lost to Follow-up|12
801887|NCT02568384|2604189|P1|Overall Study|Mobile devices incompatible with App|2
801888|NCT02568254|2604203|P6|Period 3|Unstatisfactory Lens fitting|0
801889|NCT02568254|2604204|P5|Period 3|Unstatisfactory Lens fitting|1
801890|NCT02568254|2604205|P4|Period 3|Unstatisfactory Lens fitting|0
801891|NCT02568254|2604206|P3|Period 3|Unstatisfactory Lens fitting|0
801892|NCT02568254|2604207|P2|Period 3|Unstatisfactory Lens fitting|0
801893|NCT02568254|2604208|P1|Period 3|Unstatisfactory Lens fitting|0
801894|NCT02568254|2604203|P6|Period 2|Adverse Event|0
801895|NCT02568254|2604204|P5|Period 2|Adverse Event|0
801896|NCT02568254|2604205|P4|Period 2|Adverse Event|0
801897|NCT02568254|2604206|P3|Period 2|Adverse Event|1
801898|NCT02568254|2604207|P2|Period 2|Adverse Event|0
801899|NCT02568254|2604208|P1|Period 2|Adverse Event|0
801900|NCT02567708|2604239|P2|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3
801901|NCT02567708|2604240|P1|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0
801902|NCT02567708|2604239|P2|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0
801903|NCT02567708|2604240|P1|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2
801904|NCT02567708|2604239|P2|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1
801905|NCT02567708|2604240|P1|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0
801906|NCT02567708|2604239|P2|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2
801907|NCT02567708|2604240|P1|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
801908|NCT02567552|2604281|P2|Overall Study|Adverse Event|1
801909|NCT02567552|2604282|P1|Overall Study|Adverse Event|0
801910|NCT02567188|2604312|P1|Overall Study|Protocol Violation|5
801911|NCT02567188|2604312|P1|Overall Study|Started Hemodialysis|2
801912|NCT02567188|2604312|P1|Overall Study|Moved and Changed Clinic|1
801913|NCT02567188|2604312|P1|Overall Study|Refused Treatment/ Did not Cooperate|1
801914|NCT02567188|2604312|P1|Overall Study|Withdrawal by Subject|1
801915|NCT02567188|2604312|P1|Overall Study|Adverse Event|1
801916|NCT02567188|2604312|P1|Overall Study|Lost to Follow-up|5
801917|NCT02567188|2604312|P1|Overall Study|Terminated Mircera Treatment|9
801918|NCT02567188|2604312|P1|Overall Study|Death|10
801919|NCT02566785|2604343|P2|Overall Study|Worsening condition|1
801920|NCT02566785|2604344|P1|Overall Study|Worsening condition|1
801921|NCT02566785|2604343|P2|Overall Study|Lost to Follow-up|2
801922|NCT02566785|2604344|P1|Overall Study|Lost to Follow-up|0
801923|NCT02566759|2604371|P17|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1
801924|NCT02566759|2604372|P16|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
801925|NCT02566759|2604373|P15|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
801926|NCT02566759|2604374|P14|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
801927|NCT02566759|2604375|P13|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
801928|NCT02566759|2604376|P12|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
801929|NCT02566759|2604377|P11|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
801930|NCT02566759|2604378|P10|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
801931|NCT02566759|2604379|P9|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
801932|NCT02566759|2604380|P8|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
801933|NCT02566759|2604381|P7|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
801934|NCT02566759|2604382|P6|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
801935|NCT02566759|2604383|P5|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
801936|NCT02566759|2604384|P4|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
801937|NCT02566759|2604385|P3|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
801938|NCT02566759|2604386|P2|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
801939|NCT02566759|2604387|P1|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
801940|NCT02566759|2604371|P17|All Parts|Other|0
801941|NCT02566759|2604372|P16|All Parts|Other|0
801942|NCT02566759|2604373|P15|All Parts|Other|0
801943|NCT02566759|2604374|P14|All Parts|Other|2
801944|NCT02566759|2604375|P13|All Parts|Other|0
801945|NCT02566759|2604376|P12|All Parts|Other|0
801946|NCT02566759|2604377|P11|All Parts|Other|0
801947|NCT02566759|2604378|P10|All Parts|Other|0
801948|NCT02566759|2604379|P9|All Parts|Other|0
801949|NCT02566759|2604380|P8|All Parts|Other|0
801950|NCT02566759|2604381|P7|All Parts|Other|0
801951|NCT02566759|2604382|P6|All Parts|Other|0
801952|NCT02566759|2604383|P5|All Parts|Other|0
801953|NCT02566759|2604384|P4|All Parts|Other|0
801954|NCT02566759|2604385|P3|All Parts|Other|0
801955|NCT02566759|2604386|P2|All Parts|Other|0
801956|NCT02566759|2604387|P1|All Parts|Other|0
801957|NCT02566759|2604371|P17|All Parts|Adverse Event|0
801958|NCT02566759|2604372|P16|All Parts|Adverse Event|0
801959|NCT02566759|2604373|P15|All Parts|Adverse Event|0
801960|NCT02566759|2604374|P14|All Parts|Adverse Event|3
801961|NCT02566759|2604375|P13|All Parts|Adverse Event|1
801962|NCT02566759|2604376|P12|All Parts|Adverse Event|0
801963|NCT02566759|2604377|P11|All Parts|Adverse Event|0
801964|NCT02566759|2604378|P10|All Parts|Adverse Event|0
801965|NCT02566759|2604379|P9|All Parts|Adverse Event|0
801966|NCT02566759|2604380|P8|All Parts|Adverse Event|0
801967|NCT02566759|2604381|P7|All Parts|Adverse Event|0
801968|NCT02566759|2604382|P6|All Parts|Adverse Event|0
801969|NCT02566759|2604383|P5|All Parts|Adverse Event|0
801970|NCT02566759|2604384|P4|All Parts|Adverse Event|0
801971|NCT02566759|2604385|P3|All Parts|Adverse Event|0
801972|NCT02566759|2604386|P2|All Parts|Adverse Event|0
801973|NCT02566759|2604387|P1|All Parts|Adverse Event|0
801974|NCT02566759|2604371|P17|All Parts|Withdrawal by Subject|0
801975|NCT02566759|2604372|P16|All Parts|Withdrawal by Subject|0
801976|NCT02566759|2604373|P15|All Parts|Withdrawal by Subject|0
801977|NCT02566759|2604374|P14|All Parts|Withdrawal by Subject|0
801978|NCT02566759|2604375|P13|All Parts|Withdrawal by Subject|0
801979|NCT02566759|2604376|P12|All Parts|Withdrawal by Subject|0
801980|NCT02566759|2604377|P11|All Parts|Withdrawal by Subject|0
801981|NCT02566759|2604378|P10|All Parts|Withdrawal by Subject|0
801982|NCT02566759|2604379|P9|All Parts|Withdrawal by Subject|0
801983|NCT02566759|2604380|P8|All Parts|Withdrawal by Subject|0
801984|NCT02566759|2604381|P7|All Parts|Withdrawal by Subject|0
801985|NCT02566759|2604382|P6|All Parts|Withdrawal by Subject|0
801986|NCT02566759|2604383|P5|All Parts|Withdrawal by Subject|0
801987|NCT02566759|2604384|P4|All Parts|Withdrawal by Subject|0
801988|NCT02566759|2604385|P3|All Parts|Withdrawal by Subject|0
801989|NCT02566759|2604386|P2|All Parts|Withdrawal by Subject|1
801990|NCT02566759|2604387|P1|All Parts|Withdrawal by Subject|0
801991|NCT02566005|2604563|P2|Overall Study|labor after randomization|4
801992|NCT02566005|2604564|P1|Overall Study|labor after randomization|0
801993|NCT02566005|2604563|P2|Overall Study|did not receive foley|1
801994|NCT02566005|2604564|P1|Overall Study|did not receive foley|0
801995|NCT02566005|2604563|P2|Overall Study|received foley|0
801996|NCT02566005|2604564|P1|Overall Study|received foley|8
801997|NCT02566005|2604563|P2|Overall Study|vaginal bleeding|1
801998|NCT02566005|2604564|P1|Overall Study|vaginal bleeding|0
801999|NCT02565381|2604641|P3|Overall Study|Lost to Follow-up|1
802000|NCT02565381|2604642|P2|Overall Study|Lost to Follow-up|0
802001|NCT02565381|2604643|P1|Overall Study|Lost to Follow-up|1
802002|NCT02565147|2604683|P2|Overall Study|Death|1
802003|NCT02565147|2604684|P1|Overall Study|Death|1
802004|NCT02565147|2604683|P2|Overall Study|Lost to Follow-up|1
802005|NCT02565147|2604684|P1|Overall Study|Lost to Follow-up|0
802006|NCT02565147|2604683|P2|Overall Study|Withdrawal by Subject|1
802007|NCT02565147|2604684|P1|Overall Study|Withdrawal by Subject|5
802008|NCT02565108|2604708|P2|Overall Study|Withdrew Consent|0
802009|NCT02565108|2604709|P1|Overall Study|Withdrew Consent|1
802010|NCT02565108|2604708|P2|Overall Study|Adverse Event|0
802011|NCT02565108|2604709|P1|Overall Study|Adverse Event|1
802012|NCT02564952|2604725|P1|Overall Study|Participant Met Withdrawal Criteria|1
802013|NCT02564952|2604725|P1|Overall Study|Low Efficacy|1
802014|NCT02564952|2604725|P1|Overall Study|Withdrawal by Subject|1
802015|NCT02564952|2604725|P1|Overall Study|Participant Withdrawn by Investigator|1
802016|NCT02564952|2604725|P1|Overall Study|Lost to Follow-up|1
802017|NCT02564952|2604725|P1|Overall Study|Adverse Event|6
802018|NCT02564718|2604731|P2|Overall Study|Withdrew from treatment|1
802019|NCT02564718|2604732|P1|Overall Study|Withdrew from treatment|0
802020|NCT02564211|2604760|P1|Overall Study|Adverse Event|4
802021|NCT02564055|2604772|P6|Overall Study|Withdrawal by Subject|10
802022|NCT02564055|2604773|P5|Overall Study|Withdrawal by Subject|10
802023|NCT02564055|2604774|P4|Overall Study|Withdrawal by Subject|3
802024|NCT02564055|2604775|P3|Overall Study|Withdrawal by Subject|3
802025|NCT02564055|2604776|P2|Overall Study|Withdrawal by Subject|4
802026|NCT02564055|2604777|P1|Overall Study|Withdrawal by Subject|4
802027|NCT02564055|2604772|P6|Overall Study|Physician Decision|0
802028|NCT02564055|2604773|P5|Overall Study|Physician Decision|0
802029|NCT02564055|2604774|P4|Overall Study|Physician Decision|0
802030|NCT02564055|2604775|P3|Overall Study|Physician Decision|1
802031|NCT02564055|2604776|P2|Overall Study|Physician Decision|0
802032|NCT02564055|2604777|P1|Overall Study|Physician Decision|0
802033|NCT02564055|2604772|P6|Overall Study|Lost to Follow-up|0
802034|NCT02564055|2604773|P5|Overall Study|Lost to Follow-up|1
802035|NCT02564055|2604774|P4|Overall Study|Lost to Follow-up|2
802036|NCT02564055|2604775|P3|Overall Study|Lost to Follow-up|4
802037|NCT02564055|2604776|P2|Overall Study|Lost to Follow-up|1
802038|NCT02564055|2604777|P1|Overall Study|Lost to Follow-up|0
802039|NCT02564055|2604772|P6|Overall Study|Reached stopping criteria|1
802040|NCT02564055|2604773|P5|Overall Study|Reached stopping criteria|0
802041|NCT02564055|2604774|P4|Overall Study|Reached stopping criteria|0
802042|NCT02564055|2604775|P3|Overall Study|Reached stopping criteria|0
802043|NCT02564055|2604776|P2|Overall Study|Reached stopping criteria|0
802044|NCT02564055|2604777|P1|Overall Study|Reached stopping criteria|0
802045|NCT02564055|2604772|P6|Overall Study|Protocol Violation|0
802046|NCT02564055|2604773|P5|Overall Study|Protocol Violation|0
802047|NCT02564055|2604774|P4|Overall Study|Protocol Violation|0
802048|NCT02564055|2604775|P3|Overall Study|Protocol Violation|0
802049|NCT02564055|2604776|P2|Overall Study|Protocol Violation|0
802050|NCT02564055|2604777|P1|Overall Study|Protocol Violation|1
802051|NCT02564055|2604772|P6|Overall Study|Adverse Event|1
802052|NCT02564055|2604773|P5|Overall Study|Adverse Event|4
802053|NCT02564055|2604774|P4|Overall Study|Adverse Event|1
802054|NCT02564055|2604775|P3|Overall Study|Adverse Event|4
802055|NCT02564055|2604776|P2|Overall Study|Adverse Event|0
802056|NCT02564055|2604777|P1|Overall Study|Adverse Event|1
802057|NCT02564042|2605031|P6|Overall Study|Withdrawal by Subject|12
802058|NCT02564042|2605032|P5|Overall Study|Withdrawal by Subject|10
802059|NCT02564042|2605033|P4|Overall Study|Withdrawal by Subject|2
802060|NCT02564042|2605034|P3|Overall Study|Withdrawal by Subject|2
802061|NCT02564042|2605035|P2|Overall Study|Withdrawal by Subject|3
802062|NCT02564042|2605036|P1|Overall Study|Withdrawal by Subject|5
802063|NCT02564042|2605031|P6|Overall Study|Physician Decision|0
802064|NCT02564042|2605032|P5|Overall Study|Physician Decision|0
802065|NCT02564042|2605033|P4|Overall Study|Physician Decision|1
802066|NCT02564042|2605034|P3|Overall Study|Physician Decision|0
802067|NCT02564042|2605035|P2|Overall Study|Physician Decision|0
802068|NCT02564042|2605036|P1|Overall Study|Physician Decision|1
802069|NCT02564042|2605031|P6|Overall Study|Lost to Follow-up|1
802070|NCT02564042|2605032|P5|Overall Study|Lost to Follow-up|1
802071|NCT02564042|2605033|P4|Overall Study|Lost to Follow-up|0
802072|NCT02564042|2605034|P3|Overall Study|Lost to Follow-up|1
802073|NCT02564042|2605035|P2|Overall Study|Lost to Follow-up|1
802074|NCT02564042|2605036|P1|Overall Study|Lost to Follow-up|1
802075|NCT02564042|2605031|P6|Overall Study|Adverse Event|1
802076|NCT02564042|2605032|P5|Overall Study|Adverse Event|0
802077|NCT02564042|2605033|P4|Overall Study|Adverse Event|0
802078|NCT02564042|2605034|P3|Overall Study|Adverse Event|3
802079|NCT02564042|2605035|P2|Overall Study|Adverse Event|4
802080|NCT02564042|2605036|P1|Overall Study|Adverse Event|4
802081|NCT02563899|2605306|P4|Overall Study|Withdrawal by Subject|0
802082|NCT02563899|2605307|P3|Overall Study|Withdrawal by Subject|1
802083|NCT02563899|2605308|P2|Overall Study|Withdrawal by Subject|0
802084|NCT02563899|2605309|P1|Overall Study|Withdrawal by Subject|0
802085|NCT02563899|2605306|P4|Overall Study|Protocol Violation|0
802086|NCT02563899|2605307|P3|Overall Study|Protocol Violation|0
802087|NCT02563899|2605308|P2|Overall Study|Protocol Violation|0
802088|NCT02563899|2605309|P1|Overall Study|Protocol Violation|1
802089|NCT02563106|2605371|P2|Overall Study|Other reason - not specified|1
802090|NCT02563106|2605372|P1|Overall Study|Other reason - not specified|2
802091|NCT02563106|2605371|P2|Overall Study|Physician Decision|1
802092|NCT02563106|2605372|P1|Overall Study|Physician Decision|3
802093|NCT02563106|2605371|P2|Overall Study|Lost to Follow-up|2
802094|NCT02563106|2605372|P1|Overall Study|Lost to Follow-up|3
802095|NCT02563106|2605371|P2|Overall Study|Use of non-permitted concurrent therapy|2
802096|NCT02563106|2605372|P1|Overall Study|Use of non-permitted concurrent therapy|1
802097|NCT02563106|2605371|P2|Overall Study|Protocol Violation|0
802098|NCT02563106|2605372|P1|Overall Study|Protocol Violation|1
802099|NCT02563106|2605371|P2|Overall Study|Adverse Event|15
802100|NCT02563106|2605372|P1|Overall Study|Adverse Event|17
802101|NCT02563106|2605371|P2|Overall Study|Withdrawal by Subject|8
802102|NCT02563106|2605372|P1|Overall Study|Withdrawal by Subject|7
802103|NCT02561806|2605458|P2|Post-Treatment Follow-up|Withdrawal by Subject|0
802104|NCT02561806|2605459|P1|Post-Treatment Follow-up|Withdrawal by Subject|1
802105|NCT02561806|2605458|P2|Post-Treatment Follow-up|Lost to Follow-up|1
802106|NCT02561806|2605459|P1|Post-Treatment Follow-up|Lost to Follow-up|1
802107|NCT02561806|2605458|P2|Maintenance Period|Site staff became unblinded|1
802108|NCT02561806|2605459|P1|Maintenance Period|Site staff became unblinded|0
802109|NCT02561806|2605458|P2|Maintenance Period|Withdrawal by Subject|3
802110|NCT02561806|2605459|P1|Maintenance Period|Withdrawal by Subject|5
802111|NCT02561806|2605458|P2|Maintenance Period|Protocol Violation|0
802112|NCT02561806|2605459|P1|Maintenance Period|Protocol Violation|1
802113|NCT02561806|2605458|P2|Maintenance Period|Lost to Follow-up|2
802114|NCT02561806|2605459|P1|Maintenance Period|Lost to Follow-up|2
802115|NCT02561806|2605458|P2|Maintenance Period|Lack of Efficacy|1
802116|NCT02561806|2605459|P1|Maintenance Period|Lack of Efficacy|3
802117|NCT02561806|2605458|P2|Maintenance Period|Adverse Event|1
802118|NCT02561806|2605459|P1|Maintenance Period|Adverse Event|2
802119|NCT02561806|2605458|P2|Induction Period|Randomized but not treated|1
802120|NCT02561806|2605459|P1|Induction Period|Randomized but not treated|0
802121|NCT02561806|2605458|P2|Induction Period|Site staff became unblinded|0
802122|NCT02561806|2605459|P1|Induction Period|Site staff became unblinded|1
802123|NCT02561806|2605458|P2|Induction Period|Withdrawal by Subject|2
802124|NCT02561806|2605459|P1|Induction Period|Withdrawal by Subject|0
802125|NCT02561806|2605458|P2|Induction Period|Lack of Efficacy|0
802126|NCT02561806|2605459|P1|Induction Period|Lack of Efficacy|1
802127|NCT02561806|2605458|P2|Induction Period|Adverse Event|2
802128|NCT02561806|2605459|P1|Induction Period|Adverse Event|0
802129|NCT02561572|2605526|P2|Overall Study|Protocol Violation|1
802130|NCT02561572|2605527|P1|Overall Study|Protocol Violation|0
802131|NCT02561572|2605526|P2|Overall Study|Inadequate time before surgery|1
802132|NCT02561572|2605527|P1|Overall Study|Inadequate time before surgery|2
802133|NCT02561195|2605549|P6|Overall Study|Randomized but not treated|0
802134|NCT02561195|2605550|P5|Overall Study|Randomized but not treated|0
802135|NCT02561195|2605551|P4|Overall Study|Randomized but not treated|0
802136|NCT02561195|2605552|P3|Overall Study|Randomized but not treated|0
802137|NCT02561195|2605553|P2|Overall Study|Randomized but not treated|0
802138|NCT02561195|2605554|P1|Overall Study|Randomized but not treated|1
802139|NCT02561195|2605549|P6|Overall Study|Withdrawal by Subject|0
802140|NCT02561195|2605550|P5|Overall Study|Withdrawal by Subject|6
802141|NCT02561195|2605551|P4|Overall Study|Withdrawal by Subject|2
802142|NCT02561195|2605552|P3|Overall Study|Withdrawal by Subject|4
802143|NCT02561195|2605553|P2|Overall Study|Withdrawal by Subject|4
802144|NCT02561195|2605554|P1|Overall Study|Withdrawal by Subject|3
802145|NCT02561195|2605549|P6|Overall Study|Death|0
802146|NCT02561195|2605550|P5|Overall Study|Death|0
802147|NCT02561195|2605551|P4|Overall Study|Death|2
802148|NCT02561195|2605552|P3|Overall Study|Death|0
802149|NCT02561195|2605553|P2|Overall Study|Death|1
802150|NCT02561195|2605554|P1|Overall Study|Death|2
802151|NCT02561195|2605549|P6|Overall Study|Protocol Violation|2
802152|NCT02561195|2605550|P5|Overall Study|Protocol Violation|5
802153|NCT02561195|2605551|P4|Overall Study|Protocol Violation|2
802154|NCT02561195|2605552|P3|Overall Study|Protocol Violation|1
802155|NCT02561195|2605553|P2|Overall Study|Protocol Violation|0
802156|NCT02561195|2605554|P1|Overall Study|Protocol Violation|1
802157|NCT02561195|2605549|P6|Overall Study|Other|1
802158|NCT02561195|2605550|P5|Overall Study|Other|5
802159|NCT02561195|2605551|P4|Overall Study|Other|7
802160|NCT02561195|2605552|P3|Overall Study|Other|1
802161|NCT02561195|2605553|P2|Overall Study|Other|3
802162|NCT02561195|2605554|P1|Overall Study|Other|7
802163|NCT02561195|2605549|P6|Overall Study|No longer willing to participate|3
802164|NCT02561195|2605550|P5|Overall Study|No longer willing to participate|1
802165|NCT02561195|2605551|P4|Overall Study|No longer willing to participate|4
802166|NCT02561195|2605552|P3|Overall Study|No longer willing to participate|0
802167|NCT02561195|2605553|P2|Overall Study|No longer willing to participate|4
802168|NCT02561195|2605554|P1|Overall Study|No longer willing to participate|2
802169|NCT02561195|2605549|P6|Overall Study|No longer meets eligibility criteria|1
802170|NCT02561195|2605550|P5|Overall Study|No longer meets eligibility criteria|4
802171|NCT02561195|2605551|P4|Overall Study|No longer meets eligibility criteria|4
802172|NCT02561195|2605552|P3|Overall Study|No longer meets eligibility criteria|0
802173|NCT02561195|2605553|P2|Overall Study|No longer meets eligibility criteria|1
802174|NCT02561195|2605554|P1|Overall Study|No longer meets eligibility criteria|0
802175|NCT02561195|2605549|P6|Overall Study|Lost to Follow-up|3
802176|NCT02561195|2605550|P5|Overall Study|Lost to Follow-up|3
802177|NCT02561195|2605551|P4|Overall Study|Lost to Follow-up|2
802178|NCT02561195|2605552|P3|Overall Study|Lost to Follow-up|0
802179|NCT02561195|2605553|P2|Overall Study|Lost to Follow-up|4
802180|NCT02561195|2605554|P1|Overall Study|Lost to Follow-up|3
802181|NCT02561195|2605549|P6|Overall Study|Adverse Event|0
802182|NCT02561195|2605550|P5|Overall Study|Adverse Event|4
802183|NCT02561195|2605551|P4|Overall Study|Adverse Event|3
802184|NCT02561195|2605552|P3|Overall Study|Adverse Event|0
802185|NCT02561195|2605553|P2|Overall Study|Adverse Event|5
802186|NCT02561195|2605554|P1|Overall Study|Adverse Event|4
802187|NCT02560025|2605809|P1|Overall Study|Ineligible after consent/ registration|3
802188|NCT02560012|2605815|P1|Overall Study|Study Terminated|2
802189|NCT02559622|2605823|P4|Overall Study|Patient/guardian decision|1
802190|NCT02559622|2605824|P3|Overall Study|Patient/guardian decision|0
802191|NCT02559622|2605825|P2|Overall Study|Patient/guardian decision|2
802192|NCT02559622|2605826|P1|Overall Study|Patient/guardian decision|1
802193|NCT02559622|2605823|P4|Overall Study|Adverse Event|2
802194|NCT02559622|2605824|P3|Overall Study|Adverse Event|2
802195|NCT02559622|2605825|P2|Overall Study|Adverse Event|2
802196|NCT02559622|2605826|P1|Overall Study|Adverse Event|0
802197|NCT02559622|2605823|P4|Overall Study|Progressive disease|0
802198|NCT02559622|2605824|P3|Overall Study|Progressive disease|0
802199|NCT02559622|2605825|P2|Overall Study|Progressive disease|1
802200|NCT02559622|2605826|P1|Overall Study|Progressive disease|0
802201|NCT02559414|2605908|P3|Overall Study|Other|1
802202|NCT02559414|2605909|P2|Overall Study|Other|1
802203|NCT02559414|2605910|P1|Overall Study|Other|0
802204|NCT02559414|2605908|P3|Overall Study|Withdrawal by Subject|1
802205|NCT02559414|2605909|P2|Overall Study|Withdrawal by Subject|0
802206|NCT02559414|2605910|P1|Overall Study|Withdrawal by Subject|1
802207|NCT02559414|2605908|P3|Overall Study|Lost to Follow-up|0
802208|NCT02559414|2605909|P2|Overall Study|Lost to Follow-up|1
802209|NCT02559414|2605910|P1|Overall Study|Lost to Follow-up|0
802210|NCT02558894|2605950|P2|Overall Study|Closure of Part A|1
802211|NCT02558894|2605951|P1|Overall Study|Closure of Part A|2
802212|NCT02558894|2605950|P2|Overall Study|Withdrawal by Subject|1
802213|NCT02558894|2605951|P1|Overall Study|Withdrawal by Subject|2
802214|NCT02558894|2605950|P2|Overall Study|Death; any cause, entire study duration|31
802215|NCT02558894|2605951|P1|Overall Study|Death; any cause, entire study duration|28
802216|NCT02558790|2606012|P1|Overall Study|Screen Fail|3
802217|NCT02558790|2606012|P1|Overall Study|Withdrawal by Subject|1
802218|NCT02558790|2606012|P1|Overall Study|Physician Decision|1
802219|NCT02558790|2606012|P1|Overall Study|Lost to Follow-up|2
802220|NCT02557646|2606094|P1|Overall Study|Other|14
802221|NCT02557646|2606094|P1|Overall Study|Lost to Follow-up|17
802222|NCT02557646|2606094|P1|Overall Study|Withdrawal by Subject|18
802223|NCT02557646|2606094|P1|Overall Study|Lack of Efficacy|186
802224|NCT02557646|2606094|P1|Overall Study|Death|1
802225|NCT02557646|2606094|P1|Overall Study|Adverse Event|40
802226|NCT02557399|2606119|P2|Overall Study|Withdrawal by Subject|1
802227|NCT02557399|2606120|P1|Overall Study|Withdrawal by Subject|1
802228|NCT02557399|2606119|P2|Overall Study|Protocol-defined stopping criteria|1
802229|NCT02557399|2606120|P1|Overall Study|Protocol-defined stopping criteria|0
802230|NCT02557399|2606119|P2|Overall Study|Protocol Violation|1
802231|NCT02557399|2606120|P1|Overall Study|Protocol Violation|0
802232|NCT02557399|2606119|P2|Overall Study|Adverse Event|5
802233|NCT02557399|2606120|P1|Overall Study|Adverse Event|6
802234|NCT02556632|2606180|P3|Overall Study|Treatment or Change Delay|1
802235|NCT02556632|2606181|P2|Overall Study|Treatment or Change Delay|0
802236|NCT02556632|2606182|P1|Overall Study|Treatment or Change Delay|0
802237|NCT02556632|2606180|P3|Overall Study|Disliked Study Procedures|1
802238|NCT02556632|2606181|P2|Overall Study|Disliked Study Procedures|0
802239|NCT02556632|2606182|P1|Overall Study|Disliked Study Procedures|0
802240|NCT02556632|2606180|P3|Overall Study|Ineligible|0
802241|NCT02556632|2606181|P2|Overall Study|Ineligible|1
802242|NCT02556632|2606182|P1|Overall Study|Ineligible|0
802243|NCT02556632|2606180|P3|Overall Study|Did Not Start RT|0
802244|NCT02556632|2606181|P2|Overall Study|Did Not Start RT|1
802245|NCT02556632|2606182|P1|Overall Study|Did Not Start RT|0
802246|NCT02556632|2606180|P3|Overall Study|Possibly Related Adverse Event|1
802247|NCT02556632|2606181|P2|Overall Study|Possibly Related Adverse Event|0
802248|NCT02556632|2606182|P1|Overall Study|Possibly Related Adverse Event|0
802249|NCT02556632|2606180|P3|Overall Study|Related Adverse Event|0
802250|NCT02556632|2606181|P2|Overall Study|Related Adverse Event|1
802251|NCT02556632|2606182|P1|Overall Study|Related Adverse Event|0
802252|NCT02556632|2606180|P3|Overall Study|Unrelated Adverse Event|3
802253|NCT02556632|2606181|P2|Overall Study|Unrelated Adverse Event|0
802254|NCT02556632|2606182|P1|Overall Study|Unrelated Adverse Event|1
802255|NCT02556632|2606180|P3|Overall Study|Withdrew (Unrelated Medical)|0
802256|NCT02556632|2606181|P2|Overall Study|Withdrew (Unrelated Medical)|0
802257|NCT02556632|2606182|P1|Overall Study|Withdrew (Unrelated Medical)|1
802258|NCT02556632|2606180|P3|Overall Study|Changed Mind|0
802259|NCT02556632|2606181|P2|Overall Study|Changed Mind|1
802260|NCT02556632|2606182|P1|Overall Study|Changed Mind|0
802261|NCT02556632|2606180|P3|Overall Study|Personal Issues|1
802262|NCT02556632|2606181|P2|Overall Study|Personal Issues|1
802263|NCT02556632|2606182|P1|Overall Study|Personal Issues|0
802264|NCT02556632|2606180|P3|Overall Study|No Reason|1
802265|NCT02556632|2606181|P2|Overall Study|No Reason|0
802266|NCT02556632|2606182|P1|Overall Study|No Reason|1
802267|NCT02556632|2606180|P3|Overall Study|Disliked Intervention|1
802268|NCT02556632|2606181|P2|Overall Study|Disliked Intervention|1
802269|NCT02556632|2606182|P1|Overall Study|Disliked Intervention|1
802270|NCT02556632|2606180|P3|Overall Study|Lost to Follow-up|0
802271|NCT02556632|2606181|P2|Overall Study|Lost to Follow-up|0
802272|NCT02556632|2606182|P1|Overall Study|Lost to Follow-up|1
802273|NCT02556307|2606200|P1|Overall Study|Enrolled but not treated|2
802274|NCT02556307|2606200|P1|Overall Study|Change to triple therapy|4
802275|NCT02556307|2606200|P1|Overall Study|Lost to Follow-up|36
802276|NCT02556307|2606200|P1|Overall Study|Premature treatment interruption|11
802277|NCT02556138|2606210|P1|Overall Study|Withdrawal by Subject|1
802278|NCT02555722|2606218|P2|Month 2|Adverse Event|0
802279|NCT02555722|2606219|P1|Month 2|Adverse Event|3
802280|NCT02555722|2606218|P2|Month 1|Withdrawal by Subject|0
802281|NCT02555722|2606219|P1|Month 1|Withdrawal by Subject|2
802282|NCT02555722|2606218|P2|Week 2|Lens Discomfort|1
802283|NCT02555722|2606219|P1|Week 2|Lens Discomfort|0
802284|NCT02555722|2606218|P2|Week 1|Withdrawal by Subject|0
802285|NCT02555722|2606219|P1|Week 1|Withdrawal by Subject|1
802286|NCT02555618|2606386|P2|Overall Study|Sponsor's Circumstances|0
802287|NCT02555618|2606387|P1|Overall Study|Sponsor's Circumstances|1
802288|NCT02554981|2606444|P1|Overall Study|Other Miscellaneous Reasons|3
802289|NCT02554981|2606444|P1|Overall Study|Administrative Reasons|1
802290|NCT02554981|2606444|P1|Overall Study|Adverse Event|1
802291|NCT02554877|2606472|P4|Overall Study|No longer willing to participate|0
802292|NCT02554877|2606473|P3|Overall Study|No longer willing to participate|2
802293|NCT02554877|2606474|P2|Overall Study|No longer willing to participate|2
802294|NCT02554877|2606475|P1|Overall Study|No longer willing to participate|0
802295|NCT02554877|2606472|P4|Overall Study|Insufficient clinical response|0
802296|NCT02554877|2606473|P3|Overall Study|Insufficient clinical response|0
802297|NCT02554877|2606474|P2|Overall Study|Insufficient clinical response|0
802298|NCT02554877|2606475|P1|Overall Study|Insufficient clinical response|4
802299|NCT02554877|2606472|P4|Overall Study|Other|3
802300|NCT02554877|2606473|P3|Overall Study|Other|0
802301|NCT02554877|2606474|P2|Overall Study|Other|3
802302|NCT02554877|2606475|P1|Overall Study|Other|1
802303|NCT02554877|2606472|P4|Overall Study|Protocol Violation|0
802304|NCT02554877|2606473|P3|Overall Study|Protocol Violation|1
802305|NCT02554877|2606474|P2|Overall Study|Protocol Violation|1
802306|NCT02554877|2606475|P1|Overall Study|Protocol Violation|3
802307|NCT02554877|2606472|P4|Overall Study|No longer met eligibility criteria|1
802308|NCT02554877|2606473|P3|Overall Study|No longer met eligibility criteria|1
802309|NCT02554877|2606474|P2|Overall Study|No longer met eligibility criteria|0
802310|NCT02554877|2606475|P1|Overall Study|No longer met eligibility criteria|1
802311|NCT02554877|2606472|P4|Overall Study|Did not meet entrance criteria|0
802312|NCT02554877|2606473|P3|Overall Study|Did not meet entrance criteria|1
802313|NCT02554877|2606474|P2|Overall Study|Did not meet entrance criteria|0
802314|NCT02554877|2606475|P1|Overall Study|Did not meet entrance criteria|0
802315|NCT02554877|2606472|P4|Overall Study|Lost to Follow-up|2
802316|NCT02554877|2606473|P3|Overall Study|Lost to Follow-up|1
802317|NCT02554877|2606474|P2|Overall Study|Lost to Follow-up|1
802318|NCT02554877|2606475|P1|Overall Study|Lost to Follow-up|1
802319|NCT02554877|2606472|P4|Overall Study|Adverse Event|1
802320|NCT02554877|2606473|P3|Overall Study|Adverse Event|0
802321|NCT02554877|2606474|P2|Overall Study|Adverse Event|0
802322|NCT02554877|2606475|P1|Overall Study|Adverse Event|2
802323|NCT02554279|2606574|P2|Overall Study|Other reason|6
802324|NCT02554279|2606575|P1|Overall Study|Other reason|19
802325|NCT02554279|2606574|P2|Overall Study|Protocol Violation|1
802326|NCT02554279|2606575|P1|Overall Study|Protocol Violation|2
802327|NCT02554279|2606574|P2|Overall Study|Withdrawal by Subject|4
802328|NCT02554279|2606575|P1|Overall Study|Withdrawal by Subject|6
802329|NCT02554279|2606574|P2|Overall Study|Lost to Follow-up|2
802330|NCT02554279|2606575|P1|Overall Study|Lost to Follow-up|3
802331|NCT02554279|2606574|P2|Overall Study|Adverse Event|5
802332|NCT02554279|2606575|P1|Overall Study|Adverse Event|2
802333|NCT02553772|2606616|P2|Overall Study|Other Miscellaneous Reasons|1
802334|NCT02553772|2606617|P1|Overall Study|Other Miscellaneous Reasons|0
802335|NCT02553772|2606616|P2|Overall Study|Lack of Efficacy|0
802336|NCT02553772|2606617|P1|Overall Study|Lack of Efficacy|1
802337|NCT02553772|2606616|P2|Overall Study|Withdrawal of Consent|1
802338|NCT02553772|2606617|P1|Overall Study|Withdrawal of Consent|1
802339|NCT02553772|2606616|P2|Overall Study|Lost to Follow-up|1
802340|NCT02553772|2606617|P1|Overall Study|Lost to Follow-up|2
802341|NCT02553772|2606616|P2|Overall Study|Adverse Event|3
802342|NCT02553772|2606617|P1|Overall Study|Adverse Event|2
802343|NCT02553629|2606633|P2|Overall Study|Logistic reasons|6
802344|NCT02553629|2606634|P1|Overall Study|Logistic reasons|3
802345|NCT02553538|2606650|P2|Overall Study|Died or Left Network|56
802346|NCT02553538|2606651|P1|Overall Study|Died or Left Network|54
802347|NCT02553538|2606650|P2|Overall Study|Could Not Reach by Telephone|0
802348|NCT02553538|2606651|P1|Overall Study|Could Not Reach by Telephone|133
802349|NCT02553421|2606673|P2|Overall Study|Improper Device Placement|0
802350|NCT02553421|2606674|P1|Overall Study|Improper Device Placement|3
802351|NCT02553421|2606673|P2|Overall Study|Incomplete or Insufficient Data Collecte|0
802352|NCT02553421|2606674|P1|Overall Study|Incomplete or Insufficient Data Collecte|5
802353|NCT02553421|2606673|P2|Overall Study|Lost to Follow-up|1
802354|NCT02553421|2606674|P1|Overall Study|Lost to Follow-up|21
802355|NCT02552303|2606710|P4|Follow-Up|ineligible|0
802356|NCT02552303|2606711|P3|Follow-Up|ineligible|0
802357|NCT02552303|2606712|P2|Follow-Up|ineligible|2
802358|NCT02552303|2606713|P1|Follow-Up|ineligible|0
802359|NCT02552303|2606710|P4|Follow-Up|Lost to Follow-up|0
802360|NCT02552303|2606711|P3|Follow-Up|Lost to Follow-up|1
802361|NCT02552303|2606712|P2|Follow-Up|Lost to Follow-up|0
802362|NCT02552303|2606713|P1|Follow-Up|Lost to Follow-up|0
802363|NCT02552303|2606710|P4|Allocation|ineligible|0
802364|NCT02552303|2606711|P3|Allocation|ineligible|0
802365|NCT02552303|2606712|P2|Allocation|ineligible|1
802366|NCT02552303|2606713|P1|Allocation|ineligible|1
802367|NCT02552303|2606710|P4|Allocation|Withdrawal by Subject|1
802368|NCT02552303|2606711|P3|Allocation|Withdrawal by Subject|1
802369|NCT02552303|2606712|P2|Allocation|Withdrawal by Subject|1
802370|NCT02552303|2606713|P1|Allocation|Withdrawal by Subject|2
802371|NCT02551874|2606745|P2|Overall Study|Did not enter long-term study|25
802372|NCT02551874|2606746|P1|Overall Study|Did not enter long-term study|18
802373|NCT02551874|2606745|P2|Overall Study|Did not receive randomized treatment|7
802374|NCT02551874|2606746|P1|Overall Study|Did not receive randomized treatment|0
802375|NCT02551874|2606745|P2|Overall Study|Reason not reported|4
802376|NCT02551874|2606746|P1|Overall Study|Reason not reported|10
802377|NCT02551874|2606745|P2|Overall Study|Pregnancy|1
802378|NCT02551874|2606746|P1|Overall Study|Pregnancy|0
802379|NCT02551874|2606745|P2|Overall Study|Lost to Follow-up|2
802380|NCT02551874|2606746|P1|Overall Study|Lost to Follow-up|0
802381|NCT02551731|2606775|P1|Overall Study|Withdrawal by Subject|2
802382|NCT02550288|2606817|P5|Overall Study|Withdrawal by Subject|0
802383|NCT02550288|2606818|P4|Overall Study|Withdrawal by Subject|1
802384|NCT02550288|2606819|P3|Overall Study|Withdrawal by Subject|0
802385|NCT02550288|2606820|P2|Overall Study|Withdrawal by Subject|0
802386|NCT02550288|2606821|P1|Overall Study|Withdrawal by Subject|0
802387|NCT02550288|2606817|P5|Overall Study|Participant moved|0
802388|NCT02550288|2606818|P4|Overall Study|Participant moved|1
802389|NCT02550288|2606819|P3|Overall Study|Participant moved|0
802390|NCT02550288|2606820|P2|Overall Study|Participant moved|0
802391|NCT02550288|2606821|P1|Overall Study|Participant moved|0
802392|NCT02550288|2606817|P5|Overall Study|Protocol Violation|3
802393|NCT02550288|2606818|P4|Overall Study|Protocol Violation|0
802394|NCT02550288|2606819|P3|Overall Study|Protocol Violation|1
802395|NCT02550288|2606820|P2|Overall Study|Protocol Violation|2
802396|NCT02550288|2606821|P1|Overall Study|Protocol Violation|2
802397|NCT02550288|2606817|P5|Overall Study|Physician Decision|0
802398|NCT02550288|2606818|P4|Overall Study|Physician Decision|1
802399|NCT02550288|2606819|P3|Overall Study|Physician Decision|0
802400|NCT02550288|2606820|P2|Overall Study|Physician Decision|0
802401|NCT02550288|2606821|P1|Overall Study|Physician Decision|0
802402|NCT02550288|2606817|P5|Overall Study|Adverse Event|0
802403|NCT02550288|2606818|P4|Overall Study|Adverse Event|0
802404|NCT02550288|2606819|P3|Overall Study|Adverse Event|0
802405|NCT02550288|2606820|P2|Overall Study|Adverse Event|1
802406|NCT02550288|2606821|P1|Overall Study|Adverse Event|0
802407|NCT02549573|2606976|P2|Overall Study|Protocol Violation|1
802408|NCT02549573|2606977|P1|Overall Study|Protocol Violation|0
802409|NCT02549573|2606976|P2|Overall Study|Withdrawal by Subject|2
802410|NCT02549573|2606977|P1|Overall Study|Withdrawal by Subject|0
802411|NCT02549339|2607021|P2|12-month Follow-up|Other|3
802412|NCT02549339|2607022|P1|12-month Follow-up|Other|0
802413|NCT02549339|2607021|P2|12-month Follow-up|Lost to Follow-up|3
802414|NCT02549339|2607022|P1|12-month Follow-up|Lost to Follow-up|1
802415|NCT02549339|2607021|P2|12-month Follow-up|Withdrawal by Subject|3
802416|NCT02549339|2607022|P1|12-month Follow-up|Withdrawal by Subject|8
802417|NCT02549339|2607021|P2|12-month Follow-up|Lack of Efficacy|2
802418|NCT02549339|2607022|P1|12-month Follow-up|Lack of Efficacy|0
802419|NCT02549339|2607021|P2|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2
802420|NCT02549339|2607022|P1|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
802421|NCT02549339|2607021|P2|3-day Treatment and 8-week Follow-up|Other|0
802422|NCT02549339|2607022|P1|3-day Treatment and 8-week Follow-up|Other|1
802423|NCT02549339|2607021|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
802424|NCT02549339|2607022|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1
802425|NCT02549339|2607021|P2|3-day Treatment and 8-week Follow-up|Protocol Violation|0
802426|NCT02549339|2607022|P1|3-day Treatment and 8-week Follow-up|Protocol Violation|2
802427|NCT02549027|2607036|P6|Period 5 - MK-6096 or Placebo|Protocol Violation|0
802428|NCT02549027|2607037|P5|Period 5 - MK-6096 or Placebo|Protocol Violation|2
802429|NCT02549027|2607038|P4|Period 5 - MK-6096 or Placebo|Protocol Violation|0
802430|NCT02549027|2607039|P3|Period 5 - MK-6096 or Placebo|Protocol Violation|0
802431|NCT02549027|2607040|P2|Period 5 - MK-6096 or Placebo|Protocol Violation|0
802432|NCT02549027|2607041|P1|Period 5 - MK-6096 or Placebo|Protocol Violation|0
802433|NCT02549027|2607036|P6|Washout After Period 4|Withdrawal by Subject|0
802434|NCT02549027|2607037|P5|Washout After Period 4|Withdrawal by Subject|0
802435|NCT02549027|2607038|P4|Washout After Period 4|Withdrawal by Subject|1
802436|NCT02549027|2607039|P3|Washout After Period 4|Withdrawal by Subject|1
802437|NCT02549027|2607040|P2|Washout After Period 4|Withdrawal by Subject|1
802438|NCT02549027|2607041|P1|Washout After Period 4|Withdrawal by Subject|0
802439|NCT02548455|2607181|P1|Overall Study|Visit not completed|173
802440|NCT02548455|2607181|P1|Overall Study|Lost to Follow-up|14
802441|NCT02548455|2607181|P1|Overall Study|Death|26
802442|NCT02548455|2607181|P1|Overall Study|Withdrawal by Subject|27
802443|NCT02548156|2607185|P6|Washout Period 1|Lost to Follow-up|0
802444|NCT02548156|2607186|P5|Washout Period 1|Lost to Follow-up|1
802445|NCT02548156|2607187|P4|Washout Period 1|Lost to Follow-up|0
802446|NCT02548156|2607188|P3|Washout Period 1|Lost to Follow-up|0
802447|NCT02548156|2607189|P2|Washout Period 1|Lost to Follow-up|0
802448|NCT02548156|2607190|P1|Washout Period 1|Lost to Follow-up|0
802449|NCT02548078|2607209|P2|Overall Study|Lost to Follow-up|3
802450|NCT02548078|2607210|P1|Overall Study|Lost to Follow-up|1
802451|NCT02548078|2607209|P2|Overall Study|Moved from study area|3
802452|NCT02548078|2607210|P1|Overall Study|Moved from study area|3
802453|NCT02548078|2607209|P2|Overall Study|Serious adverse event/Adverse event|0
802454|NCT02548078|2607210|P1|Overall Study|Serious adverse event/Adverse event|1
802455|NCT02547974|2607402|P4|Overall Study|Withdrawal by Subject|0
802456|NCT02547974|2607403|P3|Overall Study|Withdrawal by Subject|0
802457|NCT02547974|2607404|P2|Overall Study|Withdrawal by Subject|0
802458|NCT02547974|2607405|P1|Overall Study|Withdrawal by Subject|1
802459|NCT02547454|2607532|P1|Overall Study|No data|11
802460|NCT02547454|2607532|P1|Overall Study|Other|39
802461|NCT02547454|2607532|P1|Overall Study|Lost to Follow-up|26
802462|NCT02547454|2607532|P1|Overall Study|Death|38
802463|NCT02547454|2607532|P1|Overall Study|Due to no further need to treat|4
802464|NCT02547454|2607532|P1|Overall Study|Due to transplantation|1
802465|NCT02547454|2607532|P1|Overall Study|Due to hemodialysis|53
802466|NCT02546986|2607591|P2|Survival Follow-Up Phase|Lost to Follow-up|2
802467|NCT02546986|2607592|P1|Survival Follow-Up Phase|Lost to Follow-up|2
802468|NCT02546986|2607591|P2|Survival Follow-Up Phase|Alive|16
802469|NCT02546986|2607592|P1|Survival Follow-Up Phase|Alive|13
802470|NCT02546986|2607591|P2|Survival Follow-Up Phase|Death|12
802471|NCT02546986|2607592|P1|Survival Follow-Up Phase|Death|18
802472|NCT02546986|2607591|P2|Survival Follow-Up Phase|Missing Status|5
802473|NCT02546986|2607592|P1|Survival Follow-Up Phase|Missing Status|3
802474|NCT02546986|2607591|P2|Treatment Period|Miscellaneous|9
802475|NCT02546986|2607592|P1|Treatment Period|Miscellaneous|7
802476|NCT02546986|2607591|P2|Treatment Period|Study Terminated by Sponsor|1
802477|NCT02546986|2607592|P1|Treatment Period|Study Terminated by Sponsor|0
802478|NCT02546986|2607591|P2|Treatment Period|Non-compliance with Study Drug|1
802479|NCT02546986|2607592|P1|Treatment Period|Non-compliance with Study Drug|0
802480|NCT02546986|2607591|P2|Treatment Period|Withdrawal by Subject|1
802481|NCT02546986|2607592|P1|Treatment Period|Withdrawal by Subject|1
802482|NCT02546986|2607591|P2|Treatment Period|Protocol Violation|0
802483|NCT02546986|2607592|P1|Treatment Period|Protocol Violation|1
802484|NCT02546986|2607591|P2|Treatment Period|Physician Decision|2
802485|NCT02546986|2607592|P1|Treatment Period|Physician Decision|1
802486|NCT02546986|2607591|P2|Treatment Period|Death|4
802487|NCT02546986|2607592|P1|Treatment Period|Death|3
802488|NCT02546986|2607591|P2|Treatment Period|Symptomatic Deterioration|3
802489|NCT02546986|2607592|P1|Treatment Period|Symptomatic Deterioration|4
802490|NCT02546986|2607591|P2|Treatment Period|Adverse Event|6
802491|NCT02546986|2607592|P1|Treatment Period|Adverse Event|14
802492|NCT02546986|2607591|P2|Treatment Period|Progressive Disease|22
802493|NCT02546986|2607592|P1|Treatment Period|Progressive Disease|20
802494|NCT02546609|2607618|P3|Overall Study|travel or work schedule restriction|2
802495|NCT02546609|2607619|P2|Overall Study|travel or work schedule restriction|0
802496|NCT02546609|2607620|P1|Overall Study|travel or work schedule restriction|0
802497|NCT02546609|2607618|P3|Overall Study|Lost to Follow-up|1
802498|NCT02546609|2607619|P2|Overall Study|Lost to Follow-up|3
802499|NCT02546609|2607620|P1|Overall Study|Lost to Follow-up|2
802500|NCT02546609|2607618|P3|Overall Study|Protocol Violation|1
802501|NCT02546609|2607619|P2|Overall Study|Protocol Violation|1
802502|NCT02546609|2607620|P1|Overall Study|Protocol Violation|0
802503|NCT02546609|2607618|P3|Overall Study|Adverse Event|1
802504|NCT02546609|2607619|P2|Overall Study|Adverse Event|6
802505|NCT02546609|2607620|P1|Overall Study|Adverse Event|0
802506|NCT02546609|2607618|P3|Overall Study|Withdrawal by Subject|2
802507|NCT02546609|2607619|P2|Overall Study|Withdrawal by Subject|1
802508|NCT02546609|2607620|P1|Overall Study|Withdrawal by Subject|0
802509|NCT02545868|2607686|P3|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|34
802510|NCT02545868|2607687|P2|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|35
802511|NCT02545868|2607688|P1|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|33
802512|NCT02545543|2607761|P2|Overall Study|Enrolment of subject at >1 study site|1
802513|NCT02545543|2607762|P1|Overall Study|Enrolment of subject at >1 study site|1
802514|NCT02545543|2607761|P2|Overall Study|Noncomplaince|0
802515|NCT02545543|2607762|P1|Overall Study|Noncomplaince|1
802516|NCT02545543|2607761|P2|Overall Study|Withdrawal by Subject|8
802517|NCT02545543|2607762|P1|Overall Study|Withdrawal by Subject|9
802518|NCT02545543|2607761|P2|Overall Study|Physician Decision|0
802519|NCT02545543|2607762|P1|Overall Study|Physician Decision|3
802520|NCT02545543|2607761|P2|Overall Study|Lost to Follow-up|25
802521|NCT02545543|2607762|P1|Overall Study|Lost to Follow-up|67
802522|NCT02545322|2607786|P1|Overall Study|Withdrawal by Subject|3
802523|NCT02544074|2607842|P21|Overall Study|Tablet error|0
802524|NCT02544074|2607843|P20|Overall Study|Tablet error|0
802525|NCT02544074|2607844|P19|Overall Study|Tablet error|0
802526|NCT02544074|2607845|P18|Overall Study|Tablet error|0
802527|NCT02544074|2607846|P17|Overall Study|Tablet error|0
802528|NCT02544074|2607847|P16|Overall Study|Tablet error|0
802529|NCT02544074|2607848|P15|Overall Study|Tablet error|0
802530|NCT02544074|2607849|P14|Overall Study|Tablet error|0
802531|NCT02544074|2607850|P13|Overall Study|Tablet error|0
802532|NCT02544074|2607851|P12|Overall Study|Tablet error|0
802533|NCT02544074|2607852|P11|Overall Study|Tablet error|0
802534|NCT02544074|2607853|P10|Overall Study|Tablet error|1
802535|NCT02544074|2607854|P9|Overall Study|Tablet error|0
802536|NCT02544074|2607855|P8|Overall Study|Tablet error|0
802537|NCT02544074|2607856|P7|Overall Study|Tablet error|0
802538|NCT02544074|2607857|P6|Overall Study|Tablet error|1
802539|NCT02544074|2607858|P5|Overall Study|Tablet error|0
802540|NCT02544074|2607859|P4|Overall Study|Tablet error|0
802541|NCT02544074|2607860|P3|Overall Study|Tablet error|0
802542|NCT02544074|2607861|P2|Overall Study|Tablet error|0
802543|NCT02544074|2607862|P1|Overall Study|Tablet error|0
802544|NCT02544074|2607842|P21|Overall Study|Withdrawal by Subject|0
802545|NCT02544074|2607843|P20|Overall Study|Withdrawal by Subject|0
802546|NCT02544074|2607844|P19|Overall Study|Withdrawal by Subject|0
802547|NCT02544074|2607845|P18|Overall Study|Withdrawal by Subject|0
802548|NCT02544074|2607846|P17|Overall Study|Withdrawal by Subject|0
802549|NCT02544074|2607847|P16|Overall Study|Withdrawal by Subject|0
802550|NCT02544074|2607848|P15|Overall Study|Withdrawal by Subject|0
802551|NCT02544074|2607849|P14|Overall Study|Withdrawal by Subject|0
802552|NCT02544074|2607850|P13|Overall Study|Withdrawal by Subject|0
802553|NCT02544074|2607851|P12|Overall Study|Withdrawal by Subject|0
802554|NCT02544074|2607852|P11|Overall Study|Withdrawal by Subject|0
802555|NCT02544074|2607853|P10|Overall Study|Withdrawal by Subject|0
802556|NCT02544074|2607854|P9|Overall Study|Withdrawal by Subject|0
802557|NCT02544074|2607855|P8|Overall Study|Withdrawal by Subject|0
802558|NCT02544074|2607856|P7|Overall Study|Withdrawal by Subject|0
802559|NCT02544074|2607857|P6|Overall Study|Withdrawal by Subject|0
802560|NCT02544074|2607858|P5|Overall Study|Withdrawal by Subject|0
802561|NCT02544074|2607859|P4|Overall Study|Withdrawal by Subject|0
802562|NCT02544074|2607860|P3|Overall Study|Withdrawal by Subject|0
802563|NCT02544074|2607861|P2|Overall Study|Withdrawal by Subject|1
802564|NCT02544074|2607862|P1|Overall Study|Withdrawal by Subject|0
802565|NCT02543918|2607898|P2|Overall Study|Adverse Event|1
802566|NCT02543918|2607899|P1|Overall Study|Adverse Event|1
802567|NCT02543918|2607898|P2|Overall Study|Withdrawal by Subject|1
802568|NCT02543918|2607899|P1|Overall Study|Withdrawal by Subject|1
802569|NCT02543918|2607898|P2|Overall Study|Lost to Follow-up|1
802570|NCT02543918|2607899|P1|Overall Study|Lost to Follow-up|1
802571|NCT02543918|2607898|P2|Overall Study|Never treated|1
802572|NCT02543918|2607899|P1|Overall Study|Never treated|0
802573|NCT02543892|2607913|P8|Had Immunology Data|Withdrawal by Subject|0
802574|NCT02543892|2607914|P7|Had Immunology Data|Withdrawal by Subject|1
802575|NCT02543892|2607915|P6|Had Immunology Data|Withdrawal by Subject|0
802576|NCT02543892|2607916|P5|Had Immunology Data|Withdrawal by Subject|0
802577|NCT02543892|2607917|P4|Had Immunology Data|Withdrawal by Subject|0
802578|NCT02543892|2607918|P3|Had Immunology Data|Withdrawal by Subject|0
802579|NCT02543892|2607919|P2|Had Immunology Data|Withdrawal by Subject|0
802580|NCT02543892|2607920|P1|Had Immunology Data|Withdrawal by Subject|0
802581|NCT02543892|2607913|P8|Received Vaccination 2|Adverse Event|0
802582|NCT02543892|2607914|P7|Received Vaccination 2|Adverse Event|0
802583|NCT02543892|2607915|P6|Received Vaccination 2|Adverse Event|0
802584|NCT02543892|2607916|P5|Received Vaccination 2|Adverse Event|0
802585|NCT02543892|2607917|P4|Received Vaccination 2|Adverse Event|0
802586|NCT02543892|2607918|P3|Received Vaccination 2|Adverse Event|0
802587|NCT02543892|2607919|P2|Received Vaccination 2|Adverse Event|1
802588|NCT02543892|2607920|P1|Received Vaccination 2|Adverse Event|0
802589|NCT02543892|2607913|P8|Received Vaccination 2|Physician Decision|0
802590|NCT02543892|2607914|P7|Received Vaccination 2|Physician Decision|0
802591|NCT02543892|2607915|P6|Received Vaccination 2|Physician Decision|1
802592|NCT02543892|2607916|P5|Received Vaccination 2|Physician Decision|0
802593|NCT02543892|2607917|P4|Received Vaccination 2|Physician Decision|0
802594|NCT02543892|2607918|P3|Received Vaccination 2|Physician Decision|0
802595|NCT02543892|2607919|P2|Received Vaccination 2|Physician Decision|0
802596|NCT02543892|2607920|P1|Received Vaccination 2|Physician Decision|0
802597|NCT02543892|2607913|P8|Received Vaccination 2|Withdrawal by Subject|1
802598|NCT02543892|2607914|P7|Received Vaccination 2|Withdrawal by Subject|0
802599|NCT02543892|2607915|P6|Received Vaccination 2|Withdrawal by Subject|0
802600|NCT02543892|2607916|P5|Received Vaccination 2|Withdrawal by Subject|0
802601|NCT02543892|2607917|P4|Received Vaccination 2|Withdrawal by Subject|0
802602|NCT02543892|2607918|P3|Received Vaccination 2|Withdrawal by Subject|0
802603|NCT02543892|2607919|P2|Received Vaccination 2|Withdrawal by Subject|0
802604|NCT02543892|2607920|P1|Received Vaccination 2|Withdrawal by Subject|1
802605|NCT02543528|2607966|P5|Extended Wear Period|Withdrawal by Subject|0
802606|NCT02543528|2607967|P4|Extended Wear Period|Withdrawal by Subject|5
802607|NCT02543528|2607968|P3|Extended Wear Period|Withdrawal by Subject|10
802608|NCT02543528|2607969|P2|Extended Wear Period|Withdrawal by Subject|9
802609|NCT02543528|2607970|P1|Extended Wear Period|Withdrawal by Subject|4
802610|NCT02543528|2607966|P5|Extended Wear Period|Lost to Follow-up|0
802611|NCT02543528|2607967|P4|Extended Wear Period|Lost to Follow-up|1
802612|NCT02543528|2607968|P3|Extended Wear Period|Lost to Follow-up|0
802613|NCT02543528|2607969|P2|Extended Wear Period|Lost to Follow-up|1
802614|NCT02543528|2607970|P1|Extended Wear Period|Lost to Follow-up|2
802615|NCT02543528|2607966|P5|Extended Wear Period|Unsatisfactory Lens Fitting|0
802616|NCT02543528|2607967|P4|Extended Wear Period|Unsatisfactory Lens Fitting|0
802617|NCT02543528|2607968|P3|Extended Wear Period|Unsatisfactory Lens Fitting|1
802618|NCT02543528|2607969|P2|Extended Wear Period|Unsatisfactory Lens Fitting|0
802619|NCT02543528|2607970|P1|Extended Wear Period|Unsatisfactory Lens Fitting|0
802620|NCT02543528|2607966|P5|Extended Wear Period|Missed too many scheduled visits|0
802621|NCT02543528|2607967|P4|Extended Wear Period|Missed too many scheduled visits|3
802622|NCT02543528|2607968|P3|Extended Wear Period|Missed too many scheduled visits|0
802623|NCT02543528|2607969|P2|Extended Wear Period|Missed too many scheduled visits|0
802624|NCT02543528|2607970|P1|Extended Wear Period|Missed too many scheduled visits|1
802625|NCT02543528|2607966|P5|Extended Wear Period|Adverse Event|0
802626|NCT02543528|2607967|P4|Extended Wear Period|Adverse Event|3
802627|NCT02543528|2607968|P3|Extended Wear Period|Adverse Event|17
802628|NCT02543528|2607969|P2|Extended Wear Period|Adverse Event|11
802629|NCT02543528|2607970|P1|Extended Wear Period|Adverse Event|16
802630|NCT02543528|2607966|P5|Adaptation Period|Adverse Event|2
802631|NCT02543528|2607967|P4|Adaptation Period|Adverse Event|0
802632|NCT02543528|2607968|P3|Adaptation Period|Adverse Event|0
802633|NCT02543528|2607969|P2|Adaptation Period|Adverse Event|0
802634|NCT02543528|2607970|P1|Adaptation Period|Adverse Event|0
802635|NCT02543528|2607966|P5|Adaptation Period|Lost to Follow-up|14
802636|NCT02543528|2607967|P4|Adaptation Period|Lost to Follow-up|0
802637|NCT02543528|2607968|P3|Adaptation Period|Lost to Follow-up|0
802638|NCT02543528|2607969|P2|Adaptation Period|Lost to Follow-up|0
802639|NCT02543528|2607970|P1|Adaptation Period|Lost to Follow-up|0
802640|NCT02543528|2607966|P5|Adaptation Period|Lens Handling Difficultes|8
802641|NCT02543528|2607967|P4|Adaptation Period|Lens Handling Difficultes|0
802642|NCT02543528|2607968|P3|Adaptation Period|Lens Handling Difficultes|0
802643|NCT02543528|2607969|P2|Adaptation Period|Lens Handling Difficultes|0
802644|NCT02543528|2607970|P1|Adaptation Period|Lens Handling Difficultes|0
802645|NCT02543528|2607966|P5|Adaptation Period|Unsatisfactory Lens Fitting|2
802646|NCT02543528|2607967|P4|Adaptation Period|Unsatisfactory Lens Fitting|0
802647|NCT02543528|2607968|P3|Adaptation Period|Unsatisfactory Lens Fitting|0
802648|NCT02543528|2607969|P2|Adaptation Period|Unsatisfactory Lens Fitting|0
802649|NCT02543528|2607970|P1|Adaptation Period|Unsatisfactory Lens Fitting|0
802650|NCT02542943|2608006|P3|Overall Study|Withdrawal by Subject|0
802651|NCT02542943|2608007|P2|Overall Study|Withdrawal by Subject|1
802652|NCT02542943|2608008|P1|Overall Study|Withdrawal by Subject|0
802653|NCT02542943|2608006|P3|Overall Study|Lost to Follow-up|0
802654|NCT02542943|2608007|P2|Overall Study|Lost to Follow-up|0
802655|NCT02542943|2608008|P1|Overall Study|Lost to Follow-up|1
802656|NCT02542631|2608052|P2|Overall Study|Used Prohibited Medication|1
802657|NCT02542631|2608053|P1|Overall Study|Used Prohibited Medication|2
802658|NCT02542631|2608052|P2|Overall Study|Other|1
802659|NCT02542631|2608053|P1|Overall Study|Other|2
802660|NCT02542631|2608052|P2|Overall Study|Death|2
802661|NCT02542631|2608053|P1|Overall Study|Death|1
802662|NCT02542631|2608052|P2|Overall Study|Lost to Follow-up|5
802663|NCT02542631|2608053|P1|Overall Study|Lost to Follow-up|6
802664|NCT02542631|2608052|P2|Overall Study|Physician Decision|4
802665|NCT02542631|2608053|P1|Overall Study|Physician Decision|6
802666|NCT02542631|2608052|P2|Overall Study|Protocol Violation|1
802667|NCT02542631|2608053|P1|Overall Study|Protocol Violation|1
802668|NCT02542631|2608052|P2|Overall Study|Withdrawal by Subject|16
802669|NCT02542631|2608053|P1|Overall Study|Withdrawal by Subject|11
802670|NCT02542631|2608052|P2|Overall Study|Sponsor Termination|0
802671|NCT02542631|2608053|P1|Overall Study|Sponsor Termination|1
802672|NCT02542631|2608052|P2|Overall Study|Adverse Event|1
802673|NCT02542631|2608053|P1|Overall Study|Adverse Event|1
802674|NCT02542072|2608107|P2|Second Intervention (1 Month)|Lens discomfort|0
802675|NCT02542072|2608108|P1|Second Intervention (1 Month)|Lens discomfort|1
802676|NCT02542072|2608107|P2|Second Intervention (1 Month)|Lost to Follow-up|0
802677|NCT02542072|2608108|P1|Second Intervention (1 Month)|Lost to Follow-up|1
802678|NCT02542072|2608107|P2|First Intervention (1 Month)|Protocol Violation|0
802679|NCT02542072|2608108|P1|First Intervention (1 Month)|Protocol Violation|1
802680|NCT02542072|2608107|P2|First Intervention (1 Month)|Lens discomfort|2
802681|NCT02542072|2608108|P1|First Intervention (1 Month)|Lens discomfort|1
802682|NCT02542072|2608107|P2|First Intervention (1 Month)|Lost to Follow-up|0
802683|NCT02542072|2608108|P1|First Intervention (1 Month)|Lost to Follow-up|2
802684|NCT02542072|2608107|P2|First Intervention (1 Month)|Adverse Event|1
802685|NCT02542072|2608108|P1|First Intervention (1 Month)|Adverse Event|1
802686|NCT02540850|2608227|P3|Overall Study|Lost to Follow-up|34
802687|NCT02540850|2608228|P2|Overall Study|Lost to Follow-up|66
802688|NCT02540850|2608229|P1|Overall Study|Lost to Follow-up|69
802689|NCT02540538|2608273|P3|Overall Study|Pregnancy|0
802690|NCT02540538|2608274|P2|Overall Study|Pregnancy|1
802691|NCT02540538|2608275|P1|Overall Study|Pregnancy|0
802692|NCT02540356|2608319|P2|Overall Study|Terminated due to disease progression|0
802693|NCT02540356|2608320|P1|Overall Study|Terminated due to disease progression|1
802694|NCT02540265|2608354|P3|Overall Study|Lost to Follow-up|1
802695|NCT02540265|2608355|P2|Overall Study|Lost to Follow-up|0
802696|NCT02540265|2608356|P1|Overall Study|Lost to Follow-up|0
802697|NCT02540213|2608376|P1|Overall Study|Enrolled but not treated|2
802698|NCT02540213|2608376|P1|Overall Study|Consent withdrawn|7
802699|NCT02540213|2608376|P1|Overall Study|Lack of Efficacy|6
802700|NCT02540213|2608376|P1|Overall Study|Kidney transplant|3
802701|NCT02540213|2608376|P1|Overall Study|Administrative reasons|3
802702|NCT02540213|2608376|P1|Overall Study|Death/adverse event|18
802703|NCT02539797|2608428|P3|Overall Study|Lost to Follow-up|0
802704|NCT02539797|2608429|P2|Overall Study|Lost to Follow-up|1
802705|NCT02539797|2608430|P1|Overall Study|Lost to Follow-up|0
802706|NCT02539134|2608457|P6|Overall Study|Lost to Follow-up|0
802707|NCT02539134|2608458|P5|Overall Study|Lost to Follow-up|0
802708|NCT02539134|2608459|P4|Overall Study|Lost to Follow-up|0
802709|NCT02539134|2608460|P3|Overall Study|Lost to Follow-up|0
802710|NCT02539134|2608461|P2|Overall Study|Lost to Follow-up|0
802711|NCT02539134|2608462|P1|Overall Study|Lost to Follow-up|1
802712|NCT02538965|2608531|P1|Follow-Up Period|Withdrawal by Parent|4
802713|NCT02538965|2608531|P1|Follow-Up Period|Other = Death due to disease progression|11
802714|NCT02538965|2608531|P1|Treatment Period|Physician Decision|2
802715|NCT02538965|2608531|P1|Treatment Period|Disease Progression|1
802716|NCT02538965|2608531|P1|Treatment Period|Treatment Failure|9
802717|NCT02538965|2608531|P1|Treatment Period|Withdrawal by Parent/Guardian|2
802718|NCT02538965|2608531|P1|Treatment Period|Adverse Event|2
802719|NCT02538965|2608531|P1|Treatment Period|Other = Death due to disease progression|1
802720|NCT02538107|2608563|P1|Overall Study|Not recorded|7
802721|NCT02538107|2608563|P1|Overall Study|Other|7
802722|NCT02538107|2608563|P1|Overall Study|Surgery|1
802723|NCT02538107|2608563|P1|Overall Study|Adverse Event|4
802724|NCT02538107|2608563|P1|Overall Study|Administrative reason|5
802725|NCT02538107|2608563|P1|Overall Study|Death|4
802726|NCT02538107|2608563|P1|Overall Study|Withdrawal by Subject|17
802727|NCT02538107|2608563|P1|Overall Study|No further treatment necessary|18
802728|NCT02538107|2608563|P1|Overall Study|Administration of other ESA|11
802729|NCT02538107|2608563|P1|Overall Study|Necessity of dialysis|20
802730|NCT02538107|2608563|P1|Overall Study|Missing|5
802731|NCT02538107|2608563|P1|Overall Study|Did not receive any Mircera dose|11
802732|NCT02537522|2608615|P4|Phase II - Period 1 Bilateral|Adverse Event|1
802733|NCT02537522|2608616|P3|Phase II - Period 1 Bilateral|Adverse Event|0
802734|NCT02537522|2608617|P2|Phase II - Period 1 Bilateral|Adverse Event|0
802735|NCT02537522|2608618|P1|Phase II - Period 1 Bilateral|Adverse Event|0
802736|NCT02537522|2608615|P4|Phase I - Contralateral|unsatisfactory lens fitting|0
802737|NCT02537522|2608616|P3|Phase I - Contralateral|unsatisfactory lens fitting|0
802738|NCT02537522|2608617|P2|Phase I - Contralateral|unsatisfactory lens fitting|1
802739|NCT02537522|2608618|P1|Phase I - Contralateral|unsatisfactory lens fitting|0
802740|NCT02537522|2608615|P4|Phase I - Contralateral|incorrect randomization|0
802741|NCT02537522|2608616|P3|Phase I - Contralateral|incorrect randomization|0
802742|NCT02537522|2608617|P2|Phase I - Contralateral|incorrect randomization|1
802743|NCT02537522|2608618|P1|Phase I - Contralateral|incorrect randomization|0
802744|NCT02537522|2608615|P4|Phase I - Contralateral|Withdrawal by Subject|0
802745|NCT02537522|2608616|P3|Phase I - Contralateral|Withdrawal by Subject|0
802746|NCT02537522|2608617|P2|Phase I - Contralateral|Withdrawal by Subject|1
802747|NCT02537522|2608618|P1|Phase I - Contralateral|Withdrawal by Subject|0
802748|NCT02537522|2608615|P4|Phase I - Contralateral|Subject no longer eligible|0
802749|NCT02537522|2608616|P3|Phase I - Contralateral|Subject no longer eligible|0
802750|NCT02537522|2608617|P2|Phase I - Contralateral|Subject no longer eligible|7
802751|NCT02537522|2608618|P1|Phase I - Contralateral|Subject no longer eligible|15
802752|NCT02537431|2608626|P1|Overall Study|Withdrawal by Subject|1
802753|NCT02536781|2608657|P2|Overall Study|Lost to Follow-up|0
802754|NCT02536781|2608658|P1|Overall Study|Lost to Follow-up|2
802755|NCT02536664|2608668|P2|Overall Study|Missing|20
802756|NCT02536664|2608669|P1|Overall Study|Missing|53
802757|NCT02536664|2608668|P2|Overall Study|Other|24
802758|NCT02536664|2608669|P1|Overall Study|Other|18
802759|NCT02536664|2608668|P2|Overall Study|Withdrawal by Subject|5
802760|NCT02536664|2608669|P1|Overall Study|Withdrawal by Subject|8
802761|NCT02536664|2608668|P2|Overall Study|Intolerability|6
802762|NCT02536664|2608669|P1|Overall Study|Intolerability|8
802763|NCT02536664|2608668|P2|Overall Study|Death due to other reason|2
802764|NCT02536664|2608669|P1|Overall Study|Death due to other reason|3
802765|NCT02536664|2608668|P2|Overall Study|Death due to lymphoma|1
802766|NCT02536664|2608669|P1|Overall Study|Death due to lymphoma|2
802767|NCT02536664|2608668|P2|Overall Study|Progression|18
802768|NCT02536664|2608669|P1|Overall Study|Progression|13
802769|NCT02536664|2608668|P2|Overall Study|Inadequate completion of documentation|4
802770|NCT02536664|2608669|P1|Overall Study|Inadequate completion of documentation|2
802771|NCT02536313|2608689|P2|Overall Study|Lack of Efficacy|1
802772|NCT02536313|2608690|P1|Overall Study|Lack of Efficacy|0
802773|NCT02535741|2608706|P1|Overall Study|Missing data|6
802774|NCT02535741|2608706|P1|Overall Study|Exclusion criteria: Bilateral implant|4
802775|NCT02535741|2608706|P1|Overall Study|Lost to Follow-up|10
802776|NCT02535741|2608706|P1|Overall Study|Withdrawal by Subject|9
802777|NCT02535741|2608706|P1|Overall Study|Adverse Event|3
802778|NCT02535416|2608723|P9|Overall Study|Family bereavement overseas|0
802779|NCT02535416|2608724|P8|Overall Study|Family bereavement overseas|0
802780|NCT02535416|2608725|P7|Overall Study|Family bereavement overseas|0
802781|NCT02535416|2608726|P6|Overall Study|Family bereavement overseas|0
802782|NCT02535416|2608727|P5|Overall Study|Family bereavement overseas|0
802783|NCT02535416|2608728|P4|Overall Study|Family bereavement overseas|0
802784|NCT02535416|2608729|P3|Overall Study|Family bereavement overseas|0
802785|NCT02535416|2608730|P2|Overall Study|Family bereavement overseas|0
802786|NCT02535416|2608731|P1|Overall Study|Family bereavement overseas|1
802787|NCT02535364|2608783|P1|12-Month Follow-up Period|Subject transferred to hospice|1
802788|NCT02535364|2608783|P1|12-Month Follow-up Period|Subject received alternative therapy|2
802789|NCT02535364|2608783|P1|12-Month Follow-up Period|Underwent stem cell transplant|5
802790|NCT02535364|2608783|P1|12-Month Follow-up Period|Death|5
802791|NCT02535364|2608783|P1|12-Month Follow-up Period|Disease progression|22
802792|NCT02535364|2608783|P1|Study Treatment|Study placed on clinical hold by FDA|1
802793|NCT02535364|2608783|P1|Study Treatment|Death|1
802794|NCT02535364|2608783|P1|Part B Screening|Change in diagnosis, no longer eligible|2
802795|NCT02535364|2608783|P1|Part B Screening|Adverse Event|1
802796|NCT02535364|2608783|P1|Part B Screening|Withdrawal by Subject|1
802797|NCT02535364|2608783|P1|Part B Screening|Physician Decision|1
802798|NCT02535364|2608783|P1|Part B Screening|Death|2
802799|NCT02535364|2608783|P1|Part B Screening|Unable to manufacture JCAR015|3
802800|NCT02535364|2608783|P1|Part B Screening|Study placed on clinical hold by FDA|7
802801|NCT02535364|2608783|P1|Part A Screening Through Leukapheresis|Disease progression|1
802802|NCT02535364|2608783|P1|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2
802803|NCT02535364|2608783|P1|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22
802804|NCT02534935|2608868|P3|Overall Study|Lost to Follow-up|1
802805|NCT02534935|2608869|P2|Overall Study|Lost to Follow-up|1
802806|NCT02534935|2608870|P1|Overall Study|Lost to Follow-up|0
802807|NCT02534935|2608868|P3|Overall Study|Adverse Event|0
802808|NCT02534935|2608869|P2|Overall Study|Adverse Event|2
802809|NCT02534935|2608870|P1|Overall Study|Adverse Event|0
802810|NCT02534935|2608868|P3|Overall Study|No longer meets the eligibility criteria|0
802811|NCT02534935|2608869|P2|Overall Study|No longer meets the eligibility criteria|3
802812|NCT02534935|2608870|P1|Overall Study|No longer meets the eligibility criteria|0
802813|NCT02534935|2608868|P3|Overall Study|Withdrawal by Subject|3
802814|NCT02534935|2608869|P2|Overall Study|Withdrawal by Subject|3
802815|NCT02534935|2608870|P1|Overall Study|Withdrawal by Subject|0
802816|NCT02534935|2608868|P3|Overall Study|No longer willing to participate|1
802817|NCT02534935|2608869|P2|Overall Study|No longer willing to participate|1
802818|NCT02534935|2608870|P1|Overall Study|No longer willing to participate|0
802819|NCT02534883|2609030|P2|Overall Study|Early Termination|3
802820|NCT02534883|2609031|P1|Overall Study|Early Termination|8
802821|NCT02534493|2609047|P1|Overall Study|Withdrawal by Subject|1
802822|NCT02534493|2609047|P1|Overall Study|Lost to Follow-up|1
802823|NCT02534350|2609058|P2|Overall Study|Withdrew Consent|0
802824|NCT02534350|2609059|P1|Overall Study|Withdrew Consent|2
802825|NCT02534350|2609058|P2|Overall Study|Protocol Violation|0
802826|NCT02534350|2609059|P1|Overall Study|Protocol Violation|1
802827|NCT02534350|2609058|P2|Overall Study|Randomized But Not Treated|0
802828|NCT02534350|2609059|P1|Overall Study|Randomized But Not Treated|1
802829|NCT02534324|2609073|P2|Overall Study|Adverse Event|0
802830|NCT02534324|2609074|P1|Overall Study|Adverse Event|1
802831|NCT02534324|2609073|P2|Overall Study|Lost to Follow-up|7
802832|NCT02534324|2609074|P1|Overall Study|Lost to Follow-up|20
802833|NCT02534324|2609073|P2|Overall Study|Protocol Violation|1
802834|NCT02534324|2609074|P1|Overall Study|Protocol Violation|4
802835|NCT02533999|2609093|P2|Overall Study|Randomized but intervention not received|1
802836|NCT02533999|2609094|P1|Overall Study|Randomized but intervention not received|0
802837|NCT02533999|2609093|P2|Overall Study|Adverse Event|1
802838|NCT02533999|2609094|P1|Overall Study|Adverse Event|0
802839|NCT02533999|2609093|P2|Overall Study|Protocol Violation|0
802840|NCT02533999|2609094|P1|Overall Study|Protocol Violation|3
802841|NCT02533999|2609093|P2|Overall Study|Lost to Follow-up|5
802842|NCT02533999|2609094|P1|Overall Study|Lost to Follow-up|3
802843|NCT02533570|2609126|P3|Overall Study|Adverse Event|1
802844|NCT02533570|2609127|P2|Overall Study|Adverse Event|1
802845|NCT02533570|2609128|P1|Overall Study|Adverse Event|0
802846|NCT02533531|2609139|P1|Overall Study|Device did not turn on|1
802847|NCT02533401|2609202|P1|Overall Study|Violation of Selection Criteria|1
802848|NCT02533401|2609202|P1|Overall Study|Lost to Follow-up|1
802849|NCT02533401|2609202|P1|Overall Study|Insufficient Response/Progressed Disease|1
802850|NCT02533401|2609202|P1|Overall Study|Death|5
802851|NCT02533401|2609202|P1|Overall Study|Adverse Event/Intercurrent Disease|3
802852|NCT02533258|2609210|P1|Overall Study|Lack of Efficacy|2
802853|NCT02533258|2609210|P1|Overall Study|Progression of pleural effusion|1
802854|NCT02533258|2609210|P1|Overall Study|Economic factor|1
802855|NCT02533258|2609210|P1|Overall Study|Other|1
802856|NCT02533258|2609210|P1|Overall Study|Death|2
802857|NCT02533258|2609210|P1|Overall Study|Adverse Event|1
802858|NCT02532855|2609315|P2|Overall Study|Withdrawal by Subject|8
802859|NCT02532855|2609316|P1|Overall Study|Withdrawal by Subject|4
802860|NCT02532855|2609315|P2|Overall Study|Lost to Follow-up|3
802861|NCT02532855|2609316|P1|Overall Study|Lost to Follow-up|4
802862|NCT02532374|2609340|P1|Overall Study|Physician Decision|1
802863|NCT02532374|2609340|P1|Overall Study|Withdrawal by Subject|1
802864|NCT02532179|2609364|P1|Overall Study|Subject received depot steroid injection|1
802865|NCT02532179|2609364|P1|Overall Study|Pregnancy|1
802866|NCT02532179|2609364|P1|Overall Study|Lost to Follow-up|1
802867|NCT02531802|2609419|P21|Received Vaccination 2|Withdrawal by Subject|0
802868|NCT02531802|2609420|P20|Received Vaccination 2|Withdrawal by Subject|1
802869|NCT02531802|2609421|P19|Received Vaccination 2|Withdrawal by Subject|1
802870|NCT02531802|2609422|P18|Received Vaccination 2|Withdrawal by Subject|1
802871|NCT02531802|2609423|P17|Received Vaccination 2|Withdrawal by Subject|0
802872|NCT02531802|2609424|P16|Received Vaccination 2|Withdrawal by Subject|0
802873|NCT02531802|2609425|P15|Received Vaccination 2|Withdrawal by Subject|1
802874|NCT02531802|2609426|P14|Received Vaccination 2|Withdrawal by Subject|1
802875|NCT02531802|2609427|P13|Received Vaccination 2|Withdrawal by Subject|1
802876|NCT02531802|2609428|P12|Received Vaccination 2|Withdrawal by Subject|0
802877|NCT02531802|2609429|P11|Received Vaccination 2|Withdrawal by Subject|1
802878|NCT02531802|2609430|P10|Received Vaccination 2|Withdrawal by Subject|0
802879|NCT02531802|2609431|P9|Received Vaccination 2|Withdrawal by Subject|0
802880|NCT02531802|2609432|P8|Received Vaccination 2|Withdrawal by Subject|0
802881|NCT02531802|2609433|P7|Received Vaccination 2|Withdrawal by Subject|0
802882|NCT02531802|2609434|P6|Received Vaccination 2|Withdrawal by Subject|0
802883|NCT02531802|2609435|P5|Received Vaccination 2|Withdrawal by Subject|0
802884|NCT02531802|2609436|P4|Received Vaccination 2|Withdrawal by Subject|0
802885|NCT02531802|2609437|P3|Received Vaccination 2|Withdrawal by Subject|0
802886|NCT02531802|2609438|P2|Received Vaccination 2|Withdrawal by Subject|0
802887|NCT02531802|2609439|P1|Received Vaccination 2|Withdrawal by Subject|0
802888|NCT02531802|2609419|P21|Received Vaccination 2|Adverse Event|1
802889|NCT02531802|2609420|P20|Received Vaccination 2|Adverse Event|0
802890|NCT02531802|2609421|P19|Received Vaccination 2|Adverse Event|1
802891|NCT02531802|2609422|P18|Received Vaccination 2|Adverse Event|2
802892|NCT02531802|2609423|P17|Received Vaccination 2|Adverse Event|0
802893|NCT02531802|2609424|P16|Received Vaccination 2|Adverse Event|0
802894|NCT02531802|2609425|P15|Received Vaccination 2|Adverse Event|0
802895|NCT02531802|2609426|P14|Received Vaccination 2|Adverse Event|0
802896|NCT02531802|2609427|P13|Received Vaccination 2|Adverse Event|0
802897|NCT02531802|2609428|P12|Received Vaccination 2|Adverse Event|0
802898|NCT02531802|2609429|P11|Received Vaccination 2|Adverse Event|0
802899|NCT02531802|2609430|P10|Received Vaccination 2|Adverse Event|0
802900|NCT02531802|2609431|P9|Received Vaccination 2|Adverse Event|0
802901|NCT02531802|2609432|P8|Received Vaccination 2|Adverse Event|0
802902|NCT02531802|2609433|P7|Received Vaccination 2|Adverse Event|0
802903|NCT02531802|2609434|P6|Received Vaccination 2|Adverse Event|2
802904|NCT02531802|2609435|P5|Received Vaccination 2|Adverse Event|0
802905|NCT02531802|2609436|P4|Received Vaccination 2|Adverse Event|0
802906|NCT02531802|2609437|P3|Received Vaccination 2|Adverse Event|0
802907|NCT02531802|2609438|P2|Received Vaccination 2|Adverse Event|0
802908|NCT02531802|2609439|P1|Received Vaccination 2|Adverse Event|0
802909|NCT02531802|2609419|P21|Received Vaccination 2|Physician Decision|0
802910|NCT02531802|2609420|P20|Received Vaccination 2|Physician Decision|0
802911|NCT02531802|2609421|P19|Received Vaccination 2|Physician Decision|0
802912|NCT02531802|2609422|P18|Received Vaccination 2|Physician Decision|1
802913|NCT02531802|2609423|P17|Received Vaccination 2|Physician Decision|0
802914|NCT02531802|2609424|P16|Received Vaccination 2|Physician Decision|0
802915|NCT02531802|2609425|P15|Received Vaccination 2|Physician Decision|0
802916|NCT02531802|2609426|P14|Received Vaccination 2|Physician Decision|1
802917|NCT02531802|2609427|P13|Received Vaccination 2|Physician Decision|0
802918|NCT02531802|2609428|P12|Received Vaccination 2|Physician Decision|0
802919|NCT02531802|2609429|P11|Received Vaccination 2|Physician Decision|0
802920|NCT02531802|2609430|P10|Received Vaccination 2|Physician Decision|2
802921|NCT02531802|2609431|P9|Received Vaccination 2|Physician Decision|0
802922|NCT02531802|2609432|P8|Received Vaccination 2|Physician Decision|0
802923|NCT02531802|2609433|P7|Received Vaccination 2|Physician Decision|0
802924|NCT02531802|2609434|P6|Received Vaccination 2|Physician Decision|1
802925|NCT02531802|2609435|P5|Received Vaccination 2|Physician Decision|0
802926|NCT02531802|2609436|P4|Received Vaccination 2|Physician Decision|0
802927|NCT02531802|2609437|P3|Received Vaccination 2|Physician Decision|0
802928|NCT02531802|2609438|P2|Received Vaccination 2|Physician Decision|0
802929|NCT02531802|2609439|P1|Received Vaccination 2|Physician Decision|0
802930|NCT02531802|2609419|P21|Received Vaccination 2|Medication interfering with study taken|0
802931|NCT02531802|2609420|P20|Received Vaccination 2|Medication interfering with study taken|0
802932|NCT02531802|2609421|P19|Received Vaccination 2|Medication interfering with study taken|1
802933|NCT02531802|2609422|P18|Received Vaccination 2|Medication interfering with study taken|0
802934|NCT02531802|2609423|P17|Received Vaccination 2|Medication interfering with study taken|0
802935|NCT02531802|2609424|P16|Received Vaccination 2|Medication interfering with study taken|0
802936|NCT02531802|2609425|P15|Received Vaccination 2|Medication interfering with study taken|0
802937|NCT02531802|2609426|P14|Received Vaccination 2|Medication interfering with study taken|0
802938|NCT02531802|2609427|P13|Received Vaccination 2|Medication interfering with study taken|1
802939|NCT02531802|2609428|P12|Received Vaccination 2|Medication interfering with study taken|0
802940|NCT02531802|2609429|P11|Received Vaccination 2|Medication interfering with study taken|1
802941|NCT02531802|2609430|P10|Received Vaccination 2|Medication interfering with study taken|1
802942|NCT02531802|2609431|P9|Received Vaccination 2|Medication interfering with study taken|0
802943|NCT02531802|2609432|P8|Received Vaccination 2|Medication interfering with study taken|0
802944|NCT02531802|2609433|P7|Received Vaccination 2|Medication interfering with study taken|0
802945|NCT02531802|2609434|P6|Received Vaccination 2|Medication interfering with study taken|0
802946|NCT02531802|2609435|P5|Received Vaccination 2|Medication interfering with study taken|0
802947|NCT02531802|2609436|P4|Received Vaccination 2|Medication interfering with study taken|0
802948|NCT02531802|2609437|P3|Received Vaccination 2|Medication interfering with study taken|1
802949|NCT02531802|2609438|P2|Received Vaccination 2|Medication interfering with study taken|0
802950|NCT02531802|2609439|P1|Received Vaccination 2|Medication interfering with study taken|0
802951|NCT02531698|2609871|P2|Overall Study|Lost to Follow-up|0
802952|NCT02531698|2609872|P1|Overall Study|Lost to Follow-up|1
802953|NCT02531698|2609871|P2|Overall Study|Protocol Violation|0
802954|NCT02531698|2609872|P1|Overall Study|Protocol Violation|2
802955|NCT02531698|2609871|P2|Overall Study|Withdrawal by Subject|1
802956|NCT02531698|2609872|P1|Overall Study|Withdrawal by Subject|6
802957|NCT02531698|2609871|P2|Overall Study|Adverse Event|1
802958|NCT02531698|2609872|P1|Overall Study|Adverse Event|2
802959|NCT02531646|2610119|P3|Overall Study|equip. image processing issue|0
802960|NCT02531646|2610120|P2|Overall Study|equip. image processing issue|1
802961|NCT02531646|2610121|P1|Overall Study|equip. image processing issue|5
802962|NCT02531438|2610137|P2|Overall Study|Randomized with Exclusion Criteria|0
802963|NCT02531438|2610138|P1|Overall Study|Randomized with Exclusion Criteria|1
802964|NCT02531438|2610137|P2|Overall Study|Missed EOT/PTE Visit|2
802965|NCT02531438|2610138|P1|Overall Study|Missed EOT/PTE Visit|5
802966|NCT02531438|2610137|P2|Overall Study|Randomized, but Not Treated|0
802967|NCT02531438|2610138|P1|Overall Study|Randomized, but Not Treated|4
802968|NCT02531438|2610137|P2|Overall Study|Death|3
802969|NCT02531438|2610138|P1|Overall Study|Death|6
802970|NCT02531438|2610137|P2|Overall Study|Physician Decision|1
802971|NCT02531438|2610138|P1|Overall Study|Physician Decision|0
802972|NCT02531438|2610137|P2|Overall Study|Withdrawal by Subject|8
802973|NCT02531438|2610138|P1|Overall Study|Withdrawal by Subject|7
802974|NCT02531438|2610137|P2|Overall Study|Lost to Follow-up|3
802975|NCT02531438|2610138|P1|Overall Study|Lost to Follow-up|0
802976|NCT02531438|2610137|P2|Overall Study|Adverse Event|9
802977|NCT02531438|2610138|P1|Overall Study|Adverse Event|7
802978|NCT02531373|2610157|P9|Overall Study|Withdrawal by Subject|0
802979|NCT02531373|2610158|P8|Overall Study|Withdrawal by Subject|0
802980|NCT02531373|2610159|P7|Overall Study|Withdrawal by Subject|0
802981|NCT02531373|2610160|P6|Overall Study|Withdrawal by Subject|0
802982|NCT02531373|2610161|P5|Overall Study|Withdrawal by Subject|3
802983|NCT02531373|2610162|P4|Overall Study|Withdrawal by Subject|0
802984|NCT02531373|2610163|P3|Overall Study|Withdrawal by Subject|0
802985|NCT02531373|2610164|P2|Overall Study|Withdrawal by Subject|0
802986|NCT02531373|2610165|P1|Overall Study|Withdrawal by Subject|0
802987|NCT02531373|2610157|P9|Overall Study|Withdrawal by Parent/Guardian|3
802988|NCT02531373|2610158|P8|Overall Study|Withdrawal by Parent/Guardian|1
802989|NCT02531373|2610159|P7|Overall Study|Withdrawal by Parent/Guardian|4
802990|NCT02531373|2610160|P6|Overall Study|Withdrawal by Parent/Guardian|3
802991|NCT02531373|2610161|P5|Overall Study|Withdrawal by Parent/Guardian|0
802992|NCT02531373|2610162|P4|Overall Study|Withdrawal by Parent/Guardian|0
802993|NCT02531373|2610163|P3|Overall Study|Withdrawal by Parent/Guardian|0
802994|NCT02531373|2610164|P2|Overall Study|Withdrawal by Parent/Guardian|0
802995|NCT02531373|2610165|P1|Overall Study|Withdrawal by Parent/Guardian|0
802996|NCT02531373|2610157|P9|Overall Study|Protocol Violation|1
802997|NCT02531373|2610158|P8|Overall Study|Protocol Violation|0
802998|NCT02531373|2610159|P7|Overall Study|Protocol Violation|1
802999|NCT02531373|2610160|P6|Overall Study|Protocol Violation|1
803000|NCT02531373|2610161|P5|Overall Study|Protocol Violation|0
803001|NCT02531373|2610162|P4|Overall Study|Protocol Violation|0
803002|NCT02531373|2610163|P3|Overall Study|Protocol Violation|0
803003|NCT02531373|2610164|P2|Overall Study|Protocol Violation|0
803004|NCT02531373|2610165|P1|Overall Study|Protocol Violation|0
803005|NCT02531373|2610157|P9|Overall Study|Physician Decision|0
803006|NCT02531373|2610158|P8|Overall Study|Physician Decision|0
803007|NCT02531373|2610159|P7|Overall Study|Physician Decision|0
803008|NCT02531373|2610160|P6|Overall Study|Physician Decision|1
803009|NCT02531373|2610161|P5|Overall Study|Physician Decision|2
803010|NCT02531373|2610162|P4|Overall Study|Physician Decision|0
803011|NCT02531373|2610163|P3|Overall Study|Physician Decision|0
803012|NCT02531373|2610164|P2|Overall Study|Physician Decision|0
803013|NCT02531373|2610165|P1|Overall Study|Physician Decision|0
803014|NCT02531373|2610157|P9|Overall Study|Lost to Follow-up|0
803015|NCT02531373|2610158|P8|Overall Study|Lost to Follow-up|0
803016|NCT02531373|2610159|P7|Overall Study|Lost to Follow-up|2
803017|NCT02531373|2610160|P6|Overall Study|Lost to Follow-up|2
803018|NCT02531373|2610161|P5|Overall Study|Lost to Follow-up|0
803019|NCT02531373|2610162|P4|Overall Study|Lost to Follow-up|0
803020|NCT02531373|2610163|P3|Overall Study|Lost to Follow-up|0
803021|NCT02531373|2610164|P2|Overall Study|Lost to Follow-up|0
803022|NCT02531373|2610165|P1|Overall Study|Lost to Follow-up|0
803023|NCT02531373|2610157|P9|Overall Study|Lack of Efficacy|5
803024|NCT02531373|2610158|P8|Overall Study|Lack of Efficacy|8
803025|NCT02531373|2610159|P7|Overall Study|Lack of Efficacy|4
803026|NCT02531373|2610160|P6|Overall Study|Lack of Efficacy|2
803027|NCT02531373|2610161|P5|Overall Study|Lack of Efficacy|3
803028|NCT02531373|2610162|P4|Overall Study|Lack of Efficacy|0
803029|NCT02531373|2610163|P3|Overall Study|Lack of Efficacy|0
803030|NCT02531373|2610164|P2|Overall Study|Lack of Efficacy|0
803031|NCT02531373|2610165|P1|Overall Study|Lack of Efficacy|0
803032|NCT02530671|2610228|P2|Overall Study|Withdrawal by Subject|0
803033|NCT02530671|2610229|P1|Overall Study|Withdrawal by Subject|1
803034|NCT02530671|2610228|P2|Overall Study|Lost to Follow-up|0
803035|NCT02530671|2610229|P1|Overall Study|Lost to Follow-up|2
803036|NCT02530125|2610290|P1|Followed for Survival for 2 Years|Early termination of study|3
803037|NCT02530125|2610290|P1|Completed Treatment|Early termination of study|1
803038|NCT02529995|2610304|P2|Part B|Discontinued Study|5
803039|NCT02529995|2610305|P1|Part B|Discontinued Study|6
803040|NCT02529995|2610304|P2|Part B|Ongoing Study at Data Cut-off|7
803041|NCT02529995|2610305|P1|Part B|Ongoing Study at Data Cut-off|0
803042|NCT02529995|2610304|P2|Part A|Discontinued Study|0
803043|NCT02529995|2610305|P1|Part A|Discontinued Study|1
803044|NCT02529995|2610304|P2|Part A|Ongoing Study at Data Cut-off|16
803045|NCT02529995|2610305|P1|Part A|Ongoing Study at Data Cut-off|14
803046|NCT02529488|2610339|P1|Overall Study|Death|3
803047|NCT02529488|2610339|P1|Overall Study|Adverse Event|1
803048|NCT02528643|2610366|P2|Overall Study|No End of Study Information Available|0
803049|NCT02528643|2610367|P1|Overall Study|No End of Study Information Available|1
803050|NCT02528643|2610366|P2|Overall Study|Miscellaneous|1
803051|NCT02528643|2610367|P1|Overall Study|Miscellaneous|0
803052|NCT02528643|2610366|P2|Overall Study|Withdrawal by Subject|7
803053|NCT02528643|2610367|P1|Overall Study|Withdrawal by Subject|0
803054|NCT02528643|2610366|P2|Overall Study|Lost to Follow-up|1
803055|NCT02528643|2610367|P1|Overall Study|Lost to Follow-up|0
803056|NCT02528643|2610366|P2|Overall Study|Death|76
803057|NCT02528643|2610367|P1|Overall Study|Death|38
803058|NCT02528331|2610384|P1|Overall Study|Withdrawal by Subject|2
803059|NCT02528305|2610391|P1|Overall Study|Physician Decision|1
803060|NCT02528305|2610391|P1|Overall Study|Adverse Event|1
803061|NCT02528305|2610391|P1|Overall Study|Withdrawal by Subject|1
803062|NCT02528214|2610435|P2|Overall Study|Other than specified above|1
803063|NCT02528214|2610436|P1|Overall Study|Other than specified above|0
803064|NCT02528214|2610435|P2|Overall Study|Adverse Event|1
803065|NCT02528214|2610436|P1|Overall Study|Adverse Event|0
803066|NCT02528214|2610435|P2|Overall Study|Protocol Violation|1
803067|NCT02528214|2610436|P1|Overall Study|Protocol Violation|0
803068|NCT02527161|2610488|P1|Overall Study|Consent violation|4
803069|NCT02527161|2610488|P1|Overall Study|MRI contraindication|2
803070|NCT02527161|2610488|P1|Overall Study|Delay in or unfit for surgery|5
803071|NCT02527161|2610488|P1|Overall Study|Exclusion RA diagnosis|1
803072|NCT02527161|2610488|P1|Overall Study|Exclusion for excessive deformity|1
803073|NCT02527161|2610488|P1|Overall Study|Exclusion for BMI|2
803074|NCT02527161|2610488|P1|Overall Study|Shape Match not used in surgery|2
803075|NCT02527161|2610488|P1|Overall Study|Withdrawal by Subject|6
803076|NCT02527161|2610488|P1|Overall Study|Failed MRI|39
803077|NCT02527148|2610507|P2|Overall Study|Did not receive study intervention|0
803078|NCT02527148|2610508|P1|Overall Study|Did not receive study intervention|1
803079|NCT02526550|2610533|P1|Overall Study|Lost to Follow-up|1
803080|NCT02526524|2610545|P6|Overall Study|Sponsor Decision|0
803081|NCT02526524|2610546|P5|Overall Study|Sponsor Decision|0
803082|NCT02526524|2610547|P4|Overall Study|Sponsor Decision|0
803083|NCT02526524|2610548|P3|Overall Study|Sponsor Decision|0
803084|NCT02526524|2610549|P2|Overall Study|Sponsor Decision|0
803085|NCT02526524|2610550|P1|Overall Study|Sponsor Decision|1
803086|NCT02526524|2610545|P6|Overall Study|Physician Decision|0
803087|NCT02526524|2610546|P5|Overall Study|Physician Decision|1
803088|NCT02526524|2610547|P4|Overall Study|Physician Decision|0
803089|NCT02526524|2610548|P3|Overall Study|Physician Decision|0
803090|NCT02526524|2610549|P2|Overall Study|Physician Decision|0
803091|NCT02526524|2610550|P1|Overall Study|Physician Decision|0
803092|NCT02526524|2610545|P6|Overall Study|Loss of Glucose Control|0
803093|NCT02526524|2610546|P5|Overall Study|Loss of Glucose Control|2
803094|NCT02526524|2610547|P4|Overall Study|Loss of Glucose Control|0
803095|NCT02526524|2610548|P3|Overall Study|Loss of Glucose Control|3
803096|NCT02526524|2610549|P2|Overall Study|Loss of Glucose Control|0
803097|NCT02526524|2610550|P1|Overall Study|Loss of Glucose Control|0
803098|NCT02526524|2610545|P6|Overall Study|Protocol Violation|3
803099|NCT02526524|2610546|P5|Overall Study|Protocol Violation|4
803100|NCT02526524|2610547|P4|Overall Study|Protocol Violation|3
803101|NCT02526524|2610548|P3|Overall Study|Protocol Violation|5
803102|NCT02526524|2610549|P2|Overall Study|Protocol Violation|1
803103|NCT02526524|2610550|P1|Overall Study|Protocol Violation|3
803104|NCT02526524|2610545|P6|Overall Study|Lost to Follow-up|5
803105|NCT02526524|2610546|P5|Overall Study|Lost to Follow-up|2
803106|NCT02526524|2610547|P4|Overall Study|Lost to Follow-up|1
803107|NCT02526524|2610548|P3|Overall Study|Lost to Follow-up|8
803108|NCT02526524|2610549|P2|Overall Study|Lost to Follow-up|3
803109|NCT02526524|2610550|P1|Overall Study|Lost to Follow-up|2
803110|NCT02526524|2610545|P6|Overall Study|Adverse Event|8
803111|NCT02526524|2610546|P5|Overall Study|Adverse Event|6
803112|NCT02526524|2610547|P4|Overall Study|Adverse Event|2
803113|NCT02526524|2610548|P3|Overall Study|Adverse Event|4
803114|NCT02526524|2610549|P2|Overall Study|Adverse Event|2
803115|NCT02526524|2610550|P1|Overall Study|Adverse Event|3
803116|NCT02526524|2610545|P6|Overall Study|Withdrawal by Subject|5
803117|NCT02526524|2610546|P5|Overall Study|Withdrawal by Subject|9
803118|NCT02526524|2610547|P4|Overall Study|Withdrawal by Subject|1
803119|NCT02526524|2610548|P3|Overall Study|Withdrawal by Subject|6
803120|NCT02526524|2610549|P2|Overall Study|Withdrawal by Subject|3
803121|NCT02526524|2610550|P1|Overall Study|Withdrawal by Subject|3
803122|NCT02526290|2610564|P1|Overall Study|Physician Decision|1
803123|NCT02526290|2610564|P1|Overall Study|Withdrawal by Subject|4
803124|NCT02526290|2610564|P1|Overall Study|Adverse Event|3
803125|NCT02525094|2610649|P2|Overall Study|Not Treated|1
803126|NCT02525094|2610650|P1|Overall Study|Not Treated|1
803127|NCT02525094|2610649|P2|Overall Study|Withdrawal by Subject|6
803128|NCT02525094|2610650|P1|Overall Study|Withdrawal by Subject|5
803129|NCT02525094|2610649|P2|Overall Study|Lost to Follow-up|1
803130|NCT02525094|2610650|P1|Overall Study|Lost to Follow-up|2
803131|NCT02524665|2610688|P1|Overall Study|Lost to Follow-up|1
803132|NCT02524288|2610739|P1|Overall Study|Physician Decision|2
803133|NCT02524288|2610739|P1|Overall Study|Pregnancy|22
803134|NCT02524288|2610739|P1|Overall Study|Withdrawal by Subject|76
803135|NCT02524288|2610739|P1|Overall Study|Subject Moved|32
803136|NCT02524288|2610739|P1|Overall Study|Study Terminated By Sponsor|1417
803137|NCT02524288|2610739|P1|Overall Study|Site Discontinued Study Participation|1
803138|NCT02524288|2610739|P1|Overall Study|Screen Failure|2
803139|NCT02524288|2610739|P1|Overall Study|Protocol Violation|6
803140|NCT02524288|2610739|P1|Overall Study|Pregnancy Wish|6
803141|NCT02524288|2610739|P1|Overall Study|Non-Compliance With Study Drug|14
803142|NCT02524288|2610739|P1|Overall Study|Non-Compliance With Protocol|32
803143|NCT02524288|2610739|P1|Overall Study|Lost to Follow-up|216
803144|NCT02524288|2610739|P1|Overall Study|Adverse Event|115
803145|NCT02524158|2610749|P2|6-month Assessment|Lost to Follow-up|20
803146|NCT02524158|2610750|P1|6-month Assessment|Lost to Follow-up|21
803147|NCT02524158|2610749|P2|6-month Assessment|Withdrawal by Subject|1
803148|NCT02524158|2610750|P1|6-month Assessment|Withdrawal by Subject|1
803149|NCT02524158|2610749|P2|12-weeks Assessment|Lost to Follow-up|12
803150|NCT02524158|2610750|P1|12-weeks Assessment|Lost to Follow-up|18
803151|NCT02524158|2610749|P2|12-weeks Assessment|Withdrawal by Subject|1
803152|NCT02524158|2610750|P1|12-weeks Assessment|Withdrawal by Subject|1
803153|NCT02522624|2610817|P2|Overall Study|Technical failure|0
803154|NCT02522624|2610818|P1|Overall Study|Technical failure|1
803155|NCT02522403|2610836|P2|Overall Study|Withdrawal by Subject|4
803156|NCT02522403|2610837|P1|Overall Study|Withdrawal by Subject|2
803157|NCT02522403|2610836|P2|Overall Study|Lost to Follow-up|2
803158|NCT02522403|2610837|P1|Overall Study|Lost to Follow-up|2
803159|NCT02522286|2610851|P4|Overall Study|Withdrawal by Subject|3
803160|NCT02522286|2610852|P3|Overall Study|Withdrawal by Subject|0
803161|NCT02522286|2610853|P2|Overall Study|Withdrawal by Subject|0
803162|NCT02522286|2610854|P1|Overall Study|Withdrawal by Subject|3
803163|NCT02521948|2610880|P1|Overall Study|Did not attend one or both follow-ups|6
803164|NCT02521948|2610880|P1|Overall Study|Lost to Follow-up|1
803165|NCT02521948|2610880|P1|Overall Study|Death|4
803166|NCT02521948|2610880|P1|Overall Study|Adverse Event|2
803167|NCT02520726|2610891|P2|Overall Study|Lost to Follow-up|2
803168|NCT02520726|2610892|P1|Overall Study|Lost to Follow-up|3
803169|NCT02520388|2610906|P2|Overall Study|Other (reason not defined)|4
803170|NCT02520388|2610907|P1|Overall Study|Other (reason not defined)|4
803171|NCT02520388|2610906|P2|Overall Study|Lost to Follow-up|2
803172|NCT02520388|2610907|P1|Overall Study|Lost to Follow-up|3
803173|NCT02520388|2610906|P2|Overall Study|Adverse Event|4
803174|NCT02520388|2610907|P1|Overall Study|Adverse Event|1
803175|NCT02520388|2610906|P2|Overall Study|Subject or parent/guardian request|6
803176|NCT02520388|2610907|P1|Overall Study|Subject or parent/guardian request|0
803177|NCT02520388|2610906|P2|Overall Study|Physician Decision|0
803178|NCT02520388|2610907|P1|Overall Study|Physician Decision|1
803179|NCT02520089|2610917|P2|Overall Study|Lost to Follow-up|4
803180|NCT02520089|2610918|P1|Overall Study|Lost to Follow-up|3
803181|NCT02519855|2610928|P2|Overall Study|Lost to Follow-up|3
803182|NCT02519855|2610929|P1|Overall Study|Lost to Follow-up|3
803183|NCT02519855|2610928|P2|Overall Study|Adverse Event|1
803184|NCT02519855|2610929|P1|Overall Study|Adverse Event|0
803185|NCT02519842|2610947|P3|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2
803186|NCT02519842|2610948|P2|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
803187|NCT02519842|2610949|P1|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
803188|NCT02519842|2610947|P3|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1
803189|NCT02519842|2610948|P2|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
803190|NCT02519842|2610949|P1|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
803191|NCT02519842|2610947|P3|Optional Extension: Cycles 2-6|Completed Chemotherapy|13
803192|NCT02519842|2610948|P2|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
803193|NCT02519842|2610949|P1|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
803194|NCT02519842|2610947|P3|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2
803195|NCT02519842|2610948|P2|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
803196|NCT02519842|2610949|P1|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
803197|NCT02519842|2610947|P3|Optional Extension: Cycles 2-6|Death|1
803198|NCT02519842|2610948|P2|Optional Extension: Cycles 2-6|Death|0
803199|NCT02519842|2610949|P1|Optional Extension: Cycles 2-6|Death|0
803200|NCT02519842|2610947|P3|Optional Extension: Cycles 2-6|Withdrawal by Subject|1
803201|NCT02519842|2610948|P2|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
803202|NCT02519842|2610949|P1|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
803203|NCT02519842|2610947|P3|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3
803204|NCT02519842|2610948|P2|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
803205|NCT02519842|2610949|P1|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
803206|NCT02519842|2610947|P3|Optional Extension: Cycles 2-6|Adverse Event|1
803207|NCT02519842|2610948|P2|Optional Extension: Cycles 2-6|Adverse Event|0
803208|NCT02519842|2610949|P1|Optional Extension: Cycles 2-6|Adverse Event|0
803209|NCT02519842|2610947|P3|Optional Extension: Cycles 2-6|Physician Decision|5
803210|NCT02519842|2610948|P2|Optional Extension: Cycles 2-6|Physician Decision|0
803211|NCT02519842|2610949|P1|Optional Extension: Cycles 2-6|Physician Decision|0
803212|NCT02519842|2610947|P3|Base Study: Cycle 1|Non-compliance with Study Drug|0
803213|NCT02519842|2610948|P2|Base Study: Cycle 1|Non-compliance with Study Drug|1
803214|NCT02519842|2610949|P1|Base Study: Cycle 1|Non-compliance with Study Drug|0
803215|NCT02519842|2610947|P3|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
803216|NCT02519842|2610948|P2|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1
803217|NCT02519842|2610949|P1|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
803218|NCT02519842|2610947|P3|Base Study: Cycle 1|Adverse Event|0
803219|NCT02519842|2610948|P2|Base Study: Cycle 1|Adverse Event|0
803220|NCT02519842|2610949|P1|Base Study: Cycle 1|Adverse Event|1
803221|NCT02519842|2610947|P3|Base Study: Cycle 1|Screening Failure|0
803222|NCT02519842|2610948|P2|Base Study: Cycle 1|Screening Failure|1
803223|NCT02519842|2610949|P1|Base Study: Cycle 1|Screening Failure|1
803224|NCT02519712|2610968|P1|Overall Study|Accruals are donors|2
803225|NCT02519712|2610968|P1|Overall Study|Disease Progression|1
803226|NCT02519712|2610968|P1|Overall Study|Disease Relapse|1
803227|NCT02519595|2610975|P3|Overall Study|Protocol Violation|16
803228|NCT02519595|2610976|P2|Overall Study|Protocol Violation|22
803229|NCT02519595|2610977|P1|Overall Study|Protocol Violation|8
803230|NCT02518919|2611011|P3|Overall Study|Protocol Violation|2
803231|NCT02518919|2611012|P2|Overall Study|Protocol Violation|1
803232|NCT02518919|2611013|P1|Overall Study|Protocol Violation|1
803233|NCT02518048|2611033|P1|Overall Study|Withdrawal by Subject|1
803234|NCT02517541|2611060|P1|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2
803235|NCT02517541|2611060|P1|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4
803236|NCT02517541|2611060|P1|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1
803237|NCT02517541|2611060|P1|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2
803238|NCT02517541|2611060|P1|Test Period (SenSura Mio Convex Soft)|Adverse Event|3
803239|NCT02517541|2611060|P1|Baseline Period (Own Product)|Protocol Violation|1
803240|NCT02517528|2611066|P1|Overall Study|Withdrawal by Subject|1
803241|NCT02517515|2611076|P2|Overall Study|Not Specified|0
803242|NCT02517515|2611077|P1|Overall Study|Not Specified|1
803243|NCT02517515|2611076|P2|Overall Study|Lost to Follow-up|0
803244|NCT02517515|2611077|P1|Overall Study|Lost to Follow-up|1
803245|NCT02517515|2611076|P2|Overall Study|Withdrew Consent|1
803246|NCT02517515|2611077|P1|Overall Study|Withdrew Consent|0
803247|NCT02517515|2611076|P2|Overall Study|Adverse Event|1
803248|NCT02517515|2611077|P1|Overall Study|Adverse Event|0
803249|NCT02517463|2611094|P2|Overall Study|Lost to Follow-up|2
803250|NCT02517463|2611095|P1|Overall Study|Lost to Follow-up|5
803251|NCT02516410|2611141|P2|Overall Study|Withdrawal by Subject|1
803252|NCT02516410|2611142|P1|Overall Study|Withdrawal by Subject|0
803253|NCT02516410|2611141|P2|Overall Study|Adverse Event|1
803254|NCT02516410|2611142|P1|Overall Study|Adverse Event|0
803255|NCT02516306|2611171|P2|Period 2: Day 8 - 91|Protocol Violation|2
803256|NCT02516306|2611172|P1|Period 2: Day 8 - 91|Protocol Violation|1
803257|NCT02516202|2611181|P3|Overall Study|Stopped Follow-up|1
803258|NCT02516202|2611182|P2|Overall Study|Stopped Follow-up|0
803259|NCT02516202|2611183|P1|Overall Study|Stopped Follow-up|0
803260|NCT02516202|2611181|P3|Overall Study|Lost to Follow-up|1
803261|NCT02516202|2611182|P2|Overall Study|Lost to Follow-up|1
803262|NCT02516202|2611183|P1|Overall Study|Lost to Follow-up|1
803263|NCT02516202|2611181|P3|Overall Study|Withdrawal by Subject|1
803264|NCT02516202|2611182|P2|Overall Study|Withdrawal by Subject|0
803265|NCT02516202|2611183|P1|Overall Study|Withdrawal by Subject|1
803266|NCT02516163|2611209|P1|Overall Study|MRI contraindication exclusion|6
803267|NCT02516163|2611209|P1|Overall Study|Data not recorded|2
803268|NCT02516163|2611209|P1|Overall Study|Use of incorrect measurement technique|5
803269|NCT02516163|2611209|P1|Overall Study|Unfit/delay in surgery|3
803270|NCT02516163|2611209|P1|Overall Study|Failed MRI/incorrect MRI protocol|11
803271|NCT02516163|2611209|P1|Overall Study|Withdrawal by Subject|1
803272|NCT02516098|2611223|P2|Period 2|Withdrawal by Subject|1
803273|NCT02516098|2611224|P1|Period 2|Withdrawal by Subject|0
803274|NCT02516098|2611223|P2|Washout After Period 1|Adverse Event|1
803275|NCT02516098|2611224|P1|Washout After Period 1|Adverse Event|0
803276|NCT02516098|2611223|P2|Period 1|Protocol Violation|0
803277|NCT02516098|2611224|P1|Period 1|Protocol Violation|1
803278|NCT02515994|2611238|P2|Overall Study|Withdrawal by Subject|0
803279|NCT02515994|2611239|P1|Overall Study|Withdrawal by Subject|2
803280|NCT02515994|2611238|P2|Overall Study|Adverse Event|1
803281|NCT02515994|2611239|P1|Overall Study|Adverse Event|3
803282|NCT02515994|2611238|P2|Overall Study|No Longer Meets Eligibility Criteria|1
803283|NCT02515994|2611239|P1|Overall Study|No Longer Meets Eligibility Criteria|2
803284|NCT02515994|2611238|P2|Overall Study|Protocol Violation|5
803285|NCT02515994|2611239|P1|Overall Study|Protocol Violation|3
803286|NCT02515331|2611269|P3|Overall Study|Adverse Event|0
803287|NCT02515331|2611270|P2|Overall Study|Adverse Event|0
803288|NCT02515331|2611271|P1|Overall Study|Adverse Event|2
803289|NCT02515331|2611269|P3|Overall Study|Protocol deviation|3
803290|NCT02515331|2611270|P2|Overall Study|Protocol deviation|0
803291|NCT02515331|2611271|P1|Overall Study|Protocol deviation|0
803292|NCT02515331|2611269|P3|Overall Study|Withdrawal by Subject|1
803293|NCT02515331|2611270|P2|Overall Study|Withdrawal by Subject|0
803294|NCT02515331|2611271|P1|Overall Study|Withdrawal by Subject|0
803295|NCT02515279|2611292|P1|Overall Study|Other|22
803296|NCT02515279|2611292|P1|Overall Study|End-of-treatment visit not attended|17
803297|NCT02515279|2611292|P1|Overall Study|Withdrawal by Subject|18
803298|NCT02515279|2611292|P1|Overall Study|Lost to Follow-up|9
803299|NCT02515279|2611292|P1|Overall Study|Lack of Efficacy|31
803300|NCT02515279|2611292|P1|Overall Study|Adverse Event|7
803301|NCT02515045|2611311|P3|Overall Study|Lost to Follow-up|1
803302|NCT02515045|2611312|P2|Overall Study|Lost to Follow-up|1
803303|NCT02515045|2611313|P1|Overall Study|Lost to Follow-up|0
803304|NCT02515045|2611311|P3|Overall Study|Adverse Event|3
803305|NCT02515045|2611312|P2|Overall Study|Adverse Event|3
803306|NCT02515045|2611313|P1|Overall Study|Adverse Event|0
803307|NCT02514772|2611350|P2|Overall Study|Withdrawal by Subject|1
803308|NCT02514772|2611351|P1|Overall Study|Withdrawal by Subject|2
803309|NCT02514772|2611350|P2|Overall Study|Death|1
803310|NCT02514772|2611351|P1|Overall Study|Death|0
803311|NCT02514772|2611350|P2|Overall Study|Adverse Event|0
803312|NCT02514772|2611351|P1|Overall Study|Adverse Event|1
803313|NCT02514473|2611365|P2|Overall Study|Other|1
803314|NCT02514473|2611366|P1|Overall Study|Other|1
803315|NCT02514473|2611365|P2|Overall Study|Lost to Follow-up|1
803316|NCT02514473|2611366|P1|Overall Study|Lost to Follow-up|0
803317|NCT02514473|2611365|P2|Overall Study|Withdrawal by Subject|1
803318|NCT02514473|2611366|P1|Overall Study|Withdrawal by Subject|2
803319|NCT02514473|2611365|P2|Overall Study|Adverse Event|2
803320|NCT02514473|2611366|P1|Overall Study|Adverse Event|0
803321|NCT02514122|2611409|P2|Overall Study|Withdrawal by Subject|0
803322|NCT02514122|2611410|P1|Overall Study|Withdrawal by Subject|2
803323|NCT02513771|2611434|P2|Overall Study|Not being able to get to clinic|0
803324|NCT02513771|2611435|P1|Overall Study|Not being able to get to clinic|1
803325|NCT02513771|2611434|P2|Overall Study|Lost to Follow-up|1
803326|NCT02513771|2611435|P1|Overall Study|Lost to Follow-up|1
803327|NCT02513550|2611477|P6|Post-Treatment Follow-up Period|Labor Reasons|0
803328|NCT02513550|2611478|P5|Post-Treatment Follow-up Period|Labor Reasons|0
803329|NCT02513550|2611479|P4|Post-Treatment Follow-up Period|Labor Reasons|0
803330|NCT02513550|2611480|P3|Post-Treatment Follow-up Period|Labor Reasons|1
803331|NCT02513550|2611481|P2|Post-Treatment Follow-up Period|Labor Reasons|0
803332|NCT02513550|2611482|P1|Post-Treatment Follow-up Period|Labor Reasons|0
803333|NCT02513550|2611477|P6|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
803334|NCT02513550|2611478|P5|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
803335|NCT02513550|2611479|P4|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
803336|NCT02513550|2611480|P3|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3
803337|NCT02513550|2611481|P2|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
803338|NCT02513550|2611482|P1|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
803339|NCT02513550|2611477|P6|Post-Treatment Follow-up Period|Subject move out of town|0
803340|NCT02513550|2611478|P5|Post-Treatment Follow-up Period|Subject move out of town|0
803341|NCT02513550|2611479|P4|Post-Treatment Follow-up Period|Subject move out of town|0
803342|NCT02513550|2611480|P3|Post-Treatment Follow-up Period|Subject move out of town|1
803343|NCT02513550|2611481|P2|Post-Treatment Follow-up Period|Subject move out of town|0
803344|NCT02513550|2611482|P1|Post-Treatment Follow-up Period|Subject move out of town|0
803345|NCT02513550|2611477|P6|Post-Treatment Follow-up Period|Death|0
803346|NCT02513550|2611478|P5|Post-Treatment Follow-up Period|Death|0
803347|NCT02513550|2611479|P4|Post-Treatment Follow-up Period|Death|0
803348|NCT02513550|2611480|P3|Post-Treatment Follow-up Period|Death|1
803349|NCT02513550|2611481|P2|Post-Treatment Follow-up Period|Death|0
803350|NCT02513550|2611482|P1|Post-Treatment Follow-up Period|Death|0
803351|NCT02513550|2611477|P6|Post-Treatment Follow-up Period|Physician Decision|0
803352|NCT02513550|2611478|P5|Post-Treatment Follow-up Period|Physician Decision|0
803353|NCT02513550|2611479|P4|Post-Treatment Follow-up Period|Physician Decision|0
803354|NCT02513550|2611480|P3|Post-Treatment Follow-up Period|Physician Decision|0
803355|NCT02513550|2611481|P2|Post-Treatment Follow-up Period|Physician Decision|0
803356|NCT02513550|2611482|P1|Post-Treatment Follow-up Period|Physician Decision|2
803357|NCT02513550|2611477|P6|Post-Treatment Follow-up Period|Adverse Event|0
803358|NCT02513550|2611478|P5|Post-Treatment Follow-up Period|Adverse Event|0
803359|NCT02513550|2611479|P4|Post-Treatment Follow-up Period|Adverse Event|0
803360|NCT02513550|2611480|P3|Post-Treatment Follow-up Period|Adverse Event|4
803361|NCT02513550|2611481|P2|Post-Treatment Follow-up Period|Adverse Event|1
803362|NCT02513550|2611482|P1|Post-Treatment Follow-up Period|Adverse Event|1
803363|NCT02513550|2611477|P6|Post-Treatment Follow-up Period|Lost to Follow-up|0
803364|NCT02513550|2611478|P5|Post-Treatment Follow-up Period|Lost to Follow-up|0
803365|NCT02513550|2611479|P4|Post-Treatment Follow-up Period|Lost to Follow-up|0
803366|NCT02513550|2611480|P3|Post-Treatment Follow-up Period|Lost to Follow-up|7
803367|NCT02513550|2611481|P2|Post-Treatment Follow-up Period|Lost to Follow-up|2
803368|NCT02513550|2611482|P1|Post-Treatment Follow-up Period|Lost to Follow-up|4
803369|NCT02513550|2611477|P6|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
803370|NCT02513550|2611478|P5|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
803371|NCT02513550|2611479|P4|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
803372|NCT02513550|2611480|P3|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20
803373|NCT02513550|2611481|P2|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16
803374|NCT02513550|2611482|P1|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12
803375|NCT02513550|2611477|P6|Post-Treatment Follow-up Period|Withdrawal by Subject|0
803376|NCT02513550|2611478|P5|Post-Treatment Follow-up Period|Withdrawal by Subject|0
803377|NCT02513550|2611479|P4|Post-Treatment Follow-up Period|Withdrawal by Subject|0
803378|NCT02513550|2611480|P3|Post-Treatment Follow-up Period|Withdrawal by Subject|26
803379|NCT02513550|2611481|P2|Post-Treatment Follow-up Period|Withdrawal by Subject|20
803380|NCT02513550|2611482|P1|Post-Treatment Follow-up Period|Withdrawal by Subject|12
803381|NCT02513550|2611477|P6|Double Blind Treatment Period|Death|0
803382|NCT02513550|2611478|P5|Double Blind Treatment Period|Death|0
803383|NCT02513550|2611479|P4|Double Blind Treatment Period|Death|0
803384|NCT02513550|2611480|P3|Double Blind Treatment Period|Death|2
803385|NCT02513550|2611481|P2|Double Blind Treatment Period|Death|0
803386|NCT02513550|2611482|P1|Double Blind Treatment Period|Death|1
803387|NCT02513550|2611477|P6|Double Blind Treatment Period|Due to personal business|0
803388|NCT02513550|2611478|P5|Double Blind Treatment Period|Due to personal business|0
803389|NCT02513550|2611479|P4|Double Blind Treatment Period|Due to personal business|0
803390|NCT02513550|2611480|P3|Double Blind Treatment Period|Due to personal business|1
803391|NCT02513550|2611481|P2|Double Blind Treatment Period|Due to personal business|0
803392|NCT02513550|2611482|P1|Double Blind Treatment Period|Due to personal business|2
803393|NCT02513550|2611477|P6|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
803394|NCT02513550|2611478|P5|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
803395|NCT02513550|2611479|P4|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
803396|NCT02513550|2611480|P3|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1
803397|NCT02513550|2611481|P2|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
803398|NCT02513550|2611482|P1|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
803399|NCT02513550|2611477|P6|Double Blind Treatment Period|Site terminated by sponsor|0
803400|NCT02513550|2611478|P5|Double Blind Treatment Period|Site terminated by sponsor|0
803401|NCT02513550|2611479|P4|Double Blind Treatment Period|Site terminated by sponsor|0
803402|NCT02513550|2611480|P3|Double Blind Treatment Period|Site terminated by sponsor|3
803403|NCT02513550|2611481|P2|Double Blind Treatment Period|Site terminated by sponsor|1
803404|NCT02513550|2611482|P1|Double Blind Treatment Period|Site terminated by sponsor|1
803405|NCT02513550|2611477|P6|Double Blind Treatment Period|Physician Decision|0
803406|NCT02513550|2611478|P5|Double Blind Treatment Period|Physician Decision|0
803407|NCT02513550|2611479|P4|Double Blind Treatment Period|Physician Decision|0
803408|NCT02513550|2611480|P3|Double Blind Treatment Period|Physician Decision|4
803409|NCT02513550|2611481|P2|Double Blind Treatment Period|Physician Decision|0
803410|NCT02513550|2611482|P1|Double Blind Treatment Period|Physician Decision|2
803411|NCT02513550|2611477|P6|Double Blind Treatment Period|Protocol Violation|0
803412|NCT02513550|2611478|P5|Double Blind Treatment Period|Protocol Violation|0
803413|NCT02513550|2611479|P4|Double Blind Treatment Period|Protocol Violation|0
803414|NCT02513550|2611480|P3|Double Blind Treatment Period|Protocol Violation|4
803415|NCT02513550|2611481|P2|Double Blind Treatment Period|Protocol Violation|1
803416|NCT02513550|2611482|P1|Double Blind Treatment Period|Protocol Violation|1
803417|NCT02513550|2611477|P6|Double Blind Treatment Period|Lack of Efficacy|0
803418|NCT02513550|2611478|P5|Double Blind Treatment Period|Lack of Efficacy|0
803419|NCT02513550|2611479|P4|Double Blind Treatment Period|Lack of Efficacy|0
803420|NCT02513550|2611480|P3|Double Blind Treatment Period|Lack of Efficacy|6
803421|NCT02513550|2611481|P2|Double Blind Treatment Period|Lack of Efficacy|5
803422|NCT02513550|2611482|P1|Double Blind Treatment Period|Lack of Efficacy|4
803423|NCT02513550|2611477|P6|Double Blind Treatment Period|Lost to Follow-up|1
803424|NCT02513550|2611478|P5|Double Blind Treatment Period|Lost to Follow-up|0
803425|NCT02513550|2611479|P4|Double Blind Treatment Period|Lost to Follow-up|0
803426|NCT02513550|2611480|P3|Double Blind Treatment Period|Lost to Follow-up|11
803427|NCT02513550|2611481|P2|Double Blind Treatment Period|Lost to Follow-up|7
803428|NCT02513550|2611482|P1|Double Blind Treatment Period|Lost to Follow-up|9
803429|NCT02513550|2611477|P6|Double Blind Treatment Period|Adverse Event|0
803430|NCT02513550|2611478|P5|Double Blind Treatment Period|Adverse Event|1
803431|NCT02513550|2611479|P4|Double Blind Treatment Period|Adverse Event|0
803432|NCT02513550|2611480|P3|Double Blind Treatment Period|Adverse Event|17
803433|NCT02513550|2611481|P2|Double Blind Treatment Period|Adverse Event|13
803434|NCT02513550|2611482|P1|Double Blind Treatment Period|Adverse Event|5
803435|NCT02513550|2611477|P6|Double Blind Treatment Period|Withdrawal by Subject|0
803436|NCT02513550|2611478|P5|Double Blind Treatment Period|Withdrawal by Subject|0
803437|NCT02513550|2611479|P4|Double Blind Treatment Period|Withdrawal by Subject|0
803438|NCT02513550|2611480|P3|Double Blind Treatment Period|Withdrawal by Subject|25
803439|NCT02513550|2611481|P2|Double Blind Treatment Period|Withdrawal by Subject|11
803440|NCT02513550|2611482|P1|Double Blind Treatment Period|Withdrawal by Subject|11
803441|NCT02513160|2611558|P4|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
803442|NCT02513160|2611559|P3|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
803443|NCT02513160|2611560|P2|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1
803444|NCT02513160|2611561|P1|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
803445|NCT02513160|2611558|P4|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
803446|NCT02513160|2611559|P3|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
803447|NCT02513160|2611560|P2|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
803448|NCT02513160|2611561|P1|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1
803449|NCT02513160|2611558|P4|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
803450|NCT02513160|2611559|P3|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
803451|NCT02513160|2611560|P2|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
803452|NCT02513160|2611561|P1|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2
803453|NCT02513160|2611558|P4|Treatment Period (Day 0 to Week 6)|Noncompliance|0
803454|NCT02513160|2611559|P3|Treatment Period (Day 0 to Week 6)|Noncompliance|0
803455|NCT02513160|2611560|P2|Treatment Period (Day 0 to Week 6)|Noncompliance|0
803456|NCT02513160|2611561|P1|Treatment Period (Day 0 to Week 6)|Noncompliance|1
803457|NCT02513160|2611558|P4|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1
803458|NCT02513160|2611559|P3|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0
803459|NCT02513160|2611560|P2|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
803460|NCT02513160|2611561|P1|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
803461|NCT02513160|2611558|P4|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
803462|NCT02513160|2611559|P3|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
803463|NCT02513160|2611560|P2|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
803464|NCT02513160|2611561|P1|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10
803465|NCT02513160|2611558|P4|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
803466|NCT02513160|2611559|P3|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
803467|NCT02513160|2611560|P2|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
803468|NCT02513160|2611561|P1|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1
803469|NCT02513160|2611558|P4|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
803470|NCT02513160|2611559|P3|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
803471|NCT02513160|2611560|P2|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
803472|NCT02513160|2611561|P1|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20
803473|NCT02513160|2611558|P4|Run-In Period (Days -14 to Day -1)|Adverse Event|0
803474|NCT02513160|2611559|P3|Run-In Period (Days -14 to Day -1)|Adverse Event|0
803475|NCT02513160|2611560|P2|Run-In Period (Days -14 to Day -1)|Adverse Event|0
803476|NCT02513160|2611561|P1|Run-In Period (Days -14 to Day -1)|Adverse Event|4
803477|NCT02513160|2611558|P4|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
803478|NCT02513160|2611559|P3|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
803479|NCT02513160|2611560|P2|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
803480|NCT02513160|2611561|P1|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6
803481|NCT02513160|2611558|P4|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
803482|NCT02513160|2611559|P3|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
803483|NCT02513160|2611560|P2|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
803484|NCT02513160|2611561|P1|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214
803485|NCT02513160|2611558|P4|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
803486|NCT02513160|2611559|P3|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
803487|NCT02513160|2611560|P2|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
803488|NCT02513160|2611561|P1|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33
803489|NCT02513095|2611598|P2|Overall Study|Stampede resulted in transfers out of ER|16
803490|NCT02513095|2611599|P1|Overall Study|Stampede resulted in transfers out of ER|14
803491|NCT02512861|2611645|P2|Overall Study|Withdrawal by Subject|1
803492|NCT02512861|2611646|P1|Overall Study|Withdrawal by Subject|0
803493|NCT02512861|2611645|P2|Overall Study|Physician Decision|1
803494|NCT02512861|2611646|P1|Overall Study|Physician Decision|3
803495|NCT02512861|2611645|P2|Overall Study|Protocol Violation|7
803496|NCT02512861|2611646|P1|Overall Study|Protocol Violation|3
803497|NCT02512302|2611878|P10|Period 4|Adverse Event|0
803498|NCT02512302|2611879|P9|Period 4|Adverse Event|0
803499|NCT02512302|2611880|P8|Period 4|Adverse Event|0
803500|NCT02512302|2611881|P7|Period 4|Adverse Event|1
803501|NCT02512302|2611882|P6|Period 4|Adverse Event|0
803502|NCT02512302|2611883|P5|Period 4|Adverse Event|0
803503|NCT02512302|2611884|P4|Period 4|Adverse Event|0
803504|NCT02512302|2611885|P3|Period 4|Adverse Event|0
803505|NCT02512302|2611886|P2|Period 4|Adverse Event|0
803506|NCT02512302|2611887|P1|Period 4|Adverse Event|0
803507|NCT02512302|2611878|P10|Period 3|Lost to Follow-up|0
803508|NCT02512302|2611879|P9|Period 3|Lost to Follow-up|0
803509|NCT02512302|2611880|P8|Period 3|Lost to Follow-up|0
803510|NCT02512302|2611881|P7|Period 3|Lost to Follow-up|0
803511|NCT02512302|2611882|P6|Period 3|Lost to Follow-up|0
803512|NCT02512302|2611883|P5|Period 3|Lost to Follow-up|0
803513|NCT02512302|2611884|P4|Period 3|Lost to Follow-up|0
803514|NCT02512302|2611885|P3|Period 3|Lost to Follow-up|1
803515|NCT02512302|2611886|P2|Period 3|Lost to Follow-up|0
803516|NCT02512302|2611887|P1|Period 3|Lost to Follow-up|0
803517|NCT02512302|2611878|P10|Period 2|Adverse Event|1
803518|NCT02512302|2611879|P9|Period 2|Adverse Event|0
803519|NCT02512302|2611880|P8|Period 2|Adverse Event|0
803520|NCT02512302|2611881|P7|Period 2|Adverse Event|0
803521|NCT02512302|2611882|P6|Period 2|Adverse Event|0
803522|NCT02512302|2611883|P5|Period 2|Adverse Event|0
803523|NCT02512302|2611884|P4|Period 2|Adverse Event|0
803524|NCT02512302|2611885|P3|Period 2|Adverse Event|0
803525|NCT02512302|2611886|P2|Period 2|Adverse Event|0
803526|NCT02512302|2611887|P1|Period 2|Adverse Event|0
803527|NCT02512302|2611878|P10|Period 1|Adverse Event|0
803528|NCT02512302|2611879|P9|Period 1|Adverse Event|0
803529|NCT02512302|2611880|P8|Period 1|Adverse Event|0
803530|NCT02512302|2611881|P7|Period 1|Adverse Event|0
803531|NCT02512302|2611882|P6|Period 1|Adverse Event|0
803532|NCT02512302|2611883|P5|Period 1|Adverse Event|0
803533|NCT02512302|2611884|P4|Period 1|Adverse Event|0
803534|NCT02512302|2611885|P3|Period 1|Adverse Event|0
803535|NCT02512302|2611886|P2|Period 1|Adverse Event|1
803536|NCT02512302|2611887|P1|Period 1|Adverse Event|0
803537|NCT02511782|2611985|P3|Overall Study|Withdrawal by Subject|0
803538|NCT02511782|2611986|P2|Overall Study|Withdrawal by Subject|0
803539|NCT02511782|2611987|P1|Overall Study|Withdrawal by Subject|1
803540|NCT02511431|2612016|P6|Treatment|Lost to Follow-up|1
803541|NCT02511431|2612017|P5|Treatment|Lost to Follow-up|0
803542|NCT02511431|2612018|P4|Treatment|Lost to Follow-up|0
803543|NCT02511431|2612019|P3|Treatment|Lost to Follow-up|1
803544|NCT02511431|2612020|P2|Treatment|Lost to Follow-up|0
803545|NCT02511431|2612021|P1|Treatment|Lost to Follow-up|0
803546|NCT02510820|2612046|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
803547|NCT02510820|2612047|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
803548|NCT02510820|2612046|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
803549|NCT02510820|2612047|P1|First Intervention (4 Weeks)|Withdrawal by Subject|0
803550|NCT02510014|2612087|P2|Treatment Period|Incarceration, pregnancy, misc|5
803551|NCT02510014|2612088|P1|Treatment Period|Incarceration, pregnancy, misc|29
803552|NCT02510014|2612087|P2|Treatment Period|Protocol Violation|4
803553|NCT02510014|2612088|P1|Treatment Period|Protocol Violation|4
803554|NCT02510014|2612087|P2|Treatment Period|Withdrawn by the investigator|1
803555|NCT02510014|2612088|P1|Treatment Period|Withdrawn by the investigator|7
803556|NCT02510014|2612087|P2|Treatment Period|Withdrawal by Subject|24
803557|NCT02510014|2612088|P1|Treatment Period|Withdrawal by Subject|67
803558|NCT02510014|2612087|P2|Treatment Period|Physician Decision|0
803559|NCT02510014|2612088|P1|Treatment Period|Physician Decision|5
803560|NCT02510014|2612087|P2|Treatment Period|Lost to Follow-up|19
803561|NCT02510014|2612088|P1|Treatment Period|Lost to Follow-up|80
803562|NCT02510014|2612087|P2|Treatment Period|Withdrawal symptoms|0
803563|NCT02510014|2612088|P1|Treatment Period|Withdrawal symptoms|3
803564|NCT02510014|2612087|P2|Treatment Period|Adverse Event|4
803565|NCT02510014|2612088|P1|Treatment Period|Adverse Event|11
803566|NCT02510014|2612087|P2|Run-In Period (Days -14 to Day -1)|Not specified|1
803567|NCT02510014|2612088|P1|Run-In Period (Days -14 to Day -1)|Not specified|19
803568|NCT02510014|2612087|P2|Run-In Period (Days -14 to Day -1)|Protocol Violation|0
803569|NCT02510014|2612088|P1|Run-In Period (Days -14 to Day -1)|Protocol Violation|2
803570|NCT02510014|2612087|P2|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1
803571|NCT02510014|2612088|P1|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7
803572|NCT02510014|2612087|P2|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3
803573|NCT02510014|2612088|P1|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22
803574|NCT02510014|2612087|P2|Run-In Period (Days -14 to Day -1)|Physician Decision|1
803575|NCT02510014|2612088|P1|Run-In Period (Days -14 to Day -1)|Physician Decision|0
803576|NCT02510014|2612087|P2|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3
803577|NCT02510014|2612088|P1|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44
803578|NCT02510014|2612087|P2|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0
803579|NCT02510014|2612088|P1|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1
803580|NCT02510014|2612087|P2|Run-In Period (Days -14 to Day -1)|Adverse Event|1
803581|NCT02510014|2612088|P1|Run-In Period (Days -14 to Day -1)|Adverse Event|1
803582|NCT02509117|2612118|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1
803583|NCT02509117|2612119|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
803584|NCT02509117|2612120|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
803585|NCT02509117|2612121|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
803586|NCT02509117|2612122|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
803587|NCT02509117|2612123|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
803588|NCT02509117|2612124|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
803589|NCT02509117|2612125|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
803590|NCT02509117|2612126|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
803591|NCT02509117|2612127|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
803592|NCT02509117|2612118|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1
803593|NCT02509117|2612119|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
803594|NCT02509117|2612120|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
803595|NCT02509117|2612121|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
803596|NCT02509117|2612122|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
803597|NCT02509117|2612123|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
803598|NCT02509117|2612124|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
803599|NCT02509117|2612125|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
803600|NCT02509117|2612126|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
803601|NCT02509117|2612127|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
803602|NCT02509117|2612118|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
803603|NCT02509117|2612119|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
803604|NCT02509117|2612120|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
803605|NCT02509117|2612121|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
803606|NCT02509117|2612122|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
803607|NCT02509117|2612123|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
803608|NCT02509117|2612124|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
803609|NCT02509117|2612125|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
803610|NCT02509117|2612126|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1
803611|NCT02509117|2612127|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
803612|NCT02508701|2612447|P4|Overall Study|Lost to Follow-up|3
803613|NCT02508701|2612448|P3|Overall Study|Lost to Follow-up|5
803614|NCT02508701|2612449|P2|Overall Study|Lost to Follow-up|5
803615|NCT02508701|2612450|P1|Overall Study|Lost to Follow-up|9
803616|NCT02508194|2612491|P2|Overall Study|Principal Investigator Decision|2
803617|NCT02508194|2612492|P1|Overall Study|Principal Investigator Decision|1
803618|NCT02508194|2612491|P2|Overall Study|Error in Randomization|3
803619|NCT02508194|2612492|P1|Overall Study|Error in Randomization|1
803620|NCT02508194|2612491|P2|Overall Study|Withdrawal by Subject|18
803621|NCT02508194|2612492|P1|Overall Study|Withdrawal by Subject|20
803622|NCT02508194|2612491|P2|Overall Study|Lost to Follow-up|18
803623|NCT02508194|2612492|P1|Overall Study|Lost to Follow-up|25
803624|NCT02508194|2612491|P2|Overall Study|Death|3
803625|NCT02508194|2612492|P1|Overall Study|Death|5
803626|NCT02508116|2612532|P2|Overall Study|Physician Decision|0
803627|NCT02508116|2612533|P1|Overall Study|Physician Decision|2
803628|NCT02508116|2612532|P2|Overall Study|Protocol Violation|2
803629|NCT02508116|2612533|P1|Overall Study|Protocol Violation|1
803630|NCT02508116|2612532|P2|Overall Study|Withdrawal by Subject|2
803631|NCT02508116|2612533|P1|Overall Study|Withdrawal by Subject|3
803632|NCT02508116|2612532|P2|Overall Study|Lost to Follow-up|3
803633|NCT02508116|2612533|P1|Overall Study|Lost to Follow-up|2
803634|NCT02507752|2612560|P1|Overall Study|Participant didn't perform visit Week 24|1
803635|NCT02507752|2612560|P1|Overall Study|Participant didn't perform visit Week 12|1
803636|NCT02507752|2612560|P1|Overall Study|Infusion reaction at first infusion|1
803637|NCT02507752|2612560|P1|Overall Study|Lost to Follow-up|7
803638|NCT02507752|2612560|P1|Overall Study|Protocol Violation|6
803639|NCT02507752|2612560|P1|Overall Study|Adverse Event|1
803640|NCT02507375|2612604|P2|Overall Study|Adverse Event|1
803641|NCT02507375|2612605|P1|Overall Study|Adverse Event|0
803642|NCT02507375|2612604|P2|Overall Study|Refused treatment|1
803643|NCT02507375|2612605|P1|Overall Study|Refused treatment|0
803644|NCT02507375|2612604|P2|Overall Study|Death|1
803645|NCT02507375|2612605|P1|Overall Study|Death|0
803646|NCT02507375|2612604|P2|Overall Study|Progressive Disease|5
803647|NCT02507375|2612605|P1|Overall Study|Progressive Disease|4
803648|NCT02507219|2612622|P6|Overall Study|Withdrawal by Subject|0
803649|NCT02507219|2612623|P5|Overall Study|Withdrawal by Subject|1
803650|NCT02507219|2612624|P4|Overall Study|Withdrawal by Subject|0
803651|NCT02507219|2612625|P3|Overall Study|Withdrawal by Subject|0
803652|NCT02507219|2612626|P2|Overall Study|Withdrawal by Subject|0
803653|NCT02507219|2612627|P1|Overall Study|Withdrawal by Subject|0
803654|NCT02507219|2612622|P6|Overall Study|Physician Decision|0
803655|NCT02507219|2612623|P5|Overall Study|Physician Decision|0
803656|NCT02507219|2612624|P4|Overall Study|Physician Decision|0
803657|NCT02507219|2612625|P3|Overall Study|Physician Decision|0
803658|NCT02507219|2612626|P2|Overall Study|Physician Decision|0
803659|NCT02507219|2612627|P1|Overall Study|Physician Decision|1
803660|NCT02506881|2612656|P4|First Intervention (Day 1)|Violation of blood storage conditions|12
803661|NCT02506881|2612657|P3|First Intervention (Day 1)|Violation of blood storage conditions|12
803662|NCT02506881|2612658|P2|First Intervention (Day 1)|Violation of blood storage conditions|0
803663|NCT02506881|2612659|P1|First Intervention (Day 1)|Violation of blood storage conditions|0
803664|NCT02506881|2612656|P4|First Intervention (Day 1)|Withdrawal by Subject|0
803665|NCT02506881|2612657|P3|First Intervention (Day 1)|Withdrawal by Subject|0
803666|NCT02506881|2612658|P2|First Intervention (Day 1)|Withdrawal by Subject|0
803667|NCT02506881|2612659|P1|First Intervention (Day 1)|Withdrawal by Subject|1
803668|NCT02506881|2612656|P4|First Intervention (Day 1)|Protocol Violation|0
803669|NCT02506881|2612657|P3|First Intervention (Day 1)|Protocol Violation|1
803670|NCT02506881|2612658|P2|First Intervention (Day 1)|Protocol Violation|0
803671|NCT02506881|2612659|P1|First Intervention (Day 1)|Protocol Violation|0
803672|NCT02506257|2612733|P4|Overall Study|Protocol Violation|0
803673|NCT02506257|2612734|P3|Overall Study|Protocol Violation|1
803674|NCT02506257|2612735|P2|Overall Study|Protocol Violation|0
803675|NCT02506257|2612736|P1|Overall Study|Protocol Violation|0
803676|NCT02506257|2612733|P4|Overall Study|Adverse Event|0
803677|NCT02506257|2612734|P3|Overall Study|Adverse Event|3
803678|NCT02506257|2612735|P2|Overall Study|Adverse Event|2
803679|NCT02506257|2612736|P1|Overall Study|Adverse Event|0
803680|NCT02506101|2612768|P2|Overall Study|No enrollment and staff unavailability|0
803681|NCT02506101|2612769|P1|Overall Study|No enrollment and staff unavailability|1
803682|NCT02506101|2612768|P2|Overall Study|Transportation issues|0
803683|NCT02506101|2612769|P1|Overall Study|Transportation issues|1
803684|NCT02505334|2612785|P2|Extension Treatment Period|Unclassified|0
803685|NCT02505334|2612786|P1|Extension Treatment Period|Unclassified|3
803686|NCT02505334|2612785|P2|Extension Treatment Period|Withdrawal by Subject|0
803687|NCT02505334|2612786|P1|Extension Treatment Period|Withdrawal by Subject|6
803688|NCT02505334|2612785|P2|Extension Treatment Period|Lack of Efficacy|0
803689|NCT02505334|2612786|P1|Extension Treatment Period|Lack of Efficacy|4
803690|NCT02505334|2612785|P2|Extension Treatment Period|Adverse Event|0
803691|NCT02505334|2612786|P1|Extension Treatment Period|Adverse Event|5
803692|NCT02505334|2612785|P2|Main Treatment Period|Unclassified|10
803693|NCT02505334|2612786|P1|Main Treatment Period|Unclassified|4
803694|NCT02505334|2612785|P2|Main Treatment Period|Withdrawal by Subject|8
803695|NCT02505334|2612786|P1|Main Treatment Period|Withdrawal by Subject|1
803696|NCT02505334|2612785|P2|Main Treatment Period|Protocol Violation|1
803697|NCT02505334|2612786|P1|Main Treatment Period|Protocol Violation|0
803698|NCT02505334|2612785|P2|Main Treatment Period|Lack of Efficacy|17
803699|NCT02505334|2612786|P1|Main Treatment Period|Lack of Efficacy|7
803700|NCT02505334|2612785|P2|Main Treatment Period|Adverse Event|3
803701|NCT02505334|2612786|P1|Main Treatment Period|Adverse Event|3
803702|NCT02504827|2612922|P1|Overall Study|Could not produce sputum|1
803703|NCT02504541|2612955|P1|Overall Study|Multiple|5
803704|NCT02504541|2612955|P1|Overall Study|Other|2
803705|NCT02504541|2612955|P1|Overall Study|Termination by Sponsor|1
803706|NCT02504541|2612955|P1|Overall Study|Protocol Violation|2
803707|NCT02504541|2612955|P1|Overall Study|Met Stopping Criteria|1
803708|NCT02504541|2612955|P1|Overall Study|Lost to Follow-up|1
803709|NCT02504541|2612955|P1|Overall Study|Withdrawal by Subject|4
803710|NCT02504541|2612955|P1|Overall Study|Adverse Event|4
803711|NCT02504502|2612961|P2|Crossover to Enhanced Report|Lost to Follow-up|0
803712|NCT02504502|2612962|P1|Crossover to Enhanced Report|Lost to Follow-up|5
803713|NCT02504502|2612961|P2|Routine Care vs. Enhanced Report|Lost to Follow-up|7
803714|NCT02504502|2612962|P1|Routine Care vs. Enhanced Report|Lost to Follow-up|4
803715|NCT02504424|2612968|P1|Overall Study|Withdrawal by Subject|2
803716|NCT02504320|2612977|P4|Treatment Period 3|Adverse Event|0
803717|NCT02504320|2612978|P3|Treatment Period 3|Adverse Event|1
803718|NCT02504320|2612979|P2|Treatment Period 3|Adverse Event|0
803719|NCT02504320|2612980|P1|Treatment Period 3|Adverse Event|0
803720|NCT02504320|2612977|P4|Treatment Period 3|Positive Drug Screen|1
803721|NCT02504320|2612978|P3|Treatment Period 3|Positive Drug Screen|0
803722|NCT02504320|2612979|P2|Treatment Period 3|Positive Drug Screen|0
803723|NCT02504320|2612980|P1|Treatment Period 3|Positive Drug Screen|0
803724|NCT02504320|2612977|P4|Treatment Period 2|Positive Drug Screen|0
803725|NCT02504320|2612978|P3|Treatment Period 2|Positive Drug Screen|0
803726|NCT02504320|2612979|P2|Treatment Period 2|Positive Drug Screen|1
803727|NCT02504320|2612980|P1|Treatment Period 2|Positive Drug Screen|0
803728|NCT02504320|2612977|P4|Treatment Period 1|Positive Drug Screen|0
803729|NCT02504320|2612978|P3|Treatment Period 1|Positive Drug Screen|1
803730|NCT02504320|2612979|P2|Treatment Period 1|Positive Drug Screen|0
803731|NCT02504320|2612980|P1|Treatment Period 1|Positive Drug Screen|0
803732|NCT02504294|2613000|P2|Overall Study|Lost to Follow-up|7
803733|NCT02504294|2613001|P1|Overall Study|Lost to Follow-up|6
803734|NCT02504294|2613000|P2|Overall Study|Physician Decision|2
803735|NCT02504294|2613001|P1|Overall Study|Physician Decision|1
803736|NCT02504294|2613000|P2|Overall Study|Protocol Violation|26
803737|NCT02504294|2613001|P1|Overall Study|Protocol Violation|27
803738|NCT02504294|2613000|P2|Overall Study|Withdrawal by Subject|1
803739|NCT02504294|2613001|P1|Overall Study|Withdrawal by Subject|7
803740|NCT02504294|2613000|P2|Overall Study|Adverse Event|12
803741|NCT02504294|2613001|P1|Overall Study|Adverse Event|15
803742|NCT02503865|2613030|P3|Overall Study|Refused treatment|2
803743|NCT02503865|2613031|P2|Overall Study|Refused treatment|39
803744|NCT02503865|2613032|P1|Overall Study|Refused treatment|4
803745|NCT02503865|2613030|P3|Overall Study|Moved out of area|0
803746|NCT02503865|2613031|P2|Overall Study|Moved out of area|8
803747|NCT02503865|2613032|P1|Overall Study|Moved out of area|1
803748|NCT02503787|2613052|P1|Implant to 3 Month Endpoint|Withdrawal by Subject|1
803749|NCT02503787|2613052|P1|Implant to 3 Month Endpoint|Adverse Event|2
803750|NCT02503787|2613052|P1|Successful Trial (≥50% Pain Relief)|Physician Decision|2
803751|NCT02503787|2613052|P1|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3
803752|NCT02503787|2613052|P1|Device Trial (HD Programming Trial)|Withdrawal by Subject|1
803753|NCT02503787|2613052|P1|Device Trial (HD Programming Trial)|Lack of Efficacy|6
803754|NCT02503787|2613052|P1|Enrollment|Unable to be programmed|1
803755|NCT02503787|2613052|P1|Enrollment|Inability to implant system|1
803756|NCT02503787|2613052|P1|Enrollment|Protocol Violation|1
803757|NCT02503787|2613052|P1|Enrollment|Adverse Event|1
803758|NCT02503787|2613052|P1|Enrollment|Study closure|1
803759|NCT02503787|2613052|P1|Enrollment|Lost to Follow-up|1
803760|NCT02503787|2613052|P1|Enrollment|Insurance issue|2
803761|NCT02503787|2613052|P1|Enrollment|Physician Decision|2
803762|NCT02503787|2613052|P1|Enrollment|Inclusion/exclusion criteria not met|4
803763|NCT02503787|2613052|P1|Enrollment|Withdrawal by Subject|6
803764|NCT02503215|2613075|P1|Overall Study|Unable to use positive airway pressure|2
803765|NCT02503215|2613075|P1|Overall Study|Unable to wear compression stockings|1
803766|NCT02503202|2613086|P5|Extension: Month 6 to 24|Withdrawal by Subject|0
803767|NCT02503202|2613087|P4|Extension: Month 6 to 24|Withdrawal by Subject|4
803768|NCT02503202|2613088|P3|Extension: Month 6 to 24|Withdrawal by Subject|2
803769|NCT02503202|2613089|P2|Extension: Month 6 to 24|Withdrawal by Subject|8
803770|NCT02503202|2613090|P1|Extension: Month 6 to 24|Withdrawal by Subject|5
803771|NCT02503202|2613086|P5|Extension: Month 6 to 24|Physician Decision|0
803772|NCT02503202|2613087|P4|Extension: Month 6 to 24|Physician Decision|3
803773|NCT02503202|2613088|P3|Extension: Month 6 to 24|Physician Decision|1
803774|NCT02503202|2613089|P2|Extension: Month 6 to 24|Physician Decision|0
803775|NCT02503202|2613090|P1|Extension: Month 6 to 24|Physician Decision|1
803776|NCT02503202|2613086|P5|Extension: Month 6 to 24|Lost to Follow-up|1
803777|NCT02503202|2613087|P4|Extension: Month 6 to 24|Lost to Follow-up|10
803778|NCT02503202|2613088|P3|Extension: Month 6 to 24|Lost to Follow-up|6
803779|NCT02503202|2613089|P2|Extension: Month 6 to 24|Lost to Follow-up|8
803780|NCT02503202|2613090|P1|Extension: Month 6 to 24|Lost to Follow-up|4
803781|NCT02503202|2613086|P5|Extension: Month 6 to 24|Death|0
803782|NCT02503202|2613087|P4|Extension: Month 6 to 24|Death|0
803783|NCT02503202|2613088|P3|Extension: Month 6 to 24|Death|0
803784|NCT02503202|2613089|P2|Extension: Month 6 to 24|Death|0
803785|NCT02503202|2613090|P1|Extension: Month 6 to 24|Death|1
803786|NCT02503202|2613086|P5|Extension: Month 6 to 24|Protocol Violation|0
803787|NCT02503202|2613087|P4|Extension: Month 6 to 24|Protocol Violation|1
803788|NCT02503202|2613088|P3|Extension: Month 6 to 24|Protocol Violation|0
803789|NCT02503202|2613089|P2|Extension: Month 6 to 24|Protocol Violation|0
803790|NCT02503202|2613090|P1|Extension: Month 6 to 24|Protocol Violation|0
803791|NCT02503202|2613086|P5|Base Study: Up to Month 6|Randomized not vaccinated|0
803792|NCT02503202|2613087|P4|Base Study: Up to Month 6|Randomized not vaccinated|2
803793|NCT02503202|2613088|P3|Base Study: Up to Month 6|Randomized not vaccinated|1
803794|NCT02503202|2613089|P2|Base Study: Up to Month 6|Randomized not vaccinated|0
803795|NCT02503202|2613090|P1|Base Study: Up to Month 6|Randomized not vaccinated|0
803796|NCT02503202|2613086|P5|Base Study: Up to Month 6|Withdrawal by Subject|1
803797|NCT02503202|2613087|P4|Base Study: Up to Month 6|Withdrawal by Subject|4
803798|NCT02503202|2613088|P3|Base Study: Up to Month 6|Withdrawal by Subject|4
803799|NCT02503202|2613089|P2|Base Study: Up to Month 6|Withdrawal by Subject|3
803800|NCT02503202|2613090|P1|Base Study: Up to Month 6|Withdrawal by Subject|6
803801|NCT02503202|2613086|P5|Base Study: Up to Month 6|Physician Decision|1
803802|NCT02503202|2613087|P4|Base Study: Up to Month 6|Physician Decision|0
803803|NCT02503202|2613088|P3|Base Study: Up to Month 6|Physician Decision|0
803804|NCT02503202|2613089|P2|Base Study: Up to Month 6|Physician Decision|0
803805|NCT02503202|2613090|P1|Base Study: Up to Month 6|Physician Decision|0
803806|NCT02503202|2613086|P5|Base Study: Up to Month 6|Lost to Follow-up|1
803807|NCT02503202|2613087|P4|Base Study: Up to Month 6|Lost to Follow-up|5
803808|NCT02503202|2613088|P3|Base Study: Up to Month 6|Lost to Follow-up|10
803809|NCT02503202|2613089|P2|Base Study: Up to Month 6|Lost to Follow-up|8
803810|NCT02503202|2613090|P1|Base Study: Up to Month 6|Lost to Follow-up|11
803811|NCT02503202|2613086|P5|Base Study: Up to Month 6|Death|0
803812|NCT02503202|2613087|P4|Base Study: Up to Month 6|Death|0
803813|NCT02503202|2613088|P3|Base Study: Up to Month 6|Death|0
803814|NCT02503202|2613089|P2|Base Study: Up to Month 6|Death|1
803815|NCT02503202|2613090|P1|Base Study: Up to Month 6|Death|1
803816|NCT02503085|2613132|P4|Period 2: Washout (3 to 7 Days)|Adverse Event|0
803817|NCT02503085|2613133|P3|Period 2: Washout (3 to 7 Days)|Adverse Event|1
803818|NCT02503085|2613134|P2|Period 2: Washout (3 to 7 Days)|Adverse Event|0
803819|NCT02503085|2613135|P1|Period 2: Washout (3 to 7 Days)|Adverse Event|1
803820|NCT02502864|2613174|P1|Overall Study|Withdrawal by Subject|1
803821|NCT02502734|2613183|P2|Washout Period|Adverse Event|0
803822|NCT02502734|2613184|P1|Washout Period|Adverse Event|1
803823|NCT02502734|2613183|P2|Double-blind Treatment Period 1|Adverse Event|0
803824|NCT02502734|2613184|P1|Double-blind Treatment Period 1|Adverse Event|1
803825|NCT02502526|2613195|P3|Overall Study|Enrollment suspension|1
803826|NCT02502526|2613196|P2|Overall Study|Enrollment suspension|1
803827|NCT02502526|2613197|P1|Overall Study|Enrollment suspension|4
803828|NCT02502526|2613195|P3|Overall Study|Disqualified due to cataract grading|1
803829|NCT02502526|2613196|P2|Overall Study|Disqualified due to cataract grading|0
803830|NCT02502526|2613197|P1|Overall Study|Disqualified due to cataract grading|0
803831|NCT02502526|2613195|P3|Overall Study|Withdrawal by Subject|1
803832|NCT02502526|2613196|P2|Overall Study|Withdrawal by Subject|1
803833|NCT02502526|2613197|P1|Overall Study|Withdrawal by Subject|0
803834|NCT02502526|2613195|P3|Overall Study|Lost to Follow-up|3
803835|NCT02502526|2613196|P2|Overall Study|Lost to Follow-up|2
803836|NCT02502526|2613197|P1|Overall Study|Lost to Follow-up|2
803837|NCT02502149|2613283|P5|Intermediate|Discontinued prematurely|0
803838|NCT02502149|2613284|P4|Intermediate|Discontinued prematurely|0
803839|NCT02502149|2613285|P3|Intermediate|Discontinued prematurely|0
803840|NCT02502149|2613286|P2|Intermediate|Discontinued prematurely|0
803841|NCT02502149|2613287|P1|Intermediate|Discontinued prematurely|1
803842|NCT02501629|2613413|P2|Overall Study|Subject did not return to site|1
803843|NCT02501629|2613414|P1|Overall Study|Subject did not return to site|0
803844|NCT02501629|2613413|P2|Overall Study|Withdrawal by Subject|5
803845|NCT02501629|2613414|P1|Overall Study|Withdrawal by Subject|3
803846|NCT02501629|2613413|P2|Overall Study|Early termination by sponsor|0
803847|NCT02501629|2613414|P1|Overall Study|Early termination by sponsor|1
803848|NCT02501629|2613413|P2|Overall Study|Withdrawn from study by sponsor|0
803849|NCT02501629|2613414|P1|Overall Study|Withdrawn from study by sponsor|1
803850|NCT02501629|2613413|P2|Overall Study|Death|1
803851|NCT02501629|2613414|P1|Overall Study|Death|0
803852|NCT02500979|2613447|P2|Period 2|Change in risk|0
803853|NCT02500979|2613448|P1|Period 2|Change in risk|1
803854|NCT02500979|2613447|P2|Period 1|Subject decision|0
803855|NCT02500979|2613448|P1|Period 1|Subject decision|2
803856|NCT02500979|2613447|P2|Period 1|Adverse Event|0
803857|NCT02500979|2613448|P1|Period 1|Adverse Event|1
803858|NCT02500979|2613447|P2|Period 1|Severe non-compliance to protocol|1
803859|NCT02500979|2613448|P1|Period 1|Severe non-compliance to protocol|0
803860|NCT02500979|2613447|P2|Period 1|Hyperglycemia|0
803861|NCT02500979|2613448|P1|Period 1|Hyperglycemia|1
803862|NCT02500758|2613498|P2|Second Intervention (2 Minutes)|Protocol Violation|1
803863|NCT02500758|2613499|P1|Second Intervention (2 Minutes)|Protocol Violation|1
803864|NCT02500758|2613498|P2|Second Intervention (2 Minutes)|Lost to Follow-up|1
803865|NCT02500758|2613499|P1|Second Intervention (2 Minutes)|Lost to Follow-up|0
803866|NCT02500758|2613498|P2|Second Intervention (2 Minutes)|Withdrawal by Subject|0
803867|NCT02500758|2613499|P1|Second Intervention (2 Minutes)|Withdrawal by Subject|2
803868|NCT02500758|2613498|P2|Washout (1 Week)|Lost to Follow-up|2
803869|NCT02500758|2613499|P1|Washout (1 Week)|Lost to Follow-up|2
803870|NCT02500758|2613498|P2|First Intervention (2 Minutes)|Withdrawal by Subject|1
803871|NCT02500758|2613499|P1|First Intervention (2 Minutes)|Withdrawal by Subject|0
803872|NCT02500706|2613510|P3|Overall Study|Unclassified|1
803873|NCT02500706|2613511|P2|Overall Study|Unclassified|0
803874|NCT02500706|2613512|P1|Overall Study|Unclassified|0
803875|NCT02500706|2613510|P3|Overall Study|Withdrawal by Subject|4
803876|NCT02500706|2613511|P2|Overall Study|Withdrawal by Subject|6
803877|NCT02500706|2613512|P1|Overall Study|Withdrawal by Subject|4
803878|NCT02500706|2613510|P3|Overall Study|Lost to Follow-up|1
803879|NCT02500706|2613511|P2|Overall Study|Lost to Follow-up|1
803880|NCT02500706|2613512|P1|Overall Study|Lost to Follow-up|0
803881|NCT02500706|2613510|P3|Overall Study|Adverse Event|1
803882|NCT02500706|2613511|P2|Overall Study|Adverse Event|0
803883|NCT02500706|2613512|P1|Overall Study|Adverse Event|0
803884|NCT02500537|2613679|P2|Overall Study|Withdrawal by Subject|0
803885|NCT02500537|2613680|P1|Overall Study|Withdrawal by Subject|1
803886|NCT02500537|2613679|P2|Overall Study|Lost to Follow-up|1
803887|NCT02500537|2613680|P1|Overall Study|Lost to Follow-up|0
803888|NCT02500537|2613679|P2|Overall Study|Death|0
803889|NCT02500537|2613680|P1|Overall Study|Death|2
803890|NCT02500056|2613749|P2|Overall Study|Death|1
803891|NCT02500056|2613750|P1|Overall Study|Death|3
803892|NCT02500056|2613749|P2|Overall Study|Recurrence|0
803893|NCT02500056|2613750|P1|Overall Study|Recurrence|1
803894|NCT02500056|2613749|P2|Overall Study|Lost to Follow-up|7
803895|NCT02500056|2613750|P1|Overall Study|Lost to Follow-up|3
803896|NCT02499952|2613760|P1|Overall Study|Death|9
803897|NCT02499952|2613760|P1|Overall Study|Lost to Follow-up|1
803898|NCT02499900|2613769|P2|Extension Study Period|Not specified|2
803899|NCT02499900|2613770|P1|Extension Study Period|Not specified|0
803900|NCT02499900|2613769|P2|Extension Study Period|Lost to Follow-up|5
803901|NCT02499900|2613770|P1|Extension Study Period|Lost to Follow-up|2
803902|NCT02499900|2613769|P2|Extension Study Period|Pregnancy|2
803903|NCT02499900|2613770|P1|Extension Study Period|Pregnancy|1
803904|NCT02499900|2613769|P2|Extension Study Period|Physician Decision|5
803905|NCT02499900|2613770|P1|Extension Study Period|Physician Decision|2
803906|NCT02499900|2613769|P2|Extension Study Period|Withdrawal by Subject|2
803907|NCT02499900|2613770|P1|Extension Study Period|Withdrawal by Subject|5
803908|NCT02499900|2613769|P2|Extension Study Period|Adverse Event|4
803909|NCT02499900|2613770|P1|Extension Study Period|Adverse Event|2
803910|NCT02499900|2613769|P2|Completed Core, Continued Into Extension|Personal motivation|0
803911|NCT02499900|2613770|P1|Completed Core, Continued Into Extension|Personal motivation|1
803912|NCT02499900|2613769|P2|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0
803913|NCT02499900|2613770|P1|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1
803914|NCT02499900|2613769|P2|Completed Core, Continued Into Extension|Withdrawal by Subject|2
803915|NCT02499900|2613770|P1|Completed Core, Continued Into Extension|Withdrawal by Subject|0
803916|NCT02499900|2613769|P2|Completed Core, Continued Into Extension|Physician Decision|0
803917|NCT02499900|2613770|P1|Completed Core, Continued Into Extension|Physician Decision|1
803918|NCT02499900|2613769|P2|Core Study Period|Death|1
803919|NCT02499900|2613770|P1|Core Study Period|Death|0
803920|NCT02499900|2613769|P2|Core Study Period|Adverse Event|14
803921|NCT02499900|2613770|P1|Core Study Period|Adverse Event|18
803922|NCT02499900|2613769|P2|Core Study Period|Withdrawal by Subject|10
803923|NCT02499900|2613770|P1|Core Study Period|Withdrawal by Subject|11
803924|NCT02499900|2613769|P2|Core Study Period|Protocol Violation|0
803925|NCT02499900|2613770|P1|Core Study Period|Protocol Violation|3
803926|NCT02499900|2613769|P2|Core Study Period|Pregnancy|0
803927|NCT02499900|2613770|P1|Core Study Period|Pregnancy|1
803928|NCT02499900|2613769|P2|Core Study Period|Per sponsor request|1
803929|NCT02499900|2613770|P1|Core Study Period|Per sponsor request|0
803930|NCT02499900|2613769|P2|Core Study Period|Lost to Follow-up|2
803931|NCT02499900|2613770|P1|Core Study Period|Lost to Follow-up|1
803932|NCT02499900|2613769|P2|Core Study Period|Not specified|4
803933|NCT02499900|2613770|P1|Core Study Period|Not specified|1
803934|NCT02499575|2613801|P2|Overall Study|Protocol Violation|1
803935|NCT02499575|2613802|P1|Overall Study|Protocol Violation|0
803936|NCT02499029|2613814|P2|Overall Study|Death|0
803937|NCT02499029|2613815|P1|Overall Study|Death|1
803938|NCT02499029|2613814|P2|Overall Study|Physician Decision|1
803939|NCT02499029|2613815|P1|Overall Study|Physician Decision|2
803940|NCT02499029|2613814|P2|Overall Study|Lost to Follow-up|2
803941|NCT02499029|2613815|P1|Overall Study|Lost to Follow-up|2
803942|NCT02498821|2613829|P2|Overall Study|Screen failure|5
803943|NCT02498821|2613830|P1|Overall Study|Screen failure|3
803944|NCT02498678|2613859|P2|Overall Study|interference from the surgical team|2
803945|NCT02498678|2613860|P1|Overall Study|interference from the surgical team|0
803946|NCT02498652|2613876|P2|Overall Study|Protocol Violation|1
803947|NCT02498652|2613877|P1|Overall Study|Protocol Violation|0
803948|NCT02497976|2613987|P2|Overall Study|Moved out of area|1
803949|NCT02497976|2613988|P1|Overall Study|Moved out of area|0
803950|NCT02497976|2613987|P2|Overall Study|Withdrawal by Subject|0
803951|NCT02497976|2613988|P1|Overall Study|Withdrawal by Subject|2
803952|NCT02497781|2614083|P2|Overall Study|Lost to Follow-up|1
803953|NCT02497781|2614084|P1|Overall Study|Lost to Follow-up|1
803954|NCT02497781|2614083|P2|Overall Study|Randomised but not treated|1
803955|NCT02497781|2614084|P1|Overall Study|Randomised but not treated|1
803956|NCT02497781|2614083|P2|Overall Study|Lack of Efficacy|1
803957|NCT02497781|2614084|P1|Overall Study|Lack of Efficacy|0
803958|NCT02497781|2614083|P2|Overall Study|Withdrawal by Subject|0
803959|NCT02497781|2614084|P1|Overall Study|Withdrawal by Subject|2
803960|NCT02497755|2614147|P2|Overall Study|Protocol Violation|0
803961|NCT02497755|2614148|P1|Overall Study|Protocol Violation|1
803962|NCT02496702|2614215|P2|Overall Study|Only partially tested|2
803963|NCT02496702|2614216|P1|Overall Study|Only partially tested|0
803964|NCT02496702|2614215|P2|Overall Study|Lost to Follow-up|6
803965|NCT02496702|2614216|P1|Overall Study|Lost to Follow-up|8
803966|NCT02496533|2614238|P2|Overall Study|Late for radiologic testing|2
803967|NCT02496533|2614239|P1|Overall Study|Late for radiologic testing|0
803968|NCT02496533|2614238|P2|Overall Study|Patient did not complete all measures|4
803969|NCT02496533|2614239|P1|Overall Study|Patient did not complete all measures|0
803970|NCT02496533|2614238|P2|Overall Study|Lack of data on outcome|0
803971|NCT02496533|2614239|P1|Overall Study|Lack of data on outcome|3
803972|NCT02496221|2614251|P2|Treatment Period 2 - 4 Days|Physician Decision|0
803973|NCT02496221|2614252|P1|Treatment Period 2 - 4 Days|Physician Decision|1
803974|NCT02496221|2614251|P2|Treatment Period 2 - 4 Days|Protocol Violation|0
803975|NCT02496221|2614252|P1|Treatment Period 2 - 4 Days|Protocol Violation|1
803976|NCT02496221|2614251|P2|Treatment Period 2 - 4 Days|Adverse Event|1
803977|NCT02496221|2614252|P1|Treatment Period 2 - 4 Days|Adverse Event|0
803978|NCT02496039|2614286|P1|Overall Study|Protocol Violation|1
803979|NCT02496039|2614286|P1|Overall Study|Adverse Event|3
803980|NCT02496000|2614301|P3|Overall Study|undetermined|0
803981|NCT02496000|2614302|P2|Overall Study|undetermined|1
803982|NCT02496000|2614303|P1|Overall Study|undetermined|0
803983|NCT02496000|2614301|P3|Overall Study|Non-compliance or lack of cooperation|0
803984|NCT02496000|2614302|P2|Overall Study|Non-compliance or lack of cooperation|2
803985|NCT02496000|2614303|P1|Overall Study|Non-compliance or lack of cooperation|0
803986|NCT02496000|2614301|P3|Overall Study|Protocol Violation|1
803987|NCT02496000|2614302|P2|Overall Study|Protocol Violation|0
803988|NCT02496000|2614303|P1|Overall Study|Protocol Violation|0
803989|NCT02496000|2614301|P3|Overall Study|Lost to Follow-up|1
803990|NCT02496000|2614302|P2|Overall Study|Lost to Follow-up|0
803991|NCT02496000|2614303|P1|Overall Study|Lost to Follow-up|1
803992|NCT02496000|2614301|P3|Overall Study|Withdrawal by Subject|0
803993|NCT02496000|2614302|P2|Overall Study|Withdrawal by Subject|2
803994|NCT02496000|2614303|P1|Overall Study|Withdrawal by Subject|1
803995|NCT02495948|2614312|P2|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
803996|NCT02495948|2614313|P1|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
803997|NCT02495948|2614312|P2|Period 1, First 30 Days of Wear|Adverse Event|1
803998|NCT02495948|2614313|P1|Period 1, First 30 Days of Wear|Adverse Event|0
803999|NCT02494596|2614433|P3|Overall Study|Refused Treatment|0
804000|NCT02494596|2614434|P2|Overall Study|Refused Treatment|1
804001|NCT02494596|2614435|P1|Overall Study|Refused Treatment|0
804002|NCT02494596|2614433|P3|Overall Study|Adverse Event|0
804003|NCT02494596|2614434|P2|Overall Study|Adverse Event|1
804004|NCT02494596|2614435|P1|Overall Study|Adverse Event|0
804005|NCT02494596|2614433|P3|Overall Study|Insufficient Therapeutic Response|1
804006|NCT02494596|2614434|P2|Overall Study|Insufficient Therapeutic Response|3
804007|NCT02494596|2614435|P1|Overall Study|Insufficient Therapeutic Response|3
804008|NCT02494206|2614471|P1|Overall Study|Disease Progression|1
804009|NCT02494206|2614471|P1|Overall Study|Adverse Event|1
804010|NCT02493855|2614491|P3|Overall Study|Withdrawal by Subject|0
804011|NCT02493855|2614492|P2|Overall Study|Withdrawal by Subject|0
804012|NCT02493855|2614493|P1|Overall Study|Withdrawal by Subject|1
804013|NCT02493855|2614491|P3|Overall Study|Adverse Event|0
804014|NCT02493855|2614492|P2|Overall Study|Adverse Event|1
804015|NCT02493855|2614493|P1|Overall Study|Adverse Event|0
804016|NCT02493855|2614491|P3|Overall Study|Non-compliance|0
804017|NCT02493855|2614492|P2|Overall Study|Non-compliance|0
804018|NCT02493855|2614493|P1|Overall Study|Non-compliance|1
804019|NCT02493777|2614503|P2|Overall Study|Lost to Follow-up|1
804020|NCT02493777|2614504|P1|Overall Study|Lost to Follow-up|0
804021|NCT02493127|2614514|P2|Overall Study|Lost to Follow-up|1
804022|NCT02493127|2614515|P1|Overall Study|Lost to Follow-up|1
804023|NCT02492984|2614548|P2|Overall Study|Withdrawal by Subject|0
804024|NCT02492984|2614549|P1|Overall Study|Withdrawal by Subject|1
804025|NCT02492984|2614548|P2|Overall Study|Protocol Violation|0
804026|NCT02492984|2614549|P1|Overall Study|Protocol Violation|1
804027|NCT02492984|2614548|P2|Overall Study|Adverse Event|0
804028|NCT02492984|2614549|P1|Overall Study|Adverse Event|1
804029|NCT02492958|2614573|P4|Overall Study|Adverse Event|0
804030|NCT02492958|2614574|P3|Overall Study|Adverse Event|1
804031|NCT02492958|2614575|P2|Overall Study|Adverse Event|0
804032|NCT02492958|2614576|P1|Overall Study|Adverse Event|1
804033|NCT02492958|2614573|P4|Overall Study|Withdrawal by Subject|0
804034|NCT02492958|2614574|P3|Overall Study|Withdrawal by Subject|1
804035|NCT02492958|2614575|P2|Overall Study|Withdrawal by Subject|0
804036|NCT02492958|2614576|P1|Overall Study|Withdrawal by Subject|0
804037|NCT02492880|2614662|P1|Overall Study|Protocol Violation|1
804038|NCT02492880|2614662|P1|Overall Study|Lost to Follow-up|1
804039|NCT02492841|2614669|P3|Overall Study|Lost to Follow-up|35
804040|NCT02492841|2614670|P2|Overall Study|Lost to Follow-up|31
804041|NCT02492841|2614671|P1|Overall Study|Lost to Follow-up|34
804042|NCT02492763|2614686|P4|Overall Study|Study Terminated by Sponsor|10
804043|NCT02492763|2614687|P3|Overall Study|Study Terminated by Sponsor|6
804044|NCT02492763|2614688|P2|Overall Study|Study Terminated by Sponsor|10
804045|NCT02492763|2614689|P1|Overall Study|Study Terminated by Sponsor|13
804046|NCT02492763|2614686|P4|Overall Study|Screen Failure|1
804047|NCT02492763|2614687|P3|Overall Study|Screen Failure|0
804048|NCT02492763|2614688|P2|Overall Study|Screen Failure|0
804049|NCT02492763|2614689|P1|Overall Study|Screen Failure|0
804050|NCT02492763|2614686|P4|Overall Study|Non-Compliance With Study Drug|0
804051|NCT02492763|2614687|P3|Overall Study|Non-Compliance With Study Drug|0
804052|NCT02492763|2614688|P2|Overall Study|Non-Compliance With Study Drug|1
804053|NCT02492763|2614689|P1|Overall Study|Non-Compliance With Study Drug|0
804054|NCT02492763|2614686|P4|Overall Study|Lost to Follow-up|0
804055|NCT02492763|2614687|P3|Overall Study|Lost to Follow-up|1
804056|NCT02492763|2614688|P2|Overall Study|Lost to Follow-up|0
804057|NCT02492763|2614689|P1|Overall Study|Lost to Follow-up|0
804058|NCT02492763|2614686|P4|Overall Study|Hyperglycemia Discontinuation Criteria|0
804059|NCT02492763|2614687|P3|Overall Study|Hyperglycemia Discontinuation Criteria|0
804060|NCT02492763|2614688|P2|Overall Study|Hyperglycemia Discontinuation Criteria|1
804061|NCT02492763|2614689|P1|Overall Study|Hyperglycemia Discontinuation Criteria|0
804062|NCT02492763|2614686|P4|Overall Study|Death|0
804063|NCT02492763|2614687|P3|Overall Study|Death|1
804064|NCT02492763|2614688|P2|Overall Study|Death|0
804065|NCT02492763|2614689|P1|Overall Study|Death|0
804066|NCT02492763|2614686|P4|Overall Study|Adverse Event|2
804067|NCT02492763|2614687|P3|Overall Study|Adverse Event|1
804068|NCT02492763|2614688|P2|Overall Study|Adverse Event|1
804069|NCT02492763|2614689|P1|Overall Study|Adverse Event|3
804070|NCT02492763|2614686|P4|Overall Study|Withdrawal by Subject|0
804071|NCT02492763|2614687|P3|Overall Study|Withdrawal by Subject|1
804072|NCT02492763|2614688|P2|Overall Study|Withdrawal by Subject|2
804073|NCT02492763|2614689|P1|Overall Study|Withdrawal by Subject|0
804074|NCT02492165|2614760|P4|Overall Study|Withdrawal by Subject|0
804075|NCT02492165|2614761|P3|Overall Study|Withdrawal by Subject|0
804076|NCT02492165|2614762|P2|Overall Study|Withdrawal by Subject|1
804077|NCT02492165|2614763|P1|Overall Study|Withdrawal by Subject|0
804078|NCT02491892|2614807|P2|Overall Study|Lost to Follow-up|0
804079|NCT02491892|2614808|P1|Overall Study|Lost to Follow-up|1
804080|NCT02491892|2614807|P2|Overall Study|Refused Treatment|0
804081|NCT02491892|2614808|P1|Overall Study|Refused Treatment|1
804082|NCT02491892|2614807|P2|Overall Study|Lack of Efficacy|36
804083|NCT02491892|2614808|P1|Overall Study|Lack of Efficacy|37
804084|NCT02491892|2614807|P2|Overall Study|Death|1
804085|NCT02491892|2614808|P1|Overall Study|Death|1
804086|NCT02491892|2614807|P2|Overall Study|Adverse Event|1
804087|NCT02491892|2614808|P1|Overall Study|Adverse Event|1
804088|NCT02491463|2614856|P4|Overall Study|Lost to Follow-up|0
804089|NCT02491463|2614857|P3|Overall Study|Lost to Follow-up|3
804090|NCT02491463|2614858|P2|Overall Study|Lost to Follow-up|3
804091|NCT02491463|2614859|P1|Overall Study|Lost to Follow-up|0
804092|NCT02491463|2614856|P4|Overall Study|Migrated/moved from study area|1
804093|NCT02491463|2614857|P3|Overall Study|Migrated/moved from study area|1
804094|NCT02491463|2614858|P2|Overall Study|Migrated/moved from study area|5
804095|NCT02491463|2614859|P1|Overall Study|Migrated/moved from study area|1
804096|NCT02491463|2614856|P4|Overall Study|Withdrawal by Subject|0
804097|NCT02491463|2614857|P3|Overall Study|Withdrawal by Subject|0
804098|NCT02491463|2614858|P2|Overall Study|Withdrawal by Subject|2
804099|NCT02491463|2614859|P1|Overall Study|Withdrawal by Subject|1
804100|NCT02491411|2614945|P1|Overall Study|Physician Decision|4
804101|NCT02491073|2614957|P2|Overall Study|screen failure|0
804102|NCT02491073|2614958|P1|Overall Study|screen failure|1
804103|NCT02490475|2614999|P4|Period 2: Extension Phase|Adverse Event|0
804104|NCT02490475|2615000|P3|Period 2: Extension Phase|Adverse Event|1
804105|NCT02490475|2615001|P2|Period 2: Extension Phase|Adverse Event|0
804106|NCT02490475|2615002|P1|Period 2: Extension Phase|Adverse Event|0
804107|NCT02490475|2614999|P4|Period 2: Extension Phase|Refused Treatment|1
804108|NCT02490475|2615000|P3|Period 2: Extension Phase|Refused Treatment|0
804109|NCT02490475|2615001|P2|Period 2: Extension Phase|Refused Treatment|0
804110|NCT02490475|2615002|P1|Period 2: Extension Phase|Refused Treatment|0
804111|NCT02490475|2614999|P4|Period 2: Extension Phase|Insufficient Therapeutic Response|0
804112|NCT02490475|2615000|P3|Period 2: Extension Phase|Insufficient Therapeutic Response|2
804113|NCT02490475|2615001|P2|Period 2: Extension Phase|Insufficient Therapeutic Response|0
804114|NCT02490475|2615002|P1|Period 2: Extension Phase|Insufficient Therapeutic Response|1
804115|NCT02490475|2614999|P4|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2
804116|NCT02490475|2615000|P3|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4
804117|NCT02490475|2615001|P2|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
804118|NCT02490475|2615002|P1|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
804119|NCT02490475|2614999|P4|Period 1: First 6 Cycles|Refused Treatment|0
804120|NCT02490475|2615000|P3|Period 1: First 6 Cycles|Refused Treatment|0
804121|NCT02490475|2615001|P2|Period 1: First 6 Cycles|Refused Treatment|0
804122|NCT02490475|2615002|P1|Period 1: First 6 Cycles|Refused Treatment|1
804123|NCT02490475|2614999|P4|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
804124|NCT02490475|2615000|P3|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
804125|NCT02490475|2615001|P2|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0
804126|NCT02490475|2615002|P1|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
804127|NCT02490475|2614999|P4|Period 1: First 6 Cycles|Adverse Event|1
804128|NCT02490475|2615000|P3|Period 1: First 6 Cycles|Adverse Event|0
804129|NCT02490475|2615001|P2|Period 1: First 6 Cycles|Adverse Event|1
804130|NCT02490475|2615002|P1|Period 1: First 6 Cycles|Adverse Event|2
804131|NCT02489968|2615091|P6|Double-blind Treatment Period|Other than specified above|0
804132|NCT02489968|2615092|P5|Double-blind Treatment Period|Other than specified above|1
804133|NCT02489968|2615093|P4|Double-blind Treatment Period|Other than specified above|0
804134|NCT02489968|2615094|P3|Double-blind Treatment Period|Other than specified above|0
804135|NCT02489968|2615095|P2|Double-blind Treatment Period|Other than specified above|0
804136|NCT02489968|2615096|P1|Double-blind Treatment Period|Other than specified above|0
804137|NCT02489968|2615091|P6|Double-blind Treatment Period|Withdrawal by Subject|2
804138|NCT02489968|2615092|P5|Double-blind Treatment Period|Withdrawal by Subject|0
804139|NCT02489968|2615093|P4|Double-blind Treatment Period|Withdrawal by Subject|2
804140|NCT02489968|2615094|P3|Double-blind Treatment Period|Withdrawal by Subject|0
804141|NCT02489968|2615095|P2|Double-blind Treatment Period|Withdrawal by Subject|0
804142|NCT02489968|2615096|P1|Double-blind Treatment Period|Withdrawal by Subject|0
804143|NCT02489968|2615091|P6|Double-blind Treatment Period|Protocol Violation|1
804144|NCT02489968|2615092|P5|Double-blind Treatment Period|Protocol Violation|1
804145|NCT02489968|2615093|P4|Double-blind Treatment Period|Protocol Violation|0
804146|NCT02489968|2615094|P3|Double-blind Treatment Period|Protocol Violation|0
804147|NCT02489968|2615095|P2|Double-blind Treatment Period|Protocol Violation|0
804148|NCT02489968|2615096|P1|Double-blind Treatment Period|Protocol Violation|0
804149|NCT02489968|2615091|P6|Double-blind Treatment Period|Adverse Event|5
804150|NCT02489968|2615092|P5|Double-blind Treatment Period|Adverse Event|4
804151|NCT02489968|2615093|P4|Double-blind Treatment Period|Adverse Event|6
804152|NCT02489968|2615094|P3|Double-blind Treatment Period|Adverse Event|2
804153|NCT02489968|2615095|P2|Double-blind Treatment Period|Adverse Event|0
804154|NCT02489968|2615096|P1|Double-blind Treatment Period|Adverse Event|0
804155|NCT02489968|2615091|P6|Open-label Treatment Period|Other than specified above|0
804156|NCT02489968|2615092|P5|Open-label Treatment Period|Other than specified above|0
804157|NCT02489968|2615093|P4|Open-label Treatment Period|Other than specified above|0
804158|NCT02489968|2615094|P3|Open-label Treatment Period|Other than specified above|0
804159|NCT02489968|2615095|P2|Open-label Treatment Period|Other than specified above|189
804160|NCT02489968|2615096|P1|Open-label Treatment Period|Other than specified above|204
804161|NCT02489968|2615091|P6|Open-label Treatment Period|Withdrawal by Subject|0
804162|NCT02489968|2615092|P5|Open-label Treatment Period|Withdrawal by Subject|0
804163|NCT02489968|2615093|P4|Open-label Treatment Period|Withdrawal by Subject|0
804164|NCT02489968|2615094|P3|Open-label Treatment Period|Withdrawal by Subject|0
804165|NCT02489968|2615095|P2|Open-label Treatment Period|Withdrawal by Subject|7
804166|NCT02489968|2615096|P1|Open-label Treatment Period|Withdrawal by Subject|4
804167|NCT02489968|2615091|P6|Open-label Treatment Period|Lost to Follow-up|0
804168|NCT02489968|2615092|P5|Open-label Treatment Period|Lost to Follow-up|0
804169|NCT02489968|2615093|P4|Open-label Treatment Period|Lost to Follow-up|0
804170|NCT02489968|2615094|P3|Open-label Treatment Period|Lost to Follow-up|0
804171|NCT02489968|2615095|P2|Open-label Treatment Period|Lost to Follow-up|3
804172|NCT02489968|2615096|P1|Open-label Treatment Period|Lost to Follow-up|0
804173|NCT02489968|2615091|P6|Open-label Treatment Period|Protocol Violation|0
804174|NCT02489968|2615092|P5|Open-label Treatment Period|Protocol Violation|0
804175|NCT02489968|2615093|P4|Open-label Treatment Period|Protocol Violation|0
804176|NCT02489968|2615094|P3|Open-label Treatment Period|Protocol Violation|0
804177|NCT02489968|2615095|P2|Open-label Treatment Period|Protocol Violation|2
804178|NCT02489968|2615096|P1|Open-label Treatment Period|Protocol Violation|2
804179|NCT02489968|2615091|P6|Open-label Treatment Period|Adverse Event|0
804180|NCT02489968|2615092|P5|Open-label Treatment Period|Adverse Event|0
804181|NCT02489968|2615093|P4|Open-label Treatment Period|Adverse Event|0
804182|NCT02489968|2615094|P3|Open-label Treatment Period|Adverse Event|0
804183|NCT02489968|2615095|P2|Open-label Treatment Period|Adverse Event|7
804184|NCT02489968|2615096|P1|Open-label Treatment Period|Adverse Event|14
804185|NCT02489799|2615110|P2|Overall Study|Death|1
804186|NCT02489799|2615111|P1|Overall Study|Death|0
804187|NCT02489799|2615110|P2|Overall Study|Withdrawal by Subject|1
804188|NCT02489799|2615111|P1|Overall Study|Withdrawal by Subject|1
804189|NCT02489799|2615110|P2|Overall Study|Failure to Maintain Eligibility|6
804190|NCT02489799|2615111|P1|Overall Study|Failure to Maintain Eligibility|4
804191|NCT02489799|2615110|P2|Overall Study|Lost to Follow-up|1
804192|NCT02489799|2615111|P1|Overall Study|Lost to Follow-up|4
804193|NCT02489500|2615137|P2|Overall Study|Death|1
804194|NCT02489500|2615138|P1|Overall Study|Death|1
804195|NCT02488980|2615164|P3|Overall Study|Protocol Violation|2
804196|NCT02488980|2615165|P2|Overall Study|Protocol Violation|2
804197|NCT02488980|2615166|P1|Overall Study|Protocol Violation|2
804198|NCT02488915|2615183|P1|Overall Study|Withdrawal by Subject|1
804199|NCT02488915|2615183|P1|Overall Study|Lost to Follow-up|4
804200|NCT02488915|2615183|P1|Overall Study|Death|21
804201|NCT02488681|2615199|P1|Overall Study|Implant unsuccessful|7
804202|NCT02487979|2615232|P1|Overall Study|Progressive Disease|17
804203|NCT02487979|2615232|P1|Overall Study|Withdrawal by Subject|2
804204|NCT02487979|2615232|P1|Overall Study|Physician Decision|2
804205|NCT02487771|2615244|P2|Overall Study|Withdrawal by Subject|5
804206|NCT02487771|2615245|P1|Overall Study|Withdrawal by Subject|3
804207|NCT02487771|2615244|P2|Overall Study|Moved out of area|6
804208|NCT02487771|2615245|P1|Overall Study|Moved out of area|5
804209|NCT02487771|2615244|P2|Overall Study|Lost to Follow-up|3
804210|NCT02487771|2615245|P1|Overall Study|Lost to Follow-up|2
804211|NCT02487498|2615395|P2|Period: Period 2|Physician Decision|0
804212|NCT02487498|2615396|P1|Period: Period 2|Physician Decision|1
804213|NCT02487498|2615395|P2|Period: Period 2|Death|1
804214|NCT02487498|2615396|P1|Period: Period 2|Death|0
804215|NCT02487498|2615395|P2|Period: Period 2|Lost to Follow-up|1
804216|NCT02487498|2615396|P1|Period: Period 2|Lost to Follow-up|1
804217|NCT02487498|2615395|P2|Period: Period 2|Subject/guardian decision|1
804218|NCT02487498|2615396|P1|Period: Period 2|Subject/guardian decision|2
804219|NCT02487498|2615395|P2|Period: Period 2|Adverse Event|2
804220|NCT02487498|2615396|P1|Period: Period 2|Adverse Event|2
804221|NCT02487498|2615395|P2|Period: Washout|Non-compliance with study treatment|1
804222|NCT02487498|2615396|P1|Period: Washout|Non-compliance with study treatment|0
804223|NCT02487498|2615395|P2|Period: Washout|Physician Decision|0
804224|NCT02487498|2615396|P1|Period: Washout|Physician Decision|1
804225|NCT02487498|2615395|P2|Period: Washout|Lack of Efficacy|1
804226|NCT02487498|2615396|P1|Period: Washout|Lack of Efficacy|1
804227|NCT02487498|2615395|P2|Period: Washout|Subject/guardian decision|5
804228|NCT02487498|2615396|P1|Period: Washout|Subject/guardian decision|0
804229|NCT02487498|2615395|P2|Period: Period 1|Protocol deviation|0
804230|NCT02487498|2615396|P1|Period: Period 1|Protocol deviation|1
804231|NCT02487498|2615395|P2|Period: Period 1|Physician Decision|1
804232|NCT02487498|2615396|P1|Period: Period 1|Physician Decision|0
804233|NCT02487498|2615395|P2|Period: Period 1|Lack of Efficacy|0
804234|NCT02487498|2615396|P1|Period: Period 1|Lack of Efficacy|1
804235|NCT02487498|2615395|P2|Period: Period 1|Lost to Follow-up|2
804236|NCT02487498|2615396|P1|Period: Period 1|Lost to Follow-up|0
804237|NCT02487498|2615395|P2|Period: Period 1|Subject/guardian decision|4
804238|NCT02487498|2615396|P1|Period: Period 1|Subject/guardian decision|2
804239|NCT02487498|2615395|P2|Period: Period 1|Adverse Event|4
804240|NCT02487498|2615396|P1|Period: Period 1|Adverse Event|2
804241|NCT02487446|2615419|P2|Period 2|Adverse Event|2
804242|NCT02487446|2615420|P1|Period 2|Adverse Event|6
804243|NCT02487446|2615419|P2|Period 2|Withdrawal by Subject|1
804244|NCT02487446|2615420|P1|Period 2|Withdrawal by Subject|1
804245|NCT02487446|2615419|P2|Period 2|Lost to Follow-up|1
804246|NCT02487446|2615420|P1|Period 2|Lost to Follow-up|1
804247|NCT02487446|2615419|P2|Period 2|Protocol deviation|1
804248|NCT02487446|2615420|P1|Period 2|Protocol deviation|0
804249|NCT02487446|2615419|P2|Washout|Adverse Event|2
804250|NCT02487446|2615420|P1|Washout|Adverse Event|2
804251|NCT02487446|2615419|P2|Washout|Withdrawal by Subject|4
804252|NCT02487446|2615420|P1|Washout|Withdrawal by Subject|1
804253|NCT02487446|2615419|P2|Washout|Lost to Follow-up|2
804254|NCT02487446|2615420|P1|Washout|Lost to Follow-up|0
804255|NCT02487446|2615419|P2|Period 1|Adverse Event|5
804256|NCT02487446|2615420|P1|Period 1|Adverse Event|5
804257|NCT02487446|2615419|P2|Period 1|Withdrawal by Subject|0
804258|NCT02487446|2615420|P1|Period 1|Withdrawal by Subject|2
804259|NCT02487446|2615419|P2|Period 1|Lost to Follow-up|0
804260|NCT02487446|2615420|P1|Period 1|Lost to Follow-up|2
804261|NCT02487446|2615419|P2|Period 1|Protocol deviation|2
804262|NCT02487446|2615420|P1|Period 1|Protocol deviation|3
804263|NCT02487446|2615419|P2|Period 1|Lack of Efficacy|0
804264|NCT02487446|2615420|P1|Period 1|Lack of Efficacy|1
804265|NCT02487446|2615419|P2|Period 1|Physician Decision|1
804266|NCT02487446|2615420|P1|Period 1|Physician Decision|0
804267|NCT02487199|2615445|P2|Overall Study|Withdrew Consent|1
804268|NCT02487199|2615446|P1|Overall Study|Withdrew Consent|0
804269|NCT02487030|2615465|P7|Overall Study|Death|0
804270|NCT02487030|2615466|P6|Overall Study|Death|0
804271|NCT02487030|2615467|P5|Overall Study|Death|1
804272|NCT02487030|2615468|P4|Overall Study|Death|0
804273|NCT02487030|2615469|P3|Overall Study|Death|0
804274|NCT02487030|2615470|P2|Overall Study|Death|0
804275|NCT02487030|2615471|P1|Overall Study|Death|0
804276|NCT02487030|2615465|P7|Overall Study|Adverse Event|0
804277|NCT02487030|2615466|P6|Overall Study|Adverse Event|0
804278|NCT02487030|2615467|P5|Overall Study|Adverse Event|0
804279|NCT02487030|2615468|P4|Overall Study|Adverse Event|1
804280|NCT02487030|2615469|P3|Overall Study|Adverse Event|0
804281|NCT02487030|2615470|P2|Overall Study|Adverse Event|0
804282|NCT02487030|2615471|P1|Overall Study|Adverse Event|0
804283|NCT02487030|2615465|P7|Overall Study|Lost to Follow-up|0
804284|NCT02487030|2615466|P6|Overall Study|Lost to Follow-up|1
804285|NCT02487030|2615467|P5|Overall Study|Lost to Follow-up|0
804286|NCT02487030|2615468|P4|Overall Study|Lost to Follow-up|1
804287|NCT02487030|2615469|P3|Overall Study|Lost to Follow-up|1
804288|NCT02487030|2615470|P2|Overall Study|Lost to Follow-up|0
804289|NCT02487030|2615471|P1|Overall Study|Lost to Follow-up|0
804290|NCT02487030|2615465|P7|Overall Study|Lack of Efficacy|0
804291|NCT02487030|2615466|P6|Overall Study|Lack of Efficacy|0
804292|NCT02487030|2615467|P5|Overall Study|Lack of Efficacy|1
804293|NCT02487030|2615468|P4|Overall Study|Lack of Efficacy|0
804294|NCT02487030|2615469|P3|Overall Study|Lack of Efficacy|1
804295|NCT02487030|2615470|P2|Overall Study|Lack of Efficacy|4
804296|NCT02487030|2615471|P1|Overall Study|Lack of Efficacy|2
804297|NCT02486952|2615502|P1|Overall Study|Other|2
804298|NCT02486952|2615502|P1|Overall Study|Lost to Follow-up|26
804299|NCT02486952|2615502|P1|Overall Study|Lack of Efficacy|3
804300|NCT02486952|2615502|P1|Overall Study|Death|15
804301|NCT02486952|2615502|P1|Overall Study|Adverse Event|1
804302|NCT02486952|2615502|P1|Overall Study|Not Started Induction Therapy|3
804303|NCT02486796|2615509|P2|Overall Study|Physician Decision|0
804304|NCT02486796|2615510|P1|Overall Study|Physician Decision|1
804305|NCT02486796|2615509|P2|Overall Study|Withdrawal by Subject|1
804306|NCT02486796|2615510|P1|Overall Study|Withdrawal by Subject|1
804307|NCT02486627|2615524|P2|Overall Study|Lost to Follow-up|3
804308|NCT02486627|2615525|P1|Overall Study|Lost to Follow-up|1
804309|NCT02486627|2615524|P2|Overall Study|Significant Participant Noncompliance|1
804310|NCT02486627|2615525|P1|Overall Study|Significant Participant Noncompliance|1
804311|NCT02486627|2615524|P2|Overall Study|Consent Withdrawn by Participant|3
804312|NCT02486627|2615525|P1|Overall Study|Consent Withdrawn by Participant|4
804313|NCT02486627|2615524|P2|Overall Study|Other Unspecified|2
804314|NCT02486627|2615525|P1|Overall Study|Other Unspecified|0
804315|NCT02486627|2615524|P2|Overall Study|Death|0
804316|NCT02486627|2615525|P1|Overall Study|Death|1
804317|NCT02485925|2615542|P1|Overall Study|Lost to Follow-up|11
804318|NCT02485925|2615542|P1|Overall Study|Death|1
804319|NCT02485925|2615542|P1|Overall Study|Withdrawal by Subject|3
804320|NCT02485483|2615592|P2|Overall Study|Discontinued after baseline|0
804321|NCT02485483|2615593|P1|Overall Study|Discontinued after baseline|39
804322|NCT02485483|2615592|P2|Overall Study|Depression at baseline|0
804323|NCT02485483|2615593|P1|Overall Study|Depression at baseline|15
804324|NCT02485353|2615608|P1|Overall Study|Disease Progression|1
804325|NCT02485353|2615608|P1|Overall Study|Death|1
804326|NCT02485301|2615615|P2|Overall Study|Other|4
804327|NCT02485301|2615616|P1|Overall Study|Other|3
804328|NCT02485301|2615615|P2|Overall Study|Lost to Follow-up|17
804329|NCT02485301|2615616|P1|Overall Study|Lost to Follow-up|17
804330|NCT02485301|2615615|P2|Overall Study|Migrated/moved from study area|19
804331|NCT02485301|2615616|P1|Overall Study|Migrated/moved from study area|10
804332|NCT02485301|2615615|P2|Overall Study|Withdrawal by Subject|7
804333|NCT02485301|2615616|P1|Overall Study|Withdrawal by Subject|6
804334|NCT02485301|2615615|P2|Overall Study|Protocol Violation|1
804335|NCT02485301|2615616|P1|Overall Study|Protocol Violation|0
804336|NCT02485301|2615615|P2|Overall Study|Serious Adverse Events|1
804337|NCT02485301|2615616|P1|Overall Study|Serious Adverse Events|2
804338|NCT02485158|2615666|P1|Overall Study|expected drug side effect|1
804339|NCT02485158|2615666|P1|Overall Study|Withdrawal by Subject|3
804340|NCT02484911|2615755|P2|Overall Study|Protocol Violation|1
804341|NCT02484911|2615756|P1|Overall Study|Protocol Violation|2
804342|NCT02484911|2615755|P2|Overall Study|Withdrawal by Subject|1
804343|NCT02484911|2615756|P1|Overall Study|Withdrawal by Subject|2
804344|NCT02484729|2615798|P10|Overall Study|Failure of IntelliCap Error|1
804345|NCT02484729|2615799|P9|Overall Study|Failure of IntelliCap Error|0
804346|NCT02484729|2615800|P8|Overall Study|Failure of IntelliCap Error|0
804347|NCT02484729|2615801|P7|Overall Study|Failure of IntelliCap Error|0
804348|NCT02484729|2615802|P6|Overall Study|Failure of IntelliCap Error|0
804349|NCT02484729|2615803|P5|Overall Study|Failure of IntelliCap Error|0
804350|NCT02484729|2615804|P4|Overall Study|Failure of IntelliCap Error|0
804351|NCT02484729|2615805|P3|Overall Study|Failure of IntelliCap Error|0
804352|NCT02484729|2615806|P2|Overall Study|Failure of IntelliCap Error|0
804353|NCT02484729|2615807|P1|Overall Study|Failure of IntelliCap Error|0
804354|NCT02483975|2616005|P2|Overall Study|Physician Decision|0
804355|NCT02483975|2616006|P1|Overall Study|Physician Decision|2
804356|NCT02483975|2616005|P2|Overall Study|Lost to Follow-up|1
804357|NCT02483975|2616006|P1|Overall Study|Lost to Follow-up|0
804358|NCT02483975|2616005|P2|Overall Study|Adverse Event|1
804359|NCT02483975|2616006|P1|Overall Study|Adverse Event|0
804360|NCT02483611|2616023|P3|Overall Study|Protocol Violation|1
804361|NCT02483611|2616024|P2|Overall Study|Protocol Violation|0
804362|NCT02483611|2616025|P1|Overall Study|Protocol Violation|0
804363|NCT02483585|2616122|P2|Open-label Treatment Phase|Lost to Follow-up|5
804364|NCT02483585|2616123|P1|Open-label Treatment Phase|Lost to Follow-up|3
804365|NCT02483585|2616122|P2|Open-label Treatment Phase|Withdrawal by Subject|14
804366|NCT02483585|2616123|P1|Open-label Treatment Phase|Withdrawal by Subject|18
804367|NCT02483585|2616122|P2|Open-label Treatment Phase|Decision by Sponsor|1
804368|NCT02483585|2616123|P1|Open-label Treatment Phase|Decision by Sponsor|0
804369|NCT02483585|2616122|P2|Open-label Treatment Phase|Protocol-specified Criteria|5
804370|NCT02483585|2616123|P1|Open-label Treatment Phase|Protocol-specified Criteria|6
804371|NCT02483585|2616122|P2|Double-blind Treatment Phase|Lost to Follow-up|2
804372|NCT02483585|2616123|P1|Double-blind Treatment Phase|Lost to Follow-up|3
804373|NCT02483585|2616122|P2|Double-blind Treatment Phase|Withdrawal by Subject|12
804374|NCT02483585|2616123|P1|Double-blind Treatment Phase|Withdrawal by Subject|12
804375|NCT02483585|2616122|P2|Double-blind Treatment Phase|Decision by Sponsor|1
804376|NCT02483585|2616123|P1|Double-blind Treatment Phase|Decision by Sponsor|1
804377|NCT02482935|2616143|P2|Period 1|Withdrawal by Subject|0
804378|NCT02482935|2616144|P1|Period 1|Withdrawal by Subject|1
804379|NCT02482805|2616172|P3|Overall Study|Lost to Follow-up|0
804380|NCT02482805|2616173|P2|Overall Study|Lost to Follow-up|4
804381|NCT02482805|2616174|P1|Overall Study|Lost to Follow-up|4
804382|NCT02482571|2616188|P1|Overall Study|Withdrawal by Subject|4
804383|NCT02482571|2616188|P1|Overall Study|Scanner or Respiract failure|3
804384|NCT02482571|2616188|P1|Overall Study|Adverse Event|1
804385|NCT02482428|2616200|P5|Overall Study|subject/guardian decision|2
804386|NCT02482428|2616201|P4|Overall Study|subject/guardian decision|0
804387|NCT02482428|2616202|P3|Overall Study|subject/guardian decision|0
804388|NCT02482428|2616203|P2|Overall Study|subject/guardian decision|2
804389|NCT02482428|2616204|P1|Overall Study|subject/guardian decision|4
804390|NCT02482428|2616200|P5|Overall Study|protocol deviation|0
804391|NCT02482428|2616201|P4|Overall Study|protocol deviation|0
804392|NCT02482428|2616202|P3|Overall Study|protocol deviation|0
804393|NCT02482428|2616203|P2|Overall Study|protocol deviation|1
804394|NCT02482428|2616204|P1|Overall Study|protocol deviation|1
804395|NCT02482428|2616200|P5|Overall Study|Physician Decision|1
804396|NCT02482428|2616201|P4|Overall Study|Physician Decision|0
804397|NCT02482428|2616202|P3|Overall Study|Physician Decision|0
804398|NCT02482428|2616203|P2|Overall Study|Physician Decision|0
804399|NCT02482428|2616204|P1|Overall Study|Physician Decision|0
804400|NCT02482428|2616200|P5|Overall Study|Lost to Follow-up|4
804401|NCT02482428|2616201|P4|Overall Study|Lost to Follow-up|2
804402|NCT02482428|2616202|P3|Overall Study|Lost to Follow-up|1
804403|NCT02482428|2616203|P2|Overall Study|Lost to Follow-up|9
804404|NCT02482428|2616204|P1|Overall Study|Lost to Follow-up|4
804405|NCT02482298|2616227|P3|Overall Study|Lost to Follow-up|0
804406|NCT02482298|2616228|P2|Overall Study|Lost to Follow-up|1
804407|NCT02482298|2616229|P1|Overall Study|Lost to Follow-up|0
804408|NCT02482298|2616227|P3|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1
804409|NCT02482298|2616228|P2|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
804410|NCT02482298|2616229|P1|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
804411|NCT02482298|2616227|P3|Overall Study|Did Not Fulfill Randomization Criteria|0
804412|NCT02482298|2616228|P2|Overall Study|Did Not Fulfill Randomization Criteria|1
804413|NCT02482298|2616229|P1|Overall Study|Did Not Fulfill Randomization Criteria|0
804414|NCT02482298|2616227|P3|Overall Study|Withdrawal by Subject|2
804415|NCT02482298|2616228|P2|Overall Study|Withdrawal by Subject|1
804416|NCT02482298|2616229|P1|Overall Study|Withdrawal by Subject|2
804417|NCT02482129|2616251|P2|Overall Study|Criteria not met|0
804418|NCT02482129|2616252|P1|Overall Study|Criteria not met|1
804419|NCT02482129|2616251|P2|Overall Study|Withdrawal by Subject|0
804420|NCT02482129|2616252|P1|Overall Study|Withdrawal by Subject|2
804421|NCT02482129|2616251|P2|Overall Study|Adverse Event|0
804422|NCT02482129|2616252|P1|Overall Study|Adverse Event|1
804423|NCT02482129|2616251|P2|Overall Study|Criteria not met-prior to treatment|0
804424|NCT02482129|2616252|P1|Overall Study|Criteria not met-prior to treatment|1
804425|NCT02482129|2616251|P2|Overall Study|Unable to draw blood-prior to treatment|0
804426|NCT02482129|2616252|P1|Overall Study|Unable to draw blood-prior to treatment|1
804427|NCT02482129|2616251|P2|Overall Study|Withdrawal by subject-prior to treatment|1
804428|NCT02482129|2616252|P1|Overall Study|Withdrawal by subject-prior to treatment|0
804429|NCT02482129|2616251|P2|Overall Study|Adverse Event-prior to treatment|1
804430|NCT02482129|2616252|P1|Overall Study|Adverse Event-prior to treatment|0
804431|NCT02481934|2616279|P1|Overall Study|Death|2
804432|NCT02481050|2616375|P1|Overall Study|Other|3
804433|NCT02481050|2616375|P1|Overall Study|Withdrawal by Subject|7
804434|NCT02481050|2616375|P1|Overall Study|Disease Progression|47
804435|NCT02481050|2616375|P1|Overall Study|Adverse Event|1
804436|NCT02480712|2616395|P1|Overall Study|Lack of Efficacy|1
804437|NCT02480712|2616395|P1|Overall Study|Death|1
804438|NCT02480712|2616395|P1|Overall Study|Withdrew Consent|3
804439|NCT02480712|2616395|P1|Overall Study|Lost to Follow-up|5
804440|NCT02480712|2616395|P1|Overall Study|Enrolled but Never Treated|1
804441|NCT02480621|2616414|P2|Follow Up|Lost to Follow-up|2
804442|NCT02480621|2616415|P1|Follow Up|Lost to Follow-up|4
804443|NCT02480621|2616414|P2|Randomization|Surgeon did not give intervention|1
804444|NCT02480621|2616415|P1|Randomization|Surgeon did not give intervention|0
804445|NCT02480621|2616414|P2|Randomization|Withdrawal by Subject|0
804446|NCT02480621|2616415|P1|Randomization|Withdrawal by Subject|1
804447|NCT02480153|2616492|P2|Overall Study|Randomized but not treated|1
804448|NCT02480153|2616493|P1|Overall Study|Randomized but not treated|0
804449|NCT02480153|2616492|P2|Overall Study|Withdrew treatment; continued in study|14
804450|NCT02480153|2616493|P1|Overall Study|Withdrew treatment; continued in study|6
804451|NCT02480153|2616492|P2|Overall Study|Discontinued from treatment and study|12
804452|NCT02480153|2616493|P1|Overall Study|Discontinued from treatment and study|5
804453|NCT02480010|2616501|P2|Overall Study|Refused Treatment|3
804454|NCT02480010|2616502|P1|Overall Study|Refused Treatment|0
804455|NCT02480010|2616501|P2|Overall Study|Insufficient therapeutic response|29
804456|NCT02480010|2616502|P1|Overall Study|Insufficient therapeutic response|31
804457|NCT02480010|2616501|P2|Overall Study|Death|0
804458|NCT02480010|2616502|P1|Overall Study|Death|1
804459|NCT02480010|2616501|P2|Overall Study|Adverse Event|1
804460|NCT02480010|2616502|P1|Overall Study|Adverse Event|3
804461|NCT02479412|2616564|P9|Overall Study|Randomization to wrong PK sampling group|0
804462|NCT02479412|2616565|P8|Overall Study|Randomization to wrong PK sampling group|0
804463|NCT02479412|2616566|P7|Overall Study|Randomization to wrong PK sampling group|0
804464|NCT02479412|2616567|P6|Overall Study|Randomization to wrong PK sampling group|0
804465|NCT02479412|2616568|P5|Overall Study|Randomization to wrong PK sampling group|1
804466|NCT02479412|2616569|P4|Overall Study|Randomization to wrong PK sampling group|0
804467|NCT02479412|2616570|P3|Overall Study|Randomization to wrong PK sampling group|0
804468|NCT02479412|2616571|P2|Overall Study|Randomization to wrong PK sampling group|0
804469|NCT02479412|2616572|P1|Overall Study|Randomization to wrong PK sampling group|0
804470|NCT02479412|2616564|P9|Overall Study|Study-specific withdrawal criteria|1
804471|NCT02479412|2616565|P8|Overall Study|Study-specific withdrawal criteria|1
804472|NCT02479412|2616566|P7|Overall Study|Study-specific withdrawal criteria|0
804473|NCT02479412|2616567|P6|Overall Study|Study-specific withdrawal criteria|0
804474|NCT02479412|2616568|P5|Overall Study|Study-specific withdrawal criteria|0
804475|NCT02479412|2616569|P4|Overall Study|Study-specific withdrawal criteria|1
804476|NCT02479412|2616570|P3|Overall Study|Study-specific withdrawal criteria|1
804477|NCT02479412|2616571|P2|Overall Study|Study-specific withdrawal criteria|0
804478|NCT02479412|2616572|P1|Overall Study|Study-specific withdrawal criteria|0
804479|NCT02479412|2616564|P9|Overall Study|Adverse Event|0
804480|NCT02479412|2616565|P8|Overall Study|Adverse Event|0
804481|NCT02479412|2616566|P7|Overall Study|Adverse Event|0
804482|NCT02479412|2616567|P6|Overall Study|Adverse Event|0
804483|NCT02479412|2616568|P5|Overall Study|Adverse Event|0
804484|NCT02479412|2616569|P4|Overall Study|Adverse Event|0
804485|NCT02479412|2616570|P3|Overall Study|Adverse Event|1
804486|NCT02479412|2616571|P2|Overall Study|Adverse Event|0
804487|NCT02479412|2616572|P1|Overall Study|Adverse Event|0
804488|NCT02479139|2616649|P6|Overall Study|Other Miscellaneous Reasons|0
804489|NCT02479139|2616650|P5|Overall Study|Other Miscellaneous Reasons|1
804490|NCT02479139|2616651|P4|Overall Study|Other Miscellaneous Reasons|1
804491|NCT02479139|2616652|P3|Overall Study|Other Miscellaneous Reasons|1
804492|NCT02479139|2616653|P2|Overall Study|Other Miscellaneous Reasons|0
804493|NCT02479139|2616654|P1|Overall Study|Other Miscellaneous Reasons|1
804494|NCT02479139|2616649|P6|Overall Study|Treatment Failure/Lack of Efficacy|0
804495|NCT02479139|2616650|P5|Overall Study|Treatment Failure/Lack of Efficacy|0
804496|NCT02479139|2616651|P4|Overall Study|Treatment Failure/Lack of Efficacy|0
804497|NCT02479139|2616652|P3|Overall Study|Treatment Failure/Lack of Efficacy|1
804498|NCT02479139|2616653|P2|Overall Study|Treatment Failure/Lack of Efficacy|0
804499|NCT02479139|2616654|P1|Overall Study|Treatment Failure/Lack of Efficacy|0
804500|NCT02479139|2616649|P6|Overall Study|Withdrew Consent|1
804501|NCT02479139|2616650|P5|Overall Study|Withdrew Consent|1
804502|NCT02479139|2616651|P4|Overall Study|Withdrew Consent|4
804503|NCT02479139|2616652|P3|Overall Study|Withdrew Consent|1
804504|NCT02479139|2616653|P2|Overall Study|Withdrew Consent|6
804505|NCT02479139|2616654|P1|Overall Study|Withdrew Consent|5
804506|NCT02479139|2616649|P6|Overall Study|Lost to Follow-up|5
804507|NCT02479139|2616650|P5|Overall Study|Lost to Follow-up|3
804508|NCT02479139|2616651|P4|Overall Study|Lost to Follow-up|2
804509|NCT02479139|2616652|P3|Overall Study|Lost to Follow-up|4
804510|NCT02479139|2616653|P2|Overall Study|Lost to Follow-up|4
804511|NCT02479139|2616654|P1|Overall Study|Lost to Follow-up|2
804512|NCT02478632|2616687|P2|Overall Study|Other (Withdrawal from parent study)|5
804513|NCT02478632|2616688|P1|Overall Study|Other (Withdrawal from parent study)|4
804514|NCT02478372|2616715|P2|Overall Study|Death|2
804515|NCT02478372|2616716|P1|Overall Study|Death|0
804516|NCT02478372|2616715|P2|Overall Study|Lost to Follow-up|4
804517|NCT02478372|2616716|P1|Overall Study|Lost to Follow-up|1
804518|NCT02478372|2616715|P2|Overall Study|Protocol Violation|8
804519|NCT02478372|2616716|P1|Overall Study|Protocol Violation|12
804520|NCT02478164|2616738|P1|Overall Study|Withdrawal by Subject|1
804521|NCT02478164|2616738|P1|Overall Study|Adverse Event|1
804522|NCT02478164|2616738|P1|Overall Study|Lack of Efficacy|13
804523|NCT02477605|2616751|P2|Overall Study|Administered gas during surgery|1
804524|NCT02477605|2616752|P1|Overall Study|Administered gas during surgery|0
804525|NCT02477605|2616751|P2|Overall Study|Withdrawal by Subject|1
804526|NCT02477605|2616752|P1|Overall Study|Withdrawal by Subject|0
804527|NCT02477605|2616751|P2|Overall Study|Lost to Follow-up|2
804528|NCT02477605|2616752|P1|Overall Study|Lost to Follow-up|0
804529|NCT02477605|2616751|P2|Overall Study|Discontinued prior to treatment|0
804530|NCT02477605|2616752|P1|Overall Study|Discontinued prior to treatment|1
804531|NCT02477527|2616766|P1|Overall Study|Screen Failure|3
804532|NCT02477527|2616766|P1|Overall Study|Withdrawal by Subject|1
804533|NCT02477527|2616766|P1|Overall Study|Lost to Follow-up|2
804534|NCT02477332|2616780|P6|Overall Study|Withdrawal by Subject|0
804535|NCT02477332|2616781|P5|Overall Study|Withdrawal by Subject|1
804536|NCT02477332|2616782|P4|Overall Study|Withdrawal by Subject|2
804537|NCT02477332|2616783|P3|Overall Study|Withdrawal by Subject|1
804538|NCT02477332|2616784|P2|Overall Study|Withdrawal by Subject|3
804539|NCT02477332|2616785|P1|Overall Study|Withdrawal by Subject|0
804540|NCT02477332|2616780|P6|Overall Study|Physician Decision|1
804541|NCT02477332|2616781|P5|Overall Study|Physician Decision|0
804542|NCT02477332|2616782|P4|Overall Study|Physician Decision|3
804543|NCT02477332|2616783|P3|Overall Study|Physician Decision|1
804544|NCT02477332|2616784|P2|Overall Study|Physician Decision|0
804545|NCT02477332|2616785|P1|Overall Study|Physician Decision|0
804546|NCT02477332|2616780|P6|Overall Study|Lost to Follow-up|0
804547|NCT02477332|2616781|P5|Overall Study|Lost to Follow-up|0
804548|NCT02477332|2616782|P4|Overall Study|Lost to Follow-up|0
804549|NCT02477332|2616783|P3|Overall Study|Lost to Follow-up|2
804550|NCT02477332|2616784|P2|Overall Study|Lost to Follow-up|0
804551|NCT02477332|2616785|P1|Overall Study|Lost to Follow-up|0
804552|NCT02477332|2616780|P6|Overall Study|Technical problems|0
804553|NCT02477332|2616781|P5|Overall Study|Technical problems|0
804554|NCT02477332|2616782|P4|Overall Study|Technical problems|0
804555|NCT02477332|2616783|P3|Overall Study|Technical problems|1
804556|NCT02477332|2616784|P2|Overall Study|Technical problems|0
804557|NCT02477332|2616785|P1|Overall Study|Technical problems|0
804558|NCT02477332|2616780|P6|Overall Study|Protocol Violation|1
804559|NCT02477332|2616781|P5|Overall Study|Protocol Violation|1
804560|NCT02477332|2616782|P4|Overall Study|Protocol Violation|3
804561|NCT02477332|2616783|P3|Overall Study|Protocol Violation|3
804562|NCT02477332|2616784|P2|Overall Study|Protocol Violation|0
804563|NCT02477332|2616785|P1|Overall Study|Protocol Violation|2
804564|NCT02477332|2616780|P6|Overall Study|Pregnancy|0
804565|NCT02477332|2616781|P5|Overall Study|Pregnancy|0
804566|NCT02477332|2616782|P4|Overall Study|Pregnancy|1
804567|NCT02477332|2616783|P3|Overall Study|Pregnancy|0
804568|NCT02477332|2616784|P2|Overall Study|Pregnancy|0
804569|NCT02477332|2616785|P1|Overall Study|Pregnancy|0
804570|NCT02477332|2616780|P6|Overall Study|Non-compliance with study treatment|0
804571|NCT02477332|2616781|P5|Overall Study|Non-compliance with study treatment|0
804572|NCT02477332|2616782|P4|Overall Study|Non-compliance with study treatment|0
804573|NCT02477332|2616783|P3|Overall Study|Non-compliance with study treatment|2
804574|NCT02477332|2616784|P2|Overall Study|Non-compliance with study treatment|1
804575|NCT02477332|2616785|P1|Overall Study|Non-compliance with study treatment|0
804576|NCT02477332|2616780|P6|Overall Study|Lack of Efficacy|1
804577|NCT02477332|2616781|P5|Overall Study|Lack of Efficacy|1
804578|NCT02477332|2616782|P4|Overall Study|Lack of Efficacy|2
804579|NCT02477332|2616783|P3|Overall Study|Lack of Efficacy|1
804580|NCT02477332|2616784|P2|Overall Study|Lack of Efficacy|2
804581|NCT02477332|2616785|P1|Overall Study|Lack of Efficacy|1
804582|NCT02477332|2616780|P6|Overall Study|Adverse Event|2
804583|NCT02477332|2616781|P5|Overall Study|Adverse Event|1
804584|NCT02477332|2616782|P4|Overall Study|Adverse Event|2
804585|NCT02477332|2616783|P3|Overall Study|Adverse Event|1
804586|NCT02477332|2616784|P2|Overall Study|Adverse Event|1
804587|NCT02477332|2616785|P1|Overall Study|Adverse Event|0
804588|NCT02477020|2616861|P2|Overall Study|Lack of Efficacy|5
804589|NCT02477020|2616862|P1|Overall Study|Lack of Efficacy|14
804590|NCT02477020|2616861|P2|Overall Study|Reason not Specified|1
804591|NCT02477020|2616862|P1|Overall Study|Reason not Specified|3
804592|NCT02477020|2616861|P2|Overall Study|Voluntary Withdrawal|16
804593|NCT02477020|2616862|P1|Overall Study|Voluntary Withdrawal|7
804594|NCT02477020|2616861|P2|Overall Study|Pretreatment Event/Adverse Event|6
804595|NCT02477020|2616862|P1|Overall Study|Pretreatment Event/Adverse Event|6
804596|NCT02476994|2616892|P2|Overall Study|Based on feedback from FDA|0
804597|NCT02476994|2616893|P1|Overall Study|Based on feedback from FDA|1
804598|NCT02476617|2616962|P1|Overall Study|Lost to Follow-up|1
804599|NCT02476617|2616962|P1|Overall Study|Adverse Event|1
804600|NCT02476422|2616991|P2|Overall Study|Subject/guardian decision|1
804601|NCT02476422|2616992|P1|Overall Study|Subject/guardian decision|0
804602|NCT02476175|2617022|P1|Overall Study|Adverse Event|2
804603|NCT02475980|2617046|P1|Overall Study|Withdrawal by Subject|1
804604|NCT02475980|2617046|P1|Overall Study|Lost to Follow-up|4
804605|NCT02475733|2617057|P2|Overall Study|Physician Decision|0
804606|NCT02475733|2617058|P1|Overall Study|Physician Decision|1
804607|NCT02475733|2617057|P2|Overall Study|Withdrawal by Subject|0
804608|NCT02475733|2617058|P1|Overall Study|Withdrawal by Subject|1
804609|NCT02475564|2617115|P2|Overall Study|Intense Menstrual bleeding|0
804610|NCT02475564|2617116|P1|Overall Study|Intense Menstrual bleeding|1
804611|NCT02475564|2617115|P2|Overall Study|Lost to Follow-up|1
804612|NCT02475564|2617116|P1|Overall Study|Lost to Follow-up|2
804613|NCT02475564|2617115|P2|Overall Study|Withdrawal by Subject|0
804614|NCT02475564|2617116|P1|Overall Study|Withdrawal by Subject|1
804615|NCT02475395|2617128|P2|Overall Study|Protocol Violation|3
804616|NCT02475395|2617129|P1|Overall Study|Protocol Violation|30
804617|NCT02475278|2617139|P1|Overall Study|Reason Not Specified|1
804618|NCT02475278|2617139|P1|Overall Study|Lost to Follow-up|1
804619|NCT02474589|2617186|P2|Overall Study|Inability to complete study procedures|1
804620|NCT02474589|2617187|P1|Overall Study|Inability to complete study procedures|5
804621|NCT02474589|2617186|P2|Overall Study|Withdrawal by Subject|0
804622|NCT02474589|2617187|P1|Overall Study|Withdrawal by Subject|4
804623|NCT02474589|2617186|P2|Overall Study|Protocol Violation|1
804624|NCT02474589|2617187|P1|Overall Study|Protocol Violation|4
804625|NCT02474589|2617186|P2|Overall Study|Lost to Follow-up|1
804626|NCT02474589|2617187|P1|Overall Study|Lost to Follow-up|6
804627|NCT02474589|2617186|P2|Overall Study|Adverse Event|2
804628|NCT02474589|2617187|P1|Overall Study|Adverse Event|6
804629|NCT02474082|2617246|P2|Overall Study|Protocol deviation|1
804630|NCT02474082|2617247|P1|Overall Study|Protocol deviation|0
804631|NCT02474082|2617246|P2|Overall Study|Non-compliance with study treatment|2
804632|NCT02474082|2617247|P1|Overall Study|Non-compliance with study treatment|0
804633|NCT02474082|2617246|P2|Overall Study|Participant/guardian decision|2
804634|NCT02474082|2617247|P1|Overall Study|Participant/guardian decision|1
804635|NCT02474082|2617246|P2|Overall Study|Dose tapering not achieved|4
804636|NCT02474082|2617247|P1|Overall Study|Dose tapering not achieved|0
804637|NCT02474082|2617246|P2|Overall Study|Lost to Follow-up|2
804638|NCT02474082|2617247|P1|Overall Study|Lost to Follow-up|2
804639|NCT02474082|2617246|P2|Overall Study|Withdrawal of informed consent|11
804640|NCT02474082|2617247|P1|Overall Study|Withdrawal of informed consent|1
804641|NCT02474082|2617246|P2|Overall Study|Adverse Event|32
804642|NCT02474082|2617247|P1|Overall Study|Adverse Event|2
804643|NCT02473640|2617321|P1|Treatment Period 1|Adverse Event|1
804644|NCT02473523|2617330|P1|Overall Study|Lost to Follow-up|1
804645|NCT02473523|2617330|P1|Overall Study|Death|1
804646|NCT02473510|2617351|P2|Overall Study|Lost to Follow-up|2
804647|NCT02473510|2617352|P1|Overall Study|Lost to Follow-up|1
804648|NCT02473471|2617366|P1|Overall Study|Lost to Follow-up|1
804649|NCT02473471|2617366|P1|Overall Study|poor oral hygiene|2
804650|NCT02473445|2617397|P1|Overall Study|Sponsor Decision|20
804651|NCT02473445|2617397|P1|Overall Study|Withdrawal by Subject|2
804652|NCT02473367|2617403|P1|Period 4|Lost to Follow-up|1
804653|NCT02473367|2617403|P1|Wait 1|Withdrawal by Subject|1
804654|NCT02472977|2617424|P3|Overall Study|Subject request to discontinue treatment|0
804655|NCT02472977|2617425|P2|Overall Study|Subject request to discontinue treatment|1
804656|NCT02472977|2617426|P1|Overall Study|Subject request to discontinue treatment|0
804657|NCT02472977|2617424|P3|Overall Study|Study drug toxicity|2
804658|NCT02472977|2617425|P2|Overall Study|Study drug toxicity|0
804659|NCT02472977|2617426|P1|Overall Study|Study drug toxicity|2
804660|NCT02472977|2617424|P3|Overall Study|Withdrawal by Subject|0
804661|NCT02472977|2617425|P2|Overall Study|Withdrawal by Subject|1
804662|NCT02472977|2617426|P1|Overall Study|Withdrawal by Subject|0
804663|NCT02472977|2617424|P3|Overall Study|Disease progression|6
804664|NCT02472977|2617425|P2|Overall Study|Disease progression|25
804665|NCT02472977|2617426|P1|Overall Study|Disease progression|4
804666|NCT02472964|2617451|P2|Part 2 (Week 24-week 48)|Protocol Violation|1
804667|NCT02472964|2617452|P1|Part 2 (Week 24-week 48)|Protocol Violation|3
804668|NCT02472964|2617451|P2|Part 2 (Week 24-week 48)|Withdrawal by Subject|1
804669|NCT02472964|2617452|P1|Part 2 (Week 24-week 48)|Withdrawal by Subject|3
804670|NCT02472964|2617451|P2|Part 2 (Week 24-week 48)|Lost to Follow-up|1
804671|NCT02472964|2617452|P1|Part 2 (Week 24-week 48)|Lost to Follow-up|2
804672|NCT02472964|2617451|P2|Part 2 (Week 24-week 48)|Physician Decision|1
804673|NCT02472964|2617452|P1|Part 2 (Week 24-week 48)|Physician Decision|1
804674|NCT02472964|2617451|P2|Part 2 (Week 24-week 48)|Death|1
804675|NCT02472964|2617452|P1|Part 2 (Week 24-week 48)|Death|0
804676|NCT02472964|2617451|P2|Part 2 (Week 24-week 48)|Disease Progression|56
804677|NCT02472964|2617452|P1|Part 2 (Week 24-week 48)|Disease Progression|52
804678|NCT02472964|2617451|P2|Part 2 (Week 24-week 48)|Adverse Event|2
804679|NCT02472964|2617452|P1|Part 2 (Week 24-week 48)|Adverse Event|4
804680|NCT02472964|2617451|P2|Part 1 (up to Week 24)|Other|1
804681|NCT02472964|2617452|P1|Part 1 (up to Week 24)|Other|2
804682|NCT02472964|2617451|P2|Part 1 (up to Week 24)|Withdrawal by Subject|2
804683|NCT02472964|2617452|P1|Part 1 (up to Week 24)|Withdrawal by Subject|7
804684|NCT02472964|2617451|P2|Part 1 (up to Week 24)|Lost to Follow-up|1
804685|NCT02472964|2617452|P1|Part 1 (up to Week 24)|Lost to Follow-up|0
804686|NCT02472964|2617451|P2|Part 1 (up to Week 24)|Physician Decision|1
804687|NCT02472964|2617452|P1|Part 1 (up to Week 24)|Physician Decision|3
804688|NCT02472964|2617451|P2|Part 1 (up to Week 24)|Death|6
804689|NCT02472964|2617452|P1|Part 1 (up to Week 24)|Death|3
804690|NCT02472964|2617451|P2|Part 1 (up to Week 24)|disease progression|47
804691|NCT02472964|2617452|P1|Part 1 (up to Week 24)|disease progression|58
804692|NCT02472964|2617451|P2|Part 1 (up to Week 24)|Adverse Event|4
804693|NCT02472964|2617452|P1|Part 1 (up to Week 24)|Adverse Event|2
804694|NCT02472886|2617461|P3|Overall Study|Lack of Efficacy|1
804695|NCT02472886|2617462|P2|Overall Study|Lack of Efficacy|2
804696|NCT02472886|2617463|P1|Overall Study|Lack of Efficacy|0
804697|NCT02472847|2617491|P2|Overall Study|Withdrawal by Subject|5
804698|NCT02472847|2617492|P1|Overall Study|Withdrawal by Subject|1
804699|NCT02472756|2617498|P1|Maintenance (Approximately 2 Years)|Adverse Event|1
804700|NCT02472756|2617498|P1|Maintenance (Approximately 2 Years)|Progression Disease|2
804701|NCT02472756|2617498|P1|Maintenance (Approximately 2 Years)|Lack of Drug|7
804702|NCT02472756|2617498|P1|Induction (Approximately 6 Months)|Enrolled But Not Treated|1
804703|NCT02472756|2617498|P1|Induction (Approximately 6 Months)|Adverse Event|1
804704|NCT02472639|2617506|P2|Overall Study|Physician Decision|3
804705|NCT02472639|2617507|P1|Overall Study|Physician Decision|4
804706|NCT02472405|2617554|P1|Overall Study|Adverse Event|1
804707|NCT02472405|2617554|P1|Overall Study|Lost to Follow-up|9
804708|NCT02472366|2617562|P2|Overall Study|Lost to Follow-up|0
804709|NCT02472366|2617563|P1|Overall Study|Lost to Follow-up|1
804710|NCT02471755|2617579|P2|Overall Study|Lost to Follow-up|1
804711|NCT02471755|2617580|P1|Overall Study|Lost to Follow-up|0
804712|NCT02471755|2617579|P2|Overall Study|Withdrawal by Subject|0
804713|NCT02471755|2617580|P1|Overall Study|Withdrawal by Subject|1
804714|NCT02471612|2617596|P1|Overall Study|Lost to Follow-up|2
804715|NCT02471183|2617618|P1|Extended Treatment Period|Lack of Efficacy|1
804716|NCT02471183|2617618|P1|Main Treatment Period|Withdrawal by Subject|1
804717|NCT02471183|2617618|P1|Main Treatment Period|Adverse Event|1
804718|NCT02470429|2617654|P2|Overall Study|Withdrawal by Subject|0
804719|NCT02470429|2617655|P1|Overall Study|Withdrawal by Subject|1
804720|NCT02470429|2617654|P2|Overall Study|Adverse Event|0
804721|NCT02470429|2617655|P1|Overall Study|Adverse Event|1
804722|NCT02470403|2617673|P5|Overall Study|Subject/guardian decision|0
804723|NCT02470403|2617674|P4|Overall Study|Subject/guardian decision|4
804724|NCT02470403|2617675|P3|Overall Study|Subject/guardian decision|0
804725|NCT02470403|2617676|P2|Overall Study|Subject/guardian decision|0
804726|NCT02470403|2617677|P1|Overall Study|Subject/guardian decision|1
804727|NCT02470403|2617673|P5|Overall Study|Lost to Follow-up|0
804728|NCT02470403|2617674|P4|Overall Study|Lost to Follow-up|0
804729|NCT02470403|2617675|P3|Overall Study|Lost to Follow-up|0
804730|NCT02470403|2617676|P2|Overall Study|Lost to Follow-up|1
804731|NCT02470403|2617677|P1|Overall Study|Lost to Follow-up|0
804732|NCT02470403|2617673|P5|Overall Study|Adverse Event|0
804733|NCT02470403|2617674|P4|Overall Study|Adverse Event|0
804734|NCT02470403|2617675|P3|Overall Study|Adverse Event|0
804735|NCT02470403|2617676|P2|Overall Study|Adverse Event|0
804736|NCT02470403|2617677|P1|Overall Study|Adverse Event|1
804737|NCT02469961|2617746|P2|Overall Study|Physician Decision|1
804738|NCT02469961|2617747|P1|Overall Study|Physician Decision|4
804739|NCT02469415|2617782|P1|Overall Study|Investigational agent placed on hold|2
804740|NCT02469415|2617782|P1|Overall Study|Withdrawal by Subject|1
804741|NCT02469298|2617790|P4|Overall Study|Withdrawal by Subject|1
804742|NCT02469298|2617791|P3|Overall Study|Withdrawal by Subject|0
804743|NCT02469298|2617792|P2|Overall Study|Withdrawal by Subject|0
804744|NCT02469298|2617793|P1|Overall Study|Withdrawal by Subject|0
804745|NCT02469298|2617790|P4|Overall Study|Physician Decision|1
804746|NCT02469298|2617791|P3|Overall Study|Physician Decision|0
804747|NCT02469298|2617792|P2|Overall Study|Physician Decision|0
804748|NCT02469298|2617793|P1|Overall Study|Physician Decision|0
804749|NCT02469298|2617790|P4|Overall Study|Lost to Follow-up|0
804750|NCT02469298|2617791|P3|Overall Study|Lost to Follow-up|1
804751|NCT02469298|2617792|P2|Overall Study|Lost to Follow-up|0
804752|NCT02469298|2617793|P1|Overall Study|Lost to Follow-up|1
804753|NCT02469298|2617790|P4|Overall Study|Protocol Violation|0
804754|NCT02469298|2617791|P3|Overall Study|Protocol Violation|1
804755|NCT02469298|2617792|P2|Overall Study|Protocol Violation|1
804756|NCT02469298|2617793|P1|Overall Study|Protocol Violation|0
804757|NCT02469246|2617933|P2|Overall Study|Lost to Follow-up|0
804758|NCT02469246|2617934|P1|Overall Study|Lost to Follow-up|3
804759|NCT02469246|2617933|P2|Overall Study|Withdrew Consent|6
804760|NCT02469246|2617934|P1|Overall Study|Withdrew Consent|9
804761|NCT02469246|2617933|P2|Overall Study|Protocol Violation|1
804762|NCT02469246|2617934|P1|Overall Study|Protocol Violation|0
804763|NCT02469246|2617933|P2|Overall Study|Non-Compliance with Study Drug|0
804764|NCT02469246|2617934|P1|Overall Study|Non-Compliance with Study Drug|1
804765|NCT02469246|2617933|P2|Overall Study|Investigator's Discretion|0
804766|NCT02469246|2617934|P1|Overall Study|Investigator's Discretion|1
804767|NCT02469246|2617933|P2|Overall Study|Lack of Efficacy|0
804768|NCT02469246|2617934|P1|Overall Study|Lack of Efficacy|1
804769|NCT02469246|2617933|P2|Overall Study|Death|0
804770|NCT02469246|2617934|P1|Overall Study|Death|1
804771|NCT02469246|2617933|P2|Overall Study|Adverse Event|5
804772|NCT02469246|2617934|P1|Overall Study|Adverse Event|6
804773|NCT02469246|2617933|P2|Overall Study|Still in Study up to the Data Cut Date|264
804774|NCT02469246|2617934|P1|Overall Study|Still in Study up to the Data Cut Date|258
804775|NCT02469246|2617933|P2|Overall Study|Randomized and Never Treated|6
804776|NCT02469246|2617934|P1|Overall Study|Randomized and Never Treated|5
804777|NCT02469168|2617952|P2|Overall Study|Trial closed|0
804778|NCT02469168|2617953|P1|Overall Study|Trial closed|1
804779|NCT02469064|2617973|P2|Overall Study|Request not to receive intervention.|3
804780|NCT02469064|2617974|P1|Overall Study|Request not to receive intervention.|1
804781|NCT02468934|2617982|P1|Overall Study|Screen Failure|3
804782|NCT02468934|2617982|P1|Overall Study|Withdrawal by Subject|4
804783|NCT02468414|2618065|P2|Overall Study|Screen Failure|0
804784|NCT02468414|2618066|P1|Overall Study|Screen Failure|1
804785|NCT02468414|2618065|P2|Overall Study|Poor in-vitro secreting TARGTs|0
804786|NCT02468414|2618066|P1|Overall Study|Poor in-vitro secreting TARGTs|1
804787|NCT02468414|2618065|P2|Overall Study|Early Study Termination by Sponsor|0
804788|NCT02468414|2618066|P1|Overall Study|Early Study Termination by Sponsor|1
804789|NCT02466659|2618126|P2|Overall Study|Lost to Follow-up|2
804790|NCT02466659|2618127|P1|Overall Study|Lost to Follow-up|5
804791|NCT02466425|2618137|P2|Overall Study|Withdrawal by Parent/Guardian|0
804792|NCT02466425|2618138|P1|Overall Study|Withdrawal by Parent/Guardian|2
804793|NCT02466425|2618137|P2|Overall Study|Other|3
804794|NCT02466425|2618138|P1|Overall Study|Other|1
804795|NCT02466425|2618137|P2|Overall Study|Withdrawal by Subject|1
804796|NCT02466425|2618138|P1|Overall Study|Withdrawal by Subject|0
804797|NCT02466425|2618137|P2|Overall Study|Protocol Violation|0
804798|NCT02466425|2618138|P1|Overall Study|Protocol Violation|1
804799|NCT02466425|2618137|P2|Overall Study|Lost to Follow-up|0
804800|NCT02466425|2618138|P1|Overall Study|Lost to Follow-up|3
804801|NCT02466425|2618137|P2|Overall Study|Lack of Efficacy|1
804802|NCT02466425|2618138|P1|Overall Study|Lack of Efficacy|4
804803|NCT02466425|2618137|P2|Overall Study|Adverse Event|11
804804|NCT02466425|2618138|P1|Overall Study|Adverse Event|3
804805|NCT02465866|2618163|P4|Period 3|Withdrawal by Subject|0
804806|NCT02465866|2618164|P3|Period 3|Withdrawal by Subject|0
804807|NCT02465866|2618165|P2|Period 3|Withdrawal by Subject|1
804808|NCT02465866|2618166|P1|Period 3|Withdrawal by Subject|0
804809|NCT02465489|2618252|P1|Overall Study|Adverse Event|5
804810|NCT02465463|2618281|P2|Overall Study|Protocol Violation|0
804811|NCT02465463|2618282|P1|Overall Study|Protocol Violation|1
804812|NCT02465463|2618281|P2|Overall Study|Death|0
804813|NCT02465463|2618282|P1|Overall Study|Death|1
804814|NCT02465463|2618281|P2|Overall Study|Lost to Follow-up|1
804815|NCT02465463|2618282|P1|Overall Study|Lost to Follow-up|2
804816|NCT02465437|2618330|P4|Overall Study|Adverse Event|0
804817|NCT02465437|2618331|P3|Overall Study|Adverse Event|0
804818|NCT02465437|2618332|P2|Overall Study|Adverse Event|1
804819|NCT02465437|2618333|P1|Overall Study|Adverse Event|0
804820|NCT02465437|2618330|P4|Overall Study|Withdrawal by Subject|1
804821|NCT02465437|2618331|P3|Overall Study|Withdrawal by Subject|0
804822|NCT02465437|2618332|P2|Overall Study|Withdrawal by Subject|0
804823|NCT02465437|2618333|P1|Overall Study|Withdrawal by Subject|1
804824|NCT02465437|2618330|P4|Overall Study|Physician Decision|0
804825|NCT02465437|2618331|P3|Overall Study|Physician Decision|1
804826|NCT02465437|2618332|P2|Overall Study|Physician Decision|0
804827|NCT02465437|2618333|P1|Overall Study|Physician Decision|0
804828|NCT02465203|2618388|P3|Overall Study|Patient/guardian decision|1
804829|NCT02465203|2618389|P2|Overall Study|Patient/guardian decision|1
804830|NCT02465203|2618390|P1|Overall Study|Patient/guardian decision|1
804831|NCT02465203|2618388|P3|Overall Study|New therapy for study indication|0
804832|NCT02465203|2618389|P2|Overall Study|New therapy for study indication|0
804833|NCT02465203|2618390|P1|Overall Study|New therapy for study indication|4
804834|NCT02465203|2618388|P3|Overall Study|Study terminated by sponsor|11
804835|NCT02465203|2618389|P2|Overall Study|Study terminated by sponsor|34
804836|NCT02465203|2618390|P1|Overall Study|Study terminated by sponsor|50
804837|NCT02465203|2618388|P3|Overall Study|Protocol Violation|1
804838|NCT02465203|2618389|P2|Overall Study|Protocol Violation|1
804839|NCT02465203|2618390|P1|Overall Study|Protocol Violation|1
804840|NCT02463409|2618485|P1|Overall Study|Screen failure|1
804841|NCT02463409|2618485|P1|Overall Study|Withdrawal by Subject|1
804842|NCT02463331|2618493|P2|Overall Study|Physician Decision|0
804843|NCT02463331|2618494|P1|Overall Study|Physician Decision|3
804844|NCT02463331|2618493|P2|Overall Study|Lack of Efficacy|0
804845|NCT02463331|2618494|P1|Overall Study|Lack of Efficacy|6
804846|NCT02463331|2618493|P2|Overall Study|Pregnancy|3
804847|NCT02463331|2618494|P1|Overall Study|Pregnancy|2
804848|NCT02463331|2618493|P2|Overall Study|Lost to Follow-up|1
804849|NCT02463331|2618494|P1|Overall Study|Lost to Follow-up|1
804850|NCT02463331|2618493|P2|Overall Study|Adverse Event|2
804851|NCT02463331|2618494|P1|Overall Study|Adverse Event|4
804852|NCT02463097|2618510|P1|Overall Study|Withdrawal by Subject|1
804853|NCT02463071|2618519|P3|Overall Study|Lost to Follow-up|1
804854|NCT02463071|2618520|P2|Overall Study|Lost to Follow-up|0
804855|NCT02463071|2618521|P1|Overall Study|Lost to Follow-up|0
804856|NCT02463071|2618519|P3|Overall Study|Protocol Violation|0
804857|NCT02463071|2618520|P2|Overall Study|Protocol Violation|2
804858|NCT02463071|2618521|P1|Overall Study|Protocol Violation|0
804859|NCT02463071|2618519|P3|Overall Study|Reason not specified|4
804860|NCT02463071|2618520|P2|Overall Study|Reason not specified|9
804861|NCT02463071|2618521|P1|Overall Study|Reason not specified|7
804862|NCT02463071|2618519|P3|Overall Study|Eligibility criteria not fulfilled|0
804863|NCT02463071|2618520|P2|Overall Study|Eligibility criteria not fulfilled|0
804864|NCT02463071|2618521|P1|Overall Study|Eligibility criteria not fulfilled|1
804865|NCT02463071|2618519|P3|Overall Study|Death|0
804866|NCT02463071|2618520|P2|Overall Study|Death|0
804867|NCT02463071|2618521|P1|Overall Study|Death|1
804868|NCT02463071|2618519|P3|Overall Study|Adverse Event|1
804869|NCT02463071|2618520|P2|Overall Study|Adverse Event|5
804870|NCT02463071|2618521|P1|Overall Study|Adverse Event|3
804871|NCT02462720|2618547|P2|Part 2|Protocol Violation|1
804872|NCT02462720|2618548|P1|Part 2|Protocol Violation|0
804873|NCT02462720|2618547|P2|Part 2|Withdrawal by Subject|0
804874|NCT02462720|2618548|P1|Part 2|Withdrawal by Subject|1
804875|NCT02462473|2618558|P1|Overall Study|Other|3
804876|NCT02462473|2618558|P1|Overall Study|Death|1
804877|NCT02462057|2618643|P5|Overall Study|Joined HealthyFood Before Intervention|17
804878|NCT02462057|2618644|P4|Overall Study|Joined HealthyFood Before Intervention|16
804879|NCT02462057|2618645|P3|Overall Study|Joined HealthyFood Before Intervention|23
804880|NCT02462057|2618646|P2|Overall Study|Joined HealthyFood Before Intervention|13
804881|NCT02462057|2618647|P1|Overall Study|Joined HealthyFood Before Intervention|22
804882|NCT02462057|2618643|P5|Overall Study|Left Vitality|33
804883|NCT02462057|2618644|P4|Overall Study|Left Vitality|35
804884|NCT02462057|2618645|P3|Overall Study|Left Vitality|23
804885|NCT02462057|2618646|P2|Overall Study|Left Vitality|27
804886|NCT02462057|2618647|P1|Overall Study|Left Vitality|32
804887|NCT02461589|2618714|P10|Overall Study|Withdrawal from trial before exposure|1
804888|NCT02461589|2618715|P9|Overall Study|Withdrawal from trial before exposure|0
804889|NCT02461589|2618716|P8|Overall Study|Withdrawal from trial before exposure|0
804890|NCT02461589|2618717|P7|Overall Study|Withdrawal from trial before exposure|0
804891|NCT02461589|2618718|P6|Overall Study|Withdrawal from trial before exposure|0
804892|NCT02461589|2618719|P5|Overall Study|Withdrawal from trial before exposure|0
804893|NCT02461589|2618720|P4|Overall Study|Withdrawal from trial before exposure|0
804894|NCT02461589|2618721|P3|Overall Study|Withdrawal from trial before exposure|0
804895|NCT02461589|2618722|P2|Overall Study|Withdrawal from trial before exposure|0
804896|NCT02461589|2618723|P1|Overall Study|Withdrawal from trial before exposure|0
804897|NCT02461589|2618714|P10|Overall Study|Missing follow-up information|0
804898|NCT02461589|2618715|P9|Overall Study|Missing follow-up information|0
804899|NCT02461589|2618716|P8|Overall Study|Missing follow-up information|0
804900|NCT02461589|2618717|P7|Overall Study|Missing follow-up information|1
804901|NCT02461589|2618718|P6|Overall Study|Missing follow-up information|0
804902|NCT02461589|2618719|P5|Overall Study|Missing follow-up information|0
804903|NCT02461589|2618720|P4|Overall Study|Missing follow-up information|0
804904|NCT02461589|2618721|P3|Overall Study|Missing follow-up information|0
804905|NCT02461589|2618722|P2|Overall Study|Missing follow-up information|1
804906|NCT02461589|2618723|P1|Overall Study|Missing follow-up information|1
804907|NCT02461589|2618714|P10|Overall Study|Unclassified|2
804908|NCT02461589|2618715|P9|Overall Study|Unclassified|0
804909|NCT02461589|2618716|P8|Overall Study|Unclassified|0
804910|NCT02461589|2618717|P7|Overall Study|Unclassified|1
804911|NCT02461589|2618718|P6|Overall Study|Unclassified|0
804912|NCT02461589|2618719|P5|Overall Study|Unclassified|0
804913|NCT02461589|2618720|P4|Overall Study|Unclassified|0
804914|NCT02461589|2618721|P3|Overall Study|Unclassified|0
804915|NCT02461589|2618722|P2|Overall Study|Unclassified|0
804916|NCT02461589|2618723|P1|Overall Study|Unclassified|0
804917|NCT02461589|2618714|P10|Overall Study|Death|0
804918|NCT02461589|2618715|P9|Overall Study|Death|0
804919|NCT02461589|2618716|P8|Overall Study|Death|1
804920|NCT02461589|2618717|P7|Overall Study|Death|0
804921|NCT02461589|2618718|P6|Overall Study|Death|0
804922|NCT02461589|2618719|P5|Overall Study|Death|0
804923|NCT02461589|2618720|P4|Overall Study|Death|0
804924|NCT02461589|2618721|P3|Overall Study|Death|0
804925|NCT02461589|2618722|P2|Overall Study|Death|0
804926|NCT02461589|2618723|P1|Overall Study|Death|0
804927|NCT02461589|2618714|P10|Overall Study|Lost to Follow-up|1
804928|NCT02461589|2618715|P9|Overall Study|Lost to Follow-up|3
804929|NCT02461589|2618716|P8|Overall Study|Lost to Follow-up|1
804930|NCT02461589|2618717|P7|Overall Study|Lost to Follow-up|3
804931|NCT02461589|2618718|P6|Overall Study|Lost to Follow-up|1
804932|NCT02461589|2618719|P5|Overall Study|Lost to Follow-up|1
804933|NCT02461589|2618720|P4|Overall Study|Lost to Follow-up|3
804934|NCT02461589|2618721|P3|Overall Study|Lost to Follow-up|2
804935|NCT02461589|2618722|P2|Overall Study|Lost to Follow-up|0
804936|NCT02461589|2618723|P1|Overall Study|Lost to Follow-up|0
804937|NCT02461589|2618714|P10|Overall Study|Withdrawal by Subject|1
804938|NCT02461589|2618715|P9|Overall Study|Withdrawal by Subject|3
804939|NCT02461589|2618716|P8|Overall Study|Withdrawal by Subject|3
804940|NCT02461589|2618717|P7|Overall Study|Withdrawal by Subject|1
804941|NCT02461589|2618718|P6|Overall Study|Withdrawal by Subject|2
804942|NCT02461589|2618719|P5|Overall Study|Withdrawal by Subject|1
804943|NCT02461589|2618720|P4|Overall Study|Withdrawal by Subject|2
804944|NCT02461589|2618721|P3|Overall Study|Withdrawal by Subject|3
804945|NCT02461589|2618722|P2|Overall Study|Withdrawal by Subject|1
804946|NCT02461589|2618723|P1|Overall Study|Withdrawal by Subject|5
804947|NCT02461290|2618849|P1|Overall Study|Lost to Follow-up|3
804948|NCT02461290|2618849|P1|Overall Study|Withdrawn for Inadequate Clinical Stage|7
804949|NCT02461134|2618856|P1|Overall Study|Adverse Event|1
804950|NCT02460991|2618864|P2|Overall Study|Withdrawal by Subject|2
804951|NCT02460991|2618865|P1|Overall Study|Withdrawal by Subject|0
804952|NCT02460978|2618882|P3|Overall Study|Pregnancy|2
804953|NCT02460978|2618883|P2|Overall Study|Pregnancy|0
804954|NCT02460978|2618884|P1|Overall Study|Pregnancy|0
804955|NCT02460978|2618882|P3|Overall Study|Discontinued due to DKA/hypoglycemia|4
804956|NCT02460978|2618883|P2|Overall Study|Discontinued due to DKA/hypoglycemia|5
804957|NCT02460978|2618884|P1|Overall Study|Discontinued due to DKA/hypoglycemia|2
804958|NCT02460978|2618882|P3|Overall Study|Protocol Violation|1
804959|NCT02460978|2618883|P2|Overall Study|Protocol Violation|1
804960|NCT02460978|2618884|P1|Overall Study|Protocol Violation|1
804961|NCT02460978|2618882|P3|Overall Study|Lost to Follow-up|1
804962|NCT02460978|2618883|P2|Overall Study|Lost to Follow-up|3
804963|NCT02460978|2618884|P1|Overall Study|Lost to Follow-up|2
804964|NCT02460978|2618882|P3|Overall Study|Withdrawal by Subject|14
804965|NCT02460978|2618883|P2|Overall Study|Withdrawal by Subject|5
804966|NCT02460978|2618884|P1|Overall Study|Withdrawal by Subject|5
804967|NCT02460978|2618882|P3|Overall Study|Adverse Event|11
804968|NCT02460978|2618883|P2|Overall Study|Adverse Event|11
804969|NCT02460978|2618884|P1|Overall Study|Adverse Event|17
804970|NCT02460822|2618910|P1|Overall Study|Withdrawal by Subject|1
804971|NCT02460380|2618927|P2|Overall Study|Withdrawal by Subject|5
804972|NCT02460380|2618928|P1|Overall Study|Withdrawal by Subject|10
804973|NCT02460159|2618950|P2|Overall Study|Withdrawal by Subject|0
804974|NCT02460159|2618951|P1|Overall Study|Withdrawal by Subject|2
804975|NCT02460159|2618950|P2|Overall Study|Adverse Event|1
804976|NCT02460159|2618951|P1|Overall Study|Adverse Event|4
804977|NCT02459418|2618981|P2|Overall Study|Abnormal Transvaginal Ultrasound|0
804978|NCT02459418|2618982|P1|Overall Study|Abnormal Transvaginal Ultrasound|1
804979|NCT02459418|2618981|P2|Overall Study|Elevated Creatine Kinase|0
804980|NCT02459418|2618982|P1|Overall Study|Elevated Creatine Kinase|1
804981|NCT02459418|2618981|P2|Overall Study|Withdrawal by Subject|1
804982|NCT02459418|2618982|P1|Overall Study|Withdrawal by Subject|1
804983|NCT02459418|2618981|P2|Overall Study|Adverse Event|1
804984|NCT02459418|2618982|P1|Overall Study|Adverse Event|0
804985|NCT02459418|2618981|P2|Overall Study|Endometrial thickness of >5 mm|0
804986|NCT02459418|2618982|P1|Overall Study|Endometrial thickness of >5 mm|1
804987|NCT02459418|2618981|P2|Overall Study|Physician Decision|2
804988|NCT02459418|2618982|P1|Overall Study|Physician Decision|0
804989|NCT02459418|2618981|P2|Overall Study|Protocol Violation|2
804990|NCT02459418|2618982|P1|Overall Study|Protocol Violation|0
804991|NCT02459418|2618981|P2|Overall Study|Exclusion Criteria|0
804992|NCT02459418|2618982|P1|Overall Study|Exclusion Criteria|4
804993|NCT02459093|2619004|P2|Overall Study|Lost to Follow-up|7
804994|NCT02459093|2619005|P1|Overall Study|Lost to Follow-up|6
804995|NCT02459093|2619004|P2|Overall Study|Protocol Violation|11
804996|NCT02459093|2619005|P1|Overall Study|Protocol Violation|6
804997|NCT02458287|2619049|P4|Overall Study|Relocated Out of State|1
804998|NCT02458287|2619050|P3|Overall Study|Relocated Out of State|0
804999|NCT02458287|2619051|P2|Overall Study|Relocated Out of State|0
805000|NCT02458287|2619052|P1|Overall Study|Relocated Out of State|0
805001|NCT02458287|2619049|P4|Overall Study|Withdrawal by Subject|1
805002|NCT02458287|2619050|P3|Overall Study|Withdrawal by Subject|2
805003|NCT02458287|2619051|P2|Overall Study|Withdrawal by Subject|2
805004|NCT02458287|2619052|P1|Overall Study|Withdrawal by Subject|0
805005|NCT02458287|2619049|P4|Overall Study|Protocol Violation|0
805006|NCT02458287|2619050|P3|Overall Study|Protocol Violation|0
805007|NCT02458287|2619051|P2|Overall Study|Protocol Violation|1
805008|NCT02458287|2619052|P1|Overall Study|Protocol Violation|0
805009|NCT02458287|2619049|P4|Overall Study|Lost to Follow-up|0
805010|NCT02458287|2619050|P3|Overall Study|Lost to Follow-up|1
805011|NCT02458287|2619051|P2|Overall Study|Lost to Follow-up|1
805012|NCT02458287|2619052|P1|Overall Study|Lost to Follow-up|0
805013|NCT02458287|2619049|P4|Overall Study|Adverse Event|1
805014|NCT02458287|2619050|P3|Overall Study|Adverse Event|0
805015|NCT02458287|2619051|P2|Overall Study|Adverse Event|0
805016|NCT02458287|2619052|P1|Overall Study|Adverse Event|0
805017|NCT02457793|2619103|P6|Overall Study|Physician Decision|3
805018|NCT02457793|2619104|P5|Overall Study|Physician Decision|1
805019|NCT02457793|2619105|P4|Overall Study|Physician Decision|1
805020|NCT02457793|2619106|P3|Overall Study|Physician Decision|1
805021|NCT02457793|2619107|P2|Overall Study|Physician Decision|0
805022|NCT02457793|2619108|P1|Overall Study|Physician Decision|1
805023|NCT02457793|2619103|P6|Overall Study|Adverse Event|0
805024|NCT02457793|2619104|P5|Overall Study|Adverse Event|0
805025|NCT02457793|2619105|P4|Overall Study|Adverse Event|1
805026|NCT02457793|2619106|P3|Overall Study|Adverse Event|0
805027|NCT02457793|2619107|P2|Overall Study|Adverse Event|0
805028|NCT02457793|2619108|P1|Overall Study|Adverse Event|0
805029|NCT02457793|2619103|P6|Overall Study|Withdrawal by Subject|2
805030|NCT02457793|2619104|P5|Overall Study|Withdrawal by Subject|2
805031|NCT02457793|2619105|P4|Overall Study|Withdrawal by Subject|2
805032|NCT02457793|2619106|P3|Overall Study|Withdrawal by Subject|2
805033|NCT02457793|2619107|P2|Overall Study|Withdrawal by Subject|4
805034|NCT02457793|2619108|P1|Overall Study|Withdrawal by Subject|0
805035|NCT02457793|2619103|P6|Overall Study|Reason not specified|1
805036|NCT02457793|2619104|P5|Overall Study|Reason not specified|1
805037|NCT02457793|2619105|P4|Overall Study|Reason not specified|1
805038|NCT02457793|2619106|P3|Overall Study|Reason not specified|0
805039|NCT02457793|2619107|P2|Overall Study|Reason not specified|0
805040|NCT02457793|2619108|P1|Overall Study|Reason not specified|0
805041|NCT02457611|2619252|P1|Overall Study|Lost to Follow-up|3
805042|NCT02457247|2619311|P4|Period 2|Voluntary Withdrawal|0
805043|NCT02457247|2619312|P3|Period 2|Voluntary Withdrawal|0
805044|NCT02457247|2619313|P2|Period 2|Voluntary Withdrawal|1
805045|NCT02457247|2619314|P1|Period 2|Voluntary Withdrawal|1
805046|NCT02457247|2619311|P4|Period 2|Lost to Follow-up|0
805047|NCT02457247|2619312|P3|Period 2|Lost to Follow-up|0
805048|NCT02457247|2619313|P2|Period 2|Lost to Follow-up|1
805049|NCT02457247|2619314|P1|Period 2|Lost to Follow-up|0
805050|NCT02457247|2619311|P4|Period 2|Significant Protocol Deviation|0
805051|NCT02457247|2619312|P3|Period 2|Significant Protocol Deviation|0
805052|NCT02457247|2619313|P2|Period 2|Significant Protocol Deviation|0
805053|NCT02457247|2619314|P1|Period 2|Significant Protocol Deviation|1
805054|NCT02457247|2619311|P4|Period 2|Pretreatment Event/Adverse Event|0
805055|NCT02457247|2619312|P3|Period 2|Pretreatment Event/Adverse Event|0
805056|NCT02457247|2619313|P2|Period 2|Pretreatment Event/Adverse Event|1
805057|NCT02457247|2619314|P1|Period 2|Pretreatment Event/Adverse Event|0
805058|NCT02457247|2619311|P4|Period 1|Voluntary Withdrawal|0
805059|NCT02457247|2619312|P3|Period 1|Voluntary Withdrawal|0
805060|NCT02457247|2619313|P2|Period 1|Voluntary Withdrawal|0
805061|NCT02457247|2619314|P1|Period 1|Voluntary Withdrawal|1
805062|NCT02457247|2619311|P4|Period 1|Significant Protocol Deviation|0
805063|NCT02457247|2619312|P3|Period 1|Significant Protocol Deviation|0
805064|NCT02457247|2619313|P2|Period 1|Significant Protocol Deviation|1
805065|NCT02457247|2619314|P1|Period 1|Significant Protocol Deviation|1
805066|NCT02457247|2619311|P4|Period 1|Pretreatment Event/Adverse Event|0
805067|NCT02457247|2619312|P3|Period 1|Pretreatment Event/Adverse Event|0
805068|NCT02457247|2619313|P2|Period 1|Pretreatment Event/Adverse Event|1
805069|NCT02457247|2619314|P1|Period 1|Pretreatment Event/Adverse Event|0
805070|NCT02457182|2619336|P2|Overall Study|Lost to Follow-up|0
805071|NCT02457182|2619337|P1|Overall Study|Lost to Follow-up|1
805072|NCT02456740|2619356|P9|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
805073|NCT02456740|2619357|P8|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
805074|NCT02456740|2619358|P7|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
805075|NCT02456740|2619359|P6|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
805076|NCT02456740|2619360|P5|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2
805077|NCT02456740|2619361|P4|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
805078|NCT02456740|2619362|P3|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
805079|NCT02456740|2619363|P2|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
805080|NCT02456740|2619364|P1|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
805081|NCT02456740|2619356|P9|Active Treatment Phase (Weeks 24 - 52)|Death|0
805082|NCT02456740|2619357|P8|Active Treatment Phase (Weeks 24 - 52)|Death|1
805083|NCT02456740|2619358|P7|Active Treatment Phase (Weeks 24 - 52)|Death|0
805084|NCT02456740|2619359|P6|Active Treatment Phase (Weeks 24 - 52)|Death|0
805085|NCT02456740|2619360|P5|Active Treatment Phase (Weeks 24 - 52)|Death|0
805086|NCT02456740|2619361|P4|Active Treatment Phase (Weeks 24 - 52)|Death|0
805087|NCT02456740|2619362|P3|Active Treatment Phase (Weeks 24 - 52)|Death|0
805088|NCT02456740|2619363|P2|Active Treatment Phase (Weeks 24 - 52)|Death|0
805089|NCT02456740|2619364|P1|Active Treatment Phase (Weeks 24 - 52)|Death|0
805090|NCT02456740|2619356|P9|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
805091|NCT02456740|2619357|P8|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
805092|NCT02456740|2619358|P7|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
805093|NCT02456740|2619359|P6|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
805094|NCT02456740|2619360|P5|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11
805095|NCT02456740|2619361|P4|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10
805096|NCT02456740|2619362|P3|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
805097|NCT02456740|2619363|P2|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
805098|NCT02456740|2619364|P1|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
805099|NCT02456740|2619356|P9|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5
805100|NCT02456740|2619357|P8|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
805101|NCT02456740|2619358|P7|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
805102|NCT02456740|2619359|P6|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
805103|NCT02456740|2619360|P5|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4
805104|NCT02456740|2619361|P4|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1
805105|NCT02456740|2619362|P3|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
805106|NCT02456740|2619363|P2|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
805107|NCT02456740|2619364|P1|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
805108|NCT02456740|2619356|P9|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
805109|NCT02456740|2619357|P8|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
805110|NCT02456740|2619358|P7|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
805111|NCT02456740|2619359|P6|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
805112|NCT02456740|2619360|P5|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
805113|NCT02456740|2619361|P4|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
805114|NCT02456740|2619362|P3|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5
805115|NCT02456740|2619363|P2|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4
805116|NCT02456740|2619364|P1|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9
805117|NCT02456740|2619356|P9|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
805118|NCT02456740|2619357|P8|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
805119|NCT02456740|2619358|P7|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
805120|NCT02456740|2619359|P6|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
805121|NCT02456740|2619360|P5|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
805122|NCT02456740|2619361|P4|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
805123|NCT02456740|2619362|P3|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21
805124|NCT02456740|2619363|P2|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28
805125|NCT02456740|2619364|P1|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27
805126|NCT02456740|2619356|P9|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
805127|NCT02456740|2619357|P8|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
805128|NCT02456740|2619358|P7|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
805129|NCT02456740|2619359|P6|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
805130|NCT02456740|2619360|P5|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
805131|NCT02456740|2619361|P4|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
805132|NCT02456740|2619362|P3|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
805133|NCT02456740|2619363|P2|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
805134|NCT02456740|2619364|P1|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
805135|NCT02455518|2619390|P4|Overall Study|Protocol Violation|3
805136|NCT02455518|2619391|P3|Overall Study|Protocol Violation|1
805137|NCT02455518|2619392|P2|Overall Study|Protocol Violation|1
805138|NCT02455518|2619393|P1|Overall Study|Protocol Violation|0
805139|NCT02455388|2619409|P3|Overall Study|Withdrawal by Subject|7
805140|NCT02455388|2619410|P2|Overall Study|Withdrawal by Subject|0
805141|NCT02455388|2619411|P1|Overall Study|Withdrawal by Subject|0
805142|NCT02455388|2619409|P3|Overall Study|Protocol Violation|4
805143|NCT02455388|2619410|P2|Overall Study|Protocol Violation|0
805144|NCT02455388|2619411|P1|Overall Study|Protocol Violation|1
805145|NCT02455050|2619422|P4|Treatment Period 2|Lost to Follow-up|1
805146|NCT02455050|2619423|P3|Treatment Period 2|Lost to Follow-up|2
805147|NCT02455050|2619424|P2|Treatment Period 2|Lost to Follow-up|0
805148|NCT02455050|2619425|P1|Treatment Period 2|Lost to Follow-up|1
805149|NCT02455050|2619422|P4|Treatment Period 1|Lost to Follow-up|2
805150|NCT02455050|2619423|P3|Treatment Period 1|Lost to Follow-up|1
805151|NCT02455050|2619424|P2|Treatment Period 1|Lost to Follow-up|1
805152|NCT02455050|2619425|P1|Treatment Period 1|Lost to Follow-up|1
805153|NCT02454959|2619489|P1|Overall Study|Adverse Event|2
805154|NCT02454959|2619489|P1|Overall Study|Withdrawal by Subject|3
805155|NCT02454959|2619489|P1|Overall Study|Physician Decision|1
805156|NCT02454959|2619489|P1|Overall Study|Protocol-Specified Criteria|3
805157|NCT02454933|2619509|P2|Overall Study|Withdrawal by Subject|2
805158|NCT02454933|2619510|P1|Overall Study|Withdrawal by Subject|0
805159|NCT02454933|2619509|P2|Overall Study|Adverse Event|1
805160|NCT02454933|2619510|P1|Overall Study|Adverse Event|1
805161|NCT02454933|2619509|P2|Overall Study|Progressive disease|5
805162|NCT02454933|2619510|P1|Overall Study|Progressive disease|7
805163|NCT02454608|2619518|P3|Open Label Period|Withdrawal by Subject|8
805164|NCT02454608|2619519|P2|Open Label Period|Withdrawal by Subject|0
805165|NCT02454608|2619520|P1|Open Label Period|Withdrawal by Subject|0
805166|NCT02454608|2619518|P3|Open Label Period|Lost to Follow-up|11
805167|NCT02454608|2619519|P2|Open Label Period|Lost to Follow-up|0
805168|NCT02454608|2619520|P1|Open Label Period|Lost to Follow-up|0
805169|NCT02454608|2619518|P3|Double-Blind Period|Lack of Efficacy|0
805170|NCT02454608|2619519|P2|Double-Blind Period|Lack of Efficacy|2
805171|NCT02454608|2619520|P1|Double-Blind Period|Lack of Efficacy|0
805172|NCT02454101|2619612|P2|Overall Study|Lost to Follow-up|4
805173|NCT02454101|2619613|P1|Overall Study|Lost to Follow-up|3
805174|NCT02454101|2619612|P2|Overall Study|Adverse Event|3
805175|NCT02454101|2619613|P1|Overall Study|Adverse Event|2
805176|NCT02453841|2619635|P1|Overall Study|Unable to obtain blood samples|2
805177|NCT02453841|2619635|P1|Overall Study|Protocol Violation|1
805178|NCT02453321|2619680|P3|Overall Study|Deep Venous Thrombosis|0
805179|NCT02453321|2619681|P2|Overall Study|Deep Venous Thrombosis|1
805180|NCT02453321|2619682|P1|Overall Study|Deep Venous Thrombosis|0
805181|NCT02453321|2619680|P3|Overall Study|Weakness|2
805182|NCT02453321|2619681|P2|Overall Study|Weakness|1
805183|NCT02453321|2619682|P1|Overall Study|Weakness|1
805184|NCT02452892|2619714|P4|Follow-up|Subject left town on Day 42|0
805185|NCT02452892|2619715|P3|Follow-up|Subject left town on Day 42|0
805186|NCT02452892|2619716|P2|Follow-up|Subject left town on Day 42|0
805187|NCT02452892|2619717|P1|Follow-up|Subject left town on Day 42|1
805188|NCT02452892|2619714|P4|Follow-up|Withdrawal by Subject|1
805189|NCT02452892|2619715|P3|Follow-up|Withdrawal by Subject|0
805190|NCT02452892|2619716|P2|Follow-up|Withdrawal by Subject|0
805191|NCT02452892|2619717|P1|Follow-up|Withdrawal by Subject|0
805192|NCT02452892|2619714|P4|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
805193|NCT02452892|2619715|P3|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
805194|NCT02452892|2619716|P2|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
805195|NCT02452892|2619717|P1|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2
805196|NCT02452892|2619714|P4|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2
805197|NCT02452892|2619715|P3|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
805198|NCT02452892|2619716|P2|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
805199|NCT02452892|2619717|P1|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
805200|NCT02452892|2619714|P4|Week 1 Initial Randommization|Lost to Follow-up|0
805201|NCT02452892|2619715|P3|Week 1 Initial Randommization|Lost to Follow-up|1
805202|NCT02452892|2619716|P2|Week 1 Initial Randommization|Lost to Follow-up|0
805203|NCT02452892|2619717|P1|Week 1 Initial Randommization|Lost to Follow-up|0
805204|NCT02452892|2619714|P4|Week 1 Initial Randommization|Adverse Event|0
805205|NCT02452892|2619715|P3|Week 1 Initial Randommization|Adverse Event|0
805206|NCT02452892|2619716|P2|Week 1 Initial Randommization|Adverse Event|0
805207|NCT02452892|2619717|P1|Week 1 Initial Randommization|Adverse Event|1
805208|NCT02452320|2619789|P2|Overall Study|Adverse Event|1
805209|NCT02452320|2619790|P1|Overall Study|Adverse Event|0
805210|NCT02452047|2619803|P3|Overall Study|Withdrawal by Subject|0
805211|NCT02452047|2619804|P2|Overall Study|Withdrawal by Subject|0
805212|NCT02452047|2619805|P1|Overall Study|Withdrawal by Subject|1
805213|NCT02452047|2619803|P3|Overall Study|Lost to Follow-up|0
805214|NCT02452047|2619804|P2|Overall Study|Lost to Follow-up|1
805215|NCT02452047|2619805|P1|Overall Study|Lost to Follow-up|1
805216|NCT02452047|2619803|P3|Overall Study|Physician Decision|0
805217|NCT02452047|2619804|P2|Overall Study|Physician Decision|0
805218|NCT02452047|2619805|P1|Overall Study|Physician Decision|1
805219|NCT02452047|2619803|P3|Overall Study|Death|1
805220|NCT02452047|2619804|P2|Overall Study|Death|3
805221|NCT02452047|2619805|P1|Overall Study|Death|1
805222|NCT02452047|2619803|P3|Overall Study|Adverse Event|1
805223|NCT02452047|2619804|P2|Overall Study|Adverse Event|1
805224|NCT02452047|2619805|P1|Overall Study|Adverse Event|0
805225|NCT02451917|2619866|P2|First Intervention (24 Weeks)|Adverse Event|2
805226|NCT02451917|2619867|P1|First Intervention (24 Weeks)|Adverse Event|0
805227|NCT02451917|2619866|P2|First Intervention (24 Weeks)|Death|1
805228|NCT02451917|2619867|P1|First Intervention (24 Weeks)|Death|0
805229|NCT02451917|2619866|P2|First Intervention (24 Weeks)|Lost to Follow-up|0
805230|NCT02451917|2619867|P1|First Intervention (24 Weeks)|Lost to Follow-up|2
805231|NCT02451358|2619889|P4|Overall Study|Protocol Violation|0
805232|NCT02451358|2619890|P3|Overall Study|Protocol Violation|1
805233|NCT02451358|2619891|P2|Overall Study|Protocol Violation|1
805234|NCT02451358|2619892|P1|Overall Study|Protocol Violation|0
805235|NCT02451358|2619889|P4|Overall Study|Withdrawal by Subject|0
805236|NCT02451358|2619890|P3|Overall Study|Withdrawal by Subject|0
805237|NCT02451358|2619891|P2|Overall Study|Withdrawal by Subject|1
805238|NCT02451358|2619892|P1|Overall Study|Withdrawal by Subject|1
805239|NCT02450539|2619998|P2|Overall Study|On study treatment/follow up|25
805240|NCT02450539|2619999|P1|Overall Study|On study treatment/follow up|27
805241|NCT02450539|2619998|P2|Overall Study|Lost to Follow-up|1
805242|NCT02450539|2619999|P1|Overall Study|Lost to Follow-up|4
805243|NCT02450539|2619998|P2|Overall Study|Withdrawal by Subject|7
805244|NCT02450539|2619999|P1|Overall Study|Withdrawal by Subject|19
805245|NCT02449915|2620036|P2|Overall Study|Abnormal preop lab|1
805246|NCT02449915|2620037|P1|Overall Study|Abnormal preop lab|0
805247|NCT02449915|2620036|P2|Overall Study|Intraoperative surgical findings|1
805248|NCT02449915|2620037|P1|Overall Study|Intraoperative surgical findings|1
805249|NCT02449915|2620036|P2|Overall Study|Withdrawal by Subject|2
805250|NCT02449915|2620037|P1|Overall Study|Withdrawal by Subject|0
805251|NCT02449915|2620036|P2|Overall Study|Exclusion criteria - drug use|0
805252|NCT02449915|2620037|P1|Overall Study|Exclusion criteria - drug use|1
805253|NCT02449902|2620045|P2|Overall Study|Withdrawal by Subject|1
805254|NCT02449902|2620046|P1|Overall Study|Withdrawal by Subject|0
805255|NCT02449902|2620045|P2|Overall Study|Adverse Event|1
805256|NCT02449902|2620046|P1|Overall Study|Adverse Event|0
805257|NCT02449044|2620101|P1|Overall Study|Sponsor Discontinued Trial|3
805258|NCT02449044|2620101|P1|Overall Study|Physician Decision|9
805259|NCT02449044|2620101|P1|Overall Study|Met Withdrawal Criteria|7
805260|NCT02449044|2620101|P1|Overall Study|Adverse Event|30
805261|NCT02449044|2620101|P1|Overall Study|Withdrawal by Subject|13
805262|NCT02449044|2620101|P1|Overall Study|Lost to Follow-up|2
805263|NCT02449018|2620122|P2|Overall Study|Patient decision|0
805264|NCT02449018|2620123|P1|Overall Study|Patient decision|2
805265|NCT02449018|2620122|P2|Overall Study|Protocol deviation|0
805266|NCT02449018|2620123|P1|Overall Study|Protocol deviation|4
805267|NCT02449018|2620122|P2|Overall Study|Adverse Event|1
805268|NCT02449018|2620123|P1|Overall Study|Adverse Event|5
805269|NCT02449018|2620122|P2|Overall Study|Administrative problems|0
805270|NCT02449018|2620123|P1|Overall Study|Administrative problems|1
805271|NCT02449018|2620122|P2|Overall Study|Abnormal laboratory value|1
805272|NCT02449018|2620123|P1|Overall Study|Abnormal laboratory value|0
805273|NCT02448810|2620192|P8|Overall Study|Other (unspecified)|0
805274|NCT02448810|2620193|P7|Overall Study|Other (unspecified)|2
805275|NCT02448810|2620194|P6|Overall Study|Other (unspecified)|0
805276|NCT02448810|2620195|P5|Overall Study|Other (unspecified)|0
805277|NCT02448810|2620196|P4|Overall Study|Other (unspecified)|0
805278|NCT02448810|2620197|P3|Overall Study|Other (unspecified)|0
805279|NCT02448810|2620198|P2|Overall Study|Other (unspecified)|0
805280|NCT02448810|2620199|P1|Overall Study|Other (unspecified)|0
805281|NCT02448810|2620192|P8|Overall Study|Lost to Follow-up|0
805282|NCT02448810|2620193|P7|Overall Study|Lost to Follow-up|0
805283|NCT02448810|2620194|P6|Overall Study|Lost to Follow-up|0
805284|NCT02448810|2620195|P5|Overall Study|Lost to Follow-up|0
805285|NCT02448810|2620196|P4|Overall Study|Lost to Follow-up|0
805286|NCT02448810|2620197|P3|Overall Study|Lost to Follow-up|0
805287|NCT02448810|2620198|P2|Overall Study|Lost to Follow-up|1
805288|NCT02448810|2620199|P1|Overall Study|Lost to Follow-up|0
805289|NCT02448810|2620192|P8|Overall Study|Other (Progressive disease)|5
805290|NCT02448810|2620193|P7|Overall Study|Other (Progressive disease)|14
805291|NCT02448810|2620194|P6|Overall Study|Other (Progressive disease)|9
805292|NCT02448810|2620195|P5|Overall Study|Other (Progressive disease)|23
805293|NCT02448810|2620196|P4|Overall Study|Other (Progressive disease)|3
805294|NCT02448810|2620197|P3|Overall Study|Other (Progressive disease)|0
805295|NCT02448810|2620198|P2|Overall Study|Other (Progressive disease)|2
805296|NCT02448810|2620199|P1|Overall Study|Other (Progressive disease)|2
805297|NCT02448810|2620192|P8|Overall Study|Death|0
805298|NCT02448810|2620193|P7|Overall Study|Death|0
805299|NCT02448810|2620194|P6|Overall Study|Death|0
805300|NCT02448810|2620195|P5|Overall Study|Death|1
805301|NCT02448810|2620196|P4|Overall Study|Death|0
805302|NCT02448810|2620197|P3|Overall Study|Death|1
805303|NCT02448810|2620198|P2|Overall Study|Death|0
805304|NCT02448810|2620199|P1|Overall Study|Death|1
805305|NCT02448810|2620192|P8|Overall Study|Other (study terminated by sponsor)|1
805306|NCT02448810|2620193|P7|Overall Study|Other (study terminated by sponsor)|2
805307|NCT02448810|2620194|P6|Overall Study|Other (study terminated by sponsor)|2
805308|NCT02448810|2620195|P5|Overall Study|Other (study terminated by sponsor)|4
805309|NCT02448810|2620196|P4|Overall Study|Other (study terminated by sponsor)|0
805310|NCT02448810|2620197|P3|Overall Study|Other (study terminated by sponsor)|0
805311|NCT02448810|2620198|P2|Overall Study|Other (study terminated by sponsor)|0
805312|NCT02448810|2620199|P1|Overall Study|Other (study terminated by sponsor)|0
805313|NCT02448810|2620192|P8|Overall Study|Withdrawal by Subject|2
805314|NCT02448810|2620193|P7|Overall Study|Withdrawal by Subject|0
805315|NCT02448810|2620194|P6|Overall Study|Withdrawal by Subject|5
805316|NCT02448810|2620195|P5|Overall Study|Withdrawal by Subject|3
805317|NCT02448810|2620196|P4|Overall Study|Withdrawal by Subject|0
805318|NCT02448810|2620197|P3|Overall Study|Withdrawal by Subject|1
805319|NCT02448810|2620198|P2|Overall Study|Withdrawal by Subject|0
805320|NCT02448810|2620199|P1|Overall Study|Withdrawal by Subject|0
805321|NCT02448810|2620192|P8|Overall Study|Adverse Event|0
805322|NCT02448810|2620193|P7|Overall Study|Adverse Event|0
805323|NCT02448810|2620194|P6|Overall Study|Adverse Event|0
805324|NCT02448810|2620195|P5|Overall Study|Adverse Event|0
805325|NCT02448810|2620196|P4|Overall Study|Adverse Event|0
805326|NCT02448810|2620197|P3|Overall Study|Adverse Event|1
805327|NCT02448810|2620198|P2|Overall Study|Adverse Event|0
805328|NCT02448810|2620199|P1|Overall Study|Adverse Event|0
805329|NCT02448563|2620269|P2|Overall Study|Withdrawal by Subject|1
805330|NCT02448563|2620270|P1|Overall Study|Withdrawal by Subject|0
805331|NCT02448563|2620269|P2|Overall Study|Lost to Follow-up|10
805332|NCT02448563|2620270|P1|Overall Study|Lost to Follow-up|16
805333|NCT02448537|2620292|P3|Overall Study|Withdrawal by Subject|1
805334|NCT02448537|2620293|P2|Overall Study|Withdrawal by Subject|1
805335|NCT02448537|2620294|P1|Overall Study|Withdrawal by Subject|1
805336|NCT02447848|2620397|P1|Overall Study|Withdrawal by Subject|4
805337|NCT02447848|2620397|P1|Overall Study|Lack of Efficacy|4
805338|NCT02447848|2620397|P1|Overall Study|Patient discharged|3
805339|NCT02447458|2620409|P6|Overall Study|Other|0
805340|NCT02447458|2620410|P5|Overall Study|Other|0
805341|NCT02447458|2620411|P4|Overall Study|Other|0
805342|NCT02447458|2620412|P3|Overall Study|Other|1
805343|NCT02447458|2620413|P2|Overall Study|Other|0
805344|NCT02447458|2620414|P1|Overall Study|Other|0
805345|NCT02447432|2620512|P2|Epoch 001|Lost to Follow-up|3
805346|NCT02447432|2620513|P1|Epoch 001|Lost to Follow-up|1
805347|NCT02447432|2620512|P2|Epoch 001|Migrated/moved from study area|5
805348|NCT02447432|2620513|P1|Epoch 001|Migrated/moved from study area|3
805349|NCT02447432|2620512|P2|Epoch 001|Withdrawal by Subject|4
805350|NCT02447432|2620513|P1|Epoch 001|Withdrawal by Subject|0
805351|NCT02447432|2620512|P2|Epoch 001|Adverse Event|1
805352|NCT02447432|2620513|P1|Epoch 001|Adverse Event|1
805353|NCT02447328|2620545|P1|Overall Study|Withdrawal by Subject|1
805354|NCT02447029|2620557|P2|Overall Study|Withdrawal by Subject|2
805355|NCT02447029|2620558|P1|Overall Study|Withdrawal by Subject|3
805356|NCT02446990|2620578|P2|Overall Study|Withdrawal by Subject|199
805357|NCT02446990|2620579|P1|Overall Study|Withdrawal by Subject|231
805358|NCT02446990|2620578|P2|Overall Study|Physician Decision|0
805359|NCT02446990|2620579|P1|Overall Study|Physician Decision|1
805360|NCT02446990|2620578|P2|Overall Study|Lost to Follow-up|1
805361|NCT02446990|2620579|P1|Overall Study|Lost to Follow-up|3
805362|NCT02446990|2620578|P2|Overall Study|Death|458
805363|NCT02446990|2620579|P1|Overall Study|Death|485
805364|NCT02446743|2620613|P2|Overall Study|Other|3
805365|NCT02446743|2620614|P1|Overall Study|Other|2
805366|NCT02446743|2620613|P2|Overall Study|Adverse Event|1
805367|NCT02446743|2620614|P1|Overall Study|Adverse Event|1
805368|NCT02446743|2620613|P2|Overall Study|Lost to Follow-up|0
805369|NCT02446743|2620614|P1|Overall Study|Lost to Follow-up|1
805370|NCT02446743|2620613|P2|Overall Study|Withdrawal by Subject|1
805371|NCT02446743|2620614|P1|Overall Study|Withdrawal by Subject|1
805372|NCT02446717|2620769|P5|Overall Study|Withdrew consent|0
805373|NCT02446717|2620770|P4|Overall Study|Withdrew consent|1
805374|NCT02446717|2620771|P3|Overall Study|Withdrew consent|0
805375|NCT02446717|2620772|P2|Overall Study|Withdrew consent|0
805376|NCT02446717|2620773|P1|Overall Study|Withdrew consent|0
805377|NCT02446717|2620769|P5|Overall Study|Lost to Follow-up|1
805378|NCT02446717|2620770|P4|Overall Study|Lost to Follow-up|0
805379|NCT02446717|2620771|P3|Overall Study|Lost to Follow-up|1
805380|NCT02446717|2620772|P2|Overall Study|Lost to Follow-up|1
805381|NCT02446717|2620773|P1|Overall Study|Lost to Follow-up|0
805382|NCT02446717|2620769|P5|Overall Study|Adverse Event|0
805383|NCT02446717|2620770|P4|Overall Study|Adverse Event|0
805384|NCT02446717|2620771|P3|Overall Study|Adverse Event|1
805385|NCT02446717|2620772|P2|Overall Study|Adverse Event|0
805386|NCT02446717|2620773|P1|Overall Study|Adverse Event|0
805387|NCT02446171|2620854|P4|Overall Study|Withdrawal by Subject|0
805388|NCT02446171|2620855|P3|Overall Study|Withdrawal by Subject|2
805389|NCT02446171|2620856|P2|Overall Study|Withdrawal by Subject|0
805390|NCT02446171|2620857|P1|Overall Study|Withdrawal by Subject|0
805391|NCT02446015|2620928|P2|Overall Study|Withdrawal by Subject|0
805392|NCT02446015|2620929|P1|Overall Study|Withdrawal by Subject|1
805393|NCT02446015|2620928|P2|Overall Study|Adverse Event|1
805394|NCT02446015|2620929|P1|Overall Study|Adverse Event|0
805395|NCT02445755|2620953|P1|Overall Study|Screen Failure|5
805396|NCT02445755|2620953|P1|Overall Study|Protocol Violation|6
805397|NCT02445755|2620953|P1|Overall Study|Withdrawal by Subject|2
805398|NCT02445573|2620962|P2|Overall Study|Lost to Follow-up|1
805399|NCT02445573|2620963|P1|Overall Study|Lost to Follow-up|0
805400|NCT02445573|2620962|P2|Overall Study|Withdrawal by Subject|1
805401|NCT02445573|2620963|P1|Overall Study|Withdrawal by Subject|1
805402|NCT02444533|2621071|P2|Overall Study|Only gave post-procedure complications|2
805403|NCT02444533|2621072|P1|Overall Study|Only gave post-procedure complications|2
805404|NCT02444533|2621071|P2|Overall Study|Not able to complete forms|2
805405|NCT02444533|2621072|P1|Overall Study|Not able to complete forms|0
805406|NCT02444182|2621088|P2|Overall Study|Lost to Follow-up|4
805407|NCT02444182|2621089|P1|Overall Study|Lost to Follow-up|0
805408|NCT02444182|2621088|P2|Overall Study|non-compliance|1
805409|NCT02444182|2621089|P1|Overall Study|non-compliance|2
805410|NCT02443883|2621112|P4|Overall Study|Randomized, but never treated|1
805411|NCT02443883|2621113|P3|Overall Study|Randomized, but never treated|1
805412|NCT02443883|2621114|P2|Overall Study|Randomized, but never treated|0
805413|NCT02443883|2621115|P1|Overall Study|Randomized, but never treated|2
805414|NCT02443883|2621112|P4|Overall Study|Withdrawal by Subject|1
805415|NCT02443883|2621113|P3|Overall Study|Withdrawal by Subject|2
805416|NCT02443883|2621114|P2|Overall Study|Withdrawal by Subject|0
805417|NCT02443883|2621115|P1|Overall Study|Withdrawal by Subject|1
805418|NCT02443883|2621112|P4|Overall Study|Physician Decision|3
805419|NCT02443883|2621113|P3|Overall Study|Physician Decision|0
805420|NCT02443883|2621114|P2|Overall Study|Physician Decision|1
805421|NCT02443883|2621115|P1|Overall Study|Physician Decision|2
805422|NCT02443883|2621112|P4|Overall Study|Lost to Follow-up|0
805423|NCT02443883|2621113|P3|Overall Study|Lost to Follow-up|0
805424|NCT02443883|2621114|P2|Overall Study|Lost to Follow-up|2
805425|NCT02443883|2621115|P1|Overall Study|Lost to Follow-up|1
805426|NCT02443883|2621112|P4|Overall Study|Adverse Event|2
805427|NCT02443883|2621113|P3|Overall Study|Adverse Event|1
805428|NCT02443883|2621114|P2|Overall Study|Adverse Event|2
805429|NCT02443883|2621115|P1|Overall Study|Adverse Event|0
805430|NCT02443740|2621154|P11|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
805431|NCT02443740|2621155|P10|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
805432|NCT02443740|2621156|P9|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
805433|NCT02443740|2621157|P8|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
805434|NCT02443740|2621158|P7|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
805435|NCT02443740|2621159|P6|Intervention Period 1 (3 Days)|Withdrawal by Subject|1
805436|NCT02443740|2621160|P5|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
805437|NCT02443740|2621161|P4|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
805438|NCT02443740|2621162|P3|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
805439|NCT02443740|2621163|P2|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
805440|NCT02443740|2621164|P1|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
805441|NCT02443740|2621154|P11|Intervention Period 1 (3 Days)|Protocol Violation|0
805442|NCT02443740|2621155|P10|Intervention Period 1 (3 Days)|Protocol Violation|0
805443|NCT02443740|2621156|P9|Intervention Period 1 (3 Days)|Protocol Violation|0
805444|NCT02443740|2621157|P8|Intervention Period 1 (3 Days)|Protocol Violation|0
805445|NCT02443740|2621158|P7|Intervention Period 1 (3 Days)|Protocol Violation|1
805446|NCT02443740|2621159|P6|Intervention Period 1 (3 Days)|Protocol Violation|0
805447|NCT02443740|2621160|P5|Intervention Period 1 (3 Days)|Protocol Violation|0
805448|NCT02443740|2621161|P4|Intervention Period 1 (3 Days)|Protocol Violation|0
805449|NCT02443740|2621162|P3|Intervention Period 1 (3 Days)|Protocol Violation|0
805450|NCT02443740|2621163|P2|Intervention Period 1 (3 Days)|Protocol Violation|0
805451|NCT02443740|2621164|P1|Intervention Period 1 (3 Days)|Protocol Violation|1
805452|NCT02443740|2621154|P11|Intervention Period 1 (3 Days)|Adverse Event|0
805453|NCT02443740|2621155|P10|Intervention Period 1 (3 Days)|Adverse Event|0
805454|NCT02443740|2621156|P9|Intervention Period 1 (3 Days)|Adverse Event|0
805455|NCT02443740|2621157|P8|Intervention Period 1 (3 Days)|Adverse Event|0
805456|NCT02443740|2621158|P7|Intervention Period 1 (3 Days)|Adverse Event|0
805457|NCT02443740|2621159|P6|Intervention Period 1 (3 Days)|Adverse Event|1
805458|NCT02443740|2621160|P5|Intervention Period 1 (3 Days)|Adverse Event|0
805459|NCT02443740|2621161|P4|Intervention Period 1 (3 Days)|Adverse Event|0
805460|NCT02443740|2621162|P3|Intervention Period 1 (3 Days)|Adverse Event|0
805461|NCT02443740|2621163|P2|Intervention Period 1 (3 Days)|Adverse Event|0
805462|NCT02443740|2621164|P1|Intervention Period 1 (3 Days)|Adverse Event|0
805463|NCT02443402|2621360|P2|Overall Study|Screen Failure|2
805464|NCT02443402|2621361|P1|Overall Study|Screen Failure|1
805465|NCT02443402|2621360|P2|Overall Study|Withdrawal by Subject|1
805466|NCT02443402|2621361|P1|Overall Study|Withdrawal by Subject|3
805467|NCT02443103|2621421|P1|Overall Study|Noncompliance|1
805468|NCT02443103|2621421|P1|Overall Study|Adverse Event|2
805469|NCT02442830|2621428|P2|Overall Study|Technical Failure|1
805470|NCT02442830|2621429|P1|Overall Study|Technical Failure|0
805471|NCT02442804|2621439|P2|Overall Study|Adverse Event|0
805472|NCT02442804|2621440|P1|Overall Study|Adverse Event|1
805473|NCT02442804|2621439|P2|Overall Study|Withdrawal by Subject|1
805474|NCT02442804|2621440|P1|Overall Study|Withdrawal by Subject|0
805475|NCT02442349|2621479|P1|Overall Study|On-going Study at Data Cut-off|149
805476|NCT02442349|2621479|P1|Overall Study|Withdrawal by Subject|8
805477|NCT02442349|2621479|P1|Overall Study|Death|14
805478|NCT02442310|2621484|P1|Overall Study|Withdrawal by Subject|1
805479|NCT02442310|2621484|P1|Overall Study|Adverse Event|2
805480|NCT02442284|2621506|P1|Overall Study|Not Specified|1
805481|NCT02442284|2621506|P1|Overall Study|Lost to Follow-up|3
805482|NCT02442284|2621506|P1|Overall Study|Withdrew Consent|2
805483|NCT02442284|2621506|P1|Overall Study|Adverse Event|1
805484|NCT02442271|2621513|P1|Overall Study|Not Specified|1
805485|NCT02442271|2621513|P1|Overall Study|Lost to Follow-up|1
805486|NCT02442271|2621513|P1|Overall Study|Withdrew Consent|1
805487|NCT02442271|2621513|P1|Overall Study|Adverse Event|1
805488|NCT02441946|2621540|P3|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
805489|NCT02441946|2621541|P2|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
805490|NCT02441946|2621542|P1|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9
805491|NCT02441946|2621540|P3|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
805492|NCT02441946|2621541|P2|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
805493|NCT02441946|2621542|P1|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1
805494|NCT02441946|2621540|P3|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
805495|NCT02441946|2621541|P2|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
805496|NCT02441946|2621542|P1|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1
805497|NCT02441946|2621540|P3|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
805498|NCT02441946|2621541|P2|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
805499|NCT02441946|2621542|P1|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1
805500|NCT02441946|2621540|P3|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
805501|NCT02441946|2621541|P2|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
805502|NCT02441946|2621542|P1|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15
805503|NCT02441946|2621540|P3|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
805504|NCT02441946|2621541|P2|Cycle 1 Period 1 (2 Weeks)|Never Treated|1
805505|NCT02441946|2621542|P1|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
805506|NCT02441946|2621540|P3|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
805507|NCT02441946|2621541|P2|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3
805508|NCT02441946|2621542|P1|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
805509|NCT02441946|2621540|P3|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
805510|NCT02441946|2621541|P2|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
805511|NCT02441946|2621542|P1|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1
805512|NCT02441946|2621540|P3|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0
805513|NCT02441946|2621541|P2|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
805514|NCT02441946|2621542|P1|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
805515|NCT02441517|2621554|P1|Overall Study|Study Terminated by Sponsor|1
805516|NCT02441517|2621554|P1|Overall Study|Withdrawal by Subject|2
805517|NCT02441517|2621554|P1|Overall Study|Lost to Follow-up|1
805518|NCT02441218|2621566|P2|Overall Study|Lost to Follow-up|1
805519|NCT02441218|2621567|P1|Overall Study|Lost to Follow-up|2
805520|NCT02441218|2621566|P2|Overall Study|Withdrawal by Subject|58
805521|NCT02441218|2621567|P1|Overall Study|Withdrawal by Subject|73
805522|NCT02441218|2621566|P2|Overall Study|Death|553
805523|NCT02441218|2621567|P1|Overall Study|Death|503
805524|NCT02441179|2621593|P2|Overall Study|Withdrawal by Subject|1
805525|NCT02441179|2621594|P1|Overall Study|Withdrawal by Subject|1
805526|NCT02441114|2621612|P1|Washout2|Withdrawal by Subject|4
805527|NCT02439138|2621679|P1|Overall Study|PI decision to terminate the study|2
805528|NCT02439138|2621679|P1|Overall Study|Adverse Event|1
805529|NCT02438813|2621690|P1|Overall Study|Patients Not Treated/No EOT Visit|249
805530|NCT02438813|2621690|P1|Overall Study|Study Ended by Sponsor|80
805531|NCT02438813|2621690|P1|Overall Study|Patient Lost to Follow-Up|137
805532|NCT02438813|2621690|P1|Overall Study|Patient Decision|59
805533|NCT02438787|2621742|P3|Overall Study|Site terminated by sponsor|1
805534|NCT02438787|2621743|P2|Overall Study|Site terminated by sponsor|0
805535|NCT02438787|2621744|P1|Overall Study|Site terminated by sponsor|0
805536|NCT02438787|2621742|P3|Overall Study|Other|0
805537|NCT02438787|2621743|P2|Overall Study|Other|1
805538|NCT02438787|2621744|P1|Overall Study|Other|0
805539|NCT02438787|2621742|P3|Overall Study|Study discontinued by sponsor|69
805540|NCT02438787|2621743|P2|Overall Study|Study discontinued by sponsor|72
805541|NCT02438787|2621744|P1|Overall Study|Study discontinued by sponsor|64
805542|NCT02438787|2621742|P3|Overall Study|Withdrawal by Subject|10
805543|NCT02438787|2621743|P2|Overall Study|Withdrawal by Subject|7
805544|NCT02438787|2621744|P1|Overall Study|Withdrawal by Subject|15
805545|NCT02438787|2621742|P3|Overall Study|Protocol Violation|1
805546|NCT02438787|2621743|P2|Overall Study|Protocol Violation|0
805547|NCT02438787|2621744|P1|Overall Study|Protocol Violation|0
805548|NCT02438787|2621742|P3|Overall Study|Lost to Follow-up|0
805549|NCT02438787|2621743|P2|Overall Study|Lost to Follow-up|1
805550|NCT02438787|2621744|P1|Overall Study|Lost to Follow-up|0
805551|NCT02438787|2621742|P3|Overall Study|Lack of Efficacy|0
805552|NCT02438787|2621743|P2|Overall Study|Lack of Efficacy|2
805553|NCT02438787|2621744|P1|Overall Study|Lack of Efficacy|1
805554|NCT02438787|2621742|P3|Overall Study|Adverse Event|2
805555|NCT02438787|2621743|P2|Overall Study|Adverse Event|0
805556|NCT02438787|2621744|P1|Overall Study|Adverse Event|1
805557|NCT02438280|2621832|P2|Overall Study|Physician Decision|0
805558|NCT02438280|2621833|P1|Overall Study|Physician Decision|1
805559|NCT02438137|2621843|P2|Overall Study|Physician Decision|1
805560|NCT02438137|2621844|P1|Overall Study|Physician Decision|0
805561|NCT02438137|2621843|P2|Overall Study|Withdrawal by Subject|3
805562|NCT02438137|2621844|P1|Overall Study|Withdrawal by Subject|4
805563|NCT02438137|2621843|P2|Overall Study|Adverse Event|0
805564|NCT02438137|2621844|P1|Overall Study|Adverse Event|1
805565|NCT02438137|2621843|P2|Overall Study|Lost to Follow-up|2
805566|NCT02438137|2621844|P1|Overall Study|Lost to Follow-up|3
805567|NCT02437903|2621852|P1|Overall Study|Lost to Follow-up|3
805568|NCT02437903|2621852|P1|Overall Study|Withdrawal by Subject|1
805569|NCT02437903|2621852|P1|Overall Study|Adverse Event|1
805570|NCT02437864|2621862|P2|Overall Study|Protocol Violation|0
805571|NCT02437864|2621863|P1|Overall Study|Protocol Violation|4
805572|NCT02437513|2621877|P1|Overall Study|Withdrawal by Subject|2
805573|NCT02437409|2621902|P1|Overall Study|Screening failure|12
805574|NCT02437409|2621902|P1|Overall Study|Withdrawal by Subject|3
805575|NCT02437305|2621917|P2|Overall Study|Lost to Follow-up|12
805576|NCT02437305|2621918|P1|Overall Study|Lost to Follow-up|18
805577|NCT02437162|2621946|P3|Overall Study|Other|1
805578|NCT02437162|2621947|P2|Overall Study|Other|0
805579|NCT02437162|2621948|P1|Overall Study|Other|0
805580|NCT02437162|2621946|P3|Overall Study|Death|0
805581|NCT02437162|2621947|P2|Overall Study|Death|1
805582|NCT02437162|2621948|P1|Overall Study|Death|0
805583|NCT02437162|2621946|P3|Overall Study|Lost to Follow-up|1
805584|NCT02437162|2621947|P2|Overall Study|Lost to Follow-up|0
805585|NCT02437162|2621948|P1|Overall Study|Lost to Follow-up|1
805586|NCT02437162|2621946|P3|Overall Study|Adverse Event|0
805587|NCT02437162|2621947|P2|Overall Study|Adverse Event|1
805588|NCT02437162|2621948|P1|Overall Study|Adverse Event|0
805589|NCT02437162|2621946|P3|Overall Study|Withdrawal by Subject|9
805590|NCT02437162|2621947|P2|Overall Study|Withdrawal by Subject|7
805591|NCT02437162|2621948|P1|Overall Study|Withdrawal by Subject|13
805592|NCT02437162|2621946|P3|Overall Study|Study discontinued by Sponsor|97
805593|NCT02437162|2621947|P2|Overall Study|Study discontinued by Sponsor|98
805594|NCT02437162|2621948|P1|Overall Study|Study discontinued by Sponsor|93
805595|NCT02437162|2621946|P3|Overall Study|Randomized but not treated|1
805596|NCT02437162|2621947|P2|Overall Study|Randomized but not treated|0
805597|NCT02437162|2621948|P1|Overall Study|Randomized but not treated|0
805598|NCT02437162|2621946|P3|Overall Study|Protocol Violation|0
805599|NCT02437162|2621947|P2|Overall Study|Protocol Violation|1
805600|NCT02437162|2621948|P1|Overall Study|Protocol Violation|0
805601|NCT02436811|2622069|P3|Overall Study|Lost to Follow-up|7
805602|NCT02436811|2622070|P2|Overall Study|Lost to Follow-up|9
805603|NCT02436811|2622071|P1|Overall Study|Lost to Follow-up|2
805604|NCT02436577|2622085|P6|Overall Study|Protocol Deviation|0
805605|NCT02436577|2622086|P5|Overall Study|Protocol Deviation|0
805606|NCT02436577|2622087|P4|Overall Study|Protocol Deviation|0
805607|NCT02436577|2622088|P3|Overall Study|Protocol Deviation|0
805608|NCT02436577|2622089|P2|Overall Study|Protocol Deviation|1
805609|NCT02436577|2622090|P1|Overall Study|Protocol Deviation|0
805610|NCT02436330|2622145|P2|Cohort 6|Withdrawal by Subject|1
805611|NCT02436330|2622146|P1|Cohort 6|Withdrawal by Subject|1
805612|NCT02436330|2622145|P2|Cohort 6|Lost to Follow-up|0
805613|NCT02436330|2622146|P1|Cohort 6|Lost to Follow-up|2
805614|NCT02436330|2622145|P2|Cohort 5|Withdrawal by Subject|2
805615|NCT02436330|2622146|P1|Cohort 5|Withdrawal by Subject|3
805616|NCT02436330|2622145|P2|Cohort 5|Lost to Follow-up|2
805617|NCT02436330|2622146|P1|Cohort 5|Lost to Follow-up|3
805618|NCT02436330|2622145|P2|Cohort 4|Withdrawal by Subject|0
805619|NCT02436330|2622146|P1|Cohort 4|Withdrawal by Subject|1
805620|NCT02436330|2622145|P2|Cohort 4|Lost to Follow-up|0
805621|NCT02436330|2622146|P1|Cohort 4|Lost to Follow-up|1
805622|NCT02436330|2622145|P2|Cohort 3|Withdrawal by Subject|0
805623|NCT02436330|2622146|P1|Cohort 3|Withdrawal by Subject|4
805624|NCT02436330|2622145|P2|Cohort 3|Lost to Follow-up|0
805625|NCT02436330|2622146|P1|Cohort 3|Lost to Follow-up|1
805626|NCT02436330|2622145|P2|Cohort 2|Withdrawal by Subject|3
805627|NCT02436330|2622146|P1|Cohort 2|Withdrawal by Subject|2
805628|NCT02436330|2622145|P2|Cohort 2|Lost to Follow-up|0
805629|NCT02436330|2622146|P1|Cohort 2|Lost to Follow-up|2
805630|NCT02436330|2622145|P2|Cohort 1|Withdrawal by Subject|1
805631|NCT02436330|2622146|P1|Cohort 1|Withdrawal by Subject|0
805632|NCT02436330|2622145|P2|Cohort 1|Lost to Follow-up|2
805633|NCT02436330|2622146|P1|Cohort 1|Lost to Follow-up|5
805634|NCT02436304|2622191|P3|Overall Study|Randomized in error didn’t meet I/E crit|1
805635|NCT02436304|2622192|P2|Overall Study|Randomized in error didn’t meet I/E crit|0
805636|NCT02436304|2622193|P1|Overall Study|Randomized in error didn’t meet I/E crit|0
805637|NCT02436304|2622191|P3|Overall Study|Withdrawal by Subject|0
805638|NCT02436304|2622192|P2|Overall Study|Withdrawal by Subject|1
805639|NCT02436304|2622193|P1|Overall Study|Withdrawal by Subject|0
805640|NCT02436304|2622191|P3|Overall Study|Lost to Follow-up|0
805641|NCT02436304|2622192|P2|Overall Study|Lost to Follow-up|1
805642|NCT02436304|2622193|P1|Overall Study|Lost to Follow-up|0
805643|NCT02435966|2622222|P3|Overall Study|Withdrawal by Subject|0
805644|NCT02435966|2622223|P2|Overall Study|Withdrawal by Subject|1
805645|NCT02435966|2622224|P1|Overall Study|Withdrawal by Subject|0
805646|NCT02435836|2622232|P1|Overall Study|AE of Worsening Schizophrenia|96
805647|NCT02435836|2622232|P1|Overall Study|Met Withdrawal Criteria|7
805648|NCT02435836|2622232|P1|Overall Study|Protocol Violation|6
805649|NCT02435836|2622232|P1|Overall Study|Noncompliance|27
805650|NCT02435836|2622232|P1|Overall Study|Sponsor discontinued trial|167
805651|NCT02435836|2622232|P1|Overall Study|Adverse Event|44
805652|NCT02435836|2622232|P1|Overall Study|Insufficient Clinical Response|26
805653|NCT02435836|2622232|P1|Overall Study|Withdrawal by Subject|236
805654|NCT02435836|2622232|P1|Overall Study|Lack of Efficacy|1
805655|NCT02435836|2622232|P1|Overall Study|Lost to Follow-up|21
805656|NCT02435277|2622252|P4|Overall Study|Withdrawal by Subject|0
805657|NCT02435277|2622253|P3|Overall Study|Withdrawal by Subject|0
805658|NCT02435277|2622254|P2|Overall Study|Withdrawal by Subject|0
805659|NCT02435277|2622255|P1|Overall Study|Withdrawal by Subject|1
805660|NCT02435277|2622252|P4|Overall Study|Adverse Event|0
805661|NCT02435277|2622253|P3|Overall Study|Adverse Event|0
805662|NCT02435277|2622254|P2|Overall Study|Adverse Event|1
805663|NCT02435277|2622255|P1|Overall Study|Adverse Event|1
805664|NCT02435147|2622269|P1|Overall Study|non-evaluable DXA scan|11
805665|NCT02434939|2622276|P2|Overall Study|Adverse Event|1
805666|NCT02434939|2622277|P1|Overall Study|Adverse Event|0
805667|NCT02434939|2622276|P2|Overall Study|Withdrawal by Subject|0
805668|NCT02434939|2622277|P1|Overall Study|Withdrawal by Subject|3
805669|NCT02434939|2622276|P2|Overall Study|Lack of Efficacy|48
805670|NCT02434939|2622277|P1|Overall Study|Lack of Efficacy|34
805671|NCT02434471|2622404|P1|Overall Study|Physician Decision|9
805672|NCT02433834|2622423|P1|Overall Study|Physician Decision|1
805673|NCT02433834|2622423|P1|Overall Study|Adverse Event|6
805674|NCT02433834|2622423|P1|Overall Study|Withdrawal by Subject|14
805675|NCT02433834|2622423|P1|Overall Study|Lost to Follow-up|6
805676|NCT02433834|2622423|P1|Overall Study|Protocol Violation|3
805677|NCT02433834|2622423|P1|Overall Study|Protocol-specified criteria|7
805678|NCT02433483|2622516|P1|Overall Study|Other antineoplastic therapy/HSCT|1
805679|NCT02433483|2622516|P1|Overall Study|Unacceptable toxicity|1
805680|NCT02433340|2622543|P4|Overall Study|Not Specified|0
805681|NCT02433340|2622544|P3|Overall Study|Not Specified|0
805682|NCT02433340|2622545|P2|Overall Study|Not Specified|1
805683|NCT02433340|2622546|P1|Overall Study|Not Specified|0
805684|NCT02433340|2622543|P4|Overall Study|Required Alternative/Prohibited Therapy|0
805685|NCT02433340|2622544|P3|Overall Study|Required Alternative/Prohibited Therapy|0
805686|NCT02433340|2622545|P2|Overall Study|Required Alternative/Prohibited Therapy|0
805687|NCT02433340|2622546|P1|Overall Study|Required Alternative/Prohibited Therapy|1
805688|NCT02433340|2622543|P4|Overall Study|Lost to Follow-up|0
805689|NCT02433340|2622544|P3|Overall Study|Lost to Follow-up|0
805690|NCT02433340|2622545|P2|Overall Study|Lost to Follow-up|1
805691|NCT02433340|2622546|P1|Overall Study|Lost to Follow-up|0
805692|NCT02433340|2622543|P4|Overall Study|Withdrawal by Subject|2
805693|NCT02433340|2622544|P3|Overall Study|Withdrawal by Subject|1
805694|NCT02433340|2622545|P2|Overall Study|Withdrawal by Subject|0
805695|NCT02433340|2622546|P1|Overall Study|Withdrawal by Subject|1
805696|NCT02433340|2622543|P4|Overall Study|Adverse Event|0
805697|NCT02433340|2622544|P3|Overall Study|Adverse Event|1
805698|NCT02433340|2622545|P2|Overall Study|Adverse Event|0
805699|NCT02433340|2622546|P1|Overall Study|Adverse Event|0
805700|NCT02432105|2623459|P3|Overall Study|Randomized in error|2
805701|NCT02432105|2623460|P2|Overall Study|Randomized in error|0
805702|NCT02432105|2623461|P1|Overall Study|Randomized in error|0
805703|NCT02432105|2623459|P3|Overall Study|Culture positive for yeast|0
805704|NCT02432105|2623460|P2|Overall Study|Culture positive for yeast|1
805705|NCT02432105|2623461|P1|Overall Study|Culture positive for yeast|0
805706|NCT02432105|2623459|P3|Overall Study|Withdrawal by Subject|1
805707|NCT02432105|2623460|P2|Overall Study|Withdrawal by Subject|0
805708|NCT02432105|2623461|P1|Overall Study|Withdrawal by Subject|1
805709|NCT02432105|2623459|P3|Overall Study|Lost to Follow-up|0
805710|NCT02432105|2623460|P2|Overall Study|Lost to Follow-up|1
805711|NCT02432105|2623461|P1|Overall Study|Lost to Follow-up|1
805712|NCT02432040|2623478|P2|Overall Study|Physician Decision|1
805713|NCT02432040|2623479|P1|Overall Study|Physician Decision|1
805714|NCT02432040|2623478|P2|Overall Study|Lost to Follow-up|5
805715|NCT02432040|2623479|P1|Overall Study|Lost to Follow-up|4
805716|NCT02432040|2623478|P2|Overall Study|Lack of Efficacy|0
805717|NCT02432040|2623479|P1|Overall Study|Lack of Efficacy|3
805718|NCT02431468|2623556|P3|Overall Study|noncompliance, investigator termination,|2
805719|NCT02431468|2623557|P2|Overall Study|noncompliance, investigator termination,|2
805720|NCT02431468|2623558|P1|Overall Study|noncompliance, investigator termination,|2
805721|NCT02431468|2623556|P3|Overall Study|Withdrawal by Subject|2
805722|NCT02431468|2623557|P2|Overall Study|Withdrawal by Subject|12
805723|NCT02431468|2623558|P1|Overall Study|Withdrawal by Subject|4
805724|NCT02431468|2623556|P3|Overall Study|Adverse Event|5
805725|NCT02431468|2623557|P2|Overall Study|Adverse Event|4
805726|NCT02431468|2623558|P1|Overall Study|Adverse Event|2
805727|NCT02431247|2623611|P2|Overall Study|Non-compliance with study drug|0
805728|NCT02431247|2623612|P1|Overall Study|Non-compliance with study drug|1
805729|NCT02431247|2623611|P2|Overall Study|Ongoing|336
805730|NCT02431247|2623612|P1|Overall Study|Ongoing|339
805731|NCT02431247|2623611|P2|Overall Study|Other|1
805732|NCT02431247|2623612|P1|Overall Study|Other|2
805733|NCT02431247|2623611|P2|Overall Study|Withdrawal by Subject|6
805734|NCT02431247|2623612|P1|Overall Study|Withdrawal by Subject|4
805735|NCT02431247|2623611|P2|Overall Study|Physician Decision|0
805736|NCT02431247|2623612|P1|Overall Study|Physician Decision|3
805737|NCT02431247|2623611|P2|Overall Study|Adverse Event|15
805738|NCT02431247|2623612|P1|Overall Study|Adverse Event|8
805739|NCT02431247|2623611|P2|Overall Study|Lost to Follow-up|5
805740|NCT02431247|2623612|P1|Overall Study|Lost to Follow-up|5
805741|NCT02430870|2623674|P8|Part 2|Other Reason Not Specified|1
805742|NCT02430870|2623675|P7|Part 2|Other Reason Not Specified|0
805743|NCT02430870|2623676|P6|Part 2|Other Reason Not Specified|0
805744|NCT02430870|2623677|P5|Part 2|Other Reason Not Specified|0
805745|NCT02430870|2623678|P4|Part 2|Other Reason Not Specified|0
805746|NCT02430870|2623679|P3|Part 2|Other Reason Not Specified|0
805747|NCT02430870|2623680|P2|Part 2|Other Reason Not Specified|0
805748|NCT02430870|2623681|P1|Part 2|Other Reason Not Specified|0
805749|NCT02430870|2623674|P8|Part 2|Voluntary Withdrawal|0
805750|NCT02430870|2623675|P7|Part 2|Voluntary Withdrawal|1
805751|NCT02430870|2623676|P6|Part 2|Voluntary Withdrawal|0
805752|NCT02430870|2623677|P5|Part 2|Voluntary Withdrawal|0
805753|NCT02430870|2623678|P4|Part 2|Voluntary Withdrawal|0
805754|NCT02430870|2623679|P3|Part 2|Voluntary Withdrawal|0
805755|NCT02430870|2623680|P2|Part 2|Voluntary Withdrawal|0
805756|NCT02430870|2623681|P1|Part 2|Voluntary Withdrawal|0
805757|NCT02430532|2623755|P2|Overall Study|Adverse Event|1
805758|NCT02430532|2623756|P1|Overall Study|Adverse Event|0
805759|NCT02430532|2623755|P2|Overall Study|Consent Withdrawn|2
805760|NCT02430532|2623756|P1|Overall Study|Consent Withdrawn|0
805761|NCT02430532|2623755|P2|Overall Study|Sponsor Decision to Stop Study Early|25
805762|NCT02430532|2623756|P1|Overall Study|Sponsor Decision to Stop Study Early|30
805763|NCT02430311|2623783|P2|Part B|Death|0
805764|NCT02430311|2623784|P1|Part B|Death|1
805765|NCT02430311|2623783|P2|Part B|Adverse Event|0
805766|NCT02430311|2623784|P1|Part B|Adverse Event|1
805767|NCT02430311|2623783|P2|Part B|Withdrawal by Subject|2
805768|NCT02430311|2623784|P1|Part B|Withdrawal by Subject|2
805769|NCT02430311|2623783|P2|Part B|Meet study-specific withdrawal criteria|6
805770|NCT02430311|2623784|P1|Part B|Meet study-specific withdrawal criteria|6
805771|NCT02430311|2623783|P2|Part A|Withdrawal by Subject|0
805772|NCT02430311|2623784|P1|Part A|Withdrawal by Subject|1
805773|NCT02430311|2623783|P2|Part A|Adverse Event|1
805774|NCT02430311|2623784|P1|Part A|Adverse Event|0
805775|NCT02429791|2623832|P2|Overall Study|Withdrawal by Subject|7
805776|NCT02429791|2623833|P1|Overall Study|Withdrawal by Subject|3
805777|NCT02429791|2623832|P2|Overall Study|Protocol Violation|4
805778|NCT02429791|2623833|P1|Overall Study|Protocol Violation|1
805779|NCT02429791|2623832|P2|Overall Study|Lost to Follow-up|2
805780|NCT02429791|2623833|P1|Overall Study|Lost to Follow-up|1
805781|NCT02429791|2623832|P2|Overall Study|Lack of Efficacy|1
805782|NCT02429791|2623833|P1|Overall Study|Lack of Efficacy|2
805783|NCT02429791|2623832|P2|Overall Study|Physician Decision|2
805784|NCT02429791|2623833|P1|Overall Study|Physician Decision|0
805785|NCT02429791|2623832|P2|Overall Study|Adverse Event|2
805786|NCT02429791|2623833|P1|Overall Study|Adverse Event|6
805787|NCT02429258|2623905|P2|Overall Study|Protocol Violation|1
805788|NCT02429258|2623906|P1|Overall Study|Protocol Violation|0
805789|NCT02429258|2623905|P2|Overall Study|Withdrawal by Subject|0
805790|NCT02429258|2623906|P1|Overall Study|Withdrawal by Subject|2
805791|NCT02428699|2623932|P2|Washout Period 1|Screen Failure|2
805792|NCT02428699|2623933|P1|Washout Period 1|Screen Failure|1
805793|NCT02428413|2623972|P2|Overall Study|Nurse Refusal|0
805794|NCT02428413|2623973|P1|Overall Study|Nurse Refusal|1
805795|NCT02428413|2623972|P2|Overall Study|Missed Cases|2
805796|NCT02428413|2623973|P1|Overall Study|Missed Cases|1
805797|NCT02428413|2623972|P2|Overall Study|Case Cancelled|0
805798|NCT02428413|2623973|P1|Overall Study|Case Cancelled|2
805799|NCT02428413|2623972|P2|Overall Study|Protocol Violation|2
805800|NCT02428413|2623973|P1|Overall Study|Protocol Violation|1
805801|NCT02428413|2623972|P2|Overall Study|Device to measure WAG malfunctioned|5
805802|NCT02428413|2623973|P1|Overall Study|Device to measure WAG malfunctioned|3
805803|NCT02428231|2623987|P2|Overall Study|Adverse Event|0
805804|NCT02428231|2623988|P1|Overall Study|Adverse Event|3
805805|NCT02428231|2623987|P2|Overall Study|Required Symptomatic Therapy|1
805806|NCT02428231|2623988|P1|Overall Study|Required Symptomatic Therapy|0
805807|NCT02428231|2623987|P2|Overall Study|Not Specified|16
805808|NCT02428231|2623988|P1|Overall Study|Not Specified|10
805809|NCT02427984|2624005|P3|Overall Study|Lost to Follow-up|18
805810|NCT02427984|2624006|P2|Overall Study|Lost to Follow-up|5
805811|NCT02427984|2624007|P1|Overall Study|Lost to Follow-up|13
805812|NCT02427607|2624047|P1|Overall Study|Withdrawal by Subject|1
805813|NCT02427477|2624053|P2|Period 1|Adverse Event|0
805814|NCT02427477|2624054|P1|Period 1|Adverse Event|1
805815|NCT02427399|2624067|P5|Overall Study|Protocol Violation|15
805816|NCT02427399|2624068|P4|Overall Study|Protocol Violation|18
805817|NCT02427399|2624069|P3|Overall Study|Protocol Violation|12
805818|NCT02427399|2624070|P2|Overall Study|Protocol Violation|16
805819|NCT02427399|2624071|P1|Overall Study|Protocol Violation|14
805820|NCT02426541|2624095|P2|Overall Study|Protocol Violation|0
805821|NCT02426541|2624096|P1|Overall Study|Protocol Violation|1
805822|NCT02425826|2624113|P3|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1
805823|NCT02425826|2624114|P2|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
805824|NCT02425826|2624115|P1|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
805825|NCT02425826|2624113|P3|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1
805826|NCT02425826|2624114|P2|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0
805827|NCT02425826|2624115|P1|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8
805828|NCT02425826|2624113|P3|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4
805829|NCT02425826|2624114|P2|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0
805830|NCT02425826|2624115|P1|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12
805831|NCT02425826|2624113|P3|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6
805832|NCT02425826|2624114|P2|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0
805833|NCT02425826|2624115|P1|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8
805834|NCT02425826|2624113|P3|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2
805835|NCT02425826|2624114|P2|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0
805836|NCT02425826|2624115|P1|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7
805837|NCT02425826|2624113|P3|Placebo-controlled Phase (Week 0 - 16)|Other|0
805838|NCT02425826|2624114|P2|Placebo-controlled Phase (Week 0 - 16)|Other|1
805839|NCT02425826|2624115|P1|Placebo-controlled Phase (Week 0 - 16)|Other|3
805840|NCT02425826|2624113|P3|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0
805841|NCT02425826|2624114|P2|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4
805842|NCT02425826|2624115|P1|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10
805843|NCT02425826|2624113|P3|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0
805844|NCT02425826|2624114|P2|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1
805845|NCT02425826|2624115|P1|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9
805846|NCT02425826|2624113|P3|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
805847|NCT02425826|2624114|P2|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1
805848|NCT02425826|2624115|P1|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
805849|NCT02425826|2624113|P3|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0
805850|NCT02425826|2624114|P2|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2
805851|NCT02425826|2624115|P1|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5
805852|NCT02425111|2624169|P1|Part B: Treatment Extension Period|Lack of Efficacy|7
805853|NCT02425111|2624169|P1|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3
805854|NCT02425111|2624169|P1|Part A: Treatment Period|Lost to Follow-up|2
805855|NCT02425111|2624169|P1|Part A: Treatment Period|Voluntary Withdrawal|4
805856|NCT02425111|2624169|P1|Part A: Treatment Period|Lack of Efficacy|15
805857|NCT02425111|2624169|P1|Part A: Treatment Period|Pretreatment Event/Adverse Event|2
805858|NCT02424734|2624191|P3|Overall Study|Treatment stopped to be discharged home|0
805859|NCT02424734|2624192|P2|Overall Study|Treatment stopped to be discharged home|2
805860|NCT02424734|2624193|P1|Overall Study|Treatment stopped to be discharged home|2
805861|NCT02424591|2624212|P2|Overall Study|Protocol Violation|3
805862|NCT02424591|2624213|P1|Overall Study|Protocol Violation|2
805863|NCT02424578|2624225|P2|Overall Study|Withdrawal by Subject|1
805864|NCT02424578|2624226|P1|Overall Study|Withdrawal by Subject|0
805865|NCT02424565|2624232|P2|Period 1 (D0)|Protocol Violation|1
805866|NCT02424565|2624233|P1|Period 1 (D0)|Protocol Violation|0
805867|NCT02424344|2624252|P2|Overall Study|Adverse Event|8
805868|NCT02424344|2624253|P1|Overall Study|Adverse Event|4
805869|NCT02424344|2624252|P2|Overall Study|Lost to Follow-up|0
805870|NCT02424344|2624253|P1|Overall Study|Lost to Follow-up|1
805871|NCT02424344|2624252|P2|Overall Study|Withdrawal by Subject|1
805872|NCT02424344|2624253|P1|Overall Study|Withdrawal by Subject|2
805873|NCT02424344|2624252|P2|Overall Study|Lack of Efficacy|1
805874|NCT02424344|2624253|P1|Overall Study|Lack of Efficacy|0
805875|NCT02424149|2624265|P2|Overall Study|Withdrawal by Subject|1
805876|NCT02424149|2624266|P1|Overall Study|Withdrawal by Subject|0
805877|NCT02424149|2624265|P2|Overall Study|surgery cancelled|0
805878|NCT02424149|2624266|P1|Overall Study|surgery cancelled|2
805879|NCT02423798|2624327|P1|Overall Study|Withdrawal by Subject|3
805880|NCT02423291|2624393|P1|Overall Study|Adverse Event|1
805881|NCT02423291|2624393|P1|Overall Study|Lack of Efficacy|14
805882|NCT02423109|2624408|P2|Lens 1|Adverse Event|0
805883|NCT02423109|2624409|P1|Lens 1|Adverse Event|1
805884|NCT02422797|2624442|P2|Overall Study|Withdrawal by Subject|7
805885|NCT02422797|2624443|P1|Overall Study|Withdrawal by Subject|2
805886|NCT02422797|2624442|P2|Overall Study|Other; Reached stopping criteria|1
805887|NCT02422797|2624443|P1|Overall Study|Other; Reached stopping criteria|1
805888|NCT02422797|2624442|P2|Overall Study|Protocol Violation|3
805889|NCT02422797|2624443|P1|Overall Study|Protocol Violation|0
805890|NCT02422797|2624442|P2|Overall Study|Lost to Follow-up|1
805891|NCT02422797|2624443|P1|Overall Study|Lost to Follow-up|1
805892|NCT02422797|2624442|P2|Overall Study|Lack of Efficacy|2
805893|NCT02422797|2624443|P1|Overall Study|Lack of Efficacy|1
805894|NCT02422797|2624442|P2|Overall Study|Physician Decision|1
805895|NCT02422797|2624443|P1|Overall Study|Physician Decision|0
805896|NCT02422797|2624442|P2|Overall Study|Adverse Event|1
805897|NCT02422797|2624443|P1|Overall Study|Adverse Event|11
805898|NCT02422615|2624515|P2|Overall Study|Technical problems|1
805899|NCT02422615|2624516|P1|Overall Study|Technical problems|0
805900|NCT02422615|2624515|P2|Overall Study|Protocol Violation|1
805901|NCT02422615|2624516|P1|Overall Study|Protocol Violation|1
805902|NCT02422615|2624515|P2|Overall Study|Death|0
805903|NCT02422615|2624516|P1|Overall Study|Death|2
805904|NCT02422615|2624515|P2|Overall Study|Subject/guardian decision|5
805905|NCT02422615|2624516|P1|Overall Study|Subject/guardian decision|21
805906|NCT02422615|2624515|P2|Overall Study|Physician Decision|7
805907|NCT02422615|2624516|P1|Overall Study|Physician Decision|22
805908|NCT02422615|2624515|P2|Overall Study|Adverse Event|10
805909|NCT02422615|2624516|P1|Overall Study|Adverse Event|41
805910|NCT02422615|2624515|P2|Overall Study|Progressive disease|142
805911|NCT02422615|2624516|P1|Overall Study|Progressive disease|193
805912|NCT02422303|2624533|P2|Overall Study|Lost to Follow-up|1
805913|NCT02422303|2624534|P1|Overall Study|Lost to Follow-up|1
805914|NCT02421419|2624543|P3|Overall Study|Physician Decision|1
805915|NCT02421419|2624544|P2|Overall Study|Physician Decision|0
805916|NCT02421419|2624545|P1|Overall Study|Physician Decision|0
805917|NCT02421120|2624630|P1|Overall Study|Adverse Event|1
805918|NCT02420821|2624672|P2|Overall Study|Death|116
805919|NCT02420821|2624673|P1|Overall Study|Death|129
805920|NCT02420821|2624672|P2|Overall Study|Withdrawal by Subject|17
805921|NCT02420821|2624673|P1|Overall Study|Withdrawal by Subject|31
805922|NCT02420821|2624672|P2|Overall Study|Physician Decision|2
805923|NCT02420821|2624673|P1|Overall Study|Physician Decision|5
805924|NCT02420821|2624672|P2|Overall Study|Non-compliance|2
805925|NCT02420821|2624673|P1|Overall Study|Non-compliance|1
805926|NCT02420821|2624672|P2|Overall Study|Lost to Follow-up|0
805927|NCT02420821|2624673|P1|Overall Study|Lost to Follow-up|2
805928|NCT02420327|2624741|P1|Overall Study|Protocol Violation|1
805929|NCT02420327|2624741|P1|Overall Study|Lost to Follow-up|1
805930|NCT02420327|2624741|P1|Overall Study|Withdrawal by Subject|6
805931|NCT02420327|2624741|P1|Overall Study|Pregnancy|1
805932|NCT02420327|2624741|P1|Overall Study|Adverse Event|7
805933|NCT02420262|2624777|P2|Overall Study|Unclassified|1
805934|NCT02420262|2624778|P1|Overall Study|Unclassified|0
805935|NCT02420262|2624777|P2|Overall Study|Withdrawal by Subject|4
805936|NCT02420262|2624778|P1|Overall Study|Withdrawal by Subject|1
805937|NCT02420262|2624777|P2|Overall Study|Adverse Event|0
805938|NCT02420262|2624778|P1|Overall Study|Adverse Event|1
805939|NCT02420093|2624804|P2|Overall Study|Withdrawal by Subject|1
805940|NCT02420093|2624805|P1|Overall Study|Withdrawal by Subject|1
805941|NCT02419937|2624848|P2|Overall Study|Lost to Follow-up|0
805942|NCT02419937|2624849|P1|Overall Study|Lost to Follow-up|1
805943|NCT02419755|2624857|P2|Overall Study|Withdrawal by Subject|0
805944|NCT02419755|2624858|P1|Overall Study|Withdrawal by Subject|1
805945|NCT02419755|2624857|P2|Overall Study|Ineligible|0
805946|NCT02419755|2624858|P1|Overall Study|Ineligible|1
805947|NCT02419755|2624857|P2|Overall Study|Relapse|1
805948|NCT02419755|2624858|P1|Overall Study|Relapse|0
805949|NCT02419755|2624857|P2|Overall Study|Death|3
805950|NCT02419755|2624858|P1|Overall Study|Death|1
805951|NCT02419612|2624884|P2|Overall Study|Subject moved out of state|1
805952|NCT02419612|2624885|P1|Overall Study|Subject moved out of state|0
805953|NCT02419612|2624884|P2|Overall Study|Worsening of liver function|1
805954|NCT02419612|2624885|P1|Overall Study|Worsening of liver function|0
805955|NCT02419612|2624884|P2|Overall Study|Noncompliance With Study Drug|2
805956|NCT02419612|2624885|P1|Overall Study|Noncompliance With Study Drug|0
805957|NCT02419612|2624884|P2|Overall Study|Subject Request To Discontinue Treatment|1
805958|NCT02419612|2624885|P1|Overall Study|Subject Request To Discontinue Treatment|1
805959|NCT02419612|2624884|P2|Overall Study|Withdrawal by Subject|9
805960|NCT02419612|2624885|P1|Overall Study|Withdrawal by Subject|9
805961|NCT02419612|2624884|P2|Overall Study|Lost to Follow-up|6
805962|NCT02419612|2624885|P1|Overall Study|Lost to Follow-up|6
805963|NCT02419612|2624884|P2|Overall Study|Death|2
805964|NCT02419612|2624885|P1|Overall Study|Death|0
805965|NCT02419612|2624884|P2|Overall Study|Adverse Event|1
805966|NCT02419612|2624885|P1|Overall Study|Adverse Event|1
805967|NCT02419508|2624913|P2|Overall Study|Other - Reason not specified|1
805968|NCT02419508|2624914|P1|Overall Study|Other - Reason not specified|0
805969|NCT02419508|2624913|P2|Overall Study|Withdrawal by Subject|0
805970|NCT02419508|2624914|P1|Overall Study|Withdrawal by Subject|1
805971|NCT02419508|2624913|P2|Overall Study|Adverse Event|3
805972|NCT02419508|2624914|P1|Overall Study|Adverse Event|9
805973|NCT02419469|2624932|P1|Overall Study|Withdrawal by Subject|1
805974|NCT02419313|2624936|P2|Second Intervention|Lost to Follow-up|0
805975|NCT02419313|2624937|P1|Second Intervention|Lost to Follow-up|1
805976|NCT02419313|2624936|P2|First Intervention|Lost to Follow-up|0
805977|NCT02419313|2624937|P1|First Intervention|Lost to Follow-up|2
805978|NCT02419001|2624949|P2|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0
805979|NCT02419001|2624950|P1|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1
805980|NCT02418468|2624978|P2|Overall Study|Withdrawal of informed consent|1
805981|NCT02418468|2624979|P1|Overall Study|Withdrawal of informed consent|1
805982|NCT02418468|2624978|P2|Overall Study|Adverse Event|0
805983|NCT02418468|2624979|P1|Overall Study|Adverse Event|1
805984|NCT02417961|2625029|P1|Overall Study|Withdrawal by Subject|2
805985|NCT02417961|2625029|P1|Overall Study|Lost to Follow-up|1
805986|NCT02417961|2625029|P1|Overall Study|Adverse Event|1
805987|NCT02417935|2625041|P2|Treatment Period|Physician Decision|1
805988|NCT02417935|2625042|P1|Treatment Period|Physician Decision|3
805989|NCT02417935|2625041|P2|Treatment Period|Withdrawal by Subject|3
805990|NCT02417935|2625042|P1|Treatment Period|Withdrawal by Subject|3
805991|NCT02417935|2625041|P2|Treatment Period|Protocol Violation|1
805992|NCT02417935|2625042|P1|Treatment Period|Protocol Violation|2
805993|NCT02417935|2625041|P2|Treatment Period|Entry Criteria not met|1
805994|NCT02417935|2625042|P1|Treatment Period|Entry Criteria not met|0
805995|NCT02417935|2625041|P2|Treatment Period|Lost to Follow-up|0
805996|NCT02417935|2625042|P1|Treatment Period|Lost to Follow-up|1
805997|NCT02417935|2625041|P2|Treatment Period|Adverse Event|10
805998|NCT02417935|2625042|P1|Treatment Period|Adverse Event|12
805999|NCT02417753|2625066|P1|Overall Study|Death|1
806000|NCT02417532|2625076|P1|Overall Study|unable to complete exercises|4
806001|NCT02417233|2625137|P3|Overall Study|Mentally unstable|0
806002|NCT02417233|2625138|P2|Overall Study|Mentally unstable|1
806003|NCT02417233|2625139|P1|Overall Study|Mentally unstable|0
806004|NCT02417233|2625137|P3|Overall Study|Relocation out of study area|1
806005|NCT02417233|2625138|P2|Overall Study|Relocation out of study area|0
806006|NCT02417233|2625139|P1|Overall Study|Relocation out of study area|1
806007|NCT02417233|2625137|P3|Overall Study|Withdrawal by Subject|8
806008|NCT02417233|2625138|P2|Overall Study|Withdrawal by Subject|1
806009|NCT02417233|2625139|P1|Overall Study|Withdrawal by Subject|2
806010|NCT02417233|2625137|P3|Overall Study|Protocol Violation|2
806011|NCT02417233|2625138|P2|Overall Study|Protocol Violation|0
806012|NCT02417233|2625139|P1|Overall Study|Protocol Violation|2
806013|NCT02417233|2625137|P3|Overall Study|Lost to Follow-up|34
806014|NCT02417233|2625138|P2|Overall Study|Lost to Follow-up|39
806015|NCT02417233|2625139|P1|Overall Study|Lost to Follow-up|27
806016|NCT02417233|2625137|P3|Overall Study|Death|14
806017|NCT02417233|2625138|P2|Overall Study|Death|10
806018|NCT02417233|2625139|P1|Overall Study|Death|4
806019|NCT02416934|2625188|P2|Overall Study|re-operation|0
806020|NCT02416934|2625189|P1|Overall Study|re-operation|1
806021|NCT02416934|2625188|P2|Overall Study|surgery started late|1
806022|NCT02416934|2625189|P1|Overall Study|surgery started late|0
806023|NCT02416934|2625188|P2|Overall Study|Protocol Violation|1
806024|NCT02416934|2625189|P1|Overall Study|Protocol Violation|0
806025|NCT02416934|2625188|P2|Overall Study|recruited during continuing renewal proc|1
806026|NCT02416934|2625189|P1|Overall Study|recruited during continuing renewal proc|0
806027|NCT02416934|2625188|P2|Overall Study|Withdrawal by Subject|0
806028|NCT02416934|2625189|P1|Overall Study|Withdrawal by Subject|1
806029|NCT02416934|2625188|P2|Overall Study|Lost to Follow-up|2
806030|NCT02416934|2625189|P1|Overall Study|Lost to Follow-up|0
806031|NCT02416934|2625188|P2|Overall Study|given steroids|2
806032|NCT02416934|2625189|P1|Overall Study|given steroids|1
806033|NCT02416180|2625199|P1|Overall Study|Withdrawal by Subject|1
806034|NCT02415959|2625211|P5|Overall Study|Protocol Violation|0
806035|NCT02415959|2625212|P4|Overall Study|Protocol Violation|1
806036|NCT02415959|2625213|P3|Overall Study|Protocol Violation|0
806037|NCT02415959|2625214|P2|Overall Study|Protocol Violation|0
806038|NCT02415959|2625215|P1|Overall Study|Protocol Violation|0
806039|NCT02415959|2625211|P5|Overall Study|Adverse Event|0
806040|NCT02415959|2625212|P4|Overall Study|Adverse Event|0
806041|NCT02415959|2625213|P3|Overall Study|Adverse Event|0
806042|NCT02415959|2625214|P2|Overall Study|Adverse Event|1
806043|NCT02415959|2625215|P1|Overall Study|Adverse Event|0
806044|NCT02415595|2625280|P4|Overall Study|Other|0
806045|NCT02415595|2625281|P3|Overall Study|Other|1
806046|NCT02415595|2625282|P2|Overall Study|Other|1
806047|NCT02415595|2625283|P1|Overall Study|Other|0
806048|NCT02415595|2625280|P4|Overall Study|Withdrawal by Subject|3
806049|NCT02415595|2625281|P3|Overall Study|Withdrawal by Subject|1
806050|NCT02415595|2625282|P2|Overall Study|Withdrawal by Subject|0
806051|NCT02415595|2625283|P1|Overall Study|Withdrawal by Subject|4
806052|NCT02415595|2625280|P4|Overall Study|Reached stopping criteria|0
806053|NCT02415595|2625281|P3|Overall Study|Reached stopping criteria|1
806054|NCT02415595|2625282|P2|Overall Study|Reached stopping criteria|1
806055|NCT02415595|2625283|P1|Overall Study|Reached stopping criteria|0
806056|NCT02415595|2625280|P4|Overall Study|Poor/Non-compliance|0
806057|NCT02415595|2625281|P3|Overall Study|Poor/Non-compliance|1
806058|NCT02415595|2625282|P2|Overall Study|Poor/Non-compliance|0
806059|NCT02415595|2625283|P1|Overall Study|Poor/Non-compliance|1
806060|NCT02415595|2625280|P4|Overall Study|Lost to Follow-up|1
806061|NCT02415595|2625281|P3|Overall Study|Lost to Follow-up|1
806062|NCT02415595|2625282|P2|Overall Study|Lost to Follow-up|3
806063|NCT02415595|2625283|P1|Overall Study|Lost to Follow-up|1
806064|NCT02415595|2625280|P4|Overall Study|Lack of Efficacy|0
806065|NCT02415595|2625281|P3|Overall Study|Lack of Efficacy|0
806066|NCT02415595|2625282|P2|Overall Study|Lack of Efficacy|4
806067|NCT02415595|2625283|P1|Overall Study|Lack of Efficacy|4
806068|NCT02415595|2625280|P4|Overall Study|Adverse Event|10
806069|NCT02415595|2625281|P3|Overall Study|Adverse Event|5
806070|NCT02415595|2625282|P2|Overall Study|Adverse Event|3
806071|NCT02415595|2625283|P1|Overall Study|Adverse Event|1
806072|NCT02415595|2625280|P4|Overall Study|Administrative reason by sponsor|39
806073|NCT02415595|2625281|P3|Overall Study|Administrative reason by sponsor|41
806074|NCT02415595|2625282|P2|Overall Study|Administrative reason by sponsor|40
806075|NCT02415595|2625283|P1|Overall Study|Administrative reason by sponsor|39
806076|NCT02415127|2625456|P2|Overall Study|Adverse Event|0
806077|NCT02415127|2625457|P1|Overall Study|Adverse Event|1
806078|NCT02414958|2625474|P3|Overall Study|Other than specified|5
806079|NCT02414958|2625475|P2|Overall Study|Other than specified|4
806080|NCT02414958|2625476|P1|Overall Study|Other than specified|4
806081|NCT02414958|2625474|P3|Overall Study|Withdrawal by Subject|5
806082|NCT02414958|2625475|P2|Overall Study|Withdrawal by Subject|3
806083|NCT02414958|2625476|P1|Overall Study|Withdrawal by Subject|5
806084|NCT02414958|2625474|P3|Overall Study|Lost to Follow-up|0
806085|NCT02414958|2625475|P2|Overall Study|Lost to Follow-up|4
806086|NCT02414958|2625476|P1|Overall Study|Lost to Follow-up|7
806087|NCT02414958|2625474|P3|Overall Study|Protocol Violation|1
806088|NCT02414958|2625475|P2|Overall Study|Protocol Violation|3
806089|NCT02414958|2625476|P1|Overall Study|Protocol Violation|10
806090|NCT02414958|2625474|P3|Overall Study|Adverse Event|3
806091|NCT02414958|2625475|P2|Overall Study|Adverse Event|6
806092|NCT02414958|2625476|P1|Overall Study|Adverse Event|6
806093|NCT02414854|2625509|P4|Overall Study|Other than specified above|37
806094|NCT02414854|2625510|P3|Overall Study|Other than specified above|17
806095|NCT02414854|2625511|P2|Overall Study|Other than specified above|37
806096|NCT02414854|2625512|P1|Overall Study|Other than specified above|12
806097|NCT02414854|2625509|P4|Overall Study|Poor compliance to protocol|2
806098|NCT02414854|2625510|P3|Overall Study|Poor compliance to protocol|2
806099|NCT02414854|2625511|P2|Overall Study|Poor compliance to protocol|1
806100|NCT02414854|2625512|P1|Overall Study|Poor compliance to protocol|1
806101|NCT02414854|2625509|P4|Overall Study|Adverse Event|12
806102|NCT02414854|2625510|P3|Overall Study|Adverse Event|1
806103|NCT02414854|2625511|P2|Overall Study|Adverse Event|7
806104|NCT02414854|2625512|P1|Overall Study|Adverse Event|9
806105|NCT02414828|2625678|P4|Overall Study|Lost to Follow-up|2
806106|NCT02414828|2625679|P3|Overall Study|Lost to Follow-up|1
806107|NCT02414828|2625680|P2|Overall Study|Lost to Follow-up|1
806108|NCT02414828|2625681|P1|Overall Study|Lost to Follow-up|0
806109|NCT02414152|2625751|P1|Overall Study|Lack of Efficacy|1
806110|NCT02414152|2625751|P1|Overall Study|Withdrawal by Subject|1
806111|NCT02413593|2625778|P1|Overall Study|Adverse Event|1
806112|NCT02413593|2625778|P1|Overall Study|Lost to Follow-up|3
806113|NCT02413489|2625790|P3|Overall Study|Study Terminated By Sponsor|1
806114|NCT02413489|2625791|P2|Overall Study|Study Terminated By Sponsor|13
806115|NCT02413489|2625792|P1|Overall Study|Study Terminated By Sponsor|2
806116|NCT02413489|2625790|P3|Overall Study|Withdrawal by Subject|0
806117|NCT02413489|2625791|P2|Overall Study|Withdrawal by Subject|0
806118|NCT02413489|2625792|P1|Overall Study|Withdrawal by Subject|2
806119|NCT02413489|2625790|P3|Overall Study|Death|4
806120|NCT02413489|2625791|P2|Overall Study|Death|3
806121|NCT02413489|2625792|P1|Overall Study|Death|11
806122|NCT02413398|2625814|P2|Overall Study|Other Eligibility criteria|2
806123|NCT02413398|2625815|P1|Overall Study|Other Eligibility criteria|1
806124|NCT02413398|2625814|P2|Overall Study|Withdrawal by Subject|1
806125|NCT02413398|2625815|P1|Overall Study|Withdrawal by Subject|1
806126|NCT02413398|2625814|P2|Overall Study|Lost to Follow-up|4
806127|NCT02413398|2625815|P1|Overall Study|Lost to Follow-up|2
806128|NCT02413346|2625829|P2|Overall Study|Other Miscellaneous Reasons|3
806129|NCT02413346|2625830|P1|Overall Study|Other Miscellaneous Reasons|4
806130|NCT02413346|2625829|P2|Overall Study|Protocol Violation|0
806131|NCT02413346|2625830|P1|Overall Study|Protocol Violation|2
806132|NCT02413346|2625829|P2|Overall Study|Lost to Follow-up|21
806133|NCT02413346|2625830|P1|Overall Study|Lost to Follow-up|17
806134|NCT02413346|2625829|P2|Overall Study|Withdrawal by Subject|40
806135|NCT02413346|2625830|P1|Overall Study|Withdrawal by Subject|30
806136|NCT02413346|2625829|P2|Overall Study|Adverse Event|6
806137|NCT02413346|2625830|P1|Overall Study|Adverse Event|6
806138|NCT02413333|2625840|P2|Period 2|Protocol Deviation|0
806139|NCT02413333|2625841|P1|Period 2|Protocol Deviation|1
806140|NCT02413333|2625840|P2|Period 1|Reason Not Specified|1
806141|NCT02413333|2625841|P1|Period 1|Reason Not Specified|0
806142|NCT02413333|2625840|P2|Period 1|Adverse Event|0
806143|NCT02413333|2625841|P1|Period 1|Adverse Event|1
806144|NCT02413294|2625849|P1|Overall Study|Withdrawal by Subject|1
806145|NCT02412761|2625901|P6|First Intervention (2 Weeks)|Withdrawal by Subject|1
806146|NCT02412761|2625902|P5|First Intervention (2 Weeks)|Withdrawal by Subject|0
806147|NCT02412761|2625903|P4|First Intervention (2 Weeks)|Withdrawal by Subject|0
806148|NCT02412761|2625904|P3|First Intervention (2 Weeks)|Withdrawal by Subject|1
806149|NCT02412761|2625905|P2|First Intervention (2 Weeks)|Withdrawal by Subject|1
806150|NCT02412761|2625906|P1|First Intervention (2 Weeks)|Withdrawal by Subject|0
806151|NCT02412657|2625917|P3|Overall Study|Protocol Violation|3
806152|NCT02412657|2625918|P2|Overall Study|Protocol Violation|2
806153|NCT02412657|2625919|P1|Overall Study|Protocol Violation|0
806154|NCT02412657|2625917|P3|Overall Study|Lost to Follow-up|0
806155|NCT02412657|2625918|P2|Overall Study|Lost to Follow-up|0
806156|NCT02412657|2625919|P1|Overall Study|Lost to Follow-up|1
806157|NCT02412436|2625936|P1|Overall Study|Not Willing to Adhere to Requirements|1
806158|NCT02412436|2625936|P1|Overall Study|Death|1
806159|NCT02412436|2625936|P1|Overall Study|Unable to get to clinic|3
806160|NCT02412436|2625936|P1|Overall Study|Lost to Follow-up|6
806161|NCT02412436|2625936|P1|Overall Study|Protocol-mandated Discontinuation|7
806162|NCT02411747|2625980|P2|Overall Study|Protocol Violation|4
806163|NCT02411747|2625981|P1|Overall Study|Protocol Violation|2
806164|NCT02411747|2625980|P2|Overall Study|Withdrawal by Subject|0
806165|NCT02411747|2625981|P1|Overall Study|Withdrawal by Subject|1
806166|NCT02411578|2625996|P2|Crossover Trial Phase|Pregnancy|1
806167|NCT02411578|2625997|P1|Crossover Trial Phase|Pregnancy|0
806168|NCT02411539|2626039|P2|Overall Study|Confounding medical condition|1
806169|NCT02411539|2626040|P1|Overall Study|Confounding medical condition|0
806170|NCT02411539|2626039|P2|Overall Study|Lost to Follow-up|0
806171|NCT02411539|2626040|P1|Overall Study|Lost to Follow-up|2
806172|NCT02411292|2626128|P1|Overall Study|Lost to Follow-up|3
806173|NCT02411292|2626128|P1|Overall Study|Death|2
806174|NCT02411292|2626128|P1|Overall Study|Discharged before 3rd enoxaparin dose|16
806175|NCT02411201|2626134|P1|Overall Study|Age group completed|2
806176|NCT02411201|2626134|P1|Overall Study|Withdrawal by Subject|2
806177|NCT02411201|2626134|P1|Overall Study|Adverse Event|2
806178|NCT02411110|2626147|P2|Treatment Period 2|Personal Reasons|2
806179|NCT02411110|2626148|P1|Treatment Period 2|Personal Reasons|0
806180|NCT02411110|2626147|P2|Treatment Period 2|Lost to Follow-up|2
806181|NCT02411110|2626148|P1|Treatment Period 2|Lost to Follow-up|0
806182|NCT02411110|2626147|P2|Treatment Period 2|Adverse Event|0
806183|NCT02411110|2626148|P1|Treatment Period 2|Adverse Event|1
806184|NCT02411110|2626147|P2|Treatment Period 1|Other Miscellaneous Reasons|0
806185|NCT02411110|2626148|P1|Treatment Period 1|Other Miscellaneous Reasons|2
806186|NCT02411110|2626147|P2|Treatment Period 1|Personal Reasons|5
806187|NCT02411110|2626148|P1|Treatment Period 1|Personal Reasons|2
806188|NCT02411110|2626147|P2|Treatment Period 1|Lost to Follow-up|0
806189|NCT02411110|2626148|P1|Treatment Period 1|Lost to Follow-up|1
806190|NCT02411110|2626147|P2|Treatment Period 1|Adverse Event|2
806191|NCT02411110|2626148|P1|Treatment Period 1|Adverse Event|4
806192|NCT02410824|2626175|P2|First Intervention (One Week)|Headache|1
806193|NCT02410824|2626176|P1|First Intervention (One Week)|Headache|0
806194|NCT02410551|2626208|P1|Overall Study|FDA Clinical hold-patients taken off|2
806195|NCT02410551|2626208|P1|Overall Study|Withdrawal by Subject|1
806196|NCT02410551|2626208|P1|Overall Study|Adverse Event|1
806197|NCT02410343|2626215|P2|Extension Period (12 Months)|Early termination of study by sponsor|1
806198|NCT02410343|2626216|P1|Extension Period (12 Months)|Early termination of study by sponsor|0
806199|NCT02410343|2626215|P2|Extension Period (12 Months)|Adverse Event|0
806200|NCT02410343|2626216|P1|Extension Period (12 Months)|Adverse Event|1
806201|NCT02410343|2626215|P2|Core Period (24 Weeks)|Early termination of study by sponsor|7
806202|NCT02410343|2626216|P1|Core Period (24 Weeks)|Early termination of study by sponsor|4
806203|NCT02410343|2626215|P2|Core Period (24 Weeks)|Adverse Event|0
806204|NCT02410343|2626216|P1|Core Period (24 Weeks)|Adverse Event|1
806205|NCT02410278|2626262|P3|Study Treatment Period|GSRS Threshold Not Met|0
806206|NCT02410278|2626263|P2|Study Treatment Period|GSRS Threshold Not Met|1
806207|NCT02410278|2626264|P1|Study Treatment Period|GSRS Threshold Not Met|0
806208|NCT02410278|2626262|P3|Study Treatment Period|Other|0
806209|NCT02410278|2626263|P2|Study Treatment Period|Other|3
806210|NCT02410278|2626264|P1|Study Treatment Period|Other|0
806211|NCT02410278|2626262|P3|Study Treatment Period|Withdrawal by Subject|0
806212|NCT02410278|2626263|P2|Study Treatment Period|Withdrawal by Subject|1
806213|NCT02410278|2626264|P1|Study Treatment Period|Withdrawal by Subject|0
806214|NCT02410278|2626262|P3|Study Treatment Period|Physician Decision|1
806215|NCT02410278|2626263|P2|Study Treatment Period|Physician Decision|0
806216|NCT02410278|2626264|P1|Study Treatment Period|Physician Decision|0
806217|NCT02410278|2626262|P3|Study Treatment Period|Adverse Event|3
806218|NCT02410278|2626263|P2|Study Treatment Period|Adverse Event|6
806219|NCT02410278|2626264|P1|Study Treatment Period|Adverse Event|0
806220|NCT02410278|2626262|P3|Run-in Period|Pregnancy|0
806221|NCT02410278|2626263|P2|Run-in Period|Pregnancy|0
806222|NCT02410278|2626264|P1|Run-in Period|Pregnancy|1
806223|NCT02410278|2626262|P3|Run-in Period|Withdrawal by Subject|0
806224|NCT02410278|2626263|P2|Run-in Period|Withdrawal by Subject|0
806225|NCT02410278|2626264|P1|Run-in Period|Withdrawal by Subject|1
806226|NCT02410278|2626262|P3|Run-in Period|Lost to Follow-up|0
806227|NCT02410278|2626263|P2|Run-in Period|Lost to Follow-up|0
806228|NCT02410278|2626264|P1|Run-in Period|Lost to Follow-up|1
806229|NCT02410278|2626262|P3|Run-in Period|GSRS Threshold Not Met|0
806230|NCT02410278|2626263|P2|Run-in Period|GSRS Threshold Not Met|0
806231|NCT02410278|2626264|P1|Run-in Period|GSRS Threshold Not Met|30
806232|NCT02410278|2626262|P3|Run-in Period|Adverse Event|0
806233|NCT02410278|2626263|P2|Run-in Period|Adverse Event|0
806234|NCT02410278|2626264|P1|Run-in Period|Adverse Event|5
806235|NCT02410252|2626289|P1|Overall Study|Physician Decision|2
806236|NCT02410252|2626289|P1|Overall Study|Withdrawal by Subject|4
806237|NCT02410200|2626302|P1|Overall Study|Adverse Event|2
806238|NCT02409732|2626344|P1|Overall Study|Lost to Follow-up|2
806239|NCT02409732|2626344|P1|Overall Study|Withdrawal by Subject|4
806240|NCT02409355|2626375|P2|Overall Study|Study terminated by Sponsor|3
806241|NCT02409355|2626376|P1|Overall Study|Study terminated by Sponsor|2
806242|NCT02409355|2626375|P2|Overall Study|Death|1
806243|NCT02409355|2626376|P1|Overall Study|Death|1
806244|NCT02409355|2626375|P2|Overall Study|Withdrawal by Subject|0
806245|NCT02409355|2626376|P1|Overall Study|Withdrawal by Subject|1
806246|NCT02408068|2626405|P6|Treatment 3 (1.5 Days)|Adverse Event|0
806247|NCT02408068|2626406|P5|Treatment 3 (1.5 Days)|Adverse Event|0
806248|NCT02408068|2626407|P4|Treatment 3 (1.5 Days)|Adverse Event|0
806249|NCT02408068|2626408|P3|Treatment 3 (1.5 Days)|Adverse Event|1
806250|NCT02408068|2626409|P2|Treatment 3 (1.5 Days)|Adverse Event|0
806251|NCT02408068|2626410|P1|Treatment 3 (1.5 Days)|Adverse Event|0
806252|NCT02407704|2626437|P4|Overall Study|Withdrawal by Subject|0
806253|NCT02407704|2626438|P3|Overall Study|Withdrawal by Subject|1
806254|NCT02407704|2626439|P2|Overall Study|Withdrawal by Subject|0
806255|NCT02407704|2626440|P1|Overall Study|Withdrawal by Subject|0
806256|NCT02407704|2626437|P4|Overall Study|Protocol Violation|1
806257|NCT02407704|2626438|P3|Overall Study|Protocol Violation|0
806258|NCT02407704|2626439|P2|Overall Study|Protocol Violation|0
806259|NCT02407704|2626440|P1|Overall Study|Protocol Violation|0
806260|NCT02407704|2626437|P4|Overall Study|Lost to Follow-up|2
806261|NCT02407704|2626438|P3|Overall Study|Lost to Follow-up|0
806262|NCT02407704|2626439|P2|Overall Study|Lost to Follow-up|0
806263|NCT02407704|2626440|P1|Overall Study|Lost to Follow-up|0
806264|NCT02406612|2626537|P2|Overall Study|Guidewire Failure|1
806265|NCT02406612|2626538|P1|Overall Study|Guidewire Failure|0
806266|NCT02406612|2626537|P2|Overall Study|Intra-procedural Exclusion|3
806267|NCT02406612|2626538|P1|Overall Study|Intra-procedural Exclusion|1
806268|NCT02406612|2626537|P2|Overall Study|Screening Failure|0
806269|NCT02406612|2626538|P1|Overall Study|Screening Failure|3
806270|NCT02406586|2626553|P3|Overall Study|Withdrawal by Subject|0
806271|NCT02406586|2626554|P2|Overall Study|Withdrawal by Subject|0
806272|NCT02406586|2626555|P1|Overall Study|Withdrawal by Subject|1
806273|NCT02406586|2626553|P3|Overall Study|Lost to Follow-up|2
806274|NCT02406586|2626554|P2|Overall Study|Lost to Follow-up|4
806275|NCT02406586|2626555|P1|Overall Study|Lost to Follow-up|0
806276|NCT02406248|2626668|P1|Overall Study|Withdrawal by Subject|2
806277|NCT02406248|2626668|P1|Overall Study|Death|7
806278|NCT02405091|2626698|P3|Overall Study|Physician Decision|0
806279|NCT02405091|2626699|P2|Overall Study|Physician Decision|2
806280|NCT02405091|2626700|P1|Overall Study|Physician Decision|2
806281|NCT02405091|2626698|P3|Overall Study|Lost to Follow-up|0
806282|NCT02405091|2626699|P2|Overall Study|Lost to Follow-up|6
806283|NCT02405091|2626700|P1|Overall Study|Lost to Follow-up|5
806284|NCT02405091|2626698|P3|Overall Study|Death|0
806285|NCT02405091|2626699|P2|Overall Study|Death|1
806286|NCT02405091|2626700|P1|Overall Study|Death|0
806287|NCT02405091|2626698|P3|Overall Study|Withdrawal by Subject|0
806288|NCT02405091|2626699|P2|Overall Study|Withdrawal by Subject|8
806289|NCT02405091|2626700|P1|Overall Study|Withdrawal by Subject|4
806290|NCT02405091|2626698|P3|Overall Study|Noncompliance|2
806291|NCT02405091|2626699|P2|Overall Study|Noncompliance|6
806292|NCT02405091|2626700|P1|Overall Study|Noncompliance|1
806293|NCT02405091|2626698|P3|Overall Study|Protocol Violation|0
806294|NCT02405091|2626699|P2|Overall Study|Protocol Violation|0
806295|NCT02405091|2626700|P1|Overall Study|Protocol Violation|1
806296|NCT02405091|2626698|P3|Overall Study|Adverse Event|0
806297|NCT02405091|2626699|P2|Overall Study|Adverse Event|10
806298|NCT02405091|2626700|P1|Overall Study|Adverse Event|16
806299|NCT02404649|2626723|P2|Overall Study|Adverse Event|2
806300|NCT02404649|2626724|P1|Overall Study|Adverse Event|1
806301|NCT02404545|2626732|P2|Overall Study|Sponsor Termination|6
806302|NCT02404545|2626733|P1|Overall Study|Sponsor Termination|6
806303|NCT02404493|2626752|P2|Overall Study|Adverse Event|1
806304|NCT02404493|2626753|P1|Overall Study|Adverse Event|1
806305|NCT02404389|2626998|P5|Overall Study|Subject/guardian decision|1
806306|NCT02404389|2626999|P4|Overall Study|Subject/guardian decision|1
806307|NCT02404389|2627000|P3|Overall Study|Subject/guardian decision|0
806308|NCT02404389|2627001|P2|Overall Study|Subject/guardian decision|0
806309|NCT02404389|2627002|P1|Overall Study|Subject/guardian decision|1
806310|NCT02404389|2626998|P5|Overall Study|Adverse Event|2
806311|NCT02404389|2626999|P4|Overall Study|Adverse Event|0
806312|NCT02404389|2627000|P3|Overall Study|Adverse Event|1
806313|NCT02404389|2627001|P2|Overall Study|Adverse Event|0
806314|NCT02404389|2627002|P1|Overall Study|Adverse Event|1
806315|NCT02404103|2627040|P2|Overall Study|Lost to Follow-up|3
806316|NCT02404103|2627041|P1|Overall Study|Lost to Follow-up|3
806317|NCT02404103|2627040|P2|Overall Study|Adverse Event|0
806318|NCT02404103|2627041|P1|Overall Study|Adverse Event|1
806319|NCT02403674|2627087|P2|Overall Study|Protocol Violation|2
806320|NCT02403674|2627088|P1|Overall Study|Protocol Violation|4
806321|NCT02403674|2627087|P2|Overall Study|Pregnancy|1
806322|NCT02403674|2627088|P1|Overall Study|Pregnancy|1
806323|NCT02403674|2627087|P2|Overall Study|Not treated with study drug|2
806324|NCT02403674|2627088|P1|Overall Study|Not treated with study drug|4
806325|NCT02403674|2627087|P2|Overall Study|Physician Decision|2
806326|NCT02403674|2627088|P1|Overall Study|Physician Decision|2
806327|NCT02403674|2627087|P2|Overall Study|Withdrawal by Subject|11
806328|NCT02403674|2627088|P1|Overall Study|Withdrawal by Subject|8
806329|NCT02403674|2627087|P2|Overall Study|Noncompliance with study drug|2
806330|NCT02403674|2627088|P1|Overall Study|Noncompliance with study drug|1
806331|NCT02403674|2627087|P2|Overall Study|Lost to Follow-up|7
806332|NCT02403674|2627088|P1|Overall Study|Lost to Follow-up|6
806333|NCT02403674|2627087|P2|Overall Study|Lack of Efficacy|10
806334|NCT02403674|2627088|P1|Overall Study|Lack of Efficacy|18
806335|NCT02403674|2627087|P2|Overall Study|Death|3
806336|NCT02403674|2627088|P1|Overall Study|Death|1
806337|NCT02403674|2627087|P2|Overall Study|Adverse Event|23
806338|NCT02403674|2627088|P1|Overall Study|Adverse Event|10
806339|NCT02403206|2627129|P2|Overall Study|Reason not given|4
806340|NCT02403206|2627130|P1|Overall Study|Reason not given|2
806341|NCT02403206|2627129|P2|Overall Study|Withdrawal by Subject|3
806342|NCT02403206|2627130|P1|Overall Study|Withdrawal by Subject|3
806343|NCT02403206|2627129|P2|Overall Study|Physician Decision|0
806344|NCT02403206|2627130|P1|Overall Study|Physician Decision|2
806345|NCT02403206|2627129|P2|Overall Study|Lost to Follow-up|3
806346|NCT02403206|2627130|P1|Overall Study|Lost to Follow-up|4
806347|NCT02403180|2627141|P2|Period 2 (5 Days)|Withdrawal by Subject|1
806348|NCT02403180|2627142|P1|Period 2 (5 Days)|Withdrawal by Subject|0
806349|NCT02403180|2627141|P2|Pre-Treatment Period|Withdrawal by subject prior to treatment|1
806350|NCT02403180|2627142|P1|Pre-Treatment Period|Withdrawal by subject prior to treatment|0
806351|NCT02402933|2627171|P1|Overall Study|Discontinued; Site Termination|10
806352|NCT02402933|2627171|P1|Overall Study|Withdrawal by Subject|4
806353|NCT02402322|2627189|P3|Follow-up|Withdrawal by Subject|24
806354|NCT02402322|2627190|P2|Follow-up|Withdrawal by Subject|3
806355|NCT02402322|2627191|P1|Follow-up|Withdrawal by Subject|6
806356|NCT02402322|2627189|P3|Pretreatment|Withdrawal by Subject|1
806357|NCT02402322|2627190|P2|Pretreatment|Withdrawal by Subject|1
806358|NCT02402322|2627191|P1|Pretreatment|Withdrawal by Subject|3
806359|NCT02402166|2627238|P1|Overall Study|Lost to Follow-up|1
806360|NCT02402166|2627238|P1|Overall Study|Withdrawal by Subject|2
806361|NCT02402166|2627238|P1|Overall Study|Adverse Event|2
806362|NCT02401867|2627291|P1|Analysis|Cervical assay could not be conducted|9
806363|NCT02401867|2627291|P1|Specimen Collection|Didn't receive 1 or more tests|10
806364|NCT02401529|2627311|P2|Overall Study|Protocol Violation|0
806365|NCT02401529|2627312|P1|Overall Study|Protocol Violation|5
806366|NCT02401529|2627311|P2|Overall Study|Physician Decision|6
806367|NCT02401529|2627312|P1|Overall Study|Physician Decision|2
806368|NCT02401529|2627311|P2|Overall Study|Lost to Follow-up|1
806369|NCT02401529|2627312|P1|Overall Study|Lost to Follow-up|2
806370|NCT02401412|2627379|P2|Overall Study|Improper Enrollment per In/Ex Criteria|6
806371|NCT02401412|2627380|P1|Overall Study|Improper Enrollment per In/Ex Criteria|10
806372|NCT02401412|2627379|P2|Overall Study|Subject withdrawal prior to intervention|1
806373|NCT02401412|2627380|P1|Overall Study|Subject withdrawal prior to intervention|0
806374|NCT02401412|2627379|P2|Overall Study|Withdrawal by Subject|4
806375|NCT02401412|2627380|P1|Overall Study|Withdrawal by Subject|4
806376|NCT02401412|2627379|P2|Overall Study|Discontinued Intervention|21
806377|NCT02401412|2627380|P1|Overall Study|Discontinued Intervention|15
806378|NCT02401412|2627379|P2|Overall Study|Lost to Follow-up|0
806379|NCT02401412|2627380|P1|Overall Study|Lost to Follow-up|1
806380|NCT02401256|2627388|P1|Overall Study|Withdrawal by Subject|12
806381|NCT02401256|2627388|P1|Overall Study|Adverse Event|5
806382|NCT02401230|2627397|P3|Overall Study|Lost to Follow-up|3
806383|NCT02401230|2627398|P2|Overall Study|Lost to Follow-up|3
806384|NCT02401230|2627399|P1|Overall Study|Lost to Follow-up|1
806385|NCT02401230|2627397|P3|Overall Study|Withdrawal by Subject|1
806386|NCT02401230|2627398|P2|Overall Study|Withdrawal by Subject|1
806387|NCT02401230|2627399|P1|Overall Study|Withdrawal by Subject|2
806388|NCT02401230|2627397|P3|Overall Study|Adverse Event|0
806389|NCT02401230|2627398|P2|Overall Study|Adverse Event|2
806390|NCT02401230|2627399|P1|Overall Study|Adverse Event|3
806391|NCT02400749|2627447|P2|Week 17 - 32|Adverse Event|1
806392|NCT02400749|2627448|P1|Week 17 - 32|Adverse Event|2
806393|NCT02400749|2627447|P2|Week 17 - 32|Withdrawal by Subject|2
806394|NCT02400749|2627448|P1|Week 17 - 32|Withdrawal by Subject|3
806395|NCT02400749|2627447|P2|Week 0 -16|Protocol Violation|0
806396|NCT02400749|2627448|P1|Week 0 -16|Protocol Violation|1
806397|NCT02400749|2627447|P2|Week 0 -16|Lost to Follow-up|0
806398|NCT02400749|2627448|P1|Week 0 -16|Lost to Follow-up|2
806399|NCT02400749|2627447|P2|Week 0 -16|Adverse Event|1
806400|NCT02400749|2627448|P1|Week 0 -16|Adverse Event|3
806401|NCT02400749|2627447|P2|Week 0 -16|Withdrawal by Subject|5
806402|NCT02400749|2627448|P1|Week 0 -16|Withdrawal by Subject|5
806403|NCT02400580|2627475|P2|Overall Study|Adverse Event|0
806404|NCT02400580|2627476|P1|Overall Study|Adverse Event|1
806405|NCT02400580|2627475|P2|Overall Study|Withdrawal by Subject|1
806406|NCT02400580|2627476|P1|Overall Study|Withdrawal by Subject|1
806407|NCT02400346|2627492|P1|Overall Study|Lost to Follow-up|1
806408|NCT02400346|2627492|P1|Overall Study|Administrative or other reason(s)|2
806409|NCT02400346|2627492|P1|Overall Study|Withdrawal by Subject|7
806410|NCT02400346|2627492|P1|Overall Study|Non-compliance with IMP|1
806411|NCT02400346|2627492|P1|Overall Study|Lack of Efficacy|9
806412|NCT02400346|2627492|P1|Overall Study|Adverse Event|24
806413|NCT02400333|2627500|P4|Overall Study|Protocol Violation|1
806414|NCT02400333|2627501|P3|Overall Study|Protocol Violation|2
806415|NCT02400333|2627502|P2|Overall Study|Protocol Violation|0
806416|NCT02400333|2627503|P1|Overall Study|Protocol Violation|1
806417|NCT02400333|2627500|P4|Overall Study|Withdrawal by Subject|1
806418|NCT02400333|2627501|P3|Overall Study|Withdrawal by Subject|0
806419|NCT02400333|2627502|P2|Overall Study|Withdrawal by Subject|1
806420|NCT02400333|2627503|P1|Overall Study|Withdrawal by Subject|0
806421|NCT02399163|2627567|P1|Overall Study|Withdrawal by Participant|5
806422|NCT02399163|2627567|P1|Overall Study|Protocol Deviation|2
806423|NCT02399163|2627567|P1|Overall Study|Adverse Event|2
806424|NCT02398227|2627614|P2|Overall Study|Removed from treatment and dropped out|0
806425|NCT02398227|2627615|P1|Overall Study|Removed from treatment and dropped out|1
806426|NCT02398227|2627614|P2|Overall Study|Withdrawal by Subject|6
806427|NCT02398227|2627615|P1|Overall Study|Withdrawal by Subject|5
806428|NCT02398227|2627614|P2|Overall Study|Lost to Follow-up|12
806429|NCT02398227|2627615|P1|Overall Study|Lost to Follow-up|21
806430|NCT02397915|2627623|P4|Period 1|Physician Decision|0
806431|NCT02397915|2627624|P3|Period 1|Physician Decision|0
806432|NCT02397915|2627625|P2|Period 1|Physician Decision|0
806433|NCT02397915|2627626|P1|Period 1|Physician Decision|1
806434|NCT02397915|2627623|P4|Period 1|Protocol Violation|0
806435|NCT02397915|2627624|P3|Period 1|Protocol Violation|0
806436|NCT02397915|2627625|P2|Period 1|Protocol Violation|1
806437|NCT02397915|2627626|P1|Period 1|Protocol Violation|0
806438|NCT02397694|2627725|P2|Open Label Extension Phase|Withdrawal by Subject|0
806439|NCT02397694|2627726|P1|Open Label Extension Phase|Withdrawal by Subject|1
806440|NCT02397694|2627725|P2|Open Label Extension Phase|Still on Study Drug|30
806441|NCT02397694|2627726|P1|Open Label Extension Phase|Still on Study Drug|61
806442|NCT02397694|2627725|P2|Double-Blinded Phase|Lost to Follow-up|1
806443|NCT02397694|2627726|P1|Double-Blinded Phase|Lost to Follow-up|1
806444|NCT02397694|2627725|P2|Double-Blinded Phase|Withdrawal by Subject|0
806445|NCT02397694|2627726|P1|Double-Blinded Phase|Withdrawal by Subject|1
806446|NCT02397694|2627725|P2|Double-Blinded Phase|Non-compliance with study drug|2
806447|NCT02397694|2627726|P1|Double-Blinded Phase|Non-compliance with study drug|0
806448|NCT02397694|2627725|P2|Double-Blinded Phase|Adverse Event|0
806449|NCT02397694|2627726|P1|Double-Blinded Phase|Adverse Event|1
806450|NCT02397655|2627764|P1|Overall Study|data not completed|1301
806451|NCT02396537|2627794|P2|Overall Study|Protocol Violation|1
806452|NCT02396537|2627795|P1|Overall Study|Protocol Violation|0
806453|NCT02396420|2627801|P1|Overall Study|Death|1
806454|NCT02396316|2627823|P2|Overall Study|Treatment unblinded|1
806455|NCT02396316|2627824|P1|Overall Study|Treatment unblinded|0
806456|NCT02396316|2627823|P2|Overall Study|Protocol Violation|1
806457|NCT02396316|2627824|P1|Overall Study|Protocol Violation|0
806458|NCT02396316|2627823|P2|Overall Study|Progressive disease|3
806459|NCT02396316|2627824|P1|Overall Study|Progressive disease|6
806460|NCT02396316|2627823|P2|Overall Study|Physician Decision|0
806461|NCT02396316|2627824|P1|Overall Study|Physician Decision|1
806462|NCT02395822|2627922|P1|Overall Study|Death|1
806463|NCT02395822|2627922|P1|Overall Study|Withdrawal by Subject|1
806464|NCT02395653|2627930|P1|Overall Study|Lost to Follow-up|1
806465|NCT02395653|2627930|P1|Overall Study|Withdrawal by Subject|1
806466|NCT02395653|2627930|P1|Overall Study|Inclusion Criteria Not Met at Screening|3
806467|NCT02395653|2627930|P1|Overall Study|Investigator Decision at Screening|1
806468|NCT02395653|2627930|P1|Overall Study|SSEC Application But With 0 Dose|1
806469|NCT02395653|2627930|P1|Overall Study|Consent Withdrawn at Screening|1
806470|NCT02395653|2627930|P1|Overall Study|Exclusion Criteria Met at Screening|4
806471|NCT02395536|2627939|P2|Overall Study|Insurance issue|1
806472|NCT02395536|2627940|P1|Overall Study|Insurance issue|0
806473|NCT02395536|2627939|P2|Overall Study|Inclusion/Excusion Criteria Violation|2
806474|NCT02395536|2627940|P1|Overall Study|Inclusion/Excusion Criteria Violation|1
806475|NCT02395536|2627939|P2|Overall Study|Withdrawal by Subject|17
806476|NCT02395536|2627940|P1|Overall Study|Withdrawal by Subject|9
806477|NCT02395536|2627939|P2|Overall Study|Physician Decision|6
806478|NCT02395536|2627940|P1|Overall Study|Physician Decision|4
806479|NCT02395536|2627939|P2|Overall Study|Death|0
806480|NCT02395536|2627940|P1|Overall Study|Death|2
806481|NCT02395536|2627939|P2|Overall Study|Lost to Follow-up|4
806482|NCT02395536|2627940|P1|Overall Study|Lost to Follow-up|4
806483|NCT02395302|2627946|P1|Overall Study|Physician Decision|2
806484|NCT02395302|2627946|P1|Overall Study|Withdrawal by Subject|2
806485|NCT02395302|2627946|P1|Overall Study|Run In Failure|7
806486|NCT02395302|2627946|P1|Overall Study|Screen Failure|3
806487|NCT02395133|2627968|P4|Overall Study|Other than specified above|4
806488|NCT02395133|2627969|P3|Overall Study|Other than specified above|2
806489|NCT02395133|2627970|P2|Overall Study|Other than specified above|2
806490|NCT02395133|2627971|P1|Overall Study|Other than specified above|5
806491|NCT02395133|2627968|P4|Overall Study|Sponsor decision|1
806492|NCT02395133|2627969|P3|Overall Study|Sponsor decision|0
806493|NCT02395133|2627970|P2|Overall Study|Sponsor decision|0
806494|NCT02395133|2627971|P1|Overall Study|Sponsor decision|2
806495|NCT02395133|2627968|P4|Overall Study|Consent withdrawn with personal reason|3
806496|NCT02395133|2627969|P3|Overall Study|Consent withdrawn with personal reason|0
806497|NCT02395133|2627970|P2|Overall Study|Consent withdrawn with personal reason|1
806498|NCT02395133|2627971|P1|Overall Study|Consent withdrawn with personal reason|0
806499|NCT02395133|2627968|P4|Overall Study|Consent withdrawn with no reason given|2
806500|NCT02395133|2627969|P3|Overall Study|Consent withdrawn with no reason given|0
806501|NCT02395133|2627970|P2|Overall Study|Consent withdrawn with no reason given|3
806502|NCT02395133|2627971|P1|Overall Study|Consent withdrawn with no reason given|1
806503|NCT02395133|2627968|P4|Overall Study|Pregnancy|0
806504|NCT02395133|2627969|P3|Overall Study|Pregnancy|3
806505|NCT02395133|2627970|P2|Overall Study|Pregnancy|0
806506|NCT02395133|2627971|P1|Overall Study|Pregnancy|0
806507|NCT02395133|2627968|P4|Overall Study|Lost to Follow-up|0
806508|NCT02395133|2627969|P3|Overall Study|Lost to Follow-up|1
806509|NCT02395133|2627970|P2|Overall Study|Lost to Follow-up|1
806510|NCT02395133|2627971|P1|Overall Study|Lost to Follow-up|0
806511|NCT02395133|2627968|P4|Overall Study|Protocol Violation|3
806512|NCT02395133|2627969|P3|Overall Study|Protocol Violation|0
806513|NCT02395133|2627970|P2|Overall Study|Protocol Violation|1
806514|NCT02395133|2627971|P1|Overall Study|Protocol Violation|1
806515|NCT02395133|2627968|P4|Overall Study|Lack of Efficacy|1
806516|NCT02395133|2627969|P3|Overall Study|Lack of Efficacy|1
806517|NCT02395133|2627970|P2|Overall Study|Lack of Efficacy|0
806518|NCT02395133|2627971|P1|Overall Study|Lack of Efficacy|1
806519|NCT02395133|2627968|P4|Overall Study|Adverse Event|0
806520|NCT02395133|2627969|P3|Overall Study|Adverse Event|3
806521|NCT02395133|2627970|P2|Overall Study|Adverse Event|1
806522|NCT02395133|2627971|P1|Overall Study|Adverse Event|4
806523|NCT02395055|2628059|P2|Overall Study|Withdrawal by Subject|3
806524|NCT02395055|2628060|P1|Overall Study|Withdrawal by Subject|7
806525|NCT02395042|2628073|P3|Treatment 2 Period|Lack of Efficacy|0
806526|NCT02395042|2628074|P2|Treatment 2 Period|Lack of Efficacy|1
806527|NCT02395042|2628075|P1|Treatment 2 Period|Lack of Efficacy|1
806528|NCT02395042|2628073|P3|Treatment 1 Period|Other Miscellaneous Reasons|1
806529|NCT02395042|2628074|P2|Treatment 1 Period|Other Miscellaneous Reasons|2
806530|NCT02395042|2628075|P1|Treatment 1 Period|Other Miscellaneous Reasons|0
806531|NCT02395042|2628073|P3|Treatment 1 Period|Lost to Follow-up|0
806532|NCT02395042|2628074|P2|Treatment 1 Period|Lost to Follow-up|0
806533|NCT02395042|2628075|P1|Treatment 1 Period|Lost to Follow-up|1
806534|NCT02395042|2628073|P3|Treatment 1 Period|Lack of Efficacy|0
806535|NCT02395042|2628074|P2|Treatment 1 Period|Lack of Efficacy|1
806536|NCT02395042|2628075|P1|Treatment 1 Period|Lack of Efficacy|1
806537|NCT02395042|2628073|P3|Treatment 1 Period|Adverse Event|1
806538|NCT02395042|2628074|P2|Treatment 1 Period|Adverse Event|3
806539|NCT02395042|2628075|P1|Treatment 1 Period|Adverse Event|1
806540|NCT02394925|2628092|P1|Overall Study|Unsatisfactory Visual Response|5
806541|NCT02394925|2628092|P1|Overall Study|No longer meet eligibility criteria|1
806542|NCT02394925|2628092|P1|Overall Study|Protocol Violation|5
806543|NCT02394925|2628092|P1|Overall Study|Lost to Follow-up|9
806544|NCT02394925|2628092|P1|Overall Study|Lens handling difficulities|5
806545|NCT02394925|2628092|P1|Overall Study|Lens Discomfort|3
806546|NCT02394925|2628092|P1|Overall Study|Adverse Event|1
806547|NCT02394808|2628100|P2|Period 2|Lost to Follow-up|0
806548|NCT02394808|2628101|P1|Period 2|Lost to Follow-up|1
806549|NCT02394808|2628100|P2|Period 1|Unsatisfactory lens fitting|1
806550|NCT02394808|2628101|P1|Period 1|Unsatisfactory lens fitting|0
806551|NCT02394756|2628109|P6|Period 2|Unsatisfactory Visual Response|0
806552|NCT02394756|2628110|P5|Period 2|Unsatisfactory Visual Response|1
806553|NCT02394756|2628111|P4|Period 2|Unsatisfactory Visual Response|0
806554|NCT02394756|2628112|P3|Period 2|Unsatisfactory Visual Response|0
806555|NCT02394756|2628113|P2|Period 2|Unsatisfactory Visual Response|0
806556|NCT02394756|2628114|P1|Period 2|Unsatisfactory Visual Response|0
806557|NCT02394756|2628109|P6|Period 1|Withdrawal by Subject|0
806558|NCT02394756|2628110|P5|Period 1|Withdrawal by Subject|0
806559|NCT02394756|2628111|P4|Period 1|Withdrawal by Subject|1
806560|NCT02394756|2628112|P3|Period 1|Withdrawal by Subject|1
806561|NCT02394756|2628113|P2|Period 1|Withdrawal by Subject|1
806562|NCT02394756|2628114|P1|Period 1|Withdrawal by Subject|0
806563|NCT02394756|2628109|P6|Period 1|Lens Discomfort|1
806564|NCT02394756|2628110|P5|Period 1|Lens Discomfort|0
806565|NCT02394756|2628111|P4|Period 1|Lens Discomfort|0
806566|NCT02394756|2628112|P3|Period 1|Lens Discomfort|0
806567|NCT02394756|2628113|P2|Period 1|Lens Discomfort|0
806568|NCT02394756|2628114|P1|Period 1|Lens Discomfort|0
806569|NCT02394665|2628128|P3|Overall Study|Physician Decision|0
806570|NCT02394665|2628129|P2|Overall Study|Physician Decision|0
806571|NCT02394665|2628130|P1|Overall Study|Physician Decision|1
806572|NCT02394600|2628152|P2|Overall Study|Protocol Violation|0
806573|NCT02394600|2628153|P1|Overall Study|Protocol Violation|1
806574|NCT02394600|2628152|P2|Overall Study|Withdrawal by Subject|1
806575|NCT02394600|2628153|P1|Overall Study|Withdrawal by Subject|0
806576|NCT02394600|2628152|P2|Overall Study|Lost to Follow-up|1
806577|NCT02394600|2628153|P1|Overall Study|Lost to Follow-up|0
806578|NCT02394600|2628152|P2|Overall Study|Adverse Event|0
806579|NCT02394600|2628153|P1|Overall Study|Adverse Event|3
806580|NCT02393950|2628182|P2|Overall Study|Withdrawal by Subject|1
806581|NCT02393950|2628183|P1|Overall Study|Withdrawal by Subject|0
806582|NCT02393950|2628182|P2|Overall Study|Adverse Event|0
806583|NCT02393950|2628183|P1|Overall Study|Adverse Event|1
806584|NCT02393547|2628257|P1|Overall Study|Lost to Follow-up|1
806585|NCT02393547|2628257|P1|Overall Study|Withdrawal by Subject|3
806586|NCT02393547|2628257|P1|Overall Study|Adverse Event|2
806587|NCT02393209|2628266|P4|Overall Study|Lost to Follow-up|0
806588|NCT02393209|2628267|P3|Overall Study|Lost to Follow-up|0
806589|NCT02393209|2628268|P2|Overall Study|Lost to Follow-up|1
806590|NCT02393209|2628269|P1|Overall Study|Lost to Follow-up|0
806591|NCT02393209|2628266|P4|Overall Study|Patient Seen by Another Oncologist|0
806592|NCT02393209|2628267|P3|Overall Study|Patient Seen by Another Oncologist|0
806593|NCT02393209|2628268|P2|Overall Study|Patient Seen by Another Oncologist|1
806594|NCT02393209|2628269|P1|Overall Study|Patient Seen by Another Oncologist|0
806595|NCT02393209|2628266|P4|Overall Study|Death from Legionella Infection|0
806596|NCT02393209|2628267|P3|Overall Study|Death from Legionella Infection|0
806597|NCT02393209|2628268|P2|Overall Study|Death from Legionella Infection|1
806598|NCT02393209|2628269|P1|Overall Study|Death from Legionella Infection|0
806599|NCT02393209|2628266|P4|Overall Study|Death due to Disease Progression|0
806600|NCT02393209|2628267|P3|Overall Study|Death due to Disease Progression|0
806601|NCT02393209|2628268|P2|Overall Study|Death due to Disease Progression|2
806602|NCT02393209|2628269|P1|Overall Study|Death due to Disease Progression|2
806603|NCT02393209|2628266|P4|Overall Study|Death|0
806604|NCT02393209|2628267|P3|Overall Study|Death|0
806605|NCT02393209|2628268|P2|Overall Study|Death|2
806606|NCT02393209|2628269|P1|Overall Study|Death|2
806607|NCT02393209|2628266|P4|Overall Study|Withdrawal by Patient|0
806608|NCT02393209|2628267|P3|Overall Study|Withdrawal by Patient|0
806609|NCT02393209|2628268|P2|Overall Study|Withdrawal by Patient|0
806610|NCT02393209|2628269|P1|Overall Study|Withdrawal by Patient|1
806611|NCT02393209|2628266|P4|Overall Study|Study Terminated by Sponsor|0
806612|NCT02393209|2628267|P3|Overall Study|Study Terminated by Sponsor|0
806613|NCT02393209|2628268|P2|Overall Study|Study Terminated by Sponsor|1
806614|NCT02393209|2628269|P1|Overall Study|Study Terminated by Sponsor|1
806615|NCT02392624|2628358|P3|Overall Study|Other|1
806616|NCT02392624|2628359|P2|Overall Study|Other|1
806617|NCT02392624|2628360|P1|Overall Study|Other|49
806618|NCT02392624|2628358|P3|Overall Study|Sponsor/Investigator Decision|0
806619|NCT02392624|2628359|P2|Overall Study|Sponsor/Investigator Decision|1
806620|NCT02392624|2628360|P1|Overall Study|Sponsor/Investigator Decision|2
806621|NCT02392624|2628358|P3|Overall Study|Protocol Violation|1
806622|NCT02392624|2628359|P2|Overall Study|Protocol Violation|0
806623|NCT02392624|2628360|P1|Overall Study|Protocol Violation|0
806624|NCT02392624|2628358|P3|Overall Study|Pregnancy|0
806625|NCT02392624|2628359|P2|Overall Study|Pregnancy|0
806626|NCT02392624|2628360|P1|Overall Study|Pregnancy|1
806627|NCT02392624|2628358|P3|Overall Study|Adverse Event|2
806628|NCT02392624|2628359|P2|Overall Study|Adverse Event|1
806629|NCT02392624|2628360|P1|Overall Study|Adverse Event|4
806630|NCT02392624|2628358|P3|Overall Study|Withdrawal by Subject|9
806631|NCT02392624|2628359|P2|Overall Study|Withdrawal by Subject|12
806632|NCT02392624|2628360|P1|Overall Study|Withdrawal by Subject|15
806633|NCT02392481|2628377|P4|Overall Study|Withdrawal by Subject|0
806634|NCT02392481|2628378|P3|Overall Study|Withdrawal by Subject|1
806635|NCT02392481|2628379|P2|Overall Study|Withdrawal by Subject|0
806636|NCT02392481|2628380|P1|Overall Study|Withdrawal by Subject|0
806637|NCT02392481|2628377|P4|Overall Study|Adverse Event|2
806638|NCT02392481|2628378|P3|Overall Study|Adverse Event|1
806639|NCT02392481|2628379|P2|Overall Study|Adverse Event|0
806640|NCT02392481|2628380|P1|Overall Study|Adverse Event|0
806641|NCT02392403|2628402|P1|Overall Study|Withdrawal by Subject|1
806642|NCT02392403|2628402|P1|Overall Study|Death|1
806643|NCT02392403|2628402|P1|Overall Study|Adverse Event|1
806644|NCT02392377|2628416|P2|Overall Study|Withdrawal by Subject|1
806645|NCT02392377|2628417|P1|Overall Study|Withdrawal by Subject|0
806646|NCT02392247|2628441|P1|Overall Study|Surgery cancelled; no data|1
806647|NCT02392247|2628441|P1|Overall Study|Withdrawal by Subject|1
806648|NCT02392234|2628452|P6|Treatment Period 2 (8 Weeks)|Adverse Event|0
806649|NCT02392234|2628453|P5|Treatment Period 2 (8 Weeks)|Adverse Event|0
806650|NCT02392234|2628454|P4|Treatment Period 2 (8 Weeks)|Adverse Event|0
806651|NCT02392234|2628455|P3|Treatment Period 2 (8 Weeks)|Adverse Event|0
806652|NCT02392234|2628456|P2|Treatment Period 2 (8 Weeks)|Adverse Event|0
806653|NCT02392234|2628457|P1|Treatment Period 2 (8 Weeks)|Adverse Event|1
806654|NCT02392234|2628452|P6|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
806655|NCT02392234|2628453|P5|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
806656|NCT02392234|2628454|P4|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
806657|NCT02392234|2628455|P3|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
806658|NCT02392234|2628456|P2|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
806659|NCT02392234|2628457|P1|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
806660|NCT02392234|2628452|P6|Treatment Period 1 (8 Weeks)|Other|0
806661|NCT02392234|2628453|P5|Treatment Period 1 (8 Weeks)|Other|0
806662|NCT02392234|2628454|P4|Treatment Period 1 (8 Weeks)|Other|0
806663|NCT02392234|2628455|P3|Treatment Period 1 (8 Weeks)|Other|0
806664|NCT02392234|2628456|P2|Treatment Period 1 (8 Weeks)|Other|0
806665|NCT02392234|2628457|P1|Treatment Period 1 (8 Weeks)|Other|1
806666|NCT02392234|2628452|P6|Treatment Period 1 (8 Weeks)|Noncompliance|1
806667|NCT02392234|2628453|P5|Treatment Period 1 (8 Weeks)|Noncompliance|0
806668|NCT02392234|2628454|P4|Treatment Period 1 (8 Weeks)|Noncompliance|0
806669|NCT02392234|2628455|P3|Treatment Period 1 (8 Weeks)|Noncompliance|0
806670|NCT02392234|2628456|P2|Treatment Period 1 (8 Weeks)|Noncompliance|0
806671|NCT02392234|2628457|P1|Treatment Period 1 (8 Weeks)|Noncompliance|0
806672|NCT02392234|2628452|P6|Treatment Period 1 (8 Weeks)|Pregnancy|0
806673|NCT02392234|2628453|P5|Treatment Period 1 (8 Weeks)|Pregnancy|0
806674|NCT02392234|2628454|P4|Treatment Period 1 (8 Weeks)|Pregnancy|1
806675|NCT02392234|2628455|P3|Treatment Period 1 (8 Weeks)|Pregnancy|0
806676|NCT02392234|2628456|P2|Treatment Period 1 (8 Weeks)|Pregnancy|0
806677|NCT02392234|2628457|P1|Treatment Period 1 (8 Weeks)|Pregnancy|1
806678|NCT02392234|2628452|P6|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
806679|NCT02392234|2628453|P5|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
806680|NCT02392234|2628454|P4|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
806681|NCT02392234|2628455|P3|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
806682|NCT02392234|2628456|P2|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
806683|NCT02392234|2628457|P1|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
806684|NCT02392234|2628452|P6|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
806685|NCT02392234|2628453|P5|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2
806686|NCT02392234|2628454|P4|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
806687|NCT02392234|2628455|P3|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
806688|NCT02392234|2628456|P2|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
806689|NCT02392234|2628457|P1|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
806690|NCT02392234|2628452|P6|Treatment Period 1 (8 Weeks)|Adverse Event|1
806691|NCT02392234|2628453|P5|Treatment Period 1 (8 Weeks)|Adverse Event|1
806692|NCT02392234|2628454|P4|Treatment Period 1 (8 Weeks)|Adverse Event|0
806693|NCT02392234|2628455|P3|Treatment Period 1 (8 Weeks)|Adverse Event|1
806694|NCT02392234|2628456|P2|Treatment Period 1 (8 Weeks)|Adverse Event|0
806695|NCT02392234|2628457|P1|Treatment Period 1 (8 Weeks)|Adverse Event|1
806696|NCT02392000|2628489|P1|Overall Study|Lost to Follow-up|8
806697|NCT02392000|2628489|P1|Overall Study|Withdrawal by Subject|1
806698|NCT02392000|2628489|P1|Overall Study|Greater than mild sleep apnea exclusion|18
806699|NCT02391584|2628512|P2|12 Month (End of Study)|Lost to Follow-up|0
806700|NCT02391584|2628513|P1|12 Month (End of Study)|Lost to Follow-up|2
806701|NCT02391584|2628512|P2|6 Month|Withdrawal by Subject|0
806702|NCT02391584|2628513|P1|6 Month|Withdrawal by Subject|1
806703|NCT02391584|2628512|P2|3 Month|Lost to Follow-up|0
806704|NCT02391584|2628513|P1|3 Month|Lost to Follow-up|1
806705|NCT02391584|2628512|P2|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0
806706|NCT02391584|2628513|P1|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1
806707|NCT02391584|2628512|P2|Primary Endpoint (6-weeks)|Lost to Follow-up|2
806708|NCT02391584|2628513|P1|Primary Endpoint (6-weeks)|Lost to Follow-up|1
806709|NCT02391311|2628530|P2|Overall Study|deemed ineligible after baseline|1
806710|NCT02391311|2628531|P1|Overall Study|deemed ineligible after baseline|1
806711|NCT02391311|2628530|P2|Overall Study|Lost to Follow-up|1
806712|NCT02391311|2628531|P1|Overall Study|Lost to Follow-up|2
806713|NCT02391116|2628539|P1|Survival Follow-up|Ongoing with Survival Follow-up|12
806714|NCT02391116|2628539|P1|Survival Follow-up|Withdrawal by Subject|2
806715|NCT02391116|2628539|P1|Active Follow-up|Switching to Other Therapy|2
806716|NCT02391116|2628539|P1|Active Follow-up|Withdrawal by Subject|1
806717|NCT02391116|2628539|P1|Safety Follow-up|Deterioration of General Conditions|3
806718|NCT02391116|2628539|P1|Safety Follow-up|No Follow Up|1
806719|NCT02391116|2628539|P1|Safety Follow-up|Switching to Other Therapy|4
806720|NCT02391116|2628539|P1|Safety Follow-up|Withdrawal by Subject|4
806721|NCT02391116|2628539|P1|Safety Follow-up|Adverse Event|1
806722|NCT02391116|2628539|P1|Treatment|Ongoing with Treatment|1
806723|NCT02391116|2628539|P1|Treatment|AE with Clinical PD|3
806724|NCT02391116|2628539|P1|Treatment|Adverse Event (AE) Without Clinical PD|9
806725|NCT02391116|2628539|P1|Treatment|Protocol Violation|1
806726|NCT02391116|2628539|P1|Treatment|Withdrawal by Subject|1
806727|NCT02391038|2628592|P3|Overall Study|Progressive disease|6
806728|NCT02391038|2628593|P2|Overall Study|Progressive disease|3
806729|NCT02391038|2628594|P1|Overall Study|Progressive disease|3
806730|NCT02390557|2628711|P3|Wave 2|Survey non-respondent|23
806731|NCT02390557|2628712|P2|Wave 2|Survey non-respondent|41
806732|NCT02390557|2628713|P1|Wave 2|Survey non-respondent|72
806733|NCT02390219|2628721|P1|Overall Study|Other|2
806734|NCT02390219|2628721|P1|Overall Study|Lost to Follow-up|2
806735|NCT02390219|2628721|P1|Overall Study|Withdrawal by Subject|1
806736|NCT02390219|2628721|P1|Overall Study|Adverse Event|6
806737|NCT02390219|2628721|P1|Overall Study|Physician Decision|1
806738|NCT02390219|2628721|P1|Overall Study|Death|1
806739|NCT02390167|2628731|P1|Overall Study|Lost to Follow-up|1
806740|NCT02389829|2628814|P2|Overall Study|Lost to Follow-up|1
806741|NCT02389829|2628815|P1|Overall Study|Lost to Follow-up|0
806742|NCT02389621|2628833|P2|Posttreatment Period|Other - Miscellaneous|0
806743|NCT02389621|2628834|P1|Posttreatment Period|Other - Miscellaneous|2
806744|NCT02389621|2628833|P2|Posttreatment Period|Lost to Follow-up|1
806745|NCT02389621|2628834|P1|Posttreatment Period|Lost to Follow-up|1
806746|NCT02389621|2628833|P2|Posttreatment Period|Withdrawal by Subject|2
806747|NCT02389621|2628834|P1|Posttreatment Period|Withdrawal by Subject|3
806748|NCT02389621|2628833|P2|Posttreatment Period|Adverse Event|1
806749|NCT02389621|2628834|P1|Posttreatment Period|Adverse Event|3
806750|NCT02389621|2628833|P2|Treatment Period|Withdrawal by Subject|1
806751|NCT02389621|2628834|P1|Treatment Period|Withdrawal by Subject|1
806752|NCT02389452|2628864|P1|Overall Study|Enrolled but Not Eligible for Study|6
806753|NCT02389452|2628864|P1|Overall Study|Withdrawal by Subject|5
806754|NCT02389452|2628864|P1|Overall Study|Adverse Event|1
806755|NCT02389452|2628864|P1|Overall Study|Lost to Follow-up|13
806756|NCT02388997|2628972|P2|Overall Study|Tested positive for virus during run-in|1
806757|NCT02388997|2628973|P1|Overall Study|Tested positive for virus during run-in|0
806758|NCT02388997|2628972|P2|Overall Study|Lung function exclusion criteria|2
806759|NCT02388997|2628973|P1|Overall Study|Lung function exclusion criteria|0
806760|NCT02388997|2628972|P2|Overall Study|Withdrawal by Subject|1
806761|NCT02388997|2628973|P1|Overall Study|Withdrawal by Subject|2
806762|NCT02388997|2628972|P2|Overall Study|Adverse Event|2
806763|NCT02388997|2628973|P1|Overall Study|Adverse Event|1
806764|NCT02388932|2628991|P1|Overall Study|Death|1
806765|NCT02388776|2629004|P1|Overall Study|Lost to Follow-up|1
806766|NCT02388776|2629004|P1|Overall Study|Death|1
806767|NCT02388763|2629009|P2|Period 1, 10 Days of Wear|Withdrawal by Subject|1
806768|NCT02388763|2629010|P1|Period 1, 10 Days of Wear|Withdrawal by Subject|1
806769|NCT02388763|2629009|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|1
806770|NCT02388763|2629010|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|1
806771|NCT02388347|2629045|P5|Overall Study|Withdrawal by Subject|0
806772|NCT02388347|2629046|P4|Overall Study|Withdrawal by Subject|0
806773|NCT02388347|2629047|P3|Overall Study|Withdrawal by Subject|1
806774|NCT02388347|2629048|P2|Overall Study|Withdrawal by Subject|0
806775|NCT02388347|2629049|P1|Overall Study|Withdrawal by Subject|0
806776|NCT02388295|2629128|P3|Treatment Weeks 3 to 12|Adverse Event|0
806777|NCT02388295|2629129|P2|Treatment Weeks 3 to 12|Adverse Event|1
806778|NCT02388295|2629130|P1|Treatment Weeks 3 to 12|Adverse Event|1
806779|NCT02388295|2629128|P3|Dose Escalation Week 2|Determined not eligible|1
806780|NCT02388295|2629129|P2|Dose Escalation Week 2|Determined not eligible|1
806781|NCT02388295|2629130|P1|Dose Escalation Week 2|Determined not eligible|1
806782|NCT02388295|2629128|P3|Dose Escalation Week 2|Protocol Violation|0
806783|NCT02388295|2629129|P2|Dose Escalation Week 2|Protocol Violation|1
806784|NCT02388295|2629130|P1|Dose Escalation Week 2|Protocol Violation|0
806785|NCT02388295|2629128|P3|Dose Escalation Week 1|Determined not eligible|1
806786|NCT02388295|2629129|P2|Dose Escalation Week 1|Determined not eligible|1
806787|NCT02388295|2629130|P1|Dose Escalation Week 1|Determined not eligible|1
806788|NCT02388295|2629128|P3|Dose Escalation Week 1|Adverse Event|1
806789|NCT02388295|2629129|P2|Dose Escalation Week 1|Adverse Event|2
806790|NCT02388295|2629130|P1|Dose Escalation Week 1|Adverse Event|1
806791|NCT02388269|2629148|P3|Overall Study|Screen Failure|10
806792|NCT02388269|2629149|P2|Overall Study|Screen Failure|0
806793|NCT02388269|2629150|P1|Overall Study|Screen Failure|0
806794|NCT02388269|2629148|P3|Overall Study|Protocol Violation|0
806795|NCT02388269|2629149|P2|Overall Study|Protocol Violation|0
806796|NCT02388269|2629150|P1|Overall Study|Protocol Violation|2
806797|NCT02388269|2629148|P3|Overall Study|no diary data|0
806798|NCT02388269|2629149|P2|Overall Study|no diary data|0
806799|NCT02388269|2629150|P1|Overall Study|no diary data|3
806800|NCT02388269|2629148|P3|Overall Study|less than 50% stimulations|0
806801|NCT02388269|2629149|P2|Overall Study|less than 50% stimulations|0
806802|NCT02388269|2629150|P1|Overall Study|less than 50% stimulations|1
806803|NCT02388269|2629148|P3|Overall Study|Withdrawal by Subject|0
806804|NCT02388269|2629149|P2|Overall Study|Withdrawal by Subject|2
806805|NCT02388269|2629150|P1|Overall Study|Withdrawal by Subject|1
806806|NCT02388269|2629148|P3|Overall Study|Adverse Event|0
806807|NCT02388269|2629149|P2|Overall Study|Adverse Event|0
806808|NCT02388269|2629150|P1|Overall Study|Adverse Event|2
806809|NCT02388191|2629182|P2|Overall Study|Patient did not receive IUD|0
806810|NCT02388191|2629183|P1|Overall Study|Patient did not receive IUD|1
806811|NCT02388074|2629197|P1|Overall Study|Sample Not Returned|1
806812|NCT02388074|2629197|P1|Overall Study|Lost in Transit|2
806813|NCT02387996|2629201|P1|Overall Study|Poor/Non-Compliance|1
806814|NCT02387996|2629201|P1|Overall Study|Lost to Follow-up|1
806815|NCT02387996|2629201|P1|Overall Study|Subject Withdrew Consent|1
806816|NCT02387996|2629201|P1|Overall Study|Subject Request to Discontinue Treatment|9
806817|NCT02387996|2629201|P1|Overall Study|Adverse Event Unrelated to Study Drug|34
806818|NCT02387996|2629201|P1|Overall Study|Study Drug Toxicity|14
806819|NCT02387996|2629201|P1|Overall Study|Disease Progression|144
806820|NCT02387983|2629212|P1|Overall Study|Withdrawal by Subject|2
806821|NCT02387983|2629212|P1|Overall Study|Protocol Violation|1
806822|NCT02387983|2629212|P1|Overall Study|Adverse Event|4
806823|NCT02387580|2629271|P6|Overall Study|Withdrawal by Subject|0
806824|NCT02387580|2629272|P5|Overall Study|Withdrawal by Subject|0
806825|NCT02387580|2629273|P4|Overall Study|Withdrawal by Subject|1
806826|NCT02387580|2629274|P3|Overall Study|Withdrawal by Subject|0
806827|NCT02387580|2629275|P2|Overall Study|Withdrawal by Subject|0
806828|NCT02387580|2629276|P1|Overall Study|Withdrawal by Subject|0
806829|NCT02386098|2629377|P5|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
806830|NCT02386098|2629378|P4|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
806831|NCT02386098|2629379|P3|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
806832|NCT02386098|2629380|P2|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8
806833|NCT02386098|2629381|P1|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5
806834|NCT02386098|2629377|P5|Stage 1 (96 Weeks)|Other|0
806835|NCT02386098|2629378|P4|Stage 1 (96 Weeks)|Other|0
806836|NCT02386098|2629379|P3|Stage 1 (96 Weeks)|Other|0
806837|NCT02386098|2629380|P2|Stage 1 (96 Weeks)|Other|0
806838|NCT02386098|2629381|P1|Stage 1 (96 Weeks)|Other|1
806839|NCT02386098|2629377|P5|Stage 1 (96 Weeks)|Withdrawal by Subject|0
806840|NCT02386098|2629378|P4|Stage 1 (96 Weeks)|Withdrawal by Subject|0
806841|NCT02386098|2629379|P3|Stage 1 (96 Weeks)|Withdrawal by Subject|0
806842|NCT02386098|2629380|P2|Stage 1 (96 Weeks)|Withdrawal by Subject|1
806843|NCT02386098|2629381|P1|Stage 1 (96 Weeks)|Withdrawal by Subject|3
806844|NCT02386098|2629377|P5|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
806845|NCT02386098|2629378|P4|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
806846|NCT02386098|2629379|P3|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
806847|NCT02386098|2629380|P2|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2
806848|NCT02386098|2629381|P1|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
806849|NCT02386098|2629377|P5|Stage 1 (96 Weeks)|Lost to Follow-up|0
806850|NCT02386098|2629378|P4|Stage 1 (96 Weeks)|Lost to Follow-up|0
806851|NCT02386098|2629379|P3|Stage 1 (96 Weeks)|Lost to Follow-up|0
806852|NCT02386098|2629380|P2|Stage 1 (96 Weeks)|Lost to Follow-up|2
806853|NCT02386098|2629381|P1|Stage 1 (96 Weeks)|Lost to Follow-up|2
806854|NCT02386098|2629377|P5|Stage 1 (96 Weeks)|Adverse Event|0
806855|NCT02386098|2629378|P4|Stage 1 (96 Weeks)|Adverse Event|0
806856|NCT02386098|2629379|P3|Stage 1 (96 Weeks)|Adverse Event|0
806857|NCT02386098|2629380|P2|Stage 1 (96 Weeks)|Adverse Event|1
806858|NCT02386098|2629381|P1|Stage 1 (96 Weeks)|Adverse Event|2
806859|NCT02386098|2629377|P5|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
806860|NCT02386098|2629378|P4|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
806861|NCT02386098|2629379|P3|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
806862|NCT02386098|2629380|P2|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29
806863|NCT02386098|2629381|P1|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30
806864|NCT02385526|2629461|P3|Overall Study|Protocol Violation|0
806865|NCT02385526|2629462|P2|Overall Study|Protocol Violation|0
806866|NCT02385526|2629463|P1|Overall Study|Protocol Violation|1
806867|NCT02385526|2629461|P3|Overall Study|Physician Decision|0
806868|NCT02385526|2629462|P2|Overall Study|Physician Decision|0
806869|NCT02385526|2629463|P1|Overall Study|Physician Decision|1
806870|NCT02385526|2629461|P3|Overall Study|Lost to Follow-up|0
806871|NCT02385526|2629462|P2|Overall Study|Lost to Follow-up|1
806872|NCT02385526|2629463|P1|Overall Study|Lost to Follow-up|0
806873|NCT02385526|2629461|P3|Overall Study|Withdrawal by Subject|0
806874|NCT02385526|2629462|P2|Overall Study|Withdrawal by Subject|2
806875|NCT02385526|2629463|P1|Overall Study|Withdrawal by Subject|0
806876|NCT02385084|2629471|P6|Period 2|Protocol Violation|0
806877|NCT02385084|2629472|P5|Period 2|Protocol Violation|0
806878|NCT02385084|2629473|P4|Period 2|Protocol Violation|0
806879|NCT02385084|2629474|P3|Period 2|Protocol Violation|1
806880|NCT02385084|2629475|P2|Period 2|Protocol Violation|0
806881|NCT02385084|2629476|P1|Period 2|Protocol Violation|0
806882|NCT02384538|2629489|P2|Overall Study|Not Specified|3
806883|NCT02384538|2629490|P1|Overall Study|Not Specified|1
806884|NCT02384538|2629489|P2|Overall Study|Withdrew Consent|4
806885|NCT02384538|2629490|P1|Overall Study|Withdrew Consent|0
806886|NCT02384538|2629489|P2|Overall Study|Lack of Efficacy|4
806887|NCT02384538|2629490|P1|Overall Study|Lack of Efficacy|4
806888|NCT02384538|2629489|P2|Overall Study|Adverse Event|4
806889|NCT02384538|2629490|P1|Overall Study|Adverse Event|1
806890|NCT02384460|2629510|P2|Overall Study|Non-compliance|0
806891|NCT02384460|2629511|P1|Overall Study|Non-compliance|1
806892|NCT02384460|2629510|P2|Overall Study|Elective medical treatment|0
806893|NCT02384460|2629511|P1|Overall Study|Elective medical treatment|1
806894|NCT02384460|2629510|P2|Overall Study|Withdrawal by Subject|3
806895|NCT02384460|2629511|P1|Overall Study|Withdrawal by Subject|0
806896|NCT02384460|2629510|P2|Overall Study|Adverse Event|2
806897|NCT02384460|2629511|P1|Overall Study|Adverse Event|5
806898|NCT02384460|2629510|P2|Overall Study|Returned to previous therapeutic regimen|1
806899|NCT02384460|2629511|P1|Overall Study|Returned to previous therapeutic regimen|0
806900|NCT02384460|2629510|P2|Overall Study|Protocol Violation|1
806901|NCT02384460|2629511|P1|Overall Study|Protocol Violation|0
806902|NCT02383862|2629558|P2|3 Month Follow up|Lost to Follow-up|21
806903|NCT02383862|2629559|P1|3 Month Follow up|Lost to Follow-up|23
806904|NCT02383758|2629592|P2|Overall Study|Withdrawal by Subject|2
806905|NCT02383758|2629593|P1|Overall Study|Withdrawal by Subject|0
806906|NCT02383576|2629611|P2|Overall Study|Administrative/Other|4
806907|NCT02383576|2629612|P1|Overall Study|Administrative/Other|2
806908|NCT02383576|2629611|P2|Overall Study|Investigator's Decision|1
806909|NCT02383576|2629612|P1|Overall Study|Investigator's Decision|0
806910|NCT02383576|2629611|P2|Overall Study|Withdrew Consent|6
806911|NCT02383576|2629612|P1|Overall Study|Withdrew Consent|1
806912|NCT02383576|2629611|P2|Overall Study|Lost to Follow-up|1
806913|NCT02383576|2629612|P1|Overall Study|Lost to Follow-up|7
806914|NCT02383576|2629611|P2|Overall Study|Death|33
806915|NCT02383576|2629612|P1|Overall Study|Death|53
806916|NCT02383472|2629628|P2|Overall Study|Withdrawal by Subject|1
806917|NCT02383472|2629629|P1|Overall Study|Withdrawal by Subject|1
806918|NCT02382640|2629749|P4|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
806919|NCT02382640|2629750|P3|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
806920|NCT02382640|2629751|P2|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
806921|NCT02382640|2629752|P1|Intervention Period 4 (3 Days)|Laboratory Abnormality|1
806922|NCT02382133|2629790|P1|Overall Study|pressure injury both sites|1
806923|NCT02382133|2629790|P1|Overall Study|arterial catheter loss|4
806924|NCT02382133|2629790|P1|Overall Study|Physician Decision|2
806925|NCT02382133|2629790|P1|Overall Study|transfer out of ICU|4
806926|NCT02382133|2629790|P1|Overall Study|Death|22
806927|NCT02382016|2629797|P2|Overall Study|Withdrawal by Subject|1
806928|NCT02382016|2629798|P1|Overall Study|Withdrawal by Subject|0
806929|NCT02382016|2629797|P2|Overall Study|Lack of Efficacy|0
806930|NCT02382016|2629798|P1|Overall Study|Lack of Efficacy|1
806931|NCT02382016|2629797|P2|Overall Study|Physician Decision|0
806932|NCT02382016|2629798|P1|Overall Study|Physician Decision|3
806933|NCT02381795|2629820|P1|Overall Study|Study Terminated|2
806934|NCT02381795|2629820|P1|Overall Study|Withdrawal by Subject|1
806935|NCT02380742|2629891|P2|Overall Study|Withdrawal by Subject|0
806936|NCT02380742|2629892|P1|Overall Study|Withdrawal by Subject|1
806937|NCT02380287|2629912|P8|Overall Study|Adverse Event|0
806938|NCT02380287|2629913|P7|Overall Study|Adverse Event|0
806939|NCT02380287|2629914|P6|Overall Study|Adverse Event|0
806940|NCT02380287|2629915|P5|Overall Study|Adverse Event|0
806941|NCT02380287|2629916|P4|Overall Study|Adverse Event|0
806942|NCT02380287|2629917|P3|Overall Study|Adverse Event|1
806943|NCT02380287|2629918|P2|Overall Study|Adverse Event|0
806944|NCT02380287|2629919|P1|Overall Study|Adverse Event|0
806945|NCT02380248|2629935|P1|Overall Study|Withdrawal by Subject|3
806946|NCT02380248|2629935|P1|Overall Study|Lost to Follow-up|11
806947|NCT02379923|2629940|P1|Overall Study|Death|5
806948|NCT02379637|2629956|P2|Overall Study|Withdrawal by Subject|0
806949|NCT02379637|2629957|P1|Overall Study|Withdrawal by Subject|1
806950|NCT02379637|2629956|P2|Overall Study|Adverse Event|0
806951|NCT02379637|2629957|P1|Overall Study|Adverse Event|1
806952|NCT02379637|2629956|P2|Overall Study|Protocol Violation|1
806953|NCT02379637|2629957|P1|Overall Study|Protocol Violation|0
806954|NCT02379221|2629990|P1|Overall Study|Lost to Follow-up|1
806955|NCT02379091|2630009|P4|Overall Study|Lack of Efficacy|0
806956|NCT02379091|2630010|P3|Overall Study|Lack of Efficacy|0
806957|NCT02379091|2630011|P2|Overall Study|Lack of Efficacy|0
806958|NCT02379091|2630012|P1|Overall Study|Lack of Efficacy|3
806959|NCT02379091|2630009|P4|Overall Study|Study Termination|8
806960|NCT02379091|2630010|P3|Overall Study|Study Termination|5
806961|NCT02379091|2630011|P2|Overall Study|Study Termination|2
806962|NCT02379091|2630012|P1|Overall Study|Study Termination|7
806963|NCT02379091|2630009|P4|Overall Study|Voluntary Withdrawal|4
806964|NCT02379091|2630010|P3|Overall Study|Voluntary Withdrawal|2
806965|NCT02379091|2630011|P2|Overall Study|Voluntary Withdrawal|5
806966|NCT02379091|2630012|P1|Overall Study|Voluntary Withdrawal|2
806967|NCT02379091|2630009|P4|Overall Study|Lost to Follow-up|1
806968|NCT02379091|2630010|P3|Overall Study|Lost to Follow-up|0
806969|NCT02379091|2630011|P2|Overall Study|Lost to Follow-up|0
806970|NCT02379091|2630012|P1|Overall Study|Lost to Follow-up|0
806971|NCT02379091|2630009|P4|Overall Study|Principal Investigator Discretion|0
806972|NCT02379091|2630010|P3|Overall Study|Principal Investigator Discretion|0
806973|NCT02379091|2630011|P2|Overall Study|Principal Investigator Discretion|1
806974|NCT02379091|2630012|P1|Overall Study|Principal Investigator Discretion|0
806975|NCT02379091|2630009|P4|Overall Study|Pretreatment Event/Adverse Event|1
806976|NCT02379091|2630010|P3|Overall Study|Pretreatment Event/Adverse Event|0
806977|NCT02379091|2630011|P2|Overall Study|Pretreatment Event/Adverse Event|2
806978|NCT02379091|2630012|P1|Overall Study|Pretreatment Event/Adverse Event|0
806979|NCT02378961|2630052|P4|Overall Study|Death|0
806980|NCT02378961|2630053|P3|Overall Study|Death|1
806981|NCT02378961|2630054|P2|Overall Study|Death|0
806982|NCT02378961|2630055|P1|Overall Study|Death|0
806983|NCT02378961|2630052|P4|Overall Study|Lack of Efficacy|1
806984|NCT02378961|2630053|P3|Overall Study|Lack of Efficacy|0
806985|NCT02378961|2630054|P2|Overall Study|Lack of Efficacy|2
806986|NCT02378961|2630055|P1|Overall Study|Lack of Efficacy|4
806987|NCT02378935|2630092|P7|Overall Study|Death|0
806988|NCT02378935|2630093|P6|Overall Study|Death|0
806989|NCT02378935|2630094|P5|Overall Study|Death|0
806990|NCT02378935|2630095|P4|Overall Study|Death|0
806991|NCT02378935|2630096|P3|Overall Study|Death|1
806992|NCT02378935|2630097|P2|Overall Study|Death|0
806993|NCT02378935|2630098|P1|Overall Study|Death|0
806994|NCT02378935|2630092|P7|Overall Study|Lack of Efficacy|0
806995|NCT02378935|2630093|P6|Overall Study|Lack of Efficacy|0
806996|NCT02378935|2630094|P5|Overall Study|Lack of Efficacy|0
806997|NCT02378935|2630095|P4|Overall Study|Lack of Efficacy|6
806998|NCT02378935|2630096|P3|Overall Study|Lack of Efficacy|2
806999|NCT02378935|2630097|P2|Overall Study|Lack of Efficacy|0
807000|NCT02378935|2630098|P1|Overall Study|Lack of Efficacy|10
807001|NCT02378662|2630172|P2|Overall Study|Early Discontinuation|0
807002|NCT02378662|2630173|P1|Overall Study|Early Discontinuation|2
807003|NCT02378506|2630179|P1|Overall Study|Randomized But Not Treated|1
807004|NCT02378506|2630179|P1|Overall Study|Adverse Event|14
807005|NCT02378506|2630179|P1|Overall Study|Death|1
807006|NCT02378506|2630179|P1|Overall Study|Protocol Violation|2
807007|NCT02378506|2630179|P1|Overall Study|Withdrawal by Subject|4
807008|NCT02378506|2630179|P1|Overall Study|Lack of Efficacy|3
807009|NCT02378220|2630198|P2|Overall Study|Death|1
807010|NCT02378220|2630199|P1|Overall Study|Death|6
807011|NCT02377921|2630231|P2|Overall Study|Subject non-compliance|1
807012|NCT02377921|2630232|P1|Overall Study|Subject non-compliance|1
807013|NCT02377466|2630256|P2|Overall Study|Other: Randomized and not treated|2
807014|NCT02377466|2630257|P1|Overall Study|Other: Randomized and not treated|0
807015|NCT02377427|2630375|P5|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
807016|NCT02377427|2630376|P4|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
807017|NCT02377427|2630377|P3|Part B (From Week 20 and up to Week 80)|Protocol Violation|1
807018|NCT02377427|2630378|P2|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
807019|NCT02377427|2630379|P1|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
807020|NCT02377427|2630375|P5|Part A (Up to Week 20)|Withdrawal by Subject|0
807021|NCT02377427|2630376|P4|Part A (Up to Week 20)|Withdrawal by Subject|0
807022|NCT02377427|2630377|P3|Part A (Up to Week 20)|Withdrawal by Subject|0
807023|NCT02377427|2630378|P2|Part A (Up to Week 20)|Withdrawal by Subject|0
807024|NCT02377427|2630379|P1|Part A (Up to Week 20)|Withdrawal by Subject|2
807025|NCT02377427|2630375|P5|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
807026|NCT02377427|2630376|P4|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
807027|NCT02377427|2630377|P3|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
807028|NCT02377427|2630378|P2|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
807029|NCT02377427|2630379|P1|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1
807030|NCT02377427|2630375|P5|Part A (Up to Week 20)|Physician Decision|0
807031|NCT02377427|2630376|P4|Part A (Up to Week 20)|Physician Decision|0
807032|NCT02377427|2630377|P3|Part A (Up to Week 20)|Physician Decision|0
807033|NCT02377427|2630378|P2|Part A (Up to Week 20)|Physician Decision|0
807034|NCT02377427|2630379|P1|Part A (Up to Week 20)|Physician Decision|1
807035|NCT02376166|2630501|P1|Overall Study|Discontinued metformin early|2
807036|NCT02376166|2630501|P1|Overall Study|Adverse Event|1
807037|NCT02375971|2630529|P3|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0
807038|NCT02375971|2630530|P2|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
807039|NCT02375971|2630531|P1|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
807040|NCT02375971|2630529|P3|Follow-Up Phase (up to Day 169)|Death|4
807041|NCT02375971|2630530|P2|Follow-Up Phase (up to Day 169)|Death|4
807042|NCT02375971|2630531|P1|Follow-Up Phase (up to Day 169)|Death|4
807043|NCT02375971|2630529|P3|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
807044|NCT02375971|2630530|P2|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0
807045|NCT02375971|2630531|P1|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
807046|NCT02375971|2630529|P3|Follow-Up Phase (up to Day 169)|Adverse Event|0
807047|NCT02375971|2630530|P2|Follow-Up Phase (up to Day 169)|Adverse Event|0
807048|NCT02375971|2630531|P1|Follow-Up Phase (up to Day 169)|Adverse Event|1
807049|NCT02375971|2630529|P3|Treatment (Day 1 - Baseline)|Adverse Event|1
807050|NCT02375971|2630530|P2|Treatment (Day 1 - Baseline)|Adverse Event|0
807051|NCT02375971|2630531|P1|Treatment (Day 1 - Baseline)|Adverse Event|0
807052|NCT02375971|2630529|P3|Treatment (Day 1 - Baseline)|Lost to Follow-up|1
807053|NCT02375971|2630530|P2|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
807054|NCT02375971|2630531|P1|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
807055|NCT02375971|2630529|P3|Treatment (Day 1 - Baseline)|Physician Decision|1
807056|NCT02375971|2630530|P2|Treatment (Day 1 - Baseline)|Physician Decision|1
807057|NCT02375971|2630531|P1|Treatment (Day 1 - Baseline)|Physician Decision|1
807058|NCT02375971|2630529|P3|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2
807059|NCT02375971|2630530|P2|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
807060|NCT02375971|2630531|P1|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
807061|NCT02375724|2630573|P2|Overall Study|Adverse Event|4
807062|NCT02375724|2630574|P1|Overall Study|Adverse Event|2
807063|NCT02375724|2630573|P2|Overall Study|Protocol Violation|0
807064|NCT02375724|2630574|P1|Overall Study|Protocol Violation|1
807065|NCT02375724|2630573|P2|Overall Study|Lost to Follow-up|0
807066|NCT02375724|2630574|P1|Overall Study|Lost to Follow-up|1
807067|NCT02375724|2630573|P2|Overall Study|Withdrawal by Subject|1
807068|NCT02375724|2630574|P1|Overall Study|Withdrawal by Subject|1
807069|NCT02375724|2630573|P2|Overall Study|Lack of Efficacy|1
807070|NCT02375724|2630574|P1|Overall Study|Lack of Efficacy|1
807071|NCT02375373|2630584|P1|Overall Study|Withdrawal by Subject|11
807072|NCT02375347|2630588|P1|Overall Study|Protocol Violation|1
807073|NCT02374957|2630594|P2|Overall Study|Patient did not complete forms correctly|0
807074|NCT02374957|2630595|P1|Overall Study|Patient did not complete forms correctly|1
807075|NCT02374593|2630623|P2|Overall Study|non-compliant|0
807076|NCT02374593|2630624|P1|Overall Study|non-compliant|2
807077|NCT02374346|2630667|P1|Overall Study|operated or discharged during weekend|48
807078|NCT02373202|2630754|P4|Overall Study|Not specified|0
807079|NCT02373202|2630755|P3|Overall Study|Not specified|0
807080|NCT02373202|2630756|P2|Overall Study|Not specified|1
807081|NCT02373202|2630757|P1|Overall Study|Not specified|0
807082|NCT02373202|2630754|P4|Overall Study|Lack of Efficacy|0
807083|NCT02373202|2630755|P3|Overall Study|Lack of Efficacy|1
807084|NCT02373202|2630756|P2|Overall Study|Lack of Efficacy|0
807085|NCT02373202|2630757|P1|Overall Study|Lack of Efficacy|0
807086|NCT02373202|2630754|P4|Overall Study|Adverse Event|1
807087|NCT02373202|2630755|P3|Overall Study|Adverse Event|2
807088|NCT02373202|2630756|P2|Overall Study|Adverse Event|5
807089|NCT02373202|2630757|P1|Overall Study|Adverse Event|2
807090|NCT02372396|2630809|P2|Overall Study|Lost to Follow-up|9
807091|NCT02372396|2630810|P1|Overall Study|Lost to Follow-up|7
807092|NCT02372071|2630861|P1|Overall Study|Protocol Violation|18
807093|NCT02372058|2630866|P1|Overall Study|Withdrawal by Subject|3
807094|NCT02371759|2630895|P8|Overall Study|Withdrawal by Subject|1
807095|NCT02371759|2630896|P7|Overall Study|Withdrawal by Subject|0
807096|NCT02371759|2630897|P6|Overall Study|Withdrawal by Subject|0
807097|NCT02371759|2630898|P5|Overall Study|Withdrawal by Subject|0
807098|NCT02371759|2630899|P4|Overall Study|Withdrawal by Subject|0
807099|NCT02371759|2630900|P3|Overall Study|Withdrawal by Subject|0
807100|NCT02371759|2630901|P2|Overall Study|Withdrawal by Subject|0
807101|NCT02371759|2630902|P1|Overall Study|Withdrawal by Subject|0
807102|NCT02371759|2630895|P8|Overall Study|Protocol Violation|3
807103|NCT02371759|2630896|P7|Overall Study|Protocol Violation|0
807104|NCT02371759|2630897|P6|Overall Study|Protocol Violation|1
807105|NCT02371759|2630898|P5|Overall Study|Protocol Violation|3
807106|NCT02371759|2630899|P4|Overall Study|Protocol Violation|0
807107|NCT02371759|2630900|P3|Overall Study|Protocol Violation|1
807108|NCT02371759|2630901|P2|Overall Study|Protocol Violation|1
807109|NCT02371759|2630902|P1|Overall Study|Protocol Violation|3
807110|NCT02371616|2631114|P2|Overall Study|Other (Not specified)|5
807111|NCT02371616|2631115|P1|Overall Study|Other (Not specified)|1
807112|NCT02371616|2631114|P2|Overall Study|Withdrawal of Consent|0
807113|NCT02371616|2631115|P1|Overall Study|Withdrawal of Consent|1
807114|NCT02371616|2631114|P2|Overall Study|Adverse Event|1
807115|NCT02371616|2631115|P1|Overall Study|Adverse Event|0
807116|NCT02371616|2631114|P2|Overall Study|Protocol Violation|1
807117|NCT02371616|2631115|P1|Overall Study|Protocol Violation|2
807118|NCT02370914|2631131|P1|Overall Study|Protocol Violation|2
807119|NCT02370667|2631138|P3|Overall Study|Lost to Follow-up|0
807120|NCT02370667|2631139|P2|Overall Study|Lost to Follow-up|1
807121|NCT02370667|2631140|P1|Overall Study|Lost to Follow-up|0
807122|NCT02370615|2631204|P2|Overall Study|Adverse Event|0
807123|NCT02370615|2631205|P1|Overall Study|Adverse Event|1
807124|NCT02370602|2631248|P6|Overall Study|Pretreatment Event/Adverse Event|0
807125|NCT02370602|2631249|P5|Overall Study|Pretreatment Event/Adverse Event|0
807126|NCT02370602|2631250|P4|Overall Study|Pretreatment Event/Adverse Event|0
807127|NCT02370602|2631251|P3|Overall Study|Pretreatment Event/Adverse Event|0
807128|NCT02370602|2631252|P2|Overall Study|Pretreatment Event/Adverse Event|0
807129|NCT02370602|2631253|P1|Overall Study|Pretreatment Event/Adverse Event|1
807130|NCT02370537|2631347|P3|Part B|Withdrawal by Subject|0
807131|NCT02370537|2631348|P2|Part B|Withdrawal by Subject|1
807132|NCT02370537|2631349|P1|Part B|Withdrawal by Subject|0
807133|NCT02370537|2631347|P3|Part B|Not randomised to receive treatment|259
807134|NCT02370537|2631348|P2|Part B|Not randomised to receive treatment|2
807135|NCT02370537|2631349|P1|Part B|Not randomised to receive treatment|1
807136|NCT02370537|2631347|P3|Part A (Open-label Recruitment)|Adverse Event|1
807137|NCT02370537|2631348|P2|Part A (Open-label Recruitment)|Adverse Event|0
807138|NCT02370537|2631349|P1|Part A (Open-label Recruitment)|Adverse Event|0
807139|NCT02370537|2631347|P3|Part A (Open-label Recruitment)|Withdrawal by Subject|0
807140|NCT02370537|2631348|P2|Part A (Open-label Recruitment)|Withdrawal by Subject|1
807141|NCT02370537|2631349|P1|Part A (Open-label Recruitment)|Withdrawal by Subject|0
807142|NCT02370498|2631398|P2|Overall Study|Ongoing In Trial|33
807143|NCT02370498|2631399|P1|Overall Study|Ongoing In Trial|56
807144|NCT02370498|2631398|P2|Overall Study|Withdrawal by Subject|11
807145|NCT02370498|2631399|P1|Overall Study|Withdrawal by Subject|6
807146|NCT02370498|2631398|P2|Overall Study|Protocol Violation|2
807147|NCT02370498|2631399|P1|Overall Study|Protocol Violation|1
807148|NCT02370498|2631398|P2|Overall Study|Lost to Follow-up|0
807149|NCT02370498|2631399|P1|Overall Study|Lost to Follow-up|1
807150|NCT02370498|2631398|P2|Overall Study|Death|242
807151|NCT02370498|2631399|P1|Overall Study|Death|222
807152|NCT02370498|2631398|P2|Overall Study|Adverse Event|8
807153|NCT02370498|2631399|P1|Overall Study|Adverse Event|10
807154|NCT02370420|2631453|P2|Overall Study|Lost to Follow-up|9
807155|NCT02370420|2631454|P1|Overall Study|Lost to Follow-up|11
807156|NCT02370420|2631453|P2|Overall Study|Physician Decision|3
807157|NCT02370420|2631454|P1|Overall Study|Physician Decision|3
807158|NCT02370394|2631491|P2|Overall Study|Withdrawal by Subject|1
807159|NCT02370394|2631492|P1|Overall Study|Withdrawal by Subject|0
807160|NCT02370394|2631491|P2|Overall Study|Lost to Follow-up|1
807161|NCT02370394|2631492|P1|Overall Study|Lost to Follow-up|2
807162|NCT02370121|2631508|P2|Overall Study|Lost to Follow-up|1
807163|NCT02370121|2631509|P1|Overall Study|Lost to Follow-up|1
807164|NCT02369848|2631547|P1|Overall Study|Lost to Follow-up|1
807165|NCT02369848|2631547|P1|Overall Study|Withdrawal by Subject|2
807166|NCT02369848|2631547|P1|Overall Study|Death|1
807167|NCT02369510|2631612|P3|Overall Study|Epidural Activation|5
807168|NCT02369510|2631613|P2|Overall Study|Epidural Activation|1
807169|NCT02369510|2631614|P1|Overall Study|Epidural Activation|1
807170|NCT02369510|2631612|P3|Overall Study|Spilled Medication|1
807171|NCT02369510|2631613|P2|Overall Study|Spilled Medication|2
807172|NCT02369510|2631614|P1|Overall Study|Spilled Medication|1
807173|NCT02369341|2631645|P2|Overall Study|Migrated/moved from study area|0
807174|NCT02369341|2631646|P1|Overall Study|Migrated/moved from study area|1
807175|NCT02368314|2631713|P2|Overall Study|Adverse Event|2
807176|NCT02368314|2631714|P1|Overall Study|Adverse Event|1
807177|NCT02368314|2631713|P2|Overall Study|Withdrawal by Subject|1
807178|NCT02368314|2631714|P1|Overall Study|Withdrawal by Subject|2
807179|NCT02368210|2631726|P2|Overall Study|Adverse Event|1
807180|NCT02368210|2631727|P1|Overall Study|Adverse Event|0
807181|NCT02368210|2631726|P2|Overall Study|Withdrawal by Subject|0
807182|NCT02368210|2631727|P1|Overall Study|Withdrawal by Subject|1
807183|NCT02367911|2631754|P2|Overall Study|Lost to Follow-up|2
807184|NCT02367911|2631755|P1|Overall Study|Lost to Follow-up|2
807185|NCT02367911|2631754|P2|Overall Study|Withdrawal by Subject|2
807186|NCT02367911|2631755|P1|Overall Study|Withdrawal by Subject|3
807187|NCT02367885|2631766|P3|Overall Study|Withdrawal by Subject|0
807188|NCT02367885|2631767|P2|Overall Study|Withdrawal by Subject|0
807189|NCT02367885|2631768|P1|Overall Study|Withdrawal by Subject|1
807190|NCT02367885|2631766|P3|Overall Study|Lost to Follow-up|0
807191|NCT02367885|2631767|P2|Overall Study|Lost to Follow-up|0
807192|NCT02367885|2631768|P1|Overall Study|Lost to Follow-up|1
807193|NCT02367729|2632003|P2|Overall Study|Withdrawal by Subject|5
807194|NCT02367729|2632004|P1|Overall Study|Withdrawal by Subject|0
807195|NCT02367729|2632003|P2|Overall Study|Adverse Event|2
807196|NCT02367729|2632004|P1|Overall Study|Adverse Event|1
807197|NCT02367729|2632003|P2|Overall Study|Organic disorder diagnosed|1
807198|NCT02367729|2632004|P1|Overall Study|Organic disorder diagnosed|2
807199|NCT02367521|2632022|P2|Overall Study|unable to find transportation|0
807200|NCT02367521|2632023|P1|Overall Study|unable to find transportation|2
807201|NCT02367521|2632022|P2|Overall Study|severe headache after intervention|0
807202|NCT02367521|2632023|P1|Overall Study|severe headache after intervention|2
807203|NCT02367131|2632109|P1|Overall Study|Other than stated above|20
807204|NCT02367131|2632109|P1|Overall Study|No change/progressive disease|78
807205|NCT02367131|2632109|P1|Overall Study|Improvement/remission|2
807206|NCT02367131|2632109|P1|Overall Study|Request by patient|54
807207|NCT02367131|2632109|P1|Overall Study|No visit since the first visit|4
807208|NCT02367131|2632109|P1|Overall Study|Adverse Event|64
807209|NCT02366936|2632176|P1|Overall Study|Physician Decision|2
807210|NCT02366936|2632176|P1|Overall Study|Lost to Follow-up|4
807211|NCT02366936|2632176|P1|Overall Study|Withdrawal by Subject|2
807212|NCT02366923|2632181|P1|Overall Study|High Astigmatism|3
807213|NCT02366923|2632181|P1|Overall Study|Positive Slit Lamp Findings|2
807214|NCT02366923|2632181|P1|Overall Study|Withdrawal by Subject|1
807215|NCT02366910|2632194|P1|Overall Study|Screen Failure|3
807216|NCT02366910|2632194|P1|Overall Study|Withdrawal by Subject|2
807217|NCT02366767|2632208|P2|Overall Study|left for home after 1 day at camp|0
807218|NCT02366767|2632209|P1|Overall Study|left for home after 1 day at camp|1
807219|NCT02366689|2632222|P3|Overall Study|Pregnancy|1
807220|NCT02366689|2632223|P2|Overall Study|Pregnancy|1
807221|NCT02366689|2632224|P1|Overall Study|Pregnancy|0
807222|NCT02366689|2632222|P3|Overall Study|Lost to Follow-up|0
807223|NCT02366689|2632223|P2|Overall Study|Lost to Follow-up|2
807224|NCT02366689|2632224|P1|Overall Study|Lost to Follow-up|3
807225|NCT02366689|2632222|P3|Overall Study|Withdrawal by Subject|1
807226|NCT02366689|2632223|P2|Overall Study|Withdrawal by Subject|0
807227|NCT02366689|2632224|P1|Overall Study|Withdrawal by Subject|1
807228|NCT02366637|2632276|P2|Second Intervention Period|Study Terminated by Sponsor|1
807229|NCT02366637|2632277|P1|Second Intervention Period|Study Terminated by Sponsor|1
807230|NCT02366637|2632276|P2|First Intervention Period|Study Terminated by Sponsor|4
807231|NCT02366637|2632277|P1|First Intervention Period|Study Terminated by Sponsor|6
807232|NCT02366637|2632276|P2|First Intervention Period|Adverse Event|1
807233|NCT02366637|2632277|P1|First Intervention Period|Adverse Event|0
807234|NCT02366195|2632314|P1|Overall Study|Death|26
807235|NCT02366195|2632314|P1|Overall Study|Lost to Follow-up|1
807236|NCT02366195|2632314|P1|Overall Study|Withdrawal by Subject|6
807237|NCT02366195|2632314|P1|Overall Study|Continuing Study|79
807238|NCT02365636|2632345|P3|Overall Study|Not specified|0
807239|NCT02365636|2632346|P2|Overall Study|Not specified|0
807240|NCT02365636|2632347|P1|Overall Study|Not specified|2
807241|NCT02365636|2632345|P3|Overall Study|Lost to Follow-up|1
807242|NCT02365636|2632346|P2|Overall Study|Lost to Follow-up|0
807243|NCT02365636|2632347|P1|Overall Study|Lost to Follow-up|0
807244|NCT02365636|2632345|P3|Overall Study|Protocol Violation|0
807245|NCT02365636|2632346|P2|Overall Study|Protocol Violation|4
807246|NCT02365636|2632347|P1|Overall Study|Protocol Violation|1
807247|NCT02365636|2632345|P3|Overall Study|Adverse Event|2
807248|NCT02365636|2632346|P2|Overall Study|Adverse Event|3
807249|NCT02365636|2632347|P1|Overall Study|Adverse Event|3
807250|NCT02365558|2632391|P2|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1
807251|NCT02365558|2632392|P1|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0
807252|NCT02365558|2632391|P2|Period 1 (Day 1 Through Day 7)|Adverse Event|0
807253|NCT02365558|2632392|P1|Period 1 (Day 1 Through Day 7)|Adverse Event|1
807254|NCT02365519|2632405|P3|Randomized and Treated|Withdrawal by Subject|1
807255|NCT02365519|2632406|P2|Randomized and Treated|Withdrawal by Subject|1
807256|NCT02365519|2632407|P1|Randomized and Treated|Withdrawal by Subject|0
807257|NCT02365519|2632405|P3|Randomized and Treated|Adverse Event|0
807258|NCT02365519|2632406|P2|Randomized and Treated|Adverse Event|1
807259|NCT02365519|2632407|P1|Randomized and Treated|Adverse Event|0
807260|NCT02365298|2632428|P2|Period 2|Protocol Violation|1
807261|NCT02365298|2632429|P1|Period 2|Protocol Violation|0
807262|NCT02365298|2632428|P2|Period 2|Test Article longer available|1
807263|NCT02365298|2632429|P1|Period 2|Test Article longer available|0
807264|NCT02365298|2632428|P2|Period 2|Discontinued at request of Sponsor|0
807265|NCT02365298|2632429|P1|Period 2|Discontinued at request of Sponsor|1
807266|NCT02365298|2632428|P2|Period 2|incorrect Rx dispensed|0
807267|NCT02365298|2632429|P1|Period 2|incorrect Rx dispensed|1
807268|NCT02365233|2632448|P3|Overall Study|IRB withheld the data|2
807269|NCT02365233|2632449|P2|Overall Study|IRB withheld the data|2
807270|NCT02365233|2632450|P1|Overall Study|IRB withheld the data|1
807271|NCT02364999|2632460|P2|Overall Study|Study ongoing|194
807272|NCT02364999|2632461|P1|Overall Study|Study ongoing|179
807273|NCT02364999|2632460|P2|Overall Study|Randomized but did not receive treatment|3
807274|NCT02364999|2632461|P1|Overall Study|Randomized but did not receive treatment|2
807275|NCT02364999|2632460|P2|Overall Study|Other|1
807276|NCT02364999|2632461|P1|Overall Study|Other|1
807277|NCT02364999|2632460|P2|Overall Study|Withdrawal by Subject|10
807278|NCT02364999|2632461|P1|Overall Study|Withdrawal by Subject|13
807279|NCT02364999|2632460|P2|Overall Study|Protocol Violation|2
807280|NCT02364999|2632461|P1|Overall Study|Protocol Violation|2
807281|NCT02364999|2632460|P2|Overall Study|Objective Progression Or Relapse|0
807282|NCT02364999|2632461|P1|Overall Study|Objective Progression Or Relapse|3
807283|NCT02364999|2632460|P2|Overall Study|Global Deterioration Of Health Status|2
807284|NCT02364999|2632461|P1|Overall Study|Global Deterioration Of Health Status|0
807285|NCT02364999|2632460|P2|Overall Study|Lost to Follow-up|11
807286|NCT02364999|2632461|P1|Overall Study|Lost to Follow-up|9
807287|NCT02364999|2632460|P2|Overall Study|Death|99
807288|NCT02364999|2632461|P1|Overall Study|Death|109
807289|NCT02364180|2632491|P1|Overall Study|Screen Fail|1
807290|NCT02364037|2632497|P2|Overall Study|Lost to Follow-up|49
807291|NCT02364037|2632498|P1|Overall Study|Lost to Follow-up|37
807292|NCT02364037|2632497|P2|Overall Study|Withdrawal by Subject|4
807293|NCT02364037|2632498|P1|Overall Study|Withdrawal by Subject|7
807294|NCT02363946|2632523|P13|Overall Study|Lost to Follow-up|0
807295|NCT02363946|2632524|P12|Overall Study|Lost to Follow-up|0
807296|NCT02363946|2632525|P11|Overall Study|Lost to Follow-up|0
807297|NCT02363946|2632526|P10|Overall Study|Lost to Follow-up|0
807298|NCT02363946|2632527|P9|Overall Study|Lost to Follow-up|0
807299|NCT02363946|2632528|P8|Overall Study|Lost to Follow-up|1
807300|NCT02363946|2632529|P7|Overall Study|Lost to Follow-up|0
807301|NCT02363946|2632530|P6|Overall Study|Lost to Follow-up|0
807302|NCT02363946|2632531|P5|Overall Study|Lost to Follow-up|0
807303|NCT02363946|2632532|P4|Overall Study|Lost to Follow-up|0
807304|NCT02363946|2632533|P3|Overall Study|Lost to Follow-up|0
807305|NCT02363946|2632534|P2|Overall Study|Lost to Follow-up|0
807306|NCT02363946|2632535|P1|Overall Study|Lost to Follow-up|0
807307|NCT02363478|2632730|P1|Overall Study|Adverse Event|4
807308|NCT02363478|2632730|P1|Overall Study|Lost to Follow-up|4
807309|NCT02363439|2632737|P1|Overall Study|Lack of Efficacy|4
807310|NCT02362503|2632753|P3|Open Label Period-Up to Atleast 96 Weeks|Ongoing at the time of analysis|67
807311|NCT02362503|2632754|P2|Open Label Period-Up to Atleast 96 Weeks|Ongoing at the time of analysis|160
807312|NCT02362503|2632755|P1|Open Label Period-Up to Atleast 96 Weeks|Ongoing at the time of analysis|55
807313|NCT02362503|2632753|P3|Open Label Period-Up to Atleast 96 Weeks|Progression of disease|0
807314|NCT02362503|2632754|P2|Open Label Period-Up to Atleast 96 Weeks|Progression of disease|1
807315|NCT02362503|2632755|P1|Open Label Period-Up to Atleast 96 Weeks|Progression of disease|0
807316|NCT02362503|2632753|P3|Open Label Period-Up to Atleast 96 Weeks|No longer meets study criteria|2
807317|NCT02362503|2632754|P2|Open Label Period-Up to Atleast 96 Weeks|No longer meets study criteria|2
807318|NCT02362503|2632755|P1|Open Label Period-Up to Atleast 96 Weeks|No longer meets study criteria|0
807319|NCT02362503|2632753|P3|Open Label Period-Up to Atleast 96 Weeks|Pregnancy|0
807320|NCT02362503|2632754|P2|Open Label Period-Up to Atleast 96 Weeks|Pregnancy|1
807321|NCT02362503|2632755|P1|Open Label Period-Up to Atleast 96 Weeks|Pregnancy|0
807322|NCT02362503|2632753|P3|Open Label Period-Up to Atleast 96 Weeks|Non-compliance with study drug|5
807323|NCT02362503|2632754|P2|Open Label Period-Up to Atleast 96 Weeks|Non-compliance with study drug|8
807324|NCT02362503|2632755|P1|Open Label Period-Up to Atleast 96 Weeks|Non-compliance with study drug|3
807325|NCT02362503|2632753|P3|Open Label Period-Up to Atleast 96 Weeks|Lost to Follow-up|1
807326|NCT02362503|2632754|P2|Open Label Period-Up to Atleast 96 Weeks|Lost to Follow-up|3
807327|NCT02362503|2632755|P1|Open Label Period-Up to Atleast 96 Weeks|Lost to Follow-up|3
807328|NCT02362503|2632753|P3|Open Label Period-Up to Atleast 96 Weeks|Withdrawal by Subject|1
807329|NCT02362503|2632754|P2|Open Label Period-Up to Atleast 96 Weeks|Withdrawal by Subject|5
807330|NCT02362503|2632755|P1|Open Label Period-Up to Atleast 96 Weeks|Withdrawal by Subject|0
807331|NCT02362503|2632753|P3|Open Label Period-Up to Atleast 96 Weeks|Death|12
807332|NCT02362503|2632754|P2|Open Label Period-Up to Atleast 96 Weeks|Death|5
807333|NCT02362503|2632755|P1|Open Label Period-Up to Atleast 96 Weeks|Death|1
807334|NCT02362503|2632753|P3|Open Label Period-Up to Atleast 96 Weeks|Adverse Event|5
807335|NCT02362503|2632754|P2|Open Label Period-Up to Atleast 96 Weeks|Adverse Event|4
807336|NCT02362503|2632755|P1|Open Label Period-Up to Atleast 96 Weeks|Adverse Event|3
807337|NCT02362503|2632753|P3|Open Label Period-Up to Atleast 96 Weeks|Lack of Efficacy|6
807338|NCT02362503|2632754|P2|Open Label Period-Up to Atleast 96 Weeks|Lack of Efficacy|9
807339|NCT02362503|2632755|P1|Open Label Period-Up to Atleast 96 Weeks|Lack of Efficacy|3
807340|NCT02362503|2632753|P3|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
807341|NCT02362503|2632754|P2|Double-blind Period-Up to 8 Days|No longer meets study criteria|1
807342|NCT02362503|2632755|P1|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
807343|NCT02362503|2632753|P3|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
807344|NCT02362503|2632754|P2|Double-blind Period-Up to 8 Days|Lost to Follow-up|1
807345|NCT02362503|2632755|P1|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
807346|NCT02362503|2632753|P3|Double-blind Period-Up to 8 Days|Death|0
807347|NCT02362503|2632754|P2|Double-blind Period-Up to 8 Days|Death|1
807348|NCT02362503|2632755|P1|Double-blind Period-Up to 8 Days|Death|1
807349|NCT02362503|2632753|P3|Double-blind Period-Up to 8 Days|Adverse Event|0
807350|NCT02362503|2632754|P2|Double-blind Period-Up to 8 Days|Adverse Event|2
807351|NCT02362503|2632755|P1|Double-blind Period-Up to 8 Days|Adverse Event|0
807352|NCT02362412|2632780|P2|Treatment Period III|Lost to Follow-up|1
807353|NCT02362412|2632781|P1|Treatment Period III|Lost to Follow-up|0
807354|NCT02362360|2632815|P2|Period 1|Withdrawal by Subject|1
807355|NCT02362360|2632816|P1|Period 1|Withdrawal by Subject|2
807356|NCT02362360|2632815|P2|Period 1|Lack of Efficacy|0
807357|NCT02362360|2632816|P1|Period 1|Lack of Efficacy|1
807358|NCT02361580|2632854|P2|Overall Study|Lost to Follow-up|3
807359|NCT02361580|2632855|P1|Overall Study|Lost to Follow-up|6
807360|NCT02361216|2632867|P2|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2
807361|NCT02361216|2632868|P1|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0
807362|NCT02361216|2632867|P2|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
807363|NCT02361216|2632868|P1|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
807364|NCT02361216|2632867|P2|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11
807365|NCT02361216|2632868|P1|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6
807366|NCT02361216|2632867|P2|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0
807367|NCT02361216|2632868|P1|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1
807368|NCT02361216|2632867|P2|3 Day Treatment and 8 Week Follow/up|Adverse Event|2
807369|NCT02361216|2632868|P1|3 Day Treatment and 8 Week Follow/up|Adverse Event|1
807370|NCT02361216|2632867|P2|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1
807371|NCT02361216|2632868|P1|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0
807372|NCT02360995|2632883|P3|Overall Study|Withdrawal by Subject|0
807373|NCT02360995|2632884|P2|Overall Study|Withdrawal by Subject|1
807374|NCT02360995|2632885|P1|Overall Study|Withdrawal by Subject|0
807375|NCT02360995|2632883|P3|Overall Study|Lost to Follow-up|2
807376|NCT02360995|2632884|P2|Overall Study|Lost to Follow-up|0
807377|NCT02360995|2632885|P1|Overall Study|Lost to Follow-up|2
807378|NCT02360475|2632927|P4|Overall Study|Migrated/moved from study area|1
807379|NCT02360475|2632928|P3|Overall Study|Migrated/moved from study area|0
807380|NCT02360475|2632929|P2|Overall Study|Migrated/moved from study area|0
807381|NCT02360475|2632930|P1|Overall Study|Migrated/moved from study area|0
807382|NCT02360475|2632927|P4|Overall Study|Withdrawal by Subject|0
807383|NCT02360475|2632928|P3|Overall Study|Withdrawal by Subject|2
807384|NCT02360475|2632929|P2|Overall Study|Withdrawal by Subject|1
807385|NCT02360475|2632930|P1|Overall Study|Withdrawal by Subject|0
807386|NCT02360475|2632927|P4|Overall Study|Lost to Follow-up|4
807387|NCT02360475|2632928|P3|Overall Study|Lost to Follow-up|6
807388|NCT02360475|2632929|P2|Overall Study|Lost to Follow-up|12
807389|NCT02360475|2632930|P1|Overall Study|Lost to Follow-up|4
807390|NCT02360228|2632991|P3|Overall Study|Unstable symptoms during screening|1
807391|NCT02360228|2632992|P2|Overall Study|Unstable symptoms during screening|0
807392|NCT02360228|2632993|P1|Overall Study|Unstable symptoms during screening|0
807393|NCT02360228|2632991|P3|Overall Study|Self-discontinued medication|0
807394|NCT02360228|2632992|P2|Overall Study|Self-discontinued medication|1
807395|NCT02360228|2632993|P1|Overall Study|Self-discontinued medication|0
807396|NCT02360228|2632991|P3|Overall Study|Withdrawal by Subject|0
807397|NCT02360228|2632992|P2|Overall Study|Withdrawal by Subject|0
807398|NCT02360228|2632993|P1|Overall Study|Withdrawal by Subject|1
807399|NCT02360111|2633035|P1|Overall Study|Death|2
807400|NCT02359903|2633106|P2|Overall Study|Adverse Event|2
807401|NCT02359903|2633107|P1|Overall Study|Adverse Event|0
807402|NCT02359890|2633115|P1|Overall Study|Never treated with study catheter|6
807403|NCT02359890|2633115|P1|Overall Study|Not meeting eligibility|4
807404|NCT02359877|2633126|P4|Overall Study|Adverse Event|1
807405|NCT02359877|2633127|P3|Overall Study|Adverse Event|0
807406|NCT02359877|2633128|P2|Overall Study|Adverse Event|0
807407|NCT02359877|2633129|P1|Overall Study|Adverse Event|0
807408|NCT02359877|2633126|P4|Overall Study|Withdrawal by Subject|2
807409|NCT02359877|2633127|P3|Overall Study|Withdrawal by Subject|0
807410|NCT02359877|2633128|P2|Overall Study|Withdrawal by Subject|0
807411|NCT02359877|2633129|P1|Overall Study|Withdrawal by Subject|1
807412|NCT02359851|2633179|P1|Overall Study|Disease progression|1
807413|NCT02359851|2633179|P1|Overall Study|Death|1
807414|NCT02359435|2633189|P2|Overall Study|Lost to Follow-up|4
807415|NCT02359435|2633190|P1|Overall Study|Lost to Follow-up|4
807416|NCT02359045|2633250|P2|Overall Study|Adverse Event|1
807417|NCT02359045|2633251|P1|Overall Study|Adverse Event|0
807418|NCT02359045|2633250|P2|Overall Study|Lost to Follow-up|1
807419|NCT02359045|2633251|P1|Overall Study|Lost to Follow-up|1
807420|NCT02359045|2633250|P2|Overall Study|Eligibility criteria not fulfilled|1
807421|NCT02359045|2633251|P1|Overall Study|Eligibility criteria not fulfilled|3
807422|NCT02358863|2633488|P1|Overall Study|Physician Decision|3
807423|NCT02358668|2633495|P3|Overall Study|Withdrawal by Subject|0
807424|NCT02358668|2633496|P2|Overall Study|Withdrawal by Subject|1
807425|NCT02358668|2633497|P1|Overall Study|Withdrawal by Subject|0
807426|NCT02358668|2633495|P3|Overall Study|Adverse Event|0
807427|NCT02358668|2633496|P2|Overall Study|Adverse Event|0
807428|NCT02358668|2633497|P1|Overall Study|Adverse Event|2
807429|NCT02358473|2633637|P1|Overall Study|Physician Decision|2
807430|NCT02358473|2633637|P1|Overall Study|Withdrawal by Subject|2
807431|NCT02358473|2633637|P1|Overall Study|Adverse Event|3
807432|NCT02358473|2633637|P1|Overall Study|Disease Progession|6
807433|NCT02358044|2633648|P2|Overall Study|Withdrawal by Subject|4
807434|NCT02358044|2633649|P1|Overall Study|Withdrawal by Subject|0
807435|NCT02358044|2633648|P2|Overall Study|Physician Decision|1
807436|NCT02358044|2633649|P1|Overall Study|Physician Decision|0
807437|NCT02358044|2633648|P2|Overall Study|Lost to Follow-up|1
807438|NCT02358044|2633649|P1|Overall Study|Lost to Follow-up|2
807439|NCT02358044|2633648|P2|Overall Study|Adverse Event|1
807440|NCT02358044|2633649|P1|Overall Study|Adverse Event|0
807441|NCT02357940|2633667|P2|Overall Study|Investigator's judgement|1
807442|NCT02357940|2633668|P1|Overall Study|Investigator's judgement|0
807443|NCT02357940|2633667|P2|Overall Study|Adverse Event|1
807444|NCT02357940|2633668|P1|Overall Study|Adverse Event|0
807445|NCT02357901|2633795|P4|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7
807446|NCT02357901|2633796|P3|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6
807447|NCT02357901|2633797|P2|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17
807448|NCT02357901|2633798|P1|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0
807449|NCT02357901|2633795|P4|Treatment Period (Day 1 to Week 24)|Physician Decision|1
807450|NCT02357901|2633796|P3|Treatment Period (Day 1 to Week 24)|Physician Decision|1
807451|NCT02357901|2633797|P2|Treatment Period (Day 1 to Week 24)|Physician Decision|0
807452|NCT02357901|2633798|P1|Treatment Period (Day 1 to Week 24)|Physician Decision|0
807453|NCT02357901|2633795|P4|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3
807454|NCT02357901|2633796|P3|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
807455|NCT02357901|2633797|P2|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1
807456|NCT02357901|2633798|P1|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
807457|NCT02357901|2633795|P4|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
807458|NCT02357901|2633796|P3|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
807459|NCT02357901|2633797|P2|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
807460|NCT02357901|2633798|P1|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
807461|NCT02357901|2633795|P4|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3
807462|NCT02357901|2633796|P3|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
807463|NCT02357901|2633797|P2|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
807464|NCT02357901|2633798|P1|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0
807465|NCT02357901|2633795|P4|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
807466|NCT02357901|2633796|P3|Treatment Period (Day 1 to Week 24)|Protocol Violation|5
807467|NCT02357901|2633797|P2|Treatment Period (Day 1 to Week 24)|Protocol Violation|2
807468|NCT02357901|2633798|P1|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
807469|NCT02357901|2633795|P4|Treatment Period (Day 1 to Week 24)|Adverse Event|2
807470|NCT02357901|2633796|P3|Treatment Period (Day 1 to Week 24)|Adverse Event|10
807471|NCT02357901|2633797|P2|Treatment Period (Day 1 to Week 24)|Adverse Event|6
807472|NCT02357901|2633798|P1|Treatment Period (Day 1 to Week 24)|Adverse Event|0
807473|NCT02357901|2633795|P4|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18
807474|NCT02357901|2633796|P3|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5
807475|NCT02357901|2633797|P2|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3
807476|NCT02357901|2633798|P1|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0
807477|NCT02357901|2633795|P4|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18
807478|NCT02357901|2633796|P3|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21
807479|NCT02357901|2633797|P2|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20
807480|NCT02357901|2633798|P1|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0
807481|NCT02357901|2633795|P4|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12
807482|NCT02357901|2633796|P3|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23
807483|NCT02357901|2633797|P2|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26
807484|NCT02357901|2633798|P1|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0
807485|NCT02357901|2633795|P4|Run-In Period (Days -14 to Day -1)|Run-In failures|0
807486|NCT02357901|2633796|P3|Run-In Period (Days -14 to Day -1)|Run-In failures|0
807487|NCT02357901|2633797|P2|Run-In Period (Days -14 to Day -1)|Run-In failures|0
807488|NCT02357901|2633798|P1|Run-In Period (Days -14 to Day -1)|Run-In failures|161
807489|NCT02357459|2633859|P3|Overall Study|Job Commitments|1
807490|NCT02357459|2633860|P2|Overall Study|Job Commitments|0
807491|NCT02357459|2633861|P1|Overall Study|Job Commitments|0
807492|NCT02357459|2633859|P3|Overall Study|Pre-planned Knee surgery|2
807493|NCT02357459|2633860|P2|Overall Study|Pre-planned Knee surgery|0
807494|NCT02357459|2633861|P1|Overall Study|Pre-planned Knee surgery|0
807495|NCT02357459|2633859|P3|Overall Study|Incarceration|1
807496|NCT02357459|2633860|P2|Overall Study|Incarceration|0
807497|NCT02357459|2633861|P1|Overall Study|Incarceration|0
807498|NCT02357459|2633859|P3|Overall Study|Instruction from PCP|0
807499|NCT02357459|2633860|P2|Overall Study|Instruction from PCP|0
807500|NCT02357459|2633861|P1|Overall Study|Instruction from PCP|1
807501|NCT02357459|2633859|P3|Overall Study|Patient Relocated|0
807502|NCT02357459|2633860|P2|Overall Study|Patient Relocated|0
807503|NCT02357459|2633861|P1|Overall Study|Patient Relocated|2
807504|NCT02357459|2633859|P3|Overall Study|Lack of Efficacy|4
807505|NCT02357459|2633860|P2|Overall Study|Lack of Efficacy|4
807506|NCT02357459|2633861|P1|Overall Study|Lack of Efficacy|7
807507|NCT02357459|2633859|P3|Overall Study|Lost to Follow-up|0
807508|NCT02357459|2633860|P2|Overall Study|Lost to Follow-up|3
807509|NCT02357459|2633861|P1|Overall Study|Lost to Follow-up|1
807510|NCT02357459|2633859|P3|Overall Study|Protocol Violation|0
807511|NCT02357459|2633860|P2|Overall Study|Protocol Violation|1
807512|NCT02357459|2633861|P1|Overall Study|Protocol Violation|1
807513|NCT02357459|2633859|P3|Overall Study|Physician Decision|0
807514|NCT02357459|2633860|P2|Overall Study|Physician Decision|2
807515|NCT02357459|2633861|P1|Overall Study|Physician Decision|0
807516|NCT02357459|2633859|P3|Overall Study|Withdrawal by Subject|3
807517|NCT02357459|2633860|P2|Overall Study|Withdrawal by Subject|3
807518|NCT02357459|2633861|P1|Overall Study|Withdrawal by Subject|5
807519|NCT02357459|2633859|P3|Overall Study|Adverse Event|1
807520|NCT02357459|2633860|P2|Overall Study|Adverse Event|1
807521|NCT02357459|2633861|P1|Overall Study|Adverse Event|0
807522|NCT02357342|2633905|P2|First 6 Months|Death|0
807523|NCT02357342|2633906|P1|First 6 Months|Death|2
807524|NCT02356783|2633970|P2|Overall Study|Lost to Follow-up|3
807525|NCT02356783|2633971|P1|Overall Study|Lost to Follow-up|1
807526|NCT02356588|2633981|P2|Overall Study|Protocol Violation|1
807527|NCT02356588|2633982|P1|Overall Study|Protocol Violation|0
807528|NCT02356588|2633981|P2|Overall Study|Withdrawal by Subject|0
807529|NCT02356588|2633982|P1|Overall Study|Withdrawal by Subject|1
807530|NCT02356588|2633981|P2|Overall Study|Adverse Event|2
807531|NCT02356588|2633982|P1|Overall Study|Adverse Event|0
807532|NCT02356588|2633981|P2|Overall Study|Lack of Efficacy|10
807533|NCT02356588|2633982|P1|Overall Study|Lack of Efficacy|4
807534|NCT02356562|2634016|P2|Overall Study|site closure|0
807535|NCT02356562|2634017|P1|Overall Study|site closure|1
807536|NCT02356562|2634016|P2|Overall Study|Re-entered treatment in a previous study|0
807537|NCT02356562|2634017|P1|Overall Study|Re-entered treatment in a previous study|1
807538|NCT02356562|2634016|P2|Overall Study|Withdrawal by Subject|1
807539|NCT02356562|2634017|P1|Overall Study|Withdrawal by Subject|0
807540|NCT02355743|2634063|P1|Overall Study|Lost to Follow-up|1
807541|NCT02355743|2634063|P1|Overall Study|Withdrawal by Subject|1
807542|NCT02355691|2634071|P2|Overall Study|Loss of Research Personnel|9
807543|NCT02355691|2634072|P1|Overall Study|Loss of Research Personnel|7
807544|NCT02355028|2634091|P2|Overall Study|Deemed ineligible after randomization|4
807545|NCT02355028|2634092|P1|Overall Study|Deemed ineligible after randomization|8
807546|NCT02355028|2634091|P2|Overall Study|Withdrawal by Subject|1
807547|NCT02355028|2634092|P1|Overall Study|Withdrawal by Subject|1
807548|NCT02355028|2634091|P2|Overall Study|Adverse Event|0
807549|NCT02355028|2634092|P1|Overall Study|Adverse Event|2
807550|NCT02354976|2634128|P3|Overall Study|Adverse Event|2
807551|NCT02354976|2634129|P2|Overall Study|Adverse Event|0
807552|NCT02354976|2634130|P1|Overall Study|Adverse Event|1
807553|NCT02354976|2634128|P3|Overall Study|Study-specifc withdrawal criteria|0
807554|NCT02354976|2634129|P2|Overall Study|Study-specifc withdrawal criteria|1
807555|NCT02354976|2634130|P1|Overall Study|Study-specifc withdrawal criteria|0
807556|NCT02354976|2634128|P3|Overall Study|Other - reason not specified|1
807557|NCT02354976|2634129|P2|Overall Study|Other - reason not specified|0
807558|NCT02354976|2634130|P1|Overall Study|Other - reason not specified|1
807559|NCT02354599|2634173|P6|Overall Study|Withdrawal by Subject|0
807560|NCT02354599|2634174|P5|Overall Study|Withdrawal by Subject|0
807561|NCT02354599|2634175|P4|Overall Study|Withdrawal by Subject|0
807562|NCT02354599|2634176|P3|Overall Study|Withdrawal by Subject|0
807563|NCT02354599|2634177|P2|Overall Study|Withdrawal by Subject|1
807564|NCT02354599|2634178|P1|Overall Study|Withdrawal by Subject|1
807565|NCT02354599|2634173|P6|Overall Study|Pretreatment Event/Adverse Event|1
807566|NCT02354599|2634174|P5|Overall Study|Pretreatment Event/Adverse Event|0
807567|NCT02354599|2634175|P4|Overall Study|Pretreatment Event/Adverse Event|0
807568|NCT02354599|2634176|P3|Overall Study|Pretreatment Event/Adverse Event|0
807569|NCT02354599|2634177|P2|Overall Study|Pretreatment Event/Adverse Event|0
807570|NCT02354599|2634178|P1|Overall Study|Pretreatment Event/Adverse Event|0
807571|NCT02354417|2634252|P1|Overall Study|Physician Decision|1
807572|NCT02354235|2634258|P2|Overall Study|Conflict with the stopping criteria|1
807573|NCT02354235|2634259|P1|Overall Study|Conflict with the stopping criteria|0
807574|NCT02354235|2634258|P2|Overall Study|Withdrawal by Subject|3
807575|NCT02354235|2634259|P1|Overall Study|Withdrawal by Subject|1
807576|NCT02354235|2634258|P2|Overall Study|Physician Decision|1
807577|NCT02354235|2634259|P1|Overall Study|Physician Decision|0
807578|NCT02354235|2634258|P2|Overall Study|Adverse Event|2
807579|NCT02354235|2634259|P1|Overall Study|Adverse Event|2
807580|NCT02354222|2634275|P2|Overall Study|Conflict with the stopping criteria|4
807581|NCT02354222|2634276|P1|Overall Study|Conflict with the stopping criteria|0
807582|NCT02354222|2634275|P2|Overall Study|Withdrawal by Subject|3
807583|NCT02354222|2634276|P1|Overall Study|Withdrawal by Subject|2
807584|NCT02354222|2634275|P2|Overall Study|Pregnancy|0
807585|NCT02354222|2634276|P1|Overall Study|Pregnancy|1
807586|NCT02354222|2634275|P2|Overall Study|Physician Decision|1
807587|NCT02354222|2634276|P1|Overall Study|Physician Decision|1
807588|NCT02354222|2634275|P2|Overall Study|Adverse Event|3
807589|NCT02354222|2634276|P1|Overall Study|Adverse Event|0
807590|NCT02353871|2634292|P2|Overall Study|Lost to Follow-up|0
807591|NCT02353871|2634293|P1|Overall Study|Lost to Follow-up|2
807592|NCT02353871|2634292|P2|Overall Study|Consent withdrawn|8
807593|NCT02353871|2634293|P1|Overall Study|Consent withdrawn|1
807594|NCT02353871|2634292|P2|Overall Study|Protocol deviation|1
807595|NCT02353871|2634293|P1|Overall Study|Protocol deviation|0
807596|NCT02353572|2634326|P1|Overall Study|Study terminated|2
807597|NCT02353572|2634326|P1|Overall Study|Withdrawal by Subject|1
807598|NCT02353468|2634330|P1|Overall Study|Study terminated|3
807599|NCT02353442|2634336|P2|Overall Study|Withdrawal by Subject|4
807600|NCT02353442|2634337|P1|Overall Study|Withdrawal by Subject|3
807601|NCT02352779|2634397|P3|Overall Study|No Reason|1
807602|NCT02352779|2634398|P2|Overall Study|No Reason|0
807603|NCT02352779|2634399|P1|Overall Study|No Reason|0
807604|NCT02352779|2634397|P3|Overall Study|Other Medical Reason|1
807605|NCT02352779|2634398|P2|Overall Study|Other Medical Reason|0
807606|NCT02352779|2634399|P1|Overall Study|Other Medical Reason|0
807607|NCT02352779|2634397|P3|Overall Study|Absence of Symptoms|0
807608|NCT02352779|2634398|P2|Overall Study|Absence of Symptoms|0
807609|NCT02352779|2634399|P1|Overall Study|Absence of Symptoms|1
807610|NCT02352779|2634397|P3|Overall Study|Study Related Symptoms|0
807611|NCT02352779|2634398|P2|Overall Study|Study Related Symptoms|0
807612|NCT02352779|2634399|P1|Overall Study|Study Related Symptoms|1
807613|NCT02352779|2634397|P3|Overall Study|Changed Mind|0
807614|NCT02352779|2634398|P2|Overall Study|Changed Mind|0
807615|NCT02352779|2634399|P1|Overall Study|Changed Mind|1
807616|NCT02352779|2634397|P3|Overall Study|Disliked Intervention|0
807617|NCT02352779|2634398|P2|Overall Study|Disliked Intervention|0
807618|NCT02352779|2634399|P1|Overall Study|Disliked Intervention|1
807619|NCT02352779|2634397|P3|Overall Study|Feeling Overwhelmed|0
807620|NCT02352779|2634398|P2|Overall Study|Feeling Overwhelmed|0
807621|NCT02352779|2634399|P1|Overall Study|Feeling Overwhelmed|1
807622|NCT02352779|2634397|P3|Overall Study|Too Many Forms|0
807623|NCT02352779|2634398|P2|Overall Study|Too Many Forms|0
807624|NCT02352779|2634399|P1|Overall Study|Too Many Forms|2
807625|NCT02352779|2634397|P3|Overall Study|Personal Issues|0
807626|NCT02352779|2634398|P2|Overall Study|Personal Issues|1
807627|NCT02352779|2634399|P1|Overall Study|Personal Issues|1
807628|NCT02351960|2634429|P2|Overall Study|Significant Protocol Deviation|5
807629|NCT02351960|2634430|P1|Overall Study|Significant Protocol Deviation|0
807630|NCT02351960|2634429|P2|Overall Study|Voluntary Withdrawal|4
807631|NCT02351960|2634430|P1|Overall Study|Voluntary Withdrawal|5
807632|NCT02351960|2634429|P2|Overall Study|Pretreatment Event/Adverse Event|3
807633|NCT02351960|2634430|P1|Overall Study|Pretreatment Event/Adverse Event|6
807634|NCT02351934|2634451|P2|Follow-Up|2 ERAS Components Noncompliant|4
807635|NCT02351934|2634452|P1|Follow-Up|2 ERAS Components Noncompliant|0
807636|NCT02351934|2634451|P2|Follow-Up|1 ERAS Component Noncompliant|6
807637|NCT02351934|2634452|P1|Follow-Up|1 ERAS Component Noncompliant|0
807638|NCT02351934|2634451|P2|Follow-Up|No documentation|0
807639|NCT02351934|2634452|P1|Follow-Up|No documentation|2
807640|NCT02351934|2634451|P2|Follow-Up|Hypotension|0
807641|NCT02351934|2634452|P1|Follow-Up|Hypotension|3
807642|NCT02351934|2634451|P2|Follow-Up|Early dismissal|0
807643|NCT02351934|2634452|P1|Follow-Up|Early dismissal|3
807644|NCT02351934|2634451|P2|Follow-Up|Acute Kidney Injury|0
807645|NCT02351934|2634452|P1|Follow-Up|Acute Kidney Injury|1
807646|NCT02351934|2634451|P2|Follow-Up|POD weight<pre-op weight|0
807647|NCT02351934|2634452|P1|Follow-Up|POD weight<pre-op weight|3
807648|NCT02351934|2634451|P2|Allocation|Acute Kidney Injury on Post Op Day 1|0
807649|NCT02351934|2634452|P1|Allocation|Acute Kidney Injury on Post Op Day 1|1
807650|NCT02351934|2634451|P2|Allocation|Hypotension preventing administration|0
807651|NCT02351934|2634452|P1|Allocation|Hypotension preventing administration|2
807652|NCT02351934|2634451|P2|Allocation|POD weight<pre-op weight|0
807653|NCT02351934|2634452|P1|Allocation|POD weight<pre-op weight|3
807654|NCT02351817|2634468|P2|Period 2|Protocol Violation|0
807655|NCT02351817|2634469|P1|Period 2|Protocol Violation|1
807656|NCT02351817|2634468|P2|Period 2|Adverse Event|2
807657|NCT02351817|2634469|P1|Period 2|Adverse Event|0
807658|NCT02351817|2634468|P2|Period 1|Lack of Efficacy|1
807659|NCT02351817|2634469|P1|Period 1|Lack of Efficacy|0
807660|NCT02351817|2634468|P2|Period 1|Adverse Event|2
807661|NCT02351817|2634469|P1|Period 1|Adverse Event|1
807662|NCT02349711|2634549|P2|Overall Study|Lost to Follow-up|1
807663|NCT02349711|2634550|P1|Overall Study|Lost to Follow-up|1
807664|NCT02349711|2634549|P2|Overall Study|Withdrawal by Subject|1
807665|NCT02349711|2634550|P1|Overall Study|Withdrawal by Subject|2
807666|NCT02349542|2634583|P1|Overall Study|Withdrawal by Subject|5
807667|NCT02349451|2634592|P4|Overall Study|Withdrawal by Subject|1
807668|NCT02349451|2634593|P3|Overall Study|Withdrawal by Subject|2
807669|NCT02349451|2634594|P2|Overall Study|Withdrawal by Subject|1
807670|NCT02349451|2634595|P1|Overall Study|Withdrawal by Subject|0
807671|NCT02349360|2634644|P2|Overall Study|Withdrawal by Subject|1
807672|NCT02349360|2634645|P1|Overall Study|Withdrawal by Subject|0
807673|NCT02349295|2634656|P5|IR (Week 16-24)|Lack of Efficacy|1
807674|NCT02349295|2634657|P4|IR (Week 16-24)|Lack of Efficacy|0
807675|NCT02349295|2634658|P3|IR (Week 16-24)|Lack of Efficacy|0
807676|NCT02349295|2634659|P2|IR (Week 16-24)|Lack of Efficacy|0
807677|NCT02349295|2634660|P1|IR (Week 16-24)|Lack of Efficacy|0
807678|NCT02349295|2634656|P5|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
807679|NCT02349295|2634657|P4|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
807680|NCT02349295|2634658|P3|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
807681|NCT02349295|2634659|P2|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
807682|NCT02349295|2634660|P1|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
807683|NCT02349295|2634656|P5|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
807684|NCT02349295|2634657|P4|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
807685|NCT02349295|2634658|P3|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
807686|NCT02349295|2634659|P2|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
807687|NCT02349295|2634660|P1|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2
807688|NCT02349295|2634656|P5|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
807689|NCT02349295|2634657|P4|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
807690|NCT02349295|2634658|P3|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
807691|NCT02349295|2634659|P2|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
807692|NCT02349295|2634660|P1|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7
807693|NCT02349295|2634656|P5|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
807694|NCT02349295|2634657|P4|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
807695|NCT02349295|2634658|P3|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4
807696|NCT02349295|2634659|P2|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2
807697|NCT02349295|2634660|P1|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9
807698|NCT02349295|2634656|P5|Double Blind Treatment (Week 0-24)|Adverse Event|0
807699|NCT02349295|2634657|P4|Double Blind Treatment (Week 0-24)|Adverse Event|0
807700|NCT02349295|2634658|P3|Double Blind Treatment (Week 0-24)|Adverse Event|7
807701|NCT02349295|2634659|P2|Double Blind Treatment (Week 0-24)|Adverse Event|5
807702|NCT02349295|2634660|P1|Double Blind Treatment (Week 0-24)|Adverse Event|5
807703|NCT02349061|2634763|P2|Overall Study|Other|1
807704|NCT02349061|2634764|P1|Overall Study|Other|3
807705|NCT02349061|2634763|P2|Overall Study|Physician Decision|0
807706|NCT02349061|2634764|P1|Overall Study|Physician Decision|1
807707|NCT02349061|2634763|P2|Overall Study|Lack of Efficacy|0
807708|NCT02349061|2634764|P1|Overall Study|Lack of Efficacy|1
807709|NCT02349061|2634763|P2|Overall Study|Adverse Event|3
807710|NCT02349061|2634764|P1|Overall Study|Adverse Event|4
807711|NCT02349048|2634772|P2|Overall Study|Lost to Follow-up|0
807712|NCT02349048|2634773|P1|Overall Study|Lost to Follow-up|1
807713|NCT02349048|2634772|P2|Overall Study|Withdrawal by Subject|0
807714|NCT02349048|2634773|P1|Overall Study|Withdrawal by Subject|4
807715|NCT02348723|2634795|P2|Overall Study|Adverse Event|1
807716|NCT02348723|2634796|P1|Overall Study|Adverse Event|3
807717|NCT02348723|2634795|P2|Overall Study|Reason other than specified|1
807718|NCT02348723|2634796|P1|Overall Study|Reason other than specified|1
807719|NCT02348723|2634795|P2|Overall Study|Consent withdrawn|3
807720|NCT02348723|2634796|P1|Overall Study|Consent withdrawn|1
807721|NCT02348723|2634795|P2|Overall Study|Lost to Follow-up|1
807722|NCT02348723|2634796|P1|Overall Study|Lost to Follow-up|1
807723|NCT02348723|2634795|P2|Overall Study|Non-compliant with Protocol|0
807724|NCT02348723|2634796|P1|Overall Study|Non-compliant with Protocol|1
807725|NCT02348723|2634795|P2|Overall Study|No ablation|20
807726|NCT02348723|2634796|P1|Overall Study|No ablation|21
807727|NCT02347774|2634863|P3|On Study Treatment|ranomized in error|1
807728|NCT02347774|2634864|P2|On Study Treatment|ranomized in error|0
807729|NCT02347774|2634865|P1|On Study Treatment|ranomized in error|0
807730|NCT02347774|2634863|P3|On Study Treatment|Met Prolonged QT criteria|0
807731|NCT02347774|2634864|P2|On Study Treatment|Met Prolonged QT criteria|0
807732|NCT02347774|2634865|P1|On Study Treatment|Met Prolonged QT criteria|1
807733|NCT02347774|2634863|P3|On Study Treatment|Lost to Follow-up|1
807734|NCT02347774|2634864|P2|On Study Treatment|Lost to Follow-up|6
807735|NCT02347774|2634865|P1|On Study Treatment|Lost to Follow-up|2
807736|NCT02347774|2634863|P3|On Study Treatment|withdrew consent|12
807737|NCT02347774|2634864|P2|On Study Treatment|withdrew consent|8
807738|NCT02347774|2634865|P1|On Study Treatment|withdrew consent|9
807739|NCT02347774|2634863|P3|On Study Treatment|Protocol Violation|1
807740|NCT02347774|2634864|P2|On Study Treatment|Protocol Violation|0
807741|NCT02347774|2634865|P1|On Study Treatment|Protocol Violation|0
807742|NCT02347774|2634863|P3|On Study Treatment|non-complicance with study medication|0
807743|NCT02347774|2634864|P2|On Study Treatment|non-complicance with study medication|2
807744|NCT02347774|2634865|P1|On Study Treatment|non-complicance with study medication|0
807745|NCT02347774|2634863|P3|On Study Treatment|Lack of Efficacy|2
807746|NCT02347774|2634864|P2|On Study Treatment|Lack of Efficacy|0
807747|NCT02347774|2634865|P1|On Study Treatment|Lack of Efficacy|3
807748|NCT02347774|2634863|P3|On Study Treatment|Adverse Event|19
807749|NCT02347774|2634864|P2|On Study Treatment|Adverse Event|15
807750|NCT02347774|2634865|P1|On Study Treatment|Adverse Event|9
807751|NCT02347774|2634863|P3|Study Participation|randomized in error|1
807752|NCT02347774|2634864|P2|Study Participation|randomized in error|0
807753|NCT02347774|2634865|P1|Study Participation|randomized in error|0
807754|NCT02347774|2634863|P3|Study Participation|incarceration|0
807755|NCT02347774|2634864|P2|Study Participation|incarceration|0
807756|NCT02347774|2634865|P1|Study Participation|incarceration|1
807757|NCT02347774|2634863|P3|Study Participation|non-compliance with study drug|0
807758|NCT02347774|2634864|P2|Study Participation|non-compliance with study drug|1
807759|NCT02347774|2634865|P1|Study Participation|non-compliance with study drug|0
807760|NCT02347774|2634863|P3|Study Participation|Met Prolonged QT criteria|0
807761|NCT02347774|2634864|P2|Study Participation|Met Prolonged QT criteria|0
807762|NCT02347774|2634865|P1|Study Participation|Met Prolonged QT criteria|1
807763|NCT02347774|2634863|P3|Study Participation|withdrew consent|1
807764|NCT02347774|2634864|P2|Study Participation|withdrew consent|1
807765|NCT02347774|2634865|P1|Study Participation|withdrew consent|1
807766|NCT02347774|2634863|P3|Study Participation|Adverse Event|6
807767|NCT02347774|2634864|P2|Study Participation|Adverse Event|4
807768|NCT02347774|2634865|P1|Study Participation|Adverse Event|1
807769|NCT02347774|2634863|P3|Study Participation|Withdrawal by Subject|15
807770|NCT02347774|2634864|P2|Study Participation|Withdrawal by Subject|9
807771|NCT02347774|2634865|P1|Study Participation|Withdrawal by Subject|8
807772|NCT02347774|2634863|P3|Study Participation|Lost to Follow-up|2
807773|NCT02347774|2634864|P2|Study Participation|Lost to Follow-up|6
807774|NCT02347774|2634865|P1|Study Participation|Lost to Follow-up|3
807775|NCT02347761|2634921|P3|On Study Treatment|Adverse Event|20
807776|NCT02347761|2634922|P2|On Study Treatment|Adverse Event|8
807777|NCT02347761|2634923|P1|On Study Treatment|Adverse Event|10
807778|NCT02347761|2634921|P3|On Study Treatment|durg not working|1
807779|NCT02347761|2634922|P2|On Study Treatment|durg not working|1
807780|NCT02347761|2634923|P1|On Study Treatment|durg not working|0
807781|NCT02347761|2634921|P3|On Study Treatment|investigator discretion|0
807782|NCT02347761|2634922|P2|On Study Treatment|investigator discretion|0
807783|NCT02347761|2634923|P1|On Study Treatment|investigator discretion|2
807784|NCT02347761|2634921|P3|On Study Treatment|Lost to Follow-up|1
807785|NCT02347761|2634922|P2|On Study Treatment|Lost to Follow-up|1
807786|NCT02347761|2634923|P1|On Study Treatment|Lost to Follow-up|2
807787|NCT02347761|2634921|P3|On Study Treatment|dissastisfaction with device|4
807788|NCT02347761|2634922|P2|On Study Treatment|dissastisfaction with device|1
807789|NCT02347761|2634923|P1|On Study Treatment|dissastisfaction with device|2
807790|NCT02347761|2634921|P3|On Study Treatment|move/travel|5
807791|NCT02347761|2634922|P2|On Study Treatment|move/travel|6
807792|NCT02347761|2634923|P1|On Study Treatment|move/travel|2
807793|NCT02347761|2634921|P3|On Study Treatment|Withdrawal by Subject|5
807794|NCT02347761|2634922|P2|On Study Treatment|Withdrawal by Subject|3
807795|NCT02347761|2634923|P1|On Study Treatment|Withdrawal by Subject|7
807796|NCT02347761|2634921|P3|On Study Treatment|non-compliance with study medication|2
807797|NCT02347761|2634922|P2|On Study Treatment|non-compliance with study medication|0
807798|NCT02347761|2634923|P1|On Study Treatment|non-compliance with study medication|0
807799|NCT02347761|2634921|P3|On Study Treatment|Lack of Efficacy|4
807800|NCT02347761|2634922|P2|On Study Treatment|Lack of Efficacy|3
807801|NCT02347761|2634923|P1|On Study Treatment|Lack of Efficacy|2
807802|NCT02347761|2634921|P3|All Collected|moved/travel|0
807803|NCT02347761|2634922|P2|All Collected|moved/travel|1
807804|NCT02347761|2634923|P1|All Collected|moved/travel|0
807805|NCT02347761|2634921|P3|All Collected|exacerbation of COPD|1
807806|NCT02347761|2634922|P2|All Collected|exacerbation of COPD|0
807807|NCT02347761|2634923|P1|All Collected|exacerbation of COPD|0
807808|NCT02347761|2634921|P3|All Collected|instillation site pain|1
807809|NCT02347761|2634922|P2|All Collected|instillation site pain|0
807810|NCT02347761|2634923|P1|All Collected|instillation site pain|0
807811|NCT02347761|2634921|P3|All Collected|invetigator disretion|0
807812|NCT02347761|2634922|P2|All Collected|invetigator disretion|0
807813|NCT02347761|2634923|P1|All Collected|invetigator disretion|2
807814|NCT02347761|2634921|P3|All Collected|Withdrawal by Subject|22
807815|NCT02347761|2634922|P2|All Collected|Withdrawal by Subject|11
807816|NCT02347761|2634923|P1|All Collected|Withdrawal by Subject|11
807817|NCT02347761|2634921|P3|All Collected|Lost to Follow-up|3
807818|NCT02347761|2634922|P2|All Collected|Lost to Follow-up|2
807819|NCT02347761|2634923|P1|All Collected|Lost to Follow-up|3
807820|NCT02347761|2634921|P3|All Collected|Death|0
807821|NCT02347761|2634922|P2|All Collected|Death|0
807822|NCT02347761|2634923|P1|All Collected|Death|1
807823|NCT02347657|2634984|P2|Overall Study|Other|3
807824|NCT02347657|2634985|P1|Overall Study|Other|3
807825|NCT02347657|2634984|P2|Overall Study|Randomized but not treated|0
807826|NCT02347657|2634985|P1|Overall Study|Randomized but not treated|1
807827|NCT02347657|2634984|P2|Overall Study|Withdrawal by Subject|7
807828|NCT02347657|2634985|P1|Overall Study|Withdrawal by Subject|6
807829|NCT02347657|2634984|P2|Overall Study|Adverse Event|4
807830|NCT02347657|2634985|P1|Overall Study|Adverse Event|8
807831|NCT02347657|2634984|P2|Overall Study|Physician Decision|1
807832|NCT02347657|2634985|P1|Overall Study|Physician Decision|0
807833|NCT02347189|2635042|P1|Overall Study|No primary outcome data available|2
807834|NCT02347189|2635042|P1|Overall Study|No implant attempted of study device|9
807835|NCT02347176|2635050|P4|Overall Study|Other|0
807836|NCT02347176|2635051|P3|Overall Study|Other|2
807837|NCT02347176|2635052|P2|Overall Study|Other|2
807838|NCT02347176|2635053|P1|Overall Study|Other|1
807839|NCT02347176|2635050|P4|Overall Study|Withdrawal by Subject|3
807840|NCT02347176|2635051|P3|Overall Study|Withdrawal by Subject|5
807841|NCT02347176|2635052|P2|Overall Study|Withdrawal by Subject|5
807842|NCT02347176|2635053|P1|Overall Study|Withdrawal by Subject|9
807843|NCT02347176|2635050|P4|Overall Study|Lost to Follow-up|1
807844|NCT02347176|2635051|P3|Overall Study|Lost to Follow-up|1
807845|NCT02347176|2635052|P2|Overall Study|Lost to Follow-up|3
807846|NCT02347176|2635053|P1|Overall Study|Lost to Follow-up|2
807847|NCT02347085|2635136|P1|Overall Study|Protocol Criteria|2
807848|NCT02347085|2635136|P1|Overall Study|Lost to Follow-up|1
807849|NCT02347085|2635136|P1|Overall Study|Withdrawal by Subject|4
807850|NCT02347085|2635136|P1|Overall Study|Lack of Efficacy|1
807851|NCT02347085|2635136|P1|Overall Study|Adverse Event|2
807852|NCT02347072|2635158|P1|Overall Study|Disc due to Protocol-specified Criteria|6
807853|NCT02347072|2635158|P1|Overall Study|Protocol Violation|1
807854|NCT02347072|2635158|P1|Overall Study|Lost to Follow-up|2
807855|NCT02347072|2635158|P1|Overall Study|Physician Decision|1
807856|NCT02347072|2635158|P1|Overall Study|Withdrawal by Subject|6
807857|NCT02347072|2635158|P1|Overall Study|Adverse Event|2
807858|NCT02346877|2635192|P2|Overall Study|Missing|0
807859|NCT02346877|2635193|P1|Overall Study|Missing|5
807860|NCT02346877|2635192|P2|Overall Study|Sponsor Decision|0
807861|NCT02346877|2635193|P1|Overall Study|Sponsor Decision|12
807862|NCT02346877|2635192|P2|Overall Study|Administrative Decision|0
807863|NCT02346877|2635193|P1|Overall Study|Administrative Decision|1
807864|NCT02346877|2635192|P2|Overall Study|Adverse Event|0
807865|NCT02346877|2635193|P1|Overall Study|Adverse Event|1
807866|NCT02346721|2635203|P1|Overall Study|Lack of Efficacy|1
807867|NCT02346721|2635203|P1|Overall Study|Withdrew Consent|3
807868|NCT02346240|2635221|P17|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
807869|NCT02346240|2635222|P16|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
807870|NCT02346240|2635223|P15|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|1
807871|NCT02346240|2635224|P14|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
807872|NCT02346240|2635225|P13|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
807873|NCT02346240|2635226|P12|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
807874|NCT02346240|2635227|P11|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
807875|NCT02346240|2635228|P10|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
807876|NCT02346240|2635229|P9|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
807877|NCT02346240|2635230|P8|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
807878|NCT02346240|2635231|P7|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
807879|NCT02346240|2635232|P6|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
807880|NCT02346240|2635233|P5|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
807881|NCT02346240|2635234|P4|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
807882|NCT02346240|2635235|P3|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
807883|NCT02346240|2635236|P2|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
807884|NCT02346240|2635237|P1|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
807885|NCT02346240|2635221|P17|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
807886|NCT02346240|2635222|P16|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
807887|NCT02346240|2635223|P15|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
807888|NCT02346240|2635224|P14|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
807889|NCT02346240|2635225|P13|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
807890|NCT02346240|2635226|P12|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
807891|NCT02346240|2635227|P11|Finished Wk16 Entered Maintenance Period|Patient’s decisions|1
807892|NCT02346240|2635228|P10|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
807893|NCT02346240|2635229|P9|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
807894|NCT02346240|2635230|P8|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
807895|NCT02346240|2635231|P7|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
807896|NCT02346240|2635232|P6|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
807897|NCT02346240|2635233|P5|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
807898|NCT02346240|2635234|P4|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
807899|NCT02346240|2635235|P3|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
807900|NCT02346240|2635236|P2|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
807901|NCT02346240|2635237|P1|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
807902|NCT02346240|2635221|P17|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
807903|NCT02346240|2635222|P16|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
807904|NCT02346240|2635223|P15|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
807905|NCT02346240|2635224|P14|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
807906|NCT02346240|2635225|P13|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
807907|NCT02346240|2635226|P12|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
807908|NCT02346240|2635227|P11|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
807909|NCT02346240|2635228|P10|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|1
807910|NCT02346240|2635229|P9|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
807911|NCT02346240|2635230|P8|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
807912|NCT02346240|2635231|P7|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
807913|NCT02346240|2635232|P6|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
807914|NCT02346240|2635233|P5|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
807915|NCT02346240|2635234|P4|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
807916|NCT02346240|2635235|P3|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
807917|NCT02346240|2635236|P2|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
807918|NCT02346240|2635237|P1|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
807919|NCT02346240|2635221|P17|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
807920|NCT02346240|2635222|P16|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
807921|NCT02346240|2635223|P15|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|1
807922|NCT02346240|2635224|P14|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|1
807923|NCT02346240|2635225|P13|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
807924|NCT02346240|2635226|P12|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|1
807925|NCT02346240|2635227|P11|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
807926|NCT02346240|2635228|P10|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
807927|NCT02346240|2635229|P9|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|1
807928|NCT02346240|2635230|P8|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
807929|NCT02346240|2635231|P7|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
807930|NCT02346240|2635232|P6|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
807931|NCT02346240|2635233|P5|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
807932|NCT02346240|2635234|P4|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
807933|NCT02346240|2635235|P3|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
807934|NCT02346240|2635236|P2|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
807935|NCT02346240|2635237|P1|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
807936|NCT02346240|2635221|P17|Finished Wk16 Entered Maintenance Period|Moved out of state|0
807937|NCT02346240|2635222|P16|Finished Wk16 Entered Maintenance Period|Moved out of state|0
807938|NCT02346240|2635223|P15|Finished Wk16 Entered Maintenance Period|Moved out of state|0
807939|NCT02346240|2635224|P14|Finished Wk16 Entered Maintenance Period|Moved out of state|0
807940|NCT02346240|2635225|P13|Finished Wk16 Entered Maintenance Period|Moved out of state|0
807941|NCT02346240|2635226|P12|Finished Wk16 Entered Maintenance Period|Moved out of state|0
807942|NCT02346240|2635227|P11|Finished Wk16 Entered Maintenance Period|Moved out of state|0
807943|NCT02346240|2635228|P10|Finished Wk16 Entered Maintenance Period|Moved out of state|0
807944|NCT02346240|2635229|P9|Finished Wk16 Entered Maintenance Period|Moved out of state|0
807945|NCT02346240|2635230|P8|Finished Wk16 Entered Maintenance Period|Moved out of state|0
807946|NCT02346240|2635231|P7|Finished Wk16 Entered Maintenance Period|Moved out of state|1
807947|NCT02346240|2635232|P6|Finished Wk16 Entered Maintenance Period|Moved out of state|0
807948|NCT02346240|2635233|P5|Finished Wk16 Entered Maintenance Period|Moved out of state|0
807949|NCT02346240|2635234|P4|Finished Wk16 Entered Maintenance Period|Moved out of state|0
807950|NCT02346240|2635235|P3|Finished Wk16 Entered Maintenance Period|Moved out of state|0
807951|NCT02346240|2635236|P2|Finished Wk16 Entered Maintenance Period|Moved out of state|0
807952|NCT02346240|2635237|P1|Finished Wk16 Entered Maintenance Period|Moved out of state|0
807953|NCT02346240|2635221|P17|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|4
807954|NCT02346240|2635222|P16|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|8
807955|NCT02346240|2635223|P15|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|3
807956|NCT02346240|2635224|P14|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|3
807957|NCT02346240|2635225|P13|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
807958|NCT02346240|2635226|P12|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
807959|NCT02346240|2635227|P11|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
807960|NCT02346240|2635228|P10|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
807961|NCT02346240|2635229|P9|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
807962|NCT02346240|2635230|P8|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
807963|NCT02346240|2635231|P7|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
807964|NCT02346240|2635232|P6|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
807965|NCT02346240|2635233|P5|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
807966|NCT02346240|2635234|P4|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
807967|NCT02346240|2635235|P3|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
807968|NCT02346240|2635236|P2|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
807969|NCT02346240|2635237|P1|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
807970|NCT02346240|2635221|P17|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
807971|NCT02346240|2635222|P16|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|1
807972|NCT02346240|2635223|P15|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|4
807973|NCT02346240|2635224|P14|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|2
807974|NCT02346240|2635225|P13|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
807975|NCT02346240|2635226|P12|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|2
807976|NCT02346240|2635227|P11|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|1
807977|NCT02346240|2635228|P10|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
807978|NCT02346240|2635229|P9|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|1
807979|NCT02346240|2635230|P8|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|1
807980|NCT02346240|2635231|P7|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|1
807981|NCT02346240|2635232|P6|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|1
807982|NCT02346240|2635233|P5|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
807983|NCT02346240|2635234|P4|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
807984|NCT02346240|2635235|P3|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
807985|NCT02346240|2635236|P2|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
807986|NCT02346240|2635237|P1|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
807987|NCT02346240|2635221|P17|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
807988|NCT02346240|2635222|P16|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
807989|NCT02346240|2635223|P15|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|1
807990|NCT02346240|2635224|P14|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
807991|NCT02346240|2635225|P13|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
807992|NCT02346240|2635226|P12|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
807993|NCT02346240|2635227|P11|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
807994|NCT02346240|2635228|P10|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
807995|NCT02346240|2635229|P9|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
807996|NCT02346240|2635230|P8|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
807997|NCT02346240|2635231|P7|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
807998|NCT02346240|2635232|P6|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
807999|NCT02346240|2635233|P5|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
808000|NCT02346240|2635234|P4|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
808001|NCT02346240|2635235|P3|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
808002|NCT02346240|2635236|P2|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
808003|NCT02346240|2635237|P1|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
808004|NCT02346240|2635221|P17|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
808005|NCT02346240|2635222|P16|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|3
808006|NCT02346240|2635223|P15|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
808007|NCT02346240|2635224|P14|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
808008|NCT02346240|2635225|P13|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
808009|NCT02346240|2635226|P12|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
808010|NCT02346240|2635227|P11|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
808011|NCT02346240|2635228|P10|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
808012|NCT02346240|2635229|P9|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
808013|NCT02346240|2635230|P8|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
808014|NCT02346240|2635231|P7|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
808015|NCT02346240|2635232|P6|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
808016|NCT02346240|2635233|P5|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
808017|NCT02346240|2635234|P4|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
808018|NCT02346240|2635235|P3|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
808019|NCT02346240|2635236|P2|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
808020|NCT02346240|2635237|P1|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
808021|NCT02346240|2635221|P17|Finished Wk16 Entered Maintenance Period|Adverse Event|2
808022|NCT02346240|2635222|P16|Finished Wk16 Entered Maintenance Period|Adverse Event|1
808023|NCT02346240|2635223|P15|Finished Wk16 Entered Maintenance Period|Adverse Event|4
808024|NCT02346240|2635224|P14|Finished Wk16 Entered Maintenance Period|Adverse Event|1
808025|NCT02346240|2635225|P13|Finished Wk16 Entered Maintenance Period|Adverse Event|0
808026|NCT02346240|2635226|P12|Finished Wk16 Entered Maintenance Period|Adverse Event|0
808027|NCT02346240|2635227|P11|Finished Wk16 Entered Maintenance Period|Adverse Event|0
808028|NCT02346240|2635228|P10|Finished Wk16 Entered Maintenance Period|Adverse Event|0
808029|NCT02346240|2635229|P9|Finished Wk16 Entered Maintenance Period|Adverse Event|2
808030|NCT02346240|2635230|P8|Finished Wk16 Entered Maintenance Period|Adverse Event|1
808031|NCT02346240|2635231|P7|Finished Wk16 Entered Maintenance Period|Adverse Event|0
808032|NCT02346240|2635232|P6|Finished Wk16 Entered Maintenance Period|Adverse Event|0
808033|NCT02346240|2635233|P5|Finished Wk16 Entered Maintenance Period|Adverse Event|0
808034|NCT02346240|2635234|P4|Finished Wk16 Entered Maintenance Period|Adverse Event|0
808035|NCT02346240|2635235|P3|Finished Wk16 Entered Maintenance Period|Adverse Event|0
808036|NCT02346240|2635236|P2|Finished Wk16 Entered Maintenance Period|Adverse Event|0
808037|NCT02346240|2635237|P1|Finished Wk16 Entered Maintenance Period|Adverse Event|0
808038|NCT02346240|2635221|P17|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
808039|NCT02346240|2635222|P16|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
808040|NCT02346240|2635223|P15|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
808041|NCT02346240|2635224|P14|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
808042|NCT02346240|2635225|P13|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
808043|NCT02346240|2635226|P12|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
808044|NCT02346240|2635227|P11|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
808045|NCT02346240|2635228|P10|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
808046|NCT02346240|2635229|P9|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
808047|NCT02346240|2635230|P8|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
808048|NCT02346240|2635231|P7|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
808049|NCT02346240|2635232|P6|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
808050|NCT02346240|2635233|P5|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
808051|NCT02346240|2635234|P4|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
808052|NCT02346240|2635235|P3|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1
808053|NCT02346240|2635236|P2|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
808054|NCT02346240|2635237|P1|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
808055|NCT02346240|2635221|P17|Initial Period (Baseline to Week 16)|Non-compliance|0
808056|NCT02346240|2635222|P16|Initial Period (Baseline to Week 16)|Non-compliance|0
808057|NCT02346240|2635223|P15|Initial Period (Baseline to Week 16)|Non-compliance|0
808058|NCT02346240|2635224|P14|Initial Period (Baseline to Week 16)|Non-compliance|0
808059|NCT02346240|2635225|P13|Initial Period (Baseline to Week 16)|Non-compliance|0
808060|NCT02346240|2635226|P12|Initial Period (Baseline to Week 16)|Non-compliance|0
808061|NCT02346240|2635227|P11|Initial Period (Baseline to Week 16)|Non-compliance|0
808062|NCT02346240|2635228|P10|Initial Period (Baseline to Week 16)|Non-compliance|0
808063|NCT02346240|2635229|P9|Initial Period (Baseline to Week 16)|Non-compliance|0
808064|NCT02346240|2635230|P8|Initial Period (Baseline to Week 16)|Non-compliance|0
808065|NCT02346240|2635231|P7|Initial Period (Baseline to Week 16)|Non-compliance|0
808066|NCT02346240|2635232|P6|Initial Period (Baseline to Week 16)|Non-compliance|0
808067|NCT02346240|2635233|P5|Initial Period (Baseline to Week 16)|Non-compliance|0
808068|NCT02346240|2635234|P4|Initial Period (Baseline to Week 16)|Non-compliance|1
808069|NCT02346240|2635235|P3|Initial Period (Baseline to Week 16)|Non-compliance|0
808070|NCT02346240|2635236|P2|Initial Period (Baseline to Week 16)|Non-compliance|1
808071|NCT02346240|2635237|P1|Initial Period (Baseline to Week 16)|Non-compliance|0
808072|NCT02346240|2635221|P17|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
808073|NCT02346240|2635222|P16|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
808074|NCT02346240|2635223|P15|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
808075|NCT02346240|2635224|P14|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
808076|NCT02346240|2635225|P13|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
808077|NCT02346240|2635226|P12|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
808078|NCT02346240|2635227|P11|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
808079|NCT02346240|2635228|P10|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
808080|NCT02346240|2635229|P9|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
808081|NCT02346240|2635230|P8|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
808082|NCT02346240|2635231|P7|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
808083|NCT02346240|2635232|P6|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
808084|NCT02346240|2635233|P5|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
808085|NCT02346240|2635234|P4|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
808086|NCT02346240|2635235|P3|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3
808087|NCT02346240|2635236|P2|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
808088|NCT02346240|2635237|P1|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1
808089|NCT02346240|2635221|P17|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
808090|NCT02346240|2635222|P16|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
808091|NCT02346240|2635223|P15|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
808092|NCT02346240|2635224|P14|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
808093|NCT02346240|2635225|P13|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
808094|NCT02346240|2635226|P12|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
808095|NCT02346240|2635227|P11|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
808096|NCT02346240|2635228|P10|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
808097|NCT02346240|2635229|P9|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
808098|NCT02346240|2635230|P8|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
808099|NCT02346240|2635231|P7|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
808100|NCT02346240|2635232|P6|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
808101|NCT02346240|2635233|P5|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
808102|NCT02346240|2635234|P4|Initial Period (Baseline to Week 16)|Lost to Follow-up|3
808103|NCT02346240|2635235|P3|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
808104|NCT02346240|2635236|P2|Initial Period (Baseline to Week 16)|Lost to Follow-up|2
808105|NCT02346240|2635237|P1|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
808106|NCT02346240|2635221|P17|Initial Period (Baseline to Week 16)|Protocol Violation|0
808107|NCT02346240|2635222|P16|Initial Period (Baseline to Week 16)|Protocol Violation|0
808108|NCT02346240|2635223|P15|Initial Period (Baseline to Week 16)|Protocol Violation|0
808109|NCT02346240|2635224|P14|Initial Period (Baseline to Week 16)|Protocol Violation|0
808110|NCT02346240|2635225|P13|Initial Period (Baseline to Week 16)|Protocol Violation|0
808111|NCT02346240|2635226|P12|Initial Period (Baseline to Week 16)|Protocol Violation|0
808112|NCT02346240|2635227|P11|Initial Period (Baseline to Week 16)|Protocol Violation|0
808113|NCT02346240|2635228|P10|Initial Period (Baseline to Week 16)|Protocol Violation|0
808114|NCT02346240|2635229|P9|Initial Period (Baseline to Week 16)|Protocol Violation|0
808115|NCT02346240|2635230|P8|Initial Period (Baseline to Week 16)|Protocol Violation|0
808116|NCT02346240|2635231|P7|Initial Period (Baseline to Week 16)|Protocol Violation|0
808117|NCT02346240|2635232|P6|Initial Period (Baseline to Week 16)|Protocol Violation|0
808118|NCT02346240|2635233|P5|Initial Period (Baseline to Week 16)|Protocol Violation|0
808119|NCT02346240|2635234|P4|Initial Period (Baseline to Week 16)|Protocol Violation|0
808120|NCT02346240|2635235|P3|Initial Period (Baseline to Week 16)|Protocol Violation|0
808121|NCT02346240|2635236|P2|Initial Period (Baseline to Week 16)|Protocol Violation|1
808122|NCT02346240|2635237|P1|Initial Period (Baseline to Week 16)|Protocol Violation|0
808123|NCT02346240|2635221|P17|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
808124|NCT02346240|2635222|P16|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
808125|NCT02346240|2635223|P15|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
808126|NCT02346240|2635224|P14|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
808127|NCT02346240|2635225|P13|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
808128|NCT02346240|2635226|P12|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
808129|NCT02346240|2635227|P11|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
808130|NCT02346240|2635228|P10|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
808131|NCT02346240|2635229|P9|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
808132|NCT02346240|2635230|P8|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
808133|NCT02346240|2635231|P7|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
808134|NCT02346240|2635232|P6|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
808135|NCT02346240|2635233|P5|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
808136|NCT02346240|2635234|P4|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
808137|NCT02346240|2635235|P3|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
808138|NCT02346240|2635236|P2|Initial Period (Baseline to Week 16)|Lack of Efficacy|1
808139|NCT02346240|2635237|P1|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
808140|NCT02346240|2635221|P17|Initial Period (Baseline to Week 16)|Adverse Event|0
808141|NCT02346240|2635222|P16|Initial Period (Baseline to Week 16)|Adverse Event|0
808142|NCT02346240|2635223|P15|Initial Period (Baseline to Week 16)|Adverse Event|0
808143|NCT02346240|2635224|P14|Initial Period (Baseline to Week 16)|Adverse Event|0
808144|NCT02346240|2635225|P13|Initial Period (Baseline to Week 16)|Adverse Event|0
808145|NCT02346240|2635226|P12|Initial Period (Baseline to Week 16)|Adverse Event|0
808146|NCT02346240|2635227|P11|Initial Period (Baseline to Week 16)|Adverse Event|0
808147|NCT02346240|2635228|P10|Initial Period (Baseline to Week 16)|Adverse Event|0
808148|NCT02346240|2635229|P9|Initial Period (Baseline to Week 16)|Adverse Event|0
808149|NCT02346240|2635230|P8|Initial Period (Baseline to Week 16)|Adverse Event|0
808150|NCT02346240|2635231|P7|Initial Period (Baseline to Week 16)|Adverse Event|0
808151|NCT02346240|2635232|P6|Initial Period (Baseline to Week 16)|Adverse Event|0
808152|NCT02346240|2635233|P5|Initial Period (Baseline to Week 16)|Adverse Event|0
808153|NCT02346240|2635234|P4|Initial Period (Baseline to Week 16)|Adverse Event|1
808154|NCT02346240|2635235|P3|Initial Period (Baseline to Week 16)|Adverse Event|1
808155|NCT02346240|2635236|P2|Initial Period (Baseline to Week 16)|Adverse Event|4
808156|NCT02346240|2635237|P1|Initial Period (Baseline to Week 16)|Adverse Event|0
808157|NCT02345330|2635316|P1|Overall Study|Progressive Disease|2
808158|NCT02345330|2635316|P1|Overall Study|Death|1
808159|NCT02345252|2635328|P2|Overall Study|Still in Study up to the Data Cut Date|300
808160|NCT02345252|2635329|P1|Overall Study|Still in Study up to the Data Cut Date|304
808161|NCT02345252|2635328|P2|Overall Study|Randomized but Never Treated|2
808162|NCT02345252|2635329|P1|Overall Study|Randomized but Never Treated|0
808163|NCT02345252|2635328|P2|Overall Study|Lost to Follow-up|3
808164|NCT02345252|2635329|P1|Overall Study|Lost to Follow-up|2
808165|NCT02345252|2635328|P2|Overall Study|Withdrew Consent|9
808166|NCT02345252|2635329|P1|Overall Study|Withdrew Consent|7
808167|NCT02345252|2635328|P2|Overall Study|Protocol Violation|0
808168|NCT02345252|2635329|P1|Overall Study|Protocol Violation|1
808169|NCT02345252|2635328|P2|Overall Study|Investigator's Discretion|1
808170|NCT02345252|2635329|P1|Overall Study|Investigator's Discretion|0
808171|NCT02345252|2635328|P2|Overall Study|Death|1
808172|NCT02345252|2635329|P1|Overall Study|Death|1
808173|NCT02345252|2635328|P2|Overall Study|Adverse Event|0
808174|NCT02345252|2635329|P1|Overall Study|Adverse Event|1
808175|NCT02345226|2635345|P2|Overall Study|Still in Study up to the Data Cut Date|409
808176|NCT02345226|2635346|P1|Overall Study|Still in Study up to the Data Cut Date|405
808177|NCT02345226|2635345|P2|Overall Study|Randomized but Never Treated|4
808178|NCT02345226|2635346|P1|Overall Study|Randomized but Never Treated|2
808179|NCT02345226|2635345|P2|Overall Study|Lost to Follow-up|6
808180|NCT02345226|2635346|P1|Overall Study|Lost to Follow-up|7
808181|NCT02345226|2635345|P2|Overall Study|Withdrew Consent|16
808182|NCT02345226|2635346|P1|Overall Study|Withdrew Consent|18
808183|NCT02345226|2635345|P2|Overall Study|Non-Compliance with Study Drug|0
808184|NCT02345226|2635346|P1|Overall Study|Non-Compliance with Study Drug|1
808185|NCT02345226|2635345|P2|Overall Study|Investigator's Discretion|1
808186|NCT02345226|2635346|P1|Overall Study|Investigator's Discretion|3
808187|NCT02345226|2635345|P2|Overall Study|Lack of Efficacy|0
808188|NCT02345226|2635346|P1|Overall Study|Lack of Efficacy|1
808189|NCT02345226|2635345|P2|Overall Study|Pregnancy|1
808190|NCT02345226|2635346|P1|Overall Study|Pregnancy|0
808191|NCT02345226|2635345|P2|Overall Study|Death|0
808192|NCT02345226|2635346|P1|Overall Study|Death|1
808193|NCT02345226|2635345|P2|Overall Study|Adverse Event|4
808194|NCT02345226|2635346|P1|Overall Study|Adverse Event|2
808195|NCT02345161|2635364|P2|Overall Study|Lost to Follow-up|1
808196|NCT02345161|2635365|P1|Overall Study|Lost to Follow-up|0
808197|NCT02345161|2635364|P2|Overall Study|Physician Decision|4
808198|NCT02345161|2635365|P1|Overall Study|Physician Decision|4
808199|NCT02345161|2635364|P2|Overall Study|Adverse Event|19
808200|NCT02345161|2635365|P1|Overall Study|Adverse Event|16
808201|NCT02345161|2635364|P2|Overall Study|Withdrawal by Subject|33
808202|NCT02345161|2635365|P1|Overall Study|Withdrawal by Subject|25
808203|NCT02344745|2635486|P2|Overall Study|Data collection sheets were lost|0
808204|NCT02344745|2635487|P1|Overall Study|Data collection sheets were lost|2
808205|NCT02344342|2635532|P4|Overall Study|Industry partner dropped out|10
808206|NCT02344342|2635533|P3|Overall Study|Industry partner dropped out|14
808207|NCT02344342|2635534|P2|Overall Study|Industry partner dropped out|9
808208|NCT02344342|2635535|P1|Overall Study|Industry partner dropped out|11
808209|NCT02344004|2635584|P2|Overall Study|Ongoing|26
808210|NCT02344004|2635585|P1|Overall Study|Ongoing|110
808211|NCT02344004|2635584|P2|Overall Study|Other|0
808212|NCT02344004|2635585|P1|Overall Study|Other|6
808213|NCT02344004|2635584|P2|Overall Study|Rescue Medication|0
808214|NCT02344004|2635585|P1|Overall Study|Rescue Medication|1
808215|NCT02344004|2635584|P2|Overall Study|Withdrawal by Subject|4
808216|NCT02344004|2635585|P1|Overall Study|Withdrawal by Subject|19
808217|NCT02344004|2635584|P2|Overall Study|Physician Decision|1
808218|NCT02344004|2635585|P1|Overall Study|Physician Decision|3
808219|NCT02344004|2635584|P2|Overall Study|Death|4
808220|NCT02344004|2635585|P1|Overall Study|Death|7
808221|NCT02344004|2635584|P2|Overall Study|Adverse Event|1
808222|NCT02344004|2635585|P1|Overall Study|Adverse Event|8
808223|NCT02343263|2635628|P3|Overall Study|Physician Decision|1
808224|NCT02343263|2635629|P2|Overall Study|Physician Decision|3
808225|NCT02343263|2635630|P1|Overall Study|Physician Decision|5
808226|NCT02343159|2635659|P3|Overall Study|Enrollment Error|0
808227|NCT02343159|2635660|P2|Overall Study|Enrollment Error|0
808228|NCT02343159|2635661|P1|Overall Study|Enrollment Error|1
808229|NCT02343159|2635659|P3|Overall Study|Sponsor Decision|0
808230|NCT02343159|2635660|P2|Overall Study|Sponsor Decision|1
808231|NCT02343159|2635661|P1|Overall Study|Sponsor Decision|0
808232|NCT02343159|2635659|P3|Overall Study|Adverse Event|2
808233|NCT02343159|2635660|P2|Overall Study|Adverse Event|4
808234|NCT02343159|2635661|P1|Overall Study|Adverse Event|4
808235|NCT02343159|2635659|P3|Overall Study|Lost to Follow-up|2
808236|NCT02343159|2635660|P2|Overall Study|Lost to Follow-up|2
808237|NCT02343159|2635661|P1|Overall Study|Lost to Follow-up|0
808238|NCT02343159|2635659|P3|Overall Study|Withdrawal by Subject|2
808239|NCT02343159|2635660|P2|Overall Study|Withdrawal by Subject|0
808240|NCT02343159|2635661|P1|Overall Study|Withdrawal by Subject|3
808241|NCT02343159|2635659|P3|Overall Study|Physician Decision|1
808242|NCT02343159|2635660|P2|Overall Study|Physician Decision|0
808243|NCT02343159|2635661|P1|Overall Study|Physician Decision|2
808244|NCT02343159|2635659|P3|Overall Study|Early Study Termination|23
808245|NCT02343159|2635660|P2|Overall Study|Early Study Termination|19
808246|NCT02343159|2635661|P1|Overall Study|Early Study Termination|16
808247|NCT02343003|2635705|P2|Overall Study|terminated by sponsor|0
808248|NCT02343003|2635706|P1|Overall Study|terminated by sponsor|2
808249|NCT02343003|2635705|P2|Overall Study|exclusion criteria met|1
808250|NCT02343003|2635706|P1|Overall Study|exclusion criteria met|1
808251|NCT02343003|2635705|P2|Overall Study|Death|1
808252|NCT02343003|2635706|P1|Overall Study|Death|0
808253|NCT02343003|2635705|P2|Overall Study|Protocol Violation|0
808254|NCT02343003|2635706|P1|Overall Study|Protocol Violation|1
808255|NCT02343003|2635705|P2|Overall Study|Lost to Follow-up|1
808256|NCT02343003|2635706|P1|Overall Study|Lost to Follow-up|5
808257|NCT02343003|2635705|P2|Overall Study|Withdrawal by Subject|4
808258|NCT02343003|2635706|P1|Overall Study|Withdrawal by Subject|9
808259|NCT02342743|2635722|P1|Treatment Period|Change in prophylactic medication|1
808260|NCT02342743|2635722|P1|Treatment Period|Lost to Follow-up|8
808261|NCT02342743|2635722|P1|Treatment Period|Withdrawal by Subject|2
808262|NCT02342743|2635722|P1|Run-in Period|Change in prophylactic medication|3
808263|NCT02342743|2635722|P1|Run-in Period|Lost to Follow-up|2
808264|NCT02342743|2635722|P1|Run-in Period|Withdrawal by Subject|3
808265|NCT02342704|2635735|P2|Overall Study|Adverse Event|3
808266|NCT02342704|2635736|P1|Overall Study|Adverse Event|1
808267|NCT02342704|2635735|P2|Overall Study|Lost to Follow-up|1
808268|NCT02342704|2635736|P1|Overall Study|Lost to Follow-up|2
808269|NCT02342704|2635735|P2|Overall Study|Withdrawal by Subject|0
808270|NCT02342704|2635736|P1|Overall Study|Withdrawal by Subject|1
808271|NCT02342704|2635735|P2|Overall Study|Not Specified|1
808272|NCT02342704|2635736|P1|Overall Study|Not Specified|0
808273|NCT02342704|2635735|P2|Overall Study|Sponsor Termination|43
808274|NCT02342704|2635736|P1|Overall Study|Sponsor Termination|49
808275|NCT02342704|2635735|P2|Overall Study|Physician Decision|3
808276|NCT02342704|2635736|P1|Overall Study|Physician Decision|0
808277|NCT02342678|2635764|P2|Overall Study|Illness/medical reason|1
808278|NCT02342678|2635765|P1|Overall Study|Illness/medical reason|1
808279|NCT02342678|2635764|P2|Overall Study|Family illness/emergency|1
808280|NCT02342678|2635765|P1|Overall Study|Family illness/emergency|0
808281|NCT02342678|2635764|P2|Overall Study|Too busy to complete study|2
808282|NCT02342678|2635765|P1|Overall Study|Too busy to complete study|0
808283|NCT02342678|2635764|P2|Overall Study|Lost to Follow-up|1
808284|NCT02342678|2635765|P1|Overall Study|Lost to Follow-up|0
808285|NCT02342548|2635796|P3|Overall Study|Other|1
808286|NCT02342548|2635797|P2|Overall Study|Other|1
808287|NCT02342548|2635798|P1|Overall Study|Other|1
808288|NCT02342548|2635796|P3|Overall Study|Withdrawal by Subject|4
808289|NCT02342548|2635797|P2|Overall Study|Withdrawal by Subject|3
808290|NCT02342548|2635798|P1|Overall Study|Withdrawal by Subject|1
808291|NCT02342548|2635796|P3|Overall Study|Protocol Violation|0
808292|NCT02342548|2635797|P2|Overall Study|Protocol Violation|1
808293|NCT02342548|2635798|P1|Overall Study|Protocol Violation|0
808294|NCT02342548|2635796|P3|Overall Study|Study terminated by sponsor|25
808295|NCT02342548|2635797|P2|Overall Study|Study terminated by sponsor|39
808296|NCT02342548|2635798|P1|Overall Study|Study terminated by sponsor|20
808297|NCT02342548|2635796|P3|Overall Study|Lost to Follow-up|0
808298|NCT02342548|2635797|P2|Overall Study|Lost to Follow-up|1
808299|NCT02342548|2635798|P1|Overall Study|Lost to Follow-up|0
808300|NCT02342548|2635796|P3|Overall Study|Adverse Event|13
808301|NCT02342548|2635797|P2|Overall Study|Adverse Event|17
808302|NCT02342548|2635798|P1|Overall Study|Adverse Event|12
808303|NCT02342418|2635842|P2|Overall Study|Adverse Event|1
808304|NCT02342418|2635843|P1|Overall Study|Adverse Event|0
808305|NCT02342288|2635853|P2|Overall Study|coordinator not available|2
808306|NCT02342288|2635854|P1|Overall Study|coordinator not available|0
808307|NCT02342288|2635853|P2|Overall Study|subject cannot tolerate numbing drops|1
808308|NCT02342288|2635854|P1|Overall Study|subject cannot tolerate numbing drops|0
808309|NCT02342288|2635853|P2|Overall Study|coordinator contaminated with blood|1
808310|NCT02342288|2635854|P1|Overall Study|coordinator contaminated with blood|0
808311|NCT02342288|2635853|P2|Overall Study|Withdrawal by Subject|0
808312|NCT02342288|2635854|P1|Overall Study|Withdrawal by Subject|1
808313|NCT02342288|2635853|P2|Overall Study|anesthesia leak in system|0
808314|NCT02342288|2635854|P1|Overall Study|anesthesia leak in system|1
808315|NCT02342288|2635853|P2|Overall Study|no protocol anesthesiologist available|2
808316|NCT02342288|2635854|P1|Overall Study|no protocol anesthesiologist available|3
808317|NCT02342223|2635860|P1|Overall Study|Lost to Follow-up|1
808318|NCT02341482|2636032|P1|Overall Study|Adverse Event|1
808319|NCT02341417|2636061|P3|Overall Study|Death|1
808320|NCT02341417|2636062|P2|Overall Study|Death|0
808321|NCT02341417|2636063|P1|Overall Study|Death|0
808322|NCT02341417|2636061|P3|Overall Study|Decision by sponsor|0
808323|NCT02341417|2636062|P2|Overall Study|Decision by sponsor|0
808324|NCT02341417|2636063|P1|Overall Study|Decision by sponsor|2
808325|NCT02341417|2636061|P3|Overall Study|Withdrawal by Subject|0
808326|NCT02341417|2636062|P2|Overall Study|Withdrawal by Subject|2
808327|NCT02341417|2636063|P1|Overall Study|Withdrawal by Subject|0
808328|NCT02340962|2636124|P2|Overall Study|Lost to Follow-up|0
808329|NCT02340962|2636125|P1|Overall Study|Lost to Follow-up|1
808330|NCT02340663|2636162|P2|Overall Study|Withdrawal by Subject|1
808331|NCT02340663|2636163|P1|Overall Study|Withdrawal by Subject|3
808332|NCT02340663|2636162|P2|Overall Study|Protocol Violation|0
808333|NCT02340663|2636163|P1|Overall Study|Protocol Violation|1
808334|NCT02340663|2636162|P2|Overall Study|Lost to Follow-up|0
808335|NCT02340663|2636163|P1|Overall Study|Lost to Follow-up|1
808336|NCT02340520|2636219|P1|Overall Study|Withdrawal by Subject|1
808337|NCT02340520|2636219|P1|Overall Study|Patient did not take drug as specified|1
808338|NCT02340520|2636219|P1|Overall Study|Lost to Follow-up|1
808339|NCT02340000|2636267|P2|Time Period 2|Lost to Follow-up|8
808340|NCT02340000|2636268|P1|Time Period 2|Lost to Follow-up|10
808341|NCT02340000|2636267|P2|Time Period 2|Withdrawal by Subject|7
808342|NCT02340000|2636268|P1|Time Period 2|Withdrawal by Subject|9
808343|NCT02340000|2636267|P2|Time Period 1|Lost to Follow-up|7
808344|NCT02340000|2636268|P1|Time Period 1|Lost to Follow-up|6
808345|NCT02340000|2636267|P2|Time Period 1|Withdrawal by Subject|8
808346|NCT02340000|2636268|P1|Time Period 1|Withdrawal by Subject|6
808347|NCT02339909|2636298|P3|Overall Study|Became ineligible after randomisation|71
808348|NCT02339909|2636299|P2|Overall Study|Became ineligible after randomisation|63
808349|NCT02339909|2636300|P1|Overall Study|Became ineligible after randomisation|89
808350|NCT02339584|2636338|P2|Overall Study|Withdrawal by Subject|4
808351|NCT02339584|2636339|P1|Overall Study|Withdrawal by Subject|2
808352|NCT02339584|2636338|P2|Overall Study|Protocol Violation|1
808353|NCT02339584|2636339|P1|Overall Study|Protocol Violation|1
808354|NCT02339584|2636338|P2|Overall Study|Physician Decision|2
808355|NCT02339584|2636339|P1|Overall Study|Physician Decision|1
808356|NCT02339584|2636338|P2|Overall Study|Lack of Efficacy|1
808357|NCT02339584|2636339|P1|Overall Study|Lack of Efficacy|0
808358|NCT02339584|2636338|P2|Overall Study|Adverse Event|7
808359|NCT02339584|2636339|P1|Overall Study|Adverse Event|11
808360|NCT02339506|2636345|P2|Washout (Period 2)|Withdrawal by Subject|0
808361|NCT02339506|2636346|P1|Washout (Period 2)|Withdrawal by Subject|2
808362|NCT02339506|2636345|P2|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1
808363|NCT02339506|2636346|P1|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0
808364|NCT02339285|2636360|P3|Overall Study|Protocol Deviation|0
808365|NCT02339285|2636361|P2|Overall Study|Protocol Deviation|1
808366|NCT02339285|2636362|P1|Overall Study|Protocol Deviation|0
808367|NCT02339285|2636360|P3|Overall Study|Lost to Follow-up|1
808368|NCT02339285|2636361|P2|Overall Study|Lost to Follow-up|1
808369|NCT02339285|2636362|P1|Overall Study|Lost to Follow-up|1
808370|NCT02339285|2636360|P3|Overall Study|Withdrawal by Subject|1
808371|NCT02339285|2636361|P2|Overall Study|Withdrawal by Subject|1
808372|NCT02339285|2636362|P1|Overall Study|Withdrawal by Subject|0
808373|NCT02339155|2636408|P2|Overall Study|Withdrawal by Subject|4
808374|NCT02339155|2636409|P1|Overall Study|Withdrawal by Subject|4
808375|NCT02339155|2636408|P2|Overall Study|Physician Decision|1
808376|NCT02339155|2636409|P1|Overall Study|Physician Decision|2
808377|NCT02339155|2636408|P2|Overall Study|Lost to Follow-up|9
808378|NCT02339155|2636409|P1|Overall Study|Lost to Follow-up|8
808379|NCT02339155|2636408|P2|Overall Study|Death|1
808380|NCT02339155|2636409|P1|Overall Study|Death|1
808381|NCT02339155|2636408|P2|Overall Study|Adverse Event|6
808382|NCT02339155|2636409|P1|Overall Study|Adverse Event|0
808383|NCT02338843|2636441|P2|Overall Study|Discontinued prior to randomizat|0
808384|NCT02338843|2636442|P1|Overall Study|Discontinued prior to randomizat|1
808385|NCT02338843|2636441|P2|Overall Study|Subject Recovered|2
808386|NCT02338843|2636442|P1|Overall Study|Subject Recovered|0
808387|NCT02338843|2636441|P2|Overall Study|Withdrawal by Subject|2
808388|NCT02338843|2636442|P1|Overall Study|Withdrawal by Subject|0
808389|NCT02338843|2636441|P2|Overall Study|Physician Decision|0
808390|NCT02338843|2636442|P1|Overall Study|Physician Decision|1
808391|NCT02338843|2636441|P2|Overall Study|Death|53
808392|NCT02338843|2636442|P1|Overall Study|Death|40
808393|NCT02338843|2636441|P2|Overall Study|Adverse Event|1
808394|NCT02338843|2636442|P1|Overall Study|Adverse Event|2
808395|NCT02338492|2636470|P1|Overall Study|Reason not captured above|6
808396|NCT02338492|2636470|P1|Overall Study|Lost to Follow-up|4
808397|NCT02338492|2636470|P1|Overall Study|Adverse Event|3
808398|NCT02338492|2636470|P1|Overall Study|Death|32
808399|NCT02337907|2636531|P6|Overall Study|Adverse Event|0
808400|NCT02337907|2636532|P5|Overall Study|Adverse Event|4
808401|NCT02337907|2636533|P4|Overall Study|Adverse Event|1
808402|NCT02337907|2636534|P3|Overall Study|Adverse Event|1
808403|NCT02337907|2636535|P2|Overall Study|Adverse Event|1
808404|NCT02337907|2636536|P1|Overall Study|Adverse Event|1
808405|NCT02337907|2636531|P6|Overall Study|Lost to Follow-up|1
808406|NCT02337907|2636532|P5|Overall Study|Lost to Follow-up|0
808407|NCT02337907|2636533|P4|Overall Study|Lost to Follow-up|0
808408|NCT02337907|2636534|P3|Overall Study|Lost to Follow-up|0
808409|NCT02337907|2636535|P2|Overall Study|Lost to Follow-up|0
808410|NCT02337907|2636536|P1|Overall Study|Lost to Follow-up|0
808411|NCT02337907|2636531|P6|Overall Study|Withdrawal by Subject|0
808412|NCT02337907|2636532|P5|Overall Study|Withdrawal by Subject|5
808413|NCT02337907|2636533|P4|Overall Study|Withdrawal by Subject|2
808414|NCT02337907|2636534|P3|Overall Study|Withdrawal by Subject|0
808415|NCT02337907|2636535|P2|Overall Study|Withdrawal by Subject|3
808416|NCT02337907|2636536|P1|Overall Study|Withdrawal by Subject|2
808417|NCT02337907|2636531|P6|Overall Study|Other than listed|0
808418|NCT02337907|2636532|P5|Overall Study|Other than listed|1
808419|NCT02337907|2636533|P4|Overall Study|Other than listed|1
808420|NCT02337907|2636534|P3|Overall Study|Other than listed|0
808421|NCT02337907|2636535|P2|Overall Study|Other than listed|0
808422|NCT02337907|2636536|P1|Overall Study|Other than listed|1
808423|NCT02337491|2636573|P2|Overall Study|On Treatment|0
808424|NCT02337491|2636574|P1|Overall Study|On Treatment|2
808425|NCT02337491|2636573|P2|Overall Study|Progressive Disease|28
808426|NCT02337491|2636574|P1|Overall Study|Progressive Disease|44
808427|NCT02337491|2636573|P2|Overall Study|Withdrawal by Subject|0
808428|NCT02337491|2636574|P1|Overall Study|Withdrawal by Subject|3
808429|NCT02337491|2636573|P2|Overall Study|Adverse Event|1
808430|NCT02337491|2636574|P1|Overall Study|Adverse Event|0
808431|NCT02337491|2636573|P2|Overall Study|Death|1
808432|NCT02337491|2636574|P1|Overall Study|Death|1
808433|NCT02336607|2636622|P4|Overall Study|Withdrawal by Subject|20
808434|NCT02336607|2636623|P3|Overall Study|Withdrawal by Subject|0
808435|NCT02336607|2636624|P2|Overall Study|Withdrawal by Subject|2
808436|NCT02336607|2636625|P1|Overall Study|Withdrawal by Subject|0
808437|NCT02336607|2636622|P4|Overall Study|Adverse Event|26
808438|NCT02336607|2636623|P3|Overall Study|Adverse Event|2
808439|NCT02336607|2636624|P2|Overall Study|Adverse Event|2
808440|NCT02336607|2636625|P1|Overall Study|Adverse Event|0
808441|NCT02336607|2636622|P4|Overall Study|Protocol Violation|3
808442|NCT02336607|2636623|P3|Overall Study|Protocol Violation|1
808443|NCT02336607|2636624|P2|Overall Study|Protocol Violation|1
808444|NCT02336607|2636625|P1|Overall Study|Protocol Violation|0
808445|NCT02336607|2636622|P4|Overall Study|Lost to Follow-up|21
808446|NCT02336607|2636623|P3|Overall Study|Lost to Follow-up|0
808447|NCT02336607|2636624|P2|Overall Study|Lost to Follow-up|1
808448|NCT02336607|2636625|P1|Overall Study|Lost to Follow-up|2
808449|NCT02336607|2636622|P4|Overall Study|Lack of Efficacy|2
808450|NCT02336607|2636623|P3|Overall Study|Lack of Efficacy|0
808451|NCT02336607|2636624|P2|Overall Study|Lack of Efficacy|0
808452|NCT02336607|2636625|P1|Overall Study|Lack of Efficacy|1
808453|NCT02336607|2636622|P4|Overall Study|Physician Decision|15
808454|NCT02336607|2636623|P3|Overall Study|Physician Decision|3
808455|NCT02336607|2636624|P2|Overall Study|Physician Decision|4
808456|NCT02336607|2636625|P1|Overall Study|Physician Decision|1
808457|NCT02336425|2636739|P4|Overall Study|Study terminated.|3
808458|NCT02336425|2636740|P3|Overall Study|Study terminated.|3
808459|NCT02336425|2636741|P2|Overall Study|Study terminated.|2
808460|NCT02336425|2636742|P1|Overall Study|Study terminated.|2
808461|NCT02336282|2636792|P1|Overall Study|Not enough time to complete sessions|2
808462|NCT02336282|2636792|P1|Overall Study|Lost to Follow-up|1
808463|NCT02336282|2636792|P1|Overall Study|Uncomfortable with technology|1
808464|NCT02336282|2636792|P1|Overall Study|Unrelated illness|1
808465|NCT02336178|2636816|P1|Overall Study|Other|1
808466|NCT02336178|2636816|P1|Overall Study|Withdrawal by Subject|1
808467|NCT02336178|2636816|P1|Overall Study|Protocol Violation|1
808468|NCT02336178|2636816|P1|Overall Study|Lost to Follow-up|1
808469|NCT02335489|2636930|P1|Overall Study|Lack of Efficacy|1
808470|NCT02335489|2636930|P1|Overall Study|Physician Decision|2
808471|NCT02335489|2636930|P1|Overall Study|Withdrawal by Subject|2
808472|NCT02335489|2636930|P1|Overall Study|Lost to Follow-up|1
808473|NCT02335489|2636930|P1|Overall Study|Sponsor terminated study|4
808474|NCT02335346|2636934|P1|Overall Study|Withdrawal by Subject|1
808475|NCT02335346|2636934|P1|Overall Study|Adverse Event|11
808476|NCT02334384|2637214|P2|Overall Study|Lost to Follow-up|1
808477|NCT02334384|2637215|P1|Overall Study|Lost to Follow-up|1
808478|NCT02332889|2637254|P1|Overall Study|Physician Decision|1
808479|NCT02332876|2637260|P2|Overall Study|Lost to Follow-up|1
808480|NCT02332876|2637261|P1|Overall Study|Lost to Follow-up|1
808481|NCT02332824|2637273|P6|Overall Study|Transfer|0
808482|NCT02332824|2637274|P5|Overall Study|Transfer|0
808483|NCT02332824|2637275|P4|Overall Study|Transfer|1
808484|NCT02332824|2637276|P3|Overall Study|Transfer|1
808485|NCT02332824|2637277|P2|Overall Study|Transfer|0
808486|NCT02332824|2637278|P1|Overall Study|Transfer|0
808487|NCT02332824|2637273|P6|Overall Study|Inconvenient schedule|0
808488|NCT02332824|2637274|P5|Overall Study|Inconvenient schedule|0
808489|NCT02332824|2637275|P4|Overall Study|Inconvenient schedule|0
808490|NCT02332824|2637276|P3|Overall Study|Inconvenient schedule|0
808491|NCT02332824|2637277|P2|Overall Study|Inconvenient schedule|1
808492|NCT02332824|2637278|P1|Overall Study|Inconvenient schedule|1
808493|NCT02332824|2637273|P6|Overall Study|Voluntary Withdrawal|0
808494|NCT02332824|2637274|P5|Overall Study|Voluntary Withdrawal|0
808495|NCT02332824|2637275|P4|Overall Study|Voluntary Withdrawal|0
808496|NCT02332824|2637276|P3|Overall Study|Voluntary Withdrawal|0
808497|NCT02332824|2637277|P2|Overall Study|Voluntary Withdrawal|0
808498|NCT02332824|2637278|P1|Overall Study|Voluntary Withdrawal|1
808499|NCT02332824|2637273|P6|Overall Study|Pretreatment Event/Adverse Event|1
808500|NCT02332824|2637274|P5|Overall Study|Pretreatment Event/Adverse Event|4
808501|NCT02332824|2637275|P4|Overall Study|Pretreatment Event/Adverse Event|1
808502|NCT02332824|2637276|P3|Overall Study|Pretreatment Event/Adverse Event|1
808503|NCT02332824|2637277|P2|Overall Study|Pretreatment Event/Adverse Event|0
808504|NCT02332824|2637278|P1|Overall Study|Pretreatment Event/Adverse Event|4
808505|NCT02332798|2637319|P3|Overall Study|Abnormal laboratory findings|0
808506|NCT02332798|2637320|P2|Overall Study|Abnormal laboratory findings|0
808507|NCT02332798|2637321|P1|Overall Study|Abnormal laboratory findings|1
808508|NCT02332798|2637319|P3|Overall Study|Positive urine drug test|0
808509|NCT02332798|2637320|P2|Overall Study|Positive urine drug test|1
808510|NCT02332798|2637321|P1|Overall Study|Positive urine drug test|0
808511|NCT02332798|2637319|P3|Overall Study|Unwilling to participate in study|1
808512|NCT02332798|2637320|P2|Overall Study|Unwilling to participate in study|1
808513|NCT02332798|2637321|P1|Overall Study|Unwilling to participate in study|0
808514|NCT02332720|2637394|P23|Part A and Part B|Withdrawal by Subject|0
808515|NCT02332720|2637395|P22|Part A and Part B|Withdrawal by Subject|0
808516|NCT02332720|2637396|P21|Part A and Part B|Withdrawal by Subject|0
808517|NCT02332720|2637397|P20|Part A and Part B|Withdrawal by Subject|1
808518|NCT02332720|2637398|P19|Part A and Part B|Withdrawal by Subject|0
808519|NCT02332720|2637399|P18|Part A and Part B|Withdrawal by Subject|0
808520|NCT02332720|2637400|P17|Part A and Part B|Withdrawal by Subject|0
808521|NCT02332720|2637401|P16|Part A and Part B|Withdrawal by Subject|0
808522|NCT02332720|2637402|P15|Part A and Part B|Withdrawal by Subject|0
808523|NCT02332720|2637403|P14|Part A and Part B|Withdrawal by Subject|0
808524|NCT02332720|2637404|P13|Part A and Part B|Withdrawal by Subject|0
808525|NCT02332720|2637405|P12|Part A and Part B|Withdrawal by Subject|0
808526|NCT02332720|2637406|P11|Part A and Part B|Withdrawal by Subject|0
808527|NCT02332720|2637407|P10|Part A and Part B|Withdrawal by Subject|0
808528|NCT02332720|2637408|P9|Part A and Part B|Withdrawal by Subject|0
808529|NCT02332720|2637409|P8|Part A and Part B|Withdrawal by Subject|0
808530|NCT02332720|2637410|P7|Part A and Part B|Withdrawal by Subject|0
808531|NCT02332720|2637411|P6|Part A and Part B|Withdrawal by Subject|1
808532|NCT02332720|2637412|P5|Part A and Part B|Withdrawal by Subject|0
808533|NCT02332720|2637413|P4|Part A and Part B|Withdrawal by Subject|0
808534|NCT02332720|2637414|P3|Part A and Part B|Withdrawal by Subject|0
808535|NCT02332720|2637415|P2|Part A and Part B|Withdrawal by Subject|0
808536|NCT02332720|2637416|P1|Part A and Part B|Withdrawal by Subject|0
808537|NCT02332720|2637394|P23|Part A and Part B|Physician Decision|0
808538|NCT02332720|2637395|P22|Part A and Part B|Physician Decision|0
808539|NCT02332720|2637396|P21|Part A and Part B|Physician Decision|0
808540|NCT02332720|2637397|P20|Part A and Part B|Physician Decision|0
808541|NCT02332720|2637398|P19|Part A and Part B|Physician Decision|1
808542|NCT02332720|2637399|P18|Part A and Part B|Physician Decision|0
808543|NCT02332720|2637400|P17|Part A and Part B|Physician Decision|0
808544|NCT02332720|2637401|P16|Part A and Part B|Physician Decision|0
808545|NCT02332720|2637402|P15|Part A and Part B|Physician Decision|0
808546|NCT02332720|2637403|P14|Part A and Part B|Physician Decision|0
808547|NCT02332720|2637404|P13|Part A and Part B|Physician Decision|0
808548|NCT02332720|2637405|P12|Part A and Part B|Physician Decision|0
808549|NCT02332720|2637406|P11|Part A and Part B|Physician Decision|0
808550|NCT02332720|2637407|P10|Part A and Part B|Physician Decision|0
808551|NCT02332720|2637408|P9|Part A and Part B|Physician Decision|0
808552|NCT02332720|2637409|P8|Part A and Part B|Physician Decision|0
808553|NCT02332720|2637410|P7|Part A and Part B|Physician Decision|0
808554|NCT02332720|2637411|P6|Part A and Part B|Physician Decision|0
808555|NCT02332720|2637412|P5|Part A and Part B|Physician Decision|0
808556|NCT02332720|2637413|P4|Part A and Part B|Physician Decision|0
808557|NCT02332720|2637414|P3|Part A and Part B|Physician Decision|0
808558|NCT02332720|2637415|P2|Part A and Part B|Physician Decision|0
808559|NCT02332720|2637416|P1|Part A and Part B|Physician Decision|0
808560|NCT02332720|2637394|P23|Part A and Part B|Adverse Event|0
808561|NCT02332720|2637395|P22|Part A and Part B|Adverse Event|0
808562|NCT02332720|2637396|P21|Part A and Part B|Adverse Event|0
808563|NCT02332720|2637397|P20|Part A and Part B|Adverse Event|0
808564|NCT02332720|2637398|P19|Part A and Part B|Adverse Event|0
808565|NCT02332720|2637399|P18|Part A and Part B|Adverse Event|1
808566|NCT02332720|2637400|P17|Part A and Part B|Adverse Event|0
808567|NCT02332720|2637401|P16|Part A and Part B|Adverse Event|0
808568|NCT02332720|2637402|P15|Part A and Part B|Adverse Event|0
808569|NCT02332720|2637403|P14|Part A and Part B|Adverse Event|0
808570|NCT02332720|2637404|P13|Part A and Part B|Adverse Event|0
808571|NCT02332720|2637405|P12|Part A and Part B|Adverse Event|0
808572|NCT02332720|2637406|P11|Part A and Part B|Adverse Event|0
808573|NCT02332720|2637407|P10|Part A and Part B|Adverse Event|0
808574|NCT02332720|2637408|P9|Part A and Part B|Adverse Event|0
808575|NCT02332720|2637409|P8|Part A and Part B|Adverse Event|0
808576|NCT02332720|2637410|P7|Part A and Part B|Adverse Event|0
808577|NCT02332720|2637411|P6|Part A and Part B|Adverse Event|0
808578|NCT02332720|2637412|P5|Part A and Part B|Adverse Event|0
808579|NCT02332720|2637413|P4|Part A and Part B|Adverse Event|0
808580|NCT02332720|2637414|P3|Part A and Part B|Adverse Event|0
808581|NCT02332720|2637415|P2|Part A and Part B|Adverse Event|0
808582|NCT02332720|2637416|P1|Part A and Part B|Adverse Event|0
808583|NCT02332720|2637394|P23|Part A and Part B|Lost to Follow-up|0
808584|NCT02332720|2637395|P22|Part A and Part B|Lost to Follow-up|0
808585|NCT02332720|2637396|P21|Part A and Part B|Lost to Follow-up|0
808586|NCT02332720|2637397|P20|Part A and Part B|Lost to Follow-up|0
808587|NCT02332720|2637398|P19|Part A and Part B|Lost to Follow-up|0
808588|NCT02332720|2637399|P18|Part A and Part B|Lost to Follow-up|0
808589|NCT02332720|2637400|P17|Part A and Part B|Lost to Follow-up|0
808590|NCT02332720|2637401|P16|Part A and Part B|Lost to Follow-up|1
808591|NCT02332720|2637402|P15|Part A and Part B|Lost to Follow-up|0
808592|NCT02332720|2637403|P14|Part A and Part B|Lost to Follow-up|0
808593|NCT02332720|2637404|P13|Part A and Part B|Lost to Follow-up|0
808594|NCT02332720|2637405|P12|Part A and Part B|Lost to Follow-up|0
808595|NCT02332720|2637406|P11|Part A and Part B|Lost to Follow-up|0
808596|NCT02332720|2637407|P10|Part A and Part B|Lost to Follow-up|0
808597|NCT02332720|2637408|P9|Part A and Part B|Lost to Follow-up|0
808598|NCT02332720|2637409|P8|Part A and Part B|Lost to Follow-up|1
808599|NCT02332720|2637410|P7|Part A and Part B|Lost to Follow-up|1
808600|NCT02332720|2637411|P6|Part A and Part B|Lost to Follow-up|2
808601|NCT02332720|2637412|P5|Part A and Part B|Lost to Follow-up|0
808602|NCT02332720|2637413|P4|Part A and Part B|Lost to Follow-up|0
808603|NCT02332720|2637414|P3|Part A and Part B|Lost to Follow-up|0
808604|NCT02332720|2637415|P2|Part A and Part B|Lost to Follow-up|0
808605|NCT02332720|2637416|P1|Part A and Part B|Lost to Follow-up|1
808606|NCT02332707|2637552|P18|Overall Study|Withdrawal by Subject|0
808607|NCT02332707|2637553|P17|Overall Study|Withdrawal by Subject|0
808608|NCT02332707|2637554|P16|Overall Study|Withdrawal by Subject|0
808609|NCT02332707|2637555|P15|Overall Study|Withdrawal by Subject|0
808610|NCT02332707|2637556|P14|Overall Study|Withdrawal by Subject|0
808611|NCT02332707|2637557|P13|Overall Study|Withdrawal by Subject|0
808612|NCT02332707|2637558|P12|Overall Study|Withdrawal by Subject|0
808613|NCT02332707|2637559|P11|Overall Study|Withdrawal by Subject|0
808614|NCT02332707|2637560|P10|Overall Study|Withdrawal by Subject|3
808615|NCT02332707|2637561|P9|Overall Study|Withdrawal by Subject|0
808616|NCT02332707|2637562|P8|Overall Study|Withdrawal by Subject|0
808617|NCT02332707|2637563|P7|Overall Study|Withdrawal by Subject|0
808618|NCT02332707|2637564|P6|Overall Study|Withdrawal by Subject|0
808619|NCT02332707|2637565|P5|Overall Study|Withdrawal by Subject|0
808620|NCT02332707|2637566|P4|Overall Study|Withdrawal by Subject|0
808621|NCT02332707|2637567|P3|Overall Study|Withdrawal by Subject|1
808622|NCT02332707|2637568|P2|Overall Study|Withdrawal by Subject|0
808623|NCT02332707|2637569|P1|Overall Study|Withdrawal by Subject|0
808624|NCT02332707|2637552|P18|Overall Study|Physician Decision|0
808625|NCT02332707|2637553|P17|Overall Study|Physician Decision|0
808626|NCT02332707|2637554|P16|Overall Study|Physician Decision|0
808627|NCT02332707|2637555|P15|Overall Study|Physician Decision|0
808628|NCT02332707|2637556|P14|Overall Study|Physician Decision|0
808629|NCT02332707|2637557|P13|Overall Study|Physician Decision|1
808630|NCT02332707|2637558|P12|Overall Study|Physician Decision|0
808631|NCT02332707|2637559|P11|Overall Study|Physician Decision|0
808632|NCT02332707|2637560|P10|Overall Study|Physician Decision|0
808633|NCT02332707|2637561|P9|Overall Study|Physician Decision|0
808634|NCT02332707|2637562|P8|Overall Study|Physician Decision|0
808635|NCT02332707|2637563|P7|Overall Study|Physician Decision|0
808636|NCT02332707|2637564|P6|Overall Study|Physician Decision|0
808637|NCT02332707|2637565|P5|Overall Study|Physician Decision|0
808638|NCT02332707|2637566|P4|Overall Study|Physician Decision|1
808639|NCT02332707|2637567|P3|Overall Study|Physician Decision|0
808640|NCT02332707|2637568|P2|Overall Study|Physician Decision|0
808641|NCT02332707|2637569|P1|Overall Study|Physician Decision|0
808642|NCT02332707|2637552|P18|Overall Study|Lost to Follow-up|0
808643|NCT02332707|2637553|P17|Overall Study|Lost to Follow-up|0
808644|NCT02332707|2637554|P16|Overall Study|Lost to Follow-up|0
808645|NCT02332707|2637555|P15|Overall Study|Lost to Follow-up|0
808646|NCT02332707|2637556|P14|Overall Study|Lost to Follow-up|0
808647|NCT02332707|2637557|P13|Overall Study|Lost to Follow-up|3
808648|NCT02332707|2637558|P12|Overall Study|Lost to Follow-up|0
808649|NCT02332707|2637559|P11|Overall Study|Lost to Follow-up|2
808650|NCT02332707|2637560|P10|Overall Study|Lost to Follow-up|0
808651|NCT02332707|2637561|P9|Overall Study|Lost to Follow-up|0
808652|NCT02332707|2637562|P8|Overall Study|Lost to Follow-up|0
808653|NCT02332707|2637563|P7|Overall Study|Lost to Follow-up|0
808654|NCT02332707|2637564|P6|Overall Study|Lost to Follow-up|1
808655|NCT02332707|2637565|P5|Overall Study|Lost to Follow-up|0
808656|NCT02332707|2637566|P4|Overall Study|Lost to Follow-up|0
808657|NCT02332707|2637567|P3|Overall Study|Lost to Follow-up|0
808658|NCT02332707|2637568|P2|Overall Study|Lost to Follow-up|0
808659|NCT02332707|2637569|P1|Overall Study|Lost to Follow-up|0
808660|NCT02332707|2637552|P18|Overall Study|Adverse Event|0
808661|NCT02332707|2637553|P17|Overall Study|Adverse Event|0
808662|NCT02332707|2637554|P16|Overall Study|Adverse Event|0
808663|NCT02332707|2637555|P15|Overall Study|Adverse Event|0
808664|NCT02332707|2637556|P14|Overall Study|Adverse Event|0
808665|NCT02332707|2637557|P13|Overall Study|Adverse Event|1
808666|NCT02332707|2637558|P12|Overall Study|Adverse Event|0
808667|NCT02332707|2637559|P11|Overall Study|Adverse Event|0
808668|NCT02332707|2637560|P10|Overall Study|Adverse Event|0
808669|NCT02332707|2637561|P9|Overall Study|Adverse Event|0
808670|NCT02332707|2637562|P8|Overall Study|Adverse Event|0
808671|NCT02332707|2637563|P7|Overall Study|Adverse Event|0
808672|NCT02332707|2637564|P6|Overall Study|Adverse Event|0
808673|NCT02332707|2637565|P5|Overall Study|Adverse Event|0
808674|NCT02332707|2637566|P4|Overall Study|Adverse Event|0
808675|NCT02332707|2637567|P3|Overall Study|Adverse Event|0
808676|NCT02332707|2637568|P2|Overall Study|Adverse Event|0
808677|NCT02332707|2637569|P1|Overall Study|Adverse Event|0
808678|NCT02332590|2637663|P2|Overall Study|Other than specified above|5
808679|NCT02332590|2637664|P1|Overall Study|Other than specified above|6
808680|NCT02332590|2637663|P2|Overall Study|Randomized but not treated|0
808681|NCT02332590|2637664|P1|Overall Study|Randomized but not treated|1
808682|NCT02332590|2637663|P2|Overall Study|Poor compliance to protocol|1
808683|NCT02332590|2637664|P1|Overall Study|Poor compliance to protocol|3
808684|NCT02332590|2637663|P2|Overall Study|Lack of Efficacy|2
808685|NCT02332590|2637664|P1|Overall Study|Lack of Efficacy|4
808686|NCT02332590|2637663|P2|Overall Study|Adverse Event|11
808687|NCT02332590|2637664|P1|Overall Study|Adverse Event|15
808688|NCT02332239|2637728|P2|Overall Study|Lost to Follow-up|6
808689|NCT02332239|2637729|P1|Overall Study|Lost to Follow-up|4
808690|NCT02331446|2637781|P4|Overall Study|Lost before baseline analysis|0
808691|NCT02331446|2637782|P3|Overall Study|Lost before baseline analysis|1
808692|NCT02331446|2637783|P2|Overall Study|Lost before baseline analysis|1
808693|NCT02331446|2637784|P1|Overall Study|Lost before baseline analysis|0
808694|NCT02331446|2637781|P4|Overall Study|Physician Decision|1
808695|NCT02331446|2637782|P3|Overall Study|Physician Decision|0
808696|NCT02331446|2637783|P2|Overall Study|Physician Decision|1
808697|NCT02331446|2637784|P1|Overall Study|Physician Decision|0
808698|NCT02331446|2637781|P4|Overall Study|Disease|1
808699|NCT02331446|2637782|P3|Overall Study|Disease|2
808700|NCT02331446|2637783|P2|Overall Study|Disease|2
808701|NCT02331446|2637784|P1|Overall Study|Disease|0
808702|NCT02331446|2637781|P4|Overall Study|Personal Problem|0
808703|NCT02331446|2637782|P3|Overall Study|Personal Problem|0
808704|NCT02331446|2637783|P2|Overall Study|Personal Problem|0
808705|NCT02331446|2637784|P1|Overall Study|Personal Problem|2
808706|NCT02331446|2637781|P4|Overall Study|Lost to Follow-up|1
808707|NCT02331446|2637782|P3|Overall Study|Lost to Follow-up|0
808708|NCT02331446|2637783|P2|Overall Study|Lost to Follow-up|1
808709|NCT02331446|2637784|P1|Overall Study|Lost to Follow-up|2
808710|NCT02331368|2637854|P1|Overall Study|Withdrawal by Subject|3
808711|NCT02330055|2637978|P2|Overall Study|participant did not sleep|1
808712|NCT02330055|2637979|P1|Overall Study|participant did not sleep|0
808713|NCT02330055|2637978|P2|Overall Study|data for less than 60 minutes|3
808714|NCT02330055|2637979|P1|Overall Study|data for less than 60 minutes|3
808715|NCT02330055|2637978|P2|Overall Study|participant forgot to wear device|5
808716|NCT02330055|2637979|P1|Overall Study|participant forgot to wear device|5
808717|NCT02330055|2637978|P2|Overall Study|technical issues|0
808718|NCT02330055|2637979|P1|Overall Study|technical issues|2
808719|NCT02329730|2638026|P12|Overall Study|Withdrawal by Subject|0
808720|NCT02329730|2638027|P11|Overall Study|Withdrawal by Subject|0
808721|NCT02329730|2638028|P10|Overall Study|Withdrawal by Subject|1
808722|NCT02329730|2638029|P9|Overall Study|Withdrawal by Subject|1
808723|NCT02329730|2638030|P8|Overall Study|Withdrawal by Subject|1
808724|NCT02329730|2638031|P7|Overall Study|Withdrawal by Subject|1
808725|NCT02329730|2638032|P6|Overall Study|Withdrawal by Subject|0
808726|NCT02329730|2638033|P5|Overall Study|Withdrawal by Subject|1
808727|NCT02329730|2638034|P4|Overall Study|Withdrawal by Subject|0
808728|NCT02329730|2638035|P3|Overall Study|Withdrawal by Subject|0
808729|NCT02329730|2638036|P2|Overall Study|Withdrawal by Subject|0
808730|NCT02329730|2638037|P1|Overall Study|Withdrawal by Subject|0
808731|NCT02329730|2638026|P12|Overall Study|Protocol Violation|0
808732|NCT02329730|2638027|P11|Overall Study|Protocol Violation|0
808733|NCT02329730|2638028|P10|Overall Study|Protocol Violation|0
808734|NCT02329730|2638029|P9|Overall Study|Protocol Violation|0
808735|NCT02329730|2638030|P8|Overall Study|Protocol Violation|0
808736|NCT02329730|2638031|P7|Overall Study|Protocol Violation|0
808737|NCT02329730|2638032|P6|Overall Study|Protocol Violation|2
808738|NCT02329730|2638033|P5|Overall Study|Protocol Violation|2
808739|NCT02329730|2638034|P4|Overall Study|Protocol Violation|0
808740|NCT02329730|2638035|P3|Overall Study|Protocol Violation|0
808741|NCT02329730|2638036|P2|Overall Study|Protocol Violation|0
808742|NCT02329730|2638037|P1|Overall Study|Protocol Violation|0
808743|NCT02329431|2638148|P2|Overall Study|Lost to Follow-up|13
808744|NCT02329431|2638149|P1|Overall Study|Lost to Follow-up|20
808745|NCT02329223|2638168|P3|Overall Study|Adverse Event|0
808746|NCT02329223|2638169|P2|Overall Study|Adverse Event|1
808747|NCT02329223|2638170|P1|Overall Study|Adverse Event|0
808748|NCT02329223|2638168|P3|Overall Study|Physician Decision|1
808749|NCT02329223|2638169|P2|Overall Study|Physician Decision|0
808750|NCT02329223|2638170|P1|Overall Study|Physician Decision|0
808751|NCT02329223|2638168|P3|Overall Study|Withdrawal by Subject|5
808752|NCT02329223|2638169|P2|Overall Study|Withdrawal by Subject|2
808753|NCT02329223|2638170|P1|Overall Study|Withdrawal by Subject|1
808754|NCT02328937|2638220|P6|Period 2|Adverse Event|0
808755|NCT02328937|2638221|P5|Period 2|Adverse Event|0
808756|NCT02328937|2638222|P4|Period 2|Adverse Event|0
808757|NCT02328937|2638223|P3|Period 2|Adverse Event|1
808758|NCT02328937|2638224|P2|Period 2|Adverse Event|0
808759|NCT02328937|2638225|P1|Period 2|Adverse Event|0
808760|NCT02328937|2638220|P6|Period 1|Lost to Follow-up|0
808761|NCT02328937|2638221|P5|Period 1|Lost to Follow-up|0
808762|NCT02328937|2638222|P4|Period 1|Lost to Follow-up|1
808763|NCT02328937|2638223|P3|Period 1|Lost to Follow-up|0
808764|NCT02328937|2638224|P2|Period 1|Lost to Follow-up|0
808765|NCT02328937|2638225|P1|Period 1|Lost to Follow-up|0
808766|NCT02328105|2638273|P1|Overall Study|Still On Study in Follow-Up|4
808767|NCT02328105|2638273|P1|Overall Study|Withdrawal by Subject|1
808768|NCT02328105|2638273|P1|Overall Study|Death|6
808769|NCT02328040|2638278|P2|First Intervention (2 Days)|Withdrawal by Subject|1
808770|NCT02328040|2638279|P1|First Intervention (2 Days)|Withdrawal by Subject|1
808771|NCT02327325|2638310|P3|Overall Study|Excluded by Study Team|1
808772|NCT02327325|2638311|P2|Overall Study|Excluded by Study Team|0
808773|NCT02327325|2638312|P1|Overall Study|Excluded by Study Team|0
808774|NCT02327325|2638310|P3|Overall Study|Withdrawal by Subject|4
808775|NCT02327325|2638311|P2|Overall Study|Withdrawal by Subject|4
808776|NCT02327325|2638312|P1|Overall Study|Withdrawal by Subject|1
808777|NCT02327013|2638353|P5|Overall Study|Withdrawal before treatment|0
808778|NCT02327013|2638354|P4|Overall Study|Withdrawal before treatment|0
808779|NCT02327013|2638355|P3|Overall Study|Withdrawal before treatment|5
808780|NCT02327013|2638356|P2|Overall Study|Withdrawal before treatment|1
808781|NCT02327013|2638357|P1|Overall Study|Withdrawal before treatment|2
808782|NCT02327013|2638353|P5|Overall Study|Protocol Violation|1
808783|NCT02327013|2638354|P4|Overall Study|Protocol Violation|0
808784|NCT02327013|2638355|P3|Overall Study|Protocol Violation|3
808785|NCT02327013|2638356|P2|Overall Study|Protocol Violation|0
808786|NCT02327013|2638357|P1|Overall Study|Protocol Violation|0
808787|NCT02327013|2638353|P5|Overall Study|Administrative or other reason(s)|1
808788|NCT02327013|2638354|P4|Overall Study|Administrative or other reason(s)|1
808789|NCT02327013|2638355|P3|Overall Study|Administrative or other reason(s)|11
808790|NCT02327013|2638356|P2|Overall Study|Administrative or other reason(s)|5
808791|NCT02327013|2638357|P1|Overall Study|Administrative or other reason(s)|1
808792|NCT02327013|2638353|P5|Overall Study|Lost to Follow-up|0
808793|NCT02327013|2638354|P4|Overall Study|Lost to Follow-up|0
808794|NCT02327013|2638355|P3|Overall Study|Lost to Follow-up|5
808795|NCT02327013|2638356|P2|Overall Study|Lost to Follow-up|4
808796|NCT02327013|2638357|P1|Overall Study|Lost to Follow-up|2
808797|NCT02327013|2638353|P5|Overall Study|Withdrawal of Consent|0
808798|NCT02327013|2638354|P4|Overall Study|Withdrawal of Consent|0
808799|NCT02327013|2638355|P3|Overall Study|Withdrawal of Consent|3
808800|NCT02327013|2638356|P2|Overall Study|Withdrawal of Consent|0
808801|NCT02327013|2638357|P1|Overall Study|Withdrawal of Consent|1
808802|NCT02327013|2638353|P5|Overall Study|Non-compliance with IMP|0
808803|NCT02327013|2638354|P4|Overall Study|Non-compliance with IMP|0
808804|NCT02327013|2638355|P3|Overall Study|Non-compliance with IMP|7
808805|NCT02327013|2638356|P2|Overall Study|Non-compliance with IMP|2
808806|NCT02327013|2638357|P1|Overall Study|Non-compliance with IMP|1
808807|NCT02327013|2638353|P5|Overall Study|Lack of Efficacy|1
808808|NCT02327013|2638354|P4|Overall Study|Lack of Efficacy|0
808809|NCT02327013|2638355|P3|Overall Study|Lack of Efficacy|5
808810|NCT02327013|2638356|P2|Overall Study|Lack of Efficacy|0
808811|NCT02327013|2638357|P1|Overall Study|Lack of Efficacy|2
808812|NCT02327013|2638353|P5|Overall Study|Adverse Event|1
808813|NCT02327013|2638354|P4|Overall Study|Adverse Event|0
808814|NCT02327013|2638355|P3|Overall Study|Adverse Event|3
808815|NCT02327013|2638356|P2|Overall Study|Adverse Event|4
808816|NCT02327013|2638357|P1|Overall Study|Adverse Event|4
808817|NCT02326597|2638543|P2|Overall Study|Lost to Follow-up|32
808818|NCT02326597|2638544|P1|Overall Study|Lost to Follow-up|42
808819|NCT02326298|2638565|P10|Maintenance Period (Week 16 - Week 48)|Adverse Event|0
808820|NCT02326298|2638566|P9|Maintenance Period (Week 16 - Week 48)|Adverse Event|0
808821|NCT02326298|2638567|P8|Maintenance Period (Week 16 - Week 48)|Adverse Event|1
808822|NCT02326298|2638568|P7|Maintenance Period (Week 16 - Week 48)|Adverse Event|0
808823|NCT02326298|2638569|P6|Maintenance Period (Week 16 - Week 48)|Adverse Event|0
808824|NCT02326298|2638570|P5|Maintenance Period (Week 16 - Week 48)|Adverse Event|0
808825|NCT02326298|2638571|P4|Maintenance Period (Week 16 - Week 48)|Adverse Event|0
808826|NCT02326298|2638572|P3|Maintenance Period (Week 16 - Week 48)|Adverse Event|0
808827|NCT02326298|2638573|P2|Maintenance Period (Week 16 - Week 48)|Adverse Event|0
808828|NCT02326298|2638574|P1|Maintenance Period (Week 16 - Week 48)|Adverse Event|0
808829|NCT02326298|2638565|P10|Maintenance Period (Week 16 - Week 48)|Lost to Follow-up|0
808830|NCT02326298|2638566|P9|Maintenance Period (Week 16 - Week 48)|Lost to Follow-up|0
808831|NCT02326298|2638567|P8|Maintenance Period (Week 16 - Week 48)|Lost to Follow-up|2
808832|NCT02326298|2638568|P7|Maintenance Period (Week 16 - Week 48)|Lost to Follow-up|1
808833|NCT02326298|2638569|P6|Maintenance Period (Week 16 - Week 48)|Lost to Follow-up|0
808834|NCT02326298|2638570|P5|Maintenance Period (Week 16 - Week 48)|Lost to Follow-up|0
808835|NCT02326298|2638571|P4|Maintenance Period (Week 16 - Week 48)|Lost to Follow-up|0
808836|NCT02326298|2638572|P3|Maintenance Period (Week 16 - Week 48)|Lost to Follow-up|0
808837|NCT02326298|2638573|P2|Maintenance Period (Week 16 - Week 48)|Lost to Follow-up|0
808838|NCT02326298|2638574|P1|Maintenance Period (Week 16 - Week 48)|Lost to Follow-up|0
808839|NCT02326298|2638565|P10|Maintenance Period (Week 16 - Week 48)|No valid reason stated by patient|0
808840|NCT02326298|2638566|P9|Maintenance Period (Week 16 - Week 48)|No valid reason stated by patient|0
808841|NCT02326298|2638567|P8|Maintenance Period (Week 16 - Week 48)|No valid reason stated by patient|1
808842|NCT02326298|2638568|P7|Maintenance Period (Week 16 - Week 48)|No valid reason stated by patient|0
808843|NCT02326298|2638569|P6|Maintenance Period (Week 16 - Week 48)|No valid reason stated by patient|0
808844|NCT02326298|2638570|P5|Maintenance Period (Week 16 - Week 48)|No valid reason stated by patient|0
808845|NCT02326298|2638571|P4|Maintenance Period (Week 16 - Week 48)|No valid reason stated by patient|0
808846|NCT02326298|2638572|P3|Maintenance Period (Week 16 - Week 48)|No valid reason stated by patient|0
808847|NCT02326298|2638573|P2|Maintenance Period (Week 16 - Week 48)|No valid reason stated by patient|0
808848|NCT02326298|2638574|P1|Maintenance Period (Week 16 - Week 48)|No valid reason stated by patient|0
808849|NCT02326298|2638565|P10|Maintenance Period (Week 16 - Week 48)|Pregnancy|0
808850|NCT02326298|2638566|P9|Maintenance Period (Week 16 - Week 48)|Pregnancy|0
808851|NCT02326298|2638567|P8|Maintenance Period (Week 16 - Week 48)|Pregnancy|0
808852|NCT02326298|2638568|P7|Maintenance Period (Week 16 - Week 48)|Pregnancy|1
808853|NCT02326298|2638569|P6|Maintenance Period (Week 16 - Week 48)|Pregnancy|0
808854|NCT02326298|2638570|P5|Maintenance Period (Week 16 - Week 48)|Pregnancy|0
808855|NCT02326298|2638571|P4|Maintenance Period (Week 16 - Week 48)|Pregnancy|0
808856|NCT02326298|2638572|P3|Maintenance Period (Week 16 - Week 48)|Pregnancy|0
808857|NCT02326298|2638573|P2|Maintenance Period (Week 16 - Week 48)|Pregnancy|0
808858|NCT02326298|2638574|P1|Maintenance Period (Week 16 - Week 48)|Pregnancy|0
808859|NCT02326298|2638565|P10|Maintenance Period (Week 16 - Week 48)|Patient cannot attend visits|0
808860|NCT02326298|2638566|P9|Maintenance Period (Week 16 - Week 48)|Patient cannot attend visits|0
808861|NCT02326298|2638567|P8|Maintenance Period (Week 16 - Week 48)|Patient cannot attend visits|0
808862|NCT02326298|2638568|P7|Maintenance Period (Week 16 - Week 48)|Patient cannot attend visits|0
808863|NCT02326298|2638569|P6|Maintenance Period (Week 16 - Week 48)|Patient cannot attend visits|0
808864|NCT02326298|2638570|P5|Maintenance Period (Week 16 - Week 48)|Patient cannot attend visits|1
808865|NCT02326298|2638571|P4|Maintenance Period (Week 16 - Week 48)|Patient cannot attend visits|0
808866|NCT02326298|2638572|P3|Maintenance Period (Week 16 - Week 48)|Patient cannot attend visits|0
808867|NCT02326298|2638573|P2|Maintenance Period (Week 16 - Week 48)|Patient cannot attend visits|0
808868|NCT02326298|2638574|P1|Maintenance Period (Week 16 - Week 48)|Patient cannot attend visits|0
808869|NCT02326298|2638565|P10|Maintenance Period (Week 16 - Week 48)|Patient did not achieve PASI50 response|0
808870|NCT02326298|2638566|P9|Maintenance Period (Week 16 - Week 48)|Patient did not achieve PASI50 response|4
808871|NCT02326298|2638567|P8|Maintenance Period (Week 16 - Week 48)|Patient did not achieve PASI50 response|0
808872|NCT02326298|2638568|P7|Maintenance Period (Week 16 - Week 48)|Patient did not achieve PASI50 response|2
808873|NCT02326298|2638569|P6|Maintenance Period (Week 16 - Week 48)|Patient did not achieve PASI50 response|0
808874|NCT02326298|2638570|P5|Maintenance Period (Week 16 - Week 48)|Patient did not achieve PASI50 response|1
808875|NCT02326298|2638571|P4|Maintenance Period (Week 16 - Week 48)|Patient did not achieve PASI50 response|0
808876|NCT02326298|2638572|P3|Maintenance Period (Week 16 - Week 48)|Patient did not achieve PASI50 response|0
808877|NCT02326298|2638573|P2|Maintenance Period (Week 16 - Week 48)|Patient did not achieve PASI50 response|0
808878|NCT02326298|2638574|P1|Maintenance Period (Week 16 - Week 48)|Patient did not achieve PASI50 response|0
808879|NCT02326298|2638565|P10|Maintenance Period (Week 16 - Week 48)|Withdrawal by Subject|1
808880|NCT02326298|2638566|P9|Maintenance Period (Week 16 - Week 48)|Withdrawal by Subject|1
808881|NCT02326298|2638567|P8|Maintenance Period (Week 16 - Week 48)|Withdrawal by Subject|1
808882|NCT02326298|2638568|P7|Maintenance Period (Week 16 - Week 48)|Withdrawal by Subject|3
808883|NCT02326298|2638569|P6|Maintenance Period (Week 16 - Week 48)|Withdrawal by Subject|0
808884|NCT02326298|2638570|P5|Maintenance Period (Week 16 - Week 48)|Withdrawal by Subject|1
808885|NCT02326298|2638571|P4|Maintenance Period (Week 16 - Week 48)|Withdrawal by Subject|0
808886|NCT02326298|2638572|P3|Maintenance Period (Week 16 - Week 48)|Withdrawal by Subject|0
808887|NCT02326298|2638573|P2|Maintenance Period (Week 16 - Week 48)|Withdrawal by Subject|0
808888|NCT02326298|2638574|P1|Maintenance Period (Week 16 - Week 48)|Withdrawal by Subject|0
808889|NCT02326298|2638565|P10|Initial Period (Week 0/Baseline - Wk 16)|Withdrawal by Subject|0
808890|NCT02326298|2638566|P9|Initial Period (Week 0/Baseline - Wk 16)|Withdrawal by Subject|0
808891|NCT02326298|2638567|P8|Initial Period (Week 0/Baseline - Wk 16)|Withdrawal by Subject|0
808892|NCT02326298|2638568|P7|Initial Period (Week 0/Baseline - Wk 16)|Withdrawal by Subject|0
808893|NCT02326298|2638569|P6|Initial Period (Week 0/Baseline - Wk 16)|Withdrawal by Subject|0
808894|NCT02326298|2638570|P5|Initial Period (Week 0/Baseline - Wk 16)|Withdrawal by Subject|0
808895|NCT02326298|2638571|P4|Initial Period (Week 0/Baseline - Wk 16)|Withdrawal by Subject|0
808896|NCT02326298|2638572|P3|Initial Period (Week 0/Baseline - Wk 16)|Withdrawal by Subject|0
808897|NCT02326298|2638573|P2|Initial Period (Week 0/Baseline - Wk 16)|Withdrawal by Subject|2
808898|NCT02326298|2638574|P1|Initial Period (Week 0/Baseline - Wk 16)|Withdrawal by Subject|3
808899|NCT02326298|2638565|P10|Initial Period (Week 0/Baseline - Wk 16)|Lost to Follow-up|0
808900|NCT02326298|2638566|P9|Initial Period (Week 0/Baseline - Wk 16)|Lost to Follow-up|0
808901|NCT02326298|2638567|P8|Initial Period (Week 0/Baseline - Wk 16)|Lost to Follow-up|0
808902|NCT02326298|2638568|P7|Initial Period (Week 0/Baseline - Wk 16)|Lost to Follow-up|0
808903|NCT02326298|2638569|P6|Initial Period (Week 0/Baseline - Wk 16)|Lost to Follow-up|0
808904|NCT02326298|2638570|P5|Initial Period (Week 0/Baseline - Wk 16)|Lost to Follow-up|0
808905|NCT02326298|2638571|P4|Initial Period (Week 0/Baseline - Wk 16)|Lost to Follow-up|0
808906|NCT02326298|2638572|P3|Initial Period (Week 0/Baseline - Wk 16)|Lost to Follow-up|0
808907|NCT02326298|2638573|P2|Initial Period (Week 0/Baseline - Wk 16)|Lost to Follow-up|1
808908|NCT02326298|2638574|P1|Initial Period (Week 0/Baseline - Wk 16)|Lost to Follow-up|1
808909|NCT02326298|2638565|P10|Initial Period (Week 0/Baseline - Wk 16)|Lack of Efficacy|0
808910|NCT02326298|2638566|P9|Initial Period (Week 0/Baseline - Wk 16)|Lack of Efficacy|0
808911|NCT02326298|2638567|P8|Initial Period (Week 0/Baseline - Wk 16)|Lack of Efficacy|0
808912|NCT02326298|2638568|P7|Initial Period (Week 0/Baseline - Wk 16)|Lack of Efficacy|0
808913|NCT02326298|2638569|P6|Initial Period (Week 0/Baseline - Wk 16)|Lack of Efficacy|0
808914|NCT02326298|2638570|P5|Initial Period (Week 0/Baseline - Wk 16)|Lack of Efficacy|0
808915|NCT02326298|2638571|P4|Initial Period (Week 0/Baseline - Wk 16)|Lack of Efficacy|0
808916|NCT02326298|2638572|P3|Initial Period (Week 0/Baseline - Wk 16)|Lack of Efficacy|0
808917|NCT02326298|2638573|P2|Initial Period (Week 0/Baseline - Wk 16)|Lack of Efficacy|0
808918|NCT02326298|2638574|P1|Initial Period (Week 0/Baseline - Wk 16)|Lack of Efficacy|1
808919|NCT02326298|2638565|P10|Initial Period (Week 0/Baseline - Wk 16)|Adverse Event|0
808920|NCT02326298|2638566|P9|Initial Period (Week 0/Baseline - Wk 16)|Adverse Event|0
808921|NCT02326298|2638567|P8|Initial Period (Week 0/Baseline - Wk 16)|Adverse Event|0
808922|NCT02326298|2638568|P7|Initial Period (Week 0/Baseline - Wk 16)|Adverse Event|0
808923|NCT02326298|2638569|P6|Initial Period (Week 0/Baseline - Wk 16)|Adverse Event|0
808924|NCT02326298|2638570|P5|Initial Period (Week 0/Baseline - Wk 16)|Adverse Event|0
808925|NCT02326298|2638571|P4|Initial Period (Week 0/Baseline - Wk 16)|Adverse Event|0
808926|NCT02326298|2638572|P3|Initial Period (Week 0/Baseline - Wk 16)|Adverse Event|3
808927|NCT02326298|2638573|P2|Initial Period (Week 0/Baseline - Wk 16)|Adverse Event|0
808928|NCT02326298|2638574|P1|Initial Period (Week 0/Baseline - Wk 16)|Adverse Event|0
808929|NCT02326272|2638597|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
808930|NCT02326272|2638598|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
808931|NCT02326272|2638599|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
808932|NCT02326272|2638600|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
808933|NCT02326272|2638601|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
808934|NCT02326272|2638602|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
808935|NCT02326272|2638603|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
808936|NCT02326272|2638604|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
808937|NCT02326272|2638605|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
808938|NCT02326272|2638606|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
808939|NCT02326272|2638597|P10|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
808940|NCT02326272|2638598|P9|Maintenance Period (Week 16 to Week 48)|Non-compliance|1
808941|NCT02326272|2638599|P8|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
808942|NCT02326272|2638600|P7|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
808943|NCT02326272|2638601|P6|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
808944|NCT02326272|2638602|P5|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
808945|NCT02326272|2638603|P4|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
808946|NCT02326272|2638604|P3|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
808947|NCT02326272|2638605|P2|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
808948|NCT02326272|2638606|P1|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
808949|NCT02326272|2638597|P10|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
808950|NCT02326272|2638598|P9|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
808951|NCT02326272|2638599|P8|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
808952|NCT02326272|2638600|P7|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
808953|NCT02326272|2638601|P6|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
808954|NCT02326272|2638602|P5|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
808955|NCT02326272|2638603|P4|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
808956|NCT02326272|2638604|P3|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
808957|NCT02326272|2638605|P2|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
808958|NCT02326272|2638606|P1|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
808959|NCT02326272|2638597|P10|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
808960|NCT02326272|2638598|P9|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
808961|NCT02326272|2638599|P8|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1
808962|NCT02326272|2638600|P7|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
808963|NCT02326272|2638601|P6|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
808964|NCT02326272|2638602|P5|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
808965|NCT02326272|2638603|P4|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
808966|NCT02326272|2638604|P3|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
808967|NCT02326272|2638605|P2|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
808968|NCT02326272|2638606|P1|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
808969|NCT02326272|2638597|P10|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
808970|NCT02326272|2638598|P9|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
808971|NCT02326272|2638599|P8|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
808972|NCT02326272|2638600|P7|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
808973|NCT02326272|2638601|P6|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
808974|NCT02326272|2638602|P5|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
808975|NCT02326272|2638603|P4|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
808976|NCT02326272|2638604|P3|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
808977|NCT02326272|2638605|P2|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
808978|NCT02326272|2638606|P1|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
808979|NCT02326272|2638597|P10|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
808980|NCT02326272|2638598|P9|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
808981|NCT02326272|2638599|P8|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
808982|NCT02326272|2638600|P7|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
808983|NCT02326272|2638601|P6|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
808984|NCT02326272|2638602|P5|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
808985|NCT02326272|2638603|P4|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
808986|NCT02326272|2638604|P3|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
808987|NCT02326272|2638605|P2|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
808988|NCT02326272|2638606|P1|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
808989|NCT02326272|2638597|P10|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
808990|NCT02326272|2638598|P9|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
808991|NCT02326272|2638599|P8|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
808992|NCT02326272|2638600|P7|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
808993|NCT02326272|2638601|P6|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2
808994|NCT02326272|2638602|P5|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
808995|NCT02326272|2638603|P4|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
808996|NCT02326272|2638604|P3|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
808997|NCT02326272|2638605|P2|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
808998|NCT02326272|2638606|P1|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
808999|NCT02326272|2638597|P10|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
809000|NCT02326272|2638598|P9|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
809001|NCT02326272|2638599|P8|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
809002|NCT02326272|2638600|P7|Maintenance Period (Week 16 to Week 48)|Adverse Event|4
809003|NCT02326272|2638601|P6|Maintenance Period (Week 16 to Week 48)|Adverse Event|3
809004|NCT02326272|2638602|P5|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
809005|NCT02326272|2638603|P4|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
809006|NCT02326272|2638604|P3|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
809007|NCT02326272|2638605|P2|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
809008|NCT02326272|2638606|P1|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
809009|NCT02326272|2638597|P10|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
809010|NCT02326272|2638598|P9|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
809011|NCT02326272|2638599|P8|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
809012|NCT02326272|2638600|P7|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
809013|NCT02326272|2638601|P6|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
809014|NCT02326272|2638602|P5|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
809015|NCT02326272|2638603|P4|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
809016|NCT02326272|2638604|P3|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1
809017|NCT02326272|2638605|P2|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
809018|NCT02326272|2638606|P1|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
809019|NCT02326272|2638597|P10|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
809020|NCT02326272|2638598|P9|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
809021|NCT02326272|2638599|P8|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
809022|NCT02326272|2638600|P7|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
809023|NCT02326272|2638601|P6|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
809024|NCT02326272|2638602|P5|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
809025|NCT02326272|2638603|P4|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
809026|NCT02326272|2638604|P3|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1
809027|NCT02326272|2638605|P2|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
809028|NCT02326272|2638606|P1|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
809029|NCT02326272|2638597|P10|Initial Period (Week 0 to Week 16)|Missed two doses|0
809030|NCT02326272|2638598|P9|Initial Period (Week 0 to Week 16)|Missed two doses|0
809031|NCT02326272|2638599|P8|Initial Period (Week 0 to Week 16)|Missed two doses|0
809032|NCT02326272|2638600|P7|Initial Period (Week 0 to Week 16)|Missed two doses|0
809033|NCT02326272|2638601|P6|Initial Period (Week 0 to Week 16)|Missed two doses|0
809034|NCT02326272|2638602|P5|Initial Period (Week 0 to Week 16)|Missed two doses|0
809035|NCT02326272|2638603|P4|Initial Period (Week 0 to Week 16)|Missed two doses|0
809036|NCT02326272|2638604|P3|Initial Period (Week 0 to Week 16)|Missed two doses|1
809037|NCT02326272|2638605|P2|Initial Period (Week 0 to Week 16)|Missed two doses|0
809038|NCT02326272|2638606|P1|Initial Period (Week 0 to Week 16)|Missed two doses|0
809039|NCT02326272|2638597|P10|Initial Period (Week 0 to Week 16)|Moved from the study area|0
809040|NCT02326272|2638598|P9|Initial Period (Week 0 to Week 16)|Moved from the study area|0
809041|NCT02326272|2638599|P8|Initial Period (Week 0 to Week 16)|Moved from the study area|0
809042|NCT02326272|2638600|P7|Initial Period (Week 0 to Week 16)|Moved from the study area|0
809043|NCT02326272|2638601|P6|Initial Period (Week 0 to Week 16)|Moved from the study area|0
809044|NCT02326272|2638602|P5|Initial Period (Week 0 to Week 16)|Moved from the study area|0
809045|NCT02326272|2638603|P4|Initial Period (Week 0 to Week 16)|Moved from the study area|0
809046|NCT02326272|2638604|P3|Initial Period (Week 0 to Week 16)|Moved from the study area|1
809047|NCT02326272|2638605|P2|Initial Period (Week 0 to Week 16)|Moved from the study area|0
809048|NCT02326272|2638606|P1|Initial Period (Week 0 to Week 16)|Moved from the study area|0
809049|NCT02326272|2638597|P10|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
809050|NCT02326272|2638598|P9|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
809051|NCT02326272|2638599|P8|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
809052|NCT02326272|2638600|P7|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
809053|NCT02326272|2638601|P6|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
809054|NCT02326272|2638602|P5|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
809055|NCT02326272|2638603|P4|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
809056|NCT02326272|2638604|P3|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
809057|NCT02326272|2638605|P2|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
809058|NCT02326272|2638606|P1|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
809059|NCT02326272|2638597|P10|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
809060|NCT02326272|2638598|P9|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
809061|NCT02326272|2638599|P8|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
809062|NCT02326272|2638600|P7|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
809063|NCT02326272|2638601|P6|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
809064|NCT02326272|2638602|P5|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
809065|NCT02326272|2638603|P4|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
809066|NCT02326272|2638604|P3|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
809067|NCT02326272|2638605|P2|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2
809068|NCT02326272|2638606|P1|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
809069|NCT02326272|2638597|P10|Initial Period (Week 0 to Week 16)|Adverse Event|0
809070|NCT02326272|2638598|P9|Initial Period (Week 0 to Week 16)|Adverse Event|0
809071|NCT02326272|2638599|P8|Initial Period (Week 0 to Week 16)|Adverse Event|0
809072|NCT02326272|2638600|P7|Initial Period (Week 0 to Week 16)|Adverse Event|0
809073|NCT02326272|2638601|P6|Initial Period (Week 0 to Week 16)|Adverse Event|0
809074|NCT02326272|2638602|P5|Initial Period (Week 0 to Week 16)|Adverse Event|0
809075|NCT02326272|2638603|P4|Initial Period (Week 0 to Week 16)|Adverse Event|0
809076|NCT02326272|2638604|P3|Initial Period (Week 0 to Week 16)|Adverse Event|1
809077|NCT02326272|2638605|P2|Initial Period (Week 0 to Week 16)|Adverse Event|3
809078|NCT02326272|2638606|P1|Initial Period (Week 0 to Week 16)|Adverse Event|0
809079|NCT02325791|2638641|P4|Overall Study|Withdrawal by Subject|16
809080|NCT02325791|2638642|P3|Overall Study|Withdrawal by Subject|8
809081|NCT02325791|2638643|P2|Overall Study|Withdrawal by Subject|5
809082|NCT02325791|2638644|P1|Overall Study|Withdrawal by Subject|0
809083|NCT02325791|2638641|P4|Overall Study|Protocol Violation|0
809084|NCT02325791|2638642|P3|Overall Study|Protocol Violation|1
809085|NCT02325791|2638643|P2|Overall Study|Protocol Violation|0
809086|NCT02325791|2638644|P1|Overall Study|Protocol Violation|0
809087|NCT02325791|2638641|P4|Overall Study|Physician Decision|0
809088|NCT02325791|2638642|P3|Overall Study|Physician Decision|1
809089|NCT02325791|2638643|P2|Overall Study|Physician Decision|1
809090|NCT02325791|2638644|P1|Overall Study|Physician Decision|0
809091|NCT02325791|2638641|P4|Overall Study|Lost to Follow-up|9
809092|NCT02325791|2638642|P3|Overall Study|Lost to Follow-up|14
809093|NCT02325791|2638643|P2|Overall Study|Lost to Follow-up|15
809094|NCT02325791|2638644|P1|Overall Study|Lost to Follow-up|0
809095|NCT02325791|2638641|P4|Overall Study|Death|1
809096|NCT02325791|2638642|P3|Overall Study|Death|0
809097|NCT02325791|2638643|P2|Overall Study|Death|3
809098|NCT02325791|2638644|P1|Overall Study|Death|0
809099|NCT02325791|2638641|P4|Overall Study|Adverse Event|0
809100|NCT02325791|2638642|P3|Overall Study|Adverse Event|1
809101|NCT02325791|2638643|P2|Overall Study|Adverse Event|1
809102|NCT02325791|2638644|P1|Overall Study|Adverse Event|0
809103|NCT02325713|2638679|P16|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
809104|NCT02325713|2638680|P15|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
809105|NCT02325713|2638681|P14|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
809106|NCT02325713|2638682|P13|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
809107|NCT02325713|2638683|P12|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
809108|NCT02325713|2638684|P11|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
809109|NCT02325713|2638685|P10|Intervention Period 3 (2 Days)|Withdrawal by Subject|1
809110|NCT02325713|2638686|P9|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
809111|NCT02325713|2638687|P8|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
809112|NCT02325713|2638688|P7|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
809113|NCT02325713|2638689|P6|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
809114|NCT02325713|2638690|P5|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
809115|NCT02325713|2638691|P4|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
809116|NCT02325713|2638692|P3|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
809117|NCT02325713|2638693|P2|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
809118|NCT02325713|2638694|P1|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
809119|NCT02325713|2638679|P16|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
809120|NCT02325713|2638680|P15|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
809121|NCT02325713|2638681|P14|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
809122|NCT02325713|2638682|P13|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
809123|NCT02325713|2638683|P12|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
809124|NCT02325713|2638684|P11|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
809125|NCT02325713|2638685|P10|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
809126|NCT02325713|2638686|P9|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
809127|NCT02325713|2638687|P8|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
809128|NCT02325713|2638688|P7|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
809129|NCT02325713|2638689|P6|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
809130|NCT02325713|2638690|P5|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
809131|NCT02325713|2638691|P4|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
809132|NCT02325713|2638692|P3|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
809133|NCT02325713|2638693|P2|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
809134|NCT02325713|2638694|P1|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1
809135|NCT02325713|2638679|P16|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
809136|NCT02325713|2638680|P15|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
809137|NCT02325713|2638681|P14|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
809138|NCT02325713|2638682|P13|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
809139|NCT02325713|2638683|P12|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
809140|NCT02325713|2638684|P11|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1
809141|NCT02325713|2638685|P10|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
809142|NCT02325713|2638686|P9|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
809143|NCT02325713|2638687|P8|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
809144|NCT02325713|2638688|P7|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
809145|NCT02325713|2638689|P6|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
809146|NCT02325713|2638690|P5|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
809147|NCT02325713|2638691|P4|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
809148|NCT02325713|2638692|P3|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
809149|NCT02325713|2638693|P2|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
809150|NCT02325713|2638694|P1|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
809151|NCT02325518|2638789|P2|Overall Study|Withdrawal by Subject|1
809152|NCT02325518|2638790|P1|Overall Study|Withdrawal by Subject|0
809153|NCT02325518|2638789|P2|Overall Study|Physician Decision|1
809154|NCT02325518|2638790|P1|Overall Study|Physician Decision|0
809155|NCT02325518|2638789|P2|Overall Study|Adverse Event|1
809156|NCT02325518|2638790|P1|Overall Study|Adverse Event|4
809157|NCT02324049|2638934|P1|Part C|Study terminated|11
809158|NCT02322892|2638967|P2|Overall Study|Protocol Violation|0
809159|NCT02322892|2638968|P1|Overall Study|Protocol Violation|1
809160|NCT02322892|2638967|P2|Overall Study|Met exclusion criteria|1
809161|NCT02322892|2638968|P1|Overall Study|Met exclusion criteria|0
809162|NCT02322892|2638967|P2|Overall Study|Surgery cancelled|2
809163|NCT02322892|2638968|P1|Overall Study|Surgery cancelled|1
809164|NCT02322879|2638984|P2|First Intervention|Physician Decision|0
809165|NCT02322879|2638985|P1|First Intervention|Physician Decision|1
809166|NCT02322866|2638993|P2|Overall Study|Other Miscellaneous Reasons|6
809167|NCT02322866|2638994|P1|Overall Study|Other Miscellaneous Reasons|6
809168|NCT02322866|2638993|P2|Overall Study|Lack of Efficacy|1
809169|NCT02322866|2638994|P1|Overall Study|Lack of Efficacy|3
809170|NCT02322866|2638993|P2|Overall Study|Noncompliance with Treatment|4
809171|NCT02322866|2638994|P1|Overall Study|Noncompliance with Treatment|3
809172|NCT02322866|2638993|P2|Overall Study|Protocol Violation|0
809173|NCT02322866|2638994|P1|Overall Study|Protocol Violation|1
809174|NCT02322866|2638993|P2|Overall Study|Lost to Follow-up|39
809175|NCT02322866|2638994|P1|Overall Study|Lost to Follow-up|36
809176|NCT02322866|2638993|P2|Overall Study|Withdrawal of Consent|25
809177|NCT02322866|2638994|P1|Overall Study|Withdrawal of Consent|16
809178|NCT02322866|2638993|P2|Overall Study|Adverse Event|11
809179|NCT02322866|2638994|P1|Overall Study|Adverse Event|6
809180|NCT02322775|2639031|P2|Overall Study|Not willing to perform all FU visits|1
809181|NCT02322775|2639032|P1|Overall Study|Not willing to perform all FU visits|0
809182|NCT02322775|2639031|P2|Overall Study|Withdrawal by Subject|4
809183|NCT02322775|2639032|P1|Overall Study|Withdrawal by Subject|3
809184|NCT02322775|2639031|P2|Overall Study|Protocol Violation|0
809185|NCT02322775|2639032|P1|Overall Study|Protocol Violation|1
809186|NCT02322775|2639031|P2|Overall Study|Lost to Follow-up|1
809187|NCT02322775|2639032|P1|Overall Study|Lost to Follow-up|0
809188|NCT02322775|2639031|P2|Overall Study|Adverse Event|0
809189|NCT02322775|2639032|P1|Overall Study|Adverse Event|1
809190|NCT02322749|2639058|P6|Period 3|Withdrawal by Subject|0
809191|NCT02322749|2639059|P5|Period 3|Withdrawal by Subject|0
809192|NCT02322749|2639060|P4|Period 3|Withdrawal by Subject|0
809193|NCT02322749|2639061|P3|Period 3|Withdrawal by Subject|1
809194|NCT02322749|2639062|P2|Period 3|Withdrawal by Subject|0
809195|NCT02322749|2639063|P1|Period 3|Withdrawal by Subject|0
809196|NCT02322749|2639058|P6|Period 2|Withdrawal by Subject|0
809197|NCT02322749|2639059|P5|Period 2|Withdrawal by Subject|0
809198|NCT02322749|2639060|P4|Period 2|Withdrawal by Subject|1
809199|NCT02322749|2639061|P3|Period 2|Withdrawal by Subject|0
809200|NCT02322749|2639062|P2|Period 2|Withdrawal by Subject|0
809201|NCT02322749|2639063|P1|Period 2|Withdrawal by Subject|0
809202|NCT02322749|2639058|P6|Period 2|Adverse Event|0
809203|NCT02322749|2639059|P5|Period 2|Adverse Event|0
809204|NCT02322749|2639060|P4|Period 2|Adverse Event|1
809205|NCT02322749|2639061|P3|Period 2|Adverse Event|0
809206|NCT02322749|2639062|P2|Period 2|Adverse Event|0
809207|NCT02322749|2639063|P1|Period 2|Adverse Event|0
809208|NCT02322229|2639091|P1|Overall Study|Physician Decision|2
809209|NCT02322216|2639103|P2|Overall Study|Withdrawal by Subject|4
809210|NCT02322216|2639104|P1|Overall Study|Withdrawal by Subject|1
809211|NCT02322216|2639103|P2|Overall Study|Adverse Event|0
809212|NCT02322216|2639104|P1|Overall Study|Adverse Event|1
809213|NCT02321436|2639117|P2|Overall Study|Lost to Follow-up|1
809214|NCT02321436|2639118|P1|Overall Study|Lost to Follow-up|0
809215|NCT02321436|2639117|P2|Overall Study|Withdrawal by Subject|0
809216|NCT02321436|2639118|P1|Overall Study|Withdrawal by Subject|1
809217|NCT02321098|2639137|P3|Additional 15 Months Treatment|Withdrawal by Subject|1
809218|NCT02321098|2639138|P2|Additional 15 Months Treatment|Withdrawal by Subject|0
809219|NCT02321098|2639139|P1|Additional 15 Months Treatment|Withdrawal by Subject|0
809220|NCT02321098|2639137|P3|Additional 15 Months Treatment|Lost to Follow-up|1
809221|NCT02321098|2639138|P2|Additional 15 Months Treatment|Lost to Follow-up|0
809222|NCT02321098|2639139|P1|Additional 15 Months Treatment|Lost to Follow-up|0
809223|NCT02321098|2639137|P3|Additional 15 Months Treatment|Lack of Efficacy|6
809224|NCT02321098|2639138|P2|Additional 15 Months Treatment|Lack of Efficacy|0
809225|NCT02321098|2639139|P1|Additional 15 Months Treatment|Lack of Efficacy|0
809226|NCT02321098|2639137|P3|12 Weeks Treament|Lost to Follow-up|0
809227|NCT02321098|2639138|P2|12 Weeks Treament|Lost to Follow-up|1
809228|NCT02321098|2639139|P1|12 Weeks Treament|Lost to Follow-up|1
809229|NCT02320903|2639151|P3|Overall Study|Lost to Follow-up|5
809230|NCT02320903|2639152|P2|Overall Study|Lost to Follow-up|5
809231|NCT02320903|2639153|P1|Overall Study|Lost to Follow-up|0
809232|NCT02320903|2639151|P3|Overall Study|Exited therapy; no longer eligible|2
809233|NCT02320903|2639152|P2|Overall Study|Exited therapy; no longer eligible|2
809234|NCT02320903|2639153|P1|Overall Study|Exited therapy; no longer eligible|8
809235|NCT02320903|2639151|P3|Overall Study|Withdrawal by Subject|9
809236|NCT02320903|2639152|P2|Overall Study|Withdrawal by Subject|9
809237|NCT02320903|2639153|P1|Overall Study|Withdrawal by Subject|0
809238|NCT02320721|2639257|P2|Overall Study|Other than specified above|20
809239|NCT02320721|2639258|P1|Overall Study|Other than specified above|15
809240|NCT02320721|2639257|P2|Overall Study|Hypoglycemia|0
809241|NCT02320721|2639258|P1|Overall Study|Hypoglycemia|1
809242|NCT02320721|2639257|P2|Overall Study|Randomized but not treated|1
809243|NCT02320721|2639258|P1|Overall Study|Randomized but not treated|0
809244|NCT02320721|2639257|P2|Overall Study|Poor compliance to protocol|7
809245|NCT02320721|2639258|P1|Overall Study|Poor compliance to protocol|3
809246|NCT02320721|2639257|P2|Overall Study|Lack of Efficacy|0
809247|NCT02320721|2639258|P1|Overall Study|Lack of Efficacy|2
809248|NCT02320721|2639257|P2|Overall Study|Adverse Event|6
809249|NCT02320721|2639258|P1|Overall Study|Adverse Event|6
809250|NCT02320487|2639313|P1|Overall Study|Adverse Event|11
809251|NCT02320487|2639313|P1|Overall Study|Death|3
809252|NCT02320487|2639313|P1|Overall Study|Withdrawal by Subject|1
809253|NCT02320487|2639313|P1|Overall Study|Physician Decision|5
809254|NCT02320487|2639313|P1|Overall Study|Reason not Specified|1
809255|NCT02320396|2639333|P2|Overall Study|Withdrawal by Subject|0
809256|NCT02320396|2639334|P1|Overall Study|Withdrawal by Subject|2
809257|NCT02320396|2639333|P2|Overall Study|Protocol Violation|1
809258|NCT02320396|2639334|P1|Overall Study|Protocol Violation|0
809259|NCT02320396|2639333|P2|Overall Study|Pregnancy|1
809260|NCT02320396|2639334|P1|Overall Study|Pregnancy|0
809261|NCT02320396|2639333|P2|Overall Study|Adverse Event|2
809262|NCT02320396|2639334|P1|Overall Study|Adverse Event|2
809263|NCT02320149|2639376|P2|Overall Study|Other Miscellaneous Reasons|3
809264|NCT02320149|2639377|P1|Overall Study|Other Miscellaneous Reasons|2
809265|NCT02320149|2639376|P2|Overall Study|Lack of Efficacy|1
809266|NCT02320149|2639377|P1|Overall Study|Lack of Efficacy|0
809267|NCT02320149|2639376|P2|Overall Study|Noncompliance with Study Treatment|2
809268|NCT02320149|2639377|P1|Overall Study|Noncompliance with Study Treatment|7
809269|NCT02320149|2639376|P2|Overall Study|Protocol Violation|1
809270|NCT02320149|2639377|P1|Overall Study|Protocol Violation|2
809271|NCT02320149|2639376|P2|Overall Study|Lost to Follow-up|34
809272|NCT02320149|2639377|P1|Overall Study|Lost to Follow-up|21
809273|NCT02320149|2639376|P2|Overall Study|Withdrawal of Consent|32
809274|NCT02320149|2639377|P1|Overall Study|Withdrawal of Consent|28
809275|NCT02320149|2639376|P2|Overall Study|Adverse Event|7
809276|NCT02320149|2639377|P1|Overall Study|Adverse Event|3
809277|NCT02319668|2639423|P2|Overall Study|Other (Not specified)|2
809278|NCT02319668|2639424|P1|Overall Study|Other (Not specified)|0
809279|NCT02319642|2639438|P2|Overall Study|Withdrawal by Subject|1
809280|NCT02319642|2639439|P1|Overall Study|Withdrawal by Subject|1
809281|NCT02319642|2639438|P2|Overall Study|Lack of Efficacy|1
809282|NCT02319642|2639439|P1|Overall Study|Lack of Efficacy|1
809283|NCT02319642|2639438|P2|Overall Study|Adverse Event|4
809284|NCT02319642|2639439|P1|Overall Study|Adverse Event|2
809285|NCT02319525|2639459|P2|Overall Study|Withdrawal by Subject|1
809286|NCT02319525|2639460|P1|Overall Study|Withdrawal by Subject|2
809287|NCT02319148|2639496|P4|Second Intervention Period|Other|1
809288|NCT02319148|2639497|P3|Second Intervention Period|Other|0
809289|NCT02319148|2639498|P2|Second Intervention Period|Other|0
809290|NCT02319148|2639499|P1|Second Intervention Period|Other|0
809291|NCT02319148|2639496|P4|Second Intervention Period|No longer willing to participate|0
809292|NCT02319148|2639497|P3|Second Intervention Period|No longer willing to participate|0
809293|NCT02319148|2639498|P2|Second Intervention Period|No longer willing to participate|1
809294|NCT02319148|2639499|P1|Second Intervention Period|No longer willing to participate|0
809295|NCT02319148|2639496|P4|Second Intervention Period|Adverse event (AE) related to study drug|1
809296|NCT02319148|2639497|P3|Second Intervention Period|Adverse event (AE) related to study drug|1
809297|NCT02319148|2639498|P2|Second Intervention Period|Adverse event (AE) related to study drug|0
809298|NCT02319148|2639499|P1|Second Intervention Period|Adverse event (AE) related to study drug|0
809299|NCT02319044|2639562|P3|Overall Study|Not treated|2
809300|NCT02319044|2639563|P2|Overall Study|Not treated|2
809301|NCT02319044|2639564|P1|Overall Study|Not treated|0
809302|NCT02319044|2639562|P3|Overall Study|Study specific discontinuation criteria|1
809303|NCT02319044|2639563|P2|Overall Study|Study specific discontinuation criteria|2
809304|NCT02319044|2639564|P1|Overall Study|Study specific discontinuation criteria|2
809305|NCT02319044|2639562|P3|Overall Study|Adverse Event|8
809306|NCT02319044|2639563|P2|Overall Study|Adverse Event|2
809307|NCT02319044|2639564|P1|Overall Study|Adverse Event|17
809308|NCT02319044|2639562|P3|Overall Study|Condition under investigation worsened|46
809309|NCT02319044|2639563|P2|Overall Study|Condition under investigation worsened|50
809310|NCT02319044|2639564|P1|Overall Study|Condition under investigation worsened|100
809311|NCT02319044|2639562|P3|Overall Study|Withdrawal by Subject|6
809312|NCT02319044|2639563|P2|Overall Study|Withdrawal by Subject|3
809313|NCT02319044|2639564|P1|Overall Study|Withdrawal by Subject|3
809314|NCT02319044|2639562|P3|Overall Study|Death, PI/sponsor decision, med history|4
809315|NCT02319044|2639563|P2|Overall Study|Death, PI/sponsor decision, med history|1
809316|NCT02319044|2639564|P1|Overall Study|Death, PI/sponsor decision, med history|0
809317|NCT02319031|2639620|P2|Treatment Period|Death|0
809318|NCT02319031|2639621|P1|Treatment Period|Death|1
809319|NCT02318940|2639656|P2|Overall Study|lost the record|0
809320|NCT02318940|2639657|P1|Overall Study|lost the record|1
809321|NCT02318797|2639684|P2|Overall Study|Lost to Follow-up|96
809322|NCT02318797|2639685|P1|Overall Study|Lost to Follow-up|85
809323|NCT02318797|2639684|P2|Overall Study|Death|6
809324|NCT02318797|2639685|P1|Overall Study|Death|3
809325|NCT02318693|2639725|P2|Overall Study|Protocol Violation|1
809326|NCT02318693|2639726|P1|Overall Study|Protocol Violation|0
809327|NCT02318667|2639740|P1|Overall Study|Protocol Violation|2
809328|NCT02318667|2639740|P1|Overall Study|Lack of Efficacy|6
809329|NCT02318667|2639740|P1|Overall Study|Adverse Event|1
809330|NCT02318602|2639759|P3|Overall Study|Guardian decision to withdraw|1
809331|NCT02318602|2639760|P2|Overall Study|Guardian decision to withdraw|0
809332|NCT02318602|2639761|P1|Overall Study|Guardian decision to withdraw|0
809333|NCT02318602|2639759|P3|Overall Study|Death|0
809334|NCT02318602|2639760|P2|Overall Study|Death|0
809335|NCT02318602|2639761|P1|Overall Study|Death|1
809336|NCT02318602|2639759|P3|Overall Study|Withdrawal by Subject|0
809337|NCT02318602|2639760|P2|Overall Study|Withdrawal by Subject|3
809338|NCT02318602|2639761|P1|Overall Study|Withdrawal by Subject|0
809339|NCT02318602|2639759|P3|Overall Study|Adverse Event|1
809340|NCT02318602|2639760|P2|Overall Study|Adverse Event|1
809341|NCT02318602|2639761|P1|Overall Study|Adverse Event|0
809342|NCT02317809|2639821|P2|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0
809343|NCT02317809|2639822|P1|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1
809344|NCT02317809|2639821|P2|First Intervention Period (8 Days)|Protocol Non-Compliance|0
809345|NCT02317809|2639822|P1|First Intervention Period (8 Days)|Protocol Non-Compliance|2
809346|NCT02317614|2639910|P2|Overall Study|Death|1
809347|NCT02317614|2639911|P1|Overall Study|Death|1
809348|NCT02317614|2639910|P2|Overall Study|Withdrawal by Subject|0
809349|NCT02317614|2639911|P1|Overall Study|Withdrawal by Subject|1
809350|NCT02317614|2639910|P2|Overall Study|Lost to Follow-up|1
809351|NCT02317614|2639911|P1|Overall Study|Lost to Follow-up|1
809352|NCT02317510|2639938|P2|Overall Study|Adverse Event|1
809353|NCT02317510|2639939|P1|Overall Study|Adverse Event|0
809354|NCT02317016|2639967|P1|Part B: Day 35 to End Part B (AZD9291)|Death|5
809355|NCT02317016|2639967|P1|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2
809356|NCT02317016|2639967|P1|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1
809357|NCT02317016|2639967|P1|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23
809358|NCT02317016|2639967|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1
809359|NCT02317016|2639967|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1
809360|NCT02317016|2639967|P1|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1
809361|NCT02316847|2639995|P2|Overall Study|Withdrawn due to termination by Sponsor|67
809362|NCT02316847|2639996|P1|Overall Study|Withdrawn due to termination by Sponsor|7
809363|NCT02316847|2639995|P2|Overall Study|Noncompliance with study drug|3
809364|NCT02316847|2639996|P1|Overall Study|Noncompliance with study drug|0
809365|NCT02316847|2639995|P2|Overall Study|Withdrawal by Subject|9
809366|NCT02316847|2639996|P1|Overall Study|Withdrawal by Subject|2
809367|NCT02316847|2639995|P2|Overall Study|Pregnancy|1
809368|NCT02316847|2639996|P1|Overall Study|Pregnancy|0
809369|NCT02316847|2639995|P2|Overall Study|Physician Decision|1
809370|NCT02316847|2639996|P1|Overall Study|Physician Decision|0
809371|NCT02316847|2639995|P2|Overall Study|Lost to Follow-up|2
809372|NCT02316847|2639996|P1|Overall Study|Lost to Follow-up|0
809373|NCT02316847|2639995|P2|Overall Study|Adverse Event|3
809374|NCT02316847|2639996|P1|Overall Study|Adverse Event|0
809375|NCT02316769|2640007|P2|Overall Study|Withdrawal by Subject|0
809376|NCT02316769|2640008|P1|Overall Study|Withdrawal by Subject|1
809377|NCT02316769|2640007|P2|Overall Study|Physician Decision|0
809378|NCT02316769|2640008|P1|Overall Study|Physician Decision|1
809379|NCT02316613|2640025|P1|Overall Study|Did not met selection criteria|14
809380|NCT02316613|2640025|P1|Overall Study|No data and duplicate cases|5
809381|NCT02316613|2640025|P1|Overall Study|Participant moved/changed medical team|11
809382|NCT02316613|2640025|P1|Overall Study|Lymphoma transformation|2
809383|NCT02316613|2640025|P1|Overall Study|Lost to Follow-up|9
809384|NCT02316613|2640025|P1|Overall Study|Death|63
809385|NCT02316548|2640064|P2|Overall Study|Protocol Violation|1
809386|NCT02316548|2640065|P1|Overall Study|Protocol Violation|0
809387|NCT02316353|2640195|P2|Overall Study|Withdrawal by Subject|2
809388|NCT02316353|2640196|P1|Overall Study|Withdrawal by Subject|6
809389|NCT02316353|2640195|P2|Overall Study|Adverse Event|3
809390|NCT02316353|2640196|P1|Overall Study|Adverse Event|1
809391|NCT02316353|2640195|P2|Overall Study|Pregnancy|3
809392|NCT02316353|2640196|P1|Overall Study|Pregnancy|1
809393|NCT02315560|2640222|P1|Overall Study|noncompliance by subjects|3
809394|NCT02314637|2640469|P2|Overall Study|Other Reason|0
809395|NCT02314637|2640470|P1|Overall Study|Other Reason|1
809396|NCT02314637|2640469|P2|Overall Study|Withdrawal by Subject|4
809397|NCT02314637|2640470|P1|Overall Study|Withdrawal by Subject|5
809398|NCT02314637|2640469|P2|Overall Study|Physician Decision|2
809399|NCT02314637|2640470|P1|Overall Study|Physician Decision|5
809400|NCT02314637|2640469|P2|Overall Study|Lack of Efficacy|0
809401|NCT02314637|2640470|P1|Overall Study|Lack of Efficacy|1
809402|NCT02314637|2640469|P2|Overall Study|Adverse Event|8
809403|NCT02314637|2640470|P1|Overall Study|Adverse Event|4
809404|NCT02314247|2640535|P3|Overall Study|Progression of Disease|0
809405|NCT02314247|2640536|P2|Overall Study|Progression of Disease|2
809406|NCT02314247|2640537|P1|Overall Study|Progression of Disease|6
809407|NCT02314247|2640535|P3|Overall Study|Withdrawal by Subject|1
809408|NCT02314247|2640536|P2|Overall Study|Withdrawal by Subject|3
809409|NCT02314247|2640537|P1|Overall Study|Withdrawal by Subject|1
809410|NCT02314247|2640535|P3|Overall Study|Adverse Event|0
809411|NCT02314247|2640536|P2|Overall Study|Adverse Event|1
809412|NCT02314247|2640537|P1|Overall Study|Adverse Event|2
809413|NCT02314117|2640561|P2|Overall Study|No post-discontinuation follow-up|19
809414|NCT02314117|2640562|P1|Overall Study|No post-discontinuation follow-up|21
809415|NCT02314117|2640561|P2|Overall Study|Withdrawal by Subject|2
809416|NCT02314117|2640562|P1|Overall Study|Withdrawal by Subject|2
809417|NCT02314117|2640561|P2|Overall Study|On Treatment|6
809418|NCT02314117|2640562|P1|Overall Study|On Treatment|10
809419|NCT02314117|2640561|P2|Overall Study|Lost to Follow-up|11
809420|NCT02314117|2640562|P1|Overall Study|Lost to Follow-up|8
809421|NCT02314052|2640615|P6|Cycle One|Adverse Event|0
809422|NCT02314052|2640616|P5|Cycle One|Adverse Event|0
809423|NCT02314052|2640617|P4|Cycle One|Adverse Event|1
809424|NCT02314052|2640618|P3|Cycle One|Adverse Event|0
809425|NCT02314052|2640619|P2|Cycle One|Adverse Event|0
809426|NCT02314052|2640620|P1|Cycle One|Adverse Event|0
809427|NCT02313766|2640691|P3|Overall Study|Adverse Event|0
809428|NCT02313766|2640692|P2|Overall Study|Adverse Event|1
809429|NCT02313766|2640693|P1|Overall Study|Adverse Event|0
809430|NCT02313766|2640691|P3|Overall Study|Lost to Follow-up|0
809431|NCT02313766|2640692|P2|Overall Study|Lost to Follow-up|2
809432|NCT02313766|2640693|P1|Overall Study|Lost to Follow-up|0
809433|NCT02313766|2640691|P3|Overall Study|surgery cancelled|0
809434|NCT02313766|2640692|P2|Overall Study|surgery cancelled|0
809435|NCT02313766|2640693|P1|Overall Study|surgery cancelled|1
809436|NCT02313558|2640730|P2|Overall Study|Lost to Follow-up|4
809437|NCT02313558|2640731|P1|Overall Study|Lost to Follow-up|4
809438|NCT02313558|2640730|P2|Overall Study|Withdrawal by Subject|0
809439|NCT02313558|2640731|P1|Overall Study|Withdrawal by Subject|2
809440|NCT02313233|2640745|P2|Overall Study|Administrative reason|1
809441|NCT02313233|2640746|P1|Overall Study|Administrative reason|1
809442|NCT02313233|2640745|P2|Overall Study|Withdrawal by Subject|2
809443|NCT02313233|2640746|P1|Overall Study|Withdrawal by Subject|1
809444|NCT02313155|2640768|P2|Overall Study|Lost to Follow-up|1
809445|NCT02313155|2640769|P1|Overall Study|Lost to Follow-up|0
809446|NCT02311894|2640961|P1|Overall Study|Withdrawal by Subject|1
809447|NCT02311894|2640961|P1|Overall Study|Adverse Event|1
809448|NCT02311894|2640961|P1|Overall Study|Lost to Follow-up|1
809449|NCT02311894|2640961|P1|Overall Study|Discontinued in error|1
809450|NCT02311881|2640973|P3|Overall Study|Serious Adverse Event|0
809451|NCT02311881|2640974|P2|Overall Study|Serious Adverse Event|1
809452|NCT02311881|2640975|P1|Overall Study|Serious Adverse Event|0
809453|NCT02311881|2640973|P3|Overall Study|Participant taking another medication|1
809454|NCT02311881|2640974|P2|Overall Study|Participant taking another medication|0
809455|NCT02311881|2640975|P1|Overall Study|Participant taking another medication|0
809456|NCT02311881|2640973|P3|Overall Study|Medical Monitor Discretion|1
809457|NCT02311881|2640974|P2|Overall Study|Medical Monitor Discretion|0
809458|NCT02311881|2640975|P1|Overall Study|Medical Monitor Discretion|0
809459|NCT02311881|2640973|P3|Overall Study|Physician Decision|1
809460|NCT02311881|2640974|P2|Overall Study|Physician Decision|0
809461|NCT02311881|2640975|P1|Overall Study|Physician Decision|0
809462|NCT02311881|2640973|P3|Overall Study|Non-Compliance|2
809463|NCT02311881|2640974|P2|Overall Study|Non-Compliance|0
809464|NCT02311881|2640975|P1|Overall Study|Non-Compliance|1
809465|NCT02311881|2640973|P3|Overall Study|Protocol Deviation|0
809466|NCT02311881|2640974|P2|Overall Study|Protocol Deviation|0
809467|NCT02311881|2640975|P1|Overall Study|Protocol Deviation|1
809468|NCT02311881|2640973|P3|Overall Study|Sponsor Decision|1
809469|NCT02311881|2640974|P2|Overall Study|Sponsor Decision|1
809470|NCT02311881|2640975|P1|Overall Study|Sponsor Decision|1
809471|NCT02311881|2640973|P3|Overall Study|Withdrawal by Subject|4
809472|NCT02311881|2640974|P2|Overall Study|Withdrawal by Subject|1
809473|NCT02311881|2640975|P1|Overall Study|Withdrawal by Subject|3
809474|NCT02311881|2640973|P3|Overall Study|Subject has border line pregnancy test|0
809475|NCT02311881|2640974|P2|Overall Study|Subject has border line pregnancy test|0
809476|NCT02311881|2640975|P1|Overall Study|Subject has border line pregnancy test|1
809477|NCT02311881|2640973|P3|Overall Study|Lack of Efficacy|0
809478|NCT02311881|2640974|P2|Overall Study|Lack of Efficacy|2
809479|NCT02311881|2640975|P1|Overall Study|Lack of Efficacy|1
809480|NCT02311881|2640973|P3|Overall Study|Not Specified|1
809481|NCT02311881|2640974|P2|Overall Study|Not Specified|0
809482|NCT02311881|2640975|P1|Overall Study|Not Specified|0
809483|NCT02311881|2640973|P3|Overall Study|Withdrawal of consent|17
809484|NCT02311881|2640974|P2|Overall Study|Withdrawal of consent|16
809485|NCT02311881|2640975|P1|Overall Study|Withdrawal of consent|14
809486|NCT02311881|2640973|P3|Overall Study|Protocol Violation|3
809487|NCT02311881|2640974|P2|Overall Study|Protocol Violation|2
809488|NCT02311881|2640975|P1|Overall Study|Protocol Violation|1
809489|NCT02311881|2640973|P3|Overall Study|Lost to Follow-up|2
809490|NCT02311881|2640974|P2|Overall Study|Lost to Follow-up|3
809491|NCT02311881|2640975|P1|Overall Study|Lost to Follow-up|3
809492|NCT02311881|2640973|P3|Overall Study|Adverse Event|8
809493|NCT02311881|2640974|P2|Overall Study|Adverse Event|15
809494|NCT02311881|2640975|P1|Overall Study|Adverse Event|7
809495|NCT02311881|2640973|P3|Overall Study|Did not meet the study criteria|0
809496|NCT02311881|2640974|P2|Overall Study|Did not meet the study criteria|2
809497|NCT02311881|2640975|P1|Overall Study|Did not meet the study criteria|2
809498|NCT02311153|2641028|P2|Overall Study|Lost to Follow-up|7
809499|NCT02311153|2641029|P1|Overall Study|Lost to Follow-up|5
809500|NCT02310789|2641045|P1|Overall Study|Adverse Event|1
809501|NCT02310750|2641065|P16|HP Washout 2|Lost to Follow-up|0
809502|NCT02310750|2641066|P15|HP Washout 2|Lost to Follow-up|0
809503|NCT02310750|2641067|P14|HP Washout 2|Lost to Follow-up|0
809504|NCT02310750|2641068|P13|HP Washout 2|Lost to Follow-up|0
809505|NCT02310750|2641069|P12|HP Washout 2|Lost to Follow-up|0
809506|NCT02310750|2641070|P11|HP Washout 2|Lost to Follow-up|0
809507|NCT02310750|2641071|P10|HP Washout 2|Lost to Follow-up|0
809508|NCT02310750|2641072|P9|HP Washout 2|Lost to Follow-up|0
809509|NCT02310750|2641073|P8|HP Washout 2|Lost to Follow-up|0
809510|NCT02310750|2641074|P7|HP Washout 2|Lost to Follow-up|7
809511|NCT02310750|2641075|P6|HP Washout 2|Lost to Follow-up|0
809512|NCT02310750|2641076|P5|HP Washout 2|Lost to Follow-up|1
809513|NCT02310750|2641077|P4|HP Washout 2|Lost to Follow-up|0
809514|NCT02310750|2641078|P3|HP Washout 2|Lost to Follow-up|0
809515|NCT02310750|2641079|P2|HP Washout 2|Lost to Follow-up|0
809516|NCT02310750|2641080|P1|HP Washout 2|Lost to Follow-up|0
809517|NCT02310750|2641065|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
809518|NCT02310750|2641066|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
809519|NCT02310750|2641067|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
809520|NCT02310750|2641068|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
809521|NCT02310750|2641069|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
809522|NCT02310750|2641070|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
809523|NCT02310750|2641071|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
809524|NCT02310750|2641072|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
809525|NCT02310750|2641073|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
809526|NCT02310750|2641074|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
809527|NCT02310750|2641075|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
809528|NCT02310750|2641076|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
809529|NCT02310750|2641077|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
809530|NCT02310750|2641078|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
809531|NCT02310750|2641079|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
809532|NCT02310750|2641080|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
809533|NCT02310750|2641065|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
809534|NCT02310750|2641066|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
809535|NCT02310750|2641067|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
809536|NCT02310750|2641068|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
809537|NCT02310750|2641069|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
809538|NCT02310750|2641070|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
809539|NCT02310750|2641071|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
809540|NCT02310750|2641072|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
809541|NCT02310750|2641073|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
809542|NCT02310750|2641074|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
809543|NCT02310750|2641075|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
809544|NCT02310750|2641076|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
809545|NCT02310750|2641077|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
809546|NCT02310750|2641078|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
809547|NCT02310750|2641079|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
809548|NCT02310750|2641080|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
809549|NCT02310750|2641065|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
809550|NCT02310750|2641066|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
809551|NCT02310750|2641067|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
809552|NCT02310750|2641068|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
809553|NCT02310750|2641069|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
809554|NCT02310750|2641070|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
809555|NCT02310750|2641071|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1
809556|NCT02310750|2641072|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
809557|NCT02310750|2641073|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
809558|NCT02310750|2641074|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
809559|NCT02310750|2641075|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
809560|NCT02310750|2641076|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
809561|NCT02310750|2641077|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
809562|NCT02310750|2641078|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
809563|NCT02310750|2641079|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
809564|NCT02310750|2641080|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
809565|NCT02310750|2641065|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
809566|NCT02310750|2641066|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
809567|NCT02310750|2641067|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
809568|NCT02310750|2641068|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
809569|NCT02310750|2641069|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
809570|NCT02310750|2641070|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
809571|NCT02310750|2641071|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
809572|NCT02310750|2641072|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6
809573|NCT02310750|2641073|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
809574|NCT02310750|2641074|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
809575|NCT02310750|2641075|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2
809576|NCT02310750|2641076|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
809577|NCT02310750|2641077|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
809578|NCT02310750|2641078|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
809579|NCT02310750|2641079|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
809580|NCT02310750|2641080|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
809581|NCT02310750|2641065|P16|HP Washout 1|Lost to Follow-up|0
809582|NCT02310750|2641066|P15|HP Washout 1|Lost to Follow-up|0
809583|NCT02310750|2641067|P14|HP Washout 1|Lost to Follow-up|0
809584|NCT02310750|2641068|P13|HP Washout 1|Lost to Follow-up|0
809585|NCT02310750|2641069|P12|HP Washout 1|Lost to Follow-up|0
809586|NCT02310750|2641070|P11|HP Washout 1|Lost to Follow-up|0
809587|NCT02310750|2641071|P10|HP Washout 1|Lost to Follow-up|0
809588|NCT02310750|2641072|P9|HP Washout 1|Lost to Follow-up|0
809589|NCT02310750|2641073|P8|HP Washout 1|Lost to Follow-up|0
809590|NCT02310750|2641074|P7|HP Washout 1|Lost to Follow-up|3
809591|NCT02310750|2641075|P6|HP Washout 1|Lost to Follow-up|2
809592|NCT02310750|2641076|P5|HP Washout 1|Lost to Follow-up|2
809593|NCT02310750|2641077|P4|HP Washout 1|Lost to Follow-up|1
809594|NCT02310750|2641078|P3|HP Washout 1|Lost to Follow-up|1
809595|NCT02310750|2641079|P2|HP Washout 1|Lost to Follow-up|0
809596|NCT02310750|2641080|P1|HP Washout 1|Lost to Follow-up|0
809597|NCT02310750|2641065|P16|HP Period 1|Withdrawal by Subject|0
809598|NCT02310750|2641066|P15|HP Period 1|Withdrawal by Subject|0
809599|NCT02310750|2641067|P14|HP Period 1|Withdrawal by Subject|0
809600|NCT02310750|2641068|P13|HP Period 1|Withdrawal by Subject|0
809601|NCT02310750|2641069|P12|HP Period 1|Withdrawal by Subject|0
809602|NCT02310750|2641070|P11|HP Period 1|Withdrawal by Subject|0
809603|NCT02310750|2641071|P10|HP Period 1|Withdrawal by Subject|0
809604|NCT02310750|2641072|P9|HP Period 1|Withdrawal by Subject|0
809605|NCT02310750|2641073|P8|HP Period 1|Withdrawal by Subject|0
809606|NCT02310750|2641074|P7|HP Period 1|Withdrawal by Subject|0
809607|NCT02310750|2641075|P6|HP Period 1|Withdrawal by Subject|0
809608|NCT02310750|2641076|P5|HP Period 1|Withdrawal by Subject|0
809609|NCT02310750|2641077|P4|HP Period 1|Withdrawal by Subject|1
809610|NCT02310750|2641078|P3|HP Period 1|Withdrawal by Subject|0
809611|NCT02310750|2641079|P2|HP Period 1|Withdrawal by Subject|0
809612|NCT02310750|2641080|P1|HP Period 1|Withdrawal by Subject|1
809613|NCT02310750|2641065|P16|HP Period 1|Lost to Follow-up|0
809614|NCT02310750|2641066|P15|HP Period 1|Lost to Follow-up|0
809615|NCT02310750|2641067|P14|HP Period 1|Lost to Follow-up|0
809616|NCT02310750|2641068|P13|HP Period 1|Lost to Follow-up|0
809617|NCT02310750|2641069|P12|HP Period 1|Lost to Follow-up|0
809618|NCT02310750|2641070|P11|HP Period 1|Lost to Follow-up|0
809619|NCT02310750|2641071|P10|HP Period 1|Lost to Follow-up|0
809620|NCT02310750|2641072|P9|HP Period 1|Lost to Follow-up|0
809621|NCT02310750|2641073|P8|HP Period 1|Lost to Follow-up|0
809622|NCT02310750|2641074|P7|HP Period 1|Lost to Follow-up|1
809623|NCT02310750|2641075|P6|HP Period 1|Lost to Follow-up|0
809624|NCT02310750|2641076|P5|HP Period 1|Lost to Follow-up|0
809625|NCT02310750|2641077|P4|HP Period 1|Lost to Follow-up|0
809626|NCT02310750|2641078|P3|HP Period 1|Lost to Follow-up|0
809627|NCT02310750|2641079|P2|HP Period 1|Lost to Follow-up|0
809628|NCT02310750|2641080|P1|HP Period 1|Lost to Follow-up|0
809629|NCT02310646|2641521|P2|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0
809630|NCT02310646|2641522|P1|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1
809631|NCT02310646|2641521|P2|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0
809632|NCT02310646|2641522|P1|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1
809633|NCT02310581|2641550|P4|Overall Study|Withdrawal by Subject|1
809634|NCT02310581|2641551|P3|Overall Study|Withdrawal by Subject|0
809635|NCT02310581|2641552|P2|Overall Study|Withdrawal by Subject|1
809636|NCT02310581|2641553|P1|Overall Study|Withdrawal by Subject|2
809637|NCT02310581|2641550|P4|Overall Study|Adverse Event|0
809638|NCT02310581|2641551|P3|Overall Study|Adverse Event|1
809639|NCT02310581|2641552|P2|Overall Study|Adverse Event|1
809640|NCT02310581|2641553|P1|Overall Study|Adverse Event|1
809641|NCT02310568|2641592|P5|Stage 2 (4 Weeks)|Lost to Follow-up|0
809642|NCT02310568|2641593|P4|Stage 2 (4 Weeks)|Lost to Follow-up|2
809643|NCT02310568|2641594|P3|Stage 2 (4 Weeks)|Lost to Follow-up|0
809644|NCT02310568|2641595|P2|Stage 2 (4 Weeks)|Lost to Follow-up|0
809645|NCT02310568|2641596|P1|Stage 2 (4 Weeks)|Lost to Follow-up|0
809646|NCT02310568|2641592|P5|Stage 2 (4 Weeks)|Protocol Violation|0
809647|NCT02310568|2641593|P4|Stage 2 (4 Weeks)|Protocol Violation|1
809648|NCT02310568|2641594|P3|Stage 2 (4 Weeks)|Protocol Violation|0
809649|NCT02310568|2641595|P2|Stage 2 (4 Weeks)|Protocol Violation|0
809650|NCT02310568|2641596|P1|Stage 2 (4 Weeks)|Protocol Violation|0
809651|NCT02310568|2641592|P5|Stage 2 (4 Weeks)|Adverse Event|1
809652|NCT02310568|2641593|P4|Stage 2 (4 Weeks)|Adverse Event|1
809653|NCT02310568|2641594|P3|Stage 2 (4 Weeks)|Adverse Event|0
809654|NCT02310568|2641595|P2|Stage 2 (4 Weeks)|Adverse Event|0
809655|NCT02310568|2641596|P1|Stage 2 (4 Weeks)|Adverse Event|0
809656|NCT02310568|2641592|P5|Stage 2 (4 Weeks)|Other|0
809657|NCT02310568|2641593|P4|Stage 2 (4 Weeks)|Other|0
809658|NCT02310568|2641594|P3|Stage 2 (4 Weeks)|Other|1
809659|NCT02310568|2641595|P2|Stage 2 (4 Weeks)|Other|1
809660|NCT02310568|2641596|P1|Stage 2 (4 Weeks)|Other|0
809661|NCT02310568|2641592|P5|Stage 2 (4 Weeks)|Withdrawal by Participants|0
809662|NCT02310568|2641593|P4|Stage 2 (4 Weeks)|Withdrawal by Participants|1
809663|NCT02310568|2641594|P3|Stage 2 (4 Weeks)|Withdrawal by Participants|0
809664|NCT02310568|2641595|P2|Stage 2 (4 Weeks)|Withdrawal by Participants|0
809665|NCT02310568|2641596|P1|Stage 2 (4 Weeks)|Withdrawal by Participants|1
809666|NCT02310568|2641592|P5|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
809667|NCT02310568|2641593|P4|Stage 1 ( 4 Weeks)|Lost to Follow-up|1
809668|NCT02310568|2641594|P3|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
809669|NCT02310568|2641595|P2|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
809670|NCT02310568|2641596|P1|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
809671|NCT02310568|2641592|P5|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
809672|NCT02310568|2641593|P4|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1
809673|NCT02310568|2641594|P3|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
809674|NCT02310568|2641595|P2|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
809675|NCT02310568|2641596|P1|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
809676|NCT02310568|2641592|P5|Stage 1 ( 4 Weeks)|Adverse Event|0
809677|NCT02310568|2641593|P4|Stage 1 ( 4 Weeks)|Adverse Event|0
809678|NCT02310568|2641594|P3|Stage 1 ( 4 Weeks)|Adverse Event|1
809679|NCT02310568|2641595|P2|Stage 1 ( 4 Weeks)|Adverse Event|1
809680|NCT02310568|2641596|P1|Stage 1 ( 4 Weeks)|Adverse Event|1
809681|NCT02310568|2641592|P5|Stage 1 ( 4 Weeks)|Other|0
809682|NCT02310568|2641593|P4|Stage 1 ( 4 Weeks)|Other|0
809683|NCT02310568|2641594|P3|Stage 1 ( 4 Weeks)|Other|0
809684|NCT02310568|2641595|P2|Stage 1 ( 4 Weeks)|Other|1
809685|NCT02310568|2641596|P1|Stage 1 ( 4 Weeks)|Other|1
809686|NCT02310568|2641592|P5|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
809687|NCT02310568|2641593|P4|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
809688|NCT02310568|2641594|P3|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
809689|NCT02310568|2641595|P2|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
809690|NCT02310568|2641596|P1|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1
809691|NCT02310568|2641592|P5|Stage 1 ( 4 Weeks)|Lack of Efficacy|1
809692|NCT02310568|2641593|P4|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
809693|NCT02310568|2641594|P3|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
809694|NCT02310568|2641595|P2|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
809695|NCT02310568|2641596|P1|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
809696|NCT02310126|2641676|P2|Period 1 (15 Minutes)|Protocol Violation|1
809697|NCT02310126|2641677|P1|Period 1 (15 Minutes)|Protocol Violation|0
809698|NCT02310126|2641676|P2|Period 1 (15 Minutes)|Lost to Follow-up|1
809699|NCT02310126|2641677|P1|Period 1 (15 Minutes)|Lost to Follow-up|0
809700|NCT02309723|2641686|P3|Overall Study|Withdrawal by Subject|24
809701|NCT02309723|2641687|P2|Overall Study|Withdrawal by Subject|23
809702|NCT02309723|2641688|P1|Overall Study|Withdrawal by Subject|24
809703|NCT02309411|2641705|P3|Overall Study|Withdrawal by Subject|0
809704|NCT02309411|2641706|P2|Overall Study|Withdrawal by Subject|1
809705|NCT02309411|2641707|P1|Overall Study|Withdrawal by Subject|1
809706|NCT02309411|2641705|P3|Overall Study|Physician Decision|0
809707|NCT02309411|2641706|P2|Overall Study|Physician Decision|0
809708|NCT02309411|2641707|P1|Overall Study|Physician Decision|1
809709|NCT02309294|2641726|P1|Overall Study|Withdrawal by Subject|2
809710|NCT02309112|2641733|P3|Overall Study|Lost to Follow-up|0
809711|NCT02309112|2641734|P2|Overall Study|Lost to Follow-up|1
809712|NCT02309112|2641735|P1|Overall Study|Lost to Follow-up|0
809713|NCT02309112|2641733|P3|Overall Study|Withdrawal by Subject|1
809714|NCT02309112|2641734|P2|Overall Study|Withdrawal by Subject|0
809715|NCT02309112|2641735|P1|Overall Study|Withdrawal by Subject|1
809716|NCT02308748|2641771|P10|Period 5|Adverse Event|0
809717|NCT02308748|2641772|P9|Period 5|Adverse Event|1
809718|NCT02308748|2641773|P8|Period 5|Adverse Event|0
809719|NCT02308748|2641774|P7|Period 5|Adverse Event|0
809720|NCT02308748|2641775|P6|Period 5|Adverse Event|0
809721|NCT02308748|2641776|P5|Period 5|Adverse Event|0
809722|NCT02308748|2641777|P4|Period 5|Adverse Event|0
809723|NCT02308748|2641778|P3|Period 5|Adverse Event|0
809724|NCT02308748|2641779|P2|Period 5|Adverse Event|0
809725|NCT02308748|2641780|P1|Period 5|Adverse Event|1
809726|NCT02308748|2641771|P10|Period 3|Protocol Violation|1
809727|NCT02308748|2641772|P9|Period 3|Protocol Violation|0
809728|NCT02308748|2641773|P8|Period 3|Protocol Violation|0
809729|NCT02308748|2641774|P7|Period 3|Protocol Violation|0
809730|NCT02308748|2641775|P6|Period 3|Protocol Violation|0
809731|NCT02308748|2641776|P5|Period 3|Protocol Violation|0
809732|NCT02308748|2641777|P4|Period 3|Protocol Violation|0
809733|NCT02308748|2641778|P3|Period 3|Protocol Violation|0
809734|NCT02308748|2641779|P2|Period 3|Protocol Violation|0
809735|NCT02308748|2641780|P1|Period 3|Protocol Violation|0
809736|NCT02308748|2641771|P10|Period 2|Adverse Event|0
809737|NCT02308748|2641772|P9|Period 2|Adverse Event|0
809738|NCT02308748|2641773|P8|Period 2|Adverse Event|1
809739|NCT02308748|2641774|P7|Period 2|Adverse Event|0
809740|NCT02308748|2641775|P6|Period 2|Adverse Event|0
809741|NCT02308748|2641776|P5|Period 2|Adverse Event|0
809742|NCT02308748|2641777|P4|Period 2|Adverse Event|0
809743|NCT02308748|2641778|P3|Period 2|Adverse Event|0
809744|NCT02308748|2641779|P2|Period 2|Adverse Event|0
809745|NCT02308748|2641780|P1|Period 2|Adverse Event|0
809746|NCT02308748|2641771|P10|Period 1|Withdrawal by Subject|0
809747|NCT02308748|2641772|P9|Period 1|Withdrawal by Subject|0
809748|NCT02308748|2641773|P8|Period 1|Withdrawal by Subject|0
809749|NCT02308748|2641774|P7|Period 1|Withdrawal by Subject|0
809750|NCT02308748|2641775|P6|Period 1|Withdrawal by Subject|0
809751|NCT02308748|2641776|P5|Period 1|Withdrawal by Subject|0
809752|NCT02308748|2641777|P4|Period 1|Withdrawal by Subject|0
809753|NCT02308748|2641778|P3|Period 1|Withdrawal by Subject|1
809754|NCT02308748|2641779|P2|Period 1|Withdrawal by Subject|0
809755|NCT02308748|2641780|P1|Period 1|Withdrawal by Subject|0
809756|NCT02308124|2641831|P3|Overall Study|Adverse Event|2
809757|NCT02308124|2641832|P2|Overall Study|Adverse Event|2
809758|NCT02308124|2641833|P1|Overall Study|Adverse Event|0
809759|NCT02308124|2641831|P3|Overall Study|Lost to Follow-up|6
809760|NCT02308124|2641832|P2|Overall Study|Lost to Follow-up|6
809761|NCT02308124|2641833|P1|Overall Study|Lost to Follow-up|6
809762|NCT02307266|2641925|P3|Overall Study|Lost to Follow-up|0
809763|NCT02307266|2641926|P2|Overall Study|Lost to Follow-up|0
809764|NCT02307266|2641927|P1|Overall Study|Lost to Follow-up|3
809765|NCT02307266|2641925|P3|Overall Study|Withdrawal by Subject|1
809766|NCT02307266|2641926|P2|Overall Study|Withdrawal by Subject|0
809767|NCT02307266|2641927|P1|Overall Study|Withdrawal by Subject|2
809768|NCT02307266|2641925|P3|Overall Study|Adverse Event|5
809769|NCT02307266|2641926|P2|Overall Study|Adverse Event|1
809770|NCT02307266|2641927|P1|Overall Study|Adverse Event|3
809771|NCT02305797|2641971|P2|Overall Study|Reason not collected|1
809772|NCT02305797|2641972|P1|Overall Study|Reason not collected|0
809773|NCT02305797|2641971|P2|Overall Study|Noncompliance|12
809774|NCT02305797|2641972|P1|Overall Study|Noncompliance|14
809775|NCT02305797|2641971|P2|Overall Study|Pregnancy|2
809776|NCT02305797|2641972|P1|Overall Study|Pregnancy|0
809777|NCT02305797|2641971|P2|Overall Study|Lost to Follow-up|11
809778|NCT02305797|2641972|P1|Overall Study|Lost to Follow-up|5
809779|NCT02305797|2641971|P2|Overall Study|Lack of Efficacy|0
809780|NCT02305797|2641972|P1|Overall Study|Lack of Efficacy|6
809781|NCT02305797|2641971|P2|Overall Study|Withdrawal by Subject|10
809782|NCT02305797|2641972|P1|Overall Study|Withdrawal by Subject|9
809783|NCT02305797|2641971|P2|Overall Study|Adverse Event|2
809784|NCT02305797|2641972|P1|Overall Study|Adverse Event|11
809785|NCT02305758|2641982|P2|Overall Study|Other, not specified|1
809786|NCT02305758|2641983|P1|Overall Study|Other, not specified|2
809787|NCT02305758|2641982|P2|Overall Study|Study Terminated by Sponsor|34
809788|NCT02305758|2641983|P1|Overall Study|Study Terminated by Sponsor|21
809789|NCT02305758|2641982|P2|Overall Study|Lost to Follow-up|1
809790|NCT02305758|2641983|P1|Overall Study|Lost to Follow-up|6
809791|NCT02305758|2641982|P2|Overall Study|Withdrew consent|2
809792|NCT02305758|2641983|P1|Overall Study|Withdrew consent|9
809793|NCT02305758|2641982|P2|Overall Study|Death|27
809794|NCT02305758|2641983|P1|Overall Study|Death|27
809795|NCT02305446|2642001|P1|Overall Study|Adverse Event|1
809796|NCT02305381|2642009|P3|Overall Study|Unclassified|7
809797|NCT02305381|2642010|P2|Overall Study|Unclassified|5
809798|NCT02305381|2642011|P1|Overall Study|Unclassified|5
809799|NCT02305238|2642124|P3|Overall Study|Randomized failure|8
809800|NCT02305238|2642125|P2|Overall Study|Randomized failure|0
809801|NCT02305238|2642126|P1|Overall Study|Randomized failure|0
809802|NCT02305238|2642124|P3|Overall Study|Withdrawal by Subject|0
809803|NCT02305238|2642125|P2|Overall Study|Withdrawal by Subject|2
809804|NCT02305238|2642126|P1|Overall Study|Withdrawal by Subject|2
809805|NCT02305238|2642124|P3|Overall Study|Adverse Event|0
809806|NCT02305238|2642125|P2|Overall Study|Adverse Event|1
809807|NCT02305238|2642126|P1|Overall Study|Adverse Event|3
809808|NCT02305238|2642124|P3|Overall Study|Physician Decision|0
809809|NCT02305238|2642125|P2|Overall Study|Physician Decision|0
809810|NCT02305238|2642126|P1|Overall Study|Physician Decision|1
809811|NCT02305238|2642124|P3|Overall Study|Protocol Violation|0
809812|NCT02305238|2642125|P2|Overall Study|Protocol Violation|1
809813|NCT02305238|2642126|P1|Overall Study|Protocol Violation|0
809814|NCT02305238|2642124|P3|Overall Study|Logistical difficulties|0
809815|NCT02305238|2642125|P2|Overall Study|Logistical difficulties|1
809816|NCT02305238|2642126|P1|Overall Study|Logistical difficulties|1
809817|NCT02305238|2642124|P3|Overall Study|Progressive disease|0
809818|NCT02305238|2642125|P2|Overall Study|Progressive disease|2
809819|NCT02305238|2642126|P1|Overall Study|Progressive disease|4
809820|NCT02305238|2642124|P3|Overall Study|Death|0
809821|NCT02305238|2642125|P2|Overall Study|Death|0
809822|NCT02305238|2642126|P1|Overall Study|Death|2
809823|NCT02304926|2642158|P2|Overall Study|Lost to Follow-up|1
809824|NCT02304926|2642159|P1|Overall Study|Lost to Follow-up|2
809825|NCT02303704|2642251|P2|Overall Study|Protocol Violation|9
809826|NCT02303704|2642252|P1|Overall Study|Protocol Violation|5
809827|NCT02302846|2642268|P1|Overall Study|Withdrawal by Subject|1
809828|NCT02302807|2642274|P2|Overall Study|Death|322
809829|NCT02302807|2642275|P1|Overall Study|Death|345
809830|NCT02302807|2642274|P2|Overall Study|Lost to Follow-up|3
809831|NCT02302807|2642275|P1|Overall Study|Lost to Follow-up|3
809832|NCT02302807|2642274|P2|Overall Study|Withdrawal by Subject|9
809833|NCT02302807|2642275|P1|Overall Study|Withdrawal by Subject|27
809834|NCT02302716|2642322|P2|Overall Study|Protocol Violation|1
809835|NCT02302716|2642323|P1|Overall Study|Protocol Violation|0
809836|NCT02302716|2642322|P2|Overall Study|Withdrawal by Subject|7
809837|NCT02302716|2642323|P1|Overall Study|Withdrawal by Subject|13
809838|NCT02302716|2642322|P2|Overall Study|Physician Decision|4
809839|NCT02302716|2642323|P1|Overall Study|Physician Decision|3
809840|NCT02302716|2642322|P2|Overall Study|Lost to Follow-up|4
809841|NCT02302716|2642323|P1|Overall Study|Lost to Follow-up|2
809842|NCT02302716|2642322|P2|Overall Study|Lack of Efficacy|1
809843|NCT02302716|2642323|P1|Overall Study|Lack of Efficacy|0
809844|NCT02302716|2642322|P2|Overall Study|Death|1
809845|NCT02302716|2642323|P1|Overall Study|Death|0
809846|NCT02302716|2642322|P2|Overall Study|Adverse Event|1
809847|NCT02302716|2642323|P1|Overall Study|Adverse Event|1
809848|NCT02301988|2642398|P2|Overall Study|Adverse Event|1
809849|NCT02301988|2642399|P1|Overall Study|Adverse Event|1
809850|NCT02301988|2642398|P2|Overall Study|Death|0
809851|NCT02301988|2642399|P1|Overall Study|Death|1
809852|NCT02301988|2642398|P2|Overall Study|Lack of Efficacy|2
809853|NCT02301988|2642399|P1|Overall Study|Lack of Efficacy|3
809854|NCT02301988|2642398|P2|Overall Study|Unknown Reason|3
809855|NCT02301988|2642399|P1|Overall Study|Unknown Reason|1
809856|NCT02301988|2642398|P2|Overall Study|Physician Decision|2
809857|NCT02301988|2642399|P1|Overall Study|Physician Decision|2
809858|NCT02301988|2642398|P2|Overall Study|Withdrawal by Subject|1
809859|NCT02301988|2642399|P1|Overall Study|Withdrawal by Subject|2
809860|NCT02301975|2642432|P3|Overall Study|Withdrawal by Subject|11
809861|NCT02301975|2642433|P2|Overall Study|Withdrawal by Subject|12
809862|NCT02301975|2642434|P1|Overall Study|Withdrawal by Subject|15
809863|NCT02301975|2642432|P3|Overall Study|Physician Decision|3
809864|NCT02301975|2642433|P2|Overall Study|Physician Decision|2
809865|NCT02301975|2642434|P1|Overall Study|Physician Decision|4
809866|NCT02301975|2642432|P3|Overall Study|Lost to Follow-up|2
809867|NCT02301975|2642433|P2|Overall Study|Lost to Follow-up|2
809868|NCT02301975|2642434|P1|Overall Study|Lost to Follow-up|0
809869|NCT02301975|2642432|P3|Overall Study|Protocol Violation|3
809870|NCT02301975|2642433|P2|Overall Study|Protocol Violation|5
809871|NCT02301975|2642434|P1|Overall Study|Protocol Violation|3
809872|NCT02301975|2642432|P3|Overall Study|Lack of Efficacy|1
809873|NCT02301975|2642433|P2|Overall Study|Lack of Efficacy|1
809874|NCT02301975|2642434|P1|Overall Study|Lack of Efficacy|1
809875|NCT02301975|2642432|P3|Overall Study|Adverse Event|2
809876|NCT02301975|2642433|P2|Overall Study|Adverse Event|3
809877|NCT02301975|2642434|P1|Overall Study|Adverse Event|8
809878|NCT02301936|2642462|P2|Overall Study|Lost to Follow-up|0
809879|NCT02301936|2642463|P1|Overall Study|Lost to Follow-up|1
809880|NCT02301429|2642485|P1|Overall Study|not acceptable vascular anatomy|3
809881|NCT02301169|2642511|P2|Overall Study|Adverse Event|0
809882|NCT02301169|2642512|P1|Overall Study|Adverse Event|1
809883|NCT02300558|2642526|P1|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29
809884|NCT02300558|2642526|P1|Open-Label (OL) Extension Phase|Withdrew Consent|1
809885|NCT02300558|2642526|P1|Open-Label (OL) Extension Phase|Lack of Efficacy|2
809886|NCT02300558|2642526|P1|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6
809887|NCT02300311|2642539|P2|Overall Study|Refused to continue taking medication|0
809888|NCT02300311|2642540|P1|Overall Study|Refused to continue taking medication|18
809889|NCT02300311|2642539|P2|Overall Study|Other than the reason specified|0
809890|NCT02300311|2642540|P1|Overall Study|Other than the reason specified|1
809891|NCT02300298|2642552|P2|Disposition for Docetaxel|other adverse event|4
809892|NCT02300298|2642553|P1|Disposition for Docetaxel|other adverse event|0
809893|NCT02300298|2642552|P2|Disposition for Docetaxel|Progressive disease|6
809894|NCT02300298|2642553|P1|Disposition for Docetaxel|Progressive disease|0
809895|NCT02300298|2642552|P2|Disposition for Nintedanib|Progressive disease|0
809896|NCT02300298|2642553|P1|Disposition for Nintedanib|Progressive disease|10
809897|NCT02300129|2642563|P4|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
809898|NCT02300129|2642564|P3|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
809899|NCT02300129|2642565|P2|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
809900|NCT02300129|2642566|P1|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1
809901|NCT02300129|2642563|P4|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1
809902|NCT02300129|2642564|P3|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
809903|NCT02300129|2642565|P2|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
809904|NCT02300129|2642566|P1|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
809905|NCT02300129|2642563|P4|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
809906|NCT02300129|2642564|P3|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
809907|NCT02300129|2642565|P2|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1
809908|NCT02300129|2642566|P1|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
809909|NCT02300103|2642576|P1|Overall Study|Withdrew Consent|2
809910|NCT02300103|2642576|P1|Overall Study|Protocol Violation|1
809911|NCT02300103|2642576|P1|Overall Study|Lack of Efficacy|3
809912|NCT02299635|2642673|P1|Overall Study|Other|3
809913|NCT02299635|2642673|P1|Overall Study|Withdrawal by Subject|2
809914|NCT02299635|2642673|P1|Overall Study|Objective progression or relapse|10
809915|NCT02299635|2642673|P1|Overall Study|Global deterioration of health status|1
809916|NCT02299635|2642673|P1|Overall Study|Death|1
809917|NCT02299635|2642673|P1|Overall Study|Adverse Event|2
809918|NCT02299427|2642707|P2|Overall Study|not adherent to dog website use|0
809919|NCT02299427|2642708|P1|Overall Study|not adherent to dog website use|21
809920|NCT02299427|2642707|P2|Overall Study|Lost to Follow-up|3
809921|NCT02299427|2642708|P1|Overall Study|Lost to Follow-up|1
809922|NCT02299427|2642707|P2|Overall Study|Withdrawal by Subject|0
809923|NCT02299427|2642708|P1|Overall Study|Withdrawal by Subject|1
809924|NCT02299375|2642718|P2|Overall Study|Withdrawal by Subject|4
809925|NCT02299375|2642719|P1|Overall Study|Withdrawal by Subject|1
809926|NCT02299375|2642718|P2|Overall Study|Physician Decision|1
809927|NCT02299375|2642719|P1|Overall Study|Physician Decision|1
809928|NCT02299375|2642718|P2|Overall Study|Lost to Follow-up|2
809929|NCT02299375|2642719|P1|Overall Study|Lost to Follow-up|0
809930|NCT02299375|2642718|P2|Overall Study|Other: Study closed/terminated|55
809931|NCT02299375|2642719|P1|Overall Study|Other: Study closed/terminated|66
809932|NCT02299375|2642718|P2|Overall Study|Other: Met stopping criteria|0
809933|NCT02299375|2642719|P1|Overall Study|Other: Met stopping criteria|1
809934|NCT02299375|2642718|P2|Overall Study|Protocol Violation|3
809935|NCT02299375|2642719|P1|Overall Study|Protocol Violation|1
809936|NCT02299375|2642718|P2|Overall Study|Lack of Efficacy|3
809937|NCT02299375|2642719|P1|Overall Study|Lack of Efficacy|1
809938|NCT02299375|2642718|P2|Overall Study|Adverse Event, non-fatal|9
809939|NCT02299375|2642719|P1|Overall Study|Adverse Event, non-fatal|8
809940|NCT02299375|2642718|P2|Overall Study|Adverse Event, serious fatal|3
809941|NCT02299375|2642719|P1|Overall Study|Adverse Event, serious fatal|1
809942|NCT02299336|2642778|P1|Overall Study|Lost to Follow-up|1
809943|NCT02299336|2642778|P1|Overall Study|Death|1
809944|NCT02299336|2642778|P1|Overall Study|Adverse Event|1
809945|NCT02299336|2642778|P1|Overall Study|Withdrawal by Subject|11
809946|NCT02299206|2642802|P1|Overall Study|Withdrawal by Subject|1
809947|NCT02299206|2642802|P1|Overall Study|Lost to Follow-up|1
809948|NCT02299076|2642863|P2|Overall Study|Fraudulent Entries|14
809949|NCT02299076|2642864|P1|Overall Study|Fraudulent Entries|20
809950|NCT02298868|2642872|P1|Overall Study|Patient underwent transplant|1
809951|NCT02298868|2642872|P1|Overall Study|Death|1
809952|NCT02298868|2642872|P1|Overall Study|Adverse Event|1
809953|NCT02298192|2642943|P2|Overall Study|Adverse Event|2
809954|NCT02298192|2642944|P1|Overall Study|Adverse Event|6
809955|NCT02298192|2642943|P2|Overall Study|Lost to Follow-up|1
809956|NCT02298192|2642944|P1|Overall Study|Lost to Follow-up|2
809957|NCT02298192|2642943|P2|Overall Study|Withdrawal by Subject|1
809958|NCT02298192|2642944|P1|Overall Study|Withdrawal by Subject|6
809959|NCT02298192|2642943|P2|Overall Study|Withdrawal criteria|0
809960|NCT02298192|2642944|P1|Overall Study|Withdrawal criteria|2
809961|NCT02298192|2642943|P2|Overall Study|Unclassified|2
809962|NCT02298192|2642944|P1|Overall Study|Unclassified|3
809963|NCT02298179|2642968|P12|Overall Study|Lost to Follow-up|0
809964|NCT02298179|2642969|P11|Overall Study|Lost to Follow-up|0
809965|NCT02298179|2642970|P10|Overall Study|Lost to Follow-up|0
809966|NCT02298179|2642971|P9|Overall Study|Lost to Follow-up|0
809967|NCT02298179|2642972|P8|Overall Study|Lost to Follow-up|1
809968|NCT02298179|2642973|P7|Overall Study|Lost to Follow-up|0
809969|NCT02298179|2642974|P6|Overall Study|Lost to Follow-up|0
809970|NCT02298179|2642975|P5|Overall Study|Lost to Follow-up|0
809971|NCT02298179|2642976|P4|Overall Study|Lost to Follow-up|0
809972|NCT02298179|2642977|P3|Overall Study|Lost to Follow-up|1
809973|NCT02298179|2642978|P2|Overall Study|Lost to Follow-up|0
809974|NCT02298179|2642979|P1|Overall Study|Lost to Follow-up|0
809975|NCT02297841|2643221|P1|Overall Study|Protocol Violation|7
809976|NCT02297841|2643221|P1|Overall Study|Withdrawal by Subject|1
809977|NCT02297815|2643227|P2|Overall Study|Lost to Follow-up|140
809978|NCT02297815|2643228|P1|Overall Study|Lost to Follow-up|236
809979|NCT02297412|2643244|P2|Overall Study|Canceled|1
809980|NCT02297412|2643245|P1|Overall Study|Canceled|1
809981|NCT02296931|2643306|P2|Overall Study|Protocol Violation|2
809982|NCT02296931|2643307|P1|Overall Study|Protocol Violation|0
809983|NCT02296840|2643315|P2|Overall Study|Lost to Follow-up|17
809984|NCT02296840|2643316|P1|Overall Study|Lost to Follow-up|6
809985|NCT02296840|2643315|P2|Overall Study|Protocol Violation|1
809986|NCT02296840|2643316|P1|Overall Study|Protocol Violation|2
809987|NCT02296840|2643315|P2|Overall Study|Adverse Event|1
809988|NCT02296840|2643316|P1|Overall Study|Adverse Event|1
809989|NCT02296476|2643331|P3|Overall Study|Disease Progression|2
809990|NCT02296476|2643332|P2|Overall Study|Disease Progression|4
809991|NCT02296476|2643333|P1|Overall Study|Disease Progression|6
809992|NCT02296242|2643391|P5|Overall Study|Lack of Efficacy|3
809993|NCT02296242|2643392|P4|Overall Study|Lack of Efficacy|0
809994|NCT02296242|2643393|P3|Overall Study|Lack of Efficacy|0
809995|NCT02296242|2643394|P2|Overall Study|Lack of Efficacy|0
809996|NCT02296242|2643395|P1|Overall Study|Lack of Efficacy|0
809997|NCT02296242|2643391|P5|Overall Study|Adverse Event|0
809998|NCT02296242|2643392|P4|Overall Study|Adverse Event|1
809999|NCT02296242|2643393|P3|Overall Study|Adverse Event|0
810000|NCT02296242|2643394|P2|Overall Study|Adverse Event|0
810001|NCT02296242|2643395|P1|Overall Study|Adverse Event|0
810002|NCT02296242|2643391|P5|Overall Study|Alternative Treatment|0
810003|NCT02296242|2643392|P4|Overall Study|Alternative Treatment|1
810004|NCT02296242|2643393|P3|Overall Study|Alternative Treatment|0
810005|NCT02296242|2643394|P2|Overall Study|Alternative Treatment|0
810006|NCT02296242|2643395|P1|Overall Study|Alternative Treatment|0
810007|NCT02296242|2643391|P5|Overall Study|Physician Decision|0
810008|NCT02296242|2643392|P4|Overall Study|Physician Decision|1
810009|NCT02296242|2643393|P3|Overall Study|Physician Decision|0
810010|NCT02296242|2643394|P2|Overall Study|Physician Decision|1
810011|NCT02296242|2643395|P1|Overall Study|Physician Decision|0
810012|NCT02296242|2643391|P5|Overall Study|Screened for Other Protocol|0
810013|NCT02296242|2643392|P4|Overall Study|Screened for Other Protocol|0
810014|NCT02296242|2643393|P3|Overall Study|Screened for Other Protocol|0
810015|NCT02296242|2643394|P2|Overall Study|Screened for Other Protocol|1
810016|NCT02296242|2643395|P1|Overall Study|Screened for Other Protocol|0
810017|NCT02296242|2643391|P5|Overall Study|Need for Hydroxyurea|0
810018|NCT02296242|2643392|P4|Overall Study|Need for Hydroxyurea|0
810019|NCT02296242|2643393|P3|Overall Study|Need for Hydroxyurea|0
810020|NCT02296242|2643394|P2|Overall Study|Need for Hydroxyurea|0
810021|NCT02296242|2643395|P1|Overall Study|Need for Hydroxyurea|2
810022|NCT02296242|2643391|P5|Overall Study|Lost to Follow-up|0
810023|NCT02296242|2643392|P4|Overall Study|Lost to Follow-up|0
810024|NCT02296242|2643393|P3|Overall Study|Lost to Follow-up|0
810025|NCT02296242|2643394|P2|Overall Study|Lost to Follow-up|0
810026|NCT02296242|2643395|P1|Overall Study|Lost to Follow-up|1
810027|NCT02296242|2643391|P5|Overall Study|At Least 3 Drug Interruptions|1
810028|NCT02296242|2643392|P4|Overall Study|At Least 3 Drug Interruptions|1
810029|NCT02296242|2643393|P3|Overall Study|At Least 3 Drug Interruptions|1
810030|NCT02296242|2643394|P2|Overall Study|At Least 3 Drug Interruptions|0
810031|NCT02296242|2643395|P1|Overall Study|At Least 3 Drug Interruptions|0
810032|NCT02296242|2643391|P5|Overall Study|Patient Condition Changed|1
810033|NCT02296242|2643392|P4|Overall Study|Patient Condition Changed|0
810034|NCT02296242|2643393|P3|Overall Study|Patient Condition Changed|2
810035|NCT02296242|2643394|P2|Overall Study|Patient Condition Changed|0
810036|NCT02296242|2643395|P1|Overall Study|Patient Condition Changed|0
810037|NCT02296242|2643391|P5|Overall Study|Unacceptable Toxicity|1
810038|NCT02296242|2643392|P4|Overall Study|Unacceptable Toxicity|0
810039|NCT02296242|2643393|P3|Overall Study|Unacceptable Toxicity|0
810040|NCT02296242|2643394|P2|Overall Study|Unacceptable Toxicity|0
810041|NCT02296242|2643395|P1|Overall Study|Unacceptable Toxicity|0
810042|NCT02296242|2643391|P5|Overall Study|Disease Progression|11
810043|NCT02296242|2643392|P4|Overall Study|Disease Progression|8
810044|NCT02296242|2643393|P3|Overall Study|Disease Progression|2
810045|NCT02296242|2643394|P2|Overall Study|Disease Progression|3
810046|NCT02296242|2643395|P1|Overall Study|Disease Progression|1
810047|NCT02296242|2643391|P5|Overall Study|Withdrawal by Subject|3
810048|NCT02296242|2643392|P4|Overall Study|Withdrawal by Subject|1
810049|NCT02296242|2643393|P3|Overall Study|Withdrawal by Subject|1
810050|NCT02296242|2643394|P2|Overall Study|Withdrawal by Subject|0
810051|NCT02296242|2643395|P1|Overall Study|Withdrawal by Subject|0
810052|NCT02296242|2643391|P5|Overall Study|Death|1
810053|NCT02296242|2643392|P4|Overall Study|Death|1
810054|NCT02296242|2643393|P3|Overall Study|Death|1
810055|NCT02296242|2643394|P2|Overall Study|Death|1
810056|NCT02296242|2643395|P1|Overall Study|Death|1
810057|NCT02296138|2643415|P2|Overall Study|Other than specified|13
810058|NCT02296138|2643416|P1|Overall Study|Other than specified|15
810059|NCT02296138|2643415|P2|Overall Study|Patients with data irregularities|11
810060|NCT02296138|2643416|P1|Overall Study|Patients with data irregularities|10
810061|NCT02296138|2643415|P2|Overall Study|Not Treated|1
810062|NCT02296138|2643416|P1|Overall Study|Not Treated|1
810063|NCT02296138|2643415|P2|Overall Study|Withdrawal by Subject|131
810064|NCT02296138|2643416|P1|Overall Study|Withdrawal by Subject|184
810065|NCT02296138|2643415|P2|Overall Study|Lost to Follow-up|12
810066|NCT02296138|2643416|P1|Overall Study|Lost to Follow-up|9
810067|NCT02296138|2643415|P2|Overall Study|Protocol Violation|36
810068|NCT02296138|2643416|P1|Overall Study|Protocol Violation|35
810069|NCT02296138|2643415|P2|Overall Study|Lack of Efficacy|37
810070|NCT02296138|2643416|P1|Overall Study|Lack of Efficacy|59
810071|NCT02296138|2643415|P2|Overall Study|Adverse Event|259
810072|NCT02296138|2643416|P1|Overall Study|Adverse Event|348
810073|NCT02296125|2643432|P2|Overall Study|Any reason not specifically recorded|3
810074|NCT02296125|2643433|P1|Overall Study|Any reason not specifically recorded|3
810075|NCT02296125|2643432|P2|Overall Study|Condition under investigation worsened|151
810076|NCT02296125|2643433|P1|Overall Study|Condition under investigation worsened|87
810077|NCT02296125|2643432|P2|Overall Study|Severe non-compliance to protocol|1
810078|NCT02296125|2643433|P1|Overall Study|Severe non-compliance to protocol|0
810079|NCT02296125|2643432|P2|Overall Study|Adverse Event|50
810080|NCT02296125|2643433|P1|Overall Study|Adverse Event|36
810081|NCT02296125|2643432|P2|Overall Study|Withdrawal by Subject|8
810082|NCT02296125|2643433|P1|Overall Study|Withdrawal by Subject|12
810083|NCT02295774|2643487|P1|Overall Study|Withdrawal by Subject|2
810084|NCT02295774|2643487|P1|Overall Study|Physician Decision|1
810085|NCT02295644|2643496|P4|Overall Study|Did not meet inclusion criterion|2
810086|NCT02295644|2643497|P3|Overall Study|Did not meet inclusion criterion|1
810087|NCT02295644|2643498|P2|Overall Study|Did not meet inclusion criterion|0
810088|NCT02295644|2643499|P1|Overall Study|Did not meet inclusion criterion|0
810089|NCT02295280|2643519|P2|Overall Study|Adverse Event|1
810090|NCT02295280|2643520|P1|Overall Study|Adverse Event|0
810091|NCT02295020|2643528|P2|Overall Study|Withdrawal by Subject|2
810092|NCT02295020|2643529|P1|Overall Study|Withdrawal by Subject|3
810093|NCT02295020|2643528|P2|Overall Study|Adverse Event|1
810094|NCT02295020|2643529|P1|Overall Study|Adverse Event|0
810095|NCT02294773|2643561|P2|Overall Study|Withdrawal by Subject|2
810096|NCT02294773|2643562|P1|Overall Study|Withdrawal by Subject|0
810097|NCT02294734|2643578|P2|Overall Study|Withdrawal by Subject|2
810098|NCT02294734|2643579|P1|Overall Study|Withdrawal by Subject|4
810099|NCT02294734|2643578|P2|Overall Study|Physician Decision|1
810100|NCT02294734|2643579|P1|Overall Study|Physician Decision|2
810101|NCT02294734|2643578|P2|Overall Study|Lost to Follow-up|0
810102|NCT02294734|2643579|P1|Overall Study|Lost to Follow-up|2
810103|NCT02294734|2643578|P2|Overall Study|Met Protocol Defined Stopping Criteria|0
810104|NCT02294734|2643579|P1|Overall Study|Met Protocol Defined Stopping Criteria|1
810105|NCT02294734|2643578|P2|Overall Study|Adverse Event|5
810106|NCT02294734|2643579|P1|Overall Study|Adverse Event|5
810107|NCT02294682|2643631|P2|Overall Study|Could not swallow pills|0
810108|NCT02294682|2643632|P1|Overall Study|Could not swallow pills|1
810109|NCT02294604|2643675|P3|Overall Study|Culture contamination|0
810110|NCT02294604|2643676|P2|Overall Study|Culture contamination|2
810111|NCT02294604|2643677|P1|Overall Study|Culture contamination|1
810112|NCT02294604|2643675|P3|Overall Study|Did not provide samples for culture|0
810113|NCT02294604|2643676|P2|Overall Study|Did not provide samples for culture|1
810114|NCT02294604|2643677|P1|Overall Study|Did not provide samples for culture|0
810115|NCT02294474|2643696|P2|Overall Study|Other than specified above|12
810116|NCT02294474|2643697|P1|Overall Study|Other than specified above|12
810117|NCT02294474|2643696|P2|Overall Study|Protocol Violation|2
810118|NCT02294474|2643697|P1|Overall Study|Protocol Violation|4
810119|NCT02294474|2643696|P2|Overall Study|Lack of Efficacy|1
810120|NCT02294474|2643697|P1|Overall Study|Lack of Efficacy|2
810121|NCT02294474|2643696|P2|Overall Study|Adverse Event|7
810122|NCT02294474|2643697|P1|Overall Study|Adverse Event|7
810123|NCT02294461|2643721|P2|Overall Study|Miscellaneous|32
810124|NCT02294461|2643722|P1|Overall Study|Miscellaneous|11
810125|NCT02294461|2643721|P2|Overall Study|Adverse Event|10
810126|NCT02294461|2643722|P1|Overall Study|Adverse Event|11
810127|NCT02294461|2643721|P2|Overall Study|Disease Progression|39
810128|NCT02294461|2643722|P1|Overall Study|Disease Progression|23
810129|NCT02294461|2643721|P2|Overall Study|Withdrawal by Subject|45
810130|NCT02294461|2643722|P1|Overall Study|Withdrawal by Subject|14
810131|NCT02294461|2643721|P2|Overall Study|Protocol Violation|2
810132|NCT02294461|2643722|P1|Overall Study|Protocol Violation|0
810133|NCT02294461|2643721|P2|Overall Study|Death|3
810134|NCT02294461|2643722|P1|Overall Study|Death|3
810135|NCT02294019|2643774|P1|Overall Study|Withdrawal by Subject|1
810136|NCT02294019|2643774|P1|Overall Study|Other|1
810137|NCT02294019|2643774|P1|Overall Study|Lost to Follow-up|31
810138|NCT02294019|2643774|P1|Overall Study|Protocol Violation|68
810139|NCT02294019|2643774|P1|Overall Study|Adverse Event|2
810140|NCT02293902|2643782|P5|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
810141|NCT02293902|2643783|P4|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
810142|NCT02293902|2643784|P3|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
810143|NCT02293902|2643785|P2|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
810144|NCT02293902|2643786|P1|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
810145|NCT02293902|2643782|P5|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6
810146|NCT02293902|2643783|P4|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
810147|NCT02293902|2643784|P3|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
810148|NCT02293902|2643785|P2|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7
810149|NCT02293902|2643786|P1|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0
810150|NCT02293902|2643782|P5|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
810151|NCT02293902|2643783|P4|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
810152|NCT02293902|2643784|P3|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
810153|NCT02293902|2643785|P2|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
810154|NCT02293902|2643786|P1|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1
810155|NCT02293902|2643782|P5|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
810156|NCT02293902|2643783|P4|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
810157|NCT02293902|2643784|P3|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2
810158|NCT02293902|2643785|P2|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1
810159|NCT02293902|2643786|P1|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5
810160|NCT02293902|2643782|P5|Double-Blind Period (Up to Week 24)|Adverse Event|0
810161|NCT02293902|2643783|P4|Double-Blind Period (Up to Week 24)|Adverse Event|0
810162|NCT02293902|2643784|P3|Double-Blind Period (Up to Week 24)|Adverse Event|8
810163|NCT02293902|2643785|P2|Double-Blind Period (Up to Week 24)|Adverse Event|6
810164|NCT02293902|2643786|P1|Double-Blind Period (Up to Week 24)|Adverse Event|5
810165|NCT02293863|2643848|P3|Overall Study|Reason Not Specified|2
810166|NCT02293863|2643849|P2|Overall Study|Reason Not Specified|2
810167|NCT02293863|2643850|P1|Overall Study|Reason Not Specified|0
810168|NCT02293863|2643848|P3|Overall Study|Withdrawal by Subject|1
810169|NCT02293863|2643849|P2|Overall Study|Withdrawal by Subject|3
810170|NCT02293863|2643850|P1|Overall Study|Withdrawal by Subject|3
810171|NCT02293863|2643848|P3|Overall Study|Lost to Follow-up|2
810172|NCT02293863|2643849|P2|Overall Study|Lost to Follow-up|2
810173|NCT02293863|2643850|P1|Overall Study|Lost to Follow-up|2
810174|NCT02293863|2643848|P3|Overall Study|Death|4
810175|NCT02293863|2643849|P2|Overall Study|Death|6
810176|NCT02293863|2643850|P1|Overall Study|Death|4
810177|NCT02293538|2643915|P2|Overall Study|Withdrawal by Subject|1
810178|NCT02293538|2643916|P1|Overall Study|Withdrawal by Subject|0
810179|NCT02293538|2643915|P2|Overall Study|Lost to Follow-up|0
810180|NCT02293538|2643916|P1|Overall Study|Lost to Follow-up|1
810181|NCT02293538|2643915|P2|Overall Study|Adverse Event|1
810182|NCT02293538|2643916|P1|Overall Study|Adverse Event|0
810183|NCT02293395|2643948|P2|Overall Study|Withdrawal by Subject|7
810184|NCT02293395|2643949|P1|Overall Study|Withdrawal by Subject|8
810185|NCT02293395|2643948|P2|Overall Study|Lost to Follow-up|0
810186|NCT02293395|2643949|P1|Overall Study|Lost to Follow-up|1
810187|NCT02292849|2643958|P3|Overall Study|Physician Decision|0
810188|NCT02292849|2643959|P2|Overall Study|Physician Decision|0
810189|NCT02292849|2643960|P1|Overall Study|Physician Decision|4
810190|NCT02292849|2643958|P3|Overall Study|Lost to Follow-up|2
810191|NCT02292849|2643959|P2|Overall Study|Lost to Follow-up|2
810192|NCT02292849|2643960|P1|Overall Study|Lost to Follow-up|0
810193|NCT02292771|2643970|P2|Overall Study|Lost to Follow-up|1
810194|NCT02292771|2643971|P1|Overall Study|Lost to Follow-up|2
810195|NCT02292771|2643970|P2|Overall Study|Withdrawal by Subject|1
810196|NCT02292771|2643971|P1|Overall Study|Withdrawal by Subject|2
810197|NCT02292719|2644067|P6|Overall Study|Subject enrolled in new study.|0
810198|NCT02292719|2644068|P5|Overall Study|Subject enrolled in new study.|0
810199|NCT02292719|2644069|P4|Overall Study|Subject enrolled in new study.|0
810200|NCT02292719|2644070|P3|Overall Study|Subject enrolled in new study.|1
810201|NCT02292719|2644071|P2|Overall Study|Subject enrolled in new study.|0
810202|NCT02292719|2644072|P1|Overall Study|Subject enrolled in new study.|0
810203|NCT02292719|2644067|P6|Overall Study|Withdrawal by Subject|0
810204|NCT02292719|2644068|P5|Overall Study|Withdrawal by Subject|1
810205|NCT02292719|2644069|P4|Overall Study|Withdrawal by Subject|1
810206|NCT02292719|2644070|P3|Overall Study|Withdrawal by Subject|0
810207|NCT02292719|2644071|P2|Overall Study|Withdrawal by Subject|0
810208|NCT02292719|2644072|P1|Overall Study|Withdrawal by Subject|0
810209|NCT02292212|2644211|P1|ViE Phase|Protocol Violation|2
810210|NCT02292212|2644211|P1|ViE Phase|Withdrawal by Subject|1
810211|NCT02291861|2644255|P4|Overall Study|Not specified|1
810212|NCT02291861|2644256|P3|Overall Study|Not specified|0
810213|NCT02291861|2644257|P2|Overall Study|Not specified|0
810214|NCT02291861|2644258|P1|Overall Study|Not specified|0
810215|NCT02291861|2644255|P4|Overall Study|Lost to Follow-up|0
810216|NCT02291861|2644256|P3|Overall Study|Lost to Follow-up|4
810217|NCT02291861|2644257|P2|Overall Study|Lost to Follow-up|1
810218|NCT02291861|2644258|P1|Overall Study|Lost to Follow-up|2
810219|NCT02291861|2644255|P4|Overall Study|Noncompliance|1
810220|NCT02291861|2644256|P3|Overall Study|Noncompliance|2
810221|NCT02291861|2644257|P2|Overall Study|Noncompliance|1
810222|NCT02291861|2644258|P1|Overall Study|Noncompliance|1
810223|NCT02291861|2644255|P4|Overall Study|Withdrawal by Subject|4
810224|NCT02291861|2644256|P3|Overall Study|Withdrawal by Subject|1
810225|NCT02291861|2644257|P2|Overall Study|Withdrawal by Subject|2
810226|NCT02291861|2644258|P1|Overall Study|Withdrawal by Subject|1
810227|NCT02291861|2644255|P4|Overall Study|Protocol Violation|1
810228|NCT02291861|2644256|P3|Overall Study|Protocol Violation|0
810229|NCT02291861|2644257|P2|Overall Study|Protocol Violation|0
810230|NCT02291861|2644258|P1|Overall Study|Protocol Violation|1
810231|NCT02291861|2644255|P4|Overall Study|Death|1
810232|NCT02291861|2644256|P3|Overall Study|Death|1
810233|NCT02291861|2644257|P2|Overall Study|Death|0
810234|NCT02291861|2644258|P1|Overall Study|Death|0
810235|NCT02291861|2644255|P4|Overall Study|Adverse Event|2
810236|NCT02291861|2644256|P3|Overall Study|Adverse Event|1
810237|NCT02291861|2644257|P2|Overall Study|Adverse Event|4
810238|NCT02291861|2644258|P1|Overall Study|Adverse Event|2
810239|NCT02291679|2644321|P3|Overall Study|Not Specified|2
810240|NCT02291679|2644322|P2|Overall Study|Not Specified|4
810241|NCT02291679|2644323|P1|Overall Study|Not Specified|2
810242|NCT02291679|2644321|P3|Overall Study|Insufficient Therapeutic Response|7
810243|NCT02291679|2644322|P2|Overall Study|Insufficient Therapeutic Response|5
810244|NCT02291679|2644323|P1|Overall Study|Insufficient Therapeutic Response|5
810245|NCT02291679|2644321|P3|Overall Study|Lost to Follow-up|9
810246|NCT02291679|2644322|P2|Overall Study|Lost to Follow-up|10
810247|NCT02291679|2644323|P1|Overall Study|Lost to Follow-up|12
810248|NCT02291679|2644321|P3|Overall Study|Withdrew Consent|15
810249|NCT02291679|2644322|P2|Overall Study|Withdrew Consent|10
810250|NCT02291679|2644323|P1|Overall Study|Withdrew Consent|18
810251|NCT02291679|2644321|P3|Overall Study|Protocol Violation|7
810252|NCT02291679|2644322|P2|Overall Study|Protocol Violation|1
810253|NCT02291679|2644323|P1|Overall Study|Protocol Violation|5
810254|NCT02291679|2644321|P3|Overall Study|Adverse Event|19
810255|NCT02291679|2644322|P2|Overall Study|Adverse Event|12
810256|NCT02291679|2644323|P1|Overall Study|Adverse Event|2
810257|NCT02291549|2644354|P2|Overall Study|Withdrawal by Subject|1
810258|NCT02291549|2644355|P1|Overall Study|Withdrawal by Subject|0
810259|NCT02291549|2644354|P2|Overall Study|Lost to Follow-up|0
810260|NCT02291549|2644355|P1|Overall Study|Lost to Follow-up|1
810261|NCT02291510|2644377|P4|Overall Study|Adverse Event|1
810262|NCT02291510|2644378|P3|Overall Study|Adverse Event|0
810263|NCT02291510|2644379|P2|Overall Study|Adverse Event|0
810264|NCT02291510|2644380|P1|Overall Study|Adverse Event|0
810265|NCT02291419|2644396|P2|Overall Study|Early study termination|5
810266|NCT02291419|2644397|P1|Overall Study|Early study termination|1
810267|NCT02291237|2644415|P2|Overall Study|Subject Required Prohibited Medication|0
810268|NCT02291237|2644416|P1|Overall Study|Subject Required Prohibited Medication|2
810269|NCT02291237|2644415|P2|Overall Study|Lost to Follow-up|2
810270|NCT02291237|2644416|P1|Overall Study|Lost to Follow-up|0
810271|NCT02291237|2644415|P2|Overall Study|Withdrew Consent|11
810272|NCT02291237|2644416|P1|Overall Study|Withdrew Consent|11
810273|NCT02291237|2644415|P2|Overall Study|Investigator's Discretion|3
810274|NCT02291237|2644416|P1|Overall Study|Investigator's Discretion|0
810275|NCT02291237|2644415|P2|Overall Study|Adverse Event|3
810276|NCT02291237|2644416|P1|Overall Study|Adverse Event|1
810277|NCT02291237|2644415|P2|Overall Study|Study Terminated by Sponsor|67
810278|NCT02291237|2644416|P1|Overall Study|Study Terminated by Sponsor|72
810279|NCT02290873|2644435|P3|Overall Study|Protocol Violation|1
810280|NCT02290873|2644436|P2|Overall Study|Protocol Violation|0
810281|NCT02290873|2644437|P1|Overall Study|Protocol Violation|0
810282|NCT02290873|2644435|P3|Overall Study|Esophagogastroduodenoscopy was added|0
810283|NCT02290873|2644436|P2|Overall Study|Esophagogastroduodenoscopy was added|0
810284|NCT02290873|2644437|P1|Overall Study|Esophagogastroduodenoscopy was added|1
810285|NCT02290873|2644435|P3|Overall Study|Nellcor device error|0
810286|NCT02290873|2644436|P2|Overall Study|Nellcor device error|0
810287|NCT02290873|2644437|P1|Overall Study|Nellcor device error|1
810288|NCT02290873|2644435|P3|Overall Study|Withdrawal by Subject|1
810289|NCT02290873|2644436|P2|Overall Study|Withdrawal by Subject|1
810290|NCT02290873|2644437|P1|Overall Study|Withdrawal by Subject|0
810291|NCT02290821|2644456|P2|Overall Study|Lost to Follow-up|2
810292|NCT02290821|2644457|P1|Overall Study|Lost to Follow-up|3
810293|NCT02290821|2644456|P2|Overall Study|Unable or unwilling to cooperate with|0
810294|NCT02290821|2644457|P1|Overall Study|Unable or unwilling to cooperate with|2
810295|NCT02290821|2644456|P2|Overall Study|Withdrawal by Subject|1
810296|NCT02290821|2644457|P1|Overall Study|Withdrawal by Subject|1
810297|NCT02290691|2644465|P2|Overall Study|Lost to Follow-up|7
810298|NCT02290691|2644466|P1|Overall Study|Lost to Follow-up|7
810299|NCT02290691|2644465|P2|Overall Study|Withdrawal by Subject|1
810300|NCT02290691|2644466|P1|Overall Study|Withdrawal by Subject|1
810301|NCT02290691|2644465|P2|Overall Study|Noncompliance|1
810302|NCT02290691|2644466|P1|Overall Study|Noncompliance|0
810303|NCT02290340|2644499|P4|Overall Study|Other|1
810304|NCT02290340|2644500|P3|Overall Study|Other|0
810305|NCT02290340|2644501|P2|Overall Study|Other|0
810306|NCT02290340|2644502|P1|Overall Study|Other|1
810307|NCT02290340|2644499|P4|Overall Study|Withdrawal by Subject|0
810308|NCT02290340|2644500|P3|Overall Study|Withdrawal by Subject|0
810309|NCT02290340|2644501|P2|Overall Study|Withdrawal by Subject|0
810310|NCT02290340|2644502|P1|Overall Study|Withdrawal by Subject|1
810311|NCT02290340|2644499|P4|Overall Study|Lost to Follow-up|1
810312|NCT02290340|2644500|P3|Overall Study|Lost to Follow-up|0
810313|NCT02290340|2644501|P2|Overall Study|Lost to Follow-up|0
810314|NCT02290340|2644502|P1|Overall Study|Lost to Follow-up|0
810315|NCT02289963|2644566|P2|Overall Study|Other than specified above|2
810316|NCT02289963|2644567|P1|Overall Study|Other than specified above|0
810317|NCT02289963|2644566|P2|Overall Study|End treatment visit outside visit window|4
810318|NCT02289963|2644567|P1|Overall Study|End treatment visit outside visit window|0
810319|NCT02289963|2644566|P2|Overall Study|Last injection missed|2
810320|NCT02289963|2644567|P1|Overall Study|Last injection missed|2
810321|NCT02289963|2644566|P2|Overall Study|Withdrawal by Subject|0
810322|NCT02289963|2644567|P1|Overall Study|Withdrawal by Subject|1
810323|NCT02289963|2644566|P2|Overall Study|Poor compliance to protocol|0
810324|NCT02289963|2644567|P1|Overall Study|Poor compliance to protocol|1
810325|NCT02289963|2644566|P2|Overall Study|Adverse Event|2
810326|NCT02289963|2644567|P1|Overall Study|Adverse Event|1
810327|NCT02289898|2644618|P3|Overall Study|Not specified|10
810328|NCT02289898|2644619|P2|Overall Study|Not specified|7
810329|NCT02289898|2644620|P1|Overall Study|Not specified|8
810330|NCT02289898|2644618|P3|Overall Study|Use of another anticancer therapy|1
810331|NCT02289898|2644619|P2|Overall Study|Use of another anticancer therapy|0
810332|NCT02289898|2644620|P1|Overall Study|Use of another anticancer therapy|0
810333|NCT02289898|2644618|P3|Overall Study|Disease progression|34
810334|NCT02289898|2644619|P2|Overall Study|Disease progression|28
810335|NCT02289898|2644620|P1|Overall Study|Disease progression|34
810336|NCT02289898|2644618|P3|Overall Study|Adverse Event|5
810337|NCT02289898|2644619|P2|Overall Study|Adverse Event|5
810338|NCT02289898|2644620|P1|Overall Study|Adverse Event|3
810339|NCT02289898|2644618|P3|Overall Study|Withdrawal by Subject|1
810340|NCT02289898|2644619|P2|Overall Study|Withdrawal by Subject|4
810341|NCT02289898|2644620|P1|Overall Study|Withdrawal by Subject|0
810342|NCT02289898|2644618|P3|Overall Study|Physician Decision|2
810343|NCT02289898|2644619|P2|Overall Study|Physician Decision|5
810344|NCT02289898|2644620|P1|Overall Study|Physician Decision|2
810345|NCT02289898|2644618|P3|Overall Study|Death|3
810346|NCT02289898|2644619|P2|Overall Study|Death|4
810347|NCT02289898|2644620|P1|Overall Study|Death|5
810348|NCT02289833|2644629|P2|Overall Study|Death|8
810349|NCT02289833|2644630|P1|Overall Study|Death|15
810350|NCT02289833|2644629|P2|Overall Study|Lost to Follow-up|0
810351|NCT02289833|2644630|P1|Overall Study|Lost to Follow-up|2
810352|NCT02289833|2644629|P2|Overall Study|Disease Progression|3
810353|NCT02289833|2644630|P1|Overall Study|Disease Progression|0
810354|NCT02289833|2644629|P2|Overall Study|Clinical Progression|1
810355|NCT02289833|2644630|P1|Overall Study|Clinical Progression|0
810356|NCT02289833|2644629|P2|Overall Study|Continued Participation in Study|8
810357|NCT02289833|2644630|P1|Overall Study|Continued Participation in Study|12
810358|NCT02289820|2644668|P7|Overall Study|withdrawal of consent|0
810359|NCT02289820|2644669|P6|Overall Study|withdrawal of consent|0
810360|NCT02289820|2644670|P5|Overall Study|withdrawal of consent|0
810361|NCT02289820|2644671|P4|Overall Study|withdrawal of consent|0
810362|NCT02289820|2644672|P3|Overall Study|withdrawal of consent|0
810363|NCT02289820|2644673|P2|Overall Study|withdrawal of consent|1
810364|NCT02289820|2644674|P1|Overall Study|withdrawal of consent|0
810365|NCT02289820|2644668|P7|Overall Study|Lost to Follow-up|1
810366|NCT02289820|2644669|P6|Overall Study|Lost to Follow-up|1
810367|NCT02289820|2644670|P5|Overall Study|Lost to Follow-up|0
810368|NCT02289820|2644671|P4|Overall Study|Lost to Follow-up|1
810369|NCT02289820|2644672|P3|Overall Study|Lost to Follow-up|3
810370|NCT02289820|2644673|P2|Overall Study|Lost to Follow-up|0
810371|NCT02289820|2644674|P1|Overall Study|Lost to Follow-up|0
810372|NCT02289820|2644668|P7|Overall Study|Death|0
810373|NCT02289820|2644669|P6|Overall Study|Death|0
810374|NCT02289820|2644670|P5|Overall Study|Death|0
810375|NCT02289820|2644671|P4|Overall Study|Death|0
810376|NCT02289820|2644672|P3|Overall Study|Death|1
810377|NCT02289820|2644673|P2|Overall Study|Death|0
810378|NCT02289820|2644674|P1|Overall Study|Death|0
810379|NCT02289820|2644668|P7|Overall Study|Withdrawal by Subject|1
810380|NCT02289820|2644669|P6|Overall Study|Withdrawal by Subject|0
810381|NCT02289820|2644670|P5|Overall Study|Withdrawal by Subject|0
810382|NCT02289820|2644671|P4|Overall Study|Withdrawal by Subject|1
810383|NCT02289820|2644672|P3|Overall Study|Withdrawal by Subject|2
810384|NCT02289820|2644673|P2|Overall Study|Withdrawal by Subject|1
810385|NCT02289820|2644674|P1|Overall Study|Withdrawal by Subject|2
810386|NCT02289742|2644792|P4|Third Wear Period|Reason not given|1
810387|NCT02289742|2644793|P3|Third Wear Period|Reason not given|0
810388|NCT02289742|2644794|P2|Third Wear Period|Reason not given|0
810389|NCT02289742|2644795|P1|Third Wear Period|Reason not given|0
810390|NCT02289742|2644792|P4|Third Wear Period|Adverse Event|0
810391|NCT02289742|2644793|P3|Third Wear Period|Adverse Event|0
810392|NCT02289742|2644794|P2|Third Wear Period|Adverse Event|1
810393|NCT02289742|2644795|P1|Third Wear Period|Adverse Event|0
810394|NCT02289742|2644792|P4|First Wear Period|Other prior to treatment|1
810395|NCT02289742|2644793|P3|First Wear Period|Other prior to treatment|0
810396|NCT02289742|2644794|P2|First Wear Period|Other prior to treatment|0
810397|NCT02289742|2644795|P1|First Wear Period|Other prior to treatment|0
810398|NCT02289742|2644792|P4|First Wear Period|Adverse Event|0
810399|NCT02289742|2644793|P3|First Wear Period|Adverse Event|1
810400|NCT02289742|2644794|P2|First Wear Period|Adverse Event|0
810401|NCT02289742|2644795|P1|First Wear Period|Adverse Event|0
810402|NCT02289742|2644792|P4|First Wear Period|Adverse event prior to treatment|0
810403|NCT02289742|2644793|P3|First Wear Period|Adverse event prior to treatment|0
810404|NCT02289742|2644794|P2|First Wear Period|Adverse event prior to treatment|1
810405|NCT02289742|2644795|P1|First Wear Period|Adverse event prior to treatment|0
810406|NCT02289469|2644814|P2|Overall Study|Unable to match a control|0
810407|NCT02289469|2644815|P1|Overall Study|Unable to match a control|6
810408|NCT02289456|2644823|P1|Monotherapy Period|Miscellaneous|1
810409|NCT02289456|2644823|P1|Monotherapy Period|Study Terminated by Sponsor|2
810410|NCT02289456|2644823|P1|Monotherapy Period|Withdrawal by Subject|2
810411|NCT02289456|2644823|P1|Monotherapy Period|Symptomatic Deterioration|1
810412|NCT02289456|2644823|P1|Monotherapy Period|Progressive Disease (PD)|8
810413|NCT02289456|2644823|P1|Monotherapy Period|Adverse Event|1
810414|NCT02289456|2644823|P1|Monotherapy Period|Death|1
810415|NCT02289456|2644823|P1|Induction Period|Miscellaneous|1
810416|NCT02289456|2644823|P1|Induction Period|Withdrawal by Subject|2
810417|NCT02289456|2644823|P1|Induction Period|Symptomatic Deterioration|4
810418|NCT02289456|2644823|P1|Induction Period|Progressive Disease (PD)|4
810419|NCT02289456|2644823|P1|Induction Period|Adverse Event|11
810420|NCT02289456|2644823|P1|Induction Period|Death|2
810421|NCT02289417|2644846|P3|Overall Study|Lack of Efficacy|0
810422|NCT02289417|2644847|P2|Overall Study|Lack of Efficacy|0
810423|NCT02289417|2644848|P1|Overall Study|Lack of Efficacy|3
810424|NCT02289417|2644846|P3|Overall Study|Lost to Follow-up|1
810425|NCT02289417|2644847|P2|Overall Study|Lost to Follow-up|1
810426|NCT02289417|2644848|P1|Overall Study|Lost to Follow-up|0
810427|NCT02289417|2644846|P3|Overall Study|Withdrawal by Subject|0
810428|NCT02289417|2644847|P2|Overall Study|Withdrawal by Subject|3
810429|NCT02289417|2644848|P1|Overall Study|Withdrawal by Subject|1
810430|NCT02289417|2644846|P3|Overall Study|Adverse Event|2
810431|NCT02289417|2644847|P2|Overall Study|Adverse Event|0
810432|NCT02289417|2644848|P1|Overall Study|Adverse Event|3
810433|NCT02289079|2644942|P2|Overall Study|Lost to Follow-up|1
810434|NCT02289079|2644943|P1|Overall Study|Lost to Follow-up|0
810435|NCT02289079|2644942|P2|Overall Study|Physician Decision|0
810436|NCT02289079|2644943|P1|Overall Study|Physician Decision|2
810437|NCT02288325|2644982|P3|Double-blind Treatment Period|Multiple Reasons|2
810438|NCT02288325|2644983|P2|Double-blind Treatment Period|Multiple Reasons|8
810439|NCT02288325|2644984|P1|Double-blind Treatment Period|Multiple Reasons|0
810440|NCT02288325|2644982|P3|Double-blind Treatment Period|Non-Compliance With Study Drug|4
810441|NCT02288325|2644983|P2|Double-blind Treatment Period|Non-Compliance With Study Drug|1
810442|NCT02288325|2644984|P1|Double-blind Treatment Period|Non-Compliance With Study Drug|0
810443|NCT02288325|2644982|P3|Double-blind Treatment Period|Protocol Violation|2
810444|NCT02288325|2644983|P2|Double-blind Treatment Period|Protocol Violation|1
810445|NCT02288325|2644984|P1|Double-blind Treatment Period|Protocol Violation|0
810446|NCT02288325|2644982|P3|Double-blind Treatment Period|Lost to Follow-up|5
810447|NCT02288325|2644983|P2|Double-blind Treatment Period|Lost to Follow-up|4
810448|NCT02288325|2644984|P1|Double-blind Treatment Period|Lost to Follow-up|0
810449|NCT02288325|2644982|P3|Double-blind Treatment Period|Withdrawal of Consent|8
810450|NCT02288325|2644983|P2|Double-blind Treatment Period|Withdrawal of Consent|8
810451|NCT02288325|2644984|P1|Double-blind Treatment Period|Withdrawal of Consent|0
810452|NCT02288325|2644982|P3|Double-blind Treatment Period|Adverse Event|5
810453|NCT02288325|2644983|P2|Double-blind Treatment Period|Adverse Event|2
810454|NCT02288325|2644984|P1|Double-blind Treatment Period|Adverse Event|0
810455|NCT02288325|2644982|P3|Stabilization Period|Reason not Specified|0
810456|NCT02288325|2644983|P2|Stabilization Period|Reason not Specified|0
810457|NCT02288325|2644984|P1|Stabilization Period|Reason not Specified|15
810458|NCT02288325|2644982|P3|Stabilization Period|Non-Compliance With Study Drug|0
810459|NCT02288325|2644983|P2|Stabilization Period|Non-Compliance With Study Drug|0
810460|NCT02288325|2644984|P1|Stabilization Period|Non-Compliance With Study Drug|5
810461|NCT02288325|2644982|P3|Stabilization Period|Protocol Violation|0
810462|NCT02288325|2644983|P2|Stabilization Period|Protocol Violation|0
810463|NCT02288325|2644984|P1|Stabilization Period|Protocol Violation|8
810464|NCT02288325|2644982|P3|Stabilization Period|Lost to Follow-up|0
810465|NCT02288325|2644983|P2|Stabilization Period|Lost to Follow-up|0
810466|NCT02288325|2644984|P1|Stabilization Period|Lost to Follow-up|12
810467|NCT02288325|2644982|P3|Stabilization Period|Withdrawal of Consent|0
810468|NCT02288325|2644983|P2|Stabilization Period|Withdrawal of Consent|0
810469|NCT02288325|2644984|P1|Stabilization Period|Withdrawal of Consent|23
810470|NCT02288325|2644982|P3|Stabilization Period|Lack of Efficacy|0
810471|NCT02288325|2644983|P2|Stabilization Period|Lack of Efficacy|0
810472|NCT02288325|2644984|P1|Stabilization Period|Lack of Efficacy|22
810473|NCT02288325|2644982|P3|Stabilization Period|Adverse Event|0
810474|NCT02288325|2644983|P2|Stabilization Period|Adverse Event|0
810475|NCT02288325|2644984|P1|Stabilization Period|Adverse Event|13
810476|NCT02288325|2644982|P3|Run-in Period|Reason not Specified|0
810477|NCT02288325|2644983|P2|Run-in Period|Reason not Specified|0
810478|NCT02288325|2644984|P1|Run-in Period|Reason not Specified|8
810479|NCT02288325|2644982|P3|Run-in Period|Non-Compliance With Study Drug|0
810480|NCT02288325|2644983|P2|Run-in Period|Non-Compliance With Study Drug|0
810481|NCT02288325|2644984|P1|Run-in Period|Non-Compliance With Study Drug|3
810482|NCT02288325|2644982|P3|Run-in Period|Protocol Violation|0
810483|NCT02288325|2644983|P2|Run-in Period|Protocol Violation|0
810484|NCT02288325|2644984|P1|Run-in Period|Protocol Violation|17
810485|NCT02288325|2644982|P3|Run-in Period|Lost to Follow-up|0
810486|NCT02288325|2644983|P2|Run-in Period|Lost to Follow-up|0
810487|NCT02288325|2644984|P1|Run-in Period|Lost to Follow-up|25
810488|NCT02288325|2644982|P3|Run-in Period|Withdrawal of Consent|0
810489|NCT02288325|2644983|P2|Run-in Period|Withdrawal of Consent|0
810490|NCT02288325|2644984|P1|Run-in Period|Withdrawal of Consent|28
810491|NCT02288325|2644982|P3|Run-in Period|Lack of Efficacy|0
810492|NCT02288325|2644983|P2|Run-in Period|Lack of Efficacy|0
810493|NCT02288325|2644984|P1|Run-in Period|Lack of Efficacy|16
810494|NCT02288325|2644982|P3|Run-in Period|Adverse Event|0
810495|NCT02288325|2644983|P2|Run-in Period|Adverse Event|0
810496|NCT02288325|2644984|P1|Run-in Period|Adverse Event|48
810497|NCT02288312|2644994|P3|Overall Study|Pregnancy|0
810498|NCT02288312|2644995|P2|Overall Study|Pregnancy|0
810499|NCT02288312|2644996|P1|Overall Study|Pregnancy|1
810500|NCT02288091|2645034|P1|Overall Study|Screen fail|7
810501|NCT02288091|2645034|P1|Overall Study|Lost to Follow-up|1
810502|NCT02287883|2645044|P2|Overall Study|Non-response to survey|237
810503|NCT02287883|2645045|P1|Overall Study|Non-response to survey|229
810504|NCT02287883|2645044|P2|Overall Study|No longer eligible|182
810505|NCT02287883|2645045|P1|Overall Study|No longer eligible|222
810506|NCT02287883|2645044|P2|Overall Study|Death|7
810507|NCT02287883|2645045|P1|Overall Study|Death|8
810508|NCT02287623|2645210|P2|Overall Study|Protocol Violation|1
810509|NCT02287623|2645211|P1|Overall Study|Protocol Violation|0
810510|NCT02287610|2645227|P1|Overall Study|Excluded-investigator non-responsiveness|5
810511|NCT02287610|2645227|P1|Overall Study|Withdrawal by Subject|8
810512|NCT02287610|2645227|P1|Overall Study|Lost to Follow-up|3
810513|NCT02287402|2645266|P1|Follow-up|Voluntary Withdrawal|2
810514|NCT02287402|2645266|P1|Follow-up|Lost to Follow-up|1
810515|NCT02287402|2645266|P1|Treatment Period|Voluntary Withdrawal|10
810516|NCT02287402|2645266|P1|Treatment Period|Adverse Event|17
810517|NCT02287025|2645371|P2|Overall Study|Screening failed|1
810518|NCT02287025|2645372|P1|Overall Study|Screening failed|1
810519|NCT02287025|2645371|P2|Overall Study|Withdrawal by Subject|2
810520|NCT02287025|2645372|P1|Overall Study|Withdrawal by Subject|2
810521|NCT02287025|2645371|P2|Overall Study|Adverse Event|4
810522|NCT02287025|2645372|P1|Overall Study|Adverse Event|2
810523|NCT02287025|2645371|P2|Overall Study|Progression of disease|2
810524|NCT02287025|2645372|P1|Overall Study|Progression of disease|3
810525|NCT02287025|2645371|P2|Overall Study|Not treated|0
810526|NCT02287025|2645372|P1|Overall Study|Not treated|2
810527|NCT02286466|2645550|P2|Overall Study|Declined Clinician Assessment|1
810528|NCT02286466|2645551|P1|Overall Study|Declined Clinician Assessment|0
810529|NCT02286466|2645550|P2|Overall Study|Lost to Follow-up|4
810530|NCT02286466|2645551|P1|Overall Study|Lost to Follow-up|1
810531|NCT02286466|2645550|P2|Overall Study|Withdrawal by Subject|2
810532|NCT02286466|2645551|P1|Overall Study|Withdrawal by Subject|5
810533|NCT02286466|2645550|P2|Overall Study|Death|3
810534|NCT02286466|2645551|P1|Overall Study|Death|1
810535|NCT02286193|2645563|P1|Overall Study|Referred: Declined service|38
810536|NCT02286193|2645563|P1|Overall Study|Referred: unable to reach/resource sent|104
810537|NCT02286193|2645563|P1|Overall Study|Referred: CRS unable to make contact|62
810538|NCT02286102|2645570|P2|Overall Study|Screen Failure|1
810539|NCT02286102|2645571|P1|Overall Study|Screen Failure|1
810540|NCT02285998|2645583|P2|Overall Study|Other Reasons|10
810541|NCT02285998|2645584|P1|Overall Study|Other Reasons|7
810542|NCT02285998|2645583|P2|Overall Study|Withdrawal by Subject|61
810543|NCT02285998|2645584|P1|Overall Study|Withdrawal by Subject|53
810544|NCT02285998|2645583|P2|Overall Study|Lost to Follow-up|172
810545|NCT02285998|2645584|P1|Overall Study|Lost to Follow-up|176
810546|NCT02285998|2645583|P2|Overall Study|Physician Decision|2
810547|NCT02285998|2645584|P1|Overall Study|Physician Decision|1
810548|NCT02285998|2645583|P2|Overall Study|Adverse Event|8
810549|NCT02285998|2645584|P1|Overall Study|Adverse Event|9
810550|NCT02285777|2645636|P2|Overall Study|Lost to Follow-up|2
810551|NCT02285777|2645637|P1|Overall Study|Lost to Follow-up|4
810552|NCT02285777|2645636|P2|Overall Study|Withdrawal by Subject|1
810553|NCT02285777|2645637|P1|Overall Study|Withdrawal by Subject|1
810554|NCT02285270|2645718|P1|Overall Study|Determined to be ineligible|1
810555|NCT02285270|2645718|P1|Overall Study|Physician Decision|3
810556|NCT02285270|2645718|P1|Overall Study|Lost to Follow-up|1
810557|NCT02284893|2645726|P2|52 Week (Long Term)|Non-Compliance|3
810558|NCT02284893|2645727|P1|52 Week (Long Term)|Non-Compliance|2
810559|NCT02284893|2645726|P2|52 Week (Long Term)|Lost to Follow-up|2
810560|NCT02284893|2645727|P1|52 Week (Long Term)|Lost to Follow-up|2
810561|NCT02284893|2645726|P2|52 Week (Long Term)|Withrawal of the consent by the subject|6
810562|NCT02284893|2645727|P1|52 Week (Long Term)|Withrawal of the consent by the subject|4
810563|NCT02284893|2645726|P2|52 Week (Long Term)|Subject no longer meets study criteria|1
810564|NCT02284893|2645727|P1|52 Week (Long Term)|Subject no longer meets study criteria|0
810565|NCT02284893|2645726|P2|52 Week (Long Term)|Adverse Event|1
810566|NCT02284893|2645727|P1|52 Week (Long Term)|Adverse Event|3
810567|NCT02284893|2645726|P2|26 Week (Short Term)|Other|1
810568|NCT02284893|2645727|P1|26 Week (Short Term)|Other|1
810569|NCT02284893|2645726|P2|26 Week (Short Term)|Subject no longer meets study criteria|8
810570|NCT02284893|2645727|P1|26 Week (Short Term)|Subject no longer meets study criteria|5
810571|NCT02284893|2645726|P2|26 Week (Short Term)|Lost to Follow-up|1
810572|NCT02284893|2645727|P1|26 Week (Short Term)|Lost to Follow-up|3
810573|NCT02284893|2645726|P2|26 Week (Short Term)|Withrawal of the consent by the subject|10
810574|NCT02284893|2645727|P1|26 Week (Short Term)|Withrawal of the consent by the subject|7
810575|NCT02284893|2645726|P2|26 Week (Short Term)|Discontinuation by the subject|2
810576|NCT02284893|2645727|P1|26 Week (Short Term)|Discontinuation by the subject|2
810577|NCT02284893|2645726|P2|26 Week (Short Term)|Adverse Event|9
810578|NCT02284893|2645727|P1|26 Week (Short Term)|Adverse Event|1
810579|NCT02284568|2645804|P3|Overall Study|Withdrew before taking study drug|0
810580|NCT02284568|2645805|P2|Overall Study|Withdrew before taking study drug|1
810581|NCT02284568|2645806|P1|Overall Study|Withdrew before taking study drug|0
810582|NCT02284568|2645804|P3|Overall Study|Not specified|0
810583|NCT02284568|2645805|P2|Overall Study|Not specified|2
810584|NCT02284568|2645806|P1|Overall Study|Not specified|1
810585|NCT02284568|2645804|P3|Overall Study|Lack of Efficacy|0
810586|NCT02284568|2645805|P2|Overall Study|Lack of Efficacy|7
810587|NCT02284568|2645806|P1|Overall Study|Lack of Efficacy|4
810588|NCT02284568|2645804|P3|Overall Study|Lost to Follow-up|0
810589|NCT02284568|2645805|P2|Overall Study|Lost to Follow-up|3
810590|NCT02284568|2645806|P1|Overall Study|Lost to Follow-up|0
810591|NCT02284568|2645804|P3|Overall Study|Sponsor requested patient stop treatment|90
810592|NCT02284568|2645805|P2|Overall Study|Sponsor requested patient stop treatment|0
810593|NCT02284568|2645806|P1|Overall Study|Sponsor requested patient stop treatment|0
810594|NCT02284568|2645804|P3|Overall Study|Protocol Violation|0
810595|NCT02284568|2645805|P2|Overall Study|Protocol Violation|1
810596|NCT02284568|2645806|P1|Overall Study|Protocol Violation|0
810597|NCT02284568|2645804|P3|Overall Study|Noncompliance|0
810598|NCT02284568|2645805|P2|Overall Study|Noncompliance|0
810599|NCT02284568|2645806|P1|Overall Study|Noncompliance|1
810600|NCT02284568|2645804|P3|Overall Study|Noncompliance with study drug admin|0
810601|NCT02284568|2645805|P2|Overall Study|Noncompliance with study drug admin|2
810602|NCT02284568|2645806|P1|Overall Study|Noncompliance with study drug admin|1
810603|NCT02284568|2645804|P3|Overall Study|Withdrawal by Subject|1
810604|NCT02284568|2645805|P2|Overall Study|Withdrawal by Subject|21
810605|NCT02284568|2645806|P1|Overall Study|Withdrawal by Subject|22
810606|NCT02284568|2645804|P3|Overall Study|Adverse Event|4
810607|NCT02284568|2645805|P2|Overall Study|Adverse Event|9
810608|NCT02284568|2645806|P1|Overall Study|Adverse Event|2
810609|NCT02284347|2645857|P1|Overall Study|Withdrawn prior to treatment|1
810610|NCT02284347|2645857|P1|Overall Study|Lost to Follow-up|2
810611|NCT02284243|2645865|P2|Overall Study|Adverse Event|0
810612|NCT02284243|2645866|P1|Overall Study|Adverse Event|1
810613|NCT02284243|2645865|P2|Overall Study|Lack of Efficacy|3
810614|NCT02284243|2645866|P1|Overall Study|Lack of Efficacy|3
810615|NCT02283788|2645962|P4|Overall Study|Withdrawal by Subject|1
810616|NCT02283788|2645963|P3|Overall Study|Withdrawal by Subject|0
810617|NCT02283788|2645964|P2|Overall Study|Withdrawal by Subject|1
810618|NCT02283788|2645965|P1|Overall Study|Withdrawal by Subject|0
810619|NCT02283788|2645962|P4|Overall Study|Adverse Event|1
810620|NCT02283788|2645963|P3|Overall Study|Adverse Event|5
810621|NCT02283788|2645964|P2|Overall Study|Adverse Event|3
810622|NCT02283788|2645965|P1|Overall Study|Adverse Event|1
810623|NCT02283411|2645981|P1|Overall Study|Screen Failed|28
810624|NCT02283411|2645981|P1|Overall Study|Withdrawal by Subject|3
810625|NCT02283268|2645989|P1|Overall Study|Withdrawal by Subject|1
810626|NCT02282982|2646050|P1|Overall Study|Other, not specified|18
810627|NCT02282982|2646050|P1|Overall Study|Palivizumab is ended|11
810628|NCT02282982|2646050|P1|Overall Study|Lack of product|156
810629|NCT02282982|2646050|P1|Overall Study|Death|4
810630|NCT02282982|2646050|P1|Overall Study|Withdrew consent|2
810631|NCT02282982|2646050|P1|Overall Study|Lost to Follow-up|15
810632|NCT02282813|2646068|P3|Overall Study|Administrative reasons|0
810633|NCT02282813|2646069|P2|Overall Study|Administrative reasons|1
810634|NCT02282813|2646070|P1|Overall Study|Administrative reasons|0
810635|NCT02282813|2646068|P3|Overall Study|Lack of Efficacy|0
810636|NCT02282813|2646069|P2|Overall Study|Lack of Efficacy|0
810637|NCT02282813|2646070|P1|Overall Study|Lack of Efficacy|1
810638|NCT02282813|2646068|P3|Overall Study|Serum Ca >/=11.0mg/dL|0
810639|NCT02282813|2646069|P2|Overall Study|Serum Ca >/=11.0mg/dL|0
810640|NCT02282813|2646070|P1|Overall Study|Serum Ca >/=11.0mg/dL|1
810641|NCT02282813|2646068|P3|Overall Study|Lost to Follow-up|1
810642|NCT02282813|2646069|P2|Overall Study|Lost to Follow-up|0
810643|NCT02282813|2646070|P1|Overall Study|Lost to Follow-up|2
810644|NCT02282813|2646068|P3|Overall Study|Physician Decision|1
810645|NCT02282813|2646069|P2|Overall Study|Physician Decision|3
810646|NCT02282813|2646070|P1|Overall Study|Physician Decision|0
810647|NCT02282813|2646068|P3|Overall Study|Subject non-compliance|0
810648|NCT02282813|2646069|P2|Overall Study|Subject non-compliance|4
810649|NCT02282813|2646070|P1|Overall Study|Subject non-compliance|1
810650|NCT02282813|2646068|P3|Overall Study|Adverse Event|1
810651|NCT02282813|2646069|P2|Overall Study|Adverse Event|10
810652|NCT02282813|2646070|P1|Overall Study|Adverse Event|3
810653|NCT02282813|2646068|P3|Overall Study|Withdrawal by Subject|0
810654|NCT02282813|2646069|P2|Overall Study|Withdrawal by Subject|5
810655|NCT02282813|2646070|P1|Overall Study|Withdrawal by Subject|4
810656|NCT02282631|2646116|P2|Overall Study|Lost to Follow-up|0
810657|NCT02282631|2646117|P1|Overall Study|Lost to Follow-up|2
810658|NCT02282605|2646158|P3|Overall Study|negative SA result on Day -1|0
810659|NCT02282605|2646159|P2|Overall Study|negative SA result on Day -1|0
810660|NCT02282605|2646160|P1|Overall Study|negative SA result on Day -1|3
810661|NCT02282527|2646182|P2|Overall Study|Lack of home health aid|0
810662|NCT02282527|2646183|P1|Overall Study|Lack of home health aid|1
810663|NCT02282527|2646182|P2|Overall Study|Lost to Follow-up|1
810664|NCT02282527|2646183|P1|Overall Study|Lost to Follow-up|0
810665|NCT02281773|2646215|P5|Overall Study|Other Reason|1
810666|NCT02281773|2646216|P4|Overall Study|Other Reason|3
810667|NCT02281773|2646217|P3|Overall Study|Other Reason|2
810668|NCT02281773|2646218|P2|Overall Study|Other Reason|4
810669|NCT02281773|2646219|P1|Overall Study|Other Reason|0
810670|NCT02281773|2646215|P5|Overall Study|Withdrawal by Subject|8
810671|NCT02281773|2646216|P4|Overall Study|Withdrawal by Subject|6
810672|NCT02281773|2646217|P3|Overall Study|Withdrawal by Subject|6
810673|NCT02281773|2646218|P2|Overall Study|Withdrawal by Subject|8
810674|NCT02281773|2646219|P1|Overall Study|Withdrawal by Subject|2
810675|NCT02281773|2646215|P5|Overall Study|Lost to Follow-up|10
810676|NCT02281773|2646216|P4|Overall Study|Lost to Follow-up|2
810677|NCT02281773|2646217|P3|Overall Study|Lost to Follow-up|6
810678|NCT02281773|2646218|P2|Overall Study|Lost to Follow-up|2
810679|NCT02281773|2646219|P1|Overall Study|Lost to Follow-up|2
810680|NCT02281773|2646215|P5|Overall Study|Protocol Violation|2
810681|NCT02281773|2646216|P4|Overall Study|Protocol Violation|2
810682|NCT02281773|2646217|P3|Overall Study|Protocol Violation|0
810683|NCT02281773|2646218|P2|Overall Study|Protocol Violation|0
810684|NCT02281773|2646219|P1|Overall Study|Protocol Violation|1
810685|NCT02281773|2646215|P5|Overall Study|Adverse Event|9
810686|NCT02281773|2646216|P4|Overall Study|Adverse Event|8
810687|NCT02281773|2646217|P3|Overall Study|Adverse Event|4
810688|NCT02281773|2646218|P2|Overall Study|Adverse Event|1
810689|NCT02281773|2646219|P1|Overall Study|Adverse Event|6
810690|NCT02281552|2646307|P2|Overall Study|Adverse Event|9
810691|NCT02281552|2646308|P1|Overall Study|Adverse Event|3
810692|NCT02281552|2646307|P2|Overall Study|Insufficient clinical response|1
810693|NCT02281552|2646308|P1|Overall Study|Insufficient clinical response|0
810694|NCT02281552|2646307|P2|Overall Study|Medication error|0
810695|NCT02281552|2646308|P1|Overall Study|Medication error|1
810696|NCT02281357|2646401|P2|Overall Study|Withdrawal by Subject|3
810697|NCT02281357|2646402|P1|Overall Study|Withdrawal by Subject|4
810698|NCT02281357|2646401|P2|Overall Study|Lost to Follow-up|0
810699|NCT02281357|2646402|P1|Overall Study|Lost to Follow-up|1
810700|NCT02281357|2646401|P2|Overall Study|Adverse Event|1
810701|NCT02281357|2646402|P1|Overall Study|Adverse Event|2
810702|NCT02281318|2646416|P2|Overall Study|Withdrawal by Subject|2
810703|NCT02281318|2646417|P1|Overall Study|Withdrawal by Subject|6
810704|NCT02281318|2646416|P2|Overall Study|Physician Decision|0
810705|NCT02281318|2646417|P1|Overall Study|Physician Decision|2
810706|NCT02281318|2646416|P2|Overall Study|Lost to Follow-up|1
810707|NCT02281318|2646417|P1|Overall Study|Lost to Follow-up|2
810708|NCT02281318|2646416|P2|Overall Study|Lack of Efficacy|0
810709|NCT02281318|2646417|P1|Overall Study|Lack of Efficacy|2
810710|NCT02281318|2646416|P2|Overall Study|Adverse Event|2
810711|NCT02281318|2646417|P1|Overall Study|Adverse Event|2
810712|NCT02280863|2646463|P2|Integrated Platform|Met stopping criteria|1
810713|NCT02280863|2646464|P1|Integrated Platform|Met stopping criteria|0
810714|NCT02280499|2646548|P1|Overall Study|Adverse Event|5
810715|NCT02280499|2646548|P1|Overall Study|Lost to Follow-up|42
810716|NCT02280499|2646548|P1|Overall Study|Death|14
810717|NCT02280473|2646556|P2|Overall Study|Lost to Follow-up|1
810718|NCT02280473|2646557|P1|Overall Study|Lost to Follow-up|0
810719|NCT02280473|2646556|P2|Overall Study|Lack of Efficacy|1
810720|NCT02280473|2646557|P1|Overall Study|Lack of Efficacy|0
810721|NCT02280473|2646556|P2|Overall Study|Adverse Event|1
810722|NCT02280473|2646557|P1|Overall Study|Adverse Event|1
810723|NCT02280187|2646576|P1|Overall Study|Lost to Follow-up|218
810724|NCT02280044|2646604|P2|Overall Study|Planned alternate|2
810725|NCT02280044|2646605|P1|Overall Study|Planned alternate|0
810726|NCT02279862|2646615|P2|Overall Study|Withdrawal by Subject|0
810727|NCT02279862|2646616|P1|Overall Study|Withdrawal by Subject|1
810728|NCT02279862|2646615|P2|Overall Study|Other|2
810729|NCT02279862|2646616|P1|Overall Study|Other|1
810730|NCT02279862|2646615|P2|Overall Study|Study closed by sponsor|13
810731|NCT02279862|2646616|P1|Overall Study|Study closed by sponsor|16
810732|NCT02279862|2646615|P2|Overall Study|Disease progression|2
810733|NCT02279862|2646616|P1|Overall Study|Disease progression|5
810734|NCT02279862|2646615|P2|Overall Study|Administrative reason by sponsor|1
810735|NCT02279862|2646616|P1|Overall Study|Administrative reason by sponsor|0
810736|NCT02279862|2646615|P2|Overall Study|No longer meets criteria|1
810737|NCT02279862|2646616|P1|Overall Study|No longer meets criteria|0
810738|NCT02279862|2646615|P2|Overall Study|Study drug toxicity|6
810739|NCT02279862|2646616|P1|Overall Study|Study drug toxicity|3
810740|NCT02279498|2646714|P2|Overall Study|Undefined|1
810741|NCT02279498|2646715|P1|Overall Study|Undefined|2
810742|NCT02279498|2646714|P2|Overall Study|Withdrawal by Subject|2
810743|NCT02279498|2646715|P1|Overall Study|Withdrawal by Subject|9
810744|NCT02279498|2646714|P2|Overall Study|Lost to Follow-up|1
810745|NCT02279498|2646715|P1|Overall Study|Lost to Follow-up|0
810746|NCT02279498|2646714|P2|Overall Study|Lack of Efficacy|0
810747|NCT02279498|2646715|P1|Overall Study|Lack of Efficacy|4
810748|NCT02279498|2646714|P2|Overall Study|Adverse Event|0
810749|NCT02279498|2646715|P1|Overall Study|Adverse Event|3
810750|NCT02279420|2646724|P1|Overall Study|Lost to Follow-up|23
810751|NCT02279407|2646732|P4|Overall Study|Adverse Event|0
810752|NCT02279407|2646733|P3|Overall Study|Adverse Event|2
810753|NCT02279407|2646734|P2|Overall Study|Adverse Event|1
810754|NCT02279407|2646735|P1|Overall Study|Adverse Event|1
810755|NCT02279407|2646732|P4|Overall Study|Withdrawal by Subject|1
810756|NCT02279407|2646733|P3|Overall Study|Withdrawal by Subject|1
810757|NCT02279407|2646734|P2|Overall Study|Withdrawal by Subject|0
810758|NCT02279407|2646735|P1|Overall Study|Withdrawal by Subject|1
810759|NCT02279407|2646732|P4|Overall Study|Couldn't swallow IP; noncompliance|0
810760|NCT02279407|2646733|P3|Overall Study|Couldn't swallow IP; noncompliance|2
810761|NCT02279407|2646734|P2|Overall Study|Couldn't swallow IP; noncompliance|0
810762|NCT02279407|2646735|P1|Overall Study|Couldn't swallow IP; noncompliance|0
810763|NCT02278939|2646777|P2|Overall Study|family emergency unable to commit|0
810764|NCT02278939|2646778|P1|Overall Study|family emergency unable to commit|2
810765|NCT02278939|2646777|P2|Overall Study|death in family|0
810766|NCT02278939|2646778|P1|Overall Study|death in family|1
810767|NCT02278939|2646777|P2|Overall Study|Lost to Follow-up|1
810768|NCT02278939|2646778|P1|Overall Study|Lost to Follow-up|1
810769|NCT02278939|2646777|P2|Overall Study|lack of time|0
810770|NCT02278939|2646778|P1|Overall Study|lack of time|1
810771|NCT02278614|2646806|P2|Overall Study|left eye was not eligible|0
810772|NCT02278614|2646807|P1|Overall Study|left eye was not eligible|1
810773|NCT02278614|2646806|P2|Overall Study|Adverse Event|0
810774|NCT02278614|2646807|P1|Overall Study|Adverse Event|1
810775|NCT02278614|2646806|P2|Overall Study|Withdrawal by Subject|5
810776|NCT02278614|2646807|P1|Overall Study|Withdrawal by Subject|3
810777|NCT02278003|2646854|P2|Overall Study|Recognition task improperly completed|0
810778|NCT02278003|2646855|P1|Overall Study|Recognition task improperly completed|7
810779|NCT02278003|2646854|P2|Overall Study|Not Treated|0
810780|NCT02278003|2646855|P1|Overall Study|Not Treated|1
810781|NCT02278003|2646854|P2|Overall Study|Withdrawal by Subject|0
810782|NCT02278003|2646855|P1|Overall Study|Withdrawal by Subject|11
810783|NCT02277769|2646866|P3|Overall Study|Other than specified above|5
810784|NCT02277769|2646867|P2|Overall Study|Other than specified above|8
810785|NCT02277769|2646868|P1|Overall Study|Other than specified above|12
810786|NCT02277769|2646866|P3|Overall Study|Adverse Event|4
810787|NCT02277769|2646867|P2|Overall Study|Adverse Event|2
810788|NCT02277769|2646868|P1|Overall Study|Adverse Event|14
810789|NCT02277769|2646866|P3|Overall Study|Lack of Efficacy|4
810790|NCT02277769|2646867|P2|Overall Study|Lack of Efficacy|0
810791|NCT02277769|2646868|P1|Overall Study|Lack of Efficacy|17
810792|NCT02277769|2646866|P3|Overall Study|Protocol Violation|5
810793|NCT02277769|2646867|P2|Overall Study|Protocol Violation|3
810794|NCT02277769|2646868|P1|Overall Study|Protocol Violation|3
810795|NCT02277743|2646939|P3|Overall Study|Other than specified above|16
810796|NCT02277743|2646940|P2|Overall Study|Other than specified above|5
810797|NCT02277743|2646941|P1|Overall Study|Other than specified above|18
810798|NCT02277743|2646939|P3|Overall Study|Lack of Efficacy|3
810799|NCT02277743|2646940|P2|Overall Study|Lack of Efficacy|4
810800|NCT02277743|2646941|P1|Overall Study|Lack of Efficacy|11
810801|NCT02277743|2646939|P3|Overall Study|Adverse Event|6
810802|NCT02277743|2646940|P2|Overall Study|Adverse Event|6
810803|NCT02277743|2646941|P1|Overall Study|Adverse Event|10
810804|NCT02277743|2646939|P3|Overall Study|Protocol Violation|1
810805|NCT02277743|2646940|P2|Overall Study|Protocol Violation|1
810806|NCT02277743|2646941|P1|Overall Study|Protocol Violation|1
810807|NCT02277691|2647009|P1|Overall Study|Used Other Antihypertensive Drug|1
810808|NCT02277691|2647009|P1|Overall Study|Lack of Efficacy|5
810809|NCT02277691|2647009|P1|Overall Study|Voluntary Withdrawal|7
810810|NCT02277691|2647009|P1|Overall Study|Pretreatment Event/Adverse Event|33
810811|NCT02277119|2647055|P3|Overall Study|Protocol Violation|7
810812|NCT02277119|2647056|P2|Overall Study|Protocol Violation|3
810813|NCT02277119|2647057|P1|Overall Study|Protocol Violation|2
810814|NCT02277119|2647055|P3|Overall Study|Lack of Efficacy|1
810815|NCT02277119|2647056|P2|Overall Study|Lack of Efficacy|1
810816|NCT02277119|2647057|P1|Overall Study|Lack of Efficacy|1
810817|NCT02276612|2647090|P2|Overall Study|Lost to Follow-up|0
810818|NCT02276612|2647091|P1|Overall Study|Lost to Follow-up|1
810819|NCT02276612|2647090|P2|Overall Study|Withdrew Consent|0
810820|NCT02276612|2647091|P1|Overall Study|Withdrew Consent|1
810821|NCT02276612|2647090|P2|Overall Study|Pregnancy|0
810822|NCT02276612|2647091|P1|Overall Study|Pregnancy|1
810823|NCT02276612|2647090|P2|Overall Study|Death|0
810824|NCT02276612|2647091|P1|Overall Study|Death|1
810825|NCT02276560|2647114|P3|Overall Study|Adverse Event|0
810826|NCT02276560|2647115|P2|Overall Study|Adverse Event|0
810827|NCT02276560|2647116|P1|Overall Study|Adverse Event|1
810828|NCT02276222|2647237|P2|Overall Study|subject withdrew after randomization|0
810829|NCT02276222|2647238|P1|Overall Study|subject withdrew after randomization|1
810830|NCT02276222|2647237|P2|Overall Study|sheduling conflict|0
810831|NCT02276222|2647238|P1|Overall Study|sheduling conflict|1
810832|NCT02276222|2647237|P2|Overall Study|Physician Decision|1
810833|NCT02276222|2647238|P1|Overall Study|Physician Decision|2
810834|NCT02276222|2647237|P2|Overall Study|Lost to Follow-up|5
810835|NCT02276222|2647238|P1|Overall Study|Lost to Follow-up|15
810836|NCT02276222|2647237|P2|Overall Study|sponsor decision|3
810837|NCT02276222|2647238|P1|Overall Study|sponsor decision|0
810838|NCT02276222|2647237|P2|Overall Study|non compliance with study medication|2
810839|NCT02276222|2647238|P1|Overall Study|non compliance with study medication|6
810840|NCT02276222|2647237|P2|Overall Study|Withdrawal by Subject|33
810841|NCT02276222|2647238|P1|Overall Study|Withdrawal by Subject|79
810842|NCT02276222|2647237|P2|Overall Study|Protocol Violation|2
810843|NCT02276222|2647238|P1|Overall Study|Protocol Violation|3
810844|NCT02276222|2647237|P2|Overall Study|Lack of Efficacy|3
810845|NCT02276222|2647238|P1|Overall Study|Lack of Efficacy|13
810846|NCT02276222|2647237|P2|Overall Study|Death|4
810847|NCT02276222|2647238|P1|Overall Study|Death|3
810848|NCT02276222|2647237|P2|Overall Study|Adverse Event|11
810849|NCT02276222|2647238|P1|Overall Study|Adverse Event|62
810850|NCT02276040|2647262|P1|Overall Study|Physician Decision|15
810851|NCT02275780|2647268|P2|Extension Study: up to 192 Weeks|Ongoing|233
810852|NCT02275780|2647269|P1|Extension Study: up to 192 Weeks|Ongoing|260
810853|NCT02275780|2647268|P2|Base Study: 96 Weeks|Randomized not treated|1
810854|NCT02275780|2647269|P1|Base Study: 96 Weeks|Randomized not treated|2
810855|NCT02275780|2647268|P2|Base Study: 96 Weeks|Pregnancy|1
810856|NCT02275780|2647269|P1|Base Study: 96 Weeks|Pregnancy|2
810857|NCT02275780|2647268|P2|Base Study: 96 Weeks|Physician Decision|4
810858|NCT02275780|2647269|P1|Base Study: 96 Weeks|Physician Decision|2
810859|NCT02275780|2647268|P2|Base Study: 96 Weeks|Noncompliance with drug|6
810860|NCT02275780|2647269|P1|Base Study: 96 Weeks|Noncompliance with drug|9
810861|NCT02275780|2647268|P2|Base Study: 96 Weeks|Withdrawal by Subject|22
810862|NCT02275780|2647269|P1|Base Study: 96 Weeks|Withdrawal by Subject|19
810863|NCT02275780|2647268|P2|Base Study: 96 Weeks|Protocol Violation|6
810864|NCT02275780|2647269|P1|Base Study: 96 Weeks|Protocol Violation|1
810865|NCT02275780|2647268|P2|Base Study: 96 Weeks|Lost to Follow-up|24
810866|NCT02275780|2647269|P1|Base Study: 96 Weeks|Lost to Follow-up|28
810867|NCT02275780|2647268|P2|Base Study: 96 Weeks|Lack of Efficacy|32
810868|NCT02275780|2647269|P1|Base Study: 96 Weeks|Lack of Efficacy|21
810869|NCT02275780|2647268|P2|Base Study: 96 Weeks|Death|1
810870|NCT02275780|2647269|P1|Base Study: 96 Weeks|Death|3
810871|NCT02275780|2647268|P2|Base Study: 96 Weeks|Adverse Event|14
810872|NCT02275780|2647269|P1|Base Study: 96 Weeks|Adverse Event|6
810873|NCT02275611|2647325|P4|Inpatient Withdrawal|Withdrawal by Subject|0
810874|NCT02275611|2647326|P3|Inpatient Withdrawal|Withdrawal by Subject|0
810875|NCT02275611|2647327|P2|Inpatient Withdrawal|Withdrawal by Subject|0
810876|NCT02275611|2647328|P1|Inpatient Withdrawal|Withdrawal by Subject|1
810877|NCT02275546|2647340|P2|Treatment Period 2|Protocol Violation|1
810878|NCT02275546|2647341|P1|Treatment Period 2|Protocol Violation|0
810879|NCT02275546|2647340|P2|Treatment Period 2|Withdrawal by Subject|1
810880|NCT02275546|2647341|P1|Treatment Period 2|Withdrawal by Subject|2
810881|NCT02275481|2647351|P2|Overall Study|Physician Decision|1
810882|NCT02275481|2647352|P1|Overall Study|Physician Decision|0
810883|NCT02275481|2647351|P2|Overall Study|all other reasons combined|1
810884|NCT02275481|2647352|P1|Overall Study|all other reasons combined|2
810885|NCT02275481|2647351|P2|Overall Study|Withdrawal by Subject|0
810886|NCT02275481|2647352|P1|Overall Study|Withdrawal by Subject|3
810887|NCT02275481|2647351|P2|Overall Study|Lost to Follow-up|0
810888|NCT02275481|2647352|P1|Overall Study|Lost to Follow-up|2
810889|NCT02275481|2647351|P2|Overall Study|Death|1
810890|NCT02275481|2647352|P1|Overall Study|Death|2
810891|NCT02275364|2647358|P2|Period 1|Other reason|0
810892|NCT02275364|2647359|P1|Period 1|Other reason|1
810893|NCT02275364|2647358|P2|Period 1|Withdrawal by Subject|0
810894|NCT02275364|2647359|P1|Period 1|Withdrawal by Subject|1
810895|NCT02275052|2647420|P4|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2
810896|NCT02275052|2647421|P3|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
810897|NCT02275052|2647422|P2|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
810898|NCT02275052|2647423|P1|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
810899|NCT02275052|2647420|P4|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6
810900|NCT02275052|2647421|P3|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
810901|NCT02275052|2647422|P2|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
810902|NCT02275052|2647423|P1|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
810903|NCT02275052|2647420|P4|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4
810904|NCT02275052|2647421|P3|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
810905|NCT02275052|2647422|P2|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
810906|NCT02275052|2647423|P1|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
810907|NCT02275052|2647420|P4|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2
810908|NCT02275052|2647421|P3|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3
810909|NCT02275052|2647422|P2|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
810910|NCT02275052|2647423|P1|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
810911|NCT02275052|2647420|P4|Washout Period (12-17 Days)|Lack of Efficacy|0
810912|NCT02275052|2647421|P3|Washout Period (12-17 Days)|Lack of Efficacy|0
810913|NCT02275052|2647422|P2|Washout Period (12-17 Days)|Lack of Efficacy|0
810914|NCT02275052|2647423|P1|Washout Period (12-17 Days)|Lack of Efficacy|1
810915|NCT02275052|2647420|P4|Washout Period (12-17 Days)|Withdrawal by Subject|0
810916|NCT02275052|2647421|P3|Washout Period (12-17 Days)|Withdrawal by Subject|0
810917|NCT02275052|2647422|P2|Washout Period (12-17 Days)|Withdrawal by Subject|0
810918|NCT02275052|2647423|P1|Washout Period (12-17 Days)|Withdrawal by Subject|3
810919|NCT02275052|2647420|P4|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
810920|NCT02275052|2647421|P3|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
810921|NCT02275052|2647422|P2|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
810922|NCT02275052|2647423|P1|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2
810923|NCT02275052|2647420|P4|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
810924|NCT02275052|2647421|P3|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
810925|NCT02275052|2647422|P2|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
810926|NCT02275052|2647423|P1|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1
810927|NCT02275052|2647420|P4|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
810928|NCT02275052|2647421|P3|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
810929|NCT02275052|2647422|P2|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4
810930|NCT02275052|2647423|P1|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6
810931|NCT02275052|2647420|P4|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
810932|NCT02275052|2647421|P3|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
810933|NCT02275052|2647422|P2|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1
810934|NCT02275052|2647423|P1|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
810935|NCT02275052|2647420|P4|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
810936|NCT02275052|2647421|P3|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
810937|NCT02275052|2647422|P2|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
810938|NCT02275052|2647423|P1|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
810939|NCT02274948|2647437|P2|Overall Study|Left the area|3
810940|NCT02274948|2647438|P1|Overall Study|Left the area|4
810941|NCT02274948|2647437|P2|Overall Study|Stopped on family Practitioner advice|5
810942|NCT02274948|2647438|P1|Overall Study|Stopped on family Practitioner advice|2
810943|NCT02274948|2647437|P2|Overall Study|Withdrawal by Subject|58
810944|NCT02274948|2647438|P1|Overall Study|Withdrawal by Subject|64
810945|NCT02274948|2647437|P2|Overall Study|Lost to Follow-up|25
810946|NCT02274948|2647438|P1|Overall Study|Lost to Follow-up|28
810947|NCT02274792|2647479|P1|Overall Study|Sponsor Decision|2
810948|NCT02274792|2647479|P1|Overall Study|Protocol Specified Criteria|2
810949|NCT02274792|2647479|P1|Overall Study|Lost to Follow-up|8
810950|NCT02274792|2647479|P1|Overall Study|Withdrawal by Subject|13
810951|NCT02274766|2647489|P2|Overall Study|Adverse Event|1
810952|NCT02274766|2647490|P1|Overall Study|Adverse Event|0
810953|NCT02274766|2647489|P2|Overall Study|Subject Unwilling to Proceed|1
810954|NCT02274766|2647490|P1|Overall Study|Subject Unwilling to Proceed|0
810955|NCT02274766|2647489|P2|Overall Study|Did Not Receive Study Drug|1
810956|NCT02274766|2647490|P1|Overall Study|Did Not Receive Study Drug|1
810957|NCT02274766|2647489|P2|Overall Study|Withdrawal by Subject|6
810958|NCT02274766|2647490|P1|Overall Study|Withdrawal by Subject|3
810959|NCT02274558|2647536|P3|Overall Study|Physician Decision|1
810960|NCT02274558|2647537|P2|Overall Study|Physician Decision|2
810961|NCT02274558|2647538|P1|Overall Study|Physician Decision|0
810962|NCT02274558|2647536|P3|Overall Study|Lost to Follow-up|1
810963|NCT02274558|2647537|P2|Overall Study|Lost to Follow-up|1
810964|NCT02274558|2647538|P1|Overall Study|Lost to Follow-up|2
810965|NCT02274558|2647536|P3|Overall Study|Death|1
810966|NCT02274558|2647537|P2|Overall Study|Death|0
810967|NCT02274558|2647538|P1|Overall Study|Death|0
810968|NCT02274558|2647536|P3|Overall Study|Withdrawal by Subject|4
810969|NCT02274558|2647537|P2|Overall Study|Withdrawal by Subject|5
810970|NCT02274558|2647538|P1|Overall Study|Withdrawal by Subject|1
810971|NCT02274558|2647536|P3|Overall Study|Non-compliance|0
810972|NCT02274558|2647537|P2|Overall Study|Non-compliance|1
810973|NCT02274558|2647538|P1|Overall Study|Non-compliance|2
810974|NCT02274558|2647536|P3|Overall Study|Adverse Event|2
810975|NCT02274558|2647537|P2|Overall Study|Adverse Event|4
810976|NCT02274558|2647538|P1|Overall Study|Adverse Event|2
810977|NCT02273973|2647554|P2|Overall Study|Reason not specified|1
810978|NCT02273973|2647555|P1|Overall Study|Reason not specified|0
810979|NCT02273973|2647554|P2|Overall Study|Physician Decision|1
810980|NCT02273973|2647555|P1|Overall Study|Physician Decision|0
810981|NCT02273973|2647554|P2|Overall Study|Lost to Follow-up|1
810982|NCT02273973|2647555|P1|Overall Study|Lost to Follow-up|0
810983|NCT02273973|2647554|P2|Overall Study|Progression of disease|2
810984|NCT02273973|2647555|P1|Overall Study|Progression of disease|0
810985|NCT02273973|2647554|P2|Overall Study|Protocol Violation|0
810986|NCT02273973|2647555|P1|Overall Study|Protocol Violation|1
810987|NCT02273973|2647554|P2|Overall Study|Non-compliance|0
810988|NCT02273973|2647555|P1|Overall Study|Non-compliance|1
810989|NCT02273973|2647554|P2|Overall Study|Death|0
810990|NCT02273973|2647555|P1|Overall Study|Death|1
810991|NCT02273973|2647554|P2|Overall Study|Withdrawal by Subject|3
810992|NCT02273973|2647555|P1|Overall Study|Withdrawal by Subject|2
810993|NCT02273973|2647554|P2|Overall Study|Adverse Event|0
810994|NCT02273973|2647555|P1|Overall Study|Adverse Event|4
810995|NCT02273908|2647597|P2|Overall Study|Withdrawal by Subject|2
810996|NCT02273908|2647598|P1|Overall Study|Withdrawal by Subject|4
810997|NCT02273908|2647597|P2|Overall Study|Did not meet entrance criteria|2
810998|NCT02273908|2647598|P1|Overall Study|Did not meet entrance criteria|3
810999|NCT02273908|2647597|P2|Overall Study|Lost to Follow-up|1
811000|NCT02273908|2647598|P1|Overall Study|Lost to Follow-up|10
811001|NCT02273908|2647597|P2|Overall Study|Adverse Event|0
811002|NCT02273908|2647598|P1|Overall Study|Adverse Event|16
811003|NCT02273752|2647620|P1|Overall Study|Trial was terminated early|2
811004|NCT02273180|2647664|P2|Overall Study|Other than specified above|10
811005|NCT02273180|2647665|P1|Overall Study|Other than specified above|21
811006|NCT02273180|2647664|P2|Overall Study|Hypoglycemia(not reported as serious AE)|0
811007|NCT02273180|2647665|P1|Overall Study|Hypoglycemia(not reported as serious AE)|1
811008|NCT02273180|2647664|P2|Overall Study|Randomized but not treated|0
811009|NCT02273180|2647665|P1|Overall Study|Randomized but not treated|1
811010|NCT02273180|2647664|P2|Overall Study|Protocol Violation|7
811011|NCT02273180|2647665|P1|Overall Study|Protocol Violation|1
811012|NCT02273180|2647664|P2|Overall Study|Lack of Efficacy|0
811013|NCT02273180|2647665|P1|Overall Study|Lack of Efficacy|1
811014|NCT02273180|2647664|P2|Overall Study|Adverse Event|2
811015|NCT02273180|2647665|P1|Overall Study|Adverse Event|2
811016|NCT02273167|2647690|P3|Overall Study|Various|8
811017|NCT02273167|2647691|P2|Overall Study|Various|9
811018|NCT02273167|2647692|P1|Overall Study|Various|10
811019|NCT02273167|2647690|P3|Overall Study|Withdrawal by Subject|11
811020|NCT02273167|2647691|P2|Overall Study|Withdrawal by Subject|12
811021|NCT02273167|2647692|P1|Overall Study|Withdrawal by Subject|10
811022|NCT02273167|2647690|P3|Overall Study|Lost to Follow-up|1
811023|NCT02273167|2647691|P2|Overall Study|Lost to Follow-up|1
811024|NCT02273167|2647692|P1|Overall Study|Lost to Follow-up|0
811025|NCT02273167|2647690|P3|Overall Study|Protocol Violation|1
811026|NCT02273167|2647691|P2|Overall Study|Protocol Violation|1
811027|NCT02273167|2647692|P1|Overall Study|Protocol Violation|3
811028|NCT02273167|2647690|P3|Overall Study|Adverse Event|0
811029|NCT02273167|2647691|P2|Overall Study|Adverse Event|0
811030|NCT02273167|2647692|P1|Overall Study|Adverse Event|1
811031|NCT02273141|2647717|P2|Overall Study|Various|6
811032|NCT02273141|2647718|P1|Overall Study|Various|6
811033|NCT02273141|2647717|P2|Overall Study|Withdrawal by Subject|15
811034|NCT02273141|2647718|P1|Overall Study|Withdrawal by Subject|10
811035|NCT02273141|2647717|P2|Overall Study|Lost to Follow-up|3
811036|NCT02273141|2647718|P1|Overall Study|Lost to Follow-up|1
811037|NCT02273141|2647717|P2|Overall Study|Adverse Event|1
811038|NCT02273141|2647718|P1|Overall Study|Adverse Event|0
811039|NCT02273050|2647791|P3|Overall Study|Protocol Violation|4
811040|NCT02273050|2647792|P2|Overall Study|Protocol Violation|1
811041|NCT02273050|2647793|P1|Overall Study|Protocol Violation|3
811042|NCT02273050|2647791|P3|Overall Study|Lost to Follow-up|3
811043|NCT02273050|2647792|P2|Overall Study|Lost to Follow-up|2
811044|NCT02273050|2647793|P1|Overall Study|Lost to Follow-up|0
811045|NCT02273050|2647791|P3|Overall Study|Withdrawal by Subject|16
811046|NCT02273050|2647792|P2|Overall Study|Withdrawal by Subject|14
811047|NCT02273050|2647793|P1|Overall Study|Withdrawal by Subject|17
811048|NCT02273050|2647791|P3|Overall Study|Lack of Efficacy|1
811049|NCT02273050|2647792|P2|Overall Study|Lack of Efficacy|1
811050|NCT02273050|2647793|P1|Overall Study|Lack of Efficacy|0
811051|NCT02273050|2647791|P3|Overall Study|Dev. of study spec. withdrawal criteria|1
811052|NCT02273050|2647792|P2|Overall Study|Dev. of study spec. withdrawal criteria|1
811053|NCT02273050|2647793|P1|Overall Study|Dev. of study spec. withdrawal criteria|0
811054|NCT02273050|2647791|P3|Overall Study|Death|1
811055|NCT02273050|2647792|P2|Overall Study|Death|0
811056|NCT02273050|2647793|P1|Overall Study|Death|0
811057|NCT02273050|2647791|P3|Overall Study|Adverse Event|3
811058|NCT02273050|2647792|P2|Overall Study|Adverse Event|3
811059|NCT02273050|2647793|P1|Overall Study|Adverse Event|4
811060|NCT02273037|2647821|P2|Overall Study|Other complication|0
811061|NCT02273037|2647822|P1|Overall Study|Other complication|2
811062|NCT02273037|2647821|P2|Overall Study|Multiple delivery|2
811063|NCT02273037|2647822|P1|Overall Study|Multiple delivery|2
811064|NCT02273037|2647821|P2|Overall Study|Breech delivery|3
811065|NCT02273037|2647822|P1|Overall Study|Breech delivery|2
811066|NCT02273037|2647821|P2|Overall Study|Delivered before monitoring initiated|3
811067|NCT02273037|2647822|P1|Overall Study|Delivered before monitoring initiated|1
811068|NCT02273037|2647821|P2|Overall Study|Lost to Follow-up|0
811069|NCT02273037|2647822|P1|Overall Study|Lost to Follow-up|1
811070|NCT02272803|2647834|P2|Overall Study|Withdrawal by Subject|0
811071|NCT02272803|2647835|P1|Overall Study|Withdrawal by Subject|1
811072|NCT02272803|2647834|P2|Overall Study|Poor/non-compliance|1
811073|NCT02272803|2647835|P1|Overall Study|Poor/non-compliance|0
811074|NCT02272803|2647834|P2|Overall Study|Subject moved to care facility|1
811075|NCT02272803|2647835|P1|Overall Study|Subject moved to care facility|0
811076|NCT02272803|2647834|P2|Overall Study|Maximum clinical benefit|1
811077|NCT02272803|2647835|P1|Overall Study|Maximum clinical benefit|1
811078|NCT02272803|2647834|P2|Overall Study|Subj request to discontinue study trt|4
811079|NCT02272803|2647835|P1|Overall Study|Subj request to discontinue study trt|1
811080|NCT02272803|2647834|P2|Overall Study|Study drug toxicity|4
811081|NCT02272803|2647835|P1|Overall Study|Study drug toxicity|1
811082|NCT02272803|2647834|P2|Overall Study|Adverse Event unrelated to study drug|4
811083|NCT02272803|2647835|P1|Overall Study|Adverse Event unrelated to study drug|1
811084|NCT02272803|2647834|P2|Overall Study|Disease progression|2
811085|NCT02272803|2647835|P1|Overall Study|Disease progression|4
811086|NCT02272725|2647848|P2|Overall Study|equipment malfunction|0
811087|NCT02272725|2647849|P1|Overall Study|equipment malfunction|2
811088|NCT02271984|2647859|P12|Washout Period 4 (7 Days)|Withdrawal by Subject|0
811089|NCT02271984|2647860|P11|Washout Period 4 (7 Days)|Withdrawal by Subject|0
811090|NCT02271984|2647861|P10|Washout Period 4 (7 Days)|Withdrawal by Subject|0
811091|NCT02271984|2647862|P9|Washout Period 4 (7 Days)|Withdrawal by Subject|0
811092|NCT02271984|2647863|P8|Washout Period 4 (7 Days)|Withdrawal by Subject|1
811093|NCT02271984|2647864|P7|Washout Period 4 (7 Days)|Withdrawal by Subject|0
811094|NCT02271984|2647865|P6|Washout Period 4 (7 Days)|Withdrawal by Subject|1
811095|NCT02271984|2647866|P5|Washout Period 4 (7 Days)|Withdrawal by Subject|0
811096|NCT02271984|2647867|P4|Washout Period 4 (7 Days)|Withdrawal by Subject|0
811097|NCT02271984|2647868|P3|Washout Period 4 (7 Days)|Withdrawal by Subject|0
811098|NCT02271984|2647869|P2|Washout Period 4 (7 Days)|Withdrawal by Subject|0
811099|NCT02271984|2647870|P1|Washout Period 4 (7 Days)|Withdrawal by Subject|0
811100|NCT02271945|2647959|P2|Overall Study|Other|1
811101|NCT02271945|2647960|P1|Overall Study|Other|1
811102|NCT02271945|2647959|P2|Overall Study|Withdrawal by Subject|1
811103|NCT02271945|2647960|P1|Overall Study|Withdrawal by Subject|1
811104|NCT02271945|2647959|P2|Overall Study|Death|3
811105|NCT02271945|2647960|P1|Overall Study|Death|3
811106|NCT02271880|2647998|P2|Overall Study|Premature discontinuation of study|4
811107|NCT02271880|2647999|P1|Overall Study|Premature discontinuation of study|3
811108|NCT02271854|2648005|P1|Overall Study|Lost to Follow-up|1
811109|NCT02271854|2648005|P1|Overall Study|Unable or unwilling to cooperate with st|1
811110|NCT02271854|2648005|P1|Overall Study|Withdrawal by Subject|2
811111|NCT02271529|2648045|P1|Overall Study|Withdrawal by Subject|1
811112|NCT02270944|2648082|P2|Overall Study|Withdrawal by Subject|1
811113|NCT02270944|2648083|P1|Overall Study|Withdrawal by Subject|2
811114|NCT02270944|2648082|P2|Overall Study|Lost to Follow-up|4
811115|NCT02270944|2648083|P1|Overall Study|Lost to Follow-up|9
811116|NCT02270684|2648099|P2|Overall Study|Study terminated|0
811117|NCT02270684|2648100|P1|Overall Study|Study terminated|1
811118|NCT02270684|2648099|P2|Overall Study|Lost to Follow-up|3
811119|NCT02270684|2648100|P1|Overall Study|Lost to Follow-up|0
811120|NCT02270671|2648108|P2|Overall Study|Lost to Follow-up|1
811121|NCT02270671|2648109|P1|Overall Study|Lost to Follow-up|2
811122|NCT02270671|2648108|P2|Overall Study|Missed Post-intervention Data Collection|2
811123|NCT02270671|2648109|P1|Overall Study|Missed Post-intervention Data Collection|2
811124|NCT02270671|2648108|P2|Overall Study|Protocol Violation|1
811125|NCT02270671|2648109|P1|Overall Study|Protocol Violation|0
811126|NCT02270671|2648108|P2|Overall Study|Withdrawal by Subject|1
811127|NCT02270671|2648109|P1|Overall Study|Withdrawal by Subject|1
811128|NCT02270515|2648134|P1|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16
811129|NCT02270515|2648134|P1|Intervention Period 3: 12-18 Months|Death|3
811130|NCT02270515|2648134|P1|Intervention Period 3: 12-18 Months|Received transplant|2
811131|NCT02270515|2648134|P1|Intervention Period 3: 12-18 Months|No longer patient at study site|2
811132|NCT02270515|2648134|P1|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1
811133|NCT02270515|2648134|P1|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17
811134|NCT02270515|2648134|P1|Intervention Period 2: 6-12 Months|Death|5
811135|NCT02270515|2648134|P1|Intervention Period 2: 6-12 Months|Received transplant|1
811136|NCT02270515|2648134|P1|Intervention Period 2: 6-12 Months|No longer patient at study site|7
811137|NCT02270515|2648134|P1|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2
811138|NCT02270515|2648134|P1|Intervention Period 1: 0-6 Months|Death|7
811139|NCT02270515|2648134|P1|Intervention Period 1: 0-6 Months|Received transplant|3
811140|NCT02270515|2648134|P1|Intervention Period 1: 0-6 Months|No longer patient at study site|5
811141|NCT02270515|2648134|P1|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1
811142|NCT02269943|2648151|P2|Follow-Up Survival Period|Alive|8
811143|NCT02269943|2648152|P1|Follow-Up Survival Period|Alive|2
811144|NCT02269943|2648151|P2|Follow-Up Survival Period|Lost to Follow-up|2
811145|NCT02269943|2648152|P1|Follow-Up Survival Period|Lost to Follow-up|0
811146|NCT02269943|2648151|P2|Follow-Up Survival Period|Death|16
811147|NCT02269943|2648152|P1|Follow-Up Survival Period|Death|3
811148|NCT02269943|2648151|P2|Treatment Period|Symptomatic Deterioration|2
811149|NCT02269943|2648152|P1|Treatment Period|Symptomatic Deterioration|0
811150|NCT02269943|2648151|P2|Treatment Period|Progressive Disease|17
811151|NCT02269943|2648152|P1|Treatment Period|Progressive Disease|5
811152|NCT02269943|2648151|P2|Treatment Period|Adverse Event|10
811153|NCT02269943|2648152|P1|Treatment Period|Adverse Event|1
811154|NCT02269943|2648151|P2|Treatment Period|Death|1
811155|NCT02269943|2648152|P1|Treatment Period|Death|0
811156|NCT02269917|2648182|P2|Overall Study|Randomized but not treated|5
811157|NCT02269917|2648183|P1|Overall Study|Randomized but not treated|3
811158|NCT02269917|2648182|P2|Overall Study|Non-compliance with study drug|0
811159|NCT02269917|2648183|P1|Overall Study|Non-compliance with study drug|2
811160|NCT02269917|2648182|P2|Overall Study|Adverse Event|4
811161|NCT02269917|2648183|P1|Overall Study|Adverse Event|11
811162|NCT02269917|2648182|P2|Overall Study|Withdrawal by Subject|8
811163|NCT02269917|2648183|P1|Overall Study|Withdrawal by Subject|9
811164|NCT02269917|2648182|P2|Overall Study|Other|3
811165|NCT02269917|2648183|P1|Overall Study|Other|6
811166|NCT02269917|2648182|P2|Overall Study|Ongoing|360
811167|NCT02269917|2648183|P1|Overall Study|Ongoing|731
811168|NCT02269917|2648182|P2|Overall Study|Lost to Follow-up|3
811169|NCT02269917|2648183|P1|Overall Study|Lost to Follow-up|4
811170|NCT02269709|2648234|P1|Six Month Follow-up|Lost to Follow-up|12
811171|NCT02269709|2648234|P1|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1
811172|NCT02269709|2648234|P1|Time of Enrollment|Withdrawal by Subject|3
811173|NCT02269657|2648239|P1|Overall Study|Protocol Violation|3
811174|NCT02269475|2648259|P2|Overall Study|Withdrawal by Subject|1
811175|NCT02269475|2648260|P1|Overall Study|Withdrawal by Subject|0
811176|NCT02269475|2648259|P2|Overall Study|Meet Exclusion Criteria No. 17|0
811177|NCT02269475|2648260|P1|Overall Study|Meet Exclusion Criteria No. 17|3
811178|NCT02269098|2648273|P2|Overall Study|Lost to Follow-up|9
811179|NCT02269098|2648274|P1|Overall Study|Lost to Follow-up|14
811180|NCT02268864|2648321|P3|Overall Study|Death|0
811181|NCT02268864|2648322|P2|Overall Study|Death|1
811182|NCT02268864|2648323|P1|Overall Study|Death|0
811183|NCT02268864|2648321|P3|Overall Study|Withdrawal by Subject|0
811184|NCT02268864|2648322|P2|Overall Study|Withdrawal by Subject|0
811185|NCT02268864|2648323|P1|Overall Study|Withdrawal by Subject|2
811186|NCT02268812|2648349|P4|Overall Study|Not specified|3
811187|NCT02268812|2648350|P3|Overall Study|Not specified|1
811188|NCT02268812|2648351|P2|Overall Study|Not specified|4
811189|NCT02268812|2648352|P1|Overall Study|Not specified|5
811190|NCT02268812|2648349|P4|Overall Study|Physician Decision|1
811191|NCT02268812|2648350|P3|Overall Study|Physician Decision|0
811192|NCT02268812|2648351|P2|Overall Study|Physician Decision|1
811193|NCT02268812|2648352|P1|Overall Study|Physician Decision|3
811194|NCT02268812|2648349|P4|Overall Study|Withdrawal by Subject|0
811195|NCT02268812|2648350|P3|Overall Study|Withdrawal by Subject|0
811196|NCT02268812|2648351|P2|Overall Study|Withdrawal by Subject|1
811197|NCT02268812|2648352|P1|Overall Study|Withdrawal by Subject|0
811198|NCT02268812|2648349|P4|Overall Study|Protocol deviation|0
811199|NCT02268812|2648350|P3|Overall Study|Protocol deviation|1
811200|NCT02268812|2648351|P2|Overall Study|Protocol deviation|0
811201|NCT02268812|2648352|P1|Overall Study|Protocol deviation|0
811202|NCT02268812|2648349|P4|Overall Study|Adverse Event|10
811203|NCT02268812|2648350|P3|Overall Study|Adverse Event|7
811204|NCT02268812|2648351|P2|Overall Study|Adverse Event|26
811205|NCT02268812|2648352|P1|Overall Study|Adverse Event|8
811206|NCT02268526|2648385|P3|Overall Study|Subject/guardian decision|3
811207|NCT02268526|2648386|P2|Overall Study|Subject/guardian decision|7
811208|NCT02268526|2648387|P1|Overall Study|Subject/guardian decision|0
811209|NCT02268526|2648385|P3|Overall Study|Physician Decision|1
811210|NCT02268526|2648386|P2|Overall Study|Physician Decision|0
811211|NCT02268526|2648387|P1|Overall Study|Physician Decision|0
811212|NCT02268526|2648385|P3|Overall Study|protocol deviation|0
811213|NCT02268526|2648386|P2|Overall Study|protocol deviation|1
811214|NCT02268526|2648387|P1|Overall Study|protocol deviation|0
811215|NCT02268526|2648385|P3|Overall Study|Death|0
811216|NCT02268526|2648386|P2|Overall Study|Death|11
811217|NCT02268526|2648387|P1|Overall Study|Death|1
811218|NCT02268526|2648385|P3|Overall Study|Adverse Event|1
811219|NCT02268526|2648386|P2|Overall Study|Adverse Event|2
811220|NCT02268526|2648387|P1|Overall Study|Adverse Event|0
811221|NCT02268396|2648408|P1|Overall Study|2 Subjects no Day 29 Assessment|2
811222|NCT02268396|2648408|P1|Overall Study|Protocol-Specified Criteria|2
811223|NCT02268396|2648408|P1|Overall Study|Lost to Follow-up|2
811224|NCT02268396|2648408|P1|Overall Study|Withdrawal by Subject|1
811225|NCT02268396|2648408|P1|Overall Study|Administrative|2
811226|NCT02268396|2648408|P1|Overall Study|Adverse Event|3
811227|NCT02268214|2648420|P3|Overall Study|Not entering long-term period|5
811228|NCT02268214|2648421|P2|Overall Study|Not entering long-term period|3
811229|NCT02268214|2648422|P1|Overall Study|Not entering long-term period|2
811230|NCT02268214|2648420|P3|Overall Study|Other reasons|3
811231|NCT02268214|2648421|P2|Overall Study|Other reasons|3
811232|NCT02268214|2648422|P1|Overall Study|Other reasons|7
811233|NCT02268214|2648420|P3|Overall Study|Poor/non-compliance|2
811234|NCT02268214|2648421|P2|Overall Study|Poor/non-compliance|1
811235|NCT02268214|2648422|P1|Overall Study|Poor/non-compliance|2
811236|NCT02268214|2648420|P3|Overall Study|Subject request to discontinue treatment|6
811237|NCT02268214|2648421|P2|Overall Study|Subject request to discontinue treatment|8
811238|NCT02268214|2648422|P1|Overall Study|Subject request to discontinue treatment|10
811239|NCT02268214|2648420|P3|Overall Study|Withdrawal by Subject|10
811240|NCT02268214|2648421|P2|Overall Study|Withdrawal by Subject|5
811241|NCT02268214|2648422|P1|Overall Study|Withdrawal by Subject|4
811242|NCT02268214|2648420|P3|Overall Study|Adverse Event|9
811243|NCT02268214|2648421|P2|Overall Study|Adverse Event|14
811244|NCT02268214|2648422|P1|Overall Study|Adverse Event|11
811245|NCT02268214|2648420|P3|Overall Study|Lack of Efficacy|2
811246|NCT02268214|2648421|P2|Overall Study|Lack of Efficacy|0
811247|NCT02268214|2648422|P1|Overall Study|Lack of Efficacy|1
811248|NCT02268214|2648420|P3|Overall Study|Lost to Follow-up|4
811249|NCT02268214|2648421|P2|Overall Study|Lost to Follow-up|3
811250|NCT02268214|2648422|P1|Overall Study|Lost to Follow-up|3
811251|NCT02268214|2648420|P3|Overall Study|Pregnancy|1
811252|NCT02268214|2648421|P2|Overall Study|Pregnancy|2
811253|NCT02268214|2648422|P1|Overall Study|Pregnancy|2
811254|NCT02268214|2648420|P3|Overall Study|Subject no longer meets study criteria|0
811255|NCT02268214|2648421|P2|Overall Study|Subject no longer meets study criteria|2
811256|NCT02268214|2648422|P1|Overall Study|Subject no longer meets study criteria|0
811257|NCT02268058|2648452|P4|Overall Study|Protocol Violation|0
811258|NCT02268058|2648453|P3|Overall Study|Protocol Violation|0
811259|NCT02268058|2648454|P2|Overall Study|Protocol Violation|0
811260|NCT02268058|2648455|P1|Overall Study|Protocol Violation|1
811261|NCT02267824|2648497|P2|Overall Study|Did Not Meet Initial Dental Criteria|0
811262|NCT02267824|2648498|P1|Overall Study|Did Not Meet Initial Dental Criteria|2
811263|NCT02267824|2648497|P2|Overall Study|Protocol Violation|0
811264|NCT02267824|2648498|P1|Overall Study|Protocol Violation|3
811265|NCT02267824|2648497|P2|Overall Study|Lost to Follow-up|0
811266|NCT02267824|2648498|P1|Overall Study|Lost to Follow-up|4
811267|NCT02267824|2648497|P2|Overall Study|Pregnancy|1
811268|NCT02267824|2648498|P1|Overall Study|Pregnancy|1
811269|NCT02267187|2648541|P1|Overall Study|Screen fail|3
811270|NCT02267187|2648541|P1|Overall Study|Physician Decision|2
811271|NCT02267135|2648549|P2|Period 2 (Randomized Set)|Withdrawal by Subject|0
811272|NCT02267135|2648550|P1|Period 2 (Randomized Set)|Withdrawal by Subject|1
811273|NCT02267135|2648549|P2|Period 2 (Randomized Set)|Adverse Event|0
811274|NCT02267135|2648550|P1|Period 2 (Randomized Set)|Adverse Event|2
811275|NCT02267135|2648549|P2|Period 2 (Randomized Set)|Lost to Follow-up|1
811276|NCT02267135|2648550|P1|Period 2 (Randomized Set)|Lost to Follow-up|1
811277|NCT02267135|2648549|P2|Period 1 (Randomized Set)|Lost to Follow-up|1
811278|NCT02267135|2648550|P1|Period 1 (Randomized Set)|Lost to Follow-up|0
811279|NCT02267135|2648549|P2|Period 1 (Randomized Set)|Withdrawal by Subject|3
811280|NCT02267135|2648550|P1|Period 1 (Randomized Set)|Withdrawal by Subject|1
811281|NCT02266875|2648590|P2|Overall Study|Lost to Follow-up|0
811282|NCT02266875|2648591|P1|Overall Study|Lost to Follow-up|2
811283|NCT02266875|2648590|P2|Overall Study|Withdrawal by Subject|0
811284|NCT02266875|2648591|P1|Overall Study|Withdrawal by Subject|9
811285|NCT02266381|2648669|P3|Overall Study|Physician Decision|4
811286|NCT02266381|2648670|P2|Overall Study|Physician Decision|5
811287|NCT02266381|2648671|P1|Overall Study|Physician Decision|3
811288|NCT02265796|2648738|P2|Overall Study|Withdrawal by Subject|1
811289|NCT02265796|2648739|P1|Overall Study|Withdrawal by Subject|1
811290|NCT02265796|2648738|P2|Overall Study|started on excluded medication|0
811291|NCT02265796|2648739|P1|Overall Study|started on excluded medication|1
811292|NCT02265796|2648738|P2|Overall Study|Death|0
811293|NCT02265796|2648739|P1|Overall Study|Death|1
811294|NCT02265237|2648757|P4|As Treated (Overall Study)|Other|1
811295|NCT02265237|2648758|P3|As Treated (Overall Study)|Other|3
811296|NCT02265237|2648759|P2|As Treated (Overall Study)|Other|0
811297|NCT02265237|2648760|P1|As Treated (Overall Study)|Other|2
811298|NCT02265237|2648757|P4|As Treated (Overall Study)|Lost to Follow-up|0
811299|NCT02265237|2648758|P3|As Treated (Overall Study)|Lost to Follow-up|6
811300|NCT02265237|2648759|P2|As Treated (Overall Study)|Lost to Follow-up|2
811301|NCT02265237|2648760|P1|As Treated (Overall Study)|Lost to Follow-up|1
811302|NCT02265237|2648757|P4|As Treated (Overall Study)|Withdrawal by Subject|0
811303|NCT02265237|2648758|P3|As Treated (Overall Study)|Withdrawal by Subject|1
811304|NCT02265237|2648759|P2|As Treated (Overall Study)|Withdrawal by Subject|0
811305|NCT02265237|2648760|P1|As Treated (Overall Study)|Withdrawal by Subject|1
811306|NCT02265237|2648757|P4|As Treated (Overall Study)|Adverse Event|0
811307|NCT02265237|2648758|P3|As Treated (Overall Study)|Adverse Event|0
811308|NCT02265237|2648759|P2|As Treated (Overall Study)|Adverse Event|1
811309|NCT02265237|2648760|P1|As Treated (Overall Study)|Adverse Event|1
811310|NCT02264821|2648790|P3|Overall Study|Protocol Violation|6
811311|NCT02264821|2648791|P2|Overall Study|Protocol Violation|3
811312|NCT02264821|2648792|P1|Overall Study|Protocol Violation|1
811313|NCT02263365|2648854|P2|Overall Study|Physician Decision|18
811314|NCT02263365|2648855|P1|Overall Study|Physician Decision|22
811315|NCT02263326|2648869|P2|Overall Study|Lost to Follow-up|1
811316|NCT02263326|2648870|P1|Overall Study|Lost to Follow-up|1
811317|NCT02262754|2648931|P3|Overall Study|Other|2
811318|NCT02262754|2648932|P2|Overall Study|Other|0
811319|NCT02262754|2648933|P1|Overall Study|Other|4
811320|NCT02262754|2648931|P3|Overall Study|Withdrawal by Subject|1
811321|NCT02262754|2648932|P2|Overall Study|Withdrawal by Subject|0
811322|NCT02262754|2648933|P1|Overall Study|Withdrawal by Subject|1
811323|NCT02262754|2648931|P3|Overall Study|Protocol Violation|0
811324|NCT02262754|2648932|P2|Overall Study|Protocol Violation|0
811325|NCT02262754|2648933|P1|Overall Study|Protocol Violation|1
811326|NCT02262754|2648931|P3|Overall Study|Study terminated by sponsor|4
811327|NCT02262754|2648932|P2|Overall Study|Study terminated by sponsor|4
811328|NCT02262754|2648933|P1|Overall Study|Study terminated by sponsor|5
811329|NCT02262754|2648931|P3|Overall Study|No longer meets eligibility criteria|0
811330|NCT02262754|2648932|P2|Overall Study|No longer meets eligibility criteria|1
811331|NCT02262754|2648933|P1|Overall Study|No longer meets eligibility criteria|0
811332|NCT02262754|2648931|P3|Overall Study|Lost to Follow-up|1
811333|NCT02262754|2648932|P2|Overall Study|Lost to Follow-up|0
811334|NCT02262754|2648933|P1|Overall Study|Lost to Follow-up|0
811335|NCT02262754|2648931|P3|Overall Study|Lack of Efficacy|1
811336|NCT02262754|2648932|P2|Overall Study|Lack of Efficacy|0
811337|NCT02262754|2648933|P1|Overall Study|Lack of Efficacy|2
811338|NCT02262754|2648931|P3|Overall Study|Adverse Event|0
811339|NCT02262754|2648932|P2|Overall Study|Adverse Event|4
811340|NCT02262754|2648933|P1|Overall Study|Adverse Event|3
811341|NCT02261974|2649077|P2|Overall Study|Adverse Event|0
811342|NCT02261974|2649078|P1|Overall Study|Adverse Event|1
811343|NCT02261974|2649077|P2|Overall Study|Lost to Follow-up|0
811344|NCT02261974|2649078|P1|Overall Study|Lost to Follow-up|2
811345|NCT02261974|2649077|P2|Overall Study|Received partial treatment; FU to 1 mo|1
811346|NCT02261974|2649078|P1|Overall Study|Received partial treatment; FU to 1 mo|3
811347|NCT02261974|2649077|P2|Overall Study|Missed treatment cut-off date|3
811348|NCT02261974|2649078|P1|Overall Study|Missed treatment cut-off date|6
811349|NCT02261974|2649077|P2|Overall Study|Pregnancy|1
811350|NCT02261974|2649078|P1|Overall Study|Pregnancy|0
811351|NCT02261974|2649077|P2|Overall Study|Withdrawal by Subject|2
811352|NCT02261974|2649078|P1|Overall Study|Withdrawal by Subject|3
811353|NCT02261493|2649122|P3|Overall Study|Adverse Event|0
811354|NCT02261493|2649123|P2|Overall Study|Adverse Event|1
811355|NCT02261493|2649124|P1|Overall Study|Adverse Event|0
811356|NCT02261493|2649122|P3|Overall Study|Lack of Efficacy|0
811357|NCT02261493|2649123|P2|Overall Study|Lack of Efficacy|1
811358|NCT02261493|2649124|P1|Overall Study|Lack of Efficacy|0
811359|NCT02261493|2649122|P3|Overall Study|Pregnancy|0
811360|NCT02261493|2649123|P2|Overall Study|Pregnancy|2
811361|NCT02261493|2649124|P1|Overall Study|Pregnancy|1
811362|NCT02261493|2649122|P3|Overall Study|Lost to Follow-up|8
811363|NCT02261493|2649123|P2|Overall Study|Lost to Follow-up|27
811364|NCT02261493|2649124|P1|Overall Study|Lost to Follow-up|14
811365|NCT02261493|2649122|P3|Overall Study|Personal Reasons|16
811366|NCT02261493|2649123|P2|Overall Study|Personal Reasons|14
811367|NCT02261493|2649124|P1|Overall Study|Personal Reasons|14
811368|NCT02261493|2649122|P3|Overall Study|Protocol Violation|0
811369|NCT02261493|2649123|P2|Overall Study|Protocol Violation|0
811370|NCT02261493|2649124|P1|Overall Study|Protocol Violation|1
811371|NCT02261493|2649122|P3|Overall Study|Undisclosed alcohol abuse|0
811372|NCT02261493|2649123|P2|Overall Study|Undisclosed alcohol abuse|1
811373|NCT02261493|2649124|P1|Overall Study|Undisclosed alcohol abuse|0
811374|NCT02261493|2649122|P3|Overall Study|Physician Decision|0
811375|NCT02261493|2649123|P2|Overall Study|Physician Decision|1
811376|NCT02261493|2649124|P1|Overall Study|Physician Decision|0
811377|NCT02261493|2649122|P3|Overall Study|Noncompliance|2
811378|NCT02261493|2649123|P2|Overall Study|Noncompliance|0
811379|NCT02261493|2649124|P1|Overall Study|Noncompliance|0
811380|NCT02261467|2649152|P2|Overall Study|Adverse Event|1
811381|NCT02261467|2649153|P1|Overall Study|Adverse Event|1
811382|NCT02261467|2649152|P2|Overall Study|Lost to Follow-up|13
811383|NCT02261467|2649153|P1|Overall Study|Lost to Follow-up|2
811384|NCT02261467|2649152|P2|Overall Study|Personal Reasons|22
811385|NCT02261467|2649153|P1|Overall Study|Personal Reasons|17
811386|NCT02261467|2649152|P2|Overall Study|Protocol Violation|1
811387|NCT02261467|2649153|P1|Overall Study|Protocol Violation|0
811388|NCT02261467|2649152|P2|Overall Study|Enrolled in Error|0
811389|NCT02261467|2649153|P1|Overall Study|Enrolled in Error|1
811390|NCT02260986|2649195|P3|Overall Study|Pregnancy|0
811391|NCT02260986|2649196|P2|Overall Study|Pregnancy|0
811392|NCT02260986|2649197|P1|Overall Study|Pregnancy|2
811393|NCT02260986|2649195|P3|Overall Study|Lost to Follow-up|3
811394|NCT02260986|2649196|P2|Overall Study|Lost to Follow-up|0
811395|NCT02260986|2649197|P1|Overall Study|Lost to Follow-up|4
811396|NCT02260986|2649195|P3|Overall Study|Lack of investigation product supply|1
811397|NCT02260986|2649196|P2|Overall Study|Lack of investigation product supply|0
811398|NCT02260986|2649197|P1|Overall Study|Lack of investigation product supply|2
811399|NCT02260986|2649195|P3|Overall Study|Incorrect randomization|0
811400|NCT02260986|2649196|P2|Overall Study|Incorrect randomization|1
811401|NCT02260986|2649197|P1|Overall Study|Incorrect randomization|0
811402|NCT02260986|2649195|P3|Overall Study|Withdrawal by Subject|9
811403|NCT02260986|2649196|P2|Overall Study|Withdrawal by Subject|4
811404|NCT02260986|2649197|P1|Overall Study|Withdrawal by Subject|17
811405|NCT02260986|2649195|P3|Overall Study|Car accident|1
811406|NCT02260986|2649196|P2|Overall Study|Car accident|0
811407|NCT02260986|2649197|P1|Overall Study|Car accident|0
811408|NCT02260986|2649195|P3|Overall Study|Protocol Violation|16
811409|NCT02260986|2649196|P2|Overall Study|Protocol Violation|5
811410|NCT02260986|2649197|P1|Overall Study|Protocol Violation|14
811411|NCT02260986|2649195|P3|Overall Study|Lack of Efficacy|0
811412|NCT02260986|2649196|P2|Overall Study|Lack of Efficacy|3
811413|NCT02260986|2649197|P1|Overall Study|Lack of Efficacy|27
811414|NCT02260986|2649195|P3|Overall Study|Adverse Event|11
811415|NCT02260986|2649196|P2|Overall Study|Adverse Event|0
811416|NCT02260986|2649197|P1|Overall Study|Adverse Event|24
811417|NCT02260882|2649315|P2|Overall Study|Protocol Violation|1
811418|NCT02260882|2649316|P1|Overall Study|Protocol Violation|0
811419|NCT02260791|2649340|P2|Overall Study|Protocol deviation|3
811420|NCT02260791|2649341|P1|Overall Study|Protocol deviation|2
811421|NCT02260791|2649340|P2|Overall Study|Screen failure|1
811422|NCT02260791|2649341|P1|Overall Study|Screen failure|0
811423|NCT02260791|2649340|P2|Overall Study|Withdrawal by Subject|16
811424|NCT02260791|2649341|P1|Overall Study|Withdrawal by Subject|11
811425|NCT02260791|2649340|P2|Overall Study|Death|0
811426|NCT02260791|2649341|P1|Overall Study|Death|1
811427|NCT02260791|2649340|P2|Overall Study|Adverse Event|9
811428|NCT02260791|2649341|P1|Overall Study|Adverse Event|13
811429|NCT02260791|2649340|P2|Overall Study|Lack of Efficacy|1
811430|NCT02260791|2649341|P1|Overall Study|Lack of Efficacy|2
811431|NCT02260791|2649340|P2|Overall Study|Lost to Follow-up|4
811432|NCT02260791|2649341|P1|Overall Study|Lost to Follow-up|4
811433|NCT02260648|2649380|P3|Overall Study|Discontinue Due to Study Termination|7
811434|NCT02260648|2649381|P2|Overall Study|Discontinue Due to Study Termination|12
811435|NCT02260648|2649382|P1|Overall Study|Discontinue Due to Study Termination|13
811436|NCT02260648|2649380|P3|Overall Study|Protocol Violation|0
811437|NCT02260648|2649381|P2|Overall Study|Protocol Violation|0
811438|NCT02260648|2649382|P1|Overall Study|Protocol Violation|1
811439|NCT02260648|2649380|P3|Overall Study|Withdrawal by Subject|0
811440|NCT02260648|2649381|P2|Overall Study|Withdrawal by Subject|1
811441|NCT02260648|2649382|P1|Overall Study|Withdrawal by Subject|1
811442|NCT02260648|2649380|P3|Overall Study|Adverse Event|1
811443|NCT02260648|2649381|P2|Overall Study|Adverse Event|0
811444|NCT02260648|2649382|P1|Overall Study|Adverse Event|3
811445|NCT02260635|2649410|P2|Open-Label Extension|Withdrawal by Subject|0
811446|NCT02260635|2649411|P1|Open-Label Extension|Withdrawal by Subject|1
811447|NCT02260635|2649410|P2|Open-Label Extension|Study Termination|25
811448|NCT02260635|2649411|P1|Open-Label Extension|Study Termination|25
811449|NCT02260635|2649410|P2|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2
811450|NCT02260635|2649411|P1|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1
811451|NCT02260492|2649434|P3|Overall Study|Withdrawal by Subject|2
811452|NCT02260492|2649435|P2|Overall Study|Withdrawal by Subject|2
811453|NCT02260492|2649436|P1|Overall Study|Withdrawal by Subject|3
811454|NCT02260492|2649434|P3|Overall Study|Physician Decision|1
811455|NCT02260492|2649435|P2|Overall Study|Physician Decision|0
811456|NCT02260492|2649436|P1|Overall Study|Physician Decision|2
811457|NCT02260492|2649434|P3|Overall Study|Lost to Follow-up|0
811458|NCT02260492|2649435|P2|Overall Study|Lost to Follow-up|9
811459|NCT02260492|2649436|P1|Overall Study|Lost to Follow-up|12
811460|NCT02260492|2649434|P3|Overall Study|Death|0
811461|NCT02260492|2649435|P2|Overall Study|Death|1
811462|NCT02260492|2649436|P1|Overall Study|Death|0
811463|NCT02260492|2649434|P3|Overall Study|Adverse Event|2
811464|NCT02260492|2649435|P2|Overall Study|Adverse Event|1
811465|NCT02260492|2649436|P1|Overall Study|Adverse Event|6
811466|NCT02260388|2649469|P4|Overall Study|Lost to Follow-up|4
811467|NCT02260388|2649470|P3|Overall Study|Lost to Follow-up|3
811468|NCT02260388|2649471|P2|Overall Study|Lost to Follow-up|8
811469|NCT02260388|2649472|P1|Overall Study|Lost to Follow-up|2
811470|NCT02259582|2649506|P3|Overall Study|Lack of Subject Adherence to Protocol|1
811471|NCT02259582|2649507|P2|Overall Study|Lack of Subject Adherence to Protocol|1
811472|NCT02259582|2649508|P1|Overall Study|Lack of Subject Adherence to Protocol|1
811473|NCT02259582|2649506|P3|Overall Study|Disease progression|17
811474|NCT02259582|2649507|P2|Overall Study|Disease progression|15
811475|NCT02259582|2649508|P1|Overall Study|Disease progression|14
811476|NCT02259582|2649506|P3|Overall Study|Withdrawal by Subject|1
811477|NCT02259582|2649507|P2|Overall Study|Withdrawal by Subject|0
811478|NCT02259582|2649508|P1|Overall Study|Withdrawal by Subject|0
811479|NCT02259582|2649506|P3|Overall Study|Adverse Event|1
811480|NCT02259582|2649507|P2|Overall Study|Adverse Event|0
811481|NCT02259582|2649508|P1|Overall Study|Adverse Event|1
811482|NCT02259582|2649506|P3|Overall Study|Death|1
811483|NCT02259582|2649507|P2|Overall Study|Death|0
811484|NCT02259582|2649508|P1|Overall Study|Death|0
811485|NCT02259582|2649506|P3|Overall Study|Physician Decision|0
811486|NCT02259582|2649507|P2|Overall Study|Physician Decision|1
811487|NCT02259582|2649508|P1|Overall Study|Physician Decision|0
811488|NCT02259400|2649518|P2|Overall Study|Death|2
811489|NCT02259400|2649519|P1|Overall Study|Death|0
811490|NCT02259348|2649551|P1|Overall Study|Death|4
811491|NCT02259348|2649551|P1|Overall Study|Donors|6
811492|NCT02259114|2649568|P5|Overall Study|Not Treated|0
811493|NCT02259114|2649569|P4|Overall Study|Not Treated|0
811494|NCT02259114|2649570|P3|Overall Study|Not Treated|0
811495|NCT02259114|2649571|P2|Overall Study|Not Treated|0
811496|NCT02259114|2649572|P1|Overall Study|Not Treated|1
811497|NCT02259114|2649568|P5|Overall Study|Treatment Delay >2 wks: Toxicity|0
811498|NCT02259114|2649569|P4|Overall Study|Treatment Delay >2 wks: Toxicity|0
811499|NCT02259114|2649570|P3|Overall Study|Treatment Delay >2 wks: Toxicity|0
811500|NCT02259114|2649571|P2|Overall Study|Treatment Delay >2 wks: Toxicity|1
811501|NCT02259114|2649572|P1|Overall Study|Treatment Delay >2 wks: Toxicity|1
811502|NCT02259114|2649568|P5|Overall Study|Withdrawal by Subject|0
811503|NCT02259114|2649569|P4|Overall Study|Withdrawal by Subject|1
811504|NCT02259114|2649570|P3|Overall Study|Withdrawal by Subject|1
811505|NCT02259114|2649571|P2|Overall Study|Withdrawal by Subject|0
811506|NCT02259114|2649572|P1|Overall Study|Withdrawal by Subject|0
811507|NCT02259114|2649568|P5|Overall Study|Treatment Delay >2 wks: Adverse Event|0
811508|NCT02259114|2649569|P4|Overall Study|Treatment Delay >2 wks: Adverse Event|0
811509|NCT02259114|2649570|P3|Overall Study|Treatment Delay >2 wks: Adverse Event|1
811510|NCT02259114|2649571|P2|Overall Study|Treatment Delay >2 wks: Adverse Event|0
811511|NCT02259114|2649572|P1|Overall Study|Treatment Delay >2 wks: Adverse Event|0
811512|NCT02259114|2649568|P5|Overall Study|Death|0
811513|NCT02259114|2649569|P4|Overall Study|Death|0
811514|NCT02259114|2649570|P3|Overall Study|Death|1
811515|NCT02259114|2649571|P2|Overall Study|Death|0
811516|NCT02259114|2649572|P1|Overall Study|Death|3
811517|NCT02259114|2649568|P5|Overall Study|Adverse Event|1
811518|NCT02259114|2649569|P4|Overall Study|Adverse Event|0
811519|NCT02259114|2649570|P3|Overall Study|Adverse Event|0
811520|NCT02259114|2649571|P2|Overall Study|Adverse Event|1
811521|NCT02259114|2649572|P1|Overall Study|Adverse Event|2
811522|NCT02259114|2649568|P5|Overall Study|Progressive Disease|5
811523|NCT02259114|2649569|P4|Overall Study|Progressive Disease|2
811524|NCT02259114|2649570|P3|Overall Study|Progressive Disease|10
811525|NCT02259114|2649571|P2|Overall Study|Progressive Disease|2
811526|NCT02259114|2649572|P1|Overall Study|Progressive Disease|14
811527|NCT02258529|2649629|P1|Overall Study|Adverse Event|1
811528|NCT02258529|2649629|P1|Overall Study|Study Terminated by Sponsor|9
811529|NCT02258334|2649718|P4|Overall Study|Adverse Event|0
811530|NCT02258334|2649719|P3|Overall Study|Adverse Event|0
811531|NCT02258334|2649720|P2|Overall Study|Adverse Event|0
811532|NCT02258334|2649721|P1|Overall Study|Adverse Event|1
811533|NCT02257918|2649780|P3|Overall Study|Pregnancy|1
811534|NCT02257918|2649781|P2|Overall Study|Pregnancy|0
811535|NCT02257918|2649782|P1|Overall Study|Pregnancy|0
811536|NCT02257918|2649780|P3|Overall Study|Withdrawal by Subject|1
811537|NCT02257918|2649781|P2|Overall Study|Withdrawal by Subject|0
811538|NCT02257918|2649782|P1|Overall Study|Withdrawal by Subject|0
811539|NCT02257918|2649780|P3|Overall Study|Lost to Follow-up|0
811540|NCT02257918|2649781|P2|Overall Study|Lost to Follow-up|1
811541|NCT02257918|2649782|P1|Overall Study|Lost to Follow-up|4
811542|NCT02257684|2649832|P1|Overall Study|Sponsor's Decision|1
811543|NCT02257684|2649832|P1|Overall Study|Lack of Efficacy|1
811544|NCT02257684|2649832|P1|Overall Study|Adverse Event|2
811545|NCT02257385|2649842|P2|Overall Study|Withdrawal by Subject|4
811546|NCT02257385|2649843|P1|Overall Study|Withdrawal by Subject|4
811547|NCT02257385|2649842|P2|Overall Study|Lost to Follow-up|1
811548|NCT02257385|2649843|P1|Overall Study|Lost to Follow-up|0
811549|NCT02257385|2649842|P2|Overall Study|Protocol Violation|7
811550|NCT02257385|2649843|P1|Overall Study|Protocol Violation|5
811551|NCT02257385|2649842|P2|Overall Study|Lack of Efficacy|2
811552|NCT02257385|2649843|P1|Overall Study|Lack of Efficacy|1
811553|NCT02257385|2649842|P2|Overall Study|Adverse Event|8
811554|NCT02257385|2649843|P1|Overall Study|Adverse Event|12
811555|NCT02257372|2649853|P2|Overall Study|Withdrew consent|0
811556|NCT02257372|2649854|P1|Overall Study|Withdrew consent|1
811557|NCT02257372|2649853|P2|Overall Study|Lost to Follow-up|1
811558|NCT02257372|2649854|P1|Overall Study|Lost to Follow-up|0
811559|NCT02257372|2649853|P2|Overall Study|Protocol Violation|1
811560|NCT02257372|2649854|P1|Overall Study|Protocol Violation|1
811561|NCT02257372|2649853|P2|Overall Study|Lack of Efficacy|1
811562|NCT02257372|2649854|P1|Overall Study|Lack of Efficacy|2
811563|NCT02257372|2649853|P2|Overall Study|Adverse Event|7
811564|NCT02257372|2649854|P1|Overall Study|Adverse Event|3
811565|NCT02256982|2649864|P2|Overall Study|Disease Progression|1
811566|NCT02256982|2649865|P1|Overall Study|Disease Progression|0
811567|NCT02256969|2649874|P3|Overall Study|Screenfailed or withdrew|1
811568|NCT02256969|2649875|P2|Overall Study|Screenfailed or withdrew|1
811569|NCT02256969|2649876|P1|Overall Study|Screenfailed or withdrew|2
811570|NCT02256891|2649895|P2|Overall Study|Equipment Malfunction|1
811571|NCT02256891|2649896|P1|Overall Study|Equipment Malfunction|0
811572|NCT02256891|2649895|P2|Overall Study|Screen Fail|4
811573|NCT02256891|2649896|P1|Overall Study|Screen Fail|5
811574|NCT02256891|2649895|P2|Overall Study|Physician Decision|3
811575|NCT02256891|2649896|P1|Overall Study|Physician Decision|7
811576|NCT02256891|2649895|P2|Overall Study|Lost to Follow-up|3
811577|NCT02256891|2649896|P1|Overall Study|Lost to Follow-up|0
811578|NCT02256891|2649895|P2|Overall Study|Death|2
811579|NCT02256891|2649896|P1|Overall Study|Death|0
811580|NCT02256553|2649920|P1|Period III|Adverse Event|3
811581|NCT02256553|2649920|P1|Period II|Subject Moved|1
811582|NCT02256553|2649920|P1|Period II|Adverse Event|1
811583|NCT02256553|2649920|P1|Period I|Protocol Violation|1
811584|NCT02256553|2649920|P1|Period I|Adverse Event|5
811585|NCT02256488|2649933|P4|Overall Study|Withdrawal by Subject|2
811586|NCT02256488|2649934|P3|Overall Study|Withdrawal by Subject|0
811587|NCT02256488|2649935|P2|Overall Study|Withdrawal by Subject|0
811588|NCT02256488|2649936|P1|Overall Study|Withdrawal by Subject|1
811589|NCT02256488|2649933|P4|Overall Study|OTHER|1
811590|NCT02256488|2649934|P3|Overall Study|OTHER|1
811591|NCT02256488|2649935|P2|Overall Study|OTHER|0
811592|NCT02256488|2649936|P1|Overall Study|OTHER|1
811593|NCT02256488|2649933|P4|Overall Study|Lost to Follow-up|3
811594|NCT02256488|2649934|P3|Overall Study|Lost to Follow-up|9
811595|NCT02256488|2649935|P2|Overall Study|Lost to Follow-up|6
811596|NCT02256488|2649936|P1|Overall Study|Lost to Follow-up|6
811597|NCT02256436|2649952|P2|Overall Study|Ongoing in Study|67
811598|NCT02256436|2649953|P1|Overall Study|Ongoing in Study|108
811599|NCT02256436|2649952|P2|Overall Study|Withdrawal by Subject|30
811600|NCT02256436|2649953|P1|Overall Study|Withdrawal by Subject|7
811601|NCT02256436|2649952|P2|Overall Study|Protocol Violation|0
811602|NCT02256436|2649953|P1|Overall Study|Protocol Violation|1
811603|NCT02256436|2649952|P2|Overall Study|Physician Decision|3
811604|NCT02256436|2649953|P1|Overall Study|Physician Decision|1
811605|NCT02256436|2649952|P2|Overall Study|Lost to Follow-up|1
811606|NCT02256436|2649953|P1|Overall Study|Lost to Follow-up|1
811607|NCT02256436|2649952|P2|Overall Study|Death|158
811608|NCT02256436|2649953|P1|Overall Study|Death|137
811609|NCT02256436|2649952|P2|Overall Study|Adverse Event|13
811610|NCT02256436|2649953|P1|Overall Study|Adverse Event|15
811611|NCT02256267|2650013|P1|Period 2 (Day 7 to Day 14)|Adverse Event|1
811612|NCT02256267|2650013|P1|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1
811613|NCT02255760|2650044|P5|Overall Study|Lost to Follow-up|0
811614|NCT02255760|2650045|P4|Overall Study|Lost to Follow-up|0
811615|NCT02255760|2650046|P3|Overall Study|Lost to Follow-up|0
811616|NCT02255760|2650047|P2|Overall Study|Lost to Follow-up|1
811617|NCT02255760|2650048|P1|Overall Study|Lost to Follow-up|0
811618|NCT02255565|2650103|P3|Overall Study|Withdrawal by Subject|0
811619|NCT02255565|2650104|P2|Overall Study|Withdrawal by Subject|1
811620|NCT02255565|2650105|P1|Overall Study|Withdrawal by Subject|0
811621|NCT02255279|2650166|P2|Overall Study|Withdrawal by Subject|6
811622|NCT02255279|2650167|P1|Overall Study|Withdrawal by Subject|3
811623|NCT02255279|2650166|P2|Overall Study|Protocol Violation|1
811624|NCT02255279|2650167|P1|Overall Study|Protocol Violation|0
811625|NCT02255279|2650166|P2|Overall Study|Lost to Follow-up|2
811626|NCT02255279|2650167|P1|Overall Study|Lost to Follow-up|2
811627|NCT02255149|2650193|P1|Overall Study|Implant Failure|1
811628|NCT02255149|2650193|P1|Overall Study|Withdrawal by PI|1
811629|NCT02255149|2650193|P1|Overall Study|Withdrawal by Subject|1
811630|NCT02255149|2650193|P1|Overall Study|Lost to Follow-up|2
811631|NCT02255097|2650197|P1|Overall Study|Treatment Ongoing|36
811632|NCT02255097|2650197|P1|Overall Study|Allocated but not treated|1
811633|NCT02255097|2650197|P1|Overall Study|Withdrawal by Subject|2
811634|NCT02255097|2650197|P1|Overall Study|Progressive Disease|80
811635|NCT02255097|2650197|P1|Overall Study|Physician Decision|1
811636|NCT02255097|2650197|P1|Overall Study|Lost to Follow-up|1
811637|NCT02255097|2650197|P1|Overall Study|Death|2
811638|NCT02255097|2650197|P1|Overall Study|Excluded Medication|1
811639|NCT02255097|2650197|P1|Overall Study|Complete Response|1
811640|NCT02255097|2650197|P1|Overall Study|Clinical Progression|23
811641|NCT02255097|2650197|P1|Overall Study|Adverse Event|24
811642|NCT02254772|2650218|P1|Overall Study|Withdrawal by Subject|1
811643|NCT02254772|2650218|P1|Overall Study|Ineligible|1
811644|NCT02254681|2650224|P1|Overall Study|Lack of Efficacy|6
811645|NCT02254551|2650234|P1|Dose Escalation|Dose-limiting toxicity|2
811646|NCT02254551|2650234|P1|Dose Escalation|Physician Decision|1
811647|NCT02254486|2650244|P2|Overall Study|Various|12
811648|NCT02254486|2650245|P1|Overall Study|Various|12
811649|NCT02254486|2650244|P2|Overall Study|GFR<60mL/min|21
811650|NCT02254486|2650245|P1|Overall Study|GFR<60mL/min|16
811651|NCT02254486|2650244|P2|Overall Study|Withdrawal by Subject|15
811652|NCT02254486|2650245|P1|Overall Study|Withdrawal by Subject|17
811653|NCT02254486|2650244|P2|Overall Study|Protocol Violation|2
811654|NCT02254486|2650245|P1|Overall Study|Protocol Violation|1
811655|NCT02254486|2650244|P2|Overall Study|Lost to Follow-up|4
811656|NCT02254486|2650245|P1|Overall Study|Lost to Follow-up|2
811657|NCT02254486|2650244|P2|Overall Study|Lack of Efficacy|0
811658|NCT02254486|2650245|P1|Overall Study|Lack of Efficacy|1
811659|NCT02254486|2650244|P2|Overall Study|Adverse Event|1
811660|NCT02254486|2650245|P1|Overall Study|Adverse Event|1
811661|NCT02254460|2650261|P2|Overall Study|Adverse Event|0
811662|NCT02254460|2650262|P1|Overall Study|Adverse Event|1
811663|NCT02254421|2650270|P2|Overall Study|Withdrew Consent|1
811664|NCT02254421|2650271|P1|Overall Study|Withdrew Consent|1
811665|NCT02254421|2650270|P2|Overall Study|Death|2
811666|NCT02254421|2650271|P1|Overall Study|Death|0
811667|NCT02254421|2650270|P2|Overall Study|Randomized but Not Treated|0
811668|NCT02254421|2650271|P1|Overall Study|Randomized but Not Treated|1
811669|NCT02254408|2650285|P2|Overall Study|Lost to Follow-up|0
811670|NCT02254408|2650286|P1|Overall Study|Lost to Follow-up|1
811671|NCT02254408|2650285|P2|Overall Study|Withdrawal by Subject|3
811672|NCT02254408|2650286|P1|Overall Study|Withdrawal by Subject|3
811673|NCT02254408|2650285|P2|Overall Study|Investigator's Discretion|1
811674|NCT02254408|2650286|P1|Overall Study|Investigator's Discretion|0
811675|NCT02254408|2650285|P2|Overall Study|Death|3
811676|NCT02254408|2650286|P1|Overall Study|Death|2
811677|NCT02254408|2650285|P2|Overall Study|Adverse Event|0
811678|NCT02254408|2650286|P1|Overall Study|Adverse Event|1
811679|NCT02254408|2650285|P2|Overall Study|Randomized But Not Treated|3
811680|NCT02254408|2650286|P1|Overall Study|Randomized But Not Treated|1
811681|NCT02254304|2650298|P2|Overall Study|Personal decision|0
811682|NCT02254304|2650299|P1|Overall Study|Personal decision|1
811683|NCT02254304|2650298|P2|Overall Study|Personal causes|1
811684|NCT02254304|2650299|P1|Overall Study|Personal causes|4
811685|NCT02254304|2650298|P2|Overall Study|Injection site pain and Injection fear|0
811686|NCT02254304|2650299|P1|Overall Study|Injection site pain and Injection fear|1
811687|NCT02254304|2650298|P2|Overall Study|Withdrawal by Subject|0
811688|NCT02254304|2650299|P1|Overall Study|Withdrawal by Subject|3
811689|NCT02254304|2650298|P2|Overall Study|Protocol Violation|0
811690|NCT02254304|2650299|P1|Overall Study|Protocol Violation|1
811691|NCT02254304|2650298|P2|Overall Study|Lost to Follow-up|2
811692|NCT02254304|2650299|P1|Overall Study|Lost to Follow-up|2
811693|NCT02254304|2650298|P2|Overall Study|Adverse Event|1
811694|NCT02254304|2650299|P1|Overall Study|Adverse Event|2
811695|NCT02254291|2650359|P3|Overall Study|Missing follow-up information|1
811696|NCT02254291|2650360|P2|Overall Study|Missing follow-up information|0
811697|NCT02254291|2650361|P1|Overall Study|Missing follow-up information|0
811698|NCT02254291|2650359|P3|Overall Study|Withdrawal by Subject|1
811699|NCT02254291|2650360|P2|Overall Study|Withdrawal by Subject|3
811700|NCT02254291|2650361|P1|Overall Study|Withdrawal by Subject|0
811701|NCT02253654|2650390|P2|Overall Study|Did Not Receive Study Treatment|1
811702|NCT02253654|2650391|P1|Overall Study|Did Not Receive Study Treatment|4
811703|NCT02253654|2650390|P2|Overall Study|Death|7
811704|NCT02253654|2650391|P1|Overall Study|Death|4
811705|NCT02253654|2650390|P2|Overall Study|Lost to Follow-up|5
811706|NCT02253654|2650391|P1|Overall Study|Lost to Follow-up|2
811707|NCT02253654|2650390|P2|Overall Study|Decision by Sponsor|1
811708|NCT02253654|2650391|P1|Overall Study|Decision by Sponsor|1
811709|NCT02253654|2650390|P2|Overall Study|Withdrawal by Subject|4
811710|NCT02253654|2650391|P1|Overall Study|Withdrawal by Subject|12
811711|NCT02253433|2650413|P2|Overall Study|Medical or Other Concerns|2
811712|NCT02253433|2650414|P1|Overall Study|Medical or Other Concerns|1
811713|NCT02253433|2650413|P2|Overall Study|Too Busy|4
811714|NCT02253433|2650414|P1|Overall Study|Too Busy|0
811715|NCT02253433|2650413|P2|Overall Study|Unstable Housing/Homeless|7
811716|NCT02253433|2650414|P1|Overall Study|Unstable Housing/Homeless|0
811717|NCT02253433|2650413|P2|Overall Study|Uncomfortable with home visitors|3
811718|NCT02253433|2650414|P1|Overall Study|Uncomfortable with home visitors|0
811719|NCT02253433|2650413|P2|Overall Study|Out of Study Area|7
811720|NCT02253433|2650414|P1|Overall Study|Out of Study Area|2
811721|NCT02253433|2650413|P2|Overall Study|No Longer Interested|15
811722|NCT02253433|2650414|P1|Overall Study|No Longer Interested|3
811723|NCT02253433|2650413|P2|Overall Study|Death|1
811724|NCT02253433|2650414|P1|Overall Study|Death|1
811725|NCT02253433|2650413|P2|Overall Study|Unable to Contact|16
811726|NCT02253433|2650414|P1|Overall Study|Unable to Contact|9
811727|NCT02253147|2650666|P1|Overall Study|Withdrawal by Subject|1
811728|NCT02253147|2650666|P1|Overall Study|Lost to Follow-up|2
811729|NCT02253147|2650666|P1|Overall Study|Conditional re-treatment at W52|5
811730|NCT02253147|2650666|P1|Overall Study|Did not consent to study extension|9
811731|NCT02253147|2650666|P1|Overall Study|Protocol Violation|30
811732|NCT02252965|2650700|P2|Overall Study|Other|5
811733|NCT02252965|2650701|P1|Overall Study|Other|4
811734|NCT02252965|2650700|P2|Overall Study|Withdrawal by Subject|9
811735|NCT02252965|2650701|P1|Overall Study|Withdrawal by Subject|7
811736|NCT02252965|2650700|P2|Overall Study|Lack of Efficacy|2
811737|NCT02252965|2650701|P1|Overall Study|Lack of Efficacy|0
811738|NCT02252965|2650700|P2|Overall Study|Protocol Violation|5
811739|NCT02252965|2650701|P1|Overall Study|Protocol Violation|4
811740|NCT02252965|2650700|P2|Overall Study|Lost to Follow-up|8
811741|NCT02252965|2650701|P1|Overall Study|Lost to Follow-up|16
811742|NCT02252965|2650700|P2|Overall Study|Adverse Event|14
811743|NCT02252965|2650701|P1|Overall Study|Adverse Event|9
811744|NCT02252939|2650728|P1|Overall Study|Lost to Follow-up|3
811745|NCT02252536|2650747|P2|Overall Study|Lost to Follow-up|3
811746|NCT02252536|2650748|P1|Overall Study|Lost to Follow-up|5
811747|NCT02252146|2650855|P1|Overall Study|Inability to travel to study site|1
811748|NCT02252146|2650855|P1|Overall Study|Entered hospice care|1
811749|NCT02252146|2650855|P1|Overall Study|Lack of Efficacy|4
811750|NCT02252042|2650868|P2|Overall Study|Ongoing in study|35
811751|NCT02252042|2650869|P1|Overall Study|Ongoing in study|64
811752|NCT02252042|2650868|P2|Overall Study|Withdrawal by Subject|20
811753|NCT02252042|2650869|P1|Overall Study|Withdrawal by Subject|13
811754|NCT02252042|2650868|P2|Overall Study|Physician Decision|1
811755|NCT02252042|2650869|P1|Overall Study|Physician Decision|0
811756|NCT02252042|2650868|P2|Overall Study|Death|192
811757|NCT02252042|2650869|P1|Overall Study|Death|170
811758|NCT02252016|2650909|P2|Overall Study|Withdrawal by Subject|2
811759|NCT02252016|2650910|P1|Overall Study|Withdrawal by Subject|0
811760|NCT02252016|2650909|P2|Overall Study|Physician Decision|0
811761|NCT02252016|2650910|P1|Overall Study|Physician Decision|1
811762|NCT02252016|2650909|P2|Overall Study|Lost to Follow-up|1
811763|NCT02252016|2650910|P1|Overall Study|Lost to Follow-up|2
811764|NCT02251990|2650924|P2|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2
811765|NCT02251990|2650925|P1|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0
811766|NCT02251990|2650924|P2|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1
811767|NCT02251990|2650925|P1|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0
811768|NCT02251990|2650924|P2|Period 1 (Double-blind [DB])|Not Treated|0
811769|NCT02251990|2650925|P1|Period 1 (Double-blind [DB])|Not Treated|1
811770|NCT02251990|2650924|P2|Period 1 (Double-blind [DB])|Withdrawal by Subject|0
811771|NCT02251990|2650925|P1|Period 1 (Double-blind [DB])|Withdrawal by Subject|1
811772|NCT02251990|2650924|P2|Period 1 (Double-blind [DB])|Lack of Efficacy|0
811773|NCT02251990|2650925|P1|Period 1 (Double-blind [DB])|Lack of Efficacy|5
811774|NCT02251990|2650924|P2|Period 1 (Double-blind [DB])|Adverse Event|1
811775|NCT02251990|2650925|P1|Period 1 (Double-blind [DB])|Adverse Event|1
811776|NCT02251912|2650942|P2|Overall Study|Adverse Event|2
811777|NCT02251912|2650943|P1|Overall Study|Adverse Event|0
811778|NCT02251912|2650942|P2|Overall Study|Withdrawal by Subject|3
811779|NCT02251912|2650943|P1|Overall Study|Withdrawal by Subject|2
811780|NCT02251717|2650972|P2|Overall Study|Withdrew Consent|0
811781|NCT02251717|2650973|P1|Overall Study|Withdrew Consent|1
811782|NCT02251717|2650972|P2|Overall Study|Adverse Event|1
811783|NCT02251717|2650973|P1|Overall Study|Adverse Event|0
811784|NCT02251652|2650985|P1|Overall Study|Withdrawal by Subject|1
811785|NCT02250443|2651050|P1|Overall Study|Adverse Event|3
811786|NCT02250443|2651050|P1|Overall Study|Administrative problems|7
811787|NCT02250326|2651079|P3|Follow-Up Period|Lost to Follow-up|3
811788|NCT02250326|2651080|P2|Follow-Up Period|Lost to Follow-up|1
811789|NCT02250326|2651081|P1|Follow-Up Period|Lost to Follow-up|1
811790|NCT02250326|2651079|P3|Follow-Up Period|Unknown or Missing|3
811791|NCT02250326|2651080|P2|Follow-Up Period|Unknown or Missing|3
811792|NCT02250326|2651081|P1|Follow-Up Period|Unknown or Missing|2
811793|NCT02250326|2651079|P3|Follow-Up Period|Death|32
811794|NCT02250326|2651080|P2|Follow-Up Period|Death|26
811795|NCT02250326|2651081|P1|Follow-Up Period|Death|46
811796|NCT02250326|2651079|P3|Treatment Period|Randomized or assigned; not treated|1
811797|NCT02250326|2651080|P2|Treatment Period|Randomized or assigned; not treated|1
811798|NCT02250326|2651081|P1|Treatment Period|Randomized or assigned; not treated|2
811799|NCT02250326|2651079|P3|Treatment Period|Miscellaneous|7
811800|NCT02250326|2651080|P2|Treatment Period|Miscellaneous|2
811801|NCT02250326|2651081|P1|Treatment Period|Miscellaneous|8
811802|NCT02250326|2651079|P3|Treatment Period|Withdrawal by Subject|4
811803|NCT02250326|2651080|P2|Treatment Period|Withdrawal by Subject|5
811804|NCT02250326|2651081|P1|Treatment Period|Withdrawal by Subject|11
811805|NCT02250326|2651079|P3|Treatment Period|Symptomatic Deterioration|10
811806|NCT02250326|2651080|P2|Treatment Period|Symptomatic Deterioration|4
811807|NCT02250326|2651081|P1|Treatment Period|Symptomatic Deterioration|9
811808|NCT02250326|2651079|P3|Treatment Period|Progressive Disease|45
811809|NCT02250326|2651080|P2|Treatment Period|Progressive Disease|36
811810|NCT02250326|2651081|P1|Treatment Period|Progressive Disease|42
811811|NCT02250326|2651079|P3|Treatment Period|Adverse Event|8
811812|NCT02250326|2651080|P2|Treatment Period|Adverse Event|4
811813|NCT02250326|2651081|P1|Treatment Period|Adverse Event|8
811814|NCT02250326|2651079|P3|Treatment Period|Death|2
811815|NCT02250326|2651080|P2|Treatment Period|Death|12
811816|NCT02250326|2651081|P1|Treatment Period|Death|1
811817|NCT02250274|2651114|P2|Overall Study|Insufficient blood draw amount|6
811818|NCT02250274|2651115|P1|Overall Study|Insufficient blood draw amount|7
811819|NCT02248818|2651240|P9|Randomised Study|Administrative - randomization error|0
811820|NCT02248818|2651241|P8|Randomised Study|Administrative - randomization error|0
811821|NCT02248818|2651242|P7|Randomised Study|Administrative - randomization error|0
811822|NCT02248818|2651243|P6|Randomised Study|Administrative - randomization error|8
811823|NCT02248818|2651244|P5|Randomised Study|Administrative - randomization error|0
811824|NCT02248818|2651245|P4|Randomised Study|Administrative - randomization error|0
811825|NCT02248818|2651246|P3|Randomised Study|Administrative - randomization error|0
811826|NCT02248818|2651247|P2|Randomised Study|Administrative - randomization error|0
811827|NCT02248818|2651248|P1|Randomised Study|Administrative - randomization error|0
811828|NCT02248818|2651240|P9|Screening|Lost to Follow-up|7
811829|NCT02248818|2651241|P8|Screening|Lost to Follow-up|0
811830|NCT02248818|2651242|P7|Screening|Lost to Follow-up|0
811831|NCT02248818|2651243|P6|Screening|Lost to Follow-up|0
811832|NCT02248818|2651244|P5|Screening|Lost to Follow-up|0
811833|NCT02248818|2651245|P4|Screening|Lost to Follow-up|0
811834|NCT02248818|2651246|P3|Screening|Lost to Follow-up|0
811835|NCT02248818|2651247|P2|Screening|Lost to Follow-up|0
811836|NCT02248818|2651248|P1|Screening|Lost to Follow-up|0
811837|NCT02248818|2651240|P9|Screening|Withdrawal by Subject|6
811838|NCT02248818|2651241|P8|Screening|Withdrawal by Subject|0
811839|NCT02248818|2651242|P7|Screening|Withdrawal by Subject|0
811840|NCT02248818|2651243|P6|Screening|Withdrawal by Subject|0
811841|NCT02248818|2651244|P5|Screening|Withdrawal by Subject|0
811842|NCT02248818|2651245|P4|Screening|Withdrawal by Subject|0
811843|NCT02248818|2651246|P3|Screening|Withdrawal by Subject|0
811844|NCT02248818|2651247|P2|Screening|Withdrawal by Subject|0
811845|NCT02248818|2651248|P1|Screening|Withdrawal by Subject|0
811846|NCT02248818|2651240|P9|Screening|Physician Decision|73
811847|NCT02248818|2651241|P8|Screening|Physician Decision|0
811848|NCT02248818|2651242|P7|Screening|Physician Decision|0
811849|NCT02248818|2651243|P6|Screening|Physician Decision|0
811850|NCT02248818|2651244|P5|Screening|Physician Decision|0
811851|NCT02248818|2651245|P4|Screening|Physician Decision|0
811852|NCT02248818|2651246|P3|Screening|Physician Decision|0
811853|NCT02248818|2651247|P2|Screening|Physician Decision|0
811854|NCT02248818|2651248|P1|Screening|Physician Decision|0
811855|NCT02248818|2651240|P9|Screening|Study fully enrolled|14
811856|NCT02248818|2651241|P8|Screening|Study fully enrolled|0
811857|NCT02248818|2651242|P7|Screening|Study fully enrolled|0
811858|NCT02248818|2651243|P6|Screening|Study fully enrolled|0
811859|NCT02248818|2651244|P5|Screening|Study fully enrolled|0
811860|NCT02248818|2651245|P4|Screening|Study fully enrolled|0
811861|NCT02248818|2651246|P3|Screening|Study fully enrolled|0
811862|NCT02248818|2651247|P2|Screening|Study fully enrolled|0
811863|NCT02248818|2651248|P1|Screening|Study fully enrolled|0
811864|NCT02248818|2651240|P9|Screening|Protocol Violation|7
811865|NCT02248818|2651241|P8|Screening|Protocol Violation|0
811866|NCT02248818|2651242|P7|Screening|Protocol Violation|0
811867|NCT02248818|2651243|P6|Screening|Protocol Violation|0
811868|NCT02248818|2651244|P5|Screening|Protocol Violation|0
811869|NCT02248818|2651245|P4|Screening|Protocol Violation|0
811870|NCT02248818|2651246|P3|Screening|Protocol Violation|0
811871|NCT02248818|2651247|P2|Screening|Protocol Violation|0
811872|NCT02248818|2651248|P1|Screening|Protocol Violation|0
811873|NCT02248675|2651411|P2|Overall Study|Lost to Follow-up|1
811874|NCT02248675|2651412|P1|Overall Study|Lost to Follow-up|3
811875|NCT02248480|2651439|P2|Overall Study|Other:Physician Decision|1
811876|NCT02248480|2651440|P1|Overall Study|Other:Physician Decision|0
811877|NCT02248480|2651439|P2|Overall Study|Entry Criteria Not Met|1
811878|NCT02248480|2651440|P1|Overall Study|Entry Criteria Not Met|0
811879|NCT02248480|2651439|P2|Overall Study|Withdrawal by Subject|4
811880|NCT02248480|2651440|P1|Overall Study|Withdrawal by Subject|2
811881|NCT02248480|2651439|P2|Overall Study|Adverse Event|2
811882|NCT02248480|2651440|P1|Overall Study|Adverse Event|11
811883|NCT02248480|2651439|P2|Overall Study|Lack of Efficacy|6
811884|NCT02248480|2651440|P1|Overall Study|Lack of Efficacy|4
811885|NCT02247960|2651507|P2|Catheter Removed|Lost to Follow-up|10
811886|NCT02247960|2651508|P1|Catheter Removed|Lost to Follow-up|7
811887|NCT02247960|2651507|P2|Patient Consent and Randomization|Withdrawal by Subject|4
811888|NCT02247960|2651508|P1|Patient Consent and Randomization|Withdrawal by Subject|0
811889|NCT02247960|2651507|P2|Patient Consent and Randomization|Physician Decision|2
811890|NCT02247960|2651508|P1|Patient Consent and Randomization|Physician Decision|2
811891|NCT02247401|2651547|P3|Overall Study|Lost to Follow-up|1
811892|NCT02247401|2651548|P2|Overall Study|Lost to Follow-up|1
811893|NCT02247401|2651549|P1|Overall Study|Lost to Follow-up|1
811894|NCT02247401|2651547|P3|Overall Study|Withdrawal by Subject|1
811895|NCT02247401|2651548|P2|Overall Study|Withdrawal by Subject|1
811896|NCT02247401|2651549|P1|Overall Study|Withdrawal by Subject|4
811897|NCT02247401|2651547|P3|Overall Study|Adverse Event|0
811898|NCT02247401|2651548|P2|Overall Study|Adverse Event|0
811899|NCT02247401|2651549|P1|Overall Study|Adverse Event|1
811900|NCT02247011|2651579|P1|Overall Study|Poor quality of radiological results|125
811901|NCT02246998|2651600|P4|Overall Study|Randomized but Never Dosed|1
811902|NCT02246998|2651601|P3|Overall Study|Randomized but Never Dosed|2
811903|NCT02246998|2651602|P2|Overall Study|Randomized but Never Dosed|2
811904|NCT02246998|2651603|P1|Overall Study|Randomized but Never Dosed|1
811905|NCT02246998|2651600|P4|Overall Study|Lost to Follow-up|1
811906|NCT02246998|2651601|P3|Overall Study|Lost to Follow-up|0
811907|NCT02246998|2651602|P2|Overall Study|Lost to Follow-up|0
811908|NCT02246998|2651603|P1|Overall Study|Lost to Follow-up|1
811909|NCT02246998|2651600|P4|Overall Study|Adverse Event|0
811910|NCT02246998|2651601|P3|Overall Study|Adverse Event|1
811911|NCT02246998|2651602|P2|Overall Study|Adverse Event|1
811912|NCT02246998|2651603|P1|Overall Study|Adverse Event|0
811913|NCT02246777|2651713|P1|Overall Study|Change of residence|1
811914|NCT02246777|2651713|P1|Overall Study|Adverse Event|2
811915|NCT02246764|2651729|P3|Overall Study|Protocol Violation|1
811916|NCT02246764|2651730|P2|Overall Study|Protocol Violation|1
811917|NCT02246764|2651731|P1|Overall Study|Protocol Violation|2
811918|NCT02246764|2651729|P3|Overall Study|Physician Decision|1
811919|NCT02246764|2651730|P2|Overall Study|Physician Decision|2
811920|NCT02246764|2651731|P1|Overall Study|Physician Decision|0
811921|NCT02246764|2651729|P3|Overall Study|Disallowed Concomitant Medication|0
811922|NCT02246764|2651730|P2|Overall Study|Disallowed Concomitant Medication|0
811923|NCT02246764|2651731|P1|Overall Study|Disallowed Concomitant Medication|1
811924|NCT02246764|2651729|P3|Overall Study|Withdrawal by Subject|1
811925|NCT02246764|2651730|P2|Overall Study|Withdrawal by Subject|0
811926|NCT02246764|2651731|P1|Overall Study|Withdrawal by Subject|0
811927|NCT02246764|2651729|P3|Overall Study|Adverse Event|1
811928|NCT02246764|2651730|P2|Overall Study|Adverse Event|29
811929|NCT02246764|2651731|P1|Overall Study|Adverse Event|15
811930|NCT02246673|2651744|P5|Overall Study|Protocol Violation|0
811931|NCT02246673|2651745|P4|Overall Study|Protocol Violation|1
811932|NCT02246673|2651746|P3|Overall Study|Protocol Violation|0
811933|NCT02246673|2651747|P2|Overall Study|Protocol Violation|0
811934|NCT02246673|2651748|P1|Overall Study|Protocol Violation|0
811935|NCT02246673|2651744|P5|Overall Study|Lost to Follow-up|0
811936|NCT02246673|2651745|P4|Overall Study|Lost to Follow-up|1
811937|NCT02246673|2651746|P3|Overall Study|Lost to Follow-up|0
811938|NCT02246673|2651747|P2|Overall Study|Lost to Follow-up|0
811939|NCT02246673|2651748|P1|Overall Study|Lost to Follow-up|0
811940|NCT02246673|2651744|P5|Overall Study|Withdrawal by Subject|1
811941|NCT02246673|2651745|P4|Overall Study|Withdrawal by Subject|0
811942|NCT02246673|2651746|P3|Overall Study|Withdrawal by Subject|0
811943|NCT02246673|2651747|P2|Overall Study|Withdrawal by Subject|0
811944|NCT02246673|2651748|P1|Overall Study|Withdrawal by Subject|0
811945|NCT02246673|2651744|P5|Overall Study|Sponsor Decision|0
811946|NCT02246673|2651745|P4|Overall Study|Sponsor Decision|0
811947|NCT02246673|2651746|P3|Overall Study|Sponsor Decision|0
811948|NCT02246673|2651747|P2|Overall Study|Sponsor Decision|0
811949|NCT02246673|2651748|P1|Overall Study|Sponsor Decision|1
811950|NCT02246660|2651856|P3|Overall Study|Death|1
811951|NCT02246660|2651857|P2|Overall Study|Death|0
811952|NCT02246660|2651858|P1|Overall Study|Death|0
811953|NCT02246660|2651856|P3|Overall Study|Withdrawal by Subject|0
811954|NCT02246660|2651857|P2|Overall Study|Withdrawal by Subject|1
811955|NCT02246660|2651858|P1|Overall Study|Withdrawal by Subject|0
811956|NCT02246621|2651868|P2|Overall Study|On Study Treatment/ Follow Up|133
811957|NCT02246621|2651869|P1|Overall Study|On Study Treatment/ Follow Up|257
811958|NCT02246621|2651868|P2|Overall Study|Lost to Follow-up|1
811959|NCT02246621|2651869|P1|Overall Study|Lost to Follow-up|3
811960|NCT02246621|2651868|P2|Overall Study|Withdrawal by Subject|14
811961|NCT02246621|2651869|P1|Overall Study|Withdrawal by Subject|36
811962|NCT02246582|2651906|P2|Overall Study|Withdrawal by Subject|4
811963|NCT02246582|2651907|P1|Overall Study|Withdrawal by Subject|3
811964|NCT02246166|2651928|P2|Overall Study|Protocol Violation|0
811965|NCT02246166|2651929|P1|Overall Study|Protocol Violation|1
811966|NCT02246114|2651965|P2|Overall Study|miscarriage|0
811967|NCT02246114|2651966|P1|Overall Study|miscarriage|1
811968|NCT02245412|2652000|P3|Overall Study|Other|0
811969|NCT02245412|2652001|P2|Overall Study|Other|0
811970|NCT02245412|2652002|P1|Overall Study|Other|1
811971|NCT02245412|2652000|P3|Overall Study|Biopsy did not confirm GI GVHD|0
811972|NCT02245412|2652001|P2|Overall Study|Biopsy did not confirm GI GVHD|0
811973|NCT02245412|2652002|P1|Overall Study|Biopsy did not confirm GI GVHD|1
811974|NCT02245412|2652000|P3|Overall Study|Withdrawal by Subject|0
811975|NCT02245412|2652001|P2|Overall Study|Withdrawal by Subject|1
811976|NCT02245412|2652002|P1|Overall Study|Withdrawal by Subject|1
811977|NCT02245412|2652000|P3|Overall Study|Physician Decision|0
811978|NCT02245412|2652001|P2|Overall Study|Physician Decision|1
811979|NCT02245412|2652002|P1|Overall Study|Physician Decision|1
811980|NCT02245412|2652000|P3|Overall Study|Death|0
811981|NCT02245412|2652001|P2|Overall Study|Death|1
811982|NCT02245412|2652002|P1|Overall Study|Death|1
811983|NCT02244944|2652036|P1|Overall Study|Study Terminated|1
811984|NCT02244944|2652036|P1|Overall Study|Withdrawal by Subject|1
811985|NCT02244619|2652048|P2|Overall Study|Did not receive study intervention|21
811986|NCT02244619|2652049|P1|Overall Study|Did not receive study intervention|8
811987|NCT02244580|2652067|P1|Overall Study|No cancer tissues available|241
811988|NCT02243293|2652105|P22|Overall Study|Randomized but did'nt receive study drug|0
811989|NCT02243293|2652106|P21|Overall Study|Randomized but did'nt receive study drug|0
811990|NCT02243293|2652107|P20|Overall Study|Randomized but did'nt receive study drug|1
811991|NCT02243293|2652108|P19|Overall Study|Randomized but did'nt receive study drug|0
811992|NCT02243293|2652109|P18|Overall Study|Randomized but did'nt receive study drug|0
811993|NCT02243293|2652110|P17|Overall Study|Randomized but did'nt receive study drug|0
811994|NCT02243293|2652111|P16|Overall Study|Randomized but did'nt receive study drug|0
811995|NCT02243293|2652112|P15|Overall Study|Randomized but did'nt receive study drug|0
811996|NCT02243293|2652113|P14|Overall Study|Randomized but did'nt receive study drug|0
811997|NCT02243293|2652114|P13|Overall Study|Randomized but did'nt receive study drug|0
811998|NCT02243293|2652115|P12|Overall Study|Randomized but did'nt receive study drug|0
811999|NCT02243293|2652116|P11|Overall Study|Randomized but did'nt receive study drug|0
812000|NCT02243293|2652117|P10|Overall Study|Randomized but did'nt receive study drug|1
812001|NCT02243293|2652118|P9|Overall Study|Randomized but did'nt receive study drug|0
812002|NCT02243293|2652119|P8|Overall Study|Randomized but did'nt receive study drug|0
812003|NCT02243293|2652120|P7|Overall Study|Randomized but did'nt receive study drug|0
812004|NCT02243293|2652121|P6|Overall Study|Randomized but did'nt receive study drug|0
812005|NCT02243293|2652122|P5|Overall Study|Randomized but did'nt receive study drug|1
812006|NCT02243293|2652123|P4|Overall Study|Randomized but did'nt receive study drug|0
812007|NCT02243293|2652124|P3|Overall Study|Randomized but did'nt receive study drug|0
812008|NCT02243293|2652125|P2|Overall Study|Randomized but did'nt receive study drug|0
812009|NCT02243293|2652126|P1|Overall Study|Randomized but did'nt receive study drug|0
812010|NCT02243293|2652105|P22|Overall Study|Enrolled into a Re-treatment Study|0
812011|NCT02243293|2652106|P21|Overall Study|Enrolled into a Re-treatment Study|0
812012|NCT02243293|2652107|P20|Overall Study|Enrolled into a Re-treatment Study|0
812013|NCT02243293|2652108|P19|Overall Study|Enrolled into a Re-treatment Study|0
812014|NCT02243293|2652109|P18|Overall Study|Enrolled into a Re-treatment Study|0
812015|NCT02243293|2652110|P17|Overall Study|Enrolled into a Re-treatment Study|0
812016|NCT02243293|2652111|P16|Overall Study|Enrolled into a Re-treatment Study|0
812017|NCT02243293|2652112|P15|Overall Study|Enrolled into a Re-treatment Study|1
812018|NCT02243293|2652113|P14|Overall Study|Enrolled into a Re-treatment Study|0
812019|NCT02243293|2652114|P13|Overall Study|Enrolled into a Re-treatment Study|0
812020|NCT02243293|2652115|P12|Overall Study|Enrolled into a Re-treatment Study|0
812021|NCT02243293|2652116|P11|Overall Study|Enrolled into a Re-treatment Study|0
812022|NCT02243293|2652117|P10|Overall Study|Enrolled into a Re-treatment Study|0
812023|NCT02243293|2652118|P9|Overall Study|Enrolled into a Re-treatment Study|0
812024|NCT02243293|2652119|P8|Overall Study|Enrolled into a Re-treatment Study|0
812025|NCT02243293|2652120|P7|Overall Study|Enrolled into a Re-treatment Study|0
812026|NCT02243293|2652121|P6|Overall Study|Enrolled into a Re-treatment Study|0
812027|NCT02243293|2652122|P5|Overall Study|Enrolled into a Re-treatment Study|0
812028|NCT02243293|2652123|P4|Overall Study|Enrolled into a Re-treatment Study|0
812029|NCT02243293|2652124|P3|Overall Study|Enrolled into a Re-treatment Study|0
812030|NCT02243293|2652125|P2|Overall Study|Enrolled into a Re-treatment Study|0
812031|NCT02243293|2652126|P1|Overall Study|Enrolled into a Re-treatment Study|0
812032|NCT02243293|2652105|P22|Overall Study|Lost to Follow-up|2
812033|NCT02243293|2652106|P21|Overall Study|Lost to Follow-up|1
812034|NCT02243293|2652107|P20|Overall Study|Lost to Follow-up|0
812035|NCT02243293|2652108|P19|Overall Study|Lost to Follow-up|0
812036|NCT02243293|2652109|P18|Overall Study|Lost to Follow-up|1
812037|NCT02243293|2652110|P17|Overall Study|Lost to Follow-up|3
812038|NCT02243293|2652111|P16|Overall Study|Lost to Follow-up|0
812039|NCT02243293|2652112|P15|Overall Study|Lost to Follow-up|0
812040|NCT02243293|2652113|P14|Overall Study|Lost to Follow-up|0
812041|NCT02243293|2652114|P13|Overall Study|Lost to Follow-up|0
812042|NCT02243293|2652115|P12|Overall Study|Lost to Follow-up|2
812043|NCT02243293|2652116|P11|Overall Study|Lost to Follow-up|0
812044|NCT02243293|2652117|P10|Overall Study|Lost to Follow-up|0
812045|NCT02243293|2652118|P9|Overall Study|Lost to Follow-up|0
812046|NCT02243293|2652119|P8|Overall Study|Lost to Follow-up|0
812047|NCT02243293|2652120|P7|Overall Study|Lost to Follow-up|3
812048|NCT02243293|2652121|P6|Overall Study|Lost to Follow-up|0
812049|NCT02243293|2652122|P5|Overall Study|Lost to Follow-up|0
812050|NCT02243293|2652123|P4|Overall Study|Lost to Follow-up|1
812051|NCT02243293|2652124|P3|Overall Study|Lost to Follow-up|1
812052|NCT02243293|2652125|P2|Overall Study|Lost to Follow-up|1
812053|NCT02243293|2652126|P1|Overall Study|Lost to Follow-up|0
812054|NCT02243293|2652105|P22|Overall Study|Withdrawal by Subject|1
812055|NCT02243293|2652106|P21|Overall Study|Withdrawal by Subject|0
812056|NCT02243293|2652107|P20|Overall Study|Withdrawal by Subject|0
812057|NCT02243293|2652108|P19|Overall Study|Withdrawal by Subject|0
812058|NCT02243293|2652109|P18|Overall Study|Withdrawal by Subject|0
812059|NCT02243293|2652110|P17|Overall Study|Withdrawal by Subject|0
812060|NCT02243293|2652111|P16|Overall Study|Withdrawal by Subject|0
812061|NCT02243293|2652112|P15|Overall Study|Withdrawal by Subject|0
812062|NCT02243293|2652113|P14|Overall Study|Withdrawal by Subject|0
812063|NCT02243293|2652114|P13|Overall Study|Withdrawal by Subject|0
812064|NCT02243293|2652115|P12|Overall Study|Withdrawal by Subject|1
812065|NCT02243293|2652116|P11|Overall Study|Withdrawal by Subject|0
812066|NCT02243293|2652117|P10|Overall Study|Withdrawal by Subject|1
812067|NCT02243293|2652118|P9|Overall Study|Withdrawal by Subject|0
812068|NCT02243293|2652119|P8|Overall Study|Withdrawal by Subject|0
812069|NCT02243293|2652120|P7|Overall Study|Withdrawal by Subject|0
812070|NCT02243293|2652121|P6|Overall Study|Withdrawal by Subject|0
812071|NCT02243293|2652122|P5|Overall Study|Withdrawal by Subject|0
812072|NCT02243293|2652123|P4|Overall Study|Withdrawal by Subject|0
812073|NCT02243293|2652124|P3|Overall Study|Withdrawal by Subject|0
812074|NCT02243293|2652125|P2|Overall Study|Withdrawal by Subject|0
812075|NCT02243293|2652126|P1|Overall Study|Withdrawal by Subject|1
812076|NCT02243293|2652105|P22|Overall Study|Adverse Event|0
812077|NCT02243293|2652106|P21|Overall Study|Adverse Event|1
812078|NCT02243293|2652107|P20|Overall Study|Adverse Event|0
812079|NCT02243293|2652108|P19|Overall Study|Adverse Event|0
812080|NCT02243293|2652109|P18|Overall Study|Adverse Event|0
812081|NCT02243293|2652110|P17|Overall Study|Adverse Event|0
812082|NCT02243293|2652111|P16|Overall Study|Adverse Event|1
812083|NCT02243293|2652112|P15|Overall Study|Adverse Event|0
812084|NCT02243293|2652113|P14|Overall Study|Adverse Event|0
812085|NCT02243293|2652114|P13|Overall Study|Adverse Event|0
812086|NCT02243293|2652115|P12|Overall Study|Adverse Event|0
812087|NCT02243293|2652116|P11|Overall Study|Adverse Event|0
812088|NCT02243293|2652117|P10|Overall Study|Adverse Event|0
812089|NCT02243293|2652118|P9|Overall Study|Adverse Event|0
812090|NCT02243293|2652119|P8|Overall Study|Adverse Event|0
812091|NCT02243293|2652120|P7|Overall Study|Adverse Event|0
812092|NCT02243293|2652121|P6|Overall Study|Adverse Event|0
812093|NCT02243293|2652122|P5|Overall Study|Adverse Event|0
812094|NCT02243293|2652123|P4|Overall Study|Adverse Event|0
812095|NCT02243293|2652124|P3|Overall Study|Adverse Event|0
812096|NCT02243293|2652125|P2|Overall Study|Adverse Event|0
812097|NCT02243293|2652126|P1|Overall Study|Adverse Event|1
812098|NCT02243280|2652225|P11|Treated|Lost to Follow-up|2
812099|NCT02243280|2652226|P10|Treated|Lost to Follow-up|0
812100|NCT02243280|2652227|P9|Treated|Lost to Follow-up|1
812101|NCT02243280|2652228|P8|Treated|Lost to Follow-up|0
812102|NCT02243280|2652229|P7|Treated|Lost to Follow-up|0
812103|NCT02243280|2652230|P6|Treated|Lost to Follow-up|0
812104|NCT02243280|2652231|P5|Treated|Lost to Follow-up|0
812105|NCT02243280|2652232|P4|Treated|Lost to Follow-up|0
812106|NCT02243280|2652233|P3|Treated|Lost to Follow-up|0
812107|NCT02243280|2652234|P2|Treated|Lost to Follow-up|0
812108|NCT02243280|2652235|P1|Treated|Lost to Follow-up|0
812109|NCT02243280|2652225|P11|Treated|Adverse Event|1
812110|NCT02243280|2652226|P10|Treated|Adverse Event|0
812111|NCT02243280|2652227|P9|Treated|Adverse Event|0
812112|NCT02243280|2652228|P8|Treated|Adverse Event|0
812113|NCT02243280|2652229|P7|Treated|Adverse Event|0
812114|NCT02243280|2652230|P6|Treated|Adverse Event|0
812115|NCT02243280|2652231|P5|Treated|Adverse Event|0
812116|NCT02243280|2652232|P4|Treated|Adverse Event|0
812117|NCT02243280|2652233|P3|Treated|Adverse Event|0
812118|NCT02243280|2652234|P2|Treated|Adverse Event|0
812119|NCT02243280|2652235|P1|Treated|Adverse Event|1
812120|NCT02243202|2652290|P4|Overall Study|Randomized but not received treatment|1
812121|NCT02243202|2652291|P3|Overall Study|Randomized but not received treatment|0
812122|NCT02243202|2652292|P2|Overall Study|Randomized but not received treatment|0
812123|NCT02243202|2652293|P1|Overall Study|Randomized but not received treatment|0
812124|NCT02243202|2652290|P4|Overall Study|Other|2
812125|NCT02243202|2652291|P3|Overall Study|Other|1
812126|NCT02243202|2652292|P2|Overall Study|Other|3
812127|NCT02243202|2652293|P1|Overall Study|Other|1
812128|NCT02243202|2652290|P4|Overall Study|Withdrawal by Subject|4
812129|NCT02243202|2652291|P3|Overall Study|Withdrawal by Subject|4
812130|NCT02243202|2652292|P2|Overall Study|Withdrawal by Subject|6
812131|NCT02243202|2652293|P1|Overall Study|Withdrawal by Subject|7
812132|NCT02243202|2652290|P4|Overall Study|Protocol Violation|1
812133|NCT02243202|2652291|P3|Overall Study|Protocol Violation|2
812134|NCT02243202|2652292|P2|Overall Study|Protocol Violation|1
812135|NCT02243202|2652293|P1|Overall Study|Protocol Violation|3
812136|NCT02243202|2652290|P4|Overall Study|Lost to Follow-up|11
812137|NCT02243202|2652291|P3|Overall Study|Lost to Follow-up|14
812138|NCT02243202|2652292|P2|Overall Study|Lost to Follow-up|9
812139|NCT02243202|2652293|P1|Overall Study|Lost to Follow-up|9
812140|NCT02243202|2652290|P4|Overall Study|Adverse Event|4
812141|NCT02243202|2652291|P3|Overall Study|Adverse Event|10
812142|NCT02243202|2652292|P2|Overall Study|Adverse Event|6
812143|NCT02243202|2652293|P1|Overall Study|Adverse Event|5
812144|NCT02243176|2652329|P2|Overall Study|Adverse Event|2
812145|NCT02243176|2652330|P1|Overall Study|Adverse Event|2
812146|NCT02243176|2652329|P2|Overall Study|Withdrawal by Subject|7
812147|NCT02243176|2652330|P1|Overall Study|Withdrawal by Subject|8
812148|NCT02243176|2652329|P2|Overall Study|Protocol Violation|1
812149|NCT02243176|2652330|P1|Overall Study|Protocol Violation|2
812150|NCT02243176|2652329|P2|Overall Study|protocol specified withdrawal critera|3
812151|NCT02243176|2652330|P1|Overall Study|protocol specified withdrawal critera|1
812152|NCT02243176|2652329|P2|Overall Study|Other reason|2
812153|NCT02243176|2652330|P1|Overall Study|Other reason|1
812154|NCT02243046|2652355|P3|Overall Study|Lost to Follow-up|4
812155|NCT02243046|2652356|P2|Overall Study|Lost to Follow-up|1
812156|NCT02243046|2652357|P1|Overall Study|Lost to Follow-up|1
812157|NCT02242903|2652417|P7|Overall Study|Withdrawal by Subject|0
812158|NCT02242903|2652418|P6|Overall Study|Withdrawal by Subject|0
812159|NCT02242903|2652419|P5|Overall Study|Withdrawal by Subject|0
812160|NCT02242903|2652420|P4|Overall Study|Withdrawal by Subject|0
812161|NCT02242903|2652421|P3|Overall Study|Withdrawal by Subject|0
812162|NCT02242903|2652422|P2|Overall Study|Withdrawal by Subject|0
812163|NCT02242903|2652423|P1|Overall Study|Withdrawal by Subject|1
812164|NCT02242643|2652453|P2|Overall Study|Withdrawal by subject at Visit 2|1
812165|NCT02242643|2652454|P1|Overall Study|Withdrawal by subject at Visit 2|0
812166|NCT02242643|2652453|P2|Overall Study|Language barrier|0
812167|NCT02242643|2652454|P1|Overall Study|Language barrier|1
812168|NCT02242643|2652453|P2|Overall Study|Protocol requirements not followed|0
812169|NCT02242643|2652454|P1|Overall Study|Protocol requirements not followed|1
812170|NCT02242643|2652453|P2|Overall Study|Consent withdrawal by parent|0
812171|NCT02242643|2652454|P1|Overall Study|Consent withdrawal by parent|1
812172|NCT02242643|2652453|P2|Overall Study|Non-compliance|0
812173|NCT02242643|2652454|P1|Overall Study|Non-compliance|1
812174|NCT02242643|2652453|P2|Overall Study|Child placed in foster care by family|1
812175|NCT02242643|2652454|P1|Overall Study|Child placed in foster care by family|0
812176|NCT02242643|2652453|P2|Overall Study|Lost to Follow-up|61
812177|NCT02242643|2652454|P1|Overall Study|Lost to Follow-up|54
812178|NCT02242643|2652453|P2|Overall Study|Migrated/moved from study area|3
812179|NCT02242643|2652454|P1|Overall Study|Migrated/moved from study area|1
812180|NCT02242643|2652453|P2|Overall Study|Withdrawal by Subject|10
812181|NCT02242643|2652454|P1|Overall Study|Withdrawal by Subject|15
812182|NCT02242643|2652453|P2|Overall Study|Protocol Violation|2
812183|NCT02242643|2652454|P1|Overall Study|Protocol Violation|1
812184|NCT02242305|2652509|P2|Overall Study|Lost to Follow-up|0
812185|NCT02242305|2652510|P1|Overall Study|Lost to Follow-up|2
812186|NCT02242305|2652509|P2|Overall Study|Subject withdraws inform consent|4
812187|NCT02242305|2652510|P1|Overall Study|Subject withdraws inform consent|0
812188|NCT02242305|2652509|P2|Overall Study|Non-compliance dosing regimen or visit|2
812189|NCT02242305|2652510|P1|Overall Study|Non-compliance dosing regimen or visit|2
812190|NCT02242305|2652509|P2|Overall Study|Adverse Event|0
812191|NCT02242305|2652510|P1|Overall Study|Adverse Event|1
812192|NCT02242305|2652509|P2|Overall Study|Without spasm-like pain during 3 weeks|4
812193|NCT02242305|2652510|P1|Overall Study|Without spasm-like pain during 3 weeks|1
812194|NCT02242201|2652531|P3|Overall Study|preoperative opioid consumption|0
812195|NCT02242201|2652532|P2|Overall Study|preoperative opioid consumption|1
812196|NCT02242201|2652533|P1|Overall Study|preoperative opioid consumption|0
812197|NCT02242201|2652531|P3|Overall Study|postponed surgery|1
812198|NCT02242201|2652532|P2|Overall Study|postponed surgery|0
812199|NCT02242201|2652533|P1|Overall Study|postponed surgery|0
812200|NCT02242201|2652531|P3|Overall Study|changed surgical procedure|0
812201|NCT02242201|2652532|P2|Overall Study|changed surgical procedure|0
812202|NCT02242201|2652533|P1|Overall Study|changed surgical procedure|1
812203|NCT02242201|2652531|P3|Overall Study|planned post-op anticoagulation|0
812204|NCT02242201|2652532|P2|Overall Study|planned post-op anticoagulation|0
812205|NCT02242201|2652533|P1|Overall Study|planned post-op anticoagulation|1
812206|NCT02242201|2652531|P3|Overall Study|preoperative identified neuropathy|0
812207|NCT02242201|2652532|P2|Overall Study|preoperative identified neuropathy|0
812208|NCT02242201|2652533|P1|Overall Study|preoperative identified neuropathy|2
812209|NCT02241889|2652571|P6|Overall Study|Withdrawal by Subject|1
812210|NCT02241889|2652572|P5|Overall Study|Withdrawal by Subject|0
812211|NCT02241889|2652573|P4|Overall Study|Withdrawal by Subject|0
812212|NCT02241889|2652574|P3|Overall Study|Withdrawal by Subject|0
812213|NCT02241889|2652575|P2|Overall Study|Withdrawal by Subject|0
812214|NCT02241889|2652576|P1|Overall Study|Withdrawal by Subject|0
812215|NCT02241889|2652571|P6|Overall Study|device issues|0
812216|NCT02241889|2652572|P5|Overall Study|device issues|0
812217|NCT02241889|2652573|P4|Overall Study|device issues|0
812218|NCT02241889|2652574|P3|Overall Study|device issues|1
812219|NCT02241889|2652575|P2|Overall Study|device issues|0
812220|NCT02241889|2652576|P1|Overall Study|device issues|0
812221|NCT02241785|2652611|P1|Overall Study|Adverse Event|1
812222|NCT02241785|2652611|P1|Overall Study|Lost to Follow-up|2
812223|NCT02241785|2652611|P1|Overall Study|Withdrawal by Subject|1
812224|NCT02241785|2652611|P1|Overall Study|Sponsor Termination|43
812225|NCT02241551|2652625|P2|Overall Study|Adverse Event|0
812226|NCT02241551|2652626|P1|Overall Study|Adverse Event|1
812227|NCT02241187|2652650|P1|Overall Study|Protocol closed due to lack of accrual.|2
812228|NCT02240693|2652660|P5|Overall Study|Other than specified|0
812229|NCT02240693|2652661|P4|Overall Study|Other than specified|0
812230|NCT02240693|2652662|P3|Overall Study|Other than specified|2
812231|NCT02240693|2652663|P2|Overall Study|Other than specified|0
812232|NCT02240693|2652664|P1|Overall Study|Other than specified|0
812233|NCT02240693|2652660|P5|Overall Study|Withdrawal by Subject|0
812234|NCT02240693|2652661|P4|Overall Study|Withdrawal by Subject|1
812235|NCT02240693|2652662|P3|Overall Study|Withdrawal by Subject|2
812236|NCT02240693|2652663|P2|Overall Study|Withdrawal by Subject|0
812237|NCT02240693|2652664|P1|Overall Study|Withdrawal by Subject|0
812238|NCT02240693|2652660|P5|Overall Study|Adverse Event|1
812239|NCT02240693|2652661|P4|Overall Study|Adverse Event|0
812240|NCT02240693|2652662|P3|Overall Study|Adverse Event|0
812241|NCT02240693|2652663|P2|Overall Study|Adverse Event|0
812242|NCT02240693|2652664|P1|Overall Study|Adverse Event|0
812243|NCT02240680|2652700|P4|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
812244|NCT02240680|2652701|P3|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1
812245|NCT02240680|2652702|P2|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
812246|NCT02240680|2652703|P1|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
812247|NCT02240680|2652700|P4|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
812248|NCT02240680|2652701|P3|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1
812249|NCT02240680|2652702|P2|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
812250|NCT02240680|2652703|P1|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
812251|NCT02240680|2652700|P4|Japanese Patients (Up to 52 Weeks)|Adverse Event|7
812252|NCT02240680|2652701|P3|Japanese Patients (Up to 52 Weeks)|Adverse Event|6
812253|NCT02240680|2652702|P2|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
812254|NCT02240680|2652703|P1|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
812255|NCT02240680|2652700|P4|Overall Study (Up to 24 Weeks)|Other than specified|0
812256|NCT02240680|2652701|P3|Overall Study (Up to 24 Weeks)|Other than specified|0
812257|NCT02240680|2652702|P2|Overall Study (Up to 24 Weeks)|Other than specified|0
812258|NCT02240680|2652703|P1|Overall Study (Up to 24 Weeks)|Other than specified|1
812259|NCT02240680|2652700|P4|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
812260|NCT02240680|2652701|P3|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
812261|NCT02240680|2652702|P2|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1
812262|NCT02240680|2652703|P1|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3
812263|NCT02240680|2652700|P4|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
812264|NCT02240680|2652701|P3|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
812265|NCT02240680|2652702|P2|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
812266|NCT02240680|2652703|P1|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1
812267|NCT02240680|2652700|P4|Overall Study (Up to 24 Weeks)|Protocol Violation|0
812268|NCT02240680|2652701|P3|Overall Study (Up to 24 Weeks)|Protocol Violation|0
812269|NCT02240680|2652702|P2|Overall Study (Up to 24 Weeks)|Protocol Violation|1
812270|NCT02240680|2652703|P1|Overall Study (Up to 24 Weeks)|Protocol Violation|4
812271|NCT02240680|2652700|P4|Overall Study (Up to 24 Weeks)|Adverse Event|0
812272|NCT02240680|2652701|P3|Overall Study (Up to 24 Weeks)|Adverse Event|0
812273|NCT02240680|2652702|P2|Overall Study (Up to 24 Weeks)|Adverse Event|6
812274|NCT02240680|2652703|P1|Overall Study (Up to 24 Weeks)|Adverse Event|6
812275|NCT02240628|2652744|P2|Overall Study|Physician Decision|5
812276|NCT02240628|2652745|P1|Overall Study|Physician Decision|6
812277|NCT02240368|2652779|P3|Overall Study|Entropy failed to detect more than 50%|1
812278|NCT02240368|2652780|P2|Overall Study|Entropy failed to detect more than 50%|0
812279|NCT02240368|2652781|P1|Overall Study|Entropy failed to detect more than 50%|0
812280|NCT02240368|2652779|P3|Overall Study|Surgery lasted less then 20 minutes|0
812281|NCT02240368|2652780|P2|Overall Study|Surgery lasted less then 20 minutes|0
812282|NCT02240368|2652781|P1|Overall Study|Surgery lasted less then 20 minutes|1
812283|NCT02239978|2652832|P2|Overall Study|Withdrawal by Subject|0
812284|NCT02239978|2652833|P1|Overall Study|Withdrawal by Subject|2
812285|NCT02239939|2652850|P2|Overall Study|Lost to Follow-up|1
812286|NCT02239939|2652851|P1|Overall Study|Lost to Follow-up|0
812287|NCT02239939|2652850|P2|Overall Study|Withdrawal by Subject|1
812288|NCT02239939|2652851|P1|Overall Study|Withdrawal by Subject|1
812289|NCT02239939|2652850|P2|Overall Study|Adverse Event|0
812290|NCT02239939|2652851|P1|Overall Study|Adverse Event|1
812291|NCT02239926|2652867|P2|Overall Study|Withdrawal by Subject|1
812292|NCT02239926|2652868|P1|Overall Study|Withdrawal by Subject|0
812293|NCT02239692|2652930|P2|Overall Study|Other reason|0
812294|NCT02239692|2652931|P1|Overall Study|Other reason|1
812295|NCT02239692|2652930|P2|Overall Study|Withdrawal by Subject|5
812296|NCT02239692|2652931|P1|Overall Study|Withdrawal by Subject|3
812297|NCT02239692|2652930|P2|Overall Study|Lost to Follow-up|4
812298|NCT02239692|2652931|P1|Overall Study|Lost to Follow-up|1
812299|NCT02239692|2652930|P2|Overall Study|Physician Decision|1
812300|NCT02239692|2652931|P1|Overall Study|Physician Decision|0
812301|NCT02239692|2652930|P2|Overall Study|Adverse Event|1
812302|NCT02239692|2652931|P1|Overall Study|Adverse Event|0
812303|NCT02239692|2652930|P2|Overall Study|Incomplete colonoscopy|2
812304|NCT02239692|2652931|P1|Overall Study|Incomplete colonoscopy|1
812305|NCT02239679|2652950|P3|Overall Study|Withdrawal by Subject|1
812306|NCT02239679|2652951|P2|Overall Study|Withdrawal by Subject|3
812307|NCT02239679|2652952|P1|Overall Study|Withdrawal by Subject|2
812308|NCT02239679|2652950|P3|Overall Study|Lost to Follow-up|0
812309|NCT02239679|2652951|P2|Overall Study|Lost to Follow-up|0
812310|NCT02239679|2652952|P1|Overall Study|Lost to Follow-up|1
812311|NCT02239328|2653164|P1|Overall Study|Equipment or website malfunction|2
812312|NCT02239328|2653164|P1|Overall Study|Benign disease noted at time of surgery|6
812313|NCT02239094|2653187|P1|Overall Study|Remitted before started|1
812314|NCT02239094|2653187|P1|Overall Study|Withdrawal by Subject|1
812315|NCT02238483|2653215|P2|Overall Study|Illness in family member|0
812316|NCT02238483|2653216|P1|Overall Study|Illness in family member|1
812317|NCT02238483|2653215|P2|Overall Study|Completion status not recorded|1
812318|NCT02238483|2653216|P1|Overall Study|Completion status not recorded|1
812319|NCT02238483|2653215|P2|Overall Study|Withdrawn due to physician decision|0
812320|NCT02238483|2653216|P1|Overall Study|Withdrawn due to physician decision|1
812321|NCT02238483|2653215|P2|Overall Study|Adverse Event|3
812322|NCT02238483|2653216|P1|Overall Study|Adverse Event|7
812323|NCT02238483|2653215|P2|Overall Study|Death|0
812324|NCT02238483|2653216|P1|Overall Study|Death|1
812325|NCT02238483|2653215|P2|Overall Study|Protocol Violation|2
812326|NCT02238483|2653216|P1|Overall Study|Protocol Violation|1
812327|NCT02238483|2653215|P2|Overall Study|Lost to Follow-up|1
812328|NCT02238483|2653216|P1|Overall Study|Lost to Follow-up|1
812329|NCT02238483|2653215|P2|Overall Study|Withdrawal by Subject|7
812330|NCT02238483|2653216|P1|Overall Study|Withdrawal by Subject|2
812331|NCT02238379|2653254|P2|Overall Study|Lost to Follow-up|0
812332|NCT02238379|2653255|P1|Overall Study|Lost to Follow-up|1
812333|NCT02238080|2653281|P1|Overall Study|Other|4
812334|NCT02238080|2653281|P1|Overall Study|Withdrawal by Subject|2
812335|NCT02238080|2653281|P1|Overall Study|Treatment interrupted|6
812336|NCT02238080|2653281|P1|Overall Study|Death|13
812337|NCT02238067|2653295|P1|Overall Study|Not completed survey at Month 6|45
812338|NCT02237118|2653340|P2|Overall Study|consent withdrawn|0
812339|NCT02237118|2653341|P1|Overall Study|consent withdrawn|1
812340|NCT02237118|2653340|P2|Overall Study|Protocol Violation|1
812341|NCT02237118|2653341|P1|Overall Study|Protocol Violation|0
812342|NCT02236611|2653378|P2|Overall Study|Withdrew consent|4
812343|NCT02236611|2653379|P1|Overall Study|Withdrew consent|9
812344|NCT02236611|2653378|P2|Overall Study|Protocol deviation|5
812345|NCT02236611|2653379|P1|Overall Study|Protocol deviation|3
812346|NCT02236611|2653378|P2|Overall Study|Lost to Follow-up|2
812347|NCT02236611|2653379|P1|Overall Study|Lost to Follow-up|0
812348|NCT02236611|2653378|P2|Overall Study|Lack of Efficacy|7
812349|NCT02236611|2653379|P1|Overall Study|Lack of Efficacy|4
812350|NCT02236611|2653378|P2|Overall Study|Adverse Event|16
812351|NCT02236611|2653379|P1|Overall Study|Adverse Event|10
812352|NCT02236598|2653387|P2|Overall Study|Withdrawal by Subject|1
812353|NCT02236598|2653388|P1|Overall Study|Withdrawal by Subject|0
812354|NCT02236598|2653387|P2|Overall Study|Adverse Event|1
812355|NCT02236598|2653388|P1|Overall Study|Adverse Event|0
812356|NCT02236130|2653424|P2|Overall Study|Lost to Follow-up|12
812357|NCT02236130|2653425|P1|Overall Study|Lost to Follow-up|7
812358|NCT02235454|2653475|P1|Overall Study|Withdrawal by Subject|2
812359|NCT02235311|2653481|P2|Overall Study|Protocol Violation|1
812360|NCT02235311|2653482|P1|Overall Study|Protocol Violation|0
812361|NCT02235311|2653481|P2|Overall Study|Lost to Follow-up|1
812362|NCT02235311|2653482|P1|Overall Study|Lost to Follow-up|0
812363|NCT02235077|2653500|P2|Overall Study|Physician Decision|1
812364|NCT02235077|2653501|P1|Overall Study|Physician Decision|0
812365|NCT02235077|2653500|P2|Overall Study|Withdrawal by Subject|5
812366|NCT02235077|2653501|P1|Overall Study|Withdrawal by Subject|8
812367|NCT02235077|2653500|P2|Overall Study|Lost to Follow-up|6
812368|NCT02235077|2653501|P1|Overall Study|Lost to Follow-up|5
812369|NCT02235077|2653500|P2|Overall Study|Death|7
812370|NCT02235077|2653501|P1|Overall Study|Death|5
812371|NCT02234479|2653582|P2|Overall Study|Withdrawal by Subject|3
812372|NCT02234479|2653583|P1|Overall Study|Withdrawal by Subject|1
812373|NCT02234362|2653593|P1|Overall Study|Withdrawal by Subject|3
812374|NCT02234362|2653593|P1|Overall Study|Lost to Follow-up|6
812375|NCT02234362|2653593|P1|Overall Study|Not eligible after first screening visit|17
812376|NCT02233803|2653681|P2|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2
812377|NCT02233803|2653682|P1|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1
812378|NCT02233803|2653681|P2|Treatment Period 2 (4-Wks)|Lost to Follow-up|0
812379|NCT02233803|2653682|P1|Treatment Period 2 (4-Wks)|Lost to Follow-up|1
812380|NCT02233803|2653681|P2|Washout Period (4-Wks)|Withdrawal by Subject|1
812381|NCT02233803|2653682|P1|Washout Period (4-Wks)|Withdrawal by Subject|1
812382|NCT02233803|2653681|P2|Washout Period (4-Wks)|Physician Decision|0
812383|NCT02233803|2653682|P1|Washout Period (4-Wks)|Physician Decision|1
812384|NCT02233803|2653681|P2|Washout Period (4-Wks)|Lost to Follow-up|1
812385|NCT02233803|2653682|P1|Washout Period (4-Wks)|Lost to Follow-up|0
812386|NCT02233803|2653681|P2|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1
812387|NCT02233803|2653682|P1|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0
812388|NCT02233803|2653681|P2|Treatment Period 1 (4-Wks)|Protocol Violation|2
812389|NCT02233803|2653682|P1|Treatment Period 1 (4-Wks)|Protocol Violation|2
812390|NCT02233803|2653681|P2|Treatment Period 1 (4-Wks)|Adverse Event|1
812391|NCT02233803|2653682|P1|Treatment Period 1 (4-Wks)|Adverse Event|0
812392|NCT02233803|2653681|P2|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0
812393|NCT02233803|2653682|P1|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1
812394|NCT02233647|2653692|P1|Overall Study|Adverse Event|1
812395|NCT02233543|2653721|P2|Period 2|COPD exacerbation|0
812396|NCT02233543|2653722|P1|Period 2|COPD exacerbation|1
812397|NCT02233543|2653721|P2|Period 2|Participant required other treatment.|1
812398|NCT02233543|2653722|P1|Period 2|Participant required other treatment.|0
812399|NCT02233543|2653721|P2|Period 2|Adverse Event|0
812400|NCT02233543|2653722|P1|Period 2|Adverse Event|1
812401|NCT02233543|2653721|P2|Period 1|Participants required other treatment.|3
812402|NCT02233543|2653722|P1|Period 1|Participants required other treatment.|2
812403|NCT02233543|2653721|P2|Period 1|Withdrawal by Subject|0
812404|NCT02233543|2653722|P1|Period 1|Withdrawal by Subject|1
812405|NCT02233309|2653730|P1|Overall Study|Physician Decision|5
812406|NCT02232880|2653764|P1|Overall Study|study stopped prior to randomization|1
812407|NCT02232698|2653773|P2|Overall Study|Withdrawal by Subject|11
812408|NCT02232698|2653774|P1|Overall Study|Withdrawal by Subject|0
812409|NCT02232698|2653773|P2|Overall Study|Allocated to control group|3
812410|NCT02232698|2653774|P1|Overall Study|Allocated to control group|0
812411|NCT02232698|2653773|P2|Overall Study|Non-compliance with study device|4
812412|NCT02232698|2653774|P1|Overall Study|Non-compliance with study device|1
812413|NCT02232698|2653773|P2|Overall Study|Had device-associated symptoms|0
812414|NCT02232698|2653774|P1|Overall Study|Had device-associated symptoms|7
812415|NCT02232698|2653773|P2|Overall Study|Met exclusion criteria|1
812416|NCT02232698|2653774|P1|Overall Study|Met exclusion criteria|1
812417|NCT02232698|2653773|P2|Overall Study|Pregnancy|1
812418|NCT02232698|2653774|P1|Overall Study|Pregnancy|1
812419|NCT02232178|2653798|P3|Overall Study|surgical complication|0
812420|NCT02232178|2653799|P2|Overall Study|surgical complication|0
812421|NCT02232178|2653800|P1|Overall Study|surgical complication|1
812422|NCT02232178|2653798|P3|Overall Study|ineligibility|1
812423|NCT02232178|2653799|P2|Overall Study|ineligibility|0
812424|NCT02232178|2653800|P1|Overall Study|ineligibility|0
812425|NCT02232178|2653798|P3|Overall Study|Lost to Follow-up|0
812426|NCT02232178|2653799|P2|Overall Study|Lost to Follow-up|1
812427|NCT02232178|2653800|P1|Overall Study|Lost to Follow-up|0
812428|NCT02231918|2653831|P3|Overall Study|Adverse Event|1
812429|NCT02231918|2653832|P2|Overall Study|Adverse Event|0
812430|NCT02231918|2653833|P1|Overall Study|Adverse Event|0
812431|NCT02231918|2653831|P3|Overall Study|Withdrawal by Subject|0
812432|NCT02231918|2653832|P2|Overall Study|Withdrawal by Subject|1
812433|NCT02231918|2653833|P1|Overall Study|Withdrawal by Subject|0
812434|NCT02231749|2653897|P2|Overall Study|No longer meets Study Criteria|0
812435|NCT02231749|2653898|P1|Overall Study|No longer meets Study Criteria|1
812436|NCT02231749|2653897|P2|Overall Study|other|8
812437|NCT02231749|2653898|P1|Overall Study|other|0
812438|NCT02231749|2653897|P2|Overall Study|Pregnancy|0
812439|NCT02231749|2653898|P1|Overall Study|Pregnancy|1
812440|NCT02231749|2653897|P2|Overall Study|Poor/Non-Compliance|3
812441|NCT02231749|2653898|P1|Overall Study|Poor/Non-Compliance|0
812442|NCT02231749|2653897|P2|Overall Study|Maximum Clinical Benefit|8
812443|NCT02231749|2653898|P1|Overall Study|Maximum Clinical Benefit|5
812444|NCT02231749|2653897|P2|Overall Study|Lost to Follow-up|2
812445|NCT02231749|2653898|P1|Overall Study|Lost to Follow-up|1
812446|NCT02231749|2653897|P2|Overall Study|Participant withdrew Consent|15
812447|NCT02231749|2653898|P1|Overall Study|Participant withdrew Consent|8
812448|NCT02231749|2653897|P2|Overall Study|Participant's request to discontinue|21
812449|NCT02231749|2653898|P1|Overall Study|Participant's request to discontinue|10
812450|NCT02231749|2653897|P2|Overall Study|AE unrelated to Study drug|31
812451|NCT02231749|2653898|P1|Overall Study|AE unrelated to Study drug|32
812452|NCT02231749|2653897|P2|Overall Study|Death|1
812453|NCT02231749|2653898|P1|Overall Study|Death|1
812454|NCT02231749|2653897|P2|Overall Study|Study Drug Toxicity|63
812455|NCT02231749|2653898|P1|Overall Study|Study Drug Toxicity|134
812456|NCT02231749|2653897|P2|Overall Study|Disease progression|297
812457|NCT02231749|2653898|P1|Overall Study|Disease progression|229
812458|NCT02231580|2653916|P2|Overall Study|Adverse Event|0
812459|NCT02231580|2653917|P1|Overall Study|Adverse Event|5
812460|NCT02231164|2654034|P2|Overall Study|Withdrawal by Subject|2
812461|NCT02231164|2654035|P1|Overall Study|Withdrawal by Subject|1
812462|NCT02231164|2654034|P2|Overall Study|Lack of Efficacy|3
812463|NCT02231164|2654035|P1|Overall Study|Lack of Efficacy|4
812464|NCT02231164|2654034|P2|Overall Study|Adverse Event|1
812465|NCT02231164|2654035|P1|Overall Study|Adverse Event|1
812466|NCT02230956|2654063|P3|Overall Study|Other Miscellaneous Reason|2
812467|NCT02230956|2654064|P2|Overall Study|Other Miscellaneous Reason|1
812468|NCT02230956|2654065|P1|Overall Study|Other Miscellaneous Reason|0
812469|NCT02230956|2654063|P3|Overall Study|Protocol Violation|1
812470|NCT02230956|2654064|P2|Overall Study|Protocol Violation|1
812471|NCT02230956|2654065|P1|Overall Study|Protocol Violation|0
812472|NCT02230956|2654063|P3|Overall Study|Personal Reasons|1
812473|NCT02230956|2654064|P2|Overall Study|Personal Reasons|1
812474|NCT02230956|2654065|P1|Overall Study|Personal Reasons|2
812475|NCT02230956|2654063|P3|Overall Study|Lost to Follow-up|2
812476|NCT02230956|2654064|P2|Overall Study|Lost to Follow-up|1
812477|NCT02230956|2654065|P1|Overall Study|Lost to Follow-up|1
812478|NCT02230956|2654063|P3|Overall Study|Lack of Efficacy|1
812479|NCT02230956|2654064|P2|Overall Study|Lack of Efficacy|1
812480|NCT02230956|2654065|P1|Overall Study|Lack of Efficacy|1
812481|NCT02230956|2654063|P3|Overall Study|Adverse Event|0
812482|NCT02230956|2654064|P2|Overall Study|Adverse Event|1
812483|NCT02230956|2654065|P1|Overall Study|Adverse Event|1
812484|NCT02230904|2654087|P2|Overall Study|Safety follow up could not take place|1
812485|NCT02230904|2654088|P1|Overall Study|Safety follow up could not take place|0
812486|NCT02230683|2654121|P1|Overall Study|Adverse Event|1
812487|NCT02230670|2654138|P2|Overall Study|Progression to Child-Pugh C|2
812488|NCT02230670|2654139|P1|Overall Study|Progression to Child-Pugh C|1
812489|NCT02230670|2654138|P2|Overall Study|Protocol Violation|1
812490|NCT02230670|2654139|P1|Overall Study|Protocol Violation|0
812491|NCT02230670|2654138|P2|Overall Study|Physician Decision|1
812492|NCT02230670|2654139|P1|Overall Study|Physician Decision|0
812493|NCT02230670|2654138|P2|Overall Study|Withdrawal by Subject|2
812494|NCT02230670|2654139|P1|Overall Study|Withdrawal by Subject|2
812495|NCT02230670|2654138|P2|Overall Study|Adverse Event|2
812496|NCT02230670|2654139|P1|Overall Study|Adverse Event|1
812497|NCT02230384|2654225|P2|Phase 2 - Switch|Adverse Event|0
812498|NCT02230384|2654226|P1|Phase 2 - Switch|Adverse Event|2
812499|NCT02230384|2654225|P2|Phase 2 - Switch|Lost to Follow-up|0
812500|NCT02230384|2654226|P1|Phase 2 - Switch|Lost to Follow-up|1
812501|NCT02230384|2654225|P2|Phase 2 - Switch|Withdrawal by Subject|1
812502|NCT02230384|2654226|P1|Phase 2 - Switch|Withdrawal by Subject|0
812503|NCT02230384|2654225|P2|Phase 1|Physician Decision|1
812504|NCT02230384|2654226|P1|Phase 1|Physician Decision|0
812505|NCT02230384|2654225|P2|Phase 1|Lost to Follow-up|0
812506|NCT02230384|2654226|P1|Phase 1|Lost to Follow-up|1
812507|NCT02230332|2654234|P2|Overall Study|Protocol Violation|0
812508|NCT02230332|2654235|P1|Overall Study|Protocol Violation|1
812509|NCT02230332|2654234|P2|Overall Study|Lost to Follow-up|0
812510|NCT02230332|2654235|P1|Overall Study|Lost to Follow-up|1
812511|NCT02230332|2654234|P2|Overall Study|Adverse Event|1
812512|NCT02230332|2654235|P1|Overall Study|Adverse Event|2
812513|NCT02230306|2654251|P1|Overall Study|Did not receive study treatment|1
812514|NCT02230085|2654262|P1|Overall Study|Withdrawal by Subject|3
812515|NCT02230085|2654262|P1|Overall Study|Physician Decision|1
812516|NCT02229864|2654266|P1|3 - Year Visit|Death|2
812517|NCT02229864|2654266|P1|2 - Year Visit|Missed Visits|1
812518|NCT02229539|2654321|P3|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0
812519|NCT02229539|2654322|P2|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1
812520|NCT02229539|2654323|P1|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2
812521|NCT02229539|2654321|P3|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3
812522|NCT02229539|2654322|P2|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
812523|NCT02229539|2654323|P1|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
812524|NCT02229539|2654321|P3|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
812525|NCT02229539|2654322|P2|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
812526|NCT02229539|2654323|P1|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0
812527|NCT02229539|2654321|P3|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
812528|NCT02229539|2654322|P2|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
812529|NCT02229539|2654323|P1|Cycle 2 (Optional Continuation Phase)|Adverse Event|2
812530|NCT02229539|2654321|P3|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6
812531|NCT02229539|2654322|P2|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
812532|NCT02229539|2654323|P1|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
812533|NCT02229539|2654321|P3|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1
812534|NCT02229539|2654322|P2|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4
812535|NCT02229539|2654323|P1|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3
812536|NCT02229539|2654321|P3|Cycle 1 (Treatment Per Protocol)|Medical Problems|1
812537|NCT02229539|2654322|P2|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
812538|NCT02229539|2654323|P1|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
812539|NCT02229539|2654321|P3|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1
812540|NCT02229539|2654322|P2|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
812541|NCT02229539|2654323|P1|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
812542|NCT02229539|2654321|P3|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
812543|NCT02229539|2654322|P2|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1
812544|NCT02229539|2654323|P1|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
812545|NCT02229396|2654454|P3|Overall Study|Other Eligibility criteria|0
812546|NCT02229396|2654455|P2|Overall Study|Other Eligibility criteria|2
812547|NCT02229396|2654456|P1|Overall Study|Other Eligibility criteria|0
812548|NCT02229396|2654454|P3|Overall Study|Withdrawal by Subject|16
812549|NCT02229396|2654455|P2|Overall Study|Withdrawal by Subject|9
812550|NCT02229396|2654456|P1|Overall Study|Withdrawal by Subject|15
812551|NCT02229396|2654454|P3|Overall Study|Withdrew; no record on termination page|4
812552|NCT02229396|2654455|P2|Overall Study|Withdrew; no record on termination page|5
812553|NCT02229396|2654456|P1|Overall Study|Withdrew; no record on termination page|2
812554|NCT02229396|2654454|P3|Overall Study|Patient was incorrectly randomized|1
812555|NCT02229396|2654455|P2|Overall Study|Patient was incorrectly randomized|0
812556|NCT02229396|2654456|P1|Overall Study|Patient was incorrectly randomized|0
812557|NCT02229396|2654454|P3|Overall Study|Protocol deviation; compliance|0
812558|NCT02229396|2654455|P2|Overall Study|Protocol deviation; compliance|0
812559|NCT02229396|2654456|P1|Overall Study|Protocol deviation; compliance|1
812560|NCT02229396|2654454|P3|Overall Study|Lost to Follow-up|11
812561|NCT02229396|2654455|P2|Overall Study|Lost to Follow-up|5
812562|NCT02229396|2654456|P1|Overall Study|Lost to Follow-up|4
812563|NCT02229396|2654454|P3|Overall Study|Death|1
812564|NCT02229396|2654455|P2|Overall Study|Death|3
812565|NCT02229396|2654456|P1|Overall Study|Death|1
812566|NCT02229396|2654454|P3|Overall Study|Adverse Event|5
812567|NCT02229396|2654455|P2|Overall Study|Adverse Event|5
812568|NCT02229396|2654456|P1|Overall Study|Adverse Event|2
812569|NCT02229383|2654487|P2|Overall Study|Randomized in error|0
812570|NCT02229383|2654488|P1|Overall Study|Randomized in error|1
812571|NCT02229383|2654487|P2|Overall Study|Investigator decision|4
812572|NCT02229383|2654488|P1|Overall Study|Investigator decision|1
812573|NCT02229383|2654487|P2|Overall Study|Death|1
812574|NCT02229383|2654488|P1|Overall Study|Death|0
812575|NCT02229383|2654487|P2|Overall Study|Fire at the study center|4
812576|NCT02229383|2654488|P1|Overall Study|Fire at the study center|2
812577|NCT02229383|2654487|P2|Overall Study|Withdrawal by Subject|9
812578|NCT02229383|2654488|P1|Overall Study|Withdrawal by Subject|5
812579|NCT02229383|2654487|P2|Overall Study|Lost to Follow-up|2
812580|NCT02229383|2654488|P1|Overall Study|Lost to Follow-up|4
812581|NCT02229383|2654487|P2|Overall Study|Adverse Event|4
812582|NCT02229383|2654488|P1|Overall Study|Adverse Event|9
812583|NCT02229227|2654513|P2|Overall Study|Physician Decision|12
812584|NCT02229227|2654514|P1|Overall Study|Physician Decision|5
812585|NCT02229227|2654513|P2|Overall Study|Other|1
812586|NCT02229227|2654514|P1|Overall Study|Other|0
812587|NCT02229227|2654513|P2|Overall Study|Withdrawal by Subject|12
812588|NCT02229227|2654514|P1|Overall Study|Withdrawal by Subject|8
812589|NCT02229227|2654513|P2|Overall Study|Study terminated by sponsor|11
812590|NCT02229227|2654514|P1|Overall Study|Study terminated by sponsor|11
812591|NCT02229227|2654513|P2|Overall Study|Lost to Follow-up|3
812592|NCT02229227|2654514|P1|Overall Study|Lost to Follow-up|3
812593|NCT02229227|2654513|P2|Overall Study|Protocol defined stopping criteria|3
812594|NCT02229227|2654514|P1|Overall Study|Protocol defined stopping criteria|1
812595|NCT02229227|2654513|P2|Overall Study|Protocol Violation|8
812596|NCT02229227|2654514|P1|Overall Study|Protocol Violation|6
812597|NCT02229227|2654513|P2|Overall Study|Lack of Efficacy|3
812598|NCT02229227|2654514|P1|Overall Study|Lack of Efficacy|3
812599|NCT02229227|2654513|P2|Overall Study|Adverse Event|9
812600|NCT02229227|2654514|P1|Overall Study|Adverse Event|14
812601|NCT02229214|2654599|P2|Overall Study|Withdrawal by Subject|0
812602|NCT02229214|2654600|P1|Overall Study|Withdrawal by Subject|4
812603|NCT02229214|2654599|P2|Overall Study|Adverse Event|0
812604|NCT02229214|2654600|P1|Overall Study|Adverse Event|2
812605|NCT02228980|2654624|P4|Overall Study|Withdrawal by Subject|3
812606|NCT02228980|2654625|P3|Overall Study|Withdrawal by Subject|2
812607|NCT02228980|2654626|P2|Overall Study|Withdrawal by Subject|3
812608|NCT02228980|2654627|P1|Overall Study|Withdrawal by Subject|3
812609|NCT02228980|2654624|P4|Overall Study|Protocol Violation|0
812610|NCT02228980|2654625|P3|Overall Study|Protocol Violation|0
812611|NCT02228980|2654626|P2|Overall Study|Protocol Violation|0
812612|NCT02228980|2654627|P1|Overall Study|Protocol Violation|7
812613|NCT02228980|2654624|P4|Overall Study|Adverse Event|0
812614|NCT02228980|2654625|P3|Overall Study|Adverse Event|0
812615|NCT02228980|2654626|P2|Overall Study|Adverse Event|0
812616|NCT02228980|2654627|P1|Overall Study|Adverse Event|14
812617|NCT02228720|2654666|P1|Open Label - Day 30|Lost to Follow-up|1
812618|NCT02228395|2654674|P3|First Intervention Period|Unable to comply with study dates|1
812619|NCT02228395|2654675|P2|First Intervention Period|Unable to comply with study dates|1
812620|NCT02228395|2654676|P1|First Intervention Period|Unable to comply with study dates|0
812621|NCT02228395|2654674|P3|First Intervention Period|No longer willing to participate|0
812622|NCT02228395|2654675|P2|First Intervention Period|No longer willing to participate|0
812623|NCT02228395|2654676|P1|First Intervention Period|No longer willing to participate|1
812624|NCT02227784|2654759|P5|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3
812625|NCT02227784|2654760|P4|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
812626|NCT02227784|2654761|P3|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
812627|NCT02227784|2654762|P2|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
812628|NCT02227784|2654763|P1|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
812629|NCT02227784|2654759|P5|Open-Label Extension Phase (OLE)|Sponsor Decision|243
812630|NCT02227784|2654760|P4|Open-Label Extension Phase (OLE)|Sponsor Decision|0
812631|NCT02227784|2654761|P3|Open-Label Extension Phase (OLE)|Sponsor Decision|0
812632|NCT02227784|2654762|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
812633|NCT02227784|2654763|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|0
812634|NCT02227784|2654759|P5|Open-Label Extension Phase (OLE)|Death|1
812635|NCT02227784|2654760|P4|Open-Label Extension Phase (OLE)|Death|0
812636|NCT02227784|2654761|P3|Open-Label Extension Phase (OLE)|Death|0
812637|NCT02227784|2654762|P2|Open-Label Extension Phase (OLE)|Death|0
812638|NCT02227784|2654763|P1|Open-Label Extension Phase (OLE)|Death|0
812639|NCT02227784|2654759|P5|Open-Label Extension Phase (OLE)|Adverse Event|1
812640|NCT02227784|2654760|P4|Open-Label Extension Phase (OLE)|Adverse Event|0
812641|NCT02227784|2654761|P3|Open-Label Extension Phase (OLE)|Adverse Event|0
812642|NCT02227784|2654762|P2|Open-Label Extension Phase (OLE)|Adverse Event|0
812643|NCT02227784|2654763|P1|Open-Label Extension Phase (OLE)|Adverse Event|0
812644|NCT02227784|2654759|P5|Double-Blind Phase|Withdrawal by Subject|0
812645|NCT02227784|2654760|P4|Double-Blind Phase|Withdrawal by Subject|2
812646|NCT02227784|2654761|P3|Double-Blind Phase|Withdrawal by Subject|5
812647|NCT02227784|2654762|P2|Double-Blind Phase|Withdrawal by Subject|1
812648|NCT02227784|2654763|P1|Double-Blind Phase|Withdrawal by Subject|2
812649|NCT02227784|2654759|P5|Double-Blind Phase|Sponsor Decision|0
812650|NCT02227784|2654760|P4|Double-Blind Phase|Sponsor Decision|32
812651|NCT02227784|2654761|P3|Double-Blind Phase|Sponsor Decision|14
812652|NCT02227784|2654762|P2|Double-Blind Phase|Sponsor Decision|15
812653|NCT02227784|2654763|P1|Double-Blind Phase|Sponsor Decision|34
812654|NCT02227784|2654759|P5|Double-Blind Phase|Protocol Violation|0
812655|NCT02227784|2654760|P4|Double-Blind Phase|Protocol Violation|1
812656|NCT02227784|2654761|P3|Double-Blind Phase|Protocol Violation|1
812657|NCT02227784|2654762|P2|Double-Blind Phase|Protocol Violation|0
812658|NCT02227784|2654763|P1|Double-Blind Phase|Protocol Violation|0
812659|NCT02227784|2654759|P5|Double-Blind Phase|Physician Decision|0
812660|NCT02227784|2654760|P4|Double-Blind Phase|Physician Decision|1
812661|NCT02227784|2654761|P3|Double-Blind Phase|Physician Decision|0
812662|NCT02227784|2654762|P2|Double-Blind Phase|Physician Decision|0
812663|NCT02227784|2654763|P1|Double-Blind Phase|Physician Decision|1
812664|NCT02227784|2654759|P5|Double-Blind Phase|Adverse Event|0
812665|NCT02227784|2654760|P4|Double-Blind Phase|Adverse Event|3
812666|NCT02227784|2654761|P3|Double-Blind Phase|Adverse Event|1
812667|NCT02227784|2654762|P2|Double-Blind Phase|Adverse Event|2
812668|NCT02227784|2654763|P1|Double-Blind Phase|Adverse Event|3
812669|NCT02227368|2654819|P2|Overall Study|Adverse Event|0
812670|NCT02227368|2654820|P1|Overall Study|Adverse Event|1
812671|NCT02227368|2654819|P2|Overall Study|Lost to Follow-up|0
812672|NCT02227368|2654820|P1|Overall Study|Lost to Follow-up|1
812673|NCT02227368|2654819|P2|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4
812674|NCT02227368|2654820|P1|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0
812675|NCT02227108|2654878|P1|Overall Study|Adverse Event|6
812676|NCT02227108|2654878|P1|Overall Study|Investigator discretion|1
812677|NCT02227108|2654878|P1|Overall Study|Initiation of alternative therapy|2
812678|NCT02227108|2654878|P1|Overall Study|Progressive disease|17
812679|NCT02227108|2654878|P1|Overall Study|Other|3
812680|NCT02227108|2654878|P1|Overall Study|Did not receive treatment|2
812681|NCT02226653|2654907|P2|Treatment Period 5 Fed State|Adverse Event|1
812682|NCT02226653|2654908|P1|Treatment Period 5 Fed State|Adverse Event|0
812683|NCT02226653|2654907|P2|Treatment Period 2 Fasted State|Lost to Follow-up|0
812684|NCT02226653|2654908|P1|Treatment Period 2 Fasted State|Lost to Follow-up|1
812685|NCT02226562|2654932|P2|Overall Study|Lost to Follow-up|1
812686|NCT02226562|2654933|P1|Overall Study|Lost to Follow-up|0
812687|NCT02226549|2654951|P2|Overall Study|Lost to Follow-up|1
812688|NCT02226549|2654952|P1|Overall Study|Lost to Follow-up|0
812689|NCT02226549|2654951|P2|Overall Study|Randomized but Never Treated|0
812690|NCT02226549|2654952|P1|Overall Study|Randomized but Never Treated|1
812691|NCT02226198|2654962|P3|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
812692|NCT02226198|2654963|P2|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1
812693|NCT02226198|2654964|P1|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
812694|NCT02226198|2654962|P3|Lead-in Phase|Protocol Violation|0
812695|NCT02226198|2654963|P2|Lead-in Phase|Protocol Violation|0
812696|NCT02226198|2654964|P1|Lead-in Phase|Protocol Violation|1
812697|NCT02226172|2655037|P1|Overall Study|Ongoing in study|3
812698|NCT02226172|2655037|P1|Overall Study|Death|1
812699|NCT02226172|2655037|P1|Overall Study|Other|4
812700|NCT02226172|2655037|P1|Overall Study|Subject refused further follow-up|5
812701|NCT02226003|2655059|P3|Overall Study|Withdrawal by Subject|3
812702|NCT02226003|2655060|P2|Overall Study|Withdrawal by Subject|0
812703|NCT02226003|2655061|P1|Overall Study|Withdrawal by Subject|0
812704|NCT02226003|2655059|P3|Overall Study|Lost to Follow-up|3
812705|NCT02226003|2655060|P2|Overall Study|Lost to Follow-up|1
812706|NCT02226003|2655061|P1|Overall Study|Lost to Follow-up|2
812707|NCT02225353|2655109|P3|Overall Study|Protocol Violation|12
812708|NCT02225353|2655110|P2|Overall Study|Protocol Violation|5
812709|NCT02225353|2655111|P1|Overall Study|Protocol Violation|4
812710|NCT02225353|2655109|P3|Overall Study|Lost to Follow-up|3
812711|NCT02225353|2655110|P2|Overall Study|Lost to Follow-up|1
812712|NCT02225353|2655111|P1|Overall Study|Lost to Follow-up|0
812713|NCT02224846|2655143|P2|Period 2 (Month 12 to Month 24)|Sponsor Decision|1
812714|NCT02224846|2655144|P1|Period 2 (Month 12 to Month 24)|Sponsor Decision|2
812715|NCT02224846|2655143|P2|Period 2 (Month 12 to Month 24)|Physician Decision|2
812716|NCT02224846|2655144|P1|Period 2 (Month 12 to Month 24)|Physician Decision|0
812717|NCT02224846|2655143|P2|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43
812718|NCT02224846|2655144|P1|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25
812719|NCT02224846|2655143|P2|Period 2 (Month 12 to Month 24)|Protocol Violation|11
812720|NCT02224846|2655144|P1|Period 2 (Month 12 to Month 24)|Protocol Violation|4
812721|NCT02224846|2655143|P2|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13
812722|NCT02224846|2655144|P1|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7
812723|NCT02224846|2655143|P2|Period 2 (Month 12 to Month 24)|Death|0
812724|NCT02224846|2655144|P1|Period 2 (Month 12 to Month 24)|Death|1
812725|NCT02224846|2655143|P2|Period 2 (Month 12 to Month 24)|Adverse Event|4
812726|NCT02224846|2655144|P1|Period 2 (Month 12 to Month 24)|Adverse Event|3
812727|NCT02224846|2655143|P2|Period 2 (Month 3 to Month 12)|Physician Decision|2
812728|NCT02224846|2655144|P1|Period 2 (Month 3 to Month 12)|Physician Decision|0
812729|NCT02224846|2655143|P2|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19
812730|NCT02224846|2655144|P1|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15
812731|NCT02224846|2655143|P2|Period 2 (Month 3 to Month 12)|Protocol Violation|3
812732|NCT02224846|2655144|P1|Period 2 (Month 3 to Month 12)|Protocol Violation|0
812733|NCT02224846|2655143|P2|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5
812734|NCT02224846|2655144|P1|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3
812735|NCT02224846|2655143|P2|Period 2 (Month 3 to Month 12)|Adverse Event|2
812736|NCT02224846|2655144|P1|Period 2 (Month 3 to Month 12)|Adverse Event|1
812737|NCT02224846|2655143|P2|Period 1 (Month 3)|Sponsor Decision|1
812738|NCT02224846|2655144|P1|Period 1 (Month 3)|Sponsor Decision|2
812739|NCT02224846|2655143|P2|Period 1 (Month 3)|Withdrawal by Subject|18
812740|NCT02224846|2655144|P1|Period 1 (Month 3)|Withdrawal by Subject|8
812741|NCT02224846|2655143|P2|Period 1 (Month 3)|Protocol Violation|8
812742|NCT02224846|2655144|P1|Period 1 (Month 3)|Protocol Violation|4
812743|NCT02224846|2655143|P2|Period 1 (Month 3)|Lost to Follow-up|8
812744|NCT02224846|2655144|P1|Period 1 (Month 3)|Lost to Follow-up|3
812745|NCT02224846|2655143|P2|Period 1 (Month 3)|Adverse Event|1
812746|NCT02224846|2655144|P1|Period 1 (Month 3)|Adverse Event|2
812747|NCT02224690|2655182|P2|Overall Study|Did not meet eligibility criteria|0
812748|NCT02224690|2655183|P1|Overall Study|Did not meet eligibility criteria|1
812749|NCT02224690|2655182|P2|Overall Study|Use of G-tube|0
812750|NCT02224690|2655183|P1|Overall Study|Use of G-tube|1
812751|NCT02224690|2655182|P2|Overall Study|Met Withdrawal Criteria|0
812752|NCT02224690|2655183|P1|Overall Study|Met Withdrawal Criteria|4
812753|NCT02224690|2655182|P2|Overall Study|Adverse Event|1
812754|NCT02224690|2655183|P1|Overall Study|Adverse Event|8
812755|NCT02224664|2655195|P5|Dose Escalation Period (21 Days)|Withdrawal by Subject|4
812756|NCT02224664|2655196|P4|Dose Escalation Period (21 Days)|Withdrawal by Subject|1
812757|NCT02224664|2655197|P3|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
812758|NCT02224664|2655198|P2|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
812759|NCT02224664|2655199|P1|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
812760|NCT02224664|2655195|P5|Dose Escalation Period (21 Days)|Adverse Event|7
812761|NCT02224664|2655196|P4|Dose Escalation Period (21 Days)|Adverse Event|2
812762|NCT02224664|2655197|P3|Dose Escalation Period (21 Days)|Adverse Event|2
812763|NCT02224664|2655198|P2|Dose Escalation Period (21 Days)|Adverse Event|0
812764|NCT02224664|2655199|P1|Dose Escalation Period (21 Days)|Adverse Event|0
812765|NCT02224664|2655195|P5|Lead-in Period (3 Days)|Does not meet entrance criteria|0
812766|NCT02224664|2655196|P4|Lead-in Period (3 Days)|Does not meet entrance criteria|0
812767|NCT02224664|2655197|P3|Lead-in Period (3 Days)|Does not meet entrance criteria|0
812768|NCT02224664|2655198|P2|Lead-in Period (3 Days)|Does not meet entrance criteria|0
812769|NCT02224664|2655199|P1|Lead-in Period (3 Days)|Does not meet entrance criteria|5
812770|NCT02224638|2655281|P2|Overall Study|Adverse Event|1
812771|NCT02224638|2655282|P1|Overall Study|Adverse Event|1
812772|NCT02224625|2655290|P1|Sensitization|Adverse Event|55
812773|NCT02224625|2655290|P1|Irritation|Adverse Event|6
812774|NCT02224560|2655305|P3|Overall Study|Withdrawn by Investigator|0
812775|NCT02224560|2655306|P2|Overall Study|Withdrawn by Investigator|1
812776|NCT02224560|2655307|P1|Overall Study|Withdrawn by Investigator|1
812777|NCT02224560|2655305|P3|Overall Study|Adverse Event|1
812778|NCT02224560|2655306|P2|Overall Study|Adverse Event|1
812779|NCT02224560|2655307|P1|Overall Study|Adverse Event|4
812780|NCT02224560|2655305|P3|Overall Study|Met Withdrawal Criteria|0
812781|NCT02224560|2655306|P2|Overall Study|Met Withdrawal Criteria|0
812782|NCT02224560|2655307|P1|Overall Study|Met Withdrawal Criteria|1
812783|NCT02224560|2655305|P3|Overall Study|Withdrawal by Subject|1
812784|NCT02224560|2655306|P2|Overall Study|Withdrawal by Subject|0
812785|NCT02224560|2655307|P1|Overall Study|Withdrawal by Subject|2
812786|NCT02224560|2655305|P3|Overall Study|Protocol Deviation|0
812787|NCT02224560|2655306|P2|Overall Study|Protocol Deviation|0
812788|NCT02224560|2655307|P1|Overall Study|Protocol Deviation|1
812789|NCT02224053|2655342|P1|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2
812790|NCT02224053|2655342|P1|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1
812791|NCT02224053|2655342|P1|AZD9291 and Omeprazole Co-administration|Adverse Event|3
812792|NCT02224053|2655342|P1|AZD9291 and Omeprazole Co-administration|Protocol Violation|4
812793|NCT02224053|2655342|P1|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11
812794|NCT02223754|2655388|P2|Period 2|Test Article No Longer Available|1
812795|NCT02223754|2655389|P1|Period 2|Test Article No Longer Available|0
812796|NCT02223754|2655388|P2|Period 2|Lost to Follow-up|0
812797|NCT02223754|2655389|P1|Period 2|Lost to Follow-up|1
812798|NCT02223754|2655388|P2|Period 2|Lens Discomfort|1
812799|NCT02223754|2655389|P1|Period 2|Lens Discomfort|1
812800|NCT02223754|2655388|P2|Period 2|Protocol Violation|0
812801|NCT02223754|2655389|P1|Period 2|Protocol Violation|1
812802|NCT02223754|2655388|P2|Period 2|Adverse Event|1
812803|NCT02223754|2655389|P1|Period 2|Adverse Event|0
812804|NCT02223754|2655388|P2|Period 1|Unsatisfactory Visual Response|1
812805|NCT02223754|2655389|P1|Period 1|Unsatisfactory Visual Response|0
812806|NCT02223754|2655388|P2|Period 1|Test Article No Longer Available|5
812807|NCT02223754|2655389|P1|Period 1|Test Article No Longer Available|1
812808|NCT02223754|2655388|P2|Period 1|Withdrawal by Subject|4
812809|NCT02223754|2655389|P1|Period 1|Withdrawal by Subject|0
812810|NCT02223754|2655388|P2|Period 1|Protocol Violation|4
812811|NCT02223754|2655389|P1|Period 1|Protocol Violation|2
812812|NCT02223754|2655388|P2|Period 1|Lost to Follow-up|1
812813|NCT02223754|2655389|P1|Period 1|Lost to Follow-up|0
812814|NCT02223754|2655388|P2|Period 1|Adverse Event|0
812815|NCT02223754|2655389|P1|Period 1|Adverse Event|1
812816|NCT02223715|2655409|P1|Overall Study|Lost to Follow-up|73
812817|NCT02223715|2655409|P1|Overall Study|Death|31
812818|NCT02223390|2655497|P2|Overall Study|Lost to Follow-up|4
812819|NCT02223390|2655498|P1|Overall Study|Lost to Follow-up|9
812820|NCT02223364|2655509|P3|Overall Study|Physician Decision|0
812821|NCT02223364|2655510|P2|Overall Study|Physician Decision|0
812822|NCT02223364|2655511|P1|Overall Study|Physician Decision|1
812823|NCT02223364|2655509|P3|Overall Study|subject expired before surgery|0
812824|NCT02223364|2655510|P2|Overall Study|subject expired before surgery|0
812825|NCT02223364|2655511|P1|Overall Study|subject expired before surgery|1
812826|NCT02223364|2655509|P3|Overall Study|Protocol Violation|3
812827|NCT02223364|2655510|P2|Overall Study|Protocol Violation|0
812828|NCT02223364|2655511|P1|Overall Study|Protocol Violation|3
812829|NCT02222818|2655626|P2|Period 1|Eligibility criteria not met|3
812830|NCT02222818|2655627|P1|Period 1|Eligibility criteria not met|0
812831|NCT02222714|2655639|P5|Overall Study|Withdrawal by Subject|1
812832|NCT02222714|2655640|P4|Overall Study|Withdrawal by Subject|0
812833|NCT02222714|2655641|P3|Overall Study|Withdrawal by Subject|1
812834|NCT02222714|2655642|P2|Overall Study|Withdrawal by Subject|0
812835|NCT02222714|2655643|P1|Overall Study|Withdrawal by Subject|0
812836|NCT02222714|2655639|P5|Overall Study|Death|6
812837|NCT02222714|2655640|P4|Overall Study|Death|4
812838|NCT02222714|2655641|P3|Overall Study|Death|3
812839|NCT02222714|2655642|P2|Overall Study|Death|2
812840|NCT02222714|2655643|P1|Overall Study|Death|0
812841|NCT02222558|2655682|P6|Period 3|Withdrawal by Subject|1
812842|NCT02222558|2655683|P5|Period 3|Withdrawal by Subject|0
812843|NCT02222558|2655684|P4|Period 3|Withdrawal by Subject|0
812844|NCT02222558|2655685|P3|Period 3|Withdrawal by Subject|0
812845|NCT02222558|2655686|P2|Period 3|Withdrawal by Subject|0
812846|NCT02222558|2655687|P1|Period 3|Withdrawal by Subject|0
812847|NCT02222558|2655682|P6|Period 1: Single Dose|Withdrawal by Subject|0
812848|NCT02222558|2655683|P5|Period 1: Single Dose|Withdrawal by Subject|0
812849|NCT02222558|2655684|P4|Period 1: Single Dose|Withdrawal by Subject|0
812850|NCT02222558|2655685|P3|Period 1: Single Dose|Withdrawal by Subject|0
812851|NCT02222558|2655686|P2|Period 1: Single Dose|Withdrawal by Subject|0
812852|NCT02222558|2655687|P1|Period 1: Single Dose|Withdrawal by Subject|4
812853|NCT02222493|2655703|P2|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0
812854|NCT02222493|2655704|P1|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9
812855|NCT02222493|2655703|P2|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0
812856|NCT02222493|2655704|P1|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1
812857|NCT02222493|2655703|P2|Period 3: Week 54 Dosing-Week 78 Visit|Other|0
812858|NCT02222493|2655704|P1|Period 3: Week 54 Dosing-Week 78 Visit|Other|4
812859|NCT02222493|2655703|P2|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0
812860|NCT02222493|2655704|P1|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14
812861|NCT02222493|2655703|P2|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0
812862|NCT02222493|2655704|P1|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3
812863|NCT02222493|2655703|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3
812864|NCT02222493|2655704|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9
812865|NCT02222493|2655703|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
812866|NCT02222493|2655704|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
812867|NCT02222493|2655703|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4
812868|NCT02222493|2655704|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6
812869|NCT02222493|2655703|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0
812870|NCT02222493|2655704|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1
812871|NCT02222493|2655703|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0
812872|NCT02222493|2655704|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3
812873|NCT02222493|2655703|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9
812874|NCT02222493|2655704|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22
812875|NCT02222493|2655703|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0
812876|NCT02222493|2655704|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1
812877|NCT02222493|2655703|P2|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0
812878|NCT02222493|2655704|P1|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1
812879|NCT02222493|2655703|P2|Period 1: First Dose-Week 30 (Pre-dose)|Other|0
812880|NCT02222493|2655704|P1|Period 1: First Dose-Week 30 (Pre-dose)|Other|4
812881|NCT02222493|2655703|P2|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20
812882|NCT02222493|2655704|P1|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18
812883|NCT02222493|2655703|P2|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0
812884|NCT02222493|2655704|P1|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2
812885|NCT02222493|2655703|P2|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0
812886|NCT02222493|2655704|P1|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1
812887|NCT02222493|2655703|P2|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7
812888|NCT02222493|2655704|P1|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0
812889|NCT02222493|2655703|P2|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1
812890|NCT02222493|2655704|P1|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5
812891|NCT02222493|2655703|P2|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9
812892|NCT02222493|2655704|P1|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11
812893|NCT02222493|2655703|P2|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1
812894|NCT02222493|2655704|P1|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0
812895|NCT02222493|2655703|P2|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
812896|NCT02222493|2655704|P1|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
812897|NCT02222246|2655822|P2|Overall Study|Physician Decision|1
812898|NCT02222246|2655823|P1|Overall Study|Physician Decision|0
812899|NCT02222246|2655822|P2|Overall Study|No Emergency Department Visits|26
812900|NCT02222246|2655823|P1|Overall Study|No Emergency Department Visits|27
812901|NCT02222207|2655851|P1|Overall Study|Adverse Event|1
812902|NCT02222207|2655851|P1|Overall Study|Other reasons|2
812903|NCT02222207|2655851|P1|Overall Study|Death|1
812904|NCT02221674|2655895|P3|Overall Study|Lost to Follow-up|0
812905|NCT02221674|2655896|P2|Overall Study|Lost to Follow-up|0
812906|NCT02221674|2655897|P1|Overall Study|Lost to Follow-up|1
812907|NCT02221648|2655913|P2|Overall Study|Withdrawal by Subject|3
812908|NCT02221648|2655914|P1|Overall Study|Withdrawal by Subject|3
812909|NCT02220998|2655930|P2|Overall Study|Lost to Follow-up|4
812910|NCT02220998|2655931|P1|Overall Study|Lost to Follow-up|4
812911|NCT02220998|2655930|P2|Overall Study|Lack of Efficacy|5
812912|NCT02220998|2655931|P1|Overall Study|Lack of Efficacy|0
812913|NCT02220998|2655930|P2|Overall Study|Death|0
812914|NCT02220998|2655931|P1|Overall Study|Death|2
812915|NCT02220998|2655930|P2|Overall Study|Randomized but Never Treated|2
812916|NCT02220998|2655931|P1|Overall Study|Randomized but Never Treated|1
812917|NCT02220920|2655949|P2|Overall Study|Conflict with the stopping criteria|2
812918|NCT02220920|2655950|P1|Overall Study|Conflict with the stopping criteria|1
812919|NCT02220920|2655949|P2|Overall Study|Withdrawal by Subject|0
812920|NCT02220920|2655950|P1|Overall Study|Withdrawal by Subject|1
812921|NCT02220920|2655949|P2|Overall Study|Lack of Efficacy|1
812922|NCT02220920|2655950|P1|Overall Study|Lack of Efficacy|0
812923|NCT02220920|2655949|P2|Overall Study|Adverse Event|0
812924|NCT02220920|2655950|P1|Overall Study|Adverse Event|1
812925|NCT02220907|2655964|P1|Overall Study|Conflict with the stopping criteria|1
812926|NCT02220907|2655964|P1|Overall Study|Withdrawal by Subject|2
812927|NCT02220907|2655964|P1|Overall Study|Physician Decision|1
812928|NCT02220907|2655964|P1|Overall Study|Adverse Event|7
812929|NCT02220764|2655973|P2|Overall Study|Death|0
812930|NCT02220764|2655974|P1|Overall Study|Death|1
812931|NCT02220764|2655973|P2|Overall Study|Lost to Follow-up|1
812932|NCT02220764|2655974|P1|Overall Study|Lost to Follow-up|3
812933|NCT02220725|2655988|P4|Overall Study|Withdrawal by Subject|1
812934|NCT02220725|2655989|P3|Overall Study|Withdrawal by Subject|0
812935|NCT02220725|2655990|P2|Overall Study|Withdrawal by Subject|0
812936|NCT02220725|2655991|P1|Overall Study|Withdrawal by Subject|0
812937|NCT02220725|2655988|P4|Overall Study|Lost to Follow-up|1
812938|NCT02220725|2655989|P3|Overall Study|Lost to Follow-up|0
812939|NCT02220725|2655990|P2|Overall Study|Lost to Follow-up|0
812940|NCT02220725|2655991|P1|Overall Study|Lost to Follow-up|0
812941|NCT02220205|2656021|P2|Overall Study|Withdrawal by Subject|0
812942|NCT02220205|2656022|P1|Overall Study|Withdrawal by Subject|1
812943|NCT02219932|2656047|P2|Overall Study|Adverse Event|21
812944|NCT02219932|2656048|P1|Overall Study|Adverse Event|23
812945|NCT02219932|2656047|P2|Overall Study|Lost to Follow-up|2
812946|NCT02219932|2656048|P1|Overall Study|Lost to Follow-up|4
812947|NCT02219932|2656047|P2|Overall Study|Pregnancy|0
812948|NCT02219932|2656048|P1|Overall Study|Pregnancy|1
812949|NCT02219932|2656047|P2|Overall Study|Protocol Violation|6
812950|NCT02219932|2656048|P1|Overall Study|Protocol Violation|10
812951|NCT02219932|2656047|P2|Overall Study|Lack of Efficacy (Subject Perception)|2
812952|NCT02219932|2656048|P1|Overall Study|Lack of Efficacy (Subject Perception)|10
812953|NCT02219932|2656047|P2|Overall Study|Consent Withdrawn|7
812954|NCT02219932|2656048|P1|Overall Study|Consent Withdrawn|11
812955|NCT02219932|2656047|P2|Overall Study|Investigator Decision|1
812956|NCT02219932|2656048|P1|Overall Study|Investigator Decision|0
812957|NCT02219932|2656047|P2|Overall Study|Death|1
812958|NCT02219932|2656048|P1|Overall Study|Death|1
812959|NCT02219932|2656047|P2|Overall Study|Not Specified|11
812960|NCT02219932|2656048|P1|Overall Study|Not Specified|5
812961|NCT02219685|2656064|P2|Blinded Treatment Phase|Withdrew Consent|0
812962|NCT02219685|2656065|P1|Blinded Treatment Phase|Withdrew Consent|1
812963|NCT02219685|2656064|P2|Blinded Treatment Phase|Lost to Follow-up|0
812964|NCT02219685|2656065|P1|Blinded Treatment Phase|Lost to Follow-up|1
812965|NCT02219477|2656171|P3|Overall Study|Withdrawal by Subject|0
812966|NCT02219477|2656172|P2|Overall Study|Withdrawal by Subject|1
812967|NCT02219477|2656173|P1|Overall Study|Withdrawal by Subject|0
812968|NCT02219477|2656171|P3|Overall Study|Adverse Event|1
812969|NCT02219477|2656172|P2|Overall Study|Adverse Event|1
812970|NCT02219477|2656173|P1|Overall Study|Adverse Event|0
812971|NCT02219464|2656201|P2|Overall Study|catheter malfunction|0
812972|NCT02219464|2656202|P1|Overall Study|catheter malfunction|1
812973|NCT02219464|2656201|P2|Overall Study|case cancelled|0
812974|NCT02219464|2656202|P1|Overall Study|case cancelled|1
812975|NCT02219464|2656201|P2|Overall Study|Withdrawal by Subject|0
812976|NCT02219464|2656202|P1|Overall Study|Withdrawal by Subject|1
812977|NCT02219087|2656362|P2|Overall Study|Randomization envelope pulled out of seq|1
812978|NCT02219087|2656363|P1|Overall Study|Randomization envelope pulled out of seq|0
812979|NCT02219009|2656383|P2|Overall Study|Physician Decision|1
812980|NCT02219009|2656384|P1|Overall Study|Physician Decision|0
812981|NCT02219009|2656383|P2|Overall Study|Protocol deviation|0
812982|NCT02219009|2656384|P1|Overall Study|Protocol deviation|1
812983|NCT02219009|2656383|P2|Overall Study|Lost to Follow-up|2
812984|NCT02219009|2656384|P1|Overall Study|Lost to Follow-up|2
812985|NCT02219009|2656383|P2|Overall Study|Adverse Event|4
812986|NCT02219009|2656384|P1|Overall Study|Adverse Event|2
812987|NCT02219009|2656383|P2|Overall Study|Withdrawal by Subject|1
812988|NCT02219009|2656384|P1|Overall Study|Withdrawal by Subject|5
812989|NCT02218697|2656396|P2|Overall Study|Withdrawal by Subject|3
812990|NCT02218697|2656397|P1|Overall Study|Withdrawal by Subject|2
812991|NCT02218697|2656396|P2|Overall Study|Unwilling to be vaccinated in left arm|1
812992|NCT02218697|2656397|P1|Overall Study|Unwilling to be vaccinated in left arm|0
812993|NCT02218697|2656396|P2|Overall Study|Adverse Event|2
812994|NCT02218697|2656397|P1|Overall Study|Adverse Event|0
812995|NCT02218541|2656437|P2|Overall Study|Implant Failure|1
812996|NCT02218541|2656438|P1|Overall Study|Implant Failure|4
812997|NCT02218541|2656437|P2|Overall Study|Lost to Follow-up|1
812998|NCT02218541|2656438|P1|Overall Study|Lost to Follow-up|2
812999|NCT02218268|2656472|P2|24 Hour Washout|Physician Decision|9
813000|NCT02218268|2656473|P1|24 Hour Washout|Physician Decision|11
813001|NCT02218216|2656485|P3|Overall Study|Study terminated before completed|0
813002|NCT02218216|2656486|P2|Overall Study|Study terminated before completed|0
813003|NCT02218216|2656487|P1|Overall Study|Study terminated before completed|6
813004|NCT02217982|2656526|P2|Overall Study|Adverse Event|1
813005|NCT02217982|2656527|P1|Overall Study|Adverse Event|0
813006|NCT02217982|2656526|P2|Overall Study|Trial discontinued|0
813007|NCT02217982|2656527|P1|Overall Study|Trial discontinued|1
813008|NCT02217878|2656537|P2|Overall Study|initial diagnosis of STEMI not confirmed|0
813009|NCT02217878|2656538|P1|Overall Study|initial diagnosis of STEMI not confirmed|1
813010|NCT02217878|2656537|P2|Overall Study|required morphine due to chest pain|2
813011|NCT02217878|2656538|P1|Overall Study|required morphine due to chest pain|1
813012|NCT02217527|2656638|P2|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1
813013|NCT02217527|2656639|P1|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0
813014|NCT02217527|2656638|P2|Drug Condition 1: First Study Phase|Withdrawal by Subject|3
813015|NCT02217527|2656639|P1|Drug Condition 1: First Study Phase|Withdrawal by Subject|1
813016|NCT02217280|2656649|P1|Overall Study|Post-consent sceen fail|2
813017|NCT02217280|2656649|P1|Overall Study|Withdrawal by Subject|2
813018|NCT02216812|2656656|P2|Overall Study|Lost to Follow-up|5
813019|NCT02216812|2656657|P1|Overall Study|Lost to Follow-up|10
813020|NCT02216591|2656682|P2|Overall Study|Lost to Follow-up|1
813021|NCT02216591|2656683|P1|Overall Study|Lost to Follow-up|0
813022|NCT02216526|2656696|P3|Overall Study|Hospitalization|3
813023|NCT02216526|2656697|P2|Overall Study|Hospitalization|1
813024|NCT02216526|2656698|P1|Overall Study|Hospitalization|2
813025|NCT02216526|2656696|P3|Overall Study|Protocol Violation|2
813026|NCT02216526|2656697|P2|Overall Study|Protocol Violation|0
813027|NCT02216526|2656698|P1|Overall Study|Protocol Violation|2
813028|NCT02216526|2656696|P3|Overall Study|Death|3
813029|NCT02216526|2656697|P2|Overall Study|Death|1
813030|NCT02216526|2656698|P1|Overall Study|Death|0
813031|NCT02216526|2656696|P3|Overall Study|Adverse Event|0
813032|NCT02216526|2656697|P2|Overall Study|Adverse Event|1
813033|NCT02216526|2656698|P1|Overall Study|Adverse Event|1
813034|NCT02216357|2656816|P2|Overall Study|Inclusion or exclusion criteria not met|1
813035|NCT02216357|2656817|P1|Overall Study|Inclusion or exclusion criteria not met|2
813036|NCT02216123|2656843|P2|Overall Study|Withdrawal by Subject|0
813037|NCT02216123|2656844|P1|Overall Study|Withdrawal by Subject|2
813038|NCT02216123|2656843|P2|Overall Study|Lost to Follow-up|2
813039|NCT02216123|2656844|P1|Overall Study|Lost to Follow-up|4
813040|NCT02215954|2656936|P3|Overall Study|Not exposed|3
813041|NCT02215954|2656937|P2|Overall Study|Not exposed|1
813042|NCT02215954|2656938|P1|Overall Study|Not exposed|1
813043|NCT02215954|2656936|P3|Overall Study|Withdrawal by Subject|2
813044|NCT02215954|2656937|P2|Overall Study|Withdrawal by Subject|0
813045|NCT02215954|2656938|P1|Overall Study|Withdrawal by Subject|0
813046|NCT02215954|2656936|P3|Overall Study|Adverse Event|1
813047|NCT02215954|2656937|P2|Overall Study|Adverse Event|0
813048|NCT02215954|2656938|P1|Overall Study|Adverse Event|0
813049|NCT02215252|2656961|P3|Overall Study|Other|1
813050|NCT02215252|2656962|P2|Overall Study|Other|1
813051|NCT02215252|2656963|P1|Overall Study|Other|0
813052|NCT02215252|2656961|P3|Overall Study|Withdrawal by Subject|0
813053|NCT02215252|2656962|P2|Overall Study|Withdrawal by Subject|0
813054|NCT02215252|2656963|P1|Overall Study|Withdrawal by Subject|1
813055|NCT02215252|2656961|P3|Overall Study|Protocol Violation|0
813056|NCT02215252|2656962|P2|Overall Study|Protocol Violation|1
813057|NCT02215252|2656963|P1|Overall Study|Protocol Violation|0
813058|NCT02215252|2656961|P3|Overall Study|Does not Meet Entrance Criteria|0
813059|NCT02215252|2656962|P2|Overall Study|Does not Meet Entrance Criteria|1
813060|NCT02215252|2656963|P1|Overall Study|Does not Meet Entrance Criteria|0
813061|NCT02215252|2656961|P3|Overall Study|Lost to Follow-up|1
813062|NCT02215252|2656962|P2|Overall Study|Lost to Follow-up|0
813063|NCT02215252|2656963|P1|Overall Study|Lost to Follow-up|0
813064|NCT02215252|2656961|P3|Overall Study|Adverse Event|2
813065|NCT02215252|2656962|P2|Overall Study|Adverse Event|5
813066|NCT02215252|2656963|P1|Overall Study|Adverse Event|1
813067|NCT02214225|2657087|P3|Overall Study|randomized in error, not vaccinated|1
813068|NCT02214225|2657088|P2|Overall Study|randomized in error, not vaccinated|1
813069|NCT02214225|2657089|P1|Overall Study|randomized in error, not vaccinated|2
813070|NCT02214225|2657087|P3|Overall Study|Death|1
813071|NCT02214225|2657088|P2|Overall Study|Death|0
813072|NCT02214225|2657089|P1|Overall Study|Death|5
813073|NCT02214225|2657087|P3|Overall Study|Withdrawal by Subject|2
813074|NCT02214225|2657088|P2|Overall Study|Withdrawal by Subject|0
813075|NCT02214225|2657089|P1|Overall Study|Withdrawal by Subject|2
813076|NCT02214225|2657087|P3|Overall Study|Lost to Follow-up|18
813077|NCT02214225|2657088|P2|Overall Study|Lost to Follow-up|18
813078|NCT02214225|2657089|P1|Overall Study|Lost to Follow-up|46
813079|NCT02214186|2657148|P2|Overall Study|Protocol Violation|1
813080|NCT02214186|2657149|P1|Overall Study|Protocol Violation|1
813081|NCT02214186|2657148|P2|Overall Study|Lost to Follow-up|1
813082|NCT02214186|2657149|P1|Overall Study|Lost to Follow-up|1
813083|NCT02214121|2657217|P3|Part B|Lost to Follow-up|1
813084|NCT02214121|2657218|P2|Part B|Lost to Follow-up|0
813085|NCT02214121|2657219|P1|Part B|Lost to Follow-up|0
813086|NCT02214121|2657217|P3|Part B|Dev. of study-specific withdrawal crit.|0
813087|NCT02214121|2657218|P2|Part B|Dev. of study-specific withdrawal crit.|2
813088|NCT02214121|2657219|P1|Part B|Dev. of study-specific withdrawal crit.|0
813089|NCT02214121|2657217|P3|Part B|Patient decision|0
813090|NCT02214121|2657218|P2|Part B|Patient decision|1
813091|NCT02214121|2657219|P1|Part B|Patient decision|0
813092|NCT02214121|2657217|P3|Part A|Other|0
813093|NCT02214121|2657218|P2|Part A|Other|0
813094|NCT02214121|2657219|P1|Part A|Other|1
813095|NCT02214121|2657217|P3|Part A|Dev. of study-specific withdrawal crit.|0
813096|NCT02214121|2657218|P2|Part A|Dev. of study-specific withdrawal crit.|0
813097|NCT02214121|2657219|P1|Part A|Dev. of study-specific withdrawal crit.|4
813098|NCT02214121|2657217|P3|Part A|Patient decision|0
813099|NCT02214121|2657218|P2|Part A|Patient decision|0
813100|NCT02214121|2657219|P1|Part A|Patient decision|2
813101|NCT02213666|2657328|P1|Overall Study|Withdrawal by Subject|1
813102|NCT02213510|2657334|P2|Overall Study|Lost to Follow-up|0
813103|NCT02213510|2657335|P1|Overall Study|Lost to Follow-up|1
813104|NCT02213510|2657334|P2|Overall Study|Death|1
813105|NCT02213510|2657335|P1|Overall Study|Death|0
813106|NCT02213263|2657363|P2|Overall Study|Ongoing in study|43
813107|NCT02213263|2657364|P1|Overall Study|Ongoing in study|39
813108|NCT02213263|2657363|P2|Overall Study|Adverse Event|2
813109|NCT02213263|2657364|P1|Overall Study|Adverse Event|1
813110|NCT02213263|2657363|P2|Overall Study|Progressive disease|13
813111|NCT02213263|2657364|P1|Overall Study|Progressive disease|20
813112|NCT02213263|2657363|P2|Overall Study|No longer willing to participate|3
813113|NCT02213263|2657364|P1|Overall Study|No longer willing to participate|2
813114|NCT02213263|2657363|P2|Overall Study|Lost to Follow-up|1
813115|NCT02213263|2657364|P1|Overall Study|Lost to Follow-up|0
813116|NCT02213263|2657363|P2|Overall Study|Insufficient clinical response|3
813117|NCT02213263|2657364|P1|Overall Study|Insufficient clinical response|4
813118|NCT02213198|2657432|P2|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7
813119|NCT02213198|2657433|P1|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23
813120|NCT02213198|2657432|P2|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10
813121|NCT02213198|2657433|P1|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17
813122|NCT02213198|2657432|P2|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25
813123|NCT02213198|2657433|P1|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68
813124|NCT02213198|2657432|P2|Follow up 1 3 Mos Post BL End of TCC tx|Death|0
813125|NCT02213198|2657433|P1|Follow up 1 3 Mos Post BL End of TCC tx|Death|1
813126|NCT02213198|2657432|P2|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2
813127|NCT02213198|2657433|P1|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3
813128|NCT02213198|2657432|P2|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
813129|NCT02213198|2657433|P1|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
813130|NCT02213198|2657432|P2|Baseline|incarcerated,violent|1
813131|NCT02213198|2657433|P1|Baseline|incarcerated,violent|0
813132|NCT02213198|2657432|P2|Baseline|Lost to Follow-up|21
813133|NCT02213198|2657433|P1|Baseline|Lost to Follow-up|40
813134|NCT02213198|2657432|P2|Baseline|transferred out of clinic|9
813135|NCT02213198|2657433|P1|Baseline|transferred out of clinic|7
813136|NCT02213198|2657432|P2|Baseline|Withdrawal by Subject|11
813137|NCT02213198|2657433|P1|Baseline|Withdrawal by Subject|34
813138|NCT02213198|2657432|P2|Baseline|No show for intake|9
813139|NCT02213198|2657433|P1|Baseline|No show for intake|7
813140|NCT02213094|2657443|P2|Overall Study|Adverse Event|0
813141|NCT02213094|2657444|P1|Overall Study|Adverse Event|1
813142|NCT02213055|2657452|P2|Overall Study|Did not Return to School|0
813143|NCT02213055|2657453|P1|Overall Study|Did not Return to School|5
813144|NCT02213055|2657452|P2|Overall Study|Did not meet Inclusion Criteria|0
813145|NCT02213055|2657453|P1|Overall Study|Did not meet Inclusion Criteria|6
813146|NCT02213055|2657452|P2|Overall Study|Had another Treatment during the Study|0
813147|NCT02213055|2657453|P1|Overall Study|Had another Treatment during the Study|3
813148|NCT02213055|2657452|P2|Overall Study|Did not have Live Lice|0
813149|NCT02213055|2657453|P1|Overall Study|Did not have Live Lice|8
813150|NCT02213055|2657452|P2|Overall Study|Documentation Issue during Study|0
813151|NCT02213055|2657453|P1|Overall Study|Documentation Issue during Study|10
813152|NCT02213055|2657452|P2|Overall Study|Documentation Issue at Enrollment|0
813153|NCT02213055|2657453|P1|Overall Study|Documentation Issue at Enrollment|1
813154|NCT02213055|2657452|P2|Overall Study|Protocol was not Followed during Study|0
813155|NCT02213055|2657453|P1|Overall Study|Protocol was not Followed during Study|1
813156|NCT02213055|2657452|P2|Overall Study|Protocol was not Followed at Enrollment|0
813157|NCT02213055|2657453|P1|Overall Study|Protocol was not Followed at Enrollment|5
813158|NCT02212457|2657491|P6|Overall Study|Other|1
813159|NCT02212457|2657492|P5|Overall Study|Other|0
813160|NCT02212457|2657493|P4|Overall Study|Other|1
813161|NCT02212457|2657494|P3|Overall Study|Other|2
813162|NCT02212457|2657495|P2|Overall Study|Other|1
813163|NCT02212457|2657496|P1|Overall Study|Other|2
813164|NCT02212457|2657491|P6|Overall Study|Protocol Violation|3
813165|NCT02212457|2657492|P5|Overall Study|Protocol Violation|2
813166|NCT02212457|2657493|P4|Overall Study|Protocol Violation|1
813167|NCT02212457|2657494|P3|Overall Study|Protocol Violation|0
813168|NCT02212457|2657495|P2|Overall Study|Protocol Violation|1
813169|NCT02212457|2657496|P1|Overall Study|Protocol Violation|2
813170|NCT02212457|2657491|P6|Overall Study|Lost to Follow-up|4
813171|NCT02212457|2657492|P5|Overall Study|Lost to Follow-up|8
813172|NCT02212457|2657493|P4|Overall Study|Lost to Follow-up|1
813173|NCT02212457|2657494|P3|Overall Study|Lost to Follow-up|4
813174|NCT02212457|2657495|P2|Overall Study|Lost to Follow-up|7
813175|NCT02212457|2657496|P1|Overall Study|Lost to Follow-up|6
813176|NCT02212457|2657491|P6|Overall Study|Withdrawal by Subject|4
813177|NCT02212457|2657492|P5|Overall Study|Withdrawal by Subject|5
813178|NCT02212457|2657493|P4|Overall Study|Withdrawal by Subject|6
813179|NCT02212457|2657494|P3|Overall Study|Withdrawal by Subject|8
813180|NCT02212457|2657495|P2|Overall Study|Withdrawal by Subject|10
813181|NCT02212457|2657496|P1|Overall Study|Withdrawal by Subject|8
813182|NCT02212457|2657491|P6|Overall Study|Adverse Event|1
813183|NCT02212457|2657492|P5|Overall Study|Adverse Event|0
813184|NCT02212457|2657493|P4|Overall Study|Adverse Event|2
813185|NCT02212457|2657494|P3|Overall Study|Adverse Event|2
813186|NCT02212457|2657495|P2|Overall Study|Adverse Event|2
813187|NCT02212457|2657496|P1|Overall Study|Adverse Event|1
813188|NCT02212301|2657534|P2|Period 1|Lost to Follow-up|1
813189|NCT02212301|2657535|P1|Period 1|Lost to Follow-up|0
813190|NCT02212197|2657546|P3|Overall Study|Need for radiotherapy|0
813191|NCT02212197|2657547|P2|Overall Study|Need for radiotherapy|0
813192|NCT02212197|2657548|P1|Overall Study|Need for radiotherapy|1
813193|NCT02211638|2657601|P1|Overall Study|Protocol Violation|692
813194|NCT02211638|2657601|P1|Overall Study|Case Report Forms Uncollected|291
813195|NCT02211261|2657644|P11|Overall Study|Lost to Follow-up|0
813196|NCT02211261|2657645|P10|Overall Study|Lost to Follow-up|0
813197|NCT02211261|2657646|P9|Overall Study|Lost to Follow-up|0
813198|NCT02211261|2657647|P8|Overall Study|Lost to Follow-up|1
813199|NCT02211261|2657648|P7|Overall Study|Lost to Follow-up|0
813200|NCT02211261|2657649|P6|Overall Study|Lost to Follow-up|0
813201|NCT02211261|2657650|P5|Overall Study|Lost to Follow-up|0
813202|NCT02211261|2657651|P4|Overall Study|Lost to Follow-up|0
813203|NCT02211261|2657652|P3|Overall Study|Lost to Follow-up|0
813204|NCT02211261|2657653|P2|Overall Study|Lost to Follow-up|0
813205|NCT02211261|2657654|P1|Overall Study|Lost to Follow-up|0
813206|NCT02211261|2657644|P11|Overall Study|Other|0
813207|NCT02211261|2657645|P10|Overall Study|Other|2
813208|NCT02211261|2657646|P9|Overall Study|Other|0
813209|NCT02211261|2657647|P8|Overall Study|Other|0
813210|NCT02211261|2657648|P7|Overall Study|Other|0
813211|NCT02211261|2657649|P6|Overall Study|Other|1
813212|NCT02211261|2657650|P5|Overall Study|Other|0
813213|NCT02211261|2657651|P4|Overall Study|Other|0
813214|NCT02211261|2657652|P3|Overall Study|Other|0
813215|NCT02211261|2657653|P2|Overall Study|Other|0
813216|NCT02211261|2657654|P1|Overall Study|Other|0
813217|NCT02211261|2657644|P11|Overall Study|Withdrawal by Subject|0
813218|NCT02211261|2657645|P10|Overall Study|Withdrawal by Subject|0
813219|NCT02211261|2657646|P9|Overall Study|Withdrawal by Subject|0
813220|NCT02211261|2657647|P8|Overall Study|Withdrawal by Subject|0
813221|NCT02211261|2657648|P7|Overall Study|Withdrawal by Subject|0
813222|NCT02211261|2657649|P6|Overall Study|Withdrawal by Subject|0
813223|NCT02211261|2657650|P5|Overall Study|Withdrawal by Subject|2
813224|NCT02211261|2657651|P4|Overall Study|Withdrawal by Subject|0
813225|NCT02211261|2657652|P3|Overall Study|Withdrawal by Subject|1
813226|NCT02211261|2657653|P2|Overall Study|Withdrawal by Subject|0
813227|NCT02211261|2657654|P1|Overall Study|Withdrawal by Subject|0
813228|NCT02210208|2657775|P1|Period B (Donor Site)|7 subjects healed at or before Day 14|7
813229|NCT02210208|2657775|P1|Period A (Graft Site)|Physician decided not to graft at OR|1
813230|NCT02210208|2657775|P1|Period A (Graft Site)|Withdrawal by Subject|1
813231|NCT02210091|2657795|P2|Overall Study|Withdrawal by Sponsor|1
813232|NCT02210091|2657796|P1|Overall Study|Withdrawal by Sponsor|0
813233|NCT02210091|2657795|P2|Overall Study|Physician Decision|1
813234|NCT02210091|2657796|P1|Overall Study|Physician Decision|0
813235|NCT02210000|2657878|P2|Overall Study|Physician Decision|1
813236|NCT02210000|2657879|P1|Overall Study|Physician Decision|0
813237|NCT02210000|2657878|P2|Overall Study|Lost to Follow-up|2
813238|NCT02210000|2657879|P1|Overall Study|Lost to Follow-up|0
813239|NCT02210000|2657878|P2|Overall Study|Adverse Event|5
813240|NCT02210000|2657879|P1|Overall Study|Adverse Event|1
813241|NCT02210000|2657878|P2|Overall Study|Withdrawal by Subject|1
813242|NCT02210000|2657879|P1|Overall Study|Withdrawal by Subject|7
813243|NCT02210000|2657878|P2|Overall Study|Study Terminated|12
813244|NCT02210000|2657879|P1|Overall Study|Study Terminated|11
813245|NCT02209766|2657905|P5|Overall Study|Withdrawal by Subject|0
813246|NCT02209766|2657906|P4|Overall Study|Withdrawal by Subject|1
813247|NCT02209766|2657907|P3|Overall Study|Withdrawal by Subject|0
813248|NCT02209766|2657908|P2|Overall Study|Withdrawal by Subject|0
813249|NCT02209766|2657909|P1|Overall Study|Withdrawal by Subject|0
813250|NCT02209506|2657960|P5|Overall Study|Withdrawal by Subject|1
813251|NCT02209506|2657961|P4|Overall Study|Withdrawal by Subject|0
813252|NCT02209506|2657962|P3|Overall Study|Withdrawal by Subject|0
813253|NCT02209506|2657963|P2|Overall Study|Withdrawal by Subject|0
813254|NCT02209506|2657964|P1|Overall Study|Withdrawal by Subject|0
813255|NCT02209454|2658039|P2|Second Period|Adverse Event|0
813256|NCT02209454|2658040|P1|Second Period|Adverse Event|1
813257|NCT02209181|2658077|P4|Overall Study|Withdrawal by Subject|0
813258|NCT02209181|2658078|P3|Overall Study|Withdrawal by Subject|0
813259|NCT02209181|2658079|P2|Overall Study|Withdrawal by Subject|1
813260|NCT02209181|2658080|P1|Overall Study|Withdrawal by Subject|0
813261|NCT02209181|2658077|P4|Overall Study|Adverse Event|0
813262|NCT02209181|2658078|P3|Overall Study|Adverse Event|1
813263|NCT02209181|2658079|P2|Overall Study|Adverse Event|0
813264|NCT02209181|2658080|P1|Overall Study|Adverse Event|1
813265|NCT02207907|2658308|P2|Overall Study|Pregnancy|1
813266|NCT02207907|2658309|P1|Overall Study|Pregnancy|0
813267|NCT02207907|2658308|P2|Overall Study|Did not meet study criteria|0
813268|NCT02207907|2658309|P1|Overall Study|Did not meet study criteria|3
813269|NCT02207907|2658308|P2|Overall Study|Withdrawal by Subject|6
813270|NCT02207907|2658309|P1|Overall Study|Withdrawal by Subject|5
813271|NCT02207907|2658308|P2|Overall Study|Lost to Follow-up|1
813272|NCT02207907|2658309|P1|Overall Study|Lost to Follow-up|3
813273|NCT02207829|2658327|P2|Overall Study|Withdrew consent|14
813274|NCT02207829|2658328|P1|Overall Study|Withdrew consent|18
813275|NCT02207829|2658327|P2|Overall Study|Protocol deviation|4
813276|NCT02207829|2658328|P1|Overall Study|Protocol deviation|5
813277|NCT02207829|2658327|P2|Overall Study|Lost to Follow-up|2
813278|NCT02207829|2658328|P1|Overall Study|Lost to Follow-up|2
813279|NCT02207829|2658327|P2|Overall Study|Lack of Efficacy|5
813280|NCT02207829|2658328|P1|Overall Study|Lack of Efficacy|7
813281|NCT02207829|2658327|P2|Overall Study|Adverse Event|9
813282|NCT02207829|2658328|P1|Overall Study|Adverse Event|10
813283|NCT02207725|2658349|P4|Overall Study|Did Not Receive Treatment|1
813284|NCT02207725|2658350|P3|Overall Study|Did Not Receive Treatment|1
813285|NCT02207725|2658351|P2|Overall Study|Did Not Receive Treatment|1
813286|NCT02207725|2658352|P1|Overall Study|Did Not Receive Treatment|0
813287|NCT02207634|2658382|P2|Overall Study|Lost to Follow-up|0
813288|NCT02207634|2658383|P1|Overall Study|Lost to Follow-up|1
813289|NCT02207634|2658382|P2|Overall Study|Withdrawal by Subject|31
813290|NCT02207634|2658383|P1|Overall Study|Withdrawal by Subject|21
813291|NCT02207621|2658398|P3|Overall Study|Other(Site,Sponsor and Subject request)|5
813292|NCT02207621|2658399|P2|Overall Study|Other(Site,Sponsor and Subject request)|1
813293|NCT02207621|2658400|P1|Overall Study|Other(Site,Sponsor and Subject request)|2
813294|NCT02207621|2658398|P3|Overall Study|Death|0
813295|NCT02207621|2658399|P2|Overall Study|Death|0
813296|NCT02207621|2658400|P1|Overall Study|Death|2
813297|NCT02207621|2658398|P3|Overall Study|Protocol Violation|6
813298|NCT02207621|2658399|P2|Overall Study|Protocol Violation|10
813299|NCT02207621|2658400|P1|Overall Study|Protocol Violation|4
813300|NCT02207621|2658398|P3|Overall Study|Physician Decision|2
813301|NCT02207621|2658399|P2|Overall Study|Physician Decision|2
813302|NCT02207621|2658400|P1|Overall Study|Physician Decision|1
813303|NCT02207621|2658398|P3|Overall Study|Disallowed Concurrent Medication|2
813304|NCT02207621|2658399|P2|Overall Study|Disallowed Concurrent Medication|5
813305|NCT02207621|2658400|P1|Overall Study|Disallowed Concurrent Medication|2
813306|NCT02207621|2658398|P3|Overall Study|Lack of Efficacy|4
813307|NCT02207621|2658399|P2|Overall Study|Lack of Efficacy|2
813308|NCT02207621|2658400|P1|Overall Study|Lack of Efficacy|10
813309|NCT02207621|2658398|P3|Overall Study|Lost to Follow-up|3
813310|NCT02207621|2658399|P2|Overall Study|Lost to Follow-up|0
813311|NCT02207621|2658400|P1|Overall Study|Lost to Follow-up|1
813312|NCT02207621|2658398|P3|Overall Study|Non-Compliant|1
813313|NCT02207621|2658399|P2|Overall Study|Non-Compliant|3
813314|NCT02207621|2658400|P1|Overall Study|Non-Compliant|3
813315|NCT02207621|2658398|P3|Overall Study|Withdrawal by Subject|13
813316|NCT02207621|2658399|P2|Overall Study|Withdrawal by Subject|9
813317|NCT02207621|2658400|P1|Overall Study|Withdrawal by Subject|9
813318|NCT02207621|2658398|P3|Overall Study|Adverse Event|132
813319|NCT02207621|2658399|P2|Overall Study|Adverse Event|15
813320|NCT02207621|2658400|P1|Overall Study|Adverse Event|71
813321|NCT02207608|2658413|P2|Overall Study|Adverse Event|0
813322|NCT02207608|2658414|P1|Overall Study|Adverse Event|1
813323|NCT02207530|2658438|P1|Overall Study|Adverse Event|8
813324|NCT02207530|2658438|P1|Overall Study|Patient decision to stop study treatment|5
813325|NCT02207530|2658438|P1|Overall Study|Worsening condition under investigation|78
813326|NCT02207491|2658452|P2|Overall Study|Protocol Violation|5
813327|NCT02207491|2658453|P1|Overall Study|Protocol Violation|3
813328|NCT02207491|2658452|P2|Overall Study|Physician Decision|0
813329|NCT02207491|2658453|P1|Overall Study|Physician Decision|2
813330|NCT02207491|2658452|P2|Overall Study|Lack of Efficacy|0
813331|NCT02207491|2658453|P1|Overall Study|Lack of Efficacy|3
813332|NCT02207491|2658452|P2|Overall Study|Lost to Follow-up|1
813333|NCT02207491|2658453|P1|Overall Study|Lost to Follow-up|0
813334|NCT02207491|2658452|P2|Overall Study|Non-compliant|1
813335|NCT02207491|2658453|P1|Overall Study|Non-compliant|0
813336|NCT02207491|2658452|P2|Overall Study|Withdrawal by Subject|2
813337|NCT02207491|2658453|P1|Overall Study|Withdrawal by Subject|3
813338|NCT02207491|2658452|P2|Overall Study|Adverse Event|4
813339|NCT02207491|2658453|P1|Overall Study|Adverse Event|20
813340|NCT02207413|2658478|P6|Overall Study|Migrated/moved from study area|0
813341|NCT02207413|2658479|P5|Overall Study|Migrated/moved from study area|1
813342|NCT02207413|2658480|P4|Overall Study|Migrated/moved from study area|0
813343|NCT02207413|2658481|P3|Overall Study|Migrated/moved from study area|0
813344|NCT02207413|2658482|P2|Overall Study|Migrated/moved from study area|0
813345|NCT02207413|2658483|P1|Overall Study|Migrated/moved from study area|0
813346|NCT02207413|2658478|P6|Overall Study|Adverse Event|1
813347|NCT02207413|2658479|P5|Overall Study|Adverse Event|2
813348|NCT02207413|2658480|P4|Overall Study|Adverse Event|0
813349|NCT02207413|2658481|P3|Overall Study|Adverse Event|0
813350|NCT02207413|2658482|P2|Overall Study|Adverse Event|0
813351|NCT02207413|2658483|P1|Overall Study|Adverse Event|0
813352|NCT02207413|2658478|P6|Overall Study|Lost to Follow-up|5
813353|NCT02207413|2658479|P5|Overall Study|Lost to Follow-up|1
813354|NCT02207413|2658480|P4|Overall Study|Lost to Follow-up|1
813355|NCT02207413|2658481|P3|Overall Study|Lost to Follow-up|0
813356|NCT02207413|2658482|P2|Overall Study|Lost to Follow-up|0
813357|NCT02207413|2658483|P1|Overall Study|Lost to Follow-up|0
813358|NCT02207413|2658478|P6|Overall Study|Withdrawal by Subject|7
813359|NCT02207413|2658479|P5|Overall Study|Withdrawal by Subject|3
813360|NCT02207413|2658480|P4|Overall Study|Withdrawal by Subject|0
813361|NCT02207413|2658481|P3|Overall Study|Withdrawal by Subject|0
813362|NCT02207413|2658482|P2|Overall Study|Withdrawal by Subject|0
813363|NCT02207413|2658483|P1|Overall Study|Withdrawal by Subject|1
813364|NCT02207400|2658579|P2|Overall Study|Positive Urine Pregnancy Test|1
813365|NCT02207400|2658580|P1|Overall Study|Positive Urine Pregnancy Test|0
813366|NCT02207400|2658579|P2|Overall Study|Withdrawal by Subject|4
813367|NCT02207400|2658580|P1|Overall Study|Withdrawal by Subject|8
813368|NCT02207400|2658579|P2|Overall Study|Protocol Violation|1
813369|NCT02207400|2658580|P1|Overall Study|Protocol Violation|1
813370|NCT02207400|2658579|P2|Overall Study|Lost to Follow-up|7
813371|NCT02207400|2658580|P1|Overall Study|Lost to Follow-up|6
813372|NCT02207400|2658579|P2|Overall Study|Adverse Event|1
813373|NCT02207400|2658580|P1|Overall Study|Adverse Event|1
813374|NCT02207244|2658601|P9|Withdrawal, Retreatment Period:Week28-48|Other|0
813375|NCT02207244|2658602|P8|Withdrawal, Retreatment Period:Week28-48|Other|1
813376|NCT02207244|2658603|P7|Withdrawal, Retreatment Period:Week28-48|Other|0
813377|NCT02207244|2658604|P6|Withdrawal, Retreatment Period:Week28-48|Other|0
813378|NCT02207244|2658605|P5|Withdrawal, Retreatment Period:Week28-48|Other|0
813379|NCT02207244|2658606|P4|Withdrawal, Retreatment Period:Week28-48|Other|0
813380|NCT02207244|2658607|P3|Withdrawal, Retreatment Period:Week28-48|Other|0
813381|NCT02207244|2658608|P2|Withdrawal, Retreatment Period:Week28-48|Other|0
813382|NCT02207244|2658609|P1|Withdrawal, Retreatment Period:Week28-48|Other|0
813383|NCT02207244|2658601|P9|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
813384|NCT02207244|2658602|P8|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
813385|NCT02207244|2658603|P7|Withdrawal, Retreatment Period:Week28-48|Non-compliance|1
813386|NCT02207244|2658604|P6|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
813387|NCT02207244|2658605|P5|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
813388|NCT02207244|2658606|P4|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
813389|NCT02207244|2658607|P3|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
813390|NCT02207244|2658608|P2|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
813391|NCT02207244|2658609|P1|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
813392|NCT02207244|2658601|P9|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
813393|NCT02207244|2658602|P8|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
813394|NCT02207244|2658603|P7|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|1
813395|NCT02207244|2658604|P6|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
813396|NCT02207244|2658605|P5|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
813397|NCT02207244|2658606|P4|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
813398|NCT02207244|2658607|P3|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
813399|NCT02207244|2658608|P2|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
813400|NCT02207244|2658609|P1|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
813401|NCT02207244|2658601|P9|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|1
813402|NCT02207244|2658602|P8|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|2
813403|NCT02207244|2658603|P7|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|1
813404|NCT02207244|2658604|P6|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
813405|NCT02207244|2658605|P5|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
813406|NCT02207244|2658606|P4|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
813407|NCT02207244|2658607|P3|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
813408|NCT02207244|2658608|P2|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
813409|NCT02207244|2658609|P1|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
813410|NCT02207244|2658601|P9|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|2
813411|NCT02207244|2658602|P8|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|5
813412|NCT02207244|2658603|P7|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|2
813413|NCT02207244|2658604|P6|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
813414|NCT02207244|2658605|P5|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
813415|NCT02207244|2658606|P4|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
813416|NCT02207244|2658607|P3|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
813417|NCT02207244|2658608|P2|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
813418|NCT02207244|2658609|P1|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
813419|NCT02207244|2658601|P9|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|2
813420|NCT02207244|2658602|P8|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|2
813421|NCT02207244|2658603|P7|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
813422|NCT02207244|2658604|P6|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
813423|NCT02207244|2658605|P5|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
813424|NCT02207244|2658606|P4|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
813425|NCT02207244|2658607|P3|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
813426|NCT02207244|2658608|P2|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
813427|NCT02207244|2658609|P1|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
813428|NCT02207244|2658601|P9|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
813429|NCT02207244|2658602|P8|Withdrawal, Retreatment Period:Week28-48|Pregnancy|2
813430|NCT02207244|2658603|P7|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
813431|NCT02207244|2658604|P6|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
813432|NCT02207244|2658605|P5|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
813433|NCT02207244|2658606|P4|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
813434|NCT02207244|2658607|P3|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
813435|NCT02207244|2658608|P2|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
813436|NCT02207244|2658609|P1|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
813437|NCT02207244|2658601|P9|Withdrawal, Retreatment Period:Week28-48|Adverse Event|3
813438|NCT02207244|2658602|P8|Withdrawal, Retreatment Period:Week28-48|Adverse Event|1
813439|NCT02207244|2658603|P7|Withdrawal, Retreatment Period:Week28-48|Adverse Event|3
813440|NCT02207244|2658604|P6|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
813441|NCT02207244|2658605|P5|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
813442|NCT02207244|2658606|P4|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
813443|NCT02207244|2658607|P3|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
813444|NCT02207244|2658608|P2|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
813445|NCT02207244|2658609|P1|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
813673|NCT02204319|2659183|P1|Overall Study|Withdrawal by Subject|2
813446|NCT02207244|2658601|P9|Placebo Crossover and ACP: Week 16 - 28|Other|0
813447|NCT02207244|2658602|P8|Placebo Crossover and ACP: Week 16 - 28|Other|0
813448|NCT02207244|2658603|P7|Placebo Crossover and ACP: Week 16 - 28|Other|0
813449|NCT02207244|2658604|P6|Placebo Crossover and ACP: Week 16 - 28|Other|0
813450|NCT02207244|2658605|P5|Placebo Crossover and ACP: Week 16 - 28|Other|0
813451|NCT02207244|2658606|P4|Placebo Crossover and ACP: Week 16 - 28|Other|1
813452|NCT02207244|2658607|P3|Placebo Crossover and ACP: Week 16 - 28|Other|0
813453|NCT02207244|2658608|P2|Placebo Crossover and ACP: Week 16 - 28|Other|0
813454|NCT02207244|2658609|P1|Placebo Crossover and ACP: Week 16 - 28|Other|0
813455|NCT02207244|2658601|P9|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
813456|NCT02207244|2658602|P8|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
813457|NCT02207244|2658603|P7|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
813458|NCT02207244|2658604|P6|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|1
813459|NCT02207244|2658605|P5|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
813460|NCT02207244|2658606|P4|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|1
813461|NCT02207244|2658607|P3|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
813462|NCT02207244|2658608|P2|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
813463|NCT02207244|2658609|P1|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
813464|NCT02207244|2658601|P9|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
813465|NCT02207244|2658602|P8|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
813466|NCT02207244|2658603|P7|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
813467|NCT02207244|2658604|P6|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|2
813468|NCT02207244|2658605|P5|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|3
813469|NCT02207244|2658606|P4|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|3
813470|NCT02207244|2658607|P3|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
813471|NCT02207244|2658608|P2|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
813472|NCT02207244|2658609|P1|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
813473|NCT02207244|2658601|P9|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
813474|NCT02207244|2658602|P8|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
813475|NCT02207244|2658603|P7|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
813476|NCT02207244|2658604|P6|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|2
813477|NCT02207244|2658605|P5|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|2
813478|NCT02207244|2658606|P4|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|1
813479|NCT02207244|2658607|P3|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
813480|NCT02207244|2658608|P2|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
813481|NCT02207244|2658609|P1|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
813482|NCT02207244|2658601|P9|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
813483|NCT02207244|2658602|P8|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
813484|NCT02207244|2658603|P7|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
813485|NCT02207244|2658604|P6|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|2
813486|NCT02207244|2658605|P5|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
813487|NCT02207244|2658606|P4|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
813488|NCT02207244|2658607|P3|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
813489|NCT02207244|2658608|P2|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
813490|NCT02207244|2658609|P1|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
813491|NCT02207244|2658601|P9|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
813492|NCT02207244|2658602|P8|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
813493|NCT02207244|2658603|P7|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
813494|NCT02207244|2658604|P6|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|2
813495|NCT02207244|2658605|P5|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|3
813496|NCT02207244|2658606|P4|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
813497|NCT02207244|2658607|P3|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
813498|NCT02207244|2658608|P2|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
813499|NCT02207244|2658609|P1|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
813500|NCT02207244|2658601|P9|Placebo Controlled Period: Week 0 - 16|Other|0
813501|NCT02207244|2658602|P8|Placebo Controlled Period: Week 0 - 16|Other|0
813502|NCT02207244|2658603|P7|Placebo Controlled Period: Week 0 - 16|Other|0
813503|NCT02207244|2658604|P6|Placebo Controlled Period: Week 0 - 16|Other|0
813504|NCT02207244|2658605|P5|Placebo Controlled Period: Week 0 - 16|Other|0
813505|NCT02207244|2658606|P4|Placebo Controlled Period: Week 0 - 16|Other|0
813506|NCT02207244|2658607|P3|Placebo Controlled Period: Week 0 - 16|Other|0
813507|NCT02207244|2658608|P2|Placebo Controlled Period: Week 0 - 16|Other|1
813508|NCT02207244|2658609|P1|Placebo Controlled Period: Week 0 - 16|Other|0
813509|NCT02207244|2658601|P9|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
813510|NCT02207244|2658602|P8|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
813511|NCT02207244|2658603|P7|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
813512|NCT02207244|2658604|P6|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
813513|NCT02207244|2658605|P5|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
813514|NCT02207244|2658606|P4|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
813515|NCT02207244|2658607|P3|Placebo Controlled Period: Week 0 - 16|Non-Compliance|2
813516|NCT02207244|2658608|P2|Placebo Controlled Period: Week 0 - 16|Non-Compliance|1
813517|NCT02207244|2658609|P1|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
813518|NCT02207244|2658601|P9|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
813519|NCT02207244|2658602|P8|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
813520|NCT02207244|2658603|P7|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
813521|NCT02207244|2658604|P6|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
813522|NCT02207244|2658605|P5|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
813523|NCT02207244|2658606|P4|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
813524|NCT02207244|2658607|P3|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
813525|NCT02207244|2658608|P2|Placebo Controlled Period: Week 0 - 16|Protocol Violation|3
813526|NCT02207244|2658609|P1|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
813527|NCT02207244|2658601|P9|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
813528|NCT02207244|2658602|P8|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
813529|NCT02207244|2658603|P7|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
813530|NCT02207244|2658604|P6|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
813531|NCT02207244|2658605|P5|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
813532|NCT02207244|2658606|P4|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
813533|NCT02207244|2658607|P3|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
813534|NCT02207244|2658608|P2|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|1
813535|NCT02207244|2658609|P1|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|7
813536|NCT02207244|2658601|P9|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
813537|NCT02207244|2658602|P8|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
813538|NCT02207244|2658603|P7|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
813539|NCT02207244|2658604|P6|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
813540|NCT02207244|2658605|P5|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
813541|NCT02207244|2658606|P4|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
813542|NCT02207244|2658607|P3|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|2
813543|NCT02207244|2658608|P2|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|3
813544|NCT02207244|2658609|P1|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
813545|NCT02207244|2658601|P9|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
813546|NCT02207244|2658602|P8|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
813547|NCT02207244|2658603|P7|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
813548|NCT02207244|2658604|P6|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
813549|NCT02207244|2658605|P5|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
813550|NCT02207244|2658606|P4|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
813551|NCT02207244|2658607|P3|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
813552|NCT02207244|2658608|P2|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
813553|NCT02207244|2658609|P1|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|4
813554|NCT02207244|2658601|P9|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
813555|NCT02207244|2658602|P8|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
813556|NCT02207244|2658603|P7|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
813557|NCT02207244|2658604|P6|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
813558|NCT02207244|2658605|P5|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
813559|NCT02207244|2658606|P4|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
813560|NCT02207244|2658607|P3|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
813561|NCT02207244|2658608|P2|Placebo Controlled Period: Week 0 - 16|Adverse Event|9
813562|NCT02207244|2658609|P1|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
813563|NCT02207231|2658650|P3|Active Controlled Period: Week 16 - 48|Non-compliance|3
813564|NCT02207231|2658651|P2|Active Controlled Period: Week 16 - 48|Non-compliance|3
813565|NCT02207231|2658652|P1|Active Controlled Period: Week 16 - 48|Non-compliance|0
813566|NCT02207231|2658650|P3|Active Controlled Period: Week 16 - 48|Other|3
813567|NCT02207231|2658651|P2|Active Controlled Period: Week 16 - 48|Other|2
813568|NCT02207231|2658652|P1|Active Controlled Period: Week 16 - 48|Other|0
813569|NCT02207231|2658650|P3|Active Controlled Period: Week 16 - 48|Protocol Violation|0
813570|NCT02207231|2658651|P2|Active Controlled Period: Week 16 - 48|Protocol Violation|1
813571|NCT02207231|2658652|P1|Active Controlled Period: Week 16 - 48|Protocol Violation|0
813572|NCT02207231|2658650|P3|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10
813573|NCT02207231|2658651|P2|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4
813574|NCT02207231|2658652|P1|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1
813575|NCT02207231|2658650|P3|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5
813576|NCT02207231|2658651|P2|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2
813577|NCT02207231|2658652|P1|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1
813578|NCT02207231|2658650|P3|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11
813579|NCT02207231|2658651|P2|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3
813580|NCT02207231|2658652|P1|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0
813581|NCT02207231|2658650|P3|Active Controlled Period: Week 16 - 48|Pregnancy|1
813582|NCT02207231|2658651|P2|Active Controlled Period: Week 16 - 48|Pregnancy|0
813583|NCT02207231|2658652|P1|Active Controlled Period: Week 16 - 48|Pregnancy|0
813584|NCT02207231|2658650|P3|Active Controlled Period: Week 16 - 48|Adverse Event|9
813585|NCT02207231|2658651|P2|Active Controlled Period: Week 16 - 48|Adverse Event|6
813586|NCT02207231|2658652|P1|Active Controlled Period: Week 16 - 48|Adverse Event|1
813587|NCT02207231|2658650|P3|Placebo Controlled Period: Week 0 - 16|Noncompliance|1
813588|NCT02207231|2658651|P2|Placebo Controlled Period: Week 0 - 16|Noncompliance|2
813589|NCT02207231|2658652|P1|Placebo Controlled Period: Week 0 - 16|Noncompliance|0
813590|NCT02207231|2658650|P3|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
813591|NCT02207231|2658651|P2|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
813592|NCT02207231|2658652|P1|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
813593|NCT02207231|2658650|P3|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4
813594|NCT02207231|2658651|P2|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
813595|NCT02207231|2658652|P1|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2
813596|NCT02207231|2658650|P3|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
813597|NCT02207231|2658651|P2|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
813598|NCT02207231|2658652|P1|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
813599|NCT02207231|2658650|P3|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1
813600|NCT02207231|2658651|P2|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
813601|NCT02207231|2658652|P1|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
813602|NCT02207231|2658650|P3|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
813603|NCT02207231|2658651|P2|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
813604|NCT02207231|2658652|P1|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
813605|NCT02207088|2658684|P1|Overall Study|Adverse Event|2
813606|NCT02206607|2658699|P5|Second Intervention Period|Insufficient Clinical Response|0
813607|NCT02206607|2658700|P4|Second Intervention Period|Insufficient Clinical Response|1
813608|NCT02206607|2658701|P3|Second Intervention Period|Insufficient Clinical Response|0
813609|NCT02206607|2658702|P2|Second Intervention Period|Insufficient Clinical Response|0
813610|NCT02206607|2658703|P1|Second Intervention Period|Insufficient Clinical Response|0
813611|NCT02206607|2658699|P5|Open-Label Run-In|Withdrawal by Subject|0
813612|NCT02206607|2658700|P4|Open-Label Run-In|Withdrawal by Subject|0
813613|NCT02206607|2658701|P3|Open-Label Run-In|Withdrawal by Subject|0
813614|NCT02206607|2658702|P2|Open-Label Run-In|Withdrawal by Subject|0
813615|NCT02206607|2658703|P1|Open-Label Run-In|Withdrawal by Subject|3
813616|NCT02205814|2658776|P4|Overall Study|not compliant with study procedures|0
813617|NCT02205814|2658777|P3|Overall Study|not compliant with study procedures|1
813618|NCT02205814|2658778|P2|Overall Study|not compliant with study procedures|0
813619|NCT02205814|2658779|P1|Overall Study|not compliant with study procedures|0
813620|NCT02205814|2658776|P4|Overall Study|Withdrawal by Subject|1
813621|NCT02205814|2658777|P3|Overall Study|Withdrawal by Subject|2
813622|NCT02205814|2658778|P2|Overall Study|Withdrawal by Subject|1
813623|NCT02205814|2658779|P1|Overall Study|Withdrawal by Subject|0
813624|NCT02205814|2658776|P4|Overall Study|Protocol Violation|1
813625|NCT02205814|2658777|P3|Overall Study|Protocol Violation|0
813626|NCT02205814|2658778|P2|Overall Study|Protocol Violation|0
813627|NCT02205814|2658779|P1|Overall Study|Protocol Violation|1
813628|NCT02205814|2658776|P4|Overall Study|Physician Decision|0
813629|NCT02205814|2658777|P3|Overall Study|Physician Decision|1
813630|NCT02205814|2658778|P2|Overall Study|Physician Decision|0
813631|NCT02205814|2658779|P1|Overall Study|Physician Decision|0
813632|NCT02205814|2658776|P4|Overall Study|Lack of Efficacy|1
813633|NCT02205814|2658777|P3|Overall Study|Lack of Efficacy|1
813634|NCT02205814|2658778|P2|Overall Study|Lack of Efficacy|0
813635|NCT02205814|2658779|P1|Overall Study|Lack of Efficacy|1
813636|NCT02205814|2658776|P4|Overall Study|Lost to Follow-up|1
813637|NCT02205814|2658777|P3|Overall Study|Lost to Follow-up|0
813638|NCT02205814|2658778|P2|Overall Study|Lost to Follow-up|0
813639|NCT02205814|2658779|P1|Overall Study|Lost to Follow-up|0
813640|NCT02205476|2658832|P2|Overall Study|Study termination by Sponsor|3
813641|NCT02205476|2658833|P1|Overall Study|Study termination by Sponsor|7
813642|NCT02205333|2658872|P9|Overall Study|Withdrawal by Subject|0
813643|NCT02205333|2658873|P8|Overall Study|Withdrawal by Subject|0
813644|NCT02205333|2658874|P7|Overall Study|Withdrawal by Subject|2
813645|NCT02205333|2658875|P6|Overall Study|Withdrawal by Subject|0
813646|NCT02205333|2658876|P5|Overall Study|Withdrawal by Subject|0
813647|NCT02205333|2658877|P4|Overall Study|Withdrawal by Subject|1
813648|NCT02205333|2658878|P3|Overall Study|Withdrawal by Subject|0
813649|NCT02205333|2658879|P2|Overall Study|Withdrawal by Subject|0
813650|NCT02205333|2658880|P1|Overall Study|Withdrawal by Subject|1
813651|NCT02205333|2658872|P9|Overall Study|Death|0
813652|NCT02205333|2658873|P8|Overall Study|Death|2
813653|NCT02205333|2658874|P7|Overall Study|Death|3
813654|NCT02205333|2658875|P6|Overall Study|Death|3
813655|NCT02205333|2658876|P5|Overall Study|Death|5
813656|NCT02205333|2658877|P4|Overall Study|Death|6
813657|NCT02205333|2658878|P3|Overall Study|Death|2
813658|NCT02205333|2658879|P2|Overall Study|Death|6
813659|NCT02205333|2658880|P1|Overall Study|Death|5
813660|NCT02204917|2659053|P1|Overall Study|Protocol Violation|1
813661|NCT02204579|2659090|P1|Overall Study|Screen failures|2
813662|NCT02204449|2659144|P2|Overall Study|Withdrawal by Subject|1
813663|NCT02204449|2659145|P1|Overall Study|Withdrawal by Subject|0
813664|NCT02204449|2659144|P2|Overall Study|Death|1
813665|NCT02204449|2659145|P1|Overall Study|Death|0
813666|NCT02204449|2659144|P2|Overall Study|Lost to Follow-up|9
813667|NCT02204449|2659145|P1|Overall Study|Lost to Follow-up|7
813668|NCT02204410|2659155|P1|Overall Study|Withdrawal by Subject|3
813669|NCT02204410|2659155|P1|Overall Study|Protocol Violation|1
813670|NCT02204410|2659155|P1|Overall Study|Physician Decision|2
813671|NCT02204410|2659155|P1|Overall Study|Lost to Follow-up|5
813672|NCT02204371|2659160|P1|Overall Study|Adverse Event|1
813674|NCT02204319|2659183|P1|Overall Study|Pregnancy|1
813675|NCT02204007|2659212|P2|Overall Study|Surgery Canceled|1
813676|NCT02204007|2659213|P1|Overall Study|Surgery Canceled|1
813677|NCT02203916|2659224|P3|Overall Study|Reason Not Specified|1
813678|NCT02203916|2659225|P2|Overall Study|Reason Not Specified|2
813679|NCT02203916|2659226|P1|Overall Study|Reason Not Specified|0
813680|NCT02203916|2659224|P3|Overall Study|Lack of Efficacy|0
813681|NCT02203916|2659225|P2|Overall Study|Lack of Efficacy|0
813682|NCT02203916|2659226|P1|Overall Study|Lack of Efficacy|3
813683|NCT02203916|2659224|P3|Overall Study|Voluntary Withdrawal|8
813684|NCT02203916|2659225|P2|Overall Study|Voluntary Withdrawal|3
813685|NCT02203916|2659226|P1|Overall Study|Voluntary Withdrawal|3
813686|NCT02203916|2659224|P3|Overall Study|Lost to Follow-up|0
813687|NCT02203916|2659225|P2|Overall Study|Lost to Follow-up|1
813688|NCT02203916|2659226|P1|Overall Study|Lost to Follow-up|0
813689|NCT02203916|2659224|P3|Overall Study|Major Protocol Deviation|0
813690|NCT02203916|2659225|P2|Overall Study|Major Protocol Deviation|1
813691|NCT02203916|2659226|P1|Overall Study|Major Protocol Deviation|1
813692|NCT02203916|2659224|P3|Overall Study|Pretreatment Event/Adverse Event|2
813693|NCT02203916|2659225|P2|Overall Study|Pretreatment Event/Adverse Event|3
813694|NCT02203916|2659226|P1|Overall Study|Pretreatment Event/Adverse Event|1
813695|NCT02203838|2659250|P4|Overall Study|Other|0
813696|NCT02203838|2659251|P3|Overall Study|Other|0
813697|NCT02203838|2659252|P2|Overall Study|Other|0
813698|NCT02203838|2659253|P1|Overall Study|Other|1
813699|NCT02203838|2659250|P4|Overall Study|Physician Decision|3
813700|NCT02203838|2659251|P3|Overall Study|Physician Decision|2
813701|NCT02203838|2659252|P2|Overall Study|Physician Decision|0
813702|NCT02203838|2659253|P1|Overall Study|Physician Decision|27
813703|NCT02203838|2659250|P4|Overall Study|Withdrawal by Subject|11
813704|NCT02203838|2659251|P3|Overall Study|Withdrawal by Subject|8
813705|NCT02203838|2659252|P2|Overall Study|Withdrawal by Subject|10
813706|NCT02203838|2659253|P1|Overall Study|Withdrawal by Subject|83
813707|NCT02203838|2659250|P4|Overall Study|Protocol Violation|0
813708|NCT02203838|2659251|P3|Overall Study|Protocol Violation|0
813709|NCT02203838|2659252|P2|Overall Study|Protocol Violation|3
813710|NCT02203838|2659253|P1|Overall Study|Protocol Violation|7
813711|NCT02203838|2659250|P4|Overall Study|Lost to Follow-up|1
813712|NCT02203838|2659251|P3|Overall Study|Lost to Follow-up|2
813713|NCT02203838|2659252|P2|Overall Study|Lost to Follow-up|3
813714|NCT02203838|2659253|P1|Overall Study|Lost to Follow-up|39
813715|NCT02203838|2659250|P4|Overall Study|Adverse Event|2
813716|NCT02203838|2659251|P3|Overall Study|Adverse Event|3
813717|NCT02203838|2659252|P2|Overall Study|Adverse Event|6
813718|NCT02203838|2659253|P1|Overall Study|Adverse Event|46
813719|NCT02203838|2659250|P4|Overall Study|Lack of Efficacy|1
813720|NCT02203838|2659251|P3|Overall Study|Lack of Efficacy|1
813721|NCT02203838|2659252|P2|Overall Study|Lack of Efficacy|0
813722|NCT02203838|2659253|P1|Overall Study|Lack of Efficacy|7
813723|NCT02203721|2659333|P2|Overall Study|Illness|1
813724|NCT02203721|2659334|P1|Overall Study|Illness|0
813725|NCT02203721|2659333|P2|Overall Study|Death|2
813726|NCT02203721|2659334|P1|Overall Study|Death|0
813727|NCT02203721|2659333|P2|Overall Study|Lost to Follow-up|0
813728|NCT02203721|2659334|P1|Overall Study|Lost to Follow-up|1
813729|NCT02203331|2659437|P6|Overall Study|Lost to Follow-up|0
813730|NCT02203331|2659438|P5|Overall Study|Lost to Follow-up|1
813731|NCT02203331|2659439|P4|Overall Study|Lost to Follow-up|0
813732|NCT02203331|2659440|P3|Overall Study|Lost to Follow-up|0
813733|NCT02203331|2659441|P2|Overall Study|Lost to Follow-up|0
813734|NCT02203331|2659442|P1|Overall Study|Lost to Follow-up|0
813735|NCT02203331|2659437|P6|Overall Study|Protocol Violation|0
813736|NCT02203331|2659438|P5|Overall Study|Protocol Violation|1
813737|NCT02203331|2659439|P4|Overall Study|Protocol Violation|1
813738|NCT02203331|2659440|P3|Overall Study|Protocol Violation|0
813739|NCT02203331|2659441|P2|Overall Study|Protocol Violation|2
813740|NCT02203331|2659442|P1|Overall Study|Protocol Violation|0
813741|NCT02203331|2659437|P6|Overall Study|Lack of Efficacy|1
813742|NCT02203331|2659438|P5|Overall Study|Lack of Efficacy|0
813743|NCT02203331|2659439|P4|Overall Study|Lack of Efficacy|0
813744|NCT02203331|2659440|P3|Overall Study|Lack of Efficacy|1
813745|NCT02203331|2659441|P2|Overall Study|Lack of Efficacy|2
813746|NCT02203331|2659442|P1|Overall Study|Lack of Efficacy|0
813747|NCT02203331|2659437|P6|Overall Study|Other Reasons|0
813748|NCT02203331|2659438|P5|Overall Study|Other Reasons|0
813749|NCT02203331|2659439|P4|Overall Study|Other Reasons|2
813750|NCT02203331|2659440|P3|Overall Study|Other Reasons|0
813751|NCT02203331|2659441|P2|Overall Study|Other Reasons|2
813752|NCT02203331|2659442|P1|Overall Study|Other Reasons|1
813753|NCT02203331|2659437|P6|Overall Study|Adverse Event|3
813754|NCT02203331|2659438|P5|Overall Study|Adverse Event|3
813755|NCT02203331|2659439|P4|Overall Study|Adverse Event|4
813756|NCT02203331|2659440|P3|Overall Study|Adverse Event|3
813757|NCT02203331|2659441|P2|Overall Study|Adverse Event|8
813758|NCT02203331|2659442|P1|Overall Study|Adverse Event|4
813759|NCT02203331|2659437|P6|Overall Study|Withdrawal by Subject|3
813760|NCT02203331|2659438|P5|Overall Study|Withdrawal by Subject|0
813761|NCT02203331|2659439|P4|Overall Study|Withdrawal by Subject|0
813762|NCT02203331|2659440|P3|Overall Study|Withdrawal by Subject|1
813763|NCT02203331|2659441|P2|Overall Study|Withdrawal by Subject|0
813764|NCT02203331|2659442|P1|Overall Study|Withdrawal by Subject|1
813765|NCT02203331|2659437|P6|Overall Study|Pregnancy|0
813766|NCT02203331|2659438|P5|Overall Study|Pregnancy|2
813767|NCT02203331|2659439|P4|Overall Study|Pregnancy|0
813768|NCT02203331|2659440|P3|Overall Study|Pregnancy|0
813769|NCT02203331|2659441|P2|Overall Study|Pregnancy|0
813770|NCT02203331|2659442|P1|Overall Study|Pregnancy|1
813771|NCT02203149|2659501|P5|Part 2|Adverse Event|1
813772|NCT02203149|2659502|P4|Part 2|Adverse Event|1
813773|NCT02203149|2659503|P3|Part 2|Adverse Event|0
813774|NCT02203149|2659504|P2|Part 2|Adverse Event|0
813775|NCT02203149|2659505|P1|Part 2|Adverse Event|0
813776|NCT02203149|2659501|P5|Part 2|Withdrawal by Subject|0
813777|NCT02203149|2659502|P4|Part 2|Withdrawal by Subject|1
813778|NCT02203149|2659503|P3|Part 2|Withdrawal by Subject|0
813779|NCT02203149|2659504|P2|Part 2|Withdrawal by Subject|0
813780|NCT02203149|2659505|P1|Part 2|Withdrawal by Subject|0
813781|NCT02203149|2659501|P5|Part 2|Death|0
813782|NCT02203149|2659502|P4|Part 2|Death|1
813783|NCT02203149|2659503|P3|Part 2|Death|1
813784|NCT02203149|2659504|P2|Part 2|Death|0
813785|NCT02203149|2659505|P1|Part 2|Death|0
813786|NCT02203149|2659501|P5|Part 1|Adverse Event|0
813787|NCT02203149|2659502|P4|Part 1|Adverse Event|0
813788|NCT02203149|2659503|P3|Part 1|Adverse Event|0
813789|NCT02203149|2659504|P2|Part 1|Adverse Event|1
813790|NCT02203149|2659505|P1|Part 1|Adverse Event|0
813791|NCT02203032|2659538|P4|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2
813792|NCT02203032|2659539|P3|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3
813793|NCT02203032|2659540|P2|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1
813794|NCT02203032|2659541|P1|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0
813795|NCT02203032|2659538|P4|Blinded Phase (Week 16 to Week 44)|Death|1
813796|NCT02203032|2659539|P3|Blinded Phase (Week 16 to Week 44)|Death|0
813797|NCT02203032|2659540|P2|Blinded Phase (Week 16 to Week 44)|Death|0
813798|NCT02203032|2659541|P1|Blinded Phase (Week 16 to Week 44)|Death|0
813799|NCT02203032|2659538|P4|Blinded Phase (Week 16 to Week 44)|Other|15
813800|NCT02203032|2659539|P3|Blinded Phase (Week 16 to Week 44)|Other|1
813801|NCT02203032|2659540|P2|Blinded Phase (Week 16 to Week 44)|Other|4
813802|NCT02203032|2659541|P1|Blinded Phase (Week 16 to Week 44)|Other|0
813803|NCT02203032|2659538|P4|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20
813804|NCT02203032|2659539|P3|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19
813805|NCT02203032|2659540|P2|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8
813806|NCT02203032|2659541|P1|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0
813807|NCT02203032|2659538|P4|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8
813808|NCT02203032|2659539|P3|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3
813809|NCT02203032|2659540|P2|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2
813810|NCT02203032|2659541|P1|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0
813811|NCT02203032|2659538|P4|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
813812|NCT02203032|2659539|P3|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
813813|NCT02203032|2659540|P2|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
813814|NCT02203032|2659541|P1|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1
813815|NCT02203032|2659538|P4|Open Label Run-in (Week 0 to Week 16)|Other|0
813816|NCT02203032|2659539|P3|Open Label Run-in (Week 0 to Week 16)|Other|0
813817|NCT02203032|2659540|P2|Open Label Run-in (Week 0 to Week 16)|Other|0
813818|NCT02203032|2659541|P1|Open Label Run-in (Week 0 to Week 16)|Other|2
813819|NCT02203032|2659538|P4|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
813820|NCT02203032|2659539|P3|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
813821|NCT02203032|2659540|P2|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
813822|NCT02203032|2659541|P1|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4
813823|NCT02203032|2659538|P4|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
813824|NCT02203032|2659539|P3|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
813825|NCT02203032|2659540|P2|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
813826|NCT02203032|2659541|P1|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6
813827|NCT02203032|2659538|P4|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
813828|NCT02203032|2659539|P3|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
813829|NCT02203032|2659540|P2|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
813830|NCT02203032|2659541|P1|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3
813831|NCT02203032|2659538|P4|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
813832|NCT02203032|2659539|P3|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
813833|NCT02203032|2659540|P2|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
813834|NCT02203032|2659541|P1|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1
813835|NCT02203032|2659538|P4|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
813836|NCT02203032|2659539|P3|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
813837|NCT02203032|2659540|P2|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
813838|NCT02203032|2659541|P1|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2
813839|NCT02202980|2659569|P14|Overall Study|Withdrew Consent|0
813840|NCT02202980|2659570|P13|Overall Study|Withdrew Consent|0
813841|NCT02202980|2659571|P12|Overall Study|Withdrew Consent|0
813842|NCT02202980|2659572|P11|Overall Study|Withdrew Consent|0
813843|NCT02202980|2659573|P10|Overall Study|Withdrew Consent|0
813844|NCT02202980|2659574|P9|Overall Study|Withdrew Consent|1
813845|NCT02202980|2659575|P8|Overall Study|Withdrew Consent|0
813846|NCT02202980|2659576|P7|Overall Study|Withdrew Consent|0
813847|NCT02202980|2659577|P6|Overall Study|Withdrew Consent|0
813848|NCT02202980|2659578|P5|Overall Study|Withdrew Consent|0
813849|NCT02202980|2659579|P4|Overall Study|Withdrew Consent|0
813850|NCT02202980|2659580|P3|Overall Study|Withdrew Consent|2
813851|NCT02202980|2659581|P2|Overall Study|Withdrew Consent|1
813852|NCT02202980|2659582|P1|Overall Study|Withdrew Consent|0
813853|NCT02202980|2659569|P14|Overall Study|Lost to Follow-up|0
813854|NCT02202980|2659570|P13|Overall Study|Lost to Follow-up|1
813855|NCT02202980|2659571|P12|Overall Study|Lost to Follow-up|0
813856|NCT02202980|2659572|P11|Overall Study|Lost to Follow-up|0
813857|NCT02202980|2659573|P10|Overall Study|Lost to Follow-up|0
813858|NCT02202980|2659574|P9|Overall Study|Lost to Follow-up|1
813859|NCT02202980|2659575|P8|Overall Study|Lost to Follow-up|1
813860|NCT02202980|2659576|P7|Overall Study|Lost to Follow-up|0
813861|NCT02202980|2659577|P6|Overall Study|Lost to Follow-up|0
813862|NCT02202980|2659578|P5|Overall Study|Lost to Follow-up|0
813863|NCT02202980|2659579|P4|Overall Study|Lost to Follow-up|1
813864|NCT02202980|2659580|P3|Overall Study|Lost to Follow-up|1
813865|NCT02202980|2659581|P2|Overall Study|Lost to Follow-up|1
813866|NCT02202980|2659582|P1|Overall Study|Lost to Follow-up|0
813867|NCT02202980|2659569|P14|Overall Study|Protocol Violation|0
813868|NCT02202980|2659570|P13|Overall Study|Protocol Violation|0
813869|NCT02202980|2659571|P12|Overall Study|Protocol Violation|0
813870|NCT02202980|2659572|P11|Overall Study|Protocol Violation|0
813871|NCT02202980|2659573|P10|Overall Study|Protocol Violation|0
813872|NCT02202980|2659574|P9|Overall Study|Protocol Violation|0
813873|NCT02202980|2659575|P8|Overall Study|Protocol Violation|0
813874|NCT02202980|2659576|P7|Overall Study|Protocol Violation|0
813875|NCT02202980|2659577|P6|Overall Study|Protocol Violation|0
813876|NCT02202980|2659578|P5|Overall Study|Protocol Violation|3
813877|NCT02202980|2659579|P4|Overall Study|Protocol Violation|3
813878|NCT02202980|2659580|P3|Overall Study|Protocol Violation|0
813879|NCT02202980|2659581|P2|Overall Study|Protocol Violation|0
813880|NCT02202980|2659582|P1|Overall Study|Protocol Violation|0
813881|NCT02202980|2659569|P14|Overall Study|Lack of Efficacy|0
813882|NCT02202980|2659570|P13|Overall Study|Lack of Efficacy|10
813883|NCT02202980|2659571|P12|Overall Study|Lack of Efficacy|3
813884|NCT02202980|2659572|P11|Overall Study|Lack of Efficacy|0
813885|NCT02202980|2659573|P10|Overall Study|Lack of Efficacy|0
813886|NCT02202980|2659574|P9|Overall Study|Lack of Efficacy|2
813887|NCT02202980|2659575|P8|Overall Study|Lack of Efficacy|2
813888|NCT02202980|2659576|P7|Overall Study|Lack of Efficacy|11
813889|NCT02202980|2659577|P6|Overall Study|Lack of Efficacy|1
813890|NCT02202980|2659578|P5|Overall Study|Lack of Efficacy|3
813891|NCT02202980|2659579|P4|Overall Study|Lack of Efficacy|0
813892|NCT02202980|2659580|P3|Overall Study|Lack of Efficacy|7
813893|NCT02202980|2659581|P2|Overall Study|Lack of Efficacy|0
813894|NCT02202980|2659582|P1|Overall Study|Lack of Efficacy|1
813895|NCT02202850|2659670|P2|Overall Study|Lost to Follow-up|1
813896|NCT02202850|2659671|P1|Overall Study|Lost to Follow-up|7
813897|NCT02202850|2659670|P2|Overall Study|Enbrel treatment discontinued|3
813898|NCT02202850|2659671|P1|Overall Study|Enbrel treatment discontinued|15
813899|NCT02202850|2659670|P2|Overall Study|Other|2
813900|NCT02202850|2659671|P1|Overall Study|Other|2
813901|NCT02202785|2659724|P3|Overall Study|Reason not Specified|13
813902|NCT02202785|2659725|P2|Overall Study|Reason not Specified|7
813903|NCT02202785|2659726|P1|Overall Study|Reason not Specified|10
813904|NCT02202785|2659724|P3|Overall Study|Lost to Follow-up|0
813905|NCT02202785|2659725|P2|Overall Study|Lost to Follow-up|1
813906|NCT02202785|2659726|P1|Overall Study|Lost to Follow-up|0
813907|NCT02202785|2659724|P3|Overall Study|Withdrawal by Subject|0
813908|NCT02202785|2659725|P2|Overall Study|Withdrawal by Subject|1
813909|NCT02202785|2659726|P1|Overall Study|Withdrawal by Subject|0
813910|NCT02202785|2659724|P3|Overall Study|Study Terminated by Sponsor|4
813911|NCT02202785|2659725|P2|Overall Study|Study Terminated by Sponsor|6
813912|NCT02202785|2659726|P1|Overall Study|Study Terminated by Sponsor|1
813913|NCT02202759|2659763|P3|Overall Study|Reason not Specified|10
813914|NCT02202759|2659764|P2|Overall Study|Reason not Specified|11
813915|NCT02202759|2659765|P1|Overall Study|Reason not Specified|4
813916|NCT02202759|2659763|P3|Overall Study|Withdrawal by Subject|1
813917|NCT02202759|2659764|P2|Overall Study|Withdrawal by Subject|1
813918|NCT02202759|2659765|P1|Overall Study|Withdrawal by Subject|2
813919|NCT02202759|2659763|P3|Overall Study|Study Terminated by Sponsor|3
813920|NCT02202759|2659764|P2|Overall Study|Study Terminated by Sponsor|3
813921|NCT02202759|2659765|P1|Overall Study|Study Terminated by Sponsor|3
813922|NCT02202538|2659799|P1|Overall Study|Investigator Decision|1
813923|NCT02202538|2659799|P1|Overall Study|Did not meet all inclusion criteria|2
813924|NCT02202538|2659799|P1|Overall Study|Withdrawal by Subject|5
813925|NCT02202317|2659810|P1|Overall Study|Lost to Follow-up|1
813926|NCT02202161|2659837|P8|Overall Study|Withdrawal by Subject|0
813927|NCT02202161|2659838|P7|Overall Study|Withdrawal by Subject|0
813928|NCT02202161|2659839|P6|Overall Study|Withdrawal by Subject|0
813929|NCT02202161|2659840|P5|Overall Study|Withdrawal by Subject|1
813930|NCT02202161|2659841|P4|Overall Study|Withdrawal by Subject|0
813931|NCT02202161|2659842|P3|Overall Study|Withdrawal by Subject|0
813932|NCT02202161|2659843|P2|Overall Study|Withdrawal by Subject|0
813933|NCT02202161|2659844|P1|Overall Study|Withdrawal by Subject|0
813934|NCT02202161|2659837|P8|Overall Study|Physician Decision|3
813935|NCT02202161|2659838|P7|Overall Study|Physician Decision|0
813936|NCT02202161|2659839|P6|Overall Study|Physician Decision|0
813937|NCT02202161|2659840|P5|Overall Study|Physician Decision|0
813938|NCT02202161|2659841|P4|Overall Study|Physician Decision|0
813939|NCT02202161|2659842|P3|Overall Study|Physician Decision|0
813940|NCT02202161|2659843|P2|Overall Study|Physician Decision|0
813941|NCT02202161|2659844|P1|Overall Study|Physician Decision|0
813942|NCT02202161|2659837|P8|Overall Study|Did not meet continuation criteria|3
813943|NCT02202161|2659838|P7|Overall Study|Did not meet continuation criteria|0
813944|NCT02202161|2659839|P6|Overall Study|Did not meet continuation criteria|0
813945|NCT02202161|2659840|P5|Overall Study|Did not meet continuation criteria|0
813946|NCT02202161|2659841|P4|Overall Study|Did not meet continuation criteria|0
813947|NCT02202161|2659842|P3|Overall Study|Did not meet continuation criteria|0
813948|NCT02202161|2659843|P2|Overall Study|Did not meet continuation criteria|0
813949|NCT02202161|2659844|P1|Overall Study|Did not meet continuation criteria|0
813950|NCT02202161|2659837|P8|Overall Study|Adverse Event|0
813951|NCT02202161|2659838|P7|Overall Study|Adverse Event|0
813952|NCT02202161|2659839|P6|Overall Study|Adverse Event|1
813953|NCT02202161|2659840|P5|Overall Study|Adverse Event|0
813954|NCT02202161|2659841|P4|Overall Study|Adverse Event|0
813955|NCT02202161|2659842|P3|Overall Study|Adverse Event|0
813956|NCT02202161|2659843|P2|Overall Study|Adverse Event|1
813957|NCT02202161|2659844|P1|Overall Study|Adverse Event|1
813958|NCT02201953|2660004|P2|Overall Study|Death|3
813959|NCT02201953|2660005|P1|Overall Study|Death|0
813960|NCT02201953|2660004|P2|Overall Study|Adverse Event|5
813961|NCT02201953|2660005|P1|Overall Study|Adverse Event|0
813962|NCT02201953|2660004|P2|Overall Study|Withdrew Consent|5
813963|NCT02201953|2660005|P1|Overall Study|Withdrew Consent|2
813964|NCT02201953|2660004|P2|Overall Study|Lost to Follow-up|8
813965|NCT02201953|2660005|P1|Overall Study|Lost to Follow-up|8
813966|NCT02201953|2660004|P2|Overall Study|Lack of Efficacy|30
813967|NCT02201953|2660005|P1|Overall Study|Lack of Efficacy|9
813968|NCT02201953|2660004|P2|Overall Study|Randomized but Never Treated|5
813969|NCT02201953|2660005|P1|Overall Study|Randomized but Never Treated|1
813970|NCT02201940|2660023|P2|Overall Study|Adverse Event|1
813971|NCT02201940|2660024|P1|Overall Study|Adverse Event|0
813972|NCT02201940|2660023|P2|Overall Study|Death|0
813973|NCT02201940|2660024|P1|Overall Study|Death|1
813974|NCT02201940|2660023|P2|Overall Study|Investigator's Discretion|1
813975|NCT02201940|2660024|P1|Overall Study|Investigator's Discretion|1
813976|NCT02201940|2660023|P2|Overall Study|Withdrew Consent|1
813977|NCT02201940|2660024|P1|Overall Study|Withdrew Consent|2
813978|NCT02201940|2660023|P2|Overall Study|Lost to Follow-up|0
813979|NCT02201940|2660024|P1|Overall Study|Lost to Follow-up|5
813980|NCT02201940|2660023|P2|Overall Study|Lack of Efficacy|113
813981|NCT02201940|2660024|P1|Overall Study|Lack of Efficacy|2
813982|NCT02201940|2660023|P2|Overall Study|Randomized/Enrolled but Never Treated|0
813983|NCT02201940|2660024|P1|Overall Study|Randomized/Enrolled but Never Treated|1
813984|NCT02201901|2660043|P3|Overall Study|Adverse Event|0
813985|NCT02201901|2660044|P2|Overall Study|Adverse Event|1
813986|NCT02201901|2660045|P1|Overall Study|Adverse Event|1
813987|NCT02201901|2660043|P3|Overall Study|Withdrew Consent|2
813988|NCT02201901|2660044|P2|Overall Study|Withdrew Consent|0
813989|NCT02201901|2660045|P1|Overall Study|Withdrew Consent|2
813990|NCT02201901|2660043|P3|Overall Study|Lost to Follow-up|2
813991|NCT02201901|2660044|P2|Overall Study|Lost to Follow-up|3
813992|NCT02201901|2660045|P1|Overall Study|Lost to Follow-up|2
813993|NCT02201901|2660043|P3|Overall Study|Death|3
813994|NCT02201901|2660044|P2|Overall Study|Death|3
813995|NCT02201901|2660045|P1|Overall Study|Death|3
813996|NCT02201901|2660043|P3|Overall Study|Lack of Efficacy|6
813997|NCT02201901|2660044|P2|Overall Study|Lack of Efficacy|1
813998|NCT02201901|2660045|P1|Overall Study|Lack of Efficacy|7
813999|NCT02201901|2660043|P3|Overall Study|Randomized but never treated|0
814000|NCT02201901|2660044|P2|Overall Study|Randomized but never treated|1
814001|NCT02201901|2660045|P1|Overall Study|Randomized but never treated|0
814002|NCT02201784|2660076|P2|Overall Study|Failure to achieve adequate block|0
814003|NCT02201784|2660077|P1|Overall Study|Failure to achieve adequate block|2
814004|NCT02201524|2660095|P4|Overall Study|Other|0
814005|NCT02201524|2660096|P3|Overall Study|Other|0
814006|NCT02201524|2660097|P2|Overall Study|Other|1
814007|NCT02201524|2660098|P1|Overall Study|Other|1
814008|NCT02201524|2660095|P4|Overall Study|Withdrawal by Subject|1
814009|NCT02201524|2660096|P3|Overall Study|Withdrawal by Subject|1
814010|NCT02201524|2660097|P2|Overall Study|Withdrawal by Subject|0
814011|NCT02201524|2660098|P1|Overall Study|Withdrawal by Subject|0
814012|NCT02201524|2660095|P4|Overall Study|Protocol Violation|1
814013|NCT02201524|2660096|P3|Overall Study|Protocol Violation|0
814014|NCT02201524|2660097|P2|Overall Study|Protocol Violation|0
814015|NCT02201524|2660098|P1|Overall Study|Protocol Violation|0
814016|NCT02201524|2660095|P4|Overall Study|No longer meets eligibility criteria|2
814017|NCT02201524|2660096|P3|Overall Study|No longer meets eligibility criteria|0
814018|NCT02201524|2660097|P2|Overall Study|No longer meets eligibility criteria|0
814019|NCT02201524|2660098|P1|Overall Study|No longer meets eligibility criteria|0
814020|NCT02201524|2660095|P4|Overall Study|Lost to Follow-up|0
814021|NCT02201524|2660096|P3|Overall Study|Lost to Follow-up|2
814022|NCT02201524|2660097|P2|Overall Study|Lost to Follow-up|0
814023|NCT02201524|2660098|P1|Overall Study|Lost to Follow-up|0
814024|NCT02201524|2660095|P4|Overall Study|Insufficient clinical response|0
814025|NCT02201524|2660096|P3|Overall Study|Insufficient clinical response|0
814026|NCT02201524|2660097|P2|Overall Study|Insufficient clinical response|0
814027|NCT02201524|2660098|P1|Overall Study|Insufficient clinical response|1
814028|NCT02201524|2660095|P4|Overall Study|Adverse Event|0
814029|NCT02201524|2660096|P3|Overall Study|Adverse Event|1
814030|NCT02201524|2660097|P2|Overall Study|Adverse Event|2
814031|NCT02201524|2660098|P1|Overall Study|Adverse Event|0
814032|NCT02201329|2660223|P1|Overall Study|Withdrawal by Subject|2
814033|NCT02201329|2660223|P1|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3
814034|NCT02200510|2660317|P2|Overall Study|potential COI - joined study team|0
814035|NCT02200510|2660318|P1|Overall Study|potential COI - joined study team|1
814036|NCT02200510|2660317|P2|Overall Study|Lost to Follow-up|1
814037|NCT02200510|2660318|P1|Overall Study|Lost to Follow-up|7
814038|NCT02200510|2660317|P2|Overall Study|Protocol Violation|1
814039|NCT02200510|2660318|P1|Overall Study|Protocol Violation|0
814040|NCT02200510|2660317|P2|Overall Study|Death|1
814041|NCT02200510|2660318|P1|Overall Study|Death|1
814042|NCT02200211|2660343|P4|Overall Study|Withdrawal by Subject|0
814043|NCT02200211|2660344|P3|Overall Study|Withdrawal by Subject|0
814044|NCT02200211|2660345|P2|Overall Study|Withdrawal by Subject|0
814045|NCT02200211|2660346|P1|Overall Study|Withdrawal by Subject|1
814046|NCT02200211|2660343|P4|Overall Study|Lost to Follow-up|2
814047|NCT02200211|2660344|P3|Overall Study|Lost to Follow-up|1
814048|NCT02200211|2660345|P2|Overall Study|Lost to Follow-up|7
814049|NCT02200211|2660346|P1|Overall Study|Lost to Follow-up|7
814050|NCT02199795|2660459|P2|Overall Study|withdrew due to shoulder pain|0
814051|NCT02199795|2660460|P1|Overall Study|withdrew due to shoulder pain|1
814052|NCT02199795|2660459|P2|Overall Study|no longer met inclusion criteria|0
814053|NCT02199795|2660460|P1|Overall Study|no longer met inclusion criteria|1
814054|NCT02199509|2660501|P2|Overall Study|Misunderstood titration schedule|0
814055|NCT02199509|2660502|P1|Overall Study|Misunderstood titration schedule|1
814056|NCT02199509|2660501|P2|Overall Study|Suicidal Ideation|1
814057|NCT02199509|2660502|P1|Overall Study|Suicidal Ideation|0
814058|NCT02198963|2660527|P1|Overall Study|Withdrawal by Subject|6
814059|NCT02198963|2660527|P1|Overall Study|Adverse Event|1
814060|NCT02198235|2660569|P3|Overall Study|Lost to Follow-up|2
814061|NCT02198235|2660570|P2|Overall Study|Lost to Follow-up|2
814062|NCT02198235|2660571|P1|Overall Study|Lost to Follow-up|3
814063|NCT02198040|2660591|P3|Overall Study|Withdrawal by Subject|1
814064|NCT02198040|2660592|P2|Overall Study|Withdrawal by Subject|0
814065|NCT02198040|2660593|P1|Overall Study|Withdrawal by Subject|0
814066|NCT02198040|2660591|P3|Overall Study|Work reasons|0
814067|NCT02198040|2660592|P2|Overall Study|Work reasons|1
814068|NCT02198040|2660593|P1|Overall Study|Work reasons|0
814069|NCT02197806|2660623|P4|Overall Study|Adverse Event|1
814070|NCT02197806|2660624|P3|Overall Study|Adverse Event|0
814071|NCT02197806|2660625|P2|Overall Study|Adverse Event|1
814072|NCT02197806|2660626|P1|Overall Study|Adverse Event|0
814073|NCT02197520|2660636|P2|Period 2|Withdrawal by Subject|0
814074|NCT02197520|2660637|P1|Period 2|Withdrawal by Subject|1
814075|NCT02197520|2660636|P2|Period 2|Adverse Event|2
814076|NCT02197520|2660637|P1|Period 2|Adverse Event|0
814077|NCT02197520|2660636|P2|Period 1|Withdrawal by Subject|0
814078|NCT02197520|2660637|P1|Period 1|Withdrawal by Subject|1
814079|NCT02197377|2660683|P2|Overall Study|Insertion Failure|3
814080|NCT02197377|2660684|P1|Overall Study|Insertion Failure|0
814081|NCT02197247|2660705|P1|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9
814082|NCT02197247|2660705|P1|Part B: Day 78 to End Part B (AZD9291)|Death|1
814083|NCT02197247|2660705|P1|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1
814084|NCT02197247|2660705|P1|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2
814085|NCT02197247|2660705|P1|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2
814086|NCT02197247|2660705|P1|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5
814087|NCT02197247|2660705|P1|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2
814088|NCT02197247|2660705|P1|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2
814089|NCT02197234|2660750|P1|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22
814090|NCT02197234|2660750|P1|Part B: Day 33 to End Part B (AZD9291)|Death|6
814091|NCT02197234|2660750|P1|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1
814092|NCT02197234|2660750|P1|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1
814093|NCT02197234|2660750|P1|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1
814094|NCT02197234|2660750|P1|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1
814095|NCT02197234|2660750|P1|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1
814096|NCT02197130|2660772|P3|Overall Study|Other|3
814097|NCT02197130|2660773|P2|Overall Study|Other|0
814098|NCT02197130|2660774|P1|Overall Study|Other|1
814099|NCT02197130|2660772|P3|Overall Study|Withdrawal by Subject|4
814100|NCT02197130|2660773|P2|Overall Study|Withdrawal by Subject|3
814101|NCT02197130|2660774|P1|Overall Study|Withdrawal by Subject|0
814102|NCT02197130|2660772|P3|Overall Study|Does not meet entrance criteria|1
814103|NCT02197130|2660773|P2|Overall Study|Does not meet entrance criteria|0
814104|NCT02197130|2660774|P1|Overall Study|Does not meet entrance criteria|0
814105|NCT02197130|2660772|P3|Overall Study|Lost to Follow-up|1
814106|NCT02197130|2660773|P2|Overall Study|Lost to Follow-up|0
814107|NCT02197130|2660774|P1|Overall Study|Lost to Follow-up|2
814108|NCT02197130|2660772|P3|Overall Study|Death|0
814109|NCT02197130|2660773|P2|Overall Study|Death|1
814110|NCT02197130|2660774|P1|Overall Study|Death|0
814111|NCT02197130|2660772|P3|Overall Study|Adverse Event|23
814112|NCT02197130|2660773|P2|Overall Study|Adverse Event|4
814113|NCT02197130|2660774|P1|Overall Study|Adverse Event|13
814114|NCT02196714|2660866|P4|Overall Study|Protocol Violation|0
814115|NCT02196714|2660867|P3|Overall Study|Protocol Violation|1
814116|NCT02196714|2660868|P2|Overall Study|Protocol Violation|0
814117|NCT02196714|2660869|P1|Overall Study|Protocol Violation|0
814118|NCT02196701|2660991|P1|Overall Study|Non-adherence to Protocol|1
814119|NCT02196701|2660991|P1|Overall Study|Lost to Follow-up|1
814120|NCT02196701|2660991|P1|Overall Study|Adverse Event|1
814121|NCT02196675|2661050|P3|Overall Study|Death|1
814122|NCT02196675|2661051|P2|Overall Study|Death|0
814123|NCT02196675|2661052|P1|Overall Study|Death|0
814124|NCT02196675|2661050|P3|Overall Study|Protocol Violation|0
814125|NCT02196675|2661051|P2|Overall Study|Protocol Violation|1
814126|NCT02196675|2661052|P1|Overall Study|Protocol Violation|0
814127|NCT02196675|2661050|P3|Overall Study|Intra-operative surgical exclusion|0
814128|NCT02196675|2661051|P2|Overall Study|Intra-operative surgical exclusion|1
814129|NCT02196675|2661052|P1|Overall Study|Intra-operative surgical exclusion|1
814130|NCT02196675|2661050|P3|Overall Study|Withdrawal by Subject|0
814131|NCT02196675|2661051|P2|Overall Study|Withdrawal by Subject|0
814132|NCT02196675|2661052|P1|Overall Study|Withdrawal by Subject|1
814133|NCT02196506|2661074|P4|Phase A+|Participant withdrawn by investigator|1
814134|NCT02196506|2661075|P3|Phase A+|Participant withdrawn by investigator|0
814135|NCT02196506|2661076|P2|Phase A+|Participant withdrawn by investigator|0
814136|NCT02196506|2661077|P1|Phase A+|Participant withdrawn by investigator|0
814137|NCT02196506|2661074|P4|Phase A+|Lost to Follow-up|6
814138|NCT02196506|2661075|P3|Phase A+|Lost to Follow-up|0
814139|NCT02196506|2661076|P2|Phase A+|Lost to Follow-up|0
814140|NCT02196506|2661077|P1|Phase A+|Lost to Follow-up|0
814141|NCT02196506|2661074|P4|Phase A+|Adverse Event|1
814142|NCT02196506|2661075|P3|Phase A+|Adverse Event|0
814143|NCT02196506|2661076|P2|Phase A+|Adverse Event|0
814144|NCT02196506|2661077|P1|Phase A+|Adverse Event|0
814145|NCT02196506|2661074|P4|Phase A+|Withdrawal by Participant|5
814146|NCT02196506|2661075|P3|Phase A+|Withdrawal by Participant|0
814147|NCT02196506|2661076|P2|Phase A+|Withdrawal by Participant|0
814148|NCT02196506|2661077|P1|Phase A+|Withdrawal by Participant|0
814149|NCT02196506|2661074|P4|Phase A+|Participant Met Withdrawal Criteria|1
814150|NCT02196506|2661075|P3|Phase A+|Participant Met Withdrawal Criteria|0
814151|NCT02196506|2661076|P2|Phase A+|Participant Met Withdrawal Criteria|0
814152|NCT02196506|2661077|P1|Phase A+|Participant Met Withdrawal Criteria|0
814153|NCT02196506|2661074|P4|Phase B|Lost to Follow-up|0
814154|NCT02196506|2661075|P3|Phase B|Lost to Follow-up|1
814155|NCT02196506|2661076|P2|Phase B|Lost to Follow-up|2
814156|NCT02196506|2661077|P1|Phase B|Lost to Follow-up|0
814157|NCT02196506|2661074|P4|Phase B|Adverse Event|0
814158|NCT02196506|2661075|P3|Phase B|Adverse Event|1
814159|NCT02196506|2661076|P2|Phase B|Adverse Event|4
814160|NCT02196506|2661077|P1|Phase B|Adverse Event|0
814161|NCT02196506|2661074|P4|Phase B|Withdrawal by Participant|0
814162|NCT02196506|2661075|P3|Phase B|Withdrawal by Participant|1
814163|NCT02196506|2661076|P2|Phase B|Withdrawal by Participant|8
814164|NCT02196506|2661077|P1|Phase B|Withdrawal by Participant|0
814165|NCT02196506|2661074|P4|Phase B|Lack of Efficacy|0
814166|NCT02196506|2661075|P3|Phase B|Lack of Efficacy|2
814167|NCT02196506|2661076|P2|Phase B|Lack of Efficacy|1
814168|NCT02196506|2661077|P1|Phase B|Lack of Efficacy|0
814169|NCT02196506|2661074|P4|Phase B|Participant Met Withdrawal Criteria|0
814170|NCT02196506|2661075|P3|Phase B|Participant Met Withdrawal Criteria|1
814171|NCT02196506|2661076|P2|Phase B|Participant Met Withdrawal Criteria|0
814172|NCT02196506|2661077|P1|Phase B|Participant Met Withdrawal Criteria|0
814173|NCT02196506|2661074|P4|Phase A|Participant withdrawn by investigator|0
814174|NCT02196506|2661075|P3|Phase A|Participant withdrawn by investigator|0
814175|NCT02196506|2661076|P2|Phase A|Participant withdrawn by investigator|0
814176|NCT02196506|2661077|P1|Phase A|Participant withdrawn by investigator|10
814177|NCT02196506|2661074|P4|Phase A|Protocol deviation|0
814178|NCT02196506|2661075|P3|Phase A|Protocol deviation|0
814179|NCT02196506|2661076|P2|Phase A|Protocol deviation|0
814180|NCT02196506|2661077|P1|Phase A|Protocol deviation|12
814181|NCT02196506|2661074|P4|Phase A|Lost to Follow-up|0
814182|NCT02196506|2661075|P3|Phase A|Lost to Follow-up|0
814183|NCT02196506|2661076|P2|Phase A|Lost to Follow-up|0
814184|NCT02196506|2661077|P1|Phase A|Lost to Follow-up|9
814185|NCT02196506|2661074|P4|Phase A|Adverse Event|0
814186|NCT02196506|2661075|P3|Phase A|Adverse Event|0
814187|NCT02196506|2661076|P2|Phase A|Adverse Event|0
814188|NCT02196506|2661077|P1|Phase A|Adverse Event|22
814189|NCT02196506|2661074|P4|Phase A|Withdrawal by Subject|0
814190|NCT02196506|2661075|P3|Phase A|Withdrawal by Subject|0
814191|NCT02196506|2661076|P2|Phase A|Withdrawal by Subject|0
814192|NCT02196506|2661077|P1|Phase A|Withdrawal by Subject|34
814193|NCT02196506|2661074|P4|Phase A|Participant Met Withdrawal Criteria|0
814194|NCT02196506|2661075|P3|Phase A|Participant Met Withdrawal Criteria|0
814195|NCT02196506|2661076|P2|Phase A|Participant Met Withdrawal Criteria|0
814196|NCT02196506|2661077|P1|Phase A|Participant Met Withdrawal Criteria|34
814197|NCT02196259|2661092|P3|Overall Study|Partial data analysis|0
814198|NCT02196259|2661093|P2|Overall Study|Partial data analysis|3
814199|NCT02196259|2661094|P1|Overall Study|Partial data analysis|0
814200|NCT02196259|2661092|P3|Overall Study|Researcher choice|1
814201|NCT02196259|2661093|P2|Overall Study|Researcher choice|0
814202|NCT02196259|2661094|P1|Overall Study|Researcher choice|0
814203|NCT02196077|2661122|P1|Overall Study|Protocol Violation|24
814204|NCT02196077|2661122|P1|Overall Study|Lost to Follow-up|3
814205|NCT02196077|2661122|P1|Overall Study|Physician Decision|1
814206|NCT02196077|2661122|P1|Overall Study|Withdrawal by Subject|14
814207|NCT02196077|2661122|P1|Overall Study|Lack of Efficacy|1
814208|NCT02196077|2661122|P1|Overall Study|Adverse Event|4
814209|NCT02195986|2661172|P3|Overall Study|Non-compliance|0
814210|NCT02195986|2661173|P2|Overall Study|Non-compliance|1
814211|NCT02195986|2661174|P1|Overall Study|Non-compliance|0
814212|NCT02195986|2661172|P3|Overall Study|Protocol Violation|1
814213|NCT02195986|2661173|P2|Overall Study|Protocol Violation|1
814214|NCT02195986|2661174|P1|Overall Study|Protocol Violation|0
814215|NCT02195986|2661172|P3|Overall Study|Family Emergency|1
814216|NCT02195986|2661173|P2|Overall Study|Family Emergency|0
814217|NCT02195986|2661174|P1|Overall Study|Family Emergency|0
814218|NCT02195986|2661172|P3|Overall Study|Withdrawal by Subject|0
814219|NCT02195986|2661173|P2|Overall Study|Withdrawal by Subject|3
814220|NCT02195986|2661174|P1|Overall Study|Withdrawal by Subject|0
814221|NCT02195986|2661172|P3|Overall Study|Adverse Event|0
814222|NCT02195986|2661173|P2|Overall Study|Adverse Event|0
814223|NCT02195986|2661174|P1|Overall Study|Adverse Event|3
814224|NCT02195700|2661208|P2|Overall Study|Lost to Follow-up|1
814225|NCT02195700|2661209|P1|Overall Study|Lost to Follow-up|1
814226|NCT02195700|2661208|P2|Overall Study|Withdrawal by Subject|2
814227|NCT02195700|2661209|P1|Overall Study|Withdrawal by Subject|3
814228|NCT02195700|2661208|P2|Overall Study|Adverse Event|2
814229|NCT02195700|2661209|P1|Overall Study|Adverse Event|1
814230|NCT02195700|2661208|P2|Overall Study|Noncompliance|0
814231|NCT02195700|2661209|P1|Overall Study|Noncompliance|1
814232|NCT02195700|2661208|P2|Overall Study|Protocol Violation|2
814233|NCT02195700|2661209|P1|Overall Study|Protocol Violation|0
814234|NCT02195687|2661231|P2|Overall Study|Lost to Follow-up|1
814235|NCT02195687|2661232|P1|Overall Study|Lost to Follow-up|4
814236|NCT02195687|2661231|P2|Overall Study|Personal Reasons|1
814237|NCT02195687|2661232|P1|Overall Study|Personal Reasons|1
814238|NCT02195583|2661248|P1|Overall Study|Other Reason|2
814239|NCT02195583|2661248|P1|Overall Study|Adverse Event|2
814240|NCT02195583|2661248|P1|Overall Study|Withdrawal by Subject|4
814241|NCT02195583|2661248|P1|Overall Study|Lost to Follow-up|1
814242|NCT02195427|2661282|P2|Overall Study|Conditional re-treatment at W52|1
814243|NCT02195427|2661283|P1|Overall Study|Conditional re-treatment at W52|2
814244|NCT02195427|2661282|P2|Overall Study|Protocol Violation|14
814245|NCT02195427|2661283|P1|Overall Study|Protocol Violation|7
814246|NCT02195427|2661282|P2|Overall Study|Lost to Follow-up|1
814247|NCT02195427|2661283|P1|Overall Study|Lost to Follow-up|0
814248|NCT02195427|2661282|P2|Overall Study|Withdrawal by Subject|2
814249|NCT02195427|2661283|P1|Overall Study|Withdrawal by Subject|4
814250|NCT02195427|2661282|P2|Overall Study|Did not consent to study extension|9
814251|NCT02195427|2661283|P1|Overall Study|Did not consent to study extension|13
814252|NCT02195011|2661354|P2|Overall Study|Withdrawal by Subject|0
814253|NCT02195011|2661355|P1|Overall Study|Withdrawal by Subject|3
814254|NCT02195011|2661354|P2|Overall Study|Progressive Disease|1
814255|NCT02195011|2661355|P1|Overall Study|Progressive Disease|18
814256|NCT02195011|2661354|P2|Overall Study|Adverse Event|0
814257|NCT02195011|2661355|P1|Overall Study|Adverse Event|4
814258|NCT02194933|2661369|P2|Overall Study|Lack of Efficacy|2
814259|NCT02194933|2661370|P1|Overall Study|Lack of Efficacy|1
814260|NCT02194933|2661369|P2|Overall Study|Withdrawal by Subject|2
814261|NCT02194933|2661370|P1|Overall Study|Withdrawal by Subject|0
814262|NCT02194933|2661369|P2|Overall Study|Participant met withdrawal criteria|3
814263|NCT02194933|2661370|P1|Overall Study|Participant met withdrawal criteria|1
814264|NCT02194933|2661369|P2|Overall Study|Lost to Follow-up|2
814265|NCT02194933|2661370|P1|Overall Study|Lost to Follow-up|1
814266|NCT02194699|2661424|P2|With Potential to Receive 52 Weeks of IP|Other|16
814267|NCT02194699|2661425|P1|With Potential to Receive 52 Weeks of IP|Other|24
814268|NCT02194699|2661424|P2|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20
814269|NCT02194699|2661425|P1|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14
814270|NCT02194699|2661424|P2|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
814271|NCT02194699|2661425|P1|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
814272|NCT02194699|2661424|P2|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8
814273|NCT02194699|2661425|P1|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5
814274|NCT02194699|2661424|P2|With Potential to Receive 52 Weeks of IP|Death|3
814275|NCT02194699|2661425|P1|With Potential to Receive 52 Weeks of IP|Death|1
814276|NCT02194699|2661424|P2|With Potential to Receive 52 Weeks of IP|Adverse Event|3
814277|NCT02194699|2661425|P1|With Potential to Receive 52 Weeks of IP|Adverse Event|4
814278|NCT02194699|2661424|P2|Randomised|Duplicate patient|1
814279|NCT02194699|2661425|P1|Randomised|Duplicate patient|2
814280|NCT02194699|2661424|P2|Randomised|Without potential for 52 weeks of IP|5
814281|NCT02194699|2661425|P1|Randomised|Without potential for 52 weeks of IP|5
814282|NCT02194699|2661424|P2|Randomised|Did not receive treatment|5
814283|NCT02194699|2661425|P1|Randomised|Did not receive treatment|1
814284|NCT02194621|2661533|P3|Overall Study|Withdrawal by Subject|7
814285|NCT02194621|2661534|P2|Overall Study|Withdrawal by Subject|4
814286|NCT02194621|2661535|P1|Overall Study|Withdrawal by Subject|4
814287|NCT02194621|2661533|P3|Overall Study|6 withdrew prior to randomization|2
814288|NCT02194621|2661534|P2|Overall Study|6 withdrew prior to randomization|2
814289|NCT02194621|2661535|P1|Overall Study|6 withdrew prior to randomization|2
814290|NCT02194062|2661568|P3|Overall Study|Lost to Follow-up|5
814291|NCT02194062|2661569|P2|Overall Study|Lost to Follow-up|2
814292|NCT02194062|2661570|P1|Overall Study|Lost to Follow-up|2
814293|NCT02193828|2661585|P4|Overall Study|Withdrawal by Subject|1
814294|NCT02193828|2661586|P3|Overall Study|Withdrawal by Subject|1
814295|NCT02193828|2661587|P2|Overall Study|Withdrawal by Subject|0
814296|NCT02193828|2661588|P1|Overall Study|Withdrawal by Subject|0
814297|NCT02193178|2661661|P1|Overall Study|Dry eyes|1
814298|NCT02193178|2661661|P1|Overall Study|Lost to Follow-up|1
814299|NCT02193165|2661711|P3|6 Week Product Use|Lost to Follow-up|0
814300|NCT02193165|2661712|P2|6 Week Product Use|Lost to Follow-up|1
814301|NCT02193165|2661713|P1|6 Week Product Use|Lost to Follow-up|0
814302|NCT02193165|2661711|P3|4 Week Product Use|Lost to Follow-up|1
814303|NCT02193165|2661712|P2|4 Week Product Use|Lost to Follow-up|1
814304|NCT02193165|2661713|P1|4 Week Product Use|Lost to Follow-up|1
814305|NCT02193087|2661740|P4|Overall Study|Did Not Receive Any Vaccination|1
814306|NCT02193087|2661741|P3|Overall Study|Did Not Receive Any Vaccination|0
814307|NCT02193087|2661742|P2|Overall Study|Did Not Receive Any Vaccination|3
814308|NCT02193087|2661743|P1|Overall Study|Did Not Receive Any Vaccination|2
814309|NCT02193087|2661740|P4|Overall Study|Other Reason Not Specified|9
814310|NCT02193087|2661741|P3|Overall Study|Other Reason Not Specified|1
814311|NCT02193087|2661742|P2|Overall Study|Other Reason Not Specified|2
814312|NCT02193087|2661743|P1|Overall Study|Other Reason Not Specified|7
814313|NCT02193087|2661740|P4|Overall Study|Withdrawal by Subject|19
814314|NCT02193087|2661741|P3|Overall Study|Withdrawal by Subject|1
814315|NCT02193087|2661742|P2|Overall Study|Withdrawal by Subject|3
814316|NCT02193087|2661743|P1|Overall Study|Withdrawal by Subject|10
814317|NCT02193087|2661740|P4|Overall Study|Protocol Violation|2
814318|NCT02193087|2661741|P3|Overall Study|Protocol Violation|1
814319|NCT02193087|2661742|P2|Overall Study|Protocol Violation|0
814320|NCT02193087|2661743|P1|Overall Study|Protocol Violation|2
814321|NCT02193087|2661740|P4|Overall Study|Lost to Follow-up|37
814322|NCT02193087|2661741|P3|Overall Study|Lost to Follow-up|4
814323|NCT02193087|2661742|P2|Overall Study|Lost to Follow-up|6
814324|NCT02193087|2661743|P1|Overall Study|Lost to Follow-up|14
814325|NCT02193087|2661740|P4|Overall Study|Adverse Event|11
814326|NCT02193087|2661741|P3|Overall Study|Adverse Event|0
814327|NCT02193087|2661742|P2|Overall Study|Adverse Event|0
814328|NCT02193087|2661743|P1|Overall Study|Adverse Event|2
814329|NCT02193074|2661788|P2|Overall Study|Adverse Event|13
814330|NCT02193074|2661789|P1|Overall Study|Adverse Event|16
814331|NCT02193074|2661788|P2|Overall Study|Withdrawal by Subject|2
814332|NCT02193074|2661789|P1|Overall Study|Withdrawal by Subject|1
814333|NCT02192905|2661821|P1|Overall Study|Lost to Follow-up|1
814334|NCT02192606|2661885|P2|Overall Study|3D equipment rep unable to join|1
814335|NCT02192606|2661886|P1|Overall Study|3D equipment rep unable to join|0
814336|NCT02192606|2661885|P2|Overall Study|Physician Decision|2
814337|NCT02192606|2661886|P1|Overall Study|Physician Decision|1
814338|NCT02192606|2661885|P2|Overall Study|surgery type was changed|1
814339|NCT02192606|2661886|P1|Overall Study|surgery type was changed|1
814340|NCT02192190|2661923|P6|Overall Study|Inadequate Pain Relief|0
814341|NCT02192190|2661924|P5|Overall Study|Inadequate Pain Relief|0
814342|NCT02192190|2661925|P4|Overall Study|Inadequate Pain Relief|0
814343|NCT02192190|2661926|P3|Overall Study|Inadequate Pain Relief|1
814344|NCT02192190|2661927|P2|Overall Study|Inadequate Pain Relief|1
814345|NCT02192190|2661928|P1|Overall Study|Inadequate Pain Relief|0
814346|NCT02192190|2661923|P6|Overall Study|Positive Drug Screen|0
814347|NCT02192190|2661924|P5|Overall Study|Positive Drug Screen|0
814348|NCT02192190|2661925|P4|Overall Study|Positive Drug Screen|1
814349|NCT02192190|2661926|P3|Overall Study|Positive Drug Screen|0
814350|NCT02192190|2661927|P2|Overall Study|Positive Drug Screen|0
814351|NCT02192190|2661928|P1|Overall Study|Positive Drug Screen|0
814352|NCT02192190|2661923|P6|Overall Study|Could not Keep Visit Schedule|0
814353|NCT02192190|2661924|P5|Overall Study|Could not Keep Visit Schedule|0
814354|NCT02192190|2661925|P4|Overall Study|Could not Keep Visit Schedule|0
814355|NCT02192190|2661926|P3|Overall Study|Could not Keep Visit Schedule|0
814356|NCT02192190|2661927|P2|Overall Study|Could not Keep Visit Schedule|0
814357|NCT02192190|2661928|P1|Overall Study|Could not Keep Visit Schedule|1
814358|NCT02192190|2661923|P6|Overall Study|Withdrawal by Subject|3
814359|NCT02192190|2661924|P5|Overall Study|Withdrawal by Subject|5
814360|NCT02192190|2661925|P4|Overall Study|Withdrawal by Subject|1
814361|NCT02192190|2661926|P3|Overall Study|Withdrawal by Subject|2
814362|NCT02192190|2661927|P2|Overall Study|Withdrawal by Subject|1
814363|NCT02192190|2661928|P1|Overall Study|Withdrawal by Subject|4
814364|NCT02192190|2661923|P6|Overall Study|Terminated by Sponsor|23
814365|NCT02192190|2661924|P5|Overall Study|Terminated by Sponsor|21
814366|NCT02192190|2661925|P4|Overall Study|Terminated by Sponsor|23
814367|NCT02192190|2661926|P3|Overall Study|Terminated by Sponsor|20
814368|NCT02192190|2661927|P2|Overall Study|Terminated by Sponsor|23
814369|NCT02192190|2661928|P1|Overall Study|Terminated by Sponsor|43
814370|NCT02192190|2661923|P6|Overall Study|Physician Decision|0
814371|NCT02192190|2661924|P5|Overall Study|Physician Decision|0
814372|NCT02192190|2661925|P4|Overall Study|Physician Decision|0
814373|NCT02192190|2661926|P3|Overall Study|Physician Decision|0
814374|NCT02192190|2661927|P2|Overall Study|Physician Decision|0
814375|NCT02192190|2661928|P1|Overall Study|Physician Decision|2
814376|NCT02192190|2661923|P6|Overall Study|Lost to Follow-up|3
814377|NCT02192190|2661924|P5|Overall Study|Lost to Follow-up|4
814378|NCT02192190|2661925|P4|Overall Study|Lost to Follow-up|1
814379|NCT02192190|2661926|P3|Overall Study|Lost to Follow-up|2
814380|NCT02192190|2661927|P2|Overall Study|Lost to Follow-up|3
814381|NCT02192190|2661928|P1|Overall Study|Lost to Follow-up|3
814382|NCT02192190|2661923|P6|Overall Study|Adverse Event|0
814383|NCT02192190|2661924|P5|Overall Study|Adverse Event|0
814384|NCT02192190|2661925|P4|Overall Study|Adverse Event|0
814385|NCT02192190|2661926|P3|Overall Study|Adverse Event|0
814386|NCT02192190|2661927|P2|Overall Study|Adverse Event|1
814387|NCT02192190|2661928|P1|Overall Study|Adverse Event|1
814388|NCT02192164|2661972|P1|Overall Study|Did not meet the exclusion criteria|1
814389|NCT02192164|2661972|P1|Overall Study|Physician Decision|4
814390|NCT02192164|2661972|P1|Overall Study|Withdrawal by Subject|1
814391|NCT02192164|2661972|P1|Overall Study|Other|8
814392|NCT02191605|2662018|P5|Overall Study|Lost to Follow-up|4
814393|NCT02191605|2662019|P4|Overall Study|Lost to Follow-up|3
814394|NCT02191605|2662020|P3|Overall Study|Lost to Follow-up|7
814395|NCT02191605|2662021|P2|Overall Study|Lost to Follow-up|4
814396|NCT02191605|2662022|P1|Overall Study|Lost to Follow-up|9
814397|NCT02191579|2662041|P2|Treatment 2|Multiple Reasons Specified|25
814398|NCT02191579|2662042|P1|Treatment 2|Multiple Reasons Specified|0
814399|NCT02191579|2662041|P2|Treatment 1|Multiple Reasons Specified|58
814400|NCT02191579|2662042|P1|Treatment 1|Multiple Reasons Specified|27
814401|NCT02191267|2662057|P3|Overall Study|Withdrawal by Subject|0
814402|NCT02191267|2662058|P2|Overall Study|Withdrawal by Subject|0
814403|NCT02191267|2662059|P1|Overall Study|Withdrawal by Subject|1
814404|NCT02191137|2662070|P1|Follow-up|Adverse Event|1
814405|NCT02191137|2662070|P1|Follow-up|Ongoing/unknown|2
814406|NCT02191137|2662070|P1|Follow-up|Lost to Follow-up|2
814407|NCT02191137|2662070|P1|Treatment|Other|1
814408|NCT02191137|2662070|P1|Treatment|Adverse Event|2
814409|NCT02191137|2662070|P1|Treatment|Withdrawal by Subject|3
814410|NCT02191137|2662070|P1|Treatment|Death|4
814411|NCT02191046|2662100|P2|Overall Study|low compliance|1
814412|NCT02191046|2662101|P1|Overall Study|low compliance|5
814413|NCT02190721|2662132|P3|Overall Study|Patient was out of the city|0
814414|NCT02190721|2662133|P2|Overall Study|Patient was out of the city|1
814415|NCT02190721|2662134|P1|Overall Study|Patient was out of the city|0
814416|NCT02190604|2662257|P19|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
814417|NCT02190604|2662258|P18|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
814418|NCT02190604|2662259|P17|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
814419|NCT02190604|2662260|P16|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
814420|NCT02190604|2662261|P15|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
814421|NCT02190604|2662262|P14|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1
814422|NCT02190604|2662263|P13|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
814423|NCT02190604|2662264|P12|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
814424|NCT02190604|2662265|P11|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
814425|NCT02190604|2662266|P10|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
814426|NCT02190604|2662267|P9|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
814427|NCT02190604|2662268|P8|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
814428|NCT02190604|2662269|P7|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
814429|NCT02190604|2662270|P6|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
814430|NCT02190604|2662271|P5|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
814431|NCT02190604|2662272|P4|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
814432|NCT02190604|2662273|P3|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
814433|NCT02190604|2662274|P2|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
814434|NCT02190604|2662275|P1|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
814435|NCT02190604|2662257|P19|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
814436|NCT02190604|2662258|P18|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
814437|NCT02190604|2662259|P17|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
814438|NCT02190604|2662260|P16|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
814439|NCT02190604|2662261|P15|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2
814440|NCT02190604|2662262|P14|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
814441|NCT02190604|2662263|P13|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
814442|NCT02190604|2662264|P12|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
814443|NCT02190604|2662265|P11|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
814444|NCT02190604|2662266|P10|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
814445|NCT02190604|2662267|P9|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
814446|NCT02190604|2662268|P8|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
814447|NCT02190604|2662269|P7|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
814448|NCT02190604|2662270|P6|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
814449|NCT02190604|2662271|P5|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
814450|NCT02190604|2662272|P4|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
814451|NCT02190604|2662273|P3|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
814452|NCT02190604|2662274|P2|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
814453|NCT02190604|2662275|P1|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
814454|NCT02190591|2662466|P2|Overall Study|face presentation so she was ineligible|1
814455|NCT02190591|2662467|P1|Overall Study|face presentation so she was ineligible|0
814456|NCT02190591|2662466|P2|Overall Study|did not use peanut ball as instructed|2
814457|NCT02190591|2662467|P1|Overall Study|did not use peanut ball as instructed|0
814458|NCT02190591|2662466|P2|Overall Study|Protocol Violation|0
814459|NCT02190591|2662467|P1|Overall Study|Protocol Violation|1
814460|NCT02190591|2662466|P2|Overall Study|Withdrawal by Subject|8
814461|NCT02190591|2662467|P1|Overall Study|Withdrawal by Subject|1
814462|NCT02190435|2662479|P2|Overall Study|3 consented screen fails|0
814463|NCT02190435|2662480|P1|Overall Study|3 consented screen fails|3
814464|NCT02190435|2662479|P2|Overall Study|First 12 patients were lead-ins|0
814465|NCT02190435|2662480|P1|Overall Study|First 12 patients were lead-ins|12
814466|NCT02189941|2662508|P3|Overall Study|Non-compliance|1
814467|NCT02189941|2662509|P2|Overall Study|Non-compliance|0
814468|NCT02189941|2662510|P1|Overall Study|Non-compliance|0
814469|NCT02189863|2662538|P2|First 2 Weeks|Motion Sickness|2
814470|NCT02189863|2662539|P1|First 2 Weeks|Motion Sickness|4
814471|NCT02189837|2662554|P4|Overall Study|Sponsor Decision|1
814472|NCT02189837|2662555|P3|Overall Study|Sponsor Decision|0
814473|NCT02189837|2662556|P2|Overall Study|Sponsor Decision|0
814474|NCT02189837|2662557|P1|Overall Study|Sponsor Decision|0
814475|NCT02189837|2662554|P4|Overall Study|Withdrawal by Subject|1
814476|NCT02189837|2662555|P3|Overall Study|Withdrawal by Subject|3
814477|NCT02189837|2662556|P2|Overall Study|Withdrawal by Subject|1
814478|NCT02189837|2662557|P1|Overall Study|Withdrawal by Subject|2
814479|NCT02189759|2662587|P4|Overall Study|Lost to Follow-up|5
814480|NCT02189759|2662588|P3|Overall Study|Lost to Follow-up|2
814481|NCT02189759|2662589|P2|Overall Study|Lost to Follow-up|0
814482|NCT02189759|2662590|P1|Overall Study|Lost to Follow-up|0
814483|NCT02189252|2662647|P4|Period 1 (Visit 4b, Week 4)|Adverse Event|0
814484|NCT02189252|2662648|P3|Period 1 (Visit 4b, Week 4)|Adverse Event|0
814485|NCT02189252|2662649|P2|Period 1 (Visit 4b, Week 4)|Adverse Event|1
814486|NCT02189252|2662650|P1|Period 1 (Visit 4b, Week 4)|Adverse Event|0
814487|NCT02189252|2662647|P4|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
814488|NCT02189252|2662648|P3|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
814489|NCT02189252|2662649|P2|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1
814490|NCT02189252|2662650|P1|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
814491|NCT02188849|2662709|P2|Overall Study|Lost to Follow-up|8
814492|NCT02188849|2662710|P1|Overall Study|Lost to Follow-up|3
814493|NCT02188784|2662724|P2|Overall Study|Physician Decision|3
814494|NCT02188784|2662725|P1|Overall Study|Physician Decision|2
814495|NCT02188784|2662724|P2|Overall Study|Withdrawal by Subject|9
814496|NCT02188784|2662725|P1|Overall Study|Withdrawal by Subject|3
814497|NCT02188784|2662724|P2|Overall Study|Lost to Follow-up|0
814498|NCT02188784|2662725|P1|Overall Study|Lost to Follow-up|1
814499|NCT02188784|2662724|P2|Overall Study|Death|1
814500|NCT02188784|2662725|P1|Overall Study|Death|3
814501|NCT02187861|2662761|P4|Overall Study|Alive in Study Follow-Up|31
814502|NCT02187861|2662762|P3|Overall Study|Alive in Study Follow-Up|26
814503|NCT02187861|2662763|P2|Overall Study|Alive in Study Follow-Up|10
814504|NCT02187861|2662764|P1|Overall Study|Alive in Study Follow-Up|4
814505|NCT02187861|2662761|P4|Overall Study|Other|1
814506|NCT02187861|2662762|P3|Overall Study|Other|6
814507|NCT02187861|2662763|P2|Overall Study|Other|2
814508|NCT02187861|2662764|P1|Overall Study|Other|0
814509|NCT02187861|2662761|P4|Overall Study|Withdrawal by Subject|3
814510|NCT02187861|2662762|P3|Overall Study|Withdrawal by Subject|2
814511|NCT02187861|2662763|P2|Overall Study|Withdrawal by Subject|0
814512|NCT02187861|2662764|P1|Overall Study|Withdrawal by Subject|0
814513|NCT02187861|2662761|P4|Overall Study|Progressive Disease|11
814514|NCT02187861|2662762|P3|Overall Study|Progressive Disease|13
814515|NCT02187861|2662763|P2|Overall Study|Progressive Disease|35
814516|NCT02187861|2662764|P1|Overall Study|Progressive Disease|3
814517|NCT02187861|2662761|P4|Overall Study|Physician Decision|3
814518|NCT02187861|2662762|P3|Overall Study|Physician Decision|0
814519|NCT02187861|2662763|P2|Overall Study|Physician Decision|1
814520|NCT02187861|2662764|P1|Overall Study|Physician Decision|0
814521|NCT02187861|2662761|P4|Overall Study|Lack of Efficacy|0
814522|NCT02187861|2662762|P3|Overall Study|Lack of Efficacy|0
814523|NCT02187861|2662763|P2|Overall Study|Lack of Efficacy|1
814524|NCT02187861|2662764|P1|Overall Study|Lack of Efficacy|0
814525|NCT02187861|2662761|P4|Overall Study|Death|2
814526|NCT02187861|2662762|P3|Overall Study|Death|1
814527|NCT02187861|2662763|P2|Overall Study|Death|3
814528|NCT02187861|2662764|P1|Overall Study|Death|0
814529|NCT02187861|2662761|P4|Overall Study|Adverse Event|0
814530|NCT02187861|2662762|P3|Overall Study|Adverse Event|3
814531|NCT02187861|2662763|P2|Overall Study|Adverse Event|1
814532|NCT02187861|2662764|P1|Overall Study|Adverse Event|2
814533|NCT02187809|2662860|P1|Overall Study|The study was terminated|3
814534|NCT02187744|2662872|P2|Treatment|Participant refused continued treatment|1
814535|NCT02187744|2662873|P1|Treatment|Participant refused continued treatment|1
814536|NCT02187744|2662872|P2|Treatment|Not specified|0
814537|NCT02187744|2662873|P1|Treatment|Not specified|2
814538|NCT02187744|2662872|P2|Treatment|Lost to Follow-up|1
814539|NCT02187744|2662873|P1|Treatment|Lost to Follow-up|0
814540|NCT02187744|2662872|P2|Treatment|Related adverse event, not serious|2
814541|NCT02187744|2662873|P1|Treatment|Related adverse event, not serious|0
814542|NCT02187744|2662872|P2|Treatment|Related adverse event, serious non-fatal|1
814543|NCT02187744|2662873|P1|Treatment|Related adverse event, serious non-fatal|0
814544|NCT02187744|2662872|P2|Treatment|Death|0
814545|NCT02187744|2662873|P1|Treatment|Death|1
814546|NCT02187744|2662872|P2|Study|Related adverse event, serious non-fatal|1
814547|NCT02187744|2662873|P1|Study|Related adverse event, serious non-fatal|0
814548|NCT02187744|2662872|P2|Study|Death|0
814549|NCT02187744|2662873|P1|Study|Death|1
814550|NCT02187744|2662872|P2|Study|Related adverse event, not serious|2
814551|NCT02187744|2662873|P1|Study|Related adverse event, not serious|0
814552|NCT02187744|2662872|P2|Study|Lost to Follow-up|2
814553|NCT02187744|2662873|P1|Study|Lost to Follow-up|0
814554|NCT02187744|2662872|P2|Study|Not specified|1
814555|NCT02187744|2662873|P1|Study|Not specified|2
814556|NCT02187744|2662872|P2|Study|Participant refused further follow-up|0
814557|NCT02187744|2662873|P1|Study|Participant refused further follow-up|1
814558|NCT02187055|2662892|P3|Overall Study|Death|0
814559|NCT02187055|2662893|P2|Overall Study|Death|0
814560|NCT02187055|2662894|P1|Overall Study|Death|2
814561|NCT02187055|2662892|P3|Overall Study|Adverse Event|36
814562|NCT02187055|2662893|P2|Overall Study|Adverse Event|26
814563|NCT02187055|2662894|P1|Overall Study|Adverse Event|21
814564|NCT02187055|2662892|P3|Overall Study|Withdrawal by Subject|11
814565|NCT02187055|2662893|P2|Overall Study|Withdrawal by Subject|11
814566|NCT02187055|2662894|P1|Overall Study|Withdrawal by Subject|11
814567|NCT02187055|2662892|P3|Overall Study|Pregnancy|0
814568|NCT02187055|2662893|P2|Overall Study|Pregnancy|1
814569|NCT02187055|2662894|P1|Overall Study|Pregnancy|3
814570|NCT02187055|2662892|P3|Overall Study|Protocol Violation|4
814571|NCT02187055|2662893|P2|Overall Study|Protocol Violation|9
814572|NCT02187055|2662894|P1|Overall Study|Protocol Violation|9
814573|NCT02187055|2662892|P3|Overall Study|Other|3
814574|NCT02187055|2662893|P2|Overall Study|Other|6
814575|NCT02187055|2662894|P1|Overall Study|Other|5
814576|NCT02187055|2662892|P3|Overall Study|No longer willing to participate|10
814577|NCT02187055|2662893|P2|Overall Study|No longer willing to participate|8
814578|NCT02187055|2662894|P1|Overall Study|No longer willing to participate|6
814579|NCT02187055|2662892|P3|Overall Study|No longer meets eligibility criteria|0
814580|NCT02187055|2662893|P2|Overall Study|No longer meets eligibility criteria|2
814581|NCT02187055|2662894|P1|Overall Study|No longer meets eligibility criteria|0
814582|NCT02187055|2662892|P3|Overall Study|Lost to Follow-up|3
814583|NCT02187055|2662893|P2|Overall Study|Lost to Follow-up|7
814584|NCT02187055|2662894|P1|Overall Study|Lost to Follow-up|2
814585|NCT02187055|2662892|P3|Overall Study|Lack of Efficacy|7
814586|NCT02187055|2662893|P2|Overall Study|Lack of Efficacy|3
814587|NCT02187055|2662894|P1|Overall Study|Lack of Efficacy|10
814588|NCT02187029|2662996|P4|Overall Study|Withdrawal by Subject|0
814589|NCT02187029|2662997|P3|Overall Study|Withdrawal by Subject|0
814590|NCT02187029|2662998|P2|Overall Study|Withdrawal by Subject|0
814591|NCT02187029|2662999|P1|Overall Study|Withdrawal by Subject|1
814592|NCT02187029|2662996|P4|Overall Study|Study Terminated by Sponsor|3
814593|NCT02187029|2662997|P3|Overall Study|Study Terminated by Sponsor|10
814594|NCT02187029|2662998|P2|Overall Study|Study Terminated by Sponsor|0
814595|NCT02187029|2662999|P1|Overall Study|Study Terminated by Sponsor|0
814596|NCT02187029|2662996|P4|Overall Study|Adverse Event|0
814597|NCT02187029|2662997|P3|Overall Study|Adverse Event|1
814598|NCT02187029|2662998|P2|Overall Study|Adverse Event|1
814599|NCT02187029|2662999|P1|Overall Study|Adverse Event|0
814600|NCT02186873|2663121|P2|Overall Study|Withdrawal by Subject|2
814601|NCT02186873|2663122|P1|Overall Study|Withdrawal by Subject|7
814602|NCT02186873|2663121|P2|Overall Study|Lost to Follow-up|2
814603|NCT02186873|2663122|P1|Overall Study|Lost to Follow-up|1
814604|NCT02186873|2663121|P2|Overall Study|Lack of Efficacy|1
814605|NCT02186873|2663122|P1|Overall Study|Lack of Efficacy|0
814606|NCT02186873|2663121|P2|Overall Study|Adverse Event|3
814607|NCT02186873|2663122|P1|Overall Study|Adverse Event|1
814608|NCT02186223|2663167|P1|Overall Study|Device in place less than 48 hours|9
814609|NCT02186223|2663167|P1|Overall Study|Death|3
814610|NCT02186223|2663167|P1|Overall Study|Unable to obtain femoral access|3
814611|NCT02186223|2663167|P1|Overall Study|Not eligible for device placement|6
814612|NCT02185534|2663208|P6|First Washout Period|Protocol Violation|1
814613|NCT02185534|2663209|P5|First Washout Period|Protocol Violation|0
814614|NCT02185534|2663210|P4|First Washout Period|Protocol Violation|0
814615|NCT02185534|2663211|P3|First Washout Period|Protocol Violation|0
814616|NCT02185534|2663212|P2|First Washout Period|Protocol Violation|0
814617|NCT02185534|2663213|P1|First Washout Period|Protocol Violation|0
814618|NCT02185534|2663208|P6|First Washout Period|Withdrawal by Subject|0
814619|NCT02185534|2663209|P5|First Washout Period|Withdrawal by Subject|1
814620|NCT02185534|2663210|P4|First Washout Period|Withdrawal by Subject|0
814621|NCT02185534|2663211|P3|First Washout Period|Withdrawal by Subject|0
814622|NCT02185534|2663212|P2|First Washout Period|Withdrawal by Subject|0
814623|NCT02185534|2663213|P1|First Washout Period|Withdrawal by Subject|1
814624|NCT02185534|2663208|P6|First Period|Withdrawal by Subject|0
814625|NCT02185534|2663209|P5|First Period|Withdrawal by Subject|0
814626|NCT02185534|2663210|P4|First Period|Withdrawal by Subject|1
814627|NCT02185534|2663211|P3|First Period|Withdrawal by Subject|0
814628|NCT02185534|2663212|P2|First Period|Withdrawal by Subject|0
814629|NCT02185534|2663213|P1|First Period|Withdrawal by Subject|0
814630|NCT02185014|2663311|P1|Overall Study|Not Specified|4
814631|NCT02185014|2663311|P1|Overall Study|Subject Noncompliance|1
814632|NCT02185014|2663311|P1|Overall Study|Requires Alternative/Prohibited Therapy|5
814633|NCT02185014|2663311|P1|Overall Study|Lack of Efficacy|14
814634|NCT02185014|2663311|P1|Overall Study|Lost to Follow-up|4
814635|NCT02185014|2663311|P1|Overall Study|Withdrew Consent|8
814636|NCT02185014|2663311|P1|Overall Study|Adverse Event|18
814637|NCT02184572|2663368|P2|Overall Study|Withdrawal by Subject|9
814638|NCT02184572|2663369|P1|Overall Study|Withdrawal by Subject|14
814639|NCT02184572|2663368|P2|Overall Study|Traveling Outside The Country|0
814640|NCT02184572|2663369|P1|Overall Study|Traveling Outside The Country|1
814641|NCT02184572|2663368|P2|Overall Study|2nd blooddraw & diary card incomplete|0
814642|NCT02184572|2663369|P1|Overall Study|2nd blooddraw & diary card incomplete|1
814643|NCT02184572|2663368|P2|Overall Study|Loss Of Kaiser Insurance|0
814644|NCT02184572|2663369|P1|Overall Study|Loss Of Kaiser Insurance|1
814645|NCT02184572|2663368|P2|Overall Study|Family Out Of Country Until 9/29/2015|0
814646|NCT02184572|2663369|P1|Overall Study|Family Out Of Country Until 9/29/2015|1
814647|NCT02184572|2663368|P2|Overall Study|Lost to Follow-up|21
814648|NCT02184572|2663369|P1|Overall Study|Lost to Follow-up|29
814649|NCT02184442|2663432|P2|Overall Study|Withdrawal by Subject|11
814650|NCT02184442|2663433|P1|Overall Study|Withdrawal by Subject|3
814651|NCT02184442|2663432|P2|Overall Study|Death|65
814652|NCT02184442|2663433|P1|Overall Study|Death|61
814653|NCT02183675|2663457|P6|Treatment Period 2 (10 Days)|Adverse Event|2
814654|NCT02183675|2663458|P5|Treatment Period 2 (10 Days)|Adverse Event|0
814655|NCT02183675|2663459|P4|Treatment Period 2 (10 Days)|Adverse Event|0
814656|NCT02183675|2663460|P3|Treatment Period 2 (10 Days)|Adverse Event|0
814657|NCT02183675|2663461|P2|Treatment Period 2 (10 Days)|Adverse Event|0
814658|NCT02183675|2663462|P1|Treatment Period 2 (10 Days)|Adverse Event|0
814659|NCT02183519|2663486|P2|Overall Study|Did not respond to cough inducter|3
814660|NCT02183519|2663487|P1|Overall Study|Did not respond to cough inducter|0
814661|NCT02183519|2663486|P2|Overall Study|computer error|0
814662|NCT02183519|2663487|P1|Overall Study|computer error|3
814663|NCT02182999|2663495|P2|Overall Study|Physician Decision|0
814664|NCT02182999|2663496|P1|Overall Study|Physician Decision|1
814665|NCT02182999|2663495|P2|Overall Study|Adverse Event|3
814666|NCT02182999|2663496|P1|Overall Study|Adverse Event|4
814667|NCT02182895|2663512|P2|Overall Study|Discharged from hospital within 24 hours|4
814668|NCT02182895|2663513|P1|Overall Study|Discharged from hospital within 24 hours|2
814669|NCT02182830|2663535|P2|Overall Study|Lost to Follow-up|3
814670|NCT02182830|2663536|P1|Overall Study|Lost to Follow-up|3
814671|NCT02182830|2663535|P2|Overall Study|Consent withdrawn|8
814672|NCT02182830|2663536|P1|Overall Study|Consent withdrawn|8
814673|NCT02182830|2663535|P2|Overall Study|Trial stopped, reason missing|3
814674|NCT02182830|2663536|P1|Overall Study|Trial stopped, reason missing|3
814675|NCT02182830|2663535|P2|Overall Study|Not Treated|1
814676|NCT02182830|2663536|P1|Overall Study|Not Treated|1
814677|NCT02181790|2663584|P2|Overall Study|study terminated|0
814678|NCT02181790|2663585|P1|Overall Study|study terminated|2
814679|NCT02181673|2663595|P3|Week 24-Week 60|Physician Decision|1
814680|NCT02181673|2663596|P2|Week 24-Week 60|Physician Decision|0
814681|NCT02181673|2663597|P1|Week 24-Week 60|Physician Decision|0
814682|NCT02181673|2663595|P3|Week 24-Week 60|Lost to Follow-up|1
814683|NCT02181673|2663596|P2|Week 24-Week 60|Lost to Follow-up|0
814684|NCT02181673|2663597|P1|Week 24-Week 60|Lost to Follow-up|0
814685|NCT02181673|2663595|P3|Week 24-Week 60|Lack of Efficacy|1
814686|NCT02181673|2663596|P2|Week 24-Week 60|Lack of Efficacy|0
814687|NCT02181673|2663597|P1|Week 24-Week 60|Lack of Efficacy|0
814688|NCT02181673|2663595|P3|Week 24-Week 60|Pregnancy|1
814689|NCT02181673|2663596|P2|Week 24-Week 60|Pregnancy|0
814690|NCT02181673|2663597|P1|Week 24-Week 60|Pregnancy|0
814691|NCT02181673|2663595|P3|Week 24-Week 60|Withdrawal by Subject|2
814692|NCT02181673|2663596|P2|Week 24-Week 60|Withdrawal by Subject|2
814693|NCT02181673|2663597|P1|Week 24-Week 60|Withdrawal by Subject|0
814694|NCT02181673|2663595|P3|Week 24-Week 60|Other|1
814695|NCT02181673|2663596|P2|Week 24-Week 60|Other|2
814696|NCT02181673|2663597|P1|Week 24-Week 60|Other|0
814697|NCT02181673|2663595|P3|Week 24-Week 60|Adverse Event|10
814698|NCT02181673|2663596|P2|Week 24-Week 60|Adverse Event|4
814699|NCT02181673|2663597|P1|Week 24-Week 60|Adverse Event|0
814700|NCT02181673|2663595|P3|Up to Week 24|Randomized not Treated|1
814701|NCT02181673|2663596|P2|Up to Week 24|Randomized not Treated|0
814702|NCT02181673|2663597|P1|Up to Week 24|Randomized not Treated|0
814703|NCT02181673|2663595|P3|Up to Week 24|Other|3
814704|NCT02181673|2663596|P2|Up to Week 24|Other|0
814705|NCT02181673|2663597|P1|Up to Week 24|Other|2
814706|NCT02181673|2663595|P3|Up to Week 24|Withdrawal by Subject|1
814707|NCT02181673|2663596|P2|Up to Week 24|Withdrawal by Subject|0
814708|NCT02181673|2663597|P1|Up to Week 24|Withdrawal by Subject|10
814709|NCT02181673|2663595|P3|Up to Week 24|Physician Decision|3
814710|NCT02181673|2663596|P2|Up to Week 24|Physician Decision|0
814711|NCT02181673|2663597|P1|Up to Week 24|Physician Decision|0
814712|NCT02181673|2663595|P3|Up to Week 24|Lost to Follow-up|0
814713|NCT02181673|2663596|P2|Up to Week 24|Lost to Follow-up|0
814714|NCT02181673|2663597|P1|Up to Week 24|Lost to Follow-up|1
814715|NCT02181673|2663595|P3|Up to Week 24|Lack of Efficacy|0
814716|NCT02181673|2663596|P2|Up to Week 24|Lack of Efficacy|0
814717|NCT02181673|2663597|P1|Up to Week 24|Lack of Efficacy|1
814718|NCT02181673|2663595|P3|Up to Week 24|Death|0
814719|NCT02181673|2663596|P2|Up to Week 24|Death|0
814720|NCT02181673|2663597|P1|Up to Week 24|Death|1
814721|NCT02181673|2663595|P3|Up to Week 24|Adverse Event|3
814722|NCT02181673|2663596|P2|Up to Week 24|Adverse Event|0
814723|NCT02181673|2663597|P1|Up to Week 24|Adverse Event|2
814724|NCT02181634|2663624|P1|Overall Study|Patient opted to proceed to surgery|1
814725|NCT02181634|2663624|P1|Overall Study|Symptomatic progression|1
814726|NCT02181634|2663624|P1|Overall Study|Max number of dose reduction|1
814727|NCT02181634|2663624|P1|Overall Study|Ineligible|1
814728|NCT02181634|2663624|P1|Overall Study|Treatment delayed greater than 4 weeks|3
814729|NCT02181634|2663624|P1|Overall Study|Death|2
814730|NCT02181634|2663624|P1|Overall Study|Withdrawal by Subject|5
814731|NCT02181634|2663624|P1|Overall Study|Physician Decision|8
814732|NCT02181634|2663624|P1|Overall Study|Adverse Event|17
814733|NCT02181634|2663624|P1|Overall Study|Lack of Efficacy|33
814734|NCT02181504|2663673|P3|Overall Study|Adverse Event|1
814735|NCT02181504|2663674|P2|Overall Study|Adverse Event|1
814736|NCT02181504|2663675|P1|Overall Study|Adverse Event|1
814737|NCT02181296|2663723|P2|Overall Study|Lost to Follow-up|6
814738|NCT02181296|2663724|P1|Overall Study|Lost to Follow-up|7
814739|NCT02180438|2663800|P1|Overall Study|Lost to Follow-up|1
814740|NCT02180061|2663822|P2|Overall Study|Physician Decision|0
814741|NCT02180061|2663823|P1|Overall Study|Physician Decision|1
814742|NCT02180061|2663822|P2|Overall Study|Progressive Disease|5
814743|NCT02180061|2663823|P1|Overall Study|Progressive Disease|15
814744|NCT02180061|2663822|P2|Overall Study|Clinical Progression|1
814745|NCT02180061|2663823|P1|Overall Study|Clinical Progression|5
814746|NCT02180061|2663822|P2|Overall Study|Adverse Event|2
814747|NCT02180061|2663823|P1|Overall Study|Adverse Event|4
814748|NCT02179918|2663842|P5|Overall Study|Subject refused further follow-up|1
814749|NCT02179918|2663843|P4|Overall Study|Subject refused further follow-up|0
814750|NCT02179918|2663844|P3|Overall Study|Subject refused further follow-up|0
814751|NCT02179918|2663845|P2|Overall Study|Subject refused further follow-up|1
814752|NCT02179918|2663846|P1|Overall Study|Subject refused further follow-up|0
814753|NCT02179918|2663842|P5|Overall Study|Other|1
814754|NCT02179918|2663843|P4|Overall Study|Other|0
814755|NCT02179918|2663844|P3|Overall Study|Other|0
814756|NCT02179918|2663845|P2|Overall Study|Other|1
814757|NCT02179918|2663846|P1|Overall Study|Other|0
814758|NCT02179918|2663842|P5|Overall Study|Progressive Disease|6
814759|NCT02179918|2663843|P4|Overall Study|Progressive Disease|2
814760|NCT02179918|2663844|P3|Overall Study|Progressive Disease|1
814761|NCT02179918|2663845|P2|Overall Study|Progressive Disease|1
814762|NCT02179918|2663846|P1|Overall Study|Progressive Disease|4
814763|NCT02179918|2663842|P5|Overall Study|Lost to Follow-up|0
814764|NCT02179918|2663843|P4|Overall Study|Lost to Follow-up|0
814765|NCT02179918|2663844|P3|Overall Study|Lost to Follow-up|1
814766|NCT02179918|2663845|P2|Overall Study|Lost to Follow-up|0
814767|NCT02179918|2663846|P1|Overall Study|Lost to Follow-up|0
814768|NCT02179918|2663842|P5|Overall Study|Death|0
814769|NCT02179918|2663843|P4|Overall Study|Death|1
814770|NCT02179918|2663844|P3|Overall Study|Death|0
814771|NCT02179918|2663845|P2|Overall Study|Death|0
814772|NCT02179918|2663846|P1|Overall Study|Death|0
814773|NCT02179398|2664009|P2|Overall Study|Lost to Follow-up|1
814774|NCT02179398|2664010|P1|Overall Study|Lost to Follow-up|0
814775|NCT02179398|2664009|P2|Overall Study|Lack of obligatory data|3
814776|NCT02179398|2664010|P1|Overall Study|Lack of obligatory data|3
814777|NCT02178995|2664030|P9|Open Label|Adverse Event|0
814778|NCT02178995|2664031|P8|Open Label|Adverse Event|0
814779|NCT02178995|2664032|P7|Open Label|Adverse Event|0
814780|NCT02178995|2664033|P6|Open Label|Adverse Event|0
814781|NCT02178995|2664034|P5|Open Label|Adverse Event|0
814782|NCT02178995|2664035|P4|Open Label|Adverse Event|0
814783|NCT02178995|2664036|P3|Open Label|Adverse Event|0
814784|NCT02178995|2664037|P2|Open Label|Adverse Event|0
814785|NCT02178995|2664038|P1|Open Label|Adverse Event|2
814786|NCT02178995|2664030|P9|Double Blind|Lost to Follow-up|0
814787|NCT02178995|2664031|P8|Double Blind|Lost to Follow-up|1
814788|NCT02178995|2664032|P7|Double Blind|Lost to Follow-up|0
814789|NCT02178995|2664033|P6|Double Blind|Lost to Follow-up|0
814790|NCT02178995|2664034|P5|Double Blind|Lost to Follow-up|0
814791|NCT02178995|2664035|P4|Double Blind|Lost to Follow-up|0
814792|NCT02178995|2664036|P3|Double Blind|Lost to Follow-up|0
814793|NCT02178995|2664037|P2|Double Blind|Lost to Follow-up|1
814794|NCT02178995|2664038|P1|Double Blind|Lost to Follow-up|0
814795|NCT02178995|2664030|P9|Double Blind|Adverse Event|1
814796|NCT02178995|2664031|P8|Double Blind|Adverse Event|1
814797|NCT02178995|2664032|P7|Double Blind|Adverse Event|0
814798|NCT02178995|2664033|P6|Double Blind|Adverse Event|1
814799|NCT02178995|2664034|P5|Double Blind|Adverse Event|0
814800|NCT02178995|2664035|P4|Double Blind|Adverse Event|0
814801|NCT02178995|2664036|P3|Double Blind|Adverse Event|0
814802|NCT02178995|2664037|P2|Double Blind|Adverse Event|0
814803|NCT02178995|2664038|P1|Double Blind|Adverse Event|0
814804|NCT02178787|2664120|P2|Overall Study|Physician Decision|0
814805|NCT02178787|2664121|P1|Overall Study|Physician Decision|1
814806|NCT02178787|2664120|P2|Overall Study|No TCD window|7
814807|NCT02178787|2664121|P1|Overall Study|No TCD window|3
814808|NCT02178787|2664120|P2|Overall Study|Withdrawal by Subject|2
814809|NCT02178787|2664121|P1|Overall Study|Withdrawal by Subject|0
814810|NCT02178787|2664120|P2|Overall Study|Lost to Follow-up|0
814811|NCT02178787|2664121|P1|Overall Study|Lost to Follow-up|1
814812|NCT02178475|2664150|P1|Overall Study|Protocol-specified Criteria|99
814813|NCT02178475|2664150|P1|Overall Study|Death|13
814814|NCT02178475|2664150|P1|Overall Study|Lost to Follow-up|10
814815|NCT02178475|2664150|P1|Overall Study|Withdrawal by Subject|7
814816|NCT02178059|2664170|P2|Washout|Physician Decision|0
814817|NCT02178059|2664171|P1|Washout|Physician Decision|1
814818|NCT02177266|2664189|P2|Overall Study|Withdrawal by Subject|0
814819|NCT02177266|2664190|P1|Overall Study|Withdrawal by Subject|1
814820|NCT02177266|2664189|P2|Overall Study|Adverse Event|1
814821|NCT02177266|2664190|P1|Overall Study|Adverse Event|0
814822|NCT02177136|2664212|P3|Overall Study|Protocol Violation|1
814823|NCT02177136|2664213|P2|Overall Study|Protocol Violation|0
814824|NCT02177136|2664214|P1|Overall Study|Protocol Violation|0
814825|NCT02177136|2664212|P3|Overall Study|Adverse Event|3
814826|NCT02177136|2664213|P2|Overall Study|Adverse Event|2
814827|NCT02177136|2664214|P1|Overall Study|Adverse Event|3
814828|NCT02177136|2664212|P3|Overall Study|Discontinued due to pruritus|0
814829|NCT02177136|2664213|P2|Overall Study|Discontinued due to pruritus|3
814830|NCT02177136|2664214|P1|Overall Study|Discontinued due to pruritus|1
814831|NCT02177136|2664212|P3|Overall Study|Withdrawal by Subject|0
814832|NCT02177136|2664213|P2|Overall Study|Withdrawal by Subject|0
814833|NCT02177136|2664214|P1|Overall Study|Withdrawal by Subject|2
814834|NCT02177032|2664247|P4|Overall Study|Withdrawal by Subject|0
814835|NCT02177032|2664248|P3|Overall Study|Withdrawal by Subject|1
814836|NCT02177032|2664249|P2|Overall Study|Withdrawal by Subject|0
814837|NCT02177032|2664250|P1|Overall Study|Withdrawal by Subject|1
814838|NCT02177032|2664247|P4|Overall Study|OTHER|0
814839|NCT02177032|2664248|P3|Overall Study|OTHER|1
814840|NCT02177032|2664249|P2|Overall Study|OTHER|0
814841|NCT02177032|2664250|P1|Overall Study|OTHER|2
814842|NCT02177032|2664247|P4|Overall Study|Lost to Follow-up|0
814843|NCT02177032|2664248|P3|Overall Study|Lost to Follow-up|0
814844|NCT02177032|2664249|P2|Overall Study|Lost to Follow-up|2
814845|NCT02177032|2664250|P1|Overall Study|Lost to Follow-up|0
814846|NCT02177032|2664247|P4|Overall Study|ADMINISTRATIVE REASON|0
814847|NCT02177032|2664248|P3|Overall Study|ADMINISTRATIVE REASON|1
814848|NCT02177032|2664249|P2|Overall Study|ADMINISTRATIVE REASON|0
814849|NCT02177032|2664250|P1|Overall Study|ADMINISTRATIVE REASON|2
814850|NCT02176655|2664288|P1|Overall Study|Subjects did not treat|6
814851|NCT02176642|2664311|P2|Overall Study|Withdrawal by Subject|1
814852|NCT02176642|2664312|P1|Overall Study|Withdrawal by Subject|0
814853|NCT02176525|2664342|P8|Overall Study|not treated|0
814854|NCT02176525|2664343|P7|Overall Study|not treated|0
814855|NCT02176525|2664344|P6|Overall Study|not treated|1
814856|NCT02176525|2664345|P5|Overall Study|not treated|0
814857|NCT02176525|2664346|P4|Overall Study|not treated|0
814858|NCT02176525|2664347|P3|Overall Study|not treated|0
814859|NCT02176525|2664348|P2|Overall Study|not treated|0
814860|NCT02176525|2664349|P1|Overall Study|not treated|1
814861|NCT02176525|2664342|P8|Overall Study|Adverse Event|0
814862|NCT02176525|2664343|P7|Overall Study|Adverse Event|1
814863|NCT02176525|2664344|P6|Overall Study|Adverse Event|0
814864|NCT02176525|2664345|P5|Overall Study|Adverse Event|1
814865|NCT02176525|2664346|P4|Overall Study|Adverse Event|1
814866|NCT02176525|2664347|P3|Overall Study|Adverse Event|0
814867|NCT02176525|2664348|P2|Overall Study|Adverse Event|0
814868|NCT02176525|2664349|P1|Overall Study|Adverse Event|0
814869|NCT02176421|2664526|P1|Overall Study|Adverse Event|1
814870|NCT02176421|2664526|P1|Overall Study|Lost to Follow-up|4
814871|NCT02176356|2664535|P1|Overall Study|Other Miscellaneous Reasons|2
814872|NCT02176356|2664535|P1|Overall Study|Personal Reasons|3
814873|NCT02176356|2664535|P1|Overall Study|Lost to Follow-up|4
814874|NCT02176356|2664535|P1|Overall Study|Screen Failure|14
814875|NCT02176291|2664565|P2|Overall Study|Withdrawal by Subject|0
814876|NCT02176291|2664566|P1|Overall Study|Withdrawal by Subject|2
814877|NCT02176291|2664565|P2|Overall Study|non compliance with protocol|0
814878|NCT02176291|2664566|P1|Overall Study|non compliance with protocol|2
814879|NCT02176291|2664565|P2|Overall Study|Death|0
814880|NCT02176291|2664566|P1|Overall Study|Death|1
814881|NCT02176226|2664574|P1|Overall Study|Withdrew prior to treatment|6
814882|NCT02176226|2664574|P1|Overall Study|Lost to Follow-up|3
814883|NCT02176018|2664582|P2|Overall Study|Withdrawal by Subject|2
814884|NCT02176018|2664583|P1|Overall Study|Withdrawal by Subject|1
814885|NCT02176018|2664582|P2|Overall Study|Protocol Violation|1
814886|NCT02176018|2664583|P1|Overall Study|Protocol Violation|1
814887|NCT02176018|2664582|P2|Overall Study|Lost to Follow-up|1
814888|NCT02176018|2664583|P1|Overall Study|Lost to Follow-up|3
814889|NCT02176018|2664582|P2|Overall Study|Adverse Event|2
814890|NCT02176018|2664583|P1|Overall Study|Adverse Event|0
814891|NCT02175771|2664615|P9|Treatment Period|Not specified|0
814892|NCT02175771|2664616|P8|Treatment Period|Not specified|2
814893|NCT02175771|2664617|P7|Treatment Period|Not specified|0
814894|NCT02175771|2664618|P6|Treatment Period|Not specified|0
814895|NCT02175771|2664619|P5|Treatment Period|Not specified|1
814896|NCT02175771|2664620|P4|Treatment Period|Not specified|3
814897|NCT02175771|2664621|P3|Treatment Period|Not specified|0
814898|NCT02175771|2664622|P2|Treatment Period|Not specified|1
814899|NCT02175771|2664623|P1|Treatment Period|Not specified|0
814900|NCT02175771|2664615|P9|Treatment Period|Lack of Efficacy|0
814901|NCT02175771|2664616|P8|Treatment Period|Lack of Efficacy|1
814902|NCT02175771|2664617|P7|Treatment Period|Lack of Efficacy|0
814903|NCT02175771|2664618|P6|Treatment Period|Lack of Efficacy|1
814904|NCT02175771|2664619|P5|Treatment Period|Lack of Efficacy|0
814905|NCT02175771|2664620|P4|Treatment Period|Lack of Efficacy|0
814906|NCT02175771|2664621|P3|Treatment Period|Lack of Efficacy|0
814907|NCT02175771|2664622|P2|Treatment Period|Lack of Efficacy|0
814908|NCT02175771|2664623|P1|Treatment Period|Lack of Efficacy|0
814909|NCT02175771|2664615|P9|Treatment Period|Lost to Follow-up|2
814910|NCT02175771|2664616|P8|Treatment Period|Lost to Follow-up|2
814911|NCT02175771|2664617|P7|Treatment Period|Lost to Follow-up|1
814912|NCT02175771|2664618|P6|Treatment Period|Lost to Follow-up|2
814913|NCT02175771|2664619|P5|Treatment Period|Lost to Follow-up|1
814914|NCT02175771|2664620|P4|Treatment Period|Lost to Follow-up|3
814915|NCT02175771|2664621|P3|Treatment Period|Lost to Follow-up|1
814916|NCT02175771|2664622|P2|Treatment Period|Lost to Follow-up|3
814917|NCT02175771|2664623|P1|Treatment Period|Lost to Follow-up|0
814918|NCT02175771|2664615|P9|Treatment Period|Disease progression|0
814919|NCT02175771|2664616|P8|Treatment Period|Disease progression|2
814920|NCT02175771|2664617|P7|Treatment Period|Disease progression|0
814921|NCT02175771|2664618|P6|Treatment Period|Disease progression|0
814922|NCT02175771|2664619|P5|Treatment Period|Disease progression|0
814923|NCT02175771|2664620|P4|Treatment Period|Disease progression|0
814924|NCT02175771|2664621|P3|Treatment Period|Disease progression|0
814925|NCT02175771|2664622|P2|Treatment Period|Disease progression|0
814926|NCT02175771|2664623|P1|Treatment Period|Disease progression|0
814927|NCT02175771|2664615|P9|Treatment Period|Protocol Violation|0
814928|NCT02175771|2664616|P8|Treatment Period|Protocol Violation|1
814929|NCT02175771|2664617|P7|Treatment Period|Protocol Violation|0
814930|NCT02175771|2664618|P6|Treatment Period|Protocol Violation|0
814931|NCT02175771|2664619|P5|Treatment Period|Protocol Violation|0
814932|NCT02175771|2664620|P4|Treatment Period|Protocol Violation|0
814933|NCT02175771|2664621|P3|Treatment Period|Protocol Violation|0
814934|NCT02175771|2664622|P2|Treatment Period|Protocol Violation|0
814935|NCT02175771|2664623|P1|Treatment Period|Protocol Violation|0
814936|NCT02175771|2664615|P9|Treatment Period|Noncompliance|1
814937|NCT02175771|2664616|P8|Treatment Period|Noncompliance|0
814938|NCT02175771|2664617|P7|Treatment Period|Noncompliance|0
814939|NCT02175771|2664618|P6|Treatment Period|Noncompliance|0
814940|NCT02175771|2664619|P5|Treatment Period|Noncompliance|0
814941|NCT02175771|2664620|P4|Treatment Period|Noncompliance|0
814942|NCT02175771|2664621|P3|Treatment Period|Noncompliance|2
814943|NCT02175771|2664622|P2|Treatment Period|Noncompliance|1
814944|NCT02175771|2664623|P1|Treatment Period|Noncompliance|0
814945|NCT02175771|2664615|P9|Treatment Period|Withdrawal by Subject|2
814946|NCT02175771|2664616|P8|Treatment Period|Withdrawal by Subject|9
814947|NCT02175771|2664617|P7|Treatment Period|Withdrawal by Subject|2
814948|NCT02175771|2664618|P6|Treatment Period|Withdrawal by Subject|4
814949|NCT02175771|2664619|P5|Treatment Period|Withdrawal by Subject|2
814950|NCT02175771|2664620|P4|Treatment Period|Withdrawal by Subject|6
814951|NCT02175771|2664621|P3|Treatment Period|Withdrawal by Subject|3
814952|NCT02175771|2664622|P2|Treatment Period|Withdrawal by Subject|9
814953|NCT02175771|2664623|P1|Treatment Period|Withdrawal by Subject|0
814954|NCT02175771|2664615|P9|Treatment Period|Adverse Event|1
814955|NCT02175771|2664616|P8|Treatment Period|Adverse Event|0
814956|NCT02175771|2664617|P7|Treatment Period|Adverse Event|2
814957|NCT02175771|2664618|P6|Treatment Period|Adverse Event|3
814958|NCT02175771|2664619|P5|Treatment Period|Adverse Event|1
814959|NCT02175771|2664620|P4|Treatment Period|Adverse Event|1
814960|NCT02175771|2664621|P3|Treatment Period|Adverse Event|1
814961|NCT02175771|2664622|P2|Treatment Period|Adverse Event|2
814962|NCT02175771|2664623|P1|Treatment Period|Adverse Event|0
814963|NCT02175771|2664615|P9|Run-In Period (Pre-assignment)|Not specified|0
814964|NCT02175771|2664616|P8|Run-In Period (Pre-assignment)|Not specified|0
814965|NCT02175771|2664617|P7|Run-In Period (Pre-assignment)|Not specified|0
814966|NCT02175771|2664618|P6|Run-In Period (Pre-assignment)|Not specified|0
814967|NCT02175771|2664619|P5|Run-In Period (Pre-assignment)|Not specified|0
814968|NCT02175771|2664620|P4|Run-In Period (Pre-assignment)|Not specified|0
814969|NCT02175771|2664621|P3|Run-In Period (Pre-assignment)|Not specified|0
814970|NCT02175771|2664622|P2|Run-In Period (Pre-assignment)|Not specified|0
814971|NCT02175771|2664623|P1|Run-In Period (Pre-assignment)|Not specified|8
814972|NCT02175771|2664615|P9|Run-In Period (Pre-assignment)|Lost to Follow-up|0
814973|NCT02175771|2664616|P8|Run-In Period (Pre-assignment)|Lost to Follow-up|0
814974|NCT02175771|2664617|P7|Run-In Period (Pre-assignment)|Lost to Follow-up|0
814975|NCT02175771|2664618|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
814976|NCT02175771|2664619|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
814977|NCT02175771|2664620|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
814978|NCT02175771|2664621|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
814979|NCT02175771|2664622|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
814980|NCT02175771|2664623|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
814981|NCT02175771|2664615|P9|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
814982|NCT02175771|2664616|P8|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
814983|NCT02175771|2664617|P7|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
814984|NCT02175771|2664618|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
814985|NCT02175771|2664619|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
814986|NCT02175771|2664620|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
814987|NCT02175771|2664621|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
814988|NCT02175771|2664622|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
814989|NCT02175771|2664623|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|7
814990|NCT02175771|2664615|P9|Run-In Period (Pre-assignment)|Adverse Event|0
814991|NCT02175771|2664616|P8|Run-In Period (Pre-assignment)|Adverse Event|0
814992|NCT02175771|2664617|P7|Run-In Period (Pre-assignment)|Adverse Event|0
814993|NCT02175771|2664618|P6|Run-In Period (Pre-assignment)|Adverse Event|0
814994|NCT02175771|2664619|P5|Run-In Period (Pre-assignment)|Adverse Event|0
814995|NCT02175771|2664620|P4|Run-In Period (Pre-assignment)|Adverse Event|0
814996|NCT02175771|2664621|P3|Run-In Period (Pre-assignment)|Adverse Event|0
814997|NCT02175771|2664622|P2|Run-In Period (Pre-assignment)|Adverse Event|0
814998|NCT02175771|2664623|P1|Run-In Period (Pre-assignment)|Adverse Event|9
814999|NCT02175771|2664615|P9|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
815000|NCT02175771|2664616|P8|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
815001|NCT02175771|2664617|P7|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
815002|NCT02175771|2664618|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
815003|NCT02175771|2664619|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
815004|NCT02175771|2664620|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
815005|NCT02175771|2664621|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
815006|NCT02175771|2664622|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
815007|NCT02175771|2664623|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|11
815008|NCT02175771|2664615|P9|Run-In Period (Pre-assignment)|Exclusion criteria met|0
815009|NCT02175771|2664616|P8|Run-In Period (Pre-assignment)|Exclusion criteria met|0
815010|NCT02175771|2664617|P7|Run-In Period (Pre-assignment)|Exclusion criteria met|0
815011|NCT02175771|2664618|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
815012|NCT02175771|2664619|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
815013|NCT02175771|2664620|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
815014|NCT02175771|2664621|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
815015|NCT02175771|2664622|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
815016|NCT02175771|2664623|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|20
815017|NCT02175771|2664615|P9|Run-In Period (Pre-assignment)|Randomization criteria not met|0
815018|NCT02175771|2664616|P8|Run-In Period (Pre-assignment)|Randomization criteria not met|0
815019|NCT02175771|2664617|P7|Run-In Period (Pre-assignment)|Randomization criteria not met|0
815020|NCT02175771|2664618|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
815021|NCT02175771|2664619|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
815022|NCT02175771|2664620|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
815023|NCT02175771|2664621|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
815024|NCT02175771|2664622|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
815025|NCT02175771|2664623|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|23
815026|NCT02175745|2664681|P1|Overall Study|Not Eligible|1
815027|NCT02175368|2664703|P1|Overall Study|Lost to Follow-up|1
815028|NCT02175277|2664707|P1|Overall Study|Protocol-specified Criteria|1
815029|NCT02175199|2664730|P2|Overall Study|Sponsor Decision|0
815030|NCT02175199|2664731|P1|Overall Study|Sponsor Decision|1
815031|NCT02175199|2664730|P2|Overall Study|Randomized in Error|0
815032|NCT02175199|2664731|P1|Overall Study|Randomized in Error|1
815033|NCT02175199|2664730|P2|Overall Study|Withdrawal by Subject|5
815034|NCT02175199|2664731|P1|Overall Study|Withdrawal by Subject|1
815035|NCT02175121|2664745|P5|Overall Study|Time issues|0
815036|NCT02175121|2664746|P4|Overall Study|Time issues|0
815037|NCT02175121|2664747|P3|Overall Study|Time issues|1
815038|NCT02175121|2664748|P2|Overall Study|Time issues|0
815039|NCT02175121|2664749|P1|Overall Study|Time issues|0
815040|NCT02175121|2664745|P5|Overall Study|Schedule conflict|0
815041|NCT02175121|2664746|P4|Overall Study|Schedule conflict|0
815042|NCT02175121|2664747|P3|Overall Study|Schedule conflict|1
815043|NCT02175121|2664748|P2|Overall Study|Schedule conflict|0
815044|NCT02175121|2664749|P1|Overall Study|Schedule conflict|0
815045|NCT02175121|2664745|P5|Overall Study|Personal emergency|1
815046|NCT02175121|2664746|P4|Overall Study|Personal emergency|0
815047|NCT02175121|2664747|P3|Overall Study|Personal emergency|0
815048|NCT02175121|2664748|P2|Overall Study|Personal emergency|0
815049|NCT02175121|2664749|P1|Overall Study|Personal emergency|0
815050|NCT02175121|2664745|P5|Overall Study|Lost to Follow-up|0
815051|NCT02175121|2664746|P4|Overall Study|Lost to Follow-up|1
815052|NCT02175121|2664747|P3|Overall Study|Lost to Follow-up|0
815053|NCT02175121|2664748|P2|Overall Study|Lost to Follow-up|1
815054|NCT02175121|2664749|P1|Overall Study|Lost to Follow-up|0
815055|NCT02175121|2664745|P5|Overall Study|Lack of Efficacy|0
815056|NCT02175121|2664746|P4|Overall Study|Lack of Efficacy|0
815057|NCT02175121|2664747|P3|Overall Study|Lack of Efficacy|0
815058|NCT02175121|2664748|P2|Overall Study|Lack of Efficacy|0
815059|NCT02175121|2664749|P1|Overall Study|Lack of Efficacy|1
815060|NCT02174861|2664876|P1|Overall Study|Lost to Follow-up|26
815061|NCT02174861|2664876|P1|Overall Study|Withdrawal by Subject|124
815062|NCT02174861|2664876|P1|Overall Study|Decision by sponsor|8
815063|NCT02173769|2664888|P1|Overall Study|Protocol Violation|4
815064|NCT02173704|2664901|P2|Overall Study|Withdrawal by Subject|4
815065|NCT02173704|2664902|P1|Overall Study|Withdrawal by Subject|9
815066|NCT02173704|2664901|P2|Overall Study|Protocol Violation|0
815067|NCT02173704|2664902|P1|Overall Study|Protocol Violation|1
815068|NCT02173704|2664901|P2|Overall Study|Other|0
815069|NCT02173704|2664902|P1|Overall Study|Other|1
815070|NCT02173704|2664901|P2|Overall Study|Lost to Follow-up|0
815071|NCT02173704|2664902|P1|Overall Study|Lost to Follow-up|1
815072|NCT02173704|2664901|P2|Overall Study|Adverse Event|0
815073|NCT02173704|2664902|P1|Overall Study|Adverse Event|1
815074|NCT02173548|2664928|P2|Overall Study|Withdrawal by Subject|0
815075|NCT02173548|2664929|P1|Overall Study|Withdrawal by Subject|1
815076|NCT02173548|2664928|P2|Overall Study|Lost to Follow-up|2
815077|NCT02173548|2664929|P1|Overall Study|Lost to Follow-up|0
815078|NCT02173379|2665040|P2|Overall Study|Withdrawn by the physician|1
815079|NCT02173379|2665041|P1|Overall Study|Withdrawn by the physician|0
815080|NCT02173379|2665040|P2|Overall Study|Death|1
815081|NCT02173379|2665041|P1|Overall Study|Death|1
815082|NCT02173379|2665040|P2|Overall Study|Physician Decision|1
815083|NCT02173379|2665041|P1|Overall Study|Physician Decision|4
815084|NCT02173379|2665040|P2|Overall Study|Withdrawal by Subject|4
815085|NCT02173379|2665041|P1|Overall Study|Withdrawal by Subject|1
815086|NCT02173379|2665040|P2|Overall Study|Lost to Follow-up|0
815087|NCT02173379|2665041|P1|Overall Study|Lost to Follow-up|3
815088|NCT02173158|2665107|P1|Efficacy Phase|Adverse Event|1
815089|NCT02173054|2665124|P3|Overall Study|Withdrawal by Subject|1
815090|NCT02173054|2665125|P2|Overall Study|Withdrawal by Subject|0
815091|NCT02173054|2665126|P1|Overall Study|Withdrawal by Subject|0
815092|NCT02173054|2665124|P3|Overall Study|lack of compliance|0
815093|NCT02173054|2665125|P2|Overall Study|lack of compliance|0
815094|NCT02173054|2665126|P1|Overall Study|lack of compliance|1
815095|NCT02172625|2665171|P2|Overall Study|car accident|1
815096|NCT02172625|2665172|P1|Overall Study|car accident|0
815097|NCT02172625|2665171|P2|Overall Study|Pregnancy|1
815098|NCT02172625|2665172|P1|Overall Study|Pregnancy|0
815099|NCT02172625|2665171|P2|Overall Study|Adverse Event|1
815100|NCT02172625|2665172|P1|Overall Study|Adverse Event|0
815101|NCT02172040|2665194|P4|Overall Study|Family emergency abroad|1
815102|NCT02172040|2665195|P3|Overall Study|Family emergency abroad|0
815103|NCT02172040|2665196|P2|Overall Study|Family emergency abroad|0
815104|NCT02172040|2665197|P1|Overall Study|Family emergency abroad|0
815105|NCT02172040|2665194|P4|Overall Study|Not available for Day 13 & 14 visits|0
815106|NCT02172040|2665195|P3|Overall Study|Not available for Day 13 & 14 visits|1
815107|NCT02172040|2665196|P2|Overall Study|Not available for Day 13 & 14 visits|0
815108|NCT02172040|2665197|P1|Overall Study|Not available for Day 13 & 14 visits|0
815109|NCT02172040|2665194|P4|Overall Study|Withdrawal by Subject|0
815110|NCT02172040|2665195|P3|Overall Study|Withdrawal by Subject|1
815111|NCT02172040|2665196|P2|Overall Study|Withdrawal by Subject|0
815112|NCT02172040|2665197|P1|Overall Study|Withdrawal by Subject|0
815113|NCT02172040|2665194|P4|Overall Study|Protocol Violation|0
815114|NCT02172040|2665195|P3|Overall Study|Protocol Violation|0
815115|NCT02172040|2665196|P2|Overall Study|Protocol Violation|1
815116|NCT02172040|2665197|P1|Overall Study|Protocol Violation|0
815117|NCT02172040|2665194|P4|Overall Study|Adverse Event|0
815118|NCT02172040|2665195|P3|Overall Study|Adverse Event|0
815119|NCT02172040|2665196|P2|Overall Study|Adverse Event|2
815120|NCT02172040|2665197|P1|Overall Study|Adverse Event|0
815121|NCT02170779|2665399|P2|Overall Study|Lost to Follow-up|1
815122|NCT02170779|2665400|P1|Overall Study|Lost to Follow-up|0
815123|NCT02170779|2665399|P2|Overall Study|Withdrawal by Subject|0
815124|NCT02170779|2665400|P1|Overall Study|Withdrawal by Subject|1
815125|NCT02170688|2665427|P5|Overall Study|Physician Decision|0
815126|NCT02170688|2665428|P4|Overall Study|Physician Decision|0
815127|NCT02170688|2665429|P3|Overall Study|Physician Decision|1
815128|NCT02170688|2665430|P2|Overall Study|Physician Decision|0
815129|NCT02170688|2665431|P1|Overall Study|Physician Decision|0
815130|NCT02170688|2665427|P5|Overall Study|Full dose not received|0
815131|NCT02170688|2665428|P4|Overall Study|Full dose not received|0
815132|NCT02170688|2665429|P3|Overall Study|Full dose not received|0
815133|NCT02170688|2665430|P2|Overall Study|Full dose not received|1
815134|NCT02170688|2665431|P1|Overall Study|Full dose not received|0
815135|NCT02170688|2665427|P5|Overall Study|Exclusion Criteria: Fatty Liver|0
815136|NCT02170688|2665428|P4|Overall Study|Exclusion Criteria: Fatty Liver|2
815137|NCT02170688|2665429|P3|Overall Study|Exclusion Criteria: Fatty Liver|3
815138|NCT02170688|2665430|P2|Overall Study|Exclusion Criteria: Fatty Liver|2
815139|NCT02170688|2665431|P1|Overall Study|Exclusion Criteria: Fatty Liver|4
815140|NCT02170207|2665604|P1|Overall Study|Case report forms unavailable|5
815141|NCT02170077|2665615|P3|Overall Study|Exacerbation of seizures|1
815142|NCT02170077|2665616|P2|Overall Study|Exacerbation of seizures|2
815143|NCT02170077|2665617|P1|Overall Study|Exacerbation of seizures|0
815144|NCT02170077|2665615|P3|Overall Study|Exclusion criteria|5
815145|NCT02170077|2665616|P2|Overall Study|Exclusion criteria|2
815146|NCT02170077|2665617|P1|Overall Study|Exclusion criteria|2
815147|NCT02170077|2665615|P3|Overall Study|Lost to Follow-up|0
815148|NCT02170077|2665616|P2|Overall Study|Lost to Follow-up|1
815149|NCT02170077|2665617|P1|Overall Study|Lost to Follow-up|0
815150|NCT02170077|2665615|P3|Overall Study|Adverse Event|4
815151|NCT02170077|2665616|P2|Overall Study|Adverse Event|4
815152|NCT02170077|2665617|P1|Overall Study|Adverse Event|4
815153|NCT02170077|2665615|P3|Overall Study|Withdrawal by Subject|2
815154|NCT02170077|2665616|P2|Overall Study|Withdrawal by Subject|4
815155|NCT02170077|2665617|P1|Overall Study|Withdrawal by Subject|3
815156|NCT02170064|2665628|P3|Overall Study|Physician Decision|0
815157|NCT02170064|2665629|P2|Overall Study|Physician Decision|1
815158|NCT02170064|2665630|P1|Overall Study|Physician Decision|1
815159|NCT02170064|2665628|P3|Overall Study|Withdrawal by Subject|1
815160|NCT02170064|2665629|P2|Overall Study|Withdrawal by Subject|1
815161|NCT02170064|2665630|P1|Overall Study|Withdrawal by Subject|5
815162|NCT02170025|2665646|P2|Overall Study|Adverse Event|0
815163|NCT02170025|2665647|P1|Overall Study|Adverse Event|2
815164|NCT02169414|2665797|P4|Overall Study|Adverse Event|0
815165|NCT02169414|2665798|P3|Overall Study|Adverse Event|0
815166|NCT02169414|2665799|P2|Overall Study|Adverse Event|1
815167|NCT02169414|2665800|P1|Overall Study|Adverse Event|0
815168|NCT02169414|2665797|P4|Overall Study|Withdrawal by Subject|0
815169|NCT02169414|2665798|P3|Overall Study|Withdrawal by Subject|0
815170|NCT02169414|2665799|P2|Overall Study|Withdrawal by Subject|0
815171|NCT02169414|2665800|P1|Overall Study|Withdrawal by Subject|1
815172|NCT02169336|2665841|P3|Overall Study|Subject declined to continue dosing|1
815173|NCT02169336|2665842|P2|Overall Study|Subject declined to continue dosing|0
815174|NCT02169336|2665843|P1|Overall Study|Subject declined to continue dosing|0
815175|NCT02169336|2665841|P3|Overall Study|Physician Decision|1
815176|NCT02169336|2665842|P2|Overall Study|Physician Decision|0
815177|NCT02169336|2665843|P1|Overall Study|Physician Decision|0
815178|NCT02169336|2665841|P3|Overall Study|Withdrawal by Subject|0
815179|NCT02169336|2665842|P2|Overall Study|Withdrawal by Subject|0
815180|NCT02169336|2665843|P1|Overall Study|Withdrawal by Subject|1
815181|NCT02169336|2665841|P3|Overall Study|Adverse Event|1
815182|NCT02169336|2665842|P2|Overall Study|Adverse Event|3
815183|NCT02169336|2665843|P1|Overall Study|Adverse Event|2
815184|NCT02169336|2665841|P3|Overall Study|Lack of Efficacy|0
815185|NCT02169336|2665842|P2|Overall Study|Lack of Efficacy|1
815186|NCT02169336|2665843|P1|Overall Study|Lack of Efficacy|1
815187|NCT02169219|2665851|P1|Overall Study|Lack of Efficacy|6
815188|NCT02168816|2665877|P2|Overall Study|Lost to Follow-up|2
815189|NCT02168816|2665878|P1|Overall Study|Lost to Follow-up|2
815190|NCT02168803|2665889|P3|Overall Study|Sponsor Decision|1
815191|NCT02168803|2665890|P2|Overall Study|Sponsor Decision|0
815192|NCT02168803|2665891|P1|Overall Study|Sponsor Decision|0
815193|NCT02168803|2665889|P3|Overall Study|Death|1
815194|NCT02168803|2665890|P2|Overall Study|Death|0
815195|NCT02168803|2665891|P1|Overall Study|Death|0
815196|NCT02168803|2665889|P3|Overall Study|Adverse Event|1
815197|NCT02168803|2665890|P2|Overall Study|Adverse Event|1
815198|NCT02168803|2665891|P1|Overall Study|Adverse Event|0
815199|NCT02168803|2665889|P3|Overall Study|Physician Decision|0
815200|NCT02168803|2665890|P2|Overall Study|Physician Decision|1
815201|NCT02168803|2665891|P1|Overall Study|Physician Decision|0
815202|NCT02168803|2665889|P3|Overall Study|Withdrawal by Subject|2
815203|NCT02168803|2665890|P2|Overall Study|Withdrawal by Subject|1
815204|NCT02168803|2665891|P1|Overall Study|Withdrawal by Subject|1
815205|NCT02168803|2665889|P3|Overall Study|Lost to Follow-up|1
815206|NCT02168803|2665890|P2|Overall Study|Lost to Follow-up|0
815207|NCT02168803|2665891|P1|Overall Study|Lost to Follow-up|1
815208|NCT02168777|2665921|P3|Overall Study|Other reason|0
815209|NCT02168777|2665922|P2|Overall Study|Other reason|1
815210|NCT02168777|2665923|P1|Overall Study|Other reason|0
815211|NCT02168777|2665921|P3|Overall Study|Clinical disease progression|2
815212|NCT02168777|2665922|P2|Overall Study|Clinical disease progression|1
815213|NCT02168777|2665923|P1|Overall Study|Clinical disease progression|0
815214|NCT02168777|2665921|P3|Overall Study|Radiological disease progression|5
815215|NCT02168777|2665922|P2|Overall Study|Radiological disease progression|5
815216|NCT02168777|2665923|P1|Overall Study|Radiological disease progression|0
815217|NCT02168777|2665921|P3|Overall Study|Disease recurrence|1
815218|NCT02168777|2665922|P2|Overall Study|Disease recurrence|0
815219|NCT02168777|2665923|P1|Overall Study|Disease recurrence|0
815220|NCT02168777|2665921|P3|Overall Study|Adverse Event|1
815221|NCT02168777|2665922|P2|Overall Study|Adverse Event|0
815222|NCT02168777|2665923|P1|Overall Study|Adverse Event|1
815223|NCT02168777|2665921|P3|Overall Study|Withdrawal by Subject|2
815224|NCT02168777|2665922|P2|Overall Study|Withdrawal by Subject|0
815225|NCT02168777|2665923|P1|Overall Study|Withdrawal by Subject|1
815226|NCT02168491|2666000|P1|Overall Study|Withdrawal by Subject|1
815227|NCT02168478|2666006|P1|Overall Study|Did Not Meet Exclusionary Criteria|1
815228|NCT02168478|2666006|P1|Overall Study|Did Not Consent to Participation|2
815229|NCT02168478|2666006|P1|Overall Study|Withdrawal by Subject|1
815230|NCT02168439|2666012|P2|Overall Study|Protocol Violation|2
815231|NCT02168439|2666013|P1|Overall Study|Protocol Violation|0
815232|NCT02168387|2666031|P2|Overall Study|Death|0
815233|NCT02168387|2666032|P1|Overall Study|Death|1
815234|NCT02168387|2666031|P2|Overall Study|Planned exubation|3
815235|NCT02168387|2666032|P1|Overall Study|Planned exubation|6
815236|NCT02168270|2666064|P1|Overall Study|Lack of Efficacy|4
815237|NCT02167893|2666071|P1|Overall Study|Case report forms not collected|68
815238|NCT02167893|2666071|P1|Overall Study|Investigator health reasons|10
815239|NCT02167893|2666071|P1|Overall Study|Investigator transferred|85
815240|NCT02167139|2666109|P4|Transition-extension|Lost to Follow-up|0
815241|NCT02167139|2666110|P3|Transition-extension|Lost to Follow-up|0
815242|NCT02167139|2666111|P2|Transition-extension|Lost to Follow-up|0
815243|NCT02167139|2666112|P1|Transition-extension|Lost to Follow-up|1
815244|NCT02167139|2666109|P4|Transition-extension|Other|0
815245|NCT02167139|2666110|P3|Transition-extension|Other|1
815246|NCT02167139|2666111|P2|Transition-extension|Other|0
815247|NCT02167139|2666112|P1|Transition-extension|Other|1
815248|NCT02167139|2666109|P4|Transition-extension|Lack of Efficacy|1
815249|NCT02167139|2666110|P3|Transition-extension|Lack of Efficacy|1
815250|NCT02167139|2666111|P2|Transition-extension|Lack of Efficacy|0
815251|NCT02167139|2666112|P1|Transition-extension|Lack of Efficacy|0
815252|NCT02167139|2666109|P4|Transition-extension|Withdrawal by Subject|1
815253|NCT02167139|2666110|P3|Transition-extension|Withdrawal by Subject|4
815254|NCT02167139|2666111|P2|Transition-extension|Withdrawal by Subject|0
815255|NCT02167139|2666112|P1|Transition-extension|Withdrawal by Subject|2
815256|NCT02167139|2666109|P4|Transition-extension|Adverse Event|3
815257|NCT02167139|2666110|P3|Transition-extension|Adverse Event|2
815258|NCT02167139|2666111|P2|Transition-extension|Adverse Event|0
815259|NCT02167139|2666112|P1|Transition-extension|Adverse Event|2
815260|NCT02167139|2666109|P4|Randomised, Double-blind|Other|0
815261|NCT02167139|2666110|P3|Randomised, Double-blind|Other|0
815262|NCT02167139|2666111|P2|Randomised, Double-blind|Other|0
815263|NCT02167139|2666112|P1|Randomised, Double-blind|Other|3
815264|NCT02167139|2666109|P4|Randomised, Double-blind|Lack of Efficacy|0
815265|NCT02167139|2666110|P3|Randomised, Double-blind|Lack of Efficacy|0
815266|NCT02167139|2666111|P2|Randomised, Double-blind|Lack of Efficacy|2
815267|NCT02167139|2666112|P1|Randomised, Double-blind|Lack of Efficacy|1
815268|NCT02167139|2666109|P4|Randomised, Double-blind|Adverse Event|0
815269|NCT02167139|2666110|P3|Randomised, Double-blind|Adverse Event|0
815270|NCT02167139|2666111|P2|Randomised, Double-blind|Adverse Event|9
815271|NCT02167139|2666112|P1|Randomised, Double-blind|Adverse Event|2
815272|NCT02167139|2666109|P4|Randomised, Double-blind|Withdrawal by Subject|0
815273|NCT02167139|2666110|P3|Randomised, Double-blind|Withdrawal by Subject|0
815274|NCT02167139|2666111|P2|Randomised, Double-blind|Withdrawal by Subject|8
815275|NCT02167139|2666112|P1|Randomised, Double-blind|Withdrawal by Subject|11
815276|NCT02167035|2666128|P2|Overall Study|Randomized to incorrect Study Medication|1
815277|NCT02167035|2666129|P1|Overall Study|Randomized to incorrect Study Medication|0
815278|NCT02167035|2666128|P2|Overall Study|Lost to Follow-up|3
815279|NCT02167035|2666129|P1|Overall Study|Lost to Follow-up|3
815280|NCT02167035|2666128|P2|Overall Study|Adverse Event|2
815281|NCT02167035|2666129|P1|Overall Study|Adverse Event|2
815282|NCT02166697|2666137|P1|Overall Study|Protocol Violation|347
815283|NCT02166476|2666148|P2|Overall Study|Unable to Come for Visit|3
815284|NCT02166476|2666149|P1|Overall Study|Unable to Come for Visit|0
815285|NCT02166476|2666148|P2|Overall Study|Physician Decision|0
815286|NCT02166476|2666149|P1|Overall Study|Physician Decision|1
815287|NCT02166476|2666148|P2|Overall Study|Lost to Follow-up|10
815288|NCT02166476|2666149|P1|Overall Study|Lost to Follow-up|5
815289|NCT02166476|2666148|P2|Overall Study|Adverse Event|3
815290|NCT02166476|2666149|P1|Overall Study|Adverse Event|3
815291|NCT02166476|2666148|P2|Overall Study|Withdrawal by Subject|7
815292|NCT02166476|2666149|P1|Overall Study|Withdrawal by Subject|5
815293|NCT02165826|2666194|P3|Down-Titration Period|Reason Not Specified|2
815294|NCT02165826|2666195|P2|Down-Titration Period|Reason Not Specified|0
815295|NCT02165826|2666196|P1|Down-Titration Period|Reason Not Specified|1
815296|NCT02165826|2666194|P3|Down-Titration Period|Voluntary Withdrawal|2
815297|NCT02165826|2666195|P2|Down-Titration Period|Voluntary Withdrawal|1
815298|NCT02165826|2666196|P1|Down-Titration Period|Voluntary Withdrawal|2
815299|NCT02165826|2666194|P3|Down-Titration Period|Pre-treatment Event/Adverse Event|3
815300|NCT02165826|2666195|P2|Down-Titration Period|Pre-treatment Event/Adverse Event|10
815301|NCT02165826|2666196|P1|Down-Titration Period|Pre-treatment Event/Adverse Event|4
815302|NCT02165826|2666194|P3|Main Treatment Period|Did Not Receive Study Drug|0
815303|NCT02165826|2666195|P2|Main Treatment Period|Did Not Receive Study Drug|2
815304|NCT02165826|2666196|P1|Main Treatment Period|Did Not Receive Study Drug|0
815305|NCT02165826|2666194|P3|Main Treatment Period|Reason Not Specified|16
815306|NCT02165826|2666195|P2|Main Treatment Period|Reason Not Specified|5
815307|NCT02165826|2666196|P1|Main Treatment Period|Reason Not Specified|8
815308|NCT02165826|2666194|P3|Main Treatment Period|Lack of Efficacy|0
815309|NCT02165826|2666195|P2|Main Treatment Period|Lack of Efficacy|0
815310|NCT02165826|2666196|P1|Main Treatment Period|Lack of Efficacy|2
815311|NCT02165826|2666194|P3|Main Treatment Period|Voluntary Withdrawal|21
815312|NCT02165826|2666195|P2|Main Treatment Period|Voluntary Withdrawal|23
815313|NCT02165826|2666196|P1|Main Treatment Period|Voluntary Withdrawal|23
815314|NCT02165826|2666194|P3|Main Treatment Period|Lost to Follow-up|1
815315|NCT02165826|2666195|P2|Main Treatment Period|Lost to Follow-up|2
815316|NCT02165826|2666196|P1|Main Treatment Period|Lost to Follow-up|4
815401|NCT02164916|2666465|P2|Overall Study|Adverse Event|8
815317|NCT02165826|2666194|P3|Main Treatment Period|Major/Significant Protocol Deviation|3
815318|NCT02165826|2666195|P2|Main Treatment Period|Major/Significant Protocol Deviation|1
815319|NCT02165826|2666196|P1|Main Treatment Period|Major/Significant Protocol Deviation|0
815320|NCT02165826|2666194|P3|Main Treatment Period|Pre-treatment Event/Adverse Event|68
815321|NCT02165826|2666195|P2|Main Treatment Period|Pre-treatment Event/Adverse Event|57
815322|NCT02165826|2666196|P1|Main Treatment Period|Pre-treatment Event/Adverse Event|44
815323|NCT02165735|2666264|P2|Overall Study|Protocol Violation|1
815324|NCT02165735|2666265|P1|Overall Study|Protocol Violation|0
815325|NCT02165735|2666264|P2|Overall Study|Participant indicated lack of time|3
815326|NCT02165735|2666265|P1|Overall Study|Participant indicated lack of time|1
815327|NCT02165735|2666264|P2|Overall Study|Withdrawal by Subject|0
815328|NCT02165735|2666265|P1|Overall Study|Withdrawal by Subject|3
815329|NCT02165735|2666264|P2|Overall Study|Lost to Follow-up|10
815330|NCT02165735|2666265|P1|Overall Study|Lost to Follow-up|12
815331|NCT02165202|2666305|P2|Injection Phase|Participant unwilling to comply|0
815332|NCT02165202|2666306|P1|Injection Phase|Participant unwilling to comply|1
815333|NCT02165202|2666305|P2|Injection Phase|No longer interested|1
815334|NCT02165202|2666306|P1|Injection Phase|No longer interested|0
815335|NCT02165202|2666305|P2|Injection Phase|Study Product related Toxicity|0
815336|NCT02165202|2666306|P1|Injection Phase|Study Product related Toxicity|1
815337|NCT02165202|2666305|P2|Injection Phase|End of Study|1
815338|NCT02165202|2666306|P1|Injection Phase|End of Study|2
815339|NCT02165202|2666305|P2|Injection Phase|QTcF>500 ms or increase of>60 ms|1
815340|NCT02165202|2666306|P1|Injection Phase|QTcF>500 ms or increase of>60 ms|0
815341|NCT02165202|2666305|P2|Injection Phase|Unable to attend within Visit Window|0
815342|NCT02165202|2666306|P1|Injection Phase|Unable to attend within Visit Window|1
815343|NCT02165202|2666305|P2|Injection Phase|Reactive HIV or HIV Suspected|2
815344|NCT02165202|2666306|P1|Injection Phase|Reactive HIV or HIV Suspected|0
815345|NCT02165202|2666305|P2|Injection Phase|Abnormal Lab Value|1
815346|NCT02165202|2666306|P1|Injection Phase|Abnormal Lab Value|5
815347|NCT02165202|2666305|P2|Oral Phase|Abnormal EKG|1
815348|NCT02165202|2666306|P1|Oral Phase|Abnormal EKG|0
815349|NCT02165202|2666305|P2|Oral Phase|Relocated, no follow-up planned|0
815350|NCT02165202|2666306|P1|Oral Phase|Relocated, no follow-up planned|1
815351|NCT02165202|2666305|P2|Oral Phase|CMC advised termination|0
815352|NCT02165202|2666306|P1|Oral Phase|CMC advised termination|1
815353|NCT02165202|2666305|P2|Oral Phase|QTcF>500 ms or increase of>60 ms|0
815354|NCT02165202|2666306|P1|Oral Phase|QTcF>500 ms or increase of>60 ms|1
815355|NCT02165202|2666305|P2|Oral Phase|Clinical reasons|0
815356|NCT02165202|2666306|P1|Oral Phase|Clinical reasons|1
815357|NCT02165202|2666305|P2|Oral Phase|Unable to contact Participant|1
815358|NCT02165202|2666306|P1|Oral Phase|Unable to contact Participant|1
815359|NCT02165202|2666305|P2|Oral Phase|Study product Related Toxicity|0
815360|NCT02165202|2666306|P1|Oral Phase|Study product Related Toxicity|1
815361|NCT02165202|2666305|P2|Oral Phase|Refused further participation|1
815362|NCT02165202|2666306|P1|Oral Phase|Refused further participation|5
815363|NCT02164981|2666343|P3|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
815364|NCT02164981|2666344|P2|Phase 2 (Day 14 - Day 28)|Protocol Violation|1
815365|NCT02164981|2666345|P1|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
815366|NCT02164981|2666343|P3|Phase 2 (Day 14 - Day 28)|Adverse Event|0
815367|NCT02164981|2666344|P2|Phase 2 (Day 14 - Day 28)|Adverse Event|1
815368|NCT02164981|2666345|P1|Phase 2 (Day 14 - Day 28)|Adverse Event|2
815369|NCT02164981|2666343|P3|Phase 1 (Day 0 - Day 14)|Adverse Event|0
815370|NCT02164981|2666344|P2|Phase 1 (Day 0 - Day 14)|Adverse Event|2
815371|NCT02164981|2666345|P1|Phase 1 (Day 0 - Day 14)|Adverse Event|0
815372|NCT02164981|2666343|P3|Started|Adverse Event|0
815373|NCT02164981|2666344|P2|Started|Adverse Event|2
815374|NCT02164981|2666345|P1|Started|Adverse Event|1
815375|NCT02164981|2666343|P3|Started|Protocol Violation|0
815376|NCT02164981|2666344|P2|Started|Protocol Violation|0
815377|NCT02164981|2666345|P1|Started|Protocol Violation|2
815378|NCT02164981|2666343|P3|Started|Withdrawal by Subject|0
815379|NCT02164981|2666344|P2|Started|Withdrawal by Subject|1
815380|NCT02164981|2666345|P1|Started|Withdrawal by Subject|2
815381|NCT02164929|2666418|P4|Overall Study|Failed regional block|0
815382|NCT02164929|2666419|P3|Overall Study|Failed regional block|1
815383|NCT02164929|2666420|P2|Overall Study|Failed regional block|0
815384|NCT02164929|2666421|P1|Overall Study|Failed regional block|0
815385|NCT02164929|2666418|P4|Overall Study|Converted to open procedure|2
815386|NCT02164929|2666419|P3|Overall Study|Converted to open procedure|0
815387|NCT02164929|2666420|P2|Overall Study|Converted to open procedure|0
815388|NCT02164929|2666421|P1|Overall Study|Converted to open procedure|1
815389|NCT02164916|2666465|P2|Overall Study|Not eligible|5
815390|NCT02164916|2666466|P1|Overall Study|Not eligible|2
815391|NCT02164916|2666465|P2|Overall Study|Reason under review|6
815392|NCT02164916|2666466|P1|Overall Study|Reason under review|1
815393|NCT02164916|2666465|P2|Overall Study|Not protocol specified|1
815394|NCT02164916|2666466|P1|Overall Study|Not protocol specified|5
815395|NCT02164916|2666465|P2|Overall Study|Progression|26
815396|NCT02164916|2666466|P1|Overall Study|Progression|37
815397|NCT02164916|2666465|P2|Overall Study|Refusal unrelated to adverse event|7
815398|NCT02164916|2666466|P1|Overall Study|Refusal unrelated to adverse event|3
815399|NCT02164916|2666465|P2|Overall Study|Death|1
815400|NCT02164916|2666466|P1|Overall Study|Death|1
815402|NCT02164916|2666466|P1|Overall Study|Adverse Event|3
815403|NCT02164864|2666486|P3|Overall Study|Other than stated|14
815404|NCT02164864|2666487|P2|Overall Study|Other than stated|4
815405|NCT02164864|2666488|P1|Overall Study|Other than stated|3
815406|NCT02164864|2666486|P3|Overall Study|Consent withdrawn, not due to AE|56
815407|NCT02164864|2666487|P2|Overall Study|Consent withdrawn, not due to AE|8
815408|NCT02164864|2666488|P1|Overall Study|Consent withdrawn, not due to AE|21
815409|NCT02164864|2666486|P3|Overall Study|Lost to Follow-up|2
815410|NCT02164864|2666487|P2|Overall Study|Lost to Follow-up|3
815411|NCT02164864|2666488|P1|Overall Study|Lost to Follow-up|4
815412|NCT02164864|2666486|P3|Overall Study|Protocol Violation|1
815413|NCT02164864|2666487|P2|Overall Study|Protocol Violation|4
815414|NCT02164864|2666488|P1|Overall Study|Protocol Violation|2
815415|NCT02164864|2666486|P3|Overall Study|Other Adverse Event (AE)|49
815416|NCT02164864|2666487|P2|Overall Study|Other Adverse Event (AE)|32
815417|NCT02164864|2666488|P1|Overall Study|Other Adverse Event (AE)|52
815418|NCT02164864|2666486|P3|Overall Study|Other pre-existing disease worsening|9
815419|NCT02164864|2666487|P2|Overall Study|Other pre-existing disease worsening|4
815420|NCT02164864|2666488|P1|Overall Study|Other pre-existing disease worsening|6
815421|NCT02164864|2666486|P3|Overall Study|Trial disease worsening|1
815422|NCT02164864|2666487|P2|Overall Study|Trial disease worsening|5
815423|NCT02164864|2666488|P1|Overall Study|Trial disease worsening|7
815424|NCT02164539|2666553|P7|Treatment Phase C (1 Week)|Physician Decision|1
815425|NCT02164539|2666554|P6|Treatment Phase C (1 Week)|Physician Decision|0
815426|NCT02164539|2666555|P5|Treatment Phase C (1 Week)|Physician Decision|0
815427|NCT02164539|2666556|P4|Treatment Phase C (1 Week)|Physician Decision|0
815428|NCT02164539|2666557|P3|Treatment Phase C (1 Week)|Physician Decision|0
815429|NCT02164539|2666558|P2|Treatment Phase C (1 Week)|Physician Decision|0
815430|NCT02164539|2666559|P1|Treatment Phase C (1 Week)|Physician Decision|0
815431|NCT02164539|2666553|P7|Treatment Phase C (1 Week)|Adverse Event|1
815432|NCT02164539|2666554|P6|Treatment Phase C (1 Week)|Adverse Event|0
815433|NCT02164539|2666555|P5|Treatment Phase C (1 Week)|Adverse Event|0
815434|NCT02164539|2666556|P4|Treatment Phase C (1 Week)|Adverse Event|0
815435|NCT02164539|2666557|P3|Treatment Phase C (1 Week)|Adverse Event|0
815436|NCT02164539|2666558|P2|Treatment Phase C (1 Week)|Adverse Event|0
815437|NCT02164539|2666559|P1|Treatment Phase C (1 Week)|Adverse Event|0
815438|NCT02164539|2666553|P7|Treatment Phase C (1 Week)|Withdrawal by Subject|0
815439|NCT02164539|2666554|P6|Treatment Phase C (1 Week)|Withdrawal by Subject|0
815440|NCT02164539|2666555|P5|Treatment Phase C (1 Week)|Withdrawal by Subject|0
815441|NCT02164539|2666556|P4|Treatment Phase C (1 Week)|Withdrawal by Subject|0
815442|NCT02164539|2666557|P3|Treatment Phase C (1 Week)|Withdrawal by Subject|0
815443|NCT02164539|2666558|P2|Treatment Phase C (1 Week)|Withdrawal by Subject|0
815444|NCT02164539|2666559|P1|Treatment Phase C (1 Week)|Withdrawal by Subject|1
815445|NCT02164539|2666553|P7|Treatment Phase B (1 Week)|Physician Decision|1
815446|NCT02164539|2666554|P6|Treatment Phase B (1 Week)|Physician Decision|0
815447|NCT02164539|2666555|P5|Treatment Phase B (1 Week)|Physician Decision|1
815448|NCT02164539|2666556|P4|Treatment Phase B (1 Week)|Physician Decision|0
815449|NCT02164539|2666557|P3|Treatment Phase B (1 Week)|Physician Decision|0
815450|NCT02164539|2666558|P2|Treatment Phase B (1 Week)|Physician Decision|0
815451|NCT02164539|2666559|P1|Treatment Phase B (1 Week)|Physician Decision|0
815452|NCT02164539|2666553|P7|Treatment Phase B (1 Week)|Adverse Event|0
815453|NCT02164539|2666554|P6|Treatment Phase B (1 Week)|Adverse Event|0
815454|NCT02164539|2666555|P5|Treatment Phase B (1 Week)|Adverse Event|2
815455|NCT02164539|2666556|P4|Treatment Phase B (1 Week)|Adverse Event|0
815456|NCT02164539|2666557|P3|Treatment Phase B (1 Week)|Adverse Event|0
815457|NCT02164539|2666558|P2|Treatment Phase B (1 Week)|Adverse Event|0
815458|NCT02164539|2666559|P1|Treatment Phase B (1 Week)|Adverse Event|0
815459|NCT02164539|2666553|P7|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
815460|NCT02164539|2666554|P6|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
815461|NCT02164539|2666555|P5|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3
815462|NCT02164539|2666556|P4|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
815463|NCT02164539|2666557|P3|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
815464|NCT02164539|2666558|P2|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
815465|NCT02164539|2666559|P1|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
815466|NCT02164513|2666607|P3|Overall Study|Other: Reason not provided by site|0
815467|NCT02164513|2666608|P2|Overall Study|Other: Reason not provided by site|0
815468|NCT02164513|2666609|P1|Overall Study|Other: Reason not provided by site|1
815469|NCT02164513|2666607|P3|Overall Study|Withdrawal by Subject|130
815470|NCT02164513|2666608|P2|Overall Study|Withdrawal by Subject|261
815471|NCT02164513|2666609|P1|Overall Study|Withdrawal by Subject|192
815472|NCT02164513|2666607|P3|Overall Study|Physician Decision|28
815473|NCT02164513|2666608|P2|Overall Study|Physician Decision|57
815474|NCT02164513|2666609|P1|Overall Study|Physician Decision|47
815475|NCT02164513|2666607|P3|Overall Study|Lost to Follow-up|22
815476|NCT02164513|2666608|P2|Overall Study|Lost to Follow-up|36
815477|NCT02164513|2666609|P1|Overall Study|Lost to Follow-up|30
815478|NCT02164513|2666607|P3|Overall Study|Other: Study Closed or terminated|4
815479|NCT02164513|2666608|P2|Overall Study|Other: Study Closed or terminated|2
815480|NCT02164513|2666609|P1|Overall Study|Other: Study Closed or terminated|5
815481|NCT02164513|2666607|P3|Overall Study|Adverse Event|111
815482|NCT02164513|2666608|P2|Overall Study|Adverse Event|180
815483|NCT02164513|2666609|P1|Overall Study|Adverse Event|162
815484|NCT02164318|2666648|P4|Overall Study|Withdrawal by Subject|1
815485|NCT02164318|2666649|P3|Overall Study|Withdrawal by Subject|0
815486|NCT02164318|2666650|P2|Overall Study|Withdrawal by Subject|1
815487|NCT02164318|2666651|P1|Overall Study|Withdrawal by Subject|0
815488|NCT02163993|2666674|P5|Post-treatment Period|Withdrawal by Subject|2
815489|NCT02163993|2666675|P4|Post-treatment Period|Withdrawal by Subject|1
815490|NCT02163993|2666676|P3|Post-treatment Period|Withdrawal by Subject|0
815491|NCT02163993|2666677|P2|Post-treatment Period|Withdrawal by Subject|4
815492|NCT02163993|2666678|P1|Post-treatment Period|Withdrawal by Subject|2
815493|NCT02163993|2666674|P5|Post-treatment Period|Protocol Violation|1
815494|NCT02163993|2666675|P4|Post-treatment Period|Protocol Violation|0
815495|NCT02163993|2666676|P3|Post-treatment Period|Protocol Violation|0
815496|NCT02163993|2666677|P2|Post-treatment Period|Protocol Violation|0
815497|NCT02163993|2666678|P1|Post-treatment Period|Protocol Violation|0
815498|NCT02163993|2666674|P5|Post-treatment Period|Lost to Follow-up|0
815499|NCT02163993|2666675|P4|Post-treatment Period|Lost to Follow-up|1
815500|NCT02163993|2666676|P3|Post-treatment Period|Lost to Follow-up|3
815501|NCT02163993|2666677|P2|Post-treatment Period|Lost to Follow-up|2
815502|NCT02163993|2666678|P1|Post-treatment Period|Lost to Follow-up|2
815503|NCT02163993|2666674|P5|Post-treatment Period|Adverse Event|0
815504|NCT02163993|2666675|P4|Post-treatment Period|Adverse Event|0
815505|NCT02163993|2666676|P3|Post-treatment Period|Adverse Event|1
815506|NCT02163993|2666677|P2|Post-treatment Period|Adverse Event|0
815507|NCT02163993|2666678|P1|Post-treatment Period|Adverse Event|0
815508|NCT02163993|2666674|P5|Treatment Period|Not treated|2
815509|NCT02163993|2666675|P4|Treatment Period|Not treated|1
815510|NCT02163993|2666676|P3|Treatment Period|Not treated|0
815511|NCT02163993|2666677|P2|Treatment Period|Not treated|0
815512|NCT02163993|2666678|P1|Treatment Period|Not treated|1
815513|NCT02163993|2666674|P5|Treatment Period|Withdrawal by Subject|1
815514|NCT02163993|2666675|P4|Treatment Period|Withdrawal by Subject|4
815515|NCT02163993|2666676|P3|Treatment Period|Withdrawal by Subject|1
815516|NCT02163993|2666677|P2|Treatment Period|Withdrawal by Subject|4
815517|NCT02163993|2666678|P1|Treatment Period|Withdrawal by Subject|6
815518|NCT02163993|2666674|P5|Treatment Period|Protocol Violation|2
815519|NCT02163993|2666675|P4|Treatment Period|Protocol Violation|1
815520|NCT02163993|2666676|P3|Treatment Period|Protocol Violation|0
815521|NCT02163993|2666677|P2|Treatment Period|Protocol Violation|1
815522|NCT02163993|2666678|P1|Treatment Period|Protocol Violation|2
815523|NCT02163993|2666674|P5|Treatment Period|Physician Decision|0
815524|NCT02163993|2666675|P4|Treatment Period|Physician Decision|0
815525|NCT02163993|2666676|P3|Treatment Period|Physician Decision|0
815526|NCT02163993|2666677|P2|Treatment Period|Physician Decision|0
815527|NCT02163993|2666678|P1|Treatment Period|Physician Decision|1
815528|NCT02163993|2666674|P5|Treatment Period|Lost to Follow-up|1
815529|NCT02163993|2666675|P4|Treatment Period|Lost to Follow-up|3
815530|NCT02163993|2666676|P3|Treatment Period|Lost to Follow-up|1
815531|NCT02163993|2666677|P2|Treatment Period|Lost to Follow-up|3
815532|NCT02163993|2666678|P1|Treatment Period|Lost to Follow-up|2
815533|NCT02163993|2666674|P5|Treatment Period|Adverse Event|1
815534|NCT02163993|2666675|P4|Treatment Period|Adverse Event|0
815535|NCT02163993|2666676|P3|Treatment Period|Adverse Event|0
815536|NCT02163993|2666677|P2|Treatment Period|Adverse Event|1
815537|NCT02163993|2666678|P1|Treatment Period|Adverse Event|0
815538|NCT02163915|2666759|P5|Overall Study|Physician Decision|0
815539|NCT02163915|2666760|P4|Overall Study|Physician Decision|1
815540|NCT02163915|2666761|P3|Overall Study|Physician Decision|0
815541|NCT02163915|2666762|P2|Overall Study|Physician Decision|0
815542|NCT02163915|2666763|P1|Overall Study|Physician Decision|0
815543|NCT02163915|2666759|P5|Overall Study|Study termination|2
815544|NCT02163915|2666760|P4|Overall Study|Study termination|0
815545|NCT02163915|2666761|P3|Overall Study|Study termination|0
815546|NCT02163915|2666762|P2|Overall Study|Study termination|0
815547|NCT02163915|2666763|P1|Overall Study|Study termination|1
815548|NCT02163915|2666759|P5|Overall Study|Withdrawal by Subject|2
815549|NCT02163915|2666760|P4|Overall Study|Withdrawal by Subject|2
815550|NCT02163915|2666761|P3|Overall Study|Withdrawal by Subject|2
815551|NCT02163915|2666762|P2|Overall Study|Withdrawal by Subject|0
815552|NCT02163915|2666763|P1|Overall Study|Withdrawal by Subject|2
815553|NCT02163733|2666818|P3|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19
815554|NCT02163733|2666819|P2|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
815555|NCT02163733|2666820|P1|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
815556|NCT02163733|2666818|P3|Part B: Day 15 to End Part B (AZD9291)|Death|5
815557|NCT02163733|2666819|P2|Part B: Day 15 to End Part B (AZD9291)|Death|0
815558|NCT02163733|2666820|P1|Part B: Day 15 to End Part B (AZD9291)|Death|0
815559|NCT02163538|2666857|P2|Overall Study|Physician Decision|1
815560|NCT02163538|2666858|P1|Overall Study|Physician Decision|0
815561|NCT02163538|2666857|P2|Overall Study|Protocol Violation|0
815562|NCT02163538|2666858|P1|Overall Study|Protocol Violation|1
815563|NCT02163499|2666874|P1|Extended Dosing Phase: ZS|Various reasons|16
815564|NCT02163499|2666874|P1|Extended Dosing Phase: ZS|Hyperkalemia|5
815565|NCT02163499|2666874|P1|Extended Dosing Phase: ZS|Subject Compliance|17
815566|NCT02163499|2666874|P1|Extended Dosing Phase: ZS|Death|8
815567|NCT02163499|2666874|P1|Extended Dosing Phase: ZS|Protocol Violation|2
815568|NCT02163499|2666874|P1|Extended Dosing Phase: ZS|Lost to Follow-up|31
815569|NCT02163499|2666874|P1|Extended Dosing Phase: ZS|Physician Decision|8
815570|NCT02163499|2666874|P1|Extended Dosing Phase: ZS|Withdrawal by Subject|81
815571|NCT02163499|2666874|P1|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7
815572|NCT02163499|2666874|P1|Extended Dosing Phase: ZS|Sponsor's Decision|5
815573|NCT02163499|2666874|P1|Extended Dosing Phase: ZS|Hypokalemia|9
815574|NCT02163499|2666874|P1|Extended Dosing Phase: ZS|Expected Progression of CKD|40
815575|NCT02163499|2666874|P1|Extended Dosing Phase: ZS|Adverse Event|51
815576|NCT02163499|2666874|P1|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1
815577|NCT02163499|2666874|P1|Acute Phase: ZS 10 g TID|Physician Decision|1
815578|NCT02163499|2666874|P1|Acute Phase: ZS 10 g TID|Protocol Violation|1
815579|NCT02163499|2666874|P1|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1
815580|NCT02163499|2666874|P1|Acute Phase: ZS 10 g TID|Participant's Compliance|1
815581|NCT02163447|2666902|P3|Overall Study|Became HIV infected at time of delivery|0
815582|NCT02163447|2666903|P2|Overall Study|Became HIV infected at time of delivery|0
815583|NCT02163447|2666904|P1|Overall Study|Became HIV infected at time of delivery|1
815584|NCT02163447|2666902|P3|Overall Study|Moved out of study area|2
815585|NCT02163447|2666903|P2|Overall Study|Moved out of study area|3
815586|NCT02163447|2666904|P1|Overall Study|Moved out of study area|2
815587|NCT02163447|2666902|P3|Overall Study|Lost to Follow-up|0
815588|NCT02163447|2666903|P2|Overall Study|Lost to Follow-up|3
815589|NCT02163447|2666904|P1|Overall Study|Lost to Follow-up|1
815590|NCT02163447|2666902|P3|Overall Study|Withdrawal by Subject|1
815591|NCT02163447|2666903|P2|Overall Study|Withdrawal by Subject|0
815592|NCT02163447|2666904|P1|Overall Study|Withdrawal by Subject|2
815593|NCT02163395|2666944|P1|Overall Study|Adverse Event|1
815594|NCT02163395|2666944|P1|Overall Study|Lost to Follow-up|3
815595|NCT02163395|2666944|P1|Overall Study|Withdrawal by Subject|1
815596|NCT02163187|2666953|P2|Overall Study|Progressive disease|0
815597|NCT02163187|2666954|P1|Overall Study|Progressive disease|1
815598|NCT02163187|2666953|P2|Overall Study|Device removed|0
815599|NCT02163187|2666954|P1|Overall Study|Device removed|1
815600|NCT02162862|2666978|P3|Overall Study|Subject did not feel the med was needed|4
815601|NCT02162862|2666979|P2|Overall Study|Subject did not feel the med was needed|0
815602|NCT02162862|2666980|P1|Overall Study|Subject did not feel the med was needed|0
815603|NCT02162862|2666978|P3|Overall Study|Lost to Follow-up|0
815604|NCT02162862|2666979|P2|Overall Study|Lost to Follow-up|11
815605|NCT02162862|2666980|P1|Overall Study|Lost to Follow-up|0
815606|NCT02162758|2666993|P2|Overall Study|Study termination|1
815607|NCT02162758|2666994|P1|Overall Study|Study termination|0
815608|NCT02161757|2667028|P3|Treatment Through Study Completion|Death|1
815609|NCT02161757|2667029|P2|Treatment Through Study Completion|Death|1
815610|NCT02161757|2667030|P1|Treatment Through Study Completion|Death|2
815611|NCT02161757|2667028|P3|Treatment Through Study Completion|Other|12
815612|NCT02161757|2667029|P2|Treatment Through Study Completion|Other|19
815613|NCT02161757|2667030|P1|Treatment Through Study Completion|Other|20
815614|NCT02161757|2667028|P3|Treatment Through Study Completion|Lost to Follow-up|4
815615|NCT02161757|2667029|P2|Treatment Through Study Completion|Lost to Follow-up|2
815616|NCT02161757|2667030|P1|Treatment Through Study Completion|Lost to Follow-up|7
815617|NCT02161757|2667028|P3|Treatment Through Study Completion|Withdrawal by Subject|20
815618|NCT02161757|2667029|P2|Treatment Through Study Completion|Withdrawal by Subject|19
815619|NCT02161757|2667030|P1|Treatment Through Study Completion|Withdrawal by Subject|27
815620|NCT02161757|2667028|P3|Treatment Through Study Completion|Protocol Violation|2
815621|NCT02161757|2667029|P2|Treatment Through Study Completion|Protocol Violation|1
815622|NCT02161757|2667030|P1|Treatment Through Study Completion|Protocol Violation|0
815623|NCT02161757|2667028|P3|Treatment Through Study Completion|Adverse Event|0
815624|NCT02161757|2667029|P2|Treatment Through Study Completion|Adverse Event|1
815625|NCT02161757|2667030|P1|Treatment Through Study Completion|Adverse Event|1
815626|NCT02161757|2667028|P3|Randomised Through Start Treatment|Did not receive treatment|0
815627|NCT02161757|2667029|P2|Randomised Through Start Treatment|Did not receive treatment|2
815628|NCT02161757|2667030|P1|Randomised Through Start Treatment|Did not receive treatment|3
815629|NCT02161731|2667088|P2|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1
815630|NCT02161731|2667089|P1|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0
815631|NCT02161731|2667088|P2|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1
815632|NCT02161731|2667089|P1|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0
815633|NCT02161562|2667108|P2|Overall Study|Participant moved out of province|0
815634|NCT02161562|2667109|P1|Overall Study|Participant moved out of province|1
815635|NCT02161562|2667108|P2|Overall Study|Withdrew due to being out of the country|0
815636|NCT02161562|2667109|P1|Overall Study|Withdrew due to being out of the country|1
815637|NCT02161562|2667108|P2|Overall Study|Participant moved back to home country|0
815638|NCT02161562|2667109|P1|Overall Study|Participant moved back to home country|1
815639|NCT02161562|2667108|P2|Overall Study|Adverse Event|1
815640|NCT02161562|2667109|P1|Overall Study|Adverse Event|1
815641|NCT02161562|2667108|P2|Overall Study|Lack of Efficacy|1
815642|NCT02161562|2667109|P1|Overall Study|Lack of Efficacy|4
815643|NCT02161562|2667108|P2|Overall Study|Lost to Follow-up|1
815644|NCT02161562|2667109|P1|Overall Study|Lost to Follow-up|3
815645|NCT02161562|2667108|P2|Overall Study|Pregnancy|2
815646|NCT02161562|2667109|P1|Overall Study|Pregnancy|1
815647|NCT02161562|2667108|P2|Overall Study|Protocol Violation|4
815648|NCT02161562|2667109|P1|Overall Study|Protocol Violation|9
815649|NCT02161562|2667108|P2|Overall Study|Withdrawal by Subject|8
815650|NCT02161562|2667109|P1|Overall Study|Withdrawal by Subject|5
815651|NCT02161549|2667137|P2|Overall Study|Physician Decision|2
815652|NCT02161549|2667138|P1|Overall Study|Physician Decision|6
815653|NCT02161146|2667187|P5|Overall Study|Other Miscellaneous Reasons|0
815654|NCT02161146|2667188|P4|Overall Study|Other Miscellaneous Reasons|0
815655|NCT02161146|2667189|P3|Overall Study|Other Miscellaneous Reasons|0
815656|NCT02161146|2667190|P2|Overall Study|Other Miscellaneous Reasons|1
815657|NCT02161146|2667191|P1|Overall Study|Other Miscellaneous Reasons|0
815658|NCT02161146|2667187|P5|Overall Study|Personal Reasons|1
815659|NCT02161146|2667188|P4|Overall Study|Personal Reasons|2
815660|NCT02161146|2667189|P3|Overall Study|Personal Reasons|0
815661|NCT02161146|2667190|P2|Overall Study|Personal Reasons|1
815662|NCT02161146|2667191|P1|Overall Study|Personal Reasons|0
815663|NCT02161146|2667187|P5|Overall Study|Lost to Follow-up|0
815664|NCT02161146|2667188|P4|Overall Study|Lost to Follow-up|0
815665|NCT02161146|2667189|P3|Overall Study|Lost to Follow-up|0
815666|NCT02161146|2667190|P2|Overall Study|Lost to Follow-up|1
815667|NCT02161146|2667191|P1|Overall Study|Lost to Follow-up|0
815668|NCT02161146|2667187|P5|Overall Study|Adverse Event|0
815669|NCT02161146|2667188|P4|Overall Study|Adverse Event|1
815670|NCT02161146|2667189|P3|Overall Study|Adverse Event|0
815671|NCT02161146|2667190|P2|Overall Study|Adverse Event|1
815672|NCT02161146|2667191|P1|Overall Study|Adverse Event|1
815673|NCT02161016|2667204|P1|Overall Study|withdrawn by IRB|1
815674|NCT02160977|2667235|P2|Six Months After Surgery|Lost to Follow-up|1
815675|NCT02160977|2667236|P1|Six Months After Surgery|Lost to Follow-up|2
815676|NCT02160977|2667235|P2|Three Months After Surgery|Lost to Follow-up|2
815677|NCT02160977|2667236|P1|Three Months After Surgery|Lost to Follow-up|0
815678|NCT02160977|2667235|P2|Six Weeks After Surgery|Lost to Follow-up|0
815679|NCT02160977|2667236|P1|Six Weeks After Surgery|Lost to Follow-up|1
815680|NCT02160314|2667281|P2|Overall Study|Lost to Follow-up|1
815681|NCT02160314|2667282|P1|Overall Study|Lost to Follow-up|0
815682|NCT02160314|2667281|P2|Overall Study|Withdrawal by Subject|2
815683|NCT02160314|2667282|P1|Overall Study|Withdrawal by Subject|1
815684|NCT02160314|2667281|P2|Overall Study|Protocol Violation|4
815685|NCT02160314|2667282|P1|Overall Study|Protocol Violation|0
815686|NCT02160314|2667281|P2|Overall Study|Adverse Event|6
815687|NCT02160314|2667282|P1|Overall Study|Adverse Event|0
815688|NCT02160145|2667290|P3|Randomized Double-blind Period|Physician Decision|5
815689|NCT02160145|2667291|P2|Randomized Double-blind Period|Physician Decision|7
815690|NCT02160145|2667292|P1|Randomized Double-blind Period|Physician Decision|0
815691|NCT02160145|2667290|P3|Randomized Double-blind Period|Lost to Follow-up|3
815692|NCT02160145|2667291|P2|Randomized Double-blind Period|Lost to Follow-up|1
815693|NCT02160145|2667292|P1|Randomized Double-blind Period|Lost to Follow-up|0
815694|NCT02160145|2667290|P3|Randomized Double-blind Period|Subject decision|20
815695|NCT02160145|2667291|P2|Randomized Double-blind Period|Subject decision|21
815696|NCT02160145|2667292|P1|Randomized Double-blind Period|Subject decision|0
815697|NCT02160145|2667290|P3|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
815698|NCT02160145|2667291|P2|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
815699|NCT02160145|2667292|P1|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126
815700|NCT02160145|2667290|P3|Prerandomization Single-blind Period|Placebo run-in failure|0
815701|NCT02160145|2667291|P2|Prerandomization Single-blind Period|Placebo run-in failure|0
815702|NCT02160145|2667292|P1|Prerandomization Single-blind Period|Placebo run-in failure|23
815703|NCT02160002|2667307|P2|Overall Study|Withdrawal by Subject|1
815704|NCT02160002|2667308|P1|Overall Study|Withdrawal by Subject|2
815705|NCT02159950|2667340|P2|Overall Study|Progression|1
815706|NCT02159950|2667341|P1|Overall Study|Progression|0
815707|NCT02159950|2667340|P2|Overall Study|Adverse Event|1
815708|NCT02159950|2667341|P1|Overall Study|Adverse Event|0
815709|NCT02159482|2667413|P1|Overall Study|Physician Decision|3
815710|NCT02159482|2667413|P1|Overall Study|Withdrawal by Subject|2
815711|NCT02159469|2667418|P1|Overall Study|Multiple|29
815712|NCT02159469|2667418|P1|Overall Study|Other|1
815713|NCT02159469|2667418|P1|Overall Study|Met Stopping Criteria|3
815714|NCT02159469|2667418|P1|Overall Study|Sponsor's request|2
815715|NCT02159469|2667418|P1|Overall Study|Lost to Follow-up|1
815716|NCT02159469|2667418|P1|Overall Study|Withdrawal by Subject|9
815717|NCT02159469|2667418|P1|Overall Study|Non-compliance|2
815718|NCT02159469|2667418|P1|Overall Study|Adverse Event|5
815719|NCT02159469|2667418|P1|Overall Study|Missing Completion status|1
815720|NCT02159365|2667423|P1|Overall Study|Other|1
815721|NCT02159365|2667423|P1|Overall Study|Subject Withdrew Consent|1
815722|NCT02159365|2667423|P1|Overall Study|Subject Request to Discontinue Treatment|1
815723|NCT02159365|2667423|P1|Overall Study|Study Drug Toxicity|1
815724|NCT02159365|2667423|P1|Overall Study|Lost to Follow-up|1
815725|NCT02159365|2667423|P1|Overall Study|Adverse Event Unrelated to Study Drug|6
815726|NCT02159365|2667423|P1|Overall Study|Disease Progression|11
815727|NCT02159352|2667429|P2|Overall Study|Withdrawal by Subject|1
815728|NCT02159352|2667430|P1|Overall Study|Withdrawal by Subject|0
815729|NCT02159352|2667429|P2|Overall Study|Adverse Event|1
815730|NCT02159352|2667430|P1|Overall Study|Adverse Event|3
815731|NCT02159040|2667505|P1|Overall Study|Death|1
815732|NCT02158975|2667518|P1|Overall Study|Did not complete 1 cycle nor > 1dose|1
815733|NCT02158936|2667528|P2|Overall Study|Lost to Follow-up|1
815734|NCT02158936|2667529|P1|Overall Study|Lost to Follow-up|0
815735|NCT02158936|2667528|P2|Overall Study|Physician Decision|13
815736|NCT02158936|2667529|P1|Overall Study|Physician Decision|15
815737|NCT02158936|2667528|P2|Overall Study|Withdrawal by Subject|16
815738|NCT02158936|2667529|P1|Overall Study|Withdrawal by Subject|15
815739|NCT02158936|2667528|P2|Overall Study|Adverse Event|24
815740|NCT02158936|2667529|P1|Overall Study|Adverse Event|39
815741|NCT02158936|2667528|P2|Overall Study|Azacitidine tx discontinued|46
815742|NCT02158936|2667529|P1|Overall Study|Azacitidine tx discontinued|53
815743|NCT02158936|2667528|P2|Overall Study|Study closed/ terminated|77
815744|NCT02158936|2667529|P1|Overall Study|Study closed/ terminated|57
815745|NCT02158728|2667571|P1|Overall Study|no qualified dataset|24
815746|NCT02158728|2667571|P1|Overall Study|no procedure according to CIP done|3
815747|NCT02158442|2667588|P2|Overall Study|Perfusion staff not available|0
815748|NCT02158442|2667589|P1|Overall Study|Perfusion staff not available|1
815749|NCT02158442|2667588|P2|Overall Study|Withdrawal by Subject|0
815750|NCT02158442|2667589|P1|Overall Study|Withdrawal by Subject|1
815751|NCT02158364|2667595|P1|Overall Study|Protocol Deviation|50
815752|NCT02158364|2667595|P1|Overall Study|Case report forms uncollected|10
815753|NCT02158247|2667613|P1|Overall Study|Invisible vocal cords|5
815754|NCT02158039|2667629|P1|Overall Study|Screen Failure|9
815755|NCT02158039|2667629|P1|Overall Study|Withdrawal by Subject|1
815756|NCT02157948|2667636|P2|Overall Study|Decision by Sponsor|1
815757|NCT02157948|2667637|P1|Overall Study|Decision by Sponsor|0
815758|NCT02157948|2667636|P2|Overall Study|Protocol Specified Criteria|1
815759|NCT02157948|2667637|P1|Overall Study|Protocol Specified Criteria|2
815760|NCT02157948|2667636|P2|Overall Study|Lost to Follow-up|2
815761|NCT02157948|2667637|P1|Overall Study|Lost to Follow-up|3
815762|NCT02157948|2667636|P2|Overall Study|Withdrawal by Subject|5
815763|NCT02157948|2667637|P1|Overall Study|Withdrawal by Subject|4
815764|NCT02157935|2667649|P2|Overall Study|Adverse Event|5
815765|NCT02157935|2667650|P1|Overall Study|Adverse Event|3
815766|NCT02157935|2667649|P2|Overall Study|Death|4
815767|NCT02157935|2667650|P1|Overall Study|Death|4
815768|NCT02157935|2667649|P2|Overall Study|Lack of Efficacy|1
815769|NCT02157935|2667650|P1|Overall Study|Lack of Efficacy|0
815770|NCT02157935|2667649|P2|Overall Study|Other|12
815771|NCT02157935|2667650|P1|Overall Study|Other|5
815772|NCT02157935|2667649|P2|Overall Study|Progressive disease|2
815773|NCT02157935|2667650|P1|Overall Study|Progressive disease|0
815774|NCT02157935|2667649|P2|Overall Study|Protocol Violation|0
815775|NCT02157935|2667650|P1|Overall Study|Protocol Violation|1
815776|NCT02157935|2667649|P2|Overall Study|Screen failure|2
815777|NCT02157935|2667650|P1|Overall Study|Screen failure|1
815778|NCT02157935|2667649|P2|Overall Study|Withdrawal by Subject|39
815779|NCT02157935|2667650|P1|Overall Study|Withdrawal by Subject|25
815780|NCT02157883|2667676|P1|Part B: Day 19 to End Part B (AZD9291)|Death|3
815781|NCT02157883|2667676|P1|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1
815782|NCT02157883|2667676|P1|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15
815783|NCT02157883|2667676|P1|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3
815784|NCT02157883|2667676|P1|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1
815785|NCT02157623|2667707|P2|Overall Study|Physician Decision|3
815786|NCT02157623|2667708|P1|Overall Study|Physician Decision|4
815787|NCT02157519|2667716|P2|Overall Study|Lost to Follow-up|0
815788|NCT02157519|2667717|P1|Overall Study|Lost to Follow-up|1
815789|NCT02157519|2667716|P2|Overall Study|Withdrawal by Subject|0
815790|NCT02157519|2667717|P1|Overall Study|Withdrawal by Subject|7
815791|NCT02157519|2667716|P2|Overall Study|Death|1
815792|NCT02157519|2667717|P1|Overall Study|Death|3
815793|NCT02157376|2667737|P2|Overall Study|Investigator's misjudgement|2
815794|NCT02157376|2667738|P1|Overall Study|Investigator's misjudgement|1
815795|NCT02157376|2667737|P2|Overall Study|Not treated|3
815796|NCT02157376|2667738|P1|Overall Study|Not treated|8
815797|NCT02157376|2667737|P2|Overall Study|Withdrawal by Subject|8
815798|NCT02157376|2667738|P1|Overall Study|Withdrawal by Subject|3
815799|NCT02157376|2667737|P2|Overall Study|Eligibility criteria not fulfilled|1
815800|NCT02157376|2667738|P1|Overall Study|Eligibility criteria not fulfilled|0
815801|NCT02157376|2667737|P2|Overall Study|Death|4
815802|NCT02157376|2667738|P1|Overall Study|Death|10
815803|NCT02157298|2667748|P2|Overall Study|Withdrawal by Subject|0
815804|NCT02157298|2667749|P1|Overall Study|Withdrawal by Subject|1
815805|NCT02157298|2667748|P2|Overall Study|Poor/Non-compliance|0
815806|NCT02157298|2667749|P1|Overall Study|Poor/Non-compliance|1
815807|NCT02157298|2667748|P2|Overall Study|Subject no longer meets study criteria|2
815808|NCT02157298|2667749|P1|Overall Study|Subject no longer meets study criteria|1
815809|NCT02157298|2667748|P2|Overall Study|Adverse Event|0
815810|NCT02157298|2667749|P1|Overall Study|Adverse Event|1
815811|NCT02157116|2667788|P1|Overall Study|Failed Screening|2
815812|NCT02157116|2667788|P1|Overall Study|Physician Decision|3
815813|NCT02157116|2667788|P1|Overall Study|Withdrawal by Subject|4
815814|NCT02156492|2667806|P3|Period 3|Adverse Event|0
815815|NCT02156492|2667807|P2|Period 3|Adverse Event|1
815816|NCT02156492|2667808|P1|Period 3|Adverse Event|0
815817|NCT02156492|2667806|P3|Period 1|No Reason Given|0
815818|NCT02156492|2667807|P2|Period 1|No Reason Given|1
815819|NCT02156492|2667808|P1|Period 1|No Reason Given|0
815820|NCT02156466|2667834|P5|Overall Study|Quantiferon Positivity|0
815821|NCT02156466|2667835|P4|Overall Study|Quantiferon Positivity|1
815822|NCT02156466|2667836|P3|Overall Study|Quantiferon Positivity|0
815823|NCT02156466|2667837|P2|Overall Study|Quantiferon Positivity|0
815824|NCT02156466|2667838|P1|Overall Study|Quantiferon Positivity|0
815825|NCT02156466|2667834|P5|Overall Study|Adverse Event|0
815826|NCT02156466|2667835|P4|Overall Study|Adverse Event|1
815827|NCT02156466|2667836|P3|Overall Study|Adverse Event|1
815828|NCT02156466|2667837|P2|Overall Study|Adverse Event|0
815829|NCT02156466|2667838|P1|Overall Study|Adverse Event|0
815830|NCT02156271|2668019|P2|Overall Study|Physician Decision|3
815831|NCT02156271|2668020|P1|Overall Study|Physician Decision|4
815832|NCT02155985|2668059|P3|Overall Study|Lost to Follow-up|0
815833|NCT02155985|2668060|P2|Overall Study|Lost to Follow-up|0
815834|NCT02155985|2668061|P1|Overall Study|Lost to Follow-up|1
815835|NCT02155985|2668059|P3|Overall Study|Withdrawal by Subject|1
815836|NCT02155985|2668060|P2|Overall Study|Withdrawal by Subject|0
815837|NCT02155985|2668061|P1|Overall Study|Withdrawal by Subject|0
815838|NCT02155881|2668128|P2|Overall Study|Inappropriately randomized|2
815839|NCT02155881|2668129|P1|Overall Study|Inappropriately randomized|2
815840|NCT02155881|2668128|P2|Overall Study|Withdrawal by Subject|2
815841|NCT02155881|2668129|P1|Overall Study|Withdrawal by Subject|0
815842|NCT02155738|2668153|P4|Overall Study|Missing critical information|1
815843|NCT02155738|2668154|P3|Overall Study|Missing critical information|0
815844|NCT02155738|2668155|P2|Overall Study|Missing critical information|0
815845|NCT02155738|2668156|P1|Overall Study|Missing critical information|1
815846|NCT02155322|2668206|P1|Overall Study|Withdrawal by Subject|4
815847|NCT02155322|2668206|P1|Overall Study|Relapse/Recurrence|8
815848|NCT02155322|2668206|P1|Overall Study|Physician Decision|1
815849|NCT02155322|2668206|P1|Overall Study|Adverse Event|1
815850|NCT02155309|2668213|P3|Overall Study|Protocol Violation|1
815851|NCT02155309|2668214|P2|Overall Study|Protocol Violation|0
815852|NCT02155309|2668215|P1|Overall Study|Protocol Violation|0
815853|NCT02155283|2668222|P1|Overall Study|Protocol Violation|3
815854|NCT02155283|2668222|P1|Overall Study|Withdrawal by Subject|1
815855|NCT02155283|2668222|P1|Overall Study|Lost to Follow-up|3
815856|NCT02154425|2668249|P1|Screening Period|Adverse Event|1
815857|NCT02154139|2668308|P1|Overall Study|Investigator transferred|3
815858|NCT02154139|2668308|P1|Overall Study|Other|2
815859|NCT02154139|2668308|P1|Overall Study|Injection not administered|2
815860|NCT02154087|2668316|P1|Overall Study|Study Termination|1
815861|NCT02154061|2668322|P2|Overall Study|enrolled but not vaccinated|0
815862|NCT02154061|2668323|P1|Overall Study|enrolled but not vaccinated|1
815863|NCT02154061|2668322|P2|Overall Study|Pregnancy|0
815864|NCT02154061|2668323|P1|Overall Study|Pregnancy|1
815865|NCT02153918|2668342|P1|Overall Study|Refused further treatment|1
815866|NCT02153827|2668353|P2|Overall Study|Lost to Follow-up|9
815867|NCT02153827|2668354|P1|Overall Study|Lost to Follow-up|3
815868|NCT02153788|2668370|P2|Overall Study|Physician Decision|1
815869|NCT02153788|2668371|P1|Overall Study|Physician Decision|2
815870|NCT02153736|2668391|P2|Overall Study|Withdrawal by Subject|1
815871|NCT02153736|2668392|P1|Overall Study|Withdrawal by Subject|0
815872|NCT02153736|2668391|P2|Overall Study|Death|1
815873|NCT02153736|2668392|P1|Overall Study|Death|0
815874|NCT02153736|2668391|P2|Overall Study|Medical status change made ineligible|0
815875|NCT02153736|2668392|P1|Overall Study|Medical status change made ineligible|1
815876|NCT02153736|2668391|P2|Overall Study|Lost to Follow-up|0
815877|NCT02153736|2668392|P1|Overall Study|Lost to Follow-up|1
815878|NCT02153398|2668470|P5|Overall Study|Adverse Event|0
815879|NCT02153398|2668471|P4|Overall Study|Adverse Event|1
815880|NCT02153398|2668472|P3|Overall Study|Adverse Event|1
815881|NCT02153398|2668473|P2|Overall Study|Adverse Event|0
815882|NCT02153398|2668474|P1|Overall Study|Adverse Event|0
815883|NCT02153398|2668470|P5|Overall Study|Withdrawal by Subject|0
815884|NCT02153398|2668471|P4|Overall Study|Withdrawal by Subject|0
815885|NCT02153398|2668472|P3|Overall Study|Withdrawal by Subject|0
815886|NCT02153398|2668473|P2|Overall Study|Withdrawal by Subject|0
815887|NCT02153398|2668474|P1|Overall Study|Withdrawal by Subject|1
815888|NCT02153346|2668596|P1|Overall Study|Lost to Follow-up|11
815889|NCT02153086|2668670|P1|Overall Study|Other|2
815890|NCT02153086|2668670|P1|Overall Study|Not enrolled >=28 days and <=56 days|2
815891|NCT02152605|2668686|P2|Overall Study|Withdrew consent|2
815892|NCT02152605|2668687|P1|Overall Study|Withdrew consent|4
815893|NCT02152605|2668686|P2|Overall Study|Lost to Follow-up|0
815894|NCT02152605|2668687|P1|Overall Study|Lost to Follow-up|1
815895|NCT02152605|2668686|P2|Overall Study|Protocol deviation|4
815896|NCT02152605|2668687|P1|Overall Study|Protocol deviation|1
815897|NCT02152605|2668686|P2|Overall Study|Lack of Efficacy|4
815898|NCT02152605|2668687|P1|Overall Study|Lack of Efficacy|7
815899|NCT02152605|2668686|P2|Overall Study|Adverse Event|8
815900|NCT02152605|2668687|P1|Overall Study|Adverse Event|6
815901|NCT02152566|2668697|P1|Overall Study|Withdrawal by Subject|2
815902|NCT02152566|2668697|P1|Overall Study|Lost to Follow-up|1
815903|NCT02152371|2668703|P2|Overall Study|Reason Not Given|1
815904|NCT02152371|2668704|P1|Overall Study|Reason Not Given|0
815905|NCT02152371|2668703|P2|Overall Study|Physician Decision|2
815906|NCT02152371|2668704|P1|Overall Study|Physician Decision|0
815907|NCT02152371|2668703|P2|Overall Study|Lack of Efficacy|1
815908|NCT02152371|2668704|P1|Overall Study|Lack of Efficacy|0
815909|NCT02152371|2668703|P2|Overall Study|Lost to Follow-up|0
815910|NCT02152371|2668704|P1|Overall Study|Lost to Follow-up|1
815911|NCT02152371|2668703|P2|Overall Study|Protocol Violation|3
815912|NCT02152371|2668704|P1|Overall Study|Protocol Violation|2
815913|NCT02152371|2668703|P2|Overall Study|Withdrawal by Subject|7
815914|NCT02152371|2668704|P1|Overall Study|Withdrawal by Subject|3
815915|NCT02152371|2668703|P2|Overall Study|Adverse Event|2
815916|NCT02152371|2668704|P1|Overall Study|Adverse Event|6
815917|NCT02152007|2668740|P1|Overall Study|Withdrawal by Subject|1
815918|NCT02151981|2668801|P2|Overall Study|Eligibility criteria not fulfilled|1
815919|NCT02151981|2668802|P1|Overall Study|Eligibility criteria not fulfilled|0
815920|NCT02151981|2668801|P2|Overall Study|Ongoing Study at Data Cut-off|95
815921|NCT02151981|2668802|P1|Overall Study|Ongoing Study at Data Cut-off|224
815922|NCT02151981|2668801|P2|Overall Study|Withdrawal by Subject|18
815923|NCT02151981|2668802|P1|Overall Study|Withdrawal by Subject|19
815924|NCT02151981|2668801|P2|Overall Study|Lost to Follow-up|0
815925|NCT02151981|2668802|P1|Overall Study|Lost to Follow-up|1
815926|NCT02151981|2668801|P2|Overall Study|Death|26
815927|NCT02151981|2668802|P1|Overall Study|Death|35
815928|NCT02151851|2668820|P2|Overall Study|Adverse Event|28
815929|NCT02151851|2668821|P1|Overall Study|Adverse Event|6
815930|NCT02151851|2668820|P2|Overall Study|Subject entered into study in error|1
815931|NCT02151851|2668821|P1|Overall Study|Subject entered into study in error|0
815932|NCT02151851|2668820|P2|Overall Study|Low compliance to study visits|1
815933|NCT02151851|2668821|P1|Overall Study|Low compliance to study visits|0
815934|NCT02151851|2668820|P2|Overall Study|Medical impairment|0
815935|NCT02151851|2668821|P1|Overall Study|Medical impairment|1
815936|NCT02151851|2668820|P2|Overall Study|Withdrawal by Subject|5
815937|NCT02151851|2668821|P1|Overall Study|Withdrawal by Subject|2
815938|NCT02151851|2668820|P2|Overall Study|Protocol Violation|1
815939|NCT02151851|2668821|P1|Overall Study|Protocol Violation|0
815940|NCT02151851|2668820|P2|Overall Study|Lack of Efficacy|94
815941|NCT02151851|2668821|P1|Overall Study|Lack of Efficacy|67
815942|NCT02151786|2668833|P1|Overall Study|Unavailability of Information|8
815943|NCT02151786|2668833|P1|Overall Study|Randomized, not Treated|1
815944|NCT02151786|2668833|P1|Overall Study|Outside the Contract Period|1
815945|NCT02151786|2668833|P1|Overall Study|Unavailability of Case Report Form|26
815946|NCT02151773|2668844|P1|Overall Study|Protocol Deviation|64
815947|NCT02151643|2668854|P5|Overall Study|High Ferritin levels|1
815948|NCT02151643|2668855|P4|Overall Study|High Ferritin levels|2
815949|NCT02151643|2668856|P3|Overall Study|High Ferritin levels|2
815950|NCT02151643|2668857|P2|Overall Study|High Ferritin levels|3
815951|NCT02151643|2668858|P1|Overall Study|High Ferritin levels|3
815952|NCT02151643|2668854|P5|Overall Study|Hyperphosphataemia|1
815953|NCT02151643|2668855|P4|Overall Study|Hyperphosphataemia|0
815954|NCT02151643|2668856|P3|Overall Study|Hyperphosphataemia|0
815955|NCT02151643|2668857|P2|Overall Study|Hyperphosphataemia|0
815956|NCT02151643|2668858|P1|Overall Study|Hyperphosphataemia|1
815957|NCT02151643|2668854|P5|Overall Study|Withdrawal by Subject|1
815958|NCT02151643|2668855|P4|Overall Study|Withdrawal by Subject|1
815959|NCT02151643|2668856|P3|Overall Study|Withdrawal by Subject|1
815960|NCT02151643|2668857|P2|Overall Study|Withdrawal by Subject|1
815961|NCT02151643|2668858|P1|Overall Study|Withdrawal by Subject|0
815962|NCT02151643|2668854|P5|Overall Study|Adverse Event|0
815963|NCT02151643|2668855|P4|Overall Study|Adverse Event|4
815964|NCT02151643|2668856|P3|Overall Study|Adverse Event|1
815965|NCT02151643|2668857|P2|Overall Study|Adverse Event|0
815966|NCT02151643|2668858|P1|Overall Study|Adverse Event|2
815967|NCT02151461|2668899|P4|Overall Study|Treatment discontinuation|0
815968|NCT02151461|2668900|P3|Overall Study|Treatment discontinuation|1
815969|NCT02151461|2668901|P2|Overall Study|Treatment discontinuation|0
815970|NCT02151461|2668902|P1|Overall Study|Treatment discontinuation|0
815971|NCT02151461|2668899|P4|Overall Study|Withdrawal by Subject|1
815972|NCT02151461|2668900|P3|Overall Study|Withdrawal by Subject|1
815973|NCT02151461|2668901|P2|Overall Study|Withdrawal by Subject|0
815974|NCT02151461|2668902|P1|Overall Study|Withdrawal by Subject|1
815975|NCT02151461|2668899|P4|Overall Study|Lost to Follow-up|1
815976|NCT02151461|2668900|P3|Overall Study|Lost to Follow-up|1
815977|NCT02151461|2668901|P2|Overall Study|Lost to Follow-up|0
815978|NCT02151461|2668902|P1|Overall Study|Lost to Follow-up|0
815979|NCT02151461|2668899|P4|Overall Study|Adverse Event|2
815980|NCT02151461|2668900|P3|Overall Study|Adverse Event|0
815981|NCT02151461|2668901|P2|Overall Study|Adverse Event|1
815982|NCT02151461|2668902|P1|Overall Study|Adverse Event|5
815983|NCT02151149|2668957|P2|Follow-Up Period|Death|34
815984|NCT02151149|2668958|P1|Follow-Up Period|Death|37
815985|NCT02151149|2668957|P2|Follow-Up Period|Lost to Follow-up|3
815986|NCT02151149|2668958|P1|Follow-Up Period|Lost to Follow-up|2
815987|NCT02151149|2668957|P2|Treatment Period|Participants randomized but not treated|2
815988|NCT02151149|2668958|P1|Treatment Period|Participants randomized but not treated|3
815989|NCT02151149|2668957|P2|Treatment Period|Miscellaneous|7
815990|NCT02151149|2668958|P1|Treatment Period|Miscellaneous|8
815991|NCT02151149|2668957|P2|Treatment Period|Withdrawal by Subject|11
815992|NCT02151149|2668958|P1|Treatment Period|Withdrawal by Subject|13
815993|NCT02151149|2668957|P2|Treatment Period|Symptomatic Deterioration|10
815994|NCT02151149|2668958|P1|Treatment Period|Symptomatic Deterioration|2
815995|NCT02151149|2668957|P2|Treatment Period|Progressive Disease|24
815996|NCT02151149|2668958|P1|Treatment Period|Progressive Disease|25
815997|NCT02151149|2668957|P2|Treatment Period|Adverse Event|14
815998|NCT02151149|2668958|P1|Treatment Period|Adverse Event|17
815999|NCT02151149|2668957|P2|Treatment Period|Death|3
816000|NCT02151149|2668958|P1|Treatment Period|Death|2
816001|NCT02151058|2668985|P3|Overall Study|Lost to Follow-up|2
816002|NCT02151058|2668986|P2|Overall Study|Lost to Follow-up|0
816003|NCT02151058|2668987|P1|Overall Study|Lost to Follow-up|1
816004|NCT02151058|2668985|P3|Overall Study|Withdrawal by Subject|3
816005|NCT02151058|2668986|P2|Overall Study|Withdrawal by Subject|1
816006|NCT02151058|2668987|P1|Overall Study|Withdrawal by Subject|1
816007|NCT02150954|2669021|P2|Overall Study|Protocol Violation|0
816008|NCT02150954|2669022|P1|Overall Study|Protocol Violation|1
816009|NCT02150343|2669098|P4|Overall Study|Not specified|2
816010|NCT02150343|2669099|P3|Overall Study|Not specified|0
816011|NCT02150343|2669100|P2|Overall Study|Not specified|6
816012|NCT02150343|2669101|P1|Overall Study|Not specified|2
816013|NCT02150343|2669098|P4|Overall Study|Lost to Follow-up|3
816014|NCT02150343|2669099|P3|Overall Study|Lost to Follow-up|2
816015|NCT02150343|2669100|P2|Overall Study|Lost to Follow-up|4
816016|NCT02150343|2669101|P1|Overall Study|Lost to Follow-up|4
816017|NCT02150343|2669098|P4|Overall Study|Withdrawal by Subject|4
816018|NCT02150343|2669099|P3|Overall Study|Withdrawal by Subject|9
816019|NCT02150343|2669100|P2|Overall Study|Withdrawal by Subject|10
816020|NCT02150343|2669101|P1|Overall Study|Withdrawal by Subject|13
816021|NCT02150343|2669098|P4|Overall Study|Adverse Event|1
816022|NCT02150343|2669099|P3|Overall Study|Adverse Event|1
816023|NCT02150343|2669100|P2|Overall Study|Adverse Event|0
816024|NCT02150343|2669101|P1|Overall Study|Adverse Event|2
816025|NCT02150213|2669139|P1|Overall Study|Withdrawal by Subject|1
816026|NCT02150213|2669139|P1|Overall Study|Lost to Follow-up|1
816027|NCT02149875|2669165|P3|Overall Study|Physician Decision|2
816028|NCT02149875|2669166|P2|Overall Study|Physician Decision|2
816029|NCT02149875|2669167|P1|Overall Study|Physician Decision|1
816030|NCT02149875|2669165|P3|Overall Study|Withdrawal by Subject|2
816031|NCT02149875|2669166|P2|Overall Study|Withdrawal by Subject|2
816032|NCT02149875|2669167|P1|Overall Study|Withdrawal by Subject|3
816033|NCT02149875|2669165|P3|Overall Study|Lost to Follow-up|5
816034|NCT02149875|2669166|P2|Overall Study|Lost to Follow-up|4
816035|NCT02149875|2669167|P1|Overall Study|Lost to Follow-up|3
816036|NCT02149264|2669213|P1|Overall Study|Protocol Violation|1
816037|NCT02149264|2669213|P1|Overall Study|Physician Decision|3
816038|NCT02149264|2669213|P1|Overall Study|Adverse Event|7
816039|NCT02149264|2669213|P1|Overall Study|Withdrawal by Subject|9
816040|NCT02149108|2669228|P2|Overall Study|Lost to Follow-up|0
816041|NCT02149108|2669229|P1|Overall Study|Lost to Follow-up|1
816042|NCT02149108|2669228|P2|Overall Study|Refusal to continue trial medication|11
816043|NCT02149108|2669229|P1|Overall Study|Refusal to continue trial medication|15
816044|NCT02149108|2669228|P2|Overall Study|Other not defined above|2
816045|NCT02149108|2669229|P1|Overall Study|Other not defined above|0
816046|NCT02149108|2669228|P2|Overall Study|Other Adverse Event (AE)|18
816047|NCT02149108|2669229|P1|Overall Study|Other Adverse Event (AE)|8
816048|NCT02149108|2669228|P2|Overall Study|Worsening/adverse event cancer disease|32
816049|NCT02149108|2669229|P1|Overall Study|Worsening/adverse event cancer disease|31
816050|NCT02149108|2669228|P2|Overall Study|Progressive Disease (PD)|318
816051|NCT02149108|2669229|P1|Overall Study|Progressive Disease (PD)|324
816052|NCT02149108|2669228|P2|Overall Study|Not treated|2
816053|NCT02149108|2669229|P1|Overall Study|Not treated|1
816054|NCT02148718|2669255|P1|Overall Study|Discontinued Study Prematurely|5
816055|NCT02148718|2669255|P1|Overall Study|Protocol Violation|26
816056|NCT02148445|2669303|P2|Overall Study|Death|3
816057|NCT02148445|2669304|P1|Overall Study|Death|1
816058|NCT02147691|2669379|P2|Overall Study|Lost to Follow-up|1
816059|NCT02147691|2669380|P1|Overall Study|Lost to Follow-up|0
816060|NCT02147691|2669379|P2|Overall Study|Adverse Event|0
816061|NCT02147691|2669380|P1|Overall Study|Adverse Event|2
816062|NCT02147691|2669379|P2|Overall Study|Withdrawal by Subject|0
816063|NCT02147691|2669380|P1|Overall Study|Withdrawal by Subject|2
816064|NCT02147587|2669426|P2|Overall Study|Lack of Efficacy|1
816065|NCT02147587|2669427|P1|Overall Study|Lack of Efficacy|2
816066|NCT02147587|2669426|P2|Overall Study|Adverse Event|4
816067|NCT02147587|2669427|P1|Overall Study|Adverse Event|9
816068|NCT02147561|2669447|P1|Overall Study|Subjects who didn’t receive BOTOX|1
816069|NCT02147561|2669447|P1|Overall Study|Lost to Follow-up|3
816070|NCT02147288|2669468|P10|Overall Study|complications from concurrent hernia rep|0
816071|NCT02147288|2669469|P9|Overall Study|complications from concurrent hernia rep|0
816072|NCT02147288|2669470|P8|Overall Study|complications from concurrent hernia rep|0
816073|NCT02147288|2669471|P7|Overall Study|complications from concurrent hernia rep|0
816074|NCT02147288|2669472|P6|Overall Study|complications from concurrent hernia rep|0
816075|NCT02147288|2669473|P5|Overall Study|complications from concurrent hernia rep|0
816076|NCT02147288|2669474|P4|Overall Study|complications from concurrent hernia rep|0
816077|NCT02147288|2669475|P3|Overall Study|complications from concurrent hernia rep|0
816078|NCT02147288|2669476|P2|Overall Study|complications from concurrent hernia rep|1
816079|NCT02147288|2669477|P1|Overall Study|complications from concurrent hernia rep|0
816080|NCT02147288|2669468|P10|Overall Study|post-operative hematoma|0
816081|NCT02147288|2669469|P9|Overall Study|post-operative hematoma|0
816082|NCT02147288|2669470|P8|Overall Study|post-operative hematoma|0
816083|NCT02147288|2669471|P7|Overall Study|post-operative hematoma|0
816084|NCT02147288|2669472|P6|Overall Study|post-operative hematoma|0
816085|NCT02147288|2669473|P5|Overall Study|post-operative hematoma|0
816086|NCT02147288|2669474|P4|Overall Study|post-operative hematoma|0
816087|NCT02147288|2669475|P3|Overall Study|post-operative hematoma|0
816088|NCT02147288|2669476|P2|Overall Study|post-operative hematoma|1
816089|NCT02147288|2669477|P1|Overall Study|post-operative hematoma|1
816090|NCT02147184|2669485|P2|Overall Study|Other|0
816091|NCT02147184|2669486|P1|Overall Study|Other|1
816092|NCT02147184|2669485|P2|Overall Study|Physician Decision|2
816093|NCT02147184|2669486|P1|Overall Study|Physician Decision|0
816094|NCT02147184|2669485|P2|Overall Study|Moved out of state|3
816095|NCT02147184|2669486|P1|Overall Study|Moved out of state|3
816096|NCT02147184|2669485|P2|Overall Study|Pregnancy|0
816097|NCT02147184|2669486|P1|Overall Study|Pregnancy|6
816098|NCT02147184|2669485|P2|Overall Study|Study Burden|7
816099|NCT02147184|2669486|P1|Overall Study|Study Burden|11
816100|NCT02147184|2669485|P2|Overall Study|Lost to Follow-up|15
816101|NCT02147184|2669486|P1|Overall Study|Lost to Follow-up|28
816102|NCT02147093|2669506|P2|Period 2|Protocol Violation|0
816103|NCT02147093|2669507|P1|Period 2|Protocol Violation|2
816104|NCT02147093|2669506|P2|Period 1|Lost to Follow-up|1
816105|NCT02147093|2669507|P1|Period 1|Lost to Follow-up|0
816106|NCT02146599|2669515|P1|Overall Study|Failed to meet inclusion criteria|5
816107|NCT02146352|2669528|P1|Overall Study|Patient entered hospice care|1
816108|NCT02146352|2669528|P1|Overall Study|Death|1
816109|NCT02146326|2669546|P4|Overall Study|Unable to complete interview|6
816110|NCT02146326|2669547|P3|Overall Study|Unable to complete interview|10
816111|NCT02146326|2669548|P2|Overall Study|Unable to complete interview|0
816112|NCT02146326|2669549|P1|Overall Study|Unable to complete interview|0
816113|NCT02146326|2669546|P4|Overall Study|Death|4
816114|NCT02146326|2669547|P3|Overall Study|Death|4
816115|NCT02146326|2669548|P2|Overall Study|Death|0
816116|NCT02146326|2669549|P1|Overall Study|Death|0
816117|NCT02146326|2669546|P4|Overall Study|Incarcerated|8
816118|NCT02146326|2669547|P3|Overall Study|Incarcerated|3
816119|NCT02146326|2669548|P2|Overall Study|Incarcerated|0
816120|NCT02146326|2669549|P1|Overall Study|Incarcerated|0
816121|NCT02146326|2669546|P4|Overall Study|Separated from mental health center|0
816122|NCT02146326|2669547|P3|Overall Study|Separated from mental health center|0
816123|NCT02146326|2669548|P2|Overall Study|Separated from mental health center|33
816124|NCT02146326|2669549|P1|Overall Study|Separated from mental health center|23
816125|NCT02146326|2669546|P4|Overall Study|Withdrawal by Subject|11
816126|NCT02146326|2669547|P3|Overall Study|Withdrawal by Subject|15
816127|NCT02146326|2669548|P2|Overall Study|Withdrawal by Subject|1
816128|NCT02146326|2669549|P1|Overall Study|Withdrawal by Subject|2
816129|NCT02146326|2669546|P4|Overall Study|Lost to Follow-up|19
816130|NCT02146326|2669547|P3|Overall Study|Lost to Follow-up|11
816131|NCT02146326|2669548|P2|Overall Study|Lost to Follow-up|3
816132|NCT02146326|2669549|P1|Overall Study|Lost to Follow-up|3
816133|NCT02146248|2669711|P1|Overall Study|Withdrawal by Subject|2
816134|NCT02146131|2669721|P2|Overall Study|Physician Decision|56
816135|NCT02146131|2669722|P1|Overall Study|Physician Decision|61
816136|NCT02146105|2669728|P1|Overall Study|Withdrawal by Subject|5
816137|NCT02146105|2669728|P1|Overall Study|Adverse Event|1
816138|NCT02145468|2669779|P2|Overall Study|Withdrawal by Subject|8
816139|NCT02145468|2669780|P1|Overall Study|Withdrawal by Subject|5
816140|NCT02145390|2669836|P1|Overall Study|Withdrawal by Subject|1
816141|NCT02145156|2669877|P3|Overall Study|No match to vaccination records|41
816142|NCT02145156|2669878|P2|Overall Study|No match to vaccination records|52
816143|NCT02145156|2669879|P1|Overall Study|No match to vaccination records|60
816144|NCT02144701|2669944|P2|Overall Study|development of relapse, GVHD or death|3
816145|NCT02144701|2669945|P1|Overall Study|development of relapse, GVHD or death|9
816146|NCT02144337|2669983|P2|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0
816147|NCT02144337|2669984|P1|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1
816148|NCT02144337|2669983|P2|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0
816149|NCT02144337|2669984|P1|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2
816150|NCT02144337|2669983|P2|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0
816151|NCT02144337|2669984|P1|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1
816152|NCT02144337|2669983|P2|T2 Follow-up (Post-intervention)|Lost to Follow-up|0
816153|NCT02144337|2669984|P1|T2 Follow-up (Post-intervention)|Lost to Follow-up|2
816154|NCT02144337|2669983|P2|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
816155|NCT02144337|2669984|P1|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
816156|NCT02144220|2670013|P1|Overall Study|Protocol Violation|1
816157|NCT02144220|2670013|P1|Overall Study|Withdrawal by Subject|2
816158|NCT02144220|2670013|P1|Overall Study|Physician Decision|3
816159|NCT02144220|2670013|P1|Overall Study|Lack of Efficacy|4
816160|NCT02144220|2670013|P1|Overall Study|technology incompatibility|9
816161|NCT02144012|2670023|P2|Overall Study|Other|0
816162|NCT02144012|2670024|P1|Overall Study|Other|3
816163|NCT02144012|2670023|P2|Overall Study|Study Terminated by Sponsor|12
816164|NCT02144012|2670024|P1|Overall Study|Study Terminated by Sponsor|18
816165|NCT02144012|2670023|P2|Overall Study|Withdrawal by Subject|3
816166|NCT02144012|2670024|P1|Overall Study|Withdrawal by Subject|11
816167|NCT02144012|2670023|P2|Overall Study|Death|0
816168|NCT02144012|2670024|P1|Overall Study|Death|1
816169|NCT02144012|2670023|P2|Overall Study|Adverse Event|0
816170|NCT02144012|2670024|P1|Overall Study|Adverse Event|1
816171|NCT02143947|2670061|P2|Overall Study|Lost to Follow-up|2
816172|NCT02143947|2670062|P1|Overall Study|Lost to Follow-up|4
816173|NCT02143713|2670078|P4|Post-treatment Follow-up (12 Months)|Other|7
816174|NCT02143713|2670079|P3|Post-treatment Follow-up (12 Months)|Other|7
816175|NCT02143713|2670080|P2|Post-treatment Follow-up (12 Months)|Other|4
816176|NCT02143713|2670081|P1|Post-treatment Follow-up (12 Months)|Other|3
816177|NCT02143713|2670078|P4|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
816178|NCT02143713|2670079|P3|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
816179|NCT02143713|2670080|P2|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
816180|NCT02143713|2670081|P1|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
816181|NCT02143713|2670078|P4|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1
816182|NCT02143713|2670079|P3|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
816183|NCT02143713|2670080|P2|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
816184|NCT02143713|2670081|P1|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2
816185|NCT02143713|2670078|P4|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
816186|NCT02143713|2670079|P3|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11
816187|NCT02143713|2670080|P2|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
816188|NCT02143713|2670081|P1|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3
816189|NCT02143713|2670078|P4|Post-treatment Follow-up (12 Months)|Adverse Event|0
816190|NCT02143713|2670079|P3|Post-treatment Follow-up (12 Months)|Adverse Event|1
816191|NCT02143713|2670080|P2|Post-treatment Follow-up (12 Months)|Adverse Event|0
816192|NCT02143713|2670081|P1|Post-treatment Follow-up (12 Months)|Adverse Event|0
816193|NCT02143713|2670078|P4|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10
816194|NCT02143713|2670079|P3|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
816195|NCT02143713|2670080|P2|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7
816196|NCT02143713|2670081|P1|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
816197|NCT02143713|2670078|P4|Treatment Period (6 Months)|Lack of Efficacy|1
816198|NCT02143713|2670079|P3|Treatment Period (6 Months)|Lack of Efficacy|0
816199|NCT02143713|2670080|P2|Treatment Period (6 Months)|Lack of Efficacy|0
816200|NCT02143713|2670081|P1|Treatment Period (6 Months)|Lack of Efficacy|1
816201|NCT02143713|2670078|P4|Treatment Period (6 Months)|Exclusionary Medication|0
816202|NCT02143713|2670079|P3|Treatment Period (6 Months)|Exclusionary Medication|0
816203|NCT02143713|2670080|P2|Treatment Period (6 Months)|Exclusionary Medication|0
816204|NCT02143713|2670081|P1|Treatment Period (6 Months)|Exclusionary Medication|2
816205|NCT02143713|2670078|P4|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4
816206|NCT02143713|2670079|P3|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
816207|NCT02143713|2670080|P2|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
816208|NCT02143713|2670081|P1|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
816209|NCT02143713|2670078|P4|Treatment Period (6 Months)|Other|2
816210|NCT02143713|2670079|P3|Treatment Period (6 Months)|Other|3
816211|NCT02143713|2670080|P2|Treatment Period (6 Months)|Other|0
816212|NCT02143713|2670081|P1|Treatment Period (6 Months)|Other|3
816213|NCT02143713|2670078|P4|Treatment Period (6 Months)|Non-compliance|3
816214|NCT02143713|2670079|P3|Treatment Period (6 Months)|Non-compliance|0
816215|NCT02143713|2670080|P2|Treatment Period (6 Months)|Non-compliance|0
816216|NCT02143713|2670081|P1|Treatment Period (6 Months)|Non-compliance|1
816217|NCT02143713|2670078|P4|Treatment Period (6 Months)|Pregnancy|0
816218|NCT02143713|2670079|P3|Treatment Period (6 Months)|Pregnancy|2
816219|NCT02143713|2670080|P2|Treatment Period (6 Months)|Pregnancy|2
816220|NCT02143713|2670081|P1|Treatment Period (6 Months)|Pregnancy|0
816221|NCT02143713|2670078|P4|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
816222|NCT02143713|2670079|P3|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
816223|NCT02143713|2670080|P2|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
816224|NCT02143713|2670081|P1|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
816225|NCT02143713|2670078|P4|Treatment Period (6 Months)|Lost to Follow-up|3
816226|NCT02143713|2670079|P3|Treatment Period (6 Months)|Lost to Follow-up|4
816227|NCT02143713|2670080|P2|Treatment Period (6 Months)|Lost to Follow-up|0
816228|NCT02143713|2670081|P1|Treatment Period (6 Months)|Lost to Follow-up|3
816229|NCT02143713|2670078|P4|Treatment Period (6 Months)|Adverse Event|9
816230|NCT02143713|2670079|P3|Treatment Period (6 Months)|Adverse Event|8
816231|NCT02143713|2670080|P2|Treatment Period (6 Months)|Adverse Event|8
816232|NCT02143713|2670081|P1|Treatment Period (6 Months)|Adverse Event|7
816233|NCT02143713|2670078|P4|Treatment Period (6 Months)|Withdrawal by Subject|4
816234|NCT02143713|2670079|P3|Treatment Period (6 Months)|Withdrawal by Subject|5
816235|NCT02143713|2670080|P2|Treatment Period (6 Months)|Withdrawal by Subject|2
816236|NCT02143713|2670081|P1|Treatment Period (6 Months)|Withdrawal by Subject|1
816237|NCT02143583|2670162|P3|Overall Study|husband illness|1
816238|NCT02143583|2670163|P2|Overall Study|husband illness|0
816239|NCT02143583|2670164|P1|Overall Study|husband illness|0
816240|NCT02143583|2670162|P3|Overall Study|Withdrawal by Subject|1
816241|NCT02143583|2670163|P2|Overall Study|Withdrawal by Subject|0
816242|NCT02143583|2670164|P1|Overall Study|Withdrawal by Subject|1
816243|NCT02143141|2670177|P2|Overall Study|pain scores at 24 hours not collected|0
816333|NCT02141854|2670568|P6|Treatment Period|Pregnancy|0
816244|NCT02143141|2670178|P1|Overall Study|pain scores at 24 hours not collected|1
816245|NCT02143102|2670190|P2|Overall Study|Lost to Follow-up|0
816246|NCT02143102|2670191|P1|Overall Study|Lost to Follow-up|11
816247|NCT02142738|2670201|P2|Overall Study|Ongoing in Study|82
816248|NCT02142738|2670202|P1|Overall Study|Ongoing in Study|107
816249|NCT02142738|2670201|P2|Overall Study|Withdrawal by Subject|5
816250|NCT02142738|2670202|P1|Overall Study|Withdrawal by Subject|5
816251|NCT02142738|2670201|P2|Overall Study|Progressive Disease|1
816252|NCT02142738|2670202|P1|Overall Study|Progressive Disease|0
816253|NCT02142738|2670201|P2|Overall Study|Death|55
816254|NCT02142738|2670202|P1|Overall Study|Death|33
816255|NCT02142738|2670201|P2|Overall Study|Adverse Event|8
816256|NCT02142738|2670202|P1|Overall Study|Adverse Event|9
816257|NCT02142712|2670215|P4|Overall Study|Lost to Follow-up|0
816258|NCT02142712|2670216|P3|Overall Study|Lost to Follow-up|1
816259|NCT02142712|2670217|P2|Overall Study|Lost to Follow-up|1
816260|NCT02142712|2670218|P1|Overall Study|Lost to Follow-up|1
816261|NCT02142504|2670241|P3|Overall Study|Reason Not Specified|4
816262|NCT02142504|2670242|P2|Overall Study|Reason Not Specified|5
816263|NCT02142504|2670243|P1|Overall Study|Reason Not Specified|4
816264|NCT02142504|2670241|P3|Overall Study|Physician Decision|3
816265|NCT02142504|2670242|P2|Overall Study|Physician Decision|1
816266|NCT02142504|2670243|P1|Overall Study|Physician Decision|0
816267|NCT02142504|2670241|P3|Overall Study|Pregnancy|2
816268|NCT02142504|2670242|P2|Overall Study|Pregnancy|4
816269|NCT02142504|2670243|P1|Overall Study|Pregnancy|4
816270|NCT02142504|2670241|P3|Overall Study|Withdrawal by Subject|11
816271|NCT02142504|2670242|P2|Overall Study|Withdrawal by Subject|9
816272|NCT02142504|2670243|P1|Overall Study|Withdrawal by Subject|7
816273|NCT02142504|2670241|P3|Overall Study|Lost to Follow-up|17
816274|NCT02142504|2670242|P2|Overall Study|Lost to Follow-up|19
816275|NCT02142504|2670243|P1|Overall Study|Lost to Follow-up|12
816276|NCT02142504|2670241|P3|Overall Study|Adverse Event|4
816277|NCT02142504|2670242|P2|Overall Study|Adverse Event|3
816278|NCT02142504|2670243|P1|Overall Study|Adverse Event|2
816279|NCT02142504|2670241|P3|Overall Study|Protocol Violation|2
816280|NCT02142504|2670242|P2|Overall Study|Protocol Violation|1
816281|NCT02142504|2670243|P1|Overall Study|Protocol Violation|2
816282|NCT02142283|2670432|P2|Overall Study|Withdrawal by Subject|3
816283|NCT02142283|2670433|P1|Overall Study|Withdrawal by Subject|1
816284|NCT02142283|2670432|P2|Overall Study|Death|18
816285|NCT02142283|2670433|P1|Overall Study|Death|20
816286|NCT02141997|2670508|P4|Overall Study|Not specified|0
816287|NCT02141997|2670509|P3|Overall Study|Not specified|0
816288|NCT02141997|2670510|P2|Overall Study|Not specified|4
816289|NCT02141997|2670511|P1|Overall Study|Not specified|1
816290|NCT02141997|2670508|P4|Overall Study|Withdrew consent|0
816291|NCT02141997|2670509|P3|Overall Study|Withdrew consent|3
816292|NCT02141997|2670510|P2|Overall Study|Withdrew consent|0
816293|NCT02141997|2670511|P1|Overall Study|Withdrew consent|1
816294|NCT02141997|2670508|P4|Overall Study|Participant noncompliance|0
816295|NCT02141997|2670509|P3|Overall Study|Participant noncompliance|0
816296|NCT02141997|2670510|P2|Overall Study|Participant noncompliance|0
816297|NCT02141997|2670511|P1|Overall Study|Participant noncompliance|1
816298|NCT02141997|2670508|P4|Overall Study|Adverse Event|1
816299|NCT02141997|2670509|P3|Overall Study|Adverse Event|0
816300|NCT02141997|2670510|P2|Overall Study|Adverse Event|2
816301|NCT02141997|2670511|P1|Overall Study|Adverse Event|0
816302|NCT02141984|2670549|P1|Overall Study|Lack of Efficacy|2
816303|NCT02141854|2670568|P6|Treatment Period|Lost to Follow-up|1
816304|NCT02141854|2670569|P5|Treatment Period|Lost to Follow-up|0
816305|NCT02141854|2670570|P4|Treatment Period|Lost to Follow-up|1
816306|NCT02141854|2670571|P3|Treatment Period|Lost to Follow-up|1
816307|NCT02141854|2670572|P2|Treatment Period|Lost to Follow-up|1
816308|NCT02141854|2670573|P1|Treatment Period|Lost to Follow-up|0
816309|NCT02141854|2670568|P6|Treatment Period|Disease progression|18
816310|NCT02141854|2670569|P5|Treatment Period|Disease progression|0
816311|NCT02141854|2670570|P4|Treatment Period|Disease progression|3
816312|NCT02141854|2670571|P3|Treatment Period|Disease progression|1
816313|NCT02141854|2670572|P2|Treatment Period|Disease progression|2
816314|NCT02141854|2670573|P1|Treatment Period|Disease progression|0
816315|NCT02141854|2670568|P6|Treatment Period|Withdrawal by Subject|7
816316|NCT02141854|2670569|P5|Treatment Period|Withdrawal by Subject|4
816317|NCT02141854|2670570|P4|Treatment Period|Withdrawal by Subject|3
816318|NCT02141854|2670571|P3|Treatment Period|Withdrawal by Subject|3
816319|NCT02141854|2670572|P2|Treatment Period|Withdrawal by Subject|2
816320|NCT02141854|2670573|P1|Treatment Period|Withdrawal by Subject|0
816321|NCT02141854|2670568|P6|Treatment Period|Adverse Event|2
816322|NCT02141854|2670569|P5|Treatment Period|Adverse Event|2
816323|NCT02141854|2670570|P4|Treatment Period|Adverse Event|0
816324|NCT02141854|2670571|P3|Treatment Period|Adverse Event|2
816325|NCT02141854|2670572|P2|Treatment Period|Adverse Event|2
816326|NCT02141854|2670573|P1|Treatment Period|Adverse Event|0
816327|NCT02141854|2670568|P6|Treatment Period|Not specified|2
816328|NCT02141854|2670569|P5|Treatment Period|Not specified|1
816329|NCT02141854|2670570|P4|Treatment Period|Not specified|0
816330|NCT02141854|2670571|P3|Treatment Period|Not specified|2
816331|NCT02141854|2670572|P2|Treatment Period|Not specified|1
816332|NCT02141854|2670573|P1|Treatment Period|Not specified|0
816334|NCT02141854|2670569|P5|Treatment Period|Pregnancy|0
816335|NCT02141854|2670570|P4|Treatment Period|Pregnancy|0
816336|NCT02141854|2670571|P3|Treatment Period|Pregnancy|0
816337|NCT02141854|2670572|P2|Treatment Period|Pregnancy|1
816338|NCT02141854|2670573|P1|Treatment Period|Pregnancy|0
816339|NCT02141854|2670568|P6|Treatment Period|Lack of Efficacy|7
816340|NCT02141854|2670569|P5|Treatment Period|Lack of Efficacy|1
816341|NCT02141854|2670570|P4|Treatment Period|Lack of Efficacy|1
816342|NCT02141854|2670571|P3|Treatment Period|Lack of Efficacy|0
816343|NCT02141854|2670572|P2|Treatment Period|Lack of Efficacy|0
816344|NCT02141854|2670573|P1|Treatment Period|Lack of Efficacy|0
816345|NCT02141854|2670568|P6|Treatment Period|Noncompliance|0
816346|NCT02141854|2670569|P5|Treatment Period|Noncompliance|0
816347|NCT02141854|2670570|P4|Treatment Period|Noncompliance|1
816348|NCT02141854|2670571|P3|Treatment Period|Noncompliance|0
816349|NCT02141854|2670572|P2|Treatment Period|Noncompliance|0
816350|NCT02141854|2670573|P1|Treatment Period|Noncompliance|0
816351|NCT02141854|2670568|P6|Treatment Period|Protocol Violation|1
816352|NCT02141854|2670569|P5|Treatment Period|Protocol Violation|2
816353|NCT02141854|2670570|P4|Treatment Period|Protocol Violation|2
816354|NCT02141854|2670571|P3|Treatment Period|Protocol Violation|0
816355|NCT02141854|2670572|P2|Treatment Period|Protocol Violation|1
816356|NCT02141854|2670573|P1|Treatment Period|Protocol Violation|0
816357|NCT02141854|2670568|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
816358|NCT02141854|2670569|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
816359|NCT02141854|2670570|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
816360|NCT02141854|2670571|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
816361|NCT02141854|2670572|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
816362|NCT02141854|2670573|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
816363|NCT02141854|2670568|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
816364|NCT02141854|2670569|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
816365|NCT02141854|2670570|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
816366|NCT02141854|2670571|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
816367|NCT02141854|2670572|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
816368|NCT02141854|2670573|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|9
816369|NCT02141854|2670568|P6|Run-In Period (Pre-assignment)|Adverse Event|0
816370|NCT02141854|2670569|P5|Run-In Period (Pre-assignment)|Adverse Event|0
816371|NCT02141854|2670570|P4|Run-In Period (Pre-assignment)|Adverse Event|0
816372|NCT02141854|2670571|P3|Run-In Period (Pre-assignment)|Adverse Event|0
816373|NCT02141854|2670572|P2|Run-In Period (Pre-assignment)|Adverse Event|0
816374|NCT02141854|2670573|P1|Run-In Period (Pre-assignment)|Adverse Event|10
816375|NCT02141854|2670568|P6|Run-In Period (Pre-assignment)|Not specified|0
816376|NCT02141854|2670569|P5|Run-In Period (Pre-assignment)|Not specified|0
816377|NCT02141854|2670570|P4|Run-In Period (Pre-assignment)|Not specified|0
816378|NCT02141854|2670571|P3|Run-In Period (Pre-assignment)|Not specified|0
816379|NCT02141854|2670572|P2|Run-In Period (Pre-assignment)|Not specified|0
816380|NCT02141854|2670573|P1|Run-In Period (Pre-assignment)|Not specified|14
816381|NCT02141854|2670568|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
816382|NCT02141854|2670569|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
816383|NCT02141854|2670570|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
816384|NCT02141854|2670571|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
816385|NCT02141854|2670572|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
816386|NCT02141854|2670573|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|14
816387|NCT02141854|2670568|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
816388|NCT02141854|2670569|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
816389|NCT02141854|2670570|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
816390|NCT02141854|2670571|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
816391|NCT02141854|2670572|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
816392|NCT02141854|2670573|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|76
816393|NCT02141854|2670568|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
816394|NCT02141854|2670569|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
816395|NCT02141854|2670570|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
816396|NCT02141854|2670571|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
816397|NCT02141854|2670572|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
816398|NCT02141854|2670573|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|25
816399|NCT02141659|2670631|P6|Overall Study|Pretreatment Event/ Adverse Event|1
816400|NCT02141659|2670632|P5|Overall Study|Pretreatment Event/ Adverse Event|2
816401|NCT02141659|2670633|P4|Overall Study|Pretreatment Event/ Adverse Event|0
816402|NCT02141659|2670634|P3|Overall Study|Pretreatment Event/ Adverse Event|0
816403|NCT02141659|2670635|P2|Overall Study|Pretreatment Event/ Adverse Event|0
816404|NCT02141659|2670636|P1|Overall Study|Pretreatment Event/ Adverse Event|0
816405|NCT02141659|2670631|P6|Overall Study|Lack of Efficacy|1
816406|NCT02141659|2670632|P5|Overall Study|Lack of Efficacy|0
816407|NCT02141659|2670633|P4|Overall Study|Lack of Efficacy|0
816408|NCT02141659|2670634|P3|Overall Study|Lack of Efficacy|0
816409|NCT02141659|2670635|P2|Overall Study|Lack of Efficacy|0
816410|NCT02141659|2670636|P1|Overall Study|Lack of Efficacy|0
816411|NCT02141659|2670631|P6|Overall Study|Major Protocol Deviation|0
816412|NCT02141659|2670632|P5|Overall Study|Major Protocol Deviation|0
816413|NCT02141659|2670633|P4|Overall Study|Major Protocol Deviation|0
816414|NCT02141659|2670634|P3|Overall Study|Major Protocol Deviation|0
816415|NCT02141659|2670635|P2|Overall Study|Major Protocol Deviation|1
816416|NCT02141659|2670636|P1|Overall Study|Major Protocol Deviation|0
816417|NCT02141633|2670692|P2|Overall Study|Physician Decision|0
816418|NCT02141633|2670693|P1|Overall Study|Physician Decision|1
816419|NCT02141620|2670701|P2|Treatment Condition 1 (7 Days)|Adverse Event|0
816420|NCT02141620|2670702|P1|Treatment Condition 1 (7 Days)|Adverse Event|1
816421|NCT02141516|2670779|P3|Overall Study|Other|0
816422|NCT02141516|2670780|P2|Overall Study|Other|3
816423|NCT02141516|2670781|P1|Overall Study|Other|0
816424|NCT02141516|2670779|P3|Overall Study|Lost to Follow-up|0
816425|NCT02141516|2670780|P2|Overall Study|Lost to Follow-up|1
816426|NCT02141516|2670781|P1|Overall Study|Lost to Follow-up|0
816427|NCT02141516|2670779|P3|Overall Study|Adverse Event|0
816428|NCT02141516|2670780|P2|Overall Study|Adverse Event|1
816429|NCT02141516|2670781|P1|Overall Study|Adverse Event|0
816430|NCT02141360|2670831|P3|Overall Study|Study Terminated before Visit|0
816431|NCT02141360|2670832|P2|Overall Study|Study Terminated before Visit|0
816432|NCT02141360|2670833|P1|Overall Study|Study Terminated before Visit|1
816433|NCT02141360|2670831|P3|Overall Study|Withdrawal by Subject|0
816434|NCT02141360|2670832|P2|Overall Study|Withdrawal by Subject|0
816435|NCT02141360|2670833|P1|Overall Study|Withdrawal by Subject|6
816436|NCT02141217|2670843|P2|Overall Study|Surgical Intervention|1
816437|NCT02141217|2670844|P1|Overall Study|Surgical Intervention|1
816438|NCT02141217|2670843|P2|Overall Study|Physician Decision|0
816439|NCT02141217|2670844|P1|Overall Study|Physician Decision|1
816440|NCT02141217|2670843|P2|Overall Study|Lost to Follow-up|1
816441|NCT02141217|2670844|P1|Overall Study|Lost to Follow-up|1
816442|NCT02141217|2670843|P2|Overall Study|Withdrawal by Subject|0
816443|NCT02141217|2670844|P1|Overall Study|Withdrawal by Subject|6
816444|NCT02141217|2670843|P2|Overall Study|Protocol Violation|4
816445|NCT02141217|2670844|P1|Overall Study|Protocol Violation|1
816446|NCT02141217|2670843|P2|Overall Study|Adverse Event|2
816447|NCT02141217|2670844|P1|Overall Study|Adverse Event|1
816448|NCT02140762|2670906|P2|Overall Study|Other|1
816449|NCT02140762|2670907|P1|Overall Study|Other|0
816450|NCT02140762|2670906|P2|Overall Study|Withdrawal by Subject|4
816451|NCT02140762|2670907|P1|Overall Study|Withdrawal by Subject|6
816452|NCT02140762|2670906|P2|Overall Study|Protocol Violation|1
816453|NCT02140762|2670907|P1|Overall Study|Protocol Violation|1
816454|NCT02140762|2670906|P2|Overall Study|Lost to Follow-up|5
816455|NCT02140762|2670907|P1|Overall Study|Lost to Follow-up|9
816456|NCT02140762|2670906|P2|Overall Study|Adverse Event|1
816457|NCT02140762|2670907|P1|Overall Study|Adverse Event|1
816458|NCT02140645|2670973|P6|Overall Study|Not linked|70896
816459|NCT02140645|2670974|P5|Overall Study|Not linked|3286
816460|NCT02140645|2670975|P4|Overall Study|Not linked|13833
816461|NCT02140645|2670976|P3|Overall Study|Not linked|4236
816462|NCT02140645|2670977|P2|Overall Study|Not linked|61654
816463|NCT02140645|2670978|P1|Overall Study|Not linked|5489
816464|NCT02140567|2671076|P1|Overall Study|Problems with recording equipment|6
816465|NCT02140164|2671092|P1|Overall Study|Cystoid Macular Edema (CME) resolved|2
816466|NCT02140060|2671113|P6|Overall Study|Lack of Efficacy|0
816467|NCT02140060|2671114|P5|Overall Study|Lack of Efficacy|0
816468|NCT02140060|2671115|P4|Overall Study|Lack of Efficacy|1
816469|NCT02140060|2671116|P3|Overall Study|Lack of Efficacy|0
816470|NCT02140060|2671117|P2|Overall Study|Lack of Efficacy|0
816471|NCT02140060|2671118|P1|Overall Study|Lack of Efficacy|0
816472|NCT02140060|2671113|P6|Overall Study|Adverse Event|1
816473|NCT02140060|2671114|P5|Overall Study|Adverse Event|1
816474|NCT02140060|2671115|P4|Overall Study|Adverse Event|1
816475|NCT02140060|2671116|P3|Overall Study|Adverse Event|0
816476|NCT02140060|2671117|P2|Overall Study|Adverse Event|0
816477|NCT02140060|2671118|P1|Overall Study|Adverse Event|0
816478|NCT02139982|2671143|P10|Overall Study|Lack of Efficacy|0
816479|NCT02139982|2671144|P9|Overall Study|Lack of Efficacy|0
816480|NCT02139982|2671145|P8|Overall Study|Lack of Efficacy|0
816481|NCT02139982|2671146|P7|Overall Study|Lack of Efficacy|0
816482|NCT02139982|2671147|P6|Overall Study|Lack of Efficacy|0
816483|NCT02139982|2671148|P5|Overall Study|Lack of Efficacy|0
816484|NCT02139982|2671149|P4|Overall Study|Lack of Efficacy|1
816485|NCT02139982|2671150|P3|Overall Study|Lack of Efficacy|0
816486|NCT02139982|2671151|P2|Overall Study|Lack of Efficacy|1
816487|NCT02139982|2671152|P1|Overall Study|Lack of Efficacy|0
816488|NCT02139943|2671197|P3|Overall Study|eGFR Withdrawal Criteria|1
816489|NCT02139943|2671198|P2|Overall Study|eGFR Withdrawal Criteria|0
816490|NCT02139943|2671199|P1|Overall Study|eGFR Withdrawal Criteria|0
816491|NCT02139943|2671197|P3|Overall Study|Participant in Poor Compliance|1
816492|NCT02139943|2671198|P2|Overall Study|Participant in Poor Compliance|0
816493|NCT02139943|2671199|P1|Overall Study|Participant in Poor Compliance|1
816494|NCT02139943|2671197|P3|Overall Study|Participant wishes to discontinue|0
816495|NCT02139943|2671198|P2|Overall Study|Participant wishes to discontinue|0
816496|NCT02139943|2671199|P1|Overall Study|Participant wishes to discontinue|2
816497|NCT02139943|2671197|P3|Overall Study|Other|1
816498|NCT02139943|2671198|P2|Overall Study|Other|0
816499|NCT02139943|2671199|P1|Overall Study|Other|0
816500|NCT02139943|2671197|P3|Overall Study|Withdrawal by Subject|0
816501|NCT02139943|2671198|P2|Overall Study|Withdrawal by Subject|3
816502|NCT02139943|2671199|P1|Overall Study|Withdrawal by Subject|4
816503|NCT02139943|2671197|P3|Overall Study|Lost to Follow-up|2
816504|NCT02139943|2671198|P2|Overall Study|Lost to Follow-up|2
816505|NCT02139943|2671199|P1|Overall Study|Lost to Follow-up|3
816506|NCT02139943|2671197|P3|Overall Study|Adverse Event|2
816507|NCT02139943|2671198|P2|Overall Study|Adverse Event|1
816508|NCT02139943|2671199|P1|Overall Study|Adverse Event|0
816509|NCT02139644|2671224|P6|Treatment Period|Not specified|1
816510|NCT02139644|2671225|P5|Treatment Period|Not specified|0
816511|NCT02139644|2671226|P4|Treatment Period|Not specified|1
816512|NCT02139644|2671227|P3|Treatment Period|Not specified|1
816513|NCT02139644|2671228|P2|Treatment Period|Not specified|3
816514|NCT02139644|2671229|P1|Treatment Period|Not specified|0
816515|NCT02139644|2671224|P6|Treatment Period|Lack of Efficacy|4
816516|NCT02139644|2671225|P5|Treatment Period|Lack of Efficacy|1
816517|NCT02139644|2671226|P4|Treatment Period|Lack of Efficacy|0
816518|NCT02139644|2671227|P3|Treatment Period|Lack of Efficacy|1
816519|NCT02139644|2671228|P2|Treatment Period|Lack of Efficacy|0
816520|NCT02139644|2671229|P1|Treatment Period|Lack of Efficacy|0
816521|NCT02139644|2671224|P6|Treatment Period|Lost to Follow-up|1
816522|NCT02139644|2671225|P5|Treatment Period|Lost to Follow-up|1
816523|NCT02139644|2671226|P4|Treatment Period|Lost to Follow-up|1
816524|NCT02139644|2671227|P3|Treatment Period|Lost to Follow-up|1
816525|NCT02139644|2671228|P2|Treatment Period|Lost to Follow-up|0
816526|NCT02139644|2671229|P1|Treatment Period|Lost to Follow-up|0
816527|NCT02139644|2671224|P6|Treatment Period|Disease progression|2
816528|NCT02139644|2671225|P5|Treatment Period|Disease progression|1
816529|NCT02139644|2671226|P4|Treatment Period|Disease progression|1
816530|NCT02139644|2671227|P3|Treatment Period|Disease progression|0
816531|NCT02139644|2671228|P2|Treatment Period|Disease progression|0
816532|NCT02139644|2671229|P1|Treatment Period|Disease progression|0
816533|NCT02139644|2671224|P6|Treatment Period|Protocol Violation|1
816534|NCT02139644|2671225|P5|Treatment Period|Protocol Violation|1
816535|NCT02139644|2671226|P4|Treatment Period|Protocol Violation|1
816536|NCT02139644|2671227|P3|Treatment Period|Protocol Violation|0
816537|NCT02139644|2671228|P2|Treatment Period|Protocol Violation|0
816538|NCT02139644|2671229|P1|Treatment Period|Protocol Violation|0
816539|NCT02139644|2671224|P6|Treatment Period|Non-compliance|0
816540|NCT02139644|2671225|P5|Treatment Period|Non-compliance|0
816541|NCT02139644|2671226|P4|Treatment Period|Non-compliance|1
816542|NCT02139644|2671227|P3|Treatment Period|Non-compliance|0
816543|NCT02139644|2671228|P2|Treatment Period|Non-compliance|0
816544|NCT02139644|2671229|P1|Treatment Period|Non-compliance|0
816545|NCT02139644|2671224|P6|Treatment Period|Withdrawal by Subject|2
816546|NCT02139644|2671225|P5|Treatment Period|Withdrawal by Subject|3
816547|NCT02139644|2671226|P4|Treatment Period|Withdrawal by Subject|2
816548|NCT02139644|2671227|P3|Treatment Period|Withdrawal by Subject|2
816549|NCT02139644|2671228|P2|Treatment Period|Withdrawal by Subject|0
816550|NCT02139644|2671229|P1|Treatment Period|Withdrawal by Subject|0
816551|NCT02139644|2671224|P6|Treatment Period|Adverse Event|6
816552|NCT02139644|2671225|P5|Treatment Period|Adverse Event|1
816553|NCT02139644|2671226|P4|Treatment Period|Adverse Event|2
816554|NCT02139644|2671227|P3|Treatment Period|Adverse Event|3
816555|NCT02139644|2671228|P2|Treatment Period|Adverse Event|0
816556|NCT02139644|2671229|P1|Treatment Period|Adverse Event|0
816557|NCT02139644|2671224|P6|Run-In Period (Pre-assignment)|Not specified|0
816558|NCT02139644|2671225|P5|Run-In Period (Pre-assignment)|Not specified|0
816559|NCT02139644|2671226|P4|Run-In Period (Pre-assignment)|Not specified|0
816560|NCT02139644|2671227|P3|Run-In Period (Pre-assignment)|Not specified|0
816561|NCT02139644|2671228|P2|Run-In Period (Pre-assignment)|Not specified|0
816562|NCT02139644|2671229|P1|Run-In Period (Pre-assignment)|Not specified|6
816563|NCT02139644|2671224|P6|Run-In Period (Pre-assignment)|Adverse Event|0
816564|NCT02139644|2671225|P5|Run-In Period (Pre-assignment)|Adverse Event|0
816565|NCT02139644|2671226|P4|Run-In Period (Pre-assignment)|Adverse Event|0
816566|NCT02139644|2671227|P3|Run-In Period (Pre-assignment)|Adverse Event|0
816567|NCT02139644|2671228|P2|Run-In Period (Pre-assignment)|Adverse Event|0
816568|NCT02139644|2671229|P1|Run-In Period (Pre-assignment)|Adverse Event|3
816569|NCT02139644|2671224|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
816570|NCT02139644|2671225|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
816571|NCT02139644|2671226|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
816572|NCT02139644|2671227|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
816573|NCT02139644|2671228|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
816574|NCT02139644|2671229|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|8
816575|NCT02139644|2671224|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
816576|NCT02139644|2671225|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
816577|NCT02139644|2671226|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
816578|NCT02139644|2671227|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
816579|NCT02139644|2671228|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
816580|NCT02139644|2671229|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|11
816581|NCT02139644|2671224|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
816582|NCT02139644|2671225|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
816583|NCT02139644|2671226|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
816584|NCT02139644|2671227|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
816585|NCT02139644|2671228|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
816586|NCT02139644|2671229|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|12
816587|NCT02139644|2671224|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
816588|NCT02139644|2671225|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
816589|NCT02139644|2671226|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
816590|NCT02139644|2671227|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
816591|NCT02139644|2671228|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
816592|NCT02139644|2671229|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|30
816593|NCT02139644|2671224|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
816594|NCT02139644|2671225|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
816595|NCT02139644|2671226|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
816596|NCT02139644|2671227|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
816597|NCT02139644|2671228|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
816598|NCT02139644|2671229|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|70
816599|NCT02139046|2671334|P5|Overall Study|Other Miscellaneous Reasons|12
816600|NCT02139046|2671335|P4|Overall Study|Other Miscellaneous Reasons|9
816601|NCT02139046|2671336|P3|Overall Study|Other Miscellaneous Reasons|4
816602|NCT02139046|2671337|P2|Overall Study|Other Miscellaneous Reasons|9
816603|NCT02139046|2671338|P1|Overall Study|Other Miscellaneous Reasons|10
816604|NCT02139046|2671334|P5|Overall Study|Withdrawal due to a Gout Flare|1
816605|NCT02139046|2671335|P4|Overall Study|Withdrawal due to a Gout Flare|0
816606|NCT02139046|2671336|P3|Overall Study|Withdrawal due to a Gout Flare|1
816607|NCT02139046|2671337|P2|Overall Study|Withdrawal due to a Gout Flare|1
816608|NCT02139046|2671338|P1|Overall Study|Withdrawal due to a Gout Flare|1
816609|NCT02139046|2671334|P5|Overall Study|Lack of Efficacy|2
816610|NCT02139046|2671335|P4|Overall Study|Lack of Efficacy|1
816611|NCT02139046|2671336|P3|Overall Study|Lack of Efficacy|2
816612|NCT02139046|2671337|P2|Overall Study|Lack of Efficacy|1
816613|NCT02139046|2671338|P1|Overall Study|Lack of Efficacy|0
816614|NCT02139046|2671334|P5|Overall Study|Voluntary Withdrawal|16
816615|NCT02139046|2671335|P4|Overall Study|Voluntary Withdrawal|15
816616|NCT02139046|2671336|P3|Overall Study|Voluntary Withdrawal|10
816617|NCT02139046|2671337|P2|Overall Study|Voluntary Withdrawal|8
816618|NCT02139046|2671338|P1|Overall Study|Voluntary Withdrawal|20
816619|NCT02139046|2671334|P5|Overall Study|Lost to Follow-up|13
816620|NCT02139046|2671335|P4|Overall Study|Lost to Follow-up|18
816621|NCT02139046|2671336|P3|Overall Study|Lost to Follow-up|16
816622|NCT02139046|2671337|P2|Overall Study|Lost to Follow-up|16
816623|NCT02139046|2671338|P1|Overall Study|Lost to Follow-up|13
816624|NCT02139046|2671334|P5|Overall Study|Major Protocol Deviation|6
816625|NCT02139046|2671335|P4|Overall Study|Major Protocol Deviation|12
816626|NCT02139046|2671336|P3|Overall Study|Major Protocol Deviation|16
816627|NCT02139046|2671337|P2|Overall Study|Major Protocol Deviation|10
816628|NCT02139046|2671338|P1|Overall Study|Major Protocol Deviation|9
816629|NCT02139046|2671334|P5|Overall Study|Pretreatment Event/Adverse Event|7
816630|NCT02139046|2671335|P4|Overall Study|Pretreatment Event/Adverse Event|13
816631|NCT02139046|2671336|P3|Overall Study|Pretreatment Event/Adverse Event|10
816632|NCT02139046|2671337|P2|Overall Study|Pretreatment Event/Adverse Event|9
816633|NCT02139046|2671338|P1|Overall Study|Pretreatment Event/Adverse Event|9
816634|NCT02138838|2671378|P2|Overall Study|Withdrawal by Subject|5
816635|NCT02138838|2671379|P1|Overall Study|Withdrawal by Subject|1
816636|NCT02138838|2671378|P2|Overall Study|Study Closure|6
816637|NCT02138838|2671379|P1|Overall Study|Study Closure|7
816638|NCT02138825|2671397|P2|Safety Follow-up|withdrawn due to lung transplant|1
816639|NCT02138825|2671398|P1|Safety Follow-up|withdrawn due to lung transplant|0
816640|NCT02138825|2671397|P2|Safety Follow-up|treatment unblinded|1
816641|NCT02138825|2671398|P1|Safety Follow-up|treatment unblinded|0
816642|NCT02138825|2671397|P2|Safety Follow-up|too unwell to attend the visit|1
816643|NCT02138825|2671398|P1|Safety Follow-up|too unwell to attend the visit|0
816644|NCT02138825|2671397|P2|Safety Follow-up|progressive disease|2
816645|NCT02138825|2671398|P1|Safety Follow-up|progressive disease|0
816646|NCT02138825|2671397|P2|Safety Follow-up|logistical difficulties|1
816647|NCT02138825|2671398|P1|Safety Follow-up|logistical difficulties|0
816648|NCT02138825|2671397|P2|Safety Follow-up|withdrawal by PI|0
816649|NCT02138825|2671398|P1|Safety Follow-up|withdrawal by PI|1
816650|NCT02138825|2671397|P2|Safety Follow-up|clinic worsening|0
816651|NCT02138825|2671398|P1|Safety Follow-up|clinic worsening|1
816652|NCT02138825|2671397|P2|Safety Follow-up|Withdrawal by Subject|3
816653|NCT02138825|2671398|P1|Safety Follow-up|Withdrawal by Subject|5
816654|NCT02138825|2671397|P2|Safety Follow-up|Death|5
816655|NCT02138825|2671398|P1|Safety Follow-up|Death|11
816656|NCT02138825|2671397|P2|Safety Follow-up|Adverse Event|3
816657|NCT02138825|2671398|P1|Safety Follow-up|Adverse Event|4
816658|NCT02138825|2671397|P2|Long-term Extension|Study termination by sponsor|38
816659|NCT02138825|2671398|P1|Long-term Extension|Study termination by sponsor|32
816660|NCT02138825|2671397|P2|Main Study Treatment|Medical decision|0
816661|NCT02138825|2671398|P1|Main Study Treatment|Medical decision|1
816662|NCT02138825|2671397|P2|Main Study Treatment|Withdrawal by Subject|1
816663|NCT02138825|2671398|P1|Main Study Treatment|Withdrawal by Subject|3
816664|NCT02138825|2671397|P2|Main Study Treatment|Study terminated by sponsor|9
816665|NCT02138825|2671398|P1|Main Study Treatment|Study terminated by sponsor|10
816666|NCT02138825|2671397|P2|Main Study Treatment|Sponsor decision|18
816667|NCT02138825|2671398|P1|Main Study Treatment|Sponsor decision|12
816668|NCT02138825|2671397|P2|Main Study Treatment|Protocol Violation|2
816669|NCT02138825|2671398|P1|Main Study Treatment|Protocol Violation|2
816670|NCT02138825|2671397|P2|Main Study Treatment|Death|2
816671|NCT02138825|2671398|P1|Main Study Treatment|Death|1
816672|NCT02138825|2671397|P2|Main Study Treatment|Adverse Event|3
816673|NCT02138825|2671398|P1|Main Study Treatment|Adverse Event|11
816674|NCT02138747|2671416|P4|Treatment Period 2|Other - Miscellaneous|0
816675|NCT02138747|2671417|P3|Treatment Period 2|Other - Miscellaneous|0
816676|NCT02138747|2671418|P2|Treatment Period 2|Other - Miscellaneous|0
816677|NCT02138747|2671419|P1|Treatment Period 2|Other - Miscellaneous|3
816678|NCT02138747|2671416|P4|Treatment Period 2|Withdrawal by Subject|2
816679|NCT02138747|2671417|P3|Treatment Period 2|Withdrawal by Subject|1
816680|NCT02138747|2671418|P2|Treatment Period 2|Withdrawal by Subject|4
816681|NCT02138747|2671419|P1|Treatment Period 2|Withdrawal by Subject|5
816682|NCT02138747|2671416|P4|Treatment Period 2|Protocol Violation|0
816683|NCT02138747|2671417|P3|Treatment Period 2|Protocol Violation|0
816684|NCT02138747|2671418|P2|Treatment Period 2|Protocol Violation|0
816685|NCT02138747|2671419|P1|Treatment Period 2|Protocol Violation|1
816686|NCT02138747|2671416|P4|Treatment Period 2|Lost to Follow-up|0
816687|NCT02138747|2671417|P3|Treatment Period 2|Lost to Follow-up|0
816688|NCT02138747|2671418|P2|Treatment Period 2|Lost to Follow-up|0
816689|NCT02138747|2671419|P1|Treatment Period 2|Lost to Follow-up|2
816690|NCT02138747|2671416|P4|Treatment Period 2|Adverse Event|1
816691|NCT02138747|2671417|P3|Treatment Period 2|Adverse Event|1
816692|NCT02138747|2671418|P2|Treatment Period 2|Adverse Event|3
816693|NCT02138747|2671419|P1|Treatment Period 2|Adverse Event|6
816694|NCT02138747|2671416|P4|Treatment Period 1|Other - Miscellaneous|0
816695|NCT02138747|2671417|P3|Treatment Period 1|Other - Miscellaneous|0
816696|NCT02138747|2671418|P2|Treatment Period 1|Other - Miscellaneous|4
816697|NCT02138747|2671419|P1|Treatment Period 1|Other - Miscellaneous|2
816698|NCT02138747|2671416|P4|Treatment Period 1|Withdrawal by Subject|3
816699|NCT02138747|2671417|P3|Treatment Period 1|Withdrawal by Subject|1
816700|NCT02138747|2671418|P2|Treatment Period 1|Withdrawal by Subject|4
816701|NCT02138747|2671419|P1|Treatment Period 1|Withdrawal by Subject|8
816702|NCT02138747|2671416|P4|Treatment Period 1|Protocol Violation|0
816703|NCT02138747|2671417|P3|Treatment Period 1|Protocol Violation|0
816704|NCT02138747|2671418|P2|Treatment Period 1|Protocol Violation|2
816705|NCT02138747|2671419|P1|Treatment Period 1|Protocol Violation|0
816706|NCT02138747|2671416|P4|Treatment Period 1|Lost to Follow-up|0
816707|NCT02138747|2671417|P3|Treatment Period 1|Lost to Follow-up|1
816708|NCT02138747|2671418|P2|Treatment Period 1|Lost to Follow-up|1
816709|NCT02138747|2671419|P1|Treatment Period 1|Lost to Follow-up|0
816710|NCT02138747|2671416|P4|Treatment Period 1|Adverse Event|1
816711|NCT02138747|2671417|P3|Treatment Period 1|Adverse Event|2
816712|NCT02138747|2671418|P2|Treatment Period 1|Adverse Event|14
816713|NCT02138747|2671419|P1|Treatment Period 1|Adverse Event|10
816714|NCT02137785|2671747|P2|Overall Study|subject moved out of state|0
816715|NCT02137785|2671748|P1|Overall Study|subject moved out of state|1
816716|NCT02137785|2671747|P2|Overall Study|Withdrawal by Subject|4
816717|NCT02137785|2671748|P1|Overall Study|Withdrawal by Subject|1
816718|NCT02137785|2671747|P2|Overall Study|Lost to Follow-up|0
816719|NCT02137785|2671748|P1|Overall Study|Lost to Follow-up|1
816720|NCT02137772|2671856|P2|Overall Study|Not treated|2
816721|NCT02137772|2671857|P1|Overall Study|Not treated|3
816722|NCT02137772|2671856|P2|Overall Study|Non-compliance with study drug|0
816723|NCT02137772|2671857|P1|Overall Study|Non-compliance with study drug|1
816724|NCT02137772|2671856|P2|Overall Study|Withdrawal by Subject|17
816725|NCT02137772|2671857|P1|Overall Study|Withdrawal by Subject|28
816726|NCT02137772|2671856|P2|Overall Study|Physician Decision|5
816727|NCT02137772|2671857|P1|Overall Study|Physician Decision|15
816728|NCT02137772|2671856|P2|Overall Study|Lost to Follow-up|4
816729|NCT02137772|2671857|P1|Overall Study|Lost to Follow-up|8
816730|NCT02137772|2671856|P2|Overall Study|Death|44
816731|NCT02137772|2671857|P1|Overall Study|Death|71
816732|NCT02137772|2671856|P2|Overall Study|Adverse Event|3
816733|NCT02137772|2671857|P1|Overall Study|Adverse Event|6
816734|NCT02137226|2672071|P5|Period 2 (Re - Randomization)|Other Reason|1
816735|NCT02137226|2672072|P4|Period 2 (Re - Randomization)|Other Reason|1
816736|NCT02137226|2672073|P3|Period 2 (Re - Randomization)|Other Reason|1
816737|NCT02137226|2672074|P2|Period 2 (Re - Randomization)|Other Reason|0
816738|NCT02137226|2672075|P1|Period 2 (Re - Randomization)|Other Reason|0
816739|NCT02137226|2672071|P5|Period 2 (Re - Randomization)|Lack of Efficacy|0
816740|NCT02137226|2672072|P4|Period 2 (Re - Randomization)|Lack of Efficacy|0
816741|NCT02137226|2672073|P3|Period 2 (Re - Randomization)|Lack of Efficacy|2
816742|NCT02137226|2672074|P2|Period 2 (Re - Randomization)|Lack of Efficacy|0
816743|NCT02137226|2672075|P1|Period 2 (Re - Randomization)|Lack of Efficacy|0
816744|NCT02137226|2672071|P5|Period 2 (Re - Randomization)|Lost to Follow-up|0
816745|NCT02137226|2672072|P4|Period 2 (Re - Randomization)|Lost to Follow-up|0
816746|NCT02137226|2672073|P3|Period 2 (Re - Randomization)|Lost to Follow-up|3
816747|NCT02137226|2672074|P2|Period 2 (Re - Randomization)|Lost to Follow-up|0
816748|NCT02137226|2672075|P1|Period 2 (Re - Randomization)|Lost to Follow-up|0
816749|NCT02137226|2672071|P5|Period 2 (Re - Randomization)|Physician Decision|0
816750|NCT02137226|2672072|P4|Period 2 (Re - Randomization)|Physician Decision|1
816751|NCT02137226|2672073|P3|Period 2 (Re - Randomization)|Physician Decision|0
816752|NCT02137226|2672074|P2|Period 2 (Re - Randomization)|Physician Decision|0
816753|NCT02137226|2672075|P1|Period 2 (Re - Randomization)|Physician Decision|0
816754|NCT02137226|2672071|P5|Period 2 (Re - Randomization)|Withdrawal by Subject|4
816755|NCT02137226|2672072|P4|Period 2 (Re - Randomization)|Withdrawal by Subject|5
816756|NCT02137226|2672073|P3|Period 2 (Re - Randomization)|Withdrawal by Subject|8
816757|NCT02137226|2672074|P2|Period 2 (Re - Randomization)|Withdrawal by Subject|0
816758|NCT02137226|2672075|P1|Period 2 (Re - Randomization)|Withdrawal by Subject|0
816759|NCT02137226|2672071|P5|Period 2 (Re - Randomization)|Adverse Event|4
816760|NCT02137226|2672072|P4|Period 2 (Re - Randomization)|Adverse Event|1
816761|NCT02137226|2672073|P3|Period 2 (Re - Randomization)|Adverse Event|3
816762|NCT02137226|2672074|P2|Period 2 (Re - Randomization)|Adverse Event|0
816763|NCT02137226|2672075|P1|Period 2 (Re - Randomization)|Adverse Event|0
816764|NCT02137226|2672071|P5|Period 1 (Initial Randomization)|Other Reason|0
816765|NCT02137226|2672072|P4|Period 1 (Initial Randomization)|Other Reason|0
816766|NCT02137226|2672073|P3|Period 1 (Initial Randomization)|Other Reason|0
816767|NCT02137226|2672074|P2|Period 1 (Initial Randomization)|Other Reason|3
816768|NCT02137226|2672075|P1|Period 1 (Initial Randomization)|Other Reason|1
816769|NCT02137226|2672071|P5|Period 1 (Initial Randomization)|Lack of Efficacy|0
816770|NCT02137226|2672072|P4|Period 1 (Initial Randomization)|Lack of Efficacy|0
816771|NCT02137226|2672073|P3|Period 1 (Initial Randomization)|Lack of Efficacy|0
816772|NCT02137226|2672074|P2|Period 1 (Initial Randomization)|Lack of Efficacy|0
816773|NCT02137226|2672075|P1|Period 1 (Initial Randomization)|Lack of Efficacy|1
816774|NCT02137226|2672071|P5|Period 1 (Initial Randomization)|Lost to Follow-up|0
816775|NCT02137226|2672072|P4|Period 1 (Initial Randomization)|Lost to Follow-up|0
816776|NCT02137226|2672073|P3|Period 1 (Initial Randomization)|Lost to Follow-up|0
816777|NCT02137226|2672074|P2|Period 1 (Initial Randomization)|Lost to Follow-up|2
816778|NCT02137226|2672075|P1|Period 1 (Initial Randomization)|Lost to Follow-up|3
816779|NCT02137226|2672071|P5|Period 1 (Initial Randomization)|Physician Decision|0
816780|NCT02137226|2672072|P4|Period 1 (Initial Randomization)|Physician Decision|0
816781|NCT02137226|2672073|P3|Period 1 (Initial Randomization)|Physician Decision|0
816782|NCT02137226|2672074|P2|Period 1 (Initial Randomization)|Physician Decision|3
816783|NCT02137226|2672075|P1|Period 1 (Initial Randomization)|Physician Decision|1
816784|NCT02137226|2672071|P5|Period 1 (Initial Randomization)|Withdrawal by Subject|0
816785|NCT02137226|2672072|P4|Period 1 (Initial Randomization)|Withdrawal by Subject|0
816786|NCT02137226|2672073|P3|Period 1 (Initial Randomization)|Withdrawal by Subject|0
816787|NCT02137226|2672074|P2|Period 1 (Initial Randomization)|Withdrawal by Subject|5
816788|NCT02137226|2672075|P1|Period 1 (Initial Randomization)|Withdrawal by Subject|11
816789|NCT02137226|2672071|P5|Period 1 (Initial Randomization)|Adverse Event|0
816790|NCT02137226|2672072|P4|Period 1 (Initial Randomization)|Adverse Event|0
816791|NCT02137226|2672073|P3|Period 1 (Initial Randomization)|Adverse Event|0
816792|NCT02137226|2672074|P2|Period 1 (Initial Randomization)|Adverse Event|3
816793|NCT02137226|2672075|P1|Period 1 (Initial Randomization)|Adverse Event|3
816794|NCT02136914|2672089|P2|Overall Study|Death|1
816795|NCT02136914|2672090|P1|Overall Study|Death|0
816796|NCT02136914|2672089|P2|Overall Study|Lack of Efficacy|0
816797|NCT02136914|2672090|P1|Overall Study|Lack of Efficacy|1
816798|NCT02136914|2672089|P2|Overall Study|Did Not Receive Study Drug|0
816799|NCT02136914|2672090|P1|Overall Study|Did Not Receive Study Drug|2
816800|NCT02136914|2672089|P2|Overall Study|Lost to Follow-up|1
816801|NCT02136914|2672090|P1|Overall Study|Lost to Follow-up|1
816802|NCT02136914|2672089|P2|Overall Study|Subject Unwilling to Proceed|2
816803|NCT02136914|2672090|P1|Overall Study|Subject Unwilling to Proceed|7
816804|NCT02136914|2672089|P2|Overall Study|Withdrawal by Subject|10
816805|NCT02136914|2672090|P1|Overall Study|Withdrawal by Subject|3
816806|NCT02136914|2672089|P2|Overall Study|Sponsor's Decision to Stop the Study|7
816807|NCT02136914|2672090|P1|Overall Study|Sponsor's Decision to Stop the Study|7
816808|NCT02136134|2672165|P2|Overall Study|Subjects randomized but not treated|8
816809|NCT02136134|2672166|P1|Overall Study|Subjects randomized but not treated|10
816810|NCT02136134|2672165|P2|Overall Study|Ongoing|207
816811|NCT02136134|2672166|P1|Overall Study|Ongoing|185
816812|NCT02136134|2672165|P2|Overall Study|Other|3
816813|NCT02136134|2672166|P1|Overall Study|Other|3
816814|NCT02136134|2672165|P2|Overall Study|Withdrawal by Subject|4
816815|NCT02136134|2672166|P1|Overall Study|Withdrawal by Subject|14
816816|NCT02136134|2672165|P2|Overall Study|Death|29
816817|NCT02136134|2672166|P1|Overall Study|Death|35
816818|NCT02135848|2672204|P2|Overall Study|Withdrawal by Subject|1
816819|NCT02135848|2672205|P1|Overall Study|Withdrawal by Subject|1
816820|NCT02135848|2672204|P2|Overall Study|Adverse Event|0
816821|NCT02135848|2672205|P1|Overall Study|Adverse Event|2
816822|NCT02135692|2672263|P1|Overall Study|Withdrawal by Subject|15
816823|NCT02135692|2672263|P1|Overall Study|Lost to Follow-up|4
816824|NCT02135692|2672263|P1|Overall Study|Study closed/terminated|153
816825|NCT02135692|2672263|P1|Overall Study|Product commercially available|159
816826|NCT02135692|2672263|P1|Overall Study|Subject met Liver Stopping Criteria|1
816827|NCT02135692|2672263|P1|Overall Study|Protocol Violation|2
816828|NCT02135692|2672263|P1|Overall Study|Lack of Efficacy|2
816829|NCT02135692|2672263|P1|Overall Study|Adverse Event|3
816830|NCT02135614|2672282|P2|Overall Study|Lost to Follow-up|0
816831|NCT02135614|2672283|P1|Overall Study|Lost to Follow-up|3
816832|NCT02135614|2672282|P2|Overall Study|Withdrew Consent|2
816833|NCT02135614|2672283|P1|Overall Study|Withdrew Consent|2
816834|NCT02135614|2672282|P2|Overall Study|Investigator's Discretion|1
816835|NCT02135614|2672283|P1|Overall Study|Investigator's Discretion|0
816836|NCT02135614|2672282|P2|Overall Study|Death|0
816837|NCT02135614|2672283|P1|Overall Study|Death|1
816838|NCT02135614|2672282|P2|Overall Study|Adverse Event|1
816839|NCT02135614|2672283|P1|Overall Study|Adverse Event|0
816840|NCT02135614|2672282|P2|Overall Study|Randomized but Not Treated|1
816841|NCT02135614|2672283|P1|Overall Study|Randomized but Not Treated|2
816842|NCT02135445|2672297|P2|Overall Study|Withdrawal by Subject|0
816843|NCT02135445|2672298|P1|Overall Study|Withdrawal by Subject|1
816844|NCT02135445|2672297|P2|Overall Study|Lost to Follow-up|0
816845|NCT02135445|2672298|P1|Overall Study|Lost to Follow-up|1
816846|NCT02135107|2672364|P4|Maintenance Therapy Period|Not specified|8
816847|NCT02135107|2672365|P3|Maintenance Therapy Period|Not specified|7
816848|NCT02135107|2672366|P2|Maintenance Therapy Period|Not specified|0
816849|NCT02135107|2672367|P1|Maintenance Therapy Period|Not specified|0
816850|NCT02135107|2672364|P4|Maintenance Therapy Period|Pregnancy|1
816851|NCT02135107|2672365|P3|Maintenance Therapy Period|Pregnancy|0
816852|NCT02135107|2672366|P2|Maintenance Therapy Period|Pregnancy|0
816853|NCT02135107|2672367|P1|Maintenance Therapy Period|Pregnancy|0
816854|NCT02135107|2672364|P4|Maintenance Therapy Period|Withdrawal by Subject|4
816855|NCT02135107|2672365|P3|Maintenance Therapy Period|Withdrawal by Subject|5
816856|NCT02135107|2672366|P2|Maintenance Therapy Period|Withdrawal by Subject|0
816857|NCT02135107|2672367|P1|Maintenance Therapy Period|Withdrawal by Subject|0
816858|NCT02135107|2672364|P4|Maintenance Therapy Period|Adverse Event|7
816859|NCT02135107|2672365|P3|Maintenance Therapy Period|Adverse Event|3
816860|NCT02135107|2672366|P2|Maintenance Therapy Period|Adverse Event|0
816861|NCT02135107|2672367|P1|Maintenance Therapy Period|Adverse Event|0
816862|NCT02135107|2672364|P4|Treatment Period|Not specified|0
816863|NCT02135107|2672365|P3|Treatment Period|Not specified|0
816864|NCT02135107|2672366|P2|Treatment Period|Not specified|24
816865|NCT02135107|2672367|P1|Treatment Period|Not specified|115
816866|NCT02135107|2672364|P4|Treatment Period|Pregnancy|0
816867|NCT02135107|2672365|P3|Treatment Period|Pregnancy|0
816868|NCT02135107|2672366|P2|Treatment Period|Pregnancy|0
816869|NCT02135107|2672367|P1|Treatment Period|Pregnancy|1
816870|NCT02135107|2672364|P4|Treatment Period|Adverse Event|0
816871|NCT02135107|2672365|P3|Treatment Period|Adverse Event|0
816872|NCT02135107|2672366|P2|Treatment Period|Adverse Event|2
816873|NCT02135107|2672367|P1|Treatment Period|Adverse Event|5
816874|NCT02135107|2672364|P4|Treatment Period|Withdrawal by Subject|0
816875|NCT02135107|2672365|P3|Treatment Period|Withdrawal by Subject|0
816876|NCT02135107|2672366|P2|Treatment Period|Withdrawal by Subject|0
816877|NCT02135107|2672367|P1|Treatment Period|Withdrawal by Subject|11
816878|NCT02135029|2672413|P3|Overall Study|Death|0
816879|NCT02135029|2672414|P2|Overall Study|Death|1
816880|NCT02135029|2672415|P1|Overall Study|Death|0
816881|NCT02135029|2672413|P3|Overall Study|Other|0
816882|NCT02135029|2672414|P2|Overall Study|Other|1
816883|NCT02135029|2672415|P1|Overall Study|Other|0
816884|NCT02135029|2672413|P3|Overall Study|Withdrawal by Subject|1
816885|NCT02135029|2672414|P2|Overall Study|Withdrawal by Subject|0
816886|NCT02135029|2672415|P1|Overall Study|Withdrawal by Subject|2
816887|NCT02135029|2672413|P3|Overall Study|Lost to Follow-up|0
816888|NCT02135029|2672414|P2|Overall Study|Lost to Follow-up|1
816889|NCT02135029|2672415|P1|Overall Study|Lost to Follow-up|0
816890|NCT02135029|2672413|P3|Overall Study|Adverse Event|2
816891|NCT02135029|2672414|P2|Overall Study|Adverse Event|2
816892|NCT02135029|2672415|P1|Overall Study|Adverse Event|2
816893|NCT02134977|2672520|P1|Overall Study|Protocol Deviation|102
816894|NCT02134925|2672554|P2|Overall Study|Cancel|6
816895|NCT02134925|2672555|P1|Overall Study|Cancel|1
816896|NCT02134925|2672554|P2|Overall Study|Withdrawal by Subject|0
816897|NCT02134925|2672555|P1|Overall Study|Withdrawal by Subject|1
816898|NCT02134587|2672569|P1|Overall Study|Did not completed all meetings|30
816899|NCT02134015|2672675|P2|Overall Study|Withdrawal by Subject|7
816900|NCT02134015|2672676|P1|Overall Study|Withdrawal by Subject|3
816901|NCT02134015|2672675|P2|Overall Study|Adverse Event|10
816902|NCT02134015|2672676|P1|Overall Study|Adverse Event|9
816903|NCT02134015|2672675|P2|Overall Study|Study terminated by sponsor|3
816904|NCT02134015|2672676|P1|Overall Study|Study terminated by sponsor|2
816905|NCT02134015|2672675|P2|Overall Study|Progressive disease (per RECIST 1.1)|43
816906|NCT02134015|2672676|P1|Overall Study|Progressive disease (per RECIST 1.1)|40
816907|NCT02134015|2672675|P2|Overall Study|Clinical progression|7
816908|NCT02134015|2672676|P1|Overall Study|Clinical progression|14
816909|NCT02134015|2672675|P2|Overall Study|Reason not provided|2
816910|NCT02134015|2672676|P1|Overall Study|Reason not provided|1
816911|NCT02134015|2672675|P2|Overall Study|Death|1
816912|NCT02134015|2672676|P1|Overall Study|Death|2
816913|NCT02134015|2672675|P2|Overall Study|Protocol Violation|1
816914|NCT02134015|2672676|P1|Overall Study|Protocol Violation|0
816915|NCT02133664|2672714|P2|Overall Study|Adverse Event|6
816916|NCT02133664|2672715|P1|Overall Study|Adverse Event|3
816917|NCT02133664|2672714|P2|Overall Study|Lost to Follow-up|1
816918|NCT02133664|2672715|P1|Overall Study|Lost to Follow-up|2
816919|NCT02133508|2672731|P1|Overall Study|Lost to Follow-up|2
816920|NCT02133508|2672731|P1|Overall Study|Death|12
816921|NCT02133508|2672731|P1|Overall Study|Decision of Investigator or Sponsor|1
816922|NCT02133352|2672739|P1|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6
816923|NCT02133131|2672770|P7|Overall Study|Protocol Violation|1
816924|NCT02133131|2672771|P6|Overall Study|Protocol Violation|0
816925|NCT02133131|2672772|P5|Overall Study|Protocol Violation|0
816926|NCT02133131|2672773|P4|Overall Study|Protocol Violation|0
816927|NCT02133131|2672774|P3|Overall Study|Protocol Violation|0
816928|NCT02133131|2672775|P2|Overall Study|Protocol Violation|0
816929|NCT02133131|2672776|P1|Overall Study|Protocol Violation|0
816930|NCT02133131|2672770|P7|Overall Study|Ongoing in study|11
816931|NCT02133131|2672771|P6|Overall Study|Ongoing in study|14
816932|NCT02133131|2672772|P5|Overall Study|Ongoing in study|15
816933|NCT02133131|2672773|P4|Overall Study|Ongoing in study|0
816934|NCT02133131|2672774|P3|Overall Study|Ongoing in study|0
816935|NCT02133131|2672775|P2|Overall Study|Ongoing in study|0
816936|NCT02133131|2672776|P1|Overall Study|Ongoing in study|0
816937|NCT02133131|2672770|P7|Overall Study|Status not recorded|0
816938|NCT02133131|2672771|P6|Overall Study|Status not recorded|0
816939|NCT02133131|2672772|P5|Overall Study|Status not recorded|0
816940|NCT02133131|2672773|P4|Overall Study|Status not recorded|4
816941|NCT02133131|2672774|P3|Overall Study|Status not recorded|1
816942|NCT02133131|2672775|P2|Overall Study|Status not recorded|5
816943|NCT02133131|2672776|P1|Overall Study|Status not recorded|4
816944|NCT02133131|2672770|P7|Overall Study|Lost to Follow-up|0
816945|NCT02133131|2672771|P6|Overall Study|Lost to Follow-up|0
816946|NCT02133131|2672772|P5|Overall Study|Lost to Follow-up|0
816947|NCT02133131|2672773|P4|Overall Study|Lost to Follow-up|1
816948|NCT02133131|2672774|P3|Overall Study|Lost to Follow-up|0
816949|NCT02133131|2672775|P2|Overall Study|Lost to Follow-up|0
816950|NCT02133131|2672776|P1|Overall Study|Lost to Follow-up|1
816951|NCT02133131|2672770|P7|Overall Study|Adverse Event|0
816952|NCT02133131|2672771|P6|Overall Study|Adverse Event|0
816953|NCT02133131|2672772|P5|Overall Study|Adverse Event|0
816954|NCT02133131|2672773|P4|Overall Study|Adverse Event|1
816955|NCT02133131|2672774|P3|Overall Study|Adverse Event|0
816956|NCT02133131|2672775|P2|Overall Study|Adverse Event|0
816957|NCT02133131|2672776|P1|Overall Study|Adverse Event|0
816958|NCT02132949|2672830|P2|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|157
816959|NCT02132949|2672831|P1|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|142
816960|NCT02132949|2672830|P2|Adjuvant Treatment Period|Protocol Deviation|0
816961|NCT02132949|2672831|P1|Adjuvant Treatment Period|Protocol Deviation|1
816962|NCT02132949|2672830|P2|Adjuvant Treatment Period|Withdrawal by Subject|1
816963|NCT02132949|2672831|P1|Adjuvant Treatment Period|Withdrawal by Subject|1
816964|NCT02132949|2672830|P2|Adjuvant Treatment Period|Physician Decision|0
816965|NCT02132949|2672831|P1|Adjuvant Treatment Period|Physician Decision|1
816966|NCT02132949|2672830|P2|Adjuvant Treatment Period|Disease Relapse|1
816967|NCT02132949|2672831|P1|Adjuvant Treatment Period|Disease Relapse|0
816968|NCT02132949|2672830|P2|Adjuvant Treatment Period|Disease Progression|1
816969|NCT02132949|2672831|P1|Adjuvant Treatment Period|Disease Progression|0
816970|NCT02132949|2672830|P2|Adjuvant Treatment Period|Reason unspecified|1
816971|NCT02132949|2672831|P1|Adjuvant Treatment Period|Reason unspecified|0
816972|NCT02132949|2672830|P2|Adjuvant Treatment Period|Adverse Event|6
816973|NCT02132949|2672831|P1|Adjuvant Treatment Period|Adverse Event|4
816974|NCT02132949|2672830|P2|Neoadjuvant Treatment Period|Withdrew prior to treatment|3
816975|NCT02132949|2672831|P1|Neoadjuvant Treatment Period|Withdrew prior to treatment|0
816976|NCT02132949|2672830|P2|Neoadjuvant Treatment Period|Adverse Event|3
816977|NCT02132949|2672831|P1|Neoadjuvant Treatment Period|Adverse Event|6
816978|NCT02132949|2672830|P2|Neoadjuvant Treatment Period|Disease Progression|1
816979|NCT02132949|2672831|P1|Neoadjuvant Treatment Period|Disease Progression|1
816980|NCT02132949|2672830|P2|Neoadjuvant Treatment Period|Withdrawal by Subject|0
816981|NCT02132949|2672831|P1|Neoadjuvant Treatment Period|Withdrawal by Subject|1
816982|NCT02132949|2672830|P2|Neoadjuvant Treatment Period|Physician Decision|0
816983|NCT02132949|2672831|P1|Neoadjuvant Treatment Period|Physician Decision|2
816984|NCT02132949|2672830|P2|Neoadjuvant Treatment Period|Lack of Efficacy|1
816985|NCT02132949|2672831|P1|Neoadjuvant Treatment Period|Lack of Efficacy|0
816986|NCT02132949|2672830|P2|Neoadjuvant Treatment Period|Reason unspecified|1
816987|NCT02132949|2672831|P1|Neoadjuvant Treatment Period|Reason unspecified|3
816988|NCT02132949|2672830|P2|Neoadjuvant Treatment Period|Early surgery|3
816989|NCT02132949|2672831|P1|Neoadjuvant Treatment Period|Early surgery|4
816990|NCT02132767|2672924|P2|Overall Study|Lost to Follow-up|4
816991|NCT02132767|2672925|P1|Overall Study|Lost to Follow-up|4
816992|NCT02132767|2672924|P2|Overall Study|Withdrawal by Subject|9
816993|NCT02132767|2672925|P1|Overall Study|Withdrawal by Subject|10
816994|NCT02132767|2672924|P2|Overall Study|Death|2
816995|NCT02132767|2672925|P1|Overall Study|Death|3
816996|NCT02132637|2672947|P2|Study Period 2 (Crossover)|Physician Decision|0
816997|NCT02132637|2672948|P1|Study Period 2 (Crossover)|Physician Decision|2
816998|NCT02132637|2672947|P2|Study Period 2 (Crossover)|Adverse Event|1
816999|NCT02132637|2672948|P1|Study Period 2 (Crossover)|Adverse Event|0
817000|NCT02132637|2672947|P2|Study Period 1|Physician Decision|0
817001|NCT02132637|2672948|P1|Study Period 1|Physician Decision|1
817002|NCT02132637|2672947|P2|Study Period 1|Withdrawal by Subject|4
817003|NCT02132637|2672948|P1|Study Period 1|Withdrawal by Subject|0
817004|NCT02132611|2672972|P1|Overall Study|Death|2
817005|NCT02132247|2672990|P2|Overall Study|Protocol Violation|0
817006|NCT02132247|2672991|P1|Overall Study|Protocol Violation|1
817007|NCT02132117|2673020|P2|Overall Study|Other Miscellaneous Reasons|0
817008|NCT02132117|2673021|P1|Overall Study|Other Miscellaneous Reasons|2
817009|NCT02132117|2673020|P2|Overall Study|Personal Reasons|2
817010|NCT02132117|2673021|P1|Overall Study|Personal Reasons|1
817011|NCT02132117|2673020|P2|Overall Study|Lost to Follow-up|2
817012|NCT02132117|2673021|P1|Overall Study|Lost to Follow-up|2
817013|NCT02132117|2673020|P2|Overall Study|Adverse Event|1
817014|NCT02132117|2673021|P1|Overall Study|Adverse Event|6
817015|NCT02131662|2673042|P5|Overall Study|Not treated|3
817016|NCT02131662|2673043|P4|Overall Study|Not treated|2
817017|NCT02131662|2673044|P3|Overall Study|Not treated|2
817018|NCT02131662|2673045|P2|Overall Study|Not treated|0
817019|NCT02131662|2673046|P1|Overall Study|Not treated|2
817020|NCT02131662|2673042|P5|Overall Study|Lost to Follow-up|0
817021|NCT02131662|2673043|P4|Overall Study|Lost to Follow-up|9
817022|NCT02131662|2673044|P3|Overall Study|Lost to Follow-up|0
817023|NCT02131662|2673045|P2|Overall Study|Lost to Follow-up|3
817024|NCT02131662|2673046|P1|Overall Study|Lost to Follow-up|1
817025|NCT02131662|2673042|P5|Overall Study|Withdrawal by Subject|6
817026|NCT02131662|2673043|P4|Overall Study|Withdrawal by Subject|5
817027|NCT02131662|2673044|P3|Overall Study|Withdrawal by Subject|1
817028|NCT02131662|2673045|P2|Overall Study|Withdrawal by Subject|5
817029|NCT02131662|2673046|P1|Overall Study|Withdrawal by Subject|1
817030|NCT02131662|2673042|P5|Overall Study|Lack of Efficacy|1
817031|NCT02131662|2673043|P4|Overall Study|Lack of Efficacy|0
817032|NCT02131662|2673044|P3|Overall Study|Lack of Efficacy|0
817033|NCT02131662|2673045|P2|Overall Study|Lack of Efficacy|0
817034|NCT02131662|2673046|P1|Overall Study|Lack of Efficacy|1
817035|NCT02131662|2673042|P5|Overall Study|Wish for pregnancy|1
817036|NCT02131662|2673043|P4|Overall Study|Wish for pregnancy|0
817037|NCT02131662|2673044|P3|Overall Study|Wish for pregnancy|0
817038|NCT02131662|2673045|P2|Overall Study|Wish for pregnancy|0
817039|NCT02131662|2673046|P1|Overall Study|Wish for pregnancy|0
817040|NCT02131662|2673042|P5|Overall Study|Pregnancy|0
817041|NCT02131662|2673043|P4|Overall Study|Pregnancy|1
817042|NCT02131662|2673044|P3|Overall Study|Pregnancy|0
817043|NCT02131662|2673045|P2|Overall Study|Pregnancy|1
817044|NCT02131662|2673046|P1|Overall Study|Pregnancy|0
817045|NCT02131662|2673042|P5|Overall Study|Adverse Event|3
817046|NCT02131662|2673043|P4|Overall Study|Adverse Event|1
817047|NCT02131662|2673044|P3|Overall Study|Adverse Event|1
817048|NCT02131662|2673045|P2|Overall Study|Adverse Event|1
817049|NCT02131662|2673046|P1|Overall Study|Adverse Event|0
817050|NCT02131662|2673042|P5|Overall Study|Other|4
817051|NCT02131662|2673043|P4|Overall Study|Other|3
817052|NCT02131662|2673044|P3|Overall Study|Other|3
817053|NCT02131662|2673045|P2|Overall Study|Other|4
817054|NCT02131662|2673046|P1|Overall Study|Other|2
817055|NCT02131662|2673042|P5|Overall Study|Protocol Violation|0
817056|NCT02131662|2673043|P4|Overall Study|Protocol Violation|0
817057|NCT02131662|2673044|P3|Overall Study|Protocol Violation|0
817058|NCT02131662|2673045|P2|Overall Study|Protocol Violation|0
817059|NCT02131662|2673046|P1|Overall Study|Protocol Violation|1
817060|NCT02131636|2673092|P2|Overall Study|Adverse Event|1
817061|NCT02131636|2673093|P1|Overall Study|Adverse Event|4
817062|NCT02131636|2673092|P2|Overall Study|Lost to Follow-up|0
817063|NCT02131636|2673093|P1|Overall Study|Lost to Follow-up|4
817064|NCT02131636|2673092|P2|Overall Study|Personal Reasons|4
817065|NCT02131636|2673093|P1|Overall Study|Personal Reasons|4
817066|NCT02131532|2673109|P1|Overall Study|Other health conditions|2
817067|NCT02131532|2673109|P1|Overall Study|Physician Decision|1
817068|NCT02131532|2673109|P1|Overall Study|Withdrawal by Subject|1
817069|NCT02131324|2673201|P2|Overall Study|Lost to Follow-up|1
817070|NCT02131324|2673202|P1|Overall Study|Lost to Follow-up|1
817071|NCT02131324|2673201|P2|Overall Study|Withdrawal by Subject|2
817072|NCT02131324|2673202|P1|Overall Study|Withdrawal by Subject|1
817073|NCT02131311|2673208|P1|Overall Study|Lost to Follow-up|1
817074|NCT02131311|2673208|P1|Overall Study|Protocol Violation|1
817075|NCT02131311|2673208|P1|Overall Study|Adverse Event|2
817076|NCT02131272|2673220|P2|Overall Study|Withdrawal Criteria|0
817077|NCT02131272|2673221|P1|Overall Study|Withdrawal Criteria|1
817078|NCT02131272|2673220|P2|Overall Study|Withdrawal by Subject|1
817079|NCT02131272|2673221|P1|Overall Study|Withdrawal by Subject|0
817080|NCT02131272|2673220|P2|Overall Study|Withdrawal by parent|1
817081|NCT02131272|2673221|P1|Overall Study|Withdrawal by parent|0
817082|NCT02131259|2673239|P1|Overall Study|Missing|3
817083|NCT02131259|2673239|P1|Overall Study|Progressive disease/AE/other|1
817084|NCT02131259|2673239|P1|Overall Study|AE/other|1
817085|NCT02131259|2673239|P1|Overall Study|AE/lost to follow-up|1
817086|NCT02131259|2673239|P1|Overall Study|Progressive disease/other|2
817087|NCT02131259|2673239|P1|Overall Study|Progressive disease/relocation|1
817088|NCT02131259|2673239|P1|Overall Study|Progressive disease/Adverse Event (AE)|22
817089|NCT02131259|2673239|P1|Overall Study|Not specified|63
817090|NCT02131259|2673239|P1|Overall Study|Relocation|32
817091|NCT02131259|2673239|P1|Overall Study|Lost to Follow-up|7
817092|NCT02131259|2673239|P1|Overall Study|Adverse Event|341
817093|NCT02131259|2673239|P1|Overall Study|Progressive disease|751
817094|NCT02131233|2673246|P2|Overall Study|Withdrawal by Subject|11
817095|NCT02131233|2673247|P1|Overall Study|Withdrawal by Subject|18
817096|NCT02131233|2673246|P2|Overall Study|Pregnancy|0
817097|NCT02131233|2673247|P1|Overall Study|Pregnancy|4
817098|NCT02131233|2673246|P2|Overall Study|Physician Decision|0
817099|NCT02131233|2673247|P1|Overall Study|Physician Decision|7
817100|NCT02131233|2673246|P2|Overall Study|Non-Compliance With Study Drug|5
817101|NCT02131233|2673247|P1|Overall Study|Non-Compliance With Study Drug|8
817102|NCT02131233|2673246|P2|Overall Study|Lost to Follow-up|13
817103|NCT02131233|2673247|P1|Overall Study|Lost to Follow-up|14
817104|NCT02131233|2673246|P2|Overall Study|Lack of Efficacy|3
817105|NCT02131233|2673247|P1|Overall Study|Lack of Efficacy|6
817106|NCT02131233|2673246|P2|Overall Study|Death|1
817107|NCT02131233|2673247|P1|Overall Study|Death|0
817108|NCT02131233|2673246|P2|Overall Study|Adverse Event|6
817109|NCT02131233|2673247|P1|Overall Study|Adverse Event|7
817110|NCT02131233|2673246|P2|Overall Study|Not Treated|3
817111|NCT02131233|2673247|P1|Overall Study|Not Treated|2
817112|NCT02131064|2673281|P2|Overall Study|Other|0
817113|NCT02131064|2673282|P1|Overall Study|Other|1
817114|NCT02131064|2673281|P2|Overall Study|Ongoing|207
817115|NCT02131064|2673282|P1|Overall Study|Ongoing|214
817116|NCT02131064|2673281|P2|Overall Study|Withdrawal by Subject|14
817117|NCT02131064|2673282|P1|Overall Study|Withdrawal by Subject|6
817118|NCT02131064|2673281|P2|Overall Study|Lost to Follow-up|1
817119|NCT02131064|2673282|P1|Overall Study|Lost to Follow-up|0
817120|NCT02131064|2673281|P2|Overall Study|Death|1
817121|NCT02131064|2673282|P1|Overall Study|Death|0
817122|NCT02130765|2673345|P4|Overall Study|Did not receive treatment|0
817123|NCT02130765|2673346|P3|Overall Study|Did not receive treatment|0
817124|NCT02130765|2673347|P2|Overall Study|Did not receive treatment|0
817125|NCT02130765|2673348|P1|Overall Study|Did not receive treatment|4
817126|NCT02130557|2673573|P2|Overall Study|Ongoing|255
817127|NCT02130557|2673574|P1|Overall Study|Ongoing|260
817128|NCT02130557|2673573|P2|Overall Study|Deceased|6
817129|NCT02130557|2673574|P1|Overall Study|Deceased|1
817130|NCT02130557|2673573|P2|Overall Study|Lost to Follow-up|2
817131|NCT02130557|2673574|P1|Overall Study|Lost to Follow-up|2
817132|NCT02130557|2673573|P2|Overall Study|Withdrawal by Subject|2
817133|NCT02130557|2673574|P1|Overall Study|Withdrawal by Subject|5
817134|NCT02130557|2673573|P2|Overall Study|Randomized, not treated|3
817135|NCT02130557|2673574|P1|Overall Study|Randomized, not treated|0
817136|NCT02130284|2673606|P1|Overall Study|Screen Failure|1
817137|NCT02130284|2673606|P1|Overall Study|Subject was screened as backup for study|3
817138|NCT02130284|2673606|P1|Overall Study|Subject's sensor failed at Visit 2, Day|1
817139|NCT02130284|2673606|P1|Overall Study|Subject Withdrew Consent|1
817140|NCT02130284|2673606|P1|Overall Study|Withdrawal by Subject|3
817141|NCT02130193|2673632|P3|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
817142|NCT02130193|2673633|P2|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
817143|NCT02130193|2673634|P1|Part B: 52-week Double-blind Period|Withdrawal by Subject|0
817144|NCT02130193|2673632|P3|Part B: 52-week Double-blind Period|Physician Decision|1
817145|NCT02130193|2673633|P2|Part B: 52-week Double-blind Period|Physician Decision|0
817146|NCT02130193|2673634|P1|Part B: 52-week Double-blind Period|Physician Decision|0
817147|NCT02130193|2673632|P3|Part B: 52-week Double-blind Period|Protocol Violation|1
817148|NCT02130193|2673633|P2|Part B: 52-week Double-blind Period|Protocol Violation|2
817149|NCT02130193|2673634|P1|Part B: 52-week Double-blind Period|Protocol Violation|0
817150|NCT02130193|2673632|P3|Part B: 52-week Double-blind Period|Adverse Event|3
817151|NCT02130193|2673633|P2|Part B: 52-week Double-blind Period|Adverse Event|5
817152|NCT02130193|2673634|P1|Part B: 52-week Double-blind Period|Adverse Event|0
817153|NCT02129777|2673718|P7|Open-Label Period|Study Termination|39
817154|NCT02129777|2673719|P6|Open-Label Period|Study Termination|10
817155|NCT02129777|2673720|P5|Open-Label Period|Study Termination|0
817156|NCT02129777|2673721|P4|Open-Label Period|Study Termination|0
817157|NCT02129777|2673722|P3|Open-Label Period|Study Termination|0
817158|NCT02129777|2673723|P2|Open-Label Period|Study Termination|0
817159|NCT02129777|2673724|P1|Open-Label Period|Study Termination|0
817160|NCT02129777|2673718|P7|Open-Label Period|Withdrawal by Subject|3
817161|NCT02129777|2673719|P6|Open-Label Period|Withdrawal by Subject|1
817162|NCT02129777|2673720|P5|Open-Label Period|Withdrawal by Subject|0
817163|NCT02129777|2673721|P4|Open-Label Period|Withdrawal by Subject|0
817164|NCT02129777|2673722|P3|Open-Label Period|Withdrawal by Subject|0
817165|NCT02129777|2673723|P2|Open-Label Period|Withdrawal by Subject|0
817166|NCT02129777|2673724|P1|Open-Label Period|Withdrawal by Subject|0
817167|NCT02129777|2673718|P7|Open-Label Period|Lost to Follow-up|1
817168|NCT02129777|2673719|P6|Open-Label Period|Lost to Follow-up|1
817169|NCT02129777|2673720|P5|Open-Label Period|Lost to Follow-up|0
817170|NCT02129777|2673721|P4|Open-Label Period|Lost to Follow-up|0
817171|NCT02129777|2673722|P3|Open-Label Period|Lost to Follow-up|0
817172|NCT02129777|2673723|P2|Open-Label Period|Lost to Follow-up|0
817173|NCT02129777|2673724|P1|Open-Label Period|Lost to Follow-up|0
817174|NCT02129777|2673718|P7|Open-Label Period|Lack of Efficacy|5
817175|NCT02129777|2673719|P6|Open-Label Period|Lack of Efficacy|0
817176|NCT02129777|2673720|P5|Open-Label Period|Lack of Efficacy|0
817177|NCT02129777|2673721|P4|Open-Label Period|Lack of Efficacy|0
817178|NCT02129777|2673722|P3|Open-Label Period|Lack of Efficacy|0
817179|NCT02129777|2673723|P2|Open-Label Period|Lack of Efficacy|0
817180|NCT02129777|2673724|P1|Open-Label Period|Lack of Efficacy|0
817181|NCT02129777|2673718|P7|Double-Blind Period|Other|0
817182|NCT02129777|2673719|P6|Double-Blind Period|Other|0
817183|NCT02129777|2673720|P5|Double-Blind Period|Other|0
817184|NCT02129777|2673721|P4|Double-Blind Period|Other|0
817185|NCT02129777|2673722|P3|Double-Blind Period|Other|0
817186|NCT02129777|2673723|P2|Double-Blind Period|Other|2
817187|NCT02129777|2673724|P1|Double-Blind Period|Other|1
817188|NCT02129777|2673718|P7|Double-Blind Period|Lack of Efficacy|0
817189|NCT02129777|2673719|P6|Double-Blind Period|Lack of Efficacy|0
817190|NCT02129777|2673720|P5|Double-Blind Period|Lack of Efficacy|2
817191|NCT02129777|2673721|P4|Double-Blind Period|Lack of Efficacy|3
817192|NCT02129777|2673722|P3|Double-Blind Period|Lack of Efficacy|0
817193|NCT02129777|2673723|P2|Double-Blind Period|Lack of Efficacy|1
817194|NCT02129777|2673724|P1|Double-Blind Period|Lack of Efficacy|3
817195|NCT02129777|2673718|P7|Double-Blind Period|Pregnancy|0
817196|NCT02129777|2673719|P6|Double-Blind Period|Pregnancy|0
817197|NCT02129777|2673720|P5|Double-Blind Period|Pregnancy|1
817198|NCT02129777|2673721|P4|Double-Blind Period|Pregnancy|0
817199|NCT02129777|2673722|P3|Double-Blind Period|Pregnancy|0
817200|NCT02129777|2673723|P2|Double-Blind Period|Pregnancy|0
817201|NCT02129777|2673724|P1|Double-Blind Period|Pregnancy|0
817202|NCT02129777|2673718|P7|Double-Blind Period|Withdrawal by Subject|0
817203|NCT02129777|2673719|P6|Double-Blind Period|Withdrawal by Subject|0
817204|NCT02129777|2673720|P5|Double-Blind Period|Withdrawal by Subject|3
817205|NCT02129777|2673721|P4|Double-Blind Period|Withdrawal by Subject|2
817206|NCT02129777|2673722|P3|Double-Blind Period|Withdrawal by Subject|3
817207|NCT02129777|2673723|P2|Double-Blind Period|Withdrawal by Subject|4
817208|NCT02129777|2673724|P1|Double-Blind Period|Withdrawal by Subject|2
817209|NCT02129777|2673718|P7|Double-Blind Period|Lost to Follow-up|0
817210|NCT02129777|2673719|P6|Double-Blind Period|Lost to Follow-up|0
817211|NCT02129777|2673720|P5|Double-Blind Period|Lost to Follow-up|0
817212|NCT02129777|2673721|P4|Double-Blind Period|Lost to Follow-up|2
817213|NCT02129777|2673722|P3|Double-Blind Period|Lost to Follow-up|1
817214|NCT02129777|2673723|P2|Double-Blind Period|Lost to Follow-up|1
817215|NCT02129777|2673724|P1|Double-Blind Period|Lost to Follow-up|1
817216|NCT02129777|2673718|P7|Double-Blind Period|Adverse Event|0
817217|NCT02129777|2673719|P6|Double-Blind Period|Adverse Event|0
817218|NCT02129777|2673720|P5|Double-Blind Period|Adverse Event|1
817219|NCT02129777|2673721|P4|Double-Blind Period|Adverse Event|0
817220|NCT02129777|2673722|P3|Double-Blind Period|Adverse Event|0
817221|NCT02129777|2673723|P2|Double-Blind Period|Adverse Event|0
817222|NCT02129777|2673724|P1|Double-Blind Period|Adverse Event|0
817223|NCT02129608|2673891|P3|Overall Study|Withdrawal by Subject|2
817224|NCT02129608|2673892|P2|Overall Study|Withdrawal by Subject|0
817225|NCT02129608|2673893|P1|Overall Study|Withdrawal by Subject|0
817226|NCT02129608|2673891|P3|Overall Study|Lost to Follow-up|1
817227|NCT02129608|2673892|P2|Overall Study|Lost to Follow-up|1
817228|NCT02129608|2673893|P1|Overall Study|Lost to Follow-up|0
817229|NCT02129192|2673906|P2|Period 1 Including Washout Period|Withdrawal by Subject|1
817230|NCT02129192|2673907|P1|Period 1 Including Washout Period|Withdrawal by Subject|0
817231|NCT02129062|2673924|P1|Overall Study|Disease Progression|2
817232|NCT02129062|2673924|P1|Overall Study|Death|1
817233|NCT02128997|2673931|P2|Overall Study|Lost to Follow-up|11
817234|NCT02128997|2673932|P1|Overall Study|Lost to Follow-up|6
817235|NCT02128932|2673947|P3|Overall Study|No reason for withdrawal|7
817236|NCT02128932|2673948|P2|Overall Study|No reason for withdrawal|11
817237|NCT02128932|2673949|P1|Overall Study|No reason for withdrawal|12
817238|NCT02128932|2673947|P3|Overall Study|Lost to Follow-up|1
817239|NCT02128932|2673948|P2|Overall Study|Lost to Follow-up|1
817240|NCT02128932|2673949|P1|Overall Study|Lost to Follow-up|2
817241|NCT02128932|2673947|P3|Overall Study|Death|2
817242|NCT02128932|2673948|P2|Overall Study|Death|0
817243|NCT02128932|2673949|P1|Overall Study|Death|2
817244|NCT02128932|2673947|P3|Overall Study|Withdrawal by Subject|8
817245|NCT02128932|2673948|P2|Overall Study|Withdrawal by Subject|7
817246|NCT02128932|2673949|P1|Overall Study|Withdrawal by Subject|11
817247|NCT02128542|2674006|P2|Overall Study|Withdrew Consent|0
817248|NCT02128542|2674007|P1|Overall Study|Withdrew Consent|1
817249|NCT02128542|2674006|P2|Overall Study|Lost to Follow-up|0
817250|NCT02128542|2674007|P1|Overall Study|Lost to Follow-up|3
817251|NCT02128490|2674025|P5|Overall Study|Other Miscellaneous Reasons|1
817252|NCT02128490|2674026|P4|Overall Study|Other Miscellaneous Reasons|1
817253|NCT02128490|2674027|P3|Overall Study|Other Miscellaneous Reasons|2
817254|NCT02128490|2674028|P2|Overall Study|Other Miscellaneous Reasons|0
817255|NCT02128490|2674029|P1|Overall Study|Other Miscellaneous Reasons|0
817256|NCT02128490|2674025|P5|Overall Study|Withdraw from Study Drug, Gout Flare|1
817257|NCT02128490|2674026|P4|Overall Study|Withdraw from Study Drug, Gout Flare|0
817258|NCT02128490|2674027|P3|Overall Study|Withdraw from Study Drug, Gout Flare|0
817259|NCT02128490|2674028|P2|Overall Study|Withdraw from Study Drug, Gout Flare|0
817260|NCT02128490|2674029|P1|Overall Study|Withdraw from Study Drug, Gout Flare|0
817261|NCT02128490|2674025|P5|Overall Study|Lack of Efficacy|0
817262|NCT02128490|2674026|P4|Overall Study|Lack of Efficacy|0
817263|NCT02128490|2674027|P3|Overall Study|Lack of Efficacy|0
817264|NCT02128490|2674028|P2|Overall Study|Lack of Efficacy|1
817265|NCT02128490|2674029|P1|Overall Study|Lack of Efficacy|0
817266|NCT02128490|2674025|P5|Overall Study|Voluntary Withdrawal|2
817267|NCT02128490|2674026|P4|Overall Study|Voluntary Withdrawal|1
817268|NCT02128490|2674027|P3|Overall Study|Voluntary Withdrawal|1
817269|NCT02128490|2674028|P2|Overall Study|Voluntary Withdrawal|3
817270|NCT02128490|2674029|P1|Overall Study|Voluntary Withdrawal|3
817271|NCT02128490|2674025|P5|Overall Study|Lost to Follow-up|1
817272|NCT02128490|2674026|P4|Overall Study|Lost to Follow-up|1
817273|NCT02128490|2674027|P3|Overall Study|Lost to Follow-up|1
817274|NCT02128490|2674028|P2|Overall Study|Lost to Follow-up|0
817275|NCT02128490|2674029|P1|Overall Study|Lost to Follow-up|0
817276|NCT02128490|2674025|P5|Overall Study|Major Protocol Deviation|2
817277|NCT02128490|2674026|P4|Overall Study|Major Protocol Deviation|2
817278|NCT02128490|2674027|P3|Overall Study|Major Protocol Deviation|0
817279|NCT02128490|2674028|P2|Overall Study|Major Protocol Deviation|2
817280|NCT02128490|2674029|P1|Overall Study|Major Protocol Deviation|1
817281|NCT02128490|2674025|P5|Overall Study|Pretreatment Event/Adverse Event|0
817282|NCT02128490|2674026|P4|Overall Study|Pretreatment Event/Adverse Event|1
817283|NCT02128490|2674027|P3|Overall Study|Pretreatment Event/Adverse Event|1
817284|NCT02128490|2674028|P2|Overall Study|Pretreatment Event/Adverse Event|0
817285|NCT02128490|2674029|P1|Overall Study|Pretreatment Event/Adverse Event|1
817286|NCT02128269|2674051|P1|Treatment Period|Physician Decision|1
817287|NCT02128269|2674051|P1|Treatment Period|Adverse Event|1
817288|NCT02128217|2674057|P2|Overall Study|Lost to Follow-up|1
817289|NCT02128217|2674058|P1|Overall Study|Lost to Follow-up|0
817290|NCT02127970|2674106|P2|Overall Study|Subject Withdrew Consent|3
817291|NCT02127970|2674107|P1|Overall Study|Subject Withdrew Consent|5
817292|NCT02127970|2674106|P2|Overall Study|Pregnancy|1
817293|NCT02127970|2674107|P1|Overall Study|Pregnancy|0
817294|NCT02127970|2674106|P2|Overall Study|Reason not Specified|7
817295|NCT02127970|2674107|P1|Overall Study|Reason not Specified|4
817296|NCT02127970|2674106|P2|Overall Study|Lost to Follow-up|14
817297|NCT02127970|2674107|P1|Overall Study|Lost to Follow-up|14
817298|NCT02127970|2674106|P2|Overall Study|Death|1
817299|NCT02127970|2674107|P1|Overall Study|Death|1
817300|NCT02127970|2674106|P2|Overall Study|Adverse Event|1
817301|NCT02127970|2674107|P1|Overall Study|Adverse Event|2
817302|NCT02127372|2674242|P2|Overall Study|Withdrawal by Subject|0
817303|NCT02127372|2674243|P1|Overall Study|Withdrawal by Subject|1
817304|NCT02127307|2674253|P1|Overall Study|Other than specified above|169
817305|NCT02127307|2674253|P1|Overall Study|Death|101
817306|NCT02127307|2674253|P1|Overall Study|Lost to Follow-up|2
817307|NCT02127307|2674253|P1|Overall Study|Protocol Violation|36
817308|NCT02127281|2674259|P2|Overall Study|Lost to Follow-up|0
817309|NCT02127281|2674260|P1|Overall Study|Lost to Follow-up|1
817310|NCT02126839|2674288|P2|Overall Study|Not specified|5
817311|NCT02126839|2674289|P1|Overall Study|Not specified|5
817312|NCT02126839|2674288|P2|Overall Study|Lost to Follow-up|4
817313|NCT02126839|2674289|P1|Overall Study|Lost to Follow-up|1
817314|NCT02126839|2674288|P2|Overall Study|Sponsor request|1
817315|NCT02126839|2674289|P1|Overall Study|Sponsor request|0
817316|NCT02126839|2674288|P2|Overall Study|Protocol Violation|3
817317|NCT02126839|2674289|P1|Overall Study|Protocol Violation|2
817318|NCT02126839|2674288|P2|Overall Study|Withdrawal by parent/guardian|0
817319|NCT02126839|2674289|P1|Overall Study|Withdrawal by parent/guardian|1
817320|NCT02126839|2674288|P2|Overall Study|Withdrawal by Subject|0
817321|NCT02126839|2674289|P1|Overall Study|Withdrawal by Subject|1
817322|NCT02126839|2674288|P2|Overall Study|Adverse Event|1
817323|NCT02126839|2674289|P1|Overall Study|Adverse Event|0
817324|NCT02126670|2674316|P4|Overall Study|Withdrawal by Subject|1
817325|NCT02126670|2674317|P3|Overall Study|Withdrawal by Subject|0
817326|NCT02126670|2674318|P2|Overall Study|Withdrawal by Subject|0
817327|NCT02126670|2674319|P1|Overall Study|Withdrawal by Subject|1
817328|NCT02125877|2674371|P2|Overall Study|Adverse Event|4
817329|NCT02125877|2674372|P1|Overall Study|Adverse Event|6
817330|NCT02125877|2674371|P2|Overall Study|Protocol deviation|1
817331|NCT02125877|2674372|P1|Overall Study|Protocol deviation|4
817332|NCT02125877|2674371|P2|Overall Study|Withdrawal by Subject|1
817333|NCT02125877|2674372|P1|Overall Study|Withdrawal by Subject|2
817334|NCT02125877|2674371|P2|Overall Study|Participant/guardian decision|2
817335|NCT02125877|2674372|P1|Overall Study|Participant/guardian decision|0
817336|NCT02125877|2674371|P2|Overall Study|Administrative problems|1
817337|NCT02125877|2674372|P1|Overall Study|Administrative problems|0
817338|NCT02125877|2674371|P2|Overall Study|Death|1
817339|NCT02125877|2674372|P1|Overall Study|Death|0
817340|NCT02125877|2674371|P2|Overall Study|Physician Decision|0
817341|NCT02125877|2674372|P1|Overall Study|Physician Decision|1
817342|NCT02125838|2674402|P2|Overall Study|Lost to Follow-up|4
817343|NCT02125838|2674403|P1|Overall Study|Lost to Follow-up|4
817344|NCT02125734|2674421|P2|Period 2|Adverse Event|1
817345|NCT02125734|2674422|P1|Period 2|Adverse Event|0
817346|NCT02125604|2674432|P1|Overall Study|Adverse Event|20
817347|NCT02125604|2674432|P1|Overall Study|Consent Withdrawn|4
817348|NCT02125604|2674432|P1|Overall Study|Lost to Follow-up|2
817349|NCT02125604|2674432|P1|Overall Study|Investigator Decision|1
817350|NCT02125604|2674432|P1|Overall Study|Not Specified|4
817351|NCT02124811|2674480|P2|Overall Study|Withdrawal by Subject|0
817352|NCT02124811|2674481|P1|Overall Study|Withdrawal by Subject|1
817353|NCT02124811|2674480|P2|Overall Study|Early termination|2
817354|NCT02124811|2674481|P1|Overall Study|Early termination|2
817355|NCT02124798|2674497|P1|Overall Study|Lost to Follow-up|1
817356|NCT02124798|2674497|P1|Overall Study|Adverse Event|3
817357|NCT02124161|2674555|P2|Overall Study|Lost to Follow-up|4
817358|NCT02124161|2674556|P1|Overall Study|Lost to Follow-up|3
817359|NCT02124161|2674555|P2|Overall Study|No longer meets eligibility criteria|4
817360|NCT02124161|2674556|P1|Overall Study|No longer meets eligibility criteria|5
817361|NCT02124161|2674555|P2|Overall Study|Does not meet entrance criteria|3
817362|NCT02124161|2674556|P1|Overall Study|Does not meet entrance criteria|2
817363|NCT02124161|2674555|P2|Overall Study|Adverse Event|0
817364|NCT02124161|2674556|P1|Overall Study|Adverse Event|2
817365|NCT02124161|2674555|P2|Overall Study|Withdrawal by Subject|2
817366|NCT02124161|2674556|P1|Overall Study|Withdrawal by Subject|1
817367|NCT02124161|2674555|P2|Overall Study|Protocol Violation|1
817368|NCT02124161|2674556|P1|Overall Study|Protocol Violation|2
817369|NCT02124161|2674555|P2|Overall Study|Death|0
817370|NCT02124161|2674556|P1|Overall Study|Death|1
817371|NCT02124161|2674555|P2|Overall Study|Other unspecified|1
817372|NCT02124161|2674556|P1|Overall Study|Other unspecified|0
817373|NCT02123966|2674615|P1|Overall Study|Intercurrent Illness|1
817374|NCT02123472|2674655|P2|Period 2 (7 Days)|Withdrawal by Subject|1
817375|NCT02123472|2674656|P1|Period 2 (7 Days)|Withdrawal by Subject|0
817376|NCT02123459|2674666|P2|Washout Period (1 Day)|Adverse Event|0
817377|NCT02123459|2674667|P1|Washout Period (1 Day)|Adverse Event|1
817378|NCT02123446|2674677|P2|Washout Period (1 Day)|Physician Decision|0
817379|NCT02123446|2674678|P1|Washout Period (1 Day)|Physician Decision|1
817380|NCT02122146|2674776|P8|Part 1: Dose Escalation|Other|2
817381|NCT02122146|2674777|P7|Part 1: Dose Escalation|Other|1
817382|NCT02122146|2674778|P6|Part 1: Dose Escalation|Other|1
817383|NCT02122146|2674779|P5|Part 1: Dose Escalation|Other|0
817384|NCT02122146|2674780|P4|Part 1: Dose Escalation|Other|0
817385|NCT02122146|2674781|P3|Part 1: Dose Escalation|Other|0
817386|NCT02122146|2674782|P2|Part 1: Dose Escalation|Other|0
817387|NCT02122146|2674783|P1|Part 1: Dose Escalation|Other|1
817388|NCT02122146|2674776|P8|Part 1: Dose Escalation|Withdrawal by Subject|0
817389|NCT02122146|2674777|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
817390|NCT02122146|2674778|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
817391|NCT02122146|2674779|P5|Part 1: Dose Escalation|Withdrawal by Subject|0
817392|NCT02122146|2674780|P4|Part 1: Dose Escalation|Withdrawal by Subject|1
817393|NCT02122146|2674781|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
817394|NCT02122146|2674782|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
817395|NCT02122146|2674783|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
817396|NCT02122146|2674776|P8|Part 1: Dose Escalation|Lost to Follow-up|0
817397|NCT02122146|2674777|P7|Part 1: Dose Escalation|Lost to Follow-up|0
817398|NCT02122146|2674778|P6|Part 1: Dose Escalation|Lost to Follow-up|0
817399|NCT02122146|2674779|P5|Part 1: Dose Escalation|Lost to Follow-up|1
817400|NCT02122146|2674780|P4|Part 1: Dose Escalation|Lost to Follow-up|0
817401|NCT02122146|2674781|P3|Part 1: Dose Escalation|Lost to Follow-up|1
817402|NCT02122146|2674782|P2|Part 1: Dose Escalation|Lost to Follow-up|0
817403|NCT02122146|2674783|P1|Part 1: Dose Escalation|Lost to Follow-up|0
817404|NCT02122146|2674776|P8|Part 1: Dose Escalation|Death|0
817405|NCT02122146|2674777|P7|Part 1: Dose Escalation|Death|0
817406|NCT02122146|2674778|P6|Part 1: Dose Escalation|Death|0
817407|NCT02122146|2674779|P5|Part 1: Dose Escalation|Death|0
817408|NCT02122146|2674780|P4|Part 1: Dose Escalation|Death|0
817409|NCT02122146|2674781|P3|Part 1: Dose Escalation|Death|1
817410|NCT02122146|2674782|P2|Part 1: Dose Escalation|Death|1
817411|NCT02122146|2674783|P1|Part 1: Dose Escalation|Death|0
817412|NCT02121847|2675044|P1|Overall Study|Adverse Event|2
817413|NCT02121847|2675044|P1|Overall Study|Administrative Reasons|1
817414|NCT02121834|2675070|P7|Overall Study|Lost to Follow-up|0
817415|NCT02121834|2675071|P6|Overall Study|Lost to Follow-up|0
817416|NCT02121834|2675072|P5|Overall Study|Lost to Follow-up|0
817417|NCT02121834|2675073|P4|Overall Study|Lost to Follow-up|0
817418|NCT02121834|2675074|P3|Overall Study|Lost to Follow-up|1
817419|NCT02121834|2675075|P2|Overall Study|Lost to Follow-up|0
817420|NCT02121834|2675076|P1|Overall Study|Lost to Follow-up|0
817421|NCT02121834|2675070|P7|Overall Study|Withdrawal by Subject|0
817422|NCT02121834|2675071|P6|Overall Study|Withdrawal by Subject|0
817423|NCT02121834|2675072|P5|Overall Study|Withdrawal by Subject|0
817424|NCT02121834|2675073|P4|Overall Study|Withdrawal by Subject|0
817425|NCT02121834|2675074|P3|Overall Study|Withdrawal by Subject|1
817426|NCT02121834|2675075|P2|Overall Study|Withdrawal by Subject|1
817427|NCT02121834|2675076|P1|Overall Study|Withdrawal by Subject|0
817428|NCT02121834|2675070|P7|Overall Study|Protocol Violation|0
817429|NCT02121834|2675071|P6|Overall Study|Protocol Violation|0
817430|NCT02121834|2675072|P5|Overall Study|Protocol Violation|0
817431|NCT02121834|2675073|P4|Overall Study|Protocol Violation|0
817432|NCT02121834|2675074|P3|Overall Study|Protocol Violation|0
817433|NCT02121834|2675075|P2|Overall Study|Protocol Violation|1
817434|NCT02121834|2675076|P1|Overall Study|Protocol Violation|0
817435|NCT02121808|2675102|P1|Overall Study|Technical problem|3
817436|NCT02121795|2675113|P2|Overall Study|Still in Study up to the Data Cut Date|316
817437|NCT02121795|2675114|P1|Overall Study|Still in Study up to the Data Cut Date|315
817438|NCT02121795|2675113|P2|Overall Study|Lost to Follow-up|1
817439|NCT02121795|2675114|P1|Overall Study|Lost to Follow-up|2
817440|NCT02121795|2675113|P2|Overall Study|Withdrew Consent|10
817441|NCT02121795|2675114|P1|Overall Study|Withdrew Consent|10
817442|NCT02121795|2675113|P2|Overall Study|Protocol Violation|2
817443|NCT02121795|2675114|P1|Overall Study|Protocol Violation|0
817444|NCT02121795|2675113|P2|Overall Study|Non-Compliance with Study Drug|1
817445|NCT02121795|2675114|P1|Overall Study|Non-Compliance with Study Drug|1
817446|NCT02121795|2675113|P2|Overall Study|Investigator's Discretion|0
817447|NCT02121795|2675114|P1|Overall Study|Investigator's Discretion|1
817448|NCT02121795|2675113|P2|Overall Study|Adverse Event|0
817449|NCT02121795|2675114|P1|Overall Study|Adverse Event|4
817450|NCT02121795|2675113|P2|Overall Study|Randomized but Never Treated|4
817451|NCT02121795|2675114|P1|Overall Study|Randomized but Never Treated|1
817452|NCT02121535|2675130|P2|Period 3 (8 Trial Days)|Withdrawal by Subject|0
817453|NCT02121535|2675131|P1|Period 3 (8 Trial Days)|Withdrawal by Subject|1
817454|NCT02121535|2675130|P2|Period 1 (8 Trial Days)|Withdrawal by Subject|1
817455|NCT02121535|2675131|P1|Period 1 (8 Trial Days)|Withdrawal by Subject|0
817456|NCT02121522|2675154|P1|Overall Study|Adverse Event|1
817457|NCT02121509|2675161|P4|Washout Period (35 Days)|elevated AST and ALT levels|0
817458|NCT02121509|2675162|P3|Washout Period (35 Days)|elevated AST and ALT levels|0
817459|NCT02121509|2675163|P2|Washout Period (35 Days)|elevated AST and ALT levels|0
817460|NCT02121509|2675164|P1|Washout Period (35 Days)|elevated AST and ALT levels|1
817461|NCT02121509|2675161|P4|Washout Period (35 Days)|Withdrawal by Subject|0
817462|NCT02121509|2675162|P3|Washout Period (35 Days)|Withdrawal by Subject|0
817463|NCT02121509|2675163|P2|Washout Period (35 Days)|Withdrawal by Subject|3
817464|NCT02121509|2675164|P1|Washout Period (35 Days)|Withdrawal by Subject|0
817465|NCT02121509|2675161|P4|Washout Period (35 Days)|Adverse Event|0
817466|NCT02121509|2675162|P3|Washout Period (35 Days)|Adverse Event|0
817467|NCT02121509|2675163|P2|Washout Period (35 Days)|Adverse Event|1
817468|NCT02121509|2675164|P1|Washout Period (35 Days)|Adverse Event|1
817469|NCT02121210|2675235|P2|Overall Study|Other than specified above|2
817470|NCT02121210|2675236|P1|Overall Study|Other than specified above|0
817471|NCT02121210|2675235|P2|Overall Study|Lack of Efficacy|0
817472|NCT02121210|2675236|P1|Overall Study|Lack of Efficacy|2
817473|NCT02121210|2675235|P2|Overall Study|Adverse Event|7
817474|NCT02121210|2675236|P1|Overall Study|Adverse Event|5
817475|NCT02120833|2675261|P2|Overall Study|Lost to Follow-up|1
817476|NCT02120833|2675262|P1|Overall Study|Lost to Follow-up|1
817477|NCT02120833|2675261|P2|Overall Study|Withdrawal by Subject|0
817478|NCT02120833|2675262|P1|Overall Study|Withdrawal by Subject|2
817479|NCT02120833|2675261|P2|Overall Study|Adverse Event|0
817480|NCT02120833|2675262|P1|Overall Study|Adverse Event|1
817481|NCT02120794|2675416|P1|Overall Study|Due to insurance coverage|1
817482|NCT02120794|2675416|P1|Overall Study|Physician Decision|4
817483|NCT02120794|2675416|P1|Overall Study|Adverse Event|10
817484|NCT02120794|2675416|P1|Overall Study|Withdrawal by Subject|43
817485|NCT02120664|2675428|P5|Overall Study|Withdrawal by Subject|0
817486|NCT02120664|2675429|P4|Overall Study|Withdrawal by Subject|1
817487|NCT02120664|2675430|P3|Overall Study|Withdrawal by Subject|0
817488|NCT02120664|2675431|P2|Overall Study|Withdrawal by Subject|0
817489|NCT02120664|2675432|P1|Overall Study|Withdrawal by Subject|0
817490|NCT02120625|2675450|P1|Overall Study|Physician Decision|2
817491|NCT02120417|2675465|P2|Overall Study|Other unspecified|4
817492|NCT02120417|2675466|P1|Overall Study|Other unspecified|5
817493|NCT02120417|2675465|P2|Overall Study|Physician Decision|3
817494|NCT02120417|2675466|P1|Overall Study|Physician Decision|2
817495|NCT02120417|2675465|P2|Overall Study|Noncompliance with study treatment|2
817496|NCT02120417|2675466|P1|Overall Study|Noncompliance with study treatment|0
817497|NCT02120417|2675465|P2|Overall Study|Disease progression|45
817498|NCT02120417|2675466|P1|Overall Study|Disease progression|41
817499|NCT02120417|2675465|P2|Overall Study|Participant decision|4
817500|NCT02120417|2675466|P1|Overall Study|Participant decision|4
817501|NCT02120417|2675465|P2|Overall Study|Adverse Event|9
817502|NCT02120417|2675466|P1|Overall Study|Adverse Event|3
817503|NCT02120417|2675465|P2|Overall Study|Death|1
817504|NCT02120417|2675466|P1|Overall Study|Death|5
817505|NCT02120300|2675488|P4|Overall Study|Lost to Follow-up|0
817506|NCT02120300|2675489|P3|Overall Study|Lost to Follow-up|0
817507|NCT02120300|2675490|P2|Overall Study|Lost to Follow-up|0
817508|NCT02120300|2675491|P1|Overall Study|Lost to Follow-up|1
817509|NCT02120300|2675488|P4|Overall Study|Lack of Efficacy|1
817510|NCT02120300|2675489|P3|Overall Study|Lack of Efficacy|0
817511|NCT02120300|2675490|P2|Overall Study|Lack of Efficacy|0
817512|NCT02120300|2675491|P1|Overall Study|Lack of Efficacy|0
817513|NCT02120300|2675488|P4|Overall Study|Enrolled but Never Treated|0
817514|NCT02120300|2675489|P3|Overall Study|Enrolled but Never Treated|0
817515|NCT02120300|2675490|P2|Overall Study|Enrolled but Never Treated|0
817516|NCT02120300|2675491|P1|Overall Study|Enrolled but Never Treated|2
817517|NCT02120027|2675529|P2|Overall Study|Withdrawal by Subject|25
817518|NCT02120027|2675530|P1|Overall Study|Withdrawal by Subject|33
817519|NCT02120027|2675529|P2|Overall Study|Study terminated by Sponsor|47
817520|NCT02120027|2675530|P1|Overall Study|Study terminated by Sponsor|45
817521|NCT02120027|2675529|P2|Overall Study|Protocol Violation|21
817522|NCT02120027|2675530|P1|Overall Study|Protocol Violation|18
817523|NCT02120027|2675529|P2|Overall Study|Physician Decision|3
817524|NCT02120027|2675530|P1|Overall Study|Physician Decision|4
817525|NCT02120027|2675529|P2|Overall Study|Other|0
817526|NCT02120027|2675530|P1|Overall Study|Other|4
817527|NCT02120027|2675529|P2|Overall Study|Lost to Follow-up|13
817528|NCT02120027|2675530|P1|Overall Study|Lost to Follow-up|5
817529|NCT02120027|2675529|P2|Overall Study|Lack of Efficacy|5
817530|NCT02120027|2675530|P1|Overall Study|Lack of Efficacy|3
817531|NCT02120027|2675529|P2|Overall Study|Adverse Event|5
817532|NCT02120027|2675530|P1|Overall Study|Adverse Event|4
817533|NCT02119936|2675555|P1|Overall Study|Lost to Follow-up|10
817534|NCT02119676|2675589|P4|Overall Study|Did not receive study med|5
817535|NCT02119676|2675590|P3|Overall Study|Did not receive study med|4
817536|NCT02119676|2675591|P2|Overall Study|Did not receive study med|2
817537|NCT02119676|2675592|P1|Overall Study|Did not receive study med|2
817538|NCT02119676|2675589|P4|Overall Study|Other, unspecified|4
817539|NCT02119676|2675590|P3|Overall Study|Other, unspecified|3
817540|NCT02119676|2675591|P2|Overall Study|Other, unspecified|1
817541|NCT02119676|2675592|P1|Overall Study|Other, unspecified|2
817542|NCT02119676|2675589|P4|Overall Study|Protocol deviation|0
817543|NCT02119676|2675590|P3|Overall Study|Protocol deviation|1
817544|NCT02119676|2675591|P2|Overall Study|Protocol deviation|0
817545|NCT02119676|2675592|P1|Overall Study|Protocol deviation|0
817546|NCT02119676|2675589|P4|Overall Study|Lost to Follow-up|0
817547|NCT02119676|2675590|P3|Overall Study|Lost to Follow-up|1
817548|NCT02119676|2675591|P2|Overall Study|Lost to Follow-up|0
817549|NCT02119676|2675592|P1|Overall Study|Lost to Follow-up|0
817550|NCT02119676|2675589|P4|Overall Study|Noncompliance|0
817551|NCT02119676|2675590|P3|Overall Study|Noncompliance|0
817552|NCT02119676|2675591|P2|Overall Study|Noncompliance|1
817553|NCT02119676|2675592|P1|Overall Study|Noncompliance|0
817554|NCT02119676|2675589|P4|Overall Study|Death|1
817555|NCT02119676|2675590|P3|Overall Study|Death|2
817556|NCT02119676|2675591|P2|Overall Study|Death|3
817557|NCT02119676|2675592|P1|Overall Study|Death|9
817558|NCT02119676|2675589|P4|Overall Study|Physician Decision|2
817559|NCT02119676|2675590|P3|Overall Study|Physician Decision|3
817560|NCT02119676|2675591|P2|Overall Study|Physician Decision|2
817561|NCT02119676|2675592|P1|Overall Study|Physician Decision|4
817562|NCT02119676|2675589|P4|Overall Study|Patient decision, inc. consent withdrawn|6
817563|NCT02119676|2675590|P3|Overall Study|Patient decision, inc. consent withdrawn|5
817564|NCT02119676|2675591|P2|Overall Study|Patient decision, inc. consent withdrawn|5
817565|NCT02119676|2675592|P1|Overall Study|Patient decision, inc. consent withdrawn|4
817566|NCT02119676|2675589|P4|Overall Study|Disease progression|73
817567|NCT02119676|2675590|P3|Overall Study|Disease progression|68
817568|NCT02119676|2675591|P2|Overall Study|Disease progression|55
817569|NCT02119676|2675592|P1|Overall Study|Disease progression|53
817570|NCT02119676|2675589|P4|Overall Study|Adverse Event|10
817571|NCT02119676|2675590|P3|Overall Study|Adverse Event|10
817572|NCT02119676|2675591|P2|Overall Study|Adverse Event|17
817573|NCT02119676|2675592|P1|Overall Study|Adverse Event|9
817574|NCT02119663|2675624|P2|Overall Study|Study Terminated by the Sponsor|4
817575|NCT02119663|2675625|P1|Overall Study|Study Terminated by the Sponsor|3
817576|NCT02119663|2675624|P2|Overall Study|Subject decision|1
817577|NCT02119663|2675625|P1|Overall Study|Subject decision|0
817578|NCT02119663|2675624|P2|Overall Study|Other unspecified|0
817579|NCT02119663|2675625|P1|Overall Study|Other unspecified|2
817580|NCT02119663|2675624|P2|Overall Study|Physician Decision|2
817581|NCT02119663|2675625|P1|Overall Study|Physician Decision|1
817582|NCT02119663|2675624|P2|Overall Study|Death|2
817583|NCT02119663|2675625|P1|Overall Study|Death|3
817584|NCT02119663|2675624|P2|Overall Study|Adverse Event|5
817585|NCT02119663|2675625|P1|Overall Study|Adverse Event|5
817586|NCT02119663|2675624|P2|Overall Study|Disease progression|27
817587|NCT02119663|2675625|P1|Overall Study|Disease progression|26
817588|NCT02119650|2675643|P2|Overall Study|Multiple reasons for termination|1
817589|NCT02119650|2675644|P1|Overall Study|Multiple reasons for termination|2
817590|NCT02119650|2675643|P2|Overall Study|Physician Decision|2
817591|NCT02119650|2675644|P1|Overall Study|Physician Decision|0
817592|NCT02119650|2675643|P2|Overall Study|Study terminated by the sponsor|0
817593|NCT02119650|2675644|P1|Overall Study|Study terminated by the sponsor|1
817594|NCT02119650|2675643|P2|Overall Study|Noncompliance with study treatment|1
817595|NCT02119650|2675644|P1|Overall Study|Noncompliance with study treatment|1
817596|NCT02119650|2675643|P2|Overall Study|Death|1
817597|NCT02119650|2675644|P1|Overall Study|Death|5
817598|NCT02119650|2675643|P2|Overall Study|Disease progression|14
817599|NCT02119650|2675644|P1|Overall Study|Disease progression|11
817600|NCT02119650|2675643|P2|Overall Study|Subject decision|3
817601|NCT02119650|2675644|P1|Overall Study|Subject decision|2
817602|NCT02119650|2675643|P2|Overall Study|Adverse Event|4
817603|NCT02119650|2675644|P1|Overall Study|Adverse Event|3
817604|NCT02119325|2675658|P2|Washout Period 1|Adverse Event|1
817605|NCT02119325|2675659|P1|Washout Period 1|Adverse Event|0
817606|NCT02119299|2675703|P1|Overall Study|Pregnancy|1
817607|NCT02119299|2675703|P1|Overall Study|Lack of Efficacy|1
817608|NCT02119299|2675703|P1|Overall Study|Withdrawal by Subject|7
817609|NCT02119286|2675717|P3|Overall Study|Withdrawal by Subject|0
817610|NCT02119286|2675718|P2|Overall Study|Withdrawal by Subject|1
817611|NCT02119286|2675719|P1|Overall Study|Withdrawal by Subject|4
817612|NCT02119286|2675717|P3|Overall Study|Lost to Follow-up|1
817613|NCT02119286|2675718|P2|Overall Study|Lost to Follow-up|0
817614|NCT02119286|2675719|P1|Overall Study|Lost to Follow-up|2
817615|NCT02119286|2675717|P3|Overall Study|Lack of Efficacy|4
817616|NCT02119286|2675718|P2|Overall Study|Lack of Efficacy|3
817617|NCT02119286|2675719|P1|Overall Study|Lack of Efficacy|11
817618|NCT02119286|2675717|P3|Overall Study|Adverse Event|2
817619|NCT02119286|2675718|P2|Overall Study|Adverse Event|7
817620|NCT02119286|2675719|P1|Overall Study|Adverse Event|9
817621|NCT02119260|2675737|P7|Overall Study|Withdrew consent|0
817622|NCT02119260|2675738|P6|Overall Study|Withdrew consent|0
817623|NCT02119260|2675739|P5|Overall Study|Withdrew consent|0
817624|NCT02119260|2675740|P4|Overall Study|Withdrew consent|0
817625|NCT02119260|2675741|P3|Overall Study|Withdrew consent|1
817626|NCT02119260|2675742|P2|Overall Study|Withdrew consent|1
817627|NCT02119260|2675743|P1|Overall Study|Withdrew consent|0
817628|NCT02119260|2675737|P7|Overall Study|Adverse Event|0
817629|NCT02119260|2675738|P6|Overall Study|Adverse Event|0
817630|NCT02119260|2675739|P5|Overall Study|Adverse Event|0
817631|NCT02119260|2675740|P4|Overall Study|Adverse Event|0
817632|NCT02119260|2675741|P3|Overall Study|Adverse Event|0
817633|NCT02119260|2675742|P2|Overall Study|Adverse Event|0
817634|NCT02119260|2675743|P1|Overall Study|Adverse Event|1
817635|NCT02119104|2675813|P1|Overall Study|Protocol Violation|16
817636|NCT02118961|2675819|P2|Overall Study|Withdrawal by Subject|0
817637|NCT02118961|2675820|P1|Overall Study|Withdrawal by Subject|1
817638|NCT02118896|2675848|P10|Overall Study|Miscellaneous|0
817639|NCT02118896|2675849|P9|Overall Study|Miscellaneous|0
817640|NCT02118896|2675850|P8|Overall Study|Miscellaneous|0
817641|NCT02118896|2675851|P7|Overall Study|Miscellaneous|0
817642|NCT02118896|2675852|P6|Overall Study|Miscellaneous|4
817643|NCT02118896|2675853|P5|Overall Study|Miscellaneous|0
817644|NCT02118896|2675854|P4|Overall Study|Miscellaneous|2
817645|NCT02118896|2675855|P3|Overall Study|Miscellaneous|0
817646|NCT02118896|2675856|P2|Overall Study|Miscellaneous|2
817647|NCT02118896|2675857|P1|Overall Study|Miscellaneous|1
817648|NCT02118896|2675848|P10|Overall Study|Prohibited medication|0
817649|NCT02118896|2675849|P9|Overall Study|Prohibited medication|0
817650|NCT02118896|2675850|P8|Overall Study|Prohibited medication|0
817651|NCT02118896|2675851|P7|Overall Study|Prohibited medication|0
817652|NCT02118896|2675852|P6|Overall Study|Prohibited medication|3
817653|NCT02118896|2675853|P5|Overall Study|Prohibited medication|1
817654|NCT02118896|2675854|P4|Overall Study|Prohibited medication|0
817655|NCT02118896|2675855|P3|Overall Study|Prohibited medication|0
817656|NCT02118896|2675856|P2|Overall Study|Prohibited medication|0
817657|NCT02118896|2675857|P1|Overall Study|Prohibited medication|0
817658|NCT02118896|2675848|P10|Overall Study|Immunosuppressive regimen (not MR4)|2
817659|NCT02118896|2675849|P9|Overall Study|Immunosuppressive regimen (not MR4)|0
817660|NCT02118896|2675850|P8|Overall Study|Immunosuppressive regimen (not MR4)|0
817661|NCT02118896|2675851|P7|Overall Study|Immunosuppressive regimen (not MR4)|0
817662|NCT02118896|2675852|P6|Overall Study|Immunosuppressive regimen (not MR4)|2
817663|NCT02118896|2675853|P5|Overall Study|Immunosuppressive regimen (not MR4)|4
817664|NCT02118896|2675854|P4|Overall Study|Immunosuppressive regimen (not MR4)|2
817665|NCT02118896|2675855|P3|Overall Study|Immunosuppressive regimen (not MR4)|1
817666|NCT02118896|2675856|P2|Overall Study|Immunosuppressive regimen (not MR4)|5
817667|NCT02118896|2675857|P1|Overall Study|Immunosuppressive regimen (not MR4)|1
817668|NCT02118896|2675848|P10|Overall Study|Lost to Follow-up|0
817669|NCT02118896|2675849|P9|Overall Study|Lost to Follow-up|0
817670|NCT02118896|2675850|P8|Overall Study|Lost to Follow-up|0
817671|NCT02118896|2675851|P7|Overall Study|Lost to Follow-up|0
817672|NCT02118896|2675852|P6|Overall Study|Lost to Follow-up|1
817673|NCT02118896|2675853|P5|Overall Study|Lost to Follow-up|2
817674|NCT02118896|2675854|P4|Overall Study|Lost to Follow-up|0
817675|NCT02118896|2675855|P3|Overall Study|Lost to Follow-up|1
817676|NCT02118896|2675856|P2|Overall Study|Lost to Follow-up|2
817677|NCT02118896|2675857|P1|Overall Study|Lost to Follow-up|1
817678|NCT02118896|2675848|P10|Overall Study|Pregnancy|0
817679|NCT02118896|2675849|P9|Overall Study|Pregnancy|0
817680|NCT02118896|2675850|P8|Overall Study|Pregnancy|0
817681|NCT02118896|2675851|P7|Overall Study|Pregnancy|1
817682|NCT02118896|2675852|P6|Overall Study|Pregnancy|3
817683|NCT02118896|2675853|P5|Overall Study|Pregnancy|1
817684|NCT02118896|2675854|P4|Overall Study|Pregnancy|0
817685|NCT02118896|2675855|P3|Overall Study|Pregnancy|0
817686|NCT02118896|2675856|P2|Overall Study|Pregnancy|1
817687|NCT02118896|2675857|P1|Overall Study|Pregnancy|1
817688|NCT02118896|2675848|P10|Overall Study|Non-compliance|0
817689|NCT02118896|2675849|P9|Overall Study|Non-compliance|0
817690|NCT02118896|2675850|P8|Overall Study|Non-compliance|1
817691|NCT02118896|2675851|P7|Overall Study|Non-compliance|0
817692|NCT02118896|2675852|P6|Overall Study|Non-compliance|1
817693|NCT02118896|2675853|P5|Overall Study|Non-compliance|0
817694|NCT02118896|2675854|P4|Overall Study|Non-compliance|5
817695|NCT02118896|2675855|P3|Overall Study|Non-compliance|1
817696|NCT02118896|2675856|P2|Overall Study|Non-compliance|1
817697|NCT02118896|2675857|P1|Overall Study|Non-compliance|2
817698|NCT02118896|2675848|P10|Overall Study|Consent withdrawn|0
817699|NCT02118896|2675849|P9|Overall Study|Consent withdrawn|0
817700|NCT02118896|2675850|P8|Overall Study|Consent withdrawn|0
817701|NCT02118896|2675851|P7|Overall Study|Consent withdrawn|0
817702|NCT02118896|2675852|P6|Overall Study|Consent withdrawn|4
817703|NCT02118896|2675853|P5|Overall Study|Consent withdrawn|1
817704|NCT02118896|2675854|P4|Overall Study|Consent withdrawn|4
817705|NCT02118896|2675855|P3|Overall Study|Consent withdrawn|3
817706|NCT02118896|2675856|P2|Overall Study|Consent withdrawn|0
817707|NCT02118896|2675857|P1|Overall Study|Consent withdrawn|2
817708|NCT02118896|2675848|P10|Overall Study|Adverse Event|0
817709|NCT02118896|2675849|P9|Overall Study|Adverse Event|4
817710|NCT02118896|2675850|P8|Overall Study|Adverse Event|1
817711|NCT02118896|2675851|P7|Overall Study|Adverse Event|1
817712|NCT02118896|2675852|P6|Overall Study|Adverse Event|9
817713|NCT02118896|2675853|P5|Overall Study|Adverse Event|5
817714|NCT02118896|2675854|P4|Overall Study|Adverse Event|5
817715|NCT02118896|2675855|P3|Overall Study|Adverse Event|4
817716|NCT02118896|2675856|P2|Overall Study|Adverse Event|4
817717|NCT02118896|2675857|P1|Overall Study|Adverse Event|5
817718|NCT02118896|2675848|P10|Overall Study|Death|0
817719|NCT02118896|2675849|P9|Overall Study|Death|0
817720|NCT02118896|2675850|P8|Overall Study|Death|0
817721|NCT02118896|2675851|P7|Overall Study|Death|0
817722|NCT02118896|2675852|P6|Overall Study|Death|1
817723|NCT02118896|2675853|P5|Overall Study|Death|3
817724|NCT02118896|2675854|P4|Overall Study|Death|6
817725|NCT02118896|2675855|P3|Overall Study|Death|4
817726|NCT02118896|2675856|P2|Overall Study|Death|0
817727|NCT02118896|2675857|P1|Overall Study|Death|4
817728|NCT02118792|2675947|P2|Overall Study|Randomised but not treated|0
817729|NCT02118792|2675948|P1|Overall Study|Randomised but not treated|1
817730|NCT02118792|2675947|P2|Overall Study|Other|6
817731|NCT02118792|2675948|P1|Overall Study|Other|1
817732|NCT02118792|2675947|P2|Overall Study|Withdrawal by parent/guardian|20
817733|NCT02118792|2675948|P1|Overall Study|Withdrawal by parent/guardian|14
817734|NCT02118792|2675947|P2|Overall Study|Adverse Event|4
817735|NCT02118792|2675948|P1|Overall Study|Adverse Event|5
817736|NCT02118792|2675947|P2|Overall Study|Lost to Follow-up|4
817737|NCT02118792|2675948|P1|Overall Study|Lost to Follow-up|4
817738|NCT02118792|2675947|P2|Overall Study|Withdrawal by Subject|3
817739|NCT02118792|2675948|P1|Overall Study|Withdrawal by Subject|6
817740|NCT02118766|2675990|P2|Overall Study|Other|1
817741|NCT02118766|2675991|P1|Overall Study|Other|3
817742|NCT02118766|2675990|P2|Overall Study|Withdrawal by parent/guardian|18
817743|NCT02118766|2675991|P1|Overall Study|Withdrawal by parent/guardian|12
817744|NCT02118766|2675990|P2|Overall Study|Lost to Follow-up|4
817745|NCT02118766|2675991|P1|Overall Study|Lost to Follow-up|5
817746|NCT02118766|2675990|P2|Overall Study|Withdrawal by Subject|6
817747|NCT02118766|2675991|P1|Overall Study|Withdrawal by Subject|3
817748|NCT02118766|2675990|P2|Overall Study|Adverse Event|2
817749|NCT02118766|2675991|P1|Overall Study|Adverse Event|7
817750|NCT02118597|2676013|P1|Overall Study|Investigator's decision|1
817751|NCT02118597|2676013|P1|Overall Study|Serious Adverse Event|1
817752|NCT02118597|2676013|P1|Overall Study|Sponsor terminated the study|14
817753|NCT02117687|2676055|P2|Overall Study|Other Reasons|1
817754|NCT02117687|2676056|P1|Overall Study|Other Reasons|1
817755|NCT02117687|2676055|P2|Overall Study|Adverse Event|2
817756|NCT02117687|2676056|P1|Overall Study|Adverse Event|0
817757|NCT02117687|2676055|P2|Overall Study|Lost to Follow-up|1
817758|NCT02117687|2676056|P1|Overall Study|Lost to Follow-up|0
817759|NCT02117648|2676088|P1|Abemaciclib Safety-Extension Phase|Adverse Event|2
817760|NCT02117648|2676088|P1|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2
817761|NCT02117648|2676088|P1|Abemaciclib Safety-Extension Phase|Death|3
817762|NCT02117648|2676088|P1|Abemaciclib Safety-Extension Phase|Physician Decision|1
817763|NCT02117648|2676088|P1|Abemaciclib Safety-Extension Phase|Progressive Disease|12
817764|NCT02117648|2676088|P1|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1
817765|NCT02117648|2676088|P1|Abemaciclib + Clarithromycin Period 2|Adverse Event|1
817766|NCT02117648|2676088|P1|Abemaciclib + Clarithromycin Period 2|Death|1
817767|NCT02117648|2676088|P1|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1
817768|NCT02117648|2676088|P1|Abemaciclib Alone Period 1|Adverse Event|1
817769|NCT02117648|2676088|P1|Abemaciclib Alone Period 1|Withdrawal by Subject|1
817770|NCT02117570|2676101|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
817771|NCT02117570|2676102|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1
817772|NCT02117570|2676103|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
817773|NCT02117570|2676101|P3|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
817774|NCT02117570|2676102|P2|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
817775|NCT02117570|2676103|P1|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1
817776|NCT02117570|2676101|P3|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1
817777|NCT02117570|2676102|P2|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
817778|NCT02117570|2676103|P1|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
817779|NCT02117570|2676101|P3|Stage 2 Participants Aged 65 to 85 Years|Death|1
817780|NCT02117570|2676102|P2|Stage 2 Participants Aged 65 to 85 Years|Death|0
817781|NCT02117570|2676103|P1|Stage 2 Participants Aged 65 to 85 Years|Death|0
817782|NCT02117570|2676101|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2
817783|NCT02117570|2676102|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
817784|NCT02117570|2676103|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
817785|NCT02117570|2676101|P3|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0
817786|NCT02117570|2676102|P2|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
817787|NCT02117570|2676103|P1|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
817788|NCT02117570|2676101|P3|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1
817789|NCT02117570|2676102|P2|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2
817790|NCT02117570|2676103|P1|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0
817791|NCT02117544|2676153|P2|Period 1|Lost to follow-up (prior to treatment)|0
817792|NCT02117544|2676154|P1|Period 1|Lost to follow-up (prior to treatment)|2
817793|NCT02117479|2676169|P2|Overall Study|Other unspecified|7
817794|NCT02117479|2676170|P1|Overall Study|Other unspecified|11
817795|NCT02117479|2676169|P2|Overall Study|Physician Decision|2
817796|NCT02117479|2676170|P1|Overall Study|Physician Decision|7
817797|NCT02117479|2676169|P2|Overall Study|Study terminated by the sponsor|6
817798|NCT02117479|2676170|P1|Overall Study|Study terminated by the sponsor|4
817799|NCT02117479|2676169|P2|Overall Study|Noncompliance with study treatment|0
817800|NCT02117479|2676170|P1|Overall Study|Noncompliance with study treatment|1
817801|NCT02117479|2676169|P2|Overall Study|Disease progression|108
817802|NCT02117479|2676170|P1|Overall Study|Disease progression|104
817803|NCT02117479|2676169|P2|Overall Study|Subject decision|9
817804|NCT02117479|2676170|P1|Overall Study|Subject decision|8
817805|NCT02117479|2676169|P2|Overall Study|Adverse Event|16
817806|NCT02117479|2676170|P1|Overall Study|Adverse Event|8
817807|NCT02117479|2676169|P2|Overall Study|Death|8
817808|NCT02117479|2676170|P1|Overall Study|Death|13
817809|NCT02117427|2676189|P3|Overall Study|Death|0
817810|NCT02117427|2676190|P2|Overall Study|Death|1
817811|NCT02117427|2676191|P1|Overall Study|Death|0
817812|NCT02117427|2676189|P3|Overall Study|No longer meets inclusion criteria|0
817813|NCT02117427|2676190|P2|Overall Study|No longer meets inclusion criteria|1
817814|NCT02117427|2676191|P1|Overall Study|No longer meets inclusion criteria|0
817815|NCT02117427|2676189|P3|Overall Study|Physician Decision|0
817816|NCT02117427|2676190|P2|Overall Study|Physician Decision|2
817817|NCT02117427|2676191|P1|Overall Study|Physician Decision|0
817818|NCT02117427|2676189|P3|Overall Study|Permanent need for exogenous ESA Tx|0
817819|NCT02117427|2676190|P2|Overall Study|Permanent need for exogenous ESA Tx|1
817820|NCT02117427|2676191|P1|Overall Study|Permanent need for exogenous ESA Tx|3
817821|NCT02117427|2676189|P3|Overall Study|Permanent need for exogenous EPO Tx|0
817822|NCT02117427|2676190|P2|Overall Study|Permanent need for exogenous EPO Tx|0
817823|NCT02117427|2676191|P1|Overall Study|Permanent need for exogenous EPO Tx|2
817824|NCT02117414|2676201|P2|Overall Study|Withdrawal by Subject|4
817825|NCT02117414|2676202|P1|Overall Study|Withdrawal by Subject|10
817826|NCT02117414|2676201|P2|Overall Study|Death|2
817827|NCT02117414|2676202|P1|Overall Study|Death|5
817828|NCT02117050|2676246|P1|Overall Study|Subject Enrolled but not Dosed|1
817829|NCT02116972|2676261|P3|Overall Study|scheduling conflicts and relocation|6
817830|NCT02116972|2676262|P2|Overall Study|scheduling conflicts and relocation|3
817831|NCT02116972|2676263|P1|Overall Study|scheduling conflicts and relocation|3
817832|NCT02116972|2676261|P3|Overall Study|Lack of Efficacy|5
817833|NCT02116972|2676262|P2|Overall Study|Lack of Efficacy|6
817834|NCT02116972|2676263|P1|Overall Study|Lack of Efficacy|6
817835|NCT02116972|2676261|P3|Overall Study|Lost to Follow-up|1
817836|NCT02116972|2676262|P2|Overall Study|Lost to Follow-up|3
817837|NCT02116972|2676263|P1|Overall Study|Lost to Follow-up|4
817838|NCT02116972|2676261|P3|Overall Study|Protocol Violation|1
817839|NCT02116972|2676262|P2|Overall Study|Protocol Violation|0
817840|NCT02116972|2676263|P1|Overall Study|Protocol Violation|1
817841|NCT02116972|2676261|P3|Overall Study|Withdrawal by Subject|5
817842|NCT02116972|2676262|P2|Overall Study|Withdrawal by Subject|1
817843|NCT02116972|2676263|P1|Overall Study|Withdrawal by Subject|1
817844|NCT02116972|2676261|P3|Overall Study|Adverse Event|1
817845|NCT02116972|2676262|P2|Overall Study|Adverse Event|4
817846|NCT02116972|2676263|P1|Overall Study|Adverse Event|4
817847|NCT02116803|2676295|P2|Overall Study|Death|0
817848|NCT02116803|2676296|P1|Overall Study|Death|1
817849|NCT02116803|2676295|P2|Overall Study|Study terminated by sponsor|1
817850|NCT02116803|2676296|P1|Overall Study|Study terminated by sponsor|2
817851|NCT02116803|2676295|P2|Overall Study|Progressive disease|0
817852|NCT02116803|2676296|P1|Overall Study|Progressive disease|4
817853|NCT02116803|2676295|P2|Overall Study|Physician Decision|0
817854|NCT02116803|2676296|P1|Overall Study|Physician Decision|1
817855|NCT02116803|2676295|P2|Overall Study|Adverse Event|1
817856|NCT02116803|2676296|P1|Overall Study|Adverse Event|2
817857|NCT02116621|2676304|P2|Twelve Month Follow-up|Enrolled within 12 months of study end|8
817858|NCT02116621|2676305|P1|Twelve Month Follow-up|Enrolled within 12 months of study end|14
817859|NCT02116621|2676304|P2|Twelve Month Follow-up|Did not complete follow-up survey|3
817860|NCT02116621|2676305|P1|Twelve Month Follow-up|Did not complete follow-up survey|1
817861|NCT02116621|2676304|P2|Twelve Month Follow-up|Lost to Follow-up|1
817862|NCT02116621|2676305|P1|Twelve Month Follow-up|Lost to Follow-up|0
817863|NCT02116621|2676304|P2|Twelve Month Follow-up|Withdrawal by Subject|0
817864|NCT02116621|2676305|P1|Twelve Month Follow-up|Withdrawal by Subject|1
817865|NCT02116621|2676304|P2|Six Month Follow-up|Did not complete follow-up survey|1
817866|NCT02116621|2676305|P1|Six Month Follow-up|Did not complete follow-up survey|1
817867|NCT02116621|2676304|P2|Six Month Follow-up|Lost to Follow-up|1
817868|NCT02116621|2676305|P1|Six Month Follow-up|Lost to Follow-up|2
817869|NCT02116621|2676304|P2|Six Month Follow-up|Withdrawal by Subject|1
817870|NCT02116621|2676305|P1|Six Month Follow-up|Withdrawal by Subject|1
817871|NCT02116621|2676304|P2|Three Month Follow-up|Did not complete follow-up survey|4
817957|NCT02115815|2676500|P2|Overall Study|Withdrawal by Subject|0
817872|NCT02116621|2676305|P1|Three Month Follow-up|Did not complete follow-up survey|14
817873|NCT02116621|2676304|P2|Three Month Follow-up|Lost to Follow-up|1
817874|NCT02116621|2676305|P1|Three Month Follow-up|Lost to Follow-up|0
817875|NCT02116621|2676304|P2|Three Month Follow-up|Withdrawal by Subject|1
817876|NCT02116621|2676305|P1|Three Month Follow-up|Withdrawal by Subject|4
817877|NCT02116621|2676304|P2|Three Month Follow-up|Death|1
817878|NCT02116621|2676305|P1|Three Month Follow-up|Death|1
817879|NCT02116621|2676304|P2|Baseline|Withdrawal by Subject|4
817880|NCT02116621|2676305|P1|Baseline|Withdrawal by Subject|0
817881|NCT02116582|2676393|P1|Overall Study|Other: Transitioned to 9785-CL-0123|12
817882|NCT02116582|2676393|P1|Overall Study|Lost to Follow-up|1
817883|NCT02116582|2676393|P1|Overall Study|Other: Miscellaneous|11
817884|NCT02116582|2676393|P1|Overall Study|Withdrawal by Subject|8
817885|NCT02116582|2676393|P1|Overall Study|Protocol Violation|3
817886|NCT02116582|2676393|P1|Overall Study|Progressive Disease|148
817887|NCT02116582|2676393|P1|Overall Study|Death|9
817888|NCT02116582|2676393|P1|Overall Study|Adverse Event|22
817889|NCT02116582|2676393|P1|Overall Study|Enrolled but Never Received Study Drug|1
817890|NCT02116530|2676403|P2|Overall Study|Other Medical Problems|2
817891|NCT02116530|2676404|P1|Overall Study|Other Medical Problems|2
817892|NCT02116530|2676403|P2|Overall Study|Lost to Follow-up|0
817893|NCT02116530|2676404|P1|Overall Study|Lost to Follow-up|1
817894|NCT02116530|2676403|P2|Overall Study|Physician Decision|0
817895|NCT02116530|2676404|P1|Overall Study|Physician Decision|1
817896|NCT02116530|2676403|P2|Overall Study|Adverse Event|0
817897|NCT02116530|2676404|P1|Overall Study|Adverse Event|4
817898|NCT02116530|2676403|P2|Overall Study|Withdrawal by Subject|2
817899|NCT02116530|2676404|P1|Overall Study|Withdrawal by Subject|1
817900|NCT02116361|2676422|P4|Overall Study|Investigator Decision - Relapse|5
817901|NCT02116361|2676423|P3|Overall Study|Investigator Decision - Relapse|8
817902|NCT02116361|2676424|P2|Overall Study|Investigator Decision - Relapse|7
817903|NCT02116361|2676425|P1|Overall Study|Investigator Decision - Relapse|9
817904|NCT02116361|2676422|P4|Overall Study|Personal Reasons|9
817905|NCT02116361|2676423|P3|Overall Study|Personal Reasons|4
817906|NCT02116361|2676424|P2|Overall Study|Personal Reasons|6
817907|NCT02116361|2676425|P1|Overall Study|Personal Reasons|6
817908|NCT02116361|2676422|P4|Overall Study|Lost to Follow-up|5
817909|NCT02116361|2676423|P3|Overall Study|Lost to Follow-up|7
817910|NCT02116361|2676424|P2|Overall Study|Lost to Follow-up|5
817911|NCT02116361|2676425|P1|Overall Study|Lost to Follow-up|4
817912|NCT02116361|2676422|P4|Overall Study|Lack of Efficacy|3
817913|NCT02116361|2676423|P3|Overall Study|Lack of Efficacy|4
817914|NCT02116361|2676424|P2|Overall Study|Lack of Efficacy|7
817915|NCT02116361|2676425|P1|Overall Study|Lack of Efficacy|5
817916|NCT02116361|2676422|P4|Overall Study|Other Reasons|3
817917|NCT02116361|2676423|P3|Overall Study|Other Reasons|3
817918|NCT02116361|2676424|P2|Overall Study|Other Reasons|3
817919|NCT02116361|2676425|P1|Overall Study|Other Reasons|3
817920|NCT02116361|2676422|P4|Overall Study|Adverse Event|3
817921|NCT02116361|2676423|P3|Overall Study|Adverse Event|0
817922|NCT02116361|2676424|P2|Overall Study|Adverse Event|0
817923|NCT02116361|2676425|P1|Overall Study|Adverse Event|1
817924|NCT02116361|2676422|P4|Overall Study|Physician Decision|0
817925|NCT02116361|2676423|P3|Overall Study|Physician Decision|0
817926|NCT02116361|2676424|P2|Overall Study|Physician Decision|3
817927|NCT02116361|2676425|P1|Overall Study|Physician Decision|2
817928|NCT02116361|2676422|P4|Overall Study|Protocol Violation|2
817929|NCT02116361|2676423|P3|Overall Study|Protocol Violation|0
817930|NCT02116361|2676424|P2|Overall Study|Protocol Violation|0
817931|NCT02116361|2676425|P1|Overall Study|Protocol Violation|1
817932|NCT02116361|2676422|P4|Overall Study|Pregnancy|1
817933|NCT02116361|2676423|P3|Overall Study|Pregnancy|0
817934|NCT02116361|2676424|P2|Overall Study|Pregnancy|0
817935|NCT02116361|2676425|P1|Overall Study|Pregnancy|0
817936|NCT02116309|2676462|P2|Overall Study|Lost to Follow-up|1
817937|NCT02116309|2676463|P1|Overall Study|Lost to Follow-up|0
817938|NCT02115815|2676495|P7|Overall Study|Missed appointment, randomized in error|0
817939|NCT02115815|2676496|P6|Overall Study|Missed appointment, randomized in error|1
817940|NCT02115815|2676497|P5|Overall Study|Missed appointment, randomized in error|0
817941|NCT02115815|2676498|P4|Overall Study|Missed appointment, randomized in error|0
817942|NCT02115815|2676499|P3|Overall Study|Missed appointment, randomized in error|0
817943|NCT02115815|2676500|P2|Overall Study|Missed appointment, randomized in error|0
817944|NCT02115815|2676501|P1|Overall Study|Missed appointment, randomized in error|0
817945|NCT02115815|2676495|P7|Overall Study|Not enough drug to dose participant|0
817946|NCT02115815|2676496|P6|Overall Study|Not enough drug to dose participant|1
817947|NCT02115815|2676497|P5|Overall Study|Not enough drug to dose participant|0
817948|NCT02115815|2676498|P4|Overall Study|Not enough drug to dose participant|0
817949|NCT02115815|2676499|P3|Overall Study|Not enough drug to dose participant|0
817950|NCT02115815|2676500|P2|Overall Study|Not enough drug to dose participant|0
817951|NCT02115815|2676501|P1|Overall Study|Not enough drug to dose participant|0
817952|NCT02115815|2676495|P7|Overall Study|Withdrawal by Subject|0
817953|NCT02115815|2676496|P6|Overall Study|Withdrawal by Subject|0
817954|NCT02115815|2676497|P5|Overall Study|Withdrawal by Subject|0
817955|NCT02115815|2676498|P4|Overall Study|Withdrawal by Subject|0
817956|NCT02115815|2676499|P3|Overall Study|Withdrawal by Subject|0
817958|NCT02115815|2676501|P1|Overall Study|Withdrawal by Subject|2
817959|NCT02115321|2676659|P2|Overall Study|Death|0
817960|NCT02115321|2676660|P1|Overall Study|Death|1
817961|NCT02115308|2676682|P2|Overall Study|Safety Screening|2
817962|NCT02115308|2676683|P1|Overall Study|Safety Screening|2
817963|NCT02115269|2676699|P1|Overall Study|Didn't take study drug|2
817964|NCT02115269|2676699|P1|Overall Study|Withdrawal by Subject|2
817965|NCT02115269|2676699|P1|Overall Study|Moved to another city|7
817966|NCT02115269|2676699|P1|Overall Study|Did not complete patient diary|3
817967|NCT02115269|2676699|P1|Overall Study|Lost to Follow-up|43
817968|NCT02115256|2676719|P2|Overall Study|Withdrawal by Subject|1
817969|NCT02115256|2676720|P1|Overall Study|Withdrawal by Subject|0
817970|NCT02114931|2676734|P2|Overall Study|Other|1
817971|NCT02114931|2676735|P1|Overall Study|Other|2
817972|NCT02114931|2676734|P2|Overall Study|Physician Decision|2
817973|NCT02114931|2676735|P1|Overall Study|Physician Decision|1
817974|NCT02114931|2676734|P2|Overall Study|Lost to Follow-up|3
817975|NCT02114931|2676735|P1|Overall Study|Lost to Follow-up|3
817976|NCT02114931|2676734|P2|Overall Study|Adverse Event|6
817977|NCT02114931|2676735|P1|Overall Study|Adverse Event|4
817978|NCT02114931|2676734|P2|Overall Study|Withdrawal by Subject|18
817979|NCT02114931|2676735|P1|Overall Study|Withdrawal by Subject|15
817980|NCT02114892|2676751|P2|Overall Study|Lost to Follow-up|2
817981|NCT02114892|2676752|P1|Overall Study|Lost to Follow-up|1
817982|NCT02114697|2676788|P2|Overall Study|Study terminated|4
817983|NCT02114697|2676789|P1|Overall Study|Study terminated|5
817984|NCT02114385|2676797|P2|Overall Study|Lost to Follow-up|6
817985|NCT02114385|2676798|P1|Overall Study|Lost to Follow-up|0
817986|NCT02114385|2676797|P2|Overall Study|Withdrawal by Subject|2
817987|NCT02114385|2676798|P1|Overall Study|Withdrawal by Subject|3
817988|NCT02114268|2676826|P6|Overall Study|Withdrawn by site due to noncompliance|0
817989|NCT02114268|2676827|P5|Overall Study|Withdrawn by site due to noncompliance|0
817990|NCT02114268|2676828|P4|Overall Study|Withdrawn by site due to noncompliance|0
817991|NCT02114268|2676829|P3|Overall Study|Withdrawn by site due to noncompliance|0
817992|NCT02114268|2676830|P2|Overall Study|Withdrawn by site due to noncompliance|0
817993|NCT02114268|2676831|P1|Overall Study|Withdrawn by site due to noncompliance|1
817994|NCT02114268|2676826|P6|Overall Study|Withdrawal by Subject|1
817995|NCT02114268|2676827|P5|Overall Study|Withdrawal by Subject|0
817996|NCT02114268|2676828|P4|Overall Study|Withdrawal by Subject|0
817997|NCT02114268|2676829|P3|Overall Study|Withdrawal by Subject|0
817998|NCT02114268|2676830|P2|Overall Study|Withdrawal by Subject|0
817999|NCT02114268|2676831|P1|Overall Study|Withdrawal by Subject|1
818000|NCT02114268|2676826|P6|Overall Study|Lost to Follow-up|2
818001|NCT02114268|2676827|P5|Overall Study|Lost to Follow-up|0
818002|NCT02114268|2676828|P4|Overall Study|Lost to Follow-up|0
818003|NCT02114268|2676829|P3|Overall Study|Lost to Follow-up|1
818004|NCT02114268|2676830|P2|Overall Study|Lost to Follow-up|1
818005|NCT02114268|2676831|P1|Overall Study|Lost to Follow-up|4
818006|NCT02114203|2676900|P3|Overall Study|Withdrawal by Subject|0
818007|NCT02114203|2676901|P2|Overall Study|Withdrawal by Subject|1
818008|NCT02114203|2676902|P1|Overall Study|Withdrawal by Subject|0
818009|NCT02114203|2676900|P3|Overall Study|Adverse Event|0
818010|NCT02114203|2676901|P2|Overall Study|Adverse Event|1
818011|NCT02114203|2676902|P1|Overall Study|Adverse Event|0
818012|NCT02114177|2676936|P2|Overall Study|Other|1
818013|NCT02114177|2676937|P1|Overall Study|Other|2
818014|NCT02114177|2676936|P2|Overall Study|Withdrawal by Subject|1
818015|NCT02114177|2676937|P1|Overall Study|Withdrawal by Subject|6
818016|NCT02114177|2676936|P2|Overall Study|Lost to Follow-up|2
818017|NCT02114177|2676937|P1|Overall Study|Lost to Follow-up|1
818018|NCT02114151|2676961|P1|Overall Study|Withdrawal by Subject|5
818019|NCT02114151|2676961|P1|Overall Study|Lost to Follow-up|1
818020|NCT02114151|2676961|P1|Overall Study|Death|1
818021|NCT02113579|2676978|P2|Overall Study|Lost to Follow-up|2
818022|NCT02113579|2676979|P1|Overall Study|Lost to Follow-up|6
818023|NCT02113579|2676978|P2|Overall Study|Withdrawal by Subject|2
818024|NCT02113579|2676979|P1|Overall Study|Withdrawal by Subject|3
818025|NCT02113579|2676978|P2|Overall Study|Adverse Event|0
818026|NCT02113579|2676979|P1|Overall Study|Adverse Event|1
818027|NCT02113449|2677003|P1|Overall Study|Adverse Event|4
818028|NCT02113436|2677019|P4|Period 2: 16 Weeks|Withdrawal by Subject|1
818029|NCT02113436|2677020|P3|Period 2: 16 Weeks|Withdrawal by Subject|1
818030|NCT02113436|2677021|P2|Period 2: 16 Weeks|Withdrawal by Subject|0
818031|NCT02113436|2677022|P1|Period 2: 16 Weeks|Withdrawal by Subject|0
818032|NCT02113436|2677019|P4|Period 2: 16 Weeks|Physician Decision|0
818033|NCT02113436|2677020|P3|Period 2: 16 Weeks|Physician Decision|2
818034|NCT02113436|2677021|P2|Period 2: 16 Weeks|Physician Decision|0
818035|NCT02113436|2677022|P1|Period 2: 16 Weeks|Physician Decision|0
818036|NCT02113436|2677019|P4|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5
818037|NCT02113436|2677020|P3|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2
818038|NCT02113436|2677021|P2|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
818039|NCT02113436|2677022|P1|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
818040|NCT02113436|2677019|P4|Period 2: 16 Weeks|Adverse Event|5
818041|NCT02113436|2677020|P3|Period 2: 16 Weeks|Adverse Event|4
818042|NCT02113436|2677021|P2|Period 2: 16 Weeks|Adverse Event|0
818043|NCT02113436|2677022|P1|Period 2: 16 Weeks|Adverse Event|0
818044|NCT02113436|2677019|P4|Period 1: 8 Weeks|Withdrawal by Subject|0
818045|NCT02113436|2677020|P3|Period 1: 8 Weeks|Withdrawal by Subject|0
818046|NCT02113436|2677021|P2|Period 1: 8 Weeks|Withdrawal by Subject|0
818047|NCT02113436|2677022|P1|Period 1: 8 Weeks|Withdrawal by Subject|1
818048|NCT02113436|2677019|P4|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
818049|NCT02113436|2677020|P3|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
818050|NCT02113436|2677021|P2|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2
818051|NCT02113436|2677022|P1|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5
818052|NCT02113436|2677019|P4|Period 1: 8 Weeks|Protocol Violation|0
818053|NCT02113436|2677020|P3|Period 1: 8 Weeks|Protocol Violation|0
818054|NCT02113436|2677021|P2|Period 1: 8 Weeks|Protocol Violation|0
818055|NCT02113436|2677022|P1|Period 1: 8 Weeks|Protocol Violation|1
818056|NCT02113436|2677019|P4|Period 1: 8 Weeks|Adverse Event|0
818057|NCT02113436|2677020|P3|Period 1: 8 Weeks|Adverse Event|0
818058|NCT02113436|2677021|P2|Period 1: 8 Weeks|Adverse Event|0
818059|NCT02113436|2677022|P1|Period 1: 8 Weeks|Adverse Event|1
818060|NCT02113124|2677045|P2|Overall Study|Unable to retrieve blood sample|1
818061|NCT02113124|2677046|P1|Overall Study|Unable to retrieve blood sample|1
818062|NCT02113007|2677052|P1|Overall Study|Progressive disease|2
818063|NCT02112448|2677060|P2|Overall Study|required heparin so could not use ketoro|0
818064|NCT02112448|2677061|P1|Overall Study|required heparin so could not use ketoro|1
818065|NCT02112448|2677060|P2|Overall Study|Physician Decision|6
818066|NCT02112448|2677061|P1|Overall Study|Physician Decision|4
818067|NCT02112448|2677060|P2|Overall Study|Protocol Violation|2
818068|NCT02112448|2677061|P1|Overall Study|Protocol Violation|1
818069|NCT02112448|2677060|P2|Overall Study|lab values precluding use of ketorolac|2
818070|NCT02112448|2677061|P1|Overall Study|lab values precluding use of ketorolac|2
818071|NCT02111603|2677134|P1|Overall Study|Withdrawal by Subject|1
818072|NCT02111369|2677143|P1|Overall Study|Withdrawal by Subject|1
818073|NCT02111369|2677143|P1|Overall Study|Lost to Follow-up|2
818074|NCT02111174|2677188|P2|Secondary Outcomes (2 and 3 Month f/u)|Death|1
818075|NCT02111174|2677189|P1|Secondary Outcomes (2 and 3 Month f/u)|Death|0
818076|NCT02111174|2677188|P2|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6
818077|NCT02111174|2677189|P1|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8
818078|NCT02111174|2677188|P2|Treatment and Primary Outcome|Withdrawal by Subject|2
818079|NCT02111174|2677189|P1|Treatment and Primary Outcome|Withdrawal by Subject|2
818080|NCT02111174|2677188|P2|Treatment and Primary Outcome|Ineligible (not used in analysis)|0
818081|NCT02111174|2677189|P1|Treatment and Primary Outcome|Ineligible (not used in analysis)|1
818082|NCT02111096|2677218|P3|Overall Study|Withdrawal by Subject|8
818083|NCT02111096|2677219|P2|Overall Study|Withdrawal by Subject|2
818084|NCT02111096|2677220|P1|Overall Study|Withdrawal by Subject|4
818085|NCT02111096|2677218|P3|Overall Study|Terminated by Sponsor|54
818086|NCT02111096|2677219|P2|Overall Study|Terminated by Sponsor|35
818087|NCT02111096|2677220|P1|Overall Study|Terminated by Sponsor|53
818088|NCT02111096|2677218|P3|Overall Study|Protocol Violation|1
818089|NCT02111096|2677219|P2|Overall Study|Protocol Violation|0
818090|NCT02111096|2677220|P1|Overall Study|Protocol Violation|1
818091|NCT02111096|2677218|P3|Overall Study|Physician Decision|0
818092|NCT02111096|2677219|P2|Overall Study|Physician Decision|1
818093|NCT02111096|2677220|P1|Overall Study|Physician Decision|0
818094|NCT02111096|2677218|P3|Overall Study|Lost to Follow Up|1
818095|NCT02111096|2677219|P2|Overall Study|Lost to Follow Up|1
818096|NCT02111096|2677220|P1|Overall Study|Lost to Follow Up|1
818097|NCT02111096|2677218|P3|Overall Study|Non-Compliance with Study Drug|0
818098|NCT02111096|2677219|P2|Overall Study|Non-Compliance with Study Drug|1
818099|NCT02111096|2677220|P1|Overall Study|Non-Compliance with Study Drug|1
818100|NCT02111096|2677218|P3|Overall Study|Adverse Event|2
818101|NCT02111096|2677219|P2|Overall Study|Adverse Event|1
818102|NCT02111096|2677220|P1|Overall Study|Adverse Event|4
818103|NCT02111083|2677268|P2|Interval Between Dosing (7-8 Days)|Adverse Event|1
818104|NCT02111083|2677269|P1|Interval Between Dosing (7-8 Days)|Adverse Event|1
818105|NCT02110706|2677289|P2|Overall Study|Patients who didn't receive 2nd infusion|1
818106|NCT02110706|2677290|P1|Overall Study|Patients who didn't receive 2nd infusion|3
818107|NCT02110706|2677289|P2|Overall Study|Adverse Event|3
818108|NCT02110706|2677290|P1|Overall Study|Adverse Event|2
818109|NCT02110693|2677302|P2|Overall Study|Other|0
818110|NCT02110693|2677303|P1|Overall Study|Other|1
818111|NCT02110693|2677302|P2|Overall Study|technical difficulties|4
818112|NCT02110693|2677303|P1|Overall Study|technical difficulties|6
818113|NCT02110693|2677302|P2|Overall Study|skipped assessment|18
818114|NCT02110693|2677303|P1|Overall Study|skipped assessment|15
818115|NCT02110693|2677302|P2|Overall Study|Withdrawal by Subject|7
818116|NCT02110693|2677303|P1|Overall Study|Withdrawal by Subject|6
818117|NCT02110238|2677349|P2|14 Week Blinded Extension Phase|Withdrawal by Subject|3
818118|NCT02110238|2677350|P1|14 Week Blinded Extension Phase|Withdrawal by Subject|4
818119|NCT02110238|2677349|P2|14 Week Blinded Extension Phase|Protocol Violation|3
818120|NCT02110238|2677350|P1|14 Week Blinded Extension Phase|Protocol Violation|2
818121|NCT02110238|2677349|P2|14 Week Blinded Extension Phase|Lost to Follow-up|1
818122|NCT02110238|2677350|P1|14 Week Blinded Extension Phase|Lost to Follow-up|3
818123|NCT02110238|2677349|P2|14 Week Blinded Extension Phase|Lack of Efficacy|4
818124|NCT02110238|2677350|P1|14 Week Blinded Extension Phase|Lack of Efficacy|2
818125|NCT02110238|2677349|P2|14 Week Blinded Extension Phase|Adverse Event|1
818126|NCT02110238|2677350|P1|14 Week Blinded Extension Phase|Adverse Event|1
818127|NCT02110238|2677349|P2|12 Week Pivotal Phase|Withdrawal by Subject|3
818128|NCT02110238|2677350|P1|12 Week Pivotal Phase|Withdrawal by Subject|3
818129|NCT02110238|2677349|P2|12 Week Pivotal Phase|Protocol Violation|1
818130|NCT02110238|2677350|P1|12 Week Pivotal Phase|Protocol Violation|0
818131|NCT02110238|2677349|P2|12 Week Pivotal Phase|Physician Decision|2
818132|NCT02110238|2677350|P1|12 Week Pivotal Phase|Physician Decision|0
818133|NCT02110238|2677349|P2|12 Week Pivotal Phase|Lost to Follow-up|0
818134|NCT02110238|2677350|P1|12 Week Pivotal Phase|Lost to Follow-up|2
818135|NCT02110238|2677349|P2|12 Week Pivotal Phase|Lack of Efficacy|3
818136|NCT02110238|2677350|P1|12 Week Pivotal Phase|Lack of Efficacy|2
818137|NCT02110238|2677349|P2|12 Week Pivotal Phase|Adverse Event|0
818138|NCT02110238|2677350|P1|12 Week Pivotal Phase|Adverse Event|3
818139|NCT02109562|2677388|P3|Overall Study|Physician Decision|5
818140|NCT02109562|2677389|P2|Overall Study|Physician Decision|4
818141|NCT02109562|2677390|P1|Overall Study|Physician Decision|3
818142|NCT02109562|2677388|P3|Overall Study|Withdrawal by Subject|21
818143|NCT02109562|2677389|P2|Overall Study|Withdrawal by Subject|25
818144|NCT02109562|2677390|P1|Overall Study|Withdrawal by Subject|20
818145|NCT02109562|2677388|P3|Overall Study|Protocol Violation|1
818146|NCT02109562|2677389|P2|Overall Study|Protocol Violation|3
818147|NCT02109562|2677390|P1|Overall Study|Protocol Violation|0
818148|NCT02109562|2677388|P3|Overall Study|Lost to Follow-up|1
818149|NCT02109562|2677389|P2|Overall Study|Lost to Follow-up|0
818150|NCT02109562|2677390|P1|Overall Study|Lost to Follow-up|1
818151|NCT02109562|2677388|P3|Overall Study|Adverse Event|3
818152|NCT02109562|2677389|P2|Overall Study|Adverse Event|2
818153|NCT02109562|2677390|P1|Overall Study|Adverse Event|0
818154|NCT02109562|2677388|P3|Overall Study|Insufficient clinical response|4
818155|NCT02109562|2677389|P2|Overall Study|Insufficient clinical response|0
818156|NCT02109562|2677390|P1|Overall Study|Insufficient clinical response|2
818157|NCT02109484|2677417|P8|Overall Study|Moved away from study area|1
818158|NCT02109484|2677418|P7|Overall Study|Moved away from study area|1
818159|NCT02109484|2677419|P6|Overall Study|Moved away from study area|0
818160|NCT02109484|2677420|P5|Overall Study|Moved away from study area|0
818161|NCT02109484|2677421|P4|Overall Study|Moved away from study area|0
818162|NCT02109484|2677422|P3|Overall Study|Moved away from study area|0
818163|NCT02109484|2677423|P2|Overall Study|Moved away from study area|0
818164|NCT02109484|2677424|P1|Overall Study|Moved away from study area|0
818165|NCT02109484|2677417|P8|Overall Study|Death|2
818166|NCT02109484|2677418|P7|Overall Study|Death|0
818167|NCT02109484|2677419|P6|Overall Study|Death|0
818168|NCT02109484|2677420|P5|Overall Study|Death|0
818169|NCT02109484|2677421|P4|Overall Study|Death|0
818170|NCT02109484|2677422|P3|Overall Study|Death|0
818171|NCT02109484|2677423|P2|Overall Study|Death|0
818172|NCT02109484|2677424|P1|Overall Study|Death|0
818173|NCT02109484|2677417|P8|Overall Study|Physician Decision|0
818174|NCT02109484|2677418|P7|Overall Study|Physician Decision|0
818175|NCT02109484|2677419|P6|Overall Study|Physician Decision|0
818176|NCT02109484|2677420|P5|Overall Study|Physician Decision|2
818177|NCT02109484|2677421|P4|Overall Study|Physician Decision|0
818178|NCT02109484|2677422|P3|Overall Study|Physician Decision|0
818179|NCT02109484|2677423|P2|Overall Study|Physician Decision|0
818180|NCT02109484|2677424|P1|Overall Study|Physician Decision|0
818181|NCT02109484|2677417|P8|Overall Study|Withdrawal by Subject|0
818182|NCT02109484|2677418|P7|Overall Study|Withdrawal by Subject|1
818183|NCT02109484|2677419|P6|Overall Study|Withdrawal by Subject|1
818184|NCT02109484|2677420|P5|Overall Study|Withdrawal by Subject|1
818185|NCT02109484|2677421|P4|Overall Study|Withdrawal by Subject|0
818186|NCT02109484|2677422|P3|Overall Study|Withdrawal by Subject|0
818187|NCT02109484|2677423|P2|Overall Study|Withdrawal by Subject|0
818188|NCT02109484|2677424|P1|Overall Study|Withdrawal by Subject|0
818189|NCT02109484|2677417|P8|Overall Study|Lost to Follow-up|0
818190|NCT02109484|2677418|P7|Overall Study|Lost to Follow-up|1
818191|NCT02109484|2677419|P6|Overall Study|Lost to Follow-up|0
818192|NCT02109484|2677420|P5|Overall Study|Lost to Follow-up|1
818193|NCT02109484|2677421|P4|Overall Study|Lost to Follow-up|1
818194|NCT02109484|2677422|P3|Overall Study|Lost to Follow-up|0
818195|NCT02109484|2677423|P2|Overall Study|Lost to Follow-up|0
818196|NCT02109484|2677424|P1|Overall Study|Lost to Follow-up|0
818197|NCT02109445|2677480|P1|Overall Study|Adverse Event|1
818198|NCT02109445|2677480|P1|Overall Study|Symptomatic deterioration|2
818199|NCT02109172|2677513|P6|Overall Study|Death|0
818200|NCT02109172|2677514|P5|Overall Study|Death|1
818201|NCT02109172|2677515|P4|Overall Study|Death|0
818202|NCT02109172|2677516|P3|Overall Study|Death|0
818203|NCT02109172|2677517|P2|Overall Study|Death|0
818204|NCT02109172|2677518|P1|Overall Study|Death|0
818205|NCT02109172|2677513|P6|Overall Study|Adverse Event|1
818206|NCT02109172|2677514|P5|Overall Study|Adverse Event|0
818207|NCT02109172|2677515|P4|Overall Study|Adverse Event|0
818208|NCT02109172|2677516|P3|Overall Study|Adverse Event|1
818209|NCT02109172|2677517|P2|Overall Study|Adverse Event|0
818210|NCT02109172|2677518|P1|Overall Study|Adverse Event|0
818211|NCT02109172|2677513|P6|Overall Study|Withdrawal by Subject|0
818212|NCT02109172|2677514|P5|Overall Study|Withdrawal by Subject|0
818213|NCT02109172|2677515|P4|Overall Study|Withdrawal by Subject|1
818214|NCT02109172|2677516|P3|Overall Study|Withdrawal by Subject|0
818215|NCT02109172|2677517|P2|Overall Study|Withdrawal by Subject|0
818216|NCT02109172|2677518|P1|Overall Study|Withdrawal by Subject|1
818217|NCT02109133|2677539|P2|Overall Study|Lost to Follow-up|0
818218|NCT02109133|2677540|P1|Overall Study|Lost to Follow-up|1
818219|NCT02109107|2677552|P1|Overall Study|Lost to Follow-up|2
818220|NCT02109042|2677559|P1|Overall Study|Sponsor Decision|15
818221|NCT02108951|2677580|P1|Overall Study|Study Terminated by Sponsor|14
818222|NCT02108951|2677580|P1|Overall Study|Patient's/guardian's decision|1
818223|NCT02108951|2677580|P1|Overall Study|Lost to Follow-up|1
818224|NCT02108652|2677618|P1|Overall Study|Ongoing at data cutoff 04 July 2016|74
818225|NCT02108652|2677618|P1|Overall Study|Withdrawal by Subject|8
818226|NCT02108652|2677618|P1|Overall Study|Lost to Follow-up|2
818227|NCT02108652|2677618|P1|Overall Study|Death|226
818228|NCT02107898|2677787|P2|Overall Study|Randomized but not treated|1
818229|NCT02107898|2677788|P1|Overall Study|Randomized but not treated|0
818230|NCT02107898|2677787|P2|Overall Study|Consent withdrawn by participant|1
818231|NCT02107898|2677788|P1|Overall Study|Consent withdrawn by participant|2
818232|NCT02107898|2677787|P2|Overall Study|Participant moved|2
818233|NCT02107898|2677788|P1|Overall Study|Participant moved|0
818234|NCT02107898|2677787|P2|Overall Study|Poor compliance to protocol|1
818235|NCT02107898|2677788|P1|Overall Study|Poor compliance to protocol|0
818236|NCT02107898|2677787|P2|Overall Study|Adverse Event|7
818237|NCT02107898|2677788|P1|Overall Study|Adverse Event|4
818238|NCT02107703|2677842|P2|Overall Study|On study treatment/follow up|152
818239|NCT02107703|2677843|P1|Overall Study|On study treatment/follow up|319
818240|NCT02107703|2677842|P2|Overall Study|Lost to Follow-up|4
818241|NCT02107703|2677843|P1|Overall Study|Lost to Follow-up|6
818242|NCT02107703|2677842|P2|Overall Study|Withdrawal by Subject|19
818243|NCT02107703|2677843|P1|Overall Study|Withdrawal by Subject|36
818244|NCT02107482|2677875|P1|Overall Study|Lack of Efficacy|1
818245|NCT02107482|2677875|P1|Overall Study|Lost to Follow-up|1
818246|NCT02107482|2677875|P1|Overall Study|inconveinence|2
818247|NCT02107443|2677883|P2|Overall Study|Withdrawal: Personal Issues|3
818248|NCT02107443|2677884|P1|Overall Study|Withdrawal: Personal Issues|0
818249|NCT02107443|2677883|P2|Overall Study|Withdrawal: Disease Progression|2
818250|NCT02107443|2677884|P1|Overall Study|Withdrawal: Disease Progression|4
818251|NCT02107443|2677883|P2|Overall Study|Withdrawal: Other Medical|5
818252|NCT02107443|2677884|P1|Overall Study|Withdrawal: Other Medical|9
818253|NCT02107443|2677883|P2|Overall Study|Withdrawal: Feeling Overwhelmed|1
818254|NCT02107443|2677884|P1|Overall Study|Withdrawal: Feeling Overwhelmed|2
818255|NCT02107443|2677883|P2|Overall Study|Withdrawal: Too Time Consuming|6
818256|NCT02107443|2677884|P1|Overall Study|Withdrawal: Too Time Consuming|3
818257|NCT02107443|2677883|P2|Overall Study|Withdrawal: Too Many Forms|1
818258|NCT02107443|2677884|P1|Overall Study|Withdrawal: Too Many Forms|3
818259|NCT02107443|2677883|P2|Overall Study|Withdrawal: Changed MD/Facility|3
818260|NCT02107443|2677884|P1|Overall Study|Withdrawal: Changed MD/Facility|1
818261|NCT02107443|2677883|P2|Overall Study|Withdrawal: Changed Mind|0
818262|NCT02107443|2677884|P1|Overall Study|Withdrawal: Changed Mind|2
818263|NCT02107443|2677883|P2|Overall Study|Withdrawal: Disliked Study Procedures|2
818264|NCT02107443|2677884|P1|Overall Study|Withdrawal: Disliked Study Procedures|1
818265|NCT02107443|2677883|P2|Overall Study|Withdrawal: Hospitalization/Hospice|28
818266|NCT02107443|2677884|P1|Overall Study|Withdrawal: Hospitalization/Hospice|28
818267|NCT02107443|2677883|P2|Overall Study|Registered but Not Eligible|1
818268|NCT02107443|2677884|P1|Overall Study|Registered but Not Eligible|0
818269|NCT02107443|2677883|P2|Overall Study|Study Protocol Violation|1
818270|NCT02107443|2677884|P1|Overall Study|Study Protocol Violation|3
818271|NCT02107443|2677883|P2|Overall Study|Death|30
818272|NCT02107443|2677884|P1|Overall Study|Death|42
818273|NCT02107313|2677923|P2|Overall Study|One participant did not do the FED cohor|1
818274|NCT02107313|2677924|P1|Overall Study|One participant did not do the FED cohor|0
818275|NCT02107274|2677934|P2|Control Phase|Adverse Event|1
818276|NCT02107274|2677935|P1|Control Phase|Adverse Event|0
818277|NCT02107274|2677934|P2|Control Phase|Death|0
818278|NCT02107274|2677935|P1|Control Phase|Death|2
818279|NCT02107274|2677934|P2|Control Phase|Lost to Follow-up|1
818280|NCT02107274|2677935|P1|Control Phase|Lost to Follow-up|1
818281|NCT02107274|2677934|P2|Treatment vs. Placebo|Lost to Follow-up|2
818282|NCT02107274|2677935|P1|Treatment vs. Placebo|Lost to Follow-up|0
818283|NCT02107274|2677934|P2|Treatment vs. Placebo|Adverse Event|0
818284|NCT02107274|2677935|P1|Treatment vs. Placebo|Adverse Event|3
818285|NCT02107196|2677949|P2|4-week Randomized Withdrawal (RW) Period|Reason Missing|5
818286|NCT02107196|2677950|P1|4-week Randomized Withdrawal (RW) Period|Reason Missing|18
818287|NCT02107196|2677949|P2|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0
818288|NCT02107196|2677950|P1|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2
818289|NCT02107196|2677949|P2|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
818290|NCT02107196|2677950|P1|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1
818291|NCT02107196|2677949|P2|4-week Randomized Withdrawal (RW) Period|Adverse Event|0
818292|NCT02107196|2677950|P1|4-week Randomized Withdrawal (RW) Period|Adverse Event|2
818293|NCT02107196|2677949|P2|12-week Treatment Period|Reason Missing|8
818294|NCT02107196|2677950|P1|12-week Treatment Period|Reason Missing|11
818295|NCT02107196|2677949|P2|12-week Treatment Period|Protocol Violation|8
818296|NCT02107196|2677950|P1|12-week Treatment Period|Protocol Violation|7
818297|NCT02107196|2677949|P2|12-week Treatment Period|Withdrawal by Subject|12
818298|NCT02107196|2677950|P1|12-week Treatment Period|Withdrawal by Subject|15
818299|NCT02107196|2677949|P2|12-week Treatment Period|Physician Decision|1
818300|NCT02107196|2677950|P1|12-week Treatment Period|Physician Decision|0
818301|NCT02107196|2677949|P2|12-week Treatment Period|Lost to Follow-up|6
818302|NCT02107196|2677950|P1|12-week Treatment Period|Lost to Follow-up|3
818303|NCT02107196|2677949|P2|12-week Treatment Period|Lack of Efficacy|1
818304|NCT02107196|2677950|P1|12-week Treatment Period|Lack of Efficacy|2
818305|NCT02107196|2677949|P2|12-week Treatment Period|Adverse Event|3
818306|NCT02107196|2677950|P1|12-week Treatment Period|Adverse Event|6
818307|NCT02107092|2677963|P1|Overall Study|Expected progression of CKD|12
818308|NCT02107092|2677963|P1|Overall Study|Adverse Event|7
818309|NCT02107092|2677963|P1|Overall Study|Withdrawal by Subject|9
818310|NCT02107092|2677963|P1|Overall Study|Lost to Follow-up|2
818311|NCT02107092|2677963|P1|Overall Study|Physician Decision|3
818312|NCT02107092|2677963|P1|Overall Study|Met ECG withdrawal criteria|3
818313|NCT02107092|2677963|P1|Overall Study|Hypo-or hyperkalemia|2
818314|NCT02107092|2677963|P1|Overall Study|Subject compliance|3
818315|NCT02107092|2677963|P1|Overall Study|Miscellaneous|3
818316|NCT02107014|2677968|P1|Overall Study|Withdrew before drug: moving interstate|1
818317|NCT02106923|2678050|P6|Overall Study|Protocol Violation|1
818318|NCT02106923|2678051|P5|Overall Study|Protocol Violation|0
818319|NCT02106923|2678052|P4|Overall Study|Protocol Violation|0
818320|NCT02106923|2678053|P3|Overall Study|Protocol Violation|0
818321|NCT02106923|2678054|P2|Overall Study|Protocol Violation|0
818322|NCT02106923|2678055|P1|Overall Study|Protocol Violation|0
818323|NCT02106832|2678103|P4|Overall Study|Technical problems|0
818324|NCT02106832|2678104|P3|Overall Study|Technical problems|0
818325|NCT02106832|2678105|P2|Overall Study|Technical problems|1
818326|NCT02106832|2678106|P1|Overall Study|Technical problems|0
818327|NCT02106832|2678103|P4|Overall Study|Withdrawal by Subject|7
818328|NCT02106832|2678104|P3|Overall Study|Withdrawal by Subject|10
818329|NCT02106832|2678105|P2|Overall Study|Withdrawal by Subject|17
818330|NCT02106832|2678106|P1|Overall Study|Withdrawal by Subject|17
818331|NCT02106832|2678103|P4|Overall Study|Protocol Violation|1
818332|NCT02106832|2678104|P3|Overall Study|Protocol Violation|0
818333|NCT02106832|2678105|P2|Overall Study|Protocol Violation|0
818334|NCT02106832|2678106|P1|Overall Study|Protocol Violation|0
818335|NCT02106832|2678103|P4|Overall Study|Physician Decision|0
818336|NCT02106832|2678104|P3|Overall Study|Physician Decision|0
818337|NCT02106832|2678105|P2|Overall Study|Physician Decision|0
818338|NCT02106832|2678106|P1|Overall Study|Physician Decision|1
818339|NCT02106832|2678103|P4|Overall Study|Lost to Follow-up|3
818340|NCT02106832|2678104|P3|Overall Study|Lost to Follow-up|1
818341|NCT02106832|2678105|P2|Overall Study|Lost to Follow-up|1
818342|NCT02106832|2678106|P1|Overall Study|Lost to Follow-up|0
818343|NCT02106832|2678103|P4|Overall Study|Deterioration of general conditions|0
818344|NCT02106832|2678104|P3|Overall Study|Deterioration of general conditions|1
818345|NCT02106832|2678105|P2|Overall Study|Deterioration of general conditions|0
818346|NCT02106832|2678106|P1|Overall Study|Deterioration of general conditions|0
818347|NCT02106832|2678103|P4|Overall Study|Death|4
818348|NCT02106832|2678104|P3|Overall Study|Death|1
818349|NCT02106832|2678105|P2|Overall Study|Death|4
818350|NCT02106832|2678106|P1|Overall Study|Death|4
818351|NCT02106832|2678103|P4|Overall Study|Adverse Event|0
818352|NCT02106832|2678104|P3|Overall Study|Adverse Event|3
818353|NCT02106832|2678105|P2|Overall Study|Adverse Event|2
818354|NCT02106832|2678106|P1|Overall Study|Adverse Event|1
818355|NCT02106403|2678173|P6|Follow-Up Visit 3|Other Reason|1
818356|NCT02106403|2678174|P5|Follow-Up Visit 3|Other Reason|0
818357|NCT02106403|2678175|P4|Follow-Up Visit 3|Other Reason|0
818358|NCT02106403|2678176|P3|Follow-Up Visit 3|Other Reason|0
818359|NCT02106403|2678177|P2|Follow-Up Visit 3|Other Reason|0
818360|NCT02106403|2678178|P1|Follow-Up Visit 3|Other Reason|0
818361|NCT02106390|2678201|P3|Overall Study|Protocol Violation|0
818362|NCT02106390|2678202|P2|Overall Study|Protocol Violation|1
818363|NCT02106390|2678203|P1|Overall Study|Protocol Violation|0
818364|NCT02106390|2678201|P3|Overall Study|Adverse Event|1
818365|NCT02106390|2678202|P2|Overall Study|Adverse Event|2
818366|NCT02106390|2678203|P1|Overall Study|Adverse Event|0
818367|NCT02106390|2678201|P3|Overall Study|Other: Unspecified|2
818368|NCT02106390|2678202|P2|Overall Study|Other: Unspecified|4
818369|NCT02106390|2678203|P1|Overall Study|Other: Unspecified|1
818370|NCT02106390|2678201|P3|Overall Study|Other: Administrative Reason|12
818371|NCT02106390|2678202|P2|Overall Study|Other: Administrative Reason|5
818372|NCT02106390|2678203|P1|Overall Study|Other: Administrative Reason|8
818373|NCT02106390|2678201|P3|Overall Study|Lost to Follow-up|13
818374|NCT02106390|2678202|P2|Overall Study|Lost to Follow-up|20
818375|NCT02106390|2678203|P1|Overall Study|Lost to Follow-up|25
818376|NCT02106390|2678201|P3|Overall Study|Withdrawal by Subject|15
818377|NCT02106390|2678202|P2|Overall Study|Withdrawal by Subject|16
818378|NCT02106390|2678203|P1|Overall Study|Withdrawal by Subject|15
818379|NCT02106325|2678279|P2|Phase 3|Lost to Follow-up|1
818380|NCT02106325|2678280|P1|Phase 3|Lost to Follow-up|2
818381|NCT02106325|2678279|P2|Phase 2|Lost to Follow-up|3
818382|NCT02106325|2678280|P1|Phase 2|Lost to Follow-up|2
818383|NCT02106325|2678279|P2|Phase 1|Lost to Follow-up|2
818384|NCT02106325|2678280|P1|Phase 1|Lost to Follow-up|2
818385|NCT02106156|2678305|P3|Overall Study|Relocation/Change of Physician|0
818386|NCT02106156|2678306|P2|Overall Study|Relocation/Change of Physician|1
818387|NCT02106156|2678307|P1|Overall Study|Relocation/Change of Physician|40
818388|NCT02106156|2678305|P3|Overall Study|Hospitalization/Surgical Intervention|0
818389|NCT02106156|2678306|P2|Overall Study|Hospitalization/Surgical Intervention|0
818390|NCT02106156|2678307|P1|Overall Study|Hospitalization/Surgical Intervention|6
818391|NCT02106156|2678305|P3|Overall Study|Change of Laboratory Parameter|0
818392|NCT02106156|2678306|P2|Overall Study|Change of Laboratory Parameter|0
818393|NCT02106156|2678307|P1|Overall Study|Change of Laboratory Parameter|10
818394|NCT02106156|2678305|P3|Overall Study|Unplanned Event|0
818395|NCT02106156|2678306|P2|Overall Study|Unplanned Event|2
818396|NCT02106156|2678307|P1|Overall Study|Unplanned Event|82
818397|NCT02106156|2678305|P3|Overall Study|Lost to Follow-up|0
818398|NCT02106156|2678306|P2|Overall Study|Lost to Follow-up|8
818399|NCT02106156|2678307|P1|Overall Study|Lost to Follow-up|451
818400|NCT02106156|2678305|P3|Overall Study|Patients Request|0
818401|NCT02106156|2678306|P2|Overall Study|Patients Request|9
818402|NCT02106156|2678307|P1|Overall Study|Patients Request|307
818403|NCT02106156|2678305|P3|Overall Study|Lack of Compliance|0
818404|NCT02106156|2678306|P2|Overall Study|Lack of Compliance|7
818405|NCT02106156|2678307|P1|Overall Study|Lack of Compliance|211
818406|NCT02106156|2678305|P3|Overall Study|Concomitant Disease|0
818407|NCT02106156|2678306|P2|Overall Study|Concomitant Disease|2
818408|NCT02106156|2678307|P1|Overall Study|Concomitant Disease|74
818409|NCT02106156|2678305|P3|Overall Study|Lack of Virological Response|0
818410|NCT02106156|2678306|P2|Overall Study|Lack of Virological Response|8
818411|NCT02106156|2678307|P1|Overall Study|Lack of Virological Response|1044
818412|NCT02106156|2678305|P3|Overall Study|Lack of Tolerability|0
818413|NCT02106156|2678306|P2|Overall Study|Lack of Tolerability|3
818414|NCT02106156|2678307|P1|Overall Study|Lack of Tolerability|305
818415|NCT02106156|2678305|P3|Overall Study|Patient Died|0
818416|NCT02106156|2678306|P2|Overall Study|Patient Died|0
818417|NCT02106156|2678307|P1|Overall Study|Patient Died|19
818418|NCT02105987|2678331|P6|Continuation Phase|Protocol Violation|0
818419|NCT02105987|2678332|P5|Continuation Phase|Protocol Violation|1
818420|NCT02105987|2678333|P4|Continuation Phase|Protocol Violation|0
818421|NCT02105987|2678334|P3|Continuation Phase|Protocol Violation|0
818422|NCT02105987|2678335|P2|Continuation Phase|Protocol Violation|0
818423|NCT02105987|2678336|P1|Continuation Phase|Protocol Violation|0
818424|NCT02105987|2678331|P6|Late Switch Phase (24 Weeks)|Per sponsor request|0
818425|NCT02105987|2678332|P5|Late Switch Phase (24 Weeks)|Per sponsor request|0
818426|NCT02105987|2678333|P4|Late Switch Phase (24 Weeks)|Per sponsor request|0
818427|NCT02105987|2678334|P3|Late Switch Phase (24 Weeks)|Per sponsor request|1
818428|NCT02105987|2678335|P2|Late Switch Phase (24 Weeks)|Per sponsor request|0
818429|NCT02105987|2678336|P1|Late Switch Phase (24 Weeks)|Per sponsor request|0
818430|NCT02105987|2678331|P6|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
818431|NCT02105987|2678332|P5|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
818432|NCT02105987|2678333|P4|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1
818433|NCT02105987|2678334|P3|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
818434|NCT02105987|2678335|P2|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
818435|NCT02105987|2678336|P1|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
818436|NCT02105987|2678331|P6|Late Switch Phase (24 Weeks)|Physician Decision|0
818437|NCT02105987|2678332|P5|Late Switch Phase (24 Weeks)|Physician Decision|0
818438|NCT02105987|2678333|P4|Late Switch Phase (24 Weeks)|Physician Decision|0
818439|NCT02105987|2678334|P3|Late Switch Phase (24 Weeks)|Physician Decision|5
818440|NCT02105987|2678335|P2|Late Switch Phase (24 Weeks)|Physician Decision|0
818441|NCT02105987|2678336|P1|Late Switch Phase (24 Weeks)|Physician Decision|0
818442|NCT02105987|2678331|P6|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
818443|NCT02105987|2678332|P5|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
818444|NCT02105987|2678333|P4|Late Switch Phase (24 Weeks)|Lost to Follow-up|3
818445|NCT02105987|2678334|P3|Late Switch Phase (24 Weeks)|Lost to Follow-up|8
818446|NCT02105987|2678335|P2|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
818447|NCT02105987|2678336|P1|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
818448|NCT02105987|2678331|P6|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
818449|NCT02105987|2678332|P5|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
818450|NCT02105987|2678333|P4|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5
818451|NCT02105987|2678334|P3|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6
818452|NCT02105987|2678335|P2|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
818453|NCT02105987|2678336|P1|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
818454|NCT02105987|2678331|P6|Late Switch Phase (24 Weeks)|Protocol Violation|0
818455|NCT02105987|2678332|P5|Late Switch Phase (24 Weeks)|Protocol Violation|0
818456|NCT02105987|2678333|P4|Late Switch Phase (24 Weeks)|Protocol Violation|1
818457|NCT02105987|2678334|P3|Late Switch Phase (24 Weeks)|Protocol Violation|15
818458|NCT02105987|2678335|P2|Late Switch Phase (24 Weeks)|Protocol Violation|0
818459|NCT02105987|2678336|P1|Late Switch Phase (24 Weeks)|Protocol Violation|0
818460|NCT02105987|2678331|P6|Late Switch Phase (24 Weeks)|Adverse Event|0
818461|NCT02105987|2678332|P5|Late Switch Phase (24 Weeks)|Adverse Event|0
818462|NCT02105987|2678333|P4|Late Switch Phase (24 Weeks)|Adverse Event|4
818463|NCT02105987|2678334|P3|Late Switch Phase (24 Weeks)|Adverse Event|10
818464|NCT02105987|2678335|P2|Late Switch Phase (24 Weeks)|Adverse Event|0
818465|NCT02105987|2678336|P1|Late Switch Phase (24 Weeks)|Adverse Event|0
818466|NCT02105987|2678331|P6|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
818467|NCT02105987|2678332|P5|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
818468|NCT02105987|2678333|P4|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
818469|NCT02105987|2678334|P3|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
818470|NCT02105987|2678335|P2|Early Switch Phase (24 Weeks)|Missing Disposition Data|1
818471|NCT02105987|2678336|P1|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
818472|NCT02105987|2678331|P6|Early Switch Phase (24 Weeks)|Physician Decision|0
818473|NCT02105987|2678332|P5|Early Switch Phase (24 Weeks)|Physician Decision|0
818474|NCT02105987|2678333|P4|Early Switch Phase (24 Weeks)|Physician Decision|0
818475|NCT02105987|2678334|P3|Early Switch Phase (24 Weeks)|Physician Decision|0
818476|NCT02105987|2678335|P2|Early Switch Phase (24 Weeks)|Physician Decision|3
818477|NCT02105987|2678336|P1|Early Switch Phase (24 Weeks)|Physician Decision|4
818478|NCT02105987|2678331|P6|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
818479|NCT02105987|2678332|P5|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
818480|NCT02105987|2678333|P4|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
818481|NCT02105987|2678334|P3|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
818482|NCT02105987|2678335|P2|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
818483|NCT02105987|2678336|P1|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
818484|NCT02105987|2678331|P6|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
818485|NCT02105987|2678332|P5|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
818486|NCT02105987|2678333|P4|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
818487|NCT02105987|2678334|P3|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
818488|NCT02105987|2678335|P2|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10
818489|NCT02105987|2678336|P1|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4
818490|NCT02105987|2678331|P6|Early Switch Phase (24 Weeks)|Protocol Violation|0
818491|NCT02105987|2678332|P5|Early Switch Phase (24 Weeks)|Protocol Violation|0
818492|NCT02105987|2678333|P4|Early Switch Phase (24 Weeks)|Protocol Violation|0
818493|NCT02105987|2678334|P3|Early Switch Phase (24 Weeks)|Protocol Violation|0
818494|NCT02105987|2678335|P2|Early Switch Phase (24 Weeks)|Protocol Violation|17
818495|NCT02105987|2678336|P1|Early Switch Phase (24 Weeks)|Protocol Violation|15
818496|NCT02105987|2678331|P6|Early Switch Phase (24 Weeks)|Adverse Event|0
818497|NCT02105987|2678332|P5|Early Switch Phase (24 Weeks)|Adverse Event|0
818498|NCT02105987|2678333|P4|Early Switch Phase (24 Weeks)|Adverse Event|0
818499|NCT02105987|2678334|P3|Early Switch Phase (24 Weeks)|Adverse Event|0
818500|NCT02105987|2678335|P2|Early Switch Phase (24 Weeks)|Adverse Event|0
818501|NCT02105987|2678336|P1|Early Switch Phase (24 Weeks)|Adverse Event|10
818502|NCT02105974|2678390|P3|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18
818503|NCT02105974|2678391|P2|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12
818504|NCT02105974|2678392|P1|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0
818505|NCT02105974|2678390|P3|12 Week (Wk) Treatment Period (TP)|Physician Decision|4
818506|NCT02105974|2678391|P2|12 Week (Wk) Treatment Period (TP)|Physician Decision|7
818507|NCT02105974|2678392|P1|12 Week (Wk) Treatment Period (TP)|Physician Decision|0
818508|NCT02105974|2678390|P3|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1
818509|NCT02105974|2678391|P2|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
818510|NCT02105974|2678392|P1|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
818511|NCT02105974|2678390|P3|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2
818512|NCT02105974|2678391|P2|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1
818513|NCT02105974|2678392|P1|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0
818514|NCT02105974|2678390|P3|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6
818515|NCT02105974|2678391|P2|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2
818516|NCT02105974|2678392|P1|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0
818517|NCT02105974|2678390|P3|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9
818518|NCT02105974|2678391|P2|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6
818519|NCT02105974|2678392|P1|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0
818520|NCT02105974|2678390|P3|12 Week (Wk) Treatment Period (TP)|Adverse Event|18
818521|NCT02105974|2678391|P2|12 Week (Wk) Treatment Period (TP)|Adverse Event|14
818522|NCT02105974|2678392|P1|12 Week (Wk) Treatment Period (TP)|Adverse Event|0
818523|NCT02105974|2678390|P3|2 Week Run-in Period|Investigator discretion|0
818524|NCT02105974|2678391|P2|2 Week Run-in Period|Investigator discretion|0
818525|NCT02105974|2678392|P1|2 Week Run-in Period|Investigator discretion|8
818526|NCT02105974|2678390|P3|2 Week Run-in Period|Withdrew consent|0
818527|NCT02105974|2678391|P2|2 Week Run-in Period|Withdrew consent|0
818528|NCT02105974|2678392|P1|2 Week Run-in Period|Withdrew consent|23
818529|NCT02105974|2678390|P3|2 Week Run-in Period|Lost to Follow-up|0
818530|NCT02105974|2678391|P2|2 Week Run-in Period|Lost to Follow-up|0
818531|NCT02105974|2678392|P1|2 Week Run-in Period|Lost to Follow-up|2
818532|NCT02105974|2678390|P3|2 Week Run-in Period|Study closed/terminated|0
818533|NCT02105974|2678391|P2|2 Week Run-in Period|Study closed/terminated|0
818534|NCT02105974|2678392|P1|2 Week Run-in Period|Study closed/terminated|1
818535|NCT02105974|2678390|P3|2 Week Run-in Period|Adverse Event|0
818536|NCT02105974|2678391|P2|2 Week Run-in Period|Adverse Event|0
818537|NCT02105974|2678392|P1|2 Week Run-in Period|Adverse Event|6
818538|NCT02105974|2678390|P3|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
818539|NCT02105974|2678391|P2|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
818540|NCT02105974|2678392|P1|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603
818541|NCT02105974|2678390|P3|2 Week Run-in Period|Withdrew during pre-screen period|0
818542|NCT02105974|2678391|P2|2 Week Run-in Period|Withdrew during pre-screen period|0
818543|NCT02105974|2678392|P1|2 Week Run-in Period|Withdrew during pre-screen period|158
818544|NCT02105961|2678405|P3|Overall Study|Withdrawal by Subject|11
818545|NCT02105961|2678406|P2|Overall Study|Withdrawal by Subject|7
818546|NCT02105961|2678407|P1|Overall Study|Withdrawal by Subject|15
818547|NCT02105961|2678405|P3|Overall Study|Physician Decision|2
818548|NCT02105961|2678406|P2|Overall Study|Physician Decision|3
818549|NCT02105961|2678407|P1|Overall Study|Physician Decision|3
818550|NCT02105961|2678405|P3|Overall Study|Lost to Follow-up|1
818551|NCT02105961|2678406|P2|Overall Study|Lost to Follow-up|0
818552|NCT02105961|2678407|P1|Overall Study|Lost to Follow-up|2
818553|NCT02105961|2678405|P3|Overall Study|Lack of Efficacy|3
818554|NCT02105961|2678406|P2|Overall Study|Lack of Efficacy|0
818555|NCT02105961|2678407|P1|Overall Study|Lack of Efficacy|3
818556|NCT02105961|2678405|P3|Overall Study|Adverse Event|13
818557|NCT02105961|2678406|P2|Overall Study|Adverse Event|7
818558|NCT02105961|2678407|P1|Overall Study|Adverse Event|18
818559|NCT02105948|2678431|P4|Overall Study|Withdrawal by Subject|11
818560|NCT02105948|2678432|P3|Overall Study|Withdrawal by Subject|10
818561|NCT02105948|2678433|P2|Overall Study|Withdrawal by Subject|10
818562|NCT02105948|2678434|P1|Overall Study|Withdrawal by Subject|15
818563|NCT02105948|2678431|P4|Overall Study|Physician Decision|2
818564|NCT02105948|2678432|P3|Overall Study|Physician Decision|2
818565|NCT02105948|2678433|P2|Overall Study|Physician Decision|2
818566|NCT02105948|2678434|P1|Overall Study|Physician Decision|2
818567|NCT02105948|2678431|P4|Overall Study|Lost to Follow-up|1
818568|NCT02105948|2678432|P3|Overall Study|Lost to Follow-up|2
818569|NCT02105948|2678433|P2|Overall Study|Lost to Follow-up|0
818570|NCT02105948|2678434|P1|Overall Study|Lost to Follow-up|0
818571|NCT02105948|2678431|P4|Overall Study|Lack of Efficacy|2
818572|NCT02105948|2678432|P3|Overall Study|Lack of Efficacy|3
818573|NCT02105948|2678433|P2|Overall Study|Lack of Efficacy|1
818574|NCT02105948|2678434|P1|Overall Study|Lack of Efficacy|0
818575|NCT02105948|2678431|P4|Overall Study|Adverse Event|11
818576|NCT02105948|2678432|P3|Overall Study|Adverse Event|11
818577|NCT02105948|2678433|P2|Overall Study|Adverse Event|7
818578|NCT02105948|2678434|P1|Overall Study|Adverse Event|10
818579|NCT02105701|2678475|P4|Overall Study|Death|0
818580|NCT02105701|2678476|P3|Overall Study|Death|0
818581|NCT02105701|2678477|P2|Overall Study|Death|0
818582|NCT02105701|2678478|P1|Overall Study|Death|1
818583|NCT02105701|2678475|P4|Overall Study|Withdrawal by Subject|1
818584|NCT02105701|2678476|P3|Overall Study|Withdrawal by Subject|0
818585|NCT02105701|2678477|P2|Overall Study|Withdrawal by Subject|1
818586|NCT02105701|2678478|P1|Overall Study|Withdrawal by Subject|2
818587|NCT02105701|2678475|P4|Overall Study|Protocol Violation|0
818588|NCT02105701|2678476|P3|Overall Study|Protocol Violation|1
818589|NCT02105701|2678477|P2|Overall Study|Protocol Violation|0
818590|NCT02105701|2678478|P1|Overall Study|Protocol Violation|0
818591|NCT02105701|2678475|P4|Overall Study|Lost to Follow-up|1
818592|NCT02105701|2678476|P3|Overall Study|Lost to Follow-up|2
818593|NCT02105701|2678477|P2|Overall Study|Lost to Follow-up|0
818594|NCT02105701|2678478|P1|Overall Study|Lost to Follow-up|1
818595|NCT02105688|2678502|P2|Overall Study|Withdrawal by Subject|2
818596|NCT02105688|2678503|P1|Overall Study|Withdrawal by Subject|4
818597|NCT02105688|2678502|P2|Overall Study|Protocol Violation|1
818598|NCT02105688|2678503|P1|Overall Study|Protocol Violation|0
818599|NCT02105688|2678502|P2|Overall Study|Physician Decision|1
818600|NCT02105688|2678503|P1|Overall Study|Physician Decision|0
818601|NCT02105688|2678502|P2|Overall Study|Lost to Follow-up|4
818602|NCT02105688|2678503|P1|Overall Study|Lost to Follow-up|9
818603|NCT02105688|2678502|P2|Overall Study|Adverse Event|1
818604|NCT02105688|2678503|P1|Overall Study|Adverse Event|1
818605|NCT02105688|2678502|P2|Overall Study|Ongoing|90
818606|NCT02105688|2678503|P1|Overall Study|Ongoing|12
818607|NCT02105662|2678513|P1|Overall Study|Withdrawal by Subject|1
818608|NCT02105662|2678513|P1|Overall Study|Lost to Follow-up|5
818609|NCT02105636|2678522|P2|Overall Study|Not Reported|0
818610|NCT02105636|2678523|P1|Overall Study|Not Reported|3
818611|NCT02105636|2678522|P2|Overall Study|Reason Not Specified|2
818612|NCT02105636|2678523|P1|Overall Study|Reason Not Specified|0
818613|NCT02105636|2678522|P2|Overall Study|Poor/Non-compliance|1
818614|NCT02105636|2678523|P1|Overall Study|Poor/Non-compliance|0
818615|NCT02105636|2678522|P2|Overall Study|Maximum Clinical Benefit|1
818616|NCT02105636|2678523|P1|Overall Study|Maximum Clinical Benefit|1
818617|NCT02105636|2678522|P2|Overall Study|Subject Withdrew Consent|1
818618|NCT02105636|2678523|P1|Overall Study|Subject Withdrew Consent|4
818619|NCT02105636|2678522|P2|Overall Study|Subject Request to Discontinue Treatment|6
818620|NCT02105636|2678523|P1|Overall Study|Subject Request to Discontinue Treatment|4
818621|NCT02105636|2678522|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
818622|NCT02105636|2678523|P1|Overall Study|Adverse Event Unrelated to Study Drug|12
818623|NCT02105636|2678522|P2|Overall Study|Study Drug Toxicity|11
818624|NCT02105636|2678523|P1|Overall Study|Study Drug Toxicity|9
818625|NCT02105636|2678522|P2|Overall Study|Disease Progression|83
818626|NCT02105636|2678523|P1|Overall Study|Disease Progression|162
818627|NCT02105467|2678566|P2|Period 3|Lost to Follow-up|1
818628|NCT02105467|2678567|P1|Period 3|Lost to Follow-up|0
818629|NCT02105467|2678566|P2|Period 2|Withdrawal by Subject|2
818630|NCT02105467|2678567|P1|Period 2|Withdrawal by Subject|0
818631|NCT02105467|2678566|P2|Period 2|Death|0
818632|NCT02105467|2678567|P1|Period 2|Death|1
818633|NCT02105467|2678566|P2|Period 2|Lost to Follow-up|0
818634|NCT02105467|2678567|P1|Period 2|Lost to Follow-up|1
818635|NCT02105467|2678566|P2|Period 1|Death|0
818636|NCT02105467|2678567|P1|Period 1|Death|1
818637|NCT02105467|2678566|P2|Period 1|Lost to Follow-up|0
818638|NCT02105467|2678567|P1|Period 1|Lost to Follow-up|1
818639|NCT02105454|2678579|P1|Overall Study|Withdrawal by Subject|1
818640|NCT02105285|2678666|P3|Overall Study|Withdrawal by Subject|0
818641|NCT02105285|2678667|P2|Overall Study|Withdrawal by Subject|0
818642|NCT02105285|2678668|P1|Overall Study|Withdrawal by Subject|1
818643|NCT02105285|2678666|P3|Overall Study|Protocol Violation|0
818644|NCT02105285|2678667|P2|Overall Study|Protocol Violation|1
818645|NCT02105285|2678668|P1|Overall Study|Protocol Violation|0
818646|NCT02105285|2678666|P3|Overall Study|Adverse Event|0
818647|NCT02105285|2678667|P2|Overall Study|Adverse Event|1
818648|NCT02105285|2678668|P1|Overall Study|Adverse Event|1
818649|NCT02105272|2678687|P2|Overall Study|Withdrawal by Subject|0
818650|NCT02105272|2678688|P1|Overall Study|Withdrawal by Subject|2
818651|NCT02105272|2678687|P2|Overall Study|Protocol Violation|0
818652|NCT02105272|2678688|P1|Overall Study|Protocol Violation|2
818653|NCT02105272|2678687|P2|Overall Study|Physician Decision|1
818654|NCT02105272|2678688|P1|Overall Study|Physician Decision|0
818655|NCT02105272|2678687|P2|Overall Study|Adverse Event|2
818656|NCT02105272|2678688|P1|Overall Study|Adverse Event|1
818657|NCT02105116|2678704|P1|Overall Study|Death|1
818658|NCT02105116|2678704|P1|Overall Study|not eligible for step 2 of trial|5
818659|NCT02105012|2678711|P1|Overall Study|Lack of Efficacy|1
818660|NCT02105012|2678711|P1|Overall Study|Adverse Event|1
818661|NCT02105012|2678711|P1|Overall Study|Physician Decision|3
818662|NCT02105012|2678711|P1|Overall Study|Protocol Violation|4
818663|NCT02105012|2678711|P1|Overall Study|Lost to Follow-up|4
818664|NCT02105012|2678711|P1|Overall Study|Protocol Specified Criteria|9
818665|NCT02105012|2678711|P1|Overall Study|Withdrawal by Subject|11
818666|NCT02104947|2678745|P2|Overall Study|Other than stated above|3
818667|NCT02104947|2678746|P1|Overall Study|Other than stated above|2
818668|NCT02104947|2678745|P2|Overall Study|Adverse Event|38
818669|NCT02104947|2678746|P1|Overall Study|Adverse Event|57
818670|NCT02104947|2678745|P2|Overall Study|Protocol Violation|8
818671|NCT02104947|2678746|P1|Overall Study|Protocol Violation|6
818672|NCT02104947|2678745|P2|Overall Study|Lost to Follow-up|4
818673|NCT02104947|2678746|P1|Overall Study|Lost to Follow-up|4
818674|NCT02104947|2678745|P2|Overall Study|Withdrawal by Subject|3
818675|NCT02104947|2678746|P1|Overall Study|Withdrawal by Subject|10
818676|NCT02104895|2678764|P2|Overall Study|Withdrawal by Subject|14
818677|NCT02104895|2678765|P1|Overall Study|Withdrawal by Subject|0
818678|NCT02104804|2678805|P2|Overall Study|Withdrawal by Subject|12
818679|NCT02104804|2678806|P1|Overall Study|Withdrawal by Subject|4
818680|NCT02104804|2678805|P2|Overall Study|Adverse Event|3
818681|NCT02104804|2678806|P1|Overall Study|Adverse Event|4
818682|NCT02104804|2678805|P2|Overall Study|Protocol Violation|1
818683|NCT02104804|2678806|P1|Overall Study|Protocol Violation|0
818684|NCT02104804|2678805|P2|Overall Study|Other listed|1
818685|NCT02104804|2678806|P1|Overall Study|Other listed|2
818686|NCT02104804|2678805|P2|Overall Study|Study specific discontinuation criteria|1
818687|NCT02104804|2678806|P1|Overall Study|Study specific discontinuation criteria|6
818688|NCT02104804|2678805|P2|Overall Study|Did not take study medication|1
818689|NCT02104804|2678806|P1|Overall Study|Did not take study medication|0
818690|NCT02104505|2678888|P2|Second Intervention (14 Days)|Adverse Event|0
818691|NCT02104505|2678889|P1|Second Intervention (14 Days)|Adverse Event|2
818692|NCT02104505|2678888|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
818693|NCT02104505|2678889|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
818694|NCT02104505|2678888|P2|First Intervention (14 Days)|exclusionary condition|1
818695|NCT02104505|2678889|P1|First Intervention (14 Days)|exclusionary condition|0
818696|NCT02104505|2678888|P2|First Intervention (14 Days)|Lost to Follow-up|1
818697|NCT02104505|2678889|P1|First Intervention (14 Days)|Lost to Follow-up|0
818698|NCT02104505|2678888|P2|First Intervention (14 Days)|Withdrawal by Subject|1
818699|NCT02104505|2678889|P1|First Intervention (14 Days)|Withdrawal by Subject|0
818700|NCT02104505|2678888|P2|First Intervention (14 Days)|Adverse Event|0
818701|NCT02104505|2678889|P1|First Intervention (14 Days)|Adverse Event|2
818702|NCT02103439|2678945|P2|Overall Study|Withdrawal by Subject|1
818703|NCT02103439|2678946|P1|Overall Study|Withdrawal by Subject|3
818704|NCT02103439|2678945|P2|Overall Study|Adverse Event|2
818705|NCT02103439|2678946|P1|Overall Study|Adverse Event|0
818706|NCT02103062|2679038|P2|Overall Study|Death|1
818707|NCT02103062|2679039|P1|Overall Study|Death|0
818708|NCT02103062|2679038|P2|Overall Study|Progressive Disease|20
818709|NCT02103062|2679039|P1|Overall Study|Progressive Disease|17
818710|NCT02103062|2679038|P2|Overall Study|Adverse Event|2
818711|NCT02103062|2679039|P1|Overall Study|Adverse Event|1
818712|NCT02102490|2679130|P1|Overall Study|Lost to Follow-up|1
818713|NCT02102490|2679130|P1|Overall Study|Death|5
818714|NCT02102490|2679130|P1|Overall Study|Adverse Event|3
818715|NCT02102464|2679144|P3|Randomized Study|Withdrawal by Subject|0
818716|NCT02102464|2679145|P2|Randomized Study|Withdrawal by Subject|1
818717|NCT02102464|2679146|P1|Randomized Study|Withdrawal by Subject|0
818718|NCT02102399|2679165|P2|Overall Study|Withdrawal by Subject|4
818719|NCT02102399|2679166|P1|Overall Study|Withdrawal by Subject|6
818720|NCT02102204|2679214|P1|Overall Study|Ongoing|5
818721|NCT02102204|2679214|P1|Overall Study|Sponsor Decision|5
818722|NCT02102204|2679214|P1|Overall Study|Lost to Follow-up|65
818723|NCT02102204|2679214|P1|Overall Study|Death|92
818724|NCT02102204|2679214|P1|Overall Study|Withdrawal by Subject|137
818725|NCT02101983|2679225|P2|Overall Study|Physician Decision|0
818726|NCT02101983|2679226|P1|Overall Study|Physician Decision|1
818727|NCT02101359|2679279|P2|Overall Study|Protocol Violation|2
818728|NCT02101359|2679280|P1|Overall Study|Protocol Violation|0
818729|NCT02101359|2679279|P2|Overall Study|Lost to Follow-up|0
818730|NCT02101359|2679280|P1|Overall Study|Lost to Follow-up|1
818731|NCT02101359|2679279|P2|Overall Study|Withdrawal by Subject|4
818732|NCT02101359|2679280|P1|Overall Study|Withdrawal by Subject|5
818733|NCT02101359|2679279|P2|Overall Study|Not included|13
818734|NCT02101359|2679280|P1|Overall Study|Not included|23
818735|NCT02101294|2679286|P1|Overall Study|Lost to Follow-up|6
818736|NCT02101294|2679286|P1|Overall Study|Withdrawal by Subject|5
818737|NCT02101112|2679306|P6|Overall Study|Withdrawal by Subject|0
818738|NCT02101112|2679307|P5|Overall Study|Withdrawal by Subject|1
818739|NCT02101112|2679308|P4|Overall Study|Withdrawal by Subject|0
818740|NCT02101112|2679309|P3|Overall Study|Withdrawal by Subject|0
818741|NCT02101112|2679310|P2|Overall Study|Withdrawal by Subject|0
818742|NCT02101112|2679311|P1|Overall Study|Withdrawal by Subject|0
818743|NCT02101112|2679306|P6|Overall Study|Adverse Event|0
818744|NCT02101112|2679307|P5|Overall Study|Adverse Event|0
818745|NCT02101112|2679308|P4|Overall Study|Adverse Event|0
818746|NCT02101112|2679309|P3|Overall Study|Adverse Event|1
818747|NCT02101112|2679310|P2|Overall Study|Adverse Event|0
818748|NCT02101112|2679311|P1|Overall Study|Adverse Event|0
818749|NCT02101021|2679341|P5|Overall Study|Study Terminated by Sponsor|1
818750|NCT02101021|2679342|P4|Overall Study|Study Terminated by Sponsor|1
818751|NCT02101021|2679343|P3|Overall Study|Study Terminated by Sponsor|1
818752|NCT02101021|2679344|P2|Overall Study|Study Terminated by Sponsor|0
818753|NCT02101021|2679345|P1|Overall Study|Study Terminated by Sponsor|1
818754|NCT02101021|2679341|P5|Overall Study|Lost to Follow-up|0
818755|NCT02101021|2679342|P4|Overall Study|Lost to Follow-up|0
818756|NCT02101021|2679343|P3|Overall Study|Lost to Follow-up|0
818757|NCT02101021|2679344|P2|Overall Study|Lost to Follow-up|0
818758|NCT02101021|2679345|P1|Overall Study|Lost to Follow-up|1
818759|NCT02101021|2679341|P5|Overall Study|Withdrew Consent from study|0
818760|NCT02101021|2679342|P4|Overall Study|Withdrew Consent from study|2
818761|NCT02101021|2679343|P3|Overall Study|Withdrew Consent from study|0
818762|NCT02101021|2679344|P2|Overall Study|Withdrew Consent from study|1
818763|NCT02101021|2679345|P1|Overall Study|Withdrew Consent from study|1
818764|NCT02101021|2679341|P5|Overall Study|Death|3
818765|NCT02101021|2679342|P4|Overall Study|Death|0
818766|NCT02101021|2679343|P3|Overall Study|Death|6
818767|NCT02101021|2679344|P2|Overall Study|Death|3
818768|NCT02101021|2679345|P1|Overall Study|Death|4
818769|NCT02100839|2679394|P2|Multiple Ascending Dose|Withdrawal by Subject|0
818770|NCT02100839|2679395|P1|Multiple Ascending Dose|Withdrawal by Subject|2
818771|NCT02100839|2679394|P2|Multiple Ascending Dose|Adverse Event|0
818772|NCT02100839|2679395|P1|Multiple Ascending Dose|Adverse Event|2
818773|NCT02100670|2679422|P4|Overall Study|Withdrawal by Subject|0
818774|NCT02100670|2679423|P3|Overall Study|Withdrawal by Subject|0
818775|NCT02100670|2679424|P2|Overall Study|Withdrawal by Subject|0
818776|NCT02100670|2679425|P1|Overall Study|Withdrawal by Subject|1
818777|NCT02100670|2679422|P4|Overall Study|Physician Decision|0
818778|NCT02100670|2679423|P3|Overall Study|Physician Decision|0
818779|NCT02100670|2679424|P2|Overall Study|Physician Decision|1
818780|NCT02100670|2679425|P1|Overall Study|Physician Decision|0
818781|NCT02100670|2679422|P4|Overall Study|Poor Efficacy|0
818782|NCT02100670|2679423|P3|Overall Study|Poor Efficacy|0
818783|NCT02100670|2679424|P2|Overall Study|Poor Efficacy|1
818784|NCT02100670|2679425|P1|Overall Study|Poor Efficacy|0
818785|NCT02100670|2679422|P4|Overall Study|No swelling no pain|0
818786|NCT02100670|2679423|P3|Overall Study|No swelling no pain|0
818787|NCT02100670|2679424|P2|Overall Study|No swelling no pain|0
818788|NCT02100670|2679425|P1|Overall Study|No swelling no pain|1
818789|NCT02100670|2679422|P4|Overall Study|Withdrawal of Consent|0
818790|NCT02100670|2679423|P3|Overall Study|Withdrawal of Consent|1
818791|NCT02100670|2679424|P2|Overall Study|Withdrawal of Consent|1
818792|NCT02100670|2679425|P1|Overall Study|Withdrawal of Consent|0
818793|NCT02100670|2679422|P4|Overall Study|Protocol Violation|1
818794|NCT02100670|2679423|P3|Overall Study|Protocol Violation|0
818795|NCT02100670|2679424|P2|Overall Study|Protocol Violation|1
818796|NCT02100670|2679425|P1|Overall Study|Protocol Violation|0
818797|NCT02100670|2679422|P4|Overall Study|Lost to Follow-up|0
818798|NCT02100670|2679423|P3|Overall Study|Lost to Follow-up|0
818799|NCT02100670|2679424|P2|Overall Study|Lost to Follow-up|0
818800|NCT02100670|2679425|P1|Overall Study|Lost to Follow-up|1
818801|NCT02100670|2679422|P4|Overall Study|Adverse Event|0
818802|NCT02100670|2679423|P3|Overall Study|Adverse Event|3
818803|NCT02100670|2679424|P2|Overall Study|Adverse Event|3
818804|NCT02100670|2679425|P1|Overall Study|Adverse Event|10
818805|NCT02100644|2679485|P3|LTG Escalation Phase|Withdrawal by Subject|0
818806|NCT02100644|2679486|P2|LTG Escalation Phase|Withdrawal by Subject|0
818807|NCT02100644|2679487|P1|LTG Escalation Phase|Withdrawal by Subject|3
818808|NCT02100644|2679485|P3|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
818809|NCT02100644|2679486|P2|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
818810|NCT02100644|2679487|P1|LTG Escalation Phase|Protocol-defined Stopping Criteria|1
818811|NCT02100644|2679485|P3|LTG Escalation Phase|Adverse Event|0
818812|NCT02100644|2679486|P2|LTG Escalation Phase|Adverse Event|0
818813|NCT02100644|2679487|P1|LTG Escalation Phase|Adverse Event|9
818814|NCT02100514|2679512|P5|Extension Period|Withdrew consent|0
818815|NCT02100514|2679513|P4|Extension Period|Withdrew consent|0
818816|NCT02100514|2679514|P3|Extension Period|Withdrew consent|2
818817|NCT02100514|2679515|P2|Extension Period|Withdrew consent|0
818818|NCT02100514|2679516|P1|Extension Period|Withdrew consent|0
818819|NCT02100514|2679512|P5|Treatment Period|Other|0
818820|NCT02100514|2679513|P4|Treatment Period|Other|0
818821|NCT02100514|2679514|P3|Treatment Period|Other|0
818822|NCT02100514|2679515|P2|Treatment Period|Other|11
818823|NCT02100514|2679516|P1|Treatment Period|Other|9
818824|NCT02100514|2679512|P5|Treatment Period|Withdrawal by Subject|0
818825|NCT02100514|2679513|P4|Treatment Period|Withdrawal by Subject|0
818826|NCT02100514|2679514|P3|Treatment Period|Withdrawal by Subject|0
818827|NCT02100514|2679515|P2|Treatment Period|Withdrawal by Subject|37
818828|NCT02100514|2679516|P1|Treatment Period|Withdrawal by Subject|12
818829|NCT02100514|2679512|P5|Treatment Period|Protocol Violation|0
818830|NCT02100514|2679513|P4|Treatment Period|Protocol Violation|0
818831|NCT02100514|2679514|P3|Treatment Period|Protocol Violation|0
818832|NCT02100514|2679515|P2|Treatment Period|Protocol Violation|1
818833|NCT02100514|2679516|P1|Treatment Period|Protocol Violation|1
818834|NCT02100514|2679512|P5|Treatment Period|Did Not Meet Entrance Criteria|0
818835|NCT02100514|2679513|P4|Treatment Period|Did Not Meet Entrance Criteria|0
818836|NCT02100514|2679514|P3|Treatment Period|Did Not Meet Entrance Criteria|0
818837|NCT02100514|2679515|P2|Treatment Period|Did Not Meet Entrance Criteria|1
818838|NCT02100514|2679516|P1|Treatment Period|Did Not Meet Entrance Criteria|0
818839|NCT02100514|2679512|P5|Treatment Period|Lost to Follow-up|0
818840|NCT02100514|2679513|P4|Treatment Period|Lost to Follow-up|0
818841|NCT02100514|2679514|P3|Treatment Period|Lost to Follow-up|0
818842|NCT02100514|2679515|P2|Treatment Period|Lost to Follow-up|17
818843|NCT02100514|2679516|P1|Treatment Period|Lost to Follow-up|5
818844|NCT02100514|2679512|P5|Treatment Period|Death|0
818845|NCT02100514|2679513|P4|Treatment Period|Death|0
818846|NCT02100514|2679514|P3|Treatment Period|Death|0
818847|NCT02100514|2679515|P2|Treatment Period|Death|2
818848|NCT02100514|2679516|P1|Treatment Period|Death|2
818849|NCT02100514|2679512|P5|Treatment Period|Adverse Event|0
818850|NCT02100514|2679513|P4|Treatment Period|Adverse Event|0
818851|NCT02100514|2679514|P3|Treatment Period|Adverse Event|0
818852|NCT02100514|2679515|P2|Treatment Period|Adverse Event|5
818853|NCT02100514|2679516|P1|Treatment Period|Adverse Event|0
818854|NCT02100475|2679584|P2|Overall Study|Withdrawal criteria|0
818855|NCT02100475|2679585|P1|Overall Study|Withdrawal criteria|1
818856|NCT02100475|2679584|P2|Overall Study|Unclassified|2
818857|NCT02100475|2679585|P1|Overall Study|Unclassified|1
818858|NCT02100228|2679635|P2|Overall Study|Death|1
818859|NCT02100228|2679636|P1|Overall Study|Death|1
818860|NCT02100228|2679635|P2|Overall Study|Adverse Event|12
818861|NCT02100228|2679636|P1|Overall Study|Adverse Event|16
818862|NCT02100228|2679635|P2|Overall Study|Withdrawal by Subject|37
818863|NCT02100228|2679636|P1|Overall Study|Withdrawal by Subject|27
818864|NCT02100228|2679635|P2|Overall Study|Lost to Follow-up|1
818865|NCT02100228|2679636|P1|Overall Study|Lost to Follow-up|0
818866|NCT02100228|2679635|P2|Overall Study|Non-compliance|3
818867|NCT02100228|2679636|P1|Overall Study|Non-compliance|0
818868|NCT02100228|2679635|P2|Overall Study|Inclusion/Exclusion criteria not met|16
818869|NCT02100228|2679636|P1|Overall Study|Inclusion/Exclusion criteria not met|12
818870|NCT02100228|2679635|P2|Overall Study|Administrative reason|1
818871|NCT02100228|2679636|P1|Overall Study|Administrative reason|0
818872|NCT02100228|2679635|P2|Overall Study|Other|19
818873|NCT02100228|2679636|P1|Overall Study|Other|19
818874|NCT02100124|2679672|P3|Overall Study|Withdrawal by Subject|0
818875|NCT02100124|2679673|P2|Overall Study|Withdrawal by Subject|0
818876|NCT02100124|2679674|P1|Overall Study|Withdrawal by Subject|1
818877|NCT02100124|2679672|P3|Overall Study|Lost to Follow-up|3
818878|NCT02100124|2679673|P2|Overall Study|Lost to Follow-up|11
818879|NCT02100124|2679674|P1|Overall Study|Lost to Follow-up|5
818880|NCT02099838|2679704|P2|Overall Study|Withdrawal by Subject|1
818881|NCT02099838|2679705|P1|Overall Study|Withdrawal by Subject|0
818882|NCT02099838|2679704|P2|Overall Study|Lost to Follow-up|1
818883|NCT02099838|2679705|P1|Overall Study|Lost to Follow-up|3
818884|NCT02099838|2679704|P2|Overall Study|Death|0
818885|NCT02099838|2679705|P1|Overall Study|Death|1
818886|NCT02099708|2679735|P1|Overall Study|Other|29
818887|NCT02099708|2679735|P1|Overall Study|Lost to Follow-up|141
818888|NCT02099708|2679735|P1|Overall Study|Data Not Available|30
818889|NCT02099682|2679746|P1|Overall Study|Other|29
818890|NCT02099682|2679746|P1|Overall Study|Lost to Follow-up|31
818891|NCT02099682|2679746|P1|Overall Study|Data Not Available|51
818892|NCT02099344|2679772|P2|Overall Study|Physician Decision|0
818893|NCT02099344|2679773|P1|Overall Study|Physician Decision|1
818894|NCT02099110|2679810|P5|Overall Study|Physician Decision|1
818895|NCT02099110|2679811|P4|Overall Study|Physician Decision|2
818896|NCT02099110|2679812|P3|Overall Study|Physician Decision|1
818897|NCT02099110|2679813|P2|Overall Study|Physician Decision|0
818898|NCT02099110|2679814|P1|Overall Study|Physician Decision|3
818899|NCT02099110|2679810|P5|Overall Study|Non-compliance with study drug|1
818900|NCT02099110|2679811|P4|Overall Study|Non-compliance with study drug|0
818901|NCT02099110|2679812|P3|Overall Study|Non-compliance with study drug|0
818902|NCT02099110|2679813|P2|Overall Study|Non-compliance with study drug|0
818903|NCT02099110|2679814|P1|Overall Study|Non-compliance with study drug|2
818904|NCT02099110|2679810|P5|Overall Study|Screen failure|1
818905|NCT02099110|2679811|P4|Overall Study|Screen failure|0
818906|NCT02099110|2679812|P3|Overall Study|Screen failure|0
818907|NCT02099110|2679813|P2|Overall Study|Screen failure|0
818908|NCT02099110|2679814|P1|Overall Study|Screen failure|0
818909|NCT02099110|2679810|P5|Overall Study|Death|0
818910|NCT02099110|2679811|P4|Overall Study|Death|0
818911|NCT02099110|2679812|P3|Overall Study|Death|0
818912|NCT02099110|2679813|P2|Overall Study|Death|1
818913|NCT02099110|2679814|P1|Overall Study|Death|0
818914|NCT02099110|2679810|P5|Overall Study|Lost to Follow-up|6
818915|NCT02099110|2679811|P4|Overall Study|Lost to Follow-up|5
818916|NCT02099110|2679812|P3|Overall Study|Lost to Follow-up|11
818917|NCT02099110|2679813|P2|Overall Study|Lost to Follow-up|12
818918|NCT02099110|2679814|P1|Overall Study|Lost to Follow-up|6
818919|NCT02099110|2679810|P5|Overall Study|Adverse Event|2
818920|NCT02099110|2679811|P4|Overall Study|Adverse Event|3
818921|NCT02099110|2679812|P3|Overall Study|Adverse Event|2
818922|NCT02099110|2679813|P2|Overall Study|Adverse Event|5
818923|NCT02099110|2679814|P1|Overall Study|Adverse Event|3
818924|NCT02099110|2679810|P5|Overall Study|Withdrawal by Subject|13
818925|NCT02099110|2679811|P4|Overall Study|Withdrawal by Subject|9
818926|NCT02099110|2679812|P3|Overall Study|Withdrawal by Subject|13
818927|NCT02099110|2679813|P2|Overall Study|Withdrawal by Subject|11
818928|NCT02099110|2679814|P1|Overall Study|Withdrawal by Subject|7
818929|NCT02099110|2679810|P5|Overall Study|Participant moved|2
818930|NCT02099110|2679811|P4|Overall Study|Participant moved|0
818931|NCT02099110|2679812|P3|Overall Study|Participant moved|1
818932|NCT02099110|2679813|P2|Overall Study|Participant moved|1
818933|NCT02099110|2679814|P1|Overall Study|Participant moved|1
818934|NCT02099110|2679810|P5|Overall Study|Protocol Violation|1
818935|NCT02099110|2679811|P4|Overall Study|Protocol Violation|3
818936|NCT02099110|2679812|P3|Overall Study|Protocol Violation|0
818937|NCT02099110|2679813|P2|Overall Study|Protocol Violation|1
818938|NCT02099110|2679814|P1|Overall Study|Protocol Violation|2
818939|NCT02098746|2679888|P1|Overall Study|Data Not Available After Treatment|1
818940|NCT02098746|2679888|P1|Overall Study|Enrolled 15 Days After the First Dose|1
818941|NCT02098746|2679888|P1|Overall Study|Other Miscellaneous Reasons|1
818942|NCT02098746|2679888|P1|Overall Study|Changes of Investigator|2
818943|NCT02098733|2679896|P1|Overall Study|Lost to Follow-up|5
818944|NCT02098733|2679896|P1|Overall Study|Data Not Available|5
818945|NCT02098395|2679910|P4|Overall Study|Unclassified|2
818946|NCT02098395|2679911|P3|Overall Study|Unclassified|3
818947|NCT02098395|2679912|P2|Overall Study|Unclassified|0
818948|NCT02098395|2679913|P1|Overall Study|Unclassified|0
818949|NCT02098395|2679910|P4|Overall Study|Lost to Follow-up|3
818950|NCT02098395|2679911|P3|Overall Study|Lost to Follow-up|0
818951|NCT02098395|2679912|P2|Overall Study|Lost to Follow-up|1
818952|NCT02098395|2679913|P1|Overall Study|Lost to Follow-up|2
818953|NCT02098395|2679910|P4|Overall Study|Adverse Event|2
818954|NCT02098395|2679911|P3|Overall Study|Adverse Event|34
818955|NCT02098395|2679912|P2|Overall Study|Adverse Event|19
818956|NCT02098395|2679913|P1|Overall Study|Adverse Event|12
818957|NCT02098395|2679910|P4|Overall Study|Withdrawal by Subject|13
818958|NCT02098395|2679911|P3|Overall Study|Withdrawal by Subject|5
818959|NCT02098395|2679912|P2|Overall Study|Withdrawal by Subject|10
818960|NCT02098395|2679913|P1|Overall Study|Withdrawal by Subject|10
818961|NCT02098395|2679910|P4|Overall Study|Protocol Violation|7
818962|NCT02098395|2679911|P3|Overall Study|Protocol Violation|0
818963|NCT02098395|2679912|P2|Overall Study|Protocol Violation|2
818964|NCT02098395|2679913|P1|Overall Study|Protocol Violation|2
818965|NCT02098369|2679934|P3|Overall Study|Other|1
818966|NCT02098369|2679935|P2|Overall Study|Other|2
818967|NCT02098369|2679936|P1|Overall Study|Other|0
818968|NCT02098369|2679934|P3|Overall Study|Death|1
818969|NCT02098369|2679935|P2|Overall Study|Death|1
818970|NCT02098369|2679936|P1|Overall Study|Death|1
818971|NCT02098369|2679934|P3|Overall Study|Lost to Follow-up|3
818972|NCT02098369|2679935|P2|Overall Study|Lost to Follow-up|1
818973|NCT02098369|2679936|P1|Overall Study|Lost to Follow-up|5
818974|NCT02098369|2679934|P3|Overall Study|Withdrawal by Subject|0
818975|NCT02098369|2679935|P2|Overall Study|Withdrawal by Subject|5
818976|NCT02098369|2679936|P1|Overall Study|Withdrawal by Subject|1
818977|NCT02098109|2679974|P2|Overall Study|Protocol Violation|0
818978|NCT02098109|2679975|P1|Overall Study|Protocol Violation|3
818979|NCT02097823|2680053|P2|Overall Study|Withdrawal by Subject|1
818980|NCT02097823|2680054|P1|Overall Study|Withdrawal by Subject|1
818981|NCT02097745|2680069|P1|Overall Study|Reason Not Specified|96
818982|NCT02097745|2680069|P1|Overall Study|Administrative/Other|27
818983|NCT02097745|2680069|P1|Overall Study|Failure to Return|14
818984|NCT02097745|2680069|P1|Overall Study|Death|16
818985|NCT02097745|2680069|P1|Overall Study|Adverse Event|25
818986|NCT02097719|2680105|P2|Overall Study|Adverse Event|0
818987|NCT02097719|2680106|P1|Overall Study|Adverse Event|2
818988|NCT02097719|2680105|P2|Overall Study|Lost to Follow-up|1
818989|NCT02097719|2680106|P1|Overall Study|Lost to Follow-up|0
818990|NCT02097719|2680105|P2|Overall Study|Subject Withdrew Consent|0
818991|NCT02097719|2680106|P1|Overall Study|Subject Withdrew Consent|1
818992|NCT02097472|2680126|P8|Received Vaccination 2|Adverse Event|0
818993|NCT02097472|2680127|P7|Received Vaccination 2|Adverse Event|1
818994|NCT02097472|2680128|P6|Received Vaccination 2|Adverse Event|0
818995|NCT02097472|2680129|P5|Received Vaccination 2|Adverse Event|0
818996|NCT02097472|2680130|P4|Received Vaccination 2|Adverse Event|0
818997|NCT02097472|2680131|P3|Received Vaccination 2|Adverse Event|0
818998|NCT02097472|2680132|P2|Received Vaccination 2|Adverse Event|0
818999|NCT02097472|2680133|P1|Received Vaccination 2|Adverse Event|0
819000|NCT02097290|2680564|P1|Overall Study|Attempt|8
819001|NCT02097290|2680564|P1|Overall Study|Total Withdrawals|3
819002|NCT02097290|2680564|P1|Overall Study|Death|6
819003|NCT02097238|2680574|P1|Overall Study|Progressive Disease|17
819004|NCT02097238|2680574|P1|Overall Study|Physician Decision|1
819005|NCT02097238|2680574|P1|Overall Study|Death|1
819006|NCT02097134|2680580|P1|Overall Study|Refusal of Further Protocol Therapy|1
819007|NCT02097134|2680580|P1|Overall Study|Progressive Disease|3
819008|NCT02097134|2680580|P1|Overall Study|Non-Protocol Therapy|1
819009|NCT02097134|2680580|P1|Overall Study|Physician Decision|4
819010|NCT02097108|2680584|P1|Overall Study|patient was abroad for 6 months|1
819011|NCT02097108|2680584|P1|Overall Study|Adverse Event|1
819012|NCT02097056|2680591|P1|Overall Study|Not specified|2
819013|NCT02097056|2680591|P1|Overall Study|Adverse Event|37
819014|NCT02097056|2680591|P1|Overall Study|Lost to Follow-up|2
819015|NCT02097056|2680591|P1|Overall Study|Withdrawal by Subject|15
819016|NCT02097056|2680591|P1|Overall Study|Protocol Violation|2
819017|NCT02097030|2680599|P2|First Intervention (3 Days)|Visual Acuity|1
819018|NCT02097030|2680600|P1|First Intervention (3 Days)|Visual Acuity|0
819019|NCT02097030|2680599|P2|First Intervention (3 Days)|Lost to Follow-up|0
819020|NCT02097030|2680600|P1|First Intervention (3 Days)|Lost to Follow-up|1
819021|NCT02096952|2680661|P1|Overall Study|Adverse Event|1
819022|NCT02096900|2680667|P2|Overall Study|Surgery cancelled- medication received|1
819023|NCT02096900|2680668|P1|Overall Study|Surgery cancelled- medication received|1
819024|NCT02096900|2680667|P2|Overall Study|Did not receive medication|1
819025|NCT02096900|2680668|P1|Overall Study|Did not receive medication|3
819026|NCT02096835|2680720|P3|Overall Study|Lost to Follow-up|1
819027|NCT02096835|2680721|P2|Overall Study|Lost to Follow-up|0
819028|NCT02096835|2680722|P1|Overall Study|Lost to Follow-up|1
819029|NCT02096835|2680720|P3|Overall Study|converted to open procedures|0
819030|NCT02096835|2680721|P2|Overall Study|converted to open procedures|0
819031|NCT02096835|2680722|P1|Overall Study|converted to open procedures|1
819032|NCT02096835|2680720|P3|Overall Study|Withdrawal by Subject|0
819033|NCT02096835|2680721|P2|Overall Study|Withdrawal by Subject|0
819034|NCT02096835|2680722|P1|Overall Study|Withdrawal by Subject|1
819035|NCT02096744|2680739|P2|Treatment Period 3 (7 Days)|Withdrawal by Subject|1
819036|NCT02096744|2680740|P1|Treatment Period 3 (7 Days)|Withdrawal by Subject|0
819037|NCT02096744|2680739|P2|Treatment Period 1(7 Days)|Non compliance with the site rule|0
819038|NCT02096744|2680740|P1|Treatment Period 1(7 Days)|Non compliance with the site rule|1
819039|NCT02096744|2680739|P2|Treatment Period 1(7 Days)|Accidental early removal of the patch|1
819040|NCT02096744|2680740|P1|Treatment Period 1(7 Days)|Accidental early removal of the patch|0
819041|NCT02096705|2680794|P2|Follow-up|Subjects not reporting status|2
819042|NCT02096705|2680795|P1|Follow-up|Subjects not reporting status|1
819043|NCT02096705|2680794|P2|Follow-up|Adverse Event|2
819044|NCT02096705|2680795|P1|Follow-up|Adverse Event|2
819045|NCT02096705|2680794|P2|Follow-up|Withdrawal by Subject|0
819046|NCT02096705|2680795|P1|Follow-up|Withdrawal by Subject|1
819047|NCT02096705|2680794|P2|Treatment|Other|1
819048|NCT02096705|2680795|P1|Treatment|Other|1
819049|NCT02096705|2680794|P2|Treatment|Withdrawal by Subject|0
819050|NCT02096705|2680795|P1|Treatment|Withdrawal by Subject|1
819051|NCT02096705|2680794|P2|Treatment|Subject request to discontinue treatment|1
819052|NCT02096705|2680795|P1|Treatment|Subject request to discontinue treatment|1
819053|NCT02096705|2680794|P2|Treatment|Adverse Event|3
819054|NCT02096705|2680795|P1|Treatment|Adverse Event|6
819055|NCT02096263|2680861|P3|Overall Study|Withdrawal by Subject|8
819056|NCT02096263|2680862|P2|Overall Study|Withdrawal by Subject|7
819057|NCT02096263|2680863|P1|Overall Study|Withdrawal by Subject|5
819058|NCT02096263|2680861|P3|Overall Study|Protocol Violation|8
819059|NCT02096263|2680862|P2|Overall Study|Protocol Violation|2
819060|NCT02096263|2680863|P1|Overall Study|Protocol Violation|7
819061|NCT02096263|2680861|P3|Overall Study|Sponsor study termination|1
819062|NCT02096263|2680862|P2|Overall Study|Sponsor study termination|0
819063|NCT02096263|2680863|P1|Overall Study|Sponsor study termination|0
819064|NCT02096263|2680861|P3|Overall Study|Other|6
819065|NCT02096263|2680862|P2|Overall Study|Other|9
819066|NCT02096263|2680863|P1|Overall Study|Other|7
819067|NCT02096263|2680861|P3|Overall Study|Lost to Follow-up|15
819068|NCT02096263|2680862|P2|Overall Study|Lost to Follow-up|18
819069|NCT02096263|2680863|P1|Overall Study|Lost to Follow-up|14
819070|NCT02096263|2680861|P3|Overall Study|Adverse Event|1
819071|NCT02096263|2680862|P2|Overall Study|Adverse Event|0
819072|NCT02096263|2680863|P1|Overall Study|Adverse Event|1
819073|NCT02096042|2681051|P3|Overall Study|Disease Progression|0
819074|NCT02096042|2681052|P2|Overall Study|Disease Progression|0
819075|NCT02096042|2681053|P1|Overall Study|Disease Progression|1
819076|NCT02095873|2681062|P2|Second Intervention (8 Weeks)|Protocol Violation|0
819077|NCT02095873|2681063|P1|Second Intervention (8 Weeks)|Protocol Violation|1
819078|NCT02095873|2681062|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
819079|NCT02095873|2681063|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
819080|NCT02095873|2681062|P2|First Intervention (8 Weeks)|Withdrawal by Subject|0
819081|NCT02095873|2681063|P1|First Intervention (8 Weeks)|Withdrawal by Subject|1
819082|NCT02095691|2681075|P1|Overall Study|Physician Decision|1
819083|NCT02095535|2681107|P1|Recruitment|Protocol Violation|2
819084|NCT02095223|2681113|P2|Overall Study|Withdrawal by Subject|0
819085|NCT02095223|2681114|P1|Overall Study|Withdrawal by Subject|1
819086|NCT02095197|2681124|P2|Overall Study|Lost to Follow-up|3
819087|NCT02095197|2681125|P1|Overall Study|Lost to Follow-up|0
819088|NCT02095158|2681137|P1|Overall Study|Other Miscellaneous Reasons|1
819089|NCT02095158|2681137|P1|Overall Study|Protocol Violation|1
819090|NCT02095158|2681137|P1|Overall Study|Personal Reasons|35
819091|NCT02095158|2681137|P1|Overall Study|Lost to Follow-up|20
819092|NCT02095158|2681137|P1|Overall Study|Pregnancy|1
819093|NCT02095158|2681137|P1|Overall Study|Lack of Efficacy|3
819094|NCT02095158|2681137|P1|Overall Study|Adverse Event|14
819095|NCT02095106|2681144|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
819096|NCT02095106|2681145|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
819097|NCT02094937|2681161|P4|12 Weeks in Period 2|Randomized incorrectly|0
819098|NCT02094937|2681162|P3|12 Weeks in Period 2|Randomized incorrectly|0
819099|NCT02094937|2681163|P2|12 Weeks in Period 2|Randomized incorrectly|1
819100|NCT02094937|2681164|P1|12 Weeks in Period 2|Randomized incorrectly|0
819101|NCT02094937|2681161|P4|12 Weeks in Period 2|Withdrawal by Subject|0
819102|NCT02094937|2681162|P3|12 Weeks in Period 2|Withdrawal by Subject|2
819103|NCT02094937|2681163|P2|12 Weeks in Period 2|Withdrawal by Subject|2
819104|NCT02094937|2681164|P1|12 Weeks in Period 2|Withdrawal by Subject|0
819105|NCT02094937|2681161|P4|12 Weeks in Period 2|Protocol defined stopping criteria|11
819106|NCT02094937|2681162|P3|12 Weeks in Period 2|Protocol defined stopping criteria|6
819107|NCT02094937|2681163|P2|12 Weeks in Period 2|Protocol defined stopping criteria|5
819108|NCT02094937|2681164|P1|12 Weeks in Period 2|Protocol defined stopping criteria|0
819109|NCT02094937|2681161|P4|12 Weeks in Period 2|Lack of Efficacy|0
819110|NCT02094937|2681162|P3|12 Weeks in Period 2|Lack of Efficacy|0
819111|NCT02094937|2681163|P2|12 Weeks in Period 2|Lack of Efficacy|1
819112|NCT02094937|2681164|P1|12 Weeks in Period 2|Lack of Efficacy|0
819113|NCT02094937|2681161|P4|12 Weeks in Period 2|Adverse Event|1
819114|NCT02094937|2681162|P3|12 Weeks in Period 2|Adverse Event|4
819115|NCT02094937|2681163|P2|12 Weeks in Period 2|Adverse Event|2
819116|NCT02094937|2681164|P1|12 Weeks in Period 2|Adverse Event|0
819117|NCT02094937|2681161|P4|8 Weeks in Period 1|Withdrawal by Subject|0
819118|NCT02094937|2681162|P3|8 Weeks in Period 1|Withdrawal by Subject|0
819119|NCT02094937|2681163|P2|8 Weeks in Period 1|Withdrawal by Subject|0
819120|NCT02094937|2681164|P1|8 Weeks in Period 1|Withdrawal by Subject|4
819121|NCT02094937|2681161|P4|8 Weeks in Period 1|Physician Decision|0
819122|NCT02094937|2681162|P3|8 Weeks in Period 1|Physician Decision|0
819123|NCT02094937|2681163|P2|8 Weeks in Period 1|Physician Decision|0
819124|NCT02094937|2681164|P1|8 Weeks in Period 1|Physician Decision|1
819125|NCT02094937|2681161|P4|8 Weeks in Period 1|Protocol defined stopping criteria|0
819126|NCT02094937|2681162|P3|8 Weeks in Period 1|Protocol defined stopping criteria|0
819127|NCT02094937|2681163|P2|8 Weeks in Period 1|Protocol defined stopping criteria|0
819128|NCT02094937|2681164|P1|8 Weeks in Period 1|Protocol defined stopping criteria|41
819129|NCT02094937|2681161|P4|8 Weeks in Period 1|Protocol Violation|0
819130|NCT02094937|2681162|P3|8 Weeks in Period 1|Protocol Violation|0
819131|NCT02094937|2681163|P2|8 Weeks in Period 1|Protocol Violation|0
819132|NCT02094937|2681164|P1|8 Weeks in Period 1|Protocol Violation|2
819133|NCT02094937|2681161|P4|8 Weeks in Period 1|Lack of Efficacy|0
819134|NCT02094937|2681162|P3|8 Weeks in Period 1|Lack of Efficacy|0
819135|NCT02094937|2681163|P2|8 Weeks in Period 1|Lack of Efficacy|0
819136|NCT02094937|2681164|P1|8 Weeks in Period 1|Lack of Efficacy|3
819137|NCT02094937|2681161|P4|8 Weeks in Period 1|Adverse Event|0
819138|NCT02094937|2681162|P3|8 Weeks in Period 1|Adverse Event|0
819139|NCT02094937|2681163|P2|8 Weeks in Period 1|Adverse Event|0
819140|NCT02094937|2681164|P1|8 Weeks in Period 1|Adverse Event|9
819141|NCT02094898|2681194|P1|Overall Study|Lack of Efficacy|1
819142|NCT02094898|2681194|P1|Overall Study|Adverse Event|2
819143|NCT02094898|2681194|P1|Overall Study|Clinical Worsening|2
819144|NCT02094885|2681241|P2|Overall Study|Withdrawn due to age|0
819145|NCT02094885|2681242|P1|Overall Study|Withdrawn due to age|1
819146|NCT02094885|2681241|P2|Overall Study|Death|5
819147|NCT02094885|2681242|P1|Overall Study|Death|1
819148|NCT02094677|2681256|P2|Overall Study|Screening|1
819149|NCT02094677|2681257|P1|Overall Study|Screening|3
819150|NCT02094612|2681336|P2|Overall Study|Never started ADHD medication|23
819151|NCT02094612|2681337|P1|Overall Study|Never started ADHD medication|32
819152|NCT02094612|2681336|P2|Overall Study|Lost to Follow-up|47
819153|NCT02094612|2681337|P1|Overall Study|Lost to Follow-up|47
819154|NCT02094573|2681357|P2|Overall Study|Ongoing|76
819155|NCT02094573|2681358|P1|Overall Study|Ongoing|64
819156|NCT02094573|2681357|P2|Overall Study|Randomized but not treated|0
819157|NCT02094573|2681358|P1|Overall Study|Randomized but not treated|3
819158|NCT02094573|2681357|P2|Overall Study|Withdrawal by Subject|4
819159|NCT02094573|2681358|P1|Overall Study|Withdrawal by Subject|2
819160|NCT02094573|2681357|P2|Overall Study|Non-compliance with study drug|1
819161|NCT02094573|2681358|P1|Overall Study|Non-compliance with study drug|0
819162|NCT02094573|2681357|P2|Overall Study|Death|1
819163|NCT02094573|2681358|P1|Overall Study|Death|7
819164|NCT02094573|2681357|P2|Overall Study|Adverse Event|9
819165|NCT02094573|2681358|P1|Overall Study|Adverse Event|3
819166|NCT02094573|2681357|P2|Overall Study|Clinical Progressive Disease|3
819167|NCT02094573|2681358|P1|Overall Study|Clinical Progressive Disease|4
819168|NCT02094573|2681357|P2|Overall Study|Documented Progressive Disease|16
819169|NCT02094573|2681358|P1|Overall Study|Documented Progressive Disease|29
819170|NCT02094300|2681440|P1|Overall Study|Still be eligible for follow-up|3
819171|NCT02094300|2681440|P1|Overall Study|Lost to Follow-up|10
819172|NCT02094300|2681440|P1|Overall Study|Death|7
819173|NCT02094261|2681444|P1|Overall Study|Ongoing Study at Data Cut-off|181
819174|NCT02094261|2681444|P1|Overall Study|Withdrawal by Subject|4
819175|NCT02094261|2681444|P1|Overall Study|Lost to Follow-up|1
819176|NCT02094261|2681444|P1|Overall Study|Death|24
819177|NCT02093923|2681486|P5|Overall Study|Screen failure after randomization|0
819178|NCT02093923|2681487|P4|Overall Study|Screen failure after randomization|1
819179|NCT02093923|2681488|P3|Overall Study|Screen failure after randomization|0
819180|NCT02093923|2681489|P2|Overall Study|Screen failure after randomization|0
819181|NCT02093923|2681490|P1|Overall Study|Screen failure after randomization|0
819182|NCT02093923|2681486|P5|Overall Study|Lost to Follow-up|0
819183|NCT02093923|2681487|P4|Overall Study|Lost to Follow-up|1
819184|NCT02093923|2681488|P3|Overall Study|Lost to Follow-up|0
819185|NCT02093923|2681489|P2|Overall Study|Lost to Follow-up|0
819186|NCT02093923|2681490|P1|Overall Study|Lost to Follow-up|0
819187|NCT02093897|2681545|P1|Overall Study|Adverse event, non-fatal|1
819188|NCT02093897|2681545|P1|Overall Study|Planned age group closure - no's reached|17
819189|NCT02093897|2681545|P1|Overall Study|Physician Decision|1
819190|NCT02093689|2681648|P3|Overall Study|Physician Decision|0
819191|NCT02093689|2681649|P2|Overall Study|Physician Decision|0
819192|NCT02093689|2681650|P1|Overall Study|Physician Decision|4
819193|NCT02093520|2681658|P2|Overall Study|Not treated|22
819194|NCT02093520|2681659|P1|Overall Study|Not treated|6
819195|NCT02093390|2681671|P2|Overall Study|Withdrawal by Subject|1
819196|NCT02093390|2681672|P1|Overall Study|Withdrawal by Subject|0
819197|NCT02093351|2681711|P3|Overall Study|Death|0
819198|NCT02093351|2681712|P2|Overall Study|Death|1
819199|NCT02093351|2681713|P1|Overall Study|Death|0
819200|NCT02093351|2681711|P3|Overall Study|Condition under investigation worsened|2
819201|NCT02093351|2681712|P2|Overall Study|Condition under investigation worsened|0
819202|NCT02093351|2681713|P1|Overall Study|Condition under investigation worsened|2
819203|NCT02093351|2681711|P3|Overall Study|Adverse Event|1
819204|NCT02093351|2681712|P2|Overall Study|Adverse Event|1
819205|NCT02093351|2681713|P1|Overall Study|Adverse Event|0
819206|NCT02093221|2681769|P5|Overall Study|Study termination|7
819207|NCT02093221|2681770|P4|Overall Study|Study termination|6
819208|NCT02093221|2681771|P3|Overall Study|Study termination|4
819209|NCT02093221|2681772|P2|Overall Study|Study termination|5
819210|NCT02093221|2681773|P1|Overall Study|Study termination|6
819211|NCT02093221|2681769|P5|Overall Study|Protocol Violation|0
819212|NCT02093221|2681770|P4|Overall Study|Protocol Violation|0
819213|NCT02093221|2681771|P3|Overall Study|Protocol Violation|0
819214|NCT02093221|2681772|P2|Overall Study|Protocol Violation|1
819215|NCT02093221|2681773|P1|Overall Study|Protocol Violation|0
819216|NCT02093221|2681769|P5|Overall Study|Death|0
819217|NCT02093221|2681770|P4|Overall Study|Death|0
819218|NCT02093221|2681771|P3|Overall Study|Death|0
819219|NCT02093221|2681772|P2|Overall Study|Death|1
819220|NCT02093221|2681773|P1|Overall Study|Death|0
819221|NCT02093221|2681769|P5|Overall Study|Lost to Follow-up|0
819222|NCT02093221|2681770|P4|Overall Study|Lost to Follow-up|1
819223|NCT02093221|2681771|P3|Overall Study|Lost to Follow-up|1
819224|NCT02093221|2681772|P2|Overall Study|Lost to Follow-up|0
819225|NCT02093221|2681773|P1|Overall Study|Lost to Follow-up|2
819226|NCT02093221|2681769|P5|Overall Study|Withdrawal by Subject|1
819227|NCT02093221|2681770|P4|Overall Study|Withdrawal by Subject|1
819228|NCT02093221|2681771|P3|Overall Study|Withdrawal by Subject|4
819229|NCT02093221|2681772|P2|Overall Study|Withdrawal by Subject|1
819230|NCT02093221|2681773|P1|Overall Study|Withdrawal by Subject|1
819231|NCT02093221|2681769|P5|Overall Study|Adverse Event|0
819232|NCT02093221|2681770|P4|Overall Study|Adverse Event|0
819233|NCT02093221|2681771|P3|Overall Study|Adverse Event|0
819234|NCT02093221|2681772|P2|Overall Study|Adverse Event|0
819235|NCT02093221|2681773|P1|Overall Study|Adverse Event|1
819236|NCT02093026|2681810|P1|Overall Study|Other|157
819237|NCT02093026|2681810|P1|Overall Study|Death|10
819238|NCT02093026|2681810|P1|Overall Study|Adverse Event|26
819239|NCT02092961|2681832|P3|Overall Study|Adverse Event|0
819240|NCT02092961|2681833|P2|Overall Study|Adverse Event|4
819241|NCT02092961|2681834|P1|Overall Study|Adverse Event|2
819242|NCT02092961|2681832|P3|Overall Study|Dev. of study specific discont. criteria|0
819243|NCT02092961|2681833|P2|Overall Study|Dev. of study specific discont. criteria|0
819244|NCT02092961|2681834|P1|Overall Study|Dev. of study specific discont. criteria|3
819245|NCT02092961|2681832|P3|Overall Study|Lack of therapeutic response|3
819246|NCT02092961|2681833|P2|Overall Study|Lack of therapeutic response|1
819247|NCT02092961|2681834|P1|Overall Study|Lack of therapeutic response|2
819248|NCT02092961|2681832|P3|Overall Study|Study stopped|12
819249|NCT02092961|2681833|P2|Overall Study|Study stopped|9
819250|NCT02092961|2681834|P1|Overall Study|Study stopped|13
819251|NCT02092961|2681832|P3|Overall Study|Not reported|1
819252|NCT02092961|2681833|P2|Overall Study|Not reported|0
819253|NCT02092961|2681834|P1|Overall Study|Not reported|1
819254|NCT02092662|2681870|P2|Overall Study|Lost to Follow-up|0
819255|NCT02092662|2681871|P1|Overall Study|Lost to Follow-up|13
819256|NCT02092389|2681930|P1|Overall Study|Not specified|5
819257|NCT02092389|2681930|P1|Overall Study|Adverse Event|1
819258|NCT02092350|2681942|P2|Overall Study|Withdrawal by Subject|2
819259|NCT02092350|2681943|P1|Overall Study|Withdrawal by Subject|2
819260|NCT02092350|2681942|P2|Overall Study|Screen Failure|0
819261|NCT02092350|2681943|P1|Overall Study|Screen Failure|1
819262|NCT02092350|2681942|P2|Overall Study|Physician Decision|1
819263|NCT02092350|2681943|P1|Overall Study|Physician Decision|1
819264|NCT02092350|2681942|P2|Overall Study|Protocol Violation|0
819265|NCT02092350|2681943|P1|Overall Study|Protocol Violation|1
819266|NCT02092350|2681942|P2|Overall Study|Lost to Follow-up|1
819267|NCT02092350|2681943|P1|Overall Study|Lost to Follow-up|3
819268|NCT02092350|2681942|P2|Overall Study|Death|5
819269|NCT02092350|2681943|P1|Overall Study|Death|2
819270|NCT02092350|2681942|P2|Overall Study|Adverse Event|3
819271|NCT02092350|2681943|P1|Overall Study|Adverse Event|0
819272|NCT02092285|2681971|P1|Maintenance Phase & Follow-up|Lack of Efficacy|23
819273|NCT02092285|2681971|P1|Maintenance Phase & Follow-up|Withdrawal by Subject|11
819274|NCT02092285|2681971|P1|Maintenance Phase & Follow-up|Relapse/recurrence|29
819275|NCT02092285|2681971|P1|Maintenance Phase & Follow-up|Protocol Violation|11
819276|NCT02092285|2681971|P1|Maintenance Phase & Follow-up|Pregnancy|1
819277|NCT02092285|2681971|P1|Maintenance Phase & Follow-up|Physician Decision|10
819278|NCT02092285|2681971|P1|Maintenance Phase & Follow-up|Non-compliance with study drug|2
819279|NCT02092285|2681971|P1|Maintenance Phase & Follow-up|Lost to Follow-up|1
819280|NCT02092285|2681971|P1|Maintenance Phase & Follow-up|Adverse Event|22
819281|NCT02092285|2681971|P1|Induction Phase|Lack of Efficacy|14
819282|NCT02092285|2681971|P1|Induction Phase|Withdrawal by Subject|2
819283|NCT02092285|2681971|P1|Induction Phase|Relapse/Recurrence|7
819284|NCT02092285|2681971|P1|Induction Phase|Pregnancy|1
819285|NCT02092285|2681971|P1|Induction Phase|Physician Decision|4
819286|NCT02092285|2681971|P1|Induction Phase|Adverse Event|7
819287|NCT02092220|2681975|P2|Period 2|Nausea, Anxiety, Inconvenience|1
819288|NCT02092220|2681976|P1|Period 2|Nausea, Anxiety, Inconvenience|0
819289|NCT02092220|2681975|P2|Period 2|Severe Hypoglycaemia|0
819290|NCT02092220|2681976|P1|Period 2|Severe Hypoglycaemia|1
819291|NCT02092220|2681975|P2|Period 1|Unrelated Illness|2
819292|NCT02092220|2681976|P1|Period 1|Unrelated Illness|0
819293|NCT02092116|2682049|P2|Overall Study|Adverse Event|1
819294|NCT02092116|2682050|P1|Overall Study|Adverse Event|0
819295|NCT02092116|2682049|P2|Overall Study|Withdrawal by Subject|3
819296|NCT02092116|2682050|P1|Overall Study|Withdrawal by Subject|0
819297|NCT02091986|2682062|P3|Overall Study|Adverse Event|2
819298|NCT02091986|2682063|P2|Overall Study|Adverse Event|0
819299|NCT02091986|2682064|P1|Overall Study|Adverse Event|0
819300|NCT02091986|2682062|P3|Overall Study|Withdrawal by Subject|3
819301|NCT02091986|2682063|P2|Overall Study|Withdrawal by Subject|8
819302|NCT02091986|2682064|P1|Overall Study|Withdrawal by Subject|4
819303|NCT02091986|2682062|P3|Overall Study|Lost to Follow-up|0
819304|NCT02091986|2682063|P2|Overall Study|Lost to Follow-up|0
819305|NCT02091986|2682064|P1|Overall Study|Lost to Follow-up|1
819306|NCT02091986|2682062|P3|Overall Study|7 rand in error 1 patient decision|3
819307|NCT02091986|2682063|P2|Overall Study|7 rand in error 1 patient decision|3
819308|NCT02091986|2682064|P1|Overall Study|7 rand in error 1 patient decision|2
819309|NCT02091960|2682111|P1|Overall Study|On Study at Data Cut-off|12
819310|NCT02091960|2682111|P1|Overall Study|Miscellaneous Reasons|31
819311|NCT02091960|2682111|P1|Overall Study|Withdrawal by Subject|1
819312|NCT02091960|2682111|P1|Overall Study|Death|7
819313|NCT02091869|2682124|P2|Overall Study|Withdrawal by Subject|3
819314|NCT02091869|2682125|P1|Overall Study|Withdrawal by Subject|0
819315|NCT02091752|2682166|P1|Overall Study|Adverse Event|1
819316|NCT02091752|2682166|P1|Overall Study|Study terminated by Sponsor|2
819317|NCT02091739|2682180|P5|EP: 48 Weeks|Withdrawal by Subject|6
819318|NCT02091739|2682181|P4|EP: 48 Weeks|Withdrawal by Subject|2
819319|NCT02091739|2682182|P3|EP: 48 Weeks|Withdrawal by Subject|0
819320|NCT02091739|2682183|P2|EP: 48 Weeks|Withdrawal by Subject|0
819321|NCT02091739|2682184|P1|EP: 48 Weeks|Withdrawal by Subject|0
819322|NCT02091739|2682180|P5|EP: 48 Weeks|Adverse Event|6
819323|NCT02091739|2682181|P4|EP: 48 Weeks|Adverse Event|2
819324|NCT02091739|2682182|P3|EP: 48 Weeks|Adverse Event|0
819325|NCT02091739|2682183|P2|EP: 48 Weeks|Adverse Event|0
819326|NCT02091739|2682184|P1|EP: 48 Weeks|Adverse Event|0
819327|NCT02091739|2682180|P5|EP: 48 Weeks|Death|2
819328|NCT02091739|2682181|P4|EP: 48 Weeks|Death|3
819329|NCT02091739|2682182|P3|EP: 48 Weeks|Death|0
819330|NCT02091739|2682183|P2|EP: 48 Weeks|Death|0
819331|NCT02091739|2682184|P1|EP: 48 Weeks|Death|0
819332|NCT02091739|2682180|P5|EP: 48 Weeks|Other|0
819333|NCT02091739|2682181|P4|EP: 48 Weeks|Other|1
819334|NCT02091739|2682182|P3|EP: 48 Weeks|Other|0
819335|NCT02091739|2682183|P2|EP: 48 Weeks|Other|0
819336|NCT02091739|2682184|P1|EP: 48 Weeks|Other|0
819337|NCT02091739|2682180|P5|MP: 16 Weeks|Lost to Follow-up|0
819338|NCT02091739|2682181|P4|MP: 16 Weeks|Lost to Follow-up|0
819339|NCT02091739|2682182|P3|MP: 16 Weeks|Lost to Follow-up|1
819340|NCT02091739|2682183|P2|MP: 16 Weeks|Lost to Follow-up|0
819341|NCT02091739|2682184|P1|MP: 16 Weeks|Lost to Follow-up|0
819342|NCT02091739|2682180|P5|MP: 16 Weeks|Withdrawal by Subject|0
819343|NCT02091739|2682181|P4|MP: 16 Weeks|Withdrawal by Subject|0
819344|NCT02091739|2682182|P3|MP: 16 Weeks|Withdrawal by Subject|0
819345|NCT02091739|2682183|P2|MP: 16 Weeks|Withdrawal by Subject|4
819346|NCT02091739|2682184|P1|MP: 16 Weeks|Withdrawal by Subject|3
819347|NCT02091739|2682180|P5|MP: 16 Weeks|Adverse Event|0
819348|NCT02091739|2682181|P4|MP: 16 Weeks|Adverse Event|0
819349|NCT02091739|2682182|P3|MP: 16 Weeks|Adverse Event|1
819350|NCT02091739|2682183|P2|MP: 16 Weeks|Adverse Event|1
819351|NCT02091739|2682184|P1|MP: 16 Weeks|Adverse Event|1
819352|NCT02091726|2682203|P1|Overall Study|Lost to Follow-up|6
819353|NCT02091414|2682220|P1|Overall Study|Death|2
819354|NCT02091414|2682220|P1|Overall Study|Withdrawal by Subject|2
819355|NCT02091375|2682234|P2|Overall Study|Withdrawn by the investigator|0
819356|NCT02091375|2682235|P1|Overall Study|Withdrawn by the investigator|1
819357|NCT02091375|2682234|P2|Overall Study|Withdrawal by Subject|1
819358|NCT02091375|2682235|P1|Overall Study|Withdrawal by Subject|0
819359|NCT02091375|2682234|P2|Overall Study|Lost to Follow-up|1
819360|NCT02091375|2682235|P1|Overall Study|Lost to Follow-up|0
819361|NCT02091375|2682234|P2|Overall Study|Adverse Event|1
819362|NCT02091375|2682235|P1|Overall Study|Adverse Event|8
819363|NCT02091362|2682265|P2|Period 2|Withdrawal by Subject|1
819364|NCT02091362|2682266|P1|Period 2|Withdrawal by Subject|1
819365|NCT02091362|2682265|P2|Period 2|Lost to Follow-up|1
819366|NCT02091362|2682266|P1|Period 2|Lost to Follow-up|0
819367|NCT02091362|2682265|P2|Period 2|Adverse Event|0
819368|NCT02091362|2682266|P1|Period 2|Adverse Event|1
819369|NCT02091362|2682265|P2|Wash-out|Withdrawal by Subject|2
819370|NCT02091362|2682266|P1|Wash-out|Withdrawal by Subject|0
819371|NCT02091362|2682265|P2|Wash-out|Lost to Follow-up|1
819372|NCT02091362|2682266|P1|Wash-out|Lost to Follow-up|1
819373|NCT02091362|2682265|P2|Period 1|Adverse Event|0
819374|NCT02091362|2682266|P1|Period 1|Adverse Event|2
819375|NCT02091362|2682265|P2|Period 1|Lost to Follow-up|1
819376|NCT02091362|2682266|P1|Period 1|Lost to Follow-up|0
819377|NCT02091362|2682265|P2|Period 1|Withdrawal by Subject|3
819378|NCT02091362|2682266|P1|Period 1|Withdrawal by Subject|2
819379|NCT02091362|2682265|P2|Period 1|Protocol Violation|0
819380|NCT02091362|2682266|P1|Period 1|Protocol Violation|1
819381|NCT02091206|2682290|P4|Taper Period|Lost to Follow-up|1
819382|NCT02091206|2682291|P3|Taper Period|Lost to Follow-up|0
819383|NCT02091206|2682292|P2|Taper Period|Lost to Follow-up|0
819384|NCT02091206|2682293|P1|Taper Period|Lost to Follow-up|0
819385|NCT02091206|2682290|P4|Taper Period|Participant refused study drug|1
819386|NCT02091206|2682291|P3|Taper Period|Participant refused study drug|0
819387|NCT02091206|2682292|P2|Taper Period|Participant refused study drug|0
819388|NCT02091206|2682293|P1|Taper Period|Participant refused study drug|1
819389|NCT02091206|2682290|P4|Treatment Period|Met withdrawal criteria|0
819390|NCT02091206|2682291|P3|Treatment Period|Met withdrawal criteria|1
819391|NCT02091206|2682292|P2|Treatment Period|Met withdrawal criteria|0
819392|NCT02091206|2682293|P1|Treatment Period|Met withdrawal criteria|0
819393|NCT02091206|2682290|P4|Treatment Period|Adverse Event|0
819394|NCT02091206|2682291|P3|Treatment Period|Adverse Event|0
819395|NCT02091206|2682292|P2|Treatment Period|Adverse Event|1
819396|NCT02091206|2682293|P1|Treatment Period|Adverse Event|0
819397|NCT02090855|2682315|P1|Overall Study|no evaluable Standard of Truth results|2
819398|NCT02090764|2682328|P2|Overall Study|Lost to Follow-up|2
819399|NCT02090764|2682329|P1|Overall Study|Lost to Follow-up|2
819400|NCT02090764|2682328|P2|Overall Study|Intercurrent illness and other|1
819401|NCT02090764|2682329|P1|Overall Study|Intercurrent illness and other|1
819402|NCT02090764|2682328|P2|Overall Study|Withdrawal by Subject|1
819403|NCT02090764|2682329|P1|Overall Study|Withdrawal by Subject|2
819404|NCT02090764|2682328|P2|Overall Study|Lack of Efficacy|13
819405|NCT02090764|2682329|P1|Overall Study|Lack of Efficacy|0
819406|NCT02090764|2682328|P2|Overall Study|Adverse Event|3
819407|NCT02090764|2682329|P1|Overall Study|Adverse Event|1
819408|NCT02090413|2682338|P3|Overall Study|Lost to Follow-up|0
819409|NCT02090413|2682339|P2|Overall Study|Lost to Follow-up|1
819410|NCT02090413|2682340|P1|Overall Study|Lost to Follow-up|1
819411|NCT02090413|2682338|P3|Overall Study|Not Specified|0
819412|NCT02090413|2682339|P2|Overall Study|Not Specified|1
819413|NCT02090413|2682340|P1|Overall Study|Not Specified|2
819414|NCT02090413|2682338|P3|Overall Study|Investigator Decision|0
819415|NCT02090413|2682339|P2|Overall Study|Investigator Decision|1
819416|NCT02090413|2682340|P1|Overall Study|Investigator Decision|1
819417|NCT02090413|2682338|P3|Overall Study|Withdrawal by Subject|2
819418|NCT02090413|2682339|P2|Overall Study|Withdrawal by Subject|2
819419|NCT02090413|2682340|P1|Overall Study|Withdrawal by Subject|2
819420|NCT02090413|2682338|P3|Overall Study|Flushing event|1
819421|NCT02090413|2682339|P2|Overall Study|Flushing event|0
819422|NCT02090413|2682340|P1|Overall Study|Flushing event|2
819423|NCT02090413|2682338|P3|Overall Study|Adverse Event|20
819424|NCT02090413|2682339|P2|Overall Study|Adverse Event|15
819425|NCT02090413|2682340|P1|Overall Study|Adverse Event|11
819426|NCT02089997|2682426|P1|Overall Study|Protocol Violation|147
819427|NCT02089997|2682426|P1|Overall Study|Case report forms uncollected|99
819428|NCT02089737|2682441|P1|Overall Study|Not treated|1
819429|NCT02089737|2682441|P1|Overall Study|Survey form not completed|5
819430|NCT02089347|2682450|P2|Overall Study|Protocol Violation|0
819431|NCT02089347|2682451|P1|Overall Study|Protocol Violation|1
819432|NCT02088957|2682491|P2|Overall Study|Lack of Efficacy|0
819433|NCT02088957|2682492|P1|Overall Study|Lack of Efficacy|1
819434|NCT02088177|2682519|P1|Overall Study|Lost to Follow-up|3
819435|NCT02087943|2682531|P5|Active Treatment Phase Week 12-24|Other-Unspecified|0
819436|NCT02087943|2682532|P4|Active Treatment Phase Week 12-24|Other-Unspecified|1
819437|NCT02087943|2682533|P3|Active Treatment Phase Week 12-24|Other-Unspecified|1
819438|NCT02087943|2682534|P2|Active Treatment Phase Week 12-24|Other-Unspecified|0
819439|NCT02087943|2682535|P1|Active Treatment Phase Week 12-24|Other-Unspecified|0
819440|NCT02087943|2682531|P5|Active Treatment Phase Week 12-24|Lost to Follow-up|1
819441|NCT02087943|2682532|P4|Active Treatment Phase Week 12-24|Lost to Follow-up|0
819442|NCT02087943|2682533|P3|Active Treatment Phase Week 12-24|Lost to Follow-up|0
819443|NCT02087943|2682534|P2|Active Treatment Phase Week 12-24|Lost to Follow-up|0
819444|NCT02087943|2682535|P1|Active Treatment Phase Week 12-24|Lost to Follow-up|0
819445|NCT02087943|2682531|P5|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
819446|NCT02087943|2682532|P4|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
819447|NCT02087943|2682533|P3|Active Treatment Phase Week 12-24|Withdrawal by Subject|1
819448|NCT02087943|2682534|P2|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
819449|NCT02087943|2682535|P1|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
819450|NCT02087943|2682531|P5|Active Treatment Phase Week 12-24|Lack of Efficacy|0
819451|NCT02087943|2682532|P4|Active Treatment Phase Week 12-24|Lack of Efficacy|1
819452|NCT02087943|2682533|P3|Active Treatment Phase Week 12-24|Lack of Efficacy|1
819453|NCT02087943|2682534|P2|Active Treatment Phase Week 12-24|Lack of Efficacy|3
819454|NCT02087943|2682535|P1|Active Treatment Phase Week 12-24|Lack of Efficacy|0
819455|NCT02087943|2682531|P5|Active Treatment Phase Week 12-24|Adverse Event|1
819456|NCT02087943|2682532|P4|Active Treatment Phase Week 12-24|Adverse Event|0
819457|NCT02087943|2682533|P3|Active Treatment Phase Week 12-24|Adverse Event|2
819458|NCT02087943|2682534|P2|Active Treatment Phase Week 12-24|Adverse Event|1
819459|NCT02087943|2682535|P1|Active Treatment Phase Week 12-24|Adverse Event|0
819460|NCT02087943|2682531|P5|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
819461|NCT02087943|2682532|P4|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
819462|NCT02087943|2682533|P3|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
819463|NCT02087943|2682534|P2|Placebo-Controlled Phase Week 0-12|Protocol Violation|1
819464|NCT02087943|2682535|P1|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
819465|NCT02087943|2682531|P5|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
819466|NCT02087943|2682532|P4|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
819467|NCT02087943|2682533|P3|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
819468|NCT02087943|2682534|P2|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
819469|NCT02087943|2682535|P1|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
819470|NCT02087943|2682531|P5|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
819471|NCT02087943|2682532|P4|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
819472|NCT02087943|2682533|P3|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
819473|NCT02087943|2682534|P2|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
819474|NCT02087943|2682535|P1|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4
819475|NCT02087943|2682531|P5|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
819476|NCT02087943|2682532|P4|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
819477|NCT02087943|2682533|P3|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4
819478|NCT02087943|2682534|P2|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7
819479|NCT02087943|2682535|P1|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8
819480|NCT02087943|2682531|P5|Placebo-Controlled Phase Week 0-12|Adverse Event|0
819481|NCT02087943|2682532|P4|Placebo-Controlled Phase Week 0-12|Adverse Event|0
819482|NCT02087943|2682533|P3|Placebo-Controlled Phase Week 0-12|Adverse Event|6
819483|NCT02087943|2682534|P2|Placebo-Controlled Phase Week 0-12|Adverse Event|2
819484|NCT02087943|2682535|P1|Placebo-Controlled Phase Week 0-12|Adverse Event|1
819485|NCT02087774|2682561|P2|Overall Study|Were absent day of data collection|20
819486|NCT02087774|2682562|P1|Overall Study|Were absent day of data collection|8
819487|NCT02087670|2682582|P2|Overall Study|Withdrawal by Subject|2
819488|NCT02087670|2682583|P1|Overall Study|Withdrawal by Subject|3
819489|NCT02087423|2682619|P3|Overall Study|Ongoing treatment at data cutoff|18
819490|NCT02087423|2682620|P2|Overall Study|Ongoing treatment at data cutoff|0
819491|NCT02087423|2682621|P1|Overall Study|Ongoing treatment at data cutoff|10
819492|NCT02087423|2682619|P3|Overall Study|Adverse Event|3
819493|NCT02087423|2682620|P2|Overall Study|Adverse Event|24
819494|NCT02087423|2682621|P1|Overall Study|Adverse Event|2
819495|NCT02087423|2682619|P3|Overall Study|Withdrawal by Subject|2
819496|NCT02087423|2682620|P2|Overall Study|Withdrawal by Subject|7
819497|NCT02087423|2682621|P1|Overall Study|Withdrawal by Subject|5
819498|NCT02087423|2682619|P3|Overall Study|Physician Decision|35
819499|NCT02087423|2682620|P2|Overall Study|Physician Decision|174
819500|NCT02087423|2682621|P1|Overall Study|Physician Decision|86
819501|NCT02087241|2682645|P4|Overall Study|Study Terminated by Sponsor|4
819502|NCT02087241|2682646|P3|Overall Study|Study Terminated by Sponsor|0
819503|NCT02087241|2682647|P2|Overall Study|Study Terminated by Sponsor|2
819504|NCT02087241|2682648|P1|Overall Study|Study Terminated by Sponsor|0
819505|NCT02087241|2682645|P4|Overall Study|Progressive Disease|1
819506|NCT02087241|2682646|P3|Overall Study|Progressive Disease|0
819507|NCT02087241|2682647|P2|Overall Study|Progressive Disease|0
819508|NCT02087241|2682648|P1|Overall Study|Progressive Disease|0
819509|NCT02087241|2682645|P4|Overall Study|Withdrawal by Subject|1
819510|NCT02087241|2682646|P3|Overall Study|Withdrawal by Subject|0
819511|NCT02087241|2682647|P2|Overall Study|Withdrawal by Subject|0
819512|NCT02087241|2682648|P1|Overall Study|Withdrawal by Subject|1
819513|NCT02087241|2682645|P4|Overall Study|Death|1
819514|NCT02087241|2682646|P3|Overall Study|Death|1
819515|NCT02087241|2682647|P2|Overall Study|Death|1
819516|NCT02087241|2682648|P1|Overall Study|Death|2
819517|NCT02087176|2682674|P1|Overall Study|Study Terminated by Sponsor|2
819518|NCT02087176|2682674|P1|Overall Study|Censored|19
819519|NCT02087176|2682674|P1|Overall Study|Death|10
819520|NCT02087176|2682674|P1|Overall Study|Withdrawal by Subject|1
819521|NCT02087059|2682679|P1|Overall Study|Lost to Follow-up|1
819522|NCT02087059|2682679|P1|Overall Study|Adverse Event|5
819523|NCT02087059|2682679|P1|Overall Study|Disease Progression|1
819524|NCT02086591|2682726|P1|Overall Study|protocol terminated|3
819525|NCT02086591|2682726|P1|Overall Study|Withdrawal by Subject|1
819526|NCT02086591|2682726|P1|Overall Study|Adverse Event|1
819527|NCT02086162|2682734|P2|Overall Study|Death|0
819528|NCT02086162|2682735|P1|Overall Study|Death|1
819529|NCT02086162|2682734|P2|Overall Study|Lost to Follow-up|2
819530|NCT02086162|2682735|P1|Overall Study|Lost to Follow-up|4
819531|NCT02086162|2682734|P2|Overall Study|moved|1
819532|NCT02086162|2682735|P1|Overall Study|moved|1
819533|NCT02086162|2682734|P2|Overall Study|Withdrawal by Subject|4
819534|NCT02086162|2682735|P1|Overall Study|Withdrawal by Subject|4
819535|NCT02085785|2682747|P2|Overall Study|Lost to Follow-up|1
819536|NCT02085785|2682748|P1|Overall Study|Lost to Follow-up|0
819537|NCT02085785|2682747|P2|Overall Study|Withdrawal by Subject|1
819538|NCT02085785|2682748|P1|Overall Study|Withdrawal by Subject|2
819539|NCT02085161|2682841|P4|Overall Study|Other Reason|1
819540|NCT02085161|2682842|P3|Overall Study|Other Reason|1
819541|NCT02085161|2682843|P2|Overall Study|Other Reason|0
819542|NCT02085161|2682844|P1|Overall Study|Other Reason|1
819543|NCT02085161|2682841|P4|Overall Study|Withdrawal by Subject|3
819544|NCT02085161|2682842|P3|Overall Study|Withdrawal by Subject|0
819545|NCT02085161|2682843|P2|Overall Study|Withdrawal by Subject|4
819546|NCT02085161|2682844|P1|Overall Study|Withdrawal by Subject|2
819547|NCT02085161|2682841|P4|Overall Study|Protocol Violation|1
819548|NCT02085161|2682842|P3|Overall Study|Protocol Violation|0
819549|NCT02085161|2682843|P2|Overall Study|Protocol Violation|1
819550|NCT02085161|2682844|P1|Overall Study|Protocol Violation|0
819551|NCT02085161|2682841|P4|Overall Study|Adverse Event|5
819552|NCT02085161|2682842|P3|Overall Study|Adverse Event|4
819553|NCT02085161|2682843|P2|Overall Study|Adverse Event|5
819554|NCT02085161|2682844|P1|Overall Study|Adverse Event|8
819555|NCT02085161|2682841|P4|Overall Study|Not Treated|0
819556|NCT02085161|2682842|P3|Overall Study|Not Treated|0
819557|NCT02085161|2682843|P2|Overall Study|Not Treated|0
819558|NCT02085161|2682844|P1|Overall Study|Not Treated|1
819559|NCT02084238|2682912|P1|Overall Study|Lost to Follow-up|2
819560|NCT02084134|2682925|P2|Overall Study|Death|1
819561|NCT02084134|2682926|P1|Overall Study|Death|0
819562|NCT02084134|2682925|P2|Overall Study|Protocol Violation|2
819563|NCT02084134|2682926|P1|Overall Study|Protocol Violation|4
819564|NCT02084082|2682936|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|1
819565|NCT02084082|2682937|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
819566|NCT02084082|2682938|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
819567|NCT02084082|2682939|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|0
819568|NCT02084082|2682936|P4|Washout Period 1 (35 Days)|Adverse Event|1
819569|NCT02084082|2682937|P3|Washout Period 1 (35 Days)|Adverse Event|1
819570|NCT02084082|2682938|P2|Washout Period 1 (35 Days)|Adverse Event|0
819571|NCT02084082|2682939|P1|Washout Period 1 (35 Days)|Adverse Event|0
819572|NCT02084056|2682980|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|0
819573|NCT02084056|2682981|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
819574|NCT02084056|2682982|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
819575|NCT02084056|2682983|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|1
819576|NCT02084056|2682980|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
819577|NCT02084056|2682981|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
819578|NCT02084056|2682982|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
819579|NCT02084056|2682983|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
819580|NCT02083965|2683015|P2|Treatment Period|Not Specified|0
819581|NCT02083965|2683016|P1|Treatment Period|Not Specified|1
819582|NCT02083380|2683133|P3|Overall Study|Other|6
819583|NCT02083380|2683134|P2|Overall Study|Other|4
819584|NCT02083380|2683135|P1|Overall Study|Other|8
819585|NCT02083380|2683133|P3|Overall Study|Lost to Follow-up|3
819586|NCT02083380|2683134|P2|Overall Study|Lost to Follow-up|3
819587|NCT02083380|2683135|P1|Overall Study|Lost to Follow-up|5
819588|NCT02083380|2683133|P3|Overall Study|Adverse Event|1
819589|NCT02083380|2683134|P2|Overall Study|Adverse Event|0
819590|NCT02083380|2683135|P1|Overall Study|Adverse Event|0
819591|NCT02083380|2683133|P3|Overall Study|Physician Decision|3
819592|NCT02083380|2683134|P2|Overall Study|Physician Decision|6
819593|NCT02083380|2683135|P1|Overall Study|Physician Decision|1
819594|NCT02083380|2683133|P3|Overall Study|Withdrawal by Subject|7
819595|NCT02083380|2683134|P2|Overall Study|Withdrawal by Subject|3
819596|NCT02083380|2683135|P1|Overall Study|Withdrawal by Subject|9
819597|NCT02083380|2683133|P3|Overall Study|Lack of Efficacy|64
819598|NCT02083380|2683134|P2|Overall Study|Lack of Efficacy|79
819599|NCT02083380|2683135|P1|Overall Study|Lack of Efficacy|68
819600|NCT02083185|2683240|P3|Overall Study|Did not Receive Study Drug|0
819601|NCT02083185|2683241|P2|Overall Study|Did not Receive Study Drug|2
819602|NCT02083185|2683242|P1|Overall Study|Did not Receive Study Drug|0
819603|NCT02083185|2683240|P3|Overall Study|Study Terminated by Sponsor|0
819604|NCT02083185|2683241|P2|Overall Study|Study Terminated by Sponsor|1
819605|NCT02083185|2683242|P1|Overall Study|Study Terminated by Sponsor|0
819606|NCT02083185|2683240|P3|Overall Study|Reason not Specified|5
819607|NCT02083185|2683241|P2|Overall Study|Reason not Specified|6
819608|NCT02083185|2683242|P1|Overall Study|Reason not Specified|9
819609|NCT02083185|2683240|P3|Overall Study|Death|1
819610|NCT02083185|2683241|P2|Overall Study|Death|2
819611|NCT02083185|2683242|P1|Overall Study|Death|2
819612|NCT02083185|2683240|P3|Overall Study|Withdrawal by Subject|1
819613|NCT02083185|2683241|P2|Overall Study|Withdrawal by Subject|15
819614|NCT02083185|2683242|P1|Overall Study|Withdrawal by Subject|9
819615|NCT02083185|2683240|P3|Overall Study|Lost to Follow-up|0
819616|NCT02083185|2683241|P2|Overall Study|Lost to Follow-up|3
819617|NCT02083185|2683242|P1|Overall Study|Lost to Follow-up|0
819618|NCT02082912|2683339|P2|Overall Study|Physician Decision|1
819619|NCT02082912|2683340|P1|Overall Study|Physician Decision|0
819620|NCT02082262|2683412|P1|Overall Study|Adverse Event|48
819621|NCT02082262|2683412|P1|Overall Study|Withdrawal by Subject|3
819622|NCT02082184|2683418|P2|Overall Study|Subject non-compliance|1
819623|NCT02082184|2683419|P1|Overall Study|Subject non-compliance|0
819624|NCT02082184|2683418|P2|Overall Study|Lost to Follow-up|2
819625|NCT02082184|2683419|P1|Overall Study|Lost to Follow-up|0
819626|NCT02082184|2683418|P2|Overall Study|Protocol Violation|6
819627|NCT02082184|2683419|P1|Overall Study|Protocol Violation|0
819628|NCT02082184|2683418|P2|Overall Study|Withdrawal by Subject|2
819629|NCT02082184|2683419|P1|Overall Study|Withdrawal by Subject|3
819630|NCT02082184|2683418|P2|Overall Study|Device associated symptoms|0
819631|NCT02082184|2683419|P1|Overall Study|Device associated symptoms|5
819632|NCT02082184|2683418|P2|Overall Study|Medical diagnosis|2
819633|NCT02082184|2683419|P1|Overall Study|Medical diagnosis|1
819634|NCT02082184|2683418|P2|Overall Study|Adverse Event|0
819635|NCT02082184|2683419|P1|Overall Study|Adverse Event|1
819636|NCT02082158|2683444|P6|Overall Study|Failed Fit-testing|7
819637|NCT02082158|2683445|P5|Overall Study|Failed Fit-testing|3
819638|NCT02082158|2683446|P4|Overall Study|Failed Fit-testing|4
819639|NCT02082158|2683447|P3|Overall Study|Failed Fit-testing|14
819640|NCT02082158|2683448|P2|Overall Study|Failed Fit-testing|8
819641|NCT02082158|2683449|P1|Overall Study|Failed Fit-testing|8
819642|NCT02082158|2683444|P6|Overall Study|Withdrawal by Subject|0
819643|NCT02082158|2683445|P5|Overall Study|Withdrawal by Subject|1
819644|NCT02082158|2683446|P4|Overall Study|Withdrawal by Subject|0
819645|NCT02082158|2683447|P3|Overall Study|Withdrawal by Subject|0
819646|NCT02082158|2683448|P2|Overall Study|Withdrawal by Subject|0
819647|NCT02082158|2683449|P1|Overall Study|Withdrawal by Subject|0
819648|NCT02081859|2683471|P2|Overall Study|Other reasons|0
819649|NCT02081859|2683472|P1|Overall Study|Other reasons|2
819650|NCT02081859|2683471|P2|Overall Study|< 4 embryos|23
819651|NCT02081859|2683472|P1|Overall Study|< 4 embryos|27
819652|NCT02081859|2683471|P2|Overall Study|Unanticipated freeze all cycle|6
819653|NCT02081859|2683472|P1|Overall Study|Unanticipated freeze all cycle|2
819654|NCT02081859|2683471|P2|Overall Study|No sperm|0
819655|NCT02081859|2683472|P1|Overall Study|No sperm|1
819656|NCT02081859|2683471|P2|Overall Study|No fertilization|2
819657|NCT02081859|2683472|P1|Overall Study|No fertilization|2
819658|NCT02081690|2683480|P1|Overall Study|Withdrawal by Subject|1
819659|NCT02081690|2683480|P1|Overall Study|Physician Decision|3
819660|NCT02081690|2683480|P1|Overall Study|Death|3
819661|NCT02081677|2683491|P4|Overall Study|Unsatisfactory Lens Fitting|0
819662|NCT02081677|2683492|P3|Overall Study|Unsatisfactory Lens Fitting|0
819663|NCT02081677|2683493|P2|Overall Study|Unsatisfactory Lens Fitting|1
819664|NCT02081677|2683494|P1|Overall Study|Unsatisfactory Lens Fitting|0
819665|NCT02081677|2683491|P4|Overall Study|Not comfortable with lens care system|0
819666|NCT02081677|2683492|P3|Overall Study|Not comfortable with lens care system|0
819667|NCT02081677|2683493|P2|Overall Study|Not comfortable with lens care system|0
819668|NCT02081677|2683494|P1|Overall Study|Not comfortable with lens care system|1
819669|NCT02081677|2683491|P4|Overall Study|No Longer Meets Eligibility Criteria|0
819670|NCT02081677|2683492|P3|Overall Study|No Longer Meets Eligibility Criteria|1
819671|NCT02081677|2683493|P2|Overall Study|No Longer Meets Eligibility Criteria|0
819672|NCT02081677|2683494|P1|Overall Study|No Longer Meets Eligibility Criteria|0
819673|NCT02081677|2683491|P4|Overall Study|Adverse Event|0
819674|NCT02081677|2683492|P3|Overall Study|Adverse Event|1
819675|NCT02081677|2683493|P2|Overall Study|Adverse Event|0
819676|NCT02081677|2683494|P1|Overall Study|Adverse Event|0
819677|NCT02081599|2683586|P2|Period 2：Open-label Period|Withdrawal by Subject|0
819678|NCT02081599|2683587|P1|Period 2：Open-label Period|Withdrawal by Subject|2
819679|NCT02081599|2683586|P2|Period 2：Open-label Period|Physician Decision|0
819680|NCT02081599|2683587|P1|Period 2：Open-label Period|Physician Decision|1
819681|NCT02081599|2683586|P2|Period 2：Open-label Period|Lack of Efficacy|4
819682|NCT02081599|2683587|P1|Period 2：Open-label Period|Lack of Efficacy|2
819683|NCT02081599|2683586|P2|Period 2：Open-label Period|Adverse Event|0
819684|NCT02081599|2683587|P1|Period 2：Open-label Period|Adverse Event|1
819685|NCT02081599|2683586|P2|Period 1：Double-blind Period|stopping criteria|0
819686|NCT02081599|2683587|P1|Period 1：Double-blind Period|stopping criteria|1
819687|NCT02081599|2683586|P2|Period 1：Double-blind Period|Withdrawal by Subject|0
819688|NCT02081599|2683587|P1|Period 1：Double-blind Period|Withdrawal by Subject|1
819689|NCT02081599|2683586|P2|Period 1：Double-blind Period|Protocol Violation|1
819690|NCT02081599|2683587|P1|Period 1：Double-blind Period|Protocol Violation|0
819691|NCT02081599|2683586|P2|Period 1：Double-blind Period|Physician Decision|0
819692|NCT02081599|2683587|P1|Period 1：Double-blind Period|Physician Decision|1
819693|NCT02081599|2683586|P2|Period 1：Double-blind Period|Lack of Efficacy|1
819694|NCT02081599|2683587|P1|Period 1：Double-blind Period|Lack of Efficacy|2
819695|NCT02081599|2683586|P2|Period 1：Double-blind Period|Adverse Event|0
819696|NCT02081599|2683587|P1|Period 1：Double-blind Period|Adverse Event|3
819697|NCT02081586|2683605|P4|Overall Study|Head injury not related to study|0
819698|NCT02081586|2683606|P3|Overall Study|Head injury not related to study|1
819699|NCT02081586|2683607|P2|Overall Study|Head injury not related to study|0
819700|NCT02081586|2683608|P1|Overall Study|Head injury not related to study|0
819701|NCT02081586|2683605|P4|Overall Study|Lost to Follow-up|1
819702|NCT02081586|2683606|P3|Overall Study|Lost to Follow-up|0
819703|NCT02081586|2683607|P2|Overall Study|Lost to Follow-up|1
819704|NCT02081586|2683608|P1|Overall Study|Lost to Follow-up|0
819705|NCT02081183|2683714|P2|Overall Study|Not specified|3
819706|NCT02081183|2683715|P1|Overall Study|Not specified|3
819707|NCT02081183|2683714|P2|Overall Study|Protocol Violation|0
819708|NCT02081183|2683715|P1|Overall Study|Protocol Violation|1
819709|NCT02081183|2683714|P2|Overall Study|Lost to Follow-up|1
819710|NCT02081183|2683715|P1|Overall Study|Lost to Follow-up|0
819711|NCT02081079|2683731|P2|Overall Study|Lost to Follow-up|0
819712|NCT02081079|2683732|P1|Overall Study|Lost to Follow-up|1
819713|NCT02081079|2683731|P2|Overall Study|Lack of Efficacy|2
819714|NCT02081079|2683732|P1|Overall Study|Lack of Efficacy|3
819715|NCT02081001|2683805|P12|Overall Study|Adverse Event|0
819716|NCT02081001|2683806|P11|Overall Study|Adverse Event|0
819717|NCT02081001|2683807|P10|Overall Study|Adverse Event|0
819718|NCT02081001|2683808|P9|Overall Study|Adverse Event|0
819719|NCT02081001|2683809|P8|Overall Study|Adverse Event|0
819720|NCT02081001|2683810|P7|Overall Study|Adverse Event|0
819721|NCT02081001|2683811|P6|Overall Study|Adverse Event|0
819722|NCT02081001|2683812|P5|Overall Study|Adverse Event|1
819723|NCT02081001|2683813|P4|Overall Study|Adverse Event|0
819724|NCT02081001|2683814|P3|Overall Study|Adverse Event|0
819725|NCT02081001|2683815|P2|Overall Study|Adverse Event|0
819726|NCT02081001|2683816|P1|Overall Study|Adverse Event|0
819727|NCT02080871|2683880|P1|Overall Study|Lost to Follow-up|1
819728|NCT02080871|2683880|P1|Overall Study|Death|1
819729|NCT02080832|2683925|P3|Overall Study|Lost to Follow-up|2
819730|NCT02080832|2683926|P2|Overall Study|Lost to Follow-up|2
819731|NCT02080832|2683927|P1|Overall Study|Lost to Follow-up|0
819732|NCT02080832|2683925|P3|Overall Study|Excluded from analysis by MRI|14
819733|NCT02080832|2683926|P2|Overall Study|Excluded from analysis by MRI|10
819734|NCT02080832|2683927|P1|Overall Study|Excluded from analysis by MRI|9
819735|NCT02080481|2683985|P2|Overall Study|Never received a block.|0
819736|NCT02080481|2683986|P1|Overall Study|Never received a block.|1
819737|NCT02080091|2684013|P1|Overall Study|Other|1
819738|NCT02080091|2684013|P1|Overall Study|Withdrawal by Subject|1
819739|NCT02080091|2684013|P1|Overall Study|Death|1
819740|NCT02080091|2684013|P1|Overall Study|Study Terminated|22
819741|NCT02079909|2684022|P3|Overall Study|Relocation etc.|3
819742|NCT02079909|2684023|P2|Overall Study|Relocation etc.|2
819743|NCT02079909|2684024|P1|Overall Study|Relocation etc.|2
819744|NCT02079909|2684022|P3|Overall Study|Physician Decision|1
819745|NCT02079909|2684023|P2|Overall Study|Physician Decision|1
819746|NCT02079909|2684024|P1|Overall Study|Physician Decision|0
819747|NCT02079909|2684022|P3|Overall Study|Protocol Violation|1
819748|NCT02079909|2684023|P2|Overall Study|Protocol Violation|1
819749|NCT02079909|2684024|P1|Overall Study|Protocol Violation|0
819750|NCT02079909|2684022|P3|Overall Study|Lack of Efficacy|1
819751|NCT02079909|2684023|P2|Overall Study|Lack of Efficacy|0
819752|NCT02079909|2684024|P1|Overall Study|Lack of Efficacy|0
819753|NCT02079909|2684022|P3|Overall Study|Death|0
819754|NCT02079909|2684023|P2|Overall Study|Death|2
819755|NCT02079909|2684024|P1|Overall Study|Death|2
819756|NCT02079909|2684022|P3|Overall Study|Lost to Follow-up|1
819757|NCT02079909|2684023|P2|Overall Study|Lost to Follow-up|3
819758|NCT02079909|2684024|P1|Overall Study|Lost to Follow-up|2
819759|NCT02079909|2684022|P3|Overall Study|Withdrawal by Subject|4
819760|NCT02079909|2684023|P2|Overall Study|Withdrawal by Subject|17
819761|NCT02079909|2684024|P1|Overall Study|Withdrawal by Subject|9
819762|NCT02079909|2684022|P3|Overall Study|Adverse Event|7
819763|NCT02079909|2684023|P2|Overall Study|Adverse Event|23
819764|NCT02079909|2684024|P1|Overall Study|Adverse Event|23
819765|NCT02079844|2684041|P3|Treatment Period 2|Voluntary Withdrawal|0
819766|NCT02079844|2684042|P2|Treatment Period 2|Voluntary Withdrawal|1
819767|NCT02079844|2684043|P1|Treatment Period 2|Voluntary Withdrawal|0
819768|NCT02079844|2684041|P3|Treatment Period 1|Voluntary Withdrawal|2
819769|NCT02079844|2684042|P2|Treatment Period 1|Voluntary Withdrawal|0
819770|NCT02079844|2684043|P1|Treatment Period 1|Voluntary Withdrawal|0
819771|NCT02079805|2684101|P2|Overall Study|Voluntary Withdrawal|1
819772|NCT02079805|2684102|P1|Overall Study|Voluntary Withdrawal|0
819773|NCT02079805|2684101|P2|Overall Study|Pretreatment Event/Adverse Event|1
819774|NCT02079805|2684102|P1|Overall Study|Pretreatment Event/Adverse Event|0
819775|NCT02079649|2684124|P4|Overall Study|Randomization error (prior to treatment)|0
819776|NCT02079649|2684125|P3|Overall Study|Randomization error (prior to treatment)|1
819777|NCT02079649|2684126|P2|Overall Study|Randomization error (prior to treatment)|0
819778|NCT02079649|2684127|P1|Overall Study|Randomization error (prior to treatment)|1
819779|NCT02079649|2684124|P4|Overall Study|Withdrawal by Subject|1
819780|NCT02079649|2684125|P3|Overall Study|Withdrawal by Subject|0
819781|NCT02079649|2684126|P2|Overall Study|Withdrawal by Subject|0
819782|NCT02079649|2684127|P1|Overall Study|Withdrawal by Subject|0
819783|NCT02079649|2684124|P4|Overall Study|Lost to Follow-up|1
819784|NCT02079649|2684125|P3|Overall Study|Lost to Follow-up|0
819785|NCT02079649|2684126|P2|Overall Study|Lost to Follow-up|0
819786|NCT02079649|2684127|P1|Overall Study|Lost to Follow-up|0
819787|NCT02079610|2684144|P2|Overall Study|Withdrawal by Subject|1
819788|NCT02079610|2684145|P1|Overall Study|Withdrawal by Subject|1
819789|NCT02079532|2684155|P1|Overall Study|Not specified|3
819790|NCT02079532|2684155|P1|Overall Study|Inclusion into ReFIRST|3
819791|NCT02079532|2684155|P1|Overall Study|Administrative problems|1
819792|NCT02079532|2684155|P1|Overall Study|Withdrawal by Subject|1
819793|NCT02079532|2684155|P1|Overall Study|Protocol Violation|3
819794|NCT02079532|2684155|P1|Overall Study|Lack of Efficacy|9
819795|NCT02079532|2684155|P1|Overall Study|Additional or changed therapy|2
819796|NCT02079532|2684155|P1|Overall Study|Adverse Event|7
819797|NCT02079519|2684177|P1|Overall Study|Adverse Event|1
819798|NCT02079519|2684177|P1|Overall Study|Disease Progression|9
819799|NCT02079246|2684190|P2|OLEX-MEM|Other: Moved to nursing home|3
819800|NCT02079246|2684191|P1|OLEX-MEM|Other: Moved to nursing home|0
819801|NCT02079246|2684190|P2|OLEX-MEM|Lost to Follow-up|1
819802|NCT02079246|2684191|P1|OLEX-MEM|Lost to Follow-up|0
819803|NCT02079246|2684190|P2|OLEX-MEM|Protocol Violation|2
819804|NCT02079246|2684191|P1|OLEX-MEM|Protocol Violation|0
819805|NCT02079246|2684190|P2|OLEX-MEM|Withdrawal by Subject|7
819806|NCT02079246|2684191|P1|OLEX-MEM|Withdrawal by Subject|0
819807|NCT02079246|2684190|P2|OLEX-MEM|Adverse Event|6
819808|NCT02079246|2684191|P1|OLEX-MEM|Adverse Event|0
819809|NCT02079246|2684190|P2|OLEX|Other: Withdrawal of caregiver consent|0
819810|NCT02079246|2684191|P1|OLEX|Other: Withdrawal of caregiver consent|1
819811|NCT02079246|2684190|P2|OLEX|Other: Moved to nursing home|0
819812|NCT02079246|2684191|P1|OLEX|Other: Moved to nursing home|1
819813|NCT02079246|2684190|P2|OLEX|Other: Worsening of condition|0
819814|NCT02079246|2684191|P1|OLEX|Other: Worsening of condition|1
819815|NCT02079246|2684190|P2|OLEX|Other: Coordinator decision|0
819816|NCT02079246|2684191|P1|OLEX|Other: Coordinator decision|1
819817|NCT02079246|2684190|P2|OLEX|Other: Caregiver unavailable|0
819818|NCT02079246|2684191|P1|OLEX|Other: Caregiver unavailable|3
819819|NCT02079246|2684190|P2|OLEX|Other: Insufficient compliance|0
819820|NCT02079246|2684191|P1|OLEX|Other: Insufficient compliance|2
819821|NCT02079246|2684190|P2|OLEX|Other: Disallowed medication|0
819822|NCT02079246|2684191|P1|OLEX|Other: Disallowed medication|8
819823|NCT02079246|2684190|P2|OLEX|Results of the lead-in studies|0
819824|NCT02079246|2684191|P1|OLEX|Results of the lead-in studies|58
819825|NCT02079246|2684190|P2|OLEX|Lack of Efficacy|0
819826|NCT02079246|2684191|P1|OLEX|Lack of Efficacy|3
819827|NCT02079246|2684190|P2|OLEX|Protocol Violation|0
819828|NCT02079246|2684191|P1|OLEX|Protocol Violation|6
819829|NCT02079246|2684190|P2|OLEX|Lost to Follow-up|0
819830|NCT02079246|2684191|P1|OLEX|Lost to Follow-up|6
819831|NCT02079246|2684190|P2|OLEX|Withdrawal by Subject|0
819832|NCT02079246|2684191|P1|OLEX|Withdrawal by Subject|60
819833|NCT02079246|2684190|P2|OLEX|Adverse Event|0
819834|NCT02079246|2684191|P1|OLEX|Adverse Event|66
819835|NCT02079246|2684190|P2|OLEX|Death|0
819836|NCT02079246|2684191|P1|OLEX|Death|11
819837|NCT02079246|2684190|P2|OLEX|Withdrawal before treatment|0
819838|NCT02079246|2684191|P1|OLEX|Withdrawal before treatment|1
819839|NCT02078713|2684212|P4|Overall Study|Enrolled twice|0
819840|NCT02078713|2684213|P3|Overall Study|Enrolled twice|0
819841|NCT02078713|2684214|P2|Overall Study|Enrolled twice|1
819842|NCT02078713|2684215|P1|Overall Study|Enrolled twice|0
819843|NCT02078713|2684212|P4|Overall Study|Pregnant at baseline|0
819844|NCT02078713|2684213|P3|Overall Study|Pregnant at baseline|0
819845|NCT02078713|2684214|P2|Overall Study|Pregnant at baseline|5
819846|NCT02078713|2684215|P1|Overall Study|Pregnant at baseline|3
819847|NCT02078713|2684212|P4|Overall Study|Lost to Follow-up|0
819848|NCT02078713|2684213|P3|Overall Study|Lost to Follow-up|0
819849|NCT02078713|2684214|P2|Overall Study|Lost to Follow-up|55
819850|NCT02078713|2684215|P1|Overall Study|Lost to Follow-up|49
819851|NCT02077374|2684318|P2|Overall Study|Protocol Violation|1
819852|NCT02077374|2684319|P1|Overall Study|Protocol Violation|0
819853|NCT02077374|2684318|P2|Overall Study|Withdrawal by Subject|1
819854|NCT02077374|2684319|P1|Overall Study|Withdrawal by Subject|0
819855|NCT02077140|2684340|P5|Overall Study|Withdrawal by Subject|2
819856|NCT02077140|2684341|P4|Overall Study|Withdrawal by Subject|2
819857|NCT02077140|2684342|P3|Overall Study|Withdrawal by Subject|0
819858|NCT02077140|2684343|P2|Overall Study|Withdrawal by Subject|1
819859|NCT02077140|2684344|P1|Overall Study|Withdrawal by Subject|0
819860|NCT02077140|2684340|P5|Overall Study|Lost to Follow-up|3
819861|NCT02077140|2684341|P4|Overall Study|Lost to Follow-up|2
819862|NCT02077140|2684342|P3|Overall Study|Lost to Follow-up|2
819863|NCT02077140|2684343|P2|Overall Study|Lost to Follow-up|1
819864|NCT02077140|2684344|P1|Overall Study|Lost to Follow-up|4
819865|NCT02076334|2684567|P4|Overall Study|muscle soreness|1
819866|NCT02076334|2684568|P3|Overall Study|muscle soreness|0
819867|NCT02076334|2684569|P2|Overall Study|muscle soreness|0
819868|NCT02076334|2684570|P1|Overall Study|muscle soreness|0
819869|NCT02076334|2684567|P4|Overall Study|Lost to Follow-up|0
819870|NCT02076334|2684568|P3|Overall Study|Lost to Follow-up|1
819871|NCT02076334|2684569|P2|Overall Study|Lost to Follow-up|1
819872|NCT02076334|2684570|P1|Overall Study|Lost to Follow-up|0
819873|NCT02076334|2684567|P4|Overall Study|Protocol Violation|0
819874|NCT02076334|2684568|P3|Overall Study|Protocol Violation|0
819875|NCT02076334|2684569|P2|Overall Study|Protocol Violation|0
819876|NCT02076334|2684570|P1|Overall Study|Protocol Violation|1
819877|NCT02076178|2684603|P2|Injection Phase|Lost to Follow-up|1
819878|NCT02076178|2684604|P1|Injection Phase|Lost to Follow-up|0
819879|NCT02076178|2684603|P2|Injection Phase|Physician Decision|3
819880|NCT02076178|2684604|P1|Injection Phase|Physician Decision|0
819881|NCT02076178|2684603|P2|Injection Phase|Withdrawal by Subject|3
819882|NCT02076178|2684604|P1|Injection Phase|Withdrawal by Subject|0
819883|NCT02076178|2684603|P2|Injection Phase|Protocol defined stopping criteria|0
819884|NCT02076178|2684604|P1|Injection Phase|Protocol defined stopping criteria|1
819885|NCT02076178|2684603|P2|Oral Phase|Physician Decision|1
819886|NCT02076178|2684604|P1|Oral Phase|Physician Decision|0
819887|NCT02076178|2684603|P2|Oral Phase|Withdrawal by Subject|4
819888|NCT02076178|2684604|P1|Oral Phase|Withdrawal by Subject|0
819889|NCT02076178|2684603|P2|Oral Phase|Adverse Event|7
819890|NCT02076178|2684604|P1|Oral Phase|Adverse Event|0
819891|NCT02076009|2684682|P2|Overall Study|Subjects randomized but not treated|3
819892|NCT02076009|2684683|P1|Overall Study|Subjects randomized but not treated|2
819893|NCT02076009|2684682|P2|Overall Study|Ongoing|249
819894|NCT02076009|2684683|P1|Overall Study|Ongoing|226
819895|NCT02076009|2684682|P2|Overall Study|Progressive disease|0
819896|NCT02076009|2684683|P1|Overall Study|Progressive disease|1
819897|NCT02076009|2684682|P2|Overall Study|Lost to Follow-up|1
819898|NCT02076009|2684683|P1|Overall Study|Lost to Follow-up|1
819899|NCT02076009|2684682|P2|Overall Study|Withdrawal by Subject|3
819900|NCT02076009|2684683|P1|Overall Study|Withdrawal by Subject|9
819901|NCT02076009|2684682|P2|Overall Study|Death|30
819902|NCT02076009|2684683|P1|Overall Study|Death|44
819903|NCT02075840|2684705|P2|Overall Study|Ongoing at CCOD|82
819904|NCT02075840|2684706|P1|Overall Study|Ongoing at CCOD|99
819905|NCT02075840|2684705|P2|Overall Study|Physician Decision|3
819906|NCT02075840|2684706|P1|Overall Study|Physician Decision|1
819907|NCT02075840|2684705|P2|Overall Study|Lost to Follow-up|2
819908|NCT02075840|2684706|P1|Overall Study|Lost to Follow-up|3
819909|NCT02075840|2684705|P2|Overall Study|Death|40
819910|NCT02075840|2684706|P1|Overall Study|Death|35
819911|NCT02075840|2684705|P2|Overall Study|Adverse Event|2
819912|NCT02075840|2684706|P1|Overall Study|Adverse Event|0
819913|NCT02075840|2684705|P2|Overall Study|Reason not specified|0
819914|NCT02075840|2684706|P1|Overall Study|Reason not specified|1
819915|NCT02075840|2684705|P2|Overall Study|Withdrawal by Subject|22
819916|NCT02075840|2684706|P1|Overall Study|Withdrawal by Subject|13
819917|NCT02075658|2684762|P2|Overall Study|Physician Decision|2
819918|NCT02075658|2684763|P1|Overall Study|Physician Decision|2
819919|NCT02075632|2684773|P2|Overall Study|Withdrawal by Subject|1
819920|NCT02075632|2684774|P1|Overall Study|Withdrawal by Subject|0
819921|NCT02075632|2684773|P2|Overall Study|Lost to Follow-up|3
819922|NCT02075632|2684774|P1|Overall Study|Lost to Follow-up|0
819923|NCT02075632|2684773|P2|Overall Study|Adverse Event|1
819924|NCT02075632|2684774|P1|Overall Study|Adverse Event|1
819925|NCT02075541|2684786|P2|Overall Study|Other- unable to perform study procedure|0
819926|NCT02075541|2684787|P1|Overall Study|Other- unable to perform study procedure|1
819927|NCT02075541|2684786|P2|Overall Study|Sponsor study termination|1
819928|NCT02075541|2684787|P1|Overall Study|Sponsor study termination|0
819929|NCT02075541|2684786|P2|Overall Study|Withdrawal by Subject|3
819930|NCT02075541|2684787|P1|Overall Study|Withdrawal by Subject|1
819931|NCT02075541|2684786|P2|Overall Study|Protocol Violation|0
819932|NCT02075541|2684787|P1|Overall Study|Protocol Violation|1
819933|NCT02075541|2684786|P2|Overall Study|Serious Adverse Event|4
819934|NCT02075541|2684787|P1|Overall Study|Serious Adverse Event|1
819935|NCT02075515|2684836|P3|Overall Study|Lost to Follow-up|6
819936|NCT02075515|2684837|P2|Overall Study|Lost to Follow-up|3
819937|NCT02075515|2684838|P1|Overall Study|Lost to Follow-up|1
819938|NCT02075515|2684836|P3|Overall Study|Withdrawal by Subject|1
819939|NCT02075515|2684837|P2|Overall Study|Withdrawal by Subject|0
819940|NCT02075515|2684838|P1|Overall Study|Withdrawal by Subject|2
819941|NCT02075515|2684836|P3|Overall Study|Non-Serious Adverse Event|0
819942|NCT02075515|2684837|P2|Overall Study|Non-Serious Adverse Event|1
819943|NCT02075515|2684838|P1|Overall Study|Non-Serious Adverse Event|0
819944|NCT02075515|2684836|P3|Overall Study|Serious Adverse Event|1
819945|NCT02075515|2684837|P2|Overall Study|Serious Adverse Event|1
819946|NCT02075515|2684838|P1|Overall Study|Serious Adverse Event|1
819947|NCT02075463|2684873|P1|Overall Study|Withdrawal by Subject|1
819948|NCT02075463|2684873|P1|Overall Study|Par. reached stopping criteria|4
819949|NCT02075463|2684873|P1|Overall Study|Adverse Event|3
819950|NCT02075320|2684923|P1|Overall Study|Withdrawal by Subject|2
819951|NCT02075255|2684933|P3|Overall Study|Death|0
819952|NCT02075255|2684934|P2|Overall Study|Death|2
819953|NCT02075255|2684935|P1|Overall Study|Death|0
819954|NCT02075255|2684933|P3|Overall Study|Adverse Event|1
819955|NCT02075255|2684934|P2|Overall Study|Adverse Event|0
819956|NCT02075255|2684935|P1|Overall Study|Adverse Event|0
819957|NCT02075255|2684933|P3|Overall Study|Lost to Follow-up|1
819958|NCT02075255|2684934|P2|Overall Study|Lost to Follow-up|0
819959|NCT02075255|2684935|P1|Overall Study|Lost to Follow-up|0
819960|NCT02075255|2684933|P3|Overall Study|Withdrawal by Subject|0
819961|NCT02075255|2684934|P2|Overall Study|Withdrawal by Subject|1
819962|NCT02075255|2684935|P1|Overall Study|Withdrawal by Subject|4
819963|NCT02075255|2684933|P3|Overall Study|Study specific withdrawal criteria|1
819964|NCT02075255|2684934|P2|Overall Study|Study specific withdrawal criteria|1
819965|NCT02075255|2684935|P1|Overall Study|Study specific withdrawal criteria|0
819966|NCT02075073|2685066|P3|Overall Study|Withdrawal by Subject|0
819967|NCT02075073|2685067|P2|Overall Study|Withdrawal by Subject|1
819968|NCT02075073|2685068|P1|Overall Study|Withdrawal by Subject|0
819969|NCT02075008|2685090|P1|Overall Study|Study terminated by Sponsor|159
819970|NCT02075008|2685090|P1|Overall Study|Withdrawal by Subject|6
819971|NCT02075008|2685090|P1|Overall Study|Adverse Event|5
819972|NCT02075008|2685090|P1|Overall Study|Death|1
819973|NCT02075008|2685090|P1|Overall Study|Lack of Efficacy|1
819974|NCT02075008|2685090|P1|Overall Study|Lost to Follow-up|1
819975|NCT02075008|2685090|P1|Overall Study|Physician Decision|1
819976|NCT02075008|2685090|P1|Overall Study|Pregnancy|1
819977|NCT02075008|2685090|P1|Overall Study|Technical problems|1
819978|NCT02074982|2685113|P2|Overall Study|Death|2
819979|NCT02074982|2685114|P1|Overall Study|Death|0
819980|NCT02074982|2685113|P2|Overall Study|Subject/guardian decision|24
819981|NCT02074982|2685114|P1|Overall Study|Subject/guardian decision|15
819982|NCT02074982|2685113|P2|Overall Study|Technical problems|2
819983|NCT02074982|2685114|P1|Overall Study|Technical problems|0
819984|NCT02074982|2685113|P2|Overall Study|Protocol deviation|3
819985|NCT02074982|2685114|P1|Overall Study|Protocol deviation|4
819986|NCT02074982|2685113|P2|Overall Study|Pregnancy|2
819987|NCT02074982|2685114|P1|Overall Study|Pregnancy|1
819988|NCT02074982|2685113|P2|Overall Study|Physician Decision|1
819989|NCT02074982|2685114|P1|Overall Study|Physician Decision|1
819990|NCT02074982|2685113|P2|Overall Study|Non-compliance with study treatment|2
819991|NCT02074982|2685114|P1|Overall Study|Non-compliance with study treatment|0
819992|NCT02074982|2685113|P2|Overall Study|Lost to Follow-up|10
819993|NCT02074982|2685114|P1|Overall Study|Lost to Follow-up|9
819994|NCT02074982|2685113|P2|Overall Study|Lack of Efficacy|1
819995|NCT02074982|2685114|P1|Overall Study|Lack of Efficacy|6
819996|NCT02074982|2685113|P2|Overall Study|Adverse Event|7
819997|NCT02074982|2685114|P1|Overall Study|Adverse Event|15
819998|NCT02074553|2685161|P8|Washout Period 3|Physician Decision|1
819999|NCT02074553|2685162|P7|Washout Period 3|Physician Decision|0
820000|NCT02074553|2685163|P6|Washout Period 3|Physician Decision|0
820001|NCT02074553|2685164|P5|Washout Period 3|Physician Decision|0
820002|NCT02074553|2685165|P4|Washout Period 3|Physician Decision|0
820003|NCT02074553|2685166|P3|Washout Period 3|Physician Decision|0
820004|NCT02074553|2685167|P2|Washout Period 3|Physician Decision|0
820005|NCT02074553|2685168|P1|Washout Period 3|Physician Decision|0
820006|NCT02074553|2685161|P8|Washout Period 2|Lost to Follow-up|0
820007|NCT02074553|2685162|P7|Washout Period 2|Lost to Follow-up|0
820008|NCT02074553|2685163|P6|Washout Period 2|Lost to Follow-up|0
820009|NCT02074553|2685164|P5|Washout Period 2|Lost to Follow-up|0
820010|NCT02074553|2685165|P4|Washout Period 2|Lost to Follow-up|0
820011|NCT02074553|2685166|P3|Washout Period 2|Lost to Follow-up|1
820012|NCT02074553|2685167|P2|Washout Period 2|Lost to Follow-up|0
820013|NCT02074553|2685168|P1|Washout Period 2|Lost to Follow-up|0
820014|NCT02074553|2685161|P8|Washout Period 2|Physician Decision|0
820015|NCT02074553|2685162|P7|Washout Period 2|Physician Decision|0
820016|NCT02074553|2685163|P6|Washout Period 2|Physician Decision|1
820017|NCT02074553|2685164|P5|Washout Period 2|Physician Decision|0
820018|NCT02074553|2685165|P4|Washout Period 2|Physician Decision|0
820019|NCT02074553|2685166|P3|Washout Period 2|Physician Decision|0
820020|NCT02074553|2685167|P2|Washout Period 2|Physician Decision|0
820021|NCT02074553|2685168|P1|Washout Period 2|Physician Decision|0
820022|NCT02074553|2685161|P8|Washout Period 2|Adverse Event|0
820023|NCT02074553|2685162|P7|Washout Period 2|Adverse Event|1
820024|NCT02074553|2685163|P6|Washout Period 2|Adverse Event|0
820025|NCT02074553|2685164|P5|Washout Period 2|Adverse Event|0
820026|NCT02074553|2685165|P4|Washout Period 2|Adverse Event|0
820027|NCT02074553|2685166|P3|Washout Period 2|Adverse Event|0
820028|NCT02074553|2685167|P2|Washout Period 2|Adverse Event|0
820029|NCT02074553|2685168|P1|Washout Period 2|Adverse Event|0
820030|NCT02074553|2685161|P8|Washout Period 1|Other|0
820031|NCT02074553|2685162|P7|Washout Period 1|Other|0
820032|NCT02074553|2685163|P6|Washout Period 1|Other|1
820033|NCT02074553|2685164|P5|Washout Period 1|Other|0
820034|NCT02074553|2685165|P4|Washout Period 1|Other|0
820035|NCT02074553|2685166|P3|Washout Period 1|Other|0
820036|NCT02074553|2685167|P2|Washout Period 1|Other|0
820037|NCT02074553|2685168|P1|Washout Period 1|Other|0
820038|NCT02074553|2685161|P8|Washout Period 1|Physician Decision|0
820039|NCT02074553|2685162|P7|Washout Period 1|Physician Decision|0
820040|NCT02074553|2685163|P6|Washout Period 1|Physician Decision|0
820041|NCT02074553|2685164|P5|Washout Period 1|Physician Decision|0
820042|NCT02074553|2685165|P4|Washout Period 1|Physician Decision|1
820043|NCT02074553|2685166|P3|Washout Period 1|Physician Decision|0
820044|NCT02074553|2685167|P2|Washout Period 1|Physician Decision|0
820045|NCT02074553|2685168|P1|Washout Period 1|Physician Decision|0
820046|NCT02074553|2685161|P8|Washout Period 1|Adverse Event|0
820047|NCT02074553|2685162|P7|Washout Period 1|Adverse Event|0
820048|NCT02074553|2685163|P6|Washout Period 1|Adverse Event|0
820049|NCT02074553|2685164|P5|Washout Period 1|Adverse Event|0
820050|NCT02074553|2685165|P4|Washout Period 1|Adverse Event|0
820051|NCT02074553|2685166|P3|Washout Period 1|Adverse Event|0
820052|NCT02074553|2685167|P2|Washout Period 1|Adverse Event|0
820053|NCT02074553|2685168|P1|Washout Period 1|Adverse Event|1
820054|NCT02074553|2685161|P8|Intervention Period 1|Family Emergency|0
820055|NCT02074553|2685162|P7|Intervention Period 1|Family Emergency|0
820056|NCT02074553|2685163|P6|Intervention Period 1|Family Emergency|0
820057|NCT02074553|2685164|P5|Intervention Period 1|Family Emergency|0
820058|NCT02074553|2685165|P4|Intervention Period 1|Family Emergency|1
820059|NCT02074553|2685166|P3|Intervention Period 1|Family Emergency|0
820060|NCT02074553|2685167|P2|Intervention Period 1|Family Emergency|0
820061|NCT02074553|2685168|P1|Intervention Period 1|Family Emergency|0
820062|NCT02074514|2685350|P2|Overall Study|Withdrew Consent|1
820063|NCT02074514|2685351|P1|Overall Study|Withdrew Consent|0
820064|NCT02074514|2685350|P2|Overall Study|Lost to Follow-up|1
820065|NCT02074514|2685351|P1|Overall Study|Lost to Follow-up|0
820066|NCT02074514|2685350|P2|Overall Study|Lack of Efficacy|2
820067|NCT02074514|2685351|P1|Overall Study|Lack of Efficacy|3
820068|NCT02074059|2685492|P6|Overall Study|Death|1
820069|NCT02074059|2685493|P5|Overall Study|Death|1
820070|NCT02074059|2685494|P4|Overall Study|Death|0
820071|NCT02074059|2685495|P3|Overall Study|Death|0
820072|NCT02074059|2685496|P2|Overall Study|Death|0
820073|NCT02074059|2685497|P1|Overall Study|Death|0
820074|NCT02073682|2685546|P2|Overall Study|ID: Benefit/Risk Judgment|46
820075|NCT02073682|2685547|P1|Overall Study|ID: Benefit/Risk Judgment|32
820076|NCT02073682|2685546|P2|Overall Study|Lost to Follow-up|1
820077|NCT02073682|2685547|P1|Overall Study|Lost to Follow-up|1
820078|NCT02073682|2685546|P2|Overall Study|PD: Inconvenience of Dosing|78
820079|NCT02073682|2685547|P1|Overall Study|PD: Inconvenience of Dosing|21
820080|NCT02073682|2685546|P2|Overall Study|No reason provided|9
820081|NCT02073682|2685547|P1|Overall Study|No reason provided|11
820082|NCT02073682|2685546|P2|Overall Study|Adverse Event|62
820083|NCT02073682|2685547|P1|Overall Study|Adverse Event|79
820084|NCT02073682|2685546|P2|Overall Study|Protocol Violation|0
820085|NCT02073682|2685547|P1|Overall Study|Protocol Violation|1
820086|NCT02073682|2685546|P2|Overall Study|Cancer Progression|33
820087|NCT02073682|2685547|P1|Overall Study|Cancer Progression|53
820088|NCT02073682|2685546|P2|Overall Study|Start of New Chemotherapy Regimen|3
820089|NCT02073682|2685547|P1|Overall Study|Start of New Chemotherapy Regimen|6
820090|NCT02073682|2685546|P2|Overall Study|Withdrawal by Subject|8
820091|NCT02073682|2685547|P1|Overall Study|Withdrawal by Subject|6
820092|NCT02073682|2685546|P2|Overall Study|Surgery/Medical Procedure|1
820093|NCT02073682|2685547|P1|Overall Study|Surgery/Medical Procedure|3
820094|NCT02073682|2685546|P2|Overall Study|Platelet Count <50,000/mL|2
820095|NCT02073682|2685547|P1|Overall Study|Platelet Count <50,000/mL|1
820096|NCT02073682|2685546|P2|Overall Study|Prohibited Concomitant Medication Use|1
820097|NCT02073682|2685547|P1|Overall Study|Prohibited Concomitant Medication Use|0
820098|NCT02073682|2685546|P2|Overall Study|ID: Palliative Treatment Only|7
820099|NCT02073682|2685547|P1|Overall Study|ID: Palliative Treatment Only|10
820100|NCT02073682|2685546|P2|Overall Study|ID: Patient Noncompliance|2
820101|NCT02073682|2685547|P1|Overall Study|ID: Patient Noncompliance|1
820102|NCT02073682|2685546|P2|Overall Study|Cancer Cured|15
820103|NCT02073682|2685547|P1|Overall Study|Cancer Cured|10
820104|NCT02073682|2685546|P2|Overall Study|Death|100
820105|NCT02073682|2685547|P1|Overall Study|Death|86
820106|NCT02073682|2685546|P2|Overall Study|Low Creatinine Clearance|2
820107|NCT02073682|2685547|P1|Overall Study|Low Creatinine Clearance|1
820108|NCT02073656|2685565|P1|Primary Study|Withdrew Consent|1
820109|NCT02073656|2685565|P1|Primary Study|Death|1
820110|NCT02073656|2685565|P1|Primary Study|Lost to Follow-up|6
820111|NCT02073565|2685583|P2|Cohort C|Lost to Follow-up|2
820112|NCT02073565|2685584|P1|Cohort C|Lost to Follow-up|0
820113|NCT02073565|2685583|P2|Cohort C|Withdrawal by Subject|2
820114|NCT02073565|2685584|P1|Cohort C|Withdrawal by Subject|0
820115|NCT02073565|2685583|P2|Cohort B|Withdrawal by Subject|2
820116|NCT02073565|2685584|P1|Cohort B|Withdrawal by Subject|1
820117|NCT02073565|2685583|P2|Cohort A|Withdrawal by Subject|0
820118|NCT02073565|2685584|P1|Cohort A|Withdrawal by Subject|1
820119|NCT02072980|2685658|P2|Period 2, Second Wear|Adverse Event|1
820120|NCT02072980|2685659|P1|Period 2, Second Wear|Adverse Event|0
820121|NCT02072824|2685672|P3|Overall Study|Adverse Event|1
820122|NCT02072824|2685673|P2|Overall Study|Adverse Event|0
820123|NCT02072824|2685674|P1|Overall Study|Adverse Event|0
820124|NCT02072824|2685672|P3|Overall Study|Medication error|0
820125|NCT02072824|2685673|P2|Overall Study|Medication error|1
820126|NCT02072824|2685674|P1|Overall Study|Medication error|0
820127|NCT02072824|2685672|P3|Overall Study|No longer willing to participate|1
820128|NCT02072824|2685673|P2|Overall Study|No longer willing to participate|0
820129|NCT02072824|2685674|P1|Overall Study|No longer willing to participate|1
820130|NCT02072824|2685672|P3|Overall Study|Insufficient clinical response|1
820131|NCT02072824|2685673|P2|Overall Study|Insufficient clinical response|0
820132|NCT02072824|2685674|P1|Overall Study|Insufficient clinical response|1
820133|NCT02072226|2685719|P2|Overall Study|Patient Withdrawal of Consent|0
820134|NCT02072226|2685720|P1|Overall Study|Patient Withdrawal of Consent|1
820135|NCT02072226|2685719|P2|Overall Study|Death|0
820136|NCT02072226|2685720|P1|Overall Study|Death|1
820137|NCT02072226|2685719|P2|Overall Study|Patient Non-compliance|3
820138|NCT02072226|2685720|P1|Overall Study|Patient Non-compliance|2
820139|NCT02072226|2685719|P2|Overall Study|Lost to Follow-up|7
820140|NCT02072226|2685720|P1|Overall Study|Lost to Follow-up|11
820141|NCT02072096|2685750|P2|Overall Study|Lost to Follow-up|0
820142|NCT02072096|2685751|P1|Overall Study|Lost to Follow-up|1
820143|NCT02072096|2685750|P2|Overall Study|Study Terminated by Sponsor|30
820144|NCT02072096|2685751|P1|Overall Study|Study Terminated by Sponsor|43
820145|NCT02072096|2685750|P2|Overall Study|Physician Decision|1
820146|NCT02072096|2685751|P1|Overall Study|Physician Decision|0
820147|NCT02072096|2685750|P2|Overall Study|Death|0
820148|NCT02072096|2685751|P1|Overall Study|Death|2
820149|NCT02072096|2685750|P2|Overall Study|No Reason Provided|2
820150|NCT02072096|2685751|P1|Overall Study|No Reason Provided|4
820151|NCT02072096|2685750|P2|Overall Study|Adverse Event|2
820152|NCT02072096|2685751|P1|Overall Study|Adverse Event|5
820153|NCT02072096|2685750|P2|Overall Study|Withdrawal by Subject|7
820154|NCT02072096|2685751|P1|Overall Study|Withdrawal by Subject|5
820155|NCT02072096|2685750|P2|Overall Study|Protocol Violation|7
820156|NCT02072096|2685751|P1|Overall Study|Protocol Violation|7
820157|NCT02072096|2685750|P2|Overall Study|Lack of Efficacy|29
820158|NCT02072096|2685751|P1|Overall Study|Lack of Efficacy|18
820159|NCT02071849|2685773|P1|2-year Extended Follow-up|Adverse Event|1
820160|NCT02071849|2685773|P1|6-month Primary Endpoint|Adverse Event|1
820161|NCT02071849|2685773|P1|6-month Primary Endpoint|Did not receive device|4
820162|NCT02071771|2685839|P2|Period 1: First 10 Days|Unavailable lens power|0
820163|NCT02071771|2685840|P1|Period 1: First 10 Days|Unavailable lens power|1
820164|NCT02071771|2685839|P2|Period 1: First 10 Days|Unacceptable lens fit|0
820165|NCT02071771|2685840|P1|Period 1: First 10 Days|Unacceptable lens fit|1
820166|NCT02071082|2685895|P2|Overall Study|Lost to Follow-up|1
820167|NCT02071082|2685896|P1|Overall Study|Lost to Follow-up|1
820168|NCT02071082|2685895|P2|Overall Study|Withdrew Consent|4
820169|NCT02071082|2685896|P1|Overall Study|Withdrew Consent|0
820170|NCT02071082|2685895|P2|Overall Study|Adverse Event|1
820171|NCT02071082|2685896|P1|Overall Study|Adverse Event|0
820172|NCT02071082|2685895|P2|Overall Study|Enrolled and Never Treated|1
820173|NCT02071082|2685896|P1|Overall Study|Enrolled and Never Treated|1
820174|NCT02070965|2685927|P3|Overall Study|Subject moved|0
820175|NCT02070965|2685928|P2|Overall Study|Subject moved|0
820176|NCT02070965|2685929|P1|Overall Study|Subject moved|1
820177|NCT02070965|2685927|P3|Overall Study|Withdrawal by Subject|1
820178|NCT02070965|2685928|P2|Overall Study|Withdrawal by Subject|1
820179|NCT02070965|2685929|P1|Overall Study|Withdrawal by Subject|1
820180|NCT02070965|2685927|P3|Overall Study|Lost to Follow-up|0
820181|NCT02070965|2685928|P2|Overall Study|Lost to Follow-up|1
820182|NCT02070965|2685929|P1|Overall Study|Lost to Follow-up|0
820183|NCT02070744|2685941|P5|OLE Phase (48 Weeks)|Other|1
820184|NCT02070744|2685942|P4|OLE Phase (48 Weeks)|Other|0
820185|NCT02070744|2685943|P3|OLE Phase (48 Weeks)|Other|0
820186|NCT02070744|2685944|P2|OLE Phase (48 Weeks)|Other|0
820187|NCT02070744|2685945|P1|OLE Phase (48 Weeks)|Other|0
820188|NCT02070744|2685941|P5|OLE Phase (48 Weeks)|Withdrawal by Subject|2
820189|NCT02070744|2685942|P4|OLE Phase (48 Weeks)|Withdrawal by Subject|0
820190|NCT02070744|2685943|P3|OLE Phase (48 Weeks)|Withdrawal by Subject|0
820191|NCT02070744|2685944|P2|OLE Phase (48 Weeks)|Withdrawal by Subject|0
820192|NCT02070744|2685945|P1|OLE Phase (48 Weeks)|Withdrawal by Subject|0
820193|NCT02070744|2685941|P5|PC Phase (12 Weeks)|Randomized, but not treated|0
820194|NCT02070744|2685942|P4|PC Phase (12 Weeks)|Randomized, but not treated|1
820195|NCT02070744|2685943|P3|PC Phase (12 Weeks)|Randomized, but not treated|0
820196|NCT02070744|2685944|P2|PC Phase (12 Weeks)|Randomized, but not treated|0
820197|NCT02070744|2685945|P1|PC Phase (12 Weeks)|Randomized, but not treated|0
820198|NCT02070588|2686028|P3|Overall Study|Adverse Event|0
820199|NCT02070588|2686029|P2|Overall Study|Adverse Event|0
820200|NCT02070588|2686030|P1|Overall Study|Adverse Event|1
820201|NCT02070588|2686028|P3|Overall Study|Writhdrawal due to early termination|0
820202|NCT02070588|2686029|P2|Overall Study|Writhdrawal due to early termination|0
820203|NCT02070588|2686030|P1|Overall Study|Writhdrawal due to early termination|9
820204|NCT02070588|2686028|P3|Overall Study|Withdrawal by Subject|0
820205|NCT02070588|2686029|P2|Overall Study|Withdrawal by Subject|1
820206|NCT02070588|2686030|P1|Overall Study|Withdrawal by Subject|29
820207|NCT02070484|2686046|P2|Overall Study|Withdrawal by Subject|0
820208|NCT02070484|2686047|P1|Overall Study|Withdrawal by Subject|1
820209|NCT02070380|2686069|P4|Second Injection|Protocol Violation|5
820210|NCT02070380|2686070|P3|Second Injection|Protocol Violation|1
820211|NCT02070380|2686071|P2|Second Injection|Protocol Violation|1
820212|NCT02070380|2686072|P1|Second Injection|Protocol Violation|0
820213|NCT02070380|2686069|P4|Second Injection|Image sets missing or technically inadeq|0
820214|NCT02070380|2686070|P3|Second Injection|Image sets missing or technically inadeq|0
820215|NCT02070380|2686071|P2|Second Injection|Image sets missing or technically inadeq|1
820216|NCT02070380|2686072|P1|Second Injection|Image sets missing or technically inadeq|0
820217|NCT02070380|2686069|P4|Washout (no Second Injection/MRI)|Withdrawal by Subject|3
820218|NCT02070380|2686070|P3|Washout (no Second Injection/MRI)|Withdrawal by Subject|2
820219|NCT02070380|2686071|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|5
820220|NCT02070380|2686072|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|0
820221|NCT02069379|2686152|P4|Second Treatment Arm|Lost to Follow-up|0
820222|NCT02069379|2686153|P3|Second Treatment Arm|Lost to Follow-up|1
820223|NCT02069379|2686154|P2|Second Treatment Arm|Lost to Follow-up|0
820224|NCT02069379|2686155|P1|Second Treatment Arm|Lost to Follow-up|0
820225|NCT02069379|2686152|P4|Washout Period (4 Weeks)|Unrelated event|0
820226|NCT02069379|2686153|P3|Washout Period (4 Weeks)|Unrelated event|0
820227|NCT02069379|2686154|P2|Washout Period (4 Weeks)|Unrelated event|1
820228|NCT02069379|2686155|P1|Washout Period (4 Weeks)|Unrelated event|0
820229|NCT02069379|2686152|P4|Washout Period (4 Weeks)|Lost to Follow-up|0
820230|NCT02069379|2686153|P3|Washout Period (4 Weeks)|Lost to Follow-up|0
820231|NCT02069379|2686154|P2|Washout Period (4 Weeks)|Lost to Follow-up|1
820232|NCT02069379|2686155|P1|Washout Period (4 Weeks)|Lost to Follow-up|0
820233|NCT02069379|2686152|P4|First Treatment Arm|Lost to Follow-up|0
820234|NCT02069379|2686153|P3|First Treatment Arm|Lost to Follow-up|1
820235|NCT02069379|2686154|P2|First Treatment Arm|Lost to Follow-up|1
820236|NCT02069379|2686155|P1|First Treatment Arm|Lost to Follow-up|0
820237|NCT02069379|2686152|P4|Baseline Measurements|Ineligible based on initial assessments|2
820238|NCT02069379|2686153|P3|Baseline Measurements|Ineligible based on initial assessments|0
820239|NCT02069379|2686154|P2|Baseline Measurements|Ineligible based on initial assessments|0
820240|NCT02069379|2686155|P1|Baseline Measurements|Ineligible based on initial assessments|2
820241|NCT02069379|2686152|P4|Baseline Measurements|Lost to Follow-up|0
820242|NCT02069379|2686153|P3|Baseline Measurements|Lost to Follow-up|0
820243|NCT02069379|2686154|P2|Baseline Measurements|Lost to Follow-up|0
820244|NCT02069379|2686155|P1|Baseline Measurements|Lost to Follow-up|1
820245|NCT02069093|2686212|P1|Overall Study|Adverse Event|10
820246|NCT02069093|2686212|P1|Overall Study|Abnormal laboratory values|1
820247|NCT02069093|2686212|P1|Overall Study|Withdrawal by Subject|2
820248|NCT02069093|2686212|P1|Overall Study|Administrative problems|1
820249|NCT02069093|2686212|P1|Overall Study|Death|1
820250|NCT02069093|2686212|P1|Overall Study|New cancer therapy|1
820251|NCT02069093|2686212|P1|Overall Study|Disease progression|14
820252|NCT02068599|2686232|P3|Overall Study|Noncompliance|1
820253|NCT02068599|2686233|P2|Overall Study|Noncompliance|0
820254|NCT02068599|2686234|P1|Overall Study|Noncompliance|0
820255|NCT02068599|2686232|P3|Overall Study|Lack of Efficacy|3
820256|NCT02068599|2686233|P2|Overall Study|Lack of Efficacy|0
820257|NCT02068599|2686234|P1|Overall Study|Lack of Efficacy|0
820258|NCT02068599|2686232|P3|Overall Study|Lost to Follow-up|0
820259|NCT02068599|2686233|P2|Overall Study|Lost to Follow-up|0
820260|NCT02068599|2686234|P1|Overall Study|Lost to Follow-up|1
820261|NCT02068599|2686232|P3|Overall Study|Protocol Violation|3
820262|NCT02068599|2686233|P2|Overall Study|Protocol Violation|2
820263|NCT02068599|2686234|P1|Overall Study|Protocol Violation|4
820264|NCT02068599|2686232|P3|Overall Study|Withdrawal by Subject|5
820265|NCT02068599|2686233|P2|Overall Study|Withdrawal by Subject|7
820266|NCT02068599|2686234|P1|Overall Study|Withdrawal by Subject|2
820267|NCT02068599|2686232|P3|Overall Study|Adverse Event|1
820268|NCT02068599|2686233|P2|Overall Study|Adverse Event|1
820269|NCT02068599|2686234|P1|Overall Study|Adverse Event|4
820270|NCT02068547|2686274|P2|Overall Study|Physician Decision|0
820271|NCT02068547|2686275|P1|Overall Study|Physician Decision|1
820272|NCT02068547|2686274|P2|Overall Study|Lost to Follow-up|3
820273|NCT02068547|2686275|P1|Overall Study|Lost to Follow-up|3
820274|NCT02068495|2686285|P1|Overall Study|Protocol Deviation|49
820275|NCT02068495|2686285|P1|Overall Study|Case Report Forms Uncollected|60
820276|NCT02068443|2686297|P3|Overall Study|Other Reason Not Specified|0
820277|NCT02068443|2686298|P2|Overall Study|Other Reason Not Specified|0
820278|NCT02068443|2686299|P1|Overall Study|Other Reason Not Specified|1
820279|NCT02068443|2686297|P3|Overall Study|Lack of Efficacy|0
820280|NCT02068443|2686298|P2|Overall Study|Lack of Efficacy|1
820281|NCT02068443|2686299|P1|Overall Study|Lack of Efficacy|2
820282|NCT02068443|2686297|P3|Overall Study|Voluntary Withdrawal|1
820283|NCT02068443|2686298|P2|Overall Study|Voluntary Withdrawal|0
820284|NCT02068443|2686299|P1|Overall Study|Voluntary Withdrawal|4
820285|NCT02068443|2686297|P3|Overall Study|Pretreatment Event/Adverse Event|2
820286|NCT02068443|2686298|P2|Overall Study|Pretreatment Event/Adverse Event|5
820287|NCT02068443|2686299|P1|Overall Study|Pretreatment Event/Adverse Event|0
820288|NCT02068222|2686334|P1|Overall Study|Lost to Follow-up|1
820289|NCT02067728|2686365|P2|6 Month Measurements|Unable to attend|97
820290|NCT02067728|2686366|P1|6 Month Measurements|Unable to attend|114
820291|NCT02067728|2686365|P2|6 Month Follow up Survey|Lost to Follow-up|60
820292|NCT02067728|2686366|P1|6 Month Follow up Survey|Lost to Follow-up|48
820293|NCT02067728|2686365|P2|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28
820294|NCT02067728|2686366|P1|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7
820295|NCT02067676|2686400|P6|Overall Study|Withdrawal by Subject|0
820296|NCT02067676|2686401|P5|Overall Study|Withdrawal by Subject|0
820297|NCT02067676|2686402|P4|Overall Study|Withdrawal by Subject|0
820298|NCT02067676|2686403|P3|Overall Study|Withdrawal by Subject|0
820299|NCT02067676|2686404|P2|Overall Study|Withdrawal by Subject|0
820300|NCT02067676|2686405|P1|Overall Study|Withdrawal by Subject|1
820301|NCT02067533|2686522|P2|Overall Study|Lost to Follow-up|2
820302|NCT02067533|2686523|P1|Overall Study|Lost to Follow-up|4
820303|NCT02066922|2686538|P1|Overall Study|Adverse Event|1
820304|NCT02066415|2686593|P3|Overall Study|Lost to Follow-up|2
820305|NCT02066415|2686594|P2|Overall Study|Lost to Follow-up|2
820306|NCT02066415|2686595|P1|Overall Study|Lost to Follow-up|7
820307|NCT02066415|2686593|P3|Overall Study|Withdrawal by Subject|4
820308|NCT02066415|2686594|P2|Overall Study|Withdrawal by Subject|1
820309|NCT02066415|2686595|P1|Overall Study|Withdrawal by Subject|9
820310|NCT02066415|2686593|P3|Overall Study|Decision by Sponsor|2
820311|NCT02066415|2686594|P2|Overall Study|Decision by Sponsor|4
820312|NCT02066415|2686595|P1|Overall Study|Decision by Sponsor|5
820313|NCT02066402|2686620|P2|Overall Study|Protocol driven decision point|1
820314|NCT02066402|2686621|P1|Overall Study|Protocol driven decision point|0
820315|NCT02066402|2686620|P2|Overall Study|Progressive disease-clinical progression|1
820316|NCT02066402|2686621|P1|Overall Study|Progressive disease-clinical progression|0
820317|NCT02066402|2686620|P2|Overall Study|Withdrawal by Subject|11
820318|NCT02066402|2686621|P1|Overall Study|Withdrawal by Subject|14
820319|NCT02066402|2686620|P2|Overall Study|Lost to Follow-up|8
820320|NCT02066402|2686621|P1|Overall Study|Lost to Follow-up|11
820321|NCT02066402|2686620|P2|Overall Study|Adverse Event|2
820322|NCT02066402|2686621|P1|Overall Study|Adverse Event|1
820323|NCT02066233|2686649|P2|EG Scan II (Day 1)|difficulty intubating subject|6
820324|NCT02066233|2686650|P1|EG Scan II (Day 1)|difficulty intubating subject|6
820325|NCT02066129|2686660|P2|Overall Study|Physician Decision|1
820326|NCT02066129|2686661|P1|Overall Study|Physician Decision|1
820327|NCT02066129|2686660|P2|Overall Study|Lack of Efficacy|10
820328|NCT02066129|2686661|P1|Overall Study|Lack of Efficacy|8
820329|NCT02066129|2686660|P2|Overall Study|Withdrawal by Subject|10
820330|NCT02066129|2686661|P1|Overall Study|Withdrawal by Subject|7
820331|NCT02066129|2686660|P2|Overall Study|Lost to Follow-up|12
820332|NCT02066129|2686661|P1|Overall Study|Lost to Follow-up|13
820333|NCT02066051|2686675|P1|Overall Study|Subject developed active GVHD|1
820334|NCT02065895|2686680|P6|Overall Study|Scheduling conflicts|0
820335|NCT02065895|2686681|P5|Overall Study|Scheduling conflicts|0
820336|NCT02065895|2686682|P4|Overall Study|Scheduling conflicts|0
820337|NCT02065895|2686683|P3|Overall Study|Scheduling conflicts|0
820338|NCT02065895|2686684|P2|Overall Study|Scheduling conflicts|1
820339|NCT02065895|2686685|P1|Overall Study|Scheduling conflicts|0
820340|NCT02065895|2686680|P6|Overall Study|Protocol Violation|0
820341|NCT02065895|2686681|P5|Overall Study|Protocol Violation|0
820342|NCT02065895|2686682|P4|Overall Study|Protocol Violation|1
820343|NCT02065895|2686683|P3|Overall Study|Protocol Violation|0
820344|NCT02065895|2686684|P2|Overall Study|Protocol Violation|0
820345|NCT02065895|2686685|P1|Overall Study|Protocol Violation|1
820346|NCT02064920|2686878|P2|Overall Study|Withdrawal by Subject|3
820347|NCT02064920|2686879|P1|Overall Study|Withdrawal by Subject|1
820348|NCT02064920|2686878|P2|Overall Study|Technical Problems|1
820349|NCT02064920|2686879|P1|Overall Study|Technical Problems|0
820350|NCT02064920|2686878|P2|Overall Study|Physician Decision|1
820351|NCT02064920|2686879|P1|Overall Study|Physician Decision|0
820352|NCT02064920|2686878|P2|Overall Study|Adverse Event|4
820353|NCT02064920|2686879|P1|Overall Study|Adverse Event|0
820354|NCT02064894|2686909|P3|Overall Study|Withdrawal by Subject|115
820355|NCT02064894|2686910|P2|Overall Study|Withdrawal by Subject|102
820356|NCT02064894|2686911|P1|Overall Study|Withdrawal by Subject|43
820357|NCT02064816|2686924|P2|Overall Study|Other|3
820358|NCT02064816|2686925|P1|Overall Study|Other|1
820359|NCT02064816|2686924|P2|Overall Study|Therapeutic failure|1
820360|NCT02064816|2686925|P1|Overall Study|Therapeutic failure|0
820361|NCT02064816|2686924|P2|Overall Study|Lost to Follow-up|1
820362|NCT02064816|2686925|P1|Overall Study|Lost to Follow-up|2
820363|NCT02064816|2686924|P2|Overall Study|Withdrawal by Subject|1
820364|NCT02064816|2686925|P1|Overall Study|Withdrawal by Subject|2
820365|NCT02064816|2686924|P2|Overall Study|Adverse Event|2
820366|NCT02064816|2686925|P1|Overall Study|Adverse Event|3
820367|NCT02064439|2686966|P3|Overall Study|Other|7
820368|NCT02064439|2686967|P2|Overall Study|Other|2
820369|NCT02064439|2686968|P1|Overall Study|Other|2
820370|NCT02064439|2686966|P3|Overall Study|Safety outcome reached|10
820371|NCT02064439|2686967|P2|Overall Study|Safety outcome reached|20
820372|NCT02064439|2686968|P1|Overall Study|Safety outcome reached|12
820373|NCT02064439|2686966|P3|Overall Study|Efficacy outcome reached|57
820374|NCT02064439|2686967|P2|Overall Study|Efficacy outcome reached|16
820375|NCT02064439|2686968|P1|Overall Study|Efficacy outcome reached|18
820376|NCT02064439|2686966|P3|Overall Study|Logistical difficulties|2
820377|NCT02064439|2686967|P2|Overall Study|Logistical difficulties|5
820378|NCT02064439|2686968|P1|Overall Study|Logistical difficulties|6
820379|NCT02064439|2686966|P3|Overall Study|Physician Decision|1
820380|NCT02064439|2686967|P2|Overall Study|Physician Decision|1
820381|NCT02064439|2686968|P1|Overall Study|Physician Decision|0
820382|NCT02064439|2686966|P3|Overall Study|Non-compliance with study medication|23
820383|NCT02064439|2686967|P2|Overall Study|Non-compliance with study medication|19
820384|NCT02064439|2686968|P1|Overall Study|Non-compliance with study medication|21
820385|NCT02064439|2686966|P3|Overall Study|Lost to Follow-up|4
820386|NCT02064439|2686967|P2|Overall Study|Lost to Follow-up|3
820387|NCT02064439|2686968|P1|Overall Study|Lost to Follow-up|1
820388|NCT02064439|2686966|P3|Overall Study|Protocol Violation|3
820389|NCT02064439|2686967|P2|Overall Study|Protocol Violation|5
820390|NCT02064439|2686968|P1|Overall Study|Protocol Violation|3
820391|NCT02064439|2686966|P3|Overall Study|Withdrawal by Subject|26
820392|NCT02064439|2686967|P2|Overall Study|Withdrawal by Subject|18
820393|NCT02064439|2686968|P1|Overall Study|Withdrawal by Subject|29
820394|NCT02064439|2686966|P3|Overall Study|Death|3
820395|NCT02064439|2686967|P2|Overall Study|Death|2
820396|NCT02064439|2686968|P1|Overall Study|Death|0
820397|NCT02064439|2686966|P3|Overall Study|Adverse Event|46
820398|NCT02064439|2686967|P2|Overall Study|Adverse Event|47
820399|NCT02064439|2686968|P1|Overall Study|Adverse Event|51
820400|NCT02064231|2687003|P4|Second Test Period (Test B or Test D)|Lack of Efficacy|0
820401|NCT02064231|2687004|P3|Second Test Period (Test B or Test D)|Lack of Efficacy|0
820402|NCT02064231|2687005|P2|Second Test Period (Test B or Test D)|Lack of Efficacy|1
820403|NCT02064231|2687006|P1|Second Test Period (Test B or Test D)|Lack of Efficacy|1
820404|NCT02064231|2687003|P4|First Test Period (Test A or Test C)|Adverse Event|0
820405|NCT02064231|2687004|P3|First Test Period (Test A or Test C)|Adverse Event|1
820406|NCT02064231|2687005|P2|First Test Period (Test A or Test C)|Adverse Event|0
820407|NCT02064231|2687006|P1|First Test Period (Test A or Test C)|Adverse Event|1
820408|NCT02064231|2687003|P4|First Test Period (Test A or Test C)|Withdrawal by Subject|0
820409|NCT02064231|2687004|P3|First Test Period (Test A or Test C)|Withdrawal by Subject|0
820410|NCT02064231|2687005|P2|First Test Period (Test A or Test C)|Withdrawal by Subject|1
820411|NCT02064231|2687006|P1|First Test Period (Test A or Test C)|Withdrawal by Subject|1
820412|NCT02064231|2687003|P4|First Test Period (Test A or Test C)|Lack of Efficacy|0
820413|NCT02064231|2687004|P3|First Test Period (Test A or Test C)|Lack of Efficacy|0
820414|NCT02064231|2687005|P2|First Test Period (Test A or Test C)|Lack of Efficacy|3
820415|NCT02064231|2687006|P1|First Test Period (Test A or Test C)|Lack of Efficacy|5
820416|NCT02064205|2687018|P1|Overall Study|Withdrawal by Subject|1
820417|NCT02064166|2687036|P2|Overall Study|Adverse Event|0
820418|NCT02064166|2687037|P1|Overall Study|Adverse Event|1
820419|NCT02063880|2687067|P2|Overall Study|Ineligible|2
820420|NCT02063880|2687068|P1|Overall Study|Ineligible|0
820421|NCT02063880|2687067|P2|Overall Study|Lost to Follow-up|7
820422|NCT02063880|2687068|P1|Overall Study|Lost to Follow-up|7
820423|NCT02063880|2687067|P2|Overall Study|Death|18
820424|NCT02063880|2687068|P1|Overall Study|Death|21
820425|NCT02063854|2687085|P7|Overall Study|Did Not Receive Study Drug|0
820426|NCT02063854|2687086|P6|Overall Study|Did Not Receive Study Drug|1
820427|NCT02063854|2687087|P5|Overall Study|Did Not Receive Study Drug|0
820428|NCT02063854|2687088|P4|Overall Study|Did Not Receive Study Drug|0
820429|NCT02063854|2687089|P3|Overall Study|Did Not Receive Study Drug|0
820430|NCT02063854|2687090|P2|Overall Study|Did Not Receive Study Drug|0
820431|NCT02063854|2687091|P1|Overall Study|Did Not Receive Study Drug|0
820432|NCT02063854|2687085|P7|Overall Study|Reason Not Specified|0
820433|NCT02063854|2687086|P6|Overall Study|Reason Not Specified|0
820434|NCT02063854|2687087|P5|Overall Study|Reason Not Specified|0
820435|NCT02063854|2687088|P4|Overall Study|Reason Not Specified|0
820436|NCT02063854|2687089|P3|Overall Study|Reason Not Specified|0
820437|NCT02063854|2687090|P2|Overall Study|Reason Not Specified|0
820438|NCT02063854|2687091|P1|Overall Study|Reason Not Specified|1
820439|NCT02063854|2687085|P7|Overall Study|Surgical Dental Work Performed/Planned|1
820440|NCT02063854|2687086|P6|Overall Study|Surgical Dental Work Performed/Planned|6
820441|NCT02063854|2687087|P5|Overall Study|Surgical Dental Work Performed/Planned|1
820442|NCT02063854|2687088|P4|Overall Study|Surgical Dental Work Performed/Planned|1
820443|NCT02063854|2687089|P3|Overall Study|Surgical Dental Work Performed/Planned|6
820444|NCT02063854|2687090|P2|Overall Study|Surgical Dental Work Performed/Planned|2
820445|NCT02063854|2687091|P1|Overall Study|Surgical Dental Work Performed/Planned|5
820446|NCT02063854|2687085|P7|Overall Study|Voluntary Withdrawal|1
820447|NCT02063854|2687086|P6|Overall Study|Voluntary Withdrawal|6
820448|NCT02063854|2687087|P5|Overall Study|Voluntary Withdrawal|3
820449|NCT02063854|2687088|P4|Overall Study|Voluntary Withdrawal|1
820450|NCT02063854|2687089|P3|Overall Study|Voluntary Withdrawal|8
820451|NCT02063854|2687090|P2|Overall Study|Voluntary Withdrawal|0
820452|NCT02063854|2687091|P1|Overall Study|Voluntary Withdrawal|2
820453|NCT02063854|2687085|P7|Overall Study|Major Protocol Deviation|0
820454|NCT02063854|2687086|P6|Overall Study|Major Protocol Deviation|0
820455|NCT02063854|2687087|P5|Overall Study|Major Protocol Deviation|0
820456|NCT02063854|2687088|P4|Overall Study|Major Protocol Deviation|0
820457|NCT02063854|2687089|P3|Overall Study|Major Protocol Deviation|3
820458|NCT02063854|2687090|P2|Overall Study|Major Protocol Deviation|0
820459|NCT02063854|2687091|P1|Overall Study|Major Protocol Deviation|0
820460|NCT02063854|2687085|P7|Overall Study|Pretreatment Event/Adverse Event|4
820461|NCT02063854|2687086|P6|Overall Study|Pretreatment Event/Adverse Event|18
820462|NCT02063854|2687087|P5|Overall Study|Pretreatment Event/Adverse Event|7
820463|NCT02063854|2687088|P4|Overall Study|Pretreatment Event/Adverse Event|8
820464|NCT02063854|2687089|P3|Overall Study|Pretreatment Event/Adverse Event|13
820465|NCT02063854|2687090|P2|Overall Study|Pretreatment Event/Adverse Event|10
820466|NCT02063854|2687091|P1|Overall Study|Pretreatment Event/Adverse Event|13
820467|NCT02063737|2687175|P2|Overall Study|Lost to Follow-up|4
820468|NCT02063737|2687176|P1|Overall Study|Lost to Follow-up|11
820469|NCT02063672|2687210|P2|Overall Study|Withdrawal by Subject|2
820470|NCT02063672|2687211|P1|Overall Study|Withdrawal by Subject|2
820471|NCT02063672|2687210|P2|Overall Study|Lost to Follow-up|3
820472|NCT02063672|2687211|P1|Overall Study|Lost to Follow-up|1
820473|NCT02063672|2687210|P2|Overall Study|Death|3
820474|NCT02063672|2687211|P1|Overall Study|Death|5
820475|NCT02063672|2687210|P2|Overall Study|Ongoing Follow-up|14
820476|NCT02063672|2687211|P1|Overall Study|Ongoing Follow-up|27
820477|NCT02063659|2687258|P4|Open-Label Extension Period (OLE)|Reason not Specified|2
820478|NCT02063659|2687259|P3|Open-Label Extension Period (OLE)|Reason not Specified|0
820479|NCT02063659|2687260|P2|Open-Label Extension Period (OLE)|Reason not Specified|0
820480|NCT02063659|2687261|P1|Open-Label Extension Period (OLE)|Reason not Specified|0
820481|NCT02063659|2687258|P4|Open-Label Extension Period (OLE)|Adverse Event|7
820482|NCT02063659|2687259|P3|Open-Label Extension Period (OLE)|Adverse Event|0
820483|NCT02063659|2687260|P2|Open-Label Extension Period (OLE)|Adverse Event|0
820484|NCT02063659|2687261|P1|Open-Label Extension Period (OLE)|Adverse Event|0
820485|NCT02063659|2687258|P4|Open-Label Extension Period (OLE)|Lack of Efficacy|1
820486|NCT02063659|2687259|P3|Open-Label Extension Period (OLE)|Lack of Efficacy|0
820487|NCT02063659|2687260|P2|Open-Label Extension Period (OLE)|Lack of Efficacy|0
820488|NCT02063659|2687261|P1|Open-Label Extension Period (OLE)|Lack of Efficacy|0
820489|NCT02063659|2687258|P4|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
820490|NCT02063659|2687259|P3|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
820491|NCT02063659|2687260|P2|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
820492|NCT02063659|2687261|P1|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
820493|NCT02063659|2687258|P4|Open-Label Extension Period (OLE)|Physician Decision|1
820494|NCT02063659|2687259|P3|Open-Label Extension Period (OLE)|Physician Decision|0
820495|NCT02063659|2687260|P2|Open-Label Extension Period (OLE)|Physician Decision|0
820496|NCT02063659|2687261|P1|Open-Label Extension Period (OLE)|Physician Decision|0
820497|NCT02063659|2687258|P4|Double-Blind Treatment Period|Withdrawal of consent|0
820498|NCT02063659|2687259|P3|Double-Blind Treatment Period|Withdrawal of consent|3
820499|NCT02063659|2687260|P2|Double-Blind Treatment Period|Withdrawal of consent|1
820500|NCT02063659|2687261|P1|Double-Blind Treatment Period|Withdrawal of consent|0
820501|NCT02063659|2687258|P4|Double-Blind Treatment Period|Physician Decision|0
820502|NCT02063659|2687259|P3|Double-Blind Treatment Period|Physician Decision|0
820503|NCT02063659|2687260|P2|Double-Blind Treatment Period|Physician Decision|0
820504|NCT02063659|2687261|P1|Double-Blind Treatment Period|Physician Decision|1
820505|NCT02063659|2687258|P4|Double-Blind Treatment Period|Adverse Event|0
820506|NCT02063659|2687259|P3|Double-Blind Treatment Period|Adverse Event|0
820507|NCT02063659|2687260|P2|Double-Blind Treatment Period|Adverse Event|2
820508|NCT02063659|2687261|P1|Double-Blind Treatment Period|Adverse Event|1
820509|NCT02063217|2687344|P3|Overall Study|Withdrawal by Subject|0
820510|NCT02063217|2687345|P2|Overall Study|Withdrawal by Subject|0
820511|NCT02063217|2687346|P1|Overall Study|Withdrawal by Subject|1
820512|NCT02062879|2687382|P2|Overall Study|Withdrawal by Subject|1
820513|NCT02062879|2687383|P1|Overall Study|Withdrawal by Subject|4
820514|NCT02062658|2687419|P1|Overall Study|Lack of Efficacy|1
820515|NCT02062658|2687419|P1|Overall Study|Withdrawal by Subject|1
820516|NCT02062645|2687423|P1|Overall Study|Lost to Follow-up|5
820517|NCT02062645|2687423|P1|Overall Study|Protocol Violation|8
820518|NCT02062645|2687423|P1|Overall Study|Adverse Event|2
820519|NCT02062450|2687465|P1|Overall Study|No follow-up visit|124
820520|NCT02062437|2687479|P1|Overall Study|Pt. couldn't come due to med. condition|1
820521|NCT02062437|2687479|P1|Overall Study|Death|2
820522|NCT02062437|2687479|P1|Overall Study|Patient not available for the 2y visit|18
820523|NCT02062437|2687479|P1|Overall Study|Pt. didn't want to come for the 2y visit|31
820524|NCT02062385|2687492|P4|Overall Study|Lost to Follow-up|0
820525|NCT02062385|2687493|P3|Overall Study|Lost to Follow-up|1
820526|NCT02062385|2687494|P2|Overall Study|Lost to Follow-up|0
820527|NCT02062385|2687495|P1|Overall Study|Lost to Follow-up|0
820528|NCT02062385|2687492|P4|Overall Study|Death|1
820529|NCT02062385|2687493|P3|Overall Study|Death|0
820530|NCT02062385|2687494|P2|Overall Study|Death|0
820531|NCT02062385|2687495|P1|Overall Study|Death|0
820532|NCT02062385|2687492|P4|Overall Study|Withdrawn by parent/guardian|8
820533|NCT02062385|2687493|P3|Overall Study|Withdrawn by parent/guardian|9
820534|NCT02062385|2687494|P2|Overall Study|Withdrawn by parent/guardian|41
820535|NCT02062385|2687495|P1|Overall Study|Withdrawn by parent/guardian|46
820536|NCT02062385|2687492|P4|Overall Study|Moved|0
820537|NCT02062385|2687493|P3|Overall Study|Moved|1
820538|NCT02062385|2687494|P2|Overall Study|Moved|11
820539|NCT02062385|2687495|P1|Overall Study|Moved|10
820540|NCT02062385|2687492|P4|Overall Study|Incomplete EPI by database lock|0
820541|NCT02062385|2687493|P3|Overall Study|Incomplete EPI by database lock|0
820542|NCT02062385|2687494|P2|Overall Study|Incomplete EPI by database lock|0
820543|NCT02062385|2687495|P1|Overall Study|Incomplete EPI by database lock|2
820544|NCT02062385|2687492|P4|Overall Study|Protocol Violation|0
820545|NCT02062385|2687493|P3|Overall Study|Protocol Violation|0
820546|NCT02062385|2687494|P2|Overall Study|Protocol Violation|0
820547|NCT02062385|2687495|P1|Overall Study|Protocol Violation|1
820548|NCT02062385|2687492|P4|Overall Study|Adverse Event|0
820549|NCT02062385|2687493|P3|Overall Study|Adverse Event|1
820550|NCT02062385|2687494|P2|Overall Study|Adverse Event|13
820551|NCT02062385|2687495|P1|Overall Study|Adverse Event|19
820552|NCT02061592|2687679|P2|Period 2|Lost to Follow-up|1
820553|NCT02061592|2687680|P1|Period 2|Lost to Follow-up|0
820554|NCT02061592|2687679|P2|Period 1|Protocol Violation|0
820555|NCT02061592|2687680|P1|Period 1|Protocol Violation|1
820556|NCT02061592|2687679|P2|Period 1|Withdrawal by Subject|0
820557|NCT02061592|2687680|P1|Period 1|Withdrawal by Subject|1
820558|NCT02061540|2687692|P1|Overall Study|Withdrawal by Subject|2
820559|NCT02061540|2687692|P1|Overall Study|Adverse Event|2
820560|NCT02061280|2687860|P2|Overall Study|Lost to Follow-up|1
820561|NCT02061280|2687861|P1|Overall Study|Lost to Follow-up|5
820562|NCT02061280|2687860|P2|Overall Study|Withdrawal by Subject|2
820563|NCT02061280|2687861|P1|Overall Study|Withdrawal by Subject|1
820564|NCT02061280|2687860|P2|Overall Study|moved out of state|1
820565|NCT02061280|2687861|P1|Overall Study|moved out of state|0
820566|NCT02061280|2687860|P2|Overall Study|Protocol Violation|8
820567|NCT02061280|2687861|P1|Overall Study|Protocol Violation|12
820568|NCT02059980|2688013|P2|Overall Study|Lost to Follow-up|1
820569|NCT02059980|2688014|P1|Overall Study|Lost to Follow-up|2
820570|NCT02059395|2688052|P2|Overall Study|Lost to Follow-up|4
820571|NCT02059395|2688053|P1|Overall Study|Lost to Follow-up|2
820572|NCT02059291|2688068|P25|Epoch 4|Lack of Efficacy|0
820573|NCT02059291|2688069|P24|Epoch 4|Lack of Efficacy|1
820574|NCT02059291|2688070|P23|Epoch 4|Lack of Efficacy|0
820575|NCT02059291|2688071|P22|Epoch 4|Lack of Efficacy|0
820576|NCT02059291|2688072|P21|Epoch 4|Lack of Efficacy|0
820577|NCT02059291|2688073|P20|Epoch 4|Lack of Efficacy|0
820578|NCT02059291|2688074|P19|Epoch 4|Lack of Efficacy|0
820579|NCT02059291|2688075|P18|Epoch 4|Lack of Efficacy|0
820580|NCT02059291|2688076|P17|Epoch 4|Lack of Efficacy|0
820581|NCT02059291|2688077|P16|Epoch 4|Lack of Efficacy|0
820582|NCT02059291|2688078|P15|Epoch 4|Lack of Efficacy|0
820583|NCT02059291|2688079|P14|Epoch 4|Lack of Efficacy|0
820584|NCT02059291|2688080|P13|Epoch 4|Lack of Efficacy|0
820585|NCT02059291|2688081|P12|Epoch 4|Lack of Efficacy|0
820586|NCT02059291|2688082|P11|Epoch 4|Lack of Efficacy|0
820587|NCT02059291|2688083|P10|Epoch 4|Lack of Efficacy|0
820588|NCT02059291|2688084|P9|Epoch 4|Lack of Efficacy|0
820589|NCT02059291|2688085|P8|Epoch 4|Lack of Efficacy|0
820590|NCT02059291|2688086|P7|Epoch 4|Lack of Efficacy|0
820591|NCT02059291|2688087|P6|Epoch 4|Lack of Efficacy|0
820592|NCT02059291|2688088|P5|Epoch 4|Lack of Efficacy|0
820593|NCT02059291|2688089|P4|Epoch 4|Lack of Efficacy|0
820594|NCT02059291|2688090|P3|Epoch 4|Lack of Efficacy|0
820595|NCT02059291|2688091|P2|Epoch 4|Lack of Efficacy|0
820596|NCT02059291|2688092|P1|Epoch 4|Lack of Efficacy|0
820597|NCT02059291|2688068|P25|Epoch 4|Withdrawal by Subject|0
820598|NCT02059291|2688069|P24|Epoch 4|Withdrawal by Subject|0
820599|NCT02059291|2688070|P23|Epoch 4|Withdrawal by Subject|0
820600|NCT02059291|2688071|P22|Epoch 4|Withdrawal by Subject|0
820601|NCT02059291|2688072|P21|Epoch 4|Withdrawal by Subject|1
820602|NCT02059291|2688073|P20|Epoch 4|Withdrawal by Subject|0
820603|NCT02059291|2688074|P19|Epoch 4|Withdrawal by Subject|0
820604|NCT02059291|2688075|P18|Epoch 4|Withdrawal by Subject|0
820605|NCT02059291|2688076|P17|Epoch 4|Withdrawal by Subject|0
820606|NCT02059291|2688077|P16|Epoch 4|Withdrawal by Subject|0
820607|NCT02059291|2688078|P15|Epoch 4|Withdrawal by Subject|0
820608|NCT02059291|2688079|P14|Epoch 4|Withdrawal by Subject|0
820609|NCT02059291|2688080|P13|Epoch 4|Withdrawal by Subject|0
820610|NCT02059291|2688081|P12|Epoch 4|Withdrawal by Subject|0
820611|NCT02059291|2688082|P11|Epoch 4|Withdrawal by Subject|0
820612|NCT02059291|2688083|P10|Epoch 4|Withdrawal by Subject|0
820613|NCT02059291|2688084|P9|Epoch 4|Withdrawal by Subject|0
820614|NCT02059291|2688085|P8|Epoch 4|Withdrawal by Subject|0
820615|NCT02059291|2688086|P7|Epoch 4|Withdrawal by Subject|0
820616|NCT02059291|2688087|P6|Epoch 4|Withdrawal by Subject|0
820617|NCT02059291|2688088|P5|Epoch 4|Withdrawal by Subject|0
820618|NCT02059291|2688089|P4|Epoch 4|Withdrawal by Subject|0
820619|NCT02059291|2688090|P3|Epoch 4|Withdrawal by Subject|0
820620|NCT02059291|2688091|P2|Epoch 4|Withdrawal by Subject|0
820621|NCT02059291|2688092|P1|Epoch 4|Withdrawal by Subject|0
820622|NCT02059291|2688068|P25|Epoch 4|Pregnancy|0
820623|NCT02059291|2688069|P24|Epoch 4|Pregnancy|0
820624|NCT02059291|2688070|P23|Epoch 4|Pregnancy|0
820625|NCT02059291|2688071|P22|Epoch 4|Pregnancy|0
820626|NCT02059291|2688072|P21|Epoch 4|Pregnancy|0
820627|NCT02059291|2688073|P20|Epoch 4|Pregnancy|0
820628|NCT02059291|2688074|P19|Epoch 4|Pregnancy|0
820629|NCT02059291|2688075|P18|Epoch 4|Pregnancy|0
820630|NCT02059291|2688076|P17|Epoch 4|Pregnancy|1
820631|NCT02059291|2688077|P16|Epoch 4|Pregnancy|0
820632|NCT02059291|2688078|P15|Epoch 4|Pregnancy|0
820633|NCT02059291|2688079|P14|Epoch 4|Pregnancy|0
820634|NCT02059291|2688080|P13|Epoch 4|Pregnancy|0
820635|NCT02059291|2688081|P12|Epoch 4|Pregnancy|0
820636|NCT02059291|2688082|P11|Epoch 4|Pregnancy|0
820637|NCT02059291|2688083|P10|Epoch 4|Pregnancy|0
820638|NCT02059291|2688084|P9|Epoch 4|Pregnancy|0
820639|NCT02059291|2688085|P8|Epoch 4|Pregnancy|0
820640|NCT02059291|2688086|P7|Epoch 4|Pregnancy|0
820641|NCT02059291|2688087|P6|Epoch 4|Pregnancy|0
820642|NCT02059291|2688088|P5|Epoch 4|Pregnancy|0
820643|NCT02059291|2688089|P4|Epoch 4|Pregnancy|0
820644|NCT02059291|2688090|P3|Epoch 4|Pregnancy|0
820645|NCT02059291|2688091|P2|Epoch 4|Pregnancy|0
820646|NCT02059291|2688092|P1|Epoch 4|Pregnancy|0
820647|NCT02059291|2688068|P25|Epoch 4|Adverse Event|0
820648|NCT02059291|2688069|P24|Epoch 4|Adverse Event|0
820649|NCT02059291|2688070|P23|Epoch 4|Adverse Event|1
820650|NCT02059291|2688071|P22|Epoch 4|Adverse Event|0
820651|NCT02059291|2688072|P21|Epoch 4|Adverse Event|0
820652|NCT02059291|2688073|P20|Epoch 4|Adverse Event|0
820653|NCT02059291|2688074|P19|Epoch 4|Adverse Event|0
820654|NCT02059291|2688075|P18|Epoch 4|Adverse Event|0
820655|NCT02059291|2688076|P17|Epoch 4|Adverse Event|1
820656|NCT02059291|2688077|P16|Epoch 4|Adverse Event|0
820657|NCT02059291|2688078|P15|Epoch 4|Adverse Event|0
820658|NCT02059291|2688079|P14|Epoch 4|Adverse Event|0
820659|NCT02059291|2688080|P13|Epoch 4|Adverse Event|0
820660|NCT02059291|2688081|P12|Epoch 4|Adverse Event|0
820661|NCT02059291|2688082|P11|Epoch 4|Adverse Event|0
820662|NCT02059291|2688083|P10|Epoch 4|Adverse Event|0
820663|NCT02059291|2688084|P9|Epoch 4|Adverse Event|0
820664|NCT02059291|2688085|P8|Epoch 4|Adverse Event|0
820665|NCT02059291|2688086|P7|Epoch 4|Adverse Event|0
820666|NCT02059291|2688087|P6|Epoch 4|Adverse Event|0
820667|NCT02059291|2688088|P5|Epoch 4|Adverse Event|0
820668|NCT02059291|2688089|P4|Epoch 4|Adverse Event|0
820669|NCT02059291|2688090|P3|Epoch 4|Adverse Event|0
820670|NCT02059291|2688091|P2|Epoch 4|Adverse Event|0
820671|NCT02059291|2688092|P1|Epoch 4|Adverse Event|0
820672|NCT02059291|2688068|P25|Epoch 3|Withdrawal by Subject|0
820673|NCT02059291|2688069|P24|Epoch 3|Withdrawal by Subject|0
820674|NCT02059291|2688070|P23|Epoch 3|Withdrawal by Subject|0
820675|NCT02059291|2688071|P22|Epoch 3|Withdrawal by Subject|0
820676|NCT02059291|2688072|P21|Epoch 3|Withdrawal by Subject|0
820677|NCT02059291|2688073|P20|Epoch 3|Withdrawal by Subject|0
820678|NCT02059291|2688074|P19|Epoch 3|Withdrawal by Subject|0
820679|NCT02059291|2688075|P18|Epoch 3|Withdrawal by Subject|0
820680|NCT02059291|2688076|P17|Epoch 3|Withdrawal by Subject|0
820681|NCT02059291|2688077|P16|Epoch 3|Withdrawal by Subject|1
820682|NCT02059291|2688078|P15|Epoch 3|Withdrawal by Subject|0
820683|NCT02059291|2688079|P14|Epoch 3|Withdrawal by Subject|0
820684|NCT02059291|2688080|P13|Epoch 3|Withdrawal by Subject|0
820685|NCT02059291|2688081|P12|Epoch 3|Withdrawal by Subject|0
820686|NCT02059291|2688082|P11|Epoch 3|Withdrawal by Subject|0
820687|NCT02059291|2688083|P10|Epoch 3|Withdrawal by Subject|0
820688|NCT02059291|2688084|P9|Epoch 3|Withdrawal by Subject|0
820689|NCT02059291|2688085|P8|Epoch 3|Withdrawal by Subject|0
820690|NCT02059291|2688086|P7|Epoch 3|Withdrawal by Subject|0
820691|NCT02059291|2688087|P6|Epoch 3|Withdrawal by Subject|0
820692|NCT02059291|2688088|P5|Epoch 3|Withdrawal by Subject|0
820693|NCT02059291|2688089|P4|Epoch 3|Withdrawal by Subject|0
820694|NCT02059291|2688090|P3|Epoch 3|Withdrawal by Subject|0
820695|NCT02059291|2688091|P2|Epoch 3|Withdrawal by Subject|0
820696|NCT02059291|2688092|P1|Epoch 3|Withdrawal by Subject|0
820697|NCT02059291|2688068|P25|Epoch 3|Lack of Efficacy|0
820698|NCT02059291|2688069|P24|Epoch 3|Lack of Efficacy|0
820699|NCT02059291|2688070|P23|Epoch 3|Lack of Efficacy|0
820700|NCT02059291|2688071|P22|Epoch 3|Lack of Efficacy|0
820701|NCT02059291|2688072|P21|Epoch 3|Lack of Efficacy|0
820702|NCT02059291|2688073|P20|Epoch 3|Lack of Efficacy|0
820703|NCT02059291|2688074|P19|Epoch 3|Lack of Efficacy|0
820704|NCT02059291|2688075|P18|Epoch 3|Lack of Efficacy|0
820705|NCT02059291|2688076|P17|Epoch 3|Lack of Efficacy|0
820706|NCT02059291|2688077|P16|Epoch 3|Lack of Efficacy|3
820707|NCT02059291|2688078|P15|Epoch 3|Lack of Efficacy|0
820708|NCT02059291|2688079|P14|Epoch 3|Lack of Efficacy|0
820709|NCT02059291|2688080|P13|Epoch 3|Lack of Efficacy|0
820710|NCT02059291|2688081|P12|Epoch 3|Lack of Efficacy|0
820711|NCT02059291|2688082|P11|Epoch 3|Lack of Efficacy|0
820712|NCT02059291|2688083|P10|Epoch 3|Lack of Efficacy|0
820713|NCT02059291|2688084|P9|Epoch 3|Lack of Efficacy|0
820714|NCT02059291|2688085|P8|Epoch 3|Lack of Efficacy|0
820715|NCT02059291|2688086|P7|Epoch 3|Lack of Efficacy|0
820716|NCT02059291|2688087|P6|Epoch 3|Lack of Efficacy|0
820717|NCT02059291|2688088|P5|Epoch 3|Lack of Efficacy|0
820718|NCT02059291|2688089|P4|Epoch 3|Lack of Efficacy|0
820719|NCT02059291|2688090|P3|Epoch 3|Lack of Efficacy|0
820720|NCT02059291|2688091|P2|Epoch 3|Lack of Efficacy|0
820721|NCT02059291|2688092|P1|Epoch 3|Lack of Efficacy|0
820722|NCT02059291|2688068|P25|Epoch 3|Adverse Event|0
820723|NCT02059291|2688069|P24|Epoch 3|Adverse Event|0
820724|NCT02059291|2688070|P23|Epoch 3|Adverse Event|0
820725|NCT02059291|2688071|P22|Epoch 3|Adverse Event|0
820726|NCT02059291|2688072|P21|Epoch 3|Adverse Event|0
820727|NCT02059291|2688073|P20|Epoch 3|Adverse Event|0
820728|NCT02059291|2688074|P19|Epoch 3|Adverse Event|0
820729|NCT02059291|2688075|P18|Epoch 3|Adverse Event|0
820730|NCT02059291|2688076|P17|Epoch 3|Adverse Event|0
820731|NCT02059291|2688077|P16|Epoch 3|Adverse Event|1
820732|NCT02059291|2688078|P15|Epoch 3|Adverse Event|0
820733|NCT02059291|2688079|P14|Epoch 3|Adverse Event|0
820734|NCT02059291|2688080|P13|Epoch 3|Adverse Event|0
820735|NCT02059291|2688081|P12|Epoch 3|Adverse Event|0
820736|NCT02059291|2688082|P11|Epoch 3|Adverse Event|0
820737|NCT02059291|2688083|P10|Epoch 3|Adverse Event|0
820738|NCT02059291|2688084|P9|Epoch 3|Adverse Event|0
820739|NCT02059291|2688085|P8|Epoch 3|Adverse Event|0
820740|NCT02059291|2688086|P7|Epoch 3|Adverse Event|0
820741|NCT02059291|2688087|P6|Epoch 3|Adverse Event|0
820742|NCT02059291|2688088|P5|Epoch 3|Adverse Event|0
820743|NCT02059291|2688089|P4|Epoch 3|Adverse Event|0
820744|NCT02059291|2688090|P3|Epoch 3|Adverse Event|0
820745|NCT02059291|2688091|P2|Epoch 3|Adverse Event|0
820746|NCT02059291|2688092|P1|Epoch 3|Adverse Event|0
820747|NCT02059291|2688068|P25|Epoch 3|Physician Decision|0
820748|NCT02059291|2688069|P24|Epoch 3|Physician Decision|0
820749|NCT02059291|2688070|P23|Epoch 3|Physician Decision|0
820750|NCT02059291|2688071|P22|Epoch 3|Physician Decision|0
820751|NCT02059291|2688072|P21|Epoch 3|Physician Decision|0
820752|NCT02059291|2688073|P20|Epoch 3|Physician Decision|0
820753|NCT02059291|2688074|P19|Epoch 3|Physician Decision|0
820754|NCT02059291|2688075|P18|Epoch 3|Physician Decision|0
820755|NCT02059291|2688076|P17|Epoch 3|Physician Decision|0
820756|NCT02059291|2688077|P16|Epoch 3|Physician Decision|1
820757|NCT02059291|2688078|P15|Epoch 3|Physician Decision|0
820758|NCT02059291|2688079|P14|Epoch 3|Physician Decision|1
820759|NCT02059291|2688080|P13|Epoch 3|Physician Decision|0
820760|NCT02059291|2688081|P12|Epoch 3|Physician Decision|0
820761|NCT02059291|2688082|P11|Epoch 3|Physician Decision|0
820762|NCT02059291|2688083|P10|Epoch 3|Physician Decision|0
820763|NCT02059291|2688084|P9|Epoch 3|Physician Decision|0
820764|NCT02059291|2688085|P8|Epoch 3|Physician Decision|0
820765|NCT02059291|2688086|P7|Epoch 3|Physician Decision|0
820766|NCT02059291|2688087|P6|Epoch 3|Physician Decision|0
820767|NCT02059291|2688088|P5|Epoch 3|Physician Decision|0
820768|NCT02059291|2688089|P4|Epoch 3|Physician Decision|0
820769|NCT02059291|2688090|P3|Epoch 3|Physician Decision|0
820770|NCT02059291|2688091|P2|Epoch 3|Physician Decision|0
820771|NCT02059291|2688092|P1|Epoch 3|Physician Decision|0
820772|NCT02059291|2688068|P25|Epoch 2|Withdrawal by Subject|0
820773|NCT02059291|2688069|P24|Epoch 2|Withdrawal by Subject|0
820774|NCT02059291|2688070|P23|Epoch 2|Withdrawal by Subject|0
820775|NCT02059291|2688071|P22|Epoch 2|Withdrawal by Subject|0
820776|NCT02059291|2688072|P21|Epoch 2|Withdrawal by Subject|0
820777|NCT02059291|2688073|P20|Epoch 2|Withdrawal by Subject|0
820778|NCT02059291|2688074|P19|Epoch 2|Withdrawal by Subject|0
820779|NCT02059291|2688075|P18|Epoch 2|Withdrawal by Subject|0
820780|NCT02059291|2688076|P17|Epoch 2|Withdrawal by Subject|0
820781|NCT02059291|2688077|P16|Epoch 2|Withdrawal by Subject|0
820782|NCT02059291|2688078|P15|Epoch 2|Withdrawal by Subject|0
820783|NCT02059291|2688079|P14|Epoch 2|Withdrawal by Subject|0
820784|NCT02059291|2688080|P13|Epoch 2|Withdrawal by Subject|0
820785|NCT02059291|2688081|P12|Epoch 2|Withdrawal by Subject|0
820786|NCT02059291|2688082|P11|Epoch 2|Withdrawal by Subject|0
820787|NCT02059291|2688083|P10|Epoch 2|Withdrawal by Subject|0
820788|NCT02059291|2688084|P9|Epoch 2|Withdrawal by Subject|1
820789|NCT02059291|2688085|P8|Epoch 2|Withdrawal by Subject|0
820790|NCT02059291|2688086|P7|Epoch 2|Withdrawal by Subject|0
820791|NCT02059291|2688087|P6|Epoch 2|Withdrawal by Subject|1
820792|NCT02059291|2688088|P5|Epoch 2|Withdrawal by Subject|0
820793|NCT02059291|2688089|P4|Epoch 2|Withdrawal by Subject|0
820794|NCT02059291|2688090|P3|Epoch 2|Withdrawal by Subject|0
820795|NCT02059291|2688091|P2|Epoch 2|Withdrawal by Subject|1
820796|NCT02059291|2688092|P1|Epoch 2|Withdrawal by Subject|0
820797|NCT02059291|2688068|P25|Epoch 2|Adverse Event|0
820798|NCT02059291|2688069|P24|Epoch 2|Adverse Event|0
820799|NCT02059291|2688070|P23|Epoch 2|Adverse Event|0
820800|NCT02059291|2688071|P22|Epoch 2|Adverse Event|0
820801|NCT02059291|2688072|P21|Epoch 2|Adverse Event|0
820802|NCT02059291|2688073|P20|Epoch 2|Adverse Event|0
820803|NCT02059291|2688074|P19|Epoch 2|Adverse Event|0
820804|NCT02059291|2688075|P18|Epoch 2|Adverse Event|0
820805|NCT02059291|2688076|P17|Epoch 2|Adverse Event|0
820806|NCT02059291|2688077|P16|Epoch 2|Adverse Event|0
820807|NCT02059291|2688078|P15|Epoch 2|Adverse Event|0
820808|NCT02059291|2688079|P14|Epoch 2|Adverse Event|0
820809|NCT02059291|2688080|P13|Epoch 2|Adverse Event|0
820810|NCT02059291|2688081|P12|Epoch 2|Adverse Event|0
820811|NCT02059291|2688082|P11|Epoch 2|Adverse Event|0
820812|NCT02059291|2688083|P10|Epoch 2|Adverse Event|0
820813|NCT02059291|2688084|P9|Epoch 2|Adverse Event|1
820814|NCT02059291|2688085|P8|Epoch 2|Adverse Event|1
820815|NCT02059291|2688086|P7|Epoch 2|Adverse Event|0
820816|NCT02059291|2688087|P6|Epoch 2|Adverse Event|0
820817|NCT02059291|2688088|P5|Epoch 2|Adverse Event|0
820818|NCT02059291|2688089|P4|Epoch 2|Adverse Event|1
820819|NCT02059291|2688090|P3|Epoch 2|Adverse Event|1
820820|NCT02059291|2688091|P2|Epoch 2|Adverse Event|0
820821|NCT02059291|2688092|P1|Epoch 2|Adverse Event|0
820822|NCT02059291|2688068|P25|Epoch 2|Lack of Efficacy|0
820823|NCT02059291|2688069|P24|Epoch 2|Lack of Efficacy|0
820824|NCT02059291|2688070|P23|Epoch 2|Lack of Efficacy|0
820825|NCT02059291|2688071|P22|Epoch 2|Lack of Efficacy|0
820826|NCT02059291|2688072|P21|Epoch 2|Lack of Efficacy|0
820827|NCT02059291|2688073|P20|Epoch 2|Lack of Efficacy|0
820828|NCT02059291|2688074|P19|Epoch 2|Lack of Efficacy|0
820829|NCT02059291|2688075|P18|Epoch 2|Lack of Efficacy|0
820830|NCT02059291|2688076|P17|Epoch 2|Lack of Efficacy|0
820831|NCT02059291|2688077|P16|Epoch 2|Lack of Efficacy|0
820832|NCT02059291|2688078|P15|Epoch 2|Lack of Efficacy|0
820833|NCT02059291|2688079|P14|Epoch 2|Lack of Efficacy|0
820834|NCT02059291|2688080|P13|Epoch 2|Lack of Efficacy|0
820835|NCT02059291|2688081|P12|Epoch 2|Lack of Efficacy|0
820836|NCT02059291|2688082|P11|Epoch 2|Lack of Efficacy|0
820837|NCT02059291|2688083|P10|Epoch 2|Lack of Efficacy|0
820838|NCT02059291|2688084|P9|Epoch 2|Lack of Efficacy|0
820839|NCT02059291|2688085|P8|Epoch 2|Lack of Efficacy|0
820840|NCT02059291|2688086|P7|Epoch 2|Lack of Efficacy|0
820841|NCT02059291|2688087|P6|Epoch 2|Lack of Efficacy|1
820842|NCT02059291|2688088|P5|Epoch 2|Lack of Efficacy|0
820843|NCT02059291|2688089|P4|Epoch 2|Lack of Efficacy|1
820844|NCT02059291|2688090|P3|Epoch 2|Lack of Efficacy|0
820845|NCT02059291|2688091|P2|Epoch 2|Lack of Efficacy|0
820846|NCT02059291|2688092|P1|Epoch 2|Lack of Efficacy|0
820847|NCT02059278|2688146|P2|Overall Study|Ran out of IP and decided to discontinue|0
820848|NCT02059278|2688147|P1|Overall Study|Ran out of IP and decided to discontinue|1
820849|NCT02059278|2688146|P2|Overall Study|Withdrawal by Subject|3
820850|NCT02059278|2688147|P1|Overall Study|Withdrawal by Subject|0
820851|NCT02059278|2688146|P2|Overall Study|Lost to Follow-up|0
820852|NCT02059278|2688147|P1|Overall Study|Lost to Follow-up|1
820853|NCT02059278|2688146|P2|Overall Study|Adverse Event|1
820854|NCT02059278|2688147|P1|Overall Study|Adverse Event|1
820855|NCT02059187|2688163|P2|Overall Study|Withdrawal by Subject|8
820856|NCT02059187|2688164|P1|Overall Study|Withdrawal by Subject|12
820857|NCT02059187|2688163|P2|Overall Study|Protocol Violation|0
820858|NCT02059187|2688164|P1|Overall Study|Protocol Violation|1
820859|NCT02059187|2688163|P2|Overall Study|Physician Decision|2
820860|NCT02059187|2688164|P1|Overall Study|Physician Decision|1
820861|NCT02059187|2688163|P2|Overall Study|Non-compliance with study drug|0
820862|NCT02059187|2688164|P1|Overall Study|Non-compliance with study drug|1
820863|NCT02059187|2688163|P2|Overall Study|Lost to Follow-up|8
820864|NCT02059187|2688164|P1|Overall Study|Lost to Follow-up|9
820865|NCT02059187|2688163|P2|Overall Study|Death|1
820866|NCT02059187|2688164|P1|Overall Study|Death|1
820867|NCT02059187|2688163|P2|Overall Study|Adverse Event|3
820868|NCT02059187|2688164|P1|Overall Study|Adverse Event|0
820869|NCT02059174|2688190|P2|Period 3|Physician Decision|0
820870|NCT02059174|2688191|P1|Period 3|Physician Decision|1
820871|NCT02059174|2688190|P2|Period 2|Protocol Violation|0
820872|NCT02059174|2688191|P1|Period 2|Protocol Violation|1
820873|NCT02059174|2688190|P2|Period 2|Withdrawal by Subject|2
820874|NCT02059174|2688191|P1|Period 2|Withdrawal by Subject|0
820875|NCT02059174|2688190|P2|Period 1|Withdrawal by Subject|2
820876|NCT02059174|2688191|P1|Period 1|Withdrawal by Subject|0
820877|NCT02059161|2688215|P2|Overall Study|Non-compliance with study drug|2
820878|NCT02059161|2688216|P1|Overall Study|Non-compliance with study drug|6
820879|NCT02059161|2688215|P2|Overall Study|Randomized in error, no study drug|1
820880|NCT02059161|2688216|P1|Overall Study|Randomized in error, no study drug|0
820881|NCT02059161|2688215|P2|Overall Study|Withdrawal by Subject|13
820882|NCT02059161|2688216|P1|Overall Study|Withdrawal by Subject|16
820883|NCT02059161|2688215|P2|Overall Study|Protocol Violation|1
820884|NCT02059161|2688216|P1|Overall Study|Protocol Violation|1
820885|NCT02059161|2688215|P2|Overall Study|Physician Decision|4
820886|NCT02059161|2688216|P1|Overall Study|Physician Decision|4
820887|NCT02059161|2688215|P2|Overall Study|Lost to Follow-up|12
820888|NCT02059161|2688216|P1|Overall Study|Lost to Follow-up|20
820889|NCT02059161|2688215|P2|Overall Study|Adverse Event|6
820890|NCT02059161|2688216|P1|Overall Study|Adverse Event|2
820891|NCT02059161|2688215|P2|Overall Study|Pregnancy|2
820892|NCT02059161|2688216|P1|Overall Study|Pregnancy|0
820893|NCT02059148|2688276|P6|Treatment 1|Protocol Violation|1
820894|NCT02059148|2688277|P5|Treatment 1|Protocol Violation|0
820895|NCT02059148|2688278|P4|Treatment 1|Protocol Violation|0
820896|NCT02059148|2688279|P3|Treatment 1|Protocol Violation|0
820897|NCT02059148|2688280|P2|Treatment 1|Protocol Violation|0
820898|NCT02059148|2688281|P1|Treatment 1|Protocol Violation|0
820899|NCT02059135|2688300|P2|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1
820900|NCT02059135|2688301|P1|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0
820901|NCT02059135|2688300|P2|Neonatal Follow-up (Safety Population)|delivered at another hospital|1
820902|NCT02059135|2688301|P1|Neonatal Follow-up (Safety Population)|delivered at another hospital|0
820903|NCT02059135|2688300|P2|Neonatal Follow-up (Safety Population)|Death|2
820904|NCT02059135|2688301|P1|Neonatal Follow-up (Safety Population)|Death|3
820905|NCT02059135|2688300|P2|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0
820906|NCT02059135|2688301|P1|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1
820907|NCT02059135|2688300|P2|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1
820908|NCT02059135|2688301|P1|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0
820909|NCT02059135|2688300|P2|Maternal Follow-up (ITT Population)|declined to see site staff|1
820910|NCT02059135|2688301|P1|Maternal Follow-up (ITT Population)|declined to see site staff|0
820911|NCT02059135|2688300|P2|Maternal Follow-up (ITT Population)|Lost to Follow-up|3
820912|NCT02059135|2688301|P1|Maternal Follow-up (ITT Population)|Lost to Follow-up|0
820913|NCT02059135|2688300|P2|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2
820914|NCT02059135|2688301|P1|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3
820915|NCT02059005|2688337|P2|Overall Study|Inpatient|1
820916|NCT02059005|2688338|P1|Overall Study|Inpatient|0
820917|NCT02059005|2688337|P2|Overall Study|Incarceration|1
820918|NCT02059005|2688338|P1|Overall Study|Incarceration|0
820919|NCT02059005|2688337|P2|Overall Study|Lost to Follow-up|19
820920|NCT02059005|2688338|P1|Overall Study|Lost to Follow-up|19
820921|NCT02059005|2688337|P2|Overall Study|Death|3
820922|NCT02059005|2688338|P1|Overall Study|Death|1
820923|NCT02058992|2688348|P1|Overall Study|CRF Uncollected|20
820924|NCT02058992|2688348|P1|Overall Study|Protocol Violation|92
820925|NCT02058992|2688348|P1|Overall Study|Lost to Follow-up|4
820926|NCT02058940|2688357|P1|Overall Study|Discharged from Critical Care Unit|1
820927|NCT02058836|2688381|P2|Overall Study|Withdrawal by Subject|1
820928|NCT02058836|2688382|P1|Overall Study|Withdrawal by Subject|1
820929|NCT02058628|2688412|P2|Overall Study|Non compliance|0
820930|NCT02058628|2688413|P1|Overall Study|Non compliance|1
820931|NCT02058628|2688412|P2|Overall Study|A lot of time for study for participant|0
820932|NCT02058628|2688413|P1|Overall Study|A lot of time for study for participant|1
820933|NCT02058628|2688412|P2|Overall Study|The visit date was not in timeline|1
820934|NCT02058628|2688413|P1|Overall Study|The visit date was not in timeline|0
820935|NCT02058628|2688412|P2|Overall Study|Not in time schedule|1
820936|NCT02058628|2688413|P1|Overall Study|Not in time schedule|0
820937|NCT02058628|2688412|P2|Overall Study|Lost to Follow-up|4
820938|NCT02058628|2688413|P1|Overall Study|Lost to Follow-up|2
820939|NCT02058628|2688412|P2|Overall Study|Withdrawal by Subject|2
820940|NCT02058628|2688413|P1|Overall Study|Withdrawal by Subject|2
820941|NCT02058628|2688412|P2|Overall Study|Adverse Event|0
820942|NCT02058628|2688413|P1|Overall Study|Adverse Event|1
820943|NCT02058589|2688445|P2|Overall Study|Withdrawal by Subject|1
820944|NCT02058589|2688446|P1|Overall Study|Withdrawal by Subject|0
820945|NCT02058589|2688445|P2|Overall Study|Non-Serious Adverse Event|0
820946|NCT02058589|2688446|P1|Overall Study|Non-Serious Adverse Event|1
820947|NCT02058589|2688445|P2|Overall Study|Serious Adverse Event|1
820948|NCT02058589|2688446|P1|Overall Study|Serious Adverse Event|1
820949|NCT02058563|2688488|P2|Overall Study|Other (patient incarcerated)|1
820950|NCT02058563|2688489|P1|Overall Study|Other (patient incarcerated)|0
820951|NCT02058563|2688488|P2|Overall Study|Consent Withdrawal|1
820952|NCT02058563|2688489|P1|Overall Study|Consent Withdrawal|1
820953|NCT02058563|2688488|P2|Overall Study|Other (vaccinated later as new subject)|0
820954|NCT02058563|2688489|P1|Overall Study|Other (vaccinated later as new subject)|1
820955|NCT02058563|2688488|P2|Overall Study|Lost to Follow-up|22
820956|NCT02058563|2688489|P1|Overall Study|Lost to Follow-up|26
820957|NCT02058537|2688525|P1|Overall Study|Withdrawal by Subject|1
820958|NCT02058498|2688531|P1|Overall Study|Withdrawal by Subject|4
820959|NCT02058290|2688539|P2|Overall Study|Withdrawal by Subject|1
820960|NCT02058290|2688540|P1|Overall Study|Withdrawal by Subject|0
820961|NCT02058290|2688539|P2|Overall Study|Didn't meet intraoperative criteria|7
820962|NCT02058290|2688540|P1|Overall Study|Didn't meet intraoperative criteria|8
820963|NCT02058290|2688539|P2|Overall Study|Physician Decision|0
820964|NCT02058290|2688540|P1|Overall Study|Physician Decision|1
820965|NCT02058290|2688539|P2|Overall Study|Protocol Violation|1
820966|NCT02058290|2688540|P1|Overall Study|Protocol Violation|2
820967|NCT02058160|2688556|P2|Overall Study|Other than specified above|6
820968|NCT02058160|2688557|P1|Overall Study|Other than specified above|12
820969|NCT02058160|2688556|P2|Overall Study|Lost to Follow-up|0
820970|NCT02058160|2688557|P1|Overall Study|Lost to Follow-up|1
820971|NCT02058160|2688556|P2|Overall Study|Adverse Event|3
820972|NCT02058160|2688557|P1|Overall Study|Adverse Event|12
820973|NCT02058160|2688556|P2|Overall Study|Poor compliance to protocol|1
820974|NCT02058160|2688557|P1|Overall Study|Poor compliance to protocol|4
820975|NCT02058160|2688556|P2|Overall Study|Randomized but not treated|4
820976|NCT02058160|2688557|P1|Overall Study|Randomized but not treated|2
820977|NCT02058147|2688594|P3|Overall Study|Other than specified|0
820978|NCT02058147|2688595|P2|Overall Study|Other than specified|9
820979|NCT02058147|2688596|P1|Overall Study|Other than specified|8
820980|NCT02058147|2688594|P3|Overall Study|Poor compliance to protocol|4
820981|NCT02058147|2688595|P2|Overall Study|Poor compliance to protocol|9
820982|NCT02058147|2688596|P1|Overall Study|Poor compliance to protocol|8
820983|NCT02058147|2688594|P3|Overall Study|Lack of Efficacy|3
820984|NCT02058147|2688595|P2|Overall Study|Lack of Efficacy|0
820985|NCT02058147|2688596|P1|Overall Study|Lack of Efficacy|1
820986|NCT02058147|2688594|P3|Overall Study|Adverse Event|21
820987|NCT02058147|2688595|P2|Overall Study|Adverse Event|9
820988|NCT02058147|2688596|P1|Overall Study|Adverse Event|12
820989|NCT02058147|2688594|P3|Overall Study|Randomized but not treated|1
820990|NCT02058147|2688595|P2|Overall Study|Randomized but not treated|0
820991|NCT02058147|2688596|P1|Overall Study|Randomized but not treated|0
820992|NCT02058069|2688645|P1|Overall Study|Withdrawal by Subject|6
820993|NCT02058069|2688645|P1|Overall Study|Exclusion due to implant size|5
820994|NCT02057874|2688694|P1|Overall Study|participant did not return for scan|1
820995|NCT02057835|2688712|P10|Overall Study|Withdrawal by Subject|0
820996|NCT02057835|2688713|P9|Overall Study|Withdrawal by Subject|0
820997|NCT02057835|2688714|P8|Overall Study|Withdrawal by Subject|0
820998|NCT02057835|2688715|P7|Overall Study|Withdrawal by Subject|0
820999|NCT02057835|2688716|P6|Overall Study|Withdrawal by Subject|0
821000|NCT02057835|2688717|P5|Overall Study|Withdrawal by Subject|0
821001|NCT02057835|2688718|P4|Overall Study|Withdrawal by Subject|0
821002|NCT02057835|2688719|P3|Overall Study|Withdrawal by Subject|0
821003|NCT02057835|2688720|P2|Overall Study|Withdrawal by Subject|2
821004|NCT02057835|2688721|P1|Overall Study|Withdrawal by Subject|0
821005|NCT02057757|2688800|P2|Overall Study|Non-compliance|0
821006|NCT02057757|2688801|P1|Overall Study|Non-compliance|1
821007|NCT02057757|2688800|P2|Overall Study|Lost to Follow-up|3
821008|NCT02057757|2688801|P1|Overall Study|Lost to Follow-up|8
821009|NCT02057757|2688800|P2|Overall Study|Death|0
821010|NCT02057757|2688801|P1|Overall Study|Death|2
821011|NCT02057757|2688800|P2|Overall Study|Withdrawal by Subject|5
821012|NCT02057757|2688801|P1|Overall Study|Withdrawal by Subject|3
821013|NCT02057692|2688855|P4|Overall Study|Lost to Follow-up|1
821014|NCT02057692|2688856|P3|Overall Study|Lost to Follow-up|0
821015|NCT02057692|2688857|P2|Overall Study|Lost to Follow-up|0
821016|NCT02057692|2688858|P1|Overall Study|Lost to Follow-up|0
821017|NCT02057692|2688855|P4|Overall Study|Adverse Event|0
821018|NCT02057692|2688856|P3|Overall Study|Adverse Event|0
821019|NCT02057692|2688857|P2|Overall Study|Adverse Event|0
821020|NCT02057692|2688858|P1|Overall Study|Adverse Event|1
821021|NCT02057549|2688888|P2|Overall Study|Withdrawal by Subject|0
821022|NCT02057549|2688889|P1|Overall Study|Withdrawal by Subject|1
821023|NCT02057549|2688888|P2|Overall Study|Physician Decision|0
821024|NCT02057549|2688889|P1|Overall Study|Physician Decision|1
821025|NCT02057549|2688888|P2|Overall Study|Lost to Follow-up|0
821026|NCT02057549|2688889|P1|Overall Study|Lost to Follow-up|1
821027|NCT02057406|2688912|P3|Overall Study|Patient transportation issues|1
821028|NCT02057406|2688913|P2|Overall Study|Patient transportation issues|0
821029|NCT02057406|2688914|P1|Overall Study|Patient transportation issues|0
821030|NCT02057406|2688912|P3|Overall Study|Protocol Violation|0
821031|NCT02057406|2688913|P2|Overall Study|Protocol Violation|1
821032|NCT02057406|2688914|P1|Overall Study|Protocol Violation|0
821033|NCT02057406|2688912|P3|Overall Study|Death|0
821034|NCT02057406|2688913|P2|Overall Study|Death|0
821035|NCT02057406|2688914|P1|Overall Study|Death|1
821036|NCT02057406|2688912|P3|Overall Study|Lost to Follow-up|1
821037|NCT02057406|2688913|P2|Overall Study|Lost to Follow-up|0
821038|NCT02057406|2688914|P1|Overall Study|Lost to Follow-up|0
821039|NCT02057406|2688912|P3|Overall Study|Withdrawal by Subject|0
821040|NCT02057406|2688913|P2|Overall Study|Withdrawal by Subject|2
821041|NCT02057406|2688914|P1|Overall Study|Withdrawal by Subject|0
821042|NCT02057406|2688912|P3|Overall Study|Physician Decision|2
821043|NCT02057406|2688913|P2|Overall Study|Physician Decision|0
821044|NCT02057406|2688914|P1|Overall Study|Physician Decision|0
821045|NCT02057393|2688925|P1|Overall Study|Patient did not meet criteria|1
821046|NCT02057393|2688925|P1|Overall Study|Withdrawal by Subject|1
821047|NCT02057250|2688946|P5|Extension Phase|Other than specified above|7
821048|NCT02057250|2688947|P4|Extension Phase|Other than specified above|0
821049|NCT02057250|2688948|P3|Extension Phase|Other than specified above|0
821050|NCT02057250|2688949|P2|Extension Phase|Other than specified above|0
821051|NCT02057250|2688950|P1|Extension Phase|Other than specified above|0
821052|NCT02057250|2688946|P5|Extension Phase|Entered in this period but not treated|4
821053|NCT02057250|2688947|P4|Extension Phase|Entered in this period but not treated|0
821054|NCT02057250|2688948|P3|Extension Phase|Entered in this period but not treated|0
821055|NCT02057250|2688949|P2|Extension Phase|Entered in this period but not treated|0
821056|NCT02057250|2688950|P1|Extension Phase|Entered in this period but not treated|0
821057|NCT02057250|2688946|P5|Extension Phase|Lack of Efficacy|10
821058|NCT02057250|2688947|P4|Extension Phase|Lack of Efficacy|0
821059|NCT02057250|2688948|P3|Extension Phase|Lack of Efficacy|0
821060|NCT02057250|2688949|P2|Extension Phase|Lack of Efficacy|0
821061|NCT02057250|2688950|P1|Extension Phase|Lack of Efficacy|0
821062|NCT02057250|2688946|P5|Extension Phase|Adverse Event|15
821063|NCT02057250|2688947|P4|Extension Phase|Adverse Event|0
821064|NCT02057250|2688948|P3|Extension Phase|Adverse Event|0
821065|NCT02057250|2688949|P2|Extension Phase|Adverse Event|0
821066|NCT02057250|2688950|P1|Extension Phase|Adverse Event|0
821067|NCT02057250|2688946|P5|AID Assessment Phase|Other than specified above|0
821068|NCT02057250|2688947|P4|AID Assessment Phase|Other than specified above|1
821069|NCT02057250|2688948|P3|AID Assessment Phase|Other than specified above|1
821070|NCT02057250|2688949|P2|AID Assessment Phase|Other than specified above|1
821071|NCT02057250|2688950|P1|AID Assessment Phase|Other than specified above|1
821072|NCT02057250|2688946|P5|AID Assessment Phase|Adverse Event|0
821073|NCT02057250|2688947|P4|AID Assessment Phase|Adverse Event|1
821074|NCT02057250|2688948|P3|AID Assessment Phase|Adverse Event|6
821075|NCT02057250|2688949|P2|AID Assessment Phase|Adverse Event|2
821076|NCT02057250|2688950|P1|AID Assessment Phase|Adverse Event|3
821077|NCT02057068|2688970|P2|Overall Study|Lost to Follow-up|2
821078|NCT02057068|2688971|P1|Overall Study|Lost to Follow-up|2
821079|NCT02057068|2688970|P2|Overall Study|Carepartner (CP) Health|2
821080|NCT02057068|2688971|P1|Overall Study|Carepartner (CP) Health|4
821081|NCT02057068|2688970|P2|Overall Study|Caregiver (CG) Health|2
821082|NCT02057068|2688971|P1|Overall Study|Caregiver (CG) Health|0
821083|NCT02057068|2688970|P2|Overall Study|Withdrawal by Subject|2
821084|NCT02057068|2688971|P1|Overall Study|Withdrawal by Subject|2
821085|NCT02056834|2688981|P1|Overall Study|Lost to Follow-up|7
821086|NCT02056652|2689002|P2|Overall Study|Lost to Follow-up|3
821087|NCT02056652|2689003|P1|Overall Study|Lost to Follow-up|0
821088|NCT02056652|2689002|P2|Overall Study|Withdrawal by Subject|0
821089|NCT02056652|2689003|P1|Overall Study|Withdrawal by Subject|1
821090|NCT02056392|2689053|P6|Overall Study|Withdrawal by Subject|0
821091|NCT02056392|2689054|P5|Overall Study|Withdrawal by Subject|1
821092|NCT02056392|2689055|P4|Overall Study|Withdrawal by Subject|0
821093|NCT02056392|2689056|P3|Overall Study|Withdrawal by Subject|0
821094|NCT02056392|2689057|P2|Overall Study|Withdrawal by Subject|0
821095|NCT02056392|2689058|P1|Overall Study|Withdrawal by Subject|1
821096|NCT02056392|2689053|P6|Overall Study|Protocol Violation|0
821097|NCT02056392|2689054|P5|Overall Study|Protocol Violation|0
821098|NCT02056392|2689055|P4|Overall Study|Protocol Violation|0
821099|NCT02056392|2689056|P3|Overall Study|Protocol Violation|1
821100|NCT02056392|2689057|P2|Overall Study|Protocol Violation|0
821101|NCT02056392|2689058|P1|Overall Study|Protocol Violation|1
821102|NCT02056392|2689053|P6|Overall Study|Lost to Follow-up|0
821103|NCT02056392|2689054|P5|Overall Study|Lost to Follow-up|0
821104|NCT02056392|2689055|P4|Overall Study|Lost to Follow-up|0
821105|NCT02056392|2689056|P3|Overall Study|Lost to Follow-up|2
821106|NCT02056392|2689057|P2|Overall Study|Lost to Follow-up|1
821107|NCT02056392|2689058|P1|Overall Study|Lost to Follow-up|0
821108|NCT02055365|2689128|P1|Overall Study|Prematurely Withdrawn|1
821109|NCT02055352|2689141|P2|Overall Study|Reason unknown|5
821110|NCT02055352|2689142|P1|Overall Study|Reason unknown|1
821111|NCT02055352|2689141|P2|Overall Study|Withdrawal of informed consent|0
821112|NCT02055352|2689142|P1|Overall Study|Withdrawal of informed consent|1
821113|NCT02055352|2689141|P2|Overall Study|AE, study drug would be detrimental|3
821114|NCT02055352|2689142|P1|Overall Study|AE, study drug would be detrimental|1
821115|NCT02055352|2689141|P2|Overall Study|Use of prohibited treatment|3
821116|NCT02055352|2689142|P1|Overall Study|Use of prohibited treatment|0
821117|NCT02055352|2689141|P2|Overall Study|Patient decision|1
821118|NCT02055352|2689142|P1|Overall Study|Patient decision|1
821119|NCT02055352|2689141|P2|Overall Study|Death|2
821120|NCT02055352|2689142|P1|Overall Study|Death|1
821121|NCT02055352|2689141|P2|Overall Study|Poor compliance|1
821122|NCT02055352|2689142|P1|Overall Study|Poor compliance|1
821123|NCT02055352|2689141|P2|Overall Study|Non-eligible|1
821124|NCT02055352|2689142|P1|Overall Study|Non-eligible|0
821125|NCT02055352|2689141|P2|Overall Study|Adverse Event|1
821126|NCT02055352|2689142|P1|Overall Study|Adverse Event|0
821127|NCT02054910|2689158|P2|Overall Study|Lost to Follow-up|1
821128|NCT02054910|2689159|P1|Overall Study|Lost to Follow-up|4
821129|NCT02054897|2689178|P3|Overall Study|Randomized but not exposed|0
821130|NCT02054897|2689179|P2|Overall Study|Randomized but not exposed|0
821131|NCT02054897|2689180|P1|Overall Study|Randomized but not exposed|1
821132|NCT02054897|2689178|P3|Overall Study|Lost to Follow-up|7
821133|NCT02054897|2689179|P2|Overall Study|Lost to Follow-up|2
821134|NCT02054897|2689180|P1|Overall Study|Lost to Follow-up|4
821135|NCT02054897|2689178|P3|Overall Study|Missing follow-up information|3
821136|NCT02054897|2689179|P2|Overall Study|Missing follow-up information|5
821137|NCT02054897|2689180|P1|Overall Study|Missing follow-up information|3
821138|NCT02054897|2689178|P3|Overall Study|Withdrawal by Subject|2
821139|NCT02054897|2689179|P2|Overall Study|Withdrawal by Subject|0
821140|NCT02054897|2689180|P1|Overall Study|Withdrawal by Subject|2
821141|NCT02054715|2689227|P2|Follow-up 2|Treatment Change or Delay|0
821142|NCT02054715|2689228|P1|Follow-up 2|Treatment Change or Delay|1
821143|NCT02054715|2689227|P2|Follow-up 2|No Reason|0
821144|NCT02054715|2689228|P1|Follow-up 2|No Reason|2
821145|NCT02054715|2689227|P2|Follow-up 2|Changed Mind|1
821146|NCT02054715|2689228|P1|Follow-up 2|Changed Mind|0
821147|NCT02054715|2689227|P2|Follow-up 2|Changed MD/Facility|1
821148|NCT02054715|2689228|P1|Follow-up 2|Changed MD/Facility|0
821149|NCT02054715|2689227|P2|Follow-up 2|Hospitalization|2
821150|NCT02054715|2689228|P1|Follow-up 2|Hospitalization|0
821151|NCT02054715|2689227|P2|Follow-up 2|Death|3
821152|NCT02054715|2689228|P1|Follow-up 2|Death|3
821153|NCT02054715|2689227|P2|Follow-up 2|Ineligible|5
821154|NCT02054715|2689228|P1|Follow-up 2|Ineligible|4
821155|NCT02054715|2689227|P2|Follow-up 2|Followup Not Completed|4
821156|NCT02054715|2689228|P1|Follow-up 2|Followup Not Completed|3
821157|NCT02054715|2689227|P2|Follow-up 2|Refused|2
821158|NCT02054715|2689228|P1|Follow-up 2|Refused|3
821159|NCT02054715|2689227|P2|Follow-up 2|Lost to Followup|1
821160|NCT02054715|2689228|P1|Follow-up 2|Lost to Followup|3
821161|NCT02054715|2689227|P2|Baseline/Follow-up 1|Changed Mind|0
821162|NCT02054715|2689228|P1|Baseline/Follow-up 1|Changed Mind|1
821163|NCT02054715|2689227|P2|Baseline/Follow-up 1|Hospitalization|0
821164|NCT02054715|2689228|P1|Baseline/Follow-up 1|Hospitalization|1
821165|NCT02054715|2689227|P2|Baseline/Follow-up 1|Ineligible|0
821166|NCT02054715|2689228|P1|Baseline/Follow-up 1|Ineligible|3
821167|NCT02054715|2689227|P2|Baseline/Follow-up 1|Overwhelmed|0
821168|NCT02054715|2689228|P1|Baseline/Follow-up 1|Overwhelmed|2
821169|NCT02054715|2689227|P2|Baseline/Follow-up 1|No Reason|1
821170|NCT02054715|2689228|P1|Baseline/Follow-up 1|No Reason|0
821171|NCT02054715|2689227|P2|Baseline/Follow-up 1|Disliked Procedure|1
821172|NCT02054715|2689228|P1|Baseline/Follow-up 1|Disliked Procedure|0
821173|NCT02054715|2689227|P2|Baseline/Follow-up 1|Changed MD/Facility|1
821174|NCT02054715|2689228|P1|Baseline/Follow-up 1|Changed MD/Facility|0
821175|NCT02054715|2689227|P2|Baseline/Follow-up 1|Medical|1
821176|NCT02054715|2689228|P1|Baseline/Follow-up 1|Medical|0
821177|NCT02054715|2689227|P2|Baseline/Follow-up 1|Refused|3
821178|NCT02054715|2689228|P1|Baseline/Follow-up 1|Refused|1
821179|NCT02054702|2689242|P2|Overall Study|Withdrawal by Subject|4
821180|NCT02054702|2689243|P1|Overall Study|Withdrawal by Subject|14
821181|NCT02054702|2689242|P2|Overall Study|Physician Decision|1
821182|NCT02054702|2689243|P1|Overall Study|Physician Decision|0
821183|NCT02054702|2689242|P2|Overall Study|Met Withdrawal Criteria|1
821184|NCT02054702|2689243|P1|Overall Study|Met Withdrawal Criteria|4
821185|NCT02054702|2689242|P2|Overall Study|Adverse Event|1
821186|NCT02054702|2689243|P1|Overall Study|Adverse Event|3
821187|NCT02054702|2689242|P2|Overall Study|Lost to Follow-up|5
821188|NCT02054702|2689243|P1|Overall Study|Lost to Follow-up|3
821189|NCT02054481|2689298|P4|Overall Study|Other reason|0
821190|NCT02054481|2689299|P3|Overall Study|Other reason|2
821191|NCT02054481|2689300|P2|Overall Study|Other reason|1
821192|NCT02054481|2689301|P1|Overall Study|Other reason|2
821193|NCT02054481|2689298|P4|Overall Study|Lost to Follow-up|0
821194|NCT02054481|2689299|P3|Overall Study|Lost to Follow-up|0
821195|NCT02054481|2689300|P2|Overall Study|Lost to Follow-up|0
821196|NCT02054481|2689301|P1|Overall Study|Lost to Follow-up|1
821197|NCT02054481|2689298|P4|Overall Study|Adverse Event|1
821198|NCT02054481|2689299|P3|Overall Study|Adverse Event|0
821199|NCT02054481|2689300|P2|Overall Study|Adverse Event|1
821200|NCT02054481|2689301|P1|Overall Study|Adverse Event|1
821201|NCT02054325|2689349|P2|Overall Study|Lost to Follow-up|5
821202|NCT02054325|2689350|P1|Overall Study|Lost to Follow-up|8
821203|NCT02053753|2689360|P2|Overall Study|Lost to Follow-up|3
821204|NCT02053753|2689361|P1|Overall Study|Lost to Follow-up|4
821205|NCT02053753|2689360|P2|Overall Study|Decision by Sponsor|1
821206|NCT02053753|2689361|P1|Overall Study|Decision by Sponsor|1
821207|NCT02053753|2689360|P2|Overall Study|Withdrawal by Subject|4
821208|NCT02053753|2689361|P1|Overall Study|Withdrawal by Subject|2
821209|NCT02053610|2689385|P2|Overall Study|Violation of Selection Criteria|0
821210|NCT02053610|2689386|P1|Overall Study|Violation of Selection Criteria|1
821211|NCT02053610|2689385|P2|Overall Study|Insufficient Therapeutic Response|1
821212|NCT02053610|2689386|P1|Overall Study|Insufficient Therapeutic Response|1
821213|NCT02053610|2689385|P2|Overall Study|Did not Receive Treatment|2
821214|NCT02053610|2689386|P1|Overall Study|Did not Receive Treatment|4
821215|NCT02053610|2689385|P2|Overall Study|Refused treatment/Did not cooperate|3
821216|NCT02053610|2689386|P1|Overall Study|Refused treatment/Did not cooperate|1
821217|NCT02053610|2689385|P2|Overall Study|Disease Progression|3
821218|NCT02053610|2689386|P1|Overall Study|Disease Progression|2
821219|NCT02053610|2689385|P2|Overall Study|Administrative/Other|1
821220|NCT02053610|2689386|P1|Overall Study|Administrative/Other|1
821221|NCT02053610|2689385|P2|Overall Study|Death|5
821222|NCT02053610|2689386|P1|Overall Study|Death|5
821223|NCT02053610|2689385|P2|Overall Study|Withdrew Consent|9
821224|NCT02053610|2689386|P1|Overall Study|Withdrew Consent|2
821225|NCT02053610|2689385|P2|Overall Study|Adverse Event/Intercurrent Illness|43
821226|NCT02053610|2689386|P1|Overall Study|Adverse Event/Intercurrent Illness|25
821227|NCT02053493|2689418|P2|Overall Study|Withdrawal by Subject|1
821228|NCT02053493|2689419|P1|Overall Study|Withdrawal by Subject|1
821229|NCT02053168|2689457|P1|Overall Study|Lost to Follow-up|1
821230|NCT02053168|2689457|P1|Overall Study|Physician Decision|1
821231|NCT02053168|2689457|P1|Overall Study|Withdrawal by Subject|1
821232|NCT02052596|2689536|P2|Safety Phase|Lost due to Crohn`s disease|1
821233|NCT02052596|2689537|P1|Safety Phase|Lost due to Crohn`s disease|0
821234|NCT02052596|2689536|P2|Safety Phase|Enrolled in error|0
821235|NCT02052596|2689537|P1|Safety Phase|Enrolled in error|1
821236|NCT02052596|2689536|P2|Safety Phase|Withdrawal by Subject|11
821237|NCT02052596|2689537|P1|Safety Phase|Withdrawal by Subject|8
821238|NCT02052596|2689536|P2|Safety Phase|Protocol Violation|2
821239|NCT02052596|2689537|P1|Safety Phase|Protocol Violation|1
821240|NCT02052596|2689536|P2|Safety Phase|Lost to Follow-up|18
821241|NCT02052596|2689537|P1|Safety Phase|Lost to Follow-up|11
821242|NCT02052596|2689536|P2|Safety Phase|Adverse Event|3
821243|NCT02052596|2689537|P1|Safety Phase|Adverse Event|6
821244|NCT02052596|2689536|P2|Active Phase|Lost due to Crohn`s disease|1
821245|NCT02052596|2689537|P1|Active Phase|Lost due to Crohn`s disease|0
821246|NCT02052596|2689536|P2|Active Phase|Enrolled in error|0
821247|NCT02052596|2689537|P1|Active Phase|Enrolled in error|1
821248|NCT02052596|2689536|P2|Active Phase|Withdrawal by Subject|4
821249|NCT02052596|2689537|P1|Active Phase|Withdrawal by Subject|3
821250|NCT02052596|2689536|P2|Active Phase|Protocol Violation|2
821251|NCT02052596|2689537|P1|Active Phase|Protocol Violation|1
821252|NCT02052596|2689536|P2|Active Phase|Lost to Follow-up|11
821253|NCT02052596|2689537|P1|Active Phase|Lost to Follow-up|8
821254|NCT02052596|2689536|P2|Active Phase|Adverse Event|2
821255|NCT02052596|2689537|P1|Active Phase|Adverse Event|3
821256|NCT02052466|2689567|P1|Overall Study|Acromial fracture|1
821257|NCT02052466|2689567|P1|Overall Study|Withdrawal by Subject|1
821258|NCT02052440|2689584|P2|Overall Study|Withdrawal by Subject|1
821259|NCT02052440|2689585|P1|Overall Study|Withdrawal by Subject|0
821260|NCT02052414|2689597|P1|Overall Study|Withdrawal by Subject|3
821261|NCT02052414|2689597|P1|Overall Study|Lack of Efficacy|2
821262|NCT02052414|2689597|P1|Overall Study|Adverse Event|12
821263|NCT02052011|2689632|P2|Overall Study|Withdrawal by Subject|2
821264|NCT02052011|2689633|P1|Overall Study|Withdrawal by Subject|1
821265|NCT02052011|2689632|P2|Overall Study|Lost to Follow-up|0
821266|NCT02052011|2689633|P1|Overall Study|Lost to Follow-up|3
821267|NCT02051296|2689775|P2|Overall Study|withdraw prior to treatment|7
821268|NCT02051296|2689776|P1|Overall Study|withdraw prior to treatment|7
821269|NCT02051296|2689775|P2|Overall Study|Lost to Follow-up|2
821270|NCT02051296|2689776|P1|Overall Study|Lost to Follow-up|1
821271|NCT02050321|2689793|P1|Overall Study|Adverse Event|1
821272|NCT02050321|2689793|P1|Overall Study|Withdrawal by Subject|1
821273|NCT02050048|2689800|P2|Overall Study|Ineligible after ERCP|1
821274|NCT02050048|2689801|P1|Overall Study|Ineligible after ERCP|4
821275|NCT02050048|2689800|P2|Overall Study|Death|0
821276|NCT02050048|2689801|P1|Overall Study|Death|1
821277|NCT02050048|2689800|P2|Overall Study|Lost to Follow-up|1
821278|NCT02050048|2689801|P1|Overall Study|Lost to Follow-up|0
821279|NCT02049450|2689832|P1|Overall Study|Patients/guardian decision|1
821280|NCT02049450|2689832|P1|Overall Study|Withdrawal by Subject|1
821281|NCT02049450|2689832|P1|Overall Study|Adverse Event|2
821282|NCT02048904|2689870|P1|Overall Study|Physician Decision|70
821283|NCT02048904|2689870|P1|Overall Study|Withdrawal by Subject|7
821284|NCT02048241|2689885|P2|Overall Study|Withdrawal by Subject|1
821285|NCT02048241|2689886|P1|Overall Study|Withdrawal by Subject|0
821286|NCT02048072|2689892|P1|Overall Study|Lost to Follow-up|1
821287|NCT02048072|2689892|P1|Overall Study|Adverse Event|3
821288|NCT02047227|2689907|P2|Overall Study|Other|9
821289|NCT02047227|2689908|P1|Overall Study|Other|10
821290|NCT02047227|2689907|P2|Overall Study|All embryos discarded|11
821291|NCT02047227|2689908|P1|Overall Study|All embryos discarded|12
821292|NCT02047227|2689907|P2|Overall Study|Intention to freeze all embryos|0
821293|NCT02047227|2689908|P1|Overall Study|Intention to freeze all embryos|1
821294|NCT02047227|2689907|P2|Overall Study|No fertilization|51
821295|NCT02047227|2689908|P1|Overall Study|No fertilization|61
821296|NCT02047227|2689907|P2|Overall Study|No oocytes retrieved|20
821297|NCT02047227|2689908|P1|Overall Study|No oocytes retrieved|21
821298|NCT02047227|2689907|P2|Overall Study|Lack of ovarian response to stimulation|32
821299|NCT02047227|2689908|P1|Overall Study|Lack of ovarian response to stimulation|35
821300|NCT02047227|2689907|P2|Overall Study|Spontaneous pregnancy|0
821301|NCT02047227|2689908|P1|Overall Study|Spontaneous pregnancy|1
821302|NCT02047227|2689907|P2|Overall Study|Protocol Violation|0
821303|NCT02047227|2689908|P1|Overall Study|Protocol Violation|1
821304|NCT02047227|2689907|P2|Overall Study|Lost to Follow-up|3
821305|NCT02047227|2689908|P1|Overall Study|Lost to Follow-up|0
821306|NCT02047227|2689907|P2|Overall Study|Adverse Event|4
821307|NCT02047227|2689908|P1|Overall Study|Adverse Event|2
821308|NCT02046993|2689926|P2|Overall Study|Lost to Follow-up|1
821309|NCT02046993|2689927|P1|Overall Study|Lost to Follow-up|1
821310|NCT02046993|2689926|P2|Overall Study|Withdrawal by Subject|10
821311|NCT02046993|2689927|P1|Overall Study|Withdrawal by Subject|2
821312|NCT02046616|2689977|P1|8-Week FU Period|Lost to Follow-up|1
821313|NCT02046616|2689977|P1|24-Week Treatment Period|Not Specified|1
821314|NCT02046616|2689977|P1|24-Week Treatment Period|Physician Decision|3
821315|NCT02046616|2689977|P1|24-Week Treatment Period|Insufficient Therapeutic Response|1
821316|NCT02046616|2689977|P1|24-Week Treatment Period|Any Other Adverse Event|13
821317|NCT02046616|2689977|P1|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1
821318|NCT02046564|2689999|P2|Overall Study|Subject met withdrawal criteria|5
821319|NCT02046564|2690000|P1|Overall Study|Subject met withdrawal criteria|2
821320|NCT02046564|2689999|P2|Overall Study|Withdrawal by Subject|10
821321|NCT02046564|2690000|P1|Overall Study|Withdrawal by Subject|4
821322|NCT02046564|2689999|P2|Overall Study|Protocol Violation|1
821323|NCT02046564|2690000|P1|Overall Study|Protocol Violation|3
821324|NCT02046564|2689999|P2|Overall Study|Physician Decision|1
821325|NCT02046564|2690000|P1|Overall Study|Physician Decision|0
821326|NCT02046564|2689999|P2|Overall Study|Adverse Event|3
821327|NCT02046564|2690000|P1|Overall Study|Adverse Event|6
821328|NCT02046369|2690039|P2|Overall Study|non compliance|0
821329|NCT02046369|2690040|P1|Overall Study|non compliance|1
821330|NCT02046369|2690039|P2|Overall Study|never received study drug|1
821331|NCT02046369|2690040|P1|Overall Study|never received study drug|0
821332|NCT02046369|2690039|P2|Overall Study|Withdrawal by Subject|6
821333|NCT02046369|2690040|P1|Overall Study|Withdrawal by Subject|3
821334|NCT02046369|2690039|P2|Overall Study|Protocol Violation|2
821335|NCT02046369|2690040|P1|Overall Study|Protocol Violation|1
821336|NCT02046369|2690039|P2|Overall Study|Lost to Follow-up|3
821337|NCT02046369|2690040|P1|Overall Study|Lost to Follow-up|3
821338|NCT02046369|2690039|P2|Overall Study|Lack of Efficacy|3
821339|NCT02046369|2690040|P1|Overall Study|Lack of Efficacy|3
821340|NCT02046369|2690039|P2|Overall Study|Adverse Event|3
821341|NCT02046369|2690040|P1|Overall Study|Adverse Event|3
821342|NCT02046226|2690073|P1|Overall Study|Lost to Follow-up|7
821343|NCT02046148|2690121|P2|Overall Study|Withdrawal by Subject|2
821344|NCT02046148|2690122|P1|Overall Study|Withdrawal by Subject|0
821345|NCT02046148|2690121|P2|Overall Study|Lost to Follow-up|1
821346|NCT02046148|2690122|P1|Overall Study|Lost to Follow-up|1
821347|NCT02046122|2690166|P1|Overall Study|Withdrawal by Subject|1
821348|NCT02046122|2690166|P1|Overall Study|Physician Decision|8
821349|NCT02045979|2690188|P3|Overall Study|not specified above|0
821350|NCT02045979|2690189|P2|Overall Study|not specified above|1
821351|NCT02045979|2690190|P1|Overall Study|not specified above|0
821352|NCT02045979|2690188|P3|Overall Study|Informed Consent Withdrawn|1
821353|NCT02045979|2690189|P2|Overall Study|Informed Consent Withdrawn|0
821354|NCT02045979|2690190|P1|Overall Study|Informed Consent Withdrawn|2
821355|NCT02045875|2690227|P2|Overall Study|Withdrawal by Subject|3
821356|NCT02045875|2690228|P1|Overall Study|Withdrawal by Subject|4
821357|NCT02045875|2690227|P2|Overall Study|Lost to Follow-up|0
821358|NCT02045875|2690228|P1|Overall Study|Lost to Follow-up|3
821359|NCT02045862|2690239|P3|Overall Study|Lost to Follow-up|6
821360|NCT02045862|2690240|P2|Overall Study|Lost to Follow-up|2
821361|NCT02045862|2690241|P1|Overall Study|Lost to Follow-up|1
821362|NCT02045862|2690239|P3|Overall Study|Adverse Event|27
821363|NCT02045862|2690240|P2|Overall Study|Adverse Event|5
821364|NCT02045862|2690241|P1|Overall Study|Adverse Event|7
821365|NCT02045862|2690239|P3|Overall Study|Randomized but not Received Study Drug|8
821366|NCT02045862|2690240|P2|Overall Study|Randomized but not Received Study Drug|2
821367|NCT02045862|2690241|P1|Overall Study|Randomized but not Received Study Drug|0
821368|NCT02045862|2690239|P3|Overall Study|Lack of Efficacy|13
821369|NCT02045862|2690240|P2|Overall Study|Lack of Efficacy|4
821370|NCT02045862|2690241|P1|Overall Study|Lack of Efficacy|8
821371|NCT02045862|2690239|P3|Overall Study|Protocol Violation|6
821372|NCT02045862|2690240|P2|Overall Study|Protocol Violation|0
821373|NCT02045862|2690241|P1|Overall Study|Protocol Violation|0
821374|NCT02045862|2690239|P3|Overall Study|Withdrawal by Patient|57
821375|NCT02045862|2690240|P2|Overall Study|Withdrawal by Patient|27
821376|NCT02045862|2690241|P1|Overall Study|Withdrawal by Patient|18
821377|NCT02045862|2690239|P3|Overall Study|Miscellaneous|8
821378|NCT02045862|2690240|P2|Overall Study|Miscellaneous|0
821379|NCT02045862|2690241|P1|Overall Study|Miscellaneous|5
821380|NCT02045862|2690239|P3|Overall Study|Death|1
821381|NCT02045862|2690240|P2|Overall Study|Death|0
821382|NCT02045862|2690241|P1|Overall Study|Death|0
821383|NCT02045836|2690422|P2|Overall Study|Migrated from study area|2
821384|NCT02045836|2690423|P1|Overall Study|Migrated from study area|0
821385|NCT02045836|2690422|P2|Overall Study|Lost to Follow-up|7
821386|NCT02045836|2690423|P1|Overall Study|Lost to Follow-up|4
821387|NCT02045836|2690422|P2|Overall Study|Withdrawal by Subject|1
821388|NCT02045836|2690423|P1|Overall Study|Withdrawal by Subject|1
821389|NCT02045836|2690422|P2|Overall Study|Adverse Event|4
821390|NCT02045836|2690423|P1|Overall Study|Adverse Event|4
821391|NCT02045797|2690455|P3|Overall Study|Withdrawal by Subject|0
821392|NCT02045797|2690456|P2|Overall Study|Withdrawal by Subject|2
821393|NCT02045797|2690457|P1|Overall Study|Withdrawal by Subject|1
821394|NCT02045797|2690455|P3|Overall Study|Physician Decision|0
821395|NCT02045797|2690456|P2|Overall Study|Physician Decision|1
821396|NCT02045797|2690457|P1|Overall Study|Physician Decision|0
821397|NCT02045797|2690455|P3|Overall Study|Lost to Follow-up|1
821398|NCT02045797|2690456|P2|Overall Study|Lost to Follow-up|3
821399|NCT02045797|2690457|P1|Overall Study|Lost to Follow-up|2
821400|NCT02045797|2690455|P3|Overall Study|Lack of Efficacy|0
821401|NCT02045797|2690456|P2|Overall Study|Lack of Efficacy|0
821402|NCT02045797|2690457|P1|Overall Study|Lack of Efficacy|1
821403|NCT02045797|2690455|P3|Overall Study|Adverse Event|0
821404|NCT02045797|2690456|P2|Overall Study|Adverse Event|1
821405|NCT02045797|2690457|P1|Overall Study|Adverse Event|3
821406|NCT02045732|2690602|P2|Overall Study|At the discretion of the investigator|1
821407|NCT02045732|2690603|P1|Overall Study|At the discretion of the investigator|1
821408|NCT02044848|2690734|P2|Overall Study|Administrative Problems|3
821409|NCT02044848|2690735|P1|Overall Study|Administrative Problems|2
821410|NCT02044822|2690741|P1|Overall Study|Lost to Follow-up|1
821411|NCT02044822|2690741|P1|Overall Study|Initiation of Anti-Neoplastic Therapy|2
821412|NCT02044822|2690741|P1|Overall Study|Withdrew Consent|3
821413|NCT02044822|2690741|P1|Overall Study|Investigator's Discretion|10
821414|NCT02044822|2690741|P1|Overall Study|Study Terminated by Sponsor|77
821415|NCT02044458|2690753|P2|Overall Study|Protocol Violation|8
821416|NCT02044458|2690754|P1|Overall Study|Protocol Violation|3
821417|NCT02044302|2690840|P2|Overall Study|study terminated|0
821418|NCT02044302|2690841|P1|Overall Study|study terminated|2
821419|NCT02044094|2690847|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1
821420|NCT02044094|2690847|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1
821421|NCT02044094|2690847|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2
821422|NCT02044094|2690847|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5
821423|NCT02044094|2690847|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4
821424|NCT02044094|2690847|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3
821425|NCT02044094|2690847|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3
821426|NCT02044094|2690847|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3
821427|NCT02043938|2690904|P1|Overall Study|Investigator decision|1
821428|NCT02043938|2690904|P1|Overall Study|No show by subject|1
821429|NCT02043938|2690904|P1|Overall Study|Unable to place EEG sensors on patient|1
821430|NCT02043938|2690904|P1|Overall Study|Withdrawal by Subject|7
821431|NCT02043782|2690955|P6|Period 1|Adverse Event|0
821432|NCT02043782|2690956|P5|Period 1|Adverse Event|0
821433|NCT02043782|2690957|P4|Period 1|Adverse Event|0
821434|NCT02043782|2690958|P3|Period 1|Adverse Event|1
821435|NCT02043782|2690959|P2|Period 1|Adverse Event|0
821436|NCT02043782|2690960|P1|Period 1|Adverse Event|0
821437|NCT02043366|2691071|P6|Overall Study|Lost to Follow-up|2
821438|NCT02043366|2691072|P5|Overall Study|Lost to Follow-up|2
821439|NCT02043366|2691073|P4|Overall Study|Lost to Follow-up|2
821440|NCT02043366|2691074|P3|Overall Study|Lost to Follow-up|2
821441|NCT02043366|2691075|P2|Overall Study|Lost to Follow-up|2
821442|NCT02043366|2691076|P1|Overall Study|Lost to Follow-up|2
821443|NCT02043132|2691114|P2|Overall Study|screen failures|8
821444|NCT02043132|2691115|P1|Overall Study|screen failures|4
821445|NCT02043132|2691114|P2|Overall Study|Lost to Follow-up|1
821446|NCT02043132|2691115|P1|Overall Study|Lost to Follow-up|1
821447|NCT02043015|2691135|P1|Overall Study|Incarceration|1
821448|NCT02043015|2691135|P1|Overall Study|Participant moved away from study city|4
821449|NCT02043015|2691135|P1|Overall Study|Removed once target enrollment reached|15
821450|NCT02043015|2691135|P1|Overall Study|Withdrawal by Subject|4
821451|NCT02043015|2691135|P1|Overall Study|Lost to Follow-up|4
821452|NCT02042924|2691148|P1|Overall Study|Early Death|1
821453|NCT02042443|2691196|P2|Overall Study|Not eligible/not analyzable|6
821454|NCT02042443|2691197|P1|Overall Study|Not eligible/not analyzable|3
821455|NCT02042443|2691196|P2|Overall Study|not protocol specified|1
821456|NCT02042443|2691197|P1|Overall Study|not protocol specified|1
821457|NCT02042443|2691196|P2|Overall Study|Progression|17
821458|NCT02042443|2691197|P1|Overall Study|Progression|21
821459|NCT02042443|2691196|P2|Overall Study|Withdrawal by Subject|1
821460|NCT02042443|2691197|P1|Overall Study|Withdrawal by Subject|0
821461|NCT02042443|2691196|P2|Overall Study|Adverse Event|1
821462|NCT02042443|2691197|P1|Overall Study|Adverse Event|2
821463|NCT02042404|2691209|P2|Overall Study|Inability to meet time requirements|0
821464|NCT02042404|2691210|P1|Overall Study|Inability to meet time requirements|1
821465|NCT02042404|2691209|P2|Overall Study|Unrelated Adverse Event|0
821466|NCT02042404|2691210|P1|Overall Study|Unrelated Adverse Event|3
821467|NCT02042404|2691209|P2|Overall Study|Death|0
821468|NCT02042404|2691210|P1|Overall Study|Death|1
821469|NCT02041533|2691250|P2|Overall Study|Randomized, not treated|7
821470|NCT02041533|2691251|P1|Overall Study|Randomized, not treated|4
821471|NCT02041533|2691250|P2|Overall Study|Completed max number of chemo cycles|29
821472|NCT02041533|2691251|P1|Overall Study|Completed max number of chemo cycles|0
821473|NCT02041533|2691250|P2|Overall Study|Other reasons|1
821474|NCT02041533|2691251|P1|Overall Study|Other reasons|0
821475|NCT02041533|2691250|P2|Overall Study|Poor/non-compliance|0
821476|NCT02041533|2691251|P1|Overall Study|Poor/non-compliance|1
821477|NCT02041533|2691250|P2|Overall Study|Maximum clinical benefit|18
821478|NCT02041533|2691251|P1|Overall Study|Maximum clinical benefit|0
821479|NCT02041533|2691250|P2|Overall Study|Withdrawal by Subject|1
821480|NCT02041533|2691251|P1|Overall Study|Withdrawal by Subject|2
821481|NCT02041533|2691250|P2|Overall Study|Subject request to discontinue treatment|9
821482|NCT02041533|2691251|P1|Overall Study|Subject request to discontinue treatment|5
821483|NCT02041533|2691250|P2|Overall Study|Adverse Event unrelated to study drug|21
821484|NCT02041533|2691251|P1|Overall Study|Adverse Event unrelated to study drug|20
821485|NCT02041533|2691250|P2|Overall Study|Death|0
821486|NCT02041533|2691251|P1|Overall Study|Death|1
821487|NCT02041533|2691250|P2|Overall Study|Study drug toxicity|30
821488|NCT02041533|2691251|P1|Overall Study|Study drug toxicity|27
821489|NCT02041533|2691250|P2|Overall Study|Disease Progression|142
821490|NCT02041533|2691251|P1|Overall Study|Disease Progression|168
821491|NCT02041520|2691273|P2|Overall Study|Hypothiroidism identified during follow-|1
821492|NCT02041520|2691274|P1|Overall Study|Hypothiroidism identified during follow-|0
821493|NCT02041520|2691273|P2|Overall Study|Lost to Follow-up|1
821494|NCT02041520|2691274|P1|Overall Study|Lost to Follow-up|0
821495|NCT02041520|2691273|P2|Overall Study|Protocol Violation|0
821496|NCT02041520|2691274|P1|Overall Study|Protocol Violation|1
821497|NCT02041520|2691273|P2|Overall Study|Withdrawal by Subject|4
821498|NCT02041520|2691274|P1|Overall Study|Withdrawal by Subject|3
821499|NCT02041520|2691273|P2|Overall Study|Adverse Event|1
821500|NCT02041520|2691274|P1|Overall Study|Adverse Event|2
821501|NCT02041286|2691317|P1|Overall Study|Adverse Event|1
821502|NCT02041091|2691352|P2|Optional Safety Extension Period|Lost to Follow-up|3
821503|NCT02041091|2691353|P1|Optional Safety Extension Period|Lost to Follow-up|2
821504|NCT02041091|2691352|P2|Optional Safety Extension Period|Sponsor Decision|74
821505|NCT02041091|2691353|P1|Optional Safety Extension Period|Sponsor Decision|70
821506|NCT02041091|2691352|P2|Optional Safety Extension Period|Physician Decision|1
821507|NCT02041091|2691353|P1|Optional Safety Extension Period|Physician Decision|2
821508|NCT02041091|2691352|P2|Optional Safety Extension Period|Protocol Violation|0
821509|NCT02041091|2691353|P1|Optional Safety Extension Period|Protocol Violation|2
821510|NCT02041091|2691352|P2|Optional Safety Extension Period|Withdrawal by Subject|2
821511|NCT02041091|2691353|P1|Optional Safety Extension Period|Withdrawal by Subject|5
821512|NCT02041091|2691352|P2|Optional Safety Extension Period|Adverse Event|2
821513|NCT02041091|2691353|P1|Optional Safety Extension Period|Adverse Event|4
821514|NCT02041091|2691352|P2|Treatment|Lost to Follow-up|0
821515|NCT02041091|2691353|P1|Treatment|Lost to Follow-up|1
821516|NCT02041091|2691352|P2|Treatment|Sponsor Decision|16
821517|NCT02041091|2691353|P1|Treatment|Sponsor Decision|15
821518|NCT02041091|2691352|P2|Treatment|Physician Decision|0
821519|NCT02041091|2691353|P1|Treatment|Physician Decision|1
821520|NCT02041091|2691352|P2|Treatment|Withdrawal by Subject|4
821521|NCT02041091|2691353|P1|Treatment|Withdrawal by Subject|2
821522|NCT02041091|2691352|P2|Treatment|Adverse Event|3
821523|NCT02041091|2691353|P1|Treatment|Adverse Event|3
821524|NCT02040844|2691378|P3|Overall Study|Concomitant medication|1
821525|NCT02040844|2691379|P2|Overall Study|Concomitant medication|3
821526|NCT02040844|2691380|P1|Overall Study|Concomitant medication|1
821527|NCT02040844|2691378|P3|Overall Study|Non-specified|5
821528|NCT02040844|2691379|P2|Overall Study|Non-specified|2
821529|NCT02040844|2691380|P1|Overall Study|Non-specified|8
821530|NCT02040844|2691378|P3|Overall Study|Missing|2
821531|NCT02040844|2691379|P2|Overall Study|Missing|3
821532|NCT02040844|2691380|P1|Overall Study|Missing|13
821533|NCT02040844|2691378|P3|Overall Study|Lost to Follow-up|13
821534|NCT02040844|2691379|P2|Overall Study|Lost to Follow-up|9
821535|NCT02040844|2691380|P1|Overall Study|Lost to Follow-up|12
821536|NCT02040844|2691378|P3|Overall Study|Withdrawal by Subject|25
821537|NCT02040844|2691379|P2|Overall Study|Withdrawal by Subject|22
821538|NCT02040844|2691380|P1|Overall Study|Withdrawal by Subject|16
821539|NCT02040844|2691378|P3|Overall Study|Adverse Event|1
821540|NCT02040844|2691379|P2|Overall Study|Adverse Event|0
821541|NCT02040844|2691380|P1|Overall Study|Adverse Event|0
821542|NCT02040779|2691427|P3|Overall Study|Lack of Efficacy|0
821543|NCT02040779|2691428|P2|Overall Study|Lack of Efficacy|2
821544|NCT02040779|2691429|P1|Overall Study|Lack of Efficacy|4
821545|NCT02040779|2691427|P3|Overall Study|Lost to Follow-up|1
821546|NCT02040779|2691428|P2|Overall Study|Lost to Follow-up|2
821547|NCT02040779|2691429|P1|Overall Study|Lost to Follow-up|1
821548|NCT02040779|2691427|P3|Overall Study|Protocol Violation|0
821549|NCT02040779|2691428|P2|Overall Study|Protocol Violation|1
821550|NCT02040779|2691429|P1|Overall Study|Protocol Violation|2
821551|NCT02040779|2691427|P3|Overall Study|Non-compliance|0
821552|NCT02040779|2691428|P2|Overall Study|Non-compliance|1
821553|NCT02040779|2691429|P1|Overall Study|Non-compliance|0
821554|NCT02040779|2691427|P3|Overall Study|Withdrawal by Subject|3
821555|NCT02040779|2691428|P2|Overall Study|Withdrawal by Subject|1
821556|NCT02040779|2691429|P1|Overall Study|Withdrawal by Subject|4
821557|NCT02040779|2691427|P3|Overall Study|Adverse Event|0
821558|NCT02040779|2691428|P2|Overall Study|Adverse Event|0
821559|NCT02040779|2691429|P1|Overall Study|Adverse Event|1
821560|NCT02040766|2691469|P5|Overall Study|Lack of Efficacy|5
821561|NCT02040766|2691470|P4|Overall Study|Lack of Efficacy|6
821562|NCT02040766|2691471|P3|Overall Study|Lack of Efficacy|4
821563|NCT02040766|2691472|P2|Overall Study|Lack of Efficacy|3
821564|NCT02040766|2691473|P1|Overall Study|Lack of Efficacy|6
821565|NCT02040766|2691469|P5|Overall Study|Not reported|0
821566|NCT02040766|2691470|P4|Overall Study|Not reported|0
821567|NCT02040766|2691471|P3|Overall Study|Not reported|0
821568|NCT02040766|2691472|P2|Overall Study|Not reported|0
821569|NCT02040766|2691473|P1|Overall Study|Not reported|1
821570|NCT02040766|2691469|P5|Overall Study|Lost to Follow-up|4
821571|NCT02040766|2691470|P4|Overall Study|Lost to Follow-up|1
821572|NCT02040766|2691471|P3|Overall Study|Lost to Follow-up|3
821573|NCT02040766|2691472|P2|Overall Study|Lost to Follow-up|1
821574|NCT02040766|2691473|P1|Overall Study|Lost to Follow-up|4
821575|NCT02040766|2691469|P5|Overall Study|Protocol Violation|0
821576|NCT02040766|2691470|P4|Overall Study|Protocol Violation|3
821577|NCT02040766|2691471|P3|Overall Study|Protocol Violation|2
821578|NCT02040766|2691472|P2|Overall Study|Protocol Violation|1
821579|NCT02040766|2691473|P1|Overall Study|Protocol Violation|2
821580|NCT02040766|2691469|P5|Overall Study|Non-compliance|0
821581|NCT02040766|2691470|P4|Overall Study|Non-compliance|0
821582|NCT02040766|2691471|P3|Overall Study|Non-compliance|0
821583|NCT02040766|2691472|P2|Overall Study|Non-compliance|1
821584|NCT02040766|2691473|P1|Overall Study|Non-compliance|0
821585|NCT02040766|2691469|P5|Overall Study|Withdrawal by Subject|2
821586|NCT02040766|2691470|P4|Overall Study|Withdrawal by Subject|3
821587|NCT02040766|2691471|P3|Overall Study|Withdrawal by Subject|2
821588|NCT02040766|2691472|P2|Overall Study|Withdrawal by Subject|3
821589|NCT02040766|2691473|P1|Overall Study|Withdrawal by Subject|4
821590|NCT02040766|2691469|P5|Overall Study|Adverse Event|2
821591|NCT02040766|2691470|P4|Overall Study|Adverse Event|0
821592|NCT02040766|2691471|P3|Overall Study|Adverse Event|1
821593|NCT02040766|2691472|P2|Overall Study|Adverse Event|1
821594|NCT02040766|2691473|P1|Overall Study|Adverse Event|1
821595|NCT02040532|2691524|P1|Overall Study|Withdrawal by Subject|3
821596|NCT02040532|2691524|P1|Overall Study|Adverse Event|4
821597|NCT02040532|2691524|P1|Overall Study|Physician Decision|4
821598|NCT02040532|2691524|P1|Overall Study|Lost to Follow-up|1
821599|NCT02040428|2691537|P2|Overall Study|Withdrawal by Subject|1
821600|NCT02040428|2691538|P1|Overall Study|Withdrawal by Subject|1
821601|NCT02040428|2691537|P2|Overall Study|Death|3
821602|NCT02040428|2691538|P1|Overall Study|Death|4
821603|NCT02039778|2691586|P1|Overall Study|Never started the protocol treatment|1
821604|NCT02039778|2691586|P1|Overall Study|Withdrawal by Subject|1
821605|NCT02039778|2691586|P1|Overall Study|Death|2
821606|NCT02039687|2691598|P4|Overall Study|treatment assignment could not be confir|0
821607|NCT02039687|2691599|P3|Overall Study|treatment assignment could not be confir|2
821608|NCT02039687|2691600|P2|Overall Study|treatment assignment could not be confir|0
821609|NCT02039687|2691601|P1|Overall Study|treatment assignment could not be confir|0
821610|NCT02039687|2691598|P4|Overall Study|Withdrawal by Subject|0
821611|NCT02039687|2691599|P3|Overall Study|Withdrawal by Subject|0
821612|NCT02039687|2691600|P2|Overall Study|Withdrawal by Subject|1
821613|NCT02039687|2691601|P1|Overall Study|Withdrawal by Subject|0
821614|NCT02039687|2691598|P4|Overall Study|Adverse Event|0
821615|NCT02039687|2691599|P3|Overall Study|Adverse Event|1
821616|NCT02039687|2691600|P2|Overall Study|Adverse Event|0
821617|NCT02039687|2691601|P1|Overall Study|Adverse Event|0
821618|NCT02039674|2691636|P9|Overall Study|Ongoing in Study|4
821619|NCT02039674|2691637|P8|Overall Study|Ongoing in Study|33
821620|NCT02039674|2691638|P7|Overall Study|Ongoing in Study|34
821621|NCT02039674|2691639|P6|Overall Study|Ongoing in Study|1
821622|NCT02039674|2691640|P5|Overall Study|Ongoing in Study|6
821623|NCT02039674|2691641|P4|Overall Study|Ongoing in Study|2
821624|NCT02039674|2691642|P3|Overall Study|Ongoing in Study|5
821625|NCT02039674|2691643|P2|Overall Study|Ongoing in Study|5
821626|NCT02039674|2691644|P1|Overall Study|Ongoing in Study|7
821627|NCT02039674|2691636|P9|Overall Study|Withdrawal by Subject|2
821628|NCT02039674|2691637|P8|Overall Study|Withdrawal by Subject|5
821629|NCT02039674|2691638|P7|Overall Study|Withdrawal by Subject|3
821630|NCT02039674|2691639|P6|Overall Study|Withdrawal by Subject|1
821631|NCT02039674|2691640|P5|Overall Study|Withdrawal by Subject|2
821632|NCT02039674|2691641|P4|Overall Study|Withdrawal by Subject|0
821633|NCT02039674|2691642|P3|Overall Study|Withdrawal by Subject|1
821634|NCT02039674|2691643|P2|Overall Study|Withdrawal by Subject|1
821635|NCT02039674|2691644|P1|Overall Study|Withdrawal by Subject|2
821636|NCT02039674|2691636|P9|Overall Study|Progressive Disease|23
821637|NCT02039674|2691637|P8|Overall Study|Progressive Disease|18
821638|NCT02039674|2691638|P7|Overall Study|Progressive Disease|17
821639|NCT02039674|2691639|P6|Overall Study|Progressive Disease|0
821640|NCT02039674|2691640|P5|Overall Study|Progressive Disease|2
821641|NCT02039674|2691641|P4|Overall Study|Progressive Disease|4
821642|NCT02039674|2691642|P3|Overall Study|Progressive Disease|15
821643|NCT02039674|2691643|P2|Overall Study|Progressive Disease|13
821644|NCT02039674|2691644|P1|Overall Study|Progressive Disease|13
821645|NCT02039674|2691636|P9|Overall Study|Physician Decision|0
821646|NCT02039674|2691637|P8|Overall Study|Physician Decision|0
821647|NCT02039674|2691638|P7|Overall Study|Physician Decision|1
821648|NCT02039674|2691639|P6|Overall Study|Physician Decision|0
821649|NCT02039674|2691640|P5|Overall Study|Physician Decision|0
821650|NCT02039674|2691641|P4|Overall Study|Physician Decision|0
821651|NCT02039674|2691642|P3|Overall Study|Physician Decision|0
821652|NCT02039674|2691643|P2|Overall Study|Physician Decision|0
821653|NCT02039674|2691644|P1|Overall Study|Physician Decision|0
821654|NCT02039674|2691636|P9|Overall Study|Lost to Follow-up|0
821655|NCT02039674|2691637|P8|Overall Study|Lost to Follow-up|1
821656|NCT02039674|2691638|P7|Overall Study|Lost to Follow-up|0
821657|NCT02039674|2691639|P6|Overall Study|Lost to Follow-up|0
821658|NCT02039674|2691640|P5|Overall Study|Lost to Follow-up|0
821659|NCT02039674|2691641|P4|Overall Study|Lost to Follow-up|0
821660|NCT02039674|2691642|P3|Overall Study|Lost to Follow-up|0
821661|NCT02039674|2691643|P2|Overall Study|Lost to Follow-up|0
821662|NCT02039674|2691644|P1|Overall Study|Lost to Follow-up|0
821663|NCT02039674|2691636|P9|Overall Study|Excluded Medication|5
821664|NCT02039674|2691637|P8|Overall Study|Excluded Medication|4
821665|NCT02039674|2691638|P7|Overall Study|Excluded Medication|2
821666|NCT02039674|2691639|P6|Overall Study|Excluded Medication|4
821667|NCT02039674|2691640|P5|Overall Study|Excluded Medication|2
821668|NCT02039674|2691641|P4|Overall Study|Excluded Medication|0
821669|NCT02039674|2691642|P3|Overall Study|Excluded Medication|2
821670|NCT02039674|2691643|P2|Overall Study|Excluded Medication|1
821671|NCT02039674|2691644|P1|Overall Study|Excluded Medication|2
821672|NCT02039674|2691636|P9|Overall Study|Death|8
821673|NCT02039674|2691637|P8|Overall Study|Death|0
821674|NCT02039674|2691638|P7|Overall Study|Death|1
821675|NCT02039674|2691639|P6|Overall Study|Death|1
821676|NCT02039674|2691640|P5|Overall Study|Death|0
821677|NCT02039674|2691641|P4|Overall Study|Death|0
821678|NCT02039674|2691642|P3|Overall Study|Death|0
821679|NCT02039674|2691643|P2|Overall Study|Death|3
821680|NCT02039674|2691644|P1|Overall Study|Death|0
821681|NCT02039674|2691636|P9|Overall Study|Adverse Event|3
821682|NCT02039674|2691637|P8|Overall Study|Adverse Event|2
821683|NCT02039674|2691638|P7|Overall Study|Adverse Event|2
821684|NCT02039674|2691639|P6|Overall Study|Adverse Event|0
821685|NCT02039674|2691640|P5|Overall Study|Adverse Event|0
821686|NCT02039674|2691641|P4|Overall Study|Adverse Event|0
821687|NCT02039674|2691642|P3|Overall Study|Adverse Event|1
821688|NCT02039674|2691643|P2|Overall Study|Adverse Event|2
821689|NCT02039674|2691644|P1|Overall Study|Adverse Event|0
821690|NCT02039427|2691680|P4|Overall Study|Steroid Use|0
821691|NCT02039427|2691681|P3|Overall Study|Steroid Use|0
821692|NCT02039427|2691682|P2|Overall Study|Steroid Use|0
821693|NCT02039427|2691683|P1|Overall Study|Steroid Use|1
821694|NCT02039427|2691680|P4|Overall Study|Loss of follow - up|4
821695|NCT02039427|2691681|P3|Overall Study|Loss of follow - up|2
821696|NCT02039427|2691682|P2|Overall Study|Loss of follow - up|0
821697|NCT02039427|2691683|P1|Overall Study|Loss of follow - up|1
821698|NCT02039427|2691680|P4|Overall Study|Cancellation of surgery|0
821699|NCT02039427|2691681|P3|Overall Study|Cancellation of surgery|1
821700|NCT02039427|2691682|P2|Overall Study|Cancellation of surgery|0
821701|NCT02039427|2691683|P1|Overall Study|Cancellation of surgery|0
821702|NCT02039427|2691680|P4|Overall Study|Withdrawal on concent|1
821703|NCT02039427|2691681|P3|Overall Study|Withdrawal on concent|0
821704|NCT02039427|2691682|P2|Overall Study|Withdrawal on concent|0
821705|NCT02039427|2691683|P1|Overall Study|Withdrawal on concent|0
821706|NCT02039427|2691680|P4|Overall Study|Duration of surgery > 3h|0
821707|NCT02039427|2691681|P3|Overall Study|Duration of surgery > 3h|0
821708|NCT02039427|2691682|P2|Overall Study|Duration of surgery > 3h|1
821709|NCT02039427|2691683|P1|Overall Study|Duration of surgery > 3h|1
821710|NCT02039414|2691703|P2|Overall Study|Protocol Violation|1
821711|NCT02039414|2691704|P1|Overall Study|Protocol Violation|3
821712|NCT02039414|2691703|P2|Overall Study|Lost to Follow-up|0
821713|NCT02039414|2691704|P1|Overall Study|Lost to Follow-up|2
821714|NCT02039414|2691703|P2|Overall Study|Delivered|1
821715|NCT02039414|2691704|P1|Overall Study|Delivered|1
821716|NCT02038959|2691727|P2|Overall Study|Withdrawal by Subject|8
821717|NCT02038959|2691728|P1|Overall Study|Withdrawal by Subject|6
821718|NCT02038946|2691754|P1|Overall Study|Other reasons|1
821719|NCT02038946|2691754|P1|Overall Study|Lost to Follow-up|2
821720|NCT02038946|2691754|P1|Overall Study|Withdrawal by Subject|3
821721|NCT02038946|2691754|P1|Overall Study|Death|5
821722|NCT02038933|2691765|P1|Follow-up|Disease Progression|2
821723|NCT02038933|2691765|P1|Follow-up|Withdrawal by Subject|1
821724|NCT02038933|2691765|P1|Follow-up|Lost to Follow-up|1
821725|NCT02038933|2691765|P1|Follow-up|Adverse event unrelated to study drug|4
821726|NCT02038933|2691765|P1|Follow-up|Death|11
821727|NCT02038933|2691765|P1|Treatment|Withdrawal by Subject|1
821728|NCT02038933|2691765|P1|Treatment|Disease Progression|101
821729|NCT02038933|2691765|P1|Treatment|Study Drug Toxicity|4
821730|NCT02038933|2691765|P1|Treatment|Adverse Event Unrelated to Study Drug|6
821731|NCT02038933|2691765|P1|Treatment|Lost to Follow-up|1
821732|NCT02038933|2691765|P1|Treatment|No longer meets study criteria|1
821733|NCT02038907|2691798|P14|Overall Study|Withdrawal by Subject|0
821734|NCT02038907|2691799|P13|Overall Study|Withdrawal by Subject|0
821735|NCT02038907|2691800|P12|Overall Study|Withdrawal by Subject|0
821736|NCT02038907|2691801|P11|Overall Study|Withdrawal by Subject|1
821737|NCT02038907|2691802|P10|Overall Study|Withdrawal by Subject|0
821738|NCT02038907|2691803|P9|Overall Study|Withdrawal by Subject|0
821739|NCT02038907|2691804|P8|Overall Study|Withdrawal by Subject|0
821740|NCT02038907|2691805|P7|Overall Study|Withdrawal by Subject|0
821741|NCT02038907|2691806|P6|Overall Study|Withdrawal by Subject|0
821742|NCT02038907|2691807|P5|Overall Study|Withdrawal by Subject|0
821743|NCT02038907|2691808|P4|Overall Study|Withdrawal by Subject|0
821744|NCT02038907|2691809|P3|Overall Study|Withdrawal by Subject|0
821745|NCT02038907|2691810|P2|Overall Study|Withdrawal by Subject|0
821746|NCT02038907|2691811|P1|Overall Study|Withdrawal by Subject|0
821747|NCT02038907|2691798|P14|Overall Study|Protocol Violation|0
821748|NCT02038907|2691799|P13|Overall Study|Protocol Violation|0
821749|NCT02038907|2691800|P12|Overall Study|Protocol Violation|0
821750|NCT02038907|2691801|P11|Overall Study|Protocol Violation|1
821751|NCT02038907|2691802|P10|Overall Study|Protocol Violation|0
821752|NCT02038907|2691803|P9|Overall Study|Protocol Violation|0
821753|NCT02038907|2691804|P8|Overall Study|Protocol Violation|0
821754|NCT02038907|2691805|P7|Overall Study|Protocol Violation|0
821755|NCT02038907|2691806|P6|Overall Study|Protocol Violation|0
821756|NCT02038907|2691807|P5|Overall Study|Protocol Violation|0
821757|NCT02038907|2691808|P4|Overall Study|Protocol Violation|0
821758|NCT02038907|2691809|P3|Overall Study|Protocol Violation|0
821759|NCT02038907|2691810|P2|Overall Study|Protocol Violation|0
821760|NCT02038907|2691811|P1|Overall Study|Protocol Violation|0
821761|NCT02038829|2692339|P12|Treatment Period 6|Adverse Event|0
821762|NCT02038829|2692340|P11|Treatment Period 6|Adverse Event|0
821763|NCT02038829|2692341|P10|Treatment Period 6|Adverse Event|0
821764|NCT02038829|2692342|P9|Treatment Period 6|Adverse Event|0
821765|NCT02038829|2692343|P8|Treatment Period 6|Adverse Event|0
821766|NCT02038829|2692344|P7|Treatment Period 6|Adverse Event|0
821767|NCT02038829|2692345|P6|Treatment Period 6|Adverse Event|0
821768|NCT02038829|2692346|P5|Treatment Period 6|Adverse Event|0
821769|NCT02038829|2692347|P4|Treatment Period 6|Adverse Event|0
821770|NCT02038829|2692348|P3|Treatment Period 6|Adverse Event|1
821771|NCT02038829|2692349|P2|Treatment Period 6|Adverse Event|0
821772|NCT02038829|2692350|P1|Treatment Period 6|Adverse Event|0
821773|NCT02038829|2692339|P12|Washout Period 4|Adverse Event|0
821774|NCT02038829|2692340|P11|Washout Period 4|Adverse Event|0
821775|NCT02038829|2692341|P10|Washout Period 4|Adverse Event|0
821776|NCT02038829|2692342|P9|Washout Period 4|Adverse Event|0
821777|NCT02038829|2692343|P8|Washout Period 4|Adverse Event|0
821778|NCT02038829|2692344|P7|Washout Period 4|Adverse Event|1
821779|NCT02038829|2692345|P6|Washout Period 4|Adverse Event|0
821780|NCT02038829|2692346|P5|Washout Period 4|Adverse Event|0
821781|NCT02038829|2692347|P4|Washout Period 4|Adverse Event|0
821782|NCT02038829|2692348|P3|Washout Period 4|Adverse Event|0
821783|NCT02038829|2692349|P2|Washout Period 4|Adverse Event|0
821784|NCT02038829|2692350|P1|Washout Period 4|Adverse Event|0
821785|NCT02038829|2692339|P12|Treatment Period 4|Adverse Event|0
821786|NCT02038829|2692340|P11|Treatment Period 4|Adverse Event|0
821787|NCT02038829|2692341|P10|Treatment Period 4|Adverse Event|0
821788|NCT02038829|2692342|P9|Treatment Period 4|Adverse Event|0
821789|NCT02038829|2692343|P8|Treatment Period 4|Adverse Event|0
821790|NCT02038829|2692344|P7|Treatment Period 4|Adverse Event|0
821791|NCT02038829|2692345|P6|Treatment Period 4|Adverse Event|0
821792|NCT02038829|2692346|P5|Treatment Period 4|Adverse Event|0
821793|NCT02038829|2692347|P4|Treatment Period 4|Adverse Event|0
821794|NCT02038829|2692348|P3|Treatment Period 4|Adverse Event|0
821795|NCT02038829|2692349|P2|Treatment Period 4|Adverse Event|1
821796|NCT02038829|2692350|P1|Treatment Period 4|Adverse Event|0
821797|NCT02038829|2692339|P12|Washout Period 2|Withdrawal by Subject|0
821798|NCT02038829|2692340|P11|Washout Period 2|Withdrawal by Subject|0
821799|NCT02038829|2692341|P10|Washout Period 2|Withdrawal by Subject|0
821800|NCT02038829|2692342|P9|Washout Period 2|Withdrawal by Subject|0
821801|NCT02038829|2692343|P8|Washout Period 2|Withdrawal by Subject|0
821802|NCT02038829|2692344|P7|Washout Period 2|Withdrawal by Subject|0
821803|NCT02038829|2692345|P6|Washout Period 2|Withdrawal by Subject|1
821804|NCT02038829|2692346|P5|Washout Period 2|Withdrawal by Subject|0
821805|NCT02038829|2692347|P4|Washout Period 2|Withdrawal by Subject|0
821806|NCT02038829|2692348|P3|Washout Period 2|Withdrawal by Subject|0
821807|NCT02038829|2692349|P2|Washout Period 2|Withdrawal by Subject|0
821808|NCT02038829|2692350|P1|Washout Period 2|Withdrawal by Subject|0
821809|NCT02038829|2692339|P12|Washout Period 2|Adverse Event|0
821810|NCT02038829|2692340|P11|Washout Period 2|Adverse Event|0
821811|NCT02038829|2692341|P10|Washout Period 2|Adverse Event|0
821812|NCT02038829|2692342|P9|Washout Period 2|Adverse Event|1
821813|NCT02038829|2692343|P8|Washout Period 2|Adverse Event|0
821814|NCT02038829|2692344|P7|Washout Period 2|Adverse Event|0
821815|NCT02038829|2692345|P6|Washout Period 2|Adverse Event|0
821816|NCT02038829|2692346|P5|Washout Period 2|Adverse Event|0
821817|NCT02038829|2692347|P4|Washout Period 2|Adverse Event|0
821818|NCT02038829|2692348|P3|Washout Period 2|Adverse Event|0
821819|NCT02038829|2692349|P2|Washout Period 2|Adverse Event|0
821820|NCT02038829|2692350|P1|Washout Period 2|Adverse Event|0
821821|NCT02038829|2692339|P12|Treatment Period 2|Withdrawal by Subject|0
821822|NCT02038829|2692340|P11|Treatment Period 2|Withdrawal by Subject|0
821823|NCT02038829|2692341|P10|Treatment Period 2|Withdrawal by Subject|0
821824|NCT02038829|2692342|P9|Treatment Period 2|Withdrawal by Subject|0
821825|NCT02038829|2692343|P8|Treatment Period 2|Withdrawal by Subject|0
821826|NCT02038829|2692344|P7|Treatment Period 2|Withdrawal by Subject|0
821827|NCT02038829|2692345|P6|Treatment Period 2|Withdrawal by Subject|0
821828|NCT02038829|2692346|P5|Treatment Period 2|Withdrawal by Subject|0
821829|NCT02038829|2692347|P4|Treatment Period 2|Withdrawal by Subject|0
821830|NCT02038829|2692348|P3|Treatment Period 2|Withdrawal by Subject|0
821831|NCT02038829|2692349|P2|Treatment Period 2|Withdrawal by Subject|0
821832|NCT02038829|2692350|P1|Treatment Period 2|Withdrawal by Subject|1
821833|NCT02038829|2692339|P12|Treatment Period 2|Adverse Event|0
821834|NCT02038829|2692340|P11|Treatment Period 2|Adverse Event|1
821835|NCT02038829|2692341|P10|Treatment Period 2|Adverse Event|0
821836|NCT02038829|2692342|P9|Treatment Period 2|Adverse Event|0
821837|NCT02038829|2692343|P8|Treatment Period 2|Adverse Event|0
821838|NCT02038829|2692344|P7|Treatment Period 2|Adverse Event|0
821839|NCT02038829|2692345|P6|Treatment Period 2|Adverse Event|0
821840|NCT02038829|2692346|P5|Treatment Period 2|Adverse Event|0
821841|NCT02038829|2692347|P4|Treatment Period 2|Adverse Event|0
821842|NCT02038829|2692348|P3|Treatment Period 2|Adverse Event|0
821843|NCT02038829|2692349|P2|Treatment Period 2|Adverse Event|0
821844|NCT02038829|2692350|P1|Treatment Period 2|Adverse Event|0
821845|NCT02038829|2692339|P12|Washout Period 1|Death|0
821846|NCT02038829|2692340|P11|Washout Period 1|Death|0
821847|NCT02038829|2692341|P10|Washout Period 1|Death|0
821848|NCT02038829|2692342|P9|Washout Period 1|Death|0
821849|NCT02038829|2692343|P8|Washout Period 1|Death|0
821850|NCT02038829|2692344|P7|Washout Period 1|Death|0
821851|NCT02038829|2692345|P6|Washout Period 1|Death|0
821852|NCT02038829|2692346|P5|Washout Period 1|Death|1
821853|NCT02038829|2692347|P4|Washout Period 1|Death|0
821854|NCT02038829|2692348|P3|Washout Period 1|Death|0
821855|NCT02038829|2692349|P2|Washout Period 1|Death|0
821856|NCT02038829|2692350|P1|Washout Period 1|Death|0
821857|NCT02038790|2692384|P2|Day 0 - First Treatment|Withdrawal by Subject|1
821858|NCT02038790|2692385|P1|Day 0 - First Treatment|Withdrawal by Subject|1
821859|NCT02038764|2692421|P5|Overall Study|Other|0
821860|NCT02038764|2692422|P4|Overall Study|Other|0
821861|NCT02038764|2692423|P3|Overall Study|Other|1
821862|NCT02038764|2692424|P2|Overall Study|Other|0
821863|NCT02038764|2692425|P1|Overall Study|Other|1
821864|NCT02038764|2692421|P5|Overall Study|Withdrawal by Subject|1
821865|NCT02038764|2692422|P4|Overall Study|Withdrawal by Subject|0
821866|NCT02038764|2692423|P3|Overall Study|Withdrawal by Subject|0
821867|NCT02038764|2692424|P2|Overall Study|Withdrawal by Subject|0
821868|NCT02038764|2692425|P1|Overall Study|Withdrawal by Subject|0
821869|NCT02038764|2692421|P5|Overall Study|Lost to Follow-up|0
821870|NCT02038764|2692422|P4|Overall Study|Lost to Follow-up|0
821871|NCT02038764|2692423|P3|Overall Study|Lost to Follow-up|0
821872|NCT02038764|2692424|P2|Overall Study|Lost to Follow-up|1
821873|NCT02038764|2692425|P1|Overall Study|Lost to Follow-up|0
821874|NCT02038764|2692421|P5|Overall Study|Adverse Event|0
821875|NCT02038764|2692422|P4|Overall Study|Adverse Event|0
821876|NCT02038764|2692423|P3|Overall Study|Adverse Event|1
821877|NCT02038764|2692424|P2|Overall Study|Adverse Event|0
821878|NCT02038764|2692425|P1|Overall Study|Adverse Event|0
821879|NCT02038543|2692556|P4|Overall Study|Withdrawal by Subject|1
821880|NCT02038543|2692557|P3|Overall Study|Withdrawal by Subject|0
821881|NCT02038543|2692558|P2|Overall Study|Withdrawal by Subject|0
821882|NCT02038543|2692559|P1|Overall Study|Withdrawal by Subject|0
821883|NCT02038543|2692556|P4|Overall Study|Screen Failure|1
821884|NCT02038543|2692557|P3|Overall Study|Screen Failure|0
821885|NCT02038543|2692558|P2|Overall Study|Screen Failure|0
821886|NCT02038543|2692559|P1|Overall Study|Screen Failure|0
821887|NCT02038075|2692575|P2|Overall Study|Withdrawal by Subject|0
821888|NCT02038075|2692576|P1|Overall Study|Withdrawal by Subject|3
821889|NCT02037568|2692671|P2|Overall Study|Patient did not receive transplant|1
821890|NCT02037568|2692672|P1|Overall Study|Patient did not receive transplant|0
821891|NCT02037568|2692671|P2|Overall Study|Screen Failure|1
821892|NCT02037568|2692672|P1|Overall Study|Screen Failure|3
821893|NCT02037568|2692671|P2|Overall Study|Lost to Follow-up|13
821894|NCT02037568|2692672|P1|Overall Study|Lost to Follow-up|16
821895|NCT02037568|2692671|P2|Overall Study|Withdrawal by Subject|24
821896|NCT02037568|2692672|P1|Overall Study|Withdrawal by Subject|17
821897|NCT02037477|2692698|P4|Treatment Period 1|Pre-treatment Event/Adverse Event|0
821898|NCT02037477|2692699|P3|Treatment Period 1|Pre-treatment Event/Adverse Event|1
821899|NCT02037477|2692700|P2|Treatment Period 1|Pre-treatment Event/Adverse Event|0
821900|NCT02037477|2692701|P1|Treatment Period 1|Pre-treatment Event/Adverse Event|0
821901|NCT02036775|2692779|P6|Treatment Period 2 (6 Days)|Withdrawal by Subject|1
821902|NCT02036775|2692780|P5|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
821903|NCT02036775|2692781|P4|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
821904|NCT02036775|2692782|P3|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
821905|NCT02036775|2692783|P2|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
821906|NCT02036775|2692784|P1|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
821907|NCT02036580|2692825|P3|Overall Study|Adverse Event|0
821908|NCT02036580|2692826|P2|Overall Study|Adverse Event|0
821909|NCT02036580|2692827|P1|Overall Study|Adverse Event|1
821910|NCT02036580|2692825|P3|Overall Study|Withdrawal by Subject|0
821911|NCT02036580|2692826|P2|Overall Study|Withdrawal by Subject|1
821912|NCT02036580|2692827|P1|Overall Study|Withdrawal by Subject|0
821913|NCT02036515|2692848|P3|Overall Study|Hyperglycemia|1
821914|NCT02036515|2692849|P2|Overall Study|Hyperglycemia|0
821915|NCT02036515|2692850|P1|Overall Study|Hyperglycemia|0
821916|NCT02036515|2692848|P3|Overall Study|Withdrawal by Subject|9
821917|NCT02036515|2692849|P2|Overall Study|Withdrawal by Subject|7
821918|NCT02036515|2692850|P1|Overall Study|Withdrawal by Subject|4
821919|NCT02036515|2692848|P3|Overall Study|Screen failure|0
821920|NCT02036515|2692849|P2|Overall Study|Screen failure|2
821921|NCT02036515|2692850|P1|Overall Study|Screen failure|0
821922|NCT02036515|2692848|P3|Overall Study|Non-compliance with study drug|2
821923|NCT02036515|2692849|P2|Overall Study|Non-compliance with study drug|0
821924|NCT02036515|2692850|P1|Overall Study|Non-compliance with study drug|0
821925|NCT02036515|2692848|P3|Overall Study|Lost to Follow-up|0
821926|NCT02036515|2692849|P2|Overall Study|Lost to Follow-up|2
821927|NCT02036515|2692850|P1|Overall Study|Lost to Follow-up|0
821928|NCT02036515|2692848|P3|Overall Study|Adverse Event|2
821929|NCT02036515|2692849|P2|Overall Study|Adverse Event|1
821930|NCT02036515|2692850|P1|Overall Study|Adverse Event|1
821931|NCT02035748|2692949|P1|Overall Study|Progressive Disease|1
821932|NCT02035748|2692949|P1|Overall Study|Withdrawal by Subject|6
821933|NCT02035748|2692949|P1|Overall Study|Physician Decision|3
821934|NCT02035748|2692949|P1|Overall Study|Lost to Follow-up|2
821935|NCT02035748|2692949|P1|Overall Study|Death|3
821936|NCT02035748|2692949|P1|Overall Study|Adverse Event|5
821937|NCT02035696|2692963|P4|Overall Study|Withdrawal by Subject|1
821938|NCT02035696|2692964|P3|Overall Study|Withdrawal by Subject|2
821939|NCT02035696|2692965|P2|Overall Study|Withdrawal by Subject|0
821940|NCT02035696|2692966|P1|Overall Study|Withdrawal by Subject|3
821941|NCT02035696|2692963|P4|Overall Study|Lost to Follow-up|2
821942|NCT02035696|2692964|P3|Overall Study|Lost to Follow-up|1
821943|NCT02035696|2692965|P2|Overall Study|Lost to Follow-up|3
821944|NCT02035696|2692966|P1|Overall Study|Lost to Follow-up|0
821945|NCT02035553|2693022|P2|Overall Study|Other Reason|4
821946|NCT02035553|2693023|P1|Overall Study|Other Reason|0
821947|NCT02035553|2693022|P2|Overall Study|Lost to Follow-up|1
821948|NCT02035553|2693023|P1|Overall Study|Lost to Follow-up|0
821949|NCT02035553|2693022|P2|Overall Study|Non-compliance with Study Drug|1
821950|NCT02035553|2693023|P1|Overall Study|Non-compliance with Study Drug|0
821951|NCT02035553|2693022|P2|Overall Study|Withdrawal by Subject|7
821952|NCT02035553|2693023|P1|Overall Study|Withdrawal by Subject|4
821953|NCT02035553|2693022|P2|Overall Study|Lack of Efficacy|1
821954|NCT02035553|2693023|P1|Overall Study|Lack of Efficacy|1
821955|NCT02035553|2693022|P2|Overall Study|Physician Decision|2
821956|NCT02035553|2693023|P1|Overall Study|Physician Decision|3
821957|NCT02035553|2693022|P2|Overall Study|Adverse Event|6
821958|NCT02035553|2693023|P1|Overall Study|Adverse Event|10
821959|NCT02035553|2693022|P2|Overall Study|Death (See All-Cause Mortality Table)|1
821960|NCT02035553|2693023|P1|Overall Study|Death (See All-Cause Mortality Table)|0
821961|NCT02035475|2693029|P1|Overall Study|Equipment Error|1
821962|NCT02035475|2693029|P1|Overall Study|Physician Decision|1
821963|NCT02035475|2693029|P1|Overall Study|Withdrawal by Subject|4
821964|NCT02035332|2693040|P1|Overall Study|Procedure Aborted due to Uterine Width|1
821965|NCT02034916|2693048|P2|Overall Study|Ongoing as of data cutoff (01 Sep 2016)|20
821966|NCT02034916|2693049|P1|Overall Study|Ongoing as of data cutoff (01 Sep 2016)|15
821967|NCT02034916|2693048|P2|Overall Study|Lost to Follow-up|1
821968|NCT02034916|2693049|P1|Overall Study|Lost to Follow-up|1
821969|NCT02034916|2693048|P2|Overall Study|Withdrawal by Subject|1
821970|NCT02034916|2693049|P1|Overall Study|Withdrawal by Subject|1
821971|NCT02034916|2693048|P2|Overall Study|Death|13
821972|NCT02034916|2693049|P1|Overall Study|Death|32
821973|NCT02034877|2693084|P2|Overall Study|No Longer Willing to Participate|3
821974|NCT02034877|2693085|P1|Overall Study|No Longer Willing to Participate|0
821975|NCT02034877|2693084|P2|Overall Study|Lost to Follow-up|3
821976|NCT02034877|2693085|P1|Overall Study|Lost to Follow-up|0
821977|NCT02034799|2693103|P2|Overall Study|Death|1
821978|NCT02034799|2693104|P1|Overall Study|Death|2
821979|NCT02034799|2693103|P2|Overall Study|Lost to Follow-up|1
821980|NCT02034799|2693104|P1|Overall Study|Lost to Follow-up|0
821981|NCT02034799|2693103|P2|Overall Study|Withdrawal by Subject|2
821982|NCT02034799|2693104|P1|Overall Study|Withdrawal by Subject|0
821983|NCT02034708|2693118|P2|Wash-out (From 2 Days up to 14 Days)|other reason|2
821984|NCT02034708|2693119|P1|Wash-out (From 2 Days up to 14 Days)|other reason|3
821985|NCT02034708|2693118|P2|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
821986|NCT02034708|2693119|P1|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
821987|NCT02034708|2693118|P2|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0
821988|NCT02034708|2693119|P1|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1
821989|NCT02034708|2693118|P2|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5
821990|NCT02034708|2693119|P1|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2
821991|NCT02034591|2693130|P6|Overall Study|Withdrawal by Subject|0
821992|NCT02034591|2693131|P5|Overall Study|Withdrawal by Subject|1
821993|NCT02034591|2693132|P4|Overall Study|Withdrawal by Subject|0
821994|NCT02034591|2693133|P3|Overall Study|Withdrawal by Subject|0
821995|NCT02034591|2693134|P2|Overall Study|Withdrawal by Subject|0
821996|NCT02034591|2693135|P1|Overall Study|Withdrawal by Subject|0
821997|NCT02034565|2693190|P2|Overall Study|Adverse Event|0
821998|NCT02034565|2693191|P1|Overall Study|Adverse Event|1
821999|NCT02034552|2693208|P3|Overall Study|Non-compliance with study drug|1
822000|NCT02034552|2693209|P2|Overall Study|Non-compliance with study drug|0
822001|NCT02034552|2693210|P1|Overall Study|Non-compliance with study drug|0
822002|NCT02034552|2693208|P3|Overall Study|Withdrawal by Subject|1
822003|NCT02034552|2693209|P2|Overall Study|Withdrawal by Subject|0
822004|NCT02034552|2693210|P1|Overall Study|Withdrawal by Subject|2
822005|NCT02034552|2693208|P3|Overall Study|AE associated with disease progression|0
822006|NCT02034552|2693209|P2|Overall Study|AE associated with disease progression|1
822007|NCT02034552|2693210|P1|Overall Study|AE associated with disease progression|0
822008|NCT02034552|2693208|P3|Overall Study|AE not assoc. with disease progression|2
822009|NCT02034552|2693209|P2|Overall Study|AE not assoc. with disease progression|3
822010|NCT02034552|2693210|P1|Overall Study|AE not assoc. with disease progression|1
822011|NCT02034552|2693208|P3|Overall Study|Ongoing with treatment|11
822012|NCT02034552|2693209|P2|Overall Study|Ongoing with treatment|11
822013|NCT02034552|2693210|P1|Overall Study|Ongoing with treatment|0
822014|NCT02034552|2693208|P3|Overall Study|Never treated|0
822015|NCT02034552|2693209|P2|Overall Study|Never treated|2
822016|NCT02034552|2693210|P1|Overall Study|Never treated|3
822017|NCT02034513|2693235|P2|Overall Study|Unclassified|1
822018|NCT02034513|2693236|P1|Overall Study|Unclassified|0
822019|NCT02034513|2693235|P2|Overall Study|Withdrawal by Subject|25
822020|NCT02034513|2693236|P1|Overall Study|Withdrawal by Subject|25
822021|NCT02034513|2693235|P2|Overall Study|Protocol Violation|10
822022|NCT02034513|2693236|P1|Overall Study|Protocol Violation|7
822023|NCT02034513|2693235|P2|Overall Study|Pregnancy|3
822024|NCT02034513|2693236|P1|Overall Study|Pregnancy|0
822025|NCT02034513|2693235|P2|Overall Study|Lost to Follow-up|7
822026|NCT02034513|2693236|P1|Overall Study|Lost to Follow-up|6
822027|NCT02034513|2693235|P2|Overall Study|Lack of Efficacy|1
822028|NCT02034513|2693236|P1|Overall Study|Lack of Efficacy|0
822029|NCT02034513|2693235|P2|Overall Study|Adverse Event|10
822030|NCT02034513|2693236|P1|Overall Study|Adverse Event|11
822031|NCT02034162|2693254|P3|Double-blind|Withdrawal by Subject|0
822032|NCT02034162|2693255|P2|Double-blind|Withdrawal by Subject|7
822033|NCT02034162|2693256|P1|Double-blind|Withdrawal by Subject|5
822034|NCT02034162|2693254|P3|Double-blind|Protocol Violation|0
822035|NCT02034162|2693255|P2|Double-blind|Protocol Violation|1
822036|NCT02034162|2693256|P1|Double-blind|Protocol Violation|0
822037|NCT02034162|2693254|P3|Double-blind|Physician Decision|0
822038|NCT02034162|2693255|P2|Double-blind|Physician Decision|0
822039|NCT02034162|2693256|P1|Double-blind|Physician Decision|1
822040|NCT02034162|2693254|P3|Double-blind|Lost to Follow-up|0
822041|NCT02034162|2693255|P2|Double-blind|Lost to Follow-up|0
822042|NCT02034162|2693256|P1|Double-blind|Lost to Follow-up|3
822043|NCT02033889|2693287|P3|Overall Study|Withdrawal by Subject|13
822044|NCT02033889|2693288|P2|Overall Study|Withdrawal by Subject|10
822045|NCT02033889|2693289|P1|Overall Study|Withdrawal by Subject|18
822046|NCT02033889|2693287|P3|Overall Study|Participant moved|0
822047|NCT02033889|2693288|P2|Overall Study|Participant moved|1
822048|NCT02033889|2693289|P1|Overall Study|Participant moved|0
822049|NCT02033889|2693287|P3|Overall Study|Physician Decision|1
822050|NCT02033889|2693288|P2|Overall Study|Physician Decision|1
822051|NCT02033889|2693289|P1|Overall Study|Physician Decision|0
822052|NCT02033889|2693287|P3|Overall Study|Non-Compliance With Study Drug|0
822053|NCT02033889|2693288|P2|Overall Study|Non-Compliance With Study Drug|0
822054|NCT02033889|2693289|P1|Overall Study|Non-Compliance With Study Drug|1
822055|NCT02033889|2693287|P3|Overall Study|Lost to Follow-up|6
822056|NCT02033889|2693288|P2|Overall Study|Lost to Follow-up|5
822057|NCT02033889|2693289|P1|Overall Study|Lost to Follow-up|8
822058|NCT02033889|2693287|P3|Overall Study|Excluded Medication|0
822059|NCT02033889|2693288|P2|Overall Study|Excluded Medication|1
822060|NCT02033889|2693289|P1|Overall Study|Excluded Medication|1
822061|NCT02033889|2693287|P3|Overall Study|Death|2
822062|NCT02033889|2693288|P2|Overall Study|Death|1
822063|NCT02033889|2693289|P1|Overall Study|Death|3
822064|NCT02033889|2693287|P3|Overall Study|Adverse Event|3
822065|NCT02033889|2693288|P2|Overall Study|Adverse Event|1
822066|NCT02033889|2693289|P1|Overall Study|Adverse Event|3
822067|NCT02033369|2693486|P2|Overall Study|Protocol Violation|0
822068|NCT02033369|2693487|P1|Overall Study|Protocol Violation|2
822069|NCT02033369|2693486|P2|Overall Study|Lost to Follow-up|0
822070|NCT02033369|2693487|P1|Overall Study|Lost to Follow-up|1
822071|NCT02033369|2693486|P2|Overall Study|Withdrawal by Subject|1
822072|NCT02033369|2693487|P1|Overall Study|Withdrawal by Subject|1
822073|NCT02033369|2693486|P2|Overall Study|Not a good demographic match|2
822074|NCT02033369|2693487|P1|Overall Study|Not a good demographic match|0
822075|NCT02033369|2693486|P2|Overall Study|Physician Decision|2
822076|NCT02033369|2693487|P1|Overall Study|Physician Decision|1
822077|NCT02032901|2693562|P2|Follow-Up Period (24 Weeks)|Lost to Follow-up|1
822078|NCT02032901|2693563|P1|Follow-Up Period (24 Weeks)|Lost to Follow-up|0
822079|NCT02032901|2693562|P2|Treatment Period (12 Weeks)|Pregnancy|0
822080|NCT02032901|2693563|P1|Treatment Period (12 Weeks)|Pregnancy|1
822081|NCT02032888|2693587|P3|Follow-up Period|Not specified|0
822082|NCT02032888|2693588|P2|Follow-up Period|Not specified|0
822083|NCT02032888|2693589|P1|Follow-up Period|Not specified|1
822084|NCT02032888|2693587|P3|Follow-up Period|Death|0
822085|NCT02032888|2693588|P2|Follow-up Period|Death|1
822086|NCT02032888|2693589|P1|Follow-up Period|Death|1
822087|NCT02032888|2693587|P3|Follow-up Period|Lost to Follow-up|0
822088|NCT02032888|2693588|P2|Follow-up Period|Lost to Follow-up|1
822089|NCT02032888|2693589|P1|Follow-up Period|Lost to Follow-up|1
822090|NCT02032888|2693587|P3|Treatment Period|Not specified|0
822091|NCT02032888|2693588|P2|Treatment Period|Not specified|1
822092|NCT02032888|2693589|P1|Treatment Period|Not specified|1
822093|NCT02032888|2693587|P3|Treatment Period|Poor compliance/noncompliance|0
822094|NCT02032888|2693588|P2|Treatment Period|Poor compliance/noncompliance|1
822095|NCT02032888|2693589|P1|Treatment Period|Poor compliance/noncompliance|1
822096|NCT02032875|2693620|P2|Follow-up Period|Virologic Relapse|10
822097|NCT02032875|2693621|P1|Follow-up Period|Virologic Relapse|3
822098|NCT02032875|2693620|P2|Follow-up Period|Death|1
822099|NCT02032875|2693621|P1|Follow-up Period|Death|0
822100|NCT02032875|2693620|P2|Treatment Period|Liver transplant, Treatment extension|3
822101|NCT02032875|2693621|P1|Treatment Period|Liver transplant, Treatment extension|0
822102|NCT02032875|2693620|P2|Treatment Period|Liver transplant, No extension needed|1
822103|NCT02032875|2693621|P1|Treatment Period|Liver transplant, No extension needed|0
822104|NCT02032875|2693620|P2|Treatment Period|Adverse Event|0
822105|NCT02032875|2693621|P1|Treatment Period|Adverse Event|1
822106|NCT02032706|2693650|P1|Overall Study|Protocol Violation|1
822107|NCT02032706|2693650|P1|Overall Study|Did not qualify|5
822108|NCT02032407|2693707|P1|Overall Study|Other Miscellaneous Reasons|2
822109|NCT02032407|2693707|P1|Overall Study|Pregnancy|1
822110|NCT02032407|2693707|P1|Overall Study|Lost to Follow-up|2
822111|NCT02032238|2693720|P2|Overall Study|Lost to Follow-up|0
822112|NCT02032238|2693721|P1|Overall Study|Lost to Follow-up|2
822113|NCT02031679|2693762|P2|Overall Study|Lack of Efficacy|1
822114|NCT02031679|2693763|P1|Overall Study|Lack of Efficacy|0
822115|NCT02031679|2693762|P2|Overall Study|Protocol Violation|1
822116|NCT02031679|2693763|P1|Overall Study|Protocol Violation|0
822117|NCT02031640|2693778|P6|Double-blind Treatment Period|Lost to Follow-up|0
822118|NCT02031640|2693779|P5|Double-blind Treatment Period|Lost to Follow-up|1
822119|NCT02031640|2693780|P4|Double-blind Treatment Period|Lost to Follow-up|0
822120|NCT02031640|2693781|P3|Double-blind Treatment Period|Lost to Follow-up|0
822121|NCT02031640|2693782|P2|Double-blind Treatment Period|Lost to Follow-up|3
822122|NCT02031640|2693783|P1|Double-blind Treatment Period|Lost to Follow-up|0
822123|NCT02031640|2693778|P6|Double-blind Treatment Period|Withdrawal by Subject|1
822124|NCT02031640|2693779|P5|Double-blind Treatment Period|Withdrawal by Subject|1
822125|NCT02031640|2693780|P4|Double-blind Treatment Period|Withdrawal by Subject|1
822126|NCT02031640|2693781|P3|Double-blind Treatment Period|Withdrawal by Subject|3
822127|NCT02031640|2693782|P2|Double-blind Treatment Period|Withdrawal by Subject|2
822128|NCT02031640|2693783|P1|Double-blind Treatment Period|Withdrawal by Subject|0
822129|NCT02031640|2693778|P6|Double-blind Treatment Period|Adverse Event|0
822130|NCT02031640|2693779|P5|Double-blind Treatment Period|Adverse Event|0
822131|NCT02031640|2693780|P4|Double-blind Treatment Period|Adverse Event|2
822132|NCT02031640|2693781|P3|Double-blind Treatment Period|Adverse Event|0
822133|NCT02031640|2693782|P2|Double-blind Treatment Period|Adverse Event|0
822134|NCT02031640|2693783|P1|Double-blind Treatment Period|Adverse Event|0
822135|NCT02031640|2693778|P6|Double-blind Treatment Period|Non-compliance|0
822136|NCT02031640|2693779|P5|Double-blind Treatment Period|Non-compliance|1
822137|NCT02031640|2693780|P4|Double-blind Treatment Period|Non-compliance|1
822138|NCT02031640|2693781|P3|Double-blind Treatment Period|Non-compliance|0
822139|NCT02031640|2693782|P2|Double-blind Treatment Period|Non-compliance|1
822140|NCT02031640|2693783|P1|Double-blind Treatment Period|Non-compliance|0
822141|NCT02031640|2693778|P6|Double-blind Treatment Period|Lack of Efficacy|1
822142|NCT02031640|2693779|P5|Double-blind Treatment Period|Lack of Efficacy|5
822143|NCT02031640|2693780|P4|Double-blind Treatment Period|Lack of Efficacy|2
822144|NCT02031640|2693781|P3|Double-blind Treatment Period|Lack of Efficacy|3
822145|NCT02031640|2693782|P2|Double-blind Treatment Period|Lack of Efficacy|14
822146|NCT02031640|2693783|P1|Double-blind Treatment Period|Lack of Efficacy|0
822147|NCT02031640|2693778|P6|Double-blind Treatment Period|Protocol deviation|1
822148|NCT02031640|2693779|P5|Double-blind Treatment Period|Protocol deviation|3
822149|NCT02031640|2693780|P4|Double-blind Treatment Period|Protocol deviation|1
822150|NCT02031640|2693781|P3|Double-blind Treatment Period|Protocol deviation|0
822151|NCT02031640|2693782|P2|Double-blind Treatment Period|Protocol deviation|2
822152|NCT02031640|2693783|P1|Double-blind Treatment Period|Protocol deviation|0
822153|NCT02031640|2693778|P6|Run-In Period|Various administrative reasons|0
822154|NCT02031640|2693779|P5|Run-In Period|Various administrative reasons|0
822155|NCT02031640|2693780|P4|Run-In Period|Various administrative reasons|0
822156|NCT02031640|2693781|P3|Run-In Period|Various administrative reasons|0
822157|NCT02031640|2693782|P2|Run-In Period|Various administrative reasons|0
822158|NCT02031640|2693783|P1|Run-In Period|Various administrative reasons|17
822159|NCT02031640|2693778|P6|Run-In Period|Randomization criteria not met|0
822160|NCT02031640|2693779|P5|Run-In Period|Randomization criteria not met|0
822161|NCT02031640|2693780|P4|Run-In Period|Randomization criteria not met|0
822162|NCT02031640|2693781|P3|Run-In Period|Randomization criteria not met|0
822163|NCT02031640|2693782|P2|Run-In Period|Randomization criteria not met|0
822164|NCT02031640|2693783|P1|Run-In Period|Randomization criteria not met|85
822165|NCT02031640|2693778|P6|Run-In Period|Exclusion criteria met|0
822166|NCT02031640|2693779|P5|Run-In Period|Exclusion criteria met|0
822167|NCT02031640|2693780|P4|Run-In Period|Exclusion criteria met|0
822168|NCT02031640|2693781|P3|Run-In Period|Exclusion criteria met|0
822169|NCT02031640|2693782|P2|Run-In Period|Exclusion criteria met|0
822170|NCT02031640|2693783|P1|Run-In Period|Exclusion criteria met|8
822171|NCT02031640|2693778|P6|Run-In Period|Inclusion criteria not met|0
822172|NCT02031640|2693779|P5|Run-In Period|Inclusion criteria not met|0
822173|NCT02031640|2693780|P4|Run-In Period|Inclusion criteria not met|0
822174|NCT02031640|2693781|P3|Run-In Period|Inclusion criteria not met|0
822175|NCT02031640|2693782|P2|Run-In Period|Inclusion criteria not met|0
822176|NCT02031640|2693783|P1|Run-In Period|Inclusion criteria not met|38
822177|NCT02031640|2693778|P6|Run-In Period|Withdrawal by Subject|0
822178|NCT02031640|2693779|P5|Run-In Period|Withdrawal by Subject|0
822179|NCT02031640|2693780|P4|Run-In Period|Withdrawal by Subject|0
822180|NCT02031640|2693781|P3|Run-In Period|Withdrawal by Subject|0
822181|NCT02031640|2693782|P2|Run-In Period|Withdrawal by Subject|0
822182|NCT02031640|2693783|P1|Run-In Period|Withdrawal by Subject|17
822183|NCT02031640|2693778|P6|Run-In Period|Adverse Event|0
822184|NCT02031640|2693779|P5|Run-In Period|Adverse Event|0
822185|NCT02031640|2693780|P4|Run-In Period|Adverse Event|0
822186|NCT02031640|2693781|P3|Run-In Period|Adverse Event|0
822187|NCT02031640|2693782|P2|Run-In Period|Adverse Event|0
822188|NCT02031640|2693783|P1|Run-In Period|Adverse Event|4
822189|NCT02031640|2693778|P6|Screening Period|Enrollment closed|0
822190|NCT02031640|2693779|P5|Screening Period|Enrollment closed|0
822191|NCT02031640|2693780|P4|Screening Period|Enrollment closed|0
822192|NCT02031640|2693781|P3|Screening Period|Enrollment closed|0
822193|NCT02031640|2693782|P2|Screening Period|Enrollment closed|0
822194|NCT02031640|2693783|P1|Screening Period|Enrollment closed|26
822195|NCT02031640|2693778|P6|Screening Period|Lost to Follow-up|0
822196|NCT02031640|2693779|P5|Screening Period|Lost to Follow-up|0
822197|NCT02031640|2693780|P4|Screening Period|Lost to Follow-up|0
822198|NCT02031640|2693781|P3|Screening Period|Lost to Follow-up|0
822199|NCT02031640|2693782|P2|Screening Period|Lost to Follow-up|0
822200|NCT02031640|2693783|P1|Screening Period|Lost to Follow-up|14
822201|NCT02031640|2693778|P6|Screening Period|Exclusion criteria met|0
822202|NCT02031640|2693779|P5|Screening Period|Exclusion criteria met|0
822203|NCT02031640|2693780|P4|Screening Period|Exclusion criteria met|0
822204|NCT02031640|2693781|P3|Screening Period|Exclusion criteria met|0
822205|NCT02031640|2693782|P2|Screening Period|Exclusion criteria met|0
822206|NCT02031640|2693783|P1|Screening Period|Exclusion criteria met|30
822207|NCT02031640|2693778|P6|Screening Period|Inclusion criteria not met|0
822208|NCT02031640|2693779|P5|Screening Period|Inclusion criteria not met|0
822209|NCT02031640|2693780|P4|Screening Period|Inclusion criteria not met|0
822210|NCT02031640|2693781|P3|Screening Period|Inclusion criteria not met|0
822211|NCT02031640|2693782|P2|Screening Period|Inclusion criteria not met|0
822212|NCT02031640|2693783|P1|Screening Period|Inclusion criteria not met|312
822213|NCT02031640|2693778|P6|Screening Period|Withdrawal by Subject|0
822214|NCT02031640|2693779|P5|Screening Period|Withdrawal by Subject|0
822215|NCT02031640|2693780|P4|Screening Period|Withdrawal by Subject|0
822216|NCT02031640|2693781|P3|Screening Period|Withdrawal by Subject|0
822217|NCT02031640|2693782|P2|Screening Period|Withdrawal by Subject|0
822218|NCT02031640|2693783|P1|Screening Period|Withdrawal by Subject|29
822219|NCT02031640|2693778|P6|Screening Period|Adverse Event|0
822220|NCT02031640|2693779|P5|Screening Period|Adverse Event|0
822221|NCT02031640|2693780|P4|Screening Period|Adverse Event|0
822222|NCT02031640|2693781|P3|Screening Period|Adverse Event|0
822223|NCT02031640|2693782|P2|Screening Period|Adverse Event|0
822224|NCT02031640|2693783|P1|Screening Period|Adverse Event|1
822225|NCT02031471|2693826|P1|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1
822226|NCT02031471|2693826|P1|Long Term Extension (LTE) Period|Adverse Event|1
822227|NCT02031471|2693826|P1|24 Week Treatment Period|Hypersensitivity Reaction|1
822228|NCT02031471|2693826|P1|24 Week Treatment Period|Insufficient Therapeutic Response|1
822229|NCT02031471|2693826|P1|24 Week Treatment Period|Protocol Violation|1
822230|NCT02031471|2693826|P1|24 Week Treatment Period|Participant Decision to Withdraw|2
822231|NCT02031471|2693826|P1|24 Week Treatment Period|Adverse Event|6
822232|NCT02031458|2693859|P3|Overall Study|Lost to Follow-up|2
822233|NCT02031458|2693860|P2|Overall Study|Lost to Follow-up|1
822234|NCT02031458|2693861|P1|Overall Study|Lost to Follow-up|1
822235|NCT02031458|2693859|P3|Overall Study|On Treatment|73
822236|NCT02031458|2693860|P2|Overall Study|On Treatment|81
822237|NCT02031458|2693861|P1|Overall Study|On Treatment|43
822238|NCT02031458|2693859|P3|Overall Study|On Survival Follow-Up|73
822239|NCT02031458|2693860|P2|Overall Study|On Survival Follow-Up|83
822240|NCT02031458|2693861|P1|Overall Study|On Survival Follow-Up|46
822241|NCT02031458|2693859|P3|Overall Study|Withdrawal by Subject|3
822242|NCT02031458|2693860|P2|Overall Study|Withdrawal by Subject|9
822243|NCT02031458|2693861|P1|Overall Study|Withdrawal by Subject|6
822244|NCT02031458|2693859|P3|Overall Study|Unknown Reason|2
822245|NCT02031458|2693860|P2|Overall Study|Unknown Reason|1
822246|NCT02031458|2693861|P1|Overall Study|Unknown Reason|0
822247|NCT02031458|2693859|P3|Overall Study|Physician Decision|0
822248|NCT02031458|2693860|P2|Overall Study|Physician Decision|1
822249|NCT02031458|2693861|P1|Overall Study|Physician Decision|0
822250|NCT02031458|2693859|P3|Overall Study|Protocol Violation|0
822251|NCT02031458|2693860|P2|Overall Study|Protocol Violation|4
822252|NCT02031458|2693861|P1|Overall Study|Protocol Violation|7
822253|NCT02031458|2693859|P3|Overall Study|Death|100
822254|NCT02031458|2693860|P2|Overall Study|Death|87
822255|NCT02031458|2693861|P1|Overall Study|Death|36
822256|NCT02031276|2693958|P3|Period 3 Open-label Risankizumab SC|Not Specified|1
822257|NCT02031276|2693959|P2|Period 3 Open-label Risankizumab SC|Not Specified|0
822258|NCT02031276|2693960|P1|Period 3 Open-label Risankizumab SC|Not Specified|0
822259|NCT02031276|2693958|P3|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
822260|NCT02031276|2693959|P2|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
822261|NCT02031276|2693960|P1|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
822262|NCT02031276|2693958|P3|Period 3 Open-label Risankizumab SC|Protocol Violation|0
822263|NCT02031276|2693959|P2|Period 3 Open-label Risankizumab SC|Protocol Violation|0
822264|NCT02031276|2693960|P1|Period 3 Open-label Risankizumab SC|Protocol Violation|2
822265|NCT02031276|2693958|P3|Period 3 Open-label Risankizumab SC|Adverse Event|0
822266|NCT02031276|2693959|P2|Period 3 Open-label Risankizumab SC|Adverse Event|2
822267|NCT02031276|2693960|P1|Period 3 Open-label Risankizumab SC|Adverse Event|0
822268|NCT02031276|2693958|P3|Period 2 Open-label Risankizumab IV|Not Specified|1
822269|NCT02031276|2693959|P2|Period 2 Open-label Risankizumab IV|Not Specified|2
822270|NCT02031276|2693960|P1|Period 2 Open-label Risankizumab IV|Not Specified|0
822271|NCT02031276|2693958|P3|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
822272|NCT02031276|2693959|P2|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
822273|NCT02031276|2693960|P1|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3
822274|NCT02031276|2693958|P3|Period 2 Open-label Risankizumab IV|Adverse Event|0
822275|NCT02031276|2693959|P2|Period 2 Open-label Risankizumab IV|Adverse Event|0
822276|NCT02031276|2693960|P1|Period 2 Open-label Risankizumab IV|Adverse Event|1
822277|NCT02031276|2693958|P3|Period 1 Double-blind IV|Not specified|0
822278|NCT02031276|2693959|P2|Period 1 Double-blind IV|Not specified|1
822279|NCT02031276|2693960|P1|Period 1 Double-blind IV|Not specified|0
822280|NCT02031276|2693958|P3|Period 1 Double-blind IV|Adverse Event|1
822281|NCT02031276|2693959|P2|Period 1 Double-blind IV|Adverse Event|5
822282|NCT02031276|2693960|P1|Period 1 Double-blind IV|Adverse Event|6
822283|NCT02030600|2693994|P2|Treatment Period 2|Unclassified|0
822284|NCT02030600|2693995|P1|Treatment Period 2|Unclassified|1
822285|NCT02030600|2693994|P2|Treatment Period 2|Withdrawal by Subject|9
822286|NCT02030600|2693995|P1|Treatment Period 2|Withdrawal by Subject|13
822287|NCT02030600|2693994|P2|Treatment Period 2|Protocol Violation|2
822288|NCT02030600|2693995|P1|Treatment Period 2|Protocol Violation|1
822289|NCT02030600|2693994|P2|Treatment Period 2|Lost to Follow-up|2
822290|NCT02030600|2693995|P1|Treatment Period 2|Lost to Follow-up|4
822291|NCT02030600|2693994|P2|Treatment Period 2|Lack of Efficacy|1
822292|NCT02030600|2693995|P1|Treatment Period 2|Lack of Efficacy|2
822293|NCT02030600|2693994|P2|Treatment Period 2|Adverse Event|4
822294|NCT02030600|2693995|P1|Treatment Period 2|Adverse Event|4
822295|NCT02030600|2693994|P2|Treatment Period 1|Unclassified|0
822296|NCT02030600|2693995|P1|Treatment Period 1|Unclassified|1
822297|NCT02030600|2693994|P2|Treatment Period 1|Casebook Unsigned|0
822298|NCT02030600|2693995|P1|Treatment Period 1|Casebook Unsigned|1
822299|NCT02030600|2693994|P2|Treatment Period 1|Withdrawal by Subject|17
822300|NCT02030600|2693995|P1|Treatment Period 1|Withdrawal by Subject|13
822301|NCT02030600|2693994|P2|Treatment Period 1|Protocol Violation|17
822302|NCT02030600|2693995|P1|Treatment Period 1|Protocol Violation|22
822303|NCT02030600|2693994|P2|Treatment Period 1|Lost to Follow-up|3
822304|NCT02030600|2693995|P1|Treatment Period 1|Lost to Follow-up|11
822305|NCT02030600|2693994|P2|Treatment Period 1|Lack of Efficacy|1
822306|NCT02030600|2693995|P1|Treatment Period 1|Lack of Efficacy|0
822307|NCT02030600|2693994|P2|Treatment Period 1|Adverse Event|7
822308|NCT02030600|2693995|P1|Treatment Period 1|Adverse Event|5
822309|NCT02030535|2694016|P1|Washout Period 1 (21 Days)|Adverse Event|1
822310|NCT02030405|2694084|P1|Overall Study|Lost to Follow-up|1
822311|NCT02030405|2694084|P1|Overall Study|Withdrawal by Subject|1
822312|NCT02030119|2694093|P4|Overall Study|Ineligible (see Pre-assignment Details)|0
822313|NCT02030119|2694094|P3|Overall Study|Ineligible (see Pre-assignment Details)|1
822314|NCT02030119|2694095|P2|Overall Study|Ineligible (see Pre-assignment Details)|1
822315|NCT02030119|2694096|P1|Overall Study|Ineligible (see Pre-assignment Details)|0
822316|NCT02030119|2694093|P4|Overall Study|Withdrawal by Subject|3
822317|NCT02030119|2694094|P3|Overall Study|Withdrawal by Subject|5
822318|NCT02030119|2694095|P2|Overall Study|Withdrawal by Subject|1
822319|NCT02030119|2694096|P1|Overall Study|Withdrawal by Subject|3
822320|NCT02030041|2694134|P3|Overall Study|Withdrawal by Subject|1
822321|NCT02030041|2694135|P2|Overall Study|Withdrawal by Subject|2
822322|NCT02030041|2694136|P1|Overall Study|Withdrawal by Subject|2
822323|NCT02029989|2694149|P2|Overall Study|Protocol Violation|0
822324|NCT02029989|2694150|P1|Overall Study|Protocol Violation|1
822325|NCT02029989|2694149|P2|Overall Study|Death|1
822326|NCT02029989|2694150|P1|Overall Study|Death|0
822327|NCT02029989|2694149|P2|Overall Study|Lost to Follow-up|7
822328|NCT02029989|2694150|P1|Overall Study|Lost to Follow-up|9
822329|NCT02029989|2694149|P2|Overall Study|Physician Decision|0
822330|NCT02029989|2694150|P1|Overall Study|Physician Decision|2
822331|NCT02029989|2694149|P2|Overall Study|Change of location|3
822332|NCT02029989|2694150|P1|Overall Study|Change of location|2
822333|NCT02029989|2694149|P2|Overall Study|Withdrawal: Fear of needles|0
822334|NCT02029989|2694150|P1|Overall Study|Withdrawal: Fear of needles|1
822335|NCT02029989|2694149|P2|Overall Study|Withdrawal by Subject|0
822336|NCT02029989|2694150|P1|Overall Study|Withdrawal by Subject|1
822337|NCT02029846|2694173|P2|Overall Study|n=1 each arm|1
822338|NCT02029846|2694174|P1|Overall Study|n=1 each arm|1
822339|NCT02029638|2694212|P3|Overall Study|Decision by Study Sponsor or Regulatory|0
822340|NCT02029638|2694213|P2|Overall Study|Decision by Study Sponsor or Regulatory|0
822341|NCT02029638|2694214|P1|Overall Study|Decision by Study Sponsor or Regulatory|2
822342|NCT02029638|2694212|P3|Overall Study|Death|1
822343|NCT02029638|2694213|P2|Overall Study|Death|0
822344|NCT02029638|2694214|P1|Overall Study|Death|0
822345|NCT02029521|2694243|P2|Overall Study|Withdrawal by Subject|1
822346|NCT02029521|2694244|P1|Overall Study|Withdrawal by Subject|1
822347|NCT02029521|2694243|P2|Overall Study|Protocol Violation|0
822348|NCT02029521|2694244|P1|Overall Study|Protocol Violation|1
822349|NCT02029417|2694342|P1|Overall Study|Adverse Event|1
822350|NCT02029417|2694342|P1|Overall Study|Death|1
822351|NCT02028767|2694446|P2|Treatment Period 2|Reason other than those specified above|0
822352|NCT02028767|2694447|P1|Treatment Period 2|Reason other than those specified above|1
822353|NCT02028767|2694446|P2|Treatment Period 2|Non compliant with protocol|0
822354|NCT02028767|2694447|P1|Treatment Period 2|Non compliant with protocol|1
822355|NCT02028169|2694672|P1|Overall Study|Concomitant Medication Usage|1
822356|NCT02028169|2694672|P1|Overall Study|Cessation of Drug|1
822357|NCT02028169|2694672|P1|Overall Study|Adverse Event|1
822358|NCT02028169|2694672|P1|Overall Study|Withdrawal by Subject|2
822359|NCT02028169|2694672|P1|Overall Study|Lack of Efficacy|2
822360|NCT02028169|2694672|P1|Overall Study|Lost to Follow-up|21
822361|NCT02028065|2694698|P3|Treatment Through Study Completion|Adverse Event|5
822362|NCT02028065|2694699|P2|Treatment Through Study Completion|Adverse Event|3
822363|NCT02028065|2694700|P1|Treatment Through Study Completion|Adverse Event|3
822364|NCT02028065|2694698|P3|Treatment Through Study Completion|Withdrawal by Subject|3
822365|NCT02028065|2694699|P2|Treatment Through Study Completion|Withdrawal by Subject|4
822366|NCT02028065|2694700|P1|Treatment Through Study Completion|Withdrawal by Subject|5
822367|NCT02028065|2694698|P3|Treatment Through Study Completion|Protocol Violation|0
822368|NCT02028065|2694699|P2|Treatment Through Study Completion|Protocol Violation|4
822369|NCT02028065|2694700|P1|Treatment Through Study Completion|Protocol Violation|1
822370|NCT02028065|2694698|P3|Treatment Through Study Completion|Physician Decision|0
822371|NCT02028065|2694699|P2|Treatment Through Study Completion|Physician Decision|0
822372|NCT02028065|2694700|P1|Treatment Through Study Completion|Physician Decision|1
822373|NCT02028065|2694698|P3|Treatment Through Study Completion|Lost to Follow-up|6
822374|NCT02028065|2694699|P2|Treatment Through Study Completion|Lost to Follow-up|4
822375|NCT02028065|2694700|P1|Treatment Through Study Completion|Lost to Follow-up|2
822376|NCT02028065|2694698|P3|Randomization Through Start Treatment|Not treated|3
822377|NCT02028065|2694699|P2|Randomization Through Start Treatment|Not treated|3
822378|NCT02028065|2694700|P1|Randomization Through Start Treatment|Not treated|1
822379|NCT02027844|2694727|P3|Overall Study|Incomlete data|0
822380|NCT02027844|2694728|P2|Overall Study|Incomlete data|0
822381|NCT02027844|2694729|P1|Overall Study|Incomlete data|2
822382|NCT02027844|2694727|P3|Overall Study|Protocol Violation|0
822383|NCT02027844|2694728|P2|Overall Study|Protocol Violation|2
822384|NCT02027844|2694729|P1|Overall Study|Protocol Violation|0
822385|NCT02027844|2694727|P3|Overall Study|Lost to Follow-up|1
822386|NCT02027844|2694728|P2|Overall Study|Lost to Follow-up|2
822387|NCT02027844|2694729|P1|Overall Study|Lost to Follow-up|0
822388|NCT02027844|2694727|P3|Overall Study|Withdrawal by Subject|1
822389|NCT02027844|2694728|P2|Overall Study|Withdrawal by Subject|2
822390|NCT02027844|2694729|P1|Overall Study|Withdrawal by Subject|3
822391|NCT02027701|2694746|P1|Overall Study|Withdrawal by Subject|3
822392|NCT02027701|2694746|P1|Overall Study|Physician Decision|2
822393|NCT02027701|2694746|P1|Overall Study|Lack of Efficacy|8
822394|NCT02027701|2694746|P1|Overall Study|Adverse Event|3
822395|NCT02027402|2694764|P2|Overall Study|Withdrawal by Subject|1
822396|NCT02027402|2694765|P1|Overall Study|Withdrawal by Subject|4
822397|NCT02027311|2694779|P2|Overall Study|Protocol Violation|2
822398|NCT02027311|2694780|P1|Overall Study|Protocol Violation|3
822399|NCT02026258|2694815|P2|Recieved Allocated Intervention|Lost to Follow-up|1
822400|NCT02026258|2694816|P1|Recieved Allocated Intervention|Lost to Follow-up|0
822401|NCT02026258|2694815|P2|Recieved Allocated Intervention|Withdrawal by Subject|1
822402|NCT02026258|2694816|P1|Recieved Allocated Intervention|Withdrawal by Subject|1
822403|NCT02026258|2694815|P2|Randomized|Presence of periodontal disease|1
822404|NCT02026258|2694816|P1|Randomized|Presence of periodontal disease|1
822405|NCT02026258|2694815|P2|Randomized|Change in treatment plan|0
822406|NCT02026258|2694816|P1|Randomized|Change in treatment plan|1
822407|NCT02026258|2694815|P2|Randomized|Did not start treatment|1
822408|NCT02026258|2694816|P1|Randomized|Did not start treatment|2
822409|NCT02026141|2694850|P2|Overall Study|Protocol Violation|1
822410|NCT02026141|2694851|P1|Overall Study|Protocol Violation|0
822411|NCT02025907|2694859|P2|Overall Study|Potential misconduct,GCPcompliance issue|1
822412|NCT02025907|2694860|P1|Overall Study|Potential misconduct,GCPcompliance issue|2
822413|NCT02025907|2694859|P2|Overall Study|Adverse Event|1
822414|NCT02025907|2694860|P1|Overall Study|Adverse Event|3
822415|NCT02025907|2694859|P2|Overall Study|Lost to Follow-up|2
822416|NCT02025907|2694860|P1|Overall Study|Lost to Follow-up|2
822417|NCT02025907|2694859|P2|Overall Study|Physician Decision|0
822418|NCT02025907|2694860|P1|Overall Study|Physician Decision|2
822419|NCT02025907|2694859|P2|Overall Study|Protocol Violation|0
822420|NCT02025907|2694860|P1|Overall Study|Protocol Violation|2
822421|NCT02025907|2694859|P2|Overall Study|Withdrawal by Subject|8
822422|NCT02025907|2694860|P1|Overall Study|Withdrawal by Subject|15
822423|NCT02025907|2694859|P2|Overall Study|Lack of Efficacy|0
822424|NCT02025907|2694860|P1|Overall Study|Lack of Efficacy|1
822425|NCT02025621|2694917|P2|Overall Study|Surgery initiated before infusion|3
822426|NCT02025621|2694918|P1|Overall Study|Surgery initiated before infusion|3
822427|NCT02025621|2694917|P2|Overall Study|No longer eligible|15
822428|NCT02025621|2694918|P1|Overall Study|No longer eligible|10
822429|NCT02025621|2694917|P2|Overall Study|Death|1
822430|NCT02025621|2694918|P1|Overall Study|Death|0
822431|NCT02025621|2694917|P2|Overall Study|Withdrawal by Subject|0
822432|NCT02025621|2694918|P1|Overall Study|Withdrawal by Subject|1
822433|NCT02025179|2694939|P3|Overall Study|Lost to Follow-up|1
822434|NCT02025179|2694940|P2|Overall Study|Lost to Follow-up|0
822435|NCT02025179|2694941|P1|Overall Study|Lost to Follow-up|0
822436|NCT02024971|2694991|P1|Overall Study|Lost to Follow-up|6
822437|NCT02024971|2694991|P1|Overall Study|Data Not Available|30
822438|NCT02024932|2695004|P6|Overall Study|Abnormal laboratory value|0
822439|NCT02024932|2695005|P5|Overall Study|Abnormal laboratory value|0
822440|NCT02024932|2695006|P4|Overall Study|Abnormal laboratory value|2
822441|NCT02024932|2695007|P3|Overall Study|Abnormal laboratory value|0
822442|NCT02024932|2695008|P2|Overall Study|Abnormal laboratory value|0
822443|NCT02024932|2695009|P1|Overall Study|Abnormal laboratory value|0
822444|NCT02024932|2695004|P6|Overall Study|Adverse Event|0
822445|NCT02024932|2695005|P5|Overall Study|Adverse Event|2
822446|NCT02024932|2695006|P4|Overall Study|Adverse Event|0
822447|NCT02024932|2695007|P3|Overall Study|Adverse Event|0
822448|NCT02024932|2695008|P2|Overall Study|Adverse Event|3
822449|NCT02024932|2695009|P1|Overall Study|Adverse Event|2
822450|NCT02024867|2695068|P2|Overall Study|Lost to Follow-up|4
822451|NCT02024867|2695069|P1|Overall Study|Lost to Follow-up|6
822452|NCT02024867|2695068|P2|Overall Study|Protocol Violation|3
822453|NCT02024867|2695069|P1|Overall Study|Protocol Violation|3
822454|NCT02024698|2695094|P2|First Intervention (7 Days)|Withdrawal by Subject|1
822455|NCT02024698|2695095|P1|First Intervention (7 Days)|Withdrawal by Subject|0
822456|NCT02023879|2695173|P3|Extension Open Label Treatment|Other than specified above|2
822457|NCT02023879|2695174|P2|Extension Open Label Treatment|Other than specified above|7
822458|NCT02023879|2695175|P1|Extension Open Label Treatment|Other than specified above|2
822459|NCT02023879|2695173|P3|Extension Open Label Treatment|Participant moved|0
822460|NCT02023879|2695174|P2|Extension Open Label Treatment|Participant moved|2
822461|NCT02023879|2695175|P1|Extension Open Label Treatment|Participant moved|1
822462|NCT02023879|2695173|P3|Extension Open Label Treatment|Poor compliance to protocol|0
822463|NCT02023879|2695174|P2|Extension Open Label Treatment|Poor compliance to protocol|1
822464|NCT02023879|2695175|P1|Extension Open Label Treatment|Poor compliance to protocol|1
822465|NCT02023879|2695173|P3|Extension Open Label Treatment|Adverse Event|3
822466|NCT02023879|2695174|P2|Extension Open Label Treatment|Adverse Event|7
822467|NCT02023879|2695175|P1|Extension Open Label Treatment|Adverse Event|1
822468|NCT02023879|2695173|P3|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
822469|NCT02023879|2695174|P2|Period 1: 24-Week Double-blind Treatment|Other than specified above|3
822470|NCT02023879|2695175|P1|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
822471|NCT02023879|2695173|P3|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
822472|NCT02023879|2695174|P2|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
822473|NCT02023879|2695175|P1|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0
822474|NCT02023879|2695173|P3|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
822475|NCT02023879|2695174|P2|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0
822476|NCT02023879|2695175|P1|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
822477|NCT02023879|2695173|P3|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
822478|NCT02023879|2695174|P2|Period 1: 24-Week Double-blind Treatment|Physician Decision|1
822479|NCT02023879|2695175|P1|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
822480|NCT02023879|2695173|P3|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1
822481|NCT02023879|2695174|P2|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2
822482|NCT02023879|2695175|P1|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0
822483|NCT02023879|2695173|P3|Period 1: 24-Week Double-blind Treatment|Adverse Event|5
822484|NCT02023879|2695174|P2|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
822485|NCT02023879|2695175|P1|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
822486|NCT02023866|2695264|P1|Overall Study|Withdrawal by Subject|1
822487|NCT02023866|2695264|P1|Overall Study|Adverse Event|3
822488|NCT02023866|2695264|P1|Overall Study|Non-compliance|2
822489|NCT02023697|2695286|P3|Active Follow-up Period|PD - radiological progression|1
822490|NCT02023697|2695287|P2|Active Follow-up Period|PD - radiological progression|0
822491|NCT02023697|2695288|P1|Active Follow-up Period|PD - radiological progression|0
822492|NCT02023697|2695286|P3|Active Follow-up Period|Progressive disease-clinical progression|1
822493|NCT02023697|2695287|P2|Active Follow-up Period|Progressive disease-clinical progression|2
822494|NCT02023697|2695288|P1|Active Follow-up Period|Progressive disease-clinical progression|0
822495|NCT02023697|2695286|P3|Active Follow-up Period|Other unspecified|2
822496|NCT02023697|2695287|P2|Active Follow-up Period|Other unspecified|0
822497|NCT02023697|2695288|P1|Active Follow-up Period|Other unspecified|3
822498|NCT02023697|2695286|P3|Active Follow-up Period|Lost to Follow-up|0
822499|NCT02023697|2695287|P2|Active Follow-up Period|Lost to Follow-up|1
822500|NCT02023697|2695288|P1|Active Follow-up Period|Lost to Follow-up|0
822501|NCT02023697|2695286|P3|Active Follow-up Period|Death|75
822502|NCT02023697|2695287|P2|Active Follow-up Period|Death|73
822503|NCT02023697|2695288|P1|Active Follow-up Period|Death|76
822504|NCT02023697|2695286|P3|Active Follow-up Period|Withdrawal by Subject|6
822505|NCT02023697|2695287|P2|Active Follow-up Period|Withdrawal by Subject|12
822506|NCT02023697|2695288|P1|Active Follow-up Period|Withdrawal by Subject|3
822507|NCT02023697|2695286|P3|Active Follow-up Period|Ongoing active follow-up|31
822508|NCT02023697|2695287|P2|Active Follow-up Period|Ongoing active follow-up|31
822509|NCT02023697|2695288|P1|Active Follow-up Period|Ongoing active follow-up|35
822510|NCT02023697|2695286|P3|Treatment Period|Withdrawal by Subject|10
822511|NCT02023697|2695287|P2|Treatment Period|Withdrawal by Subject|4
822512|NCT02023697|2695288|P1|Treatment Period|Withdrawal by Subject|4
822513|NCT02023697|2695286|P3|Treatment Period|Progressive disease-clinical progression|28
822514|NCT02023697|2695287|P2|Treatment Period|Progressive disease-clinical progression|8
822515|NCT02023697|2695288|P1|Treatment Period|Progressive disease-clinical progression|10
822516|NCT02023697|2695286|P3|Treatment Period|Other unspecified|5
822517|NCT02023697|2695287|P2|Treatment Period|Other unspecified|3
822518|NCT02023697|2695288|P1|Treatment Period|Other unspecified|1
822519|NCT02023697|2695286|P3|Treatment Period|Adverse Event|23
822520|NCT02023697|2695287|P2|Treatment Period|Adverse Event|25
822521|NCT02023697|2695288|P1|Treatment Period|Adverse Event|13
822522|NCT02023697|2695286|P3|Treatment Period|Never Treated|10
822523|NCT02023697|2695287|P2|Treatment Period|Never Treated|6
822524|NCT02023697|2695288|P1|Treatment Period|Never Treated|5
822525|NCT02023697|2695286|P3|Treatment Period|PD - radiological progression|26
822526|NCT02023697|2695287|P2|Treatment Period|PD - radiological progression|17
822527|NCT02023697|2695288|P1|Treatment Period|PD - radiological progression|13
822528|NCT02023268|2695401|P2|Overall Study|Withdrawal by Subject|1
822529|NCT02023268|2695402|P1|Overall Study|Withdrawal by Subject|0
822530|NCT02023268|2695401|P2|Overall Study|Adverse Event|2
822531|NCT02023268|2695402|P1|Overall Study|Adverse Event|0
822532|NCT02023268|2695401|P2|Overall Study|Lack of Efficacy|1
822533|NCT02023268|2695402|P1|Overall Study|Lack of Efficacy|0
822534|NCT02023151|2695408|P1|Overall Study|Lost to Follow-up|4
822535|NCT02023112|2695478|P2|Overall Study|Withdrawal by Subject|1
822536|NCT02023112|2695479|P1|Overall Study|Withdrawal by Subject|2
822537|NCT02023099|2695500|P3|Overall Study|Non-treatment-emergent Fatal AE|1
822538|NCT02023099|2695501|P2|Overall Study|Non-treatment-emergent Fatal AE|0
822539|NCT02023099|2695502|P1|Overall Study|Non-treatment-emergent Fatal AE|0
822540|NCT02023099|2695500|P3|Overall Study|Withdrawn Consent|1
822541|NCT02023099|2695501|P2|Overall Study|Withdrawn Consent|0
822542|NCT02023099|2695502|P1|Overall Study|Withdrawn Consent|3
822543|NCT02023099|2695500|P3|Overall Study|Non-fatal Adverse Event (AE)|1
822544|NCT02023099|2695501|P2|Overall Study|Non-fatal Adverse Event (AE)|0
822545|NCT02023099|2695502|P1|Overall Study|Non-fatal Adverse Event (AE)|0
822546|NCT02022748|2695525|P3|Overall Study|Withdrawal by Subject|0
822547|NCT02022748|2695526|P2|Overall Study|Withdrawal by Subject|1
822548|NCT02022748|2695527|P1|Overall Study|Withdrawal by Subject|0
822549|NCT02022748|2695525|P3|Overall Study|Adverse Event|0
822550|NCT02022748|2695526|P2|Overall Study|Adverse Event|1
822551|NCT02022748|2695527|P1|Overall Study|Adverse Event|1
822552|NCT02022670|2695553|P3|Overall Study|Adverse Event|1
822553|NCT02022670|2695554|P2|Overall Study|Adverse Event|0
822554|NCT02022670|2695555|P1|Overall Study|Adverse Event|1
822555|NCT02022007|2695604|P3|Overall Study|Noncompliant|1
822556|NCT02022007|2695605|P2|Overall Study|Noncompliant|0
822557|NCT02022007|2695606|P1|Overall Study|Noncompliant|0
822558|NCT02022007|2695604|P3|Overall Study|Withdrawal by Subject|1
822559|NCT02022007|2695605|P2|Overall Study|Withdrawal by Subject|1
822560|NCT02022007|2695606|P1|Overall Study|Withdrawal by Subject|1
822561|NCT02021643|2695671|P4|Overall Study|Withdrew Consent|0
822562|NCT02021643|2695672|P3|Overall Study|Withdrew Consent|0
822563|NCT02021643|2695673|P2|Overall Study|Withdrew Consent|1
822564|NCT02021643|2695674|P1|Overall Study|Withdrew Consent|0
822565|NCT02021643|2695671|P4|Overall Study|Lost to Follow-up|0
822566|NCT02021643|2695672|P3|Overall Study|Lost to Follow-up|0
822567|NCT02021643|2695673|P2|Overall Study|Lost to Follow-up|1
822568|NCT02021643|2695674|P1|Overall Study|Lost to Follow-up|0
822569|NCT02021643|2695671|P4|Overall Study|Lack of Efficacy|12
822570|NCT02021643|2695672|P3|Overall Study|Lack of Efficacy|0
822571|NCT02021643|2695673|P2|Overall Study|Lack of Efficacy|6
822572|NCT02021643|2695674|P1|Overall Study|Lack of Efficacy|7
822573|NCT02021643|2695671|P4|Overall Study|Investigator's Discretion|0
822574|NCT02021643|2695672|P3|Overall Study|Investigator's Discretion|0
822575|NCT02021643|2695673|P2|Overall Study|Investigator's Discretion|0
822576|NCT02021643|2695674|P1|Overall Study|Investigator's Discretion|1
822577|NCT02021643|2695671|P4|Overall Study|Death|0
822578|NCT02021643|2695672|P3|Overall Study|Death|0
822579|NCT02021643|2695673|P2|Overall Study|Death|1
822580|NCT02021643|2695674|P1|Overall Study|Death|0
822581|NCT02021643|2695671|P4|Overall Study|Adverse Event|0
822582|NCT02021643|2695672|P3|Overall Study|Adverse Event|0
822583|NCT02021643|2695673|P2|Overall Study|Adverse Event|1
822584|NCT02021643|2695674|P1|Overall Study|Adverse Event|0
822585|NCT02021643|2695671|P4|Overall Study|Enrolled but Never Treated|0
822586|NCT02021643|2695672|P3|Overall Study|Enrolled but Never Treated|0
822587|NCT02021643|2695673|P2|Overall Study|Enrolled but Never Treated|0
822588|NCT02021643|2695674|P1|Overall Study|Enrolled but Never Treated|1
822589|NCT02021565|2695716|P2|3-month Follow-up|Protocol Violation|2
822590|NCT02021565|2695717|P1|3-month Follow-up|Protocol Violation|3
822591|NCT02021565|2695716|P2|3-month Follow-up|Withdrawal by Subject|0
822592|NCT02021565|2695717|P1|3-month Follow-up|Withdrawal by Subject|4
822593|NCT02021565|2695716|P2|3-month Follow-up|Death|0
822594|NCT02021565|2695717|P1|3-month Follow-up|Death|3
822595|NCT02021565|2695716|P2|Baseline Through Intervention|Lost to Follow-up|2
822596|NCT02021565|2695717|P1|Baseline Through Intervention|Lost to Follow-up|4
822597|NCT02021565|2695716|P2|Baseline Through Intervention|Protocol Violation|7
822598|NCT02021565|2695717|P1|Baseline Through Intervention|Protocol Violation|0
822599|NCT02021565|2695716|P2|Baseline Through Intervention|Withdrawal by Subject|8
822600|NCT02021565|2695717|P1|Baseline Through Intervention|Withdrawal by Subject|8
822601|NCT02021565|2695716|P2|Baseline Through Intervention|Death|1
822602|NCT02021565|2695717|P1|Baseline Through Intervention|Death|0
822603|NCT02021331|2695737|P2|Overall Study|Adverse Event|2
822604|NCT02021331|2695738|P1|Overall Study|Adverse Event|0
822605|NCT02021292|2695750|P2|Overall Study|Death|1
822606|NCT02021292|2695751|P1|Overall Study|Death|0
822607|NCT02021292|2695750|P2|Overall Study|Lost to Follow-up|1
822608|NCT02021292|2695751|P1|Overall Study|Lost to Follow-up|0
822609|NCT02021292|2695750|P2|Overall Study|Physician Decision|1
822610|NCT02021292|2695751|P1|Overall Study|Physician Decision|0
822611|NCT02020941|2695777|P1|Overall Study|Disease Progression|4
822612|NCT02020941|2695777|P1|Overall Study|Withdrawal by Subject|1
822613|NCT02020941|2695777|P1|Overall Study|Physician Decision|2
822614|NCT02020941|2695777|P1|Overall Study|Adverse Event|1
822615|NCT02020889|2695788|P2|Overall Study|Withdrawal by Subject|2
822616|NCT02020889|2695789|P1|Overall Study|Withdrawal by Subject|3
822617|NCT02020889|2695788|P2|Overall Study|Physician Decision|0
822618|NCT02020889|2695789|P1|Overall Study|Physician Decision|2
822619|NCT02020889|2695788|P2|Overall Study|Lost to Follow-up|0
822620|NCT02020889|2695789|P1|Overall Study|Lost to Follow-up|1
822621|NCT02020889|2695788|P2|Overall Study|Lack of Efficacy|0
822622|NCT02020889|2695789|P1|Overall Study|Lack of Efficacy|1
822623|NCT02020889|2695788|P2|Overall Study|Adverse Event|1
822624|NCT02020889|2695789|P1|Overall Study|Adverse Event|0
822625|NCT02020863|2695843|P1|Overall Study|Team chose not to place an a line|1
822626|NCT02020863|2695843|P1|Overall Study|Discovery of Metastatic disease|4
822627|NCT02020616|2695858|P7|Overall Study|Lack of Efficacy|0
822628|NCT02020616|2695859|P6|Overall Study|Lack of Efficacy|0
822629|NCT02020616|2695860|P5|Overall Study|Lack of Efficacy|1
822630|NCT02020616|2695861|P4|Overall Study|Lack of Efficacy|0
822631|NCT02020616|2695862|P3|Overall Study|Lack of Efficacy|0
822632|NCT02020616|2695863|P2|Overall Study|Lack of Efficacy|0
822633|NCT02020616|2695864|P1|Overall Study|Lack of Efficacy|0
822634|NCT02020616|2695858|P7|Overall Study|Randomized in Error|0
822635|NCT02020616|2695859|P6|Overall Study|Randomized in Error|0
822636|NCT02020616|2695860|P5|Overall Study|Randomized in Error|0
822637|NCT02020616|2695861|P4|Overall Study|Randomized in Error|1
822638|NCT02020616|2695862|P3|Overall Study|Randomized in Error|0
822639|NCT02020616|2695863|P2|Overall Study|Randomized in Error|0
822640|NCT02020616|2695864|P1|Overall Study|Randomized in Error|0
822641|NCT02020616|2695858|P7|Overall Study|Early Termination Criteria Met|0
822642|NCT02020616|2695859|P6|Overall Study|Early Termination Criteria Met|1
822643|NCT02020616|2695860|P5|Overall Study|Early Termination Criteria Met|0
822644|NCT02020616|2695861|P4|Overall Study|Early Termination Criteria Met|0
822645|NCT02020616|2695862|P3|Overall Study|Early Termination Criteria Met|1
822646|NCT02020616|2695863|P2|Overall Study|Early Termination Criteria Met|0
822647|NCT02020616|2695864|P1|Overall Study|Early Termination Criteria Met|0
822648|NCT02020616|2695858|P7|Overall Study|Lost to Follow-up|0
822649|NCT02020616|2695859|P6|Overall Study|Lost to Follow-up|1
822650|NCT02020616|2695860|P5|Overall Study|Lost to Follow-up|1
822651|NCT02020616|2695861|P4|Overall Study|Lost to Follow-up|1
822652|NCT02020616|2695862|P3|Overall Study|Lost to Follow-up|0
822653|NCT02020616|2695863|P2|Overall Study|Lost to Follow-up|1
822654|NCT02020616|2695864|P1|Overall Study|Lost to Follow-up|0
822655|NCT02020616|2695858|P7|Overall Study|Withdrawal by Subject|1
822656|NCT02020616|2695859|P6|Overall Study|Withdrawal by Subject|1
822657|NCT02020616|2695860|P5|Overall Study|Withdrawal by Subject|0
822658|NCT02020616|2695861|P4|Overall Study|Withdrawal by Subject|0
822659|NCT02020616|2695862|P3|Overall Study|Withdrawal by Subject|1
822660|NCT02020616|2695863|P2|Overall Study|Withdrawal by Subject|0
822661|NCT02020616|2695864|P1|Overall Study|Withdrawal by Subject|0
822662|NCT02020616|2695858|P7|Overall Study|Physician Decision|2
822663|NCT02020616|2695859|P6|Overall Study|Physician Decision|1
822664|NCT02020616|2695860|P5|Overall Study|Physician Decision|0
822665|NCT02020616|2695861|P4|Overall Study|Physician Decision|0
822666|NCT02020616|2695862|P3|Overall Study|Physician Decision|0
822667|NCT02020616|2695863|P2|Overall Study|Physician Decision|0
822668|NCT02020616|2695864|P1|Overall Study|Physician Decision|0
822669|NCT02020616|2695858|P7|Overall Study|Adverse Event|1
822670|NCT02020616|2695859|P6|Overall Study|Adverse Event|1
822671|NCT02020616|2695860|P5|Overall Study|Adverse Event|0
822672|NCT02020616|2695861|P4|Overall Study|Adverse Event|0
822673|NCT02020616|2695862|P3|Overall Study|Adverse Event|0
822674|NCT02020616|2695863|P2|Overall Study|Adverse Event|0
822675|NCT02020616|2695864|P1|Overall Study|Adverse Event|0
822676|NCT02020577|2695957|P2|Overall Study|Other than stated above|1
822677|NCT02020577|2695958|P1|Overall Study|Other than stated above|0
822678|NCT02020577|2695957|P2|Overall Study|Withdrawal by Subject|1
822679|NCT02020577|2695958|P1|Overall Study|Withdrawal by Subject|0
822680|NCT02020577|2695957|P2|Overall Study|Other AE or clinical progression|15
822681|NCT02020577|2695958|P1|Overall Study|Other AE or clinical progression|0
822682|NCT02020577|2695957|P2|Overall Study|Progressive disease|38
822683|NCT02020577|2695958|P1|Overall Study|Progressive disease|3
822684|NCT02020512|2695985|P1|Overall Study|Protocol Violation|4
822685|NCT02020512|2695985|P1|Overall Study|Lost to Follow-up|3
822686|NCT02020512|2695985|P1|Overall Study|Adverse Event|1
822687|NCT02020031|2696037|P2|Overall Study|Physician Decision|1
822688|NCT02020031|2696038|P1|Overall Study|Physician Decision|1
822689|NCT02019979|2696046|P1|Overall Study|study terminated|14
822690|NCT02019719|2696057|P5|Overall Study|Physician Decision|0
822691|NCT02019719|2696058|P4|Overall Study|Physician Decision|0
822692|NCT02019719|2696059|P3|Overall Study|Physician Decision|0
822693|NCT02019719|2696060|P2|Overall Study|Physician Decision|0
822694|NCT02019719|2696061|P1|Overall Study|Physician Decision|2
822695|NCT02019719|2696057|P5|Overall Study|Protocol defined stopping criteria|1
822696|NCT02019719|2696058|P4|Overall Study|Protocol defined stopping criteria|1
822697|NCT02019719|2696059|P3|Overall Study|Protocol defined stopping criteria|0
822698|NCT02019719|2696060|P2|Overall Study|Protocol defined stopping criteria|0
822699|NCT02019719|2696061|P1|Overall Study|Protocol defined stopping criteria|2
822700|NCT02019719|2696057|P5|Overall Study|Protocol Violation|0
822701|NCT02019719|2696058|P4|Overall Study|Protocol Violation|0
822702|NCT02019719|2696059|P3|Overall Study|Protocol Violation|0
822703|NCT02019719|2696060|P2|Overall Study|Protocol Violation|1
822704|NCT02019719|2696061|P1|Overall Study|Protocol Violation|1
822705|NCT02019719|2696057|P5|Overall Study|Adverse Event|1
822706|NCT02019719|2696058|P4|Overall Study|Adverse Event|1
822707|NCT02019719|2696059|P3|Overall Study|Adverse Event|0
822708|NCT02019719|2696060|P2|Overall Study|Adverse Event|0
822709|NCT02019719|2696061|P1|Overall Study|Adverse Event|1
822710|NCT02019550|2696177|P2|Treatment Period 1 (4 Weeks)|Adverse Event|1
822711|NCT02019550|2696178|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
822712|NCT02019472|2696219|P3|Overall Study|Other|6
822713|NCT02019472|2696220|P2|Overall Study|Other|8
822714|NCT02019472|2696221|P1|Overall Study|Other|3
822715|NCT02019472|2696219|P3|Overall Study|Withdrawal by Subject|11
822716|NCT02019472|2696220|P2|Overall Study|Withdrawal by Subject|10
822717|NCT02019472|2696221|P1|Overall Study|Withdrawal by Subject|11
822718|NCT02019472|2696219|P3|Overall Study|Pregnancy|2
822719|NCT02019472|2696220|P2|Overall Study|Pregnancy|2
822720|NCT02019472|2696221|P1|Overall Study|Pregnancy|1
822721|NCT02019472|2696219|P3|Overall Study|Physician Decision|0
822722|NCT02019472|2696220|P2|Overall Study|Physician Decision|2
822723|NCT02019472|2696221|P1|Overall Study|Physician Decision|1
822724|NCT02019472|2696219|P3|Overall Study|Lost to Follow-up|1
822725|NCT02019472|2696220|P2|Overall Study|Lost to Follow-up|2
822726|NCT02019472|2696221|P1|Overall Study|Lost to Follow-up|0
822727|NCT02019472|2696219|P3|Overall Study|Lack of Efficacy|4
822728|NCT02019472|2696220|P2|Overall Study|Lack of Efficacy|4
822729|NCT02019472|2696221|P1|Overall Study|Lack of Efficacy|7
822730|NCT02019472|2696219|P3|Overall Study|Death|1
822731|NCT02019472|2696220|P2|Overall Study|Death|1
822732|NCT02019472|2696221|P1|Overall Study|Death|0
822733|NCT02019472|2696219|P3|Overall Study|Adverse Event|17
822734|NCT02019472|2696220|P2|Overall Study|Adverse Event|23
822735|NCT02019472|2696221|P1|Overall Study|Adverse Event|14
822736|NCT02019277|2696242|P1|Overall Study|Adverse Event|1
822737|NCT02019277|2696242|P1|Overall Study|Did no Cooperate|1
822738|NCT02019277|2696242|P1|Overall Study|Death|7
822739|NCT02019277|2696242|P1|Overall Study|Withdrawal by Subject|3
822740|NCT02018822|2696261|P3|Overall Study|Lost to Follow-up|5
822741|NCT02018822|2696262|P2|Overall Study|Lost to Follow-up|6
822742|NCT02018822|2696263|P1|Overall Study|Lost to Follow-up|6
822743|NCT02018822|2696261|P3|Overall Study|Physician Decision|1
822744|NCT02018822|2696262|P2|Overall Study|Physician Decision|1
822745|NCT02018822|2696263|P1|Overall Study|Physician Decision|0
822746|NCT02018822|2696261|P3|Overall Study|filling replaced by crown|0
822747|NCT02018822|2696262|P2|Overall Study|filling replaced by crown|1
822748|NCT02018822|2696263|P1|Overall Study|filling replaced by crown|0
822749|NCT02018562|2696318|P2|Overall Study|Discharged prior to study completion|0
822750|NCT02018562|2696319|P1|Overall Study|Discharged prior to study completion|1
822751|NCT02018562|2696318|P2|Overall Study|Withdrawal by Subject|0
822752|NCT02018562|2696319|P1|Overall Study|Withdrawal by Subject|2
822753|NCT02017522|2696348|P1|Overall Study|Withdrawal by Subject|1
822754|NCT02017015|2696364|P1|Overall Study|Physician Decision|2
822755|NCT02017015|2696364|P1|Overall Study|Non-compliance with study drug|2
822756|NCT02017015|2696364|P1|Overall Study|Progressive Disease|31
822757|NCT02017015|2696364|P1|Overall Study|Death|4
822758|NCT02017015|2696364|P1|Overall Study|Withdrawal by Subject|21
822759|NCT02017015|2696364|P1|Overall Study|Adverse Event|9
822760|NCT02016898|2696389|P2|Overall Study|Lost to Follow-up|4
822761|NCT02016898|2696390|P1|Overall Study|Lost to Follow-up|4
822762|NCT02016898|2696389|P2|Overall Study|Death|1
822763|NCT02016898|2696390|P1|Overall Study|Death|1
822764|NCT02016716|2696447|P3|Overall Study|Lost to Follow-up|1
822765|NCT02016716|2696448|P2|Overall Study|Lost to Follow-up|2
822766|NCT02016716|2696449|P1|Overall Study|Lost to Follow-up|1
822767|NCT02016716|2696447|P3|Overall Study|Protocol-specified Criteria|0
822768|NCT02016716|2696448|P2|Overall Study|Protocol-specified Criteria|1
822769|NCT02016716|2696449|P1|Overall Study|Protocol-specified Criteria|0
822770|NCT02016716|2696447|P3|Overall Study|Withdrawal by Subject|5
822771|NCT02016716|2696448|P2|Overall Study|Withdrawal by Subject|5
822772|NCT02016716|2696449|P1|Overall Study|Withdrawal by Subject|5
822773|NCT02016690|2696470|P1|Overall Study|Hospitalized for RSV at study start|3
822774|NCT02016690|2696470|P1|Overall Study|Did not meet inclusion criteria|13
822775|NCT02016690|2696470|P1|Overall Study|Excluded from SAS: Ineligible for study|2
822776|NCT02016690|2696470|P1|Overall Study|Excluded from SAS: Early treatment|2
822777|NCT02016690|2696470|P1|Overall Study|Excluded from SAS: Duplication|2
822778|NCT02016690|2696470|P1|Overall Study|Excluded from SAS: Enrollment violation|2
822779|NCT02016625|2696483|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0
822780|NCT02016625|2696484|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2
822781|NCT02016625|2696483|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0
822782|NCT02016625|2696484|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1
822783|NCT02016625|2696483|P2|Cyclo or Tac (Single Dose, Day 1)|not treated|1
822784|NCT02016625|2696484|P1|Cyclo or Tac (Single Dose, Day 1)|not treated|0
822785|NCT02016482|2696539|P2|Period B|Required Alternative/Prohibited Therapy|2
822786|NCT02016482|2696540|P1|Period B|Required Alternative/Prohibited Therapy|0
822787|NCT02016482|2696539|P2|Period B|Not Specified|0
822788|NCT02016482|2696540|P1|Period B|Not Specified|4
822789|NCT02016482|2696539|P2|Period B|Lack of Efficacy|4
822790|NCT02016482|2696540|P1|Period B|Lack of Efficacy|6
822791|NCT02016482|2696539|P2|Period B|Lost to Follow-up|0
822792|NCT02016482|2696540|P1|Period B|Lost to Follow-up|2
822793|NCT02016482|2696539|P2|Period B|Withdrawal by Subject|1
822794|NCT02016482|2696540|P1|Period B|Withdrawal by Subject|1
822795|NCT02016482|2696539|P2|Period A|Required Alternative/Prohibited Therapy|1
822796|NCT02016482|2696540|P1|Period A|Required Alternative/Prohibited Therapy|0
822797|NCT02016482|2696539|P2|Period A|Protocol Violation|1
822798|NCT02016482|2696540|P1|Period A|Protocol Violation|0
822799|NCT02016482|2696539|P2|Period A|Not Specified|0
822800|NCT02016482|2696540|P1|Period A|Not Specified|3
822801|NCT02016482|2696539|P2|Period A|Lack of Efficacy|1
822802|NCT02016482|2696540|P1|Period A|Lack of Efficacy|2
822803|NCT02016482|2696539|P2|Period A|Lost to Follow-up|3
822804|NCT02016482|2696540|P1|Period A|Lost to Follow-up|3
822805|NCT02016482|2696539|P2|Period A|Withdrawal by Subject|4
822806|NCT02016482|2696540|P1|Period A|Withdrawal by Subject|3
822807|NCT02016482|2696539|P2|Period A|Adverse Event|5
822808|NCT02016482|2696540|P1|Period A|Adverse Event|3
822809|NCT02016183|2696628|P1|Overall Study|Protocol Violation|52
822810|NCT02016183|2696628|P1|Overall Study|Case Report Forms Uncollected|13
822811|NCT02016170|2696638|P3|Overall Study|Protocol Violation|0
822812|NCT02016170|2696639|P2|Overall Study|Protocol Violation|0
822813|NCT02016170|2696640|P1|Overall Study|Protocol Violation|1
822814|NCT02016170|2696638|P3|Overall Study|Adverse Event|0
822815|NCT02016170|2696639|P2|Overall Study|Adverse Event|1
822816|NCT02016170|2696640|P1|Overall Study|Adverse Event|1
822817|NCT02016105|2696651|P6|EXTENSION PERIOD|Lost to Follow-up|2
822818|NCT02016105|2696652|P5|EXTENSION PERIOD|Lost to Follow-up|0
822819|NCT02016105|2696653|P4|EXTENSION PERIOD|Lost to Follow-up|0
822820|NCT02016105|2696654|P3|EXTENSION PERIOD|Lost to Follow-up|0
822821|NCT02016105|2696655|P2|EXTENSION PERIOD|Lost to Follow-up|0
822822|NCT02016105|2696656|P1|EXTENSION PERIOD|Lost to Follow-up|0
822823|NCT02016105|2696651|P6|EXTENSION PERIOD|Non-compliance with study indication|0
822824|NCT02016105|2696652|P5|EXTENSION PERIOD|Non-compliance with study indication|1
822825|NCT02016105|2696653|P4|EXTENSION PERIOD|Non-compliance with study indication|0
822826|NCT02016105|2696654|P3|EXTENSION PERIOD|Non-compliance with study indication|0
822827|NCT02016105|2696655|P2|EXTENSION PERIOD|Non-compliance with study indication|0
822828|NCT02016105|2696656|P1|EXTENSION PERIOD|Non-compliance with study indication|0
822829|NCT02016105|2696651|P6|EXTENSION PERIOD|Withdrawal by Subject|2
822830|NCT02016105|2696652|P5|EXTENSION PERIOD|Withdrawal by Subject|2
822831|NCT02016105|2696653|P4|EXTENSION PERIOD|Withdrawal by Subject|2
822832|NCT02016105|2696654|P3|EXTENSION PERIOD|Withdrawal by Subject|2
822833|NCT02016105|2696655|P2|EXTENSION PERIOD|Withdrawal by Subject|0
822834|NCT02016105|2696656|P1|EXTENSION PERIOD|Withdrawal by Subject|0
822835|NCT02016105|2696651|P6|EXTENSION PERIOD|Adverse Event|0
822836|NCT02016105|2696652|P5|EXTENSION PERIOD|Adverse Event|1
822837|NCT02016105|2696653|P4|EXTENSION PERIOD|Adverse Event|0
822838|NCT02016105|2696654|P3|EXTENSION PERIOD|Adverse Event|2
822839|NCT02016105|2696655|P2|EXTENSION PERIOD|Adverse Event|0
822840|NCT02016105|2696656|P1|EXTENSION PERIOD|Adverse Event|0
822841|NCT02016105|2696651|P6|EXTENSION PERIOD|Lack of Efficacy|1
822842|NCT02016105|2696652|P5|EXTENSION PERIOD|Lack of Efficacy|1
822843|NCT02016105|2696653|P4|EXTENSION PERIOD|Lack of Efficacy|3
822844|NCT02016105|2696654|P3|EXTENSION PERIOD|Lack of Efficacy|1
822845|NCT02016105|2696655|P2|EXTENSION PERIOD|Lack of Efficacy|0
822846|NCT02016105|2696656|P1|EXTENSION PERIOD|Lack of Efficacy|0
822847|NCT02016105|2696651|P6|EXTENSION PERIOD|New therapy for study indication|1
822848|NCT02016105|2696652|P5|EXTENSION PERIOD|New therapy for study indication|1
822849|NCT02016105|2696653|P4|EXTENSION PERIOD|New therapy for study indication|0
822850|NCT02016105|2696654|P3|EXTENSION PERIOD|New therapy for study indication|0
822851|NCT02016105|2696655|P2|EXTENSION PERIOD|New therapy for study indication|0
822852|NCT02016105|2696656|P1|EXTENSION PERIOD|New therapy for study indication|0
822853|NCT02016105|2696651|P6|TREATMENT PERIOD 2|Lost to Follow-up|1
822854|NCT02016105|2696652|P5|TREATMENT PERIOD 2|Lost to Follow-up|0
822855|NCT02016105|2696653|P4|TREATMENT PERIOD 2|Lost to Follow-up|0
822856|NCT02016105|2696654|P3|TREATMENT PERIOD 2|Lost to Follow-up|1
822857|NCT02016105|2696655|P2|TREATMENT PERIOD 2|Lost to Follow-up|0
822858|NCT02016105|2696656|P1|TREATMENT PERIOD 2|Lost to Follow-up|0
822859|NCT02016105|2696651|P6|TREATMENT PERIOD 2|Withdrawal by Subject|7
822860|NCT02016105|2696652|P5|TREATMENT PERIOD 2|Withdrawal by Subject|1
822861|NCT02016105|2696653|P4|TREATMENT PERIOD 2|Withdrawal by Subject|1
822862|NCT02016105|2696654|P3|TREATMENT PERIOD 2|Withdrawal by Subject|3
822863|NCT02016105|2696655|P2|TREATMENT PERIOD 2|Withdrawal by Subject|0
822864|NCT02016105|2696656|P1|TREATMENT PERIOD 2|Withdrawal by Subject|0
822865|NCT02016105|2696651|P6|TREATMENT PERIOD 2|Adverse Event|1
822866|NCT02016105|2696652|P5|TREATMENT PERIOD 2|Adverse Event|0
822867|NCT02016105|2696653|P4|TREATMENT PERIOD 2|Adverse Event|4
822868|NCT02016105|2696654|P3|TREATMENT PERIOD 2|Adverse Event|0
822869|NCT02016105|2696655|P2|TREATMENT PERIOD 2|Adverse Event|0
822870|NCT02016105|2696656|P1|TREATMENT PERIOD 2|Adverse Event|0
822871|NCT02016105|2696651|P6|TREATMENT PERIOD 2|Death|1
822872|NCT02016105|2696652|P5|TREATMENT PERIOD 2|Death|0
822873|NCT02016105|2696653|P4|TREATMENT PERIOD 2|Death|0
822874|NCT02016105|2696654|P3|TREATMENT PERIOD 2|Death|0
822875|NCT02016105|2696655|P2|TREATMENT PERIOD 2|Death|0
822876|NCT02016105|2696656|P1|TREATMENT PERIOD 2|Death|0
822877|NCT02016105|2696651|P6|TREATMENT PERIOD 2|Pregnancy|1
822878|NCT02016105|2696652|P5|TREATMENT PERIOD 2|Pregnancy|0
822879|NCT02016105|2696653|P4|TREATMENT PERIOD 2|Pregnancy|0
822880|NCT02016105|2696654|P3|TREATMENT PERIOD 2|Pregnancy|0
822881|NCT02016105|2696655|P2|TREATMENT PERIOD 2|Pregnancy|0
822882|NCT02016105|2696656|P1|TREATMENT PERIOD 2|Pregnancy|0
822883|NCT02016105|2696651|P6|TREATMENT PERIOD 2|Lack of Efficacy|2
822884|NCT02016105|2696652|P5|TREATMENT PERIOD 2|Lack of Efficacy|3
822885|NCT02016105|2696653|P4|TREATMENT PERIOD 2|Lack of Efficacy|6
822886|NCT02016105|2696654|P3|TREATMENT PERIOD 2|Lack of Efficacy|2
822887|NCT02016105|2696655|P2|TREATMENT PERIOD 2|Lack of Efficacy|0
822888|NCT02016105|2696656|P1|TREATMENT PERIOD 2|Lack of Efficacy|0
822889|NCT02016105|2696651|P6|TREATMENT PERIOD 2|Non compliance study medication|1
822890|NCT02016105|2696652|P5|TREATMENT PERIOD 2|Non compliance study medication|0
822891|NCT02016105|2696653|P4|TREATMENT PERIOD 2|Non compliance study medication|0
822892|NCT02016105|2696654|P3|TREATMENT PERIOD 2|Non compliance study medication|0
822893|NCT02016105|2696655|P2|TREATMENT PERIOD 2|Non compliance study medication|0
822894|NCT02016105|2696656|P1|TREATMENT PERIOD 2|Non compliance study medication|0
822895|NCT02016105|2696651|P6|TREATMENT PERIOD 1|Lost to Follow-up|0
822896|NCT02016105|2696652|P5|TREATMENT PERIOD 1|Lost to Follow-up|0
822897|NCT02016105|2696653|P4|TREATMENT PERIOD 1|Lost to Follow-up|0
822898|NCT02016105|2696654|P3|TREATMENT PERIOD 1|Lost to Follow-up|0
822899|NCT02016105|2696655|P2|TREATMENT PERIOD 1|Lost to Follow-up|4
822900|NCT02016105|2696656|P1|TREATMENT PERIOD 1|Lost to Follow-up|6
822901|NCT02016105|2696651|P6|TREATMENT PERIOD 1|Withdrawal by Subject|0
822902|NCT02016105|2696652|P5|TREATMENT PERIOD 1|Withdrawal by Subject|0
822903|NCT02016105|2696653|P4|TREATMENT PERIOD 1|Withdrawal by Subject|0
822904|NCT02016105|2696654|P3|TREATMENT PERIOD 1|Withdrawal by Subject|0
822905|NCT02016105|2696655|P2|TREATMENT PERIOD 1|Withdrawal by Subject|11
822906|NCT02016105|2696656|P1|TREATMENT PERIOD 1|Withdrawal by Subject|15
822907|NCT02016105|2696651|P6|TREATMENT PERIOD 1|Adverse Event|0
822908|NCT02016105|2696652|P5|TREATMENT PERIOD 1|Adverse Event|0
822909|NCT02016105|2696653|P4|TREATMENT PERIOD 1|Adverse Event|0
822910|NCT02016105|2696654|P3|TREATMENT PERIOD 1|Adverse Event|0
822911|NCT02016105|2696655|P2|TREATMENT PERIOD 1|Adverse Event|5
822912|NCT02016105|2696656|P1|TREATMENT PERIOD 1|Adverse Event|3
822913|NCT02016105|2696651|P6|TREATMENT PERIOD 1|Pregnancy|0
822914|NCT02016105|2696652|P5|TREATMENT PERIOD 1|Pregnancy|0
822915|NCT02016105|2696653|P4|TREATMENT PERIOD 1|Pregnancy|0
822916|NCT02016105|2696654|P3|TREATMENT PERIOD 1|Pregnancy|0
822917|NCT02016105|2696655|P2|TREATMENT PERIOD 1|Pregnancy|1
822918|NCT02016105|2696656|P1|TREATMENT PERIOD 1|Pregnancy|0
822919|NCT02016105|2696651|P6|TREATMENT PERIOD 1|Lack of Efficacy|0
822920|NCT02016105|2696652|P5|TREATMENT PERIOD 1|Lack of Efficacy|0
822921|NCT02016105|2696653|P4|TREATMENT PERIOD 1|Lack of Efficacy|0
822922|NCT02016105|2696654|P3|TREATMENT PERIOD 1|Lack of Efficacy|0
822923|NCT02016105|2696655|P2|TREATMENT PERIOD 1|Lack of Efficacy|2
822924|NCT02016105|2696656|P1|TREATMENT PERIOD 1|Lack of Efficacy|4
822925|NCT02016105|2696651|P6|TREATMENT PERIOD 1|Physician Decision|0
822926|NCT02016105|2696652|P5|TREATMENT PERIOD 1|Physician Decision|0
822927|NCT02016105|2696653|P4|TREATMENT PERIOD 1|Physician Decision|0
822928|NCT02016105|2696654|P3|TREATMENT PERIOD 1|Physician Decision|0
822929|NCT02016105|2696655|P2|TREATMENT PERIOD 1|Physician Decision|2
822930|NCT02016105|2696656|P1|TREATMENT PERIOD 1|Physician Decision|0
822931|NCT02016105|2696651|P6|TREATMENT PERIOD 1|Protocol Violation|0
822932|NCT02016105|2696652|P5|TREATMENT PERIOD 1|Protocol Violation|0
822933|NCT02016105|2696653|P4|TREATMENT PERIOD 1|Protocol Violation|0
822934|NCT02016105|2696654|P3|TREATMENT PERIOD 1|Protocol Violation|0
822935|NCT02016105|2696655|P2|TREATMENT PERIOD 1|Protocol Violation|8
822936|NCT02016105|2696656|P1|TREATMENT PERIOD 1|Protocol Violation|2
822937|NCT02015793|2696715|P2|Overall Study|Withdrawal by Subject|1
822938|NCT02015793|2696716|P1|Overall Study|Withdrawal by Subject|1
822939|NCT02015793|2696715|P2|Overall Study|Adverse Event|3
822940|NCT02015793|2696716|P1|Overall Study|Adverse Event|3
822941|NCT02015754|2696746|P1|Overall Study|Lost to Follow-up|1
822942|NCT02015754|2696746|P1|Overall Study|Change in treatment modality|5
822943|NCT02015754|2696746|P1|Overall Study|Disease progression|5
822944|NCT02015676|2696766|P3|Overall Study|Disease progression|1
822945|NCT02015676|2696767|P2|Overall Study|Disease progression|1
822946|NCT02015676|2696768|P1|Overall Study|Disease progression|3
822947|NCT02015676|2696766|P3|Overall Study|Death|0
822948|NCT02015676|2696767|P2|Overall Study|Death|1
822949|NCT02015676|2696768|P1|Overall Study|Death|0
822950|NCT02015676|2696766|P3|Overall Study|Administrative reasons|1
822951|NCT02015676|2696767|P2|Overall Study|Administrative reasons|3
822952|NCT02015676|2696768|P1|Overall Study|Administrative reasons|0
822953|NCT02015676|2696766|P3|Overall Study|Withdrawal by Subject|1
822954|NCT02015676|2696767|P2|Overall Study|Withdrawal by Subject|7
822955|NCT02015676|2696768|P1|Overall Study|Withdrawal by Subject|1
822956|NCT02015676|2696766|P3|Overall Study|Protocol Violation|0
822957|NCT02015676|2696767|P2|Overall Study|Protocol Violation|0
822958|NCT02015676|2696768|P1|Overall Study|Protocol Violation|1
822959|NCT02015676|2696766|P3|Overall Study|Lack of Efficacy|0
822960|NCT02015676|2696767|P2|Overall Study|Lack of Efficacy|4
822961|NCT02015676|2696768|P1|Overall Study|Lack of Efficacy|2
822962|NCT02015676|2696766|P3|Overall Study|Adverse Event|0
822963|NCT02015676|2696767|P2|Overall Study|Adverse Event|18
822964|NCT02015676|2696768|P1|Overall Study|Adverse Event|2
822965|NCT02015663|2696784|P2|Overall Study|Administrative problems|11
822966|NCT02015663|2696785|P1|Overall Study|Administrative problems|10
822967|NCT02015663|2696784|P2|Overall Study|Adverse Event|0
822968|NCT02015663|2696785|P1|Overall Study|Adverse Event|3
822969|NCT02015663|2696784|P2|Overall Study|Protocol Violation|1
822970|NCT02015663|2696785|P1|Overall Study|Protocol Violation|0
822971|NCT02015663|2696784|P2|Overall Study|Withdrawal by Subject|0
822972|NCT02015663|2696785|P1|Overall Study|Withdrawal by Subject|1
822973|NCT02015663|2696784|P2|Overall Study|unsatisfactory therapeutic effect|0
822974|NCT02015663|2696785|P1|Overall Study|unsatisfactory therapeutic effect|1
822975|NCT02015637|2696816|P2|Overall Study|Did not take study drug|0
822976|NCT02015637|2696817|P1|Overall Study|Did not take study drug|2
822977|NCT02015637|2696816|P2|Overall Study|Adverse Event|0
822978|NCT02015637|2696817|P1|Overall Study|Adverse Event|3
822979|NCT02015637|2696816|P2|Overall Study|Lost to Follow-up|5
822980|NCT02015637|2696817|P1|Overall Study|Lost to Follow-up|3
822981|NCT02015546|2696828|P3|Overall Study|Screem Failure|3
822982|NCT02015546|2696829|P2|Overall Study|Screem Failure|1
822983|NCT02015546|2696830|P1|Overall Study|Screem Failure|2
822984|NCT02015546|2696828|P3|Overall Study|Withdrawal by Subject|1
822985|NCT02015546|2696829|P2|Overall Study|Withdrawal by Subject|1
822986|NCT02015546|2696830|P1|Overall Study|Withdrawal by Subject|1
822987|NCT02015481|2696862|P1|Overall Study|Death|1
822988|NCT02015221|2696886|P2|Overall Study|Lost to Follow-up|0
822989|NCT02015221|2696887|P1|Overall Study|Lost to Follow-up|1
822990|NCT02015221|2696886|P2|Overall Study|Withdrawal by Subject|6
822991|NCT02015221|2696887|P1|Overall Study|Withdrawal by Subject|8
822992|NCT02015195|2696900|P7|Overall Study|Adverse Event|0
822993|NCT02015195|2696901|P6|Overall Study|Adverse Event|0
822994|NCT02015195|2696902|P5|Overall Study|Adverse Event|0
822995|NCT02015195|2696903|P4|Overall Study|Adverse Event|1
822996|NCT02015195|2696904|P3|Overall Study|Adverse Event|0
822997|NCT02015195|2696905|P2|Overall Study|Adverse Event|0
822998|NCT02015195|2696906|P1|Overall Study|Adverse Event|0
822999|NCT02015039|2696929|P2|Overall Study|Not eligible|1
823000|NCT02015039|2696930|P1|Overall Study|Not eligible|0
823001|NCT02014740|2696950|P2|Overall Study|Withdrawal by Subject|1
823002|NCT02014740|2696951|P1|Overall Study|Withdrawal by Subject|2
823003|NCT02014740|2696950|P2|Overall Study|Lost to Follow-up|4
823004|NCT02014740|2696951|P1|Overall Study|Lost to Follow-up|4
823005|NCT02014584|2696959|P6|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
823006|NCT02014584|2696960|P5|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1
823007|NCT02014584|2696961|P4|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
823008|NCT02014584|2696962|P3|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
823009|NCT02014584|2696963|P2|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
823010|NCT02014584|2696964|P1|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
823011|NCT02014584|2696959|P6|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
823012|NCT02014584|2696960|P5|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
823013|NCT02014584|2696961|P4|Open-Label Period (24 Weeks)|Withdrawal by Subject|1
823014|NCT02014584|2696962|P3|Open-Label Period (24 Weeks)|Withdrawal by Subject|3
823015|NCT02014584|2696963|P2|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
823016|NCT02014584|2696964|P1|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
823017|NCT02014584|2696959|P6|Open-Label Period (24 Weeks)|Lost to Follow-up|0
823018|NCT02014584|2696960|P5|Open-Label Period (24 Weeks)|Lost to Follow-up|0
823019|NCT02014584|2696961|P4|Open-Label Period (24 Weeks)|Lost to Follow-up|0
823020|NCT02014584|2696962|P3|Open-Label Period (24 Weeks)|Lost to Follow-up|2
823021|NCT02014584|2696963|P2|Open-Label Period (24 Weeks)|Lost to Follow-up|0
823022|NCT02014584|2696964|P1|Open-Label Period (24 Weeks)|Lost to Follow-up|0
823023|NCT02014584|2696959|P6|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
823024|NCT02014584|2696960|P5|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
823025|NCT02014584|2696961|P4|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
823026|NCT02014584|2696962|P3|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
823027|NCT02014584|2696963|P2|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5
823028|NCT02014584|2696964|P1|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2
823029|NCT02014584|2696959|P6|Double-Blind Period (24 Weeks)|Protocol Violation|0
823030|NCT02014584|2696960|P5|Double-Blind Period (24 Weeks)|Protocol Violation|0
823031|NCT02014584|2696961|P4|Double-Blind Period (24 Weeks)|Protocol Violation|0
823032|NCT02014584|2696962|P3|Double-Blind Period (24 Weeks)|Protocol Violation|0
823033|NCT02014584|2696963|P2|Double-Blind Period (24 Weeks)|Protocol Violation|1
823034|NCT02014584|2696964|P1|Double-Blind Period (24 Weeks)|Protocol Violation|0
823035|NCT02014480|2697081|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|1
823036|NCT02014480|2697082|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
823037|NCT02014480|2697083|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
823038|NCT02014480|2697084|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
823039|NCT02014480|2697085|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
823040|NCT02014480|2697086|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
823041|NCT02014480|2697081|P6|Treatment Period 3 (14 Days)|Adverse Event|1
823042|NCT02014480|2697082|P5|Treatment Period 3 (14 Days)|Adverse Event|0
823043|NCT02014480|2697083|P4|Treatment Period 3 (14 Days)|Adverse Event|0
823044|NCT02014480|2697084|P3|Treatment Period 3 (14 Days)|Adverse Event|1
823045|NCT02014480|2697085|P2|Treatment Period 3 (14 Days)|Adverse Event|0
823046|NCT02014480|2697086|P1|Treatment Period 3 (14 Days)|Adverse Event|0
823047|NCT02014480|2697081|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
823048|NCT02014480|2697082|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
823049|NCT02014480|2697083|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
823050|NCT02014480|2697084|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
823051|NCT02014480|2697085|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
823052|NCT02014480|2697086|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
823053|NCT02014480|2697081|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
823054|NCT02014480|2697082|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
823055|NCT02014480|2697083|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
823056|NCT02014480|2697084|P3|Treatment Period 2 (14 Days)|Protocol Violation|2
823057|NCT02014480|2697085|P2|Treatment Period 2 (14 Days)|Protocol Violation|1
823058|NCT02014480|2697086|P1|Treatment Period 2 (14 Days)|Protocol Violation|1
823144|NCT02013687|2697412|P2|Overall Study|Protocol Violation|0
823059|NCT02014480|2697081|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
823060|NCT02014480|2697082|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
823061|NCT02014480|2697083|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
823062|NCT02014480|2697084|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
823063|NCT02014480|2697085|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
823064|NCT02014480|2697086|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
823065|NCT02014480|2697081|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
823066|NCT02014480|2697082|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
823067|NCT02014480|2697083|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|2
823068|NCT02014480|2697084|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
823069|NCT02014480|2697085|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
823070|NCT02014480|2697086|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
823071|NCT02014480|2697081|P6|Treatment Period 1 (14 Days)|Lack of Efficacy|0
823072|NCT02014480|2697082|P5|Treatment Period 1 (14 Days)|Lack of Efficacy|0
823073|NCT02014480|2697083|P4|Treatment Period 1 (14 Days)|Lack of Efficacy|0
823074|NCT02014480|2697084|P3|Treatment Period 1 (14 Days)|Lack of Efficacy|1
823075|NCT02014480|2697085|P2|Treatment Period 1 (14 Days)|Lack of Efficacy|0
823076|NCT02014480|2697086|P1|Treatment Period 1 (14 Days)|Lack of Efficacy|0
823077|NCT02014467|2697105|P2|Overall Study|Withdrawal by Subject|4
823078|NCT02014467|2697106|P1|Overall Study|Withdrawal by Subject|16
823079|NCT02014467|2697105|P2|Overall Study|Physician Decision|3
823080|NCT02014467|2697106|P1|Overall Study|Physician Decision|2
823081|NCT02014467|2697105|P2|Overall Study|Protocol Violation|0
823082|NCT02014467|2697106|P1|Overall Study|Protocol Violation|3
823083|NCT02014467|2697105|P2|Overall Study|Adverse Event|0
823084|NCT02014467|2697106|P1|Overall Study|Adverse Event|4
823085|NCT02014441|2697166|P1|Overall Study|Continuing in Study|21
823086|NCT02014441|2697166|P1|Overall Study|Withdrawal by Subject|9
823087|NCT02014402|2697262|P4|Overall Study|Lost to Follow-up|2
823088|NCT02014402|2697263|P3|Overall Study|Lost to Follow-up|1
823089|NCT02014402|2697264|P2|Overall Study|Lost to Follow-up|0
823090|NCT02014402|2697265|P1|Overall Study|Lost to Follow-up|0
823091|NCT02014402|2697262|P4|Overall Study|Subject did not have transportation|0
823092|NCT02014402|2697263|P3|Overall Study|Subject did not have transportation|0
823093|NCT02014402|2697264|P2|Overall Study|Subject did not have transportation|1
823094|NCT02014402|2697265|P1|Overall Study|Subject did not have transportation|0
823095|NCT02014402|2697262|P4|Overall Study|Withdrawal by Subject|1
823096|NCT02014402|2697263|P3|Overall Study|Withdrawal by Subject|2
823097|NCT02014402|2697264|P2|Overall Study|Withdrawal by Subject|2
823098|NCT02014402|2697265|P1|Overall Study|Withdrawal by Subject|1
823099|NCT02014402|2697262|P4|Overall Study|Adverse Event|0
823100|NCT02014402|2697263|P3|Overall Study|Adverse Event|0
823101|NCT02014402|2697264|P2|Overall Study|Adverse Event|0
823102|NCT02014402|2697265|P1|Overall Study|Adverse Event|1
823103|NCT02014272|2697305|P2|Intervention Period 1|Adverse Event|1
823104|NCT02014272|2697306|P1|Intervention Period 1|Adverse Event|0
823105|NCT02014272|2697305|P2|Intervention Period 1|Withdrawal by Subject|0
823106|NCT02014272|2697306|P1|Intervention Period 1|Withdrawal by Subject|1
823107|NCT02013830|2697338|P1|Overall Study|Refused treatment|1
823108|NCT02013830|2697338|P1|Overall Study|Insufficient therapeutic response|25
823109|NCT02013830|2697338|P1|Overall Study|Death|1
823110|NCT02013830|2697338|P1|Overall Study|Adverse Event|3
823111|NCT02013817|2697349|P1|Overall Study|Not specified|9
823112|NCT02013817|2697349|P1|Overall Study|Death|2
823113|NCT02013817|2697349|P1|Overall Study|Withdrawal by Subject|4
823114|NCT02013817|2697349|P1|Overall Study|Adverse Event|12
823115|NCT02013791|2697367|P9|Period 1|Other Miscellaneous Reasons|0
823116|NCT02013791|2697368|P8|Period 1|Other Miscellaneous Reasons|0
823117|NCT02013791|2697369|P7|Period 1|Other Miscellaneous Reasons|0
823118|NCT02013791|2697370|P6|Period 1|Other Miscellaneous Reasons|0
823119|NCT02013791|2697371|P5|Period 1|Other Miscellaneous Reasons|0
823120|NCT02013791|2697372|P4|Period 1|Other Miscellaneous Reasons|0
823121|NCT02013791|2697373|P3|Period 1|Other Miscellaneous Reasons|0
823122|NCT02013791|2697374|P2|Period 1|Other Miscellaneous Reasons|2
823123|NCT02013791|2697375|P1|Period 1|Other Miscellaneous Reasons|0
823124|NCT02013791|2697367|P9|Period 1|Lost to Follow-up|0
823125|NCT02013791|2697368|P8|Period 1|Lost to Follow-up|1
823126|NCT02013791|2697369|P7|Period 1|Lost to Follow-up|1
823127|NCT02013791|2697370|P6|Period 1|Lost to Follow-up|0
823128|NCT02013791|2697371|P5|Period 1|Lost to Follow-up|0
823129|NCT02013791|2697372|P4|Period 1|Lost to Follow-up|1
823130|NCT02013791|2697373|P3|Period 1|Lost to Follow-up|0
823131|NCT02013791|2697374|P2|Period 1|Lost to Follow-up|0
823132|NCT02013791|2697375|P1|Period 1|Lost to Follow-up|0
823133|NCT02013765|2697396|P1|Overall Study|Trial was terminated by sponsor|1
823134|NCT02013687|2697410|P4|Overall Study|Missed visits due to patient travel|0
823135|NCT02013687|2697411|P3|Overall Study|Missed visits due to patient travel|1
823136|NCT02013687|2697412|P2|Overall Study|Missed visits due to patient travel|0
823137|NCT02013687|2697413|P1|Overall Study|Missed visits due to patient travel|0
823138|NCT02013687|2697410|P4|Overall Study|Withdrawal by Subject|1
823139|NCT02013687|2697411|P3|Overall Study|Withdrawal by Subject|0
823140|NCT02013687|2697412|P2|Overall Study|Withdrawal by Subject|0
823141|NCT02013687|2697413|P1|Overall Study|Withdrawal by Subject|0
823142|NCT02013687|2697410|P4|Overall Study|Protocol Violation|1
823143|NCT02013687|2697411|P3|Overall Study|Protocol Violation|0
823145|NCT02013687|2697413|P1|Overall Study|Protocol Violation|0
823146|NCT02013687|2697410|P4|Overall Study|Lost to Follow-up|0
823147|NCT02013687|2697411|P3|Overall Study|Lost to Follow-up|1
823148|NCT02013687|2697412|P2|Overall Study|Lost to Follow-up|0
823149|NCT02013687|2697413|P1|Overall Study|Lost to Follow-up|0
823150|NCT02013622|2697443|P1|Overall Study|Lack of Efficacy|1
823151|NCT02013622|2697443|P1|Overall Study|Protocol Deviation|1
823152|NCT02013622|2697443|P1|Overall Study|Withdrawal by Subject|6
823153|NCT02013622|2697443|P1|Overall Study|Met Withdrawal Criteria|3
823154|NCT02013622|2697443|P1|Overall Study|Adverse Event|3
823155|NCT02013622|2697443|P1|Overall Study|Lost to Follow-up|10
823156|NCT02013609|2697463|P1|Overall Study|Met Withdrawal Criteria|3
823157|NCT02013609|2697463|P1|Overall Study|Adverse Event|3
823158|NCT02013609|2697463|P1|Overall Study|Lost to Follow-up|3
823159|NCT02013609|2697463|P1|Overall Study|Withdrawal by Subject|9
823160|NCT02013544|2697488|P2|Overall Study|Entry criteria not met/non-compliance|3
823161|NCT02013544|2697489|P1|Overall Study|Entry criteria not met/non-compliance|2
823162|NCT02013544|2697488|P2|Overall Study|Physician Decision|1
823163|NCT02013544|2697489|P1|Overall Study|Physician Decision|0
823164|NCT02013544|2697488|P2|Overall Study|Withdrawal by Subject|8
823165|NCT02013544|2697489|P1|Overall Study|Withdrawal by Subject|2
823166|NCT02013544|2697488|P2|Overall Study|Lost to Follow-up|3
823167|NCT02013544|2697489|P1|Overall Study|Lost to Follow-up|2
823168|NCT02013544|2697488|P2|Overall Study|Adverse Event|5
823169|NCT02013544|2697489|P1|Overall Study|Adverse Event|5
823170|NCT02013531|2697511|P1|Overall Study|Withdrawal by Subject|1
823171|NCT02013531|2697511|P1|Overall Study|Met Withdrawal Criteria|1
823172|NCT02013531|2697511|P1|Overall Study|Lost to Follow-up|3
823173|NCT02013388|2697541|P8|Overall Study|work emergency|0
823174|NCT02013388|2697542|P7|Overall Study|work emergency|0
823175|NCT02013388|2697543|P6|Overall Study|work emergency|0
823176|NCT02013388|2697544|P5|Overall Study|work emergency|1
823177|NCT02013388|2697545|P4|Overall Study|work emergency|0
823178|NCT02013388|2697546|P3|Overall Study|work emergency|0
823179|NCT02013388|2697547|P2|Overall Study|work emergency|0
823180|NCT02013388|2697548|P1|Overall Study|work emergency|1
823181|NCT02013206|2697605|P2|Overall Study|Other reasons off treatment|2
823182|NCT02013206|2697606|P1|Overall Study|Other reasons off treatment|5
823183|NCT02013206|2697605|P2|Overall Study|Death|2
823184|NCT02013206|2697606|P1|Overall Study|Death|1
823185|NCT02013206|2697605|P2|Overall Study|Patient non-compliance|0
823186|NCT02013206|2697606|P1|Overall Study|Patient non-compliance|1
823187|NCT02013206|2697605|P2|Overall Study|Patient refusal|0
823188|NCT02013206|2697606|P1|Overall Study|Patient refusal|2
823189|NCT02013206|2697605|P2|Overall Study|Adverse Event|0
823190|NCT02013206|2697606|P1|Overall Study|Adverse Event|1
823191|NCT02013206|2697605|P2|Overall Study|Symptomatic deterioration|1
823192|NCT02013206|2697606|P1|Overall Study|Symptomatic deterioration|3
823193|NCT02013206|2697605|P2|Overall Study|Progressive disease (PD)|17
823194|NCT02013206|2697606|P1|Overall Study|Progressive disease (PD)|14
823195|NCT02013167|2697628|P2|Overall Study|Death|160
823196|NCT02013167|2697629|P1|Overall Study|Death|85
823197|NCT02013167|2697628|P2|Overall Study|Lost to Follow-up|1
823198|NCT02013167|2697629|P1|Overall Study|Lost to Follow-up|0
823199|NCT02013167|2697628|P2|Overall Study|Sponsor Decision|3
823200|NCT02013167|2697629|P1|Overall Study|Sponsor Decision|1
823201|NCT02013167|2697628|P2|Overall Study|Withdrawal by Subject|14
823202|NCT02013167|2697629|P1|Overall Study|Withdrawal by Subject|15
823203|NCT02012959|2697705|P5|Treatment Phase A|Adverse Event|0
823204|NCT02012959|2697706|P4|Treatment Phase A|Adverse Event|0
823205|NCT02012959|2697707|P3|Treatment Phase A|Adverse Event|0
823206|NCT02012959|2697708|P2|Treatment Phase A|Adverse Event|0
823207|NCT02012959|2697709|P1|Treatment Phase A|Adverse Event|2
823208|NCT02012686|2697722|P2|Overall Study|electrocardiography monitoring noise|1
823209|NCT02012686|2697723|P1|Overall Study|electrocardiography monitoring noise|0
823210|NCT02012686|2697722|P2|Overall Study|muscle contraction|1
823211|NCT02012686|2697723|P1|Overall Study|muscle contraction|0
823212|NCT02012452|2697770|P2|Overall Study|Withdrawal by Subject|0
823213|NCT02012452|2697771|P1|Overall Study|Withdrawal by Subject|4
823214|NCT02012452|2697770|P2|Overall Study|Lost to Follow-up|1
823215|NCT02012452|2697771|P1|Overall Study|Lost to Follow-up|2
823216|NCT02012218|2697784|P5|Overall Study|Protocol Deviation|0
823217|NCT02012218|2697785|P4|Overall Study|Protocol Deviation|0
823218|NCT02012218|2697786|P3|Overall Study|Protocol Deviation|0
823219|NCT02012218|2697787|P2|Overall Study|Protocol Deviation|0
823220|NCT02012218|2697788|P1|Overall Study|Protocol Deviation|1
823221|NCT02012218|2697784|P5|Overall Study|Protocol Specified|0
823222|NCT02012218|2697785|P4|Overall Study|Protocol Specified|0
823223|NCT02012218|2697786|P3|Overall Study|Protocol Specified|0
823224|NCT02012218|2697787|P2|Overall Study|Protocol Specified|0
823225|NCT02012218|2697788|P1|Overall Study|Protocol Specified|1
823226|NCT02012218|2697784|P5|Overall Study|Lost to Follow-up|0
823227|NCT02012218|2697785|P4|Overall Study|Lost to Follow-up|0
823228|NCT02012218|2697786|P3|Overall Study|Lost to Follow-up|1
823229|NCT02012218|2697787|P2|Overall Study|Lost to Follow-up|1
823230|NCT02012218|2697788|P1|Overall Study|Lost to Follow-up|0
823231|NCT02012218|2697784|P5|Overall Study|Adverse Event|0
823232|NCT02012218|2697785|P4|Overall Study|Adverse Event|1
823233|NCT02012218|2697786|P3|Overall Study|Adverse Event|0
823234|NCT02012218|2697787|P2|Overall Study|Adverse Event|0
823235|NCT02012218|2697788|P1|Overall Study|Adverse Event|1
823236|NCT02012218|2697784|P5|Overall Study|Withdrawal by Subject|1
823237|NCT02012218|2697785|P4|Overall Study|Withdrawal by Subject|1
823238|NCT02012218|2697786|P3|Overall Study|Withdrawal by Subject|1
823239|NCT02012218|2697787|P2|Overall Study|Withdrawal by Subject|0
823240|NCT02012218|2697788|P1|Overall Study|Withdrawal by Subject|1
823241|NCT02011893|2697800|P3|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1
823242|NCT02011893|2697801|P2|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
823243|NCT02011893|2697802|P1|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
823244|NCT02011893|2697800|P3|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2
823245|NCT02011893|2697801|P2|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
823246|NCT02011893|2697802|P1|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
823247|NCT02011893|2697800|P3|Period 1 (Randomization to 12 Weeks)|Physician Decision|1
823248|NCT02011893|2697801|P2|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
823249|NCT02011893|2697802|P1|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
823250|NCT02011893|2697800|P3|Enrollment to Randomization|Insurance/Financial Reasons|0
823251|NCT02011893|2697801|P2|Enrollment to Randomization|Insurance/Financial Reasons|0
823252|NCT02011893|2697802|P1|Enrollment to Randomization|Insurance/Financial Reasons|2
823253|NCT02011893|2697800|P3|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
823254|NCT02011893|2697801|P2|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
823255|NCT02011893|2697802|P1|Enrollment to Randomization|Temporary Trial Stimulation Failure|9
823256|NCT02011893|2697800|P3|Enrollment to Randomization|Screening Failure|0
823257|NCT02011893|2697801|P2|Enrollment to Randomization|Screening Failure|0
823258|NCT02011893|2697802|P1|Enrollment to Randomization|Screening Failure|29
823259|NCT02011893|2697800|P3|Enrollment to Randomization|Withdrawal by Subject|0
823260|NCT02011893|2697801|P2|Enrollment to Randomization|Withdrawal by Subject|0
823261|NCT02011893|2697802|P1|Enrollment to Randomization|Withdrawal by Subject|21
823262|NCT02011893|2697800|P3|Enrollment to Randomization|Physician Decision|0
823263|NCT02011893|2697801|P2|Enrollment to Randomization|Physician Decision|0
823264|NCT02011893|2697802|P1|Enrollment to Randomization|Physician Decision|10
823265|NCT02011893|2697800|P3|Enrollment to Randomization|Adverse Event|0
823266|NCT02011893|2697801|P2|Enrollment to Randomization|Adverse Event|0
823267|NCT02011893|2697802|P1|Enrollment to Randomization|Adverse Event|2
823268|NCT02011542|2697813|P1|Overall Study|Physician Decision|1
823269|NCT02011113|2697944|P1|Overall Study|Study terminated by sponsor|11
823270|NCT02011113|2697944|P1|Overall Study|Investigator's judgement- DP|3
823271|NCT02011113|2697944|P1|Overall Study|Insufficient effect of Pomalidomide|1
823272|NCT02011113|2697944|P1|Overall Study|Death|1
823273|NCT02011113|2697944|P1|Overall Study|Disease Progression (DP)|16
823274|NCT02011113|2697944|P1|Overall Study|Adverse Event|4
823275|NCT02010684|2697973|P2|Overall Study|Withdrawal by Subject|5
823276|NCT02010684|2697974|P1|Overall Study|Withdrawal by Subject|4
823277|NCT02010684|2697973|P2|Overall Study|Lost to Follow-up|18
823278|NCT02010684|2697974|P1|Overall Study|Lost to Follow-up|8
823279|NCT02010632|2697992|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
823280|NCT02010632|2697993|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
823281|NCT02010567|2698004|P5|Overall Study|Adverse Event|1
823282|NCT02010567|2698005|P4|Overall Study|Adverse Event|0
823283|NCT02010567|2698006|P3|Overall Study|Adverse Event|1
823284|NCT02010567|2698007|P2|Overall Study|Adverse Event|0
823285|NCT02010567|2698008|P1|Overall Study|Adverse Event|0
823286|NCT02010255|2698033|P14|Overall Study|Randomized but Not Treated|1
823287|NCT02010255|2698034|P13|Overall Study|Randomized but Not Treated|0
823288|NCT02010255|2698035|P12|Overall Study|Randomized but Not Treated|0
823289|NCT02010255|2698036|P11|Overall Study|Randomized but Not Treated|0
823290|NCT02010255|2698037|P10|Overall Study|Randomized but Not Treated|0
823291|NCT02010255|2698038|P9|Overall Study|Randomized but Not Treated|0
823292|NCT02010255|2698039|P8|Overall Study|Randomized but Not Treated|0
823293|NCT02010255|2698040|P7|Overall Study|Randomized but Not Treated|0
823294|NCT02010255|2698041|P6|Overall Study|Randomized but Not Treated|0
823295|NCT02010255|2698042|P5|Overall Study|Randomized but Not Treated|0
823296|NCT02010255|2698043|P4|Overall Study|Randomized but Not Treated|0
823297|NCT02010255|2698044|P3|Overall Study|Randomized but Not Treated|0
823298|NCT02010255|2698045|P2|Overall Study|Randomized but Not Treated|0
823299|NCT02010255|2698046|P1|Overall Study|Randomized but Not Treated|0
823300|NCT02010255|2698033|P14|Overall Study|Lost to Follow-up|0
823301|NCT02010255|2698034|P13|Overall Study|Lost to Follow-up|0
823302|NCT02010255|2698035|P12|Overall Study|Lost to Follow-up|0
823303|NCT02010255|2698036|P11|Overall Study|Lost to Follow-up|0
823304|NCT02010255|2698037|P10|Overall Study|Lost to Follow-up|0
823305|NCT02010255|2698038|P9|Overall Study|Lost to Follow-up|0
823306|NCT02010255|2698039|P8|Overall Study|Lost to Follow-up|0
823307|NCT02010255|2698040|P7|Overall Study|Lost to Follow-up|0
823308|NCT02010255|2698041|P6|Overall Study|Lost to Follow-up|0
823309|NCT02010255|2698042|P5|Overall Study|Lost to Follow-up|1
823310|NCT02010255|2698043|P4|Overall Study|Lost to Follow-up|0
823311|NCT02010255|2698044|P3|Overall Study|Lost to Follow-up|1
823312|NCT02010255|2698045|P2|Overall Study|Lost to Follow-up|0
823313|NCT02010255|2698046|P1|Overall Study|Lost to Follow-up|0
823314|NCT02010255|2698033|P14|Overall Study|Adverse Event|0
823315|NCT02010255|2698034|P13|Overall Study|Adverse Event|0
823316|NCT02010255|2698035|P12|Overall Study|Adverse Event|0
823317|NCT02010255|2698036|P11|Overall Study|Adverse Event|0
823318|NCT02010255|2698037|P10|Overall Study|Adverse Event|0
823319|NCT02010255|2698038|P9|Overall Study|Adverse Event|0
823320|NCT02010255|2698039|P8|Overall Study|Adverse Event|0
823321|NCT02010255|2698040|P7|Overall Study|Adverse Event|0
823322|NCT02010255|2698041|P6|Overall Study|Adverse Event|0
823323|NCT02010255|2698042|P5|Overall Study|Adverse Event|0
823324|NCT02010255|2698043|P4|Overall Study|Adverse Event|0
823325|NCT02010255|2698044|P3|Overall Study|Adverse Event|0
823326|NCT02010255|2698045|P2|Overall Study|Adverse Event|0
823327|NCT02010255|2698046|P1|Overall Study|Adverse Event|1
823328|NCT02010255|2698033|P14|Overall Study|Withdrew Consent|0
823329|NCT02010255|2698034|P13|Overall Study|Withdrew Consent|0
823330|NCT02010255|2698035|P12|Overall Study|Withdrew Consent|0
823331|NCT02010255|2698036|P11|Overall Study|Withdrew Consent|0
823332|NCT02010255|2698037|P10|Overall Study|Withdrew Consent|0
823333|NCT02010255|2698038|P9|Overall Study|Withdrew Consent|0
823334|NCT02010255|2698039|P8|Overall Study|Withdrew Consent|0
823335|NCT02010255|2698040|P7|Overall Study|Withdrew Consent|0
823336|NCT02010255|2698041|P6|Overall Study|Withdrew Consent|0
823337|NCT02010255|2698042|P5|Overall Study|Withdrew Consent|0
823338|NCT02010255|2698043|P4|Overall Study|Withdrew Consent|1
823339|NCT02010255|2698044|P3|Overall Study|Withdrew Consent|0
823340|NCT02010255|2698045|P2|Overall Study|Withdrew Consent|0
823341|NCT02010255|2698046|P1|Overall Study|Withdrew Consent|1
823342|NCT02010255|2698033|P14|Overall Study|Lack of Efficacy|0
823343|NCT02010255|2698034|P13|Overall Study|Lack of Efficacy|0
823344|NCT02010255|2698035|P12|Overall Study|Lack of Efficacy|0
823345|NCT02010255|2698036|P11|Overall Study|Lack of Efficacy|1
823346|NCT02010255|2698037|P10|Overall Study|Lack of Efficacy|0
823347|NCT02010255|2698038|P9|Overall Study|Lack of Efficacy|0
823348|NCT02010255|2698039|P8|Overall Study|Lack of Efficacy|0
823349|NCT02010255|2698040|P7|Overall Study|Lack of Efficacy|0
823350|NCT02010255|2698041|P6|Overall Study|Lack of Efficacy|0
823351|NCT02010255|2698042|P5|Overall Study|Lack of Efficacy|1
823352|NCT02010255|2698043|P4|Overall Study|Lack of Efficacy|1
823353|NCT02010255|2698044|P3|Overall Study|Lack of Efficacy|2
823354|NCT02010255|2698045|P2|Overall Study|Lack of Efficacy|1
823355|NCT02010255|2698046|P1|Overall Study|Lack of Efficacy|4
823356|NCT02010255|2698033|P14|Overall Study|Death|0
823357|NCT02010255|2698034|P13|Overall Study|Death|0
823358|NCT02010255|2698035|P12|Overall Study|Death|1
823359|NCT02010255|2698036|P11|Overall Study|Death|1
823360|NCT02010255|2698037|P10|Overall Study|Death|0
823361|NCT02010255|2698038|P9|Overall Study|Death|1
823362|NCT02010255|2698039|P8|Overall Study|Death|1
823363|NCT02010255|2698040|P7|Overall Study|Death|1
823364|NCT02010255|2698041|P6|Overall Study|Death|0
823365|NCT02010255|2698042|P5|Overall Study|Death|2
823366|NCT02010255|2698043|P4|Overall Study|Death|4
823367|NCT02010255|2698044|P3|Overall Study|Death|4
823368|NCT02010255|2698045|P2|Overall Study|Death|1
823369|NCT02010255|2698046|P1|Overall Study|Death|0
823370|NCT02009878|2698390|P3|Overall Study|Participant Met Withdrawal Criteria|0
823371|NCT02009878|2698391|P2|Overall Study|Participant Met Withdrawal Criteria|1
823372|NCT02009878|2698392|P1|Overall Study|Participant Met Withdrawal Criteria|0
823373|NCT02009865|2698426|P2|Overall Study|Withdrawal by Subject|1
823374|NCT02009865|2698427|P1|Overall Study|Withdrawal by Subject|1
823375|NCT02009865|2698426|P2|Overall Study|Protocol Violation|2
823376|NCT02009865|2698427|P1|Overall Study|Protocol Violation|0
823377|NCT02009865|2698426|P2|Overall Study|Adverse Event|2
823378|NCT02009865|2698427|P1|Overall Study|Adverse Event|0
823379|NCT02009722|2698443|P2|Overall Study|Did not receive intervention|1
823380|NCT02009722|2698444|P1|Overall Study|Did not receive intervention|0
823381|NCT02009722|2698443|P2|Overall Study|Protocol Violation|2
823382|NCT02009722|2698444|P1|Overall Study|Protocol Violation|1
823383|NCT02009696|2698468|P1|Overall Study|Withdrawal by Subject|2
823384|NCT02009163|2698485|P3|Randomized-withdrawal Period|Not specified|5
823385|NCT02009163|2698486|P2|Randomized-withdrawal Period|Not specified|9
823386|NCT02009163|2698487|P1|Randomized-withdrawal Period|Not specified|0
823387|NCT02009163|2698485|P3|Randomized-withdrawal Period|Pregnancy|2
823388|NCT02009163|2698486|P2|Randomized-withdrawal Period|Pregnancy|0
823389|NCT02009163|2698487|P1|Randomized-withdrawal Period|Pregnancy|0
823390|NCT02009163|2698485|P3|Randomized-withdrawal Period|Protocol Violation|2
823391|NCT02009163|2698486|P2|Randomized-withdrawal Period|Protocol Violation|1
823392|NCT02009163|2698487|P1|Randomized-withdrawal Period|Protocol Violation|0
823393|NCT02009163|2698485|P3|Randomized-withdrawal Period|Relapse Criteria Met|5
823394|NCT02009163|2698486|P2|Randomized-withdrawal Period|Relapse Criteria Met|40
823395|NCT02009163|2698487|P1|Randomized-withdrawal Period|Relapse Criteria Met|0
823396|NCT02009163|2698485|P3|Randomized-withdrawal Period|Adverse Event|6
823397|NCT02009163|2698486|P2|Randomized-withdrawal Period|Adverse Event|0
823398|NCT02009163|2698487|P1|Randomized-withdrawal Period|Adverse Event|0
823399|NCT02009163|2698485|P3|Randomized-withdrawal Period|Lost to Follow-up|6
823400|NCT02009163|2698486|P2|Randomized-withdrawal Period|Lost to Follow-up|13
823401|NCT02009163|2698487|P1|Randomized-withdrawal Period|Lost to Follow-up|0
823402|NCT02009163|2698485|P3|Randomized-withdrawal Period|Withdrawal by Subject|9
823403|NCT02009163|2698486|P2|Randomized-withdrawal Period|Withdrawal by Subject|25
823404|NCT02009163|2698487|P1|Randomized-withdrawal Period|Withdrawal by Subject|0
823405|NCT02009163|2698485|P3|Open-label Period (Non-randomized)|Not specified|0
823406|NCT02009163|2698486|P2|Open-label Period (Non-randomized)|Not specified|0
823407|NCT02009163|2698487|P1|Open-label Period (Non-randomized)|Not specified|13
823408|NCT02009163|2698485|P3|Open-label Period (Non-randomized)|Pregnancy|0
823409|NCT02009163|2698486|P2|Open-label Period (Non-randomized)|Pregnancy|0
823410|NCT02009163|2698487|P1|Open-label Period (Non-randomized)|Pregnancy|1
823411|NCT02009163|2698485|P3|Open-label Period (Non-randomized)|Protocol Violation|0
823412|NCT02009163|2698486|P2|Open-label Period (Non-randomized)|Protocol Violation|0
823413|NCT02009163|2698487|P1|Open-label Period (Non-randomized)|Protocol Violation|10
823414|NCT02009163|2698485|P3|Open-label Period (Non-randomized)|Lost to Follow-up|0
823415|NCT02009163|2698486|P2|Open-label Period (Non-randomized)|Lost to Follow-up|0
823416|NCT02009163|2698487|P1|Open-label Period (Non-randomized)|Lost to Follow-up|20
823417|NCT02009163|2698485|P3|Open-label Period (Non-randomized)|Adverse Event|0
823418|NCT02009163|2698486|P2|Open-label Period (Non-randomized)|Adverse Event|0
823419|NCT02009163|2698487|P1|Open-label Period (Non-randomized)|Adverse Event|22
823420|NCT02009163|2698485|P3|Open-label Period (Non-randomized)|Withdrawal by Subject|0
823421|NCT02009163|2698486|P2|Open-label Period (Non-randomized)|Withdrawal by Subject|0
823422|NCT02009163|2698487|P1|Open-label Period (Non-randomized)|Withdrawal by Subject|29
823423|NCT02009163|2698485|P3|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
823424|NCT02009163|2698486|P2|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
823425|NCT02009163|2698487|P1|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48
823426|NCT02009046|2698522|P2|Overall Study|Lost to Follow-up|206
823427|NCT02009046|2698523|P1|Overall Study|Lost to Follow-up|256
823428|NCT02008565|2698618|P4|Overall Study|Protocol Violation|0
823429|NCT02008565|2698619|P3|Overall Study|Protocol Violation|2
823430|NCT02008565|2698620|P2|Overall Study|Protocol Violation|1
823431|NCT02008565|2698621|P1|Overall Study|Protocol Violation|1
823432|NCT02008526|2698682|P3|Overall Study|Lost to Follow-up|6
823433|NCT02008526|2698683|P2|Overall Study|Lost to Follow-up|9
823434|NCT02008526|2698684|P1|Overall Study|Lost to Follow-up|5
823435|NCT02008526|2698682|P3|Overall Study|Withdrawal by Subject|2
823436|NCT02008526|2698683|P2|Overall Study|Withdrawal by Subject|3
823437|NCT02008526|2698684|P1|Overall Study|Withdrawal by Subject|3
823438|NCT02008526|2698682|P3|Overall Study|Death|1
823439|NCT02008526|2698683|P2|Overall Study|Death|2
823440|NCT02008526|2698684|P1|Overall Study|Death|0
823441|NCT02008227|2698697|P2|Overall Study|Ongoing Survival Follow-up|106
823442|NCT02008227|2698698|P1|Overall Study|Ongoing Survival Follow-up|135
823443|NCT02008227|2698697|P2|Overall Study|Ongoing on Study Treatment|85
823444|NCT02008227|2698698|P1|Overall Study|Ongoing on Study Treatment|4
823445|NCT02008227|2698697|P2|Overall Study|Withdrawal by Subject|34
823446|NCT02008227|2698698|P1|Overall Study|Withdrawal by Subject|63
823447|NCT02008227|2698697|P2|Overall Study|Death|383
823448|NCT02008227|2698698|P1|Overall Study|Death|407
823449|NCT02008227|2698697|P2|Overall Study|Lost to Follow-up|5
823450|NCT02008227|2698698|P1|Overall Study|Lost to Follow-up|3
823451|NCT02007954|2698759|P1|Overall Study|Death|1
823452|NCT02007954|2698759|P1|Overall Study|Disease progression and unrelated AE|1
823453|NCT02007954|2698759|P1|Overall Study|Switch in treatment modality|2
823454|NCT02007954|2698759|P1|Overall Study|Received liver transplant|3
823455|NCT02007577|2698778|P2|Overall Study|Withdrawal by Subject|1
823456|NCT02007577|2698779|P1|Overall Study|Withdrawal by Subject|0
823457|NCT02007577|2698778|P2|Overall Study|Adverse Event|0
823458|NCT02007577|2698779|P1|Overall Study|Adverse Event|1
823459|NCT02007512|2698791|P4|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
823460|NCT02007512|2698792|P3|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
823461|NCT02007512|2698793|P2|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3
823462|NCT02007512|2698794|P1|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
823463|NCT02007512|2698791|P4|Open Label Treatment Period|Disease progression|11
823464|NCT02007512|2698792|P3|Open Label Treatment Period|Disease progression|0
823465|NCT02007512|2698793|P2|Open Label Treatment Period|Disease progression|17
823466|NCT02007512|2698794|P1|Open Label Treatment Period|Disease progression|0
823467|NCT02007512|2698791|P4|Open Label Treatment Period|Other|1
823468|NCT02007512|2698792|P3|Open Label Treatment Period|Other|0
823469|NCT02007512|2698793|P2|Open Label Treatment Period|Other|0
823470|NCT02007512|2698794|P1|Open Label Treatment Period|Other|0
823471|NCT02007512|2698791|P4|Open Label Treatment Period|Adverse Event|0
823472|NCT02007512|2698792|P3|Open Label Treatment Period|Adverse Event|0
823473|NCT02007512|2698793|P2|Open Label Treatment Period|Adverse Event|1
823474|NCT02007512|2698794|P1|Open Label Treatment Period|Adverse Event|0
823475|NCT02007512|2698791|P4|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1
823476|NCT02007512|2698792|P3|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5
823477|NCT02007512|2698793|P2|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11
823478|NCT02007512|2698794|P1|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10
823479|NCT02007512|2698791|P4|Double Blind Treatment Period|Other|2
823480|NCT02007512|2698792|P3|Double Blind Treatment Period|Other|1
823481|NCT02007512|2698793|P2|Double Blind Treatment Period|Other|0
823482|NCT02007512|2698794|P1|Double Blind Treatment Period|Other|0
823483|NCT02007512|2698791|P4|Double Blind Treatment Period|Protocol Violation|1
823484|NCT02007512|2698792|P3|Double Blind Treatment Period|Protocol Violation|0
823485|NCT02007512|2698793|P2|Double Blind Treatment Period|Protocol Violation|0
823486|NCT02007512|2698794|P1|Double Blind Treatment Period|Protocol Violation|0
823487|NCT02007512|2698791|P4|Double Blind Treatment Period|Withdrawal by Subject|3
823488|NCT02007512|2698792|P3|Double Blind Treatment Period|Withdrawal by Subject|3
823489|NCT02007512|2698793|P2|Double Blind Treatment Period|Withdrawal by Subject|2
823490|NCT02007512|2698794|P1|Double Blind Treatment Period|Withdrawal by Subject|4
823491|NCT02007512|2698791|P4|Double Blind Treatment Period|Disease progression|51
823492|NCT02007512|2698792|P3|Double Blind Treatment Period|Disease progression|45
823493|NCT02007512|2698793|P2|Double Blind Treatment Period|Disease progression|49
823494|NCT02007512|2698794|P1|Double Blind Treatment Period|Disease progression|44
823495|NCT02007512|2698791|P4|Double Blind Treatment Period|Death|0
823496|NCT02007512|2698792|P3|Double Blind Treatment Period|Death|0
823497|NCT02007512|2698793|P2|Double Blind Treatment Period|Death|0
823498|NCT02007512|2698794|P1|Double Blind Treatment Period|Death|1
823499|NCT02007512|2698791|P4|Double Blind Treatment Period|Adverse Event|2
823500|NCT02007512|2698792|P3|Double Blind Treatment Period|Adverse Event|6
823501|NCT02007512|2698793|P2|Double Blind Treatment Period|Adverse Event|2
823502|NCT02007512|2698794|P1|Double Blind Treatment Period|Adverse Event|4
823503|NCT02007434|2698872|P8|Overall Study|Non-compliance|0
823504|NCT02007434|2698873|P7|Overall Study|Non-compliance|0
823505|NCT02007434|2698874|P6|Overall Study|Non-compliance|0
823506|NCT02007434|2698875|P5|Overall Study|Non-compliance|0
823507|NCT02007434|2698876|P4|Overall Study|Non-compliance|0
823508|NCT02007434|2698877|P3|Overall Study|Non-compliance|1
823509|NCT02007434|2698878|P2|Overall Study|Non-compliance|0
823510|NCT02007434|2698879|P1|Overall Study|Non-compliance|1
823511|NCT02007434|2698872|P8|Overall Study|Lost to Follow-up|0
823512|NCT02007434|2698873|P7|Overall Study|Lost to Follow-up|0
823513|NCT02007434|2698874|P6|Overall Study|Lost to Follow-up|0
823514|NCT02007434|2698875|P5|Overall Study|Lost to Follow-up|0
823515|NCT02007434|2698876|P4|Overall Study|Lost to Follow-up|0
823516|NCT02007434|2698877|P3|Overall Study|Lost to Follow-up|0
823517|NCT02007434|2698878|P2|Overall Study|Lost to Follow-up|1
823518|NCT02007434|2698879|P1|Overall Study|Lost to Follow-up|0
823519|NCT02007278|2699010|P2|Overall Study|Mis-randomization|1
823520|NCT02007278|2699011|P1|Overall Study|Mis-randomization|1
823521|NCT02007278|2699010|P2|Overall Study|Incorrect medication administration|0
823522|NCT02007278|2699011|P1|Overall Study|Incorrect medication administration|1
823523|NCT02007278|2699010|P2|Overall Study|Ingestion of drugs not allowed in study|1
823524|NCT02007278|2699011|P1|Overall Study|Ingestion of drugs not allowed in study|0
823525|NCT02007278|2699010|P2|Overall Study|Failure to comply with an eligibility|1
823526|NCT02007278|2699011|P1|Overall Study|Failure to comply with an eligibility|0
823527|NCT02007252|2699033|P2|Overall Study|Adverse Event|4
823528|NCT02007252|2699034|P1|Overall Study|Adverse Event|7
823529|NCT02007252|2699033|P2|Overall Study|Abnormal laboratory value(s)|0
823530|NCT02007252|2699034|P1|Overall Study|Abnormal laboratory value(s)|1
823531|NCT02007252|2699033|P2|Overall Study|Administrative problems|7
823532|NCT02007252|2699034|P1|Overall Study|Administrative problems|3
823533|NCT02007096|2699049|P2|Overall Study|no mesh placed|1
823534|NCT02007096|2699050|P1|Overall Study|no mesh placed|0
823535|NCT02007096|2699049|P2|Overall Study|converted to open surgery|1
823536|NCT02007096|2699050|P1|Overall Study|converted to open surgery|1
823537|NCT02007096|2699049|P2|Overall Study|did not follow postoperative protocol|11
823538|NCT02007096|2699050|P1|Overall Study|did not follow postoperative protocol|8
823539|NCT02007096|2699049|P2|Overall Study|did not inject saline|3
823540|NCT02007096|2699050|P1|Overall Study|did not inject saline|0
823541|NCT02007096|2699049|P2|Overall Study|medication not available|0
823542|NCT02007096|2699050|P1|Overall Study|medication not available|2
823543|NCT02007070|2699062|P1|Overall Study|Progressive Disease|21
823544|NCT02007070|2699062|P1|Overall Study|Physician Decision|1
823545|NCT02007070|2699062|P1|Overall Study|Protocol Violation|2
823546|NCT02007070|2699062|P1|Overall Study|Death|1
823547|NCT02007070|2699062|P1|Overall Study|Clinical Progression|4
823548|NCT02007070|2699062|P1|Overall Study|Adverse Event|4
823549|NCT02006732|2699119|P4|Overall Study|Withdrawal by Subject|1
823550|NCT02006732|2699120|P3|Overall Study|Withdrawal by Subject|4
823551|NCT02006732|2699121|P2|Overall Study|Withdrawal by Subject|0
823552|NCT02006732|2699122|P1|Overall Study|Withdrawal by Subject|3
823553|NCT02006732|2699119|P4|Overall Study|Lost to Follow-up|0
823554|NCT02006732|2699120|P3|Overall Study|Lost to Follow-up|0
823555|NCT02006732|2699121|P2|Overall Study|Lost to Follow-up|1
823556|NCT02006732|2699122|P1|Overall Study|Lost to Follow-up|0
823557|NCT02006732|2699119|P4|Overall Study|Protocol Violation|0
823558|NCT02006732|2699120|P3|Overall Study|Protocol Violation|0
823559|NCT02006732|2699121|P2|Overall Study|Protocol Violation|1
823560|NCT02006732|2699122|P1|Overall Study|Protocol Violation|1
823561|NCT02006732|2699119|P4|Overall Study|Lack of Efficacy|1
823562|NCT02006732|2699120|P3|Overall Study|Lack of Efficacy|1
823563|NCT02006732|2699121|P2|Overall Study|Lack of Efficacy|3
823564|NCT02006732|2699122|P1|Overall Study|Lack of Efficacy|6
823565|NCT02006732|2699119|P4|Overall Study|Adverse Event|2
823566|NCT02006732|2699120|P3|Overall Study|Adverse Event|4
823567|NCT02006732|2699121|P2|Overall Study|Adverse Event|7
823568|NCT02006732|2699122|P1|Overall Study|Adverse Event|10
823569|NCT02006719|2699162|P2|Overall Study|Other/Unknown|1
823570|NCT02006719|2699163|P1|Overall Study|Other/Unknown|0
823571|NCT02006719|2699162|P2|Overall Study|Adverse Event|1
823572|NCT02006719|2699163|P1|Overall Study|Adverse Event|1
823573|NCT02006719|2699162|P2|Overall Study|Protocol Violation|0
823574|NCT02006719|2699163|P1|Overall Study|Protocol Violation|2
823575|NCT02006719|2699162|P2|Overall Study|Lost to Follow-up|1
823576|NCT02006719|2699163|P1|Overall Study|Lost to Follow-up|5
823577|NCT02006719|2699162|P2|Overall Study|Withdrawal by Subject|2
823578|NCT02006719|2699163|P1|Overall Study|Withdrawal by Subject|10
823579|NCT02006706|2699193|P1|Overall Study|Lost to Follow-up|1
823580|NCT02006667|2699198|P1|Overall Study|Withdrawal by Subject|1
823581|NCT02006667|2699198|P1|Overall Study|Death|2
823582|NCT02006667|2699198|P1|Overall Study|Adverse Event|3
823583|NCT02006654|2699210|P2|Overall Study|moving out of state|1
823584|NCT02006654|2699211|P1|Overall Study|moving out of state|0
823585|NCT02006654|2699210|P2|Overall Study|disallowed medication|0
823586|NCT02006654|2699211|P1|Overall Study|disallowed medication|1
823587|NCT02006654|2699210|P2|Overall Study|mood disorder|1
823588|NCT02006654|2699211|P1|Overall Study|mood disorder|0
823589|NCT02006654|2699210|P2|Overall Study|faecal incontinence|1
823590|NCT02006654|2699211|P1|Overall Study|faecal incontinence|0
823591|NCT02006654|2699210|P2|Overall Study|worsening cognitive condition|1
823592|NCT02006654|2699211|P1|Overall Study|worsening cognitive condition|0
823593|NCT02006654|2699210|P2|Overall Study|insufficient compliance|0
823594|NCT02006654|2699211|P1|Overall Study|insufficient compliance|1
823595|NCT02006654|2699210|P2|Overall Study|patient's will|1
823596|NCT02006654|2699211|P1|Overall Study|patient's will|2
823597|NCT02006654|2699210|P2|Overall Study|Lost to Follow-up|0
823598|NCT02006654|2699211|P1|Overall Study|Lost to Follow-up|1
823599|NCT02006654|2699210|P2|Overall Study|Protocol Violation|8
823600|NCT02006654|2699211|P1|Overall Study|Protocol Violation|5
823601|NCT02006654|2699210|P2|Overall Study|Withdrawal by Subject|12
823602|NCT02006654|2699211|P1|Overall Study|Withdrawal by Subject|14
823603|NCT02006654|2699210|P2|Overall Study|Death|0
823604|NCT02006654|2699211|P1|Overall Study|Death|1
823605|NCT02006654|2699210|P2|Overall Study|Adverse Event|17
823606|NCT02006654|2699211|P1|Overall Study|Adverse Event|16
823607|NCT02006654|2699210|P2|Overall Study|Withdrawal before treatment|2
823608|NCT02006654|2699211|P1|Overall Study|Withdrawal before treatment|4
823609|NCT02006641|2699240|P3|Overall Study|Other reason: protocol non-compliance|1
823610|NCT02006641|2699241|P2|Overall Study|Other reason: protocol non-compliance|0
823611|NCT02006641|2699242|P1|Overall Study|Other reason: protocol non-compliance|0
823612|NCT02006641|2699240|P3|Overall Study|Other reason: caregiver impossibility|1
823613|NCT02006641|2699241|P2|Overall Study|Other reason: caregiver impossibility|0
823614|NCT02006641|2699242|P1|Overall Study|Other reason: caregiver impossibility|0
823615|NCT02006641|2699240|P3|Overall Study|Other reason: hospitalisation|0
823616|NCT02006641|2699241|P2|Overall Study|Other reason: hospitalisation|1
823617|NCT02006641|2699242|P1|Overall Study|Other reason: hospitalisation|0
823618|NCT02006641|2699240|P3|Overall Study|Other reason: patient's wife has died|1
823619|NCT02006641|2699241|P2|Overall Study|Other reason: patient's wife has died|0
823620|NCT02006641|2699242|P1|Overall Study|Other reason: patient's wife has died|0
823621|NCT02006641|2699240|P3|Overall Study|Other reason: caregiver in hospital|0
823622|NCT02006641|2699241|P2|Overall Study|Other reason: caregiver in hospital|1
823623|NCT02006641|2699242|P1|Overall Study|Other reason: caregiver in hospital|0
823624|NCT02006641|2699240|P3|Overall Study|Other reason: patient has moved|1
823625|NCT02006641|2699241|P2|Overall Study|Other reason: patient has moved|0
823626|NCT02006641|2699242|P1|Overall Study|Other reason: patient has moved|1
823627|NCT02006641|2699240|P3|Overall Study|Other reason:patient didn't want to come|1
823628|NCT02006641|2699241|P2|Overall Study|Other reason:patient didn't want to come|0
823629|NCT02006641|2699242|P1|Overall Study|Other reason:patient didn't want to come|0
823630|NCT02006641|2699240|P3|Overall Study|Other reason: patient didn't show up|0
823631|NCT02006641|2699241|P2|Overall Study|Other reason: patient didn't show up|0
823632|NCT02006641|2699242|P1|Overall Study|Other reason: patient didn't show up|1
823633|NCT02006641|2699240|P3|Overall Study|Withdrawal by Subject|11
823634|NCT02006641|2699241|P2|Overall Study|Withdrawal by Subject|12
823635|NCT02006641|2699242|P1|Overall Study|Withdrawal by Subject|7
823636|NCT02006641|2699240|P3|Overall Study|Lost to Follow-up|0
823637|NCT02006641|2699241|P2|Overall Study|Lost to Follow-up|1
823638|NCT02006641|2699242|P1|Overall Study|Lost to Follow-up|0
823639|NCT02006641|2699240|P3|Overall Study|Protocol Violation|2
823640|NCT02006641|2699241|P2|Overall Study|Protocol Violation|2
823641|NCT02006641|2699242|P1|Overall Study|Protocol Violation|0
823642|NCT02006641|2699240|P3|Overall Study|Adverse Event|15
823643|NCT02006641|2699241|P2|Overall Study|Adverse Event|11
823644|NCT02006641|2699242|P1|Overall Study|Adverse Event|15
823645|NCT02006641|2699240|P3|Overall Study|Withdrawal before treatment|3
823646|NCT02006641|2699241|P2|Overall Study|Withdrawal before treatment|5
823647|NCT02006641|2699242|P1|Overall Study|Withdrawal before treatment|2
823648|NCT02005692|2699341|P1|Overall Study|Discharged earlier than anticipated|5
823649|NCT02005692|2699341|P1|Overall Study|Withdrawal by Subject|1
823650|NCT02005692|2699341|P1|Overall Study|Protocol Violation|1
823651|NCT02005562|2699361|P2|Overall Study|Physician Decision|1
823652|NCT02005562|2699362|P1|Overall Study|Physician Decision|0
823653|NCT02005562|2699361|P2|Overall Study|No transplant|4
823654|NCT02005562|2699362|P1|Overall Study|No transplant|1
823655|NCT02005562|2699361|P2|Overall Study|Withdrawal by Subject|2
823656|NCT02005562|2699362|P1|Overall Study|Withdrawal by Subject|2
823657|NCT02005562|2699361|P2|Overall Study|Graft loss|6
823658|NCT02005562|2699362|P1|Overall Study|Graft loss|7
823659|NCT02005562|2699361|P2|Overall Study|Death|2
823660|NCT02005562|2699362|P1|Overall Study|Death|2
823661|NCT02005484|2699404|P1|Overall Study|Sponsor decision|1
823662|NCT02005484|2699404|P1|Overall Study|Changed to a Different Study|1
823663|NCT02005484|2699404|P1|Overall Study|Disease progression|1
823664|NCT02005484|2699404|P1|Overall Study|Death|1
823665|NCT02005471|2699416|P2|Overall Study|Withdrawal by Subject|7
823666|NCT02005471|2699417|P1|Overall Study|Withdrawal by Subject|18
823667|NCT02005471|2699416|P2|Overall Study|Progressive Disease|0
823668|NCT02005471|2699417|P1|Overall Study|Progressive Disease|3
823669|NCT02005471|2699416|P2|Overall Study|Physician Decision|1
823670|NCT02005471|2699417|P1|Overall Study|Physician Decision|2
823671|NCT02005471|2699416|P2|Overall Study|Lost to Follow-up|0
823672|NCT02005471|2699417|P1|Overall Study|Lost to Follow-up|1
823673|NCT02005471|2699416|P2|Overall Study|Death|15
823674|NCT02005471|2699417|P1|Overall Study|Death|26
823675|NCT02005471|2699416|P2|Overall Study|Adverse Event|0
823676|NCT02005471|2699417|P1|Overall Study|Adverse Event|1
823677|NCT02005471|2699416|P2|Overall Study|Ongoing in Study|171
823678|NCT02005471|2699417|P1|Overall Study|Ongoing in Study|144
823679|NCT02005211|2699481|P7|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
823680|NCT02005211|2699482|P6|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
823681|NCT02005211|2699483|P5|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1
823682|NCT02005211|2699484|P4|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
823683|NCT02005211|2699485|P3|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
823684|NCT02005211|2699486|P2|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
823685|NCT02005211|2699487|P1|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
823686|NCT02005029|2699522|P2|First Intervention (1 Day)|participant withdrawn for noncompliance|0
823687|NCT02005029|2699523|P1|First Intervention (1 Day)|participant withdrawn for noncompliance|1
823688|NCT02004886|2699575|P4|Overall Study|Unable to attend future visits|0
823689|NCT02004886|2699576|P3|Overall Study|Unable to attend future visits|0
823690|NCT02004886|2699577|P2|Overall Study|Unable to attend future visits|0
823691|NCT02004886|2699578|P1|Overall Study|Unable to attend future visits|1
823692|NCT02004886|2699575|P4|Overall Study|Adverse Event|0
823693|NCT02004886|2699576|P3|Overall Study|Adverse Event|0
823694|NCT02004886|2699577|P2|Overall Study|Adverse Event|1
823695|NCT02004886|2699578|P1|Overall Study|Adverse Event|0
823696|NCT02004873|2699628|P1|Overall Study|Withdrawal by Subject|1
823697|NCT02004873|2699628|P1|Overall Study|Death|23
823698|NCT02004873|2699628|P1|Overall Study|Missed 6-month visit|4
823699|NCT02004873|2699628|P1|Overall Study|Awaiting 6-month visit|390
823700|NCT02004873|2699628|P1|Overall Study|Implant unsuccessful|6
823701|NCT02004847|2699637|P2|Overall Study|Protocol Violation|1
823702|NCT02004847|2699638|P1|Overall Study|Protocol Violation|1
823703|NCT02004262|2699784|P6|Overall Study|Study Terminated by Sponsor|5
823704|NCT02004262|2699785|P5|Overall Study|Study Terminated by Sponsor|1
823705|NCT02004262|2699786|P4|Overall Study|Study Terminated by Sponsor|1
823706|NCT02004262|2699787|P3|Overall Study|Study Terminated by Sponsor|2
823707|NCT02004262|2699788|P2|Overall Study|Study Terminated by Sponsor|3
823708|NCT02004262|2699789|P1|Overall Study|Study Terminated by Sponsor|4
823709|NCT02004262|2699784|P6|Overall Study|Lost to Follow-up|0
823710|NCT02004262|2699785|P5|Overall Study|Lost to Follow-up|0
823711|NCT02004262|2699786|P4|Overall Study|Lost to Follow-up|0
823712|NCT02004262|2699787|P3|Overall Study|Lost to Follow-up|0
823713|NCT02004262|2699788|P2|Overall Study|Lost to Follow-up|1
823714|NCT02004262|2699789|P1|Overall Study|Lost to Follow-up|1
823715|NCT02004262|2699784|P6|Overall Study|Withdrawal by Subject|3
823716|NCT02004262|2699785|P5|Overall Study|Withdrawal by Subject|1
823717|NCT02004262|2699786|P4|Overall Study|Withdrawal by Subject|0
823718|NCT02004262|2699787|P3|Overall Study|Withdrawal by Subject|4
823719|NCT02004262|2699788|P2|Overall Study|Withdrawal by Subject|0
823720|NCT02004262|2699789|P1|Overall Study|Withdrawal by Subject|1
823721|NCT02004262|2699784|P6|Overall Study|Death|22
823722|NCT02004262|2699785|P5|Overall Study|Death|29
823723|NCT02004262|2699786|P4|Overall Study|Death|28
823724|NCT02004262|2699787|P3|Overall Study|Death|66
823725|NCT02004262|2699788|P2|Overall Study|Death|64
823726|NCT02004262|2699789|P1|Overall Study|Death|67
823727|NCT02004236|2699809|P3|Overall Study|Lack of Efficacy|16
823728|NCT02004236|2699810|P2|Overall Study|Lack of Efficacy|0
823729|NCT02004236|2699811|P1|Overall Study|Lack of Efficacy|0
823730|NCT02004093|2699871|P2|Overall Study|Not specified|1
823731|NCT02004093|2699872|P1|Overall Study|Not specified|3
823732|NCT02004093|2699871|P2|Overall Study|Withdrawal by Subject|7
823733|NCT02004093|2699872|P1|Overall Study|Withdrawal by Subject|3
823734|NCT02004093|2699871|P2|Overall Study|Lost to Follow-up|1
823735|NCT02004093|2699872|P1|Overall Study|Lost to Follow-up|0
823736|NCT02004093|2699871|P2|Overall Study|Protocol Violation|1
823737|NCT02004093|2699872|P1|Overall Study|Protocol Violation|0
823738|NCT02004093|2699871|P2|Overall Study|Lack of Efficacy|62
823739|NCT02004093|2699872|P1|Overall Study|Lack of Efficacy|66
823740|NCT02004093|2699871|P2|Overall Study|Death|1
823741|NCT02004093|2699872|P1|Overall Study|Death|2
823742|NCT02003963|2699904|P2|Overall Study|Lost to Follow-up|1
823743|NCT02003963|2699905|P1|Overall Study|Lost to Follow-up|2
823744|NCT02003924|2699927|P2|Overall Study|Adverse Event|29
823745|NCT02003924|2699928|P1|Overall Study|Adverse Event|91
823746|NCT02003924|2699927|P2|Overall Study|Withdrawal by Subject|34
823747|NCT02003924|2699928|P1|Overall Study|Withdrawal by Subject|49
823748|NCT02003924|2699927|P2|Overall Study|Other than specified|19
823749|NCT02003924|2699928|P1|Overall Study|Other than specified|18
823750|NCT02003924|2699927|P2|Overall Study|Lost to Follow-up|1
823751|NCT02003924|2699928|P1|Overall Study|Lost to Follow-up|2
823752|NCT02003924|2699927|P2|Overall Study|Protocol Violation|2
823753|NCT02003924|2699928|P1|Overall Study|Protocol Violation|1
823754|NCT02003924|2699927|P2|Overall Study|Disease progression|207
823755|NCT02003924|2699928|P1|Overall Study|Disease progression|138
823756|NCT02003924|2699927|P2|Overall Study|Ongoing in study|176
823757|NCT02003924|2699928|P1|Overall Study|Ongoing in study|634
823758|NCT02003638|2700028|P2|Overall Study|Withdrawal by Subject|0
823759|NCT02003638|2700029|P1|Overall Study|Withdrawal by Subject|1
823760|NCT02003534|2700035|P1|Overall Study|Lost to Follow-up|47
823761|NCT02003391|2700047|P2|Overall Study|Adverse Event|0
823762|NCT02003391|2700048|P1|Overall Study|Adverse Event|1
823763|NCT02003391|2700047|P2|Overall Study|Protocol Violation|1
823764|NCT02003391|2700048|P1|Overall Study|Protocol Violation|0
823765|NCT02003391|2700047|P2|Overall Study|Withdrawal by Subject|1
823766|NCT02003391|2700048|P1|Overall Study|Withdrawal by Subject|2
823767|NCT02003365|2700061|P3|Overall Study|Lost to Follow-up|1
823768|NCT02003365|2700062|P2|Overall Study|Lost to Follow-up|0
823769|NCT02003365|2700063|P1|Overall Study|Lost to Follow-up|0
823770|NCT02003014|2700087|P1|Overall Study|Investigator's transfer|4
823771|NCT02003014|2700087|P1|Overall Study|Patient did not visit the study site|5
823772|NCT02003014|2700087|P1|Overall Study|Treatment started after contract period|1
823773|NCT02003014|2700087|P1|Overall Study|Case report forms uncollected|9
823774|NCT02002689|2700169|P1|Overall Study|Adverse Event|3
823775|NCT02002689|2700169|P1|Overall Study|Disease Progression|7
823776|NCT02002533|2700188|P2|Overall Study|Lost to Follow-up|1
823777|NCT02002533|2700189|P1|Overall Study|Lost to Follow-up|0
823778|NCT02002533|2700188|P2|Overall Study|Adverse Event|3
823779|NCT02002533|2700189|P1|Overall Study|Adverse Event|0
823780|NCT02002533|2700188|P2|Overall Study|Protocol Violation|1
823781|NCT02002533|2700189|P1|Overall Study|Protocol Violation|0
823782|NCT02002533|2700188|P2|Overall Study|Withdrawal by Subject|13
823783|NCT02002533|2700189|P1|Overall Study|Withdrawal by Subject|6
823784|NCT02002221|2700214|P2|Overall Study|Patient withdrew consent|1
823785|NCT02002221|2700215|P1|Overall Study|Patient withdrew consent|0
823786|NCT02002221|2700214|P2|Overall Study|Unsatisfactory therapeutic effect|1
823787|NCT02002221|2700215|P1|Overall Study|Unsatisfactory therapeutic effect|0
823788|NCT02002221|2700214|P2|Overall Study|Adverse Event|1
823789|NCT02002221|2700215|P1|Overall Study|Adverse Event|2
823790|NCT02002091|2700242|P2|Screening|Death|2
823791|NCT02002091|2700243|P1|Screening|Death|3
823792|NCT02002091|2700242|P2|Screening|Lost to Follow-up|12
823793|NCT02002091|2700243|P1|Screening|Lost to Follow-up|10
823794|NCT02001987|2700278|P1|LTE Period (52 Weeks)|Other|3
823795|NCT02001987|2700278|P1|LTE Period (52 Weeks)|Lack of Efficacy|1
823796|NCT02001987|2700278|P1|LTE Period (52 Weeks)|Withdrawal by Subject|1
823797|NCT02001987|2700278|P1|LTE Period (52 Weeks)|Physician Decision|2
823798|NCT02001987|2700278|P1|LTE Period (52 Weeks)|Lost to Follow-up|2
823799|NCT02001987|2700278|P1|Core Study Period (24 Weeks)|Lack of Efficacy|3
823800|NCT02001987|2700278|P1|Core Study Period (24 Weeks)|Protocol Violation|3
823801|NCT02001987|2700278|P1|Core Study Period (24 Weeks)|Withdrawal by Subject|4
823802|NCT02001987|2700278|P1|Core Study Period (24 Weeks)|Physician Decision|1
823803|NCT02001987|2700278|P1|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2
823804|NCT02001987|2700278|P1|Core Study Period (24 Weeks)|Death|1
823805|NCT02001987|2700278|P1|Core Study Period (24 Weeks)|Adverse Event|9
823806|NCT02001558|2700363|P2|Overall Study|Lost to Follow-up|14
823807|NCT02001558|2700364|P1|Overall Study|Lost to Follow-up|8
823808|NCT02001181|2700398|P2|Overall Study|Withdrawal by Subject|1
823809|NCT02001181|2700399|P1|Overall Study|Withdrawal by Subject|0
823810|NCT02001181|2700398|P2|Overall Study|Lost to Follow-up|0
823811|NCT02001181|2700399|P1|Overall Study|Lost to Follow-up|1
823812|NCT02001181|2700398|P2|Overall Study|Adverse Event|2
823813|NCT02001181|2700399|P1|Overall Study|Adverse Event|0
823814|NCT02001051|2700415|P2|Overall Study|Deemed not eligible following enrollment|1
823815|NCT02001051|2700416|P1|Overall Study|Deemed not eligible following enrollment|0
823816|NCT02000921|2700468|P3|Overall Study|Physician Decision|0
823817|NCT02000921|2700469|P2|Overall Study|Physician Decision|2
823818|NCT02000921|2700470|P1|Overall Study|Physician Decision|0
823819|NCT02000921|2700468|P3|Overall Study|Lost to Follow-up|5
823820|NCT02000921|2700469|P2|Overall Study|Lost to Follow-up|4
823821|NCT02000921|2700470|P1|Overall Study|Lost to Follow-up|2
823822|NCT02000921|2700468|P3|Overall Study|Withdrawal by Subject|5
823823|NCT02000921|2700469|P2|Overall Study|Withdrawal by Subject|10
823824|NCT02000921|2700470|P1|Overall Study|Withdrawal by Subject|3
823825|NCT02000752|2700489|P2|Overall Study|Shift Changes|5
823826|NCT02000752|2700490|P1|Overall Study|Shift Changes|12
823827|NCT02000752|2700489|P2|Overall Study|Dystocic delivery|8
823828|NCT02000752|2700490|P1|Overall Study|Dystocic delivery|19
823829|NCT02000622|2700504|P2|Overall Study|Withdrawal by Subject|7
823830|NCT02000622|2700505|P1|Overall Study|Withdrawal by Subject|5
823831|NCT02000622|2700504|P2|Overall Study|Death|46
823832|NCT02000622|2700505|P1|Overall Study|Death|94
823833|NCT02000622|2700504|P2|Overall Study|Lost to Follow-up|0
823834|NCT02000622|2700505|P1|Overall Study|Lost to Follow-up|1
823835|NCT02000622|2700504|P2|Overall Study|Withdrawn due to site closure|0
823836|NCT02000622|2700505|P1|Overall Study|Withdrawn due to site closure|1
823837|NCT02000531|2700527|P2|Overall Study|Discontinued due to data cut-off|8
823838|NCT02000531|2700528|P1|Overall Study|Discontinued due to data cut-off|3
823839|NCT02000531|2700527|P2|Overall Study|Lost to Follow-up|0
823840|NCT02000531|2700528|P1|Overall Study|Lost to Follow-up|1
823841|NCT02000440|2700536|P1|Overall Study|Other-Protocol-defined Stopping Criteria|1
823842|NCT02000440|2700536|P1|Overall Study|Adverse Event|3
823843|NCT02000427|2700556|P1|Overall Study|Death|22
823844|NCT01999894|2700613|P1|Overall Study|Inclusion/exclusion criteria not met|1
823845|NCT01999894|2700613|P1|Overall Study|Other Reason|3
823846|NCT01999894|2700613|P1|Overall Study|Lost to Follow-up|10
823847|NCT01999894|2700613|P1|Overall Study|Withdrawal by Subject|7
823848|NCT01999894|2700613|P1|Overall Study|Protocol Violation|1
823849|NCT01999894|2700613|P1|Overall Study|Lack of Efficacy|5
823850|NCT01999894|2700613|P1|Overall Study|Adverse Event|9
823851|NCT01999322|2700666|P2|Overall Study|Adverse Event|0
823852|NCT01999322|2700667|P1|Overall Study|Adverse Event|1
823853|NCT01999218|2700719|P3|Overall Study|Treated but excluded at 1 trial site|2
823854|NCT01999218|2700720|P2|Overall Study|Treated but excluded at 1 trial site|5
823855|NCT01999218|2700721|P1|Overall Study|Treated but excluded at 1 trial site|3
823856|NCT01999218|2700719|P3|Overall Study|Adverse Event|7
823857|NCT01999218|2700720|P2|Overall Study|Adverse Event|7
823858|NCT01999218|2700721|P1|Overall Study|Adverse Event|9
823859|NCT01999218|2700719|P3|Overall Study|Excluded Medication|2
823860|NCT01999218|2700720|P2|Overall Study|Excluded Medication|1
823861|NCT01999218|2700721|P1|Overall Study|Excluded Medication|1
823862|NCT01999218|2700719|P3|Overall Study|Death|2
823863|NCT01999218|2700720|P2|Overall Study|Death|1
823864|NCT01999218|2700721|P1|Overall Study|Death|7
823865|NCT01999218|2700719|P3|Overall Study|Creatinine/eGFR|1
823866|NCT01999218|2700720|P2|Overall Study|Creatinine/eGFR|0
823867|NCT01999218|2700721|P1|Overall Study|Creatinine/eGFR|0
823868|NCT01999218|2700719|P3|Overall Study|Withdrawal by Subject|34
823869|NCT01999218|2700720|P2|Overall Study|Withdrawal by Subject|29
823870|NCT01999218|2700721|P1|Overall Study|Withdrawal by Subject|28
823871|NCT01999218|2700719|P3|Overall Study|Participant moves|3
823872|NCT01999218|2700720|P2|Overall Study|Participant moves|5
823873|NCT01999218|2700721|P1|Overall Study|Participant moves|2
823874|NCT01999218|2700719|P3|Overall Study|Study Terminated By Sponsor|12
823875|NCT01999218|2700720|P2|Overall Study|Study Terminated By Sponsor|5
823876|NCT01999218|2700721|P1|Overall Study|Study Terminated By Sponsor|7
823877|NCT01999218|2700719|P3|Overall Study|Screen failure|0
823878|NCT01999218|2700720|P2|Overall Study|Screen failure|1
823879|NCT01999218|2700721|P1|Overall Study|Screen failure|0
823880|NCT01999218|2700719|P3|Overall Study|Protocol Violation|4
823881|NCT01999218|2700720|P2|Overall Study|Protocol Violation|5
823882|NCT01999218|2700721|P1|Overall Study|Protocol Violation|4
823883|NCT01999218|2700719|P3|Overall Study|Physician Decision|6
823884|NCT01999218|2700720|P2|Overall Study|Physician Decision|4
823885|NCT01999218|2700721|P1|Overall Study|Physician Decision|1
823886|NCT01999218|2700719|P3|Overall Study|Non-Compliance With Study Drug|1
823887|NCT01999218|2700720|P2|Overall Study|Non-Compliance With Study Drug|4
823888|NCT01999218|2700721|P1|Overall Study|Non-Compliance With Study Drug|6
823889|NCT01999218|2700719|P3|Overall Study|Lost to Follow-up|18
823890|NCT01999218|2700720|P2|Overall Study|Lost to Follow-up|17
823891|NCT01999218|2700721|P1|Overall Study|Lost to Follow-up|22
823892|NCT01999218|2700719|P3|Overall Study|Lack of Efficacy|1
823893|NCT01999218|2700720|P2|Overall Study|Lack of Efficacy|0
823894|NCT01999218|2700721|P1|Overall Study|Lack of Efficacy|1
823895|NCT01999218|2700719|P3|Overall Study|Hyperglycemia|17
823896|NCT01999218|2700720|P2|Overall Study|Hyperglycemia|17
823897|NCT01999218|2700721|P1|Overall Study|Hyperglycemia|18
823898|NCT01999114|2700766|P5|Overall Study|Administrative|2
823899|NCT01999114|2700767|P4|Overall Study|Administrative|1
823900|NCT01999114|2700768|P3|Overall Study|Administrative|1
823901|NCT01999114|2700769|P2|Overall Study|Administrative|0
823902|NCT01999114|2700770|P1|Overall Study|Administrative|0
823903|NCT01999114|2700766|P5|Overall Study|Lost to Follow-up|0
823904|NCT01999114|2700767|P4|Overall Study|Lost to Follow-up|0
823905|NCT01999114|2700768|P3|Overall Study|Lost to Follow-up|1
823906|NCT01999114|2700769|P2|Overall Study|Lost to Follow-up|0
823907|NCT01999114|2700770|P1|Overall Study|Lost to Follow-up|0
823908|NCT01999114|2700766|P5|Overall Study|Withdrawal by Subject|1
823909|NCT01999114|2700767|P4|Overall Study|Withdrawal by Subject|0
823910|NCT01999114|2700768|P3|Overall Study|Withdrawal by Subject|1
823911|NCT01999114|2700769|P2|Overall Study|Withdrawal by Subject|0
823912|NCT01999114|2700770|P1|Overall Study|Withdrawal by Subject|0
823913|NCT01999114|2700766|P5|Overall Study|Adverse Event|1
823914|NCT01999114|2700767|P4|Overall Study|Adverse Event|2
823915|NCT01999114|2700768|P3|Overall Study|Adverse Event|2
823916|NCT01999114|2700769|P2|Overall Study|Adverse Event|7
823917|NCT01999114|2700770|P1|Overall Study|Adverse Event|8
823918|NCT01998919|2700836|P2|Overall Study|Not specified|2
823919|NCT01998919|2700837|P1|Overall Study|Not specified|5
823920|NCT01998919|2700836|P2|Overall Study|Lost to Follow-up|0
823921|NCT01998919|2700837|P1|Overall Study|Lost to Follow-up|2
823922|NCT01998919|2700836|P2|Overall Study|Withdrawal by Subject|4
823923|NCT01998919|2700837|P1|Overall Study|Withdrawal by Subject|2
823924|NCT01998919|2700836|P2|Overall Study|Disease progression|22
823925|NCT01998919|2700837|P1|Overall Study|Disease progression|31
823926|NCT01998919|2700836|P2|Overall Study|Adverse Event|5
823927|NCT01998919|2700837|P1|Overall Study|Adverse Event|0
823928|NCT01998919|2700836|P2|Overall Study|Death|2
823929|NCT01998919|2700837|P1|Overall Study|Death|2
823930|NCT01998906|2700858|P3|Overall Study|Not specified|4
823931|NCT01998906|2700859|P2|Overall Study|Not specified|8
823932|NCT01998906|2700860|P1|Overall Study|Not specified|3
823933|NCT01998906|2700858|P3|Overall Study|Administrative/Other|3
823934|NCT01998906|2700859|P2|Overall Study|Administrative/Other|1
823935|NCT01998906|2700860|P1|Overall Study|Administrative/Other|2
823936|NCT01998906|2700858|P3|Overall Study|Withdrawal by Subject|3
823937|NCT01998906|2700859|P2|Overall Study|Withdrawal by Subject|4
823938|NCT01998906|2700860|P1|Overall Study|Withdrawal by Subject|1
823939|NCT01998906|2700858|P3|Overall Study|Violation of Selection Criteria|1
823940|NCT01998906|2700859|P2|Overall Study|Violation of Selection Criteria|0
823941|NCT01998906|2700860|P1|Overall Study|Violation of Selection Criteria|0
823942|NCT01998906|2700858|P3|Overall Study|Failure to return|4
823943|NCT01998906|2700859|P2|Overall Study|Failure to return|2
823944|NCT01998906|2700860|P1|Overall Study|Failure to return|0
823945|NCT01998906|2700858|P3|Overall Study|Lack of Efficacy|8
823946|NCT01998906|2700859|P2|Overall Study|Lack of Efficacy|9
823947|NCT01998906|2700860|P1|Overall Study|Lack of Efficacy|10
823948|NCT01998906|2700858|P3|Overall Study|Death|17
823949|NCT01998906|2700859|P2|Overall Study|Death|30
823950|NCT01998906|2700860|P1|Overall Study|Death|21
823951|NCT01998906|2700858|P3|Overall Study|Participants ongoing in follow−up|58
823952|NCT01998906|2700859|P2|Overall Study|Participants ongoing in follow−up|60
823953|NCT01998906|2700860|P1|Overall Study|Participants ongoing in follow−up|77
823954|NCT01998893|2700904|P1|Overall Study|Transformation to high-grade lymphoma|1
823955|NCT01998893|2700904|P1|Overall Study|Withdrawal by Subject|1
823956|NCT01998893|2700904|P1|Overall Study|Protocol Violation|2
823957|NCT01998893|2700904|P1|Overall Study|Physician Decision|2
823958|NCT01998893|2700904|P1|Overall Study|Lost to Follow-up|8
823959|NCT01998893|2700904|P1|Overall Study|Death|1
823960|NCT01998893|2700904|P1|Overall Study|Adverse Event|2
823961|NCT01998880|2700916|P2|Overall Study|Did Not Receive Treatment|2
823962|NCT01998880|2700917|P1|Overall Study|Did Not Receive Treatment|3
823963|NCT01998880|2700916|P2|Overall Study|Violation of Selection Criteria at Entry|1
823964|NCT01998880|2700917|P1|Overall Study|Violation of Selection Criteria at Entry|0
823965|NCT01998880|2700916|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
823966|NCT01998880|2700917|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
823967|NCT01998880|2700916|P2|Overall Study|Administrative/Other|1
823968|NCT01998880|2700917|P1|Overall Study|Administrative/Other|1
823969|NCT01998880|2700916|P2|Overall Study|Insufficient Therapeutic Response|5
823970|NCT01998880|2700917|P1|Overall Study|Insufficient Therapeutic Response|1
823971|NCT01998880|2700916|P2|Overall Study|Death|6
823972|NCT01998880|2700917|P1|Overall Study|Death|3
823973|NCT01998880|2700916|P2|Overall Study|Withdrew Consent|1
823974|NCT01998880|2700917|P1|Overall Study|Withdrew Consent|2
823975|NCT01998880|2700916|P2|Overall Study|Disease Progression|8
823976|NCT01998880|2700917|P1|Overall Study|Disease Progression|1
823977|NCT01998880|2700916|P2|Overall Study|Adverse Events or Intercurrent Illness|16
823978|NCT01998880|2700917|P1|Overall Study|Adverse Events or Intercurrent Illness|16
823979|NCT01998737|2700949|P2|Overall Study|Corrupted database|0
823980|NCT01998737|2700950|P1|Overall Study|Corrupted database|23
823981|NCT01998633|2700962|P1|Overall Study|Death|1
823982|NCT01998581|2700980|P2|Overall Study|Randomized but withdrew before treatment|0
823983|NCT01998581|2700981|P1|Overall Study|Randomized but withdrew before treatment|1
823984|NCT01998581|2700980|P2|Overall Study|Other reasons|2
823985|NCT01998581|2700981|P1|Overall Study|Other reasons|3
823986|NCT01998581|2700980|P2|Overall Study|Adverse Event|1
823987|NCT01998581|2700981|P1|Overall Study|Adverse Event|1
823988|NCT01998581|2700980|P2|Overall Study|Lost to Follow-up|4
823989|NCT01998581|2700981|P1|Overall Study|Lost to Follow-up|12
823990|NCT01998581|2700980|P2|Overall Study|Withdrawal by Subject|1
823991|NCT01998581|2700981|P1|Overall Study|Withdrawal by Subject|8
823992|NCT01998581|2700980|P2|Overall Study|Protocol Violation|0
823993|NCT01998581|2700981|P1|Overall Study|Protocol Violation|1
823994|NCT01998581|2700980|P2|Overall Study|Refused repeat treatment|4
823995|NCT01998581|2700981|P1|Overall Study|Refused repeat treatment|20
823996|NCT01998477|2700993|P2|Overall Study|Withdrawal by Subject|0
823997|NCT01998477|2700994|P1|Overall Study|Withdrawal by Subject|6
823998|NCT01998477|2700993|P2|Overall Study|Lost to Follow-up|5
823999|NCT01998477|2700994|P1|Overall Study|Lost to Follow-up|4
824000|NCT01998399|2701040|P2|Overall Study|Withdrawal by Subject|1
824001|NCT01998399|2701041|P1|Overall Study|Withdrawal by Subject|0
824002|NCT01998399|2701040|P2|Overall Study|Study stopped before dosing completed|3
824003|NCT01998399|2701041|P1|Overall Study|Study stopped before dosing completed|3
824004|NCT01998399|2701040|P2|Overall Study|Death|2
824005|NCT01998399|2701041|P1|Overall Study|Death|4
824006|NCT01998399|2701040|P2|Overall Study|Lost to Follow-up|3
824007|NCT01998399|2701041|P1|Overall Study|Lost to Follow-up|1
824008|NCT01997892|2701103|P1|Overall Study|Study completion data not recorded|35
824009|NCT01997892|2701103|P1|Overall Study|Other|3
824010|NCT01997892|2701103|P1|Overall Study|Renal transplant|8
824011|NCT01997892|2701103|P1|Overall Study|Death|14
824012|NCT01997892|2701103|P1|Overall Study|Lost to Follow-up|6
824013|NCT01997892|2701103|P1|Overall Study|Physician Decision|2
824014|NCT01996904|2701282|P2|Overall Study|Lost to Follow-up|27
824015|NCT01996904|2701283|P1|Overall Study|Lost to Follow-up|38
824016|NCT01996748|2701302|P2|Overall Study|Lost to Follow-up|1
824017|NCT01996748|2701303|P1|Overall Study|Lost to Follow-up|4
824018|NCT01996748|2701302|P2|Overall Study|Withdrawal by Subject|1
824019|NCT01996748|2701303|P1|Overall Study|Withdrawal by Subject|0
824020|NCT01996748|2701302|P2|Overall Study|Adverse Event|4
824021|NCT01996748|2701303|P1|Overall Study|Adverse Event|1
824022|NCT01996748|2701302|P2|Overall Study|Physician Decision|0
824023|NCT01996748|2701303|P1|Overall Study|Physician Decision|2
824024|NCT01996748|2701302|P2|Overall Study|Personal reason|0
824025|NCT01996748|2701303|P1|Overall Study|Personal reason|1
824026|NCT01996709|2701317|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
824027|NCT01996709|2701318|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
824028|NCT01996709|2701317|P2|Overall Study|Subject Non-Compliant|0
824029|NCT01996709|2701318|P1|Overall Study|Subject Non-Compliant|1
824030|NCT01996709|2701317|P2|Overall Study|Lost to Follow-up|0
824031|NCT01996709|2701318|P1|Overall Study|Lost to Follow-up|3
824032|NCT01996709|2701317|P2|Overall Study|Withdrawal by Subject|0
824033|NCT01996709|2701318|P1|Overall Study|Withdrawal by Subject|1
824034|NCT01996592|2701365|P1|Overall Study|change in mode of delivery|4
824035|NCT01996592|2701365|P1|Overall Study|Withdrawal by Subject|5
824036|NCT01996592|2701365|P1|Overall Study|change in surgical date|4
824037|NCT01996592|2701365|P1|Overall Study|no response to text/no diary entry|32
824038|NCT01996332|2701401|P1|Overall Study|Lost to Follow-up|34
824039|NCT01996332|2701401|P1|Overall Study|Physician Decision|17
824040|NCT01996332|2701401|P1|Overall Study|Clinical Deterioration|28
824041|NCT01996332|2701401|P1|Overall Study|Other|20
824042|NCT01996332|2701401|P1|Overall Study|Withdrawal by Subject|71
824043|NCT01996332|2701401|P1|Overall Study|Protocol Violation|9
824044|NCT01996332|2701401|P1|Overall Study|Death|264
824045|NCT01996332|2701401|P1|Overall Study|Lack of Efficacy|1245
824046|NCT01996332|2701401|P1|Overall Study|Adverse Event|117
824047|NCT01996319|2701409|P2|Overall Study|Adverse Event|2
824048|NCT01996319|2701410|P1|Overall Study|Adverse Event|2
824049|NCT01996319|2701409|P2|Overall Study|Severe or moderate (COPD) Exacerbation|1
824050|NCT01996319|2701410|P1|Overall Study|Severe or moderate (COPD) Exacerbation|5
824051|NCT01996319|2701409|P2|Overall Study|Protocol Violation|0
824052|NCT01996319|2701410|P1|Overall Study|Protocol Violation|1
824053|NCT01996033|2701430|P1|Overall Study|Lost to Follow-up|3
824054|NCT01996033|2701430|P1|Overall Study|Withdrawal by Subject|4
824055|NCT01996033|2701430|P1|Overall Study|Physician Decision|1
824056|NCT01996033|2701430|P1|Overall Study|Death|1
824057|NCT01995539|2701443|P1|Overall Study|Subject missed visit 3,4, came in for V5|1
824058|NCT01995539|2701443|P1|Overall Study|Lost to Follow-up|5
824059|NCT01995539|2701443|P1|Overall Study|Withdrawal by Subject|11
824060|NCT01995539|2701443|P1|Overall Study|Withdrawal by Investigator|15
824061|NCT01995539|2701443|P1|Overall Study|Screening Failure|1
824062|NCT01995526|2701448|P1|Overall Study|Physician Decision|1
824063|NCT01995513|2701456|P3|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|18
824064|NCT01995513|2701457|P2|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|27
824065|NCT01995513|2701458|P1|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
824066|NCT01995513|2701456|P3|Double Blind Treatment Period|Disease Progression|93
824067|NCT01995513|2701457|P2|Double Blind Treatment Period|Disease Progression|82
824068|NCT01995513|2701458|P1|Double Blind Treatment Period|Disease Progression|0
824069|NCT01995513|2701456|P3|Double Blind Treatment Period|Death|1
824070|NCT01995513|2701457|P2|Double Blind Treatment Period|Death|0
824071|NCT01995513|2701458|P1|Double Blind Treatment Period|Death|0
824072|NCT01995513|2701456|P3|Double Blind Treatment Period|Withdrawal by Subject|6
824073|NCT01995513|2701457|P2|Double Blind Treatment Period|Withdrawal by Subject|4
824074|NCT01995513|2701458|P1|Double Blind Treatment Period|Withdrawal by Subject|0
824075|NCT01995513|2701456|P3|Double Blind Treatment Period|Other|2
824076|NCT01995513|2701457|P2|Double Blind Treatment Period|Other|1
824077|NCT01995513|2701458|P1|Double Blind Treatment Period|Other|0
824078|NCT01995513|2701456|P3|Double Blind Treatment Period|Adverse Event|5
824079|NCT01995513|2701457|P2|Double Blind Treatment Period|Adverse Event|12
824080|NCT01995513|2701458|P1|Double Blind Treatment Period|Adverse Event|0
824081|NCT01995513|2701456|P3|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
824082|NCT01995513|2701457|P2|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
824083|NCT01995513|2701458|P1|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|84
824084|NCT01995513|2701456|P3|Open Label Treatment Period|Death|0
824085|NCT01995513|2701457|P2|Open Label Treatment Period|Death|0
824086|NCT01995513|2701458|P1|Open Label Treatment Period|Death|8
824087|NCT01995513|2701456|P3|Open Label Treatment Period|Adverse Event|0
824088|NCT01995513|2701457|P2|Open Label Treatment Period|Adverse Event|0
824089|NCT01995513|2701458|P1|Open Label Treatment Period|Adverse Event|35
824090|NCT01995513|2701456|P3|Open Label Treatment Period|No PSA response at week 13|0
824091|NCT01995513|2701457|P2|Open Label Treatment Period|No PSA response at week 13|0
824092|NCT01995513|2701458|P1|Open Label Treatment Period|No PSA response at week 13|43
824093|NCT01995513|2701456|P3|Open Label Treatment Period|Disease Progression|0
824094|NCT01995513|2701457|P2|Open Label Treatment Period|Disease Progression|0
824095|NCT01995513|2701458|P1|Open Label Treatment Period|Disease Progression|64
824096|NCT01995513|2701456|P3|Open Label Treatment Period|Protocol Violation|0
824097|NCT01995513|2701457|P2|Open Label Treatment Period|Protocol Violation|0
824098|NCT01995513|2701458|P1|Open Label Treatment Period|Protocol Violation|1
824099|NCT01995513|2701456|P3|Open Label Treatment Period|Withdrawal by Subject|0
824100|NCT01995513|2701457|P2|Open Label Treatment Period|Withdrawal by Subject|0
824101|NCT01995513|2701458|P1|Open Label Treatment Period|Withdrawal by Subject|14
824102|NCT01995513|2701456|P3|Open Label Treatment Period|Other|0
824103|NCT01995513|2701457|P2|Open Label Treatment Period|Other|0
824104|NCT01995513|2701458|P1|Open Label Treatment Period|Other|9
824105|NCT01995461|2701501|P1|Overall Study|Withdrawal by Subject|2
824106|NCT01995461|2701501|P1|Overall Study|Lost to Follow-up|2
824107|NCT01995461|2701501|P1|Overall Study|Death|1
824108|NCT01995357|2701507|P6|Period 5|Adverse Event|0
824109|NCT01995357|2701508|P5|Period 5|Adverse Event|0
824110|NCT01995357|2701509|P4|Period 5|Adverse Event|0
824111|NCT01995357|2701510|P3|Period 5|Adverse Event|1
824112|NCT01995357|2701511|P2|Period 5|Adverse Event|0
824113|NCT01995357|2701512|P1|Period 5|Adverse Event|1
824114|NCT01995357|2701507|P6|Period 5|Lack of Efficacy|0
824115|NCT01995357|2701508|P5|Period 5|Lack of Efficacy|0
824116|NCT01995357|2701509|P4|Period 5|Lack of Efficacy|0
824117|NCT01995357|2701510|P3|Period 5|Lack of Efficacy|0
824118|NCT01995357|2701511|P2|Period 5|Lack of Efficacy|0
824119|NCT01995357|2701512|P1|Period 5|Lack of Efficacy|1
824120|NCT01995201|2701530|P7|From Week 24 Until Week 48|Protocol Violation|0
824121|NCT01995201|2701531|P6|From Week 24 Until Week 48|Protocol Violation|0
824122|NCT01995201|2701532|P5|From Week 24 Until Week 48|Protocol Violation|2
824123|NCT01995201|2701533|P4|From Week 24 Until Week 48|Protocol Violation|0
824124|NCT01995201|2701534|P3|From Week 24 Until Week 48|Protocol Violation|1
824125|NCT01995201|2701535|P2|From Week 24 Until Week 48|Protocol Violation|0
824126|NCT01995201|2701536|P1|From Week 24 Until Week 48|Protocol Violation|0
824127|NCT01995201|2701530|P7|From Week 24 Until Week 48|Physician Decision|0
824128|NCT01995201|2701531|P6|From Week 24 Until Week 48|Physician Decision|0
824129|NCT01995201|2701532|P5|From Week 24 Until Week 48|Physician Decision|1
824130|NCT01995201|2701533|P4|From Week 24 Until Week 48|Physician Decision|0
824131|NCT01995201|2701534|P3|From Week 24 Until Week 48|Physician Decision|0
824132|NCT01995201|2701535|P2|From Week 24 Until Week 48|Physician Decision|0
824133|NCT01995201|2701536|P1|From Week 24 Until Week 48|Physician Decision|0
824134|NCT01995201|2701530|P7|From Week 24 Until Week 48|Withdrawal by Subject|0
824135|NCT01995201|2701531|P6|From Week 24 Until Week 48|Withdrawal by Subject|0
824136|NCT01995201|2701532|P5|From Week 24 Until Week 48|Withdrawal by Subject|1
824137|NCT01995201|2701533|P4|From Week 24 Until Week 48|Withdrawal by Subject|0
824138|NCT01995201|2701534|P3|From Week 24 Until Week 48|Withdrawal by Subject|1
824139|NCT01995201|2701535|P2|From Week 24 Until Week 48|Withdrawal by Subject|0
824140|NCT01995201|2701536|P1|From Week 24 Until Week 48|Withdrawal by Subject|0
824141|NCT01995201|2701530|P7|From Week 24 Until Week 48|Lost to Follow-up|0
824142|NCT01995201|2701531|P6|From Week 24 Until Week 48|Lost to Follow-up|1
824143|NCT01995201|2701532|P5|From Week 24 Until Week 48|Lost to Follow-up|1
824144|NCT01995201|2701533|P4|From Week 24 Until Week 48|Lost to Follow-up|0
824145|NCT01995201|2701534|P3|From Week 24 Until Week 48|Lost to Follow-up|0
824146|NCT01995201|2701535|P2|From Week 24 Until Week 48|Lost to Follow-up|0
824147|NCT01995201|2701536|P1|From Week 24 Until Week 48|Lost to Follow-up|0
824148|NCT01995201|2701530|P7|From Week 24 Until Week 48|Lack of Efficacy|1
824149|NCT01995201|2701531|P6|From Week 24 Until Week 48|Lack of Efficacy|2
824150|NCT01995201|2701532|P5|From Week 24 Until Week 48|Lack of Efficacy|0
824151|NCT01995201|2701533|P4|From Week 24 Until Week 48|Lack of Efficacy|0
824152|NCT01995201|2701534|P3|From Week 24 Until Week 48|Lack of Efficacy|1
824153|NCT01995201|2701535|P2|From Week 24 Until Week 48|Lack of Efficacy|0
824154|NCT01995201|2701536|P1|From Week 24 Until Week 48|Lack of Efficacy|0
824155|NCT01995201|2701530|P7|From Week 24 Until Week 48|Death|0
824156|NCT01995201|2701531|P6|From Week 24 Until Week 48|Death|2
824157|NCT01995201|2701532|P5|From Week 24 Until Week 48|Death|0
824158|NCT01995201|2701533|P4|From Week 24 Until Week 48|Death|0
824159|NCT01995201|2701534|P3|From Week 24 Until Week 48|Death|0
824160|NCT01995201|2701535|P2|From Week 24 Until Week 48|Death|0
824161|NCT01995201|2701536|P1|From Week 24 Until Week 48|Death|0
824162|NCT01995201|2701530|P7|From Week 24 Until Week 48|Adverse Event|1
824163|NCT01995201|2701531|P6|From Week 24 Until Week 48|Adverse Event|3
824164|NCT01995201|2701532|P5|From Week 24 Until Week 48|Adverse Event|1
824165|NCT01995201|2701533|P4|From Week 24 Until Week 48|Adverse Event|1
824166|NCT01995201|2701534|P3|From Week 24 Until Week 48|Adverse Event|2
824167|NCT01995201|2701535|P2|From Week 24 Until Week 48|Adverse Event|0
824168|NCT01995201|2701536|P1|From Week 24 Until Week 48|Adverse Event|0
824169|NCT01995201|2701530|P7|From Baseline Until Week 24|Protocol Violation|0
824170|NCT01995201|2701531|P6|From Baseline Until Week 24|Protocol Violation|0
824171|NCT01995201|2701532|P5|From Baseline Until Week 24|Protocol Violation|0
824172|NCT01995201|2701533|P4|From Baseline Until Week 24|Protocol Violation|0
824173|NCT01995201|2701534|P3|From Baseline Until Week 24|Protocol Violation|0
824174|NCT01995201|2701535|P2|From Baseline Until Week 24|Protocol Violation|9
824175|NCT01995201|2701536|P1|From Baseline Until Week 24|Protocol Violation|0
824176|NCT01995201|2701530|P7|From Baseline Until Week 24|Physician Decision|0
824177|NCT01995201|2701531|P6|From Baseline Until Week 24|Physician Decision|0
824178|NCT01995201|2701532|P5|From Baseline Until Week 24|Physician Decision|0
824179|NCT01995201|2701533|P4|From Baseline Until Week 24|Physician Decision|0
824180|NCT01995201|2701534|P3|From Baseline Until Week 24|Physician Decision|0
824181|NCT01995201|2701535|P2|From Baseline Until Week 24|Physician Decision|2
824182|NCT01995201|2701536|P1|From Baseline Until Week 24|Physician Decision|0
824183|NCT01995201|2701530|P7|From Baseline Until Week 24|Withdrawal by Subject|0
824184|NCT01995201|2701531|P6|From Baseline Until Week 24|Withdrawal by Subject|0
824185|NCT01995201|2701532|P5|From Baseline Until Week 24|Withdrawal by Subject|0
824186|NCT01995201|2701533|P4|From Baseline Until Week 24|Withdrawal by Subject|0
824187|NCT01995201|2701534|P3|From Baseline Until Week 24|Withdrawal by Subject|0
824188|NCT01995201|2701535|P2|From Baseline Until Week 24|Withdrawal by Subject|8
824189|NCT01995201|2701536|P1|From Baseline Until Week 24|Withdrawal by Subject|2
824190|NCT01995201|2701530|P7|From Baseline Until Week 24|Lost to Follow-up|0
824191|NCT01995201|2701531|P6|From Baseline Until Week 24|Lost to Follow-up|0
824192|NCT01995201|2701532|P5|From Baseline Until Week 24|Lost to Follow-up|0
824193|NCT01995201|2701533|P4|From Baseline Until Week 24|Lost to Follow-up|0
824194|NCT01995201|2701534|P3|From Baseline Until Week 24|Lost to Follow-up|0
824195|NCT01995201|2701535|P2|From Baseline Until Week 24|Lost to Follow-up|3
824196|NCT01995201|2701536|P1|From Baseline Until Week 24|Lost to Follow-up|2
824197|NCT01995201|2701530|P7|From Baseline Until Week 24|Lack of Efficacy|0
824198|NCT01995201|2701531|P6|From Baseline Until Week 24|Lack of Efficacy|0
824199|NCT01995201|2701532|P5|From Baseline Until Week 24|Lack of Efficacy|0
824200|NCT01995201|2701533|P4|From Baseline Until Week 24|Lack of Efficacy|0
824201|NCT01995201|2701534|P3|From Baseline Until Week 24|Lack of Efficacy|0
824202|NCT01995201|2701535|P2|From Baseline Until Week 24|Lack of Efficacy|5
824203|NCT01995201|2701536|P1|From Baseline Until Week 24|Lack of Efficacy|2
824204|NCT01995201|2701530|P7|From Baseline Until Week 24|Death|0
824205|NCT01995201|2701531|P6|From Baseline Until Week 24|Death|0
824206|NCT01995201|2701532|P5|From Baseline Until Week 24|Death|0
824207|NCT01995201|2701533|P4|From Baseline Until Week 24|Death|0
824208|NCT01995201|2701534|P3|From Baseline Until Week 24|Death|0
824209|NCT01995201|2701535|P2|From Baseline Until Week 24|Death|1
824210|NCT01995201|2701536|P1|From Baseline Until Week 24|Death|0
824211|NCT01995201|2701530|P7|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
824212|NCT01995201|2701531|P6|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
824213|NCT01995201|2701532|P5|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
824214|NCT01995201|2701533|P4|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
824215|NCT01995201|2701534|P3|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
824216|NCT01995201|2701535|P2|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3
824217|NCT01995201|2701536|P1|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
824218|NCT01995201|2701530|P7|From Baseline Until Week 24|Adverse Event|0
824219|NCT01995201|2701531|P6|From Baseline Until Week 24|Adverse Event|0
824220|NCT01995201|2701532|P5|From Baseline Until Week 24|Adverse Event|0
824221|NCT01995201|2701533|P4|From Baseline Until Week 24|Adverse Event|0
824222|NCT01995201|2701534|P3|From Baseline Until Week 24|Adverse Event|0
824223|NCT01995201|2701535|P2|From Baseline Until Week 24|Adverse Event|15
824224|NCT01995201|2701536|P1|From Baseline Until Week 24|Adverse Event|4
824225|NCT01995136|2701645|P1|Overall Study|Change in residence|1
824226|NCT01995071|2701661|P12|Overall Study|Incarcerated|0
824227|NCT01995071|2701662|P11|Overall Study|Incarcerated|0
824228|NCT01995071|2701663|P10|Overall Study|Incarcerated|0
824229|NCT01995071|2701664|P9|Overall Study|Incarcerated|0
824230|NCT01995071|2701665|P8|Overall Study|Incarcerated|1
824231|NCT01995071|2701666|P7|Overall Study|Incarcerated|0
824232|NCT01995071|2701667|P6|Overall Study|Incarcerated|0
824233|NCT01995071|2701668|P5|Overall Study|Incarcerated|0
824234|NCT01995071|2701669|P4|Overall Study|Incarcerated|0
824235|NCT01995071|2701670|P3|Overall Study|Incarcerated|0
824236|NCT01995071|2701671|P2|Overall Study|Incarcerated|0
824237|NCT01995071|2701672|P1|Overall Study|Incarcerated|0
824238|NCT01995071|2701661|P12|Overall Study|Lost to Follow-up|0
824239|NCT01995071|2701662|P11|Overall Study|Lost to Follow-up|0
824240|NCT01995071|2701663|P10|Overall Study|Lost to Follow-up|0
824241|NCT01995071|2701664|P9|Overall Study|Lost to Follow-up|1
824242|NCT01995071|2701665|P8|Overall Study|Lost to Follow-up|1
824243|NCT01995071|2701666|P7|Overall Study|Lost to Follow-up|0
824244|NCT01995071|2701667|P6|Overall Study|Lost to Follow-up|0
824245|NCT01995071|2701668|P5|Overall Study|Lost to Follow-up|0
824246|NCT01995071|2701669|P4|Overall Study|Lost to Follow-up|0
824247|NCT01995071|2701670|P3|Overall Study|Lost to Follow-up|0
824248|NCT01995071|2701671|P2|Overall Study|Lost to Follow-up|0
824249|NCT01995071|2701672|P1|Overall Study|Lost to Follow-up|1
824250|NCT01995071|2701661|P12|Overall Study|Moved|0
824251|NCT01995071|2701662|P11|Overall Study|Moved|1
824252|NCT01995071|2701663|P10|Overall Study|Moved|0
824253|NCT01995071|2701664|P9|Overall Study|Moved|0
824254|NCT01995071|2701665|P8|Overall Study|Moved|0
824255|NCT01995071|2701666|P7|Overall Study|Moved|0
824256|NCT01995071|2701667|P6|Overall Study|Moved|0
824257|NCT01995071|2701668|P5|Overall Study|Moved|1
824258|NCT01995071|2701669|P4|Overall Study|Moved|0
824259|NCT01995071|2701670|P3|Overall Study|Moved|1
824260|NCT01995071|2701671|P2|Overall Study|Moved|0
824261|NCT01995071|2701672|P1|Overall Study|Moved|0
824262|NCT01995071|2701661|P12|Overall Study|Adverse Event|0
824263|NCT01995071|2701662|P11|Overall Study|Adverse Event|0
824264|NCT01995071|2701663|P10|Overall Study|Adverse Event|0
824265|NCT01995071|2701664|P9|Overall Study|Adverse Event|0
824266|NCT01995071|2701665|P8|Overall Study|Adverse Event|0
824267|NCT01995071|2701666|P7|Overall Study|Adverse Event|1
824268|NCT01995071|2701667|P6|Overall Study|Adverse Event|0
824269|NCT01995071|2701668|P5|Overall Study|Adverse Event|0
824270|NCT01995071|2701669|P4|Overall Study|Adverse Event|0
824271|NCT01995071|2701670|P3|Overall Study|Adverse Event|0
824272|NCT01995071|2701671|P2|Overall Study|Adverse Event|0
824273|NCT01995071|2701672|P1|Overall Study|Adverse Event|0
824274|NCT01994902|2701807|P2|Test Period 2|Other|3
824275|NCT01994902|2701808|P1|Test Period 2|Other|0
824276|NCT01994902|2701807|P2|Test Period 2|Lack of Efficacy|1
824277|NCT01994902|2701808|P1|Test Period 2|Lack of Efficacy|0
824278|NCT01994902|2701807|P2|Test Period 2|Withdrawal by Subject|2
824279|NCT01994902|2701808|P1|Test Period 2|Withdrawal by Subject|0
824280|NCT01994902|2701807|P2|Test Period 1|bag too small|0
824281|NCT01994902|2701808|P1|Test Period 1|bag too small|1
824282|NCT01994902|2701807|P2|Test Period 1|Lack of Efficacy|1
824283|NCT01994902|2701808|P1|Test Period 1|Lack of Efficacy|0
824284|NCT01994902|2701807|P2|Test Period 1|Adverse Event|1
824285|NCT01994902|2701808|P1|Test Period 1|Adverse Event|2
824286|NCT01994902|2701807|P2|Test Period 1|device deficiency with adverse event|1
824287|NCT01994902|2701808|P1|Test Period 1|device deficiency with adverse event|0
824288|NCT01994902|2701807|P2|Test Period 1|Withdrawal by Subject|0
824289|NCT01994902|2701808|P1|Test Period 1|Withdrawal by Subject|3
824290|NCT01994876|2701814|P2|Test Period 2|Protocol Violation|1
824291|NCT01994876|2701815|P1|Test Period 2|Protocol Violation|0
824292|NCT01994876|2701814|P2|Test Period 2|Adverse Event|0
824293|NCT01994876|2701815|P1|Test Period 2|Adverse Event|1
824294|NCT01994876|2701814|P2|Test Period 1|Adverse Event|1
824295|NCT01994876|2701815|P1|Test Period 1|Adverse Event|0
824296|NCT01994876|2701814|P2|Test Period 1|Withdrawal by Subject|1
824297|NCT01994876|2701815|P1|Test Period 1|Withdrawal by Subject|0
824298|NCT01994863|2701823|P2|Period 2|Withdrawal by Subject|1
824299|NCT01994863|2701824|P1|Period 2|Withdrawal by Subject|1
824300|NCT01994863|2701823|P2|Period 2|Lack of Efficacy|2
824301|NCT01994863|2701824|P1|Period 2|Lack of Efficacy|0
824302|NCT01994863|2701823|P2|Period 2|Adverse Event|1
824303|NCT01994863|2701824|P1|Period 2|Adverse Event|0
824304|NCT01994863|2701823|P2|Period 1|Lack of Efficacy|0
824305|NCT01994863|2701824|P1|Period 1|Lack of Efficacy|1
824306|NCT01994863|2701823|P2|Period 1|Trial stopped by sponsor|3
824307|NCT01994863|2701824|P1|Period 1|Trial stopped by sponsor|1
824308|NCT01994863|2701823|P2|Period 1|Withdrawal by Subject|0
824309|NCT01994863|2701824|P1|Period 1|Withdrawal by Subject|1
824310|NCT01994863|2701823|P2|Period 1|Adverse Event|0
824311|NCT01994863|2701824|P1|Period 1|Adverse Event|4
824312|NCT01994837|2701830|P1|Overall Study|Removed from study due to no response|1
824313|NCT01994837|2701830|P1|Overall Study|Proceeded to transplant|1
824314|NCT01994837|2701830|P1|Overall Study|Chose palliative care|1
824315|NCT01994837|2701830|P1|Overall Study|Adverse event not related to progression|1
824316|NCT01994837|2701830|P1|Overall Study|Fatal progressive disease|2
824317|NCT01994837|2701830|P1|Overall Study|Adv event related to progressive disease|3
824318|NCT01994837|2701830|P1|Overall Study|Progressive disease per protocol|23
824319|NCT01994720|2701887|P2|Overall Study|Withdrawal by Subject|56
824320|NCT01994720|2701888|P1|Overall Study|Withdrawal by Subject|46
824321|NCT01994629|2701930|P2|Overall Study|Lost to Follow-up|3
824322|NCT01994629|2701931|P1|Overall Study|Lost to Follow-up|0
824323|NCT01994629|2701930|P2|Overall Study|Withdrawal by Subject|0
824324|NCT01994629|2701931|P1|Overall Study|Withdrawal by Subject|1
824325|NCT01994395|2701966|P2|Overall Study|Withdrawal by Subject|2
824326|NCT01994395|2701967|P1|Overall Study|Withdrawal by Subject|1
824327|NCT01994291|2701992|P3|Overall Study|Other|0
824328|NCT01994291|2701993|P2|Overall Study|Other|2
824329|NCT01994291|2701994|P1|Overall Study|Other|1
824330|NCT01994291|2701992|P3|Overall Study|Withdrawal by Subject|5
824331|NCT01994291|2701993|P2|Overall Study|Withdrawal by Subject|3
824332|NCT01994291|2701994|P1|Overall Study|Withdrawal by Subject|6
824333|NCT01994291|2701992|P3|Overall Study|Protocol Violation|0
824334|NCT01994291|2701993|P2|Overall Study|Protocol Violation|0
824335|NCT01994291|2701994|P1|Overall Study|Protocol Violation|1
824336|NCT01994291|2701992|P3|Overall Study|Medication error without associated AE|1
824337|NCT01994291|2701993|P2|Overall Study|Medication error without associated AE|0
824338|NCT01994291|2701994|P1|Overall Study|Medication error without associated AE|1
824339|NCT01994291|2701992|P3|Overall Study|Does not meet entrance criteria|0
824340|NCT01994291|2701993|P2|Overall Study|Does not meet entrance criteria|0
824341|NCT01994291|2701994|P1|Overall Study|Does not meet entrance criteria|1
824342|NCT01994291|2701992|P3|Overall Study|Lost to Follow-up|0
824343|NCT01994291|2701993|P2|Overall Study|Lost to Follow-up|1
824344|NCT01994291|2701994|P1|Overall Study|Lost to Follow-up|1
824345|NCT01994291|2701992|P3|Overall Study|Adverse Event|3
824346|NCT01994291|2701993|P2|Overall Study|Adverse Event|1
824347|NCT01994291|2701994|P1|Overall Study|Adverse Event|4
824348|NCT01994226|2702050|P2|Overall Study|Early Cessation of treatment|11
824349|NCT01994226|2702051|P1|Overall Study|Early Cessation of treatment|6
824350|NCT01994226|2702050|P2|Overall Study|Protocol Violation|10
824351|NCT01994226|2702051|P1|Overall Study|Protocol Violation|13
824352|NCT01993940|2702059|P2|Overall Study|Other - Miscellaneous|1
824353|NCT01993940|2702060|P1|Overall Study|Other - Miscellaneous|1
824354|NCT01993940|2702059|P2|Overall Study|Death|0
824355|NCT01993940|2702060|P1|Overall Study|Death|1
824356|NCT01993940|2702059|P2|Overall Study|Protocol Violation|8
824357|NCT01993940|2702060|P1|Overall Study|Protocol Violation|5
824358|NCT01993940|2702059|P2|Overall Study|Lost to Follow-up|5
824359|NCT01993940|2702060|P1|Overall Study|Lost to Follow-up|2
824360|NCT01993940|2702059|P2|Overall Study|Withdrawal by Subject|19
824361|NCT01993940|2702060|P1|Overall Study|Withdrawal by Subject|15
824362|NCT01993940|2702059|P2|Overall Study|Adverse Event|11
824363|NCT01993940|2702060|P1|Overall Study|Adverse Event|16
824364|NCT01993927|2702074|P1|Overall Study|Protocol Violation|11
824365|NCT01993927|2702074|P1|Overall Study|Case Report Forms Uncollected|18
824366|NCT01993888|2702082|P2|Overall Study|Withdrawal by Subject|1
824367|NCT01993888|2702083|P1|Overall Study|Withdrawal by Subject|0
824368|NCT01993888|2702082|P2|Overall Study|Lost to Follow-up|1
824369|NCT01993888|2702083|P1|Overall Study|Lost to Follow-up|1
824370|NCT01993888|2702082|P2|Overall Study|Death|1
824371|NCT01993888|2702083|P1|Overall Study|Death|1
824372|NCT01993823|2702112|P2|Overall Study|Lost to Follow-up|4
824373|NCT01993823|2702113|P1|Overall Study|Lost to Follow-up|1
824374|NCT01993823|2702112|P2|Overall Study|Protocol Violation|1
824375|NCT01993823|2702113|P1|Overall Study|Protocol Violation|0
824376|NCT01993823|2702112|P2|Overall Study|Requested by the patient|11
824377|NCT01993823|2702113|P1|Overall Study|Requested by the patient|6
824378|NCT01993030|2702160|P2|Overall Study|Adverse Event|4
824379|NCT01993030|2702161|P1|Overall Study|Adverse Event|0
824380|NCT01992757|2702205|P1|Overall Study|2 patients excluded due to FFP given.|2
824381|NCT01992536|2702220|P10|Overall Study|Withdrawal by Subject|0
824382|NCT01992536|2702221|P9|Overall Study|Withdrawal by Subject|0
824383|NCT01992536|2702222|P8|Overall Study|Withdrawal by Subject|0
824384|NCT01992536|2702223|P7|Overall Study|Withdrawal by Subject|0
824385|NCT01992536|2702224|P6|Overall Study|Withdrawal by Subject|0
824386|NCT01992536|2702225|P5|Overall Study|Withdrawal by Subject|0
824387|NCT01992536|2702226|P4|Overall Study|Withdrawal by Subject|2
824388|NCT01992536|2702227|P3|Overall Study|Withdrawal by Subject|0
824389|NCT01992536|2702228|P2|Overall Study|Withdrawal by Subject|1
824390|NCT01992536|2702229|P1|Overall Study|Withdrawal by Subject|0
824391|NCT01992536|2702220|P10|Overall Study|Lost to Follow-up|1
824392|NCT01992536|2702221|P9|Overall Study|Lost to Follow-up|1
824393|NCT01992536|2702222|P8|Overall Study|Lost to Follow-up|0
824394|NCT01992536|2702223|P7|Overall Study|Lost to Follow-up|0
824395|NCT01992536|2702224|P6|Overall Study|Lost to Follow-up|1
824396|NCT01992536|2702225|P5|Overall Study|Lost to Follow-up|0
824397|NCT01992536|2702226|P4|Overall Study|Lost to Follow-up|0
824398|NCT01992536|2702227|P3|Overall Study|Lost to Follow-up|1
824399|NCT01992536|2702228|P2|Overall Study|Lost to Follow-up|2
824400|NCT01992536|2702229|P1|Overall Study|Lost to Follow-up|4
824401|NCT01992536|2702220|P10|Overall Study|Administrative Reason|0
824402|NCT01992536|2702221|P9|Overall Study|Administrative Reason|0
824403|NCT01992536|2702222|P8|Overall Study|Administrative Reason|0
824404|NCT01992536|2702223|P7|Overall Study|Administrative Reason|7
824405|NCT01992536|2702224|P6|Overall Study|Administrative Reason|0
824406|NCT01992536|2702225|P5|Overall Study|Administrative Reason|0
824407|NCT01992536|2702226|P4|Overall Study|Administrative Reason|0
824408|NCT01992536|2702227|P3|Overall Study|Administrative Reason|0
824409|NCT01992536|2702228|P2|Overall Study|Administrative Reason|0
824410|NCT01992536|2702229|P1|Overall Study|Administrative Reason|0
824411|NCT01992107|2702480|P3|Overall Study|Withdrawal by Subject|8
824412|NCT01992107|2702481|P2|Overall Study|Withdrawal by Subject|7
824413|NCT01992107|2702482|P1|Overall Study|Withdrawal by Subject|13
824414|NCT01992107|2702480|P3|Overall Study|noncompliance and were unavailable|2
824415|NCT01992107|2702481|P2|Overall Study|noncompliance and were unavailable|3
824416|NCT01992107|2702482|P1|Overall Study|noncompliance and were unavailable|7
824417|NCT01992107|2702480|P3|Overall Study|Lost to Follow-up|26
824418|NCT01992107|2702481|P2|Overall Study|Lost to Follow-up|22
824419|NCT01992107|2702482|P1|Overall Study|Lost to Follow-up|46
824420|NCT01992107|2702480|P3|Overall Study|Adverse Event|0
824421|NCT01992107|2702481|P2|Overall Study|Adverse Event|1
824422|NCT01992107|2702482|P1|Overall Study|Adverse Event|0
824423|NCT01992107|2702480|P3|Overall Study|Administrative reasons|0
824424|NCT01992107|2702481|P2|Overall Study|Administrative reasons|0
824425|NCT01992107|2702482|P1|Overall Study|Administrative reasons|2
824426|NCT01992094|2702538|P3|Overall Study|Withdrawal by Subject|4
824427|NCT01992094|2702539|P2|Overall Study|Withdrawal by Subject|3
824428|NCT01992094|2702540|P1|Overall Study|Withdrawal by Subject|7
824429|NCT01992094|2702538|P3|Overall Study|Protocol Violation|1
824430|NCT01992094|2702539|P2|Overall Study|Protocol Violation|0
824431|NCT01992094|2702540|P1|Overall Study|Protocol Violation|1
824432|NCT01992094|2702538|P3|Overall Study|OTHER|0
824433|NCT01992094|2702539|P2|Overall Study|OTHER|0
824434|NCT01992094|2702540|P1|Overall Study|OTHER|4
824435|NCT01992094|2702538|P3|Overall Study|Lost to Follow-up|13
824436|NCT01992094|2702539|P2|Overall Study|Lost to Follow-up|9
824437|NCT01992094|2702540|P1|Overall Study|Lost to Follow-up|26
824438|NCT01992094|2702538|P3|Overall Study|Death|2
824439|NCT01992094|2702539|P2|Overall Study|Death|5
824440|NCT01992094|2702540|P1|Overall Study|Death|5
824441|NCT01992094|2702538|P3|Overall Study|Adverse Event|0
824442|NCT01992094|2702539|P2|Overall Study|Adverse Event|0
824443|NCT01992094|2702540|P1|Overall Study|Adverse Event|1
824444|NCT01992094|2702538|P3|Overall Study|ADMINISTRATIVE REASON|1
824445|NCT01992094|2702539|P2|Overall Study|ADMINISTRATIVE REASON|7
824446|NCT01992094|2702540|P1|Overall Study|ADMINISTRATIVE REASON|6
824447|NCT01991470|2702672|P1|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1
824448|NCT01991470|2702672|P1|Enlite 3 Period|Physician Decision|8
824449|NCT01991470|2702672|P1|Enlite 3 Period|Physician Decision|2
824450|NCT01991470|2702672|P1|Enlite 3 Period|Lost to Follow-up|1
824451|NCT01991470|2702672|P1|Enlite 1 Period|Inclusion/Exclusion not met|1
824452|NCT01991470|2702672|P1|Enlite 1 Period|Adverse Event|1
824453|NCT01991470|2702672|P1|Enlite 1 Period|Withdrawal by Subject|18
824454|NCT01991314|2702686|P2|Overall Study|Lost to Follow-up|10
824455|NCT01991314|2702687|P1|Overall Study|Lost to Follow-up|6
824456|NCT01991314|2702686|P2|Overall Study|Adverse Event|1
824457|NCT01991314|2702687|P1|Overall Study|Adverse Event|5
824458|NCT01990859|2702709|P1|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17
824459|NCT01990859|2702709|P1|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5
824460|NCT01990742|2702834|P2|Overall Study|Facility closed|270
824461|NCT01990742|2702835|P1|Overall Study|Facility closed|0
824462|NCT01990742|2702834|P2|Overall Study|Withdrawal by facility|1083
824463|NCT01990742|2702835|P1|Overall Study|Withdrawal by facility|407
824464|NCT01990664|2702871|P2|Overall Study|Unsatisfactory Visual Response|1
824465|NCT01990664|2702872|P1|Overall Study|Unsatisfactory Visual Response|0
824466|NCT01990664|2702871|P2|Overall Study|Lens Handling Difficulties|0
824467|NCT01990664|2702872|P1|Overall Study|Lens Handling Difficulties|1
824468|NCT01990664|2702871|P2|Overall Study|Lens Discomfort|1
824469|NCT01990664|2702872|P1|Overall Study|Lens Discomfort|1
824470|NCT01990664|2702871|P2|Overall Study|Protocol Violation|0
824471|NCT01990664|2702872|P1|Overall Study|Protocol Violation|1
824472|NCT01990664|2702871|P2|Overall Study|Withdrawal by Subject|3
824473|NCT01990664|2702872|P1|Overall Study|Withdrawal by Subject|2
824474|NCT01990664|2702871|P2|Overall Study|Lost to Follow-up|6
824475|NCT01990664|2702872|P1|Overall Study|Lost to Follow-up|2
824476|NCT01990560|2702878|P1|Overall Study|Withdrawal by Subject|1
824477|NCT01990534|2702892|P1|Overall Study|Overall Survival Follow-up|25
824478|NCT01990534|2702892|P1|Overall Study|Progression Free Survival Follow-up|11
824479|NCT01990534|2702892|P1|Overall Study|Reason Not Specified|2
824480|NCT01990534|2702892|P1|Overall Study|Withdrawal by Subject|3
824481|NCT01990534|2702892|P1|Overall Study|Symptomatic Deterioration|1
824482|NCT01990534|2702892|P1|Overall Study|Withdrawal of Informed Consent|2
824483|NCT01990534|2702892|P1|Overall Study|Protocol Violation|1
824484|NCT01990534|2702892|P1|Overall Study|Progressive disease|3
824485|NCT01990534|2702892|P1|Overall Study|Death|12
824486|NCT01990339|2702908|P1|Overall Study|Lost to Follow-up|861
824487|NCT01990339|2702908|P1|Overall Study|Voluntary Withdrawal|1402
824488|NCT01990339|2702908|P1|Overall Study|Data Not Available|49
824489|NCT01990313|2702913|P1|Overall Study|Lost to Follow-up|1
824490|NCT01990261|2702918|P1|Overall Study|Lost to Follow-up|2
824491|NCT01990261|2702918|P1|Overall Study|Dossier not Approved|1
824492|NCT01990261|2702918|P1|Overall Study|PD Before Treatment Start|1
824493|NCT01990261|2702918|P1|Overall Study|Disease Progression (PD)|8
824494|NCT01990261|2702918|P1|Overall Study|Death From other Causes|1
824495|NCT01990261|2702918|P1|Overall Study|Death due to Disease Progression (PD)|10
824496|NCT01990261|2702918|P1|Overall Study|Death Before Treatment Start|2
824497|NCT01989689|2702955|P2|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1
824498|NCT01989689|2702956|P1|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0
824499|NCT01989689|2702955|P2|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2
824500|NCT01989689|2702956|P1|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0
824501|NCT01989676|2702968|P2|Overall Study|Discontinued|68
824502|NCT01989676|2702969|P1|Overall Study|Discontinued|59
824503|NCT01989676|2702968|P2|Overall Study|Ongoing at data cutoff|279
824504|NCT01989676|2702969|P1|Overall Study|Ongoing at data cutoff|279
824505|NCT01989572|2702995|P6|Overall Study|alternative therapy|3
824506|NCT01989572|2702996|P5|Overall Study|alternative therapy|1
824507|NCT01989572|2702997|P4|Overall Study|alternative therapy|0
824508|NCT01989572|2702998|P3|Overall Study|alternative therapy|0
824509|NCT01989572|2702999|P2|Overall Study|alternative therapy|0
824510|NCT01989572|2703000|P1|Overall Study|alternative therapy|3
824511|NCT01989572|2702995|P6|Overall Study|not start protocol therapy|18
824512|NCT01989572|2702996|P5|Overall Study|not start protocol therapy|4
824513|NCT01989572|2702997|P4|Overall Study|not start protocol therapy|3
824514|NCT01989572|2702998|P3|Overall Study|not start protocol therapy|2
824515|NCT01989572|2702999|P2|Overall Study|not start protocol therapy|1
824516|NCT01989572|2703000|P1|Overall Study|not start protocol therapy|5
824517|NCT01989572|2702995|P6|Overall Study|unknown/not specify|5
824518|NCT01989572|2702996|P5|Overall Study|unknown/not specify|3
824519|NCT01989572|2702997|P4|Overall Study|unknown/not specify|3
824520|NCT01989572|2702998|P3|Overall Study|unknown/not specify|1
824521|NCT01989572|2702999|P2|Overall Study|unknown/not specify|4
824522|NCT01989572|2703000|P1|Overall Study|unknown/not specify|3
824523|NCT01989572|2702995|P6|Overall Study|maximum dose reached|0
824524|NCT01989572|2702996|P5|Overall Study|maximum dose reached|1
824525|NCT01989572|2702997|P4|Overall Study|maximum dose reached|0
824526|NCT01989572|2702998|P3|Overall Study|maximum dose reached|0
824527|NCT01989572|2702999|P2|Overall Study|maximum dose reached|1
824528|NCT01989572|2703000|P1|Overall Study|maximum dose reached|0
824529|NCT01989572|2702995|P6|Overall Study|error|1
824530|NCT01989572|2702996|P5|Overall Study|error|1
824531|NCT01989572|2702997|P4|Overall Study|error|1
824532|NCT01989572|2702998|P3|Overall Study|error|1
824533|NCT01989572|2702999|P2|Overall Study|error|1
824534|NCT01989572|2703000|P1|Overall Study|error|2
824535|NCT01989572|2702995|P6|Overall Study|complicating disease|0
824536|NCT01989572|2702996|P5|Overall Study|complicating disease|1
824537|NCT01989572|2702997|P4|Overall Study|complicating disease|0
824538|NCT01989572|2702998|P3|Overall Study|complicating disease|2
824539|NCT01989572|2702999|P2|Overall Study|complicating disease|1
824540|NCT01989572|2703000|P1|Overall Study|complicating disease|1
824541|NCT01989572|2702995|P6|Overall Study|Withdrawal by Subject|4
824542|NCT01989572|2702996|P5|Overall Study|Withdrawal by Subject|12
824543|NCT01989572|2702997|P4|Overall Study|Withdrawal by Subject|1
824544|NCT01989572|2702998|P3|Overall Study|Withdrawal by Subject|5
824545|NCT01989572|2702999|P2|Overall Study|Withdrawal by Subject|1
824546|NCT01989572|2703000|P1|Overall Study|Withdrawal by Subject|4
824547|NCT01989572|2702995|P6|Overall Study|Death|0
824548|NCT01989572|2702996|P5|Overall Study|Death|1
824549|NCT01989572|2702997|P4|Overall Study|Death|0
824550|NCT01989572|2702998|P3|Overall Study|Death|0
824551|NCT01989572|2702999|P2|Overall Study|Death|0
824552|NCT01989572|2703000|P1|Overall Study|Death|0
824553|NCT01989572|2702995|P6|Overall Study|Adverse Event|0
824554|NCT01989572|2702996|P5|Overall Study|Adverse Event|3
824555|NCT01989572|2702997|P4|Overall Study|Adverse Event|0
824556|NCT01989572|2702998|P3|Overall Study|Adverse Event|3
824557|NCT01989572|2702999|P2|Overall Study|Adverse Event|1
824558|NCT01989572|2703000|P1|Overall Study|Adverse Event|2
824559|NCT01989572|2702995|P6|Overall Study|Lack of Efficacy|79
824560|NCT01989572|2702996|P5|Overall Study|Lack of Efficacy|71
824561|NCT01989572|2702997|P4|Overall Study|Lack of Efficacy|43
824562|NCT01989572|2702998|P3|Overall Study|Lack of Efficacy|48
824563|NCT01989572|2702999|P2|Overall Study|Lack of Efficacy|48
824564|NCT01989572|2703000|P1|Overall Study|Lack of Efficacy|35
824565|NCT01989455|2703033|P5|Overall Study|Technical problems with infusion|1
824566|NCT01989455|2703034|P4|Overall Study|Technical problems with infusion|0
824567|NCT01989455|2703035|P3|Overall Study|Technical problems with infusion|1
824568|NCT01989455|2703036|P2|Overall Study|Technical problems with infusion|0
824569|NCT01989455|2703037|P1|Overall Study|Technical problems with infusion|0
824570|NCT01989455|2703033|P5|Overall Study|Withdrawal by Subject|0
824571|NCT01989455|2703034|P4|Overall Study|Withdrawal by Subject|0
824572|NCT01989455|2703035|P3|Overall Study|Withdrawal by Subject|0
824573|NCT01989455|2703036|P2|Overall Study|Withdrawal by Subject|1
824574|NCT01989455|2703037|P1|Overall Study|Withdrawal by Subject|0
824575|NCT01989455|2703033|P5|Overall Study|Adverse Event|0
824576|NCT01989455|2703034|P4|Overall Study|Adverse Event|0
824577|NCT01989455|2703035|P3|Overall Study|Adverse Event|0
824578|NCT01989455|2703036|P2|Overall Study|Adverse Event|1
824579|NCT01989455|2703037|P1|Overall Study|Adverse Event|0
824580|NCT01989169|2703081|P2|Period 2|Adverse Event|1
824581|NCT01989169|2703082|P1|Period 2|Adverse Event|0
824582|NCT01989156|2703095|P3|End of Study (Population at Day 90)|Employment Conflict|0
824583|NCT01989156|2703096|P2|End of Study (Population at Day 90)|Employment Conflict|1
824584|NCT01989156|2703097|P1|End of Study (Population at Day 90)|Employment Conflict|0
824585|NCT01989156|2703095|P3|End of Study (Population at Day 90)|Moved out of state|0
824586|NCT01989156|2703096|P2|End of Study (Population at Day 90)|Moved out of state|0
824587|NCT01989156|2703097|P1|End of Study (Population at Day 90)|Moved out of state|1
824588|NCT01989156|2703095|P3|End of Study (Population at Day 90)|Physician Decision|1
824589|NCT01989156|2703096|P2|End of Study (Population at Day 90)|Physician Decision|0
824590|NCT01989156|2703097|P1|End of Study (Population at Day 90)|Physician Decision|1
824591|NCT01989156|2703095|P3|End of Study (Population at Day 90)|Lost to Follow-up|0
824592|NCT01989156|2703096|P2|End of Study (Population at Day 90)|Lost to Follow-up|2
824593|NCT01989156|2703097|P1|End of Study (Population at Day 90)|Lost to Follow-up|3
824594|NCT01989156|2703095|P3|End of Study (Population at Day 90)|Withdrawal by Subject|2
824595|NCT01989156|2703096|P2|End of Study (Population at Day 90)|Withdrawal by Subject|2
824596|NCT01989156|2703097|P1|End of Study (Population at Day 90)|Withdrawal by Subject|2
824597|NCT01989156|2703095|P3|Confinement Period (Population at Day 5)|Adverse Event|1
824598|NCT01989156|2703096|P2|Confinement Period (Population at Day 5)|Adverse Event|0
824599|NCT01989156|2703097|P1|Confinement Period (Population at Day 5)|Adverse Event|0
824600|NCT01989156|2703095|P3|Confinement Period (Population at Day 5)|Patient Anxiety|1
824601|NCT01989156|2703096|P2|Confinement Period (Population at Day 5)|Patient Anxiety|0
824602|NCT01989156|2703097|P1|Confinement Period (Population at Day 5)|Patient Anxiety|0
824603|NCT01989156|2703095|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|3
824693|NCT01987960|2703307|P3|Period 1|Adverse Event|0
824604|NCT01989156|2703096|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
824605|NCT01989156|2703097|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|0
824606|NCT01988662|2703157|P2|Overall Study|Adverse Event|1
824607|NCT01988662|2703158|P1|Overall Study|Adverse Event|3
824608|NCT01988662|2703157|P2|Overall Study|Subject/guardian decision|1
824609|NCT01988662|2703158|P1|Overall Study|Subject/guardian decision|1
824610|NCT01988402|2703185|P2|Overall Study|Withdrawal by Subject|0
824611|NCT01988402|2703186|P1|Overall Study|Withdrawal by Subject|1
824612|NCT01988402|2703185|P2|Overall Study|Adverse Event|2
824613|NCT01988402|2703186|P1|Overall Study|Adverse Event|1
824614|NCT01988012|2703237|P1|Overall Study|Protocol Violation|1
824615|NCT01988012|2703237|P1|Overall Study|Physician Decision|1
824616|NCT01988012|2703237|P1|Overall Study|Lost to Follow-up|1
824617|NCT01988012|2703237|P1|Overall Study|Patient Withdrawal of Consent|4
824618|NCT01988012|2703237|P1|Overall Study|Insufficient Therapeutic Response|3
824619|NCT01988012|2703237|P1|Overall Study|Adverse Event|5
824620|NCT01987986|2703263|P4|Overall Study|Adverse Event|0
824621|NCT01987986|2703264|P3|Overall Study|Adverse Event|2
824622|NCT01987986|2703265|P2|Overall Study|Adverse Event|0
824623|NCT01987986|2703266|P1|Overall Study|Adverse Event|1
824624|NCT01987986|2703263|P4|Overall Study|Lost to Follow-up|0
824625|NCT01987986|2703264|P3|Overall Study|Lost to Follow-up|0
824626|NCT01987986|2703265|P2|Overall Study|Lost to Follow-up|0
824627|NCT01987986|2703266|P1|Overall Study|Lost to Follow-up|1
824628|NCT01987960|2703306|P4|Period 3|Administrative or other reason|43
824629|NCT01987960|2703307|P3|Period 3|Administrative or other reason|0
824630|NCT01987960|2703308|P2|Period 3|Administrative or other reason|0
824631|NCT01987960|2703309|P1|Period 3|Administrative or other reason|0
824632|NCT01987960|2703306|P4|Period 3|Lost to Follow-up|5
824633|NCT01987960|2703307|P3|Period 3|Lost to Follow-up|0
824634|NCT01987960|2703308|P2|Period 3|Lost to Follow-up|0
824635|NCT01987960|2703309|P1|Period 3|Lost to Follow-up|0
824636|NCT01987960|2703306|P4|Period 3|Withdrawal by Subject|9
824637|NCT01987960|2703307|P3|Period 3|Withdrawal by Subject|0
824638|NCT01987960|2703308|P2|Period 3|Withdrawal by Subject|0
824639|NCT01987960|2703309|P1|Period 3|Withdrawal by Subject|0
824640|NCT01987960|2703306|P4|Period 3|Protocol Violation|6
824641|NCT01987960|2703307|P3|Period 3|Protocol Violation|0
824642|NCT01987960|2703308|P2|Period 3|Protocol Violation|0
824643|NCT01987960|2703309|P1|Period 3|Protocol Violation|0
824644|NCT01987960|2703306|P4|Period 3|Non-compliance with IMP|1
824645|NCT01987960|2703307|P3|Period 3|Non-compliance with IMP|0
824646|NCT01987960|2703308|P2|Period 3|Non-compliance with IMP|0
824647|NCT01987960|2703309|P1|Period 3|Non-compliance with IMP|0
824648|NCT01987960|2703306|P4|Period 3|Adverse Event|7
824649|NCT01987960|2703307|P3|Period 3|Adverse Event|0
824650|NCT01987960|2703308|P2|Period 3|Adverse Event|0
824651|NCT01987960|2703309|P1|Period 3|Adverse Event|0
824652|NCT01987960|2703306|P4|Period 2|Administrative or other reason|0
824653|NCT01987960|2703307|P3|Period 2|Administrative or other reason|7
824654|NCT01987960|2703308|P2|Period 2|Administrative or other reason|5
824655|NCT01987960|2703309|P1|Period 2|Administrative or other reason|0
824656|NCT01987960|2703306|P4|Period 2|Withdrawal by Subject|0
824657|NCT01987960|2703307|P3|Period 2|Withdrawal by Subject|1
824658|NCT01987960|2703308|P2|Period 2|Withdrawal by Subject|0
824659|NCT01987960|2703309|P1|Period 2|Withdrawal by Subject|0
824660|NCT01987960|2703306|P4|Period 2|Adverse Event|0
824661|NCT01987960|2703307|P3|Period 2|Adverse Event|1
824662|NCT01987960|2703308|P2|Period 2|Adverse Event|0
824663|NCT01987960|2703309|P1|Period 2|Adverse Event|0
824664|NCT01987960|2703306|P4|Period 1|Withdrawal of consent before treatment|0
824665|NCT01987960|2703307|P3|Period 1|Withdrawal of consent before treatment|0
824666|NCT01987960|2703308|P2|Period 1|Withdrawal of consent before treatment|0
824667|NCT01987960|2703309|P1|Period 1|Withdrawal of consent before treatment|4
824668|NCT01987960|2703306|P4|Period 1|administrative or other reason|0
824669|NCT01987960|2703307|P3|Period 1|administrative or other reason|0
824670|NCT01987960|2703308|P2|Period 1|administrative or other reason|0
824671|NCT01987960|2703309|P1|Period 1|administrative or other reason|75
824672|NCT01987960|2703306|P4|Period 1|Lost to Follow-up|0
824673|NCT01987960|2703307|P3|Period 1|Lost to Follow-up|0
824674|NCT01987960|2703308|P2|Period 1|Lost to Follow-up|0
824675|NCT01987960|2703309|P1|Period 1|Lost to Follow-up|40
824676|NCT01987960|2703306|P4|Period 1|Withdrawal by Subject|0
824677|NCT01987960|2703307|P3|Period 1|Withdrawal by Subject|0
824678|NCT01987960|2703308|P2|Period 1|Withdrawal by Subject|0
824679|NCT01987960|2703309|P1|Period 1|Withdrawal by Subject|21
824680|NCT01987960|2703306|P4|Period 1|Protocol Violation|0
824681|NCT01987960|2703307|P3|Period 1|Protocol Violation|0
824682|NCT01987960|2703308|P2|Period 1|Protocol Violation|0
824683|NCT01987960|2703309|P1|Period 1|Protocol Violation|12
824684|NCT01987960|2703306|P4|Period 1|Non-compliance with IMP|0
824685|NCT01987960|2703307|P3|Period 1|Non-compliance with IMP|0
824686|NCT01987960|2703308|P2|Period 1|Non-compliance with IMP|0
824687|NCT01987960|2703309|P1|Period 1|Non-compliance with IMP|6
824688|NCT01987960|2703306|P4|Period 1|Lack of Efficacy|0
824689|NCT01987960|2703307|P3|Period 1|Lack of Efficacy|0
824690|NCT01987960|2703308|P2|Period 1|Lack of Efficacy|0
824691|NCT01987960|2703309|P1|Period 1|Lack of Efficacy|4
824692|NCT01987960|2703306|P4|Period 1|Adverse Event|0
824694|NCT01987960|2703308|P2|Period 1|Adverse Event|0
824695|NCT01987960|2703309|P1|Period 1|Adverse Event|24
824696|NCT01987908|2703321|P3|Post-Treatment Observation Period|Other: Bad Veins|0
824697|NCT01987908|2703322|P2|Post-Treatment Observation Period|Other: Bad Veins|1
824698|NCT01987908|2703323|P1|Post-Treatment Observation Period|Other: Bad Veins|0
824699|NCT01987908|2703321|P3|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
824700|NCT01987908|2703322|P2|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2
824701|NCT01987908|2703323|P1|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
824702|NCT01987908|2703321|P3|Treatment Period|Adverse Event|1
824703|NCT01987908|2703322|P2|Treatment Period|Adverse Event|1
824704|NCT01987908|2703323|P1|Treatment Period|Adverse Event|0
824705|NCT01987908|2703321|P3|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
824706|NCT01987908|2703322|P2|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
824707|NCT01987908|2703323|P1|Placebo Lead-in Period|Other: Study Termination by Sponsor|4
824708|NCT01987908|2703321|P3|Placebo Lead-in Period|Withdrawal by Subject|0
824709|NCT01987908|2703322|P2|Placebo Lead-in Period|Withdrawal by Subject|0
824710|NCT01987908|2703323|P1|Placebo Lead-in Period|Withdrawal by Subject|1
824711|NCT01987908|2703321|P3|Placebo Lead-in Period|Physician Decision|0
824712|NCT01987908|2703322|P2|Placebo Lead-in Period|Physician Decision|0
824713|NCT01987908|2703323|P1|Placebo Lead-in Period|Physician Decision|2
824714|NCT01987908|2703321|P3|Placebo Lead-in Period|Adverse Event|0
824715|NCT01987908|2703322|P2|Placebo Lead-in Period|Adverse Event|0
824716|NCT01987908|2703323|P1|Placebo Lead-in Period|Adverse Event|2
824717|NCT01987895|2703406|P2|Overall Study|randomized before giving IC|1
824718|NCT01987895|2703407|P1|Overall Study|randomized before giving IC|0
824719|NCT01987895|2703406|P2|Overall Study|Lost to Follow-up|5
824720|NCT01987895|2703407|P1|Overall Study|Lost to Follow-up|3
824721|NCT01987895|2703406|P2|Overall Study|Death|7
824722|NCT01987895|2703407|P1|Overall Study|Death|7
824723|NCT01987895|2703406|P2|Overall Study|Physician Decision|10
824724|NCT01987895|2703407|P1|Overall Study|Physician Decision|8
824725|NCT01987895|2703406|P2|Overall Study|Withdrawal by Subject|7
824726|NCT01987895|2703407|P1|Overall Study|Withdrawal by Subject|12
824727|NCT01987765|2703431|P1|Overall Study|Lost to Follow-up|37
824728|NCT01987765|2703431|P1|Overall Study|Protocol Violation|65
824729|NCT01987557|2703455|P3|Overall Study|Adverse Event|0
824730|NCT01987557|2703456|P2|Overall Study|Adverse Event|2
824731|NCT01987557|2703457|P1|Overall Study|Adverse Event|0
824732|NCT01987557|2703455|P3|Overall Study|Withdrawal by Subject|2
824733|NCT01987557|2703456|P2|Overall Study|Withdrawal by Subject|1
824734|NCT01987557|2703457|P1|Overall Study|Withdrawal by Subject|2
824735|NCT01987557|2703455|P3|Overall Study|Protocol Violation|1
824736|NCT01987557|2703456|P2|Overall Study|Protocol Violation|0
824737|NCT01987557|2703457|P1|Overall Study|Protocol Violation|1
824738|NCT01987505|2703467|P1|Overall Study|Death|4
824739|NCT01987505|2703467|P1|Overall Study|Investigator Decision|2
824740|NCT01987505|2703467|P1|Overall Study|Lost to Follow-up|15
824741|NCT01987505|2703467|P1|Overall Study|Other Reason|2
824742|NCT01987505|2703467|P1|Overall Study|Withdrawal by Subject|2
824743|NCT01987505|2703467|P1|Overall Study|Other|9
824744|NCT01987479|2703497|P1|Overall Study|Adverse Event|7
824745|NCT01987479|2703497|P1|Overall Study|Lost to Follow-up|1
824746|NCT01987479|2703497|P1|Overall Study|Other|5
824747|NCT01987479|2703497|P1|Overall Study|Participant/legal guardian decision|1
824748|NCT01987479|2703497|P1|Overall Study|Physician Decision|2
824749|NCT01987479|2703497|P1|Overall Study|Protocol Violation|1
824750|NCT01987453|2703525|P3|Overall Study|Lack of Efficacy|0
824751|NCT01987453|2703526|P2|Overall Study|Lack of Efficacy|12
824752|NCT01987453|2703527|P1|Overall Study|Lack of Efficacy|1
824753|NCT01987453|2703525|P3|Overall Study|Death|1
824754|NCT01987453|2703526|P2|Overall Study|Death|0
824755|NCT01987453|2703527|P1|Overall Study|Death|0
824756|NCT01987232|2703609|P5|Overall Study|Ongoing in Study|0
824757|NCT01987232|2703610|P4|Overall Study|Ongoing in Study|1
824758|NCT01987232|2703611|P3|Overall Study|Ongoing in Study|0
824759|NCT01987232|2703612|P2|Overall Study|Ongoing in Study|0
824760|NCT01987232|2703613|P1|Overall Study|Ongoing in Study|0
824761|NCT01986985|2703700|P1|Overall Study|Scan not completed due to malfunction|3
824762|NCT01986985|2703700|P1|Overall Study|Withdrawal by Subject|4
824763|NCT01986855|2703740|P3|Overall Study|Withdrawal by Subject|5
824764|NCT01986855|2703741|P2|Overall Study|Withdrawal by Subject|8
824765|NCT01986855|2703742|P1|Overall Study|Withdrawal by Subject|7
824766|NCT01986855|2703740|P3|Overall Study|Participant Moved|2
824767|NCT01986855|2703741|P2|Overall Study|Participant Moved|0
824768|NCT01986855|2703742|P1|Overall Study|Participant Moved|0
824769|NCT01986855|2703740|P3|Overall Study|Screen Failure|0
824770|NCT01986855|2703741|P2|Overall Study|Screen Failure|1
824771|NCT01986855|2703742|P1|Overall Study|Screen Failure|0
824772|NCT01986855|2703740|P3|Overall Study|Lost to Follow-up|0
824773|NCT01986855|2703741|P2|Overall Study|Lost to Follow-up|1
824774|NCT01986855|2703742|P1|Overall Study|Lost to Follow-up|2
824775|NCT01986855|2703740|P3|Overall Study|Death|4
824776|NCT01986855|2703741|P2|Overall Study|Death|4
824777|NCT01986855|2703742|P1|Overall Study|Death|3
824778|NCT01986855|2703740|P3|Overall Study|Adverse Event|0
824779|NCT01986855|2703741|P2|Overall Study|Adverse Event|0
824780|NCT01986855|2703742|P1|Overall Study|Adverse Event|1
824781|NCT01986829|2703771|P1|Overall Study|Death|1
824782|NCT01986751|2703819|P2|Overall Study|improperly consented|2
824783|NCT01986751|2703820|P1|Overall Study|improperly consented|10
824784|NCT01986231|2703874|P1|Overall Study|Adverse Event|1
824785|NCT01986140|2703881|P2|Overall Study|progression disease|1
824786|NCT01986140|2703882|P1|Overall Study|progression disease|0
824787|NCT01986140|2703881|P2|Overall Study|Adverse Event|1
824788|NCT01986140|2703882|P1|Overall Study|Adverse Event|0
824789|NCT01986140|2703881|P2|Overall Study|found not eligible|0
824790|NCT01986140|2703882|P1|Overall Study|found not eligible|3
824791|NCT01986140|2703881|P2|Overall Study|alternative treatment|1
824792|NCT01986140|2703882|P1|Overall Study|alternative treatment|1
824793|NCT01986140|2703881|P2|Overall Study|Withdrawal by Subject|25
824794|NCT01986140|2703882|P1|Overall Study|Withdrawal by Subject|31
824795|NCT01986062|2703890|P2|Overall Study|Lost to Follow-up|1
824796|NCT01986062|2703891|P1|Overall Study|Lost to Follow-up|1
824797|NCT01985321|2703964|P2|Overall Study|Subject treated wrong type of sore|0
824798|NCT01985321|2703965|P1|Overall Study|Subject treated wrong type of sore|1
824799|NCT01985321|2703964|P2|Overall Study|Lost to Follow-up|2
824800|NCT01985321|2703965|P1|Overall Study|Lost to Follow-up|5
824801|NCT01985321|2703964|P2|Overall Study|Withdrawal by Subject|0
824802|NCT01985321|2703965|P1|Overall Study|Withdrawal by Subject|1
824803|NCT01985321|2703964|P2|Overall Study|Protocol Violation|3
824804|NCT01985321|2703965|P1|Overall Study|Protocol Violation|4
824805|NCT01985126|2703975|P2|Overall Study|Withdrawal by Subject|7
824806|NCT01985126|2703976|P1|Overall Study|Withdrawal by Subject|2
824807|NCT01985126|2703975|P2|Overall Study|Study Terminated By Sponsor|22
824808|NCT01985126|2703976|P1|Overall Study|Study Terminated By Sponsor|1
824809|NCT01985126|2703975|P2|Overall Study|Lost to Follow-up|8
824810|NCT01985126|2703976|P1|Overall Study|Lost to Follow-up|0
824811|NCT01985126|2703975|P2|Overall Study|Death|69
824812|NCT01985126|2703976|P1|Overall Study|Death|15
824813|NCT01984892|2703994|P1|Overall Study|Progressive disease|7
824814|NCT01984697|2704005|P5|Overall Study|Pregnancy|1
824815|NCT01984697|2704006|P4|Overall Study|Pregnancy|0
824816|NCT01984697|2704007|P3|Overall Study|Pregnancy|1
824817|NCT01984697|2704008|P2|Overall Study|Pregnancy|0
824818|NCT01984697|2704009|P1|Overall Study|Pregnancy|2
824819|NCT01984697|2704005|P5|Overall Study|Death|0
824820|NCT01984697|2704006|P4|Overall Study|Death|1
824821|NCT01984697|2704007|P3|Overall Study|Death|0
824822|NCT01984697|2704008|P2|Overall Study|Death|0
824823|NCT01984697|2704009|P1|Overall Study|Death|0
824824|NCT01984697|2704005|P5|Overall Study|Missed last follow-up visit|0
824825|NCT01984697|2704006|P4|Overall Study|Missed last follow-up visit|0
824826|NCT01984697|2704007|P3|Overall Study|Missed last follow-up visit|0
824827|NCT01984697|2704008|P2|Overall Study|Missed last follow-up visit|0
824828|NCT01984697|2704009|P1|Overall Study|Missed last follow-up visit|1
824829|NCT01984697|2704005|P5|Overall Study|Withdrawal by Subject|13
824830|NCT01984697|2704006|P4|Overall Study|Withdrawal by Subject|11
824831|NCT01984697|2704007|P3|Overall Study|Withdrawal by Subject|13
824832|NCT01984697|2704008|P2|Overall Study|Withdrawal by Subject|21
824833|NCT01984697|2704009|P1|Overall Study|Withdrawal by Subject|15
824834|NCT01984697|2704005|P5|Overall Study|Protocol Violation|0
824835|NCT01984697|2704006|P4|Overall Study|Protocol Violation|2
824836|NCT01984697|2704007|P3|Overall Study|Protocol Violation|3
824837|NCT01984697|2704008|P2|Overall Study|Protocol Violation|5
824838|NCT01984697|2704009|P1|Overall Study|Protocol Violation|8
824839|NCT01984697|2704005|P5|Overall Study|Physician Decision|0
824840|NCT01984697|2704006|P4|Overall Study|Physician Decision|1
824841|NCT01984697|2704007|P3|Overall Study|Physician Decision|0
824842|NCT01984697|2704008|P2|Overall Study|Physician Decision|0
824843|NCT01984697|2704009|P1|Overall Study|Physician Decision|3
824844|NCT01984697|2704005|P5|Overall Study|Lost to Follow-up|21
824845|NCT01984697|2704006|P4|Overall Study|Lost to Follow-up|6
824846|NCT01984697|2704007|P3|Overall Study|Lost to Follow-up|10
824847|NCT01984697|2704008|P2|Overall Study|Lost to Follow-up|5
824848|NCT01984697|2704009|P1|Overall Study|Lost to Follow-up|14
824849|NCT01984697|2704005|P5|Overall Study|Adverse Event|0
824850|NCT01984697|2704006|P4|Overall Study|Adverse Event|0
824851|NCT01984697|2704007|P3|Overall Study|Adverse Event|2
824852|NCT01984697|2704008|P2|Overall Study|Adverse Event|0
824853|NCT01984697|2704009|P1|Overall Study|Adverse Event|0
824854|NCT01984684|2704128|P2|Overall Study|Subject had inadequate IV access|1
824855|NCT01984684|2704129|P1|Overall Study|Subject had inadequate IV access|0
824856|NCT01984684|2704128|P2|Overall Study|Study drug not available at site|1
824857|NCT01984684|2704129|P1|Overall Study|Study drug not available at site|1
824858|NCT01984684|2704128|P2|Overall Study|Subject incarcerated|0
824859|NCT01984684|2704129|P1|Overall Study|Subject incarcerated|1
824860|NCT01984684|2704128|P2|Overall Study|Noncompliance with study drug|1
824861|NCT01984684|2704129|P1|Overall Study|Noncompliance with study drug|2
824862|NCT01984684|2704128|P2|Overall Study|Death|1
824863|NCT01984684|2704129|P1|Overall Study|Death|0
824864|NCT01984684|2704128|P2|Overall Study|Protocol Violation|2
824865|NCT01984684|2704129|P1|Overall Study|Protocol Violation|4
824866|NCT01984684|2704128|P2|Overall Study|Physician Decision|2
824867|NCT01984684|2704129|P1|Overall Study|Physician Decision|4
824868|NCT01984684|2704128|P2|Overall Study|Lack of Efficacy|6
824869|NCT01984684|2704129|P1|Overall Study|Lack of Efficacy|3
824870|NCT01984684|2704128|P2|Overall Study|Withdrawal by Subject|9
824871|NCT01984684|2704129|P1|Overall Study|Withdrawal by Subject|9
824872|NCT01984684|2704128|P2|Overall Study|Adverse Event|12
824873|NCT01984684|2704129|P1|Overall Study|Adverse Event|8
824874|NCT01984684|2704128|P2|Overall Study|Lost to Follow-up|24
824875|NCT01984684|2704129|P1|Overall Study|Lost to Follow-up|25
824876|NCT01984424|2704147|P2|Overall Study|Lost to Follow-up|1
824877|NCT01984424|2704148|P1|Overall Study|Lost to Follow-up|0
824878|NCT01984424|2704147|P2|Overall Study|Sponsor Decision|1
824879|NCT01984424|2704148|P1|Overall Study|Sponsor Decision|0
824880|NCT01984424|2704147|P2|Overall Study|Withdrawal by Subject|5
824881|NCT01984424|2704148|P1|Overall Study|Withdrawal by Subject|3
824882|NCT01984294|2704203|P3|Overall Study|Adverse Event|0
824883|NCT01984294|2704204|P2|Overall Study|Adverse Event|1
824884|NCT01984294|2704205|P1|Overall Study|Adverse Event|0
824885|NCT01984294|2704203|P3|Overall Study|Lack of Efficacy|6
824886|NCT01984294|2704204|P2|Overall Study|Lack of Efficacy|2
824887|NCT01984294|2704205|P1|Overall Study|Lack of Efficacy|4
824888|NCT01984294|2704203|P3|Overall Study|Randomized but Never Treated|1
824889|NCT01984294|2704204|P2|Overall Study|Randomized but Never Treated|0
824890|NCT01984294|2704205|P1|Overall Study|Randomized but Never Treated|0
824891|NCT01984242|2704228|P3|Overall Study|Ongoing in Study|61
824892|NCT01984242|2704229|P2|Overall Study|Ongoing in Study|65
824893|NCT01984242|2704230|P1|Overall Study|Ongoing in Study|60
824894|NCT01984242|2704228|P3|Overall Study|Randomized, but not treated|1
824895|NCT01984242|2704229|P2|Overall Study|Randomized, but not treated|0
824896|NCT01984242|2704230|P1|Overall Study|Randomized, but not treated|0
824897|NCT01984242|2704228|P3|Overall Study|Other|1
824898|NCT01984242|2704229|P2|Overall Study|Other|0
824899|NCT01984242|2704230|P1|Overall Study|Other|1
824900|NCT01984242|2704228|P3|Overall Study|Lost to Follow-up|1
824901|NCT01984242|2704229|P2|Overall Study|Lost to Follow-up|0
824902|NCT01984242|2704230|P1|Overall Study|Lost to Follow-up|0
824903|NCT01984242|2704228|P3|Overall Study|Physician Decision|2
824904|NCT01984242|2704229|P2|Overall Study|Physician Decision|0
824905|NCT01984242|2704230|P1|Overall Study|Physician Decision|1
824906|NCT01984242|2704228|P3|Overall Study|Withdrawal by Subject|5
824907|NCT01984242|2704229|P2|Overall Study|Withdrawal by Subject|2
824908|NCT01984242|2704230|P1|Overall Study|Withdrawal by Subject|2
824909|NCT01984242|2704228|P3|Overall Study|Death|30
824910|NCT01984242|2704229|P2|Overall Study|Death|36
824911|NCT01984242|2704230|P1|Overall Study|Death|37
824912|NCT01984229|2704380|P2|Safety Follow-up Period|Lost to Follow-up|0
824913|NCT01984229|2704381|P1|Safety Follow-up Period|Lost to Follow-up|1
824914|NCT01984229|2704380|P2|Safety Follow-up Period|Adverse Event|1
824915|NCT01984229|2704381|P1|Safety Follow-up Period|Adverse Event|1
824916|NCT01983930|2704433|P2|Overall Study|Adverse Event|1
824917|NCT01983930|2704434|P1|Overall Study|Adverse Event|0
824918|NCT01983930|2704433|P2|Overall Study|Withdrawal by Subject|8
824919|NCT01983930|2704434|P1|Overall Study|Withdrawal by Subject|9
824920|NCT01983683|2704487|P2|Overall Study|Sponsor Decision|1
824921|NCT01983683|2704488|P1|Overall Study|Sponsor Decision|1
824922|NCT01983683|2704487|P2|Overall Study|Lost to Follow-up|8
824923|NCT01983683|2704488|P1|Overall Study|Lost to Follow-up|4
824924|NCT01983683|2704487|P2|Overall Study|Physician Decision|9
824925|NCT01983683|2704488|P1|Overall Study|Physician Decision|8
824926|NCT01983683|2704487|P2|Overall Study|Death|15
824927|NCT01983683|2704488|P1|Overall Study|Death|11
824928|NCT01983683|2704487|P2|Overall Study|Withdrawal by Subject|18
824929|NCT01983683|2704488|P1|Overall Study|Withdrawal by Subject|14
824930|NCT01983254|2704540|P2|Overall Study|too ill|8
824931|NCT01983254|2704541|P1|Overall Study|too ill|11
824932|NCT01983254|2704540|P2|Overall Study|Lost to Follow-up|16
824933|NCT01983254|2704541|P1|Overall Study|Lost to Follow-up|17
824934|NCT01983254|2704540|P2|Overall Study|Death|6
824935|NCT01983254|2704541|P1|Overall Study|Death|6
824936|NCT01983111|2704553|P2|Overall Study|Protocol Violation|1
824937|NCT01983111|2704554|P1|Overall Study|Protocol Violation|0
824938|NCT01983111|2704553|P2|Overall Study|Adverse Event|0
824939|NCT01983111|2704554|P1|Overall Study|Adverse Event|4
824940|NCT01983111|2704553|P2|Overall Study|Withdrawal by Subject|6
824941|NCT01983111|2704554|P1|Overall Study|Withdrawal by Subject|8
824942|NCT01982812|2704589|P2|Overall Study|Adverse Event|5
824943|NCT01982812|2704590|P1|Overall Study|Adverse Event|0
824944|NCT01982812|2704589|P2|Overall Study|Death|5
824945|NCT01982812|2704590|P1|Overall Study|Death|1
824946|NCT01982773|2704604|P2|Overall Study|Lost to Follow-up|1
824947|NCT01982773|2704605|P1|Overall Study|Lost to Follow-up|7
824948|NCT01982773|2704604|P2|Overall Study|Withdrawal by Subject|3
824949|NCT01982773|2704605|P1|Overall Study|Withdrawal by Subject|1
824950|NCT01982682|2704626|P1|Overall Study|Physician Decision|1
824951|NCT01982435|2704640|P2|Overall Study|Adverse Event|0
824952|NCT01982435|2704641|P1|Overall Study|Adverse Event|1
824953|NCT01982292|2704680|P2|Overall Study|Technical Problems|0
824954|NCT01982292|2704681|P1|Overall Study|Technical Problems|2
824955|NCT01982292|2704680|P2|Overall Study|Patient/Guardian Decision|1
824956|NCT01982292|2704681|P1|Overall Study|Patient/Guardian Decision|3
824957|NCT01982292|2704680|P2|Overall Study|Protocol Deviation|0
824958|NCT01982292|2704681|P1|Overall Study|Protocol Deviation|1
824959|NCT01982292|2704680|P2|Overall Study|Non-Compliance With Study Treatment|0
824960|NCT01982292|2704681|P1|Overall Study|Non-Compliance With Study Treatment|1
824961|NCT01982292|2704680|P2|Overall Study|Lost to Follow-up|0
824962|NCT01982292|2704681|P1|Overall Study|Lost to Follow-up|2
824963|NCT01982292|2704680|P2|Overall Study|Death|0
824964|NCT01982292|2704681|P1|Overall Study|Death|1
824965|NCT01982292|2704680|P2|Overall Study|Adverse Event|0
824966|NCT01982292|2704681|P1|Overall Study|Adverse Event|2
824967|NCT01982253|2704702|P3|Overall Study|Study terminated by sponsor|4
824968|NCT01982253|2704703|P2|Overall Study|Study terminated by sponsor|4
824969|NCT01982253|2704704|P1|Overall Study|Study terminated by sponsor|1
824970|NCT01982253|2704702|P3|Overall Study|Withdrawal by Subject|0
824971|NCT01982253|2704703|P2|Overall Study|Withdrawal by Subject|0
824972|NCT01982253|2704704|P1|Overall Study|Withdrawal by Subject|1
824973|NCT01981954|2704728|P1|Fixed-Dose Assessment Period|Lack of Efficacy|1
824974|NCT01981954|2704728|P1|Titration Period|Protocol Deviation|1
824975|NCT01981616|2704797|P2|Overall Study|Protocol Violation|0
824976|NCT01981616|2704798|P1|Overall Study|Protocol Violation|1
824977|NCT01981616|2704797|P2|Overall Study|Adverse Event|1
824978|NCT01981616|2704798|P1|Overall Study|Adverse Event|0
824979|NCT01981473|2704824|P3|Overall Study|Received treatment for >24 months|6
824980|NCT01981473|2704825|P2|Overall Study|Received treatment for >24 months|0
824981|NCT01981473|2704826|P1|Overall Study|Received treatment for >24 months|2
824982|NCT01981473|2704824|P3|Overall Study|Received treatment for < 6 months|1
824983|NCT01981473|2704825|P2|Overall Study|Received treatment for < 6 months|0
824984|NCT01981473|2704826|P1|Overall Study|Received treatment for < 6 months|0
824985|NCT01981473|2704824|P3|Overall Study|Incorrect diagnosis of RA|1
824986|NCT01981473|2704825|P2|Overall Study|Incorrect diagnosis of RA|0
824987|NCT01981473|2704826|P1|Overall Study|Incorrect diagnosis of RA|0
824988|NCT01981356|2704867|P2|Overall Study|Protocol Violation|0
824989|NCT01981356|2704868|P1|Overall Study|Protocol Violation|2
824990|NCT01981356|2704867|P2|Overall Study|Withdrawal by Subject|1
824991|NCT01981356|2704868|P1|Overall Study|Withdrawal by Subject|1
824992|NCT01981356|2704867|P2|Overall Study|Lost to Follow-up|1
824993|NCT01981356|2704868|P1|Overall Study|Lost to Follow-up|4
824994|NCT01981122|2704895|P2|Overall Study|Death|15
824995|NCT01981122|2704896|P1|Overall Study|Death|14
824996|NCT01981122|2704895|P2|Overall Study|Investigator Or Dendreon Discretion|1
824997|NCT01981122|2704896|P1|Overall Study|Investigator Or Dendreon Discretion|0
824998|NCT01981122|2704895|P2|Overall Study|Lost to Follow-up|1
824999|NCT01981122|2704896|P1|Overall Study|Lost to Follow-up|0
825000|NCT01981122|2704895|P2|Overall Study|Protocol Violation|1
825001|NCT01981122|2704896|P1|Overall Study|Protocol Violation|0
825002|NCT01981122|2704895|P2|Overall Study|Withdrawal by Subject|2
825003|NCT01981122|2704896|P1|Overall Study|Withdrawal by Subject|0
825004|NCT01981096|2704904|P2|Overall Study|Lost to Follow-up|0
825005|NCT01981096|2704905|P1|Overall Study|Lost to Follow-up|2
825006|NCT01981096|2704904|P2|Overall Study|Withdrawal by Subject|1
825007|NCT01981096|2704905|P1|Overall Study|Withdrawal by Subject|0
825008|NCT01981096|2704904|P2|Overall Study|Parent illness|0
825009|NCT01981096|2704905|P1|Overall Study|Parent illness|1
825010|NCT01980992|2704926|P2|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1
825011|NCT01980992|2704927|P1|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0
825012|NCT01980992|2704926|P2|52 Weeks Open Label Active Wheat OIT|Non-compliance|0
825013|NCT01980992|2704927|P1|52 Weeks Open Label Active Wheat OIT|Non-compliance|1
825014|NCT01980992|2704926|P2|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0
825015|NCT01980992|2704927|P1|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2
825016|NCT01980992|2704926|P2|52 Weeks Blinded Study Treatment|Non-compliance|0
825017|NCT01980992|2704927|P1|52 Weeks Blinded Study Treatment|Non-compliance|1
825018|NCT01980992|2704926|P2|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
825019|NCT01980992|2704927|P1|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
825020|NCT01980992|2704926|P2|52 Weeks Blinded Study Treatment|Dosing Symptoms|3
825021|NCT01980992|2704927|P1|52 Weeks Blinded Study Treatment|Dosing Symptoms|0
825022|NCT01980940|2704952|P8|Overall Study|Protocol Violation|0
825023|NCT01980940|2704953|P7|Overall Study|Protocol Violation|0
825024|NCT01980940|2704954|P6|Overall Study|Protocol Violation|2
825025|NCT01980940|2704955|P5|Overall Study|Protocol Violation|0
825026|NCT01980940|2704956|P4|Overall Study|Protocol Violation|0
825027|NCT01980940|2704957|P3|Overall Study|Protocol Violation|0
825028|NCT01980940|2704958|P2|Overall Study|Protocol Violation|0
825029|NCT01980940|2704959|P1|Overall Study|Protocol Violation|0
825030|NCT01980888|2705013|P2|Overall Study|Non-Compliance with Study Drug|2
825031|NCT01980888|2705014|P1|Overall Study|Non-Compliance with Study Drug|3
825032|NCT01980888|2705013|P2|Overall Study|Investigator's Discretion|3
825033|NCT01980888|2705014|P1|Overall Study|Investigator's Discretion|8
825034|NCT01980888|2705013|P2|Overall Study|Withdrew Consent|6
825035|NCT01980888|2705014|P1|Overall Study|Withdrew Consent|17
825036|NCT01980888|2705013|P2|Overall Study|Study Terminated by Sponsor|122
825037|NCT01980888|2705014|P1|Overall Study|Study Terminated by Sponsor|116
825038|NCT01980875|2705033|P3|Overall Study|Lost to Follow-up|1
825039|NCT01980875|2705034|P2|Overall Study|Lost to Follow-up|0
825040|NCT01980875|2705035|P1|Overall Study|Lost to Follow-up|0
825041|NCT01980875|2705033|P3|Overall Study|Study Terminated by Sponsor|22
825042|NCT01980875|2705034|P2|Overall Study|Study Terminated by Sponsor|24
825043|NCT01980875|2705035|P1|Overall Study|Study Terminated by Sponsor|7
825044|NCT01980875|2705033|P3|Overall Study|Withdrew Consent|1
825045|NCT01980875|2705034|P2|Overall Study|Withdrew Consent|1
825046|NCT01980875|2705035|P1|Overall Study|Withdrew Consent|1
825047|NCT01980628|2705067|P1|Overall Study|PD, Subj non-Compliant,Study Terminated|42
825048|NCT01980628|2705067|P1|Overall Study|Withdrawal by Subject|4
825049|NCT01980628|2705067|P1|Overall Study|Physician Decision|5
825050|NCT01980628|2705067|P1|Overall Study|Adverse Event|12
825051|NCT01980095|2705115|P2|Overall Study|Study drug discontinued|0
825052|NCT01980095|2705116|P1|Overall Study|Study drug discontinued|1
825053|NCT01980095|2705115|P2|Overall Study|Safety issue|1
825054|NCT01980095|2705116|P1|Overall Study|Safety issue|0
825055|NCT01980095|2705115|P2|Overall Study|Poor compliance|0
825056|NCT01980095|2705116|P1|Overall Study|Poor compliance|5
825057|NCT01980095|2705115|P2|Overall Study|Withdrawal by Subject|3
825058|NCT01980095|2705116|P1|Overall Study|Withdrawal by Subject|2
825059|NCT01980095|2705115|P2|Overall Study|Lost to Follow-up|7
825060|NCT01980095|2705116|P1|Overall Study|Lost to Follow-up|6
825061|NCT01979952|2705126|P2|Overall Study|Other than specified above|0
825062|NCT01979952|2705127|P1|Overall Study|Other than specified above|1
825063|NCT01979952|2705126|P2|Overall Study|Withdrawal by Subject|1
825064|NCT01979952|2705127|P1|Overall Study|Withdrawal by Subject|2
825065|NCT01979952|2705126|P2|Overall Study|Protocol Violation|0
825066|NCT01979952|2705127|P1|Overall Study|Protocol Violation|1
825067|NCT01979952|2705126|P2|Overall Study|Adverse Event|5
825068|NCT01979952|2705127|P1|Overall Study|Adverse Event|4
825069|NCT01979185|2705194|P2|Period 2|Not specified|1
825070|NCT01979185|2705195|P1|Period 2|Not specified|0
825071|NCT01978262|2705360|P1|Overall Study|Lost to Follow-up|2
825072|NCT01978262|2705360|P1|Overall Study|Withdrawal by Subject|9
825073|NCT01978236|2705365|P1|Overall Study|Discontinued due to study close|2
825074|NCT01978145|2705384|P2|Treatment Period 2|Par. reached defined stopping criteria|5
825075|NCT01978145|2705385|P1|Treatment Period 2|Par. reached defined stopping criteria|8
825076|NCT01978145|2705384|P2|Treatment Period 2|Withdrawal by Subject|4
825077|NCT01978145|2705385|P1|Treatment Period 2|Withdrawal by Subject|7
825078|NCT01978145|2705384|P2|Treatment Period 2|Lost to Follow-up|1
825079|NCT01978145|2705385|P1|Treatment Period 2|Lost to Follow-up|1
825080|NCT01978145|2705384|P2|Treatment Period 2|Protocol Violation|1
825081|NCT01978145|2705385|P1|Treatment Period 2|Protocol Violation|0
825082|NCT01978145|2705384|P2|Treatment Period 2|Adverse Event|3
825083|NCT01978145|2705385|P1|Treatment Period 2|Adverse Event|3
825084|NCT01978145|2705384|P2|Washout Period 1|Par. reached defined stopping criteria|1
825085|NCT01978145|2705385|P1|Washout Period 1|Par. reached defined stopping criteria|0
825086|NCT01978145|2705384|P2|Washout Period 1|Withdrawal by Subject|1
825087|NCT01978145|2705385|P1|Washout Period 1|Withdrawal by Subject|1
825088|NCT01978145|2705384|P2|Washout Period 1|Adverse Event|1
825089|NCT01978145|2705385|P1|Washout Period 1|Adverse Event|0
825090|NCT01978145|2705384|P2|Treatment Period 1|Par. reached defined stopping criteria|3
825091|NCT01978145|2705385|P1|Treatment Period 1|Par. reached defined stopping criteria|2
825092|NCT01978145|2705384|P2|Treatment Period 1|Withdrawal by Subject|4
825093|NCT01978145|2705385|P1|Treatment Period 1|Withdrawal by Subject|5
825094|NCT01978145|2705384|P2|Treatment Period 1|Physician Decision|0
825095|NCT01978145|2705385|P1|Treatment Period 1|Physician Decision|1
825096|NCT01978145|2705384|P2|Treatment Period 1|Adverse Event|9
825097|NCT01978145|2705385|P1|Treatment Period 1|Adverse Event|1
825098|NCT01978119|2705401|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
825099|NCT01978119|2705402|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
825100|NCT01978119|2705401|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
825101|NCT01978119|2705402|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
825102|NCT01978119|2705401|P2|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0
825103|NCT01978119|2705402|P1|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1
825104|NCT01978093|2705428|P2|Overall Study|N/A for vaccine administration|1
825105|NCT01978093|2705429|P1|Overall Study|N/A for vaccine administration|0
825106|NCT01978093|2705428|P2|Overall Study|Child was in care of grandmother|1
825107|NCT01978093|2705429|P1|Overall Study|Child was in care of grandmother|0
825108|NCT01978093|2705428|P2|Overall Study|Mother lost custody of child|1
825109|NCT01978093|2705429|P1|Overall Study|Mother lost custody of child|0
825110|NCT01978093|2705428|P2|Overall Study|Lost kaiser health plan unable to contac|0
825111|NCT01978093|2705429|P1|Overall Study|Lost kaiser health plan unable to contac|1
825112|NCT01978093|2705428|P2|Overall Study|Loss of kaiser coverage|10
825113|NCT01978093|2705429|P1|Overall Study|Loss of kaiser coverage|4
825114|NCT01978093|2705428|P2|Overall Study|Migrated/moved from study area|13
825115|NCT01978093|2705429|P1|Overall Study|Migrated/moved from study area|11
825116|NCT01978093|2705428|P2|Overall Study|Lost to Follow-up|15
825117|NCT01978093|2705429|P1|Overall Study|Lost to Follow-up|11
825118|NCT01978093|2705428|P2|Overall Study|Withdrawal by Subject|25
825119|NCT01978093|2705429|P1|Overall Study|Withdrawal by Subject|29
825120|NCT01978093|2705428|P2|Overall Study|Protocol Violation|2
825121|NCT01978093|2705429|P1|Overall Study|Protocol Violation|8
825122|NCT01978093|2705428|P2|Overall Study|Adverse Event|5
825123|NCT01978093|2705429|P1|Overall Study|Adverse Event|0
825124|NCT01978093|2705428|P2|Overall Study|Death|0
825125|NCT01978093|2705429|P1|Overall Study|Death|1
825126|NCT01977820|2705473|P2|Overall Study|Sponsor terminated the study|1
825127|NCT01977820|2705474|P1|Overall Study|Sponsor terminated the study|1
825128|NCT01977794|2705482|P2|Overall Study|Other|1
825129|NCT01977794|2705483|P1|Overall Study|Other|0
825130|NCT01977794|2705482|P2|Overall Study|Withdrew consent|1
825131|NCT01977794|2705483|P1|Overall Study|Withdrew consent|2
825132|NCT01977794|2705482|P2|Overall Study|Death|1
825133|NCT01977794|2705483|P1|Overall Study|Death|1
825134|NCT01977794|2705482|P2|Overall Study|Protocol Violation|0
825135|NCT01977794|2705483|P1|Overall Study|Protocol Violation|1
825136|NCT01977794|2705482|P2|Overall Study|Lost to Follow-up|1
825137|NCT01977794|2705483|P1|Overall Study|Lost to Follow-up|2
825138|NCT01977794|2705482|P2|Overall Study|Adverse Event|2
825139|NCT01977794|2705483|P1|Overall Study|Adverse Event|2
825140|NCT01977729|2705518|P1|Overall Study|Study terminated|1
825141|NCT01977690|2705530|P2|Overall Study|Withdrawal by Subject|4
825142|NCT01977690|2705531|P1|Overall Study|Withdrawal by Subject|0
825143|NCT01977677|2705540|P3|Overall Study|Unrelated Adverse Event|1
825144|NCT01977677|2705541|P2|Overall Study|Unrelated Adverse Event|0
825145|NCT01977677|2705542|P1|Overall Study|Unrelated Adverse Event|0
825146|NCT01977625|2705553|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
825147|NCT01977625|2705554|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
825148|NCT01977625|2705553|P2|First Intervention (4 Weeks)|Withdrawal by Subject|0
825149|NCT01977625|2705554|P1|First Intervention (4 Weeks)|Withdrawal by Subject|3
825150|NCT01977612|2705564|P2|Overall Study|Lost to Follow-up|1
825151|NCT01977612|2705565|P1|Overall Study|Lost to Follow-up|1
825152|NCT01977573|2705587|P4|Overall Study|Withdrawal by Subject|1
825153|NCT01977573|2705588|P3|Overall Study|Withdrawal by Subject|1
825154|NCT01977573|2705589|P2|Overall Study|Withdrawal by Subject|1
825155|NCT01977573|2705590|P1|Overall Study|Withdrawal by Subject|6
825156|NCT01977573|2705587|P4|Overall Study|Reached Defined Stopping Criteria|0
825157|NCT01977573|2705588|P3|Overall Study|Reached Defined Stopping Criteria|1
825158|NCT01977573|2705589|P2|Overall Study|Reached Defined Stopping Criteria|1
825159|NCT01977573|2705590|P1|Overall Study|Reached Defined Stopping Criteria|2
825160|NCT01977573|2705587|P4|Overall Study|Protocol Violation|0
825161|NCT01977573|2705588|P3|Overall Study|Protocol Violation|0
825162|NCT01977573|2705589|P2|Overall Study|Protocol Violation|1
825163|NCT01977573|2705590|P1|Overall Study|Protocol Violation|3
825164|NCT01977573|2705587|P4|Overall Study|Physician Decision|0
825165|NCT01977573|2705588|P3|Overall Study|Physician Decision|0
825166|NCT01977573|2705589|P2|Overall Study|Physician Decision|0
825167|NCT01977573|2705590|P1|Overall Study|Physician Decision|1
825168|NCT01977573|2705587|P4|Overall Study|Lost to Follow-up|1
825169|NCT01977573|2705588|P3|Overall Study|Lost to Follow-up|0
825170|NCT01977573|2705589|P2|Overall Study|Lost to Follow-up|0
825171|NCT01977573|2705590|P1|Overall Study|Lost to Follow-up|1
825172|NCT01977573|2705587|P4|Overall Study|Adverse Event|1
825173|NCT01977573|2705588|P3|Overall Study|Adverse Event|2
825174|NCT01977573|2705589|P2|Overall Study|Adverse Event|0
825175|NCT01977573|2705590|P1|Overall Study|Adverse Event|7
825176|NCT01977482|2705704|P6|Overall Study|Withdrawal by Subject|5
825177|NCT01977482|2705705|P5|Overall Study|Withdrawal by Subject|1
825178|NCT01977482|2705706|P4|Overall Study|Withdrawal by Subject|3
825179|NCT01977482|2705707|P3|Overall Study|Withdrawal by Subject|1
825180|NCT01977482|2705708|P2|Overall Study|Withdrawal by Subject|4
825181|NCT01977482|2705709|P1|Overall Study|Withdrawal by Subject|2
825182|NCT01977482|2705704|P6|Overall Study|Other-Protocol-defined Stopping Criteria|0
825183|NCT01977482|2705705|P5|Overall Study|Other-Protocol-defined Stopping Criteria|0
825184|NCT01977482|2705706|P4|Overall Study|Other-Protocol-defined Stopping Criteria|1
825185|NCT01977482|2705707|P3|Overall Study|Other-Protocol-defined Stopping Criteria|2
825186|NCT01977482|2705708|P2|Overall Study|Other-Protocol-defined Stopping Criteria|3
825187|NCT01977482|2705709|P1|Overall Study|Other-Protocol-defined Stopping Criteria|0
825188|NCT01977482|2705704|P6|Overall Study|Protocol Violation|0
825189|NCT01977482|2705705|P5|Overall Study|Protocol Violation|0
825190|NCT01977482|2705706|P4|Overall Study|Protocol Violation|0
825191|NCT01977482|2705707|P3|Overall Study|Protocol Violation|1
825192|NCT01977482|2705708|P2|Overall Study|Protocol Violation|0
825193|NCT01977482|2705709|P1|Overall Study|Protocol Violation|0
825194|NCT01977482|2705704|P6|Overall Study|Physician Decision|0
825195|NCT01977482|2705705|P5|Overall Study|Physician Decision|0
825196|NCT01977482|2705706|P4|Overall Study|Physician Decision|0
825197|NCT01977482|2705707|P3|Overall Study|Physician Decision|0
825198|NCT01977482|2705708|P2|Overall Study|Physician Decision|1
825199|NCT01977482|2705709|P1|Overall Study|Physician Decision|0
825200|NCT01977482|2705704|P6|Overall Study|Lost to Follow-up|0
825201|NCT01977482|2705705|P5|Overall Study|Lost to Follow-up|0
825202|NCT01977482|2705706|P4|Overall Study|Lost to Follow-up|0
825203|NCT01977482|2705707|P3|Overall Study|Lost to Follow-up|0
825204|NCT01977482|2705708|P2|Overall Study|Lost to Follow-up|0
825205|NCT01977482|2705709|P1|Overall Study|Lost to Follow-up|1
825206|NCT01977482|2705704|P6|Overall Study|Adverse Event|0
825207|NCT01977482|2705705|P5|Overall Study|Adverse Event|2
825208|NCT01977482|2705706|P4|Overall Study|Adverse Event|0
825209|NCT01977482|2705707|P3|Overall Study|Adverse Event|1
825210|NCT01977482|2705708|P2|Overall Study|Adverse Event|1
825211|NCT01977482|2705709|P1|Overall Study|Adverse Event|0
825212|NCT01977456|2705824|P1|Overall Study|Death|5
825213|NCT01977352|2705833|P2|Overall Study|Lost to Follow-up|2
825214|NCT01977352|2705834|P1|Overall Study|Lost to Follow-up|1
825215|NCT01977222|2705852|P1|Overall Study|Withdrawal by Subject|1
825216|NCT01977092|2705865|P2|Overall Study|In prison|11
825217|NCT01977092|2705866|P1|Overall Study|In prison|3
825218|NCT01977092|2705865|P2|Overall Study|Withdrawal by Subject|1
825219|NCT01977092|2705866|P1|Overall Study|Withdrawal by Subject|2
825220|NCT01977092|2705865|P2|Overall Study|Lost to Follow-up|14
825221|NCT01977092|2705866|P1|Overall Study|Lost to Follow-up|23
825222|NCT01977092|2705865|P2|Overall Study|Death|4
825223|NCT01977092|2705866|P1|Overall Study|Death|3
825224|NCT01976845|2705907|P3|Overall Study|Physician Decision|3
825225|NCT01976845|2705908|P2|Overall Study|Physician Decision|8
825226|NCT01976845|2705909|P1|Overall Study|Physician Decision|8
825227|NCT01976806|2705934|P2|Overall Study|Withdrawal by Subject|1
825228|NCT01976806|2705935|P1|Overall Study|Withdrawal by Subject|1
825229|NCT01976806|2705934|P2|Overall Study|Adverse Event|1
825230|NCT01976806|2705935|P1|Overall Study|Adverse Event|1
825231|NCT01976806|2705934|P2|Overall Study|Lost to Follow-up|4
825232|NCT01976806|2705935|P1|Overall Study|Lost to Follow-up|1
825233|NCT01976663|2705963|P1|Overall Study|Lost to Follow-up|3
825234|NCT01976663|2705963|P1|Overall Study|Adverse Event|2
825235|NCT01976663|2705963|P1|Overall Study|Screen Failure|3
825236|NCT01976663|2705963|P1|Overall Study|Withdrawal by Subject|4
825237|NCT01976663|2705963|P1|Overall Study|Personal Reasons|6
825238|NCT01976663|2705963|P1|Overall Study|Completed 18 mos but no repeat treatment|24
825239|NCT01976624|2705982|P1|Overall Study|Participants age less than 19 years|12
825240|NCT01976624|2705982|P1|Overall Study|Participants contraindicated|2
825241|NCT01976507|2706010|P1|Overall Study|ablation not done, drug not given|1
825242|NCT01976507|2706010|P1|Overall Study|Adverse Event|6
825243|NCT01976338|2706043|P2|Overall Study|Adverse Event|1
825244|NCT01976338|2706044|P1|Overall Study|Adverse Event|5
825245|NCT01976338|2706043|P2|Overall Study|Withdrawal by Subject|2
825246|NCT01976338|2706044|P1|Overall Study|Withdrawal by Subject|5
825247|NCT01976338|2706043|P2|Overall Study|Lost to Follow-up|0
825248|NCT01976338|2706044|P1|Overall Study|Lost to Follow-up|3
825249|NCT01976338|2706043|P2|Overall Study|Physician Decision|1
825250|NCT01976338|2706044|P1|Overall Study|Physician Decision|0
825251|NCT01976312|2706071|P2|Overall Study|Protocol Violation|0
825252|NCT01976312|2706072|P1|Overall Study|Protocol Violation|2
825253|NCT01976312|2706071|P2|Overall Study|Adverse Event|6
825254|NCT01976312|2706072|P1|Overall Study|Adverse Event|6
825255|NCT01976312|2706071|P2|Overall Study|Withdrawal by Subject|2
825256|NCT01976312|2706072|P1|Overall Study|Withdrawal by Subject|7
825257|NCT01976312|2706071|P2|Overall Study|Lost to Follow-up|0
825258|NCT01976312|2706072|P1|Overall Study|Lost to Follow-up|2
825259|NCT01976312|2706071|P2|Overall Study|Pregnancy|1
825260|NCT01976312|2706072|P1|Overall Study|Pregnancy|0
825261|NCT01976299|2706093|P2|Overall Study|See clarification above in comments|2
825262|NCT01976299|2706094|P1|Overall Study|See clarification above in comments|9
825263|NCT01976299|2706093|P2|Overall Study|Lost to Follow-up|1
825264|NCT01976299|2706094|P1|Overall Study|Lost to Follow-up|7
825265|NCT01976299|2706093|P2|Overall Study|Death|2
825266|NCT01976299|2706094|P1|Overall Study|Death|4
825267|NCT01976299|2706093|P2|Overall Study|Withdrawal by Subject|1
825268|NCT01976299|2706094|P1|Overall Study|Withdrawal by Subject|3
825269|NCT01976104|2706121|P4|Overall Study|Other|0
825270|NCT01976104|2706122|P3|Overall Study|Other|0
825271|NCT01976104|2706123|P2|Overall Study|Other|1
825272|NCT01976104|2706124|P1|Overall Study|Other|0
825273|NCT01976104|2706121|P4|Overall Study|Withdrawal by Subject|1
825274|NCT01976104|2706122|P3|Overall Study|Withdrawal by Subject|0
825275|NCT01976104|2706123|P2|Overall Study|Withdrawal by Subject|0
825276|NCT01976104|2706124|P1|Overall Study|Withdrawal by Subject|3
825277|NCT01976104|2706121|P4|Overall Study|Subject Choice|1
825278|NCT01976104|2706122|P3|Overall Study|Subject Choice|0
825279|NCT01976104|2706123|P2|Overall Study|Subject Choice|1
825280|NCT01976104|2706124|P1|Overall Study|Subject Choice|0
825281|NCT01976104|2706121|P4|Overall Study|Lost to Follow-up|1
825282|NCT01976104|2706122|P3|Overall Study|Lost to Follow-up|1
825283|NCT01976104|2706123|P2|Overall Study|Lost to Follow-up|0
825284|NCT01976104|2706124|P1|Overall Study|Lost to Follow-up|3
825285|NCT01976104|2706121|P4|Overall Study|Adverse Event|0
825286|NCT01976104|2706122|P3|Overall Study|Adverse Event|1
825287|NCT01976104|2706123|P2|Overall Study|Adverse Event|0
825288|NCT01976104|2706124|P1|Overall Study|Adverse Event|0
825289|NCT01975948|2706158|P4|Overall Study|Withdrawal by Subject|6
825290|NCT01975948|2706159|P3|Overall Study|Withdrawal by Subject|7
825291|NCT01975948|2706160|P2|Overall Study|Withdrawal by Subject|21
825292|NCT01975948|2706161|P1|Overall Study|Withdrawal by Subject|17
825293|NCT01975675|2706232|P4|Overall Study|Death|0
825294|NCT01975675|2706233|P3|Overall Study|Death|0
825295|NCT01975675|2706234|P2|Overall Study|Death|1
825296|NCT01975675|2706235|P1|Overall Study|Death|0
825297|NCT01975389|2706268|P2|Overall Study|Randomized, not treated|5
825298|NCT01975389|2706269|P1|Overall Study|Randomized, not treated|4
825299|NCT01975389|2706268|P2|Overall Study|Other|9
825300|NCT01975389|2706269|P1|Overall Study|Other|6
825301|NCT01975389|2706268|P2|Overall Study|Withdrawal by Subject|76
825302|NCT01975389|2706269|P1|Overall Study|Withdrawal by Subject|90
825303|NCT01975389|2706268|P2|Overall Study|Lost to Follow-up|86
825304|NCT01975389|2706269|P1|Overall Study|Lost to Follow-up|81
825305|NCT01975389|2706268|P2|Overall Study|Death|54
825306|NCT01975389|2706269|P1|Overall Study|Death|61
825307|NCT01975389|2706268|P2|Overall Study|Adverse Event|6
825308|NCT01975389|2706269|P1|Overall Study|Adverse Event|10
825309|NCT01975376|2706329|P2|Overall Study|Randomized, Not Treated|8
825310|NCT01975376|2706330|P1|Overall Study|Randomized, Not Treated|16
825311|NCT01975376|2706329|P2|Overall Study|Other|4
825312|NCT01975376|2706330|P1|Overall Study|Other|2
825313|NCT01975376|2706329|P2|Overall Study|Withdrew consent|62
825314|NCT01975376|2706330|P1|Overall Study|Withdrew consent|68
825315|NCT01975376|2706329|P2|Overall Study|Lost to Follow-up|66
825316|NCT01975376|2706330|P1|Overall Study|Lost to Follow-up|70
825317|NCT01975376|2706329|P2|Overall Study|Death|72
825318|NCT01975376|2706330|P1|Overall Study|Death|65
825319|NCT01975376|2706329|P2|Overall Study|Adverse Event|5
825320|NCT01975376|2706330|P1|Overall Study|Adverse Event|5
825321|NCT01975285|2706390|P2|Overall Study|Failed Block and follow up|2
825322|NCT01975285|2706391|P1|Overall Study|Failed Block and follow up|2
825323|NCT01975246|2706407|P2|Overall Study|Other than stated|1
825324|NCT01975246|2706408|P1|Overall Study|Other than stated|0
825325|NCT01975246|2706407|P2|Overall Study|Protocol Violation|0
825326|NCT01975246|2706408|P1|Overall Study|Protocol Violation|1
825327|NCT01975246|2706407|P2|Overall Study|Lack of Efficacy|0
825328|NCT01975246|2706408|P1|Overall Study|Lack of Efficacy|1
825329|NCT01975246|2706407|P2|Overall Study|Adverse Event|1
825330|NCT01975246|2706408|P1|Overall Study|Adverse Event|2
825331|NCT01975220|2706421|P6|Test Period 1|Not treated|0
825332|NCT01975220|2706422|P5|Test Period 1|Not treated|0
825333|NCT01975220|2706423|P4|Test Period 1|Not treated|0
825334|NCT01975220|2706424|P3|Test Period 1|Not treated|0
825335|NCT01975220|2706425|P2|Test Period 1|Not treated|1
825336|NCT01975220|2706426|P1|Test Period 1|Not treated|0
825337|NCT01974895|2706482|P2|Overall Study|Other (Reason unknown)|8
825338|NCT01974895|2706483|P1|Overall Study|Other (Reason unknown)|9
825339|NCT01974895|2706482|P2|Overall Study|Other (Missed Visit)|0
825340|NCT01974895|2706483|P1|Overall Study|Other (Missed Visit)|1
825341|NCT01974895|2706482|P2|Overall Study|Withdrawal by Subject|1
825342|NCT01974895|2706483|P1|Overall Study|Withdrawal by Subject|0
825343|NCT01974895|2706482|P2|Overall Study|Lost to Follow-up|6
825344|NCT01974895|2706483|P1|Overall Study|Lost to Follow-up|4
825345|NCT01974895|2706482|P2|Overall Study|Protocol Violation|0
825346|NCT01974895|2706483|P1|Overall Study|Protocol Violation|1
825347|NCT01974817|2706513|P1|Overall Study|Protocol Violation|2
825348|NCT01974817|2706513|P1|Overall Study|Lost to Follow-up|2
825349|NCT01974817|2706513|P1|Overall Study|Death|4
825350|NCT01974752|2706519|P2|Overall Study|Other Eligibility Criteria|1
825351|NCT01974752|2706520|P1|Overall Study|Other Eligibility Criteria|0
825352|NCT01974752|2706519|P2|Overall Study|Withdrawal by Subject|3
825353|NCT01974752|2706520|P1|Overall Study|Withdrawal by Subject|2
825354|NCT01974752|2706519|P2|Overall Study|Lost to Follow-up|0
825355|NCT01974752|2706520|P1|Overall Study|Lost to Follow-up|2
825356|NCT01974752|2706519|P2|Overall Study|Death|11
825357|NCT01974752|2706520|P1|Overall Study|Death|33
825358|NCT01974323|2706943|P2|Overall Study|Adverse Event|2
825359|NCT01974323|2706944|P1|Overall Study|Adverse Event|2
825360|NCT01974323|2706943|P2|Overall Study|Lack of Efficacy|1
825361|NCT01974323|2706944|P1|Overall Study|Lack of Efficacy|1
825362|NCT01974323|2706943|P2|Overall Study|Pregnancy|1
825363|NCT01974323|2706944|P1|Overall Study|Pregnancy|2
825364|NCT01974323|2706943|P2|Overall Study|Lost to Follow-up|40
825365|NCT01974323|2706944|P1|Overall Study|Lost to Follow-up|45
825366|NCT01974323|2706943|P2|Overall Study|Personal Reasons|19
825367|NCT01974323|2706944|P1|Overall Study|Personal Reasons|15
825368|NCT01974323|2706943|P2|Overall Study|Protocol Violation|2
825369|NCT01974323|2706944|P1|Overall Study|Protocol Violation|2
825370|NCT01974323|2706943|P2|Overall Study|Other Reasons|28
825371|NCT01974323|2706944|P1|Overall Study|Other Reasons|25
825372|NCT01974141|2706977|P2|Overall Study|Adverse Event|5
825373|NCT01974141|2706978|P1|Overall Study|Adverse Event|4
825374|NCT01974141|2706977|P2|Overall Study|Lack of Efficacy|1
825375|NCT01974141|2706978|P1|Overall Study|Lack of Efficacy|0
825376|NCT01974141|2706977|P2|Overall Study|Pregnancy|3
825377|NCT01974141|2706978|P1|Overall Study|Pregnancy|3
825378|NCT01974141|2706977|P2|Overall Study|Lost to Follow-up|29
825379|NCT01974141|2706978|P1|Overall Study|Lost to Follow-up|38
825380|NCT01974141|2706977|P2|Overall Study|Personal Reasons|20
825381|NCT01974141|2706978|P1|Overall Study|Personal Reasons|21
825382|NCT01974141|2706977|P2|Overall Study|Protocol Violation|6
825383|NCT01974141|2706978|P1|Overall Study|Protocol Violation|2
825384|NCT01974141|2706977|P2|Overall Study|Other Reasons|18
825385|NCT01974141|2706978|P1|Overall Study|Other Reasons|28
825386|NCT01973595|2707055|P4|Washout|Withdrawal by Subject|0
825387|NCT01973595|2707056|P3|Washout|Withdrawal by Subject|1
825388|NCT01973595|2707057|P2|Washout|Withdrawal by Subject|0
825389|NCT01973595|2707058|P1|Washout|Withdrawal by Subject|1
825390|NCT01973491|2707072|P1|Treatment Period (16 Weeks)|Adverse Event|1
825391|NCT01973491|2707072|P1|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1
825392|NCT01973491|2707072|P1|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17
825393|NCT01973439|2707088|P1|Overall Study|PK curve incomplete|2
825394|NCT01973439|2707088|P1|Overall Study|Vomiting after commencing once daily|1
825395|NCT01973439|2707088|P1|Overall Study|Lost samples from one PK Day|2
825396|NCT01973387|2707110|P2|Overall Study|Randomized, not treated|2
825397|NCT01973387|2707111|P1|Overall Study|Randomized, not treated|2
825398|NCT01973387|2707110|P2|Overall Study|Death|3
825399|NCT01973387|2707111|P1|Overall Study|Death|4
825400|NCT01973387|2707110|P2|Overall Study|Progressive disease or relapse|5
825401|NCT01973387|2707111|P1|Overall Study|Progressive disease or relapse|16
825402|NCT01973387|2707110|P2|Overall Study|Study terminated by sponsor|0
825403|NCT01973387|2707111|P1|Overall Study|Study terminated by sponsor|63
825404|NCT01973387|2707110|P2|Overall Study|Withdrawal by Subject|4
825405|NCT01973387|2707111|P1|Overall Study|Withdrawal by Subject|7
825406|NCT01973387|2707110|P2|Overall Study|Adverse Event|4
825407|NCT01973387|2707111|P1|Overall Study|Adverse Event|14
825408|NCT01973231|2707152|P2|Overall Study|Withdrawal by Subject|9
825409|NCT01973231|2707153|P1|Overall Study|Withdrawal by Subject|7
825410|NCT01973231|2707152|P2|Overall Study|unclassified|1
825411|NCT01973231|2707153|P1|Overall Study|unclassified|2
825412|NCT01973231|2707152|P2|Overall Study|Lost to Follow-up|1
825413|NCT01973231|2707153|P1|Overall Study|Lost to Follow-up|1
825414|NCT01973231|2707152|P2|Overall Study|Protocol Violation|1
825415|NCT01973231|2707153|P1|Overall Study|Protocol Violation|1
825416|NCT01973218|2707173|P2|Overall Study|Withdrawal by Subject|0
825417|NCT01973218|2707174|P1|Overall Study|Withdrawal by Subject|1
825418|NCT01973218|2707173|P2|Overall Study|Adverse Event|0
825419|NCT01973218|2707174|P1|Overall Study|Adverse Event|1
825420|NCT01972841|2707267|P6|Overall Study|Did not have end of treatment page|0
825421|NCT01972841|2707268|P5|Overall Study|Did not have end of treatment page|1
825422|NCT01972841|2707269|P4|Overall Study|Did not have end of treatment page|0
825423|NCT01972841|2707270|P3|Overall Study|Did not have end of treatment page|0
825424|NCT01972841|2707271|P2|Overall Study|Did not have end of treatment page|0
825425|NCT01972841|2707272|P1|Overall Study|Did not have end of treatment page|0
825426|NCT01972841|2707267|P6|Overall Study|Miscellaneous|4
825427|NCT01972841|2707268|P5|Overall Study|Miscellaneous|0
825428|NCT01972841|2707269|P4|Overall Study|Miscellaneous|1
825429|NCT01972841|2707270|P3|Overall Study|Miscellaneous|4
825430|NCT01972841|2707271|P2|Overall Study|Miscellaneous|0
825431|NCT01972841|2707272|P1|Overall Study|Miscellaneous|0
825432|NCT01972841|2707267|P6|Overall Study|Withdrawal by participants|34
825433|NCT01972841|2707268|P5|Overall Study|Withdrawal by participants|33
825434|NCT01972841|2707269|P4|Overall Study|Withdrawal by participants|16
825435|NCT01972841|2707270|P3|Overall Study|Withdrawal by participants|23
825436|NCT01972841|2707271|P2|Overall Study|Withdrawal by participants|27
825437|NCT01972841|2707272|P1|Overall Study|Withdrawal by participants|21
825438|NCT01972841|2707267|P6|Overall Study|Protocol Violation|4
825439|NCT01972841|2707268|P5|Overall Study|Protocol Violation|9
825440|NCT01972841|2707269|P4|Overall Study|Protocol Violation|5
825441|NCT01972841|2707270|P3|Overall Study|Protocol Violation|3
825442|NCT01972841|2707271|P2|Overall Study|Protocol Violation|2
825443|NCT01972841|2707272|P1|Overall Study|Protocol Violation|2
825444|NCT01972841|2707267|P6|Overall Study|Lost to Follow-up|3
825445|NCT01972841|2707268|P5|Overall Study|Lost to Follow-up|9
825446|NCT01972841|2707269|P4|Overall Study|Lost to Follow-up|2
825447|NCT01972841|2707270|P3|Overall Study|Lost to Follow-up|4
825448|NCT01972841|2707271|P2|Overall Study|Lost to Follow-up|2
825449|NCT01972841|2707272|P1|Overall Study|Lost to Follow-up|4
825450|NCT01972841|2707267|P6|Overall Study|Lack of Efficacy|1
825451|NCT01972841|2707268|P5|Overall Study|Lack of Efficacy|4
825452|NCT01972841|2707269|P4|Overall Study|Lack of Efficacy|2
825453|NCT01972841|2707270|P3|Overall Study|Lack of Efficacy|0
825454|NCT01972841|2707271|P2|Overall Study|Lack of Efficacy|0
825455|NCT01972841|2707272|P1|Overall Study|Lack of Efficacy|1
825456|NCT01972841|2707267|P6|Overall Study|Adverse Event|26
825457|NCT01972841|2707268|P5|Overall Study|Adverse Event|21
825458|NCT01972841|2707269|P4|Overall Study|Adverse Event|9
825459|NCT01972841|2707270|P3|Overall Study|Adverse Event|12
825460|NCT01972841|2707271|P2|Overall Study|Adverse Event|8
825461|NCT01972841|2707272|P1|Overall Study|Adverse Event|13
825462|NCT01972841|2707267|P6|Overall Study|Randomized but Never Received Treatment|13
825463|NCT01972841|2707268|P5|Overall Study|Randomized but Never Received Treatment|6
825464|NCT01972841|2707269|P4|Overall Study|Randomized but Never Received Treatment|2
825465|NCT01972841|2707270|P3|Overall Study|Randomized but Never Received Treatment|4
825466|NCT01972841|2707271|P2|Overall Study|Randomized but Never Received Treatment|5
825467|NCT01972841|2707272|P1|Overall Study|Randomized but Never Received Treatment|2
825468|NCT01972776|2707706|P6|Part 2|Administrative problems|7
825469|NCT01972776|2707707|P5|Part 2|Administrative problems|10
825470|NCT01972776|2707708|P4|Part 2|Administrative problems|0
825471|NCT01972776|2707709|P3|Part 2|Administrative problems|0
825472|NCT01972776|2707710|P2|Part 2|Administrative problems|0
825473|NCT01972776|2707711|P1|Part 2|Administrative problems|0
825474|NCT01972776|2707706|P6|Part 2|Adverse Event|0
825475|NCT01972776|2707707|P5|Part 2|Adverse Event|3
825476|NCT01972776|2707708|P4|Part 2|Adverse Event|0
825477|NCT01972776|2707709|P3|Part 2|Adverse Event|0
825478|NCT01972776|2707710|P2|Part 2|Adverse Event|0
825479|NCT01972776|2707711|P1|Part 2|Adverse Event|0
825480|NCT01972776|2707706|P6|Part 1|Adverse Event|0
825481|NCT01972776|2707707|P5|Part 1|Adverse Event|0
825482|NCT01972776|2707708|P4|Part 1|Adverse Event|1
825483|NCT01972776|2707709|P3|Part 1|Adverse Event|1
825484|NCT01972776|2707710|P2|Part 1|Adverse Event|0
825485|NCT01972776|2707711|P1|Part 1|Adverse Event|0
825486|NCT01972776|2707706|P6|Part 1|Withdrawal by Subject|0
825487|NCT01972776|2707707|P5|Part 1|Withdrawal by Subject|0
825488|NCT01972776|2707708|P4|Part 1|Withdrawal by Subject|0
825489|NCT01972776|2707709|P3|Part 1|Withdrawal by Subject|1
825490|NCT01972776|2707710|P2|Part 1|Withdrawal by Subject|0
825491|NCT01972776|2707711|P1|Part 1|Withdrawal by Subject|0
825492|NCT01972724|2707782|P3|Open-Label|Significant Protocol Deviation|2
825493|NCT01972724|2707783|P2|Open-Label|Significant Protocol Deviation|0
825494|NCT01972724|2707784|P1|Open-Label|Significant Protocol Deviation|0
825495|NCT01972724|2707782|P3|Open-Label|Withdrew Consent|3
825496|NCT01972724|2707783|P2|Open-Label|Withdrew Consent|0
825497|NCT01972724|2707784|P1|Open-Label|Withdrew Consent|0
825498|NCT01972724|2707782|P3|Double-Blind|Significant Protocol Deviation|0
825499|NCT01972724|2707783|P2|Double-Blind|Significant Protocol Deviation|8
825500|NCT01972724|2707784|P1|Double-Blind|Significant Protocol Deviation|5
825501|NCT01972724|2707782|P3|Double-Blind|Withdrawal of Consent|0
825502|NCT01972724|2707783|P2|Double-Blind|Withdrawal of Consent|1
825503|NCT01972724|2707784|P1|Double-Blind|Withdrawal of Consent|2
825504|NCT01972724|2707782|P3|Double-Blind|Adverse Event|0
825505|NCT01972724|2707783|P2|Double-Blind|Adverse Event|0
825506|NCT01972724|2707784|P1|Double-Blind|Adverse Event|1
825507|NCT01972724|2707782|P3|Double-Blind|Rescue Criteria Met|0
825508|NCT01972724|2707783|P2|Double-Blind|Rescue Criteria Met|0
825509|NCT01972724|2707784|P1|Double-Blind|Rescue Criteria Met|1
825510|NCT01972659|2707797|P2|Overall Study|problems realted to acceleromyograph|1
825511|NCT01972659|2707798|P1|Overall Study|problems realted to acceleromyograph|2
825512|NCT01972659|2707797|P2|Overall Study|Protocol Violation|2
825513|NCT01972659|2707798|P1|Overall Study|Protocol Violation|2
825514|NCT01972568|2707807|P3|Overall Study|Adverse Event|5
825515|NCT01972568|2707808|P2|Overall Study|Adverse Event|6
825516|NCT01972568|2707809|P1|Overall Study|Adverse Event|5
825517|NCT01972568|2707807|P3|Overall Study|Lost to Follow-up|0
825518|NCT01972568|2707808|P2|Overall Study|Lost to Follow-up|0
825519|NCT01972568|2707809|P1|Overall Study|Lost to Follow-up|1
825520|NCT01972568|2707807|P3|Overall Study|Withdrawal by Subject|7
825521|NCT01972568|2707808|P2|Overall Study|Withdrawal by Subject|3
825522|NCT01972568|2707809|P1|Overall Study|Withdrawal by Subject|6
825523|NCT01972568|2707807|P3|Overall Study|Protocol Violation|2
825524|NCT01972568|2707808|P2|Overall Study|Protocol Violation|2
825525|NCT01972568|2707809|P1|Overall Study|Protocol Violation|1
825526|NCT01972568|2707807|P3|Overall Study|Lack of Efficacy|2
825527|NCT01972568|2707808|P2|Overall Study|Lack of Efficacy|1
825528|NCT01972568|2707809|P1|Overall Study|Lack of Efficacy|0
825529|NCT01972568|2707807|P3|Overall Study|Other events|0
825530|NCT01972568|2707808|P2|Overall Study|Other events|0
825531|NCT01972568|2707809|P1|Overall Study|Other events|3
825532|NCT01972529|2707848|P4|Overall Study|Not treated|1
825533|NCT01972529|2707849|P3|Overall Study|Not treated|2
825534|NCT01972529|2707850|P2|Overall Study|Not treated|1
825535|NCT01972529|2707851|P1|Overall Study|Not treated|0
825536|NCT01972529|2707848|P4|Overall Study|Not Specified|2
825537|NCT01972529|2707849|P3|Overall Study|Not Specified|0
825538|NCT01972529|2707850|P2|Overall Study|Not Specified|0
825539|NCT01972529|2707851|P1|Overall Study|Not Specified|0
825540|NCT01972529|2707848|P4|Overall Study|Withdrawl of Consent|1
825541|NCT01972529|2707849|P3|Overall Study|Withdrawl of Consent|0
825542|NCT01972529|2707850|P2|Overall Study|Withdrawl of Consent|2
825543|NCT01972529|2707851|P1|Overall Study|Withdrawl of Consent|1
825544|NCT01972529|2707848|P4|Overall Study|Participant Choice|0
825545|NCT01972529|2707849|P3|Overall Study|Participant Choice|0
825546|NCT01972529|2707850|P2|Overall Study|Participant Choice|1
825547|NCT01972529|2707851|P1|Overall Study|Participant Choice|0
825548|NCT01972529|2707848|P4|Overall Study|Lost to Follow-up|0
825549|NCT01972529|2707849|P3|Overall Study|Lost to Follow-up|0
825550|NCT01972529|2707850|P2|Overall Study|Lost to Follow-up|0
825551|NCT01972529|2707851|P1|Overall Study|Lost to Follow-up|1
825552|NCT01972529|2707848|P4|Overall Study|Adverse Event|0
825553|NCT01972529|2707849|P3|Overall Study|Adverse Event|0
825554|NCT01972529|2707850|P2|Overall Study|Adverse Event|1
825555|NCT01972529|2707851|P1|Overall Study|Adverse Event|0
825556|NCT01972464|2707896|P2|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
825557|NCT01972464|2707897|P1|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
825558|NCT01972464|2707896|P2|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1
825559|NCT01972464|2707897|P1|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0
825560|NCT01972464|2707896|P2|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0
825561|NCT01972464|2707897|P1|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1
825562|NCT01972464|2707896|P2|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3
825563|NCT01972464|2707897|P1|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2
825564|NCT01972438|2707913|P2|Post Month 12 Study Period|Early Study Closure|4
825565|NCT01972438|2707914|P1|Post Month 12 Study Period|Early Study Closure|3
825566|NCT01972438|2707913|P2|Months 6-12 Study Period|Early Study Closure|2
825567|NCT01972438|2707914|P1|Months 6-12 Study Period|Early Study Closure|2
825568|NCT01972438|2707913|P2|Months 6-12 Study Period|Death|0
825569|NCT01972438|2707914|P1|Months 6-12 Study Period|Death|1
825570|NCT01972438|2707913|P2|Months 3-6 Crossover Period|Early Study Closure|1
825571|NCT01972438|2707914|P1|Months 3-6 Crossover Period|Early Study Closure|0
825572|NCT01972438|2707913|P2|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2
825573|NCT01972438|2707914|P1|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1
825574|NCT01972438|2707913|P2|Baseline-Month 3 Crossover Period|Unable to donate blood|1
825575|NCT01972438|2707914|P1|Baseline-Month 3 Crossover Period|Unable to donate blood|0
825576|NCT01972438|2707913|P2|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0
825577|NCT01972438|2707914|P1|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1
825578|NCT01972438|2707913|P2|Baseline-Month 3 Crossover Period|Death|0
825579|NCT01972438|2707914|P1|Baseline-Month 3 Crossover Period|Death|1
825580|NCT01972308|2707968|P2|Overall Study|Death|1
825581|NCT01972308|2707969|P1|Overall Study|Death|4
825582|NCT01972308|2707968|P2|Overall Study|Lost to Follow-up|6
825583|NCT01972308|2707969|P1|Overall Study|Lost to Follow-up|4
825584|NCT01972308|2707968|P2|Overall Study|Withdrawal by Subject|1
825585|NCT01972308|2707969|P1|Overall Study|Withdrawal by Subject|0
825586|NCT01972217|2707989|P4|Part B Double-blind, Randomised Period|Withdrawal by Subject|1
825587|NCT01972217|2707990|P3|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
825588|NCT01972217|2707991|P2|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
825589|NCT01972217|2707992|P1|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
825590|NCT01972217|2707989|P4|Part B Double-blind, Randomised Period|Lost to Follow-up|1
825591|NCT01972217|2707990|P3|Part B Double-blind, Randomised Period|Lost to Follow-up|2
825592|NCT01972217|2707991|P2|Part B Double-blind, Randomised Period|Lost to Follow-up|0
825593|NCT01972217|2707992|P1|Part B Double-blind, Randomised Period|Lost to Follow-up|0
825594|NCT01972217|2707989|P4|Part B Double-blind, Randomised Period|Screen failure|1
825595|NCT01972217|2707990|P3|Part B Double-blind, Randomised Period|Screen failure|0
825596|NCT01972217|2707991|P2|Part B Double-blind, Randomised Period|Screen failure|0
825597|NCT01972217|2707992|P1|Part B Double-blind, Randomised Period|Screen failure|0
825598|NCT01972217|2707989|P4|Part B Double-blind, Randomised Period|Reason not recorded|0
825599|NCT01972217|2707990|P3|Part B Double-blind, Randomised Period|Reason not recorded|1
825600|NCT01972217|2707991|P2|Part B Double-blind, Randomised Period|Reason not recorded|0
825601|NCT01972217|2707992|P1|Part B Double-blind, Randomised Period|Reason not recorded|0
825602|NCT01972217|2707989|P4|Part B Double-blind, Randomised Period|Death|44
825603|NCT01972217|2707990|P3|Part B Double-blind, Randomised Period|Death|43
825604|NCT01972217|2707991|P2|Part B Double-blind, Randomised Period|Death|0
825605|NCT01972217|2707992|P1|Part B Double-blind, Randomised Period|Death|0
825606|NCT01972217|2707989|P4|Part A: Open-label Safety Run-in Period|Death|0
825607|NCT01972217|2707990|P3|Part A: Open-label Safety Run-in Period|Death|0
825608|NCT01972217|2707991|P2|Part A: Open-label Safety Run-in Period|Death|1
825609|NCT01972217|2707992|P1|Part A: Open-label Safety Run-in Period|Death|0
825610|NCT01972217|2707989|P4|Part A: Open-label Safety Run-in Period|Adverse Event|0
825611|NCT01972217|2707990|P3|Part A: Open-label Safety Run-in Period|Adverse Event|0
825612|NCT01972217|2707991|P2|Part A: Open-label Safety Run-in Period|Adverse Event|1
825613|NCT01972217|2707992|P1|Part A: Open-label Safety Run-in Period|Adverse Event|0
825614|NCT01972217|2707989|P4|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
825615|NCT01972217|2707990|P3|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
825616|NCT01972217|2707991|P2|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9
825617|NCT01972217|2707992|P1|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1
825618|NCT01972217|2707989|P4|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
825619|NCT01972217|2707990|P3|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
825620|NCT01972217|2707991|P2|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1
825621|NCT01972217|2707992|P1|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
825622|NCT01972152|2708038|P6|Second Treatment Visit|Protocol Violation|0
825623|NCT01972152|2708039|P5|Second Treatment Visit|Protocol Violation|0
825624|NCT01972152|2708040|P4|Second Treatment Visit|Protocol Violation|0
825625|NCT01972152|2708041|P3|Second Treatment Visit|Protocol Violation|0
825626|NCT01972152|2708042|P2|Second Treatment Visit|Protocol Violation|1
825627|NCT01972152|2708043|P1|Second Treatment Visit|Protocol Violation|0
825628|NCT01972152|2708038|P6|First Treatment Visit|Lost to Follow-up|0
825629|NCT01972152|2708039|P5|First Treatment Visit|Lost to Follow-up|0
825630|NCT01972152|2708040|P4|First Treatment Visit|Lost to Follow-up|0
825631|NCT01972152|2708041|P3|First Treatment Visit|Lost to Follow-up|0
825632|NCT01972152|2708042|P2|First Treatment Visit|Lost to Follow-up|1
825633|NCT01972152|2708043|P1|First Treatment Visit|Lost to Follow-up|0
825634|NCT01971723|2708080|P2|Overall Study|Protocol Violation|2
825635|NCT01971723|2708081|P1|Overall Study|Protocol Violation|1
825636|NCT01971723|2708080|P2|Overall Study|Withdrawal by Subject|1
825637|NCT01971723|2708081|P1|Overall Study|Withdrawal by Subject|1
825638|NCT01971645|2708114|P3|Overall Study|Protocol Violation|1
825639|NCT01971645|2708115|P2|Overall Study|Protocol Violation|0
825640|NCT01971645|2708116|P1|Overall Study|Protocol Violation|0
825641|NCT01971645|2708114|P3|Overall Study|Lost to Follow-up|1
825642|NCT01971645|2708115|P2|Overall Study|Lost to Follow-up|0
825643|NCT01971645|2708116|P1|Overall Study|Lost to Follow-up|1
825644|NCT01971645|2708114|P3|Overall Study|Adverse Event|0
825645|NCT01971645|2708115|P2|Overall Study|Adverse Event|0
825646|NCT01971645|2708116|P1|Overall Study|Adverse Event|1
825647|NCT01971567|2708150|P2|Overall Study|Lost to Follow-up|0
825648|NCT01971567|2708151|P1|Overall Study|Lost to Follow-up|1
825649|NCT01971567|2708150|P2|Overall Study|Withdrawal by Subject|2
825650|NCT01971567|2708151|P1|Overall Study|Withdrawal by Subject|3
825651|NCT01971554|2708177|P4|Overall Study|Lost to Follow-up|0
825652|NCT01971554|2708178|P3|Overall Study|Lost to Follow-up|0
825653|NCT01971554|2708179|P2|Overall Study|Lost to Follow-up|0
825654|NCT01971554|2708180|P1|Overall Study|Lost to Follow-up|1
825655|NCT01971476|2708217|P3|Cohort 2: 12 to <18 Years|Adverse Event|0
825656|NCT01971476|2708218|P2|Cohort 2: 12 to <18 Years|Adverse Event|1
825657|NCT01971476|2708219|P1|Cohort 2: 12 to <18 Years|Adverse Event|0
825658|NCT01971476|2708217|P3|Cohort 2: 12 to <18 Years|Other not defined|0
825659|NCT01971476|2708218|P2|Cohort 2: 12 to <18 Years|Other not defined|3
825660|NCT01971476|2708219|P1|Cohort 2: 12 to <18 Years|Other not defined|6
825661|NCT01971476|2708217|P3|Cohort 1: 2 to <12 Years|Other not defined|6
825662|NCT01971476|2708218|P2|Cohort 1: 2 to <12 Years|Other not defined|3
825663|NCT01971476|2708219|P1|Cohort 1: 2 to <12 Years|Other not defined|3
825664|NCT01971203|2708329|P2|Overall Study|Adverse Event|0
825665|NCT01971203|2708330|P1|Overall Study|Adverse Event|1
825666|NCT01971203|2708329|P2|Overall Study|Withdrawal by Subject|6
825667|NCT01971203|2708330|P1|Overall Study|Withdrawal by Subject|5
825668|NCT01971203|2708329|P2|Overall Study|Protocol Violation|2
825669|NCT01971203|2708330|P1|Overall Study|Protocol Violation|3
825670|NCT01970995|2708357|P3|End of Study (Population at Day 90)|Withdrawal by Subject|1
825671|NCT01970995|2708358|P2|End of Study (Population at Day 90)|Withdrawal by Subject|0
825672|NCT01970995|2708359|P1|End of Study (Population at Day 90)|Withdrawal by Subject|1
825673|NCT01970995|2708357|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
825674|NCT01970995|2708358|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
825675|NCT01970995|2708359|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
825676|NCT01970982|2708382|P3|Overall Study|Withdrawal by Subject|2
825677|NCT01970982|2708383|P2|Overall Study|Withdrawal by Subject|0
825678|NCT01970982|2708384|P1|Overall Study|Withdrawal by Subject|0
825679|NCT01970878|2708406|P4|Overall Study|No Completion Status|0
825680|NCT01970878|2708407|P3|Overall Study|No Completion Status|0
825681|NCT01970878|2708408|P2|Overall Study|No Completion Status|1
825682|NCT01970878|2708409|P1|Overall Study|No Completion Status|0
825683|NCT01970878|2708406|P4|Overall Study|Physician Decision|0
825684|NCT01970878|2708407|P3|Overall Study|Physician Decision|1
825685|NCT01970878|2708408|P2|Overall Study|Physician Decision|1
825686|NCT01970878|2708409|P1|Overall Study|Physician Decision|0
825687|NCT01970878|2708406|P4|Overall Study|Protocol Specified Criteria|6
825688|NCT01970878|2708407|P3|Overall Study|Protocol Specified Criteria|3
825689|NCT01970878|2708408|P2|Overall Study|Protocol Specified Criteria|4
825690|NCT01970878|2708409|P1|Overall Study|Protocol Specified Criteria|10
825691|NCT01970878|2708406|P4|Overall Study|Adverse Event|3
825692|NCT01970878|2708407|P3|Overall Study|Adverse Event|4
825693|NCT01970878|2708408|P2|Overall Study|Adverse Event|7
825694|NCT01970878|2708409|P1|Overall Study|Adverse Event|12
825695|NCT01970878|2708406|P4|Overall Study|Lack of Efficacy|0
825696|NCT01970878|2708407|P3|Overall Study|Lack of Efficacy|2
825697|NCT01970878|2708408|P2|Overall Study|Lack of Efficacy|1
825698|NCT01970878|2708409|P1|Overall Study|Lack of Efficacy|2
825699|NCT01970878|2708406|P4|Overall Study|Administrative Reasons|4
825700|NCT01970878|2708407|P3|Overall Study|Administrative Reasons|0
825701|NCT01970878|2708408|P2|Overall Study|Administrative Reasons|0
825702|NCT01970878|2708409|P1|Overall Study|Administrative Reasons|1
825703|NCT01970878|2708406|P4|Overall Study|Lost to Follow-up|4
825704|NCT01970878|2708407|P3|Overall Study|Lost to Follow-up|2
825705|NCT01970878|2708408|P2|Overall Study|Lost to Follow-up|3
825706|NCT01970878|2708409|P1|Overall Study|Lost to Follow-up|1
825707|NCT01970878|2708406|P4|Overall Study|Withdrawal by Subject|7
825708|NCT01970878|2708407|P3|Overall Study|Withdrawal by Subject|14
825709|NCT01970878|2708408|P2|Overall Study|Withdrawal by Subject|10
825710|NCT01970878|2708409|P1|Overall Study|Withdrawal by Subject|11
825711|NCT01970865|2708452|P17|Overall Study|Study ongoing|2
825712|NCT01970865|2708453|P16|Overall Study|Study ongoing|29
825713|NCT01970865|2708454|P15|Overall Study|Study ongoing|29
825714|NCT01970865|2708455|P14|Overall Study|Study ongoing|41
825715|NCT01970865|2708456|P13|Overall Study|Study ongoing|43
825716|NCT01970865|2708457|P12|Overall Study|Study ongoing|22
825717|NCT01970865|2708458|P11|Overall Study|Study ongoing|29
825718|NCT01970865|2708459|P10|Overall Study|Study ongoing|3
825719|NCT01970865|2708460|P9|Overall Study|Study ongoing|1
825720|NCT01970865|2708461|P8|Overall Study|Study ongoing|0
825721|NCT01970865|2708462|P7|Overall Study|Study ongoing|2
825722|NCT01970865|2708463|P6|Overall Study|Study ongoing|0
825723|NCT01970865|2708464|P5|Overall Study|Study ongoing|8
825724|NCT01970865|2708465|P4|Overall Study|Study ongoing|6
825725|NCT01970865|2708466|P3|Overall Study|Study ongoing|0
825726|NCT01970865|2708467|P2|Overall Study|Study ongoing|2
825727|NCT01970865|2708468|P1|Overall Study|Study ongoing|0
825728|NCT01970865|2708452|P17|Overall Study|Other|0
825729|NCT01970865|2708453|P16|Overall Study|Other|1
825730|NCT01970865|2708454|P15|Overall Study|Other|0
825731|NCT01970865|2708455|P14|Overall Study|Other|1
825732|NCT01970865|2708456|P13|Overall Study|Other|0
825733|NCT01970865|2708457|P12|Overall Study|Other|0
825734|NCT01970865|2708458|P11|Overall Study|Other|0
825735|NCT01970865|2708459|P10|Overall Study|Other|0
825736|NCT01970865|2708460|P9|Overall Study|Other|0
825737|NCT01970865|2708461|P8|Overall Study|Other|0
825738|NCT01970865|2708462|P7|Overall Study|Other|0
825739|NCT01970865|2708463|P6|Overall Study|Other|0
825740|NCT01970865|2708464|P5|Overall Study|Other|0
825741|NCT01970865|2708465|P4|Overall Study|Other|1
825742|NCT01970865|2708466|P3|Overall Study|Other|0
825743|NCT01970865|2708467|P2|Overall Study|Other|0
825744|NCT01970865|2708468|P1|Overall Study|Other|0
825745|NCT01970865|2708452|P17|Overall Study|Withdrawal by Subject|0
825746|NCT01970865|2708453|P16|Overall Study|Withdrawal by Subject|7
825747|NCT01970865|2708454|P15|Overall Study|Withdrawal by Subject|2
825748|NCT01970865|2708455|P14|Overall Study|Withdrawal by Subject|5
825749|NCT01970865|2708456|P13|Overall Study|Withdrawal by Subject|2
825750|NCT01970865|2708457|P12|Overall Study|Withdrawal by Subject|1
825751|NCT01970865|2708458|P11|Overall Study|Withdrawal by Subject|0
825752|NCT01970865|2708459|P10|Overall Study|Withdrawal by Subject|0
825753|NCT01970865|2708460|P9|Overall Study|Withdrawal by Subject|0
825754|NCT01970865|2708461|P8|Overall Study|Withdrawal by Subject|0
825755|NCT01970865|2708462|P7|Overall Study|Withdrawal by Subject|0
825756|NCT01970865|2708463|P6|Overall Study|Withdrawal by Subject|0
825757|NCT01970865|2708464|P5|Overall Study|Withdrawal by Subject|2
825758|NCT01970865|2708465|P4|Overall Study|Withdrawal by Subject|1
825759|NCT01970865|2708466|P3|Overall Study|Withdrawal by Subject|0
825760|NCT01970865|2708467|P2|Overall Study|Withdrawal by Subject|0
825761|NCT01970865|2708468|P1|Overall Study|Withdrawal by Subject|0
825762|NCT01970865|2708452|P17|Overall Study|Lost to Follow-up|0
825763|NCT01970865|2708453|P16|Overall Study|Lost to Follow-up|0
825764|NCT01970865|2708454|P15|Overall Study|Lost to Follow-up|0
825765|NCT01970865|2708455|P14|Overall Study|Lost to Follow-up|0
825766|NCT01970865|2708456|P13|Overall Study|Lost to Follow-up|1
825767|NCT01970865|2708457|P12|Overall Study|Lost to Follow-up|0
825768|NCT01970865|2708458|P11|Overall Study|Lost to Follow-up|0
825769|NCT01970865|2708459|P10|Overall Study|Lost to Follow-up|0
825770|NCT01970865|2708460|P9|Overall Study|Lost to Follow-up|0
825771|NCT01970865|2708461|P8|Overall Study|Lost to Follow-up|0
825772|NCT01970865|2708462|P7|Overall Study|Lost to Follow-up|0
825773|NCT01970865|2708463|P6|Overall Study|Lost to Follow-up|0
825774|NCT01970865|2708464|P5|Overall Study|Lost to Follow-up|1
825775|NCT01970865|2708465|P4|Overall Study|Lost to Follow-up|1
825776|NCT01970865|2708466|P3|Overall Study|Lost to Follow-up|0
825777|NCT01970865|2708467|P2|Overall Study|Lost to Follow-up|0
825778|NCT01970865|2708468|P1|Overall Study|Lost to Follow-up|0
825779|NCT01970865|2708452|P17|Overall Study|Death|1
825780|NCT01970865|2708453|P16|Overall Study|Death|10
825781|NCT01970865|2708454|P15|Overall Study|Death|15
825782|NCT01970865|2708455|P14|Overall Study|Death|19
825783|NCT01970865|2708456|P13|Overall Study|Death|14
825784|NCT01970865|2708457|P12|Overall Study|Death|4
825785|NCT01970865|2708458|P11|Overall Study|Death|1
825786|NCT01970865|2708459|P10|Overall Study|Death|1
825787|NCT01970865|2708460|P9|Overall Study|Death|2
825788|NCT01970865|2708461|P8|Overall Study|Death|3
825789|NCT01970865|2708462|P7|Overall Study|Death|1
825790|NCT01970865|2708463|P6|Overall Study|Death|3
825791|NCT01970865|2708464|P5|Overall Study|Death|6
825792|NCT01970865|2708465|P4|Overall Study|Death|4
825793|NCT01970865|2708466|P3|Overall Study|Death|3
825794|NCT01970865|2708467|P2|Overall Study|Death|1
825795|NCT01970865|2708468|P1|Overall Study|Death|3
825796|NCT01970488|2708902|P5|Part 2: Post Week 16|Lost to Follow-up|2
825797|NCT01970488|2708903|P4|Part 2: Post Week 16|Lost to Follow-up|1
825798|NCT01970488|2708904|P3|Part 2: Post Week 16|Lost to Follow-up|1
825799|NCT01970488|2708905|P2|Part 2: Post Week 16|Lost to Follow-up|0
825800|NCT01970488|2708906|P1|Part 2: Post Week 16|Lost to Follow-up|0
825801|NCT01970488|2708902|P5|Part 2: Post Week 16|Withdrawal by Subject|3
825802|NCT01970488|2708903|P4|Part 2: Post Week 16|Withdrawal by Subject|3
825803|NCT01970488|2708904|P3|Part 2: Post Week 16|Withdrawal by Subject|8
825804|NCT01970488|2708905|P2|Part 2: Post Week 16|Withdrawal by Subject|0
825805|NCT01970488|2708906|P1|Part 2: Post Week 16|Withdrawal by Subject|0
825806|NCT01970488|2708902|P5|Part 2: Post Week 16|Adverse Event|1
825807|NCT01970488|2708903|P4|Part 2: Post Week 16|Adverse Event|1
825808|NCT01970488|2708904|P3|Part 2: Post Week 16|Adverse Event|5
825809|NCT01970488|2708905|P2|Part 2: Post Week 16|Adverse Event|0
825810|NCT01970488|2708906|P1|Part 2: Post Week 16|Adverse Event|0
825811|NCT01970488|2708902|P5|Part 2: Post Week 16|Lack of Efficacy|1
825812|NCT01970488|2708903|P4|Part 2: Post Week 16|Lack of Efficacy|3
825813|NCT01970488|2708904|P3|Part 2: Post Week 16|Lack of Efficacy|2
825814|NCT01970488|2708905|P2|Part 2: Post Week 16|Lack of Efficacy|0
825815|NCT01970488|2708906|P1|Part 2: Post Week 16|Lack of Efficacy|0
825816|NCT01970488|2708902|P5|Part 2: Post Week 16|Non-compliance|0
825817|NCT01970488|2708903|P4|Part 2: Post Week 16|Non-compliance|0
825818|NCT01970488|2708904|P3|Part 2: Post Week 16|Non-compliance|1
825819|NCT01970488|2708905|P2|Part 2: Post Week 16|Non-compliance|0
825820|NCT01970488|2708906|P1|Part 2: Post Week 16|Non-compliance|0
825821|NCT01970488|2708902|P5|Part 2: Post Week 16|Physician Decision|1
825822|NCT01970488|2708903|P4|Part 2: Post Week 16|Physician Decision|0
825823|NCT01970488|2708904|P3|Part 2: Post Week 16|Physician Decision|0
825824|NCT01970488|2708905|P2|Part 2: Post Week 16|Physician Decision|0
825825|NCT01970488|2708906|P1|Part 2: Post Week 16|Physician Decision|0
825826|NCT01970488|2708902|P5|Part 1: Through Week 16|Lost to Follow-up|0
825827|NCT01970488|2708903|P4|Part 1: Through Week 16|Lost to Follow-up|0
825828|NCT01970488|2708904|P3|Part 1: Through Week 16|Lost to Follow-up|0
825829|NCT01970488|2708905|P2|Part 1: Through Week 16|Lost to Follow-up|2
825830|NCT01970488|2708906|P1|Part 1: Through Week 16|Lost to Follow-up|0
825831|NCT01970488|2708902|P5|Part 1: Through Week 16|Withdrawal by Subject|0
825832|NCT01970488|2708903|P4|Part 1: Through Week 16|Withdrawal by Subject|0
825833|NCT01970488|2708904|P3|Part 1: Through Week 16|Withdrawal by Subject|0
825834|NCT01970488|2708905|P2|Part 1: Through Week 16|Withdrawal by Subject|2
825835|NCT01970488|2708906|P1|Part 1: Through Week 16|Withdrawal by Subject|3
825836|NCT01970488|2708902|P5|Part 1: Through Week 16|Adverse Event|0
825837|NCT01970488|2708903|P4|Part 1: Through Week 16|Adverse Event|0
825838|NCT01970488|2708904|P3|Part 1: Through Week 16|Adverse Event|0
825839|NCT01970488|2708905|P2|Part 1: Through Week 16|Adverse Event|5
825840|NCT01970488|2708906|P1|Part 1: Through Week 16|Adverse Event|6
825841|NCT01970488|2708902|P5|Part 1: Through Week 16|Protocol Violation|0
825842|NCT01970488|2708903|P4|Part 1: Through Week 16|Protocol Violation|0
825843|NCT01970488|2708904|P3|Part 1: Through Week 16|Protocol Violation|0
825844|NCT01970488|2708905|P2|Part 1: Through Week 16|Protocol Violation|2
825845|NCT01970488|2708906|P1|Part 1: Through Week 16|Protocol Violation|1
825846|NCT01970488|2708902|P5|Part 1: Through Week 16|Protocol-specified Criteria|0
825847|NCT01970488|2708903|P4|Part 1: Through Week 16|Protocol-specified Criteria|0
825848|NCT01970488|2708904|P3|Part 1: Through Week 16|Protocol-specified Criteria|0
825849|NCT01970488|2708905|P2|Part 1: Through Week 16|Protocol-specified Criteria|2
825850|NCT01970488|2708906|P1|Part 1: Through Week 16|Protocol-specified Criteria|1
825851|NCT01970475|2708973|P2|Overall Study|Protocol Violation|0
825852|NCT01970475|2708974|P1|Overall Study|Protocol Violation|1
825853|NCT01970475|2708973|P2|Overall Study|Lost to Follow-up|2
825854|NCT01970475|2708974|P1|Overall Study|Lost to Follow-up|2
825855|NCT01970475|2708973|P2|Overall Study|Adverse Event|3
825856|NCT01970475|2708974|P1|Overall Study|Adverse Event|7
825857|NCT01970475|2708973|P2|Overall Study|Withdrawal by Subject|6
825858|NCT01970475|2708974|P1|Overall Study|Withdrawal by Subject|11
825859|NCT01970462|2708994|P2|Overall Study|Lost to Follow-up|2
825860|NCT01970462|2708995|P1|Overall Study|Lost to Follow-up|0
825861|NCT01970397|2709009|P2|Overall Study|Protocol Violation|1
825862|NCT01970397|2709010|P1|Overall Study|Protocol Violation|1
825863|NCT01970397|2709009|P2|Overall Study|Personal Reasons|2
825864|NCT01970397|2709010|P1|Overall Study|Personal Reasons|1
825865|NCT01970397|2709009|P2|Overall Study|Lost to Follow-up|1
825866|NCT01970397|2709010|P1|Overall Study|Lost to Follow-up|0
825867|NCT01970397|2709009|P2|Overall Study|Adverse Event|1
825868|NCT01970397|2709010|P1|Overall Study|Adverse Event|0
825869|NCT01970371|2709023|P3|Overall Study|Lost to Follow-up|1
825870|NCT01970371|2709024|P2|Overall Study|Lost to Follow-up|0
825871|NCT01970371|2709025|P1|Overall Study|Lost to Follow-up|0
825872|NCT01970371|2709023|P3|Overall Study|Death|12
825873|NCT01970371|2709024|P2|Overall Study|Death|13
825874|NCT01970371|2709025|P1|Overall Study|Death|8
825875|NCT01969799|2709050|P2|Overall Study|Physician Decision|0
825876|NCT01969799|2709051|P1|Overall Study|Physician Decision|1
825877|NCT01969799|2709050|P2|Overall Study|Lost to Follow-up|2
825878|NCT01969799|2709051|P1|Overall Study|Lost to Follow-up|0
825879|NCT01969799|2709050|P2|Overall Study|Death|11
825880|NCT01969799|2709051|P1|Overall Study|Death|16
825881|NCT01969799|2709050|P2|Overall Study|Adverse Event|1
825882|NCT01969799|2709051|P1|Overall Study|Adverse Event|0
825883|NCT01969721|2709088|P4|Overall Study|Discontinued during washout periods.|2
825884|NCT01969721|2709089|P3|Overall Study|Discontinued during washout periods.|1
825885|NCT01969721|2709090|P2|Overall Study|Discontinued during washout periods.|1
825886|NCT01969721|2709091|P1|Overall Study|Discontinued during washout periods.|0
825887|NCT01969721|2709088|P4|Overall Study|Other not defined above|0
825888|NCT01969721|2709089|P3|Overall Study|Other not defined above|0
825889|NCT01969721|2709090|P2|Overall Study|Other not defined above|2
825890|NCT01969721|2709091|P1|Overall Study|Other not defined above|0
825891|NCT01969721|2709088|P4|Overall Study|Non compliant with protocol|2
825892|NCT01969721|2709089|P3|Overall Study|Non compliant with protocol|0
825893|NCT01969721|2709090|P2|Overall Study|Non compliant with protocol|1
825894|NCT01969721|2709091|P1|Overall Study|Non compliant with protocol|1
825895|NCT01969721|2709088|P4|Overall Study|Lack of Efficacy|0
825896|NCT01969721|2709089|P3|Overall Study|Lack of Efficacy|1
825897|NCT01969721|2709090|P2|Overall Study|Lack of Efficacy|0
825898|NCT01969721|2709091|P1|Overall Study|Lack of Efficacy|0
825899|NCT01969721|2709088|P4|Overall Study|Adverse Event|2
825900|NCT01969721|2709089|P3|Overall Study|Adverse Event|3
825901|NCT01969721|2709090|P2|Overall Study|Adverse Event|8
825902|NCT01969721|2709091|P1|Overall Study|Adverse Event|3
825903|NCT01969565|2709136|P1|Overall Study|Withdrawal by Subject|1
825904|NCT01969084|2709217|P2|Overall Study|Adverse Event|1
825905|NCT01969084|2709218|P1|Overall Study|Adverse Event|0
825906|NCT01969058|2709234|P2|Overall Study|Adverse Event|0
825907|NCT01969058|2709235|P1|Overall Study|Adverse Event|1
825908|NCT01969058|2709234|P2|Overall Study|Withdrawal by Subject|0
825909|NCT01969058|2709235|P1|Overall Study|Withdrawal by Subject|2
825910|NCT01968980|2709271|P2|Overall Study|Other unspecified|2
825911|NCT01968980|2709272|P1|Overall Study|Other unspecified|1
825912|NCT01968980|2709271|P2|Overall Study|Withdrawal by Subject|5
825913|NCT01968980|2709272|P1|Overall Study|Withdrawal by Subject|13
825914|NCT01968980|2709271|P2|Overall Study|Does not meet entry criteria|3
825915|NCT01968980|2709272|P1|Overall Study|Does not meet entry criteria|1
825916|NCT01968980|2709271|P2|Overall Study|Adverse Event|3
825917|NCT01968980|2709272|P1|Overall Study|Adverse Event|1
825918|NCT01968980|2709271|P2|Overall Study|Death|1
825919|NCT01968980|2709272|P1|Overall Study|Death|0
825920|NCT01968967|2709334|P5|Extension Period|Withdrew Consent|5
825921|NCT01968967|2709335|P4|Extension Period|Withdrew Consent|0
825922|NCT01968967|2709336|P3|Extension Period|Withdrew Consent|2
825923|NCT01968967|2709337|P2|Extension Period|Withdrew Consent|0
825924|NCT01968967|2709338|P1|Extension Period|Withdrew Consent|0
825925|NCT01968967|2709334|P5|Treatment Period|Randomized Not Treated|0
825926|NCT01968967|2709335|P4|Treatment Period|Randomized Not Treated|0
825927|NCT01968967|2709336|P3|Treatment Period|Randomized Not Treated|0
825928|NCT01968967|2709337|P2|Treatment Period|Randomized Not Treated|5
825929|NCT01968967|2709338|P1|Treatment Period|Randomized Not Treated|6
825930|NCT01968967|2709334|P5|Treatment Period|Death|0
825931|NCT01968967|2709335|P4|Treatment Period|Death|0
825932|NCT01968967|2709336|P3|Treatment Period|Death|0
825933|NCT01968967|2709337|P2|Treatment Period|Death|2
825934|NCT01968967|2709338|P1|Treatment Period|Death|9
825935|NCT01968967|2709334|P5|Treatment Period|Adverse Event|0
825936|NCT01968967|2709335|P4|Treatment Period|Adverse Event|0
825937|NCT01968967|2709336|P3|Treatment Period|Adverse Event|0
825938|NCT01968967|2709337|P2|Treatment Period|Adverse Event|8
825939|NCT01968967|2709338|P1|Treatment Period|Adverse Event|9
825940|NCT01968967|2709334|P5|Treatment Period|Protocol Violation|0
825941|NCT01968967|2709335|P4|Treatment Period|Protocol Violation|0
825942|NCT01968967|2709336|P3|Treatment Period|Protocol Violation|0
825943|NCT01968967|2709337|P2|Treatment Period|Protocol Violation|2
825944|NCT01968967|2709338|P1|Treatment Period|Protocol Violation|1
825945|NCT01968967|2709334|P5|Treatment Period|Lost to Follow-up|0
825946|NCT01968967|2709335|P4|Treatment Period|Lost to Follow-up|0
825947|NCT01968967|2709336|P3|Treatment Period|Lost to Follow-up|0
825948|NCT01968967|2709337|P2|Treatment Period|Lost to Follow-up|31
825949|NCT01968967|2709338|P1|Treatment Period|Lost to Follow-up|26
825950|NCT01968967|2709334|P5|Treatment Period|Did Not Meet Entrance Criteria|0
825951|NCT01968967|2709335|P4|Treatment Period|Did Not Meet Entrance Criteria|0
825952|NCT01968967|2709336|P3|Treatment Period|Did Not Meet Entrance Criteria|0
825953|NCT01968967|2709337|P2|Treatment Period|Did Not Meet Entrance Criteria|3
825954|NCT01968967|2709338|P1|Treatment Period|Did Not Meet Entrance Criteria|2
825955|NCT01968967|2709334|P5|Treatment Period|Withdrawal by Subject|0
825956|NCT01968967|2709335|P4|Treatment Period|Withdrawal by Subject|0
825957|NCT01968967|2709336|P3|Treatment Period|Withdrawal by Subject|0
825958|NCT01968967|2709337|P2|Treatment Period|Withdrawal by Subject|61
825959|NCT01968967|2709338|P1|Treatment Period|Withdrawal by Subject|71
825960|NCT01968967|2709334|P5|Treatment Period|Other|0
825961|NCT01968967|2709335|P4|Treatment Period|Other|0
825962|NCT01968967|2709336|P3|Treatment Period|Other|0
825963|NCT01968967|2709337|P2|Treatment Period|Other|22
825964|NCT01968967|2709338|P1|Treatment Period|Other|22
825965|NCT01968954|2709407|P2|Overall Study|Did not met inclusion criteria|2
825966|NCT01968954|2709408|P1|Overall Study|Did not met inclusion criteria|0
825967|NCT01968954|2709407|P2|Overall Study|Protocol Violation|1
825968|NCT01968954|2709408|P1|Overall Study|Protocol Violation|0
825969|NCT01968954|2709407|P2|Overall Study|Other|8
825970|NCT01968954|2709408|P1|Overall Study|Other|7
825971|NCT01968954|2709407|P2|Overall Study|Withdrawal by Subject|23
825972|NCT01968954|2709408|P1|Overall Study|Withdrawal by Subject|20
825973|NCT01968954|2709407|P2|Overall Study|Lost to Follow-up|4
825974|NCT01968954|2709408|P1|Overall Study|Lost to Follow-up|6
825975|NCT01968954|2709407|P2|Overall Study|Death|2
825976|NCT01968954|2709408|P1|Overall Study|Death|1
825977|NCT01968954|2709407|P2|Overall Study|Adverse Event|3
825978|NCT01968954|2709408|P1|Overall Study|Adverse Event|6
825979|NCT01968811|2709472|P1|Overall Study|post op.ref. of subject to other hospita|1
825980|NCT01968811|2709472|P1|Overall Study|Protocol Violation|4
825981|NCT01968694|2709479|P2|Washout (1 Month)|Lost to Follow-up|1
825982|NCT01968694|2709480|P1|Washout (1 Month)|Lost to Follow-up|0
825983|NCT01968551|2709497|P3|Extension Phase|Lost to Follow-up|1
825984|NCT01968551|2709498|P2|Extension Phase|Lost to Follow-up|0
825985|NCT01968551|2709499|P1|Extension Phase|Lost to Follow-up|1
825986|NCT01968551|2709497|P3|Extension Phase|Withdrew Consent|1
825987|NCT01968551|2709498|P2|Extension Phase|Withdrew Consent|0
825988|NCT01968551|2709499|P1|Extension Phase|Withdrew Consent|0
825989|NCT01968551|2709497|P3|Extension Phase|Death|0
825990|NCT01968551|2709498|P2|Extension Phase|Death|1
825991|NCT01968551|2709499|P1|Extension Phase|Death|0
825992|NCT01968551|2709497|P3|Extension Phase|Adverse Event|2
825993|NCT01968551|2709498|P2|Extension Phase|Adverse Event|0
825994|NCT01968551|2709499|P1|Extension Phase|Adverse Event|0
825995|NCT01968551|2709497|P3|Open Label Phase (48 Weeks)|Lost to Follow-up|2
825996|NCT01968551|2709498|P2|Open Label Phase (48 Weeks)|Lost to Follow-up|0
825997|NCT01968551|2709499|P1|Open Label Phase (48 Weeks)|Lost to Follow-up|0
825998|NCT01968551|2709497|P3|Open Label Phase (48 Weeks)|Withdrew Consent|3
825999|NCT01968551|2709498|P2|Open Label Phase (48 Weeks)|Withdrew Consent|1
826000|NCT01968551|2709499|P1|Open Label Phase (48 Weeks)|Withdrew Consent|1
826084|NCT01967173|2709766|P2|Overall Study|Withdrawal by Subject|14
826001|NCT01968551|2709497|P3|Open Label Phase (48 Weeks)|Investigator’s Discretion|0
826002|NCT01968551|2709498|P2|Open Label Phase (48 Weeks)|Investigator’s Discretion|1
826003|NCT01968551|2709499|P1|Open Label Phase (48 Weeks)|Investigator’s Discretion|0
826004|NCT01968551|2709497|P3|Open Label Phase (48 Weeks)|Randomized but Never Treated|0
826005|NCT01968551|2709498|P2|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
826006|NCT01968551|2709499|P1|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
826007|NCT01968434|2709515|P2|Overall Study|Lost to Follow-up|6
826008|NCT01968434|2709516|P1|Overall Study|Lost to Follow-up|3
826009|NCT01968226|2709526|P1|Overall Study|[F-18] RDG-K5 was not available|2
826010|NCT01968213|2709532|P2|Overall Study|Ongoing|9
826011|NCT01968213|2709533|P1|Overall Study|Ongoing|90
826012|NCT01967940|2709570|P4|Part 2|Unknown Reason|1
826013|NCT01967940|2709571|P3|Part 2|Unknown Reason|0
826014|NCT01967940|2709572|P2|Part 2|Unknown Reason|0
826015|NCT01967940|2709573|P1|Part 2|Unknown Reason|0
826016|NCT01967940|2709570|P4|Part 2|Adverse Event|1
826017|NCT01967940|2709571|P3|Part 2|Adverse Event|0
826018|NCT01967940|2709572|P2|Part 2|Adverse Event|0
826019|NCT01967940|2709573|P1|Part 2|Adverse Event|0
826020|NCT01967940|2709570|P4|Part 2|Enrolled in Part 2 and Never Treated|1
826021|NCT01967940|2709571|P3|Part 2|Enrolled in Part 2 and Never Treated|0
826022|NCT01967940|2709572|P2|Part 2|Enrolled in Part 2 and Never Treated|0
826023|NCT01967940|2709573|P1|Part 2|Enrolled in Part 2 and Never Treated|0
826024|NCT01967732|2709615|P4|First Intervention (Day 1)|Poor venous access|0
826025|NCT01967732|2709616|P3|First Intervention (Day 1)|Poor venous access|0
826026|NCT01967732|2709617|P2|First Intervention (Day 1)|Poor venous access|1
826027|NCT01967732|2709618|P1|First Intervention (Day 1)|Poor venous access|0
826028|NCT01967732|2709615|P4|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
826029|NCT01967732|2709616|P3|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
826030|NCT01967732|2709617|P2|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1
826031|NCT01967732|2709618|P1|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
826032|NCT01967719|2709632|P4|Second Intervention (Day 3)|Withdrawal by Subject|0
826033|NCT01967719|2709633|P3|Second Intervention (Day 3)|Withdrawal by Subject|0
826034|NCT01967719|2709634|P2|Second Intervention (Day 3)|Withdrawal by Subject|1
826035|NCT01967719|2709635|P1|Second Intervention (Day 3)|Withdrawal by Subject|0
826036|NCT01967719|2709632|P4|First Intervention (Day 1)|Withdrawal by Subject|1
826037|NCT01967719|2709633|P3|First Intervention (Day 1)|Withdrawal by Subject|0
826038|NCT01967719|2709634|P2|First Intervention (Day 1)|Withdrawal by Subject|1
826039|NCT01967719|2709635|P1|First Intervention (Day 1)|Withdrawal by Subject|0
826040|NCT01967706|2709650|P4|First Intervention (Day 1)|Withdrawal by Subject|0
826041|NCT01967706|2709651|P3|First Intervention (Day 1)|Withdrawal by Subject|0
826042|NCT01967706|2709652|P2|First Intervention (Day 1)|Withdrawal by Subject|0
826043|NCT01967706|2709653|P1|First Intervention (Day 1)|Withdrawal by Subject|1
826044|NCT01967628|2709674|P2|Overall Study|Low protein concentration in sample|25
826045|NCT01967628|2709675|P1|Overall Study|Low protein concentration in sample|20
826046|NCT01967628|2709674|P2|Overall Study|Lost to Follow-up|0
826047|NCT01967628|2709675|P1|Overall Study|Lost to Follow-up|1
826048|NCT01967628|2709674|P2|Overall Study|Unable to complete bronchoscopy|6
826049|NCT01967628|2709675|P1|Overall Study|Unable to complete bronchoscopy|4
826050|NCT01967628|2709674|P2|Overall Study|Withdrawal by Subject|0
826051|NCT01967628|2709675|P1|Overall Study|Withdrawal by Subject|2
826052|NCT01967550|2709683|P2|Overall Study|Non Compliance|1
826053|NCT01967550|2709684|P1|Overall Study|Non Compliance|0
826054|NCT01967550|2709683|P2|Overall Study|Protocol Violation|1
826055|NCT01967550|2709684|P1|Overall Study|Protocol Violation|2
826056|NCT01967550|2709683|P2|Overall Study|Adverse Event|0
826057|NCT01967550|2709684|P1|Overall Study|Adverse Event|2
826058|NCT01967550|2709683|P2|Overall Study|Withdrawal by Subject|0
826059|NCT01967550|2709684|P1|Overall Study|Withdrawal by Subject|1
826060|NCT01967277|2709714|P2|Overall Study|Unrelated illness|1
826061|NCT01967277|2709715|P1|Overall Study|Unrelated illness|0
826062|NCT01967277|2709714|P2|Overall Study|Lost to Follow-up|2
826063|NCT01967277|2709715|P1|Overall Study|Lost to Follow-up|1
826064|NCT01967225|2709727|P2|Overall Study|Protocol Violation|0
826065|NCT01967225|2709728|P1|Overall Study|Protocol Violation|2
826066|NCT01967225|2709727|P2|Overall Study|Logistical difficulties|0
826067|NCT01967225|2709728|P1|Overall Study|Logistical difficulties|1
826068|NCT01967225|2709727|P2|Overall Study|Protocol driven decision point|0
826069|NCT01967225|2709728|P1|Overall Study|Protocol driven decision point|1
826070|NCT01967225|2709727|P2|Overall Study|Switching to other therapy|0
826071|NCT01967225|2709728|P1|Overall Study|Switching to other therapy|2
826072|NCT01967225|2709727|P2|Overall Study|Lack of Efficacy|1
826073|NCT01967225|2709728|P1|Overall Study|Lack of Efficacy|1
826074|NCT01967225|2709727|P2|Overall Study|Withdrawal by Subject|1
826075|NCT01967225|2709728|P1|Overall Study|Withdrawal by Subject|2
826076|NCT01967225|2709727|P2|Overall Study|Adverse Event|1
826077|NCT01967225|2709728|P1|Overall Study|Adverse Event|3
826078|NCT01967173|2709760|P8|Overall Study|Withdrawal by Subject|12
826079|NCT01967173|2709761|P7|Overall Study|Withdrawal by Subject|10
826080|NCT01967173|2709762|P6|Overall Study|Withdrawal by Subject|9
826081|NCT01967173|2709763|P5|Overall Study|Withdrawal by Subject|8
826082|NCT01967173|2709764|P4|Overall Study|Withdrawal by Subject|7
826083|NCT01967173|2709765|P3|Overall Study|Withdrawal by Subject|10
826085|NCT01967173|2709767|P1|Overall Study|Withdrawal by Subject|15
826086|NCT01967173|2709760|P8|Overall Study|Adverse Event|1
826087|NCT01967173|2709761|P7|Overall Study|Adverse Event|0
826088|NCT01967173|2709762|P6|Overall Study|Adverse Event|0
826089|NCT01967173|2709763|P5|Overall Study|Adverse Event|0
826090|NCT01967173|2709764|P4|Overall Study|Adverse Event|0
826091|NCT01967173|2709765|P3|Overall Study|Adverse Event|0
826092|NCT01967173|2709766|P2|Overall Study|Adverse Event|0
826093|NCT01967173|2709767|P1|Overall Study|Adverse Event|0
826094|NCT01967173|2709760|P8|Overall Study|Pregnancy|1
826095|NCT01967173|2709761|P7|Overall Study|Pregnancy|1
826096|NCT01967173|2709762|P6|Overall Study|Pregnancy|0
826097|NCT01967173|2709763|P5|Overall Study|Pregnancy|0
826098|NCT01967173|2709764|P4|Overall Study|Pregnancy|0
826099|NCT01967173|2709765|P3|Overall Study|Pregnancy|0
826100|NCT01967173|2709766|P2|Overall Study|Pregnancy|0
826101|NCT01967173|2709767|P1|Overall Study|Pregnancy|0
826102|NCT01967173|2709760|P8|Overall Study|Lack of Efficacy|2
826103|NCT01967173|2709761|P7|Overall Study|Lack of Efficacy|0
826104|NCT01967173|2709762|P6|Overall Study|Lack of Efficacy|1
826105|NCT01967173|2709763|P5|Overall Study|Lack of Efficacy|0
826106|NCT01967173|2709764|P4|Overall Study|Lack of Efficacy|2
826107|NCT01967173|2709765|P3|Overall Study|Lack of Efficacy|2
826108|NCT01967173|2709766|P2|Overall Study|Lack of Efficacy|0
826109|NCT01967173|2709767|P1|Overall Study|Lack of Efficacy|2
826110|NCT01967173|2709760|P8|Overall Study|Physician Decision|0
826111|NCT01967173|2709761|P7|Overall Study|Physician Decision|1
826112|NCT01967173|2709762|P6|Overall Study|Physician Decision|1
826113|NCT01967173|2709763|P5|Overall Study|Physician Decision|1
826114|NCT01967173|2709764|P4|Overall Study|Physician Decision|1
826115|NCT01967173|2709765|P3|Overall Study|Physician Decision|2
826116|NCT01967173|2709766|P2|Overall Study|Physician Decision|0
826117|NCT01967173|2709767|P1|Overall Study|Physician Decision|2
826118|NCT01967173|2709760|P8|Overall Study|Lost to Follow-up|8
826119|NCT01967173|2709761|P7|Overall Study|Lost to Follow-up|6
826120|NCT01967173|2709762|P6|Overall Study|Lost to Follow-up|12
826121|NCT01967173|2709763|P5|Overall Study|Lost to Follow-up|8
826122|NCT01967173|2709764|P4|Overall Study|Lost to Follow-up|4
826123|NCT01967173|2709765|P3|Overall Study|Lost to Follow-up|2
826124|NCT01967173|2709766|P2|Overall Study|Lost to Follow-up|3
826125|NCT01967173|2709767|P1|Overall Study|Lost to Follow-up|5
826126|NCT01967147|2709781|P2|Overall Study|Other|5
826127|NCT01967147|2709782|P1|Overall Study|Other|4
826128|NCT01967147|2709781|P2|Overall Study|Non-compliance with Study Drug|3
826129|NCT01967147|2709782|P1|Overall Study|Non-compliance with Study Drug|0
826130|NCT01967147|2709781|P2|Overall Study|Withdrawal by Subject|4
826131|NCT01967147|2709782|P1|Overall Study|Withdrawal by Subject|2
826132|NCT01967147|2709781|P2|Overall Study|Lost to Follow-up|2
826133|NCT01967147|2709782|P1|Overall Study|Lost to Follow-up|1
826134|NCT01967147|2709781|P2|Overall Study|Lack of Efficacy|4
826135|NCT01967147|2709782|P1|Overall Study|Lack of Efficacy|1
826136|NCT01967147|2709781|P2|Overall Study|Adverse Event|2
826137|NCT01967147|2709782|P1|Overall Study|Adverse Event|5
826138|NCT01967069|2709812|P2|Overall Study|Lack of Efficacy|1
826139|NCT01967069|2709813|P1|Overall Study|Lack of Efficacy|0
826140|NCT01967069|2709812|P2|Overall Study|Withdrawal by Subject|3
826141|NCT01967069|2709813|P1|Overall Study|Withdrawal by Subject|1
826142|NCT01967069|2709812|P2|Overall Study|Lost to Follow-up|2
826143|NCT01967069|2709813|P1|Overall Study|Lost to Follow-up|5
826144|NCT01967069|2709812|P2|Overall Study|Adverse Event|2
826145|NCT01967069|2709813|P1|Overall Study|Adverse Event|2
826146|NCT01966432|2709970|P3|Overall Study|SBIRT program ended|20
826147|NCT01966432|2709971|P2|Overall Study|SBIRT program ended|8
826148|NCT01966432|2709972|P1|Overall Study|SBIRT program ended|1
826149|NCT01966432|2709970|P3|Overall Study|Subject Incarcerated|1
826150|NCT01966432|2709971|P2|Overall Study|Subject Incarcerated|0
826151|NCT01966432|2709972|P1|Overall Study|Subject Incarcerated|0
826152|NCT01966432|2709970|P3|Overall Study|Withdrawal by Subject|0
826153|NCT01966432|2709971|P2|Overall Study|Withdrawal by Subject|3
826154|NCT01966432|2709972|P1|Overall Study|Withdrawal by Subject|1
826155|NCT01966432|2709970|P3|Overall Study|Lost to Follow-up|5
826156|NCT01966432|2709971|P2|Overall Study|Lost to Follow-up|2
826157|NCT01966432|2709972|P1|Overall Study|Lost to Follow-up|3
826158|NCT01966120|2710042|P2|Overall Study|Lost to Follow-up|1
826159|NCT01966120|2710043|P1|Overall Study|Lost to Follow-up|1
826160|NCT01966120|2710042|P2|Overall Study|Withdrawal by Subject|5
826161|NCT01966120|2710043|P1|Overall Study|Withdrawal by Subject|0
826162|NCT01966068|2710067|P1|Overall Study|Lost to Follow-up|81
826163|NCT01966068|2710067|P1|Overall Study|Withdrawal by Subject|57
826164|NCT01966042|2710072|P1|Overall Study|Death|2
826165|NCT01966003|2710081|P2|Overall Study|Other|1
826166|NCT01966003|2710082|P1|Overall Study|Other|1
826167|NCT01966003|2710081|P2|Overall Study|Plan to Receive Commercial Bevacizumab|67
826168|NCT01966003|2710082|P1|Overall Study|Plan to Receive Commercial Bevacizumab|44
826169|NCT01966003|2710081|P2|Overall Study|Plan to Receive Other Anticancer Therapy|127
826170|NCT01966003|2710082|P1|Overall Study|Plan to Receive Other Anticancer Therapy|131
826171|NCT01966003|2710081|P2|Overall Study|Withdrawal by Subject|19
826172|NCT01966003|2710082|P1|Overall Study|Withdrawal by Subject|29
826173|NCT01966003|2710081|P2|Overall Study|Physician Decision|13
826174|NCT01966003|2710082|P1|Overall Study|Physician Decision|12
826175|NCT01966003|2710081|P2|Overall Study|Lost to Follow-up|3
826176|NCT01966003|2710082|P1|Overall Study|Lost to Follow-up|4
826177|NCT01966003|2710081|P2|Overall Study|Protocol Violation|4
826178|NCT01966003|2710082|P1|Overall Study|Protocol Violation|6
826179|NCT01966003|2710081|P2|Overall Study|Death|36
826180|NCT01966003|2710082|P1|Overall Study|Death|43
826181|NCT01965938|2710100|P2|Overall Study|Withdrawal by Subject|0
826182|NCT01965938|2710101|P1|Overall Study|Withdrawal by Subject|1
826183|NCT01965834|2710132|P1|Overall Study|Lack of Efficacy|4
826184|NCT01965652|2710173|P2|Overall Study|Pregnancy|1
826185|NCT01965652|2710174|P1|Overall Study|Pregnancy|0
826186|NCT01965652|2710173|P2|Overall Study|Other - Miscellaneous|21
826187|NCT01965652|2710174|P1|Overall Study|Other - Miscellaneous|18
826188|NCT01965652|2710173|P2|Overall Study|Death|4
826189|NCT01965652|2710174|P1|Overall Study|Death|3
826190|NCT01965652|2710173|P2|Overall Study|Protocol Violation|38
826191|NCT01965652|2710174|P1|Overall Study|Protocol Violation|34
826192|NCT01965652|2710173|P2|Overall Study|Lost to Follow-up|40
826193|NCT01965652|2710174|P1|Overall Study|Lost to Follow-up|53
826194|NCT01965652|2710173|P2|Overall Study|Withdrawal by Subject|69
826195|NCT01965652|2710174|P1|Overall Study|Withdrawal by Subject|62
826196|NCT01965652|2710173|P2|Overall Study|Adverse Event|37
826197|NCT01965652|2710174|P1|Overall Study|Adverse Event|40
826198|NCT01965600|2710204|P4|Second Intervention|Study terminated by Sponsor|2
826199|NCT01965600|2710205|P3|Second Intervention|Study terminated by Sponsor|2
826200|NCT01965600|2710206|P2|Second Intervention|Study terminated by Sponsor|0
826201|NCT01965600|2710207|P1|Second Intervention|Study terminated by Sponsor|0
826202|NCT01965600|2710204|P4|Washout Period of Approximately 15 Days|Adverse Event|1
826203|NCT01965600|2710205|P3|Washout Period of Approximately 15 Days|Adverse Event|0
826204|NCT01965600|2710206|P2|Washout Period of Approximately 15 Days|Adverse Event|0
826205|NCT01965600|2710207|P1|Washout Period of Approximately 15 Days|Adverse Event|0
826206|NCT01965600|2710204|P4|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
826207|NCT01965600|2710205|P3|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
826208|NCT01965600|2710206|P2|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
826209|NCT01965600|2710207|P1|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1
826210|NCT01965600|2710204|P4|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
826211|NCT01965600|2710205|P3|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
826212|NCT01965600|2710206|P2|Washout Period of Approximately 15 Days|Withdrawal by Subject|1
826213|NCT01965600|2710207|P1|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
826214|NCT01965600|2710204|P4|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
826215|NCT01965600|2710205|P3|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2
826216|NCT01965600|2710206|P2|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3
826217|NCT01965600|2710207|P1|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
826218|NCT01965535|2710264|P2|Overall Study|Lack of Efficacy|1
826219|NCT01965535|2710265|P1|Overall Study|Lack of Efficacy|2
826220|NCT01965431|2710279|P6|Overall Study|Other than stated above|6
826221|NCT01965431|2710280|P5|Overall Study|Other than stated above|6
826222|NCT01965431|2710281|P4|Overall Study|Other than stated above|6
826223|NCT01965431|2710282|P3|Overall Study|Other than stated above|6
826224|NCT01965431|2710283|P2|Overall Study|Other than stated above|5
826225|NCT01965431|2710284|P1|Overall Study|Other than stated above|6
826226|NCT01965431|2710279|P6|Overall Study|Adverse Event|0
826227|NCT01965431|2710280|P5|Overall Study|Adverse Event|0
826228|NCT01965431|2710281|P4|Overall Study|Adverse Event|0
826229|NCT01965431|2710282|P3|Overall Study|Adverse Event|0
826230|NCT01965431|2710283|P2|Overall Study|Adverse Event|1
826231|NCT01965431|2710284|P1|Overall Study|Adverse Event|0
826232|NCT01965327|2710308|P1|Overall Study|Physician Decision|2
826233|NCT01965262|2710522|P2|Second Intervention (7 Days)|Poor visual acuity|0
826234|NCT01965262|2710523|P1|Second Intervention (7 Days)|Poor visual acuity|1
826235|NCT01965262|2710522|P2|Second Intervention (7 Days)|Poor lens fit|9
826236|NCT01965262|2710523|P1|Second Intervention (7 Days)|Poor lens fit|0
826237|NCT01965262|2710522|P2|Second Intervention (7 Days)|Discontinued|1
826238|NCT01965262|2710523|P1|Second Intervention (7 Days)|Discontinued|0
826239|NCT01965158|2710587|P2|Overall Study|Other - Miscellaneous|0
826240|NCT01965158|2710588|P1|Overall Study|Other - Miscellaneous|3
826241|NCT01965158|2710587|P2|Overall Study|Protocol Violation|1
826242|NCT01965158|2710588|P1|Overall Study|Protocol Violation|1
826243|NCT01965158|2710587|P2|Overall Study|Lost to Follow-up|5
826244|NCT01965158|2710588|P1|Overall Study|Lost to Follow-up|7
826245|NCT01965158|2710587|P2|Overall Study|Withdrawal by Subject|24
826246|NCT01965158|2710588|P1|Overall Study|Withdrawal by Subject|16
826247|NCT01965158|2710587|P2|Overall Study|Adverse Event|5
826248|NCT01965158|2710588|P1|Overall Study|Adverse Event|14
826249|NCT01964976|2710629|P1|Overall Study|Protocol Violation|31
826250|NCT01964950|2710643|P1|Overall Study|Protocol Violation|25
826251|NCT01964898|2710657|P2|Overall Study|Withdrawal by Subject|0
826252|NCT01964898|2710658|P1|Overall Study|Withdrawal by Subject|1
826253|NCT01964898|2710657|P2|Overall Study|Lost to Follow-up|5
826254|NCT01964898|2710658|P1|Overall Study|Lost to Follow-up|3
826255|NCT01964898|2710657|P2|Overall Study|did not receive the allocated interventi|1
826256|NCT01964898|2710658|P1|Overall Study|did not receive the allocated interventi|2
826257|NCT01964898|2710657|P2|Overall Study|ineligible post-randomization|1
826258|NCT01964898|2710658|P1|Overall Study|ineligible post-randomization|1
826259|NCT01964716|2710680|P2|Overall Study|Death|0
826260|NCT01964716|2710681|P1|Overall Study|Death|1
826261|NCT01964716|2710680|P2|Overall Study|No longer met eligibility criteria|1
826262|NCT01964716|2710681|P1|Overall Study|No longer met eligibility criteria|1
826263|NCT01964716|2710680|P2|Overall Study|Lost to Follow-up|2
826264|NCT01964716|2710681|P1|Overall Study|Lost to Follow-up|1
826265|NCT01964716|2710680|P2|Overall Study|Withdrawal by Subject|3
826266|NCT01964716|2710681|P1|Overall Study|Withdrawal by Subject|2
826267|NCT01964547|2710719|P2|Overall Study|Withdrawal by Investigator|1
826268|NCT01964547|2710720|P1|Overall Study|Withdrawal by Investigator|0
826269|NCT01964547|2710719|P2|Overall Study|Lost to Follow-up|1
826270|NCT01964547|2710720|P1|Overall Study|Lost to Follow-up|0
826271|NCT01964547|2710719|P2|Overall Study|Withdrawal by Subject|7
826272|NCT01964547|2710720|P1|Overall Study|Withdrawal by Subject|4
826273|NCT01964547|2710719|P2|Overall Study|Adverse Event|2
826274|NCT01964547|2710720|P1|Overall Study|Adverse Event|8
826275|NCT01964521|2710744|P1|Overall Study|Lost to Follow-up|4
826276|NCT01964352|2710753|P4|Overall Study|Other than stated above|2
826277|NCT01964352|2710754|P3|Overall Study|Other than stated above|1
826278|NCT01964352|2710755|P2|Overall Study|Other than stated above|2
826279|NCT01964352|2710756|P1|Overall Study|Other than stated above|0
826280|NCT01964352|2710753|P4|Overall Study|Withdrawal by Subject|0
826281|NCT01964352|2710754|P3|Overall Study|Withdrawal by Subject|1
826282|NCT01964352|2710755|P2|Overall Study|Withdrawal by Subject|2
826283|NCT01964352|2710756|P1|Overall Study|Withdrawal by Subject|4
826284|NCT01964352|2710753|P4|Overall Study|Lost to Follow-up|1
826285|NCT01964352|2710754|P3|Overall Study|Lost to Follow-up|0
826286|NCT01964352|2710755|P2|Overall Study|Lost to Follow-up|0
826287|NCT01964352|2710756|P1|Overall Study|Lost to Follow-up|1
826288|NCT01964352|2710753|P4|Overall Study|Protocol Violation|2
826289|NCT01964352|2710754|P3|Overall Study|Protocol Violation|0
826290|NCT01964352|2710755|P2|Overall Study|Protocol Violation|4
826291|NCT01964352|2710756|P1|Overall Study|Protocol Violation|2
826292|NCT01964352|2710753|P4|Overall Study|Lack of Efficacy|0
826293|NCT01964352|2710754|P3|Overall Study|Lack of Efficacy|0
826294|NCT01964352|2710755|P2|Overall Study|Lack of Efficacy|0
826295|NCT01964352|2710756|P1|Overall Study|Lack of Efficacy|6
826296|NCT01964352|2710753|P4|Overall Study|Adverse Event|3
826297|NCT01964352|2710754|P3|Overall Study|Adverse Event|4
826298|NCT01964352|2710755|P2|Overall Study|Adverse Event|3
826299|NCT01964352|2710756|P1|Overall Study|Adverse Event|13
826300|NCT01964326|2710786|P1|Overall Study|Did not meet eligibility criteria|1
826301|NCT01964326|2710786|P1|Overall Study|Other|9
826302|NCT01964326|2710786|P1|Overall Study|Investigator Discretion|1
826303|NCT01964326|2710786|P1|Overall Study|Physician Decision|55
826304|NCT01964326|2710786|P1|Overall Study|No Longer Meets Eligibility Criteria|1
826305|NCT01964326|2710786|P1|Overall Study|Pregnancy|1
826306|NCT01964326|2710786|P1|Overall Study|Withdrawal by Subject|87
826307|NCT01964326|2710786|P1|Overall Study|Lost to Follow-up|88
826308|NCT01964326|2710786|P1|Overall Study|Protocol Violation|4
826309|NCT01964326|2710786|P1|Overall Study|Death|2
826310|NCT01964326|2710786|P1|Overall Study|Adverse Event|48
826311|NCT01964222|2710795|P2|Overall Study|Screening Failure|0
826312|NCT01964222|2710796|P1|Overall Study|Screening Failure|2
826313|NCT01964222|2710795|P2|Overall Study|Withdrawal by Subject|6
826314|NCT01964222|2710796|P1|Overall Study|Withdrawal by Subject|6
826315|NCT01964222|2710795|P2|Overall Study|Lost to Follow-up|5
826316|NCT01964222|2710796|P1|Overall Study|Lost to Follow-up|7
826317|NCT01964105|2710813|P3|Overall Study|Lost to Follow-up|0
826318|NCT01964105|2710814|P2|Overall Study|Lost to Follow-up|13
826319|NCT01964105|2710815|P1|Overall Study|Lost to Follow-up|2
826320|NCT01963767|2710842|P2|Overall Study|Adverse Event|0
826321|NCT01963767|2710843|P1|Overall Study|Adverse Event|2
826322|NCT01963767|2710842|P2|Overall Study|Withdrawal by Subject|2
826323|NCT01963767|2710843|P1|Overall Study|Withdrawal by Subject|4
826324|NCT01963676|2710853|P2|Overall Study|Withdrawal by Subject|0
826325|NCT01963676|2710854|P1|Overall Study|Withdrawal by Subject|1
826326|NCT01963611|2710867|P5|Overall Study|Other|45
826327|NCT01963611|2710868|P4|Overall Study|Other|45
826328|NCT01963611|2710869|P3|Overall Study|Other|48
826329|NCT01963611|2710870|P2|Overall Study|Other|46
826330|NCT01963611|2710871|P1|Overall Study|Other|47
826331|NCT01963611|2710867|P5|Overall Study|Withdrawal by Subject|3
826332|NCT01963611|2710868|P4|Overall Study|Withdrawal by Subject|1
826333|NCT01963611|2710869|P3|Overall Study|Withdrawal by Subject|1
826334|NCT01963611|2710870|P2|Overall Study|Withdrawal by Subject|2
826335|NCT01963611|2710871|P1|Overall Study|Withdrawal by Subject|3
826336|NCT01963611|2710867|P5|Overall Study|Lack of Efficacy|0
826337|NCT01963611|2710868|P4|Overall Study|Lack of Efficacy|1
826338|NCT01963611|2710869|P3|Overall Study|Lack of Efficacy|0
826339|NCT01963611|2710870|P2|Overall Study|Lack of Efficacy|0
826340|NCT01963611|2710871|P1|Overall Study|Lack of Efficacy|0
826341|NCT01963611|2710867|P5|Overall Study|Protocol Violation|0
826342|NCT01963611|2710868|P4|Overall Study|Protocol Violation|1
826343|NCT01963611|2710869|P3|Overall Study|Protocol Violation|0
826344|NCT01963611|2710870|P2|Overall Study|Protocol Violation|0
826345|NCT01963611|2710871|P1|Overall Study|Protocol Violation|0
826346|NCT01963611|2710867|P5|Overall Study|Adverse Event|3
826347|NCT01963611|2710868|P4|Overall Study|Adverse Event|4
826348|NCT01963611|2710869|P3|Overall Study|Adverse Event|3
826349|NCT01963611|2710870|P2|Overall Study|Adverse Event|1
826350|NCT01963611|2710871|P1|Overall Study|Adverse Event|1
826351|NCT01963403|2710930|P2|Overall Study|Implant removal|1
826352|NCT01963403|2710931|P1|Overall Study|Implant removal|0
826353|NCT01963403|2710930|P2|Overall Study|Lost to Follow-up|3
826354|NCT01963403|2710931|P1|Overall Study|Lost to Follow-up|2
826355|NCT01963260|2710953|P10|Overall Study|Withdrawal by Subject|0
826356|NCT01963260|2710954|P9|Overall Study|Withdrawal by Subject|0
826357|NCT01963260|2710955|P8|Overall Study|Withdrawal by Subject|0
826358|NCT01963260|2710956|P7|Overall Study|Withdrawal by Subject|0
826359|NCT01963260|2710957|P6|Overall Study|Withdrawal by Subject|0
826360|NCT01963260|2710958|P5|Overall Study|Withdrawal by Subject|2
826361|NCT01963260|2710959|P4|Overall Study|Withdrawal by Subject|1
826362|NCT01963260|2710960|P3|Overall Study|Withdrawal by Subject|0
826363|NCT01963260|2710961|P2|Overall Study|Withdrawal by Subject|0
826364|NCT01963260|2710962|P1|Overall Study|Withdrawal by Subject|2
826365|NCT01962974|2711070|P1|Overall Study|Study termination|7
826366|NCT01962922|2711097|P2|Extendion Portion (up to Month 6)|Physician Decision|0
826367|NCT01962922|2711098|P1|Extendion Portion (up to Month 6)|Physician Decision|1
826368|NCT01962922|2711097|P2|Extendion Portion (up to Month 6)|no longer wished to participate in study|3
826369|NCT01962922|2711098|P1|Extendion Portion (up to Month 6)|no longer wished to participate in study|4
826370|NCT01962922|2711097|P2|PK Portion Day 7|non-compliance|0
826371|NCT01962922|2711098|P1|PK Portion Day 7|non-compliance|1
826372|NCT01962922|2711097|P2|PK Portion Day 7|Withdrawal by Subject|0
826373|NCT01962922|2711098|P1|PK Portion Day 7|Withdrawal by Subject|3
826374|NCT01962493|2711175|P2|Overall Study|Withdrawal by Subject|2
826375|NCT01962493|2711176|P1|Overall Study|Withdrawal by Subject|4
826376|NCT01962493|2711175|P2|Overall Study|Protocol Violation|1
826377|NCT01962493|2711176|P1|Overall Study|Protocol Violation|0
826378|NCT01962493|2711175|P2|Overall Study|Adverse Event|2
826379|NCT01962493|2711176|P1|Overall Study|Adverse Event|1
826380|NCT01962441|2711199|P3|Retreatment Substudy|Lost to Follow-up|0
826381|NCT01962441|2711200|P2|Retreatment Substudy|Lost to Follow-up|0
826382|NCT01962441|2711201|P1|Retreatment Substudy|Lost to Follow-up|1
826383|NCT01962441|2711199|P3|Retreatment Substudy|Lack of Efficacy|0
826384|NCT01962441|2711200|P2|Retreatment Substudy|Lack of Efficacy|0
826385|NCT01962441|2711201|P1|Retreatment Substudy|Lack of Efficacy|1
826386|NCT01962441|2711199|P3|Randomized Period|Protocol Violation|0
826387|NCT01962441|2711200|P2|Randomized Period|Protocol Violation|1
826388|NCT01962441|2711201|P1|Randomized Period|Protocol Violation|0
826389|NCT01962441|2711199|P3|Randomized Period|Death|2
826390|NCT01962441|2711200|P2|Randomized Period|Death|0
826391|NCT01962441|2711201|P1|Randomized Period|Death|0
826392|NCT01962441|2711199|P3|Randomized Period|Adverse Event|0
826393|NCT01962441|2711200|P2|Randomized Period|Adverse Event|1
826394|NCT01962441|2711201|P1|Randomized Period|Adverse Event|1
826395|NCT01962441|2711199|P3|Randomized Period|Withdrew Consent|2
826396|NCT01962441|2711200|P2|Randomized Period|Withdrew Consent|3
826397|NCT01962441|2711201|P1|Randomized Period|Withdrew Consent|3
826398|NCT01962441|2711199|P3|Randomized Period|Lost to Follow-up|4
826399|NCT01962441|2711200|P2|Randomized Period|Lost to Follow-up|4
826400|NCT01962441|2711201|P1|Randomized Period|Lost to Follow-up|2
826401|NCT01962441|2711199|P3|Randomized Period|Randomized but Never Treated|3
826402|NCT01962441|2711200|P2|Randomized Period|Randomized but Never Treated|2
826403|NCT01962441|2711201|P1|Randomized Period|Randomized but Never Treated|4
826404|NCT01962298|2711245|P5|Overall Study|Physician Decision|1
826405|NCT01962298|2711246|P4|Overall Study|Physician Decision|0
826406|NCT01962298|2711247|P3|Overall Study|Physician Decision|0
826407|NCT01962298|2711248|P2|Overall Study|Physician Decision|1
826408|NCT01962298|2711249|P1|Overall Study|Physician Decision|0
826409|NCT01962298|2711245|P5|Overall Study|Incorrect data recorded|0
826410|NCT01962298|2711246|P4|Overall Study|Incorrect data recorded|0
826411|NCT01962298|2711247|P3|Overall Study|Incorrect data recorded|0
826412|NCT01962298|2711248|P2|Overall Study|Incorrect data recorded|1
826413|NCT01962298|2711249|P1|Overall Study|Incorrect data recorded|0
826414|NCT01962298|2711245|P5|Overall Study|Insufficient data|1
826415|NCT01962298|2711246|P4|Overall Study|Insufficient data|0
826416|NCT01962298|2711247|P3|Overall Study|Insufficient data|1
826417|NCT01962298|2711248|P2|Overall Study|Insufficient data|2
826418|NCT01962298|2711249|P1|Overall Study|Insufficient data|0
826419|NCT01962298|2711245|P5|Overall Study|Data quality insufficient|4
826420|NCT01962298|2711246|P4|Overall Study|Data quality insufficient|1
826421|NCT01962298|2711247|P3|Overall Study|Data quality insufficient|3
826422|NCT01962298|2711248|P2|Overall Study|Data quality insufficient|0
826423|NCT01962298|2711249|P1|Overall Study|Data quality insufficient|2
826424|NCT01962298|2711245|P5|Overall Study|Protocol Violation|0
826425|NCT01962298|2711246|P4|Overall Study|Protocol Violation|1
826426|NCT01962298|2711247|P3|Overall Study|Protocol Violation|1
826427|NCT01962298|2711248|P2|Overall Study|Protocol Violation|0
826428|NCT01962298|2711249|P1|Overall Study|Protocol Violation|1
826429|NCT01961544|2711276|P1|Overall Study|Aggravation of Steral Pain|1
826430|NCT01961544|2711276|P1|Overall Study|Poor Tolerance|1
826431|NCT01961544|2711276|P1|Overall Study|Physician Decision|2
826432|NCT01961544|2711276|P1|Overall Study|Adverse Event|1
826433|NCT01961544|2711276|P1|Overall Study|Withdrawal by Subject|7
826434|NCT01961544|2711276|P1|Overall Study|Protocol Violation|1
826435|NCT01961349|2711284|P3|Overall Study|registration error, personal reason etc|1
826436|NCT01961349|2711285|P2|Overall Study|registration error, personal reason etc|2
826437|NCT01961349|2711286|P1|Overall Study|registration error, personal reason etc|2
826438|NCT01961349|2711284|P3|Overall Study|Adverse Event|1
826439|NCT01961349|2711285|P2|Overall Study|Adverse Event|0
826440|NCT01961349|2711286|P1|Overall Study|Adverse Event|0
826441|NCT01961349|2711284|P3|Overall Study|Withdrawal by Subject|0
826442|NCT01961349|2711285|P2|Overall Study|Withdrawal by Subject|4
826443|NCT01961349|2711286|P1|Overall Study|Withdrawal by Subject|1
826444|NCT01961323|2711297|P1|Overall Study|screen failure|34
826445|NCT01961323|2711297|P1|Overall Study|Lost to Follow-up|8
826446|NCT01961323|2711297|P1|Overall Study|Withdrawal by Subject|7
826447|NCT01961297|2711305|P2|Overall Study|unconfirmed diagnosis of SD|1
826448|NCT01961297|2711306|P1|Overall Study|unconfirmed diagnosis of SD|2
826449|NCT01961115|2711332|P3|Overall Study|Adverse Event|1
826450|NCT01961115|2711333|P2|Overall Study|Adverse Event|0
826451|NCT01961115|2711334|P1|Overall Study|Adverse Event|1
826452|NCT01961115|2711332|P3|Overall Study|Disease Progression|3
826453|NCT01961115|2711333|P2|Overall Study|Disease Progression|0
826454|NCT01961115|2711334|P1|Overall Study|Disease Progression|1
826455|NCT01960907|2711377|P2|Overall Study|Withdrawal by Subject|42
826456|NCT01960907|2711378|P1|Overall Study|Withdrawal by Subject|32
826457|NCT01960907|2711377|P2|Overall Study|Death|3
826458|NCT01960907|2711378|P1|Overall Study|Death|4
826459|NCT01960855|2711393|P5|Overall Study|Lost to Follow-up|2
826460|NCT01960855|2711394|P4|Overall Study|Lost to Follow-up|0
826461|NCT01960855|2711395|P3|Overall Study|Lost to Follow-up|0
826462|NCT01960855|2711396|P2|Overall Study|Lost to Follow-up|1
826463|NCT01960855|2711397|P1|Overall Study|Lost to Follow-up|2
826464|NCT01960855|2711393|P5|Overall Study|Consent withdrawn by subject|1
826465|NCT01960855|2711394|P4|Overall Study|Consent withdrawn by subject|1
826466|NCT01960855|2711395|P3|Overall Study|Consent withdrawn by subject|2
826467|NCT01960855|2711396|P2|Overall Study|Consent withdrawn by subject|1
826468|NCT01960855|2711397|P1|Overall Study|Consent withdrawn by subject|3
826469|NCT01960855|2711393|P5|Overall Study|Not specified|0
826470|NCT01960855|2711394|P4|Overall Study|Not specified|1
826471|NCT01960855|2711395|P3|Overall Study|Not specified|1
826472|NCT01960855|2711396|P2|Overall Study|Not specified|1
826473|NCT01960855|2711397|P1|Overall Study|Not specified|2
826474|NCT01960855|2711393|P5|Overall Study|Lack of Efficacy|0
826475|NCT01960855|2711394|P4|Overall Study|Lack of Efficacy|0
826476|NCT01960855|2711395|P3|Overall Study|Lack of Efficacy|0
826477|NCT01960855|2711396|P2|Overall Study|Lack of Efficacy|1
826478|NCT01960855|2711397|P1|Overall Study|Lack of Efficacy|1
826479|NCT01960855|2711393|P5|Overall Study|Adverse Event|2
826480|NCT01960855|2711394|P4|Overall Study|Adverse Event|2
826481|NCT01960855|2711395|P3|Overall Study|Adverse Event|6
826482|NCT01960855|2711396|P2|Overall Study|Adverse Event|0
826483|NCT01960855|2711397|P1|Overall Study|Adverse Event|2
826484|NCT01960855|2711393|P5|Overall Study|Subject noncompliant|0
826485|NCT01960855|2711394|P4|Overall Study|Subject noncompliant|0
826486|NCT01960855|2711395|P3|Overall Study|Subject noncompliant|0
826487|NCT01960855|2711396|P2|Overall Study|Subject noncompliant|0
826488|NCT01960855|2711397|P1|Overall Study|Subject noncompliant|1
826489|NCT01960842|2711429|P1|Overall Study|Withdrawal by Subject|2
826490|NCT01960842|2711429|P1|Overall Study|Adverse Event|1
826491|NCT01960816|2711452|P1|Overall Study|Lost to Follow-up|1
826492|NCT01960725|2711460|P2|Overall Study|unable to obtain blood sample|2
826493|NCT01960725|2711461|P1|Overall Study|unable to obtain blood sample|1
826494|NCT01960725|2711460|P2|Overall Study|Withdrawal by Subject|0
826495|NCT01960725|2711461|P1|Overall Study|Withdrawal by Subject|1
826496|NCT01960725|2711460|P2|Overall Study|Lost to Follow-up|3
826497|NCT01960725|2711461|P1|Overall Study|Lost to Follow-up|4
826498|NCT01960348|2711540|P2|Overall Study|Protocol Violation|0
826499|NCT01960348|2711541|P1|Overall Study|Protocol Violation|1
826500|NCT01960348|2711540|P2|Overall Study|Physician Decision|1
826501|NCT01960348|2711541|P1|Overall Study|Physician Decision|0
826502|NCT01960348|2711540|P2|Overall Study|Withdrawal by Subject|11
826503|NCT01960348|2711541|P1|Overall Study|Withdrawal by Subject|1
826504|NCT01960348|2711540|P2|Overall Study|Adverse event, serious non-fatal|3
826505|NCT01960348|2711541|P1|Overall Study|Adverse event, serious non-fatal|0
826506|NCT01960348|2711540|P2|Overall Study|Adverse event, serious fatal|5
826507|NCT01960348|2711541|P1|Overall Study|Adverse event, serious fatal|6
826508|NCT01960348|2711540|P2|Overall Study|Adverse event, not serious|2
826509|NCT01960348|2711541|P1|Overall Study|Adverse event, not serious|2
826510|NCT01960296|2711561|P2|Overall Study|Received different procedure|3
826511|NCT01960296|2711562|P1|Overall Study|Received different procedure|1
826512|NCT01960296|2711561|P2|Overall Study|Postponed surgery|0
826513|NCT01960296|2711562|P1|Overall Study|Postponed surgery|1
826514|NCT01960140|2711582|P1|Period 2 (Days 3-18)|Adverse Event|2
826515|NCT01960114|2711593|P2|Overall Study|Could not swallow study medication|1
826516|NCT01960114|2711594|P1|Overall Study|Could not swallow study medication|0
826517|NCT01960114|2711593|P2|Overall Study|Adverse Event|0
826518|NCT01960114|2711594|P1|Overall Study|Adverse Event|1
826519|NCT01959932|2711640|P3|Overall Study|Withdrawal by Subject|0
826520|NCT01959932|2711641|P2|Overall Study|Withdrawal by Subject|0
826521|NCT01959932|2711642|P1|Overall Study|Withdrawal by Subject|1
826522|NCT01959919|2711660|P1|Overall Study|Did not meet the eligibility criteria|2
826523|NCT01959880|2711674|P4|Overall Study|Study completed early-FDA approved|152
826524|NCT01959880|2711675|P3|Overall Study|Study completed early-FDA approved|179
826525|NCT01959880|2711676|P2|Overall Study|Study completed early-FDA approved|311
826526|NCT01959880|2711677|P1|Overall Study|Study completed early-FDA approved|1003
826527|NCT01959880|2711674|P4|Overall Study|Explantation w/o study device reimplant.|12
826528|NCT01959880|2711675|P3|Overall Study|Explantation w/o study device reimplant.|5
826529|NCT01959880|2711676|P2|Overall Study|Explantation w/o study device reimplant.|17
826530|NCT01959880|2711677|P1|Overall Study|Explantation w/o study device reimplant.|22
826531|NCT01959880|2711674|P4|Overall Study|Lost to Follow-up|8
826532|NCT01959880|2711675|P3|Overall Study|Lost to Follow-up|15
826533|NCT01959880|2711676|P2|Overall Study|Lost to Follow-up|18
826534|NCT01959880|2711677|P1|Overall Study|Lost to Follow-up|95
826535|NCT01959880|2711674|P4|Overall Study|Death|2
826536|NCT01959880|2711675|P3|Overall Study|Death|1
826537|NCT01959880|2711676|P2|Overall Study|Death|10
826538|NCT01959880|2711677|P1|Overall Study|Death|1
826539|NCT01959880|2711674|P4|Overall Study|Withdrawal by Subject|7
826540|NCT01959880|2711675|P3|Overall Study|Withdrawal by Subject|8
826541|NCT01959880|2711676|P2|Overall Study|Withdrawal by Subject|13
826542|NCT01959880|2711677|P1|Overall Study|Withdrawal by Subject|11
826543|NCT01959841|2711702|P3|Overall Study|Platelet count below on day1 or 4|11
826544|NCT01959841|2711703|P2|Overall Study|Platelet count below on day1 or 4|15
826545|NCT01959841|2711704|P1|Overall Study|Platelet count below on day1 or 4|11
826546|NCT01959841|2711702|P3|Overall Study|Clinical laboratory value|6
826547|NCT01959841|2711703|P2|Overall Study|Clinical laboratory value|6
826548|NCT01959841|2711704|P1|Overall Study|Clinical laboratory value|2
826549|NCT01959841|2711702|P3|Overall Study|Withdrawal by Subject|5
826550|NCT01959841|2711703|P2|Overall Study|Withdrawal by Subject|7
826551|NCT01959841|2711704|P1|Overall Study|Withdrawal by Subject|7
826552|NCT01959841|2711702|P3|Overall Study|Protocol Violation|16
826553|NCT01959841|2711703|P2|Overall Study|Protocol Violation|23
826554|NCT01959841|2711704|P1|Overall Study|Protocol Violation|16
826555|NCT01959841|2711702|P3|Overall Study|Physician Decision|3
826556|NCT01959841|2711703|P2|Overall Study|Physician Decision|2
826557|NCT01959841|2711704|P1|Overall Study|Physician Decision|0
826558|NCT01959841|2711702|P3|Overall Study|Lost to Follow-up|0
826559|NCT01959841|2711703|P2|Overall Study|Lost to Follow-up|1
826560|NCT01959841|2711704|P1|Overall Study|Lost to Follow-up|1
826561|NCT01959841|2711702|P3|Overall Study|Lack of Efficacy|0
826562|NCT01959841|2711703|P2|Overall Study|Lack of Efficacy|0
826563|NCT01959841|2711704|P1|Overall Study|Lack of Efficacy|5
826564|NCT01959841|2711702|P3|Overall Study|Adverse Event|2
826565|NCT01959841|2711703|P2|Overall Study|Adverse Event|3
826566|NCT01959841|2711704|P1|Overall Study|Adverse Event|1
826567|NCT01959607|2711734|P4|First Intervention (Day 1)|Withdrawal by Subject|0
826568|NCT01959607|2711735|P3|First Intervention (Day 1)|Withdrawal by Subject|0
826569|NCT01959607|2711736|P2|First Intervention (Day 1)|Withdrawal by Subject|1
826570|NCT01959607|2711737|P1|First Intervention (Day 1)|Withdrawal by Subject|1
826571|NCT01959581|2711750|P1|Overall Study|Lost to Follow-up|5
826572|NCT01959529|2711756|P2|Overall Study|Lack of glycaemic control|1
826573|NCT01959529|2711757|P1|Overall Study|Lack of glycaemic control|1
826574|NCT01959529|2711756|P2|Overall Study|Hypoglycaemia|1
826575|NCT01959529|2711757|P1|Overall Study|Hypoglycaemia|1
826576|NCT01959529|2711756|P2|Overall Study|Other|68
826577|NCT01959529|2711757|P1|Overall Study|Other|70
826578|NCT01959529|2711756|P2|Overall Study|Lost to Follow-up|1
826579|NCT01959529|2711757|P1|Overall Study|Lost to Follow-up|4
826580|NCT01959529|2711756|P2|Overall Study|Adverse event (not hypoglycaemia)|1
826581|NCT01959529|2711757|P1|Overall Study|Adverse event (not hypoglycaemia)|0
826582|NCT01959516|2711769|P2|Epoch 2|Moderate or severe COPD exacerbation|1
826583|NCT01959516|2711770|P1|Epoch 2|Moderate or severe COPD exacerbation|0
826584|NCT01959516|2711769|P2|Epoch 2|Subject withdrew consent|0
826585|NCT01959516|2711770|P1|Epoch 2|Subject withdrew consent|1
826586|NCT01959516|2711769|P2|Epoch 2|unsatisfactory therapeutic effect|0
826587|NCT01959516|2711770|P1|Epoch 2|unsatisfactory therapeutic effect|1
826588|NCT01959516|2711769|P2|Epoch 1|Protocol deviation|1
826589|NCT01959516|2711770|P1|Epoch 1|Protocol deviation|0
826590|NCT01959516|2711769|P2|Epoch 1|Moderate or severe COPD exacerbation|1
826591|NCT01959516|2711770|P1|Epoch 1|Moderate or severe COPD exacerbation|0
826592|NCT01959516|2711769|P2|Epoch 1|Use of prohibited treatment|0
826593|NCT01959516|2711770|P1|Epoch 1|Use of prohibited treatment|1
826594|NCT01959516|2711769|P2|Epoch 1|Administrative problems|0
826595|NCT01959516|2711770|P1|Epoch 1|Administrative problems|1
826596|NCT01959516|2711769|P2|Epoch 1|Subject withdrew consent|2
826597|NCT01959516|2711770|P1|Epoch 1|Subject withdrew consent|3
826598|NCT01959516|2711769|P2|Epoch 1|unsatisfactory therapeutic effect|0
826599|NCT01959516|2711770|P1|Epoch 1|unsatisfactory therapeutic effect|1
826600|NCT01959516|2711769|P2|Epoch 1|Adverse Event|1
826601|NCT01959516|2711770|P1|Epoch 1|Adverse Event|4
826602|NCT01959503|2711780|P2|Overall Study|Randomized but not treated|1
826603|NCT01959503|2711781|P1|Overall Study|Randomized but not treated|1
826604|NCT01959503|2711780|P2|Overall Study|Death|1
826605|NCT01959503|2711781|P1|Overall Study|Death|2
826606|NCT01959412|2711801|P6|Overall Study|Adverse Event|0
826607|NCT01959412|2711802|P5|Overall Study|Adverse Event|0
826608|NCT01959412|2711803|P4|Overall Study|Adverse Event|1
826609|NCT01959412|2711804|P3|Overall Study|Adverse Event|0
826610|NCT01959412|2711805|P2|Overall Study|Adverse Event|0
826611|NCT01959412|2711806|P1|Overall Study|Adverse Event|0
826612|NCT01959412|2711801|P6|Overall Study|Protocol deviation|0
826613|NCT01959412|2711802|P5|Overall Study|Protocol deviation|3
826614|NCT01959412|2711803|P4|Overall Study|Protocol deviation|1
826615|NCT01959412|2711804|P3|Overall Study|Protocol deviation|0
826616|NCT01959412|2711805|P2|Overall Study|Protocol deviation|1
826617|NCT01959412|2711806|P1|Overall Study|Protocol deviation|1
826618|NCT01959035|2711844|P1|Overall Study|Other (no primary reason given)|1
826619|NCT01959035|2711844|P1|Overall Study|Lost to Follow-up|1
826620|NCT01959035|2711844|P1|Overall Study|Withdrawal by Subject|4
826621|NCT01959035|2711844|P1|Overall Study|Adverse Event|5
826622|NCT01958827|2711870|P1|Overall Study|Concomitant Prohibited Medicine for AE|1
826623|NCT01958827|2711870|P1|Overall Study|Lack of Efficacy|6
826624|NCT01958827|2711870|P1|Overall Study|Adverse Event|3
826625|NCT01958671|2711901|P3|Overall Study|Withdrawal by Subject|13
826626|NCT01958671|2711902|P2|Overall Study|Withdrawal by Subject|10
826627|NCT01958671|2711903|P1|Overall Study|Withdrawal by Subject|8
826628|NCT01958671|2711901|P3|Overall Study|Participant moved|1
826629|NCT01958671|2711902|P2|Overall Study|Participant moved|0
826630|NCT01958671|2711903|P1|Overall Study|Participant moved|0
826631|NCT01958671|2711901|P3|Overall Study|Study site terminated by sponsor|1
826632|NCT01958671|2711902|P2|Overall Study|Study site terminated by sponsor|0
826633|NCT01958671|2711903|P1|Overall Study|Study site terminated by sponsor|1
826634|NCT01958671|2711901|P3|Overall Study|Protocol Violation|0
826635|NCT01958671|2711902|P2|Overall Study|Protocol Violation|1
826636|NCT01958671|2711903|P1|Overall Study|Protocol Violation|0
826637|NCT01958671|2711901|P3|Overall Study|Pregnancy|1
826638|NCT01958671|2711902|P2|Overall Study|Pregnancy|0
826639|NCT01958671|2711903|P1|Overall Study|Pregnancy|0
826640|NCT01958671|2711901|P3|Overall Study|Non-compliance with study drug|1
826641|NCT01958671|2711902|P2|Overall Study|Non-compliance with study drug|1
826642|NCT01958671|2711903|P1|Overall Study|Non-compliance with study drug|1
826643|NCT01958671|2711901|P3|Overall Study|Lost to Follow-up|7
826644|NCT01958671|2711902|P2|Overall Study|Lost to Follow-up|11
826645|NCT01958671|2711903|P1|Overall Study|Lost to Follow-up|7
826646|NCT01958671|2711901|P3|Overall Study|Hyperglycemia|2
826647|NCT01958671|2711902|P2|Overall Study|Hyperglycemia|0
826648|NCT01958671|2711903|P1|Overall Study|Hyperglycemia|0
826649|NCT01958671|2711901|P3|Overall Study|Excluded medication|1
826650|NCT01958671|2711902|P2|Overall Study|Excluded medication|0
826651|NCT01958671|2711903|P1|Overall Study|Excluded medication|0
826652|NCT01958671|2711901|P3|Overall Study|Death|0
826653|NCT01958671|2711902|P2|Overall Study|Death|0
826654|NCT01958671|2711903|P1|Overall Study|Death|1
826655|NCT01958671|2711901|P3|Overall Study|Adverse Event|5
826656|NCT01958671|2711902|P2|Overall Study|Adverse Event|1
826657|NCT01958671|2711903|P1|Overall Study|Adverse Event|1
826658|NCT01958619|2711977|P4|Overall Study|Protocol Violation|0
826659|NCT01958619|2711978|P3|Overall Study|Protocol Violation|1
826660|NCT01958619|2711979|P2|Overall Study|Protocol Violation|0
826661|NCT01958619|2711980|P1|Overall Study|Protocol Violation|2
826662|NCT01958489|2712041|P2|Period 2|Adverse Event|1
826663|NCT01958489|2712042|P1|Period 2|Adverse Event|0
826664|NCT01958437|2712058|P4|Overall Study|Incidental MRI findings|1
826665|NCT01958437|2712059|P3|Overall Study|Incidental MRI findings|1
826666|NCT01958437|2712060|P2|Overall Study|Incidental MRI findings|0
826667|NCT01958437|2712061|P1|Overall Study|Incidental MRI findings|0
826668|NCT01958281|2712128|P3|Overall Study|Withdrew Consent|0
826669|NCT01958281|2712129|P2|Overall Study|Withdrew Consent|0
826670|NCT01958281|2712130|P1|Overall Study|Withdrew Consent|1
826671|NCT01958281|2712128|P3|Overall Study|Adverse Event|0
826672|NCT01958281|2712129|P2|Overall Study|Adverse Event|2
826673|NCT01958281|2712130|P1|Overall Study|Adverse Event|0
826674|NCT01958281|2712128|P3|Overall Study|Lack of Efficacy|0
826675|NCT01958281|2712129|P2|Overall Study|Lack of Efficacy|2
826676|NCT01958281|2712130|P1|Overall Study|Lack of Efficacy|5
826677|NCT01958164|2712206|P2|Overall Study|Lost to Follow-up|3
826678|NCT01958164|2712207|P1|Overall Study|Lost to Follow-up|2
826679|NCT01958164|2712206|P2|Overall Study|Adverse Event|2
826680|NCT01958164|2712207|P1|Overall Study|Adverse Event|0
826681|NCT01958060|2712226|P6|Overall Study|Not treated|0
826682|NCT01958060|2712227|P5|Overall Study|Not treated|1
826683|NCT01958060|2712228|P4|Overall Study|Not treated|0
826684|NCT01958060|2712229|P3|Overall Study|Not treated|0
826685|NCT01958060|2712230|P2|Overall Study|Not treated|0
826686|NCT01958060|2712231|P1|Overall Study|Not treated|2
826687|NCT01958021|2712256|P2|Overall Study|Death|0
826688|NCT01958021|2712257|P1|Overall Study|Death|2
826689|NCT01958021|2712256|P2|Overall Study|Protocol Violation|1
826690|NCT01958021|2712257|P1|Overall Study|Protocol Violation|3
826691|NCT01958021|2712256|P2|Overall Study|Physician Decision|13
826692|NCT01958021|2712257|P1|Overall Study|Physician Decision|10
826693|NCT01958021|2712256|P2|Overall Study|Subject/guardian decision|13
826694|NCT01958021|2712257|P1|Overall Study|Subject/guardian decision|12
826695|NCT01958021|2712256|P2|Overall Study|Adverse Event|7
826696|NCT01958021|2712257|P1|Overall Study|Adverse Event|25
826697|NCT01958021|2712256|P2|Overall Study|Progressive disease|146
826698|NCT01958021|2712257|P1|Overall Study|Progressive disease|87
826699|NCT01958008|2712269|P4|Overall Study|Other adverse event|0
826700|NCT01958008|2712270|P3|Overall Study|Other adverse event|0
826701|NCT01958008|2712271|P2|Overall Study|Other adverse event|0
826702|NCT01958008|2712272|P1|Overall Study|Other adverse event|1
826703|NCT01958008|2712269|P4|Overall Study|Worsening of disease under study|0
826704|NCT01958008|2712270|P3|Overall Study|Worsening of disease under study|1
826705|NCT01958008|2712271|P2|Overall Study|Worsening of disease under study|0
826706|NCT01958008|2712272|P1|Overall Study|Worsening of disease under study|0
826707|NCT01957865|2712312|P3|Overall Study|Lost to Follow-up|2
826708|NCT01957865|2712313|P2|Overall Study|Lost to Follow-up|2
826709|NCT01957865|2712314|P1|Overall Study|Lost to Follow-up|0
826710|NCT01957865|2712312|P3|Overall Study|Found HIV negative|1
826711|NCT01957865|2712313|P2|Overall Study|Found HIV negative|0
826712|NCT01957865|2712314|P1|Overall Study|Found HIV negative|0
826713|NCT01957579|2712347|P4|Overall Study|Death|0
826714|NCT01957579|2712348|P3|Overall Study|Death|2
826715|NCT01957579|2712349|P2|Overall Study|Death|0
826716|NCT01957579|2712350|P1|Overall Study|Death|0
826717|NCT01957579|2712347|P4|Overall Study|Withdrawal of concent|0
826718|NCT01957579|2712348|P3|Overall Study|Withdrawal of concent|0
826719|NCT01957579|2712349|P2|Overall Study|Withdrawal of concent|1
826720|NCT01957579|2712350|P1|Overall Study|Withdrawal of concent|0
826721|NCT01957553|2712417|P2|Test Period 2 (21 +- 1 Days)|Other|0
826722|NCT01957553|2712418|P1|Test Period 2 (21 +- 1 Days)|Other|1
826723|NCT01957553|2712417|P2|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1
826724|NCT01957553|2712418|P1|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0
826725|NCT01957553|2712417|P2|Test Period 2 (21 +- 1 Days)|completed early by mistake|1
826726|NCT01957553|2712418|P1|Test Period 2 (21 +- 1 Days)|completed early by mistake|0
826727|NCT01957553|2712417|P2|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2
826728|NCT01957553|2712418|P1|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1
826729|NCT01957553|2712417|P2|Test Period 2 (21 +- 1 Days)|Adverse Event|3
826730|NCT01957553|2712418|P1|Test Period 2 (21 +- 1 Days)|Adverse Event|1
826731|NCT01957553|2712417|P2|Test Period 1 (21 +- 1 Days)|screen failure|0
826732|NCT01957553|2712418|P1|Test Period 1 (21 +- 1 Days)|screen failure|1
826733|NCT01957553|2712417|P2|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0
826734|NCT01957553|2712418|P1|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2
826735|NCT01957553|2712417|P2|Test Period 1 (21 +- 1 Days)|Adverse Event|0
826736|NCT01957553|2712418|P1|Test Period 1 (21 +- 1 Days)|Adverse Event|2
826737|NCT01957553|2712417|P2|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3
826738|NCT01957553|2712418|P1|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2
826739|NCT01957488|2712424|P6|Test Period 3|Lack of Efficacy|0
826740|NCT01957488|2712425|P5|Test Period 3|Lack of Efficacy|0
826741|NCT01957488|2712426|P4|Test Period 3|Lack of Efficacy|0
826742|NCT01957488|2712427|P3|Test Period 3|Lack of Efficacy|0
826743|NCT01957488|2712428|P2|Test Period 3|Lack of Efficacy|1
826744|NCT01957488|2712429|P1|Test Period 3|Lack of Efficacy|0
826745|NCT01957488|2712424|P6|Test Period 3|Withdrawal by Subject|0
826746|NCT01957488|2712425|P5|Test Period 3|Withdrawal by Subject|0
826747|NCT01957488|2712426|P4|Test Period 3|Withdrawal by Subject|0
826748|NCT01957488|2712427|P3|Test Period 3|Withdrawal by Subject|0
826749|NCT01957488|2712428|P2|Test Period 3|Withdrawal by Subject|0
826750|NCT01957488|2712429|P1|Test Period 3|Withdrawal by Subject|1
826751|NCT01957488|2712424|P6|Test Period 2|Discontinue due to personal problems|1
826752|NCT01957488|2712425|P5|Test Period 2|Discontinue due to personal problems|0
826753|NCT01957488|2712426|P4|Test Period 2|Discontinue due to personal problems|0
826754|NCT01957488|2712427|P3|Test Period 2|Discontinue due to personal problems|0
826755|NCT01957488|2712428|P2|Test Period 2|Discontinue due to personal problems|0
826756|NCT01957488|2712429|P1|Test Period 2|Discontinue due to personal problems|0
826757|NCT01957488|2712424|P6|Test Period 2|Adverse Event|0
826758|NCT01957488|2712425|P5|Test Period 2|Adverse Event|2
826759|NCT01957488|2712426|P4|Test Period 2|Adverse Event|0
826760|NCT01957488|2712427|P3|Test Period 2|Adverse Event|0
826761|NCT01957488|2712428|P2|Test Period 2|Adverse Event|0
826762|NCT01957488|2712429|P1|Test Period 2|Adverse Event|0
826763|NCT01957488|2712424|P6|Test Period 2|Withdrawal by Subject|0
826764|NCT01957488|2712425|P5|Test Period 2|Withdrawal by Subject|0
826765|NCT01957488|2712426|P4|Test Period 2|Withdrawal by Subject|0
826766|NCT01957488|2712427|P3|Test Period 2|Withdrawal by Subject|0
826767|NCT01957488|2712428|P2|Test Period 2|Withdrawal by Subject|1
826768|NCT01957488|2712429|P1|Test Period 2|Withdrawal by Subject|0
826769|NCT01957488|2712424|P6|Test Period 2|Other|0
826770|NCT01957488|2712425|P5|Test Period 2|Other|0
826771|NCT01957488|2712426|P4|Test Period 2|Other|0
826772|NCT01957488|2712427|P3|Test Period 2|Other|0
826773|NCT01957488|2712428|P2|Test Period 2|Other|0
826774|NCT01957488|2712429|P1|Test Period 2|Other|1
826775|NCT01957488|2712424|P6|Test Period 2|Protocol Violation|0
826776|NCT01957488|2712425|P5|Test Period 2|Protocol Violation|0
826777|NCT01957488|2712426|P4|Test Period 2|Protocol Violation|1
826778|NCT01957488|2712427|P3|Test Period 2|Protocol Violation|1
826779|NCT01957488|2712428|P2|Test Period 2|Protocol Violation|0
826780|NCT01957488|2712429|P1|Test Period 2|Protocol Violation|2
826781|NCT01957488|2712424|P6|Test Period 1|screen failure|1
826782|NCT01957488|2712425|P5|Test Period 1|screen failure|0
826783|NCT01957488|2712426|P4|Test Period 1|screen failure|0
826784|NCT01957488|2712427|P3|Test Period 1|screen failure|0
826785|NCT01957488|2712428|P2|Test Period 1|screen failure|0
826786|NCT01957488|2712429|P1|Test Period 1|screen failure|0
826787|NCT01957488|2712424|P6|Test Period 1|subject did not want to wait for cut bag|0
826788|NCT01957488|2712425|P5|Test Period 1|subject did not want to wait for cut bag|1
826789|NCT01957488|2712426|P4|Test Period 1|subject did not want to wait for cut bag|0
826790|NCT01957488|2712427|P3|Test Period 1|subject did not want to wait for cut bag|0
826791|NCT01957488|2712428|P2|Test Period 1|subject did not want to wait for cut bag|0
826792|NCT01957488|2712429|P1|Test Period 1|subject did not want to wait for cut bag|0
826793|NCT01957488|2712424|P6|Test Period 1|Withdrawal by Subject|2
826794|NCT01957488|2712425|P5|Test Period 1|Withdrawal by Subject|1
826795|NCT01957488|2712426|P4|Test Period 1|Withdrawal by Subject|1
826796|NCT01957488|2712427|P3|Test Period 1|Withdrawal by Subject|0
826797|NCT01957488|2712428|P2|Test Period 1|Withdrawal by Subject|0
826798|NCT01957488|2712429|P1|Test Period 1|Withdrawal by Subject|0
826799|NCT01957488|2712424|P6|Test Period 1|Adverse Event|0
826800|NCT01957488|2712425|P5|Test Period 1|Adverse Event|1
826801|NCT01957488|2712426|P4|Test Period 1|Adverse Event|0
826802|NCT01957488|2712427|P3|Test Period 1|Adverse Event|1
826803|NCT01957488|2712428|P2|Test Period 1|Adverse Event|1
826804|NCT01957488|2712429|P1|Test Period 1|Adverse Event|0
826805|NCT01957488|2712424|P6|Test Period 1|Protocol Violation|3
826806|NCT01957488|2712425|P5|Test Period 1|Protocol Violation|0
826807|NCT01957488|2712426|P4|Test Period 1|Protocol Violation|1
826808|NCT01957488|2712427|P3|Test Period 1|Protocol Violation|2
826809|NCT01957488|2712428|P2|Test Period 1|Protocol Violation|2
826810|NCT01957488|2712429|P1|Test Period 1|Protocol Violation|1
826811|NCT01957488|2712424|P6|Test Period 1|Lost to Follow-up|0
826812|NCT01957488|2712425|P5|Test Period 1|Lost to Follow-up|0
826813|NCT01957488|2712426|P4|Test Period 1|Lost to Follow-up|1
826814|NCT01957488|2712427|P3|Test Period 1|Lost to Follow-up|1
826815|NCT01957488|2712428|P2|Test Period 1|Lost to Follow-up|0
826816|NCT01957488|2712429|P1|Test Period 1|Lost to Follow-up|2
826817|NCT01957475|2712437|P2|Test Period 2|Adverse Event|0
826818|NCT01957475|2712438|P1|Test Period 2|Adverse Event|1
826819|NCT01957475|2712437|P2|Test Period 1|Lack of Efficacy|1
826820|NCT01957475|2712438|P1|Test Period 1|Lack of Efficacy|0
826821|NCT01957475|2712437|P2|Test Period 1|Other|0
826822|NCT01957475|2712438|P1|Test Period 1|Other|1
826823|NCT01957475|2712437|P2|Test Period 1|Withdrawal by Subject|0
826824|NCT01957475|2712438|P1|Test Period 1|Withdrawal by Subject|1
826825|NCT01957462|2712444|P2|Test Period 1|Adverse Event|0
826826|NCT01957462|2712445|P1|Test Period 1|Adverse Event|1
826827|NCT01957462|2712444|P2|Test Period 1|Withdrawal by Subject|0
826828|NCT01957462|2712445|P1|Test Period 1|Withdrawal by Subject|1
826829|NCT01957397|2712456|P2|Test Period 3|the adhesive did not work|0
826830|NCT01957397|2712457|P1|Test Period 3|the adhesive did not work|1
826831|NCT01957397|2712456|P2|Test Period 3|Adverse Event|2
826832|NCT01957397|2712457|P1|Test Period 3|Adverse Event|1
826833|NCT01957397|2712456|P2|Test Period 2|Adverse Event|1
826834|NCT01957397|2712457|P1|Test Period 2|Adverse Event|0
826835|NCT01957397|2712456|P2|Test Period 1|Withdrawal by Subject|0
826836|NCT01957397|2712457|P1|Test Period 1|Withdrawal by Subject|1
826837|NCT01957397|2712456|P2|Test Period 1|sudden leakage/small bag|1
826838|NCT01957397|2712457|P1|Test Period 1|sudden leakage/small bag|1
826839|NCT01957215|2712482|P2|Overall Study|Withdrawal by Subject|5
826840|NCT01957215|2712483|P1|Overall Study|Withdrawal by Subject|7
826841|NCT01957215|2712482|P2|Overall Study|Protocol Violation|2
826842|NCT01957215|2712483|P1|Overall Study|Protocol Violation|1
826843|NCT01957215|2712482|P2|Overall Study|Lost to Follow-up|3
826844|NCT01957215|2712483|P1|Overall Study|Lost to Follow-up|3
826845|NCT01957215|2712482|P2|Overall Study|Adverse Event|2
826846|NCT01957215|2712483|P1|Overall Study|Adverse Event|2
826847|NCT01957202|2712511|P18|Treatment Period 3 (8 Days)|Adverse Event|0
826848|NCT01957202|2712512|P17|Treatment Period 3 (8 Days)|Adverse Event|1
826849|NCT01957202|2712513|P16|Treatment Period 3 (8 Days)|Adverse Event|0
826850|NCT01957202|2712514|P15|Treatment Period 3 (8 Days)|Adverse Event|0
826851|NCT01957202|2712515|P14|Treatment Period 3 (8 Days)|Adverse Event|0
826852|NCT01957202|2712516|P13|Treatment Period 3 (8 Days)|Adverse Event|0
826853|NCT01957202|2712517|P12|Treatment Period 3 (8 Days)|Adverse Event|0
826854|NCT01957202|2712518|P11|Treatment Period 3 (8 Days)|Adverse Event|0
826855|NCT01957202|2712519|P10|Treatment Period 3 (8 Days)|Adverse Event|0
826856|NCT01957202|2712520|P9|Treatment Period 3 (8 Days)|Adverse Event|0
826857|NCT01957202|2712521|P8|Treatment Period 3 (8 Days)|Adverse Event|0
826858|NCT01957202|2712522|P7|Treatment Period 3 (8 Days)|Adverse Event|0
826859|NCT01957202|2712523|P6|Treatment Period 3 (8 Days)|Adverse Event|0
826860|NCT01957202|2712524|P5|Treatment Period 3 (8 Days)|Adverse Event|0
826861|NCT01957202|2712525|P4|Treatment Period 3 (8 Days)|Adverse Event|0
826862|NCT01957202|2712526|P3|Treatment Period 3 (8 Days)|Adverse Event|0
826863|NCT01957202|2712527|P2|Treatment Period 3 (8 Days)|Adverse Event|0
826864|NCT01957202|2712528|P1|Treatment Period 3 (8 Days)|Adverse Event|0
826865|NCT01957202|2712511|P18|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
826866|NCT01957202|2712512|P17|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
826867|NCT01957202|2712513|P16|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
826868|NCT01957202|2712514|P15|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
826869|NCT01957202|2712515|P14|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
826870|NCT01957202|2712516|P13|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
826871|NCT01957202|2712517|P12|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
826872|NCT01957202|2712518|P11|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
826873|NCT01957202|2712519|P10|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
826874|NCT01957202|2712520|P9|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
826875|NCT01957202|2712521|P8|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
826876|NCT01957202|2712522|P7|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
826877|NCT01957202|2712523|P6|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
826878|NCT01957202|2712524|P5|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
826879|NCT01957202|2712525|P4|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
826880|NCT01957202|2712526|P3|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
826881|NCT01957202|2712527|P2|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
826882|NCT01957202|2712528|P1|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
826883|NCT01957163|2712553|P3|Overall Study|Withdrawal by Subject|4
826884|NCT01957163|2712554|P2|Overall Study|Withdrawal by Subject|2
826885|NCT01957163|2712555|P1|Overall Study|Withdrawal by Subject|4
826886|NCT01957163|2712553|P3|Overall Study|Lost to Follow-up|0
826887|NCT01957163|2712554|P2|Overall Study|Lost to Follow-up|1
826888|NCT01957163|2712555|P1|Overall Study|Lost to Follow-up|0
826889|NCT01957163|2712553|P3|Overall Study|Met Protocol-Defined Stopping Criteria|1
826890|NCT01957163|2712554|P2|Overall Study|Met Protocol-Defined Stopping Criteria|0
826891|NCT01957163|2712555|P1|Overall Study|Met Protocol-Defined Stopping Criteria|0
826892|NCT01957163|2712553|P3|Overall Study|Protocol Violation|0
826893|NCT01957163|2712554|P2|Overall Study|Protocol Violation|2
826894|NCT01957163|2712555|P1|Overall Study|Protocol Violation|1
826895|NCT01957163|2712553|P3|Overall Study|Lack of Efficacy|9
826896|NCT01957163|2712554|P2|Overall Study|Lack of Efficacy|4
826897|NCT01957163|2712555|P1|Overall Study|Lack of Efficacy|5
826898|NCT01957163|2712553|P3|Overall Study|Adverse Event|4
826899|NCT01957163|2712554|P2|Overall Study|Adverse Event|2
826900|NCT01957163|2712555|P1|Overall Study|Adverse Event|5
826901|NCT01957137|2712566|P1|Randomized Portion|Withdrawal by Subject|1
826902|NCT01957137|2712566|P1|Randomized Portion|Adverse Event|1
826903|NCT01957111|2712596|P2|Overall Study|Withdrawal by Subject|1
826904|NCT01957111|2712597|P1|Overall Study|Withdrawal by Subject|1
826905|NCT01956240|2712615|P2|Overall Study|Adverse Event|4
826906|NCT01956240|2712616|P1|Overall Study|Adverse Event|17
826907|NCT01956240|2712615|P2|Overall Study|Lost to Follow-up|20
826908|NCT01956240|2712616|P1|Overall Study|Lost to Follow-up|6
826909|NCT01956123|2712626|P4|COS Cycle 3|Withdrawal by Subject|1
826910|NCT01956123|2712627|P3|COS Cycle 3|Withdrawal by Subject|0
826911|NCT01956123|2712628|P2|COS Cycle 3|Withdrawal by Subject|0
826912|NCT01956123|2712629|P1|COS Cycle 3|Withdrawal by Subject|0
826913|NCT01956123|2712626|P4|COS Cycle 3|Personal Reasons|0
826914|NCT01956123|2712627|P3|COS Cycle 3|Personal Reasons|1
826915|NCT01956123|2712628|P2|COS Cycle 3|Personal Reasons|0
826916|NCT01956123|2712629|P1|COS Cycle 3|Personal Reasons|0
826917|NCT01956123|2712626|P4|COS Cycle 3|Adverse Event|0
826918|NCT01956123|2712627|P3|COS Cycle 3|Adverse Event|3
826919|NCT01956123|2712628|P2|COS Cycle 3|Adverse Event|0
826920|NCT01956123|2712629|P1|COS Cycle 3|Adverse Event|0
826921|NCT01956123|2712626|P4|COS Cycle 3|Protocol Violation|1
826922|NCT01956123|2712627|P3|COS Cycle 3|Protocol Violation|2
826923|NCT01956123|2712628|P2|COS Cycle 3|Protocol Violation|0
826924|NCT01956123|2712629|P1|COS Cycle 3|Protocol Violation|0
826925|NCT01956123|2712626|P4|COS Cycle 2|Withdrawal by Subject|0
826926|NCT01956123|2712627|P3|COS Cycle 2|Withdrawal by Subject|0
826927|NCT01956123|2712628|P2|COS Cycle 2|Withdrawal by Subject|0
826928|NCT01956123|2712629|P1|COS Cycle 2|Withdrawal by Subject|1
826929|NCT01956123|2712626|P4|COS Cycle 2|Personal Reasons|0
826930|NCT01956123|2712627|P3|COS Cycle 2|Personal Reasons|0
826931|NCT01956123|2712628|P2|COS Cycle 2|Personal Reasons|0
826932|NCT01956123|2712629|P1|COS Cycle 2|Personal Reasons|2
826933|NCT01956123|2712626|P4|COS Cycle 2|Adverse Event|0
826934|NCT01956123|2712627|P3|COS Cycle 2|Adverse Event|0
826935|NCT01956123|2712628|P2|COS Cycle 2|Adverse Event|4
826936|NCT01956123|2712629|P1|COS Cycle 2|Adverse Event|3
826937|NCT01956123|2712626|P4|COS Cycle 2|Protocol Violation|0
826938|NCT01956123|2712627|P3|COS Cycle 2|Protocol Violation|0
826939|NCT01956123|2712628|P2|COS Cycle 2|Protocol Violation|3
826940|NCT01956123|2712629|P1|COS Cycle 2|Protocol Violation|8
826941|NCT01956110|2712681|P2|Overall Study|Personal reasons|1
826942|NCT01956110|2712682|P1|Overall Study|Personal reasons|1
826943|NCT01956110|2712681|P2|Overall Study|Adverse Event|10
826944|NCT01956110|2712682|P1|Overall Study|Adverse Event|9
826945|NCT01956110|2712681|P2|Overall Study|Protocol Violation|11
826946|NCT01956110|2712682|P1|Overall Study|Protocol Violation|25
826947|NCT01955733|2712813|P3|Period 2|Other not defined above|2
826948|NCT01955733|2712814|P2|Period 2|Other not defined above|2
826949|NCT01955733|2712815|P1|Period 2|Other not defined above|0
826950|NCT01955733|2712813|P3|Period 2|Lost to Follow-up|0
826951|NCT01955733|2712814|P2|Period 2|Lost to Follow-up|0
826952|NCT01955733|2712815|P1|Period 2|Lost to Follow-up|2
826953|NCT01955733|2712813|P3|Period 2|Study terminated by sponsor|16
826954|NCT01955733|2712814|P2|Period 2|Study terminated by sponsor|14
826955|NCT01955733|2712815|P1|Period 2|Study terminated by sponsor|8
826956|NCT01955733|2712813|P3|Period 2|Withdrawal by Subject|2
826957|NCT01955733|2712814|P2|Period 2|Withdrawal by Subject|3
826958|NCT01955733|2712815|P1|Period 2|Withdrawal by Subject|1
826959|NCT01955733|2712813|P3|Period 2|Physician Decision|1
826960|NCT01955733|2712814|P2|Period 2|Physician Decision|0
826961|NCT01955733|2712815|P1|Period 2|Physician Decision|0
826962|NCT01955733|2712813|P3|Period 2|Adverse Event|0
826963|NCT01955733|2712814|P2|Period 2|Adverse Event|0
826964|NCT01955733|2712815|P1|Period 2|Adverse Event|1
826965|NCT01955733|2712813|P3|Period 1|Lost to Follow-up|0
826966|NCT01955733|2712814|P2|Period 1|Lost to Follow-up|0
826967|NCT01955733|2712815|P1|Period 1|Lost to Follow-up|1
826968|NCT01955707|2712908|P2|Overall Study|Not Specified|2
826969|NCT01955707|2712909|P1|Overall Study|Not Specified|4
826970|NCT01955707|2712908|P2|Overall Study|Death|14
826971|NCT01955707|2712909|P1|Overall Study|Death|13
826972|NCT01955707|2712908|P2|Overall Study|Withdrawal by Subject|3
826973|NCT01955707|2712909|P1|Overall Study|Withdrawal by Subject|0
826974|NCT01955707|2712908|P2|Overall Study|Lost to Follow-up|1
826975|NCT01955707|2712909|P1|Overall Study|Lost to Follow-up|2
826976|NCT01955707|2712908|P2|Overall Study|Adverse Event|2
826977|NCT01955707|2712909|P1|Overall Study|Adverse Event|1
826978|NCT01955161|2713177|P3|Overall Study|Other reason: patient's will|1
826979|NCT01955161|2713178|P2|Overall Study|Other reason: patient's will|0
826980|NCT01955161|2713179|P1|Overall Study|Other reason: patient's will|0
826981|NCT01955161|2713177|P3|Overall Study|Other reason: primary biliary cirrhosis|0
826982|NCT01955161|2713178|P2|Overall Study|Other reason: primary biliary cirrhosis|0
826983|NCT01955161|2713179|P1|Overall Study|Other reason: primary biliary cirrhosis|1
826984|NCT01955161|2713177|P3|Overall Study|Other reason: insufficient compliance|1
826985|NCT01955161|2713178|P2|Overall Study|Other reason: insufficient compliance|0
826986|NCT01955161|2713179|P1|Overall Study|Other reason: insufficient compliance|0
826987|NCT01955161|2713177|P3|Overall Study|Other reason: moved to nursing home|0
826988|NCT01955161|2713178|P2|Overall Study|Other reason: moved to nursing home|1
826989|NCT01955161|2713179|P1|Overall Study|Other reason: moved to nursing home|0
826990|NCT01955161|2713177|P3|Overall Study|Other reason: caregiver unavailable|0
826991|NCT01955161|2713178|P2|Overall Study|Other reason: caregiver unavailable|0
826992|NCT01955161|2713179|P1|Overall Study|Other reason: caregiver unavailable|1
826993|NCT01955161|2713177|P3|Overall Study|Other reason: disallowed medication|1
826994|NCT01955161|2713178|P2|Overall Study|Other reason: disallowed medication|0
826995|NCT01955161|2713179|P1|Overall Study|Other reason: disallowed medication|1
826996|NCT01955161|2713177|P3|Overall Study|Other reason: physician decision|1
826997|NCT01955161|2713178|P2|Overall Study|Other reason: physician decision|1
826998|NCT01955161|2713179|P1|Overall Study|Other reason: physician decision|0
826999|NCT01955161|2713177|P3|Overall Study|Protocol Violation|0
827000|NCT01955161|2713178|P2|Overall Study|Protocol Violation|0
827001|NCT01955161|2713179|P1|Overall Study|Protocol Violation|2
827002|NCT01955161|2713177|P3|Overall Study|Withdrawal by Subject|12
827003|NCT01955161|2713178|P2|Overall Study|Withdrawal by Subject|8
827004|NCT01955161|2713179|P1|Overall Study|Withdrawal by Subject|9
827005|NCT01955161|2713177|P3|Overall Study|Death|3
827006|NCT01955161|2713178|P2|Overall Study|Death|1
827007|NCT01955161|2713179|P1|Overall Study|Death|1
827008|NCT01955161|2713177|P3|Overall Study|Adverse Event|15
827009|NCT01955161|2713178|P2|Overall Study|Adverse Event|14
827010|NCT01955161|2713179|P1|Overall Study|Adverse Event|10
827011|NCT01955161|2713177|P3|Overall Study|Withdrawal before treatment|1
827012|NCT01955161|2713178|P2|Overall Study|Withdrawal before treatment|0
827013|NCT01955161|2713179|P1|Overall Study|Withdrawal before treatment|2
827014|NCT01955122|2713219|P2|Overall Study|Physician Decision|5
827015|NCT01955122|2713220|P1|Overall Study|Physician Decision|5
827016|NCT01955083|2713240|P2|Overall Study|Lost to Follow-up|1
827017|NCT01955083|2713241|P1|Overall Study|Lost to Follow-up|1
827018|NCT01955044|2713274|P3|Overall Study|Death|0
827019|NCT01955044|2713275|P2|Overall Study|Death|1
827020|NCT01955044|2713276|P1|Overall Study|Death|1
827021|NCT01955005|2713289|P2|Overall Study|Withdrawal by Subject|5
827022|NCT01955005|2713290|P1|Overall Study|Withdrawal by Subject|3
827023|NCT01954771|2713303|P3|Overall Study|Missing HbA1c and CGMS of end-point|3
827024|NCT01954771|2713304|P2|Overall Study|Missing HbA1c and CGMS of end-point|1
827025|NCT01954771|2713305|P1|Overall Study|Missing HbA1c and CGMS of end-point|5
827026|NCT01954771|2713303|P3|Overall Study|Missing CGMS of end-point|0
827027|NCT01954771|2713304|P2|Overall Study|Missing CGMS of end-point|1
827028|NCT01954771|2713305|P1|Overall Study|Missing CGMS of end-point|1
827029|NCT01954771|2713303|P3|Overall Study|Missing HbA1c of end-point|0
827030|NCT01954771|2713304|P2|Overall Study|Missing HbA1c of end-point|1
827031|NCT01954771|2713305|P1|Overall Study|Missing HbA1c of end-point|1
827032|NCT01954745|2713322|P1|Overall Study|Death|1
827033|NCT01954745|2713322|P1|Overall Study|Adverse Event|2
827034|NCT01954745|2713322|P1|Overall Study|Clinical Progression|5
827035|NCT01954745|2713322|P1|Overall Study|Radiological Progression|11
827036|NCT01954394|2713353|P2|Overall Study|Other than specified above|21
827037|NCT01954394|2713354|P1|Overall Study|Other than specified above|10
827038|NCT01954394|2713353|P2|Overall Study|Related to Study Drug administration|2
827039|NCT01954394|2713354|P1|Overall Study|Related to Study Drug administration|2
827040|NCT01954394|2713353|P2|Overall Study|Participant Moved|4
827041|NCT01954394|2713354|P1|Overall Study|Participant Moved|0
827042|NCT01954394|2713353|P2|Overall Study|Poor compliance to protocol|7
827043|NCT01954394|2713354|P1|Overall Study|Poor compliance to protocol|7
827044|NCT01954394|2713353|P2|Overall Study|Adverse Event|23
827045|NCT01954394|2713354|P1|Overall Study|Adverse Event|10
827046|NCT01954394|2713353|P2|Overall Study|Enrolled but not treated|0
827047|NCT01954394|2713354|P1|Overall Study|Enrolled but not treated|1
827048|NCT01954251|2713456|P2|Overall Study|Withdrawal by Subject|6
827049|NCT01954251|2713457|P1|Overall Study|Withdrawal by Subject|2
827050|NCT01954251|2713456|P2|Overall Study|Lost to Follow-up|6
827051|NCT01954251|2713457|P1|Overall Study|Lost to Follow-up|6
827052|NCT01954251|2713456|P2|Overall Study|Adverse Event|7
827053|NCT01954251|2713457|P1|Overall Study|Adverse Event|5
827054|NCT01954121|2713554|P2|Overall Study|Subject did not follow instructions|2
827055|NCT01954121|2713555|P1|Overall Study|Subject did not follow instructions|0
827056|NCT01954121|2713554|P2|Overall Study|Non-compliant patient|1
827057|NCT01954121|2713555|P1|Overall Study|Non-compliant patient|1
827058|NCT01954121|2713554|P2|Overall Study|Non-compliant with study procedures|0
827059|NCT01954121|2713555|P1|Overall Study|Non-compliant with study procedures|1
827060|NCT01954121|2713554|P2|Overall Study|SAE, non-fatal|4
827061|NCT01954121|2713555|P1|Overall Study|SAE, non-fatal|1
827062|NCT01954121|2713554|P2|Overall Study|AE, non-serious non-fatal|22
827063|NCT01954121|2713555|P1|Overall Study|AE, non-serious non-fatal|5
827064|NCT01954121|2713554|P2|Overall Study|AE, serious fatal|0
827065|NCT01954121|2713555|P1|Overall Study|AE, serious fatal|1
827066|NCT01954121|2713554|P2|Overall Study|Pregnancy|1
827067|NCT01954121|2713555|P1|Overall Study|Pregnancy|1
827068|NCT01954121|2713554|P2|Overall Study|Withdrawal by Subject|12
827069|NCT01954121|2713555|P1|Overall Study|Withdrawal by Subject|18
827070|NCT01954121|2713554|P2|Overall Study|Lost to Follow-up|6
827071|NCT01954121|2713555|P1|Overall Study|Lost to Follow-up|5
827072|NCT01954121|2713554|P2|Overall Study|Protocol Violation|2
827073|NCT01954121|2713555|P1|Overall Study|Protocol Violation|0
827074|NCT01954121|2713554|P2|Overall Study|Lack of Efficacy|41
827075|NCT01954121|2713555|P1|Overall Study|Lack of Efficacy|94
827076|NCT01954082|2713571|P2|Overall Study|Randomized not Treated|2
827077|NCT01954082|2713572|P1|Overall Study|Randomized not Treated|4
827078|NCT01954082|2713571|P2|Overall Study|Infant Moved|1
827079|NCT01954082|2713572|P1|Overall Study|Infant Moved|0
827080|NCT01954082|2713571|P2|Overall Study|Comfort Care|1
827081|NCT01954082|2713572|P1|Overall Study|Comfort Care|0
827082|NCT01954082|2713571|P2|Overall Study|Miscalculation of Final Dose Day|3
827083|NCT01954082|2713572|P1|Overall Study|Miscalculation of Final Dose Day|0
827084|NCT01954082|2713571|P2|Overall Study|Redirection of Care|2
827085|NCT01954082|2713572|P1|Overall Study|Redirection of Care|0
827086|NCT01954082|2713571|P2|Overall Study|Discontinued Early Prior to Transfer|2
827087|NCT01954082|2713572|P1|Overall Study|Discontinued Early Prior to Transfer|3
827088|NCT01954082|2713571|P2|Overall Study|Withdrawal by Subject|1
827089|NCT01954082|2713572|P1|Overall Study|Withdrawal by Subject|0
827090|NCT01954082|2713571|P2|Overall Study|Parent Decision|0
827091|NCT01954082|2713572|P1|Overall Study|Parent Decision|1
827092|NCT01954082|2713571|P2|Overall Study|Physician Decision|0
827093|NCT01954082|2713572|P1|Overall Study|Physician Decision|2
827094|NCT01954082|2713571|P2|Overall Study|Non-compliance|4
827095|NCT01954082|2713572|P1|Overall Study|Non-compliance|6
827096|NCT01954082|2713571|P2|Overall Study|Intolerance|1
827097|NCT01954082|2713572|P1|Overall Study|Intolerance|0
827098|NCT01954082|2713571|P2|Overall Study|Adverse Event|4
827099|NCT01954082|2713572|P1|Overall Study|Adverse Event|10
827100|NCT01954082|2713571|P2|Overall Study|Study Suspension|36
827101|NCT01954082|2713572|P1|Overall Study|Study Suspension|42
827102|NCT01953354|2713638|P2|Overall Study|Disease Exacerbation|0
827103|NCT01953354|2713639|P1|Overall Study|Disease Exacerbation|1
827104|NCT01953354|2713638|P2|Overall Study|Decision of Sponsor|1
827105|NCT01953354|2713639|P1|Overall Study|Decision of Sponsor|0
827106|NCT01953354|2713638|P2|Overall Study|Withdrawal by Subject|1
827107|NCT01953354|2713639|P1|Overall Study|Withdrawal by Subject|0
827108|NCT01953328|2713667|P8|Overall Study|Lost to Follow-up|0
827109|NCT01953328|2713668|P7|Overall Study|Lost to Follow-up|0
827110|NCT01953328|2713669|P6|Overall Study|Lost to Follow-up|0
827111|NCT01953328|2713670|P5|Overall Study|Lost to Follow-up|1
827112|NCT01953328|2713671|P4|Overall Study|Lost to Follow-up|0
827113|NCT01953328|2713672|P3|Overall Study|Lost to Follow-up|0
827114|NCT01953328|2713673|P2|Overall Study|Lost to Follow-up|0
827115|NCT01953328|2713674|P1|Overall Study|Lost to Follow-up|0
827116|NCT01953328|2713667|P8|Overall Study|Withdrawal by Subject|0
827117|NCT01953328|2713668|P7|Overall Study|Withdrawal by Subject|0
827118|NCT01953328|2713669|P6|Overall Study|Withdrawal by Subject|0
827119|NCT01953328|2713670|P5|Overall Study|Withdrawal by Subject|1
827120|NCT01953328|2713671|P4|Overall Study|Withdrawal by Subject|0
827121|NCT01953328|2713672|P3|Overall Study|Withdrawal by Subject|0
827122|NCT01953328|2713673|P2|Overall Study|Withdrawal by Subject|0
827123|NCT01953328|2713674|P1|Overall Study|Withdrawal by Subject|0
827124|NCT01953224|2713887|P2|Overall Study|Withdrawal by Subject|2
827125|NCT01953224|2713888|P1|Overall Study|Withdrawal by Subject|1
827126|NCT01953224|2713887|P2|Overall Study|Lost to Follow-up|1
827127|NCT01953224|2713888|P1|Overall Study|Lost to Follow-up|1
827128|NCT01952834|2713923|P1|Overall Study|Adverse Event|1
827129|NCT01952691|2713930|P1|Overall Study|Lost to Follow-up|2
827130|NCT01952665|2713957|P2|Overall Study|Protocol Violation|1
827131|NCT01952665|2713958|P1|Overall Study|Protocol Violation|0
827132|NCT01952665|2713957|P2|Overall Study|Adverse Event|1
827133|NCT01952665|2713958|P1|Overall Study|Adverse Event|2
827134|NCT01952665|2713957|P2|Overall Study|Lost to Follow-up|2
827135|NCT01952665|2713958|P1|Overall Study|Lost to Follow-up|1
827136|NCT01952665|2713957|P2|Overall Study|Physician Decision|2
827137|NCT01952665|2713958|P1|Overall Study|Physician Decision|3
827138|NCT01952574|2714113|P4|Overall Study|Lost to Follow-up|0
827139|NCT01952574|2714114|P3|Overall Study|Lost to Follow-up|1
827140|NCT01952574|2714115|P2|Overall Study|Lost to Follow-up|0
827141|NCT01952574|2714116|P1|Overall Study|Lost to Follow-up|2
827142|NCT01952574|2714113|P4|Overall Study|Sponsor Decision|2
827143|NCT01952574|2714114|P3|Overall Study|Sponsor Decision|5
827144|NCT01952574|2714115|P2|Overall Study|Sponsor Decision|0
827145|NCT01952574|2714116|P1|Overall Study|Sponsor Decision|6
827146|NCT01952574|2714113|P4|Overall Study|Withdrawal by Subject|4
827147|NCT01952574|2714114|P3|Overall Study|Withdrawal by Subject|3
827148|NCT01952574|2714115|P2|Overall Study|Withdrawal by Subject|3
827149|NCT01952574|2714116|P1|Overall Study|Withdrawal by Subject|9
827150|NCT01952366|2714149|P1|Overall Study|Withdrawal by Subject|9
827151|NCT01952366|2714149|P1|Overall Study|Death|22
827152|NCT01952145|2714164|P2|Overall Study|Unclassified|1
827153|NCT01952145|2714165|P1|Overall Study|Unclassified|1
827154|NCT01952145|2714164|P2|Overall Study|Withdrawal Criteria|11
827155|NCT01952145|2714165|P1|Overall Study|Withdrawal Criteria|16
827156|NCT01952145|2714164|P2|Overall Study|Adverse Event|0
827157|NCT01952145|2714165|P1|Overall Study|Adverse Event|9
827158|NCT01952145|2714164|P2|Overall Study|Death|1
827159|NCT01952145|2714165|P1|Overall Study|Death|0
827160|NCT01952145|2714164|P2|Overall Study|Protocol Violation|1
827161|NCT01952145|2714165|P1|Overall Study|Protocol Violation|2
827162|NCT01952080|2714179|P4|Overall Study|Protocol Non-compliance|0
827163|NCT01952080|2714180|P3|Overall Study|Protocol Non-compliance|0
827164|NCT01952080|2714181|P2|Overall Study|Protocol Non-compliance|1
827165|NCT01952080|2714182|P1|Overall Study|Protocol Non-compliance|0
827166|NCT01952080|2714179|P4|Overall Study|Withdrawal by Subject|1
827167|NCT01952080|2714180|P3|Overall Study|Withdrawal by Subject|0
827168|NCT01952080|2714181|P2|Overall Study|Withdrawal by Subject|0
827169|NCT01952080|2714182|P1|Overall Study|Withdrawal by Subject|0
827170|NCT01951703|2714261|P2|Second Intervention|Unsatisfactory Lens fitting|1
827171|NCT01951703|2714262|P1|Second Intervention|Unsatisfactory Lens fitting|0
827172|NCT01951703|2714261|P2|Second Intervention|Protocol Violation|1
827173|NCT01951703|2714262|P1|Second Intervention|Protocol Violation|0
827174|NCT01951703|2714261|P2|First Intervention|Physician Decision|0
827175|NCT01951703|2714262|P1|First Intervention|Physician Decision|1
827176|NCT01951703|2714261|P2|First Intervention|Subject was not compliant|1
827177|NCT01951703|2714262|P1|First Intervention|Subject was not compliant|1
827178|NCT01951703|2714261|P2|First Intervention|Withdrawal by Subject|0
827179|NCT01951703|2714262|P1|First Intervention|Withdrawal by Subject|1
827180|NCT01951586|2714287|P2|Overall Study|Withdrawal by Subject|13
827181|NCT01951586|2714288|P1|Overall Study|Withdrawal by Subject|7
827182|NCT01951586|2714287|P2|Overall Study|Death|100
827183|NCT01951586|2714288|P1|Overall Study|Death|52
827184|NCT01951573|2714312|P2|Washout Period|Adverse Event|1
827185|NCT01951573|2714313|P1|Washout Period|Adverse Event|0
827186|NCT01951417|2714323|P1|Overall Study|Lost to Follow-up|6
827187|NCT01951417|2714323|P1|Overall Study|Protocol Violation|2
827188|NCT01951417|2714323|P1|Overall Study|Withdrawal by Subject|1
827189|NCT01951170|2714346|P1|Overall Study|Investigator decision|1
827190|NCT01951092|2714369|P1|Overall Study|Transfer of Care|1
827191|NCT01951092|2714369|P1|Overall Study|Incarceration|1
827192|NCT01951092|2714369|P1|Overall Study|Lost to Follow-up|10
827193|NCT01950741|2714380|P1|Overall Study|Withdrawal by Subject|1
827194|NCT01950741|2714380|P1|Overall Study|Death|1
827195|NCT01950741|2714380|P1|Overall Study|Lost to Follow-up|1
827196|NCT01950364|2714395|P2|Overall Study|Protocol Violation|1
827197|NCT01950364|2714396|P1|Overall Study|Protocol Violation|0
827198|NCT01950364|2714395|P2|Overall Study|Withdrawal by Subject|1
827199|NCT01950364|2714396|P1|Overall Study|Withdrawal by Subject|0
827200|NCT01950364|2714395|P2|Overall Study|Disease Progression|2
827201|NCT01950364|2714396|P1|Overall Study|Disease Progression|5
827202|NCT01950364|2714395|P2|Overall Study|Stem Cell Transplant|6
827203|NCT01950364|2714396|P1|Overall Study|Stem Cell Transplant|2
827204|NCT01950364|2714395|P2|Overall Study|Adverse Event|0
827205|NCT01950364|2714396|P1|Overall Study|Adverse Event|3
827206|NCT01950273|2714496|P2|Overall Study|Other not defined above|0
827207|NCT01950273|2714497|P1|Overall Study|Other not defined above|1
827208|NCT01950273|2714496|P2|Overall Study|Withdrawal by Subject|0
827209|NCT01950273|2714497|P1|Overall Study|Withdrawal by Subject|2
827210|NCT01950273|2714496|P2|Overall Study|Protocol Violation|0
827211|NCT01950273|2714497|P1|Overall Study|Protocol Violation|1
827212|NCT01949870|2714528|P1|Overall Study|Eligibility requirements not fulfilled|2
827213|NCT01949870|2714528|P1|Overall Study|Study termination|1
827214|NCT01949870|2714528|P1|Overall Study|Adverse Event|1
827215|NCT01949870|2714528|P1|Overall Study|Lack of Efficacy|2
827216|NCT01949532|2714691|P2|Overall Study|On-study at the Data Cut-off Date|3
827217|NCT01949532|2714692|P1|Overall Study|On-study at the Data Cut-off Date|3
827218|NCT01949155|2714767|P2|Overall Study|Protocol Violation|0
827219|NCT01949155|2714768|P1|Overall Study|Protocol Violation|1
827220|NCT01949155|2714767|P2|Overall Study|Lost to Follow-up|0
827221|NCT01949155|2714768|P1|Overall Study|Lost to Follow-up|1
827222|NCT01949142|2714780|P2|Overall Study|Parent changed their mind|0
827223|NCT01949142|2714781|P1|Overall Study|Parent changed their mind|1
827224|NCT01949142|2714780|P2|Overall Study|Lost to Follow-up|1
827225|NCT01949142|2714781|P1|Overall Study|Lost to Follow-up|1
827226|NCT01949142|2714780|P2|Overall Study|Withdrawal of consent|0
827227|NCT01949142|2714781|P1|Overall Study|Withdrawal of consent|1
827228|NCT01949116|2714793|P2|Overall Study|Withdrawal by Subject|3
827229|NCT01949116|2714794|P1|Overall Study|Withdrawal by Subject|5
827230|NCT01949116|2714793|P2|Overall Study|Lost to Follow-up|3
827231|NCT01949116|2714794|P1|Overall Study|Lost to Follow-up|1
827232|NCT01949116|2714793|P2|Overall Study|Death|0
827233|NCT01949116|2714794|P1|Overall Study|Death|2
827234|NCT01949090|2714831|P5|Overall Study|Lost to Follow-up|1
827235|NCT01949090|2714832|P4|Overall Study|Lost to Follow-up|1
827236|NCT01949090|2714833|P3|Overall Study|Lost to Follow-up|0
827237|NCT01949090|2714834|P2|Overall Study|Lost to Follow-up|1
827238|NCT01949090|2714835|P1|Overall Study|Lost to Follow-up|2
827239|NCT01949090|2714831|P5|Overall Study|Protocol non-compliance|1
827240|NCT01949090|2714832|P4|Overall Study|Protocol non-compliance|0
827241|NCT01949090|2714833|P3|Overall Study|Protocol non-compliance|0
827242|NCT01949090|2714834|P2|Overall Study|Protocol non-compliance|0
827243|NCT01949090|2714835|P1|Overall Study|Protocol non-compliance|0
827244|NCT01949090|2714831|P5|Overall Study|Withdrawal by Subject|1
827245|NCT01949090|2714832|P4|Overall Study|Withdrawal by Subject|0
827246|NCT01949090|2714833|P3|Overall Study|Withdrawal by Subject|0
827247|NCT01949090|2714834|P2|Overall Study|Withdrawal by Subject|0
827248|NCT01949090|2714835|P1|Overall Study|Withdrawal by Subject|2
827249|NCT01949090|2714831|P5|Overall Study|Serious Adverse Event|1
827250|NCT01949090|2714832|P4|Overall Study|Serious Adverse Event|0
827251|NCT01949090|2714833|P3|Overall Study|Serious Adverse Event|2
827252|NCT01949090|2714834|P2|Overall Study|Serious Adverse Event|1
827253|NCT01949090|2714835|P1|Overall Study|Serious Adverse Event|0
827254|NCT01949051|2715012|P6|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
827255|NCT01949051|2715013|P5|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
827256|NCT01949051|2715014|P4|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
827257|NCT01949051|2715015|P3|Treatment Period 2 (7 Days)|Withdrawal by Subject|1
827258|NCT01949051|2715016|P2|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
827259|NCT01949051|2715017|P1|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
827260|NCT01949051|2715012|P6|Treatment Period 2 (7 Days)|Lost to Follow-up|0
827261|NCT01949051|2715013|P5|Treatment Period 2 (7 Days)|Lost to Follow-up|0
827262|NCT01949051|2715014|P4|Treatment Period 2 (7 Days)|Lost to Follow-up|0
827263|NCT01949051|2715015|P3|Treatment Period 2 (7 Days)|Lost to Follow-up|0
827264|NCT01949051|2715016|P2|Treatment Period 2 (7 Days)|Lost to Follow-up|1
827265|NCT01949051|2715017|P1|Treatment Period 2 (7 Days)|Lost to Follow-up|0
827266|NCT01949051|2715012|P6|Treatment Period 2 (7 Days)|Protocol Violation|1
827267|NCT01949051|2715013|P5|Treatment Period 2 (7 Days)|Protocol Violation|0
827268|NCT01949051|2715014|P4|Treatment Period 2 (7 Days)|Protocol Violation|0
827269|NCT01949051|2715015|P3|Treatment Period 2 (7 Days)|Protocol Violation|0
827270|NCT01949051|2715016|P2|Treatment Period 2 (7 Days)|Protocol Violation|0
827271|NCT01949051|2715017|P1|Treatment Period 2 (7 Days)|Protocol Violation|0
827272|NCT01949051|2715012|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
827273|NCT01949051|2715013|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|0
827274|NCT01949051|2715014|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
827275|NCT01949051|2715015|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
827276|NCT01949051|2715016|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
827277|NCT01949051|2715017|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|1
827278|NCT01949051|2715012|P6|Treatment Period 1 (7 Days)|Protocol Violation|0
827279|NCT01949051|2715013|P5|Treatment Period 1 (7 Days)|Protocol Violation|0
827280|NCT01949051|2715014|P4|Treatment Period 1 (7 Days)|Protocol Violation|1
827281|NCT01949051|2715015|P3|Treatment Period 1 (7 Days)|Protocol Violation|0
827282|NCT01949051|2715016|P2|Treatment Period 1 (7 Days)|Protocol Violation|0
827283|NCT01949051|2715017|P1|Treatment Period 1 (7 Days)|Protocol Violation|1
827284|NCT01948908|2715046|P3|Overall Study|Protocol Violation|2
827285|NCT01948908|2715047|P2|Overall Study|Protocol Violation|0
827286|NCT01948908|2715048|P1|Overall Study|Protocol Violation|1
827287|NCT01948830|2715064|P2|Overall Study|Death|4
827288|NCT01948830|2715065|P1|Overall Study|Death|3
827289|NCT01948830|2715064|P2|Overall Study|Adverse Event|2
827290|NCT01948830|2715065|P1|Overall Study|Adverse Event|9
827291|NCT01948830|2715064|P2|Overall Study|Withdrawal by Subject|17
827292|NCT01948830|2715065|P1|Overall Study|Withdrawal by Subject|14
827293|NCT01948830|2715064|P2|Overall Study|Lost to Follow-up|4
827294|NCT01948830|2715065|P1|Overall Study|Lost to Follow-up|5
827295|NCT01948830|2715064|P2|Overall Study|Protocol deviation|2
827296|NCT01948830|2715065|P1|Overall Study|Protocol deviation|1
827297|NCT01948830|2715064|P2|Overall Study|Physician Decision|3
827298|NCT01948830|2715065|P1|Overall Study|Physician Decision|1
827299|NCT01948791|2715097|P1|Overall Study|Screening failure|35
827300|NCT01948791|2715097|P1|Overall Study|Others|7
827301|NCT01948791|2715097|P1|Overall Study|Management issues|1
827302|NCT01948791|2715097|P1|Overall Study|Lost to Follow-up|6
827303|NCT01948791|2715097|P1|Overall Study|Withdrawal by Subject|5
827304|NCT01948791|2715097|P1|Overall Study|Protocol Violation|2
827305|NCT01948791|2715097|P1|Overall Study|Lack of Efficacy|3
827306|NCT01948791|2715097|P1|Overall Study|Adverse Event|12
827307|NCT01948258|2715140|P1|Overall Study|Removed from statistical analysis|2
827308|NCT01948258|2715140|P1|Overall Study|Health Care Professional|43
827309|NCT01948258|2715140|P1|Overall Study|Withdrawal by Subject|6
827310|NCT01948258|2715140|P1|Overall Study|Withdrawal by SPD|8
827311|NCT01948258|2715140|P1|Overall Study|Lost to Follow-up|27
827312|NCT01948258|2715140|P1|Overall Study|Did not complete by cut-off date|35
827313|NCT01948258|2715140|P1|Overall Study|Pregnancy|41
827314|NCT01948193|2715146|P1|Overall Study|Lost to Follow-up|7
827315|NCT01948193|2715146|P1|Overall Study|Serious event|2
827316|NCT01948076|2715168|P2|Overall Study|Withdrawal by Subject|1
827317|NCT01948076|2715169|P1|Overall Study|Withdrawal by Subject|0
827318|NCT01948063|2715179|P2|Overall Study|Blood samples were accidentally thawed|0
827319|NCT01948063|2715180|P1|Overall Study|Blood samples were accidentally thawed|1
827320|NCT01948063|2715179|P2|Overall Study|Discovered an enrollment in other study|1
827321|NCT01948063|2715180|P1|Overall Study|Discovered an enrollment in other study|0
827322|NCT01948063|2715179|P2|Overall Study|Boston MCI halted research protocol|1
827323|NCT01948063|2715180|P1|Overall Study|Boston MCI halted research protocol|0
827324|NCT01948050|2715188|P2|Overall Study|Withdrawal by Subject|1
827325|NCT01948050|2715189|P1|Overall Study|Withdrawal by Subject|0
827326|NCT01947855|2715257|P3|Overall Study|Withdrawal by Subject|0
827327|NCT01947855|2715258|P2|Overall Study|Withdrawal by Subject|0
827328|NCT01947855|2715259|P1|Overall Study|Withdrawal by Subject|1
827329|NCT01947582|2715267|P1|Overall Study|Withdrawal by Subject|1
827330|NCT01947517|2715276|P2|Overall Study|Withdrawal by Subject|1
827331|NCT01947517|2715277|P1|Overall Study|Withdrawal by Subject|1
827332|NCT01947491|2715295|P4|Overall Study|Adverse Event|2
827333|NCT01947491|2715296|P3|Overall Study|Adverse Event|0
827334|NCT01947491|2715297|P2|Overall Study|Adverse Event|1
827335|NCT01947491|2715298|P1|Overall Study|Adverse Event|0
827336|NCT01947491|2715295|P4|Overall Study|Worsening of condition|0
827337|NCT01947491|2715296|P3|Overall Study|Worsening of condition|0
827338|NCT01947491|2715297|P2|Overall Study|Worsening of condition|1
827339|NCT01947491|2715298|P1|Overall Study|Worsening of condition|0
827340|NCT01947491|2715295|P4|Overall Study|Withdrawal by Subject|0
827341|NCT01947491|2715296|P3|Overall Study|Withdrawal by Subject|1
827342|NCT01947491|2715297|P2|Overall Study|Withdrawal by Subject|1
827343|NCT01947491|2715298|P1|Overall Study|Withdrawal by Subject|1
827344|NCT01947491|2715295|P4|Overall Study|Protocol Violation|0
827345|NCT01947491|2715296|P3|Overall Study|Protocol Violation|0
827346|NCT01947491|2715297|P2|Overall Study|Protocol Violation|0
827347|NCT01947491|2715298|P1|Overall Study|Protocol Violation|1
827348|NCT01947491|2715295|P4|Overall Study|Lack of Efficacy|1
827349|NCT01947491|2715296|P3|Overall Study|Lack of Efficacy|0
827350|NCT01947491|2715297|P2|Overall Study|Lack of Efficacy|0
827351|NCT01947491|2715298|P1|Overall Study|Lack of Efficacy|1
827352|NCT01947491|2715295|P4|Overall Study|Lost to Follow-up|2
827353|NCT01947491|2715296|P3|Overall Study|Lost to Follow-up|1
827354|NCT01947491|2715297|P2|Overall Study|Lost to Follow-up|3
827355|NCT01947491|2715298|P1|Overall Study|Lost to Follow-up|5
827356|NCT01947127|2715342|P2|Overall Study|Data loss|4
827357|NCT01947127|2715343|P1|Overall Study|Data loss|4
827358|NCT01947127|2715342|P2|Overall Study|Withdrawal by Subject|1
827359|NCT01947127|2715343|P1|Overall Study|Withdrawal by Subject|1
827360|NCT01947127|2715342|P2|Overall Study|Protocol Violation|38
827361|NCT01947127|2715343|P1|Overall Study|Protocol Violation|18
827362|NCT01946529|2715367|P3|Completion of All Therapy|Some pts. still receiving study therapy|6
827363|NCT01946529|2715368|P2|Completion of All Therapy|Some pts. still receiving study therapy|16
827364|NCT01946529|2715369|P1|Completion of All Therapy|Some pts. still receiving study therapy|1
827365|NCT01946529|2715367|P3|End of Window Therapy (2 Courses)|Physician Decision|0
827366|NCT01946529|2715368|P2|End of Window Therapy (2 Courses)|Physician Decision|1
827367|NCT01946529|2715369|P1|End of Window Therapy (2 Courses)|Physician Decision|0
827368|NCT01946438|2715380|P4|Overall Study|Withdrawal by Subject|0
827369|NCT01946438|2715381|P3|Overall Study|Withdrawal by Subject|0
827370|NCT01946438|2715382|P2|Overall Study|Withdrawal by Subject|0
827371|NCT01946438|2715383|P1|Overall Study|Withdrawal by Subject|1
827372|NCT01946438|2715380|P4|Overall Study|Protocol Violation|0
827373|NCT01946438|2715381|P3|Overall Study|Protocol Violation|1
827374|NCT01946438|2715382|P2|Overall Study|Protocol Violation|0
827375|NCT01946438|2715383|P1|Overall Study|Protocol Violation|0
827376|NCT01946438|2715380|P4|Overall Study|Serious Adverse event|0
827377|NCT01946438|2715381|P3|Overall Study|Serious Adverse event|0
827378|NCT01946438|2715382|P2|Overall Study|Serious Adverse event|0
827379|NCT01946438|2715383|P1|Overall Study|Serious Adverse event|1
827380|NCT01946438|2715380|P4|Overall Study|Adverse Event|1
827381|NCT01946438|2715381|P3|Overall Study|Adverse Event|0
827382|NCT01946438|2715382|P2|Overall Study|Adverse Event|0
827383|NCT01946438|2715383|P1|Overall Study|Adverse Event|0
827384|NCT01946425|2715411|P2|Overall Study|Withdrawal by Subject|0
827385|NCT01946425|2715412|P1|Overall Study|Withdrawal by Subject|1
827386|NCT01946425|2715411|P2|Overall Study|Protocol Violation|0
827387|NCT01946425|2715412|P1|Overall Study|Protocol Violation|1
827388|NCT01946412|2715426|P1|Overall Study|Difficulty in swallowing|1
827389|NCT01946412|2715426|P1|Overall Study|Continued with commercial Kalydeco|2
827390|NCT01946412|2715426|P1|Overall Study|Non-Compliance|1
827391|NCT01946412|2715426|P1|Overall Study|Adverse Event|1
827392|NCT01946204|2715471|P2|Overall Study|Other|3
827393|NCT01946204|2715472|P1|Overall Study|Other|7
827394|NCT01946204|2715471|P2|Overall Study|Ongoing|687
827395|NCT01946204|2715472|P1|Overall Study|Ongoing|316
827396|NCT01946204|2715471|P2|Overall Study|Lost to Follow-up|7
827397|NCT01946204|2715472|P1|Overall Study|Lost to Follow-up|3
827398|NCT01946204|2715471|P2|Overall Study|Withdrawal by Subject|50
827399|NCT01946204|2715472|P1|Overall Study|Withdrawal by Subject|37
827400|NCT01946204|2715471|P2|Overall Study|Death|59
827401|NCT01946204|2715472|P1|Overall Study|Death|38
827402|NCT01946178|2715488|P1|Overall Study|Lost to Follow-up|1
827403|NCT01946178|2715488|P1|Overall Study|Pregnancy|1
827404|NCT01945996|2715515|P2|Overall Study|Lost to Follow-up|5
827405|NCT01945996|2715516|P1|Overall Study|Lost to Follow-up|3
827406|NCT01945944|2715592|P2|Overall Study|Withdrawal by Subject|1
827407|NCT01945944|2715593|P1|Overall Study|Withdrawal by Subject|0
827408|NCT01945944|2715592|P2|Overall Study|Physician Decision|0
827409|NCT01945944|2715593|P1|Overall Study|Physician Decision|1
827410|NCT01945944|2715592|P2|Overall Study|Adverse Event|2
827411|NCT01945944|2715593|P1|Overall Study|Adverse Event|0
827412|NCT01945866|2715617|P2|Overall Study|Eyes did not complete or were dropped|0
827413|NCT01945866|2715618|P1|Overall Study|Eyes did not complete or were dropped|2
827414|NCT01945775|2715639|P2|Overall Study|Lost to Follow-up|6
827415|NCT01945775|2715640|P1|Overall Study|Lost to Follow-up|7
827416|NCT01945775|2715639|P2|Overall Study|Withdrawal by Subject|20
827417|NCT01945775|2715640|P1|Overall Study|Withdrawal by Subject|7
827418|NCT01945775|2715639|P2|Overall Study|Death|53
827419|NCT01945775|2715640|P1|Overall Study|Death|107
827420|NCT01945775|2715639|P2|Overall Study|On going|65
827421|NCT01945775|2715640|P1|Overall Study|On going|166
827422|NCT01945489|2715671|P2|Cycle 2|Lost to Follow-up|1
827423|NCT01945489|2715672|P1|Cycle 2|Lost to Follow-up|0
827424|NCT01945489|2715671|P2|Cycle 2|Adverse Event|0
827425|NCT01945489|2715672|P1|Cycle 2|Adverse Event|1
827426|NCT01945489|2715671|P2|Cycle 1|Other Miscellaneous Reasons|1
827427|NCT01945489|2715672|P1|Cycle 1|Other Miscellaneous Reasons|3
827428|NCT01945489|2715671|P2|Cycle 1|Protocol Violation|1
827429|NCT01945489|2715672|P1|Cycle 1|Protocol Violation|0
827430|NCT01945489|2715671|P2|Cycle 1|Personal Reasons|2
827431|NCT01945489|2715672|P1|Cycle 1|Personal Reasons|4
827432|NCT01945489|2715671|P2|Cycle 1|Lost to Follow-up|0
827433|NCT01945489|2715672|P1|Cycle 1|Lost to Follow-up|4
827434|NCT01945489|2715671|P2|Cycle 1|Adverse Event|0
827435|NCT01945489|2715672|P1|Cycle 1|Adverse Event|2
827436|NCT01945281|2715726|P2|Overall Study|Technical Problems|0
827437|NCT01945281|2715727|P1|Overall Study|Technical Problems|1
827438|NCT01945281|2715726|P2|Overall Study|Physician Decision|1
827439|NCT01945281|2715727|P1|Overall Study|Physician Decision|1
827440|NCT01945281|2715726|P2|Overall Study|Death|3
827441|NCT01945281|2715727|P1|Overall Study|Death|3
827442|NCT01945281|2715726|P2|Overall Study|Adverse Event|0
827443|NCT01945281|2715727|P1|Overall Study|Adverse Event|1
827444|NCT01945242|2715739|P2|Overall Study|Physician Decision|3
827445|NCT01945242|2715740|P1|Overall Study|Physician Decision|3
827446|NCT01945216|2715755|P1|Overall Study|Protocol Violation|42
827447|NCT01945216|2715755|P1|Overall Study|Case report forms uncollected|52
827448|NCT01945086|2715813|P3|Overall Study|Adverse Event|1
827449|NCT01945086|2715814|P2|Overall Study|Adverse Event|0
827450|NCT01945086|2715815|P1|Overall Study|Adverse Event|0
827451|NCT01945086|2715813|P3|Overall Study|Withdrawal by Subject|1
827452|NCT01945086|2715814|P2|Overall Study|Withdrawal by Subject|0
827453|NCT01945086|2715815|P1|Overall Study|Withdrawal by Subject|1
827454|NCT01945034|2715859|P3|Overall Study|Protocol Violation|1
827455|NCT01945034|2715860|P2|Overall Study|Protocol Violation|0
827456|NCT01945034|2715861|P1|Overall Study|Protocol Violation|1
827457|NCT01945034|2715859|P3|Overall Study|Lost to Follow-up|2
827458|NCT01945034|2715860|P2|Overall Study|Lost to Follow-up|0
827459|NCT01945034|2715861|P1|Overall Study|Lost to Follow-up|0
827460|NCT01945034|2715859|P3|Overall Study|Other|3
827461|NCT01945034|2715860|P2|Overall Study|Other|1
827462|NCT01945034|2715861|P1|Overall Study|Other|0
827463|NCT01945034|2715859|P3|Overall Study|Withdrawal by Subject|1
827464|NCT01945034|2715860|P2|Overall Study|Withdrawal by Subject|3
827465|NCT01945034|2715861|P1|Overall Study|Withdrawal by Subject|0
827466|NCT01945034|2715859|P3|Overall Study|Medication Error|0
827467|NCT01945034|2715860|P2|Overall Study|Medication Error|1
827468|NCT01945034|2715861|P1|Overall Study|Medication Error|0
827469|NCT01945021|2715911|P1|Overall Study|Non-RECIST disease progression|1
827470|NCT01945021|2715911|P1|Overall Study|Withdrawal of consent|3
827471|NCT01945021|2715911|P1|Overall Study|Withdrawal by Subject|2
827472|NCT01945021|2715911|P1|Overall Study|Global deterioration of health-related s|1
827473|NCT01945021|2715911|P1|Overall Study|Disease progression by RECIST v1.1|30
827474|NCT01945021|2715911|P1|Overall Study|Pregnancy|1
827475|NCT01945021|2715911|P1|Overall Study|Death|1
827476|NCT01945021|2715911|P1|Overall Study|Adverse Event|8
827564|NCT01942161|2716418|P1|Overall Study|Withdrawal by Subject|3
827477|NCT01944969|2715925|P1|Overall Study|Administrative or other reasons|23
827478|NCT01944969|2715925|P1|Overall Study|Non-compliance with IMP|1
827479|NCT01944969|2715925|P1|Overall Study|Lack of Efficacy|1
827480|NCT01944969|2715925|P1|Overall Study|Adverse Event|1
827481|NCT01944839|2715949|P2|Overall Study|Subject non-compliance|3
827482|NCT01944839|2715950|P1|Overall Study|Subject non-compliance|0
827483|NCT01944839|2715949|P2|Overall Study|Lost to Follow-up|0
827484|NCT01944839|2715950|P1|Overall Study|Lost to Follow-up|1
827485|NCT01944839|2715949|P2|Overall Study|Withdrawal by Subject|17
827486|NCT01944839|2715950|P1|Overall Study|Withdrawal by Subject|9
827487|NCT01944839|2715949|P2|Overall Study|Adverse Event|5
827488|NCT01944839|2715950|P1|Overall Study|Adverse Event|10
827489|NCT01944839|2715949|P2|Overall Study|Protocol Violation|1
827490|NCT01944839|2715950|P1|Overall Study|Protocol Violation|0
827491|NCT01944839|2715949|P2|Overall Study|Physician Decision|2
827492|NCT01944839|2715950|P1|Overall Study|Physician Decision|2
827493|NCT01944774|2715959|P3|Overall Study|Lost to Follow-up|0
827494|NCT01944774|2715960|P2|Overall Study|Lost to Follow-up|1
827495|NCT01944774|2715961|P1|Overall Study|Lost to Follow-up|0
827496|NCT01944774|2715959|P3|Overall Study|Lack of Efficacy|2
827497|NCT01944774|2715960|P2|Overall Study|Lack of Efficacy|2
827498|NCT01944774|2715961|P1|Overall Study|Lack of Efficacy|1
827499|NCT01944774|2715959|P3|Overall Study|Adverse Event|3
827500|NCT01944774|2715960|P2|Overall Study|Adverse Event|2
827501|NCT01944774|2715961|P1|Overall Study|Adverse Event|3
827502|NCT01944774|2715959|P3|Overall Study|Withdrawal by Subject|3
827503|NCT01944774|2715960|P2|Overall Study|Withdrawal by Subject|3
827504|NCT01944774|2715961|P1|Overall Study|Withdrawal by Subject|2
827505|NCT01944722|2716004|P1|Overall Study|>ASCUS Cytology|1122
827506|NCT01944722|2716004|P1|Overall Study|Unsatisfactory Cytology Result|63
827507|NCT01944722|2716004|P1|Overall Study|NILM Subjects <30 years old|8106
827508|NCT01944722|2716004|P1|Overall Study|Withdrawal by Subject|8
827509|NCT01944722|2716004|P1|Overall Study|Specimens Mislabeled|2
827510|NCT01944722|2716004|P1|Overall Study|Missing Specimens|3
827511|NCT01944722|2716004|P1|Overall Study|Insufficient Volume for Test|1
827512|NCT01944722|2716004|P1|Overall Study|Improper Storage/Transport|5
827513|NCT01944722|2716004|P1|Overall Study|Specimen Shipping Issues|34
827514|NCT01944722|2716004|P1|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171
827515|NCT01944670|2716038|P1|Overall Study|Lost to Follow-up|2
827516|NCT01944631|2716060|P2|Overall Study|Withdrawal by Subject|1
827517|NCT01944631|2716061|P1|Overall Study|Withdrawal by Subject|0
827518|NCT01944631|2716060|P2|Overall Study|Lost to Follow-up|1
827519|NCT01944631|2716061|P1|Overall Study|Lost to Follow-up|3
827520|NCT01944631|2716060|P2|Overall Study|Adverse Event|0
827521|NCT01944631|2716061|P1|Overall Study|Adverse Event|1
827522|NCT01944462|2716077|P1|PPPP Educational Program|Lost to Follow-up|60
827523|NCT01944098|2716107|P2|Overall Study|Physician Decision|0
827524|NCT01944098|2716108|P1|Overall Study|Physician Decision|1
827525|NCT01944059|2716120|P1|Overall Study|Adverse Event|2
827526|NCT01944059|2716120|P1|Overall Study|Withdrawal by Subject|1
827527|NCT01944059|2716120|P1|Overall Study|Physician Decision|3
827528|NCT01944059|2716120|P1|Overall Study|Lost to Follow-up|1
827529|NCT01943552|2716193|P2|Overall Study|Other Reasons|17
827530|NCT01943552|2716194|P1|Overall Study|Other Reasons|16
827531|NCT01943552|2716193|P2|Overall Study|Withdrawal by Subject|6
827532|NCT01943552|2716194|P1|Overall Study|Withdrawal by Subject|6
827533|NCT01943552|2716193|P2|Overall Study|Adverse Event|2
827534|NCT01943552|2716194|P1|Overall Study|Adverse Event|3
827535|NCT01943539|2716210|P2|Overall Study|Non-compliance with at-home intervention|0
827536|NCT01943539|2716211|P1|Overall Study|Non-compliance with at-home intervention|4
827537|NCT01943435|2716247|P3|6 Month Follow up|Lost to Follow-up|15
827538|NCT01943435|2716248|P2|6 Month Follow up|Lost to Follow-up|7
827539|NCT01943435|2716249|P1|6 Month Follow up|Lost to Follow-up|12
827540|NCT01943435|2716247|P3|2 Month Follow up|Lost to Follow-up|0
827541|NCT01943435|2716248|P2|2 Month Follow up|Lost to Follow-up|3
827542|NCT01943435|2716249|P1|2 Month Follow up|Lost to Follow-up|2
827543|NCT01943435|2716247|P3|Intervention Period|Withdrawal by Subject|4
827544|NCT01943435|2716248|P2|Intervention Period|Withdrawal by Subject|3
827545|NCT01943435|2716249|P1|Intervention Period|Withdrawal by Subject|3
827546|NCT01943435|2716247|P3|Baseline Eligibility and Randomization|Withdrawal by Subject|3
827547|NCT01943435|2716248|P2|Baseline Eligibility and Randomization|Withdrawal by Subject|12
827548|NCT01943435|2716249|P1|Baseline Eligibility and Randomization|Withdrawal by Subject|4
827549|NCT01943292|2716272|P3|Overall Study|Withdrawal by Subject|0
827550|NCT01943292|2716273|P2|Overall Study|Withdrawal by Subject|0
827551|NCT01943292|2716274|P1|Overall Study|Withdrawal by Subject|1
827552|NCT01942785|2716301|P1|Overall Study|Protocol Violation|1
827553|NCT01942785|2716301|P1|Overall Study|Withdrawal by Subject|1
827554|NCT01942785|2716301|P1|Overall Study|Adverse Event|2
827555|NCT01942733|2716330|P1|Overall Study|Administrative|1
827556|NCT01942733|2716330|P1|Overall Study|Non-compliance with IMP|1
827557|NCT01942733|2716330|P1|Overall Study|Lost to Follow-up|1
827558|NCT01942590|2716382|P2|Overall Study|Adverse Event|0
827559|NCT01942590|2716383|P1|Overall Study|Adverse Event|1
827560|NCT01942590|2716382|P2|Overall Study|Withdrawal by Subject|1
827561|NCT01942590|2716383|P1|Overall Study|Withdrawal by Subject|0
827562|NCT01942161|2716416|P3|Overall Study|Withdrawal by Subject|1
827563|NCT01942161|2716417|P2|Overall Study|Withdrawal by Subject|3
827565|NCT01942161|2716416|P3|Overall Study|Protocol Violation|0
827566|NCT01942161|2716417|P2|Overall Study|Protocol Violation|0
827567|NCT01942161|2716418|P1|Overall Study|Protocol Violation|1
827568|NCT01942161|2716416|P3|Overall Study|Physician Decision|0
827569|NCT01942161|2716417|P2|Overall Study|Physician Decision|1
827570|NCT01942161|2716418|P1|Overall Study|Physician Decision|3
827571|NCT01942161|2716416|P3|Overall Study|Adverse Event|5
827572|NCT01942161|2716417|P2|Overall Study|Adverse Event|2
827573|NCT01942161|2716418|P1|Overall Study|Adverse Event|1
827574|NCT01942148|2716438|P1|Overall Study|Use of the prohibition medicine|1
827575|NCT01942148|2716438|P1|Overall Study|Withdrawal by Subject|8
827576|NCT01942148|2716438|P1|Overall Study|Protocol Violation|1
827577|NCT01942148|2716438|P1|Overall Study|Physician Decision|11
827578|NCT01942148|2716438|P1|Overall Study|Lack of Efficacy|2
827579|NCT01942148|2716438|P1|Overall Study|Adverse Event|4
827580|NCT01942135|2716446|P2|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75
827581|NCT01942135|2716447|P1|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238
827582|NCT01942135|2716446|P2|Overall Study|Withdrawal by Subject|2
827583|NCT01942135|2716447|P1|Overall Study|Withdrawal by Subject|4
827584|NCT01942135|2716446|P2|Overall Study|Participant Refused toContinue Treatment|1
827585|NCT01942135|2716447|P1|Overall Study|Participant Refused toContinue Treatment|1
827586|NCT01942135|2716446|P2|Overall Study|ObjectiveProgression+Progressive Disease|87
827587|NCT01942135|2716447|P1|Overall Study|ObjectiveProgression+Progressive Disease|85
827588|NCT01942135|2716446|P2|Overall Study|Death|1
827589|NCT01942135|2716447|P1|Overall Study|Death|0
827590|NCT01942135|2716446|P2|Overall Study|Randomized Not Treated|2
827591|NCT01942135|2716447|P1|Overall Study|Randomized Not Treated|2
827592|NCT01942135|2716446|P2|Overall Study|Global deterioration of health status|3
827593|NCT01942135|2716447|P1|Overall Study|Global deterioration of health status|8
827594|NCT01942135|2716446|P2|Overall Study|Adverse Event|3
827595|NCT01942135|2716447|P1|Overall Study|Adverse Event|9
827596|NCT01941940|2716484|P1|Overall Study|Other|1
827597|NCT01941940|2716484|P1|Overall Study|Other|1
827598|NCT01941940|2716484|P1|Overall Study|Death|1
827599|NCT01941940|2716484|P1|Overall Study|Withdrawal by Subject|15
827600|NCT01941940|2716484|P1|Overall Study|Physician Decision|2
827601|NCT01941940|2716484|P1|Overall Study|Lost to Follow-up|2
827602|NCT01941940|2716484|P1|Overall Study|Adverse Event|11
827603|NCT01941498|2716533|P1|Overall Study|Relocated out of state|1
827604|NCT01941186|2716651|P2|Follow-up|Lost to Follow-up|0
827605|NCT01941186|2716652|P1|Follow-up|Lost to Follow-up|1
827606|NCT01941095|2716678|P1|Overall Study|Lost to Follow-up|10
827607|NCT01941095|2716678|P1|Overall Study|Withdrawal by Subject|17
827608|NCT01941095|2716678|P1|Overall Study|Physician Decision|3
827609|NCT01941095|2716678|P1|Overall Study|Adverse Event|11
827610|NCT01941095|2716678|P1|Overall Study|Anaphylaxis or serious hypersensitivity|2
827611|NCT01941095|2716678|P1|Overall Study|Insufficient therapeutic response|13
827612|NCT01940939|2716703|P2|Overall Study|Withdrawal by Subject|8
827613|NCT01940939|2716704|P1|Overall Study|Withdrawal by Subject|2
827614|NCT01940900|2716716|P2|Overall Study|other|0
827615|NCT01940900|2716717|P1|Overall Study|other|1
827616|NCT01940900|2716716|P2|Overall Study|subject non-compliance|1
827617|NCT01940900|2716717|P1|Overall Study|subject non-compliance|1
827618|NCT01940900|2716716|P2|Overall Study|Sponsor Decision|0
827619|NCT01940900|2716717|P1|Overall Study|Sponsor Decision|1
827620|NCT01940900|2716716|P2|Overall Study|Lost to Follow-up|0
827621|NCT01940900|2716717|P1|Overall Study|Lost to Follow-up|1
827622|NCT01940900|2716716|P2|Overall Study|Withdrawal by Subject|15
827623|NCT01940900|2716717|P1|Overall Study|Withdrawal by Subject|11
827624|NCT01940900|2716716|P2|Overall Study|Adverse Event|15
827625|NCT01940900|2716717|P1|Overall Study|Adverse Event|10
827626|NCT01940900|2716716|P2|Overall Study|Physician Decision|0
827627|NCT01940900|2716717|P1|Overall Study|Physician Decision|4
827628|NCT01940497|2716767|P2|Overall Study|Ongoing at data cut-off|117
827629|NCT01940497|2716768|P1|Overall Study|Ongoing at data cut-off|116
827630|NCT01940497|2716767|P2|Overall Study|Withdrawal by Subject|0
827631|NCT01940497|2716768|P1|Overall Study|Withdrawal by Subject|2
827632|NCT01940497|2716767|P2|Overall Study|Protocol Violation|0
827633|NCT01940497|2716768|P1|Overall Study|Protocol Violation|1
827634|NCT01940497|2716767|P2|Overall Study|Failure to return|1
827635|NCT01940497|2716768|P1|Overall Study|Failure to return|0
827636|NCT01940497|2716767|P2|Overall Study|Adverse event/Intercurrent illness|0
827637|NCT01940497|2716768|P1|Overall Study|Adverse event/Intercurrent illness|1
827638|NCT01940484|2716807|P1|Overall Study|Adverse Event|1
827639|NCT01940484|2716807|P1|Overall Study|Death|2
827640|NCT01940484|2716807|P1|Overall Study|Underwent transplantation|4
827641|NCT01940484|2716807|P1|Overall Study|Withdrawal by Subject|3
827642|NCT01940471|2716827|P2|Open-Label Extension|Still on Open-Label Treatment|8
827643|NCT01940471|2716828|P1|Open-Label Extension|Still on Open-Label Treatment|14
827644|NCT01940471|2716827|P2|Double-Blind Phase|Still on Double-Blind Treatment|270
827645|NCT01940471|2716828|P1|Double-Blind Phase|Still on Double-Blind Treatment|537
827646|NCT01940471|2716827|P2|Double-Blind Phase|HBsAg Seroconversion|0
827647|NCT01940471|2716828|P1|Double-Blind Phase|HBsAg Seroconversion|1
827648|NCT01940471|2716827|P2|Double-Blind Phase|Protocol Violation|1
827649|NCT01940471|2716828|P1|Double-Blind Phase|Protocol Violation|0
827650|NCT01940471|2716827|P2|Double-Blind Phase|Lack of Efficacy|0
827651|NCT01940471|2716828|P1|Double-Blind Phase|Lack of Efficacy|1
827652|NCT01940471|2716827|P2|Double-Blind Phase|Death|0
827653|NCT01940471|2716828|P1|Double-Blind Phase|Death|1
827654|NCT01940471|2716827|P2|Double-Blind Phase|Protocol-Specified Criteria|0
827655|NCT01940471|2716828|P1|Double-Blind Phase|Protocol-Specified Criteria|2
827656|NCT01940471|2716827|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
827657|NCT01940471|2716828|P1|Double-Blind Phase|Non-Compliance with Study Drug|2
827658|NCT01940471|2716827|P2|Double-Blind Phase|Investigator's Discretion|1
827659|NCT01940471|2716828|P1|Double-Blind Phase|Investigator's Discretion|2
827660|NCT01940471|2716827|P2|Double-Blind Phase|Pregnancy|1
827661|NCT01940471|2716828|P1|Double-Blind Phase|Pregnancy|2
827662|NCT01940471|2716827|P2|Double-Blind Phase|Lost to Follow-up|2
827663|NCT01940471|2716828|P1|Double-Blind Phase|Lost to Follow-up|2
827664|NCT01940471|2716827|P2|Double-Blind Phase|Adverse Event|3
827665|NCT01940471|2716828|P1|Double-Blind Phase|Adverse Event|6
827666|NCT01940471|2716827|P2|Double-Blind Phase|Withdrew Consent|5
827667|NCT01940471|2716828|P1|Double-Blind Phase|Withdrew Consent|11
827668|NCT01940471|2716827|P2|Double-Blind Phase|Randomized but Never Treated|1
827669|NCT01940471|2716828|P1|Double-Blind Phase|Randomized but Never Treated|1
827670|NCT01940354|2716846|P2|Overall Study|Withdrawal by Subject|2
827671|NCT01940354|2716847|P1|Overall Study|Withdrawal by Subject|4
827672|NCT01940341|2716859|P2|Open-label Extension Phase|Still on Study|1
827673|NCT01940341|2716860|P1|Open-label Extension Phase|Still on Study|4
827674|NCT01940341|2716859|P2|Double-Blind Phase|Still on Double-Blind Treatment|132
827675|NCT01940341|2716860|P1|Double-Blind Phase|Still on Double-Blind Treatment|269
827676|NCT01940341|2716859|P2|Double-Blind Phase|Protocol Specified Criteria|0
827677|NCT01940341|2716860|P1|Double-Blind Phase|Protocol Specified Criteria|1
827678|NCT01940341|2716859|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
827679|NCT01940341|2716860|P1|Double-Blind Phase|Non-Compliance with Study Drug|0
827680|NCT01940341|2716859|P2|Double-Blind Phase|Investigator's Discretion|0
827681|NCT01940341|2716860|P1|Double-Blind Phase|Investigator's Discretion|1
827682|NCT01940341|2716859|P2|Double-Blind Phase|Pregnancy|1
827683|NCT01940341|2716860|P1|Double-Blind Phase|Pregnancy|0
827684|NCT01940341|2716859|P2|Double-Blind Phase|Lost to Follow-up|1
827685|NCT01940341|2716860|P1|Double-Blind Phase|Lost to Follow-up|4
827686|NCT01940341|2716859|P2|Double-Blind Phase|Withdrew Consent|2
827687|NCT01940341|2716860|P1|Double-Blind Phase|Withdrew Consent|3
827688|NCT01940341|2716859|P2|Double-Blind Phase|Adverse Event|2
827689|NCT01940341|2716860|P1|Double-Blind Phase|Adverse Event|3
827690|NCT01940341|2716859|P2|Double-Blind Phase|Randomized but Never Treated|1
827691|NCT01940341|2716860|P1|Double-Blind Phase|Randomized but Never Treated|0
827692|NCT01940120|2716891|P1|Overall Study|Withdrawal by Subject|8
827693|NCT01940120|2716891|P1|Overall Study|Death|40
827694|NCT01939977|2717047|P2|Overall Study|Did not receive study medication|1
827695|NCT01939977|2717048|P1|Overall Study|Did not receive study medication|0
827696|NCT01939977|2717047|P2|Overall Study|Did not meet inclusion criteria|0
827697|NCT01939977|2717048|P1|Overall Study|Did not meet inclusion criteria|1
827698|NCT01939977|2717047|P2|Overall Study|Withdrawal by Subject|2
827699|NCT01939977|2717048|P1|Overall Study|Withdrawal by Subject|0
827700|NCT01939977|2717047|P2|Overall Study|Physician Decision|1
827701|NCT01939977|2717048|P1|Overall Study|Physician Decision|1
827702|NCT01939977|2717047|P2|Overall Study|Lack of Efficacy|0
827703|NCT01939977|2717048|P1|Overall Study|Lack of Efficacy|3
827704|NCT01939977|2717047|P2|Overall Study|Adverse Event|3
827705|NCT01939977|2717048|P1|Overall Study|Adverse Event|4
827706|NCT01939548|2717093|P3|Overall Study|Did not complete follow-up|0
827707|NCT01939548|2717094|P2|Overall Study|Did not complete follow-up|1
827708|NCT01939548|2717095|P1|Overall Study|Did not complete follow-up|0
827709|NCT01939548|2717093|P3|Overall Study|Participant withdrew consent|0
827710|NCT01939548|2717094|P2|Overall Study|Participant withdrew consent|2
827711|NCT01939548|2717095|P1|Overall Study|Participant withdrew consent|0
827712|NCT01939548|2717093|P3|Overall Study|Participant unwilling to continue|0
827713|NCT01939548|2717094|P2|Overall Study|Participant unwilling to continue|1
827714|NCT01939548|2717095|P1|Overall Study|Participant unwilling to continue|0
827715|NCT01939548|2717093|P3|Overall Study|Participant dropped|1
827716|NCT01939548|2717094|P2|Overall Study|Participant dropped|0
827717|NCT01939548|2717095|P1|Overall Study|Participant dropped|0
827718|NCT01939548|2717093|P3|Overall Study|Death|1
827719|NCT01939548|2717094|P2|Overall Study|Death|0
827720|NCT01939548|2717095|P1|Overall Study|Death|0
827721|NCT01939548|2717093|P3|Overall Study|Adverse Event|7
827722|NCT01939548|2717094|P2|Overall Study|Adverse Event|9
827723|NCT01939548|2717095|P1|Overall Study|Adverse Event|2
827724|NCT01939548|2717093|P3|Overall Study|Lost to Follow-up|3
827725|NCT01939548|2717094|P2|Overall Study|Lost to Follow-up|5
827726|NCT01939548|2717095|P1|Overall Study|Lost to Follow-up|5
827727|NCT01939548|2717093|P3|Overall Study|Protocol Violation|5
827728|NCT01939548|2717094|P2|Overall Study|Protocol Violation|6
827729|NCT01939548|2717095|P1|Overall Study|Protocol Violation|7
827730|NCT01939548|2717093|P3|Overall Study|Withdrawal by Subject|1
827731|NCT01939548|2717094|P2|Overall Study|Withdrawal by Subject|4
827732|NCT01939548|2717095|P1|Overall Study|Withdrawal by Subject|4
827733|NCT01939548|2717093|P3|Overall Study|Did Not Meet Entrance Criteria|0
827734|NCT01939548|2717094|P2|Overall Study|Did Not Meet Entrance Criteria|0
827735|NCT01939548|2717095|P1|Overall Study|Did Not Meet Entrance Criteria|1
827736|NCT01939548|2717093|P3|Overall Study|Insufficient Clinical Response|0
827737|NCT01939548|2717094|P2|Overall Study|Insufficient Clinical Response|0
827738|NCT01939548|2717095|P1|Overall Study|Insufficient Clinical Response|1
827739|NCT01939548|2717093|P3|Overall Study|Study Terminated by Sponsor|12
827740|NCT01939548|2717094|P2|Overall Study|Study Terminated by Sponsor|19
827741|NCT01939548|2717095|P1|Overall Study|Study Terminated by Sponsor|17
827742|NCT01939548|2717093|P3|Overall Study|Non compliance|0
827743|NCT01939548|2717094|P2|Overall Study|Non compliance|2
827744|NCT01939548|2717095|P1|Overall Study|Non compliance|0
827745|NCT01939496|2717169|P3|Overall Study|Other|1
827746|NCT01939496|2717170|P2|Overall Study|Other|0
827747|NCT01939496|2717171|P1|Overall Study|Other|2
827748|NCT01939496|2717169|P3|Overall Study|Blood Pressure Withdrawal Criteria|0
827749|NCT01939496|2717170|P2|Overall Study|Blood Pressure Withdrawal Criteria|1
827750|NCT01939496|2717171|P1|Overall Study|Blood Pressure Withdrawal Criteria|0
827751|NCT01939496|2717169|P3|Overall Study|Withdrawal by Subject|1
827752|NCT01939496|2717170|P2|Overall Study|Withdrawal by Subject|1
827753|NCT01939496|2717171|P1|Overall Study|Withdrawal by Subject|0
827754|NCT01939496|2717169|P3|Overall Study|Protocol Violation|0
827755|NCT01939496|2717170|P2|Overall Study|Protocol Violation|0
827756|NCT01939496|2717171|P1|Overall Study|Protocol Violation|3
827757|NCT01939496|2717169|P3|Overall Study|Physician Decision|0
827758|NCT01939496|2717170|P2|Overall Study|Physician Decision|0
827759|NCT01939496|2717171|P1|Overall Study|Physician Decision|1
827760|NCT01939496|2717169|P3|Overall Study|Lost to Follow-up|0
827761|NCT01939496|2717170|P2|Overall Study|Lost to Follow-up|1
827762|NCT01939496|2717171|P1|Overall Study|Lost to Follow-up|1
827763|NCT01939496|2717169|P3|Overall Study|Adverse Event|0
827764|NCT01939496|2717170|P2|Overall Study|Adverse Event|0
827765|NCT01939496|2717171|P1|Overall Study|Adverse Event|2
827766|NCT01939314|2717238|P2|Overall Study|Lost to Follow-up|6
827767|NCT01939314|2717239|P1|Overall Study|Lost to Follow-up|5
827768|NCT01939314|2717238|P2|Overall Study|Pregnancy|1
827769|NCT01939314|2717239|P1|Overall Study|Pregnancy|0
827770|NCT01939314|2717238|P2|Overall Study|Protocol Violation|0
827771|NCT01939314|2717239|P1|Overall Study|Protocol Violation|1
827772|NCT01939314|2717238|P2|Overall Study|Withdrawal by Subject|1
827773|NCT01939314|2717239|P1|Overall Study|Withdrawal by Subject|3
827774|NCT01939223|2717260|P2|Overall Study|Withdrawal by Subject|0
827775|NCT01939223|2717261|P1|Overall Study|Withdrawal by Subject|6
827776|NCT01939223|2717260|P2|Overall Study|Study stopped by Sponsor|7
827777|NCT01939223|2717261|P1|Overall Study|Study stopped by Sponsor|5
827778|NCT01939223|2717260|P2|Overall Study|Disease recurrence (radiological)|3
827779|NCT01939223|2717261|P1|Overall Study|Disease recurrence (radiological)|1
827780|NCT01939223|2717260|P2|Overall Study|AE not assoc. with disease recurrence|1
827781|NCT01939223|2717261|P1|Overall Study|AE not assoc. with disease recurrence|1
827782|NCT01939197|2717276|P7|Overall Study|Lost to Follow-up|2
827783|NCT01939197|2717277|P6|Overall Study|Lost to Follow-up|1
827784|NCT01939197|2717278|P5|Overall Study|Lost to Follow-up|3
827785|NCT01939197|2717279|P4|Overall Study|Lost to Follow-up|1
827786|NCT01939197|2717280|P3|Overall Study|Lost to Follow-up|0
827787|NCT01939197|2717281|P2|Overall Study|Lost to Follow-up|1
827788|NCT01939197|2717282|P1|Overall Study|Lost to Follow-up|0
827789|NCT01939197|2717276|P7|Overall Study|Withdrawal by Subject|0
827790|NCT01939197|2717277|P6|Overall Study|Withdrawal by Subject|0
827791|NCT01939197|2717278|P5|Overall Study|Withdrawal by Subject|1
827792|NCT01939197|2717279|P4|Overall Study|Withdrawal by Subject|0
827793|NCT01939197|2717280|P3|Overall Study|Withdrawal by Subject|0
827794|NCT01939197|2717281|P2|Overall Study|Withdrawal by Subject|0
827795|NCT01939197|2717282|P1|Overall Study|Withdrawal by Subject|1
827796|NCT01939002|2717353|P2|Overall Study|Not Specified|2
827797|NCT01939002|2717354|P1|Overall Study|Not Specified|1
827798|NCT01939002|2717353|P2|Overall Study|Withdrawal by Subject|3
827799|NCT01939002|2717354|P1|Overall Study|Withdrawal by Subject|5
827800|NCT01939002|2717353|P2|Overall Study|Adverse Event|13
827801|NCT01939002|2717354|P1|Overall Study|Adverse Event|13
827802|NCT01938625|2717437|P2|Overall Study|Adverse Event|1
827803|NCT01938625|2717438|P1|Overall Study|Adverse Event|0
827804|NCT01938625|2717437|P2|Overall Study|Withdrawal by Subject|1
827805|NCT01938625|2717438|P1|Overall Study|Withdrawal by Subject|0
827806|NCT01938573|2717458|P2|Overall Study|Operation at other hospital|0
827807|NCT01938573|2717459|P1|Overall Study|Operation at other hospital|1
827808|NCT01938573|2717458|P2|Overall Study|Lack of Efficacy|0
827809|NCT01938573|2717459|P1|Overall Study|Lack of Efficacy|1
827810|NCT01938430|2717479|P14|Overall Study|Withdrew Consent|0
827811|NCT01938430|2717480|P13|Overall Study|Withdrew Consent|0
827812|NCT01938430|2717481|P12|Overall Study|Withdrew Consent|0
827813|NCT01938430|2717482|P11|Overall Study|Withdrew Consent|0
827814|NCT01938430|2717483|P10|Overall Study|Withdrew Consent|0
827815|NCT01938430|2717484|P9|Overall Study|Withdrew Consent|1
827816|NCT01938430|2717485|P8|Overall Study|Withdrew Consent|0
827817|NCT01938430|2717486|P7|Overall Study|Withdrew Consent|0
827818|NCT01938430|2717487|P6|Overall Study|Withdrew Consent|0
827819|NCT01938430|2717488|P5|Overall Study|Withdrew Consent|0
827820|NCT01938430|2717489|P4|Overall Study|Withdrew Consent|0
827821|NCT01938430|2717490|P3|Overall Study|Withdrew Consent|0
827822|NCT01938430|2717491|P2|Overall Study|Withdrew Consent|0
827823|NCT01938430|2717492|P1|Overall Study|Withdrew Consent|0
827824|NCT01938430|2717479|P14|Overall Study|Lost to Follow-up|0
827825|NCT01938430|2717480|P13|Overall Study|Lost to Follow-up|0
827826|NCT01938430|2717481|P12|Overall Study|Lost to Follow-up|0
827827|NCT01938430|2717482|P11|Overall Study|Lost to Follow-up|0
827828|NCT01938430|2717483|P10|Overall Study|Lost to Follow-up|0
827829|NCT01938430|2717484|P9|Overall Study|Lost to Follow-up|0
827830|NCT01938430|2717485|P8|Overall Study|Lost to Follow-up|0
827831|NCT01938430|2717486|P7|Overall Study|Lost to Follow-up|0
827832|NCT01938430|2717487|P6|Overall Study|Lost to Follow-up|1
827833|NCT01938430|2717488|P5|Overall Study|Lost to Follow-up|0
827834|NCT01938430|2717489|P4|Overall Study|Lost to Follow-up|0
827835|NCT01938430|2717490|P3|Overall Study|Lost to Follow-up|1
827836|NCT01938430|2717491|P2|Overall Study|Lost to Follow-up|0
827837|NCT01938430|2717492|P1|Overall Study|Lost to Follow-up|0
827838|NCT01938430|2717479|P14|Overall Study|Lack of Efficacy|0
827839|NCT01938430|2717480|P13|Overall Study|Lack of Efficacy|0
827840|NCT01938430|2717481|P12|Overall Study|Lack of Efficacy|1
827841|NCT01938430|2717482|P11|Overall Study|Lack of Efficacy|2
827842|NCT01938430|2717483|P10|Overall Study|Lack of Efficacy|0
827843|NCT01938430|2717484|P9|Overall Study|Lack of Efficacy|1
827844|NCT01938430|2717485|P8|Overall Study|Lack of Efficacy|0
827845|NCT01938430|2717486|P7|Overall Study|Lack of Efficacy|0
827846|NCT01938430|2717487|P6|Overall Study|Lack of Efficacy|0
827847|NCT01938430|2717488|P5|Overall Study|Lack of Efficacy|0
827848|NCT01938430|2717489|P4|Overall Study|Lack of Efficacy|1
827849|NCT01938430|2717490|P3|Overall Study|Lack of Efficacy|1
827850|NCT01938430|2717491|P2|Overall Study|Lack of Efficacy|1
827851|NCT01938430|2717492|P1|Overall Study|Lack of Efficacy|3
827852|NCT01938430|2717479|P14|Overall Study|Investigator's Discretion|0
827853|NCT01938430|2717480|P13|Overall Study|Investigator's Discretion|0
827854|NCT01938430|2717481|P12|Overall Study|Investigator's Discretion|0
827855|NCT01938430|2717482|P11|Overall Study|Investigator's Discretion|0
827856|NCT01938430|2717483|P10|Overall Study|Investigator's Discretion|0
827857|NCT01938430|2717484|P9|Overall Study|Investigator's Discretion|0
827858|NCT01938430|2717485|P8|Overall Study|Investigator's Discretion|0
827859|NCT01938430|2717486|P7|Overall Study|Investigator's Discretion|0
827860|NCT01938430|2717487|P6|Overall Study|Investigator's Discretion|0
827861|NCT01938430|2717488|P5|Overall Study|Investigator's Discretion|0
827862|NCT01938430|2717489|P4|Overall Study|Investigator's Discretion|0
827863|NCT01938430|2717490|P3|Overall Study|Investigator's Discretion|1
827864|NCT01938430|2717491|P2|Overall Study|Investigator's Discretion|0
827865|NCT01938430|2717492|P1|Overall Study|Investigator's Discretion|0
827866|NCT01938430|2717479|P14|Overall Study|Death|0
827867|NCT01938430|2717480|P13|Overall Study|Death|0
827868|NCT01938430|2717481|P12|Overall Study|Death|0
827869|NCT01938430|2717482|P11|Overall Study|Death|0
827870|NCT01938430|2717483|P10|Overall Study|Death|3
827871|NCT01938430|2717484|P9|Overall Study|Death|2
827872|NCT01938430|2717485|P8|Overall Study|Death|1
827873|NCT01938430|2717486|P7|Overall Study|Death|1
827874|NCT01938430|2717487|P6|Overall Study|Death|0
827875|NCT01938430|2717488|P5|Overall Study|Death|0
827876|NCT01938430|2717489|P4|Overall Study|Death|1
827877|NCT01938430|2717490|P3|Overall Study|Death|2
827878|NCT01938430|2717491|P2|Overall Study|Death|2
827879|NCT01938430|2717492|P1|Overall Study|Death|1
827880|NCT01938430|2717479|P14|Overall Study|Adverse Event|0
827881|NCT01938430|2717480|P13|Overall Study|Adverse Event|0
827882|NCT01938430|2717481|P12|Overall Study|Adverse Event|0
827883|NCT01938430|2717482|P11|Overall Study|Adverse Event|0
827884|NCT01938430|2717483|P10|Overall Study|Adverse Event|0
827885|NCT01938430|2717484|P9|Overall Study|Adverse Event|0
827886|NCT01938430|2717485|P8|Overall Study|Adverse Event|0
827887|NCT01938430|2717486|P7|Overall Study|Adverse Event|1
827888|NCT01938430|2717487|P6|Overall Study|Adverse Event|0
827889|NCT01938430|2717488|P5|Overall Study|Adverse Event|0
827890|NCT01938430|2717489|P4|Overall Study|Adverse Event|0
827891|NCT01938430|2717490|P3|Overall Study|Adverse Event|0
827892|NCT01938430|2717491|P2|Overall Study|Adverse Event|0
827893|NCT01938430|2717492|P1|Overall Study|Adverse Event|0
827894|NCT01938430|2717479|P14|Overall Study|Randomized but Not Treated|1
827895|NCT01938430|2717480|P13|Overall Study|Randomized but Not Treated|0
827896|NCT01938430|2717481|P12|Overall Study|Randomized but Not Treated|0
827897|NCT01938430|2717482|P11|Overall Study|Randomized but Not Treated|1
827898|NCT01938430|2717483|P10|Overall Study|Randomized but Not Treated|0
827899|NCT01938430|2717484|P9|Overall Study|Randomized but Not Treated|0
827900|NCT01938430|2717485|P8|Overall Study|Randomized but Not Treated|0
827901|NCT01938430|2717486|P7|Overall Study|Randomized but Not Treated|0
827902|NCT01938430|2717487|P6|Overall Study|Randomized but Not Treated|0
827903|NCT01938430|2717488|P5|Overall Study|Randomized but Not Treated|0
827904|NCT01938430|2717489|P4|Overall Study|Randomized but Not Treated|0
827905|NCT01938430|2717490|P3|Overall Study|Randomized but Not Treated|0
827906|NCT01938430|2717491|P2|Overall Study|Randomized but Not Treated|0
827907|NCT01938430|2717492|P1|Overall Study|Randomized but Not Treated|0
827908|NCT01938391|2717817|P1|12 Month Follow up|Withdrawal by Subject|1
827909|NCT01938391|2717817|P1|12 Month Follow up|Physician Decision|1
827910|NCT01938391|2717817|P1|6 Month Follow up|Withdrawal by Subject|1
827911|NCT01937871|2717936|P3|Overall Study|Entry Criteria Not Met|1
827912|NCT01937871|2717937|P2|Overall Study|Entry Criteria Not Met|2
827913|NCT01937871|2717938|P1|Overall Study|Entry Criteria Not Met|1
827914|NCT01937871|2717936|P3|Overall Study|Physician Decision|0
827915|NCT01937871|2717937|P2|Overall Study|Physician Decision|1
827916|NCT01937871|2717938|P1|Overall Study|Physician Decision|0
827917|NCT01937871|2717936|P3|Overall Study|Withdrawal by Subject|4
827918|NCT01937871|2717937|P2|Overall Study|Withdrawal by Subject|6
827919|NCT01937871|2717938|P1|Overall Study|Withdrawal by Subject|9
827920|NCT01937871|2717936|P3|Overall Study|Lost to Follow-up|4
827921|NCT01937871|2717937|P2|Overall Study|Lost to Follow-up|2
827922|NCT01937871|2717938|P1|Overall Study|Lost to Follow-up|8
827923|NCT01937871|2717936|P3|Overall Study|Adverse Event|2
827924|NCT01937871|2717937|P2|Overall Study|Adverse Event|6
827925|NCT01937871|2717938|P1|Overall Study|Adverse Event|6
827926|NCT01937715|2718014|P5|Overall Study|Other|0
827927|NCT01937715|2718015|P4|Overall Study|Other|3
827928|NCT01937715|2718016|P3|Overall Study|Other|0
827929|NCT01937715|2718017|P2|Overall Study|Other|0
827930|NCT01937715|2718018|P1|Overall Study|Other|0
827931|NCT01937715|2718014|P5|Overall Study|Withdrawal by Subject|2
827932|NCT01937715|2718015|P4|Overall Study|Withdrawal by Subject|0
827933|NCT01937715|2718016|P3|Overall Study|Withdrawal by Subject|0
827934|NCT01937715|2718017|P2|Overall Study|Withdrawal by Subject|1
827935|NCT01937715|2718018|P1|Overall Study|Withdrawal by Subject|0
827936|NCT01937715|2718014|P5|Overall Study|Death|0
827937|NCT01937715|2718015|P4|Overall Study|Death|1
827938|NCT01937715|2718016|P3|Overall Study|Death|0
827939|NCT01937715|2718017|P2|Overall Study|Death|0
827940|NCT01937715|2718018|P1|Overall Study|Death|0
827941|NCT01937390|2718209|P1|Overall Study|Fail to return|21
827942|NCT01937390|2718209|P1|Overall Study|Withdrawal by Subject|5
827943|NCT01937390|2718209|P1|Overall Study|Lost to Follow-up|7
827944|NCT01937390|2718209|P1|Overall Study|Death|2
827945|NCT01937364|2718219|P2|Overall Study|Adverse Event|1
827946|NCT01937364|2718220|P1|Overall Study|Adverse Event|2
827947|NCT01937351|2718232|P2|Overall Study|Not treated w device, per protocol fail|0
827948|NCT01937351|2718233|P1|Overall Study|Not treated w device, per protocol fail|4
827949|NCT01937351|2718232|P2|Overall Study|Death|0
827950|NCT01937351|2718233|P1|Overall Study|Death|1
827951|NCT01937351|2718232|P2|Overall Study|Withdrawal by Subject|2
827952|NCT01937351|2718233|P1|Overall Study|Withdrawal by Subject|4
827953|NCT01937312|2718241|P2|Overall Study|Withdrawal of subject prior to treatment|1
827954|NCT01937312|2718242|P1|Overall Study|Withdrawal of subject prior to treatment|1
827955|NCT01937312|2718241|P2|Overall Study|Lack of Efficacy|1
827956|NCT01937312|2718242|P1|Overall Study|Lack of Efficacy|0
827957|NCT01937312|2718241|P2|Overall Study|Adverse Event|1
827958|NCT01937312|2718242|P1|Overall Study|Adverse Event|10
827959|NCT01937299|2718257|P2|Overall Study|Withdrawal by Subject|0
827960|NCT01937299|2718258|P1|Overall Study|Withdrawal by Subject|1
827961|NCT01937299|2718257|P2|Overall Study|Lack of Efficacy|4
827962|NCT01937299|2718258|P1|Overall Study|Lack of Efficacy|0
827963|NCT01937299|2718257|P2|Overall Study|Adverse Event|0
827964|NCT01937299|2718258|P1|Overall Study|Adverse Event|13
827965|NCT01937130|2718293|P4|Overall Study|Patient lost to FU due to death|0
827966|NCT01937130|2718294|P3|Overall Study|Patient lost to FU due to death|0
827967|NCT01937130|2718295|P2|Overall Study|Patient lost to FU due to death|0
827968|NCT01937130|2718296|P1|Overall Study|Patient lost to FU due to death|2
827969|NCT01937130|2718293|P4|Overall Study|Patients unable to swallow|0
827970|NCT01937130|2718294|P3|Overall Study|Patients unable to swallow|0
827971|NCT01937130|2718295|P2|Overall Study|Patients unable to swallow|1
827972|NCT01937130|2718296|P1|Overall Study|Patients unable to swallow|0
827973|NCT01937130|2718293|P4|Overall Study|Physician Decision|0
827974|NCT01937130|2718294|P3|Overall Study|Physician Decision|0
827975|NCT01937130|2718295|P2|Overall Study|Physician Decision|1
827976|NCT01937130|2718296|P1|Overall Study|Physician Decision|0
827977|NCT01937130|2718293|P4|Overall Study|Lost to Follow-up|0
827978|NCT01937130|2718294|P3|Overall Study|Lost to Follow-up|2
827979|NCT01937130|2718295|P2|Overall Study|Lost to Follow-up|0
827980|NCT01937130|2718296|P1|Overall Study|Lost to Follow-up|2
827981|NCT01937130|2718293|P4|Overall Study|Death|0
827982|NCT01937130|2718294|P3|Overall Study|Death|1
827983|NCT01937130|2718295|P2|Overall Study|Death|1
827984|NCT01937130|2718296|P1|Overall Study|Death|1
827985|NCT01937130|2718293|P4|Overall Study|Adverse Event|1
827986|NCT01937130|2718294|P3|Overall Study|Adverse Event|0
827987|NCT01937130|2718295|P2|Overall Study|Adverse Event|1
827988|NCT01937130|2718296|P1|Overall Study|Adverse Event|0
827989|NCT01937130|2718293|P4|Overall Study|Withdrawal by Subject|1
827990|NCT01937130|2718294|P3|Overall Study|Withdrawal by Subject|0
827991|NCT01937130|2718295|P2|Overall Study|Withdrawal by Subject|0
827992|NCT01937130|2718296|P1|Overall Study|Withdrawal by Subject|0
827993|NCT01936974|2718334|P2|Overall Study|Physician Decision|5
827994|NCT01936974|2718335|P1|Overall Study|Physician Decision|2
827995|NCT01936870|2718365|P1|Overall Study|No Drug Administration|1
827996|NCT01936870|2718365|P1|Overall Study|Protocol Violation|12
827997|NCT01936870|2718365|P1|Overall Study|No Visit After Treatment|176
827998|NCT01936649|2718402|P1|Overall Study|Other than specified above|5
827999|NCT01936649|2718402|P1|Overall Study|Protocol Violation|2
828000|NCT01936649|2718402|P1|Overall Study|Physician Decision|2
828001|NCT01936649|2718402|P1|Overall Study|Withdrawal by Subject|4
828002|NCT01936623|2718409|P2|Overall Study|Lost to Follow-up|5
828003|NCT01936623|2718410|P1|Overall Study|Lost to Follow-up|0
828004|NCT01936363|2718454|P2|Overall Study|Ongoing|5
828005|NCT01936363|2718455|P1|Overall Study|Ongoing|7
828006|NCT01936181|2718481|P4|Transition-extension|Withdrawal by Subject|1
828007|NCT01936181|2718482|P3|Transition-extension|Withdrawal by Subject|2
828008|NCT01936181|2718483|P2|Transition-extension|Withdrawal by Subject|0
828009|NCT01936181|2718484|P1|Transition-extension|Withdrawal by Subject|7
828010|NCT01936181|2718481|P4|Transition-extension|Physician Decision|1
828011|NCT01936181|2718482|P3|Transition-extension|Physician Decision|0
828012|NCT01936181|2718483|P2|Transition-extension|Physician Decision|0
828013|NCT01936181|2718484|P1|Transition-extension|Physician Decision|2
828014|NCT01936181|2718481|P4|Transition-extension|Lost to Follow-up|2
828015|NCT01936181|2718482|P3|Transition-extension|Lost to Follow-up|1
828016|NCT01936181|2718483|P2|Transition-extension|Lost to Follow-up|0
828017|NCT01936181|2718484|P1|Transition-extension|Lost to Follow-up|3
828018|NCT01936181|2718481|P4|Transition-extension|Adverse Event|1
828019|NCT01936181|2718482|P3|Transition-extension|Adverse Event|3
828020|NCT01936181|2718483|P2|Transition-extension|Adverse Event|0
828021|NCT01936181|2718484|P1|Transition-extension|Adverse Event|3
828022|NCT01936181|2718481|P4|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
828023|NCT01936181|2718482|P3|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
828024|NCT01936181|2718483|P2|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
828025|NCT01936181|2718484|P1|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
828026|NCT01936181|2718481|P4|Randomised, Double-blind|Withdrawal by Subject|0
828027|NCT01936181|2718482|P3|Randomised, Double-blind|Withdrawal by Subject|0
828028|NCT01936181|2718483|P2|Randomised, Double-blind|Withdrawal by Subject|26
828029|NCT01936181|2718484|P1|Randomised, Double-blind|Withdrawal by Subject|23
828030|NCT01936181|2718481|P4|Randomised, Double-blind|Physician Decision|0
828031|NCT01936181|2718482|P3|Randomised, Double-blind|Physician Decision|0
828032|NCT01936181|2718483|P2|Randomised, Double-blind|Physician Decision|4
828033|NCT01936181|2718484|P1|Randomised, Double-blind|Physician Decision|4
828034|NCT01936181|2718481|P4|Randomised, Double-blind|Pregnancy|0
828035|NCT01936181|2718482|P3|Randomised, Double-blind|Pregnancy|0
828036|NCT01936181|2718483|P2|Randomised, Double-blind|Pregnancy|1
828037|NCT01936181|2718484|P1|Randomised, Double-blind|Pregnancy|0
828038|NCT01936181|2718481|P4|Randomised, Double-blind|Lost to Follow-up|0
828039|NCT01936181|2718482|P3|Randomised, Double-blind|Lost to Follow-up|0
828040|NCT01936181|2718483|P2|Randomised, Double-blind|Lost to Follow-up|1
828041|NCT01936181|2718484|P1|Randomised, Double-blind|Lost to Follow-up|0
828042|NCT01936181|2718481|P4|Randomised, Double-blind|Lack of Efficacy|0
828043|NCT01936181|2718482|P3|Randomised, Double-blind|Lack of Efficacy|0
828044|NCT01936181|2718483|P2|Randomised, Double-blind|Lack of Efficacy|6
828045|NCT01936181|2718484|P1|Randomised, Double-blind|Lack of Efficacy|5
828046|NCT01936181|2718481|P4|Randomised, Double-blind|Protocol Violation|0
828047|NCT01936181|2718482|P3|Randomised, Double-blind|Protocol Violation|0
828048|NCT01936181|2718483|P2|Randomised, Double-blind|Protocol Violation|5
828049|NCT01936181|2718484|P1|Randomised, Double-blind|Protocol Violation|1
828050|NCT01936181|2718481|P4|Randomised, Double-blind|Adverse Event|0
828051|NCT01936181|2718482|P3|Randomised, Double-blind|Adverse Event|0
828052|NCT01936181|2718483|P2|Randomised, Double-blind|Adverse Event|21
828053|NCT01936181|2718484|P1|Randomised, Double-blind|Adverse Event|27
828054|NCT01935947|2718498|P3|Overall Study|Death|0
828055|NCT01935947|2718499|P2|Overall Study|Death|0
828056|NCT01935947|2718500|P1|Overall Study|Death|1
828057|NCT01935947|2718498|P3|Overall Study|Diease Progression|2
828058|NCT01935947|2718499|P2|Overall Study|Diease Progression|2
828059|NCT01935947|2718500|P1|Overall Study|Diease Progression|2
828060|NCT01935947|2718498|P3|Overall Study|Adverse Event|0
828061|NCT01935947|2718499|P2|Overall Study|Adverse Event|2
828062|NCT01935947|2718500|P1|Overall Study|Adverse Event|0
828063|NCT01934894|2718559|P2|Overall Study|Progressive Disease|2
828064|NCT01934894|2718560|P1|Overall Study|Progressive Disease|3
828065|NCT01934894|2718559|P2|Overall Study|Withdrawal by Subject|1
828066|NCT01934894|2718560|P1|Overall Study|Withdrawal by Subject|0
828067|NCT01934894|2718559|P2|Overall Study|Death|0
828068|NCT01934894|2718560|P1|Overall Study|Death|2
828069|NCT01934894|2718559|P2|Overall Study|Adverse Event|2
828070|NCT01934894|2718560|P1|Overall Study|Adverse Event|1
828071|NCT01934790|2718575|P1|Active Follow up|Other reason|1
828072|NCT01934790|2718575|P1|Active Follow up|Progressive disease|1
828073|NCT01934790|2718575|P1|Active Follow up|Physician Decision|2
828074|NCT01934790|2718575|P1|Active Follow up|Death|20
828075|NCT01934790|2718575|P1|Treatment|Study drug never administered|1
828076|NCT01934790|2718575|P1|Treatment|Withdrawal by Subject|2
828077|NCT01934790|2718575|P1|Treatment|Radiological progression|4
828078|NCT01934790|2718575|P1|Treatment|Clinical progression|6
828079|NCT01934790|2718575|P1|Treatment|Adverse Event|3
828080|NCT01934504|2718642|P4|Overall Study|Study Terminated by Sponsor|5
828081|NCT01934504|2718643|P3|Overall Study|Study Terminated by Sponsor|5
828082|NCT01934504|2718644|P2|Overall Study|Study Terminated by Sponsor|0
828083|NCT01934504|2718645|P1|Overall Study|Study Terminated by Sponsor|1
828084|NCT01934504|2718642|P4|Overall Study|Protocol Deviation|2
828085|NCT01934504|2718643|P3|Overall Study|Protocol Deviation|0
828086|NCT01934504|2718644|P2|Overall Study|Protocol Deviation|0
828087|NCT01934504|2718645|P1|Overall Study|Protocol Deviation|0
828088|NCT01934218|2718678|P2|Open-Label Phase|Failure to Exam Primary Evaluation|1
828089|NCT01934218|2718679|P1|Open-Label Phase|Failure to Exam Primary Evaluation|0
828090|NCT01934218|2718678|P2|Open-Label Phase|Noncompliance with Study Protocol|2
828091|NCT01934218|2718679|P1|Open-Label Phase|Noncompliance with Study Protocol|4
828092|NCT01934218|2718678|P2|Open-Label Phase|Withdrawal by Subject|11
828093|NCT01934218|2718679|P1|Open-Label Phase|Withdrawal by Subject|13
828094|NCT01934218|2718678|P2|Open-Label Phase|Protocol Violation|0
828095|NCT01934218|2718679|P1|Open-Label Phase|Protocol Violation|1
828096|NCT01934218|2718678|P2|Open-Label Phase|Physician Decision|0
828097|NCT01934218|2718679|P1|Open-Label Phase|Physician Decision|1
828098|NCT01934218|2718678|P2|Open-Label Phase|Lost to Follow-up|2
828099|NCT01934218|2718679|P1|Open-Label Phase|Lost to Follow-up|4
828100|NCT01934218|2718678|P2|Open-Label Phase|Lack of Efficacy|4
828101|NCT01934218|2718679|P1|Open-Label Phase|Lack of Efficacy|1
828102|NCT01934218|2718678|P2|Open-Label Phase|Adverse Event|4
828103|NCT01934218|2718679|P1|Open-Label Phase|Adverse Event|2
828104|NCT01934218|2718678|P2|Double-blind Phase|Protocol Violation of Study Eligibility|2
828105|NCT01934218|2718679|P1|Double-blind Phase|Protocol Violation of Study Eligibility|1
828106|NCT01934218|2718678|P2|Double-blind Phase|Noncompliance with Study Protocol|8
828107|NCT01934218|2718679|P1|Double-blind Phase|Noncompliance with Study Protocol|5
828108|NCT01934218|2718678|P2|Double-blind Phase|Withdrawal by Subject|13
828109|NCT01934218|2718679|P1|Double-blind Phase|Withdrawal by Subject|16
828110|NCT01934218|2718678|P2|Double-blind Phase|Protocol Violation|0
828111|NCT01934218|2718679|P1|Double-blind Phase|Protocol Violation|4
828112|NCT01934218|2718678|P2|Double-blind Phase|Physician Decision|2
828113|NCT01934218|2718679|P1|Double-blind Phase|Physician Decision|1
828114|NCT01934218|2718678|P2|Double-blind Phase|Lost to Follow-up|14
828115|NCT01934218|2718679|P1|Double-blind Phase|Lost to Follow-up|7
828116|NCT01934218|2718678|P2|Double-blind Phase|Lack of Efficacy|7
828117|NCT01934218|2718679|P1|Double-blind Phase|Lack of Efficacy|6
828118|NCT01934218|2718678|P2|Double-blind Phase|Adverse Event|8
828119|NCT01934218|2718679|P1|Double-blind Phase|Adverse Event|8
828120|NCT01934192|2718690|P4|Overall Study|Physician Decision|0
828121|NCT01934192|2718691|P3|Overall Study|Physician Decision|0
828122|NCT01934192|2718692|P2|Overall Study|Physician Decision|2
828123|NCT01934192|2718693|P1|Overall Study|Physician Decision|3
828124|NCT01934192|2718690|P4|Overall Study|Other: reached stopping criteria|0
828125|NCT01934192|2718691|P3|Overall Study|Other: reached stopping criteria|1
828126|NCT01934192|2718692|P2|Overall Study|Other: reached stopping criteria|5
828127|NCT01934192|2718693|P1|Overall Study|Other: reached stopping criteria|6
828128|NCT01934192|2718690|P4|Overall Study|Protocol Violation|1
828129|NCT01934192|2718691|P3|Overall Study|Protocol Violation|0
828130|NCT01934192|2718692|P2|Overall Study|Protocol Violation|0
828131|NCT01934192|2718693|P1|Overall Study|Protocol Violation|0
828132|NCT01934010|2718830|P3|Overall Study|Lost to Follow-up|0
828133|NCT01934010|2718831|P2|Overall Study|Lost to Follow-up|4
828134|NCT01934010|2718832|P1|Overall Study|Lost to Follow-up|7
828135|NCT01934010|2718830|P3|Overall Study|Withdrawal by Subject|2
828136|NCT01934010|2718831|P2|Overall Study|Withdrawal by Subject|6
828137|NCT01934010|2718832|P1|Overall Study|Withdrawal by Subject|15
828138|NCT01934010|2718830|P3|Overall Study|Adverse Event|0
828139|NCT01934010|2718831|P2|Overall Study|Adverse Event|1
828140|NCT01934010|2718832|P1|Overall Study|Adverse Event|1
828141|NCT01933932|2718851|P2|Overall Study|Eligibility criteria not fulfilled|1
828142|NCT01933932|2718852|P1|Overall Study|Eligibility criteria not fulfilled|0
828143|NCT01933932|2718851|P2|Overall Study|Withdrawal by Subject|14
828144|NCT01933932|2718852|P1|Overall Study|Withdrawal by Subject|11
828145|NCT01933932|2718851|P2|Overall Study|Death|163
828146|NCT01933932|2718852|P1|Overall Study|Death|173
828147|NCT01933919|2718870|P2|Open-label Long-term Phase|Other|2
828148|NCT01933919|2718871|P1|Open-label Long-term Phase|Other|1
828149|NCT01933919|2718870|P2|Open-label Long-term Phase|Lost to Follow-up|0
828150|NCT01933919|2718871|P1|Open-label Long-term Phase|Lost to Follow-up|1
828151|NCT01933919|2718870|P2|Open-label Long-term Phase|Withdrawal by Subject|4
828152|NCT01933919|2718871|P1|Open-label Long-term Phase|Withdrawal by Subject|3
828153|NCT01933919|2718870|P2|Open-label Long-term Phase|Adverse Event|0
828154|NCT01933919|2718871|P1|Open-label Long-term Phase|Adverse Event|2
828155|NCT01933919|2718870|P2|Double-blind Placebo-controlled Phase|Lack of Efficacy|2
828156|NCT01933919|2718871|P1|Double-blind Placebo-controlled Phase|Lack of Efficacy|0
828157|NCT01933919|2718870|P2|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1
828158|NCT01933919|2718871|P1|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0
828159|NCT01933919|2718870|P2|Double-blind Placebo-controlled Phase|Adverse Event|1
828160|NCT01933919|2718871|P1|Double-blind Placebo-controlled Phase|Adverse Event|0
828161|NCT01933880|2718907|P2|Overall Study|Protocol Violation|0
828162|NCT01933880|2718908|P1|Overall Study|Protocol Violation|1
828163|NCT01933880|2718907|P2|Overall Study|Other|0
828164|NCT01933880|2718908|P1|Overall Study|Other|4
828165|NCT01933880|2718907|P2|Overall Study|Followup exceeded 4 days to visit window|0
828166|NCT01933880|2718908|P1|Overall Study|Followup exceeded 4 days to visit window|19
828167|NCT01933880|2718907|P2|Overall Study|Concomitant medication Interference|1
828168|NCT01933880|2718908|P1|Overall Study|Concomitant medication Interference|0
828169|NCT01933880|2718907|P2|Overall Study|Lack of Efficacy|0
828170|NCT01933880|2718908|P1|Overall Study|Lack of Efficacy|1
828171|NCT01933880|2718907|P2|Overall Study|Withdrawal by Subject|0
828172|NCT01933880|2718908|P1|Overall Study|Withdrawal by Subject|5
828173|NCT01933672|2718984|P7|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
828174|NCT01933672|2718985|P6|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
828175|NCT01933672|2718986|P5|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
828176|NCT01933672|2718987|P4|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
828177|NCT01933672|2718988|P3|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
828178|NCT01933672|2718989|P2|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1
828179|NCT01933672|2718990|P1|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
828180|NCT01933672|2718984|P7|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
828181|NCT01933672|2718985|P6|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
828182|NCT01933672|2718986|P5|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
828183|NCT01933672|2718987|P4|Third Intervention Period (12-16 Days)|Lost to Follow-up|1
828184|NCT01933672|2718988|P3|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
828185|NCT01933672|2718989|P2|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
828186|NCT01933672|2718990|P1|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
828187|NCT01933672|2718984|P7|Second Intervention Period (12-16 Days)|Other|0
828188|NCT01933672|2718985|P6|Second Intervention Period (12-16 Days)|Other|0
828189|NCT01933672|2718986|P5|Second Intervention Period (12-16 Days)|Other|0
828190|NCT01933672|2718987|P4|Second Intervention Period (12-16 Days)|Other|0
828191|NCT01933672|2718988|P3|Second Intervention Period (12-16 Days)|Other|1
828192|NCT01933672|2718989|P2|Second Intervention Period (12-16 Days)|Other|1
828193|NCT01933672|2718990|P1|Second Intervention Period (12-16 Days)|Other|0
828194|NCT01933672|2718984|P7|First Intervention Period (12-16 Days)|Other|0
828195|NCT01933672|2718985|P6|First Intervention Period (12-16 Days)|Other|1
828196|NCT01933672|2718986|P5|First Intervention Period (12-16 Days)|Other|0
828197|NCT01933672|2718987|P4|First Intervention Period (12-16 Days)|Other|0
828198|NCT01933672|2718988|P3|First Intervention Period (12-16 Days)|Other|1
828199|NCT01933672|2718989|P2|First Intervention Period (12-16 Days)|Other|0
828200|NCT01933672|2718990|P1|First Intervention Period (12-16 Days)|Other|0
828201|NCT01933672|2718984|P7|First Intervention Period (12-16 Days)|Lost to Follow-up|0
828202|NCT01933672|2718985|P6|First Intervention Period (12-16 Days)|Lost to Follow-up|0
828203|NCT01933672|2718986|P5|First Intervention Period (12-16 Days)|Lost to Follow-up|1
828204|NCT01933672|2718987|P4|First Intervention Period (12-16 Days)|Lost to Follow-up|0
828205|NCT01933672|2718988|P3|First Intervention Period (12-16 Days)|Lost to Follow-up|0
828206|NCT01933672|2718989|P2|First Intervention Period (12-16 Days)|Lost to Follow-up|0
828207|NCT01933672|2718990|P1|First Intervention Period (12-16 Days)|Lost to Follow-up|0
828208|NCT01933672|2718984|P7|Metformin Run-in Period|Other|0
828209|NCT01933672|2718985|P6|Metformin Run-in Period|Other|0
828210|NCT01933672|2718986|P5|Metformin Run-in Period|Other|0
828211|NCT01933672|2718987|P4|Metformin Run-in Period|Other|0
828212|NCT01933672|2718988|P3|Metformin Run-in Period|Other|0
828213|NCT01933672|2718989|P2|Metformin Run-in Period|Other|0
828214|NCT01933672|2718990|P1|Metformin Run-in Period|Other|5
828215|NCT01933672|2718984|P7|Metformin Run-in Period|No longer meets eligibility criteria|0
828216|NCT01933672|2718985|P6|Metformin Run-in Period|No longer meets eligibility criteria|0
828217|NCT01933672|2718986|P5|Metformin Run-in Period|No longer meets eligibility criteria|0
828218|NCT01933672|2718987|P4|Metformin Run-in Period|No longer meets eligibility criteria|0
828219|NCT01933672|2718988|P3|Metformin Run-in Period|No longer meets eligibility criteria|0
828220|NCT01933672|2718989|P2|Metformin Run-in Period|No longer meets eligibility criteria|0
828221|NCT01933672|2718990|P1|Metformin Run-in Period|No longer meets eligibility criteria|4
828222|NCT01933672|2718984|P7|Metformin Run-in Period|Adverse Event|0
828223|NCT01933672|2718985|P6|Metformin Run-in Period|Adverse Event|0
828224|NCT01933672|2718986|P5|Metformin Run-in Period|Adverse Event|0
828225|NCT01933672|2718987|P4|Metformin Run-in Period|Adverse Event|0
828226|NCT01933672|2718988|P3|Metformin Run-in Period|Adverse Event|0
828227|NCT01933672|2718989|P2|Metformin Run-in Period|Adverse Event|0
828228|NCT01933672|2718990|P1|Metformin Run-in Period|Adverse Event|1
828229|NCT01933334|2719065|P2|Overall Study|Withdrawal by Subject|1
828230|NCT01933334|2719066|P1|Overall Study|Withdrawal by Subject|0
828231|NCT01933334|2719065|P2|Overall Study|Adverse Event|1
828232|NCT01933334|2719066|P1|Overall Study|Adverse Event|5
828233|NCT01933048|2719095|P2|Overall Study|unknown reasons|1
828234|NCT01933048|2719096|P1|Overall Study|unknown reasons|1
828235|NCT01933048|2719095|P2|Overall Study|Physician Decision|0
828236|NCT01933048|2719096|P1|Overall Study|Physician Decision|1
828237|NCT01933048|2719095|P2|Overall Study|Protocol Violation|8
828238|NCT01933048|2719096|P1|Overall Study|Protocol Violation|7
828239|NCT01933048|2719095|P2|Overall Study|personal reasons|1
828240|NCT01933048|2719096|P1|Overall Study|personal reasons|1
828241|NCT01933048|2719095|P2|Overall Study|Lost to Follow-up|18
828242|NCT01933048|2719096|P1|Overall Study|Lost to Follow-up|15
828243|NCT01932970|2719109|P1|Overall Study|Protocol Specified Criteria|10
828244|NCT01932970|2719109|P1|Overall Study|Lost to Follow-up|2
828245|NCT01932970|2719109|P1|Overall Study|Death|1
828246|NCT01932970|2719109|P1|Overall Study|Withdrawal by Subject|5
828247|NCT01932788|2719119|P2|Overall Study|Withdrawal by Subject|5
828248|NCT01932788|2719120|P1|Overall Study|Withdrawal by Subject|0
828249|NCT01932788|2719119|P2|Overall Study|Lack of Efficacy|0
828250|NCT01932788|2719120|P1|Overall Study|Lack of Efficacy|2
828251|NCT01932788|2719119|P2|Overall Study|Lost to Follow-up|46
828252|NCT01932788|2719120|P1|Overall Study|Lost to Follow-up|18
828253|NCT01932788|2719119|P2|Overall Study|Protocol Violation|0
828254|NCT01932788|2719120|P1|Overall Study|Protocol Violation|18
828255|NCT01932762|2719130|P4|Overall Study|Physician Decision|0
828256|NCT01932762|2719131|P3|Overall Study|Physician Decision|0
828257|NCT01932762|2719132|P2|Overall Study|Physician Decision|0
828258|NCT01932762|2719133|P1|Overall Study|Physician Decision|1
828259|NCT01932762|2719130|P4|Overall Study|Lost to Follow-up|1
828260|NCT01932762|2719131|P3|Overall Study|Lost to Follow-up|0
828261|NCT01932762|2719132|P2|Overall Study|Lost to Follow-up|0
828262|NCT01932762|2719133|P1|Overall Study|Lost to Follow-up|4
828263|NCT01932762|2719130|P4|Overall Study|Withdrawal by Subject|0
828264|NCT01932762|2719131|P3|Overall Study|Withdrawal by Subject|0
828265|NCT01932762|2719132|P2|Overall Study|Withdrawal by Subject|2
828266|NCT01932762|2719133|P1|Overall Study|Withdrawal by Subject|1
828267|NCT01931865|2719380|P1|Overall Study|Withdrawal by Subject|2
828268|NCT01931865|2719380|P1|Overall Study|Lost to Follow-up|2
828269|NCT01931839|2719393|P7|Overall Study|Other|0
828270|NCT01931839|2719394|P6|Overall Study|Other|0
828271|NCT01931839|2719395|P5|Overall Study|Other|0
828272|NCT01931839|2719396|P4|Overall Study|Other|0
828273|NCT01931839|2719397|P3|Overall Study|Other|6
828274|NCT01931839|2719398|P2|Overall Study|Other|2
828275|NCT01931839|2719399|P1|Overall Study|Other|4
828276|NCT01931839|2719393|P7|Overall Study|Lost to Follow-up|0
828277|NCT01931839|2719394|P6|Overall Study|Lost to Follow-up|0
828278|NCT01931839|2719395|P5|Overall Study|Lost to Follow-up|0
828279|NCT01931839|2719396|P4|Overall Study|Lost to Follow-up|5
828280|NCT01931839|2719397|P3|Overall Study|Lost to Follow-up|4
828281|NCT01931839|2719398|P2|Overall Study|Lost to Follow-up|2
828282|NCT01931839|2719399|P1|Overall Study|Lost to Follow-up|1
828283|NCT01931839|2719393|P7|Overall Study|Other non-compliance|0
828284|NCT01931839|2719394|P6|Overall Study|Other non-compliance|3
828285|NCT01931839|2719395|P5|Overall Study|Other non-compliance|0
828286|NCT01931839|2719396|P4|Overall Study|Other non-compliance|3
828287|NCT01931839|2719397|P3|Overall Study|Other non-compliance|12
828288|NCT01931839|2719398|P2|Overall Study|Other non-compliance|9
828289|NCT01931839|2719399|P1|Overall Study|Other non-compliance|15
828290|NCT01931839|2719393|P7|Overall Study|Withdrawal of consent (not due to AE)|2
828291|NCT01931839|2719394|P6|Overall Study|Withdrawal of consent (not due to AE)|2
828292|NCT01931839|2719395|P5|Overall Study|Withdrawal of consent (not due to AE)|0
828293|NCT01931839|2719396|P4|Overall Study|Withdrawal of consent (not due to AE)|3
828294|NCT01931839|2719397|P3|Overall Study|Withdrawal of consent (not due to AE)|13
828295|NCT01931839|2719398|P2|Overall Study|Withdrawal of consent (not due to AE)|8
828296|NCT01931839|2719399|P1|Overall Study|Withdrawal of consent (not due to AE)|11
828297|NCT01931839|2719393|P7|Overall Study|Adverse Event|1
828298|NCT01931839|2719394|P6|Overall Study|Adverse Event|0
828299|NCT01931839|2719395|P5|Overall Study|Adverse Event|0
828300|NCT01931839|2719396|P4|Overall Study|Adverse Event|3
828301|NCT01931839|2719397|P3|Overall Study|Adverse Event|1
828302|NCT01931839|2719398|P2|Overall Study|Adverse Event|4
828303|NCT01931839|2719399|P1|Overall Study|Adverse Event|9
828304|NCT01931839|2719393|P7|Overall Study|Withdrawal of consent|0
828305|NCT01931839|2719394|P6|Overall Study|Withdrawal of consent|0
828306|NCT01931839|2719395|P5|Overall Study|Withdrawal of consent|1
828307|NCT01931839|2719396|P4|Overall Study|Withdrawal of consent|0
828308|NCT01931839|2719397|P3|Overall Study|Withdrawal of consent|0
828309|NCT01931839|2719398|P2|Overall Study|Withdrawal of consent|0
828310|NCT01931839|2719399|P1|Overall Study|Withdrawal of consent|0
828311|NCT01931839|2719393|P7|Overall Study|Physician Decision|1
828312|NCT01931839|2719394|P6|Overall Study|Physician Decision|0
828313|NCT01931839|2719395|P5|Overall Study|Physician Decision|0
828314|NCT01931839|2719396|P4|Overall Study|Physician Decision|0
828315|NCT01931839|2719397|P3|Overall Study|Physician Decision|1
828316|NCT01931839|2719398|P2|Overall Study|Physician Decision|0
828317|NCT01931839|2719399|P1|Overall Study|Physician Decision|1
828318|NCT01931839|2719393|P7|Overall Study|Death|0
828319|NCT01931839|2719394|P6|Overall Study|Death|0
828320|NCT01931839|2719395|P5|Overall Study|Death|0
828321|NCT01931839|2719396|P4|Overall Study|Death|0
828322|NCT01931839|2719397|P3|Overall Study|Death|2
828323|NCT01931839|2719398|P2|Overall Study|Death|1
828324|NCT01931839|2719399|P1|Overall Study|Death|0
828325|NCT01931735|2719471|P4|Observational Non-Randomized Phase|Withdrawal by Subject|1
828326|NCT01931735|2719472|P3|Observational Non-Randomized Phase|Withdrawal by Subject|0
828327|NCT01931735|2719473|P2|Observational Non-Randomized Phase|Withdrawal by Subject|0
828328|NCT01931735|2719474|P1|Observational Non-Randomized Phase|Withdrawal by Subject|0
828329|NCT01931735|2719471|P4|Observational Non-Randomized Phase|Adverse Event|1
828330|NCT01931735|2719472|P3|Observational Non-Randomized Phase|Adverse Event|0
828331|NCT01931735|2719473|P2|Observational Non-Randomized Phase|Adverse Event|0
828332|NCT01931735|2719474|P1|Observational Non-Randomized Phase|Adverse Event|0
828333|NCT01931735|2719471|P4|Randomized Phase|Lost to Follow-up|0
828334|NCT01931735|2719472|P3|Randomized Phase|Lost to Follow-up|5
828335|NCT01931735|2719473|P2|Randomized Phase|Lost to Follow-up|2
828336|NCT01931735|2719474|P1|Randomized Phase|Lost to Follow-up|2
828337|NCT01931670|2719521|P3|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2
828338|NCT01931670|2719522|P2|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
828339|NCT01931670|2719523|P1|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
828340|NCT01931670|2719521|P3|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13
828341|NCT01931670|2719522|P2|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3
828342|NCT01931670|2719523|P1|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6
828343|NCT01931670|2719521|P3|Post-Treatment Follow-Up (PTFU) Period|Not Specified|3
828344|NCT01931670|2719522|P2|Post-Treatment Follow-Up (PTFU) Period|Not Specified|3
828345|NCT01931670|2719523|P1|Post-Treatment Follow-Up (PTFU) Period|Not Specified|6
828346|NCT01931670|2719521|P3|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2
828347|NCT01931670|2719522|P2|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
828348|NCT01931670|2719523|P1|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
828349|NCT01931670|2719521|P3|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1
828350|NCT01931670|2719522|P2|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2
828351|NCT01931670|2719523|P1|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0
828352|NCT01931670|2719521|P3|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
828353|NCT01931670|2719522|P2|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
828354|NCT01931670|2719523|P1|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3
828355|NCT01931670|2719521|P3|Treatment Period|Lost to Follow-up|7
828356|NCT01931670|2719522|P2|Treatment Period|Lost to Follow-up|5
828357|NCT01931670|2719523|P1|Treatment Period|Lost to Follow-up|19
828358|NCT01931670|2719521|P3|Treatment Period|Consent Withdrawn by Subject|7
828359|NCT01931670|2719522|P2|Treatment Period|Consent Withdrawn by Subject|12
828360|NCT01931670|2719523|P1|Treatment Period|Consent Withdrawn by Subject|17
828361|NCT01931670|2719521|P3|Treatment Period|Not Specified|2
828362|NCT01931670|2719522|P2|Treatment Period|Not Specified|7
828363|NCT01931670|2719523|P1|Treatment Period|Not Specified|8
828364|NCT01931670|2719521|P3|Treatment Period|Pregnancy|0
828365|NCT01931670|2719522|P2|Treatment Period|Pregnancy|2
828366|NCT01931670|2719523|P1|Treatment Period|Pregnancy|7
828367|NCT01931670|2719521|P3|Treatment Period|Lack of Efficacy|2
828368|NCT01931670|2719522|P2|Treatment Period|Lack of Efficacy|2
828369|NCT01931670|2719523|P1|Treatment Period|Lack of Efficacy|11
828370|NCT01931670|2719521|P3|Treatment Period|Adverse Event|21
828371|NCT01931670|2719522|P2|Treatment Period|Adverse Event|8
828372|NCT01931670|2719523|P1|Treatment Period|Adverse Event|19
828373|NCT01931670|2719521|P3|Treatment Period|Subject Noncompliant|5
828374|NCT01931670|2719522|P2|Treatment Period|Subject Noncompliant|9
828375|NCT01931670|2719523|P1|Treatment Period|Subject Noncompliant|4
828376|NCT01931670|2719521|P3|Treatment Period|Surgery/Invasive Intervention|0
828377|NCT01931670|2719522|P2|Treatment Period|Surgery/Invasive Intervention|2
828378|NCT01931670|2719523|P1|Treatment Period|Surgery/Invasive Intervention|4
828379|NCT01931670|2719521|P3|Treatment Period|Exclusionary Medication Received|1
828380|NCT01931670|2719522|P2|Treatment Period|Exclusionary Medication Received|1
828381|NCT01931670|2719523|P1|Treatment Period|Exclusionary Medication Received|1
828382|NCT01931475|2719646|P2|Period 2: Extension Treatment Phase|Lack of Efficacy|1
828383|NCT01931475|2719647|P1|Period 2: Extension Treatment Phase|Lack of Efficacy|1
828384|NCT01931475|2719646|P2|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0
828385|NCT01931475|2719647|P1|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1
828386|NCT01931475|2719646|P2|Period 2: Extension Treatment Phase|Physician Decision|1
828387|NCT01931475|2719647|P1|Period 2: Extension Treatment Phase|Physician Decision|1
828388|NCT01931475|2719646|P2|Period 2: Extension Treatment Phase|Withdrawal by Subject|9
828389|NCT01931475|2719647|P1|Period 2: Extension Treatment Phase|Withdrawal by Subject|0
828390|NCT01931475|2719646|P2|Period 2: Extension Treatment Phase|Protocol Violation|0
828391|NCT01931475|2719647|P1|Period 2: Extension Treatment Phase|Protocol Violation|1
828392|NCT01931475|2719646|P2|Period 2: Extension Treatment Phase|Adverse Event|8
828393|NCT01931475|2719647|P1|Period 2: Extension Treatment Phase|Adverse Event|0
828394|NCT01931475|2719646|P2|Period 1: Double-Blind Treatment Phase|Physician Decision|1
828395|NCT01931475|2719647|P1|Period 1: Double-Blind Treatment Phase|Physician Decision|0
828396|NCT01931475|2719646|P2|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3
828397|NCT01931475|2719647|P1|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2
828398|NCT01931475|2719646|P2|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12
828399|NCT01931475|2719647|P1|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16
828400|NCT01931475|2719646|P2|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0
828401|NCT01931475|2719647|P1|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1
828402|NCT01931475|2719646|P2|Period 1: Double-Blind Treatment Phase|Adverse Event|10
828403|NCT01931475|2719647|P1|Period 1: Double-Blind Treatment Phase|Adverse Event|20
828404|NCT01931462|2719674|P1|Overall Study|Withdrawal by Subject|1
828405|NCT01931397|2719685|P1|Overall Study|moved out of state|1
828406|NCT01931397|2719685|P1|Overall Study|Withdrawal by Subject|8
828407|NCT01931397|2719685|P1|Overall Study|Physician Decision|2
828408|NCT01931150|2719696|P2|Overall Study|Withdrawal by Subject|2
828409|NCT01931150|2719697|P1|Overall Study|Withdrawal by Subject|1
828410|NCT01931059|2719705|P2|Day3|Lost to Follow-up|0
828411|NCT01931059|2719706|P1|Day3|Lost to Follow-up|1
828412|NCT01931059|2719705|P2|Day 1|Pregnancy|1
828413|NCT01931059|2719706|P1|Day 1|Pregnancy|0
828414|NCT01930890|2719722|P4|Overall Study|Adverse Event|0
828415|NCT01930890|2719723|P3|Overall Study|Adverse Event|0
828416|NCT01930890|2719724|P2|Overall Study|Adverse Event|1
828417|NCT01930890|2719725|P1|Overall Study|Adverse Event|0
828418|NCT01930890|2719722|P4|Overall Study|Consent Withdrawn|1
828419|NCT01930890|2719723|P3|Overall Study|Consent Withdrawn|0
828420|NCT01930890|2719724|P2|Overall Study|Consent Withdrawn|3
828421|NCT01930890|2719725|P1|Overall Study|Consent Withdrawn|0
828422|NCT01930890|2719722|P4|Overall Study|Investigator Decision|0
828423|NCT01930890|2719723|P3|Overall Study|Investigator Decision|0
828424|NCT01930890|2719724|P2|Overall Study|Investigator Decision|1
828425|NCT01930890|2719725|P1|Overall Study|Investigator Decision|0
828426|NCT01930890|2719722|P4|Overall Study|Death|1
828427|NCT01930890|2719723|P3|Overall Study|Death|0
828428|NCT01930890|2719724|P2|Overall Study|Death|0
828429|NCT01930890|2719725|P1|Overall Study|Death|0
828430|NCT01930890|2719722|P4|Overall Study|Study Termination|25
828431|NCT01930890|2719723|P3|Overall Study|Study Termination|13
828432|NCT01930890|2719724|P2|Overall Study|Study Termination|28
828433|NCT01930890|2719725|P1|Overall Study|Study Termination|14
828434|NCT01930799|2719739|P1|Overall Study|Lost to Follow-up|5
828435|NCT01930799|2719739|P1|Overall Study|Withdrawal by Subject|3
828436|NCT01930162|2719847|P1|Overall Study|Death|1
828437|NCT01930162|2719847|P1|Overall Study|Abnormal test procedure result(s)|4
828438|NCT01930045|2719883|P6|Pause (up to 37 Days)|Protocol Violation|1
828439|NCT01930045|2719884|P5|Pause (up to 37 Days)|Protocol Violation|0
828440|NCT01930045|2719885|P4|Pause (up to 37 Days)|Protocol Violation|0
828441|NCT01930045|2719886|P3|Pause (up to 37 Days)|Protocol Violation|0
828442|NCT01930045|2719887|P2|Pause (up to 37 Days)|Protocol Violation|0
828443|NCT01930045|2719888|P1|Pause (up to 37 Days)|Protocol Violation|0
828444|NCT01930045|2719883|P6|Pause (up to 37 Days)|Withdrawal by Subject|1
828445|NCT01930045|2719884|P5|Pause (up to 37 Days)|Withdrawal by Subject|0
828446|NCT01930045|2719885|P4|Pause (up to 37 Days)|Withdrawal by Subject|0
828447|NCT01930045|2719886|P3|Pause (up to 37 Days)|Withdrawal by Subject|0
828448|NCT01930045|2719887|P2|Pause (up to 37 Days)|Withdrawal by Subject|0
828449|NCT01930045|2719888|P1|Pause (up to 37 Days)|Withdrawal by Subject|0
828450|NCT01929993|2719915|P2|Overall Study|Absent CIN, invasion present or artifact|22
828451|NCT01929993|2719916|P1|Overall Study|Absent CIN, invasion present or artifact|26
828452|NCT01929993|2719915|P2|Overall Study|Protocol Violation|6
828453|NCT01929993|2719916|P1|Overall Study|Protocol Violation|4
828454|NCT01929980|2719922|P1|Overall Study|Physician Decision|1
828455|NCT01929876|2719930|P1|Period 2|Non-Compliance|1
828456|NCT01929863|2719943|P2|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1
828457|NCT01929863|2719944|P1|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0
828458|NCT01929863|2719943|P2|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1
828459|NCT01929863|2719944|P1|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0
828460|NCT01929863|2719943|P2|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0
828461|NCT01929863|2719944|P1|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1
828462|NCT01929707|2719999|P8|Intervention Period 2|Withdrawal by Subject|0
828463|NCT01929707|2720000|P7|Intervention Period 2|Withdrawal by Subject|0
828464|NCT01929707|2720001|P6|Intervention Period 2|Withdrawal by Subject|2
828465|NCT01929707|2720002|P5|Intervention Period 2|Withdrawal by Subject|0
828466|NCT01929707|2720003|P4|Intervention Period 2|Withdrawal by Subject|0
828467|NCT01929707|2720004|P3|Intervention Period 2|Withdrawal by Subject|0
828468|NCT01929707|2720005|P2|Intervention Period 2|Withdrawal by Subject|0
828469|NCT01929707|2720006|P1|Intervention Period 2|Withdrawal by Subject|0
828470|NCT01929707|2719999|P8|Intervention Period 1|Withdrawal by Subject|0
828471|NCT01929707|2720000|P7|Intervention Period 1|Withdrawal by Subject|0
828472|NCT01929707|2720001|P6|Intervention Period 1|Withdrawal by Subject|0
828473|NCT01929707|2720002|P5|Intervention Period 1|Withdrawal by Subject|0
828474|NCT01929707|2720003|P4|Intervention Period 1|Withdrawal by Subject|2
828475|NCT01929707|2720004|P3|Intervention Period 1|Withdrawal by Subject|0
828476|NCT01929707|2720005|P2|Intervention Period 1|Withdrawal by Subject|0
828477|NCT01929707|2720006|P1|Intervention Period 1|Withdrawal by Subject|0
828478|NCT01929707|2719999|P8|Intervention Period 1|Lost to Follow-up|0
828479|NCT01929707|2720000|P7|Intervention Period 1|Lost to Follow-up|0
828480|NCT01929707|2720001|P6|Intervention Period 1|Lost to Follow-up|0
828481|NCT01929707|2720002|P5|Intervention Period 1|Lost to Follow-up|0
828482|NCT01929707|2720003|P4|Intervention Period 1|Lost to Follow-up|1
828483|NCT01929707|2720004|P3|Intervention Period 1|Lost to Follow-up|0
828484|NCT01929707|2720005|P2|Intervention Period 1|Lost to Follow-up|0
828485|NCT01929707|2720006|P1|Intervention Period 1|Lost to Follow-up|0
828486|NCT01929681|2720038|P2|Overall Study|Physician Decision|1
828487|NCT01929681|2720039|P1|Overall Study|Physician Decision|1
828488|NCT01929681|2720038|P2|Overall Study|Withdrawal by Subject|0
828489|NCT01929681|2720039|P1|Overall Study|Withdrawal by Subject|1
828490|NCT01929317|2720084|P2|Long-term Phase|Study Closed/Terminated|3
828491|NCT01929317|2720085|P1|Long-term Phase|Study Closed/Terminated|5
828492|NCT01929317|2720084|P2|Long-term Phase|Protocol-defined Stopping Criteria|0
828493|NCT01929317|2720085|P1|Long-term Phase|Protocol-defined Stopping Criteria|1
828494|NCT01929317|2720084|P2|Long-term Phase|Protocol Violation|0
828495|NCT01929317|2720085|P1|Long-term Phase|Protocol Violation|1
828496|NCT01929317|2720084|P2|Long-term Phase|Withdrawal by Subject|0
828497|NCT01929317|2720085|P1|Long-term Phase|Withdrawal by Subject|4
828498|NCT01929317|2720084|P2|Long-term Phase|Physician Decision|0
828499|NCT01929317|2720085|P1|Long-term Phase|Physician Decision|3
828500|NCT01929317|2720084|P2|Long-term Phase|Adverse Event|1
828501|NCT01929317|2720085|P1|Long-term Phase|Adverse Event|5
828502|NCT01929317|2720084|P2|Dose Increase Effect Verification Phase|Withdrawal by Subject|0
828503|NCT01929317|2720085|P1|Dose Increase Effect Verification Phase|Withdrawal by Subject|3
828504|NCT01929317|2720084|P2|Dose Increase Effect Verification Phase|Physician Decision|0
828505|NCT01929317|2720085|P1|Dose Increase Effect Verification Phase|Physician Decision|1
828506|NCT01929317|2720084|P2|Dose Increase Effect Verification Phase|Adverse Event|1
828507|NCT01929317|2720085|P1|Dose Increase Effect Verification Phase|Adverse Event|5
828508|NCT01929135|2720154|P2|Overall Study|Lost to Follow-up|1
828509|NCT01929135|2720155|P1|Overall Study|Lost to Follow-up|1
828510|NCT01929109|2720174|P5|Period 1 (All Groups)|Deviation from protocol|0
828511|NCT01929109|2720175|P4|Period 1 (All Groups)|Deviation from protocol|0
828512|NCT01929109|2720176|P3|Period 1 (All Groups)|Deviation from protocol|1
828513|NCT01929109|2720177|P2|Period 1 (All Groups)|Deviation from protocol|0
828514|NCT01929109|2720178|P1|Period 1 (All Groups)|Deviation from protocol|0
828515|NCT01929083|2720197|P2|Intervention 2|Adverse Event|1
828516|NCT01929083|2720198|P1|Intervention 2|Adverse Event|0
828517|NCT01929083|2720197|P2|Intervention 1|Nonadherent to study medications|0
828518|NCT01929083|2720198|P1|Intervention 1|Nonadherent to study medications|1
828519|NCT01929083|2720197|P2|Intervention 1|Lost to Follow-up|0
828520|NCT01929083|2720198|P1|Intervention 1|Lost to Follow-up|2
828521|NCT01929044|2720224|P2|Overall Study|Not Treated|3
828522|NCT01929044|2720225|P1|Overall Study|Not Treated|1
828523|NCT01929044|2720224|P2|Overall Study|Protocol Violation|14
828524|NCT01929044|2720225|P1|Overall Study|Protocol Violation|9
828525|NCT01929044|2720224|P2|Overall Study|Adverse Event|0
828526|NCT01929044|2720225|P1|Overall Study|Adverse Event|1
828527|NCT01929031|2720247|P6|Overall Study|Reason other than specified above|0
828528|NCT01929031|2720248|P5|Overall Study|Reason other than specified above|1
828529|NCT01929031|2720249|P4|Overall Study|Reason other than specified above|0
828530|NCT01929031|2720250|P3|Overall Study|Reason other than specified above|0
828531|NCT01929031|2720251|P2|Overall Study|Reason other than specified above|1
828532|NCT01929031|2720252|P1|Overall Study|Reason other than specified above|0
828533|NCT01929031|2720247|P6|Overall Study|Protocol Violation|1
828534|NCT01929031|2720248|P5|Overall Study|Protocol Violation|0
828535|NCT01929031|2720249|P4|Overall Study|Protocol Violation|0
828536|NCT01929031|2720250|P3|Overall Study|Protocol Violation|0
828537|NCT01929031|2720251|P2|Overall Study|Protocol Violation|0
828538|NCT01929031|2720252|P1|Overall Study|Protocol Violation|1
828539|NCT01929031|2720247|P6|Overall Study|Adverse Event|0
828540|NCT01929031|2720248|P5|Overall Study|Adverse Event|0
828541|NCT01929031|2720249|P4|Overall Study|Adverse Event|0
828542|NCT01929031|2720250|P3|Overall Study|Adverse Event|1
828543|NCT01929031|2720251|P2|Overall Study|Adverse Event|1
828544|NCT01929031|2720252|P1|Overall Study|Adverse Event|3
828545|NCT01928940|2720276|P2|Overall Study|Adverse Event|1
828546|NCT01928940|2720277|P1|Overall Study|Adverse Event|0
828547|NCT01928927|2720320|P2|Overall Study|Withdrawal by Subject|1
828548|NCT01928927|2720321|P1|Overall Study|Withdrawal by Subject|1
828549|NCT01928927|2720320|P2|Overall Study|Lost to Follow-up|0
828550|NCT01928927|2720321|P1|Overall Study|Lost to Follow-up|1
828551|NCT01928862|2720448|P5|Overall Study|Lost to Follow-up|1
828552|NCT01928862|2720449|P4|Overall Study|Lost to Follow-up|0
828553|NCT01928862|2720450|P3|Overall Study|Lost to Follow-up|0
828554|NCT01928862|2720451|P2|Overall Study|Lost to Follow-up|0
828555|NCT01928862|2720452|P1|Overall Study|Lost to Follow-up|1
828556|NCT01928771|2720526|P3|Overall Study|Severe Non-Compliance to Protocol|2
828557|NCT01928771|2720527|P2|Overall Study|Severe Non-Compliance to Protocol|2
828558|NCT01928771|2720528|P1|Overall Study|Severe Non-Compliance to Protocol|4
828559|NCT01928771|2720526|P3|Overall Study|Other Reasons|14
828560|NCT01928771|2720527|P2|Overall Study|Other Reasons|9
828561|NCT01928771|2720528|P1|Overall Study|Other Reasons|9
828562|NCT01928771|2720526|P3|Overall Study|Study-Specific Withdrawal Criteria|1
828563|NCT01928771|2720527|P2|Overall Study|Study-Specific Withdrawal Criteria|1
828564|NCT01928771|2720528|P1|Overall Study|Study-Specific Withdrawal Criteria|0
828565|NCT01928771|2720526|P3|Overall Study|Withdrawal by Subject|17
828566|NCT01928771|2720527|P2|Overall Study|Withdrawal by Subject|15
828567|NCT01928771|2720528|P1|Overall Study|Withdrawal by Subject|20
828568|NCT01928771|2720526|P3|Overall Study|Lost to Follow-up|3
828569|NCT01928771|2720527|P2|Overall Study|Lost to Follow-up|6
828570|NCT01928771|2720528|P1|Overall Study|Lost to Follow-up|5
828571|NCT01928771|2720526|P3|Overall Study|Death|2
828572|NCT01928771|2720527|P2|Overall Study|Death|2
828573|NCT01928771|2720528|P1|Overall Study|Death|2
828574|NCT01928771|2720526|P3|Overall Study|Adverse Event|1
828575|NCT01928771|2720527|P2|Overall Study|Adverse Event|5
828576|NCT01928771|2720528|P1|Overall Study|Adverse Event|6
828577|NCT01928615|2720640|P1|Overall Study|Study Terminated by Sponsor|2
828578|NCT01928472|2720659|P4|Overall Study|Unclassified|0
828579|NCT01928472|2720660|P3|Overall Study|Unclassified|1
828580|NCT01928472|2720661|P2|Overall Study|Unclassified|0
828581|NCT01928472|2720662|P1|Overall Study|Unclassified|0
828582|NCT01928472|2720659|P4|Overall Study|Administrative Reason|0
828583|NCT01928472|2720660|P3|Overall Study|Administrative Reason|0
828584|NCT01928472|2720661|P2|Overall Study|Administrative Reason|1
828585|NCT01928472|2720662|P1|Overall Study|Administrative Reason|2
828586|NCT01928472|2720659|P4|Overall Study|Lost to Follow-up|0
828587|NCT01928472|2720660|P3|Overall Study|Lost to Follow-up|4
828588|NCT01928472|2720661|P2|Overall Study|Lost to Follow-up|3
828589|NCT01928472|2720662|P1|Overall Study|Lost to Follow-up|2
828590|NCT01928472|2720659|P4|Overall Study|Withdrawal by Subject|2
828591|NCT01928472|2720660|P3|Overall Study|Withdrawal by Subject|1
828592|NCT01928472|2720661|P2|Overall Study|Withdrawal by Subject|4
828593|NCT01928472|2720662|P1|Overall Study|Withdrawal by Subject|4
828594|NCT01928472|2720659|P4|Overall Study|Death|0
828595|NCT01928472|2720660|P3|Overall Study|Death|1
828596|NCT01928472|2720661|P2|Overall Study|Death|0
828597|NCT01928472|2720662|P1|Overall Study|Death|0
828598|NCT01928433|2720732|P3|Overall Study|Other reasons|4
828599|NCT01928433|2720733|P2|Overall Study|Other reasons|3
828600|NCT01928433|2720734|P1|Overall Study|Other reasons|3
828601|NCT01928433|2720732|P3|Overall Study|Lost to Follow-up|3
828602|NCT01928433|2720733|P2|Overall Study|Lost to Follow-up|2
828603|NCT01928433|2720734|P1|Overall Study|Lost to Follow-up|0
828604|NCT01928433|2720732|P3|Overall Study|Negative screening urine culture|10
828605|NCT01928433|2720733|P2|Overall Study|Negative screening urine culture|6
828606|NCT01928433|2720734|P1|Overall Study|Negative screening urine culture|7
828607|NCT01928433|2720732|P3|Overall Study|Withdrawal by Subject|0
828608|NCT01928433|2720733|P2|Overall Study|Withdrawal by Subject|4
828609|NCT01928433|2720734|P1|Overall Study|Withdrawal by Subject|0
828610|NCT01928433|2720732|P3|Overall Study|Lack of Efficacy|4
828611|NCT01928433|2720733|P2|Overall Study|Lack of Efficacy|4
828612|NCT01928433|2720734|P1|Overall Study|Lack of Efficacy|5
828613|NCT01928433|2720732|P3|Overall Study|Protocol Violation|2
828614|NCT01928433|2720733|P2|Overall Study|Protocol Violation|0
828615|NCT01928433|2720734|P1|Overall Study|Protocol Violation|0
828616|NCT01928433|2720732|P3|Overall Study|Adverse Event|5
828617|NCT01928433|2720733|P2|Overall Study|Adverse Event|2
828618|NCT01928433|2720734|P1|Overall Study|Adverse Event|5
828619|NCT01928381|2720757|P7|Part 2 - Post Third Intervention|Protocol Violation|0
828620|NCT01928381|2720758|P6|Part 2 - Post Third Intervention|Protocol Violation|0
828621|NCT01928381|2720759|P5|Part 2 - Post Third Intervention|Protocol Violation|0
828622|NCT01928381|2720760|P4|Part 2 - Post Third Intervention|Protocol Violation|0
828623|NCT01928381|2720761|P3|Part 2 - Post Third Intervention|Protocol Violation|1
828624|NCT01928381|2720762|P2|Part 2 - Post Third Intervention|Protocol Violation|0
828625|NCT01928381|2720763|P1|Part 2 - Post Third Intervention|Protocol Violation|0
828626|NCT01928381|2720757|P7|Part 2 - Second Intervention|Lost to Follow-up|0
828627|NCT01928381|2720758|P6|Part 2 - Second Intervention|Lost to Follow-up|0
828628|NCT01928381|2720759|P5|Part 2 - Second Intervention|Lost to Follow-up|0
828629|NCT01928381|2720760|P4|Part 2 - Second Intervention|Lost to Follow-up|1
828630|NCT01928381|2720761|P3|Part 2 - Second Intervention|Lost to Follow-up|0
828631|NCT01928381|2720762|P2|Part 2 - Second Intervention|Lost to Follow-up|1
828632|NCT01928381|2720763|P1|Part 2 - Second Intervention|Lost to Follow-up|0
828633|NCT01928381|2720757|P7|Washout First Intervention|Protocol Violation|0
828634|NCT01928381|2720758|P6|Washout First Intervention|Protocol Violation|0
828635|NCT01928381|2720759|P5|Washout First Intervention|Protocol Violation|1
828636|NCT01928381|2720760|P4|Washout First Intervention|Protocol Violation|0
828637|NCT01928381|2720761|P3|Washout First Intervention|Protocol Violation|0
828638|NCT01928381|2720762|P2|Washout First Intervention|Protocol Violation|0
828639|NCT01928381|2720763|P1|Washout First Intervention|Protocol Violation|0
828640|NCT01928381|2720757|P7|Part 2 - First Intervention|Lost to Follow-up|0
828641|NCT01928381|2720758|P6|Part 2 - First Intervention|Lost to Follow-up|0
828642|NCT01928381|2720759|P5|Part 2 - First Intervention|Lost to Follow-up|0
828643|NCT01928381|2720760|P4|Part 2 - First Intervention|Lost to Follow-up|1
828644|NCT01928381|2720761|P3|Part 2 - First Intervention|Lost to Follow-up|0
828645|NCT01928381|2720762|P2|Part 2 - First Intervention|Lost to Follow-up|0
828646|NCT01928381|2720763|P1|Part 2 - First Intervention|Lost to Follow-up|0
828647|NCT01928381|2720757|P7|Part 2 - First Intervention|Eligibility criterion not met|1
828648|NCT01928381|2720758|P6|Part 2 - First Intervention|Eligibility criterion not met|1
828649|NCT01928381|2720759|P5|Part 2 - First Intervention|Eligibility criterion not met|0
828650|NCT01928381|2720760|P4|Part 2 - First Intervention|Eligibility criterion not met|0
828651|NCT01928381|2720761|P3|Part 2 - First Intervention|Eligibility criterion not met|0
828652|NCT01928381|2720762|P2|Part 2 - First Intervention|Eligibility criterion not met|0
828653|NCT01928381|2720763|P1|Part 2 - First Intervention|Eligibility criterion not met|0
828654|NCT01928381|2720757|P7|Part 2 - First Intervention|Study specific withdrawal criteria|0
828655|NCT01928381|2720758|P6|Part 2 - First Intervention|Study specific withdrawal criteria|0
828656|NCT01928381|2720759|P5|Part 2 - First Intervention|Study specific withdrawal criteria|0
828657|NCT01928381|2720760|P4|Part 2 - First Intervention|Study specific withdrawal criteria|0
828658|NCT01928381|2720761|P3|Part 2 - First Intervention|Study specific withdrawal criteria|1
828659|NCT01928381|2720762|P2|Part 2 - First Intervention|Study specific withdrawal criteria|0
828660|NCT01928381|2720763|P1|Part 2 - First Intervention|Study specific withdrawal criteria|0
828661|NCT01928381|2720757|P7|Part 2 - First Intervention|Withdrawal by Subject|0
828662|NCT01928381|2720758|P6|Part 2 - First Intervention|Withdrawal by Subject|0
828663|NCT01928381|2720759|P5|Part 2 - First Intervention|Withdrawal by Subject|0
828664|NCT01928381|2720760|P4|Part 2 - First Intervention|Withdrawal by Subject|0
828665|NCT01928381|2720761|P3|Part 2 - First Intervention|Withdrawal by Subject|1
828666|NCT01928381|2720762|P2|Part 2 - First Intervention|Withdrawal by Subject|0
828667|NCT01928381|2720763|P1|Part 2 - First Intervention|Withdrawal by Subject|0
828668|NCT01928381|2720757|P7|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
828669|NCT01928381|2720758|P6|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
828670|NCT01928381|2720759|P5|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
828671|NCT01928381|2720760|P4|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
828672|NCT01928381|2720761|P3|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
828673|NCT01928381|2720762|P2|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
828674|NCT01928381|2720763|P1|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10
828675|NCT01928381|2720757|P7|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
828676|NCT01928381|2720758|P6|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
828677|NCT01928381|2720759|P5|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
828678|NCT01928381|2720760|P4|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
828679|NCT01928381|2720761|P3|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
828680|NCT01928381|2720762|P2|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
828681|NCT01928381|2720763|P1|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1
828682|NCT01928381|2720757|P7|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
828683|NCT01928381|2720758|P6|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
828684|NCT01928381|2720759|P5|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
828685|NCT01928381|2720760|P4|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
828686|NCT01928381|2720761|P3|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
828687|NCT01928381|2720762|P2|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
828688|NCT01928381|2720763|P1|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2
828689|NCT01928381|2720757|P7|Placebo run-in & Part 2 Eligibility|Adverse Event|0
828690|NCT01928381|2720758|P6|Placebo run-in & Part 2 Eligibility|Adverse Event|0
828691|NCT01928381|2720759|P5|Placebo run-in & Part 2 Eligibility|Adverse Event|0
828692|NCT01928381|2720760|P4|Placebo run-in & Part 2 Eligibility|Adverse Event|0
828693|NCT01928381|2720761|P3|Placebo run-in & Part 2 Eligibility|Adverse Event|0
828694|NCT01928381|2720762|P2|Placebo run-in & Part 2 Eligibility|Adverse Event|0
828695|NCT01928381|2720763|P1|Placebo run-in & Part 2 Eligibility|Adverse Event|1
828696|NCT01928381|2720757|P7|Part 1 - Pain Training|Protocol Violation|0
828697|NCT01928381|2720758|P6|Part 1 - Pain Training|Protocol Violation|0
828698|NCT01928381|2720759|P5|Part 1 - Pain Training|Protocol Violation|0
828699|NCT01928381|2720760|P4|Part 1 - Pain Training|Protocol Violation|0
828700|NCT01928381|2720761|P3|Part 1 - Pain Training|Protocol Violation|0
828701|NCT01928381|2720762|P2|Part 1 - Pain Training|Protocol Violation|0
828702|NCT01928381|2720763|P1|Part 1 - Pain Training|Protocol Violation|1
828703|NCT01928381|2720757|P7|Part 1 - Pain Training|Lost to Follow-up|0
828704|NCT01928381|2720758|P6|Part 1 - Pain Training|Lost to Follow-up|0
828705|NCT01928381|2720759|P5|Part 1 - Pain Training|Lost to Follow-up|0
828706|NCT01928381|2720760|P4|Part 1 - Pain Training|Lost to Follow-up|0
828707|NCT01928381|2720761|P3|Part 1 - Pain Training|Lost to Follow-up|0
828708|NCT01928381|2720762|P2|Part 1 - Pain Training|Lost to Follow-up|0
828709|NCT01928381|2720763|P1|Part 1 - Pain Training|Lost to Follow-up|4
828710|NCT01928381|2720757|P7|Part 1 - Pain Training|Withdrawal by Subject|0
828711|NCT01928381|2720758|P6|Part 1 - Pain Training|Withdrawal by Subject|0
828712|NCT01928381|2720759|P5|Part 1 - Pain Training|Withdrawal by Subject|0
828713|NCT01928381|2720760|P4|Part 1 - Pain Training|Withdrawal by Subject|0
828714|NCT01928381|2720761|P3|Part 1 - Pain Training|Withdrawal by Subject|0
828715|NCT01928381|2720762|P2|Part 1 - Pain Training|Withdrawal by Subject|0
828716|NCT01928381|2720763|P1|Part 1 - Pain Training|Withdrawal by Subject|1
828717|NCT01928381|2720757|P7|Part 1 - Pain Training|Pain training criteria not met|0
828718|NCT01928381|2720758|P6|Part 1 - Pain Training|Pain training criteria not met|0
828719|NCT01928381|2720759|P5|Part 1 - Pain Training|Pain training criteria not met|0
828720|NCT01928381|2720760|P4|Part 1 - Pain Training|Pain training criteria not met|0
828721|NCT01928381|2720761|P3|Part 1 - Pain Training|Pain training criteria not met|0
828722|NCT01928381|2720762|P2|Part 1 - Pain Training|Pain training criteria not met|0
828723|NCT01928381|2720763|P1|Part 1 - Pain Training|Pain training criteria not met|29
828724|NCT01928381|2720757|P7|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
828725|NCT01928381|2720758|P6|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
828726|NCT01928381|2720759|P5|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
828727|NCT01928381|2720760|P4|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
828728|NCT01928381|2720761|P3|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
828729|NCT01928381|2720762|P2|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
828730|NCT01928381|2720763|P1|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60
828731|NCT01928082|2720790|P1|Overall Study|Study terminated.|1
828732|NCT01927757|2720808|P1|Overall Study|Ethical Reasons|4
828733|NCT01927757|2720808|P1|Overall Study|Other|1
828734|NCT01927757|2720808|P1|Overall Study|Decision by Sponsor|2
828735|NCT01927757|2720808|P1|Overall Study|Lost to Follow-up|2
828736|NCT01927757|2720808|P1|Overall Study|Withdrawal by Subject|14
828737|NCT01927419|2720836|P2|Overall Study|Not reported|0
828738|NCT01927419|2720837|P1|Overall Study|Not reported|1
828739|NCT01927419|2720836|P2|Overall Study|Not specified|1
828740|NCT01927419|2720837|P1|Overall Study|Not specified|2
828741|NCT01927419|2720836|P2|Overall Study|Withdrawal by Subject|1
828742|NCT01927419|2720837|P1|Overall Study|Withdrawal by Subject|3
828743|NCT01927419|2720836|P2|Overall Study|Adverse event unrelated to study drug|1
828744|NCT01927419|2720837|P1|Overall Study|Adverse event unrelated to study drug|6
828745|NCT01927419|2720836|P2|Overall Study|Death|1
828746|NCT01927419|2720837|P1|Overall Study|Death|0
828747|NCT01927419|2720836|P2|Overall Study|Study drug toxicity|7
828748|NCT01927419|2720837|P1|Overall Study|Study drug toxicity|43
828749|NCT01927419|2720836|P2|Overall Study|Disease progression|17
828750|NCT01927419|2720837|P1|Overall Study|Disease progression|15
828751|NCT01927055|2720871|P3|Double-Blind|Extended Vacation|0
828752|NCT01927055|2720872|P2|Double-Blind|Extended Vacation|1
828753|NCT01927055|2720873|P1|Double-Blind|Extended Vacation|0
828754|NCT01927055|2720871|P3|Double-Blind|Supine Hypertension|1
828755|NCT01927055|2720872|P2|Double-Blind|Supine Hypertension|0
828756|NCT01927055|2720873|P1|Double-Blind|Supine Hypertension|0
828757|NCT01927055|2720871|P3|Double-Blind|Study Stopped|7
828758|NCT01927055|2720872|P2|Double-Blind|Study Stopped|7
828759|NCT01927055|2720873|P1|Double-Blind|Study Stopped|0
828760|NCT01927055|2720871|P3|Double-Blind|Withdrawal by Subject|3
828761|NCT01927055|2720872|P2|Double-Blind|Withdrawal by Subject|2
828762|NCT01927055|2720873|P1|Double-Blind|Withdrawal by Subject|0
828763|NCT01927055|2720871|P3|Double-Blind|Protocol Violation|1
828764|NCT01927055|2720872|P2|Double-Blind|Protocol Violation|0
828765|NCT01927055|2720873|P1|Double-Blind|Protocol Violation|0
828766|NCT01927055|2720871|P3|Double-Blind|Adverse Event|1
828767|NCT01927055|2720872|P2|Double-Blind|Adverse Event|1
828768|NCT01927055|2720873|P1|Double-Blind|Adverse Event|0
828769|NCT01927055|2720871|P3|Open-label|Difficulty attending study visits|0
828770|NCT01927055|2720872|P2|Open-label|Difficulty attending study visits|0
828771|NCT01927055|2720873|P1|Open-label|Difficulty attending study visits|1
828772|NCT01927055|2720871|P3|Open-label|Supine Hypertension|0
828773|NCT01927055|2720872|P2|Open-label|Supine Hypertension|0
828774|NCT01927055|2720873|P1|Open-label|Supine Hypertension|4
828775|NCT01927055|2720871|P3|Open-label|Study Stopped|0
828776|NCT01927055|2720872|P2|Open-label|Study Stopped|0
828777|NCT01927055|2720873|P1|Open-label|Study Stopped|4
828778|NCT01927055|2720871|P3|Open-label|Withdrawal by Subject|0
828779|NCT01927055|2720872|P2|Open-label|Withdrawal by Subject|0
828780|NCT01927055|2720873|P1|Open-label|Withdrawal by Subject|1
828781|NCT01927055|2720871|P3|Open-label|Adverse Event|0
828782|NCT01927055|2720872|P2|Open-label|Adverse Event|0
828783|NCT01927055|2720873|P1|Open-label|Adverse Event|6
828784|NCT01926782|2720897|P6|Overall Study|Related to study drug administration|2
828785|NCT01926782|2720898|P5|Overall Study|Related to study drug administration|0
828786|NCT01926782|2720899|P4|Overall Study|Related to study drug administration|0
828787|NCT01926782|2720900|P3|Overall Study|Related to study drug administration|0
828788|NCT01926782|2720901|P2|Overall Study|Related to study drug administration|0
828789|NCT01926782|2720902|P1|Overall Study|Related to study drug administration|0
828790|NCT01926782|2720897|P6|Overall Study|Withdrawal by Subject|5
828791|NCT01926782|2720898|P5|Overall Study|Withdrawal by Subject|0
828792|NCT01926782|2720899|P4|Overall Study|Withdrawal by Subject|1
828793|NCT01926782|2720900|P3|Overall Study|Withdrawal by Subject|8
828794|NCT01926782|2720901|P2|Overall Study|Withdrawal by Subject|1
828795|NCT01926782|2720902|P1|Overall Study|Withdrawal by Subject|6
828796|NCT01926782|2720897|P6|Overall Study|Randomized and not treated|0
828797|NCT01926782|2720898|P5|Overall Study|Randomized and not treated|0
828798|NCT01926782|2720899|P4|Overall Study|Randomized and not treated|1
828799|NCT01926782|2720900|P3|Overall Study|Randomized and not treated|0
828800|NCT01926782|2720901|P2|Overall Study|Randomized and not treated|0
828801|NCT01926782|2720902|P1|Overall Study|Randomized and not treated|0
828802|NCT01926782|2720897|P6|Overall Study|Poor compliance to protocol|6
828803|NCT01926782|2720898|P5|Overall Study|Poor compliance to protocol|1
828804|NCT01926782|2720899|P4|Overall Study|Poor compliance to protocol|0
828805|NCT01926782|2720900|P3|Overall Study|Poor compliance to protocol|8
828806|NCT01926782|2720901|P2|Overall Study|Poor compliance to protocol|3
828807|NCT01926782|2720902|P1|Overall Study|Poor compliance to protocol|5
828808|NCT01926782|2720897|P6|Overall Study|Adverse Event|14
828809|NCT01926782|2720898|P5|Overall Study|Adverse Event|3
828810|NCT01926782|2720899|P4|Overall Study|Adverse Event|4
828811|NCT01926782|2720900|P3|Overall Study|Adverse Event|17
828812|NCT01926782|2720901|P2|Overall Study|Adverse Event|4
828813|NCT01926782|2720902|P1|Overall Study|Adverse Event|13
828814|NCT01926782|2720897|P6|Overall Study|Other than specified|11
828815|NCT01926782|2720898|P5|Overall Study|Other than specified|4
828816|NCT01926782|2720899|P4|Overall Study|Other than specified|12
828817|NCT01926782|2720900|P3|Overall Study|Other than specified|5
828818|NCT01926782|2720901|P2|Overall Study|Other than specified|3
828819|NCT01926782|2720902|P1|Overall Study|Other than specified|2
828820|NCT01926782|2720897|P6|Overall Study|Physician Decision|0
828821|NCT01926782|2720898|P5|Overall Study|Physician Decision|0
828822|NCT01926782|2720899|P4|Overall Study|Physician Decision|1
828823|NCT01926782|2720900|P3|Overall Study|Physician Decision|1
828824|NCT01926782|2720901|P2|Overall Study|Physician Decision|2
828825|NCT01926782|2720902|P1|Overall Study|Physician Decision|0
828826|NCT01926782|2720897|P6|Overall Study|Participant moved|3
828827|NCT01926782|2720898|P5|Overall Study|Participant moved|0
828828|NCT01926782|2720899|P4|Overall Study|Participant moved|1
828829|NCT01926782|2720900|P3|Overall Study|Participant moved|1
828830|NCT01926782|2720901|P2|Overall Study|Participant moved|0
828831|NCT01926782|2720902|P1|Overall Study|Participant moved|2
828832|NCT01926626|2721051|P1|Overall Study|Lost to Follow-up|7
828833|NCT01926626|2721051|P1|Overall Study|Withdrawal by Subject|15
828834|NCT01926119|2721061|P1|Overall Study|Withdrawal by Subject|1
828835|NCT01926028|2721074|P3|Overall Study|Non compliance or other reasons|0
828836|NCT01926028|2721075|P2|Overall Study|Non compliance or other reasons|2
828837|NCT01926028|2721076|P1|Overall Study|Non compliance or other reasons|4
828838|NCT01926028|2721074|P3|Overall Study|Withdrawal by Subject|2
828839|NCT01926028|2721075|P2|Overall Study|Withdrawal by Subject|9
828840|NCT01926028|2721076|P1|Overall Study|Withdrawal by Subject|9
828841|NCT01926028|2721074|P3|Overall Study|Physician Decision|0
828842|NCT01926028|2721075|P2|Overall Study|Physician Decision|5
828843|NCT01926028|2721076|P1|Overall Study|Physician Decision|1
828844|NCT01926028|2721074|P3|Overall Study|Lost to Follow-up|0
828845|NCT01926028|2721075|P2|Overall Study|Lost to Follow-up|6
828846|NCT01926028|2721076|P1|Overall Study|Lost to Follow-up|7
828847|NCT01926015|2721112|P2|Overall Study|Randomized not treated|0
828848|NCT01926015|2721113|P1|Overall Study|Randomized not treated|2
828849|NCT01926015|2721112|P2|Overall Study|Withdrawal by parent/guardian|1
828850|NCT01926015|2721113|P1|Overall Study|Withdrawal by parent/guardian|0
828851|NCT01925950|2721145|P2|Part 2|Withdrawal by Subject|0
828852|NCT01925950|2721146|P1|Part 2|Withdrawal by Subject|1
828853|NCT01925768|2721165|P2|Overall Study|Non-compliance with study drug|1
828854|NCT01925768|2721166|P1|Overall Study|Non-compliance with study drug|0
828855|NCT01925768|2721165|P2|Overall Study|Withdrawal by Subject|4
828856|NCT01925768|2721166|P1|Overall Study|Withdrawal by Subject|1
828857|NCT01925768|2721165|P2|Overall Study|Lack of Efficacy|6
828858|NCT01925768|2721166|P1|Overall Study|Lack of Efficacy|3
828859|NCT01925768|2721165|P2|Overall Study|Adverse Event|10
828860|NCT01925768|2721166|P1|Overall Study|Adverse Event|5
828861|NCT01925768|2721165|P2|Overall Study|Protocol Violation|2
828862|NCT01925768|2721166|P1|Overall Study|Protocol Violation|1
828863|NCT01925768|2721165|P2|Overall Study|Lost to Follow-up|0
828864|NCT01925768|2721166|P1|Overall Study|Lost to Follow-up|1
828865|NCT01925703|2721174|P1|Overall Study|Discharge prior to full iron repletion|1
828866|NCT01925703|2721174|P1|Overall Study|Lost to Follow-up|2
828867|NCT01925703|2721174|P1|Overall Study|Physician Decision|1
828868|NCT01925612|2721185|P5|Overall Study|Adverse Event|2
828869|NCT01925612|2721186|P4|Overall Study|Adverse Event|1
828870|NCT01925612|2721187|P3|Overall Study|Adverse Event|0
828871|NCT01925612|2721188|P2|Overall Study|Adverse Event|3
828872|NCT01925612|2721189|P1|Overall Study|Adverse Event|3
828873|NCT01925612|2721185|P5|Overall Study|Progressive Disease|0
828874|NCT01925612|2721186|P4|Overall Study|Progressive Disease|0
828875|NCT01925612|2721187|P3|Overall Study|Progressive Disease|1
828876|NCT01925612|2721188|P2|Overall Study|Progressive Disease|1
828877|NCT01925612|2721189|P1|Overall Study|Progressive Disease|1
828878|NCT01925417|2721239|P1|Overall Study|Death|1
828879|NCT01925417|2721239|P1|Overall Study|Withdrawal by Subject|2
828880|NCT01925274|2721271|P3|Overall Study|Protocol amendment|6
828881|NCT01925274|2721272|P2|Overall Study|Protocol amendment|3
828882|NCT01925274|2721273|P1|Overall Study|Protocol amendment|1
828883|NCT01925274|2721271|P3|Overall Study|Study terminated by sponsor|0
828884|NCT01925274|2721272|P2|Overall Study|Study terminated by sponsor|0
828885|NCT01925274|2721273|P1|Overall Study|Study terminated by sponsor|4
828886|NCT01925274|2721271|P3|Overall Study|Withdrawal by Subject|0
828887|NCT01925274|2721272|P2|Overall Study|Withdrawal by Subject|2
828888|NCT01925274|2721273|P1|Overall Study|Withdrawal by Subject|1
828889|NCT01925274|2721271|P3|Overall Study|Lost to Follow-up|0
828890|NCT01925274|2721272|P2|Overall Study|Lost to Follow-up|1
828891|NCT01925274|2721273|P1|Overall Study|Lost to Follow-up|0
828892|NCT01925274|2721271|P3|Overall Study|Death|0
828893|NCT01925274|2721272|P2|Overall Study|Death|0
828894|NCT01925274|2721273|P1|Overall Study|Death|1
828895|NCT01925209|2721354|P4|Follow-up|Withdrawal by Subject|2
828896|NCT01925209|2721355|P3|Follow-up|Withdrawal by Subject|0
828897|NCT01925209|2721356|P2|Follow-up|Withdrawal by Subject|2
828898|NCT01925209|2721357|P1|Follow-up|Withdrawal by Subject|0
828899|NCT01925209|2721354|P4|Follow-up|Non-compliance with study treatment|1
828900|NCT01925209|2721355|P3|Follow-up|Non-compliance with study treatment|0
828901|NCT01925209|2721356|P2|Follow-up|Non-compliance with study treatment|0
828902|NCT01925209|2721357|P1|Follow-up|Non-compliance with study treatment|0
828903|NCT01925209|2721354|P4|Follow-up|Physician Decision|0
828904|NCT01925209|2721355|P3|Follow-up|Physician Decision|1
828905|NCT01925209|2721356|P2|Follow-up|Physician Decision|0
828906|NCT01925209|2721357|P1|Follow-up|Physician Decision|0
828907|NCT01925209|2721354|P4|Follow-up|Adverse Event|1
828908|NCT01925209|2721355|P3|Follow-up|Adverse Event|0
828909|NCT01925209|2721356|P2|Follow-up|Adverse Event|4
828910|NCT01925209|2721357|P1|Follow-up|Adverse Event|1
828911|NCT01925209|2721354|P4|Maintenance Treatment Epoch|Adverse Event|0
828912|NCT01925209|2721355|P3|Maintenance Treatment Epoch|Adverse Event|1
828913|NCT01925209|2721356|P2|Maintenance Treatment Epoch|Adverse Event|0
828914|NCT01925209|2721357|P1|Maintenance Treatment Epoch|Adverse Event|0
828915|NCT01925209|2721354|P4|Maintenance Treatment Epoch|Withdrawal by Subject|2
828916|NCT01925209|2721355|P3|Maintenance Treatment Epoch|Withdrawal by Subject|1
828917|NCT01925209|2721356|P2|Maintenance Treatment Epoch|Withdrawal by Subject|1
828918|NCT01925209|2721357|P1|Maintenance Treatment Epoch|Withdrawal by Subject|0
828919|NCT01925209|2721354|P4|Treatment Epoch|Adverse Event|1
828920|NCT01925209|2721355|P3|Treatment Epoch|Adverse Event|3
828921|NCT01925209|2721356|P2|Treatment Epoch|Adverse Event|5
828922|NCT01925209|2721357|P1|Treatment Epoch|Adverse Event|3
828923|NCT01925209|2721354|P4|Treatment Epoch|Withdrawal by Subject|2
828924|NCT01925209|2721355|P3|Treatment Epoch|Withdrawal by Subject|3
828925|NCT01925209|2721356|P2|Treatment Epoch|Withdrawal by Subject|3
828926|NCT01925209|2721357|P1|Treatment Epoch|Withdrawal by Subject|4
828927|NCT01925209|2721354|P4|Treatment Epoch|Protocol deviation|1
828928|NCT01925209|2721355|P3|Treatment Epoch|Protocol deviation|1
828929|NCT01925209|2721356|P2|Treatment Epoch|Protocol deviation|0
828930|NCT01925209|2721357|P1|Treatment Epoch|Protocol deviation|0
828931|NCT01925209|2721354|P4|Treatment Epoch|Death|0
828932|NCT01925209|2721355|P3|Treatment Epoch|Death|0
828933|NCT01925209|2721356|P2|Treatment Epoch|Death|0
828934|NCT01925209|2721357|P1|Treatment Epoch|Death|1
828935|NCT01925209|2721354|P4|Treatment Epoch|Non-compliance with study treatment|1
828936|NCT01925209|2721355|P3|Treatment Epoch|Non-compliance with study treatment|0
828937|NCT01925209|2721356|P2|Treatment Epoch|Non-compliance with study treatment|0
828938|NCT01925209|2721357|P1|Treatment Epoch|Non-compliance with study treatment|0
828939|NCT01925209|2721354|P4|Treatment Epoch|Physician Decision|0
828940|NCT01925209|2721355|P3|Treatment Epoch|Physician Decision|0
828941|NCT01925209|2721356|P2|Treatment Epoch|Physician Decision|0
828942|NCT01925209|2721357|P1|Treatment Epoch|Physician Decision|1
828943|NCT01925183|2721389|P2|Overall Study|Adverse Event|0
828944|NCT01925183|2721390|P1|Overall Study|Adverse Event|1
828945|NCT01925170|2721398|P1|Overall Study|Unverified cancer status|53
828946|NCT01924845|2721458|P1|Overall Study|Protocol Violation|1
828947|NCT01924845|2721458|P1|Overall Study|Withdrawal by Subject|2
828948|NCT01924845|2721458|P1|Overall Study|Adverse Event|3
828949|NCT01924767|2721471|P5|Overall Study|Adverse Event|0
828950|NCT01924767|2721472|P4|Overall Study|Adverse Event|0
828951|NCT01924767|2721473|P3|Overall Study|Adverse Event|1
828952|NCT01924767|2721474|P2|Overall Study|Adverse Event|0
828953|NCT01924767|2721475|P1|Overall Study|Adverse Event|1
828954|NCT01924533|2721591|P2|Overall Study|Other Eligibility criteria|1
828955|NCT01924533|2721592|P1|Overall Study|Other Eligibility criteria|1
828956|NCT01924533|2721591|P2|Overall Study|Withdrawal by Subject|3
828957|NCT01924533|2721592|P1|Overall Study|Withdrawal by Subject|7
828958|NCT01924533|2721591|P2|Overall Study|Lost to Follow-up|1
828959|NCT01924533|2721592|P1|Overall Study|Lost to Follow-up|0
828960|NCT01924533|2721591|P2|Overall Study|Death|200
828961|NCT01924533|2721592|P1|Overall Study|Death|181
828962|NCT01924429|2721622|P2|Washout Period (2 Weeks)|Withdrawal by Subject|2
828963|NCT01924429|2721623|P1|Washout Period (2 Weeks)|Withdrawal by Subject|3
828964|NCT01924364|2721666|P1|Overall Study|Physician Decision|3
828965|NCT01924299|2721683|P2|Period 2|Adverse Event|1
828966|NCT01924299|2721684|P1|Period 2|Adverse Event|0
828967|NCT01924299|2721683|P2|Period 2|Withdrawal by Subject|0
828968|NCT01924299|2721684|P1|Period 2|Withdrawal by Subject|1
828969|NCT01924182|2721706|P2|Overall Study|Withdrawal by Subject|0
828970|NCT01924182|2721707|P1|Overall Study|Withdrawal by Subject|1
828971|NCT01923896|2721726|P2|Overall Study|Adverse Event|0
828972|NCT01923896|2721727|P1|Overall Study|Adverse Event|1
828973|NCT01923740|2721750|P2|3 Year Clinical Follow-up|Death|0
828974|NCT01923740|2721751|P1|3 Year Clinical Follow-up|Death|1
828975|NCT01923740|2721750|P2|2 Year Clinical Follow-up|ICF withdrawal|0
828976|NCT01923740|2721751|P1|2 Year Clinical Follow-up|ICF withdrawal|1
828977|NCT01923740|2721750|P2|2 Year Clinical Follow-up|Lost to Follow-up|2
828978|NCT01923740|2721751|P1|2 Year Clinical Follow-up|Lost to Follow-up|0
828979|NCT01923740|2721750|P2|2 Year Clinical Follow-up|Death|1
828980|NCT01923740|2721751|P1|2 Year Clinical Follow-up|Death|1
828981|NCT01923740|2721750|P2|1 Year Clinical Follow-up|Lost to Follow-up|0
828982|NCT01923740|2721751|P1|1 Year Clinical Follow-up|Lost to Follow-up|1
828983|NCT01923740|2721750|P2|270-day Clinical Follow-up|Death|4
828984|NCT01923740|2721751|P1|270-day Clinical Follow-up|Death|0
828985|NCT01923467|2722128|P1|Overall Study|Subject non-interest|479
828986|NCT01923467|2722128|P1|Overall Study|Lost to Follow-up|62
828987|NCT01923389|2722134|P2|Overall Study|Protocol Violation|0
828988|NCT01923389|2722135|P1|Overall Study|Protocol Violation|1
828989|NCT01923363|2722157|P1|Overall Study|Protocol Violation|1
828990|NCT01923311|2722166|P2|Overall Study|Study Terminated by Sponsor|0
828991|NCT01923311|2722167|P1|Overall Study|Study Terminated by Sponsor|12
828992|NCT01923311|2722166|P2|Overall Study|Withdrew Consent|0
828993|NCT01923311|2722167|P1|Overall Study|Withdrew Consent|1
828994|NCT01923311|2722166|P2|Overall Study|Non-Compliance with Study Drug|1
828995|NCT01923311|2722167|P1|Overall Study|Non-Compliance with Study Drug|2
828996|NCT01923311|2722166|P2|Overall Study|Investigator's Discretion|0
828997|NCT01923311|2722167|P1|Overall Study|Investigator's Discretion|1
828998|NCT01923311|2722166|P2|Overall Study|Pregnancy|0
828999|NCT01923311|2722167|P1|Overall Study|Pregnancy|1
829000|NCT01923168|2722213|P3|Overall Study|Death|1
829001|NCT01923168|2722214|P2|Overall Study|Death|0
829002|NCT01923168|2722215|P1|Overall Study|Death|0
829003|NCT01923168|2722213|P3|Overall Study|Progressive disease|7
829004|NCT01923168|2722214|P2|Overall Study|Progressive disease|3
829005|NCT01923168|2722215|P1|Overall Study|Progressive disease|4
829006|NCT01923168|2722213|P3|Overall Study|Physician Decision|5
829007|NCT01923168|2722214|P2|Overall Study|Physician Decision|9
829008|NCT01923168|2722215|P1|Overall Study|Physician Decision|6
829009|NCT01923168|2722213|P3|Overall Study|Adverse Event|0
829010|NCT01923168|2722214|P2|Overall Study|Adverse Event|12
829011|NCT01923168|2722215|P1|Overall Study|Adverse Event|12
829012|NCT01923168|2722213|P3|Overall Study|Subject/guardian decision|4
829013|NCT01923168|2722214|P2|Overall Study|Subject/guardian decision|14
829014|NCT01923168|2722215|P1|Overall Study|Subject/guardian decision|14
829015|NCT01923168|2722213|P3|Overall Study|Protocol Violation|0
829016|NCT01923168|2722214|P2|Overall Study|Protocol Violation|1
829017|NCT01923168|2722215|P1|Overall Study|Protocol Violation|1
829018|NCT01922934|2722287|P2|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284
829019|NCT01922934|2722288|P1|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21
829020|NCT01922934|2722287|P2|Visit 0 - Patient Contacted & Consented|No response or could not reach|0
829021|NCT01922934|2722288|P1|Visit 0 - Patient Contacted & Consented|No response or could not reach|66
829022|NCT01922934|2722287|P2|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0
829023|NCT01922934|2722288|P1|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169
829024|NCT01922934|2722287|P2|Eligible Patients|Did not meet inclusion criteria|81
829025|NCT01922934|2722288|P1|Eligible Patients|Did not meet inclusion criteria|36
829026|NCT01922934|2722287|P2|Eligible Patients|Physician Decision|0
829027|NCT01922934|2722288|P1|Eligible Patients|Physician Decision|17
829028|NCT01922934|2722287|P2|Eligible Patients|Death|7
829029|NCT01922934|2722288|P1|Eligible Patients|Death|0
829030|NCT01922739|2722300|P1|Open-label Treatment Period|Sponsor request - investigator leaving|1
829031|NCT01922739|2722300|P1|Open-label Treatment Period|Physician Decision|1
829032|NCT01922739|2722300|P1|Open-label Treatment Period|Lost to Follow-up|2
829033|NCT01922739|2722300|P1|Open-label Treatment Period|Noncompliance to study procedures|1
829034|NCT01922739|2722300|P1|Open-label Treatment Period|Pregnancy|1
829035|NCT01922739|2722300|P1|Open-label Treatment Period|Protocol Violation|5
829036|NCT01922739|2722300|P1|Open-label Treatment Period|Noncompliance to study medication|3
829037|NCT01922739|2722300|P1|Open-label Treatment Period|Withdrawal by Subject|14
829038|NCT01922739|2722300|P1|Open-label Treatment Period|Adverse Event|6
829039|NCT01922739|2722300|P1|Titration/Adjustment Period|Lack of Efficacy|3
829040|NCT01922739|2722300|P1|Titration/Adjustment Period|Lost to Follow-up|1
829041|NCT01922739|2722300|P1|Titration/Adjustment Period|Withdrawal by Subject|5
829042|NCT01922739|2722300|P1|Titration/Adjustment Period|Adverse Event|3
829043|NCT01922349|2722329|P4|Multiple Rising Dose (MRD) Period|Adverse Event|1
829044|NCT01922349|2722330|P3|Multiple Rising Dose (MRD) Period|Adverse Event|0
829045|NCT01922349|2722331|P2|Multiple Rising Dose (MRD) Period|Adverse Event|0
829046|NCT01922349|2722332|P1|Multiple Rising Dose (MRD) Period|Adverse Event|0
829047|NCT01922271|2722439|P2|WASHOUT Period|Withdrawal by Subject|0
829048|NCT01922271|2722440|P1|WASHOUT Period|Withdrawal by Subject|1
829049|NCT01922089|2722481|P2|Overall Study|Lost to Follow-up|1
829050|NCT01922089|2722482|P1|Overall Study|Lost to Follow-up|0
829051|NCT01922089|2722481|P2|Overall Study|Death|1
829052|NCT01922089|2722482|P1|Overall Study|Death|2
829053|NCT01922089|2722481|P2|Overall Study|Physician Decision|3
829054|NCT01922089|2722482|P1|Overall Study|Physician Decision|2
829055|NCT01922089|2722481|P2|Overall Study|administrative problems|1
829056|NCT01922089|2722482|P1|Overall Study|administrative problems|4
829057|NCT01922089|2722481|P2|Overall Study|Withdrawal by Subject|4
829058|NCT01922089|2722482|P1|Overall Study|Withdrawal by Subject|3
829059|NCT01922089|2722481|P2|Overall Study|Protocol Deviation|7
829060|NCT01922089|2722482|P1|Overall Study|Protocol Deviation|10
829061|NCT01922089|2722481|P2|Overall Study|Adverse Event|13
829062|NCT01922089|2722482|P1|Overall Study|Adverse Event|18
829063|NCT01922037|2722494|P2|Overall Study|Other unspecified|66
829064|NCT01922037|2722495|P1|Overall Study|Other unspecified|2
829065|NCT01922037|2722494|P2|Overall Study|Investigator/Sponsor decision|4
829066|NCT01922037|2722495|P1|Overall Study|Investigator/Sponsor decision|1
829067|NCT01922037|2722494|P2|Overall Study|Participant non-compliance|46
829068|NCT01922037|2722495|P1|Overall Study|Participant non-compliance|4
829069|NCT01922037|2722494|P2|Overall Study|Pregnancy|2
829070|NCT01922037|2722495|P1|Overall Study|Pregnancy|0
829071|NCT01922037|2722494|P2|Overall Study|Death|5
829072|NCT01922037|2722495|P1|Overall Study|Death|0
829073|NCT01922037|2722494|P2|Overall Study|Adverse Event|7
829074|NCT01922037|2722495|P1|Overall Study|Adverse Event|1
829075|NCT01922037|2722494|P2|Overall Study|Withdrawal by Subject|44
829076|NCT01922037|2722495|P1|Overall Study|Withdrawal by Subject|2
829077|NCT01922011|2722589|P2|Overall Study|Randomized in error|0
829078|NCT01922011|2722590|P1|Overall Study|Randomized in error|1
829079|NCT01922011|2722589|P2|Overall Study|Lack of willing home health agency|0
829080|NCT01922011|2722590|P1|Overall Study|Lack of willing home health agency|1
829081|NCT01922011|2722589|P2|Overall Study|Not Treated|0
829082|NCT01922011|2722590|P1|Overall Study|Not Treated|1
829083|NCT01922011|2722589|P2|Overall Study|Missed Test-of-Cure Visit|2
829084|NCT01922011|2722590|P1|Overall Study|Missed Test-of-Cure Visit|0
829085|NCT01922011|2722589|P2|Overall Study|Lost to Follow-up|1
829086|NCT01922011|2722590|P1|Overall Study|Lost to Follow-up|0
829087|NCT01922011|2722589|P2|Overall Study|Parent/Guardian Decision|0
829088|NCT01922011|2722590|P1|Overall Study|Parent/Guardian Decision|3
829089|NCT01922011|2722589|P2|Overall Study|Physician Decision|1
829090|NCT01922011|2722590|P1|Overall Study|Physician Decision|0
829091|NCT01922011|2722589|P2|Overall Study|Protocol Violation|1
829092|NCT01922011|2722590|P1|Overall Study|Protocol Violation|0
829093|NCT01921829|2722657|P2|Overall Study|Withdrawal by Subject|1
829094|NCT01921829|2722658|P1|Overall Study|Withdrawal by Subject|0
829095|NCT01921387|2722732|P1|Overall Study|Adverse Event|1
829096|NCT01921348|2722741|P2|Overall Study|Lost to Follow-up|2
829097|NCT01921348|2722742|P1|Overall Study|Lost to Follow-up|0
829098|NCT01921348|2722741|P2|Overall Study|Withdrawal by Subject|0
829099|NCT01921348|2722742|P1|Overall Study|Withdrawal by Subject|1
829100|NCT01921270|2722771|P1|Overall Study|Withdrawal by Subject|1
829101|NCT01921257|2722787|P1|Overall Study|Withdrawal by Subject|1
829102|NCT01921257|2722787|P1|Overall Study|Protocol Violation|1
829103|NCT01921257|2722787|P1|Overall Study|Adverse Event|1
829104|NCT01921205|2722794|P2|Overall Study|Non Compliance Of Child|1
829105|NCT01921205|2722795|P1|Overall Study|Non Compliance Of Child|0
829106|NCT01921205|2722794|P2|Overall Study|Non Compliance Of The Parent|1
829107|NCT01921205|2722795|P1|Overall Study|Non Compliance Of The Parent|0
829108|NCT01921205|2722794|P2|Overall Study|The Excessive Use Of Rescue Medication|1
829109|NCT01921205|2722795|P1|Overall Study|The Excessive Use Of Rescue Medication|0
829110|NCT01921205|2722794|P2|Overall Study|Use Of Prohibited Medication|1
829111|NCT01921205|2722795|P1|Overall Study|Use Of Prohibited Medication|0
829112|NCT01921205|2722794|P2|Overall Study|Withdrawal by Subject|5
829113|NCT01921205|2722795|P1|Overall Study|Withdrawal by Subject|6
829114|NCT01921205|2722794|P2|Overall Study|Lost to Follow-up|1
829115|NCT01921205|2722795|P1|Overall Study|Lost to Follow-up|1
829116|NCT01921205|2722794|P2|Overall Study|Protocol Violation|3
829117|NCT01921205|2722795|P1|Overall Study|Protocol Violation|1
829118|NCT01921205|2722794|P2|Overall Study|Lack of Efficacy|0
829119|NCT01921205|2722795|P1|Overall Study|Lack of Efficacy|1
829120|NCT01921205|2722794|P2|Overall Study|Adverse Event|7
829121|NCT01921205|2722795|P1|Overall Study|Adverse Event|12
829122|NCT01921101|2722836|P2|Overall Study|Death|6
829123|NCT01921101|2722837|P1|Overall Study|Death|16
829124|NCT01920958|2722845|P1|Overall Study|Did Not Fulfill Inclusion Criteria|5
829125|NCT01920893|2722863|P2|Overall Study|Lack of Efficacy|0
829126|NCT01920893|2722864|P1|Overall Study|Lack of Efficacy|2
829127|NCT01920893|2722863|P2|Overall Study|Adverse Event|2
829128|NCT01920893|2722864|P1|Overall Study|Adverse Event|5
829129|NCT01920854|2722897|P7|Overall Study|Withdrawal by Subject|1
829130|NCT01920854|2722898|P6|Overall Study|Withdrawal by Subject|0
829131|NCT01920854|2722899|P5|Overall Study|Withdrawal by Subject|1
829132|NCT01920854|2722900|P4|Overall Study|Withdrawal by Subject|0
829133|NCT01920854|2722901|P3|Overall Study|Withdrawal by Subject|0
829134|NCT01920854|2722902|P2|Overall Study|Withdrawal by Subject|0
829135|NCT01920854|2722903|P1|Overall Study|Withdrawal by Subject|1
829136|NCT01920594|2723063|P2|Overall Study|Investigator discretion|1
829137|NCT01920594|2723064|P1|Overall Study|Investigator discretion|0
829138|NCT01920594|2723063|P2|Overall Study|Recovery|0
829139|NCT01920594|2723064|P1|Overall Study|Recovery|2
829140|NCT01920594|2723063|P2|Overall Study|Lost to Follow-up|0
829141|NCT01920594|2723064|P1|Overall Study|Lost to Follow-up|1
829142|NCT01920594|2723063|P2|Overall Study|Adverse Event|2
829143|NCT01920594|2723064|P1|Overall Study|Adverse Event|4
829144|NCT01920568|2723114|P2|Overall Study|Death due to disease progression|12
829145|NCT01920568|2723115|P1|Overall Study|Death due to disease progression|25
829146|NCT01920568|2723114|P2|Overall Study|Withdrawal by Subject|55
829147|NCT01920568|2723115|P1|Overall Study|Withdrawal by Subject|79
829148|NCT01920568|2723114|P2|Overall Study|Physician Decision|4
829149|NCT01920568|2723115|P1|Overall Study|Physician Decision|13
829150|NCT01920568|2723114|P2|Overall Study|Lost to Follow-up|2
829151|NCT01920568|2723115|P1|Overall Study|Lost to Follow-up|2
829152|NCT01920568|2723114|P2|Overall Study|Protocol Violation|3
829153|NCT01920568|2723115|P1|Overall Study|Protocol Violation|5
829154|NCT01920568|2723114|P2|Overall Study|Adverse Event|8
829155|NCT01920568|2723115|P1|Overall Study|Adverse Event|27
829156|NCT01920555|2723141|P5|Overall Study|Lost to Follow-up|0
829157|NCT01920555|2723142|P4|Overall Study|Lost to Follow-up|1
829158|NCT01920555|2723143|P3|Overall Study|Lost to Follow-up|0
829159|NCT01920555|2723144|P2|Overall Study|Lost to Follow-up|1
829160|NCT01920555|2723145|P1|Overall Study|Lost to Follow-up|0
829161|NCT01920555|2723141|P5|Overall Study|Travel Difficulties|1
829162|NCT01920555|2723142|P4|Overall Study|Travel Difficulties|0
829163|NCT01920555|2723143|P3|Overall Study|Travel Difficulties|0
829164|NCT01920555|2723144|P2|Overall Study|Travel Difficulties|1
829165|NCT01920555|2723145|P1|Overall Study|Travel Difficulties|1
829166|NCT01920555|2723141|P5|Overall Study|Lack of Efficacy|0
829167|NCT01920555|2723142|P4|Overall Study|Lack of Efficacy|0
829168|NCT01920555|2723143|P3|Overall Study|Lack of Efficacy|0
829169|NCT01920555|2723144|P2|Overall Study|Lack of Efficacy|0
829170|NCT01920555|2723145|P1|Overall Study|Lack of Efficacy|2
829171|NCT01920555|2723141|P5|Overall Study|Physician Decision|0
829172|NCT01920555|2723142|P4|Overall Study|Physician Decision|2
829173|NCT01920555|2723143|P3|Overall Study|Physician Decision|1
829174|NCT01920555|2723144|P2|Overall Study|Physician Decision|2
829175|NCT01920555|2723145|P1|Overall Study|Physician Decision|1
829176|NCT01920178|2723220|P2|Overall Study|Lost to Follow-up|1
829177|NCT01920178|2723221|P1|Overall Study|Lost to Follow-up|2
829178|NCT01919801|2723239|P2|Overall Study|Other|1
829179|NCT01919801|2723240|P1|Overall Study|Other|0
829180|NCT01919801|2723239|P2|Overall Study|Lost to Follow-up|1
829181|NCT01919801|2723240|P1|Overall Study|Lost to Follow-up|0
829182|NCT01919801|2723239|P2|Overall Study|Physician Decision|1
829183|NCT01919801|2723240|P1|Overall Study|Physician Decision|0
829184|NCT01919801|2723239|P2|Overall Study|Withdrawal by Subject|0
829185|NCT01919801|2723240|P1|Overall Study|Withdrawal by Subject|1
829186|NCT01919723|2723265|P2|Overall Study|Blood Samples Hemolyzed|2
829187|NCT01919723|2723266|P1|Overall Study|Blood Samples Hemolyzed|2
829188|NCT01919307|2723306|P1|Overall Study|Withdrawal by Subject|9
829189|NCT01919229|2723316|P3|Overall Study|Subject/guardian decision|1
829190|NCT01919229|2723317|P2|Overall Study|Subject/guardian decision|0
829191|NCT01919229|2723318|P1|Overall Study|Subject/guardian decision|0
829192|NCT01918371|2723383|P2|Overall Study|Missing Data|1
829193|NCT01918371|2723384|P1|Overall Study|Missing Data|1
829194|NCT01918332|2723462|P4|Overall Study|lipid result by central lab did not meet|0
829195|NCT01918332|2723463|P3|Overall Study|lipid result by central lab did not meet|1
829196|NCT01918332|2723464|P2|Overall Study|lipid result by central lab did not meet|0
829197|NCT01918332|2723465|P1|Overall Study|lipid result by central lab did not meet|0
829198|NCT01918332|2723462|P4|Overall Study|Protocol Violation|3
829199|NCT01918332|2723463|P3|Overall Study|Protocol Violation|6
829200|NCT01918332|2723464|P2|Overall Study|Protocol Violation|2
829201|NCT01918332|2723465|P1|Overall Study|Protocol Violation|6
829202|NCT01918332|2723462|P4|Overall Study|Withdrawal by Subject|3
829203|NCT01918332|2723463|P3|Overall Study|Withdrawal by Subject|2
829204|NCT01918332|2723464|P2|Overall Study|Withdrawal by Subject|3
829205|NCT01918332|2723465|P1|Overall Study|Withdrawal by Subject|2
829206|NCT01918332|2723462|P4|Overall Study|Adverse Event|1
829207|NCT01918332|2723463|P3|Overall Study|Adverse Event|0
829208|NCT01918332|2723464|P2|Overall Study|Adverse Event|0
829209|NCT01918332|2723465|P1|Overall Study|Adverse Event|0
829210|NCT01918306|2723477|P4|Overall Study|progress disease, crossover|0
829211|NCT01918306|2723478|P3|Overall Study|progress disease, crossover|1
829212|NCT01918306|2723479|P2|Overall Study|progress disease, crossover|0
829213|NCT01918306|2723480|P1|Overall Study|progress disease, crossover|0
829214|NCT01918306|2723477|P4|Overall Study|Lack of Efficacy|0
829215|NCT01918306|2723478|P3|Overall Study|Lack of Efficacy|0
829216|NCT01918306|2723479|P2|Overall Study|Lack of Efficacy|0
829217|NCT01918306|2723480|P1|Overall Study|Lack of Efficacy|1
829218|NCT01918306|2723477|P4|Overall Study|neutropenia|0
829219|NCT01918306|2723478|P3|Overall Study|neutropenia|0
829220|NCT01918306|2723479|P2|Overall Study|neutropenia|0
829221|NCT01918306|2723480|P1|Overall Study|neutropenia|1
829222|NCT01918306|2723477|P4|Overall Study|Withdrawal by Subject|2
829223|NCT01918306|2723478|P3|Overall Study|Withdrawal by Subject|0
829224|NCT01918306|2723479|P2|Overall Study|Withdrawal by Subject|0
829225|NCT01918306|2723480|P1|Overall Study|Withdrawal by Subject|0
829226|NCT01918306|2723477|P4|Overall Study|progresive disease|1
829227|NCT01918306|2723478|P3|Overall Study|progresive disease|1
829228|NCT01918306|2723479|P2|Overall Study|progresive disease|0
829229|NCT01918306|2723480|P1|Overall Study|progresive disease|4
829230|NCT01918085|2723502|P2|Test Period 1: Strata Strip|Adverse Event|1
829231|NCT01918085|2723503|P1|Test Period 1: Strata Strip|Adverse Event|0
829232|NCT01918033|2723514|P3|Overall Study|Withdrawal by Subject|0
829233|NCT01918033|2723515|P2|Overall Study|Withdrawal by Subject|1
829234|NCT01918033|2723516|P1|Overall Study|Withdrawal by Subject|2
829235|NCT01918033|2723514|P3|Overall Study|Protocol Violation|1
829236|NCT01918033|2723515|P2|Overall Study|Protocol Violation|0
829237|NCT01918033|2723516|P1|Overall Study|Protocol Violation|2
829238|NCT01918033|2723514|P3|Overall Study|Lost to Follow-up|0
829239|NCT01918033|2723515|P2|Overall Study|Lost to Follow-up|1
829240|NCT01918033|2723516|P1|Overall Study|Lost to Follow-up|0
829241|NCT01918033|2723514|P3|Overall Study|Adverse Event|2
829242|NCT01918033|2723515|P2|Overall Study|Adverse Event|0
829243|NCT01918033|2723516|P1|Overall Study|Adverse Event|1
829244|NCT01917656|2723587|P2|Overall Study|Lost to Follow-up|4
829245|NCT01917656|2723588|P1|Overall Study|Lost to Follow-up|3
829246|NCT01917656|2723587|P2|Overall Study|Withdrawal by Subject|3
829247|NCT01917656|2723588|P1|Overall Study|Withdrawal by Subject|4
829248|NCT01917656|2723587|P2|Overall Study|Unclassified|3
829249|NCT01917656|2723588|P1|Overall Study|Unclassified|0
829250|NCT01917656|2723587|P2|Overall Study|Withdrawal criteria|14
829251|NCT01917656|2723588|P1|Overall Study|Withdrawal criteria|8
829252|NCT01917656|2723587|P2|Overall Study|Adverse Event|0
829253|NCT01917656|2723588|P1|Overall Study|Adverse Event|11
829254|NCT01917526|2723614|P2|Overall Study|Protocol Violation|1
829255|NCT01917526|2723615|P1|Overall Study|Protocol Violation|1
829256|NCT01917344|2723632|P1|Overall Study|Withdrawal by Subject|1
829257|NCT01917006|2723652|P8|Open-label Period|Lost to Follow-up|1
829258|NCT01917006|2723653|P7|Open-label Period|Lost to Follow-up|0
829259|NCT01917006|2723654|P6|Open-label Period|Lost to Follow-up|0
829260|NCT01917006|2723655|P5|Open-label Period|Lost to Follow-up|0
829261|NCT01917006|2723656|P4|Open-label Period|Lost to Follow-up|0
829262|NCT01917006|2723657|P3|Open-label Period|Lost to Follow-up|0
829263|NCT01917006|2723658|P2|Open-label Period|Lost to Follow-up|0
829264|NCT01917006|2723659|P1|Open-label Period|Lost to Follow-up|0
829265|NCT01917006|2723652|P8|Open-label Period|Adverse Event|1
829266|NCT01917006|2723653|P7|Open-label Period|Adverse Event|0
829267|NCT01917006|2723654|P6|Open-label Period|Adverse Event|0
829268|NCT01917006|2723655|P5|Open-label Period|Adverse Event|0
829269|NCT01917006|2723656|P4|Open-label Period|Adverse Event|0
829270|NCT01917006|2723657|P3|Open-label Period|Adverse Event|0
829271|NCT01917006|2723658|P2|Open-label Period|Adverse Event|0
829272|NCT01917006|2723659|P1|Open-label Period|Adverse Event|0
829273|NCT01917006|2723652|P8|Randomized-treatment Period|Other Miscellaneous Reasons|0
829274|NCT01917006|2723653|P7|Randomized-treatment Period|Other Miscellaneous Reasons|1
829275|NCT01917006|2723654|P6|Randomized-treatment Period|Other Miscellaneous Reasons|0
829276|NCT01917006|2723655|P5|Randomized-treatment Period|Other Miscellaneous Reasons|0
829277|NCT01917006|2723656|P4|Randomized-treatment Period|Other Miscellaneous Reasons|0
829278|NCT01917006|2723657|P3|Randomized-treatment Period|Other Miscellaneous Reasons|0
829279|NCT01917006|2723658|P2|Randomized-treatment Period|Other Miscellaneous Reasons|0
829280|NCT01917006|2723659|P1|Randomized-treatment Period|Other Miscellaneous Reasons|0
829281|NCT01917006|2723652|P8|Randomized-treatment Period|Protocol Violation|0
829282|NCT01917006|2723653|P7|Randomized-treatment Period|Protocol Violation|0
829283|NCT01917006|2723654|P6|Randomized-treatment Period|Protocol Violation|0
829284|NCT01917006|2723655|P5|Randomized-treatment Period|Protocol Violation|0
829285|NCT01917006|2723656|P4|Randomized-treatment Period|Protocol Violation|0
829286|NCT01917006|2723657|P3|Randomized-treatment Period|Protocol Violation|0
829287|NCT01917006|2723658|P2|Randomized-treatment Period|Protocol Violation|0
829288|NCT01917006|2723659|P1|Randomized-treatment Period|Protocol Violation|1
829289|NCT01917006|2723652|P8|Randomized-treatment Period|Personal Reasons|0
829290|NCT01917006|2723653|P7|Randomized-treatment Period|Personal Reasons|0
829291|NCT01917006|2723654|P6|Randomized-treatment Period|Personal Reasons|1
829292|NCT01917006|2723655|P5|Randomized-treatment Period|Personal Reasons|0
829293|NCT01917006|2723656|P4|Randomized-treatment Period|Personal Reasons|0
829294|NCT01917006|2723657|P3|Randomized-treatment Period|Personal Reasons|0
829295|NCT01917006|2723658|P2|Randomized-treatment Period|Personal Reasons|0
829296|NCT01917006|2723659|P1|Randomized-treatment Period|Personal Reasons|0
829297|NCT01917006|2723652|P8|Randomized-treatment Period|Lost to Follow-up|0
829298|NCT01917006|2723653|P7|Randomized-treatment Period|Lost to Follow-up|0
829299|NCT01917006|2723654|P6|Randomized-treatment Period|Lost to Follow-up|0
829300|NCT01917006|2723655|P5|Randomized-treatment Period|Lost to Follow-up|0
829301|NCT01917006|2723656|P4|Randomized-treatment Period|Lost to Follow-up|1
829302|NCT01917006|2723657|P3|Randomized-treatment Period|Lost to Follow-up|0
829303|NCT01917006|2723658|P2|Randomized-treatment Period|Lost to Follow-up|0
829304|NCT01917006|2723659|P1|Randomized-treatment Period|Lost to Follow-up|1
829305|NCT01916980|2723692|P2|Overall Study|Withdrawal by Subject|0
829306|NCT01916980|2723693|P1|Overall Study|Withdrawal by Subject|1
829307|NCT01916980|2723692|P2|Overall Study|Lack of Efficacy|2
829308|NCT01916980|2723693|P1|Overall Study|Lack of Efficacy|2
829309|NCT01916980|2723692|P2|Overall Study|Adverse Event|2
829310|NCT01916980|2723693|P1|Overall Study|Adverse Event|4
829311|NCT01916967|2723712|P3|Overall Study|Protocol Violation|0
829312|NCT01916967|2723713|P2|Overall Study|Protocol Violation|1
829313|NCT01916967|2723714|P1|Overall Study|Protocol Violation|0
829314|NCT01916967|2723712|P3|Overall Study|Physician Decision|1
829315|NCT01916967|2723713|P2|Overall Study|Physician Decision|0
829316|NCT01916967|2723714|P1|Overall Study|Physician Decision|0
829317|NCT01916967|2723712|P3|Overall Study|Lack of Efficacy|6
829318|NCT01916967|2723713|P2|Overall Study|Lack of Efficacy|0
829319|NCT01916967|2723714|P1|Overall Study|Lack of Efficacy|0
829320|NCT01916967|2723712|P3|Overall Study|Adverse Event|2
829321|NCT01916967|2723713|P2|Overall Study|Adverse Event|0
829322|NCT01916967|2723714|P1|Overall Study|Adverse Event|0
829323|NCT01916824|2723770|P2|Overall Study|Withdrawal by Subject|3
829324|NCT01916824|2723771|P1|Overall Study|Withdrawal by Subject|2
829325|NCT01916824|2723770|P2|Overall Study|Physician Decision|0
829326|NCT01916824|2723771|P1|Overall Study|Physician Decision|2
829327|NCT01916824|2723770|P2|Overall Study|Lost to Follow-up|6
829328|NCT01916824|2723771|P1|Overall Study|Lost to Follow-up|3
829329|NCT01916304|2723840|P1|Overall Study|Screening failure|17
829330|NCT01916226|2723852|P4|Overall Study|Physician Decision|1
829331|NCT01916226|2723853|P3|Overall Study|Physician Decision|0
829332|NCT01916226|2723854|P2|Overall Study|Physician Decision|0
829333|NCT01916226|2723855|P1|Overall Study|Physician Decision|0
829334|NCT01916226|2723852|P4|Overall Study|Protocol Violation|1
829335|NCT01916226|2723853|P3|Overall Study|Protocol Violation|0
829336|NCT01916226|2723854|P2|Overall Study|Protocol Violation|1
829337|NCT01916226|2723855|P1|Overall Study|Protocol Violation|0
829338|NCT01916226|2723852|P4|Overall Study|Lack of Efficacy|1
829339|NCT01916226|2723853|P3|Overall Study|Lack of Efficacy|2
829340|NCT01916226|2723854|P2|Overall Study|Lack of Efficacy|0
829341|NCT01916226|2723855|P1|Overall Study|Lack of Efficacy|0
829342|NCT01916226|2723852|P4|Overall Study|Adverse Event|1
829343|NCT01916226|2723853|P3|Overall Study|Adverse Event|1
829344|NCT01916226|2723854|P2|Overall Study|Adverse Event|0
829345|NCT01916226|2723855|P1|Overall Study|Adverse Event|1
829346|NCT01916109|2723889|P1|Overall Study|Withdrawal by Subject|1
829347|NCT01915940|2723895|P3|Treatment Period|Other Miscellaneous Reasons|0
829348|NCT01915940|2723896|P2|Treatment Period|Other Miscellaneous Reasons|1
829349|NCT01915940|2723897|P1|Treatment Period|Other Miscellaneous Reasons|0
829350|NCT01915940|2723895|P3|Treatment Period|Adverse Event|1
829351|NCT01915940|2723896|P2|Treatment Period|Adverse Event|9
829352|NCT01915940|2723897|P1|Treatment Period|Adverse Event|0
829353|NCT01915940|2723895|P3|Treatment Period|Decision of Participant|3
829354|NCT01915940|2723896|P2|Treatment Period|Decision of Participant|1
829355|NCT01915940|2723897|P1|Treatment Period|Decision of Participant|0
829356|NCT01915940|2723895|P3|Pre-randomization Washout Period|Not Qualified for Randomization|0
829357|NCT01915940|2723896|P2|Pre-randomization Washout Period|Not Qualified for Randomization|0
829358|NCT01915940|2723897|P1|Pre-randomization Washout Period|Not Qualified for Randomization|39
829359|NCT01915914|2723913|P4|Follow-up Phase|Physician Decision|1
829360|NCT01915914|2723914|P3|Follow-up Phase|Physician Decision|0
829361|NCT01915914|2723915|P2|Follow-up Phase|Physician Decision|0
829362|NCT01915914|2723916|P1|Follow-up Phase|Physician Decision|0
829363|NCT01915914|2723913|P4|Follow-up Phase|Withdrawal by Subject|1
829364|NCT01915914|2723914|P3|Follow-up Phase|Withdrawal by Subject|0
829365|NCT01915914|2723915|P2|Follow-up Phase|Withdrawal by Subject|0
829366|NCT01915914|2723916|P1|Follow-up Phase|Withdrawal by Subject|0
829367|NCT01915914|2723913|P4|Maintenance Phase|Missing|0
829368|NCT01915914|2723914|P3|Maintenance Phase|Missing|0
829369|NCT01915914|2723915|P2|Maintenance Phase|Missing|1
829370|NCT01915914|2723916|P1|Maintenance Phase|Missing|0
829371|NCT01915914|2723913|P4|Maintenance Phase|Lost to Follow-up|0
829372|NCT01915914|2723914|P3|Maintenance Phase|Lost to Follow-up|1
829373|NCT01915914|2723915|P2|Maintenance Phase|Lost to Follow-up|4
829374|NCT01915914|2723916|P1|Maintenance Phase|Lost to Follow-up|0
829375|NCT01915914|2723913|P4|Maintenance Phase|Withdrawal by Subject|0
829376|NCT01915914|2723914|P3|Maintenance Phase|Withdrawal by Subject|1
829377|NCT01915914|2723915|P2|Maintenance Phase|Withdrawal by Subject|1
829378|NCT01915914|2723916|P1|Maintenance Phase|Withdrawal by Subject|0
829379|NCT01915914|2723913|P4|Acute Phase|Missing|0
829380|NCT01915914|2723914|P3|Acute Phase|Missing|0
829381|NCT01915914|2723915|P2|Acute Phase|Missing|0
829382|NCT01915914|2723916|P1|Acute Phase|Missing|1
829383|NCT01915914|2723913|P4|Acute Phase|"Not Achieved treatment success"|0
829384|NCT01915914|2723914|P3|Acute Phase|"Not Achieved treatment success"|0
829385|NCT01915914|2723915|P2|Acute Phase|"Not Achieved treatment success"|0
829386|NCT01915914|2723916|P1|Acute Phase|"Not Achieved treatment success"|1
829387|NCT01915914|2723913|P4|Acute Phase|Accepted Other Topic Therapies|0
829388|NCT01915914|2723914|P3|Acute Phase|Accepted Other Topic Therapies|0
829389|NCT01915914|2723915|P2|Acute Phase|Accepted Other Topic Therapies|0
829390|NCT01915914|2723916|P1|Acute Phase|Accepted Other Topic Therapies|1
829391|NCT01915914|2723913|P4|Acute Phase|Physician Decision|0
829392|NCT01915914|2723914|P3|Acute Phase|Physician Decision|0
829393|NCT01915914|2723915|P2|Acute Phase|Physician Decision|0
829394|NCT01915914|2723916|P1|Acute Phase|Physician Decision|1
829395|NCT01915914|2723913|P4|Acute Phase|Lost to Follow-up|0
829396|NCT01915914|2723914|P3|Acute Phase|Lost to Follow-up|0
829397|NCT01915914|2723915|P2|Acute Phase|Lost to Follow-up|0
829398|NCT01915914|2723916|P1|Acute Phase|Lost to Follow-up|4
829399|NCT01915914|2723913|P4|Acute Phase|Withdrawal by Subject|0
829400|NCT01915914|2723914|P3|Acute Phase|Withdrawal by Subject|0
829401|NCT01915914|2723915|P2|Acute Phase|Withdrawal by Subject|0
829402|NCT01915914|2723916|P1|Acute Phase|Withdrawal by Subject|4
829403|NCT01915849|2723948|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
829404|NCT01915849|2723949|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
829405|NCT01915849|2723950|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
829406|NCT01915849|2723951|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
829407|NCT01915849|2723948|P4|Treatment Period 1 (4 Days)|Protocol Violation|0
829408|NCT01915849|2723949|P3|Treatment Period 1 (4 Days)|Protocol Violation|0
829409|NCT01915849|2723950|P2|Treatment Period 1 (4 Days)|Protocol Violation|0
829410|NCT01915849|2723951|P1|Treatment Period 1 (4 Days)|Protocol Violation|1
829411|NCT01915732|2723976|P2|Overall Study|Poor Conscious Effect|1
829412|NCT01915732|2723977|P1|Overall Study|Poor Conscious Effect|0
829413|NCT01915732|2723976|P2|Overall Study|Improper Facial Procedure|1
829414|NCT01915732|2723977|P1|Overall Study|Improper Facial Procedure|0
829415|NCT01915732|2723976|P2|Overall Study|Job Transfer|1
829416|NCT01915732|2723977|P1|Overall Study|Job Transfer|0
829417|NCT01915732|2723976|P2|Overall Study|Par. Refused to Hospital Visits|1
829418|NCT01915732|2723977|P1|Overall Study|Par. Refused to Hospital Visits|0
829419|NCT01915732|2723976|P2|Overall Study|Par. not Willing to Continue Treatment|1
829420|NCT01915732|2723977|P1|Overall Study|Par. not Willing to Continue Treatment|0
829421|NCT01915732|2723976|P2|Overall Study|Got Well|1
829422|NCT01915732|2723977|P1|Overall Study|Got Well|0
829423|NCT01915732|2723976|P2|Overall Study|Par. Unable to Come to the Hospital|1
829424|NCT01915732|2723977|P1|Overall Study|Par. Unable to Come to the Hospital|0
829425|NCT01915732|2723976|P2|Overall Study|Poor Perceived Efficacy|0
829426|NCT01915732|2723977|P1|Overall Study|Poor Perceived Efficacy|1
829427|NCT01915732|2723976|P2|Overall Study|Pregnancy|0
829428|NCT01915732|2723977|P1|Overall Study|Pregnancy|1
829429|NCT01915732|2723976|P2|Overall Study|Recovered|0
829430|NCT01915732|2723977|P1|Overall Study|Recovered|1
829431|NCT01915732|2723976|P2|Overall Study|Drug Release Error|0
829432|NCT01915732|2723977|P1|Overall Study|Drug Release Error|1
829433|NCT01915732|2723976|P2|Overall Study|Par. Conscious Ineffective Vol Exit|0
829434|NCT01915732|2723977|P1|Overall Study|Par. Conscious Ineffective Vol Exit|1
829435|NCT01915732|2723976|P2|Overall Study|Par. Improved, Voluntary (Vol) exit|0
829436|NCT01915732|2723977|P1|Overall Study|Par. Improved, Voluntary (Vol) exit|1
829437|NCT01915732|2723976|P2|Overall Study|Lost to Follow-up|26
829438|NCT01915732|2723977|P1|Overall Study|Lost to Follow-up|22
829439|NCT01915732|2723976|P2|Overall Study|Lack of Efficacy|11
829440|NCT01915732|2723977|P1|Overall Study|Lack of Efficacy|6
829441|NCT01915732|2723976|P2|Overall Study|Protocol Violation|5
829442|NCT01915732|2723977|P1|Overall Study|Protocol Violation|5
829443|NCT01915732|2723976|P2|Overall Study|Adverse Event|4
829444|NCT01915732|2723977|P1|Overall Study|Adverse Event|12
829445|NCT01915732|2723976|P2|Overall Study|Failure to Meet Randomization Criteria|0
829446|NCT01915732|2723977|P1|Overall Study|Failure to Meet Randomization Criteria|1
829447|NCT01915732|2723976|P2|Overall Study|Withdrawal by Subject|18
829448|NCT01915732|2723977|P1|Overall Study|Withdrawal by Subject|18
829449|NCT01914926|2724045|P2|Overall Study|uncooperative, agitated and removed|1
829450|NCT01914926|2724046|P1|Overall Study|uncooperative, agitated and removed|0
829451|NCT01914926|2724045|P2|Overall Study|Adverse Event|0
829452|NCT01914926|2724046|P1|Overall Study|Adverse Event|1
829453|NCT01914757|2724055|P3|Overall Study|Other reasons|4
829454|NCT01914757|2724056|P2|Overall Study|Other reasons|9
829455|NCT01914757|2724057|P1|Overall Study|Other reasons|5
829456|NCT01914757|2724055|P3|Overall Study|Eligibility criteria not fulfilled|2
829457|NCT01914757|2724056|P2|Overall Study|Eligibility criteria not fulfilled|0
829458|NCT01914757|2724057|P1|Overall Study|Eligibility criteria not fulfilled|2
829459|NCT01914757|2724055|P3|Overall Study|Study specific withdrawal criteria|0
829460|NCT01914757|2724056|P2|Overall Study|Study specific withdrawal criteria|1
829461|NCT01914757|2724057|P1|Overall Study|Study specific withdrawal criteria|0
829462|NCT01914757|2724055|P3|Overall Study|Adverse Event|4
829463|NCT01914757|2724056|P2|Overall Study|Adverse Event|3
829464|NCT01914757|2724057|P1|Overall Study|Adverse Event|4
829465|NCT01914757|2724055|P3|Overall Study|Death|1
829466|NCT01914757|2724056|P2|Overall Study|Death|2
829467|NCT01914757|2724057|P1|Overall Study|Death|2
829468|NCT01914757|2724055|P3|Overall Study|Withdrawal by Subject|19
829469|NCT01914757|2724056|P2|Overall Study|Withdrawal by Subject|27
829470|NCT01914757|2724057|P1|Overall Study|Withdrawal by Subject|15
829471|NCT01914757|2724055|P3|Overall Study|Lost to Follow-up|6
829472|NCT01914757|2724056|P2|Overall Study|Lost to Follow-up|8
829473|NCT01914757|2724057|P1|Overall Study|Lost to Follow-up|5
829474|NCT01914757|2724055|P3|Overall Study|Severe non-compliance to protocol|2
829475|NCT01914757|2724056|P2|Overall Study|Severe non-compliance to protocol|1
829476|NCT01914757|2724057|P1|Overall Study|Severe non-compliance to protocol|3
829477|NCT01914679|2724131|P1|Overall Study|Sponsor terminated study|4
829478|NCT01914679|2724131|P1|Overall Study|Lack of Efficacy|1
829479|NCT01914666|2724138|P3|Treatment Period|Physician Decision|2
829480|NCT01914666|2724139|P2|Treatment Period|Physician Decision|0
829481|NCT01914666|2724140|P1|Treatment Period|Physician Decision|0
829482|NCT01914666|2724138|P3|Treatment Period|Withdrawal by Subject|2
829483|NCT01914666|2724139|P2|Treatment Period|Withdrawal by Subject|2
829484|NCT01914666|2724140|P1|Treatment Period|Withdrawal by Subject|3
829485|NCT01914666|2724138|P3|Treatment Period|Adverse Event|2
829486|NCT01914666|2724139|P2|Treatment Period|Adverse Event|4
829487|NCT01914666|2724140|P1|Treatment Period|Adverse Event|10
829488|NCT01914666|2724138|P3|Treatment Period|Lack of Efficacy|2
829489|NCT01914666|2724139|P2|Treatment Period|Lack of Efficacy|0
829490|NCT01914666|2724140|P1|Treatment Period|Lack of Efficacy|0
829491|NCT01913483|2724262|P2|Overall Study|Death|17
829492|NCT01913483|2724263|P1|Overall Study|Death|14
829493|NCT01913483|2724262|P2|Overall Study|Lost to Follow-up|3
829494|NCT01913483|2724263|P1|Overall Study|Lost to Follow-up|6
829495|NCT01913483|2724262|P2|Overall Study|Withdrawal by Subject|2
829496|NCT01913483|2724263|P1|Overall Study|Withdrawal by Subject|1
829497|NCT01913470|2724275|P2|Overall Study|Withdrawal by Subject|1
829498|NCT01913470|2724276|P1|Overall Study|Withdrawal by Subject|0
829499|NCT01913470|2724275|P2|Overall Study|Physician Decision|1
829500|NCT01913470|2724276|P1|Overall Study|Physician Decision|0
829501|NCT01913470|2724275|P2|Overall Study|Lost to Follow-up|1
829502|NCT01913470|2724276|P1|Overall Study|Lost to Follow-up|0
829503|NCT01913405|2724294|P1|Overall Study|Adverse Event|1
829504|NCT01913405|2724294|P1|Overall Study|Withdrawal by Subject|1
829505|NCT01913041|2724361|P1|Overall Study|Physician Decision|1
829506|NCT01913041|2724361|P1|Overall Study|Withdrawal by Subject|3
829507|NCT01913041|2724361|P1|Overall Study|Protocol Violation|35
829508|NCT01912781|2724367|P2|Overall Study|Withdrawal by Subject|0
829509|NCT01912781|2724368|P1|Overall Study|Withdrawal by Subject|2
829510|NCT01912768|2724399|P2|Overall Study|Randomized in error|0
829511|NCT01912768|2724400|P1|Overall Study|Randomized in error|1
829512|NCT01912768|2724399|P2|Overall Study|Withdrawal by Subject|3
829513|NCT01912768|2724400|P1|Overall Study|Withdrawal by Subject|5
829514|NCT01912768|2724399|P2|Overall Study|Lost to Follow-up|1
829515|NCT01912768|2724400|P1|Overall Study|Lost to Follow-up|2
829516|NCT01912768|2724399|P2|Overall Study|Adverse Event|0
829517|NCT01912768|2724400|P1|Overall Study|Adverse Event|2
829518|NCT01912729|2724431|P2|Overall Study|Withdrawal by Subject|1
829519|NCT01912729|2724432|P1|Overall Study|Withdrawal by Subject|0
829520|NCT01912599|2724443|P2|Overall Study|Withdrawal by Subject|1
829521|NCT01912599|2724444|P1|Overall Study|Withdrawal by Subject|0
829522|NCT01912404|2724469|P2|Overall Study|Due to personal reasons|0
829523|NCT01912404|2724470|P1|Overall Study|Due to personal reasons|1
829524|NCT01912339|2724483|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46
829525|NCT01912339|2724484|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0
829526|NCT01912339|2724485|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120
829527|NCT01912339|2724483|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1
829528|NCT01912339|2724484|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
829529|NCT01912339|2724485|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
829530|NCT01912339|2724483|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1
829531|NCT01912339|2724484|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
829532|NCT01912339|2724485|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
829533|NCT01912339|2724483|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1
829534|NCT01912339|2724484|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
829535|NCT01912339|2724485|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
829536|NCT01912339|2724483|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1
829537|NCT01912339|2724484|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
829538|NCT01912339|2724485|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
829539|NCT01912339|2724483|P3|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
829540|NCT01912339|2724484|P2|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
829541|NCT01912339|2724485|P1|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1
829542|NCT01912339|2724483|P3|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
829543|NCT01912339|2724484|P2|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
829544|NCT01912339|2724485|P1|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1
829545|NCT01912339|2724483|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3
829546|NCT01912339|2724484|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0
829547|NCT01912339|2724485|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1
829548|NCT01912339|2724483|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
829549|NCT01912339|2724484|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
829550|NCT01912339|2724485|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5
829551|NCT01912339|2724483|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
829552|NCT01912339|2724484|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
829553|NCT01912339|2724485|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5
829554|NCT01912339|2724483|P3|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
829555|NCT01912339|2724484|P2|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
829556|NCT01912339|2724485|P1|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1
829557|NCT01912339|2724483|P3|Blinded (0 to 3 Months)|Open Prostatectomy|0
829558|NCT01912339|2724484|P2|Blinded (0 to 3 Months)|Open Prostatectomy|0
829559|NCT01912339|2724485|P1|Blinded (0 to 3 Months)|Open Prostatectomy|1
829560|NCT01912339|2724483|P3|Blinded (0 to 3 Months)|Declined to participate|0
829561|NCT01912339|2724484|P2|Blinded (0 to 3 Months)|Declined to participate|0
829562|NCT01912339|2724485|P1|Blinded (0 to 3 Months)|Declined to participate|1
829563|NCT01912222|2724502|P3|Part B: Treatment Period|Withdrawal by Subject|2
829564|NCT01912222|2724503|P2|Part B: Treatment Period|Withdrawal by Subject|1
829565|NCT01912222|2724504|P1|Part B: Treatment Period|Withdrawal by Subject|2
829566|NCT01912222|2724502|P3|Part B: Treatment Period|Adverse Event|3
829567|NCT01912222|2724503|P2|Part B: Treatment Period|Adverse Event|2
829568|NCT01912222|2724504|P1|Part B: Treatment Period|Adverse Event|1
829569|NCT01912222|2724502|P3|Part B: Treatment Period|Progressive disease|15
829570|NCT01912222|2724503|P2|Part B: Treatment Period|Progressive disease|12
829571|NCT01912222|2724504|P1|Part B: Treatment Period|Progressive disease|10
829572|NCT01912222|2724502|P3|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
829573|NCT01912222|2724503|P2|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
829574|NCT01912222|2724504|P1|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1
829575|NCT01911845|2724527|P1|Overall Study|Other (not specified)|3
829576|NCT01911845|2724527|P1|Overall Study|Lost to Follow-up|1
829577|NCT01911845|2724527|P1|Overall Study|Adverse Event|2
829578|NCT01911819|2724544|P3|Overall Study|Withdrawal by Subject|0
829579|NCT01911819|2724545|P2|Overall Study|Withdrawal by Subject|1
829580|NCT01911819|2724546|P1|Overall Study|Withdrawal by Subject|1
829581|NCT01911819|2724544|P3|Overall Study|Adverse Event|0
829582|NCT01911819|2724545|P2|Overall Study|Adverse Event|1
829583|NCT01911819|2724546|P1|Overall Study|Adverse Event|0
829584|NCT01911793|2724559|P2|Overall Study|Physician Decision|5
829585|NCT01911793|2724560|P1|Overall Study|Physician Decision|1
829586|NCT01911780|2724584|P2|Extension Period (52 Weeks)|Personal reason|1
829587|NCT01911780|2724585|P1|Extension Period (52 Weeks)|Personal reason|1
829588|NCT01911780|2724584|P2|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2
829589|NCT01911780|2724585|P1|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0
829590|NCT01911780|2724584|P2|Extension Period (52 Weeks)|Adverse Event|0
829591|NCT01911780|2724585|P1|Extension Period (52 Weeks)|Adverse Event|3
829592|NCT01911780|2724584|P2|Double-blind Period (8 Weeks)|Personal reason|0
829593|NCT01911780|2724585|P1|Double-blind Period (8 Weeks)|Personal reason|1
829594|NCT01911780|2724584|P2|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
829595|NCT01911780|2724585|P1|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
829596|NCT01911780|2724584|P2|Double-blind Period (8 Weeks)|Adverse Event|2
829597|NCT01911780|2724585|P1|Double-blind Period (8 Weeks)|Adverse Event|1
829598|NCT01911546|2724619|P1|Overall Study|Everolimus was discontinued|5
829599|NCT01911546|2724619|P1|Overall Study|Lost to Follow-up|1
829600|NCT01911442|2724629|P3|Overall Study|Mother's Work Schedule|0
829601|NCT01911442|2724630|P2|Overall Study|Mother's Work Schedule|1
829602|NCT01911442|2724631|P1|Overall Study|Mother's Work Schedule|0
829603|NCT01911442|2724629|P3|Overall Study|Withdrawal by Subject|6
829604|NCT01911442|2724630|P2|Overall Study|Withdrawal by Subject|0
829605|NCT01911442|2724631|P1|Overall Study|Withdrawal by Subject|1
829606|NCT01911442|2724629|P3|Overall Study|Lost to Follow-up|1
829607|NCT01911442|2724630|P2|Overall Study|Lost to Follow-up|0
829608|NCT01911442|2724631|P1|Overall Study|Lost to Follow-up|2
829609|NCT01911442|2724629|P3|Overall Study|Lack of Efficacy|1
829610|NCT01911442|2724630|P2|Overall Study|Lack of Efficacy|1
829611|NCT01911442|2724631|P1|Overall Study|Lack of Efficacy|1
829612|NCT01911442|2724629|P3|Overall Study|Adverse Event|4
829613|NCT01911442|2724630|P2|Overall Study|Adverse Event|2
829614|NCT01911442|2724631|P1|Overall Study|Adverse Event|2
829615|NCT01911429|2724660|P3|Overall Study|subject left study|0
829616|NCT01911429|2724661|P2|Overall Study|subject left study|0
829617|NCT01911429|2724662|P1|Overall Study|subject left study|1
829618|NCT01911429|2724660|P3|Overall Study|Accidental randomization|1
829619|NCT01911429|2724661|P2|Overall Study|Accidental randomization|0
829620|NCT01911429|2724662|P1|Overall Study|Accidental randomization|0
829621|NCT01911429|2724660|P3|Overall Study|Withdrawal by Subject|4
829622|NCT01911429|2724661|P2|Overall Study|Withdrawal by Subject|5
829623|NCT01911429|2724662|P1|Overall Study|Withdrawal by Subject|5
829624|NCT01911429|2724660|P3|Overall Study|Protocol Violation|1
829625|NCT01911429|2724661|P2|Overall Study|Protocol Violation|0
829626|NCT01911429|2724662|P1|Overall Study|Protocol Violation|0
829627|NCT01911429|2724660|P3|Overall Study|Lost to Follow-up|1
829628|NCT01911429|2724661|P2|Overall Study|Lost to Follow-up|0
829629|NCT01911429|2724662|P1|Overall Study|Lost to Follow-up|0
829630|NCT01911429|2724660|P3|Overall Study|Lack of Efficacy|4
829631|NCT01911429|2724661|P2|Overall Study|Lack of Efficacy|2
829632|NCT01911429|2724662|P1|Overall Study|Lack of Efficacy|1
829633|NCT01911429|2724660|P3|Overall Study|Adverse Event|9
829634|NCT01911429|2724661|P2|Overall Study|Adverse Event|3
829635|NCT01911429|2724662|P1|Overall Study|Adverse Event|5
829636|NCT01911273|2724754|P2|Overall Study|Withdrawal by Subject|2
829637|NCT01911273|2724755|P1|Overall Study|Withdrawal by Subject|0
829638|NCT01911273|2724754|P2|Overall Study|Progression of Disease|0
829639|NCT01911273|2724755|P1|Overall Study|Progression of Disease|1
829640|NCT01911260|2724789|P4|Follow-up Period|transference or evasion of school|12
829641|NCT01911260|2724790|P3|Follow-up Period|transference or evasion of school|15
829642|NCT01911260|2724791|P2|Follow-up Period|transference or evasion of school|20
829643|NCT01911260|2724792|P1|Follow-up Period|transference or evasion of school|13
829644|NCT01911260|2724789|P4|Supplementation Period|less than 12 weeks supplementation|2
829645|NCT01911260|2724790|P3|Supplementation Period|less than 12 weeks supplementation|1
829646|NCT01911260|2724791|P2|Supplementation Period|less than 12 weeks supplementation|3
829647|NCT01911260|2724792|P1|Supplementation Period|less than 12 weeks supplementation|0
829648|NCT01911260|2724789|P4|Supplementation Period|refused to receive supplement|0
829649|NCT01911260|2724790|P3|Supplementation Period|refused to receive supplement|1
829650|NCT01911260|2724791|P2|Supplementation Period|refused to receive supplement|0
829651|NCT01911260|2724792|P1|Supplementation Period|refused to receive supplement|1
829652|NCT01911260|2724789|P4|Supplementation Period|Adverse Event|0
829653|NCT01911260|2724790|P3|Supplementation Period|Adverse Event|1
829654|NCT01911260|2724791|P2|Supplementation Period|Adverse Event|0
829655|NCT01911260|2724792|P1|Supplementation Period|Adverse Event|2
829656|NCT01911260|2724789|P4|Supplementation Period|transference or evasion of school|6
829657|NCT01911260|2724790|P3|Supplementation Period|transference or evasion of school|7
829658|NCT01911260|2724791|P2|Supplementation Period|transference or evasion of school|9
829659|NCT01911260|2724792|P1|Supplementation Period|transference or evasion of school|7
829660|NCT01910441|2724878|P2|Overall Study|Physician Decision|1
829661|NCT01910441|2724879|P1|Overall Study|Physician Decision|0
829662|NCT01910441|2724878|P2|Overall Study|Adverse Event|0
829663|NCT01910441|2724879|P1|Overall Study|Adverse Event|1
829664|NCT01910441|2724878|P2|Overall Study|Non-compliance|1
829665|NCT01910441|2724879|P1|Overall Study|Non-compliance|0
829666|NCT01910441|2724878|P2|Overall Study|Withdrawal by Subject|1
829667|NCT01910441|2724879|P1|Overall Study|Withdrawal by Subject|0
829668|NCT01910441|2724878|P2|Overall Study|Lost to Follow-up|5
829669|NCT01910441|2724879|P1|Overall Study|Lost to Follow-up|6
829670|NCT01910441|2724878|P2|Overall Study|Sponsor decision|2
829671|NCT01910441|2724879|P1|Overall Study|Sponsor decision|0
829672|NCT01910402|2724887|P2|Continuation Phase|Withdrawal by Subject|0
829673|NCT01910402|2724888|P1|Continuation Phase|Withdrawal by Subject|2
829674|NCT01910402|2724887|P2|Continuation Phase|Protocol Violation|0
829675|NCT01910402|2724888|P1|Continuation Phase|Protocol Violation|3
829676|NCT01910402|2724887|P2|Continuation Phase|Adverse Event|0
829677|NCT01910402|2724888|P1|Continuation Phase|Adverse Event|1
829678|NCT01910402|2724887|P2|Continuation Phase|Ongoing|0
829679|NCT01910402|2724888|P1|Continuation Phase|Ongoing|84
829680|NCT01910402|2724887|P2|Randomized Phase|Withdrawal by Subject|7
829681|NCT01910402|2724888|P1|Randomized Phase|Withdrawal by Subject|5
829682|NCT01910402|2724887|P2|Randomized Phase|Protocol Violation|13
829683|NCT01910402|2724888|P1|Randomized Phase|Protocol Violation|10
829684|NCT01910402|2724887|P2|Randomized Phase|Lost to Follow-up|13
829685|NCT01910402|2724888|P1|Randomized Phase|Lost to Follow-up|11
829686|NCT01910402|2724887|P2|Randomized Phase|Lack of Efficacy|4
829687|NCT01910402|2724888|P1|Randomized Phase|Lack of Efficacy|5
829688|NCT01910402|2724887|P2|Randomized Phase|Physician Decision|0
829689|NCT01910402|2724888|P1|Randomized Phase|Physician Decision|1
829690|NCT01910402|2724887|P2|Randomized Phase|Adverse Event|18
829691|NCT01910402|2724888|P1|Randomized Phase|Adverse Event|10
829692|NCT01910389|2724958|P2|Overall Study|Study Closed|8
829693|NCT01910389|2724959|P1|Overall Study|Study Closed|13
829694|NCT01910389|2724958|P2|Overall Study|Withdrawal by Subject|0
829695|NCT01910389|2724959|P1|Overall Study|Withdrawal by Subject|2
829696|NCT01910181|2725000|P1|Overall Study|Alive in Follow-Up|12
829697|NCT01910181|2725000|P1|Overall Study|Alive on Treatment|14
829698|NCT01910181|2725000|P1|Overall Study|Death|20
829699|NCT01910116|2725027|P2|Overall Study|incomplete data|1
829700|NCT01910116|2725028|P1|Overall Study|incomplete data|0
829701|NCT01910116|2725027|P2|Overall Study|uncertain allocation|3
829702|NCT01910116|2725028|P1|Overall Study|uncertain allocation|1
829703|NCT01910116|2725027|P2|Overall Study|Withdrawal by Subject|3
829704|NCT01910116|2725028|P1|Overall Study|Withdrawal by Subject|8
829705|NCT01910116|2725027|P2|Overall Study|Protocol Violation|2
829706|NCT01910116|2725028|P1|Overall Study|Protocol Violation|1
829707|NCT01910116|2725027|P2|Overall Study|Lost to Follow-up|0
829708|NCT01910116|2725028|P1|Overall Study|Lost to Follow-up|1
829709|NCT01910116|2725027|P2|Overall Study|Lack of Efficacy|4
829710|NCT01910116|2725028|P1|Overall Study|Lack of Efficacy|3
829711|NCT01910116|2725027|P2|Overall Study|Adverse Event|3
829712|NCT01910116|2725028|P1|Overall Study|Adverse Event|0
829713|NCT01909804|2725125|P12|Overall Study|Protocol Violation|1
829714|NCT01909804|2725126|P11|Overall Study|Protocol Violation|0
829715|NCT01909804|2725127|P10|Overall Study|Protocol Violation|0
829716|NCT01909804|2725128|P9|Overall Study|Protocol Violation|0
829717|NCT01909804|2725129|P8|Overall Study|Protocol Violation|0
829718|NCT01909804|2725130|P7|Overall Study|Protocol Violation|0
829719|NCT01909804|2725131|P6|Overall Study|Protocol Violation|0
829720|NCT01909804|2725132|P5|Overall Study|Protocol Violation|0
829721|NCT01909804|2725133|P4|Overall Study|Protocol Violation|0
829722|NCT01909804|2725134|P3|Overall Study|Protocol Violation|0
829723|NCT01909804|2725135|P2|Overall Study|Protocol Violation|0
829724|NCT01909804|2725136|P1|Overall Study|Protocol Violation|0
829725|NCT01909804|2725125|P12|Overall Study|Withdrew Consent|0
829726|NCT01909804|2725126|P11|Overall Study|Withdrew Consent|0
829727|NCT01909804|2725127|P10|Overall Study|Withdrew Consent|0
829728|NCT01909804|2725128|P9|Overall Study|Withdrew Consent|0
829729|NCT01909804|2725129|P8|Overall Study|Withdrew Consent|0
829730|NCT01909804|2725130|P7|Overall Study|Withdrew Consent|0
829731|NCT01909804|2725131|P6|Overall Study|Withdrew Consent|1
829732|NCT01909804|2725132|P5|Overall Study|Withdrew Consent|1
829733|NCT01909804|2725133|P4|Overall Study|Withdrew Consent|0
829734|NCT01909804|2725134|P3|Overall Study|Withdrew Consent|0
829735|NCT01909804|2725135|P2|Overall Study|Withdrew Consent|0
829736|NCT01909804|2725136|P1|Overall Study|Withdrew Consent|0
829737|NCT01909804|2725125|P12|Overall Study|Lack of Efficacy|1
829738|NCT01909804|2725126|P11|Overall Study|Lack of Efficacy|0
829739|NCT01909804|2725127|P10|Overall Study|Lack of Efficacy|1
829740|NCT01909804|2725128|P9|Overall Study|Lack of Efficacy|0
829741|NCT01909804|2725129|P8|Overall Study|Lack of Efficacy|1
829742|NCT01909804|2725130|P7|Overall Study|Lack of Efficacy|1
829743|NCT01909804|2725131|P6|Overall Study|Lack of Efficacy|3
829744|NCT01909804|2725132|P5|Overall Study|Lack of Efficacy|7
829745|NCT01909804|2725133|P4|Overall Study|Lack of Efficacy|0
829746|NCT01909804|2725134|P3|Overall Study|Lack of Efficacy|0
829747|NCT01909804|2725135|P2|Overall Study|Lack of Efficacy|1
829748|NCT01909804|2725136|P1|Overall Study|Lack of Efficacy|4
829749|NCT01909804|2725125|P12|Overall Study|Death|0
829750|NCT01909804|2725126|P11|Overall Study|Death|1
829751|NCT01909804|2725127|P10|Overall Study|Death|0
829752|NCT01909804|2725128|P9|Overall Study|Death|0
829753|NCT01909804|2725129|P8|Overall Study|Death|0
829754|NCT01909804|2725130|P7|Overall Study|Death|0
829755|NCT01909804|2725131|P6|Overall Study|Death|0
829756|NCT01909804|2725132|P5|Overall Study|Death|0
829757|NCT01909804|2725133|P4|Overall Study|Death|0
829758|NCT01909804|2725134|P3|Overall Study|Death|0
829759|NCT01909804|2725135|P2|Overall Study|Death|0
829760|NCT01909804|2725136|P1|Overall Study|Death|0
829761|NCT01909804|2725125|P12|Overall Study|Randomized but Never Treated|1
829762|NCT01909804|2725126|P11|Overall Study|Randomized but Never Treated|0
829763|NCT01909804|2725127|P10|Overall Study|Randomized but Never Treated|0
829764|NCT01909804|2725128|P9|Overall Study|Randomized but Never Treated|0
829765|NCT01909804|2725129|P8|Overall Study|Randomized but Never Treated|0
829766|NCT01909804|2725130|P7|Overall Study|Randomized but Never Treated|1
829767|NCT01909804|2725131|P6|Overall Study|Randomized but Never Treated|0
829768|NCT01909804|2725132|P5|Overall Study|Randomized but Never Treated|0
829769|NCT01909804|2725133|P4|Overall Study|Randomized but Never Treated|0
829770|NCT01909804|2725134|P3|Overall Study|Randomized but Never Treated|0
829771|NCT01909804|2725135|P2|Overall Study|Randomized but Never Treated|0
829772|NCT01909804|2725136|P1|Overall Study|Randomized but Never Treated|0
829773|NCT01909778|2725182|P1|Overall Study|failed screening|1
829774|NCT01909674|2725261|P2|Overall Study|Withdrawal by Subject|2
829775|NCT01909674|2725262|P1|Overall Study|Withdrawal by Subject|5
829776|NCT01909466|2725281|P2|Overall Study|Lack of Efficacy|0
829777|NCT01909466|2725282|P1|Overall Study|Lack of Efficacy|1
829778|NCT01909466|2725281|P2|Overall Study|Withdrawal by Subject|9
829779|NCT01909466|2725282|P1|Overall Study|Withdrawal by Subject|11
829780|NCT01909466|2725281|P2|Overall Study|Physician Decision|0
829781|NCT01909466|2725282|P1|Overall Study|Physician Decision|2
829782|NCT01909466|2725281|P2|Overall Study|Met Withdrawal Criteria|3
829783|NCT01909466|2725282|P1|Overall Study|Met Withdrawal Criteria|0
829784|NCT01909466|2725281|P2|Overall Study|Adverse Event|4
829785|NCT01909466|2725282|P1|Overall Study|Adverse Event|3
829786|NCT01909466|2725281|P2|Overall Study|Lost to Follow-up|7
829787|NCT01909466|2725282|P1|Overall Study|Lost to Follow-up|5
829788|NCT01909336|2725305|P3|Overall Study|Physician Decision|1
829789|NCT01909336|2725306|P2|Overall Study|Physician Decision|1
829790|NCT01909336|2725307|P1|Overall Study|Physician Decision|0
829791|NCT01909336|2725305|P3|Overall Study|Lost to Follow-up|2
829792|NCT01909336|2725306|P2|Overall Study|Lost to Follow-up|2
829793|NCT01909336|2725307|P1|Overall Study|Lost to Follow-up|4
829794|NCT01908907|2725396|P2|Overall Study|Protocol Violation|0
829795|NCT01908907|2725397|P1|Overall Study|Protocol Violation|1
829796|NCT01908907|2725396|P2|Overall Study|Physician Decision|0
829797|NCT01908907|2725397|P1|Overall Study|Physician Decision|1
829798|NCT01908829|2725441|P3|Overall Study|Withdrawal by Subject|22
829799|NCT01908829|2725442|P2|Overall Study|Withdrawal by Subject|29
829800|NCT01908829|2725443|P1|Overall Study|Withdrawal by Subject|26
829801|NCT01908829|2725441|P3|Overall Study|Lack of Efficacy|2
829802|NCT01908829|2725442|P2|Overall Study|Lack of Efficacy|3
829803|NCT01908829|2725443|P1|Overall Study|Lack of Efficacy|1
829804|NCT01908829|2725441|P3|Overall Study|Protocol Violation|0
829805|NCT01908829|2725442|P2|Overall Study|Protocol Violation|2
829806|NCT01908829|2725443|P1|Overall Study|Protocol Violation|2
829807|NCT01908829|2725441|P3|Overall Study|Miscellaneous|0
829808|NCT01908829|2725442|P2|Overall Study|Miscellaneous|2
829809|NCT01908829|2725443|P1|Overall Study|Miscellaneous|0
829810|NCT01908829|2725441|P3|Overall Study|Discontinued (no EoT page)|0
829811|NCT01908829|2725442|P2|Overall Study|Discontinued (no EoT page)|0
829812|NCT01908829|2725443|P1|Overall Study|Discontinued (no EoT page)|2
829813|NCT01908829|2725441|P3|Overall Study|Randomized no double-blind drug received|1
829814|NCT01908829|2725442|P2|Overall Study|Randomized no double-blind drug received|0
829815|NCT01908829|2725443|P1|Overall Study|Randomized no double-blind drug received|1
829816|NCT01908829|2725441|P3|Overall Study|Lost to Follow-up|1
829817|NCT01908829|2725442|P2|Overall Study|Lost to Follow-up|2
829818|NCT01908829|2725443|P1|Overall Study|Lost to Follow-up|4
829819|NCT01908829|2725441|P3|Overall Study|Adverse Event|13
829820|NCT01908829|2725442|P2|Overall Study|Adverse Event|11
829821|NCT01908829|2725443|P1|Overall Study|Adverse Event|13
829822|NCT01908803|2725558|P2|Overall Study|Adverse Event (pre-treatment)|0
829823|NCT01908803|2725559|P1|Overall Study|Adverse Event (pre-treatment)|1
829824|NCT01908803|2725558|P2|Overall Study|Randomization Error|0
829825|NCT01908803|2725559|P1|Overall Study|Randomization Error|1
829826|NCT01908803|2725558|P2|Overall Study|Withdrawal by Subject|0
829827|NCT01908803|2725559|P1|Overall Study|Withdrawal by Subject|1
829828|NCT01908803|2725558|P2|Overall Study|Physician Decision|1
829829|NCT01908803|2725559|P1|Overall Study|Physician Decision|0
829830|NCT01908803|2725558|P2|Overall Study|Adverse Event|0
829831|NCT01908803|2725559|P1|Overall Study|Adverse Event|1
829832|NCT01908582|2725570|P1|Period 2|Withdrawal by Subject|1
829833|NCT01908582|2725570|P1|Period 2|Physician Decision|1
829834|NCT01908140|2725583|P2|Overall Study|Adverse Event|23
829835|NCT01908140|2725584|P1|Overall Study|Adverse Event|22
829836|NCT01908140|2725583|P2|Overall Study|Protocol Violation|9
829837|NCT01908140|2725584|P1|Overall Study|Protocol Violation|8
829838|NCT01908140|2725583|P2|Overall Study|Lost to Follow-up|6
829839|NCT01908140|2725584|P1|Overall Study|Lost to Follow-up|1
829840|NCT01908140|2725583|P2|Overall Study|Withdrawal by Subject|24
829841|NCT01908140|2725584|P1|Overall Study|Withdrawal by Subject|23
829842|NCT01908140|2725583|P2|Overall Study|Lack of Efficacy|5
829843|NCT01908140|2725584|P1|Overall Study|Lack of Efficacy|7
829844|NCT01908140|2725583|P2|Overall Study|Other or Progressive Disease|12
829845|NCT01908140|2725584|P1|Overall Study|Other or Progressive Disease|5
829846|NCT01907906|2725605|P2|Overall Study|Physician Decision|1
829847|NCT01907906|2725606|P1|Overall Study|Physician Decision|3
829848|NCT01907906|2725605|P2|Overall Study|Withdrawal by Subject|0
829849|NCT01907906|2725606|P1|Overall Study|Withdrawal by Subject|1
829850|NCT01907854|2725686|P2|Overall Study|Unclassified|3
829851|NCT01907854|2725687|P1|Overall Study|Unclassified|4
829852|NCT01907854|2725686|P2|Overall Study|Lost to Follow-up|2
829853|NCT01907854|2725687|P1|Overall Study|Lost to Follow-up|2
829854|NCT01907854|2725686|P2|Overall Study|Withdrawal by Subject|7
829855|NCT01907854|2725687|P1|Overall Study|Withdrawal by Subject|9
829856|NCT01907854|2725686|P2|Overall Study|Protocol Violation|1
829857|NCT01907854|2725687|P1|Overall Study|Protocol Violation|1
829858|NCT01907815|2725707|P2|Overall Study|Withdrawal by Subject|0
829859|NCT01907815|2725708|P1|Overall Study|Withdrawal by Subject|1
829860|NCT01907516|2725724|P2|First Intervention (3 Weeks)|Developed DKA during study|0
829861|NCT01907516|2725725|P1|First Intervention (3 Weeks)|Developed DKA during study|1
829862|NCT01907516|2725724|P2|First Intervention (3 Weeks)|Delivered before second arm|4
829863|NCT01907516|2725725|P1|First Intervention (3 Weeks)|Delivered before second arm|3
829864|NCT01907516|2725724|P2|First Intervention (3 Weeks)|Lost to Follow-up|3
829865|NCT01907516|2725725|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
829866|NCT01907516|2725724|P2|First Intervention (3 Weeks)|Withdrawal by Subject|9
829867|NCT01907516|2725725|P1|First Intervention (3 Weeks)|Withdrawal by Subject|5
829868|NCT01907217|2725766|P2|Overall Study|Withdrawal by Subject|2
829869|NCT01907217|2725767|P1|Overall Study|Withdrawal by Subject|0
829870|NCT01907087|2725875|P1|Overall Study|Withdrawal by Subject|1
829871|NCT01906372|2725936|P1|Overall Study|Withdrawal by Subject|2
829872|NCT01905943|2725966|P1|Overall Study|Ongoing in study|777
829873|NCT01905943|2725966|P1|Overall Study|Adverse Event|10
829874|NCT01905943|2725966|P1|Overall Study|Death|105
829875|NCT01905943|2725966|P1|Overall Study|Investigator discretion|4
829876|NCT01905943|2725966|P1|Overall Study|Lost to Follow-up|9
829877|NCT01905943|2725966|P1|Overall Study|Disease progression|2
829878|NCT01905943|2725966|P1|Overall Study|Renal cell carcinoma|1
829879|NCT01905943|2725966|P1|Overall Study|Moved away from site|1
829880|NCT01905943|2725966|P1|Overall Study|Withdrawal of consent|63
829881|NCT01905683|2726083|P1|Overall Study|Lost to Follow-up|4
829882|NCT01905683|2726083|P1|Overall Study|Adverse Event|4
829883|NCT01905683|2726083|P1|Overall Study|Withdrawal by Subject|20
829884|NCT01905683|2726083|P1|Overall Study|Lack of Efficacy|8
829885|NCT01905683|2726083|P1|Overall Study|Physician Decision|1
829886|NCT01905683|2726083|P1|Overall Study|Re-injection criteria not met; others|13
829887|NCT01905683|2726083|P1|Overall Study|Protocol Violation|1
829888|NCT01905657|2726099|P3|Overall Study|Excluded from Efficacy Analysis|0
829889|NCT01905657|2726100|P2|Overall Study|Excluded from Efficacy Analysis|0
829890|NCT01905657|2726101|P1|Overall Study|Excluded from Efficacy Analysis|1
829891|NCT01905657|2726099|P3|Overall Study|Continuing in Study|11
829892|NCT01905657|2726100|P2|Overall Study|Continuing in Study|74
829893|NCT01905657|2726101|P1|Overall Study|Continuing in Study|74
829894|NCT01905657|2726099|P3|Overall Study|Withdrawal by Subject|45
829895|NCT01905657|2726100|P2|Overall Study|Withdrawal by Subject|10
829896|NCT01905657|2726101|P1|Overall Study|Withdrawal by Subject|5
829897|NCT01905657|2726099|P3|Overall Study|Protocol Violation|1
829898|NCT01905657|2726100|P2|Overall Study|Protocol Violation|1
829899|NCT01905657|2726101|P1|Overall Study|Protocol Violation|2
829900|NCT01905657|2726099|P3|Overall Study|Progressive Disease|89
829901|NCT01905657|2726100|P2|Overall Study|Progressive Disease|126
829902|NCT01905657|2726101|P1|Overall Study|Progressive Disease|124
829903|NCT01905657|2726099|P3|Overall Study|Physician Decision|113
829904|NCT01905657|2726100|P2|Overall Study|Physician Decision|74
829905|NCT01905657|2726101|P1|Overall Study|Physician Decision|82
829906|NCT01905657|2726099|P3|Overall Study|Other|1
829907|NCT01905657|2726100|P2|Overall Study|Other|7
829908|NCT01905657|2726101|P1|Overall Study|Other|3
829909|NCT01905657|2726099|P3|Overall Study|Death|21
829910|NCT01905657|2726100|P2|Overall Study|Death|21
829911|NCT01905657|2726101|P1|Overall Study|Death|21
829912|NCT01905657|2726099|P3|Overall Study|Adverse Event|47
829913|NCT01905657|2726100|P2|Overall Study|Adverse Event|32
829914|NCT01905657|2726101|P1|Overall Study|Adverse Event|33
829915|NCT01905657|2726099|P3|Overall Study|Not Treated|0
829916|NCT01905657|2726100|P2|Overall Study|Not Treated|1
829917|NCT01905657|2726101|P1|Overall Study|Not Treated|0
829918|NCT01905553|2726126|P2|Period 2|Adverse Event|0
829919|NCT01905553|2726127|P1|Period 2|Adverse Event|1
829920|NCT01905540|2726141|P4|Period 3|Not specified|1
829921|NCT01905540|2726142|P3|Period 3|Not specified|1
829922|NCT01905540|2726143|P2|Period 3|Not specified|0
829923|NCT01905540|2726144|P1|Period 3|Not specified|1
829924|NCT01905267|2726179|P2|Overall Study|Physician Decision|2
829925|NCT01905267|2726180|P1|Overall Study|Physician Decision|2
829926|NCT01904773|2726201|P9|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
829927|NCT01904773|2726202|P8|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
829928|NCT01904773|2726203|P7|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
829929|NCT01904773|2726204|P6|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
829930|NCT01904773|2726205|P5|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
829931|NCT01904773|2726206|P4|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
829932|NCT01904773|2726207|P3|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
829933|NCT01904773|2726208|P2|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1
829934|NCT01904773|2726209|P1|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
829935|NCT01904773|2726201|P9|Fifth Intervention|Adverse Event|0
829936|NCT01904773|2726202|P8|Fifth Intervention|Adverse Event|1
829937|NCT01904773|2726203|P7|Fifth Intervention|Adverse Event|0
829938|NCT01904773|2726204|P6|Fifth Intervention|Adverse Event|0
829939|NCT01904773|2726205|P5|Fifth Intervention|Adverse Event|0
829940|NCT01904773|2726206|P4|Fifth Intervention|Adverse Event|0
829941|NCT01904773|2726207|P3|Fifth Intervention|Adverse Event|0
829942|NCT01904773|2726208|P2|Fifth Intervention|Adverse Event|0
829943|NCT01904773|2726209|P1|Fifth Intervention|Adverse Event|0
829944|NCT01904773|2726201|P9|Placebo Washout First Intervention|Condition worsened|0
829945|NCT01904773|2726202|P8|Placebo Washout First Intervention|Condition worsened|0
829946|NCT01904773|2726203|P7|Placebo Washout First Intervention|Condition worsened|0
829947|NCT01904773|2726204|P6|Placebo Washout First Intervention|Condition worsened|0
829948|NCT01904773|2726205|P5|Placebo Washout First Intervention|Condition worsened|0
829949|NCT01904773|2726206|P4|Placebo Washout First Intervention|Condition worsened|0
829950|NCT01904773|2726207|P3|Placebo Washout First Intervention|Condition worsened|0
829951|NCT01904773|2726208|P2|Placebo Washout First Intervention|Condition worsened|1
829952|NCT01904773|2726209|P1|Placebo Washout First Intervention|Condition worsened|0
829953|NCT01904773|2726201|P9|First Intervention|Adverse Event|0
829954|NCT01904773|2726202|P8|First Intervention|Adverse Event|0
829955|NCT01904773|2726203|P7|First Intervention|Adverse Event|1
829956|NCT01904773|2726204|P6|First Intervention|Adverse Event|0
829957|NCT01904773|2726205|P5|First Intervention|Adverse Event|0
829958|NCT01904773|2726206|P4|First Intervention|Adverse Event|0
829959|NCT01904773|2726207|P3|First Intervention|Adverse Event|0
829960|NCT01904773|2726208|P2|First Intervention|Adverse Event|0
829961|NCT01904773|2726209|P1|First Intervention|Adverse Event|0
829962|NCT01904773|2726201|P9|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
829963|NCT01904773|2726202|P8|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
829964|NCT01904773|2726203|P7|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
829965|NCT01904773|2726204|P6|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
829966|NCT01904773|2726205|P5|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
829967|NCT01904773|2726206|P4|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
829968|NCT01904773|2726207|P3|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
829969|NCT01904773|2726208|P2|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
829970|NCT01904773|2726209|P1|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1
829971|NCT01904773|2726201|P9|Screen|Withdrawal by Subject|0
829972|NCT01904773|2726202|P8|Screen|Withdrawal by Subject|0
829973|NCT01904773|2726203|P7|Screen|Withdrawal by Subject|0
829974|NCT01904773|2726204|P6|Screen|Withdrawal by Subject|0
829975|NCT01904773|2726205|P5|Screen|Withdrawal by Subject|0
829976|NCT01904773|2726206|P4|Screen|Withdrawal by Subject|0
829977|NCT01904773|2726207|P3|Screen|Withdrawal by Subject|0
829978|NCT01904773|2726208|P2|Screen|Withdrawal by Subject|0
829979|NCT01904773|2726209|P1|Screen|Withdrawal by Subject|1
829980|NCT01904773|2726201|P9|Screen|Screen failure|0
829981|NCT01904773|2726202|P8|Screen|Screen failure|0
829982|NCT01904773|2726203|P7|Screen|Screen failure|0
829983|NCT01904773|2726204|P6|Screen|Screen failure|0
829984|NCT01904773|2726205|P5|Screen|Screen failure|0
829985|NCT01904773|2726206|P4|Screen|Screen failure|0
829986|NCT01904773|2726207|P3|Screen|Screen failure|0
829987|NCT01904773|2726208|P2|Screen|Screen failure|0
829988|NCT01904773|2726209|P1|Screen|Screen failure|3
829989|NCT01904760|2726226|P2|Overall Study|Protocol Violation|0
829990|NCT01904760|2726227|P1|Overall Study|Protocol Violation|1
829991|NCT01904721|2726242|P7|Overall Study|Adverse Event|0
829992|NCT01904721|2726243|P6|Overall Study|Adverse Event|1
829993|NCT01904721|2726244|P5|Overall Study|Adverse Event|3
829994|NCT01904721|2726245|P4|Overall Study|Adverse Event|0
829995|NCT01904721|2726246|P3|Overall Study|Adverse Event|0
829996|NCT01904721|2726247|P2|Overall Study|Adverse Event|0
829997|NCT01904721|2726248|P1|Overall Study|Adverse Event|0
829998|NCT01904721|2726242|P7|Overall Study|Lack of Efficacy|1
829999|NCT01904721|2726243|P6|Overall Study|Lack of Efficacy|0
830000|NCT01904721|2726244|P5|Overall Study|Lack of Efficacy|0
830001|NCT01904721|2726245|P4|Overall Study|Lack of Efficacy|0
830002|NCT01904721|2726246|P3|Overall Study|Lack of Efficacy|0
830003|NCT01904721|2726247|P2|Overall Study|Lack of Efficacy|0
830004|NCT01904721|2726248|P1|Overall Study|Lack of Efficacy|0
830005|NCT01904721|2726242|P7|Overall Study|Lost to Follow-up|1
830006|NCT01904721|2726243|P6|Overall Study|Lost to Follow-up|3
830007|NCT01904721|2726244|P5|Overall Study|Lost to Follow-up|1
830008|NCT01904721|2726245|P4|Overall Study|Lost to Follow-up|0
830009|NCT01904721|2726246|P3|Overall Study|Lost to Follow-up|0
830010|NCT01904721|2726247|P2|Overall Study|Lost to Follow-up|0
830011|NCT01904721|2726248|P1|Overall Study|Lost to Follow-up|0
830012|NCT01904721|2726242|P7|Overall Study|Personal Reasons|3
830013|NCT01904721|2726243|P6|Overall Study|Personal Reasons|3
830014|NCT01904721|2726244|P5|Overall Study|Personal Reasons|2
830015|NCT01904721|2726245|P4|Overall Study|Personal Reasons|0
830016|NCT01904721|2726246|P3|Overall Study|Personal Reasons|0
830017|NCT01904721|2726247|P2|Overall Study|Personal Reasons|0
830018|NCT01904721|2726248|P1|Overall Study|Personal Reasons|0
830019|NCT01904721|2726242|P7|Overall Study|Other Reasons|2
830020|NCT01904721|2726243|P6|Overall Study|Other Reasons|2
830021|NCT01904721|2726244|P5|Overall Study|Other Reasons|2
830022|NCT01904721|2726245|P4|Overall Study|Other Reasons|1
830023|NCT01904721|2726246|P3|Overall Study|Other Reasons|1
830024|NCT01904721|2726247|P2|Overall Study|Other Reasons|0
830025|NCT01904721|2726248|P1|Overall Study|Other Reasons|0
830026|NCT01904604|2726278|P3|Overall Study|Unrelated illness|0
830027|NCT01904604|2726279|P2|Overall Study|Unrelated illness|1
830028|NCT01904604|2726280|P1|Overall Study|Unrelated illness|0
830029|NCT01904604|2726278|P3|Overall Study|Increased syncope|0
830030|NCT01904604|2726279|P2|Overall Study|Increased syncope|1
830031|NCT01904604|2726280|P1|Overall Study|Increased syncope|0
830032|NCT01904604|2726278|P3|Overall Study|Patch site reactions|0
830033|NCT01904604|2726279|P2|Overall Study|Patch site reactions|1
830034|NCT01904604|2726280|P1|Overall Study|Patch site reactions|0
830035|NCT01904604|2726278|P3|Overall Study|Anxiety about OFC/Refused OFC|0
830036|NCT01904604|2726279|P2|Overall Study|Anxiety about OFC/Refused OFC|0
830037|NCT01904604|2726280|P1|Overall Study|Anxiety about OFC/Refused OFC|2
830038|NCT01904604|2726278|P3|Overall Study|Non-compliance|0
830039|NCT01904604|2726279|P2|Overall Study|Non-compliance|0
830040|NCT01904604|2726280|P1|Overall Study|Non-compliance|1
830041|NCT01904604|2726278|P3|Overall Study|Withdrew before receiving dosing|0
830042|NCT01904604|2726279|P2|Overall Study|Withdrew before receiving dosing|1
830043|NCT01904604|2726280|P1|Overall Study|Withdrew before receiving dosing|0
830044|NCT01904279|2726334|P2|Overall Study|Withdrawal by Subject|0
830045|NCT01904279|2726335|P1|Overall Study|Withdrawal by Subject|1
830046|NCT01904279|2726334|P2|Overall Study|Lack of Efficacy|3
830047|NCT01904279|2726335|P1|Overall Study|Lack of Efficacy|2
830048|NCT01904149|2726361|P6|Overall Study|non compliance with study drug|0
830049|NCT01904149|2726362|P5|Overall Study|non compliance with study drug|0
830050|NCT01904149|2726363|P4|Overall Study|non compliance with study drug|0
830051|NCT01904149|2726364|P3|Overall Study|non compliance with study drug|0
830052|NCT01904149|2726365|P2|Overall Study|non compliance with study drug|0
830053|NCT01904149|2726366|P1|Overall Study|non compliance with study drug|1
830054|NCT01904149|2726361|P6|Overall Study|Protocol Violation|0
830055|NCT01904149|2726362|P5|Overall Study|Protocol Violation|0
830056|NCT01904149|2726363|P4|Overall Study|Protocol Violation|0
830057|NCT01904149|2726364|P3|Overall Study|Protocol Violation|0
830058|NCT01904149|2726365|P2|Overall Study|Protocol Violation|1
830059|NCT01904149|2726366|P1|Overall Study|Protocol Violation|0
830060|NCT01904149|2726361|P6|Overall Study|Withdrawal by Subject|0
830061|NCT01904149|2726362|P5|Overall Study|Withdrawal by Subject|1
830062|NCT01904149|2726363|P4|Overall Study|Withdrawal by Subject|0
830063|NCT01904149|2726364|P3|Overall Study|Withdrawal by Subject|1
830064|NCT01904149|2726365|P2|Overall Study|Withdrawal by Subject|3
830065|NCT01904149|2726366|P1|Overall Study|Withdrawal by Subject|1
830066|NCT01904149|2726361|P6|Overall Study|Lack of Efficacy|1
830067|NCT01904149|2726362|P5|Overall Study|Lack of Efficacy|3
830068|NCT01904149|2726363|P4|Overall Study|Lack of Efficacy|3
830069|NCT01904149|2726364|P3|Overall Study|Lack of Efficacy|1
830070|NCT01904149|2726365|P2|Overall Study|Lack of Efficacy|3
830071|NCT01904149|2726366|P1|Overall Study|Lack of Efficacy|0
830072|NCT01904149|2726361|P6|Overall Study|Adverse Event|2
830073|NCT01904149|2726362|P5|Overall Study|Adverse Event|1
830074|NCT01904149|2726363|P4|Overall Study|Adverse Event|1
830075|NCT01904149|2726364|P3|Overall Study|Adverse Event|0
830076|NCT01904149|2726365|P2|Overall Study|Adverse Event|4
830077|NCT01904149|2726366|P1|Overall Study|Adverse Event|3
830078|NCT01904058|2726417|P4|Overall Study|Pregnancy|1
830079|NCT01904058|2726418|P3|Overall Study|Pregnancy|0
830080|NCT01904058|2726419|P2|Overall Study|Pregnancy|0
830081|NCT01904058|2726420|P1|Overall Study|Pregnancy|0
830082|NCT01904058|2726417|P4|Overall Study|Withdrawal by Subject|0
830083|NCT01904058|2726418|P3|Overall Study|Withdrawal by Subject|1
830084|NCT01904058|2726419|P2|Overall Study|Withdrawal by Subject|0
830085|NCT01904058|2726420|P1|Overall Study|Withdrawal by Subject|1
830086|NCT01904058|2726417|P4|Overall Study|Adverse Event|0
830087|NCT01904058|2726418|P3|Overall Study|Adverse Event|0
830088|NCT01904058|2726419|P2|Overall Study|Adverse Event|0
830089|NCT01904058|2726420|P1|Overall Study|Adverse Event|2
830090|NCT01903993|2726460|P2|Overall Study|Lost to Follow-up|1
830091|NCT01903993|2726461|P1|Overall Study|Lost to Follow-up|2
830092|NCT01903993|2726460|P2|Overall Study|Withdrawal by Subject|5
830093|NCT01903993|2726461|P1|Overall Study|Withdrawal by Subject|13
830094|NCT01903993|2726460|P2|Overall Study|Death|89
830095|NCT01903993|2726461|P1|Overall Study|Death|108
830096|NCT01903876|2726478|P2|Six-Month Follow-up Period|Lost to Follow-up|145
830097|NCT01903876|2726479|P1|Six-Month Follow-up Period|Lost to Follow-up|91
830098|NCT01903876|2726478|P2|Baseline to Post-Intervention Period|Lost to Follow-up|108
830099|NCT01903876|2726479|P1|Baseline to Post-Intervention Period|Lost to Follow-up|184
830100|NCT01903863|2726489|P2|Overall Study|Physician Decision|0
830101|NCT01903863|2726490|P1|Overall Study|Physician Decision|2
830102|NCT01903720|2726531|P1|Overall Study|Treatment with alternative drug|1
830103|NCT01903720|2726531|P1|Overall Study|Lost to Follow-up|2
830104|NCT01903720|2726531|P1|Overall Study|Rescinding of informed consent|2
830105|NCT01903720|2726531|P1|Overall Study|Adverse Event|1
830106|NCT01903720|2726531|P1|Overall Study|Inclusion / exclusion criteria not met|6
830107|NCT01903460|2726569|P4|Overall Study|Adverse Event|1
830108|NCT01903460|2726570|P3|Overall Study|Adverse Event|0
830109|NCT01903460|2726571|P2|Overall Study|Adverse Event|0
830110|NCT01903460|2726572|P1|Overall Study|Adverse Event|0
830111|NCT01903434|2726589|P2|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2
830112|NCT01903434|2726590|P1|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0
830113|NCT01903434|2726589|P2|Washout Period 1 (at Least 14 Days)|Adverse Event|0
830114|NCT01903434|2726590|P1|Washout Period 1 (at Least 14 Days)|Adverse Event|1
830115|NCT01903252|2726617|P6|Maintenance, Open-Label|Other|2
830116|NCT01903252|2726618|P5|Maintenance, Open-Label|Other|6
830117|NCT01903252|2726619|P4|Maintenance, Open-Label|Other|2
830118|NCT01903252|2726620|P3|Maintenance, Open-Label|Other|0
830119|NCT01903252|2726621|P2|Maintenance, Open-Label|Other|0
830120|NCT01903252|2726622|P1|Maintenance, Open-Label|Other|0
830121|NCT01903252|2726617|P6|Maintenance, Open-Label|Withdrawal by Subject|2
830122|NCT01903252|2726618|P5|Maintenance, Open-Label|Withdrawal by Subject|6
830123|NCT01903252|2726619|P4|Maintenance, Open-Label|Withdrawal by Subject|1
830124|NCT01903252|2726620|P3|Maintenance, Open-Label|Withdrawal by Subject|0
830125|NCT01903252|2726621|P2|Maintenance, Open-Label|Withdrawal by Subject|0
830126|NCT01903252|2726622|P1|Maintenance, Open-Label|Withdrawal by Subject|0
830127|NCT01903252|2726617|P6|Maintenance, Open-Label|Adverse Event|14
830128|NCT01903252|2726618|P5|Maintenance, Open-Label|Adverse Event|9
830129|NCT01903252|2726619|P4|Maintenance, Open-Label|Adverse Event|3
830130|NCT01903252|2726620|P3|Maintenance, Open-Label|Adverse Event|0
830131|NCT01903252|2726621|P2|Maintenance, Open-Label|Adverse Event|0
830132|NCT01903252|2726622|P1|Maintenance, Open-Label|Adverse Event|0
830133|NCT01903252|2726617|P6|Extended Induction, Open-Label|Physician Decision|0
830134|NCT01903252|2726618|P5|Extended Induction, Open-Label|Physician Decision|0
830135|NCT01903252|2726619|P4|Extended Induction, Open-Label|Physician Decision|0
830136|NCT01903252|2726620|P3|Extended Induction, Open-Label|Physician Decision|1
830137|NCT01903252|2726621|P2|Extended Induction, Open-Label|Physician Decision|0
830138|NCT01903252|2726622|P1|Extended Induction, Open-Label|Physician Decision|0
830139|NCT01903252|2726617|P6|Extended Induction, Open-Label|Withdrawal by Subject|0
830140|NCT01903252|2726618|P5|Extended Induction, Open-Label|Withdrawal by Subject|0
830141|NCT01903252|2726619|P4|Extended Induction, Open-Label|Withdrawal by Subject|0
830142|NCT01903252|2726620|P3|Extended Induction, Open-Label|Withdrawal by Subject|5
830143|NCT01903252|2726621|P2|Extended Induction, Open-Label|Withdrawal by Subject|0
830144|NCT01903252|2726622|P1|Extended Induction, Open-Label|Withdrawal by Subject|0
830145|NCT01903252|2726617|P6|Extended Induction, Open-Label|Adverse Event|0
830146|NCT01903252|2726618|P5|Extended Induction, Open-Label|Adverse Event|0
830147|NCT01903252|2726619|P4|Extended Induction, Open-Label|Adverse Event|0
830148|NCT01903252|2726620|P3|Extended Induction, Open-Label|Adverse Event|17
830149|NCT01903252|2726621|P2|Extended Induction, Open-Label|Adverse Event|0
830150|NCT01903252|2726622|P1|Extended Induction, Open-Label|Adverse Event|0
830151|NCT01903252|2726617|P6|Double-Blind Induction|non-compliance,|0
830152|NCT01903252|2726618|P5|Double-Blind Induction|non-compliance,|0
830153|NCT01903252|2726619|P4|Double-Blind Induction|non-compliance,|0
830154|NCT01903252|2726620|P3|Double-Blind Induction|non-compliance,|0
830155|NCT01903252|2726621|P2|Double-Blind Induction|non-compliance,|7
830156|NCT01903252|2726622|P1|Double-Blind Induction|non-compliance,|7
830157|NCT01903252|2726617|P6|Double-Blind Induction|Physician Decision|0
830158|NCT01903252|2726618|P5|Double-Blind Induction|Physician Decision|0
830159|NCT01903252|2726619|P4|Double-Blind Induction|Physician Decision|0
830160|NCT01903252|2726620|P3|Double-Blind Induction|Physician Decision|0
830161|NCT01903252|2726621|P2|Double-Blind Induction|Physician Decision|3
830162|NCT01903252|2726622|P1|Double-Blind Induction|Physician Decision|2
830163|NCT01903252|2726617|P6|Double-Blind Induction|Withdrawal by Subject|0
830164|NCT01903252|2726618|P5|Double-Blind Induction|Withdrawal by Subject|0
830165|NCT01903252|2726619|P4|Double-Blind Induction|Withdrawal by Subject|0
830166|NCT01903252|2726620|P3|Double-Blind Induction|Withdrawal by Subject|0
830167|NCT01903252|2726621|P2|Double-Blind Induction|Withdrawal by Subject|13
830168|NCT01903252|2726622|P1|Double-Blind Induction|Withdrawal by Subject|10
830169|NCT01903252|2726617|P6|Double-Blind Induction|Adverse Event|0
830170|NCT01903252|2726618|P5|Double-Blind Induction|Adverse Event|0
830171|NCT01903252|2726619|P4|Double-Blind Induction|Adverse Event|0
830172|NCT01903252|2726620|P3|Double-Blind Induction|Adverse Event|0
830173|NCT01903252|2726621|P2|Double-Blind Induction|Adverse Event|18
830174|NCT01903252|2726622|P1|Double-Blind Induction|Adverse Event|20
830175|NCT01903031|2726735|P3|Overall Study|NuvaRing removed prior to Day 21 visit|1
830176|NCT01903031|2726736|P2|Overall Study|NuvaRing removed prior to Day 21 visit|0
830177|NCT01903031|2726737|P1|Overall Study|NuvaRing removed prior to Day 21 visit|0
830178|NCT01903031|2726735|P3|Overall Study|Lost to Follow-up|1
830179|NCT01903031|2726736|P2|Overall Study|Lost to Follow-up|0
830180|NCT01903031|2726737|P1|Overall Study|Lost to Follow-up|0
830181|NCT01903031|2726735|P3|Overall Study|Protocol Violation|2
830182|NCT01903031|2726736|P2|Overall Study|Protocol Violation|0
830183|NCT01903031|2726737|P1|Overall Study|Protocol Violation|0
830184|NCT01903031|2726735|P3|Overall Study|Withdrawal by Subject|1
830185|NCT01903031|2726736|P2|Overall Study|Withdrawal by Subject|1
830186|NCT01903031|2726737|P1|Overall Study|Withdrawal by Subject|0
830187|NCT01903031|2726735|P3|Overall Study|Adverse Event|0
830188|NCT01903031|2726736|P2|Overall Study|Adverse Event|1
830189|NCT01903031|2726737|P1|Overall Study|Adverse Event|0
830190|NCT01903031|2726735|P3|Overall Study|Missed Day 21 Primary Endpoint Visit|0
830191|NCT01903031|2726736|P2|Overall Study|Missed Day 21 Primary Endpoint Visit|0
830192|NCT01903031|2726737|P1|Overall Study|Missed Day 21 Primary Endpoint Visit|1
830193|NCT01903031|2726735|P3|Overall Study|Not Able to Attend Clinic|0
830194|NCT01903031|2726736|P2|Overall Study|Not Able to Attend Clinic|1
830195|NCT01903031|2726737|P1|Overall Study|Not Able to Attend Clinic|1
830196|NCT01902888|2726793|P1|Overall Study|Study Terminated|3
830197|NCT01902628|2726807|P1|Overall Study|Lost to Follow-up|35
830198|NCT01902628|2726807|P1|Overall Study|Adverse Event|41
830199|NCT01902628|2726807|P1|Overall Study|Withdrawal of participant's consent|7
830200|NCT01902303|2726835|P2|Overall Study|Did not develop a cold sore|19
830201|NCT01902303|2726836|P1|Overall Study|Did not develop a cold sore|21
830202|NCT01902303|2726835|P2|Overall Study|subject lost investigational product|1
830203|NCT01902303|2726836|P1|Overall Study|subject lost investigational product|0
830204|NCT01902303|2726835|P2|Overall Study|Protocol Violation|2
830205|NCT01902303|2726836|P1|Overall Study|Protocol Violation|2
830206|NCT01902303|2726835|P2|Overall Study|Lost to Follow-up|1
830207|NCT01902303|2726836|P1|Overall Study|Lost to Follow-up|0
830208|NCT01902303|2726835|P2|Overall Study|Adverse Event|1
830209|NCT01902303|2726836|P1|Overall Study|Adverse Event|0
830210|NCT01902134|2726850|P6|Overall Study|not specified|0
830211|NCT01902134|2726851|P5|Overall Study|not specified|1
830212|NCT01902134|2726852|P4|Overall Study|not specified|0
830213|NCT01902134|2726853|P3|Overall Study|not specified|2
830214|NCT01902134|2726854|P2|Overall Study|not specified|1
830215|NCT01902134|2726855|P1|Overall Study|not specified|0
830216|NCT01902134|2726850|P6|Overall Study|no compliance|0
830217|NCT01902134|2726851|P5|Overall Study|no compliance|0
830218|NCT01902134|2726852|P4|Overall Study|no compliance|0
830219|NCT01902134|2726853|P3|Overall Study|no compliance|0
830220|NCT01902134|2726854|P2|Overall Study|no compliance|0
830221|NCT01902134|2726855|P1|Overall Study|no compliance|1
830222|NCT01902134|2726850|P6|Overall Study|Withdrawal by Subject|4
830223|NCT01902134|2726851|P5|Overall Study|Withdrawal by Subject|5
830224|NCT01902134|2726852|P4|Overall Study|Withdrawal by Subject|1
830225|NCT01902134|2726853|P3|Overall Study|Withdrawal by Subject|9
830226|NCT01902134|2726854|P2|Overall Study|Withdrawal by Subject|8
830227|NCT01902134|2726855|P1|Overall Study|Withdrawal by Subject|4
830228|NCT01902134|2726850|P6|Overall Study|Protocol Violation|1
830229|NCT01902134|2726851|P5|Overall Study|Protocol Violation|0
830230|NCT01902134|2726852|P4|Overall Study|Protocol Violation|0
830231|NCT01902134|2726853|P3|Overall Study|Protocol Violation|0
830232|NCT01902134|2726854|P2|Overall Study|Protocol Violation|0
830233|NCT01902134|2726855|P1|Overall Study|Protocol Violation|0
830234|NCT01902134|2726850|P6|Overall Study|Physician Decision|0
830235|NCT01902134|2726851|P5|Overall Study|Physician Decision|0
830236|NCT01902134|2726852|P4|Overall Study|Physician Decision|0
830237|NCT01902134|2726853|P3|Overall Study|Physician Decision|0
830238|NCT01902134|2726854|P2|Overall Study|Physician Decision|1
830239|NCT01902134|2726855|P1|Overall Study|Physician Decision|0
830240|NCT01902134|2726850|P6|Overall Study|Lack of Efficacy|1
830241|NCT01902134|2726851|P5|Overall Study|Lack of Efficacy|0
830242|NCT01902134|2726852|P4|Overall Study|Lack of Efficacy|0
830243|NCT01902134|2726853|P3|Overall Study|Lack of Efficacy|2
830244|NCT01902134|2726854|P2|Overall Study|Lack of Efficacy|0
830245|NCT01902134|2726855|P1|Overall Study|Lack of Efficacy|0
830246|NCT01902134|2726850|P6|Overall Study|Adverse Event|3
830247|NCT01902134|2726851|P5|Overall Study|Adverse Event|1
830248|NCT01902134|2726852|P4|Overall Study|Adverse Event|1
830249|NCT01902134|2726853|P3|Overall Study|Adverse Event|2
830250|NCT01902134|2726854|P2|Overall Study|Adverse Event|1
830251|NCT01902134|2726855|P1|Overall Study|Adverse Event|3
830252|NCT01901848|2726879|P2|Removed From Analyses|CPT practice cases to establish fidelity|0
830253|NCT01901848|2726880|P1|Removed From Analyses|CPT practice cases to establish fidelity|10
830254|NCT01901848|2726879|P2|Randomized and Treated|Lost to Follow-up|6
830255|NCT01901848|2726880|P1|Randomized and Treated|Lost to Follow-up|3
830256|NCT01901653|2726922|P13|Overall Study|Alive at Study Termination by Sponsor|1
830257|NCT01901653|2726923|P12|Overall Study|Alive at Study Termination by Sponsor|1
830258|NCT01901653|2726924|P11|Overall Study|Alive at Study Termination by Sponsor|0
830259|NCT01901653|2726925|P10|Overall Study|Alive at Study Termination by Sponsor|2
830260|NCT01901653|2726926|P9|Overall Study|Alive at Study Termination by Sponsor|0
830261|NCT01901653|2726927|P8|Overall Study|Alive at Study Termination by Sponsor|0
830262|NCT01901653|2726928|P7|Overall Study|Alive at Study Termination by Sponsor|0
830263|NCT01901653|2726929|P6|Overall Study|Alive at Study Termination by Sponsor|0
830264|NCT01901653|2726930|P5|Overall Study|Alive at Study Termination by Sponsor|0
830265|NCT01901653|2726931|P4|Overall Study|Alive at Study Termination by Sponsor|0
830266|NCT01901653|2726932|P3|Overall Study|Alive at Study Termination by Sponsor|1
830267|NCT01901653|2726933|P2|Overall Study|Alive at Study Termination by Sponsor|0
830268|NCT01901653|2726934|P1|Overall Study|Alive at Study Termination by Sponsor|0
830269|NCT01901653|2726922|P13|Overall Study|Withdrawal by Subject|0
830270|NCT01901653|2726923|P12|Overall Study|Withdrawal by Subject|0
830271|NCT01901653|2726924|P11|Overall Study|Withdrawal by Subject|0
830272|NCT01901653|2726925|P10|Overall Study|Withdrawal by Subject|0
830273|NCT01901653|2726926|P9|Overall Study|Withdrawal by Subject|0
830274|NCT01901653|2726927|P8|Overall Study|Withdrawal by Subject|0
830275|NCT01901653|2726928|P7|Overall Study|Withdrawal by Subject|1
830276|NCT01901653|2726929|P6|Overall Study|Withdrawal by Subject|0
830277|NCT01901653|2726930|P5|Overall Study|Withdrawal by Subject|0
830278|NCT01901653|2726931|P4|Overall Study|Withdrawal by Subject|0
830279|NCT01901653|2726932|P3|Overall Study|Withdrawal by Subject|0
830280|NCT01901653|2726933|P2|Overall Study|Withdrawal by Subject|0
830281|NCT01901653|2726934|P1|Overall Study|Withdrawal by Subject|0
830282|NCT01901653|2726922|P13|Overall Study|Lost to Follow-up|0
830283|NCT01901653|2726923|P12|Overall Study|Lost to Follow-up|0
830284|NCT01901653|2726924|P11|Overall Study|Lost to Follow-up|0
830285|NCT01901653|2726925|P10|Overall Study|Lost to Follow-up|0
830286|NCT01901653|2726926|P9|Overall Study|Lost to Follow-up|0
830287|NCT01901653|2726927|P8|Overall Study|Lost to Follow-up|1
830288|NCT01901653|2726928|P7|Overall Study|Lost to Follow-up|0
830289|NCT01901653|2726929|P6|Overall Study|Lost to Follow-up|1
830290|NCT01901653|2726930|P5|Overall Study|Lost to Follow-up|0
830291|NCT01901653|2726931|P4|Overall Study|Lost to Follow-up|0
830292|NCT01901653|2726932|P3|Overall Study|Lost to Follow-up|2
830293|NCT01901653|2726933|P2|Overall Study|Lost to Follow-up|0
830294|NCT01901653|2726934|P1|Overall Study|Lost to Follow-up|1
830295|NCT01901653|2726922|P13|Overall Study|Death|4
830296|NCT01901653|2726923|P12|Overall Study|Death|15
830297|NCT01901653|2726924|P11|Overall Study|Death|2
830298|NCT01901653|2726925|P10|Overall Study|Death|16
830299|NCT01901653|2726926|P9|Overall Study|Death|1
830300|NCT01901653|2726927|P8|Overall Study|Death|9
830301|NCT01901653|2726928|P7|Overall Study|Death|6
830302|NCT01901653|2726929|P6|Overall Study|Death|2
830303|NCT01901653|2726930|P5|Overall Study|Death|2
830304|NCT01901653|2726931|P4|Overall Study|Death|3
830305|NCT01901653|2726932|P3|Overall Study|Death|8
830306|NCT01901653|2726933|P2|Overall Study|Death|1
830307|NCT01901653|2726934|P1|Overall Study|Death|2
830308|NCT01901393|2727002|P2|Overall Study|Adverse Event|0
830309|NCT01901393|2727003|P1|Overall Study|Adverse Event|1
830310|NCT01901341|2727021|P2|Overall Study|Withdrawal by Subject|1
830311|NCT01901341|2727022|P1|Overall Study|Withdrawal by Subject|1
830312|NCT01901341|2727021|P2|Overall Study|Study Terminated by Sponsor|15
830313|NCT01901341|2727022|P1|Overall Study|Study Terminated by Sponsor|13
830314|NCT01901341|2727021|P2|Overall Study|Protocol Violation|0
830315|NCT01901341|2727022|P1|Overall Study|Protocol Violation|2
830316|NCT01901341|2727021|P2|Overall Study|Lost to Follow-up|1
830317|NCT01901341|2727022|P1|Overall Study|Lost to Follow-up|0
830318|NCT01901341|2727021|P2|Overall Study|Lack of Efficacy|2
830319|NCT01901341|2727022|P1|Overall Study|Lack of Efficacy|0
830320|NCT01901341|2727021|P2|Overall Study|Adverse Event|2
830321|NCT01901341|2727022|P1|Overall Study|Adverse Event|4
830322|NCT01901328|2727036|P2|Overall Study|Lack of Efficacy|1
830323|NCT01901328|2727037|P1|Overall Study|Lack of Efficacy|0
830324|NCT01901328|2727036|P2|Overall Study|Withdrawal by Subject|2
830325|NCT01901328|2727037|P1|Overall Study|Withdrawal by Subject|1
830326|NCT01901328|2727036|P2|Overall Study|Study Terminated by Sponsor|16
830327|NCT01901328|2727037|P1|Overall Study|Study Terminated by Sponsor|19
830328|NCT01901328|2727036|P2|Overall Study|Protocol Violation|1
830329|NCT01901328|2727037|P1|Overall Study|Protocol Violation|1
830330|NCT01901328|2727036|P2|Overall Study|Physician Decision|1
830331|NCT01901328|2727037|P1|Overall Study|Physician Decision|0
830332|NCT01901328|2727036|P2|Overall Study|Lost to Follow-up|0
830333|NCT01901328|2727037|P1|Overall Study|Lost to Follow-up|1
830334|NCT01901302|2727051|P2|Overall Study|Withdrawal by Subject|0
830335|NCT01901302|2727052|P1|Overall Study|Withdrawal by Subject|2
830336|NCT01901302|2727051|P2|Overall Study|Study Terminated by Sponsor|20
830337|NCT01901302|2727052|P1|Overall Study|Study Terminated by Sponsor|23
830338|NCT01901302|2727051|P2|Overall Study|Lack of Efficacy|2
830339|NCT01901302|2727052|P1|Overall Study|Lack of Efficacy|0
830340|NCT01901302|2727051|P2|Overall Study|Adverse Event|1
830341|NCT01901302|2727052|P1|Overall Study|Adverse Event|2
830342|NCT01901224|2727077|P1|Overall Study|study was not funded and terminated|2
830343|NCT01901185|2727112|P1|Overall Study|Withdrawal by Subject|2
830344|NCT01900665|2727121|P2|Open Label Period|Withdrawal by Subject|28
830345|NCT01900665|2727122|P1|Open Label Period|Withdrawal by Subject|20
830346|NCT01900665|2727121|P2|Open Label Period|Sponsor Decision|765
830347|NCT01900665|2727122|P1|Open Label Period|Sponsor Decision|802
830348|NCT01900665|2727121|P2|Open Label Period|Protocol Violation|1
830349|NCT01900665|2727122|P1|Open Label Period|Protocol Violation|0
830350|NCT01900665|2727121|P2|Open Label Period|Physician Decision|4
830351|NCT01900665|2727122|P1|Open Label Period|Physician Decision|4
830352|NCT01900665|2727121|P2|Open Label Period|Parent/Caregiver Decision|34
830353|NCT01900665|2727122|P1|Open Label Period|Parent/Caregiver Decision|33
830354|NCT01900665|2727121|P2|Open Label Period|Lost to Follow-up|1
830355|NCT01900665|2727122|P1|Open Label Period|Lost to Follow-up|1
830356|NCT01900665|2727121|P2|Open Label Period|Death|6
830357|NCT01900665|2727122|P1|Open Label Period|Death|5
830358|NCT01900665|2727121|P2|Open Label Period|Adverse Event|20
830359|NCT01900665|2727122|P1|Open Label Period|Adverse Event|16
830360|NCT01900665|2727121|P2|Placebo Controlled Period|Entry Criteria Not Met|9
830361|NCT01900665|2727122|P1|Placebo Controlled Period|Entry Criteria Not Met|5
830362|NCT01900665|2727121|P2|Placebo Controlled Period|Caregiver Decision|41
830363|NCT01900665|2727122|P1|Placebo Controlled Period|Caregiver Decision|33
830364|NCT01900665|2727121|P2|Placebo Controlled Period|Lost to Follow-up|0
830365|NCT01900665|2727122|P1|Placebo Controlled Period|Lost to Follow-up|3
830366|NCT01900665|2727121|P2|Placebo Controlled Period|Physician Decision|7
830367|NCT01900665|2727122|P1|Placebo Controlled Period|Physician Decision|11
830368|NCT01900665|2727121|P2|Placebo Controlled Period|Withdrawal by Subject|45
830369|NCT01900665|2727122|P1|Placebo Controlled Period|Withdrawal by Subject|33
830370|NCT01900665|2727121|P2|Placebo Controlled Period|Protocol Violation|7
830371|NCT01900665|2727122|P1|Placebo Controlled Period|Protocol Violation|1
830372|NCT01900665|2727121|P2|Placebo Controlled Period|Adverse Event|39
830373|NCT01900665|2727122|P1|Placebo Controlled Period|Adverse Event|48
830374|NCT01900665|2727121|P2|Placebo Controlled Period|Death|16
830375|NCT01900665|2727122|P1|Placebo Controlled Period|Death|9
830376|NCT01900652|2727165|P2|Overall Study|Physician Decision|1
830377|NCT01900652|2727166|P1|Overall Study|Physician Decision|1
830378|NCT01900652|2727165|P2|Overall Study|Adverse Event|1
830379|NCT01900652|2727166|P1|Overall Study|Adverse Event|2
830380|NCT01900652|2727165|P2|Overall Study|Death|0
830381|NCT01900652|2727166|P1|Overall Study|Death|3
830382|NCT01900652|2727165|P2|Overall Study|Consent withdrawn by subject|1
830383|NCT01900652|2727166|P1|Overall Study|Consent withdrawn by subject|1
830384|NCT01900652|2727165|P2|Overall Study|Progressive Disease|0
830385|NCT01900652|2727166|P1|Overall Study|Progressive Disease|1
830386|NCT01900444|2727200|P1|Overall Study|Lost to Follow-up|1
830387|NCT01900444|2727200|P1|Overall Study|Protocol Violation|2
830388|NCT01900431|2727213|P3|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3
830389|NCT01900431|2727214|P2|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
830390|NCT01900431|2727215|P1|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
830391|NCT01900431|2727213|P3|Open-Label Treatment Period (Part C)|Lack of Efficacy|3
830392|NCT01900431|2727214|P2|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
830393|NCT01900431|2727215|P1|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
830394|NCT01900431|2727213|P3|Open-Label Treatment Period (Part C)|Adverse Event|2
830395|NCT01900431|2727214|P2|Open-Label Treatment Period (Part C)|Adverse Event|0
830396|NCT01900431|2727215|P1|Open-Label Treatment Period (Part C)|Adverse Event|0
830397|NCT01900431|2727213|P3|Extended Treatment Period (Part B)|Other than specified above|0
830398|NCT01900431|2727214|P2|Extended Treatment Period (Part B)|Other than specified above|1
830399|NCT01900431|2727215|P1|Extended Treatment Period (Part B)|Other than specified above|0
830400|NCT01900431|2727213|P3|Extended Treatment Period (Part B)|Lack of Efficacy|0
830401|NCT01900431|2727214|P2|Extended Treatment Period (Part B)|Lack of Efficacy|7
830402|NCT01900431|2727215|P1|Extended Treatment Period (Part B)|Lack of Efficacy|1
830403|NCT01900431|2727213|P3|Extended Treatment Period (Part B)|Adverse Event|0
830404|NCT01900431|2727214|P2|Extended Treatment Period (Part B)|Adverse Event|2
830405|NCT01900431|2727215|P1|Extended Treatment Period (Part B)|Adverse Event|0
830406|NCT01900431|2727213|P3|Principal Treatment Period (Part A)|Other than specified above|0
830407|NCT01900431|2727214|P2|Principal Treatment Period (Part A)|Other than specified above|1
830408|NCT01900431|2727215|P1|Principal Treatment Period (Part A)|Other than specified above|0
830409|NCT01900431|2727213|P3|Principal Treatment Period (Part A)|Lack of Efficacy|0
830410|NCT01900431|2727214|P2|Principal Treatment Period (Part A)|Lack of Efficacy|6
830411|NCT01900431|2727215|P1|Principal Treatment Period (Part A)|Lack of Efficacy|6
830412|NCT01900431|2727213|P3|Principal Treatment Period (Part A)|Adverse Event|0
830413|NCT01900431|2727214|P2|Principal Treatment Period (Part A)|Adverse Event|3
830414|NCT01900431|2727215|P1|Principal Treatment Period (Part A)|Adverse Event|1
830415|NCT01900314|2727257|P2|Overall Study|Withdrawal by Subject|3
830416|NCT01900314|2727258|P1|Overall Study|Withdrawal by Subject|3
830417|NCT01900314|2727257|P2|Overall Study|Protocol Violation|1
830418|NCT01900314|2727258|P1|Overall Study|Protocol Violation|0
830419|NCT01900314|2727257|P2|Overall Study|Lost to Follow-up|0
830420|NCT01900314|2727258|P1|Overall Study|Lost to Follow-up|1
830421|NCT01900054|2727288|P1|Overall Study|Withdrawal by Subject|1
830422|NCT01900054|2727288|P1|Overall Study|Physician Decision|1
830423|NCT01899768|2727297|P1|Part B|Withdrawal by Subject|1
830424|NCT01899768|2727297|P1|Part B|Adverse Event|1
830425|NCT01899768|2727297|P1|Part A|Withdrawal by Subject|1
830426|NCT01899768|2727297|P1|Part A|Adverse Event|2
830427|NCT01899742|2727371|P2|Overall Study|Withdrawal by Subject|5
830428|NCT01899742|2727372|P1|Overall Study|Withdrawal by Subject|9
830429|NCT01899742|2727371|P2|Overall Study|Protocol Violation|2
830430|NCT01899742|2727372|P1|Overall Study|Protocol Violation|2
830431|NCT01899742|2727371|P2|Overall Study|Lack of Efficacy|5
830432|NCT01899742|2727372|P1|Overall Study|Lack of Efficacy|1
830433|NCT01899742|2727371|P2|Overall Study|Adverse Event|4
830434|NCT01899742|2727372|P1|Overall Study|Adverse Event|5
830435|NCT01899144|2727411|P1|Treatment Period 5|Not specified|1
830436|NCT01899144|2727411|P1|Treatment Period 3|Not specified|2
830437|NCT01899144|2727411|P1|Treatment Period 2|Not specified|1
830438|NCT01898884|2727438|P9|Multiple Dose Period|Randomized Not Treated|1
830439|NCT01898884|2727439|P8|Multiple Dose Period|Randomized Not Treated|0
830440|NCT01898884|2727440|P7|Multiple Dose Period|Randomized Not Treated|0
830441|NCT01898884|2727441|P6|Multiple Dose Period|Randomized Not Treated|0
830442|NCT01898884|2727442|P5|Multiple Dose Period|Randomized Not Treated|0
830443|NCT01898884|2727443|P4|Multiple Dose Period|Randomized Not Treated|0
830444|NCT01898884|2727444|P3|Multiple Dose Period|Randomized Not Treated|0
830445|NCT01898884|2727445|P2|Multiple Dose Period|Randomized Not Treated|0
830446|NCT01898884|2727446|P1|Multiple Dose Period|Randomized Not Treated|0
830447|NCT01898884|2727438|P9|Multiple Dose Period|Adverse Event|0
830448|NCT01898884|2727439|P8|Multiple Dose Period|Adverse Event|0
830449|NCT01898884|2727440|P7|Multiple Dose Period|Adverse Event|1
830450|NCT01898884|2727441|P6|Multiple Dose Period|Adverse Event|0
830451|NCT01898884|2727442|P5|Multiple Dose Period|Adverse Event|0
830452|NCT01898884|2727443|P4|Multiple Dose Period|Adverse Event|0
830453|NCT01898884|2727444|P3|Multiple Dose Period|Adverse Event|0
830454|NCT01898884|2727445|P2|Multiple Dose Period|Adverse Event|0
830455|NCT01898884|2727446|P1|Multiple Dose Period|Adverse Event|0
830456|NCT01898598|2727621|P2|Overall Study|Other|1
830457|NCT01898598|2727622|P1|Overall Study|Other|0
830458|NCT01898598|2727621|P2|Overall Study|Lost to Follow-up|1
830459|NCT01898598|2727622|P1|Overall Study|Lost to Follow-up|0
830460|NCT01898598|2727621|P2|Overall Study|Withdrawal by Subject|0
830461|NCT01898598|2727622|P1|Overall Study|Withdrawal by Subject|3
830462|NCT01898598|2727621|P2|Overall Study|Adverse Event|0
830463|NCT01898598|2727622|P1|Overall Study|Adverse Event|1
830464|NCT01898442|2727641|P3|Overall Study|Patient vomited pills|1
830465|NCT01898442|2727642|P2|Overall Study|Patient vomited pills|0
830466|NCT01898442|2727643|P1|Overall Study|Patient vomited pills|0
830467|NCT01898442|2727641|P3|Overall Study|Hemolysis/technical problems|2
830468|NCT01898442|2727642|P2|Overall Study|Hemolysis/technical problems|2
830469|NCT01898442|2727643|P1|Overall Study|Hemolysis/technical problems|1
830470|NCT01898286|2727678|P1|Overall Study|Lost to Follow-up|1
830471|NCT01898286|2727678|P1|Overall Study|Protocol Violation|1
830472|NCT01898286|2727678|P1|Overall Study|Withdrawal by Subject|1
830473|NCT01898208|2727688|P3|Overall Study|Lost to Follow-up|1
830474|NCT01898208|2727689|P2|Overall Study|Lost to Follow-up|1
830475|NCT01898208|2727690|P1|Overall Study|Lost to Follow-up|3
830476|NCT01898208|2727688|P3|Overall Study|System/Technical Error|3
830477|NCT01898208|2727689|P2|Overall Study|System/Technical Error|2
830478|NCT01898208|2727690|P1|Overall Study|System/Technical Error|1
830479|NCT01898208|2727688|P3|Overall Study|Non-Blood Specimens in Bottles|4
830480|NCT01898208|2727689|P2|Overall Study|Non-Blood Specimens in Bottles|5
830481|NCT01898208|2727690|P1|Overall Study|Non-Blood Specimens in Bottles|3
830482|NCT01898208|2727688|P3|Overall Study|Negative Gram Stain|6
830483|NCT01898208|2727689|P2|Overall Study|Negative Gram Stain|9
830484|NCT01898208|2727690|P1|Overall Study|Negative Gram Stain|6
830485|NCT01898208|2727688|P3|Overall Study|Death/comfort care within 24 hours|8
830486|NCT01898208|2727689|P2|Overall Study|Death/comfort care within 24 hours|9
830487|NCT01898208|2727690|P1|Overall Study|Death/comfort care within 24 hours|10
830488|NCT01898208|2727688|P3|Overall Study|Positive blood culture|15
830489|NCT01898208|2727689|P2|Overall Study|Positive blood culture|23
830490|NCT01898208|2727690|P1|Overall Study|Positive blood culture|17
830491|NCT01898195|2727737|P3|Smoking Abstinence|Did not have good measurements|36
830492|NCT01898195|2727738|P2|Smoking Abstinence|Did not have good measurements|38
830493|NCT01898195|2727739|P1|Smoking Abstinence|Did not have good measurements|35
830494|NCT01898091|2727752|P2|Overall Study|Withdrawal by Subject|5
830495|NCT01898091|2727753|P1|Overall Study|Withdrawal by Subject|1
830496|NCT01898091|2727752|P2|Overall Study|Lost to Follow-up|1
830497|NCT01898091|2727753|P1|Overall Study|Lost to Follow-up|1
830498|NCT01897727|2727807|P2|Overall Study|Exclusion: central sleep apnea|1
830499|NCT01897727|2727808|P1|Overall Study|Exclusion: central sleep apnea|0
830500|NCT01897493|2727814|P1|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1
830501|NCT01897233|2727850|P1|Part B (24 Weeks)|Physician Decision|1
830502|NCT01897233|2727850|P1|Part B (24 Weeks)|Withdrawal by Subject|2
830503|NCT01897233|2727850|P1|Part B (24 Weeks)|Adverse Event|1
830504|NCT01896986|2727902|P2|Overall Study|samples lost|23
830505|NCT01896986|2727903|P1|Overall Study|samples lost|14
830506|NCT01896934|2727909|P1|Overall Study|Withdrawal by Subject|1
830507|NCT01896934|2727909|P1|Overall Study|Adverse Event|1
830508|NCT01896895|2727918|P4|Double-blind MP|Lost to Follow-up|0
830509|NCT01896895|2727919|P3|Double-blind MP|Lost to Follow-up|1
830510|NCT01896895|2727920|P2|Double-blind MP|Lost to Follow-up|0
830511|NCT01896895|2727921|P1|Double-blind MP|Lost to Follow-up|1
830512|NCT01896895|2727918|P4|Double-blind MP|Withdrawal by Subject|0
830513|NCT01896895|2727919|P3|Double-blind MP|Withdrawal by Subject|1
830514|NCT01896895|2727920|P2|Double-blind MP|Withdrawal by Subject|2
830515|NCT01896895|2727921|P1|Double-blind MP|Withdrawal by Subject|0
830516|NCT01896895|2727918|P4|Double-blind MP|Physician Decision|0
830517|NCT01896895|2727919|P3|Double-blind MP|Physician Decision|1
830518|NCT01896895|2727920|P2|Double-blind MP|Physician Decision|0
830519|NCT01896895|2727921|P1|Double-blind MP|Physician Decision|0
830520|NCT01896726|2727936|P1|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1
830521|NCT01896726|2727936|P1|Treatment Period 2 (Days 23-31)|Adverse Event|1
830522|NCT01896700|2727951|P2|Overall Study|Withdrawal by Subject|1
830523|NCT01896700|2727952|P1|Overall Study|Withdrawal by Subject|0
830524|NCT01896700|2727951|P2|Overall Study|Adverse Event|5
830525|NCT01896700|2727952|P1|Overall Study|Adverse Event|4
830526|NCT01896557|2727983|P2|Clopidogrel + GI Protector|Reading error|3
830527|NCT01896557|2727984|P1|Clopidogrel + GI Protector|Reading error|1
830528|NCT01896557|2727983|P2|Clopidogrel + GI Protector|low adherence|1
830529|NCT01896557|2727984|P1|Clopidogrel + GI Protector|low adherence|1
830530|NCT01896557|2727983|P2|Clopidogrel Alone|Adverse Event|0
830531|NCT01896557|2727984|P1|Clopidogrel Alone|Adverse Event|1
830532|NCT01896297|2728021|P1|Overall Study|Died in post treatment phase|1
830533|NCT01896232|2728028|P2|Overall Study|Lost to Follow-up|12
830534|NCT01896232|2728029|P1|Overall Study|Lost to Follow-up|9
830535|NCT01896232|2728028|P2|Overall Study|Sponsor Decision|0
830536|NCT01896232|2728029|P1|Overall Study|Sponsor Decision|2
830537|NCT01896232|2728028|P2|Overall Study|Withdrawal by Subject|31
830538|NCT01896232|2728029|P1|Overall Study|Withdrawal by Subject|32
830539|NCT01896232|2728028|P2|Overall Study|Death|10
830540|NCT01896232|2728029|P1|Overall Study|Death|6
830541|NCT01896193|2728057|P2|Overall Study|Withdrew Consent|0
830542|NCT01896193|2728058|P1|Overall Study|Withdrew Consent|1
830543|NCT01896193|2728057|P2|Overall Study|Protocol Violation|1
830544|NCT01896193|2728058|P1|Overall Study|Protocol Violation|0
830545|NCT01896193|2728057|P2|Overall Study|Lack of Efficacy|11
830546|NCT01896193|2728058|P1|Overall Study|Lack of Efficacy|20
830547|NCT01896050|2728110|P2|Overall Study|Death|0
830548|NCT01896050|2728111|P1|Overall Study|Death|1
830549|NCT01896050|2728110|P2|Overall Study|Adverse Event|2
830550|NCT01896050|2728111|P1|Overall Study|Adverse Event|37
830551|NCT01895608|2728159|P4|Overall Study|Withdrawal by Subject|0
830552|NCT01895608|2728160|P3|Overall Study|Withdrawal by Subject|2
830553|NCT01895608|2728161|P2|Overall Study|Withdrawal by Subject|0
830554|NCT01895608|2728162|P1|Overall Study|Withdrawal by Subject|0
830555|NCT01895608|2728159|P4|Overall Study|change in health status|0
830556|NCT01895608|2728160|P3|Overall Study|change in health status|1
830557|NCT01895608|2728161|P2|Overall Study|change in health status|1
830558|NCT01895608|2728162|P1|Overall Study|change in health status|0
830559|NCT01895543|2728192|P1|Overall Study|Other (Not fulfilling above criteria)|24
830560|NCT01895543|2728192|P1|Overall Study|Physician Decision|2
830561|NCT01895543|2728192|P1|Overall Study|Protocol Violation|1
830562|NCT01895543|2728192|P1|Overall Study|Subject's substantial non-compliance|6
830563|NCT01895543|2728192|P1|Overall Study|Adverse Event|28
830564|NCT01895543|2728192|P1|Overall Study|Lost to Follow-up|25
830565|NCT01895543|2728192|P1|Overall Study|Withdrawal by Subject|43
830566|NCT01895452|2728208|P2|Overall Study|Noncompliance with study drug|1
830567|NCT01895452|2728209|P1|Overall Study|Noncompliance with study drug|0
830568|NCT01895452|2728208|P2|Overall Study|Underlying disease|3
830569|NCT01895452|2728209|P1|Overall Study|Underlying disease|0
830570|NCT01895452|2728208|P2|Overall Study|Withdrawal by Subject|14
830571|NCT01895452|2728209|P1|Overall Study|Withdrawal by Subject|2
830572|NCT01895452|2728208|P2|Overall Study|Pregnancy|1
830573|NCT01895452|2728209|P1|Overall Study|Pregnancy|0
830574|NCT01895452|2728208|P2|Overall Study|Lost to Follow-up|5
830575|NCT01895452|2728209|P1|Overall Study|Lost to Follow-up|1
830576|NCT01895452|2728208|P2|Overall Study|Adverse Event|4
830577|NCT01895452|2728209|P1|Overall Study|Adverse Event|1
830578|NCT01895335|2728219|P1|Overall Study|Other than Specified Above|44
830579|NCT01895335|2728219|P1|Overall Study|Included But Not treated|1
830580|NCT01895335|2728219|P1|Overall Study|Poor Compliance to Protocol|11
830581|NCT01895335|2728219|P1|Overall Study|Lack of Efficacy|53
830582|NCT01895335|2728219|P1|Overall Study|Adverse Event|106
830583|NCT01895322|2728236|P1|Overall Study|Protocol Violation|10
830584|NCT01895322|2728236|P1|Overall Study|Withdrawal by Subject|2
830585|NCT01895322|2728236|P1|Overall Study|Adverse Event|1
830586|NCT01895309|2728245|P2|Overall Study|Withdrawal by Subject|18
830587|NCT01895309|2728246|P1|Overall Study|Withdrawal by Subject|9
830588|NCT01895309|2728245|P2|Overall Study|Physician Decision|10
830589|NCT01895309|2728246|P1|Overall Study|Physician Decision|15
830590|NCT01895309|2728245|P2|Overall Study|Lost to Follow-up|3
830591|NCT01895309|2728246|P1|Overall Study|Lost to Follow-up|1
830592|NCT01895309|2728245|P2|Overall Study|Lack of Efficacy|3
830593|NCT01895309|2728246|P1|Overall Study|Lack of Efficacy|1
830594|NCT01895309|2728245|P2|Overall Study|Protocol Violation|0
830595|NCT01895309|2728246|P1|Overall Study|Protocol Violation|1
830596|NCT01895309|2728245|P2|Overall Study|Adverse Event|17
830597|NCT01895309|2728246|P1|Overall Study|Adverse Event|13
830598|NCT01895270|2728260|P2|Isradipine Taper (W7-8)|Withdrawal by Subject|1
830599|NCT01895270|2728261|P1|Isradipine Taper (W7-8)|Withdrawal by Subject|0
830600|NCT01895270|2728260|P2|Isradipine Taper (W7-8)|Lost to Follow-up|1
830601|NCT01895270|2728261|P1|Isradipine Taper (W7-8)|Lost to Follow-up|0
830602|NCT01895270|2728260|P2|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5
830603|NCT01895270|2728261|P1|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3
830604|NCT01895270|2728260|P2|Study Medications Induction (W1-4)|Blood pressure issues|1
830605|NCT01895270|2728261|P1|Study Medications Induction (W1-4)|Blood pressure issues|0
830606|NCT01895270|2728260|P2|Study Medications Induction (W1-4)|noncompliance- missed medications|1
830607|NCT01895270|2728261|P1|Study Medications Induction (W1-4)|noncompliance- missed medications|3
830608|NCT01895270|2728260|P2|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2
830609|NCT01895270|2728261|P1|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3
830610|NCT01895270|2728260|P2|Study Medications Induction (W1-4)|Withdrawal by Subject|2
830611|NCT01895270|2728261|P1|Study Medications Induction (W1-4)|Withdrawal by Subject|0
830612|NCT01895101|2728280|P3|Overall Study|coagulation disorder|0
830613|NCT01895101|2728281|P2|Overall Study|coagulation disorder|1
830614|NCT01895101|2728282|P1|Overall Study|coagulation disorder|0
830615|NCT01895101|2728280|P3|Overall Study|Death|0
830616|NCT01895101|2728281|P2|Overall Study|Death|1
830617|NCT01895101|2728282|P1|Overall Study|Death|0
830618|NCT01895101|2728280|P3|Overall Study|another study, enrolled in other study|0
830619|NCT01895101|2728281|P2|Overall Study|another study, enrolled in other study|1
830620|NCT01895101|2728282|P1|Overall Study|another study, enrolled in other study|0
830621|NCT01895101|2728280|P3|Overall Study|Withdrawal by Subject|2
830622|NCT01895101|2728281|P2|Overall Study|Withdrawal by Subject|1
830623|NCT01895101|2728282|P1|Overall Study|Withdrawal by Subject|0
830624|NCT01895101|2728280|P3|Overall Study|OPCAB procedure|3
830625|NCT01895101|2728281|P2|Overall Study|OPCAB procedure|1
830626|NCT01895101|2728282|P1|Overall Study|OPCAB procedure|1
830627|NCT01894984|2728317|P2|Overall Study|Other|175
830628|NCT01894984|2728318|P1|Overall Study|Other|314
830629|NCT01894620|2728375|P2|Overall Study|Withdrawal by Subject|1
830630|NCT01894620|2728376|P1|Overall Study|Withdrawal by Subject|0
830631|NCT01894607|2728384|P1|Overall Study|Ineligible|1
830632|NCT01894581|2728391|P2|Overall Study|Screen Failure|4
830633|NCT01894581|2728392|P1|Overall Study|Screen Failure|3
830634|NCT01894581|2728391|P2|Overall Study|Withdrawal by Subject|3
830635|NCT01894581|2728392|P1|Overall Study|Withdrawal by Subject|2
830636|NCT01894477|2728409|P2|Overall Study|protocol changed due SC changed to cord|1
830637|NCT01894477|2728410|P1|Overall Study|protocol changed due SC changed to cord|0
830638|NCT01894477|2728409|P2|Overall Study|Protocol Violation|1
830639|NCT01894477|2728410|P1|Overall Study|Protocol Violation|0
830640|NCT01894256|2728421|P3|Part B|Lack of Efficacy|13
830641|NCT01894256|2728422|P2|Part B|Lack of Efficacy|12
830642|NCT01894256|2728423|P1|Part B|Lack of Efficacy|15
830643|NCT01894256|2728421|P3|Part B|Withdrawal by Subject|0
830644|NCT01894256|2728422|P2|Part B|Withdrawal by Subject|1
830645|NCT01894256|2728423|P1|Part B|Withdrawal by Subject|0
830646|NCT01894256|2728421|P3|Part B|Death|1
830647|NCT01894256|2728422|P2|Part B|Death|1
830648|NCT01894256|2728423|P1|Part B|Death|0
830649|NCT01894256|2728421|P3|Part A|Adverse Event|0
830650|NCT01894256|2728422|P2|Part A|Adverse Event|1
830651|NCT01894256|2728423|P1|Part A|Adverse Event|0
830652|NCT01894230|2728469|P2|Overall Study|Death|0
830653|NCT01894230|2728470|P1|Overall Study|Death|1
830654|NCT01894230|2728469|P2|Overall Study|Non-adherent|1
830655|NCT01894230|2728470|P1|Overall Study|Non-adherent|0
830656|NCT01894230|2728469|P2|Overall Study|Withdrawal by Subject|4
830657|NCT01894230|2728470|P1|Overall Study|Withdrawal by Subject|4
830658|NCT01894230|2728469|P2|Overall Study|Lost to Follow-up|2
830659|NCT01894230|2728470|P1|Overall Study|Lost to Follow-up|2
830660|NCT01894100|2728496|P2|Overall Study|Withdrawal by Subject|0
830661|NCT01894100|2728497|P1|Overall Study|Withdrawal by Subject|3
830662|NCT01894100|2728496|P2|Overall Study|Lost to Follow-up|1
830663|NCT01894100|2728497|P1|Overall Study|Lost to Follow-up|0
830664|NCT01894022|2728522|P2|Overall Study|Study Closed/terminated|10
830665|NCT01894022|2728523|P1|Overall Study|Study Closed/terminated|7
830666|NCT01894022|2728522|P2|Overall Study|Adverse Event, non-fatal|0
830667|NCT01894022|2728523|P1|Overall Study|Adverse Event, non-fatal|1
830668|NCT01894022|2728522|P2|Overall Study|Death|0
830669|NCT01894022|2728523|P1|Overall Study|Death|1
830670|NCT01893905|2728577|P2|Overall Study|Other reason|3
830671|NCT01893905|2728578|P1|Overall Study|Other reason|1
830672|NCT01893905|2728577|P2|Overall Study|Lack of adherence to treatment|0
830673|NCT01893905|2728578|P1|Overall Study|Lack of adherence to treatment|2
830674|NCT01893905|2728577|P2|Overall Study|Protocol Violation|1
830675|NCT01893905|2728578|P1|Overall Study|Protocol Violation|6
830676|NCT01893905|2728577|P2|Overall Study|Lost to Follow-up|0
830677|NCT01893905|2728578|P1|Overall Study|Lost to Follow-up|1
830678|NCT01893905|2728577|P2|Overall Study|Lack of Efficacy|7
830679|NCT01893905|2728578|P1|Overall Study|Lack of Efficacy|5
830680|NCT01893905|2728577|P2|Overall Study|Adverse Event|3
830681|NCT01893905|2728578|P1|Overall Study|Adverse Event|9
830682|NCT01893905|2728577|P2|Overall Study|Withdrawal by Subject|0
830683|NCT01893905|2728578|P1|Overall Study|Withdrawal by Subject|1
830684|NCT01893411|2728609|P3|Overall Study|Lost to Follow-up|1
830685|NCT01893411|2728610|P2|Overall Study|Lost to Follow-up|0
830686|NCT01893411|2728611|P1|Overall Study|Lost to Follow-up|2
830687|NCT01893411|2728609|P3|Overall Study|Withdrawal by Subject|3
830688|NCT01893411|2728610|P2|Overall Study|Withdrawal by Subject|4
830689|NCT01893411|2728611|P1|Overall Study|Withdrawal by Subject|7
830690|NCT01893411|2728609|P3|Overall Study|Adverse Event|0
830691|NCT01893411|2728610|P2|Overall Study|Adverse Event|0
830692|NCT01893411|2728611|P1|Overall Study|Adverse Event|1
830693|NCT01893411|2728609|P3|Overall Study|Not Specified|3
830694|NCT01893411|2728610|P2|Overall Study|Not Specified|1
830695|NCT01893411|2728611|P1|Overall Study|Not Specified|3
830696|NCT01893411|2728609|P3|Overall Study|Lack of Efficacy|0
830697|NCT01893411|2728610|P2|Overall Study|Lack of Efficacy|1
830698|NCT01893411|2728611|P1|Overall Study|Lack of Efficacy|2
830699|NCT01893411|2728609|P3|Overall Study|Physician Decision|2
830700|NCT01893411|2728610|P2|Overall Study|Physician Decision|1
830701|NCT01893411|2728611|P1|Overall Study|Physician Decision|1
830702|NCT01893411|2728609|P3|Overall Study|Protocol Violation|0
830703|NCT01893411|2728610|P2|Overall Study|Protocol Violation|0
830704|NCT01893411|2728611|P1|Overall Study|Protocol Violation|1
830705|NCT01893346|2728693|P4|Overall Study|Withdrawal by Subject|0
830706|NCT01893346|2728694|P3|Overall Study|Withdrawal by Subject|0
830707|NCT01893346|2728695|P2|Overall Study|Withdrawal by Subject|0
830708|NCT01893346|2728696|P1|Overall Study|Withdrawal by Subject|2
830709|NCT01893346|2728693|P4|Overall Study|Protocol Violation|0
830710|NCT01893346|2728694|P3|Overall Study|Protocol Violation|0
830711|NCT01893346|2728695|P2|Overall Study|Protocol Violation|0
830712|NCT01893346|2728696|P1|Overall Study|Protocol Violation|1
830713|NCT01893346|2728693|P4|Overall Study|Lost to Follow-up|0
830714|NCT01893346|2728694|P3|Overall Study|Lost to Follow-up|0
830715|NCT01893346|2728695|P2|Overall Study|Lost to Follow-up|1
830716|NCT01893346|2728696|P1|Overall Study|Lost to Follow-up|0
830717|NCT01893281|2728710|P1|Overall Study|Withdrawal by Subject|1
830718|NCT01893281|2728710|P1|Overall Study|Protocol Violation|1
830719|NCT01893281|2728710|P1|Overall Study|Adverse Event|1
830720|NCT01893203|2728717|P1|Overall Study|Withdrawal by Subject|1
830721|NCT01892722|2728741|P2|Overall Study|Withdrawal by Subject|5
830722|NCT01892722|2728742|P1|Overall Study|Withdrawal by Subject|3
830723|NCT01892722|2728741|P2|Overall Study|Lack of Efficacy|7
830724|NCT01892722|2728742|P1|Overall Study|Lack of Efficacy|0
830725|NCT01892722|2728741|P2|Overall Study|Adverse Event|2
830726|NCT01892722|2728742|P1|Overall Study|Adverse Event|3
830727|NCT01892722|2728741|P2|Overall Study|Physician Decision|2
830728|NCT01892722|2728742|P1|Overall Study|Physician Decision|1
830729|NCT01892722|2728741|P2|Overall Study|Patient/guardian decision|2
830730|NCT01892722|2728742|P1|Overall Study|Patient/guardian decision|0
830731|NCT01892722|2728741|P2|Overall Study|Administrative problems|1
830732|NCT01892722|2728742|P1|Overall Study|Administrative problems|0
830733|NCT01892722|2728741|P2|Overall Study|Protocol deviation|1
830734|NCT01892722|2728742|P1|Overall Study|Protocol deviation|0
830735|NCT01892657|2728758|P1|Overall Study|Protocol Violation|12
830736|NCT01892657|2728758|P1|Overall Study|Withdrawal by Subject|6
830737|NCT01892293|2728797|P1|Overall Study|Apheresed but not treated|4
830738|NCT01892189|2728841|P9|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
830739|NCT01892189|2728842|P8|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
830740|NCT01892189|2728843|P7|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
830741|NCT01892189|2728844|P6|Washout Period 1 (7 Days)|Noncompliance, Irritability|1
830742|NCT01892189|2728845|P5|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
830743|NCT01892189|2728846|P4|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
830744|NCT01892189|2728847|P3|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
830745|NCT01892189|2728848|P2|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
830746|NCT01892189|2728849|P1|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
830747|NCT01892189|2728841|P9|Washout Period 1 (7 Days)|Withdrawal by Subject|1
830748|NCT01892189|2728842|P8|Washout Period 1 (7 Days)|Withdrawal by Subject|0
830749|NCT01892189|2728843|P7|Washout Period 1 (7 Days)|Withdrawal by Subject|1
830750|NCT01892189|2728844|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
830751|NCT01892189|2728845|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
830752|NCT01892189|2728846|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|1
830753|NCT01892189|2728847|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|2
830754|NCT01892189|2728848|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
830755|NCT01892189|2728849|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
830756|NCT01892189|2728841|P9|Washout Period 1 (7 Days)|Adverse Event|1
830757|NCT01892189|2728842|P8|Washout Period 1 (7 Days)|Adverse Event|0
830758|NCT01892189|2728843|P7|Washout Period 1 (7 Days)|Adverse Event|0
830759|NCT01892189|2728844|P6|Washout Period 1 (7 Days)|Adverse Event|0
830760|NCT01892189|2728845|P5|Washout Period 1 (7 Days)|Adverse Event|0
830761|NCT01892189|2728846|P4|Washout Period 1 (7 Days)|Adverse Event|0
830762|NCT01892189|2728847|P3|Washout Period 1 (7 Days)|Adverse Event|0
830763|NCT01892189|2728848|P2|Washout Period 1 (7 Days)|Adverse Event|0
830764|NCT01892189|2728849|P1|Washout Period 1 (7 Days)|Adverse Event|0
830765|NCT01892163|2728891|P2|Overall Study|Lost to Follow-up|0
830766|NCT01892163|2728892|P1|Overall Study|Lost to Follow-up|1
830767|NCT01892163|2728891|P2|Overall Study|Death|1
830768|NCT01892163|2728892|P1|Overall Study|Death|1
830769|NCT01892020|2728904|P2|Period 2|Protocol Violation|0
830770|NCT01892020|2728905|P1|Period 2|Protocol Violation|1
830771|NCT01892020|2728904|P2|Period 1|Unclassified|1
830772|NCT01892020|2728905|P1|Period 1|Unclassified|0
830773|NCT01892020|2728904|P2|Period 1|Protocol Violation|4
830774|NCT01892020|2728905|P1|Period 1|Protocol Violation|2
830775|NCT01892020|2728904|P2|Period 1|Adverse Event|1
830776|NCT01892020|2728905|P1|Period 1|Adverse Event|1
830777|NCT01891890|2728930|P3|Overall Study|Study ended before endpoint reached|6
830778|NCT01891890|2728931|P2|Overall Study|Study ended before endpoint reached|3
830779|NCT01891890|2728932|P1|Overall Study|Study ended before endpoint reached|7
830780|NCT01891890|2728930|P3|Overall Study|Lost to Follow-up|1
830781|NCT01891890|2728931|P2|Overall Study|Lost to Follow-up|0
830782|NCT01891890|2728932|P1|Overall Study|Lost to Follow-up|0
830783|NCT01891864|2728975|P6|Extension Period|Lost to Follow-up|0
830784|NCT01891864|2728976|P5|Extension Period|Lost to Follow-up|0
830785|NCT01891864|2728977|P4|Extension Period|Lost to Follow-up|0
830786|NCT01891864|2728978|P3|Extension Period|Lost to Follow-up|2
830787|NCT01891864|2728979|P2|Extension Period|Lost to Follow-up|0
830788|NCT01891864|2728980|P1|Extension Period|Lost to Follow-up|0
830789|NCT01891864|2728975|P6|Extension Period|Withdrawal by Subject|0
830790|NCT01891864|2728976|P5|Extension Period|Withdrawal by Subject|4
830791|NCT01891864|2728977|P4|Extension Period|Withdrawal by Subject|2
830792|NCT01891864|2728978|P3|Extension Period|Withdrawal by Subject|1
830793|NCT01891864|2728979|P2|Extension Period|Withdrawal by Subject|0
830794|NCT01891864|2728980|P1|Extension Period|Withdrawal by Subject|0
830795|NCT01891864|2728975|P6|Extension Period|Adverse Event|0
830796|NCT01891864|2728976|P5|Extension Period|Adverse Event|2
830797|NCT01891864|2728977|P4|Extension Period|Adverse Event|2
830798|NCT01891864|2728978|P3|Extension Period|Adverse Event|4
830799|NCT01891864|2728979|P2|Extension Period|Adverse Event|0
830800|NCT01891864|2728980|P1|Extension Period|Adverse Event|0
830801|NCT01891864|2728975|P6|Extension Period|Pregnancy|0
830802|NCT01891864|2728976|P5|Extension Period|Pregnancy|0
830803|NCT01891864|2728977|P4|Extension Period|Pregnancy|0
830804|NCT01891864|2728978|P3|Extension Period|Pregnancy|1
830805|NCT01891864|2728979|P2|Extension Period|Pregnancy|0
830806|NCT01891864|2728980|P1|Extension Period|Pregnancy|0
830807|NCT01891864|2728975|P6|Extension Period|Lack of Efficacy|0
830808|NCT01891864|2728976|P5|Extension Period|Lack of Efficacy|1
830809|NCT01891864|2728977|P4|Extension Period|Lack of Efficacy|1
830810|NCT01891864|2728978|P3|Extension Period|Lack of Efficacy|0
830811|NCT01891864|2728979|P2|Extension Period|Lack of Efficacy|0
830812|NCT01891864|2728980|P1|Extension Period|Lack of Efficacy|0
830813|NCT01891864|2728975|P6|Treatment Period 2|Withdrawal by Subject|1
830814|NCT01891864|2728976|P5|Treatment Period 2|Withdrawal by Subject|1
830815|NCT01891864|2728977|P4|Treatment Period 2|Withdrawal by Subject|4
830816|NCT01891864|2728978|P3|Treatment Period 2|Withdrawal by Subject|3
830817|NCT01891864|2728979|P2|Treatment Period 2|Withdrawal by Subject|0
830818|NCT01891864|2728980|P1|Treatment Period 2|Withdrawal by Subject|0
830819|NCT01891864|2728975|P6|Treatment Period 2|Termination of Site|0
830820|NCT01891864|2728976|P5|Treatment Period 2|Termination of Site|2
830821|NCT01891864|2728977|P4|Treatment Period 2|Termination of Site|0
830822|NCT01891864|2728978|P3|Treatment Period 2|Termination of Site|0
830823|NCT01891864|2728979|P2|Treatment Period 2|Termination of Site|0
830824|NCT01891864|2728980|P1|Treatment Period 2|Termination of Site|0
830825|NCT01891864|2728975|P6|Treatment Period 2|Adverse Event|4
830826|NCT01891864|2728976|P5|Treatment Period 2|Adverse Event|0
830827|NCT01891864|2728977|P4|Treatment Period 2|Adverse Event|2
830828|NCT01891864|2728978|P3|Treatment Period 2|Adverse Event|1
830829|NCT01891864|2728979|P2|Treatment Period 2|Adverse Event|0
830830|NCT01891864|2728980|P1|Treatment Period 2|Adverse Event|0
830831|NCT01891864|2728975|P6|Treatment Period 2|Lack of Efficacy|0
830832|NCT01891864|2728976|P5|Treatment Period 2|Lack of Efficacy|1
830833|NCT01891864|2728977|P4|Treatment Period 2|Lack of Efficacy|0
830834|NCT01891864|2728978|P3|Treatment Period 2|Lack of Efficacy|1
830835|NCT01891864|2728979|P2|Treatment Period 2|Lack of Efficacy|0
830836|NCT01891864|2728980|P1|Treatment Period 2|Lack of Efficacy|0
830837|NCT01891864|2728975|P6|Treatment Period 2|Site Termination|0
830838|NCT01891864|2728976|P5|Treatment Period 2|Site Termination|0
830839|NCT01891864|2728977|P4|Treatment Period 2|Site Termination|2
830840|NCT01891864|2728978|P3|Treatment Period 2|Site Termination|1
830841|NCT01891864|2728979|P2|Treatment Period 2|Site Termination|0
830842|NCT01891864|2728980|P1|Treatment Period 2|Site Termination|0
830843|NCT01891864|2728975|P6|Treatment Period 2|Physician Decision|0
830844|NCT01891864|2728976|P5|Treatment Period 2|Physician Decision|0
830845|NCT01891864|2728977|P4|Treatment Period 2|Physician Decision|0
830846|NCT01891864|2728978|P3|Treatment Period 2|Physician Decision|1
830847|NCT01891864|2728979|P2|Treatment Period 2|Physician Decision|0
830848|NCT01891864|2728980|P1|Treatment Period 2|Physician Decision|0
830849|NCT01891864|2728975|P6|Treatment Period 2|Protocol Violation|0
830850|NCT01891864|2728976|P5|Treatment Period 2|Protocol Violation|0
830851|NCT01891864|2728977|P4|Treatment Period 2|Protocol Violation|1
830852|NCT01891864|2728978|P3|Treatment Period 2|Protocol Violation|0
830853|NCT01891864|2728979|P2|Treatment Period 2|Protocol Violation|0
830854|NCT01891864|2728980|P1|Treatment Period 2|Protocol Violation|0
830855|NCT01891864|2728975|P6|Treatment Period 1|Lost to Follow-up|0
830856|NCT01891864|2728976|P5|Treatment Period 1|Lost to Follow-up|0
830857|NCT01891864|2728977|P4|Treatment Period 1|Lost to Follow-up|0
830858|NCT01891864|2728978|P3|Treatment Period 1|Lost to Follow-up|0
830859|NCT01891864|2728979|P2|Treatment Period 1|Lost to Follow-up|0
830860|NCT01891864|2728980|P1|Treatment Period 1|Lost to Follow-up|1
830861|NCT01891864|2728975|P6|Treatment Period 1|Withdrawal by Subject|0
830862|NCT01891864|2728976|P5|Treatment Period 1|Withdrawal by Subject|0
830863|NCT01891864|2728977|P4|Treatment Period 1|Withdrawal by Subject|0
830864|NCT01891864|2728978|P3|Treatment Period 1|Withdrawal by Subject|0
830865|NCT01891864|2728979|P2|Treatment Period 1|Withdrawal by Subject|5
830866|NCT01891864|2728980|P1|Treatment Period 1|Withdrawal by Subject|2
830867|NCT01891864|2728975|P6|Treatment Period 1|Adverse Event / Injection Site Reaction|0
830868|NCT01891864|2728976|P5|Treatment Period 1|Adverse Event / Injection Site Reaction|0
830869|NCT01891864|2728977|P4|Treatment Period 1|Adverse Event / Injection Site Reaction|0
830870|NCT01891864|2728978|P3|Treatment Period 1|Adverse Event / Injection Site Reaction|0
830871|NCT01891864|2728979|P2|Treatment Period 1|Adverse Event / Injection Site Reaction|4
830872|NCT01891864|2728980|P1|Treatment Period 1|Adverse Event / Injection Site Reaction|4
830873|NCT01891864|2728975|P6|Treatment Period 1|Adverse Event, Serious, Fatal|0
830874|NCT01891864|2728976|P5|Treatment Period 1|Adverse Event, Serious, Fatal|0
830875|NCT01891864|2728977|P4|Treatment Period 1|Adverse Event, Serious, Fatal|0
830876|NCT01891864|2728978|P3|Treatment Period 1|Adverse Event, Serious, Fatal|0
830877|NCT01891864|2728979|P2|Treatment Period 1|Adverse Event, Serious, Fatal|1
830878|NCT01891864|2728980|P1|Treatment Period 1|Adverse Event, Serious, Fatal|0
830879|NCT01891864|2728975|P6|Treatment Period 1|Physician Decision|0
830880|NCT01891864|2728976|P5|Treatment Period 1|Physician Decision|0
830881|NCT01891864|2728977|P4|Treatment Period 1|Physician Decision|0
830882|NCT01891864|2728978|P3|Treatment Period 1|Physician Decision|0
830883|NCT01891864|2728979|P2|Treatment Period 1|Physician Decision|1
830884|NCT01891864|2728980|P1|Treatment Period 1|Physician Decision|0
830885|NCT01891864|2728975|P6|Treatment Period 1|Protocol Violation / IMP non-compliance|0
830886|NCT01891864|2728976|P5|Treatment Period 1|Protocol Violation / IMP non-compliance|0
830887|NCT01891864|2728977|P4|Treatment Period 1|Protocol Violation / IMP non-compliance|0
830888|NCT01891864|2728978|P3|Treatment Period 1|Protocol Violation / IMP non-compliance|0
830889|NCT01891864|2728979|P2|Treatment Period 1|Protocol Violation / IMP non-compliance|1
830890|NCT01891864|2728980|P1|Treatment Period 1|Protocol Violation / IMP non-compliance|1
830891|NCT01891669|2729023|P10|Overall Study|Other|0
830892|NCT01891669|2729024|P9|Overall Study|Other|0
830893|NCT01891669|2729025|P8|Overall Study|Other|1
830894|NCT01891669|2729026|P7|Overall Study|Other|0
830895|NCT01891669|2729027|P6|Overall Study|Other|0
830896|NCT01891669|2729028|P5|Overall Study|Other|0
830897|NCT01891669|2729029|P4|Overall Study|Other|0
830898|NCT01891669|2729030|P3|Overall Study|Other|0
830899|NCT01891669|2729031|P2|Overall Study|Other|0
830900|NCT01891669|2729032|P1|Overall Study|Other|1
830901|NCT01891669|2729023|P10|Overall Study|Withdrawal by Subject|1
830902|NCT01891669|2729024|P9|Overall Study|Withdrawal by Subject|1
830903|NCT01891669|2729025|P8|Overall Study|Withdrawal by Subject|2
830904|NCT01891669|2729026|P7|Overall Study|Withdrawal by Subject|1
830905|NCT01891669|2729027|P6|Overall Study|Withdrawal by Subject|0
830906|NCT01891669|2729028|P5|Overall Study|Withdrawal by Subject|0
830907|NCT01891669|2729029|P4|Overall Study|Withdrawal by Subject|0
830908|NCT01891669|2729030|P3|Overall Study|Withdrawal by Subject|0
830909|NCT01891669|2729031|P2|Overall Study|Withdrawal by Subject|1
830910|NCT01891669|2729032|P1|Overall Study|Withdrawal by Subject|1
830911|NCT01891669|2729023|P10|Overall Study|Death|1
830912|NCT01891669|2729024|P9|Overall Study|Death|0
830913|NCT01891669|2729025|P8|Overall Study|Death|1
830914|NCT01891669|2729026|P7|Overall Study|Death|0
830915|NCT01891669|2729027|P6|Overall Study|Death|0
830916|NCT01891669|2729028|P5|Overall Study|Death|0
830917|NCT01891669|2729029|P4|Overall Study|Death|0
830918|NCT01891669|2729030|P3|Overall Study|Death|0
830919|NCT01891669|2729031|P2|Overall Study|Death|0
830920|NCT01891669|2729032|P1|Overall Study|Death|0
830921|NCT01890967|2729223|P6|Overall Study|Withdrawal by Subject|1
830922|NCT01890967|2729224|P5|Overall Study|Withdrawal by Subject|3
830923|NCT01890967|2729225|P4|Overall Study|Withdrawal by Subject|3
830924|NCT01890967|2729226|P3|Overall Study|Withdrawal by Subject|2
830925|NCT01890967|2729227|P2|Overall Study|Withdrawal by Subject|4
830926|NCT01890967|2729228|P1|Overall Study|Withdrawal by Subject|3
830927|NCT01890967|2729223|P6|Overall Study|Sponsor Decision|3
830928|NCT01890967|2729224|P5|Overall Study|Sponsor Decision|2
830929|NCT01890967|2729225|P4|Overall Study|Sponsor Decision|3
830930|NCT01890967|2729226|P3|Overall Study|Sponsor Decision|1
830931|NCT01890967|2729227|P2|Overall Study|Sponsor Decision|0
830932|NCT01890967|2729228|P1|Overall Study|Sponsor Decision|2
830933|NCT01890967|2729223|P6|Overall Study|Protocol Violation|1
830934|NCT01890967|2729224|P5|Overall Study|Protocol Violation|4
830935|NCT01890967|2729225|P4|Overall Study|Protocol Violation|2
830936|NCT01890967|2729226|P3|Overall Study|Protocol Violation|3
830937|NCT01890967|2729227|P2|Overall Study|Protocol Violation|3
830938|NCT01890967|2729228|P1|Overall Study|Protocol Violation|0
830939|NCT01890967|2729223|P6|Overall Study|Lost to Follow-up|1
830940|NCT01890967|2729224|P5|Overall Study|Lost to Follow-up|0
830941|NCT01890967|2729225|P4|Overall Study|Lost to Follow-up|1
830942|NCT01890967|2729226|P3|Overall Study|Lost to Follow-up|1
830943|NCT01890967|2729227|P2|Overall Study|Lost to Follow-up|1
830944|NCT01890967|2729228|P1|Overall Study|Lost to Follow-up|1
830945|NCT01890967|2729223|P6|Overall Study|Death|0
830946|NCT01890967|2729224|P5|Overall Study|Death|0
830947|NCT01890967|2729225|P4|Overall Study|Death|0
830948|NCT01890967|2729226|P3|Overall Study|Death|0
830949|NCT01890967|2729227|P2|Overall Study|Death|0
830950|NCT01890967|2729228|P1|Overall Study|Death|1
830951|NCT01890967|2729223|P6|Overall Study|Adverse Event|7
830952|NCT01890967|2729224|P5|Overall Study|Adverse Event|1
830953|NCT01890967|2729225|P4|Overall Study|Adverse Event|2
830954|NCT01890967|2729226|P3|Overall Study|Adverse Event|3
830955|NCT01890967|2729227|P2|Overall Study|Adverse Event|3
830956|NCT01890967|2729228|P1|Overall Study|Adverse Event|3
830957|NCT01890915|2729306|P2|Overall Study|Equipment Malfunction|1
830958|NCT01890915|2729307|P1|Overall Study|Equipment Malfunction|0
830959|NCT01890915|2729306|P2|Overall Study|Protocol Violation|0
830960|NCT01890915|2729307|P1|Overall Study|Protocol Violation|2
830961|NCT01890915|2729306|P2|Overall Study|Adverse Event|0
830962|NCT01890915|2729307|P1|Overall Study|Adverse Event|1
830963|NCT01890785|2729323|P6|Third Intervention|Withdrawal by Subject|0
830964|NCT01890785|2729324|P5|Third Intervention|Withdrawal by Subject|0
830965|NCT01890785|2729325|P4|Third Intervention|Withdrawal by Subject|0
830966|NCT01890785|2729326|P3|Third Intervention|Withdrawal by Subject|0
830967|NCT01890785|2729327|P2|Third Intervention|Withdrawal by Subject|1
830968|NCT01890785|2729328|P1|Third Intervention|Withdrawal by Subject|0
830969|NCT01890759|2729347|P2|Overall Study|Withdrawal by Subject|8
830970|NCT01890759|2729348|P1|Overall Study|Withdrawal by Subject|2
830971|NCT01890759|2729347|P2|Overall Study|Lost to Follow-up|2
830972|NCT01890759|2729348|P1|Overall Study|Lost to Follow-up|0
830973|NCT01890759|2729347|P2|Overall Study|Protocol Violation|2
830974|NCT01890759|2729348|P1|Overall Study|Protocol Violation|0
830975|NCT01890746|2729382|P2|Overall Study|Ongoing|50
830976|NCT01890746|2729383|P1|Overall Study|Ongoing|44
830977|NCT01890746|2729382|P2|Overall Study|Death|14
830978|NCT01890746|2729383|P1|Overall Study|Death|23
830979|NCT01890746|2729382|P2|Overall Study|Withdrawal by Subject|8
830980|NCT01890746|2729383|P1|Overall Study|Withdrawal by Subject|4
830981|NCT01890746|2729382|P2|Overall Study|Physician Decision|2
830982|NCT01890746|2729383|P1|Overall Study|Physician Decision|2
830983|NCT01890746|2729382|P2|Overall Study|Adverse Event|0
830984|NCT01890746|2729383|P1|Overall Study|Adverse Event|1
830985|NCT01890512|2729480|P1|Overall Study|Protocol Violation|1
830986|NCT01890512|2729480|P1|Overall Study|Withdrawal by Subject|1
830987|NCT01890512|2729480|P1|Overall Study|Physician Decision|1
830988|NCT01890473|2729486|P2|Overall Study|Poor/non-compliance|0
830989|NCT01890473|2729487|P1|Overall Study|Poor/non-compliance|1
830990|NCT01890473|2729486|P2|Overall Study|Lost to Follow-up|0
830991|NCT01890473|2729487|P1|Overall Study|Lost to Follow-up|1
830992|NCT01890434|2729513|P1|Overall Study|Withdrawal by PI for ICA not performed|2
830993|NCT01890434|2729513|P1|Overall Study|Unable to contact|1
830994|NCT01890434|2729513|P1|Overall Study|Moved out of position|1
830995|NCT01890434|2729513|P1|Overall Study|Uncontactable by phone|1
830996|NCT01890434|2729513|P1|Overall Study|Participant didn't complete MRI|1
830997|NCT01890434|2729513|P1|Overall Study|GSPECT at rest was not done|1
830998|NCT01890434|2729513|P1|Overall Study|Decline to return for GSPECT|1
830999|NCT01890434|2729513|P1|Overall Study|Could not get whole set of images|1
831000|NCT01890434|2729513|P1|Overall Study|CRC didn't contact participant for FU|1
831001|NCT01890434|2729513|P1|Overall Study|Assessment discrepancy|1
831002|NCT01890434|2729513|P1|Overall Study|PCI at external hospital|1
831003|NCT01890434|2729513|P1|Overall Study|Adverse Event|8
831004|NCT01890421|2729543|P1|Overall Study|Other reason|10
831005|NCT01890421|2729543|P1|Overall Study|Adverse Event|1
831006|NCT01890148|2729582|P1|Overall Study|Adverse Event|1
831007|NCT01890122|2729602|P4|Overall Study|Randomized but not Treated|0
831008|NCT01890122|2729603|P3|Overall Study|Randomized but not Treated|0
831009|NCT01890122|2729604|P2|Overall Study|Randomized but not Treated|1
831010|NCT01890122|2729605|P1|Overall Study|Randomized but not Treated|1
831011|NCT01890122|2729602|P4|Overall Study|Reason not Specified|2
831012|NCT01890122|2729603|P3|Overall Study|Reason not Specified|1
831013|NCT01890122|2729604|P2|Overall Study|Reason not Specified|1
831014|NCT01890122|2729605|P1|Overall Study|Reason not Specified|0
831015|NCT01890122|2729602|P4|Overall Study|Lack of Efficacy|41
831016|NCT01890122|2729603|P3|Overall Study|Lack of Efficacy|7
831017|NCT01890122|2729604|P2|Overall Study|Lack of Efficacy|24
831018|NCT01890122|2729605|P1|Overall Study|Lack of Efficacy|14
831019|NCT01890122|2729602|P4|Overall Study|Voluntary Withdrawal|11
831020|NCT01890122|2729603|P3|Overall Study|Voluntary Withdrawal|2
831021|NCT01890122|2729604|P2|Overall Study|Voluntary Withdrawal|8
831022|NCT01890122|2729605|P1|Overall Study|Voluntary Withdrawal|8
831023|NCT01890122|2729602|P4|Overall Study|Lost to Follow-up|2
831024|NCT01890122|2729603|P3|Overall Study|Lost to Follow-up|2
831025|NCT01890122|2729604|P2|Overall Study|Lost to Follow-up|1
831026|NCT01890122|2729605|P1|Overall Study|Lost to Follow-up|0
831027|NCT01890122|2729602|P4|Overall Study|Major Protocol Deviation|1
831028|NCT01890122|2729603|P3|Overall Study|Major Protocol Deviation|0
831029|NCT01890122|2729604|P2|Overall Study|Major Protocol Deviation|1
831030|NCT01890122|2729605|P1|Overall Study|Major Protocol Deviation|3
831031|NCT01890122|2729602|P4|Overall Study|Adverse Event|2
831032|NCT01890122|2729603|P3|Overall Study|Adverse Event|1
831033|NCT01890122|2729604|P2|Overall Study|Adverse Event|1
831034|NCT01890122|2729605|P1|Overall Study|Adverse Event|1
831035|NCT01889251|2729756|P2|Overall Study|Adverse Event|0
831036|NCT01889251|2729757|P1|Overall Study|Adverse Event|1
831037|NCT01889238|2729763|P1|Overall Study|Treatment ongoing|9
831038|NCT01888965|2729780|P1|Overall Study|Lack of Efficacy|4
831039|NCT01888965|2729780|P1|Overall Study|Adverse Event|5
831040|NCT01888900|2729792|P2|Overall Study|failed treatment|2
831041|NCT01888900|2729793|P1|Overall Study|failed treatment|0
831042|NCT01888432|2729815|P2|24-month Analysis (FAS)|Death|4
831043|NCT01888432|2729816|P1|24-month Analysis (FAS)|Death|8
831044|NCT01888432|2729815|P2|24-month Analysis (FAS)|Withdrawal by Subject|6
831045|NCT01888432|2729816|P1|24-month Analysis (FAS)|Withdrawal by Subject|7
831046|NCT01888432|2729815|P2|24-month Analysis (FAS)|Physician Decision|4
831047|NCT01888432|2729816|P1|24-month Analysis (FAS)|Physician Decision|2
831048|NCT01888432|2729815|P2|24-month Analysis (FAS)|Lost to Follow-up|2
831049|NCT01888432|2729816|P1|24-month Analysis (FAS)|Lost to Follow-up|0
831050|NCT01888432|2729815|P2|24-month Analysis (FAS)|Graft loss|1
831051|NCT01888432|2729816|P1|24-month Analysis (FAS)|Graft loss|0
831052|NCT01888432|2729815|P2|12-month Analysis (FAS)|Death|3
831053|NCT01888432|2729816|P1|12-month Analysis (FAS)|Death|4
831054|NCT01888432|2729815|P2|12-month Analysis (FAS)|Withdrawal by Subject|3
831055|NCT01888432|2729816|P1|12-month Analysis (FAS)|Withdrawal by Subject|6
831056|NCT01888432|2729815|P2|12-month Analysis (FAS)|Physician Decision|1
831057|NCT01888432|2729816|P1|12-month Analysis (FAS)|Physician Decision|1
831058|NCT01888432|2729815|P2|12-month Analysis (FAS)|Lost to Follow-up|2
831059|NCT01888432|2729816|P1|12-month Analysis (FAS)|Lost to Follow-up|0
831060|NCT01888367|2729851|P3|Overall Study|30-Day Visit Too Early (< 28 Days)|0
831061|NCT01888367|2729852|P2|Overall Study|30-Day Visit Too Early (< 28 Days)|0
831062|NCT01888367|2729853|P1|Overall Study|30-Day Visit Too Early (< 28 Days)|1
831063|NCT01888367|2729851|P3|Overall Study|Protocol Violation|1
831064|NCT01888367|2729852|P2|Overall Study|Protocol Violation|0
831065|NCT01888367|2729853|P1|Overall Study|Protocol Violation|0
831066|NCT01888367|2729851|P3|Overall Study|Lost to Follow-up|0
831067|NCT01888367|2729852|P2|Overall Study|Lost to Follow-up|1
831068|NCT01888367|2729853|P1|Overall Study|Lost to Follow-up|1
831069|NCT01888367|2729851|P3|Overall Study|Withdrawal by Subject|1
831070|NCT01888367|2729852|P2|Overall Study|Withdrawal by Subject|0
831071|NCT01888367|2729853|P1|Overall Study|Withdrawal by Subject|1
831072|NCT01888367|2729851|P3|Overall Study|Death|1
831073|NCT01888367|2729852|P2|Overall Study|Death|0
831074|NCT01888367|2729853|P1|Overall Study|Death|2
831075|NCT01888367|2729851|P3|Overall Study|Physician Decision|2
831076|NCT01888367|2729852|P2|Overall Study|Physician Decision|4
831077|NCT01888367|2729853|P1|Overall Study|Physician Decision|3
831078|NCT01888003|2729873|P3|Overall Study|Study Terminated|40
831079|NCT01888003|2729874|P2|Overall Study|Study Terminated|6
831080|NCT01888003|2729875|P1|Overall Study|Study Terminated|5
831081|NCT01887678|2729915|P2|Overall Study|Specified|2
831082|NCT01887678|2729916|P1|Overall Study|Specified|1
831083|NCT01887678|2729915|P2|Overall Study|Non-compliance|3
831084|NCT01887678|2729916|P1|Overall Study|Non-compliance|0
831085|NCT01887678|2729915|P2|Overall Study|Lack of Efficacy|2
831086|NCT01887678|2729916|P1|Overall Study|Lack of Efficacy|1
831087|NCT01887678|2729915|P2|Overall Study|Deterioration of clinical condition|4
831088|NCT01887678|2729916|P1|Overall Study|Deterioration of clinical condition|0
831089|NCT01887678|2729915|P2|Overall Study|Lost to Follow-up|2
831090|NCT01887678|2729916|P1|Overall Study|Lost to Follow-up|4
831091|NCT01887678|2729915|P2|Overall Study|Withdrawal of consent|4
831092|NCT01887678|2729916|P1|Overall Study|Withdrawal of consent|3
831093|NCT01887678|2729915|P2|Overall Study|Exceeded rescue medication dosage|5
831094|NCT01887678|2729916|P1|Overall Study|Exceeded rescue medication dosage|4
831095|NCT01887678|2729915|P2|Overall Study|Adverse Event|6
831096|NCT01887678|2729916|P1|Overall Study|Adverse Event|4
831097|NCT01887418|2729984|P3|Overall Study|Travelling difficulties|1
831098|NCT01887418|2729985|P2|Overall Study|Travelling difficulties|0
831099|NCT01887418|2729986|P1|Overall Study|Travelling difficulties|0
831100|NCT01887353|2730005|P2|Overall Study|Study stopped early|3
831101|NCT01887353|2730006|P1|Overall Study|Study stopped early|4
831102|NCT01887288|2730012|P1|Overall Study|The study was terminated and the PI has|16
831103|NCT01887210|2730019|P2|Overall Study|Lost to Follow-up|1
831104|NCT01887210|2730020|P1|Overall Study|Lost to Follow-up|0
831105|NCT01887210|2730019|P2|Overall Study|Withdrawal by Subject|3
831106|NCT01887210|2730020|P1|Overall Study|Withdrawal by Subject|1
831107|NCT01886833|2730064|P1|Overall Study|IgA not available from both periods|204
831108|NCT01886781|2730087|P2|Overall Study|Worsening of symptoms|1
831109|NCT01886781|2730088|P1|Overall Study|Worsening of symptoms|1
831110|NCT01886781|2730087|P2|Overall Study|Withdrawal by Subject|1
831111|NCT01886781|2730088|P1|Overall Study|Withdrawal by Subject|2
831112|NCT01886781|2730087|P2|Overall Study|Lost to Follow-up|0
831113|NCT01886781|2730088|P1|Overall Study|Lost to Follow-up|5
831114|NCT01886781|2730087|P2|Overall Study|Adverse Event|0
831115|NCT01886781|2730088|P1|Overall Study|Adverse Event|1
831116|NCT01886781|2730087|P2|Overall Study|Protocol Violation|0
831117|NCT01886781|2730088|P1|Overall Study|Protocol Violation|5
831118|NCT01886716|2730098|P4|Week 3|Lost to Follow-up|1
831119|NCT01886716|2730099|P3|Week 3|Lost to Follow-up|0
831120|NCT01886716|2730100|P2|Week 3|Lost to Follow-up|1
831121|NCT01886716|2730101|P1|Week 3|Lost to Follow-up|1
831122|NCT01886716|2730098|P4|Week 2|Lost to Follow-up|3
831123|NCT01886716|2730099|P3|Week 2|Lost to Follow-up|1
831124|NCT01886716|2730100|P2|Week 2|Lost to Follow-up|2
831125|NCT01886716|2730101|P1|Week 2|Lost to Follow-up|3
831126|NCT01886716|2730098|P4|Week 1|Lost to Follow-up|2
831127|NCT01886716|2730099|P3|Week 1|Lost to Follow-up|2
831128|NCT01886716|2730100|P2|Week 1|Lost to Follow-up|0
831129|NCT01886716|2730101|P1|Week 1|Lost to Follow-up|0
831130|NCT01886690|2730117|P2|Overall Study|Personal Reasons|1
831131|NCT01886690|2730118|P1|Overall Study|Personal Reasons|0
831132|NCT01886690|2730117|P2|Overall Study|Protocol Violation|1
831133|NCT01886690|2730118|P1|Overall Study|Protocol Violation|0
831134|NCT01886313|2730134|P2|Overall Study|Adverse Event|1
831135|NCT01886313|2730135|P1|Overall Study|Adverse Event|1
831136|NCT01886300|2730141|P1|Overall Study|Trial terminated by sponsor|16
831137|NCT01886287|2730152|P1|Overall Study|Clinical progression due to disease|1
831138|NCT01886287|2730152|P1|Overall Study|Radiographic disease progression|1
831139|NCT01885936|2730170|P2|Overall Study|Withdrawal by Subject|0
831140|NCT01885936|2730171|P1|Overall Study|Withdrawal by Subject|1
831141|NCT01885559|2730205|P2|Overall Study|Protocol Violation|1
831142|NCT01885559|2730206|P1|Overall Study|Protocol Violation|0
831143|NCT01885559|2730205|P2|Overall Study|Less than full participation|19
831144|NCT01885559|2730206|P1|Overall Study|Less than full participation|9
831145|NCT01885559|2730205|P2|Overall Study|Lost to Follow-up|16
831146|NCT01885559|2730206|P1|Overall Study|Lost to Follow-up|15
831147|NCT01885208|2730228|P2|Overall Study|Unclassified|38
831148|NCT01885208|2730229|P1|Overall Study|Unclassified|32
831149|NCT01885104|2730270|P2|Overall Study|Physician Decision|0
831150|NCT01885104|2730271|P1|Overall Study|Physician Decision|1
831151|NCT01885104|2730270|P2|Overall Study|Lost to Follow-up|1
831152|NCT01885104|2730271|P1|Overall Study|Lost to Follow-up|0
831153|NCT01885104|2730270|P2|Overall Study|Withdrawal of Consent|0
831154|NCT01885104|2730271|P1|Overall Study|Withdrawal of Consent|1
831155|NCT01885000|2730281|P2|Overall Study|Protocol Violation|1
831156|NCT01885000|2730282|P1|Overall Study|Protocol Violation|0
831157|NCT01885000|2730281|P2|Overall Study|Withdrawal by Subject|1
831158|NCT01885000|2730282|P1|Overall Study|Withdrawal by Subject|1
831159|NCT01885000|2730281|P2|Overall Study|Adverse Event|0
831160|NCT01885000|2730282|P1|Overall Study|Adverse Event|1
831161|NCT01884688|2730303|P1|Overall Study|Screen Failure|2
831162|NCT01884675|2730309|P2|Overall Study|Study closed/terminated|2
831163|NCT01884675|2730310|P1|Overall Study|Study closed/terminated|3
831164|NCT01884597|2730353|P3|Overall Study|Death|0
831165|NCT01884597|2730354|P2|Overall Study|Death|1
831166|NCT01884597|2730355|P1|Overall Study|Death|0
831167|NCT01884597|2730353|P3|Overall Study|Lack of Efficacy|0
831168|NCT01884597|2730354|P2|Overall Study|Lack of Efficacy|0
831169|NCT01884597|2730355|P1|Overall Study|Lack of Efficacy|1
831170|NCT01884597|2730353|P3|Overall Study|Adverse Event|1
831171|NCT01884597|2730354|P2|Overall Study|Adverse Event|0
831172|NCT01884597|2730355|P1|Overall Study|Adverse Event|0
831173|NCT01884571|2730384|P1|Overall Study|Disease progression|3
831174|NCT01884571|2730384|P1|Overall Study|Withdrawal by Subject|2
831175|NCT01884571|2730384|P1|Overall Study|Death|2
831176|NCT01884571|2730384|P1|Overall Study|Adverse Event|1
831177|NCT01884545|2730399|P4|Overall Study|Non-adherence|0
831178|NCT01884545|2730400|P3|Overall Study|Non-adherence|0
831179|NCT01884545|2730401|P2|Overall Study|Non-adherence|2
831180|NCT01884545|2730402|P1|Overall Study|Non-adherence|0
831181|NCT01884545|2730399|P4|Overall Study|Patient withdrawn|5
831182|NCT01884545|2730400|P3|Overall Study|Patient withdrawn|5
831183|NCT01884545|2730401|P2|Overall Study|Patient withdrawn|12
831184|NCT01884545|2730402|P1|Overall Study|Patient withdrawn|7
831185|NCT01884545|2730399|P4|Overall Study|Lost to Follow-up|4
831186|NCT01884545|2730400|P3|Overall Study|Lost to Follow-up|9
831187|NCT01884545|2730401|P2|Overall Study|Lost to Follow-up|4
831188|NCT01884545|2730402|P1|Overall Study|Lost to Follow-up|6
831189|NCT01884311|2730553|P1|Overall Study|Precautionary measure|1
831190|NCT01884311|2730553|P1|Overall Study|withdrew consent due to AEs|1
831191|NCT01884311|2730553|P1|Overall Study|Withdrawal by Subject|3
831192|NCT01884025|2730572|P2|Overall Study|Lost to Follow-up|4
831193|NCT01884025|2730573|P1|Overall Study|Lost to Follow-up|3
831194|NCT01883895|2730633|P1|Overall Study|Lost to Follow-up|2
831195|NCT01883635|2730647|P2|Overall Study|Withdrawal by Subject|0
831196|NCT01883635|2730648|P1|Overall Study|Withdrawal by Subject|4
831197|NCT01883453|2730662|P2|Overall Study|No episode of common cold|23
831198|NCT01883453|2730663|P1|Overall Study|No episode of common cold|25
831199|NCT01882985|2730689|P1|Overall Study|Withdrawal by Subject|1
831200|NCT01882985|2730689|P1|Overall Study|Lost to Follow-up|1
831201|NCT01882907|2730698|P2|Overall Study|Withdrawal by Subject|6
831202|NCT01882907|2730699|P1|Overall Study|Withdrawal by Subject|0
831203|NCT01882907|2730698|P2|Overall Study|Protocol Violation|14
831204|NCT01882907|2730699|P1|Overall Study|Protocol Violation|10
831205|NCT01882907|2730698|P2|Overall Study|Lost to Follow-up|4
831206|NCT01882907|2730699|P1|Overall Study|Lost to Follow-up|1
831207|NCT01882907|2730698|P2|Overall Study|Lack of Efficacy|3
831208|NCT01882907|2730699|P1|Overall Study|Lack of Efficacy|0
831209|NCT01882907|2730698|P2|Overall Study|Adverse Event|1
831210|NCT01882907|2730699|P1|Overall Study|Adverse Event|3
831211|NCT01882829|2730735|P1|Overall Study|Withdrawal by Subject|1
831212|NCT01882829|2730735|P1|Overall Study|Protocol Violation|1
831213|NCT01882829|2730735|P1|Overall Study|Adverse Event|4
831214|NCT01882803|2730749|P1|Overall Study|Withdrawal by Subject|4
831215|NCT01882803|2730749|P1|Overall Study|Protocol Violation|1
831216|NCT01882803|2730749|P1|Overall Study|Physician Decision|7
831217|NCT01882803|2730749|P1|Overall Study|Death|7
831218|NCT01882803|2730749|P1|Overall Study|Adverse Event|22
831219|NCT01882803|2730749|P1|Overall Study|Disease Progression|53
831220|NCT01882647|2730767|P2|Overall Study|Withdrawal by Subject|4
831221|NCT01882647|2730768|P1|Overall Study|Withdrawal by Subject|0
831222|NCT01882647|2730767|P2|Overall Study|Lost to Follow-up|2
831223|NCT01882647|2730768|P1|Overall Study|Lost to Follow-up|2
831224|NCT01882465|2730808|P7|Period 2|Protocol Violation|0
831225|NCT01882465|2730809|P6|Period 2|Protocol Violation|0
831226|NCT01882465|2730810|P5|Period 2|Protocol Violation|1
831227|NCT01882465|2730811|P4|Period 2|Protocol Violation|0
831228|NCT01882465|2730812|P3|Period 2|Protocol Violation|0
831229|NCT01882465|2730813|P2|Period 2|Protocol Violation|0
831230|NCT01882465|2730814|P1|Period 2|Protocol Violation|0
831231|NCT01882465|2730808|P7|Period 1|Withdrawal by Subject|1
831232|NCT01882465|2730809|P6|Period 1|Withdrawal by Subject|0
831233|NCT01882465|2730810|P5|Period 1|Withdrawal by Subject|0
831234|NCT01882465|2730811|P4|Period 1|Withdrawal by Subject|0
831235|NCT01882465|2730812|P3|Period 1|Withdrawal by Subject|0
831236|NCT01882465|2730813|P2|Period 1|Withdrawal by Subject|0
831237|NCT01882465|2730814|P1|Period 1|Withdrawal by Subject|0
831238|NCT01882465|2730808|P7|Period 1|Lens Discomfort|0
831239|NCT01882465|2730809|P6|Period 1|Lens Discomfort|0
831240|NCT01882465|2730810|P5|Period 1|Lens Discomfort|0
831241|NCT01882465|2730811|P4|Period 1|Lens Discomfort|1
831242|NCT01882465|2730812|P3|Period 1|Lens Discomfort|0
831243|NCT01882465|2730813|P2|Period 1|Lens Discomfort|0
831244|NCT01882465|2730814|P1|Period 1|Lens Discomfort|0
831245|NCT01882439|2730826|P4|Overall Study|Adverse event unrelated to study drug|1
831246|NCT01882439|2730827|P3|Overall Study|Adverse event unrelated to study drug|1
831247|NCT01882439|2730828|P2|Overall Study|Adverse event unrelated to study drug|2
831248|NCT01882439|2730829|P1|Overall Study|Adverse event unrelated to study drug|2
831249|NCT01882439|2730826|P4|Overall Study|Insufficient clinical response|2
831250|NCT01882439|2730827|P3|Overall Study|Insufficient clinical response|4
831251|NCT01882439|2730828|P2|Overall Study|Insufficient clinical response|4
831252|NCT01882439|2730829|P1|Overall Study|Insufficient clinical response|1
831253|NCT01882439|2730826|P4|Overall Study|Medication error with no associated AE|0
831254|NCT01882439|2730827|P3|Overall Study|Medication error with no associated AE|2
831255|NCT01882439|2730828|P2|Overall Study|Medication error with no associated AE|0
831256|NCT01882439|2730829|P1|Overall Study|Medication error with no associated AE|0
831257|NCT01882439|2730826|P4|Overall Study|No longer willing to participate|3
831258|NCT01882439|2730827|P3|Overall Study|No longer willing to participate|2
831259|NCT01882439|2730828|P2|Overall Study|No longer willing to participate|4
831260|NCT01882439|2730829|P1|Overall Study|No longer willing to participate|1
831261|NCT01882439|2730826|P4|Overall Study|Protocol Violation|1
831262|NCT01882439|2730827|P3|Overall Study|Protocol Violation|0
831263|NCT01882439|2730828|P2|Overall Study|Protocol Violation|2
831264|NCT01882439|2730829|P1|Overall Study|Protocol Violation|2
831265|NCT01882439|2730826|P4|Overall Study|Pregnancy|0
831266|NCT01882439|2730827|P3|Overall Study|Pregnancy|0
831267|NCT01882439|2730828|P2|Overall Study|Pregnancy|1
831268|NCT01882439|2730829|P1|Overall Study|Pregnancy|0
831269|NCT01882439|2730826|P4|Overall Study|Adverse event related to study drug|2
831270|NCT01882439|2730827|P3|Overall Study|Adverse event related to study drug|1
831271|NCT01882439|2730828|P2|Overall Study|Adverse event related to study drug|8
831272|NCT01882439|2730829|P1|Overall Study|Adverse event related to study drug|3
831273|NCT01882257|2731026|P3|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4
831274|NCT01882257|2731027|P2|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11
831275|NCT01882257|2731028|P1|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0
831276|NCT01882257|2731026|P3|Study Origination to Beginning Therapy|Withdrawal by Subject|1
831277|NCT01882257|2731027|P2|Study Origination to Beginning Therapy|Withdrawal by Subject|2
831278|NCT01882257|2731028|P1|Study Origination to Beginning Therapy|Withdrawal by Subject|0
831279|NCT01881776|2731060|P3|Overall Study|Protocol Violation|1
831280|NCT01881776|2731061|P2|Overall Study|Protocol Violation|2
831281|NCT01881776|2731062|P1|Overall Study|Protocol Violation|0
831282|NCT01881776|2731060|P3|Overall Study|Lost to Follow-up|1
831283|NCT01881776|2731061|P2|Overall Study|Lost to Follow-up|2
831284|NCT01881776|2731062|P1|Overall Study|Lost to Follow-up|1
831285|NCT01881737|2731088|P1|Overall Study|Worsening of baseline behavior|1
831286|NCT01881737|2731088|P1|Overall Study|Withdrawal by Subject|1
831287|NCT01881737|2731088|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
831288|NCT01881230|2731100|P3|Overall Study|Untreated: Withdrawal Before Study Start|0
831289|NCT01881230|2731101|P2|Overall Study|Untreated: Withdrawal Before Study Start|0
831290|NCT01881230|2731102|P1|Overall Study|Untreated: Withdrawal Before Study Start|1
831291|NCT01881230|2731100|P3|Overall Study|Untreated: Death|1
831292|NCT01881230|2731101|P2|Overall Study|Untreated: Death|0
831293|NCT01881230|2731102|P1|Overall Study|Untreated: Death|0
831294|NCT01881230|2731100|P3|Overall Study|Untreated: Other|1
831295|NCT01881230|2731101|P2|Overall Study|Untreated: Other|0
831296|NCT01881230|2731102|P1|Overall Study|Untreated: Other|0
831297|NCT01881230|2731100|P3|Overall Study|Miscellaneous|0
831298|NCT01881230|2731101|P2|Overall Study|Miscellaneous|3
831299|NCT01881230|2731102|P1|Overall Study|Miscellaneous|3
831300|NCT01881230|2731100|P3|Overall Study|Protocol Violation|0
831301|NCT01881230|2731101|P2|Overall Study|Protocol Violation|1
831302|NCT01881230|2731102|P1|Overall Study|Protocol Violation|1
831303|NCT01881230|2731100|P3|Overall Study|Given Commercially Available Drug|2
831304|NCT01881230|2731101|P2|Overall Study|Given Commercially Available Drug|0
831305|NCT01881230|2731102|P1|Overall Study|Given Commercially Available Drug|0
831306|NCT01881230|2731100|P3|Overall Study|Non-Compliance with Study Drug|0
831307|NCT01881230|2731101|P2|Overall Study|Non-Compliance with Study Drug|2
831308|NCT01881230|2731102|P1|Overall Study|Non-Compliance with Study Drug|1
831309|NCT01881230|2731100|P3|Overall Study|Physician Decision|6
831310|NCT01881230|2731101|P2|Overall Study|Physician Decision|3
831311|NCT01881230|2731102|P1|Overall Study|Physician Decision|4
831312|NCT01881230|2731100|P3|Overall Study|Withdrawal by Subject|6
831313|NCT01881230|2731101|P2|Overall Study|Withdrawal by Subject|4
831314|NCT01881230|2731102|P1|Overall Study|Withdrawal by Subject|6
831315|NCT01881230|2731100|P3|Overall Study|Symptomatic Deterioration|1
831316|NCT01881230|2731101|P2|Overall Study|Symptomatic Deterioration|3
831317|NCT01881230|2731102|P1|Overall Study|Symptomatic Deterioration|3
831318|NCT01881230|2731100|P3|Overall Study|Progressive Disease|36
831319|NCT01881230|2731101|P2|Overall Study|Progressive Disease|35
831320|NCT01881230|2731102|P1|Overall Study|Progressive Disease|31
831321|NCT01881230|2731100|P3|Overall Study|Adverse Event|12
831322|NCT01881230|2731101|P2|Overall Study|Adverse Event|13
831323|NCT01881230|2731102|P1|Overall Study|Adverse Event|9
831324|NCT01881230|2731100|P3|Overall Study|Death|1
831325|NCT01881230|2731101|P2|Overall Study|Death|0
831326|NCT01881230|2731102|P1|Overall Study|Death|2
831327|NCT01881126|2731130|P2|Overall Study|Adverse Event|1
831328|NCT01881126|2731131|P1|Overall Study|Adverse Event|0
831329|NCT01881126|2731130|P2|Overall Study|Non-compliance|1
831330|NCT01881126|2731131|P1|Overall Study|Non-compliance|1
831331|NCT01880736|2731223|P4|Overall Study|Withdrawal Criteria|5
831332|NCT01880736|2731224|P3|Overall Study|Withdrawal Criteria|1
831333|NCT01880736|2731225|P2|Overall Study|Withdrawal Criteria|2
831334|NCT01880736|2731226|P1|Overall Study|Withdrawal Criteria|1
831335|NCT01880736|2731223|P4|Overall Study|Adverse Event|1
831336|NCT01880736|2731224|P3|Overall Study|Adverse Event|0
831337|NCT01880736|2731225|P2|Overall Study|Adverse Event|0
831338|NCT01880736|2731226|P1|Overall Study|Adverse Event|0
831339|NCT01880593|2731310|P2|Overall Study|Withdrawal by Subject|1
831340|NCT01880593|2731311|P1|Overall Study|Withdrawal by Subject|6
831341|NCT01880593|2731310|P2|Overall Study|Lack of Efficacy|5
831342|NCT01880593|2731311|P1|Overall Study|Lack of Efficacy|1
831343|NCT01880593|2731310|P2|Overall Study|Adverse Event|0
831344|NCT01880593|2731311|P1|Overall Study|Adverse Event|1
831345|NCT01880515|2731331|P2|Overall Study|Disease Progression|7
831346|NCT01880515|2731332|P1|Overall Study|Disease Progression|5
831347|NCT01880515|2731331|P2|Overall Study|Lost to Follow-up|2
831348|NCT01880515|2731332|P1|Overall Study|Lost to Follow-up|3
831349|NCT01880437|2731343|P3|Overall Study|Study terminated by Sponsor|2
831350|NCT01880437|2731344|P2|Overall Study|Study terminated by Sponsor|0
831351|NCT01880437|2731345|P1|Overall Study|Study terminated by Sponsor|3
831352|NCT01880437|2731343|P3|Overall Study|Death|17
831353|NCT01880437|2731344|P2|Overall Study|Death|4
831354|NCT01880437|2731345|P1|Overall Study|Death|12
831355|NCT01880424|2731371|P2|Overall Study|Not specified|0
831356|NCT01880424|2731372|P1|Overall Study|Not specified|1
831357|NCT01880424|2731371|P2|Overall Study|Withdrawal by Subject|30
831358|NCT01880424|2731372|P1|Overall Study|Withdrawal by Subject|10
831359|NCT01880424|2731371|P2|Overall Study|Protocol Violation|13
831360|NCT01880424|2731372|P1|Overall Study|Protocol Violation|11
831361|NCT01880424|2731371|P2|Overall Study|Lost to Follow-up|2
831362|NCT01880424|2731372|P1|Overall Study|Lost to Follow-up|3
831363|NCT01880424|2731371|P2|Overall Study|Lack of Efficacy|4
831364|NCT01880424|2731372|P1|Overall Study|Lack of Efficacy|1
831365|NCT01880424|2731371|P2|Overall Study|Adverse Event|6
831366|NCT01880424|2731372|P1|Overall Study|Adverse Event|7
831367|NCT01880086|2731428|P2|Overall Study|Lost to Follow-up|1
831368|NCT01880086|2731429|P1|Overall Study|Lost to Follow-up|1
831369|NCT01879852|2731449|P2|Overall Study|Withdrawal by Subject|0
831370|NCT01879852|2731450|P1|Overall Study|Withdrawal by Subject|2
831371|NCT01879722|2731494|P10|Overall Study|Voluntary Withdrawal|0
831372|NCT01879722|2731495|P9|Overall Study|Voluntary Withdrawal|1
831373|NCT01879722|2731496|P8|Overall Study|Voluntary Withdrawal|0
831374|NCT01879722|2731497|P7|Overall Study|Voluntary Withdrawal|0
831375|NCT01879722|2731498|P6|Overall Study|Voluntary Withdrawal|0
831376|NCT01879722|2731499|P5|Overall Study|Voluntary Withdrawal|0
831377|NCT01879722|2731500|P4|Overall Study|Voluntary Withdrawal|0
831378|NCT01879722|2731501|P3|Overall Study|Voluntary Withdrawal|0
831379|NCT01879722|2731502|P2|Overall Study|Voluntary Withdrawal|0
831380|NCT01879722|2731503|P1|Overall Study|Voluntary Withdrawal|0
831381|NCT01879722|2731494|P10|Overall Study|Pretreatment Event/Adverse Event|0
831382|NCT01879722|2731495|P9|Overall Study|Pretreatment Event/Adverse Event|1
831383|NCT01879722|2731496|P8|Overall Study|Pretreatment Event/Adverse Event|1
831384|NCT01879722|2731497|P7|Overall Study|Pretreatment Event/Adverse Event|0
831385|NCT01879722|2731498|P6|Overall Study|Pretreatment Event/Adverse Event|0
831386|NCT01879722|2731499|P5|Overall Study|Pretreatment Event/Adverse Event|1
831387|NCT01879722|2731500|P4|Overall Study|Pretreatment Event/Adverse Event|1
831388|NCT01879722|2731501|P3|Overall Study|Pretreatment Event/Adverse Event|0
831389|NCT01879722|2731502|P2|Overall Study|Pretreatment Event/Adverse Event|1
831390|NCT01879722|2731503|P1|Overall Study|Pretreatment Event/Adverse Event|0
831391|NCT01879683|2731651|P1|Overall Study|Did not Complete 4-week Follow-up Visit|1
831392|NCT01879618|2731658|P1|Overall Study|Adverse Event|5
831393|NCT01879618|2731658|P1|Overall Study|Protocol Violation|6
831394|NCT01879618|2731658|P1|Overall Study|Surgery;changed schedule; not available|8
831395|NCT01879618|2731658|P1|Overall Study|Withdrawal by Subject|1
831396|NCT01879618|2731658|P1|Overall Study|Does not meet entrance criteria|1
831397|NCT01879579|2731665|P2|Overall Study|Discontinued insulin - possible allergy|1
831398|NCT01879579|2731666|P1|Overall Study|Discontinued insulin - possible allergy|0
831399|NCT01879579|2731665|P2|Overall Study|Phenotypic type 1 diabetes|1
831400|NCT01879579|2731666|P1|Overall Study|Phenotypic type 1 diabetes|0
831401|NCT01879579|2731665|P2|Overall Study|Did not initiate insulin treatment|0
831402|NCT01879579|2731666|P1|Overall Study|Did not initiate insulin treatment|1
831403|NCT01879579|2731665|P2|Overall Study|Did not enroll in texting platform|0
831404|NCT01879579|2731666|P1|Overall Study|Did not enroll in texting platform|1
831405|NCT01879579|2731665|P2|Overall Study|Phone incompatible with texting platform|0
831406|NCT01879579|2731666|P1|Overall Study|Phone incompatible with texting platform|3
831407|NCT01879553|2731696|P2|Overall Study|Withdrawal by Subject|0
831408|NCT01879553|2731697|P1|Overall Study|Withdrawal by Subject|1
831409|NCT01879410|2731731|P2|Overall Study|Randomised in Error|2
831410|NCT01879410|2731732|P1|Overall Study|Randomised in Error|1
831411|NCT01879410|2731731|P2|Overall Study|Withdrawal by Subject|8
831412|NCT01879410|2731732|P1|Overall Study|Withdrawal by Subject|7
831413|NCT01879410|2731731|P2|Overall Study|Lost to Follow-up|1
831414|NCT01879410|2731732|P1|Overall Study|Lost to Follow-up|2
831415|NCT01879410|2731731|P2|Overall Study|Protocol Violation|7
831416|NCT01879410|2731732|P1|Overall Study|Protocol Violation|1
831417|NCT01879410|2731731|P2|Overall Study|Lack of Efficacy|6
831418|NCT01879410|2731732|P1|Overall Study|Lack of Efficacy|4
831419|NCT01879410|2731731|P2|Overall Study|Adverse Event|14
831420|NCT01879410|2731732|P1|Overall Study|Adverse Event|9
831421|NCT01879319|2731799|P2|Overall Study|Lost to Follow-up|5
831422|NCT01879319|2731800|P1|Overall Study|Lost to Follow-up|1
831423|NCT01879319|2731799|P2|Overall Study|Withdrawal by Subject|0
831424|NCT01879319|2731800|P1|Overall Study|Withdrawal by Subject|1
831425|NCT01879072|2731817|P1|Overall Study|Withdrawal by Subject|48
831426|NCT01878214|2731942|P2|Overall Study|Lost to Follow-up|36
831427|NCT01878214|2731943|P1|Overall Study|Lost to Follow-up|35
831428|NCT01878214|2731942|P2|Overall Study|Death|1
831429|NCT01878214|2731943|P1|Overall Study|Death|0
831430|NCT01878214|2731942|P2|Overall Study|Withdrawal by Subject|7
831431|NCT01878214|2731943|P1|Overall Study|Withdrawal by Subject|18
831432|NCT01878175|2731957|P1|Overall Study|Developed contraindicated health problem|2
831433|NCT01878149|2731976|P2|Overall Study|Did Not Meet Eligibility Criteria|2
831434|NCT01878149|2731977|P1|Overall Study|Did Not Meet Eligibility Criteria|2
831435|NCT01878097|2731985|P2|Implementation Year 4|Surveys not fully completed|3007
831436|NCT01878097|2731986|P1|Implementation Year 4|Surveys not fully completed|3604
831437|NCT01878097|2731985|P2|Implementation Year 3|Surveys not fully completed|2980
831438|NCT01878097|2731986|P1|Implementation Year 3|Surveys not fully completed|3494
831439|NCT01878097|2731985|P2|Implementation Year 2|Surveys not fully completed|2841
831440|NCT01878097|2731986|P1|Implementation Year 2|Surveys not fully completed|3281
831441|NCT01878097|2731985|P2|Implementation Year 1|Surveys not fully completed|2549
831442|NCT01878097|2731986|P1|Implementation Year 1|Surveys not fully completed|3202
831443|NCT01878097|2731985|P2|Baseline|Surveys not fully completed|1800
831444|NCT01878097|2731986|P1|Baseline|Surveys not fully completed|2497
831445|NCT01877720|2732023|P2|Overall Study|Adverse Event|0
831446|NCT01877720|2732024|P1|Overall Study|Adverse Event|1
831447|NCT01877668|2732053|P5|Overall Study|Adverse event unrelated to study drug|1
831448|NCT01877668|2732054|P4|Overall Study|Adverse event unrelated to study drug|0
831449|NCT01877668|2732055|P3|Overall Study|Adverse event unrelated to study drug|2
831450|NCT01877668|2732056|P2|Overall Study|Adverse event unrelated to study drug|1
831451|NCT01877668|2732057|P1|Overall Study|Adverse event unrelated to study drug|4
831452|NCT01877668|2732053|P5|Overall Study|Adverse event related to study drug|1
831453|NCT01877668|2732054|P4|Overall Study|Adverse event related to study drug|2
831454|NCT01877668|2732055|P3|Overall Study|Adverse event related to study drug|2
831455|NCT01877668|2732056|P2|Overall Study|Adverse event related to study drug|2
831456|NCT01877668|2732057|P1|Overall Study|Adverse event related to study drug|2
831457|NCT01877668|2732053|P5|Overall Study|Protocol Violation|3
831458|NCT01877668|2732054|P4|Overall Study|Protocol Violation|0
831459|NCT01877668|2732055|P3|Overall Study|Protocol Violation|0
831460|NCT01877668|2732056|P2|Overall Study|Protocol Violation|1
831461|NCT01877668|2732057|P1|Overall Study|Protocol Violation|1
831462|NCT01877668|2732053|P5|Overall Study|Not specified|3
831463|NCT01877668|2732054|P4|Overall Study|Not specified|1
831464|NCT01877668|2732055|P3|Overall Study|Not specified|1
831465|NCT01877668|2732056|P2|Overall Study|Not specified|1
831466|NCT01877668|2732057|P1|Overall Study|Not specified|1
831467|NCT01877668|2732053|P5|Overall Study|Withdrawal by Subject|2
831468|NCT01877668|2732054|P4|Overall Study|Withdrawal by Subject|2
831469|NCT01877668|2732055|P3|Overall Study|Withdrawal by Subject|3
831470|NCT01877668|2732056|P2|Overall Study|Withdrawal by Subject|0
831471|NCT01877668|2732057|P1|Overall Study|Withdrawal by Subject|2
831472|NCT01877668|2732053|P5|Overall Study|Lost to Follow-up|0
831473|NCT01877668|2732054|P4|Overall Study|Lost to Follow-up|0
831474|NCT01877668|2732055|P3|Overall Study|Lost to Follow-up|1
831475|NCT01877668|2732056|P2|Overall Study|Lost to Follow-up|2
831476|NCT01877668|2732057|P1|Overall Study|Lost to Follow-up|0
831477|NCT01877668|2732053|P5|Overall Study|Insufficient clinical response|0
831478|NCT01877668|2732054|P4|Overall Study|Insufficient clinical response|2
831479|NCT01877668|2732055|P3|Overall Study|Insufficient clinical response|2
831480|NCT01877668|2732056|P2|Overall Study|Insufficient clinical response|1
831481|NCT01877668|2732057|P1|Overall Study|Insufficient clinical response|0
831482|NCT01877668|2732053|P5|Overall Study|No longer met study criteria|0
831483|NCT01877668|2732054|P4|Overall Study|No longer met study criteria|0
831484|NCT01877668|2732055|P3|Overall Study|No longer met study criteria|1
831485|NCT01877668|2732056|P2|Overall Study|No longer met study criteria|0
831486|NCT01877668|2732057|P1|Overall Study|No longer met study criteria|1
831487|NCT01877668|2732053|P5|Overall Study|Death|0
831488|NCT01877668|2732054|P4|Overall Study|Death|1
831489|NCT01877668|2732055|P3|Overall Study|Death|0
831490|NCT01877668|2732056|P2|Overall Study|Death|0
831491|NCT01877668|2732057|P1|Overall Study|Death|0
831492|NCT01877655|2732288|P2|Overall Study|Randomized but Never Received Drug|5
831493|NCT01877655|2732289|P1|Overall Study|Randomized but Never Received Drug|8
831494|NCT01877655|2732288|P2|Overall Study|Miscellaneous|4
831495|NCT01877655|2732289|P1|Overall Study|Miscellaneous|4
831496|NCT01877655|2732288|P2|Overall Study|Physician Decision|10
831497|NCT01877655|2732289|P1|Overall Study|Physician Decision|11
831498|NCT01877655|2732288|P2|Overall Study|Withdrawal by Subject|26
831499|NCT01877655|2732289|P1|Overall Study|Withdrawal by Subject|18
831500|NCT01877655|2732288|P2|Overall Study|Death|52
831501|NCT01877655|2732289|P1|Overall Study|Death|57
831502|NCT01877421|2732380|P18|Phase 2|Protocol Violation|0
831503|NCT01877421|2732381|P17|Phase 2|Protocol Violation|0
831504|NCT01877421|2732382|P16|Phase 2|Protocol Violation|0
831505|NCT01877421|2732383|P15|Phase 2|Protocol Violation|0
831506|NCT01877421|2732384|P14|Phase 2|Protocol Violation|0
831507|NCT01877421|2732385|P13|Phase 2|Protocol Violation|0
831508|NCT01877421|2732386|P12|Phase 2|Protocol Violation|0
831509|NCT01877421|2732387|P11|Phase 2|Protocol Violation|1
831510|NCT01877421|2732388|P10|Phase 2|Protocol Violation|0
831511|NCT01877421|2732389|P9|Phase 2|Protocol Violation|0
831512|NCT01877421|2732390|P8|Phase 2|Protocol Violation|0
831513|NCT01877421|2732391|P7|Phase 2|Protocol Violation|0
831514|NCT01877421|2732392|P6|Phase 2|Protocol Violation|0
831515|NCT01877421|2732393|P5|Phase 2|Protocol Violation|0
831516|NCT01877421|2732394|P4|Phase 2|Protocol Violation|0
831517|NCT01877421|2732395|P3|Phase 2|Protocol Violation|0
831518|NCT01877421|2732396|P2|Phase 2|Protocol Violation|0
831519|NCT01877421|2732397|P1|Phase 2|Protocol Violation|0
831520|NCT01877421|2732380|P18|Phase 2|Withdrawal by Subject|0
831521|NCT01877421|2732381|P17|Phase 2|Withdrawal by Subject|0
831522|NCT01877421|2732382|P16|Phase 2|Withdrawal by Subject|1
831523|NCT01877421|2732383|P15|Phase 2|Withdrawal by Subject|0
831524|NCT01877421|2732384|P14|Phase 2|Withdrawal by Subject|0
831525|NCT01877421|2732385|P13|Phase 2|Withdrawal by Subject|1
831526|NCT01877421|2732386|P12|Phase 2|Withdrawal by Subject|0
831527|NCT01877421|2732387|P11|Phase 2|Withdrawal by Subject|1
831528|NCT01877421|2732388|P10|Phase 2|Withdrawal by Subject|0
831529|NCT01877421|2732389|P9|Phase 2|Withdrawal by Subject|1
831530|NCT01877421|2732390|P8|Phase 2|Withdrawal by Subject|0
831531|NCT01877421|2732391|P7|Phase 2|Withdrawal by Subject|0
831532|NCT01877421|2732392|P6|Phase 2|Withdrawal by Subject|0
831533|NCT01877421|2732393|P5|Phase 2|Withdrawal by Subject|0
831534|NCT01877421|2732394|P4|Phase 2|Withdrawal by Subject|0
831535|NCT01877421|2732395|P3|Phase 2|Withdrawal by Subject|0
831536|NCT01877421|2732396|P2|Phase 2|Withdrawal by Subject|0
831537|NCT01877421|2732397|P1|Phase 2|Withdrawal by Subject|0
831538|NCT01877421|2732380|P18|Phase 2|Lost to Follow-up|0
831539|NCT01877421|2732381|P17|Phase 2|Lost to Follow-up|0
831540|NCT01877421|2732382|P16|Phase 2|Lost to Follow-up|0
831541|NCT01877421|2732383|P15|Phase 2|Lost to Follow-up|0
831542|NCT01877421|2732384|P14|Phase 2|Lost to Follow-up|0
831543|NCT01877421|2732385|P13|Phase 2|Lost to Follow-up|0
831544|NCT01877421|2732386|P12|Phase 2|Lost to Follow-up|0
831545|NCT01877421|2732387|P11|Phase 2|Lost to Follow-up|0
831546|NCT01877421|2732388|P10|Phase 2|Lost to Follow-up|0
831547|NCT01877421|2732389|P9|Phase 2|Lost to Follow-up|0
831548|NCT01877421|2732390|P8|Phase 2|Lost to Follow-up|0
831549|NCT01877421|2732391|P7|Phase 2|Lost to Follow-up|1
831550|NCT01877421|2732392|P6|Phase 2|Lost to Follow-up|0
831551|NCT01877421|2732393|P5|Phase 2|Lost to Follow-up|0
831552|NCT01877421|2732394|P4|Phase 2|Lost to Follow-up|0
831553|NCT01877421|2732395|P3|Phase 2|Lost to Follow-up|0
831554|NCT01877421|2732396|P2|Phase 2|Lost to Follow-up|0
831555|NCT01877421|2732397|P1|Phase 2|Lost to Follow-up|0
831556|NCT01877408|2732507|P2|Overall Study|Lost to Follow-up|2
831557|NCT01877408|2732508|P1|Overall Study|Lost to Follow-up|0
831558|NCT01877278|2732541|P2|Overall Study|Lost to Follow-up|3
831559|NCT01877278|2732542|P1|Overall Study|Lost to Follow-up|3
831560|NCT01877265|2732550|P6|Treatment Period 3|Lost to Follow-up|0
831561|NCT01877265|2732551|P5|Treatment Period 3|Lost to Follow-up|0
831562|NCT01877265|2732552|P4|Treatment Period 3|Lost to Follow-up|0
831563|NCT01877265|2732553|P3|Treatment Period 3|Lost to Follow-up|0
831564|NCT01877265|2732554|P2|Treatment Period 3|Lost to Follow-up|0
831565|NCT01877265|2732555|P1|Treatment Period 3|Lost to Follow-up|1
831566|NCT01877265|2732550|P6|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1
831567|NCT01877265|2732551|P5|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
831568|NCT01877265|2732552|P4|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
831569|NCT01877265|2732553|P3|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
831570|NCT01877265|2732554|P2|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
831571|NCT01877265|2732555|P1|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
831572|NCT01877265|2732550|P6|Treatment Period 1|Sponsor Decision|0
831573|NCT01877265|2732551|P5|Treatment Period 1|Sponsor Decision|0
831574|NCT01877265|2732552|P4|Treatment Period 1|Sponsor Decision|0
831575|NCT01877265|2732553|P3|Treatment Period 1|Sponsor Decision|1
831576|NCT01877265|2732554|P2|Treatment Period 1|Sponsor Decision|0
831577|NCT01877265|2732555|P1|Treatment Period 1|Sponsor Decision|0
831578|NCT01876979|2732612|P2|Overall Study|Physician Decision|3
831579|NCT01876979|2732613|P1|Overall Study|Physician Decision|2
831580|NCT01876823|2732619|P1|Overall Study|Patients moved|2
831581|NCT01876823|2732619|P1|Overall Study|Physician Decision|2
831582|NCT01876823|2732619|P1|Overall Study|Withdrawal by Subject|5
831583|NCT01876810|2732632|P2|Overall Study|Physician Decision|1
831584|NCT01876810|2732633|P1|Overall Study|Physician Decision|0
831585|NCT01876784|2732645|P2|Overall Study|Ongoing|40
831586|NCT01876784|2732646|P1|Overall Study|Ongoing|41
831587|NCT01876784|2732645|P2|Overall Study|Other than specified above|6
831588|NCT01876784|2732646|P1|Overall Study|Other than specified above|5
831589|NCT01876784|2732645|P2|Overall Study|Randomized but not treated|1
831590|NCT01876784|2732646|P1|Overall Study|Randomized but not treated|2
831591|NCT01876784|2732645|P2|Overall Study|Death|0
831592|NCT01876784|2732646|P1|Overall Study|Death|1
831593|NCT01876784|2732645|P2|Overall Study|Lost to Follow-up|1
831594|NCT01876784|2732646|P1|Overall Study|Lost to Follow-up|0
831595|NCT01876784|2732645|P2|Overall Study|Disease progression|67
831596|NCT01876784|2732646|P1|Overall Study|Disease progression|37
831597|NCT01876784|2732645|P2|Overall Study|Protocol Violation|0
831598|NCT01876784|2732646|P1|Overall Study|Protocol Violation|1
831599|NCT01876784|2732645|P2|Overall Study|Adverse Event|2
831600|NCT01876784|2732646|P1|Overall Study|Adverse Event|15
831601|NCT01876784|2732645|P2|Overall Study|Withdrawal by Subject|2
831602|NCT01876784|2732646|P1|Overall Study|Withdrawal by Subject|17
831603|NCT01876732|2732652|P1|Overall Study|MMA was not over 800mg/dL|75
831604|NCT01876706|2732657|P1|Overall Study|Lost to Follow-up|2
831605|NCT01876706|2732657|P1|Overall Study|BPH Intervention|2
831606|NCT01876420|2732674|P1|Overall Study|Missed 30 day visit|1
831607|NCT01876381|2732686|P1|Overall Study|Withdrawal by Subject|1
831608|NCT01876381|2732686|P1|Overall Study|Physician Decision|1
831609|NCT01876381|2732686|P1|Overall Study|Lack of Efficacy|5
831610|NCT01876368|2732693|P2|Overall Study|Subject/guardian decision|1
831611|NCT01876368|2732694|P1|Overall Study|Subject/guardian decision|3
831612|NCT01876368|2732693|P2|Overall Study|Protocol deviation|3
831613|NCT01876368|2732694|P1|Overall Study|Protocol deviation|3
831614|NCT01876368|2732693|P2|Overall Study|Physician Decision|2
831615|NCT01876368|2732694|P1|Overall Study|Physician Decision|0
831616|NCT01876368|2732693|P2|Overall Study|Non-compliance with study treatment|1
831617|NCT01876368|2732694|P1|Overall Study|Non-compliance with study treatment|0
831618|NCT01876368|2732693|P2|Overall Study|Lost to Follow-up|1
831619|NCT01876368|2732694|P1|Overall Study|Lost to Follow-up|0
831620|NCT01876368|2732693|P2|Overall Study|Lack of Efficacy|0
831621|NCT01876368|2732694|P1|Overall Study|Lack of Efficacy|1
831622|NCT01876368|2732693|P2|Overall Study|Adverse Event|5
831623|NCT01876368|2732694|P1|Overall Study|Adverse Event|2
831624|NCT01875991|2732738|P2|Overall Study|Sponsor Decision|0
831625|NCT01875991|2732739|P1|Overall Study|Sponsor Decision|1
831626|NCT01875991|2732738|P2|Overall Study|Withdrawal by Subject|6
831627|NCT01875991|2732739|P1|Overall Study|Withdrawal by Subject|6
831628|NCT01875874|2732775|P1|Overall Study|Death|3
831629|NCT01875848|2732782|P2|Overall Study|Withdrawal by Subject|0
831630|NCT01875848|2732783|P1|Overall Study|Withdrawal by Subject|2
831631|NCT01875731|2732800|P2|Overall Study|Fail to obtain lab sample|0
831632|NCT01875731|2732801|P1|Overall Study|Fail to obtain lab sample|1
831633|NCT01875471|2732820|P2|Overall Study|Unsatisfactory Lens Fitting|0
831634|NCT01875471|2732821|P1|Overall Study|Unsatisfactory Lens Fitting|1
831635|NCT01875471|2732820|P2|Overall Study|Adverse Event|1
831636|NCT01875471|2732821|P1|Overall Study|Adverse Event|0
831637|NCT01875445|2732829|P2|Overall Study|Withdrawal by Subject|0
831638|NCT01875445|2732830|P1|Overall Study|Withdrawal by Subject|2
831639|NCT01875445|2732829|P2|Overall Study|Lost to Follow-up|0
831640|NCT01875445|2732830|P1|Overall Study|Lost to Follow-up|5
831641|NCT01875185|2732840|P2|Overall Study|study was terminated|48
831642|NCT01875185|2732841|P1|Overall Study|study was terminated|52
831643|NCT01874665|2732889|P2|Overall Study|Other|0
831644|NCT01874665|2732890|P1|Overall Study|Other|2
831645|NCT01874665|2732889|P2|Overall Study|Documented Progressive Disease|7
831646|NCT01874665|2732890|P1|Overall Study|Documented Progressive Disease|11
831647|NCT01874665|2732889|P2|Overall Study|Study Terminated by Sponsor|2
831648|NCT01874665|2732890|P1|Overall Study|Study Terminated by Sponsor|0
831649|NCT01874665|2732889|P2|Overall Study|Clinical Progressive Disease|3
831650|NCT01874665|2732890|P1|Overall Study|Clinical Progressive Disease|4
831651|NCT01874665|2732889|P2|Overall Study|Physician Decision|0
831652|NCT01874665|2732890|P1|Overall Study|Physician Decision|3
831653|NCT01874665|2732889|P2|Overall Study|Withdrawal by Subject|1
831654|NCT01874665|2732890|P1|Overall Study|Withdrawal by Subject|4
831655|NCT01874665|2732889|P2|Overall Study|Adverse Event|2
831656|NCT01874665|2732890|P1|Overall Study|Adverse Event|6
831657|NCT01874535|2732918|P2|Overall Study|incomplete symptom resolution|35
831658|NCT01874535|2732919|P1|Overall Study|incomplete symptom resolution|45
831659|NCT01874535|2732918|P2|Overall Study|Lost to Follow-up|9
831660|NCT01874535|2732919|P1|Overall Study|Lost to Follow-up|10
831661|NCT01874353|2732927|P2|Overall Study|Withdrawal by Subject|9
831662|NCT01874353|2732928|P1|Overall Study|Withdrawal by Subject|7
831663|NCT01874353|2732927|P2|Overall Study|Death|27
831664|NCT01874353|2732928|P1|Overall Study|Death|45
831665|NCT01874353|2732927|P2|Overall Study|Lost to Follow-up|1
831666|NCT01874353|2732928|P1|Overall Study|Lost to Follow-up|1
831667|NCT01874353|2732927|P2|Overall Study|Other|0
831668|NCT01874353|2732928|P1|Overall Study|Other|2
831669|NCT01874340|2732955|P4|Overall Study|Withdrawal by Subject|1
831670|NCT01874340|2732956|P3|Overall Study|Withdrawal by Subject|0
831671|NCT01874340|2732957|P2|Overall Study|Withdrawal by Subject|0
831672|NCT01874340|2732958|P1|Overall Study|Withdrawal by Subject|0
831673|NCT01874340|2732955|P4|Overall Study|Study terminated by Sponsor|4
831674|NCT01874340|2732956|P3|Overall Study|Study terminated by Sponsor|8
831675|NCT01874340|2732957|P2|Overall Study|Study terminated by Sponsor|8
831676|NCT01874340|2732958|P1|Overall Study|Study terminated by Sponsor|6
831677|NCT01874275|2732986|P2|Overall Study|Lost to Follow-up|0
831678|NCT01874275|2732987|P1|Overall Study|Lost to Follow-up|1
831679|NCT01874145|2733010|P2|Extension Period|Lost to Follow-up|1
831680|NCT01874145|2733011|P1|Extension Period|Lost to Follow-up|1
831681|NCT01874145|2733010|P2|Extension Period|Withdrawal by Subject|1
831682|NCT01874145|2733011|P1|Extension Period|Withdrawal by Subject|2
831683|NCT01874145|2733010|P2|Extension Period|Adverse Event|2
831684|NCT01874145|2733011|P1|Extension Period|Adverse Event|3
831685|NCT01874145|2733010|P2|Core Period|Withdrawal by Subject|4
831686|NCT01874145|2733011|P1|Core Period|Withdrawal by Subject|0
831687|NCT01874145|2733010|P2|Core Period|Adverse Event|1
831688|NCT01874145|2733011|P1|Core Period|Adverse Event|0
831689|NCT01874145|2733010|P2|Core Period|Physician Decision|1
831690|NCT01874145|2733011|P1|Core Period|Physician Decision|1
831691|NCT01874145|2733010|P2|Core Period|Protocol Violation|1
831692|NCT01874145|2733011|P1|Core Period|Protocol Violation|1
831693|NCT01874145|2733010|P2|Core Period|Non-compliance|0
831694|NCT01874145|2733011|P1|Core Period|Non-compliance|1
831695|NCT01874054|2733070|P1|Follow-up Period|Continuing in Follow-up|48
831696|NCT01874054|2733070|P1|Follow-up Period|Withdrawal by Subject|1
831697|NCT01874054|2733070|P1|Treatment Period|Non-AE related|2
831698|NCT01874054|2733070|P1|Treatment Period|Withdrawal by Subject|6
831699|NCT01874054|2733070|P1|Treatment Period|Physician Decision|3
831700|NCT01874054|2733070|P1|Treatment Period|Adverse Event|20
831701|NCT01874054|2733070|P1|Treatment Period|Progressive Disease|7
831702|NCT01873950|2733092|P5|Period 5|Withdrawal by Subject|0
831703|NCT01873950|2733093|P4|Period 5|Withdrawal by Subject|1
831704|NCT01873950|2733094|P3|Period 5|Withdrawal by Subject|0
831705|NCT01873950|2733095|P2|Period 5|Withdrawal by Subject|0
831706|NCT01873950|2733096|P1|Period 5|Withdrawal by Subject|0
831707|NCT01873859|2733133|P2|Overall Study|Withdrawal by Subject|4
831708|NCT01873859|2733134|P1|Overall Study|Withdrawal by Subject|0
831709|NCT01873729|2733142|P1|Overall Study|Withdrawal by Subject|1
831710|NCT01873417|2733147|P1|Overall Study|Physician Decision|3
831711|NCT01873417|2733147|P1|Overall Study|Withdrawal by Subject|2
831712|NCT01873417|2733147|P1|Overall Study|Lost to Follow-up|2
831713|NCT01873417|2733147|P1|Overall Study|Adverse Event|24
831714|NCT01873417|2733147|P1|Overall Study|Did Not Receive Any Study Drug|4
831715|NCT01872910|2733164|P6|Overall Study|Lost to Follow-up|0
831716|NCT01872910|2733165|P5|Overall Study|Lost to Follow-up|0
831717|NCT01872910|2733166|P4|Overall Study|Lost to Follow-up|0
831718|NCT01872910|2733167|P3|Overall Study|Lost to Follow-up|2
831719|NCT01872910|2733168|P2|Overall Study|Lost to Follow-up|0
831720|NCT01872910|2733169|P1|Overall Study|Lost to Follow-up|2
831721|NCT01872715|2733214|P1|Overall Study|Withdrawal by Subject|2
831722|NCT01872715|2733214|P1|Overall Study|Protocol Violation|1
831723|NCT01872715|2733214|P1|Overall Study|Adverse Event|1
831724|NCT01872689|2733233|P4|Open-Label Period (Only For Monotherapy)|Adverse Event|0
831725|NCT01872689|2733234|P3|Open-Label Period (Only For Monotherapy)|Adverse Event|0
831726|NCT01872689|2733235|P2|Open-Label Period (Only For Monotherapy)|Adverse Event|1
831727|NCT01872689|2733236|P1|Open-Label Period (Only For Monotherapy)|Adverse Event|2
831728|NCT01872689|2733233|P4|Open-Label Period (Only For Monotherapy)|Death|0
831729|NCT01872689|2733234|P3|Open-Label Period (Only For Monotherapy)|Death|0
831730|NCT01872689|2733235|P2|Open-Label Period (Only For Monotherapy)|Death|3
831731|NCT01872689|2733236|P1|Open-Label Period (Only For Monotherapy)|Death|5
831732|NCT01872689|2733233|P4|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
831733|NCT01872689|2733234|P3|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
831734|NCT01872689|2733235|P2|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3
831735|NCT01872689|2733236|P1|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1
831736|NCT01872689|2733233|P4|Open-Label Period (Only For Monotherapy)|Physician Decision|0
831737|NCT01872689|2733234|P3|Open-Label Period (Only For Monotherapy)|Physician Decision|0
831738|NCT01872689|2733235|P2|Open-Label Period (Only For Monotherapy)|Physician Decision|1
831739|NCT01872689|2733236|P1|Open-Label Period (Only For Monotherapy)|Physician Decision|0
831740|NCT01872689|2733233|P4|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
831741|NCT01872689|2733234|P3|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
831742|NCT01872689|2733235|P2|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12
831743|NCT01872689|2733236|P1|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11
831744|NCT01872689|2733233|P4|Open-Label Period (Only For Monotherapy)|Other|0
831745|NCT01872689|2733234|P3|Open-Label Period (Only For Monotherapy)|Other|0
831746|NCT01872689|2733235|P2|Open-Label Period (Only For Monotherapy)|Other|3
831747|NCT01872689|2733236|P1|Open-Label Period (Only For Monotherapy)|Other|2
831748|NCT01872689|2733233|P4|Double-Blind/Placebo-Controlled Period|Adverse Event|7
831749|NCT01872689|2733234|P3|Double-Blind/Placebo-Controlled Period|Adverse Event|10
831750|NCT01872689|2733235|P2|Double-Blind/Placebo-Controlled Period|Adverse Event|3
831751|NCT01872689|2733236|P1|Double-Blind/Placebo-Controlled Period|Adverse Event|6
831752|NCT01872689|2733233|P4|Double-Blind/Placebo-Controlled Period|Death|9
831753|NCT01872689|2733234|P3|Double-Blind/Placebo-Controlled Period|Death|14
831754|NCT01872689|2733235|P2|Double-Blind/Placebo-Controlled Period|Death|4
831755|NCT01872689|2733236|P1|Double-Blind/Placebo-Controlled Period|Death|3
831756|NCT01872689|2733233|P4|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
831757|NCT01872689|2733234|P3|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
831758|NCT01872689|2733235|P2|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
831759|NCT01872689|2733236|P1|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
831760|NCT01872689|2733233|P4|Double-Blind/Placebo-Controlled Period|Physician Decision|1
831761|NCT01872689|2733234|P3|Double-Blind/Placebo-Controlled Period|Physician Decision|3
831762|NCT01872689|2733235|P2|Double-Blind/Placebo-Controlled Period|Physician Decision|3
831763|NCT01872689|2733236|P1|Double-Blind/Placebo-Controlled Period|Physician Decision|0
831764|NCT01872689|2733233|P4|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
831765|NCT01872689|2733234|P3|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
831766|NCT01872689|2733235|P2|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
831767|NCT01872689|2733236|P1|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
831768|NCT01872689|2733233|P4|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16
831769|NCT01872689|2733234|P3|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14
831770|NCT01872689|2733235|P2|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8
831771|NCT01872689|2733236|P1|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9
831772|NCT01872689|2733233|P4|Double-Blind/Placebo-Controlled Period|Other|3
831773|NCT01872689|2733234|P3|Double-Blind/Placebo-Controlled Period|Other|6
831774|NCT01872689|2733235|P2|Double-Blind/Placebo-Controlled Period|Other|1
831775|NCT01872689|2733236|P1|Double-Blind/Placebo-Controlled Period|Other|1
831776|NCT01872689|2733233|P4|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
831777|NCT01872689|2733234|P3|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
831778|NCT01872689|2733235|P2|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1
831779|NCT01872689|2733236|P1|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
831780|NCT01872611|2733312|P2|Overall Study|Reason not provided|6
831781|NCT01872611|2733313|P1|Overall Study|Reason not provided|6
831782|NCT01872611|2733312|P2|Overall Study|Withdrawal by Subject|1
831783|NCT01872611|2733313|P1|Overall Study|Withdrawal by Subject|6
831784|NCT01872611|2733312|P2|Overall Study|Physician Decision|0
831785|NCT01872611|2733313|P1|Overall Study|Physician Decision|1
831786|NCT01872611|2733312|P2|Overall Study|Lost to Follow-up|1
831787|NCT01872611|2733313|P1|Overall Study|Lost to Follow-up|8
831788|NCT01872611|2733312|P2|Overall Study|Death, prior to treatment|1
831789|NCT01872611|2733313|P1|Overall Study|Death, prior to treatment|0
831790|NCT01872611|2733312|P2|Overall Study|Death|1
831791|NCT01872611|2733313|P1|Overall Study|Death|0
831792|NCT01872611|2733312|P2|Overall Study|Adverse Event, prior to treatment|1
831793|NCT01872611|2733313|P1|Overall Study|Adverse Event, prior to treatment|0
831794|NCT01872611|2733312|P2|Overall Study|Adverse Event|1
831795|NCT01872611|2733313|P1|Overall Study|Adverse Event|3
831796|NCT01872078|2733335|P4|Overall Study|Patient met exclusion criterion 16.|1
831797|NCT01872078|2733336|P3|Overall Study|Patient met exclusion criterion 16.|0
831798|NCT01872078|2733337|P2|Overall Study|Patient met exclusion criterion 16.|0
831799|NCT01872078|2733338|P1|Overall Study|Patient met exclusion criterion 16.|0
831800|NCT01872078|2733335|P4|Overall Study|Withdrawal by Subject|0
831801|NCT01872078|2733336|P3|Overall Study|Withdrawal by Subject|1
831802|NCT01872078|2733337|P2|Overall Study|Withdrawal by Subject|0
831803|NCT01872078|2733338|P1|Overall Study|Withdrawal by Subject|0
831804|NCT01872078|2733335|P4|Overall Study|Protocol Violation|0
831805|NCT01872078|2733336|P3|Overall Study|Protocol Violation|1
831806|NCT01872078|2733337|P2|Overall Study|Protocol Violation|0
831807|NCT01872078|2733338|P1|Overall Study|Protocol Violation|0
831808|NCT01872078|2733335|P4|Overall Study|Dose administration non-compliance|1
831809|NCT01872078|2733336|P3|Overall Study|Dose administration non-compliance|0
831810|NCT01872078|2733337|P2|Overall Study|Dose administration non-compliance|0
831811|NCT01872078|2733338|P1|Overall Study|Dose administration non-compliance|0
831812|NCT01872078|2733335|P4|Overall Study|Adverse Event|0
831813|NCT01872078|2733336|P3|Overall Study|Adverse Event|1
831814|NCT01872078|2733337|P2|Overall Study|Adverse Event|0
831815|NCT01872078|2733338|P1|Overall Study|Adverse Event|0
831816|NCT01871870|2733348|P1|Overall Study|hyperglycemia|2
831817|NCT01871870|2733348|P1|Overall Study|Hardware issues|7
831818|NCT01871805|2733359|P6|Phase II|Lost to Follow-up|13
831819|NCT01871805|2733360|P5|Phase II|Lost to Follow-up|0
831820|NCT01871805|2733361|P4|Phase II|Lost to Follow-up|0
831821|NCT01871805|2733362|P3|Phase II|Lost to Follow-up|0
831822|NCT01871805|2733363|P2|Phase II|Lost to Follow-up|0
831823|NCT01871805|2733364|P1|Phase II|Lost to Follow-up|0
831824|NCT01871805|2733359|P6|Phase II|Alive in Survival Follow-up|29
831825|NCT01871805|2733360|P5|Phase II|Alive in Survival Follow-up|0
831826|NCT01871805|2733361|P4|Phase II|Alive in Survival Follow-up|0
831827|NCT01871805|2733362|P3|Phase II|Alive in Survival Follow-up|0
831828|NCT01871805|2733363|P2|Phase II|Alive in Survival Follow-up|0
831829|NCT01871805|2733364|P1|Phase II|Alive in Survival Follow-up|0
831830|NCT01871805|2733359|P6|Phase II|Death|45
831831|NCT01871805|2733360|P5|Phase II|Death|0
831832|NCT01871805|2733361|P4|Phase II|Death|0
831833|NCT01871805|2733362|P3|Phase II|Death|0
831834|NCT01871805|2733363|P2|Phase II|Death|0
831835|NCT01871805|2733364|P1|Phase II|Death|0
831836|NCT01871805|2733359|P6|Phase I|Lost to Follow-up|0
831837|NCT01871805|2733360|P5|Phase I|Lost to Follow-up|0
831838|NCT01871805|2733361|P4|Phase I|Lost to Follow-up|0
831839|NCT01871805|2733362|P3|Phase I|Lost to Follow-up|3
831840|NCT01871805|2733363|P2|Phase I|Lost to Follow-up|1
831841|NCT01871805|2733364|P1|Phase I|Lost to Follow-up|0
831842|NCT01871805|2733359|P6|Phase I|Alive in Survival Follow-up|0
831843|NCT01871805|2733360|P5|Phase I|Alive in Survival Follow-up|4
831844|NCT01871805|2733361|P4|Phase I|Alive in Survival Follow-up|5
831845|NCT01871805|2733362|P3|Phase I|Alive in Survival Follow-up|4
831846|NCT01871805|2733363|P2|Phase I|Alive in Survival Follow-up|2
831847|NCT01871805|2733364|P1|Phase I|Alive in Survival Follow-up|0
831848|NCT01871805|2733359|P6|Phase I|Death|0
831849|NCT01871805|2733360|P5|Phase I|Death|9
831850|NCT01871805|2733361|P4|Phase I|Death|2
831851|NCT01871805|2733362|P3|Phase I|Death|6
831852|NCT01871805|2733363|P2|Phase I|Death|4
831853|NCT01871805|2733364|P1|Phase I|Death|7
831854|NCT01871558|2733436|P2|Overall Study|Withdrawal by Subject|0
831855|NCT01871558|2733437|P1|Overall Study|Withdrawal by Subject|2
831856|NCT01871558|2733436|P2|Overall Study|antidiabetic drug prematurely stopped|1
831857|NCT01871558|2733437|P1|Overall Study|antidiabetic drug prematurely stopped|1
831858|NCT01871558|2733436|P2|Overall Study|Other reason|1
831859|NCT01871558|2733437|P1|Overall Study|Other reason|0
831860|NCT01871532|2733457|P2|Overall Study|Withdrawal by Subject|2
831861|NCT01871532|2733458|P1|Overall Study|Withdrawal by Subject|1
831862|NCT01871519|2733492|P1|Overall Study|Withdrawal by Subject|49
831863|NCT01871519|2733492|P1|Overall Study|Lost to Follow-up|15
831864|NCT01871519|2733492|P1|Overall Study|Death|26
831865|NCT01871402|2733522|P2|Overall Study|Non-compliance|1
831866|NCT01871402|2733523|P1|Overall Study|Non-compliance|0
831867|NCT01871402|2733522|P2|Overall Study|Withdrawal by Subject|2
831868|NCT01871402|2733523|P1|Overall Study|Withdrawal by Subject|0
831869|NCT01871402|2733522|P2|Overall Study|Lost to Follow-up|0
831870|NCT01871402|2733523|P1|Overall Study|Lost to Follow-up|1
831871|NCT01871285|2733541|P4|First Intervention (1 Day)|Lost to Follow-up|0
831872|NCT01871285|2733542|P3|First Intervention (1 Day)|Lost to Follow-up|1
831873|NCT01871285|2733543|P2|First Intervention (1 Day)|Lost to Follow-up|1
831874|NCT01871285|2733544|P1|First Intervention (1 Day)|Lost to Follow-up|0
831875|NCT01871285|2733541|P4|First Intervention (1 Day)|Adverse Event|0
831876|NCT01871285|2733542|P3|First Intervention (1 Day)|Adverse Event|0
831877|NCT01871285|2733543|P2|First Intervention (1 Day)|Adverse Event|0
831878|NCT01871285|2733544|P1|First Intervention (1 Day)|Adverse Event|1
831879|NCT01871142|2733570|P1|Overall Study|Adverse Event|1
831880|NCT01871090|2733586|P2|Overall Study|Subject Non-Compliance|1
831881|NCT01871090|2733587|P1|Overall Study|Subject Non-Compliance|0
831882|NCT01871090|2733586|P2|Overall Study|Interrogation not completed correctly|0
831883|NCT01871090|2733587|P1|Overall Study|Interrogation not completed correctly|1
831884|NCT01871090|2733586|P2|Overall Study|Interrogation not done in Emergency Room|22
831885|NCT01871090|2733587|P1|Overall Study|Interrogation not done in Emergency Room|1
831886|NCT01870999|2733600|P3|Overall Study|Protocol Violation|1
831887|NCT01870999|2733601|P2|Overall Study|Protocol Violation|0
831888|NCT01870999|2733602|P1|Overall Study|Protocol Violation|0
831889|NCT01870999|2733600|P3|Overall Study|Withdrawal by Subject|5
831890|NCT01870999|2733601|P2|Overall Study|Withdrawal by Subject|2
831891|NCT01870999|2733602|P1|Overall Study|Withdrawal by Subject|0
831892|NCT01870999|2733600|P3|Overall Study|Subject withdrawn by Investigator|0
831893|NCT01870999|2733601|P2|Overall Study|Subject withdrawn by Investigator|0
831894|NCT01870999|2733602|P1|Overall Study|Subject withdrawn by Investigator|1
831895|NCT01870999|2733600|P3|Overall Study|Subject met withdrawal criteria|0
831896|NCT01870999|2733601|P2|Overall Study|Subject met withdrawal criteria|2
831897|NCT01870999|2733602|P1|Overall Study|Subject met withdrawal criteria|3
831898|NCT01870999|2733600|P3|Overall Study|Adverse Event|1
831899|NCT01870999|2733601|P2|Overall Study|Adverse Event|4
831900|NCT01870999|2733602|P1|Overall Study|Adverse Event|0
831901|NCT01870973|2733660|P2|Overall Study|Lost to Follow-up|3
831902|NCT01870973|2733661|P1|Overall Study|Lost to Follow-up|10
831903|NCT01870921|2733667|P1|Overall Study|Other|1
831904|NCT01870921|2733667|P1|Overall Study|Subject Lost to Follow up|2
831905|NCT01870921|2733667|P1|Overall Study|Severe non-compliance to protocol|7
831906|NCT01870921|2733667|P1|Overall Study|Subject decision|80
831907|NCT01870843|2733686|P1|Overall Study|Withdrawal by Subject|18
831908|NCT01870843|2733686|P1|Overall Study|Death|1
831909|NCT01870843|2733686|P1|Overall Study|Lost to Follow-up|24
831910|NCT01870843|2733686|P1|Overall Study|Adverse Event|10
831911|NCT01870778|2733701|P2|Overall Study|Lost to Follow-up|2
831912|NCT01870778|2733702|P1|Overall Study|Lost to Follow-up|0
831913|NCT01870778|2733701|P2|Overall Study|Withdrawal by Subject|7
831914|NCT01870778|2733702|P1|Overall Study|Withdrawal by Subject|8
831915|NCT01870739|2733728|P2|Add-on Period (40 Weeks)|Patient withdrew consent|0
831916|NCT01870739|2733729|P1|Add-on Period (40 Weeks)|Patient withdrew consent|1
831917|NCT01870739|2733728|P2|Add-on Period (40 Weeks)|Protocol deviation|1
831918|NCT01870739|2733729|P1|Add-on Period (40 Weeks)|Protocol deviation|1
831919|NCT01870739|2733728|P2|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0
832006|NCT01868477|2734179|P2|Overall Study|Withdrawal by Subject|0
831920|NCT01870739|2733729|P1|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1
831921|NCT01870739|2733728|P2|Add-on Period (40 Weeks)|Adverse Event|1
831922|NCT01870739|2733729|P1|Add-on Period (40 Weeks)|Adverse Event|0
831923|NCT01870739|2733728|P2|Single Drug Treatment (12 Weeks)|Administrative problems|2
831924|NCT01870739|2733729|P1|Single Drug Treatment (12 Weeks)|Administrative problems|3
831925|NCT01870739|2733728|P2|Single Drug Treatment (12 Weeks)|Adverse Event|1
831926|NCT01870739|2733729|P1|Single Drug Treatment (12 Weeks)|Adverse Event|0
831927|NCT01870739|2733728|P2|Single Drug Treatment (12 Weeks)|Protocol deviation|1
831928|NCT01870739|2733729|P1|Single Drug Treatment (12 Weeks)|Protocol deviation|0
831929|NCT01870726|2733768|P7|Overall Study|Progressive disease|10
831930|NCT01870726|2733769|P6|Overall Study|Progressive disease|4
831931|NCT01870726|2733770|P5|Overall Study|Progressive disease|6
831932|NCT01870726|2733771|P4|Overall Study|Progressive disease|5
831933|NCT01870726|2733772|P3|Overall Study|Progressive disease|4
831934|NCT01870726|2733773|P2|Overall Study|Progressive disease|5
831935|NCT01870726|2733774|P1|Overall Study|Progressive disease|5
831936|NCT01870726|2733768|P7|Overall Study|Adverse Event|0
831937|NCT01870726|2733769|P6|Overall Study|Adverse Event|1
831938|NCT01870726|2733770|P5|Overall Study|Adverse Event|1
831939|NCT01870726|2733771|P4|Overall Study|Adverse Event|0
831940|NCT01870726|2733772|P3|Overall Study|Adverse Event|0
831941|NCT01870726|2733773|P2|Overall Study|Adverse Event|0
831942|NCT01870726|2733774|P1|Overall Study|Adverse Event|0
831943|NCT01870726|2733768|P7|Overall Study|Withdrawal by Subject|0
831944|NCT01870726|2733769|P6|Overall Study|Withdrawal by Subject|0
831945|NCT01870726|2733770|P5|Overall Study|Withdrawal by Subject|0
831946|NCT01870726|2733771|P4|Overall Study|Withdrawal by Subject|0
831947|NCT01870726|2733772|P3|Overall Study|Withdrawal by Subject|0
831948|NCT01870726|2733773|P2|Overall Study|Withdrawal by Subject|1
831949|NCT01870726|2733774|P1|Overall Study|Withdrawal by Subject|0
831950|NCT01870726|2733768|P7|Overall Study|Withdrawal of informed consent|0
831951|NCT01870726|2733769|P6|Overall Study|Withdrawal of informed consent|0
831952|NCT01870726|2733770|P5|Overall Study|Withdrawal of informed consent|0
831953|NCT01870726|2733771|P4|Overall Study|Withdrawal of informed consent|1
831954|NCT01870726|2733772|P3|Overall Study|Withdrawal of informed consent|0
831955|NCT01870726|2733773|P2|Overall Study|Withdrawal of informed consent|0
831956|NCT01870726|2733774|P1|Overall Study|Withdrawal of informed consent|0
831957|NCT01870583|2733869|P3|Overall Study|Lost to Follow-up|5
831958|NCT01870583|2733870|P2|Overall Study|Lost to Follow-up|13
831959|NCT01870583|2733871|P1|Overall Study|Lost to Follow-up|11
831960|NCT01870583|2733869|P3|Overall Study|Protocol Violation|3
831961|NCT01870583|2733870|P2|Overall Study|Protocol Violation|5
831962|NCT01870583|2733871|P1|Overall Study|Protocol Violation|0
831963|NCT01870076|2733894|P4|Overall Study|Withdrawal by Subject|0
831964|NCT01870076|2733895|P3|Overall Study|Withdrawal by Subject|1
831965|NCT01870076|2733896|P2|Overall Study|Withdrawal by Subject|0
831966|NCT01870076|2733897|P1|Overall Study|Withdrawal by Subject|1
831967|NCT01869959|2733915|P5|Treatment Period|Withdrawal by Subject|0
831968|NCT01869959|2733916|P4|Treatment Period|Withdrawal by Subject|0
831969|NCT01869959|2733917|P3|Treatment Period|Withdrawal by Subject|0
831970|NCT01869959|2733918|P2|Treatment Period|Withdrawal by Subject|1
831971|NCT01869959|2733919|P1|Treatment Period|Withdrawal by Subject|0
831972|NCT01869959|2733915|P5|Treatment Period|Sponsor decision|0
831973|NCT01869959|2733916|P4|Treatment Period|Sponsor decision|1
831974|NCT01869959|2733917|P3|Treatment Period|Sponsor decision|0
831975|NCT01869959|2733918|P2|Treatment Period|Sponsor decision|1
831976|NCT01869959|2733919|P1|Treatment Period|Sponsor decision|0
831977|NCT01869959|2733915|P5|Treatment Period|Adverse Event|0
831978|NCT01869959|2733916|P4|Treatment Period|Adverse Event|1
831979|NCT01869959|2733917|P3|Treatment Period|Adverse Event|3
831980|NCT01869959|2733918|P2|Treatment Period|Adverse Event|0
831981|NCT01869959|2733919|P1|Treatment Period|Adverse Event|1
831982|NCT01869959|2733915|P5|Randomization Period|Physician Decision|1
831983|NCT01869959|2733916|P4|Randomization Period|Physician Decision|0
831984|NCT01869959|2733917|P3|Randomization Period|Physician Decision|0
831985|NCT01869959|2733918|P2|Randomization Period|Physician Decision|0
831986|NCT01869959|2733919|P1|Randomization Period|Physician Decision|0
831987|NCT01869699|2733989|P2|Overall Study|Withdrawal by Subject|0
831988|NCT01869699|2733990|P1|Overall Study|Withdrawal by Subject|1
831989|NCT01869348|2734053|P2|Overall Study|Withdrawal by Subject|1
831990|NCT01869348|2734054|P1|Overall Study|Withdrawal by Subject|1
831991|NCT01868997|2734087|P2|Overall Study|Not Specified|1
831992|NCT01868997|2734088|P1|Overall Study|Not Specified|3
831993|NCT01868997|2734087|P2|Overall Study|Lack of Efficacy|0
831994|NCT01868997|2734088|P1|Overall Study|Lack of Efficacy|2
831995|NCT01868997|2734087|P2|Overall Study|Adverse Event|5
831996|NCT01868997|2734088|P1|Overall Study|Adverse Event|2
831997|NCT01868893|2734104|P1|Overall Study|Neutropenia|1
831998|NCT01868893|2734104|P1|Overall Study|Commercial availability of study drug|17
831999|NCT01868893|2734104|P1|Overall Study|Adverse Event|2
832000|NCT01868542|2734150|P2|Overall Study|Unclassified|1
832001|NCT01868542|2734151|P1|Overall Study|Unclassified|0
832002|NCT01868542|2734150|P2|Overall Study|Protocol Violation|1
832003|NCT01868542|2734151|P1|Overall Study|Protocol Violation|0
832004|NCT01868503|2734169|P1|Overall Study|Protocol Violation|1
832005|NCT01868503|2734169|P1|Overall Study|Withdrawal by Subject|1
832007|NCT01868477|2734180|P1|Overall Study|Withdrawal by Subject|1
832008|NCT01868477|2734179|P2|Overall Study|Disease progression|1
832009|NCT01868477|2734180|P1|Overall Study|Disease progression|1
832010|NCT01868477|2734179|P2|Overall Study|Adverse Event|4
832011|NCT01868477|2734180|P1|Overall Study|Adverse Event|2
832012|NCT01868243|2734251|P2|Overall Study|Death|1
832013|NCT01868243|2734252|P1|Overall Study|Death|0
832014|NCT01868074|2734262|P2|Overall Study|Withdrawal by Subject|2
832015|NCT01868074|2734263|P1|Overall Study|Withdrawal by Subject|4
832016|NCT01868074|2734262|P2|Overall Study|Lost to Follow-up|2
832017|NCT01868074|2734263|P1|Overall Study|Lost to Follow-up|3
832018|NCT01868035|2734273|P1|Overall Study|Non-compliance|1
832019|NCT01868035|2734273|P1|Overall Study|Progressive Disease|2
832020|NCT01868035|2734273|P1|Overall Study|Withdrawal by Subject|1
832021|NCT01868035|2734273|P1|Overall Study|Lost to Follow-up|3
832022|NCT01868009|2734289|P2|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0
832023|NCT01868009|2734290|P1|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1
832024|NCT01868009|2734289|P2|Period 2 (5-9 Days)|Adverse Event|0
832025|NCT01868009|2734290|P1|Period 2 (5-9 Days)|Adverse Event|1
832026|NCT01868009|2734289|P2|Period 1 (5-9 Days)|Adverse Event|2
832027|NCT01868009|2734290|P1|Period 1 (5-9 Days)|Adverse Event|0
832028|NCT01867710|2734304|P4|Overall Study|Other|0
832029|NCT01867710|2734305|P3|Overall Study|Other|0
832030|NCT01867710|2734306|P2|Overall Study|Other|1
832031|NCT01867710|2734307|P1|Overall Study|Other|0
832032|NCT01867710|2734304|P4|Overall Study|Eligible Criteria Not Met|0
832033|NCT01867710|2734305|P3|Overall Study|Eligible Criteria Not Met|1
832034|NCT01867710|2734306|P2|Overall Study|Eligible Criteria Not Met|0
832035|NCT01867710|2734307|P1|Overall Study|Eligible Criteria Not Met|0
832036|NCT01867710|2734304|P4|Overall Study|Withdrawal by Subject|0
832037|NCT01867710|2734305|P3|Overall Study|Withdrawal by Subject|0
832038|NCT01867710|2734306|P2|Overall Study|Withdrawal by Subject|1
832039|NCT01867710|2734307|P1|Overall Study|Withdrawal by Subject|0
832040|NCT01867710|2734304|P4|Overall Study|Protocol Violation|1
832041|NCT01867710|2734305|P3|Overall Study|Protocol Violation|0
832042|NCT01867710|2734306|P2|Overall Study|Protocol Violation|0
832043|NCT01867710|2734307|P1|Overall Study|Protocol Violation|1
832044|NCT01867710|2734304|P4|Overall Study|Physician Decision|0
832045|NCT01867710|2734305|P3|Overall Study|Physician Decision|1
832046|NCT01867710|2734306|P2|Overall Study|Physician Decision|0
832047|NCT01867710|2734307|P1|Overall Study|Physician Decision|0
832048|NCT01867710|2734304|P4|Overall Study|Death|0
832049|NCT01867710|2734305|P3|Overall Study|Death|1
832050|NCT01867710|2734306|P2|Overall Study|Death|1
832051|NCT01867710|2734307|P1|Overall Study|Death|0
832052|NCT01867710|2734304|P4|Overall Study|Other Adverse Events|3
832053|NCT01867710|2734305|P3|Overall Study|Other Adverse Events|1
832054|NCT01867710|2734306|P2|Overall Study|Other Adverse Events|0
832055|NCT01867710|2734307|P1|Overall Study|Other Adverse Events|1
832056|NCT01867710|2734304|P4|Overall Study|Palliative Radiation Required|1
832057|NCT01867710|2734305|P3|Overall Study|Palliative Radiation Required|1
832058|NCT01867710|2734306|P2|Overall Study|Palliative Radiation Required|0
832059|NCT01867710|2734307|P1|Overall Study|Palliative Radiation Required|0
832060|NCT01867710|2734304|P4|Overall Study|Adverse Event Sustained Toxicity>Grade 1|0
832061|NCT01867710|2734305|P3|Overall Study|Adverse Event Sustained Toxicity>Grade 1|0
832062|NCT01867710|2734306|P2|Overall Study|Adverse Event Sustained Toxicity>Grade 1|0
832063|NCT01867710|2734307|P1|Overall Study|Adverse Event Sustained Toxicity>Grade 1|1
832064|NCT01867710|2734304|P4|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|0
832065|NCT01867710|2734305|P3|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|0
832066|NCT01867710|2734306|P2|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|2
832067|NCT01867710|2734307|P1|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|0
832068|NCT01867710|2734304|P4|Overall Study|Disease Progression|2
832069|NCT01867710|2734305|P3|Overall Study|Disease Progression|4
832070|NCT01867710|2734306|P2|Overall Study|Disease Progression|2
832071|NCT01867710|2734307|P1|Overall Study|Disease Progression|5
832072|NCT01867658|2734321|P1|Overall Study|Subject could not be contacted|1
832073|NCT01867658|2734321|P1|Overall Study|Death|2
832074|NCT01867658|2734321|P1|Overall Study|Withdrawal by Subject|6
832075|NCT01867580|2734345|P2|Overall Study|Wound recurrence|1
832076|NCT01867580|2734346|P1|Overall Study|Wound recurrence|0
832077|NCT01867580|2734345|P2|Overall Study|Continuation of therapy|1
832078|NCT01867580|2734346|P1|Overall Study|Continuation of therapy|0
832079|NCT01867580|2734345|P2|Overall Study|Osteomyelitis|1
832080|NCT01867580|2734346|P1|Overall Study|Osteomyelitis|0
832081|NCT01867580|2734345|P2|Overall Study|Interruption to therapy|0
832082|NCT01867580|2734346|P1|Overall Study|Interruption to therapy|3
832083|NCT01867580|2734345|P2|Overall Study|Missed follow-up assessment|1
832084|NCT01867580|2734346|P1|Overall Study|Missed follow-up assessment|2
832085|NCT01867580|2734345|P2|Overall Study|Sponsor terminated study|0
832086|NCT01867580|2734346|P1|Overall Study|Sponsor terminated study|1
832087|NCT01867580|2734345|P2|Overall Study|Lost to Follow-up|5
832088|NCT01867580|2734346|P1|Overall Study|Lost to Follow-up|3
832089|NCT01867580|2734345|P2|Overall Study|Physician Decision|12
832090|NCT01867580|2734346|P1|Overall Study|Physician Decision|17
832091|NCT01867580|2734345|P2|Overall Study|Withdrawal by Subject|3
832092|NCT01867580|2734346|P1|Overall Study|Withdrawal by Subject|2
832093|NCT01867424|2734371|P2|Overall Study|Patient noncompliance|1
832094|NCT01867424|2734372|P1|Overall Study|Patient noncompliance|2
832095|NCT01867307|2734386|P2|Overall Study|Other Adverse Event|3
832096|NCT01867307|2734387|P1|Overall Study|Other Adverse Event|1
832097|NCT01867307|2734386|P2|Overall Study|Protocol Violation|0
832098|NCT01867307|2734387|P1|Overall Study|Protocol Violation|2
832099|NCT01867216|2734400|P7|Overall Study|Unable to Place Catheter for Blood Draws|0
832100|NCT01867216|2734401|P6|Overall Study|Unable to Place Catheter for Blood Draws|0
832101|NCT01867216|2734402|P5|Overall Study|Unable to Place Catheter for Blood Draws|0
832102|NCT01867216|2734403|P4|Overall Study|Unable to Place Catheter for Blood Draws|0
832103|NCT01867216|2734404|P3|Overall Study|Unable to Place Catheter for Blood Draws|0
832104|NCT01867216|2734405|P2|Overall Study|Unable to Place Catheter for Blood Draws|0
832105|NCT01867216|2734406|P1|Overall Study|Unable to Place Catheter for Blood Draws|1
832106|NCT01867216|2734400|P7|Overall Study|Physician Decision|0
832107|NCT01867216|2734401|P6|Overall Study|Physician Decision|0
832108|NCT01867216|2734402|P5|Overall Study|Physician Decision|0
832109|NCT01867216|2734403|P4|Overall Study|Physician Decision|0
832110|NCT01867216|2734404|P3|Overall Study|Physician Decision|0
832111|NCT01867216|2734405|P2|Overall Study|Physician Decision|0
832112|NCT01867216|2734406|P1|Overall Study|Physician Decision|1
832113|NCT01867216|2734400|P7|Overall Study|Withdrawal by Subject|1
832114|NCT01867216|2734401|P6|Overall Study|Withdrawal by Subject|0
832115|NCT01867216|2734402|P5|Overall Study|Withdrawal by Subject|1
832116|NCT01867216|2734403|P4|Overall Study|Withdrawal by Subject|0
832117|NCT01867216|2734404|P3|Overall Study|Withdrawal by Subject|0
832118|NCT01867216|2734405|P2|Overall Study|Withdrawal by Subject|0
832119|NCT01867216|2734406|P1|Overall Study|Withdrawal by Subject|2
832120|NCT01867086|2734478|P1|Overall Study|Disease Progression|1
832121|NCT01867047|2734487|P2|Overall Study|surgery not indicated in protocol|2
832122|NCT01867047|2734488|P1|Overall Study|surgery not indicated in protocol|1
832123|NCT01867047|2734487|P2|Overall Study|Physician Decision|0
832124|NCT01867047|2734488|P1|Overall Study|Physician Decision|2
832125|NCT01867047|2734487|P2|Overall Study|Withdrawal by Subject|0
832126|NCT01867047|2734488|P1|Overall Study|Withdrawal by Subject|2
832127|NCT01867047|2734487|P2|Overall Study|Lost to Follow-up|3
832128|NCT01867047|2734488|P1|Overall Study|Lost to Follow-up|3
832129|NCT01867021|2734508|P2|Overall Study|Withdrawal by Subject|6
832130|NCT01867021|2734509|P1|Overall Study|Withdrawal by Subject|1
832131|NCT01867021|2734508|P2|Overall Study|Lost to Follow-up|2
832132|NCT01867021|2734509|P1|Overall Study|Lost to Follow-up|0
832133|NCT01867021|2734508|P2|Overall Study|Death|0
832134|NCT01867021|2734509|P1|Overall Study|Death|1
832135|NCT01867021|2734508|P2|Overall Study|Not Eligible|1
832136|NCT01867021|2734509|P1|Overall Study|Not Eligible|0
832137|NCT01867021|2734508|P2|Overall Study|Adverse Event|1
832138|NCT01867021|2734509|P1|Overall Study|Adverse Event|0
832139|NCT01866709|2734540|P2|Overall Study|Adverse Event|0
832140|NCT01866709|2734541|P1|Overall Study|Adverse Event|1
832141|NCT01866423|2734582|P1|Overall Study|Sponsor Decision|1
832142|NCT01866423|2734582|P1|Overall Study|Lack of Efficacy|3
832143|NCT01866319|2734595|P3|Overall Study|Remain on study|176
832144|NCT01866319|2734596|P2|Overall Study|Remain on study|190
832145|NCT01866319|2734597|P1|Overall Study|Remain on study|131
832146|NCT01866319|2734595|P3|Overall Study|Withdrawal by Subject|6
832147|NCT01866319|2734596|P2|Overall Study|Withdrawal by Subject|9
832148|NCT01866319|2734597|P1|Overall Study|Withdrawal by Subject|31
832149|NCT01866319|2734595|P3|Overall Study|Physician Decision|0
832150|NCT01866319|2734596|P2|Overall Study|Physician Decision|0
832151|NCT01866319|2734597|P1|Overall Study|Physician Decision|1
832152|NCT01866319|2734595|P3|Overall Study|Lost to Follow-up|6
832153|NCT01866319|2734596|P2|Overall Study|Lost to Follow-up|0
832154|NCT01866319|2734597|P1|Overall Study|Lost to Follow-up|3
832155|NCT01866319|2734595|P3|Overall Study|Death|77
832156|NCT01866319|2734596|P2|Overall Study|Death|74
832157|NCT01866319|2734597|P1|Overall Study|Death|97
832158|NCT01866319|2734595|P3|Overall Study|Clinical progression|0
832159|NCT01866319|2734596|P2|Overall Study|Clinical progression|0
832160|NCT01866319|2734597|P1|Overall Study|Clinical progression|1
832161|NCT01866319|2734595|P3|Overall Study|Adverse Event|12
832162|NCT01866319|2734596|P2|Overall Study|Adverse Event|6
832163|NCT01866319|2734597|P1|Overall Study|Adverse Event|13
832164|NCT01866293|2734696|P1|Overall Study|Adverse Event|2
832165|NCT01865812|2734738|P1|Overall Study|Adverse Event|2
832166|NCT01865747|2734746|P2|Primary Intent to Treat (PITT)|Other|1
832167|NCT01865747|2734747|P1|Primary Intent to Treat (PITT)|Other|0
832168|NCT01865747|2734746|P2|Primary Intent to Treat (PITT)|Progressive Disease|92
832169|NCT01865747|2734747|P1|Primary Intent to Treat (PITT)|Progressive Disease|82
832170|NCT01865747|2734746|P2|Primary Intent to Treat (PITT)|Withdrawal by Subject|7
832171|NCT01865747|2734747|P1|Primary Intent to Treat (PITT)|Withdrawal by Subject|3
832172|NCT01865747|2734746|P2|Primary Intent to Treat (PITT)|Physician Decision|2
832173|NCT01865747|2734747|P1|Primary Intent to Treat (PITT)|Physician Decision|4
832174|NCT01865747|2734746|P2|Primary Intent to Treat (PITT)|Protocol Violation|1
832175|NCT01865747|2734747|P1|Primary Intent to Treat (PITT)|Protocol Violation|1
832176|NCT01865747|2734746|P2|Primary Intent to Treat (PITT)|Lack of Efficacy|0
832177|NCT01865747|2734747|P1|Primary Intent to Treat (PITT)|Lack of Efficacy|2
832178|NCT01865747|2734746|P2|Primary Intent to Treat (PITT)|Clinical Deterioration|29
832179|NCT01865747|2734747|P1|Primary Intent to Treat (PITT)|Clinical Deterioration|18
832180|NCT01865747|2734746|P2|Primary Intent to Treat (PITT)|Adverse Event|20
832181|NCT01865747|2734747|P1|Primary Intent to Treat (PITT)|Adverse Event|21
832182|NCT01865747|2734746|P2|Overall Study (ITT)|Reason Not Provided|1
832183|NCT01865747|2734747|P1|Overall Study (ITT)|Reason Not Provided|0
832184|NCT01865747|2734746|P2|Overall Study (ITT)|Progressive Disease|158
832185|NCT01865747|2734747|P1|Overall Study (ITT)|Progressive Disease|122
832186|NCT01865747|2734746|P2|Overall Study (ITT)|Sponsor Decision|1
832187|NCT01865747|2734747|P1|Overall Study (ITT)|Sponsor Decision|0
832188|NCT01865747|2734746|P2|Overall Study (ITT)|Withdrawal by Subject|11
832189|NCT01865747|2734747|P1|Overall Study (ITT)|Withdrawal by Subject|6
832190|NCT01865747|2734746|P2|Overall Study (ITT)|Physician Decision|2
832191|NCT01865747|2734747|P1|Overall Study (ITT)|Physician Decision|5
832192|NCT01865747|2734746|P2|Overall Study (ITT)|Protocol Violation|1
832193|NCT01865747|2734747|P1|Overall Study (ITT)|Protocol Violation|1
832194|NCT01865747|2734746|P2|Overall Study (ITT)|Lack of Efficacy|0
832195|NCT01865747|2734747|P1|Overall Study (ITT)|Lack of Efficacy|3
832196|NCT01865747|2734746|P2|Overall Study (ITT)|Clinical Deterioration|50
832197|NCT01865747|2734747|P1|Overall Study (ITT)|Clinical Deterioration|29
832198|NCT01865747|2734746|P2|Overall Study (ITT)|Adverse Event|31
832199|NCT01865747|2734747|P1|Overall Study (ITT)|Adverse Event|32
832200|NCT01865084|2734765|P3|Open Label Extension (OLE) Period|Withdrawal by Subject|2
832201|NCT01865084|2734766|P2|Open Label Extension (OLE) Period|Withdrawal by Subject|2
832202|NCT01865084|2734767|P1|Open Label Extension (OLE) Period|Withdrawal by Subject|0
832203|NCT01865084|2734765|P3|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2
832204|NCT01865084|2734766|P2|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8
832205|NCT01865084|2734767|P1|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0
832206|NCT01865084|2734765|P3|Open Label Extension (OLE) Period|Lost to Follow-up|0
832207|NCT01865084|2734766|P2|Open Label Extension (OLE) Period|Lost to Follow-up|1
832208|NCT01865084|2734767|P1|Open Label Extension (OLE) Period|Lost to Follow-up|0
832209|NCT01865084|2734765|P3|Open Label Extension (OLE) Period|Lack of Efficacy|2
832210|NCT01865084|2734766|P2|Open Label Extension (OLE) Period|Lack of Efficacy|0
832211|NCT01865084|2734767|P1|Open Label Extension (OLE) Period|Lack of Efficacy|0
832212|NCT01865084|2734765|P3|Open Label Extension (OLE) Period|Adverse Event|1
832213|NCT01865084|2734766|P2|Open Label Extension (OLE) Period|Adverse Event|0
832214|NCT01865084|2734767|P1|Open Label Extension (OLE) Period|Adverse Event|0
832215|NCT01865084|2734765|P3|Double Blind Period (DB)|Withdrawal by Subject|0
832216|NCT01865084|2734766|P2|Double Blind Period (DB)|Withdrawal by Subject|0
832217|NCT01865084|2734767|P1|Double Blind Period (DB)|Withdrawal by Subject|1
832218|NCT01865084|2734765|P3|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4
832219|NCT01865084|2734766|P2|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
832220|NCT01865084|2734767|P1|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
832221|NCT01865084|2734765|P3|Double Blind Period (DB)|Protocol Violation|1
832222|NCT01865084|2734766|P2|Double Blind Period (DB)|Protocol Violation|0
832223|NCT01865084|2734767|P1|Double Blind Period (DB)|Protocol Violation|0
832224|NCT01865084|2734765|P3|Double Blind Period (DB)|Adverse Event|1
832225|NCT01865084|2734766|P2|Double Blind Period (DB)|Adverse Event|2
832226|NCT01865084|2734767|P1|Double Blind Period (DB)|Adverse Event|2
832227|NCT01864525|2734799|P2|Overall Study|Adverse Event|0
832228|NCT01864525|2734800|P1|Overall Study|Adverse Event|1
832229|NCT01864200|2734823|P2|Overall Study|Protocol Violation|0
832230|NCT01864200|2734824|P1|Overall Study|Protocol Violation|1
832231|NCT01864200|2734823|P2|Overall Study|Lost to Follow-up|3
832232|NCT01864200|2734824|P1|Overall Study|Lost to Follow-up|1
832233|NCT01864174|2734832|P2|Off Treatment Follow-Up|Subject Withdrew Consent|0
832234|NCT01864174|2734833|P1|Off Treatment Follow-Up|Subject Withdrew Consent|1
832235|NCT01864174|2734832|P2|Off Treatment Follow-Up|Other|0
832236|NCT01864174|2734833|P1|Off Treatment Follow-Up|Other|2
832237|NCT01864174|2734832|P2|Double Blind - Compliant Randomized|Other|10
832238|NCT01864174|2734833|P1|Double Blind - Compliant Randomized|Other|6
832239|NCT01864174|2734832|P2|Double Blind - Compliant Randomized|Poor/Non-compliance|0
832240|NCT01864174|2734833|P1|Double Blind - Compliant Randomized|Poor/Non-compliance|1
832241|NCT01864174|2734832|P2|Double Blind - Compliant Randomized|Lost to Follow-up|10
832242|NCT01864174|2734833|P1|Double Blind - Compliant Randomized|Lost to Follow-up|3
832243|NCT01864174|2734832|P2|Double Blind - Compliant Randomized|Death|0
832244|NCT01864174|2734833|P1|Double Blind - Compliant Randomized|Death|1
832245|NCT01864174|2734832|P2|Double Blind - Compliant Randomized|Subject Withdrew Consent|5
832246|NCT01864174|2734833|P1|Double Blind - Compliant Randomized|Subject Withdrew Consent|4
832247|NCT01864174|2734832|P2|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0
832248|NCT01864174|2734833|P1|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2
832249|NCT01864174|2734832|P2|Double Blind - Compliant Randomized|Adverse Event|1
832250|NCT01864174|2734833|P1|Double Blind - Compliant Randomized|Adverse Event|6
832251|NCT01864174|2734832|P2|Double Blind Treatment - All Treated|Removed due to site non-compliance|14
832252|NCT01864174|2734833|P1|Double Blind Treatment - All Treated|Removed due to site non-compliance|15
832253|NCT01864148|2734852|P5|Overall Study|Not Dosed|0
832254|NCT01864148|2734853|P4|Overall Study|Not Dosed|1
832255|NCT01864148|2734854|P3|Overall Study|Not Dosed|0
832256|NCT01864148|2734855|P2|Overall Study|Not Dosed|0
832257|NCT01864148|2734856|P1|Overall Study|Not Dosed|0
832258|NCT01864148|2734852|P5|Overall Study|Adverse Event|7
832259|NCT01864148|2734853|P4|Overall Study|Adverse Event|7
832260|NCT01864148|2734854|P3|Overall Study|Adverse Event|4
832261|NCT01864148|2734855|P2|Overall Study|Adverse Event|2
832262|NCT01864148|2734856|P1|Overall Study|Adverse Event|4
832263|NCT01864148|2734852|P5|Overall Study|Lost to Follow-up|1
832264|NCT01864148|2734853|P4|Overall Study|Lost to Follow-up|2
832265|NCT01864148|2734854|P3|Overall Study|Lost to Follow-up|0
832266|NCT01864148|2734855|P2|Overall Study|Lost to Follow-up|0
832267|NCT01864148|2734856|P1|Overall Study|Lost to Follow-up|0
832268|NCT01864148|2734852|P5|Overall Study|Withdrawal by Subject|8
832269|NCT01864148|2734853|P4|Overall Study|Withdrawal by Subject|8
832270|NCT01864148|2734854|P3|Overall Study|Withdrawal by Subject|6
832271|NCT01864148|2734855|P2|Overall Study|Withdrawal by Subject|2
832272|NCT01864148|2734856|P1|Overall Study|Withdrawal by Subject|9
832273|NCT01864148|2734852|P5|Overall Study|Investigator Decision|6
832274|NCT01864148|2734853|P4|Overall Study|Investigator Decision|4
832275|NCT01864148|2734854|P3|Overall Study|Investigator Decision|0
832276|NCT01864148|2734855|P2|Overall Study|Investigator Decision|0
832277|NCT01864148|2734856|P1|Overall Study|Investigator Decision|5
832278|NCT01864148|2734852|P5|Overall Study|Death|0
832279|NCT01864148|2734853|P4|Overall Study|Death|1
832280|NCT01864148|2734854|P3|Overall Study|Death|0
832281|NCT01864148|2734855|P2|Overall Study|Death|0
832282|NCT01864148|2734856|P1|Overall Study|Death|0
832283|NCT01864148|2734852|P5|Overall Study|Not Specified|1
832284|NCT01864148|2734853|P4|Overall Study|Not Specified|3
832285|NCT01864148|2734854|P3|Overall Study|Not Specified|1
832286|NCT01864148|2734855|P2|Overall Study|Not Specified|1
832287|NCT01864148|2734856|P1|Overall Study|Not Specified|2
832288|NCT01864005|2734885|P2|Overall Study|Need GP IIb/IIIa|3
832289|NCT01864005|2734886|P1|Overall Study|Need GP IIb/IIIa|1
832290|NCT01864005|2734885|P2|Overall Study|Disease need|1
832291|NCT01864005|2734886|P1|Overall Study|Disease need|1
832292|NCT01864005|2734885|P2|Overall Study|Incorrect enrolment|0
832293|NCT01864005|2734886|P1|Overall Study|Incorrect enrolment|1
832294|NCT01864005|2734885|P2|Overall Study|Withdrawal by Subject|1
832295|NCT01864005|2734886|P1|Overall Study|Withdrawal by Subject|0
832296|NCT01864005|2734885|P2|Overall Study|Protocol Violation|1
832297|NCT01864005|2734886|P1|Overall Study|Protocol Violation|0
832298|NCT01863953|2734903|P3|Overall Study|Adverse Event|1
832299|NCT01863953|2734904|P2|Overall Study|Adverse Event|0
832300|NCT01863953|2734905|P1|Overall Study|Adverse Event|0
832301|NCT01863771|2734919|P4|Maintenance Phase|Withdrawal by Subject|3
832302|NCT01863771|2734920|P3|Maintenance Phase|Withdrawal by Subject|2
832303|NCT01863771|2734921|P2|Maintenance Phase|Withdrawal by Subject|1
832304|NCT01863771|2734922|P1|Maintenance Phase|Withdrawal by Subject|0
832305|NCT01863771|2734919|P4|Maintenance Phase|Pregnancy|0
832306|NCT01863771|2734920|P3|Maintenance Phase|Pregnancy|0
832307|NCT01863771|2734921|P2|Maintenance Phase|Pregnancy|1
832308|NCT01863771|2734922|P1|Maintenance Phase|Pregnancy|0
832309|NCT01863771|2734919|P4|Maintenance Phase|Physician Decision|1
832310|NCT01863771|2734920|P3|Maintenance Phase|Physician Decision|2
832311|NCT01863771|2734921|P2|Maintenance Phase|Physician Decision|0
832312|NCT01863771|2734922|P1|Maintenance Phase|Physician Decision|0
832313|NCT01863771|2734919|P4|Maintenance Phase|Lack of Efficacy|38
832314|NCT01863771|2734920|P3|Maintenance Phase|Lack of Efficacy|7
832315|NCT01863771|2734921|P2|Maintenance Phase|Lack of Efficacy|3
832316|NCT01863771|2734922|P1|Maintenance Phase|Lack of Efficacy|0
832317|NCT01863771|2734919|P4|Maintenance Phase|Adverse Event|1
832318|NCT01863771|2734920|P3|Maintenance Phase|Adverse Event|1
832319|NCT01863771|2734921|P2|Maintenance Phase|Adverse Event|0
832320|NCT01863771|2734922|P1|Maintenance Phase|Adverse Event|0
832321|NCT01863771|2734919|P4|Induction Phase|Withdrawal by Subject|0
832322|NCT01863771|2734920|P3|Induction Phase|Withdrawal by Subject|0
832323|NCT01863771|2734921|P2|Induction Phase|Withdrawal by Subject|0
832324|NCT01863771|2734922|P1|Induction Phase|Withdrawal by Subject|2
832325|NCT01863771|2734919|P4|Induction Phase|Lack of Efficacy|0
832326|NCT01863771|2734920|P3|Induction Phase|Lack of Efficacy|0
832327|NCT01863771|2734921|P2|Induction Phase|Lack of Efficacy|0
832328|NCT01863771|2734922|P1|Induction Phase|Lack of Efficacy|10
832329|NCT01863771|2734919|P4|Induction Phase|Adverse Event|0
832330|NCT01863771|2734920|P3|Induction Phase|Adverse Event|0
832331|NCT01863771|2734921|P2|Induction Phase|Adverse Event|0
832332|NCT01863771|2734922|P1|Induction Phase|Adverse Event|9
832333|NCT01863758|2734934|P1|Prophylactic Treatment-Phase II|Lost to Follow-up|1
832334|NCT01863758|2734934|P1|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1
832335|NCT01863680|2734942|P1|Overall Study|Other|6
832336|NCT01863680|2734942|P1|Overall Study|Did not undergo IVF/ET|14
832337|NCT01863680|2734942|P1|Overall Study|Withdrawal by Subject|1
832338|NCT01863680|2734942|P1|Overall Study|Spontaneous pregnancy|2
832339|NCT01863680|2734942|P1|Overall Study|Risk of OHSS|17
832340|NCT01863680|2734942|P1|Overall Study|Adverse Event|17
832341|NCT01863667|2734950|P2|Overall Study|Withdrawal by Subject|2
832342|NCT01863667|2734951|P1|Overall Study|Withdrawal by Subject|2
832343|NCT01863667|2734950|P2|Overall Study|Study terminated by Sponsor|30
832344|NCT01863667|2734951|P1|Overall Study|Study terminated by Sponsor|30
832345|NCT01863667|2734950|P2|Overall Study|Adverse Event|0
832346|NCT01863667|2734951|P1|Overall Study|Adverse Event|1
832347|NCT01863433|2734975|P1|Overall Study|Protocol Violation|1
832348|NCT01863368|2734985|P2|Phase II, Day 35 to Day 90|Lost to Follow-up|0
832349|NCT01863368|2734986|P1|Phase II, Day 35 to Day 90|Lost to Follow-up|1
832350|NCT01863368|2734985|P2|Phase II, Day 35 to Day 90|Adverse Event|0
832351|NCT01863368|2734986|P1|Phase II, Day 35 to Day 90|Adverse Event|1
832352|NCT01863368|2734985|P2|Phase I, Day 0 to Day 35|Withdrawal by Subject|2
832353|NCT01863368|2734986|P1|Phase I, Day 0 to Day 35|Withdrawal by Subject|0
832354|NCT01863368|2734985|P2|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1
832355|NCT01863368|2734986|P1|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0
832356|NCT01863368|2734985|P2|Phase I, Day 0 to Day 35|Lost to Follow-up|0
832357|NCT01863368|2734986|P1|Phase I, Day 0 to Day 35|Lost to Follow-up|1
832358|NCT01863368|2734985|P2|Phase I, Day 0 to Day 35|Adverse Event|4
832359|NCT01863368|2734986|P1|Phase I, Day 0 to Day 35|Adverse Event|2
832360|NCT01862991|2735011|P3|Overall Study|Protocol Violation|0
832361|NCT01862991|2735012|P2|Overall Study|Protocol Violation|0
832362|NCT01862991|2735013|P1|Overall Study|Protocol Violation|1
832363|NCT01862991|2735011|P3|Overall Study|Lost to Follow-up|1
832364|NCT01862991|2735012|P2|Overall Study|Lost to Follow-up|1
832365|NCT01862991|2735013|P1|Overall Study|Lost to Follow-up|2
832366|NCT01862874|2735026|P2|Overall Study|Death|1
832367|NCT01862874|2735027|P1|Overall Study|Death|0
832368|NCT01862874|2735026|P2|Overall Study|Withdrawal by Subject|40
832369|NCT01862874|2735027|P1|Overall Study|Withdrawal by Subject|46
832370|NCT01862874|2735026|P2|Overall Study|Withdrawn by parent/guardian|1
832371|NCT01862874|2735027|P1|Overall Study|Withdrawn by parent/guardian|1
832372|NCT01862874|2735026|P2|Overall Study|Physician Decision|3
832373|NCT01862874|2735027|P1|Overall Study|Physician Decision|5
832374|NCT01862874|2735026|P2|Overall Study|Lost to Follow-up|29
832375|NCT01862874|2735027|P1|Overall Study|Lost to Follow-up|26
832376|NCT01862874|2735026|P2|Overall Study|Adverse Event|3
832377|NCT01862874|2735027|P1|Overall Study|Adverse Event|0
832378|NCT01862874|2735026|P2|Overall Study|Randomized not treated|0
832379|NCT01862874|2735027|P1|Overall Study|Randomized not treated|1
832380|NCT01862484|2735045|P2|Overall Study|Withdrawal by Subject|3
832381|NCT01862484|2735046|P1|Overall Study|Withdrawal by Subject|0
832382|NCT01862484|2735045|P2|Overall Study|Protocol Violation|2
832383|NCT01862484|2735046|P1|Overall Study|Protocol Violation|0
832384|NCT01862484|2735045|P2|Overall Study|Lost to Follow-up|2
832385|NCT01862484|2735046|P1|Overall Study|Lost to Follow-up|1
832386|NCT01862484|2735045|P2|Overall Study|Lack of Efficacy|1
832387|NCT01862484|2735046|P1|Overall Study|Lack of Efficacy|1
832388|NCT01862250|2735065|P1|Overall Study|Adverse Event|4
832389|NCT01862029|2735086|P1|Overall Study|Physician Decision|1
832390|NCT01861522|2735189|P2|Overall Study|Withdrawal by Subject|0
832391|NCT01861522|2735190|P1|Overall Study|Withdrawal by Subject|2
832392|NCT01861522|2735189|P2|Overall Study|Adverse Event|0
832393|NCT01861522|2735190|P1|Overall Study|Adverse Event|1
832394|NCT01860989|2735214|P1|Overall Study|Unsatisfactory therapeutic|5
832395|NCT01860976|2735220|P2|Long Term Extension|Ongoing treatment at time of analysis|100
832396|NCT01860976|2735221|P1|Long Term Extension|Ongoing treatment at time of analysis|106
832397|NCT01860976|2735220|P2|Long Term Extension|Withdrawal by Subject|0
832398|NCT01860976|2735221|P1|Long Term Extension|Withdrawal by Subject|1
832399|NCT01860976|2735220|P2|Long Term Extension|Subject request to discontinue treatment|0
832400|NCT01860976|2735221|P1|Long Term Extension|Subject request to discontinue treatment|2
832401|NCT01860976|2735220|P2|Long Term Extension|Lack of Efficacy|7
832402|NCT01860976|2735221|P1|Long Term Extension|Lack of Efficacy|3
832403|NCT01860976|2735220|P2|Long Term Extension|Adverse Event|0
832404|NCT01860976|2735221|P1|Long Term Extension|Adverse Event|1
832405|NCT01860976|2735220|P2|Open-Label|Ongoing OL treatment at time of analysis|45
832406|NCT01860976|2735221|P1|Open-Label|Ongoing OL treatment at time of analysis|46
832407|NCT01860976|2735220|P2|Open-Label|Other Reasons|1
832408|NCT01860976|2735221|P1|Open-Label|Other Reasons|1
832409|NCT01860976|2735220|P2|Open-Label|Withdrawal by Subject|1
832410|NCT01860976|2735221|P1|Open-Label|Withdrawal by Subject|4
832411|NCT01860976|2735220|P2|Open-Label|Subject request discontinue treatment|3
832412|NCT01860976|2735221|P1|Open-Label|Subject request discontinue treatment|4
832413|NCT01860976|2735220|P2|Open-Label|Lost to Follow-up|2
832414|NCT01860976|2735221|P1|Open-Label|Lost to Follow-up|1
832415|NCT01860976|2735220|P2|Open-Label|Lack of Efficacy|8
832416|NCT01860976|2735221|P1|Open-Label|Lack of Efficacy|16
832417|NCT01860976|2735220|P2|Open-Label|Adverse Event|4
832418|NCT01860976|2735221|P1|Open-Label|Adverse Event|2
832419|NCT01860976|2735220|P2|Blinded Treatment|Early Escape: Transitioned to OL period|89
832420|NCT01860976|2735221|P1|Blinded Treatment|Early Escape: Transitioned to OL period|76
832421|NCT01860976|2735220|P2|Blinded Treatment|Entered Open-Label in error|1
832422|NCT01860976|2735221|P1|Blinded Treatment|Entered Open-Label in error|0
832423|NCT01860976|2735220|P2|Blinded Treatment|Subject no longer met criteria|0
832424|NCT01860976|2735221|P1|Blinded Treatment|Subject no longer met criteria|1
832425|NCT01860976|2735220|P2|Blinded Treatment|Withdrawal by Subject|5
832426|NCT01860976|2735221|P1|Blinded Treatment|Withdrawal by Subject|3
832427|NCT01860976|2735220|P2|Blinded Treatment|Subject request to discontinue treatment|3
832428|NCT01860976|2735221|P1|Blinded Treatment|Subject request to discontinue treatment|2
832429|NCT01860976|2735220|P2|Blinded Treatment|Lack of Efficacy|12
832430|NCT01860976|2735221|P1|Blinded Treatment|Lack of Efficacy|5
832431|NCT01860976|2735220|P2|Blinded Treatment|Adverse Event|3
832432|NCT01860976|2735221|P1|Blinded Treatment|Adverse Event|1
832433|NCT01860846|2735243|P1|Overall Study|Lost to Follow-up|33
832434|NCT01860703|2735254|P4|Overall Study|Personal reason|0
832435|NCT01860703|2735255|P3|Overall Study|Personal reason|1
832436|NCT01860703|2735256|P2|Overall Study|Personal reason|0
832437|NCT01860703|2735257|P1|Overall Study|Personal reason|1
832438|NCT01860703|2735254|P4|Overall Study|Withdrawal by Subject|0
832439|NCT01860703|2735255|P3|Overall Study|Withdrawal by Subject|0
832440|NCT01860703|2735256|P2|Overall Study|Withdrawal by Subject|1
832441|NCT01860703|2735257|P1|Overall Study|Withdrawal by Subject|0
832442|NCT01860703|2735254|P4|Overall Study|Adverse Event|2
832443|NCT01860703|2735255|P3|Overall Study|Adverse Event|0
832444|NCT01860703|2735256|P2|Overall Study|Adverse Event|4
832445|NCT01860703|2735257|P1|Overall Study|Adverse Event|1
832446|NCT01860677|2735289|P2|Second Intervention (1 Day)|Lost to Follow-up|0
832447|NCT01860677|2735290|P1|Second Intervention (1 Day)|Lost to Follow-up|7
832448|NCT01860534|2735328|P2|ROP #2|discharged prior to ROP #2|0
832449|NCT01860534|2735329|P1|ROP #2|discharged prior to ROP #2|1
832450|NCT01860534|2735328|P2|ROP #1|Needed treatment for ROP|1
832451|NCT01860534|2735329|P1|ROP #1|Needed treatment for ROP|0
832452|NCT01860079|2735377|P2|Overall Study|Physician Decision|22
832453|NCT01860079|2735378|P1|Overall Study|Physician Decision|14
832454|NCT01860040|2735386|P2|Overall Study|Withdrawal by Subject|0
832455|NCT01860040|2735387|P1|Overall Study|Withdrawal by Subject|1
832456|NCT01859988|2735398|P6|Overall Study|Other than specified above|3
832457|NCT01859988|2735399|P5|Overall Study|Other than specified above|5
832458|NCT01859988|2735400|P4|Overall Study|Other than specified above|3
832459|NCT01859988|2735401|P3|Overall Study|Other than specified above|11
832460|NCT01859988|2735402|P2|Overall Study|Other than specified above|2
832461|NCT01859988|2735403|P1|Overall Study|Other than specified above|0
832462|NCT01859988|2735398|P6|Overall Study|Protocol Violation|0
832463|NCT01859988|2735399|P5|Overall Study|Protocol Violation|0
832464|NCT01859988|2735400|P4|Overall Study|Protocol Violation|0
832465|NCT01859988|2735401|P3|Overall Study|Protocol Violation|1
832466|NCT01859988|2735402|P2|Overall Study|Protocol Violation|0
832467|NCT01859988|2735403|P1|Overall Study|Protocol Violation|0
832468|NCT01859988|2735398|P6|Overall Study|Lost to Follow-up|2
832469|NCT01859988|2735399|P5|Overall Study|Lost to Follow-up|3
832470|NCT01859988|2735400|P4|Overall Study|Lost to Follow-up|0
832471|NCT01859988|2735401|P3|Overall Study|Lost to Follow-up|3
832472|NCT01859988|2735402|P2|Overall Study|Lost to Follow-up|2
832473|NCT01859988|2735403|P1|Overall Study|Lost to Follow-up|1
832474|NCT01859988|2735398|P6|Overall Study|Adverse Event|2
832475|NCT01859988|2735399|P5|Overall Study|Adverse Event|2
832476|NCT01859988|2735400|P4|Overall Study|Adverse Event|1
832477|NCT01859988|2735401|P3|Overall Study|Adverse Event|3
832478|NCT01859988|2735402|P2|Overall Study|Adverse Event|1
832479|NCT01859988|2735403|P1|Overall Study|Adverse Event|2
832480|NCT01859988|2735398|P6|Overall Study|Physician Decision|1
832481|NCT01859988|2735399|P5|Overall Study|Physician Decision|4
832482|NCT01859988|2735400|P4|Overall Study|Physician Decision|3
832483|NCT01859988|2735401|P3|Overall Study|Physician Decision|1
832484|NCT01859988|2735402|P2|Overall Study|Physician Decision|3
832485|NCT01859988|2735403|P1|Overall Study|Physician Decision|1
832486|NCT01859988|2735398|P6|Overall Study|Lack of Efficacy|9
832487|NCT01859988|2735399|P5|Overall Study|Lack of Efficacy|7
832488|NCT01859988|2735400|P4|Overall Study|Lack of Efficacy|0
832489|NCT01859988|2735401|P3|Overall Study|Lack of Efficacy|5
832490|NCT01859988|2735402|P2|Overall Study|Lack of Efficacy|1
832491|NCT01859988|2735403|P1|Overall Study|Lack of Efficacy|1
832492|NCT01859988|2735398|P6|Overall Study|Withdrawal by Subject|2
832493|NCT01859988|2735399|P5|Overall Study|Withdrawal by Subject|2
832494|NCT01859988|2735400|P4|Overall Study|Withdrawal by Subject|3
832495|NCT01859988|2735401|P3|Overall Study|Withdrawal by Subject|4
832496|NCT01859988|2735402|P2|Overall Study|Withdrawal by Subject|3
832497|NCT01859988|2735403|P1|Overall Study|Withdrawal by Subject|6
832498|NCT01859949|2735497|P2|Overall Study|Adverse Event|1
832499|NCT01859949|2735498|P1|Overall Study|Adverse Event|0
832500|NCT01859949|2735497|P2|Overall Study|Protocol Violation|1
832501|NCT01859949|2735498|P1|Overall Study|Protocol Violation|1
832502|NCT01859949|2735497|P2|Overall Study|Withdrawal by Subject|10
832503|NCT01859949|2735498|P1|Overall Study|Withdrawal by Subject|11
832504|NCT01859949|2735497|P2|Overall Study|Physician Decision|4
832505|NCT01859949|2735498|P1|Overall Study|Physician Decision|2
832506|NCT01859949|2735497|P2|Overall Study|Family Matters|1
832507|NCT01859949|2735498|P1|Overall Study|Family Matters|0
832508|NCT01859793|2735516|P2|Washout Period (4 Weeks)|Lost to Follow-up|1
832509|NCT01859793|2735517|P1|Washout Period (4 Weeks)|Lost to Follow-up|1
832510|NCT01859793|2735516|P2|First Intervention (8 Weeks)|Withdrawal by Subject|1
832511|NCT01859793|2735517|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
832512|NCT01859793|2735516|P2|First Intervention (8 Weeks)|Adverse Event|0
832513|NCT01859793|2735517|P1|First Intervention (8 Weeks)|Adverse Event|1
832514|NCT01859793|2735516|P2|First Intervention (8 Weeks)|Protocol Violation|0
832515|NCT01859793|2735517|P1|First Intervention (8 Weeks)|Protocol Violation|2
832516|NCT01859715|2735530|P3|Overall Study|No 2nd VAS|23
832517|NCT01859715|2735531|P2|Overall Study|No 2nd VAS|8
832518|NCT01859715|2735532|P1|Overall Study|No 2nd VAS|16
832519|NCT01859702|2735543|P1|Overall Study|Adverse Event|2
832520|NCT01859702|2735543|P1|Overall Study|Protocol deviation|3
832521|NCT01859598|2735557|P1|Visit 2 at 3 Months|Lost to Follow-up|1742
832522|NCT01859507|2735565|P1|Overall Study|left the country|4
832523|NCT01859494|2735570|P1|Overall Study|Adverse Event|1
832524|NCT01859390|2735581|P2|Overall Study|Shipment Error|1
832525|NCT01859390|2735582|P1|Overall Study|Shipment Error|0
832526|NCT01859390|2735581|P2|Overall Study|Tube Cracked|2
832527|NCT01859390|2735582|P1|Overall Study|Tube Cracked|0
832528|NCT01859390|2735581|P2|Overall Study|Sample Missing Collection Date|1
832529|NCT01859390|2735582|P1|Overall Study|Sample Missing Collection Date|0
832530|NCT01859390|2735581|P2|Overall Study|Insufficient Sputum Collected|3
832531|NCT01859390|2735582|P1|Overall Study|Insufficient Sputum Collected|1
832532|NCT01859143|2735716|P2|Overall Study|Lost to Follow-up|0
832533|NCT01859143|2735717|P1|Overall Study|Lost to Follow-up|2
832534|NCT01858766|2735773|P19|Overall Study|Withdrew Consent|0
832535|NCT01858766|2735774|P18|Overall Study|Withdrew Consent|0
832536|NCT01858766|2735775|P17|Overall Study|Withdrew Consent|0
832537|NCT01858766|2735776|P16|Overall Study|Withdrew Consent|0
832538|NCT01858766|2735777|P15|Overall Study|Withdrew Consent|0
832539|NCT01858766|2735778|P14|Overall Study|Withdrew Consent|0
832540|NCT01858766|2735779|P13|Overall Study|Withdrew Consent|0
832541|NCT01858766|2735780|P12|Overall Study|Withdrew Consent|1
832542|NCT01858766|2735781|P11|Overall Study|Withdrew Consent|0
832543|NCT01858766|2735782|P10|Overall Study|Withdrew Consent|0
832544|NCT01858766|2735783|P9|Overall Study|Withdrew Consent|0
832545|NCT01858766|2735784|P8|Overall Study|Withdrew Consent|0
832546|NCT01858766|2735785|P7|Overall Study|Withdrew Consent|0
832547|NCT01858766|2735786|P6|Overall Study|Withdrew Consent|0
832548|NCT01858766|2735787|P5|Overall Study|Withdrew Consent|0
832549|NCT01858766|2735788|P4|Overall Study|Withdrew Consent|0
832550|NCT01858766|2735789|P3|Overall Study|Withdrew Consent|0
832551|NCT01858766|2735790|P2|Overall Study|Withdrew Consent|0
832552|NCT01858766|2735791|P1|Overall Study|Withdrew Consent|0
832553|NCT01858766|2735773|P19|Overall Study|Lost to Follow-up|1
832554|NCT01858766|2735774|P18|Overall Study|Lost to Follow-up|0
832555|NCT01858766|2735775|P17|Overall Study|Lost to Follow-up|1
832556|NCT01858766|2735776|P16|Overall Study|Lost to Follow-up|1
832557|NCT01858766|2735777|P15|Overall Study|Lost to Follow-up|3
832558|NCT01858766|2735778|P14|Overall Study|Lost to Follow-up|0
832559|NCT01858766|2735779|P13|Overall Study|Lost to Follow-up|0
832560|NCT01858766|2735780|P12|Overall Study|Lost to Follow-up|1
832561|NCT01858766|2735781|P11|Overall Study|Lost to Follow-up|0
832562|NCT01858766|2735782|P10|Overall Study|Lost to Follow-up|0
832563|NCT01858766|2735783|P9|Overall Study|Lost to Follow-up|0
832564|NCT01858766|2735784|P8|Overall Study|Lost to Follow-up|2
832565|NCT01858766|2735785|P7|Overall Study|Lost to Follow-up|0
832566|NCT01858766|2735786|P6|Overall Study|Lost to Follow-up|1
832567|NCT01858766|2735787|P5|Overall Study|Lost to Follow-up|0
832568|NCT01858766|2735788|P4|Overall Study|Lost to Follow-up|0
832569|NCT01858766|2735789|P3|Overall Study|Lost to Follow-up|0
832570|NCT01858766|2735790|P2|Overall Study|Lost to Follow-up|0
832571|NCT01858766|2735791|P1|Overall Study|Lost to Follow-up|0
832572|NCT01858766|2735773|P19|Overall Study|Lack of Efficacy|3
832573|NCT01858766|2735774|P18|Overall Study|Lack of Efficacy|3
832574|NCT01858766|2735775|P17|Overall Study|Lack of Efficacy|2
832575|NCT01858766|2735776|P16|Overall Study|Lack of Efficacy|5
832576|NCT01858766|2735777|P15|Overall Study|Lack of Efficacy|5
832577|NCT01858766|2735778|P14|Overall Study|Lack of Efficacy|3
832578|NCT01858766|2735779|P13|Overall Study|Lack of Efficacy|5
832579|NCT01858766|2735780|P12|Overall Study|Lack of Efficacy|3
832580|NCT01858766|2735781|P11|Overall Study|Lack of Efficacy|0
832581|NCT01858766|2735782|P10|Overall Study|Lack of Efficacy|0
832582|NCT01858766|2735783|P9|Overall Study|Lack of Efficacy|0
832583|NCT01858766|2735784|P8|Overall Study|Lack of Efficacy|0
832584|NCT01858766|2735785|P7|Overall Study|Lack of Efficacy|0
832585|NCT01858766|2735786|P6|Overall Study|Lack of Efficacy|2
832586|NCT01858766|2735787|P5|Overall Study|Lack of Efficacy|1
832587|NCT01858766|2735788|P4|Overall Study|Lack of Efficacy|0
832588|NCT01858766|2735789|P3|Overall Study|Lack of Efficacy|0
832589|NCT01858766|2735790|P2|Overall Study|Lack of Efficacy|0
832590|NCT01858766|2735791|P1|Overall Study|Lack of Efficacy|1
832591|NCT01858766|2735773|P19|Overall Study|Death|0
832592|NCT01858766|2735774|P18|Overall Study|Death|0
832593|NCT01858766|2735775|P17|Overall Study|Death|0
832594|NCT01858766|2735776|P16|Overall Study|Death|0
832595|NCT01858766|2735777|P15|Overall Study|Death|0
832596|NCT01858766|2735778|P14|Overall Study|Death|0
832597|NCT01858766|2735779|P13|Overall Study|Death|0
832598|NCT01858766|2735780|P12|Overall Study|Death|0
832599|NCT01858766|2735781|P11|Overall Study|Death|0
832600|NCT01858766|2735782|P10|Overall Study|Death|0
832601|NCT01858766|2735783|P9|Overall Study|Death|0
832602|NCT01858766|2735784|P8|Overall Study|Death|0
832603|NCT01858766|2735785|P7|Overall Study|Death|0
832604|NCT01858766|2735786|P6|Overall Study|Death|0
832605|NCT01858766|2735787|P5|Overall Study|Death|0
832606|NCT01858766|2735788|P4|Overall Study|Death|0
832607|NCT01858766|2735789|P3|Overall Study|Death|1
832608|NCT01858766|2735790|P2|Overall Study|Death|0
832609|NCT01858766|2735791|P1|Overall Study|Death|0
832610|NCT01858766|2735773|P19|Overall Study|Randomized but Never Treated|0
832611|NCT01858766|2735774|P18|Overall Study|Randomized but Never Treated|1
832612|NCT01858766|2735775|P17|Overall Study|Randomized but Never Treated|0
832613|NCT01858766|2735776|P16|Overall Study|Randomized but Never Treated|0
832614|NCT01858766|2735777|P15|Overall Study|Randomized but Never Treated|0
832615|NCT01858766|2735778|P14|Overall Study|Randomized but Never Treated|0
832616|NCT01858766|2735779|P13|Overall Study|Randomized but Never Treated|0
832617|NCT01858766|2735780|P12|Overall Study|Randomized but Never Treated|0
832618|NCT01858766|2735781|P11|Overall Study|Randomized but Never Treated|0
832619|NCT01858766|2735782|P10|Overall Study|Randomized but Never Treated|0
832620|NCT01858766|2735783|P9|Overall Study|Randomized but Never Treated|0
832621|NCT01858766|2735784|P8|Overall Study|Randomized but Never Treated|0
832622|NCT01858766|2735785|P7|Overall Study|Randomized but Never Treated|0
832623|NCT01858766|2735786|P6|Overall Study|Randomized but Never Treated|1
832624|NCT01858766|2735787|P5|Overall Study|Randomized but Never Treated|0
832625|NCT01858766|2735788|P4|Overall Study|Randomized but Never Treated|0
832626|NCT01858766|2735789|P3|Overall Study|Randomized but Never Treated|0
832627|NCT01858766|2735790|P2|Overall Study|Randomized but Never Treated|0
832628|NCT01858766|2735791|P1|Overall Study|Randomized but Never Treated|0
832629|NCT01858701|2735862|P2|Period 2, Second 30 Days of Wear|Comfort|1
832630|NCT01858701|2735863|P1|Period 2, Second 30 Days of Wear|Comfort|0
832631|NCT01858701|2735862|P2|Washout Period, 1-13 Days|Withdrawal by Subject|2
832632|NCT01858701|2735863|P1|Washout Period, 1-13 Days|Withdrawal by Subject|1
832633|NCT01858701|2735862|P2|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0
832634|NCT01858701|2735863|P1|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1
832635|NCT01858701|2735862|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
832636|NCT01858701|2735863|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
832637|NCT01858636|2735869|P1|Overall Study|Withdrawal by Subject|1
832638|NCT01858636|2735869|P1|Overall Study|Lost to Follow-up|1
832639|NCT01858636|2735869|P1|Overall Study|Death|1
832640|NCT01858636|2735869|P1|Overall Study|Physician Decision|1
832641|NCT01858636|2735869|P1|Overall Study|No Device Deployment Attempted|24
832642|NCT01858389|2735922|P2|Overall Study|Did not receive treatment|3
832643|NCT01858389|2735923|P1|Overall Study|Did not receive treatment|0
832644|NCT01858389|2735922|P2|Overall Study|Adverse Event|1
832645|NCT01858389|2735923|P1|Overall Study|Adverse Event|3
832646|NCT01858389|2735922|P2|Overall Study|Not specified|4
832647|NCT01858389|2735923|P1|Overall Study|Not specified|2
832648|NCT01858389|2735922|P2|Overall Study|Progressive disease|11
832649|NCT01858389|2735923|P1|Overall Study|Progressive disease|10
832650|NCT01858389|2735922|P2|Overall Study|Withdrawal by Subject|1
832651|NCT01858389|2735923|P1|Overall Study|Withdrawal by Subject|0
832652|NCT01858389|2735922|P2|Overall Study|Study terminated by sponsor|2
832653|NCT01858389|2735923|P1|Overall Study|Study terminated by sponsor|0
832654|NCT01858389|2735922|P2|Overall Study|Death|3
832655|NCT01858389|2735923|P1|Overall Study|Death|1
832656|NCT01858376|2735938|P1|Overall Study|Dropped d/t lab work not fitting criter|4
832657|NCT01857622|2735977|P3|Overall Study|Withdrawal by Subject|0
832658|NCT01857622|2735978|P2|Overall Study|Withdrawal by Subject|0
832659|NCT01857622|2735979|P1|Overall Study|Withdrawal by Subject|1
832660|NCT01857622|2735977|P3|Overall Study|Protocol Violation|0
832661|NCT01857622|2735978|P2|Overall Study|Protocol Violation|1
832662|NCT01857622|2735979|P1|Overall Study|Protocol Violation|4
832663|NCT01857622|2735977|P3|Overall Study|Physician Decision|0
832664|NCT01857622|2735978|P2|Overall Study|Physician Decision|0
832665|NCT01857622|2735979|P1|Overall Study|Physician Decision|1
832666|NCT01857622|2735977|P3|Overall Study|Adverse Event|2
832667|NCT01857622|2735978|P2|Overall Study|Adverse Event|0
832668|NCT01857622|2735979|P1|Overall Study|Adverse Event|5
832669|NCT01857583|2735991|P4|Overall Study|Withdrawal by Subject|2
832670|NCT01857583|2735992|P3|Overall Study|Withdrawal by Subject|1
832671|NCT01857583|2735993|P2|Overall Study|Withdrawal by Subject|0
832672|NCT01857583|2735994|P1|Overall Study|Withdrawal by Subject|1
832673|NCT01857583|2735991|P4|Overall Study|Physician Decision|1
832674|NCT01857583|2735992|P3|Overall Study|Physician Decision|0
832675|NCT01857583|2735993|P2|Overall Study|Physician Decision|0
832676|NCT01857583|2735994|P1|Overall Study|Physician Decision|0
832677|NCT01857583|2735991|P4|Overall Study|Death|0
832678|NCT01857583|2735992|P3|Overall Study|Death|1
832679|NCT01857583|2735993|P2|Overall Study|Death|1
832680|NCT01857583|2735994|P1|Overall Study|Death|0
832681|NCT01857583|2735991|P4|Overall Study|Adverse Event|1
832682|NCT01857583|2735992|P3|Overall Study|Adverse Event|1
832683|NCT01857583|2735993|P2|Overall Study|Adverse Event|0
832684|NCT01857583|2735994|P1|Overall Study|Adverse Event|0
832685|NCT01857531|2736004|P1|Overall Study|Withdrawal by Subject|4
832686|NCT01857323|2736022|P1|Overall Study|Did not complete 180 doses|48
832687|NCT01857323|2736022|P1|Overall Study|Not specified|4
832688|NCT01857323|2736022|P1|Overall Study|Lost to Follow-up|1
832689|NCT01857323|2736022|P1|Overall Study|Protocol Violation|6
832690|NCT01857323|2736022|P1|Overall Study|Non-compliance|1
832691|NCT01857323|2736022|P1|Overall Study|Withdrawal by Subject|3
832692|NCT01857323|2736022|P1|Overall Study|Adverse Event|1
832693|NCT01857206|2736071|P2|Overall Study|Withdrawal by Subject|0
832694|NCT01857206|2736072|P1|Overall Study|Withdrawal by Subject|1
832695|NCT01857206|2736071|P2|Overall Study|Unclassified|3
832696|NCT01857206|2736072|P1|Overall Study|Unclassified|3
832697|NCT01857206|2736071|P2|Overall Study|Lost to Follow-up|6
832698|NCT01857206|2736072|P1|Overall Study|Lost to Follow-up|9
832699|NCT01857206|2736071|P2|Overall Study|ADMINISTRATIVE REASON|1
832700|NCT01857206|2736072|P1|Overall Study|ADMINISTRATIVE REASON|0
832701|NCT01857102|2736090|P2|Period 2|Unsatisfactory Lens Fit|0
832702|NCT01857102|2736091|P1|Period 2|Unsatisfactory Lens Fit|1
832703|NCT01857102|2736090|P2|Period 2|Lens Discomfort|0
832704|NCT01857102|2736091|P1|Period 2|Lens Discomfort|1
832705|NCT01857102|2736090|P2|Period 1|Physician Decision|0
832706|NCT01857102|2736091|P1|Period 1|Physician Decision|1
832707|NCT01857102|2736090|P2|Period 1|Unsatisfactory Visual Response|0
832708|NCT01857102|2736091|P1|Period 1|Unsatisfactory Visual Response|1
832709|NCT01857102|2736090|P2|Period 1|Unsatisfactory Lens Fit|0
832710|NCT01857102|2736091|P1|Period 1|Unsatisfactory Lens Fit|1
832711|NCT01857102|2736090|P2|Period 1|Lost to Follow-up|3
832712|NCT01857102|2736091|P1|Period 1|Lost to Follow-up|0
832713|NCT01857102|2736090|P2|Period 1|No longer meets Eligibility Criteria|2
832714|NCT01857102|2736091|P1|Period 1|No longer meets Eligibility Criteria|0
832715|NCT01857063|2736101|P2|Period 2 (7 Days)|Withdrawal by Subject|0
832716|NCT01857063|2736102|P1|Period 2 (7 Days)|Withdrawal by Subject|1
832717|NCT01857063|2736101|P2|Period 2 (7 Days)|Physician Decision|1
832718|NCT01857063|2736102|P1|Period 2 (7 Days)|Physician Decision|1
832719|NCT01857063|2736101|P2|Period 2 (7 Days)|Adverse Event|1
832720|NCT01857063|2736102|P1|Period 2 (7 Days)|Adverse Event|2
832721|NCT01857063|2736101|P2|Period 1 (7 Days)|Withdrawal by Subject|3
832722|NCT01857063|2736102|P1|Period 1 (7 Days)|Withdrawal by Subject|1
832723|NCT01857063|2736101|P2|Period 1 (7 Days)|Physician Decision|0
832724|NCT01857063|2736102|P1|Period 1 (7 Days)|Physician Decision|1
832725|NCT01857063|2736101|P2|Period 1 (7 Days)|Adverse Event|1
832726|NCT01857063|2736102|P1|Period 1 (7 Days)|Adverse Event|0
832727|NCT01856907|2736135|P3|Overall Study|Withdrawal by Subject|0
832728|NCT01856907|2736136|P2|Overall Study|Withdrawal by Subject|1
832729|NCT01856907|2736137|P1|Overall Study|Withdrawal by Subject|0
832730|NCT01856907|2736135|P3|Overall Study|Pregnancy|0
832731|NCT01856907|2736136|P2|Overall Study|Pregnancy|1
832732|NCT01856907|2736137|P1|Overall Study|Pregnancy|0
832733|NCT01856907|2736135|P3|Overall Study|Pregnancy|0
832734|NCT01856907|2736136|P2|Overall Study|Pregnancy|1
832735|NCT01856907|2736137|P1|Overall Study|Pregnancy|0
832736|NCT01856686|2736190|P2|Overall Study|Lost to Follow-up|11
832737|NCT01856686|2736191|P1|Overall Study|Lost to Follow-up|5
832738|NCT01856673|2736234|P3|Overall Study|Protocol Violation|1
832739|NCT01856673|2736235|P2|Overall Study|Protocol Violation|0
832740|NCT01856673|2736236|P1|Overall Study|Protocol Violation|1
832741|NCT01856673|2736234|P3|Overall Study|Death|0
832742|NCT01856673|2736235|P2|Overall Study|Death|1
832743|NCT01856673|2736236|P1|Overall Study|Death|2
832744|NCT01856673|2736234|P3|Overall Study|Paperwork errors|0
832745|NCT01856673|2736235|P2|Overall Study|Paperwork errors|0
832746|NCT01856673|2736236|P1|Overall Study|Paperwork errors|4
832747|NCT01856673|2736234|P3|Overall Study|Psychologist decision|0
832748|NCT01856673|2736235|P2|Overall Study|Psychologist decision|0
832749|NCT01856673|2736236|P1|Overall Study|Psychologist decision|3
832750|NCT01856673|2736234|P3|Overall Study|Unknown reasons|0
832751|NCT01856673|2736235|P2|Overall Study|Unknown reasons|0
832752|NCT01856673|2736236|P1|Overall Study|Unknown reasons|20
832753|NCT01856673|2736234|P3|Overall Study|Lost to Follow-up|0
832754|NCT01856673|2736235|P2|Overall Study|Lost to Follow-up|34
832755|NCT01856673|2736236|P1|Overall Study|Lost to Follow-up|22
832756|NCT01856673|2736234|P3|Overall Study|Withdrawal by Subject|33
832757|NCT01856673|2736235|P2|Overall Study|Withdrawal by Subject|50
832758|NCT01856673|2736236|P1|Overall Study|Withdrawal by Subject|46
832759|NCT01856595|2736256|P9|Overall Study|Withdrawal by Subject|0
832760|NCT01856595|2736257|P8|Overall Study|Withdrawal by Subject|0
832761|NCT01856595|2736258|P7|Overall Study|Withdrawal by Subject|1
832762|NCT01856595|2736259|P6|Overall Study|Withdrawal by Subject|0
832763|NCT01856595|2736260|P5|Overall Study|Withdrawal by Subject|0
832764|NCT01856595|2736261|P4|Overall Study|Withdrawal by Subject|0
832765|NCT01856595|2736262|P3|Overall Study|Withdrawal by Subject|0
832766|NCT01856595|2736263|P2|Overall Study|Withdrawal by Subject|1
832767|NCT01856595|2736264|P1|Overall Study|Withdrawal by Subject|0
832768|NCT01856569|2736497|P1|Overall Study|Did not met inclusion criteria|8
832769|NCT01856569|2736497|P1|Overall Study|Lost to Follow-up|3
832770|NCT01856569|2736497|P1|Overall Study|Changed Site/Structure|1
832771|NCT01856569|2736497|P1|Overall Study|Other|1
832772|NCT01856322|2736552|P3|Overall Study|off study due to lack of accrual|3
832773|NCT01856322|2736553|P2|Overall Study|off study due to lack of accrual|0
832774|NCT01856322|2736554|P1|Overall Study|off study due to lack of accrual|0
832775|NCT01856257|2736587|P4|Overall Study|Donor complication|1
832776|NCT01856257|2736588|P3|Overall Study|Donor complication|0
832777|NCT01856257|2736589|P2|Overall Study|Donor complication|0
832778|NCT01856257|2736590|P1|Overall Study|Donor complication|0
832779|NCT01856257|2736587|P4|Overall Study|Withdrawal by Subject|0
832780|NCT01856257|2736588|P3|Overall Study|Withdrawal by Subject|0
832781|NCT01856257|2736589|P2|Overall Study|Withdrawal by Subject|1
832782|NCT01856257|2736590|P1|Overall Study|Withdrawal by Subject|1
832783|NCT01856257|2736587|P4|Overall Study|Physician Decision|1
832784|NCT01856257|2736588|P3|Overall Study|Physician Decision|0
832785|NCT01856257|2736589|P2|Overall Study|Physician Decision|0
832786|NCT01856257|2736590|P1|Overall Study|Physician Decision|0
832787|NCT01856257|2736587|P4|Overall Study|Death|0
832788|NCT01856257|2736588|P3|Overall Study|Death|0
832789|NCT01856257|2736589|P2|Overall Study|Death|0
832790|NCT01856257|2736590|P1|Overall Study|Death|2
832791|NCT01855958|2736758|P2|Overall Study|Withdrawal by Subject|0
832792|NCT01855958|2736759|P1|Overall Study|Withdrawal by Subject|1
832793|NCT01855945|2736789|P12|Overall Study|Withdrawal by Subject|1
832794|NCT01855945|2736790|P11|Overall Study|Withdrawal by Subject|4
832795|NCT01855945|2736791|P10|Overall Study|Withdrawal by Subject|2
832796|NCT01855945|2736792|P9|Overall Study|Withdrawal by Subject|0
832797|NCT01855945|2736793|P8|Overall Study|Withdrawal by Subject|0
832798|NCT01855945|2736794|P7|Overall Study|Withdrawal by Subject|1
832799|NCT01855945|2736795|P6|Overall Study|Withdrawal by Subject|0
832800|NCT01855945|2736796|P5|Overall Study|Withdrawal by Subject|1
832801|NCT01855945|2736797|P4|Overall Study|Withdrawal by Subject|1
832802|NCT01855945|2736798|P3|Overall Study|Withdrawal by Subject|4
832803|NCT01855945|2736799|P2|Overall Study|Withdrawal by Subject|0
832804|NCT01855945|2736800|P1|Overall Study|Withdrawal by Subject|4
832805|NCT01855945|2736789|P12|Overall Study|Other - Unclassified|0
832806|NCT01855945|2736790|P11|Overall Study|Other - Unclassified|1
832807|NCT01855945|2736791|P10|Overall Study|Other - Unclassified|0
832808|NCT01855945|2736792|P9|Overall Study|Other - Unclassified|0
832809|NCT01855945|2736793|P8|Overall Study|Other - Unclassified|1
832810|NCT01855945|2736794|P7|Overall Study|Other - Unclassified|2
832811|NCT01855945|2736795|P6|Overall Study|Other - Unclassified|0
832812|NCT01855945|2736796|P5|Overall Study|Other - Unclassified|0
832813|NCT01855945|2736797|P4|Overall Study|Other - Unclassified|0
832814|NCT01855945|2736798|P3|Overall Study|Other - Unclassified|1
832815|NCT01855945|2736799|P2|Overall Study|Other - Unclassified|1
832816|NCT01855945|2736800|P1|Overall Study|Other - Unclassified|1
832817|NCT01855945|2736789|P12|Overall Study|Lost to Follow-up|2
832818|NCT01855945|2736790|P11|Overall Study|Lost to Follow-up|0
832819|NCT01855945|2736791|P10|Overall Study|Lost to Follow-up|0
832820|NCT01855945|2736792|P9|Overall Study|Lost to Follow-up|2
832821|NCT01855945|2736793|P8|Overall Study|Lost to Follow-up|7
832822|NCT01855945|2736794|P7|Overall Study|Lost to Follow-up|4
832823|NCT01855945|2736795|P6|Overall Study|Lost to Follow-up|3
832824|NCT01855945|2736796|P5|Overall Study|Lost to Follow-up|0
832825|NCT01855945|2736797|P4|Overall Study|Lost to Follow-up|3
832826|NCT01855945|2736798|P3|Overall Study|Lost to Follow-up|7
832827|NCT01855945|2736799|P2|Overall Study|Lost to Follow-up|10
832828|NCT01855945|2736800|P1|Overall Study|Lost to Follow-up|11
832829|NCT01855945|2736789|P12|Overall Study|Death|0
832830|NCT01855945|2736790|P11|Overall Study|Death|0
832831|NCT01855945|2736791|P10|Overall Study|Death|0
832832|NCT01855945|2736792|P9|Overall Study|Death|0
832833|NCT01855945|2736793|P8|Overall Study|Death|0
832834|NCT01855945|2736794|P7|Overall Study|Death|2
832835|NCT01855945|2736795|P6|Overall Study|Death|0
832836|NCT01855945|2736796|P5|Overall Study|Death|0
832837|NCT01855945|2736797|P4|Overall Study|Death|0
832838|NCT01855945|2736798|P3|Overall Study|Death|0
832839|NCT01855945|2736799|P2|Overall Study|Death|0
832840|NCT01855945|2736800|P1|Overall Study|Death|0
832841|NCT01855945|2736789|P12|Overall Study|Adverse Event|0
832842|NCT01855945|2736790|P11|Overall Study|Adverse Event|0
832843|NCT01855945|2736791|P10|Overall Study|Adverse Event|0
832844|NCT01855945|2736792|P9|Overall Study|Adverse Event|0
832845|NCT01855945|2736793|P8|Overall Study|Adverse Event|0
832846|NCT01855945|2736794|P7|Overall Study|Adverse Event|1
832847|NCT01855945|2736795|P6|Overall Study|Adverse Event|0
832848|NCT01855945|2736796|P5|Overall Study|Adverse Event|0
832849|NCT01855945|2736797|P4|Overall Study|Adverse Event|0
832850|NCT01855945|2736798|P3|Overall Study|Adverse Event|0
832851|NCT01855945|2736799|P2|Overall Study|Adverse Event|0
832852|NCT01855945|2736800|P1|Overall Study|Adverse Event|0
832853|NCT01855919|2736936|P2|Overall Study|Protocol Violation|4
832854|NCT01855919|2736937|P1|Overall Study|Protocol Violation|1
832855|NCT01855919|2736936|P2|Overall Study|Entry Criteria Not Met|1
832856|NCT01855919|2736937|P1|Overall Study|Entry Criteria Not Met|1
832857|NCT01855919|2736936|P2|Overall Study|Withdrawal by Subject|10
832858|NCT01855919|2736937|P1|Overall Study|Withdrawal by Subject|4
832859|NCT01855919|2736936|P2|Overall Study|Lack of Efficacy|3
832860|NCT01855919|2736937|P1|Overall Study|Lack of Efficacy|1
832861|NCT01855919|2736936|P2|Overall Study|Adverse Event|8
832862|NCT01855919|2736937|P1|Overall Study|Adverse Event|16
832863|NCT01855789|2736969|P4|2) Week 24 up to End of Study|Other|1
832864|NCT01855789|2736970|P3|2) Week 24 up to End of Study|Other|0
832865|NCT01855789|2736971|P2|2) Week 24 up to End of Study|Other|0
832866|NCT01855789|2736972|P1|2) Week 24 up to End of Study|Other|0
832867|NCT01855789|2736969|P4|2) Week 24 up to End of Study|Sponsor Decision|1
832868|NCT01855789|2736970|P3|2) Week 24 up to End of Study|Sponsor Decision|0
832869|NCT01855789|2736971|P2|2) Week 24 up to End of Study|Sponsor Decision|0
832870|NCT01855789|2736972|P1|2) Week 24 up to End of Study|Sponsor Decision|0
832871|NCT01855789|2736969|P4|2) Week 24 up to End of Study|Participant Non-compliance|1
832872|NCT01855789|2736970|P3|2) Week 24 up to End of Study|Participant Non-compliance|0
832873|NCT01855789|2736971|P2|2) Week 24 up to End of Study|Participant Non-compliance|1
832874|NCT01855789|2736972|P1|2) Week 24 up to End of Study|Participant Non-compliance|0
832875|NCT01855789|2736969|P4|2) Week 24 up to End of Study|Physician Decision|4
832876|NCT01855789|2736970|P3|2) Week 24 up to End of Study|Physician Decision|2
832877|NCT01855789|2736971|P2|2) Week 24 up to End of Study|Physician Decision|0
832878|NCT01855789|2736972|P1|2) Week 24 up to End of Study|Physician Decision|0
832879|NCT01855789|2736969|P4|2) Week 24 up to End of Study|Withdrawal by Subject|8
832880|NCT01855789|2736970|P3|2) Week 24 up to End of Study|Withdrawal by Subject|5
832881|NCT01855789|2736971|P2|2) Week 24 up to End of Study|Withdrawal by Subject|7
832882|NCT01855789|2736972|P1|2) Week 24 up to End of Study|Withdrawal by Subject|0
832883|NCT01855789|2736969|P4|2) Week 24 up to End of Study|Protocol Violation|1
832884|NCT01855789|2736970|P3|2) Week 24 up to End of Study|Protocol Violation|0
832885|NCT01855789|2736971|P2|2) Week 24 up to End of Study|Protocol Violation|0
832886|NCT01855789|2736972|P1|2) Week 24 up to End of Study|Protocol Violation|0
832887|NCT01855789|2736969|P4|2) Week 24 up to End of Study|Lost to Follow-up|4
832888|NCT01855789|2736970|P3|2) Week 24 up to End of Study|Lost to Follow-up|1
832889|NCT01855789|2736971|P2|2) Week 24 up to End of Study|Lost to Follow-up|1
832890|NCT01855789|2736972|P1|2) Week 24 up to End of Study|Lost to Follow-up|0
832891|NCT01855789|2736969|P4|2) Week 24 up to End of Study|Lack of Efficacy|16
832892|NCT01855789|2736970|P3|2) Week 24 up to End of Study|Lack of Efficacy|5
832893|NCT01855789|2736971|P2|2) Week 24 up to End of Study|Lack of Efficacy|2
832894|NCT01855789|2736972|P1|2) Week 24 up to End of Study|Lack of Efficacy|0
832895|NCT01855789|2736969|P4|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1
832896|NCT01855789|2736970|P3|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
832897|NCT01855789|2736971|P2|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
832898|NCT01855789|2736972|P1|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
832899|NCT01855789|2736969|P4|2) Week 24 up to End of Study|Adverse Event|21
832900|NCT01855789|2736970|P3|2) Week 24 up to End of Study|Adverse Event|5
832901|NCT01855789|2736971|P2|2) Week 24 up to End of Study|Adverse Event|4
832902|NCT01855789|2736972|P1|2) Week 24 up to End of Study|Adverse Event|0
832903|NCT01855789|2736969|P4|1) Baseline up to Week 24|Other|0
832904|NCT01855789|2736970|P3|1) Baseline up to Week 24|Other|0
832905|NCT01855789|2736971|P2|1) Baseline up to Week 24|Other|0
832906|NCT01855789|2736972|P1|1) Baseline up to Week 24|Other|4
832907|NCT01855789|2736969|P4|1) Baseline up to Week 24|Sponsor Decision|0
832908|NCT01855789|2736970|P3|1) Baseline up to Week 24|Sponsor Decision|0
832909|NCT01855789|2736971|P2|1) Baseline up to Week 24|Sponsor Decision|0
832910|NCT01855789|2736972|P1|1) Baseline up to Week 24|Sponsor Decision|3
832911|NCT01855789|2736969|P4|1) Baseline up to Week 24|Participant Non-compliance|0
832912|NCT01855789|2736970|P3|1) Baseline up to Week 24|Participant Non-compliance|0
832913|NCT01855789|2736971|P2|1) Baseline up to Week 24|Participant Non-compliance|0
832914|NCT01855789|2736972|P1|1) Baseline up to Week 24|Participant Non-compliance|3
832915|NCT01855789|2736969|P4|1) Baseline up to Week 24|Pregnancy|0
832916|NCT01855789|2736970|P3|1) Baseline up to Week 24|Pregnancy|0
832917|NCT01855789|2736971|P2|1) Baseline up to Week 24|Pregnancy|0
832918|NCT01855789|2736972|P1|1) Baseline up to Week 24|Pregnancy|1
832919|NCT01855789|2736969|P4|1) Baseline up to Week 24|Physician Decision|0
832920|NCT01855789|2736970|P3|1) Baseline up to Week 24|Physician Decision|0
832921|NCT01855789|2736971|P2|1) Baseline up to Week 24|Physician Decision|0
832922|NCT01855789|2736972|P1|1) Baseline up to Week 24|Physician Decision|4
832923|NCT01855789|2736969|P4|1) Baseline up to Week 24|Withdrawal by Subject|0
832924|NCT01855789|2736970|P3|1) Baseline up to Week 24|Withdrawal by Subject|0
832925|NCT01855789|2736971|P2|1) Baseline up to Week 24|Withdrawal by Subject|0
832926|NCT01855789|2736972|P1|1) Baseline up to Week 24|Withdrawal by Subject|31
832927|NCT01855789|2736969|P4|1) Baseline up to Week 24|Protocol Violation|0
832928|NCT01855789|2736970|P3|1) Baseline up to Week 24|Protocol Violation|0
832929|NCT01855789|2736971|P2|1) Baseline up to Week 24|Protocol Violation|0
832930|NCT01855789|2736972|P1|1) Baseline up to Week 24|Protocol Violation|4
832931|NCT01855789|2736969|P4|1) Baseline up to Week 24|Lost to Follow-up|0
832932|NCT01855789|2736970|P3|1) Baseline up to Week 24|Lost to Follow-up|0
832933|NCT01855789|2736971|P2|1) Baseline up to Week 24|Lost to Follow-up|0
832934|NCT01855789|2736972|P1|1) Baseline up to Week 24|Lost to Follow-up|11
832935|NCT01855789|2736969|P4|1) Baseline up to Week 24|Lack of Efficacy|0
832936|NCT01855789|2736970|P3|1) Baseline up to Week 24|Lack of Efficacy|0
832937|NCT01855789|2736971|P2|1) Baseline up to Week 24|Lack of Efficacy|0
832938|NCT01855789|2736972|P1|1) Baseline up to Week 24|Lack of Efficacy|16
832939|NCT01855789|2736969|P4|1) Baseline up to Week 24|Death|0
832940|NCT01855789|2736970|P3|1) Baseline up to Week 24|Death|0
832941|NCT01855789|2736971|P2|1) Baseline up to Week 24|Death|0
832942|NCT01855789|2736972|P1|1) Baseline up to Week 24|Death|2
832943|NCT01855789|2736969|P4|1) Baseline up to Week 24|Adverse Event|0
832944|NCT01855789|2736970|P3|1) Baseline up to Week 24|Adverse Event|0
832945|NCT01855789|2736971|P2|1) Baseline up to Week 24|Adverse Event|0
832946|NCT01855789|2736972|P1|1) Baseline up to Week 24|Adverse Event|37
832947|NCT01855425|2736994|P1|Overall Study|Physician Decision|20
832948|NCT01855074|2736998|P1|Overall Study|Started but not treated|1
832949|NCT01855074|2736998|P1|Overall Study|Withdrawal by Subject|8
832950|NCT01855074|2736998|P1|Overall Study|Lost to Follow-up|4
832951|NCT01855074|2736998|P1|Overall Study|Adverse Event|1
832952|NCT01854944|2737010|P3|Overall Study|Withdrawal by Subject|1
832953|NCT01854944|2737011|P2|Overall Study|Withdrawal by Subject|0
832954|NCT01854944|2737012|P1|Overall Study|Withdrawal by Subject|0
832955|NCT01854827|2737066|P1|Overall Study|Death|1
832956|NCT01854710|2737078|P6|Overall Study|CRI procedural error|2
832957|NCT01854710|2737079|P5|Overall Study|CRI procedural error|2
832958|NCT01854710|2737080|P4|Overall Study|CRI procedural error|2
832959|NCT01854710|2737081|P3|Overall Study|CRI procedural error|2
832960|NCT01854710|2737082|P2|Overall Study|CRI procedural error|2
832961|NCT01854710|2737083|P1|Overall Study|CRI procedural error|2
832962|NCT01854710|2737078|P6|Overall Study|Withdrawal by Subject|0
832963|NCT01854710|2737079|P5|Overall Study|Withdrawal by Subject|0
832964|NCT01854710|2737080|P4|Overall Study|Withdrawal by Subject|0
832965|NCT01854710|2737081|P3|Overall Study|Withdrawal by Subject|0
832966|NCT01854710|2737082|P2|Overall Study|Withdrawal by Subject|1
832967|NCT01854710|2737083|P1|Overall Study|Withdrawal by Subject|2
832968|NCT01854697|2737104|P5|Overall Study|Not Specified|0
832969|NCT01854697|2737105|P4|Overall Study|Not Specified|0
832970|NCT01854697|2737106|P3|Overall Study|Not Specified|1
832971|NCT01854697|2737107|P2|Overall Study|Not Specified|1
832972|NCT01854697|2737108|P1|Overall Study|Not Specified|0
832973|NCT01854697|2737104|P5|Overall Study|Withdrew Consent|0
832974|NCT01854697|2737105|P4|Overall Study|Withdrew Consent|1
832975|NCT01854697|2737106|P3|Overall Study|Withdrew Consent|0
832976|NCT01854697|2737107|P2|Overall Study|Withdrew Consent|1
832977|NCT01854697|2737108|P1|Overall Study|Withdrew Consent|0
832978|NCT01854697|2737104|P5|Overall Study|To enter another AbbVie study|1
832979|NCT01854697|2737105|P4|Overall Study|To enter another AbbVie study|0
832980|NCT01854697|2737106|P3|Overall Study|To enter another AbbVie study|0
832981|NCT01854697|2737107|P2|Overall Study|To enter another AbbVie study|0
832982|NCT01854697|2737108|P1|Overall Study|To enter another AbbVie study|1
832983|NCT01854697|2737104|P5|Overall Study|Lost to Follow-up|0
832984|NCT01854697|2737105|P4|Overall Study|Lost to Follow-up|2
832985|NCT01854697|2737106|P3|Overall Study|Lost to Follow-up|1
832986|NCT01854697|2737107|P2|Overall Study|Lost to Follow-up|1
832987|NCT01854697|2737108|P1|Overall Study|Lost to Follow-up|4
832988|NCT01854697|2737104|P5|Overall Study|Adverse Event|1
832989|NCT01854697|2737105|P4|Overall Study|Adverse Event|0
832990|NCT01854697|2737106|P3|Overall Study|Adverse Event|0
832991|NCT01854697|2737107|P2|Overall Study|Adverse Event|0
832992|NCT01854697|2737108|P1|Overall Study|Adverse Event|1
832993|NCT01854658|2737152|P4|Overall Study|Administrative reasons|2
832994|NCT01854658|2737153|P3|Overall Study|Administrative reasons|2
832995|NCT01854658|2737154|P2|Overall Study|Administrative reasons|1
832996|NCT01854658|2737155|P1|Overall Study|Administrative reasons|5
832997|NCT01854658|2737152|P4|Overall Study|Adverse Event|19
832998|NCT01854658|2737153|P3|Overall Study|Adverse Event|23
832999|NCT01854658|2737154|P2|Overall Study|Adverse Event|14
833000|NCT01854658|2737155|P1|Overall Study|Adverse Event|21
833001|NCT01854658|2737152|P4|Overall Study|Lack of Efficacy|7
833002|NCT01854658|2737153|P3|Overall Study|Lack of Efficacy|4
833003|NCT01854658|2737154|P2|Overall Study|Lack of Efficacy|8
833004|NCT01854658|2737155|P1|Overall Study|Lack of Efficacy|3
833005|NCT01854658|2737152|P4|Overall Study|Protocol-specified criteria|7
833006|NCT01854658|2737153|P3|Overall Study|Protocol-specified criteria|10
833007|NCT01854658|2737154|P2|Overall Study|Protocol-specified criteria|15
833008|NCT01854658|2737155|P1|Overall Study|Protocol-specified criteria|15
833009|NCT01854658|2737152|P4|Overall Study|Withdrawal by Subject|15
833010|NCT01854658|2737153|P3|Overall Study|Withdrawal by Subject|29
833011|NCT01854658|2737154|P2|Overall Study|Withdrawal by Subject|21
833012|NCT01854658|2737155|P1|Overall Study|Withdrawal by Subject|28
833013|NCT01854658|2737152|P4|Overall Study|Lost to Follow-up|4
833014|NCT01854658|2737153|P3|Overall Study|Lost to Follow-up|8
833015|NCT01854658|2737154|P2|Overall Study|Lost to Follow-up|9
833016|NCT01854658|2737155|P1|Overall Study|Lost to Follow-up|8
833017|NCT01854658|2737152|P4|Overall Study|Physician Decision|4
833018|NCT01854658|2737153|P3|Overall Study|Physician Decision|2
833019|NCT01854658|2737154|P2|Overall Study|Physician Decision|5
833020|NCT01854658|2737155|P1|Overall Study|Physician Decision|7
833021|NCT01854658|2737152|P4|Overall Study|Protocol Violation|1
833022|NCT01854658|2737153|P3|Overall Study|Protocol Violation|2
833023|NCT01854658|2737154|P2|Overall Study|Protocol Violation|2
833024|NCT01854658|2737155|P1|Overall Study|Protocol Violation|6
833025|NCT01854645|2737190|P5|Overall Study|Adverse Event|11
833026|NCT01854645|2737191|P4|Overall Study|Adverse Event|20
833027|NCT01854645|2737192|P3|Overall Study|Adverse Event|19
833028|NCT01854645|2737193|P2|Overall Study|Adverse Event|31
833029|NCT01854645|2737194|P1|Overall Study|Adverse Event|33
833030|NCT01854645|2737190|P5|Overall Study|Lack of Efficacy|9
833031|NCT01854645|2737191|P4|Overall Study|Lack of Efficacy|3
833032|NCT01854645|2737192|P3|Overall Study|Lack of Efficacy|9
833033|NCT01854645|2737193|P2|Overall Study|Lack of Efficacy|12
833034|NCT01854645|2737194|P1|Overall Study|Lack of Efficacy|7
833035|NCT01854645|2737190|P5|Overall Study|Withdrawal by Subject|24
833036|NCT01854645|2737191|P4|Overall Study|Withdrawal by Subject|21
833037|NCT01854645|2737192|P3|Overall Study|Withdrawal by Subject|30
833038|NCT01854645|2737193|P2|Overall Study|Withdrawal by Subject|41
833039|NCT01854645|2737194|P1|Overall Study|Withdrawal by Subject|31
833040|NCT01854645|2737190|P5|Overall Study|Physician Decision|7
833041|NCT01854645|2737191|P4|Overall Study|Physician Decision|3
833042|NCT01854645|2737192|P3|Overall Study|Physician Decision|3
833043|NCT01854645|2737193|P2|Overall Study|Physician Decision|5
833044|NCT01854645|2737194|P1|Overall Study|Physician Decision|1
833045|NCT01854645|2737190|P5|Overall Study|Lost to Follow-up|0
833046|NCT01854645|2737191|P4|Overall Study|Lost to Follow-up|5
833047|NCT01854645|2737192|P3|Overall Study|Lost to Follow-up|8
833048|NCT01854645|2737193|P2|Overall Study|Lost to Follow-up|7
833049|NCT01854645|2737194|P1|Overall Study|Lost to Follow-up|10
833050|NCT01854645|2737190|P5|Overall Study|Protocol Violation|1
833051|NCT01854645|2737191|P4|Overall Study|Protocol Violation|4
833052|NCT01854645|2737192|P3|Overall Study|Protocol Violation|5
833053|NCT01854645|2737193|P2|Overall Study|Protocol Violation|0
833054|NCT01854645|2737194|P1|Overall Study|Protocol Violation|3
833055|NCT01854645|2737190|P5|Overall Study|Administrative Reasons / Missing|1
833056|NCT01854645|2737191|P4|Overall Study|Administrative Reasons / Missing|1
833057|NCT01854645|2737192|P3|Overall Study|Administrative Reasons / Missing|0
833058|NCT01854645|2737193|P2|Overall Study|Administrative Reasons / Missing|0
833059|NCT01854645|2737194|P1|Overall Study|Administrative Reasons / Missing|0
833060|NCT01854645|2737190|P5|Overall Study|Protocol-Specified Criteria|7
833061|NCT01854645|2737191|P4|Overall Study|Protocol-Specified Criteria|5
833062|NCT01854645|2737192|P3|Overall Study|Protocol-Specified Criteria|8
833063|NCT01854645|2737193|P2|Overall Study|Protocol-Specified Criteria|10
833064|NCT01854645|2737194|P1|Overall Study|Protocol-Specified Criteria|13
833065|NCT01854528|2737275|P2|Overall Study|Virologic Failure|9
833066|NCT01854528|2737276|P1|Overall Study|Virologic Failure|0
833067|NCT01854528|2737275|P2|Overall Study|Withdrawal by Subject|2
833068|NCT01854528|2737276|P1|Overall Study|Withdrawal by Subject|0
833069|NCT01854528|2737275|P2|Overall Study|Adverse Event|4
833070|NCT01854528|2737276|P1|Overall Study|Adverse Event|0
833071|NCT01854047|2737347|P5|Overall Study|Other than specified above|8
833072|NCT01854047|2737348|P4|Overall Study|Other than specified above|5
833073|NCT01854047|2737349|P3|Overall Study|Other than specified above|3
833074|NCT01854047|2737350|P2|Overall Study|Other than specified above|3
833075|NCT01854047|2737351|P1|Overall Study|Other than specified above|3
833076|NCT01854047|2737347|P5|Overall Study|Randomized but not treated|4
833077|NCT01854047|2737348|P4|Overall Study|Randomized but not treated|0
833078|NCT01854047|2737349|P3|Overall Study|Randomized but not treated|2
833079|NCT01854047|2737350|P2|Overall Study|Randomized but not treated|1
833080|NCT01854047|2737351|P1|Overall Study|Randomized but not treated|0
833081|NCT01854047|2737347|P5|Overall Study|Adverse Event|7
833082|NCT01854047|2737348|P4|Overall Study|Adverse Event|10
833083|NCT01854047|2737349|P3|Overall Study|Adverse Event|6
833084|NCT01854047|2737350|P2|Overall Study|Adverse Event|4
833085|NCT01854047|2737351|P1|Overall Study|Adverse Event|5
833086|NCT01854047|2737347|P5|Overall Study|Poor compliance to protocol|0
833087|NCT01854047|2737348|P4|Overall Study|Poor compliance to protocol|0
833088|NCT01854047|2737349|P3|Overall Study|Poor compliance to protocol|2
833089|NCT01854047|2737350|P2|Overall Study|Poor compliance to protocol|0
833090|NCT01854047|2737351|P1|Overall Study|Poor compliance to protocol|3
833091|NCT01854047|2737347|P5|Overall Study|Lack of Efficacy|0
833092|NCT01854047|2737348|P4|Overall Study|Lack of Efficacy|0
833093|NCT01854047|2737349|P3|Overall Study|Lack of Efficacy|0
833094|NCT01854047|2737350|P2|Overall Study|Lack of Efficacy|0
833095|NCT01854047|2737351|P1|Overall Study|Lack of Efficacy|1
833096|NCT01853982|2737482|P2|Overall Study|Lost to Follow-up|1
833097|NCT01853982|2737483|P1|Overall Study|Lost to Follow-up|0
833098|NCT01853982|2737482|P2|Overall Study|Death|0
833099|NCT01853982|2737483|P1|Overall Study|Death|1
833100|NCT01853982|2737482|P2|Overall Study|Withdrawal by Subject|0
833101|NCT01853982|2737483|P1|Overall Study|Withdrawal by Subject|1
833102|NCT01853839|2737489|P1|Overall Study|Lost to follow-up or no valid BP measure|336
833103|NCT01853839|2737489|P1|Overall Study|End of treatment visit too early|33
833104|NCT01853839|2737489|P1|Overall Study|Not meet ITT population definition|58
833105|NCT01853839|2737489|P1|Overall Study|Violated inclusion criteria|2
833106|NCT01853696|2737511|P2|Overall Study|Lost to Follow-up|4
833107|NCT01853696|2737512|P1|Overall Study|Lost to Follow-up|5
833108|NCT01853696|2737511|P2|Overall Study|Withdrawal by Subject|1
833109|NCT01853696|2737512|P1|Overall Study|Withdrawal by Subject|1
833110|NCT01853475|2737548|P3|Overall Study|Withdrawal by Subject|0
833111|NCT01853475|2737549|P2|Overall Study|Withdrawal by Subject|1
833112|NCT01853475|2737550|P1|Overall Study|Withdrawal by Subject|0
833113|NCT01853462|2737569|P2|Overall Study|Withdrawal by Subject|1
833114|NCT01853462|2737570|P1|Overall Study|Withdrawal by Subject|1
833115|NCT01853397|2737640|P4|Overall Study|Subject Noncompliance|1
833116|NCT01853397|2737641|P3|Overall Study|Subject Noncompliance|0
833117|NCT01853397|2737642|P2|Overall Study|Subject Noncompliance|0
833118|NCT01853397|2737643|P1|Overall Study|Subject Noncompliance|0
833119|NCT01853397|2737640|P4|Overall Study|Withdrawal by Subject|1
833120|NCT01853397|2737641|P3|Overall Study|Withdrawal by Subject|0
833121|NCT01853397|2737642|P2|Overall Study|Withdrawal by Subject|0
833122|NCT01853397|2737643|P1|Overall Study|Withdrawal by Subject|0
833123|NCT01853384|2737671|P2|Completed Follow up Visit 2|Lost to Follow-up|1
833124|NCT01853384|2737672|P1|Completed Follow up Visit 2|Lost to Follow-up|0
833125|NCT01853384|2737671|P2|Completed Follow up Visit 2|Death|0
833126|NCT01853384|2737672|P1|Completed Follow up Visit 2|Death|1
833127|NCT01853384|2737671|P2|Completed Follow up Visit 2|Withdrawal by Subject|2
833128|NCT01853384|2737672|P1|Completed Follow up Visit 2|Withdrawal by Subject|1
833129|NCT01853384|2737671|P2|Completed Follow up Visit 2|Adverse Event|0
833130|NCT01853384|2737672|P1|Completed Follow up Visit 2|Adverse Event|1
833131|NCT01853384|2737671|P2|Completed Follow up Visit 1|Withdrawal by Subject|0
833132|NCT01853384|2737672|P1|Completed Follow up Visit 1|Withdrawal by Subject|1
833133|NCT01853384|2737671|P2|Completed Follow up Visit 1|Early Termination|9
833134|NCT01853384|2737672|P1|Completed Follow up Visit 1|Early Termination|13
833135|NCT01853384|2737671|P2|Randomized|Other|3
833136|NCT01853384|2737672|P1|Randomized|Other|3
833137|NCT01853384|2737671|P2|Randomized|Sponsor Decision|34
833138|NCT01853384|2737672|P1|Randomized|Sponsor Decision|47
833139|NCT01853384|2737671|P2|Randomized|Withdrawal by Subject|3
833140|NCT01853384|2737672|P1|Randomized|Withdrawal by Subject|5
833141|NCT01853384|2737671|P2|Randomized|Lost to Follow-up|1
833142|NCT01853384|2737672|P1|Randomized|Lost to Follow-up|1
833143|NCT01853384|2737671|P2|Randomized|Death|2
833144|NCT01853384|2737672|P1|Randomized|Death|1
833145|NCT01853384|2737671|P2|Randomized|Adverse Event|3
833146|NCT01853384|2737672|P1|Randomized|Adverse Event|5
833147|NCT01853280|2737712|P2|Overall Study|Ineligible|1
833148|NCT01853280|2737713|P1|Overall Study|Ineligible|0
833149|NCT01853280|2737712|P2|Overall Study|Withdrawal by Subject|1
833150|NCT01853280|2737713|P1|Overall Study|Withdrawal by Subject|0
833151|NCT01853280|2737712|P2|Overall Study|Physician Decision|1
833152|NCT01853280|2737713|P1|Overall Study|Physician Decision|0
833153|NCT01853280|2737712|P2|Overall Study|Lost to Follow-up|1
833154|NCT01853280|2737713|P1|Overall Study|Lost to Follow-up|0
833155|NCT01853280|2737712|P2|Overall Study|Lack of Efficacy|2
833156|NCT01853280|2737713|P1|Overall Study|Lack of Efficacy|2
833157|NCT01853254|2737719|P1|Overall Study|Administrative/Other|16
833158|NCT01853254|2737719|P1|Overall Study|Withdrawal of Consent|16
833159|NCT01853254|2737719|P1|Overall Study|Other Protocol Violation|1
833160|NCT01853254|2737719|P1|Overall Study|Refusal of Treatment|1
833161|NCT01853254|2737719|P1|Overall Study|Insufficient Therapeutic Response|22
833162|NCT01853254|2737719|P1|Overall Study|Failure to Return|43
833163|NCT01853254|2737719|P1|Overall Study|Death|1
833164|NCT01853254|2737719|P1|Overall Study|Adverse Event/Intercurrent Illness|3
833165|NCT01853254|2737719|P1|Overall Study|Abnormal Laboratory Test|1
833166|NCT01853176|2737736|P2|Overall Study|Study terminated|0
833167|NCT01853176|2737737|P1|Overall Study|Study terminated|4
833168|NCT01853072|2737756|P2|Overall Study|Reason not specified|6
833169|NCT01853072|2737757|P1|Overall Study|Reason not specified|9
833170|NCT01853072|2737756|P2|Overall Study|Withdrawal by Subject|2
833171|NCT01853072|2737757|P1|Overall Study|Withdrawal by Subject|1
833172|NCT01853072|2737756|P2|Overall Study|Physician Decision|1
833173|NCT01853072|2737757|P1|Overall Study|Physician Decision|1
833174|NCT01853072|2737756|P2|Overall Study|Non-compliance with study drug|1
833175|NCT01853072|2737757|P1|Overall Study|Non-compliance with study drug|0
833176|NCT01853072|2737756|P2|Overall Study|Lost to Follow-up|3
833177|NCT01853072|2737757|P1|Overall Study|Lost to Follow-up|0
833178|NCT01853072|2737756|P2|Overall Study|Death|4
833179|NCT01853072|2737757|P1|Overall Study|Death|1
833180|NCT01853072|2737756|P2|Overall Study|Adverse Event|3
833181|NCT01853072|2737757|P1|Overall Study|Adverse Event|0
833182|NCT01853072|2737756|P2|Overall Study|Adverse event prior to treatment|1
833183|NCT01853072|2737757|P1|Overall Study|Adverse event prior to treatment|0
833184|NCT01853046|2737777|P2|Overall Study|Disease progression|3
833185|NCT01853046|2737778|P1|Overall Study|Disease progression|13
833186|NCT01853046|2737777|P2|Overall Study|Adverse Event|2
833187|NCT01853046|2737778|P1|Overall Study|Adverse Event|4
833188|NCT01853046|2737777|P2|Overall Study|Withdrawal by Subject|1
833189|NCT01853046|2737778|P1|Overall Study|Withdrawal by Subject|1
833190|NCT01852825|2737846|P3|Overall Study|Withdrawal by Subject|0
833191|NCT01852825|2737847|P2|Overall Study|Withdrawal by Subject|0
833192|NCT01852825|2737848|P1|Overall Study|Withdrawal by Subject|2
833193|NCT01852812|2737874|P3|Overall Study|Non-compliance With Study Drug|0
833194|NCT01852812|2737875|P2|Overall Study|Non-compliance With Study Drug|1
833195|NCT01852812|2737876|P1|Overall Study|Non-compliance With Study Drug|0
833196|NCT01852812|2737874|P3|Overall Study|Adverse Event|1
833197|NCT01852812|2737875|P2|Overall Study|Adverse Event|0
833198|NCT01852812|2737876|P1|Overall Study|Adverse Event|0
833199|NCT01852591|2737914|P1|Overall Study|Not Evaluable at Time of Analysis|1
833200|NCT01852591|2737914|P1|Overall Study|Withdrawal by Subject|2
833201|NCT01852292|2737955|P2|Overall Study|Progressive disease|52
833202|NCT01852292|2737956|P1|Overall Study|Progressive disease|42
833203|NCT01852292|2737955|P2|Overall Study|Study terminated by Sponsor|1
833204|NCT01852292|2737956|P1|Overall Study|Study terminated by Sponsor|0
833205|NCT01852292|2737955|P2|Overall Study|Non-compliance with study treatment|0
833206|NCT01852292|2737956|P1|Overall Study|Non-compliance with study treatment|1
833207|NCT01852292|2737955|P2|Overall Study|Protocol Violation|0
833208|NCT01852292|2737956|P1|Overall Study|Protocol Violation|2
833209|NCT01852292|2737955|P2|Overall Study|Physician Decision|2
833210|NCT01852292|2737956|P1|Overall Study|Physician Decision|6
833211|NCT01852292|2737955|P2|Overall Study|Adverse Event|11
833212|NCT01852292|2737956|P1|Overall Study|Adverse Event|8
833213|NCT01852292|2737955|P2|Overall Study|Patient/guardian decision|4
833214|NCT01852292|2737956|P1|Overall Study|Patient/guardian decision|8
833215|NCT01852292|2737955|P2|Overall Study|Death|8
833216|NCT01852292|2737956|P1|Overall Study|Death|9
833217|NCT01852292|2737955|P2|Overall Study|Untreated - did not receive study drug|1
833218|NCT01852292|2737956|P1|Overall Study|Untreated - did not receive study drug|3
833219|NCT01852214|2737980|P2|Washout Period|Withdrawal by Subject|1
833220|NCT01852214|2737981|P1|Washout Period|Withdrawal by Subject|0
833221|NCT01852214|2737980|P2|Period 1|Withdrawal by Subject|1
833222|NCT01852214|2737981|P1|Period 1|Withdrawal by Subject|0
833223|NCT01852214|2737980|P2|Period 1|Adverse Event|2
833224|NCT01852214|2737981|P1|Period 1|Adverse Event|1
833225|NCT01852162|2738008|P2|Overall Study|Withdrawal by Subject|1
833226|NCT01852162|2738009|P1|Overall Study|Withdrawal by Subject|3
833227|NCT01852162|2738008|P2|Overall Study|Adverse Event|0
833228|NCT01852162|2738009|P1|Overall Study|Adverse Event|1
833229|NCT01852110|2738025|P6|Overall Study|Withdrawal by Subject|0
833230|NCT01852110|2738026|P5|Overall Study|Withdrawal by Subject|0
833231|NCT01852110|2738027|P4|Overall Study|Withdrawal by Subject|0
833232|NCT01852110|2738028|P3|Overall Study|Withdrawal by Subject|0
833233|NCT01852110|2738029|P2|Overall Study|Withdrawal by Subject|4
833234|NCT01852110|2738030|P1|Overall Study|Withdrawal by Subject|4
833235|NCT01852110|2738025|P6|Overall Study|Study Terminated by Sponsor|0
833236|NCT01852110|2738026|P5|Overall Study|Study Terminated by Sponsor|0
833237|NCT01852110|2738027|P4|Overall Study|Study Terminated by Sponsor|0
833238|NCT01852110|2738028|P3|Overall Study|Study Terminated by Sponsor|0
833239|NCT01852110|2738029|P2|Overall Study|Study Terminated by Sponsor|32
833240|NCT01852110|2738030|P1|Overall Study|Study Terminated by Sponsor|30
833241|NCT01852110|2738025|P6|Overall Study|Protocol Violation|0
833242|NCT01852110|2738026|P5|Overall Study|Protocol Violation|0
833243|NCT01852110|2738027|P4|Overall Study|Protocol Violation|0
833244|NCT01852110|2738028|P3|Overall Study|Protocol Violation|0
833245|NCT01852110|2738029|P2|Overall Study|Protocol Violation|1
833246|NCT01852110|2738030|P1|Overall Study|Protocol Violation|0
833247|NCT01852110|2738025|P6|Overall Study|Physician Decision|0
833248|NCT01852110|2738026|P5|Overall Study|Physician Decision|0
833249|NCT01852110|2738027|P4|Overall Study|Physician Decision|0
833250|NCT01852110|2738028|P3|Overall Study|Physician Decision|0
833251|NCT01852110|2738029|P2|Overall Study|Physician Decision|0
833252|NCT01852110|2738030|P1|Overall Study|Physician Decision|1
833253|NCT01852110|2738025|P6|Overall Study|Non-compliance with Study Drug|0
833254|NCT01852110|2738026|P5|Overall Study|Non-compliance with Study Drug|0
833255|NCT01852110|2738027|P4|Overall Study|Non-compliance with Study Drug|0
833256|NCT01852110|2738028|P3|Overall Study|Non-compliance with Study Drug|0
833257|NCT01852110|2738029|P2|Overall Study|Non-compliance with Study Drug|1
833258|NCT01852110|2738030|P1|Overall Study|Non-compliance with Study Drug|2
833259|NCT01852110|2738025|P6|Overall Study|Lost to Follow-up|0
833260|NCT01852110|2738026|P5|Overall Study|Lost to Follow-up|0
833261|NCT01852110|2738027|P4|Overall Study|Lost to Follow-up|0
833262|NCT01852110|2738028|P3|Overall Study|Lost to Follow-up|0
833263|NCT01852110|2738029|P2|Overall Study|Lost to Follow-up|3
833264|NCT01852110|2738030|P1|Overall Study|Lost to Follow-up|1
833265|NCT01852110|2738025|P6|Overall Study|Adverse Event|0
833266|NCT01852110|2738026|P5|Overall Study|Adverse Event|0
833267|NCT01852110|2738027|P4|Overall Study|Adverse Event|0
833268|NCT01852110|2738028|P3|Overall Study|Adverse Event|0
833269|NCT01852110|2738029|P2|Overall Study|Adverse Event|5
833270|NCT01852110|2738030|P1|Overall Study|Adverse Event|12
833271|NCT01851863|2738104|P4|Overall Study|Lost to Follow-up|3
833272|NCT01851863|2738105|P3|Overall Study|Lost to Follow-up|2
833273|NCT01851863|2738106|P2|Overall Study|Lost to Follow-up|4
833274|NCT01851863|2738107|P1|Overall Study|Lost to Follow-up|3
833275|NCT01851863|2738104|P4|Overall Study|Did not receive study medication|0
833276|NCT01851863|2738105|P3|Overall Study|Did not receive study medication|3
833277|NCT01851863|2738106|P2|Overall Study|Did not receive study medication|5
833278|NCT01851863|2738107|P1|Overall Study|Did not receive study medication|2
833279|NCT01851720|2738136|P2|Overall Study|Lost to Follow-up|1
833280|NCT01851720|2738137|P1|Overall Study|Lost to Follow-up|0
833281|NCT01851590|2738167|P3|Overall Study|Lack of Efficacy|0
833282|NCT01851590|2738168|P2|Overall Study|Lack of Efficacy|1
833283|NCT01851590|2738169|P1|Overall Study|Lack of Efficacy|0
833284|NCT01851590|2738167|P3|Overall Study|Adverse Event|2
833285|NCT01851590|2738168|P2|Overall Study|Adverse Event|0
833286|NCT01851590|2738169|P1|Overall Study|Adverse Event|0
833287|NCT01851590|2738167|P3|Overall Study|Withdrawal by Subject|1
833288|NCT01851590|2738168|P2|Overall Study|Withdrawal by Subject|0
833289|NCT01851590|2738169|P1|Overall Study|Withdrawal by Subject|0
833290|NCT01851330|2738192|P3|Overall Study|Investigator’s Discretion|1
833291|NCT01851330|2738193|P2|Overall Study|Investigator’s Discretion|0
833292|NCT01851330|2738194|P1|Overall Study|Investigator’s Discretion|0
833293|NCT01851330|2738192|P3|Overall Study|Withdrew Consent|0
833294|NCT01851330|2738193|P2|Overall Study|Withdrew Consent|1
833295|NCT01851330|2738194|P1|Overall Study|Withdrew Consent|2
833296|NCT01851330|2738192|P3|Overall Study|Lost to Follow-up|9
833297|NCT01851330|2738193|P2|Overall Study|Lost to Follow-up|6
833298|NCT01851330|2738194|P1|Overall Study|Lost to Follow-up|1
833299|NCT01851330|2738192|P3|Overall Study|Lack of Efficacy|2
833300|NCT01851330|2738193|P2|Overall Study|Lack of Efficacy|9
833301|NCT01851330|2738194|P1|Overall Study|Lack of Efficacy|10
833302|NCT01850641|2738247|P1|Overall Study|Increase in serum ferritin|1
833303|NCT01850641|2738247|P1|Overall Study|Decrease in serum calcium|2
833304|NCT01850641|2738247|P1|Overall Study|Decrease in serum phosphorus|1
833305|NCT01850641|2738247|P1|Overall Study|Physician Decision|1
833306|NCT01850615|2738261|P2|Overall Study|Unclassified|1
833307|NCT01850615|2738262|P1|Overall Study|Unclassified|0
833308|NCT01850615|2738261|P2|Overall Study|Lost to Follow-up|1
833309|NCT01850615|2738262|P1|Overall Study|Lost to Follow-up|0
833310|NCT01850615|2738261|P2|Overall Study|Withdrawal by Subject|1
833311|NCT01850615|2738262|P1|Overall Study|Withdrawal by Subject|3
833312|NCT01850615|2738261|P2|Overall Study|Adverse Event|1
833313|NCT01850615|2738262|P1|Overall Study|Adverse Event|2
833314|NCT01850615|2738261|P2|Overall Study|Protocol Violation|1
833315|NCT01850615|2738262|P1|Overall Study|Protocol Violation|4
833316|NCT01850602|2738280|P2|Overall Study|Increase in serum ferritin|0
833317|NCT01850602|2738281|P1|Overall Study|Increase in serum ferritin|1
833318|NCT01850602|2738280|P2|Overall Study|Decrease in serum calcium|3
833319|NCT01850602|2738281|P1|Overall Study|Decrease in serum calcium|2
833320|NCT01850602|2738280|P2|Overall Study|Withdrawal by Subject|4
833321|NCT01850602|2738281|P1|Overall Study|Withdrawal by Subject|2
833322|NCT01850602|2738280|P2|Overall Study|Physician Decision|1
833323|NCT01850602|2738281|P1|Overall Study|Physician Decision|2
833324|NCT01850602|2738280|P2|Overall Study|Adverse Event|10
833325|NCT01850602|2738281|P1|Overall Study|Adverse Event|7
833326|NCT01850589|2738295|P2|Overall Study|Withdrawal by Subject|0
833327|NCT01850589|2738296|P1|Overall Study|Withdrawal by Subject|8
833328|NCT01850030|2738361|P2|Overall Study|pregnancy not confirmed at visit 4|249
833329|NCT01850030|2738362|P1|Overall Study|pregnancy not confirmed at visit 4|248
833330|NCT01850030|2738361|P2|Overall Study|Protocol Violation|28
833331|NCT01850030|2738362|P1|Overall Study|Protocol Violation|24
833332|NCT01850030|2738361|P2|Overall Study|Withdrawal by Subject|4
833333|NCT01850030|2738362|P1|Overall Study|Withdrawal by Subject|3
833334|NCT01850030|2738361|P2|Overall Study|Lost to Follow-up|5
833335|NCT01850030|2738362|P1|Overall Study|Lost to Follow-up|5
833336|NCT01850030|2738361|P2|Overall Study|Lack of Efficacy|1
833337|NCT01850030|2738362|P1|Overall Study|Lack of Efficacy|3
833338|NCT01850030|2738361|P2|Overall Study|Adverse Event|82
833339|NCT01850030|2738362|P1|Overall Study|Adverse Event|64
833340|NCT01850004|2738374|P1|Overall Study|AE Unrelated to Study Drug|1
833341|NCT01850004|2738374|P1|Overall Study|Subject Request to Discontinue Treatment|1
833342|NCT01850004|2738374|P1|Overall Study|Subject Withdrew Consent|4
833343|NCT01850004|2738374|P1|Overall Study|Poor/Non-compliance|1
833344|NCT01850004|2738374|P1|Overall Study|Subject Moved|1
833345|NCT01849848|2738381|P1|Overall Study|Progression of the primary disease|3
833346|NCT01849848|2738381|P1|Overall Study|Physician Decision|1
833347|NCT01849588|2738479|P1|Overall Study|Lack of Efficacy|3
833348|NCT01849562|2738489|P3|Overall Study|Non-compliance with Study Drug|0
833349|NCT01849562|2738490|P2|Overall Study|Non-compliance with Study Drug|0
833350|NCT01849562|2738491|P1|Overall Study|Non-compliance with Study Drug|1
833351|NCT01849562|2738489|P3|Overall Study|Lost to Follow-up|0
833352|NCT01849562|2738490|P2|Overall Study|Lost to Follow-up|0
833353|NCT01849562|2738491|P1|Overall Study|Lost to Follow-up|1
833354|NCT01849497|2738504|P2|Overall Study|Lost to Follow-up|1
833355|NCT01849497|2738505|P1|Overall Study|Lost to Follow-up|0
833356|NCT01849497|2738504|P2|Overall Study|Sponsor Decision|1
833357|NCT01849497|2738505|P1|Overall Study|Sponsor Decision|0
833358|NCT01849497|2738504|P2|Overall Study|Withdrawal by Subject|2
833359|NCT01849497|2738505|P1|Overall Study|Withdrawal by Subject|1
833360|NCT01849458|2738513|P1|Overall Study|Lost to Follow-up|4
833361|NCT01849289|2738552|P2|Overall Study|Unclassified|18
833362|NCT01849289|2738553|P1|Overall Study|Unclassified|25
833363|NCT01849289|2738552|P2|Overall Study|Withdrawal criteria|0
833364|NCT01849289|2738553|P1|Overall Study|Withdrawal criteria|1
833365|NCT01849289|2738552|P2|Overall Study|Protocol Violation|3
833366|NCT01849289|2738553|P1|Overall Study|Protocol Violation|3
833367|NCT01849289|2738552|P2|Overall Study|Adverse Event|3
833368|NCT01849289|2738553|P1|Overall Study|Adverse Event|3
833369|NCT01849276|2738569|P1|Followed for Survival for 5 Years|Early termination of the study|1
833370|NCT01849276|2738569|P1|Followed for Survival for 5 Years|Death|1
833371|NCT01848990|2738609|P3|Overall Study|Other|2
833372|NCT01848990|2738610|P2|Overall Study|Other|4
833373|NCT01848990|2738611|P1|Overall Study|Other|1
833374|NCT01848990|2738609|P3|Overall Study|Death|1
833375|NCT01848990|2738610|P2|Overall Study|Death|0
833376|NCT01848990|2738611|P1|Overall Study|Death|1
833377|NCT01848990|2738609|P3|Overall Study|Non Compliance|0
833378|NCT01848990|2738610|P2|Overall Study|Non Compliance|0
833379|NCT01848990|2738611|P1|Overall Study|Non Compliance|1
833380|NCT01848990|2738609|P3|Overall Study|Physician Decision|0
833381|NCT01848990|2738610|P2|Overall Study|Physician Decision|1
833382|NCT01848990|2738611|P1|Overall Study|Physician Decision|1
833383|NCT01848990|2738609|P3|Overall Study|Withdrawal by Subject|11
833384|NCT01848990|2738610|P2|Overall Study|Withdrawal by Subject|10
833385|NCT01848990|2738611|P1|Overall Study|Withdrawal by Subject|29
833386|NCT01848990|2738609|P3|Overall Study|Protocol Violation|0
833387|NCT01848990|2738610|P2|Overall Study|Protocol Violation|1
833388|NCT01848990|2738611|P1|Overall Study|Protocol Violation|1
833389|NCT01848990|2738609|P3|Overall Study|Lost to Follow-up|2
833390|NCT01848990|2738610|P2|Overall Study|Lost to Follow-up|2
833391|NCT01848990|2738611|P1|Overall Study|Lost to Follow-up|6
833392|NCT01848990|2738609|P3|Overall Study|Adverse Event|0
833393|NCT01848990|2738610|P2|Overall Study|Adverse Event|2
833394|NCT01848990|2738611|P1|Overall Study|Adverse Event|6
833395|NCT01848938|2738681|P2|Overall Study|Lost to Follow-up|1
833396|NCT01848938|2738682|P1|Overall Study|Lost to Follow-up|1
833397|NCT01848834|2738731|P5|Overall Study|Not Treated|0
833398|NCT01848834|2738732|P4|Overall Study|Not Treated|0
833399|NCT01848834|2738733|P3|Overall Study|Not Treated|0
833400|NCT01848834|2738734|P2|Overall Study|Not Treated|1
833401|NCT01848834|2738735|P1|Overall Study|Not Treated|0
833402|NCT01848834|2738731|P5|Overall Study|Withdrawal by Subject|7
833403|NCT01848834|2738732|P4|Overall Study|Withdrawal by Subject|0
833404|NCT01848834|2738733|P3|Overall Study|Withdrawal by Subject|3
833405|NCT01848834|2738734|P2|Overall Study|Withdrawal by Subject|2
833406|NCT01848834|2738735|P1|Overall Study|Withdrawal by Subject|0
833407|NCT01848834|2738731|P5|Overall Study|Protocol Violation|2
833408|NCT01848834|2738732|P4|Overall Study|Protocol Violation|0
833409|NCT01848834|2738733|P3|Overall Study|Protocol Violation|1
833410|NCT01848834|2738734|P2|Overall Study|Protocol Violation|0
833411|NCT01848834|2738735|P1|Overall Study|Protocol Violation|0
833412|NCT01848834|2738731|P5|Overall Study|Progressive Disease|78
833413|NCT01848834|2738732|P4|Overall Study|Progressive Disease|36
833414|NCT01848834|2738733|P3|Overall Study|Progressive Disease|21
833415|NCT01848834|2738734|P2|Overall Study|Progressive Disease|41
833416|NCT01848834|2738735|P1|Overall Study|Progressive Disease|27
833417|NCT01848834|2738731|P5|Overall Study|Death|3
833418|NCT01848834|2738732|P4|Overall Study|Death|0
833419|NCT01848834|2738733|P3|Overall Study|Death|0
833420|NCT01848834|2738734|P2|Overall Study|Death|1
833421|NCT01848834|2738735|P1|Overall Study|Death|0
833422|NCT01848834|2738731|P5|Overall Study|Complete Response|0
833423|NCT01848834|2738732|P4|Overall Study|Complete Response|0
833424|NCT01848834|2738733|P3|Overall Study|Complete Response|0
833425|NCT01848834|2738734|P2|Overall Study|Complete Response|1
833426|NCT01848834|2738735|P1|Overall Study|Complete Response|0
833427|NCT01848834|2738731|P5|Overall Study|Adverse Event|15
833428|NCT01848834|2738732|P4|Overall Study|Adverse Event|1
833429|NCT01848834|2738733|P3|Overall Study|Adverse Event|6
833430|NCT01848834|2738734|P2|Overall Study|Adverse Event|8
833431|NCT01848834|2738735|P1|Overall Study|Adverse Event|3
833432|NCT01848834|2738731|P5|Overall Study|Physician Decision|1
833433|NCT01848834|2738732|P4|Overall Study|Physician Decision|0
833434|NCT01848834|2738733|P3|Overall Study|Physician Decision|0
833435|NCT01848834|2738734|P2|Overall Study|Physician Decision|0
833436|NCT01848834|2738735|P1|Overall Study|Physician Decision|0
833437|NCT01848834|2738731|P5|Overall Study|Ongoing in Study|26
833438|NCT01848834|2738732|P4|Overall Study|Ongoing in Study|0
833439|NCT01848834|2738733|P3|Overall Study|Ongoing in Study|1
833440|NCT01848834|2738734|P2|Overall Study|Ongoing in Study|6
833441|NCT01848834|2738735|P1|Overall Study|Ongoing in Study|0
833442|NCT01848756|2738770|P1|Overall Study|Enrolled in Error|1
833443|NCT01848756|2738770|P1|Overall Study|Withdrawal by Subject|1
833444|NCT01848756|2738770|P1|Overall Study|Adverse Event|1
833445|NCT01848288|2738784|P1|Overall Study|Withdrawal by Subject|1
833446|NCT01848288|2738784|P1|Overall Study|Protocol Violation|1
833447|NCT01848288|2738784|P1|Overall Study|Death|1
833448|NCT01848210|2738795|P2|Overall Study|Administrative|0
833449|NCT01848210|2738796|P1|Overall Study|Administrative|1
833450|NCT01848210|2738795|P2|Overall Study|Chronic Venous Insufficiency Course|2
833451|NCT01848210|2738796|P1|Overall Study|Chronic Venous Insufficiency Course|1
833452|NCT01848210|2738795|P2|Overall Study|Hepatic Function Alteration|0
833453|NCT01848210|2738796|P1|Overall Study|Hepatic Function Alteration|4
833454|NCT01848210|2738795|P2|Overall Study|Hypesensitivity|0
833455|NCT01848210|2738796|P1|Overall Study|Hypesensitivity|1
833456|NCT01848210|2738795|P2|Overall Study|Discontinuation Criterion|7
833457|NCT01848210|2738796|P1|Overall Study|Discontinuation Criterion|5
833458|NCT01848210|2738795|P2|Overall Study|Adverse Event|9
833459|NCT01848210|2738796|P1|Overall Study|Adverse Event|7
833460|NCT01848210|2738795|P2|Overall Study|Impedition Condition|9
833461|NCT01848210|2738796|P1|Overall Study|Impedition Condition|5
833462|NCT01848210|2738795|P2|Overall Study|Use of Forbidden Drugs|10
833463|NCT01848210|2738796|P1|Overall Study|Use of Forbidden Drugs|9
833464|NCT01848210|2738795|P2|Overall Study|Protocol Violation|5
833465|NCT01848210|2738796|P1|Overall Study|Protocol Violation|3
833466|NCT01848210|2738795|P2|Overall Study|Lost to Follow-up|12
833467|NCT01848210|2738796|P1|Overall Study|Lost to Follow-up|24
833468|NCT01848210|2738795|P2|Overall Study|Informed Consent Form Withdrawal|24
833469|NCT01848210|2738796|P1|Overall Study|Informed Consent Form Withdrawal|28
833470|NCT01848145|2738818|P1|Subsequent Infusions: Weeks 3-8|Death|1
833471|NCT01848145|2738818|P1|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3
833472|NCT01848145|2738818|P1|Subsequent Infusions: Weeks 3-8|Disease Progression|6
833473|NCT01848145|2738818|P1|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1
833474|NCT01848145|2738818|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1
833475|NCT01848145|2738818|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1
833476|NCT01848145|2738818|P1|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1
833477|NCT01847885|2738858|P3|Randomization|Screen Failure|0
833478|NCT01847885|2738859|P2|Randomization|Screen Failure|3
833479|NCT01847885|2738860|P1|Randomization|Screen Failure|0
833480|NCT01847885|2738858|P3|Randomization|Withdrawal by Subject|2
833481|NCT01847885|2738859|P2|Randomization|Withdrawal by Subject|0
833482|NCT01847885|2738860|P1|Randomization|Withdrawal by Subject|0
833483|NCT01847885|2738858|P3|Randomization|Protocol Violation|0
833484|NCT01847885|2738859|P2|Randomization|Protocol Violation|1
833485|NCT01847885|2738860|P1|Randomization|Protocol Violation|0
833486|NCT01847885|2738858|P3|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
833487|NCT01847885|2738859|P2|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
833488|NCT01847885|2738860|P1|Initial Enrollment (Consented)|Pending prior to enrollment stop|6
833489|NCT01847885|2738858|P3|Initial Enrollment (Consented)|Screen failure|0
833490|NCT01847885|2738859|P2|Initial Enrollment (Consented)|Screen failure|0
833491|NCT01847885|2738860|P1|Initial Enrollment (Consented)|Screen failure|39
833492|NCT01847885|2738858|P3|Initial Enrollment (Consented)|Withdrawal by Subject|0
833493|NCT01847885|2738859|P2|Initial Enrollment (Consented)|Withdrawal by Subject|0
833494|NCT01847885|2738860|P1|Initial Enrollment (Consented)|Withdrawal by Subject|2
833495|NCT01847885|2738858|P3|Initial Enrollment (Consented)|Protocol Violation|0
833496|NCT01847885|2738859|P2|Initial Enrollment (Consented)|Protocol Violation|0
833497|NCT01847885|2738860|P1|Initial Enrollment (Consented)|Protocol Violation|1
833498|NCT01847443|2738950|P4|Washout Period Before Study Period 4|Positive alcohol test|0
833499|NCT01847443|2738951|P3|Washout Period Before Study Period 4|Positive alcohol test|0
833500|NCT01847443|2738952|P2|Washout Period Before Study Period 4|Positive alcohol test|0
833501|NCT01847443|2738953|P1|Washout Period Before Study Period 4|Positive alcohol test|1
833502|NCT01847443|2738950|P4|Washout Period Before Study Period 4|Withdrawal by Subject|0
833503|NCT01847443|2738951|P3|Washout Period Before Study Period 4|Withdrawal by Subject|0
833504|NCT01847443|2738952|P2|Washout Period Before Study Period 4|Withdrawal by Subject|0
833505|NCT01847443|2738953|P1|Washout Period Before Study Period 4|Withdrawal by Subject|1
833506|NCT01847443|2738950|P4|Washout Period Before Study Period 3|Other reason|0
833507|NCT01847443|2738951|P3|Washout Period Before Study Period 3|Other reason|0
833508|NCT01847443|2738952|P2|Washout Period Before Study Period 3|Other reason|0
833509|NCT01847443|2738953|P1|Washout Period Before Study Period 3|Other reason|1
833510|NCT01847443|2738950|P4|Washout Period Before Study Period 2|Other reason|0
833511|NCT01847443|2738951|P3|Washout Period Before Study Period 2|Other reason|0
833512|NCT01847443|2738952|P2|Washout Period Before Study Period 2|Other reason|0
833513|NCT01847443|2738953|P1|Washout Period Before Study Period 2|Other reason|1
833514|NCT01847443|2738950|P4|Washout Period Before Study Period 2|Adverse Event|0
833515|NCT01847443|2738951|P3|Washout Period Before Study Period 2|Adverse Event|0
833516|NCT01847443|2738952|P2|Washout Period Before Study Period 2|Adverse Event|1
833517|NCT01847443|2738953|P1|Washout Period Before Study Period 2|Adverse Event|1
833518|NCT01847443|2738950|P4|Study Period 1|Withdrawal by Subject|0
833519|NCT01847443|2738951|P3|Study Period 1|Withdrawal by Subject|0
833520|NCT01847443|2738952|P2|Study Period 1|Withdrawal by Subject|1
833521|NCT01847443|2738953|P1|Study Period 1|Withdrawal by Subject|0
833522|NCT01846741|2739014|P1|Baseline Visit|Subject did not meet entry criteria|2
833523|NCT01846624|2739162|P1|Overall Study|Died during induction, no midostaurin|1
833524|NCT01846507|2739170|P1|Overall Study|Missing data|2
833525|NCT01846507|2739170|P1|Overall Study|Protocol Violation|1
833526|NCT01846507|2739170|P1|Overall Study|Lost to Follow-up|4
833527|NCT01846442|2739257|P4|Overall Study|Left the city/Lost medication|1
833528|NCT01846442|2739258|P3|Overall Study|Left the city/Lost medication|1
833529|NCT01846442|2739259|P2|Overall Study|Left the city/Lost medication|0
833530|NCT01846442|2739260|P1|Overall Study|Left the city/Lost medication|1
833531|NCT01846442|2739257|P4|Overall Study|Withdrawal by Subject|1
833532|NCT01846442|2739258|P3|Overall Study|Withdrawal by Subject|0
833533|NCT01846442|2739259|P2|Overall Study|Withdrawal by Subject|2
833534|NCT01846442|2739260|P1|Overall Study|Withdrawal by Subject|3
833535|NCT01846442|2739257|P4|Overall Study|Lost to Follow-up|0
833536|NCT01846442|2739258|P3|Overall Study|Lost to Follow-up|1
833537|NCT01846442|2739259|P2|Overall Study|Lost to Follow-up|0
833538|NCT01846442|2739260|P1|Overall Study|Lost to Follow-up|0
833539|NCT01846442|2739257|P4|Overall Study|Adverse Event|1
833540|NCT01846442|2739258|P3|Overall Study|Adverse Event|2
833541|NCT01846442|2739259|P2|Overall Study|Adverse Event|4
833542|NCT01846442|2739260|P1|Overall Study|Adverse Event|2
833543|NCT01846416|2739301|P3|Overall Study|Lost to Follow-up|1
833544|NCT01846416|2739302|P2|Overall Study|Lost to Follow-up|2
833545|NCT01846416|2739303|P1|Overall Study|Lost to Follow-up|0
833546|NCT01846416|2739301|P3|Overall Study|Ongoing as of 7 January 2015|3
833547|NCT01846416|2739302|P2|Overall Study|Ongoing as of 7 January 2015|41
833548|NCT01846416|2739303|P1|Overall Study|Ongoing as of 7 January 2015|21
833549|NCT01846416|2739301|P3|Overall Study|Other|0
833550|NCT01846416|2739302|P2|Overall Study|Other|0
833551|NCT01846416|2739303|P1|Overall Study|Other|1
833552|NCT01846416|2739301|P3|Overall Study|Withdrawal by Subject|0
833553|NCT01846416|2739302|P2|Overall Study|Withdrawal by Subject|7
833554|NCT01846416|2739303|P1|Overall Study|Withdrawal by Subject|1
833555|NCT01846416|2739301|P3|Overall Study|Death|9
833556|NCT01846416|2739302|P2|Overall Study|Death|43
833557|NCT01846416|2739303|P1|Overall Study|Death|8
833558|NCT01846299|2739348|P2|Overall Study|Adverse Event|0
833559|NCT01846299|2739349|P1|Overall Study|Adverse Event|2
833560|NCT01846299|2739348|P2|Overall Study|Withdrawal by Subject|6
833561|NCT01846299|2739349|P1|Overall Study|Withdrawal by Subject|1
833562|NCT01846299|2739348|P2|Overall Study|Lost to Follow-up|0
833563|NCT01846299|2739349|P1|Overall Study|Lost to Follow-up|3
833564|NCT01846299|2739348|P2|Overall Study|Death|2
833565|NCT01846299|2739349|P1|Overall Study|Death|1
833566|NCT01846299|2739348|P2|Overall Study|Protocol deviation|0
833567|NCT01846299|2739349|P1|Overall Study|Protocol deviation|1
833568|NCT01846299|2739348|P2|Overall Study|Physician Decision|2
833569|NCT01846299|2739349|P1|Overall Study|Physician Decision|4
833570|NCT01846221|2739387|P2|Overall Study|Age Exclusion|0
833571|NCT01846221|2739388|P1|Overall Study|Age Exclusion|1
833572|NCT01846221|2739387|P2|Overall Study|Catheter Failure|0
833573|NCT01846221|2739388|P1|Overall Study|Catheter Failure|2
833574|NCT01846208|2739405|P3|Overall Study|Refused SU OFC|1
833575|NCT01846208|2739406|P2|Overall Study|Refused SU OFC|0
833576|NCT01846208|2739407|P1|Overall Study|Refused SU OFC|0
833577|NCT01846208|2739405|P3|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
833578|NCT01846208|2739406|P2|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
833579|NCT01846208|2739407|P1|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1
833580|NCT01846208|2739405|P3|Overall Study|Non-compliance|0
833581|NCT01846208|2739406|P2|Overall Study|Non-compliance|1
833582|NCT01846208|2739407|P1|Overall Study|Non-compliance|1
833583|NCT01846208|2739405|P3|Overall Study|Withdrawal by Subject|0
833584|NCT01846208|2739406|P2|Overall Study|Withdrawal by Subject|0
833585|NCT01846208|2739407|P1|Overall Study|Withdrawal by Subject|5
833586|NCT01846208|2739405|P3|Overall Study|Dosing Symptoms|6
833587|NCT01846208|2739406|P2|Overall Study|Dosing Symptoms|2
833588|NCT01846208|2739407|P1|Overall Study|Dosing Symptoms|1
833589|NCT01846208|2739405|P3|Overall Study|Withdrew prior to treatment|1
833590|NCT01846208|2739406|P2|Overall Study|Withdrew prior to treatment|1
833591|NCT01846208|2739407|P1|Overall Study|Withdrew prior to treatment|1
833592|NCT01846104|2739424|P1|Overall Study|Withdrawal by Subject|1
833593|NCT01846039|2739430|P1|Overall Study|Subject Withdrew Consent|1
833594|NCT01846039|2739430|P1|Overall Study|Protocol Violation|1
833595|NCT01845974|2739442|P2|Overall Study|screen failure|0
833596|NCT01845974|2739443|P1|Overall Study|screen failure|1
833597|NCT01845831|2739451|P5|Inpatient Phase|Withdrawal by Subject|0
833598|NCT01845831|2739452|P4|Inpatient Phase|Withdrawal by Subject|0
833599|NCT01845831|2739453|P3|Inpatient Phase|Withdrawal by Subject|0
833600|NCT01845831|2739454|P2|Inpatient Phase|Withdrawal by Subject|1
833601|NCT01845831|2739455|P1|Inpatient Phase|Withdrawal by Subject|1
833602|NCT01845077|2739527|P6|Washout Period|Protocol Violation|0
833603|NCT01845077|2739528|P5|Washout Period|Protocol Violation|1
833604|NCT01845077|2739529|P4|Washout Period|Protocol Violation|1
833605|NCT01845077|2739530|P3|Washout Period|Protocol Violation|0
833606|NCT01845077|2739531|P2|Washout Period|Protocol Violation|0
833607|NCT01845077|2739532|P1|Washout Period|Protocol Violation|0
833608|NCT01845077|2739527|P6|Washout Period|elevated lab values (not clinic. sign.)|0
833609|NCT01845077|2739528|P5|Washout Period|elevated lab values (not clinic. sign.)|0
833610|NCT01845077|2739529|P4|Washout Period|elevated lab values (not clinic. sign.)|0
833611|NCT01845077|2739530|P3|Washout Period|elevated lab values (not clinic. sign.)|1
833612|NCT01845077|2739531|P2|Washout Period|elevated lab values (not clinic. sign.)|0
833613|NCT01845077|2739532|P1|Washout Period|elevated lab values (not clinic. sign.)|0
833614|NCT01845077|2739527|P6|Washout Period|Adverse Event|0
833615|NCT01845077|2739528|P5|Washout Period|Adverse Event|0
833616|NCT01845077|2739529|P4|Washout Period|Adverse Event|0
833617|NCT01845077|2739530|P3|Washout Period|Adverse Event|0
833618|NCT01845077|2739531|P2|Washout Period|Adverse Event|0
833619|NCT01845077|2739532|P1|Washout Period|Adverse Event|1
833620|NCT01845077|2739527|P6|Washout Period|Lost to Follow-up|1
833621|NCT01845077|2739528|P5|Washout Period|Lost to Follow-up|0
833622|NCT01845077|2739529|P4|Washout Period|Lost to Follow-up|1
833623|NCT01845077|2739530|P3|Washout Period|Lost to Follow-up|0
833624|NCT01845077|2739531|P2|Washout Period|Lost to Follow-up|1
833625|NCT01845077|2739532|P1|Washout Period|Lost to Follow-up|0
833626|NCT01845025|2739578|P2|Overall Study|Missing|1
833627|NCT01845025|2739579|P1|Overall Study|Missing|1
833628|NCT01845025|2739578|P2|Overall Study|Protocol deviation|6
833629|NCT01845025|2739579|P1|Overall Study|Protocol deviation|3
833630|NCT01845025|2739578|P2|Overall Study|Death|0
833631|NCT01845025|2739579|P1|Overall Study|Death|2
833632|NCT01845025|2739578|P2|Overall Study|Administrative problems|8
833633|NCT01845025|2739579|P1|Overall Study|Administrative problems|8
833634|NCT01845025|2739578|P2|Overall Study|Lost to Follow-up|13
833635|NCT01845025|2739579|P1|Overall Study|Lost to Follow-up|13
833636|NCT01845025|2739578|P2|Overall Study|Withdrawal by Subject|44
833637|NCT01845025|2739579|P1|Overall Study|Withdrawal by Subject|48
833638|NCT01845025|2739578|P2|Overall Study|Unsatisfactory therapeutic effect|2
833639|NCT01845025|2739579|P1|Overall Study|Unsatisfactory therapeutic effect|4
833640|NCT01845025|2739578|P2|Overall Study|Adverse Event|3
833641|NCT01845025|2739579|P1|Overall Study|Adverse Event|6
833642|NCT01844895|2739601|P1|Day 29 - Day113 - Autoinjector|planned surgery|1
833643|NCT01844895|2739601|P1|Day 29 - Day113 - Autoinjector|Difficulty using device|3
833644|NCT01844895|2739601|P1|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1
833645|NCT01844895|2739601|P1|Day 29 - Day113 - Autoinjector|Adverse Event|1
833646|NCT01844895|2739601|P1|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1
833647|NCT01844895|2739601|P1|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1
833648|NCT01844895|2739601|P1|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1
833649|NCT01844856|2739619|P2|Overall Study|Randomized but was a Screen Failure|1
833650|NCT01844856|2739620|P1|Overall Study|Randomized but was a Screen Failure|0
833651|NCT01844856|2739619|P2|Overall Study|Inadvertently Not Scheduled|0
833652|NCT01844856|2739620|P1|Overall Study|Inadvertently Not Scheduled|1
833653|NCT01844856|2739619|P2|Overall Study|Enterococcus Resistant|1
833654|NCT01844856|2739620|P1|Overall Study|Enterococcus Resistant|0
833655|NCT01844856|2739619|P2|Overall Study|Noncompliance|3
833656|NCT01844856|2739620|P1|Overall Study|Noncompliance|2
833657|NCT01844856|2739619|P2|Overall Study|Withdrawal by Subject|2
833658|NCT01844856|2739620|P1|Overall Study|Withdrawal by Subject|3
833659|NCT01844856|2739619|P2|Overall Study|Adverse Event|6
833660|NCT01844856|2739620|P1|Overall Study|Adverse Event|3
833661|NCT01844856|2739619|P2|Overall Study|Lost to Follow-up|3
833662|NCT01844856|2739620|P1|Overall Study|Lost to Follow-up|15
833663|NCT01844830|2739632|P2|Overall Study|Withdrawal by Subject|0
833664|NCT01844830|2739633|P1|Overall Study|Withdrawal by Subject|1
833665|NCT01844817|2739663|P2|Treatment|Other|3
833666|NCT01844817|2739664|P1|Treatment|Other|0
833667|NCT01844817|2739663|P2|Treatment|Lost to Follow-up|1
833668|NCT01844817|2739664|P1|Treatment|Lost to Follow-up|0
833669|NCT01844817|2739663|P2|Treatment|Death|8
833670|NCT01844817|2739664|P1|Treatment|Death|10
833671|NCT01844817|2739663|P2|Treatment|Withdrawal by Subject|6
833672|NCT01844817|2739664|P1|Treatment|Withdrawal by Subject|10
833673|NCT01844817|2739663|P2|Treatment|Adverse Event|9
833674|NCT01844817|2739664|P1|Treatment|Adverse Event|17
833675|NCT01844817|2739663|P2|Treatment|Progressive Disease|36
833676|NCT01844817|2739664|P1|Treatment|Progressive Disease|27
833677|NCT01844817|2739663|P2|Enrolled and Randomized|Withdrawal by Subject|3
833678|NCT01844817|2739664|P1|Enrolled and Randomized|Withdrawal by Subject|2
833679|NCT01844778|2739677|P3|Overall Study|Adverse Event|2
833680|NCT01844778|2739678|P2|Overall Study|Adverse Event|2
833681|NCT01844778|2739679|P1|Overall Study|Adverse Event|0
833682|NCT01844778|2739677|P3|Overall Study|Withdrawal by Subject|0
833683|NCT01844778|2739678|P2|Overall Study|Withdrawal by Subject|0
833684|NCT01844778|2739679|P1|Overall Study|Withdrawal by Subject|2
833685|NCT01844778|2739677|P3|Overall Study|Protocol deviation|2
833686|NCT01844778|2739678|P2|Overall Study|Protocol deviation|1
833687|NCT01844778|2739679|P1|Overall Study|Protocol deviation|0
833688|NCT01844765|2739705|P2|Overall Study|Untreated|0
833689|NCT01844765|2739706|P1|Overall Study|Untreated|1
833690|NCT01844765|2739705|P2|Overall Study|Protocol Violation|0
833691|NCT01844765|2739706|P1|Overall Study|Protocol Violation|1
833692|NCT01844765|2739705|P2|Overall Study|Disease progression|0
833693|NCT01844765|2739706|P1|Overall Study|Disease progression|1
833694|NCT01844765|2739705|P2|Overall Study|Administrative problems|1
833695|NCT01844765|2739706|P1|Overall Study|Administrative problems|1
833696|NCT01844765|2739705|P2|Overall Study|Withdrawal by Subject|1
833697|NCT01844765|2739706|P1|Overall Study|Withdrawal by Subject|0
833698|NCT01844765|2739705|P2|Overall Study|Adverse Event|4
833699|NCT01844765|2739706|P1|Overall Study|Adverse Event|5
833700|NCT01844700|2739726|P2|Overall Study|stopped taking meds|1
833701|NCT01844700|2739727|P1|Overall Study|stopped taking meds|0
833702|NCT01844700|2739726|P2|Overall Study|Withdrawal by Subject|0
833703|NCT01844700|2739727|P1|Overall Study|Withdrawal by Subject|1
833704|NCT01844700|2739726|P2|Overall Study|refused medication switch|0
833705|NCT01844700|2739727|P1|Overall Study|refused medication switch|1
833706|NCT01844700|2739726|P2|Overall Study|Lack of Efficacy|0
833707|NCT01844700|2739727|P1|Overall Study|Lack of Efficacy|1
833708|NCT01844687|2739739|P1|Visit 4|Withdrawal by Subject|2
833709|NCT01844687|2739739|P1|Visit 4|Lost to Follow-up|1
833710|NCT01844687|2739739|P1|Visit 4|Pregnancy|1
833711|NCT01844687|2739739|P1|Visit 3|child care problems|1
833712|NCT01844687|2739739|P1|Visit 3|Withdrawal by Subject|3
833713|NCT01844687|2739739|P1|Visit 3|Lost to Follow-up|1
833714|NCT01844687|2739739|P1|Visit 2|Protocol Violation|1
833715|NCT01844687|2739739|P1|Visit 2|Withdrawal by Subject|1
833716|NCT01844687|2739739|P1|Visit 1|Lost to Follow-up|5
833717|NCT01844687|2739739|P1|Visit 1|Protocol Violation|3
833718|NCT01844531|2739802|P4|Overall Study|Withdrawal by Subject|0
833719|NCT01844531|2739803|P3|Overall Study|Withdrawal by Subject|0
833720|NCT01844531|2739804|P2|Overall Study|Withdrawal by Subject|1
833721|NCT01844531|2739805|P1|Overall Study|Withdrawal by Subject|0
833722|NCT01844518|2739835|P1|Long-Term Extension|Still in On-Going Study|149
833723|NCT01844518|2739835|P1|Long-Term Extension|No Longer Met Study Criteria|1
833724|NCT01844518|2739835|P1|Long-Term Extension|Adverse Event|1
833725|NCT01844518|2739835|P1|Long-Term Extension|Lack of Efficacy|6
833726|NCT01844518|2739835|P1|Short-Term (ST) Period|Poor/Non-Compliance|1
833727|NCT01844518|2739835|P1|Short-Term (ST) Period|Withdrawal of Consent|2
833728|NCT01844518|2739835|P1|Short-Term (ST) Period|Lack of Efficacy|3
833729|NCT01844518|2739835|P1|Short-Term (ST) Period|Adverse Event|3
833730|NCT01844505|2739852|P3|Overall Study|Not Reported|1
833731|NCT01844505|2739853|P2|Overall Study|Not Reported|0
833732|NCT01844505|2739854|P1|Overall Study|Not Reported|0
833733|NCT01844505|2739852|P3|Overall Study|Other Reasons|2
833734|NCT01844505|2739853|P2|Overall Study|Other Reasons|2
833735|NCT01844505|2739854|P1|Overall Study|Other Reasons|4
833736|NCT01844505|2739852|P3|Overall Study|Subject no longer meets criteria|0
833737|NCT01844505|2739853|P2|Overall Study|Subject no longer meets criteria|1
833738|NCT01844505|2739854|P1|Overall Study|Subject no longer meets criteria|0
833739|NCT01844505|2739852|P3|Overall Study|Poor/non-compliance|1
833740|NCT01844505|2739853|P2|Overall Study|Poor/non-compliance|1
833741|NCT01844505|2739854|P1|Overall Study|Poor/non-compliance|1
833742|NCT01844505|2739852|P3|Overall Study|Maximum clinical benefit|2
833743|NCT01844505|2739853|P2|Overall Study|Maximum clinical benefit|11
833744|NCT01844505|2739854|P1|Overall Study|Maximum clinical benefit|8
833745|NCT01844505|2739852|P3|Overall Study|Lost to Follow-up|0
833746|NCT01844505|2739853|P2|Overall Study|Lost to Follow-up|0
833747|NCT01844505|2739854|P1|Overall Study|Lost to Follow-up|1
833748|NCT01844505|2739852|P3|Overall Study|Withdrawal by Subject|0
833749|NCT01844505|2739853|P2|Overall Study|Withdrawal by Subject|3
833750|NCT01844505|2739854|P1|Overall Study|Withdrawal by Subject|0
833751|NCT01844505|2739852|P3|Overall Study|Subject request discontinue treatment|8
833752|NCT01844505|2739853|P2|Overall Study|Subject request discontinue treatment|14
833753|NCT01844505|2739854|P1|Overall Study|Subject request discontinue treatment|17
833754|NCT01844505|2739852|P3|Overall Study|Adverse event unrelated to study drug|6
833755|NCT01844505|2739853|P2|Overall Study|Adverse event unrelated to study drug|15
833756|NCT01844505|2739854|P1|Overall Study|Adverse event unrelated to study drug|7
833757|NCT01844505|2739852|P3|Overall Study|Death|1
833758|NCT01844505|2739853|P2|Overall Study|Death|3
833759|NCT01844505|2739854|P1|Overall Study|Death|1
833760|NCT01844505|2739852|P3|Overall Study|Study drug toxicity|50
833761|NCT01844505|2739853|P2|Overall Study|Study drug toxicity|131
833762|NCT01844505|2739854|P1|Overall Study|Study drug toxicity|40
833763|NCT01844505|2739852|P3|Overall Study|Disease progression|224
833764|NCT01844505|2739853|P2|Overall Study|Disease progression|88
833765|NCT01844505|2739854|P1|Overall Study|Disease progression|170
833766|NCT01843972|2739965|P10|Overall Study|Withdrawal by Subject|0
833767|NCT01843972|2739966|P9|Overall Study|Withdrawal by Subject|0
833768|NCT01843972|2739967|P8|Overall Study|Withdrawal by Subject|0
833769|NCT01843972|2739968|P7|Overall Study|Withdrawal by Subject|0
833770|NCT01843972|2739969|P6|Overall Study|Withdrawal by Subject|0
833771|NCT01843972|2739970|P5|Overall Study|Withdrawal by Subject|1
833772|NCT01843972|2739971|P4|Overall Study|Withdrawal by Subject|0
833773|NCT01843972|2739972|P3|Overall Study|Withdrawal by Subject|0
833774|NCT01843972|2739973|P2|Overall Study|Withdrawal by Subject|0
833775|NCT01843972|2739974|P1|Overall Study|Withdrawal by Subject|0
833776|NCT01843933|2740044|P2|Overall Study|Data lost|4
833777|NCT01843933|2740045|P1|Overall Study|Data lost|6
833778|NCT01843842|2740064|P2|Overall Study|Do not meet inclusion criteria|1
833779|NCT01843842|2740065|P1|Overall Study|Do not meet inclusion criteria|1
833780|NCT01843777|2740087|P2|Overall Study|Withdrawal by Subject|0
833781|NCT01843777|2740088|P1|Overall Study|Withdrawal by Subject|1
833782|NCT01843673|2740096|P1|Overall Study|Withdrawal by Subject|4
833783|NCT01843673|2740096|P1|Overall Study|Lack of Efficacy|2
833784|NCT01843660|2740108|P1|Overall Study|Other|30
833785|NCT01843374|2740149|P2|Overall Study|Withdrawing due to Other reason|46
833786|NCT01843374|2740150|P1|Overall Study|Withdrawing due to Other reason|20
833787|NCT01843374|2740149|P2|Overall Study|Withdrawal by Subject|20
833788|NCT01843374|2740150|P1|Overall Study|Withdrawal by Subject|14
833789|NCT01843374|2740149|P2|Overall Study|Death|313
833790|NCT01843374|2740150|P1|Overall Study|Death|155
833791|NCT01843348|2740177|P3|Overall Study|Various reasons|6
833792|NCT01843348|2740178|P2|Overall Study|Various reasons|9
833793|NCT01843348|2740179|P1|Overall Study|Various reasons|4
833794|NCT01843348|2740177|P3|Overall Study|Graft loss/retransplantation|11
833795|NCT01843348|2740178|P2|Overall Study|Graft loss/retransplantation|8
833796|NCT01843348|2740179|P1|Overall Study|Graft loss/retransplantation|5
833797|NCT01843348|2740177|P3|Overall Study|Death|4
833798|NCT01843348|2740178|P2|Overall Study|Death|3
833799|NCT01843348|2740179|P1|Overall Study|Death|5
833800|NCT01843348|2740177|P3|Overall Study|Lost to Follow-up|2
833801|NCT01843348|2740178|P2|Overall Study|Lost to Follow-up|4
833802|NCT01843348|2740179|P1|Overall Study|Lost to Follow-up|5
833803|NCT01843348|2740177|P3|Overall Study|Withdrawal by Subject|18
833804|NCT01843348|2740178|P2|Overall Study|Withdrawal by Subject|16
833805|NCT01843348|2740179|P1|Overall Study|Withdrawal by Subject|4
833806|NCT01843205|2740219|P2|First Treatment (11 Days)|Withdrawal by Subject|0
833807|NCT01843205|2740220|P1|First Treatment (11 Days)|Withdrawal by Subject|1
833808|NCT01843192|2740281|P3|Overall Study|Intra-operative exclusions per protocol|2
833809|NCT01843192|2740282|P2|Overall Study|Intra-operative exclusions per protocol|6
833810|NCT01843192|2740283|P1|Overall Study|Intra-operative exclusions per protocol|2
833811|NCT01842958|2740314|P2|Overall Study|Lost to Follow-up|1
833812|NCT01842958|2740315|P1|Overall Study|Lost to Follow-up|1
833813|NCT01842633|2740388|P3|Overall Study|Technical issues|0
833814|NCT01842633|2740389|P2|Overall Study|Technical issues|0
833815|NCT01842633|2740390|P1|Overall Study|Technical issues|1
833816|NCT01842633|2740388|P3|Overall Study|Withdrawal by Subject|0
833817|NCT01842633|2740389|P2|Overall Study|Withdrawal by Subject|1
833818|NCT01842633|2740390|P1|Overall Study|Withdrawal by Subject|0
833819|NCT01842633|2740388|P3|Overall Study|Adverse Event|0
833820|NCT01842633|2740389|P2|Overall Study|Adverse Event|1
833821|NCT01842633|2740390|P1|Overall Study|Adverse Event|1
833822|NCT01842633|2740388|P3|Overall Study|Screen Failure|0
833823|NCT01842633|2740389|P2|Overall Study|Screen Failure|0
833824|NCT01842633|2740390|P1|Overall Study|Screen Failure|1
833825|NCT01842620|2740437|P2|Period 1|Withdrawal by Subject|0
833826|NCT01842620|2740438|P1|Period 1|Withdrawal by Subject|1
833827|NCT01842607|2740454|P1|Overall Study|Withdrawal by Subject|14
833828|NCT01842607|2740454|P1|Overall Study|Physician Decision|9
833829|NCT01842607|2740454|P1|Overall Study|Lost to Follow-up|3
833830|NCT01842607|2740454|P1|Overall Study|Protocol defined stopping criteria|2
833831|NCT01842607|2740454|P1|Overall Study|Protocol Violation|8
833832|NCT01842607|2740454|P1|Overall Study|Lack of Efficacy|19
833833|NCT01842607|2740454|P1|Overall Study|Adverse Event|11
833834|NCT01842438|2740486|P2|T2: 6month Follow-up|Death|1
833835|NCT01842438|2740487|P1|T2: 6month Follow-up|Death|0
833836|NCT01842438|2740486|P2|T2: 6month Follow-up|Withdrawal by Subject|3
833837|NCT01842438|2740487|P1|T2: 6month Follow-up|Withdrawal by Subject|4
833838|NCT01842438|2740486|P2|T1: Immediately After the Intervention|Withdrawal by Subject|8
833839|NCT01842438|2740487|P1|T1: Immediately After the Intervention|Withdrawal by Subject|6
833840|NCT01842334|2740501|P2|Overall Study|Moved away mid-study|1
833841|NCT01842334|2740502|P1|Overall Study|Moved away mid-study|0
833842|NCT01842334|2740501|P2|Overall Study|Withdrawal by Subject|3
833843|NCT01842334|2740502|P1|Overall Study|Withdrawal by Subject|3
833844|NCT01841970|2740508|P1|Overall Study|Lost to Follow-up|8
833845|NCT01841970|2740508|P1|Overall Study|Physician Decision|2
833846|NCT01841970|2740508|P1|Overall Study|Withdrawal by Subject|1
833847|NCT01841762|2740532|P1|Post-Treatment Safety Follow-Up Period|Other, administrative error|1
833848|NCT01841762|2740532|P1|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6
833849|NCT01841762|2740532|P1|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7
833850|NCT01841762|2740532|P1|Post-Treatment Safety Follow-Up Period|Death|1
833851|NCT01841762|2740532|P1|Treatment Period|Other, including non-compliance|5
833852|NCT01841762|2740532|P1|Treatment Period|Physician Decision|2
833853|NCT01841762|2740532|P1|Treatment Period|Lost to Follow-up|1
833854|NCT01841762|2740532|P1|Treatment Period|Withdrawal by Subject|7
833855|NCT01841762|2740532|P1|Treatment Period|Death|1
833856|NCT01841762|2740532|P1|Treatment Period|Adverse Event|16
833857|NCT01841762|2740532|P1|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51
833858|NCT01841697|2740542|P2|Overall Study|Withdrawal by Subject|16
833859|NCT01841697|2740543|P1|Overall Study|Withdrawal by Subject|16
833860|NCT01841697|2740542|P2|Overall Study|Lost to Follow-up|1
833861|NCT01841697|2740543|P1|Overall Study|Lost to Follow-up|4
833862|NCT01841697|2740542|P2|Overall Study|Death|1
833863|NCT01841697|2740543|P1|Overall Study|Death|0
833864|NCT01841593|2740583|P2|Second Intervention (Days 8 to 14)|Adverse Event|0
833865|NCT01841593|2740584|P1|Second Intervention (Days 8 to 14)|Adverse Event|1
833866|NCT01841593|2740583|P2|First Intervention (Days 1 to 7)|Protocol Violation|1
833867|NCT01841593|2740584|P1|First Intervention (Days 1 to 7)|Protocol Violation|0
833868|NCT01841567|2740600|P1|Overall Study|Adverse Event|3
833869|NCT01840943|2740628|P2|Overall Study|Lost to Follow-up|4
833870|NCT01840943|2740629|P1|Overall Study|Lost to Follow-up|4
833871|NCT01840943|2740628|P2|Overall Study|Physician Decision|2
833872|NCT01840943|2740629|P1|Overall Study|Physician Decision|4
833873|NCT01840943|2740628|P2|Overall Study|Withdrawal by Subject|6
833874|NCT01840943|2740629|P1|Overall Study|Withdrawal by Subject|5
833875|NCT01840605|2740665|P2|Overall Study|Physician Decision|1
833876|NCT01840605|2740666|P1|Overall Study|Physician Decision|2
833877|NCT01840605|2740665|P2|Overall Study|Adverse Event|1
833878|NCT01840605|2740666|P1|Overall Study|Adverse Event|0
833879|NCT01840410|2740680|P2|Overall Study|Adverse Event|1
833880|NCT01840410|2740681|P1|Overall Study|Adverse Event|1
833881|NCT01840410|2740680|P2|Overall Study|Withdrawal by Subject|1
833882|NCT01840410|2740681|P1|Overall Study|Withdrawal by Subject|2
833883|NCT01840410|2740680|P2|Overall Study|Lost to Follow-up|0
833884|NCT01840410|2740681|P1|Overall Study|Lost to Follow-up|1
833885|NCT01840410|2740680|P2|Overall Study|Protocol deviation|0
833886|NCT01840410|2740681|P1|Overall Study|Protocol deviation|1
833887|NCT01840410|2740680|P2|Overall Study|Pregnancy|0
833888|NCT01840410|2740681|P1|Overall Study|Pregnancy|1
833889|NCT01840410|2740680|P2|Overall Study|Physician Decision|2
833890|NCT01840410|2740681|P1|Overall Study|Physician Decision|1
833891|NCT01840163|2740730|P2|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35
833892|NCT01840163|2740731|P1|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43
833893|NCT01840163|2740730|P2|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40
833894|NCT01840163|2740731|P1|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48
833895|NCT01840163|2740730|P2|First Follow up -Primary Outcome|Lost to Follow-up|16
833896|NCT01840163|2740731|P1|First Follow up -Primary Outcome|Lost to Follow-up|19
833897|NCT01839656|2740818|P2|Overall Study|Adverse Event|0
833898|NCT01839656|2740819|P1|Overall Study|Adverse Event|1
833899|NCT01839656|2740818|P2|Overall Study|Early study closure|11
833900|NCT01839656|2740819|P1|Overall Study|Early study closure|0
833901|NCT01839656|2740818|P2|Overall Study|Adverse event, serious fatal|4
833902|NCT01839656|2740819|P1|Overall Study|Adverse event, serious fatal|1
833903|NCT01839656|2740818|P2|Overall Study|Withdrawal by Subject|1
833904|NCT01839656|2740819|P1|Overall Study|Withdrawal by Subject|1
833905|NCT01839279|2740907|P3|Overall Study|Classified as 'Other'|0
833906|NCT01839279|2740908|P2|Overall Study|Classified as 'Other'|0
833907|NCT01839279|2740909|P1|Overall Study|Classified as 'Other'|5
833908|NCT01839279|2740907|P3|Overall Study|Withdrawal by Subject|1
833909|NCT01839279|2740908|P2|Overall Study|Withdrawal by Subject|1
833910|NCT01839279|2740909|P1|Overall Study|Withdrawal by Subject|4
833911|NCT01839279|2740907|P3|Overall Study|Adverse Event|1
833912|NCT01839279|2740908|P2|Overall Study|Adverse Event|1
833913|NCT01839279|2740909|P1|Overall Study|Adverse Event|4
833914|NCT01838941|2740947|P1|Overall Study|Withdrawal by Subject|1
833915|NCT01838941|2740947|P1|Overall Study|Adverse Event|1
833916|NCT01838694|2741048|P2|Overall Study|Adverse Event|1
833917|NCT01838694|2741049|P1|Overall Study|Adverse Event|0
833918|NCT01838681|2741058|P4|Period B/A+|Administrative or other reasons|28
833919|NCT01838681|2741059|P3|Period B/A+|Administrative or other reasons|10
833920|NCT01838681|2741060|P2|Period B/A+|Administrative or other reasons|6
833921|NCT01838681|2741061|P1|Period B/A+|Administrative or other reasons|0
833922|NCT01838681|2741058|P4|Period B/A+|Withdrawal before treatment|0
833923|NCT01838681|2741059|P3|Period B/A+|Withdrawal before treatment|0
833924|NCT01838681|2741060|P2|Period B/A+|Withdrawal before treatment|1
833925|NCT01838681|2741061|P1|Period B/A+|Withdrawal before treatment|0
833926|NCT01838681|2741058|P4|Period B/A+|Lost to Follow-up|11
833927|NCT01838681|2741059|P3|Period B/A+|Lost to Follow-up|5
833928|NCT01838681|2741060|P2|Period B/A+|Lost to Follow-up|2
833929|NCT01838681|2741061|P1|Period B/A+|Lost to Follow-up|0
833930|NCT01838681|2741058|P4|Period B/A+|Non-compliance with IMP|3
833931|NCT01838681|2741059|P3|Period B/A+|Non-compliance with IMP|3
833932|NCT01838681|2741060|P2|Period B/A+|Non-compliance with IMP|2
833933|NCT01838681|2741061|P1|Period B/A+|Non-compliance with IMP|0
833934|NCT01838681|2741058|P4|Period B/A+|Protocol Violation|6
833935|NCT01838681|2741059|P3|Period B/A+|Protocol Violation|4
833936|NCT01838681|2741060|P2|Period B/A+|Protocol Violation|1
833937|NCT01838681|2741061|P1|Period B/A+|Protocol Violation|0
833938|NCT01838681|2741058|P4|Period B/A+|Withdrawal by Subject|47
833939|NCT01838681|2741059|P3|Period B/A+|Withdrawal by Subject|35
833940|NCT01838681|2741060|P2|Period B/A+|Withdrawal by Subject|28
833941|NCT01838681|2741061|P1|Period B/A+|Withdrawal by Subject|0
833942|NCT01838681|2741058|P4|Period B/A+|Lack of Efficacy|6
833943|NCT01838681|2741059|P3|Period B/A+|Lack of Efficacy|11
833944|NCT01838681|2741060|P2|Period B/A+|Lack of Efficacy|9
833945|NCT01838681|2741061|P1|Period B/A+|Lack of Efficacy|0
833946|NCT01838681|2741058|P4|Period B/A+|Adverse Event|16
833947|NCT01838681|2741059|P3|Period B/A+|Adverse Event|27
833948|NCT01838681|2741060|P2|Period B/A+|Adverse Event|13
833949|NCT01838681|2741061|P1|Period B/A+|Adverse Event|0
833950|NCT01838681|2741058|P4|Period A|Administrative or other reasons|0
833951|NCT01838681|2741059|P3|Period A|Administrative or other reasons|0
833952|NCT01838681|2741060|P2|Period A|Administrative or other reasons|0
833953|NCT01838681|2741061|P1|Period A|Administrative or other reasons|17
833954|NCT01838681|2741058|P4|Period A|Withdrawal before treatment|0
833955|NCT01838681|2741059|P3|Period A|Withdrawal before treatment|0
833956|NCT01838681|2741060|P2|Period A|Withdrawal before treatment|0
833957|NCT01838681|2741061|P1|Period A|Withdrawal before treatment|4
833958|NCT01838681|2741058|P4|Period A|Lost to Follow-up|0
833959|NCT01838681|2741059|P3|Period A|Lost to Follow-up|0
833960|NCT01838681|2741060|P2|Period A|Lost to Follow-up|0
833961|NCT01838681|2741061|P1|Period A|Lost to Follow-up|4
833962|NCT01838681|2741058|P4|Period A|Non-compliance with IMP|0
833963|NCT01838681|2741059|P3|Period A|Non-compliance with IMP|0
833964|NCT01838681|2741060|P2|Period A|Non-compliance with IMP|0
833965|NCT01838681|2741061|P1|Period A|Non-compliance with IMP|6
833966|NCT01838681|2741058|P4|Period A|Protocol Violation|0
833967|NCT01838681|2741059|P3|Period A|Protocol Violation|0
833968|NCT01838681|2741060|P2|Period A|Protocol Violation|0
833969|NCT01838681|2741061|P1|Period A|Protocol Violation|16
833970|NCT01838681|2741058|P4|Period A|Withdrawal by Subject|0
833971|NCT01838681|2741059|P3|Period A|Withdrawal by Subject|0
833972|NCT01838681|2741060|P2|Period A|Withdrawal by Subject|0
833973|NCT01838681|2741061|P1|Period A|Withdrawal by Subject|70
833974|NCT01838681|2741058|P4|Period A|Early response|0
833975|NCT01838681|2741059|P3|Period A|Early response|0
833976|NCT01838681|2741060|P2|Period A|Early response|0
833977|NCT01838681|2741061|P1|Period A|Early response|148
833978|NCT01838681|2741058|P4|Period A|Lack of Efficacy|0
833979|NCT01838681|2741059|P3|Period A|Lack of Efficacy|0
833980|NCT01838681|2741060|P2|Period A|Lack of Efficacy|0
833981|NCT01838681|2741061|P1|Period A|Lack of Efficacy|21
833982|NCT01838681|2741058|P4|Period A|Adverse Event|0
833983|NCT01838681|2741059|P3|Period A|Adverse Event|0
833984|NCT01838681|2741060|P2|Period A|Adverse Event|0
833985|NCT01838681|2741061|P1|Period A|Adverse Event|39
833986|NCT01838642|2741169|P1|Overall Study|Died on study|1
833987|NCT01838616|2741182|P2|Pick-up Arm|Technical problems|0
833988|NCT01838616|2741183|P1|Pick-up Arm|Technical problems|1
833989|NCT01838616|2741182|P2|Pick-up Arm|Withdrawal by Subject|0
833990|NCT01838616|2741183|P1|Pick-up Arm|Withdrawal by Subject|1
833991|NCT01838616|2741182|P2|Pick-up Arm|Adverse Event|0
833992|NCT01838616|2741183|P1|Pick-up Arm|Adverse Event|9
833993|NCT01838616|2741182|P2|Pick-up Arm|Lack of Efficacy|0
833994|NCT01838616|2741183|P1|Pick-up Arm|Lack of Efficacy|4
833995|NCT01838616|2741182|P2|Continuation Period|Technical problems|1
833996|NCT01838616|2741183|P1|Continuation Period|Technical problems|0
833997|NCT01838616|2741182|P2|Continuation Period|Withdrawal by Subject|4
833998|NCT01838616|2741183|P1|Continuation Period|Withdrawal by Subject|0
833999|NCT01838616|2741182|P2|Continuation Period|Lost to Follow-up|0
834000|NCT01838616|2741183|P1|Continuation Period|Lost to Follow-up|1
834001|NCT01838616|2741182|P2|Continuation Period|Protocol Violation|0
834002|NCT01838616|2741183|P1|Continuation Period|Protocol Violation|2
834003|NCT01838616|2741182|P2|Continuation Period|Adverse Event|4
834004|NCT01838616|2741183|P1|Continuation Period|Adverse Event|8
834005|NCT01838616|2741182|P2|Continuation Period|Lack of Efficacy|5
834006|NCT01838616|2741183|P1|Continuation Period|Lack of Efficacy|3
834007|NCT01838616|2741182|P2|Titration Period|Protocol Violation|1
834008|NCT01838616|2741183|P1|Titration Period|Protocol Violation|0
834009|NCT01838616|2741182|P2|Titration Period|Not specified|0
834010|NCT01838616|2741183|P1|Titration Period|Not specified|1
834011|NCT01838616|2741182|P2|Titration Period|Technical problems|0
834012|NCT01838616|2741183|P1|Titration Period|Technical problems|1
834013|NCT01838616|2741182|P2|Titration Period|Withdrawal by Subject|5
834014|NCT01838616|2741183|P1|Titration Period|Withdrawal by Subject|5
834015|NCT01838616|2741182|P2|Titration Period|Lack of Efficacy|12
834016|NCT01838616|2741183|P1|Titration Period|Lack of Efficacy|5
834017|NCT01838616|2741182|P2|Titration Period|Adverse Event|48
834018|NCT01838616|2741183|P1|Titration Period|Adverse Event|18
834019|NCT01838590|2741254|P2|Overall Study|Lost to Follow-up|1
834020|NCT01838590|2741255|P1|Overall Study|Lost to Follow-up|0
834021|NCT01838590|2741254|P2|Overall Study|Lack of Efficacy|4
834022|NCT01838590|2741255|P1|Overall Study|Lack of Efficacy|12
834023|NCT01838499|2741279|P2|Overall Study|Withdrawal by Subject|9
834024|NCT01838499|2741280|P1|Overall Study|Withdrawal by Subject|19
834025|NCT01838499|2741279|P2|Overall Study|Adverse Event|1
834026|NCT01838499|2741280|P1|Overall Study|Adverse Event|2
834027|NCT01838499|2741279|P2|Overall Study|Lack of Efficacy|2
834028|NCT01838499|2741280|P1|Overall Study|Lack of Efficacy|1
834029|NCT01838499|2741279|P2|Overall Study|Lost to Follow-up|4
834030|NCT01838499|2741280|P1|Overall Study|Lost to Follow-up|2
834031|NCT01838499|2741279|P2|Overall Study|Protocol Violation|1
834032|NCT01838499|2741280|P1|Overall Study|Protocol Violation|0
834033|NCT01838213|2741307|P2|Overall Study|Ineligible|191
834034|NCT01838213|2741308|P1|Overall Study|Ineligible|166
834035|NCT01838044|2741316|P2|Overall Study|Lost to Follow-up|2
834036|NCT01838044|2741317|P1|Overall Study|Lost to Follow-up|0
834037|NCT01838044|2741316|P2|Overall Study|Medication error without associated AE|1
834038|NCT01838044|2741317|P1|Overall Study|Medication error without associated AE|0
834039|NCT01838044|2741316|P2|Overall Study|Insufficient clinical response|2
834040|NCT01838044|2741317|P1|Overall Study|Insufficient clinical response|1
834041|NCT01838044|2741316|P2|Overall Study|Withdrawal by Subject|2
834042|NCT01838044|2741317|P1|Overall Study|Withdrawal by Subject|0
834043|NCT01838044|2741316|P2|Overall Study|Protocol Violation|3
834044|NCT01838044|2741317|P1|Overall Study|Protocol Violation|3
834045|NCT01838044|2741316|P2|Overall Study|Adverse Event|6
834046|NCT01838044|2741317|P1|Overall Study|Adverse Event|4
834047|NCT01837966|2741350|P2|Overall Study|Withdrawal by Subject|1
834048|NCT01837966|2741351|P1|Overall Study|Withdrawal by Subject|2
834049|NCT01837823|2741357|P1|Overall Study|Lost to Follow-up|6
834050|NCT01837797|2741388|P5|Period 3|Other|2
834051|NCT01837797|2741389|P4|Period 3|Other|0
834052|NCT01837797|2741390|P3|Period 3|Other|0
834053|NCT01837797|2741391|P2|Period 3|Other|0
834054|NCT01837797|2741392|P1|Period 3|Other|0
834055|NCT01837797|2741388|P5|Period 3|Administrative reasons|20
834056|NCT01837797|2741389|P4|Period 3|Administrative reasons|0
834057|NCT01837797|2741390|P3|Period 3|Administrative reasons|0
834058|NCT01837797|2741391|P2|Period 3|Administrative reasons|0
834059|NCT01837797|2741392|P1|Period 3|Administrative reasons|0
834060|NCT01837797|2741388|P5|Period 3|Adverse Event|1
834061|NCT01837797|2741389|P4|Period 3|Adverse Event|0
834062|NCT01837797|2741390|P3|Period 3|Adverse Event|0
834063|NCT01837797|2741391|P2|Period 3|Adverse Event|0
834064|NCT01837797|2741392|P1|Period 3|Adverse Event|0
834065|NCT01837797|2741388|P5|Period 2|Adverse Event|0
834066|NCT01837797|2741389|P4|Period 2|Adverse Event|1
834067|NCT01837797|2741390|P3|Period 2|Adverse Event|0
834068|NCT01837797|2741391|P2|Period 2|Adverse Event|0
834069|NCT01837797|2741392|P1|Period 2|Adverse Event|0
834070|NCT01837797|2741388|P5|Period 2|Administrative or other reasons|0
834071|NCT01837797|2741389|P4|Period 2|Administrative or other reasons|4
834072|NCT01837797|2741390|P3|Period 2|Administrative or other reasons|2
834073|NCT01837797|2741391|P2|Period 2|Administrative or other reasons|5
834074|NCT01837797|2741392|P1|Period 2|Administrative or other reasons|0
834075|NCT01837797|2741388|P5|Period 1|Other|0
834076|NCT01837797|2741389|P4|Period 1|Other|0
834077|NCT01837797|2741390|P3|Period 1|Other|0
834078|NCT01837797|2741391|P2|Period 1|Other|0
834079|NCT01837797|2741392|P1|Period 1|Other|10
834080|NCT01837797|2741388|P5|Period 1|Withdrawal of consent before treatment|0
834081|NCT01837797|2741389|P4|Period 1|Withdrawal of consent before treatment|0
834082|NCT01837797|2741390|P3|Period 1|Withdrawal of consent before treatment|0
834083|NCT01837797|2741391|P2|Period 1|Withdrawal of consent before treatment|0
834084|NCT01837797|2741392|P1|Period 1|Withdrawal of consent before treatment|1
834085|NCT01837797|2741388|P5|Period 1|Administrative reasons|0
834086|NCT01837797|2741389|P4|Period 1|Administrative reasons|0
834087|NCT01837797|2741390|P3|Period 1|Administrative reasons|0
834088|NCT01837797|2741391|P2|Period 1|Administrative reasons|0
834089|NCT01837797|2741392|P1|Period 1|Administrative reasons|76
834090|NCT01837797|2741388|P5|Period 1|Withdrawal by Subject|0
834091|NCT01837797|2741389|P4|Period 1|Withdrawal by Subject|0
834092|NCT01837797|2741390|P3|Period 1|Withdrawal by Subject|0
834093|NCT01837797|2741391|P2|Period 1|Withdrawal by Subject|0
834094|NCT01837797|2741392|P1|Period 1|Withdrawal by Subject|6
834095|NCT01837797|2741388|P5|Period 1|Adverse Event|0
834096|NCT01837797|2741389|P4|Period 1|Adverse Event|0
834097|NCT01837797|2741390|P3|Period 1|Adverse Event|0
834098|NCT01837797|2741391|P2|Period 1|Adverse Event|0
834099|NCT01837797|2741392|P1|Period 1|Adverse Event|9
834100|NCT01837719|2741427|P1|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1
834101|NCT01837719|2741427|P1|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1
834102|NCT01837680|2741496|P2|Overall Study|switched to oral hypoglycemic or diet|4
834103|NCT01837680|2741497|P1|Overall Study|switched to oral hypoglycemic or diet|2
834104|NCT01837680|2741496|P2|Overall Study|allergic reaction|0
834105|NCT01837680|2741497|P1|Overall Study|allergic reaction|6
834106|NCT01837680|2741496|P2|Overall Study|lack of insurance|2
834107|NCT01837680|2741497|P1|Overall Study|lack of insurance|0
834108|NCT01837680|2741496|P2|Overall Study|Lost to Follow-up|2
834109|NCT01837680|2741497|P1|Overall Study|Lost to Follow-up|2
834110|NCT01836549|2741605|P7|Overall Study|Patient inevaluable to start therapy|1
834111|NCT01836549|2741606|P6|Overall Study|Patient inevaluable to start therapy|0
834112|NCT01836549|2741607|P5|Overall Study|Patient inevaluable to start therapy|0
834113|NCT01836549|2741608|P4|Overall Study|Patient inevaluable to start therapy|0
834114|NCT01836549|2741609|P3|Overall Study|Patient inevaluable to start therapy|0
834115|NCT01836549|2741610|P2|Overall Study|Patient inevaluable to start therapy|0
834116|NCT01836549|2741611|P1|Overall Study|Patient inevaluable to start therapy|0
834117|NCT01836549|2741605|P7|Overall Study|Patient declared ineligible|0
834118|NCT01836549|2741606|P6|Overall Study|Patient declared ineligible|0
834119|NCT01836549|2741607|P5|Overall Study|Patient declared ineligible|0
834120|NCT01836549|2741608|P4|Overall Study|Patient declared ineligible|1
834121|NCT01836549|2741609|P3|Overall Study|Patient declared ineligible|0
834122|NCT01836549|2741610|P2|Overall Study|Patient declared ineligible|0
834123|NCT01836549|2741611|P1|Overall Study|Patient declared ineligible|0
834124|NCT01836549|2741605|P7|Overall Study|Did not receive study drug|0
834125|NCT01836549|2741606|P6|Overall Study|Did not receive study drug|0
834126|NCT01836549|2741607|P5|Overall Study|Did not receive study drug|0
834127|NCT01836549|2741608|P4|Overall Study|Did not receive study drug|0
834128|NCT01836549|2741609|P3|Overall Study|Did not receive study drug|1
834129|NCT01836549|2741610|P2|Overall Study|Did not receive study drug|0
834130|NCT01836549|2741611|P1|Overall Study|Did not receive study drug|0
834131|NCT01836523|2741635|P4|Overall Study|Unclassified|29
834132|NCT01836523|2741636|P3|Overall Study|Unclassified|19
834133|NCT01836523|2741637|P2|Overall Study|Unclassified|28
834134|NCT01836523|2741638|P1|Overall Study|Unclassified|17
834135|NCT01836523|2741635|P4|Overall Study|Met Withdrawal Criteria|27
834136|NCT01836523|2741636|P3|Overall Study|Met Withdrawal Criteria|21
834137|NCT01836523|2741637|P2|Overall Study|Met Withdrawal Criteria|13
834138|NCT01836523|2741638|P1|Overall Study|Met Withdrawal Criteria|13
834139|NCT01836523|2741635|P4|Overall Study|Protocol Violation|4
834140|NCT01836523|2741636|P3|Overall Study|Protocol Violation|2
834141|NCT01836523|2741637|P2|Overall Study|Protocol Violation|3
834142|NCT01836523|2741638|P1|Overall Study|Protocol Violation|6
834143|NCT01836523|2741635|P4|Overall Study|Adverse Event|14
834144|NCT01836523|2741636|P3|Overall Study|Adverse Event|49
834145|NCT01836523|2741637|P2|Overall Study|Adverse Event|41
834146|NCT01836523|2741638|P1|Overall Study|Adverse Event|15
834147|NCT01836471|2741665|P5|Overall Study|Non compliance with tx|0
834148|NCT01836471|2741666|P4|Overall Study|Non compliance with tx|0
834149|NCT01836471|2741667|P3|Overall Study|Non compliance with tx|0
834150|NCT01836471|2741668|P2|Overall Study|Non compliance with tx|1
834151|NCT01836471|2741669|P1|Overall Study|Non compliance with tx|1
834152|NCT01836471|2741665|P5|Overall Study|Adverse Event|2
834153|NCT01836471|2741666|P4|Overall Study|Adverse Event|1
834154|NCT01836471|2741667|P3|Overall Study|Adverse Event|1
834155|NCT01836471|2741668|P2|Overall Study|Adverse Event|3
834156|NCT01836471|2741669|P1|Overall Study|Adverse Event|6
834157|NCT01836471|2741665|P5|Overall Study|Lost to Follow-up|1
834158|NCT01836471|2741666|P4|Overall Study|Lost to Follow-up|1
834159|NCT01836471|2741667|P3|Overall Study|Lost to Follow-up|0
834160|NCT01836471|2741668|P2|Overall Study|Lost to Follow-up|0
834161|NCT01836471|2741669|P1|Overall Study|Lost to Follow-up|0
834162|NCT01836471|2741665|P5|Overall Study|Physician Decision|0
834163|NCT01836471|2741666|P4|Overall Study|Physician Decision|0
834164|NCT01836471|2741667|P3|Overall Study|Physician Decision|0
834165|NCT01836471|2741668|P2|Overall Study|Physician Decision|1
834166|NCT01836471|2741669|P1|Overall Study|Physician Decision|0
834167|NCT01836471|2741665|P5|Overall Study|Withdrawal by Subject|2
834168|NCT01836471|2741666|P4|Overall Study|Withdrawal by Subject|0
834169|NCT01836471|2741667|P3|Overall Study|Withdrawal by Subject|1
834170|NCT01836471|2741668|P2|Overall Study|Withdrawal by Subject|4
834171|NCT01836471|2741669|P1|Overall Study|Withdrawal by Subject|3
834172|NCT01836471|2741665|P5|Overall Study|Pregnancy|0
834173|NCT01836471|2741666|P4|Overall Study|Pregnancy|0
834174|NCT01836471|2741667|P3|Overall Study|Pregnancy|0
834175|NCT01836471|2741668|P2|Overall Study|Pregnancy|0
834176|NCT01836471|2741669|P1|Overall Study|Pregnancy|1
834177|NCT01836458|2741698|P4|Overall Study|Unsatisfactory therapeutic effect|6
834178|NCT01836458|2741699|P3|Overall Study|Unsatisfactory therapeutic effect|5
834179|NCT01836458|2741700|P2|Overall Study|Unsatisfactory therapeutic effect|2
834180|NCT01836458|2741701|P1|Overall Study|Unsatisfactory therapeutic effect|3
834181|NCT01836276|2741786|P2|Overall Study|Lost to Follow-up|51
834182|NCT01836276|2741787|P1|Overall Study|Lost to Follow-up|28
834183|NCT01835899|2741858|P3|Overall Study|Other than stated above|0
834184|NCT01835899|2741859|P2|Overall Study|Other than stated above|1
834185|NCT01835899|2741860|P1|Overall Study|Other than stated above|0
834186|NCT01835899|2741858|P3|Overall Study|Adverse Event|1
834187|NCT01835899|2741859|P2|Overall Study|Adverse Event|0
834188|NCT01835899|2741860|P1|Overall Study|Adverse Event|0
834189|NCT01835587|2741906|P4|Overall Study|Miscellaneous|0
834190|NCT01835587|2741907|P3|Overall Study|Miscellaneous|0
834191|NCT01835587|2741908|P2|Overall Study|Miscellaneous|1
834192|NCT01835587|2741909|P1|Overall Study|Miscellaneous|0
834193|NCT01835587|2741906|P4|Overall Study|Death|1
834194|NCT01835587|2741907|P3|Overall Study|Death|0
834195|NCT01835587|2741908|P2|Overall Study|Death|0
834196|NCT01835587|2741909|P1|Overall Study|Death|0
834197|NCT01835587|2741906|P4|Overall Study|Adverse Event|2
834198|NCT01835587|2741907|P3|Overall Study|Adverse Event|2
834199|NCT01835587|2741908|P2|Overall Study|Adverse Event|0
834200|NCT01835587|2741909|P1|Overall Study|Adverse Event|0
834201|NCT01835587|2741906|P4|Overall Study|Withdrawal by Subject|3
834202|NCT01835587|2741907|P3|Overall Study|Withdrawal by Subject|0
834203|NCT01835587|2741908|P2|Overall Study|Withdrawal by Subject|0
834204|NCT01835587|2741909|P1|Overall Study|Withdrawal by Subject|2
834205|NCT01835587|2741906|P4|Overall Study|Disease Recurrence or Relapse|3
834206|NCT01835587|2741907|P3|Overall Study|Disease Recurrence or Relapse|0
834207|NCT01835587|2741908|P2|Overall Study|Disease Recurrence or Relapse|3
834208|NCT01835587|2741909|P1|Overall Study|Disease Recurrence or Relapse|0
834209|NCT01835548|2741970|P3|Double-Blind Treatment Period|Withdrawal by Subject|0
834210|NCT01835548|2741971|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
834211|NCT01835548|2741972|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
834212|NCT01835548|2741970|P3|Double-Blind Treatment Period|Adverse Event|0
834213|NCT01835548|2741971|P2|Double-Blind Treatment Period|Adverse Event|1
834214|NCT01835548|2741972|P1|Double-Blind Treatment Period|Adverse Event|0
834215|NCT01835548|2741970|P3|Dose Optimization Period|Withdrawal by Subject|1
834216|NCT01835548|2741971|P2|Dose Optimization Period|Withdrawal by Subject|0
834217|NCT01835548|2741972|P1|Dose Optimization Period|Withdrawal by Subject|0
834218|NCT01835548|2741970|P3|Dose Optimization Period|Adverse Event|1
834219|NCT01835548|2741971|P2|Dose Optimization Period|Adverse Event|0
834220|NCT01835548|2741972|P1|Dose Optimization Period|Adverse Event|0
834221|NCT01835470|2742001|P1|Long Term Treatment Period|Lack of Efficacy|1
834222|NCT01835470|2742001|P1|Long Term Treatment Period|Subject Request to Discontinue|1
834223|NCT01835431|2742013|P2|Overall Study|Protocol Violation|0
834224|NCT01835431|2742014|P1|Overall Study|Protocol Violation|1
834225|NCT01835431|2742013|P2|Overall Study|Withdrawal by Subject|10
834226|NCT01835431|2742014|P1|Overall Study|Withdrawal by Subject|6
834227|NCT01835431|2742013|P2|Overall Study|other|2
834228|NCT01835431|2742014|P1|Overall Study|other|0
834229|NCT01835431|2742013|P2|Overall Study|Adverse Event|0
834230|NCT01835431|2742014|P1|Overall Study|Adverse Event|1
834231|NCT01835132|2742052|P1|Initial Phase|Insufficient Therapeutic Response|2
834232|NCT01835015|2742097|P5|Overall Study|Adverse Event|0
834233|NCT01835015|2742098|P4|Overall Study|Adverse Event|0
834234|NCT01835015|2742099|P3|Overall Study|Adverse Event|1
834235|NCT01835015|2742100|P2|Overall Study|Adverse Event|0
834236|NCT01835015|2742101|P1|Overall Study|Adverse Event|0
834237|NCT01834586|2742184|P1|Overall Study|Adverse Event|1
834238|NCT01834274|2742224|P2|Overall Study|Other|1
834239|NCT01834274|2742225|P1|Overall Study|Other|2
834240|NCT01834274|2742224|P2|Overall Study|Lost to Follow-up|1
834241|NCT01834274|2742225|P1|Overall Study|Lost to Follow-up|3
834242|NCT01834274|2742224|P2|Overall Study|Withdrawal by Subject|1
834243|NCT01834274|2742225|P1|Overall Study|Withdrawal by Subject|1
834244|NCT01834274|2742224|P2|Overall Study|Study Termination|38
834245|NCT01834274|2742225|P1|Overall Study|Study Termination|41
834246|NCT01834222|2742248|P1|Overall Study|Not meet inclusion/exclusion criteria|1
834247|NCT01833897|2742343|P1|Overall Study|Lack of Efficacy|1
834248|NCT01833533|2742468|P2|Overall Study|Not Specified|7
834249|NCT01833533|2742469|P1|Overall Study|Not Specified|2
834250|NCT01833533|2742468|P2|Overall Study|To Enter an Extension Study|4
834251|NCT01833533|2742469|P1|Overall Study|To Enter an Extension Study|0
834252|NCT01833533|2742468|P2|Overall Study|Lost to Follow-up|9
834253|NCT01833533|2742469|P1|Overall Study|Lost to Follow-up|4
834254|NCT01833533|2742468|P2|Overall Study|Adverse Event|1
834255|NCT01833533|2742469|P1|Overall Study|Adverse Event|0
834256|NCT01833494|2742483|P1|Overall Study|Increase in serum ferritin|1
834257|NCT01833494|2742483|P1|Overall Study|Decrease in serum calcium|4
834258|NCT01833494|2742483|P1|Overall Study|Decrease in serum phosphorus|4
834259|NCT01833494|2742483|P1|Overall Study|Withdrawal by Subject|6
834260|NCT01833494|2742483|P1|Overall Study|Physician Decision|6
834261|NCT01833494|2742483|P1|Overall Study|Adverse Event|24
834262|NCT01833169|2742520|P1|Overall Study|Physician Decision|2
834263|NCT01833169|2742520|P1|Overall Study|Death|3
834264|NCT01833169|2742520|P1|Overall Study|Withdrawal by Subject|9
834265|NCT01833169|2742520|P1|Overall Study|Adverse Event|33
834266|NCT01833169|2742520|P1|Overall Study|Disease Progression|99
834267|NCT01833065|2742589|P5|Overall Study|Others|4
834268|NCT01833065|2742590|P4|Overall Study|Others|1
834269|NCT01833065|2742591|P3|Overall Study|Others|1
834270|NCT01833065|2742592|P2|Overall Study|Others|1
834271|NCT01833065|2742593|P1|Overall Study|Others|2
834272|NCT01833065|2742589|P5|Overall Study|Trial terminated by sponsor|13
834273|NCT01833065|2742590|P4|Overall Study|Trial terminated by sponsor|3
834274|NCT01833065|2742591|P3|Overall Study|Trial terminated by sponsor|7
834275|NCT01833065|2742592|P2|Overall Study|Trial terminated by sponsor|8
834276|NCT01833065|2742593|P1|Overall Study|Trial terminated by sponsor|8
834277|NCT01833065|2742589|P5|Overall Study|Subject's substantial non-compliance|0
834278|NCT01833065|2742590|P4|Overall Study|Subject's substantial non-compliance|0
834279|NCT01833065|2742591|P3|Overall Study|Subject's substantial non-compliance|0
834280|NCT01833065|2742592|P2|Overall Study|Subject's substantial non-compliance|1
834281|NCT01833065|2742593|P1|Overall Study|Subject's substantial non-compliance|0
834282|NCT01833065|2742589|P5|Overall Study|Withdrawal by Subject|11
834283|NCT01833065|2742590|P4|Overall Study|Withdrawal by Subject|3
834284|NCT01833065|2742591|P3|Overall Study|Withdrawal by Subject|4
834285|NCT01833065|2742592|P2|Overall Study|Withdrawal by Subject|2
834286|NCT01833065|2742593|P1|Overall Study|Withdrawal by Subject|6
834287|NCT01833065|2742589|P5|Overall Study|Lost to Follow-up|3
834288|NCT01833065|2742590|P4|Overall Study|Lost to Follow-up|0
834289|NCT01833065|2742591|P3|Overall Study|Lost to Follow-up|0
834290|NCT01833065|2742592|P2|Overall Study|Lost to Follow-up|0
834291|NCT01833065|2742593|P1|Overall Study|Lost to Follow-up|1
834292|NCT01833065|2742589|P5|Overall Study|Protocol Violation|2
834293|NCT01833065|2742590|P4|Overall Study|Protocol Violation|0
834294|NCT01833065|2742591|P3|Overall Study|Protocol Violation|0
834295|NCT01833065|2742592|P2|Overall Study|Protocol Violation|0
834296|NCT01833065|2742593|P1|Overall Study|Protocol Violation|1
834297|NCT01833065|2742589|P5|Overall Study|Adverse Event|3
834298|NCT01833065|2742590|P4|Overall Study|Adverse Event|2
834299|NCT01833065|2742591|P3|Overall Study|Adverse Event|0
834300|NCT01833065|2742592|P2|Overall Study|Adverse Event|1
834301|NCT01833065|2742593|P1|Overall Study|Adverse Event|6
834302|NCT01832766|2742624|P2|Washout|Lost to Follow-up|1
834303|NCT01832766|2742625|P1|Washout|Lost to Follow-up|0
834304|NCT01832493|2742691|P1|Overall Study|Unable to place LV lead|2
834305|NCT01832493|2742691|P1|Overall Study|Protocol Violation|4
834306|NCT01832493|2742691|P1|Overall Study|Physician Decision|2
834307|NCT01832155|2742711|P2|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0
834308|NCT01832155|2742712|P1|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1
834309|NCT01832155|2742711|P2|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0
834310|NCT01832155|2742712|P1|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1
834311|NCT01831817|2742817|P4|Overall Study|Withdrawl of Consent|0
834312|NCT01831817|2742818|P3|Overall Study|Withdrawl of Consent|0
834313|NCT01831817|2742819|P2|Overall Study|Withdrawl of Consent|0
834314|NCT01831817|2742820|P1|Overall Study|Withdrawl of Consent|3
834315|NCT01831817|2742817|P4|Overall Study|Lost to Follow-up|0
834316|NCT01831817|2742818|P3|Overall Study|Lost to Follow-up|0
834317|NCT01831817|2742819|P2|Overall Study|Lost to Follow-up|0
834318|NCT01831817|2742820|P1|Overall Study|Lost to Follow-up|1
834319|NCT01831791|2742858|P1|Overall Study|Withdrawal by Subject|10
834320|NCT01831765|2742887|P3|Overall Study|Lost to Follow-up|3
834321|NCT01831765|2742888|P2|Overall Study|Lost to Follow-up|3
834322|NCT01831765|2742889|P1|Overall Study|Lost to Follow-up|2
834323|NCT01831765|2742887|P3|Overall Study|Withdrawal criteria|16
834324|NCT01831765|2742888|P2|Overall Study|Withdrawal criteria|10
834325|NCT01831765|2742889|P1|Overall Study|Withdrawal criteria|12
834326|NCT01831765|2742887|P3|Overall Study|Withdrawal by Subject|17
834327|NCT01831765|2742888|P2|Overall Study|Withdrawal by Subject|7
834328|NCT01831765|2742889|P1|Overall Study|Withdrawal by Subject|22
834329|NCT01831765|2742887|P3|Overall Study|Adverse Event|3
834330|NCT01831765|2742888|P2|Overall Study|Adverse Event|3
834331|NCT01831765|2742889|P1|Overall Study|Adverse Event|5
834332|NCT01831765|2742887|P3|Overall Study|Other, site closed|0
834333|NCT01831765|2742888|P2|Overall Study|Other, site closed|1
834334|NCT01831765|2742889|P1|Overall Study|Other, site closed|1
834335|NCT01831765|2742887|P3|Overall Study|Death|1
834336|NCT01831765|2742888|P2|Overall Study|Death|1
834337|NCT01831765|2742889|P1|Overall Study|Death|0
834338|NCT01831765|2742887|P3|Overall Study|Pregnancy|2
834339|NCT01831765|2742888|P2|Overall Study|Pregnancy|1
834340|NCT01831765|2742889|P1|Overall Study|Pregnancy|1
834341|NCT01831765|2742887|P3|Overall Study|Other, sponsor withdrew subject|0
834342|NCT01831765|2742888|P2|Overall Study|Other, sponsor withdrew subject|1
834343|NCT01831765|2742889|P1|Overall Study|Other, sponsor withdrew subject|0
834344|NCT01831765|2742887|P3|Overall Study|Lack of Efficacy|0
834345|NCT01831765|2742888|P2|Overall Study|Lack of Efficacy|0
834346|NCT01831765|2742889|P1|Overall Study|Lack of Efficacy|1
834347|NCT01831726|2742915|P1|Overall Study|Subject/guardian decision|7
834348|NCT01831726|2742915|P1|Overall Study|Physician Decision|1
834349|NCT01831726|2742915|P1|Overall Study|Disease Progression|49
834350|NCT01831726|2742915|P1|Overall Study|Death|7
834351|NCT01831726|2742915|P1|Overall Study|Adverse Event|16
834352|NCT01831466|2742934|P12|Overall Study|Adverse Event|2
834353|NCT01831466|2742935|P11|Overall Study|Adverse Event|0
834354|NCT01831466|2742936|P10|Overall Study|Adverse Event|1
834355|NCT01831466|2742937|P9|Overall Study|Adverse Event|1
834356|NCT01831466|2742938|P8|Overall Study|Adverse Event|1
834357|NCT01831466|2742939|P7|Overall Study|Adverse Event|0
834358|NCT01831466|2742940|P6|Overall Study|Adverse Event|7
834359|NCT01831466|2742941|P5|Overall Study|Adverse Event|3
834360|NCT01831466|2742942|P4|Overall Study|Adverse Event|6
834361|NCT01831466|2742943|P3|Overall Study|Adverse Event|4
834362|NCT01831466|2742944|P2|Overall Study|Adverse Event|0
834363|NCT01831466|2742945|P1|Overall Study|Adverse Event|0
834364|NCT01831466|2742934|P12|Overall Study|Lack of Efficacy|0
834365|NCT01831466|2742935|P11|Overall Study|Lack of Efficacy|2
834366|NCT01831466|2742936|P10|Overall Study|Lack of Efficacy|2
834367|NCT01831466|2742937|P9|Overall Study|Lack of Efficacy|2
834368|NCT01831466|2742938|P8|Overall Study|Lack of Efficacy|1
834369|NCT01831466|2742939|P7|Overall Study|Lack of Efficacy|1
834370|NCT01831466|2742940|P6|Overall Study|Lack of Efficacy|8
834371|NCT01831466|2742941|P5|Overall Study|Lack of Efficacy|9
834372|NCT01831466|2742942|P4|Overall Study|Lack of Efficacy|6
834373|NCT01831466|2742943|P3|Overall Study|Lack of Efficacy|7
834374|NCT01831466|2742944|P2|Overall Study|Lack of Efficacy|8
834375|NCT01831466|2742945|P1|Overall Study|Lack of Efficacy|5
834376|NCT01831466|2742934|P12|Overall Study|Lost to Follow-up|1
834377|NCT01831466|2742935|P11|Overall Study|Lost to Follow-up|0
834378|NCT01831466|2742936|P10|Overall Study|Lost to Follow-up|1
834379|NCT01831466|2742937|P9|Overall Study|Lost to Follow-up|0
834380|NCT01831466|2742938|P8|Overall Study|Lost to Follow-up|0
834381|NCT01831466|2742939|P7|Overall Study|Lost to Follow-up|0
834382|NCT01831466|2742940|P6|Overall Study|Lost to Follow-up|3
834383|NCT01831466|2742941|P5|Overall Study|Lost to Follow-up|0
834384|NCT01831466|2742942|P4|Overall Study|Lost to Follow-up|2
834385|NCT01831466|2742943|P3|Overall Study|Lost to Follow-up|4
834386|NCT01831466|2742944|P2|Overall Study|Lost to Follow-up|1
834387|NCT01831466|2742945|P1|Overall Study|Lost to Follow-up|0
834388|NCT01831466|2742934|P12|Overall Study|Withdrawal by Subject|1
834389|NCT01831466|2742935|P11|Overall Study|Withdrawal by Subject|0
834390|NCT01831466|2742936|P10|Overall Study|Withdrawal by Subject|1
834391|NCT01831466|2742937|P9|Overall Study|Withdrawal by Subject|0
834392|NCT01831466|2742938|P8|Overall Study|Withdrawal by Subject|0
834393|NCT01831466|2742939|P7|Overall Study|Withdrawal by Subject|0
834394|NCT01831466|2742940|P6|Overall Study|Withdrawal by Subject|5
834395|NCT01831466|2742941|P5|Overall Study|Withdrawal by Subject|3
834396|NCT01831466|2742942|P4|Overall Study|Withdrawal by Subject|3
834397|NCT01831466|2742943|P3|Overall Study|Withdrawal by Subject|3
834398|NCT01831466|2742944|P2|Overall Study|Withdrawal by Subject|3
834399|NCT01831466|2742945|P1|Overall Study|Withdrawal by Subject|6
834400|NCT01831466|2742934|P12|Overall Study|Death|0
834401|NCT01831466|2742935|P11|Overall Study|Death|0
834402|NCT01831466|2742936|P10|Overall Study|Death|0
834403|NCT01831466|2742937|P9|Overall Study|Death|0
834404|NCT01831466|2742938|P8|Overall Study|Death|0
834405|NCT01831466|2742939|P7|Overall Study|Death|0
834406|NCT01831466|2742940|P6|Overall Study|Death|0
834407|NCT01831466|2742941|P5|Overall Study|Death|0
834408|NCT01831466|2742942|P4|Overall Study|Death|0
834409|NCT01831466|2742943|P3|Overall Study|Death|0
834410|NCT01831466|2742944|P2|Overall Study|Death|1
834411|NCT01831466|2742945|P1|Overall Study|Death|0
834412|NCT01831466|2742934|P12|Overall Study|Non-compliance with study treatment|0
834413|NCT01831466|2742935|P11|Overall Study|Non-compliance with study treatment|0
834414|NCT01831466|2742936|P10|Overall Study|Non-compliance with study treatment|0
834415|NCT01831466|2742937|P9|Overall Study|Non-compliance with study treatment|0
834416|NCT01831466|2742938|P8|Overall Study|Non-compliance with study treatment|0
834417|NCT01831466|2742939|P7|Overall Study|Non-compliance with study treatment|0
834418|NCT01831466|2742940|P6|Overall Study|Non-compliance with study treatment|1
834419|NCT01831466|2742941|P5|Overall Study|Non-compliance with study treatment|0
834420|NCT01831466|2742942|P4|Overall Study|Non-compliance with study treatment|0
834421|NCT01831466|2742943|P3|Overall Study|Non-compliance with study treatment|1
834422|NCT01831466|2742944|P2|Overall Study|Non-compliance with study treatment|1
834423|NCT01831466|2742945|P1|Overall Study|Non-compliance with study treatment|2
834424|NCT01831466|2742934|P12|Overall Study|Not specified|0
834425|NCT01831466|2742935|P11|Overall Study|Not specified|0
834426|NCT01831466|2742936|P10|Overall Study|Not specified|0
834427|NCT01831466|2742937|P9|Overall Study|Not specified|0
834428|NCT01831466|2742938|P8|Overall Study|Not specified|0
834429|NCT01831466|2742939|P7|Overall Study|Not specified|0
834430|NCT01831466|2742940|P6|Overall Study|Not specified|1
834431|NCT01831466|2742941|P5|Overall Study|Not specified|2
834432|NCT01831466|2742942|P4|Overall Study|Not specified|2
834433|NCT01831466|2742943|P3|Overall Study|Not specified|2
834434|NCT01831466|2742944|P2|Overall Study|Not specified|3
834435|NCT01831466|2742945|P1|Overall Study|Not specified|2
834436|NCT01831466|2742934|P12|Overall Study|Protocol Violation|0
834437|NCT01831466|2742935|P11|Overall Study|Protocol Violation|0
834438|NCT01831466|2742936|P10|Overall Study|Protocol Violation|0
834439|NCT01831466|2742937|P9|Overall Study|Protocol Violation|0
834440|NCT01831466|2742938|P8|Overall Study|Protocol Violation|0
834441|NCT01831466|2742939|P7|Overall Study|Protocol Violation|0
834442|NCT01831466|2742940|P6|Overall Study|Protocol Violation|1
834443|NCT01831466|2742941|P5|Overall Study|Protocol Violation|0
834444|NCT01831466|2742942|P4|Overall Study|Protocol Violation|0
834445|NCT01831466|2742943|P3|Overall Study|Protocol Violation|2
834446|NCT01831466|2742944|P2|Overall Study|Protocol Violation|1
834447|NCT01831466|2742945|P1|Overall Study|Protocol Violation|1
834448|NCT01831258|2743067|P2|Overall Study|Lost to Follow-up|2
834449|NCT01831258|2743068|P1|Overall Study|Lost to Follow-up|3
834450|NCT01831258|2743067|P2|Overall Study|Withdrawal by Subject|1
834451|NCT01831258|2743068|P1|Overall Study|Withdrawal by Subject|2
834452|NCT01830972|2743163|P2|Part IV|Non-Compliance|0
834453|NCT01830972|2743164|P1|Part IV|Non-Compliance|1
834454|NCT01830972|2743163|P2|Part IV|Withdrawal by Subject|1
834455|NCT01830972|2743164|P1|Part IV|Withdrawal by Subject|2
834456|NCT01830972|2743163|P2|Part III|Noncompliance|0
834457|NCT01830972|2743164|P1|Part III|Noncompliance|1
834458|NCT01830972|2743163|P2|Part III|Withdrawal by Subject|0
834459|NCT01830972|2743164|P1|Part III|Withdrawal by Subject|1
834460|NCT01830972|2743163|P2|Part II|Withdrawal by Subject|2
834461|NCT01830972|2743164|P1|Part II|Withdrawal by Subject|2
834462|NCT01830920|2743208|P5|Overall Study|Not specified|3
834463|NCT01830920|2743209|P4|Overall Study|Not specified|5
834464|NCT01830920|2743210|P3|Overall Study|Not specified|1
834465|NCT01830920|2743211|P2|Overall Study|Not specified|1
834466|NCT01830920|2743212|P1|Overall Study|Not specified|15
834467|NCT01830920|2743208|P5|Overall Study|Death|4
834468|NCT01830920|2743209|P4|Overall Study|Death|4
834469|NCT01830920|2743210|P3|Overall Study|Death|5
834470|NCT01830920|2743211|P2|Overall Study|Death|3
834471|NCT01830920|2743212|P1|Overall Study|Death|3
834472|NCT01830920|2743208|P5|Overall Study|Withdrawal by Subject|1
834473|NCT01830920|2743209|P4|Overall Study|Withdrawal by Subject|7
834474|NCT01830920|2743210|P3|Overall Study|Withdrawal by Subject|1
834475|NCT01830920|2743211|P2|Overall Study|Withdrawal by Subject|2
834476|NCT01830920|2743212|P1|Overall Study|Withdrawal by Subject|2
834477|NCT01830920|2743208|P5|Overall Study|Adverse Event|0
834478|NCT01830920|2743209|P4|Overall Study|Adverse Event|0
834479|NCT01830920|2743210|P3|Overall Study|Adverse Event|1
834480|NCT01830920|2743211|P2|Overall Study|Adverse Event|0
834481|NCT01830920|2743212|P1|Overall Study|Adverse Event|1
834482|NCT01830881|2743251|P2|Overall Study|Changed decision to have an abortion|1
834483|NCT01830881|2743252|P1|Overall Study|Changed decision to have an abortion|0
834484|NCT01830855|2743300|P4|Overall Study|Lost to Follow-up|33
834485|NCT01830855|2743301|P3|Overall Study|Lost to Follow-up|23
834486|NCT01830855|2743302|P2|Overall Study|Lost to Follow-up|20
834487|NCT01830855|2743303|P1|Overall Study|Lost to Follow-up|47
834488|NCT01830855|2743300|P4|Overall Study|No longer willing to participate|17
834489|NCT01830855|2743301|P3|Overall Study|No longer willing to participate|12
834490|NCT01830855|2743302|P2|Overall Study|No longer willing to participate|13
834491|NCT01830855|2743303|P1|Overall Study|No longer willing to participate|32
834492|NCT01830855|2743300|P4|Overall Study|Withdrawal by Subject|12
834493|NCT01830855|2743301|P3|Overall Study|Withdrawal by Subject|10
834494|NCT01830855|2743302|P2|Overall Study|Withdrawal by Subject|14
834495|NCT01830855|2743303|P1|Overall Study|Withdrawal by Subject|33
834496|NCT01830855|2743300|P4|Overall Study|Protocol deviation|6
834497|NCT01830855|2743301|P3|Overall Study|Protocol deviation|6
834498|NCT01830855|2743302|P2|Overall Study|Protocol deviation|5
834499|NCT01830855|2743303|P1|Overall Study|Protocol deviation|10
834500|NCT01830855|2743300|P4|Overall Study|Adverse Event|3
834501|NCT01830855|2743301|P3|Overall Study|Adverse Event|6
834502|NCT01830855|2743302|P2|Overall Study|Adverse Event|5
834503|NCT01830855|2743303|P1|Overall Study|Adverse Event|11
834504|NCT01830855|2743300|P4|Overall Study|No longer meets eligibility criteria|5
834505|NCT01830855|2743301|P3|Overall Study|No longer meets eligibility criteria|3
834506|NCT01830855|2743302|P2|Overall Study|No longer meets eligibility criteria|2
834507|NCT01830855|2743303|P1|Overall Study|No longer meets eligibility criteria|11
834508|NCT01830855|2743300|P4|Overall Study|Pregnancy|1
834509|NCT01830855|2743301|P3|Overall Study|Pregnancy|2
834510|NCT01830855|2743302|P2|Overall Study|Pregnancy|1
834511|NCT01830855|2743303|P1|Overall Study|Pregnancy|3
834512|NCT01830855|2743300|P4|Overall Study|Medication error without associated AE|1
834513|NCT01830855|2743301|P3|Overall Study|Medication error without associated AE|0
834514|NCT01830855|2743302|P2|Overall Study|Medication error without associated AE|0
834515|NCT01830855|2743303|P1|Overall Study|Medication error without associated AE|1
834516|NCT01830855|2743300|P4|Overall Study|Other|4
834517|NCT01830855|2743301|P3|Overall Study|Other|4
834518|NCT01830855|2743302|P2|Overall Study|Other|1
834519|NCT01830855|2743303|P1|Overall Study|Other|7
834520|NCT01830595|2743440|P2|Washout|Withdrawal by Subject|2
834521|NCT01830595|2743441|P1|Washout|Withdrawal by Subject|2
834522|NCT01830595|2743440|P2|First Period|Withdrawal by Subject|3
834523|NCT01830595|2743441|P1|First Period|Withdrawal by Subject|1
834524|NCT01830543|2743458|P3|Overall Study|Other|37
834525|NCT01830543|2743459|P2|Overall Study|Other|17
834526|NCT01830543|2743460|P1|Overall Study|Other|12
834527|NCT01830543|2743458|P3|Overall Study|Withdrawal by consent|3
834528|NCT01830543|2743459|P2|Overall Study|Withdrawal by consent|3
834529|NCT01830543|2743460|P1|Overall Study|Withdrawal by consent|3
834530|NCT01830543|2743458|P3|Overall Study|Physician Decision|12
834531|NCT01830543|2743459|P2|Overall Study|Physician Decision|5
834532|NCT01830543|2743460|P1|Overall Study|Physician Decision|11
834533|NCT01830543|2743458|P3|Overall Study|Protocol Violation|7
834534|NCT01830543|2743459|P2|Overall Study|Protocol Violation|7
834535|NCT01830543|2743460|P1|Overall Study|Protocol Violation|3
834536|NCT01830543|2743458|P3|Overall Study|Death|22
834537|NCT01830543|2743459|P2|Overall Study|Death|22
834538|NCT01830543|2743460|P1|Overall Study|Death|20
834539|NCT01830543|2743458|P3|Overall Study|Adverse Event|76
834540|NCT01830543|2743459|P2|Overall Study|Adverse Event|77
834541|NCT01830543|2743460|P1|Overall Study|Adverse Event|91
834542|NCT01830543|2743458|P3|Overall Study|Subject Decision|57
834543|NCT01830543|2743459|P2|Overall Study|Subject Decision|21
834544|NCT01830543|2743460|P1|Overall Study|Subject Decision|19
834545|NCT01830127|2743592|P2|Overall Study|Other reason not defined above|2
834546|NCT01830127|2743593|P1|Overall Study|Other reason not defined above|0
834547|NCT01830127|2743592|P2|Overall Study|Withdrawal by Subject|1
834548|NCT01830127|2743593|P1|Overall Study|Withdrawal by Subject|1
834549|NCT01830127|2743592|P2|Overall Study|Lack of Efficacy|0
834550|NCT01830127|2743593|P1|Overall Study|Lack of Efficacy|3
834551|NCT01830127|2743592|P2|Overall Study|Adverse Event|6
834552|NCT01830127|2743593|P1|Overall Study|Adverse Event|1
834553|NCT01829711|2743617|P1|Overall Study|Still in Follow Up|50
834554|NCT01829711|2743617|P1|Overall Study|Death|3
834555|NCT01829711|2743617|P1|Overall Study|Withdrawal by Subject|2
834556|NCT01829711|2743617|P1|Overall Study|Lost to Follow-up|1
834557|NCT01829711|2743617|P1|Overall Study|Not specified|24
834558|NCT01829477|2743672|P2|Overall Study|Withdrawal by Subject|0
834559|NCT01829477|2743673|P1|Overall Study|Withdrawal by Subject|1
834560|NCT01829477|2743672|P2|Overall Study|Study Terminated by Sponsor|15
834561|NCT01829477|2743673|P1|Overall Study|Study Terminated by Sponsor|15
834562|NCT01829464|2743686|P3|Overall Study|Lack of Efficacy|0
834563|NCT01829464|2743687|P2|Overall Study|Lack of Efficacy|1
834564|NCT01829464|2743688|P1|Overall Study|Lack of Efficacy|0
834565|NCT01829464|2743686|P3|Overall Study|Study terminated by sponsor|25
834566|NCT01829464|2743687|P2|Overall Study|Study terminated by sponsor|28
834567|NCT01829464|2743688|P1|Overall Study|Study terminated by sponsor|25
834568|NCT01829464|2743686|P3|Overall Study|Withdrawal by Subject|0
834569|NCT01829464|2743687|P2|Overall Study|Withdrawal by Subject|0
834570|NCT01829464|2743688|P1|Overall Study|Withdrawal by Subject|2
834571|NCT01829464|2743686|P3|Overall Study|Lost to Follow-up|1
834572|NCT01829464|2743687|P2|Overall Study|Lost to Follow-up|0
834573|NCT01829464|2743688|P1|Overall Study|Lost to Follow-up|0
834574|NCT01829464|2743686|P3|Overall Study|Adverse Event|0
834575|NCT01829464|2743687|P2|Overall Study|Adverse Event|0
834576|NCT01829464|2743688|P1|Overall Study|Adverse Event|1
834577|NCT01829243|2743713|P2|First Intervention|Screen Failure|2
834578|NCT01829243|2743714|P1|First Intervention|Screen Failure|4
834579|NCT01829230|2743728|P2|Overall Study|Lost to Follow-up|1
834580|NCT01829230|2743729|P1|Overall Study|Lost to Follow-up|1
834581|NCT01829230|2743728|P2|Overall Study|Withdrawal by Subject|1
834582|NCT01829230|2743729|P1|Overall Study|Withdrawal by Subject|0
834583|NCT01829230|2743728|P2|Overall Study|Protocol Violation|2
834584|NCT01829230|2743729|P1|Overall Study|Protocol Violation|0
834585|NCT01829191|2743743|P2|Overall Study|Subject was fit for ortho - k|1
834586|NCT01829191|2743744|P1|Overall Study|Subject was fit for ortho - k|0
834587|NCT01829191|2743743|P2|Overall Study|Lost to Follow-up|1
834588|NCT01829191|2743744|P1|Overall Study|Lost to Follow-up|0
834589|NCT01829191|2743743|P2|Overall Study|Withdrawal by Subject|3
834590|NCT01829191|2743744|P1|Overall Study|Withdrawal by Subject|2
834591|NCT01829191|2743743|P2|Overall Study|Protocol Violation|1
834592|NCT01829191|2743744|P1|Overall Study|Protocol Violation|4
834593|NCT01829191|2743743|P2|Overall Study|Lens handling difficulty|4
834594|NCT01829191|2743744|P1|Overall Study|Lens handling difficulty|1
834595|NCT01829191|2743743|P2|Overall Study|Lens discomfort|3
834596|NCT01829191|2743744|P1|Overall Study|Lens discomfort|0
834597|NCT01829191|2743743|P2|Overall Study|Relocation|1
834598|NCT01829191|2743744|P1|Overall Study|Relocation|0
834599|NCT01829165|2743753|P2|Overall Study|Did not complete intervention|0
834600|NCT01829165|2743754|P1|Overall Study|Did not complete intervention|2
834601|NCT01829113|2743762|P2|Overall Study|Physician Decision|1
834602|NCT01829113|2743763|P1|Overall Study|Physician Decision|1
834603|NCT01829113|2743762|P2|Overall Study|No Study Treatment Received|2
834604|NCT01829113|2743763|P1|Overall Study|No Study Treatment Received|3
834605|NCT01829113|2743762|P2|Overall Study|Sponsor Decision|1
834606|NCT01829113|2743763|P1|Overall Study|Sponsor Decision|1
834607|NCT01829113|2743762|P2|Overall Study|Death|6
834608|NCT01829113|2743763|P1|Overall Study|Death|4
834609|NCT01829113|2743762|P2|Overall Study|Withdrawal by Subject|10
834610|NCT01829113|2743763|P1|Overall Study|Withdrawal by Subject|17
834611|NCT01829113|2743762|P2|Overall Study|Adverse Event|10
834612|NCT01829113|2743763|P1|Overall Study|Adverse Event|14
834613|NCT01829113|2743762|P2|Overall Study|Disease Progression|48
834614|NCT01829113|2743763|P1|Overall Study|Disease Progression|37
834615|NCT01829048|2743780|P5|Overall Study|Withdrawal by Subject|0
834616|NCT01829048|2743781|P4|Overall Study|Withdrawal by Subject|2
834617|NCT01829048|2743782|P3|Overall Study|Withdrawal by Subject|0
834618|NCT01829048|2743783|P2|Overall Study|Withdrawal by Subject|0
834619|NCT01829048|2743784|P1|Overall Study|Withdrawal by Subject|0
834620|NCT01828567|2743897|P2|Overall Study|Excluded - did not meet criteria|1
834621|NCT01828567|2743898|P1|Overall Study|Excluded - did not meet criteria|4
834622|NCT01828567|2743897|P2|Overall Study|Lost to Follow-up|9
834623|NCT01828567|2743898|P1|Overall Study|Lost to Follow-up|27
834624|NCT01828281|2743946|P2|Overall Study|Withdrawal by Subject|0
834625|NCT01828281|2743947|P1|Overall Study|Withdrawal by Subject|1
834626|NCT01828112|2743980|P2|Overall Study|Subject/guardian decision|8
834627|NCT01828112|2743981|P1|Overall Study|Subject/guardian decision|6
834628|NCT01828112|2743980|P2|Overall Study|Progressive disease|82
834629|NCT01828112|2743981|P1|Overall Study|Progressive disease|56
834630|NCT01828112|2743980|P2|Overall Study|Physician Decision|5
834631|NCT01828112|2743981|P1|Overall Study|Physician Decision|5
834632|NCT01828112|2743980|P2|Overall Study|Death|5
834633|NCT01828112|2743981|P1|Overall Study|Death|9
834634|NCT01828112|2743980|P2|Overall Study|Adverse Event|8
834635|NCT01828112|2743981|P1|Overall Study|Adverse Event|6
834636|NCT01828099|2743989|P2|Overall Study|Subject/guardian decision|23
834637|NCT01828099|2743990|P1|Overall Study|Subject/guardian decision|7
834638|NCT01828099|2743989|P2|Overall Study|Protocol Violation|0
834639|NCT01828099|2743990|P1|Overall Study|Protocol Violation|1
834640|NCT01828099|2743989|P2|Overall Study|Progressive disease|94
834641|NCT01828099|2743990|P1|Overall Study|Progressive disease|51
834642|NCT01828099|2743989|P2|Overall Study|Physician Decision|11
834643|NCT01828099|2743990|P1|Overall Study|Physician Decision|7
834644|NCT01828099|2743989|P2|Overall Study|Non-compliance with study treatment|0
834645|NCT01828099|2743990|P1|Overall Study|Non-compliance with study treatment|2
834646|NCT01828099|2743989|P2|Overall Study|Lost to Follow-up|0
834647|NCT01828099|2743990|P1|Overall Study|Lost to Follow-up|2
834648|NCT01828099|2743989|P2|Overall Study|Death|11
834649|NCT01828099|2743990|P1|Overall Study|Death|9
834650|NCT01828099|2743989|P2|Overall Study|Adverse Event|18
834651|NCT01828099|2743990|P1|Overall Study|Adverse Event|15
834652|NCT01827839|2743996|P1|Overall Study|Consent Withdrawal|2
834653|NCT01827839|2743996|P1|Overall Study|Adverse Event|1
834654|NCT01827670|2744020|P2|Overall Study|Lost to Follow-up|1
834655|NCT01827670|2744021|P1|Overall Study|Lost to Follow-up|0
834656|NCT01827670|2744020|P2|Overall Study|Withdrawal of Consent|2
834657|NCT01827670|2744021|P1|Overall Study|Withdrawal of Consent|3
834658|NCT01827592|2744040|P3|Overall Study|Others|3
834659|NCT01827592|2744041|P2|Overall Study|Others|1
834660|NCT01827592|2744042|P1|Overall Study|Others|0
834661|NCT01827592|2744040|P3|Overall Study|Trial terminated by Sponsor|51
834662|NCT01827592|2744041|P2|Overall Study|Trial terminated by Sponsor|53
834663|NCT01827592|2744042|P1|Overall Study|Trial terminated by Sponsor|47
834664|NCT01827592|2744040|P3|Overall Study|Patient's substantial non-compliance|6
834665|NCT01827592|2744041|P2|Overall Study|Patient's substantial non-compliance|1
834666|NCT01827592|2744042|P1|Overall Study|Patient's substantial non-compliance|1
834667|NCT01827592|2744040|P3|Overall Study|Withdrawal by Subject|11
834668|NCT01827592|2744041|P2|Overall Study|Withdrawal by Subject|11
834669|NCT01827592|2744042|P1|Overall Study|Withdrawal by Subject|12
834670|NCT01827592|2744040|P3|Overall Study|Lost to Follow-up|2
834671|NCT01827592|2744041|P2|Overall Study|Lost to Follow-up|2
834672|NCT01827592|2744042|P1|Overall Study|Lost to Follow-up|1
834673|NCT01827592|2744040|P3|Overall Study|Protocol Violation|0
834674|NCT01827592|2744041|P2|Overall Study|Protocol Violation|1
834675|NCT01827592|2744042|P1|Overall Study|Protocol Violation|2
834676|NCT01827592|2744040|P3|Overall Study|Physician Decision|1
834677|NCT01827592|2744041|P2|Overall Study|Physician Decision|2
834678|NCT01827592|2744042|P1|Overall Study|Physician Decision|0
834679|NCT01827592|2744040|P3|Overall Study|Adverse Event|2
834680|NCT01827592|2744041|P2|Overall Study|Adverse Event|9
834681|NCT01827592|2744042|P1|Overall Study|Adverse Event|11
834682|NCT01827371|2744107|P4|Overall Study|Temporary study halt to vaccinations|13
834683|NCT01827371|2744108|P3|Overall Study|Temporary study halt to vaccinations|5
834684|NCT01827371|2744109|P2|Overall Study|Temporary study halt to vaccinations|2
834685|NCT01827371|2744110|P1|Overall Study|Temporary study halt to vaccinations|11
834686|NCT01827371|2744107|P4|Overall Study|Physician Decision|1
834687|NCT01827371|2744108|P3|Overall Study|Physician Decision|0
834688|NCT01827371|2744109|P2|Overall Study|Physician Decision|1
834689|NCT01827371|2744110|P1|Overall Study|Physician Decision|0
834690|NCT01827371|2744107|P4|Overall Study|Withdrawal by Subject|3
834691|NCT01827371|2744108|P3|Overall Study|Withdrawal by Subject|2
834692|NCT01827371|2744109|P2|Overall Study|Withdrawal by Subject|2
834693|NCT01827371|2744110|P1|Overall Study|Withdrawal by Subject|1
834694|NCT01827371|2744107|P4|Overall Study|Protocol Violation|0
834695|NCT01827371|2744108|P3|Overall Study|Protocol Violation|0
834696|NCT01827371|2744109|P2|Overall Study|Protocol Violation|0
834697|NCT01827371|2744110|P1|Overall Study|Protocol Violation|1
834698|NCT01827371|2744107|P4|Overall Study|Lost to Follow-up|4
834699|NCT01827371|2744108|P3|Overall Study|Lost to Follow-up|0
834700|NCT01827371|2744109|P2|Overall Study|Lost to Follow-up|2
834701|NCT01827371|2744110|P1|Overall Study|Lost to Follow-up|0
834702|NCT01827371|2744107|P4|Overall Study|Adverse Event|2
834703|NCT01827371|2744108|P3|Overall Study|Adverse Event|4
834704|NCT01827371|2744109|P2|Overall Study|Adverse Event|0
834705|NCT01827371|2744110|P1|Overall Study|Adverse Event|0
834706|NCT01827332|2744169|P2|Overall Study|Lost to Follow-up|1
834707|NCT01827332|2744170|P1|Overall Study|Lost to Follow-up|2
834708|NCT01827319|2744178|P1|Overall Study|Lost to Follow-up|3
834709|NCT01827267|2744201|P2|Overall Study|Still on study|2
834710|NCT01827267|2744202|P1|Overall Study|Still on study|0
834711|NCT01827267|2744201|P2|Overall Study|Sponsor Discontinued Study|8
834712|NCT01827267|2744202|P1|Overall Study|Sponsor Discontinued Study|2
834713|NCT01827267|2744201|P2|Overall Study|Disease Progression|1
834714|NCT01827267|2744202|P1|Overall Study|Disease Progression|1
834715|NCT01827267|2744201|P2|Overall Study|Physician Decision|0
834716|NCT01827267|2744202|P1|Overall Study|Physician Decision|1
834717|NCT01827267|2744201|P2|Overall Study|Did not receive study drug|1
834718|NCT01827267|2744202|P1|Overall Study|Did not receive study drug|1
834719|NCT01827254|2744217|P1|Overall Study|Intolerance to treatment|4
834720|NCT01827254|2744217|P1|Overall Study|Disease progression|36
834721|NCT01827254|2744217|P1|Overall Study|Did not complete re-challenge|1
834722|NCT01827254|2744217|P1|Overall Study|Discontinued prior initiation: sunitinib|1
834723|NCT01827254|2744217|P1|Overall Study|Invalidated centre|3
834724|NCT01827254|2744217|P1|Overall Study|Case report form not completed|4
834725|NCT01827254|2744217|P1|Overall Study|Death|10
834726|NCT01826981|2744242|P15|Overall Study|Enrolled/Randomized but Not Treated|0
834727|NCT01826981|2744243|P14|Overall Study|Enrolled/Randomized but Not Treated|0
834728|NCT01826981|2744244|P13|Overall Study|Enrolled/Randomized but Not Treated|0
834729|NCT01826981|2744245|P12|Overall Study|Enrolled/Randomized but Not Treated|0
834730|NCT01826981|2744246|P11|Overall Study|Enrolled/Randomized but Not Treated|0
834731|NCT01826981|2744247|P10|Overall Study|Enrolled/Randomized but Not Treated|0
834732|NCT01826981|2744248|P9|Overall Study|Enrolled/Randomized but Not Treated|0
834733|NCT01826981|2744249|P8|Overall Study|Enrolled/Randomized but Not Treated|1
834734|NCT01826981|2744250|P7|Overall Study|Enrolled/Randomized but Not Treated|0
834735|NCT01826981|2744251|P6|Overall Study|Enrolled/Randomized but Not Treated|0
834736|NCT01826981|2744252|P5|Overall Study|Enrolled/Randomized but Not Treated|0
834737|NCT01826981|2744253|P4|Overall Study|Enrolled/Randomized but Not Treated|0
834738|NCT01826981|2744254|P3|Overall Study|Enrolled/Randomized but Not Treated|0
834739|NCT01826981|2744255|P2|Overall Study|Enrolled/Randomized but Not Treated|0
834740|NCT01826981|2744256|P1|Overall Study|Enrolled/Randomized but Not Treated|0
834741|NCT01826981|2744242|P15|Overall Study|Upper G-I Haemorrhage|0
834742|NCT01826981|2744243|P14|Overall Study|Upper G-I Haemorrhage|1
834743|NCT01826981|2744244|P13|Overall Study|Upper G-I Haemorrhage|0
834744|NCT01826981|2744245|P12|Overall Study|Upper G-I Haemorrhage|0
834745|NCT01826981|2744246|P11|Overall Study|Upper G-I Haemorrhage|0
834746|NCT01826981|2744247|P10|Overall Study|Upper G-I Haemorrhage|0
834747|NCT01826981|2744248|P9|Overall Study|Upper G-I Haemorrhage|0
834748|NCT01826981|2744249|P8|Overall Study|Upper G-I Haemorrhage|0
834749|NCT01826981|2744250|P7|Overall Study|Upper G-I Haemorrhage|0
834750|NCT01826981|2744251|P6|Overall Study|Upper G-I Haemorrhage|0
834751|NCT01826981|2744252|P5|Overall Study|Upper G-I Haemorrhage|0
834752|NCT01826981|2744253|P4|Overall Study|Upper G-I Haemorrhage|0
834753|NCT01826981|2744254|P3|Overall Study|Upper G-I Haemorrhage|0
834754|NCT01826981|2744255|P2|Overall Study|Upper G-I Haemorrhage|0
834755|NCT01826981|2744256|P1|Overall Study|Upper G-I Haemorrhage|0
834756|NCT01826981|2744242|P15|Overall Study|Adverse Event|0
834757|NCT01826981|2744243|P14|Overall Study|Adverse Event|0
834758|NCT01826981|2744244|P13|Overall Study|Adverse Event|0
834759|NCT01826981|2744245|P12|Overall Study|Adverse Event|0
834760|NCT01826981|2744246|P11|Overall Study|Adverse Event|0
834761|NCT01826981|2744247|P10|Overall Study|Adverse Event|0
834762|NCT01826981|2744248|P9|Overall Study|Adverse Event|0
834763|NCT01826981|2744249|P8|Overall Study|Adverse Event|0
834764|NCT01826981|2744250|P7|Overall Study|Adverse Event|0
834765|NCT01826981|2744251|P6|Overall Study|Adverse Event|0
834766|NCT01826981|2744252|P5|Overall Study|Adverse Event|1
834767|NCT01826981|2744253|P4|Overall Study|Adverse Event|0
834768|NCT01826981|2744254|P3|Overall Study|Adverse Event|0
834769|NCT01826981|2744255|P2|Overall Study|Adverse Event|0
834770|NCT01826981|2744256|P1|Overall Study|Adverse Event|0
834771|NCT01826981|2744242|P15|Overall Study|Withdrew Consent|0
834772|NCT01826981|2744243|P14|Overall Study|Withdrew Consent|1
834773|NCT01826981|2744244|P13|Overall Study|Withdrew Consent|0
834774|NCT01826981|2744245|P12|Overall Study|Withdrew Consent|1
834775|NCT01826981|2744246|P11|Overall Study|Withdrew Consent|0
834776|NCT01826981|2744247|P10|Overall Study|Withdrew Consent|0
834777|NCT01826981|2744248|P9|Overall Study|Withdrew Consent|0
834778|NCT01826981|2744249|P8|Overall Study|Withdrew Consent|1
834779|NCT01826981|2744250|P7|Overall Study|Withdrew Consent|1
834780|NCT01826981|2744251|P6|Overall Study|Withdrew Consent|0
834781|NCT01826981|2744252|P5|Overall Study|Withdrew Consent|0
834782|NCT01826981|2744253|P4|Overall Study|Withdrew Consent|0
834783|NCT01826981|2744254|P3|Overall Study|Withdrew Consent|0
834784|NCT01826981|2744255|P2|Overall Study|Withdrew Consent|0
834785|NCT01826981|2744256|P1|Overall Study|Withdrew Consent|0
834786|NCT01826981|2744242|P15|Overall Study|Lost to Follow-up|0
834787|NCT01826981|2744243|P14|Overall Study|Lost to Follow-up|0
834788|NCT01826981|2744244|P13|Overall Study|Lost to Follow-up|1
834789|NCT01826981|2744245|P12|Overall Study|Lost to Follow-up|1
834790|NCT01826981|2744246|P11|Overall Study|Lost to Follow-up|1
834791|NCT01826981|2744247|P10|Overall Study|Lost to Follow-up|1
834792|NCT01826981|2744248|P9|Overall Study|Lost to Follow-up|0
834793|NCT01826981|2744249|P8|Overall Study|Lost to Follow-up|1
834794|NCT01826981|2744250|P7|Overall Study|Lost to Follow-up|0
834795|NCT01826981|2744251|P6|Overall Study|Lost to Follow-up|1
834796|NCT01826981|2744252|P5|Overall Study|Lost to Follow-up|1
834797|NCT01826981|2744253|P4|Overall Study|Lost to Follow-up|0
834798|NCT01826981|2744254|P3|Overall Study|Lost to Follow-up|0
834799|NCT01826981|2744255|P2|Overall Study|Lost to Follow-up|0
834800|NCT01826981|2744256|P1|Overall Study|Lost to Follow-up|0
834801|NCT01826981|2744242|P15|Overall Study|Lack of Efficacy|0
834802|NCT01826981|2744243|P14|Overall Study|Lack of Efficacy|3
834803|NCT01826981|2744244|P13|Overall Study|Lack of Efficacy|0
834804|NCT01826981|2744245|P12|Overall Study|Lack of Efficacy|0
834805|NCT01826981|2744246|P11|Overall Study|Lack of Efficacy|1
834806|NCT01826981|2744247|P10|Overall Study|Lack of Efficacy|0
834807|NCT01826981|2744248|P9|Overall Study|Lack of Efficacy|7
834808|NCT01826981|2744249|P8|Overall Study|Lack of Efficacy|8
834809|NCT01826981|2744250|P7|Overall Study|Lack of Efficacy|0
834810|NCT01826981|2744251|P6|Overall Study|Lack of Efficacy|0
834811|NCT01826981|2744252|P5|Overall Study|Lack of Efficacy|5
834812|NCT01826981|2744253|P4|Overall Study|Lack of Efficacy|0
834813|NCT01826981|2744254|P3|Overall Study|Lack of Efficacy|0
834814|NCT01826981|2744255|P2|Overall Study|Lack of Efficacy|1
834815|NCT01826981|2744256|P1|Overall Study|Lack of Efficacy|0
834816|NCT01826604|2744442|P2|Overall Study|Lost to Follow-up|9
834817|NCT01826604|2744443|P1|Overall Study|Lost to Follow-up|8
834818|NCT01826422|2744487|P2|Overall Study|Withdrawal by Subject|3
834819|NCT01826422|2744488|P1|Overall Study|Withdrawal by Subject|1
834820|NCT01826370|2744532|P1|Overall Study|Other reason not defined above|2
834821|NCT01826370|2744532|P1|Overall Study|Lost to Follow-up|12
834822|NCT01826370|2744532|P1|Overall Study|Protocol Violation|6
834823|NCT01826214|2744544|P2|Overall Study|Subject/guardian decision|3
834824|NCT01826214|2744545|P1|Overall Study|Subject/guardian decision|2
834825|NCT01826214|2744544|P2|Overall Study|Study terminated by Sponsor|1
834826|NCT01826214|2744545|P1|Overall Study|Study terminated by Sponsor|0
834827|NCT01826214|2744544|P2|Overall Study|Progressive disease|21
834828|NCT01826214|2744545|P1|Overall Study|Progressive disease|22
834829|NCT01826214|2744544|P2|Overall Study|Physician Decision|2
834830|NCT01826214|2744545|P1|Overall Study|Physician Decision|0
834831|NCT01826214|2744544|P2|Overall Study|Lost to Follow-up|0
834832|NCT01826214|2744545|P1|Overall Study|Lost to Follow-up|1
834833|NCT01826214|2744544|P2|Overall Study|Death|1
834834|NCT01826214|2744545|P1|Overall Study|Death|3
834835|NCT01826214|2744544|P2|Overall Study|Adverse Event|6
834836|NCT01826214|2744545|P1|Overall Study|Adverse Event|7
834837|NCT01826201|2744563|P1|Overall Study|Non compliance with protocol|4
834838|NCT01825941|2744571|P2|Overall Study|Lost to Follow-up|1
834839|NCT01825941|2744572|P1|Overall Study|Lost to Follow-up|4
834840|NCT01825876|2744591|P2|Period 2|Withdrawal by Subject|1
834841|NCT01825876|2744592|P1|Period 2|Withdrawal by Subject|0
834842|NCT01825837|2744613|P4|PART II|reason unspecified|0
834843|NCT01825837|2744614|P3|PART II|reason unspecified|2
834844|NCT01825837|2744615|P2|PART II|reason unspecified|2
834845|NCT01825837|2744616|P1|PART II|reason unspecified|2
834846|NCT01825837|2744613|P4|PART II|Treatment failure|0
834847|NCT01825837|2744614|P3|PART II|Treatment failure|5
834848|NCT01825837|2744615|P2|PART II|Treatment failure|4
834849|NCT01825837|2744616|P1|PART II|Treatment failure|6
834850|NCT01825837|2744613|P4|PART II|Adverse Event|0
834851|NCT01825837|2744614|P3|PART II|Adverse Event|1
834852|NCT01825837|2744615|P2|PART II|Adverse Event|3
834853|NCT01825837|2744616|P1|PART II|Adverse Event|3
834854|NCT01825837|2744613|P4|PART II|Patient non-compliance|0
834855|NCT01825837|2744614|P3|PART II|Patient non-compliance|4
834856|NCT01825837|2744615|P2|PART II|Patient non-compliance|2
834857|NCT01825837|2744616|P1|PART II|Patient non-compliance|5
834858|NCT01825837|2744613|P4|PART II|Withdrawal by Subject|0
834859|NCT01825837|2744614|P3|PART II|Withdrawal by Subject|7
834860|NCT01825837|2744615|P2|PART II|Withdrawal by Subject|3
834861|NCT01825837|2744616|P1|PART II|Withdrawal by Subject|3
834862|NCT01825837|2744613|P4|PART I|reason unspecified|3
834863|NCT01825837|2744614|P3|PART I|reason unspecified|0
834864|NCT01825837|2744615|P2|PART I|reason unspecified|0
834865|NCT01825837|2744616|P1|PART I|reason unspecified|0
834866|NCT01825837|2744613|P4|PART I|Treatment failure|7
834867|NCT01825837|2744614|P3|PART I|Treatment failure|0
834868|NCT01825837|2744615|P2|PART I|Treatment failure|0
834869|NCT01825837|2744616|P1|PART I|Treatment failure|0
834870|NCT01825837|2744613|P4|PART I|Patient non-compliance|1
834871|NCT01825837|2744614|P3|PART I|Patient non-compliance|0
834872|NCT01825837|2744615|P2|PART I|Patient non-compliance|0
834873|NCT01825837|2744616|P1|PART I|Patient non-compliance|0
834874|NCT01825837|2744613|P4|PART I|Withdrawal by Subject|6
834875|NCT01825837|2744614|P3|PART I|Withdrawal by Subject|0
834876|NCT01825837|2744615|P2|PART I|Withdrawal by Subject|0
834877|NCT01825837|2744616|P1|PART I|Withdrawal by Subject|0
834878|NCT01825798|2744626|P2|Overall Study|Lost to Follow-up|0
834879|NCT01825798|2744627|P1|Overall Study|Lost to Follow-up|1
834880|NCT01825798|2744626|P2|Overall Study|Adverse Event|5
834881|NCT01825798|2744627|P1|Overall Study|Adverse Event|1
834882|NCT01825577|2744664|P1|Overall Study|Lack of Efficacy|3
834883|NCT01825577|2744664|P1|Overall Study|Withdrawn by family members|2
834884|NCT01825577|2744664|P1|Overall Study|Withdrawal by Subject|1
834885|NCT01825577|2744664|P1|Overall Study|Physician Decision|2
834886|NCT01825200|2744688|P2|Overall Study|Withdrawal by Subject|1
834887|NCT01825200|2744689|P1|Overall Study|Withdrawal by Subject|0
834888|NCT01825200|2744688|P2|Overall Study|Lost to Follow-up|6
834889|NCT01825200|2744689|P1|Overall Study|Lost to Follow-up|5
834890|NCT01824979|2744712|P2|Overall Study|Protocol Violation|13
834891|NCT01824979|2744713|P1|Overall Study|Protocol Violation|6
834892|NCT01824979|2744712|P2|Overall Study|Physician Decision|0
834893|NCT01824979|2744713|P1|Overall Study|Physician Decision|2
834894|NCT01824979|2744712|P2|Overall Study|Withdrawal by Subject|0
834895|NCT01824979|2744713|P1|Overall Study|Withdrawal by Subject|5
834896|NCT01824823|2744730|P2|Overall Study|Off-treatment reason not submitted|0
834897|NCT01824823|2744731|P1|Overall Study|Off-treatment reason not submitted|1
834898|NCT01824823|2744730|P2|Overall Study|Lack of Efficacy|1
834899|NCT01824823|2744731|P1|Overall Study|Lack of Efficacy|1
834900|NCT01824602|2744741|P4|Overall Study|Treatment failure|1
834901|NCT01824602|2744742|P3|Overall Study|Treatment failure|0
834902|NCT01824602|2744743|P2|Overall Study|Treatment failure|0
834903|NCT01824602|2744744|P1|Overall Study|Treatment failure|0
834904|NCT01824602|2744741|P4|Overall Study|Adverse Event|2
834905|NCT01824602|2744742|P3|Overall Study|Adverse Event|2
834906|NCT01824602|2744743|P2|Overall Study|Adverse Event|0
834907|NCT01824602|2744744|P1|Overall Study|Adverse Event|1
834908|NCT01824602|2744741|P4|Overall Study|Patient non-compliance|0
834909|NCT01824602|2744742|P3|Overall Study|Patient non-compliance|1
834910|NCT01824602|2744743|P2|Overall Study|Patient non-compliance|0
834911|NCT01824602|2744744|P1|Overall Study|Patient non-compliance|0
834912|NCT01824602|2744741|P4|Overall Study|Withdrawal by Subject|2
834913|NCT01824602|2744742|P3|Overall Study|Withdrawal by Subject|1
834914|NCT01824602|2744743|P2|Overall Study|Withdrawal by Subject|0
834915|NCT01824602|2744744|P1|Overall Study|Withdrawal by Subject|0
834916|NCT01824576|2744783|P1|Overall Study|Device deficiency|2
834917|NCT01824498|2744801|P6|Washout (8 Weeks)|Withdrawal by Subject|0
834918|NCT01824498|2744802|P5|Washout (8 Weeks)|Withdrawal by Subject|1
834919|NCT01824498|2744803|P4|Washout (8 Weeks)|Withdrawal by Subject|1
834920|NCT01824498|2744804|P3|Washout (8 Weeks)|Withdrawal by Subject|2
834921|NCT01824498|2744805|P2|Washout (8 Weeks)|Withdrawal by Subject|0
834922|NCT01824498|2744806|P1|Washout (8 Weeks)|Withdrawal by Subject|2
834923|NCT01824355|2744837|P1|Overall Study|unevaluable reference method results per|1
834924|NCT01824355|2744837|P1|Overall Study|Adverse Event|2
834925|NCT01824342|2744848|P2|Overall Study|Death|0
834926|NCT01824342|2744849|P1|Overall Study|Death|2
834927|NCT01824342|2744848|P2|Overall Study|Physician Decision|0
834928|NCT01824342|2744849|P1|Overall Study|Physician Decision|5
834929|NCT01824342|2744848|P2|Overall Study|Disease Progression|1
834930|NCT01824342|2744849|P1|Overall Study|Disease Progression|1
834931|NCT01824342|2744848|P2|Overall Study|Adverse Event|1
834932|NCT01824342|2744849|P1|Overall Study|Adverse Event|1
834933|NCT01824342|2744848|P2|Overall Study|Withdrawal by Subject|3
834934|NCT01824342|2744849|P1|Overall Study|Withdrawal by Subject|0
834935|NCT01824303|2744863|P2|Randomized Study|Other Miscellaneous Reasons|0
834936|NCT01824303|2744864|P1|Randomized Study|Other Miscellaneous Reasons|1
834937|NCT01824303|2744863|P2|Randomized Study|Withdrawal by Subject|1
834938|NCT01824303|2744864|P1|Randomized Study|Withdrawal by Subject|1
834939|NCT01823679|2744892|P1|Overall Study|Death|1
834940|NCT01823536|2744945|P6|Overall Study|Subject moved out of the state|0
834941|NCT01823536|2744946|P5|Overall Study|Subject moved out of the state|1
834942|NCT01823536|2744947|P4|Overall Study|Subject moved out of the state|0
834943|NCT01823536|2744948|P3|Overall Study|Subject moved out of the state|0
834944|NCT01823536|2744949|P2|Overall Study|Subject moved out of the state|0
834945|NCT01823536|2744950|P1|Overall Study|Subject moved out of the state|0
834946|NCT01823536|2744945|P6|Overall Study|Met exclusion criterion No 6|0
834947|NCT01823536|2744946|P5|Overall Study|Met exclusion criterion No 6|0
834948|NCT01823536|2744947|P4|Overall Study|Met exclusion criterion No 6|1
834949|NCT01823536|2744948|P3|Overall Study|Met exclusion criterion No 6|0
834950|NCT01823536|2744949|P2|Overall Study|Met exclusion criterion No 6|0
834951|NCT01823536|2744950|P1|Overall Study|Met exclusion criterion No 6|0
834952|NCT01823536|2744945|P6|Overall Study|Visit 1 delayed, unable to reschedule|0
834953|NCT01823536|2744946|P5|Overall Study|Visit 1 delayed, unable to reschedule|0
834954|NCT01823536|2744947|P4|Overall Study|Visit 1 delayed, unable to reschedule|0
834955|NCT01823536|2744948|P3|Overall Study|Visit 1 delayed, unable to reschedule|1
834956|NCT01823536|2744949|P2|Overall Study|Visit 1 delayed, unable to reschedule|0
834957|NCT01823536|2744950|P1|Overall Study|Visit 1 delayed, unable to reschedule|0
834958|NCT01823536|2744945|P6|Overall Study|Withdrawal by Subject|0
834959|NCT01823536|2744946|P5|Overall Study|Withdrawal by Subject|0
834960|NCT01823536|2744947|P4|Overall Study|Withdrawal by Subject|0
834961|NCT01823536|2744948|P3|Overall Study|Withdrawal by Subject|0
834962|NCT01823536|2744949|P2|Overall Study|Withdrawal by Subject|1
834963|NCT01823536|2744950|P1|Overall Study|Withdrawal by Subject|1
834964|NCT01823536|2744945|P6|Overall Study|Protocol Violation|0
834965|NCT01823536|2744946|P5|Overall Study|Protocol Violation|0
834966|NCT01823536|2744947|P4|Overall Study|Protocol Violation|0
834967|NCT01823536|2744948|P3|Overall Study|Protocol Violation|0
834968|NCT01823536|2744949|P2|Overall Study|Protocol Violation|1
834969|NCT01823536|2744950|P1|Overall Study|Protocol Violation|0
834970|NCT01823536|2744945|P6|Overall Study|Lost to Follow-up|0
834971|NCT01823536|2744946|P5|Overall Study|Lost to Follow-up|1
834972|NCT01823536|2744947|P4|Overall Study|Lost to Follow-up|1
834973|NCT01823536|2744948|P3|Overall Study|Lost to Follow-up|0
834974|NCT01823536|2744949|P2|Overall Study|Lost to Follow-up|0
834975|NCT01823536|2744950|P1|Overall Study|Lost to Follow-up|1
834976|NCT01823341|2745001|P1|Overall Study|Adverse Event|1
834977|NCT01823341|2745001|P1|Overall Study|Withdrawal by Subject|7
834978|NCT01823341|2745001|P1|Overall Study|Failed run-in|7
834979|NCT01823289|2745044|P1|Overall Study|Creatinine clearance<30milliliter/minute|1
834980|NCT01823289|2745044|P1|Overall Study|Drug affected efficacy and safety|1
834981|NCT01823289|2745044|P1|Overall Study|Transaminase increased more than 3 times|1
834982|NCT01823289|2745044|P1|Overall Study|Administered contraindicated medicine|1
834983|NCT01823289|2745044|P1|Overall Study|Physician Decision|9
834984|NCT01823289|2745044|P1|Overall Study|Lack of Efficacy|1
834985|NCT01823289|2745044|P1|Overall Study|Adverse Event|5
834986|NCT01823289|2745044|P1|Overall Study|Lost to Follow-up|5
834987|NCT01823224|2745052|P2|Overall Study|Withdrawal by Subject|1
834988|NCT01823224|2745053|P1|Overall Study|Withdrawal by Subject|0
834989|NCT01823224|2745052|P2|Overall Study|missed med dose|1
834990|NCT01823224|2745053|P1|Overall Study|missed med dose|0
834991|NCT01823224|2745052|P2|Overall Study|pharmacy error|1
834992|NCT01823224|2745053|P1|Overall Study|pharmacy error|0
834993|NCT01823224|2745052|P2|Overall Study|didn't qualify|2
834994|NCT01823224|2745053|P1|Overall Study|didn't qualify|1
834995|NCT01823224|2745052|P2|Overall Study|Lost to Follow-up|6
834996|NCT01823224|2745053|P1|Overall Study|Lost to Follow-up|5
834997|NCT01823146|2745063|P2|Overall Study|Lost to Follow-up|1
834998|NCT01823146|2745064|P1|Overall Study|Lost to Follow-up|2
834999|NCT01823146|2745063|P2|Overall Study|Withdrawal by Subject|1
835000|NCT01823146|2745064|P1|Overall Study|Withdrawal by Subject|0
835001|NCT01822899|2745076|P2|Overall Study|Withdrawal by Subject|7
835002|NCT01822899|2745077|P1|Overall Study|Withdrawal by Subject|5
835003|NCT01822899|2745076|P2|Overall Study|Lost to Follow-up|0
835004|NCT01822899|2745077|P1|Overall Study|Lost to Follow-up|1
835005|NCT01822899|2745076|P2|Overall Study|Protocol Violation|3
835006|NCT01822899|2745077|P1|Overall Study|Protocol Violation|6
835007|NCT01822899|2745076|P2|Overall Study|Lack of Efficacy|3
835008|NCT01822899|2745077|P1|Overall Study|Lack of Efficacy|6
835009|NCT01822899|2745076|P2|Overall Study|Adverse Event|5
835010|NCT01822899|2745077|P1|Overall Study|Adverse Event|6
835011|NCT01822821|2745087|P2|Overall Study|Other reasons|0
835012|NCT01822821|2745088|P1|Overall Study|Other reasons|1
835013|NCT01822821|2745087|P2|Overall Study|Eligible surgery cancelled|1
835014|NCT01822821|2745088|P1|Overall Study|Eligible surgery cancelled|1
835015|NCT01822756|2745117|P5|Overall Study|disease progression & patient preference|0
835016|NCT01822756|2745118|P4|Overall Study|disease progression & patient preference|0
835017|NCT01822756|2745119|P3|Overall Study|disease progression & patient preference|1
835018|NCT01822756|2745120|P2|Overall Study|disease progression & patient preference|0
835019|NCT01822756|2745121|P1|Overall Study|disease progression & patient preference|2
835020|NCT01822756|2745117|P5|Overall Study|Physician Decision|0
835021|NCT01822756|2745118|P4|Overall Study|Physician Decision|0
835022|NCT01822756|2745119|P3|Overall Study|Physician Decision|0
835023|NCT01822756|2745120|P2|Overall Study|Physician Decision|1
835024|NCT01822756|2745121|P1|Overall Study|Physician Decision|0
835025|NCT01822756|2745117|P5|Overall Study|Lost to Follow-up|1
835026|NCT01822756|2745118|P4|Overall Study|Lost to Follow-up|0
835027|NCT01822756|2745119|P3|Overall Study|Lost to Follow-up|1
835028|NCT01822756|2745120|P2|Overall Study|Lost to Follow-up|0
835029|NCT01822756|2745121|P1|Overall Study|Lost to Follow-up|1
835030|NCT01822756|2745117|P5|Overall Study|Death|0
835031|NCT01822756|2745118|P4|Overall Study|Death|0
835032|NCT01822756|2745119|P3|Overall Study|Death|1
835033|NCT01822756|2745120|P2|Overall Study|Death|2
835034|NCT01822756|2745121|P1|Overall Study|Death|2
835035|NCT01822756|2745117|P5|Overall Study|Disease progression|6
835036|NCT01822756|2745118|P4|Overall Study|Disease progression|2
835037|NCT01822756|2745119|P3|Overall Study|Disease progression|7
835038|NCT01822756|2745120|P2|Overall Study|Disease progression|1
835039|NCT01822756|2745121|P1|Overall Study|Disease progression|11
835040|NCT01822756|2745117|P5|Overall Study|Adverse Event|0
835041|NCT01822756|2745118|P4|Overall Study|Adverse Event|2
835042|NCT01822756|2745119|P3|Overall Study|Adverse Event|0
835043|NCT01822756|2745120|P2|Overall Study|Adverse Event|0
835044|NCT01822756|2745121|P1|Overall Study|Adverse Event|0
835045|NCT01822691|2745163|P1|Overall Study|Withdrawal by Subject|2
835046|NCT01822678|2745174|P3|Overall Study|Lost to Follow-up|1
835047|NCT01822678|2745175|P2|Overall Study|Lost to Follow-up|2
835048|NCT01822678|2745176|P1|Overall Study|Lost to Follow-up|0
835049|NCT01822678|2745174|P3|Overall Study|Lack of Efficacy|5
835050|NCT01822678|2745175|P2|Overall Study|Lack of Efficacy|6
835051|NCT01822678|2745176|P1|Overall Study|Lack of Efficacy|3
835052|NCT01822678|2745174|P3|Overall Study|Adverse Event|1
835053|NCT01822678|2745175|P2|Overall Study|Adverse Event|3
835054|NCT01822678|2745176|P1|Overall Study|Adverse Event|4
835055|NCT01822678|2745174|P3|Overall Study|Withdrawal by Subject|4
835056|NCT01822678|2745175|P2|Overall Study|Withdrawal by Subject|4
835057|NCT01822678|2745176|P1|Overall Study|Withdrawal by Subject|5
835058|NCT01822665|2745184|P1|Overall Study|Other Reason|5
835059|NCT01822665|2745184|P1|Overall Study|Adverse Event|3
835060|NCT01822561|2745227|P1|Overall Study|Withdrawal by Subject|2
835149|NCT01819727|2745675|P2|Overall Study|Pregnancy|0
835061|NCT01822535|2745248|P2|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0
835062|NCT01822535|2745249|P1|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1
835063|NCT01822535|2745248|P2|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2
835064|NCT01822535|2745249|P1|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4
835065|NCT01822535|2745248|P2|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0
835066|NCT01822535|2745249|P1|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2
835067|NCT01822223|2745273|P2|Overall Study|Death|1
835068|NCT01822223|2745274|P1|Overall Study|Death|0
835069|NCT01821963|2745319|P1|Overall Study|Adverse Event|1
835070|NCT01821937|2745325|P2|Overall Study|Adverse Event|3
835071|NCT01821937|2745326|P1|Overall Study|Adverse Event|0
835072|NCT01821807|2745350|P2|Overall Study|Lost to Follow-up|1
835073|NCT01821807|2745351|P1|Overall Study|Lost to Follow-up|3
835074|NCT01821118|2745439|P2|Overall Study|Death|1
835075|NCT01821118|2745440|P1|Overall Study|Death|0
835076|NCT01820585|2745491|P4|Overall Study|Pregnancy|0
835077|NCT01820585|2745492|P3|Overall Study|Pregnancy|0
835078|NCT01820585|2745493|P2|Overall Study|Pregnancy|1
835079|NCT01820585|2745494|P1|Overall Study|Pregnancy|0
835080|NCT01820585|2745491|P4|Overall Study|at sponsor request|0
835081|NCT01820585|2745492|P3|Overall Study|at sponsor request|1
835082|NCT01820585|2745493|P2|Overall Study|at sponsor request|0
835083|NCT01820585|2745494|P1|Overall Study|at sponsor request|0
835084|NCT01820585|2745491|P4|Overall Study|Subject non-compliance|2
835085|NCT01820585|2745492|P3|Overall Study|Subject non-compliance|1
835086|NCT01820585|2745493|P2|Overall Study|Subject non-compliance|0
835087|NCT01820585|2745494|P1|Overall Study|Subject non-compliance|0
835088|NCT01820585|2745491|P4|Overall Study|Protocol Violation|1
835089|NCT01820585|2745492|P3|Overall Study|Protocol Violation|1
835090|NCT01820585|2745493|P2|Overall Study|Protocol Violation|1
835091|NCT01820585|2745494|P1|Overall Study|Protocol Violation|3
835092|NCT01820585|2745491|P4|Overall Study|Lost to Follow-up|3
835093|NCT01820585|2745492|P3|Overall Study|Lost to Follow-up|0
835094|NCT01820585|2745493|P2|Overall Study|Lost to Follow-up|3
835095|NCT01820585|2745494|P1|Overall Study|Lost to Follow-up|3
835096|NCT01820585|2745491|P4|Overall Study|Withdrawal by Subject|8
835097|NCT01820585|2745492|P3|Overall Study|Withdrawal by Subject|3
835098|NCT01820585|2745493|P2|Overall Study|Withdrawal by Subject|7
835099|NCT01820585|2745494|P1|Overall Study|Withdrawal by Subject|3
835100|NCT01820585|2745491|P4|Overall Study|Lack of Efficacy|1
835101|NCT01820585|2745492|P3|Overall Study|Lack of Efficacy|5
835102|NCT01820585|2745493|P2|Overall Study|Lack of Efficacy|7
835103|NCT01820585|2745494|P1|Overall Study|Lack of Efficacy|9
835104|NCT01820585|2745491|P4|Overall Study|Adverse Event|34
835105|NCT01820585|2745492|P3|Overall Study|Adverse Event|23
835106|NCT01820585|2745493|P2|Overall Study|Adverse Event|13
835107|NCT01820585|2745494|P1|Overall Study|Adverse Event|9
835108|NCT01820559|2745507|P3|Overall Study|Lack of Efficacy|3
835109|NCT01820559|2745508|P2|Overall Study|Lack of Efficacy|2
835110|NCT01820559|2745509|P1|Overall Study|Lack of Efficacy|3
835111|NCT01820559|2745507|P3|Overall Study|At sponsor request|1
835112|NCT01820559|2745508|P2|Overall Study|At sponsor request|0
835113|NCT01820559|2745509|P1|Overall Study|At sponsor request|0
835114|NCT01820559|2745507|P3|Overall Study|Lost to Follow-up|2
835115|NCT01820559|2745508|P2|Overall Study|Lost to Follow-up|2
835116|NCT01820559|2745509|P1|Overall Study|Lost to Follow-up|3
835117|NCT01820559|2745507|P3|Overall Study|Subject's non-compliance|2
835118|NCT01820559|2745508|P2|Overall Study|Subject's non-compliance|0
835119|NCT01820559|2745509|P1|Overall Study|Subject's non-compliance|1
835120|NCT01820559|2745507|P3|Overall Study|Protocol Violation|3
835121|NCT01820559|2745508|P2|Overall Study|Protocol Violation|1
835122|NCT01820559|2745509|P1|Overall Study|Protocol Violation|2
835123|NCT01820559|2745507|P3|Overall Study|Withdrawal by Subject|5
835124|NCT01820559|2745508|P2|Overall Study|Withdrawal by Subject|2
835125|NCT01820559|2745509|P1|Overall Study|Withdrawal by Subject|1
835126|NCT01820559|2745507|P3|Overall Study|Adverse Event|13
835127|NCT01820559|2745508|P2|Overall Study|Adverse Event|6
835128|NCT01820559|2745509|P1|Overall Study|Adverse Event|4
835129|NCT01820364|2745530|P2|Part II: LGX818 + MEK162|Study Termination|1
835130|NCT01820364|2745531|P1|Part II: LGX818 + MEK162|Study Termination|0
835131|NCT01820364|2745530|P2|Part I: LGX818|Disease Progression|0
835132|NCT01820364|2745531|P1|Part I: LGX818|Disease Progression|4
835133|NCT01820364|2745530|P2|Part I: LGX818|Adverse Event|0
835134|NCT01820364|2745531|P1|Part I: LGX818|Adverse Event|6
835135|NCT01820364|2745530|P2|Part I: LGX818|Administrative Problems|0
835136|NCT01820364|2745531|P1|Part I: LGX818|Administrative Problems|3
835137|NCT01820364|2745530|P2|Part I: LGX818|Death|0
835138|NCT01820364|2745531|P1|Part I: LGX818|Death|1
835139|NCT01819727|2745675|P2|Overall Study|Quit due to lack of health benifits|1
835140|NCT01819727|2745676|P1|Overall Study|Quit due to lack of health benifits|0
835141|NCT01819727|2745675|P2|Overall Study|Unable to demostrate ability self-inject|1
835142|NCT01819727|2745676|P1|Overall Study|Unable to demostrate ability self-inject|0
835143|NCT01819727|2745675|P2|Overall Study|Withdrawal by Subject|11
835144|NCT01819727|2745676|P1|Overall Study|Withdrawal by Subject|6
835145|NCT01819727|2745675|P2|Overall Study|Study Terminated by Sponsor|1
835146|NCT01819727|2745676|P1|Overall Study|Study Terminated by Sponsor|0
835147|NCT01819727|2745675|P2|Overall Study|Protocol Violation|2
835148|NCT01819727|2745676|P1|Overall Study|Protocol Violation|0
835150|NCT01819727|2745676|P1|Overall Study|Pregnancy|1
835151|NCT01819727|2745675|P2|Overall Study|Physician Decision|2
835152|NCT01819727|2745676|P1|Overall Study|Physician Decision|3
835153|NCT01819727|2745675|P2|Overall Study|Lost to Follow-up|1
835154|NCT01819727|2745676|P1|Overall Study|Lost to Follow-up|1
835155|NCT01819727|2745675|P2|Overall Study|Death|0
835156|NCT01819727|2745676|P1|Overall Study|Death|1
835157|NCT01819727|2745675|P2|Overall Study|Adverse Event|9
835158|NCT01819727|2745676|P1|Overall Study|Adverse Event|8
835159|NCT01819272|2745728|P6|Overall Study|Loss of Glucose Control|0
835160|NCT01819272|2745729|P5|Overall Study|Loss of Glucose Control|2
835161|NCT01819272|2745730|P4|Overall Study|Loss of Glucose Control|1
835162|NCT01819272|2745731|P3|Overall Study|Loss of Glucose Control|0
835163|NCT01819272|2745732|P2|Overall Study|Loss of Glucose Control|1
835164|NCT01819272|2745733|P1|Overall Study|Loss of Glucose Control|2
835165|NCT01819272|2745728|P6|Overall Study|Withdrawal of Consent|1
835166|NCT01819272|2745729|P5|Overall Study|Withdrawal of Consent|0
835167|NCT01819272|2745730|P4|Overall Study|Withdrawal of Consent|1
835168|NCT01819272|2745731|P3|Overall Study|Withdrawal of Consent|2
835169|NCT01819272|2745732|P2|Overall Study|Withdrawal of Consent|1
835170|NCT01819272|2745733|P1|Overall Study|Withdrawal of Consent|0
835171|NCT01819272|2745728|P6|Overall Study|Physician Decision|0
835172|NCT01819272|2745729|P5|Overall Study|Physician Decision|0
835173|NCT01819272|2745730|P4|Overall Study|Physician Decision|0
835174|NCT01819272|2745731|P3|Overall Study|Physician Decision|0
835175|NCT01819272|2745732|P2|Overall Study|Physician Decision|1
835176|NCT01819272|2745733|P1|Overall Study|Physician Decision|0
835177|NCT01819272|2745728|P6|Overall Study|Protocol Violation|3
835178|NCT01819272|2745729|P5|Overall Study|Protocol Violation|2
835179|NCT01819272|2745730|P4|Overall Study|Protocol Violation|1
835180|NCT01819272|2745731|P3|Overall Study|Protocol Violation|0
835181|NCT01819272|2745732|P2|Overall Study|Protocol Violation|0
835182|NCT01819272|2745733|P1|Overall Study|Protocol Violation|0
835183|NCT01819272|2745728|P6|Overall Study|Lost to Follow-up|3
835184|NCT01819272|2745729|P5|Overall Study|Lost to Follow-up|0
835185|NCT01819272|2745730|P4|Overall Study|Lost to Follow-up|0
835186|NCT01819272|2745731|P3|Overall Study|Lost to Follow-up|1
835187|NCT01819272|2745732|P2|Overall Study|Lost to Follow-up|0
835188|NCT01819272|2745733|P1|Overall Study|Lost to Follow-up|3
835189|NCT01819272|2745728|P6|Overall Study|Adverse Event|0
835190|NCT01819272|2745729|P5|Overall Study|Adverse Event|0
835191|NCT01819272|2745730|P4|Overall Study|Adverse Event|2
835192|NCT01819272|2745731|P3|Overall Study|Adverse Event|0
835193|NCT01819272|2745732|P2|Overall Study|Adverse Event|0
835194|NCT01819272|2745733|P1|Overall Study|Adverse Event|1
835195|NCT01819194|2745759|P1|Overall Study|Loss of study articles|2
835196|NCT01819129|2745766|P2|Overall Study|Withdrawal Criteria|15
835197|NCT01819129|2745767|P1|Overall Study|Withdrawal Criteria|20
835198|NCT01819129|2745766|P2|Overall Study|Death|1
835199|NCT01819129|2745767|P1|Overall Study|Death|1
835200|NCT01819129|2745766|P2|Overall Study|Adverse Event|4
835201|NCT01819129|2745767|P1|Overall Study|Adverse Event|1
835202|NCT01819129|2745766|P2|Overall Study|Lack of Efficacy|1
835203|NCT01819129|2745767|P1|Overall Study|Lack of Efficacy|0
835204|NCT01819129|2745766|P2|Overall Study|Lost to Follow-up|2
835205|NCT01819129|2745767|P1|Overall Study|Lost to Follow-up|5
835206|NCT01819129|2745766|P2|Overall Study|Withdrawal by Subject|15
835207|NCT01819129|2745767|P1|Overall Study|Withdrawal by Subject|15
835208|NCT01819129|2745766|P2|Overall Study|Other, Subject moved out of the country|1
835209|NCT01819129|2745767|P1|Overall Study|Other, Subject moved out of the country|0
835210|NCT01819129|2745766|P2|Overall Study|Other, weight gain, hypoglycaemic events|0
835211|NCT01819129|2745767|P1|Overall Study|Other, weight gain, hypoglycaemic events|1
835212|NCT01819129|2745766|P2|Overall Study|Other, Subject wanted HbA1c to be > 7%|0
835213|NCT01819129|2745767|P1|Overall Study|Other, Subject wanted HbA1c to be > 7%|1
835214|NCT01818752|2745781|P2|Overall Study|Randomized but not Dosed|4
835215|NCT01818752|2745782|P1|Overall Study|Randomized but not Dosed|7
835216|NCT01818752|2745781|P2|Overall Study|Continuing Treatment|4
835217|NCT01818752|2745782|P1|Overall Study|Continuing Treatment|1
835218|NCT01818752|2745781|P2|Overall Study|Other|8
835219|NCT01818752|2745782|P1|Overall Study|Other|7
835220|NCT01818752|2745781|P2|Overall Study|Disease Progression|48
835221|NCT01818752|2745782|P1|Overall Study|Disease Progression|54
835222|NCT01818752|2745781|P2|Overall Study|Physician Decision|8
835223|NCT01818752|2745782|P1|Overall Study|Physician Decision|9
835224|NCT01818752|2745781|P2|Overall Study|Withdrawal by Subject|14
835225|NCT01818752|2745782|P1|Overall Study|Withdrawal by Subject|15
835226|NCT01818752|2745781|P2|Overall Study|Non-compliance|20
835227|NCT01818752|2745782|P1|Overall Study|Non-compliance|16
835228|NCT01818752|2745781|P2|Overall Study|Death|18
835229|NCT01818752|2745782|P1|Overall Study|Death|14
835230|NCT01818752|2745781|P2|Overall Study|Adverse Event|74
835231|NCT01818752|2745782|P1|Overall Study|Adverse Event|64
835232|NCT01818700|2745800|P1|Overall Study|Other|1
835233|NCT01818700|2745800|P1|Overall Study|Protocol Violation|2
835234|NCT01818700|2745800|P1|Overall Study|Withdrawal by Subject|27
835235|NCT01818700|2745800|P1|Overall Study|Lost to Follow-up|5
835236|NCT01818700|2745800|P1|Overall Study|Lack of Efficacy|2
835237|NCT01818700|2745800|P1|Overall Study|Adverse Event|67
835238|NCT01818596|2745811|P2|Overall Study|Still on Study|6
835239|NCT01818596|2745812|P1|Overall Study|Still on Study|232
835240|NCT01818596|2745811|P2|Overall Study|Lost to Follow-up|0
835241|NCT01818596|2745812|P1|Overall Study|Lost to Follow-up|2
835242|NCT01818596|2745811|P2|Overall Study|Protocol Violation|0
835243|NCT01818596|2745812|P1|Overall Study|Protocol Violation|1
835244|NCT01818596|2745811|P2|Overall Study|Withdrew Consent|0
835245|NCT01818596|2745812|P1|Overall Study|Withdrew Consent|3
835246|NCT01818596|2745811|P2|Overall Study|Adverse Event|0
835247|NCT01818596|2745812|P1|Overall Study|Adverse Event|4
835248|NCT01818596|2745811|P2|Overall Study|Enrolled but Not Treated|0
835249|NCT01818596|2745812|P1|Overall Study|Enrolled but Not Treated|4
835250|NCT01818531|2745845|P2|Overall Study|Withdrawn for failure to place block|1
835251|NCT01818531|2745846|P1|Overall Study|Withdrawn for failure to place block|0
835252|NCT01818531|2745845|P2|Overall Study|Withdrawn for long-acting opioid patch|1
835253|NCT01818531|2745846|P1|Overall Study|Withdrawn for long-acting opioid patch|0
835254|NCT01818531|2745845|P2|Overall Study|Withdrawn for case delay after block|0
835255|NCT01818531|2745846|P1|Overall Study|Withdrawn for case delay after block|1
835256|NCT01818336|2745894|P2|Overall Study|Lost to Follow-up|1
835257|NCT01818336|2745895|P1|Overall Study|Lost to Follow-up|0
835258|NCT01818336|2745894|P2|Overall Study|Declined retest visit|11
835259|NCT01818336|2745895|P1|Overall Study|Declined retest visit|0
835260|NCT01818297|2745903|P2|Open Label Phase (3-12 Months)|Early study closure|10
835261|NCT01818297|2745904|P1|Open Label Phase (3-12 Months)|Early study closure|17
835262|NCT01818297|2745903|P2|Open Label Phase (3-12 Months)|Physician Decision|0
835263|NCT01818297|2745904|P1|Open Label Phase (3-12 Months)|Physician Decision|1
835264|NCT01818297|2745903|P2|Blinded Phase (Randomization - 3 Months)|Adverse Event|1
835265|NCT01818297|2745904|P1|Blinded Phase (Randomization - 3 Months)|Adverse Event|0
835266|NCT01818141|2745947|P2|Overall Study|Lost to Follow-up|2
835267|NCT01818141|2745948|P1|Overall Study|Lost to Follow-up|0
835268|NCT01818141|2745947|P2|Overall Study|No baseline C.diff colonies|1
835269|NCT01818141|2745948|P1|Overall Study|No baseline C.diff colonies|1
835270|NCT01818141|2745947|P2|Overall Study|Withdrawal by Subject|0
835271|NCT01818141|2745948|P1|Overall Study|Withdrawal by Subject|2
835272|NCT01817790|2746013|P2|Overall Study|Other: Could not attend appointment|1
835273|NCT01817790|2746014|P1|Overall Study|Other: Could not attend appointment|1
835274|NCT01817790|2746013|P2|Overall Study|Withdrawal by Subject|3
835275|NCT01817790|2746014|P1|Overall Study|Withdrawal by Subject|1
835276|NCT01817790|2746013|P2|Overall Study|Protocol Violation|1
835277|NCT01817790|2746014|P1|Overall Study|Protocol Violation|2
835278|NCT01817790|2746013|P2|Overall Study|Lost to Follow-up|1
835279|NCT01817790|2746014|P1|Overall Study|Lost to Follow-up|0
835280|NCT01817790|2746013|P2|Overall Study|Adverse Event|2
835281|NCT01817790|2746014|P1|Overall Study|Adverse Event|0
835282|NCT01817777|2746058|P3|Interventional Phase (20 Weeks)|Early Study Termination|3
835283|NCT01817777|2746059|P2|Interventional Phase (20 Weeks)|Early Study Termination|1
835284|NCT01817777|2746060|P1|Interventional Phase (20 Weeks)|Early Study Termination|0
835285|NCT01817777|2746058|P3|Interventional Phase (20 Weeks)|Lost to Follow-up|2
835286|NCT01817777|2746059|P2|Interventional Phase (20 Weeks)|Lost to Follow-up|1
835287|NCT01817777|2746060|P1|Interventional Phase (20 Weeks)|Lost to Follow-up|0
835288|NCT01817777|2746058|P3|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
835289|NCT01817777|2746059|P2|Interventional Phase (20 Weeks)|Withdrawal by Subject|3
835290|NCT01817777|2746060|P1|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
835291|NCT01817777|2746058|P3|Observational Phase (8 Weeks)|Early Study Termination|0
835292|NCT01817777|2746059|P2|Observational Phase (8 Weeks)|Early Study Termination|0
835293|NCT01817777|2746060|P1|Observational Phase (8 Weeks)|Early Study Termination|2
835294|NCT01817777|2746058|P3|Observational Phase (8 Weeks)|Lost to Follow-up|0
835295|NCT01817777|2746059|P2|Observational Phase (8 Weeks)|Lost to Follow-up|0
835296|NCT01817777|2746060|P1|Observational Phase (8 Weeks)|Lost to Follow-up|3
835297|NCT01817764|2746084|P2|Overall Study|Withdrawal by Subject|12
835298|NCT01817764|2746085|P1|Overall Study|Withdrawal by Subject|10
835299|NCT01817764|2746084|P2|Overall Study|Lost to Follow-up|4
835300|NCT01817764|2746085|P1|Overall Study|Lost to Follow-up|1
835301|NCT01817764|2746084|P2|Overall Study|Protocol Violation|5
835302|NCT01817764|2746085|P1|Overall Study|Protocol Violation|7
835303|NCT01817764|2746084|P2|Overall Study|Lack of Efficacy|7
835304|NCT01817764|2746085|P1|Overall Study|Lack of Efficacy|9
835305|NCT01817764|2746084|P2|Overall Study|Adverse Event|10
835306|NCT01817764|2746085|P1|Overall Study|Adverse Event|7
835307|NCT01817725|2746093|P1|Overall Study|Withdrawal by Subject|1
835308|NCT01816893|2746161|P2|Washout Period|Withdrawal by Subject|0
835309|NCT01816893|2746162|P1|Washout Period|Withdrawal by Subject|2
835310|NCT01816685|2746197|P2|Overall Study|Surgery Cancelled|2
835311|NCT01816685|2746198|P1|Overall Study|Surgery Cancelled|3
835312|NCT01816685|2746197|P2|Overall Study|Lost to Follow-up|9
835313|NCT01816685|2746198|P1|Overall Study|Lost to Follow-up|7
835314|NCT01816477|2746208|P2|Overall Study|Unable to tolerate catheter placement|0
835315|NCT01816477|2746209|P1|Overall Study|Unable to tolerate catheter placement|3
835316|NCT01816477|2746208|P2|Overall Study|Withdrawal by Subject|1
835317|NCT01816477|2746209|P1|Overall Study|Withdrawal by Subject|13
835318|NCT01816295|2746263|P2|OLE Phase|Lack of Efficacy|7
835319|NCT01816295|2746264|P1|OLE Phase|Lack of Efficacy|3
835320|NCT01816295|2746263|P2|OLE Phase|Withdrawal by Subject|10
835321|NCT01816295|2746264|P1|OLE Phase|Withdrawal by Subject|10
835322|NCT01816295|2746263|P2|OLE Phase|Sponsor Decision|9
835323|NCT01816295|2746264|P1|OLE Phase|Sponsor Decision|7
835324|NCT01816295|2746263|P2|OLE Phase|Protocol Violation|4
835325|NCT01816295|2746264|P1|OLE Phase|Protocol Violation|4
835326|NCT01816295|2746263|P2|OLE Phase|Physician Decision|1
835327|NCT01816295|2746264|P1|OLE Phase|Physician Decision|3
835328|NCT01816295|2746263|P2|OLE Phase|Lost to Follow-up|5
835329|NCT01816295|2746264|P1|OLE Phase|Lost to Follow-up|5
835330|NCT01816295|2746263|P2|OLE Phase|Entry Criteria Not Met|5
835331|NCT01816295|2746264|P1|OLE Phase|Entry Criteria Not Met|3
835332|NCT01816295|2746263|P2|OLE Phase|Death|0
835333|NCT01816295|2746264|P1|OLE Phase|Death|1
835334|NCT01816295|2746263|P2|OLE Phase|Adverse Event|15
835335|NCT01816295|2746264|P1|OLE Phase|Adverse Event|17
835336|NCT01816295|2746263|P2|Double Blind Phase|Withdrawal by Subject|20
835337|NCT01816295|2746264|P1|Double Blind Phase|Withdrawal by Subject|22
835338|NCT01816295|2746263|P2|Double Blind Phase|Sponsor Decision|8
835339|NCT01816295|2746264|P1|Double Blind Phase|Sponsor Decision|8
835340|NCT01816295|2746263|P2|Double Blind Phase|Protocol Violation|11
835341|NCT01816295|2746264|P1|Double Blind Phase|Protocol Violation|17
835342|NCT01816295|2746263|P2|Double Blind Phase|Physician Decision|2
835343|NCT01816295|2746264|P1|Double Blind Phase|Physician Decision|2
835344|NCT01816295|2746263|P2|Double Blind Phase|Lost to Follow-up|5
835345|NCT01816295|2746264|P1|Double Blind Phase|Lost to Follow-up|3
835346|NCT01816295|2746263|P2|Double Blind Phase|Entry Criteria Not Met|2
835347|NCT01816295|2746264|P1|Double Blind Phase|Entry Criteria Not Met|0
835348|NCT01816295|2746263|P2|Double Blind Phase|Adverse Event|8
835349|NCT01816295|2746264|P1|Double Blind Phase|Adverse Event|11
835350|NCT01816243|2746279|P1|Overall Study|Amputation|3
835351|NCT01816243|2746279|P1|Overall Study|Not eligible for the study|1
835352|NCT01816243|2746279|P1|Overall Study|Lack of Efficacy|1
835353|NCT01816243|2746279|P1|Overall Study|Lost to Follow-up|1
835354|NCT01816243|2746279|P1|Overall Study|Adverse Event|6
835355|NCT01816074|2746290|P4|Phase 2|Withdrawal by Subject|0
835356|NCT01816074|2746291|P3|Phase 2|Withdrawal by Subject|0
835357|NCT01816074|2746292|P2|Phase 2|Withdrawal by Subject|0
835358|NCT01816074|2746293|P1|Phase 2|Withdrawal by Subject|1
835359|NCT01816074|2746290|P4|Phase 2|Physician Decision|1
835360|NCT01816074|2746291|P3|Phase 2|Physician Decision|0
835361|NCT01816074|2746292|P2|Phase 2|Physician Decision|0
835362|NCT01816074|2746293|P1|Phase 2|Physician Decision|0
835363|NCT01816074|2746290|P4|Phase 2|Unsatisfied with Randomization assignmen|0
835364|NCT01816074|2746291|P3|Phase 2|Unsatisfied with Randomization assignmen|0
835365|NCT01816074|2746292|P2|Phase 2|Unsatisfied with Randomization assignmen|0
835366|NCT01816074|2746293|P1|Phase 2|Unsatisfied with Randomization assignmen|1
835367|NCT01816074|2746290|P4|Phase 2|Time commitment Issues|0
835368|NCT01816074|2746291|P3|Phase 2|Time commitment Issues|0
835369|NCT01816074|2746292|P2|Phase 2|Time commitment Issues|2
835370|NCT01816074|2746293|P1|Phase 2|Time commitment Issues|0
835371|NCT01816074|2746290|P4|Phase 1|Time commitment issues|0
835372|NCT01816074|2746291|P3|Phase 1|Time commitment issues|1
835373|NCT01816074|2746292|P2|Phase 1|Time commitment issues|0
835374|NCT01816074|2746293|P1|Phase 1|Time commitment issues|0
835375|NCT01816048|2746321|P1|Overall Study|Disease Progression|3
835376|NCT01816048|2746321|P1|Overall Study|Withdrawal by Subject|1
835377|NCT01816048|2746321|P1|Overall Study|Death|1
835378|NCT01816048|2746321|P1|Overall Study|Adverse Event|1
835379|NCT01815918|2746336|P2|Overall Study|Lack of Efficacy|15
835380|NCT01815918|2746337|P1|Overall Study|Lack of Efficacy|15
835381|NCT01815918|2746336|P2|Overall Study|Patient samples not analyzable|4
835382|NCT01815918|2746337|P1|Overall Study|Patient samples not analyzable|3
835383|NCT01815840|2746353|P2|Overall Study|Sponsor Termination Treatment|0
835384|NCT01815840|2746354|P1|Overall Study|Sponsor Termination Treatment|1
835385|NCT01815840|2746353|P2|Overall Study|Refused Treatment|1
835386|NCT01815840|2746354|P1|Overall Study|Refused Treatment|5
835387|NCT01815840|2746353|P2|Overall Study|Lost to Follow-up|6
835388|NCT01815840|2746354|P1|Overall Study|Lost to Follow-up|3
835389|NCT01815840|2746353|P2|Overall Study|Investigators Decision|3
835390|NCT01815840|2746354|P1|Overall Study|Investigators Decision|2
835391|NCT01815840|2746353|P2|Overall Study|Disease progression|2
835392|NCT01815840|2746354|P1|Overall Study|Disease progression|3
835393|NCT01815840|2746353|P2|Overall Study|Death|2
835394|NCT01815840|2746354|P1|Overall Study|Death|2
835395|NCT01815840|2746353|P2|Overall Study|Adverse Event|16
835396|NCT01815840|2746354|P1|Overall Study|Adverse Event|10
835397|NCT01815840|2746353|P2|Overall Study|Administrative/Other|3
835398|NCT01815840|2746354|P1|Overall Study|Administrative/Other|1
835399|NCT01815840|2746353|P2|Overall Study|Withdrew Consent|30
835400|NCT01815840|2746354|P1|Overall Study|Withdrew Consent|31
835401|NCT01815840|2746353|P2|Overall Study|Missing|0
835402|NCT01815840|2746354|P1|Overall Study|Missing|1
835403|NCT01815736|2746384|P2|Overall Study|Still on Study|449
835404|NCT01815736|2746385|P1|Overall Study|Still on Study|929
835405|NCT01815736|2746384|P2|Overall Study|Lost to Follow-up|7
835406|NCT01815736|2746385|P1|Overall Study|Lost to Follow-up|6
835407|NCT01815736|2746384|P2|Overall Study|Withdrew Consent|15
835408|NCT01815736|2746385|P1|Overall Study|Withdrew Consent|7
835409|NCT01815736|2746384|P2|Overall Study|Investigator's Discretion|0
835410|NCT01815736|2746385|P1|Overall Study|Investigator's Discretion|4
835411|NCT01815736|2746384|P2|Overall Study|Death|0
835412|NCT01815736|2746385|P1|Overall Study|Death|4
835413|NCT01815736|2746384|P2|Overall Study|Adverse Event|4
835414|NCT01815736|2746385|P1|Overall Study|Adverse Event|7
835415|NCT01815736|2746384|P2|Overall Study|Randomized but Not Treated|3
835416|NCT01815736|2746385|P1|Overall Study|Randomized but Not Treated|4
835417|NCT01815138|2746438|P2|Overall Study|Physician Decision|5
835418|NCT01815138|2746439|P1|Overall Study|Physician Decision|8
835419|NCT01815138|2746438|P2|Overall Study|Withdrawal by Subject|1
835420|NCT01815138|2746439|P1|Overall Study|Withdrawal by Subject|0
835421|NCT01815099|2746451|P1|Overall Study|unable to attend study visits|1
835422|NCT01815099|2746451|P1|Overall Study|Lack of Efficacy|1
835423|NCT01814878|2746465|P2|Overall Study|Other|0
835424|NCT01814878|2746466|P1|Overall Study|Other|2
835425|NCT01814878|2746465|P2|Overall Study|Screening failure (drop-out)|3
835426|NCT01814878|2746466|P1|Overall Study|Screening failure (drop-out)|0
835427|NCT01814878|2746465|P2|Overall Study|Physician Decision|1
835428|NCT01814878|2746466|P1|Overall Study|Physician Decision|3
835429|NCT01814878|2746465|P2|Overall Study|Protocol Violation|5
835430|NCT01814878|2746466|P1|Overall Study|Protocol Violation|5
835431|NCT01814878|2746465|P2|Overall Study|Withdrawal by Subject|16
835432|NCT01814878|2746466|P1|Overall Study|Withdrawal by Subject|20
835433|NCT01814878|2746465|P2|Overall Study|Adverse Event|5
835434|NCT01814878|2746466|P1|Overall Study|Adverse Event|16
835435|NCT01814800|2746486|P1|Overall Study|Subject relocation|1
835436|NCT01814800|2746486|P1|Overall Study|Sponsor decision|1
835437|NCT01814800|2746486|P1|Overall Study|Pregnancy|1
835438|NCT01814800|2746486|P1|Overall Study|Adverse Event|2
835439|NCT01814761|2746546|P2|Overall Study|Lost to Follow-up|5
835440|NCT01814761|2746547|P1|Overall Study|Lost to Follow-up|1
835441|NCT01814761|2746546|P2|Overall Study|Ocular Adverse Event|15
835442|NCT01814761|2746547|P1|Overall Study|Ocular Adverse Event|6
835443|NCT01814761|2746546|P2|Overall Study|Other Reasons|10
835444|NCT01814761|2746547|P1|Overall Study|Other Reasons|1
835445|NCT01814748|2746561|P2|Overall Study|Withdrawal by Subject|4
835446|NCT01814748|2746562|P1|Overall Study|Withdrawal by Subject|6
835447|NCT01814748|2746561|P2|Overall Study|Study site terminated by sponsor|1
835448|NCT01814748|2746562|P1|Overall Study|Study site terminated by sponsor|1
835449|NCT01814748|2746561|P2|Overall Study|Lost to Follow-up|2
835450|NCT01814748|2746562|P1|Overall Study|Lost to Follow-up|1
835451|NCT01814696|2746606|P2|Overall Study|Randomized to wrong group|0
835452|NCT01814696|2746607|P1|Overall Study|Randomized to wrong group|1
835453|NCT01814696|2746606|P2|Overall Study|Withdrawal by Subject|0
835454|NCT01814696|2746607|P1|Overall Study|Withdrawal by Subject|1
835455|NCT01814670|2746625|P1|Overall Study|Protocol Violation|12
835456|NCT01814553|2746635|P2|Overall Study|Other than stated|8
835457|NCT01814553|2746636|P1|Overall Study|Other than stated|7
835458|NCT01814553|2746635|P2|Overall Study|Withdrawal by Subject|1
835459|NCT01814553|2746636|P1|Overall Study|Withdrawal by Subject|1
835460|NCT01814553|2746635|P2|Overall Study|Other Adverse Event|5
835461|NCT01814553|2746636|P1|Overall Study|Other Adverse Event|4
835462|NCT01814553|2746635|P2|Overall Study|PD per clinical progression|8
835463|NCT01814553|2746636|P1|Overall Study|PD per clinical progression|6
835464|NCT01814397|2746650|P1|Overall Study|Withdrawal by Subject|7
835465|NCT01814397|2746650|P1|Overall Study|Adverse Event|7
835466|NCT01814371|2746659|P2|Overall Study|Lost to Follow-up|27
835467|NCT01814371|2746660|P1|Overall Study|Lost to Follow-up|30
835468|NCT01814332|2746693|P2|Overall Study|Lost to Follow-up|1
835469|NCT01814332|2746694|P1|Overall Study|Lost to Follow-up|5
835470|NCT01814332|2746693|P2|Overall Study|Protocol Violation|4
835471|NCT01814332|2746694|P1|Overall Study|Protocol Violation|0
835472|NCT01814332|2746693|P2|Overall Study|Withdrawal by Subject|8
835473|NCT01814332|2746694|P1|Overall Study|Withdrawal by Subject|3
835474|NCT01814332|2746693|P2|Overall Study|Adverse Event|3
835475|NCT01814332|2746694|P1|Overall Study|Adverse Event|8
835476|NCT01814137|2746716|P2|Overall Study|Unclassified|1
835477|NCT01814137|2746717|P1|Overall Study|Unclassified|2
835478|NCT01814137|2746716|P2|Overall Study|Physician Decision|1
835479|NCT01814137|2746717|P1|Overall Study|Physician Decision|1
835480|NCT01814137|2746716|P2|Overall Study|Withdrawal by Subject|2
835481|NCT01814137|2746717|P1|Overall Study|Withdrawal by Subject|2
835482|NCT01814137|2746716|P2|Overall Study|Adverse Event|1
835483|NCT01814137|2746717|P1|Overall Study|Adverse Event|0
835484|NCT01814046|2746733|P3|Drug Administration|Death due to complications of RSV|0
835485|NCT01814046|2746734|P2|Drug Administration|Death due to complications of RSV|0
835486|NCT01814046|2746735|P1|Drug Administration|Death due to complications of RSV|1
835487|NCT01813890|2746749|P3|Overall Study|Lack of Efficacy|2
835488|NCT01813890|2746750|P2|Overall Study|Lack of Efficacy|1
835489|NCT01813890|2746751|P1|Overall Study|Lack of Efficacy|9
835490|NCT01813890|2746749|P3|Overall Study|Adverse Event|4
835491|NCT01813890|2746750|P2|Overall Study|Adverse Event|3
835492|NCT01813890|2746751|P1|Overall Study|Adverse Event|0
835493|NCT01813721|2746780|P1|Overall Study|Withdrawal by Subject|1
835494|NCT01813721|2746780|P1|Overall Study|Ineligibility determined|63
835495|NCT01813474|2746835|P3|Overall Study|Death|1
835496|NCT01813474|2746836|P2|Overall Study|Death|0
835497|NCT01813474|2746837|P1|Overall Study|Death|0
835498|NCT01813474|2746835|P3|Overall Study|Lack of Efficacy|9
835499|NCT01813474|2746836|P2|Overall Study|Lack of Efficacy|6
835500|NCT01813474|2746837|P1|Overall Study|Lack of Efficacy|2
835501|NCT01813474|2746835|P3|Overall Study|Adverse Event|0
835502|NCT01813474|2746836|P2|Overall Study|Adverse Event|1
835503|NCT01813474|2746837|P1|Overall Study|Adverse Event|1
835504|NCT01813474|2746835|P3|Overall Study|Withdrawal by Subject|1
835505|NCT01813474|2746836|P2|Overall Study|Withdrawal by Subject|0
835506|NCT01813474|2746837|P1|Overall Study|Withdrawal by Subject|0
835507|NCT01813422|2746861|P2|Overall Study|Lost to Follow-up|4
835508|NCT01813422|2746862|P1|Overall Study|Lost to Follow-up|2
835509|NCT01813422|2746861|P2|Overall Study|Sponsor Decision|1
835510|NCT01813422|2746862|P1|Overall Study|Sponsor Decision|2
835511|NCT01813422|2746861|P2|Overall Study|Death|3
835512|NCT01813422|2746862|P1|Overall Study|Death|2
835513|NCT01813422|2746861|P2|Overall Study|Withdrawal by Subject|8
835514|NCT01813422|2746862|P1|Overall Study|Withdrawal by Subject|14
835515|NCT01813019|2746900|P2|Overall Study|Protocol Deviation|1
835516|NCT01813019|2746901|P1|Overall Study|Protocol Deviation|2
835517|NCT01813019|2746900|P2|Overall Study|administrative problems|0
835518|NCT01813019|2746901|P1|Overall Study|administrative problems|2
835519|NCT01813019|2746900|P2|Overall Study|Withdrawal by Subject|2
835520|NCT01813019|2746901|P1|Overall Study|Withdrawal by Subject|3
835521|NCT01813019|2746900|P2|Overall Study|Adverse Event|3
835522|NCT01813019|2746901|P1|Overall Study|Adverse Event|0
835523|NCT01812837|2746912|P3|Overall Study|Protocol Violation|0
835524|NCT01812837|2746913|P2|Overall Study|Protocol Violation|0
835525|NCT01812837|2746914|P1|Overall Study|Protocol Violation|1
835526|NCT01812837|2746912|P3|Overall Study|Lost to Follow-up|0
835527|NCT01812837|2746913|P2|Overall Study|Lost to Follow-up|1
835528|NCT01812837|2746914|P1|Overall Study|Lost to Follow-up|1
835529|NCT01812707|2746926|P4|Overall Study|Consent withdrawn by participant|0
835530|NCT01812707|2746927|P3|Overall Study|Consent withdrawn by participant|0
835531|NCT01812707|2746928|P2|Overall Study|Consent withdrawn by participant|0
835532|NCT01812707|2746929|P1|Overall Study|Consent withdrawn by participant|1
835533|NCT01812707|2746926|P4|Overall Study|Poor compliance to protocol|0
835534|NCT01812707|2746927|P3|Overall Study|Poor compliance to protocol|0
835535|NCT01812707|2746928|P2|Overall Study|Poor compliance to protocol|0
835536|NCT01812707|2746929|P1|Overall Study|Poor compliance to protocol|1
835537|NCT01812707|2746926|P4|Overall Study|Adverse Event|2
835538|NCT01812707|2746927|P3|Overall Study|Adverse Event|0
835539|NCT01812707|2746928|P2|Overall Study|Adverse Event|0
835540|NCT01812707|2746929|P1|Overall Study|Adverse Event|0
835541|NCT01812655|2746977|P3|Overall Study|Protocol Violation|0
835542|NCT01812655|2746978|P2|Overall Study|Protocol Violation|1
835543|NCT01812655|2746979|P1|Overall Study|Protocol Violation|1
835544|NCT01812057|2747004|P2|Overall Study|Physician Decision|0
835545|NCT01812057|2747005|P1|Overall Study|Physician Decision|1
835546|NCT01812057|2747004|P2|Overall Study|Protocol Violation|0
835547|NCT01812057|2747005|P1|Overall Study|Protocol Violation|1
835548|NCT01811953|2747108|P6|Overall Study|Protocol Violation|0
835549|NCT01811953|2747109|P5|Overall Study|Protocol Violation|1
835550|NCT01811953|2747110|P4|Overall Study|Protocol Violation|0
835551|NCT01811953|2747111|P3|Overall Study|Protocol Violation|0
835552|NCT01811953|2747112|P2|Overall Study|Protocol Violation|0
835553|NCT01811953|2747113|P1|Overall Study|Protocol Violation|0
835554|NCT01811953|2747108|P6|Overall Study|Adverse Event|1
835555|NCT01811953|2747109|P5|Overall Study|Adverse Event|0
835556|NCT01811953|2747110|P4|Overall Study|Adverse Event|1
835557|NCT01811953|2747111|P3|Overall Study|Adverse Event|0
835558|NCT01811953|2747112|P2|Overall Study|Adverse Event|0
835559|NCT01811953|2747113|P1|Overall Study|Adverse Event|0
835560|NCT01811732|2747170|P2|Overall Study|Correct study drug not available on site|0
835561|NCT01811732|2747171|P1|Overall Study|Correct study drug not available on site|1
835562|NCT01811732|2747170|P2|Overall Study|Admitted to another facility|0
835563|NCT01811732|2747171|P1|Overall Study|Admitted to another facility|1
835564|NCT01811732|2747170|P2|Overall Study|Subject incarcerated|2
835565|NCT01811732|2747171|P1|Overall Study|Subject incarcerated|1
835566|NCT01811732|2747170|P2|Overall Study|Protocol Violation|1
835567|NCT01811732|2747171|P1|Overall Study|Protocol Violation|0
835568|NCT01811732|2747170|P2|Overall Study|Insufficient venous access|1
835569|NCT01811732|2747171|P1|Overall Study|Insufficient venous access|0
835570|NCT01811732|2747170|P2|Overall Study|Death|1
835571|NCT01811732|2747171|P1|Overall Study|Death|1
835572|NCT01811732|2747170|P2|Overall Study|Physician Decision|0
835573|NCT01811732|2747171|P1|Overall Study|Physician Decision|2
835574|NCT01811732|2747170|P2|Overall Study|Non-compliance with study drug/procedure|3
835575|NCT01811732|2747171|P1|Overall Study|Non-compliance with study drug/procedure|3
835576|NCT01811732|2747170|P2|Overall Study|Lack of Efficacy|1
835577|NCT01811732|2747171|P1|Overall Study|Lack of Efficacy|3
835578|NCT01811732|2747170|P2|Overall Study|Adverse Event|9
835579|NCT01811732|2747171|P1|Overall Study|Adverse Event|3
835580|NCT01811732|2747170|P2|Overall Study|Withdrawal by Subject|10
835581|NCT01811732|2747171|P1|Overall Study|Withdrawal by Subject|16
835582|NCT01811732|2747170|P2|Overall Study|Lost to Follow-up|30
835583|NCT01811732|2747171|P1|Overall Study|Lost to Follow-up|24
835584|NCT01811706|2747181|P2|First Intervention ( 4 Weeks)|Adverse Event|0
835585|NCT01811706|2747182|P1|First Intervention ( 4 Weeks)|Adverse Event|1
835586|NCT01811563|2747199|P2|Overall Study|Incorrect Randomization procedure|1
835587|NCT01811563|2747200|P1|Overall Study|Incorrect Randomization procedure|0
835588|NCT01811563|2747199|P2|Overall Study|Lost to Follow-up|2
835589|NCT01811563|2747200|P1|Overall Study|Lost to Follow-up|5
835590|NCT01811485|2747229|P3|Overall Study|Protocol Deviation|0
835591|NCT01811485|2747230|P2|Overall Study|Protocol Deviation|1
835592|NCT01811485|2747231|P1|Overall Study|Protocol Deviation|0
835593|NCT01811485|2747229|P3|Overall Study|Administrative problems|0
835594|NCT01811485|2747230|P2|Overall Study|Administrative problems|0
835595|NCT01811485|2747231|P1|Overall Study|Administrative problems|1
835596|NCT01811485|2747229|P3|Overall Study|Unsatisfactory therapeutic effect|3
835597|NCT01811485|2747230|P2|Overall Study|Unsatisfactory therapeutic effect|0
835598|NCT01811485|2747231|P1|Overall Study|Unsatisfactory therapeutic effect|0
835599|NCT01811485|2747229|P3|Overall Study|Adverse Event|2
835600|NCT01811485|2747230|P2|Overall Study|Adverse Event|3
835601|NCT01811485|2747231|P1|Overall Study|Adverse Event|1
835602|NCT01811472|2747251|P3|Overall Study|Subject/guardian decision|0
835603|NCT01811472|2747252|P2|Overall Study|Subject/guardian decision|0
835604|NCT01811472|2747253|P1|Overall Study|Subject/guardian decision|1
835605|NCT01811472|2747251|P3|Overall Study|Lost to Follow-up|1
835606|NCT01811472|2747252|P2|Overall Study|Lost to Follow-up|0
835607|NCT01811472|2747253|P1|Overall Study|Lost to Follow-up|0
835608|NCT01811472|2747251|P3|Overall Study|Adverse Event|4
835609|NCT01811472|2747252|P2|Overall Study|Adverse Event|0
835610|NCT01811472|2747253|P1|Overall Study|Adverse Event|1
835611|NCT01811238|2747340|P1|Overall Study|subject refused study medication|6
835612|NCT01811238|2747340|P1|Overall Study|Lack of Efficacy|4
835613|NCT01811238|2747340|P1|Overall Study|Protocol Violation|4
835614|NCT01811238|2747340|P1|Overall Study|Adverse Event|25
835615|NCT01811238|2747340|P1|Overall Study|Withdrawal by Subject|42
835616|NCT01811186|2747364|P2|Overall Study|Lost to Follow-up|2
835617|NCT01811186|2747365|P1|Overall Study|Lost to Follow-up|4
835618|NCT01811186|2747364|P2|Overall Study|Lack of Efficacy|6
835619|NCT01811186|2747365|P1|Overall Study|Lack of Efficacy|3
835620|NCT01811186|2747364|P2|Overall Study|Withdrawal by Subject|10
835621|NCT01811186|2747365|P1|Overall Study|Withdrawal by Subject|5
835622|NCT01811186|2747364|P2|Overall Study|Protocol Violation|6
835623|NCT01811186|2747365|P1|Overall Study|Protocol Violation|5
835624|NCT01811186|2747364|P2|Overall Study|Adverse Event|38
835625|NCT01811186|2747365|P1|Overall Study|Adverse Event|54
835626|NCT01810939|2747398|P3|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
835627|NCT01810939|2747399|P2|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1
835628|NCT01810939|2747400|P1|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
835629|NCT01810939|2747398|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1
835630|NCT01810939|2747399|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2
835631|NCT01810939|2747400|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0
835632|NCT01810939|2747398|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14
835633|NCT01810939|2747399|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2
835634|NCT01810939|2747400|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0
835635|NCT01810939|2747398|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2
835636|NCT01810939|2747399|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1
835637|NCT01810939|2747400|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0
835638|NCT01810939|2747398|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
835639|NCT01810939|2747399|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
835640|NCT01810939|2747400|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0
835641|NCT01810939|2747398|P3|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1
835642|NCT01810939|2747399|P2|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
835643|NCT01810939|2747400|P1|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
835644|NCT01810939|2747398|P3|Part B Placebo-Controlled Withdrawal|Death|1
835645|NCT01810939|2747399|P2|Part B Placebo-Controlled Withdrawal|Death|0
835646|NCT01810939|2747400|P1|Part B Placebo-Controlled Withdrawal|Death|0
835647|NCT01810939|2747398|P3|Part B Placebo-Controlled Withdrawal|Adverse Event|1
835648|NCT01810939|2747399|P2|Part B Placebo-Controlled Withdrawal|Adverse Event|1
835649|NCT01810939|2747400|P1|Part B Placebo-Controlled Withdrawal|Adverse Event|0
835650|NCT01810939|2747398|P3|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
835651|NCT01810939|2747399|P2|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1
835652|NCT01810939|2747400|P1|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
835653|NCT01810939|2747398|P3|Part B Placebo-Controlled Withdrawal|Physician Decision|1
835654|NCT01810939|2747399|P2|Part B Placebo-Controlled Withdrawal|Physician Decision|1
835655|NCT01810939|2747400|P1|Part B Placebo-Controlled Withdrawal|Physician Decision|0
835656|NCT01810939|2747398|P3|Part A Treatment Period|Protocol-specified (Low K+)|0
835657|NCT01810939|2747399|P2|Part A Treatment Period|Protocol-specified (Low K+)|0
835658|NCT01810939|2747400|P1|Part A Treatment Period|Protocol-specified (Low K+)|1
835659|NCT01810939|2747398|P3|Part A Treatment Period|Protocol-specified (High K+)|0
835660|NCT01810939|2747399|P2|Part A Treatment Period|Protocol-specified (High K+)|0
835661|NCT01810939|2747400|P1|Part A Treatment Period|Protocol-specified (High K+)|3
835662|NCT01810939|2747398|P3|Part A Treatment Period|Protocol-specified (eGFR)|0
835663|NCT01810939|2747399|P2|Part A Treatment Period|Protocol-specified (eGFR)|0
835664|NCT01810939|2747400|P1|Part A Treatment Period|Protocol-specified (eGFR)|2
835665|NCT01810939|2747398|P3|Part A Treatment Period|Withdrawal by Subject|0
835666|NCT01810939|2747399|P2|Part A Treatment Period|Withdrawal by Subject|0
835667|NCT01810939|2747400|P1|Part A Treatment Period|Withdrawal by Subject|5
835668|NCT01810939|2747398|P3|Part A Treatment Period|Adverse Event|0
835669|NCT01810939|2747399|P2|Part A Treatment Period|Adverse Event|0
835670|NCT01810939|2747400|P1|Part A Treatment Period|Adverse Event|10
835671|NCT01810939|2747398|P3|Part A Treatment Period|Protocol Violation|0
835672|NCT01810939|2747399|P2|Part A Treatment Period|Protocol Violation|0
835673|NCT01810939|2747400|P1|Part A Treatment Period|Protocol Violation|2
835674|NCT01810939|2747398|P3|Part A Treatment Period|Non-compliance with Study Drug|0
835675|NCT01810939|2747399|P2|Part A Treatment Period|Non-compliance with Study Drug|0
835676|NCT01810939|2747400|P1|Part A Treatment Period|Non-compliance with Study Drug|1
835677|NCT01810783|2747413|P1|Overall Study|Enrolled, not treated|1
835678|NCT01810783|2747413|P1|Overall Study|Adminstrative or other reason(s)|23
835679|NCT01810783|2747413|P1|Overall Study|Non-compliance with IMP|4
835680|NCT01810783|2747413|P1|Overall Study|Protocol Violation|5
835681|NCT01810783|2747413|P1|Overall Study|Lost to Follow-up|10
835682|NCT01810783|2747413|P1|Overall Study|Lack of Efficacy|12
835683|NCT01810783|2747413|P1|Overall Study|Withdrawal by Subject|22
835684|NCT01810783|2747413|P1|Overall Study|Adverse Event|32
835685|NCT01810432|2747438|P2|Period 2|Lost to Follow-up|1
835686|NCT01810432|2747439|P1|Period 2|Lost to Follow-up|1
835687|NCT01810432|2747438|P2|Period 2|Physician Decision|0
835688|NCT01810432|2747439|P1|Period 2|Physician Decision|1
835689|NCT01810432|2747438|P2|Period 2|Withdrawal by Subject|1
835690|NCT01810432|2747439|P1|Period 2|Withdrawal by Subject|2
835691|NCT01810432|2747438|P2|Washout|Adverse Event|0
835692|NCT01810432|2747439|P1|Washout|Adverse Event|1
835693|NCT01810432|2747438|P2|Washout|Protocol Violation|1
835694|NCT01810432|2747439|P1|Washout|Protocol Violation|0
835695|NCT01810380|2747452|P3|Overall Study|Administrative or other reasons|9
835696|NCT01810380|2747453|P2|Overall Study|Administrative or other reasons|13
835697|NCT01810380|2747454|P1|Overall Study|Administrative or other reasons|11
835698|NCT01810380|2747452|P3|Overall Study|Withdrawal by Subject|6
835699|NCT01810380|2747453|P2|Overall Study|Withdrawal by Subject|0
835700|NCT01810380|2747454|P1|Overall Study|Withdrawal by Subject|6
835701|NCT01810380|2747452|P3|Overall Study|Protocol Violation|1
835702|NCT01810380|2747453|P2|Overall Study|Protocol Violation|0
835703|NCT01810380|2747454|P1|Overall Study|Protocol Violation|1
835704|NCT01810380|2747452|P3|Overall Study|Lack of Efficacy|11
835705|NCT01810380|2747453|P2|Overall Study|Lack of Efficacy|10
835706|NCT01810380|2747454|P1|Overall Study|Lack of Efficacy|24
835707|NCT01810380|2747452|P3|Overall Study|Adverse Event|4
835708|NCT01810380|2747453|P2|Overall Study|Adverse Event|14
835709|NCT01810380|2747454|P1|Overall Study|Adverse Event|11
835710|NCT01810380|2747452|P3|Overall Study|Randomised not treated|1
835711|NCT01810380|2747453|P2|Overall Study|Randomised not treated|1
835712|NCT01810380|2747454|P1|Overall Study|Randomised not treated|2
835713|NCT01810302|2747515|P2|Overall Study|Physician Decision|1
835714|NCT01810302|2747516|P1|Overall Study|Physician Decision|0
835715|NCT01810302|2747515|P2|Overall Study|Death|0
835716|NCT01810302|2747516|P1|Overall Study|Death|1
835717|NCT01810263|2747543|P2|Overall Study|Lost to Follow-up|7
835718|NCT01810263|2747544|P1|Overall Study|Lost to Follow-up|8
835719|NCT01810042|2747550|P1|Overall Study|Lost to Follow-up|10
835720|NCT01810016|2747560|P3|Overall Study|Death|1
835721|NCT01810016|2747561|P2|Overall Study|Death|0
835722|NCT01810016|2747562|P1|Overall Study|Death|0
835723|NCT01810016|2747560|P3|Overall Study|Progressive disease|0
835724|NCT01810016|2747561|P2|Overall Study|Progressive disease|1
835725|NCT01810016|2747562|P1|Overall Study|Progressive disease|1
835726|NCT01809327|2747632|P5|Overall Study|Other|9
835727|NCT01809327|2747633|P4|Overall Study|Other|4
835728|NCT01809327|2747634|P3|Overall Study|Other|7
835729|NCT01809327|2747635|P2|Overall Study|Other|15
835730|NCT01809327|2747636|P1|Overall Study|Other|14
835731|NCT01809327|2747632|P5|Overall Study|Pregnancy|0
835732|NCT01809327|2747633|P4|Overall Study|Pregnancy|0
835733|NCT01809327|2747634|P3|Overall Study|Pregnancy|0
835734|NCT01809327|2747635|P2|Overall Study|Pregnancy|0
835735|NCT01809327|2747636|P1|Overall Study|Pregnancy|1
835736|NCT01809327|2747632|P5|Overall Study|Physician Decision|0
835737|NCT01809327|2747633|P4|Overall Study|Physician Decision|0
835738|NCT01809327|2747634|P3|Overall Study|Physician Decision|0
835739|NCT01809327|2747635|P2|Overall Study|Physician Decision|1
835740|NCT01809327|2747636|P1|Overall Study|Physician Decision|1
835741|NCT01809327|2747632|P5|Overall Study|Protocol Violation|0
835742|NCT01809327|2747633|P4|Overall Study|Protocol Violation|0
835743|NCT01809327|2747634|P3|Overall Study|Protocol Violation|0
835744|NCT01809327|2747635|P2|Overall Study|Protocol Violation|1
835745|NCT01809327|2747636|P1|Overall Study|Protocol Violation|0
835746|NCT01809327|2747632|P5|Overall Study|Death|0
835747|NCT01809327|2747633|P4|Overall Study|Death|0
835748|NCT01809327|2747634|P3|Overall Study|Death|0
835749|NCT01809327|2747635|P2|Overall Study|Death|0
835750|NCT01809327|2747636|P1|Overall Study|Death|1
835751|NCT01809327|2747632|P5|Overall Study|Adverse Event|8
835752|NCT01809327|2747633|P4|Overall Study|Adverse Event|4
835753|NCT01809327|2747634|P3|Overall Study|Adverse Event|7
835754|NCT01809327|2747635|P2|Overall Study|Adverse Event|3
835755|NCT01809327|2747636|P1|Overall Study|Adverse Event|4
835756|NCT01809327|2747632|P5|Overall Study|Withdrawal by Subject|5
835757|NCT01809327|2747633|P4|Overall Study|Withdrawal by Subject|2
835758|NCT01809327|2747634|P3|Overall Study|Withdrawal by Subject|4
835759|NCT01809327|2747635|P2|Overall Study|Withdrawal by Subject|4
835760|NCT01809327|2747636|P1|Overall Study|Withdrawal by Subject|6
835761|NCT01809327|2747632|P5|Overall Study|Lost to Follow-up|3
835762|NCT01809327|2747633|P4|Overall Study|Lost to Follow-up|2
835763|NCT01809327|2747634|P3|Overall Study|Lost to Follow-up|4
835764|NCT01809327|2747635|P2|Overall Study|Lost to Follow-up|2
835765|NCT01809327|2747636|P1|Overall Study|Lost to Follow-up|5
835766|NCT01809314|2747678|P1|Overall Study|Lost to Follow-up|724
835767|NCT01809314|2747678|P1|Overall Study|Insufficient Therapeutic Response|14
835768|NCT01809314|2747678|P1|Overall Study|Adverse Event|6
835769|NCT01809314|2747678|P1|Overall Study|Withdrawal Prior to Treatment|1
835770|NCT01809262|2747684|P10|Period 3 (Third Dose + Washout)|Adverse Event|0
835771|NCT01809262|2747685|P9|Period 3 (Third Dose + Washout)|Adverse Event|0
835772|NCT01809262|2747686|P8|Period 3 (Third Dose + Washout)|Adverse Event|0
835773|NCT01809262|2747687|P7|Period 3 (Third Dose + Washout)|Adverse Event|0
835774|NCT01809262|2747688|P6|Period 3 (Third Dose + Washout)|Adverse Event|0
835775|NCT01809262|2747689|P5|Period 3 (Third Dose + Washout)|Adverse Event|0
835776|NCT01809262|2747690|P4|Period 3 (Third Dose + Washout)|Adverse Event|0
835777|NCT01809262|2747691|P3|Period 3 (Third Dose + Washout)|Adverse Event|0
835778|NCT01809262|2747692|P2|Period 3 (Third Dose + Washout)|Adverse Event|1
835779|NCT01809262|2747693|P1|Period 3 (Third Dose + Washout)|Adverse Event|0
835780|NCT01809262|2747684|P10|Period 1 (First Dose + Washout)|Adverse Event|0
835781|NCT01809262|2747685|P9|Period 1 (First Dose + Washout)|Adverse Event|0
835782|NCT01809262|2747686|P8|Period 1 (First Dose + Washout)|Adverse Event|0
835783|NCT01809262|2747687|P7|Period 1 (First Dose + Washout)|Adverse Event|0
835784|NCT01809262|2747688|P6|Period 1 (First Dose + Washout)|Adverse Event|0
835785|NCT01809262|2747689|P5|Period 1 (First Dose + Washout)|Adverse Event|1
835786|NCT01809262|2747690|P4|Period 1 (First Dose + Washout)|Adverse Event|0
835787|NCT01809262|2747691|P3|Period 1 (First Dose + Washout)|Adverse Event|0
835788|NCT01809262|2747692|P2|Period 1 (First Dose + Washout)|Adverse Event|0
835789|NCT01809262|2747693|P1|Period 1 (First Dose + Washout)|Adverse Event|0
835790|NCT01809210|2747767|P7|Overall Study|Death|1
835791|NCT01809210|2747768|P6|Overall Study|Death|3
835792|NCT01809210|2747769|P5|Overall Study|Death|1
835793|NCT01809210|2747770|P4|Overall Study|Death|0
835794|NCT01809210|2747771|P3|Overall Study|Death|2
835795|NCT01809210|2747772|P2|Overall Study|Death|1
835796|NCT01809210|2747773|P1|Overall Study|Death|1
835797|NCT01809210|2747767|P7|Overall Study|Withdrawal by Subject|4
835798|NCT01809210|2747768|P6|Overall Study|Withdrawal by Subject|0
835799|NCT01809210|2747769|P5|Overall Study|Withdrawal by Subject|1
835800|NCT01809210|2747770|P4|Overall Study|Withdrawal by Subject|1
835801|NCT01809210|2747771|P3|Overall Study|Withdrawal by Subject|1
835802|NCT01809210|2747772|P2|Overall Study|Withdrawal by Subject|0
835803|NCT01809210|2747773|P1|Overall Study|Withdrawal by Subject|0
835804|NCT01809197|2747847|P2|Overall Study|Product not available|1
835805|NCT01809197|2747848|P1|Overall Study|Product not available|0
835806|NCT01809197|2747847|P2|Overall Study|Withdrawal by Subject|1
835807|NCT01809197|2747848|P1|Overall Study|Withdrawal by Subject|1
835808|NCT01809197|2747847|P2|Overall Study|Decision Unrelated to an Adverse Event|0
835809|NCT01809197|2747848|P1|Overall Study|Decision Unrelated to an Adverse Event|1
835810|NCT01809197|2747847|P2|Overall Study|Non-Compliance|1
835811|NCT01809197|2747848|P1|Overall Study|Non-Compliance|1
835812|NCT01809197|2747847|P2|Overall Study|Failed slit lamp exam|0
835813|NCT01809197|2747848|P1|Overall Study|Failed slit lamp exam|1
835814|NCT01809197|2747847|P2|Overall Study|Adverse Event|3
835815|NCT01809197|2747848|P1|Overall Study|Adverse Event|2
835816|NCT01809197|2747847|P2|Overall Study|Lost to Follow-up|2
835817|NCT01809197|2747848|P1|Overall Study|Lost to Follow-up|4
835818|NCT01808651|2747919|P3|Study Period 1|Participant Decision|3
835819|NCT01808651|2747920|P2|Study Period 1|Participant Decision|7
835820|NCT01808651|2747921|P1|Study Period 1|Participant Decision|9
835821|NCT01808651|2747919|P3|Study Period 1|Adverse Event|1
835822|NCT01808651|2747920|P2|Study Period 1|Adverse Event|4
835823|NCT01808651|2747921|P1|Study Period 1|Adverse Event|10
835824|NCT01808651|2747919|P3|Study Period 1|Lack of Efficacy|0
835825|NCT01808651|2747920|P2|Study Period 1|Lack of Efficacy|1
835826|NCT01808651|2747921|P1|Study Period 1|Lack of Efficacy|2
835827|NCT01808651|2747919|P3|Study Period 1|Physician Decision|0
835828|NCT01808651|2747920|P2|Study Period 1|Physician Decision|2
835829|NCT01808651|2747921|P1|Study Period 1|Physician Decision|3
835830|NCT01808651|2747919|P3|Study Period 1|Protocol Violation|1
835831|NCT01808651|2747920|P2|Study Period 1|Protocol Violation|0
835832|NCT01808651|2747921|P1|Study Period 1|Protocol Violation|1
835833|NCT01808651|2747919|P3|Study Period 1|Lost to Follow-up|0
835834|NCT01808651|2747920|P2|Study Period 1|Lost to Follow-up|3
835835|NCT01808651|2747921|P1|Study Period 1|Lost to Follow-up|1
835836|NCT01808612|2747956|P3|Discontinuation Period|Lost to Follow-up|0
835837|NCT01808612|2747957|P2|Discontinuation Period|Lost to Follow-up|1
835838|NCT01808612|2747958|P1|Discontinuation Period|Lost to Follow-up|0
835839|NCT01808612|2747956|P3|Discontinuation Period|Physician Decision|0
835840|NCT01808612|2747957|P2|Discontinuation Period|Physician Decision|0
835841|NCT01808612|2747958|P1|Discontinuation Period|Physician Decision|1
835842|NCT01808612|2747956|P3|Discontinuation Period|Adverse Event|0
835843|NCT01808612|2747957|P2|Discontinuation Period|Adverse Event|0
835844|NCT01808612|2747958|P1|Discontinuation Period|Adverse Event|1
835845|NCT01808612|2747956|P3|Treatment Period|Lack of Efficacy|2
835846|NCT01808612|2747957|P2|Treatment Period|Lack of Efficacy|1
835847|NCT01808612|2747958|P1|Treatment Period|Lack of Efficacy|1
835848|NCT01808612|2747956|P3|Treatment Period|Sponsor Decision|0
835849|NCT01808612|2747957|P2|Treatment Period|Sponsor Decision|0
835850|NCT01808612|2747958|P1|Treatment Period|Sponsor Decision|1
835851|NCT01808612|2747956|P3|Treatment Period|Physician Decision|4
835852|NCT01808612|2747957|P2|Treatment Period|Physician Decision|0
835853|NCT01808612|2747958|P1|Treatment Period|Physician Decision|1
835854|NCT01808612|2747956|P3|Treatment Period|Withdrawal by Subject|4
835855|NCT01808612|2747957|P2|Treatment Period|Withdrawal by Subject|0
835856|NCT01808612|2747958|P1|Treatment Period|Withdrawal by Subject|1
835857|NCT01808612|2747956|P3|Treatment Period|Protocol Violation|0
835858|NCT01808612|2747957|P2|Treatment Period|Protocol Violation|0
835859|NCT01808612|2747958|P1|Treatment Period|Protocol Violation|1
835860|NCT01808612|2747956|P3|Treatment Period|Lost to Follow-up|1
835861|NCT01808612|2747957|P2|Treatment Period|Lost to Follow-up|2
835862|NCT01808612|2747958|P1|Treatment Period|Lost to Follow-up|2
835863|NCT01808612|2747956|P3|Treatment Period|Adverse Event|3
835864|NCT01808612|2747957|P2|Treatment Period|Adverse Event|4
835865|NCT01808612|2747958|P1|Treatment Period|Adverse Event|8
835866|NCT01808534|2748024|P1|Overall Study|Physician Decision|1
835867|NCT01808534|2748024|P1|Overall Study|Disease progression|3
835868|NCT01808508|2748035|P3|Overall Study|Lost to Follow-up|0
835869|NCT01808508|2748036|P2|Overall Study|Lost to Follow-up|0
835870|NCT01808508|2748037|P1|Overall Study|Lost to Follow-up|1
835871|NCT01808339|2748054|P6|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
835872|NCT01808339|2748055|P5|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
835873|NCT01808339|2748056|P4|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
835874|NCT01808339|2748057|P3|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1
835875|NCT01808339|2748058|P2|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
835876|NCT01808339|2748059|P1|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
835877|NCT01808339|2748054|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
835878|NCT01808339|2748055|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
835879|NCT01808339|2748056|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
835880|NCT01808339|2748057|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
835881|NCT01808339|2748058|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
835882|NCT01808339|2748059|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
835883|NCT01808339|2748054|P6|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
835884|NCT01808339|2748055|P5|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2
835885|NCT01808339|2748056|P4|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
835886|NCT01808339|2748057|P3|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
835887|NCT01808339|2748058|P2|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
835888|NCT01808339|2748059|P1|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
835889|NCT01808313|2748103|P1|Overall Study|Physician Decision|1
835890|NCT01808313|2748103|P1|Overall Study|Lost to Follow-up|1
835891|NCT01808313|2748103|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
835892|NCT01808313|2748103|P1|Overall Study|Protocol Violation|2
835893|NCT01808313|2748103|P1|Overall Study|Adverse Event|5
835894|NCT01808261|2748133|P2|Overall Study|Lost to Follow-up|1
835895|NCT01808261|2748134|P1|Overall Study|Lost to Follow-up|3
835896|NCT01808261|2748133|P2|Overall Study|Consent withdrawn by subject|7
835897|NCT01808261|2748134|P1|Overall Study|Consent withdrawn by subject|6
835898|NCT01808261|2748133|P2|Overall Study|Adverse event, non-fatal|0
835899|NCT01808261|2748134|P1|Overall Study|Adverse event, non-fatal|2
835900|NCT01808261|2748133|P2|Overall Study|Study Closed/Terminated|23
835901|NCT01808261|2748134|P1|Overall Study|Study Closed/Terminated|25
835902|NCT01808261|2748133|P2|Overall Study|Physician Decision|2
835903|NCT01808261|2748134|P1|Overall Study|Physician Decision|0
835904|NCT01808248|2748190|P1|Overall Study|Lost to Follow-up|1
835905|NCT01808248|2748190|P1|Overall Study|Withdrawal by Subject|1
835906|NCT01808248|2748190|P1|Overall Study|Lack of Efficacy|3
835907|NCT01808209|2748204|P2|Overall Study|Lost to Follow-up|1
835908|NCT01808209|2748205|P1|Overall Study|Lost to Follow-up|0
835909|NCT01808144|2748249|P2|Overall Study|Adverse Event|15
835910|NCT01808144|2748250|P1|Overall Study|Adverse Event|11
835911|NCT01808144|2748249|P2|Overall Study|Gout flare|1
835912|NCT01808144|2748250|P1|Overall Study|Gout flare|0
835913|NCT01808144|2748249|P2|Overall Study|Protocol Violation|6
835914|NCT01808144|2748250|P1|Overall Study|Protocol Violation|6
835915|NCT01808144|2748249|P2|Overall Study|Lost to Follow-up|3
835916|NCT01808144|2748250|P1|Overall Study|Lost to Follow-up|6
835917|NCT01808144|2748249|P2|Overall Study|Withdrawal by Subject|23
835918|NCT01808144|2748250|P1|Overall Study|Withdrawal by Subject|16
835919|NCT01808144|2748249|P2|Overall Study|Death|0
835920|NCT01808144|2748250|P1|Overall Study|Death|1
835921|NCT01808118|2748258|P3|Period 2|Switched to other therapy|0
835922|NCT01808118|2748259|P2|Period 2|Switched to other therapy|1
835923|NCT01808118|2748260|P1|Period 2|Switched to other therapy|0
835924|NCT01808118|2748258|P3|Period 2|Investigator no longer conducting trials|0
835925|NCT01808118|2748259|P2|Period 2|Investigator no longer conducting trials|1
835926|NCT01808118|2748260|P1|Period 2|Investigator no longer conducting trials|0
835927|NCT01808118|2748258|P3|Period 2|Lost to Follow-up|2
835928|NCT01808118|2748259|P2|Period 2|Lost to Follow-up|0
835929|NCT01808118|2748260|P1|Period 2|Lost to Follow-up|0
835930|NCT01808118|2748258|P3|Period 2|Withdrew consent|6
835931|NCT01808118|2748259|P2|Period 2|Withdrew consent|7
835932|NCT01808118|2748260|P1|Period 2|Withdrew consent|0
835933|NCT01808118|2748258|P3|Period 2|Adverse Event|0
835934|NCT01808118|2748259|P2|Period 2|Adverse Event|4
835935|NCT01808118|2748260|P1|Period 2|Adverse Event|0
835936|NCT01808118|2748258|P3|Period 1|Lack of Efficacy|0
835937|NCT01808118|2748259|P2|Period 1|Lack of Efficacy|0
835938|NCT01808118|2748260|P1|Period 1|Lack of Efficacy|1
835939|NCT01808118|2748258|P3|Period 1|Non-compliance per sponsor|0
835940|NCT01808118|2748259|P2|Period 1|Non-compliance per sponsor|0
835941|NCT01808118|2748260|P1|Period 1|Non-compliance per sponsor|1
835942|NCT01808118|2748258|P3|Period 1|Investigator decision: site closure|0
835943|NCT01808118|2748259|P2|Period 1|Investigator decision: site closure|0
835944|NCT01808118|2748260|P1|Period 1|Investigator decision: site closure|2
835945|NCT01808118|2748258|P3|Period 1|Non-conformance with inclusion criteria|0
835946|NCT01808118|2748259|P2|Period 1|Non-conformance with inclusion criteria|0
835947|NCT01808118|2748260|P1|Period 1|Non-conformance with inclusion criteria|3
835948|NCT01808118|2748258|P3|Period 1|Did not meet inclusion criteria|0
835949|NCT01808118|2748259|P2|Period 1|Did not meet inclusion criteria|0
835950|NCT01808118|2748260|P1|Period 1|Did not meet inclusion criteria|3
835951|NCT01808118|2748258|P3|Period 1|Enrolled in error|0
835952|NCT01808118|2748259|P2|Period 1|Enrolled in error|0
835953|NCT01808118|2748260|P1|Period 1|Enrolled in error|7
835954|NCT01808118|2748258|P3|Period 1|Did not meet criteria for remission|0
835955|NCT01808118|2748259|P2|Period 1|Did not meet criteria for remission|0
835956|NCT01808118|2748260|P1|Period 1|Did not meet criteria for remission|303
835957|NCT01808118|2748258|P3|Period 1|Lost to Follow-up|0
835958|NCT01808118|2748259|P2|Period 1|Lost to Follow-up|0
835959|NCT01808118|2748260|P1|Period 1|Lost to Follow-up|9
835960|NCT01808118|2748258|P3|Period 1|Withdrew consent|0
835961|NCT01808118|2748259|P2|Period 1|Withdrew consent|0
835962|NCT01808118|2748260|P1|Period 1|Withdrew consent|24
835963|NCT01808118|2748258|P3|Period 1|Adverse Event|0
835964|NCT01808118|2748259|P2|Period 1|Adverse Event|0
835965|NCT01808118|2748260|P1|Period 1|Adverse Event|15
835966|NCT01808092|2748323|P2|Overall Study|Other Eligibility criteria|5
835967|NCT01808092|2748324|P1|Overall Study|Other Eligibility criteria|3
835968|NCT01808092|2748323|P2|Overall Study|Withdrawal by Subject|4
835969|NCT01808092|2748324|P1|Overall Study|Withdrawal by Subject|9
835970|NCT01808092|2748323|P2|Overall Study|Lost to Follow-up|7
835971|NCT01808092|2748324|P1|Overall Study|Lost to Follow-up|3
835972|NCT01808092|2748323|P2|Overall Study|Death|29
835973|NCT01808092|2748324|P1|Overall Study|Death|39
835974|NCT01808066|2748426|P1|Overall Study|Withdrawal by Subject|15
835975|NCT01807949|2748433|P3|Overall Study|Randomized But Not Treated|2
835976|NCT01807949|2748434|P2|Overall Study|Randomized But Not Treated|2
835977|NCT01807949|2748435|P1|Overall Study|Randomized But Not Treated|0
835978|NCT01807949|2748433|P3|Overall Study|Undefined|2
835979|NCT01807949|2748434|P2|Overall Study|Undefined|1
835980|NCT01807949|2748435|P1|Overall Study|Undefined|0
835981|NCT01807949|2748433|P3|Overall Study|Non-Compliance|1
835982|NCT01807949|2748434|P2|Overall Study|Non-Compliance|0
835983|NCT01807949|2748435|P1|Overall Study|Non-Compliance|0
835984|NCT01807949|2748433|P3|Overall Study|Withdrawal by Subject|2
835985|NCT01807949|2748434|P2|Overall Study|Withdrawal by Subject|2
835986|NCT01807949|2748435|P1|Overall Study|Withdrawal by Subject|1
835987|NCT01807949|2748433|P3|Overall Study|Adverse Event|2
835988|NCT01807949|2748434|P2|Overall Study|Adverse Event|2
835989|NCT01807949|2748435|P1|Overall Study|Adverse Event|1
835990|NCT01807923|2748487|P3|Overall Study|Randomized But Not Treated|5
835991|NCT01807923|2748488|P2|Overall Study|Randomized But Not Treated|2
835992|NCT01807923|2748489|P1|Overall Study|Randomized But Not Treated|3
835993|NCT01807923|2748487|P3|Overall Study|Not Eligible (Genotype)|1
835994|NCT01807923|2748488|P2|Overall Study|Not Eligible (Genotype)|0
835995|NCT01807923|2748489|P1|Overall Study|Not Eligible (Genotype)|0
835996|NCT01807923|2748487|P3|Overall Study|Physician Decision|1
835997|NCT01807923|2748488|P2|Overall Study|Physician Decision|0
835998|NCT01807923|2748489|P1|Overall Study|Physician Decision|0
835999|NCT01807923|2748487|P3|Overall Study|Withdrawal of Consent (not due to AE)|2
836000|NCT01807923|2748488|P2|Overall Study|Withdrawal of Consent (not due to AE)|3
836001|NCT01807923|2748489|P1|Overall Study|Withdrawal of Consent (not due to AE)|0
836002|NCT01807923|2748487|P3|Overall Study|Adverse Event|2
836003|NCT01807923|2748488|P2|Overall Study|Adverse Event|1
836004|NCT01807923|2748489|P1|Overall Study|Adverse Event|2
836005|NCT01807650|2748551|P1|Overall Study|Other|2
836006|NCT01807650|2748551|P1|Overall Study|Adverse Event|5
836007|NCT01807650|2748551|P1|Overall Study|Lack of Full Wound Closure at Day 28|13
836008|NCT01807520|2748658|P7|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1
836009|NCT01807520|2748659|P6|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2
836010|NCT01807520|2748660|P5|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
836011|NCT01807520|2748661|P4|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
836012|NCT01807520|2748662|P3|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
836013|NCT01807520|2748663|P2|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
836014|NCT01807520|2748664|P1|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
836015|NCT01807520|2748658|P7|Follow-up Period (132-140 Weeks)|Study terminated|0
836016|NCT01807520|2748659|P6|Follow-up Period (132-140 Weeks)|Study terminated|1
836017|NCT01807520|2748660|P5|Follow-up Period (132-140 Weeks)|Study terminated|0
836018|NCT01807520|2748661|P4|Follow-up Period (132-140 Weeks)|Study terminated|0
836019|NCT01807520|2748662|P3|Follow-up Period (132-140 Weeks)|Study terminated|0
836020|NCT01807520|2748663|P2|Follow-up Period (132-140 Weeks)|Study terminated|0
836021|NCT01807520|2748664|P1|Follow-up Period (132-140 Weeks)|Study terminated|0
836022|NCT01807520|2748658|P7|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
836023|NCT01807520|2748659|P6|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1
836024|NCT01807520|2748660|P5|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
836025|NCT01807520|2748661|P4|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
836026|NCT01807520|2748662|P3|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
836027|NCT01807520|2748663|P2|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
836028|NCT01807520|2748664|P1|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
836029|NCT01807520|2748658|P7|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
836030|NCT01807520|2748659|P6|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
836031|NCT01807520|2748660|P5|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
836032|NCT01807520|2748661|P4|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
836033|NCT01807520|2748662|P3|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
836034|NCT01807520|2748663|P2|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6
836035|NCT01807520|2748664|P1|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5
836036|NCT01807520|2748658|P7|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
836037|NCT01807520|2748659|P6|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
836038|NCT01807520|2748660|P5|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
836039|NCT01807520|2748661|P4|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
836040|NCT01807520|2748662|P3|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
836041|NCT01807520|2748663|P2|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
836042|NCT01807520|2748664|P1|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
836043|NCT01807520|2748658|P7|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
836044|NCT01807520|2748659|P6|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
836045|NCT01807520|2748660|P5|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1
836046|NCT01807520|2748661|P4|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
836047|NCT01807520|2748662|P3|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
836048|NCT01807520|2748663|P2|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3
836049|NCT01807520|2748664|P1|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5
836050|NCT01807520|2748658|P7|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
836051|NCT01807520|2748659|P6|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
836052|NCT01807520|2748660|P5|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
836053|NCT01807520|2748661|P4|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1
836054|NCT01807520|2748662|P3|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
836055|NCT01807520|2748663|P2|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
836056|NCT01807520|2748664|P1|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4
836057|NCT01807520|2748658|P7|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
836058|NCT01807520|2748659|P6|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
836059|NCT01807520|2748660|P5|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
836060|NCT01807520|2748661|P4|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
836061|NCT01807520|2748662|P3|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
836062|NCT01807520|2748663|P2|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2
836063|NCT01807520|2748664|P1|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
836064|NCT01807520|2748658|P7|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
836065|NCT01807520|2748659|P6|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
836066|NCT01807520|2748660|P5|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
836067|NCT01807520|2748661|P4|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
836068|NCT01807520|2748662|P3|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
836069|NCT01807520|2748663|P2|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
836070|NCT01807520|2748664|P1|Treatment Period 2 (16-132 Weeks)|Pregnancy|1
836071|NCT01807520|2748658|P7|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
836072|NCT01807520|2748659|P6|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
836073|NCT01807520|2748660|P5|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
836074|NCT01807520|2748661|P4|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1
836075|NCT01807520|2748662|P3|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
836076|NCT01807520|2748663|P2|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
836077|NCT01807520|2748664|P1|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
836078|NCT01807520|2748658|P7|Treatment Period 2 (16-132 Weeks)|Study terminated|0
836079|NCT01807520|2748659|P6|Treatment Period 2 (16-132 Weeks)|Study terminated|0
836080|NCT01807520|2748660|P5|Treatment Period 2 (16-132 Weeks)|Study terminated|2
836081|NCT01807520|2748661|P4|Treatment Period 2 (16-132 Weeks)|Study terminated|0
836082|NCT01807520|2748662|P3|Treatment Period 2 (16-132 Weeks)|Study terminated|0
836083|NCT01807520|2748663|P2|Treatment Period 2 (16-132 Weeks)|Study terminated|4
836084|NCT01807520|2748664|P1|Treatment Period 2 (16-132 Weeks)|Study terminated|7
836085|NCT01807520|2748658|P7|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
836086|NCT01807520|2748659|P6|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
836087|NCT01807520|2748660|P5|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
836088|NCT01807520|2748661|P4|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
836089|NCT01807520|2748662|P3|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
836090|NCT01807520|2748663|P2|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
836091|NCT01807520|2748664|P1|Treatment Period 1 (0-16 Weeks)|Adverse Event|2
836092|NCT01807520|2748658|P7|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
836093|NCT01807520|2748659|P6|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
836094|NCT01807520|2748660|P5|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
836095|NCT01807520|2748661|P4|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
836096|NCT01807520|2748662|P3|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2
836097|NCT01807520|2748663|P2|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
836098|NCT01807520|2748664|P1|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
836099|NCT01807520|2748658|P7|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
836100|NCT01807520|2748659|P6|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
836101|NCT01807520|2748660|P5|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
836102|NCT01807520|2748661|P4|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
836103|NCT01807520|2748662|P3|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
836104|NCT01807520|2748663|P2|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
836105|NCT01807520|2748664|P1|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1
836106|NCT01807520|2748658|P7|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
836107|NCT01807520|2748659|P6|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
836108|NCT01807520|2748660|P5|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
836109|NCT01807520|2748661|P4|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
836110|NCT01807520|2748662|P3|Treatment Period 1 (0-16 Weeks)|Physician Decision|1
836111|NCT01807520|2748663|P2|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
836112|NCT01807520|2748664|P1|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
836113|NCT01807520|2748658|P7|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
836114|NCT01807520|2748659|P6|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
836115|NCT01807520|2748660|P5|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
836116|NCT01807520|2748661|P4|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
836117|NCT01807520|2748662|P3|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
836118|NCT01807520|2748663|P2|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
836119|NCT01807520|2748664|P1|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
836120|NCT01807520|2748658|P7|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
836121|NCT01807520|2748659|P6|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
836122|NCT01807520|2748660|P5|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
836123|NCT01807520|2748661|P4|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
836124|NCT01807520|2748662|P3|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3
836125|NCT01807520|2748663|P2|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1
836126|NCT01807520|2748664|P1|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
836127|NCT01807234|2748697|P6|Overall Study|Lack of Efficacy|1
836128|NCT01807234|2748698|P5|Overall Study|Lack of Efficacy|1
836129|NCT01807234|2748699|P4|Overall Study|Lack of Efficacy|0
836130|NCT01807234|2748700|P3|Overall Study|Lack of Efficacy|0
836131|NCT01807234|2748701|P2|Overall Study|Lack of Efficacy|0
836132|NCT01807234|2748702|P1|Overall Study|Lack of Efficacy|0
836133|NCT01807234|2748697|P6|Overall Study|Withdrawal by Subject|1
836134|NCT01807234|2748698|P5|Overall Study|Withdrawal by Subject|2
836135|NCT01807234|2748699|P4|Overall Study|Withdrawal by Subject|1
836136|NCT01807234|2748700|P3|Overall Study|Withdrawal by Subject|1
836137|NCT01807234|2748701|P2|Overall Study|Withdrawal by Subject|1
836138|NCT01807234|2748702|P1|Overall Study|Withdrawal by Subject|3
836139|NCT01807234|2748697|P6|Overall Study|Lost to Follow-up|2
836140|NCT01807234|2748698|P5|Overall Study|Lost to Follow-up|1
836141|NCT01807234|2748699|P4|Overall Study|Lost to Follow-up|1
836142|NCT01807234|2748700|P3|Overall Study|Lost to Follow-up|1
836143|NCT01807234|2748701|P2|Overall Study|Lost to Follow-up|5
836144|NCT01807234|2748702|P1|Overall Study|Lost to Follow-up|2
836145|NCT01807156|2748737|P1|Overall Study|Physician Decision|1
836146|NCT01806961|2748761|P1|Overall Study|sponsor decision|16
836147|NCT01806896|2748767|P2|Overall Study|Other|0
836148|NCT01806896|2748768|P1|Overall Study|Other|1
836149|NCT01806896|2748767|P2|Overall Study|Adverse Event|0
836150|NCT01806896|2748768|P1|Overall Study|Adverse Event|2
836151|NCT01806779|2748835|P3|Overall Study|Withdrawal by Subject|22
836152|NCT01806779|2748836|P2|Overall Study|Withdrawal by Subject|23
836153|NCT01806779|2748837|P1|Overall Study|Withdrawal by Subject|20
836154|NCT01806779|2748835|P3|Overall Study|Lost to Follow-up|0
836155|NCT01806779|2748836|P2|Overall Study|Lost to Follow-up|20
836156|NCT01806779|2748837|P1|Overall Study|Lost to Follow-up|19
836157|NCT01806779|2748835|P3|Overall Study|Lack of Efficacy|0
836158|NCT01806779|2748836|P2|Overall Study|Lack of Efficacy|1
836159|NCT01806779|2748837|P1|Overall Study|Lack of Efficacy|1
836160|NCT01806779|2748835|P3|Overall Study|Physician Decision|1
836161|NCT01806779|2748836|P2|Overall Study|Physician Decision|0
836162|NCT01806779|2748837|P1|Overall Study|Physician Decision|2
836163|NCT01806714|2748852|P2|Overall Study|No functioning phone number|170
836164|NCT01806714|2748853|P1|Overall Study|No functioning phone number|200
836165|NCT01806662|2748863|P2|Second Intervention (Weeks 16-32)|Lost to Follow-up|1
836166|NCT01806662|2748864|P1|Second Intervention (Weeks 16-32)|Lost to Follow-up|0
836167|NCT01806662|2748863|P2|Second Intervention (Weeks 16-32)|Lack of Efficacy|3
836168|NCT01806662|2748864|P1|Second Intervention (Weeks 16-32)|Lack of Efficacy|2
836169|NCT01806662|2748863|P2|First Intervention (Weeks 0-16)|Adverse Event|1
836170|NCT01806662|2748864|P1|First Intervention (Weeks 0-16)|Adverse Event|0
836171|NCT01806662|2748863|P2|First Intervention (Weeks 0-16)|Withdrawal by Subject|0
836172|NCT01806662|2748864|P1|First Intervention (Weeks 0-16)|Withdrawal by Subject|4
836173|NCT01806623|2748870|P1|Overall Study|Did not meet the inclusion criteria|56
836174|NCT01806623|2748870|P1|Overall Study|Adverse Event|1
836175|NCT01806623|2748870|P1|Overall Study|Withdrawal by Subject|1
836176|NCT01806597|2748890|P6|Follow-up Period (Week 132 to Week 140)|Physician Decision|1
836177|NCT01806597|2748891|P5|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
836178|NCT01806597|2748892|P4|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
836179|NCT01806597|2748893|P3|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
836180|NCT01806597|2748894|P2|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
836181|NCT01806597|2748895|P1|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
836182|NCT01806597|2748890|P6|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2
836183|NCT01806597|2748891|P5|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
836184|NCT01806597|2748892|P4|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
836185|NCT01806597|2748893|P3|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
836186|NCT01806597|2748894|P2|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
836187|NCT01806597|2748895|P1|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
836188|NCT01806597|2748890|P6|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2
836189|NCT01806597|2748891|P5|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
836190|NCT01806597|2748892|P4|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
836191|NCT01806597|2748893|P3|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
836192|NCT01806597|2748894|P2|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
836193|NCT01806597|2748895|P1|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
836194|NCT01806597|2748890|P6|Follow-up Period (Week 132 to Week 140)|Adverse Event|2
836195|NCT01806597|2748891|P5|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
836196|NCT01806597|2748892|P4|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
836197|NCT01806597|2748893|P3|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
836198|NCT01806597|2748894|P2|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
836199|NCT01806597|2748895|P1|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
836200|NCT01806597|2748890|P6|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5
836201|NCT01806597|2748891|P5|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
836202|NCT01806597|2748892|P4|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
836203|NCT01806597|2748893|P3|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
836204|NCT01806597|2748894|P2|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
836205|NCT01806597|2748895|P1|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
836206|NCT01806597|2748890|P6|Treatment Period 2 (Week 16 to Week 132)|Death|0
836207|NCT01806597|2748891|P5|Treatment Period 2 (Week 16 to Week 132)|Death|0
836208|NCT01806597|2748892|P4|Treatment Period 2 (Week 16 to Week 132)|Death|0
836209|NCT01806597|2748893|P3|Treatment Period 2 (Week 16 to Week 132)|Death|0
836210|NCT01806597|2748894|P2|Treatment Period 2 (Week 16 to Week 132)|Death|0
836211|NCT01806597|2748895|P1|Treatment Period 2 (Week 16 to Week 132)|Death|1
836212|NCT01806597|2748890|P6|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
836213|NCT01806597|2748891|P5|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
836214|NCT01806597|2748892|P4|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
836215|NCT01806597|2748893|P3|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
836216|NCT01806597|2748894|P2|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
836217|NCT01806597|2748895|P1|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
836218|NCT01806597|2748890|P6|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
836219|NCT01806597|2748891|P5|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
836220|NCT01806597|2748892|P4|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
836221|NCT01806597|2748893|P3|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6
836222|NCT01806597|2748894|P2|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
836223|NCT01806597|2748895|P1|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10
836224|NCT01806597|2748890|P6|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
836225|NCT01806597|2748891|P5|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
836226|NCT01806597|2748892|P4|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
836227|NCT01806597|2748893|P3|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
836228|NCT01806597|2748894|P2|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
836229|NCT01806597|2748895|P1|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
836230|NCT01806597|2748890|P6|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
836231|NCT01806597|2748891|P5|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
836232|NCT01806597|2748892|P4|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
836233|NCT01806597|2748893|P3|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
836234|NCT01806597|2748894|P2|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
836235|NCT01806597|2748895|P1|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2
836236|NCT01806597|2748890|P6|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
836237|NCT01806597|2748891|P5|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
836238|NCT01806597|2748892|P4|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
836239|NCT01806597|2748893|P3|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
836240|NCT01806597|2748894|P2|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
836241|NCT01806597|2748895|P1|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
836242|NCT01806597|2748890|P6|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
836243|NCT01806597|2748891|P5|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
836244|NCT01806597|2748892|P4|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
836245|NCT01806597|2748893|P3|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
836246|NCT01806597|2748894|P2|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
836247|NCT01806597|2748895|P1|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2
836248|NCT01806597|2748890|P6|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
836249|NCT01806597|2748891|P5|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
836250|NCT01806597|2748892|P4|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1
836251|NCT01806597|2748893|P3|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3
836252|NCT01806597|2748894|P2|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5
836253|NCT01806597|2748895|P1|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12
836254|NCT01806597|2748890|P6|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0
836255|NCT01806597|2748891|P5|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1
836256|NCT01806597|2748892|P4|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3
836257|NCT01806597|2748893|P3|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4
836258|NCT01806597|2748894|P2|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6
836259|NCT01806597|2748895|P1|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9
836260|NCT01806597|2748890|P6|Period 1 (Baseline to Week 16)|Physician Decision|0
836261|NCT01806597|2748891|P5|Period 1 (Baseline to Week 16)|Physician Decision|0
836262|NCT01806597|2748892|P4|Period 1 (Baseline to Week 16)|Physician Decision|0
836263|NCT01806597|2748893|P3|Period 1 (Baseline to Week 16)|Physician Decision|0
836264|NCT01806597|2748894|P2|Period 1 (Baseline to Week 16)|Physician Decision|1
836265|NCT01806597|2748895|P1|Period 1 (Baseline to Week 16)|Physician Decision|0
836266|NCT01806597|2748890|P6|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
836267|NCT01806597|2748891|P5|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
836268|NCT01806597|2748892|P4|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
836269|NCT01806597|2748893|P3|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
836270|NCT01806597|2748894|P2|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
836271|NCT01806597|2748895|P1|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3
836272|NCT01806597|2748890|P6|Period 1 (Baseline to Week 16)|Protocol Violation|0
836273|NCT01806597|2748891|P5|Period 1 (Baseline to Week 16)|Protocol Violation|0
836274|NCT01806597|2748892|P4|Period 1 (Baseline to Week 16)|Protocol Violation|0
836275|NCT01806597|2748893|P3|Period 1 (Baseline to Week 16)|Protocol Violation|0
836276|NCT01806597|2748894|P2|Period 1 (Baseline to Week 16)|Protocol Violation|1
836277|NCT01806597|2748895|P1|Period 1 (Baseline to Week 16)|Protocol Violation|0
836278|NCT01806597|2748890|P6|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
836279|NCT01806597|2748891|P5|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
836280|NCT01806597|2748892|P4|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
836281|NCT01806597|2748893|P3|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
836282|NCT01806597|2748894|P2|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
836283|NCT01806597|2748895|P1|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
836284|NCT01806597|2748890|P6|Period 1 (Baseline to Week 16)|Adverse Event|0
836285|NCT01806597|2748891|P5|Period 1 (Baseline to Week 16)|Adverse Event|2
836286|NCT01806597|2748892|P4|Period 1 (Baseline to Week 16)|Adverse Event|0
836287|NCT01806597|2748893|P3|Period 1 (Baseline to Week 16)|Adverse Event|0
836288|NCT01806597|2748894|P2|Period 1 (Baseline to Week 16)|Adverse Event|1
836289|NCT01806597|2748895|P1|Period 1 (Baseline to Week 16)|Adverse Event|1
836290|NCT01806584|2748931|P2|Overall Study|Other unspecified|0
836291|NCT01806584|2748932|P1|Overall Study|Other unspecified|1
836292|NCT01806584|2748931|P2|Overall Study|Withdrawal by Subject|1
836293|NCT01806584|2748932|P1|Overall Study|Withdrawal by Subject|1
836294|NCT01806584|2748931|P2|Overall Study|Study terminated by sponsor|14
836295|NCT01806584|2748932|P1|Overall Study|Study terminated by sponsor|9
836296|NCT01806584|2748931|P2|Overall Study|Lost to Follow-up|2
836297|NCT01806584|2748932|P1|Overall Study|Lost to Follow-up|0
836298|NCT01806584|2748931|P2|Overall Study|Death|0
836299|NCT01806584|2748932|P1|Overall Study|Death|1
836300|NCT01806584|2748931|P2|Overall Study|Adverse Event|1
836301|NCT01806584|2748932|P1|Overall Study|Adverse Event|2
836302|NCT01806545|2748946|P2|Overall Study|Withdrawal by Subject|2
836303|NCT01806545|2748947|P1|Overall Study|Withdrawal by Subject|3
836304|NCT01806545|2748946|P2|Overall Study|Lost to Follow-up|0
836305|NCT01806545|2748947|P1|Overall Study|Lost to Follow-up|1
836306|NCT01806545|2748946|P2|Overall Study|Adverse Event|3
836307|NCT01806545|2748947|P1|Overall Study|Adverse Event|2
836308|NCT01806389|2748969|P1|Overall Study|Withdrawal by Subject|4
836309|NCT01806298|2748983|P1|Overall Study|Other|5
836310|NCT01806298|2748983|P1|Overall Study|Withdrawal by Subject|1
836311|NCT01806298|2748983|P1|Overall Study|Protocol Non-compliance|1
836312|NCT01806298|2748983|P1|Overall Study|Adverse Event|3
836313|NCT01806051|2748993|P1|Overall Study|Withdrawal by Subject|6
836314|NCT01805180|2749091|P3|Lead-in Donor Phase|screen failure|0
836315|NCT01805180|2749092|P2|Lead-in Donor Phase|screen failure|0
836316|NCT01805180|2749093|P1|Lead-in Donor Phase|screen failure|1
836317|NCT01804946|2749131|P2|Overall Study|Do not meet inclusion criteria|2
836318|NCT01804946|2749132|P1|Overall Study|Do not meet inclusion criteria|1
836319|NCT01804946|2749131|P2|Overall Study|Insufficient data available|1
836320|NCT01804946|2749132|P1|Overall Study|Insufficient data available|0
836321|NCT01804946|2749131|P2|Overall Study|Adverse Event|1
836322|NCT01804946|2749132|P1|Overall Study|Adverse Event|0
836323|NCT01804946|2749131|P2|Overall Study|Protocol Violation|0
836324|NCT01804946|2749132|P1|Overall Study|Protocol Violation|1
836325|NCT01804842|2749170|P3|Overall Study|Personal Reason|1
836326|NCT01804842|2749171|P2|Overall Study|Personal Reason|0
836327|NCT01804842|2749172|P1|Overall Study|Personal Reason|0
836328|NCT01804842|2749170|P3|Overall Study|Non-Compliance|0
836329|NCT01804842|2749171|P2|Overall Study|Non-Compliance|1
836330|NCT01804842|2749172|P1|Overall Study|Non-Compliance|1
836331|NCT01804842|2749170|P3|Overall Study|Lost to Follow-up|0
836332|NCT01804842|2749171|P2|Overall Study|Lost to Follow-up|0
836333|NCT01804842|2749172|P1|Overall Study|Lost to Follow-up|1
836334|NCT01804842|2749170|P3|Overall Study|Adverse Event|0
836335|NCT01804842|2749171|P2|Overall Study|Adverse Event|1
836336|NCT01804842|2749172|P1|Overall Study|Adverse Event|1
836337|NCT01804673|2749189|P1|Overall Study|Other|4
836338|NCT01804673|2749189|P1|Overall Study|Use of Prohibited Medication|1
836339|NCT01804673|2749189|P1|Overall Study|No Further Therapy Required|84
836340|NCT01804673|2749189|P1|Overall Study|Change to Oral Therapy|37
836341|NCT01804673|2749189|P1|Overall Study|Lack of Efficacy|9
836342|NCT01804673|2749189|P1|Overall Study|Withdrawal by Subject|1
836343|NCT01804673|2749189|P1|Overall Study|Adverse Event|4
836344|NCT01804140|2749209|P1|Overall Study|No sampling or biopsy procedures done|114
836345|NCT01803737|2749278|P2|Overall Study|Lost to Follow-up|2
836346|NCT01803737|2749279|P1|Overall Study|Lost to Follow-up|0
836347|NCT01803737|2749278|P2|Overall Study|Medical Reason|1
836348|NCT01803737|2749279|P1|Overall Study|Medical Reason|0
836349|NCT01803737|2749278|P2|Overall Study|Lack of Time|0
836350|NCT01803737|2749279|P1|Overall Study|Lack of Time|1
836351|NCT01803711|2749303|P2|Overall Study|Adverse Event|1
836352|NCT01803711|2749304|P1|Overall Study|Adverse Event|1
836353|NCT01803646|2749322|P2|Overall Study|Lost to Follow-up|1
836354|NCT01803646|2749323|P1|Overall Study|Lost to Follow-up|5
836355|NCT01803646|2749322|P2|Overall Study|Randomization error|2
836356|NCT01803646|2749323|P1|Overall Study|Randomization error|1
836357|NCT01803646|2749322|P2|Overall Study|Withdrawal by Subject|6
836358|NCT01803646|2749323|P1|Overall Study|Withdrawal by Subject|9
836359|NCT01803646|2749322|P2|Overall Study|Adverse Event|1
836360|NCT01803646|2749323|P1|Overall Study|Adverse Event|1
836361|NCT01803646|2749322|P2|Overall Study|Protocol Violation|0
836362|NCT01803646|2749323|P1|Overall Study|Protocol Violation|1
836363|NCT01803607|2749335|P2|Overall Study|Withdrawal by Subject|5
836364|NCT01803607|2749336|P1|Overall Study|Withdrawal by Subject|6
836365|NCT01803607|2749335|P2|Overall Study|Study terminated by sponsor|56
836366|NCT01803607|2749336|P1|Overall Study|Study terminated by sponsor|54
836367|NCT01803607|2749335|P2|Overall Study|Protocol Violation|2
836368|NCT01803607|2749336|P1|Overall Study|Protocol Violation|3
836369|NCT01803607|2749335|P2|Overall Study|Lack of Efficacy|1
836370|NCT01803607|2749336|P1|Overall Study|Lack of Efficacy|0
836371|NCT01803607|2749335|P2|Overall Study|Adverse Event|3
836372|NCT01803607|2749336|P1|Overall Study|Adverse Event|5
836373|NCT01803464|2749360|P4|Overall Study|Withdrawal by Subject|0
836374|NCT01803464|2749361|P3|Overall Study|Withdrawal by Subject|0
836375|NCT01803464|2749362|P2|Overall Study|Withdrawal by Subject|0
836376|NCT01803464|2749363|P1|Overall Study|Withdrawal by Subject|1
836377|NCT01803464|2749360|P4|Overall Study|Incomplete data|0
836378|NCT01803464|2749361|P3|Overall Study|Incomplete data|4
836379|NCT01803464|2749362|P2|Overall Study|Incomplete data|0
836380|NCT01803464|2749363|P1|Overall Study|Incomplete data|0
836381|NCT01802775|2749383|P2|Overall Study|Lost to Follow-up|2
836382|NCT01802775|2749384|P1|Overall Study|Lost to Follow-up|1
836383|NCT01802775|2749383|P2|Overall Study|Withdrawal by Subject|5
836384|NCT01802775|2749384|P1|Overall Study|Withdrawal by Subject|3
836385|NCT01802775|2749383|P2|Overall Study|Adverse Event|1
836386|NCT01802775|2749384|P1|Overall Study|Adverse Event|1
836387|NCT01802775|2749383|P2|Overall Study|Physician Decision|0
836388|NCT01802775|2749384|P1|Overall Study|Physician Decision|1
836389|NCT01802775|2749383|P2|Overall Study|Reason not provided|1
836390|NCT01802775|2749384|P1|Overall Study|Reason not provided|0
836391|NCT01802775|2749383|P2|Overall Study|Death|3
836392|NCT01802775|2749384|P1|Overall Study|Death|0
836393|NCT01802632|2749406|P6|Overall Study|Other (not specified)|1
836394|NCT01802632|2749407|P5|Overall Study|Other (not specified)|0
836395|NCT01802632|2749408|P4|Overall Study|Other (not specified)|1
836396|NCT01802632|2749409|P3|Overall Study|Other (not specified)|7
836397|NCT01802632|2749410|P2|Overall Study|Other (not specified)|0
836398|NCT01802632|2749411|P1|Overall Study|Other (not specified)|0
836399|NCT01802632|2749406|P6|Overall Study|Ongoing Study at Data Cut-off|22
836400|NCT01802632|2749407|P5|Overall Study|Ongoing Study at Data Cut-off|6
836401|NCT01802632|2749408|P4|Overall Study|Ongoing Study at Data Cut-off|50
836402|NCT01802632|2749409|P3|Overall Study|Ongoing Study at Data Cut-off|115
836403|NCT01802632|2749410|P2|Overall Study|Ongoing Study at Data Cut-off|16
836404|NCT01802632|2749411|P1|Overall Study|Ongoing Study at Data Cut-off|168
836405|NCT01802632|2749406|P6|Overall Study|Objective Disease Progression|4
836406|NCT01802632|2749407|P5|Overall Study|Objective Disease Progression|4
836407|NCT01802632|2749408|P4|Overall Study|Objective Disease Progression|6
836408|NCT01802632|2749409|P3|Overall Study|Objective Disease Progression|104
836409|NCT01802632|2749410|P2|Overall Study|Objective Disease Progression|12
836410|NCT01802632|2749411|P1|Overall Study|Objective Disease Progression|1
836411|NCT01802632|2749406|P6|Overall Study|Withdrawal by Subject|1
836412|NCT01802632|2749407|P5|Overall Study|Withdrawal by Subject|0
836413|NCT01802632|2749408|P4|Overall Study|Withdrawal by Subject|3
836414|NCT01802632|2749409|P3|Overall Study|Withdrawal by Subject|7
836415|NCT01802632|2749410|P2|Overall Study|Withdrawal by Subject|2
836416|NCT01802632|2749411|P1|Overall Study|Withdrawal by Subject|4
836417|NCT01802632|2749406|P6|Overall Study|Death|0
836418|NCT01802632|2749407|P5|Overall Study|Death|2
836419|NCT01802632|2749408|P4|Overall Study|Death|0
836420|NCT01802632|2749409|P3|Overall Study|Death|38
836421|NCT01802632|2749410|P2|Overall Study|Death|1
836422|NCT01802632|2749411|P1|Overall Study|Death|28
836423|NCT01802515|2749445|P3|Overall Study|Withdrawal by Subject|0
836424|NCT01802515|2749446|P2|Overall Study|Withdrawal by Subject|0
836425|NCT01802515|2749447|P1|Overall Study|Withdrawal by Subject|3
836426|NCT01802320|2749458|P1|Overall Study|Withdrawal by Subject|1
836427|NCT01802320|2749458|P1|Overall Study|Death|1
836428|NCT01802073|2749534|P2|Overall Study|Physician Decision|7
836429|NCT01802073|2749535|P1|Overall Study|Physician Decision|0
836430|NCT01802073|2749534|P2|Overall Study|Withdrawal by Subject|1
836431|NCT01802073|2749535|P1|Overall Study|Withdrawal by Subject|1
836432|NCT01802073|2749534|P2|Overall Study|Non-compliant|2
836433|NCT01802073|2749535|P1|Overall Study|Non-compliant|4
836434|NCT01802073|2749534|P2|Overall Study|Lost to Follow-up|1
836435|NCT01802073|2749535|P1|Overall Study|Lost to Follow-up|0
836436|NCT01801982|2749551|P1|Overall Study|Lost to Follow-up|1
836437|NCT01801917|2749565|P4|Period 1 - Randomized|Adverse Event|0
836438|NCT01801917|2749566|P3|Period 1 - Randomized|Adverse Event|1
836439|NCT01801917|2749567|P2|Period 1 - Randomized|Adverse Event|0
836440|NCT01801917|2749568|P1|Period 1 - Randomized|Adverse Event|1
836441|NCT01801735|2749588|P1|Overall Study|Other, including site closure|19
836442|NCT01801735|2749588|P1|Overall Study|Death|1
836443|NCT01801735|2749588|P1|Overall Study|Physician Decision|3
836444|NCT01801735|2749588|P1|Overall Study|Non-compliance with Trial Drug|13
836445|NCT01801735|2749588|P1|Overall Study|Lost to Follow-up|15
836446|NCT01801735|2749588|P1|Overall Study|Protocol Violation|25
836447|NCT01801735|2749588|P1|Overall Study|Withdrawal by Subject|27
836448|NCT01801735|2749588|P1|Overall Study|Lack of Efficacy|28
836449|NCT01801735|2749588|P1|Overall Study|Adverse Event|79
836450|NCT01801475|2749595|P5|Overall Study|Withdrawal by Subject|1
836451|NCT01801475|2749596|P4|Overall Study|Withdrawal by Subject|0
836452|NCT01801475|2749597|P3|Overall Study|Withdrawal by Subject|0
836453|NCT01801475|2749598|P2|Overall Study|Withdrawal by Subject|0
836454|NCT01801475|2749599|P1|Overall Study|Withdrawal by Subject|0
836455|NCT01801436|2749624|P1|Overall Study|Progressive disease|4
836456|NCT01801436|2749624|P1|Overall Study|Adverse Event|2
836457|NCT01801436|2749624|P1|Overall Study|Withdrawal by Subject|3
836458|NCT01801358|2749662|P6|Overall Study|Withdrawal by Subject|2
836459|NCT01801358|2749663|P5|Overall Study|Withdrawal by Subject|0
836460|NCT01801358|2749664|P4|Overall Study|Withdrawal by Subject|1
836461|NCT01801358|2749665|P3|Overall Study|Withdrawal by Subject|0
836462|NCT01801358|2749666|P2|Overall Study|Withdrawal by Subject|0
836463|NCT01801358|2749667|P1|Overall Study|Withdrawal by Subject|0
836464|NCT01801358|2749662|P6|Overall Study|Progressive Disease|5
836465|NCT01801358|2749663|P5|Overall Study|Progressive Disease|6
836466|NCT01801358|2749664|P4|Overall Study|Progressive Disease|5
836467|NCT01801358|2749665|P3|Overall Study|Progressive Disease|4
836468|NCT01801358|2749666|P2|Overall Study|Progressive Disease|4
836469|NCT01801358|2749667|P1|Overall Study|Progressive Disease|6
836470|NCT01801358|2749662|P6|Overall Study|Physician Decision|0
836471|NCT01801358|2749663|P5|Overall Study|Physician Decision|0
836472|NCT01801358|2749664|P4|Overall Study|Physician Decision|0
836473|NCT01801358|2749665|P3|Overall Study|Physician Decision|1
836474|NCT01801358|2749666|P2|Overall Study|Physician Decision|0
836475|NCT01801358|2749667|P1|Overall Study|Physician Decision|0
836476|NCT01801358|2749662|P6|Overall Study|Adverse Event|1
836477|NCT01801358|2749663|P5|Overall Study|Adverse Event|0
836478|NCT01801358|2749664|P4|Overall Study|Adverse Event|0
836479|NCT01801358|2749665|P3|Overall Study|Adverse Event|1
836480|NCT01801358|2749666|P2|Overall Study|Adverse Event|2
836481|NCT01801358|2749667|P1|Overall Study|Adverse Event|0
836482|NCT01801280|2749789|P4|Period 4|Protocol Violation|0
836483|NCT01801280|2749790|P3|Period 4|Protocol Violation|1
836484|NCT01801280|2749791|P2|Period 4|Protocol Violation|0
836485|NCT01801280|2749792|P1|Period 4|Protocol Violation|0
836486|NCT01801280|2749789|P4|Period 2|Withdrawal by Subject|0
836487|NCT01801280|2749790|P3|Period 2|Withdrawal by Subject|0
836488|NCT01801280|2749791|P2|Period 2|Withdrawal by Subject|0
836489|NCT01801280|2749792|P1|Period 2|Withdrawal by Subject|1
836490|NCT01801280|2749789|P4|Period 1|Withdrawal by Subject|0
836491|NCT01801280|2749790|P3|Period 1|Withdrawal by Subject|0
836492|NCT01801280|2749791|P2|Period 1|Withdrawal by Subject|1
836493|NCT01801280|2749792|P1|Period 1|Withdrawal by Subject|0
836494|NCT01801111|2749807|P1|Overall Study|Progressive Disease|81
836495|NCT01801111|2749807|P1|Overall Study|Study Terminated by Sponsor|27
836496|NCT01801111|2749807|P1|Overall Study|Withdrawal by Subject|4
836497|NCT01801111|2749807|P1|Overall Study|Other|1
836498|NCT01801111|2749807|P1|Overall Study|Physician Decision|5
836499|NCT01801111|2749807|P1|Overall Study|Death|8
836500|NCT01801111|2749807|P1|Overall Study|Adverse Event|12
836501|NCT01800968|2749848|P2|Overall Study|Physician Decision|0
836502|NCT01800968|2749849|P1|Overall Study|Physician Decision|1
836503|NCT01800968|2749848|P2|Overall Study|Withdrawal by Subject|9
836504|NCT01800968|2749849|P1|Overall Study|Withdrawal by Subject|7
836505|NCT01800968|2749848|P2|Overall Study|Lost to Follow-up|7
836506|NCT01800968|2749849|P1|Overall Study|Lost to Follow-up|5
836507|NCT01800968|2749848|P2|Overall Study|Death|16
836508|NCT01800968|2749849|P1|Overall Study|Death|23
836509|NCT01800916|2749891|P9|Test Period 1 (1 Week)|Adverse Event|0
836510|NCT01800916|2749892|P8|Test Period 1 (1 Week)|Adverse Event|0
836511|NCT01800916|2749893|P7|Test Period 1 (1 Week)|Adverse Event|0
836512|NCT01800916|2749894|P6|Test Period 1 (1 Week)|Adverse Event|0
836513|NCT01800916|2749895|P5|Test Period 1 (1 Week)|Adverse Event|1
836514|NCT01800916|2749896|P4|Test Period 1 (1 Week)|Adverse Event|0
836515|NCT01800916|2749897|P3|Test Period 1 (1 Week)|Adverse Event|0
836516|NCT01800916|2749898|P2|Test Period 1 (1 Week)|Adverse Event|0
836517|NCT01800916|2749899|P1|Test Period 1 (1 Week)|Adverse Event|0
836518|NCT01800916|2749891|P9|Test Period 1 (1 Week)|Convex product user|0
836519|NCT01800916|2749892|P8|Test Period 1 (1 Week)|Convex product user|0
836520|NCT01800916|2749893|P7|Test Period 1 (1 Week)|Convex product user|0
836521|NCT01800916|2749894|P6|Test Period 1 (1 Week)|Convex product user|0
836522|NCT01800916|2749895|P5|Test Period 1 (1 Week)|Convex product user|0
836523|NCT01800916|2749896|P4|Test Period 1 (1 Week)|Convex product user|1
836524|NCT01800916|2749897|P3|Test Period 1 (1 Week)|Convex product user|0
836525|NCT01800916|2749898|P2|Test Period 1 (1 Week)|Convex product user|0
836526|NCT01800916|2749899|P1|Test Period 1 (1 Week)|Convex product user|0
836527|NCT01800903|2749909|P6|Second Test Period|unable to catheterise|0
836528|NCT01800903|2749910|P5|Second Test Period|unable to catheterise|0
836529|NCT01800903|2749911|P4|Second Test Period|unable to catheterise|0
836530|NCT01800903|2749912|P3|Second Test Period|unable to catheterise|0
836531|NCT01800903|2749913|P2|Second Test Period|unable to catheterise|0
836532|NCT01800903|2749914|P1|Second Test Period|unable to catheterise|1
836533|NCT01799993|2750011|P2|Overall Study|Subject didn't return for follow-up|1
836534|NCT01799993|2750012|P1|Overall Study|Subject didn't return for follow-up|0
836535|NCT01799993|2750011|P2|Overall Study|Other|0
836536|NCT01799993|2750012|P1|Overall Study|Other|1
836537|NCT01799993|2750011|P2|Overall Study|Withdrawal by parent/guardian|1
836538|NCT01799993|2750012|P1|Overall Study|Withdrawal by parent/guardian|0
836539|NCT01799993|2750011|P2|Overall Study|Non-compliance with medical device|0
836540|NCT01799993|2750012|P1|Overall Study|Non-compliance with medical device|1
836541|NCT01799993|2750011|P2|Overall Study|Protocol deviation|0
836542|NCT01799993|2750012|P1|Overall Study|Protocol deviation|1
836543|NCT01799993|2750011|P2|Overall Study|Logistical difficulties|0
836544|NCT01799993|2750012|P1|Overall Study|Logistical difficulties|1
836545|NCT01799993|2750011|P2|Overall Study|Recovery|1
836546|NCT01799993|2750012|P1|Overall Study|Recovery|0
836547|NCT01799993|2750011|P2|Overall Study|Lack of Efficacy|0
836548|NCT01799993|2750012|P1|Overall Study|Lack of Efficacy|1
836549|NCT01799993|2750011|P2|Overall Study|Adverse Event|0
836550|NCT01799993|2750012|P1|Overall Study|Adverse Event|1
836551|NCT01799993|2750011|P2|Overall Study|Screen failure|1
836552|NCT01799993|2750012|P1|Overall Study|Screen failure|0
836553|NCT01799993|2750011|P2|Overall Study|Deterioration of general conditions|0
836554|NCT01799993|2750012|P1|Overall Study|Deterioration of general conditions|2
836555|NCT01799993|2750011|P2|Overall Study|Protocol Violation|1
836556|NCT01799993|2750012|P1|Overall Study|Protocol Violation|1
836557|NCT01799993|2750011|P2|Overall Study|Protocol driven decision point|3
836558|NCT01799993|2750012|P1|Overall Study|Protocol driven decision point|0
836559|NCT01799993|2750011|P2|Overall Study|Withdrawal by parent/guardian/LAR|3
836560|NCT01799993|2750012|P1|Overall Study|Withdrawal by parent/guardian/LAR|5
836561|NCT01799993|2750011|P2|Overall Study|Lost to Follow-up|8
836562|NCT01799993|2750012|P1|Overall Study|Lost to Follow-up|5
836563|NCT01799993|2750011|P2|Overall Study|Withdrawal by Subject|24
836564|NCT01799993|2750012|P1|Overall Study|Withdrawal by Subject|23
836565|NCT01799993|2750011|P2|Overall Study|Death|45
836566|NCT01799993|2750012|P1|Overall Study|Death|61
836567|NCT01799993|2750011|P2|Overall Study|"Didn't complete CRF page End of FU"|40
836568|NCT01799993|2750012|P1|Overall Study|"Didn't complete CRF page End of FU"|30
836569|NCT01799941|2750044|P1|Overall Study|Not Specified|15
836570|NCT01799941|2750044|P1|Overall Study|Lost to Follow-up|17
836571|NCT01799941|2750044|P1|Overall Study|Lack of Efficacy|3
836572|NCT01799941|2750044|P1|Overall Study|Investigator Decision|4
836573|NCT01799941|2750044|P1|Overall Study|Death|2
836574|NCT01799941|2750044|P1|Overall Study|Withdrawal by Subject|21
836575|NCT01799941|2750044|P1|Overall Study|Adverse Event|34
836576|NCT01799720|2750101|P3|Overall Study|Pregnancy|1
836577|NCT01799720|2750102|P2|Overall Study|Pregnancy|0
836578|NCT01799720|2750103|P1|Overall Study|Pregnancy|0
836579|NCT01799720|2750101|P3|Overall Study|Protocol Violation|0
836580|NCT01799720|2750102|P2|Overall Study|Protocol Violation|1
836581|NCT01799720|2750103|P1|Overall Study|Protocol Violation|0
836582|NCT01799720|2750101|P3|Overall Study|Withdrawal by Subject|0
836583|NCT01799720|2750102|P2|Overall Study|Withdrawal by Subject|0
836584|NCT01799720|2750103|P1|Overall Study|Withdrawal by Subject|3
836585|NCT01799590|2750141|P3|Overall Study|Other|1
836586|NCT01799590|2750142|P2|Overall Study|Other|0
836587|NCT01799590|2750143|P1|Overall Study|Other|3
836588|NCT01799590|2750141|P3|Overall Study|Use of prohibited concomitant drugs|0
836589|NCT01799590|2750142|P2|Overall Study|Use of prohibited concomitant drugs|0
836590|NCT01799590|2750143|P1|Overall Study|Use of prohibited concomitant drugs|1
836591|NCT01799590|2750141|P3|Overall Study|Using drugs with restricted days of use|2
836592|NCT01799590|2750142|P2|Overall Study|Using drugs with restricted days of use|3
836593|NCT01799590|2750143|P1|Overall Study|Using drugs with restricted days of use|0
836594|NCT01799590|2750141|P3|Overall Study|Aggravation of complications|1
836595|NCT01799590|2750142|P2|Overall Study|Aggravation of complications|1
836596|NCT01799590|2750143|P1|Overall Study|Aggravation of complications|0
836597|NCT01799590|2750141|P3|Overall Study|Participants convenience|2
836598|NCT01799590|2750142|P2|Overall Study|Participants convenience|4
836599|NCT01799590|2750143|P1|Overall Study|Participants convenience|4
836600|NCT01799590|2750141|P3|Overall Study|Lack of Efficacy|3
836601|NCT01799590|2750142|P2|Overall Study|Lack of Efficacy|1
836602|NCT01799590|2750143|P1|Overall Study|Lack of Efficacy|3
836603|NCT01799590|2750141|P3|Overall Study|Pregnancy|0
836604|NCT01799590|2750142|P2|Overall Study|Pregnancy|0
836605|NCT01799590|2750143|P1|Overall Study|Pregnancy|2
836606|NCT01799590|2750141|P3|Overall Study|Adverse Event|5
836607|NCT01799590|2750142|P2|Overall Study|Adverse Event|7
836608|NCT01799590|2750143|P1|Overall Study|Adverse Event|13
836609|NCT01799239|2750186|P2|Period 2 (7 Days)|Protocol Violation|0
836610|NCT01799239|2750187|P1|Period 2 (7 Days)|Protocol Violation|1
836611|NCT01799239|2750186|P2|Period 2 (7 Days)|Withdrawal by Subject|1
836612|NCT01799239|2750187|P1|Period 2 (7 Days)|Withdrawal by Subject|1
836613|NCT01799239|2750186|P2|Period 1 (7 Days)|Protocol Violation|1
836614|NCT01799239|2750187|P1|Period 1 (7 Days)|Protocol Violation|0
836615|NCT01799239|2750186|P2|Period 1 (7 Days)|Withdrawal by Subject|0
836616|NCT01799239|2750187|P1|Period 1 (7 Days)|Withdrawal by Subject|2
836617|NCT01799239|2750186|P2|Period 1 (7 Days)|Lack of Efficacy|0
836618|NCT01799239|2750187|P1|Period 1 (7 Days)|Lack of Efficacy|1
836619|NCT01799226|2750195|P2|Overall Study|Disqualified at Day 14|0
836620|NCT01799226|2750196|P1|Overall Study|Disqualified at Day 14|1
836621|NCT01799226|2750195|P2|Overall Study|Withdrawal by Subject|0
836622|NCT01799226|2750196|P1|Overall Study|Withdrawal by Subject|1
836623|NCT01798992|2750208|P4|Overall Study|Insufficient biopsy tissue|0
836624|NCT01798992|2750209|P3|Overall Study|Insufficient biopsy tissue|1
836625|NCT01798992|2750210|P2|Overall Study|Insufficient biopsy tissue|0
836626|NCT01798992|2750211|P1|Overall Study|Insufficient biopsy tissue|0
836627|NCT01798992|2750208|P4|Overall Study|Lost to Follow-up|0
836628|NCT01798992|2750209|P3|Overall Study|Lost to Follow-up|1
836629|NCT01798992|2750210|P2|Overall Study|Lost to Follow-up|1
836630|NCT01798992|2750211|P1|Overall Study|Lost to Follow-up|0
836631|NCT01798992|2750208|P4|Overall Study|Administrative withdrawal|1
836632|NCT01798992|2750209|P3|Overall Study|Administrative withdrawal|0
836633|NCT01798992|2750210|P2|Overall Study|Administrative withdrawal|1
836634|NCT01798992|2750211|P1|Overall Study|Administrative withdrawal|0
836635|NCT01798927|2750231|P1|Overall Study|Withdrawal by Subject|1
836636|NCT01798706|2750239|P2|Overall Study|Other than specified above|9
836637|NCT01798706|2750240|P1|Overall Study|Other than specified above|5
836638|NCT01798706|2750239|P2|Overall Study|Poor compliance to protocol|0
836639|NCT01798706|2750240|P1|Overall Study|Poor compliance to protocol|1
836640|NCT01798706|2750239|P2|Overall Study|Lack of Efficacy|2
836641|NCT01798706|2750240|P1|Overall Study|Lack of Efficacy|0
836642|NCT01798706|2750239|P2|Overall Study|Adverse Event|10
836643|NCT01798706|2750240|P1|Overall Study|Adverse Event|15
836644|NCT01798485|2750302|P2|Overall Study|Clinical Progression|24
836645|NCT01798485|2750303|P1|Overall Study|Clinical Progression|35
836646|NCT01798485|2750302|P2|Overall Study|Sponsor Decision|54
836647|NCT01798485|2750303|P1|Overall Study|Sponsor Decision|61
836648|NCT01798485|2750302|P2|Overall Study|Death|22
836649|NCT01798485|2750303|P1|Overall Study|Death|25
836650|NCT01798485|2750302|P2|Overall Study|Objective Disease Progression|106
836651|NCT01798485|2750303|P1|Overall Study|Objective Disease Progression|152
836652|NCT01798485|2750302|P2|Overall Study|Physician Decision|10
836653|NCT01798485|2750303|P1|Overall Study|Physician Decision|14
836654|NCT01798485|2750302|P2|Overall Study|Lost to Follow-up|3
836655|NCT01798485|2750303|P1|Overall Study|Lost to Follow-up|0
836656|NCT01798485|2750302|P2|Overall Study|Withdrawal by Subject|31
836657|NCT01798485|2750303|P1|Overall Study|Withdrawal by Subject|27
836658|NCT01798485|2750302|P2|Overall Study|Adverse Event|40
836659|NCT01798485|2750303|P1|Overall Study|Adverse Event|32
836660|NCT01798134|2750440|P1|Overall Study|Liver transplant/surgery|4
836661|NCT01798134|2750440|P1|Overall Study|Physician Decision|3
836662|NCT01798134|2750440|P1|Overall Study|Adverse Event|3
836663|NCT01798134|2750440|P1|Overall Study|Death|2
836664|NCT01798134|2750440|P1|Overall Study|Withdrawal by Subject|3
836665|NCT01798134|2750440|P1|Overall Study|Lost to Follow-up|1
836666|NCT01798056|2750449|P2|Overall Study|Other|2
836667|NCT01798056|2750450|P1|Overall Study|Other|0
836668|NCT01798056|2750449|P2|Overall Study|Lost to Follow-up|1
836669|NCT01798056|2750450|P1|Overall Study|Lost to Follow-up|1
836670|NCT01798056|2750449|P2|Overall Study|Migrated/moved from study area|1
836671|NCT01798056|2750450|P1|Overall Study|Migrated/moved from study area|1
836672|NCT01798056|2750449|P2|Overall Study|Withdrawal by Subject|9
836673|NCT01798056|2750450|P1|Overall Study|Withdrawal by Subject|12
836674|NCT01798056|2750449|P2|Overall Study|Serious Adverse Event|12
836675|NCT01798056|2750450|P1|Overall Study|Serious Adverse Event|13
836676|NCT01798004|2750484|P1|Overall Study|Enrollment another COG therapeutic trial|32
836677|NCT01798004|2750484|P1|Overall Study|Initiation of other non-protocol therapy|5
836678|NCT01798004|2750484|P1|Overall Study|Patient/parent refusal|7
836679|NCT01798004|2750484|P1|Overall Study|Ineligible|4
836680|NCT01798004|2750484|P1|Overall Study|Withdrawal by Subject|4
836681|NCT01798004|2750484|P1|Overall Study|Physician Decision|25
836682|NCT01798004|2750484|P1|Overall Study|Lack of Efficacy|8
836683|NCT01798004|2750484|P1|Overall Study|Death|2
836684|NCT01797783|2750490|P2|Overall Study|Withdrawal by Subject|0
836685|NCT01797783|2750491|P1|Overall Study|Withdrawal by Subject|1
836686|NCT01797783|2750490|P2|Overall Study|Adverse Event|1
836687|NCT01797783|2750491|P1|Overall Study|Adverse Event|1
836688|NCT01797731|2750515|P2|Overall Study|Didn't have proper radiographs required|3
836689|NCT01797731|2750516|P1|Overall Study|Didn't have proper radiographs required|3
836690|NCT01797705|2750524|P1|Overall Study|Withdrawal by Subject|1
836691|NCT01797705|2750524|P1|Overall Study|Equipment anomalies during sleep studies|4
836692|NCT01797536|2750589|P4|Overall Study|Adverse Event|0
836693|NCT01797536|2750590|P3|Overall Study|Adverse Event|0
836694|NCT01797536|2750591|P2|Overall Study|Adverse Event|1
836695|NCT01797536|2750592|P1|Overall Study|Adverse Event|0
836696|NCT01797445|2750664|P2|Overall Study|Still on Study|383
836697|NCT01797445|2750665|P1|Overall Study|Still on Study|381
836698|NCT01797445|2750664|P2|Overall Study|Lost to Follow-up|15
836699|NCT01797445|2750665|P1|Overall Study|Lost to Follow-up|22
836700|NCT01797445|2750664|P2|Overall Study|Withdrew Consent|19
836701|NCT01797445|2750665|P1|Overall Study|Withdrew Consent|12
836702|NCT01797445|2750664|P2|Overall Study|Protocol Violation|1
836703|NCT01797445|2750665|P1|Overall Study|Protocol Violation|0
836704|NCT01797445|2750664|P2|Overall Study|Noncompliance with Study Drug|1
836705|NCT01797445|2750665|P1|Overall Study|Noncompliance with Study Drug|3
836706|NCT01797445|2750664|P2|Overall Study|Investigator's Discretion|12
836707|NCT01797445|2750665|P1|Overall Study|Investigator's Discretion|8
836708|NCT01797445|2750664|P2|Overall Study|Lack of Efficacy|2
836709|NCT01797445|2750665|P1|Overall Study|Lack of Efficacy|1
836710|NCT01797445|2750664|P2|Overall Study|Death|2
836711|NCT01797445|2750665|P1|Overall Study|Death|1
836712|NCT01797445|2750664|P2|Overall Study|Adverse Event|0
836713|NCT01797445|2750665|P1|Overall Study|Adverse Event|3
836714|NCT01797445|2750664|P2|Overall Study|Randomized but Not Treated|2
836715|NCT01797445|2750665|P1|Overall Study|Randomized but Not Treated|4
836716|NCT01797120|2750723|P2|Overall Study|never start protocol therapy|0
836717|NCT01797120|2750724|P1|Overall Study|never start protocol therapy|2
836718|NCT01797120|2750723|P2|Overall Study|still on treatment|4
836719|NCT01797120|2750724|P1|Overall Study|still on treatment|2
836720|NCT01797120|2750723|P2|Overall Study|Physician Decision|0
836721|NCT01797120|2750724|P1|Overall Study|Physician Decision|3
836722|NCT01797120|2750723|P2|Overall Study|Non-compliance|0
836723|NCT01797120|2750724|P1|Overall Study|Non-compliance|1
836724|NCT01797120|2750723|P2|Overall Study|Symptomatic progression|1
836725|NCT01797120|2750724|P1|Overall Study|Symptomatic progression|2
836726|NCT01797120|2750723|P2|Overall Study|Withdrawal by Subject|6
836727|NCT01797120|2750724|P1|Overall Study|Withdrawal by Subject|6
836728|NCT01797120|2750723|P2|Overall Study|Adverse Event|5
836729|NCT01797120|2750724|P1|Overall Study|Adverse Event|13
836730|NCT01797120|2750723|P2|Overall Study|Disesae progression|49
836731|NCT01797120|2750724|P1|Overall Study|Disesae progression|37
836732|NCT01797094|2750738|P2|Overall Study|Other Miscellaneous Reasons|0
836733|NCT01797094|2750739|P1|Overall Study|Other Miscellaneous Reasons|1
836734|NCT01797094|2750738|P2|Overall Study|Protocol Violation|1
836735|NCT01797094|2750739|P1|Overall Study|Protocol Violation|0
836736|NCT01797094|2750738|P2|Overall Study|Personal Reasons|0
836737|NCT01797094|2750739|P1|Overall Study|Personal Reasons|4
836738|NCT01797094|2750738|P2|Overall Study|Adverse Event|1
836739|NCT01797094|2750739|P1|Overall Study|Adverse Event|1
836740|NCT01797081|2750761|P4|Overall Study|Protocol Violation|1
836741|NCT01797081|2750762|P3|Overall Study|Protocol Violation|0
836742|NCT01797081|2750763|P2|Overall Study|Protocol Violation|0
836743|NCT01797081|2750764|P1|Overall Study|Protocol Violation|0
836744|NCT01797081|2750761|P4|Overall Study|Personal Reasons|8
836745|NCT01797081|2750762|P3|Overall Study|Personal Reasons|4
836746|NCT01797081|2750763|P2|Overall Study|Personal Reasons|4
836747|NCT01797081|2750764|P1|Overall Study|Personal Reasons|12
836748|NCT01797081|2750761|P4|Overall Study|Pregnancy|0
836749|NCT01797081|2750762|P3|Overall Study|Pregnancy|0
836750|NCT01797081|2750763|P2|Overall Study|Pregnancy|0
836751|NCT01797081|2750764|P1|Overall Study|Pregnancy|1
836752|NCT01797081|2750761|P4|Overall Study|Adverse Event|0
836753|NCT01797081|2750762|P3|Overall Study|Adverse Event|1
836754|NCT01797081|2750763|P2|Overall Study|Adverse Event|0
836755|NCT01797081|2750764|P1|Overall Study|Adverse Event|1
836756|NCT01796964|2750805|P2|Overall Study|Withdrawal by Subject|1
836757|NCT01796964|2750806|P1|Overall Study|Withdrawal by Subject|1
836758|NCT01796964|2750805|P2|Overall Study|Protocol Violation|1
836759|NCT01796964|2750806|P1|Overall Study|Protocol Violation|0
836760|NCT01796964|2750805|P2|Overall Study|Death|0
836761|NCT01796964|2750806|P1|Overall Study|Death|1
836762|NCT01796964|2750805|P2|Overall Study|Adverse Event|1
836763|NCT01796964|2750806|P1|Overall Study|Adverse Event|1
836764|NCT01796860|2750828|P1|Overall Study|Withdrawal by Subject|3
836765|NCT01796548|2750834|P1|Overall Study|Other|2
836766|NCT01796548|2750834|P1|Overall Study|Lost to Follow-up|1
836767|NCT01796301|2750848|P2|Overall Study|Decision by Sponsor|1
836768|NCT01796301|2750849|P1|Overall Study|Decision by Sponsor|0
836769|NCT01796301|2750848|P2|Overall Study|Death|1
836770|NCT01796301|2750849|P1|Overall Study|Death|0
836771|NCT01796301|2750848|P2|Overall Study|Lost to Follow-up|3
836772|NCT01796301|2750849|P1|Overall Study|Lost to Follow-up|3
836773|NCT01796301|2750848|P2|Overall Study|Withdrawal by Subject|15
836774|NCT01796301|2750849|P1|Overall Study|Withdrawal by Subject|15
836775|NCT01795937|2750905|P3|Overall Study|Physician Decision|0
836776|NCT01795937|2750906|P2|Overall Study|Physician Decision|1
836777|NCT01795937|2750907|P1|Overall Study|Physician Decision|0
836778|NCT01795937|2750905|P3|Overall Study|Withdrawal by Subject|0
836779|NCT01795937|2750906|P2|Overall Study|Withdrawal by Subject|0
836780|NCT01795937|2750907|P1|Overall Study|Withdrawal by Subject|1
836781|NCT01795898|2750936|P1|Overall Study|Physician Decision|1
836782|NCT01795898|2750936|P1|Overall Study|Withdrew consent & had adverse events|3
836783|NCT01795898|2750936|P1|Overall Study|Death|1
836784|NCT01795898|2750936|P1|Overall Study|No pain|1
836785|NCT01795898|2750936|P1|Overall Study|Diagnosed with metastasis|1
836786|NCT01795898|2750936|P1|Overall Study|Withdrawal of consent|6
836787|NCT01795898|2750936|P1|Overall Study|Lost to Follow-up|20
836788|NCT01795898|2750936|P1|Overall Study|Adverse Event|27
836789|NCT01795547|2750972|P2|Overall Study|Not stated|1
836790|NCT01795547|2750973|P1|Overall Study|Not stated|0
836791|NCT01795547|2750972|P2|Overall Study|Others|1
836792|NCT01795547|2750973|P1|Overall Study|Others|4
836793|NCT01795547|2750972|P2|Overall Study|Non-compliance with IMP|1
836794|NCT01795547|2750973|P1|Overall Study|Non-compliance with IMP|1
836795|NCT01795547|2750972|P2|Overall Study|Not Treated|10
836796|NCT01795547|2750973|P1|Overall Study|Not Treated|4
836797|NCT01795547|2750972|P2|Overall Study|Withdrawal of consent|12
836798|NCT01795547|2750973|P1|Overall Study|Withdrawal of consent|7
836799|NCT01795547|2750972|P2|Overall Study|Lost to Follow-up|5
836800|NCT01795547|2750973|P1|Overall Study|Lost to Follow-up|2
836801|NCT01795547|2750972|P2|Overall Study|Protocol Violation|4
836802|NCT01795547|2750973|P1|Overall Study|Protocol Violation|6
836803|NCT01795547|2750972|P2|Overall Study|Lack of Efficacy|3
836804|NCT01795547|2750973|P1|Overall Study|Lack of Efficacy|8
836805|NCT01795547|2750972|P2|Overall Study|Adverse Event|27
836806|NCT01795547|2750973|P1|Overall Study|Adverse Event|16
836807|NCT01795495|2751005|P3|Overall Study|Physician Decision|1
836808|NCT01795495|2751006|P2|Overall Study|Physician Decision|0
836809|NCT01795495|2751007|P1|Overall Study|Physician Decision|0
836810|NCT01795495|2751005|P3|Overall Study|Protocol Violation|1
836811|NCT01795495|2751006|P2|Overall Study|Protocol Violation|0
836812|NCT01795495|2751007|P1|Overall Study|Protocol Violation|1
836813|NCT01794949|2751020|P2|Overall Study|Lost to Follow-up|0
836814|NCT01794949|2751021|P1|Overall Study|Lost to Follow-up|1
836815|NCT01794845|2751032|P1|Overall Study|Withdrawal by Subject|1
836816|NCT01794000|2751095|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
836817|NCT01794000|2751096|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|3
836818|NCT01794000|2751095|P2|Double-Blind Phase (DBP)|Withdrawal by Subject|11
836819|NCT01794000|2751096|P1|Double-Blind Phase (DBP)|Withdrawal by Subject|6
836820|NCT01794000|2751095|P2|Double-Blind Phase (DBP)|Sponsor Decision|149
836821|NCT01794000|2751096|P1|Double-Blind Phase (DBP)|Sponsor Decision|148
836822|NCT01794000|2751095|P2|Double-Blind Phase (DBP)|Physician Decision|0
836823|NCT01794000|2751096|P1|Double-Blind Phase (DBP)|Physician Decision|2
836824|NCT01794000|2751095|P2|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2
836825|NCT01794000|2751096|P1|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5
836826|NCT01794000|2751095|P2|Double-Blind Phase (DBP)|Entry Criteria Not Met|0
836827|NCT01794000|2751096|P1|Double-Blind Phase (DBP)|Entry Criteria Not Met|2
836828|NCT01794000|2751095|P2|Double-Blind Phase (DBP)|Death|2
836829|NCT01794000|2751096|P1|Double-Blind Phase (DBP)|Death|1
836830|NCT01794000|2751095|P2|Double-Blind Phase (DBP)|Adverse Event|2
836831|NCT01794000|2751096|P1|Double-Blind Phase (DBP)|Adverse Event|5
836832|NCT01793935|2751129|P2|Overall Study|Lost to Follow-up|1
836833|NCT01793935|2751130|P1|Overall Study|Lost to Follow-up|0
836834|NCT01793935|2751129|P2|Overall Study|Patient did not take study medication|1
836835|NCT01793935|2751130|P1|Overall Study|Patient did not take study medication|1
836836|NCT01793935|2751129|P2|Overall Study|Adverse Event|0
836837|NCT01793935|2751130|P1|Overall Study|Adverse Event|2
836838|NCT01793935|2751129|P2|Overall Study|Protocol Violation|1
836839|NCT01793935|2751130|P1|Overall Study|Protocol Violation|2
836840|NCT01793935|2751129|P2|Overall Study|Pregnancy|0
836841|NCT01793935|2751130|P1|Overall Study|Pregnancy|1
836842|NCT01793883|2751167|P3|Overall Study|Respiratory distress during spirometry|1
836843|NCT01793883|2751168|P2|Overall Study|Respiratory distress during spirometry|0
836844|NCT01793883|2751169|P1|Overall Study|Respiratory distress during spirometry|0
836845|NCT01793883|2751167|P3|Overall Study|Dosing error|0
836846|NCT01793883|2751168|P2|Overall Study|Dosing error|1
836847|NCT01793883|2751169|P1|Overall Study|Dosing error|0
836848|NCT01793883|2751167|P3|Overall Study|Met exclusion criteria|0
836849|NCT01793883|2751168|P2|Overall Study|Met exclusion criteria|0
836850|NCT01793883|2751169|P1|Overall Study|Met exclusion criteria|1
836851|NCT01793883|2751167|P3|Overall Study|Unable to complete measurements|0
836852|NCT01793883|2751168|P2|Overall Study|Unable to complete measurements|0
836853|NCT01793883|2751169|P1|Overall Study|Unable to complete measurements|1
836854|NCT01793883|2751167|P3|Overall Study|Unable to complete spriometry|0
836855|NCT01793883|2751168|P2|Overall Study|Unable to complete spriometry|0
836856|NCT01793883|2751169|P1|Overall Study|Unable to complete spriometry|1
836857|NCT01793883|2751167|P3|Overall Study|Randomized in error|0
836858|NCT01793883|2751168|P2|Overall Study|Randomized in error|0
836859|NCT01793883|2751169|P1|Overall Study|Randomized in error|1
836860|NCT01793883|2751167|P3|Overall Study|Lost to Follow-up|3
836861|NCT01793883|2751168|P2|Overall Study|Lost to Follow-up|1
836862|NCT01793883|2751169|P1|Overall Study|Lost to Follow-up|5
836863|NCT01793883|2751167|P3|Overall Study|Subject noncompliance|1
836864|NCT01793883|2751168|P2|Overall Study|Subject noncompliance|1
836865|NCT01793883|2751169|P1|Overall Study|Subject noncompliance|0
836866|NCT01793883|2751167|P3|Overall Study|Withdrawal by Subject|3
836867|NCT01793883|2751168|P2|Overall Study|Withdrawal by Subject|7
836868|NCT01793883|2751169|P1|Overall Study|Withdrawal by Subject|3
836869|NCT01793688|2751177|P1|Overall Study|Protocol Violation|2
836870|NCT01792830|2751223|P11|Overall Study|Adverse Event|0
836871|NCT01792830|2751224|P10|Overall Study|Adverse Event|0
836872|NCT01792830|2751225|P9|Overall Study|Adverse Event|1
836873|NCT01792830|2751226|P8|Overall Study|Adverse Event|0
836874|NCT01792830|2751227|P7|Overall Study|Adverse Event|0
836875|NCT01792830|2751228|P6|Overall Study|Adverse Event|0
836876|NCT01792830|2751229|P5|Overall Study|Adverse Event|0
836877|NCT01792830|2751230|P4|Overall Study|Adverse Event|0
836878|NCT01792830|2751231|P3|Overall Study|Adverse Event|0
836879|NCT01792830|2751232|P2|Overall Study|Adverse Event|0
836880|NCT01792830|2751233|P1|Overall Study|Adverse Event|0
836881|NCT01792830|2751223|P11|Overall Study|Death|1
836882|NCT01792830|2751224|P10|Overall Study|Death|0
836883|NCT01792830|2751225|P9|Overall Study|Death|1
836884|NCT01792830|2751226|P8|Overall Study|Death|0
836885|NCT01792830|2751227|P7|Overall Study|Death|1
836886|NCT01792830|2751228|P6|Overall Study|Death|0
836887|NCT01792830|2751229|P5|Overall Study|Death|0
836888|NCT01792830|2751230|P4|Overall Study|Death|1
836889|NCT01792830|2751231|P3|Overall Study|Death|0
836890|NCT01792830|2751232|P2|Overall Study|Death|0
836891|NCT01792830|2751233|P1|Overall Study|Death|3
836892|NCT01792830|2751223|P11|Overall Study|Withdrawal by Subject|2
836893|NCT01792830|2751224|P10|Overall Study|Withdrawal by Subject|0
836894|NCT01792830|2751225|P9|Overall Study|Withdrawal by Subject|7
836895|NCT01792830|2751226|P8|Overall Study|Withdrawal by Subject|1
836896|NCT01792830|2751227|P7|Overall Study|Withdrawal by Subject|1
836897|NCT01792830|2751228|P6|Overall Study|Withdrawal by Subject|1
836898|NCT01792830|2751229|P5|Overall Study|Withdrawal by Subject|1
836899|NCT01792830|2751230|P4|Overall Study|Withdrawal by Subject|2
836900|NCT01792830|2751231|P3|Overall Study|Withdrawal by Subject|0
836901|NCT01792830|2751232|P2|Overall Study|Withdrawal by Subject|0
836902|NCT01792830|2751233|P1|Overall Study|Withdrawal by Subject|22
836903|NCT01792635|2751320|P3|Part B|Study terminated|3
836904|NCT01792635|2751321|P2|Part B|Study terminated|4
836905|NCT01792635|2751322|P1|Part B|Study terminated|0
836906|NCT01792635|2751320|P3|Part B|Adverse Event|1
836907|NCT01792635|2751321|P2|Part B|Adverse Event|0
836908|NCT01792635|2751322|P1|Part B|Adverse Event|0
836909|NCT01792518|2751350|P2|Overall Study|Other Reason|1
836910|NCT01792518|2751351|P1|Overall Study|Other Reason|0
836911|NCT01792518|2751350|P2|Overall Study|Withdrawal by Subject|0
836912|NCT01792518|2751351|P1|Overall Study|Withdrawal by Subject|2
836913|NCT01792518|2751350|P2|Overall Study|Lost to Follow-up|1
836914|NCT01792518|2751351|P1|Overall Study|Lost to Follow-up|3
836915|NCT01792518|2751350|P2|Overall Study|Protocol Violation|1
836916|NCT01792518|2751351|P1|Overall Study|Protocol Violation|0
836917|NCT01792518|2751350|P2|Overall Study|Adverse Event|4
836918|NCT01792518|2751351|P1|Overall Study|Adverse Event|3
836919|NCT01792284|2751361|P3|Randomization Period 2|Withdrawal by Subject|0
836920|NCT01792284|2751362|P2|Randomization Period 2|Withdrawal by Subject|2
836921|NCT01792284|2751363|P1|Randomization Period 2|Withdrawal by Subject|0
836922|NCT01792284|2751361|P3|Randomization Period 2|Protocol Violation|0
836923|NCT01792284|2751362|P2|Randomization Period 2|Protocol Violation|1
836924|NCT01792284|2751363|P1|Randomization Period 2|Protocol Violation|0
836925|NCT01792284|2751361|P3|Randomization Period 1|Lost to Follow-up|1
836926|NCT01792284|2751362|P2|Randomization Period 1|Lost to Follow-up|0
836927|NCT01792284|2751363|P1|Randomization Period 1|Lost to Follow-up|0
836928|NCT01792284|2751361|P3|Randomization Period 1|Adverse Event|2
836929|NCT01792284|2751362|P2|Randomization Period 1|Adverse Event|0
836930|NCT01792284|2751363|P1|Randomization Period 1|Adverse Event|0
836931|NCT01792284|2751361|P3|Randomization Period 1|Physician Decision|1
836932|NCT01792284|2751362|P2|Randomization Period 1|Physician Decision|1
836933|NCT01792284|2751363|P1|Randomization Period 1|Physician Decision|0
836934|NCT01792284|2751361|P3|Randomization Period 1|Withdrawal by Subject|1
836935|NCT01792284|2751362|P2|Randomization Period 1|Withdrawal by Subject|1
836936|NCT01792284|2751363|P1|Randomization Period 1|Withdrawal by Subject|0
836937|NCT01792284|2751361|P3|Lead-in Period|Protocol Required Discontinuation|0
836938|NCT01792284|2751362|P2|Lead-in Period|Protocol Required Discontinuation|0
836939|NCT01792284|2751363|P1|Lead-in Period|Protocol Required Discontinuation|1
836940|NCT01792284|2751361|P3|Lead-in Period|Physician Decision|0
836941|NCT01792284|2751362|P2|Lead-in Period|Physician Decision|0
836942|NCT01792284|2751363|P1|Lead-in Period|Physician Decision|1
836943|NCT01792284|2751361|P3|Lead-in Period|Withdrawal by Subject|0
836944|NCT01792284|2751362|P2|Lead-in Period|Withdrawal by Subject|0
836945|NCT01792284|2751363|P1|Lead-in Period|Withdrawal by Subject|10
836946|NCT01792284|2751361|P3|Lead-in Period|Protocol Violation|0
836947|NCT01792284|2751362|P2|Lead-in Period|Protocol Violation|0
836948|NCT01792284|2751363|P1|Lead-in Period|Protocol Violation|1
836949|NCT01792284|2751361|P3|Lead-in Period|Lost to Follow-up|0
836950|NCT01792284|2751362|P2|Lead-in Period|Lost to Follow-up|0
836951|NCT01792284|2751363|P1|Lead-in Period|Lost to Follow-up|2
836952|NCT01792284|2751361|P3|Lead-in Period|Adverse Event|0
836953|NCT01792284|2751362|P2|Lead-in Period|Adverse Event|0
836954|NCT01792284|2751363|P1|Lead-in Period|Adverse Event|15
836955|NCT01791894|2751422|P1|Overall Study|Adverse Event|1
836956|NCT01791803|2751433|P4|Overall Study|Death|2
836957|NCT01791803|2751434|P3|Overall Study|Death|2
836958|NCT01791803|2751435|P2|Overall Study|Death|0
836959|NCT01791803|2751436|P1|Overall Study|Death|0
836960|NCT01791803|2751433|P4|Overall Study|Physician Decision|1
836961|NCT01791803|2751434|P3|Overall Study|Physician Decision|0
836962|NCT01791803|2751435|P2|Overall Study|Physician Decision|2
836963|NCT01791803|2751436|P1|Overall Study|Physician Decision|0
836964|NCT01791803|2751433|P4|Overall Study|Withdrawal by Subject|2
836965|NCT01791803|2751434|P3|Overall Study|Withdrawal by Subject|0
836966|NCT01791803|2751435|P2|Overall Study|Withdrawal by Subject|0
836967|NCT01791803|2751436|P1|Overall Study|Withdrawal by Subject|0
836968|NCT01791725|2751454|P3|Overall Study|Withdrawal by Subject|0
836969|NCT01791725|2751455|P2|Overall Study|Withdrawal by Subject|1
836970|NCT01791725|2751456|P1|Overall Study|Withdrawal by Subject|0
836971|NCT01791517|2751479|P12|Phase II|Pre-Existing Ocular Issue|1
836972|NCT01791517|2751480|P11|Phase II|Pre-Existing Ocular Issue|0
836973|NCT01791517|2751481|P10|Phase II|Pre-Existing Ocular Issue|0
836974|NCT01791517|2751482|P9|Phase II|Pre-Existing Ocular Issue|0
836975|NCT01791517|2751483|P8|Phase II|Pre-Existing Ocular Issue|0
836976|NCT01791517|2751484|P7|Phase II|Pre-Existing Ocular Issue|0
836977|NCT01791517|2751485|P6|Phase II|Pre-Existing Ocular Issue|0
836978|NCT01791517|2751486|P5|Phase II|Pre-Existing Ocular Issue|0
836979|NCT01791517|2751487|P4|Phase II|Pre-Existing Ocular Issue|0
836980|NCT01791517|2751488|P3|Phase II|Pre-Existing Ocular Issue|0
836981|NCT01791517|2751489|P2|Phase II|Pre-Existing Ocular Issue|0
836982|NCT01791517|2751490|P1|Phase II|Pre-Existing Ocular Issue|0
836983|NCT01791517|2751479|P12|Phase II|Unsatisfactory Lens Fitting|0
836984|NCT01791517|2751480|P11|Phase II|Unsatisfactory Lens Fitting|0
836985|NCT01791517|2751481|P10|Phase II|Unsatisfactory Lens Fitting|1
836986|NCT01791517|2751482|P9|Phase II|Unsatisfactory Lens Fitting|0
836987|NCT01791517|2751483|P8|Phase II|Unsatisfactory Lens Fitting|0
836988|NCT01791517|2751484|P7|Phase II|Unsatisfactory Lens Fitting|0
836989|NCT01791517|2751485|P6|Phase II|Unsatisfactory Lens Fitting|0
836990|NCT01791517|2751486|P5|Phase II|Unsatisfactory Lens Fitting|0
836991|NCT01791517|2751487|P4|Phase II|Unsatisfactory Lens Fitting|0
836992|NCT01791517|2751488|P3|Phase II|Unsatisfactory Lens Fitting|0
836993|NCT01791517|2751489|P2|Phase II|Unsatisfactory Lens Fitting|0
836994|NCT01791517|2751490|P1|Phase II|Unsatisfactory Lens Fitting|0
836995|NCT01791517|2751479|P12|Phase II|Lens Handling Difficulties|0
836996|NCT01791517|2751480|P11|Phase II|Lens Handling Difficulties|0
836997|NCT01791517|2751481|P10|Phase II|Lens Handling Difficulties|0
836998|NCT01791517|2751482|P9|Phase II|Lens Handling Difficulties|1
836999|NCT01791517|2751483|P8|Phase II|Lens Handling Difficulties|0
837000|NCT01791517|2751484|P7|Phase II|Lens Handling Difficulties|0
837001|NCT01791517|2751485|P6|Phase II|Lens Handling Difficulties|0
837002|NCT01791517|2751486|P5|Phase II|Lens Handling Difficulties|0
837003|NCT01791517|2751487|P4|Phase II|Lens Handling Difficulties|0
837004|NCT01791517|2751488|P3|Phase II|Lens Handling Difficulties|0
837005|NCT01791517|2751489|P2|Phase II|Lens Handling Difficulties|0
837006|NCT01791517|2751490|P1|Phase II|Lens Handling Difficulties|0
837007|NCT01791517|2751479|P12|Phase II|Adverse Event|0
837008|NCT01791517|2751480|P11|Phase II|Adverse Event|0
837009|NCT01791517|2751481|P10|Phase II|Adverse Event|1
837010|NCT01791517|2751482|P9|Phase II|Adverse Event|0
837011|NCT01791517|2751483|P8|Phase II|Adverse Event|1
837012|NCT01791517|2751484|P7|Phase II|Adverse Event|2
837013|NCT01791517|2751485|P6|Phase II|Adverse Event|0
837014|NCT01791517|2751486|P5|Phase II|Adverse Event|0
837015|NCT01791517|2751487|P4|Phase II|Adverse Event|0
837016|NCT01791517|2751488|P3|Phase II|Adverse Event|0
837017|NCT01791517|2751489|P2|Phase II|Adverse Event|0
837018|NCT01791517|2751490|P1|Phase II|Adverse Event|0
837019|NCT01791517|2751479|P12|Phase II|Lack of Efficacy|0
837020|NCT01791517|2751480|P11|Phase II|Lack of Efficacy|0
837021|NCT01791517|2751481|P10|Phase II|Lack of Efficacy|0
837022|NCT01791517|2751482|P9|Phase II|Lack of Efficacy|0
837023|NCT01791517|2751483|P8|Phase II|Lack of Efficacy|0
837024|NCT01791517|2751484|P7|Phase II|Lack of Efficacy|0
837025|NCT01791517|2751485|P6|Phase II|Lack of Efficacy|0
837026|NCT01791517|2751486|P5|Phase II|Lack of Efficacy|1
837027|NCT01791517|2751487|P4|Phase II|Lack of Efficacy|0
837028|NCT01791517|2751488|P3|Phase II|Lack of Efficacy|0
837029|NCT01791517|2751489|P2|Phase II|Lack of Efficacy|0
837030|NCT01791517|2751490|P1|Phase II|Lack of Efficacy|0
837031|NCT01791517|2751479|P12|Phase II|Withdrawal by Subject|0
837032|NCT01791517|2751480|P11|Phase II|Withdrawal by Subject|1
837033|NCT01791517|2751481|P10|Phase II|Withdrawal by Subject|0
837034|NCT01791517|2751482|P9|Phase II|Withdrawal by Subject|0
837035|NCT01791517|2751483|P8|Phase II|Withdrawal by Subject|1
837036|NCT01791517|2751484|P7|Phase II|Withdrawal by Subject|0
837037|NCT01791517|2751485|P6|Phase II|Withdrawal by Subject|2
837038|NCT01791517|2751486|P5|Phase II|Withdrawal by Subject|0
837039|NCT01791517|2751487|P4|Phase II|Withdrawal by Subject|0
837040|NCT01791517|2751488|P3|Phase II|Withdrawal by Subject|0
837041|NCT01791517|2751489|P2|Phase II|Withdrawal by Subject|0
837042|NCT01791517|2751490|P1|Phase II|Withdrawal by Subject|1
837043|NCT01791517|2751479|P12|Phase II|Lost to Follow-up|0
837044|NCT01791517|2751480|P11|Phase II|Lost to Follow-up|0
837045|NCT01791517|2751481|P10|Phase II|Lost to Follow-up|1
837046|NCT01791517|2751482|P9|Phase II|Lost to Follow-up|1
837047|NCT01791517|2751483|P8|Phase II|Lost to Follow-up|1
837048|NCT01791517|2751484|P7|Phase II|Lost to Follow-up|0
837049|NCT01791517|2751485|P6|Phase II|Lost to Follow-up|2
837050|NCT01791517|2751486|P5|Phase II|Lost to Follow-up|1
837051|NCT01791517|2751487|P4|Phase II|Lost to Follow-up|0
837052|NCT01791517|2751488|P3|Phase II|Lost to Follow-up|1
837053|NCT01791517|2751489|P2|Phase II|Lost to Follow-up|0
837054|NCT01791517|2751490|P1|Phase II|Lost to Follow-up|1
837055|NCT01791517|2751479|P12|Phase I: Period 3|Adverse Event|0
837056|NCT01791517|2751480|P11|Phase I: Period 3|Adverse Event|0
837057|NCT01791517|2751481|P10|Phase I: Period 3|Adverse Event|0
837058|NCT01791517|2751482|P9|Phase I: Period 3|Adverse Event|0
837059|NCT01791517|2751483|P8|Phase I: Period 3|Adverse Event|0
837060|NCT01791517|2751484|P7|Phase I: Period 3|Adverse Event|0
837061|NCT01791517|2751485|P6|Phase I: Period 3|Adverse Event|0
837062|NCT01791517|2751486|P5|Phase I: Period 3|Adverse Event|0
837063|NCT01791517|2751487|P4|Phase I: Period 3|Adverse Event|1
837064|NCT01791517|2751488|P3|Phase I: Period 3|Adverse Event|0
837065|NCT01791517|2751489|P2|Phase I: Period 3|Adverse Event|0
837066|NCT01791517|2751490|P1|Phase I: Period 3|Adverse Event|0
837067|NCT01791517|2751479|P12|Phase I: Period 3|Lost to Follow-up|0
837068|NCT01791517|2751480|P11|Phase I: Period 3|Lost to Follow-up|0
837069|NCT01791517|2751481|P10|Phase I: Period 3|Lost to Follow-up|0
837070|NCT01791517|2751482|P9|Phase I: Period 3|Lost to Follow-up|0
837071|NCT01791517|2751483|P8|Phase I: Period 3|Lost to Follow-up|0
837072|NCT01791517|2751484|P7|Phase I: Period 3|Lost to Follow-up|0
837073|NCT01791517|2751485|P6|Phase I: Period 3|Lost to Follow-up|0
837074|NCT01791517|2751486|P5|Phase I: Period 3|Lost to Follow-up|1
837075|NCT01791517|2751487|P4|Phase I: Period 3|Lost to Follow-up|0
837076|NCT01791517|2751488|P3|Phase I: Period 3|Lost to Follow-up|0
837077|NCT01791517|2751489|P2|Phase I: Period 3|Lost to Follow-up|1
837078|NCT01791517|2751490|P1|Phase I: Period 3|Lost to Follow-up|0
837079|NCT01791517|2751479|P12|Phase I: Period 3|Lens Discomfort|1
837080|NCT01791517|2751480|P11|Phase I: Period 3|Lens Discomfort|0
837081|NCT01791517|2751481|P10|Phase I: Period 3|Lens Discomfort|0
837082|NCT01791517|2751482|P9|Phase I: Period 3|Lens Discomfort|0
837083|NCT01791517|2751483|P8|Phase I: Period 3|Lens Discomfort|0
837084|NCT01791517|2751484|P7|Phase I: Period 3|Lens Discomfort|0
837085|NCT01791517|2751485|P6|Phase I: Period 3|Lens Discomfort|0
837086|NCT01791517|2751486|P5|Phase I: Period 3|Lens Discomfort|0
837087|NCT01791517|2751487|P4|Phase I: Period 3|Lens Discomfort|0
837088|NCT01791517|2751488|P3|Phase I: Period 3|Lens Discomfort|0
837089|NCT01791517|2751489|P2|Phase I: Period 3|Lens Discomfort|0
837090|NCT01791517|2751490|P1|Phase I: Period 3|Lens Discomfort|0
837091|NCT01791517|2751479|P12|Phase I: Period 2|Lost to Follow-up|0
837092|NCT01791517|2751480|P11|Phase I: Period 2|Lost to Follow-up|0
837093|NCT01791517|2751481|P10|Phase I: Period 2|Lost to Follow-up|0
837094|NCT01791517|2751482|P9|Phase I: Period 2|Lost to Follow-up|0
837095|NCT01791517|2751483|P8|Phase I: Period 2|Lost to Follow-up|0
837096|NCT01791517|2751484|P7|Phase I: Period 2|Lost to Follow-up|0
837097|NCT01791517|2751485|P6|Phase I: Period 2|Lost to Follow-up|0
837098|NCT01791517|2751486|P5|Phase I: Period 2|Lost to Follow-up|0
837099|NCT01791517|2751487|P4|Phase I: Period 2|Lost to Follow-up|0
837100|NCT01791517|2751488|P3|Phase I: Period 2|Lost to Follow-up|2
837101|NCT01791517|2751489|P2|Phase I: Period 2|Lost to Follow-up|3
837102|NCT01791517|2751490|P1|Phase I: Period 2|Lost to Follow-up|0
837103|NCT01791517|2751479|P12|Phase I: Period 2|Lens Discomfort|0
837104|NCT01791517|2751480|P11|Phase I: Period 2|Lens Discomfort|0
837105|NCT01791517|2751481|P10|Phase I: Period 2|Lens Discomfort|0
837106|NCT01791517|2751482|P9|Phase I: Period 2|Lens Discomfort|0
837107|NCT01791517|2751483|P8|Phase I: Period 2|Lens Discomfort|0
837108|NCT01791517|2751484|P7|Phase I: Period 2|Lens Discomfort|0
837109|NCT01791517|2751485|P6|Phase I: Period 2|Lens Discomfort|1
837110|NCT01791517|2751486|P5|Phase I: Period 2|Lens Discomfort|0
837111|NCT01791517|2751487|P4|Phase I: Period 2|Lens Discomfort|0
837112|NCT01791517|2751488|P3|Phase I: Period 2|Lens Discomfort|0
837113|NCT01791517|2751489|P2|Phase I: Period 2|Lens Discomfort|0
837114|NCT01791517|2751490|P1|Phase I: Period 2|Lens Discomfort|0
837115|NCT01791517|2751479|P12|Phase I: Period 2|Unsatisfactory Visual Response|0
837116|NCT01791517|2751480|P11|Phase I: Period 2|Unsatisfactory Visual Response|1
837117|NCT01791517|2751481|P10|Phase I: Period 2|Unsatisfactory Visual Response|0
837118|NCT01791517|2751482|P9|Phase I: Period 2|Unsatisfactory Visual Response|0
837119|NCT01791517|2751483|P8|Phase I: Period 2|Unsatisfactory Visual Response|0
837120|NCT01791517|2751484|P7|Phase I: Period 2|Unsatisfactory Visual Response|0
837121|NCT01791517|2751485|P6|Phase I: Period 2|Unsatisfactory Visual Response|0
837122|NCT01791517|2751486|P5|Phase I: Period 2|Unsatisfactory Visual Response|0
837123|NCT01791517|2751487|P4|Phase I: Period 2|Unsatisfactory Visual Response|0
837124|NCT01791517|2751488|P3|Phase I: Period 2|Unsatisfactory Visual Response|0
837125|NCT01791517|2751489|P2|Phase I: Period 2|Unsatisfactory Visual Response|0
837126|NCT01791517|2751490|P1|Phase I: Period 2|Unsatisfactory Visual Response|0
837127|NCT01791517|2751479|P12|Phase I: Period 2|Withdrawal by Subject|0
837128|NCT01791517|2751480|P11|Phase I: Period 2|Withdrawal by Subject|1
837129|NCT01791517|2751481|P10|Phase I: Period 2|Withdrawal by Subject|1
837130|NCT01791517|2751482|P9|Phase I: Period 2|Withdrawal by Subject|0
837131|NCT01791517|2751483|P8|Phase I: Period 2|Withdrawal by Subject|0
837132|NCT01791517|2751484|P7|Phase I: Period 2|Withdrawal by Subject|0
837133|NCT01791517|2751485|P6|Phase I: Period 2|Withdrawal by Subject|0
837134|NCT01791517|2751486|P5|Phase I: Period 2|Withdrawal by Subject|0
837135|NCT01791517|2751487|P4|Phase I: Period 2|Withdrawal by Subject|0
837136|NCT01791517|2751488|P3|Phase I: Period 2|Withdrawal by Subject|0
837137|NCT01791517|2751489|P2|Phase I: Period 2|Withdrawal by Subject|0
837138|NCT01791517|2751490|P1|Phase I: Period 2|Withdrawal by Subject|0
837139|NCT01791517|2751479|P12|Phase I: Period 2|Protocol Violation|0
837140|NCT01791517|2751480|P11|Phase I: Period 2|Protocol Violation|0
837141|NCT01791517|2751481|P10|Phase I: Period 2|Protocol Violation|0
837142|NCT01791517|2751482|P9|Phase I: Period 2|Protocol Violation|0
837143|NCT01791517|2751483|P8|Phase I: Period 2|Protocol Violation|0
837144|NCT01791517|2751484|P7|Phase I: Period 2|Protocol Violation|0
837145|NCT01791517|2751485|P6|Phase I: Period 2|Protocol Violation|0
837146|NCT01791517|2751486|P5|Phase I: Period 2|Protocol Violation|0
837147|NCT01791517|2751487|P4|Phase I: Period 2|Protocol Violation|1
837148|NCT01791517|2751488|P3|Phase I: Period 2|Protocol Violation|0
837149|NCT01791517|2751489|P2|Phase I: Period 2|Protocol Violation|0
837150|NCT01791517|2751490|P1|Phase I: Period 2|Protocol Violation|0
837151|NCT01791517|2751479|P12|Phase I: Period 2|Unsatisfactory Lens Fit|0
837152|NCT01791517|2751480|P11|Phase I: Period 2|Unsatisfactory Lens Fit|0
837153|NCT01791517|2751481|P10|Phase I: Period 2|Unsatisfactory Lens Fit|0
837154|NCT01791517|2751482|P9|Phase I: Period 2|Unsatisfactory Lens Fit|0
837155|NCT01791517|2751483|P8|Phase I: Period 2|Unsatisfactory Lens Fit|0
837156|NCT01791517|2751484|P7|Phase I: Period 2|Unsatisfactory Lens Fit|0
837157|NCT01791517|2751485|P6|Phase I: Period 2|Unsatisfactory Lens Fit|0
837158|NCT01791517|2751486|P5|Phase I: Period 2|Unsatisfactory Lens Fit|0
837159|NCT01791517|2751487|P4|Phase I: Period 2|Unsatisfactory Lens Fit|0
837160|NCT01791517|2751488|P3|Phase I: Period 2|Unsatisfactory Lens Fit|0
837161|NCT01791517|2751489|P2|Phase I: Period 2|Unsatisfactory Lens Fit|0
837162|NCT01791517|2751490|P1|Phase I: Period 2|Unsatisfactory Lens Fit|1
837163|NCT01791517|2751479|P12|Phase I: Period 1|Lens Handling DIfficulties|1
837164|NCT01791517|2751480|P11|Phase I: Period 1|Lens Handling DIfficulties|0
837165|NCT01791517|2751481|P10|Phase I: Period 1|Lens Handling DIfficulties|0
837166|NCT01791517|2751482|P9|Phase I: Period 1|Lens Handling DIfficulties|0
837167|NCT01791517|2751483|P8|Phase I: Period 1|Lens Handling DIfficulties|0
837168|NCT01791517|2751484|P7|Phase I: Period 1|Lens Handling DIfficulties|0
837169|NCT01791517|2751485|P6|Phase I: Period 1|Lens Handling DIfficulties|0
837170|NCT01791517|2751486|P5|Phase I: Period 1|Lens Handling DIfficulties|0
837171|NCT01791517|2751487|P4|Phase I: Period 1|Lens Handling DIfficulties|0
837172|NCT01791517|2751488|P3|Phase I: Period 1|Lens Handling DIfficulties|0
837173|NCT01791517|2751489|P2|Phase I: Period 1|Lens Handling DIfficulties|0
837174|NCT01791517|2751490|P1|Phase I: Period 1|Lens Handling DIfficulties|0
837175|NCT01791517|2751479|P12|Phase I: Period 1|Lost to Follow-up|0
837176|NCT01791517|2751480|P11|Phase I: Period 1|Lost to Follow-up|0
837177|NCT01791517|2751481|P10|Phase I: Period 1|Lost to Follow-up|1
837178|NCT01791517|2751482|P9|Phase I: Period 1|Lost to Follow-up|1
837179|NCT01791517|2751483|P8|Phase I: Period 1|Lost to Follow-up|0
837180|NCT01791517|2751484|P7|Phase I: Period 1|Lost to Follow-up|1
837181|NCT01791517|2751485|P6|Phase I: Period 1|Lost to Follow-up|0
837182|NCT01791517|2751486|P5|Phase I: Period 1|Lost to Follow-up|0
837183|NCT01791517|2751487|P4|Phase I: Period 1|Lost to Follow-up|1
837184|NCT01791517|2751488|P3|Phase I: Period 1|Lost to Follow-up|0
837185|NCT01791517|2751489|P2|Phase I: Period 1|Lost to Follow-up|0
837186|NCT01791517|2751490|P1|Phase I: Period 1|Lost to Follow-up|0
837187|NCT01791517|2751479|P12|Phase I: Period 1|Protocol Violation|0
837188|NCT01791517|2751480|P11|Phase I: Period 1|Protocol Violation|0
837189|NCT01791517|2751481|P10|Phase I: Period 1|Protocol Violation|0
837190|NCT01791517|2751482|P9|Phase I: Period 1|Protocol Violation|0
837191|NCT01791517|2751483|P8|Phase I: Period 1|Protocol Violation|0
837192|NCT01791517|2751484|P7|Phase I: Period 1|Protocol Violation|0
837193|NCT01791517|2751485|P6|Phase I: Period 1|Protocol Violation|0
837194|NCT01791517|2751486|P5|Phase I: Period 1|Protocol Violation|0
837195|NCT01791517|2751487|P4|Phase I: Period 1|Protocol Violation|0
837196|NCT01791517|2751488|P3|Phase I: Period 1|Protocol Violation|0
837197|NCT01791517|2751489|P2|Phase I: Period 1|Protocol Violation|1
837198|NCT01791517|2751490|P1|Phase I: Period 1|Protocol Violation|0
837199|NCT01791517|2751479|P12|Phase I: Period 1|Unsatisfactory Lens Fitting|0
837200|NCT01791517|2751480|P11|Phase I: Period 1|Unsatisfactory Lens Fitting|0
837201|NCT01791517|2751481|P10|Phase I: Period 1|Unsatisfactory Lens Fitting|0
837202|NCT01791517|2751482|P9|Phase I: Period 1|Unsatisfactory Lens Fitting|0
837203|NCT01791517|2751483|P8|Phase I: Period 1|Unsatisfactory Lens Fitting|0
837204|NCT01791517|2751484|P7|Phase I: Period 1|Unsatisfactory Lens Fitting|0
837205|NCT01791517|2751485|P6|Phase I: Period 1|Unsatisfactory Lens Fitting|0
837206|NCT01791517|2751486|P5|Phase I: Period 1|Unsatisfactory Lens Fitting|0
837207|NCT01791517|2751487|P4|Phase I: Period 1|Unsatisfactory Lens Fitting|0
837208|NCT01791517|2751488|P3|Phase I: Period 1|Unsatisfactory Lens Fitting|0
837209|NCT01791517|2751489|P2|Phase I: Period 1|Unsatisfactory Lens Fitting|0
837210|NCT01791517|2751490|P1|Phase I: Period 1|Unsatisfactory Lens Fitting|1
837211|NCT01791517|2751479|P12|Phase I: Period 1|Adverse Event|0
837212|NCT01791517|2751480|P11|Phase I: Period 1|Adverse Event|0
837213|NCT01791517|2751481|P10|Phase I: Period 1|Adverse Event|0
837214|NCT01791517|2751482|P9|Phase I: Period 1|Adverse Event|0
837215|NCT01791517|2751483|P8|Phase I: Period 1|Adverse Event|0
837216|NCT01791517|2751484|P7|Phase I: Period 1|Adverse Event|0
837217|NCT01791517|2751485|P6|Phase I: Period 1|Adverse Event|0
837218|NCT01791517|2751486|P5|Phase I: Period 1|Adverse Event|0
837219|NCT01791517|2751487|P4|Phase I: Period 1|Adverse Event|1
837220|NCT01791517|2751488|P3|Phase I: Period 1|Adverse Event|1
837221|NCT01791517|2751489|P2|Phase I: Period 1|Adverse Event|0
837222|NCT01791517|2751490|P1|Phase I: Period 1|Adverse Event|0
837223|NCT01791517|2751479|P12|Phase I: Period 1|Withdrawal by Subject|0
837224|NCT01791517|2751480|P11|Phase I: Period 1|Withdrawal by Subject|0
837225|NCT01791517|2751481|P10|Phase I: Period 1|Withdrawal by Subject|0
837226|NCT01791517|2751482|P9|Phase I: Period 1|Withdrawal by Subject|0
837227|NCT01791517|2751483|P8|Phase I: Period 1|Withdrawal by Subject|0
837228|NCT01791517|2751484|P7|Phase I: Period 1|Withdrawal by Subject|0
837229|NCT01791517|2751485|P6|Phase I: Period 1|Withdrawal by Subject|1
837230|NCT01791517|2751486|P5|Phase I: Period 1|Withdrawal by Subject|1
837231|NCT01791517|2751487|P4|Phase I: Period 1|Withdrawal by Subject|0
837232|NCT01791517|2751488|P3|Phase I: Period 1|Withdrawal by Subject|1
837233|NCT01791517|2751489|P2|Phase I: Period 1|Withdrawal by Subject|1
837234|NCT01791517|2751490|P1|Phase I: Period 1|Withdrawal by Subject|0
837235|NCT01791413|2751554|P2|Overall Study|Lost to Follow-up|1
837236|NCT01791413|2751555|P1|Overall Study|Lost to Follow-up|5
837237|NCT01791244|2751564|P2|Overall Study|Laboratory Abnormality|1
837238|NCT01791244|2751565|P1|Overall Study|Laboratory Abnormality|0
837239|NCT01791244|2751564|P2|Overall Study|Insufficient clinical response|10
837240|NCT01791244|2751565|P1|Overall Study|Insufficient clinical response|10
837241|NCT01791244|2751564|P2|Overall Study|Adverse Event|7
837242|NCT01791244|2751565|P1|Overall Study|Adverse Event|5
837243|NCT01791205|2751601|P2|Phase II|Physician’s decision|0
837244|NCT01791205|2751602|P1|Phase II|Physician’s decision|1
837245|NCT01791205|2751601|P2|Phase II|Remission of disease|0
837246|NCT01791205|2751602|P1|Phase II|Remission of disease|1
837247|NCT01791205|2751601|P2|Phase II|Lost to Follow-up|0
837248|NCT01791205|2751602|P1|Phase II|Lost to Follow-up|1
837249|NCT01791205|2751601|P2|Phase II|Safety|0
837250|NCT01791205|2751602|P1|Phase II|Safety|1
837251|NCT01791205|2751601|P2|Phase II|Adverse Event|0
837252|NCT01791205|2751602|P1|Phase II|Adverse Event|2
837253|NCT01791205|2751601|P2|Phase II|Lack of Efficacy|0
837254|NCT01791205|2751602|P1|Phase II|Lack of Efficacy|6
837255|NCT01791153|2751686|P4|Overall Study|Withdrawal by Subject|1
837256|NCT01791153|2751687|P3|Overall Study|Withdrawal by Subject|2
837257|NCT01791153|2751688|P2|Overall Study|Withdrawal by Subject|2
837258|NCT01791153|2751689|P1|Overall Study|Withdrawal by Subject|6
837259|NCT01791153|2751686|P4|Overall Study|Protocol Violation|1
837260|NCT01791153|2751687|P3|Overall Study|Protocol Violation|0
837261|NCT01791153|2751688|P2|Overall Study|Protocol Violation|0
837262|NCT01791153|2751689|P1|Overall Study|Protocol Violation|0
837263|NCT01791153|2751686|P4|Overall Study|Physician Decision|1
837264|NCT01791153|2751687|P3|Overall Study|Physician Decision|0
837265|NCT01791153|2751688|P2|Overall Study|Physician Decision|0
837266|NCT01791153|2751689|P1|Overall Study|Physician Decision|0
837267|NCT01791153|2751686|P4|Overall Study|Non-Compliance|0
837268|NCT01791153|2751687|P3|Overall Study|Non-Compliance|0
837269|NCT01791153|2751688|P2|Overall Study|Non-Compliance|0
837270|NCT01791153|2751689|P1|Overall Study|Non-Compliance|1
837271|NCT01791153|2751686|P4|Overall Study|Lack of Efficacy|2
837272|NCT01791153|2751687|P3|Overall Study|Lack of Efficacy|2
837273|NCT01791153|2751688|P2|Overall Study|Lack of Efficacy|3
837274|NCT01791153|2751689|P1|Overall Study|Lack of Efficacy|1
837275|NCT01791153|2751686|P4|Overall Study|Adverse Event|0
837276|NCT01791153|2751687|P3|Overall Study|Adverse Event|2
837277|NCT01791153|2751688|P2|Overall Study|Adverse Event|3
837278|NCT01791153|2751689|P1|Overall Study|Adverse Event|7
837279|NCT01790828|2751745|P1|Overall Study|Not specified|34
837280|NCT01790633|2751803|P2|Overall Study|RT failure and no follow-up ELISA|3
837281|NCT01790633|2751804|P1|Overall Study|RT failure and no follow-up ELISA|0
837282|NCT01790633|2751803|P2|Overall Study|Did not have serology performed|0
837283|NCT01790633|2751804|P1|Overall Study|Did not have serology performed|47
837284|NCT01790633|2751803|P2|Overall Study|Protocol Violation|2
837285|NCT01790633|2751804|P1|Overall Study|Protocol Violation|1
837286|NCT01790594|2751817|P3|Overall Study|Terminated prior to week 76|0
837287|NCT01790594|2751818|P2|Overall Study|Terminated prior to week 76|2
837288|NCT01790594|2751819|P1|Overall Study|Terminated prior to week 76|0
837289|NCT01790594|2751817|P3|Overall Study|Transplant was not done|3
837290|NCT01790594|2751818|P2|Overall Study|Transplant was not done|0
837291|NCT01790594|2751819|P1|Overall Study|Transplant was not done|0
837292|NCT01790594|2751817|P3|Overall Study|Withdrawal by Subject|0
837293|NCT01790594|2751818|P2|Overall Study|Withdrawal by Subject|0
837294|NCT01790594|2751819|P1|Overall Study|Withdrawal by Subject|2
837295|NCT01790594|2751817|P3|Overall Study|Physician Decision|0
837296|NCT01790594|2751818|P2|Overall Study|Physician Decision|1
837297|NCT01790594|2751819|P1|Overall Study|Physician Decision|2
837298|NCT01790594|2751817|P3|Overall Study|Death|0
837299|NCT01790594|2751818|P2|Overall Study|Death|0
837300|NCT01790594|2751819|P1|Overall Study|Death|1
837301|NCT01790568|2751896|P2|Overall Study|Progression prior to transplant|1
837302|NCT01790568|2751897|P1|Overall Study|Progression prior to transplant|0
837303|NCT01790516|2751905|P2|Overall Study|Physician Decision|0
837304|NCT01790516|2751906|P1|Overall Study|Physician Decision|1
837305|NCT01790438|2751930|P2|Overall Study|Protocol Required Discontinuation|1
837306|NCT01790438|2751931|P1|Overall Study|Protocol Required Discontinuation|7
837307|NCT01790438|2751930|P2|Overall Study|Sponsor Decision|3
837308|NCT01790438|2751931|P1|Overall Study|Sponsor Decision|0
837309|NCT01790438|2751930|P2|Overall Study|Physician Decision|1
837310|NCT01790438|2751931|P1|Overall Study|Physician Decision|3
837311|NCT01790438|2751930|P2|Overall Study|Withdrawal by Subject|2
837312|NCT01790438|2751931|P1|Overall Study|Withdrawal by Subject|13
837313|NCT01790438|2751930|P2|Overall Study|Lost to Follow-up|2
837314|NCT01790438|2751931|P1|Overall Study|Lost to Follow-up|5
837315|NCT01790438|2751930|P2|Overall Study|Death|0
837316|NCT01790438|2751931|P1|Overall Study|Death|4
837317|NCT01790438|2751930|P2|Overall Study|Adverse Event|2
837318|NCT01790438|2751931|P1|Overall Study|Adverse Event|3
837319|NCT01789970|2752000|P3|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
837320|NCT01789970|2752001|P2|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1
837321|NCT01789970|2752002|P1|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
837322|NCT01789970|2752000|P3|Double-blind Treatment Period (12 Weeks)|Not specified|3
837323|NCT01789970|2752001|P2|Double-blind Treatment Period (12 Weeks)|Not specified|1
837324|NCT01789970|2752002|P1|Double-blind Treatment Period (12 Weeks)|Not specified|0
837325|NCT01789970|2752000|P3|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
837326|NCT01789970|2752001|P2|Double-blind Treatment Period (12 Weeks)|Pregnancy|1
837327|NCT01789970|2752002|P1|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
837328|NCT01789970|2752000|P3|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2
837329|NCT01789970|2752001|P2|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1
837330|NCT01789970|2752002|P1|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0
837331|NCT01789970|2752000|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1
837332|NCT01789970|2752001|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2
837333|NCT01789970|2752002|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0
837334|NCT01789970|2752000|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
837335|NCT01789970|2752001|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
837336|NCT01789970|2752002|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
837337|NCT01789970|2752000|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7
837338|NCT01789970|2752001|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
837339|NCT01789970|2752002|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
837340|NCT01789970|2752000|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9
837341|NCT01789970|2752001|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7
837342|NCT01789970|2752002|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
837343|NCT01789970|2752000|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
837344|NCT01789970|2752001|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
837345|NCT01789970|2752002|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
837346|NCT01789970|2752000|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|15
837347|NCT01789970|2752001|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|9
837348|NCT01789970|2752002|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
837349|NCT01789970|2752000|P3|Open-label Titration Period|Dropped out prior to dosing|0
837350|NCT01789970|2752001|P2|Open-label Titration Period|Dropped out prior to dosing|0
837351|NCT01789970|2752002|P1|Open-label Titration Period|Dropped out prior to dosing|2
837352|NCT01789970|2752000|P3|Open-label Titration Period|Not specified|0
837353|NCT01789970|2752001|P2|Open-label Titration Period|Not specified|0
837354|NCT01789970|2752002|P1|Open-label Titration Period|Not specified|76
837355|NCT01789970|2752000|P3|Open-label Titration Period|Pregnancy|0
837356|NCT01789970|2752001|P2|Open-label Titration Period|Pregnancy|0
837357|NCT01789970|2752002|P1|Open-label Titration Period|Pregnancy|2
837358|NCT01789970|2752000|P3|Open-label Titration Period|Noncompliance with study procedures|0
837359|NCT01789970|2752001|P2|Open-label Titration Period|Noncompliance with study procedures|0
837360|NCT01789970|2752002|P1|Open-label Titration Period|Noncompliance with study procedures|8
837361|NCT01789970|2752000|P3|Open-label Titration Period|Noncompliance with study rescue meds|0
837362|NCT01789970|2752001|P2|Open-label Titration Period|Noncompliance with study rescue meds|0
837363|NCT01789970|2752002|P1|Open-label Titration Period|Noncompliance with study rescue meds|2
837364|NCT01789970|2752000|P3|Open-label Titration Period|Noncompliance to study drug admin|0
837365|NCT01789970|2752001|P2|Open-label Titration Period|Noncompliance to study drug admin|0
837366|NCT01789970|2752002|P1|Open-label Titration Period|Noncompliance to study drug admin|11
837367|NCT01789970|2752000|P3|Open-label Titration Period|Lost to Follow-up|0
837368|NCT01789970|2752001|P2|Open-label Titration Period|Lost to Follow-up|0
837369|NCT01789970|2752002|P1|Open-label Titration Period|Lost to Follow-up|5
837370|NCT01789970|2752000|P3|Open-label Titration Period|Protocol Violation|0
837371|NCT01789970|2752001|P2|Open-label Titration Period|Protocol Violation|0
837372|NCT01789970|2752002|P1|Open-label Titration Period|Protocol Violation|18
837373|NCT01789970|2752000|P3|Open-label Titration Period|Withdrawal by Subject|0
837374|NCT01789970|2752001|P2|Open-label Titration Period|Withdrawal by Subject|0
837375|NCT01789970|2752002|P1|Open-label Titration Period|Withdrawal by Subject|31
837376|NCT01789970|2752000|P3|Open-label Titration Period|Lack of Efficacy|0
837377|NCT01789970|2752001|P2|Open-label Titration Period|Lack of Efficacy|0
837378|NCT01789970|2752002|P1|Open-label Titration Period|Lack of Efficacy|31
837379|NCT01789970|2752000|P3|Open-label Titration Period|Adverse Event|0
837380|NCT01789970|2752001|P2|Open-label Titration Period|Adverse Event|0
837381|NCT01789970|2752002|P1|Open-label Titration Period|Adverse Event|68
837382|NCT01789606|2752054|P2|Overall Study|Ineligible or not Willing to Continue|348
837383|NCT01789606|2752055|P1|Overall Study|Ineligible or not Willing to Continue|0
837384|NCT01789606|2752054|P2|Overall Study|Lost to Follow-up|14
837385|NCT01789606|2752055|P1|Overall Study|Lost to Follow-up|0
837386|NCT01789606|2752054|P2|Overall Study|Adverse Event|3
837387|NCT01789606|2752055|P1|Overall Study|Adverse Event|0
837388|NCT01789606|2752054|P2|Overall Study|Protocol Violation|55
837389|NCT01789606|2752055|P1|Overall Study|Protocol Violation|0
837390|NCT01789606|2752054|P2|Overall Study|No Study Medication Taken|1
837391|NCT01789606|2752055|P1|Overall Study|No Study Medication Taken|0
837392|NCT01789606|2752054|P2|Overall Study|Administrative Reasons|6
837393|NCT01789606|2752055|P1|Overall Study|Administrative Reasons|17
837394|NCT01789606|2752054|P2|Overall Study|Ineligible|2
837395|NCT01789606|2752055|P1|Overall Study|Ineligible|6
837396|NCT01789606|2752054|P2|Overall Study|Withdrawal by Subject|1
837397|NCT01789606|2752055|P1|Overall Study|Withdrawal by Subject|0
837398|NCT01789606|2752054|P2|Overall Study|Participant not Purchased the Product|20
837399|NCT01789606|2752055|P1|Overall Study|Participant not Purchased the Product|0
837400|NCT01789567|2752073|P1|Overall Study|Death|6
837401|NCT01789476|2752082|P2|Overall Study|Unable to get IV access|0
837402|NCT01789476|2752083|P1|Overall Study|Unable to get IV access|1
837403|NCT01789476|2752082|P2|Overall Study|Adverse Event|0
837404|NCT01789476|2752083|P1|Overall Study|Adverse Event|1
837405|NCT01789476|2752082|P2|Overall Study|Lack of Efficacy|2
837406|NCT01789476|2752083|P1|Overall Study|Lack of Efficacy|6
837407|NCT01788943|2752116|P2|Overall Study|Withdrawal by Subject|0
837408|NCT01788943|2752117|P1|Overall Study|Withdrawal by Subject|1
837409|NCT01788566|2752146|P1|Overall Study|Clinical Progressive Disease|3
837410|NCT01788566|2752146|P1|Overall Study|Adverse Event|1
837411|NCT01788566|2752146|P1|Overall Study|Death|4
837412|NCT01788358|2752156|P1|Overall Study|Adverse Event|51
837413|NCT01788358|2752156|P1|Overall Study|Lack of Efficacy|1
837414|NCT01788358|2752156|P1|Overall Study|Withdrawal by Subject|26
837415|NCT01788358|2752156|P1|Overall Study|Protocol Violation|3
837416|NCT01788358|2752156|P1|Overall Study|Lost to Follow-up|5
837417|NCT01788358|2752156|P1|Overall Study|Logistical difficulties|1
837418|NCT01788358|2752156|P1|Overall Study|Other|11
837419|NCT01788228|2752170|P2|Overall Study|Migrated/moved from study area|0
837420|NCT01788228|2752171|P1|Overall Study|Migrated/moved from study area|1
837421|NCT01788215|2752190|P2|Overall Study|Lost to Follow-up|0
837422|NCT01788215|2752191|P1|Overall Study|Lost to Follow-up|2
837423|NCT01788215|2752190|P2|Overall Study|Withdrawal by Subject|1
837424|NCT01788215|2752191|P1|Overall Study|Withdrawal by Subject|0
837425|NCT01788163|2752220|P9|Overall Study|Withdrawal by Subject|1
837426|NCT01788163|2752221|P8|Overall Study|Withdrawal by Subject|0
837427|NCT01788163|2752222|P7|Overall Study|Withdrawal by Subject|0
837428|NCT01788163|2752223|P6|Overall Study|Withdrawal by Subject|0
837429|NCT01788163|2752224|P5|Overall Study|Withdrawal by Subject|0
837430|NCT01788163|2752225|P4|Overall Study|Withdrawal by Subject|0
837431|NCT01788163|2752226|P3|Overall Study|Withdrawal by Subject|0
837432|NCT01788163|2752227|P2|Overall Study|Withdrawal by Subject|0
837433|NCT01788163|2752228|P1|Overall Study|Withdrawal by Subject|2
837434|NCT01788163|2752220|P9|Overall Study|Other|15
837435|NCT01788163|2752221|P8|Overall Study|Other|48
837436|NCT01788163|2752222|P7|Overall Study|Other|1
837437|NCT01788163|2752223|P6|Overall Study|Other|7
837438|NCT01788163|2752224|P5|Overall Study|Other|0
837439|NCT01788163|2752225|P4|Overall Study|Other|0
837440|NCT01788163|2752226|P3|Overall Study|Other|0
837441|NCT01788163|2752227|P2|Overall Study|Other|0
837442|NCT01788163|2752228|P1|Overall Study|Other|53
837443|NCT01788046|2752391|P2|Overall Study|Protocol Specified Criteria|1
837444|NCT01788046|2752392|P1|Overall Study|Protocol Specified Criteria|25
837445|NCT01788046|2752391|P2|Overall Study|Death|5
837446|NCT01788046|2752392|P1|Overall Study|Death|7
837447|NCT01788046|2752391|P2|Overall Study|Lost to Follow-up|19
837448|NCT01788046|2752392|P1|Overall Study|Lost to Follow-up|12
837449|NCT01788046|2752391|P2|Overall Study|Withdrawal by Subject|12
837450|NCT01788046|2752392|P1|Overall Study|Withdrawal by Subject|12
837451|NCT01787838|2752415|P1|Overall Study|refused|1413
837452|NCT01787825|2752419|P2|Overall Study|Data Not Analyzable|1
837453|NCT01787825|2752420|P1|Overall Study|Data Not Analyzable|5
837454|NCT01787825|2752419|P2|Overall Study|Subject Did Not Ingest Capsules|0
837455|NCT01787825|2752420|P1|Overall Study|Subject Did Not Ingest Capsules|1
837456|NCT01787760|2752438|P3|Overall Study|Near vision blur|0
837457|NCT01787760|2752439|P2|Overall Study|Near vision blur|0
837458|NCT01787760|2752440|P1|Overall Study|Near vision blur|1
837459|NCT01787760|2752438|P3|Overall Study|Unsatisfactory visual response|0
837460|NCT01787760|2752439|P2|Overall Study|Unsatisfactory visual response|1
837461|NCT01787760|2752440|P1|Overall Study|Unsatisfactory visual response|1
837462|NCT01787760|2752438|P3|Overall Study|Unsatisfactory physiological response|0
837463|NCT01787760|2752439|P2|Overall Study|Unsatisfactory physiological response|4
837464|NCT01787760|2752440|P1|Overall Study|Unsatisfactory physiological response|2
837465|NCT01787760|2752438|P3|Overall Study|Unsatisfactory lens fitting performance|0
837466|NCT01787760|2752439|P2|Overall Study|Unsatisfactory lens fitting performance|6
837467|NCT01787760|2752440|P1|Overall Study|Unsatisfactory lens fitting performance|3
837468|NCT01787760|2752438|P3|Overall Study|Stroke|0
837469|NCT01787760|2752439|P2|Overall Study|Stroke|0
837470|NCT01787760|2752440|P1|Overall Study|Stroke|1
837471|NCT01787760|2752438|P3|Overall Study|Lost to Follow-up|1
837472|NCT01787760|2752439|P2|Overall Study|Lost to Follow-up|0
837473|NCT01787760|2752440|P1|Overall Study|Lost to Follow-up|1
837474|NCT01787760|2752438|P3|Overall Study|Withdrawal by Subject|2
837475|NCT01787760|2752439|P2|Overall Study|Withdrawal by Subject|1
837476|NCT01787760|2752440|P1|Overall Study|Withdrawal by Subject|5
837477|NCT01787760|2752438|P3|Overall Study|Protocol Violation|1
837478|NCT01787760|2752439|P2|Overall Study|Protocol Violation|0
837479|NCT01787760|2752440|P1|Overall Study|Protocol Violation|6
837480|NCT01787760|2752438|P3|Overall Study|Lens handling difficulty|0
837481|NCT01787760|2752439|P2|Overall Study|Lens handling difficulty|2
837482|NCT01787760|2752440|P1|Overall Study|Lens handling difficulty|1
837483|NCT01787760|2752438|P3|Overall Study|Lens discomfort|0
837484|NCT01787760|2752439|P2|Overall Study|Lens discomfort|0
837485|NCT01787760|2752440|P1|Overall Study|Lens discomfort|3
837486|NCT01787760|2752438|P3|Overall Study|Relocation|0
837487|NCT01787760|2752439|P2|Overall Study|Relocation|1
837488|NCT01787760|2752440|P1|Overall Study|Relocation|1
837489|NCT01787760|2752438|P3|Overall Study|Dryness|0
837490|NCT01787760|2752439|P2|Overall Study|Dryness|1
837491|NCT01787760|2752440|P1|Overall Study|Dryness|0
837492|NCT01787760|2752438|P3|Overall Study|Decompensated on left exotropia|1
837493|NCT01787760|2752439|P2|Overall Study|Decompensated on left exotropia|0
837494|NCT01787760|2752440|P1|Overall Study|Decompensated on left exotropia|0
837495|NCT01787760|2752438|P3|Overall Study|Anisometropia > -1.00D in spherical equi|0
837496|NCT01787760|2752439|P2|Overall Study|Anisometropia > -1.00D in spherical equi|0
837497|NCT01787760|2752440|P1|Overall Study|Anisometropia > -1.00D in spherical equi|1
837498|NCT01787591|2752454|P4|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1
837499|NCT01787591|2752455|P3|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
837500|NCT01787591|2752456|P2|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
837501|NCT01787591|2752457|P1|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
837502|NCT01787461|2752485|P2|Overall Study|Protocol Violation|0
837503|NCT01787461|2752486|P1|Overall Study|Protocol Violation|3
837504|NCT01787461|2752485|P2|Overall Study|Withdrawal by Subject|4
837505|NCT01787461|2752486|P1|Overall Study|Withdrawal by Subject|3
837506|NCT01787461|2752485|P2|Overall Study|No longer met eligibility criteria|0
837507|NCT01787461|2752486|P1|Overall Study|No longer met eligibility criteria|1
837508|NCT01787461|2752485|P2|Overall Study|Lost to Follow-up|2
837509|NCT01787461|2752486|P1|Overall Study|Lost to Follow-up|3
837510|NCT01787461|2752485|P2|Overall Study|Adverse Event|3
837511|NCT01787461|2752486|P1|Overall Study|Adverse Event|4
837512|NCT01787279|2752542|P1|Overall Study|Lack of Efficacy|1
837513|NCT01787279|2752542|P1|Overall Study|Lost to Follow-up|2
837514|NCT01787188|2752568|P3|Overall Study|Other, including patient moved|0
837515|NCT01787188|2752569|P2|Overall Study|Other, including patient moved|3
837516|NCT01787188|2752570|P1|Overall Study|Other, including patient moved|0
837517|NCT01787188|2752568|P3|Overall Study|Lost to Follow-up|2
837518|NCT01787188|2752569|P2|Overall Study|Lost to Follow-up|2
837519|NCT01787188|2752570|P1|Overall Study|Lost to Follow-up|1
837520|NCT01787188|2752568|P3|Overall Study|Protocol Violation|3
837521|NCT01787188|2752569|P2|Overall Study|Protocol Violation|2
837522|NCT01787188|2752570|P1|Overall Study|Protocol Violation|3
837523|NCT01787188|2752568|P3|Overall Study|Withdrawal by Subject|2
837524|NCT01787188|2752569|P2|Overall Study|Withdrawal by Subject|3
837525|NCT01787188|2752570|P1|Overall Study|Withdrawal by Subject|4
837526|NCT01787188|2752568|P3|Overall Study|Non-compliance with Study Drug|0
837527|NCT01787188|2752569|P2|Overall Study|Non-compliance with Study Drug|1
837528|NCT01787188|2752570|P1|Overall Study|Non-compliance with Study Drug|0
837529|NCT01787188|2752568|P3|Overall Study|Lack of Efficacy|5
837530|NCT01787188|2752569|P2|Overall Study|Lack of Efficacy|3
837531|NCT01787188|2752570|P1|Overall Study|Lack of Efficacy|7
837532|NCT01787188|2752568|P3|Overall Study|Adverse Event|6
837533|NCT01787188|2752569|P2|Overall Study|Adverse Event|4
837534|NCT01787188|2752570|P1|Overall Study|Adverse Event|2
837535|NCT01787032|2752642|P6|Overall Study|Protocol Violation|1
837536|NCT01787032|2752643|P5|Overall Study|Protocol Violation|1
837537|NCT01787032|2752644|P4|Overall Study|Protocol Violation|0
837538|NCT01787032|2752645|P3|Overall Study|Protocol Violation|0
837539|NCT01787032|2752646|P2|Overall Study|Protocol Violation|0
837540|NCT01787032|2752647|P1|Overall Study|Protocol Violation|0
837541|NCT01786993|2752671|P2|Overall Study|Hospice Admission|0
837542|NCT01786993|2752672|P1|Overall Study|Hospice Admission|1
837543|NCT01786993|2752671|P2|Overall Study|System Explant|0
837544|NCT01786993|2752672|P1|Overall Study|System Explant|1
837545|NCT01786993|2752671|P2|Overall Study|Subject Non-Compliance|0
837546|NCT01786993|2752672|P1|Overall Study|Subject Non-Compliance|1
837547|NCT01786993|2752671|P2|Overall Study|Lost to Follow-up|1
837548|NCT01786993|2752672|P1|Overall Study|Lost to Follow-up|0
837549|NCT01786993|2752671|P2|Overall Study|Withdrawal by Subject|2
837550|NCT01786993|2752672|P1|Overall Study|Withdrawal by Subject|3
837551|NCT01786993|2752671|P2|Overall Study|Death|7
837552|NCT01786993|2752672|P1|Overall Study|Death|6
837553|NCT01786707|2752731|P2|Overall Study|Lost to Follow-up|1
837554|NCT01786707|2752732|P1|Overall Study|Lost to Follow-up|1
837555|NCT01786668|2752744|P4|Overall Study|Lost to Follow-up|0
837556|NCT01786668|2752745|P3|Overall Study|Lost to Follow-up|1
837557|NCT01786668|2752746|P2|Overall Study|Lost to Follow-up|0
837558|NCT01786668|2752747|P1|Overall Study|Lost to Follow-up|1
837559|NCT01786668|2752744|P4|Overall Study|Pregnancy|1
837560|NCT01786668|2752745|P3|Overall Study|Pregnancy|0
837561|NCT01786668|2752746|P2|Overall Study|Pregnancy|0
837562|NCT01786668|2752747|P1|Overall Study|Pregnancy|0
837563|NCT01786668|2752744|P4|Overall Study|Withdrawal by Subject|1
837564|NCT01786668|2752745|P3|Overall Study|Withdrawal by Subject|3
837565|NCT01786668|2752746|P2|Overall Study|Withdrawal by Subject|0
837566|NCT01786668|2752747|P1|Overall Study|Withdrawal by Subject|0
837567|NCT01786668|2752744|P4|Overall Study|Adverse Event|2
837568|NCT01786668|2752745|P3|Overall Study|Adverse Event|1
837569|NCT01786668|2752746|P2|Overall Study|Adverse Event|1
837570|NCT01786668|2752747|P1|Overall Study|Adverse Event|0
837571|NCT01786629|2752847|P2|Overall Study|Adverse Event|1
837572|NCT01786629|2752848|P1|Overall Study|Adverse Event|0
837573|NCT01786629|2752847|P2|Overall Study|Lack of Efficacy|4
837574|NCT01786629|2752848|P1|Overall Study|Lack of Efficacy|0
837575|NCT01786551|2752854|P1|Overall Study|Participant withdrew consent|2
837576|NCT01786330|2752862|P2|Overall Study|Protocol Violation|0
837577|NCT01786330|2752863|P1|Overall Study|Protocol Violation|1
837578|NCT01786330|2752862|P2|Overall Study|Excluded intraoperatively|1
837579|NCT01786330|2752863|P1|Overall Study|Excluded intraoperatively|0
837580|NCT01786330|2752862|P2|Overall Study|Lost to Follow-up|1
837581|NCT01786330|2752863|P1|Overall Study|Lost to Follow-up|0
837582|NCT01786330|2752862|P2|Overall Study|Withdrawal by Subject|1
837583|NCT01786330|2752863|P1|Overall Study|Withdrawal by Subject|0
837584|NCT01786174|2752901|P2|Overall Study|Discontinued Study Drug|0
837585|NCT01786174|2752902|P1|Overall Study|Discontinued Study Drug|2
837586|NCT01786109|2752932|P3|Overall Study|adverse effects colon preparation|1
837587|NCT01786109|2752933|P2|Overall Study|adverse effects colon preparation|0
837588|NCT01786109|2752934|P1|Overall Study|adverse effects colon preparation|0
837589|NCT01786109|2752932|P3|Overall Study|unrelated illness|1
837590|NCT01786109|2752933|P2|Overall Study|unrelated illness|0
837591|NCT01786109|2752934|P1|Overall Study|unrelated illness|0
837592|NCT01786109|2752932|P3|Overall Study|fail manometry barostat tube placement|0
837593|NCT01786109|2752933|P2|Overall Study|fail manometry barostat tube placement|0
837594|NCT01786109|2752934|P1|Overall Study|fail manometry barostat tube placement|1
837595|NCT01785875|2752963|P3|Overall Study|Missing|3
837596|NCT01785875|2752964|P2|Overall Study|Missing|1
837597|NCT01785875|2752965|P1|Overall Study|Missing|0
837598|NCT01785875|2752963|P3|Overall Study|Protocol Specified Criteria|55
837599|NCT01785875|2752964|P2|Overall Study|Protocol Specified Criteria|214
837600|NCT01785875|2752965|P1|Overall Study|Protocol Specified Criteria|207
837601|NCT01785875|2752963|P3|Overall Study|Sponsor Decision|0
837602|NCT01785875|2752964|P2|Overall Study|Sponsor Decision|2
837603|NCT01785875|2752965|P1|Overall Study|Sponsor Decision|0
837604|NCT01785875|2752963|P3|Overall Study|Death|7
837605|NCT01785875|2752964|P2|Overall Study|Death|16
837606|NCT01785875|2752965|P1|Overall Study|Death|27
837607|NCT01785875|2752963|P3|Overall Study|Lost to Follow-up|6
837608|NCT01785875|2752964|P2|Overall Study|Lost to Follow-up|22
837609|NCT01785875|2752965|P1|Overall Study|Lost to Follow-up|19
837610|NCT01785875|2752963|P3|Overall Study|Withdrawal by Subject|36
837611|NCT01785875|2752964|P2|Overall Study|Withdrawal by Subject|34
837612|NCT01785875|2752965|P1|Overall Study|Withdrawal by Subject|41
837613|NCT01785849|2753034|P2|Overall Study|Lost to Follow-up|11
837614|NCT01785849|2753035|P1|Overall Study|Lost to Follow-up|10
837615|NCT01785849|2753034|P2|Overall Study|Sponsor Decision|1
837616|NCT01785849|2753035|P1|Overall Study|Sponsor Decision|0
837617|NCT01785849|2753034|P2|Overall Study|Withdrawal by Subject|12
837618|NCT01785849|2753035|P1|Overall Study|Withdrawal by Subject|15
837619|NCT01785849|2753034|P2|Overall Study|Protocol Specified Criteria|1
837620|NCT01785849|2753035|P1|Overall Study|Protocol Specified Criteria|29
837621|NCT01785849|2753034|P2|Overall Study|Death|9
837622|NCT01785849|2753035|P1|Overall Study|Death|7
837623|NCT01785628|2753053|P2|Overall Study|Lost to Follow-up|3
837624|NCT01785628|2753054|P1|Overall Study|Lost to Follow-up|2
837625|NCT01785615|2753077|P4|Dietary Phase|Lost to Follow-up|24
837626|NCT01785615|2753078|P3|Dietary Phase|Lost to Follow-up|0
837627|NCT01785615|2753079|P2|Dietary Phase|Lost to Follow-up|0
837628|NCT01785615|2753080|P1|Dietary Phase|Lost to Follow-up|0
837629|NCT01785602|2753152|P2|Overall Study|Administrative problems|3
837630|NCT01785602|2753153|P1|Overall Study|Administrative problems|7
837631|NCT01785602|2753152|P2|Overall Study|Adverse Event|5
837632|NCT01785602|2753153|P1|Overall Study|Adverse Event|3
837633|NCT01785602|2753152|P2|Overall Study|Lost to Follow-up|1
837634|NCT01785602|2753153|P1|Overall Study|Lost to Follow-up|1
837635|NCT01785602|2753152|P2|Overall Study|Withdrawal by Subject|0
837636|NCT01785602|2753153|P1|Overall Study|Withdrawal by Subject|2
837637|NCT01785524|2753163|P2|Overall Study|Withdrawal by Subject|2
837638|NCT01785524|2753164|P1|Overall Study|Withdrawal by Subject|2
837639|NCT01785472|2753183|P3|Overall Study|Technical problems|1
837640|NCT01785472|2753184|P2|Overall Study|Technical problems|0
837641|NCT01785472|2753185|P1|Overall Study|Technical problems|0
837642|NCT01785472|2753183|P3|Overall Study|Subject/guardian decision|11
837643|NCT01785472|2753184|P2|Overall Study|Subject/guardian decision|10
837644|NCT01785472|2753185|P1|Overall Study|Subject/guardian decision|15
837645|NCT01785472|2753183|P3|Overall Study|Protocol deviation|2
837646|NCT01785472|2753184|P2|Overall Study|Protocol deviation|2
837647|NCT01785472|2753185|P1|Overall Study|Protocol deviation|0
837648|NCT01785472|2753183|P3|Overall Study|Physician Decision|1
837649|NCT01785472|2753184|P2|Overall Study|Physician Decision|1
837650|NCT01785472|2753185|P1|Overall Study|Physician Decision|1
837651|NCT01785472|2753183|P3|Overall Study|Lost to Follow-up|0
837652|NCT01785472|2753184|P2|Overall Study|Lost to Follow-up|2
837653|NCT01785472|2753185|P1|Overall Study|Lost to Follow-up|1
837654|NCT01785472|2753183|P3|Overall Study|Lack of Efficacy|1
837655|NCT01785472|2753184|P2|Overall Study|Lack of Efficacy|0
837656|NCT01785472|2753185|P1|Overall Study|Lack of Efficacy|2
837657|NCT01785472|2753183|P3|Overall Study|Adverse Event|6
837658|NCT01785472|2753184|P2|Overall Study|Adverse Event|4
837659|NCT01785472|2753185|P1|Overall Study|Adverse Event|5
837660|NCT01785160|2753258|P1|Washout Period of at Least 7 Days|Consent withdrawn|1
837661|NCT01785160|2753258|P1|Treatment Period 1: Raltegravir|Not treated|1
837662|NCT01784965|2753293|P2|Overall Study|Adverse Event|8
837663|NCT01784965|2753294|P1|Overall Study|Adverse Event|0
837664|NCT01784965|2753293|P2|Overall Study|Withdrawal by Subject|3
837665|NCT01784965|2753294|P1|Overall Study|Withdrawal by Subject|6
837666|NCT01784029|2753370|P3|Overall Study|Lost to Follow-up|22
837667|NCT01784029|2753371|P2|Overall Study|Lost to Follow-up|20
837668|NCT01784029|2753372|P1|Overall Study|Lost to Follow-up|19
837669|NCT01783938|2753382|P2|Overall Study|Not Specified|0
837670|NCT01783938|2753383|P1|Overall Study|Not Specified|1
837671|NCT01783938|2753382|P2|Overall Study|Withdrew Consent|0
837672|NCT01783938|2753383|P1|Overall Study|Withdrew Consent|3
837673|NCT01783938|2753382|P2|Overall Study|Request to Discontinue Study Treatment|2
837674|NCT01783938|2753383|P1|Overall Study|Request to Discontinue Study Treatment|1
837675|NCT01783938|2753382|P2|Overall Study|Adverse Event Unrelated to Study Drug|2
837676|NCT01783938|2753383|P1|Overall Study|Adverse Event Unrelated to Study Drug|2
837677|NCT01783938|2753382|P2|Overall Study|Study Drug Toxicity|10
837678|NCT01783938|2753383|P1|Overall Study|Study Drug Toxicity|22
837679|NCT01783938|2753382|P2|Overall Study|Disease Progression|39
837680|NCT01783938|2753383|P1|Overall Study|Disease Progression|18
837681|NCT01783886|2753411|P3|Overall Study|Adverse Event|4
837682|NCT01783886|2753412|P2|Overall Study|Adverse Event|5
837683|NCT01783886|2753413|P1|Overall Study|Adverse Event|4
837684|NCT01783886|2753411|P3|Overall Study|Withdrawal of consent by participant|4
837685|NCT01783886|2753412|P2|Overall Study|Withdrawal of consent by participant|3
837686|NCT01783886|2753413|P1|Overall Study|Withdrawal of consent by participant|1
837687|NCT01783886|2753411|P3|Overall Study|Protocol deviation|2
837688|NCT01783886|2753412|P2|Overall Study|Protocol deviation|0
837689|NCT01783886|2753413|P1|Overall Study|Protocol deviation|0
837690|NCT01783886|2753411|P3|Overall Study|Lost to Follow-up|0
837691|NCT01783886|2753412|P2|Overall Study|Lost to Follow-up|3
837692|NCT01783886|2753413|P1|Overall Study|Lost to Follow-up|0
837693|NCT01783821|2753473|P2|Overall Study|Screen Failure|1
837694|NCT01783821|2753474|P1|Overall Study|Screen Failure|1
837695|NCT01783743|2753492|P2|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236
837696|NCT01783743|2753493|P1|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305
837697|NCT01783743|2753492|P2|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684
837698|NCT01783743|2753493|P1|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591
837699|NCT01783743|2753492|P2|Screening of Subjects by CTA During MDA|Absent at MDA|4439
837700|NCT01783743|2753493|P1|Screening of Subjects by CTA During MDA|Absent at MDA|3427
837701|NCT01783730|2753507|P1|Overall Study|Failed to meet inclusion criteria|6
837702|NCT01783678|2753532|P6|Overall Study|Withdrew Consent|0
837703|NCT01783678|2753533|P5|Overall Study|Withdrew Consent|0
837704|NCT01783678|2753534|P4|Overall Study|Withdrew Consent|2
837705|NCT01783678|2753535|P3|Overall Study|Withdrew Consent|0
837706|NCT01783678|2753536|P2|Overall Study|Withdrew Consent|1
837707|NCT01783678|2753537|P1|Overall Study|Withdrew Consent|1
837708|NCT01783678|2753532|P6|Overall Study|Lost to Follow-up|0
837709|NCT01783678|2753533|P5|Overall Study|Lost to Follow-up|1
837710|NCT01783678|2753534|P4|Overall Study|Lost to Follow-up|2
837711|NCT01783678|2753535|P3|Overall Study|Lost to Follow-up|0
837712|NCT01783678|2753536|P2|Overall Study|Lost to Follow-up|4
837713|NCT01783678|2753537|P1|Overall Study|Lost to Follow-up|0
837714|NCT01783678|2753532|P6|Overall Study|Lack of Efficacy|5
837715|NCT01783678|2753533|P5|Overall Study|Lack of Efficacy|6
837716|NCT01783678|2753534|P4|Overall Study|Lack of Efficacy|3
837717|NCT01783678|2753535|P3|Overall Study|Lack of Efficacy|1
837718|NCT01783678|2753536|P2|Overall Study|Lack of Efficacy|13
837719|NCT01783678|2753537|P1|Overall Study|Lack of Efficacy|1
837720|NCT01783678|2753532|P6|Overall Study|Randomized but Not Treated|0
837721|NCT01783678|2753533|P5|Overall Study|Randomized but Not Treated|0
837722|NCT01783678|2753534|P4|Overall Study|Randomized but Not Treated|1
837723|NCT01783678|2753535|P3|Overall Study|Randomized but Not Treated|0
837724|NCT01783678|2753536|P2|Overall Study|Randomized but Not Treated|0
837725|NCT01783678|2753537|P1|Overall Study|Randomized but Not Treated|0
837726|NCT01783548|2753641|P2|Overall Study|Lack of Efficacy|1
837727|NCT01783548|2753642|P1|Overall Study|Lack of Efficacy|1
837728|NCT01783548|2753641|P2|Overall Study|Lost to Follow-up|3
837729|NCT01783548|2753642|P1|Overall Study|Lost to Follow-up|8
837730|NCT01783548|2753641|P2|Overall Study|Protocol Violation|2
837731|NCT01783548|2753642|P1|Overall Study|Protocol Violation|2
837732|NCT01783548|2753641|P2|Overall Study|Non-compliance|0
837733|NCT01783548|2753642|P1|Overall Study|Non-compliance|4
837734|NCT01783548|2753641|P2|Overall Study|Withdrawal by Subject|8
837735|NCT01783548|2753642|P1|Overall Study|Withdrawal by Subject|11
837736|NCT01783548|2753641|P2|Overall Study|Adverse Event|4
837737|NCT01783548|2753642|P1|Overall Study|Adverse Event|8
837738|NCT01783496|2753660|P6|Overall Study|Withdrawal by Subject|0
837739|NCT01783496|2753661|P5|Overall Study|Withdrawal by Subject|0
837740|NCT01783496|2753662|P4|Overall Study|Withdrawal by Subject|0
837741|NCT01783496|2753663|P3|Overall Study|Withdrawal by Subject|0
837742|NCT01783496|2753664|P2|Overall Study|Withdrawal by Subject|0
837743|NCT01783496|2753665|P1|Overall Study|Withdrawal by Subject|1
837744|NCT01783496|2753660|P6|Overall Study|Lost to Follow-up|1
837745|NCT01783496|2753661|P5|Overall Study|Lost to Follow-up|0
837746|NCT01783496|2753662|P4|Overall Study|Lost to Follow-up|2
837747|NCT01783496|2753663|P3|Overall Study|Lost to Follow-up|0
837748|NCT01783496|2753664|P2|Overall Study|Lost to Follow-up|0
837749|NCT01783496|2753665|P1|Overall Study|Lost to Follow-up|0
837750|NCT01783483|2753693|P2|Overall Study|Physician Decision|1
837751|NCT01783483|2753694|P1|Overall Study|Physician Decision|1
837752|NCT01783483|2753693|P2|Overall Study|Withdrawal by Subject|1
837753|NCT01783483|2753694|P1|Overall Study|Withdrawal by Subject|2
837754|NCT01783483|2753693|P2|Overall Study|Lost to Follow-up|10
837755|NCT01783483|2753694|P1|Overall Study|Lost to Follow-up|14
837756|NCT01783483|2753693|P2|Overall Study|Death|3
837757|NCT01783483|2753694|P1|Overall Study|Death|3
837758|NCT01783418|2753732|P2|Overall Study|Withdrawal by Subject|0
837759|NCT01783418|2753733|P1|Overall Study|Withdrawal by Subject|1
837760|NCT01783015|2753786|P3|Open Label Treatment|Study Terminated by Sponsor|6
837761|NCT01783015|2753787|P2|Open Label Treatment|Study Terminated by Sponsor|0
837762|NCT01783015|2753788|P1|Open Label Treatment|Study Terminated by Sponsor|0
837763|NCT01783015|2753786|P3|Blinded Treatment|Study Terminated by Sponsor|0
837764|NCT01783015|2753787|P2|Blinded Treatment|Study Terminated by Sponsor|0
837765|NCT01783015|2753788|P1|Blinded Treatment|Study Terminated by Sponsor|2
837766|NCT01783015|2753786|P3|Blinded Treatment|Withdrawal by Subject|0
837767|NCT01783015|2753787|P2|Blinded Treatment|Withdrawal by Subject|1
837768|NCT01783015|2753788|P1|Blinded Treatment|Withdrawal by Subject|0
837769|NCT01783015|2753786|P3|Blinded Treatment|Protocol Violation|0
837770|NCT01783015|2753787|P2|Blinded Treatment|Protocol Violation|1
837771|NCT01783015|2753788|P1|Blinded Treatment|Protocol Violation|0
837772|NCT01783015|2753786|P3|Blinded Treatment|Adverse Event|0
837773|NCT01783015|2753787|P2|Blinded Treatment|Adverse Event|1
837774|NCT01783015|2753788|P1|Blinded Treatment|Adverse Event|0
837775|NCT01782885|2753901|P2|Overall Study|Lost to Follow-up|6
837776|NCT01782885|2753902|P1|Overall Study|Lost to Follow-up|4
837777|NCT01782872|2753928|P4|Overall Study|Withdrawal by Subject|0
837778|NCT01782872|2753929|P3|Overall Study|Withdrawal by Subject|0
837779|NCT01782872|2753930|P2|Overall Study|Withdrawal by Subject|1
837780|NCT01782872|2753931|P1|Overall Study|Withdrawal by Subject|0
837781|NCT01782872|2753928|P4|Overall Study|Protocol Violation|1
837782|NCT01782872|2753929|P3|Overall Study|Protocol Violation|0
837783|NCT01782872|2753930|P2|Overall Study|Protocol Violation|0
837784|NCT01782872|2753931|P1|Overall Study|Protocol Violation|0
837785|NCT01782859|2753955|P2|Overall Study|Withdrawal by Subject|1
837786|NCT01782859|2753956|P1|Overall Study|Withdrawal by Subject|0
837787|NCT01782859|2753955|P2|Overall Study|Protocol Violation|6
837788|NCT01782859|2753956|P1|Overall Study|Protocol Violation|6
837789|NCT01782742|2753978|P2|Double-blind Treatment Phase|Adverse Event|0
837790|NCT01782742|2753979|P1|Double-blind Treatment Phase|Adverse Event|1
837791|NCT01782690|2754012|P1|Overall Study|Study completion unknown|7
837792|NCT01782690|2754012|P1|Overall Study|Death|133
837793|NCT01782690|2754012|P1|Overall Study|Tumor progression|74
837794|NCT01782690|2754012|P1|Overall Study|Patient's wish|21
837795|NCT01782690|2754012|P1|Overall Study|Physician Decision|13
837796|NCT01782690|2754012|P1|Overall Study|Absent rash|9
837797|NCT01782690|2754012|P1|Overall Study|Withdrawal of informed consent|2
837798|NCT01782690|2754012|P1|Overall Study|Lost to Follow-up|31
837799|NCT01782690|2754012|P1|Overall Study|Toxicity of erlotinib|1
837800|NCT01782690|2754012|P1|Overall Study|Toxicity of gemcitabine|1
837801|NCT01782690|2754012|P1|Overall Study|Not reported|7
837802|NCT01782664|2754034|P6|Overall Study|Withdrawal by Subject|0
837803|NCT01782664|2754035|P5|Overall Study|Withdrawal by Subject|0
837804|NCT01782664|2754036|P4|Overall Study|Withdrawal by Subject|0
837805|NCT01782664|2754037|P3|Overall Study|Withdrawal by Subject|0
837806|NCT01782664|2754038|P2|Overall Study|Withdrawal by Subject|2
837807|NCT01782664|2754039|P1|Overall Study|Withdrawal by Subject|2
837808|NCT01782664|2754034|P6|Overall Study|Protocol Violation|0
837809|NCT01782664|2754035|P5|Overall Study|Protocol Violation|0
837810|NCT01782664|2754036|P4|Overall Study|Protocol Violation|1
837811|NCT01782664|2754037|P3|Overall Study|Protocol Violation|0
837812|NCT01782664|2754038|P2|Overall Study|Protocol Violation|1
837813|NCT01782664|2754039|P1|Overall Study|Protocol Violation|0
837814|NCT01782664|2754034|P6|Overall Study|Lack of Efficacy|0
837815|NCT01782664|2754035|P5|Overall Study|Lack of Efficacy|0
837816|NCT01782664|2754036|P4|Overall Study|Lack of Efficacy|2
837817|NCT01782664|2754037|P3|Overall Study|Lack of Efficacy|2
837818|NCT01782664|2754038|P2|Overall Study|Lack of Efficacy|0
837819|NCT01782664|2754039|P1|Overall Study|Lack of Efficacy|2
837820|NCT01782664|2754034|P6|Overall Study|Adverse Event|0
837821|NCT01782664|2754035|P5|Overall Study|Adverse Event|0
837822|NCT01782664|2754036|P4|Overall Study|Adverse Event|2
837823|NCT01782664|2754037|P3|Overall Study|Adverse Event|2
837824|NCT01782664|2754038|P2|Overall Study|Adverse Event|2
837825|NCT01782664|2754039|P1|Overall Study|Adverse Event|2
837826|NCT01782495|2754196|P11|Overall Study|Withdrew Consent|0
837827|NCT01782495|2754197|P10|Overall Study|Withdrew Consent|0
837828|NCT01782495|2754198|P9|Overall Study|Withdrew Consent|0
837829|NCT01782495|2754199|P8|Overall Study|Withdrew Consent|1
837830|NCT01782495|2754200|P7|Overall Study|Withdrew Consent|0
837831|NCT01782495|2754201|P6|Overall Study|Withdrew Consent|0
837832|NCT01782495|2754202|P5|Overall Study|Withdrew Consent|0
837833|NCT01782495|2754203|P4|Overall Study|Withdrew Consent|0
837834|NCT01782495|2754204|P3|Overall Study|Withdrew Consent|0
837835|NCT01782495|2754205|P2|Overall Study|Withdrew Consent|1
837836|NCT01782495|2754206|P1|Overall Study|Withdrew Consent|0
837837|NCT01782495|2754196|P11|Overall Study|Adverse Event|0
837838|NCT01782495|2754197|P10|Overall Study|Adverse Event|0
837839|NCT01782495|2754198|P9|Overall Study|Adverse Event|0
837840|NCT01782495|2754199|P8|Overall Study|Adverse Event|2
837841|NCT01782495|2754200|P7|Overall Study|Adverse Event|0
837842|NCT01782495|2754201|P6|Overall Study|Adverse Event|0
837843|NCT01782495|2754202|P5|Overall Study|Adverse Event|0
837844|NCT01782495|2754203|P4|Overall Study|Adverse Event|0
837845|NCT01782495|2754204|P3|Overall Study|Adverse Event|0
837846|NCT01782495|2754205|P2|Overall Study|Adverse Event|0
837847|NCT01782495|2754206|P1|Overall Study|Adverse Event|0
837848|NCT01782482|2754265|P2|Overall Study|Habitually wearing toric lens OS|1
837849|NCT01782482|2754266|P1|Overall Study|Habitually wearing toric lens OS|0
837850|NCT01782482|2754265|P2|Overall Study|Randomized in Error|2
837851|NCT01782482|2754266|P1|Overall Study|Randomized in Error|2
837852|NCT01782482|2754265|P2|Overall Study|Withdrawal by Subject|3
837853|NCT01782482|2754266|P1|Overall Study|Withdrawal by Subject|2
837854|NCT01782482|2754265|P2|Overall Study|Protocol Violation|0
837855|NCT01782482|2754266|P1|Overall Study|Protocol Violation|1
837856|NCT01782482|2754265|P2|Overall Study|Physician Decision|0
837857|NCT01782482|2754266|P1|Overall Study|Physician Decision|1
837858|NCT01782482|2754265|P2|Overall Study|Lost to Follow-up|3
837859|NCT01782482|2754266|P1|Overall Study|Lost to Follow-up|2
837860|NCT01782482|2754265|P2|Overall Study|Adverse Event|1
837861|NCT01782482|2754266|P1|Overall Study|Adverse Event|2
837862|NCT01782469|2754274|P1|Overall Study|Lost to Follow-up|1
837863|NCT01782326|2754284|P2|Double-blind Treatment|Technical problems|5
837864|NCT01782326|2754285|P1|Double-blind Treatment|Technical problems|0
837865|NCT01782326|2754284|P2|Double-blind Treatment|Protocol deviation|7
837866|NCT01782326|2754285|P1|Double-blind Treatment|Protocol deviation|8
837867|NCT01782326|2754284|P2|Double-blind Treatment|Physician Decision|16
837868|NCT01782326|2754285|P1|Double-blind Treatment|Physician Decision|13
837869|NCT01782326|2754284|P2|Double-blind Treatment|Lack of Efficacy|22
837870|NCT01782326|2754285|P1|Double-blind Treatment|Lack of Efficacy|17
837871|NCT01782326|2754284|P2|Double-blind Treatment|Subject/guardian decision|125
837872|NCT01782326|2754285|P1|Double-blind Treatment|Subject/guardian decision|111
837873|NCT01782326|2754284|P2|Double-blind Treatment|Adverse Event|145
837874|NCT01782326|2754285|P1|Double-blind Treatment|Adverse Event|129
837875|NCT01782326|2754284|P2|Planned Treatment Epoch|Technical problems|4
837876|NCT01782326|2754285|P1|Planned Treatment Epoch|Technical problems|0
837877|NCT01782326|2754284|P2|Planned Treatment Epoch|Lost to Follow-up|4
837878|NCT01782326|2754285|P1|Planned Treatment Epoch|Lost to Follow-up|4
837879|NCT01782326|2754284|P2|Planned Treatment Epoch|Protocol deviation|3
837880|NCT01782326|2754285|P1|Planned Treatment Epoch|Protocol deviation|2
837881|NCT01782326|2754284|P2|Planned Treatment Epoch|Physician Decision|16
837882|NCT01782326|2754285|P1|Planned Treatment Epoch|Physician Decision|18
837883|NCT01782326|2754284|P2|Planned Treatment Epoch|Death|30
837884|NCT01782326|2754285|P1|Planned Treatment Epoch|Death|29
837885|NCT01782326|2754284|P2|Planned Treatment Epoch|Subject/guardian decision|151
837886|NCT01782326|2754285|P1|Planned Treatment Epoch|Subject/guardian decision|149
837887|NCT01782313|2754345|P1|Survival Follow up|Lost to Follow-up|1
837888|NCT01782313|2754345|P1|Continued Treatment After 16 Weeks|Withdrawal by Subject|1
837889|NCT01782313|2754345|P1|Continued Treatment After 16 Weeks|Progressive Disease|6
837890|NCT01782313|2754345|P1|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1
837891|NCT01782313|2754345|P1|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5
837892|NCT01782313|2754345|P1|Treated Cycle 3|Progressive Disease|21
837893|NCT01782313|2754345|P1|Reached First Response/Completed 2 Cycle|Progressive Disease|3
837894|NCT01782313|2754345|P1|Reached First Response/Completed 2 Cycle|Adverse Event|3
837895|NCT01782222|2754359|P3|Overall Study|Moved to other state|0
837896|NCT01782222|2754360|P2|Overall Study|Moved to other state|1
837897|NCT01782222|2754361|P1|Overall Study|Moved to other state|0
837898|NCT01782222|2754359|P3|Overall Study|Withdrawal by Subject|1
837899|NCT01782222|2754360|P2|Overall Study|Withdrawal by Subject|4
837900|NCT01782222|2754361|P1|Overall Study|Withdrawal by Subject|1
837901|NCT01782222|2754359|P3|Overall Study|Protocol Violation|0
837902|NCT01782222|2754360|P2|Overall Study|Protocol Violation|0
837903|NCT01782222|2754361|P1|Overall Study|Protocol Violation|1
837904|NCT01782222|2754359|P3|Overall Study|Lack of Efficacy|0
837905|NCT01782222|2754360|P2|Overall Study|Lack of Efficacy|1
837906|NCT01782222|2754361|P1|Overall Study|Lack of Efficacy|2
837907|NCT01782222|2754359|P3|Overall Study|Adverse Event|3
837908|NCT01782222|2754360|P2|Overall Study|Adverse Event|5
837909|NCT01782222|2754361|P1|Overall Study|Adverse Event|4
837910|NCT01781975|2754395|P2|Overall Study|Withdrawal by Subject|1
837911|NCT01781975|2754396|P1|Overall Study|Withdrawal by Subject|1
837912|NCT01781975|2754395|P2|Overall Study|Death|0
837913|NCT01781975|2754396|P1|Overall Study|Death|1
837914|NCT01781962|2754402|P1|Overall Study|Other Miscellaneous Reasons|5
837915|NCT01781832|2754408|P1|Overall Study|Withdrawal by Subject|1
837916|NCT01781637|2754428|P2|Overall Study|Withdrawal by Subject|0
837917|NCT01781637|2754429|P1|Overall Study|Withdrawal by Subject|1
837918|NCT01781637|2754428|P2|Overall Study|Lack of Efficacy|6
837919|NCT01781637|2754429|P1|Overall Study|Lack of Efficacy|2
837920|NCT01781637|2754428|P2|Overall Study|Adverse Event|0
837921|NCT01781637|2754429|P1|Overall Study|Adverse Event|1
837922|NCT01781299|2754516|P2|Overall Study|Withdrawal by Subject|1
837923|NCT01781299|2754517|P1|Overall Study|Withdrawal by Subject|0
837924|NCT01781286|2754525|P6|Overall Study|Noncompliance|0
837925|NCT01781286|2754526|P5|Overall Study|Noncompliance|0
837926|NCT01781286|2754527|P4|Overall Study|Noncompliance|1
837927|NCT01781286|2754528|P3|Overall Study|Noncompliance|0
837928|NCT01781286|2754529|P2|Overall Study|Noncompliance|0
837929|NCT01781286|2754530|P1|Overall Study|Noncompliance|0
837930|NCT01781286|2754525|P6|Overall Study|Time Constraints|0
837931|NCT01781286|2754526|P5|Overall Study|Time Constraints|0
837932|NCT01781286|2754527|P4|Overall Study|Time Constraints|0
837933|NCT01781286|2754528|P3|Overall Study|Time Constraints|2
837934|NCT01781286|2754529|P2|Overall Study|Time Constraints|0
837935|NCT01781286|2754530|P1|Overall Study|Time Constraints|2
837936|NCT01781286|2754525|P6|Overall Study|Lost to Follow-up|1
837937|NCT01781286|2754526|P5|Overall Study|Lost to Follow-up|0
837938|NCT01781286|2754527|P4|Overall Study|Lost to Follow-up|0
837939|NCT01781286|2754528|P3|Overall Study|Lost to Follow-up|0
837940|NCT01781286|2754529|P2|Overall Study|Lost to Follow-up|0
837941|NCT01781286|2754530|P1|Overall Study|Lost to Follow-up|0
837942|NCT01781026|2754581|P1|Overall Study|Lack of Efficacy|2
837943|NCT01780987|2754587|P2|Overall Study|Not Receiving any Study Medication|1
837944|NCT01780987|2754588|P1|Overall Study|Not Receiving any Study Medication|0
837945|NCT01780987|2754587|P2|Overall Study|Changing Residence|0
837946|NCT01780987|2754588|P1|Overall Study|Changing Residence|1
837947|NCT01780987|2754587|P2|Overall Study|Request of Changing Hospital|1
837948|NCT01780987|2754588|P1|Overall Study|Request of Changing Hospital|0
837949|NCT01780987|2754587|P2|Overall Study|Withdrawal by Subject|0
837950|NCT01780987|2754588|P1|Overall Study|Withdrawal by Subject|2
837951|NCT01780987|2754587|P2|Overall Study|Adverse Event|4
837952|NCT01780987|2754588|P1|Overall Study|Adverse Event|0
837953|NCT01780974|2754606|P2|Overall Study|Adverse Event|3
837954|NCT01780974|2754607|P1|Overall Study|Adverse Event|1
837955|NCT01780974|2754606|P2|Overall Study|Death|0
837956|NCT01780974|2754607|P1|Overall Study|Death|1
837957|NCT01780935|2754617|P2|Overall Study|Patient withdrew consent|9
837958|NCT01780935|2754618|P1|Overall Study|Patient withdrew consent|8
837959|NCT01780935|2754617|P2|Overall Study|Protocol deviation|1
837960|NCT01780935|2754618|P1|Overall Study|Protocol deviation|0
837961|NCT01780935|2754617|P2|Overall Study|Physician Decision|1
837962|NCT01780935|2754618|P1|Overall Study|Physician Decision|1
837963|NCT01780935|2754617|P2|Overall Study|Lost to Follow-up|6
837964|NCT01780935|2754618|P1|Overall Study|Lost to Follow-up|2
837965|NCT01780935|2754617|P2|Overall Study|Death|6
837966|NCT01780935|2754618|P1|Overall Study|Death|1
837967|NCT01780935|2754617|P2|Overall Study|Adverse Event|4
837968|NCT01780935|2754618|P1|Overall Study|Adverse Event|2
837969|NCT01780935|2754617|P2|Overall Study|Admin problems due to early termination|309
837970|NCT01780935|2754618|P1|Overall Study|Admin problems due to early termination|321
837971|NCT01780584|2754722|P3|Overall Study|Protocol Violation|1
837972|NCT01780584|2754723|P2|Overall Study|Protocol Violation|0
837973|NCT01780584|2754724|P1|Overall Study|Protocol Violation|0
837974|NCT01780584|2754722|P3|Overall Study|Adverse Event|0
837975|NCT01780584|2754723|P2|Overall Study|Adverse Event|1
837976|NCT01780584|2754724|P1|Overall Study|Adverse Event|0
837977|NCT01780584|2754722|P3|Overall Study|Death|1
837978|NCT01780584|2754723|P2|Overall Study|Death|0
837979|NCT01780584|2754724|P1|Overall Study|Death|1
837980|NCT01780545|2754746|P2|Overall Study|Lost to Follow-up|1
837981|NCT01780545|2754747|P1|Overall Study|Lost to Follow-up|1
837982|NCT01780545|2754746|P2|Overall Study|Withdrawal by Subject|1
837983|NCT01780545|2754747|P1|Overall Study|Withdrawal by Subject|3
837984|NCT01780506|2754765|P2|Open-Label Extension Phase|Enrolled but not Treated|1
837985|NCT01780506|2754766|P1|Open-Label Extension Phase|Enrolled but not Treated|0
837986|NCT01780506|2754765|P2|Double-Blind Phase|Lost to Follow-up|26
837987|NCT01780506|2754766|P1|Double-Blind Phase|Lost to Follow-up|23
837988|NCT01780506|2754765|P2|Double-Blind Phase|Withdrew Consent|24
837989|NCT01780506|2754766|P1|Double-Blind Phase|Withdrew Consent|23
837990|NCT01780506|2754765|P2|Double-Blind Phase|Protocol Violation|3
837991|NCT01780506|2754766|P1|Double-Blind Phase|Protocol Violation|4
837992|NCT01780506|2754765|P2|Double-Blind Phase|Non-Compliance with Study Drug|3
837993|NCT01780506|2754766|P1|Double-Blind Phase|Non-Compliance with Study Drug|4
837994|NCT01780506|2754765|P2|Double-Blind Phase|Investigator's Discretion|2
837995|NCT01780506|2754766|P1|Double-Blind Phase|Investigator's Discretion|5
837996|NCT01780506|2754765|P2|Double-Blind Phase|Lack of Efficacy|1
837997|NCT01780506|2754766|P1|Double-Blind Phase|Lack of Efficacy|1
837998|NCT01780506|2754765|P2|Double-Blind Phase|Pregnancy|1
837999|NCT01780506|2754766|P1|Double-Blind Phase|Pregnancy|2
838000|NCT01780506|2754765|P2|Double-Blind Phase|Death|2
838001|NCT01780506|2754766|P1|Double-Blind Phase|Death|1
838002|NCT01780506|2754765|P2|Double-Blind Phase|Adverse Event|14
838003|NCT01780506|2754766|P1|Double-Blind Phase|Adverse Event|4
838004|NCT01780506|2754765|P2|Double-Blind Phase|Randomized but not Treated|2
838005|NCT01780506|2754766|P1|Double-Blind Phase|Randomized but not Treated|3
838006|NCT01780389|2754820|P1|Overall Study|Adverse Event|1
838007|NCT01779869|2754858|P1|Overall Study|Physician Decision|2
838008|NCT01779648|2754864|P2|Overall Study|Protocol Violation|0
838009|NCT01779648|2754865|P1|Overall Study|Protocol Violation|1
838010|NCT01779440|2754895|P2|Overall Study|Withdrawal by Subject|5
838011|NCT01779440|2754896|P1|Overall Study|Withdrawal by Subject|3
838012|NCT01778985|2754954|P2|Overall Study|Protocol Violation|1
838013|NCT01778985|2754955|P1|Overall Study|Protocol Violation|4
838014|NCT01778985|2754954|P2|Overall Study|Physician Decision|2
838015|NCT01778985|2754955|P1|Overall Study|Physician Decision|2
838016|NCT01778985|2754954|P2|Overall Study|Lost to Follow-up|0
838017|NCT01778985|2754955|P1|Overall Study|Lost to Follow-up|1
838018|NCT01778855|2755001|P2|Overall Study|Death|1
838019|NCT01778855|2755002|P1|Overall Study|Death|0
838020|NCT01778751|2755010|P2|Overall Study|Transfered care|0
838021|NCT01778751|2755011|P1|Overall Study|Transfered care|1
838022|NCT01778751|2755010|P2|Overall Study|Withdrawal by Subject|2
838023|NCT01778751|2755011|P1|Overall Study|Withdrawal by Subject|0
838024|NCT01778751|2755010|P2|Overall Study|Lost to Follow-up|0
838025|NCT01778751|2755011|P1|Overall Study|Lost to Follow-up|1
838026|NCT01778530|2755062|P1|Overall Study|Adverse event/side effect|1
838027|NCT01778530|2755062|P1|Overall Study|Progression on study|1
838028|NCT01778127|2755093|P3|Overall Study|Withdrawal by Subject|4
838029|NCT01778127|2755094|P2|Overall Study|Withdrawal by Subject|1
838030|NCT01778127|2755095|P1|Overall Study|Withdrawal by Subject|3
838031|NCT01778127|2755093|P3|Overall Study|Lost to Follow-up|2
838032|NCT01778127|2755094|P2|Overall Study|Lost to Follow-up|1
838033|NCT01778127|2755095|P1|Overall Study|Lost to Follow-up|5
838034|NCT01778062|2755138|P2|Overall Study|major protocol deviation|3
838035|NCT01778062|2755139|P1|Overall Study|major protocol deviation|4
838036|NCT01778062|2755138|P2|Overall Study|Consent Withdrawal|5
838037|NCT01778062|2755139|P1|Overall Study|Consent Withdrawal|1
838038|NCT01778062|2755138|P2|Overall Study|Adverse Event|3
838039|NCT01778062|2755139|P1|Overall Study|Adverse Event|1
838040|NCT01778049|2755153|P6|Double Blind Treatment Period|Other reason not defined above|1
838041|NCT01778049|2755154|P5|Double Blind Treatment Period|Other reason not defined above|2
838042|NCT01778049|2755155|P4|Double Blind Treatment Period|Other reason not defined above|2
838043|NCT01778049|2755156|P3|Double Blind Treatment Period|Other reason not defined above|4
838044|NCT01778049|2755157|P2|Double Blind Treatment Period|Other reason not defined above|0
838045|NCT01778049|2755158|P1|Double Blind Treatment Period|Other reason not defined above|0
838046|NCT01778049|2755153|P6|Double Blind Treatment Period|Not treated|0
838047|NCT01778049|2755154|P5|Double Blind Treatment Period|Not treated|2
838048|NCT01778049|2755155|P4|Double Blind Treatment Period|Not treated|2
838049|NCT01778049|2755156|P3|Double Blind Treatment Period|Not treated|0
838050|NCT01778049|2755157|P2|Double Blind Treatment Period|Not treated|0
838051|NCT01778049|2755158|P1|Double Blind Treatment Period|Not treated|0
838052|NCT01778049|2755153|P6|Double Blind Treatment Period|Withdrawal by Subject|1
838053|NCT01778049|2755154|P5|Double Blind Treatment Period|Withdrawal by Subject|0
838054|NCT01778049|2755155|P4|Double Blind Treatment Period|Withdrawal by Subject|2
838055|NCT01778049|2755156|P3|Double Blind Treatment Period|Withdrawal by Subject|1
838056|NCT01778049|2755157|P2|Double Blind Treatment Period|Withdrawal by Subject|0
838057|NCT01778049|2755158|P1|Double Blind Treatment Period|Withdrawal by Subject|0
838058|NCT01778049|2755153|P6|Double Blind Treatment Period|Lost to Follow-up|2
838059|NCT01778049|2755154|P5|Double Blind Treatment Period|Lost to Follow-up|5
838060|NCT01778049|2755155|P4|Double Blind Treatment Period|Lost to Follow-up|1
838061|NCT01778049|2755156|P3|Double Blind Treatment Period|Lost to Follow-up|4
838062|NCT01778049|2755157|P2|Double Blind Treatment Period|Lost to Follow-up|0
838063|NCT01778049|2755158|P1|Double Blind Treatment Period|Lost to Follow-up|0
838064|NCT01778049|2755153|P6|Double Blind Treatment Period|Protocol Violation|0
838065|NCT01778049|2755154|P5|Double Blind Treatment Period|Protocol Violation|0
838066|NCT01778049|2755155|P4|Double Blind Treatment Period|Protocol Violation|0
838067|NCT01778049|2755156|P3|Double Blind Treatment Period|Protocol Violation|2
838068|NCT01778049|2755157|P2|Double Blind Treatment Period|Protocol Violation|0
838069|NCT01778049|2755158|P1|Double Blind Treatment Period|Protocol Violation|0
838070|NCT01778049|2755153|P6|Double Blind Treatment Period|Lack of Efficacy|1
838071|NCT01778049|2755154|P5|Double Blind Treatment Period|Lack of Efficacy|0
838072|NCT01778049|2755155|P4|Double Blind Treatment Period|Lack of Efficacy|0
838073|NCT01778049|2755156|P3|Double Blind Treatment Period|Lack of Efficacy|0
838074|NCT01778049|2755157|P2|Double Blind Treatment Period|Lack of Efficacy|0
838075|NCT01778049|2755158|P1|Double Blind Treatment Period|Lack of Efficacy|0
838076|NCT01778049|2755153|P6|Double Blind Treatment Period|Adverse Event|2
838077|NCT01778049|2755154|P5|Double Blind Treatment Period|Adverse Event|3
838078|NCT01778049|2755155|P4|Double Blind Treatment Period|Adverse Event|5
838079|NCT01778049|2755156|P3|Double Blind Treatment Period|Adverse Event|4
838080|NCT01778049|2755157|P2|Double Blind Treatment Period|Adverse Event|0
838081|NCT01778049|2755158|P1|Double Blind Treatment Period|Adverse Event|0
838082|NCT01778049|2755153|P6|Open Label Treatment Period|Other reason not defined above|0
838083|NCT01778049|2755154|P5|Open Label Treatment Period|Other reason not defined above|0
838084|NCT01778049|2755155|P4|Open Label Treatment Period|Other reason not defined above|0
838085|NCT01778049|2755156|P3|Open Label Treatment Period|Other reason not defined above|0
838086|NCT01778049|2755157|P2|Open Label Treatment Period|Other reason not defined above|94
838087|NCT01778049|2755158|P1|Open Label Treatment Period|Other reason not defined above|77
838088|NCT01778049|2755153|P6|Open Label Treatment Period|Not treated|0
838089|NCT01778049|2755154|P5|Open Label Treatment Period|Not treated|0
838090|NCT01778049|2755155|P4|Open Label Treatment Period|Not treated|0
838091|NCT01778049|2755156|P3|Open Label Treatment Period|Not treated|0
838092|NCT01778049|2755157|P2|Open Label Treatment Period|Not treated|1
838093|NCT01778049|2755158|P1|Open Label Treatment Period|Not treated|2
838094|NCT01778049|2755153|P6|Open Label Treatment Period|Withdrawal by Subject|0
838095|NCT01778049|2755154|P5|Open Label Treatment Period|Withdrawal by Subject|0
838096|NCT01778049|2755155|P4|Open Label Treatment Period|Withdrawal by Subject|0
838097|NCT01778049|2755156|P3|Open Label Treatment Period|Withdrawal by Subject|0
838098|NCT01778049|2755157|P2|Open Label Treatment Period|Withdrawal by Subject|10
838099|NCT01778049|2755158|P1|Open Label Treatment Period|Withdrawal by Subject|4
838100|NCT01778049|2755153|P6|Open Label Treatment Period|Lost to Follow-up|0
838101|NCT01778049|2755154|P5|Open Label Treatment Period|Lost to Follow-up|0
838102|NCT01778049|2755155|P4|Open Label Treatment Period|Lost to Follow-up|0
838103|NCT01778049|2755156|P3|Open Label Treatment Period|Lost to Follow-up|0
838104|NCT01778049|2755157|P2|Open Label Treatment Period|Lost to Follow-up|3
838105|NCT01778049|2755158|P1|Open Label Treatment Period|Lost to Follow-up|4
838106|NCT01778049|2755153|P6|Open Label Treatment Period|Protocol Violation|0
838107|NCT01778049|2755154|P5|Open Label Treatment Period|Protocol Violation|0
838108|NCT01778049|2755155|P4|Open Label Treatment Period|Protocol Violation|0
838109|NCT01778049|2755156|P3|Open Label Treatment Period|Protocol Violation|0
838110|NCT01778049|2755157|P2|Open Label Treatment Period|Protocol Violation|5
838111|NCT01778049|2755158|P1|Open Label Treatment Period|Protocol Violation|5
838112|NCT01778049|2755153|P6|Open Label Treatment Period|Lack of Efficacy|0
838113|NCT01778049|2755154|P5|Open Label Treatment Period|Lack of Efficacy|0
838114|NCT01778049|2755155|P4|Open Label Treatment Period|Lack of Efficacy|0
838115|NCT01778049|2755156|P3|Open Label Treatment Period|Lack of Efficacy|0
838116|NCT01778049|2755157|P2|Open Label Treatment Period|Lack of Efficacy|1
838117|NCT01778049|2755158|P1|Open Label Treatment Period|Lack of Efficacy|1
838118|NCT01778049|2755153|P6|Open Label Treatment Period|Adverse Event|0
838119|NCT01778049|2755154|P5|Open Label Treatment Period|Adverse Event|0
838120|NCT01778049|2755155|P4|Open Label Treatment Period|Adverse Event|0
838121|NCT01778049|2755156|P3|Open Label Treatment Period|Adverse Event|0
838122|NCT01778049|2755157|P2|Open Label Treatment Period|Adverse Event|15
838123|NCT01778049|2755158|P1|Open Label Treatment Period|Adverse Event|5
838124|NCT01778023|2755176|P2|Overall Study|Withdrawal by Subject|3
838125|NCT01778023|2755177|P1|Overall Study|Withdrawal by Subject|0
838126|NCT01778010|2755194|P1|Overall Study|rash while on placebo|1
838127|NCT01778010|2755194|P1|Overall Study|Arrested|1
838128|NCT01778010|2755194|P1|Overall Study|abnormal ECG before meds|1
838129|NCT01778010|2755194|P1|Overall Study|Withdrawal by Subject|2
838130|NCT01777997|2755235|P1|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1
838131|NCT01777997|2755235|P1|Weeks 48 to 72/96 on ART|Death|1
838132|NCT01777997|2755235|P1|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1
838133|NCT01777997|2755235|P1|12 Week lead-in of no ART|Severe debilitation|2
838134|NCT01777932|2755257|P1|Overall Study|Patient refused further treatment|10
838135|NCT01777932|2755257|P1|Overall Study|Reimbursement limit|9
838136|NCT01777932|2755257|P1|Overall Study|Investigator decision|10
838137|NCT01777932|2755257|P1|Overall Study|Lost to Follow-up|3
838138|NCT01777932|2755257|P1|Overall Study|Adverse Event|34
838139|NCT01777932|2755257|P1|Overall Study|Death|3
838140|NCT01777932|2755257|P1|Overall Study|Disease progression|136
838141|NCT01777854|2755271|P2|Overall Study|Physician Decision|3
838142|NCT01777854|2755272|P1|Overall Study|Physician Decision|3
838143|NCT01777776|2755280|P4|Overall Study|Withdrawal by Subject|1
838144|NCT01777776|2755281|P3|Overall Study|Withdrawal by Subject|0
838145|NCT01777776|2755282|P2|Overall Study|Withdrawal by Subject|0
838146|NCT01777776|2755283|P1|Overall Study|Withdrawal by Subject|0
838147|NCT01777776|2755280|P4|Overall Study|Disease Progression|3
838148|NCT01777776|2755281|P3|Overall Study|Disease Progression|6
838149|NCT01777776|2755282|P2|Overall Study|Disease Progression|8
838150|NCT01777776|2755283|P1|Overall Study|Disease Progression|4
838151|NCT01777776|2755280|P4|Overall Study|Adverse Event|0
838152|NCT01777776|2755281|P3|Overall Study|Adverse Event|0
838153|NCT01777776|2755282|P2|Overall Study|Adverse Event|4
838154|NCT01777776|2755283|P1|Overall Study|Adverse Event|2
838155|NCT01777763|2755342|P2|Overall Study|Treatment Failure|6
838156|NCT01777763|2755343|P1|Overall Study|Treatment Failure|1
838157|NCT01777763|2755342|P2|Overall Study|Withdrawal by Subject|2
838158|NCT01777763|2755343|P1|Overall Study|Withdrawal by Subject|0
838159|NCT01777763|2755342|P2|Overall Study|Protocol Violation|7
838160|NCT01777763|2755343|P1|Overall Study|Protocol Violation|1
838161|NCT01777763|2755342|P2|Overall Study|Adverse Event|32
838162|NCT01777763|2755343|P1|Overall Study|Adverse Event|2
838163|NCT01777620|2755367|P2|Overall Study|Subject Withdrawal|0
838164|NCT01777620|2755368|P1|Overall Study|Subject Withdrawal|1
838165|NCT01777581|2755394|P2|Overall Study|Lack of Efficacy|1
838166|NCT01777581|2755395|P1|Overall Study|Lack of Efficacy|0
838167|NCT01777581|2755394|P2|Overall Study|Adverse Event|0
838168|NCT01777581|2755395|P1|Overall Study|Adverse Event|2
838169|NCT01777581|2755394|P2|Overall Study|Lost to Follow-up|1
838170|NCT01777581|2755395|P1|Overall Study|Lost to Follow-up|1
838171|NCT01777542|2755413|P2|Second Intervention (20 Weeks)|Adverse Event|1
838172|NCT01777542|2755414|P1|Second Intervention (20 Weeks)|Adverse Event|0
838173|NCT01777334|2755482|P2|Overall Study|Withdrawal by Subject|11
838174|NCT01777334|2755483|P1|Overall Study|Withdrawal by Subject|14
838175|NCT01777334|2755482|P2|Overall Study|Lost to Follow-up|2
838176|NCT01777334|2755483|P1|Overall Study|Lost to Follow-up|3
838177|NCT01777334|2755482|P2|Overall Study|Protocol Violation|7
838178|NCT01777334|2755483|P1|Overall Study|Protocol Violation|3
838179|NCT01777334|2755482|P2|Overall Study|Lack of Efficacy|29
838180|NCT01777334|2755483|P1|Overall Study|Lack of Efficacy|15
838181|NCT01777334|2755482|P2|Overall Study|Adverse Event|14
838182|NCT01777334|2755483|P1|Overall Study|Adverse Event|18
838183|NCT01777321|2755493|P2|Overall Study|Withdrawal by Subject|1
838184|NCT01777321|2755494|P1|Overall Study|Withdrawal by Subject|0
838185|NCT01777282|2755535|P5|Overall Study|Moved, transfer abroad, did not enter FU|0
838186|NCT01777282|2755536|P4|Overall Study|Moved, transfer abroad, did not enter FU|0
838187|NCT01777282|2755537|P3|Overall Study|Moved, transfer abroad, did not enter FU|1
838188|NCT01777282|2755538|P2|Overall Study|Moved, transfer abroad, did not enter FU|0
838189|NCT01777282|2755539|P1|Overall Study|Moved, transfer abroad, did not enter FU|1
838190|NCT01777282|2755535|P5|Overall Study|Protocol Violation|2
838191|NCT01777282|2755536|P4|Overall Study|Protocol Violation|0
838192|NCT01777282|2755537|P3|Overall Study|Protocol Violation|1
838193|NCT01777282|2755538|P2|Overall Study|Protocol Violation|0
838194|NCT01777282|2755539|P1|Overall Study|Protocol Violation|2
838195|NCT01777282|2755535|P5|Overall Study|Withdrawal by Subject|2
838196|NCT01777282|2755536|P4|Overall Study|Withdrawal by Subject|1
838197|NCT01777282|2755537|P3|Overall Study|Withdrawal by Subject|0
838198|NCT01777282|2755538|P2|Overall Study|Withdrawal by Subject|0
838199|NCT01777282|2755539|P1|Overall Study|Withdrawal by Subject|4
838200|NCT01777282|2755535|P5|Overall Study|Adverse Event|3
838201|NCT01777282|2755536|P4|Overall Study|Adverse Event|1
838202|NCT01777282|2755537|P3|Overall Study|Adverse Event|2
838203|NCT01777282|2755538|P2|Overall Study|Adverse Event|4
838204|NCT01777282|2755539|P1|Overall Study|Adverse Event|4
838205|NCT01777282|2755535|P5|Overall Study|New Antidiabetic Medication|0
838206|NCT01777282|2755536|P4|Overall Study|New Antidiabetic Medication|0
838207|NCT01777282|2755537|P3|Overall Study|New Antidiabetic Medication|1
838208|NCT01777282|2755538|P2|Overall Study|New Antidiabetic Medication|0
838209|NCT01777282|2755539|P1|Overall Study|New Antidiabetic Medication|0
838210|NCT01777282|2755535|P5|Overall Study|Persistent Hyperglycemia|0
838211|NCT01777282|2755536|P4|Overall Study|Persistent Hyperglycemia|0
838212|NCT01777282|2755537|P3|Overall Study|Persistent Hyperglycemia|1
838213|NCT01777282|2755538|P2|Overall Study|Persistent Hyperglycemia|0
838214|NCT01777282|2755539|P1|Overall Study|Persistent Hyperglycemia|0
838215|NCT01777269|2755583|P2|Overall Study|Withdrawal by Subject|9
838216|NCT01777269|2755584|P1|Overall Study|Withdrawal by Subject|9
838217|NCT01777269|2755583|P2|Overall Study|Physician Decision|2
838218|NCT01777269|2755584|P1|Overall Study|Physician Decision|5
838219|NCT01777269|2755583|P2|Overall Study|Lost to Follow-up|0
838220|NCT01777269|2755584|P1|Overall Study|Lost to Follow-up|4
838221|NCT01777269|2755583|P2|Overall Study|Participants reached stopping criteria|1
838222|NCT01777269|2755584|P1|Overall Study|Participants reached stopping criteria|1
838223|NCT01777269|2755583|P2|Overall Study|Protocol Violation|4
838224|NCT01777269|2755584|P1|Overall Study|Protocol Violation|4
838225|NCT01777269|2755583|P2|Overall Study|Lack of Efficacy|10
838226|NCT01777269|2755584|P1|Overall Study|Lack of Efficacy|8
838227|NCT01777269|2755583|P2|Overall Study|Adverse Event|33
838228|NCT01777269|2755584|P1|Overall Study|Adverse Event|24
838229|NCT01777191|2755621|P2|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3
838230|NCT01777191|2755622|P1|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1
838231|NCT01777191|2755621|P2|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2
838232|NCT01777191|2755622|P1|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1
838233|NCT01777191|2755621|P2|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
838234|NCT01777191|2755622|P1|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
838235|NCT01777191|2755621|P2|Safety Extension Per (Week 12-Week 48)|Death|1
838236|NCT01777191|2755622|P1|Safety Extension Per (Week 12-Week 48)|Death|0
838237|NCT01777191|2755621|P2|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
838238|NCT01777191|2755622|P1|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
838239|NCT01777191|2755621|P2|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0
838240|NCT01777191|2755622|P1|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1
838241|NCT01777191|2755621|P2|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
838242|NCT01777191|2755622|P1|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
838243|NCT01777191|2755621|P2|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3
838244|NCT01777191|2755622|P1|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0
838245|NCT01777191|2755621|P2|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2
838246|NCT01777191|2755622|P1|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1
838247|NCT01777191|2755621|P2|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
838248|NCT01777191|2755622|P1|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
838249|NCT01777191|2755621|P2|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1
838250|NCT01777191|2755622|P1|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2
838251|NCT01776554|2755685|P2|Overall Study|Unclassified|1
838252|NCT01776554|2755686|P1|Overall Study|Unclassified|4
838253|NCT01776554|2755685|P2|Overall Study|Protocol Violation|0
838254|NCT01776554|2755686|P1|Overall Study|Protocol Violation|1
838255|NCT01776554|2755685|P2|Overall Study|Administrative Reason|5
838256|NCT01776554|2755686|P1|Overall Study|Administrative Reason|2
838257|NCT01776554|2755685|P2|Overall Study|Lost to Follow-up|9
838258|NCT01776554|2755686|P1|Overall Study|Lost to Follow-up|6
838259|NCT01776554|2755685|P2|Overall Study|Withdrawal by Subject|8
838260|NCT01776554|2755686|P1|Overall Study|Withdrawal by Subject|3
838261|NCT01776554|2755685|P2|Overall Study|Adverse Event|0
838262|NCT01776554|2755686|P1|Overall Study|Adverse Event|1
838263|NCT01776541|2755729|P2|Overall Study|Withdrawal by Subject|20
838264|NCT01776541|2755730|P1|Overall Study|Withdrawal by Subject|12
838265|NCT01776541|2755729|P2|Overall Study|Protocol Violation|1
838266|NCT01776541|2755730|P1|Overall Study|Protocol Violation|2
838267|NCT01776541|2755729|P2|Overall Study|Unclassified|4
838268|NCT01776541|2755730|P1|Overall Study|Unclassified|5
838269|NCT01776541|2755729|P2|Overall Study|Lost to Follow-up|48
838270|NCT01776541|2755730|P1|Overall Study|Lost to Follow-up|27
838271|NCT01776541|2755729|P2|Overall Study|Death|0
838272|NCT01776541|2755730|P1|Overall Study|Death|4
838273|NCT01776541|2755729|P2|Overall Study|Administrative Reason|2
838274|NCT01776541|2755730|P1|Overall Study|Administrative Reason|6
838275|NCT01776424|2755752|P3|Overall Study|Withdrawal by Subject|15
838276|NCT01776424|2755753|P2|Overall Study|Withdrawal by Subject|11
838277|NCT01776424|2755754|P1|Overall Study|Withdrawal by Subject|10
838278|NCT01776424|2755752|P3|Overall Study|Lost to Follow-up|9
838279|NCT01776424|2755753|P2|Overall Study|Lost to Follow-up|8
838280|NCT01776424|2755754|P1|Overall Study|Lost to Follow-up|10
838281|NCT01776008|2755785|P1|Overall Study|ineligible|2
838282|NCT01775995|2755799|P2|Overall Study|Lost to Follow-up|1
838283|NCT01775995|2755800|P1|Overall Study|Lost to Follow-up|1
838284|NCT01775787|2755904|P2|Second 7-10 Days|concerns with using IV|1
838285|NCT01775787|2755905|P1|Second 7-10 Days|concerns with using IV|0
838286|NCT01775787|2755904|P2|Second 7-10 Days|time commitment|1
838287|NCT01775787|2755905|P1|Second 7-10 Days|time commitment|0
838288|NCT01775787|2755904|P2|First 7-10 Days|concerns with using IV|2
838289|NCT01775787|2755905|P1|First 7-10 Days|concerns with using IV|1
838290|NCT01775787|2755904|P2|First 7-10 Days|time commitment|2
838291|NCT01775787|2755905|P1|First 7-10 Days|time commitment|0
838292|NCT01775787|2755904|P2|First 7-10 Days|family emergency|1
838293|NCT01775787|2755905|P1|First 7-10 Days|family emergency|0
838294|NCT01775787|2755904|P2|First 7-10 Days|Adverse Event|1
838295|NCT01775787|2755905|P1|First 7-10 Days|Adverse Event|0
838296|NCT01775670|2755961|P2|Overall Study|Lost to Follow-up|1
838297|NCT01775670|2755962|P1|Overall Study|Lost to Follow-up|1
838298|NCT01775553|2755988|P1|Overall Study|Disease Progression|12
838299|NCT01775553|2755988|P1|Overall Study|Adverse Event|1
838300|NCT01775189|2755996|P7|Treatment Phase: Washout Period 3|Protocol Violation|1
838301|NCT01775189|2755997|P6|Treatment Phase: Washout Period 3|Protocol Violation|0
838302|NCT01775189|2755998|P5|Treatment Phase: Washout Period 3|Protocol Violation|0
838303|NCT01775189|2755999|P4|Treatment Phase: Washout Period 3|Protocol Violation|1
838304|NCT01775189|2756000|P3|Treatment Phase: Washout Period 3|Protocol Violation|0
838305|NCT01775189|2756001|P2|Treatment Phase: Washout Period 3|Protocol Violation|0
838306|NCT01775189|2756002|P1|Treatment Phase: Washout Period 3|Protocol Violation|0
838307|NCT01775189|2755996|P7|Treatment Phase: Washout Period 2|Protocol Violation|0
838308|NCT01775189|2755997|P6|Treatment Phase: Washout Period 2|Protocol Violation|0
838309|NCT01775189|2755998|P5|Treatment Phase: Washout Period 2|Protocol Violation|0
838310|NCT01775189|2755999|P4|Treatment Phase: Washout Period 2|Protocol Violation|1
838311|NCT01775189|2756000|P3|Treatment Phase: Washout Period 2|Protocol Violation|0
838312|NCT01775189|2756001|P2|Treatment Phase: Washout Period 2|Protocol Violation|0
838313|NCT01775189|2756002|P1|Treatment Phase: Washout Period 2|Protocol Violation|0
838314|NCT01775189|2755996|P7|Treatment Phase: Washout Period 1|Protocol Violation|0
838315|NCT01775189|2755997|P6|Treatment Phase: Washout Period 1|Protocol Violation|1
838316|NCT01775189|2755998|P5|Treatment Phase: Washout Period 1|Protocol Violation|0
838317|NCT01775189|2755999|P4|Treatment Phase: Washout Period 1|Protocol Violation|0
838318|NCT01775189|2756000|P3|Treatment Phase: Washout Period 1|Protocol Violation|0
838319|NCT01775189|2756001|P2|Treatment Phase: Washout Period 1|Protocol Violation|0
838320|NCT01775189|2756002|P1|Treatment Phase: Washout Period 1|Protocol Violation|0
838321|NCT01775189|2755996|P7|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
838322|NCT01775189|2755997|P6|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
838323|NCT01775189|2755998|P5|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
838324|NCT01775189|2755999|P4|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
838325|NCT01775189|2756000|P3|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7
838326|NCT01775189|2756001|P2|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2
838327|NCT01775189|2756002|P1|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
838328|NCT01775189|2755996|P7|Drug Discrimination Phase: Day 2|Protocol Violation|0
838329|NCT01775189|2755997|P6|Drug Discrimination Phase: Day 2|Protocol Violation|0
838330|NCT01775189|2755998|P5|Drug Discrimination Phase: Day 2|Protocol Violation|0
838331|NCT01775189|2755999|P4|Drug Discrimination Phase: Day 2|Protocol Violation|0
838332|NCT01775189|2756000|P3|Drug Discrimination Phase: Day 2|Protocol Violation|0
838333|NCT01775189|2756001|P2|Drug Discrimination Phase: Day 2|Protocol Violation|1
838334|NCT01775189|2756002|P1|Drug Discrimination Phase: Day 2|Protocol Violation|0
838335|NCT01775189|2755996|P7|Drug Discrimination Phase: Day 1|Adverse Event|0
838336|NCT01775189|2755997|P6|Drug Discrimination Phase: Day 1|Adverse Event|0
838337|NCT01775189|2755998|P5|Drug Discrimination Phase: Day 1|Adverse Event|0
838338|NCT01775189|2755999|P4|Drug Discrimination Phase: Day 1|Adverse Event|0
838339|NCT01775189|2756000|P3|Drug Discrimination Phase: Day 1|Adverse Event|0
838340|NCT01775189|2756001|P2|Drug Discrimination Phase: Day 1|Adverse Event|3
838341|NCT01775189|2756002|P1|Drug Discrimination Phase: Day 1|Adverse Event|0
838342|NCT01775137|2756221|P1|Overall Study|Withdrawal by participants|5
838343|NCT01775137|2756221|P1|Overall Study|Adverse Event|1
838344|NCT01775137|2756221|P1|Overall Study|Unsatisfactory therapeutic effect|2
838345|NCT01775137|2756221|P1|Overall Study|Protocol deviation|2
838346|NCT01775137|2756221|P1|Overall Study|Death|1
838347|NCT01775124|2756248|P2|Extension Period|Withdrawal by Subject|12
838348|NCT01775124|2756249|P1|Extension Period|Withdrawal by Subject|9
838349|NCT01775124|2756248|P2|Extension Period|Lost to Follow-up|1
838350|NCT01775124|2756249|P1|Extension Period|Lost to Follow-up|0
838351|NCT01775124|2756248|P2|Extension Period|Administrative problems|1
838352|NCT01775124|2756249|P1|Extension Period|Administrative problems|0
838353|NCT01775124|2756248|P2|Extension Period|Physician Decision|2
838354|NCT01775124|2756249|P1|Extension Period|Physician Decision|0
838355|NCT01775124|2756248|P2|Extension Period|Adverse Event|2
838356|NCT01775124|2756249|P1|Extension Period|Adverse Event|3
838357|NCT01775124|2756248|P2|Core Period|Adverse Event|5
838358|NCT01775124|2756249|P1|Core Period|Adverse Event|5
838359|NCT01775124|2756248|P2|Core Period|Withdrawal by Subject|2
838360|NCT01775124|2756249|P1|Core Period|Withdrawal by Subject|4
838361|NCT01775124|2756248|P2|Core Period|Administrative problems|0
838362|NCT01775124|2756249|P1|Core Period|Administrative problems|1
838363|NCT01775124|2756248|P2|Core Period|Death|1
838364|NCT01775124|2756249|P1|Core Period|Death|0
838365|NCT01775124|2756248|P2|Core Period|Physician Decision|1
838366|NCT01775124|2756249|P1|Core Period|Physician Decision|1
838367|NCT01775124|2756248|P2|Core Period|Disease Progression|1
838368|NCT01775124|2756249|P1|Core Period|Disease Progression|0
838369|NCT01774981|2756284|P8|Overall Study|Death|0
838370|NCT01774981|2756285|P7|Overall Study|Death|0
838371|NCT01774981|2756286|P6|Overall Study|Death|0
838372|NCT01774981|2756287|P5|Overall Study|Death|1
838373|NCT01774981|2756288|P4|Overall Study|Death|0
838374|NCT01774981|2756289|P3|Overall Study|Death|0
838375|NCT01774981|2756290|P2|Overall Study|Death|0
838376|NCT01774981|2756291|P1|Overall Study|Death|0
838377|NCT01774981|2756284|P8|Overall Study|Withdrawal by Subject|1
838378|NCT01774981|2756285|P7|Overall Study|Withdrawal by Subject|0
838379|NCT01774981|2756286|P6|Overall Study|Withdrawal by Subject|0
838380|NCT01774981|2756287|P5|Overall Study|Withdrawal by Subject|0
838381|NCT01774981|2756288|P4|Overall Study|Withdrawal by Subject|0
838382|NCT01774981|2756289|P3|Overall Study|Withdrawal by Subject|0
838383|NCT01774981|2756290|P2|Overall Study|Withdrawal by Subject|0
838384|NCT01774981|2756291|P1|Overall Study|Withdrawal by Subject|0
838385|NCT01774981|2756284|P8|Overall Study|Adverse Event|0
838386|NCT01774981|2756285|P7|Overall Study|Adverse Event|0
838387|NCT01774981|2756286|P6|Overall Study|Adverse Event|1
838388|NCT01774981|2756287|P5|Overall Study|Adverse Event|0
838389|NCT01774981|2756288|P4|Overall Study|Adverse Event|0
838390|NCT01774981|2756289|P3|Overall Study|Adverse Event|0
838391|NCT01774981|2756290|P2|Overall Study|Adverse Event|0
838392|NCT01774981|2756291|P1|Overall Study|Adverse Event|0
838393|NCT01774968|2756323|P2|Overall Study|Withdrawal by Subject|11
838394|NCT01774968|2756324|P1|Overall Study|Withdrawal by Subject|6
838395|NCT01774968|2756323|P2|Overall Study|Sponsor Decision|2
838396|NCT01774968|2756324|P1|Overall Study|Sponsor Decision|0
838397|NCT01774968|2756323|P2|Overall Study|Protocol Violation|13
838398|NCT01774968|2756324|P1|Overall Study|Protocol Violation|14
838399|NCT01774968|2756323|P2|Overall Study|Physician Decision|1
838400|NCT01774968|2756324|P1|Overall Study|Physician Decision|5
838401|NCT01774968|2756323|P2|Overall Study|Lost to Follow-up|3
838402|NCT01774968|2756324|P1|Overall Study|Lost to Follow-up|1
838403|NCT01774968|2756323|P2|Overall Study|Death|1
838404|NCT01774968|2756324|P1|Overall Study|Death|0
838405|NCT01774968|2756323|P2|Overall Study|Adverse Event|4
838406|NCT01774968|2756324|P1|Overall Study|Adverse Event|4
838407|NCT01774929|2756358|P1|Overall Study|Adverse Event|3
838408|NCT01774903|2756364|P1|Overall Study|Ineligible to continue the trial|1
838409|NCT01774903|2756364|P1|Overall Study|Lack of Efficacy|1
838410|NCT01774903|2756364|P1|Overall Study|Withdrawal by Subject|2
838411|NCT01774903|2756364|P1|Overall Study|Adverse Event|7
838412|NCT01774786|2756382|P2|Overall Study|Ineligible for Study|3
838413|NCT01774786|2756383|P1|Overall Study|Ineligible for Study|1
838414|NCT01774786|2756382|P2|Overall Study|Physician Decision|0
838415|NCT01774786|2756383|P1|Overall Study|Physician Decision|1
838416|NCT01774786|2756382|P2|Overall Study|Withdrawal by Subject|12
838417|NCT01774786|2756383|P1|Overall Study|Withdrawal by Subject|15
838418|NCT01774786|2756382|P2|Overall Study|Lost to Follow-up|4
838419|NCT01774786|2756383|P1|Overall Study|Lost to Follow-up|3
838420|NCT01774786|2756382|P2|Overall Study|Death|262
838421|NCT01774786|2756383|P1|Overall Study|Death|242
838422|NCT01774786|2756382|P2|Overall Study|In Follow-up|62
838423|NCT01774786|2756383|P1|Overall Study|In Follow-up|65
838424|NCT01774786|2756382|P2|Overall Study|Between Treatment and Follow-up|2
838425|NCT01774786|2756383|P1|Overall Study|Between Treatment and Follow-up|6
838426|NCT01774786|2756382|P2|Overall Study|On Treatment|47
838427|NCT01774786|2756383|P1|Overall Study|On Treatment|55
838428|NCT01774721|2756413|P2|Overall Study|Ongoing in study|120
838429|NCT01774721|2756414|P1|Overall Study|Ongoing in study|136
838430|NCT01774721|2756413|P2|Overall Study|Did not meet eligibility criteria|3
838431|NCT01774721|2756414|P1|Overall Study|Did not meet eligibility criteria|0
838432|NCT01774721|2756413|P2|Overall Study|Lost to Follow-up|1
838433|NCT01774721|2756414|P1|Overall Study|Lost to Follow-up|1
838434|NCT01774721|2756413|P2|Overall Study|Withdrawal by Subject|10
838435|NCT01774721|2756414|P1|Overall Study|Withdrawal by Subject|14
838436|NCT01774721|2756413|P2|Overall Study|Death|91
838437|NCT01774721|2756414|P1|Overall Study|Death|76
838438|NCT01774591|2756479|P2|Overall Study|Adverse Event|2
838439|NCT01774591|2756480|P1|Overall Study|Adverse Event|0
838440|NCT01774591|2756479|P2|Overall Study|Withdrawal by Subject|1
838441|NCT01774591|2756480|P1|Overall Study|Withdrawal by Subject|0
838442|NCT01774591|2756479|P2|Overall Study|Physician Decision|1
838443|NCT01774591|2756480|P1|Overall Study|Physician Decision|1
838444|NCT01774344|2756492|P2|Overall Study|Non-compliance with study drug|2
838445|NCT01774344|2756493|P1|Overall Study|Non-compliance with study drug|0
838446|NCT01774344|2756492|P2|Overall Study|Physician Decision|1
838447|NCT01774344|2756493|P1|Overall Study|Physician Decision|0
838448|NCT01774344|2756492|P2|Overall Study|Adverse event (AE)|1
838449|NCT01774344|2756493|P1|Overall Study|Adverse event (AE)|0
838450|NCT01774344|2756492|P2|Overall Study|AE not related to disease progression|47
838451|NCT01774344|2756493|P1|Overall Study|AE not related to disease progression|12
838452|NCT01774344|2756492|P2|Overall Study|Ongoing with treatment|65
838453|NCT01774344|2756493|P1|Overall Study|Ongoing with treatment|10
838454|NCT01774344|2756492|P2|Overall Study|Other|0
838455|NCT01774344|2756493|P1|Overall Study|Other|1
838456|NCT01774344|2756492|P2|Overall Study|Study drug never administered|5
838457|NCT01774344|2756493|P1|Overall Study|Study drug never administered|1
838458|NCT01774344|2756492|P2|Overall Study|Withdrawal by Subject|26
838459|NCT01774344|2756493|P1|Overall Study|Withdrawal by Subject|5
838460|NCT01774344|2756492|P2|Overall Study|Protocol Violation|1
838461|NCT01774344|2756493|P1|Overall Study|Protocol Violation|3
838462|NCT01774305|2756509|P2|Overall Study|Physician Decision|0
838463|NCT01774305|2756510|P1|Overall Study|Physician Decision|1
838464|NCT01774253|2756518|P1|Overall Study|Death|1
838465|NCT01774253|2756518|P1|Overall Study|Withdrawal by Subject|2
838466|NCT01774253|2756518|P1|Overall Study|Physician Decision|2
838467|NCT01774253|2756518|P1|Overall Study|Lack of Efficacy|4
838468|NCT01774110|2756537|P1|Overall Study|Lost to Follow-up|7
838469|NCT01774097|2756545|P2|Overall Study|Adverse Event|1
838470|NCT01774097|2756546|P1|Overall Study|Adverse Event|1
838471|NCT01774097|2756545|P2|Overall Study|Withdrawal by Subject|1
838472|NCT01774097|2756546|P1|Overall Study|Withdrawal by Subject|1
838473|NCT01774084|2756576|P2|Overall Study|Personal reasons|0
838474|NCT01774084|2756577|P1|Overall Study|Personal reasons|1
838475|NCT01773889|2756607|P1|Overall Study|lack of funding|2
838476|NCT01773473|2756613|P2|Overall Study|Lost to Follow-up|0
838477|NCT01773473|2756614|P1|Overall Study|Lost to Follow-up|2
838478|NCT01773473|2756613|P2|Overall Study|Withdrawal by Subject|3
838479|NCT01773473|2756614|P1|Overall Study|Withdrawal by Subject|5
838480|NCT01773473|2756613|P2|Overall Study|Non-Compliance with study drug|4
838481|NCT01773473|2756614|P1|Overall Study|Non-Compliance with study drug|1
838482|NCT01773473|2756613|P2|Overall Study|Lack of Efficacy|1
838483|NCT01773473|2756614|P1|Overall Study|Lack of Efficacy|0
838484|NCT01773473|2756613|P2|Overall Study|Sponsor Decision|0
838485|NCT01773473|2756614|P1|Overall Study|Sponsor Decision|2
838486|NCT01773473|2756613|P2|Overall Study|Physician Decision|5
838487|NCT01773473|2756614|P1|Overall Study|Physician Decision|3
838488|NCT01773473|2756613|P2|Overall Study|Protocol Violation|4
838489|NCT01773473|2756614|P1|Overall Study|Protocol Violation|0
838490|NCT01773473|2756613|P2|Overall Study|Adverse Event|2
838491|NCT01773473|2756614|P1|Overall Study|Adverse Event|3
838492|NCT01773291|2756635|P3|Overall Study|Withdrawal by Subject|1
838493|NCT01773291|2756636|P2|Overall Study|Withdrawal by Subject|0
838494|NCT01773291|2756637|P1|Overall Study|Withdrawal by Subject|0
838495|NCT01773291|2756635|P3|Overall Study|Protocol Violation|0
838496|NCT01773291|2756636|P2|Overall Study|Protocol Violation|0
838497|NCT01773291|2756637|P1|Overall Study|Protocol Violation|1
838498|NCT01773226|2756648|P1|Overall Study|Withdrawal by Subject|1
838499|NCT01773122|2756667|P4|Overall Study|Due to amended age eligibility criteria|1
838500|NCT01773122|2756668|P3|Overall Study|Due to amended age eligibility criteria|0
838501|NCT01773122|2756669|P2|Overall Study|Due to amended age eligibility criteria|1
838502|NCT01773122|2756670|P1|Overall Study|Due to amended age eligibility criteria|3
838503|NCT01773070|2756684|P1|Overall Study|Death (unrelated to study procedures)|3
838504|NCT01773070|2756684|P1|Overall Study|Other|15
838505|NCT01773070|2756684|P1|Overall Study|Lost to Follow-up|39
838506|NCT01773070|2756684|P1|Overall Study|Withdrawal by Subject|24
838507|NCT01772823|2756694|P2|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0
838508|NCT01772823|2756695|P1|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1
838509|NCT01772823|2756694|P2|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
838510|NCT01772823|2756695|P1|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
838511|NCT01772823|2756694|P2|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2
838512|NCT01772823|2756695|P1|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1
838513|NCT01772823|2756694|P2|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5
838514|NCT01772823|2756695|P1|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6
838515|NCT01772823|2756694|P2|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
838516|NCT01772823|2756695|P1|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
838517|NCT01772823|2756694|P2|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0
838518|NCT01772823|2756695|P1|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1
838519|NCT01772823|2756694|P2|Treatment Phase (Week 0- Week 48)|Incarcerated|0
838520|NCT01772823|2756695|P1|Treatment Phase (Week 0- Week 48)|Incarcerated|1
838521|NCT01772823|2756694|P2|Treatment Phase (Week 0- Week 48)|Moved out of area|3
838522|NCT01772823|2756695|P1|Treatment Phase (Week 0- Week 48)|Moved out of area|4
838523|NCT01772823|2756694|P2|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1
838524|NCT01772823|2756695|P1|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6
838525|NCT01772823|2756694|P2|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13
838526|NCT01772823|2756695|P1|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15
838527|NCT01772823|2756694|P2|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0
838528|NCT01772823|2756695|P1|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1
838529|NCT01772823|2756694|P2|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0
838530|NCT01772823|2756695|P1|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6
838531|NCT01772823|2756694|P2|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1
838532|NCT01772823|2756695|P1|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2
838533|NCT01772823|2756694|P2|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0
838534|NCT01772823|2756695|P1|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1
838535|NCT01772823|2756694|P2|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
838536|NCT01772823|2756695|P1|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
838537|NCT01772823|2756694|P2|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0
838538|NCT01772823|2756695|P1|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1
838539|NCT01772576|2756817|P1|Overall Study|Withdrawal by Subject|6
838540|NCT01772576|2756817|P1|Overall Study|Adverse Event|6
838541|NCT01772576|2756817|P1|Overall Study|Study device not used|3
838542|NCT01772576|2756817|P1|Overall Study|Lost to Follow-up|3
838543|NCT01772576|2756817|P1|Overall Study|Protocol Violation|1
838544|NCT01772576|2756817|P1|Overall Study|Death|15
838545|NCT01772550|2756829|P3|Overall Study|Adverse Event|1
838546|NCT01772550|2756830|P2|Overall Study|Adverse Event|0
838547|NCT01772550|2756831|P1|Overall Study|Adverse Event|0
838634|NCT01770379|2757244|P1|Overall Study|Adverse Event|1
838548|NCT01772550|2756829|P3|Overall Study|Unable to insert IV in antecubital vein|5
838549|NCT01772550|2756830|P2|Overall Study|Unable to insert IV in antecubital vein|1
838550|NCT01772550|2756831|P1|Overall Study|Unable to insert IV in antecubital vein|1
838551|NCT01772537|2756872|P3|Overall Study|unsuccessful lumbar drain placement|0
838552|NCT01772537|2756873|P2|Overall Study|unsuccessful lumbar drain placement|0
838553|NCT01772537|2756874|P1|Overall Study|unsuccessful lumbar drain placement|1
838554|NCT01772368|2756888|P1|Overall Study|Not specified|1
838555|NCT01772368|2756888|P1|Overall Study|Protocol Violation|2
838556|NCT01772368|2756888|P1|Overall Study|Withdrawal by Subject|3
838557|NCT01772368|2756888|P1|Overall Study|Adverse Event|1
838558|NCT01772316|2756934|P1|Overall Study|Withdrawn by sponsor decision|5
838559|NCT01772316|2756934|P1|Overall Study|Inform consent withdrawn|1
838560|NCT01772316|2756934|P1|Overall Study|Serious adverse event|1
838561|NCT01772147|2756955|P3|Overall Study|Lack of Efficacy|6
838562|NCT01772147|2756956|P2|Overall Study|Lack of Efficacy|6
838563|NCT01772147|2756957|P1|Overall Study|Lack of Efficacy|8
838564|NCT01772147|2756955|P3|Overall Study|Protocol Deviation|1
838565|NCT01772147|2756956|P2|Overall Study|Protocol Deviation|1
838566|NCT01772147|2756957|P1|Overall Study|Protocol Deviation|2
838567|NCT01772147|2756955|P3|Overall Study|Lost to Follow-up|1
838568|NCT01772147|2756956|P2|Overall Study|Lost to Follow-up|0
838569|NCT01772147|2756957|P1|Overall Study|Lost to Follow-up|1
838570|NCT01772147|2756955|P3|Overall Study|Withdrew Consent|4
838571|NCT01772147|2756956|P2|Overall Study|Withdrew Consent|8
838572|NCT01772147|2756957|P1|Overall Study|Withdrew Consent|7
838573|NCT01772147|2756955|P3|Overall Study|Adverse Event|6
838574|NCT01772147|2756956|P2|Overall Study|Adverse Event|10
838575|NCT01772147|2756957|P1|Overall Study|Adverse Event|13
838576|NCT01772134|2756977|P3|Overall Study|Randomized Study Medication Not Received|1
838577|NCT01772134|2756978|P2|Overall Study|Randomized Study Medication Not Received|0
838578|NCT01772134|2756979|P1|Overall Study|Randomized Study Medication Not Received|2
838579|NCT01772134|2756977|P3|Overall Study|Protocol-defined Stopping Criteria|0
838580|NCT01772134|2756978|P2|Overall Study|Protocol-defined Stopping Criteria|0
838581|NCT01772134|2756979|P1|Overall Study|Protocol-defined Stopping Criteria|1
838582|NCT01772134|2756977|P3|Overall Study|Lack of Efficacy|3
838583|NCT01772134|2756978|P2|Overall Study|Lack of Efficacy|5
838584|NCT01772134|2756979|P1|Overall Study|Lack of Efficacy|11
838585|NCT01772134|2756977|P3|Overall Study|Protocol Deviation|3
838586|NCT01772134|2756978|P2|Overall Study|Protocol Deviation|3
838587|NCT01772134|2756979|P1|Overall Study|Protocol Deviation|4
838588|NCT01772134|2756977|P3|Overall Study|Lost to Follow-up|0
838589|NCT01772134|2756978|P2|Overall Study|Lost to Follow-up|0
838590|NCT01772134|2756979|P1|Overall Study|Lost to Follow-up|2
838591|NCT01772134|2756977|P3|Overall Study|Withdrew Consent|5
838592|NCT01772134|2756978|P2|Overall Study|Withdrew Consent|1
838593|NCT01772134|2756979|P1|Overall Study|Withdrew Consent|3
838594|NCT01772134|2756977|P3|Overall Study|Adverse Event|10
838595|NCT01772134|2756978|P2|Overall Study|Adverse Event|5
838596|NCT01772134|2756979|P1|Overall Study|Adverse Event|6
838597|NCT01771913|2757016|P2|Overall Study|Withdrawal by Subject|0
838598|NCT01771913|2757017|P1|Overall Study|Withdrawal by Subject|1
838599|NCT01770860|2757036|P1|Overall Study|Administrative decision made by the PI|1
838600|NCT01770860|2757036|P1|Overall Study|Lost to Follow-up|1
838601|NCT01770860|2757036|P1|Overall Study|Withdrawal by Subject|4
838602|NCT01770743|2757084|P5|Overall Study|Moving Out of State|0
838603|NCT01770743|2757085|P4|Overall Study|Moving Out of State|0
838604|NCT01770743|2757086|P3|Overall Study|Moving Out of State|0
838605|NCT01770743|2757087|P2|Overall Study|Moving Out of State|1
838606|NCT01770743|2757088|P1|Overall Study|Moving Out of State|0
838607|NCT01770743|2757084|P5|Overall Study|Sponsor Terminated Subject|0
838608|NCT01770743|2757085|P4|Overall Study|Sponsor Terminated Subject|1
838609|NCT01770743|2757086|P3|Overall Study|Sponsor Terminated Subject|0
838610|NCT01770743|2757087|P2|Overall Study|Sponsor Terminated Subject|0
838611|NCT01770743|2757088|P1|Overall Study|Sponsor Terminated Subject|1
838612|NCT01770743|2757084|P5|Overall Study|Lost to Follow-up|1
838613|NCT01770743|2757085|P4|Overall Study|Lost to Follow-up|0
838614|NCT01770743|2757086|P3|Overall Study|Lost to Follow-up|0
838615|NCT01770743|2757087|P2|Overall Study|Lost to Follow-up|2
838616|NCT01770743|2757088|P1|Overall Study|Lost to Follow-up|0
838617|NCT01770743|2757084|P5|Overall Study|Withdrawal by Subject|1
838618|NCT01770743|2757085|P4|Overall Study|Withdrawal by Subject|1
838619|NCT01770743|2757086|P3|Overall Study|Withdrawal by Subject|1
838620|NCT01770743|2757087|P2|Overall Study|Withdrawal by Subject|0
838621|NCT01770743|2757088|P1|Overall Study|Withdrawal by Subject|0
838622|NCT01770743|2757084|P5|Overall Study|Adverse Event|0
838623|NCT01770743|2757085|P4|Overall Study|Adverse Event|0
838624|NCT01770743|2757086|P3|Overall Study|Adverse Event|0
838625|NCT01770743|2757087|P2|Overall Study|Adverse Event|0
838626|NCT01770743|2757088|P1|Overall Study|Adverse Event|1
838627|NCT01770509|2757190|P2|Overall Study|Lost to Follow-up|2
838628|NCT01770509|2757191|P1|Overall Study|Lost to Follow-up|1
838629|NCT01770509|2757190|P2|Overall Study|Injury|1
838630|NCT01770509|2757191|P1|Overall Study|Injury|0
838631|NCT01770392|2757227|P1|Washout Period of at Least 14 Days|Adverse Event|1
838632|NCT01770379|2757242|P3|Overall Study|Adverse Event|2
838633|NCT01770379|2757243|P2|Overall Study|Adverse Event|3
838635|NCT01770379|2757242|P3|Overall Study|Lack of Efficacy|6
838636|NCT01770379|2757243|P2|Overall Study|Lack of Efficacy|6
838637|NCT01770379|2757244|P1|Overall Study|Lack of Efficacy|8
838638|NCT01770379|2757242|P3|Overall Study|Lost to Follow-up|2
838639|NCT01770379|2757243|P2|Overall Study|Lost to Follow-up|0
838640|NCT01770379|2757244|P1|Overall Study|Lost to Follow-up|0
838641|NCT01770379|2757242|P3|Overall Study|Physician Decision|2
838642|NCT01770379|2757243|P2|Overall Study|Physician Decision|1
838643|NCT01770379|2757244|P1|Overall Study|Physician Decision|0
838644|NCT01770379|2757242|P3|Overall Study|Protocol Violation|1
838645|NCT01770379|2757243|P2|Overall Study|Protocol Violation|1
838646|NCT01770379|2757244|P1|Overall Study|Protocol Violation|0
838647|NCT01770379|2757242|P3|Overall Study|study terminated by sponsor|22
838648|NCT01770379|2757243|P2|Overall Study|study terminated by sponsor|23
838649|NCT01770379|2757244|P1|Overall Study|study terminated by sponsor|22
838650|NCT01770379|2757242|P3|Overall Study|Withdrawal by Subject|7
838651|NCT01770379|2757243|P2|Overall Study|Withdrawal by Subject|10
838652|NCT01770379|2757244|P1|Overall Study|Withdrawal by Subject|7
838653|NCT01770379|2757242|P3|Overall Study|Technical issues|0
838654|NCT01770379|2757243|P2|Overall Study|Technical issues|0
838655|NCT01770379|2757244|P1|Overall Study|Technical issues|1
838656|NCT01770145|2757281|P1|Treatment|Withdrawal by Subject|1
838657|NCT01770145|2757281|P1|Treatment|Adverse Event|3
838658|NCT01770145|2757281|P1|Baseline|Unable to define optimal dose|4
838659|NCT01770145|2757281|P1|Baseline|Lost to Follow-up|1
838660|NCT01770145|2757281|P1|Baseline|Withdrawal by Subject|1
838661|NCT01770145|2757281|P1|Baseline|Adverse Event|20
838662|NCT01769508|2757301|P1|Overall Study|Lost to Follow-up|1
838663|NCT01769508|2757301|P1|Overall Study|Adverse Event|1
838664|NCT01769508|2757301|P1|Overall Study|Withdrawal by Subject|1
838665|NCT01769508|2757301|P1|Overall Study|Death|3
838666|NCT01769456|2757310|P1|Overall Study|Parental request to youth to withdraw|1
838667|NCT01769456|2757310|P1|Overall Study|No wk 0 visit w/in 30 days of screening|5
838668|NCT01769456|2757310|P1|Overall Study|Moved out of the area|3
838669|NCT01769456|2757310|P1|Overall Study|Did not receive PCC intervention|6
838670|NCT01769456|2757310|P1|Overall Study|Withdrawal by Subject|3
838671|NCT01769456|2757310|P1|Overall Study|Lost to Follow-up|19
838672|NCT01769443|2757331|P2|Overall Study|Study closure|0
838673|NCT01769443|2757332|P1|Overall Study|Study closure|1
838674|NCT01769391|2757376|P2|Overall Study|Investigator Decision|0
838675|NCT01769391|2757377|P1|Overall Study|Investigator Decision|2
838676|NCT01769391|2757376|P2|Overall Study|Withdrawal by Subject|3
838677|NCT01769391|2757377|P1|Overall Study|Withdrawal by Subject|4
838678|NCT01769391|2757376|P2|Overall Study|Progressive Disease|2
838679|NCT01769391|2757377|P1|Overall Study|Progressive Disease|1
838680|NCT01769391|2757376|P2|Overall Study|Adverse Event|3
838681|NCT01769391|2757377|P1|Overall Study|Adverse Event|0
838682|NCT01769391|2757376|P2|Overall Study|Death|1
838683|NCT01769391|2757377|P1|Overall Study|Death|10
838684|NCT01769378|2757396|P2|Overall Study|Lost to Follow-up|0
838685|NCT01769378|2757397|P1|Overall Study|Lost to Follow-up|2
838686|NCT01769378|2757396|P2|Overall Study|Sponsor Decision|0
838687|NCT01769378|2757397|P1|Overall Study|Sponsor Decision|1
838688|NCT01769378|2757396|P2|Overall Study|Withdrawal by Subject|3
838689|NCT01769378|2757397|P1|Overall Study|Withdrawal by Subject|10
838690|NCT01769378|2757396|P2|Overall Study|Protocol Violation|1
838691|NCT01769378|2757397|P1|Overall Study|Protocol Violation|1
838692|NCT01769378|2757396|P2|Overall Study|Entry criteria not met|0
838693|NCT01769378|2757397|P1|Overall Study|Entry criteria not met|1
838694|NCT01769378|2757396|P2|Overall Study|Adverse Event|0
838695|NCT01769378|2757397|P1|Overall Study|Adverse Event|10
838696|NCT01769339|2757477|P1|Overall Study|Adverse Event|1
838697|NCT01769339|2757477|P1|Overall Study|Lost to Follow-up|42
838698|NCT01769326|2757488|P4|Overall Study|Got sick and could not complete study|0
838699|NCT01769326|2757489|P3|Overall Study|Got sick and could not complete study|1
838700|NCT01769326|2757490|P2|Overall Study|Got sick and could not complete study|0
838701|NCT01769326|2757491|P1|Overall Study|Got sick and could not complete study|0
838702|NCT01769326|2757488|P4|Overall Study|got a job|0
838703|NCT01769326|2757489|P3|Overall Study|got a job|0
838704|NCT01769326|2757490|P2|Overall Study|got a job|1
838705|NCT01769326|2757491|P1|Overall Study|got a job|0
838706|NCT01769326|2757488|P4|Overall Study|unrelated injry|0
838707|NCT01769326|2757489|P3|Overall Study|unrelated injry|0
838708|NCT01769326|2757490|P2|Overall Study|unrelated injry|1
838709|NCT01769326|2757491|P1|Overall Study|unrelated injry|1
838710|NCT01769326|2757488|P4|Overall Study|Lost to Follow-up|0
838711|NCT01769326|2757489|P3|Overall Study|Lost to Follow-up|0
838712|NCT01769326|2757490|P2|Overall Study|Lost to Follow-up|2
838713|NCT01769326|2757491|P1|Overall Study|Lost to Follow-up|1
838714|NCT01769196|2757544|P2|Overall Study|Withdrew consent|40
838715|NCT01769196|2757545|P1|Overall Study|Withdrew consent|36
838716|NCT01769196|2757544|P2|Overall Study|Participant never dosed with study drug|0
838717|NCT01769196|2757545|P1|Overall Study|Participant never dosed with study drug|1
838718|NCT01769196|2757544|P2|Overall Study|Study terminated by sponsor|161
838719|NCT01769196|2757545|P1|Overall Study|Study terminated by sponsor|160
838720|NCT01769196|2757544|P2|Overall Study|Protocol Violation|3
838721|NCT01769196|2757545|P1|Overall Study|Protocol Violation|0
838722|NCT01769196|2757544|P2|Overall Study|Protocol defined criteria for withdrawal|11
838723|NCT01769196|2757545|P1|Overall Study|Protocol defined criteria for withdrawal|9
838724|NCT01769196|2757544|P2|Overall Study|Progressive disease|6
838725|NCT01769196|2757545|P1|Overall Study|Progressive disease|11
838726|NCT01769196|2757544|P2|Overall Study|Lack of Efficacy|2
838727|NCT01769196|2757545|P1|Overall Study|Lack of Efficacy|3
838728|NCT01769196|2757544|P2|Overall Study|Investigator Discretion|3
838729|NCT01769196|2757545|P1|Overall Study|Investigator Discretion|7
838730|NCT01769196|2757544|P2|Overall Study|Death|26
838731|NCT01769196|2757545|P1|Overall Study|Death|21
838732|NCT01769196|2757544|P2|Overall Study|Adverse Event|20
838733|NCT01769196|2757545|P1|Overall Study|Adverse Event|24
838734|NCT01769105|2757575|P2|Cross-over|Lost to Follow-up|0
838735|NCT01769105|2757576|P1|Cross-over|Lost to Follow-up|5
838736|NCT01769105|2757575|P2|First Intervention|Protocol Violation|2
838737|NCT01769105|2757576|P1|First Intervention|Protocol Violation|2
838738|NCT01768676|2757634|P2|Overall Study|Withdrawal by Subject|10
838739|NCT01768676|2757635|P1|Overall Study|Withdrawal by Subject|3
838740|NCT01768676|2757634|P2|Overall Study|Physician Decision|1
838741|NCT01768676|2757635|P1|Overall Study|Physician Decision|4
838742|NCT01768676|2757634|P2|Overall Study|Protocol Violation|1
838743|NCT01768676|2757635|P1|Overall Study|Protocol Violation|1
838744|NCT01768676|2757634|P2|Overall Study|Lost to Follow-up|16
838745|NCT01768676|2757635|P1|Overall Study|Lost to Follow-up|13
838746|NCT01768676|2757634|P2|Overall Study|Adverse Event|3
838747|NCT01768676|2757635|P1|Overall Study|Adverse Event|3
838748|NCT01768572|2757652|P3|Overall Study|Other, Not due to an adverse event|1
838749|NCT01768572|2757653|P2|Overall Study|Other, Not due to an adverse event|1
838750|NCT01768572|2757654|P1|Overall Study|Other, Not due to an adverse event|1
838751|NCT01768572|2757652|P3|Overall Study|Lack of Efficacy|1
838752|NCT01768572|2757653|P2|Overall Study|Lack of Efficacy|3
838753|NCT01768572|2757654|P1|Overall Study|Lack of Efficacy|1
838754|NCT01768572|2757652|P3|Overall Study|Adverse Event|4
838755|NCT01768572|2757653|P2|Overall Study|Adverse Event|8
838756|NCT01768572|2757654|P1|Overall Study|Adverse Event|7
838757|NCT01768559|2757665|P3|Overall Study|Other than specified|5
838758|NCT01768559|2757666|P2|Overall Study|Other than specified|8
838759|NCT01768559|2757667|P1|Overall Study|Other than specified|9
838760|NCT01768559|2757665|P3|Overall Study|Poor compliance to protocol|2
838761|NCT01768559|2757666|P2|Overall Study|Poor compliance to protocol|3
838762|NCT01768559|2757667|P1|Overall Study|Poor compliance to protocol|0
838763|NCT01768559|2757665|P3|Overall Study|Lack of Efficacy|0
838764|NCT01768559|2757666|P2|Overall Study|Lack of Efficacy|4
838765|NCT01768559|2757667|P1|Overall Study|Lack of Efficacy|6
838766|NCT01768559|2757665|P3|Overall Study|Adverse Event|5
838767|NCT01768559|2757666|P2|Overall Study|Adverse Event|2
838768|NCT01768559|2757667|P1|Overall Study|Adverse Event|15
838769|NCT01768559|2757665|P3|Overall Study|Randomized but not treated|1
838770|NCT01768559|2757666|P2|Overall Study|Randomized but not treated|0
838771|NCT01768559|2757667|P1|Overall Study|Randomized but not treated|0
838772|NCT01768286|2757732|P4|Overall Study|Withdrew Consent|0
838773|NCT01768286|2757733|P3|Overall Study|Withdrew Consent|1
838774|NCT01768286|2757734|P2|Overall Study|Withdrew Consent|0
838775|NCT01768286|2757735|P1|Overall Study|Withdrew Consent|0
838776|NCT01768286|2757732|P4|Overall Study|Lack of Efficacy|1
838777|NCT01768286|2757733|P3|Overall Study|Lack of Efficacy|0
838778|NCT01768286|2757734|P2|Overall Study|Lack of Efficacy|4
838779|NCT01768286|2757735|P1|Overall Study|Lack of Efficacy|7
838780|NCT01768286|2757732|P4|Overall Study|Randomized But Not Treated|0
838781|NCT01768286|2757733|P3|Overall Study|Randomized But Not Treated|1
838782|NCT01768286|2757734|P2|Overall Study|Randomized But Not Treated|0
838783|NCT01768286|2757735|P1|Overall Study|Randomized But Not Treated|0
838784|NCT01768117|2757797|P1|Overall Study|Protocol Violation|3
838785|NCT01768117|2757797|P1|Overall Study|Withdrawal by Subject|2
838786|NCT01768117|2757797|P1|Overall Study|Lost to Follow-up|1
838787|NCT01767987|2757861|P2|Overall Study|Physician Decision|1
838788|NCT01767987|2757862|P1|Overall Study|Physician Decision|4
838789|NCT01767597|2757928|P2|Overall Study|Withdrawal by Subject|0
838790|NCT01767597|2757929|P1|Overall Study|Withdrawal by Subject|1
838791|NCT01767597|2757928|P2|Overall Study|Incomplete intervention|1
838792|NCT01767597|2757929|P1|Overall Study|Incomplete intervention|3
838793|NCT01767519|2757938|P3|Overall Study|Adverse Event|1
838794|NCT01767519|2757939|P2|Overall Study|Adverse Event|5
838795|NCT01767519|2757940|P1|Overall Study|Adverse Event|5
838796|NCT01767519|2757938|P3|Overall Study|Lack of Efficacy|0
838797|NCT01767519|2757939|P2|Overall Study|Lack of Efficacy|0
838798|NCT01767519|2757940|P1|Overall Study|Lack of Efficacy|1
838799|NCT01767519|2757938|P3|Overall Study|Lost to Follow-up|2
838800|NCT01767519|2757939|P2|Overall Study|Lost to Follow-up|1
838801|NCT01767519|2757940|P1|Overall Study|Lost to Follow-up|3
838802|NCT01767519|2757938|P3|Overall Study|Personal Reasons|0
838803|NCT01767519|2757939|P2|Overall Study|Personal Reasons|0
838804|NCT01767519|2757940|P1|Overall Study|Personal Reasons|1
838805|NCT01767519|2757938|P3|Overall Study|Protocol Violation|0
838806|NCT01767519|2757939|P2|Overall Study|Protocol Violation|3
838807|NCT01767519|2757940|P1|Overall Study|Protocol Violation|0
838808|NCT01767519|2757938|P3|Overall Study|Other Reasons|2
838809|NCT01767519|2757939|P2|Overall Study|Other Reasons|4
838810|NCT01767519|2757940|P1|Overall Study|Other Reasons|4
838811|NCT01767467|2757981|P2|End of Study Phase (up to Month 13)|Subject Unavailable|2
838812|NCT01767467|2757982|P1|End of Study Phase (up to Month 13)|Subject Unavailable|0
838813|NCT01767467|2757981|P2|End of Study Phase (up to Month 13)|Physician Decision|0
838814|NCT01767467|2757982|P1|End of Study Phase (up to Month 13)|Physician Decision|1
838815|NCT01767467|2757981|P2|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1
838816|NCT01767467|2757982|P1|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0
838817|NCT01767467|2757981|P2|End of Study Phase (up to Month 13)|Lost to Follow-up|4
838818|NCT01767467|2757982|P1|End of Study Phase (up to Month 13)|Lost to Follow-up|6
838819|NCT01767467|2757981|P2|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3
838820|NCT01767467|2757982|P1|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0
838821|NCT01767467|2757981|P2|End of Study Phase (up to Month 13)|Withdrawal by Subject|14
838822|NCT01767467|2757982|P1|End of Study Phase (up to Month 13)|Withdrawal by Subject|9
838823|NCT01767467|2757981|P2|End of Study Phase (up to Month 13)|Protocol Violation|0
838824|NCT01767467|2757982|P1|End of Study Phase (up to Month 13)|Protocol Violation|2
838825|NCT01767467|2757981|P2|End of Study Phase (up to Month 13)|Adverse Event|39
838826|NCT01767467|2757982|P1|End of Study Phase (up to Month 13)|Adverse Event|29
838827|NCT01767467|2757981|P2|Vaccination Phase (up to Month 2)|Subject unavailable|1
838828|NCT01767467|2757982|P1|Vaccination Phase (up to Month 2)|Subject unavailable|0
838829|NCT01767467|2757981|P2|Vaccination Phase (up to Month 2)|Physician Decision|0
838830|NCT01767467|2757982|P1|Vaccination Phase (up to Month 2)|Physician Decision|1
838831|NCT01767467|2757981|P2|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1
838832|NCT01767467|2757982|P1|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0
838833|NCT01767467|2757981|P2|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10
838834|NCT01767467|2757982|P1|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7
838835|NCT01767467|2757981|P2|Vaccination Phase (up to Month 2)|Protocol Violation|0
838836|NCT01767467|2757982|P1|Vaccination Phase (up to Month 2)|Protocol Violation|1
838837|NCT01767467|2757981|P2|Vaccination Phase (up to Month 2)|Adverse Event|8
838838|NCT01767467|2757982|P1|Vaccination Phase (up to Month 2)|Adverse Event|8
838839|NCT01767376|2758033|P3|Overall Study|Withdrawal by Subject|0
838840|NCT01767376|2758034|P2|Overall Study|Withdrawal by Subject|1
838841|NCT01767376|2758035|P1|Overall Study|Withdrawal by Subject|1
838842|NCT01767376|2758033|P3|Overall Study|Lost to Follow-up|0
838843|NCT01767376|2758034|P2|Overall Study|Lost to Follow-up|2
838844|NCT01767376|2758035|P1|Overall Study|Lost to Follow-up|3
838845|NCT01767116|2758116|P2|Overall Study|Lost to Follow-up|2
838846|NCT01767116|2758117|P1|Overall Study|Lost to Follow-up|2
838847|NCT01766921|2758175|P2|Overall Study|Withdrawal by Subject|5
838848|NCT01766921|2758176|P1|Overall Study|Withdrawal by Subject|14
838849|NCT01766921|2758175|P2|Overall Study|Protocol Violation|1
838850|NCT01766921|2758176|P1|Overall Study|Protocol Violation|1
838851|NCT01766921|2758175|P2|Overall Study|Unclassified|2
838852|NCT01766921|2758176|P1|Overall Study|Unclassified|2
838853|NCT01766921|2758175|P2|Overall Study|Lost to Follow-up|3
838854|NCT01766921|2758176|P1|Overall Study|Lost to Follow-up|1
838855|NCT01766921|2758175|P2|Overall Study|Death|1
838856|NCT01766921|2758176|P1|Overall Study|Death|1
838857|NCT01766921|2758175|P2|Overall Study|Administrative Reason|5
838858|NCT01766921|2758176|P1|Overall Study|Administrative Reason|5
838859|NCT01766778|2758197|P2|Overall Study|Withdrawal by Subject|0
838860|NCT01766778|2758198|P1|Overall Study|Withdrawal by Subject|1
838861|NCT01766778|2758197|P2|Overall Study|Adverse Event|4
838862|NCT01766778|2758198|P1|Overall Study|Adverse Event|4
838863|NCT01766336|2758252|P2|Overall Study|Withdrawal by Subject|15
838864|NCT01766336|2758253|P1|Overall Study|Withdrawal by Subject|18
838865|NCT01766336|2758252|P2|Overall Study|Sponsor Decision|43
838866|NCT01766336|2758253|P1|Overall Study|Sponsor Decision|52
838867|NCT01766336|2758252|P2|Overall Study|Protocol Violation|1
838868|NCT01766336|2758253|P1|Overall Study|Protocol Violation|0
838869|NCT01766336|2758252|P2|Overall Study|Physician Decision|2
838870|NCT01766336|2758253|P1|Overall Study|Physician Decision|4
838871|NCT01766336|2758252|P2|Overall Study|Lost to Follow-up|3
838872|NCT01766336|2758253|P1|Overall Study|Lost to Follow-up|1
838873|NCT01766336|2758252|P2|Overall Study|Death|3
838874|NCT01766336|2758253|P1|Overall Study|Death|4
838875|NCT01766336|2758252|P2|Overall Study|Adverse Event|8
838876|NCT01766336|2758253|P1|Overall Study|Adverse Event|11
838877|NCT01766310|2758261|P2|Overall Study|Lost to Follow-up|3
838878|NCT01766310|2758262|P1|Overall Study|Lost to Follow-up|1
838879|NCT01766206|2758270|P1|Overall Study|Withdrawal and inappropriate enrollment|1
838880|NCT01766206|2758270|P1|Overall Study|Inappropriate enrollment|18
838881|NCT01766206|2758270|P1|Overall Study|Lost to Follow-up|10
838882|NCT01766206|2758270|P1|Overall Study|Withdrawal by Subject|22
838883|NCT01766050|2758297|P1|Overall Study|Withdrawal by Subject|2
838884|NCT01766050|2758297|P1|Overall Study|Lost to Follow-up|1
838885|NCT01766050|2758297|P1|Overall Study|Adverse Event|1
838886|NCT01766037|2758432|P2|Overall Study|nausea / discomfort|0
838887|NCT01766037|2758433|P1|Overall Study|nausea / discomfort|3
838888|NCT01766037|2758432|P2|Overall Study|medical - unrelated|2
838889|NCT01766037|2758433|P1|Overall Study|medical - unrelated|1
838890|NCT01766037|2758432|P2|Overall Study|Moved from area|0
838891|NCT01766037|2758433|P1|Overall Study|Moved from area|5
838892|NCT01766037|2758432|P2|Overall Study|Withdrawal by Subject|16
838893|NCT01766037|2758433|P1|Overall Study|Withdrawal by Subject|18
838894|NCT01766037|2758432|P2|Overall Study|Physician Decision|1
838895|NCT01766037|2758433|P1|Overall Study|Physician Decision|0
838896|NCT01766037|2758432|P2|Overall Study|Lost to Follow-up|10
838897|NCT01766037|2758433|P1|Overall Study|Lost to Follow-up|0
838898|NCT01766037|2758432|P2|Overall Study|Lack of Efficacy|0
838899|NCT01766037|2758433|P1|Overall Study|Lack of Efficacy|1
838900|NCT01766037|2758432|P2|Overall Study|Adverse Event|0
838901|NCT01766037|2758433|P1|Overall Study|Adverse Event|1
838902|NCT01765764|2758502|P3|Treatment Period|Other Miscellaneous Reasons|2
838903|NCT01765764|2758503|P2|Treatment Period|Other Miscellaneous Reasons|2
838904|NCT01765764|2758504|P1|Treatment Period|Other Miscellaneous Reasons|1
838905|NCT01765764|2758502|P3|Treatment Period|Personal Reasons|1
838906|NCT01765764|2758503|P2|Treatment Period|Personal Reasons|2
838907|NCT01765764|2758504|P1|Treatment Period|Personal Reasons|1
838908|NCT01765764|2758502|P3|Treatment Period|Lost to Follow-up|2
838909|NCT01765764|2758503|P2|Treatment Period|Lost to Follow-up|3
838910|NCT01765764|2758504|P1|Treatment Period|Lost to Follow-up|0
838911|NCT01765764|2758502|P3|Treatment Period|Adverse Event|1
838912|NCT01765764|2758503|P2|Treatment Period|Adverse Event|2
838913|NCT01765764|2758504|P1|Treatment Period|Adverse Event|1
838914|NCT01765751|2758524|P3|Overall Study|Lost to Follow-up|1
838915|NCT01765751|2758525|P2|Overall Study|Lost to Follow-up|2
838916|NCT01765751|2758526|P1|Overall Study|Lost to Follow-up|0
838917|NCT01765673|2758558|P1|Overall Study|No transportation for 2nd/3rd visits|1
838918|NCT01765582|2758584|P3|Overall Study|Withdrawal of Consent|10
838919|NCT01765582|2758585|P2|Overall Study|Withdrawal of Consent|6
838920|NCT01765582|2758586|P1|Overall Study|Withdrawal of Consent|11
838921|NCT01765582|2758584|P3|Overall Study|Sponsor Decision|42
838922|NCT01765582|2758585|P2|Overall Study|Sponsor Decision|42
838923|NCT01765582|2758586|P1|Overall Study|Sponsor Decision|46
838924|NCT01765582|2758584|P3|Overall Study|Death|33
838925|NCT01765582|2758585|P2|Overall Study|Death|36
838926|NCT01765582|2758586|P1|Overall Study|Death|31
838927|NCT01765582|2758584|P3|Overall Study|Lost to Follow-up|1
838928|NCT01765582|2758585|P2|Overall Study|Lost to Follow-up|2
838929|NCT01765582|2758586|P1|Overall Study|Lost to Follow-up|2
838930|NCT01765582|2758584|P3|Overall Study|Other|9
838931|NCT01765582|2758585|P2|Overall Study|Other|6
838932|NCT01765582|2758586|P1|Overall Study|Other|3
838933|NCT01765569|2758619|P1|Period C|Death|1
838934|NCT01765569|2758619|P1|Period B|Withdrawal by Subject|1
838935|NCT01765543|2758640|P1|Overall Study|Withdrawal by Subject|2
838936|NCT01765543|2758640|P1|Overall Study|Death|1
838937|NCT01765426|2758692|P4|Overall Study|Lost to Follow-up|0
838938|NCT01765426|2758693|P3|Overall Study|Lost to Follow-up|0
838939|NCT01765426|2758694|P2|Overall Study|Lost to Follow-up|1
838940|NCT01765426|2758695|P1|Overall Study|Lost to Follow-up|0
838941|NCT01765270|2758751|P2|Overall Study|Withdrawal by Subject|1
838942|NCT01765270|2758752|P1|Overall Study|Withdrawal by Subject|0
838943|NCT01765270|2758751|P2|Overall Study|Physician Decision|0
838944|NCT01765270|2758752|P1|Overall Study|Physician Decision|1
838945|NCT01765192|2758774|P2|End of Treatment Period 2 to Final Visit|Adverse Event|1
838946|NCT01765192|2758775|P1|End of Treatment Period 2 to Final Visit|Adverse Event|0
838947|NCT01765192|2758774|P2|Treatment Period 2|Reason not specified|2
838948|NCT01765192|2758775|P1|Treatment Period 2|Reason not specified|0
838949|NCT01765192|2758774|P2|Washout Period|Reason not specified|0
838950|NCT01765192|2758775|P1|Washout Period|Reason not specified|1
838951|NCT01765192|2758774|P2|Washout Period|Voluntary Withdrawal|1
838952|NCT01765192|2758775|P1|Washout Period|Voluntary Withdrawal|1
838953|NCT01765192|2758774|P2|Treatment Period 1|Adverse Event|1
838954|NCT01765192|2758775|P1|Treatment Period 1|Adverse Event|0
838955|NCT01765179|2758793|P1|Overall Study|Ca elevated 10.6|1
838956|NCT01765179|2758793|P1|Overall Study|work conflict|1
838957|NCT01765179|2758793|P1|Overall Study|lack of venous access|1
838958|NCT01765179|2758793|P1|Overall Study|Out of country unable to finish study|1
838959|NCT01765179|2758793|P1|Overall Study|prohibited med|1
838960|NCT01765179|2758793|P1|Overall Study|Hematocrit >54%|3
838961|NCT01765179|2758793|P1|Overall Study|Withdrawal by Subject|8
838962|NCT01765179|2758793|P1|Overall Study|Protocol Violation|1
838963|NCT01765179|2758793|P1|Overall Study|Non-compliance with study drug|2
838964|NCT01765179|2758793|P1|Overall Study|Lost to Follow-up|5
838965|NCT01765179|2758793|P1|Overall Study|Adverse Event|3
838966|NCT01765153|2758800|P2|Rest Phase 2|Lost to Follow-up|1
838967|NCT01765153|2758801|P1|Rest Phase 2|Lost to Follow-up|2
838968|NCT01765153|2758800|P2|Training Phase 2|Withdrawal by Subject|1
838969|NCT01765153|2758801|P1|Training Phase 2|Withdrawal by Subject|0
838970|NCT01765153|2758800|P2|Rest Phase 1|Withdrawal by Subject|1
838971|NCT01765153|2758801|P1|Rest Phase 1|Withdrawal by Subject|0
838972|NCT01765153|2758800|P2|Training Phase 1|Poor participation in intervention|1
838973|NCT01765153|2758801|P1|Training Phase 1|Poor participation in intervention|0
838974|NCT01765153|2758800|P2|Training Phase 1|Format of intervention differed|0
838975|NCT01765153|2758801|P1|Training Phase 1|Format of intervention differed|1
838976|NCT01764997|2758908|P5|Study Drug Treatment Period|Other than specified above|10
838977|NCT01764997|2758909|P4|Study Drug Treatment Period|Other than specified above|0
838978|NCT01764997|2758910|P3|Study Drug Treatment Period|Other than specified above|0
838979|NCT01764997|2758911|P2|Study Drug Treatment Period|Other than specified above|0
838980|NCT01764997|2758912|P1|Study Drug Treatment Period|Other than specified above|0
838981|NCT01764997|2758908|P5|Study Drug Treatment Period|Lack of Efficacy|2
838982|NCT01764997|2758909|P4|Study Drug Treatment Period|Lack of Efficacy|0
838983|NCT01764997|2758910|P3|Study Drug Treatment Period|Lack of Efficacy|0
838984|NCT01764997|2758911|P2|Study Drug Treatment Period|Lack of Efficacy|0
838985|NCT01764997|2758912|P1|Study Drug Treatment Period|Lack of Efficacy|0
838986|NCT01764997|2758908|P5|Study Drug Treatment Period|Adverse Event|24
838987|NCT01764997|2758909|P4|Study Drug Treatment Period|Adverse Event|0
838988|NCT01764997|2758910|P3|Study Drug Treatment Period|Adverse Event|0
838989|NCT01764997|2758911|P2|Study Drug Treatment Period|Adverse Event|1
838990|NCT01764997|2758912|P1|Study Drug Treatment Period|Adverse Event|0
838991|NCT01764997|2758908|P5|Run-in Period|Other than specified above|0
838992|NCT01764997|2758909|P4|Run-in Period|Other than specified above|0
838993|NCT01764997|2758910|P3|Run-in Period|Other than specified above|0
838994|NCT01764997|2758911|P2|Run-in Period|Other than specified above|0
838995|NCT01764997|2758912|P1|Run-in Period|Other than specified above|17
838996|NCT01764997|2758908|P5|Run-in Period|Poor compliance to protocol|0
838997|NCT01764997|2758909|P4|Run-in Period|Poor compliance to protocol|0
838998|NCT01764997|2758910|P3|Run-in Period|Poor compliance to protocol|0
838999|NCT01764997|2758911|P2|Run-in Period|Poor compliance to protocol|0
839000|NCT01764997|2758912|P1|Run-in Period|Poor compliance to protocol|1
839001|NCT01764997|2758908|P5|Run-in Period|Lack of Efficacy|0
839002|NCT01764997|2758909|P4|Run-in Period|Lack of Efficacy|0
839003|NCT01764997|2758910|P3|Run-in Period|Lack of Efficacy|0
839004|NCT01764997|2758911|P2|Run-in Period|Lack of Efficacy|0
839005|NCT01764997|2758912|P1|Run-in Period|Lack of Efficacy|5
839006|NCT01764997|2758908|P5|Run-in Period|Adverse Event|0
839007|NCT01764997|2758909|P4|Run-in Period|Adverse Event|0
839008|NCT01764997|2758910|P3|Run-in Period|Adverse Event|0
839009|NCT01764997|2758911|P2|Run-in Period|Adverse Event|0
839010|NCT01764997|2758912|P1|Run-in Period|Adverse Event|15
839011|NCT01764945|2758939|P8|Overall Study|Adverse Event|0
839012|NCT01764945|2758940|P7|Overall Study|Adverse Event|1
839013|NCT01764945|2758941|P6|Overall Study|Adverse Event|0
839014|NCT01764945|2758942|P5|Overall Study|Adverse Event|0
839015|NCT01764945|2758943|P4|Overall Study|Adverse Event|0
839016|NCT01764945|2758944|P3|Overall Study|Adverse Event|0
839017|NCT01764945|2758945|P2|Overall Study|Adverse Event|1
839018|NCT01764945|2758946|P1|Overall Study|Adverse Event|0
839019|NCT01764841|2758992|P4|Overall Study|Lost to Follow-up|0
839020|NCT01764841|2758993|P3|Overall Study|Lost to Follow-up|1
839021|NCT01764841|2758994|P2|Overall Study|Lost to Follow-up|0
839022|NCT01764841|2758995|P1|Overall Study|Lost to Follow-up|3
839023|NCT01764841|2758992|P4|Overall Study|Withdrawal by Subject|15
839024|NCT01764841|2758993|P3|Overall Study|Withdrawal by Subject|11
839025|NCT01764841|2758994|P2|Overall Study|Withdrawal by Subject|24
839026|NCT01764841|2758995|P1|Overall Study|Withdrawal by Subject|16
839027|NCT01764841|2758992|P4|Overall Study|Protocol Violation|0
839028|NCT01764841|2758993|P3|Overall Study|Protocol Violation|0
839029|NCT01764841|2758994|P2|Overall Study|Protocol Violation|1
839030|NCT01764841|2758995|P1|Overall Study|Protocol Violation|0
839031|NCT01764841|2758992|P4|Overall Study|No Follow Up|0
839032|NCT01764841|2758993|P3|Overall Study|No Follow Up|1
839033|NCT01764841|2758994|P2|Overall Study|No Follow Up|0
839034|NCT01764841|2758995|P1|Overall Study|No Follow Up|1
839035|NCT01764841|2758992|P4|Overall Study|Death|4
839036|NCT01764841|2758993|P3|Overall Study|Death|1
839037|NCT01764841|2758994|P2|Overall Study|Death|0
839038|NCT01764841|2758995|P1|Overall Study|Death|3
839039|NCT01764841|2758992|P4|Overall Study|Logistical Difficulties|0
839040|NCT01764841|2758993|P3|Overall Study|Logistical Difficulties|0
839041|NCT01764841|2758994|P2|Overall Study|Logistical Difficulties|1
839042|NCT01764841|2758995|P1|Overall Study|Logistical Difficulties|0
839043|NCT01764633|2759038|P2|Overall Study|Lost to Follow-up|5
839044|NCT01764633|2759039|P1|Overall Study|Lost to Follow-up|13
839045|NCT01764633|2759038|P2|Overall Study|Withdrawal by Subject|88
839046|NCT01764633|2759039|P1|Overall Study|Withdrawal by Subject|105
839047|NCT01764386|2759068|P2|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
839048|NCT01764386|2759069|P1|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
839049|NCT01764386|2759068|P2|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
839050|NCT01764386|2759069|P1|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
839051|NCT01764386|2759068|P2|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26
839052|NCT01764386|2759069|P1|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0
839053|NCT01764386|2759068|P2|Uncontrolled Treatment Period (UTP)|Adverse Event|13
839054|NCT01764386|2759069|P1|Uncontrolled Treatment Period (UTP)|Adverse Event|2
839055|NCT01764386|2759068|P2|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2
839056|NCT01764386|2759069|P1|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6
839057|NCT01764386|2759068|P2|Controlled Treatment Period (CTP)|Lost to Follow-up|5
839058|NCT01764386|2759069|P1|Controlled Treatment Period (CTP)|Lost to Follow-up|9
839059|NCT01764386|2759068|P2|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0
839060|NCT01764386|2759069|P1|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32
839061|NCT01764386|2759068|P2|Controlled Treatment Period (CTP)|Adverse Event|0
839062|NCT01764386|2759069|P1|Controlled Treatment Period (CTP)|Adverse Event|35
839063|NCT01764022|2759112|P2|Overall Study|Protocol Violation|0
839064|NCT01764022|2759113|P1|Overall Study|Protocol Violation|1
839065|NCT01764022|2759112|P2|Overall Study|Lost to Follow-up|0
839066|NCT01764022|2759113|P1|Overall Study|Lost to Follow-up|2
839067|NCT01764022|2759112|P2|Overall Study|Physician Decision|2
839068|NCT01764022|2759113|P1|Overall Study|Physician Decision|0
839069|NCT01764022|2759112|P2|Overall Study|Lack of Efficacy|1
839070|NCT01764022|2759113|P1|Overall Study|Lack of Efficacy|0
839071|NCT01764022|2759112|P2|Overall Study|Withdrawal by Subject|6
839072|NCT01764022|2759113|P1|Overall Study|Withdrawal by Subject|2
839073|NCT01764022|2759112|P2|Overall Study|Death|5
839074|NCT01764022|2759113|P1|Overall Study|Death|3
839075|NCT01763996|2759145|P2|Treatment Period 2|Adverse Event|1
839076|NCT01763996|2759146|P1|Treatment Period 2|Adverse Event|0
839077|NCT01763918|2759176|P4|Overall Study|Sponsor Decision|0
839078|NCT01763918|2759177|P3|Overall Study|Sponsor Decision|9
839079|NCT01763918|2759178|P2|Overall Study|Sponsor Decision|0
839080|NCT01763918|2759179|P1|Overall Study|Sponsor Decision|4
839081|NCT01763918|2759176|P4|Overall Study|Withdrawal by Subject|2
839082|NCT01763918|2759177|P3|Overall Study|Withdrawal by Subject|1
839083|NCT01763918|2759178|P2|Overall Study|Withdrawal by Subject|1
839084|NCT01763918|2759179|P1|Overall Study|Withdrawal by Subject|2
839085|NCT01763905|2759277|P4|Overall Study|Lost to Follow-up|0
839086|NCT01763905|2759278|P3|Overall Study|Lost to Follow-up|1
839087|NCT01763905|2759279|P2|Overall Study|Lost to Follow-up|0
839088|NCT01763905|2759280|P1|Overall Study|Lost to Follow-up|0
839089|NCT01763905|2759277|P4|Overall Study|Decision by sponsor|0
839090|NCT01763905|2759278|P3|Overall Study|Decision by sponsor|8
839091|NCT01763905|2759279|P2|Overall Study|Decision by sponsor|0
839092|NCT01763905|2759280|P1|Overall Study|Decision by sponsor|5
839093|NCT01763905|2759277|P4|Overall Study|Withdrawal by Subject|1
839094|NCT01763905|2759278|P3|Overall Study|Withdrawal by Subject|0
839095|NCT01763905|2759279|P2|Overall Study|Withdrawal by Subject|1
839096|NCT01763905|2759280|P1|Overall Study|Withdrawal by Subject|1
839097|NCT01763866|2759398|P24|Overall Study|Death|0
839098|NCT01763866|2759399|P23|Overall Study|Death|0
839099|NCT01763866|2759400|P22|Overall Study|Death|0
839100|NCT01763866|2759401|P21|Overall Study|Death|0
839101|NCT01763866|2759402|P20|Overall Study|Death|0
839102|NCT01763866|2759403|P19|Overall Study|Death|0
839103|NCT01763866|2759404|P18|Overall Study|Death|0
839104|NCT01763866|2759405|P17|Overall Study|Death|1
839105|NCT01763866|2759406|P16|Overall Study|Death|0
839106|NCT01763866|2759407|P15|Overall Study|Death|0
839107|NCT01763866|2759408|P14|Overall Study|Death|0
839108|NCT01763866|2759409|P13|Overall Study|Death|0
839109|NCT01763866|2759410|P12|Overall Study|Death|0
839110|NCT01763866|2759411|P11|Overall Study|Death|0
839111|NCT01763866|2759412|P10|Overall Study|Death|0
839112|NCT01763866|2759413|P9|Overall Study|Death|0
839113|NCT01763866|2759414|P8|Overall Study|Death|0
839114|NCT01763866|2759415|P7|Overall Study|Death|0
839115|NCT01763866|2759416|P6|Overall Study|Death|0
839116|NCT01763866|2759417|P5|Overall Study|Death|0
839117|NCT01763866|2759418|P4|Overall Study|Death|0
839118|NCT01763866|2759419|P3|Overall Study|Death|0
839119|NCT01763866|2759420|P2|Overall Study|Death|0
839120|NCT01763866|2759421|P1|Overall Study|Death|0
839121|NCT01763866|2759398|P24|Overall Study|Lost to Follow-up|1
839122|NCT01763866|2759399|P23|Overall Study|Lost to Follow-up|0
839123|NCT01763866|2759400|P22|Overall Study|Lost to Follow-up|0
839124|NCT01763866|2759401|P21|Overall Study|Lost to Follow-up|0
839125|NCT01763866|2759402|P20|Overall Study|Lost to Follow-up|1
839126|NCT01763866|2759403|P19|Overall Study|Lost to Follow-up|1
839127|NCT01763866|2759404|P18|Overall Study|Lost to Follow-up|0
839128|NCT01763866|2759405|P17|Overall Study|Lost to Follow-up|0
839129|NCT01763866|2759406|P16|Overall Study|Lost to Follow-up|0
839130|NCT01763866|2759407|P15|Overall Study|Lost to Follow-up|1
839131|NCT01763866|2759408|P14|Overall Study|Lost to Follow-up|0
839132|NCT01763866|2759409|P13|Overall Study|Lost to Follow-up|1
839133|NCT01763866|2759410|P12|Overall Study|Lost to Follow-up|0
839134|NCT01763866|2759411|P11|Overall Study|Lost to Follow-up|0
839135|NCT01763866|2759412|P10|Overall Study|Lost to Follow-up|0
839136|NCT01763866|2759413|P9|Overall Study|Lost to Follow-up|0
839137|NCT01763866|2759414|P8|Overall Study|Lost to Follow-up|0
839138|NCT01763866|2759415|P7|Overall Study|Lost to Follow-up|1
839139|NCT01763866|2759416|P6|Overall Study|Lost to Follow-up|0
839140|NCT01763866|2759417|P5|Overall Study|Lost to Follow-up|0
839141|NCT01763866|2759418|P4|Overall Study|Lost to Follow-up|0
839142|NCT01763866|2759419|P3|Overall Study|Lost to Follow-up|0
839143|NCT01763866|2759420|P2|Overall Study|Lost to Follow-up|0
839144|NCT01763866|2759421|P1|Overall Study|Lost to Follow-up|0
839145|NCT01763866|2759398|P24|Overall Study|Decision by sponsor|0
839146|NCT01763866|2759399|P23|Overall Study|Decision by sponsor|1
839147|NCT01763866|2759400|P22|Overall Study|Decision by sponsor|0
839148|NCT01763866|2759401|P21|Overall Study|Decision by sponsor|2
839149|NCT01763866|2759402|P20|Overall Study|Decision by sponsor|0
839150|NCT01763866|2759403|P19|Overall Study|Decision by sponsor|4
839151|NCT01763866|2759404|P18|Overall Study|Decision by sponsor|0
839152|NCT01763866|2759405|P17|Overall Study|Decision by sponsor|0
839153|NCT01763866|2759406|P16|Overall Study|Decision by sponsor|0
839154|NCT01763866|2759407|P15|Overall Study|Decision by sponsor|5
839155|NCT01763866|2759408|P14|Overall Study|Decision by sponsor|0
839156|NCT01763866|2759409|P13|Overall Study|Decision by sponsor|1
839157|NCT01763866|2759410|P12|Overall Study|Decision by sponsor|0
839158|NCT01763866|2759411|P11|Overall Study|Decision by sponsor|6
839159|NCT01763866|2759412|P10|Overall Study|Decision by sponsor|0
839160|NCT01763866|2759413|P9|Overall Study|Decision by sponsor|2
839161|NCT01763866|2759414|P8|Overall Study|Decision by sponsor|0
839162|NCT01763866|2759415|P7|Overall Study|Decision by sponsor|2
839163|NCT01763866|2759416|P6|Overall Study|Decision by sponsor|0
839164|NCT01763866|2759417|P5|Overall Study|Decision by sponsor|2
839165|NCT01763866|2759418|P4|Overall Study|Decision by sponsor|0
839166|NCT01763866|2759419|P3|Overall Study|Decision by sponsor|1
839167|NCT01763866|2759420|P2|Overall Study|Decision by sponsor|0
839168|NCT01763866|2759421|P1|Overall Study|Decision by sponsor|0
839169|NCT01763866|2759398|P24|Overall Study|Withdrawal by Subject|1
839170|NCT01763866|2759399|P23|Overall Study|Withdrawal by Subject|2
839171|NCT01763866|2759400|P22|Overall Study|Withdrawal by Subject|1
839172|NCT01763866|2759401|P21|Overall Study|Withdrawal by Subject|2
839173|NCT01763866|2759402|P20|Overall Study|Withdrawal by Subject|1
839174|NCT01763866|2759403|P19|Overall Study|Withdrawal by Subject|1
839175|NCT01763866|2759404|P18|Overall Study|Withdrawal by Subject|1
839176|NCT01763866|2759405|P17|Overall Study|Withdrawal by Subject|0
839177|NCT01763866|2759406|P16|Overall Study|Withdrawal by Subject|3
839178|NCT01763866|2759407|P15|Overall Study|Withdrawal by Subject|6
839179|NCT01763866|2759408|P14|Overall Study|Withdrawal by Subject|0
839180|NCT01763866|2759409|P13|Overall Study|Withdrawal by Subject|2
839181|NCT01763866|2759410|P12|Overall Study|Withdrawal by Subject|2
839182|NCT01763866|2759411|P11|Overall Study|Withdrawal by Subject|2
839183|NCT01763866|2759412|P10|Overall Study|Withdrawal by Subject|1
839184|NCT01763866|2759413|P9|Overall Study|Withdrawal by Subject|1
839185|NCT01763866|2759414|P8|Overall Study|Withdrawal by Subject|0
839186|NCT01763866|2759415|P7|Overall Study|Withdrawal by Subject|4
839187|NCT01763866|2759416|P6|Overall Study|Withdrawal by Subject|3
839188|NCT01763866|2759417|P5|Overall Study|Withdrawal by Subject|0
839189|NCT01763866|2759418|P4|Overall Study|Withdrawal by Subject|0
839190|NCT01763866|2759419|P3|Overall Study|Withdrawal by Subject|4
839191|NCT01763866|2759420|P2|Overall Study|Withdrawal by Subject|1
839192|NCT01763866|2759421|P1|Overall Study|Withdrawal by Subject|2
839193|NCT01763827|2759981|P6|Overall Study|Lost to Follow-up|1
839194|NCT01763827|2759982|P5|Overall Study|Lost to Follow-up|2
839195|NCT01763827|2759983|P4|Overall Study|Lost to Follow-up|1
839196|NCT01763827|2759984|P3|Overall Study|Lost to Follow-up|1
839197|NCT01763827|2759985|P2|Overall Study|Lost to Follow-up|1
839198|NCT01763827|2759986|P1|Overall Study|Lost to Follow-up|0
839199|NCT01763827|2759981|P6|Overall Study|Decision by sponsor|1
839200|NCT01763827|2759982|P5|Overall Study|Decision by sponsor|2
839201|NCT01763827|2759983|P4|Overall Study|Decision by sponsor|0
839202|NCT01763827|2759984|P3|Overall Study|Decision by sponsor|3
839203|NCT01763827|2759985|P2|Overall Study|Decision by sponsor|0
839204|NCT01763827|2759986|P1|Overall Study|Decision by sponsor|2
839205|NCT01763827|2759981|P6|Overall Study|Withdrawal by Subject|0
839206|NCT01763827|2759982|P5|Overall Study|Withdrawal by Subject|2
839207|NCT01763827|2759983|P4|Overall Study|Withdrawal by Subject|0
839208|NCT01763827|2759984|P3|Overall Study|Withdrawal by Subject|0
839209|NCT01763827|2759985|P2|Overall Study|Withdrawal by Subject|0
839210|NCT01763827|2759986|P1|Overall Study|Withdrawal by Subject|1
839211|NCT01763047|2760157|P2|Period 2|Unsatisfactory lens Fitting|1
839212|NCT01763047|2760158|P1|Period 2|Unsatisfactory lens Fitting|0
839213|NCT01763047|2760157|P2|Period 2|Protocol Violation|2
839214|NCT01763047|2760158|P1|Period 2|Protocol Violation|0
839215|NCT01763047|2760157|P2|Period 2|Unsatisfactory Visual Response|1
839216|NCT01763047|2760158|P1|Period 2|Unsatisfactory Visual Response|1
839217|NCT01763047|2760157|P2|Period 2|Study Site office Closed|1
839218|NCT01763047|2760158|P1|Period 2|Study Site office Closed|1
839219|NCT01763047|2760157|P2|Period 2|No longer meets Eligibility Criteria|0
839220|NCT01763047|2760158|P1|Period 2|No longer meets Eligibility Criteria|1
839221|NCT01763047|2760157|P2|Period 2|Lens Discomfort|0
839222|NCT01763047|2760158|P1|Period 2|Lens Discomfort|1
839223|NCT01763047|2760157|P2|Period 1|Study Site office Closed|1
839224|NCT01763047|2760158|P1|Period 1|Study Site office Closed|0
839225|NCT01763047|2760157|P2|Period 1|Lens Power Not Available|1
839226|NCT01763047|2760158|P1|Period 1|Lens Power Not Available|0
839227|NCT01763047|2760157|P2|Period 1|Unsatisfactory Visual Response|3
839228|NCT01763047|2760158|P1|Period 1|Unsatisfactory Visual Response|0
839229|NCT01763047|2760157|P2|Period 1|Adverse Event|1
839230|NCT01763047|2760158|P1|Period 1|Adverse Event|0
839231|NCT01763047|2760157|P2|Period 1|No Longer Meets Eligibility criteria|0
839232|NCT01763047|2760158|P1|Period 1|No Longer Meets Eligibility criteria|1
839233|NCT01763047|2760157|P2|Period 1|Protocol Violation|4
839234|NCT01763047|2760158|P1|Period 1|Protocol Violation|4
839235|NCT01763047|2760157|P2|Period 1|Test Article Not Available|1
839236|NCT01763047|2760158|P1|Period 1|Test Article Not Available|4
839237|NCT01762943|2760197|P2|Overall Study|Withdrawal by Subject|1
839238|NCT01762943|2760198|P1|Overall Study|Withdrawal by Subject|2
839239|NCT01762943|2760197|P2|Overall Study|Protocol Violation|0
839240|NCT01762943|2760198|P1|Overall Study|Protocol Violation|1
839241|NCT01762943|2760197|P2|Overall Study|Physician Decision|1
839242|NCT01762943|2760198|P1|Overall Study|Physician Decision|1
839243|NCT01762800|2760215|P2|Overall Study|Withdrawal by Subject|4
839244|NCT01762800|2760216|P1|Overall Study|Withdrawal by Subject|7
839245|NCT01762800|2760215|P2|Overall Study|Physician Decision|1
839246|NCT01762800|2760216|P1|Overall Study|Physician Decision|1
839247|NCT01762800|2760215|P2|Overall Study|Study Closed/Terminated|1
839248|NCT01762800|2760216|P1|Overall Study|Study Closed/Terminated|0
839249|NCT01762800|2760215|P2|Overall Study|Lack of Efficacy|2
839250|NCT01762800|2760216|P1|Overall Study|Lack of Efficacy|3
839251|NCT01762800|2760215|P2|Overall Study|Adverse Event|13
839252|NCT01762800|2760216|P1|Overall Study|Adverse Event|8
839253|NCT01762761|2760290|P2|Overall Study|Physician Decision|1
839254|NCT01762761|2760291|P1|Overall Study|Physician Decision|0
839255|NCT01762761|2760290|P2|Overall Study|Protocol Violation|1
839256|NCT01762761|2760291|P1|Overall Study|Protocol Violation|0
839257|NCT01762761|2760290|P2|Overall Study|Lack of Efficacy|0
839258|NCT01762761|2760291|P1|Overall Study|Lack of Efficacy|1
839259|NCT01762761|2760290|P2|Overall Study|Adverse Event|2
839260|NCT01762761|2760291|P1|Overall Study|Adverse Event|1
839261|NCT01762345|2760369|P1|Overall Study|Protocol Violation|2
839262|NCT01762345|2760369|P1|Overall Study|Adverse Event|5
839263|NCT01761565|2760417|P1|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1
839264|NCT01761266|2760441|P2|Overall Study|Ongoing as of data-cut off|107
839265|NCT01761266|2760442|P1|Overall Study|Ongoing as of data-cut off|109
839266|NCT01761266|2760441|P2|Overall Study|Withdrawal by Subject|8
839267|NCT01761266|2760442|P1|Overall Study|Withdrawal by Subject|13
839268|NCT01761266|2760441|P2|Overall Study|Lost to Follow-up|11
839269|NCT01761266|2760442|P1|Overall Study|Lost to Follow-up|5
839270|NCT01761266|2760441|P2|Overall Study|Death|350
839271|NCT01761266|2760442|P1|Overall Study|Death|351
839272|NCT01761162|2760499|P1|Overall Study|Withdrawal by Subject|3
839273|NCT01760954|2760536|P4|Post-treatment Follow-up (12 Months)|Other|6
839274|NCT01760954|2760537|P3|Post-treatment Follow-up (12 Months)|Other|9
839275|NCT01760954|2760538|P2|Post-treatment Follow-up (12 Months)|Other|8
839276|NCT01760954|2760539|P1|Post-treatment Follow-up (12 Months)|Other|13
839277|NCT01760954|2760536|P4|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
839278|NCT01760954|2760537|P3|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1
839279|NCT01760954|2760538|P2|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
839280|NCT01760954|2760539|P1|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
839281|NCT01760954|2760536|P4|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
839282|NCT01760954|2760537|P3|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
839283|NCT01760954|2760538|P2|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4
839284|NCT01760954|2760539|P1|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1
839285|NCT01760954|2760536|P4|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
839286|NCT01760954|2760537|P3|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
839287|NCT01760954|2760538|P2|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10
839288|NCT01760954|2760539|P1|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6
839289|NCT01760954|2760536|P4|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0
839290|NCT01760954|2760537|P3|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2
839291|NCT01760954|2760538|P2|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7
839292|NCT01760954|2760539|P1|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4
839293|NCT01760954|2760536|P4|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9
839294|NCT01760954|2760537|P3|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
839295|NCT01760954|2760538|P2|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
839296|NCT01760954|2760539|P1|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
839297|NCT01760954|2760536|P4|Treatment Period (6 Months)|Exclusionary Medication|0
839298|NCT01760954|2760537|P3|Treatment Period (6 Months)|Exclusionary Medication|0
839299|NCT01760954|2760538|P2|Treatment Period (6 Months)|Exclusionary Medication|0
839300|NCT01760954|2760539|P1|Treatment Period (6 Months)|Exclusionary Medication|1
839301|NCT01760954|2760536|P4|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
839302|NCT01760954|2760537|P3|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
839303|NCT01760954|2760538|P2|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6
839304|NCT01760954|2760539|P1|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1
839305|NCT01760954|2760536|P4|Treatment Period (6 Months)|Other|1
839306|NCT01760954|2760537|P3|Treatment Period (6 Months)|Other|3
839307|NCT01760954|2760538|P2|Treatment Period (6 Months)|Other|3
839308|NCT01760954|2760539|P1|Treatment Period (6 Months)|Other|0
839309|NCT01760954|2760536|P4|Treatment Period (6 Months)|Non-compliance|3
839310|NCT01760954|2760537|P3|Treatment Period (6 Months)|Non-compliance|0
839311|NCT01760954|2760538|P2|Treatment Period (6 Months)|Non-compliance|4
839312|NCT01760954|2760539|P1|Treatment Period (6 Months)|Non-compliance|1
839313|NCT01760954|2760536|P4|Treatment Period (6 Months)|Pregnancy|2
839314|NCT01760954|2760537|P3|Treatment Period (6 Months)|Pregnancy|3
839315|NCT01760954|2760538|P2|Treatment Period (6 Months)|Pregnancy|0
839316|NCT01760954|2760539|P1|Treatment Period (6 Months)|Pregnancy|5
839317|NCT01760954|2760536|P4|Treatment Period (6 Months)|Surgery or invasive intervention for end|2
839318|NCT01760954|2760537|P3|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
839319|NCT01760954|2760538|P2|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
839320|NCT01760954|2760539|P1|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
839321|NCT01760954|2760536|P4|Treatment Period (6 Months)|Lost to Follow-up|3
839322|NCT01760954|2760537|P3|Treatment Period (6 Months)|Lost to Follow-up|4
839323|NCT01760954|2760538|P2|Treatment Period (6 Months)|Lost to Follow-up|1
839324|NCT01760954|2760539|P1|Treatment Period (6 Months)|Lost to Follow-up|9
839325|NCT01760954|2760536|P4|Treatment Period (6 Months)|Adverse Event|10
839326|NCT01760954|2760537|P3|Treatment Period (6 Months)|Adverse Event|4
839327|NCT01760954|2760538|P2|Treatment Period (6 Months)|Adverse Event|3
839328|NCT01760954|2760539|P1|Treatment Period (6 Months)|Adverse Event|5
839329|NCT01760954|2760536|P4|Treatment Period (6 Months)|Withdrawal by Subject|5
839330|NCT01760954|2760537|P3|Treatment Period (6 Months)|Withdrawal by Subject|4
839331|NCT01760954|2760538|P2|Treatment Period (6 Months)|Withdrawal by Subject|8
839332|NCT01760954|2760539|P1|Treatment Period (6 Months)|Withdrawal by Subject|8
839333|NCT01760876|2760676|P1|Overall Study|Very poor baseline OCT quality|2
839334|NCT01760876|2760676|P1|Overall Study|Major depression|1
839335|NCT01760876|2760676|P1|Overall Study|Impaired renal function|1
839336|NCT01760876|2760676|P1|Overall Study|Carcinoma of prostate|1
839337|NCT01760876|2760676|P1|Overall Study|Non-cardiac death (head injury)|1
839338|NCT01759511|2760973|P1|Overall Study|Withdrawal by Subject|3
839339|NCT01759511|2760973|P1|Overall Study|Study Terminated by Sponsor|13
839340|NCT01759511|2760973|P1|Overall Study|Protocol-Specified Criteria for Withdraw|4
839341|NCT01759511|2760973|P1|Overall Study|Progressive Disease|5
839342|NCT01759511|2760973|P1|Overall Study|Physician Decision|1
839343|NCT01759511|2760973|P1|Overall Study|Lack of Efficacy|2
839344|NCT01759511|2760973|P1|Overall Study|Death|2
839345|NCT01759511|2760973|P1|Overall Study|Adverse Event|4
839346|NCT01759446|2760986|P5|Overall Study|Withdrawal by Subject|0
839347|NCT01759446|2760987|P4|Overall Study|Withdrawal by Subject|1
839348|NCT01759446|2760988|P3|Overall Study|Withdrawal by Subject|0
839349|NCT01759446|2760989|P2|Overall Study|Withdrawal by Subject|1
839350|NCT01759446|2760990|P1|Overall Study|Withdrawal by Subject|0
839351|NCT01759446|2760986|P5|Overall Study|Protocol Violation|0
839352|NCT01759446|2760987|P4|Overall Study|Protocol Violation|0
839353|NCT01759446|2760988|P3|Overall Study|Protocol Violation|1
839354|NCT01759446|2760989|P2|Overall Study|Protocol Violation|0
839355|NCT01759446|2760990|P1|Overall Study|Protocol Violation|1
839356|NCT01759420|2761002|P1|Overall Study|Inaccurate EKG machine readings|1
839357|NCT01759420|2761002|P1|Overall Study|Screen failure|5
839358|NCT01759407|2761009|P2|Overall Study|Protocol Violation|2
839359|NCT01759407|2761010|P1|Overall Study|Protocol Violation|0
839360|NCT01759381|2761022|P2|Overall Study|Death|0
839361|NCT01759381|2761023|P1|Overall Study|Death|1
839362|NCT01759368|2761031|P2|Overall Study|Lost to Follow-up|0
839363|NCT01759368|2761032|P1|Overall Study|Lost to Follow-up|1
839364|NCT01759290|2761050|P1|Overall Study|Unknown reason|4
839365|NCT01759290|2761050|P1|Overall Study|Lost to Follow-up|53
839366|NCT01759290|2761050|P1|Overall Study|Death|17
839367|NCT01759290|2761050|P1|Overall Study|Physician Decision|2
839368|NCT01759290|2761050|P1|Overall Study|Subjects withdrawn consent|5
839369|NCT01759264|2761110|P1|Overall Study|Discontinued Humira Due to Business Trip|1
839370|NCT01759264|2761110|P1|Overall Study|Withdrawal by Subject|3
839371|NCT01759264|2761110|P1|Overall Study|Lost to Follow-up|2
839372|NCT01759264|2761110|P1|Overall Study|Not Specified|2
839373|NCT01759264|2761110|P1|Overall Study|Adverse Event|1
839374|NCT01759264|2761110|P1|Overall Study|Serious Adverse Events (SAEs)|1
839375|NCT01758900|2761138|P2|Overall Study|difficulty for further intubation|8
839376|NCT01758900|2761139|P1|Overall Study|difficulty for further intubation|7
839377|NCT01758289|2761255|P1|Overall Study|Adverse Event|9
839378|NCT01758289|2761255|P1|Overall Study|Premature Study Termination|44
839379|NCT01757847|2761281|P2|Overall Study|Withdrawal by Subject|4
839380|NCT01757847|2761282|P1|Overall Study|Withdrawal by Subject|3
839381|NCT01757821|2761290|P1|Overall Study|Adverse Event|1
839382|NCT01757704|2761305|P2|Overall Study|Protocol Violation|3
839383|NCT01757704|2761306|P1|Overall Study|Protocol Violation|1
839384|NCT01757691|2761324|P2|Overall Study|Administrative problems|0
839385|NCT01757691|2761325|P1|Overall Study|Administrative problems|2
839386|NCT01757405|2761373|P2|Overall Study|Withdrawal by Subject|1
839387|NCT01757405|2761374|P1|Overall Study|Withdrawal by Subject|0
839388|NCT01757405|2761373|P2|Overall Study|Lost to Follow-up|1
839389|NCT01757405|2761374|P1|Overall Study|Lost to Follow-up|1
839390|NCT01757275|2761392|P2|Overall Study|Not treated|4
839391|NCT01757275|2761393|P1|Overall Study|Not treated|3
839392|NCT01757275|2761392|P2|Overall Study|Withdrawal by Subject|4
839393|NCT01757275|2761393|P1|Overall Study|Withdrawal by Subject|2
839394|NCT01757275|2761392|P2|Overall Study|Adverse Event|3
839395|NCT01757275|2761393|P1|Overall Study|Adverse Event|3
839396|NCT01757275|2761392|P2|Overall Study|Lost to Follow-up|2
839397|NCT01757275|2761393|P1|Overall Study|Lost to Follow-up|1
839398|NCT01757197|2761415|P1|Overall Study|Death|2
839399|NCT01757184|2761424|P2|Double-Blind Period|Adverse Event|0
839400|NCT01757184|2761425|P1|Double-Blind Period|Adverse Event|1
839401|NCT01757171|2761449|P2|Overall Study|ECOG decline|0
839402|NCT01757171|2761450|P1|Overall Study|ECOG decline|1
839403|NCT01757171|2761449|P2|Overall Study|Hospitalization|0
839404|NCT01757171|2761450|P1|Overall Study|Hospitalization|1
839405|NCT01757171|2761449|P2|Overall Study|Disease Progression|0
839406|NCT01757171|2761450|P1|Overall Study|Disease Progression|1
839407|NCT01757171|2761449|P2|Overall Study|Adverse Event|1
839408|NCT01757171|2761450|P1|Overall Study|Adverse Event|5
839409|NCT01756300|2761484|P1|Overall Study|Withdrawal by Subject|1
839410|NCT01756300|2761484|P1|Overall Study|Death|1
839411|NCT01756274|2761506|P1|Overall Study|Laboratory error|1
839412|NCT01756274|2761506|P1|Overall Study|Protocol Violation|2
839413|NCT01756235|2761513|P1|Overall Study|Adalimumab Treatment was not Documented|2
839414|NCT01756157|2761534|P2|First Intervention Period|Lost to Follow-up|2
839415|NCT01756157|2761535|P1|First Intervention Period|Lost to Follow-up|0
839416|NCT01756157|2761534|P2|First Intervention Period|Withdrawal by Subject|0
839417|NCT01756157|2761535|P1|First Intervention Period|Withdrawal by Subject|1
839418|NCT01756079|2761549|P1|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4
839419|NCT01756079|2761549|P1|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20
839420|NCT01756079|2761549|P1|Treatment / Follow-up: Week 4 to Week 72|No information available|2
839421|NCT01756079|2761549|P1|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5
839422|NCT01756079|2761549|P1|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4
839423|NCT01756053|2761555|P2|Period 2 (10 Days)|Protocol Violation|2
839424|NCT01756053|2761556|P1|Period 2 (10 Days)|Protocol Violation|0
839425|NCT01756053|2761555|P2|Period 1 (10 Days)|Protocol Violation|1
839426|NCT01756053|2761556|P1|Period 1 (10 Days)|Protocol Violation|1
839427|NCT01755702|2761576|P1|Washout Period II|Other Reason|5
839428|NCT01755702|2761576|P1|Wash Out Period I|Other Reason|3
839429|NCT01755689|2761623|P5|Overall Study|Pregnancy|2
839430|NCT01755689|2761624|P4|Overall Study|Pregnancy|4
839431|NCT01755689|2761625|P3|Overall Study|Pregnancy|2
839432|NCT01755689|2761626|P2|Overall Study|Pregnancy|1
839433|NCT01755689|2761627|P1|Overall Study|Pregnancy|1
839434|NCT01755689|2761623|P5|Overall Study|Lost to Follow-up|2
839435|NCT01755689|2761624|P4|Overall Study|Lost to Follow-up|0
839436|NCT01755689|2761625|P3|Overall Study|Lost to Follow-up|1
839437|NCT01755689|2761626|P2|Overall Study|Lost to Follow-up|0
839438|NCT01755689|2761627|P1|Overall Study|Lost to Follow-up|1
839439|NCT01755689|2761623|P5|Overall Study|Migrated/moved from study area|1
839440|NCT01755689|2761624|P4|Overall Study|Migrated/moved from study area|1
839441|NCT01755689|2761625|P3|Overall Study|Migrated/moved from study area|1
839442|NCT01755689|2761626|P2|Overall Study|Migrated/moved from study area|1
839443|NCT01755689|2761627|P1|Overall Study|Migrated/moved from study area|0
839444|NCT01755689|2761623|P5|Overall Study|Withdrawal by Subject|1
839445|NCT01755689|2761624|P4|Overall Study|Withdrawal by Subject|1
839446|NCT01755689|2761625|P3|Overall Study|Withdrawal by Subject|2
839447|NCT01755689|2761626|P2|Overall Study|Withdrawal by Subject|3
839448|NCT01755689|2761627|P1|Overall Study|Withdrawal by Subject|1
839449|NCT01755637|2761702|P2|Period 1|Adverse Event|1
839450|NCT01755637|2761703|P1|Period 1|Adverse Event|0
839451|NCT01755546|2761721|P1|Long Term Treatment|other and ongoing|41
839452|NCT01755546|2761721|P1|Long Term Treatment|Lost to Follow-up|17
839453|NCT01755546|2761721|P1|Long Term Treatment|Withdrawal by Subject|35
839454|NCT01755546|2761721|P1|Long Term Treatment|Protocol Violation|10
839455|NCT01755546|2761721|P1|Long Term Treatment|Lack of Efficacy|6
839456|NCT01755546|2761721|P1|Long Term Treatment|Adverse Event|12
839457|NCT01755546|2761721|P1|Titration Phase|Withdrawal by Subject|8
839458|NCT01755546|2761721|P1|Titration Phase|Other and Continuing|22
839459|NCT01755546|2761721|P1|Titration Phase|Lost to Follow-up|2
839460|NCT01755546|2761721|P1|Titration Phase|Protocol Violation|9
839461|NCT01755546|2761721|P1|Titration Phase|Lack of Efficacy|18
839462|NCT01755546|2761721|P1|Titration Phase|Adverse Event|11
839463|NCT01755546|2761721|P1|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5
839464|NCT01755546|2761721|P1|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1
839465|NCT01755546|2761721|P1|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3
839466|NCT01755546|2761721|P1|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1
839467|NCT01755416|2761738|P2|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2
839468|NCT01755416|2761739|P1|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1
839469|NCT01755234|2761747|P2|Overall Study|unblinded|0
839470|NCT01755234|2761748|P1|Overall Study|unblinded|1
839471|NCT01755234|2761747|P2|Overall Study|Withdrawal by Subject|1
839472|NCT01755234|2761748|P1|Overall Study|Withdrawal by Subject|0
839473|NCT01755234|2761747|P2|Overall Study|case cancelled|0
839474|NCT01755234|2761748|P1|Overall Study|case cancelled|1
839475|NCT01755234|2761747|P2|Overall Study|Change in surgical case|1
839476|NCT01755234|2761748|P1|Overall Study|Change in surgical case|2
839477|NCT01755234|2761747|P2|Overall Study|Lost to Follow-up|6
839478|NCT01755234|2761748|P1|Overall Study|Lost to Follow-up|11
839479|NCT01755156|2761779|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|31
839480|NCT01755156|2761780|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|27
839481|NCT01755156|2761779|P2|Phase B (Weeks 24-104)|Lost to Follow-up|5
839482|NCT01755156|2761780|P1|Phase B (Weeks 24-104)|Lost to Follow-up|12
839483|NCT01755156|2761779|P2|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
839484|NCT01755156|2761780|P1|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
839485|NCT01755156|2761779|P2|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2
839486|NCT01755156|2761780|P1|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0
839487|NCT01755156|2761779|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|13
839488|NCT01755156|2761780|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|6
839489|NCT01755156|2761779|P2|Phase A (Weeks 0-24)|Protocol Violation|1
839490|NCT01755156|2761780|P1|Phase A (Weeks 0-24)|Protocol Violation|1
839491|NCT01755156|2761779|P2|Phase A (Weeks 0-24)|Physician Decision|1
839492|NCT01755156|2761780|P1|Phase A (Weeks 0-24)|Physician Decision|0
839493|NCT01755156|2761779|P2|Phase A (Weeks 0-24)|Non-compliance with study drug|0
839494|NCT01755156|2761780|P1|Phase A (Weeks 0-24)|Non-compliance with study drug|1
839495|NCT01755156|2761779|P2|Phase A (Weeks 0-24)|Lost to Follow-up|3
839496|NCT01755156|2761780|P1|Phase A (Weeks 0-24)|Lost to Follow-up|5
839497|NCT01755156|2761779|P2|Phase A (Weeks 0-24)|Lack of Efficacy|0
839498|NCT01755156|2761780|P1|Phase A (Weeks 0-24)|Lack of Efficacy|1
839499|NCT01755156|2761779|P2|Phase A (Weeks 0-24)|Adverse Event|3
839500|NCT01755156|2761780|P1|Phase A (Weeks 0-24)|Adverse Event|2
839501|NCT01755091|2761844|P3|Overall Study|Physician Decision|2
839502|NCT01755091|2761845|P2|Overall Study|Physician Decision|1
839503|NCT01755091|2761846|P1|Overall Study|Physician Decision|1
839504|NCT01755091|2761844|P3|Overall Study|Lost to Follow-up|1
839505|NCT01755091|2761845|P2|Overall Study|Lost to Follow-up|0
839506|NCT01755091|2761846|P1|Overall Study|Lost to Follow-up|1
839507|NCT01755091|2761844|P3|Overall Study|Adverse Event|1
839508|NCT01755091|2761845|P2|Overall Study|Adverse Event|1
839509|NCT01755091|2761846|P1|Overall Study|Adverse Event|1
839510|NCT01755091|2761844|P3|Overall Study|Withdrawal by Subject|3
839511|NCT01755091|2761845|P2|Overall Study|Withdrawal by Subject|1
839512|NCT01755091|2761846|P1|Overall Study|Withdrawal by Subject|6
839513|NCT01755026|2761871|P2|Overall Study|Withdrawal by Subject|1
839514|NCT01755026|2761872|P1|Overall Study|Withdrawal by Subject|1
839515|NCT01755026|2761871|P2|Overall Study|Adverse Event|0
839516|NCT01755026|2761872|P1|Overall Study|Adverse Event|1
839517|NCT01754922|2761895|P2|Overall Study|Adverse Event|1
839518|NCT01754922|2761896|P1|Overall Study|Adverse Event|0
839519|NCT01754766|2761909|P3|Overall Study|Personal reasons|0
839520|NCT01754766|2761910|P2|Overall Study|Personal reasons|1
839521|NCT01754766|2761911|P1|Overall Study|Personal reasons|1
839522|NCT01754727|2761925|P1|Overall Study|Adalimumab Treatment was not Documented|2
839523|NCT01754493|2762052|P1|Overall Study|Scheduling conflict|1
839524|NCT01754493|2762052|P1|Overall Study|Moved out of town|1
839525|NCT01754493|2762052|P1|Overall Study|Withdrawal by Subject|1
839526|NCT01754493|2762052|P1|Overall Study|Lost to Follow-up|3
839527|NCT01754493|2762052|P1|Overall Study|Adverse Event|1
839528|NCT01754467|2762077|P1|Overall Study|Lost to Follow-up|1
839529|NCT01754402|2762087|P3|Overall Study|Lack of Efficacy|1
839530|NCT01754402|2762088|P2|Overall Study|Lack of Efficacy|0
839531|NCT01754402|2762089|P1|Overall Study|Lack of Efficacy|0
839532|NCT01754402|2762087|P3|Overall Study|Withdrawal by Subject|1
839533|NCT01754402|2762088|P2|Overall Study|Withdrawal by Subject|0
839534|NCT01754402|2762089|P1|Overall Study|Withdrawal by Subject|0
839535|NCT01754402|2762087|P3|Overall Study|Adverse Event|1
839536|NCT01754402|2762088|P2|Overall Study|Adverse Event|2
839537|NCT01754402|2762089|P1|Overall Study|Adverse Event|2
839538|NCT01754402|2762087|P3|Overall Study|Death|1
839539|NCT01754402|2762088|P2|Overall Study|Death|0
839540|NCT01754402|2762089|P1|Overall Study|Death|0
839541|NCT01754376|2762123|P1|Overall Study|Lack of Efficacy|2
839542|NCT01754376|2762123|P1|Overall Study|Adverse Event|1
839543|NCT01754259|2762134|P2|Overall Study|Lost to Follow-up|1
839544|NCT01754259|2762135|P1|Overall Study|Lost to Follow-up|0
839545|NCT01754259|2762134|P2|Overall Study|Adverse Event|1
839546|NCT01754259|2762135|P1|Overall Study|Adverse Event|3
839547|NCT01754259|2762134|P2|Overall Study|Withdrawal by Subject|4
839548|NCT01754259|2762135|P1|Overall Study|Withdrawal by Subject|2
839549|NCT01754194|2762145|P2|Overall Study|Not Specified|8
839550|NCT01754194|2762146|P1|Overall Study|Not Specified|9
839551|NCT01754194|2762145|P2|Overall Study|Withdrawal by Subject|5
839552|NCT01754194|2762146|P1|Overall Study|Withdrawal by Subject|4
839553|NCT01754194|2762145|P2|Overall Study|Lost to Follow-up|14
839554|NCT01754194|2762146|P1|Overall Study|Lost to Follow-up|39
839555|NCT01754129|2762166|P1|Overall Study|Inclusion/exclusion criteria violation|3
839556|NCT01754129|2762166|P1|Overall Study|Withdrew consent|1
839557|NCT01754129|2762166|P1|Overall Study|Lost to Follow-up|7
839558|NCT01754129|2762166|P1|Overall Study|Duodopa discontinuation|9
839559|NCT01754129|2762166|P1|Overall Study|Death|13
839560|NCT01753999|2762189|P2|Period 2 -Cross to Alternate Arm|Physician Decision|2
839561|NCT01753999|2762190|P1|Period 2 -Cross to Alternate Arm|Physician Decision|0
839562|NCT01753999|2762189|P2|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|4
839563|NCT01753999|2762190|P1|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|2
839564|NCT01753999|2762189|P2|Period 2 -Cross to Alternate Arm|Lost to Follow-up|20
839565|NCT01753999|2762190|P1|Period 2 -Cross to Alternate Arm|Lost to Follow-up|15
839566|NCT01753999|2762189|P2|Period 1 - Initial Assignment|Lost to Follow-up|27
839567|NCT01753999|2762190|P1|Period 1 - Initial Assignment|Lost to Follow-up|17
839568|NCT01753999|2762189|P2|Period 1 - Initial Assignment|Withdrawal by Subject|20
839569|NCT01753999|2762190|P1|Period 1 - Initial Assignment|Withdrawal by Subject|21
839570|NCT01753999|2762189|P2|Period 1 - Initial Assignment|Physician Decision|3
839571|NCT01753999|2762190|P1|Period 1 - Initial Assignment|Physician Decision|1
839572|NCT01753856|2762200|P2|Overall Study|Sponsor Decision|0
839573|NCT01753856|2762201|P1|Overall Study|Sponsor Decision|2
839574|NCT01753856|2762200|P2|Overall Study|Withdrawal by Subject|2
839575|NCT01753856|2762201|P1|Overall Study|Withdrawal by Subject|0
839576|NCT01753856|2762200|P2|Overall Study|Adverse Event|0
839577|NCT01753856|2762201|P1|Overall Study|Adverse Event|1
839578|NCT01753570|2762273|P3|Overall Study|Withdrawal by Subject|0
839579|NCT01753570|2762274|P2|Overall Study|Withdrawal by Subject|4
839580|NCT01753570|2762275|P1|Overall Study|Withdrawal by Subject|1
839581|NCT01753570|2762273|P3|Overall Study|Physician Decision|0
839582|NCT01753570|2762274|P2|Overall Study|Physician Decision|1
839583|NCT01753570|2762275|P1|Overall Study|Physician Decision|0
839584|NCT01753570|2762273|P3|Overall Study|Adverse Event|1
839585|NCT01753570|2762274|P2|Overall Study|Adverse Event|0
839586|NCT01753570|2762275|P1|Overall Study|Adverse Event|1
839587|NCT01753518|2762318|P2|Postpartum Follow-up|Lost to Follow-up|15
839588|NCT01753518|2762319|P1|Postpartum Follow-up|Lost to Follow-up|22
839589|NCT01753518|2762318|P2|Intention-to-Treat Analysis|Body Mass Index>50|1
839590|NCT01753518|2762319|P1|Intention-to-Treat Analysis|Body Mass Index>50|0
839591|NCT01753518|2762318|P2|Intention-to-Treat Analysis|Multifetal gestation|3
839592|NCT01753518|2762319|P1|Intention-to-Treat Analysis|Multifetal gestation|2
839593|NCT01753518|2762318|P2|Intention-to-Treat Analysis|Missing consent form|3
839594|NCT01753518|2762319|P1|Intention-to-Treat Analysis|Missing consent form|5
839595|NCT01753336|2762341|P1|Overall Study|Withdrawal by Subject|1
839596|NCT01753336|2762341|P1|Overall Study|Sponsor's decision|2
839597|NCT01753336|2762341|P1|Overall Study|Physician Decision|2
839598|NCT01753336|2762341|P1|Overall Study|Lost to Follow-up|3
839599|NCT01753336|2762341|P1|Overall Study|Patient decision|12
839600|NCT01753323|2762353|P3|Overall Study|Adverse Event|1
839601|NCT01753323|2762354|P2|Overall Study|Adverse Event|0
839602|NCT01753323|2762355|P1|Overall Study|Adverse Event|0
839603|NCT01753323|2762353|P3|Overall Study|Protocol deviation|0
839604|NCT01753323|2762354|P2|Overall Study|Protocol deviation|0
839605|NCT01753323|2762355|P1|Overall Study|Protocol deviation|1
839606|NCT01753323|2762353|P3|Overall Study|Lack of Efficacy|8
839607|NCT01753323|2762354|P2|Overall Study|Lack of Efficacy|0
839608|NCT01753323|2762355|P1|Overall Study|Lack of Efficacy|0
839609|NCT01753310|2762393|P2|Overall Study|Withdrawal by Subject|0
839610|NCT01753310|2762394|P1|Overall Study|Withdrawal by Subject|1
839611|NCT01753310|2762393|P2|Overall Study|Sponsor decision|0
839612|NCT01753310|2762394|P1|Overall Study|Sponsor decision|1
839613|NCT01753310|2762393|P2|Overall Study|Subject decision|2
839614|NCT01753310|2762394|P1|Overall Study|Subject decision|2
839615|NCT01753310|2762393|P2|Overall Study|Lost to Follow-up|0
839616|NCT01753310|2762394|P1|Overall Study|Lost to Follow-up|2
839617|NCT01753310|2762393|P2|Overall Study|Adverse Event|0
839618|NCT01753310|2762394|P1|Overall Study|Adverse Event|1
839619|NCT01753310|2762393|P2|Overall Study|Entered into open label extension study|22
839620|NCT01753310|2762394|P1|Overall Study|Entered into open label extension study|25
839621|NCT01753115|2762417|P3|Overall Study|Used excluded drug|0
839622|NCT01753115|2762418|P2|Overall Study|Used excluded drug|1
839623|NCT01753115|2762419|P1|Overall Study|Used excluded drug|0
839624|NCT01753115|2762417|P3|Overall Study|Subject non-compliant|0
839625|NCT01753115|2762418|P2|Overall Study|Subject non-compliant|3
839626|NCT01753115|2762419|P1|Overall Study|Subject non-compliant|3
839627|NCT01753115|2762417|P3|Overall Study|Withdrawal by Subject|6
839628|NCT01753115|2762418|P2|Overall Study|Withdrawal by Subject|5
839629|NCT01753115|2762419|P1|Overall Study|Withdrawal by Subject|6
839630|NCT01753115|2762417|P3|Overall Study|Lost to Follow-up|8
839631|NCT01753115|2762418|P2|Overall Study|Lost to Follow-up|6
839632|NCT01753115|2762419|P1|Overall Study|Lost to Follow-up|3
839633|NCT01753076|2762429|P2|Overall Study|Other-Reached Protocol-defined Stopping|0
839634|NCT01753076|2762430|P1|Overall Study|Other-Reached Protocol-defined Stopping|1
839635|NCT01753076|2762429|P2|Overall Study|Withdrawal by Subject|24
839636|NCT01753076|2762430|P1|Overall Study|Withdrawal by Subject|14
839637|NCT01753076|2762429|P2|Overall Study|Physician Decision|2
839638|NCT01753076|2762430|P1|Overall Study|Physician Decision|4
839639|NCT01753076|2762429|P2|Overall Study|Lost to Follow-up|1
839640|NCT01753076|2762430|P1|Overall Study|Lost to Follow-up|2
839641|NCT01753076|2762429|P2|Overall Study|Lack of Efficacy|1
839642|NCT01753076|2762430|P1|Overall Study|Lack of Efficacy|3
839643|NCT01753076|2762429|P2|Overall Study|Adverse Event|18
839644|NCT01753076|2762430|P1|Overall Study|Adverse Event|17
839645|NCT01752907|2762456|P2|Overall Study|Decision by Sponsor|9
839646|NCT01752907|2762457|P1|Overall Study|Decision by Sponsor|6
839647|NCT01752907|2762456|P2|Overall Study|Lost to Follow-up|1
839648|NCT01752907|2762457|P1|Overall Study|Lost to Follow-up|2
839649|NCT01752907|2762456|P2|Overall Study|Withdrawal by Subject|10
839650|NCT01752907|2762457|P1|Overall Study|Withdrawal by Subject|4
839651|NCT01752855|2762477|P2|Overall Study|Lack of Efficacy|2
839652|NCT01752855|2762478|P1|Overall Study|Lack of Efficacy|0
839653|NCT01752855|2762477|P2|Overall Study|Withdrew Consent|2
839654|NCT01752855|2762478|P1|Overall Study|Withdrew Consent|0
839655|NCT01752855|2762477|P2|Overall Study|Adverse Event|0
839656|NCT01752855|2762478|P1|Overall Study|Adverse Event|1
839657|NCT01752023|2762524|P2|Overall Study|Physician Decision|1
839658|NCT01752023|2762525|P1|Overall Study|Physician Decision|2
839659|NCT01751867|2762712|P2|Overall Study|Randomized but not treated.|1
839660|NCT01751867|2762713|P1|Overall Study|Randomized but not treated.|2
839661|NCT01751867|2762712|P2|Overall Study|Other|37
839662|NCT01751867|2762713|P1|Overall Study|Other|11
839663|NCT01751867|2762712|P2|Overall Study|Death|5
839664|NCT01751867|2762713|P1|Overall Study|Death|0
839665|NCT01751867|2762712|P2|Overall Study|Protocol Violation|2
839666|NCT01751867|2762713|P1|Overall Study|Protocol Violation|0
839667|NCT01751867|2762712|P2|Overall Study|Physician Decision|7
839668|NCT01751867|2762713|P1|Overall Study|Physician Decision|4
839669|NCT01751867|2762712|P2|Overall Study|Withdrawal by Subject|1
839670|NCT01751867|2762713|P1|Overall Study|Withdrawal by Subject|3
839671|NCT01751867|2762712|P2|Overall Study|Poor Compliance|5
839672|NCT01751867|2762713|P1|Overall Study|Poor Compliance|0
839673|NCT01751867|2762712|P2|Overall Study|Adverse Event|15
839674|NCT01751867|2762713|P1|Overall Study|Adverse Event|8
839675|NCT01751867|2762712|P2|Overall Study|Diease Progression|18
839676|NCT01751867|2762713|P1|Overall Study|Diease Progression|4
839677|NCT01751867|2762712|P2|Overall Study|Completed treatment,dropped in follow-up|8
839678|NCT01751867|2762713|P1|Overall Study|Completed treatment,dropped in follow-up|4
839679|NCT01751802|2762733|P2|Overall Study|Adverse Event|2
839680|NCT01751802|2762734|P1|Overall Study|Adverse Event|4
839681|NCT01751724|2762748|P2|Overall Study|withdrawn by parent|2
839682|NCT01751724|2762749|P1|Overall Study|withdrawn by parent|0
839683|NCT01751724|2762748|P2|Overall Study|extubated bef.start assigned treatment|0
839684|NCT01751724|2762749|P1|Overall Study|extubated bef.start assigned treatment|1
839685|NCT01751412|2762775|P1|Overall Study|Disease Progression Before Treatment|1
839686|NCT01751178|2762864|P3|Overall Study|Other Reason (unknown)|2
839687|NCT01751178|2762865|P2|Overall Study|Other Reason (unknown)|0
839688|NCT01751178|2762866|P1|Overall Study|Other Reason (unknown)|1
839689|NCT01751178|2762864|P3|Overall Study|Adverse Event|0
839690|NCT01751178|2762865|P2|Overall Study|Adverse Event|0
839691|NCT01751178|2762866|P1|Overall Study|Adverse Event|2
839692|NCT01751165|2762886|P3|Overall Study|Lost to Follow-up|1
839693|NCT01751165|2762887|P2|Overall Study|Lost to Follow-up|1
839694|NCT01751165|2762888|P1|Overall Study|Lost to Follow-up|1
839695|NCT01751165|2762886|P3|Overall Study|Serious adverse event|0
839696|NCT01751165|2762887|P2|Overall Study|Serious adverse event|2
839697|NCT01751165|2762888|P1|Overall Study|Serious adverse event|0
839698|NCT01751165|2762886|P3|Overall Study|Withdrawal by Subject|1
839699|NCT01751165|2762887|P2|Overall Study|Withdrawal by Subject|0
839700|NCT01751165|2762888|P1|Overall Study|Withdrawal by Subject|0
839701|NCT01751165|2762886|P3|Overall Study|Adverse event, serious fatal|1
839702|NCT01751165|2762887|P2|Overall Study|Adverse event, serious fatal|0
839703|NCT01751165|2762888|P1|Overall Study|Adverse event, serious fatal|1
839704|NCT01751113|2762928|P6|Treatment Period 3 (4 Weeks)|Adverse Event|1
839705|NCT01751113|2762929|P5|Treatment Period 3 (4 Weeks)|Adverse Event|0
839706|NCT01751113|2762930|P4|Treatment Period 3 (4 Weeks)|Adverse Event|0
839707|NCT01751113|2762931|P3|Treatment Period 3 (4 Weeks)|Adverse Event|0
839708|NCT01751113|2762932|P2|Treatment Period 3 (4 Weeks)|Adverse Event|0
839709|NCT01751113|2762933|P1|Treatment Period 3 (4 Weeks)|Adverse Event|0
839710|NCT01751113|2762928|P6|Treatment Period 1 (4 Weeks)|Adverse Event|0
839711|NCT01751113|2762929|P5|Treatment Period 1 (4 Weeks)|Adverse Event|1
839712|NCT01751113|2762930|P4|Treatment Period 1 (4 Weeks)|Adverse Event|1
839713|NCT01751113|2762931|P3|Treatment Period 1 (4 Weeks)|Adverse Event|0
839714|NCT01751113|2762932|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
839715|NCT01751113|2762933|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
839716|NCT01751087|2762974|P3|Overall Study|Physician Decision|1
839717|NCT01751087|2762975|P2|Overall Study|Physician Decision|0
839718|NCT01751087|2762976|P1|Overall Study|Physician Decision|0
839719|NCT01751087|2762974|P3|Overall Study|Withdrawal by Subject|0
839720|NCT01751087|2762975|P2|Overall Study|Withdrawal by Subject|0
839721|NCT01751087|2762976|P1|Overall Study|Withdrawal by Subject|1
839722|NCT01750840|2763064|P1|Overall Study|Lost to Follow-up|4
839723|NCT01750684|2763071|P2|Overall Study|Protocol Violation|0
839724|NCT01750684|2763072|P1|Overall Study|Protocol Violation|1
839725|NCT01750684|2763071|P2|Overall Study|Withdrawn by Sponsor|1
839726|NCT01750684|2763072|P1|Overall Study|Withdrawn by Sponsor|0
839727|NCT01750684|2763071|P2|Overall Study|Non-compliance with Study Drug|1
839728|NCT01750684|2763072|P1|Overall Study|Non-compliance with Study Drug|0
839729|NCT01750684|2763071|P2|Overall Study|Death|0
839730|NCT01750684|2763072|P1|Overall Study|Death|1
839731|NCT01750346|2763109|P3|Overall Study|Adverse Event|0
839732|NCT01750346|2763110|P2|Overall Study|Adverse Event|0
839733|NCT01750346|2763111|P1|Overall Study|Adverse Event|1
839734|NCT01750294|2763137|P1|Overall Study|Safety Endpoint|1
839735|NCT01750294|2763137|P1|Overall Study|Withdrawal by Subject|1
839736|NCT01750281|2763144|P3|Overall Study|Did not receive treatment|0
839737|NCT01750281|2763145|P2|Overall Study|Did not receive treatment|1
839738|NCT01750281|2763146|P1|Overall Study|Did not receive treatment|0
839739|NCT01750281|2763144|P3|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9
839740|NCT01750281|2763145|P2|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7
839741|NCT01750281|2763146|P1|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6
839742|NCT01750281|2763144|P3|Overall Study|Discontinued Selumetinib/Placebo|75
839743|NCT01750281|2763145|P2|Overall Study|Discontinued Selumetinib/Placebo|77
839744|NCT01750281|2763146|P1|Overall Study|Discontinued Selumetinib/Placebo|37
839745|NCT01750242|2763176|P1|Overall Study|Unreadable Images|3
839746|NCT01750229|2763181|P1|Long-term Follow-up Phase|Withdrawal by Subject|1
839747|NCT01750229|2763181|P1|Long-term Follow-up Phase|Adverse Event|2
839748|NCT01750229|2763181|P1|Randomized Crossover Phase|Withdrawal by Subject|1
839749|NCT01750229|2763181|P1|Randomized Crossover Phase|Adverse Event|1
839750|NCT01749982|2763204|P4|Overall Study|Withdrawal by Subject|1
839751|NCT01749982|2763205|P3|Overall Study|Withdrawal by Subject|0
839752|NCT01749982|2763206|P2|Overall Study|Withdrawal by Subject|0
839753|NCT01749982|2763207|P1|Overall Study|Withdrawal by Subject|0
839754|NCT01749982|2763204|P4|Overall Study|Lost to Follow-up|1
839755|NCT01749982|2763205|P3|Overall Study|Lost to Follow-up|0
839756|NCT01749982|2763206|P2|Overall Study|Lost to Follow-up|0
839757|NCT01749982|2763207|P1|Overall Study|Lost to Follow-up|0
839758|NCT01749982|2763204|P4|Overall Study|Physician Decision|1
839759|NCT01749982|2763205|P3|Overall Study|Physician Decision|0
839760|NCT01749982|2763206|P2|Overall Study|Physician Decision|0
839761|NCT01749982|2763207|P1|Overall Study|Physician Decision|0
839762|NCT01749800|2763272|P3|Overall Study|Withdrawal by Subject|0
839763|NCT01749800|2763273|P2|Overall Study|Withdrawal by Subject|1
839764|NCT01749800|2763274|P1|Overall Study|Withdrawal by Subject|0
839765|NCT01749800|2763272|P3|Overall Study|not meeting inclusion criteria|0
839766|NCT01749800|2763273|P2|Overall Study|not meeting inclusion criteria|0
839767|NCT01749800|2763274|P1|Overall Study|not meeting inclusion criteria|3
839768|NCT01749735|2763284|P2|Overall Study|Withdrawal by Subject|0
839769|NCT01749735|2763285|P1|Overall Study|Withdrawal by Subject|1
839770|NCT01748890|2763374|P1|Overall Study|Insufficient recruitment for analysis|4
839771|NCT01748760|2763429|P2|Overall Study|Lost to Follow-up|1
839772|NCT01748760|2763430|P1|Overall Study|Lost to Follow-up|5
839773|NCT01748760|2763429|P2|Overall Study|Withdrawal by Subject|1
839774|NCT01748760|2763430|P1|Overall Study|Withdrawal by Subject|1
839775|NCT01748292|2763466|P2|Overall Study|Withdrawal by Subject|2
839776|NCT01748292|2763467|P1|Overall Study|Withdrawal by Subject|0
839777|NCT01748292|2763466|P2|Overall Study|Death|3
839778|NCT01748292|2763467|P1|Overall Study|Death|0
839779|NCT01748292|2763466|P2|Overall Study|Lost to Follow-up|3
839780|NCT01748292|2763467|P1|Overall Study|Lost to Follow-up|0
839781|NCT01748292|2763466|P2|Overall Study|Adverse Event|4
839782|NCT01748292|2763467|P1|Overall Study|Adverse Event|2
839783|NCT01748162|2763497|P2|Overall Study|reasons not available|2
839784|NCT01748162|2763498|P1|Overall Study|reasons not available|3
839785|NCT01748162|2763497|P2|Overall Study|participant consented but did not begin|1
839786|NCT01748162|2763498|P1|Overall Study|participant consented but did not begin|0
839787|NCT01748162|2763497|P2|Overall Study|no additional croup episodes to evaluate|2
839788|NCT01748162|2763498|P1|Overall Study|no additional croup episodes to evaluate|2
839789|NCT01748071|2763509|P3|Overall Study|Adverse Event|0
839790|NCT01748071|2763510|P2|Overall Study|Adverse Event|2
839791|NCT01748071|2763511|P1|Overall Study|Adverse Event|2
839792|NCT01747811|2763798|P2|Overall Study|Lack of Efficacy|4
839793|NCT01747811|2763799|P1|Overall Study|Lack of Efficacy|2
839794|NCT01747772|2763815|P1|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9
839795|NCT01747655|2763823|P2|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0
839796|NCT01747655|2763824|P1|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1
839797|NCT01747655|2763823|P2|PEG-J Period (Duodopa Treatment)|Patient Decision|0
839798|NCT01747655|2763824|P1|PEG-J Period (Duodopa Treatment)|Patient Decision|8
839799|NCT01747655|2763823|P2|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0
839800|NCT01747655|2763824|P1|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5
839801|NCT01747629|2763854|P2|Overall Study|Not specified|1
839802|NCT01747629|2763855|P1|Overall Study|Not specified|2
839803|NCT01747629|2763854|P2|Overall Study|Not treated|0
839804|NCT01747629|2763855|P1|Overall Study|Not treated|1
839805|NCT01747629|2763854|P2|Overall Study|Inclusion criteria not met|0
839806|NCT01747629|2763855|P1|Overall Study|Inclusion criteria not met|1
839807|NCT01747629|2763854|P2|Overall Study|Noncompliance|1
839808|NCT01747629|2763855|P1|Overall Study|Noncompliance|1
839809|NCT01747629|2763854|P2|Overall Study|Withdrawal by Subject|2
839810|NCT01747629|2763855|P1|Overall Study|Withdrawal by Subject|2
839811|NCT01747629|2763854|P2|Overall Study|Adverse Event|2
839812|NCT01747629|2763855|P1|Overall Study|Adverse Event|1
839813|NCT01747551|2763889|P2|Overall Study|Other|0
839814|NCT01747551|2763890|P1|Overall Study|Other|2
839815|NCT01747551|2763889|P2|Overall Study|Physician Decision|1
839816|NCT01747551|2763890|P1|Overall Study|Physician Decision|2
839817|NCT01747551|2763889|P2|Overall Study|Withdrawal by Subject|1
839818|NCT01747551|2763890|P1|Overall Study|Withdrawal by Subject|3
839819|NCT01747551|2763889|P2|Overall Study|Prolonged Treatment Delay|0
839820|NCT01747551|2763890|P1|Overall Study|Prolonged Treatment Delay|2
839821|NCT01747551|2763889|P2|Overall Study|Adverse Event|1
839822|NCT01747551|2763890|P1|Overall Study|Adverse Event|7
839823|NCT01747551|2763889|P2|Overall Study|Death|1
839824|NCT01747551|2763890|P1|Overall Study|Death|3
839825|NCT01747551|2763889|P2|Overall Study|Progressive Disease|17
839826|NCT01747551|2763890|P1|Overall Study|Progressive Disease|24
839827|NCT01746901|2763946|P9|Treatment Phase: Fourth Intervention|Protocol Violation|1
839828|NCT01746901|2763947|P8|Treatment Phase: Fourth Intervention|Protocol Violation|0
839829|NCT01746901|2763948|P7|Treatment Phase: Fourth Intervention|Protocol Violation|1
839830|NCT01746901|2763949|P6|Treatment Phase: Fourth Intervention|Protocol Violation|0
839831|NCT01746901|2763950|P5|Treatment Phase: Fourth Intervention|Protocol Violation|0
839832|NCT01746901|2763951|P4|Treatment Phase: Fourth Intervention|Protocol Violation|0
839833|NCT01746901|2763952|P3|Treatment Phase: Fourth Intervention|Protocol Violation|0
839834|NCT01746901|2763953|P2|Treatment Phase: Fourth Intervention|Protocol Violation|0
839835|NCT01746901|2763954|P1|Treatment Phase: Fourth Intervention|Protocol Violation|0
839836|NCT01746901|2763946|P9|Treatment Phase: Fourth Intervention|Adverse Event|1
839837|NCT01746901|2763947|P8|Treatment Phase: Fourth Intervention|Adverse Event|0
839838|NCT01746901|2763948|P7|Treatment Phase: Fourth Intervention|Adverse Event|0
839839|NCT01746901|2763949|P6|Treatment Phase: Fourth Intervention|Adverse Event|1
839840|NCT01746901|2763950|P5|Treatment Phase: Fourth Intervention|Adverse Event|0
839841|NCT01746901|2763951|P4|Treatment Phase: Fourth Intervention|Adverse Event|0
839842|NCT01746901|2763952|P3|Treatment Phase: Fourth Intervention|Adverse Event|0
839843|NCT01746901|2763953|P2|Treatment Phase: Fourth Intervention|Adverse Event|0
839844|NCT01746901|2763954|P1|Treatment Phase: Fourth Intervention|Adverse Event|0
839845|NCT01746901|2763946|P9|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
839846|NCT01746901|2763947|P8|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
839847|NCT01746901|2763948|P7|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
839848|NCT01746901|2763949|P6|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
839849|NCT01746901|2763950|P5|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
839850|NCT01746901|2763951|P4|Treatment Phase: Fourth Intervention|Lost to Follow-up|1
839851|NCT01746901|2763952|P3|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
839852|NCT01746901|2763953|P2|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
839853|NCT01746901|2763954|P1|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
839854|NCT01746901|2763946|P9|Treatment Phase: Third Intervention|Protocol Violation|0
839855|NCT01746901|2763947|P8|Treatment Phase: Third Intervention|Protocol Violation|0
839856|NCT01746901|2763948|P7|Treatment Phase: Third Intervention|Protocol Violation|1
839857|NCT01746901|2763949|P6|Treatment Phase: Third Intervention|Protocol Violation|1
839858|NCT01746901|2763950|P5|Treatment Phase: Third Intervention|Protocol Violation|0
839859|NCT01746901|2763951|P4|Treatment Phase: Third Intervention|Protocol Violation|0
839860|NCT01746901|2763952|P3|Treatment Phase: Third Intervention|Protocol Violation|0
839861|NCT01746901|2763953|P2|Treatment Phase: Third Intervention|Protocol Violation|0
839862|NCT01746901|2763954|P1|Treatment Phase: Third Intervention|Protocol Violation|0
839863|NCT01746901|2763946|P9|Treatment Phase: Second Intervention|Withdrawal by Subject|0
839864|NCT01746901|2763947|P8|Treatment Phase: Second Intervention|Withdrawal by Subject|1
839865|NCT01746901|2763948|P7|Treatment Phase: Second Intervention|Withdrawal by Subject|0
839866|NCT01746901|2763949|P6|Treatment Phase: Second Intervention|Withdrawal by Subject|0
839867|NCT01746901|2763950|P5|Treatment Phase: Second Intervention|Withdrawal by Subject|0
839868|NCT01746901|2763951|P4|Treatment Phase: Second Intervention|Withdrawal by Subject|0
839869|NCT01746901|2763952|P3|Treatment Phase: Second Intervention|Withdrawal by Subject|0
839870|NCT01746901|2763953|P2|Treatment Phase: Second Intervention|Withdrawal by Subject|0
839871|NCT01746901|2763954|P1|Treatment Phase: Second Intervention|Withdrawal by Subject|0
839872|NCT01746901|2763946|P9|Treatment Phase: First Intervention|Protocol Violation|0
839873|NCT01746901|2763947|P8|Treatment Phase: First Intervention|Protocol Violation|0
839874|NCT01746901|2763948|P7|Treatment Phase: First Intervention|Protocol Violation|1
839875|NCT01746901|2763949|P6|Treatment Phase: First Intervention|Protocol Violation|0
839876|NCT01746901|2763950|P5|Treatment Phase: First Intervention|Protocol Violation|0
839877|NCT01746901|2763951|P4|Treatment Phase: First Intervention|Protocol Violation|0
839878|NCT01746901|2763952|P3|Treatment Phase: First Intervention|Protocol Violation|0
839879|NCT01746901|2763953|P2|Treatment Phase: First Intervention|Protocol Violation|0
839880|NCT01746901|2763954|P1|Treatment Phase: First Intervention|Protocol Violation|0
839881|NCT01746901|2763946|P9|Drug Discrimination Phase: Day 2|Protocol Violation|0
839882|NCT01746901|2763947|P8|Drug Discrimination Phase: Day 2|Protocol Violation|0
839883|NCT01746901|2763948|P7|Drug Discrimination Phase: Day 2|Protocol Violation|0
839884|NCT01746901|2763949|P6|Drug Discrimination Phase: Day 2|Protocol Violation|0
839885|NCT01746901|2763950|P5|Drug Discrimination Phase: Day 2|Protocol Violation|0
839886|NCT01746901|2763951|P4|Drug Discrimination Phase: Day 2|Protocol Violation|0
839887|NCT01746901|2763952|P3|Drug Discrimination Phase: Day 2|Protocol Violation|3
839888|NCT01746901|2763953|P2|Drug Discrimination Phase: Day 2|Protocol Violation|3
839889|NCT01746901|2763954|P1|Drug Discrimination Phase: Day 2|Protocol Violation|0
839890|NCT01746901|2763946|P9|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
839891|NCT01746901|2763947|P8|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
839892|NCT01746901|2763948|P7|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
839893|NCT01746901|2763949|P6|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
839894|NCT01746901|2763950|P5|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
839895|NCT01746901|2763951|P4|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
839896|NCT01746901|2763952|P3|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10
839897|NCT01746901|2763953|P2|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9
839898|NCT01746901|2763954|P1|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
839899|NCT01746901|2763946|P9|Drug Discrimination Phase: Day 2|Adverse Event|0
839900|NCT01746901|2763947|P8|Drug Discrimination Phase: Day 2|Adverse Event|0
839901|NCT01746901|2763948|P7|Drug Discrimination Phase: Day 2|Adverse Event|0
839902|NCT01746901|2763949|P6|Drug Discrimination Phase: Day 2|Adverse Event|0
839903|NCT01746901|2763950|P5|Drug Discrimination Phase: Day 2|Adverse Event|0
839904|NCT01746901|2763951|P4|Drug Discrimination Phase: Day 2|Adverse Event|0
839905|NCT01746901|2763952|P3|Drug Discrimination Phase: Day 2|Adverse Event|1
839906|NCT01746901|2763953|P2|Drug Discrimination Phase: Day 2|Adverse Event|2
839907|NCT01746901|2763954|P1|Drug Discrimination Phase: Day 2|Adverse Event|0
839908|NCT01746901|2763946|P9|Drug Discrimination Phase: Day 1|Adverse Event|0
839909|NCT01746901|2763947|P8|Drug Discrimination Phase: Day 1|Adverse Event|0
839910|NCT01746901|2763948|P7|Drug Discrimination Phase: Day 1|Adverse Event|0
839911|NCT01746901|2763949|P6|Drug Discrimination Phase: Day 1|Adverse Event|0
839912|NCT01746901|2763950|P5|Drug Discrimination Phase: Day 1|Adverse Event|0
839913|NCT01746901|2763951|P4|Drug Discrimination Phase: Day 1|Adverse Event|0
839914|NCT01746901|2763952|P3|Drug Discrimination Phase: Day 1|Adverse Event|0
839915|NCT01746901|2763953|P2|Drug Discrimination Phase: Day 1|Adverse Event|3
839916|NCT01746901|2763954|P1|Drug Discrimination Phase: Day 1|Adverse Event|0
839917|NCT01746901|2763946|P9|Naloxone Challenge Phase|Did not meet entrance criteria|0
839918|NCT01746901|2763947|P8|Naloxone Challenge Phase|Did not meet entrance criteria|0
839919|NCT01746901|2763948|P7|Naloxone Challenge Phase|Did not meet entrance criteria|0
839920|NCT01746901|2763949|P6|Naloxone Challenge Phase|Did not meet entrance criteria|0
839921|NCT01746901|2763950|P5|Naloxone Challenge Phase|Did not meet entrance criteria|0
839922|NCT01746901|2763951|P4|Naloxone Challenge Phase|Did not meet entrance criteria|0
839923|NCT01746901|2763952|P3|Naloxone Challenge Phase|Did not meet entrance criteria|0
839924|NCT01746901|2763953|P2|Naloxone Challenge Phase|Did not meet entrance criteria|0
839925|NCT01746901|2763954|P1|Naloxone Challenge Phase|Did not meet entrance criteria|1
839926|NCT01746901|2763946|P9|Naloxone Challenge Phase|Adverse Event|0
839927|NCT01746901|2763947|P8|Naloxone Challenge Phase|Adverse Event|0
839928|NCT01746901|2763948|P7|Naloxone Challenge Phase|Adverse Event|0
839929|NCT01746901|2763949|P6|Naloxone Challenge Phase|Adverse Event|0
839930|NCT01746901|2763950|P5|Naloxone Challenge Phase|Adverse Event|0
839931|NCT01746901|2763951|P4|Naloxone Challenge Phase|Adverse Event|0
839932|NCT01746901|2763952|P3|Naloxone Challenge Phase|Adverse Event|0
839933|NCT01746901|2763953|P2|Naloxone Challenge Phase|Adverse Event|0
839934|NCT01746901|2763954|P1|Naloxone Challenge Phase|Adverse Event|2
839935|NCT01746862|2764277|P2|Overall Study|Entered puberty during the study|0
839936|NCT01746862|2764278|P1|Overall Study|Entered puberty during the study|1
839937|NCT01746862|2764277|P2|Overall Study|Consent withdrawal by parent’s guardian|2
839938|NCT01746862|2764278|P1|Overall Study|Consent withdrawal by parent’s guardian|5
839939|NCT01746862|2764277|P2|Overall Study|Protocol Violation|0
839940|NCT01746862|2764278|P1|Overall Study|Protocol Violation|1
839941|NCT01746862|2764277|P2|Overall Study|Withdrawal by Subject|1
839942|NCT01746862|2764278|P1|Overall Study|Withdrawal by Subject|1
839943|NCT01746732|2764329|P3|Period 2|Lost to Follow-up|1
839944|NCT01746732|2764330|P2|Period 2|Lost to Follow-up|0
839945|NCT01746732|2764331|P1|Period 2|Lost to Follow-up|0
839946|NCT01746732|2764329|P3|Period 2|Adverse Event|1
839947|NCT01746732|2764330|P2|Period 2|Adverse Event|0
839948|NCT01746732|2764331|P1|Period 2|Adverse Event|0
839949|NCT01746732|2764329|P3|Period 2|Withdrawal by Subject|2
839950|NCT01746732|2764330|P2|Period 2|Withdrawal by Subject|0
839951|NCT01746732|2764331|P1|Period 2|Withdrawal by Subject|0
839952|NCT01746732|2764329|P3|Period 1|Physician Decision|0
839953|NCT01746732|2764330|P2|Period 1|Physician Decision|1
839954|NCT01746732|2764331|P1|Period 1|Physician Decision|0
839955|NCT01746732|2764329|P3|Lead-In Period|Withdrawal by Subject|0
839956|NCT01746732|2764330|P2|Lead-In Period|Withdrawal by Subject|0
839957|NCT01746732|2764331|P1|Lead-In Period|Withdrawal by Subject|1
839958|NCT01746368|2764371|P2|Overall Study|Withdrawal by Subject|1
839959|NCT01746368|2764372|P1|Overall Study|Withdrawal by Subject|0
839960|NCT01746368|2764371|P2|Overall Study|Lost to Follow-up|0
839961|NCT01746368|2764372|P1|Overall Study|Lost to Follow-up|2
839962|NCT01746173|2764399|P1|Overall Study|Disease Progression|2
839963|NCT01746108|2764407|P3|Overall Study|Lost to Follow-up|0
839964|NCT01746108|2764408|P2|Overall Study|Lost to Follow-up|1
839965|NCT01746108|2764409|P1|Overall Study|Lost to Follow-up|0
839966|NCT01746108|2764407|P3|Overall Study|Withdrawal by Subject|0
839967|NCT01746108|2764408|P2|Overall Study|Withdrawal by Subject|1
839968|NCT01746108|2764409|P1|Overall Study|Withdrawal by Subject|0
839969|NCT01746108|2764407|P3|Overall Study|Adverse event, non-fatal|0
839970|NCT01746108|2764408|P2|Overall Study|Adverse event, non-fatal|1
839971|NCT01746108|2764409|P1|Overall Study|Adverse event, non-fatal|0
839972|NCT01746108|2764407|P3|Overall Study|Migrated /moved from study area|0
839973|NCT01746108|2764408|P2|Overall Study|Migrated /moved from study area|1
839974|NCT01746108|2764409|P1|Overall Study|Migrated /moved from study area|0
839975|NCT01745848|2764507|P1|Overall Study|Adverse Event|6
839976|NCT01745393|2764514|P2|12-month Follow-up|Lost to Follow-up|5
839977|NCT01745393|2764515|P1|12-month Follow-up|Lost to Follow-up|6
839978|NCT01745393|2764514|P2|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0
839979|NCT01745393|2764515|P1|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1
839980|NCT01745393|2764514|P2|Treatment to End-of-treatment Assessment|Lost to Follow-up|8
839981|NCT01745393|2764515|P1|Treatment to End-of-treatment Assessment|Lost to Follow-up|20
839982|NCT01745380|2764527|P2|Overall Study|Lack of Efficacy|1
839983|NCT01745380|2764528|P1|Overall Study|Lack of Efficacy|0
839984|NCT01745380|2764527|P2|Overall Study|Lost to Follow-up|0
839985|NCT01745380|2764528|P1|Overall Study|Lost to Follow-up|1
839986|NCT01745146|2764566|P2|Overall Study|Lost to Follow-up|0
839987|NCT01745146|2764567|P1|Overall Study|Lost to Follow-up|2
839988|NCT01745146|2764566|P2|Overall Study|Withdrawal by Subject|3
839989|NCT01745146|2764567|P1|Overall Study|Withdrawal by Subject|1
839990|NCT01745094|2764591|P4|Overall Study|Untenable Due to Recurrent Cystitis|0
839991|NCT01745094|2764592|P3|Overall Study|Untenable Due to Recurrent Cystitis|0
839992|NCT01745094|2764593|P2|Overall Study|Untenable Due to Recurrent Cystitis|0
839993|NCT01745094|2764594|P1|Overall Study|Untenable Due to Recurrent Cystitis|1
839994|NCT01745094|2764591|P4|Overall Study|Show no Stable Solifenacin Intake|0
839995|NCT01745094|2764592|P3|Overall Study|Show no Stable Solifenacin Intake|1
839996|NCT01745094|2764593|P2|Overall Study|Show no Stable Solifenacin Intake|0
839997|NCT01745094|2764594|P1|Overall Study|Show no Stable Solifenacin Intake|0
839998|NCT01745094|2764591|P4|Overall Study|Need Further Examinations Due to Biopsy|0
839999|NCT01745094|2764592|P3|Overall Study|Need Further Examinations Due to Biopsy|1
840000|NCT01745094|2764593|P2|Overall Study|Need Further Examinations Due to Biopsy|0
840001|NCT01745094|2764594|P1|Overall Study|Need Further Examinations Due to Biopsy|0
840002|NCT01745094|2764591|P4|Overall Study|Protocol Violation|1
840003|NCT01745094|2764592|P3|Overall Study|Protocol Violation|3
840004|NCT01745094|2764593|P2|Overall Study|Protocol Violation|0
840005|NCT01745094|2764594|P1|Overall Study|Protocol Violation|1
840006|NCT01745094|2764591|P4|Overall Study|Withdrawal by Subject|2
840007|NCT01745094|2764592|P3|Overall Study|Withdrawal by Subject|1
840008|NCT01745094|2764593|P2|Overall Study|Withdrawal by Subject|0
840009|NCT01745094|2764594|P1|Overall Study|Withdrawal by Subject|2
840010|NCT01745094|2764591|P4|Overall Study|Adverse Event|0
840011|NCT01745094|2764592|P3|Overall Study|Adverse Event|3
840012|NCT01745094|2764593|P2|Overall Study|Adverse Event|0
840013|NCT01745094|2764594|P1|Overall Study|Adverse Event|0
840014|NCT01745094|2764591|P4|Overall Study|Not Meeting the Eligibility Criteria|0
840015|NCT01745094|2764592|P3|Overall Study|Not Meeting the Eligibility Criteria|3
840016|NCT01745094|2764593|P2|Overall Study|Not Meeting the Eligibility Criteria|0
840017|NCT01745094|2764594|P1|Overall Study|Not Meeting the Eligibility Criteria|1
840018|NCT01744977|2764695|P2|Overall Study|No longer meets inclusion|0
840019|NCT01744977|2764696|P1|Overall Study|No longer meets inclusion|6
840020|NCT01744977|2764695|P2|Overall Study|Lost to Follow-up|0
840021|NCT01744977|2764696|P1|Overall Study|Lost to Follow-up|2
840022|NCT01744977|2764695|P2|Overall Study|Death|3
840023|NCT01744977|2764696|P1|Overall Study|Death|2
840024|NCT01744977|2764695|P2|Overall Study|Withdrawal by Subject|2
840025|NCT01744977|2764696|P1|Overall Study|Withdrawal by Subject|1
840026|NCT01744782|2764767|P1|Overall Study|Death|1
840027|NCT01744691|2764827|P1|Overall Study|Physician Decision|4
840028|NCT01744691|2764827|P1|Overall Study|Withdrawal of consent for treatment|3
840029|NCT01744691|2764827|P1|Overall Study|Unacceptable toxicity, AE or death|18
840030|NCT01744691|2764827|P1|Overall Study|Progressive Disease|18
840031|NCT01744496|2764834|P2|Maintenance Period|Subject left town|0
840032|NCT01744496|2764835|P1|Maintenance Period|Subject left town|1
840033|NCT01744496|2764834|P2|Maintenance Period|Withdrawal by Subject|1
840034|NCT01744496|2764835|P1|Maintenance Period|Withdrawal by Subject|1
840035|NCT01744496|2764834|P2|Maintenance Period|Protocol Violation|0
840036|NCT01744496|2764835|P1|Maintenance Period|Protocol Violation|1
840037|NCT01744496|2764834|P2|Maintenance Period|Adverse Event|3
840038|NCT01744496|2764835|P1|Maintenance Period|Adverse Event|1
840039|NCT01744496|2764834|P2|Titration Period|Personal reasons|1
840040|NCT01744496|2764835|P1|Titration Period|Personal reasons|0
840041|NCT01744496|2764834|P2|Titration Period|Adverse Event|1
840042|NCT01744496|2764835|P1|Titration Period|Adverse Event|2
840043|NCT01744483|2764856|P3|Overall Study|Routed to OSH|1
840044|NCT01744483|2764857|P2|Overall Study|Routed to OSH|0
840045|NCT01744483|2764858|P1|Overall Study|Routed to OSH|2
840046|NCT01744483|2764856|P3|Overall Study|No ICU Admit|2
840047|NCT01744483|2764857|P2|Overall Study|No ICU Admit|1
840048|NCT01744483|2764858|P1|Overall Study|No ICU Admit|5
840049|NCT01744483|2764856|P3|Overall Study|Withdrawal by Subject|2
840050|NCT01744483|2764857|P2|Overall Study|Withdrawal by Subject|6
840051|NCT01744483|2764858|P1|Overall Study|Withdrawal by Subject|4
840052|NCT01744483|2764856|P3|Overall Study|Protocol Violation|1
840053|NCT01744483|2764857|P2|Overall Study|Protocol Violation|2
840054|NCT01744483|2764858|P1|Overall Study|Protocol Violation|1
840055|NCT01744483|2764856|P3|Overall Study|Lost to Follow-up|11
840056|NCT01744483|2764857|P2|Overall Study|Lost to Follow-up|9
840057|NCT01744483|2764858|P1|Overall Study|Lost to Follow-up|8
840058|NCT01744483|2764856|P3|Overall Study|Death|11
840059|NCT01744483|2764857|P2|Overall Study|Death|4
840060|NCT01744483|2764858|P1|Overall Study|Death|9
840061|NCT01744392|2764866|P1|Overall Study|Physician Decision|1
840062|NCT01744197|2764906|P2|Overall Study|No patch received|2
840063|NCT01744197|2764907|P1|Overall Study|No patch received|2
840064|NCT01744197|2764906|P2|Overall Study|Received 1 patch|1
840065|NCT01744197|2764907|P1|Overall Study|Received 1 patch|2
840066|NCT01743469|2765009|P4|Follow-up Period - Post-Treatment|Lost to Follow-up|0
840067|NCT01743469|2765010|P3|Follow-up Period - Post-Treatment|Lost to Follow-up|0
840068|NCT01743469|2765011|P2|Follow-up Period - Post-Treatment|Lost to Follow-up|1
840069|NCT01743469|2765012|P1|Follow-up Period - Post-Treatment|Lost to Follow-up|1
840070|NCT01743469|2765009|P4|Follow-up Period - Post-Treatment|Death|16
840071|NCT01743469|2765010|P3|Follow-up Period - Post-Treatment|Death|22
840072|NCT01743469|2765011|P2|Follow-up Period - Post-Treatment|Death|47
840073|NCT01743469|2765012|P1|Follow-up Period - Post-Treatment|Death|43
840074|NCT01743469|2765009|P4|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
840075|NCT01743469|2765010|P3|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
840076|NCT01743469|2765011|P2|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
840077|NCT01743469|2765012|P1|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
840078|NCT01743469|2765009|P4|Active Treatment Phase|Missing|0
840079|NCT01743469|2765010|P3|Active Treatment Phase|Missing|0
840080|NCT01743469|2765011|P2|Active Treatment Phase|Missing|0
840081|NCT01743469|2765012|P1|Active Treatment Phase|Missing|1
840082|NCT01743469|2765009|P4|Active Treatment Phase|Withdrawal by Subject|0
840083|NCT01743469|2765010|P3|Active Treatment Phase|Withdrawal by Subject|0
840084|NCT01743469|2765011|P2|Active Treatment Phase|Withdrawal by Subject|3
840085|NCT01743469|2765012|P1|Active Treatment Phase|Withdrawal by Subject|2
840086|NCT01743469|2765009|P4|Active Treatment Phase|Disease Progression|20
840087|NCT01743469|2765010|P3|Active Treatment Phase|Disease Progression|30
840088|NCT01743469|2765011|P2|Active Treatment Phase|Disease Progression|47
840089|NCT01743469|2765012|P1|Active Treatment Phase|Disease Progression|40
840090|NCT01743469|2765009|P4|Active Treatment Phase|Adverse Event|1
840091|NCT01743469|2765010|P3|Active Treatment Phase|Adverse Event|8
840092|NCT01743469|2765011|P2|Active Treatment Phase|Adverse Event|5
840093|NCT01743469|2765012|P1|Active Treatment Phase|Adverse Event|10
840094|NCT01743092|2765052|P2|Overall Study|Lost to Follow-up|15
840095|NCT01743092|2765053|P1|Overall Study|Lost to Follow-up|14
840096|NCT01743027|2765065|P4|Overall Study|Withdrawal by Subject|1
840097|NCT01743027|2765066|P3|Overall Study|Withdrawal by Subject|3
840098|NCT01743027|2765067|P2|Overall Study|Withdrawal by Subject|0
840099|NCT01743027|2765068|P1|Overall Study|Withdrawal by Subject|1
840100|NCT01743027|2765065|P4|Overall Study|Protocol Violation|0
840101|NCT01743027|2765066|P3|Overall Study|Protocol Violation|1
840102|NCT01743027|2765067|P2|Overall Study|Protocol Violation|1
840103|NCT01743027|2765068|P1|Overall Study|Protocol Violation|1
840104|NCT01743027|2765065|P4|Overall Study|Progressive Disease|0
840105|NCT01743027|2765066|P3|Overall Study|Progressive Disease|3
840106|NCT01743027|2765067|P2|Overall Study|Progressive Disease|4
840107|NCT01743027|2765068|P1|Overall Study|Progressive Disease|1
840108|NCT01743027|2765065|P4|Overall Study|Lost to Follow-up|0
840109|NCT01743027|2765066|P3|Overall Study|Lost to Follow-up|2
840110|NCT01743027|2765067|P2|Overall Study|Lost to Follow-up|0
840111|NCT01743027|2765068|P1|Overall Study|Lost to Follow-up|0
840112|NCT01743027|2765065|P4|Overall Study|Adverse Event|0
840113|NCT01743027|2765066|P3|Overall Study|Adverse Event|0
840114|NCT01743027|2765067|P2|Overall Study|Adverse Event|0
840115|NCT01743027|2765068|P1|Overall Study|Adverse Event|2
840116|NCT01743001|2765108|P2|Overall Study|Death|0
840117|NCT01743001|2765109|P1|Overall Study|Death|1
840118|NCT01743001|2765108|P2|Overall Study|Pregnancy|0
840119|NCT01743001|2765109|P1|Overall Study|Pregnancy|1
840120|NCT01743001|2765108|P2|Overall Study|Physician Decision|0
840121|NCT01743001|2765109|P1|Overall Study|Physician Decision|1
840122|NCT01742897|2765132|P1|Overall Study|Other|1
840123|NCT01742897|2765132|P1|Overall Study|Withdrawal by Subject|1
840124|NCT01742897|2765132|P1|Overall Study|Adverse Event|3
840125|NCT01742091|2765184|P6|Overall Study|Lost to Follow-up|1
840126|NCT01742091|2765185|P5|Overall Study|Lost to Follow-up|0
840127|NCT01742091|2765186|P4|Overall Study|Lost to Follow-up|0
840128|NCT01742091|2765187|P3|Overall Study|Lost to Follow-up|0
840129|NCT01742091|2765188|P2|Overall Study|Lost to Follow-up|0
840130|NCT01742091|2765189|P1|Overall Study|Lost to Follow-up|0
840131|NCT01742091|2765184|P6|Overall Study|Withdrawal by Subject|0
840132|NCT01742091|2765185|P5|Overall Study|Withdrawal by Subject|0
840133|NCT01742091|2765186|P4|Overall Study|Withdrawal by Subject|1
840134|NCT01742091|2765187|P3|Overall Study|Withdrawal by Subject|0
840135|NCT01742091|2765188|P2|Overall Study|Withdrawal by Subject|0
840136|NCT01742091|2765189|P1|Overall Study|Withdrawal by Subject|0
840137|NCT01742091|2765184|P6|Overall Study|Physician Decision|1
840138|NCT01742091|2765185|P5|Overall Study|Physician Decision|0
840139|NCT01742091|2765186|P4|Overall Study|Physician Decision|0
840140|NCT01742091|2765187|P3|Overall Study|Physician Decision|0
840141|NCT01742091|2765188|P2|Overall Study|Physician Decision|0
840142|NCT01742091|2765189|P1|Overall Study|Physician Decision|0
840143|NCT01742091|2765184|P6|Overall Study|Adverse Event|0
840144|NCT01742091|2765185|P5|Overall Study|Adverse Event|1
840145|NCT01742091|2765186|P4|Overall Study|Adverse Event|0
840146|NCT01742091|2765187|P3|Overall Study|Adverse Event|0
840147|NCT01742091|2765188|P2|Overall Study|Adverse Event|0
840148|NCT01742091|2765189|P1|Overall Study|Adverse Event|0
840149|NCT01741792|2765229|P3|Overall Study|Death|12
840150|NCT01741792|2765230|P2|Overall Study|Death|1
840151|NCT01741792|2765231|P1|Overall Study|Death|6
840152|NCT01741701|2765298|P2|Overall Study|Withdrawal by Subject|1
840153|NCT01741701|2765299|P1|Overall Study|Withdrawal by Subject|0
840154|NCT01741701|2765298|P2|Overall Study|Adverse Event|1
840155|NCT01741701|2765299|P1|Overall Study|Adverse Event|5
840156|NCT01741688|2765315|P1|Overall Study|Withdrawal by Subject|1
840157|NCT01741688|2765315|P1|Overall Study|Lack of insurance coverage|2
840158|NCT01741259|2765497|P2|Overall Study|Withdrawal by Subject|2
840159|NCT01741259|2765498|P1|Overall Study|Withdrawal by Subject|0
840160|NCT01741259|2765497|P2|Overall Study|Protocol Violation|4
840161|NCT01741259|2765498|P1|Overall Study|Protocol Violation|6
840162|NCT01741012|2765552|P1|Overall Study|Withdrawal by Subject|2
840163|NCT01741012|2765552|P1|Overall Study|Lost to Follow-up|1
840164|NCT01740440|2765624|P1|Overall Study|Lost to Follow-up|3
840165|NCT01740427|2765632|P2|Overall Study|Study terminated by Sponsor|0
840166|NCT01740427|2765633|P1|Overall Study|Study terminated by Sponsor|1
840167|NCT01740427|2765632|P2|Overall Study|Lost to Follow-up|0
840168|NCT01740427|2765633|P1|Overall Study|Lost to Follow-up|1
840169|NCT01740427|2765632|P2|Overall Study|Protocol Violation|3
840170|NCT01740427|2765633|P1|Overall Study|Protocol Violation|5
840171|NCT01740427|2765632|P2|Overall Study|Death|2
840172|NCT01740427|2765633|P1|Overall Study|Death|6
840173|NCT01740427|2765632|P2|Overall Study|Unspecified reasons|4
840174|NCT01740427|2765633|P1|Overall Study|Unspecified reasons|6
840175|NCT01740427|2765632|P2|Overall Study|Subject refused continued treatment|9
840176|NCT01740427|2765633|P1|Overall Study|Subject refused continued treatment|12
840177|NCT01740427|2765632|P2|Overall Study|Global deterioration of health status|9
840178|NCT01740427|2765633|P1|Overall Study|Global deterioration of health status|16
840179|NCT01740427|2765632|P2|Overall Study|Adverse Event|9
840180|NCT01740427|2765633|P1|Overall Study|Adverse Event|20
840181|NCT01740427|2765632|P2|Overall Study|Objective progression or relapse|125
840182|NCT01740427|2765633|P1|Overall Study|Objective progression or relapse|172
840183|NCT01740427|2765632|P2|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|61
840184|NCT01740427|2765633|P1|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|205
840185|NCT01740401|2765685|P1|Overall Study|Did not reach primary endpoint|2
840186|NCT01740401|2765685|P1|Overall Study|Adverse Event|2
840187|NCT01740401|2765685|P1|Overall Study|Progression of disease|6
840188|NCT01740388|2765694|P2|Overall Study|Subjects missing data, completed|36
840189|NCT01740388|2765695|P1|Overall Study|Subjects missing data, completed|41
840190|NCT01740388|2765694|P2|Overall Study|Physician Decision|6
840191|NCT01740388|2765695|P1|Overall Study|Physician Decision|2
840192|NCT01740388|2765694|P2|Overall Study|Lost to Follow-up|0
840193|NCT01740388|2765695|P1|Overall Study|Lost to Follow-up|2
840194|NCT01740388|2765694|P2|Overall Study|Withdrawal by Subject|2
840195|NCT01740388|2765695|P1|Overall Study|Withdrawal by Subject|1
840196|NCT01740297|2765747|P3|Overall Study|Sponsor Decision|0
840197|NCT01740297|2765748|P2|Overall Study|Sponsor Decision|1
840198|NCT01740297|2765749|P1|Overall Study|Sponsor Decision|0
840199|NCT01740297|2765747|P3|Overall Study|Death|19
840200|NCT01740297|2765748|P2|Overall Study|Death|23
840201|NCT01740297|2765749|P1|Overall Study|Death|8
840202|NCT01740297|2765747|P3|Overall Study|Withdrawal by Subject|11
840203|NCT01740297|2765748|P2|Overall Study|Withdrawal by Subject|9
840204|NCT01740297|2765749|P1|Overall Study|Withdrawal by Subject|1
840205|NCT01740297|2765747|P3|Overall Study|Continuing Study|68
840206|NCT01740297|2765748|P2|Overall Study|Continuing Study|67
840207|NCT01740297|2765749|P1|Overall Study|Continuing Study|10
840208|NCT01740128|2765800|P2|Overall Study|Insufficient protocol compliance|2
840209|NCT01740128|2765801|P1|Overall Study|Insufficient protocol compliance|2
840210|NCT01740128|2765800|P2|Overall Study|Withdrawal by Subject|0
840211|NCT01740128|2765801|P1|Overall Study|Withdrawal by Subject|1
840212|NCT01740128|2765800|P2|Overall Study|Lost to Follow-up|2
840213|NCT01740128|2765801|P1|Overall Study|Lost to Follow-up|2
840214|NCT01740128|2765800|P2|Overall Study|Protocol Violation|2
840215|NCT01740128|2765801|P1|Overall Study|Protocol Violation|1
840216|NCT01740128|2765800|P2|Overall Study|Pregnancy|1
840217|NCT01740128|2765801|P1|Overall Study|Pregnancy|0
840218|NCT01740089|2765830|P3|After 12 Weeks|Withdrawal by Subject|1
840219|NCT01740089|2765831|P2|After 12 Weeks|Withdrawal by Subject|1
840220|NCT01740089|2765832|P1|After 12 Weeks|Withdrawal by Subject|1
840221|NCT01740089|2765830|P3|After 12 Weeks|Protocol Violation|1
840222|NCT01740089|2765831|P2|After 12 Weeks|Protocol Violation|1
840223|NCT01740089|2765832|P1|After 12 Weeks|Protocol Violation|1
840224|NCT01740089|2765830|P3|After 12 Weeks|Adverse Event|5
840225|NCT01740089|2765831|P2|After 12 Weeks|Adverse Event|0
840226|NCT01740089|2765832|P1|After 12 Weeks|Adverse Event|2
840227|NCT01740089|2765830|P3|After 12 Weeks|Lack of Efficacy|4
840228|NCT01740089|2765831|P2|After 12 Weeks|Lack of Efficacy|1
840229|NCT01740089|2765832|P1|After 12 Weeks|Lack of Efficacy|3
840230|NCT01740089|2765830|P3|First 12 Weeks of Treatment|Withdrawal by Subject|0
840231|NCT01740089|2765831|P2|First 12 Weeks of Treatment|Withdrawal by Subject|1
840232|NCT01740089|2765832|P1|First 12 Weeks of Treatment|Withdrawal by Subject|0
840233|NCT01740089|2765830|P3|First 12 Weeks of Treatment|Adverse Event|2
840234|NCT01740089|2765831|P2|First 12 Weeks of Treatment|Adverse Event|1
840235|NCT01740089|2765832|P1|First 12 Weeks of Treatment|Adverse Event|0
840236|NCT01739803|2765850|P2|Overall Study|Lost to Follow-up|6
840237|NCT01739803|2765851|P1|Overall Study|Lost to Follow-up|9
840238|NCT01739790|2765863|P2|Overall Study|Early Trial Termination|4
840239|NCT01739790|2765864|P1|Overall Study|Early Trial Termination|2
840240|NCT01739595|2765873|P3|Overall Study|Drug discrepancy|0
840241|NCT01739595|2765874|P2|Overall Study|Drug discrepancy|0
840242|NCT01739595|2765875|P1|Overall Study|Drug discrepancy|1
840243|NCT01739595|2765873|P3|Overall Study|Lab assessment|0
840244|NCT01739595|2765874|P2|Overall Study|Lab assessment|0
840245|NCT01739595|2765875|P1|Overall Study|Lab assessment|1
840246|NCT01739595|2765873|P3|Overall Study|Protocol Violation|0
840247|NCT01739595|2765874|P2|Overall Study|Protocol Violation|0
840248|NCT01739595|2765875|P1|Overall Study|Protocol Violation|1
840249|NCT01739595|2765873|P3|Overall Study|Eligibility issue|0
840250|NCT01739595|2765874|P2|Overall Study|Eligibility issue|0
840251|NCT01739595|2765875|P1|Overall Study|Eligibility issue|3
840252|NCT01739595|2765873|P3|Overall Study|Withdrawal by Subject|2
840253|NCT01739595|2765874|P2|Overall Study|Withdrawal by Subject|1
840254|NCT01739595|2765875|P1|Overall Study|Withdrawal by Subject|2
840255|NCT01739595|2765873|P3|Overall Study|Lost to Follow-up|0
840256|NCT01739595|2765874|P2|Overall Study|Lost to Follow-up|0
840257|NCT01739595|2765875|P1|Overall Study|Lost to Follow-up|2
840258|NCT01739595|2765873|P3|Overall Study|Adverse Event|0
840259|NCT01739595|2765874|P2|Overall Study|Adverse Event|0
840260|NCT01739595|2765875|P1|Overall Study|Adverse Event|3
840261|NCT01739348|2765900|P4|Part II (Extension Study)|Withdrawal by Subject|7
840262|NCT01739348|2765901|P3|Part II (Extension Study)|Withdrawal by Subject|4
840263|NCT01739348|2765902|P2|Part II (Extension Study)|Withdrawal by Subject|2
840264|NCT01739348|2765903|P1|Part II (Extension Study)|Withdrawal by Subject|5
840265|NCT01739348|2765900|P4|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16
840266|NCT01739348|2765901|P3|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8
840267|NCT01739348|2765902|P2|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12
840268|NCT01739348|2765903|P1|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18
840269|NCT01739348|2765900|P4|Part II (Extension Study)|Participant Moved|3
840270|NCT01739348|2765901|P3|Part II (Extension Study)|Participant Moved|0
840271|NCT01739348|2765902|P2|Part II (Extension Study)|Participant Moved|3
840272|NCT01739348|2765903|P1|Part II (Extension Study)|Participant Moved|3
840273|NCT01739348|2765900|P4|Part II (Extension Study)|Study Terminated by Sponsor|323
840274|NCT01739348|2765901|P3|Part II (Extension Study)|Study Terminated by Sponsor|34
840275|NCT01739348|2765902|P2|Part II (Extension Study)|Study Terminated by Sponsor|315
840276|NCT01739348|2765903|P1|Part II (Extension Study)|Study Terminated by Sponsor|329
840277|NCT01739348|2765900|P4|Part II (Extension Study)|Physician Decision|12
840278|NCT01739348|2765901|P3|Part II (Extension Study)|Physician Decision|6
840279|NCT01739348|2765902|P2|Part II (Extension Study)|Physician Decision|11
840280|NCT01739348|2765903|P1|Part II (Extension Study)|Physician Decision|7
840281|NCT01739348|2765900|P4|Part II (Extension Study)|Non-Compliance with Study Drug|1
840282|NCT01739348|2765901|P3|Part II (Extension Study)|Non-Compliance with Study Drug|0
840283|NCT01739348|2765902|P2|Part II (Extension Study)|Non-Compliance with Study Drug|0
840284|NCT01739348|2765903|P1|Part II (Extension Study)|Non-Compliance with Study Drug|0
840285|NCT01739348|2765900|P4|Part II (Extension Study)|Lost to Follow-up|1
840286|NCT01739348|2765901|P3|Part II (Extension Study)|Lost to Follow-up|0
840287|NCT01739348|2765902|P2|Part II (Extension Study)|Lost to Follow-up|4
840288|NCT01739348|2765903|P1|Part II (Extension Study)|Lost to Follow-up|3
840289|NCT01739348|2765900|P4|Part II (Extension Study)|Lack of Efficacy|1
840290|NCT01739348|2765901|P3|Part II (Extension Study)|Lack of Efficacy|0
840291|NCT01739348|2765902|P2|Part II (Extension Study)|Lack of Efficacy|5
840292|NCT01739348|2765903|P1|Part II (Extension Study)|Lack of Efficacy|1
840293|NCT01739348|2765900|P4|Part II (Extension Study)|Death|6
840294|NCT01739348|2765901|P3|Part II (Extension Study)|Death|2
840295|NCT01739348|2765902|P2|Part II (Extension Study)|Death|3
840296|NCT01739348|2765903|P1|Part II (Extension Study)|Death|3
840297|NCT01739348|2765900|P4|Part II (Extension Study)|Adverse Event|26
840298|NCT01739348|2765901|P3|Part II (Extension Study)|Adverse Event|7
840299|NCT01739348|2765902|P2|Part II (Extension Study)|Adverse Event|11
840300|NCT01739348|2765903|P1|Part II (Extension Study)|Adverse Event|10
840301|NCT01739348|2765900|P4|Part I (Base Study)|Withdrawal by Subject|20
840302|NCT01739348|2765901|P3|Part I (Base Study)|Withdrawal by Subject|7
840303|NCT01739348|2765902|P2|Part I (Base Study)|Withdrawal by Subject|21
840304|NCT01739348|2765903|P1|Part I (Base Study)|Withdrawal by Subject|23
840305|NCT01739348|2765900|P4|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18
840306|NCT01739348|2765901|P3|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2
840307|NCT01739348|2765902|P2|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25
840308|NCT01739348|2765903|P1|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27
840309|NCT01739348|2765900|P4|Part I (Base Study)|Participant Moved|7
840310|NCT01739348|2765901|P3|Part I (Base Study)|Participant Moved|1
840311|NCT01739348|2765902|P2|Part I (Base Study)|Participant Moved|3
840312|NCT01739348|2765903|P1|Part I (Base Study)|Participant Moved|4
840313|NCT01739348|2765900|P4|Part I (Base Study)|Study Terminated by Sponsor|86
840314|NCT01739348|2765901|P3|Part I (Base Study)|Study Terminated by Sponsor|0
840315|NCT01739348|2765902|P2|Part I (Base Study)|Study Terminated by Sponsor|73
840316|NCT01739348|2765903|P1|Part I (Base Study)|Study Terminated by Sponsor|72
840317|NCT01739348|2765900|P4|Part I (Base Study)|Site Discontinued Study Participation|0
840318|NCT01739348|2765901|P3|Part I (Base Study)|Site Discontinued Study Participation|0
840319|NCT01739348|2765902|P2|Part I (Base Study)|Site Discontinued Study Participation|3
840320|NCT01739348|2765903|P1|Part I (Base Study)|Site Discontinued Study Participation|1
840321|NCT01739348|2765900|P4|Part I (Base Study)|Screen Failure|0
840322|NCT01739348|2765901|P3|Part I (Base Study)|Screen Failure|0
840323|NCT01739348|2765902|P2|Part I (Base Study)|Screen Failure|0
840324|NCT01739348|2765903|P1|Part I (Base Study)|Screen Failure|2
840325|NCT01739348|2765900|P4|Part I (Base Study)|Protocol Violation|2
840326|NCT01739348|2765901|P3|Part I (Base Study)|Protocol Violation|1
840327|NCT01739348|2765902|P2|Part I (Base Study)|Protocol Violation|0
840328|NCT01739348|2765903|P1|Part I (Base Study)|Protocol Violation|2
840329|NCT01739348|2765900|P4|Part I (Base Study)|Physician Decision|4
840330|NCT01739348|2765901|P3|Part I (Base Study)|Physician Decision|1
840331|NCT01739348|2765902|P2|Part I (Base Study)|Physician Decision|7
840332|NCT01739348|2765903|P1|Part I (Base Study)|Physician Decision|10
840333|NCT01739348|2765900|P4|Part I (Base Study)|Non-Compliance with Study Drug|0
840334|NCT01739348|2765901|P3|Part I (Base Study)|Non-Compliance with Study Drug|0
840335|NCT01739348|2765902|P2|Part I (Base Study)|Non-Compliance with Study Drug|2
840336|NCT01739348|2765903|P1|Part I (Base Study)|Non-Compliance with Study Drug|3
840337|NCT01739348|2765900|P4|Part I (Base Study)|Lost to Follow-up|4
840338|NCT01739348|2765901|P3|Part I (Base Study)|Lost to Follow-up|4
840339|NCT01739348|2765902|P2|Part I (Base Study)|Lost to Follow-up|2
840340|NCT01739348|2765903|P1|Part I (Base Study)|Lost to Follow-up|4
840341|NCT01739348|2765900|P4|Part I (Base Study)|Lack of Efficacy|7
840342|NCT01739348|2765901|P3|Part I (Base Study)|Lack of Efficacy|0
840343|NCT01739348|2765902|P2|Part I (Base Study)|Lack of Efficacy|8
840344|NCT01739348|2765903|P1|Part I (Base Study)|Lack of Efficacy|3
840345|NCT01739348|2765900|P4|Part I (Base Study)|Death|8
840346|NCT01739348|2765901|P3|Part I (Base Study)|Death|2
840347|NCT01739348|2765902|P2|Part I (Base Study)|Death|7
840348|NCT01739348|2765903|P1|Part I (Base Study)|Death|10
840349|NCT01739348|2765900|P4|Part I (Base Study)|Adverse Event|33
840350|NCT01739348|2765901|P3|Part I (Base Study)|Adverse Event|8
840351|NCT01739348|2765902|P2|Part I (Base Study)|Adverse Event|52
840352|NCT01739348|2765903|P1|Part I (Base Study)|Adverse Event|41
840353|NCT01739335|2765975|P2|Overall Study|Ineligible patient randomized|1
840354|NCT01739335|2765976|P1|Overall Study|Ineligible patient randomized|0
840355|NCT01739335|2765975|P2|Overall Study|Lost to Follow-up|4
840356|NCT01739335|2765976|P1|Overall Study|Lost to Follow-up|7
840357|NCT01738984|2766010|P2|Overall Study|Lost to Follow-up|39
840358|NCT01738984|2766011|P1|Overall Study|Lost to Follow-up|59
840359|NCT01738984|2766010|P2|Overall Study|Withdrawal by Subject|0
840360|NCT01738984|2766011|P1|Overall Study|Withdrawal by Subject|1
840361|NCT01738984|2766010|P2|Overall Study|Pregnancy|0
840362|NCT01738984|2766011|P1|Overall Study|Pregnancy|4
840363|NCT01738971|2766024|P3|Overall Study|Lost to Follow-up|17
840364|NCT01738971|2766025|P2|Overall Study|Lost to Follow-up|30
840365|NCT01738971|2766026|P1|Overall Study|Lost to Follow-up|19
840366|NCT01738919|2766042|P2|Overall Study|Not treated in accordance to guidelines|1
840367|NCT01738919|2766043|P1|Overall Study|Not treated in accordance to guidelines|0
840368|NCT01738919|2766042|P2|Overall Study|Withdrawal by Subject|1
840369|NCT01738919|2766043|P1|Overall Study|Withdrawal by Subject|0
840370|NCT01738919|2766042|P2|Overall Study|Immigrated|1
840371|NCT01738919|2766043|P1|Overall Study|Immigrated|0
840372|NCT01738919|2766042|P2|Overall Study|Lost to Follow-up|0
840373|NCT01738919|2766043|P1|Overall Study|Lost to Follow-up|1
840374|NCT01738646|2766193|P1|Overall Study|Still Receiving Treatment|2
840375|NCT01738581|2766203|P2|Overall Study|Lost to Follow-up|0
840376|NCT01738581|2766204|P1|Overall Study|Lost to Follow-up|1
840377|NCT01738503|2766228|P7|PET Imaging Sub-study|Scheduling issues with imaging facility|1
840378|NCT01738503|2766229|P6|PET Imaging Sub-study|Scheduling issues with imaging facility|1
840379|NCT01738503|2766230|P5|PET Imaging Sub-study|Scheduling issues with imaging facility|0
840380|NCT01738503|2766231|P4|PET Imaging Sub-study|Scheduling issues with imaging facility|0
840381|NCT01738503|2766232|P3|PET Imaging Sub-study|Scheduling issues with imaging facility|0
840382|NCT01738503|2766233|P2|PET Imaging Sub-study|Scheduling issues with imaging facility|0
840383|NCT01738503|2766234|P1|PET Imaging Sub-study|Scheduling issues with imaging facility|0
840384|NCT01738503|2766228|P7|PET Imaging Sub-study|Adverse Event|0
840385|NCT01738503|2766229|P6|PET Imaging Sub-study|Adverse Event|1
840386|NCT01738503|2766230|P5|PET Imaging Sub-study|Adverse Event|0
840387|NCT01738503|2766231|P4|PET Imaging Sub-study|Adverse Event|0
840388|NCT01738503|2766232|P3|PET Imaging Sub-study|Adverse Event|0
840389|NCT01738503|2766233|P2|PET Imaging Sub-study|Adverse Event|0
840390|NCT01738503|2766234|P1|PET Imaging Sub-study|Adverse Event|0
840391|NCT01738503|2766228|P7|Treatment Period|Not specified|0
840392|NCT01738503|2766229|P6|Treatment Period|Not specified|0
840393|NCT01738503|2766230|P5|Treatment Period|Not specified|0
840394|NCT01738503|2766231|P4|Treatment Period|Not specified|0
840395|NCT01738503|2766232|P3|Treatment Period|Not specified|1
840396|NCT01738503|2766233|P2|Treatment Period|Not specified|0
840397|NCT01738503|2766234|P1|Treatment Period|Not specified|0
840398|NCT01738503|2766228|P7|Treatment Period|Protocol Violation|0
840399|NCT01738503|2766229|P6|Treatment Period|Protocol Violation|2
840400|NCT01738503|2766230|P5|Treatment Period|Protocol Violation|4
840401|NCT01738503|2766231|P4|Treatment Period|Protocol Violation|0
840402|NCT01738503|2766232|P3|Treatment Period|Protocol Violation|1
840403|NCT01738503|2766233|P2|Treatment Period|Protocol Violation|3
840404|NCT01738503|2766234|P1|Treatment Period|Protocol Violation|0
840405|NCT01738503|2766228|P7|Treatment Period|Withdrawal by Subject|1
840406|NCT01738503|2766229|P6|Treatment Period|Withdrawal by Subject|1
840407|NCT01738503|2766230|P5|Treatment Period|Withdrawal by Subject|1
840408|NCT01738503|2766231|P4|Treatment Period|Withdrawal by Subject|1
840409|NCT01738503|2766232|P3|Treatment Period|Withdrawal by Subject|0
840410|NCT01738503|2766233|P2|Treatment Period|Withdrawal by Subject|1
840411|NCT01738503|2766234|P1|Treatment Period|Withdrawal by Subject|0
840412|NCT01738503|2766228|P7|Treatment Period|Lost to Follow-up|5
840413|NCT01738503|2766229|P6|Treatment Period|Lost to Follow-up|1
840414|NCT01738503|2766230|P5|Treatment Period|Lost to Follow-up|1
840415|NCT01738503|2766231|P4|Treatment Period|Lost to Follow-up|4
840416|NCT01738503|2766232|P3|Treatment Period|Lost to Follow-up|3
840417|NCT01738503|2766233|P2|Treatment Period|Lost to Follow-up|0
840418|NCT01738503|2766234|P1|Treatment Period|Lost to Follow-up|0
840419|NCT01738503|2766228|P7|Treatment Period|Adverse Event|2
840420|NCT01738503|2766229|P6|Treatment Period|Adverse Event|2
840421|NCT01738503|2766230|P5|Treatment Period|Adverse Event|2
840422|NCT01738503|2766231|P4|Treatment Period|Adverse Event|1
840423|NCT01738503|2766232|P3|Treatment Period|Adverse Event|0
840424|NCT01738503|2766233|P2|Treatment Period|Adverse Event|1
840425|NCT01738503|2766234|P1|Treatment Period|Adverse Event|0
840426|NCT01738503|2766228|P7|Induction/Stabilization (Days -14 to -1)|Not specified|0
840427|NCT01738503|2766229|P6|Induction/Stabilization (Days -14 to -1)|Not specified|0
840428|NCT01738503|2766230|P5|Induction/Stabilization (Days -14 to -1)|Not specified|0
840429|NCT01738503|2766231|P4|Induction/Stabilization (Days -14 to -1)|Not specified|0
840430|NCT01738503|2766232|P3|Induction/Stabilization (Days -14 to -1)|Not specified|0
840431|NCT01738503|2766233|P2|Induction/Stabilization (Days -14 to -1)|Not specified|0
840432|NCT01738503|2766234|P1|Induction/Stabilization (Days -14 to -1)|Not specified|35
840433|NCT01738477|2766432|P2|Overall Study|Lost to Follow-up|4
840434|NCT01738477|2766433|P1|Overall Study|Lost to Follow-up|1
840435|NCT01738438|2766461|P1|Overall Study|Adverse Event|3
840436|NCT01738438|2766461|P1|Overall Study|Disease Progression|32
840437|NCT01738191|2766478|P2|Overall Study|Withdrawal by Subject|1
840438|NCT01738191|2766479|P1|Overall Study|Withdrawal by Subject|4
840439|NCT01737996|2766502|P3|Overall Study|Withdrawal by Subject|1
840440|NCT01737996|2766503|P2|Overall Study|Withdrawal by Subject|0
840441|NCT01737996|2766504|P1|Overall Study|Withdrawal by Subject|0
840442|NCT01737996|2766502|P3|Overall Study|Adverse Event|1
840443|NCT01737996|2766503|P2|Overall Study|Adverse Event|1
840444|NCT01737996|2766504|P1|Overall Study|Adverse Event|0
840445|NCT01737931|2766566|P3|Overall Study|Physician Decision|0
840446|NCT01737931|2766567|P2|Overall Study|Physician Decision|1
840447|NCT01737931|2766568|P1|Overall Study|Physician Decision|0
840448|NCT01737931|2766566|P3|Overall Study|Withdrawal by Subject|1
840449|NCT01737931|2766567|P2|Overall Study|Withdrawal by Subject|1
840450|NCT01737931|2766568|P1|Overall Study|Withdrawal by Subject|0
840451|NCT01737879|2766583|P1|Overall Study|Sponsor decision|40
840452|NCT01737879|2766583|P1|Overall Study|Death|1
840453|NCT01737840|2766592|P2|Overall Study|Diagnosed with an other pathology|2
840454|NCT01737840|2766593|P1|Overall Study|Diagnosed with an other pathology|2
840455|NCT01737762|2766603|P2|Overall Study|Trial termination|9
840456|NCT01737762|2766604|P1|Overall Study|Trial termination|11
840457|NCT01737762|2766603|P2|Overall Study|Moved from area|1
840458|NCT01737762|2766604|P1|Overall Study|Moved from area|2
840459|NCT01737762|2766603|P2|Overall Study|Physician Decision|1
840460|NCT01737762|2766604|P1|Overall Study|Physician Decision|1
840461|NCT01737762|2766603|P2|Overall Study|Progressive disease|2
840462|NCT01737762|2766604|P1|Overall Study|Progressive disease|1
840463|NCT01737762|2766603|P2|Overall Study|Withdrawal by Subject|2
840464|NCT01737762|2766604|P1|Overall Study|Withdrawal by Subject|2
840465|NCT01737762|2766603|P2|Overall Study|Lost to Follow-up|0
840466|NCT01737762|2766604|P1|Overall Study|Lost to Follow-up|1
840467|NCT01737762|2766603|P2|Overall Study|Adverse Event|2
840468|NCT01737762|2766604|P1|Overall Study|Adverse Event|2
840469|NCT01737710|2766617|P5|Overall Study|Vaccinated in Error/Ineligible|0
840470|NCT01737710|2766618|P4|Overall Study|Vaccinated in Error/Ineligible|0
840471|NCT01737710|2766619|P3|Overall Study|Vaccinated in Error/Ineligible|0
840472|NCT01737710|2766620|P2|Overall Study|Vaccinated in Error/Ineligible|1
840473|NCT01737710|2766621|P1|Overall Study|Vaccinated in Error/Ineligible|1
840474|NCT01737710|2766617|P5|Overall Study|Withdrawal by Subject|0
840475|NCT01737710|2766618|P4|Overall Study|Withdrawal by Subject|0
840476|NCT01737710|2766619|P3|Overall Study|Withdrawal by Subject|1
840477|NCT01737710|2766620|P2|Overall Study|Withdrawal by Subject|1
840478|NCT01737710|2766621|P1|Overall Study|Withdrawal by Subject|1
840479|NCT01737710|2766617|P5|Overall Study|Lost to Follow-up|0
840480|NCT01737710|2766618|P4|Overall Study|Lost to Follow-up|0
840481|NCT01737710|2766619|P3|Overall Study|Lost to Follow-up|2
840482|NCT01737710|2766620|P2|Overall Study|Lost to Follow-up|2
840483|NCT01737710|2766621|P1|Overall Study|Lost to Follow-up|0
840484|NCT01737697|2766663|P15|Subacute Phase|Death|0
840485|NCT01737697|2766664|P14|Subacute Phase|Death|0
840486|NCT01737697|2766665|P13|Subacute Phase|Death|0
840487|NCT01737697|2766666|P12|Subacute Phase|Death|0
840488|NCT01737697|2766667|P11|Subacute Phase|Death|1
840489|NCT01737697|2766668|P10|Subacute Phase|Death|0
840490|NCT01737697|2766669|P9|Subacute Phase|Death|0
840491|NCT01737697|2766670|P8|Subacute Phase|Death|0
840492|NCT01737697|2766671|P7|Subacute Phase|Death|0
840493|NCT01737697|2766672|P6|Subacute Phase|Death|0
840494|NCT01737697|2766673|P5|Subacute Phase|Death|0
840495|NCT01737697|2766674|P4|Subacute Phase|Death|0
840496|NCT01737697|2766675|P3|Subacute Phase|Death|0
840497|NCT01737697|2766676|P2|Subacute Phase|Death|0
840498|NCT01737697|2766677|P1|Subacute Phase|Death|0
840499|NCT01737697|2766663|P15|Subacute Phase|Physician Decision|0
840500|NCT01737697|2766664|P14|Subacute Phase|Physician Decision|0
840501|NCT01737697|2766665|P13|Subacute Phase|Physician Decision|0
840502|NCT01737697|2766666|P12|Subacute Phase|Physician Decision|0
840503|NCT01737697|2766667|P11|Subacute Phase|Physician Decision|0
840504|NCT01737697|2766668|P10|Subacute Phase|Physician Decision|0
840505|NCT01737697|2766669|P9|Subacute Phase|Physician Decision|1
840506|NCT01737697|2766670|P8|Subacute Phase|Physician Decision|0
840507|NCT01737697|2766671|P7|Subacute Phase|Physician Decision|0
840508|NCT01737697|2766672|P6|Subacute Phase|Physician Decision|0
840509|NCT01737697|2766673|P5|Subacute Phase|Physician Decision|0
840510|NCT01737697|2766674|P4|Subacute Phase|Physician Decision|0
840511|NCT01737697|2766675|P3|Subacute Phase|Physician Decision|0
840512|NCT01737697|2766676|P2|Subacute Phase|Physician Decision|0
840513|NCT01737697|2766677|P1|Subacute Phase|Physician Decision|0
840514|NCT01737697|2766663|P15|Subacute Phase|Protocol Violation|0
840515|NCT01737697|2766664|P14|Subacute Phase|Protocol Violation|0
840516|NCT01737697|2766665|P13|Subacute Phase|Protocol Violation|0
840517|NCT01737697|2766666|P12|Subacute Phase|Protocol Violation|0
840518|NCT01737697|2766667|P11|Subacute Phase|Protocol Violation|1
840519|NCT01737697|2766668|P10|Subacute Phase|Protocol Violation|0
840520|NCT01737697|2766669|P9|Subacute Phase|Protocol Violation|0
840521|NCT01737697|2766670|P8|Subacute Phase|Protocol Violation|0
840522|NCT01737697|2766671|P7|Subacute Phase|Protocol Violation|0
840523|NCT01737697|2766672|P6|Subacute Phase|Protocol Violation|1
840524|NCT01737697|2766673|P5|Subacute Phase|Protocol Violation|0
840525|NCT01737697|2766674|P4|Subacute Phase|Protocol Violation|0
840526|NCT01737697|2766675|P3|Subacute Phase|Protocol Violation|0
840527|NCT01737697|2766676|P2|Subacute Phase|Protocol Violation|0
840528|NCT01737697|2766677|P1|Subacute Phase|Protocol Violation|0
840529|NCT01737697|2766663|P15|Subacute Phase|Hypo-or hyperkalemia|0
840530|NCT01737697|2766664|P14|Subacute Phase|Hypo-or hyperkalemia|1
840531|NCT01737697|2766665|P13|Subacute Phase|Hypo-or hyperkalemia|0
840532|NCT01737697|2766666|P12|Subacute Phase|Hypo-or hyperkalemia|1
840533|NCT01737697|2766667|P11|Subacute Phase|Hypo-or hyperkalemia|0
840534|NCT01737697|2766668|P10|Subacute Phase|Hypo-or hyperkalemia|0
840535|NCT01737697|2766669|P9|Subacute Phase|Hypo-or hyperkalemia|0
840536|NCT01737697|2766670|P8|Subacute Phase|Hypo-or hyperkalemia|0
840537|NCT01737697|2766671|P7|Subacute Phase|Hypo-or hyperkalemia|0
840538|NCT01737697|2766672|P6|Subacute Phase|Hypo-or hyperkalemia|0
840539|NCT01737697|2766673|P5|Subacute Phase|Hypo-or hyperkalemia|0
840540|NCT01737697|2766674|P4|Subacute Phase|Hypo-or hyperkalemia|0
840541|NCT01737697|2766675|P3|Subacute Phase|Hypo-or hyperkalemia|0
840542|NCT01737697|2766676|P2|Subacute Phase|Hypo-or hyperkalemia|0
840543|NCT01737697|2766677|P1|Subacute Phase|Hypo-or hyperkalemia|0
840544|NCT01737697|2766663|P15|Subacute Phase|Lost to Follow-up|1
840545|NCT01737697|2766664|P14|Subacute Phase|Lost to Follow-up|0
840546|NCT01737697|2766665|P13|Subacute Phase|Lost to Follow-up|0
840547|NCT01737697|2766666|P12|Subacute Phase|Lost to Follow-up|0
840548|NCT01737697|2766667|P11|Subacute Phase|Lost to Follow-up|0
840549|NCT01737697|2766668|P10|Subacute Phase|Lost to Follow-up|0
840550|NCT01737697|2766669|P9|Subacute Phase|Lost to Follow-up|0
840551|NCT01737697|2766670|P8|Subacute Phase|Lost to Follow-up|0
840552|NCT01737697|2766671|P7|Subacute Phase|Lost to Follow-up|0
840553|NCT01737697|2766672|P6|Subacute Phase|Lost to Follow-up|0
840554|NCT01737697|2766673|P5|Subacute Phase|Lost to Follow-up|0
840555|NCT01737697|2766674|P4|Subacute Phase|Lost to Follow-up|0
840556|NCT01737697|2766675|P3|Subacute Phase|Lost to Follow-up|0
840557|NCT01737697|2766676|P2|Subacute Phase|Lost to Follow-up|0
840558|NCT01737697|2766677|P1|Subacute Phase|Lost to Follow-up|0
840559|NCT01737697|2766663|P15|Subacute Phase|Withdrawal by Subject|0
840560|NCT01737697|2766664|P14|Subacute Phase|Withdrawal by Subject|1
840561|NCT01737697|2766665|P13|Subacute Phase|Withdrawal by Subject|1
840562|NCT01737697|2766666|P12|Subacute Phase|Withdrawal by Subject|1
840563|NCT01737697|2766667|P11|Subacute Phase|Withdrawal by Subject|0
840564|NCT01737697|2766668|P10|Subacute Phase|Withdrawal by Subject|1
840565|NCT01737697|2766669|P9|Subacute Phase|Withdrawal by Subject|0
840566|NCT01737697|2766670|P8|Subacute Phase|Withdrawal by Subject|2
840567|NCT01737697|2766671|P7|Subacute Phase|Withdrawal by Subject|0
840568|NCT01737697|2766672|P6|Subacute Phase|Withdrawal by Subject|1
840569|NCT01737697|2766673|P5|Subacute Phase|Withdrawal by Subject|0
840570|NCT01737697|2766674|P4|Subacute Phase|Withdrawal by Subject|0
840571|NCT01737697|2766675|P3|Subacute Phase|Withdrawal by Subject|0
840572|NCT01737697|2766676|P2|Subacute Phase|Withdrawal by Subject|0
840573|NCT01737697|2766677|P1|Subacute Phase|Withdrawal by Subject|0
840574|NCT01737697|2766663|P15|Subacute Phase|Adverse Event|0
840575|NCT01737697|2766664|P14|Subacute Phase|Adverse Event|0
840576|NCT01737697|2766665|P13|Subacute Phase|Adverse Event|1
840577|NCT01737697|2766666|P12|Subacute Phase|Adverse Event|1
840578|NCT01737697|2766667|P11|Subacute Phase|Adverse Event|4
840579|NCT01737697|2766668|P10|Subacute Phase|Adverse Event|1
840580|NCT01737697|2766669|P9|Subacute Phase|Adverse Event|1
840581|NCT01737697|2766670|P8|Subacute Phase|Adverse Event|1
840582|NCT01737697|2766671|P7|Subacute Phase|Adverse Event|1
840583|NCT01737697|2766672|P6|Subacute Phase|Adverse Event|1
840584|NCT01737697|2766673|P5|Subacute Phase|Adverse Event|0
840585|NCT01737697|2766674|P4|Subacute Phase|Adverse Event|0
840586|NCT01737697|2766675|P3|Subacute Phase|Adverse Event|0
840587|NCT01737697|2766676|P2|Subacute Phase|Adverse Event|0
840588|NCT01737697|2766677|P1|Subacute Phase|Adverse Event|0
840589|NCT01737697|2766663|P15|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
840590|NCT01737697|2766664|P14|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
840591|NCT01737697|2766665|P13|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
840592|NCT01737697|2766666|P12|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
840593|NCT01737697|2766667|P11|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
840594|NCT01737697|2766668|P10|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
840595|NCT01737697|2766669|P9|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
840596|NCT01737697|2766670|P8|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
840597|NCT01737697|2766671|P7|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
840598|NCT01737697|2766672|P6|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
840599|NCT01737697|2766673|P5|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
840600|NCT01737697|2766674|P4|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4
840601|NCT01737697|2766675|P3|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
840602|NCT01737697|2766676|P2|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
840603|NCT01737697|2766677|P1|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
840604|NCT01737697|2766663|P15|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
840605|NCT01737697|2766664|P14|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
840606|NCT01737697|2766665|P13|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
840607|NCT01737697|2766666|P12|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
840608|NCT01737697|2766667|P11|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
840609|NCT01737697|2766668|P10|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
840610|NCT01737697|2766669|P9|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
840611|NCT01737697|2766670|P8|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
840612|NCT01737697|2766671|P7|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
840613|NCT01737697|2766672|P6|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
840614|NCT01737697|2766673|P5|Acute Phase-Initial 48 Hours|Lost to Follow-up|1
840615|NCT01737697|2766674|P4|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
840616|NCT01737697|2766675|P3|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
840617|NCT01737697|2766676|P2|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
840618|NCT01737697|2766677|P1|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
840619|NCT01737697|2766663|P15|Acute Phase-Initial 48 Hours|Sponsor's decision|0
840620|NCT01737697|2766664|P14|Acute Phase-Initial 48 Hours|Sponsor's decision|0
840621|NCT01737697|2766665|P13|Acute Phase-Initial 48 Hours|Sponsor's decision|0
840622|NCT01737697|2766666|P12|Acute Phase-Initial 48 Hours|Sponsor's decision|0
840623|NCT01737697|2766667|P11|Acute Phase-Initial 48 Hours|Sponsor's decision|0
840624|NCT01737697|2766668|P10|Acute Phase-Initial 48 Hours|Sponsor's decision|0
840625|NCT01737697|2766669|P9|Acute Phase-Initial 48 Hours|Sponsor's decision|0
840626|NCT01737697|2766670|P8|Acute Phase-Initial 48 Hours|Sponsor's decision|0
840627|NCT01737697|2766671|P7|Acute Phase-Initial 48 Hours|Sponsor's decision|0
840628|NCT01737697|2766672|P6|Acute Phase-Initial 48 Hours|Sponsor's decision|0
840629|NCT01737697|2766673|P5|Acute Phase-Initial 48 Hours|Sponsor's decision|0
840630|NCT01737697|2766674|P4|Acute Phase-Initial 48 Hours|Sponsor's decision|0
840631|NCT01737697|2766675|P3|Acute Phase-Initial 48 Hours|Sponsor's decision|0
840632|NCT01737697|2766676|P2|Acute Phase-Initial 48 Hours|Sponsor's decision|1
840633|NCT01737697|2766677|P1|Acute Phase-Initial 48 Hours|Sponsor's decision|0
840634|NCT01737697|2766663|P15|Acute Phase-Initial 48 Hours|Family emergency|0
840635|NCT01737697|2766664|P14|Acute Phase-Initial 48 Hours|Family emergency|0
840636|NCT01737697|2766665|P13|Acute Phase-Initial 48 Hours|Family emergency|0
840637|NCT01737697|2766666|P12|Acute Phase-Initial 48 Hours|Family emergency|0
840638|NCT01737697|2766667|P11|Acute Phase-Initial 48 Hours|Family emergency|0
840639|NCT01737697|2766668|P10|Acute Phase-Initial 48 Hours|Family emergency|0
840640|NCT01737697|2766669|P9|Acute Phase-Initial 48 Hours|Family emergency|0
840641|NCT01737697|2766670|P8|Acute Phase-Initial 48 Hours|Family emergency|0
840642|NCT01737697|2766671|P7|Acute Phase-Initial 48 Hours|Family emergency|0
840643|NCT01737697|2766672|P6|Acute Phase-Initial 48 Hours|Family emergency|0
840644|NCT01737697|2766673|P5|Acute Phase-Initial 48 Hours|Family emergency|0
840645|NCT01737697|2766674|P4|Acute Phase-Initial 48 Hours|Family emergency|1
840646|NCT01737697|2766675|P3|Acute Phase-Initial 48 Hours|Family emergency|0
840647|NCT01737697|2766676|P2|Acute Phase-Initial 48 Hours|Family emergency|0
840648|NCT01737697|2766677|P1|Acute Phase-Initial 48 Hours|Family emergency|0
840649|NCT01737697|2766663|P15|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
840650|NCT01737697|2766664|P14|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
840651|NCT01737697|2766665|P13|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
840652|NCT01737697|2766666|P12|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
840653|NCT01737697|2766667|P11|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
840654|NCT01737697|2766668|P10|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
840655|NCT01737697|2766669|P9|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
840656|NCT01737697|2766670|P8|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
840657|NCT01737697|2766671|P7|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
840658|NCT01737697|2766672|P6|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
840659|NCT01737697|2766673|P5|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
840660|NCT01737697|2766674|P4|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
840661|NCT01737697|2766675|P3|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3
840662|NCT01737697|2766676|P2|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
840663|NCT01737697|2766677|P1|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
840664|NCT01737697|2766663|P15|Acute Phase-Initial 48 Hours|Adverse Event|0
840665|NCT01737697|2766664|P14|Acute Phase-Initial 48 Hours|Adverse Event|0
840666|NCT01737697|2766665|P13|Acute Phase-Initial 48 Hours|Adverse Event|0
840667|NCT01737697|2766666|P12|Acute Phase-Initial 48 Hours|Adverse Event|0
840668|NCT01737697|2766667|P11|Acute Phase-Initial 48 Hours|Adverse Event|0
840669|NCT01737697|2766668|P10|Acute Phase-Initial 48 Hours|Adverse Event|0
840670|NCT01737697|2766669|P9|Acute Phase-Initial 48 Hours|Adverse Event|0
840671|NCT01737697|2766670|P8|Acute Phase-Initial 48 Hours|Adverse Event|0
840672|NCT01737697|2766671|P7|Acute Phase-Initial 48 Hours|Adverse Event|0
840673|NCT01737697|2766672|P6|Acute Phase-Initial 48 Hours|Adverse Event|0
840674|NCT01737697|2766673|P5|Acute Phase-Initial 48 Hours|Adverse Event|1
840675|NCT01737697|2766674|P4|Acute Phase-Initial 48 Hours|Adverse Event|1
840676|NCT01737697|2766675|P3|Acute Phase-Initial 48 Hours|Adverse Event|0
840677|NCT01737697|2766676|P2|Acute Phase-Initial 48 Hours|Adverse Event|1
840678|NCT01737697|2766677|P1|Acute Phase-Initial 48 Hours|Adverse Event|0
840679|NCT01737268|2766818|P1|Overall Study|In consideration of the patient’s safety|1
840680|NCT01737268|2766818|P1|Overall Study|Worsening of Target Disease|2
840681|NCT01737268|2766818|P1|Overall Study|Adverse Event|6
840682|NCT01737021|2766832|P2|Overall Study|Lost to Follow-up|3
840683|NCT01737021|2766833|P1|Overall Study|Lost to Follow-up|5
840684|NCT01736917|2766879|P1|Overall Study|Protocol Violation|10
840685|NCT01736917|2766879|P1|Overall Study|Adverse Event|1
840686|NCT01736696|2766893|P7|Overall Study|Withdrawal by Subject|0
840687|NCT01736696|2766894|P6|Overall Study|Withdrawal by Subject|0
840688|NCT01736696|2766895|P5|Overall Study|Withdrawal by Subject|0
840689|NCT01736696|2766896|P4|Overall Study|Withdrawal by Subject|0
840690|NCT01736696|2766897|P3|Overall Study|Withdrawal by Subject|1
840691|NCT01736696|2766898|P2|Overall Study|Withdrawal by Subject|0
840692|NCT01736696|2766899|P1|Overall Study|Withdrawal by Subject|0
840693|NCT01736657|2767216|P1|Overall Study|insufficient vascular access|1
840694|NCT01736579|2767225|P2|Overall Study|Termination of Study by Sponsor|2
840695|NCT01736579|2767226|P1|Overall Study|Termination of Study by Sponsor|2
840696|NCT01736566|2767265|P5|Long Term Follow-up|Still collecting data|1
840697|NCT01736566|2767266|P4|Long Term Follow-up|Still collecting data|0
840698|NCT01736566|2767267|P3|Long Term Follow-up|Still collecting data|49
840699|NCT01736566|2767268|P2|Long Term Follow-up|Still collecting data|0
840700|NCT01736566|2767269|P1|Long Term Follow-up|Still collecting data|42
840701|NCT01736553|2767354|P2|Overall Study|Lost to Follow-up|2
840702|NCT01736553|2767355|P1|Overall Study|Lost to Follow-up|2
840703|NCT01736553|2767354|P2|Overall Study|Withdrawal by Subject|2
840704|NCT01736553|2767355|P1|Overall Study|Withdrawal by Subject|5
840705|NCT01736553|2767354|P2|Overall Study|Death|0
840706|NCT01736553|2767355|P1|Overall Study|Death|12
840707|NCT01736540|2767406|P1|Overall Study|Unable to make MRI appointment|3
840708|NCT01736540|2767406|P1|Overall Study|No show for MRI appointment|1
840709|NCT01736540|2767406|P1|Overall Study|Unable to tolerate MRI; claustrophobic|1
840710|NCT01736540|2767406|P1|Overall Study|Protocol Violation|1
840711|NCT01736540|2767406|P1|Overall Study|Withdrawal by Subject|5
840712|NCT01736540|2767406|P1|Overall Study|Abnormal test procedure|1
840713|NCT01736540|2767406|P1|Overall Study|Death|1
840714|NCT01736540|2767406|P1|Overall Study|Did not complete scan within 45 days|2
840715|NCT01736475|2767472|P2|Overall Study|Other - Surgical procedure|0
840716|NCT01736475|2767473|P1|Overall Study|Other - Surgical procedure|1
840717|NCT01736475|2767472|P2|Overall Study|Other - Screen failure|0
840718|NCT01736475|2767473|P1|Overall Study|Other - Screen failure|1
840719|NCT01736475|2767472|P2|Overall Study|Protocol Violation|0
840720|NCT01736475|2767473|P1|Overall Study|Protocol Violation|4
840721|NCT01736475|2767472|P2|Overall Study|Withdrawal by Subject|0
840722|NCT01736475|2767473|P1|Overall Study|Withdrawal by Subject|2
840723|NCT01736475|2767472|P2|Overall Study|Adverse Event|0
840724|NCT01736475|2767473|P1|Overall Study|Adverse Event|4
840725|NCT01736397|2767528|P2|Overall Study|Not stated|4
840726|NCT01736397|2767529|P1|Overall Study|Not stated|1
840727|NCT01736397|2767528|P2|Overall Study|Adverse Event|3
840728|NCT01736397|2767529|P1|Overall Study|Adverse Event|6
840729|NCT01736397|2767528|P2|Overall Study|Lost to Follow-up|1
840730|NCT01736397|2767529|P1|Overall Study|Lost to Follow-up|0
840731|NCT01736397|2767528|P2|Overall Study|Withdrawal by Subject|5
840732|NCT01736397|2767529|P1|Overall Study|Withdrawal by Subject|6
840733|NCT01736397|2767528|P2|Overall Study|Lack of Efficacy|11
840734|NCT01736397|2767529|P1|Overall Study|Lack of Efficacy|1
840735|NCT01736254|2767541|P1|Period 3 (Days 13 to 23)|Adverse Event|1
840736|NCT01736254|2767541|P1|Period 2 (Days 2 to 12)|Adverse Event|3
840737|NCT01736215|2767606|P1|Overall Study|Insufficient data to perform analysis|8
840738|NCT01736215|2767606|P1|Overall Study|Progressive disease stop chemotherapy|1
840739|NCT01736215|2767606|P1|Overall Study|Adverse Event|4
840740|NCT01736215|2767606|P1|Overall Study|Early termination of erythropoietin use|1
840741|NCT01736176|2767618|P1|Overall Study|Unable to Complete PEG Placement|1
840742|NCT01736176|2767618|P1|Overall Study|Lack of Efficacy|3
840743|NCT01736176|2767618|P1|Overall Study|Withdrawal by Subject|4
840744|NCT01736176|2767618|P1|Overall Study|Adverse Event|3
840745|NCT01735916|2767665|P3|Overall Study|Withdrawal by Subject|0
840746|NCT01735916|2767666|P2|Overall Study|Withdrawal by Subject|0
840747|NCT01735916|2767667|P1|Overall Study|Withdrawal by Subject|3
840748|NCT01735916|2767665|P3|Overall Study|Early termination of study by sponsor|7
840749|NCT01735916|2767666|P2|Overall Study|Early termination of study by sponsor|19
840750|NCT01735916|2767667|P1|Overall Study|Early termination of study by sponsor|4
840751|NCT01735916|2767665|P3|Overall Study|Subject not eligible to be randomized|0
840752|NCT01735916|2767666|P2|Overall Study|Subject not eligible to be randomized|0
840753|NCT01735916|2767667|P1|Overall Study|Subject not eligible to be randomized|11
840754|NCT01735630|2767705|P2|Overall Study|Withdrawal by Subject|9
840755|NCT01735630|2767706|P1|Overall Study|Withdrawal by Subject|7
840756|NCT01735630|2767705|P2|Overall Study|Sponsor Decision|1
840757|NCT01735630|2767706|P1|Overall Study|Sponsor Decision|2
840758|NCT01735630|2767705|P2|Overall Study|Physician Decision|1
840759|NCT01735630|2767706|P1|Overall Study|Physician Decision|0
840760|NCT01735630|2767705|P2|Overall Study|Lost to Follow-up|0
840761|NCT01735630|2767706|P1|Overall Study|Lost to Follow-up|1
840762|NCT01735630|2767705|P2|Overall Study|Adverse Event|7
840763|NCT01735630|2767706|P1|Overall Study|Adverse Event|8
840764|NCT01735396|2767733|P1|Overall Study|not evaluable|1
840765|NCT01735201|2767762|P8|Overall Study|Other Miscellaneous Reasons|1
840766|NCT01735201|2767763|P7|Overall Study|Other Miscellaneous Reasons|1
840767|NCT01735201|2767764|P6|Overall Study|Other Miscellaneous Reasons|2
840768|NCT01735201|2767765|P5|Overall Study|Other Miscellaneous Reasons|0
840769|NCT01735201|2767766|P4|Overall Study|Other Miscellaneous Reasons|1
840770|NCT01735201|2767767|P3|Overall Study|Other Miscellaneous Reasons|0
840771|NCT01735201|2767768|P2|Overall Study|Other Miscellaneous Reasons|0
840772|NCT01735201|2767769|P1|Overall Study|Other Miscellaneous Reasons|0
840773|NCT01735201|2767762|P8|Overall Study|Protocol Violation|0
840774|NCT01735201|2767763|P7|Overall Study|Protocol Violation|0
840775|NCT01735201|2767764|P6|Overall Study|Protocol Violation|0
840776|NCT01735201|2767765|P5|Overall Study|Protocol Violation|0
840777|NCT01735201|2767766|P4|Overall Study|Protocol Violation|0
840778|NCT01735201|2767767|P3|Overall Study|Protocol Violation|0
840779|NCT01735201|2767768|P2|Overall Study|Protocol Violation|0
840780|NCT01735201|2767769|P1|Overall Study|Protocol Violation|1
840781|NCT01735201|2767762|P8|Overall Study|Personal Reasons|0
840782|NCT01735201|2767763|P7|Overall Study|Personal Reasons|0
840783|NCT01735201|2767764|P6|Overall Study|Personal Reasons|0
840784|NCT01735201|2767765|P5|Overall Study|Personal Reasons|0
840785|NCT01735201|2767766|P4|Overall Study|Personal Reasons|0
840786|NCT01735201|2767767|P3|Overall Study|Personal Reasons|0
840787|NCT01735201|2767768|P2|Overall Study|Personal Reasons|0
840788|NCT01735201|2767769|P1|Overall Study|Personal Reasons|1
840789|NCT01735201|2767762|P8|Overall Study|Adverse Event|1
840790|NCT01735201|2767763|P7|Overall Study|Adverse Event|2
840791|NCT01735201|2767764|P6|Overall Study|Adverse Event|3
840792|NCT01735201|2767765|P5|Overall Study|Adverse Event|1
840793|NCT01735201|2767766|P4|Overall Study|Adverse Event|1
840794|NCT01735201|2767767|P3|Overall Study|Adverse Event|0
840795|NCT01735201|2767768|P2|Overall Study|Adverse Event|1
840796|NCT01735201|2767769|P1|Overall Study|Adverse Event|1
840797|NCT01735175|2767805|P2|Overall Study|Other (mostly EOS/EOT visit missing)|7
840798|NCT01735175|2767806|P1|Overall Study|Other (mostly EOS/EOT visit missing)|13
840799|NCT01735175|2767805|P2|Overall Study|Death|2
840800|NCT01735175|2767806|P1|Overall Study|Death|3
840801|NCT01735175|2767805|P2|Overall Study|Lost to Follow-up|2
840802|NCT01735175|2767806|P1|Overall Study|Lost to Follow-up|4
840803|NCT01735175|2767805|P2|Overall Study|Withdrawal by Subject|2
840804|NCT01735175|2767806|P1|Overall Study|Withdrawal by Subject|9
840805|NCT01734993|2767826|P1|Overall Study|Lack of Efficacy|1
840806|NCT01734993|2767826|P1|Overall Study|Adverse Event|1
840807|NCT01734785|2767863|P4|Double−Blind Period|Not treated|0
840808|NCT01734785|2767864|P3|Double−Blind Period|Not treated|0
840809|NCT01734785|2767865|P2|Double−Blind Period|Not treated|0
840810|NCT01734785|2767866|P1|Double−Blind Period|Not treated|1
840811|NCT01734785|2767863|P4|Double−Blind Period|Withdrawal by Subject|0
840812|NCT01734785|2767864|P3|Double−Blind Period|Withdrawal by Subject|0
840813|NCT01734785|2767865|P2|Double−Blind Period|Withdrawal by Subject|0
840814|NCT01734785|2767866|P1|Double−Blind Period|Withdrawal by Subject|2
840815|NCT01734785|2767863|P4|Double−Blind Period|Lost to Follow-up|0
840816|NCT01734785|2767864|P3|Double−Blind Period|Lost to Follow-up|2
840817|NCT01734785|2767865|P2|Double−Blind Period|Lost to Follow-up|4
840818|NCT01734785|2767866|P1|Double−Blind Period|Lost to Follow-up|2
840819|NCT01734785|2767863|P4|Double−Blind Period|Protocol Violation|0
840820|NCT01734785|2767864|P3|Double−Blind Period|Protocol Violation|1
840821|NCT01734785|2767865|P2|Double−Blind Period|Protocol Violation|1
840822|NCT01734785|2767866|P1|Double−Blind Period|Protocol Violation|0
840823|NCT01734785|2767863|P4|Double−Blind Period|Lack of Efficacy|0
840824|NCT01734785|2767864|P3|Double−Blind Period|Lack of Efficacy|0
840825|NCT01734785|2767865|P2|Double−Blind Period|Lack of Efficacy|1
840826|NCT01734785|2767866|P1|Double−Blind Period|Lack of Efficacy|0
840827|NCT01734785|2767863|P4|Double−Blind Period|Adverse Event|0
840828|NCT01734785|2767864|P3|Double−Blind Period|Adverse Event|2
840829|NCT01734785|2767865|P2|Double−Blind Period|Adverse Event|3
840830|NCT01734785|2767866|P1|Double−Blind Period|Adverse Event|0
840831|NCT01734785|2767863|P4|Open−Label Period|Other Reasons|224
840832|NCT01734785|2767864|P3|Open−Label Period|Other Reasons|0
840833|NCT01734785|2767865|P2|Open−Label Period|Other Reasons|0
840834|NCT01734785|2767866|P1|Open−Label Period|Other Reasons|0
840835|NCT01734785|2767863|P4|Open−Label Period|Withdrawal by Subject|12
840836|NCT01734785|2767864|P3|Open−Label Period|Withdrawal by Subject|0
840837|NCT01734785|2767865|P2|Open−Label Period|Withdrawal by Subject|0
840838|NCT01734785|2767866|P1|Open−Label Period|Withdrawal by Subject|0
840839|NCT01734785|2767863|P4|Open−Label Period|Lost to Follow-up|14
840840|NCT01734785|2767864|P3|Open−Label Period|Lost to Follow-up|0
840841|NCT01734785|2767865|P2|Open−Label Period|Lost to Follow-up|0
840842|NCT01734785|2767866|P1|Open−Label Period|Lost to Follow-up|0
840843|NCT01734785|2767863|P4|Open−Label Period|Protocol Violation|13
840844|NCT01734785|2767864|P3|Open−Label Period|Protocol Violation|0
840845|NCT01734785|2767865|P2|Open−Label Period|Protocol Violation|0
840846|NCT01734785|2767866|P1|Open−Label Period|Protocol Violation|0
840847|NCT01734785|2767863|P4|Open−Label Period|Lack of Efficacy|1
840848|NCT01734785|2767864|P3|Open−Label Period|Lack of Efficacy|0
840849|NCT01734785|2767865|P2|Open−Label Period|Lack of Efficacy|0
840850|NCT01734785|2767866|P1|Open−Label Period|Lack of Efficacy|0
840851|NCT01734785|2767863|P4|Open−Label Period|Adverse Event|9
840852|NCT01734785|2767864|P3|Open−Label Period|Adverse Event|0
840853|NCT01734785|2767865|P2|Open−Label Period|Adverse Event|0
840854|NCT01734785|2767866|P1|Open−Label Period|Adverse Event|0
840855|NCT01734772|2767883|P2|Overall Study|Withdrawal by Subject|1
840856|NCT01734772|2767884|P1|Overall Study|Withdrawal by Subject|0
840857|NCT01734772|2767883|P2|Overall Study|Adverse Event|2
840858|NCT01734772|2767884|P1|Overall Study|Adverse Event|1
840859|NCT01734395|2767931|P1|Overall Study|Missing the reasons for not completed|3
840860|NCT01734395|2767931|P1|Overall Study|Withdrawal by Subject|10
840861|NCT01734395|2767931|P1|Overall Study|Adverse Event|40
840862|NCT01734395|2767931|P1|Overall Study|Lack of Efficacy|5
840863|NCT01734395|2767931|P1|Overall Study|Lost to Follow-up|287
840864|NCT01734395|2767931|P1|Overall Study|Not specified|65
840865|NCT01733758|2767989|P4|Overall Study|Inv Decision, HbA1c not controlled|1
840866|NCT01733758|2767990|P3|Overall Study|Inv Decision, HbA1c not controlled|0
840867|NCT01733758|2767991|P2|Overall Study|Inv Decision, HbA1c not controlled|1
840868|NCT01733758|2767992|P1|Overall Study|Inv Decision, HbA1c not controlled|1
840869|NCT01733758|2767989|P4|Overall Study|Intro of New Anti-Diabetic Medication|1
840870|NCT01733758|2767990|P3|Overall Study|Intro of New Anti-Diabetic Medication|0
840871|NCT01733758|2767991|P2|Overall Study|Intro of New Anti-Diabetic Medication|0
840872|NCT01733758|2767992|P1|Overall Study|Intro of New Anti-Diabetic Medication|4
840873|NCT01733758|2767989|P4|Overall Study|Non-compliance|0
840874|NCT01733758|2767990|P3|Overall Study|Non-compliance|0
840875|NCT01733758|2767991|P2|Overall Study|Non-compliance|0
840876|NCT01733758|2767992|P1|Overall Study|Non-compliance|1
840877|NCT01733758|2767989|P4|Overall Study|Protocol Violation|2
840878|NCT01733758|2767990|P3|Overall Study|Protocol Violation|2
840879|NCT01733758|2767991|P2|Overall Study|Protocol Violation|1
840880|NCT01733758|2767992|P1|Overall Study|Protocol Violation|0
840881|NCT01733758|2767989|P4|Overall Study|Persistent Hyperglycemia|0
840882|NCT01733758|2767990|P3|Overall Study|Persistent Hyperglycemia|0
840883|NCT01733758|2767991|P2|Overall Study|Persistent Hyperglycemia|2
840884|NCT01733758|2767992|P1|Overall Study|Persistent Hyperglycemia|3
840885|NCT01733758|2767989|P4|Overall Study|Withdrawal by Subject|3
840886|NCT01733758|2767990|P3|Overall Study|Withdrawal by Subject|5
840887|NCT01733758|2767991|P2|Overall Study|Withdrawal by Subject|1
840888|NCT01733758|2767992|P1|Overall Study|Withdrawal by Subject|1
840889|NCT01733758|2767989|P4|Overall Study|Adverse Event|1
840890|NCT01733758|2767990|P3|Overall Study|Adverse Event|8
840891|NCT01733758|2767991|P2|Overall Study|Adverse Event|7
840892|NCT01733758|2767992|P1|Overall Study|Adverse Event|5
840893|NCT01733732|2768058|P2|Overall Study|Did not attend all study visits|0
840894|NCT01733732|2768059|P1|Overall Study|Did not attend all study visits|1
840895|NCT01733732|2768058|P2|Overall Study|Adverse Event|0
840896|NCT01733732|2768059|P1|Overall Study|Adverse Event|1
840897|NCT01733680|2768095|P2|Overall Study|Withdrawal by Subject|1
840898|NCT01733680|2768096|P1|Overall Study|Withdrawal by Subject|0
840899|NCT01733329|2768135|P2|Overall Study|Uterine artery injury|0
840900|NCT01733329|2768136|P1|Overall Study|Uterine artery injury|1
840901|NCT01733329|2768135|P2|Overall Study|Protocol Violation|1
840902|NCT01733329|2768136|P1|Overall Study|Protocol Violation|1
840903|NCT01733316|2768148|P1|Long Term Extension Phase|Sponsor Decision|2
840904|NCT01733316|2768148|P1|Long Term Extension Phase|Consent Withdrawn by Subject|2
840905|NCT01733316|2768148|P1|Long Term Extension Phase|Adverse Event|1
840906|NCT01733316|2768148|P1|RP103 Phase|Non-compliance|1
840907|NCT01733121|2768186|P2|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
840908|NCT01733121|2768187|P1|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
840909|NCT01733121|2768186|P2|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3
840910|NCT01733121|2768187|P1|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
840911|NCT01733121|2768186|P2|Double-Blind Period (Week 0 to 6)|Non-compliance|2
840912|NCT01733121|2768187|P1|Double-Blind Period (Week 0 to 6)|Non-compliance|3
840913|NCT01733121|2768186|P2|Double-Blind Period (Week 0 to 6)|Adverse Event|0
840914|NCT01733121|2768187|P1|Double-Blind Period (Week 0 to 6)|Adverse Event|2
840915|NCT01732926|2768229|P2|Overall Study|Blind Broken by Subject or Study Site|1
840916|NCT01732926|2768230|P1|Overall Study|Blind Broken by Subject or Study Site|1
840917|NCT01732926|2768229|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|6
840918|NCT01732926|2768230|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|7
840919|NCT01732926|2768229|P2|Overall Study|Other Reason|4
840920|NCT01732926|2768230|P1|Overall Study|Other Reason|21
840921|NCT01732926|2768229|P2|Overall Study|Physician Decision|11
840922|NCT01732926|2768230|P1|Overall Study|Physician Decision|24
840923|NCT01732926|2768229|P2|Overall Study|Withdrawal by Subject|8
840924|NCT01732926|2768230|P1|Overall Study|Withdrawal by Subject|46
840925|NCT01732926|2768229|P2|Overall Study|Study Terminated by Sponsor|80
840926|NCT01732926|2768230|P1|Overall Study|Study Terminated by Sponsor|168
840927|NCT01732913|2768246|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|2
840928|NCT01732913|2768247|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|3
840929|NCT01732913|2768246|P2|Overall Study|Other|1
840930|NCT01732913|2768247|P1|Overall Study|Other|7
840931|NCT01732913|2768246|P2|Overall Study|Physician Decision|7
840932|NCT01732913|2768247|P1|Overall Study|Physician Decision|14
840933|NCT01732913|2768246|P2|Overall Study|Withdrawal by Subject|4
840934|NCT01732913|2768247|P1|Overall Study|Withdrawal by Subject|27
840935|NCT01732913|2768246|P2|Overall Study|Study Terminated by Sponsor|55
840936|NCT01732913|2768247|P1|Overall Study|Study Terminated by Sponsor|105
840937|NCT01732835|2768261|P1|2-year Extended Follow-up|Death|1
840938|NCT01732835|2768261|P1|2-year Extended Follow-up|Adverse Event|3
840939|NCT01732835|2768261|P1|2-year Extended Follow-up|Withdrawal by Subject|1
840940|NCT01732835|2768261|P1|6-month Primary Endpoint|Adverse Event|3
840941|NCT01732835|2768261|P1|6-month Primary Endpoint|Withdrawal by Subject|2
840942|NCT01732835|2768261|P1|6-month Primary Endpoint|Did not receive device|19
840943|NCT01732822|2768294|P2|Overall Study|Withdrawal by Subject|113
840944|NCT01732822|2768295|P1|Overall Study|Withdrawal by Subject|123
840945|NCT01732796|2768368|P3|Overall Study|Other reason not defined above|2
840946|NCT01732796|2768369|P2|Overall Study|Other reason not defined above|0
840947|NCT01732796|2768370|P1|Overall Study|Other reason not defined above|1
840948|NCT01732796|2768368|P3|Overall Study|Withdrawal by Subject|2
840949|NCT01732796|2768369|P2|Overall Study|Withdrawal by Subject|8
840950|NCT01732796|2768370|P1|Overall Study|Withdrawal by Subject|6
840951|NCT01732796|2768368|P3|Overall Study|Lost to Follow-up|0
840952|NCT01732796|2768369|P2|Overall Study|Lost to Follow-up|0
840953|NCT01732796|2768370|P1|Overall Study|Lost to Follow-up|2
840954|NCT01732796|2768368|P3|Overall Study|Lack of Efficacy|5
840955|NCT01732796|2768369|P2|Overall Study|Lack of Efficacy|18
840956|NCT01732796|2768370|P1|Overall Study|Lack of Efficacy|21
840957|NCT01732796|2768368|P3|Overall Study|Adverse Event|4
840958|NCT01732796|2768369|P2|Overall Study|Adverse Event|16
840959|NCT01732796|2768370|P1|Overall Study|Adverse Event|16
840960|NCT01732783|2768389|P3|Overall Study|Withdrawal by Subject|0
840961|NCT01732783|2768390|P2|Overall Study|Withdrawal by Subject|0
840962|NCT01732783|2768391|P1|Overall Study|Withdrawal by Subject|1
840963|NCT01732783|2768389|P3|Overall Study|Administrative Decision|1
840964|NCT01732783|2768390|P2|Overall Study|Administrative Decision|2
840965|NCT01732783|2768391|P1|Overall Study|Administrative Decision|8
840966|NCT01732783|2768389|P3|Overall Study|Lost to Follow-up|1
840967|NCT01732783|2768390|P2|Overall Study|Lost to Follow-up|1
840968|NCT01732783|2768391|P1|Overall Study|Lost to Follow-up|7
840969|NCT01732783|2768389|P3|Overall Study|Death|1
840970|NCT01732783|2768390|P2|Overall Study|Death|4
840971|NCT01732783|2768391|P1|Overall Study|Death|13
840972|NCT01732783|2768389|P3|Overall Study|Discontinued Panitumumab Treatment|7
840973|NCT01732783|2768390|P2|Overall Study|Discontinued Panitumumab Treatment|25
840974|NCT01732783|2768391|P1|Overall Study|Discontinued Panitumumab Treatment|106
840975|NCT01732770|2768455|P2|Overall Study|Death|0
840976|NCT01732770|2768456|P1|Overall Study|Death|1
840977|NCT01732770|2768455|P2|Overall Study|Decision by Sponsor|2
840978|NCT01732770|2768456|P1|Overall Study|Decision by Sponsor|2
840979|NCT01732770|2768455|P2|Overall Study|Withdrawal by Subject|3
840980|NCT01732770|2768456|P1|Overall Study|Withdrawal by Subject|5
840981|NCT01732770|2768455|P2|Overall Study|Lost to Follow-up|3
840982|NCT01732770|2768456|P1|Overall Study|Lost to Follow-up|2
840983|NCT01732757|2768471|P3|Overall Study|Lost to Follow-up|0
840984|NCT01732757|2768472|P2|Overall Study|Lost to Follow-up|0
840985|NCT01732757|2768473|P1|Overall Study|Lost to Follow-up|1
840986|NCT01732692|2768513|P2|Overall Study|Adverse Event|1
840987|NCT01732692|2768514|P1|Overall Study|Adverse Event|0
840988|NCT01732640|2768528|P2|Overall Study|Death|1
840989|NCT01732640|2768529|P1|Overall Study|Death|0
840990|NCT01732640|2768528|P2|Overall Study|Adverse Event|1
840991|NCT01732640|2768529|P1|Overall Study|Adverse Event|0
840992|NCT01732588|2768547|P3|First Intervention (7 Days)|Adverse Event|0
840993|NCT01732588|2768548|P2|First Intervention (7 Days)|Adverse Event|1
840994|NCT01732588|2768549|P1|First Intervention (7 Days)|Adverse Event|0
840995|NCT01732549|2768565|P2|Overall Study|Not Specified|14
840996|NCT01732549|2768566|P1|Overall Study|Not Specified|8
840997|NCT01732549|2768565|P2|Overall Study|Disease progression|50
840998|NCT01732549|2768566|P1|Overall Study|Disease progression|37
840999|NCT01732549|2768565|P2|Overall Study|Consent withdrawn|6
841000|NCT01732549|2768566|P1|Overall Study|Consent withdrawn|13
841001|NCT01732549|2768565|P2|Overall Study|Adverse Event|3
841002|NCT01732549|2768566|P1|Overall Study|Adverse Event|13
841003|NCT01732536|2768588|P2|Overall Study|Withdrawal by Subject|1
841004|NCT01732536|2768589|P1|Overall Study|Withdrawal by Subject|1
841005|NCT01732510|2768612|P7|Overall Study|Study Terminated By Sponsor|6
841006|NCT01732510|2768613|P6|Overall Study|Study Terminated By Sponsor|12
841007|NCT01732510|2768614|P5|Overall Study|Study Terminated By Sponsor|0
841008|NCT01732510|2768615|P4|Overall Study|Study Terminated By Sponsor|1
841009|NCT01732510|2768616|P3|Overall Study|Study Terminated By Sponsor|0
841010|NCT01732510|2768617|P2|Overall Study|Study Terminated By Sponsor|0
841011|NCT01732510|2768618|P1|Overall Study|Study Terminated By Sponsor|0
841012|NCT01732510|2768612|P7|Overall Study|Pregnancy|0
841013|NCT01732510|2768613|P6|Overall Study|Pregnancy|0
841014|NCT01732510|2768614|P5|Overall Study|Pregnancy|0
841015|NCT01732510|2768615|P4|Overall Study|Pregnancy|1
841016|NCT01732510|2768616|P3|Overall Study|Pregnancy|0
841017|NCT01732510|2768617|P2|Overall Study|Pregnancy|0
841018|NCT01732510|2768618|P1|Overall Study|Pregnancy|0
841019|NCT01732510|2768612|P7|Overall Study|Physician Decision|0
841020|NCT01732510|2768613|P6|Overall Study|Physician Decision|0
841021|NCT01732510|2768614|P5|Overall Study|Physician Decision|0
841022|NCT01732510|2768615|P4|Overall Study|Physician Decision|0
841023|NCT01732510|2768616|P3|Overall Study|Physician Decision|0
841024|NCT01732510|2768617|P2|Overall Study|Physician Decision|1
841025|NCT01732510|2768618|P1|Overall Study|Physician Decision|0
841026|NCT01732510|2768612|P7|Overall Study|Lost to Follow-up|0
841027|NCT01732510|2768613|P6|Overall Study|Lost to Follow-up|1
841028|NCT01732510|2768614|P5|Overall Study|Lost to Follow-up|0
841029|NCT01732510|2768615|P4|Overall Study|Lost to Follow-up|1
841030|NCT01732510|2768616|P3|Overall Study|Lost to Follow-up|1
841031|NCT01732510|2768617|P2|Overall Study|Lost to Follow-up|0
841032|NCT01732510|2768618|P1|Overall Study|Lost to Follow-up|0
841033|NCT01732510|2768612|P7|Overall Study|Withdrawal by Subject|1
841034|NCT01732510|2768613|P6|Overall Study|Withdrawal by Subject|0
841035|NCT01732510|2768614|P5|Overall Study|Withdrawal by Subject|5
841036|NCT01732510|2768615|P4|Overall Study|Withdrawal by Subject|1
841037|NCT01732510|2768616|P3|Overall Study|Withdrawal by Subject|2
841038|NCT01732510|2768617|P2|Overall Study|Withdrawal by Subject|3
841039|NCT01732510|2768618|P1|Overall Study|Withdrawal by Subject|1
841040|NCT01732510|2768612|P7|Overall Study|Protocol Violation|0
841041|NCT01732510|2768613|P6|Overall Study|Protocol Violation|0
841042|NCT01732510|2768614|P5|Overall Study|Protocol Violation|0
841043|NCT01732510|2768615|P4|Overall Study|Protocol Violation|1
841044|NCT01732510|2768616|P3|Overall Study|Protocol Violation|0
841045|NCT01732510|2768617|P2|Overall Study|Protocol Violation|0
841046|NCT01732510|2768618|P1|Overall Study|Protocol Violation|0
841047|NCT01732510|2768612|P7|Overall Study|Adverse Event|1
841048|NCT01732510|2768613|P6|Overall Study|Adverse Event|0
841049|NCT01732510|2768614|P5|Overall Study|Adverse Event|0
841050|NCT01732510|2768615|P4|Overall Study|Adverse Event|0
841051|NCT01732510|2768616|P3|Overall Study|Adverse Event|1
841052|NCT01732510|2768617|P2|Overall Study|Adverse Event|1
841053|NCT01732510|2768618|P1|Overall Study|Adverse Event|0
841054|NCT01732484|2768697|P1|Overall Study|chronical illness|5
841055|NCT01732484|2768697|P1|Overall Study|Lost to Follow-up|14
841056|NCT01732484|2768697|P1|Overall Study|Death|7
841057|NCT01732471|2768705|P1|Overall Study|Withdrawal by Subject|1
841058|NCT01732458|2768716|P4|Overall Study|Screen Failure|0
841059|NCT01732458|2768717|P3|Overall Study|Screen Failure|0
841060|NCT01732458|2768718|P2|Overall Study|Screen Failure|1
841061|NCT01732458|2768719|P1|Overall Study|Screen Failure|0
841062|NCT01732458|2768716|P4|Overall Study|Protocol Violation|2
841063|NCT01732458|2768717|P3|Overall Study|Protocol Violation|0
841064|NCT01732458|2768718|P2|Overall Study|Protocol Violation|0
841065|NCT01732458|2768719|P1|Overall Study|Protocol Violation|2
841066|NCT01732458|2768716|P4|Overall Study|Physician Decision|0
841067|NCT01732458|2768717|P3|Overall Study|Physician Decision|2
841068|NCT01732458|2768718|P2|Overall Study|Physician Decision|2
841069|NCT01732458|2768719|P1|Overall Study|Physician Decision|1
841070|NCT01732458|2768716|P4|Overall Study|Non-Compliance With Study Drug|0
841071|NCT01732458|2768717|P3|Overall Study|Non-Compliance With Study Drug|1
841072|NCT01732458|2768718|P2|Overall Study|Non-Compliance With Study Drug|0
841073|NCT01732458|2768719|P1|Overall Study|Non-Compliance With Study Drug|0
841074|NCT01732458|2768716|P4|Overall Study|Lost to Follow-up|0
841075|NCT01732458|2768717|P3|Overall Study|Lost to Follow-up|0
841076|NCT01732458|2768718|P2|Overall Study|Lost to Follow-up|2
841077|NCT01732458|2768719|P1|Overall Study|Lost to Follow-up|0
841078|NCT01732107|2768831|P1|Overall Study|Withdrawal by Subject|2
841079|NCT01732107|2768831|P1|Overall Study|Physician Decision|1
841080|NCT01732107|2768831|P1|Overall Study|Disease Progression|8
841081|NCT01732107|2768831|P1|Overall Study|Adverse Event|2
841082|NCT01731990|2768848|P2|Overall Study|Death|0
841083|NCT01731990|2768849|P1|Overall Study|Death|1
841084|NCT01731990|2768848|P2|Overall Study|Protocol deviation|2
841085|NCT01731990|2768849|P1|Overall Study|Protocol deviation|1
841086|NCT01731990|2768848|P2|Overall Study|Withdrawal by Subject|1
841087|NCT01731990|2768849|P1|Overall Study|Withdrawal by Subject|1
841088|NCT01731990|2768848|P2|Overall Study|Adverse Event|5
841089|NCT01731990|2768849|P1|Overall Study|Adverse Event|1
841090|NCT01731938|2768865|P2|Primary Part II|Missed Week 6 visit|3
841091|NCT01731938|2768866|P1|Primary Part II|Missed Week 6 visit|2
841092|NCT01731938|2768865|P2|Primary Part II|Death|1
841093|NCT01731938|2768866|P1|Primary Part II|Death|2
841094|NCT01731938|2768865|P2|Primary Part II|Lost to Follow-up|5
841095|NCT01731938|2768866|P1|Primary Part II|Lost to Follow-up|4
841096|NCT01731938|2768865|P2|Primary Part II|Withdrawal by Subject|4
841097|NCT01731938|2768866|P1|Primary Part II|Withdrawal by Subject|5
841098|NCT01731938|2768865|P2|Preliminary Part I|Missed Week 6 visit|3
841099|NCT01731938|2768866|P1|Preliminary Part I|Missed Week 6 visit|0
841100|NCT01731938|2768865|P2|Preliminary Part I|Lost to Follow-up|3
841101|NCT01731938|2768866|P1|Preliminary Part I|Lost to Follow-up|0
841102|NCT01731938|2768865|P2|Preliminary Part I|Physician Decision|0
841103|NCT01731938|2768866|P1|Preliminary Part I|Physician Decision|1
841104|NCT01731938|2768865|P2|Preliminary Part I|Withdrawal by Subject|2
841105|NCT01731938|2768866|P1|Preliminary Part I|Withdrawal by Subject|2
841106|NCT01731470|2768878|P1|Overall Study|Did not meet study criteria|1
841107|NCT01731470|2768878|P1|Overall Study|Withdrawal by Subject|1
841108|NCT01731002|2768905|P3|Overall Study|Inappropriate use of study medications|1
841109|NCT01731002|2768906|P2|Overall Study|Inappropriate use of study medications|0
841110|NCT01731002|2768907|P1|Overall Study|Inappropriate use of study medications|0
841111|NCT01731002|2768905|P3|Overall Study|Elevated IOP|0
841112|NCT01731002|2768906|P2|Overall Study|Elevated IOP|0
841113|NCT01731002|2768907|P1|Overall Study|Elevated IOP|1
841114|NCT01731002|2768905|P3|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
841115|NCT01731002|2768906|P2|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
841116|NCT01731002|2768907|P1|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2
841117|NCT01731002|2768905|P3|Overall Study|Test Agent Discontinuation|0
841118|NCT01731002|2768906|P2|Overall Study|Test Agent Discontinuation|1
841119|NCT01731002|2768907|P1|Overall Study|Test Agent Discontinuation|0
841120|NCT01731002|2768905|P3|Overall Study|Lost to Follow-up|0
841121|NCT01731002|2768906|P2|Overall Study|Lost to Follow-up|0
841122|NCT01731002|2768907|P1|Overall Study|Lost to Follow-up|1
841123|NCT01731002|2768905|P3|Overall Study|Non-Compliant|0
841124|NCT01731002|2768906|P2|Overall Study|Non-Compliant|1
841125|NCT01731002|2768907|P1|Overall Study|Non-Compliant|0
841126|NCT01731002|2768905|P3|Overall Study|Adverse Event|2
841127|NCT01731002|2768906|P2|Overall Study|Adverse Event|2
841128|NCT01731002|2768907|P1|Overall Study|Adverse Event|0
841129|NCT01730378|2768936|P2|Overall Study|Lost to Follow-up|0
841130|NCT01730378|2768937|P1|Overall Study|Lost to Follow-up|1
841131|NCT01730339|2768968|P2|Overall Study|Un-specified|0
841132|NCT01730339|2768969|P1|Overall Study|Un-specified|1
841133|NCT01730339|2768968|P2|Overall Study|Lost to Follow-up|1
841134|NCT01730339|2768969|P1|Overall Study|Lost to Follow-up|1
841135|NCT01730339|2768968|P2|Overall Study|Withdrawal by Subject|2
841136|NCT01730339|2768969|P1|Overall Study|Withdrawal by Subject|3
841137|NCT01730053|2769009|P6|Overall Study|Other than specified|9
841138|NCT01730053|2769010|P5|Overall Study|Other than specified|7
841139|NCT01730053|2769011|P4|Overall Study|Other than specified|4
841140|NCT01730053|2769012|P3|Overall Study|Other than specified|5
841141|NCT01730053|2769013|P2|Overall Study|Other than specified|6
841142|NCT01730053|2769014|P1|Overall Study|Other than specified|2
841143|NCT01730053|2769009|P6|Overall Study|Poor compliance to protocol|2
841144|NCT01730053|2769010|P5|Overall Study|Poor compliance to protocol|0
841145|NCT01730053|2769011|P4|Overall Study|Poor compliance to protocol|0
841146|NCT01730053|2769012|P3|Overall Study|Poor compliance to protocol|2
841147|NCT01730053|2769013|P2|Overall Study|Poor compliance to protocol|2
841148|NCT01730053|2769014|P1|Overall Study|Poor compliance to protocol|1
841149|NCT01730053|2769009|P6|Overall Study|Adverse Event|2
841150|NCT01730053|2769010|P5|Overall Study|Adverse Event|2
841151|NCT01730053|2769011|P4|Overall Study|Adverse Event|3
841152|NCT01730053|2769012|P3|Overall Study|Adverse Event|3
841153|NCT01730053|2769013|P2|Overall Study|Adverse Event|6
841154|NCT01730053|2769014|P1|Overall Study|Adverse Event|2
841155|NCT01730053|2769009|P6|Overall Study|Physician Decision|0
841156|NCT01730053|2769010|P5|Overall Study|Physician Decision|0
841157|NCT01730053|2769011|P4|Overall Study|Physician Decision|1
841158|NCT01730053|2769012|P3|Overall Study|Physician Decision|0
841159|NCT01730053|2769013|P2|Overall Study|Physician Decision|0
841160|NCT01730053|2769014|P1|Overall Study|Physician Decision|0
841161|NCT01730053|2769009|P6|Overall Study|Participant moved|0
841162|NCT01730053|2769010|P5|Overall Study|Participant moved|0
841163|NCT01730053|2769011|P4|Overall Study|Participant moved|0
841164|NCT01730053|2769012|P3|Overall Study|Participant moved|1
841165|NCT01730053|2769013|P2|Overall Study|Participant moved|0
841166|NCT01730053|2769014|P1|Overall Study|Participant moved|0
841167|NCT01730040|2769173|P7|Overall Study|Poor compliance to protocol|1
841168|NCT01730040|2769174|P6|Overall Study|Poor compliance to protocol|0
841169|NCT01730040|2769175|P5|Overall Study|Poor compliance to protocol|0
841170|NCT01730040|2769176|P4|Overall Study|Poor compliance to protocol|0
841171|NCT01730040|2769177|P3|Overall Study|Poor compliance to protocol|0
841172|NCT01730040|2769178|P2|Overall Study|Poor compliance to protocol|4
841173|NCT01730040|2769179|P1|Overall Study|Poor compliance to protocol|2
841174|NCT01730040|2769173|P7|Overall Study|Adverse Event|2
841175|NCT01730040|2769174|P6|Overall Study|Adverse Event|1
841176|NCT01730040|2769175|P5|Overall Study|Adverse Event|1
841177|NCT01730040|2769176|P4|Overall Study|Adverse Event|3
841178|NCT01730040|2769177|P3|Overall Study|Adverse Event|5
841179|NCT01730040|2769178|P2|Overall Study|Adverse Event|3
841180|NCT01730040|2769179|P1|Overall Study|Adverse Event|4
841181|NCT01730040|2769173|P7|Overall Study|Other than specified|4
841182|NCT01730040|2769174|P6|Overall Study|Other than specified|4
841183|NCT01730040|2769175|P5|Overall Study|Other than specified|5
841184|NCT01730040|2769176|P4|Overall Study|Other than specified|5
841185|NCT01730040|2769177|P3|Overall Study|Other than specified|5
841186|NCT01730040|2769178|P2|Overall Study|Other than specified|8
841187|NCT01730040|2769179|P1|Overall Study|Other than specified|7
841188|NCT01730040|2769173|P7|Overall Study|Physician Decision|1
841189|NCT01730040|2769174|P6|Overall Study|Physician Decision|1
841190|NCT01730040|2769175|P5|Overall Study|Physician Decision|0
841191|NCT01730040|2769176|P4|Overall Study|Physician Decision|0
841192|NCT01730040|2769177|P3|Overall Study|Physician Decision|0
841193|NCT01730040|2769178|P2|Overall Study|Physician Decision|0
841194|NCT01730040|2769179|P1|Overall Study|Physician Decision|0
841195|NCT01730040|2769173|P7|Overall Study|Subject moved|1
841196|NCT01730040|2769174|P6|Overall Study|Subject moved|0
841197|NCT01730040|2769175|P5|Overall Study|Subject moved|0
841198|NCT01730040|2769176|P4|Overall Study|Subject moved|0
841199|NCT01730040|2769177|P3|Overall Study|Subject moved|1
841200|NCT01730040|2769178|P2|Overall Study|Subject moved|0
841201|NCT01730040|2769179|P1|Overall Study|Subject moved|0
841202|NCT01730040|2769173|P7|Overall Study|Randomized but not treated|0
841203|NCT01730040|2769174|P6|Overall Study|Randomized but not treated|1
841204|NCT01730040|2769175|P5|Overall Study|Randomized but not treated|0
841205|NCT01730040|2769176|P4|Overall Study|Randomized but not treated|0
841206|NCT01730040|2769177|P3|Overall Study|Randomized but not treated|0
841207|NCT01730040|2769178|P2|Overall Study|Randomized but not treated|0
841208|NCT01730040|2769179|P1|Overall Study|Randomized but not treated|0
841209|NCT01729871|2769368|P2|Overall Study|Other|9
841210|NCT01729871|2769369|P1|Overall Study|Other|4
841211|NCT01729871|2769368|P2|Overall Study|Withdrawal by Subject|3
841212|NCT01729871|2769369|P1|Overall Study|Withdrawal by Subject|0
841213|NCT01729871|2769368|P2|Overall Study|Protocol Violation|0
841214|NCT01729871|2769369|P1|Overall Study|Protocol Violation|1
841215|NCT01729871|2769368|P2|Overall Study|Physician Decision|2
841216|NCT01729871|2769369|P1|Overall Study|Physician Decision|0
841217|NCT01729871|2769368|P2|Overall Study|Lack of Efficacy|1
841218|NCT01729871|2769369|P1|Overall Study|Lack of Efficacy|0
841219|NCT01729871|2769368|P2|Overall Study|Death|1
841220|NCT01729871|2769369|P1|Overall Study|Death|0
841221|NCT01729871|2769368|P2|Overall Study|Adverse Event|7
841222|NCT01729871|2769369|P1|Overall Study|Adverse Event|7
841223|NCT01729819|2769403|P2|Overall Study|Withdrawal by Subject|2
841224|NCT01729819|2769404|P1|Overall Study|Withdrawal by Subject|0
841225|NCT01729819|2769403|P2|Overall Study|Protocol Violation|1
841226|NCT01729819|2769404|P1|Overall Study|Protocol Violation|0
841227|NCT01729819|2769403|P2|Overall Study|Other reason|0
841228|NCT01729819|2769404|P1|Overall Study|Other reason|1
841229|NCT01729819|2769403|P2|Overall Study|Lost to Follow-up|0
841230|NCT01729819|2769404|P1|Overall Study|Lost to Follow-up|2
841231|NCT01729819|2769403|P2|Overall Study|Lack of Efficacy|0
841232|NCT01729819|2769404|P1|Overall Study|Lack of Efficacy|1
841233|NCT01729819|2769403|P2|Overall Study|Adverse Event|4
841234|NCT01729819|2769404|P1|Overall Study|Adverse Event|2
841235|NCT01729754|2769423|P10|Part 3|Other Protocol Specified Criteria|0
841236|NCT01729754|2769424|P9|Part 3|Other Protocol Specified Criteria|0
841237|NCT01729754|2769425|P8|Part 3|Other Protocol Specified Criteria|1
841238|NCT01729754|2769426|P7|Part 3|Other Protocol Specified Criteria|0
841239|NCT01729754|2769427|P6|Part 3|Other Protocol Specified Criteria|2
841240|NCT01729754|2769428|P5|Part 3|Other Protocol Specified Criteria|0
841241|NCT01729754|2769429|P4|Part 3|Other Protocol Specified Criteria|0
841242|NCT01729754|2769430|P3|Part 3|Other Protocol Specified Criteria|0
841243|NCT01729754|2769431|P2|Part 3|Other Protocol Specified Criteria|0
841244|NCT01729754|2769432|P1|Part 3|Other Protocol Specified Criteria|0
841245|NCT01729754|2769423|P10|Part 3|Withdrawal by Subject|0
841246|NCT01729754|2769424|P9|Part 3|Withdrawal by Subject|0
841247|NCT01729754|2769425|P8|Part 3|Withdrawal by Subject|2
841248|NCT01729754|2769426|P7|Part 3|Withdrawal by Subject|0
841249|NCT01729754|2769427|P6|Part 3|Withdrawal by Subject|1
841250|NCT01729754|2769428|P5|Part 3|Withdrawal by Subject|2
841251|NCT01729754|2769429|P4|Part 3|Withdrawal by Subject|0
841252|NCT01729754|2769430|P3|Part 3|Withdrawal by Subject|1
841253|NCT01729754|2769431|P2|Part 3|Withdrawal by Subject|4
841254|NCT01729754|2769432|P1|Part 3|Withdrawal by Subject|0
841255|NCT01729754|2769423|P10|Part 3|Physician Decision|0
841256|NCT01729754|2769424|P9|Part 3|Physician Decision|0
841257|NCT01729754|2769425|P8|Part 3|Physician Decision|0
841258|NCT01729754|2769426|P7|Part 3|Physician Decision|0
841259|NCT01729754|2769427|P6|Part 3|Physician Decision|0
841260|NCT01729754|2769428|P5|Part 3|Physician Decision|0
841261|NCT01729754|2769429|P4|Part 3|Physician Decision|0
841262|NCT01729754|2769430|P3|Part 3|Physician Decision|1
841263|NCT01729754|2769431|P2|Part 3|Physician Decision|0
841264|NCT01729754|2769432|P1|Part 3|Physician Decision|0
841265|NCT01729754|2769423|P10|Part 3|Lost to Follow-up|0
841266|NCT01729754|2769424|P9|Part 3|Lost to Follow-up|1
841267|NCT01729754|2769425|P8|Part 3|Lost to Follow-up|0
841268|NCT01729754|2769426|P7|Part 3|Lost to Follow-up|0
841269|NCT01729754|2769427|P6|Part 3|Lost to Follow-up|3
841270|NCT01729754|2769428|P5|Part 3|Lost to Follow-up|0
841271|NCT01729754|2769429|P4|Part 3|Lost to Follow-up|0
841272|NCT01729754|2769430|P3|Part 3|Lost to Follow-up|2
841273|NCT01729754|2769431|P2|Part 3|Lost to Follow-up|1
841274|NCT01729754|2769432|P1|Part 3|Lost to Follow-up|0
841275|NCT01729754|2769423|P10|Part 3|Lack of Efficacy|4
841276|NCT01729754|2769424|P9|Part 3|Lack of Efficacy|0
841277|NCT01729754|2769425|P8|Part 3|Lack of Efficacy|0
841278|NCT01729754|2769426|P7|Part 3|Lack of Efficacy|0
841279|NCT01729754|2769427|P6|Part 3|Lack of Efficacy|0
841280|NCT01729754|2769428|P5|Part 3|Lack of Efficacy|2
841281|NCT01729754|2769429|P4|Part 3|Lack of Efficacy|0
841282|NCT01729754|2769430|P3|Part 3|Lack of Efficacy|0
841283|NCT01729754|2769431|P2|Part 3|Lack of Efficacy|0
841284|NCT01729754|2769432|P1|Part 3|Lack of Efficacy|0
841285|NCT01729754|2769423|P10|Part 3|Death|0
841286|NCT01729754|2769424|P9|Part 3|Death|0
841287|NCT01729754|2769425|P8|Part 3|Death|0
841288|NCT01729754|2769426|P7|Part 3|Death|0
841289|NCT01729754|2769427|P6|Part 3|Death|2
841290|NCT01729754|2769428|P5|Part 3|Death|0
841291|NCT01729754|2769429|P4|Part 3|Death|0
841292|NCT01729754|2769430|P3|Part 3|Death|0
841293|NCT01729754|2769431|P2|Part 3|Death|0
841294|NCT01729754|2769432|P1|Part 3|Death|0
841295|NCT01729754|2769423|P10|Part 3|Adverse Event|3
841296|NCT01729754|2769424|P9|Part 3|Adverse Event|0
841297|NCT01729754|2769425|P8|Part 3|Adverse Event|0
841298|NCT01729754|2769426|P7|Part 3|Adverse Event|0
841299|NCT01729754|2769427|P6|Part 3|Adverse Event|5
841300|NCT01729754|2769428|P5|Part 3|Adverse Event|0
841301|NCT01729754|2769429|P4|Part 3|Adverse Event|0
841302|NCT01729754|2769430|P3|Part 3|Adverse Event|1
841303|NCT01729754|2769431|P2|Part 3|Adverse Event|0
841304|NCT01729754|2769432|P1|Part 3|Adverse Event|0
841305|NCT01729754|2769423|P10|Part 2|Other Protocol Specified Criteria|0
841306|NCT01729754|2769424|P9|Part 2|Other Protocol Specified Criteria|0
841307|NCT01729754|2769425|P8|Part 2|Other Protocol Specified Criteria|1
841308|NCT01729754|2769426|P7|Part 2|Other Protocol Specified Criteria|0
841309|NCT01729754|2769427|P6|Part 2|Other Protocol Specified Criteria|0
841310|NCT01729754|2769428|P5|Part 2|Other Protocol Specified Criteria|0
841311|NCT01729754|2769429|P4|Part 2|Other Protocol Specified Criteria|0
841312|NCT01729754|2769430|P3|Part 2|Other Protocol Specified Criteria|0
841313|NCT01729754|2769431|P2|Part 2|Other Protocol Specified Criteria|0
841314|NCT01729754|2769432|P1|Part 2|Other Protocol Specified Criteria|1
841315|NCT01729754|2769423|P10|Part 2|Withdrawal by Subject|4
841316|NCT01729754|2769424|P9|Part 2|Withdrawal by Subject|1
841317|NCT01729754|2769425|P8|Part 2|Withdrawal by Subject|1
841318|NCT01729754|2769426|P7|Part 2|Withdrawal by Subject|0
841319|NCT01729754|2769427|P6|Part 2|Withdrawal by Subject|0
841320|NCT01729754|2769428|P5|Part 2|Withdrawal by Subject|0
841321|NCT01729754|2769429|P4|Part 2|Withdrawal by Subject|2
841322|NCT01729754|2769430|P3|Part 2|Withdrawal by Subject|0
841323|NCT01729754|2769431|P2|Part 2|Withdrawal by Subject|0
841324|NCT01729754|2769432|P1|Part 2|Withdrawal by Subject|3
841325|NCT01729754|2769423|P10|Part 2|Pregnancy|1
841326|NCT01729754|2769424|P9|Part 2|Pregnancy|0
841327|NCT01729754|2769425|P8|Part 2|Pregnancy|0
841328|NCT01729754|2769426|P7|Part 2|Pregnancy|0
841329|NCT01729754|2769427|P6|Part 2|Pregnancy|0
841330|NCT01729754|2769428|P5|Part 2|Pregnancy|0
841331|NCT01729754|2769429|P4|Part 2|Pregnancy|1
841332|NCT01729754|2769430|P3|Part 2|Pregnancy|0
841333|NCT01729754|2769431|P2|Part 2|Pregnancy|0
841334|NCT01729754|2769432|P1|Part 2|Pregnancy|0
841335|NCT01729754|2769423|P10|Part 2|Non-Compliance with Study Drug|1
841336|NCT01729754|2769424|P9|Part 2|Non-Compliance with Study Drug|0
841337|NCT01729754|2769425|P8|Part 2|Non-Compliance with Study Drug|0
841338|NCT01729754|2769426|P7|Part 2|Non-Compliance with Study Drug|0
841339|NCT01729754|2769427|P6|Part 2|Non-Compliance with Study Drug|0
841340|NCT01729754|2769428|P5|Part 2|Non-Compliance with Study Drug|0
841341|NCT01729754|2769429|P4|Part 2|Non-Compliance with Study Drug|0
841342|NCT01729754|2769430|P3|Part 2|Non-Compliance with Study Drug|0
841343|NCT01729754|2769431|P2|Part 2|Non-Compliance with Study Drug|0
841344|NCT01729754|2769432|P1|Part 2|Non-Compliance with Study Drug|0
841345|NCT01729754|2769423|P10|Part 2|Lost to Follow-up|2
841346|NCT01729754|2769424|P9|Part 2|Lost to Follow-up|0
841347|NCT01729754|2769425|P8|Part 2|Lost to Follow-up|1
841348|NCT01729754|2769426|P7|Part 2|Lost to Follow-up|0
841349|NCT01729754|2769427|P6|Part 2|Lost to Follow-up|0
841350|NCT01729754|2769428|P5|Part 2|Lost to Follow-up|0
841351|NCT01729754|2769429|P4|Part 2|Lost to Follow-up|2
841352|NCT01729754|2769430|P3|Part 2|Lost to Follow-up|0
841353|NCT01729754|2769431|P2|Part 2|Lost to Follow-up|0
841354|NCT01729754|2769432|P1|Part 2|Lost to Follow-up|0
841355|NCT01729754|2769423|P10|Part 2|Lack of Efficacy|2
841356|NCT01729754|2769424|P9|Part 2|Lack of Efficacy|2
841357|NCT01729754|2769425|P8|Part 2|Lack of Efficacy|0
841358|NCT01729754|2769426|P7|Part 2|Lack of Efficacy|0
841359|NCT01729754|2769427|P6|Part 2|Lack of Efficacy|0
841360|NCT01729754|2769428|P5|Part 2|Lack of Efficacy|0
841361|NCT01729754|2769429|P4|Part 2|Lack of Efficacy|0
841362|NCT01729754|2769430|P3|Part 2|Lack of Efficacy|0
841363|NCT01729754|2769431|P2|Part 2|Lack of Efficacy|0
841364|NCT01729754|2769432|P1|Part 2|Lack of Efficacy|0
841365|NCT01729754|2769423|P10|Part 2|Adverse Event|2
841366|NCT01729754|2769424|P9|Part 2|Adverse Event|1
841367|NCT01729754|2769425|P8|Part 2|Adverse Event|0
841368|NCT01729754|2769426|P7|Part 2|Adverse Event|0
841369|NCT01729754|2769427|P6|Part 2|Adverse Event|0
841370|NCT01729754|2769428|P5|Part 2|Adverse Event|0
841371|NCT01729754|2769429|P4|Part 2|Adverse Event|0
841372|NCT01729754|2769430|P3|Part 2|Adverse Event|0
841373|NCT01729754|2769431|P2|Part 2|Adverse Event|0
841374|NCT01729754|2769432|P1|Part 2|Adverse Event|2
841375|NCT01729754|2769423|P10|Part 1|Other Protocol Specified Criteria|4
841376|NCT01729754|2769424|P9|Part 1|Other Protocol Specified Criteria|0
841377|NCT01729754|2769425|P8|Part 1|Other Protocol Specified Criteria|0
841378|NCT01729754|2769426|P7|Part 1|Other Protocol Specified Criteria|1
841379|NCT01729754|2769427|P6|Part 1|Other Protocol Specified Criteria|0
841380|NCT01729754|2769428|P5|Part 1|Other Protocol Specified Criteria|0
841381|NCT01729754|2769429|P4|Part 1|Other Protocol Specified Criteria|0
841382|NCT01729754|2769430|P3|Part 1|Other Protocol Specified Criteria|0
841383|NCT01729754|2769431|P2|Part 1|Other Protocol Specified Criteria|0
841384|NCT01729754|2769432|P1|Part 1|Other Protocol Specified Criteria|2
841385|NCT01729754|2769423|P10|Part 1|Withdrawal by Subject|6
841386|NCT01729754|2769424|P9|Part 1|Withdrawal by Subject|0
841387|NCT01729754|2769425|P8|Part 1|Withdrawal by Subject|0
841388|NCT01729754|2769426|P7|Part 1|Withdrawal by Subject|5
841389|NCT01729754|2769427|P6|Part 1|Withdrawal by Subject|0
841390|NCT01729754|2769428|P5|Part 1|Withdrawal by Subject|0
841391|NCT01729754|2769429|P4|Part 1|Withdrawal by Subject|7
841392|NCT01729754|2769430|P3|Part 1|Withdrawal by Subject|0
841393|NCT01729754|2769431|P2|Part 1|Withdrawal by Subject|0
841394|NCT01729754|2769432|P1|Part 1|Withdrawal by Subject|5
841395|NCT01729754|2769423|P10|Part 1|Protocol Violation|0
841396|NCT01729754|2769424|P9|Part 1|Protocol Violation|0
841397|NCT01729754|2769425|P8|Part 1|Protocol Violation|0
841398|NCT01729754|2769426|P7|Part 1|Protocol Violation|1
841399|NCT01729754|2769427|P6|Part 1|Protocol Violation|0
841400|NCT01729754|2769428|P5|Part 1|Protocol Violation|0
841401|NCT01729754|2769429|P4|Part 1|Protocol Violation|1
841402|NCT01729754|2769430|P3|Part 1|Protocol Violation|0
841403|NCT01729754|2769431|P2|Part 1|Protocol Violation|0
841404|NCT01729754|2769432|P1|Part 1|Protocol Violation|2
841405|NCT01729754|2769423|P10|Part 1|Progressive Disease|1
841406|NCT01729754|2769424|P9|Part 1|Progressive Disease|0
841407|NCT01729754|2769425|P8|Part 1|Progressive Disease|0
841408|NCT01729754|2769426|P7|Part 1|Progressive Disease|0
841409|NCT01729754|2769427|P6|Part 1|Progressive Disease|0
841410|NCT01729754|2769428|P5|Part 1|Progressive Disease|0
841411|NCT01729754|2769429|P4|Part 1|Progressive Disease|0
841412|NCT01729754|2769430|P3|Part 1|Progressive Disease|0
841413|NCT01729754|2769431|P2|Part 1|Progressive Disease|0
841414|NCT01729754|2769432|P1|Part 1|Progressive Disease|0
841415|NCT01729754|2769423|P10|Part 1|Pregnancy|1
841416|NCT01729754|2769424|P9|Part 1|Pregnancy|0
841417|NCT01729754|2769425|P8|Part 1|Pregnancy|0
841418|NCT01729754|2769426|P7|Part 1|Pregnancy|0
841419|NCT01729754|2769427|P6|Part 1|Pregnancy|0
841420|NCT01729754|2769428|P5|Part 1|Pregnancy|0
841421|NCT01729754|2769429|P4|Part 1|Pregnancy|1
841422|NCT01729754|2769430|P3|Part 1|Pregnancy|0
841423|NCT01729754|2769431|P2|Part 1|Pregnancy|0
841424|NCT01729754|2769432|P1|Part 1|Pregnancy|0
841425|NCT01729754|2769423|P10|Part 1|Physician Decision|4
841426|NCT01729754|2769424|P9|Part 1|Physician Decision|0
841427|NCT01729754|2769425|P8|Part 1|Physician Decision|0
841428|NCT01729754|2769426|P7|Part 1|Physician Decision|0
841429|NCT01729754|2769427|P6|Part 1|Physician Decision|0
841430|NCT01729754|2769428|P5|Part 1|Physician Decision|0
841431|NCT01729754|2769429|P4|Part 1|Physician Decision|0
841432|NCT01729754|2769430|P3|Part 1|Physician Decision|0
841433|NCT01729754|2769431|P2|Part 1|Physician Decision|0
841434|NCT01729754|2769432|P1|Part 1|Physician Decision|0
841435|NCT01729754|2769423|P10|Part 1|Non-compliance with Study Drug|0
841436|NCT01729754|2769424|P9|Part 1|Non-compliance with Study Drug|0
841437|NCT01729754|2769425|P8|Part 1|Non-compliance with Study Drug|0
841438|NCT01729754|2769426|P7|Part 1|Non-compliance with Study Drug|0
841439|NCT01729754|2769427|P6|Part 1|Non-compliance with Study Drug|0
841440|NCT01729754|2769428|P5|Part 1|Non-compliance with Study Drug|0
841441|NCT01729754|2769429|P4|Part 1|Non-compliance with Study Drug|0
841442|NCT01729754|2769430|P3|Part 1|Non-compliance with Study Drug|0
841443|NCT01729754|2769431|P2|Part 1|Non-compliance with Study Drug|0
841444|NCT01729754|2769432|P1|Part 1|Non-compliance with Study Drug|1
841445|NCT01729754|2769423|P10|Part 1|Lost to Follow-up|3
841446|NCT01729754|2769424|P9|Part 1|Lost to Follow-up|0
841447|NCT01729754|2769425|P8|Part 1|Lost to Follow-up|0
841448|NCT01729754|2769426|P7|Part 1|Lost to Follow-up|3
841449|NCT01729754|2769427|P6|Part 1|Lost to Follow-up|0
841450|NCT01729754|2769428|P5|Part 1|Lost to Follow-up|0
841451|NCT01729754|2769429|P4|Part 1|Lost to Follow-up|2
841452|NCT01729754|2769430|P3|Part 1|Lost to Follow-up|0
841453|NCT01729754|2769431|P2|Part 1|Lost to Follow-up|0
841454|NCT01729754|2769432|P1|Part 1|Lost to Follow-up|1
841455|NCT01729754|2769423|P10|Part 1|Lack of Efficacy|0
841456|NCT01729754|2769424|P9|Part 1|Lack of Efficacy|0
841457|NCT01729754|2769425|P8|Part 1|Lack of Efficacy|0
841458|NCT01729754|2769426|P7|Part 1|Lack of Efficacy|2
841459|NCT01729754|2769427|P6|Part 1|Lack of Efficacy|0
841460|NCT01729754|2769428|P5|Part 1|Lack of Efficacy|0
841461|NCT01729754|2769429|P4|Part 1|Lack of Efficacy|0
841462|NCT01729754|2769430|P3|Part 1|Lack of Efficacy|0
841463|NCT01729754|2769431|P2|Part 1|Lack of Efficacy|0
841464|NCT01729754|2769432|P1|Part 1|Lack of Efficacy|1
841465|NCT01729754|2769423|P10|Part 1|Adverse Event|5
841466|NCT01729754|2769424|P9|Part 1|Adverse Event|0
841467|NCT01729754|2769425|P8|Part 1|Adverse Event|0
841468|NCT01729754|2769426|P7|Part 1|Adverse Event|2
841469|NCT01729754|2769427|P6|Part 1|Adverse Event|0
841470|NCT01729754|2769428|P5|Part 1|Adverse Event|0
841471|NCT01729754|2769429|P4|Part 1|Adverse Event|1
841472|NCT01729754|2769430|P3|Part 1|Adverse Event|0
841473|NCT01729754|2769431|P2|Part 1|Adverse Event|0
841474|NCT01729754|2769432|P1|Part 1|Adverse Event|2
841475|NCT01729728|2769639|P3|Overall Study|Protocol Violation|1
841476|NCT01729728|2769640|P2|Overall Study|Protocol Violation|0
841477|NCT01729728|2769641|P1|Overall Study|Protocol Violation|1
841478|NCT01729728|2769639|P3|Overall Study|Adverse Event|0
841479|NCT01729728|2769640|P2|Overall Study|Adverse Event|6
841480|NCT01729728|2769641|P1|Overall Study|Adverse Event|0
841481|NCT01729559|2769774|P2|Overall Study|Protocol Violation|28
841482|NCT01729559|2769775|P1|Overall Study|Protocol Violation|31
841483|NCT01729039|2769818|P2|Overall Study|Withdrawal by Subject|7
841484|NCT01729039|2769819|P1|Overall Study|Withdrawal by Subject|8
841485|NCT01729039|2769818|P2|Overall Study|disqualified|5
841486|NCT01729039|2769819|P1|Overall Study|disqualified|2
841487|NCT01729026|2769835|P2|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2
841488|NCT01729026|2769836|P1|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1
841489|NCT01729026|2769835|P2|Randomization to 3-month Follow-up|Lost to Follow-up|2
841490|NCT01729026|2769836|P1|Randomization to 3-month Follow-up|Lost to Follow-up|2
841491|NCT01728792|2769847|P5|Overall Study|Lost to Follow-up|0
841492|NCT01728792|2769848|P4|Overall Study|Lost to Follow-up|2
841493|NCT01728792|2769849|P3|Overall Study|Lost to Follow-up|4
841494|NCT01728792|2769850|P2|Overall Study|Lost to Follow-up|1
841495|NCT01728792|2769851|P1|Overall Study|Lost to Follow-up|2
841496|NCT01728792|2769847|P5|Overall Study|Withdrawal of Consent|0
841497|NCT01728792|2769848|P4|Overall Study|Withdrawal of Consent|1
841498|NCT01728792|2769849|P3|Overall Study|Withdrawal of Consent|0
841499|NCT01728792|2769850|P2|Overall Study|Withdrawal of Consent|1
841500|NCT01728792|2769851|P1|Overall Study|Withdrawal of Consent|1
841501|NCT01728584|2769902|P4|Overall Study|Other reason (not specified)|1
841502|NCT01728584|2769903|P3|Overall Study|Other reason (not specified)|0
841503|NCT01728584|2769904|P2|Overall Study|Other reason (not specified)|0
841504|NCT01728584|2769905|P1|Overall Study|Other reason (not specified)|1
841505|NCT01728584|2769902|P4|Overall Study|Screen failure|0
841506|NCT01728584|2769903|P3|Overall Study|Screen failure|0
841507|NCT01728584|2769904|P2|Overall Study|Screen failure|0
841508|NCT01728584|2769905|P1|Overall Study|Screen failure|1
841509|NCT01728584|2769902|P4|Overall Study|Withdrawal by Subject|0
841510|NCT01728584|2769903|P3|Overall Study|Withdrawal by Subject|0
841511|NCT01728584|2769904|P2|Overall Study|Withdrawal by Subject|0
841512|NCT01728584|2769905|P1|Overall Study|Withdrawal by Subject|1
841513|NCT01728584|2769902|P4|Overall Study|Physician Decision|0
841514|NCT01728584|2769903|P3|Overall Study|Physician Decision|1
841515|NCT01728584|2769904|P2|Overall Study|Physician Decision|0
841516|NCT01728584|2769905|P1|Overall Study|Physician Decision|4
841517|NCT01728584|2769902|P4|Overall Study|Adverse Event|0
841518|NCT01728584|2769903|P3|Overall Study|Adverse Event|0
841519|NCT01728584|2769904|P2|Overall Study|Adverse Event|0
841520|NCT01728584|2769905|P1|Overall Study|Adverse Event|1
841521|NCT01728376|2769963|P6|Overall Study|Subject/Parent/Legal Guardian Decision|1
841522|NCT01728376|2769964|P5|Overall Study|Subject/Parent/Legal Guardian Decision|0
841523|NCT01728376|2769965|P4|Overall Study|Subject/Parent/Legal Guardian Decision|1
841524|NCT01728376|2769966|P3|Overall Study|Subject/Parent/Legal Guardian Decision|0
841525|NCT01728376|2769967|P2|Overall Study|Subject/Parent/Legal Guardian Decision|0
841526|NCT01728376|2769968|P1|Overall Study|Subject/Parent/Legal Guardian Decision|0
841527|NCT01728376|2769963|P6|Overall Study|Did not receive treatment|0
841528|NCT01728376|2769964|P5|Overall Study|Did not receive treatment|0
841529|NCT01728376|2769965|P4|Overall Study|Did not receive treatment|0
841530|NCT01728376|2769966|P3|Overall Study|Did not receive treatment|0
841531|NCT01728376|2769967|P2|Overall Study|Did not receive treatment|1
841532|NCT01728376|2769968|P1|Overall Study|Did not receive treatment|0
841533|NCT01728376|2769963|P6|Overall Study|No relevant bacteria|1
841534|NCT01728376|2769964|P5|Overall Study|No relevant bacteria|1
841535|NCT01728376|2769965|P4|Overall Study|No relevant bacteria|0
841536|NCT01728376|2769966|P3|Overall Study|No relevant bacteria|0
841537|NCT01728376|2769967|P2|Overall Study|No relevant bacteria|0
841538|NCT01728376|2769968|P1|Overall Study|No relevant bacteria|2
841539|NCT01728376|2769963|P6|Overall Study|Persistent Positive Blood Cultures|0
841540|NCT01728376|2769964|P5|Overall Study|Persistent Positive Blood Cultures|0
841541|NCT01728376|2769965|P4|Overall Study|Persistent Positive Blood Cultures|0
841542|NCT01728376|2769966|P3|Overall Study|Persistent Positive Blood Cultures|1
841543|NCT01728376|2769967|P2|Overall Study|Persistent Positive Blood Cultures|0
841544|NCT01728376|2769968|P1|Overall Study|Persistent Positive Blood Cultures|1
841545|NCT01728376|2769963|P6|Overall Study|Adverse Event|0
841546|NCT01728376|2769964|P5|Overall Study|Adverse Event|1
841547|NCT01728376|2769965|P4|Overall Study|Adverse Event|1
841548|NCT01728376|2769966|P3|Overall Study|Adverse Event|1
841549|NCT01728376|2769967|P2|Overall Study|Adverse Event|1
841550|NCT01728376|2769968|P1|Overall Study|Adverse Event|1
841551|NCT01728324|2770041|P3|Termination of RBV|Protocol Violation (Placebo Period)|0
841552|NCT01728324|2770042|P2|Termination of RBV|Protocol Violation (Placebo Period)|1
841553|NCT01728324|2770043|P1|Termination of RBV|Protocol Violation (Placebo Period)|0
841554|NCT01728324|2770041|P3|Termination of RBV|Adverse Event (Placebo Period)|0
841555|NCT01728324|2770042|P2|Termination of RBV|Adverse Event (Placebo Period)|1
841556|NCT01728324|2770043|P1|Termination of RBV|Adverse Event (Placebo Period)|0
841557|NCT01728324|2770041|P3|Termination of RBV|Other than stated|1
841558|NCT01728324|2770042|P2|Termination of RBV|Other than stated|3
841559|NCT01728324|2770043|P1|Termination of RBV|Other than stated|1
841560|NCT01728324|2770041|P3|Termination of RBV|Withdrawal by Subject|2
841561|NCT01728324|2770042|P2|Termination of RBV|Withdrawal by Subject|5
841562|NCT01728324|2770043|P1|Termination of RBV|Withdrawal by Subject|9
841563|NCT01728324|2770041|P3|Termination of RBV|Lack of Efficacy|7
841564|NCT01728324|2770042|P2|Termination of RBV|Lack of Efficacy|11
841565|NCT01728324|2770043|P1|Termination of RBV|Lack of Efficacy|14
841566|NCT01728324|2770041|P3|Termination of RBV|Adverse Event|5
841567|NCT01728324|2770042|P2|Termination of RBV|Adverse Event|16
841568|NCT01728324|2770043|P1|Termination of RBV|Adverse Event|15
841569|NCT01728324|2770041|P3|Termination of FDV|Protocol Violation (Placebo Period)|0
841570|NCT01728324|2770042|P2|Termination of FDV|Protocol Violation (Placebo Period)|1
841571|NCT01728324|2770043|P1|Termination of FDV|Protocol Violation (Placebo Period)|0
841572|NCT01728324|2770041|P3|Termination of FDV|Adverse Event (Placebo Period)|0
841573|NCT01728324|2770042|P2|Termination of FDV|Adverse Event (Placebo Period)|1
841574|NCT01728324|2770043|P1|Termination of FDV|Adverse Event (Placebo Period)|0
841575|NCT01728324|2770041|P3|Termination of FDV|Other than stated|0
841576|NCT01728324|2770042|P2|Termination of FDV|Other than stated|3
841577|NCT01728324|2770043|P1|Termination of FDV|Other than stated|1
841578|NCT01728324|2770041|P3|Termination of FDV|Withdrawal by Subject|2
841579|NCT01728324|2770042|P2|Termination of FDV|Withdrawal by Subject|6
841580|NCT01728324|2770043|P1|Termination of FDV|Withdrawal by Subject|9
841581|NCT01728324|2770041|P3|Termination of FDV|Lack of Efficacy|8
841582|NCT01728324|2770042|P2|Termination of FDV|Lack of Efficacy|12
841583|NCT01728324|2770043|P1|Termination of FDV|Lack of Efficacy|14
841584|NCT01728324|2770041|P3|Termination of FDV|Adverse Event|4
841585|NCT01728324|2770042|P2|Termination of FDV|Adverse Event|13
841586|NCT01728324|2770043|P1|Termination of FDV|Adverse Event|14
841587|NCT01728324|2770041|P3|Termination of DBV|Protocol Violation (Placebo Period)|0
841588|NCT01728324|2770042|P2|Termination of DBV|Protocol Violation (Placebo Period)|1
841589|NCT01728324|2770043|P1|Termination of DBV|Protocol Violation (Placebo Period)|0
841590|NCT01728324|2770041|P3|Termination of DBV|Adverse Event (Placebo Period)|0
841591|NCT01728324|2770042|P2|Termination of DBV|Adverse Event (Placebo Period)|1
841592|NCT01728324|2770043|P1|Termination of DBV|Adverse Event (Placebo Period)|0
841593|NCT01728324|2770041|P3|Termination of DBV|Other than stated|0
841594|NCT01728324|2770042|P2|Termination of DBV|Other than stated|3
841595|NCT01728324|2770043|P1|Termination of DBV|Other than stated|1
841596|NCT01728324|2770041|P3|Termination of DBV|Withdrawal by Subject|2
841597|NCT01728324|2770042|P2|Termination of DBV|Withdrawal by Subject|6
841598|NCT01728324|2770043|P1|Termination of DBV|Withdrawal by Subject|9
841599|NCT01728324|2770041|P3|Termination of DBV|Lack of Efficacy|8
841600|NCT01728324|2770042|P2|Termination of DBV|Lack of Efficacy|12
841601|NCT01728324|2770043|P1|Termination of DBV|Lack of Efficacy|14
841602|NCT01728324|2770041|P3|Termination of DBV|Adverse Event|4
841603|NCT01728324|2770042|P2|Termination of DBV|Adverse Event|13
841604|NCT01728324|2770043|P1|Termination of DBV|Adverse Event|14
841605|NCT01728246|2770064|P2|Overall Study|Adverse Event|5
841606|NCT01728246|2770065|P1|Overall Study|Adverse Event|8
841607|NCT01728246|2770064|P2|Overall Study|Lack of Efficacy|1
841608|NCT01728246|2770065|P1|Overall Study|Lack of Efficacy|1
841609|NCT01728246|2770064|P2|Overall Study|Lost to Follow-up|22
841610|NCT01728246|2770065|P1|Overall Study|Lost to Follow-up|23
841611|NCT01728246|2770064|P2|Overall Study|Withdrawal by Subject|3
841612|NCT01728246|2770065|P1|Overall Study|Withdrawal by Subject|2
841613|NCT01728246|2770064|P2|Overall Study|Protocol Violation|0
841614|NCT01728246|2770065|P1|Overall Study|Protocol Violation|1
841615|NCT01728246|2770064|P2|Overall Study|Participant needed rescue medication|5
841616|NCT01728246|2770065|P1|Overall Study|Participant needed rescue medication|1
841617|NCT01728116|2770083|P2|Overall Study|various not noted previously|0
841618|NCT01728116|2770084|P1|Overall Study|various not noted previously|5
841619|NCT01728116|2770083|P2|Overall Study|Incorrectly enrolled in Study|1
841620|NCT01728116|2770084|P1|Overall Study|Incorrectly enrolled in Study|0
841621|NCT01728116|2770083|P2|Overall Study|Inter-current finding at procedure|0
841622|NCT01728116|2770084|P1|Overall Study|Inter-current finding at procedure|1
841623|NCT01728116|2770083|P2|Overall Study|Subject Non-Compliance|0
841624|NCT01728116|2770084|P1|Overall Study|Subject Non-Compliance|2
841625|NCT01728116|2770083|P2|Overall Study|Physician Decision|0
841626|NCT01728116|2770084|P1|Overall Study|Physician Decision|2
841627|NCT01728116|2770083|P2|Overall Study|Lost to Follow-up|2
841628|NCT01728116|2770084|P1|Overall Study|Lost to Follow-up|9
841629|NCT01728116|2770083|P2|Overall Study|Procedure/device failure|0
841630|NCT01728116|2770084|P1|Overall Study|Procedure/device failure|7
841631|NCT01728116|2770083|P2|Overall Study|Adverse Event|0
841632|NCT01728116|2770084|P1|Overall Study|Adverse Event|13
841633|NCT01728116|2770083|P2|Overall Study|Withdrawal by Subject|9
841634|NCT01728116|2770084|P1|Overall Study|Withdrawal by Subject|16
841635|NCT01728116|2770083|P2|Overall Study|Sponsor Terminated Study|35
841636|NCT01728116|2770084|P1|Overall Study|Sponsor Terminated Study|106
841637|NCT01728077|2770109|P2|Overall Study|Non compliance|0
841638|NCT01728077|2770110|P1|Overall Study|Non compliance|1
841639|NCT01728077|2770109|P2|Overall Study|Patient moving|0
841640|NCT01728077|2770110|P1|Overall Study|Patient moving|1
841641|NCT01728077|2770109|P2|Overall Study|Death|1
841642|NCT01728077|2770110|P1|Overall Study|Death|0
841643|NCT01728077|2770109|P2|Overall Study|Subject choice|3
841644|NCT01728077|2770110|P1|Overall Study|Subject choice|2
841645|NCT01728077|2770109|P2|Overall Study|Lost to Follow-up|0
841646|NCT01728077|2770110|P1|Overall Study|Lost to Follow-up|1
841647|NCT01728077|2770109|P2|Overall Study|Lack of Efficacy|1
841648|NCT01728077|2770110|P1|Overall Study|Lack of Efficacy|3
841649|NCT01727713|2770199|P1|Overall Study|Protocol Deviation|2
841650|NCT01727713|2770199|P1|Overall Study|Withdrawal by Subject|13
841651|NCT01727713|2770199|P1|Overall Study|Participant Met Withdrawal Criteria|5
841652|NCT01727713|2770199|P1|Overall Study|Adverse Event|10
841653|NCT01727713|2770199|P1|Overall Study|Lost to Follow-up|5
841654|NCT01727700|2770226|P3|Overall Study|Protocol Violation|0
841655|NCT01727700|2770227|P2|Overall Study|Protocol Violation|0
841656|NCT01727700|2770228|P1|Overall Study|Protocol Violation|2
841657|NCT01727700|2770226|P3|Overall Study|Particpant withdrew consent|1
841658|NCT01727700|2770227|P2|Overall Study|Particpant withdrew consent|3
841659|NCT01727700|2770228|P1|Overall Study|Particpant withdrew consent|0
841660|NCT01727700|2770226|P3|Overall Study|Adverse Event|1
841661|NCT01727700|2770227|P2|Overall Study|Adverse Event|7
841662|NCT01727700|2770228|P1|Overall Study|Adverse Event|0
841663|NCT01727505|2770251|P2|Second 24 Hours|Missing data|1
841664|NCT01727505|2770252|P1|Second 24 Hours|Missing data|0
841665|NCT01727505|2770251|P2|First 24 Hours|Adverse Event|1
841666|NCT01727505|2770252|P1|First 24 Hours|Adverse Event|0
841667|NCT01727297|2770277|P2|Overall Study|Other (e.g. AF detection pre-implant)|8
841668|NCT01727297|2770278|P1|Overall Study|Other (e.g. AF detection pre-implant)|29
841669|NCT01727297|2770277|P2|Overall Study|Physician Decision|5
841670|NCT01727297|2770278|P1|Overall Study|Physician Decision|19
841671|NCT01727297|2770277|P2|Overall Study|Withdrawal by Subject|27
841672|NCT01727297|2770278|P1|Overall Study|Withdrawal by Subject|26
841673|NCT01727297|2770277|P2|Overall Study|Lost to Follow-up|0
841674|NCT01727297|2770278|P1|Overall Study|Lost to Follow-up|11
841675|NCT01727297|2770277|P2|Overall Study|Adverse Event|1
841676|NCT01727297|2770278|P1|Overall Study|Adverse Event|3
841677|NCT01727297|2770277|P2|Overall Study|Protocol Violation|10
841678|NCT01727297|2770278|P1|Overall Study|Protocol Violation|1
841679|NCT01727297|2770277|P2|Overall Study|Death|0
841680|NCT01727297|2770278|P1|Overall Study|Death|13
841681|NCT01727258|2770294|P3|Overall Study|Lost to Follow-up|0
841682|NCT01727258|2770295|P2|Overall Study|Lost to Follow-up|0
841683|NCT01727258|2770296|P1|Overall Study|Lost to Follow-up|1
841684|NCT01727258|2770294|P3|Overall Study|Withdrawal by Subject|0
841685|NCT01727258|2770295|P2|Overall Study|Withdrawal by Subject|1
841686|NCT01727258|2770296|P1|Overall Study|Withdrawal by Subject|1
841687|NCT01727258|2770294|P3|Overall Study|Noncompliance with Study Drug|1
841688|NCT01727258|2770295|P2|Overall Study|Noncompliance with Study Drug|0
841689|NCT01727258|2770296|P1|Overall Study|Noncompliance with Study Drug|0
841690|NCT01727258|2770294|P3|Overall Study|Adverse Event|0
841691|NCT01727258|2770295|P2|Overall Study|Adverse Event|2
841692|NCT01727258|2770296|P1|Overall Study|Adverse Event|0
841693|NCT01727141|2770338|P4|Overall Study|Withdrawal by Subject|11
841694|NCT01727141|2770339|P3|Overall Study|Withdrawal by Subject|2
841695|NCT01727141|2770340|P2|Overall Study|Withdrawal by Subject|4
841696|NCT01727141|2770341|P1|Overall Study|Withdrawal by Subject|4
841697|NCT01727141|2770338|P4|Overall Study|Protocol deviation|1
841698|NCT01727141|2770339|P3|Overall Study|Protocol deviation|0
841699|NCT01727141|2770340|P2|Overall Study|Protocol deviation|1
841700|NCT01727141|2770341|P1|Overall Study|Protocol deviation|1
841701|NCT01727141|2770338|P4|Overall Study|Death|1
841702|NCT01727141|2770339|P3|Overall Study|Death|1
841703|NCT01727141|2770340|P2|Overall Study|Death|1
841704|NCT01727141|2770341|P1|Overall Study|Death|0
841705|NCT01727141|2770338|P4|Overall Study|Lost to Follow-up|0
841706|NCT01727141|2770339|P3|Overall Study|Lost to Follow-up|0
841707|NCT01727141|2770340|P2|Overall Study|Lost to Follow-up|2
841708|NCT01727141|2770341|P1|Overall Study|Lost to Follow-up|0
841709|NCT01727141|2770338|P4|Overall Study|Physician Decision|2
841710|NCT01727141|2770339|P3|Overall Study|Physician Decision|0
841711|NCT01727141|2770340|P2|Overall Study|Physician Decision|1
841712|NCT01727141|2770341|P1|Overall Study|Physician Decision|0
841713|NCT01727024|2770406|P2|Period 1|Withdrawal by Subject|3
841714|NCT01727024|2770407|P1|Period 1|Withdrawal by Subject|2
841715|NCT01727024|2770406|P2|Period 1|Lost to Follow-up|1
841716|NCT01727024|2770407|P1|Period 1|Lost to Follow-up|1
841717|NCT01726803|2770422|P2|Overall Study|Withdrawal by Subject|0
841718|NCT01726803|2770423|P1|Overall Study|Withdrawal by Subject|1
841719|NCT01726803|2770422|P2|Overall Study|Lost to Follow-up|1
841720|NCT01726803|2770423|P1|Overall Study|Lost to Follow-up|6
841721|NCT01726517|2770465|P5|Overall Study|Withdrawal by Subject|0
841722|NCT01726517|2770466|P4|Overall Study|Withdrawal by Subject|0
841723|NCT01726517|2770467|P3|Overall Study|Withdrawal by Subject|1
841724|NCT01726517|2770468|P2|Overall Study|Withdrawal by Subject|0
841725|NCT01726517|2770469|P1|Overall Study|Withdrawal by Subject|0
841726|NCT01726335|2770525|P1|Overall Study|Exacerbation of psychotic symptoms|1
841727|NCT01726335|2770525|P1|Overall Study|Lost to Follow-up|2
841728|NCT01726335|2770525|P1|Overall Study|Adverse Event|4
841729|NCT01726335|2770525|P1|Overall Study|Withdrawal by Subject|15
841730|NCT01726335|2770525|P1|Overall Study|Lost to Follow-up|2
841731|NCT01726049|2770543|P2|Overall Study|refused second HC|2
841732|NCT01726049|2770544|P1|Overall Study|refused second HC|0
841733|NCT01726049|2770543|P2|Overall Study|Adverse Event|1
841734|NCT01726049|2770544|P1|Overall Study|Adverse Event|4
841735|NCT01726049|2770543|P2|Overall Study|Death|1
841736|NCT01726049|2770544|P1|Overall Study|Death|1
841737|NCT01726023|2770558|P2|Overall Study|Withdrawal by Subject|8
841738|NCT01726023|2770559|P1|Overall Study|Withdrawal by Subject|16
841739|NCT01726023|2770558|P2|Overall Study|Other Eligibility criteria|7
841740|NCT01726023|2770559|P1|Overall Study|Other Eligibility criteria|7
841741|NCT01726023|2770558|P2|Overall Study|Lost to Follow-up|10
841742|NCT01726023|2770559|P1|Overall Study|Lost to Follow-up|5
841743|NCT01726023|2770558|P2|Overall Study|Death|1
841744|NCT01726023|2770559|P1|Overall Study|Death|1
841745|NCT01725750|2770678|P2|Overall Study|Withdrawal by Subject|9
841746|NCT01725750|2770679|P1|Overall Study|Withdrawal by Subject|0
841747|NCT01725750|2770678|P2|Overall Study|Lost to Follow-up|1
841748|NCT01725750|2770679|P1|Overall Study|Lost to Follow-up|1
841749|NCT01725750|2770678|P2|Overall Study|Adverse Event|0
841750|NCT01725750|2770679|P1|Overall Study|Adverse Event|1
841751|NCT01725529|2770706|P3|Overall Study|Withdrawal by Subject|8
841752|NCT01725529|2770707|P2|Overall Study|Withdrawal by Subject|14
841753|NCT01725529|2770708|P1|Overall Study|Withdrawal by Subject|12
841754|NCT01725529|2770706|P3|Overall Study|Protocol Violation|1
841755|NCT01725529|2770707|P2|Overall Study|Protocol Violation|1
841756|NCT01725529|2770708|P1|Overall Study|Protocol Violation|0
841757|NCT01725529|2770706|P3|Overall Study|Lost to Follow-up|1
841758|NCT01725529|2770707|P2|Overall Study|Lost to Follow-up|1
841759|NCT01725529|2770708|P1|Overall Study|Lost to Follow-up|2
841760|NCT01725529|2770706|P3|Overall Study|Adverse Event|0
841761|NCT01725529|2770707|P2|Overall Study|Adverse Event|0
841762|NCT01725529|2770708|P1|Overall Study|Adverse Event|1
841763|NCT01725451|2770734|P4|Period 4|Adverse Event|0
841764|NCT01725451|2770735|P3|Period 4|Adverse Event|1
841765|NCT01725451|2770736|P2|Period 4|Adverse Event|0
841766|NCT01725451|2770737|P1|Period 4|Adverse Event|0
841767|NCT01725451|2770734|P4|Washout From Period 3|Adverse Event|0
841768|NCT01725451|2770735|P3|Washout From Period 3|Adverse Event|0
841769|NCT01725451|2770736|P2|Washout From Period 3|Adverse Event|1
841770|NCT01725451|2770737|P1|Washout From Period 3|Adverse Event|0
841771|NCT01725451|2770734|P4|Washout From Period 3|Protocol Violation|0
841772|NCT01725451|2770735|P3|Washout From Period 3|Protocol Violation|1
841773|NCT01725451|2770736|P2|Washout From Period 3|Protocol Violation|0
841774|NCT01725451|2770737|P1|Washout From Period 3|Protocol Violation|0
841775|NCT01725451|2770734|P4|Period 1|Withdrawal by Subject|0
841776|NCT01725451|2770735|P3|Period 1|Withdrawal by Subject|0
841777|NCT01725451|2770736|P2|Period 1|Withdrawal by Subject|0
841778|NCT01725451|2770737|P1|Period 1|Withdrawal by Subject|1
841779|NCT01725386|2770759|P2|Overall Study|Withdrawal by Subject|0
841780|NCT01725386|2770760|P1|Overall Study|Withdrawal by Subject|10
841781|NCT01725386|2770759|P2|Overall Study|Lost to Follow-up|6
841782|NCT01725386|2770760|P1|Overall Study|Lost to Follow-up|81
841783|NCT01725386|2770759|P2|Overall Study|Death|40
841784|NCT01725386|2770760|P1|Overall Study|Death|84
841785|NCT01725308|2770779|P3|Treatment Period II|Miscellaneous|7
841786|NCT01725308|2770780|P2|Treatment Period II|Miscellaneous|3
841787|NCT01725308|2770781|P1|Treatment Period II|Miscellaneous|5
841788|NCT01725308|2770779|P3|Treatment Period II|Protocol Deviations|1
841789|NCT01725308|2770780|P2|Treatment Period II|Protocol Deviations|0
841790|NCT01725308|2770781|P1|Treatment Period II|Protocol Deviations|0
841791|NCT01725308|2770779|P3|Treatment Period II|Lost to Follow-up|3
841792|NCT01725308|2770780|P2|Treatment Period II|Lost to Follow-up|5
841793|NCT01725308|2770781|P1|Treatment Period II|Lost to Follow-up|1
841794|NCT01725308|2770779|P3|Treatment Period II|Withdrawal of Consent|16
841795|NCT01725308|2770780|P2|Treatment Period II|Withdrawal of Consent|2
841796|NCT01725308|2770781|P1|Treatment Period II|Withdrawal of Consent|28
841797|NCT01725308|2770779|P3|Treatment Period II|Changes in the Episodes|5
841798|NCT01725308|2770780|P2|Treatment Period II|Changes in the Episodes|0
841799|NCT01725308|2770781|P1|Treatment Period II|Changes in the Episodes|1
841800|NCT01725308|2770779|P3|Treatment Period II|Worsening of the Target Disease|2
841801|NCT01725308|2770780|P2|Treatment Period II|Worsening of the Target Disease|4
841802|NCT01725308|2770781|P1|Treatment Period II|Worsening of the Target Disease|1
841803|NCT01725308|2770779|P3|Treatment Period II|Insufficient Response|6
841804|NCT01725308|2770780|P2|Treatment Period II|Insufficient Response|4
841805|NCT01725308|2770781|P1|Treatment Period II|Insufficient Response|2
841806|NCT01725308|2770779|P3|Treatment Period II|Adverse Event|20
841807|NCT01725308|2770780|P2|Treatment Period II|Adverse Event|8
841808|NCT01725308|2770781|P1|Treatment Period II|Adverse Event|13
841809|NCT01725308|2770779|P3|Treatment Period II|Did Not Receive Drug|0
841810|NCT01725308|2770780|P2|Treatment Period II|Did Not Receive Drug|0
841811|NCT01725308|2770781|P1|Treatment Period II|Did Not Receive Drug|4
841898|NCT01724021|2771249|P1|Overall Study|Missing|1
841812|NCT01725308|2770779|P3|Treatment Period II|Did Not Meet Transition Criteria|4
841813|NCT01725308|2770780|P2|Treatment Period II|Did Not Meet Transition Criteria|3
841814|NCT01725308|2770781|P1|Treatment Period II|Did Not Meet Transition Criteria|0
841815|NCT01725308|2770779|P3|Treatment Period I|Miscellaneous|3
841816|NCT01725308|2770780|P2|Treatment Period I|Miscellaneous|0
841817|NCT01725308|2770781|P1|Treatment Period I|Miscellaneous|2
841818|NCT01725308|2770779|P3|Treatment Period I|Protocol Deviations|1
841819|NCT01725308|2770780|P2|Treatment Period I|Protocol Deviations|1
841820|NCT01725308|2770781|P1|Treatment Period I|Protocol Deviations|3
841821|NCT01725308|2770779|P3|Treatment Period I|Lost to Follow-up|2
841822|NCT01725308|2770780|P2|Treatment Period I|Lost to Follow-up|2
841823|NCT01725308|2770781|P1|Treatment Period I|Lost to Follow-up|3
841824|NCT01725308|2770779|P3|Treatment Period I|Withdrawal of Consent|5
841825|NCT01725308|2770780|P2|Treatment Period I|Withdrawal of Consent|7
841826|NCT01725308|2770781|P1|Treatment Period I|Withdrawal of Consent|12
841827|NCT01725308|2770779|P3|Treatment Period I|Changes in the Episodes|2
841828|NCT01725308|2770780|P2|Treatment Period I|Changes in the Episodes|0
841829|NCT01725308|2770781|P1|Treatment Period I|Changes in the Episodes|3
841830|NCT01725308|2770779|P3|Treatment Period I|Worsening of the Target Disease|2
841831|NCT01725308|2770780|P2|Treatment Period I|Worsening of the Target Disease|0
841832|NCT01725308|2770781|P1|Treatment Period I|Worsening of the Target Disease|8
841833|NCT01725308|2770779|P3|Treatment Period I|Insufficient Response|5
841834|NCT01725308|2770780|P2|Treatment Period I|Insufficient Response|0
841835|NCT01725308|2770781|P1|Treatment Period I|Insufficient Response|7
841836|NCT01725308|2770779|P3|Treatment Period I|Adverse Event|21
841837|NCT01725308|2770780|P2|Treatment Period I|Adverse Event|4
841838|NCT01725308|2770781|P1|Treatment Period I|Adverse Event|5
841839|NCT01725308|2770779|P3|Treatment Period I|Did Not Receive Drug|0
841840|NCT01725308|2770780|P2|Treatment Period I|Did Not Receive Drug|0
841841|NCT01725308|2770781|P1|Treatment Period I|Did Not Receive Drug|1
841842|NCT01725282|2770928|P4|Overall Study|Lack of Efficacy|1
841843|NCT01725282|2770929|P3|Overall Study|Lack of Efficacy|0
841844|NCT01725282|2770930|P2|Overall Study|Lack of Efficacy|1
841845|NCT01725282|2770931|P1|Overall Study|Lack of Efficacy|0
841846|NCT01725282|2770928|P4|Overall Study|Withdrawal by Subject|1
841847|NCT01725282|2770929|P3|Overall Study|Withdrawal by Subject|1
841848|NCT01725282|2770930|P2|Overall Study|Withdrawal by Subject|0
841849|NCT01725282|2770931|P1|Overall Study|Withdrawal by Subject|0
841850|NCT01725282|2770928|P4|Overall Study|Study Site Withdrawal|0
841851|NCT01725282|2770929|P3|Overall Study|Study Site Withdrawal|0
841852|NCT01725282|2770930|P2|Overall Study|Study Site Withdrawal|1
841853|NCT01725282|2770931|P1|Overall Study|Study Site Withdrawal|0
841854|NCT01725282|2770928|P4|Overall Study|Met Exclusion Criteria|0
841855|NCT01725282|2770929|P3|Overall Study|Met Exclusion Criteria|1
841856|NCT01725282|2770930|P2|Overall Study|Met Exclusion Criteria|0
841857|NCT01725282|2770931|P1|Overall Study|Met Exclusion Criteria|0
841858|NCT01725282|2770928|P4|Overall Study|Exacerbation of Target Disease|1
841859|NCT01725282|2770929|P3|Overall Study|Exacerbation of Target Disease|0
841860|NCT01725282|2770930|P2|Overall Study|Exacerbation of Target Disease|0
841861|NCT01725282|2770931|P1|Overall Study|Exacerbation of Target Disease|1
841862|NCT01725282|2770928|P4|Overall Study|Adverse Event|4
841863|NCT01725282|2770929|P3|Overall Study|Adverse Event|6
841864|NCT01725282|2770930|P2|Overall Study|Adverse Event|3
841865|NCT01725282|2770931|P1|Overall Study|Adverse Event|1
841866|NCT01725217|2770964|P3|Overall Study|Withdrawal by Subject|0
841867|NCT01725217|2770965|P2|Overall Study|Withdrawal by Subject|0
841868|NCT01725217|2770966|P1|Overall Study|Withdrawal by Subject|1
841869|NCT01725126|2771000|P6|Overall Study|Withdrawal by Subject|0
841870|NCT01725126|2771001|P5|Overall Study|Withdrawal by Subject|0
841871|NCT01725126|2771002|P4|Overall Study|Withdrawal by Subject|1
841872|NCT01725126|2771003|P3|Overall Study|Withdrawal by Subject|0
841873|NCT01725126|2771004|P2|Overall Study|Withdrawal by Subject|0
841874|NCT01725126|2771005|P1|Overall Study|Withdrawal by Subject|0
841875|NCT01725126|2771000|P6|Overall Study|Protocol Violation|0
841876|NCT01725126|2771001|P5|Overall Study|Protocol Violation|0
841877|NCT01725126|2771002|P4|Overall Study|Protocol Violation|0
841878|NCT01725126|2771003|P3|Overall Study|Protocol Violation|0
841879|NCT01725126|2771004|P2|Overall Study|Protocol Violation|1
841880|NCT01725126|2771005|P1|Overall Study|Protocol Violation|0
841881|NCT01724528|2771203|P2|Overall Study|Patient refused to attend last visit|0
841882|NCT01724528|2771204|P1|Overall Study|Patient refused to attend last visit|1
841883|NCT01724528|2771203|P2|Overall Study|Protocol Violation|1
841884|NCT01724528|2771204|P1|Overall Study|Protocol Violation|0
841885|NCT01724528|2771203|P2|Overall Study|Withdrawal by Subject|2
841886|NCT01724528|2771204|P1|Overall Study|Withdrawal by Subject|0
841887|NCT01724528|2771203|P2|Overall Study|Death|0
841888|NCT01724528|2771204|P1|Overall Study|Death|3
841889|NCT01724359|2771218|P1|Overall Study|Not specified|20
841890|NCT01724359|2771218|P1|Overall Study|Death|1
841891|NCT01724359|2771218|P1|Overall Study|Adverse Event|10
841892|NCT01724216|2771231|P1|Overall Study|Scan was not completed|1
841893|NCT01724177|2771235|P1|Overall Study|Serious Adverse Event Related|1
841894|NCT01724177|2771235|P1|Overall Study|Nervous participant|1
841895|NCT01724177|2771235|P1|Overall Study|Progressive disease or Relapsed Disease|16
841896|NCT01724177|2771235|P1|Overall Study|Adverse Event|8
841897|NCT01724021|2771248|P2|Overall Study|Missing|1
841899|NCT01724021|2771248|P2|Overall Study|Reason Not Specified|39
841900|NCT01724021|2771249|P1|Overall Study|Reason Not Specified|36
841901|NCT01724021|2771248|P2|Overall Study|Lost to Follow-up|15
841902|NCT01724021|2771249|P1|Overall Study|Lost to Follow-up|15
841903|NCT01724021|2771248|P2|Overall Study|Participant request/ Withdrew consent|14
841904|NCT01724021|2771249|P1|Overall Study|Participant request/ Withdrew consent|18
841905|NCT01724021|2771248|P2|Overall Study|Death|58
841906|NCT01724021|2771249|P1|Overall Study|Death|46
841907|NCT01724021|2771248|P2|Overall Study|Adverse Event|6
841908|NCT01724021|2771249|P1|Overall Study|Adverse Event|11
841909|NCT01723904|2771281|P1|Overall Study|Unable to follow protocol/ judged by inv|3
841910|NCT01723904|2771281|P1|Overall Study|Adverse Event|5
841911|NCT01723904|2771281|P1|Overall Study|Noncompliant|3
841912|NCT01723397|2771302|P2|Study Period 2|Protocol Violation|1
841913|NCT01723397|2771303|P1|Study Period 2|Protocol Violation|0
841914|NCT01723397|2771302|P2|Study Period 1|Protocol Violation|1
841915|NCT01723397|2771303|P1|Study Period 1|Protocol Violation|0
841916|NCT01723254|2771317|P8|Overall Study|Withdrawal by Subject|2
841917|NCT01723254|2771318|P7|Overall Study|Withdrawal by Subject|1
841918|NCT01723254|2771319|P6|Overall Study|Withdrawal by Subject|1
841919|NCT01723254|2771320|P5|Overall Study|Withdrawal by Subject|1
841920|NCT01723254|2771321|P4|Overall Study|Withdrawal by Subject|0
841921|NCT01723254|2771322|P3|Overall Study|Withdrawal by Subject|1
841922|NCT01723254|2771323|P2|Overall Study|Withdrawal by Subject|2
841923|NCT01723254|2771324|P1|Overall Study|Withdrawal by Subject|1
841924|NCT01723254|2771317|P8|Overall Study|Protocol Violation|0
841925|NCT01723254|2771318|P7|Overall Study|Protocol Violation|0
841926|NCT01723254|2771319|P6|Overall Study|Protocol Violation|0
841927|NCT01723254|2771320|P5|Overall Study|Protocol Violation|0
841928|NCT01723254|2771321|P4|Overall Study|Protocol Violation|0
841929|NCT01723254|2771322|P3|Overall Study|Protocol Violation|0
841930|NCT01723254|2771323|P2|Overall Study|Protocol Violation|1
841931|NCT01723254|2771324|P1|Overall Study|Protocol Violation|0
841932|NCT01723254|2771317|P8|Overall Study|Move/Left to another country/city|0
841933|NCT01723254|2771318|P7|Overall Study|Move/Left to another country/city|0
841934|NCT01723254|2771319|P6|Overall Study|Move/Left to another country/city|0
841935|NCT01723254|2771320|P5|Overall Study|Move/Left to another country/city|1
841936|NCT01723254|2771321|P4|Overall Study|Move/Left to another country/city|1
841937|NCT01723254|2771322|P3|Overall Study|Move/Left to another country/city|2
841938|NCT01723254|2771323|P2|Overall Study|Move/Left to another country/city|0
841939|NCT01723254|2771324|P1|Overall Study|Move/Left to another country/city|0
841940|NCT01723254|2771317|P8|Overall Study|No longer have time to participate|0
841941|NCT01723254|2771318|P7|Overall Study|No longer have time to participate|0
841942|NCT01723254|2771319|P6|Overall Study|No longer have time to participate|0
841943|NCT01723254|2771320|P5|Overall Study|No longer have time to participate|0
841944|NCT01723254|2771321|P4|Overall Study|No longer have time to participate|1
841945|NCT01723254|2771322|P3|Overall Study|No longer have time to participate|0
841946|NCT01723254|2771323|P2|Overall Study|No longer have time to participate|0
841947|NCT01723254|2771324|P1|Overall Study|No longer have time to participate|0
841948|NCT01723254|2771317|P8|Overall Study|Personal issues|0
841949|NCT01723254|2771318|P7|Overall Study|Personal issues|0
841950|NCT01723254|2771319|P6|Overall Study|Personal issues|1
841951|NCT01723254|2771320|P5|Overall Study|Personal issues|0
841952|NCT01723254|2771321|P4|Overall Study|Personal issues|0
841953|NCT01723254|2771322|P3|Overall Study|Personal issues|0
841954|NCT01723254|2771323|P2|Overall Study|Personal issues|0
841955|NCT01723254|2771324|P1|Overall Study|Personal issues|0
841956|NCT01723254|2771317|P8|Overall Study|Conflict with work schedule|1
841957|NCT01723254|2771318|P7|Overall Study|Conflict with work schedule|0
841958|NCT01723254|2771319|P6|Overall Study|Conflict with work schedule|0
841959|NCT01723254|2771320|P5|Overall Study|Conflict with work schedule|0
841960|NCT01723254|2771321|P4|Overall Study|Conflict with work schedule|0
841961|NCT01723254|2771322|P3|Overall Study|Conflict with work schedule|0
841962|NCT01723254|2771323|P2|Overall Study|Conflict with work schedule|0
841963|NCT01723254|2771324|P1|Overall Study|Conflict with work schedule|0
841964|NCT01723228|2771376|P2|Overall Study|Not Specified|1
841965|NCT01723228|2771377|P1|Overall Study|Not Specified|2
841966|NCT01723228|2771376|P2|Overall Study|Lost to Follow-up|1
841967|NCT01723228|2771377|P1|Overall Study|Lost to Follow-up|2
841968|NCT01723228|2771376|P2|Overall Study|Protocol Violation|2
841969|NCT01723228|2771377|P1|Overall Study|Protocol Violation|0
841970|NCT01723228|2771376|P2|Overall Study|Withdrawal by Subject|1
841971|NCT01723228|2771377|P1|Overall Study|Withdrawal by Subject|2
841972|NCT01723228|2771376|P2|Overall Study|Adverse Event|6
841973|NCT01723228|2771377|P1|Overall Study|Adverse Event|2
841974|NCT01722994|2771395|P2|Overall Study|Missing data|17
841975|NCT01722994|2771396|P1|Overall Study|Missing data|25
841976|NCT01722877|2771415|P1|Overall Study|Lost to Follow-up|1
841977|NCT01722877|2771415|P1|Overall Study|Death|1
841978|NCT01722331|2771486|P7|Part 3|Other Protocol Specified Criteria|0
841979|NCT01722331|2771487|P6|Part 3|Other Protocol Specified Criteria|0
841980|NCT01722331|2771488|P5|Part 3|Other Protocol Specified Criteria|0
841981|NCT01722331|2771489|P4|Part 3|Other Protocol Specified Criteria|0
841982|NCT01722331|2771490|P3|Part 3|Other Protocol Specified Criteria|0
841983|NCT01722331|2771491|P2|Part 3|Other Protocol Specified Criteria|1
841984|NCT01722331|2771492|P1|Part 3|Other Protocol Specified Criteria|1
841985|NCT01722331|2771486|P7|Part 3|Withdrawal by Subject|1
841986|NCT01722331|2771487|P6|Part 3|Withdrawal by Subject|2
841987|NCT01722331|2771488|P5|Part 3|Withdrawal by Subject|0
841988|NCT01722331|2771489|P4|Part 3|Withdrawal by Subject|0
841989|NCT01722331|2771490|P3|Part 3|Withdrawal by Subject|0
841990|NCT01722331|2771491|P2|Part 3|Withdrawal by Subject|7
841991|NCT01722331|2771492|P1|Part 3|Withdrawal by Subject|4
841992|NCT01722331|2771486|P7|Part 3|Protocol Violation|0
841993|NCT01722331|2771487|P6|Part 3|Protocol Violation|0
841994|NCT01722331|2771488|P5|Part 3|Protocol Violation|0
841995|NCT01722331|2771489|P4|Part 3|Protocol Violation|0
841996|NCT01722331|2771490|P3|Part 3|Protocol Violation|0
841997|NCT01722331|2771491|P2|Part 3|Protocol Violation|1
841998|NCT01722331|2771492|P1|Part 3|Protocol Violation|2
841999|NCT01722331|2771486|P7|Part 3|Physician Decision|1
842000|NCT01722331|2771487|P6|Part 3|Physician Decision|0
842001|NCT01722331|2771488|P5|Part 3|Physician Decision|0
842002|NCT01722331|2771489|P4|Part 3|Physician Decision|0
842003|NCT01722331|2771490|P3|Part 3|Physician Decision|0
842004|NCT01722331|2771491|P2|Part 3|Physician Decision|1
842005|NCT01722331|2771492|P1|Part 3|Physician Decision|1
842006|NCT01722331|2771486|P7|Part 3|Non-Compliance with Study Drug|0
842007|NCT01722331|2771487|P6|Part 3|Non-Compliance with Study Drug|0
842008|NCT01722331|2771488|P5|Part 3|Non-Compliance with Study Drug|0
842009|NCT01722331|2771489|P4|Part 3|Non-Compliance with Study Drug|0
842010|NCT01722331|2771490|P3|Part 3|Non-Compliance with Study Drug|0
842011|NCT01722331|2771491|P2|Part 3|Non-Compliance with Study Drug|1
842012|NCT01722331|2771492|P1|Part 3|Non-Compliance with Study Drug|0
842013|NCT01722331|2771486|P7|Part 3|Lost to Follow-up|0
842014|NCT01722331|2771487|P6|Part 3|Lost to Follow-up|1
842015|NCT01722331|2771488|P5|Part 3|Lost to Follow-up|0
842016|NCT01722331|2771489|P4|Part 3|Lost to Follow-up|0
842017|NCT01722331|2771490|P3|Part 3|Lost to Follow-up|0
842018|NCT01722331|2771491|P2|Part 3|Lost to Follow-up|4
842019|NCT01722331|2771492|P1|Part 3|Lost to Follow-up|3
842020|NCT01722331|2771486|P7|Part 3|Lack of Efficacy|0
842021|NCT01722331|2771487|P6|Part 3|Lack of Efficacy|0
842022|NCT01722331|2771488|P5|Part 3|Lack of Efficacy|0
842023|NCT01722331|2771489|P4|Part 3|Lack of Efficacy|0
842024|NCT01722331|2771490|P3|Part 3|Lack of Efficacy|0
842025|NCT01722331|2771491|P2|Part 3|Lack of Efficacy|0
842026|NCT01722331|2771492|P1|Part 3|Lack of Efficacy|1
842027|NCT01722331|2771486|P7|Part 3|Death|0
842028|NCT01722331|2771487|P6|Part 3|Death|0
842029|NCT01722331|2771488|P5|Part 3|Death|0
842030|NCT01722331|2771489|P4|Part 3|Death|0
842031|NCT01722331|2771490|P3|Part 3|Death|0
842032|NCT01722331|2771491|P2|Part 3|Death|0
842033|NCT01722331|2771492|P1|Part 3|Death|1
842034|NCT01722331|2771486|P7|Part 3|Adverse Event|0
842035|NCT01722331|2771487|P6|Part 3|Adverse Event|0
842036|NCT01722331|2771488|P5|Part 3|Adverse Event|0
842037|NCT01722331|2771489|P4|Part 3|Adverse Event|1
842038|NCT01722331|2771490|P3|Part 3|Adverse Event|0
842039|NCT01722331|2771491|P2|Part 3|Adverse Event|2
842040|NCT01722331|2771492|P1|Part 3|Adverse Event|2
842041|NCT01722331|2771486|P7|Part 2|Other Protocol Specified Criteria|1
842042|NCT01722331|2771487|P6|Part 2|Other Protocol Specified Criteria|2
842043|NCT01722331|2771488|P5|Part 2|Other Protocol Specified Criteria|0
842044|NCT01722331|2771489|P4|Part 2|Other Protocol Specified Criteria|0
842045|NCT01722331|2771490|P3|Part 2|Other Protocol Specified Criteria|10
842046|NCT01722331|2771491|P2|Part 2|Other Protocol Specified Criteria|0
842047|NCT01722331|2771492|P1|Part 2|Other Protocol Specified Criteria|6
842048|NCT01722331|2771486|P7|Part 2|Withdrawal by Subject|2
842049|NCT01722331|2771487|P6|Part 2|Withdrawal by Subject|2
842050|NCT01722331|2771488|P5|Part 2|Withdrawal by Subject|0
842051|NCT01722331|2771489|P4|Part 2|Withdrawal by Subject|0
842052|NCT01722331|2771490|P3|Part 2|Withdrawal by Subject|3
842053|NCT01722331|2771491|P2|Part 2|Withdrawal by Subject|0
842054|NCT01722331|2771492|P1|Part 2|Withdrawal by Subject|5
842055|NCT01722331|2771486|P7|Part 2|Protocol Violation|0
842056|NCT01722331|2771487|P6|Part 2|Protocol Violation|0
842057|NCT01722331|2771488|P5|Part 2|Protocol Violation|0
842058|NCT01722331|2771489|P4|Part 2|Protocol Violation|0
842059|NCT01722331|2771490|P3|Part 2|Protocol Violation|0
842060|NCT01722331|2771491|P2|Part 2|Protocol Violation|0
842061|NCT01722331|2771492|P1|Part 2|Protocol Violation|1
842062|NCT01722331|2771486|P7|Part 2|Progressive Disease|0
842063|NCT01722331|2771487|P6|Part 2|Progressive Disease|0
842064|NCT01722331|2771488|P5|Part 2|Progressive Disease|0
842065|NCT01722331|2771489|P4|Part 2|Progressive Disease|0
842066|NCT01722331|2771490|P3|Part 2|Progressive Disease|1
842067|NCT01722331|2771491|P2|Part 2|Progressive Disease|0
842068|NCT01722331|2771492|P1|Part 2|Progressive Disease|0
842069|NCT01722331|2771486|P7|Part 2|Pregnancy|0
842070|NCT01722331|2771487|P6|Part 2|Pregnancy|1
842071|NCT01722331|2771488|P5|Part 2|Pregnancy|0
842072|NCT01722331|2771489|P4|Part 2|Pregnancy|0
842073|NCT01722331|2771490|P3|Part 2|Pregnancy|0
842074|NCT01722331|2771491|P2|Part 2|Pregnancy|0
842075|NCT01722331|2771492|P1|Part 2|Pregnancy|0
842076|NCT01722331|2771486|P7|Part 2|Physician Decision|0
842077|NCT01722331|2771487|P6|Part 2|Physician Decision|0
842078|NCT01722331|2771488|P5|Part 2|Physician Decision|0
842079|NCT01722331|2771489|P4|Part 2|Physician Decision|0
842080|NCT01722331|2771490|P3|Part 2|Physician Decision|2
842081|NCT01722331|2771491|P2|Part 2|Physician Decision|0
842082|NCT01722331|2771492|P1|Part 2|Physician Decision|0
842083|NCT01722331|2771486|P7|Part 2|Non-Compliance with Study Drug|0
842084|NCT01722331|2771487|P6|Part 2|Non-Compliance with Study Drug|0
842085|NCT01722331|2771488|P5|Part 2|Non-Compliance with Study Drug|0
842086|NCT01722331|2771489|P4|Part 2|Non-Compliance with Study Drug|0
842087|NCT01722331|2771490|P3|Part 2|Non-Compliance with Study Drug|1
842088|NCT01722331|2771491|P2|Part 2|Non-Compliance with Study Drug|0
842089|NCT01722331|2771492|P1|Part 2|Non-Compliance with Study Drug|1
842090|NCT01722331|2771486|P7|Part 2|Lost to Follow-up|1
842091|NCT01722331|2771487|P6|Part 2|Lost to Follow-up|1
842092|NCT01722331|2771488|P5|Part 2|Lost to Follow-up|0
842093|NCT01722331|2771489|P4|Part 2|Lost to Follow-up|0
842094|NCT01722331|2771490|P3|Part 2|Lost to Follow-up|3
842095|NCT01722331|2771491|P2|Part 2|Lost to Follow-up|0
842096|NCT01722331|2771492|P1|Part 2|Lost to Follow-up|0
842097|NCT01722331|2771486|P7|Part 2|Lack of Efficacy|3
842098|NCT01722331|2771487|P6|Part 2|Lack of Efficacy|3
842099|NCT01722331|2771488|P5|Part 2|Lack of Efficacy|0
842100|NCT01722331|2771489|P4|Part 2|Lack of Efficacy|0
842101|NCT01722331|2771490|P3|Part 2|Lack of Efficacy|11
842102|NCT01722331|2771491|P2|Part 2|Lack of Efficacy|0
842103|NCT01722331|2771492|P1|Part 2|Lack of Efficacy|3
842104|NCT01722331|2771486|P7|Part 2|Adverse Event|0
842105|NCT01722331|2771487|P6|Part 2|Adverse Event|1
842106|NCT01722331|2771488|P5|Part 2|Adverse Event|0
842107|NCT01722331|2771489|P4|Part 2|Adverse Event|0
842108|NCT01722331|2771490|P3|Part 2|Adverse Event|0
842109|NCT01722331|2771491|P2|Part 2|Adverse Event|0
842110|NCT01722331|2771492|P1|Part 2|Adverse Event|3
842111|NCT01722331|2771486|P7|Part 1|Withdrawal by Subject|0
842112|NCT01722331|2771487|P6|Part 1|Withdrawal by Subject|0
842113|NCT01722331|2771488|P5|Part 1|Withdrawal by Subject|3
842114|NCT01722331|2771489|P4|Part 1|Withdrawal by Subject|0
842115|NCT01722331|2771490|P3|Part 1|Withdrawal by Subject|3
842116|NCT01722331|2771491|P2|Part 1|Withdrawal by Subject|0
842117|NCT01722331|2771492|P1|Part 1|Withdrawal by Subject|2
842118|NCT01722331|2771486|P7|Part 1|Protocol Violation|0
842119|NCT01722331|2771487|P6|Part 1|Protocol Violation|0
842120|NCT01722331|2771488|P5|Part 1|Protocol Violation|1
842121|NCT01722331|2771489|P4|Part 1|Protocol Violation|0
842122|NCT01722331|2771490|P3|Part 1|Protocol Violation|0
842123|NCT01722331|2771491|P2|Part 1|Protocol Violation|0
842124|NCT01722331|2771492|P1|Part 1|Protocol Violation|1
842125|NCT01722331|2771486|P7|Part 1|Progressive Disease|0
842126|NCT01722331|2771487|P6|Part 1|Progressive Disease|0
842127|NCT01722331|2771488|P5|Part 1|Progressive Disease|1
842128|NCT01722331|2771489|P4|Part 1|Progressive Disease|0
842129|NCT01722331|2771490|P3|Part 1|Progressive Disease|0
842130|NCT01722331|2771491|P2|Part 1|Progressive Disease|0
842131|NCT01722331|2771492|P1|Part 1|Progressive Disease|0
842132|NCT01722331|2771486|P7|Part 1|Pregnancy|0
842133|NCT01722331|2771487|P6|Part 1|Pregnancy|0
842134|NCT01722331|2771488|P5|Part 1|Pregnancy|0
842135|NCT01722331|2771489|P4|Part 1|Pregnancy|0
842136|NCT01722331|2771490|P3|Part 1|Pregnancy|0
842137|NCT01722331|2771491|P2|Part 1|Pregnancy|0
842138|NCT01722331|2771492|P1|Part 1|Pregnancy|1
842139|NCT01722331|2771486|P7|Part 1|Physician Decision|0
842140|NCT01722331|2771487|P6|Part 1|Physician Decision|0
842141|NCT01722331|2771488|P5|Part 1|Physician Decision|1
842142|NCT01722331|2771489|P4|Part 1|Physician Decision|0
842143|NCT01722331|2771490|P3|Part 1|Physician Decision|3
842144|NCT01722331|2771491|P2|Part 1|Physician Decision|0
842145|NCT01722331|2771492|P1|Part 1|Physician Decision|0
842146|NCT01722331|2771486|P7|Part 1|Lost to Follow-up|0
842147|NCT01722331|2771487|P6|Part 1|Lost to Follow-up|0
842148|NCT01722331|2771488|P5|Part 1|Lost to Follow-up|1
842149|NCT01722331|2771489|P4|Part 1|Lost to Follow-up|0
842150|NCT01722331|2771490|P3|Part 1|Lost to Follow-up|2
842151|NCT01722331|2771491|P2|Part 1|Lost to Follow-up|0
842152|NCT01722331|2771492|P1|Part 1|Lost to Follow-up|1
842153|NCT01722331|2771486|P7|Part 1|Lack of Efficacy|0
842154|NCT01722331|2771487|P6|Part 1|Lack of Efficacy|0
842155|NCT01722331|2771488|P5|Part 1|Lack of Efficacy|2
842156|NCT01722331|2771489|P4|Part 1|Lack of Efficacy|0
842157|NCT01722331|2771490|P3|Part 1|Lack of Efficacy|1
842158|NCT01722331|2771491|P2|Part 1|Lack of Efficacy|0
842159|NCT01722331|2771492|P1|Part 1|Lack of Efficacy|0
842160|NCT01722331|2771486|P7|Part 1|Adverse Event|0
842161|NCT01722331|2771487|P6|Part 1|Adverse Event|0
842162|NCT01722331|2771488|P5|Part 1|Adverse Event|0
842163|NCT01722331|2771489|P4|Part 1|Adverse Event|0
842164|NCT01722331|2771490|P3|Part 1|Adverse Event|0
842165|NCT01722331|2771491|P2|Part 1|Adverse Event|0
842166|NCT01722331|2771492|P1|Part 1|Adverse Event|5
842167|NCT01722266|2771571|P4|Overall Study|Dropped out due to Nausea|0
842168|NCT01722266|2771572|P3|Overall Study|Dropped out due to Nausea|2
842169|NCT01722266|2771573|P2|Overall Study|Dropped out due to Nausea|0
842170|NCT01722266|2771574|P1|Overall Study|Dropped out due to Nausea|0
842171|NCT01722266|2771571|P4|Overall Study|Tolerated only 0.6 mg liraglutide|0
842172|NCT01722266|2771572|P3|Overall Study|Tolerated only 0.6 mg liraglutide|3
842173|NCT01722266|2771573|P2|Overall Study|Tolerated only 0.6 mg liraglutide|1
842174|NCT01722266|2771574|P1|Overall Study|Tolerated only 0.6 mg liraglutide|0
842175|NCT01722266|2771571|P4|Overall Study|Withdrawal by Subject|0
842176|NCT01722266|2771572|P3|Overall Study|Withdrawal by Subject|0
842177|NCT01722266|2771573|P2|Overall Study|Withdrawal by Subject|2
842178|NCT01722266|2771574|P1|Overall Study|Withdrawal by Subject|1
842179|NCT01722162|2771602|P2|Overall Study|Noncompliance|1
842180|NCT01722162|2771603|P1|Overall Study|Noncompliance|0
842181|NCT01722162|2771602|P2|Overall Study|Insurance denial post enrollment|1
842182|NCT01722162|2771603|P1|Overall Study|Insurance denial post enrollment|0
842183|NCT01722162|2771602|P2|Overall Study|Adverse Event|1
842184|NCT01722162|2771603|P1|Overall Study|Adverse Event|1
842185|NCT01722162|2771602|P2|Overall Study|Unrelated to study adverse event|2
842186|NCT01722162|2771603|P1|Overall Study|Unrelated to study adverse event|2
842187|NCT01722162|2771602|P2|Overall Study|Found ineligible|0
842188|NCT01722162|2771603|P1|Overall Study|Found ineligible|1
842189|NCT01722162|2771602|P2|Overall Study|Withdrawal by Subject|1
842190|NCT01722162|2771603|P1|Overall Study|Withdrawal by Subject|1
842191|NCT01722097|2771613|P2|Overall Study|Patient sheets not returned|5
842192|NCT01722097|2771614|P1|Overall Study|Patient sheets not returned|6
842193|NCT01722071|2771622|P2|Overall Study|Protocol Violation|0
842194|NCT01722071|2771623|P1|Overall Study|Protocol Violation|1
842195|NCT01722045|2771629|P1|Overall Study|Relocation (did not wish to transfer)|1
842196|NCT01722045|2771629|P1|Overall Study|Physician Decision|3
842197|NCT01722045|2771629|P1|Overall Study|Protocol Deviation|1
842198|NCT01722045|2771629|P1|Overall Study|Lost to Follow-up|4
842199|NCT01722045|2771629|P1|Overall Study|Withdrawal by Subject|8
842200|NCT01722045|2771629|P1|Overall Study|Death|3
842201|NCT01722045|2771629|P1|Overall Study|Adverse Event|8
842202|NCT01721772|2771654|P2|Overall Study|Not specified|1
842203|NCT01721772|2771655|P1|Overall Study|Not specified|0
842204|NCT01721772|2771654|P2|Overall Study|Maximum clinical benefit|1
842205|NCT01721772|2771655|P1|Overall Study|Maximum clinical benefit|1
842206|NCT01721772|2771654|P2|Overall Study|Withdrawal by Subject|5
842207|NCT01721772|2771655|P1|Overall Study|Withdrawal by Subject|7
842208|NCT01721772|2771654|P2|Overall Study|Unrelated adverse event|3
842209|NCT01721772|2771655|P1|Overall Study|Unrelated adverse event|2
842210|NCT01721772|2771654|P2|Overall Study|Study drug toxicity|7
842211|NCT01721772|2771655|P1|Overall Study|Study drug toxicity|5
842212|NCT01721772|2771654|P2|Overall Study|Disease progression|175
842213|NCT01721772|2771655|P1|Overall Study|Disease progression|96
842214|NCT01721759|2771675|P1|Overall Study|Withdrawal by Subject|1
842215|NCT01721759|2771675|P1|Overall Study|Adverse event unrelated to study drug|9
842216|NCT01721759|2771675|P1|Overall Study|Study drug toxicity|14
842217|NCT01721759|2771675|P1|Overall Study|Disease progression|78
842218|NCT01721746|2771683|P3|Treatment Period|Other|1
842219|NCT01721746|2771684|P2|Treatment Period|Other|1
842220|NCT01721746|2771685|P1|Treatment Period|Other|2
842221|NCT01721746|2771683|P3|Treatment Period|Subject No Longer Met Study Criteria|0
842222|NCT01721746|2771684|P2|Treatment Period|Subject No Longer Met Study Criteria|0
842223|NCT01721746|2771685|P1|Treatment Period|Subject No Longer Met Study Criteria|4
842224|NCT01721746|2771683|P3|Treatment Period|Poor/Non-compliance|0
842225|NCT01721746|2771684|P2|Treatment Period|Poor/Non-compliance|0
842226|NCT01721746|2771685|P1|Treatment Period|Poor/Non-compliance|1
842227|NCT01721746|2771683|P3|Treatment Period|Maximum Clinical Benefit|3
842228|NCT01721746|2771684|P2|Treatment Period|Maximum Clinical Benefit|0
842229|NCT01721746|2771685|P1|Treatment Period|Maximum Clinical Benefit|1
842230|NCT01721746|2771683|P3|Treatment Period|Subject Withdrew Consent|2
842231|NCT01721746|2771684|P2|Treatment Period|Subject Withdrew Consent|0
842232|NCT01721746|2771685|P1|Treatment Period|Subject Withdrew Consent|3
842233|NCT01721746|2771683|P3|Treatment Period|Subject Request to Discontinue Treatment|6
842234|NCT01721746|2771684|P2|Treatment Period|Subject Request to Discontinue Treatment|1
842235|NCT01721746|2771685|P1|Treatment Period|Subject Request to Discontinue Treatment|19
842236|NCT01721746|2771683|P3|Treatment Period|Adverse Event Unrelated to Study Drug|2
842237|NCT01721746|2771684|P2|Treatment Period|Adverse Event Unrelated to Study Drug|1
842238|NCT01721746|2771685|P1|Treatment Period|Adverse Event Unrelated to Study Drug|6
842239|NCT01721746|2771683|P3|Treatment Period|Study Drug Toxicity|9
842240|NCT01721746|2771684|P2|Treatment Period|Study Drug Toxicity|2
842241|NCT01721746|2771685|P1|Treatment Period|Study Drug Toxicity|15
842242|NCT01721746|2771683|P3|Treatment Period|Disease Progression|34
842243|NCT01721746|2771684|P2|Treatment Period|Disease Progression|40
842244|NCT01721746|2771685|P1|Treatment Period|Disease Progression|182
842245|NCT01721486|2771725|P2|Overall Study|Physician Decision|1
842246|NCT01721486|2771726|P1|Overall Study|Physician Decision|0
842247|NCT01721486|2771725|P2|Overall Study|Protocol Violation|0
842248|NCT01721486|2771726|P1|Overall Study|Protocol Violation|1
842249|NCT01721408|2771747|P2|Overall Study|Does not meet entrance criteria|0
842250|NCT01721408|2771748|P1|Overall Study|Does not meet entrance criteria|1
842251|NCT01721408|2771747|P2|Overall Study|Lost to Follow-up|2
842252|NCT01721408|2771748|P1|Overall Study|Lost to Follow-up|1
842253|NCT01721408|2771747|P2|Overall Study|Other|3
842254|NCT01721408|2771748|P1|Overall Study|Other|3
842255|NCT01721408|2771747|P2|Overall Study|Protocol Violation|2
842256|NCT01721408|2771748|P1|Overall Study|Protocol Violation|0
842257|NCT01721408|2771747|P2|Overall Study|No longer willing to participate study|10
842258|NCT01721408|2771748|P1|Overall Study|No longer willing to participate study|9
842259|NCT01721408|2771747|P2|Overall Study|Insufficient clinical response|6
842260|NCT01721408|2771748|P1|Overall Study|Insufficient clinical response|15
842261|NCT01721408|2771747|P2|Overall Study|Death|0
842262|NCT01721408|2771748|P1|Overall Study|Death|1
842263|NCT01721408|2771747|P2|Overall Study|Adverse Event|1
842264|NCT01721408|2771748|P1|Overall Study|Adverse Event|6
842265|NCT01721330|2771764|P2|Overall Study|Withdrawal by Subject|1
842266|NCT01721330|2771765|P1|Overall Study|Withdrawal by Subject|0
842267|NCT01721317|2771773|P2|Overall Study|Withdrawal by Subject|1
842268|NCT01721317|2771774|P1|Overall Study|Withdrawal by Subject|0
842269|NCT01721317|2771773|P2|Overall Study|Physician Decision|1
842270|NCT01721317|2771774|P1|Overall Study|Physician Decision|0
842271|NCT01721317|2771773|P2|Overall Study|Study Closed / Terminated|2
842272|NCT01721317|2771774|P1|Overall Study|Study Closed / Terminated|2
842273|NCT01721200|2771853|P2|Overall Study|Lost to Follow-up|5
842274|NCT01721200|2771854|P1|Overall Study|Lost to Follow-up|3
842275|NCT01721161|2771879|P2|Overall Study|Not Specified|1
842276|NCT01721161|2771880|P1|Overall Study|Not Specified|0
842277|NCT01721161|2771879|P2|Overall Study|Withdrawal by Subject|1
842278|NCT01721161|2771880|P1|Overall Study|Withdrawal by Subject|1
842279|NCT01721161|2771879|P2|Overall Study|Lost to Follow-up|2
842280|NCT01721161|2771880|P1|Overall Study|Lost to Follow-up|1
842281|NCT01721161|2771879|P2|Overall Study|Adverse Event|3
842282|NCT01721161|2771880|P1|Overall Study|Adverse Event|2
842283|NCT01721109|2771903|P1|Overall Study|Lost to Follow-up|2
842284|NCT01721109|2771903|P1|Overall Study|Withdrew Consent|1
842285|NCT01721109|2771903|P1|Overall Study|Non- Compliance with Study Drug|3
842286|NCT01721109|2771903|P1|Overall Study|Lack of Efficacy|1
842287|NCT01721096|2771918|P2|Overall Study|Site didn't entered reason;registrystudy|0
842288|NCT01721096|2771919|P1|Overall Study|Site didn't entered reason;registrystudy|1
842289|NCT01721096|2771918|P2|Overall Study|Lost to Follow-up|2
842290|NCT01721096|2771919|P1|Overall Study|Lost to Follow-up|12
842291|NCT01721096|2771918|P2|Overall Study|Physician Decision|0
842292|NCT01721096|2771919|P1|Overall Study|Physician Decision|1
842293|NCT01721096|2771918|P2|Overall Study|Withdrawal by Subject|0
842294|NCT01721096|2771919|P1|Overall Study|Withdrawal by Subject|1
842295|NCT01721096|2771918|P2|Overall Study|Death|8
842296|NCT01721096|2771919|P1|Overall Study|Death|12
842297|NCT01721070|2772068|P1|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1
842298|NCT01721057|2772079|P7|Rescue Period|Lack of Efficacy|0
842299|NCT01721057|2772080|P6|Rescue Period|Lack of Efficacy|0
842300|NCT01721057|2772081|P5|Rescue Period|Lack of Efficacy|0
842301|NCT01721057|2772082|P4|Rescue Period|Lack of Efficacy|2
842302|NCT01721057|2772083|P3|Rescue Period|Lack of Efficacy|0
842303|NCT01721057|2772084|P2|Rescue Period|Lack of Efficacy|0
842304|NCT01721057|2772085|P1|Rescue Period|Lack of Efficacy|0
842305|NCT01721057|2772079|P7|Rescue Period|Adverse Event|0
842306|NCT01721057|2772080|P6|Rescue Period|Adverse Event|0
842307|NCT01721057|2772081|P5|Rescue Period|Adverse Event|0
842308|NCT01721057|2772082|P4|Rescue Period|Adverse Event|1
842309|NCT01721057|2772083|P3|Rescue Period|Adverse Event|0
842310|NCT01721057|2772084|P2|Rescue Period|Adverse Event|0
842311|NCT01721057|2772085|P1|Rescue Period|Adverse Event|0
842312|NCT01721057|2772079|P7|Treatment Period|Death|0
842313|NCT01721057|2772080|P6|Treatment Period|Death|0
842314|NCT01721057|2772081|P5|Treatment Period|Death|0
842315|NCT01721057|2772082|P4|Treatment Period|Death|0
842316|NCT01721057|2772083|P3|Treatment Period|Death|0
842317|NCT01721057|2772084|P2|Treatment Period|Death|0
842318|NCT01721057|2772085|P1|Treatment Period|Death|2
842319|NCT01721057|2772079|P7|Treatment Period|Physician Decision|0
842320|NCT01721057|2772080|P6|Treatment Period|Physician Decision|0
842321|NCT01721057|2772081|P5|Treatment Period|Physician Decision|0
842322|NCT01721057|2772082|P4|Treatment Period|Physician Decision|0
842323|NCT01721057|2772083|P3|Treatment Period|Physician Decision|3
842324|NCT01721057|2772084|P2|Treatment Period|Physician Decision|1
842325|NCT01721057|2772085|P1|Treatment Period|Physician Decision|0
842326|NCT01721057|2772079|P7|Treatment Period|Lost to Follow-up|0
842327|NCT01721057|2772080|P6|Treatment Period|Lost to Follow-up|0
842328|NCT01721057|2772081|P5|Treatment Period|Lost to Follow-up|0
842329|NCT01721057|2772082|P4|Treatment Period|Lost to Follow-up|0
842330|NCT01721057|2772083|P3|Treatment Period|Lost to Follow-up|0
842331|NCT01721057|2772084|P2|Treatment Period|Lost to Follow-up|0
842332|NCT01721057|2772085|P1|Treatment Period|Lost to Follow-up|1
842333|NCT01721057|2772079|P7|Treatment Period|Lack of Efficacy|0
842334|NCT01721057|2772080|P6|Treatment Period|Lack of Efficacy|0
842335|NCT01721057|2772081|P5|Treatment Period|Lack of Efficacy|0
842336|NCT01721057|2772082|P4|Treatment Period|Lack of Efficacy|0
842337|NCT01721057|2772083|P3|Treatment Period|Lack of Efficacy|0
842338|NCT01721057|2772084|P2|Treatment Period|Lack of Efficacy|3
842339|NCT01721057|2772085|P1|Treatment Period|Lack of Efficacy|7
842340|NCT01721057|2772079|P7|Treatment Period|Adverse Event|0
842341|NCT01721057|2772080|P6|Treatment Period|Adverse Event|0
842342|NCT01721057|2772081|P5|Treatment Period|Adverse Event|0
842343|NCT01721057|2772082|P4|Treatment Period|Adverse Event|0
842344|NCT01721057|2772083|P3|Treatment Period|Adverse Event|12
842345|NCT01721057|2772084|P2|Treatment Period|Adverse Event|10
842346|NCT01721057|2772085|P1|Treatment Period|Adverse Event|7
842347|NCT01721057|2772079|P7|Treatment Period|Withdrawal by Subject|0
842348|NCT01721057|2772080|P6|Treatment Period|Withdrawal by Subject|0
842349|NCT01721057|2772081|P5|Treatment Period|Withdrawal by Subject|0
842350|NCT01721057|2772082|P4|Treatment Period|Withdrawal by Subject|0
842351|NCT01721057|2772083|P3|Treatment Period|Withdrawal by Subject|8
842352|NCT01721057|2772084|P2|Treatment Period|Withdrawal by Subject|5
842353|NCT01721057|2772085|P1|Treatment Period|Withdrawal by Subject|11
842354|NCT01721044|2772158|P3|Treatment Period|Withdrawal by Subject|1
842355|NCT01721044|2772159|P2|Treatment Period|Withdrawal by Subject|6
842356|NCT01721044|2772160|P1|Treatment Period|Withdrawal by Subject|7
842357|NCT01721044|2772158|P3|Treatment Period|Protocol Violation|0
842358|NCT01721044|2772159|P2|Treatment Period|Protocol Violation|0
842359|NCT01721044|2772160|P1|Treatment Period|Protocol Violation|1
842360|NCT01721044|2772158|P3|Treatment Period|Physician Decision|2
842361|NCT01721044|2772159|P2|Treatment Period|Physician Decision|0
842362|NCT01721044|2772160|P1|Treatment Period|Physician Decision|1
842363|NCT01721044|2772158|P3|Treatment Period|Lost to Follow-up|1
842364|NCT01721044|2772159|P2|Treatment Period|Lost to Follow-up|0
842365|NCT01721044|2772160|P1|Treatment Period|Lost to Follow-up|0
842366|NCT01721044|2772158|P3|Treatment Period|Lack of Efficacy|4
842367|NCT01721044|2772159|P2|Treatment Period|Lack of Efficacy|4
842368|NCT01721044|2772160|P1|Treatment Period|Lack of Efficacy|16
842369|NCT01721044|2772158|P3|Treatment Period|Death|1
842370|NCT01721044|2772159|P2|Treatment Period|Death|0
842371|NCT01721044|2772160|P1|Treatment Period|Death|0
842372|NCT01721044|2772158|P3|Treatment Period|Adverse Event|10
842373|NCT01721044|2772159|P2|Treatment Period|Adverse Event|7
842374|NCT01721044|2772160|P1|Treatment Period|Adverse Event|7
842375|NCT01720797|2772233|P2|Overall Study|Withdrawal by Subject|0
842376|NCT01720797|2772234|P1|Overall Study|Withdrawal by Subject|3
842377|NCT01720602|2772240|P1|Overall Study|Progressive disease on therapy|2
842378|NCT01720602|2772240|P1|Overall Study|Adverse Event|3
842379|NCT01720446|2772250|P4|Overall Study|Withdrawal by Subject|4
842380|NCT01720446|2772251|P3|Overall Study|Withdrawal by Subject|4
842381|NCT01720446|2772252|P2|Overall Study|Withdrawal by Subject|5
842382|NCT01720446|2772253|P1|Overall Study|Withdrawal by Subject|2
842383|NCT01720446|2772250|P4|Overall Study|Lost to Follow-up|16
842384|NCT01720446|2772251|P3|Overall Study|Lost to Follow-up|16
842385|NCT01720446|2772252|P2|Overall Study|Lost to Follow-up|6
842386|NCT01720446|2772253|P1|Overall Study|Lost to Follow-up|12
842387|NCT01720043|2772395|P1|Overall Study|Withdrawal by Subject|1
842388|NCT01719861|2772399|P1|Cycle 2|Death|1
842389|NCT01719861|2772399|P1|Cycle 1|Death|4
842390|NCT01719783|2772409|P2|Dose 2|Physician Decision|0
842391|NCT01719783|2772410|P1|Dose 2|Physician Decision|1
842392|NCT01719757|2772496|P1|Overall Study|well controlled pain|27
842393|NCT01719757|2772496|P1|Overall Study|Protocol Violation|1
842394|NCT01719757|2772496|P1|Overall Study|Lost to Follow-up|20
842395|NCT01719757|2772496|P1|Overall Study|Withdrawal by Subject|15
842396|NCT01719757|2772496|P1|Overall Study|Adverse Event|38
842397|NCT01719224|2772541|P2|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2
842398|NCT01719224|2772542|P1|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4
842399|NCT01719172|2772551|P1|Overall Study|Death|1
842400|NCT01719172|2772551|P1|Overall Study|Lost to Follow-up|1
842401|NCT01719003|2772565|P9|Overall Study|Lack of Efficacy|0
842402|NCT01719003|2772566|P8|Overall Study|Lack of Efficacy|0
842403|NCT01719003|2772567|P7|Overall Study|Lack of Efficacy|1
842404|NCT01719003|2772568|P6|Overall Study|Lack of Efficacy|0
842405|NCT01719003|2772569|P5|Overall Study|Lack of Efficacy|0
842406|NCT01719003|2772570|P4|Overall Study|Lack of Efficacy|0
842407|NCT01719003|2772571|P3|Overall Study|Lack of Efficacy|0
842408|NCT01719003|2772572|P2|Overall Study|Lack of Efficacy|0
842409|NCT01719003|2772573|P1|Overall Study|Lack of Efficacy|0
842410|NCT01719003|2772565|P9|Overall Study|Reason other than those specified|1
842411|NCT01719003|2772566|P8|Overall Study|Reason other than those specified|3
842412|NCT01719003|2772567|P7|Overall Study|Reason other than those specified|0
842413|NCT01719003|2772568|P6|Overall Study|Reason other than those specified|1
842414|NCT01719003|2772569|P5|Overall Study|Reason other than those specified|4
842415|NCT01719003|2772570|P4|Overall Study|Reason other than those specified|3
842416|NCT01719003|2772571|P3|Overall Study|Reason other than those specified|2
842417|NCT01719003|2772572|P2|Overall Study|Reason other than those specified|0
842418|NCT01719003|2772573|P1|Overall Study|Reason other than those specified|0
842419|NCT01719003|2772565|P9|Overall Study|Refusal to continue, not due to AE|1
842420|NCT01719003|2772566|P8|Overall Study|Refusal to continue, not due to AE|7
842421|NCT01719003|2772567|P7|Overall Study|Refusal to continue, not due to AE|8
842422|NCT01719003|2772568|P6|Overall Study|Refusal to continue, not due to AE|3
842423|NCT01719003|2772569|P5|Overall Study|Refusal to continue, not due to AE|4
842424|NCT01719003|2772570|P4|Overall Study|Refusal to continue, not due to AE|4
842425|NCT01719003|2772571|P3|Overall Study|Refusal to continue, not due to AE|4
842426|NCT01719003|2772572|P2|Overall Study|Refusal to continue, not due to AE|5
842427|NCT01719003|2772573|P1|Overall Study|Refusal to continue, not due to AE|2
842428|NCT01719003|2772565|P9|Overall Study|Lost to Follow-up|2
842429|NCT01719003|2772566|P8|Overall Study|Lost to Follow-up|2
842430|NCT01719003|2772567|P7|Overall Study|Lost to Follow-up|3
842431|NCT01719003|2772568|P6|Overall Study|Lost to Follow-up|4
842432|NCT01719003|2772569|P5|Overall Study|Lost to Follow-up|3
842433|NCT01719003|2772570|P4|Overall Study|Lost to Follow-up|2
842434|NCT01719003|2772571|P3|Overall Study|Lost to Follow-up|7
842435|NCT01719003|2772572|P2|Overall Study|Lost to Follow-up|6
842436|NCT01719003|2772573|P1|Overall Study|Lost to Follow-up|0
842437|NCT01719003|2772565|P9|Overall Study|Adverse Event|0
842438|NCT01719003|2772566|P8|Overall Study|Adverse Event|5
842439|NCT01719003|2772567|P7|Overall Study|Adverse Event|6
842440|NCT01719003|2772568|P6|Overall Study|Adverse Event|3
842441|NCT01719003|2772569|P5|Overall Study|Adverse Event|4
842442|NCT01719003|2772570|P4|Overall Study|Adverse Event|3
842443|NCT01719003|2772571|P3|Overall Study|Adverse Event|4
842444|NCT01719003|2772572|P2|Overall Study|Adverse Event|5
842445|NCT01719003|2772573|P1|Overall Study|Adverse Event|6
842446|NCT01719003|2772565|P9|Overall Study|Non compliant with protocol|0
842447|NCT01719003|2772566|P8|Overall Study|Non compliant with protocol|3
842448|NCT01719003|2772567|P7|Overall Study|Non compliant with protocol|2
842449|NCT01719003|2772568|P6|Overall Study|Non compliant with protocol|1
842450|NCT01719003|2772569|P5|Overall Study|Non compliant with protocol|2
842451|NCT01719003|2772570|P4|Overall Study|Non compliant with protocol|1
842452|NCT01719003|2772571|P3|Overall Study|Non compliant with protocol|0
842453|NCT01719003|2772572|P2|Overall Study|Non compliant with protocol|1
842454|NCT01719003|2772573|P1|Overall Study|Non compliant with protocol|1
842455|NCT01718535|2772654|P10|Overall Study|Bidirectional Sequencing not possible|0
842456|NCT01718535|2772655|P9|Overall Study|Bidirectional Sequencing not possible|0
842457|NCT01718535|2772656|P8|Overall Study|Bidirectional Sequencing not possible|0
842458|NCT01718535|2772657|P7|Overall Study|Bidirectional Sequencing not possible|0
842459|NCT01718535|2772658|P6|Overall Study|Bidirectional Sequencing not possible|0
842460|NCT01718535|2772659|P5|Overall Study|Bidirectional Sequencing not possible|0
842461|NCT01718535|2772660|P4|Overall Study|Bidirectional Sequencing not possible|1
842462|NCT01718535|2772661|P3|Overall Study|Bidirectional Sequencing not possible|0
842463|NCT01718535|2772662|P2|Overall Study|Bidirectional Sequencing not possible|0
842464|NCT01718535|2772663|P1|Overall Study|Bidirectional Sequencing not possible|1
842465|NCT01718509|2772687|P2|Overall Study|Lack of Efficacy|0
842466|NCT01718509|2772688|P1|Overall Study|Lack of Efficacy|1
842467|NCT01718509|2772687|P2|Overall Study|Protocol Violation|2
842468|NCT01718509|2772688|P1|Overall Study|Protocol Violation|4
842469|NCT01718509|2772687|P2|Overall Study|Not specified|11
842470|NCT01718509|2772688|P1|Overall Study|Not specified|13
842471|NCT01718509|2772687|P2|Overall Study|Adverse Event|7
842472|NCT01718509|2772688|P1|Overall Study|Adverse Event|5
842473|NCT01718509|2772687|P2|Overall Study|Withdrawal by Subject|13
842474|NCT01718509|2772688|P1|Overall Study|Withdrawal by Subject|7
842475|NCT01718509|2772687|P2|Overall Study|Lost to Follow-up|15
842476|NCT01718509|2772688|P1|Overall Study|Lost to Follow-up|18
842477|NCT01718483|2772734|P2|Overall Study|Lack of Efficacy|0
842478|NCT01718483|2772735|P1|Overall Study|Lack of Efficacy|1
842479|NCT01718483|2772734|P2|Overall Study|Pregnancy|1
842480|NCT01718483|2772735|P1|Overall Study|Pregnancy|1
842481|NCT01718483|2772734|P2|Overall Study|Not specified|4
842482|NCT01718483|2772735|P1|Overall Study|Not specified|1
842483|NCT01718483|2772734|P2|Overall Study|Protocol Violation|2
842484|NCT01718483|2772735|P1|Overall Study|Protocol Violation|4
842485|NCT01718483|2772734|P2|Overall Study|Lost to Follow-up|3
842486|NCT01718483|2772735|P1|Overall Study|Lost to Follow-up|8
842487|NCT01718483|2772734|P2|Overall Study|Adverse Event|12
842488|NCT01718483|2772735|P1|Overall Study|Adverse Event|5
842489|NCT01718483|2772734|P2|Overall Study|Withdrawal by Subject|12
842490|NCT01718483|2772735|P1|Overall Study|Withdrawal by Subject|14
842491|NCT01718353|2772781|P2|Overall Study|Randomized but not treated|0
842492|NCT01718353|2772782|P1|Overall Study|Randomized but not treated|2
842493|NCT01718353|2772781|P2|Overall Study|Principal Investigator's Decision|4
842494|NCT01718353|2772782|P1|Overall Study|Principal Investigator's Decision|10
842495|NCT01718353|2772781|P2|Overall Study|Lost to Follow-up|1
842496|NCT01718353|2772782|P1|Overall Study|Lost to Follow-up|0
842497|NCT01717989|2772813|P1|Overall Study|Other|40
842498|NCT01717989|2772813|P1|Overall Study|Protocol-specified criteria|551
842499|NCT01717989|2772813|P1|Overall Study|Death|439
842500|NCT01717989|2772813|P1|Overall Study|Lost to Follow-up|11
842501|NCT01717989|2772813|P1|Overall Study|Physician Decision|2
842502|NCT01717989|2772813|P1|Overall Study|Withdrawal by Subject|11
842503|NCT01717989|2772813|P1|Overall Study|Protocol deviation|6
842504|NCT01717989|2772813|P1|Overall Study|Ineligibility determined|6
842505|NCT01717976|2772881|P2|Overall Study|Protocol Violation|1
842506|NCT01717976|2772882|P1|Overall Study|Protocol Violation|0
842507|NCT01717859|2772937|P1|Overall Study|Withdrawal by Subject|2
842508|NCT01717859|2772937|P1|Overall Study|Lost to Follow-up|1
842509|NCT01717859|2772937|P1|Overall Study|Patient concerned about mental health|1
842510|NCT01717859|2772937|P1|Overall Study|Moved out of state|1
842511|NCT01717859|2772937|P1|Overall Study|Adverse Event|5
842512|NCT01717768|2772958|P12|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
842513|NCT01717768|2772959|P11|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
842514|NCT01717768|2772960|P10|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1
842515|NCT01717768|2772961|P9|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
842516|NCT01717768|2772962|P8|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
842517|NCT01717768|2772963|P7|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
842518|NCT01717768|2772964|P6|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
842519|NCT01717768|2772965|P5|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
842520|NCT01717768|2772966|P4|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
842521|NCT01717768|2772967|P3|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
842522|NCT01717768|2772968|P2|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
842523|NCT01717768|2772969|P1|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
842524|NCT01717768|2772958|P12|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
842525|NCT01717768|2772959|P11|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
842526|NCT01717768|2772960|P10|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
842527|NCT01717768|2772961|P9|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
842528|NCT01717768|2772962|P8|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2
842529|NCT01717768|2772963|P7|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
842530|NCT01717768|2772964|P6|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
842531|NCT01717768|2772965|P5|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
842532|NCT01717768|2772966|P4|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
842533|NCT01717768|2772967|P3|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
842534|NCT01717768|2772968|P2|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
842535|NCT01717768|2772969|P1|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
842536|NCT01717768|2772958|P12|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1
842537|NCT01717768|2772959|P11|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
842538|NCT01717768|2772960|P10|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
842539|NCT01717768|2772961|P9|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
842540|NCT01717768|2772962|P8|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
842541|NCT01717768|2772963|P7|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
842542|NCT01717768|2772964|P6|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
842543|NCT01717768|2772965|P5|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
842544|NCT01717768|2772966|P4|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
842545|NCT01717768|2772967|P3|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
842546|NCT01717768|2772968|P2|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
842547|NCT01717768|2772969|P1|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
842548|NCT01717768|2772958|P12|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
842549|NCT01717768|2772959|P11|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
842550|NCT01717768|2772960|P10|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
842551|NCT01717768|2772961|P9|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
842552|NCT01717768|2772962|P8|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
842553|NCT01717768|2772963|P7|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
842554|NCT01717768|2772964|P6|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
842555|NCT01717768|2772965|P5|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
842556|NCT01717768|2772966|P4|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
842557|NCT01717768|2772967|P3|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
842558|NCT01717768|2772968|P2|Part 1 (Duration of 15 Days)|Lost to Follow-up|1
842559|NCT01717768|2772969|P1|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
842560|NCT01717638|2773020|P13|Overall Study|Withdrawal by Subject|18
842561|NCT01717638|2773021|P12|Overall Study|Withdrawal by Subject|0
842562|NCT01717638|2773022|P11|Overall Study|Withdrawal by Subject|0
842563|NCT01717638|2773023|P10|Overall Study|Withdrawal by Subject|1
842564|NCT01717638|2773024|P9|Overall Study|Withdrawal by Subject|2
842565|NCT01717638|2773025|P8|Overall Study|Withdrawal by Subject|1
842566|NCT01717638|2773026|P7|Overall Study|Withdrawal by Subject|2
842567|NCT01717638|2773027|P6|Overall Study|Withdrawal by Subject|0
842568|NCT01717638|2773028|P5|Overall Study|Withdrawal by Subject|1
842569|NCT01717638|2773029|P4|Overall Study|Withdrawal by Subject|0
842570|NCT01717638|2773030|P3|Overall Study|Withdrawal by Subject|1
842571|NCT01717638|2773031|P2|Overall Study|Withdrawal by Subject|1
842572|NCT01717638|2773032|P1|Overall Study|Withdrawal by Subject|0
842573|NCT01717638|2773020|P13|Overall Study|Father in hospital|1
842574|NCT01717638|2773021|P12|Overall Study|Father in hospital|0
842575|NCT01717638|2773022|P11|Overall Study|Father in hospital|0
842576|NCT01717638|2773023|P10|Overall Study|Father in hospital|0
842577|NCT01717638|2773024|P9|Overall Study|Father in hospital|0
842578|NCT01717638|2773025|P8|Overall Study|Father in hospital|0
842579|NCT01717638|2773026|P7|Overall Study|Father in hospital|0
842580|NCT01717638|2773027|P6|Overall Study|Father in hospital|0
842581|NCT01717638|2773028|P5|Overall Study|Father in hospital|0
842582|NCT01717638|2773029|P4|Overall Study|Father in hospital|0
842583|NCT01717638|2773030|P3|Overall Study|Father in hospital|0
842584|NCT01717638|2773031|P2|Overall Study|Father in hospital|0
842585|NCT01717638|2773032|P1|Overall Study|Father in hospital|0
842586|NCT01717638|2773020|P13|Overall Study|Lost to Follow-up|0
842587|NCT01717638|2773021|P12|Overall Study|Lost to Follow-up|0
842588|NCT01717638|2773022|P11|Overall Study|Lost to Follow-up|0
842589|NCT01717638|2773023|P10|Overall Study|Lost to Follow-up|0
842590|NCT01717638|2773024|P9|Overall Study|Lost to Follow-up|0
842591|NCT01717638|2773025|P8|Overall Study|Lost to Follow-up|0
842592|NCT01717638|2773026|P7|Overall Study|Lost to Follow-up|0
842593|NCT01717638|2773027|P6|Overall Study|Lost to Follow-up|1
842594|NCT01717638|2773028|P5|Overall Study|Lost to Follow-up|0
842595|NCT01717638|2773029|P4|Overall Study|Lost to Follow-up|0
842596|NCT01717638|2773030|P3|Overall Study|Lost to Follow-up|0
842597|NCT01717638|2773031|P2|Overall Study|Lost to Follow-up|0
842598|NCT01717638|2773032|P1|Overall Study|Lost to Follow-up|0
842599|NCT01717456|2773176|P2|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
842600|NCT01717456|2773177|P1|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
842601|NCT01717456|2773176|P2|End of Treatment|Lost to Follow-up|1
842602|NCT01717456|2773177|P1|End of Treatment|Lost to Follow-up|0
842603|NCT01717456|2773176|P2|End of Treatment|Physician Decision|1
842604|NCT01717456|2773177|P1|End of Treatment|Physician Decision|0
842605|NCT01717391|2773245|P1|Overall Study|FLT technical failure|3
842606|NCT01717391|2773245|P1|Overall Study|Physician Decision|1
842607|NCT01717391|2773245|P1|Overall Study|Withdrawal by Subject|5
842608|NCT01717326|2773274|P20|Overall Study|Withdrawal by Subject|3
842609|NCT01717326|2773275|P19|Overall Study|Withdrawal by Subject|2
842610|NCT01717326|2773276|P18|Overall Study|Withdrawal by Subject|0
842611|NCT01717326|2773277|P17|Overall Study|Withdrawal by Subject|0
842612|NCT01717326|2773278|P16|Overall Study|Withdrawal by Subject|1
842613|NCT01717326|2773279|P15|Overall Study|Withdrawal by Subject|0
842614|NCT01717326|2773280|P14|Overall Study|Withdrawal by Subject|0
842615|NCT01717326|2773281|P13|Overall Study|Withdrawal by Subject|1
842616|NCT01717326|2773282|P12|Overall Study|Withdrawal by Subject|0
842617|NCT01717326|2773283|P11|Overall Study|Withdrawal by Subject|0
842618|NCT01717326|2773284|P10|Overall Study|Withdrawal by Subject|1
842619|NCT01717326|2773285|P9|Overall Study|Withdrawal by Subject|0
842620|NCT01717326|2773286|P8|Overall Study|Withdrawal by Subject|0
842621|NCT01717326|2773287|P7|Overall Study|Withdrawal by Subject|0
842622|NCT01717326|2773288|P6|Overall Study|Withdrawal by Subject|0
842623|NCT01717326|2773289|P5|Overall Study|Withdrawal by Subject|0
842624|NCT01717326|2773290|P4|Overall Study|Withdrawal by Subject|0
842625|NCT01717326|2773291|P3|Overall Study|Withdrawal by Subject|0
842626|NCT01717326|2773292|P2|Overall Study|Withdrawal by Subject|1
842627|NCT01717326|2773293|P1|Overall Study|Withdrawal by Subject|0
842628|NCT01717326|2773274|P20|Overall Study|Protocol Violation|0
842629|NCT01717326|2773275|P19|Overall Study|Protocol Violation|0
842630|NCT01717326|2773276|P18|Overall Study|Protocol Violation|0
842631|NCT01717326|2773277|P17|Overall Study|Protocol Violation|0
842632|NCT01717326|2773278|P16|Overall Study|Protocol Violation|0
842633|NCT01717326|2773279|P15|Overall Study|Protocol Violation|0
842634|NCT01717326|2773280|P14|Overall Study|Protocol Violation|0
842635|NCT01717326|2773281|P13|Overall Study|Protocol Violation|0
842636|NCT01717326|2773282|P12|Overall Study|Protocol Violation|0
842637|NCT01717326|2773283|P11|Overall Study|Protocol Violation|0
842638|NCT01717326|2773284|P10|Overall Study|Protocol Violation|0
842639|NCT01717326|2773285|P9|Overall Study|Protocol Violation|0
842640|NCT01717326|2773286|P8|Overall Study|Protocol Violation|0
842641|NCT01717326|2773287|P7|Overall Study|Protocol Violation|0
842642|NCT01717326|2773288|P6|Overall Study|Protocol Violation|0
842643|NCT01717326|2773289|P5|Overall Study|Protocol Violation|1
842644|NCT01717326|2773290|P4|Overall Study|Protocol Violation|0
842645|NCT01717326|2773291|P3|Overall Study|Protocol Violation|0
842646|NCT01717326|2773292|P2|Overall Study|Protocol Violation|0
842647|NCT01717326|2773293|P1|Overall Study|Protocol Violation|0
842648|NCT01717326|2773274|P20|Overall Study|Physician Decision|0
842649|NCT01717326|2773275|P19|Overall Study|Physician Decision|0
842650|NCT01717326|2773276|P18|Overall Study|Physician Decision|0
842651|NCT01717326|2773277|P17|Overall Study|Physician Decision|0
842652|NCT01717326|2773278|P16|Overall Study|Physician Decision|0
842653|NCT01717326|2773279|P15|Overall Study|Physician Decision|0
842654|NCT01717326|2773280|P14|Overall Study|Physician Decision|0
842655|NCT01717326|2773281|P13|Overall Study|Physician Decision|0
842656|NCT01717326|2773282|P12|Overall Study|Physician Decision|0
842657|NCT01717326|2773283|P11|Overall Study|Physician Decision|0
842658|NCT01717326|2773284|P10|Overall Study|Physician Decision|1
842659|NCT01717326|2773285|P9|Overall Study|Physician Decision|0
842660|NCT01717326|2773286|P8|Overall Study|Physician Decision|0
842661|NCT01717326|2773287|P7|Overall Study|Physician Decision|0
842662|NCT01717326|2773288|P6|Overall Study|Physician Decision|0
842663|NCT01717326|2773289|P5|Overall Study|Physician Decision|0
842664|NCT01717326|2773290|P4|Overall Study|Physician Decision|0
842665|NCT01717326|2773291|P3|Overall Study|Physician Decision|0
842666|NCT01717326|2773292|P2|Overall Study|Physician Decision|0
842667|NCT01717326|2773293|P1|Overall Study|Physician Decision|0
842668|NCT01717326|2773274|P20|Overall Study|Lost to Follow-up|3
842669|NCT01717326|2773275|P19|Overall Study|Lost to Follow-up|2
842670|NCT01717326|2773276|P18|Overall Study|Lost to Follow-up|0
842671|NCT01717326|2773277|P17|Overall Study|Lost to Follow-up|1
842672|NCT01717326|2773278|P16|Overall Study|Lost to Follow-up|2
842673|NCT01717326|2773279|P15|Overall Study|Lost to Follow-up|0
842674|NCT01717326|2773280|P14|Overall Study|Lost to Follow-up|0
842675|NCT01717326|2773281|P13|Overall Study|Lost to Follow-up|0
842676|NCT01717326|2773282|P12|Overall Study|Lost to Follow-up|0
842677|NCT01717326|2773283|P11|Overall Study|Lost to Follow-up|1
842678|NCT01717326|2773284|P10|Overall Study|Lost to Follow-up|0
842679|NCT01717326|2773285|P9|Overall Study|Lost to Follow-up|0
842680|NCT01717326|2773286|P8|Overall Study|Lost to Follow-up|0
842681|NCT01717326|2773287|P7|Overall Study|Lost to Follow-up|1
842682|NCT01717326|2773288|P6|Overall Study|Lost to Follow-up|0
842683|NCT01717326|2773289|P5|Overall Study|Lost to Follow-up|1
842684|NCT01717326|2773290|P4|Overall Study|Lost to Follow-up|2
842685|NCT01717326|2773291|P3|Overall Study|Lost to Follow-up|0
842686|NCT01717326|2773292|P2|Overall Study|Lost to Follow-up|0
842687|NCT01717326|2773293|P1|Overall Study|Lost to Follow-up|3
842688|NCT01717326|2773274|P20|Overall Study|Death|0
842689|NCT01717326|2773275|P19|Overall Study|Death|0
842690|NCT01717326|2773276|P18|Overall Study|Death|0
842691|NCT01717326|2773277|P17|Overall Study|Death|0
842692|NCT01717326|2773278|P16|Overall Study|Death|0
842693|NCT01717326|2773279|P15|Overall Study|Death|0
842694|NCT01717326|2773280|P14|Overall Study|Death|0
842695|NCT01717326|2773281|P13|Overall Study|Death|0
842696|NCT01717326|2773282|P12|Overall Study|Death|0
842697|NCT01717326|2773283|P11|Overall Study|Death|1
842698|NCT01717326|2773284|P10|Overall Study|Death|0
842699|NCT01717326|2773285|P9|Overall Study|Death|0
842700|NCT01717326|2773286|P8|Overall Study|Death|0
842701|NCT01717326|2773287|P7|Overall Study|Death|0
842702|NCT01717326|2773288|P6|Overall Study|Death|0
842703|NCT01717326|2773289|P5|Overall Study|Death|0
842704|NCT01717326|2773290|P4|Overall Study|Death|0
842705|NCT01717326|2773291|P3|Overall Study|Death|0
842706|NCT01717326|2773292|P2|Overall Study|Death|0
842707|NCT01717326|2773293|P1|Overall Study|Death|0
842708|NCT01717313|2773557|P2|Phase B (Weeks 24 to 54)|Lost to Follow-up|3
842709|NCT01717313|2773558|P1|Phase B (Weeks 24 to 54)|Lost to Follow-up|1
842710|NCT01717313|2773557|P2|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9
842711|NCT01717313|2773558|P1|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7
842712|NCT01717313|2773557|P2|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
842713|NCT01717313|2773558|P1|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
842714|NCT01717313|2773557|P2|Interphase|Completed Phase A Did Not Enter Phase B|0
842715|NCT01717313|2773558|P1|Interphase|Completed Phase A Did Not Enter Phase B|1
842716|NCT01717313|2773557|P2|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
842717|NCT01717313|2773558|P1|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
842718|NCT01717313|2773557|P2|Phase A (Weeks 0 to 24)|Adverse Event|2
842719|NCT01717313|2773558|P1|Phase A (Weeks 0 to 24)|Adverse Event|4
842720|NCT01717313|2773557|P2|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6
842721|NCT01717313|2773558|P1|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12
842722|NCT01717313|2773557|P2|Phase A (Weeks 0 to 24)|Lost to Follow-up|3
842723|NCT01717313|2773558|P1|Phase A (Weeks 0 to 24)|Lost to Follow-up|1
842724|NCT01717313|2773557|P2|Phase A (Weeks 0 to 24)|Death|1
842725|NCT01717313|2773558|P1|Phase A (Weeks 0 to 24)|Death|0
842726|NCT01717287|2773596|P2|Overall Study|Protocol Violation|1
842727|NCT01717287|2773597|P1|Overall Study|Protocol Violation|0
842728|NCT01717287|2773596|P2|Overall Study|Lost to Follow-up|2
842729|NCT01717287|2773597|P1|Overall Study|Lost to Follow-up|0
842730|NCT01717040|2773634|P2|Overall Study|New Substance Use Disorder|0
842731|NCT01717040|2773635|P1|Overall Study|New Substance Use Disorder|1
842732|NCT01717040|2773634|P2|Overall Study|Required Medication Change|1
842733|NCT01717040|2773635|P1|Overall Study|Required Medication Change|0
842734|NCT01717040|2773634|P2|Overall Study|Adverse Event|0
842735|NCT01717040|2773635|P1|Overall Study|Adverse Event|1
842736|NCT01717040|2773634|P2|Overall Study|Lack of Efficacy|1
842737|NCT01717040|2773635|P1|Overall Study|Lack of Efficacy|1
842738|NCT01717040|2773634|P2|Overall Study|Lost to Follow-up|3
842739|NCT01717040|2773635|P1|Overall Study|Lost to Follow-up|2
842740|NCT01716754|2773653|P4|Overall Study|Withdrawal by Subject|3
842741|NCT01716754|2773654|P3|Overall Study|Withdrawal by Subject|4
842742|NCT01716754|2773655|P2|Overall Study|Withdrawal by Subject|0
842743|NCT01716754|2773656|P1|Overall Study|Withdrawal by Subject|5
842744|NCT01716754|2773653|P4|Overall Study|Adverse Event|1
842745|NCT01716754|2773654|P3|Overall Study|Adverse Event|2
842746|NCT01716754|2773655|P2|Overall Study|Adverse Event|2
842747|NCT01716754|2773656|P1|Overall Study|Adverse Event|4
842748|NCT01716754|2773653|P4|Overall Study|Lost to Follow-up|1
842749|NCT01716754|2773654|P3|Overall Study|Lost to Follow-up|0
842750|NCT01716754|2773655|P2|Overall Study|Lost to Follow-up|0
842751|NCT01716754|2773656|P1|Overall Study|Lost to Follow-up|1
842752|NCT01716754|2773653|P4|Overall Study|Physician Decision|0
842753|NCT01716754|2773654|P3|Overall Study|Physician Decision|0
842754|NCT01716754|2773655|P2|Overall Study|Physician Decision|0
842755|NCT01716754|2773656|P1|Overall Study|Physician Decision|1
842756|NCT01716754|2773653|P4|Overall Study|Non-compliance with study treatment|0
842757|NCT01716754|2773654|P3|Overall Study|Non-compliance with study treatment|1
842758|NCT01716754|2773655|P2|Overall Study|Non-compliance with study treatment|0
842759|NCT01716754|2773656|P1|Overall Study|Non-compliance with study treatment|0
842760|NCT01716754|2773653|P4|Overall Study|Protocol deviation|2
842761|NCT01716754|2773654|P3|Overall Study|Protocol deviation|7
842762|NCT01716754|2773655|P2|Overall Study|Protocol deviation|2
842763|NCT01716754|2773656|P1|Overall Study|Protocol deviation|0
842764|NCT01716754|2773653|P4|Overall Study|Death|1
842765|NCT01716754|2773654|P3|Overall Study|Death|0
842766|NCT01716754|2773655|P2|Overall Study|Death|0
842767|NCT01716754|2773656|P1|Overall Study|Death|0
842768|NCT01716663|2773677|P1|Overall Study|Treated with non-study catheter|2
842769|NCT01716663|2773677|P1|Overall Study|Withdrawn prior to procedure|4
842770|NCT01716585|2773687|P2|Open-label Treatment|Withdrawal by Subject|3
842771|NCT01716585|2773688|P1|Open-label Treatment|Withdrawal by Subject|0
842772|NCT01716585|2773687|P2|Open-label Treatment|Virologic Failure|2
842773|NCT01716585|2773688|P1|Open-label Treatment|Virologic Failure|0
842774|NCT01716585|2773687|P2|Open-label Treatment|Adverse Event|2
842775|NCT01716585|2773688|P1|Open-label Treatment|Adverse Event|0
842776|NCT01716585|2773687|P2|Double-blind Treatment|Not Specified|0
842777|NCT01716585|2773688|P1|Double-blind Treatment|Not Specified|1
842778|NCT01716585|2773687|P2|Double-blind Treatment|Subject Noncompliant|0
842779|NCT01716585|2773688|P1|Double-blind Treatment|Subject Noncompliant|1
842780|NCT01716585|2773687|P2|Double-blind Treatment|Lost to Follow-up|0
842781|NCT01716585|2773688|P1|Double-blind Treatment|Lost to Follow-up|2
842782|NCT01716585|2773687|P2|Double-blind Treatment|Withdrawal by Subject|0
842783|NCT01716585|2773688|P1|Double-blind Treatment|Withdrawal by Subject|3
842784|NCT01716585|2773687|P2|Double-blind Treatment|Adverse Event|1
842785|NCT01716585|2773688|P1|Double-blind Treatment|Adverse Event|2
842786|NCT01716585|2773687|P2|Double-blind Treatment|Did Not Receive Study Drug|1
842787|NCT01716585|2773688|P1|Double-blind Treatment|Did Not Receive Study Drug|4
842788|NCT01716559|2773700|P1|Overall Study|Other withdrawal reason|75
842789|NCT01716559|2773700|P1|Overall Study|Withdrawal by Subject|4
842790|NCT01716559|2773700|P1|Overall Study|Death|21
842791|NCT01716559|2773700|P1|Overall Study|Adverse Event|11
842792|NCT01716520|2773708|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
842793|NCT01716520|2773709|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
842794|NCT01716520|2773710|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
842795|NCT01716520|2773711|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
842796|NCT01716520|2773712|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
842797|NCT01716520|2773713|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
842798|NCT01716520|2773708|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|2
842799|NCT01716520|2773709|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
842800|NCT01716520|2773710|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
842801|NCT01716520|2773711|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
842802|NCT01716520|2773712|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
842803|NCT01716520|2773713|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
842804|NCT01716520|2773708|P6|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
842805|NCT01716520|2773709|P5|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
842806|NCT01716520|2773710|P4|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
842807|NCT01716520|2773711|P3|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
842808|NCT01716520|2773712|P2|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1
842809|NCT01716520|2773713|P1|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
842810|NCT01716520|2773708|P6|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1
842811|NCT01716520|2773709|P5|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
842812|NCT01716520|2773710|P4|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
842813|NCT01716520|2773711|P3|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
842814|NCT01716520|2773712|P2|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
842815|NCT01716520|2773713|P1|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
842816|NCT01716520|2773708|P6|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
842817|NCT01716520|2773709|P5|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
842818|NCT01716520|2773710|P4|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
842819|NCT01716520|2773711|P3|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
842820|NCT01716520|2773712|P2|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
842821|NCT01716520|2773713|P1|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1
842822|NCT01716520|2773708|P6|Washout Period 2 (10 to 14 Days)|Adverse Event|1
842823|NCT01716520|2773709|P5|Washout Period 2 (10 to 14 Days)|Adverse Event|0
842824|NCT01716520|2773710|P4|Washout Period 2 (10 to 14 Days)|Adverse Event|0
842825|NCT01716520|2773711|P3|Washout Period 2 (10 to 14 Days)|Adverse Event|1
842826|NCT01716520|2773712|P2|Washout Period 2 (10 to 14 Days)|Adverse Event|0
842827|NCT01716520|2773713|P1|Washout Period 2 (10 to 14 Days)|Adverse Event|1
842828|NCT01716520|2773708|P6|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
842829|NCT01716520|2773709|P5|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
842830|NCT01716520|2773710|P4|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1
842831|NCT01716520|2773711|P3|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
842832|NCT01716520|2773712|P2|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
842833|NCT01716520|2773713|P1|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
842834|NCT01716520|2773708|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
842835|NCT01716520|2773709|P5|Treatment Period 2 (14 Days)|Protocol Violation|1
842836|NCT01716520|2773710|P4|Treatment Period 2 (14 Days)|Protocol Violation|0
842837|NCT01716520|2773711|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
842838|NCT01716520|2773712|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
842839|NCT01716520|2773713|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
842840|NCT01716520|2773708|P6|Treatment Period 2 (14 Days)|Adverse Event|0
842841|NCT01716520|2773709|P5|Treatment Period 2 (14 Days)|Adverse Event|1
842842|NCT01716520|2773710|P4|Treatment Period 2 (14 Days)|Adverse Event|0
842843|NCT01716520|2773711|P3|Treatment Period 2 (14 Days)|Adverse Event|0
842844|NCT01716520|2773712|P2|Treatment Period 2 (14 Days)|Adverse Event|0
842845|NCT01716520|2773713|P1|Treatment Period 2 (14 Days)|Adverse Event|0
842846|NCT01716520|2773708|P6|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
842847|NCT01716520|2773709|P5|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
842848|NCT01716520|2773710|P4|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
842849|NCT01716520|2773711|P3|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
842850|NCT01716520|2773712|P2|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
842851|NCT01716520|2773713|P1|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
842852|NCT01716520|2773708|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
842853|NCT01716520|2773709|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
842854|NCT01716520|2773710|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
842855|NCT01716520|2773711|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
842856|NCT01716520|2773712|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
842857|NCT01716520|2773713|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
842858|NCT01716520|2773708|P6|Washout Period 1 (10 to 14 Days)|Adverse Event|0
842859|NCT01716520|2773709|P5|Washout Period 1 (10 to 14 Days)|Adverse Event|0
842860|NCT01716520|2773710|P4|Washout Period 1 (10 to 14 Days)|Adverse Event|0
842861|NCT01716520|2773711|P3|Washout Period 1 (10 to 14 Days)|Adverse Event|0
842862|NCT01716520|2773712|P2|Washout Period 1 (10 to 14 Days)|Adverse Event|1
842863|NCT01716520|2773713|P1|Washout Period 1 (10 to 14 Days)|Adverse Event|0
842864|NCT01716520|2773708|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
842865|NCT01716520|2773709|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
842866|NCT01716520|2773710|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
842867|NCT01716520|2773711|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
842868|NCT01716520|2773712|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
842869|NCT01716520|2773713|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
842870|NCT01716520|2773708|P6|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
842871|NCT01716520|2773709|P5|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
842872|NCT01716520|2773710|P4|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
842873|NCT01716520|2773711|P3|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2
842874|NCT01716520|2773712|P2|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
842875|NCT01716520|2773713|P1|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
842876|NCT01716520|2773708|P6|Treatment Period 1 (14 Days)|Adverse Event|0
842877|NCT01716520|2773709|P5|Treatment Period 1 (14 Days)|Adverse Event|0
842878|NCT01716520|2773710|P4|Treatment Period 1 (14 Days)|Adverse Event|0
842879|NCT01716520|2773711|P3|Treatment Period 1 (14 Days)|Adverse Event|0
842880|NCT01716520|2773712|P2|Treatment Period 1 (14 Days)|Adverse Event|0
842881|NCT01716520|2773713|P1|Treatment Period 1 (14 Days)|Adverse Event|1
842882|NCT01716234|2773768|P7|Overall Study|Withdrawal by Subject|0
842883|NCT01716234|2773769|P6|Overall Study|Withdrawal by Subject|3
842884|NCT01716234|2773770|P5|Overall Study|Withdrawal by Subject|1
842885|NCT01716234|2773771|P4|Overall Study|Withdrawal by Subject|2
842886|NCT01716234|2773772|P3|Overall Study|Withdrawal by Subject|2
842887|NCT01716234|2773773|P2|Overall Study|Withdrawal by Subject|0
842888|NCT01716234|2773774|P1|Overall Study|Withdrawal by Subject|3
842889|NCT01716234|2773768|P7|Overall Study|Adverse Event|0
842890|NCT01716234|2773769|P6|Overall Study|Adverse Event|6
842891|NCT01716234|2773770|P5|Overall Study|Adverse Event|3
842892|NCT01716234|2773771|P4|Overall Study|Adverse Event|8
842893|NCT01716234|2773772|P3|Overall Study|Adverse Event|2
842894|NCT01716234|2773773|P2|Overall Study|Adverse Event|10
842895|NCT01716234|2773774|P1|Overall Study|Adverse Event|7
842896|NCT01716234|2773768|P7|Overall Study|Did not meet protocol eligibility|0
842897|NCT01716234|2773769|P6|Overall Study|Did not meet protocol eligibility|4
842898|NCT01716234|2773770|P5|Overall Study|Did not meet protocol eligibility|0
842899|NCT01716234|2773771|P4|Overall Study|Did not meet protocol eligibility|0
842900|NCT01716234|2773772|P3|Overall Study|Did not meet protocol eligibility|1
842901|NCT01716234|2773773|P2|Overall Study|Did not meet protocol eligibility|0
842902|NCT01716234|2773774|P1|Overall Study|Did not meet protocol eligibility|0
842903|NCT01716234|2773768|P7|Overall Study|Lack of Efficacy|0
842904|NCT01716234|2773769|P6|Overall Study|Lack of Efficacy|0
842905|NCT01716234|2773770|P5|Overall Study|Lack of Efficacy|0
842906|NCT01716234|2773771|P4|Overall Study|Lack of Efficacy|1
842907|NCT01716234|2773772|P3|Overall Study|Lack of Efficacy|0
842908|NCT01716234|2773773|P2|Overall Study|Lack of Efficacy|0
842909|NCT01716234|2773774|P1|Overall Study|Lack of Efficacy|0
842910|NCT01716234|2773768|P7|Overall Study|Protocol Violation|0
842911|NCT01716234|2773769|P6|Overall Study|Protocol Violation|1
842912|NCT01716234|2773770|P5|Overall Study|Protocol Violation|1
842913|NCT01716234|2773771|P4|Overall Study|Protocol Violation|1
842914|NCT01716234|2773772|P3|Overall Study|Protocol Violation|0
842915|NCT01716234|2773773|P2|Overall Study|Protocol Violation|0
842916|NCT01716234|2773774|P1|Overall Study|Protocol Violation|0
842917|NCT01716169|2773837|P1|Overall Study|inconsistent dressing application|1
842918|NCT01716169|2773837|P1|Overall Study|Withdrawal by Subject|1
842919|NCT01716169|2773837|P1|Overall Study|Lost to Follow-up|1
842920|NCT01716169|2773837|P1|Overall Study|Adverse Event|1
842921|NCT01716156|2773846|P3|Overall Study|Lost to Follow-up|0
842922|NCT01716156|2773847|P2|Overall Study|Lost to Follow-up|0
842923|NCT01716156|2773848|P1|Overall Study|Lost to Follow-up|1
842924|NCT01716156|2773846|P3|Overall Study|Withdrawal by Subject|2
842925|NCT01716156|2773847|P2|Overall Study|Withdrawal by Subject|1
842926|NCT01716156|2773848|P1|Overall Study|Withdrawal by Subject|0
842927|NCT01716156|2773846|P3|Overall Study|Protocol Violation|0
842928|NCT01716156|2773847|P2|Overall Study|Protocol Violation|0
842929|NCT01716156|2773848|P1|Overall Study|Protocol Violation|1
842930|NCT01716104|2773874|P2|Overall Study|Do not meet inclusion criteria|7
842931|NCT01716104|2773875|P1|Overall Study|Do not meet inclusion criteria|6
842932|NCT01716052|2773901|P2|Overall Study|Withdrawal of funding|1
842933|NCT01716052|2773902|P1|Overall Study|Withdrawal of funding|1
842934|NCT01715896|2773944|P2|Overall Study|Other|5
842935|NCT01715896|2773945|P1|Overall Study|Other|2
842936|NCT01715896|2773944|P2|Overall Study|Withdrawal by Subject|4
842937|NCT01715896|2773945|P1|Overall Study|Withdrawal by Subject|1
842938|NCT01715896|2773944|P2|Overall Study|Lost to Follow-up|2
842939|NCT01715896|2773945|P1|Overall Study|Lost to Follow-up|0
842940|NCT01715857|2774018|P1|Overall Study|Did Not Meet Eligibility Criteria|96
842941|NCT01715831|2774028|P1|Overall Study|Adverse Event|1
842942|NCT01715415|2774046|P2|Open-label Treatment|Subject Noncompliant|1
842943|NCT01715415|2774047|P1|Open-label Treatment|Subject Noncompliant|0
842944|NCT01715415|2774046|P2|Open-label Treatment|Adverse Event|1
842945|NCT01715415|2774047|P1|Open-label Treatment|Adverse Event|0
842946|NCT01715415|2774046|P2|Double-blind Treatment|Not Specified|0
842947|NCT01715415|2774047|P1|Double-blind Treatment|Not Specified|1
842948|NCT01715415|2774046|P2|Double-blind Treatment|Withdrawal by Subject|1
842949|NCT01715415|2774047|P1|Double-blind Treatment|Withdrawal by Subject|1
842950|NCT01715415|2774046|P2|Double-blind Treatment|Adverse Event|0
842951|NCT01715415|2774047|P1|Double-blind Treatment|Adverse Event|3
842952|NCT01715415|2774046|P2|Double-blind Treatment|Did Not Receive Study Drug|1
842953|NCT01715415|2774047|P1|Double-blind Treatment|Did Not Receive Study Drug|0
842954|NCT01715298|2774061|P2|Overall Study|Patient/guardian decision|9
842955|NCT01715298|2774062|P1|Overall Study|Patient/guardian decision|7
842956|NCT01715298|2774061|P2|Overall Study|Lost to Follow-up|2
842957|NCT01715298|2774062|P1|Overall Study|Lost to Follow-up|0
842958|NCT01715285|2774100|P2|Overall Study|Other|5
842959|NCT01715285|2774101|P1|Overall Study|Other|7
842960|NCT01715285|2774100|P2|Overall Study|Ongoing|112
842961|NCT01715285|2774101|P1|Overall Study|Ongoing|257
842962|NCT01715285|2774100|P2|Overall Study|Physician Decision|19
842963|NCT01715285|2774101|P1|Overall Study|Physician Decision|11
842964|NCT01715285|2774100|P2|Overall Study|Withdrawal Of Consent|41
842965|NCT01715285|2774101|P1|Overall Study|Withdrawal Of Consent|31
842966|NCT01715285|2774100|P2|Overall Study|Progressive Disease|369
842967|NCT01715285|2774101|P1|Overall Study|Progressive Disease|209
842968|NCT01715285|2774100|P2|Overall Study|Noncompliance With Study Drug|2
842969|NCT01715285|2774101|P1|Overall Study|Noncompliance With Study Drug|4
842970|NCT01715285|2774100|P2|Overall Study|Death|21
842971|NCT01715285|2774101|P1|Overall Study|Death|26
842972|NCT01715285|2774100|P2|Overall Study|Lost to Follow-up|2
842973|NCT01715285|2774101|P1|Overall Study|Lost to Follow-up|3
842974|NCT01715285|2774100|P2|Overall Study|Adverse Event|31
842975|NCT01715285|2774101|P1|Overall Study|Adverse Event|49
842976|NCT01715129|2774130|P1|Overall Study|Other|1
842977|NCT01715129|2774130|P1|Overall Study|Lost to Follow-up|1
842978|NCT01715129|2774130|P1|Overall Study|Consent Withdrawn|2
842979|NCT01715129|2774130|P1|Overall Study|Protocol Violation|1
842980|NCT01715129|2774130|P1|Overall Study|Lack of Efficacy|3
842981|NCT01715129|2774130|P1|Overall Study|Adverse Event, fatal|1
842982|NCT01714947|2774156|P1|Part B|Progressive Disease|3
842983|NCT01714817|2774197|P2|Overall Study|Hypersensitivity to the medication|1
842984|NCT01714817|2774198|P1|Overall Study|Hypersensitivity to the medication|0
842985|NCT01714817|2774197|P2|Overall Study|Antiproteinuric changed/dose increased|1
842986|NCT01714817|2774198|P1|Overall Study|Antiproteinuric changed/dose increased|0
842987|NCT01714817|2774197|P2|Overall Study|Need of use of Prohibited Medications|0
842988|NCT01714817|2774198|P1|Overall Study|Need of use of Prohibited Medications|1
842989|NCT01714817|2774197|P2|Overall Study|Change in Concomitant Medication|1
842990|NCT01714817|2774198|P1|Overall Study|Change in Concomitant Medication|0
842991|NCT01714817|2774197|P2|Overall Study|Not treated- received ACE inhibition|0
842992|NCT01714817|2774198|P1|Overall Study|Not treated- received ACE inhibition|1
842993|NCT01714817|2774197|P2|Overall Study|Participant no longer meets criteria|2
842994|NCT01714817|2774198|P1|Overall Study|Participant no longer meets criteria|6
842995|NCT01714817|2774197|P2|Overall Study|Pregnancy|0
842996|NCT01714817|2774198|P1|Overall Study|Pregnancy|2
842997|NCT01714817|2774197|P2|Overall Study|Poor / non-compliance|1
842998|NCT01714817|2774198|P1|Overall Study|Poor / non-compliance|0
842999|NCT01714817|2774197|P2|Overall Study|Lost to Follow-up|2
843000|NCT01714817|2774198|P1|Overall Study|Lost to Follow-up|0
843001|NCT01714817|2774197|P2|Overall Study|Death|1
843002|NCT01714817|2774198|P1|Overall Study|Death|1
843003|NCT01714817|2774197|P2|Overall Study|Withdrawal by Subject|7
843004|NCT01714817|2774198|P1|Overall Study|Withdrawal by Subject|6
843005|NCT01714817|2774197|P2|Overall Study|Adverse Event|17
843006|NCT01714817|2774198|P1|Overall Study|Adverse Event|20
843007|NCT01714817|2774197|P2|Overall Study|Lack of Efficacy|9
843008|NCT01714817|2774198|P1|Overall Study|Lack of Efficacy|11
843009|NCT01714635|2774231|P3|Overall Study|Missed 6-month exam|0
843010|NCT01714635|2774232|P2|Overall Study|Missed 6-month exam|0
843011|NCT01714635|2774233|P1|Overall Study|Missed 6-month exam|1
843012|NCT01714635|2774231|P3|Overall Study|Discontinued|2
843013|NCT01714635|2774232|P2|Overall Study|Discontinued|0
843014|NCT01714635|2774233|P1|Overall Study|Discontinued|1
843015|NCT01714609|2774249|P2|Overall Study|Protocol Violation|0
843016|NCT01714609|2774250|P1|Overall Study|Protocol Violation|1
843017|NCT01714544|2774256|P1|Overall Study|Withdrawal by Subject|1
843018|NCT01714544|2774256|P1|Overall Study|Physician Decision|1
843019|NCT01714544|2774256|P1|Overall Study|Lost to Follow-up|1
843020|NCT01714310|2774327|P3|Double Blind Adjunctive Treatment|Protocol Violation|0
843021|NCT01714310|2774328|P2|Double Blind Adjunctive Treatment|Protocol Violation|2
843022|NCT01714310|2774329|P1|Double Blind Adjunctive Treatment|Protocol Violation|1
843023|NCT01714310|2774327|P3|Double Blind Adjunctive Treatment|Adverse Event|0
843024|NCT01714310|2774328|P2|Double Blind Adjunctive Treatment|Adverse Event|1
843025|NCT01714310|2774329|P1|Double Blind Adjunctive Treatment|Adverse Event|1
843026|NCT01714310|2774327|P3|Open Lisdexamfetamine Titration|Adverse Event|3
843027|NCT01714310|2774328|P2|Open Lisdexamfetamine Titration|Adverse Event|0
843028|NCT01714310|2774329|P1|Open Lisdexamfetamine Titration|Adverse Event|0
843029|NCT01714310|2774327|P3|Open Lisdexamfetamine Titration|Protocol Violation|1
843030|NCT01714310|2774328|P2|Open Lisdexamfetamine Titration|Protocol Violation|0
843031|NCT01714310|2774329|P1|Open Lisdexamfetamine Titration|Protocol Violation|0
843032|NCT01713998|2774407|P3|Overall Study|Withdrawal by Subject|0
843033|NCT01713998|2774408|P2|Overall Study|Withdrawal by Subject|0
843034|NCT01713998|2774409|P1|Overall Study|Withdrawal by Subject|1
843035|NCT01713998|2774407|P3|Overall Study|Lost to Follow-up|2
843036|NCT01713998|2774408|P2|Overall Study|Lost to Follow-up|0
843037|NCT01713998|2774409|P1|Overall Study|Lost to Follow-up|2
843038|NCT01713946|2774430|P3|Overall Study|Patients never switched to everolimus|5
843039|NCT01713946|2774431|P2|Overall Study|Patients never switched to everolimus|0
843040|NCT01713946|2774432|P1|Overall Study|Patients never switched to everolimus|0
843041|NCT01713946|2774430|P3|Overall Study|Did not continue in Post-Ext. Phase|0
843042|NCT01713946|2774431|P2|Overall Study|Did not continue in Post-Ext. Phase|2
843043|NCT01713946|2774432|P1|Overall Study|Did not continue in Post-Ext. Phase|1
843044|NCT01713946|2774430|P3|Overall Study|Did not continue in Ext|0
843045|NCT01713946|2774431|P2|Overall Study|Did not continue in Ext|3
843046|NCT01713946|2774432|P1|Overall Study|Did not continue in Ext|0
843047|NCT01713946|2774430|P3|Overall Study|Administrative problems|0
843048|NCT01713946|2774431|P2|Overall Study|Administrative problems|0
843049|NCT01713946|2774432|P1|Overall Study|Administrative problems|1
843050|NCT01713946|2774430|P3|Overall Study|Lost to Follow-up|1
843051|NCT01713946|2774431|P2|Overall Study|Lost to Follow-up|0
843052|NCT01713946|2774432|P1|Overall Study|Lost to Follow-up|0
843053|NCT01713946|2774430|P3|Overall Study|Protocol Violation|1
843054|NCT01713946|2774431|P2|Overall Study|Protocol Violation|4
843055|NCT01713946|2774432|P1|Overall Study|Protocol Violation|2
843056|NCT01713946|2774430|P3|Overall Study|Lack of Efficacy|14
843057|NCT01713946|2774431|P2|Overall Study|Lack of Efficacy|8
843058|NCT01713946|2774432|P1|Overall Study|Lack of Efficacy|8
843059|NCT01713946|2774430|P3|Overall Study|Withdrawal by Subject|8
843060|NCT01713946|2774431|P2|Overall Study|Withdrawal by Subject|12
843061|NCT01713946|2774432|P1|Overall Study|Withdrawal by Subject|12
843062|NCT01713946|2774430|P3|Overall Study|Adverse Event|13
843063|NCT01713946|2774431|P2|Overall Study|Adverse Event|14
843064|NCT01713946|2774432|P1|Overall Study|Adverse Event|19
843065|NCT01713946|2774430|P3|Overall Study|Death|2
843066|NCT01713946|2774431|P2|Overall Study|Death|2
843067|NCT01713946|2774432|P1|Overall Study|Death|0
843068|NCT01713933|2774523|P1|Overall Study|Excluded from analysis as a BMI outlier|1
843069|NCT01713933|2774523|P1|Overall Study|Withdrawal by Subject|3
843070|NCT01713933|2774523|P1|Overall Study|Lost to Follow-up|2
843071|NCT01713686|2774535|P1|Overall Study|Withdrawal by Subject|6
843072|NCT01713686|2774535|P1|Overall Study|Lost to Follow-up|9
843073|NCT01713582|2774605|P21|Overall Study|Disease progression and adverse event|0
843074|NCT01713582|2774606|P20|Overall Study|Disease progression and adverse event|0
843075|NCT01713582|2774607|P19|Overall Study|Disease progression and adverse event|0
843076|NCT01713582|2774608|P18|Overall Study|Disease progression and adverse event|0
843077|NCT01713582|2774609|P17|Overall Study|Disease progression and adverse event|1
843078|NCT01713582|2774610|P16|Overall Study|Disease progression and adverse event|0
843079|NCT01713582|2774611|P15|Overall Study|Disease progression and adverse event|0
843080|NCT01713582|2774612|P14|Overall Study|Disease progression and adverse event|0
843081|NCT01713582|2774613|P13|Overall Study|Disease progression and adverse event|0
843082|NCT01713582|2774614|P12|Overall Study|Disease progression and adverse event|0
843083|NCT01713582|2774615|P11|Overall Study|Disease progression and adverse event|0
843084|NCT01713582|2774616|P10|Overall Study|Disease progression and adverse event|0
843085|NCT01713582|2774617|P9|Overall Study|Disease progression and adverse event|0
843086|NCT01713582|2774618|P8|Overall Study|Disease progression and adverse event|0
843087|NCT01713582|2774619|P7|Overall Study|Disease progression and adverse event|0
843088|NCT01713582|2774620|P6|Overall Study|Disease progression and adverse event|0
843089|NCT01713582|2774621|P5|Overall Study|Disease progression and adverse event|0
843090|NCT01713582|2774622|P4|Overall Study|Disease progression and adverse event|0
843091|NCT01713582|2774623|P3|Overall Study|Disease progression and adverse event|0
843092|NCT01713582|2774624|P2|Overall Study|Disease progression and adverse event|0
843093|NCT01713582|2774625|P1|Overall Study|Disease progression and adverse event|0
843094|NCT01713582|2774605|P21|Overall Study|Stopped to receive bone marrow graft|0
843095|NCT01713582|2774606|P20|Overall Study|Stopped to receive bone marrow graft|0
843096|NCT01713582|2774607|P19|Overall Study|Stopped to receive bone marrow graft|0
843097|NCT01713582|2774608|P18|Overall Study|Stopped to receive bone marrow graft|0
843098|NCT01713582|2774609|P17|Overall Study|Stopped to receive bone marrow graft|1
843099|NCT01713582|2774610|P16|Overall Study|Stopped to receive bone marrow graft|0
843100|NCT01713582|2774611|P15|Overall Study|Stopped to receive bone marrow graft|0
843101|NCT01713582|2774612|P14|Overall Study|Stopped to receive bone marrow graft|0
843102|NCT01713582|2774613|P13|Overall Study|Stopped to receive bone marrow graft|0
843103|NCT01713582|2774614|P12|Overall Study|Stopped to receive bone marrow graft|0
843104|NCT01713582|2774615|P11|Overall Study|Stopped to receive bone marrow graft|0
843105|NCT01713582|2774616|P10|Overall Study|Stopped to receive bone marrow graft|0
843106|NCT01713582|2774617|P9|Overall Study|Stopped to receive bone marrow graft|0
843107|NCT01713582|2774618|P8|Overall Study|Stopped to receive bone marrow graft|0
843108|NCT01713582|2774619|P7|Overall Study|Stopped to receive bone marrow graft|0
843109|NCT01713582|2774620|P6|Overall Study|Stopped to receive bone marrow graft|0
843110|NCT01713582|2774621|P5|Overall Study|Stopped to receive bone marrow graft|0
843111|NCT01713582|2774622|P4|Overall Study|Stopped to receive bone marrow graft|0
843112|NCT01713582|2774623|P3|Overall Study|Stopped to receive bone marrow graft|0
843113|NCT01713582|2774624|P2|Overall Study|Stopped to receive bone marrow graft|0
843114|NCT01713582|2774625|P1|Overall Study|Stopped to receive bone marrow graft|0
843115|NCT01713582|2774605|P21|Overall Study|Withdrawal by Subject|0
843116|NCT01713582|2774606|P20|Overall Study|Withdrawal by Subject|0
843117|NCT01713582|2774607|P19|Overall Study|Withdrawal by Subject|0
843118|NCT01713582|2774608|P18|Overall Study|Withdrawal by Subject|1
843119|NCT01713582|2774609|P17|Overall Study|Withdrawal by Subject|0
843120|NCT01713582|2774610|P16|Overall Study|Withdrawal by Subject|0
843121|NCT01713582|2774611|P15|Overall Study|Withdrawal by Subject|0
843122|NCT01713582|2774612|P14|Overall Study|Withdrawal by Subject|0
843123|NCT01713582|2774613|P13|Overall Study|Withdrawal by Subject|0
843124|NCT01713582|2774614|P12|Overall Study|Withdrawal by Subject|0
843125|NCT01713582|2774615|P11|Overall Study|Withdrawal by Subject|0
843126|NCT01713582|2774616|P10|Overall Study|Withdrawal by Subject|0
843127|NCT01713582|2774617|P9|Overall Study|Withdrawal by Subject|0
843128|NCT01713582|2774618|P8|Overall Study|Withdrawal by Subject|0
843129|NCT01713582|2774619|P7|Overall Study|Withdrawal by Subject|0
843130|NCT01713582|2774620|P6|Overall Study|Withdrawal by Subject|0
843131|NCT01713582|2774621|P5|Overall Study|Withdrawal by Subject|0
843132|NCT01713582|2774622|P4|Overall Study|Withdrawal by Subject|0
843133|NCT01713582|2774623|P3|Overall Study|Withdrawal by Subject|0
843134|NCT01713582|2774624|P2|Overall Study|Withdrawal by Subject|0
843135|NCT01713582|2774625|P1|Overall Study|Withdrawal by Subject|0
843136|NCT01713582|2774605|P21|Overall Study|Lack of Efficacy|0
843137|NCT01713582|2774606|P20|Overall Study|Lack of Efficacy|0
843138|NCT01713582|2774607|P19|Overall Study|Lack of Efficacy|0
843139|NCT01713582|2774608|P18|Overall Study|Lack of Efficacy|0
843140|NCT01713582|2774609|P17|Overall Study|Lack of Efficacy|0
843141|NCT01713582|2774610|P16|Overall Study|Lack of Efficacy|0
843142|NCT01713582|2774611|P15|Overall Study|Lack of Efficacy|0
843143|NCT01713582|2774612|P14|Overall Study|Lack of Efficacy|0
843144|NCT01713582|2774613|P13|Overall Study|Lack of Efficacy|0
843145|NCT01713582|2774614|P12|Overall Study|Lack of Efficacy|0
843146|NCT01713582|2774615|P11|Overall Study|Lack of Efficacy|2
843147|NCT01713582|2774616|P10|Overall Study|Lack of Efficacy|1
843148|NCT01713582|2774617|P9|Overall Study|Lack of Efficacy|0
843149|NCT01713582|2774618|P8|Overall Study|Lack of Efficacy|0
843150|NCT01713582|2774619|P7|Overall Study|Lack of Efficacy|0
843151|NCT01713582|2774620|P6|Overall Study|Lack of Efficacy|0
843152|NCT01713582|2774621|P5|Overall Study|Lack of Efficacy|0
843153|NCT01713582|2774622|P4|Overall Study|Lack of Efficacy|0
843154|NCT01713582|2774623|P3|Overall Study|Lack of Efficacy|0
843155|NCT01713582|2774624|P2|Overall Study|Lack of Efficacy|0
843156|NCT01713582|2774625|P1|Overall Study|Lack of Efficacy|0
843157|NCT01713582|2774605|P21|Overall Study|Withdrawal of consent|0
843158|NCT01713582|2774606|P20|Overall Study|Withdrawal of consent|0
843159|NCT01713582|2774607|P19|Overall Study|Withdrawal of consent|1
843160|NCT01713582|2774608|P18|Overall Study|Withdrawal of consent|0
843161|NCT01713582|2774609|P17|Overall Study|Withdrawal of consent|0
843162|NCT01713582|2774610|P16|Overall Study|Withdrawal of consent|0
843163|NCT01713582|2774611|P15|Overall Study|Withdrawal of consent|0
843164|NCT01713582|2774612|P14|Overall Study|Withdrawal of consent|0
843165|NCT01713582|2774613|P13|Overall Study|Withdrawal of consent|0
843166|NCT01713582|2774614|P12|Overall Study|Withdrawal of consent|0
843167|NCT01713582|2774615|P11|Overall Study|Withdrawal of consent|0
843168|NCT01713582|2774616|P10|Overall Study|Withdrawal of consent|1
843169|NCT01713582|2774617|P9|Overall Study|Withdrawal of consent|0
843170|NCT01713582|2774618|P8|Overall Study|Withdrawal of consent|0
843171|NCT01713582|2774619|P7|Overall Study|Withdrawal of consent|0
843172|NCT01713582|2774620|P6|Overall Study|Withdrawal of consent|1
843173|NCT01713582|2774621|P5|Overall Study|Withdrawal of consent|0
843174|NCT01713582|2774622|P4|Overall Study|Withdrawal of consent|0
843175|NCT01713582|2774623|P3|Overall Study|Withdrawal of consent|1
843176|NCT01713582|2774624|P2|Overall Study|Withdrawal of consent|0
843177|NCT01713582|2774625|P1|Overall Study|Withdrawal of consent|0
843178|NCT01713582|2774605|P21|Overall Study|Adverse event-unrelated|0
843179|NCT01713582|2774606|P20|Overall Study|Adverse event-unrelated|0
843180|NCT01713582|2774607|P19|Overall Study|Adverse event-unrelated|0
843181|NCT01713582|2774608|P18|Overall Study|Adverse event-unrelated|0
843182|NCT01713582|2774609|P17|Overall Study|Adverse event-unrelated|0
843183|NCT01713582|2774610|P16|Overall Study|Adverse event-unrelated|0
843184|NCT01713582|2774611|P15|Overall Study|Adverse event-unrelated|1
843185|NCT01713582|2774612|P14|Overall Study|Adverse event-unrelated|1
843186|NCT01713582|2774613|P13|Overall Study|Adverse event-unrelated|0
843187|NCT01713582|2774614|P12|Overall Study|Adverse event-unrelated|0
843188|NCT01713582|2774615|P11|Overall Study|Adverse event-unrelated|0
843189|NCT01713582|2774616|P10|Overall Study|Adverse event-unrelated|0
843190|NCT01713582|2774617|P9|Overall Study|Adverse event-unrelated|0
843191|NCT01713582|2774618|P8|Overall Study|Adverse event-unrelated|1
843192|NCT01713582|2774619|P7|Overall Study|Adverse event-unrelated|1
843193|NCT01713582|2774620|P6|Overall Study|Adverse event-unrelated|1
843194|NCT01713582|2774621|P5|Overall Study|Adverse event-unrelated|0
843195|NCT01713582|2774622|P4|Overall Study|Adverse event-unrelated|0
843196|NCT01713582|2774623|P3|Overall Study|Adverse event-unrelated|0
843197|NCT01713582|2774624|P2|Overall Study|Adverse event-unrelated|0
843198|NCT01713582|2774625|P1|Overall Study|Adverse event-unrelated|0
843199|NCT01713582|2774605|P21|Overall Study|Adverse event-related|0
843200|NCT01713582|2774606|P20|Overall Study|Adverse event-related|0
843201|NCT01713582|2774607|P19|Overall Study|Adverse event-related|1
843202|NCT01713582|2774608|P18|Overall Study|Adverse event-related|0
843203|NCT01713582|2774609|P17|Overall Study|Adverse event-related|0
843204|NCT01713582|2774610|P16|Overall Study|Adverse event-related|0
843205|NCT01713582|2774611|P15|Overall Study|Adverse event-related|0
843206|NCT01713582|2774612|P14|Overall Study|Adverse event-related|0
843207|NCT01713582|2774613|P13|Overall Study|Adverse event-related|0
843208|NCT01713582|2774614|P12|Overall Study|Adverse event-related|0
843209|NCT01713582|2774615|P11|Overall Study|Adverse event-related|1
843210|NCT01713582|2774616|P10|Overall Study|Adverse event-related|1
843211|NCT01713582|2774617|P9|Overall Study|Adverse event-related|0
843212|NCT01713582|2774618|P8|Overall Study|Adverse event-related|0
843213|NCT01713582|2774619|P7|Overall Study|Adverse event-related|0
843214|NCT01713582|2774620|P6|Overall Study|Adverse event-related|0
843215|NCT01713582|2774621|P5|Overall Study|Adverse event-related|0
843216|NCT01713582|2774622|P4|Overall Study|Adverse event-related|0
843217|NCT01713582|2774623|P3|Overall Study|Adverse event-related|0
843218|NCT01713582|2774624|P2|Overall Study|Adverse event-related|0
843219|NCT01713582|2774625|P1|Overall Study|Adverse event-related|0
843220|NCT01713582|2774605|P21|Overall Study|Death|0
843221|NCT01713582|2774606|P20|Overall Study|Death|0
843222|NCT01713582|2774607|P19|Overall Study|Death|0
843223|NCT01713582|2774608|P18|Overall Study|Death|0
843224|NCT01713582|2774609|P17|Overall Study|Death|0
843225|NCT01713582|2774610|P16|Overall Study|Death|0
843226|NCT01713582|2774611|P15|Overall Study|Death|0
843227|NCT01713582|2774612|P14|Overall Study|Death|0
843228|NCT01713582|2774613|P13|Overall Study|Death|0
843229|NCT01713582|2774614|P12|Overall Study|Death|0
843230|NCT01713582|2774615|P11|Overall Study|Death|3
843231|NCT01713582|2774616|P10|Overall Study|Death|4
843232|NCT01713582|2774617|P9|Overall Study|Death|3
843233|NCT01713582|2774618|P8|Overall Study|Death|2
843234|NCT01713582|2774619|P7|Overall Study|Death|3
843235|NCT01713582|2774620|P6|Overall Study|Death|3
843236|NCT01713582|2774621|P5|Overall Study|Death|1
843237|NCT01713582|2774622|P4|Overall Study|Death|1
843238|NCT01713582|2774623|P3|Overall Study|Death|0
843239|NCT01713582|2774624|P2|Overall Study|Death|0
843240|NCT01713582|2774625|P1|Overall Study|Death|0
843241|NCT01713582|2774605|P21|Overall Study|Disease progression|15
843242|NCT01713582|2774606|P20|Overall Study|Disease progression|5
843243|NCT01713582|2774607|P19|Overall Study|Disease progression|3
843244|NCT01713582|2774608|P18|Overall Study|Disease progression|2
843245|NCT01713582|2774609|P17|Overall Study|Disease progression|5
843246|NCT01713582|2774610|P16|Overall Study|Disease progression|6
843247|NCT01713582|2774611|P15|Overall Study|Disease progression|6
843248|NCT01713582|2774612|P14|Overall Study|Disease progression|3
843249|NCT01713582|2774613|P13|Overall Study|Disease progression|3
843250|NCT01713582|2774614|P12|Overall Study|Disease progression|5
843251|NCT01713582|2774615|P11|Overall Study|Disease progression|10
843252|NCT01713582|2774616|P10|Overall Study|Disease progression|11
843253|NCT01713582|2774617|P9|Overall Study|Disease progression|3
843254|NCT01713582|2774618|P8|Overall Study|Disease progression|3
843255|NCT01713582|2774619|P7|Overall Study|Disease progression|3
843256|NCT01713582|2774620|P6|Overall Study|Disease progression|3
843257|NCT01713582|2774621|P5|Overall Study|Disease progression|3
843258|NCT01713582|2774622|P4|Overall Study|Disease progression|2
843259|NCT01713582|2774623|P3|Overall Study|Disease progression|3
843260|NCT01713582|2774624|P2|Overall Study|Disease progression|3
843261|NCT01713582|2774625|P1|Overall Study|Disease progression|3
843262|NCT01713530|2774788|P2|Overall Study|Unclassified|2
843263|NCT01713530|2774789|P1|Overall Study|Unclassified|4
843264|NCT01713530|2774788|P2|Overall Study|Withdrawal criteria|12
843265|NCT01713530|2774789|P1|Overall Study|Withdrawal criteria|21
843266|NCT01713530|2774788|P2|Overall Study|Adverse Event|5
843267|NCT01713530|2774789|P1|Overall Study|Adverse Event|0
843268|NCT01713348|2774820|P4|Overall Study|Lost to Follow-up|0
843269|NCT01713348|2774821|P3|Overall Study|Lost to Follow-up|0
843270|NCT01713348|2774822|P2|Overall Study|Lost to Follow-up|0
843271|NCT01713348|2774823|P1|Overall Study|Lost to Follow-up|1
843272|NCT01713348|2774820|P4|Overall Study|Withdrawal by Subject|0
843273|NCT01713348|2774821|P3|Overall Study|Withdrawal by Subject|2
843274|NCT01713348|2774822|P2|Overall Study|Withdrawal by Subject|2
843275|NCT01713348|2774823|P1|Overall Study|Withdrawal by Subject|3
843276|NCT01713283|2774853|P2|Overall Study|Lost to Follow-up|1
843277|NCT01713283|2774854|P1|Overall Study|Lost to Follow-up|1
843278|NCT01713283|2774853|P2|Overall Study|Lack of Efficacy|2
843279|NCT01713283|2774854|P1|Overall Study|Lack of Efficacy|10
843280|NCT01713036|2774876|P1|Overall Study|Death|1
843281|NCT01712984|2774916|P3|Overall Study|Withdrawal by Subject|7
843282|NCT01712984|2774917|P2|Overall Study|Withdrawal by Subject|6
843283|NCT01712984|2774918|P1|Overall Study|Withdrawal by Subject|6
843284|NCT01712984|2774916|P3|Overall Study|Lost to Follow-up|1
843285|NCT01712984|2774917|P2|Overall Study|Lost to Follow-up|10
843286|NCT01712984|2774918|P1|Overall Study|Lost to Follow-up|8
843287|NCT01712984|2774916|P3|Overall Study|Protocol Violation|1
843288|NCT01712984|2774917|P2|Overall Study|Protocol Violation|0
843289|NCT01712984|2774918|P1|Overall Study|Protocol Violation|2
843290|NCT01712984|2774916|P3|Overall Study|Adverse Event|1
843291|NCT01712984|2774917|P2|Overall Study|Adverse Event|0
843292|NCT01712984|2774918|P1|Overall Study|Adverse Event|0
843293|NCT01712854|2774938|P1|Overall Study|Physician Decision|1
843294|NCT01712685|2774961|P1|Overall Study|pt declined to participate before trmt|1
843295|NCT01712516|2774977|P4|Overall Study|Withdrawal by Subject|9
843296|NCT01712516|2774978|P3|Overall Study|Withdrawal by Subject|3
843297|NCT01712516|2774979|P2|Overall Study|Withdrawal by Subject|9
843298|NCT01712516|2774980|P1|Overall Study|Withdrawal by Subject|3
843299|NCT01712516|2774977|P4|Overall Study|Physician Decision|1
843300|NCT01712516|2774978|P3|Overall Study|Physician Decision|0
843301|NCT01712516|2774979|P2|Overall Study|Physician Decision|0
843302|NCT01712516|2774980|P1|Overall Study|Physician Decision|2
843303|NCT01712516|2774977|P4|Overall Study|Protocol deviation|0
843304|NCT01712516|2774978|P3|Overall Study|Protocol deviation|1
843305|NCT01712516|2774979|P2|Overall Study|Protocol deviation|0
843306|NCT01712516|2774980|P1|Overall Study|Protocol deviation|1
843307|NCT01712516|2774977|P4|Overall Study|Death|0
843308|NCT01712516|2774978|P3|Overall Study|Death|0
843309|NCT01712516|2774979|P2|Overall Study|Death|1
843310|NCT01712516|2774980|P1|Overall Study|Death|0
843311|NCT01712516|2774977|P4|Overall Study|Lost to Follow-up|1
843312|NCT01712516|2774978|P3|Overall Study|Lost to Follow-up|2
843313|NCT01712516|2774979|P2|Overall Study|Lost to Follow-up|0
843314|NCT01712516|2774980|P1|Overall Study|Lost to Follow-up|0
843315|NCT01712516|2774977|P4|Overall Study|Technical problems|2
843316|NCT01712516|2774978|P3|Overall Study|Technical problems|0
843317|NCT01712516|2774979|P2|Overall Study|Technical problems|0
843318|NCT01712516|2774980|P1|Overall Study|Technical problems|0
843319|NCT01712490|2775032|P2|Overall Study|Lost to Follow-up|29
843320|NCT01712490|2775033|P1|Overall Study|Lost to Follow-up|16
843321|NCT01712490|2775032|P2|Overall Study|Withdrawal by Subject|44
843322|NCT01712490|2775033|P1|Overall Study|Withdrawal by Subject|36
843323|NCT01712490|2775032|P2|Overall Study|Other|11
843324|NCT01712490|2775033|P1|Overall Study|Other|11
843325|NCT01712490|2775032|P2|Overall Study|Ongoing|586
843326|NCT01712490|2775033|P1|Overall Study|Ongoing|601
843327|NCT01712399|2775070|P1|Overall Study|Study closure|345
843328|NCT01712399|2775070|P1|Overall Study|Adverse Event|11
843329|NCT01712399|2775070|P1|Overall Study|Death|1
843330|NCT01712399|2775070|P1|Overall Study|Withdrawal by Subject|39
843331|NCT01712399|2775070|P1|Overall Study|Lost to Follow-up|1
843332|NCT01712334|2775116|P2|Treatment Period 1|Randomized in Error|2
843333|NCT01712334|2775117|P1|Treatment Period 1|Randomized in Error|0
843334|NCT01712256|2775125|P1|Overall Study|Lost to Follow-up|1
843335|NCT01712204|2775136|P2|Overall Study|Protocol Violation|1
843336|NCT01712204|2775137|P1|Overall Study|Protocol Violation|1
843337|NCT01712204|2775136|P2|Overall Study|Lost to Follow-up|0
843338|NCT01712204|2775137|P1|Overall Study|Lost to Follow-up|1
843339|NCT01712204|2775136|P2|Overall Study|Withdrawal by Subject|3
843340|NCT01712204|2775137|P1|Overall Study|Withdrawal by Subject|3
843341|NCT01712204|2775136|P2|Overall Study|Adverse Event|1
843342|NCT01712204|2775137|P1|Overall Study|Adverse Event|3
843343|NCT01712178|2775145|P2|Overall Study|Lost to Follow-up|1
843344|NCT01712178|2775146|P1|Overall Study|Lost to Follow-up|0
843345|NCT01712178|2775145|P2|Overall Study|Serious adverse event/withdrew consent|1
843346|NCT01712178|2775146|P1|Overall Study|Serious adverse event/withdrew consent|0
843347|NCT01712178|2775145|P2|Overall Study|Withdrew consent due to an adverse event|1
843348|NCT01712178|2775146|P1|Overall Study|Withdrew consent due to an adverse event|1
843349|NCT01712074|2775171|P3|Double Blind Period|No longer met eligibility criteria|0
843350|NCT01712074|2775172|P2|Double Blind Period|No longer met eligibility criteria|3
843351|NCT01712074|2775173|P1|Double Blind Period|No longer met eligibility criteria|0
843352|NCT01712074|2775171|P3|Double Blind Period|Protocol Violation|1
843353|NCT01712074|2775172|P2|Double Blind Period|Protocol Violation|0
843354|NCT01712074|2775173|P1|Double Blind Period|Protocol Violation|0
843355|NCT01712074|2775171|P3|Double Blind Period|Other|1
843356|NCT01712074|2775172|P2|Double Blind Period|Other|4
843357|NCT01712074|2775173|P1|Double Blind Period|Other|0
843358|NCT01712074|2775171|P3|Double Blind Period|Lost to Follow-up|1
843359|NCT01712074|2775172|P2|Double Blind Period|Lost to Follow-up|2
843360|NCT01712074|2775173|P1|Double Blind Period|Lost to Follow-up|0
843361|NCT01712074|2775171|P3|Double Blind Period|Death|0
843362|NCT01712074|2775172|P2|Double Blind Period|Death|1
843363|NCT01712074|2775173|P1|Double Blind Period|Death|0
843364|NCT01712074|2775171|P3|Double Blind Period|No longer willing to participate|4
843365|NCT01712074|2775172|P2|Double Blind Period|No longer willing to participate|2
843366|NCT01712074|2775173|P1|Double Blind Period|No longer willing to participate|0
843367|NCT01712074|2775171|P3|Double Blind Period|Adverse Event|1
843368|NCT01712074|2775172|P2|Double Blind Period|Adverse Event|2
843369|NCT01712074|2775173|P1|Double Blind Period|Adverse Event|0
843370|NCT01712074|2775171|P3|Placebo Run-in Period|No longer willing to participate|0
843371|NCT01712074|2775172|P2|Placebo Run-in Period|No longer willing to participate|0
843372|NCT01712074|2775173|P1|Placebo Run-in Period|No longer willing to participate|1
843373|NCT01712074|2775171|P3|Placebo Run-in Period|Other|0
843374|NCT01712074|2775172|P2|Placebo Run-in Period|Other|0
843375|NCT01712074|2775173|P1|Placebo Run-in Period|Other|1
843376|NCT01712074|2775171|P3|Placebo Run-in Period|No longer meets eligibility criteria|0
843377|NCT01712074|2775172|P2|Placebo Run-in Period|No longer meets eligibility criteria|0
843378|NCT01712074|2775173|P1|Placebo Run-in Period|No longer meets eligibility criteria|5
843379|NCT01712074|2775171|P3|Placebo Run-in Period|Lost to Follow-up|0
843380|NCT01712074|2775172|P2|Placebo Run-in Period|Lost to Follow-up|0
843381|NCT01712074|2775173|P1|Placebo Run-in Period|Lost to Follow-up|1
843382|NCT01712074|2775171|P3|Placebo Run-in Period|Adverse Event|0
843383|NCT01712074|2775172|P2|Placebo Run-in Period|Adverse Event|0
843384|NCT01712074|2775173|P1|Placebo Run-in Period|Adverse Event|2
843385|NCT01712061|2775229|P3|Overall Study|Other|0
843386|NCT01712061|2775230|P2|Overall Study|Other|3
843387|NCT01712061|2775231|P1|Overall Study|Other|0
843388|NCT01712061|2775229|P3|Overall Study|Withdrawal by Subject|1
843389|NCT01712061|2775230|P2|Overall Study|Withdrawal by Subject|7
843390|NCT01712061|2775231|P1|Overall Study|Withdrawal by Subject|1
843391|NCT01712061|2775229|P3|Overall Study|Medication Error Without Associated AE|0
843392|NCT01712061|2775230|P2|Overall Study|Medication Error Without Associated AE|1
843393|NCT01712061|2775231|P1|Overall Study|Medication Error Without Associated AE|0
843394|NCT01712061|2775229|P3|Overall Study|Did Not Meet Entrance Criteria|3
843395|NCT01712061|2775230|P2|Overall Study|Did Not Meet Entrance Criteria|6
843396|NCT01712061|2775231|P1|Overall Study|Did Not Meet Entrance Criteria|4
843397|NCT01712061|2775229|P3|Overall Study|Lost to Follow-up|1
843398|NCT01712061|2775230|P2|Overall Study|Lost to Follow-up|0
843399|NCT01712061|2775231|P1|Overall Study|Lost to Follow-up|1
843400|NCT01712061|2775229|P3|Overall Study|Death|1
843401|NCT01712061|2775230|P2|Overall Study|Death|0
843402|NCT01712061|2775231|P1|Overall Study|Death|0
843403|NCT01712061|2775229|P3|Overall Study|Adverse Event|5
843404|NCT01712061|2775230|P2|Overall Study|Adverse Event|9
843405|NCT01712061|2775231|P1|Overall Study|Adverse Event|4
843406|NCT01712009|2775271|P3|Overall Study|Decision by Sponsor|12
843407|NCT01712009|2775272|P2|Overall Study|Decision by Sponsor|14
843408|NCT01712009|2775273|P1|Overall Study|Decision by Sponsor|12
843409|NCT01712009|2775271|P3|Overall Study|Lost to Follow-up|1
843410|NCT01712009|2775272|P2|Overall Study|Lost to Follow-up|0
843411|NCT01712009|2775273|P1|Overall Study|Lost to Follow-up|2
843412|NCT01712009|2775271|P3|Overall Study|Withdrawal by Subject|8
843413|NCT01712009|2775272|P2|Overall Study|Withdrawal by Subject|15
843414|NCT01712009|2775273|P1|Overall Study|Withdrawal by Subject|24
843415|NCT01711866|2775307|P1|Overall Study|Adverse Event|2
843416|NCT01711866|2775307|P1|Overall Study|Withdrawal by Subject|3
843417|NCT01711866|2775307|P1|Overall Study|Noncompliant|3
843418|NCT01711853|2775312|P1|Overall Study|Not treated|3
843419|NCT01711736|2775319|P2|Overall Study|Migrated/moved from study area|1
843420|NCT01711736|2775320|P1|Overall Study|Migrated/moved from study area|2
843421|NCT01711736|2775319|P2|Overall Study|Withdrawal by Subject|6
843422|NCT01711736|2775320|P1|Overall Study|Withdrawal by Subject|6
843423|NCT01711736|2775319|P2|Overall Study|Lost to Follow-up|1
843424|NCT01711736|2775320|P1|Overall Study|Lost to Follow-up|4
843425|NCT01711645|2775348|P1|Overall Study|Physician Decision|5
843426|NCT01711645|2775348|P1|Overall Study|Lost to Follow-up|6
843427|NCT01711645|2775348|P1|Overall Study|Withdrawal by Subject|8
843428|NCT01711619|2775385|P2|Overall Study|Lost to Follow-up|0
843429|NCT01711619|2775386|P1|Overall Study|Lost to Follow-up|1
843430|NCT01711619|2775385|P2|Overall Study|Adverse Event|0
843431|NCT01711619|2775386|P1|Overall Study|Adverse Event|2
843432|NCT01711619|2775385|P2|Overall Study|Protocol Violation|3
843433|NCT01711619|2775386|P1|Overall Study|Protocol Violation|2
843434|NCT01711619|2775385|P2|Overall Study|Withdrawal by Subject|7
843435|NCT01711619|2775386|P1|Overall Study|Withdrawal by Subject|3
843436|NCT01711619|2775385|P2|Overall Study|Early study termination|14
843437|NCT01711619|2775386|P1|Overall Study|Early study termination|10
843438|NCT01711359|2775408|P3|Treatment Period|Randomized, Not Treated|0
843439|NCT01711359|2775409|P2|Treatment Period|Randomized, Not Treated|1
843440|NCT01711359|2775410|P1|Treatment Period|Randomized, Not Treated|3
843441|NCT01711359|2775408|P3|Treatment Period|Lost to Follow-up|1
843442|NCT01711359|2775409|P2|Treatment Period|Lost to Follow-up|1
843443|NCT01711359|2775410|P1|Treatment Period|Lost to Follow-up|1
843444|NCT01711359|2775408|P3|Treatment Period|Sponsor Decision|0
843445|NCT01711359|2775409|P2|Treatment Period|Sponsor Decision|0
843446|NCT01711359|2775410|P1|Treatment Period|Sponsor Decision|1
843447|NCT01711359|2775408|P3|Treatment Period|Entry Criteria Not Met|0
843448|NCT01711359|2775409|P2|Treatment Period|Entry Criteria Not Met|0
843449|NCT01711359|2775410|P1|Treatment Period|Entry Criteria Not Met|1
843450|NCT01711359|2775408|P3|Treatment Period|Death|0
843451|NCT01711359|2775409|P2|Treatment Period|Death|0
843452|NCT01711359|2775410|P1|Treatment Period|Death|3
843453|NCT01711359|2775408|P3|Treatment Period|Physician Decision|2
843454|NCT01711359|2775409|P2|Treatment Period|Physician Decision|3
843455|NCT01711359|2775410|P1|Treatment Period|Physician Decision|4
843456|NCT01711359|2775408|P3|Treatment Period|Adverse Event|24
843457|NCT01711359|2775409|P2|Treatment Period|Adverse Event|10
843458|NCT01711359|2775410|P1|Treatment Period|Adverse Event|8
843459|NCT01711359|2775408|P3|Treatment Period|Lack of Efficacy|2
843460|NCT01711359|2775409|P2|Treatment Period|Lack of Efficacy|2
843461|NCT01711359|2775410|P1|Treatment Period|Lack of Efficacy|13
843462|NCT01711359|2775408|P3|Treatment Period|Withdrawal by Subject|13
843463|NCT01711359|2775409|P2|Treatment Period|Withdrawal by Subject|7
843464|NCT01711359|2775410|P1|Treatment Period|Withdrawal by Subject|18
843465|NCT01711216|2775481|P1|Overall Study|no reason specified|22
843466|NCT01711216|2775481|P1|Overall Study|variety of other minor reasons|83
843467|NCT01711216|2775481|P1|Overall Study|Lost to Follow-up|46
843468|NCT01711216|2775481|P1|Overall Study|Withdrawal by Subject|6
843469|NCT01711216|2775481|P1|Overall Study|Pregnancy|56
843470|NCT01711216|2775481|P1|Overall Study|Adverse Event|4
843471|NCT01710800|2775540|P1|Overall Study|Protocol Violation|1
843472|NCT01710800|2775540|P1|Overall Study|Withdrawal by Subject|21
843473|NCT01710709|2775604|P1|Overall Study|Lack of Efficacy|3
843474|NCT01710709|2775604|P1|Overall Study|Protocol Violation|5
843475|NCT01710709|2775604|P1|Overall Study|Withdrawal by Subject|53
843476|NCT01710709|2775604|P1|Overall Study|Participant withdrawn by investigator|2
843477|NCT01710709|2775604|P1|Overall Study|Participant met withdrawal criteria|33
843478|NCT01710709|2775604|P1|Overall Study|Adverse Event|48
843479|NCT01710709|2775604|P1|Overall Study|Lost to Follow-up|29
843480|NCT01710657|2775619|P3|Overall Study|Lack of Efficacy|1
843481|NCT01710657|2775620|P2|Overall Study|Lack of Efficacy|1
843482|NCT01710657|2775621|P1|Overall Study|Lack of Efficacy|0
843483|NCT01710657|2775619|P3|Overall Study|Withdrawal by Subject|2
843484|NCT01710657|2775620|P2|Overall Study|Withdrawal by Subject|1
843485|NCT01710657|2775621|P1|Overall Study|Withdrawal by Subject|0
843486|NCT01710657|2775619|P3|Overall Study|Adverse Event|28
843487|NCT01710657|2775620|P2|Overall Study|Adverse Event|8
843488|NCT01710657|2775621|P1|Overall Study|Adverse Event|14
843489|NCT01710657|2775619|P3|Overall Study|Protocol Violation|0
843490|NCT01710657|2775620|P2|Overall Study|Protocol Violation|2
843491|NCT01710657|2775621|P1|Overall Study|Protocol Violation|2
843492|NCT01710657|2775619|P3|Overall Study|Lost to Follow-up|1
843493|NCT01710657|2775620|P2|Overall Study|Lost to Follow-up|0
843494|NCT01710657|2775621|P1|Overall Study|Lost to Follow-up|2
843495|NCT01710527|2775638|P2|Period 2: Washout Period (7 Days)|Personal reasons|1
843496|NCT01710527|2775639|P1|Period 2: Washout Period (7 Days)|Personal reasons|0
843497|NCT01710514|2775665|P2|Overall Study|Withdrawal by Subject|0
843498|NCT01710514|2775666|P1|Overall Study|Withdrawal by Subject|1
843499|NCT01710514|2775665|P2|Overall Study|Adverse Event|7
843500|NCT01710514|2775666|P1|Overall Study|Adverse Event|6
843501|NCT01710501|2775687|P3|Overall Study|Lost to Follow-up|0
843502|NCT01710501|2775688|P2|Overall Study|Lost to Follow-up|0
843503|NCT01710501|2775689|P1|Overall Study|Lost to Follow-up|2
843504|NCT01710358|2775721|P3|Rescue Period|Withdrawal by Subject|0
843505|NCT01710358|2775722|P2|Rescue Period|Withdrawal by Subject|8
843506|NCT01710358|2775723|P1|Rescue Period|Withdrawal by Subject|0
843507|NCT01710358|2775721|P3|Rescue Period|Lack of Efficacy|0
843508|NCT01710358|2775722|P2|Rescue Period|Lack of Efficacy|7
843509|NCT01710358|2775723|P1|Rescue Period|Lack of Efficacy|0
843510|NCT01710358|2775721|P3|Rescue Period|Death|0
843511|NCT01710358|2775722|P2|Rescue Period|Death|1
843512|NCT01710358|2775723|P1|Rescue Period|Death|0
843513|NCT01710358|2775721|P3|Rescue Period|Adverse Event|0
843514|NCT01710358|2775722|P2|Rescue Period|Adverse Event|15
843515|NCT01710358|2775723|P1|Rescue Period|Adverse Event|0
843516|NCT01710358|2775721|P3|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7
843517|NCT01710358|2775722|P2|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3
843518|NCT01710358|2775723|P1|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4
843519|NCT01710358|2775721|P3|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0
843520|NCT01710358|2775722|P2|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2
843521|NCT01710358|2775723|P1|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1
843522|NCT01710358|2775721|P3|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
843523|NCT01710358|2775722|P2|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1
843524|NCT01710358|2775723|P1|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
843525|NCT01710358|2775721|P3|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1
843526|NCT01710358|2775722|P2|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
843527|NCT01710358|2775723|P1|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
843528|NCT01710358|2775721|P3|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1
843529|NCT01710358|2775722|P2|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
843530|NCT01710358|2775723|P1|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
843531|NCT01710358|2775721|P3|Treatment Period Part B (Weeks 24 to 52)|Death|1
843532|NCT01710358|2775722|P2|Treatment Period Part B (Weeks 24 to 52)|Death|0
843533|NCT01710358|2775723|P1|Treatment Period Part B (Weeks 24 to 52)|Death|1
843534|NCT01710358|2775721|P3|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5
843535|NCT01710358|2775722|P2|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16
843536|NCT01710358|2775723|P1|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10
843537|NCT01710358|2775721|P3|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0
843538|NCT01710358|2775722|P2|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
843539|NCT01710358|2775723|P1|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
843540|NCT01710358|2775721|P3|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12
843541|NCT01710358|2775722|P2|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5
843542|NCT01710358|2775723|P1|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15
843543|NCT01710358|2775721|P3|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
843544|NCT01710358|2775722|P2|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
843545|NCT01710358|2775723|P1|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4
843546|NCT01710358|2775721|P3|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
843547|NCT01710358|2775722|P2|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
843548|NCT01710358|2775723|P1|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1
843549|NCT01710358|2775721|P3|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
843550|NCT01710358|2775722|P2|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1
843551|NCT01710358|2775723|P1|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
843552|NCT01710358|2775721|P3|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3
843553|NCT01710358|2775722|P2|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1
843554|NCT01710358|2775723|P1|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15
843555|NCT01710358|2775721|P3|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
843556|NCT01710358|2775722|P2|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
843557|NCT01710358|2775723|P1|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0
843558|NCT01710358|2775721|P3|Treatment Period Part A (Weeks 0 to 24)|Death|0
843559|NCT01710358|2775722|P2|Treatment Period Part A (Weeks 0 to 24)|Death|2
843560|NCT01710358|2775723|P1|Treatment Period Part A (Weeks 0 to 24)|Death|0
843561|NCT01710358|2775721|P3|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7
843562|NCT01710358|2775722|P2|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18
843563|NCT01710358|2775723|P1|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15
843564|NCT01710345|2775794|P3|Overall Study|Drug Dosing Error|0
843565|NCT01710345|2775795|P2|Overall Study|Drug Dosing Error|0
843566|NCT01710345|2775796|P1|Overall Study|Drug Dosing Error|1
843567|NCT01710345|2775794|P3|Overall Study|Lack of Efficacy|1
843568|NCT01710345|2775795|P2|Overall Study|Lack of Efficacy|3
843569|NCT01710345|2775796|P1|Overall Study|Lack of Efficacy|2
843570|NCT01710345|2775794|P3|Overall Study|Adverse Event|0
843571|NCT01710345|2775795|P2|Overall Study|Adverse Event|2
843572|NCT01710345|2775796|P1|Overall Study|Adverse Event|0
843573|NCT01710046|2775823|P2|Overall Study|Lost to Follow-up|0
843574|NCT01710046|2775824|P1|Overall Study|Lost to Follow-up|1
843575|NCT01710033|2775864|P5|Stage 2|Adverse Event|1
843576|NCT01710033|2775865|P4|Stage 2|Adverse Event|0
843577|NCT01710033|2775866|P3|Stage 2|Adverse Event|0
843578|NCT01710033|2775867|P2|Stage 2|Adverse Event|0
843579|NCT01710033|2775868|P1|Stage 2|Adverse Event|0
843580|NCT01710020|2775949|P1|Period 1|Protocol Violation|1
843581|NCT01709903|2775968|P2|Overall Study|Adverse Event|18
843582|NCT01709903|2775969|P1|Overall Study|Adverse Event|11
843583|NCT01709903|2775968|P2|Overall Study|Withdrawal by Subject|6
843584|NCT01709903|2775969|P1|Overall Study|Withdrawal by Subject|6
843585|NCT01709903|2775968|P2|Overall Study|Lack of Efficacy|3
843586|NCT01709903|2775969|P1|Overall Study|Lack of Efficacy|3
843587|NCT01709903|2775968|P2|Overall Study|Protocol Violation|2
843588|NCT01709903|2775969|P1|Overall Study|Protocol Violation|3
843589|NCT01709903|2775968|P2|Overall Study|Death|0
843590|NCT01709903|2775969|P1|Overall Study|Death|2
843591|NCT01709903|2775968|P2|Overall Study|Lost to Follow-up|2
843592|NCT01709903|2775969|P1|Overall Study|Lost to Follow-up|0
843593|NCT01709903|2775968|P2|Overall Study|no longer needed study drug|1
843594|NCT01709903|2775969|P1|Overall Study|no longer needed study drug|0
843595|NCT01709903|2775968|P2|Overall Study|In ability to use device|1
843596|NCT01709903|2775969|P1|Overall Study|In ability to use device|1
843597|NCT01709903|2775968|P2|Overall Study|Abnormal test procedure results|0
843598|NCT01709903|2775969|P1|Overall Study|Abnormal test procedure results|1
843599|NCT01709903|2775968|P2|Overall Study|administrative problems|6
843600|NCT01709903|2775969|P1|Overall Study|administrative problems|2
843601|NCT01709864|2775993|P2|Overall Study|Death|1
843602|NCT01709864|2775994|P1|Overall Study|Death|0
843603|NCT01709864|2775993|P2|Overall Study|Adverse Event|2
843604|NCT01709864|2775994|P1|Overall Study|Adverse Event|0
843605|NCT01709864|2775993|P2|Overall Study|non-compliance with study treatment|1
843606|NCT01709864|2775994|P1|Overall Study|non-compliance with study treatment|1
843607|NCT01709864|2775993|P2|Overall Study|Lost to Follow-up|0
843608|NCT01709864|2775994|P1|Overall Study|Lost to Follow-up|1
843609|NCT01709864|2775993|P2|Overall Study|subject/guardian decision|6
843610|NCT01709864|2775994|P1|Overall Study|subject/guardian decision|5
843611|NCT01709864|2775993|P2|Overall Study|Physician Decision|1
843612|NCT01709864|2775994|P1|Overall Study|Physician Decision|0
843613|NCT01709708|2776065|P2|Overall Study|Protocol Violation|2
843614|NCT01709708|2776066|P1|Overall Study|Protocol Violation|1
843615|NCT01709695|2776090|P2|Overall Study|Withdrawal by Subject|1
843616|NCT01709695|2776091|P1|Overall Study|Withdrawal by Subject|1
843617|NCT01709578|2776116|P3|Overall Study|Other, not related to safety or efficacy|5
843618|NCT01709578|2776117|P2|Overall Study|Other, not related to safety or efficacy|7
843619|NCT01709578|2776118|P1|Overall Study|Other, not related to safety or efficacy|2
843620|NCT01709578|2776116|P3|Overall Study|Poor compliance to protocol|1
843621|NCT01709578|2776117|P2|Overall Study|Poor compliance to protocol|2
843622|NCT01709578|2776118|P1|Overall Study|Poor compliance to protocol|1
843623|NCT01709578|2776116|P3|Overall Study|Lack of Efficacy|2
843624|NCT01709578|2776117|P2|Overall Study|Lack of Efficacy|4
843625|NCT01709578|2776118|P1|Overall Study|Lack of Efficacy|5
843626|NCT01709578|2776116|P3|Overall Study|Adverse Event|17
843627|NCT01709578|2776117|P2|Overall Study|Adverse Event|18
843628|NCT01709578|2776118|P1|Overall Study|Adverse Event|9
843629|NCT01709578|2776116|P3|Overall Study|Rescued and entered in long term safety|26
843630|NCT01709578|2776117|P2|Overall Study|Rescued and entered in long term safety|25
843631|NCT01709578|2776118|P1|Overall Study|Rescued and entered in long term safety|63
843632|NCT01709513|2776249|P3|Overall Study|Other|7
843633|NCT01709513|2776250|P2|Overall Study|Other|11
843634|NCT01709513|2776251|P1|Overall Study|Other|3
843635|NCT01709513|2776249|P3|Overall Study|Poor compliance to protocol|0
843636|NCT01709513|2776250|P2|Overall Study|Poor compliance to protocol|0
843637|NCT01709513|2776251|P1|Overall Study|Poor compliance to protocol|2
843638|NCT01709513|2776249|P3|Overall Study|Adverse Event|23
843639|NCT01709513|2776250|P2|Overall Study|Adverse Event|31
843640|NCT01709513|2776251|P1|Overall Study|Adverse Event|16
843641|NCT01709513|2776249|P3|Overall Study|Randomized but not treated|0
843642|NCT01709513|2776250|P2|Overall Study|Randomized but not treated|1
843643|NCT01709513|2776251|P1|Overall Study|Randomized but not treated|0
843644|NCT01709500|2776312|P2|Overall Study|Treatment ongoing|78
843645|NCT01709500|2776313|P1|Overall Study|Treatment ongoing|156
843646|NCT01709500|2776312|P2|Overall Study|Related to IMP administration|0
843647|NCT01709500|2776313|P1|Overall Study|Related to IMP administration|1
843648|NCT01709500|2776312|P2|Overall Study|Other|1
843649|NCT01709500|2776313|P1|Overall Study|Other|3
843650|NCT01709500|2776312|P2|Overall Study|Poor compliance to protocol|1
843651|NCT01709500|2776313|P1|Overall Study|Poor compliance to protocol|2
843652|NCT01709500|2776312|P2|Overall Study|Adverse Event|1
843653|NCT01709500|2776313|P1|Overall Study|Adverse Event|5
843654|NCT01709500|2776312|P2|Overall Study|Randomized but not treated|1
843655|NCT01709500|2776313|P1|Overall Study|Randomized but not treated|0
843656|NCT01709409|2776391|P2|Overall Study|Protocol Violation|0
843657|NCT01709409|2776392|P1|Overall Study|Protocol Violation|1
843658|NCT01709383|2776400|P2|Overall Study|Lost to Follow-up|0
843659|NCT01709383|2776401|P1|Overall Study|Lost to Follow-up|1
843660|NCT01709331|2776419|P1|Overall Study|Adverse Event|1
843661|NCT01709305|2776425|P5|Phase 2|Withdrawal by Subject|12
843662|NCT01709305|2776426|P4|Phase 2|Withdrawal by Subject|15
843663|NCT01709305|2776427|P3|Phase 2|Withdrawal by Subject|6
843664|NCT01709305|2776428|P2|Phase 2|Withdrawal by Subject|8
843665|NCT01709305|2776429|P1|Phase 2|Withdrawal by Subject|0
843666|NCT01709305|2776425|P5|Phase 2|Protocol Violation|9
843667|NCT01709305|2776426|P4|Phase 2|Protocol Violation|13
843668|NCT01709305|2776427|P3|Phase 2|Protocol Violation|19
843669|NCT01709305|2776428|P2|Phase 2|Protocol Violation|19
843670|NCT01709305|2776429|P1|Phase 2|Protocol Violation|0
843671|NCT01709305|2776425|P5|Phase 2|Physician Decision|2
843672|NCT01709305|2776426|P4|Phase 2|Physician Decision|1
843673|NCT01709305|2776427|P3|Phase 2|Physician Decision|0
843674|NCT01709305|2776428|P2|Phase 2|Physician Decision|2
843675|NCT01709305|2776429|P1|Phase 2|Physician Decision|0
843676|NCT01709305|2776425|P5|Phase 2|Travel, moving, etc.|5
843677|NCT01709305|2776426|P4|Phase 2|Travel, moving, etc.|3
843678|NCT01709305|2776427|P3|Phase 2|Travel, moving, etc.|3
843679|NCT01709305|2776428|P2|Phase 2|Travel, moving, etc.|2
843680|NCT01709305|2776429|P1|Phase 2|Travel, moving, etc.|0
843681|NCT01709305|2776425|P5|Phase 2|Lost to Follow-up|5
843682|NCT01709305|2776426|P4|Phase 2|Lost to Follow-up|9
843683|NCT01709305|2776427|P3|Phase 2|Lost to Follow-up|6
843684|NCT01709305|2776428|P2|Phase 2|Lost to Follow-up|10
843685|NCT01709305|2776429|P1|Phase 2|Lost to Follow-up|0
843686|NCT01709305|2776425|P5|Phase 2|Laboratory Adverse Event|1
843687|NCT01709305|2776426|P4|Phase 2|Laboratory Adverse Event|1
843688|NCT01709305|2776427|P3|Phase 2|Laboratory Adverse Event|0
843689|NCT01709305|2776428|P2|Phase 2|Laboratory Adverse Event|1
843690|NCT01709305|2776429|P1|Phase 2|Laboratory Adverse Event|0
843691|NCT01709305|2776425|P5|Phase 2|Hyperglycemia (lack of efficacy)|2
843692|NCT01709305|2776426|P4|Phase 2|Hyperglycemia (lack of efficacy)|0
843693|NCT01709305|2776427|P3|Phase 2|Hyperglycemia (lack of efficacy)|0
843694|NCT01709305|2776428|P2|Phase 2|Hyperglycemia (lack of efficacy)|0
843695|NCT01709305|2776429|P1|Phase 2|Hyperglycemia (lack of efficacy)|0
843696|NCT01709305|2776425|P5|Phase 2|Death|0
843697|NCT01709305|2776426|P4|Phase 2|Death|0
843698|NCT01709305|2776427|P3|Phase 2|Death|1
843699|NCT01709305|2776428|P2|Phase 2|Death|0
843700|NCT01709305|2776429|P1|Phase 2|Death|0
843701|NCT01709305|2776425|P5|Phase 2|Clinical Adverse Event|11
843702|NCT01709305|2776426|P4|Phase 2|Clinical Adverse Event|6
843703|NCT01709305|2776427|P3|Phase 2|Clinical Adverse Event|10
843704|NCT01709305|2776428|P2|Phase 2|Clinical Adverse Event|10
843705|NCT01709305|2776429|P1|Phase 2|Clinical Adverse Event|0
843706|NCT01709305|2776425|P5|Phase 1|Withdrawal by Subject|0
843707|NCT01709305|2776426|P4|Phase 1|Withdrawal by Subject|0
843708|NCT01709305|2776427|P3|Phase 1|Withdrawal by Subject|0
843709|NCT01709305|2776428|P2|Phase 1|Withdrawal by Subject|0
843710|NCT01709305|2776429|P1|Phase 1|Withdrawal by Subject|218
843711|NCT01709305|2776425|P5|Phase 1|Protocol Violation|0
843712|NCT01709305|2776426|P4|Phase 1|Protocol Violation|0
843713|NCT01709305|2776427|P3|Phase 1|Protocol Violation|0
843714|NCT01709305|2776428|P2|Phase 1|Protocol Violation|0
843715|NCT01709305|2776429|P1|Phase 1|Protocol Violation|118
843716|NCT01709305|2776425|P5|Phase 1|Physician Decision|0
843717|NCT01709305|2776426|P4|Phase 1|Physician Decision|0
843718|NCT01709305|2776427|P3|Phase 1|Physician Decision|0
843719|NCT01709305|2776428|P2|Phase 1|Physician Decision|0
843720|NCT01709305|2776429|P1|Phase 1|Physician Decision|13
843721|NCT01709305|2776425|P5|Phase 1|Travel, moving, etc.|0
843722|NCT01709305|2776426|P4|Phase 1|Travel, moving, etc.|0
843723|NCT01709305|2776427|P3|Phase 1|Travel, moving, etc.|0
843724|NCT01709305|2776428|P2|Phase 1|Travel, moving, etc.|0
843725|NCT01709305|2776429|P1|Phase 1|Travel, moving, etc.|30
843726|NCT01709305|2776425|P5|Phase 1|Lost to Follow-up|0
843727|NCT01709305|2776426|P4|Phase 1|Lost to Follow-up|0
843728|NCT01709305|2776427|P3|Phase 1|Lost to Follow-up|0
843729|NCT01709305|2776428|P2|Phase 1|Lost to Follow-up|0
843730|NCT01709305|2776429|P1|Phase 1|Lost to Follow-up|147
843731|NCT01709305|2776425|P5|Phase 1|Laboratory Adverse Event|0
843732|NCT01709305|2776426|P4|Phase 1|Laboratory Adverse Event|0
843733|NCT01709305|2776427|P3|Phase 1|Laboratory Adverse Event|0
843734|NCT01709305|2776428|P2|Phase 1|Laboratory Adverse Event|0
843735|NCT01709305|2776429|P1|Phase 1|Laboratory Adverse Event|16
843736|NCT01709305|2776425|P5|Phase 1|Hyperglycemia (lack of efficacy)|0
843737|NCT01709305|2776426|P4|Phase 1|Hyperglycemia (lack of efficacy)|0
843738|NCT01709305|2776427|P3|Phase 1|Hyperglycemia (lack of efficacy)|0
843739|NCT01709305|2776428|P2|Phase 1|Hyperglycemia (lack of efficacy)|0
843740|NCT01709305|2776429|P1|Phase 1|Hyperglycemia (lack of efficacy)|13
843741|NCT01709305|2776425|P5|Phase 1|Death|0
843742|NCT01709305|2776426|P4|Phase 1|Death|0
843743|NCT01709305|2776427|P3|Phase 1|Death|0
843744|NCT01709305|2776428|P2|Phase 1|Death|0
843745|NCT01709305|2776429|P1|Phase 1|Death|2
843746|NCT01709305|2776425|P5|Phase 1|Clinical Adverse Event|0
843747|NCT01709305|2776426|P4|Phase 1|Clinical Adverse Event|0
843748|NCT01709305|2776427|P3|Phase 1|Clinical Adverse Event|0
843749|NCT01709305|2776428|P2|Phase 1|Clinical Adverse Event|0
843750|NCT01709305|2776429|P1|Phase 1|Clinical Adverse Event|80
843751|NCT01709227|2776466|P2|Overall Study|Pleural Peritoneal communication|9
843752|NCT01709227|2776467|P1|Overall Study|Pleural Peritoneal communication|0
843753|NCT01709227|2776466|P2|Overall Study|Physician Decision|0
843754|NCT01709227|2776467|P1|Overall Study|Physician Decision|1
843755|NCT01709162|2776493|P2|Overall Study|Withdrawal by Subject|1
843756|NCT01709162|2776494|P1|Overall Study|Withdrawal by Subject|0
843757|NCT01709162|2776493|P2|Overall Study|Not specified|0
843758|NCT01709162|2776494|P1|Overall Study|Not specified|1
843759|NCT01709162|2776493|P2|Overall Study|Administrative reason by sponsor|1
843760|NCT01709162|2776494|P1|Overall Study|Administrative reason by sponsor|0
843761|NCT01709162|2776493|P2|Overall Study|Study drug toxicity|0
843762|NCT01709162|2776494|P1|Overall Study|Study drug toxicity|2
843763|NCT01709162|2776493|P2|Overall Study|Disease progression|3
843764|NCT01709162|2776494|P1|Overall Study|Disease progression|3
843765|NCT01709110|2776515|P2|Overall Study|Caregiver Decision|1
843766|NCT01709110|2776516|P1|Overall Study|Caregiver Decision|1
843767|NCT01709110|2776515|P2|Overall Study|Lack of Efficacy|1
843768|NCT01709110|2776516|P1|Overall Study|Lack of Efficacy|1
843769|NCT01709110|2776515|P2|Overall Study|Sponsor Decision|2
843770|NCT01709110|2776516|P1|Overall Study|Sponsor Decision|2
843771|NCT01709110|2776515|P2|Overall Study|Physician Decision|10
843772|NCT01709110|2776516|P1|Overall Study|Physician Decision|4
843773|NCT01709110|2776515|P2|Overall Study|Withdrawal by Subject|89
843774|NCT01709110|2776516|P1|Overall Study|Withdrawal by Subject|96
843775|NCT01709110|2776515|P2|Overall Study|Protocol Violation|6
843776|NCT01709110|2776516|P1|Overall Study|Protocol Violation|4
843777|NCT01709110|2776515|P2|Overall Study|Lost to Follow-up|5
843778|NCT01709110|2776516|P1|Overall Study|Lost to Follow-up|7
843779|NCT01709110|2776515|P2|Overall Study|Death|6
843780|NCT01709110|2776516|P1|Overall Study|Death|14
843781|NCT01709110|2776515|P2|Overall Study|Adverse Event|48
843782|NCT01709110|2776516|P1|Overall Study|Adverse Event|56
843783|NCT01709084|2776546|P2|Overall Study|Not Treated|2
843784|NCT01709084|2776547|P1|Overall Study|Not Treated|0
843785|NCT01709084|2776546|P2|Overall Study|Participant Reached a Virologic Endpoint|1
843786|NCT01709084|2776547|P1|Overall Study|Participant Reached a Virologic Endpoint|0
843787|NCT01709084|2776546|P2|Overall Study|Other|3
843788|NCT01709084|2776547|P1|Overall Study|Other|5
843789|NCT01709084|2776546|P2|Overall Study|Adverse Event|0
843790|NCT01709084|2776547|P1|Overall Study|Adverse Event|5
843791|NCT01709084|2776546|P2|Overall Study|Withdrawal by Subject|2
843792|NCT01709084|2776547|P1|Overall Study|Withdrawal by Subject|2
843793|NCT01709084|2776546|P2|Overall Study|Lost to Follow-up|7
843794|NCT01709084|2776547|P1|Overall Study|Lost to Follow-up|4
843795|NCT01708954|2776575|P3|Step 2|Withdrawal by Subject|0
843796|NCT01708954|2776576|P2|Step 2|Withdrawal by Subject|1
843797|NCT01708954|2776577|P1|Step 2|Withdrawal by Subject|1
843798|NCT01708954|2776575|P3|Step 2|Adverse Event|0
843799|NCT01708954|2776576|P2|Step 2|Adverse Event|2
843800|NCT01708954|2776577|P1|Step 2|Adverse Event|3
843801|NCT01708954|2776575|P3|Step 2|Disease progression|0
843802|NCT01708954|2776576|P2|Step 2|Disease progression|4
843803|NCT01708954|2776577|P1|Step 2|Disease progression|9
843804|NCT01708954|2776575|P3|Step 1|Ineligible or never received treatment|8
843805|NCT01708954|2776576|P2|Step 1|Ineligible or never received treatment|2
843806|NCT01708954|2776577|P1|Step 1|Ineligible or never received treatment|4
843807|NCT01708954|2776575|P3|Step 1|Off-treatment reason not submitted|1
843808|NCT01708954|2776576|P2|Step 1|Off-treatment reason not submitted|1
843809|NCT01708954|2776577|P1|Step 1|Off-treatment reason not submitted|1
843810|NCT01708954|2776575|P3|Step 1|Symptomatic deterioration|1
843811|NCT01708954|2776576|P2|Step 1|Symptomatic deterioration|0
843812|NCT01708954|2776577|P1|Step 1|Symptomatic deterioration|1
843813|NCT01708954|2776575|P3|Step 1|Crossed over to Step 2|0
843814|NCT01708954|2776576|P2|Step 1|Crossed over to Step 2|0
843815|NCT01708954|2776577|P1|Step 1|Crossed over to Step 2|2
843816|NCT01708954|2776575|P3|Step 1|Other complicating disease|0
843817|NCT01708954|2776576|P2|Step 1|Other complicating disease|2
843818|NCT01708954|2776577|P1|Step 1|Other complicating disease|0
843819|NCT01708954|2776575|P3|Step 1|Withdrawal by Subject|3
843820|NCT01708954|2776576|P2|Step 1|Withdrawal by Subject|5
843821|NCT01708954|2776577|P1|Step 1|Withdrawal by Subject|2
843822|NCT01708954|2776575|P3|Step 1|Death|3
843823|NCT01708954|2776576|P2|Step 1|Death|2
843824|NCT01708954|2776577|P1|Step 1|Death|3
843825|NCT01708954|2776575|P3|Step 1|Adverse Event|13
843826|NCT01708954|2776576|P2|Step 1|Adverse Event|11
843827|NCT01708954|2776577|P1|Step 1|Adverse Event|3
843828|NCT01708954|2776575|P3|Step 1|Disease progression|14
843829|NCT01708954|2776576|P2|Step 1|Disease progression|17
843830|NCT01708954|2776577|P1|Step 1|Disease progression|26
843831|NCT01708915|2776602|P4|Overall Study|Other reasons than stated above|2
843832|NCT01708915|2776603|P3|Overall Study|Other reasons than stated above|0
843833|NCT01708915|2776604|P2|Overall Study|Other reasons than stated above|1
843834|NCT01708915|2776605|P1|Overall Study|Other reasons than stated above|1
843835|NCT01708915|2776602|P4|Overall Study|Withdrawal by Subject|2
843836|NCT01708915|2776603|P3|Overall Study|Withdrawal by Subject|2
843837|NCT01708915|2776604|P2|Overall Study|Withdrawal by Subject|1
843838|NCT01708915|2776605|P1|Overall Study|Withdrawal by Subject|0
843839|NCT01708915|2776602|P4|Overall Study|Protocol Violation|1
843840|NCT01708915|2776603|P3|Overall Study|Protocol Violation|0
843841|NCT01708915|2776604|P2|Overall Study|Protocol Violation|0
843842|NCT01708915|2776605|P1|Overall Study|Protocol Violation|0
843843|NCT01708915|2776602|P4|Overall Study|Lack of Efficacy|15
843844|NCT01708915|2776603|P3|Overall Study|Lack of Efficacy|35
843845|NCT01708915|2776604|P2|Overall Study|Lack of Efficacy|60
843846|NCT01708915|2776605|P1|Overall Study|Lack of Efficacy|84
843847|NCT01708915|2776602|P4|Overall Study|Adverse Event|13
843848|NCT01708915|2776603|P3|Overall Study|Adverse Event|9
843849|NCT01708915|2776604|P2|Overall Study|Adverse Event|0
843850|NCT01708915|2776605|P1|Overall Study|Adverse Event|1
843851|NCT01708902|2776634|P7|Overall Study|Other Reason|0
843852|NCT01708902|2776635|P6|Overall Study|Other Reason|2
843853|NCT01708902|2776636|P5|Overall Study|Other Reason|1
843854|NCT01708902|2776637|P4|Overall Study|Other Reason|1
843855|NCT01708902|2776638|P3|Overall Study|Other Reason|1
843856|NCT01708902|2776639|P2|Overall Study|Other Reason|0
843857|NCT01708902|2776640|P1|Overall Study|Other Reason|1
843858|NCT01708902|2776634|P7|Overall Study|Refused to continue trial medication|1
843859|NCT01708902|2776635|P6|Overall Study|Refused to continue trial medication|1
843860|NCT01708902|2776636|P5|Overall Study|Refused to continue trial medication|8
843861|NCT01708902|2776637|P4|Overall Study|Refused to continue trial medication|2
843862|NCT01708902|2776638|P3|Overall Study|Refused to continue trial medication|4
843863|NCT01708902|2776639|P2|Overall Study|Refused to continue trial medication|0
843864|NCT01708902|2776640|P1|Overall Study|Refused to continue trial medication|8
843865|NCT01708902|2776634|P7|Overall Study|Lost to Follow-up|1
843866|NCT01708902|2776635|P6|Overall Study|Lost to Follow-up|0
843867|NCT01708902|2776636|P5|Overall Study|Lost to Follow-up|0
843868|NCT01708902|2776637|P4|Overall Study|Lost to Follow-up|2
843869|NCT01708902|2776638|P3|Overall Study|Lost to Follow-up|2
843870|NCT01708902|2776639|P2|Overall Study|Lost to Follow-up|1
843871|NCT01708902|2776640|P1|Overall Study|Lost to Follow-up|2
843872|NCT01708902|2776634|P7|Overall Study|Non compliance with protocol|0
843873|NCT01708902|2776635|P6|Overall Study|Non compliance with protocol|0
843874|NCT01708902|2776636|P5|Overall Study|Non compliance with protocol|0
843875|NCT01708902|2776637|P4|Overall Study|Non compliance with protocol|3
843876|NCT01708902|2776638|P3|Overall Study|Non compliance with protocol|1
843877|NCT01708902|2776639|P2|Overall Study|Non compliance with protocol|2
843878|NCT01708902|2776640|P1|Overall Study|Non compliance with protocol|0
843879|NCT01708902|2776634|P7|Overall Study|Lack of Efficacy|0
843880|NCT01708902|2776635|P6|Overall Study|Lack of Efficacy|1
843881|NCT01708902|2776636|P5|Overall Study|Lack of Efficacy|0
843882|NCT01708902|2776637|P4|Overall Study|Lack of Efficacy|0
843883|NCT01708902|2776638|P3|Overall Study|Lack of Efficacy|0
843884|NCT01708902|2776639|P2|Overall Study|Lack of Efficacy|1
843885|NCT01708902|2776640|P1|Overall Study|Lack of Efficacy|3
843886|NCT01708902|2776634|P7|Overall Study|Adverse Event|5
843887|NCT01708902|2776635|P6|Overall Study|Adverse Event|3
843888|NCT01708902|2776636|P5|Overall Study|Adverse Event|7
843889|NCT01708902|2776637|P4|Overall Study|Adverse Event|2
843890|NCT01708902|2776638|P3|Overall Study|Adverse Event|9
843891|NCT01708902|2776639|P2|Overall Study|Adverse Event|4
843892|NCT01708902|2776640|P1|Overall Study|Adverse Event|3
843893|NCT01708291|2776713|P2|Overall Study|fighting|1
843894|NCT01708291|2776714|P1|Overall Study|fighting|2
843895|NCT01708187|2776753|P2|Overall Study|Lost to Follow-up|1
843896|NCT01708187|2776754|P1|Overall Study|Lost to Follow-up|0
843897|NCT01708174|2776763|P3|Treatment Period|Adverse Event|0
843898|NCT01708174|2776764|P2|Treatment Period|Adverse Event|1
843899|NCT01708174|2776765|P1|Treatment Period|Adverse Event|0
843900|NCT01708174|2776763|P3|Treatment Period|Death|1
843901|NCT01708174|2776764|P2|Treatment Period|Death|0
843902|NCT01708174|2776765|P1|Treatment Period|Death|0
843903|NCT01708174|2776763|P3|Treatment Period|Progressive disease|0
843904|NCT01708174|2776764|P2|Treatment Period|Progressive disease|1
843905|NCT01708174|2776765|P1|Treatment Period|Progressive disease|0
843906|NCT01708174|2776763|P3|Treatment Period|Withdrawal by Subject|0
843907|NCT01708174|2776764|P2|Treatment Period|Withdrawal by Subject|0
843908|NCT01708174|2776765|P1|Treatment Period|Withdrawal by Subject|1
843909|NCT01708161|2776797|P6|Overall Study|Disease progression|0
843910|NCT01708161|2776798|P5|Overall Study|Disease progression|3
843911|NCT01708161|2776799|P4|Overall Study|Disease progression|13
843912|NCT01708161|2776800|P3|Overall Study|Disease progression|5
843913|NCT01708161|2776801|P2|Overall Study|Disease progression|5
843914|NCT01708161|2776802|P1|Overall Study|Disease progression|3
843915|NCT01708161|2776797|P6|Overall Study|Administrative problems|0
843916|NCT01708161|2776798|P5|Overall Study|Administrative problems|0
843917|NCT01708161|2776799|P4|Overall Study|Administrative problems|0
843918|NCT01708161|2776800|P3|Overall Study|Administrative problems|0
843919|NCT01708161|2776801|P2|Overall Study|Administrative problems|1
843920|NCT01708161|2776802|P1|Overall Study|Administrative problems|0
843921|NCT01708161|2776797|P6|Overall Study|Withdrawal by Subject|0
843922|NCT01708161|2776798|P5|Overall Study|Withdrawal by Subject|0
843923|NCT01708161|2776799|P4|Overall Study|Withdrawal by Subject|0
843924|NCT01708161|2776800|P3|Overall Study|Withdrawal by Subject|1
843925|NCT01708161|2776801|P2|Overall Study|Withdrawal by Subject|1
843926|NCT01708161|2776802|P1|Overall Study|Withdrawal by Subject|0
843927|NCT01708161|2776797|P6|Overall Study|Death|1
843928|NCT01708161|2776798|P5|Overall Study|Death|0
843929|NCT01708161|2776799|P4|Overall Study|Death|1
843930|NCT01708161|2776800|P3|Overall Study|Death|0
843931|NCT01708161|2776801|P2|Overall Study|Death|0
843932|NCT01708161|2776802|P1|Overall Study|Death|0
843933|NCT01708161|2776797|P6|Overall Study|Adverse Event|0
843934|NCT01708161|2776798|P5|Overall Study|Adverse Event|3
843935|NCT01708161|2776799|P4|Overall Study|Adverse Event|2
843936|NCT01708161|2776800|P3|Overall Study|Adverse Event|4
843937|NCT01708161|2776801|P2|Overall Study|Adverse Event|3
843938|NCT01708161|2776802|P1|Overall Study|Adverse Event|1
843939|NCT01708057|2776853|P3|Overall Study|Withdrawal due to study termination.|1
843940|NCT01708057|2776854|P2|Overall Study|Withdrawal due to study termination.|1
843941|NCT01708057|2776855|P1|Overall Study|Withdrawal due to study termination.|1
843942|NCT01707667|2776913|P2|Period 1|expulsion of colonic sensor catheter|0
843943|NCT01707667|2776914|P1|Period 1|expulsion of colonic sensor catheter|1
843944|NCT01707290|2776956|P2|Overall Study|Other unspecified|0
843945|NCT01707290|2776957|P1|Overall Study|Other unspecified|17
843946|NCT01707290|2776956|P2|Overall Study|Commercial drug available|1
843947|NCT01707290|2776957|P1|Overall Study|Commercial drug available|60
843948|NCT01707290|2776956|P2|Overall Study|Withdrawal of Consent (Not Due to AE)|0
843949|NCT01707290|2776957|P1|Overall Study|Withdrawal of Consent (Not Due to AE)|4
843950|NCT01707290|2776956|P2|Overall Study|Lost to Follow-up|0
843951|NCT01707290|2776957|P1|Overall Study|Lost to Follow-up|3
843952|NCT01707290|2776956|P2|Overall Study|Physician Decision|0
843953|NCT01707290|2776957|P1|Overall Study|Physician Decision|1
843954|NCT01707290|2776956|P2|Overall Study|Adverse event (AE)|0
843955|NCT01707290|2776957|P1|Overall Study|Adverse event (AE)|1
843956|NCT01706926|2777051|P4|Overall Study|Other|3
843957|NCT01706926|2777052|P3|Overall Study|Other|4
843958|NCT01706926|2777053|P2|Overall Study|Other|4
843959|NCT01706926|2777054|P1|Overall Study|Other|4
843960|NCT01706926|2777051|P4|Overall Study|Withdrawal by Subject|2
843961|NCT01706926|2777052|P3|Overall Study|Withdrawal by Subject|1
843962|NCT01706926|2777053|P2|Overall Study|Withdrawal by Subject|0
843963|NCT01706926|2777054|P1|Overall Study|Withdrawal by Subject|2
843964|NCT01706926|2777051|P4|Overall Study|Lost to Follow-up|0
843965|NCT01706926|2777052|P3|Overall Study|Lost to Follow-up|1
843966|NCT01706926|2777053|P2|Overall Study|Lost to Follow-up|0
843967|NCT01706926|2777054|P1|Overall Study|Lost to Follow-up|0
843968|NCT01706770|2777173|P2|Overall Study|Physician Decision|0
843969|NCT01706770|2777174|P1|Overall Study|Physician Decision|1
843970|NCT01706770|2777173|P2|Overall Study|Lost to Follow-up|0
843971|NCT01706770|2777174|P1|Overall Study|Lost to Follow-up|1
843972|NCT01706575|2777222|P1|Overall Study|Started but not Treated|6
843973|NCT01706575|2777222|P1|Overall Study|Lost to Follow-up|2
843974|NCT01706575|2777222|P1|Overall Study|Participant Withdrew Consent|4
843975|NCT01706536|2777243|P5|Overall Study|non compliance|0
843976|NCT01706536|2777244|P4|Overall Study|non compliance|0
843977|NCT01706536|2777245|P3|Overall Study|non compliance|0
843978|NCT01706536|2777246|P2|Overall Study|non compliance|1
843979|NCT01706536|2777247|P1|Overall Study|non compliance|0
843980|NCT01706536|2777243|P5|Overall Study|Lack of Efficacy|0
843981|NCT01706536|2777244|P4|Overall Study|Lack of Efficacy|1
843982|NCT01706536|2777245|P3|Overall Study|Lack of Efficacy|0
843983|NCT01706536|2777246|P2|Overall Study|Lack of Efficacy|0
843984|NCT01706536|2777247|P1|Overall Study|Lack of Efficacy|1
843985|NCT01706536|2777243|P5|Overall Study|Adverse Event|2
843986|NCT01706536|2777244|P4|Overall Study|Adverse Event|3
843987|NCT01706536|2777245|P3|Overall Study|Adverse Event|4
843988|NCT01706536|2777246|P2|Overall Study|Adverse Event|3
843989|NCT01706536|2777247|P1|Overall Study|Adverse Event|2
843990|NCT01706536|2777243|P5|Overall Study|Withdrawal by Subject|0
843991|NCT01706536|2777244|P4|Overall Study|Withdrawal by Subject|0
843992|NCT01706536|2777245|P3|Overall Study|Withdrawal by Subject|1
843993|NCT01706536|2777246|P2|Overall Study|Withdrawal by Subject|0
843994|NCT01706536|2777247|P1|Overall Study|Withdrawal by Subject|1
843995|NCT01706458|2777306|P2|Overall Study|Physician Decision|4
843996|NCT01706458|2777307|P1|Overall Study|Physician Decision|3
843997|NCT01706328|2777331|P3|12-week Double-blind Treatment Period|Withdrawal by Subject|11
843998|NCT01706328|2777332|P2|12-week Double-blind Treatment Period|Withdrawal by Subject|8
843999|NCT01706328|2777333|P1|12-week Double-blind Treatment Period|Withdrawal by Subject|0
844000|NCT01706328|2777331|P3|12-week Double-blind Treatment Period|Physician Decision|2
844001|NCT01706328|2777332|P2|12-week Double-blind Treatment Period|Physician Decision|2
844002|NCT01706328|2777333|P1|12-week Double-blind Treatment Period|Physician Decision|0
844003|NCT01706328|2777331|P3|12-week Double-blind Treatment Period|Lost to Follow-up|1
844004|NCT01706328|2777332|P2|12-week Double-blind Treatment Period|Lost to Follow-up|3
844005|NCT01706328|2777333|P1|12-week Double-blind Treatment Period|Lost to Follow-up|0
844006|NCT01706328|2777331|P3|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9
844007|NCT01706328|2777332|P2|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11
844008|NCT01706328|2777333|P1|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0
844009|NCT01706328|2777331|P3|12-week Double-blind Treatment Period|Protocol Violation|2
844010|NCT01706328|2777332|P2|12-week Double-blind Treatment Period|Protocol Violation|4
844011|NCT01706328|2777333|P1|12-week Double-blind Treatment Period|Protocol Violation|0
844012|NCT01706328|2777331|P3|12-week Double-blind Treatment Period|Lack of Efficacy|4
844013|NCT01706328|2777332|P2|12-week Double-blind Treatment Period|Lack of Efficacy|4
844014|NCT01706328|2777333|P1|12-week Double-blind Treatment Period|Lack of Efficacy|0
844015|NCT01706328|2777331|P3|12-week Double-blind Treatment Period|Adverse Event|16
844016|NCT01706328|2777332|P2|12-week Double-blind Treatment Period|Adverse Event|14
844017|NCT01706328|2777333|P1|12-week Double-blind Treatment Period|Adverse Event|0
844018|NCT01706328|2777331|P3|2-week Run-in Period|Lost to Follow-up|0
844019|NCT01706328|2777332|P2|2-week Run-in Period|Lost to Follow-up|0
844020|NCT01706328|2777333|P1|2-week Run-in Period|Lost to Follow-up|2
844021|NCT01706328|2777331|P3|2-week Run-in Period|Adverse Event|0
844022|NCT01706328|2777332|P2|2-week Run-in Period|Adverse Event|0
844023|NCT01706328|2777333|P1|2-week Run-in Period|Adverse Event|4
844024|NCT01706328|2777331|P3|2-week Run-in Period|Physician Decision|0
844025|NCT01706328|2777332|P2|2-week Run-in Period|Physician Decision|0
844026|NCT01706328|2777333|P1|2-week Run-in Period|Physician Decision|4
844027|NCT01706328|2777331|P3|2-week Run-in Period|Withdrawal by Subject|0
844028|NCT01706328|2777332|P2|2-week Run-in Period|Withdrawal by Subject|0
844029|NCT01706328|2777333|P1|2-week Run-in Period|Withdrawal by Subject|15
844030|NCT01706328|2777331|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
844031|NCT01706328|2777332|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
844032|NCT01706328|2777333|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140
844033|NCT01706250|2777352|P1|Overall Study|Lost to Follow-up|2
844034|NCT01706159|2777383|P2|Overall Study|Unclassified|1
844035|NCT01706159|2777384|P1|Overall Study|Unclassified|6
844036|NCT01706159|2777383|P2|Overall Study|Withdrawal Criteria|1
844037|NCT01706159|2777384|P1|Overall Study|Withdrawal Criteria|2
844038|NCT01706146|2777398|P1|Overall Study|Developed AF and need for antiplatelets|2
844039|NCT01706146|2777398|P1|Overall Study|Adverse Event|3
844040|NCT01706146|2777398|P1|Overall Study|Withdrawal by Subject|1
844041|NCT01705730|2777403|P1|Overall Study|Reason not Specified|4
844042|NCT01705730|2777403|P1|Overall Study|Lost to Follow-up|1
844043|NCT01705730|2777403|P1|Overall Study|Adverse Event|3
844044|NCT01705730|2777403|P1|Overall Study|Lack of Efficacy|1
844045|NCT01705717|2777443|P2|Overall Study|Not Specified|2
844046|NCT01705717|2777444|P1|Overall Study|Not Specified|0
844047|NCT01705717|2777443|P2|Overall Study|Lack of Efficacy|1
844048|NCT01705717|2777444|P1|Overall Study|Lack of Efficacy|0
844049|NCT01705717|2777443|P2|Overall Study|Adverse Event|2
844050|NCT01705717|2777444|P1|Overall Study|Adverse Event|2
844051|NCT01705691|2777461|P2|Overall Study|Other|1
844052|NCT01705691|2777462|P1|Overall Study|Other|0
844053|NCT01705691|2777461|P2|Overall Study|Lost to Follow-up|1
844054|NCT01705691|2777462|P1|Overall Study|Lost to Follow-up|1
844055|NCT01705691|2777461|P2|Overall Study|Withdrawal by Subject|2
844056|NCT01705691|2777462|P1|Overall Study|Withdrawal by Subject|1
844057|NCT01705691|2777461|P2|Overall Study|Death|2
844058|NCT01705691|2777462|P1|Overall Study|Death|1
844059|NCT01705652|2777482|P2|Overall Study|non-compliance|1
844060|NCT01705652|2777483|P1|Overall Study|non-compliance|1
844061|NCT01705652|2777482|P2|Overall Study|Withdrawal by Subject|2
844062|NCT01705652|2777483|P1|Overall Study|Withdrawal by Subject|1
844063|NCT01705652|2777482|P2|Overall Study|Adverse Event|0
844064|NCT01705652|2777483|P1|Overall Study|Adverse Event|1
844065|NCT01705587|2777491|P2|Overall Study|Withdrawal by Subject|1
844066|NCT01705587|2777492|P1|Overall Study|Withdrawal by Subject|0
844067|NCT01705574|2777510|P2|Overall Study|Still on Study|125
844068|NCT01705574|2777511|P1|Overall Study|Still on Study|135
844069|NCT01705574|2777510|P2|Overall Study|Lost to Follow-up|15
844070|NCT01705574|2777511|P1|Overall Study|Lost to Follow-up|11
844071|NCT01705574|2777510|P2|Overall Study|Withdrew Consent|5
844072|NCT01705574|2777511|P1|Overall Study|Withdrew Consent|8
844073|NCT01705574|2777510|P2|Overall Study|Protocol Violation|0
844074|NCT01705574|2777511|P1|Overall Study|Protocol Violation|1
844075|NCT01705574|2777510|P2|Overall Study|Non-Compliance with Study Drug|4
844076|NCT01705574|2777511|P1|Overall Study|Non-Compliance with Study Drug|4
844077|NCT01705574|2777510|P2|Overall Study|Pregnancy|1
844078|NCT01705574|2777511|P1|Overall Study|Pregnancy|1
844079|NCT01705574|2777510|P2|Overall Study|Adverse Event|9
844080|NCT01705574|2777511|P1|Overall Study|Adverse Event|3
844081|NCT01705574|2777510|P2|Overall Study|Randomized but Not Treated|4
844082|NCT01705574|2777511|P1|Overall Study|Randomized but Not Treated|4
844083|NCT01705145|2777529|P1|Part B|Adverse Event|1
844084|NCT01705080|2777569|P4|Overall Study|Missed 6M Visit|0
844085|NCT01705080|2777570|P3|Overall Study|Missed 6M Visit|1
844086|NCT01705080|2777571|P2|Overall Study|Missed 6M Visit|1
844087|NCT01705080|2777572|P1|Overall Study|Missed 6M Visit|3
844088|NCT01705080|2777569|P4|Overall Study|Protocol Violation|0
844089|NCT01705080|2777570|P3|Overall Study|Protocol Violation|0
844090|NCT01705080|2777571|P2|Overall Study|Protocol Violation|0
844091|NCT01705080|2777572|P1|Overall Study|Protocol Violation|2
844092|NCT01705080|2777569|P4|Overall Study|Lost to Follow-up|2
844093|NCT01705080|2777570|P3|Overall Study|Lost to Follow-up|0
844094|NCT01705080|2777571|P2|Overall Study|Lost to Follow-up|0
844095|NCT01705080|2777572|P1|Overall Study|Lost to Follow-up|0
844096|NCT01705080|2777569|P4|Overall Study|Physician Decision|8
844097|NCT01705080|2777570|P3|Overall Study|Physician Decision|1
844098|NCT01705080|2777571|P2|Overall Study|Physician Decision|2
844099|NCT01705080|2777572|P1|Overall Study|Physician Decision|1
844100|NCT01705080|2777569|P4|Overall Study|Withdrawal by Subject|12
844101|NCT01705080|2777570|P3|Overall Study|Withdrawal by Subject|0
844102|NCT01705080|2777571|P2|Overall Study|Withdrawal by Subject|1
844103|NCT01705080|2777572|P1|Overall Study|Withdrawal by Subject|1
844104|NCT01705080|2777569|P4|Overall Study|Death|0
844105|NCT01705080|2777570|P3|Overall Study|Death|0
844106|NCT01705080|2777571|P2|Overall Study|Death|1
844107|NCT01705080|2777572|P1|Overall Study|Death|0
844108|NCT01705080|2777569|P4|Overall Study|Failed Procedure|0
844109|NCT01705080|2777570|P3|Overall Study|Failed Procedure|0
844110|NCT01705080|2777571|P2|Overall Study|Failed Procedure|2
844111|NCT01705080|2777572|P1|Overall Study|Failed Procedure|0
844112|NCT01705080|2777569|P4|Overall Study|Screen Failure Post Consent|20
844113|NCT01705080|2777570|P3|Overall Study|Screen Failure Post Consent|3
844114|NCT01705080|2777571|P2|Overall Study|Screen Failure Post Consent|9
844115|NCT01705080|2777572|P1|Overall Study|Screen Failure Post Consent|8
844116|NCT01704846|2777601|P2|Treatment Period 2|Withdrawal by Subject|1
844117|NCT01704846|2777602|P1|Treatment Period 2|Withdrawal by Subject|0
844118|NCT01704755|2777657|P2|Overall Study|Withdrew consent and personal issues|0
844119|NCT01704755|2777658|P1|Overall Study|Withdrew consent and personal issues|1
844120|NCT01704755|2777657|P2|Overall Study|Other (not specified)|1
844121|NCT01704755|2777658|P1|Overall Study|Other (not specified)|3
844122|NCT01704755|2777657|P2|Overall Study|Withdrew consent|1
844123|NCT01704755|2777658|P1|Overall Study|Withdrew consent|1
844124|NCT01704755|2777657|P2|Overall Study|Lost to Follow-up|4
844125|NCT01704755|2777658|P1|Overall Study|Lost to Follow-up|3
844126|NCT01704755|2777657|P2|Overall Study|Adverse Event|1
844127|NCT01704755|2777658|P1|Overall Study|Adverse Event|4
844128|NCT01704651|2777672|P2|Overall Study|Post-op did not have laparotomy|1
844129|NCT01704651|2777673|P1|Overall Study|Post-op did not have laparotomy|2
844130|NCT01704651|2777672|P2|Overall Study|Nasogastric tube placement in surgery|1
844131|NCT01704651|2777673|P1|Overall Study|Nasogastric tube placement in surgery|1
844132|NCT01704651|2777672|P2|Overall Study|Pre-op change in treatment plan|4
844133|NCT01704651|2777673|P1|Overall Study|Pre-op change in treatment plan|1
844134|NCT01704651|2777672|P2|Overall Study|Pre-op withdrawal by subject|1
844135|NCT01704651|2777673|P1|Overall Study|Pre-op withdrawal by subject|1
844136|NCT01704599|2777681|P1|Overall Study|Adverse Event|1
844137|NCT01704495|2777721|P4|Optional Safety Extension|Withdrawal by Subject|2
844138|NCT01704495|2777722|P3|Optional Safety Extension|Withdrawal by Subject|1
844139|NCT01704495|2777723|P2|Optional Safety Extension|Withdrawal by Subject|0
844140|NCT01704495|2777724|P1|Optional Safety Extension|Withdrawal by Subject|2
844141|NCT01704495|2777721|P4|Optional Safety Extension|Other reason|28
844142|NCT01704495|2777722|P3|Optional Safety Extension|Other reason|30
844143|NCT01704495|2777723|P2|Optional Safety Extension|Other reason|29
844144|NCT01704495|2777724|P1|Optional Safety Extension|Other reason|27
844145|NCT01704495|2777721|P4|Optional Safety Extension|Adverse Event|1
844146|NCT01704495|2777722|P3|Optional Safety Extension|Adverse Event|0
844147|NCT01704495|2777723|P2|Optional Safety Extension|Adverse Event|4
844148|NCT01704495|2777724|P1|Optional Safety Extension|Adverse Event|0
844149|NCT01704495|2777721|P4|Subjects Randomized|Eligibility criteria not fulfilled|3
844150|NCT01704495|2777722|P3|Subjects Randomized|Eligibility criteria not fulfilled|4
844151|NCT01704495|2777723|P2|Subjects Randomized|Eligibility criteria not fulfilled|3
844152|NCT01704495|2777724|P1|Subjects Randomized|Eligibility criteria not fulfilled|1
844153|NCT01704495|2777721|P4|Subjects Randomized|Protocol Violation|0
844154|NCT01704495|2777722|P3|Subjects Randomized|Protocol Violation|2
844155|NCT01704495|2777723|P2|Subjects Randomized|Protocol Violation|1
844156|NCT01704495|2777724|P1|Subjects Randomized|Protocol Violation|1
844157|NCT01704495|2777721|P4|Subjects Randomized|Withdrawal by Subject|5
844158|NCT01704495|2777722|P3|Subjects Randomized|Withdrawal by Subject|5
844159|NCT01704495|2777723|P2|Subjects Randomized|Withdrawal by Subject|5
844160|NCT01704495|2777724|P1|Subjects Randomized|Withdrawal by Subject|5
844161|NCT01704495|2777721|P4|Subjects Randomized|Adverse Event|7
844162|NCT01704495|2777722|P3|Subjects Randomized|Adverse Event|0
844163|NCT01704495|2777723|P2|Subjects Randomized|Adverse Event|2
844164|NCT01704495|2777724|P1|Subjects Randomized|Adverse Event|8
844165|NCT01704495|2777721|P4|Subjects Randomized|Discontinuation criteria met|0
844166|NCT01704495|2777722|P3|Subjects Randomized|Discontinuation criteria met|2
844167|NCT01704495|2777723|P2|Subjects Randomized|Discontinuation criteria met|2
844168|NCT01704495|2777724|P1|Subjects Randomized|Discontinuation criteria met|4
844169|NCT01704495|2777721|P4|Subjects Randomized|Other Reason|2
844170|NCT01704495|2777722|P3|Subjects Randomized|Other Reason|3
844171|NCT01704495|2777723|P2|Subjects Randomized|Other Reason|2
844172|NCT01704495|2777724|P1|Subjects Randomized|Other Reason|3
844173|NCT01704287|2777940|P5|Switch to Pembrolizumab Treatment Period|Ongoing in Study|16
844174|NCT01704287|2777941|P4|Switch to Pembrolizumab Treatment Period|Ongoing in Study|21
844175|NCT01704287|2777942|P3|Switch to Pembrolizumab Treatment Period|Ongoing in Study|0
844176|NCT01704287|2777943|P2|Switch to Pembrolizumab Treatment Period|Ongoing in Study|0
844177|NCT01704287|2777944|P1|Switch to Pembrolizumab Treatment Period|Ongoing in Study|0
844178|NCT01704287|2777940|P5|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
844179|NCT01704287|2777941|P4|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1
844180|NCT01704287|2777942|P3|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
844181|NCT01704287|2777943|P2|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
844182|NCT01704287|2777944|P1|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
844183|NCT01704287|2777940|P5|Switch to Pembrolizumab Treatment Period|Death|28
844184|NCT01704287|2777941|P4|Switch to Pembrolizumab Treatment Period|Death|29
844185|NCT01704287|2777942|P3|Switch to Pembrolizumab Treatment Period|Death|0
844186|NCT01704287|2777943|P2|Switch to Pembrolizumab Treatment Period|Death|0
844187|NCT01704287|2777944|P1|Switch to Pembrolizumab Treatment Period|Death|0
844188|NCT01704287|2777940|P5|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1
844189|NCT01704287|2777941|P4|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2
844190|NCT01704287|2777942|P3|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
844191|NCT01704287|2777943|P2|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
844192|NCT01704287|2777944|P1|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
844193|NCT01704287|2777940|P5|Initial Treatment Period|Switched to Pembrolizumab|0
844194|NCT01704287|2777941|P4|Initial Treatment Period|Switched to Pembrolizumab|0
844195|NCT01704287|2777942|P3|Initial Treatment Period|Switched to Pembrolizumab|98
844196|NCT01704287|2777943|P2|Initial Treatment Period|Switched to Pembrolizumab|0
844197|NCT01704287|2777944|P1|Initial Treatment Period|Switched to Pembrolizumab|0
844198|NCT01704287|2777940|P5|Initial Treatment Period|Lost to Follow-up|0
844199|NCT01704287|2777941|P4|Initial Treatment Period|Lost to Follow-up|0
844200|NCT01704287|2777942|P3|Initial Treatment Period|Lost to Follow-up|3
844201|NCT01704287|2777943|P2|Initial Treatment Period|Lost to Follow-up|1
844202|NCT01704287|2777944|P1|Initial Treatment Period|Lost to Follow-up|3
844203|NCT01704287|2777940|P5|Initial Treatment Period|Ongoing in Study|0
844204|NCT01704287|2777941|P4|Initial Treatment Period|Ongoing in Study|0
844205|NCT01704287|2777942|P3|Initial Treatment Period|Ongoing in Study|44
844206|NCT01704287|2777943|P2|Initial Treatment Period|Ongoing in Study|62
844207|NCT01704287|2777944|P1|Initial Treatment Period|Ongoing in Study|52
844208|NCT01704287|2777940|P5|Initial Treatment Period|Other|0
844209|NCT01704287|2777941|P4|Initial Treatment Period|Other|0
844210|NCT01704287|2777942|P3|Initial Treatment Period|Other|0
844211|NCT01704287|2777943|P2|Initial Treatment Period|Other|0
844212|NCT01704287|2777944|P1|Initial Treatment Period|Other|1
844213|NCT01704287|2777940|P5|Initial Treatment Period|Withdrawal by Subject|0
844214|NCT01704287|2777941|P4|Initial Treatment Period|Withdrawal by Subject|0
844215|NCT01704287|2777942|P3|Initial Treatment Period|Withdrawal by Subject|4
844216|NCT01704287|2777943|P2|Initial Treatment Period|Withdrawal by Subject|1
844217|NCT01704287|2777944|P1|Initial Treatment Period|Withdrawal by Subject|1
844218|NCT01704287|2777940|P5|Initial Treatment Period|Death|0
844219|NCT01704287|2777941|P4|Initial Treatment Period|Death|0
844220|NCT01704287|2777942|P3|Initial Treatment Period|Death|30
844221|NCT01704287|2777943|P2|Initial Treatment Period|Death|117
844222|NCT01704287|2777944|P1|Initial Treatment Period|Death|123
844223|NCT01704261|2777979|P2|Overall Study|Lost to Follow-up|0
844224|NCT01704261|2777980|P1|Overall Study|Lost to Follow-up|1
844225|NCT01704261|2777979|P2|Overall Study|Withdrawal by Subject|15
844226|NCT01704261|2777980|P1|Overall Study|Withdrawal by Subject|12
844227|NCT01704079|2778007|P2|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1
844228|NCT01704079|2778008|P1|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0
844229|NCT01704079|2778007|P2|Overall Study|Subject noncompliance|3
844230|NCT01704079|2778008|P1|Overall Study|Subject noncompliance|2
844231|NCT01704079|2778007|P2|Overall Study|Protocol Violation|0
844232|NCT01704079|2778008|P1|Overall Study|Protocol Violation|1
844233|NCT01704079|2778007|P2|Overall Study|Adverse Event|7
844234|NCT01704079|2778008|P1|Overall Study|Adverse Event|4
844235|NCT01704079|2778007|P2|Overall Study|Lost to Follow-up|5
844236|NCT01704079|2778008|P1|Overall Study|Lost to Follow-up|2
844237|NCT01704079|2778007|P2|Overall Study|Withdrawal by Subject|7
844238|NCT01704079|2778008|P1|Overall Study|Withdrawal by Subject|5
844239|NCT01703988|2778024|P4|Overall Study|Investigator Judgment|1
844240|NCT01703988|2778025|P3|Overall Study|Investigator Judgment|0
844241|NCT01703988|2778026|P2|Overall Study|Investigator Judgment|0
844242|NCT01703988|2778027|P1|Overall Study|Investigator Judgment|0
844243|NCT01703858|2778057|P3|Overall Study|Withdrawal by Subject|0
844244|NCT01703858|2778058|P2|Overall Study|Withdrawal by Subject|1
844245|NCT01703858|2778059|P1|Overall Study|Withdrawal by Subject|0
844246|NCT01703845|2778084|P2|Overall Study|other than stated above|0
844247|NCT01703845|2778085|P1|Overall Study|other than stated above|1
844248|NCT01703845|2778084|P2|Overall Study|Protocol Violation|0
844249|NCT01703845|2778085|P1|Overall Study|Protocol Violation|1
844250|NCT01703845|2778084|P2|Overall Study|Adverse Event|0
844251|NCT01703845|2778085|P1|Overall Study|Adverse Event|1
844252|NCT01703832|2778122|P2|Overall Study|Withdrawal by Subject|0
844253|NCT01703832|2778123|P1|Overall Study|Withdrawal by Subject|1
844254|NCT01703819|2778155|P2|Overall Study|Withdrawal by Subject|1
844255|NCT01703819|2778156|P1|Overall Study|Withdrawal by Subject|0
844256|NCT01703819|2778155|P2|Overall Study|Adverse Event|1
844257|NCT01703819|2778156|P1|Overall Study|Adverse Event|0
844258|NCT01703741|2778186|P1|Overall Study|Subject started testosterone injections|1
844259|NCT01703741|2778186|P1|Overall Study|Subject cannot comply with study visits|1
844260|NCT01703741|2778186|P1|Overall Study|Subject did not want to continue|2
844261|NCT01703741|2778186|P1|Overall Study|Lost to Follow-up|3
844262|NCT01703741|2778186|P1|Overall Study|Protocol Violation|1
844263|NCT01703741|2778186|P1|Overall Study|Physician Decision|2
844264|NCT01703741|2778186|P1|Overall Study|Adverse Event|2
844265|NCT01703741|2778186|P1|Overall Study|Withdrawal by Subject|6
844266|NCT01703286|2778229|P6|Period 2 Including Washout|Adverse Event|0
844267|NCT01703286|2778230|P5|Period 2 Including Washout|Adverse Event|0
844268|NCT01703286|2778231|P4|Period 2 Including Washout|Adverse Event|1
844269|NCT01703286|2778232|P3|Period 2 Including Washout|Adverse Event|0
844270|NCT01703286|2778233|P2|Period 2 Including Washout|Adverse Event|0
844271|NCT01703286|2778234|P1|Period 2 Including Washout|Adverse Event|0
844272|NCT01703286|2778229|P6|Period 1 Including Washout|Withdrawal by Subject|1
844273|NCT01703286|2778230|P5|Period 1 Including Washout|Withdrawal by Subject|0
844274|NCT01703286|2778231|P4|Period 1 Including Washout|Withdrawal by Subject|1
844275|NCT01703286|2778232|P3|Period 1 Including Washout|Withdrawal by Subject|0
844276|NCT01703286|2778233|P2|Period 1 Including Washout|Withdrawal by Subject|0
844277|NCT01703286|2778234|P1|Period 1 Including Washout|Withdrawal by Subject|0
844278|NCT01703260|2778257|P3|Overall Study|Study Termination|0
844279|NCT01703260|2778258|P2|Overall Study|Study Termination|2
844280|NCT01703260|2778259|P1|Overall Study|Study Termination|1
844281|NCT01703260|2778257|P3|Overall Study|Withdrawal by Subject|1
844282|NCT01703260|2778258|P2|Overall Study|Withdrawal by Subject|0
844283|NCT01703260|2778259|P1|Overall Study|Withdrawal by Subject|0
844284|NCT01703260|2778257|P3|Overall Study|Lost to Follow-up|0
844285|NCT01703260|2778258|P2|Overall Study|Lost to Follow-up|0
844286|NCT01703260|2778259|P1|Overall Study|Lost to Follow-up|1
844287|NCT01703260|2778257|P3|Overall Study|Adverse Event|2
844288|NCT01703260|2778258|P2|Overall Study|Adverse Event|2
844289|NCT01703260|2778259|P1|Overall Study|Adverse Event|1
844290|NCT01703221|2778285|P3|Phase B - (Week 25 to 52)|Lack of Efficacy|3
844291|NCT01703221|2778286|P2|Phase B - (Week 25 to 52)|Lack of Efficacy|10
844292|NCT01703221|2778287|P1|Phase B - (Week 25 to 52)|Lack of Efficacy|12
844293|NCT01703221|2778285|P3|Phase B - (Week 25 to 52)|Adverse Event|2
844294|NCT01703221|2778286|P2|Phase B - (Week 25 to 52)|Adverse Event|3
844295|NCT01703221|2778287|P1|Phase B - (Week 25 to 52)|Adverse Event|2
844296|NCT01703221|2778285|P3|Phase B - (Week 25 to 52)|Withdrawal by Subject|0
844297|NCT01703221|2778286|P2|Phase B - (Week 25 to 52)|Withdrawal by Subject|1
844298|NCT01703221|2778287|P1|Phase B - (Week 25 to 52)|Withdrawal by Subject|2
844299|NCT01703221|2778285|P3|Phase A (Up to 24 Weeks)|Protocol Violation|1
844300|NCT01703221|2778286|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
844301|NCT01703221|2778287|P1|Phase A (Up to 24 Weeks)|Protocol Violation|0
844302|NCT01703221|2778285|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
844303|NCT01703221|2778286|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
844304|NCT01703221|2778287|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2
844305|NCT01703221|2778285|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
844306|NCT01703221|2778286|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
844307|NCT01703221|2778287|P1|Phase A (Up to 24 Weeks)|Physician Decision|1
844308|NCT01703221|2778285|P3|Phase A (Up to 24 Weeks)|Lack of Efficacy|1
844309|NCT01703221|2778286|P2|Phase A (Up to 24 Weeks)|Lack of Efficacy|0
844310|NCT01703221|2778287|P1|Phase A (Up to 24 Weeks)|Lack of Efficacy|2
844311|NCT01703221|2778285|P3|Phase A (Up to 24 Weeks)|Adverse Event|0
844312|NCT01703221|2778286|P2|Phase A (Up to 24 Weeks)|Adverse Event|4
844313|NCT01703221|2778287|P1|Phase A (Up to 24 Weeks)|Adverse Event|2
844314|NCT01703208|2778318|P2|Overall Study|Protocol Deviation|0
844315|NCT01703208|2778319|P1|Overall Study|Protocol Deviation|2
844316|NCT01703208|2778318|P2|Overall Study|Technical Problems|1
844317|NCT01703208|2778319|P1|Overall Study|Technical Problems|0
844318|NCT01703208|2778318|P2|Overall Study|Adverse Event|19
844319|NCT01703208|2778319|P1|Overall Study|Adverse Event|14
844320|NCT01703208|2778318|P2|Overall Study|Withdrawal by Subject|209
844321|NCT01703208|2778319|P1|Overall Study|Withdrawal by Subject|205
844322|NCT01703208|2778318|P2|Overall Study|Study Terminated by Sponsor|1716
844323|NCT01703208|2778319|P1|Overall Study|Study Terminated by Sponsor|1710
844324|NCT01703208|2778318|P2|Overall Study|Protocol Violation|1
844325|NCT01703208|2778319|P1|Overall Study|Protocol Violation|1
844326|NCT01703208|2778318|P2|Overall Study|Progressive disease|2
844327|NCT01703208|2778319|P1|Overall Study|Progressive disease|2
844328|NCT01703208|2778318|P2|Overall Study|Physician Decision|13
844329|NCT01703208|2778319|P1|Overall Study|Physician Decision|11
844330|NCT01703208|2778318|P2|Overall Study|Site Discontinued Study Participation|27
844331|NCT01703208|2778319|P1|Overall Study|Site Discontinued Study Participation|23
844332|NCT01703208|2778318|P2|Overall Study|Excluded Medication|2
844333|NCT01703208|2778319|P1|Overall Study|Excluded Medication|1
844334|NCT01703208|2778318|P2|Overall Study|Non-Compliance with Study Drug|0
844335|NCT01703208|2778319|P1|Overall Study|Non-Compliance with Study Drug|1
844336|NCT01703208|2778318|P2|Overall Study|Lost to Follow-up|62
844337|NCT01703208|2778319|P1|Overall Study|Lost to Follow-up|68
844338|NCT01703208|2778318|P2|Overall Study|Lack of Efficacy|2
844339|NCT01703208|2778319|P1|Overall Study|Lack of Efficacy|1
844340|NCT01703208|2778318|P2|Overall Study|Death|48
844341|NCT01703208|2778319|P1|Overall Study|Death|61
844342|NCT01703091|2778383|P2|Overall Study|Sponsor Decision|0
844343|NCT01703091|2778384|P1|Overall Study|Sponsor Decision|1
844344|NCT01703091|2778383|P2|Overall Study|Withdrawal by Subject|0
844345|NCT01703091|2778384|P1|Overall Study|Withdrawal by Subject|1
844346|NCT01703091|2778383|P2|Overall Study|Physician Decision|1
844347|NCT01703091|2778384|P1|Overall Study|Physician Decision|2
844348|NCT01703091|2778383|P2|Overall Study|Adverse Event|3
844349|NCT01703091|2778384|P1|Overall Study|Adverse Event|5
844350|NCT01703000|2778400|P1|Overall Study|Death|1
844351|NCT01702987|2778433|P2|Overall Study|Withdrawal by Subject|0
844352|NCT01702987|2778434|P1|Overall Study|Withdrawal by Subject|1
844353|NCT01702961|2778440|P1|Overall Study|Ongoing|11
844354|NCT01702961|2778440|P1|Overall Study|Lost to Follow-up|2
844355|NCT01702961|2778440|P1|Overall Study|Death|6
844356|NCT01702961|2778440|P1|Overall Study|Relapse|20
844357|NCT01702961|2778440|P1|Overall Study|Progressive disease|5
844358|NCT01702961|2778440|P1|Overall Study|Additional treatment|3
844359|NCT01702532|2778460|P2|Overall Study|Adverse Event|1
844360|NCT01702532|2778461|P1|Overall Study|Adverse Event|0
844361|NCT01702519|2778471|P2|Washout Period|Withdrawal by Subject|2
844362|NCT01702519|2778472|P1|Washout Period|Withdrawal by Subject|0
844363|NCT01702519|2778471|P2|Washout Period|Lost to Follow-up|0
844364|NCT01702519|2778472|P1|Washout Period|Lost to Follow-up|1
844365|NCT01702454|2778490|P2|Overall Study|Lost to Follow-up|6
844366|NCT01702454|2778491|P1|Overall Study|Lost to Follow-up|3
844367|NCT01702454|2778490|P2|Overall Study|Migrated/moved from study area|1
844368|NCT01702454|2778491|P1|Overall Study|Migrated/moved from study area|0
844369|NCT01702454|2778490|P2|Overall Study|Consent withdrawal|1
844370|NCT01702454|2778491|P1|Overall Study|Consent withdrawal|0
844371|NCT01702428|2778573|P4|Overall Study|Withdrawal by Subject|10
844372|NCT01702428|2778574|P3|Overall Study|Withdrawal by Subject|14
844373|NCT01702428|2778575|P2|Overall Study|Withdrawal by Subject|23
844374|NCT01702428|2778576|P1|Overall Study|Withdrawal by Subject|21
844375|NCT01702428|2778573|P4|Overall Study|Protocol Violation|0
844376|NCT01702428|2778574|P3|Overall Study|Protocol Violation|1
844377|NCT01702428|2778575|P2|Overall Study|Protocol Violation|0
844378|NCT01702428|2778576|P1|Overall Study|Protocol Violation|3
844379|NCT01702428|2778573|P4|Overall Study|Parents too busy|0
844380|NCT01702428|2778574|P3|Overall Study|Parents too busy|0
844381|NCT01702428|2778575|P2|Overall Study|Parents too busy|0
844382|NCT01702428|2778576|P1|Overall Study|Parents too busy|1
844383|NCT01702428|2778573|P4|Overall Study|Mother transferred care|0
844384|NCT01702428|2778574|P3|Overall Study|Mother transferred care|0
844385|NCT01702428|2778575|P2|Overall Study|Mother transferred care|1
844386|NCT01702428|2778576|P1|Overall Study|Mother transferred care|0
844387|NCT01702428|2778573|P4|Overall Study|Lost Health Plan|2
844388|NCT01702428|2778574|P3|Overall Study|Lost Health Plan|0
844389|NCT01702428|2778575|P2|Overall Study|Lost Health Plan|5
844390|NCT01702428|2778576|P1|Overall Study|Lost Health Plan|3
844391|NCT01702428|2778573|P4|Overall Study|Lost Coverage|1
844392|NCT01702428|2778574|P3|Overall Study|Lost Coverage|0
844393|NCT01702428|2778575|P2|Overall Study|Lost Coverage|0
844394|NCT01702428|2778576|P1|Overall Study|Lost Coverage|0
844395|NCT01702428|2778573|P4|Overall Study|Parents cannot assist to site|0
844396|NCT01702428|2778574|P3|Overall Study|Parents cannot assist to site|1
844397|NCT01702428|2778575|P2|Overall Study|Parents cannot assist to site|0
844398|NCT01702428|2778576|P1|Overall Study|Parents cannot assist to site|1
844399|NCT01702428|2778573|P4|Overall Study|Lost to Follow-up|44
844400|NCT01702428|2778574|P3|Overall Study|Lost to Follow-up|37
844401|NCT01702428|2778575|P2|Overall Study|Lost to Follow-up|41
844402|NCT01702428|2778576|P1|Overall Study|Lost to Follow-up|33
844403|NCT01702428|2778573|P4|Overall Study|Adverse Event|0
844404|NCT01702428|2778574|P3|Overall Study|Adverse Event|0
844405|NCT01702428|2778575|P2|Overall Study|Adverse Event|0
844406|NCT01702428|2778576|P1|Overall Study|Adverse Event|2
844407|NCT01702363|2778663|P1|Overall Study|Withdrawal by Subject|2
844408|NCT01702363|2778663|P1|Overall Study|Lack of Efficacy|4
844409|NCT01702363|2778663|P1|Overall Study|Adverse Event|14
844410|NCT01702311|2778680|P2|Overall Study|Physician Decision|4
844411|NCT01702311|2778681|P1|Overall Study|Physician Decision|3
844412|NCT01702311|2778680|P2|Overall Study|Discharge less than 24 hours|7
844413|NCT01702311|2778681|P1|Overall Study|Discharge less than 24 hours|10
844414|NCT01702311|2778680|P2|Overall Study|Withdrawal by Subject|2
844415|NCT01702311|2778681|P1|Overall Study|Withdrawal by Subject|3
844416|NCT01702298|2778711|P1|Overall Study|Withdrawal by Subject|1
844417|NCT01702246|2778739|P1|Overall Study|Physician Decision|1
844418|NCT01702246|2778739|P1|Overall Study|Withdrawal by Subject|2
844419|NCT01702246|2778739|P1|Overall Study|Lost to Follow-up|2
844420|NCT01702025|2778793|P4|Overall Study|Adverse Event|0
844421|NCT01702025|2778794|P3|Overall Study|Adverse Event|1
844422|NCT01702025|2778795|P2|Overall Study|Adverse Event|1
844423|NCT01702025|2778796|P1|Overall Study|Adverse Event|1
844424|NCT01702025|2778793|P4|Overall Study|Equipment failure|0
844425|NCT01702025|2778794|P3|Overall Study|Equipment failure|0
844426|NCT01702025|2778795|P2|Overall Study|Equipment failure|0
844427|NCT01702025|2778796|P1|Overall Study|Equipment failure|1
844428|NCT01701973|2778825|P8|Aim 1: First Intervention (1 Day)|Adverse Event|0
844429|NCT01701973|2778826|P7|Aim 1: First Intervention (1 Day)|Adverse Event|0
844430|NCT01701973|2778827|P6|Aim 1: First Intervention (1 Day)|Adverse Event|0
844431|NCT01701973|2778828|P5|Aim 1: First Intervention (1 Day)|Adverse Event|0
844432|NCT01701973|2778829|P4|Aim 1: First Intervention (1 Day)|Adverse Event|0
844433|NCT01701973|2778830|P3|Aim 1: First Intervention (1 Day)|Adverse Event|0
844434|NCT01701973|2778831|P2|Aim 1: First Intervention (1 Day)|Adverse Event|1
844435|NCT01701973|2778832|P1|Aim 1: First Intervention (1 Day)|Adverse Event|0
844436|NCT01701674|2778879|P1|Overall Study|Unable to safely complete treatment|1
844437|NCT01701401|2778965|P4|Overall Study|Protocol Violation|0
844438|NCT01701401|2778966|P3|Overall Study|Protocol Violation|1
844439|NCT01701401|2778967|P2|Overall Study|Protocol Violation|0
844440|NCT01701401|2778968|P1|Overall Study|Protocol Violation|0
844441|NCT01701401|2778965|P4|Overall Study|Adverse Event|0
844442|NCT01701401|2778966|P3|Overall Study|Adverse Event|0
844443|NCT01701401|2778967|P2|Overall Study|Adverse Event|0
844444|NCT01701401|2778968|P1|Overall Study|Adverse Event|1
844445|NCT01701401|2778965|P4|Overall Study|Lack of Efficacy|0
844446|NCT01701401|2778966|P3|Overall Study|Lack of Efficacy|2
844447|NCT01701401|2778967|P2|Overall Study|Lack of Efficacy|0
844448|NCT01701401|2778968|P1|Overall Study|Lack of Efficacy|1
844449|NCT01701401|2778965|P4|Overall Study|Withdrew Consent|2
844450|NCT01701401|2778966|P3|Overall Study|Withdrew Consent|1
844451|NCT01701401|2778967|P2|Overall Study|Withdrew Consent|3
844452|NCT01701401|2778968|P1|Overall Study|Withdrew Consent|0
844453|NCT01701401|2778965|P4|Overall Study|Lost to Follow-up|3
844454|NCT01701401|2778966|P3|Overall Study|Lost to Follow-up|1
844455|NCT01701401|2778967|P2|Overall Study|Lost to Follow-up|5
844456|NCT01701401|2778968|P1|Overall Study|Lost to Follow-up|5
844457|NCT01701401|2778965|P4|Overall Study|Randomized But Not Treated|1
844458|NCT01701401|2778966|P3|Overall Study|Randomized But Not Treated|0
844459|NCT01701401|2778967|P2|Overall Study|Randomized But Not Treated|1
844460|NCT01701401|2778968|P1|Overall Study|Randomized But Not Treated|3
844461|NCT01701362|2779020|P2|Overall Study|Reasons other than those mentioned above|5
844462|NCT01701362|2779021|P1|Overall Study|Reasons other than those mentioned above|3
844463|NCT01701362|2779020|P2|Overall Study|Randomized but not treated|2
844464|NCT01701362|2779021|P1|Overall Study|Randomized but not treated|1
844465|NCT01701362|2779020|P2|Overall Study|Death|1
844466|NCT01701362|2779021|P1|Overall Study|Death|0
844467|NCT01701362|2779020|P2|Overall Study|Insufficient clinical response|6
844468|NCT01701362|2779021|P1|Overall Study|Insufficient clinical response|6
844469|NCT01701362|2779020|P2|Overall Study|Lost to Follow-up|9
844470|NCT01701362|2779021|P1|Overall Study|Lost to Follow-up|6
844471|NCT01701362|2779020|P2|Overall Study|No longer willing to participate|14
844472|NCT01701362|2779021|P1|Overall Study|No longer willing to participate|8
844473|NCT01701362|2779020|P2|Overall Study|Protocol Violation|3
844474|NCT01701362|2779021|P1|Overall Study|Protocol Violation|5
844475|NCT01701362|2779020|P2|Overall Study|Adverse events related to study drug|10
844476|NCT01701362|2779021|P1|Overall Study|Adverse events related to study drug|12
844477|NCT01701362|2779020|P2|Overall Study|Adverse events not related to study drug|6
844478|NCT01701362|2779021|P1|Overall Study|Adverse events not related to study drug|1
844479|NCT01701258|2779059|P13|Assessment and Scheduling|Investigator Terminated|0
844480|NCT01701258|2779060|P12|Assessment and Scheduling|Investigator Terminated|0
844481|NCT01701258|2779061|P11|Assessment and Scheduling|Investigator Terminated|0
844482|NCT01701258|2779062|P10|Assessment and Scheduling|Investigator Terminated|0
844483|NCT01701258|2779063|P9|Assessment and Scheduling|Investigator Terminated|0
844484|NCT01701258|2779064|P8|Assessment and Scheduling|Investigator Terminated|0
844485|NCT01701258|2779065|P7|Assessment and Scheduling|Investigator Terminated|0
844486|NCT01701258|2779066|P6|Assessment and Scheduling|Investigator Terminated|0
844487|NCT01701258|2779067|P5|Assessment and Scheduling|Investigator Terminated|0
844488|NCT01701258|2779068|P4|Assessment and Scheduling|Investigator Terminated|0
844489|NCT01701258|2779069|P3|Assessment and Scheduling|Investigator Terminated|0
844490|NCT01701258|2779070|P2|Assessment and Scheduling|Investigator Terminated|0
844491|NCT01701258|2779071|P1|Assessment and Scheduling|Investigator Terminated|2
844492|NCT01701258|2779059|P13|Assessment and Scheduling|Withdrawal by Subject|0
844493|NCT01701258|2779060|P12|Assessment and Scheduling|Withdrawal by Subject|0
844494|NCT01701258|2779061|P11|Assessment and Scheduling|Withdrawal by Subject|0
844495|NCT01701258|2779062|P10|Assessment and Scheduling|Withdrawal by Subject|0
844496|NCT01701258|2779063|P9|Assessment and Scheduling|Withdrawal by Subject|0
844497|NCT01701258|2779064|P8|Assessment and Scheduling|Withdrawal by Subject|0
844498|NCT01701258|2779065|P7|Assessment and Scheduling|Withdrawal by Subject|0
844499|NCT01701258|2779066|P6|Assessment and Scheduling|Withdrawal by Subject|0
844500|NCT01701258|2779067|P5|Assessment and Scheduling|Withdrawal by Subject|0
844501|NCT01701258|2779068|P4|Assessment and Scheduling|Withdrawal by Subject|0
844502|NCT01701258|2779069|P3|Assessment and Scheduling|Withdrawal by Subject|0
844503|NCT01701258|2779070|P2|Assessment and Scheduling|Withdrawal by Subject|0
844504|NCT01701258|2779071|P1|Assessment and Scheduling|Withdrawal by Subject|14
844505|NCT01701258|2779059|P13|Assessment and Scheduling|Lost to Follow-up|0
844506|NCT01701258|2779060|P12|Assessment and Scheduling|Lost to Follow-up|0
844507|NCT01701258|2779061|P11|Assessment and Scheduling|Lost to Follow-up|0
844508|NCT01701258|2779062|P10|Assessment and Scheduling|Lost to Follow-up|0
844509|NCT01701258|2779063|P9|Assessment and Scheduling|Lost to Follow-up|0
844510|NCT01701258|2779064|P8|Assessment and Scheduling|Lost to Follow-up|0
844511|NCT01701258|2779065|P7|Assessment and Scheduling|Lost to Follow-up|0
844512|NCT01701258|2779066|P6|Assessment and Scheduling|Lost to Follow-up|0
844513|NCT01701258|2779067|P5|Assessment and Scheduling|Lost to Follow-up|0
844514|NCT01701258|2779068|P4|Assessment and Scheduling|Lost to Follow-up|0
844515|NCT01701258|2779069|P3|Assessment and Scheduling|Lost to Follow-up|0
844516|NCT01701258|2779070|P2|Assessment and Scheduling|Lost to Follow-up|0
844517|NCT01701258|2779071|P1|Assessment and Scheduling|Lost to Follow-up|10
844518|NCT01701258|2779059|P13|Assessment and Scheduling|Found to be Ineligible|0
844519|NCT01701258|2779060|P12|Assessment and Scheduling|Found to be Ineligible|0
844520|NCT01701258|2779061|P11|Assessment and Scheduling|Found to be Ineligible|0
844521|NCT01701258|2779062|P10|Assessment and Scheduling|Found to be Ineligible|0
844522|NCT01701258|2779063|P9|Assessment and Scheduling|Found to be Ineligible|0
844523|NCT01701258|2779064|P8|Assessment and Scheduling|Found to be Ineligible|0
844524|NCT01701258|2779065|P7|Assessment and Scheduling|Found to be Ineligible|0
844525|NCT01701258|2779066|P6|Assessment and Scheduling|Found to be Ineligible|0
844526|NCT01701258|2779067|P5|Assessment and Scheduling|Found to be Ineligible|0
844527|NCT01701258|2779068|P4|Assessment and Scheduling|Found to be Ineligible|0
844528|NCT01701258|2779069|P3|Assessment and Scheduling|Found to be Ineligible|0
844529|NCT01701258|2779070|P2|Assessment and Scheduling|Found to be Ineligible|0
844530|NCT01701258|2779071|P1|Assessment and Scheduling|Found to be Ineligible|57
844531|NCT01701245|2779125|P2|Overall Study|Did not complete the open label period|12
844532|NCT01701245|2779126|P1|Overall Study|Did not complete the open label period|11
844533|NCT01701245|2779125|P2|Overall Study|Protocol Violation|3
844534|NCT01701245|2779126|P1|Overall Study|Protocol Violation|1
844535|NCT01701063|2779173|P3|Overall Study|Other|1
844536|NCT01701063|2779174|P2|Overall Study|Other|0
844537|NCT01701063|2779175|P1|Overall Study|Other|0
844538|NCT01701063|2779173|P3|Overall Study|Withdrawal by Subject|1
844539|NCT01701063|2779174|P2|Overall Study|Withdrawal by Subject|0
844540|NCT01701063|2779175|P1|Overall Study|Withdrawal by Subject|0
844541|NCT01701063|2779173|P3|Overall Study|Lost to Follow-up|0
844542|NCT01701063|2779174|P2|Overall Study|Lost to Follow-up|1
844543|NCT01701063|2779175|P1|Overall Study|Lost to Follow-up|0
844544|NCT01700985|2779259|P2|Overall Study|Incarcerated|1
844545|NCT01700985|2779260|P1|Overall Study|Incarcerated|0
844546|NCT01700959|2779282|P6|Overall Study|Side effects|1
844547|NCT01700959|2779283|P5|Overall Study|Side effects|4
844548|NCT01700959|2779284|P4|Overall Study|Side effects|4
844549|NCT01700959|2779285|P3|Overall Study|Side effects|8
844550|NCT01700959|2779286|P2|Overall Study|Side effects|4
844551|NCT01700959|2779287|P1|Overall Study|Side effects|1
844552|NCT01700959|2779282|P6|Overall Study|Noncompliant|9
844553|NCT01700959|2779283|P5|Overall Study|Noncompliant|15
844554|NCT01700959|2779284|P4|Overall Study|Noncompliant|18
844555|NCT01700959|2779285|P3|Overall Study|Noncompliant|17
844556|NCT01700959|2779286|P2|Overall Study|Noncompliant|9
844557|NCT01700959|2779287|P1|Overall Study|Noncompliant|9
844558|NCT01700959|2779282|P6|Overall Study|Ineligible|1
844559|NCT01700959|2779283|P5|Overall Study|Ineligible|0
844560|NCT01700959|2779284|P4|Overall Study|Ineligible|0
844561|NCT01700959|2779285|P3|Overall Study|Ineligible|2
844562|NCT01700959|2779286|P2|Overall Study|Ineligible|1
844563|NCT01700959|2779287|P1|Overall Study|Ineligible|2
844564|NCT01700959|2779282|P6|Overall Study|Withdrawal by Subject|12
844565|NCT01700959|2779283|P5|Overall Study|Withdrawal by Subject|8
844566|NCT01700959|2779284|P4|Overall Study|Withdrawal by Subject|11
844567|NCT01700959|2779285|P3|Overall Study|Withdrawal by Subject|12
844568|NCT01700959|2779286|P2|Overall Study|Withdrawal by Subject|9
844569|NCT01700959|2779287|P1|Overall Study|Withdrawal by Subject|15
844570|NCT01700959|2779282|P6|Overall Study|Adverse Event|2
844571|NCT01700959|2779283|P5|Overall Study|Adverse Event|0
844572|NCT01700959|2779284|P4|Overall Study|Adverse Event|2
844573|NCT01700959|2779285|P3|Overall Study|Adverse Event|1
844574|NCT01700959|2779286|P2|Overall Study|Adverse Event|1
844575|NCT01700959|2779287|P1|Overall Study|Adverse Event|0
844576|NCT01700530|2779358|P3|Overall Study|Withdrawal by Subject|1
844577|NCT01700530|2779359|P2|Overall Study|Withdrawal by Subject|3
844578|NCT01700530|2779360|P1|Overall Study|Withdrawal by Subject|0
844579|NCT01700387|2779409|P2|Overall Study|Lost to Follow-up|1
844580|NCT01700387|2779410|P1|Overall Study|Lost to Follow-up|2
844581|NCT01700387|2779409|P2|Overall Study|Adverse Event|1
844582|NCT01700387|2779410|P1|Overall Study|Adverse Event|1
844583|NCT01700387|2779409|P2|Overall Study|Withdrawal by Subject|2
844584|NCT01700387|2779410|P1|Overall Study|Withdrawal by Subject|1
844585|NCT01700348|2779420|P1|Overall Study|Lost to Follow-up|1
844586|NCT01700348|2779420|P1|Overall Study|Withdrawal by Subject|22
844587|NCT01700192|2779438|P2|Overall Study|Never received study drug|0
844588|NCT01700192|2779439|P1|Overall Study|Never received study drug|1
844589|NCT01700192|2779438|P2|Overall Study|Withdrawal by Subject|64
844590|NCT01700192|2779439|P1|Overall Study|Withdrawal by Subject|56
844591|NCT01700192|2779438|P2|Overall Study|Technical problems|1
844592|NCT01700192|2779439|P1|Overall Study|Technical problems|0
844593|NCT01700192|2779438|P2|Overall Study|Protocol Violation|4
844594|NCT01700192|2779439|P1|Overall Study|Protocol Violation|3
844595|NCT01700192|2779438|P2|Overall Study|Progressive disease|0
844596|NCT01700192|2779439|P1|Overall Study|Progressive disease|1
844597|NCT01700192|2779438|P2|Overall Study|Pregnancy|4
844598|NCT01700192|2779439|P1|Overall Study|Pregnancy|1
844599|NCT01700192|2779438|P2|Overall Study|Physician Decision|3
844600|NCT01700192|2779439|P1|Overall Study|Physician Decision|2
844601|NCT01700192|2779438|P2|Overall Study|Noncompliance with study drug|5
844602|NCT01700192|2779439|P1|Overall Study|Noncompliance with study drug|0
844603|NCT01700192|2779438|P2|Overall Study|Lost to Follow-up|29
844604|NCT01700192|2779439|P1|Overall Study|Lost to Follow-up|42
844605|NCT01700192|2779438|P2|Overall Study|Lack of Efficacy|0
844606|NCT01700192|2779439|P1|Overall Study|Lack of Efficacy|1
844607|NCT01700192|2779438|P2|Overall Study|Adverse Event|18
844608|NCT01700192|2779439|P1|Overall Study|Adverse Event|73
844609|NCT01700179|2779457|P1|Overall Study|Physician Decision|2
844610|NCT01700140|2779464|P3|Overall Study|Inclusion/exclusion criteria deviation|0
844611|NCT01700140|2779465|P2|Overall Study|Inclusion/exclusion criteria deviation|4
844612|NCT01700140|2779466|P1|Overall Study|Inclusion/exclusion criteria deviation|1
844613|NCT01700140|2779464|P3|Overall Study|Adverse Event|0
844614|NCT01700140|2779465|P2|Overall Study|Adverse Event|1
844615|NCT01700140|2779466|P1|Overall Study|Adverse Event|0
844616|NCT01700140|2779464|P3|Overall Study|Aggravation of symptoms|0
844617|NCT01700140|2779465|P2|Overall Study|Aggravation of symptoms|0
844618|NCT01700140|2779466|P1|Overall Study|Aggravation of symptoms|1
844619|NCT01700140|2779464|P3|Overall Study|Use of chemotherapy or surgical therapy|0
844620|NCT01700140|2779465|P2|Overall Study|Use of chemotherapy or surgical therapy|1
844621|NCT01700140|2779466|P1|Overall Study|Use of chemotherapy or surgical therapy|0
844622|NCT01700140|2779464|P3|Overall Study|Discontinuation of radiotherapy|0
844623|NCT01700140|2779465|P2|Overall Study|Discontinuation of radiotherapy|0
844624|NCT01700140|2779466|P1|Overall Study|Discontinuation of radiotherapy|1
844625|NCT01700140|2779464|P3|Overall Study|Use of rescue drugs|1
844626|NCT01700140|2779465|P2|Overall Study|Use of rescue drugs|3
844627|NCT01700140|2779466|P1|Overall Study|Use of rescue drugs|3
844628|NCT01699867|2779507|P1|Overall Study|Screening Failure|3
844629|NCT01699815|2779514|P2|Overall Study|Adverse Event|1
844630|NCT01699815|2779515|P1|Overall Study|Adverse Event|0
844631|NCT01699815|2779514|P2|Overall Study|record could not be located|0
844632|NCT01699815|2779515|P1|Overall Study|record could not be located|1
844633|NCT01699815|2779514|P2|Overall Study|Protocol Violation|7
844634|NCT01699815|2779515|P1|Overall Study|Protocol Violation|4
844635|NCT01699789|2779527|P2|Overall Study|Lost to Follow-up|101
844636|NCT01699789|2779528|P1|Overall Study|Lost to Follow-up|83
844637|NCT01699789|2779527|P2|Overall Study|Death|2
844638|NCT01699789|2779528|P1|Overall Study|Death|1
844639|NCT01699789|2779527|P2|Overall Study|Withdrawal by Subject|23
844640|NCT01699789|2779528|P1|Overall Study|Withdrawal by Subject|18
844641|NCT01699750|2779598|P2|Overall Study|Other|2
844642|NCT01699750|2779599|P1|Overall Study|Other|0
844643|NCT01699750|2779598|P2|Overall Study|Withdrew Consent|1
844644|NCT01699750|2779599|P1|Overall Study|Withdrew Consent|0
844645|NCT01699685|2779634|P2|Period 2|Lost to Follow-up|0
844646|NCT01699685|2779635|P1|Period 2|Lost to Follow-up|1
844647|NCT01699685|2779634|P2|Period 1|Patient request|1
844648|NCT01699685|2779635|P1|Period 1|Patient request|0
844649|NCT01699685|2779634|P2|Period 1|Other|1
844650|NCT01699685|2779635|P1|Period 1|Other|0
844651|NCT01699685|2779634|P2|Period 1|Medical or ethical, noncompliance|0
844652|NCT01699685|2779635|P1|Period 1|Medical or ethical, noncompliance|2
844653|NCT01699685|2779634|P2|Period 1|Adverse Event|1
844654|NCT01699685|2779635|P1|Period 1|Adverse Event|1
844655|NCT01699178|2779670|P2|Overall Study|ineligible/noncompliant/ subject reason|4
844656|NCT01699178|2779671|P1|Overall Study|ineligible/noncompliant/ subject reason|4
844657|NCT01699178|2779670|P2|Overall Study|PSA increase of >1.4 ng/mL|3
844658|NCT01699178|2779671|P1|Overall Study|PSA increase of >1.4 ng/mL|4
844659|NCT01699178|2779670|P2|Overall Study|Hematocrit >54%|1
844660|NCT01699178|2779671|P1|Overall Study|Hematocrit >54%|1
844661|NCT01699178|2779670|P2|Overall Study|Withdrawal by Subject|12
844662|NCT01699178|2779671|P1|Overall Study|Withdrawal by Subject|4
844663|NCT01699178|2779670|P2|Overall Study|Physician Decision|0
844664|NCT01699178|2779671|P1|Overall Study|Physician Decision|1
844665|NCT01699178|2779670|P2|Overall Study|Non-compliance with Study Drug|1
844666|NCT01699178|2779671|P1|Overall Study|Non-compliance with Study Drug|3
844667|NCT01699178|2779670|P2|Overall Study|Lost to Follow-up|6
844668|NCT01699178|2779671|P1|Overall Study|Lost to Follow-up|1
844669|NCT01699178|2779670|P2|Overall Study|Adverse Event|5
844670|NCT01699178|2779671|P1|Overall Study|Adverse Event|1
844671|NCT01699087|2779687|P1|Overall Study|Unable to make future visits|2
844672|NCT01699087|2779687|P1|Overall Study|Screen failure (prior to treatment)|15
844673|NCT01699087|2779687|P1|Overall Study|Lost to Follow-up|7
844674|NCT01699022|2779701|P1|Overall Study|Early discontinuation from the study|3
844675|NCT01698814|2779716|P2|Overall Study|Randomized in error|0
844676|NCT01698814|2779717|P1|Overall Study|Randomized in error|1
844677|NCT01698814|2779716|P2|Overall Study|Pregnancy|0
844678|NCT01698814|2779717|P1|Overall Study|Pregnancy|1
844679|NCT01698814|2779716|P2|Overall Study|Lost to Follow-up|1
844680|NCT01698814|2779717|P1|Overall Study|Lost to Follow-up|0
844681|NCT01698814|2779716|P2|Overall Study|Adverse Event|2
844682|NCT01698814|2779717|P1|Overall Study|Adverse Event|0
844683|NCT01698801|2779723|P1|Follow Up Phase|Death|4
844684|NCT01698801|2779723|P1|Follow Up Phase|Withdrawal by Subject|1
844685|NCT01698801|2779723|P1|Treatment Phase|Disease progression|1
844686|NCT01698801|2779723|P1|Treatment Phase|Withdrawal by Subject|1
844687|NCT01698801|2779723|P1|Treatment Phase|Not specified|4
844688|NCT01698801|2779723|P1|Treatment Phase|Protocol Violation|1
844689|NCT01698801|2779723|P1|Treatment Phase|Adverse Event|4
844690|NCT01698775|2779734|P2|Phase B|Withdrawal by Subject|2
844691|NCT01698775|2779735|P1|Phase B|Withdrawal by Subject|6
844692|NCT01698775|2779734|P2|Phase B|Protocol Violation|1
844693|NCT01698775|2779735|P1|Phase B|Protocol Violation|1
844694|NCT01698775|2779734|P2|Phase B|Physician Decision|1
844695|NCT01698775|2779735|P1|Phase B|Physician Decision|1
844696|NCT01698775|2779734|P2|Phase B|Lost to Follow-up|1
844697|NCT01698775|2779735|P1|Phase B|Lost to Follow-up|0
844698|NCT01698775|2779734|P2|Phase B|Lack of Efficacy|1
844699|NCT01698775|2779735|P1|Phase B|Lack of Efficacy|0
844700|NCT01698775|2779734|P2|Phase B|Death|1
844701|NCT01698775|2779735|P1|Phase B|Death|0
844702|NCT01698775|2779734|P2|Phase B|Adverse Event|3
844703|NCT01698775|2779735|P1|Phase B|Adverse Event|6
844704|NCT01698775|2779734|P2|Phase B|Hyperglycemia Discontinuation Criteria|1
844705|NCT01698775|2779735|P1|Phase B|Hyperglycemia Discontinuation Criteria|0
844706|NCT01698775|2779734|P2|Phase A|Kidney [transplant]|1
844707|NCT01698775|2779735|P1|Phase A|Kidney [transplant]|0
844708|NCT01698775|2779734|P2|Phase A|Withdrawal by Subject|4
844709|NCT01698775|2779735|P1|Phase A|Withdrawal by Subject|3
844710|NCT01698775|2779734|P2|Phase A|Protocol Violation|0
844711|NCT01698775|2779735|P1|Phase A|Protocol Violation|1
844712|NCT01698775|2779734|P2|Phase A|Lost to Follow-up|2
844713|NCT01698775|2779735|P1|Phase A|Lost to Follow-up|1
844714|NCT01698775|2779734|P2|Phase A|Lack of Efficacy|0
844715|NCT01698775|2779735|P1|Phase A|Lack of Efficacy|1
844716|NCT01698775|2779734|P2|Phase A|Death|1
844717|NCT01698775|2779735|P1|Phase A|Death|1
844718|NCT01698775|2779734|P2|Phase A|Adverse Event|1
844719|NCT01698775|2779735|P1|Phase A|Adverse Event|2
844720|NCT01698554|2779784|P4|Overall Study|Other Miscellaneous Reasons|0
844721|NCT01698554|2779785|P3|Overall Study|Other Miscellaneous Reasons|0
844722|NCT01698554|2779786|P2|Overall Study|Other Miscellaneous Reasons|0
844723|NCT01698554|2779787|P1|Overall Study|Other Miscellaneous Reasons|1
844724|NCT01698554|2779784|P4|Overall Study|Protocol Violation|0
844725|NCT01698554|2779785|P3|Overall Study|Protocol Violation|1
844726|NCT01698554|2779786|P2|Overall Study|Protocol Violation|0
844727|NCT01698554|2779787|P1|Overall Study|Protocol Violation|2
844728|NCT01698554|2779784|P4|Overall Study|Personal Reasons|1
844729|NCT01698554|2779785|P3|Overall Study|Personal Reasons|1
844730|NCT01698554|2779786|P2|Overall Study|Personal Reasons|5
844731|NCT01698554|2779787|P1|Overall Study|Personal Reasons|0
844732|NCT01698554|2779784|P4|Overall Study|Lost to Follow-up|0
844733|NCT01698554|2779785|P3|Overall Study|Lost to Follow-up|0
844734|NCT01698554|2779786|P2|Overall Study|Lost to Follow-up|0
844735|NCT01698554|2779787|P1|Overall Study|Lost to Follow-up|1
844736|NCT01698554|2779784|P4|Overall Study|Adverse Event|1
844737|NCT01698554|2779785|P3|Overall Study|Adverse Event|0
844738|NCT01698554|2779786|P2|Overall Study|Adverse Event|5
844739|NCT01698554|2779787|P1|Overall Study|Adverse Event|2
844740|NCT01698320|2779847|P3|40-Week Open-Label Period|Lost to Follow-up|0
844741|NCT01698320|2779848|P2|40-Week Open-Label Period|Lost to Follow-up|2
844742|NCT01698320|2779849|P1|40-Week Open-Label Period|Lost to Follow-up|0
844743|NCT01698320|2779847|P3|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
844744|NCT01698320|2779848|P2|40-Week Open-Label Period|Sponsor requested subject withdrawal|1
844745|NCT01698320|2779849|P1|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
844746|NCT01698320|2779847|P3|40-Week Open-Label Period|Pregnancy|1
844747|NCT01698320|2779848|P2|40-Week Open-Label Period|Pregnancy|2
844748|NCT01698320|2779849|P1|40-Week Open-Label Period|Pregnancy|0
844749|NCT01698320|2779847|P3|40-Week Open-Label Period|Withdrawal by Subject|7
844750|NCT01698320|2779848|P2|40-Week Open-Label Period|Withdrawal by Subject|11
844751|NCT01698320|2779849|P1|40-Week Open-Label Period|Withdrawal by Subject|0
844752|NCT01698320|2779847|P3|40-Week Open-Label Period|Adverse Event|2
844753|NCT01698320|2779848|P2|40-Week Open-Label Period|Adverse Event|3
844754|NCT01698320|2779849|P1|40-Week Open-Label Period|Adverse Event|0
844755|NCT01698320|2779847|P3|12-Week Double-Blind Period|Lost to Follow-up|4
844756|NCT01698320|2779848|P2|12-Week Double-Blind Period|Lost to Follow-up|0
844757|NCT01698320|2779849|P1|12-Week Double-Blind Period|Lost to Follow-up|0
844758|NCT01698320|2779847|P3|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2
844759|NCT01698320|2779848|P2|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
844760|NCT01698320|2779849|P1|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
844761|NCT01698320|2779847|P3|12-Week Double-Blind Period|Pregnancy|1
844762|NCT01698320|2779848|P2|12-Week Double-Blind Period|Pregnancy|1
844763|NCT01698320|2779849|P1|12-Week Double-Blind Period|Pregnancy|0
844764|NCT01698320|2779847|P3|12-Week Double-Blind Period|Protocol Violation|2
844765|NCT01698320|2779848|P2|12-Week Double-Blind Period|Protocol Violation|0
844766|NCT01698320|2779849|P1|12-Week Double-Blind Period|Protocol Violation|0
844767|NCT01698320|2779847|P3|12-Week Double-Blind Period|Withdrawal by Subject|2
844768|NCT01698320|2779848|P2|12-Week Double-Blind Period|Withdrawal by Subject|2
844769|NCT01698320|2779849|P1|12-Week Double-Blind Period|Withdrawal by Subject|0
844770|NCT01698320|2779847|P3|12-Week Double-Blind Period|Adverse Event|1
844771|NCT01698320|2779848|P2|12-Week Double-Blind Period|Adverse Event|1
844772|NCT01698320|2779849|P1|12-Week Double-Blind Period|Adverse Event|0
844773|NCT01698320|2779847|P3|Run-In Period (Week -1 to Day 0)|Not specified|0
844774|NCT01698320|2779848|P2|Run-In Period (Week -1 to Day 0)|Not specified|0
844775|NCT01698320|2779849|P1|Run-In Period (Week -1 to Day 0)|Not specified|1
844776|NCT01698320|2779847|P3|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
844777|NCT01698320|2779848|P2|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
844778|NCT01698320|2779849|P1|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1
844779|NCT01698320|2779847|P3|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
844780|NCT01698320|2779848|P2|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
844781|NCT01698320|2779849|P1|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1
844782|NCT01698320|2779847|P3|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
844783|NCT01698320|2779848|P2|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
844784|NCT01698320|2779849|P1|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24
844785|NCT01698268|2779869|P2|Overall Study|Physician Decision|1
844786|NCT01698268|2779870|P1|Overall Study|Physician Decision|2
844787|NCT01698008|2779878|P2|Overall Study|Withdrawal by Subject|2
844788|NCT01698008|2779879|P1|Overall Study|Withdrawal by Subject|1
844789|NCT01697969|2779885|P1|Overall Study|Did not meet inc/exc criteria|3
844790|NCT01697956|2779892|P2|Overall Study|Protocol Violation|1
844791|NCT01697956|2779893|P1|Overall Study|Protocol Violation|1
844792|NCT01697748|2779923|P2|Overall Study|Lost to Follow-up|65
844793|NCT01697748|2779924|P1|Overall Study|Lost to Follow-up|53
844794|NCT01697748|2779923|P2|Overall Study|ineligible uterine incision|1
844795|NCT01697748|2779924|P1|Overall Study|ineligible uterine incision|4
844796|NCT01697748|2779923|P2|Overall Study|ineligible skin incision|2
844797|NCT01697748|2779924|P1|Overall Study|ineligible skin incision|1
844798|NCT01697696|2779934|P2|Overall Study|Subject/guardian decision|35
844799|NCT01697696|2779935|P1|Overall Study|Subject/guardian decision|31
844800|NCT01697696|2779934|P2|Overall Study|Lost to Follow-up|7
844801|NCT01697696|2779935|P1|Overall Study|Lost to Follow-up|10
844802|NCT01697696|2779934|P2|Overall Study|Death|2
844803|NCT01697696|2779935|P1|Overall Study|Death|4
844804|NCT01697696|2779934|P2|Overall Study|Physician Decision|0
844805|NCT01697696|2779935|P1|Overall Study|Physician Decision|1
844806|NCT01697696|2779934|P2|Overall Study|Protocol deviation|0
844807|NCT01697696|2779935|P1|Overall Study|Protocol deviation|1
844808|NCT01697696|2779934|P2|Overall Study|Study terminated by sponsor|3
844809|NCT01697696|2779935|P1|Overall Study|Study terminated by sponsor|0
844810|NCT01697592|2779967|P10|Phase B (Week 25 to Week 52)|Adverse Event|0
844811|NCT01697592|2779968|P9|Phase B (Week 25 to Week 52)|Adverse Event|2
844812|NCT01697592|2779969|P8|Phase B (Week 25 to Week 52)|Adverse Event|0
844813|NCT01697592|2779970|P7|Phase B (Week 25 to Week 52)|Adverse Event|1
844814|NCT01697592|2779971|P6|Phase B (Week 25 to Week 52)|Adverse Event|1
844815|NCT01697592|2779972|P5|Phase B (Week 25 to Week 52)|Adverse Event|0
844816|NCT01697592|2779973|P4|Phase B (Week 25 to Week 52)|Adverse Event|2
844817|NCT01697592|2779974|P3|Phase B (Week 25 to Week 52)|Adverse Event|1
844818|NCT01697592|2779975|P2|Phase B (Week 25 to Week 52)|Adverse Event|1
844819|NCT01697592|2779976|P1|Phase B (Week 25 to Week 52)|Adverse Event|2
844820|NCT01697592|2779967|P10|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
844821|NCT01697592|2779968|P9|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
844822|NCT01697592|2779969|P8|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
844823|NCT01697592|2779970|P7|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
844824|NCT01697592|2779971|P6|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
844825|NCT01697592|2779972|P5|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
844826|NCT01697592|2779973|P4|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
844827|NCT01697592|2779974|P3|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
844828|NCT01697592|2779975|P2|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
844829|NCT01697592|2779976|P1|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2
844830|NCT01697592|2779967|P10|Phase B (Week 25 to Week 52)|Physician Decision|0
844831|NCT01697592|2779968|P9|Phase B (Week 25 to Week 52)|Physician Decision|0
844832|NCT01697592|2779969|P8|Phase B (Week 25 to Week 52)|Physician Decision|0
844833|NCT01697592|2779970|P7|Phase B (Week 25 to Week 52)|Physician Decision|0
844834|NCT01697592|2779971|P6|Phase B (Week 25 to Week 52)|Physician Decision|0
844835|NCT01697592|2779972|P5|Phase B (Week 25 to Week 52)|Physician Decision|0
844836|NCT01697592|2779973|P4|Phase B (Week 25 to Week 52)|Physician Decision|1
844837|NCT01697592|2779974|P3|Phase B (Week 25 to Week 52)|Physician Decision|0
844838|NCT01697592|2779975|P2|Phase B (Week 25 to Week 52)|Physician Decision|0
844839|NCT01697592|2779976|P1|Phase B (Week 25 to Week 52)|Physician Decision|1
844840|NCT01697592|2779967|P10|Phase A (Up to 24 Weeks)|Adverse Event|1
844841|NCT01697592|2779968|P9|Phase A (Up to 24 Weeks)|Adverse Event|0
844842|NCT01697592|2779969|P8|Phase A (Up to 24 Weeks)|Adverse Event|0
844843|NCT01697592|2779970|P7|Phase A (Up to 24 Weeks)|Adverse Event|1
844844|NCT01697592|2779971|P6|Phase A (Up to 24 Weeks)|Adverse Event|0
844845|NCT01697592|2779972|P5|Phase A (Up to 24 Weeks)|Adverse Event|0
844846|NCT01697592|2779973|P4|Phase A (Up to 24 Weeks)|Adverse Event|2
844847|NCT01697592|2779974|P3|Phase A (Up to 24 Weeks)|Adverse Event|1
844848|NCT01697592|2779975|P2|Phase A (Up to 24 Weeks)|Adverse Event|2
844849|NCT01697592|2779976|P1|Phase A (Up to 24 Weeks)|Adverse Event|0
844850|NCT01697592|2779967|P10|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
844851|NCT01697592|2779968|P9|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
844852|NCT01697592|2779969|P8|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
844853|NCT01697592|2779970|P7|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
844854|NCT01697592|2779971|P6|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
844855|NCT01697592|2779972|P5|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
844856|NCT01697592|2779973|P4|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
844857|NCT01697592|2779974|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
844858|NCT01697592|2779975|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
844859|NCT01697592|2779976|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
844860|NCT01697592|2779967|P10|Phase A (Up to 24 Weeks)|Protocol Violation|0
844861|NCT01697592|2779968|P9|Phase A (Up to 24 Weeks)|Protocol Violation|0
844862|NCT01697592|2779969|P8|Phase A (Up to 24 Weeks)|Protocol Violation|0
844863|NCT01697592|2779970|P7|Phase A (Up to 24 Weeks)|Protocol Violation|0
844864|NCT01697592|2779971|P6|Phase A (Up to 24 Weeks)|Protocol Violation|0
844865|NCT01697592|2779972|P5|Phase A (Up to 24 Weeks)|Protocol Violation|0
844866|NCT01697592|2779973|P4|Phase A (Up to 24 Weeks)|Protocol Violation|0
844867|NCT01697592|2779974|P3|Phase A (Up to 24 Weeks)|Protocol Violation|0
844868|NCT01697592|2779975|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
844869|NCT01697592|2779976|P1|Phase A (Up to 24 Weeks)|Protocol Violation|1
844870|NCT01697592|2779967|P10|Phase A (Up to 24 Weeks)|Physician Decision|0
844871|NCT01697592|2779968|P9|Phase A (Up to 24 Weeks)|Physician Decision|0
844872|NCT01697592|2779969|P8|Phase A (Up to 24 Weeks)|Physician Decision|0
844873|NCT01697592|2779970|P7|Phase A (Up to 24 Weeks)|Physician Decision|0
844874|NCT01697592|2779971|P6|Phase A (Up to 24 Weeks)|Physician Decision|1
844875|NCT01697592|2779972|P5|Phase A (Up to 24 Weeks)|Physician Decision|0
844876|NCT01697592|2779973|P4|Phase A (Up to 24 Weeks)|Physician Decision|0
844877|NCT01697592|2779974|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
844878|NCT01697592|2779975|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
844879|NCT01697592|2779976|P1|Phase A (Up to 24 Weeks)|Physician Decision|0
844880|NCT01697592|2779967|P10|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
844881|NCT01697592|2779968|P9|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
844882|NCT01697592|2779969|P8|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
844883|NCT01697592|2779970|P7|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
844884|NCT01697592|2779971|P6|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
844885|NCT01697592|2779972|P5|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
844886|NCT01697592|2779973|P4|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
844887|NCT01697592|2779974|P3|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
844888|NCT01697592|2779975|P2|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
844889|NCT01697592|2779976|P1|Phase A (Up to 24 Weeks)|Lost to Follow-up|1
844890|NCT01697579|2780045|P7|Optional Extension-Cycles 2-6|Lost to Follow-up|1
844891|NCT01697579|2780046|P6|Optional Extension-Cycles 2-6|Lost to Follow-up|0
844892|NCT01697579|2780047|P5|Optional Extension-Cycles 2-6|Lost to Follow-up|0
844893|NCT01697579|2780048|P4|Optional Extension-Cycles 2-6|Lost to Follow-up|0
844894|NCT01697579|2780049|P3|Optional Extension-Cycles 2-6|Lost to Follow-up|0
844895|NCT01697579|2780050|P2|Optional Extension-Cycles 2-6|Lost to Follow-up|0
844896|NCT01697579|2780051|P1|Optional Extension-Cycles 2-6|Lost to Follow-up|0
844897|NCT01697579|2780045|P7|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4
844898|NCT01697579|2780046|P6|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6
844899|NCT01697579|2780047|P5|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
844900|NCT01697579|2780048|P4|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
844901|NCT01697579|2780049|P3|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
844902|NCT01697579|2780050|P2|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
844903|NCT01697579|2780051|P1|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
844904|NCT01697579|2780045|P7|Optional Extension-Cycles 2-6|Participant Moved|2
844905|NCT01697579|2780046|P6|Optional Extension-Cycles 2-6|Participant Moved|0
844906|NCT01697579|2780047|P5|Optional Extension-Cycles 2-6|Participant Moved|0
844907|NCT01697579|2780048|P4|Optional Extension-Cycles 2-6|Participant Moved|0
844908|NCT01697579|2780049|P3|Optional Extension-Cycles 2-6|Participant Moved|0
844909|NCT01697579|2780050|P2|Optional Extension-Cycles 2-6|Participant Moved|0
844910|NCT01697579|2780051|P1|Optional Extension-Cycles 2-6|Participant Moved|0
844911|NCT01697579|2780045|P7|Optional Extension-Cycles 2-6|Technical Problems|1
844912|NCT01697579|2780046|P6|Optional Extension-Cycles 2-6|Technical Problems|0
844913|NCT01697579|2780047|P5|Optional Extension-Cycles 2-6|Technical Problems|0
844914|NCT01697579|2780048|P4|Optional Extension-Cycles 2-6|Technical Problems|0
844915|NCT01697579|2780049|P3|Optional Extension-Cycles 2-6|Technical Problems|0
844916|NCT01697579|2780050|P2|Optional Extension-Cycles 2-6|Technical Problems|0
844917|NCT01697579|2780051|P1|Optional Extension-Cycles 2-6|Technical Problems|0
844918|NCT01697579|2780045|P7|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2
844919|NCT01697579|2780046|P6|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
844920|NCT01697579|2780047|P5|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
844921|NCT01697579|2780048|P4|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
844922|NCT01697579|2780049|P3|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
844923|NCT01697579|2780050|P2|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
844924|NCT01697579|2780051|P1|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
844925|NCT01697579|2780045|P7|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11
844926|NCT01697579|2780046|P6|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4
844927|NCT01697579|2780047|P5|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
844928|NCT01697579|2780048|P4|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
844929|NCT01697579|2780049|P3|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
844930|NCT01697579|2780050|P2|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
844931|NCT01697579|2780051|P1|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
844932|NCT01697579|2780045|P7|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24
844933|NCT01697579|2780046|P6|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15
844934|NCT01697579|2780047|P5|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
844935|NCT01697579|2780048|P4|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
844936|NCT01697579|2780049|P3|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
844937|NCT01697579|2780050|P2|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
844938|NCT01697579|2780051|P1|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
844939|NCT01697579|2780045|P7|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
844940|NCT01697579|2780046|P6|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1
844941|NCT01697579|2780047|P5|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
844942|NCT01697579|2780048|P4|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
844943|NCT01697579|2780049|P3|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
844944|NCT01697579|2780050|P2|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
844945|NCT01697579|2780051|P1|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
844946|NCT01697579|2780045|P7|Optional Extension-Cycles 2-6|Excluded Medication|2
844947|NCT01697579|2780046|P6|Optional Extension-Cycles 2-6|Excluded Medication|1
844948|NCT01697579|2780047|P5|Optional Extension-Cycles 2-6|Excluded Medication|0
844949|NCT01697579|2780048|P4|Optional Extension-Cycles 2-6|Excluded Medication|0
844950|NCT01697579|2780049|P3|Optional Extension-Cycles 2-6|Excluded Medication|0
844951|NCT01697579|2780050|P2|Optional Extension-Cycles 2-6|Excluded Medication|0
844952|NCT01697579|2780051|P1|Optional Extension-Cycles 2-6|Excluded Medication|0
844953|NCT01697579|2780045|P7|Optional Extension-Cycles 2-6|Protocol Violation|4
844954|NCT01697579|2780046|P6|Optional Extension-Cycles 2-6|Protocol Violation|0
844955|NCT01697579|2780047|P5|Optional Extension-Cycles 2-6|Protocol Violation|0
844956|NCT01697579|2780048|P4|Optional Extension-Cycles 2-6|Protocol Violation|0
844957|NCT01697579|2780049|P3|Optional Extension-Cycles 2-6|Protocol Violation|0
844958|NCT01697579|2780050|P2|Optional Extension-Cycles 2-6|Protocol Violation|0
844959|NCT01697579|2780051|P1|Optional Extension-Cycles 2-6|Protocol Violation|0
844960|NCT01697579|2780045|P7|Optional Extension-Cycles 2-6|Physician Decision|11
844961|NCT01697579|2780046|P6|Optional Extension-Cycles 2-6|Physician Decision|7
844962|NCT01697579|2780047|P5|Optional Extension-Cycles 2-6|Physician Decision|0
844963|NCT01697579|2780048|P4|Optional Extension-Cycles 2-6|Physician Decision|0
844964|NCT01697579|2780049|P3|Optional Extension-Cycles 2-6|Physician Decision|0
844965|NCT01697579|2780050|P2|Optional Extension-Cycles 2-6|Physician Decision|0
844966|NCT01697579|2780051|P1|Optional Extension-Cycles 2-6|Physician Decision|0
844967|NCT01697579|2780045|P7|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5
844968|NCT01697579|2780046|P6|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1
844969|NCT01697579|2780047|P5|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
844970|NCT01697579|2780048|P4|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
844971|NCT01697579|2780049|P3|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
844972|NCT01697579|2780050|P2|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
844973|NCT01697579|2780051|P1|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
844974|NCT01697579|2780045|P7|Optional Extension-Cycles 2-6|Death|2
844975|NCT01697579|2780046|P6|Optional Extension-Cycles 2-6|Death|0
844976|NCT01697579|2780047|P5|Optional Extension-Cycles 2-6|Death|0
844977|NCT01697579|2780048|P4|Optional Extension-Cycles 2-6|Death|0
844978|NCT01697579|2780049|P3|Optional Extension-Cycles 2-6|Death|0
844979|NCT01697579|2780050|P2|Optional Extension-Cycles 2-6|Death|0
844980|NCT01697579|2780051|P1|Optional Extension-Cycles 2-6|Death|0
844981|NCT01697579|2780045|P7|Base Study-Cycle 1|Technical Problems|0
844982|NCT01697579|2780046|P6|Base Study-Cycle 1|Technical Problems|0
844983|NCT01697579|2780047|P5|Base Study-Cycle 1|Technical Problems|0
844984|NCT01697579|2780048|P4|Base Study-Cycle 1|Technical Problems|1
844985|NCT01697579|2780049|P3|Base Study-Cycle 1|Technical Problems|1
844986|NCT01697579|2780050|P2|Base Study-Cycle 1|Technical Problems|0
844987|NCT01697579|2780051|P1|Base Study-Cycle 1|Technical Problems|0
844988|NCT01697579|2780045|P7|Base Study-Cycle 1|Consent Withdrawn by Participant|0
844989|NCT01697579|2780046|P6|Base Study-Cycle 1|Consent Withdrawn by Participant|0
844990|NCT01697579|2780047|P5|Base Study-Cycle 1|Consent Withdrawn by Participant|0
844991|NCT01697579|2780048|P4|Base Study-Cycle 1|Consent Withdrawn by Participant|0
844992|NCT01697579|2780049|P3|Base Study-Cycle 1|Consent Withdrawn by Participant|0
844993|NCT01697579|2780050|P2|Base Study-Cycle 1|Consent Withdrawn by Participant|1
844994|NCT01697579|2780051|P1|Base Study-Cycle 1|Consent Withdrawn by Participant|0
844995|NCT01697579|2780045|P7|Base Study-Cycle 1|Protocol Violation|0
844996|NCT01697579|2780046|P6|Base Study-Cycle 1|Protocol Violation|0
844997|NCT01697579|2780047|P5|Base Study-Cycle 1|Protocol Violation|3
844998|NCT01697579|2780048|P4|Base Study-Cycle 1|Protocol Violation|0
844999|NCT01697579|2780049|P3|Base Study-Cycle 1|Protocol Violation|0
845000|NCT01697579|2780050|P2|Base Study-Cycle 1|Protocol Violation|0
845001|NCT01697579|2780051|P1|Base Study-Cycle 1|Protocol Violation|0
845002|NCT01697579|2780045|P7|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
845003|NCT01697579|2780046|P6|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
845004|NCT01697579|2780047|P5|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
845005|NCT01697579|2780048|P4|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
845006|NCT01697579|2780049|P3|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
845007|NCT01697579|2780050|P2|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
845008|NCT01697579|2780051|P1|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1
845009|NCT01697579|2780045|P7|Base Study-Cycle 1|Adverse Event|0
845010|NCT01697579|2780046|P6|Base Study-Cycle 1|Adverse Event|0
845011|NCT01697579|2780047|P5|Base Study-Cycle 1|Adverse Event|0
845012|NCT01697579|2780048|P4|Base Study-Cycle 1|Adverse Event|0
845013|NCT01697579|2780049|P3|Base Study-Cycle 1|Adverse Event|0
845014|NCT01697579|2780050|P2|Base Study-Cycle 1|Adverse Event|0
845015|NCT01697579|2780051|P1|Base Study-Cycle 1|Adverse Event|1
845016|NCT01697501|2780163|P1|Overall Study|Protocol Violation|2
845017|NCT01697462|2780206|P1|Overall Study|Missing|5
845018|NCT01697462|2780206|P1|Overall Study|Other|10
845019|NCT01697462|2780206|P1|Overall Study|Death|1
845020|NCT01697462|2780206|P1|Overall Study|Investigator Decision|21
845021|NCT01697462|2780206|P1|Overall Study|Withdrawal by Subject|12
845022|NCT01697462|2780206|P1|Overall Study|Lost to Follow-up|21
845023|NCT01697462|2780206|P1|Overall Study|Adverse Event|6
845024|NCT01697462|2780206|P1|Overall Study|Disease Progression|1
845025|NCT01697449|2780213|P1|Overall Study|Missing|25
845026|NCT01697449|2780213|P1|Overall Study|Other|1
845027|NCT01697449|2780213|P1|Overall Study|Death|2
845028|NCT01697449|2780213|P1|Overall Study|Physician Decision|1
845029|NCT01697449|2780213|P1|Overall Study|Withdrawal by Subject|2
845030|NCT01697449|2780213|P1|Overall Study|Lost to Follow-up|5
845031|NCT01697449|2780213|P1|Overall Study|Adverse Event|7
845032|NCT01697449|2780213|P1|Overall Study|Disease progression|47
845033|NCT01697358|2780224|P2|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26
845034|NCT01697358|2780225|P1|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34
845035|NCT01697358|2780224|P2|Period II: 6-24M Long-term Follow-up|Adverse Event|3
845036|NCT01697358|2780225|P1|Period II: 6-24M Long-term Follow-up|Adverse Event|0
845037|NCT01697358|2780224|P2|Period II: 6-24M Long-term Follow-up|Death|1
845038|NCT01697358|2780225|P1|Period II: 6-24M Long-term Follow-up|Death|1
845039|NCT01697358|2780224|P2|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
845040|NCT01697358|2780225|P1|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
845041|NCT01697358|2780224|P2|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10
845042|NCT01697358|2780225|P1|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8
845043|NCT01697358|2780224|P2|Period II: 6-24M Long-term Follow-up|Physician Decision|12
845127|NCT01696643|2780420|P1|Overall Study|Lost to Follow-up|67
845044|NCT01697358|2780225|P1|Period II: 6-24M Long-term Follow-up|Physician Decision|3
845045|NCT01697358|2780224|P2|Period I: Randomization to 6 Months|Lost to Follow-up|0
845046|NCT01697358|2780225|P1|Period I: Randomization to 6 Months|Lost to Follow-up|2
845047|NCT01697358|2780224|P2|Period I: Randomization to 6 Months|Adverse Event|1
845048|NCT01697358|2780225|P1|Period I: Randomization to 6 Months|Adverse Event|1
845049|NCT01697358|2780224|P2|Period I: Randomization to 6 Months|Physician Decision|0
845050|NCT01697358|2780225|P1|Period I: Randomization to 6 Months|Physician Decision|4
845051|NCT01697358|2780224|P2|Period I: Randomization to 6 Months|Withdrawal by Subject|0
845052|NCT01697358|2780225|P1|Period I: Randomization to 6 Months|Withdrawal by Subject|6
845053|NCT01697345|2780241|P1|Overall Study|Withdrawal by Subject|1
845054|NCT01697319|2780266|P1|Extension Phase|Terminated by Sponsor|15
845055|NCT01697319|2780266|P1|Primary Phase|Withdrawal by Subject|1
845056|NCT01696994|2780275|P2|Overall Study|Refused Screen (Ovarian Screening)|3582
845057|NCT01696994|2780276|P1|Overall Study|Refused Screen (Ovarian Screening)|0
845058|NCT01696994|2780275|P2|Overall Study|Refused ASU (Control)|0
845059|NCT01696994|2780276|P1|Overall Study|Refused ASU (Control)|311
845060|NCT01696994|2780275|P2|Overall Study|No Ovaries at Baseline|4851
845061|NCT01696994|2780276|P1|Overall Study|No Ovaries at Baseline|4807
845062|NCT01696994|2780275|P2|Overall Study|Died Before ASU (Control)|0
845063|NCT01696994|2780276|P1|Overall Study|Died Before ASU (Control)|73
845064|NCT01696994|2780275|P2|Overall Study|Died Before Randomization|2
845065|NCT01696994|2780276|P1|Overall Study|Died Before Randomization|1
845066|NCT01696994|2780275|P2|Overall Study|Cancer Before Rand. (Ovarian Screening)|2
845067|NCT01696994|2780276|P1|Overall Study|Cancer Before Rand. (Ovarian Screening)|0
845068|NCT01696981|2780304|P2|Overall Study|Refused Screen (Colorectal Screening)|10346
845069|NCT01696981|2780305|P1|Overall Study|Refused Screen (Colorectal Screening)|0
845070|NCT01696981|2780304|P2|Overall Study|Refused ASU (Control)|0
845071|NCT01696981|2780305|P1|Overall Study|Refused ASU (Control)|920
845072|NCT01696981|2780304|P2|Overall Study|Died Before ASU (Control)|0
845073|NCT01696981|2780305|P1|Overall Study|Died Before ASU (Control)|278
845074|NCT01696981|2780304|P2|Overall Study|Died Before Randomization|8
845075|NCT01696981|2780305|P1|Overall Study|Died Before Randomization|3
845076|NCT01696981|2780304|P2|Overall Study|Cancer Before Rand. (Colo. Screening)|20
845077|NCT01696981|2780305|P1|Overall Study|Cancer Before Rand. (Colo. Screening)|0
845078|NCT01696968|2780325|P2|Overall Study|Refused Screen (Lung Screening)|6796
845079|NCT01696968|2780326|P1|Overall Study|Refused Screen (Lung Screening)|0
845080|NCT01696968|2780325|P2|Overall Study|Refused ASU (Control)|0
845081|NCT01696968|2780326|P1|Overall Study|Refused ASU (Control)|920
845082|NCT01696968|2780325|P2|Overall Study|Died Before ASU (Control)|0
845083|NCT01696968|2780326|P1|Overall Study|Died Before ASU (Control)|278
845084|NCT01696968|2780325|P2|Overall Study|Died Before Randomization|8
845085|NCT01696968|2780326|P1|Overall Study|Died Before Randomization|3
845086|NCT01696968|2780325|P2|Overall Study|Cancer Before Rand. (Lung Screening)|8
845087|NCT01696968|2780326|P1|Overall Study|Cancer Before Rand. (Lung Screening)|0
845088|NCT01696942|2780348|P2|Overall Study|screen failure|1
845089|NCT01696942|2780349|P1|Overall Study|screen failure|0
845090|NCT01696942|2780348|P2|Overall Study|Protocol Violation|2
845091|NCT01696942|2780349|P1|Overall Study|Protocol Violation|1
845092|NCT01696942|2780348|P2|Overall Study|Withdrawal by Subject|0
845093|NCT01696942|2780349|P1|Overall Study|Withdrawal by Subject|1
845094|NCT01696929|2780357|P1|Overall Study|Physician Decision|1
845095|NCT01696877|2780364|P2|Overall Study|Adverse Event|1
845096|NCT01696877|2780365|P1|Overall Study|Adverse Event|0
845097|NCT01696773|2780379|P2|Days 15-27, Washout|Adverse Event|0
845098|NCT01696773|2780380|P1|Days 15-27, Washout|Adverse Event|1
845099|NCT01696695|2780407|P1|Overall Study|Major Protocol Violation|192
845100|NCT01696695|2780407|P1|Overall Study|Other|74
845101|NCT01696695|2780407|P1|Overall Study|Lost to Follow-up|48
845102|NCT01696695|2780407|P1|Overall Study|Withdrawal by Subject|92
845103|NCT01696695|2780407|P1|Overall Study|Adverse Event|74
845104|NCT01696695|2780407|P1|Overall Study|Death|29
845105|NCT01696695|2780407|P1|Overall Study|Disease progression|373
845106|NCT01696643|2780419|P2|Overall Study|Participant Did Not Receive Study Drug|2
845107|NCT01696643|2780420|P1|Overall Study|Participant Did Not Receive Study Drug|2
845108|NCT01696643|2780419|P2|Overall Study|Medical Monitor Decision|2
845109|NCT01696643|2780420|P1|Overall Study|Medical Monitor Decision|0
845110|NCT01696643|2780419|P2|Overall Study|Participant Incarcerated|1
845111|NCT01696643|2780420|P1|Overall Study|Participant Incarcerated|0
845112|NCT01696643|2780419|P2|Overall Study|Site Error|1
845113|NCT01696643|2780420|P1|Overall Study|Site Error|2
845114|NCT01696643|2780419|P2|Overall Study|Participant on Restricted Bed Rest|0
845115|NCT01696643|2780420|P1|Overall Study|Participant on Restricted Bed Rest|1
845116|NCT01696643|2780419|P2|Overall Study|Withdrawal by Subject|149
845117|NCT01696643|2780420|P1|Overall Study|Withdrawal by Subject|142
845118|NCT01696643|2780419|P2|Overall Study|Study Terminated by Sponsor|294
845119|NCT01696643|2780420|P1|Overall Study|Study Terminated by Sponsor|286
845120|NCT01696643|2780419|P2|Overall Study|Protocol Violation|7
845121|NCT01696643|2780420|P1|Overall Study|Protocol Violation|7
845122|NCT01696643|2780419|P2|Overall Study|Pregnancy|1
845123|NCT01696643|2780420|P1|Overall Study|Pregnancy|0
845124|NCT01696643|2780419|P2|Overall Study|Physician Decision|2
845125|NCT01696643|2780420|P1|Overall Study|Physician Decision|3
845126|NCT01696643|2780419|P2|Overall Study|Lost to Follow-up|67
845128|NCT01696643|2780419|P2|Overall Study|Lack of Efficacy|0
845129|NCT01696643|2780420|P1|Overall Study|Lack of Efficacy|3
845130|NCT01696643|2780419|P2|Overall Study|Death|2
845131|NCT01696643|2780420|P1|Overall Study|Death|1
845132|NCT01696643|2780419|P2|Overall Study|Adverse Event|7
845133|NCT01696643|2780420|P1|Overall Study|Adverse Event|15
845134|NCT01696214|2780448|P4|Overall Study|Lost to Follow-up|0
845135|NCT01696214|2780449|P3|Overall Study|Lost to Follow-up|0
845136|NCT01696214|2780450|P2|Overall Study|Lost to Follow-up|1
845137|NCT01696214|2780451|P1|Overall Study|Lost to Follow-up|0
845138|NCT01696188|2780463|P2|Overall Study|Protocol Violation|1
845139|NCT01696188|2780464|P1|Overall Study|Protocol Violation|1
845140|NCT01696071|2780495|P2|Treatment Period 2: 4 Weeks|Adverse Event|0
845141|NCT01696071|2780496|P1|Treatment Period 2: 4 Weeks|Adverse Event|1
845142|NCT01696058|2780524|P2|Overall Study|Other reason prematurely discontinued|3
845143|NCT01696058|2780525|P1|Overall Study|Other reason prematurely discontinued|5
845144|NCT01696058|2780524|P2|Overall Study|Withdrawal by Subject|6
845145|NCT01696058|2780525|P1|Overall Study|Withdrawal by Subject|4
845146|NCT01696058|2780524|P2|Overall Study|Lost to Follow-up|5
845147|NCT01696058|2780525|P1|Overall Study|Lost to Follow-up|2
845148|NCT01696058|2780524|P2|Overall Study|Protocol Violation|3
845149|NCT01696058|2780525|P1|Overall Study|Protocol Violation|9
845150|NCT01696058|2780524|P2|Overall Study|Lack of Efficacy|3
845151|NCT01696058|2780525|P1|Overall Study|Lack of Efficacy|2
845152|NCT01696058|2780524|P2|Overall Study|Adverse Event|11
845153|NCT01696058|2780525|P1|Overall Study|Adverse Event|21
845154|NCT01696045|2780553|P2|Overall Study|Disease progression|2
845155|NCT01696045|2780554|P1|Overall Study|Disease progression|2
845156|NCT01696045|2780553|P2|Overall Study|Study drug toxicity|5
845157|NCT01696045|2780554|P1|Overall Study|Study drug toxicity|1
845158|NCT01695993|2780573|P3|Overall Study|Changed Medical Facility|1
845159|NCT01695993|2780574|P2|Overall Study|Changed Medical Facility|0
845160|NCT01695993|2780575|P1|Overall Study|Changed Medical Facility|0
845161|NCT01695993|2780573|P3|Overall Study|To ill to continue|0
845162|NCT01695993|2780574|P2|Overall Study|To ill to continue|2
845163|NCT01695993|2780575|P1|Overall Study|To ill to continue|1
845164|NCT01695993|2780573|P3|Overall Study|Withdrawal by Subject|2
845165|NCT01695993|2780574|P2|Overall Study|Withdrawal by Subject|2
845166|NCT01695993|2780575|P1|Overall Study|Withdrawal by Subject|2
845167|NCT01695993|2780573|P3|Overall Study|Lost to Follow-up|3
845168|NCT01695993|2780574|P2|Overall Study|Lost to Follow-up|1
845169|NCT01695993|2780575|P1|Overall Study|Lost to Follow-up|2
845170|NCT01695772|2780583|P1|Overall Study|Unspecified Reason|1
845171|NCT01695772|2780583|P1|Overall Study|Protocol Violation|2
845172|NCT01695772|2780583|P1|Overall Study|Lost to Follow-up|4
845173|NCT01695772|2780583|P1|Overall Study|Investigator Decision|5
845174|NCT01695772|2780583|P1|Overall Study|Progressive Disease|8
845175|NCT01695772|2780583|P1|Overall Study|Withdrawal by Subject|18
845176|NCT01695746|2780595|P1|Overall Study|Participant not willing to participate|3
845177|NCT01695746|2780595|P1|Overall Study|Protocol Violation|5
845178|NCT01695746|2780595|P1|Overall Study|Non-compliance by the participant|3
845179|NCT01695746|2780595|P1|Overall Study|Adverse Event|1
845180|NCT01695239|2780644|P4|Overall Study|Protocol Violation|0
845181|NCT01695239|2780645|P3|Overall Study|Protocol Violation|0
845182|NCT01695239|2780646|P2|Overall Study|Protocol Violation|0
845183|NCT01695239|2780647|P1|Overall Study|Protocol Violation|1
845184|NCT01695239|2780644|P4|Overall Study|Lost to Follow-up|0
845185|NCT01695239|2780645|P3|Overall Study|Lost to Follow-up|0
845186|NCT01695239|2780646|P2|Overall Study|Lost to Follow-up|0
845187|NCT01695239|2780647|P1|Overall Study|Lost to Follow-up|1
845188|NCT01695239|2780644|P4|Overall Study|Sponsor Decision|0
845189|NCT01695239|2780645|P3|Overall Study|Sponsor Decision|1
845190|NCT01695239|2780646|P2|Overall Study|Sponsor Decision|0
845191|NCT01695239|2780647|P1|Overall Study|Sponsor Decision|3
845192|NCT01695239|2780644|P4|Overall Study|Withdrawal by Subject|0
845193|NCT01695239|2780645|P3|Overall Study|Withdrawal by Subject|1
845194|NCT01695239|2780646|P2|Overall Study|Withdrawal by Subject|1
845195|NCT01695239|2780647|P1|Overall Study|Withdrawal by Subject|3
845196|NCT01695239|2780644|P4|Overall Study|Lack of Efficacy|0
845197|NCT01695239|2780645|P3|Overall Study|Lack of Efficacy|2
845198|NCT01695239|2780646|P2|Overall Study|Lack of Efficacy|0
845199|NCT01695239|2780647|P1|Overall Study|Lack of Efficacy|4
845200|NCT01695239|2780644|P4|Overall Study|Adverse Event|3
845201|NCT01695239|2780645|P3|Overall Study|Adverse Event|2
845202|NCT01695239|2780646|P2|Overall Study|Adverse Event|2
845203|NCT01695239|2780647|P1|Overall Study|Adverse Event|2
845204|NCT01695239|2780644|P4|Overall Study|Entry Criteria Not Met|3
845205|NCT01695239|2780645|P3|Overall Study|Entry Criteria Not Met|3
845206|NCT01695239|2780646|P2|Overall Study|Entry Criteria Not Met|1
845207|NCT01695239|2780647|P1|Overall Study|Entry Criteria Not Met|1
845208|NCT01695239|2780644|P4|Overall Study|On Study Treatment|0
845209|NCT01695239|2780645|P3|Overall Study|On Study Treatment|1
845210|NCT01695239|2780646|P2|Overall Study|On Study Treatment|0
845211|NCT01695239|2780647|P1|Overall Study|On Study Treatment|0
845212|NCT01694771|2780763|P2|Overall Study|Other reasons|6
845213|NCT01694771|2780764|P1|Overall Study|Other reasons|5
845214|NCT01694771|2780763|P2|Overall Study|Consent withdrawn|9
845215|NCT01694771|2780764|P1|Overall Study|Consent withdrawn|7
845216|NCT01694771|2780763|P2|Overall Study|Lost to Follow-up|3
845217|NCT01694771|2780764|P1|Overall Study|Lost to Follow-up|2
845218|NCT01694771|2780763|P2|Overall Study|Non compliance protocol|6
845219|NCT01694771|2780764|P1|Overall Study|Non compliance protocol|7
845220|NCT01694771|2780763|P2|Overall Study|Lack of Efficacy|0
845221|NCT01694771|2780764|P1|Overall Study|Lack of Efficacy|1
845222|NCT01694771|2780763|P2|Overall Study|Adverse Event|16
845223|NCT01694771|2780764|P1|Overall Study|Adverse Event|18
845224|NCT01694706|2780788|P3|Overall Study|other reason not defined above|0
845225|NCT01694706|2780789|P2|Overall Study|other reason not defined above|0
845226|NCT01694706|2780790|P1|Overall Study|other reason not defined above|1
845227|NCT01694706|2780788|P3|Overall Study|Adverse Event|0
845228|NCT01694706|2780789|P2|Overall Study|Adverse Event|1
845229|NCT01694706|2780790|P1|Overall Study|Adverse Event|0
845230|NCT01694420|2780835|P1|Overall Study|Lost to Follow-up|3
845231|NCT01693614|2780963|P3|Overall Study|Withdrawal by Subject|5
845232|NCT01693614|2780964|P2|Overall Study|Withdrawal by Subject|0
845233|NCT01693614|2780965|P1|Overall Study|Withdrawal by Subject|1
845234|NCT01693614|2780963|P3|Overall Study|Withdrawal by subject/guardian|2
845235|NCT01693614|2780964|P2|Overall Study|Withdrawal by subject/guardian|0
845236|NCT01693614|2780965|P1|Overall Study|Withdrawal by subject/guardian|0
845237|NCT01693614|2780963|P3|Overall Study|Physician Decision|4
845238|NCT01693614|2780964|P2|Overall Study|Physician Decision|1
845239|NCT01693614|2780965|P1|Overall Study|Physician Decision|1
845240|NCT01693614|2780963|P3|Overall Study|Death|0
845241|NCT01693614|2780964|P2|Overall Study|Death|0
845242|NCT01693614|2780965|P1|Overall Study|Death|1
845243|NCT01693614|2780963|P3|Overall Study|Protocol Violation|1
845244|NCT01693614|2780964|P2|Overall Study|Protocol Violation|2
845245|NCT01693614|2780965|P1|Overall Study|Protocol Violation|5
845246|NCT01693614|2780963|P3|Overall Study|Disease progression|7
845247|NCT01693614|2780964|P2|Overall Study|Disease progression|8
845248|NCT01693614|2780965|P1|Overall Study|Disease progression|11
845249|NCT01693614|2780963|P3|Overall Study|Adverse Event|5
845250|NCT01693614|2780964|P2|Overall Study|Adverse Event|11
845251|NCT01693614|2780965|P1|Overall Study|Adverse Event|7
845252|NCT01693367|2780993|P2|Overall Study|Physician Decision|1
845253|NCT01693367|2780994|P1|Overall Study|Physician Decision|0
845254|NCT01693367|2780993|P2|Overall Study|Withdrawal by Subject|1
845255|NCT01693367|2780994|P1|Overall Study|Withdrawal by Subject|1
845256|NCT01693185|2781012|P2|Overall Study|diagnostic procedure after colonoscopy|6
845257|NCT01693185|2781013|P1|Overall Study|diagnostic procedure after colonoscopy|0
845258|NCT01693120|2781029|P1|Phased RF Study Procedure and Follow-up|Other reasons|7
845259|NCT01693120|2781029|P1|Phased RF Study Procedure and Follow-up|Protocol Violation|1
845260|NCT01693120|2781029|P1|Phased RF Study Procedure and Follow-up|Physician Decision|3
845261|NCT01693120|2781029|P1|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5
845262|NCT01693120|2781029|P1|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1
845263|NCT01693120|2781029|P1|Enrollment|Not specified|1
845264|NCT01693120|2781029|P1|Enrollment|Study closed|8
845265|NCT01693120|2781029|P1|Enrollment|Adverse Event|1
845266|NCT01693120|2781029|P1|Enrollment|Physician Decision|3
845267|NCT01693120|2781029|P1|Enrollment|Protocol Violation|46
845268|NCT01693120|2781029|P1|Enrollment|Withdrawal by Subject|10
845269|NCT01693120|2781029|P1|Enrollment|Lost to Follow-up|1
845270|NCT01693068|2781038|P3|Cross-over (Dacarbazine To Pimasertib)|On-study|1
845271|NCT01693068|2781039|P2|Cross-over (Dacarbazine To Pimasertib)|On-study|0
845272|NCT01693068|2781040|P1|Cross-over (Dacarbazine To Pimasertib)|On-study|0
845273|NCT01693068|2781038|P3|Randomization Period|On-study|0
845274|NCT01693068|2781039|P2|Randomization Period|On-study|5
845275|NCT01693068|2781040|P1|Randomization Period|On-study|2
845276|NCT01693029|2781072|P2|Overall Study|Non-compliance|1
845277|NCT01693029|2781073|P1|Overall Study|Non-compliance|2
845278|NCT01693029|2781072|P2|Overall Study|Death|8
845279|NCT01693029|2781073|P1|Overall Study|Death|5
845280|NCT01693029|2781072|P2|Overall Study|Adverse Event|6
845281|NCT01693029|2781073|P1|Overall Study|Adverse Event|1
845282|NCT01693029|2781072|P2|Overall Study|Lost to Follow-up|1
845283|NCT01693029|2781073|P1|Overall Study|Lost to Follow-up|0
845284|NCT01693029|2781072|P2|Overall Study|Physician Decision|2
845285|NCT01693029|2781073|P1|Overall Study|Physician Decision|0
845286|NCT01693029|2781072|P2|Overall Study|Change in dialysis modality|1
845287|NCT01693029|2781073|P1|Overall Study|Change in dialysis modality|2
845288|NCT01693029|2781072|P2|Overall Study|Protocol Violation|7
845289|NCT01693029|2781073|P1|Overall Study|Protocol Violation|6
845290|NCT01693029|2781072|P2|Overall Study|Bindinging anti-EPO antibodies|2
845291|NCT01693029|2781073|P1|Overall Study|Bindinging anti-EPO antibodies|6
845292|NCT01693029|2781072|P2|Overall Study|Kidney transplantation|7
845293|NCT01693029|2781073|P1|Overall Study|Kidney transplantation|7
845294|NCT01693029|2781072|P2|Overall Study|Withdrawal by Subject|22
845295|NCT01693029|2781073|P1|Overall Study|Withdrawal by Subject|15
845296|NCT01692938|2781104|P2|Overall Study|Study completed prior to site completion|3
845297|NCT01692938|2781105|P1|Overall Study|Study completed prior to site completion|3
845298|NCT01692938|2781104|P2|Overall Study|Protocol Deviation|1
845299|NCT01692938|2781105|P1|Overall Study|Protocol Deviation|1
845300|NCT01692782|2781116|P3|Overall Study|Withdrawal by Subject|3
845301|NCT01692782|2781117|P2|Overall Study|Withdrawal by Subject|10
845302|NCT01692782|2781118|P1|Overall Study|Withdrawal by Subject|3
845303|NCT01692782|2781116|P3|Overall Study|SAE not related to study drug|0
845304|NCT01692782|2781117|P2|Overall Study|SAE not related to study drug|1
845305|NCT01692782|2781118|P1|Overall Study|SAE not related to study drug|0
845306|NCT01692782|2781116|P3|Overall Study|Non-compliant with study visits|1
845307|NCT01692782|2781117|P2|Overall Study|Non-compliant with study visits|0
845308|NCT01692782|2781118|P1|Overall Study|Non-compliant with study visits|0
845309|NCT01692782|2781116|P3|Overall Study|Non-complance with study drug|1
845310|NCT01692782|2781117|P2|Overall Study|Non-complance with study drug|4
845311|NCT01692782|2781118|P1|Overall Study|Non-complance with study drug|0
845312|NCT01692782|2781116|P3|Overall Study|Protocol Violation|2
845313|NCT01692782|2781117|P2|Overall Study|Protocol Violation|0
845314|NCT01692782|2781118|P1|Overall Study|Protocol Violation|1
845315|NCT01692782|2781116|P3|Overall Study|Pregnancy|0
845316|NCT01692782|2781117|P2|Overall Study|Pregnancy|0
845317|NCT01692782|2781118|P1|Overall Study|Pregnancy|1
845318|NCT01692782|2781116|P3|Overall Study|Lost to Follow-up|1
845319|NCT01692782|2781117|P2|Overall Study|Lost to Follow-up|7
845320|NCT01692782|2781118|P1|Overall Study|Lost to Follow-up|2
845321|NCT01692782|2781116|P3|Overall Study|Lack of Efficacy|0
845322|NCT01692782|2781117|P2|Overall Study|Lack of Efficacy|2
845323|NCT01692782|2781118|P1|Overall Study|Lack of Efficacy|1
845324|NCT01692782|2781116|P3|Overall Study|Adverse Event|2
845325|NCT01692782|2781117|P2|Overall Study|Adverse Event|32
845326|NCT01692782|2781118|P1|Overall Study|Adverse Event|12
845327|NCT01692730|2781208|P2|Overall Study|Lost to Follow-up|227
845328|NCT01692730|2781209|P1|Overall Study|Lost to Follow-up|225
845329|NCT01692626|2781223|P2|Overall Study|Withdrawal by Subject|0
845330|NCT01692626|2781224|P1|Overall Study|Withdrawal by Subject|1
845331|NCT01692626|2781223|P2|Overall Study|Protocol Violation|2
845332|NCT01692626|2781224|P1|Overall Study|Protocol Violation|1
845333|NCT01692626|2781223|P2|Overall Study|Adverse Event|3
845334|NCT01692626|2781224|P1|Overall Study|Adverse Event|2
845335|NCT01692626|2781223|P2|Overall Study|Death|1
845336|NCT01692626|2781224|P1|Overall Study|Death|0
845337|NCT01692301|2781251|P2|Overall Study|Lost to Follow-up|1
845338|NCT01692301|2781252|P1|Overall Study|Lost to Follow-up|1
845339|NCT01692301|2781251|P2|Overall Study|Physician Decision|2
845340|NCT01692301|2781252|P1|Overall Study|Physician Decision|2
845341|NCT01692301|2781251|P2|Overall Study|Technical problems|1
845342|NCT01692301|2781252|P1|Overall Study|Technical problems|0
845343|NCT01692301|2781251|P2|Overall Study|Patient/guardian decision|15
845344|NCT01692301|2781252|P1|Overall Study|Patient/guardian decision|16
845345|NCT01692301|2781251|P2|Overall Study|Protocol deviation|2
845346|NCT01692301|2781252|P1|Overall Study|Protocol deviation|9
845347|NCT01692301|2781251|P2|Overall Study|Non-compliance with study treatment|2
845348|NCT01692301|2781252|P1|Overall Study|Non-compliance with study treatment|1
845349|NCT01692301|2781251|P2|Overall Study|Lack of Efficacy|5
845350|NCT01692301|2781252|P1|Overall Study|Lack of Efficacy|0
845351|NCT01692301|2781251|P2|Overall Study|Death|2
845352|NCT01692301|2781252|P1|Overall Study|Death|1
845353|NCT01692301|2781251|P2|Overall Study|Adverse Event|12
845354|NCT01692301|2781252|P1|Overall Study|Adverse Event|15
845355|NCT01692197|2781278|P1|Overall Study|Failed Screening|3
845356|NCT01691898|2781291|P6|Overall Study|Other|1
845357|NCT01691898|2781292|P5|Overall Study|Other|0
845358|NCT01691898|2781293|P4|Overall Study|Other|0
845359|NCT01691898|2781294|P3|Overall Study|Other|1
845360|NCT01691898|2781295|P2|Overall Study|Other|2
845361|NCT01691898|2781296|P1|Overall Study|Other|0
845362|NCT01691898|2781291|P6|Overall Study|Withdrawal by Subject|3
845363|NCT01691898|2781292|P5|Overall Study|Withdrawal by Subject|2
845364|NCT01691898|2781293|P4|Overall Study|Withdrawal by Subject|1
845365|NCT01691898|2781294|P3|Overall Study|Withdrawal by Subject|1
845366|NCT01691898|2781295|P2|Overall Study|Withdrawal by Subject|5
845367|NCT01691898|2781296|P1|Overall Study|Withdrawal by Subject|8
845368|NCT01691898|2781291|P6|Overall Study|Lost to Follow-up|0
845369|NCT01691898|2781292|P5|Overall Study|Lost to Follow-up|0
845370|NCT01691898|2781293|P4|Overall Study|Lost to Follow-up|0
845371|NCT01691898|2781294|P3|Overall Study|Lost to Follow-up|0
845372|NCT01691898|2781295|P2|Overall Study|Lost to Follow-up|0
845373|NCT01691898|2781296|P1|Overall Study|Lost to Follow-up|1
845374|NCT01691898|2781291|P6|Overall Study|Progression of Disease|2
845375|NCT01691898|2781292|P5|Overall Study|Progression of Disease|1
845376|NCT01691898|2781293|P4|Overall Study|Progression of Disease|0
845377|NCT01691898|2781294|P3|Overall Study|Progression of Disease|1
845378|NCT01691898|2781295|P2|Overall Study|Progression of Disease|3
845379|NCT01691898|2781296|P1|Overall Study|Progression of Disease|2
845380|NCT01691898|2781291|P6|Overall Study|Adverse Event|0
845381|NCT01691898|2781292|P5|Overall Study|Adverse Event|0
845382|NCT01691898|2781293|P4|Overall Study|Adverse Event|1
845383|NCT01691898|2781294|P3|Overall Study|Adverse Event|0
845384|NCT01691898|2781295|P2|Overall Study|Adverse Event|1
845385|NCT01691898|2781296|P1|Overall Study|Adverse Event|0
845386|NCT01691898|2781291|P6|Overall Study|Death|20
845387|NCT01691898|2781292|P5|Overall Study|Death|5
845388|NCT01691898|2781293|P4|Overall Study|Death|2
845389|NCT01691898|2781294|P3|Overall Study|Death|4
845390|NCT01691898|2781295|P2|Overall Study|Death|28
845391|NCT01691898|2781296|P1|Overall Study|Death|31
845392|NCT01691898|2781291|P6|Overall Study|Ongoing in Study|14
845393|NCT01691898|2781292|P5|Overall Study|Ongoing in Study|31
845394|NCT01691898|2781293|P4|Overall Study|Ongoing in Study|5
845395|NCT01691898|2781294|P3|Overall Study|Ongoing in Study|11
845396|NCT01691898|2781295|P2|Overall Study|Ongoing in Study|19
845397|NCT01691898|2781296|P1|Overall Study|Ongoing in Study|18
845398|NCT01691885|2781442|P2|Washout Period (7-9 Days)|Adverse Event|1
845399|NCT01691885|2781443|P1|Washout Period (7-9 Days)|Adverse Event|0
845400|NCT01691885|2781442|P2|Treatment Period 1(7-14 Days)|Adverse Event|1
845401|NCT01691885|2781443|P1|Treatment Period 1(7-14 Days)|Adverse Event|1
845402|NCT01691859|2781449|P1|Overall Study|Withdrawal by Subject|31
845403|NCT01691859|2781449|P1|Overall Study|Physician Decision|6
845404|NCT01691859|2781449|P1|Overall Study|Lost to Follow-up|5
845405|NCT01691859|2781449|P1|Overall Study|Study closed/terminated|50
845406|NCT01691859|2781449|P1|Overall Study|Product commercially available|221
845407|NCT01691859|2781449|P1|Overall Study|Protocol Violation|4
845408|NCT01691859|2781449|P1|Overall Study|Lack of Efficacy|11
845409|NCT01691859|2781449|P1|Overall Study|Adverse Event|19
845410|NCT01691794|2781471|P3|Overall Study|Did not complete first 24 weeks of study|3
845411|NCT01691794|2781472|P2|Overall Study|Did not complete first 24 weeks of study|3
845412|NCT01691794|2781473|P1|Overall Study|Did not complete first 24 weeks of study|0
845413|NCT01691794|2781471|P3|Overall Study|Completed Only first 24 weeks of study|3
845414|NCT01691794|2781472|P2|Overall Study|Completed Only first 24 weeks of study|2
845415|NCT01691794|2781473|P1|Overall Study|Completed Only first 24 weeks of study|0
845416|NCT01691794|2781471|P3|Overall Study|Adverse Event|1
845417|NCT01691794|2781472|P2|Overall Study|Adverse Event|1
845418|NCT01691794|2781473|P1|Overall Study|Adverse Event|0
845419|NCT01691794|2781471|P3|Overall Study|Participant request to discontinue|0
845420|NCT01691794|2781472|P2|Overall Study|Participant request to discontinue|1
845421|NCT01691794|2781473|P1|Overall Study|Participant request to discontinue|0
845422|NCT01691794|2781471|P3|Overall Study|Lack of Efficacy|1
845423|NCT01691794|2781472|P2|Overall Study|Lack of Efficacy|7
845424|NCT01691794|2781473|P1|Overall Study|Lack of Efficacy|0
845425|NCT01691794|2781471|P3|Overall Study|Death|1
845426|NCT01691794|2781472|P2|Overall Study|Death|0
845427|NCT01691794|2781473|P1|Overall Study|Death|0
845428|NCT01691794|2781471|P3|Overall Study|Poor/Non-Compliance|1
845429|NCT01691794|2781472|P2|Overall Study|Poor/Non-Compliance|4
845430|NCT01691794|2781473|P1|Overall Study|Poor/Non-Compliance|1
845431|NCT01691781|2781489|P2|Overall Study|Adverse Event|1
845432|NCT01691781|2781490|P1|Overall Study|Adverse Event|0
845433|NCT01691781|2781489|P2|Overall Study|Protocol Violation|2
845434|NCT01691781|2781490|P1|Overall Study|Protocol Violation|2
845435|NCT01691781|2781489|P2|Overall Study|Physician Decision|1
845436|NCT01691781|2781490|P1|Overall Study|Physician Decision|1
845437|NCT01691781|2781489|P2|Overall Study|Withdrawal by Subject|3
845438|NCT01691781|2781490|P1|Overall Study|Withdrawal by Subject|4
845439|NCT01691612|2781513|P1|Overall Study|Adverse Event|1
845440|NCT01691612|2781513|P1|Overall Study|deemed ineligible after 1st visit|6
845441|NCT01691521|2781624|P3|Overall Study|Withdrawal by Subject|4
845442|NCT01691521|2781625|P2|Overall Study|Withdrawal by Subject|9
845443|NCT01691521|2781626|P1|Overall Study|Withdrawal by Subject|5
845444|NCT01691521|2781624|P3|Overall Study|Physician Decision|0
845445|NCT01691521|2781625|P2|Overall Study|Physician Decision|1
845446|NCT01691521|2781626|P1|Overall Study|Physician Decision|2
845447|NCT01691521|2781624|P3|Overall Study|Lost to Follow-up|2
845448|NCT01691521|2781625|P2|Overall Study|Lost to Follow-up|2
845449|NCT01691521|2781626|P1|Overall Study|Lost to Follow-up|0
845450|NCT01691521|2781624|P3|Overall Study|Protocol Violation|0
845451|NCT01691521|2781625|P2|Overall Study|Protocol Violation|3
845452|NCT01691521|2781626|P1|Overall Study|Protocol Violation|0
845453|NCT01691521|2781624|P3|Overall Study|Lack of Efficacy|2
845454|NCT01691521|2781625|P2|Overall Study|Lack of Efficacy|1
845455|NCT01691521|2781626|P1|Overall Study|Lack of Efficacy|1
845456|NCT01691521|2781624|P3|Overall Study|Adverse Event|1
845457|NCT01691521|2781625|P2|Overall Study|Adverse Event|0
845458|NCT01691521|2781626|P1|Overall Study|Adverse Event|4
845459|NCT01691508|2781648|P2|Overall Study|Withdrawal by Subject|0
845460|NCT01691508|2781649|P1|Overall Study|Withdrawal by Subject|1
845461|NCT01691508|2781648|P2|Overall Study|Adverse Event|3
845462|NCT01691508|2781649|P1|Overall Study|Adverse Event|3
845463|NCT01691482|2781663|P2|Treatment Period 2|Protocol Violation|1
845464|NCT01691482|2781664|P1|Treatment Period 2|Protocol Violation|1
845465|NCT01691482|2781663|P2|Treatment Period 2|Adverse Event|1
845466|NCT01691482|2781664|P1|Treatment Period 2|Adverse Event|0
845467|NCT01691430|2781682|P2|Overall Study|Lost to Follow-up|3
845468|NCT01691430|2781683|P1|Overall Study|Lost to Follow-up|0
845469|NCT01691430|2781682|P2|Overall Study|Withdrawal by Subject|1
845470|NCT01691430|2781683|P1|Overall Study|Withdrawal by Subject|5
845471|NCT01691430|2781682|P2|Overall Study|Death|16
845472|NCT01691430|2781683|P1|Overall Study|Death|17
845473|NCT01691248|2781780|P2|Overall Study|Not Treated|7
845474|NCT01691248|2781781|P1|Overall Study|Not Treated|4
845475|NCT01691248|2781780|P2|Overall Study|Reason not provided|4
845476|NCT01691248|2781781|P1|Overall Study|Reason not provided|4
845477|NCT01691248|2781780|P2|Overall Study|Lost to Follow-up|5
845478|NCT01691248|2781781|P1|Overall Study|Lost to Follow-up|2
845479|NCT01691248|2781780|P2|Overall Study|Confirmed CDAD|31
845480|NCT01691248|2781781|P1|Overall Study|Confirmed CDAD|14
845481|NCT01691248|2781780|P2|Overall Study|Withdrawal by Subject|18
845482|NCT01691248|2781781|P1|Overall Study|Withdrawal by Subject|20
845483|NCT01691248|2781780|P2|Overall Study|Adverse Event|22
845484|NCT01691248|2781781|P1|Overall Study|Adverse Event|24
845485|NCT01691248|2781780|P2|Overall Study|Protocol Violation|27
845486|NCT01691248|2781781|P1|Overall Study|Protocol Violation|43
845487|NCT01691105|2781793|P2|12 Month Biochemical Verification|subject did not self-report abstinence|401
845488|NCT01691105|2781794|P1|12 Month Biochemical Verification|subject did not self-report abstinence|352
845489|NCT01691105|2781793|P2|12 Month Biochemical Verification|Lost to Follow-up|71
845490|NCT01691105|2781794|P1|12 Month Biochemical Verification|Lost to Follow-up|50
845491|NCT01691105|2781793|P2|12 Month Biochemical Verification|Death|30
845492|NCT01691105|2781794|P1|12 Month Biochemical Verification|Death|22
845493|NCT01691105|2781793|P2|12 Month Follow-up|Death|30
845494|NCT01691105|2781794|P1|12 Month Follow-up|Death|22
845495|NCT01691105|2781793|P2|12 Month Follow-up|Lost to Follow-up|71
845496|NCT01691105|2781794|P1|12 Month Follow-up|Lost to Follow-up|50
845497|NCT01691105|2781793|P2|6 Month Follow-up|Death|13
845498|NCT01691105|2781794|P1|6 Month Follow-up|Death|13
845499|NCT01691105|2781793|P2|6 Month Follow-up|Lost to Follow-up|58
845500|NCT01691105|2781794|P1|6 Month Follow-up|Lost to Follow-up|39
845501|NCT01691105|2781793|P2|1 Month Follow-up|Death|3
845502|NCT01691105|2781794|P1|1 Month Follow-up|Death|2
845503|NCT01691105|2781793|P2|1 Month Follow-up|Lost to Follow-up|38
845504|NCT01691105|2781794|P1|1 Month Follow-up|Lost to Follow-up|41
845505|NCT01691092|2781814|P1|Overall Study|screen fail|19
845506|NCT01691092|2781814|P1|Overall Study|used for different study|2
845507|NCT01691092|2781814|P1|Overall Study|non-compliance|3
845508|NCT01691092|2781814|P1|Overall Study|Withdrawal by Subject|3
845509|NCT01691092|2781814|P1|Overall Study|Physician Decision|4
845510|NCT01691092|2781814|P1|Overall Study|Lost to Follow-up|10
845511|NCT01691014|2781827|P4|Overall Study|Lack of Efficacy|0
845512|NCT01691014|2781828|P3|Overall Study|Lack of Efficacy|7
845513|NCT01691014|2781829|P2|Overall Study|Lack of Efficacy|3
845514|NCT01691014|2781830|P1|Overall Study|Lack of Efficacy|2
845515|NCT01691014|2781827|P4|Overall Study|Adverse Event|1
845516|NCT01691014|2781828|P3|Overall Study|Adverse Event|1
845517|NCT01691014|2781829|P2|Overall Study|Adverse Event|5
845518|NCT01691014|2781830|P1|Overall Study|Adverse Event|0
845519|NCT01691014|2781827|P4|Overall Study|Withdrawal by Subject|1
845520|NCT01691014|2781828|P3|Overall Study|Withdrawal by Subject|1
845521|NCT01691014|2781829|P2|Overall Study|Withdrawal by Subject|1
845522|NCT01691014|2781830|P1|Overall Study|Withdrawal by Subject|0
845523|NCT01691014|2781827|P4|Overall Study|Other|0
845524|NCT01691014|2781828|P3|Overall Study|Other|2
845525|NCT01691014|2781829|P2|Overall Study|Other|0
845526|NCT01691014|2781830|P1|Overall Study|Other|0
845527|NCT01691014|2781827|P4|Overall Study|Premature Termination|3
845528|NCT01691014|2781828|P3|Overall Study|Premature Termination|0
845529|NCT01691014|2781829|P2|Overall Study|Premature Termination|6
845530|NCT01691014|2781830|P1|Overall Study|Premature Termination|1
845531|NCT01690988|2781875|P3|Overall Study|Sedated|2
845532|NCT01690988|2781876|P2|Overall Study|Sedated|1
845533|NCT01690988|2781877|P1|Overall Study|Sedated|1
845534|NCT01690988|2781875|P3|Overall Study|Death|1
845535|NCT01690988|2781876|P2|Overall Study|Death|1
845536|NCT01690988|2781877|P1|Overall Study|Death|1
845537|NCT01690988|2781875|P3|Overall Study|Determined ineligible|0
845538|NCT01690988|2781876|P2|Overall Study|Determined ineligible|0
845539|NCT01690988|2781877|P1|Overall Study|Determined ineligible|1
845540|NCT01690988|2781875|P3|Overall Study|Operation Cancelled|0
845541|NCT01690988|2781876|P2|Overall Study|Operation Cancelled|1
845542|NCT01690988|2781877|P1|Overall Study|Operation Cancelled|1
845543|NCT01690988|2781875|P3|Overall Study|Physician Decision|1
845544|NCT01690988|2781876|P2|Overall Study|Physician Decision|0
845545|NCT01690988|2781877|P1|Overall Study|Physician Decision|0
845546|NCT01690988|2781875|P3|Overall Study|Withdrawal by Subject|3
845547|NCT01690988|2781876|P2|Overall Study|Withdrawal by Subject|2
845548|NCT01690988|2781877|P1|Overall Study|Withdrawal by Subject|2
845549|NCT01690299|2781945|P6|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1
845550|NCT01690299|2781946|P5|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
845551|NCT01690299|2781947|P4|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
845552|NCT01690299|2781948|P3|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
845553|NCT01690299|2781949|P2|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
845554|NCT01690299|2781950|P1|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
845555|NCT01690299|2781945|P6|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
845556|NCT01690299|2781946|P5|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13
845557|NCT01690299|2781947|P4|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
845558|NCT01690299|2781948|P3|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
845559|NCT01690299|2781949|P2|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
845560|NCT01690299|2781950|P1|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
845561|NCT01690299|2781945|P6|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11
845562|NCT01690299|2781946|P5|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5
845563|NCT01690299|2781947|P4|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8
845564|NCT01690299|2781948|P3|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
845565|NCT01690299|2781949|P2|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
845644|NCT01689363|2782290|P2|Overall Study|Protocol Violation|1
845566|NCT01690299|2781950|P1|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
845567|NCT01690299|2781945|P6|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
845568|NCT01690299|2781946|P5|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
845569|NCT01690299|2781947|P4|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
845570|NCT01690299|2781948|P3|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
845571|NCT01690299|2781949|P2|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
845572|NCT01690299|2781950|P1|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
845573|NCT01690299|2781945|P6|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8
845574|NCT01690299|2781946|P5|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10
845575|NCT01690299|2781947|P4|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9
845576|NCT01690299|2781948|P3|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
845577|NCT01690299|2781949|P2|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
845578|NCT01690299|2781950|P1|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
845579|NCT01690299|2781945|P6|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
845580|NCT01690299|2781946|P5|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4
845581|NCT01690299|2781947|P4|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
845582|NCT01690299|2781948|P3|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
845583|NCT01690299|2781949|P2|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
845584|NCT01690299|2781950|P1|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
845585|NCT01690299|2781945|P6|Placebo-controlled Phase (Weeks 0-16)|Other|0
845586|NCT01690299|2781946|P5|Placebo-controlled Phase (Weeks 0-16)|Other|0
845587|NCT01690299|2781947|P4|Placebo-controlled Phase (Weeks 0-16)|Other|0
845588|NCT01690299|2781948|P3|Placebo-controlled Phase (Weeks 0-16)|Other|1
845589|NCT01690299|2781949|P2|Placebo-controlled Phase (Weeks 0-16)|Other|1
845590|NCT01690299|2781950|P1|Placebo-controlled Phase (Weeks 0-16)|Other|2
845591|NCT01690299|2781945|P6|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
845592|NCT01690299|2781946|P5|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
845593|NCT01690299|2781947|P4|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
845594|NCT01690299|2781948|P3|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
845595|NCT01690299|2781949|P2|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3
845596|NCT01690299|2781950|P1|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1
845597|NCT01690299|2781945|P6|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
845598|NCT01690299|2781946|P5|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
845599|NCT01690299|2781947|P4|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
845600|NCT01690299|2781948|P3|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
845601|NCT01690299|2781949|P2|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
845602|NCT01690299|2781950|P1|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4
845603|NCT01690299|2781945|P6|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
845604|NCT01690299|2781946|P5|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
845605|NCT01690299|2781947|P4|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
845606|NCT01690299|2781948|P3|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1
845607|NCT01690299|2781949|P2|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
845608|NCT01690299|2781950|P1|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
845609|NCT01690143|2782047|P1|Overall Study|Withdrawal by Subject|1
845610|NCT01690130|2782057|P2|Overall Study|Subject have cancelled visit.|0
845611|NCT01690130|2782058|P1|Overall Study|Subject have cancelled visit.|1
845612|NCT01690052|2782105|P2|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2
845613|NCT01690052|2782106|P1|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1
845614|NCT01689974|2782123|P2|Overall Study|Termination of Study|5
845615|NCT01689974|2782124|P1|Overall Study|Termination of Study|5
845616|NCT01689857|2782153|P2|Overall Study|Lost to Follow-up|2
845617|NCT01689857|2782154|P1|Overall Study|Lost to Follow-up|5
845618|NCT01689649|2782179|P1|Overall Study|Lost to Follow-up|5
845619|NCT01689649|2782179|P1|Overall Study|Protocol Violation|3
845620|NCT01689649|2782179|P1|Overall Study|Non-compliance|11
845621|NCT01689649|2782179|P1|Overall Study|Lack of Efficacy|3
845622|NCT01689532|2782191|P2|Overall Study|Physician Decision|0
845623|NCT01689532|2782192|P1|Overall Study|Physician Decision|2
845624|NCT01689532|2782191|P2|Overall Study|Withdrawal by Subject|2
845625|NCT01689532|2782192|P1|Overall Study|Withdrawal by Subject|1
845626|NCT01689532|2782191|P2|Overall Study|Lack of Efficacy|2
845627|NCT01689532|2782192|P1|Overall Study|Lack of Efficacy|2
845628|NCT01689532|2782191|P2|Overall Study|Adverse Event|5
845629|NCT01689532|2782192|P1|Overall Study|Adverse Event|9
845630|NCT01689519|2782256|P2|Overall Study|Physician Decision|3
845631|NCT01689519|2782257|P1|Overall Study|Physician Decision|0
845632|NCT01689519|2782256|P2|Overall Study|Withdrawal by Subject|17
845633|NCT01689519|2782257|P1|Overall Study|Withdrawal by Subject|17
845634|NCT01689519|2782256|P2|Overall Study|Lost to Follow-up|2
845635|NCT01689519|2782257|P1|Overall Study|Lost to Follow-up|6
845636|NCT01689519|2782256|P2|Overall Study|Death|116
845637|NCT01689519|2782257|P1|Overall Study|Death|143
845638|NCT01689363|2782284|P8|Overall Study|Protocol Violation|0
845639|NCT01689363|2782285|P7|Overall Study|Protocol Violation|0
845640|NCT01689363|2782286|P6|Overall Study|Protocol Violation|0
845641|NCT01689363|2782287|P5|Overall Study|Protocol Violation|0
845642|NCT01689363|2782288|P4|Overall Study|Protocol Violation|0
845643|NCT01689363|2782289|P3|Overall Study|Protocol Violation|0
845645|NCT01689363|2782291|P1|Overall Study|Protocol Violation|0
845646|NCT01689337|2782346|P1|Overall Study|Study Discontinuation|1
845647|NCT01689207|2782385|P11|Overall Study|Adverse Event|0
845648|NCT01689207|2782386|P10|Overall Study|Adverse Event|0
845649|NCT01689207|2782387|P9|Overall Study|Adverse Event|1
845650|NCT01689207|2782388|P8|Overall Study|Adverse Event|0
845651|NCT01689207|2782389|P7|Overall Study|Adverse Event|0
845652|NCT01689207|2782390|P6|Overall Study|Adverse Event|1
845653|NCT01689207|2782391|P5|Overall Study|Adverse Event|2
845654|NCT01689207|2782392|P4|Overall Study|Adverse Event|0
845655|NCT01689207|2782393|P3|Overall Study|Adverse Event|0
845656|NCT01689207|2782394|P2|Overall Study|Adverse Event|1
845657|NCT01689207|2782395|P1|Overall Study|Adverse Event|0
845658|NCT01688921|2782502|P2|Overall Study|informed consent|0
845659|NCT01688921|2782503|P1|Overall Study|informed consent|3
845660|NCT01688921|2782502|P2|Overall Study|Protocol Violation|1
845661|NCT01688921|2782503|P1|Overall Study|Protocol Violation|0
845662|NCT01688921|2782502|P2|Overall Study|Physician Decision|1
845663|NCT01688921|2782503|P1|Overall Study|Physician Decision|6
845664|NCT01688921|2782502|P2|Overall Study|Lost to Follow-up|13
845665|NCT01688921|2782503|P1|Overall Study|Lost to Follow-up|7
845666|NCT01688882|2782528|P2|Overall Study|Administrative problems|0
845667|NCT01688882|2782529|P1|Overall Study|Administrative problems|1
845668|NCT01688882|2782528|P2|Overall Study|Unsatisfactory therapeutic effect|1
845669|NCT01688882|2782529|P1|Overall Study|Unsatisfactory therapeutic effect|1
845670|NCT01688882|2782528|P2|Overall Study|Adverse Event|0
845671|NCT01688882|2782529|P1|Overall Study|Adverse Event|1
845672|NCT01688830|2782574|P21|Overall Study|Lost to Follow-up|0
845673|NCT01688830|2782575|P20|Overall Study|Lost to Follow-up|0
845674|NCT01688830|2782576|P19|Overall Study|Lost to Follow-up|0
845675|NCT01688830|2782577|P18|Overall Study|Lost to Follow-up|0
845676|NCT01688830|2782578|P17|Overall Study|Lost to Follow-up|0
845677|NCT01688830|2782579|P16|Overall Study|Lost to Follow-up|0
845678|NCT01688830|2782580|P15|Overall Study|Lost to Follow-up|0
845679|NCT01688830|2782581|P14|Overall Study|Lost to Follow-up|0
845680|NCT01688830|2782582|P13|Overall Study|Lost to Follow-up|0
845681|NCT01688830|2782583|P12|Overall Study|Lost to Follow-up|0
845682|NCT01688830|2782584|P11|Overall Study|Lost to Follow-up|1
845683|NCT01688830|2782585|P10|Overall Study|Lost to Follow-up|0
845684|NCT01688830|2782586|P9|Overall Study|Lost to Follow-up|0
845685|NCT01688830|2782587|P8|Overall Study|Lost to Follow-up|0
845686|NCT01688830|2782588|P7|Overall Study|Lost to Follow-up|0
845687|NCT01688830|2782589|P6|Overall Study|Lost to Follow-up|0
845688|NCT01688830|2782590|P5|Overall Study|Lost to Follow-up|0
845689|NCT01688830|2782591|P4|Overall Study|Lost to Follow-up|0
845690|NCT01688830|2782592|P3|Overall Study|Lost to Follow-up|0
845691|NCT01688830|2782593|P2|Overall Study|Lost to Follow-up|0
845692|NCT01688830|2782594|P1|Overall Study|Lost to Follow-up|0
845693|NCT01688726|2782740|P2|Overall Study|Relocated abroad|1
845694|NCT01688726|2782741|P1|Overall Study|Relocated abroad|0
845695|NCT01688726|2782740|P2|Overall Study|Adverse Event|0
845696|NCT01688726|2782741|P1|Overall Study|Adverse Event|1
845697|NCT01688635|2782753|P2|Washout 3|Withdrawal by Subject|0
845698|NCT01688635|2782754|P1|Washout 3|Withdrawal by Subject|1
845699|NCT01688635|2782753|P2|Washout 2|Sponsor Decision|2
845700|NCT01688635|2782754|P1|Washout 2|Sponsor Decision|1
845701|NCT01688635|2782753|P2|Washout 2|Withdrawal by Subject|0
845702|NCT01688635|2782754|P1|Washout 2|Withdrawal by Subject|1
845703|NCT01688635|2782753|P2|Washout 2|Physician Decision|0
845704|NCT01688635|2782754|P1|Washout 2|Physician Decision|1
845705|NCT01688635|2782753|P2|Washout 1|Physician Decision|1
845706|NCT01688635|2782754|P1|Washout 1|Physician Decision|0
845707|NCT01688635|2782753|P2|Washout 1|Adverse Event|1
845708|NCT01688635|2782754|P1|Washout 1|Adverse Event|0
845709|NCT01688635|2782753|P2|Washout 1|Withdrawal by Subject|0
845710|NCT01688635|2782754|P1|Washout 1|Withdrawal by Subject|1
845711|NCT01688466|2782776|P2|Overall Study|Not evaluable|1
845712|NCT01688466|2782777|P1|Overall Study|Not evaluable|0
845713|NCT01688466|2782776|P2|Overall Study|Adverse Event|4
845714|NCT01688466|2782777|P1|Overall Study|Adverse Event|0
845715|NCT01688466|2782776|P2|Overall Study|Death|1
845716|NCT01688466|2782777|P1|Overall Study|Death|0
845717|NCT01688466|2782776|P2|Overall Study|Withdrawal by Subject|1
845718|NCT01688466|2782777|P1|Overall Study|Withdrawal by Subject|2
845719|NCT01688050|2782847|P1|Overall Study|Still be eligible for follow-up|37
845720|NCT01688050|2782847|P1|Overall Study|Withdrawal by Subject|2
845721|NCT01688050|2782847|P1|Overall Study|Lost to Follow-up|5
845722|NCT01688050|2782847|P1|Overall Study|Conversion to open repair|1
845723|NCT01688050|2782847|P1|Overall Study|Death|5
845724|NCT01688037|2782856|P3|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
845725|NCT01688037|2782857|P2|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1
845726|NCT01688037|2782858|P1|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
845727|NCT01688037|2782856|P3|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1
845728|NCT01688037|2782857|P2|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
845729|NCT01688037|2782858|P1|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
845730|NCT01688037|2782856|P3|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0
845731|NCT01688037|2782857|P2|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2
845732|NCT01688037|2782858|P1|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1
845733|NCT01688037|2782856|P3|Open-Label Period (Week 6 to 12)|Non-compliance|2
845734|NCT01688037|2782857|P2|Open-Label Period (Week 6 to 12)|Non-compliance|0
845735|NCT01688037|2782858|P1|Open-Label Period (Week 6 to 12)|Non-compliance|0
845736|NCT01688037|2782856|P3|Open-Label Period (Week 6 to 12)|Adverse Event|1
845737|NCT01688037|2782857|P2|Open-Label Period (Week 6 to 12)|Adverse Event|1
845738|NCT01688037|2782858|P1|Open-Label Period (Week 6 to 12)|Adverse Event|4
845739|NCT01688037|2782856|P3|Double-Blind Period (Week 0 to 6)|Physician Decision|0
845740|NCT01688037|2782857|P2|Double-Blind Period (Week 0 to 6)|Physician Decision|1
845741|NCT01688037|2782858|P1|Double-Blind Period (Week 0 to 6)|Physician Decision|0
845742|NCT01688037|2782856|P3|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
845743|NCT01688037|2782857|P2|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
845744|NCT01688037|2782858|P1|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
845745|NCT01688037|2782856|P3|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
845746|NCT01688037|2782857|P2|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0
845747|NCT01688037|2782858|P1|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4
845748|NCT01688037|2782856|P3|Double-Blind Period (Week 0 to 6)|Non-compliance|3
845749|NCT01688037|2782857|P2|Double-Blind Period (Week 0 to 6)|Non-compliance|2
845750|NCT01688037|2782858|P1|Double-Blind Period (Week 0 to 6)|Non-compliance|1
845751|NCT01688037|2782856|P3|Double-Blind Period (Week 0 to 6)|Adverse Event|1
845752|NCT01688037|2782857|P2|Double-Blind Period (Week 0 to 6)|Adverse Event|0
845753|NCT01688037|2782858|P1|Double-Blind Period (Week 0 to 6)|Adverse Event|1
845754|NCT01687998|2782874|P2|Overall Study|Lost to Follow-up|7
845755|NCT01687998|2782875|P1|Overall Study|Lost to Follow-up|9
845756|NCT01687998|2782874|P2|Overall Study|Known to be Alive at Study End|62
845757|NCT01687998|2782875|P1|Overall Study|Known to be Alive at Study End|54
845758|NCT01687998|2782874|P2|Overall Study|Withdrawal by Subject|51
845759|NCT01687998|2782875|P1|Overall Study|Withdrawal by Subject|49
845760|NCT01687712|2782911|P2|Cycle 3|Miscarriage/Spontaneous Abortion|0
845761|NCT01687712|2782912|P1|Cycle 3|Miscarriage/Spontaneous Abortion|1
845762|NCT01687712|2782911|P2|Cycle 3|Ectopic Pregnancy|0
845763|NCT01687712|2782912|P1|Cycle 3|Ectopic Pregnancy|1
845764|NCT01687712|2782911|P2|Cycle 3|Early Pregnancy Loss|2
845765|NCT01687712|2782912|P1|Cycle 3|Early Pregnancy Loss|1
845766|NCT01687712|2782911|P2|Cycle 3|Not Biochemically Pregnant|22
845767|NCT01687712|2782912|P1|Cycle 3|Not Biochemically Pregnant|21
845768|NCT01687712|2782911|P2|Cycle 2|Miscarriage/Spontaneous Abortion|1
845769|NCT01687712|2782912|P1|Cycle 2|Miscarriage/Spontaneous Abortion|0
845770|NCT01687712|2782911|P2|Cycle 2|Still Birth|0
845771|NCT01687712|2782912|P1|Cycle 2|Still Birth|1
845772|NCT01687712|2782911|P2|Cycle 2|Ectopic Pregnancy|1
845773|NCT01687712|2782912|P1|Cycle 2|Ectopic Pregnancy|0
845774|NCT01687712|2782911|P2|Cycle 2|Early Pregnancy Loss|16
845775|NCT01687712|2782912|P1|Cycle 2|Early Pregnancy Loss|18
845776|NCT01687712|2782911|P2|Cycle 2|Not Biochemically Pregnant|77
845777|NCT01687712|2782912|P1|Cycle 2|Not Biochemically Pregnant|74
845778|NCT01687712|2782911|P2|Cycle 1|Lost to Follow-up|1
845779|NCT01687712|2782912|P1|Cycle 1|Lost to Follow-up|1
845780|NCT01687712|2782911|P2|Cycle 1|Intrauterine Fetal Death|1
845781|NCT01687712|2782912|P1|Cycle 1|Intrauterine Fetal Death|0
845782|NCT01687712|2782911|P2|Cycle 1|Abortion|0
845783|NCT01687712|2782912|P1|Cycle 1|Abortion|3
845784|NCT01687712|2782911|P2|Cycle 1|Miscarriage/Spontaneous Abortion|14
845785|NCT01687712|2782912|P1|Cycle 1|Miscarriage/Spontaneous Abortion|9
845786|NCT01687712|2782911|P2|Cycle 1|Heterotropic Pregnancy|0
845787|NCT01687712|2782912|P1|Cycle 1|Heterotropic Pregnancy|1
845788|NCT01687712|2782911|P2|Cycle 1|Ectopic Pregnancy|5
845789|NCT01687712|2782912|P1|Cycle 1|Ectopic Pregnancy|5
845790|NCT01687712|2782911|P2|Cycle 1|Early Pregnancy Loss|60
845791|NCT01687712|2782912|P1|Cycle 1|Early Pregnancy Loss|43
845792|NCT01687712|2782911|P2|Cycle 1|Not Biochemically Pregnant|348
845793|NCT01687712|2782912|P1|Cycle 1|Not Biochemically Pregnant|386
845794|NCT01687478|2782952|P2|Overall Study|Entry Criteria Not Met|2
845795|NCT01687478|2782953|P1|Overall Study|Entry Criteria Not Met|6
845796|NCT01687478|2782952|P2|Overall Study|Physician Decision|3
845797|NCT01687478|2782953|P1|Overall Study|Physician Decision|1
845798|NCT01687478|2782952|P2|Overall Study|Withdrawal by Subject|19
845799|NCT01687478|2782953|P1|Overall Study|Withdrawal by Subject|21
845800|NCT01687478|2782952|P2|Overall Study|Protocol Violation|2
845801|NCT01687478|2782953|P1|Overall Study|Protocol Violation|0
845802|NCT01687478|2782952|P2|Overall Study|Lost to Follow-up|3
845803|NCT01687478|2782953|P1|Overall Study|Lost to Follow-up|1
845804|NCT01687478|2782952|P2|Overall Study|Adverse Event|10
845805|NCT01687478|2782953|P1|Overall Study|Adverse Event|3
845806|NCT01687296|2782988|P2|Overall Study|Withdrawal by Subject|3
845807|NCT01687296|2782989|P1|Overall Study|Withdrawal by Subject|6
845808|NCT01687296|2782988|P2|Overall Study|Protocol Violation|1
845809|NCT01687296|2782989|P1|Overall Study|Protocol Violation|0
845810|NCT01687296|2782988|P2|Overall Study|Lack of Efficacy|1
845811|NCT01687296|2782989|P1|Overall Study|Lack of Efficacy|1
845812|NCT01687283|2783011|P2|Overall Study|Withdrawal by Subject|8
845813|NCT01687283|2783012|P1|Overall Study|Withdrawal by Subject|9
845814|NCT01687283|2783011|P2|Overall Study|Investigator discretion|0
845815|NCT01687283|2783012|P1|Overall Study|Investigator discretion|2
845816|NCT01687283|2783011|P2|Overall Study|Lost to Follow-up|1
845817|NCT01687283|2783012|P1|Overall Study|Lost to Follow-up|1
845903|NCT01687166|2783152|P1|Overall Study|Attempt subject|2
845818|NCT01687283|2783011|P2|Overall Study|protocol defined stopping criteria|10
845819|NCT01687283|2783012|P1|Overall Study|protocol defined stopping criteria|8
845820|NCT01687283|2783011|P2|Overall Study|Protocol Violation|3
845821|NCT01687283|2783012|P1|Overall Study|Protocol Violation|1
845822|NCT01687283|2783011|P2|Overall Study|Lack of Efficacy|1
845823|NCT01687283|2783012|P1|Overall Study|Lack of Efficacy|3
845824|NCT01687283|2783011|P2|Overall Study|Adverse Event|4
845825|NCT01687283|2783012|P1|Overall Study|Adverse Event|11
845826|NCT01687270|2783035|P1|Overall Study|Lost to Follow-up|1
845827|NCT01687270|2783035|P1|Overall Study|Lack of Efficacy|11
845828|NCT01687257|2783046|P3|Overall Study|Investigator's Discretion|0
845829|NCT01687257|2783047|P2|Overall Study|Investigator's Discretion|3
845830|NCT01687257|2783048|P1|Overall Study|Investigator's Discretion|0
845831|NCT01687257|2783046|P3|Overall Study|Adverse Event|0
845832|NCT01687257|2783047|P2|Overall Study|Adverse Event|0
845833|NCT01687257|2783048|P1|Overall Study|Adverse Event|1
845834|NCT01687257|2783046|P3|Overall Study|Subject Withdrew Consent|1
845835|NCT01687257|2783047|P2|Overall Study|Subject Withdrew Consent|1
845836|NCT01687257|2783048|P1|Overall Study|Subject Withdrew Consent|1
845837|NCT01687257|2783046|P3|Overall Study|Efficacy Failure|5
845838|NCT01687257|2783047|P2|Overall Study|Efficacy Failure|0
845839|NCT01687257|2783048|P1|Overall Study|Efficacy Failure|6
845840|NCT01687218|2783113|P6|Overall Study|Relocated, no follow-up planned|0
845841|NCT01687218|2783114|P5|Overall Study|Relocated, no follow-up planned|0
845842|NCT01687218|2783115|P4|Overall Study|Relocated, no follow-up planned|1
845843|NCT01687218|2783116|P3|Overall Study|Relocated, no follow-up planned|1
845844|NCT01687218|2783117|P2|Overall Study|Relocated, no follow-up planned|0
845845|NCT01687218|2783118|P1|Overall Study|Relocated, no follow-up planned|1
845846|NCT01687218|2783113|P6|Overall Study|Withdrawal by Subject|0
845847|NCT01687218|2783114|P5|Overall Study|Withdrawal by Subject|1
845848|NCT01687218|2783115|P4|Overall Study|Withdrawal by Subject|1
845849|NCT01687218|2783116|P3|Overall Study|Withdrawal by Subject|0
845850|NCT01687218|2783117|P2|Overall Study|Withdrawal by Subject|3
845851|NCT01687218|2783118|P1|Overall Study|Withdrawal by Subject|2
845852|NCT01687166|2783149|P4|Overall Study|Insurance|1
845853|NCT01687166|2783150|P3|Overall Study|Insurance|1
845854|NCT01687166|2783151|P2|Overall Study|Insurance|0
845855|NCT01687166|2783152|P1|Overall Study|Insurance|0
845856|NCT01687166|2783149|P4|Overall Study|Physician choice to use different device|0
845857|NCT01687166|2783150|P3|Overall Study|Physician choice to use different device|4
845858|NCT01687166|2783151|P2|Overall Study|Physician choice to use different device|2
845859|NCT01687166|2783152|P1|Overall Study|Physician choice to use different device|1
845860|NCT01687166|2783149|P4|Overall Study|Patient unable to be compliant|0
845861|NCT01687166|2783150|P3|Overall Study|Patient unable to be compliant|0
845862|NCT01687166|2783151|P2|Overall Study|Patient unable to be compliant|0
845863|NCT01687166|2783152|P1|Overall Study|Patient unable to be compliant|1
845864|NCT01687166|2783149|P4|Overall Study|Subject moved out of state|0
845865|NCT01687166|2783150|P3|Overall Study|Subject moved out of state|0
845866|NCT01687166|2783151|P2|Overall Study|Subject moved out of state|1
845867|NCT01687166|2783152|P1|Overall Study|Subject moved out of state|0
845868|NCT01687166|2783149|P4|Overall Study|Protocol Violation|0
845869|NCT01687166|2783150|P3|Overall Study|Protocol Violation|1
845870|NCT01687166|2783151|P2|Overall Study|Protocol Violation|1
845871|NCT01687166|2783152|P1|Overall Study|Protocol Violation|1
845872|NCT01687166|2783149|P4|Overall Study|Death|0
845873|NCT01687166|2783150|P3|Overall Study|Death|0
845874|NCT01687166|2783151|P2|Overall Study|Death|1
845875|NCT01687166|2783152|P1|Overall Study|Death|1
845876|NCT01687166|2783149|P4|Overall Study|Equipment/Device Availability|0
845877|NCT01687166|2783150|P3|Overall Study|Equipment/Device Availability|0
845878|NCT01687166|2783151|P2|Overall Study|Equipment/Device Availability|1
845879|NCT01687166|2783152|P1|Overall Study|Equipment/Device Availability|0
845880|NCT01687166|2783149|P4|Overall Study|Lost to Follow-up|0
845881|NCT01687166|2783150|P3|Overall Study|Lost to Follow-up|1
845882|NCT01687166|2783151|P2|Overall Study|Lost to Follow-up|5
845883|NCT01687166|2783152|P1|Overall Study|Lost to Follow-up|2
845884|NCT01687166|2783149|P4|Overall Study|Withdrawal by Subject|0
845885|NCT01687166|2783150|P3|Overall Study|Withdrawal by Subject|3
845886|NCT01687166|2783151|P2|Overall Study|Withdrawal by Subject|4
845887|NCT01687166|2783152|P1|Overall Study|Withdrawal by Subject|11
845888|NCT01687166|2783149|P4|Overall Study|Physician Decision|0
845889|NCT01687166|2783150|P3|Overall Study|Physician Decision|1
845890|NCT01687166|2783151|P2|Overall Study|Physician Decision|2
845891|NCT01687166|2783152|P1|Overall Study|Physician Decision|3
845892|NCT01687166|2783149|P4|Overall Study|Adverse Event|0
845893|NCT01687166|2783150|P3|Overall Study|Adverse Event|0
845894|NCT01687166|2783151|P2|Overall Study|Adverse Event|1
845895|NCT01687166|2783152|P1|Overall Study|Adverse Event|2
845896|NCT01687166|2783149|P4|Overall Study|Did not meet eligibility criteria|1
845897|NCT01687166|2783150|P3|Overall Study|Did not meet eligibility criteria|1
845898|NCT01687166|2783151|P2|Overall Study|Did not meet eligibility criteria|6
845899|NCT01687166|2783152|P1|Overall Study|Did not meet eligibility criteria|4
845900|NCT01687166|2783149|P4|Overall Study|Attempt subject|0
845901|NCT01687166|2783150|P3|Overall Study|Attempt subject|2
845902|NCT01687166|2783151|P2|Overall Study|Attempt subject|3
845904|NCT01687101|2783168|P1|Overall Study|Lost to Follow-up|7
845905|NCT01686958|2783193|P1|Overall Study|Withdrawal by Subject|1
845906|NCT01686932|2783206|P2|Period 1|Adverse Event|1
845907|NCT01686932|2783207|P1|Period 1|Adverse Event|1
845908|NCT01686828|2783237|P4|Overall Study|Weight Loss|0
845909|NCT01686828|2783238|P3|Overall Study|Weight Loss|1
845910|NCT01686828|2783239|P2|Overall Study|Weight Loss|0
845911|NCT01686828|2783240|P1|Overall Study|Weight Loss|0
845912|NCT01686828|2783237|P4|Overall Study|New Job|0
845913|NCT01686828|2783238|P3|Overall Study|New Job|0
845914|NCT01686828|2783239|P2|Overall Study|New Job|1
845915|NCT01686828|2783240|P1|Overall Study|New Job|0
845916|NCT01686828|2783237|P4|Overall Study|Physician Decision|0
845917|NCT01686828|2783238|P3|Overall Study|Physician Decision|0
845918|NCT01686828|2783239|P2|Overall Study|Physician Decision|0
845919|NCT01686828|2783240|P1|Overall Study|Physician Decision|1
845920|NCT01686633|2783314|P3|Overall Study|Lost to Follow-up|1
845921|NCT01686633|2783315|P2|Overall Study|Lost to Follow-up|1
845922|NCT01686633|2783316|P1|Overall Study|Lost to Follow-up|0
845923|NCT01686633|2783314|P3|Overall Study|Protocol-defined Stopping Criteria|1
845924|NCT01686633|2783315|P2|Overall Study|Protocol-defined Stopping Criteria|0
845925|NCT01686633|2783316|P1|Overall Study|Protocol-defined Stopping Criteria|1
845926|NCT01686633|2783314|P3|Overall Study|Protocol Violation|0
845927|NCT01686633|2783315|P2|Overall Study|Protocol Violation|3
845928|NCT01686633|2783316|P1|Overall Study|Protocol Violation|2
845929|NCT01686633|2783314|P3|Overall Study|Adverse Event|3
845930|NCT01686633|2783315|P2|Overall Study|Adverse Event|3
845931|NCT01686633|2783316|P1|Overall Study|Adverse Event|4
845932|NCT01686633|2783314|P3|Overall Study|Physician Decision|4
845933|NCT01686633|2783315|P2|Overall Study|Physician Decision|4
845934|NCT01686633|2783316|P1|Overall Study|Physician Decision|3
845935|NCT01686633|2783314|P3|Overall Study|Withdrawal by Subject|5
845936|NCT01686633|2783315|P2|Overall Study|Withdrawal by Subject|8
845937|NCT01686633|2783316|P1|Overall Study|Withdrawal by Subject|8
845938|NCT01686633|2783314|P3|Overall Study|Lack of Efficacy|11
845939|NCT01686633|2783315|P2|Overall Study|Lack of Efficacy|13
845940|NCT01686633|2783316|P1|Overall Study|Lack of Efficacy|33
845941|NCT01686581|2783339|P1|Overall Study|Reason Missing|1
845942|NCT01686581|2783339|P1|Overall Study|Other Miscellaneous Reasons|36
845943|NCT01686581|2783339|P1|Overall Study|Thinks it is Inconvenient|17
845944|NCT01686581|2783339|P1|Overall Study|Trying to get Pregnant or Nursing|2
845945|NCT01686581|2783339|P1|Overall Study|Thinks Injections Take Too Much Time|2
845946|NCT01686581|2783339|P1|Overall Study|Thinks Injections Too Painful|8
845947|NCT01686581|2783339|P1|Overall Study|Participant Concerned about Risks|6
845948|NCT01686581|2783339|P1|Overall Study|Lack of Efficacy|90
845949|NCT01686581|2783339|P1|Overall Study|Side-effects or Health Problems|15
845950|NCT01686568|2783352|P2|Sub-Study|Not consented for sub-study|2
845951|NCT01686568|2783353|P1|Sub-Study|Not consented for sub-study|2
845952|NCT01686568|2783352|P2|Main Study|Liver enzymes above range of exclusion|0
845953|NCT01686568|2783353|P1|Main Study|Liver enzymes above range of exclusion|1
845954|NCT01686568|2783352|P2|Main Study|Noncompliance with protocol|1
845955|NCT01686568|2783353|P1|Main Study|Noncompliance with protocol|0
845956|NCT01686568|2783352|P2|Main Study|Withdrawal by Subject|3
845957|NCT01686568|2783353|P1|Main Study|Withdrawal by Subject|1
845958|NCT01685983|2783445|P1|Overall Study|Other|7
845959|NCT01685983|2783445|P1|Overall Study|Noncompliance with Study Drug|1
845960|NCT01685983|2783445|P1|Overall Study|Physician Decision|13
845961|NCT01685983|2783445|P1|Overall Study|Progressive Disease|32
845962|NCT01685983|2783445|P1|Overall Study|Protocol Violation|2
845963|NCT01685983|2783445|P1|Overall Study|Withdrawal by Subject|19
845964|NCT01685983|2783445|P1|Overall Study|Death|1
845965|NCT01685983|2783445|P1|Overall Study|Adverse Event|7
845966|NCT01685840|2783457|P2|Overall Study|Had VAD, Dialysis or Transplant|17
845967|NCT01685840|2783458|P1|Overall Study|Had VAD, Dialysis or Transplant|11
845968|NCT01685840|2783457|P2|Overall Study|Futility|200
845969|NCT01685840|2783458|P1|Overall Study|Futility|197
845970|NCT01685840|2783457|P2|Overall Study|Withdrawal by Subject|17
845971|NCT01685840|2783458|P1|Overall Study|Withdrawal by Subject|14
845972|NCT01685840|2783457|P2|Overall Study|Physician Decision|7
845973|NCT01685840|2783458|P1|Overall Study|Physician Decision|3
845974|NCT01685840|2783457|P2|Overall Study|Lost to Follow-up|25
845975|NCT01685840|2783458|P1|Overall Study|Lost to Follow-up|27
845976|NCT01685840|2783457|P2|Overall Study|Death|66
845977|NCT01685840|2783458|P1|Overall Study|Death|77
845978|NCT01685801|2783502|P4|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
845979|NCT01685801|2783503|P3|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
845980|NCT01685801|2783504|P2|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
845981|NCT01685801|2783505|P1|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
845982|NCT01685801|2783502|P4|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1
845983|NCT01685801|2783503|P3|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
845984|NCT01685801|2783504|P2|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
845985|NCT01685801|2783505|P1|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
845986|NCT01685697|2783527|P2|Overall Study|Protocol Violation|3
845987|NCT01685697|2783528|P1|Overall Study|Protocol Violation|3
845988|NCT01685606|2783562|P1|Overall Study|Withdrawal by Subject|1
845989|NCT01685437|2783590|P1|Overall Study|Unable to make visits due to work|1
845990|NCT01685437|2783590|P1|Overall Study|Protocol Violation|4
845991|NCT01685437|2783590|P1|Overall Study|Adverse Event|1
845992|NCT01685437|2783590|P1|Overall Study|Lost to Follow-up|3
845993|NCT01685437|2783590|P1|Overall Study|Withdrawal by Subject|22
845994|NCT01685372|2783604|P2|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4
845995|NCT01685372|2783605|P1|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3
845996|NCT01685216|2783693|P1|Overall Study|Did not receive study drug|1
845997|NCT01685203|2783710|P7|Overall Study|Patient's decision|0
845998|NCT01685203|2783711|P6|Overall Study|Patient's decision|1
845999|NCT01685203|2783712|P5|Overall Study|Patient's decision|0
846000|NCT01685203|2783713|P4|Overall Study|Patient's decision|0
846001|NCT01685203|2783714|P3|Overall Study|Patient's decision|0
846002|NCT01685203|2783715|P2|Overall Study|Patient's decision|0
846003|NCT01685203|2783716|P1|Overall Study|Patient's decision|0
846004|NCT01685203|2783710|P7|Overall Study|Adverse event and withdrew consent|0
846005|NCT01685203|2783711|P6|Overall Study|Adverse event and withdrew consent|0
846006|NCT01685203|2783712|P5|Overall Study|Adverse event and withdrew consent|0
846007|NCT01685203|2783713|P4|Overall Study|Adverse event and withdrew consent|0
846008|NCT01685203|2783714|P3|Overall Study|Adverse event and withdrew consent|0
846009|NCT01685203|2783715|P2|Overall Study|Adverse event and withdrew consent|0
846010|NCT01685203|2783716|P1|Overall Study|Adverse event and withdrew consent|1
846011|NCT01685203|2783710|P7|Overall Study|Adverse Event|0
846012|NCT01685203|2783711|P6|Overall Study|Adverse Event|2
846013|NCT01685203|2783712|P5|Overall Study|Adverse Event|0
846014|NCT01685203|2783713|P4|Overall Study|Adverse Event|0
846015|NCT01685203|2783714|P3|Overall Study|Adverse Event|0
846016|NCT01685203|2783715|P2|Overall Study|Adverse Event|0
846017|NCT01685203|2783716|P1|Overall Study|Adverse Event|0
846018|NCT01685203|2783710|P7|Overall Study|Lost to Follow-up|0
846019|NCT01685203|2783711|P6|Overall Study|Lost to Follow-up|0
846020|NCT01685203|2783712|P5|Overall Study|Lost to Follow-up|0
846021|NCT01685203|2783713|P4|Overall Study|Lost to Follow-up|1
846022|NCT01685203|2783714|P3|Overall Study|Lost to Follow-up|0
846023|NCT01685203|2783715|P2|Overall Study|Lost to Follow-up|3
846024|NCT01685203|2783716|P1|Overall Study|Lost to Follow-up|3
846025|NCT01685060|2783760|P1|Overall Study|Death|8
846026|NCT01685060|2783760|P1|Overall Study|Lost to Follow-up|1
846027|NCT01685060|2783760|P1|Overall Study|Subject/guardian decision|20
846028|NCT01685060|2783760|P1|Overall Study|Physician Decision|14
846029|NCT01685060|2783760|P1|Overall Study|Progressive disease|69
846030|NCT01685060|2783760|P1|Overall Study|Adverse Event|12
846031|NCT01685060|2783760|P1|Overall Study|Rollover patients|16
846032|NCT01684930|2783786|P2|Overall Study|Withdrawal by Subject|1
846033|NCT01684930|2783787|P1|Overall Study|Withdrawal by Subject|3
846034|NCT01684878|2783807|P4|Part 2: Randomized Phase|Participant noncompliance|1
846035|NCT01684878|2783808|P3|Part 2: Randomized Phase|Participant noncompliance|0
846036|NCT01684878|2783809|P2|Part 2: Randomized Phase|Participant noncompliance|0
846037|NCT01684878|2783810|P1|Part 2: Randomized Phase|Participant noncompliance|0
846038|NCT01684878|2783807|P4|Part 2: Randomized Phase|Alive at data-cut|7
846039|NCT01684878|2783808|P3|Part 2: Randomized Phase|Alive at data-cut|13
846040|NCT01684878|2783809|P2|Part 2: Randomized Phase|Alive at data-cut|0
846041|NCT01684878|2783810|P1|Part 2: Randomized Phase|Alive at data-cut|0
846042|NCT01684878|2783807|P4|Part 2: Randomized Phase|Death|68
846043|NCT01684878|2783808|P3|Part 2: Randomized Phase|Death|62
846044|NCT01684878|2783809|P2|Part 2: Randomized Phase|Death|0
846045|NCT01684878|2783810|P1|Part 2: Randomized Phase|Death|0
846046|NCT01684878|2783807|P4|Part 2: Randomized Phase|Lost to Follow-up|0
846047|NCT01684878|2783808|P3|Part 2: Randomized Phase|Lost to Follow-up|2
846048|NCT01684878|2783809|P2|Part 2: Randomized Phase|Lost to Follow-up|0
846049|NCT01684878|2783810|P1|Part 2: Randomized Phase|Lost to Follow-up|0
846050|NCT01684878|2783807|P4|Part 2: Randomized Phase|Participant withdrew consent|2
846051|NCT01684878|2783808|P3|Part 2: Randomized Phase|Participant withdrew consent|1
846052|NCT01684878|2783809|P2|Part 2: Randomized Phase|Participant withdrew consent|0
846053|NCT01684878|2783810|P1|Part 2: Randomized Phase|Participant withdrew consent|0
846054|NCT01684878|2783807|P4|Part 1: Safety Run in Phase|Lost to Follow-up|0
846055|NCT01684878|2783808|P3|Part 1: Safety Run in Phase|Lost to Follow-up|0
846056|NCT01684878|2783809|P2|Part 1: Safety Run in Phase|Lost to Follow-up|2
846057|NCT01684878|2783810|P1|Part 1: Safety Run in Phase|Lost to Follow-up|0
846058|NCT01684878|2783807|P4|Part 1: Safety Run in Phase|Death|0
846059|NCT01684878|2783808|P3|Part 1: Safety Run in Phase|Death|0
846060|NCT01684878|2783809|P2|Part 1: Safety Run in Phase|Death|20
846061|NCT01684878|2783810|P1|Part 1: Safety Run in Phase|Death|15
846062|NCT01684878|2783807|P4|Part 1: Safety Run in Phase|Participants withdrawn consent|0
846063|NCT01684878|2783808|P3|Part 1: Safety Run in Phase|Participants withdrawn consent|0
846064|NCT01684878|2783809|P2|Part 1: Safety Run in Phase|Participants withdrawn consent|1
846065|NCT01684878|2783810|P1|Part 1: Safety Run in Phase|Participants withdrawn consent|1
846066|NCT01684423|2783914|P5|Overall Study|Withdrawal by Subject|0
846067|NCT01684423|2783915|P4|Overall Study|Withdrawal by Subject|0
846068|NCT01684423|2783916|P3|Overall Study|Withdrawal by Subject|1
846069|NCT01684423|2783917|P2|Overall Study|Withdrawal by Subject|0
846070|NCT01684423|2783918|P1|Overall Study|Withdrawal by Subject|0
846071|NCT01684215|2783975|P4|Overall Study|Ongoing at date of cut-off|38
846072|NCT01684215|2783976|P3|Overall Study|Ongoing at date of cut-off|4
846073|NCT01684215|2783977|P2|Overall Study|Ongoing at date of cut-off|0
846074|NCT01684215|2783978|P1|Overall Study|Ongoing at date of cut-off|0
846075|NCT01684215|2783975|P4|Overall Study|Death|1
846076|NCT01684215|2783976|P3|Overall Study|Death|0
846077|NCT01684215|2783977|P2|Overall Study|Death|0
846078|NCT01684215|2783978|P1|Overall Study|Death|0
846079|NCT01684215|2783975|P4|Overall Study|Other|0
846080|NCT01684215|2783976|P3|Overall Study|Other|1
846081|NCT01684215|2783977|P2|Overall Study|Other|0
846082|NCT01684215|2783978|P1|Overall Study|Other|0
846083|NCT01684215|2783975|P4|Overall Study|Objective progression or relapse|0
846084|NCT01684215|2783976|P3|Overall Study|Objective progression or relapse|0
846085|NCT01684215|2783977|P2|Overall Study|Objective progression or relapse|6
846086|NCT01684215|2783978|P1|Overall Study|Objective progression or relapse|5
846087|NCT01684215|2783975|P4|Overall Study|Adverse Event|4
846088|NCT01684215|2783976|P3|Overall Study|Adverse Event|1
846089|NCT01684215|2783977|P2|Overall Study|Adverse Event|0
846090|NCT01684215|2783978|P1|Overall Study|Adverse Event|1
846091|NCT01684046|2784052|P2|Period 1, First 30 Days|Adverse Event|2
846092|NCT01684046|2784053|P1|Period 1, First 30 Days|Adverse Event|0
846093|NCT01684033|2784059|P2|Period 2, Second 30 Days|Adverse Event|0
846094|NCT01684033|2784060|P1|Period 2, Second 30 Days|Adverse Event|1
846095|NCT01684033|2784059|P2|Period 1, First 30 Days|Lost to Follow-up|0
846096|NCT01684033|2784060|P1|Period 1, First 30 Days|Lost to Follow-up|1
846097|NCT01684033|2784059|P2|Period 1, First 30 Days|Withdrawal by Subject|0
846098|NCT01684033|2784060|P1|Period 1, First 30 Days|Withdrawal by Subject|1
846099|NCT01684033|2784059|P2|Period 1, First 30 Days|Noncompliance|0
846100|NCT01684033|2784060|P1|Period 1, First 30 Days|Noncompliance|1
846101|NCT01684033|2784059|P2|Period 1, First 30 Days|Adverse Event|1
846102|NCT01684033|2784060|P1|Period 1, First 30 Days|Adverse Event|1
846103|NCT01683838|2784094|P2|Overall Study|not specified|3
846104|NCT01683838|2784095|P1|Overall Study|not specified|4
846105|NCT01683838|2784094|P2|Overall Study|Lost to Follow-up|1
846106|NCT01683838|2784095|P1|Overall Study|Lost to Follow-up|1
846107|NCT01683838|2784094|P2|Overall Study|Withdrawal by Subject|5
846108|NCT01683838|2784095|P1|Overall Study|Withdrawal by Subject|6
846109|NCT01683838|2784094|P2|Overall Study|Protocol Violation|1
846110|NCT01683838|2784095|P1|Overall Study|Protocol Violation|3
846111|NCT01683838|2784094|P2|Overall Study|Adverse Event|2
846112|NCT01683838|2784095|P1|Overall Study|Adverse Event|12
846113|NCT01683604|2784135|P1|Overall Study|Other|2
846114|NCT01683604|2784135|P1|Overall Study|Lack of Efficacy|1
846115|NCT01683604|2784135|P1|Overall Study|Adverse Event|2
846116|NCT01683409|2784320|P5|Washout Period 2 (Weeks 29-32)|Physician Decision|0
846117|NCT01683409|2784321|P4|Washout Period 2 (Weeks 29-32)|Physician Decision|0
846118|NCT01683409|2784322|P3|Washout Period 2 (Weeks 29-32)|Physician Decision|1
846119|NCT01683409|2784323|P2|Washout Period 2 (Weeks 29-32)|Physician Decision|0
846120|NCT01683409|2784324|P1|Washout Period 2 (Weeks 29-32)|Physician Decision|0
846121|NCT01683409|2784320|P5|Washout Period 2 (Weeks 29-32)|Adverse Event|3
846122|NCT01683409|2784321|P4|Washout Period 2 (Weeks 29-32)|Adverse Event|0
846123|NCT01683409|2784322|P3|Washout Period 2 (Weeks 29-32)|Adverse Event|0
846124|NCT01683409|2784323|P2|Washout Period 2 (Weeks 29-32)|Adverse Event|0
846125|NCT01683409|2784324|P1|Washout Period 2 (Weeks 29-32)|Adverse Event|0
846126|NCT01683409|2784320|P5|Washout Period 1 (Weeks 25-28)|Adverse Event|2
846127|NCT01683409|2784321|P4|Washout Period 1 (Weeks 25-28)|Adverse Event|1
846128|NCT01683409|2784322|P3|Washout Period 1 (Weeks 25-28)|Adverse Event|0
846129|NCT01683409|2784323|P2|Washout Period 1 (Weeks 25-28)|Adverse Event|4
846130|NCT01683409|2784324|P1|Washout Period 1 (Weeks 25-28)|Adverse Event|0
846131|NCT01683409|2784320|P5|Washout Period 1 (Weeks 25-28)|Physician Decision|0
846132|NCT01683409|2784321|P4|Washout Period 1 (Weeks 25-28)|Physician Decision|0
846133|NCT01683409|2784322|P3|Washout Period 1 (Weeks 25-28)|Physician Decision|0
846134|NCT01683409|2784323|P2|Washout Period 1 (Weeks 25-28)|Physician Decision|0
846135|NCT01683409|2784324|P1|Washout Period 1 (Weeks 25-28)|Physician Decision|1
846136|NCT01683409|2784320|P5|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
846137|NCT01683409|2784321|P4|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
846138|NCT01683409|2784322|P3|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
846139|NCT01683409|2784323|P2|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
846140|NCT01683409|2784324|P1|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
846141|NCT01683409|2784320|P5|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
846142|NCT01683409|2784321|P4|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
846143|NCT01683409|2784322|P3|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
846144|NCT01683409|2784323|P2|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
846145|NCT01683409|2784324|P1|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
846146|NCT01683409|2784320|P5|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
846147|NCT01683409|2784321|P4|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
846148|NCT01683409|2784322|P3|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1
846149|NCT01683409|2784323|P2|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
846150|NCT01683409|2784324|P1|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
846151|NCT01683409|2784320|P5|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
846152|NCT01683409|2784321|P4|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
846153|NCT01683409|2784322|P3|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
846154|NCT01683409|2784323|P2|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
846241|NCT01682863|2784520|P1|Overall Study|Death|1
846155|NCT01683409|2784324|P1|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
846156|NCT01683409|2784320|P5|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
846157|NCT01683409|2784321|P4|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
846158|NCT01683409|2784322|P3|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
846159|NCT01683409|2784323|P2|Treatment Period (Weeks 1-24)|Lost to Follow-up|1
846160|NCT01683409|2784324|P1|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
846161|NCT01683409|2784320|P5|Treatment Period (Weeks 1-24)|Adverse Event|1
846162|NCT01683409|2784321|P4|Treatment Period (Weeks 1-24)|Adverse Event|1
846163|NCT01683409|2784322|P3|Treatment Period (Weeks 1-24)|Adverse Event|0
846164|NCT01683409|2784323|P2|Treatment Period (Weeks 1-24)|Adverse Event|3
846165|NCT01683409|2784324|P1|Treatment Period (Weeks 1-24)|Adverse Event|0
846166|NCT01683409|2784320|P5|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
846167|NCT01683409|2784321|P4|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
846168|NCT01683409|2784322|P3|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1
846169|NCT01683409|2784323|P2|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
846170|NCT01683409|2784324|P1|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
846171|NCT01683383|2784367|P2|Overall Study|Infant was not transported|0
846172|NCT01683383|2784368|P1|Overall Study|Infant was not transported|1
846173|NCT01683266|2784384|P2|Overall Study|Serious Adverse Event of Hypoglycemia|1
846174|NCT01683266|2784385|P1|Overall Study|Serious Adverse Event of Hypoglycemia|0
846175|NCT01683266|2784384|P2|Overall Study|Possibly Hypoglycemia|0
846176|NCT01683266|2784385|P1|Overall Study|Possibly Hypoglycemia|1
846177|NCT01683266|2784384|P2|Overall Study|Perceived Lack of Efficacy|1
846178|NCT01683266|2784385|P1|Overall Study|Perceived Lack of Efficacy|1
846179|NCT01683266|2784384|P2|Overall Study|Nonserious Hypoglycemia|3
846180|NCT01683266|2784385|P1|Overall Study|Nonserious Hypoglycemia|0
846181|NCT01683266|2784384|P2|Overall Study|Site Closure / Site Withdrawal|3
846182|NCT01683266|2784385|P1|Overall Study|Site Closure / Site Withdrawal|1
846183|NCT01683266|2784384|P2|Overall Study|Lost to Follow-up|0
846184|NCT01683266|2784385|P1|Overall Study|Lost to Follow-up|5
846185|NCT01683266|2784384|P2|Overall Study|Selection Criterion / Protocol Violation|5
846186|NCT01683266|2784385|P1|Overall Study|Selection Criterion / Protocol Violation|7
846187|NCT01683266|2784384|P2|Overall Study|Personal Reason|25
846188|NCT01683266|2784385|P1|Overall Study|Personal Reason|17
846189|NCT01683266|2784384|P2|Overall Study|Protocol Violation|6
846190|NCT01683266|2784385|P1|Overall Study|Protocol Violation|13
846191|NCT01683266|2784384|P2|Overall Study|Lack of Efficacy|2
846192|NCT01683266|2784385|P1|Overall Study|Lack of Efficacy|5
846193|NCT01683266|2784384|P2|Overall Study|Adverse Event|4
846194|NCT01683266|2784385|P1|Overall Study|Adverse Event|5
846195|NCT01683058|2784413|P1|Overall Study|Lack of Efficacy|2
846196|NCT01683058|2784413|P1|Overall Study|Withdrawal by Subject|7
846197|NCT01683058|2784413|P1|Overall Study|Subject Met Withdrawal Criteria|5
846198|NCT01683058|2784413|P1|Overall Study|Adverse Event|6
846199|NCT01683058|2784413|P1|Overall Study|Lost to Follow-up|9
846200|NCT01683019|2784444|P3|Overall Study|Withdrawal by Subject|4
846201|NCT01683019|2784445|P2|Overall Study|Withdrawal by Subject|1
846202|NCT01683019|2784446|P1|Overall Study|Withdrawal by Subject|2
846203|NCT01682876|2784469|P4|Overall Study|Other|1
846204|NCT01682876|2784470|P3|Overall Study|Other|1
846205|NCT01682876|2784471|P2|Overall Study|Other|0
846206|NCT01682876|2784472|P1|Overall Study|Other|1
846207|NCT01682876|2784469|P4|Overall Study|Withdrawal by Subject|2
846208|NCT01682876|2784470|P3|Overall Study|Withdrawal by Subject|0
846209|NCT01682876|2784471|P2|Overall Study|Withdrawal by Subject|0
846210|NCT01682876|2784472|P1|Overall Study|Withdrawal by Subject|4
846211|NCT01682876|2784469|P4|Overall Study|Protocol Violation|1
846212|NCT01682876|2784470|P3|Overall Study|Protocol Violation|1
846213|NCT01682876|2784471|P2|Overall Study|Protocol Violation|1
846214|NCT01682876|2784472|P1|Overall Study|Protocol Violation|1
846215|NCT01682876|2784469|P4|Overall Study|Lost to Follow-up|11
846216|NCT01682876|2784470|P3|Overall Study|Lost to Follow-up|9
846217|NCT01682876|2784471|P2|Overall Study|Lost to Follow-up|15
846218|NCT01682876|2784472|P1|Overall Study|Lost to Follow-up|11
846219|NCT01682876|2784469|P4|Overall Study|Adverse Event|1
846220|NCT01682876|2784470|P3|Overall Study|Adverse Event|0
846221|NCT01682876|2784471|P2|Overall Study|Adverse Event|0
846222|NCT01682876|2784472|P1|Overall Study|Adverse Event|0
846223|NCT01682876|2784469|P4|Overall Study|Administrative reason|3
846224|NCT01682876|2784470|P3|Overall Study|Administrative reason|0
846225|NCT01682876|2784471|P2|Overall Study|Administrative reason|4
846226|NCT01682876|2784472|P1|Overall Study|Administrative reason|4
846227|NCT01682863|2784518|P3|Overall Study|Physician Decision|1
846228|NCT01682863|2784519|P2|Overall Study|Physician Decision|0
846229|NCT01682863|2784520|P1|Overall Study|Physician Decision|0
846230|NCT01682863|2784518|P3|Overall Study|Adverse Event|2
846231|NCT01682863|2784519|P2|Overall Study|Adverse Event|1
846232|NCT01682863|2784520|P1|Overall Study|Adverse Event|0
846233|NCT01682863|2784518|P3|Overall Study|Technical problems|0
846234|NCT01682863|2784519|P2|Overall Study|Technical problems|0
846235|NCT01682863|2784520|P1|Overall Study|Technical problems|1
846236|NCT01682863|2784518|P3|Overall Study|Protocol deviation|1
846237|NCT01682863|2784519|P2|Overall Study|Protocol deviation|0
846238|NCT01682863|2784520|P1|Overall Study|Protocol deviation|1
846239|NCT01682863|2784518|P3|Overall Study|Death|4
846240|NCT01682863|2784519|P2|Overall Study|Death|3
846242|NCT01682863|2784518|P3|Overall Study|Lost to Follow-up|6
846243|NCT01682863|2784519|P2|Overall Study|Lost to Follow-up|1
846244|NCT01682863|2784520|P1|Overall Study|Lost to Follow-up|5
846245|NCT01682863|2784518|P3|Overall Study|Subject/guardian decision|10
846246|NCT01682863|2784519|P2|Overall Study|Subject/guardian decision|12
846247|NCT01682863|2784520|P1|Overall Study|Subject/guardian decision|19
846248|NCT01682837|2784549|P1|Baseline|Withdrawal by Subject|5
846249|NCT01682759|2784593|P2|Overall Study|Withdrawal by Subject|55
846250|NCT01682759|2784594|P1|Overall Study|Withdrawal by Subject|56
846251|NCT01682759|2784593|P2|Overall Study|Physician Decision|1
846252|NCT01682759|2784594|P1|Overall Study|Physician Decision|1
846253|NCT01682759|2784593|P2|Overall Study|Lost to Follow-up|13
846254|NCT01682759|2784594|P1|Overall Study|Lost to Follow-up|10
846255|NCT01682759|2784593|P2|Overall Study|Death|1
846256|NCT01682759|2784594|P1|Overall Study|Death|2
846257|NCT01682720|2784618|P4|Overall Study|Adverse Event|1
846258|NCT01682720|2784619|P3|Overall Study|Adverse Event|1
846259|NCT01682720|2784620|P2|Overall Study|Adverse Event|0
846260|NCT01682720|2784621|P1|Overall Study|Adverse Event|1
846261|NCT01682720|2784618|P4|Overall Study|Subject Withdrew Consent|2
846262|NCT01682720|2784619|P3|Overall Study|Subject Withdrew Consent|2
846263|NCT01682720|2784620|P2|Overall Study|Subject Withdrew Consent|0
846264|NCT01682720|2784621|P1|Overall Study|Subject Withdrew Consent|0
846265|NCT01682720|2784618|P4|Overall Study|Lost to Follow-up|6
846266|NCT01682720|2784619|P3|Overall Study|Lost to Follow-up|0
846267|NCT01682720|2784620|P2|Overall Study|Lost to Follow-up|1
846268|NCT01682720|2784621|P1|Overall Study|Lost to Follow-up|1
846269|NCT01682720|2784618|P4|Overall Study|Efficacy Failure|30
846270|NCT01682720|2784619|P3|Overall Study|Efficacy Failure|3
846271|NCT01682720|2784620|P2|Overall Study|Efficacy Failure|3
846272|NCT01682720|2784621|P1|Overall Study|Efficacy Failure|0
846273|NCT01682720|2784618|P4|Overall Study|Terminated by Sponsor|0
846274|NCT01682720|2784619|P3|Overall Study|Terminated by Sponsor|0
846275|NCT01682720|2784620|P2|Overall Study|Terminated by Sponsor|0
846276|NCT01682720|2784621|P1|Overall Study|Terminated by Sponsor|83
846277|NCT01682720|2784618|P4|Overall Study|Randomized but Not Treated|0
846278|NCT01682720|2784619|P3|Overall Study|Randomized but Not Treated|1
846279|NCT01682720|2784620|P2|Overall Study|Randomized but Not Treated|1
846280|NCT01682720|2784621|P1|Overall Study|Randomized but Not Treated|0
846281|NCT01682681|2784638|P1|Overall Study|Low compliance|13
846282|NCT01682681|2784638|P1|Overall Study|Other|21
846283|NCT01682681|2784638|P1|Overall Study|tapering of topiramate|5
846284|NCT01682681|2784638|P1|Overall Study|Adverse Event|46
846285|NCT01682681|2784638|P1|Overall Study|Lost to Follow-up|174
846286|NCT01682681|2784638|P1|Overall Study|Moved to other hospital|10
846287|NCT01682681|2784638|P1|Overall Study|Withdrawal by Subject|1
846288|NCT01682681|2784638|P1|Overall Study|Lack of Efficacy|62
846289|NCT01682603|2784667|P1|Overall Study|Lost to Follow-up|3
846290|NCT01682512|2784712|P3|Overall Study|Other than stated above|2
846291|NCT01682512|2784713|P2|Overall Study|Other than stated above|4
846292|NCT01682512|2784714|P1|Overall Study|Other than stated above|2
846293|NCT01682512|2784712|P3|Overall Study|Secondary lack of efficacy|0
846294|NCT01682512|2784713|P2|Overall Study|Secondary lack of efficacy|1
846295|NCT01682512|2784714|P1|Overall Study|Secondary lack of efficacy|1
846296|NCT01682512|2784712|P3|Overall Study|Primary lack of efficacy|7
846297|NCT01682512|2784713|P2|Overall Study|Primary lack of efficacy|7
846298|NCT01682512|2784714|P1|Overall Study|Primary lack of efficacy|10
846299|NCT01682512|2784712|P3|Overall Study|Protocol Violation|2
846300|NCT01682512|2784713|P2|Overall Study|Protocol Violation|3
846301|NCT01682512|2784714|P1|Overall Study|Protocol Violation|2
846302|NCT01682512|2784712|P3|Overall Study|Lost to Follow-up|2
846303|NCT01682512|2784713|P2|Overall Study|Lost to Follow-up|0
846304|NCT01682512|2784714|P1|Overall Study|Lost to Follow-up|3
846305|NCT01682512|2784712|P3|Overall Study|Study terminated by sponsor|0
846306|NCT01682512|2784713|P2|Overall Study|Study terminated by sponsor|43
846307|NCT01682512|2784714|P1|Overall Study|Study terminated by sponsor|46
846308|NCT01682512|2784712|P3|Overall Study|Physician Decision|0
846309|NCT01682512|2784713|P2|Overall Study|Physician Decision|2
846310|NCT01682512|2784714|P1|Overall Study|Physician Decision|0
846311|NCT01682512|2784712|P3|Overall Study|Withdrawal by Subject|3
846312|NCT01682512|2784713|P2|Overall Study|Withdrawal by Subject|6
846313|NCT01682512|2784714|P1|Overall Study|Withdrawal by Subject|2
846314|NCT01682512|2784712|P3|Overall Study|Adverse Event|2
846315|NCT01682512|2784713|P2|Overall Study|Adverse Event|5
846316|NCT01682512|2784714|P1|Overall Study|Adverse Event|6
846317|NCT01682460|2784739|P1|Overall Study|Did not meet inclusion criteria|2
846318|NCT01682460|2784739|P1|Overall Study|Withdrawal by Subject|2
846319|NCT01682083|2784793|P2|Overall Study|Physician Decision|4
846320|NCT01682083|2784794|P1|Overall Study|Physician Decision|5
846321|NCT01682083|2784793|P2|Overall Study|Death|93
846322|NCT01682083|2784794|P1|Overall Study|Death|60
846323|NCT01682083|2784793|P2|Overall Study|Withdrawal by Subject|40
846324|NCT01682083|2784794|P1|Overall Study|Withdrawal by Subject|31
846325|NCT01682083|2784793|P2|Overall Study|Lost to Follow-up|18
846326|NCT01682083|2784794|P1|Overall Study|Lost to Follow-up|11
846327|NCT01682044|2784806|P1|Overall Study|Progression|3
846328|NCT01682044|2784806|P1|Overall Study|Death|1
846329|NCT01682031|2784818|P2|Overall Study|Patient stopped selenium on his own|1
846330|NCT01682031|2784819|P1|Overall Study|Patient stopped selenium on his own|0
846331|NCT01682031|2784818|P2|Overall Study|Patient could not swallow tablets|0
846332|NCT01682031|2784819|P1|Overall Study|Patient could not swallow tablets|1
846333|NCT01682031|2784818|P2|Overall Study|MRI results indicate increased nodul|1
846334|NCT01682031|2784819|P1|Overall Study|MRI results indicate increased nodul|0
846335|NCT01682031|2784818|P2|Overall Study|Adverse Event|2
846336|NCT01682031|2784819|P1|Overall Study|Adverse Event|0
846337|NCT01682031|2784818|P2|Overall Study|Withdrawal by Subject|1
846338|NCT01682031|2784819|P1|Overall Study|Withdrawal by Subject|0
846339|NCT01681992|2784842|P3|Overall Study|Withdrawal by Subject|25
846340|NCT01681992|2784843|P2|Overall Study|Withdrawal by Subject|30
846341|NCT01681992|2784844|P1|Overall Study|Withdrawal by Subject|27
846342|NCT01681992|2784842|P3|Overall Study|Protocol Violation|1
846343|NCT01681992|2784843|P2|Overall Study|Protocol Violation|0
846344|NCT01681992|2784844|P1|Overall Study|Protocol Violation|0
846345|NCT01681992|2784842|P3|Overall Study|As Per Sponsor Decision|1
846346|NCT01681992|2784843|P2|Overall Study|As Per Sponsor Decision|0
846347|NCT01681992|2784844|P1|Overall Study|As Per Sponsor Decision|0
846348|NCT01681992|2784842|P3|Overall Study|Lost to Follow-up|53
846349|NCT01681992|2784843|P2|Overall Study|Lost to Follow-up|38
846350|NCT01681992|2784844|P1|Overall Study|Lost to Follow-up|36
846351|NCT01681992|2784842|P3|Overall Study|Adverse Event|3
846352|NCT01681992|2784843|P2|Overall Study|Adverse Event|2
846353|NCT01681992|2784844|P1|Overall Study|Adverse Event|3
846354|NCT01681849|2784933|P3|Overall Study|Lost to Follow-up|6
846355|NCT01681849|2784934|P2|Overall Study|Lost to Follow-up|2
846356|NCT01681849|2784935|P1|Overall Study|Lost to Follow-up|3
846357|NCT01681849|2784933|P3|Overall Study|Withdrawal by Subject|33
846358|NCT01681849|2784934|P2|Overall Study|Withdrawal by Subject|5
846359|NCT01681849|2784935|P1|Overall Study|Withdrawal by Subject|3
846360|NCT01681849|2784933|P3|Overall Study|Protocol Violation|0
846361|NCT01681849|2784934|P2|Overall Study|Protocol Violation|0
846362|NCT01681849|2784935|P1|Overall Study|Protocol Violation|2
846363|NCT01681836|2784944|P2|Second Intervention|Withdrawal by Subject|1
846364|NCT01681836|2784945|P1|Second Intervention|Withdrawal by Subject|0
846365|NCT01681628|2784971|P2|19 Months Follow-up|Lost to Follow-up|43
846366|NCT01681628|2784972|P1|19 Months Follow-up|Lost to Follow-up|61
846367|NCT01681628|2784971|P2|19 Months Follow-up|Death|0
846368|NCT01681628|2784972|P1|19 Months Follow-up|Death|1
846369|NCT01681628|2784971|P2|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15
846370|NCT01681628|2784972|P1|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0
846371|NCT01681628|2784971|P2|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6
846372|NCT01681628|2784972|P1|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14
846373|NCT01681576|2784985|P2|Period 2|Non-compliance with study treatment|0
846374|NCT01681576|2784986|P1|Period 2|Non-compliance with study treatment|1
846375|NCT01681576|2784985|P2|Period 2|subject/guardian decision|1
846376|NCT01681576|2784986|P1|Period 2|subject/guardian decision|3
846377|NCT01681576|2784985|P2|Period 1|Protocol Deviation|0
846378|NCT01681576|2784986|P1|Period 1|Protocol Deviation|1
846379|NCT01681576|2784985|P2|Period 1|Adverse Event|0
846380|NCT01681576|2784986|P1|Period 1|Adverse Event|1
846381|NCT01681511|2785002|P2|Overall Study|No post-catheter sample collected|4
846382|NCT01681511|2785003|P1|Overall Study|No post-catheter sample collected|11
846383|NCT01681511|2785002|P2|Overall Study|No Daily Urine Sample Collected|1
846384|NCT01681511|2785003|P1|Overall Study|No Daily Urine Sample Collected|0
846385|NCT01681511|2785002|P2|Overall Study|No Baseline Dips Stick & Urine Culture|6
846386|NCT01681511|2785003|P1|Overall Study|No Baseline Dips Stick & Urine Culture|3
846387|NCT01681511|2785002|P2|Overall Study|Failed Inclusion/Exclusion|0
846388|NCT01681511|2785003|P1|Overall Study|Failed Inclusion/Exclusion|3
846389|NCT01681511|2785002|P2|Overall Study|No Treatment Received|3
846390|NCT01681511|2785003|P1|Overall Study|No Treatment Received|1
846391|NCT01681472|2785021|P4|Overall Study|Adverse Event|0
846392|NCT01681472|2785022|P3|Overall Study|Adverse Event|0
846393|NCT01681472|2785023|P2|Overall Study|Adverse Event|1
846394|NCT01681472|2785024|P1|Overall Study|Adverse Event|0
846395|NCT01681433|2785036|P2|Overall Study|Lost to Follow-up|1
846396|NCT01681433|2785037|P1|Overall Study|Lost to Follow-up|0
846397|NCT01681433|2785036|P2|Overall Study|Adverse Event|4
846398|NCT01681433|2785037|P1|Overall Study|Adverse Event|2
846399|NCT01681433|2785036|P2|Overall Study|Protocol Violation|0
846400|NCT01681433|2785037|P1|Overall Study|Protocol Violation|2
846401|NCT01681433|2785036|P2|Overall Study|Withdrawal by Subject|5
846402|NCT01681433|2785037|P1|Overall Study|Withdrawal by Subject|5
846403|NCT01681433|2785036|P2|Overall Study|Lack of Efficacy|23
846404|NCT01681433|2785037|P1|Overall Study|Lack of Efficacy|23
846405|NCT01681368|2785055|P1|Overall Study|Refused further follow up|1
846406|NCT01681368|2785055|P1|Overall Study|Refused further treatment|1
846407|NCT01681277|2785072|P5|Overall Study|Adverse Event|0
846408|NCT01681277|2785073|P4|Overall Study|Adverse Event|0
846409|NCT01681277|2785074|P3|Overall Study|Adverse Event|0
846410|NCT01681277|2785075|P2|Overall Study|Adverse Event|0
846411|NCT01681277|2785076|P1|Overall Study|Adverse Event|1
846412|NCT01681212|2785117|P1|Overall Study|Administrative reason by sponsor|1
846413|NCT01681212|2785117|P1|Overall Study|No longer met study criteria|5
846414|NCT01681069|2785175|P2|Overall Study|Adverse Event|1
846415|NCT01681069|2785176|P1|Overall Study|Adverse Event|0
846416|NCT01681069|2785175|P2|Overall Study|Protocol Violation|1
846417|NCT01681069|2785176|P1|Overall Study|Protocol Violation|1
846418|NCT01681069|2785175|P2|Overall Study|Withdrawal by Subject|5
846419|NCT01681069|2785176|P1|Overall Study|Withdrawal by Subject|4
846420|NCT01681004|2785213|P2|Study Completion|Death|1
846421|NCT01681004|2785214|P1|Study Completion|Death|1
846422|NCT01681004|2785213|P2|Study Completion|Site Termination|1
846423|NCT01681004|2785214|P1|Study Completion|Site Termination|2
846424|NCT01681004|2785213|P2|Study Completion|Physician Decision|3
846425|NCT01681004|2785214|P1|Study Completion|Physician Decision|1
846426|NCT01681004|2785213|P2|Study Completion|Lost to Follow-up|3
846427|NCT01681004|2785214|P1|Study Completion|Lost to Follow-up|8
846428|NCT01681004|2785213|P2|Primary Endpoint: 6 Months|Withdrawal by Subject|2
846429|NCT01681004|2785214|P1|Primary Endpoint: 6 Months|Withdrawal by Subject|1
846430|NCT01680991|2785271|P3|Overall Study|PD confirmed in other hospital|0
846431|NCT01680991|2785272|P2|Overall Study|PD confirmed in other hospital|0
846432|NCT01680991|2785273|P1|Overall Study|PD confirmed in other hospital|1
846433|NCT01680991|2785271|P3|Overall Study|Bad physical condition|1
846434|NCT01680991|2785272|P2|Overall Study|Bad physical condition|0
846435|NCT01680991|2785273|P1|Overall Study|Bad physical condition|0
846436|NCT01680991|2785271|P3|Overall Study|Physician Decision|2
846437|NCT01680991|2785272|P2|Overall Study|Physician Decision|7
846438|NCT01680991|2785273|P1|Overall Study|Physician Decision|0
846439|NCT01680991|2785271|P3|Overall Study|Progressive disease (PD)|0
846440|NCT01680991|2785272|P2|Overall Study|Progressive disease (PD)|10
846441|NCT01680991|2785273|P1|Overall Study|Progressive disease (PD)|0
846442|NCT01680991|2785271|P3|Overall Study|Withdrawal by Subject|0
846443|NCT01680991|2785272|P2|Overall Study|Withdrawal by Subject|1
846444|NCT01680991|2785273|P1|Overall Study|Withdrawal by Subject|5
846445|NCT01680991|2785271|P3|Overall Study|Protocol Violation|0
846446|NCT01680991|2785272|P2|Overall Study|Protocol Violation|1
846447|NCT01680991|2785273|P1|Overall Study|Protocol Violation|0
846448|NCT01680991|2785271|P3|Overall Study|Death|1
846449|NCT01680991|2785272|P2|Overall Study|Death|0
846450|NCT01680991|2785273|P1|Overall Study|Death|1
846451|NCT01680991|2785271|P3|Overall Study|Adverse Event|0
846452|NCT01680991|2785272|P2|Overall Study|Adverse Event|0
846453|NCT01680991|2785273|P1|Overall Study|Adverse Event|1
846454|NCT01680861|2785353|P2|Early Post-transplant Period|Protocol Violation|1
846455|NCT01680861|2785354|P1|Early Post-transplant Period|Protocol Violation|1
846456|NCT01680497|2785427|P1|Overall Study|Lost to Follow-up|2
846457|NCT01680458|2785437|P1|Overall Study|Protocol Violation|3
846458|NCT01680341|2785448|P2|Overall Study|Unclassified|15
846459|NCT01680341|2785449|P1|Overall Study|Unclassified|18
846460|NCT01680341|2785448|P2|Overall Study|Adverse Event|2
846461|NCT01680341|2785449|P1|Overall Study|Adverse Event|3
846462|NCT01680159|2785520|P1|Increased Dose Period|Withdrawal by Subject|2
846463|NCT01680159|2785520|P1|Increased Dose Period|Adverse Event|6
846464|NCT01680159|2785520|P1|Screening Period|Not meet criteria for dose-up period|7
846465|NCT01680016|2785547|P4|Overall Study|Withdrawal by Subject|1
846466|NCT01680016|2785548|P3|Overall Study|Withdrawal by Subject|1
846467|NCT01680016|2785549|P2|Overall Study|Withdrawal by Subject|7
846468|NCT01680016|2785550|P1|Overall Study|Withdrawal by Subject|5
846469|NCT01680016|2785547|P4|Overall Study|Protocol Violation|0
846470|NCT01680016|2785548|P3|Overall Study|Protocol Violation|0
846471|NCT01680016|2785549|P2|Overall Study|Protocol Violation|1
846472|NCT01680016|2785550|P1|Overall Study|Protocol Violation|0
846473|NCT01680016|2785547|P4|Overall Study|The Subject went out of The Trial|0
846474|NCT01680016|2785548|P3|Overall Study|The Subject went out of The Trial|3
846475|NCT01680016|2785549|P2|Overall Study|The Subject went out of The Trial|0
846476|NCT01680016|2785550|P1|Overall Study|The Subject went out of The Trial|1
846477|NCT01680016|2785547|P4|Overall Study|Adverse Event|4
846478|NCT01680016|2785548|P3|Overall Study|Adverse Event|1
846479|NCT01680016|2785549|P2|Overall Study|Adverse Event|0
846480|NCT01680016|2785550|P1|Overall Study|Adverse Event|0
846481|NCT01679613|2785612|P4|Overall Study|other than stated above|2
846482|NCT01679613|2785613|P3|Overall Study|other than stated above|2
846483|NCT01679613|2785614|P2|Overall Study|other than stated above|1
846484|NCT01679613|2785615|P1|Overall Study|other than stated above|0
846485|NCT01679301|2785656|P3|Screening Period|screen failure|0
846486|NCT01679301|2785657|P2|Screening Period|screen failure|0
846487|NCT01679301|2785658|P1|Screening Period|screen failure|3
846488|NCT01679236|2785666|P2|Overall Study|Lost to Follow-up|15
846489|NCT01679236|2785667|P1|Overall Study|Lost to Follow-up|15
846490|NCT01679002|2785714|P3|Overall Study|Adverse Event|0
846491|NCT01679002|2785715|P2|Overall Study|Adverse Event|1
846492|NCT01679002|2785716|P1|Overall Study|Adverse Event|1
846493|NCT01678911|2785743|P2|Second Intervention|Lost to Follow-up|0
846494|NCT01678911|2785744|P1|Second Intervention|Lost to Follow-up|2
846495|NCT01678820|2785790|P3|Overall Study|Not treated with double-blind study drug|2
846496|NCT01678820|2785791|P2|Overall Study|Not treated with double-blind study drug|2
846497|NCT01678820|2785792|P1|Overall Study|Not treated with double-blind study drug|0
846498|NCT01678820|2785790|P3|Overall Study|Protocol Violation|4
846499|NCT01678820|2785791|P2|Overall Study|Protocol Violation|5
846500|NCT01678820|2785792|P1|Overall Study|Protocol Violation|4
846501|NCT01678820|2785790|P3|Overall Study|Physician Decision|1
846502|NCT01678820|2785791|P2|Overall Study|Physician Decision|0
846503|NCT01678820|2785792|P1|Overall Study|Physician Decision|0
846504|NCT01678820|2785790|P3|Overall Study|Non-compliance with study drug|0
846505|NCT01678820|2785791|P2|Overall Study|Non-compliance with study drug|1
846506|NCT01678820|2785792|P1|Overall Study|Non-compliance with study drug|0
846507|NCT01678820|2785790|P3|Overall Study|Lost to Follow-up|2
846508|NCT01678820|2785791|P2|Overall Study|Lost to Follow-up|2
846509|NCT01678820|2785792|P1|Overall Study|Lost to Follow-up|7
846510|NCT01678820|2785790|P3|Overall Study|Adverse Event|2
846511|NCT01678820|2785791|P2|Overall Study|Adverse Event|2
846512|NCT01678820|2785792|P1|Overall Study|Adverse Event|2
846513|NCT01678820|2785790|P3|Overall Study|Protocol Specified Criteria|1
846514|NCT01678820|2785791|P2|Overall Study|Protocol Specified Criteria|3
846515|NCT01678820|2785792|P1|Overall Study|Protocol Specified Criteria|2
846516|NCT01678820|2785790|P3|Overall Study|Withdrawal by Subject|2
846517|NCT01678820|2785791|P2|Overall Study|Withdrawal by Subject|5
846518|NCT01678820|2785792|P1|Overall Study|Withdrawal by Subject|2
846519|NCT01678820|2785790|P3|Overall Study|Study Terminated by Sponsor|43
846520|NCT01678820|2785791|P2|Overall Study|Study Terminated by Sponsor|43
846521|NCT01678820|2785792|P1|Overall Study|Study Terminated by Sponsor|45
846522|NCT01678807|2785837|P3|Overall Study|Withdrawn by Parent/Guardian|0
846523|NCT01678807|2785838|P2|Overall Study|Withdrawn by Parent/Guardian|1
846524|NCT01678807|2785839|P1|Overall Study|Withdrawn by Parent/Guardian|0
846525|NCT01678807|2785837|P3|Overall Study|Adverse Event|0
846526|NCT01678807|2785838|P2|Overall Study|Adverse Event|4
846527|NCT01678807|2785839|P1|Overall Study|Adverse Event|4
846528|NCT01678313|2785857|P2|Prostate Biopsy at 3 Months|Not received prostate biopsy|12
846529|NCT01678313|2785858|P1|Prostate Biopsy at 3 Months|Not received prostate biopsy|11
846530|NCT01678313|2785857|P2|PSA >4 ng/dL at 3 Months|PSA≦4|9
846531|NCT01678313|2785858|P1|PSA >4 ng/dL at 3 Months|PSA≦4|8
846532|NCT01678313|2785857|P2|Completed the 3-month Therapy|Physician Decision|4
846533|NCT01678313|2785858|P1|Completed the 3-month Therapy|Physician Decision|3
846534|NCT01678313|2785857|P2|Completed the 3-month Therapy|Lost to Follow-up|8
846535|NCT01678313|2785858|P1|Completed the 3-month Therapy|Lost to Follow-up|3
846536|NCT01678131|2785892|P3|Overall Study|Withdrawal by Subject|2
846537|NCT01678131|2785893|P2|Overall Study|Withdrawal by Subject|0
846538|NCT01678131|2785894|P1|Overall Study|Withdrawal by Subject|0
846539|NCT01678131|2785892|P3|Overall Study|Adverse Event|0
846540|NCT01678131|2785893|P2|Overall Study|Adverse Event|1
846541|NCT01678131|2785894|P1|Overall Study|Adverse Event|0
846542|NCT01677988|2785902|P1|Overall Study|Lack of Efficacy|2
846543|NCT01677936|2785915|P2|Overall Study|Protocol Violation|4
846544|NCT01677936|2785916|P1|Overall Study|Protocol Violation|0
846545|NCT01677936|2785915|P2|Overall Study|Lost to Follow-up|0
846546|NCT01677936|2785916|P1|Overall Study|Lost to Follow-up|1
846547|NCT01677936|2785915|P2|Overall Study|Adverse Event|0
846548|NCT01677936|2785916|P1|Overall Study|Adverse Event|1
846549|NCT01677936|2785915|P2|Overall Study|Protocol Violation|0
846550|NCT01677936|2785916|P1|Overall Study|Protocol Violation|3
846551|NCT01677936|2785915|P2|Overall Study|Lost to Follow-up|1
846552|NCT01677936|2785916|P1|Overall Study|Lost to Follow-up|4
846553|NCT01677910|2785927|P4|Open-Label Extension Period (OLE)|Lost to Follow-up|1
846554|NCT01677910|2785928|P3|Open-Label Extension Period (OLE)|Lost to Follow-up|0
846555|NCT01677910|2785929|P2|Open-Label Extension Period (OLE)|Lost to Follow-up|0
846556|NCT01677910|2785930|P1|Open-Label Extension Period (OLE)|Lost to Follow-up|0
846557|NCT01677910|2785927|P4|Open-Label Extension Period (OLE)|Adverse Event|15
846558|NCT01677910|2785928|P3|Open-Label Extension Period (OLE)|Adverse Event|0
846559|NCT01677910|2785929|P2|Open-Label Extension Period (OLE)|Adverse Event|0
846560|NCT01677910|2785930|P1|Open-Label Extension Period (OLE)|Adverse Event|0
846561|NCT01677910|2785927|P4|Open-Label Extension Period (OLE)|Lack of Efficacy|5
846562|NCT01677910|2785928|P3|Open-Label Extension Period (OLE)|Lack of Efficacy|0
846563|NCT01677910|2785929|P2|Open-Label Extension Period (OLE)|Lack of Efficacy|0
846564|NCT01677910|2785930|P1|Open-Label Extension Period (OLE)|Lack of Efficacy|0
846565|NCT01677910|2785927|P4|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
846566|NCT01677910|2785928|P3|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
846567|NCT01677910|2785929|P2|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
846568|NCT01677910|2785930|P1|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
846569|NCT01677910|2785927|P4|Open-Label Extension Period (OLE)|Reason not Specified|2
846570|NCT01677910|2785928|P3|Open-Label Extension Period (OLE)|Reason not Specified|0
846571|NCT01677910|2785929|P2|Open-Label Extension Period (OLE)|Reason not Specified|0
846572|NCT01677910|2785930|P1|Open-Label Extension Period (OLE)|Reason not Specified|0
846573|NCT01677910|2785927|P4|Open-Label Extension Period (OLE)|Physician Decision|4
846574|NCT01677910|2785928|P3|Open-Label Extension Period (OLE)|Physician Decision|0
846575|NCT01677910|2785929|P2|Open-Label Extension Period (OLE)|Physician Decision|0
846576|NCT01677910|2785930|P1|Open-Label Extension Period (OLE)|Physician Decision|0
846577|NCT01677910|2785927|P4|Double-Blind Treatment Period|Reason Not Specified|0
846578|NCT01677910|2785928|P3|Double-Blind Treatment Period|Reason Not Specified|0
846579|NCT01677910|2785929|P2|Double-Blind Treatment Period|Reason Not Specified|1
846580|NCT01677910|2785930|P1|Double-Blind Treatment Period|Reason Not Specified|0
846581|NCT01677910|2785927|P4|Double-Blind Treatment Period|Withdrawal of consent|0
846582|NCT01677910|2785928|P3|Double-Blind Treatment Period|Withdrawal of consent|3
846583|NCT01677910|2785929|P2|Double-Blind Treatment Period|Withdrawal of consent|0
846584|NCT01677910|2785930|P1|Double-Blind Treatment Period|Withdrawal of consent|1
846585|NCT01677910|2785927|P4|Double-Blind Treatment Period|Physician Decision|0
846586|NCT01677910|2785928|P3|Double-Blind Treatment Period|Physician Decision|1
846587|NCT01677910|2785929|P2|Double-Blind Treatment Period|Physician Decision|0
846588|NCT01677910|2785930|P1|Double-Blind Treatment Period|Physician Decision|0
846589|NCT01677910|2785927|P4|Double-Blind Treatment Period|Adverse Event|0
846590|NCT01677910|2785928|P3|Double-Blind Treatment Period|Adverse Event|3
846591|NCT01677910|2785929|P2|Double-Blind Treatment Period|Adverse Event|2
846592|NCT01677910|2785930|P1|Double-Blind Treatment Period|Adverse Event|6
846593|NCT01677858|2785957|P5|Overall Study|Lost to Follow-up|1
846594|NCT01677858|2785958|P4|Overall Study|Lost to Follow-up|0
846595|NCT01677858|2785959|P3|Overall Study|Lost to Follow-up|0
846596|NCT01677858|2785960|P2|Overall Study|Lost to Follow-up|0
846597|NCT01677858|2785961|P1|Overall Study|Lost to Follow-up|0
846598|NCT01677858|2785957|P5|Overall Study|Withdrawal by Subject|15
846599|NCT01677858|2785958|P4|Overall Study|Withdrawal by Subject|0
846600|NCT01677858|2785959|P3|Overall Study|Withdrawal by Subject|1
846601|NCT01677858|2785960|P2|Overall Study|Withdrawal by Subject|1
846602|NCT01677858|2785961|P1|Overall Study|Withdrawal by Subject|0
846603|NCT01677858|2785957|P5|Overall Study|Progressive Disease|43
846604|NCT01677858|2785958|P4|Overall Study|Progressive Disease|3
846605|NCT01677858|2785959|P3|Overall Study|Progressive Disease|9
846606|NCT01677858|2785960|P2|Overall Study|Progressive Disease|1
846607|NCT01677858|2785961|P1|Overall Study|Progressive Disease|2
846608|NCT01677858|2785957|P5|Overall Study|Physician Decision|12
846609|NCT01677858|2785958|P4|Overall Study|Physician Decision|0
846610|NCT01677858|2785959|P3|Overall Study|Physician Decision|2
846611|NCT01677858|2785960|P2|Overall Study|Physician Decision|0
846612|NCT01677858|2785961|P1|Overall Study|Physician Decision|1
846613|NCT01677858|2785957|P5|Overall Study|Death|1
846614|NCT01677858|2785958|P4|Overall Study|Death|0
846615|NCT01677858|2785959|P3|Overall Study|Death|0
846616|NCT01677858|2785960|P2|Overall Study|Death|0
846617|NCT01677858|2785961|P1|Overall Study|Death|0
846618|NCT01677858|2785957|P5|Overall Study|Adverse Event|13
846619|NCT01677858|2785958|P4|Overall Study|Adverse Event|3
846620|NCT01677858|2785959|P3|Overall Study|Adverse Event|2
846621|NCT01677858|2785960|P2|Overall Study|Adverse Event|0
846622|NCT01677858|2785961|P1|Overall Study|Adverse Event|0
846623|NCT01677767|2786034|P1|Overall Study|Non-compliance by the participants|3
846624|NCT01677767|2786034|P1|Overall Study|Withdrawal by Subject|10
846625|NCT01677767|2786034|P1|Overall Study|Protocol Violation|4
846626|NCT01677767|2786034|P1|Overall Study|Death|4
846627|NCT01677767|2786034|P1|Overall Study|Adverse Event|1
846628|NCT01677624|2786048|P1|Overall Study|Insuf Resp: intra-articular hemorrhage|1
846629|NCT01677507|2786053|P2|Second Assigment|Adverse Event|3
846630|NCT01677507|2786054|P1|Second Assigment|Adverse Event|1
846631|NCT01677507|2786053|P2|Second Assigment|Withdrawal by Subject|2
846632|NCT01677507|2786054|P1|Second Assigment|Withdrawal by Subject|2
846633|NCT01677507|2786053|P2|Initial Assignment|Protocol Violation|1
846634|NCT01677507|2786054|P1|Initial Assignment|Protocol Violation|0
846635|NCT01677507|2786053|P2|Initial Assignment|Adverse Event|1
846636|NCT01677507|2786054|P1|Initial Assignment|Adverse Event|0
846637|NCT01677377|2786067|P3|Overall Study|Pregnancy|1
846638|NCT01677377|2786068|P2|Overall Study|Pregnancy|0
846639|NCT01677377|2786069|P1|Overall Study|Pregnancy|0
846640|NCT01677377|2786067|P3|Overall Study|Lack of Efficacy|1
846641|NCT01677377|2786068|P2|Overall Study|Lack of Efficacy|0
846642|NCT01677377|2786069|P1|Overall Study|Lack of Efficacy|0
846643|NCT01677377|2786067|P3|Overall Study|Withdrawal by Subject|3
846644|NCT01677377|2786068|P2|Overall Study|Withdrawal by Subject|0
846645|NCT01677377|2786069|P1|Overall Study|Withdrawal by Subject|0
846646|NCT01677377|2786067|P3|Overall Study|Lost to Follow-up|1
846647|NCT01677377|2786068|P2|Overall Study|Lost to Follow-up|1
846648|NCT01677377|2786069|P1|Overall Study|Lost to Follow-up|0
846649|NCT01677377|2786067|P3|Overall Study|Protocol Violation|0
846650|NCT01677377|2786068|P2|Overall Study|Protocol Violation|0
846651|NCT01677377|2786069|P1|Overall Study|Protocol Violation|1
846652|NCT01677299|2786270|P4|Overall Study|Withdrawal by Subject|1
846653|NCT01677299|2786271|P3|Overall Study|Withdrawal by Subject|0
846654|NCT01677299|2786272|P2|Overall Study|Withdrawal by Subject|1
846655|NCT01677299|2786273|P1|Overall Study|Withdrawal by Subject|0
846656|NCT01677299|2786270|P4|Overall Study|Adverse Event|0
846657|NCT01677299|2786271|P3|Overall Study|Adverse Event|1
846658|NCT01677299|2786272|P2|Overall Study|Adverse Event|2
846659|NCT01677299|2786273|P1|Overall Study|Adverse Event|0
846660|NCT01677195|2786305|P3|Overall Study|Protocol Violation|4
846661|NCT01677195|2786306|P2|Overall Study|Protocol Violation|3
846662|NCT01677195|2786307|P1|Overall Study|Protocol Violation|7
846663|NCT01677195|2786305|P3|Overall Study|Pregnancy|0
846664|NCT01677195|2786306|P2|Overall Study|Pregnancy|1
846665|NCT01677195|2786307|P1|Overall Study|Pregnancy|0
846666|NCT01677195|2786305|P3|Overall Study|Physician Decision|2
846667|NCT01677195|2786306|P2|Overall Study|Physician Decision|2
846668|NCT01677195|2786307|P1|Overall Study|Physician Decision|1
846669|NCT01677195|2786305|P3|Overall Study|Adverse Event|1
846670|NCT01677195|2786306|P2|Overall Study|Adverse Event|4
846671|NCT01677195|2786307|P1|Overall Study|Adverse Event|6
846672|NCT01677195|2786305|P3|Overall Study|Withdrawal by Subject|1
846673|NCT01677195|2786306|P2|Overall Study|Withdrawal by Subject|0
846674|NCT01677195|2786307|P1|Overall Study|Withdrawal by Subject|1
846675|NCT01677195|2786305|P3|Overall Study|Lost to Follow-up|22
846676|NCT01677195|2786306|P2|Overall Study|Lost to Follow-up|22
846677|NCT01677195|2786307|P1|Overall Study|Lost to Follow-up|14
846678|NCT01677182|2786318|P3|Overall Study|Other reasons|2
846679|NCT01677182|2786319|P2|Overall Study|Other reasons|5
846680|NCT01677182|2786320|P1|Overall Study|Other reasons|1
846681|NCT01677182|2786318|P3|Overall Study|Lack of Efficacy|1
846682|NCT01677182|2786319|P2|Overall Study|Lack of Efficacy|0
846683|NCT01677182|2786320|P1|Overall Study|Lack of Efficacy|3
846684|NCT01677182|2786318|P3|Overall Study|Study termination|11
846685|NCT01677182|2786319|P2|Overall Study|Study termination|9
846686|NCT01677182|2786320|P1|Overall Study|Study termination|12
846687|NCT01677182|2786318|P3|Overall Study|Withdrawal by Subject|10
846688|NCT01677182|2786319|P2|Overall Study|Withdrawal by Subject|12
846689|NCT01677182|2786320|P1|Overall Study|Withdrawal by Subject|7
846690|NCT01677182|2786318|P3|Overall Study|Lost to Follow-up|3
846691|NCT01677182|2786319|P2|Overall Study|Lost to Follow-up|0
846692|NCT01677182|2786320|P1|Overall Study|Lost to Follow-up|4
846693|NCT01677182|2786318|P3|Overall Study|Protocol Violation|4
846694|NCT01677182|2786319|P2|Overall Study|Protocol Violation|1
846695|NCT01677182|2786320|P1|Overall Study|Protocol Violation|5
846696|NCT01677182|2786318|P3|Overall Study|Adverse Event|8
846697|NCT01677182|2786319|P2|Overall Study|Adverse Event|1
846698|NCT01677182|2786320|P1|Overall Study|Adverse Event|2
846699|NCT01676961|2786352|P1|Overall Study|Withdrawal by Subject|1
846700|NCT01676961|2786352|P1|Overall Study|Lost to Follow-up|1
846701|NCT01676961|2786352|P1|Overall Study|Death|3
846702|NCT01676896|2786360|P3|Overall Study|Withdrawal by Subject|19
846703|NCT01676896|2786361|P2|Overall Study|Withdrawal by Subject|7
846704|NCT01676896|2786362|P1|Overall Study|Withdrawal by Subject|12
846705|NCT01676727|2786457|P1|Overall Study|Valve explanted|1
846706|NCT01676727|2786457|P1|Overall Study|Not willing to attend 1-year visit|2
846707|NCT01676727|2786457|P1|Overall Study|Screening failure|5
846708|NCT01676727|2786457|P1|Overall Study|Withdrawal by Subject|6
846709|NCT01676727|2786457|P1|Overall Study|Death|18
846710|NCT01676701|2786471|P2|Overall Study|Sponsor Decision|4
846711|NCT01676701|2786472|P1|Overall Study|Sponsor Decision|3
846712|NCT01676701|2786471|P2|Overall Study|Protocol Violation|0
846713|NCT01676701|2786472|P1|Overall Study|Protocol Violation|1
846714|NCT01676220|2786557|P2|Overall Study|No More Need of Insulin|0
846715|NCT01676220|2786558|P1|Overall Study|No More Need of Insulin|1
846716|NCT01676220|2786557|P2|Overall Study|Non Serious Hypoglycemia|0
846717|NCT01676220|2786558|P1|Overall Study|Non Serious Hypoglycemia|2
846718|NCT01676220|2786557|P2|Overall Study|Perceived Lack of Efficacy|1
846719|NCT01676220|2786558|P1|Overall Study|Perceived Lack of Efficacy|3
846720|NCT01676220|2786557|P2|Overall Study|Site Closure/Site Withdrawal|4
846721|NCT01676220|2786558|P1|Overall Study|Site Closure/Site Withdrawal|1
846722|NCT01676220|2786557|P2|Overall Study|Selection Criterion/Protocol Violation|9
846723|NCT01676220|2786558|P1|Overall Study|Selection Criterion/Protocol Violation|9
846724|NCT01676220|2786557|P2|Overall Study|Lost to Follow-up|18
846725|NCT01676220|2786558|P1|Overall Study|Lost to Follow-up|11
846726|NCT01676220|2786557|P2|Overall Study|Personal Reason|45
846727|NCT01676220|2786558|P1|Overall Study|Personal Reason|34
846728|NCT01676220|2786557|P2|Overall Study|Received Rescue Therapy|22
846729|NCT01676220|2786558|P1|Overall Study|Received Rescue Therapy|14
846730|NCT01676220|2786557|P2|Overall Study|Protocol Violation|12
846731|NCT01676220|2786558|P1|Overall Study|Protocol Violation|11
846732|NCT01676220|2786557|P2|Overall Study|Lack of Efficacy|5
846733|NCT01676220|2786558|P1|Overall Study|Lack of Efficacy|2
846734|NCT01676220|2786557|P2|Overall Study|Adverse Event|8
846735|NCT01676220|2786558|P1|Overall Study|Adverse Event|10
846736|NCT01676220|2786557|P2|Overall Study|Randomized But Not Treated|1
846737|NCT01676220|2786558|P1|Overall Study|Randomized But Not Treated|4
846738|NCT01676116|2786590|P2|Overall Study|Protocol Violation|3
846739|NCT01676116|2786591|P1|Overall Study|Protocol Violation|9
846740|NCT01676116|2786590|P2|Overall Study|Unclassified|10
846741|NCT01676116|2786591|P1|Overall Study|Unclassified|4
846742|NCT01676116|2786590|P2|Overall Study|Adverse Event|2
846743|NCT01676116|2786591|P1|Overall Study|Adverse Event|1
846744|NCT01676116|2786590|P2|Overall Study|Withdrawal criteria|14
846745|NCT01676116|2786591|P1|Overall Study|Withdrawal criteria|2
846746|NCT01676012|2786613|P1|Overall Study|incomplete set of videos|1
846747|NCT01676012|2786613|P1|Overall Study|Adverse Event|2
846748|NCT01675661|2786624|P2|Overall Study|Other reason|2
846749|NCT01675661|2786625|P1|Overall Study|Other reason|1
846750|NCT01675661|2786624|P2|Overall Study|Death|1
846751|NCT01675661|2786625|P1|Overall Study|Death|0
846752|NCT01675661|2786624|P2|Overall Study|Physician Decision|2
846753|NCT01675661|2786625|P1|Overall Study|Physician Decision|0
846754|NCT01675661|2786624|P2|Overall Study|Withdrawal by Subject|7
846755|NCT01675661|2786625|P1|Overall Study|Withdrawal by Subject|3
846756|NCT01675661|2786624|P2|Overall Study|Moved away|6
846757|NCT01675661|2786625|P1|Overall Study|Moved away|5
846758|NCT01675661|2786624|P2|Overall Study|Practical problems|5
846759|NCT01675661|2786625|P1|Overall Study|Practical problems|9
846760|NCT01675661|2786624|P2|Overall Study|Lost to Follow-up|23
846761|NCT01675661|2786625|P1|Overall Study|Lost to Follow-up|22
846762|NCT01675622|2786654|P2|Overall Study|not specified|4
846763|NCT01675622|2786655|P1|Overall Study|not specified|5
846764|NCT01675622|2786654|P2|Overall Study|Lost to Follow-up|3
846765|NCT01675622|2786655|P1|Overall Study|Lost to Follow-up|1
846766|NCT01675622|2786654|P2|Overall Study|Lack of Efficacy|4
846767|NCT01675622|2786655|P1|Overall Study|Lack of Efficacy|2
846768|NCT01675622|2786654|P2|Overall Study|Protocol Violation|1
846769|NCT01675622|2786655|P1|Overall Study|Protocol Violation|4
846770|NCT01675622|2786654|P2|Overall Study|Adverse Event|10
846771|NCT01675622|2786655|P1|Overall Study|Adverse Event|12
846772|NCT01675622|2786654|P2|Overall Study|Withdrawal by Subject|2
846773|NCT01675622|2786655|P1|Overall Study|Withdrawal by Subject|2
846774|NCT01675544|2786679|P1|Overall Study|Withdrawal by Subject|2
846775|NCT01675531|2786684|P1|Overall Study|Protocol Violation|8
846776|NCT01675531|2786684|P1|Overall Study|Lack of Efficacy|1
846777|NCT01675531|2786684|P1|Overall Study|Withdrawal by Subject|7
846778|NCT01675531|2786684|P1|Overall Study|Adverse Event|9
846779|NCT01675492|2786691|P1|Overall Study|study completed early - product approval|42
846780|NCT01675479|2786696|P1|Overall Study|Lost to Follow-up|11
846781|NCT01675427|2786710|P1|Overall Study|Not Specified|2
846782|NCT01675427|2786710|P1|Overall Study|Lost to Follow-up|5
846783|NCT01675427|2786710|P1|Overall Study|Sample not Collected by Mistake|2
846784|NCT01675427|2786710|P1|Overall Study|Participant Refused Sample Collection|18
846785|NCT01675427|2786710|P1|Overall Study|Withdrawal by Subject|7
846786|NCT01675167|2786997|P3|Double-blind Treatment Phase|Not specified|5
846787|NCT01675167|2786998|P2|Double-blind Treatment Phase|Not specified|7
846788|NCT01675167|2786999|P1|Double-blind Treatment Phase|Not specified|0
846789|NCT01675167|2786997|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9
846790|NCT01675167|2786998|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
846791|NCT01675167|2786999|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
846792|NCT01675167|2786997|P3|Double-blind Treatment Phase|Lost to Follow-up|5
846793|NCT01675167|2786998|P2|Double-blind Treatment Phase|Lost to Follow-up|1
846794|NCT01675167|2786999|P1|Double-blind Treatment Phase|Lost to Follow-up|0
846795|NCT01675167|2786997|P3|Double-blind Treatment Phase|Protocol Violation|11
846796|NCT01675167|2786998|P2|Double-blind Treatment Phase|Protocol Violation|4
846797|NCT01675167|2786999|P1|Double-blind Treatment Phase|Protocol Violation|0
846798|NCT01675167|2786997|P3|Double-blind Treatment Phase|Adverse Event|13
846799|NCT01675167|2786998|P2|Double-blind Treatment Phase|Adverse Event|5
846800|NCT01675167|2786999|P1|Double-blind Treatment Phase|Adverse Event|0
846801|NCT01675167|2786997|P3|Double-blind Treatment Phase|Withdrawal by Subject|6
846802|NCT01675167|2786998|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
846803|NCT01675167|2786999|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
846804|NCT01675167|2786997|P3|Double-blind Treatment Phase|Lack of Efficacy|61
846805|NCT01675167|2786998|P2|Double-blind Treatment Phase|Lack of Efficacy|19
846806|NCT01675167|2786999|P1|Double-blind Treatment Phase|Lack of Efficacy|0
846807|NCT01675167|2786997|P3|Open-label Titration Phase|Not specified|0
846808|NCT01675167|2786998|P2|Open-label Titration Phase|Not specified|0
846809|NCT01675167|2786999|P1|Open-label Titration Phase|Not specified|55
846810|NCT01675167|2786997|P3|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
846811|NCT01675167|2786998|P2|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
846812|NCT01675167|2786999|P1|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1
846813|NCT01675167|2786997|P3|Open-label Titration Phase|Lost to Follow-up|0
846814|NCT01675167|2786998|P2|Open-label Titration Phase|Lost to Follow-up|0
846815|NCT01675167|2786999|P1|Open-label Titration Phase|Lost to Follow-up|15
846816|NCT01675167|2786997|P3|Open-label Titration Phase|Protocol Violation|0
846817|NCT01675167|2786998|P2|Open-label Titration Phase|Protocol Violation|0
846818|NCT01675167|2786999|P1|Open-label Titration Phase|Protocol Violation|43
846819|NCT01675167|2786997|P3|Open-label Titration Phase|Withdrawal by Subject|0
846820|NCT01675167|2786998|P2|Open-label Titration Phase|Withdrawal by Subject|0
846821|NCT01675167|2786999|P1|Open-label Titration Phase|Withdrawal by Subject|46
846822|NCT01675167|2786997|P3|Open-label Titration Phase|Lack of Efficacy|0
846823|NCT01675167|2786998|P2|Open-label Titration Phase|Lack of Efficacy|0
846824|NCT01675167|2786999|P1|Open-label Titration Phase|Lack of Efficacy|63
846825|NCT01675167|2786997|P3|Open-label Titration Phase|Adverse Event|0
846826|NCT01675167|2786998|P2|Open-label Titration Phase|Adverse Event|0
846827|NCT01675167|2786999|P1|Open-label Titration Phase|Adverse Event|81
846828|NCT01675141|2787021|P1|Overall Study|No treatment, per protocol|1
846829|NCT01675141|2787021|P1|Overall Study|Physician Decision|4
846830|NCT01675141|2787021|P1|Overall Study|Withdrawal by Subject|3
846831|NCT01675141|2787021|P1|Overall Study|Lenalidomide outside NIH|3
846832|NCT01675128|2787034|P3|Overall Study|Pulmonary complication; off study|0
846833|NCT01675128|2787035|P2|Overall Study|Pulmonary complication; off study|1
846834|NCT01675128|2787036|P1|Overall Study|Pulmonary complication; off study|0
846835|NCT01675128|2787034|P3|Overall Study|Refused further treatment|0
846836|NCT01675128|2787035|P2|Overall Study|Refused further treatment|0
846837|NCT01675128|2787036|P1|Overall Study|Refused further treatment|1
846838|NCT01675128|2787034|P3|Overall Study|Disease progression on study|1
846839|NCT01675128|2787035|P2|Overall Study|Disease progression on study|1
846840|NCT01675128|2787036|P1|Overall Study|Disease progression on study|1
846841|NCT01675050|2787064|P2|Period One Treatment|Withdrawal by Subject|0
846842|NCT01675050|2787065|P1|Period One Treatment|Withdrawal by Subject|1
846843|NCT01675011|2787075|P2|Overall Study|Trial terminated by Sponsor|1
846844|NCT01675011|2787076|P1|Overall Study|Trial terminated by Sponsor|3
846845|NCT01674725|2787084|P2|Overall Study|Lost to Follow-up|1
846846|NCT01674725|2787085|P1|Overall Study|Lost to Follow-up|0
846847|NCT01674725|2787084|P2|Overall Study|Withdrawal by Subject|0
846848|NCT01674725|2787085|P1|Overall Study|Withdrawal by Subject|1
846849|NCT01674725|2787084|P2|Overall Study|Did not receive study drug|0
846850|NCT01674725|2787085|P1|Overall Study|Did not receive study drug|1
846851|NCT01674725|2787084|P2|Overall Study|Adverse Event|0
846852|NCT01674725|2787085|P1|Overall Study|Adverse Event|1
846853|NCT01674712|2787104|P5|Overall Study|Lack of Efficacy|1
846854|NCT01674712|2787105|P4|Overall Study|Lack of Efficacy|0
846855|NCT01674712|2787106|P3|Overall Study|Lack of Efficacy|1
846856|NCT01674712|2787107|P2|Overall Study|Lack of Efficacy|0
846857|NCT01674712|2787108|P1|Overall Study|Lack of Efficacy|0
846858|NCT01674712|2787104|P5|Overall Study|Administrative|1
846859|NCT01674712|2787105|P4|Overall Study|Administrative|0
846860|NCT01674712|2787106|P3|Overall Study|Administrative|0
846861|NCT01674712|2787107|P2|Overall Study|Administrative|1
846862|NCT01674712|2787108|P1|Overall Study|Administrative|0
846863|NCT01674712|2787104|P5|Overall Study|Withdrawal by Subject|3
846864|NCT01674712|2787105|P4|Overall Study|Withdrawal by Subject|4
846865|NCT01674712|2787106|P3|Overall Study|Withdrawal by Subject|5
846866|NCT01674712|2787107|P2|Overall Study|Withdrawal by Subject|2
846867|NCT01674712|2787108|P1|Overall Study|Withdrawal by Subject|2
846868|NCT01674712|2787104|P5|Overall Study|Protocol Violation|0
846869|NCT01674712|2787105|P4|Overall Study|Protocol Violation|0
846870|NCT01674712|2787106|P3|Overall Study|Protocol Violation|0
846871|NCT01674712|2787107|P2|Overall Study|Protocol Violation|0
846872|NCT01674712|2787108|P1|Overall Study|Protocol Violation|2
846873|NCT01674712|2787104|P5|Overall Study|Lost to Follow-up|0
846874|NCT01674712|2787105|P4|Overall Study|Lost to Follow-up|0
846875|NCT01674712|2787106|P3|Overall Study|Lost to Follow-up|0
846876|NCT01674712|2787107|P2|Overall Study|Lost to Follow-up|0
846877|NCT01674712|2787108|P1|Overall Study|Lost to Follow-up|1
846878|NCT01674712|2787104|P5|Overall Study|Adverse Event|6
846879|NCT01674712|2787105|P4|Overall Study|Adverse Event|4
846880|NCT01674712|2787106|P3|Overall Study|Adverse Event|3
846881|NCT01674712|2787107|P2|Overall Study|Adverse Event|6
846882|NCT01674712|2787108|P1|Overall Study|Adverse Event|5
846883|NCT01674647|2787132|P2|30-day Safety Follow-up Period|Lost to Follow-up|5
846884|NCT01674647|2787133|P1|30-day Safety Follow-up Period|Lost to Follow-up|8
846885|NCT01674647|2787132|P2|30-day Safety Follow-up Period|Withdrawal by Subject|8
846886|NCT01674647|2787133|P1|30-day Safety Follow-up Period|Withdrawal by Subject|7
846887|NCT01674647|2787132|P2|30-day Safety Follow-up Period|Logistical difficulties|3
846888|NCT01674647|2787133|P1|30-day Safety Follow-up Period|Logistical difficulties|1
846889|NCT01674647|2787132|P2|30-day Safety Follow-up Period|Protocol Violation|22
846890|NCT01674647|2787133|P1|30-day Safety Follow-up Period|Protocol Violation|39
846891|NCT01674647|2787132|P2|30-day Safety Follow-up Period|Non-compliance with study drug|1
846892|NCT01674647|2787133|P1|30-day Safety Follow-up Period|Non-compliance with study drug|0
846893|NCT01674647|2787132|P2|30-day Safety Follow-up Period|Death|2
846894|NCT01674647|2787133|P1|30-day Safety Follow-up Period|Death|3
846895|NCT01674647|2787132|P2|Treatment Period|Protocol Violation|36
846896|NCT01674647|2787133|P1|Treatment Period|Protocol Violation|56
846897|NCT01674647|2787132|P2|Treatment Period|Treatment failure|14
846898|NCT01674647|2787133|P1|Treatment Period|Treatment failure|0
846899|NCT01674647|2787132|P2|Treatment Period|Logistical difficulties|8
846900|NCT01674647|2787133|P1|Treatment Period|Logistical difficulties|5
846901|NCT01674647|2787132|P2|Treatment Period|Switching to other therapy|2
846902|NCT01674647|2787133|P1|Treatment Period|Switching to other therapy|5
846903|NCT01674647|2787132|P2|Treatment Period|Withdrawal by Subject|16
846904|NCT01674647|2787133|P1|Treatment Period|Withdrawal by Subject|19
846905|NCT01674647|2787132|P2|Treatment Period|Lost to Follow-up|1
846906|NCT01674647|2787133|P1|Treatment Period|Lost to Follow-up|1
846907|NCT01674647|2787132|P2|Treatment Period|Non-compliance with study drug|0
846908|NCT01674647|2787133|P1|Treatment Period|Non-compliance with study drug|3
846909|NCT01674647|2787132|P2|Treatment Period|Adverse Event|22
846910|NCT01674647|2787133|P1|Treatment Period|Adverse Event|60
846911|NCT01674647|2787132|P2|Treatment Period|Physician Decision|1
846912|NCT01674647|2787133|P1|Treatment Period|Physician Decision|3
846913|NCT01674647|2787132|P2|Treatment Period|Efficacy outcome reached|1
846914|NCT01674647|2787133|P1|Treatment Period|Efficacy outcome reached|0
846915|NCT01674647|2787132|P2|Treatment Period|Death|1
846916|NCT01674647|2787133|P1|Treatment Period|Death|4
846917|NCT01674634|2787159|P1|Overall Study|Lost to Follow-up|3
846918|NCT01674634|2787159|P1|Overall Study|Withdrawal by Subject|3
846919|NCT01674569|2787205|P6|Overall Study|Withdrawal by Subject|0
846920|NCT01674569|2787206|P5|Overall Study|Withdrawal by Subject|0
846921|NCT01674569|2787207|P4|Overall Study|Withdrawal by Subject|0
846922|NCT01674569|2787208|P3|Overall Study|Withdrawal by Subject|1
846923|NCT01674569|2787209|P2|Overall Study|Withdrawal by Subject|0
846924|NCT01674569|2787210|P1|Overall Study|Withdrawal by Subject|0
846925|NCT01674569|2787205|P6|Overall Study|Protocol Violation|0
846926|NCT01674569|2787206|P5|Overall Study|Protocol Violation|0
846927|NCT01674569|2787207|P4|Overall Study|Protocol Violation|0
846928|NCT01674569|2787208|P3|Overall Study|Protocol Violation|1
846929|NCT01674569|2787209|P2|Overall Study|Protocol Violation|1
846930|NCT01674569|2787210|P1|Overall Study|Protocol Violation|0
846931|NCT01674569|2787205|P6|Overall Study|Adverse Event|2
846932|NCT01674569|2787206|P5|Overall Study|Adverse Event|2
846933|NCT01674569|2787207|P4|Overall Study|Adverse Event|1
846934|NCT01674569|2787208|P3|Overall Study|Adverse Event|0
846935|NCT01674569|2787209|P2|Overall Study|Adverse Event|2
846936|NCT01674569|2787210|P1|Overall Study|Adverse Event|0
846937|NCT01674062|2787216|P2|Overall Study|Programming Error|0
846938|NCT01674062|2787217|P1|Overall Study|Programming Error|1
846939|NCT01674062|2787216|P2|Overall Study|Death|1
846940|NCT01674062|2787217|P1|Overall Study|Death|0
846941|NCT01674062|2787216|P2|Overall Study|Adverse Event|1
846942|NCT01674062|2787217|P1|Overall Study|Adverse Event|1
846943|NCT01674062|2787216|P2|Overall Study|Not Specified|1
846944|NCT01674062|2787217|P1|Overall Study|Not Specified|8
846945|NCT01674062|2787216|P2|Overall Study|Insufficient Therapeutic Response|26
846946|NCT01674062|2787217|P1|Overall Study|Insufficient Therapeutic Response|56
846947|NCT01674010|2787232|P3|Randomization Phase 2|Withdrawal by Subject|7
846948|NCT01674010|2787233|P2|Randomization Phase 2|Withdrawal by Subject|8
846949|NCT01674010|2787234|P1|Randomization Phase 2|Withdrawal by Subject|0
846950|NCT01674010|2787232|P3|Randomization Phase 2|Sponsor Decision|45
846951|NCT01674010|2787233|P2|Randomization Phase 2|Sponsor Decision|42
846952|NCT01674010|2787234|P1|Randomization Phase 2|Sponsor Decision|0
846953|NCT01674010|2787232|P3|Randomization Phase 2|Protocol Violation|1
846954|NCT01674010|2787233|P2|Randomization Phase 2|Protocol Violation|1
846955|NCT01674010|2787234|P1|Randomization Phase 2|Protocol Violation|0
846956|NCT01674010|2787232|P3|Randomization Phase 2|Pregnancy|1
846957|NCT01674010|2787233|P2|Randomization Phase 2|Pregnancy|1
846958|NCT01674010|2787234|P1|Randomization Phase 2|Pregnancy|0
846959|NCT01674010|2787232|P3|Randomization Phase 2|Physician Decision|2
846960|NCT01674010|2787233|P2|Randomization Phase 2|Physician Decision|0
846961|NCT01674010|2787234|P1|Randomization Phase 2|Physician Decision|0
846962|NCT01674010|2787232|P3|Randomization Phase 2|Mood episode recurrence|2
846963|NCT01674010|2787233|P2|Randomization Phase 2|Mood episode recurrence|8
846964|NCT01674010|2787234|P1|Randomization Phase 2|Mood episode recurrence|0
846965|NCT01674010|2787232|P3|Randomization Phase 2|Lost to Follow-up|2
846966|NCT01674010|2787233|P2|Randomization Phase 2|Lost to Follow-up|1
846967|NCT01674010|2787234|P1|Randomization Phase 2|Lost to Follow-up|0
846968|NCT01674010|2787232|P3|Randomization Phase 2|Adverse Event|1
846969|NCT01674010|2787233|P2|Randomization Phase 2|Adverse Event|1
846970|NCT01674010|2787234|P1|Randomization Phase 2|Adverse Event|0
846971|NCT01674010|2787232|P3|Open Treatment Phase 1|Withdrawal by Subject|0
846972|NCT01674010|2787233|P2|Open Treatment Phase 1|Withdrawal by Subject|0
846973|NCT01674010|2787234|P1|Open Treatment Phase 1|Withdrawal by Subject|25
846974|NCT01674010|2787232|P3|Open Treatment Phase 1|Did not remain in a stable remission|0
846975|NCT01674010|2787233|P2|Open Treatment Phase 1|Did not remain in a stable remission|0
846976|NCT01674010|2787234|P1|Open Treatment Phase 1|Did not remain in a stable remission|30
846977|NCT01674010|2787232|P3|Open Treatment Phase 1|Sponsor Decision|0
846978|NCT01674010|2787233|P2|Open Treatment Phase 1|Sponsor Decision|0
846979|NCT01674010|2787234|P1|Open Treatment Phase 1|Sponsor Decision|79
846980|NCT01674010|2787232|P3|Open Treatment Phase 1|Protocol Violation|0
846981|NCT01674010|2787233|P2|Open Treatment Phase 1|Protocol Violation|0
846982|NCT01674010|2787234|P1|Open Treatment Phase 1|Protocol Violation|7
846983|NCT01674010|2787232|P3|Open Treatment Phase 1|Physician Decision|0
846984|NCT01674010|2787233|P2|Open Treatment Phase 1|Physician Decision|0
846985|NCT01674010|2787234|P1|Open Treatment Phase 1|Physician Decision|9
846986|NCT01674010|2787232|P3|Open Treatment Phase 1|Lost to Follow-up|0
846987|NCT01674010|2787233|P2|Open Treatment Phase 1|Lost to Follow-up|0
846988|NCT01674010|2787234|P1|Open Treatment Phase 1|Lost to Follow-up|19
846989|NCT01674010|2787232|P3|Open Treatment Phase 1|Death|0
846990|NCT01674010|2787233|P2|Open Treatment Phase 1|Death|0
846991|NCT01674010|2787234|P1|Open Treatment Phase 1|Death|1
846992|NCT01674010|2787232|P3|Open Treatment Phase 1|Adverse Event|0
846993|NCT01674010|2787233|P2|Open Treatment Phase 1|Adverse Event|0
846994|NCT01674010|2787234|P1|Open Treatment Phase 1|Adverse Event|10
846995|NCT01673984|2787253|P2|Overall Study|Study termination|6
846996|NCT01673984|2787254|P1|Overall Study|Study termination|9
846997|NCT01673984|2787253|P2|Overall Study|Adverse Event|0
846998|NCT01673984|2787254|P1|Overall Study|Adverse Event|1
846999|NCT01673867|2787304|P2|Treatment|Physician Decision|1
847000|NCT01673867|2787305|P1|Treatment|Physician Decision|0
847001|NCT01673867|2787304|P2|Treatment|Symptomatic deterioration|1
847002|NCT01673867|2787305|P1|Treatment|Symptomatic deterioration|0
847003|NCT01673867|2787304|P2|Treatment|Required prolonged hospitalization|1
847004|NCT01673867|2787305|P1|Treatment|Required prolonged hospitalization|0
847005|NCT01673867|2787304|P2|Treatment|Health status not improved|0
847006|NCT01673867|2787305|P1|Treatment|Health status not improved|1
847007|NCT01673867|2787304|P2|Treatment|Required steroid therapy|0
847008|NCT01673867|2787305|P1|Treatment|Required steroid therapy|1
847009|NCT01673867|2787304|P2|Treatment|No longer meets criteria|0
847010|NCT01673867|2787305|P1|Treatment|No longer meets criteria|2
847011|NCT01673867|2787304|P2|Treatment|Maximum clinical benefit|10
847012|NCT01673867|2787305|P1|Treatment|Maximum clinical benefit|0
847013|NCT01673867|2787304|P2|Treatment|Withdrawal by Subject|6
847014|NCT01673867|2787305|P1|Treatment|Withdrawal by Subject|4
847015|NCT01673867|2787304|P2|Treatment|Requested treatment discontinuation|16
847016|NCT01673867|2787305|P1|Treatment|Requested treatment discontinuation|5
847017|NCT01673867|2787304|P2|Treatment|AE unrelated to study drug|11
847018|NCT01673867|2787305|P1|Treatment|AE unrelated to study drug|19
847019|NCT01673867|2787304|P2|Treatment|Death|1
847020|NCT01673867|2787305|P1|Treatment|Death|1
847021|NCT01673867|2787304|P2|Treatment|Study Drug Toxicity|42
847022|NCT01673867|2787305|P1|Treatment|Study Drug Toxicity|17
847023|NCT01673867|2787304|P2|Treatment|Disease Progression|179
847024|NCT01673867|2787305|P1|Treatment|Disease Progression|194
847025|NCT01673867|2787304|P2|Randomization|No longer meets criteria|5
847026|NCT01673867|2787305|P1|Randomization|No longer meets criteria|4
847027|NCT01673867|2787304|P2|Randomization|Lost to Follow-up|1
847028|NCT01673867|2787305|P1|Randomization|Lost to Follow-up|0
847029|NCT01673867|2787304|P2|Randomization|Withdrawal by Subject|12
847030|NCT01673867|2787305|P1|Randomization|Withdrawal by Subject|0
847031|NCT01673867|2787304|P2|Randomization|Requested treatment discontinuation|4
847032|NCT01673867|2787305|P1|Randomization|Requested treatment discontinuation|0
847033|NCT01673867|2787304|P2|Randomization|AE unrelated to study drug|0
847034|NCT01673867|2787305|P1|Randomization|AE unrelated to study drug|1
847035|NCT01673854|2787331|P1|Vem 2 Phase (Vemurafenib Retreatment)|Death|1
847036|NCT01673854|2787331|P1|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1
847037|NCT01673854|2787331|P1|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5
847038|NCT01673854|2787331|P1|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12
847039|NCT01673854|2787331|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7
847040|NCT01673854|2787331|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2
847041|NCT01673854|2787331|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1
847042|NCT01673854|2787331|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1
847043|NCT01673854|2787331|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1
847044|NCT01673854|2787331|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2
847045|NCT01673854|2787331|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6
847046|NCT01673854|2787331|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7
847047|NCT01673698|2787354|P2|Overall Study|Lost to Follow-up|13
847048|NCT01673698|2787355|P1|Overall Study|Lost to Follow-up|51
847049|NCT01673620|2787365|P2|Overall Study|Adverse Event|0
847050|NCT01673620|2787366|P1|Overall Study|Adverse Event|1
847051|NCT01673594|2787376|P2|Overall Study|Withdrawal by Subject|1
847052|NCT01673594|2787377|P1|Overall Study|Withdrawal by Subject|0
847053|NCT01673594|2787376|P2|Overall Study|Physician Decision|4
847054|NCT01673594|2787377|P1|Overall Study|Physician Decision|2
847055|NCT01673594|2787376|P2|Overall Study|Lost to Follow-up|0
847056|NCT01673594|2787377|P1|Overall Study|Lost to Follow-up|1
847057|NCT01673594|2787376|P2|Overall Study|Adverse Event|1
847058|NCT01673594|2787377|P1|Overall Study|Adverse Event|3
847059|NCT01673490|2787396|P1|Overall Study|Withdrawal by Subject|3
847060|NCT01673490|2787396|P1|Overall Study|Adverse Event|3
847061|NCT01673490|2787396|P1|Overall Study|Lost to Follow-up|1
847062|NCT01673347|2787413|P1|Overall Study|failure of allograft|7
847063|NCT01673282|2787422|P2|Overall Study|Other|6
847064|NCT01673282|2787423|P1|Overall Study|Other|1
847065|NCT01673282|2787422|P2|Overall Study|Withdrawal by Subject|3
847066|NCT01673282|2787423|P1|Overall Study|Withdrawal by Subject|3
847067|NCT01673282|2787422|P2|Overall Study|Lost to Follow-up|10
847068|NCT01673282|2787423|P1|Overall Study|Lost to Follow-up|11
847069|NCT01673282|2787422|P2|Overall Study|Lack of Efficacy|2
847070|NCT01673282|2787423|P1|Overall Study|Lack of Efficacy|9
847071|NCT01673282|2787422|P2|Overall Study|Adverse Drug Reaction - Vimpat|5
847072|NCT01673282|2787423|P1|Overall Study|Adverse Drug Reaction - Vimpat|9
847073|NCT01673178|2787459|P5|Overall Study|Other|0
847074|NCT01673178|2787460|P4|Overall Study|Other|1
847075|NCT01673178|2787461|P3|Overall Study|Other|2
847076|NCT01673178|2787462|P2|Overall Study|Other|0
847077|NCT01673178|2787463|P1|Overall Study|Other|1
847078|NCT01673178|2787459|P5|Overall Study|Adverse Event|0
847079|NCT01673178|2787460|P4|Overall Study|Adverse Event|2
847080|NCT01673178|2787461|P3|Overall Study|Adverse Event|0
847081|NCT01673178|2787462|P2|Overall Study|Adverse Event|0
847082|NCT01673178|2787463|P1|Overall Study|Adverse Event|1
847083|NCT01673178|2787459|P5|Overall Study|Protocol Violation|0
847084|NCT01673178|2787460|P4|Overall Study|Protocol Violation|1
847085|NCT01673178|2787461|P3|Overall Study|Protocol Violation|0
847086|NCT01673178|2787462|P2|Overall Study|Protocol Violation|1
847087|NCT01673178|2787463|P1|Overall Study|Protocol Violation|1
847088|NCT01673178|2787459|P5|Overall Study|Withdrawal by Subject|2
847089|NCT01673178|2787460|P4|Overall Study|Withdrawal by Subject|4
847090|NCT01673178|2787461|P3|Overall Study|Withdrawal by Subject|1
847091|NCT01673178|2787462|P2|Overall Study|Withdrawal by Subject|0
847092|NCT01673178|2787463|P1|Overall Study|Withdrawal by Subject|0
847093|NCT01673178|2787459|P5|Overall Study|Lost to Follow-up|0
847094|NCT01673178|2787460|P4|Overall Study|Lost to Follow-up|0
847095|NCT01673178|2787461|P3|Overall Study|Lost to Follow-up|0
847096|NCT01673178|2787462|P2|Overall Study|Lost to Follow-up|1
847097|NCT01673178|2787463|P1|Overall Study|Lost to Follow-up|0
847098|NCT01673126|2787702|P2|Overall Study|change of diagnosis|3
847099|NCT01673126|2787703|P1|Overall Study|change of diagnosis|4
847100|NCT01673009|2787723|P1|Overall Study|Withdrawal by Subject|8
847101|NCT01673009|2787723|P1|Overall Study|Physician Decision|5
847102|NCT01672970|2787808|P1|Overall Study|Enrolled but not treated|1
847103|NCT01672970|2787808|P1|Overall Study|Other|9
847104|NCT01672970|2787808|P1|Overall Study|Lost to Follow-up|5
847105|NCT01672970|2787808|P1|Overall Study|Withdrawal by Subject|2
847106|NCT01672970|2787808|P1|Overall Study|Adverse Event|18
847107|NCT01672970|2787808|P1|Overall Study|Lack of Efficacy|12
847108|NCT01672957|2787844|P1|Overall Study|ICF Signed After Transplantation|5
847109|NCT01672957|2787844|P1|Overall Study|Death|2
847110|NCT01672957|2787844|P1|Overall Study|Protocol Violation|48
847111|NCT01672892|2787859|P2|Overall Study|Protocol Violation|3
847112|NCT01672892|2787860|P1|Overall Study|Protocol Violation|8
847113|NCT01672788|2787880|P4|Washout Period 2 (7 Days)|Adverse Event|1
847114|NCT01672788|2787881|P3|Washout Period 2 (7 Days)|Adverse Event|0
847115|NCT01672788|2787882|P2|Washout Period 2 (7 Days)|Adverse Event|0
847116|NCT01672788|2787883|P1|Washout Period 2 (7 Days)|Adverse Event|0
847117|NCT01672736|2787913|P1|Overall Study|Available drug expired on 31 May 16|3
847118|NCT01672723|2787917|P2|First Intervention|Adverse Event|0
847119|NCT01672723|2787918|P1|First Intervention|Adverse Event|3
847120|NCT01672294|2787955|P4|Overall Study|Lost to Follow-up|9
847121|NCT01672294|2787956|P3|Overall Study|Lost to Follow-up|7
847122|NCT01672294|2787957|P2|Overall Study|Lost to Follow-up|16
847123|NCT01672294|2787958|P1|Overall Study|Lost to Follow-up|1
847124|NCT01672294|2787955|P4|Overall Study|Excluded by study|0
847125|NCT01672294|2787956|P3|Overall Study|Excluded by study|0
847126|NCT01672294|2787957|P2|Overall Study|Excluded by study|1
847127|NCT01672294|2787958|P1|Overall Study|Excluded by study|1
847128|NCT01672294|2787955|P4|Overall Study|Withdrawal by Subject|4
847129|NCT01672294|2787956|P3|Overall Study|Withdrawal by Subject|4
847130|NCT01672294|2787957|P2|Overall Study|Withdrawal by Subject|4
847131|NCT01672294|2787958|P1|Overall Study|Withdrawal by Subject|4
847132|NCT01671748|2787998|P2|4 Week run-in Phase|Not eligible|0
847133|NCT01671748|2787999|P1|4 Week run-in Phase|Not eligible|9
847134|NCT01671748|2787998|P2|4 Week run-in Phase|Adverse Event|0
847135|NCT01671748|2787999|P1|4 Week run-in Phase|Adverse Event|1
847136|NCT01671748|2787998|P2|4 Week run-in Phase|Withdrawal by Subject|0
847137|NCT01671748|2787999|P1|4 Week run-in Phase|Withdrawal by Subject|1
847138|NCT01671488|2788026|P1|Overall Study|Withdrawal by Subject|1
847139|NCT01671319|2788032|P1|Overall Study|Withdrawal by Subject|1
847140|NCT01671280|2788047|P1|Overall Study|Withdrawal by Subject|2
847141|NCT01671111|2788058|P1|Overall Study|Other|24
847142|NCT01671111|2788058|P1|Overall Study|Physician Decision|1
847143|NCT01671111|2788058|P1|Overall Study|Withdrawal by Subject|2
847144|NCT01671111|2788058|P1|Overall Study|Lack of Efficacy|1
847145|NCT01671111|2788058|P1|Overall Study|Adverse Event|2
847146|NCT01671059|2788068|P1|Overall Study|Lack of Efficacy|1
847147|NCT01671059|2788068|P1|Overall Study|Adverse Event|4
847148|NCT01670721|2788160|P1|Overall Study|Other than specified above|38
847149|NCT01670721|2788160|P1|Overall Study|Participant's decision|15
847150|NCT01670656|2788172|P5|Overall Study|Subject moved|0
847151|NCT01670656|2788173|P4|Overall Study|Subject moved|1
847152|NCT01670656|2788174|P3|Overall Study|Subject moved|0
847153|NCT01670656|2788175|P2|Overall Study|Subject moved|0
847154|NCT01670656|2788176|P1|Overall Study|Subject moved|0
847155|NCT01670656|2788172|P5|Overall Study|Lost to Follow-up|3
847156|NCT01670656|2788173|P4|Overall Study|Lost to Follow-up|0
847157|NCT01670656|2788174|P3|Overall Study|Lost to Follow-up|0
847158|NCT01670656|2788175|P2|Overall Study|Lost to Follow-up|0
847159|NCT01670656|2788176|P1|Overall Study|Lost to Follow-up|0
847160|NCT01670656|2788172|P5|Overall Study|Subject withdrew consent|1
847161|NCT01670656|2788173|P4|Overall Study|Subject withdrew consent|1
847162|NCT01670656|2788174|P3|Overall Study|Subject withdrew consent|2
847163|NCT01670656|2788175|P2|Overall Study|Subject withdrew consent|1
847164|NCT01670656|2788176|P1|Overall Study|Subject withdrew consent|0
847165|NCT01670656|2788172|P5|Overall Study|Adverse Event|3
847166|NCT01670656|2788173|P4|Overall Study|Adverse Event|3
847167|NCT01670656|2788174|P3|Overall Study|Adverse Event|2
847168|NCT01670656|2788175|P2|Overall Study|Adverse Event|2
847169|NCT01670656|2788176|P1|Overall Study|Adverse Event|2
847170|NCT01670656|2788172|P5|Overall Study|Non-compliance with protocol|2
847171|NCT01670656|2788173|P4|Overall Study|Non-compliance with protocol|1
847172|NCT01670656|2788174|P3|Overall Study|Non-compliance with protocol|1
847173|NCT01670656|2788175|P2|Overall Study|Non-compliance with protocol|3
847174|NCT01670656|2788176|P1|Overall Study|Non-compliance with protocol|0
847175|NCT01670656|2788172|P5|Overall Study|Withdrawal by Subject|0
847176|NCT01670656|2788173|P4|Overall Study|Withdrawal by Subject|0
847177|NCT01670656|2788174|P3|Overall Study|Withdrawal by Subject|0
847178|NCT01670656|2788175|P2|Overall Study|Withdrawal by Subject|1
847179|NCT01670656|2788176|P1|Overall Study|Withdrawal by Subject|1
847180|NCT01670656|2788172|P5|Overall Study|Pregnancy|1
847181|NCT01670656|2788173|P4|Overall Study|Pregnancy|0
847182|NCT01670656|2788174|P3|Overall Study|Pregnancy|0
847183|NCT01670656|2788175|P2|Overall Study|Pregnancy|0
847184|NCT01670656|2788176|P1|Overall Study|Pregnancy|0
847185|NCT01670656|2788172|P5|Overall Study|Non-compliance with study drug|1
847186|NCT01670656|2788173|P4|Overall Study|Non-compliance with study drug|0
847187|NCT01670656|2788174|P3|Overall Study|Non-compliance with study drug|3
847188|NCT01670656|2788175|P2|Overall Study|Non-compliance with study drug|0
847189|NCT01670656|2788176|P1|Overall Study|Non-compliance with study drug|0
847190|NCT01670526|2788205|P2|Overall Study|Lost to Follow-up|5
847191|NCT01670526|2788206|P1|Overall Study|Lost to Follow-up|9
847192|NCT01670526|2788205|P2|Overall Study|Withdrawal by Subject|1
847193|NCT01670526|2788206|P1|Overall Study|Withdrawal by Subject|3
847194|NCT01670292|2788227|P1|Overall Study|Lost to Follow-up|14
847195|NCT01670279|2788268|P4|Overall Study|Participant met withdrawal criteria|1
847196|NCT01670279|2788269|P3|Overall Study|Participant met withdrawal criteria|0
847197|NCT01670279|2788270|P2|Overall Study|Participant met withdrawal criteria|0
847198|NCT01670279|2788271|P1|Overall Study|Participant met withdrawal criteria|0
847199|NCT01670279|2788268|P4|Overall Study|Physician Decision|0
847200|NCT01670279|2788269|P3|Overall Study|Physician Decision|0
847201|NCT01670279|2788270|P2|Overall Study|Physician Decision|1
847202|NCT01670279|2788271|P1|Overall Study|Physician Decision|0
847203|NCT01670279|2788268|P4|Overall Study|Adverse Event|0
847204|NCT01670279|2788269|P3|Overall Study|Adverse Event|0
847205|NCT01670279|2788270|P2|Overall Study|Adverse Event|1
847206|NCT01670279|2788271|P1|Overall Study|Adverse Event|0
847207|NCT01670188|2788313|P2|Overall Study|Death|1
847208|NCT01670188|2788314|P1|Overall Study|Death|0
847209|NCT01670045|2788320|P1|Overall Study|Lost to Follow-up|11
847210|NCT01670045|2788320|P1|Overall Study|Death|1
847211|NCT01670045|2788320|P1|Overall Study|Adverse Event|1
847212|NCT01670045|2788320|P1|Overall Study|Withdrawal by Subject|3
847213|NCT01670019|2788338|P2|Overall Study|Withdrawal by Subject|0
847214|NCT01670019|2788339|P1|Overall Study|Withdrawal by Subject|6
847215|NCT01670019|2788338|P2|Overall Study|Adverse Event|0
847216|NCT01670019|2788339|P1|Overall Study|Adverse Event|3
847217|NCT01669902|2788353|P1|Overall Study|Other|8
847218|NCT01669902|2788353|P1|Overall Study|Lack of Efficacy|10
847219|NCT01669902|2788353|P1|Overall Study|Adverse Event|11
847220|NCT01669811|2788388|P2|Overall Study|Eligibility Criteria Not Fulfilled|2
847221|NCT01669811|2788389|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
847222|NCT01669811|2788388|P2|Overall Study|Adverse Event|6
847223|NCT01669811|2788389|P1|Overall Study|Adverse Event|2
847224|NCT01669811|2788388|P2|Overall Study|Withdrawal by Subject|2
847225|NCT01669811|2788389|P1|Overall Study|Withdrawal by Subject|1
847226|NCT01669811|2788388|P2|Overall Study|Investigator decision|1
847227|NCT01669811|2788389|P1|Overall Study|Investigator decision|0
847228|NCT01669798|2788407|P1|Overall Study|Physician Decision|5
847229|NCT01669629|2788513|P2|Period 1|protocol deviation|2
847230|NCT01669629|2788514|P1|Period 1|protocol deviation|1
847231|NCT01669577|2788537|P1|Overall Study|Physician Decision|34
847232|NCT01669577|2788537|P1|Overall Study|Lost to Follow-up|78
847233|NCT01669577|2788537|P1|Overall Study|Death|22
847234|NCT01669174|2788562|P2|Overall Study|Administrative problems|2
847235|NCT01669174|2788563|P1|Overall Study|Administrative problems|1
847236|NCT01669174|2788562|P2|Overall Study|Adverse Event|2
847237|NCT01669174|2788563|P1|Overall Study|Adverse Event|2
847238|NCT01669174|2788562|P2|Overall Study|Lost to Follow-up|0
847239|NCT01669174|2788563|P1|Overall Study|Lost to Follow-up|1
847240|NCT01669174|2788562|P2|Overall Study|Subject withdrew consent|2
847241|NCT01669174|2788563|P1|Overall Study|Subject withdrew consent|2
847242|NCT01669122|2788579|P1|Washout Period II|Protocol Violation|2
847243|NCT01669122|2788579|P1|Period I|Lost to Follow-up|1
847244|NCT01668797|2788672|P4|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38
847245|NCT01668797|2788673|P3|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49
847246|NCT01668797|2788674|P2|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
847247|NCT01668797|2788675|P1|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
847248|NCT01668797|2788672|P4|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2
847249|NCT01668797|2788673|P3|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4
847250|NCT01668797|2788674|P2|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
847251|NCT01668797|2788675|P1|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
847252|NCT01668797|2788672|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30
847253|NCT01668797|2788673|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11
847254|NCT01668797|2788674|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
847255|NCT01668797|2788675|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
847256|NCT01668797|2788672|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10
847257|NCT01668797|2788673|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2
847258|NCT01668797|2788674|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
847259|NCT01668797|2788675|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
847260|NCT01668797|2788672|P4|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
847261|NCT01668797|2788673|P3|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2
847262|NCT01668797|2788674|P2|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
847263|NCT01668797|2788675|P1|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
847264|NCT01668797|2788672|P4|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5
847265|NCT01668797|2788673|P3|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3
847266|NCT01668797|2788674|P2|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
847267|NCT01668797|2788675|P1|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
847268|NCT01668797|2788672|P4|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2
847269|NCT01668797|2788673|P3|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5
847270|NCT01668797|2788674|P2|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
847271|NCT01668797|2788675|P1|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
847272|NCT01668797|2788672|P4|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
847273|NCT01668797|2788673|P3|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
847274|NCT01668797|2788674|P2|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
847275|NCT01668797|2788675|P1|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
847276|NCT01668797|2788672|P4|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6
847277|NCT01668797|2788673|P3|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4
847278|NCT01668797|2788674|P2|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
847279|NCT01668797|2788675|P1|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
847280|NCT01668797|2788672|P4|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
847281|NCT01668797|2788673|P3|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
847282|NCT01668797|2788674|P2|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86
847283|NCT01668797|2788675|P1|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
847284|NCT01668797|2788672|P4|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
847285|NCT01668797|2788673|P3|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
847286|NCT01668797|2788674|P2|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43
847287|NCT01668797|2788675|P1|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
847288|NCT01668797|2788672|P4|Phase B (Stabilization Phase)|Lack of Efficacy|0
847289|NCT01668797|2788673|P3|Phase B (Stabilization Phase)|Lack of Efficacy|0
847290|NCT01668797|2788674|P2|Phase B (Stabilization Phase)|Lack of Efficacy|21
847291|NCT01668797|2788675|P1|Phase B (Stabilization Phase)|Lack of Efficacy|0
847292|NCT01668797|2788672|P4|Phase B (Stabilization Phase)|Protocol Violation|0
847293|NCT01668797|2788673|P3|Phase B (Stabilization Phase)|Protocol Violation|0
847294|NCT01668797|2788674|P2|Phase B (Stabilization Phase)|Protocol Violation|3
847295|NCT01668797|2788675|P1|Phase B (Stabilization Phase)|Protocol Violation|0
847296|NCT01668797|2788672|P4|Phase B (Stabilization Phase)|Withdrawal by Subject|0
847297|NCT01668797|2788673|P3|Phase B (Stabilization Phase)|Withdrawal by Subject|0
847298|NCT01668797|2788674|P2|Phase B (Stabilization Phase)|Withdrawal by Subject|60
847299|NCT01668797|2788675|P1|Phase B (Stabilization Phase)|Withdrawal by Subject|0
847300|NCT01668797|2788672|P4|Phase B (Stabilization Phase)|Physician Decision|0
847301|NCT01668797|2788673|P3|Phase B (Stabilization Phase)|Physician Decision|0
847302|NCT01668797|2788674|P2|Phase B (Stabilization Phase)|Physician Decision|11
847303|NCT01668797|2788675|P1|Phase B (Stabilization Phase)|Physician Decision|0
847304|NCT01668797|2788672|P4|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
847305|NCT01668797|2788673|P3|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
847306|NCT01668797|2788674|P2|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22
847307|NCT01668797|2788675|P1|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
847308|NCT01668797|2788672|P4|Phase B (Stabilization Phase)|Lost to Follow-up|0
847309|NCT01668797|2788673|P3|Phase B (Stabilization Phase)|Lost to Follow-up|0
847310|NCT01668797|2788674|P2|Phase B (Stabilization Phase)|Lost to Follow-up|16
847311|NCT01668797|2788675|P1|Phase B (Stabilization Phase)|Lost to Follow-up|0
847312|NCT01668797|2788672|P4|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
847313|NCT01668797|2788673|P3|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
847314|NCT01668797|2788674|P2|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
847315|NCT01668797|2788675|P1|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19
847316|NCT01668797|2788672|P4|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
847317|NCT01668797|2788673|P3|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
847318|NCT01668797|2788674|P2|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
847319|NCT01668797|2788675|P1|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8
847320|NCT01668797|2788672|P4|Phase A (Conversion Phase)|Lack of Efficacy|0
847321|NCT01668797|2788673|P3|Phase A (Conversion Phase)|Lack of Efficacy|0
847322|NCT01668797|2788674|P2|Phase A (Conversion Phase)|Lack of Efficacy|0
847323|NCT01668797|2788675|P1|Phase A (Conversion Phase)|Lack of Efficacy|7
847324|NCT01668797|2788672|P4|Phase A (Conversion Phase)|Protocol Violation|0
847325|NCT01668797|2788673|P3|Phase A (Conversion Phase)|Protocol Violation|0
847326|NCT01668797|2788674|P2|Phase A (Conversion Phase)|Protocol Violation|0
847327|NCT01668797|2788675|P1|Phase A (Conversion Phase)|Protocol Violation|2
847328|NCT01668797|2788672|P4|Phase A (Conversion Phase)|Withdrawal by Subject|0
847329|NCT01668797|2788673|P3|Phase A (Conversion Phase)|Withdrawal by Subject|0
847330|NCT01668797|2788674|P2|Phase A (Conversion Phase)|Withdrawal by Subject|0
847331|NCT01668797|2788675|P1|Phase A (Conversion Phase)|Withdrawal by Subject|16
847332|NCT01668797|2788672|P4|Phase A (Conversion Phase)|Physician Decision|0
847333|NCT01668797|2788673|P3|Phase A (Conversion Phase)|Physician Decision|0
847334|NCT01668797|2788674|P2|Phase A (Conversion Phase)|Physician Decision|0
847335|NCT01668797|2788675|P1|Phase A (Conversion Phase)|Physician Decision|2
847336|NCT01668797|2788672|P4|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
847337|NCT01668797|2788673|P3|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
847338|NCT01668797|2788674|P2|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
847339|NCT01668797|2788675|P1|Phase A (Conversion Phase)|Met Withdrawal Criteria|3
847340|NCT01668797|2788672|P4|Phase A (Conversion Phase)|Lost to Follow-up|0
847341|NCT01668797|2788673|P3|Phase A (Conversion Phase)|Lost to Follow-up|0
847342|NCT01668797|2788674|P2|Phase A (Conversion Phase)|Lost to Follow-up|0
847343|NCT01668797|2788675|P1|Phase A (Conversion Phase)|Lost to Follow-up|3
847344|NCT01668784|2788740|P2|Treated (Overall)|Not Specified|4
847345|NCT01668784|2788741|P1|Treated (Overall)|Not Specified|0
847346|NCT01668784|2788740|P2|Treated (Overall)|Maximal Clinical Benefit|3
847347|NCT01668784|2788741|P1|Treated (Overall)|Maximal Clinical Benefit|2
847348|NCT01668784|2788740|P2|Treated (Overall)|Withdrawal by Subject|3
847349|NCT01668784|2788741|P1|Treated (Overall)|Withdrawal by Subject|2
847350|NCT01668784|2788740|P2|Treated (Overall)|Request to Discontinue Study Treatment|18
847351|NCT01668784|2788741|P1|Treated (Overall)|Request to Discontinue Study Treatment|5
847352|NCT01668784|2788740|P2|Treated (Overall)|Adverse Event Unrelated to Study Drug|14
847353|NCT01668784|2788741|P1|Treated (Overall)|Adverse Event Unrelated to Study Drug|9
847354|NCT01668784|2788740|P2|Treated (Overall)|Death|1
847355|NCT01668784|2788741|P1|Treated (Overall)|Death|1
847356|NCT01668784|2788740|P2|Treated (Overall)|Study Drug Toxicity|53
847357|NCT01668784|2788741|P1|Treated (Overall)|Study Drug Toxicity|35
847358|NCT01668784|2788740|P2|Treated (Overall)|Disease Progression|273
847359|NCT01668784|2788741|P1|Treated (Overall)|Disease Progression|285
847360|NCT01668784|2788740|P2|Randomized (Pre-treatment)|Not Specified|1
847361|NCT01668784|2788741|P1|Randomized (Pre-treatment)|Not Specified|0
847362|NCT01668784|2788740|P2|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1
847363|NCT01668784|2788741|P1|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2
847364|NCT01668784|2788740|P2|Randomized (Pre-treatment)|Poor/Non-Compliance|0
847365|NCT01668784|2788741|P1|Randomized (Pre-treatment)|Poor/Non-Compliance|1
847366|NCT01668784|2788740|P2|Randomized (Pre-treatment)|Withdrawal by Subject|8
847367|NCT01668784|2788741|P1|Randomized (Pre-treatment)|Withdrawal by Subject|1
847368|NCT01668784|2788740|P2|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3
847369|NCT01668784|2788741|P1|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0
847370|NCT01668784|2788740|P2|Randomized (Pre-treatment)|Disease Progression|1
847371|NCT01668784|2788741|P1|Randomized (Pre-treatment)|Disease Progression|0
847372|NCT01668667|2788769|P4|Overall Study|Withdrawal by Subject|5
847373|NCT01668667|2788770|P3|Overall Study|Withdrawal by Subject|5
847374|NCT01668667|2788771|P2|Overall Study|Withdrawal by Subject|4
847375|NCT01668667|2788772|P1|Overall Study|Withdrawal by Subject|7
847376|NCT01668667|2788769|P4|Overall Study|Physician Decision|0
847377|NCT01668667|2788770|P3|Overall Study|Physician Decision|1
847378|NCT01668667|2788771|P2|Overall Study|Physician Decision|0
847379|NCT01668667|2788772|P1|Overall Study|Physician Decision|3
847380|NCT01668667|2788769|P4|Overall Study|Lost to Follow-up|6
847381|NCT01668667|2788770|P3|Overall Study|Lost to Follow-up|7
847382|NCT01668667|2788771|P2|Overall Study|Lost to Follow-up|4
847383|NCT01668667|2788772|P1|Overall Study|Lost to Follow-up|9
847384|NCT01668667|2788769|P4|Overall Study|Protocol Violation|5
847385|NCT01668667|2788770|P3|Overall Study|Protocol Violation|12
847386|NCT01668667|2788771|P2|Overall Study|Protocol Violation|10
847387|NCT01668667|2788772|P1|Overall Study|Protocol Violation|6
847388|NCT01668667|2788769|P4|Overall Study|Lack of Efficacy|3
847389|NCT01668667|2788770|P3|Overall Study|Lack of Efficacy|2
847390|NCT01668667|2788771|P2|Overall Study|Lack of Efficacy|2
847391|NCT01668667|2788772|P1|Overall Study|Lack of Efficacy|3
847392|NCT01668667|2788769|P4|Overall Study|Adverse Event|4
847393|NCT01668667|2788770|P3|Overall Study|Adverse Event|4
847394|NCT01668667|2788771|P2|Overall Study|Adverse Event|6
847395|NCT01668667|2788772|P1|Overall Study|Adverse Event|3
847396|NCT01668654|2788794|P1|Overall Study|Withdrawal by Subject|1
847397|NCT01668654|2788794|P1|Overall Study|Study Closed/Terminated|3
847398|NCT01668589|2788855|P4|Overall Study|Other|15
847399|NCT01668589|2788856|P3|Overall Study|Other|7
847400|NCT01668589|2788857|P2|Overall Study|Other|10
847401|NCT01668589|2788858|P1|Overall Study|Other|44
847402|NCT01668589|2788855|P4|Overall Study|Death|11
847403|NCT01668589|2788856|P3|Overall Study|Death|2
847404|NCT01668589|2788857|P2|Overall Study|Death|3
847405|NCT01668589|2788858|P1|Overall Study|Death|12
847406|NCT01668589|2788855|P4|Overall Study|Full Consent/Agreement Withdrawn|4
847407|NCT01668589|2788856|P3|Overall Study|Full Consent/Agreement Withdrawn|11
847408|NCT01668589|2788857|P2|Overall Study|Full Consent/Agreement Withdrawn|8
847409|NCT01668589|2788858|P1|Overall Study|Full Consent/Agreement Withdrawn|54
847410|NCT01668589|2788855|P4|Overall Study|Lost to Follow-up|5
847411|NCT01668589|2788856|P3|Overall Study|Lost to Follow-up|15
847412|NCT01668589|2788857|P2|Overall Study|Lost to Follow-up|37
847413|NCT01668589|2788858|P1|Overall Study|Lost to Follow-up|29
847414|NCT01668173|2788896|P1|Overall Study|Trial suspension|4
847415|NCT01668173|2788896|P1|Overall Study|Adverse Event|3
847416|NCT01668004|2789022|P1|Overall Study|Non-compliance with treatment|2
847417|NCT01668004|2789022|P1|Overall Study|Lack of Efficacy|9
847418|NCT01668004|2789022|P1|Overall Study|Lost to Follow-up|5
847419|NCT01668004|2789022|P1|Overall Study|Withdrawal by Subject|2
847420|NCT01668004|2789022|P1|Overall Study|Adverse Event|7
847421|NCT01667926|2789044|P3|Overall Study|Side effects|0
847422|NCT01667926|2789045|P2|Overall Study|Side effects|0
847423|NCT01667926|2789046|P1|Overall Study|Side effects|3
847424|NCT01667926|2789044|P3|Overall Study|Lost to Follow-up|1
847425|NCT01667926|2789045|P2|Overall Study|Lost to Follow-up|2
847426|NCT01667926|2789046|P1|Overall Study|Lost to Follow-up|1
847427|NCT01667926|2789044|P3|Overall Study|Inclusion/Exclusion Criteria|5
847428|NCT01667926|2789045|P2|Overall Study|Inclusion/Exclusion Criteria|0
847429|NCT01667926|2789046|P1|Overall Study|Inclusion/Exclusion Criteria|0
847430|NCT01667926|2789044|P3|Overall Study|Time committment|2
847431|NCT01667926|2789045|P2|Overall Study|Time committment|0
847432|NCT01667926|2789046|P1|Overall Study|Time committment|0
847433|NCT01667926|2789044|P3|Overall Study|Physician Decision|1
847434|NCT01667926|2789045|P2|Overall Study|Physician Decision|0
847435|NCT01667926|2789046|P1|Overall Study|Physician Decision|0
847436|NCT01667926|2789044|P3|Overall Study|Withdrawal by Subject|2
847437|NCT01667926|2789045|P2|Overall Study|Withdrawal by Subject|2
847438|NCT01667926|2789046|P1|Overall Study|Withdrawal by Subject|1
847439|NCT01667900|2789059|P20|Part B|Death|0
847440|NCT01667900|2789060|P19|Part B|Death|0
847441|NCT01667900|2789061|P18|Part B|Death|0
847442|NCT01667900|2789062|P17|Part B|Death|1
847443|NCT01667900|2789063|P16|Part B|Death|0
847444|NCT01667900|2789064|P15|Part B|Death|0
847445|NCT01667900|2789065|P14|Part B|Death|0
847446|NCT01667900|2789066|P13|Part B|Death|0
847447|NCT01667900|2789067|P12|Part B|Death|0
847448|NCT01667900|2789068|P11|Part B|Death|0
847449|NCT01667900|2789069|P10|Part B|Death|0
847450|NCT01667900|2789070|P9|Part B|Death|0
847451|NCT01667900|2789071|P8|Part B|Death|0
847452|NCT01667900|2789072|P7|Part B|Death|0
847453|NCT01667900|2789073|P6|Part B|Death|0
847454|NCT01667900|2789074|P5|Part B|Death|0
847455|NCT01667900|2789075|P4|Part B|Death|0
847456|NCT01667900|2789076|P3|Part B|Death|0
847457|NCT01667900|2789077|P2|Part B|Death|0
847458|NCT01667900|2789078|P1|Part B|Death|0
847459|NCT01667731|2789148|P5|Overall Study|Death|0
847460|NCT01667731|2789149|P4|Overall Study|Death|0
847461|NCT01667731|2789150|P3|Overall Study|Death|0
847462|NCT01667731|2789151|P2|Overall Study|Death|1
847463|NCT01667731|2789152|P1|Overall Study|Death|0
847464|NCT01667731|2789148|P5|Overall Study|Subject Withdrew Consent|1
847465|NCT01667731|2789149|P4|Overall Study|Subject Withdrew Consent|0
847466|NCT01667731|2789150|P3|Overall Study|Subject Withdrew Consent|1
847467|NCT01667731|2789151|P2|Overall Study|Subject Withdrew Consent|0
847468|NCT01667731|2789152|P1|Overall Study|Subject Withdrew Consent|2
847469|NCT01667731|2789148|P5|Overall Study|Lost to Follow-up|2
847470|NCT01667731|2789149|P4|Overall Study|Lost to Follow-up|1
847471|NCT01667731|2789150|P3|Overall Study|Lost to Follow-up|1
847472|NCT01667731|2789151|P2|Overall Study|Lost to Follow-up|3
847473|NCT01667731|2789152|P1|Overall Study|Lost to Follow-up|2
847474|NCT01667731|2789148|P5|Overall Study|Efficacy Failure|24
847475|NCT01667731|2789149|P4|Overall Study|Efficacy Failure|1
847476|NCT01667731|2789150|P3|Overall Study|Efficacy Failure|0
847477|NCT01667731|2789151|P2|Overall Study|Efficacy Failure|12
847478|NCT01667731|2789152|P1|Overall Study|Efficacy Failure|1
847479|NCT01667731|2789148|P5|Overall Study|Enrolled but not treated|1
847480|NCT01667731|2789149|P4|Overall Study|Enrolled but not treated|0
847481|NCT01667731|2789150|P3|Overall Study|Enrolled but not treated|0
847482|NCT01667731|2789151|P2|Overall Study|Enrolled but not treated|0
847483|NCT01667731|2789152|P1|Overall Study|Enrolled but not treated|0
847484|NCT01667679|2789207|P2|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1
847485|NCT01667679|2789208|P1|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0
847486|NCT01667679|2789207|P2|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1
847487|NCT01667679|2789208|P1|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0
847488|NCT01667679|2789207|P2|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1
847489|NCT01667679|2789208|P1|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0
847490|NCT01667679|2789207|P2|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1
847491|NCT01667679|2789208|P1|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0
847492|NCT01667679|2789207|P2|Treatment Period 2 (<=12 Weeks)|Adverse Event|0
847493|NCT01667679|2789208|P1|Treatment Period 2 (<=12 Weeks)|Adverse Event|1
847494|NCT01667679|2789207|P2|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0
847495|NCT01667679|2789208|P1|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1
847496|NCT01667679|2789207|P2|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0
847497|NCT01667679|2789208|P1|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1
847498|NCT01667679|2789207|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance|4
847499|NCT01667679|2789208|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance|3
847500|NCT01667679|2789207|P2|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10
847501|NCT01667679|2789208|P1|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8
847502|NCT01667679|2789207|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0
847503|NCT01667679|2789208|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2
847504|NCT01667679|2789207|P2|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4
847505|NCT01667679|2789208|P1|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6
847506|NCT01667679|2789207|P2|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1
847507|NCT01667679|2789208|P1|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0
847508|NCT01667679|2789207|P2|Treatment Period 1 (<=12 Weeks)|Non-compliance|3
847509|NCT01667679|2789208|P1|Treatment Period 1 (<=12 Weeks)|Non-compliance|0
847510|NCT01667679|2789207|P2|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2
847511|NCT01667679|2789208|P1|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0
847512|NCT01667679|2789207|P2|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2
847513|NCT01667679|2789208|P1|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0
847514|NCT01667679|2789207|P2|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
847515|NCT01667679|2789208|P1|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
847516|NCT01667679|2789207|P2|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13
847517|NCT01667679|2789208|P1|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6
847518|NCT01667679|2789207|P2|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0
847519|NCT01667679|2789208|P1|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1
847520|NCT01667679|2789207|P2|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0
847521|NCT01667679|2789208|P1|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2
847522|NCT01667679|2789207|P2|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0
847523|NCT01667679|2789208|P1|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2
847524|NCT01667679|2789207|P2|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6
847525|NCT01667679|2789208|P1|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2
847526|NCT01667432|2789293|P1|Overall Study|Missing Information|4
847527|NCT01667432|2789293|P1|Overall Study|Reason Not Specified|2
847528|NCT01667432|2789293|P1|Overall Study|Principal Investigator Decision|1
847529|NCT01667432|2789293|P1|Overall Study|Protocol Deviation|2
847530|NCT01667432|2789293|P1|Overall Study|Adverse Event|1
847531|NCT01667432|2789293|P1|Overall Study|Insufficient Therapeutic Response|4
847532|NCT01667432|2789293|P1|Overall Study|Refused Treatment/Withdrew Consent|1
847533|NCT01667432|2789293|P1|Overall Study|Lost to Follow-up|3
847534|NCT01667432|2789293|P1|Overall Study|Moved to Another Center|3
847535|NCT01667432|2789293|P1|Overall Study|Failure to Return|10
847536|NCT01667432|2789293|P1|Overall Study|Premature Study Termination|26
847537|NCT01667419|2789302|P4|Overall Study|Continued in ongoing study|60
847538|NCT01667419|2789303|P3|Overall Study|Continued in ongoing study|65
847539|NCT01667419|2789304|P2|Overall Study|Continued in ongoing study|116
847540|NCT01667419|2789305|P1|Overall Study|Continued in ongoing study|121
847541|NCT01667419|2789302|P4|Overall Study|Death|20
847542|NCT01667419|2789303|P3|Overall Study|Death|19
847543|NCT01667419|2789304|P2|Overall Study|Death|28
847544|NCT01667419|2789305|P1|Overall Study|Death|16
847545|NCT01667419|2789302|P4|Overall Study|Lost to Follow-up|2
847546|NCT01667419|2789303|P3|Overall Study|Lost to Follow-up|0
847547|NCT01667419|2789304|P2|Overall Study|Lost to Follow-up|5
847548|NCT01667419|2789305|P1|Overall Study|Lost to Follow-up|2
847549|NCT01667419|2789302|P4|Overall Study|Protocol Violation|0
847550|NCT01667419|2789303|P3|Overall Study|Protocol Violation|0
847551|NCT01667419|2789304|P2|Overall Study|Protocol Violation|0
847552|NCT01667419|2789305|P1|Overall Study|Protocol Violation|1
847553|NCT01667419|2789302|P4|Overall Study|Non-compliance|1
847554|NCT01667419|2789303|P3|Overall Study|Non-compliance|0
847555|NCT01667419|2789304|P2|Overall Study|Non-compliance|0
847556|NCT01667419|2789305|P1|Overall Study|Non-compliance|0
847557|NCT01667419|2789302|P4|Overall Study|Withdrawal by Subject|8
847558|NCT01667419|2789303|P3|Overall Study|Withdrawal by Subject|9
847559|NCT01667419|2789304|P2|Overall Study|Withdrawal by Subject|8
847560|NCT01667419|2789305|P1|Overall Study|Withdrawal by Subject|15
847561|NCT01667419|2789302|P4|Overall Study|Reason Not Specified|0
847562|NCT01667419|2789303|P3|Overall Study|Reason Not Specified|0
847563|NCT01667419|2789304|P2|Overall Study|Reason Not Specified|0
847564|NCT01667419|2789305|P1|Overall Study|Reason Not Specified|2
847565|NCT01667224|2789353|P2|Overall Study|Protocol Violation|1
847566|NCT01667224|2789354|P1|Overall Study|Protocol Violation|1
847567|NCT01667224|2789353|P2|Overall Study|Withdrawal by Subject|1
847568|NCT01667224|2789354|P1|Overall Study|Withdrawal by Subject|3
847569|NCT01667107|2789368|P2|Overall Study|Lack of Efficacy|1
847570|NCT01667107|2789369|P1|Overall Study|Lack of Efficacy|0
847571|NCT01667107|2789368|P2|Overall Study|Protocol Violation|1
847572|NCT01667107|2789369|P1|Overall Study|Protocol Violation|0
847573|NCT01667107|2789368|P2|Overall Study|Tolerability issues|2
847574|NCT01667107|2789369|P1|Overall Study|Tolerability issues|0
847575|NCT01667107|2789368|P2|Overall Study|Adverse Event|3
847576|NCT01667107|2789369|P1|Overall Study|Adverse Event|4
847577|NCT01666951|2789428|P2|Overall Study|Not dosed|1
847578|NCT01666951|2789429|P1|Overall Study|Not dosed|1
847579|NCT01666782|2789480|P2|Overall Study|Enrolled both years; year 1 data used|0
847580|NCT01666782|2789481|P1|Overall Study|Enrolled both years; year 1 data used|4
847581|NCT01666782|2789480|P2|Overall Study|Received 2 doses of vaccine|1
847582|NCT01666782|2789481|P1|Overall Study|Received 2 doses of vaccine|0
847583|NCT01666314|2789505|P4|Overall Study|Reason not Specified|5
847584|NCT01666314|2789506|P3|Overall Study|Reason not Specified|5
847585|NCT01666314|2789507|P2|Overall Study|Reason not Specified|7
847586|NCT01666314|2789508|P1|Overall Study|Reason not Specified|10
847587|NCT01666314|2789505|P4|Overall Study|Withdrawal by Subject|3
847588|NCT01666314|2789506|P3|Overall Study|Withdrawal by Subject|2
847589|NCT01666314|2789507|P2|Overall Study|Withdrawal by Subject|1
847590|NCT01666314|2789508|P1|Overall Study|Withdrawal by Subject|1
847591|NCT01666314|2789505|P4|Overall Study|Unsatisfactory Therapeutic Response|1
847592|NCT01666314|2789506|P3|Overall Study|Unsatisfactory Therapeutic Response|1
847593|NCT01666314|2789507|P2|Overall Study|Unsatisfactory Therapeutic Response|2
847594|NCT01666314|2789508|P1|Overall Study|Unsatisfactory Therapeutic Response|7
847595|NCT01666314|2789505|P4|Overall Study|Symptomatic Deterioration|0
847596|NCT01666314|2789506|P3|Overall Study|Symptomatic Deterioration|2
847597|NCT01666314|2789507|P2|Overall Study|Symptomatic Deterioration|0
847598|NCT01666314|2789508|P1|Overall Study|Symptomatic Deterioration|1
847599|NCT01666314|2789505|P4|Overall Study|Progressive Disease|20
847600|NCT01666314|2789506|P3|Overall Study|Progressive Disease|19
847601|NCT01666314|2789507|P2|Overall Study|Progressive Disease|9
847602|NCT01666314|2789508|P1|Overall Study|Progressive Disease|11
847603|NCT01666314|2789505|P4|Overall Study|Adverse Event|7
847604|NCT01666314|2789506|P3|Overall Study|Adverse Event|7
847605|NCT01666314|2789507|P2|Overall Study|Adverse Event|13
847606|NCT01666314|2789508|P1|Overall Study|Adverse Event|3
847607|NCT01666119|2789644|P1|Overall Study|Subject experiencing withdrawal symptoms|5
847608|NCT01666119|2789644|P1|Overall Study|non compliance with study medication, pa|18
847609|NCT01666119|2789644|P1|Overall Study|Lost to Follow-up|7
847610|NCT01666119|2789644|P1|Overall Study|Withdrawal by Subject|16
847611|NCT01666119|2789644|P1|Overall Study|Adverse Event|6
847612|NCT01666002|2789651|P2|Overall Study|Lost to Follow-up|0
847613|NCT01666002|2789652|P1|Overall Study|Lost to Follow-up|5
847614|NCT01665911|2789673|P1|Overall Study|Adverse Event|1
847615|NCT01665911|2789673|P1|Overall Study|Withdrawal by Subject|1
847616|NCT01665911|2789673|P1|Overall Study|Protocol Violation|4
847617|NCT01665807|2789682|P3|Overall Study|Withdrawal by Subject|1
847618|NCT01665807|2789683|P2|Overall Study|Withdrawal by Subject|0
847619|NCT01665807|2789684|P1|Overall Study|Withdrawal by Subject|2
847620|NCT01665599|2789695|P1|Overall Study|Could Not Continue Due to Time Constrain|1
847621|NCT01665599|2789695|P1|Overall Study|Participant Left for More Than 3 Months|1
847622|NCT01665599|2789695|P1|Overall Study|Lost to Follow-up|2
847623|NCT01665599|2789695|P1|Overall Study|Death|1
847624|NCT01665599|2789695|P1|Overall Study|Investigator/Sponsor decision|1
847625|NCT01665599|2789695|P1|Overall Study|Consent Withdrawn|1
847626|NCT01665599|2789695|P1|Overall Study|Adverse Event|1
847627|NCT01665430|2789731|P1|Overall Study|Other Unspecified|2
847628|NCT01665430|2789731|P1|Overall Study|Withdrawal by Subject|6
847629|NCT01665430|2789731|P1|Overall Study|Adverse Event|1
847630|NCT01665144|2789829|P2|Overall Study|Withdrawal by Subject|77
847631|NCT01665144|2789830|P1|Overall Study|Withdrawal by Subject|96
847632|NCT01665144|2789829|P2|Overall Study|Adverse Event|18
847633|NCT01665144|2789830|P1|Overall Study|Adverse Event|45
847634|NCT01665144|2789829|P2|Overall Study|Lack of Efficacy|11
847635|NCT01665144|2789830|P1|Overall Study|Lack of Efficacy|16
847636|NCT01665144|2789829|P2|Overall Study|Physician Decision|1
847637|NCT01665144|2789830|P1|Overall Study|Physician Decision|13
847638|NCT01665144|2789829|P2|Overall Study|Lost to Follow-up|8
847639|NCT01665144|2789830|P1|Overall Study|Lost to Follow-up|9
847640|NCT01665144|2789829|P2|Overall Study|Progressive disease|4
847641|NCT01665144|2789830|P1|Overall Study|Progressive disease|8
847642|NCT01665144|2789829|P2|Overall Study|Non-compliance w/study treatment|0
847643|NCT01665144|2789830|P1|Overall Study|Non-compliance w/study treatment|5
847644|NCT01665144|2789829|P2|Overall Study|Protocol deviation|1
847645|NCT01665144|2789830|P1|Overall Study|Protocol deviation|3
847646|NCT01665144|2789829|P2|Overall Study|Death|1
847647|NCT01665144|2789830|P1|Overall Study|Death|3
847648|NCT01665144|2789829|P2|Overall Study|Technical problems|0
847649|NCT01665144|2789830|P1|Overall Study|Technical problems|2
847650|NCT01665144|2789829|P2|Overall Study|New therapy for study indication|1
847651|NCT01665144|2789830|P1|Overall Study|New therapy for study indication|2
847652|NCT01664949|2789888|P2|Overall Study|Other Miscellaneous Reasons|1
847653|NCT01664949|2789889|P1|Overall Study|Other Miscellaneous Reasons|3
847654|NCT01664949|2789888|P2|Overall Study|Protocol Violation|5
847655|NCT01664949|2789889|P1|Overall Study|Protocol Violation|5
847656|NCT01664949|2789888|P2|Overall Study|Personal Reasons|4
847657|NCT01664949|2789889|P1|Overall Study|Personal Reasons|3
847658|NCT01664949|2789888|P2|Overall Study|Lost to Follow-up|2
847659|NCT01664949|2789889|P1|Overall Study|Lost to Follow-up|1
847660|NCT01664949|2789888|P2|Overall Study|Lack of Efficacy|1
847661|NCT01664949|2789889|P1|Overall Study|Lack of Efficacy|1
847662|NCT01664949|2789888|P2|Overall Study|Adverse Event|12
847663|NCT01664949|2789889|P1|Overall Study|Adverse Event|11
847664|NCT01664923|2789905|P2|Overall Study|Miscellaneous|1
847665|NCT01664923|2789906|P1|Overall Study|Miscellaneous|5
847666|NCT01664923|2789905|P2|Overall Study|Adverse Event|12
847667|NCT01664923|2789906|P1|Overall Study|Adverse Event|16
847668|NCT01664923|2789905|P2|Overall Study|Disease Progression|139
847669|NCT01664923|2789906|P1|Overall Study|Disease Progression|58
847670|NCT01664923|2789905|P2|Overall Study|Withdrawal by Subject|5
847671|NCT01664923|2789906|P1|Overall Study|Withdrawal by Subject|11
847672|NCT01664923|2789905|P2|Overall Study|Protocol Violation|0
847673|NCT01664923|2789906|P1|Overall Study|Protocol Violation|2
847674|NCT01664923|2789905|P2|Overall Study|Lost to Follow-up|1
847675|NCT01664923|2789906|P1|Overall Study|Lost to Follow-up|0
847676|NCT01664923|2789905|P2|Overall Study|Death|0
847677|NCT01664923|2789906|P1|Overall Study|Death|1
847678|NCT01664624|2789969|P4|Overall Study|Adverse Event|0
847679|NCT01664624|2789970|P3|Overall Study|Adverse Event|0
847680|NCT01664624|2789971|P2|Overall Study|Adverse Event|1
847681|NCT01664624|2789972|P1|Overall Study|Adverse Event|0
847682|NCT01664533|2790019|P1|Overall Study|Protocol Violation|3
847683|NCT01664533|2790019|P1|Overall Study|Study termination|9
847684|NCT01664533|2790019|P1|Overall Study|Lost to Follow-up|3
847685|NCT01664533|2790019|P1|Overall Study|Death|42
847686|NCT01664494|2790027|P1|Overall Study|Lost to Follow-up|99
847687|NCT01664494|2790027|P1|Overall Study|Not specified|49
847688|NCT01664494|2790027|P1|Overall Study|Death|18
847689|NCT01664494|2790027|P1|Overall Study|Withdrawal by Subject|27
847690|NCT01664247|2790034|P2|Overall Study|Unclassified|29
847691|NCT01664247|2790035|P1|Overall Study|Unclassified|5
847692|NCT01664247|2790034|P2|Overall Study|Withdrawal Criteria|4
847693|NCT01664247|2790035|P1|Overall Study|Withdrawal Criteria|1
847694|NCT01664247|2790034|P2|Overall Study|Protocol Violation|5
847695|NCT01664247|2790035|P1|Overall Study|Protocol Violation|3
847696|NCT01664247|2790034|P2|Overall Study|Adverse Event|3
847697|NCT01664247|2790035|P1|Overall Study|Adverse Event|5
847698|NCT01664104|2790112|P1|Overall Study|Unknown: Reason Unrelated to TCZ|2
847699|NCT01664104|2790112|P1|Overall Study|Other|1
847700|NCT01664104|2790112|P1|Overall Study|Lost to Follow-up|4
847701|NCT01664104|2790112|P1|Overall Study|Withdrawal by Subject|1
847702|NCT01664104|2790112|P1|Overall Study|Lack of Efficacy|2
847703|NCT01664104|2790112|P1|Overall Study|Adverse Event|6
847704|NCT01664052|2790181|P2|Phase 2|No device placement|4
847705|NCT01664052|2790182|P1|Phase 2|No device placement|0
847706|NCT01664052|2790181|P2|Phase 1|No HSG 1 hr post placement|0
847707|NCT01664052|2790182|P1|Phase 1|No HSG 1 hr post placement|1
847708|NCT01664052|2790181|P2|Phase 1|No device placement|0
847709|NCT01664052|2790182|P1|Phase 1|No device placement|6
847710|NCT01664039|2790200|P2|Overall Study|Noncompliance|1
847711|NCT01664039|2790201|P1|Overall Study|Noncompliance|1
847712|NCT01664039|2790200|P2|Overall Study|Withdrawal by Subject|3
847713|NCT01664039|2790201|P1|Overall Study|Withdrawal by Subject|1
847714|NCT01664039|2790200|P2|Overall Study|Lost to Follow-up|1
847715|NCT01664039|2790201|P1|Overall Study|Lost to Follow-up|1
847716|NCT01664039|2790200|P2|Overall Study|Adverse Event|4
847717|NCT01664039|2790201|P1|Overall Study|Adverse Event|3
847718|NCT01663987|2790223|P2|Overall Study|Other reason not defined above|0
847719|NCT01663987|2790224|P1|Overall Study|Other reason not defined above|3
847720|NCT01663987|2790223|P2|Overall Study|Withdrawal by Subject|3
847721|NCT01663987|2790224|P1|Overall Study|Withdrawal by Subject|2
847722|NCT01663987|2790223|P2|Overall Study|Lost to Follow-up|1
847723|NCT01663987|2790224|P1|Overall Study|Lost to Follow-up|1
847724|NCT01663987|2790223|P2|Overall Study|Adverse Event|2
847725|NCT01663987|2790224|P1|Overall Study|Adverse Event|7
847726|NCT01663740|2790269|P2|Overall Study|No end of study status|0
847727|NCT01663740|2790270|P1|Overall Study|No end of study status|3
847728|NCT01663740|2790269|P2|Overall Study|Withdrawal by Subject|1
847729|NCT01663740|2790270|P1|Overall Study|Withdrawal by Subject|2
847730|NCT01663740|2790269|P2|Overall Study|Death|1
847731|NCT01663740|2790270|P1|Overall Study|Death|0
847732|NCT01663740|2790269|P2|Overall Study|Inclusion/Exclusion not met|0
847733|NCT01663740|2790270|P1|Overall Study|Inclusion/Exclusion not met|1
847734|NCT01663740|2790269|P2|Overall Study|Other|2
847735|NCT01663740|2790270|P1|Overall Study|Other|9
847736|NCT01663740|2790269|P2|Overall Study|Lost to Follow-up|4
847737|NCT01663740|2790270|P1|Overall Study|Lost to Follow-up|1
847738|NCT01663727|2790330|P2|Overall Study|Lost to Follow-up|3
847739|NCT01663727|2790331|P1|Overall Study|Lost to Follow-up|8
847740|NCT01663727|2790330|P2|Overall Study|Alive in Follow-Up|132
847741|NCT01663727|2790331|P1|Overall Study|Alive in Follow-Up|143
847742|NCT01663727|2790330|P2|Overall Study|Alive on Treatment|39
847743|NCT01663727|2790331|P1|Overall Study|Alive on Treatment|31
847744|NCT01663727|2790330|P2|Overall Study|Death|65
847745|NCT01663727|2790331|P1|Overall Study|Death|60
847746|NCT01663714|2790359|P1|Long-Term Follow-Up|Non-compliance|1
847747|NCT01663714|2790359|P1|Long-Term Follow-Up|Death|4
847748|NCT01663714|2790359|P1|Long-Term Follow-Up|Lost to Follow-up|1
847749|NCT01663714|2790359|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16
847750|NCT01663714|2790359|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|11
847751|NCT01663714|2790359|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
847752|NCT01663623|2790388|P2|Overall Study|Withdrawal by Subject|1
847753|NCT01663623|2790389|P1|Overall Study|Withdrawal by Subject|2
847754|NCT01663623|2790388|P2|Overall Study|Physician Decision|4
847755|NCT01663623|2790389|P1|Overall Study|Physician Decision|1
847756|NCT01663623|2790388|P2|Overall Study|Other-Study closed/terminated|1
847757|NCT01663623|2790389|P1|Overall Study|Other-Study closed/terminated|1
847758|NCT01663623|2790388|P2|Overall Study|Protocol Violation|1
847759|NCT01663623|2790389|P1|Overall Study|Protocol Violation|0
847760|NCT01663623|2790388|P2|Overall Study|Lack of Efficacy|6
847761|NCT01663623|2790389|P1|Overall Study|Lack of Efficacy|5
847762|NCT01663623|2790388|P2|Overall Study|Adverse Event|7
847763|NCT01663623|2790389|P1|Overall Study|Adverse Event|3
847764|NCT01663532|2790399|P2|Overall Study|Lack of Efficacy|60
847765|NCT01663532|2790400|P1|Overall Study|Lack of Efficacy|15
847766|NCT01663532|2790399|P2|Overall Study|Withdrawal by Subject|17
847767|NCT01663532|2790400|P1|Overall Study|Withdrawal by Subject|35
847768|NCT01663532|2790399|P2|Overall Study|Physician Decision|1
847769|NCT01663532|2790400|P1|Overall Study|Physician Decision|1
847770|NCT01663532|2790399|P2|Overall Study|Met Withdrawal Criteria|6
847771|NCT01663532|2790400|P1|Overall Study|Met Withdrawal Criteria|7
847772|NCT01663532|2790399|P2|Overall Study|Adverse Event|13
847773|NCT01663532|2790400|P1|Overall Study|Adverse Event|7
847774|NCT01663532|2790399|P2|Overall Study|Lost to Follow-up|10
847775|NCT01663532|2790400|P1|Overall Study|Lost to Follow-up|9
847776|NCT01663506|2790418|P1|Overall Study|Switched to Subcutaneous Tocilizumab|2
847777|NCT01663506|2790418|P1|Overall Study|Adverse Event|1
847778|NCT01663506|2790418|P1|Overall Study|Lost to Follow-up|1
847779|NCT01663506|2790418|P1|Overall Study|Consent Withdrawal by Subject|1
847780|NCT01663506|2790418|P1|Overall Study|Lack of Efficacy|3
847781|NCT01663233|2790467|P2|Overall Study|Lost to Follow-up|1
847782|NCT01663233|2790468|P1|Overall Study|Lost to Follow-up|0
847783|NCT01663233|2790467|P2|Overall Study|Protocol Deviation|4
847784|NCT01663233|2790468|P1|Overall Study|Protocol Deviation|1
847785|NCT01663233|2790467|P2|Overall Study|Withdrawal by Subject|2
847786|NCT01663233|2790468|P1|Overall Study|Withdrawal by Subject|3
847787|NCT01663103|2790492|P2|Overall Study|dog bite|0
847788|NCT01663103|2790493|P1|Overall Study|dog bite|1
847789|NCT01663103|2790492|P2|Overall Study|Adverse Event|0
847790|NCT01663103|2790493|P1|Overall Study|Adverse Event|1
847791|NCT01663103|2790492|P2|Overall Study|Withdrawal by Subject|2
847792|NCT01663103|2790493|P1|Overall Study|Withdrawal by Subject|1
847793|NCT01662999|2790521|P6|Period 3|Withdrawal by Subject|0
847794|NCT01662999|2790522|P5|Period 3|Withdrawal by Subject|0
847795|NCT01662999|2790523|P4|Period 3|Withdrawal by Subject|0
847796|NCT01662999|2790524|P3|Period 3|Withdrawal by Subject|0
847797|NCT01662999|2790525|P2|Period 3|Withdrawal by Subject|1
847798|NCT01662999|2790526|P1|Period 3|Withdrawal by Subject|0
847799|NCT01662986|2790597|P2|Overall Study|Other than stated above|0
847800|NCT01662986|2790598|P1|Overall Study|Other than stated above|3
847801|NCT01662986|2790597|P2|Overall Study|Not Treated|0
847802|NCT01662986|2790598|P1|Overall Study|Not Treated|1
847803|NCT01662986|2790597|P2|Overall Study|Withdrawal by Subject|2
847804|NCT01662986|2790598|P1|Overall Study|Withdrawal by Subject|2
847805|NCT01662986|2790597|P2|Overall Study|Lost to Follow-up|4
847806|NCT01662986|2790598|P1|Overall Study|Lost to Follow-up|5
847807|NCT01662986|2790597|P2|Overall Study|Protocol Violation|3
847808|NCT01662986|2790598|P1|Overall Study|Protocol Violation|2
847809|NCT01662986|2790597|P2|Overall Study|Adverse Event|4
847810|NCT01662986|2790598|P1|Overall Study|Adverse Event|5
847811|NCT01662648|2790720|P2|Overall Study|LOE and Participant non-compliant|1
847812|NCT01662648|2790721|P1|Overall Study|LOE and Participant non-compliant|0
847813|NCT01662648|2790720|P2|Overall Study|LOE and other reason unspecified|0
847814|NCT01662648|2790721|P1|Overall Study|LOE and other reason unspecified|1
847815|NCT01662648|2790720|P2|Overall Study|Adverse event and lack of efficacy (LOE)|0
847816|NCT01662648|2790721|P1|Overall Study|Adverse event and lack of efficacy (LOE)|3
847817|NCT01662648|2790720|P2|Overall Study|Other|11
847818|NCT01662648|2790721|P1|Overall Study|Other|8
847819|NCT01662648|2790720|P2|Overall Study|Participant non-compliant|20
847820|NCT01662648|2790721|P1|Overall Study|Participant non-compliant|16
847821|NCT01662648|2790720|P2|Overall Study|Withdrawal by Subject|53
847822|NCT01662648|2790721|P1|Overall Study|Withdrawal by Subject|36
847823|NCT01662648|2790720|P2|Overall Study|Lost to Follow-up|36
847824|NCT01662648|2790721|P1|Overall Study|Lost to Follow-up|24
847825|NCT01662648|2790720|P2|Overall Study|Participant ineligible to continue trial|1
847826|NCT01662648|2790721|P1|Overall Study|Participant ineligible to continue trial|1
847827|NCT01662648|2790720|P2|Overall Study|Lack of Efficacy|16
847828|NCT01662648|2790721|P1|Overall Study|Lack of Efficacy|17
847829|NCT01662648|2790720|P2|Overall Study|Adverse Event|37
847830|NCT01662648|2790721|P1|Overall Study|Adverse Event|40
847831|NCT01662648|2790720|P2|Overall Study|Death|3
847832|NCT01662648|2790721|P1|Overall Study|Death|1
847833|NCT01662635|2790743|P1|Overall Study|scarce samples for evaluation|30
847834|NCT01662505|2790794|P3|Overall Study|Not specified above|2
847835|NCT01662505|2790795|P2|Overall Study|Not specified above|3
847836|NCT01662505|2790796|P1|Overall Study|Not specified above|1
847837|NCT01662505|2790794|P3|Overall Study|Refused cont. medication|1
847838|NCT01662505|2790795|P2|Overall Study|Refused cont. medication|0
847839|NCT01662505|2790796|P1|Overall Study|Refused cont. medication|0
847840|NCT01662505|2790794|P3|Overall Study|Progressive disease|5
847841|NCT01662505|2790795|P2|Overall Study|Progressive disease|1
847842|NCT01662505|2790796|P1|Overall Study|Progressive disease|6
847843|NCT01662492|2790820|P3|Overall Study|Lack of Efficacy|2
847844|NCT01662492|2790821|P2|Overall Study|Lack of Efficacy|1
847845|NCT01662492|2790822|P1|Overall Study|Lack of Efficacy|1
847846|NCT01662492|2790820|P3|Overall Study|Lost to Follow-up|2
847847|NCT01662492|2790821|P2|Overall Study|Lost to Follow-up|0
847848|NCT01662492|2790822|P1|Overall Study|Lost to Follow-up|0
847849|NCT01662492|2790820|P3|Overall Study|Protocol Violation|0
847850|NCT01662492|2790821|P2|Overall Study|Protocol Violation|0
847851|NCT01662492|2790822|P1|Overall Study|Protocol Violation|1
847852|NCT01662492|2790820|P3|Overall Study|Withdrawal by Subject|1
847853|NCT01662492|2790821|P2|Overall Study|Withdrawal by Subject|0
847854|NCT01662492|2790822|P1|Overall Study|Withdrawal by Subject|0
847855|NCT01662492|2790820|P3|Overall Study|Other miscellaneous reasons.|1
847856|NCT01662492|2790821|P2|Overall Study|Other miscellaneous reasons.|0
847857|NCT01662492|2790822|P1|Overall Study|Other miscellaneous reasons.|1
847858|NCT01662440|2790846|P4|Overall Study|Withdrawal by Subject|2
847859|NCT01662440|2790847|P3|Overall Study|Withdrawal by Subject|2
847860|NCT01662440|2790848|P2|Overall Study|Withdrawal by Subject|2
847861|NCT01662440|2790849|P1|Overall Study|Withdrawal by Subject|5
847862|NCT01662440|2790846|P4|Overall Study|Protocol Violation|0
847863|NCT01662440|2790847|P3|Overall Study|Protocol Violation|0
847864|NCT01662440|2790848|P2|Overall Study|Protocol Violation|0
847865|NCT01662440|2790849|P1|Overall Study|Protocol Violation|1
847866|NCT01662440|2790846|P4|Overall Study|Subject moved to another country.|0
847867|NCT01662440|2790847|P3|Overall Study|Subject moved to another country.|0
847868|NCT01662440|2790848|P2|Overall Study|Subject moved to another country.|1
847869|NCT01662440|2790849|P1|Overall Study|Subject moved to another country.|0
847870|NCT01662440|2790846|P4|Overall Study|Lost to Follow-up|1
847871|NCT01662440|2790847|P3|Overall Study|Lost to Follow-up|4
847872|NCT01662440|2790848|P2|Overall Study|Lost to Follow-up|2
847873|NCT01662440|2790849|P1|Overall Study|Lost to Follow-up|2
847874|NCT01662440|2790846|P4|Overall Study|Death|0
847875|NCT01662440|2790847|P3|Overall Study|Death|0
847876|NCT01662440|2790848|P2|Overall Study|Death|1
847877|NCT01662440|2790849|P1|Overall Study|Death|0
847878|NCT01662440|2790846|P4|Overall Study|Adverse Event|1
847879|NCT01662440|2790847|P3|Overall Study|Adverse Event|0
847880|NCT01662440|2790848|P2|Overall Study|Adverse Event|0
847881|NCT01662440|2790849|P1|Overall Study|Adverse Event|1
847882|NCT01662362|2790897|P1|Overall Study|Lost to Follow-up|38
847883|NCT01662336|2790902|P1|Overall Study|Withdrawal by Subject|6
847884|NCT01662336|2790902|P1|Overall Study|Other|29
847885|NCT01662336|2790902|P1|Overall Study|No longer on LPV/r|30
847886|NCT01662336|2790902|P1|Overall Study|Adverse Event|1
847887|NCT01662310|2790928|P5|Open-Label Extension Phase|Withdrawal by Subject|7
847888|NCT01662310|2790929|P4|Open-Label Extension Phase|Withdrawal by Subject|2
847889|NCT01662310|2790930|P3|Open-Label Extension Phase|Withdrawal by Subject|0
847890|NCT01662310|2790931|P2|Open-Label Extension Phase|Withdrawal by Subject|0
847891|NCT01662310|2790932|P1|Open-Label Extension Phase|Withdrawal by Subject|0
847892|NCT01662310|2790928|P5|Open-Label Extension Phase|Pregnancy|0
847893|NCT01662310|2790929|P4|Open-Label Extension Phase|Pregnancy|1
847894|NCT01662310|2790930|P3|Open-Label Extension Phase|Pregnancy|0
847895|NCT01662310|2790931|P2|Open-Label Extension Phase|Pregnancy|0
847896|NCT01662310|2790932|P1|Open-Label Extension Phase|Pregnancy|0
847897|NCT01662310|2790928|P5|Open-Label Extension Phase|Lost to Follow-up|1
847898|NCT01662310|2790929|P4|Open-Label Extension Phase|Lost to Follow-up|2
847899|NCT01662310|2790930|P3|Open-Label Extension Phase|Lost to Follow-up|0
847900|NCT01662310|2790931|P2|Open-Label Extension Phase|Lost to Follow-up|0
847901|NCT01662310|2790932|P1|Open-Label Extension Phase|Lost to Follow-up|0
847902|NCT01662310|2790928|P5|Open-Label Extension Phase|Lack of Efficacy|2
847903|NCT01662310|2790929|P4|Open-Label Extension Phase|Lack of Efficacy|2
847904|NCT01662310|2790930|P3|Open-Label Extension Phase|Lack of Efficacy|0
847905|NCT01662310|2790931|P2|Open-Label Extension Phase|Lack of Efficacy|0
847906|NCT01662310|2790932|P1|Open-Label Extension Phase|Lack of Efficacy|0
847907|NCT01662310|2790928|P5|Open-Label Extension Phase|Death|0
847908|NCT01662310|2790929|P4|Open-Label Extension Phase|Death|1
847909|NCT01662310|2790930|P3|Open-Label Extension Phase|Death|0
847910|NCT01662310|2790931|P2|Open-Label Extension Phase|Death|0
847911|NCT01662310|2790932|P1|Open-Label Extension Phase|Death|0
847912|NCT01662310|2790928|P5|Open-Label Extension Phase|Adverse Event|0
847913|NCT01662310|2790929|P4|Open-Label Extension Phase|Adverse Event|3
847914|NCT01662310|2790930|P3|Open-Label Extension Phase|Adverse Event|0
847915|NCT01662310|2790931|P2|Open-Label Extension Phase|Adverse Event|0
847916|NCT01662310|2790932|P1|Open-Label Extension Phase|Adverse Event|0
847917|NCT01662310|2790928|P5|Double-Blind Phase|Randomized but not treated|0
847918|NCT01662310|2790929|P4|Double-Blind Phase|Randomized but not treated|0
847919|NCT01662310|2790930|P3|Double-Blind Phase|Randomized but not treated|0
847920|NCT01662310|2790931|P2|Double-Blind Phase|Randomized but not treated|1
847921|NCT01662310|2790932|P1|Double-Blind Phase|Randomized but not treated|0
847922|NCT01662310|2790928|P5|Double-Blind Phase|Other|0
847923|NCT01662310|2790929|P4|Double-Blind Phase|Other|0
847924|NCT01662310|2790930|P3|Double-Blind Phase|Other|1
847925|NCT01662310|2790931|P2|Double-Blind Phase|Other|0
847926|NCT01662310|2790932|P1|Double-Blind Phase|Other|0
847927|NCT01662310|2790928|P5|Double-Blind Phase|Withdrawal by Subject|0
847928|NCT01662310|2790929|P4|Double-Blind Phase|Withdrawal by Subject|0
847929|NCT01662310|2790930|P3|Double-Blind Phase|Withdrawal by Subject|3
847930|NCT01662310|2790931|P2|Double-Blind Phase|Withdrawal by Subject|9
847931|NCT01662310|2790932|P1|Double-Blind Phase|Withdrawal by Subject|0
847932|NCT01662310|2790928|P5|Double-Blind Phase|Pregnancy|0
847933|NCT01662310|2790929|P4|Double-Blind Phase|Pregnancy|0
847934|NCT01662310|2790930|P3|Double-Blind Phase|Pregnancy|0
847935|NCT01662310|2790931|P2|Double-Blind Phase|Pregnancy|2
847936|NCT01662310|2790932|P1|Double-Blind Phase|Pregnancy|0
847937|NCT01662310|2790928|P5|Double-Blind Phase|Lost to Follow-up|0
847938|NCT01662310|2790929|P4|Double-Blind Phase|Lost to Follow-up|0
847939|NCT01662310|2790930|P3|Double-Blind Phase|Lost to Follow-up|0
847940|NCT01662310|2790931|P2|Double-Blind Phase|Lost to Follow-up|3
847941|NCT01662310|2790932|P1|Double-Blind Phase|Lost to Follow-up|0
847942|NCT01662310|2790928|P5|Double-Blind Phase|Adverse Event|0
847943|NCT01662310|2790929|P4|Double-Blind Phase|Adverse Event|0
847944|NCT01662310|2790930|P3|Double-Blind Phase|Adverse Event|1
847945|NCT01662310|2790931|P2|Double-Blind Phase|Adverse Event|0
847946|NCT01662310|2790932|P1|Double-Blind Phase|Adverse Event|0
847947|NCT01662310|2790928|P5|Run-In or Stabilization Phase|Other|0
847948|NCT01662310|2790929|P4|Run-In or Stabilization Phase|Other|0
847949|NCT01662310|2790930|P3|Run-In or Stabilization Phase|Other|0
847950|NCT01662310|2790931|P2|Run-In or Stabilization Phase|Other|0
847951|NCT01662310|2790932|P1|Run-In or Stabilization Phase|Other|1
847952|NCT01662310|2790928|P5|Run-In or Stabilization Phase|Withdrawal by Subject|0
847953|NCT01662310|2790929|P4|Run-In or Stabilization Phase|Withdrawal by Subject|0
847954|NCT01662310|2790930|P3|Run-In or Stabilization Phase|Withdrawal by Subject|0
847955|NCT01662310|2790931|P2|Run-In or Stabilization Phase|Withdrawal by Subject|0
847956|NCT01662310|2790932|P1|Run-In or Stabilization Phase|Withdrawal by Subject|25
847957|NCT01662310|2790928|P5|Run-In or Stabilization Phase|Protocol Violation|0
847958|NCT01662310|2790929|P4|Run-In or Stabilization Phase|Protocol Violation|0
847959|NCT01662310|2790930|P3|Run-In or Stabilization Phase|Protocol Violation|0
847960|NCT01662310|2790931|P2|Run-In or Stabilization Phase|Protocol Violation|0
847961|NCT01662310|2790932|P1|Run-In or Stabilization Phase|Protocol Violation|15
847962|NCT01662310|2790928|P5|Run-In or Stabilization Phase|Lost to Follow-up|0
847963|NCT01662310|2790929|P4|Run-In or Stabilization Phase|Lost to Follow-up|0
847964|NCT01662310|2790930|P3|Run-In or Stabilization Phase|Lost to Follow-up|0
847965|NCT01662310|2790931|P2|Run-In or Stabilization Phase|Lost to Follow-up|0
847966|NCT01662310|2790932|P1|Run-In or Stabilization Phase|Lost to Follow-up|4
847967|NCT01662310|2790928|P5|Run-In or Stabilization Phase|Lack of Efficacy|0
847968|NCT01662310|2790929|P4|Run-In or Stabilization Phase|Lack of Efficacy|0
847969|NCT01662310|2790930|P3|Run-In or Stabilization Phase|Lack of Efficacy|0
847970|NCT01662310|2790931|P2|Run-In or Stabilization Phase|Lack of Efficacy|0
847971|NCT01662310|2790932|P1|Run-In or Stabilization Phase|Lack of Efficacy|9
847972|NCT01662310|2790928|P5|Run-In or Stabilization Phase|Adverse Event|0
847973|NCT01662310|2790929|P4|Run-In or Stabilization Phase|Adverse Event|0
847974|NCT01662310|2790930|P3|Run-In or Stabilization Phase|Adverse Event|0
847975|NCT01662310|2790931|P2|Run-In or Stabilization Phase|Adverse Event|0
847976|NCT01662310|2790932|P1|Run-In or Stabilization Phase|Adverse Event|11
847977|NCT01662102|2791013|P2|Overall Study|Sponsor's decision|0
847978|NCT01662102|2791014|P1|Overall Study|Sponsor's decision|1
847979|NCT01662063|2791022|P3|Overall Study|Not Specified|0
847980|NCT01662063|2791023|P2|Overall Study|Not Specified|1
847981|NCT01662063|2791024|P1|Overall Study|Not Specified|0
847982|NCT01662063|2791022|P3|Overall Study|Physician Decision|0
847983|NCT01662063|2791023|P2|Overall Study|Physician Decision|2
847984|NCT01662063|2791024|P1|Overall Study|Physician Decision|0
847985|NCT01662063|2791022|P3|Overall Study|Withdrawal by Subject|1
847986|NCT01662063|2791023|P2|Overall Study|Withdrawal by Subject|4
847987|NCT01662063|2791024|P1|Overall Study|Withdrawal by Subject|2
847988|NCT01662063|2791022|P3|Overall Study|Protocol Violation|0
847989|NCT01662063|2791023|P2|Overall Study|Protocol Violation|0
847990|NCT01662063|2791024|P1|Overall Study|Protocol Violation|1
847991|NCT01662063|2791022|P3|Overall Study|Lost to Follow-up|0
847992|NCT01662063|2791023|P2|Overall Study|Lost to Follow-up|4
847993|NCT01662063|2791024|P1|Overall Study|Lost to Follow-up|0
847994|NCT01662063|2791022|P3|Overall Study|Lack of Efficacy|0
847995|NCT01662063|2791023|P2|Overall Study|Lack of Efficacy|6
847996|NCT01662063|2791024|P1|Overall Study|Lack of Efficacy|1
847997|NCT01662063|2791022|P3|Overall Study|Adverse Event or Intercurrent Illness|0
847998|NCT01662063|2791023|P2|Overall Study|Adverse Event or Intercurrent Illness|12
847999|NCT01662063|2791024|P1|Overall Study|Adverse Event or Intercurrent Illness|1
848000|NCT01662024|2791103|P1|Overall Study|Withdrawal by Subject|3
848001|NCT01662024|2791103|P1|Overall Study|Pregnancy|2
848002|NCT01661972|2791115|P2|Overall Study|Withdrawal by Subject|1
848003|NCT01661972|2791116|P1|Overall Study|Withdrawal by Subject|0
848004|NCT01661972|2791115|P2|Overall Study|Death during Treatment period|1
848005|NCT01661972|2791116|P1|Overall Study|Death during Treatment period|1
848006|NCT01661972|2791115|P2|Overall Study|Adverse Event|2
848007|NCT01661972|2791116|P1|Overall Study|Adverse Event|1
848008|NCT01661933|2791126|P1|High-dose Gluten Challenge|Withdrawal by Subject|2
848009|NCT01661933|2791126|P1|Low-dose Gluten Challenge|Physician Decision|2
848010|NCT01661881|2791133|P1|Overall Study|Disease Progression|1
848011|NCT01661790|2791141|P2|Overall Study|Lost to Follow-up|2
848012|NCT01661790|2791142|P1|Overall Study|Lost to Follow-up|0
848013|NCT01661595|2791267|P4|Phase 2: Week 5-8.|Protocol Violation|0
848014|NCT01661595|2791268|P3|Phase 2: Week 5-8.|Protocol Violation|1
848015|NCT01661595|2791269|P2|Phase 2: Week 5-8.|Protocol Violation|0
848016|NCT01661595|2791270|P1|Phase 2: Week 5-8.|Protocol Violation|0
848017|NCT01661595|2791267|P4|Phase 1: Week 0-4|Adverse Event|0
848018|NCT01661595|2791268|P3|Phase 1: Week 0-4|Adverse Event|0
848019|NCT01661595|2791269|P2|Phase 1: Week 0-4|Adverse Event|0
848020|NCT01661595|2791270|P1|Phase 1: Week 0-4|Adverse Event|1
848021|NCT01661205|2791389|P1|Overall Study|Physician Decision|2
848022|NCT01661179|2791400|P1|Overall Study|Other Eligibility criteria|4
848023|NCT01661179|2791400|P1|Overall Study|Withdrawal by Subject|1
848024|NCT01661179|2791400|P1|Overall Study|Death|1
848025|NCT01661140|2791404|P3|Double-Blind Period|Administrative/Other|6
848026|NCT01661140|2791405|P2|Double-Blind Period|Administrative/Other|7
848027|NCT01661140|2791406|P1|Double-Blind Period|Administrative/Other|0
848028|NCT01661140|2791404|P3|Double-Blind Period|Sponsor Termination|17
848029|NCT01661140|2791405|P2|Double-Blind Period|Sponsor Termination|14
848030|NCT01661140|2791406|P1|Double-Blind Period|Sponsor Termination|0
848031|NCT01661140|2791404|P3|Double-Blind Period|Investigator's Decision|2
848032|NCT01661140|2791405|P2|Double-Blind Period|Investigator's Decision|1
848033|NCT01661140|2791406|P1|Double-Blind Period|Investigator's Decision|0
848034|NCT01661140|2791404|P3|Double-Blind Period|Withdrawal by Subject|3
848035|NCT01661140|2791405|P2|Double-Blind Period|Withdrawal by Subject|1
848036|NCT01661140|2791406|P1|Double-Blind Period|Withdrawal by Subject|0
848037|NCT01661140|2791404|P3|Double-Blind Period|Protocol Violation|3
848038|NCT01661140|2791405|P2|Double-Blind Period|Protocol Violation|2
848039|NCT01661140|2791406|P1|Double-Blind Period|Protocol Violation|0
848040|NCT01661140|2791404|P3|Double-Blind Period|Adverse Event|18
848041|NCT01661140|2791405|P2|Double-Blind Period|Adverse Event|16
848042|NCT01661140|2791406|P1|Double-Blind Period|Adverse Event|0
848043|NCT01661140|2791404|P3|Double-Blind Period|Refused Treatment|1
848044|NCT01661140|2791405|P2|Double-Blind Period|Refused Treatment|0
848045|NCT01661140|2791406|P1|Double-Blind Period|Refused Treatment|0
848046|NCT01661140|2791404|P3|Open-Label Period|Lost to Follow-up|0
848047|NCT01661140|2791405|P2|Open-Label Period|Lost to Follow-up|0
848048|NCT01661140|2791406|P1|Open-Label Period|Lost to Follow-up|2
848049|NCT01661140|2791404|P3|Open-Label Period|Did not meet EULAR criteria|0
848050|NCT01661140|2791405|P2|Open-Label Period|Did not meet EULAR criteria|0
848051|NCT01661140|2791406|P1|Open-Label Period|Did not meet EULAR criteria|1
848052|NCT01661140|2791404|P3|Open-Label Period|Sponsor termination|0
848053|NCT01661140|2791405|P2|Open-Label Period|Sponsor termination|0
848054|NCT01661140|2791406|P1|Open-Label Period|Sponsor termination|16
848055|NCT01661140|2791404|P3|Open-Label Period|Administrative/Other|0
848056|NCT01661140|2791405|P2|Open-Label Period|Administrative/Other|0
848057|NCT01661140|2791406|P1|Open-Label Period|Administrative/Other|1
848058|NCT01661140|2791404|P3|Open-Label Period|Death|0
848059|NCT01661140|2791405|P2|Open-Label Period|Death|0
848060|NCT01661140|2791406|P1|Open-Label Period|Death|1
848061|NCT01661140|2791404|P3|Open-Label Period|Investigator Decision|0
848062|NCT01661140|2791405|P2|Open-Label Period|Investigator Decision|0
848063|NCT01661140|2791406|P1|Open-Label Period|Investigator Decision|3
848064|NCT01661140|2791404|P3|Open-Label Period|Withdrawal by Subject|0
848065|NCT01661140|2791405|P2|Open-Label Period|Withdrawal by Subject|0
848066|NCT01661140|2791406|P1|Open-Label Period|Withdrawal by Subject|5
848067|NCT01661140|2791404|P3|Open-Label Period|Protocol Violation|0
848068|NCT01661140|2791405|P2|Open-Label Period|Protocol Violation|0
848069|NCT01661140|2791406|P1|Open-Label Period|Protocol Violation|3
848070|NCT01661140|2791404|P3|Open-Label Period|Adverse Event|0
848071|NCT01661140|2791405|P2|Open-Label Period|Adverse Event|0
848072|NCT01661140|2791406|P1|Open-Label Period|Adverse Event|44
848073|NCT01661062|2791458|P1|Overall Study|Withdrawal by Subject|2
848074|NCT01661062|2791458|P1|Overall Study|Completed Treatment Off Study|3
848075|NCT01660906|2791463|P1|Overall Study|Discontinued due to study drug toxicity|3
848076|NCT01660763|2791546|P2|Overall Study|Patient ready for early discharge|4
848077|NCT01660763|2791547|P1|Overall Study|Patient ready for early discharge|28
848078|NCT01660763|2791546|P2|Overall Study|Withdrawal by Subject|0
848079|NCT01660763|2791547|P1|Overall Study|Withdrawal by Subject|4
848080|NCT01660763|2791546|P2|Overall Study|Protocol Violation|0
848081|NCT01660763|2791547|P1|Overall Study|Protocol Violation|1
848082|NCT01660763|2791546|P2|Overall Study|Adverse Event|7
848083|NCT01660763|2791547|P1|Overall Study|Adverse Event|22
848084|NCT01660763|2791546|P2|Overall Study|Lack of Efficacy|50
848085|NCT01660763|2791547|P1|Overall Study|Lack of Efficacy|45
848086|NCT01660451|2791595|P3|Overall Study|Ongoing with treatment|46
848087|NCT01660451|2791596|P2|Overall Study|Ongoing with treatment|3
848088|NCT01660451|2791597|P1|Overall Study|Ongoing with treatment|3
848089|NCT01660451|2791595|P3|Overall Study|Withdrawal by Subject|16
848090|NCT01660451|2791596|P2|Overall Study|Withdrawal by Subject|0
848091|NCT01660451|2791597|P1|Overall Study|Withdrawal by Subject|1
848092|NCT01660451|2791595|P3|Overall Study|Physician Decision|5
848093|NCT01660451|2791596|P2|Overall Study|Physician Decision|2
848094|NCT01660451|2791597|P1|Overall Study|Physician Decision|1
848095|NCT01660451|2791595|P3|Overall Study|Protocol Deviation|1
848096|NCT01660451|2791596|P2|Overall Study|Protocol Deviation|0
848097|NCT01660451|2791597|P1|Overall Study|Protocol Deviation|0
848098|NCT01660451|2791595|P3|Overall Study|Sponsor Decision|1
848099|NCT01660451|2791596|P2|Overall Study|Sponsor Decision|0
848100|NCT01660451|2791597|P1|Overall Study|Sponsor Decision|0
848101|NCT01660451|2791595|P3|Overall Study|AE with Clinical PD|9
848102|NCT01660451|2791596|P2|Overall Study|AE with Clinical PD|3
848103|NCT01660451|2791597|P1|Overall Study|AE with Clinical PD|1
848104|NCT01660451|2791595|P3|Overall Study|Adverse Event (AE) without Clinical PD|26
848105|NCT01660451|2791596|P2|Overall Study|Adverse Event (AE) without Clinical PD|8
848106|NCT01660451|2791597|P1|Overall Study|Adverse Event (AE) without Clinical PD|11
848107|NCT01660451|2791595|P3|Overall Study|Protocol Violation|1
848108|NCT01660451|2791596|P2|Overall Study|Protocol Violation|1
848109|NCT01660451|2791597|P1|Overall Study|Protocol Violation|0
848110|NCT01660412|2791625|P2|Overall Study|Protocol Violation|3
848111|NCT01660412|2791626|P1|Overall Study|Protocol Violation|0
848112|NCT01660334|2791632|P1|Overall Study|Lost to Follow-up|1
848113|NCT01660022|2791875|P6|First Sequence (7 Days)|Protocol Violation|1
848114|NCT01660022|2791876|P5|First Sequence (7 Days)|Protocol Violation|0
848115|NCT01660022|2791877|P4|First Sequence (7 Days)|Protocol Violation|0
848116|NCT01660022|2791878|P3|First Sequence (7 Days)|Protocol Violation|0
848117|NCT01660022|2791879|P2|First Sequence (7 Days)|Protocol Violation|0
848118|NCT01660022|2791880|P1|First Sequence (7 Days)|Protocol Violation|0
848119|NCT01660022|2791875|P6|First Sequence (7 Days)|Adverse Event|3
848120|NCT01660022|2791876|P5|First Sequence (7 Days)|Adverse Event|1
848121|NCT01660022|2791877|P4|First Sequence (7 Days)|Adverse Event|0
848122|NCT01660022|2791878|P3|First Sequence (7 Days)|Adverse Event|0
848123|NCT01660022|2791879|P2|First Sequence (7 Days)|Adverse Event|0
848124|NCT01660022|2791880|P1|First Sequence (7 Days)|Adverse Event|0
848125|NCT01660022|2791875|P6|First Sequence (7 Days)|Withdrawal by Subject|0
848126|NCT01660022|2791876|P5|First Sequence (7 Days)|Withdrawal by Subject|0
848127|NCT01660022|2791877|P4|First Sequence (7 Days)|Withdrawal by Subject|1
848128|NCT01660022|2791878|P3|First Sequence (7 Days)|Withdrawal by Subject|0
848129|NCT01660022|2791879|P2|First Sequence (7 Days)|Withdrawal by Subject|1
848130|NCT01660022|2791880|P1|First Sequence (7 Days)|Withdrawal by Subject|0
848131|NCT01659996|2791939|P3|Overall Study|Withdrawal by Subject|5
848132|NCT01659996|2791940|P2|Overall Study|Withdrawal by Subject|1
848133|NCT01659996|2791941|P1|Overall Study|Withdrawal by Subject|4
848134|NCT01659996|2791939|P3|Overall Study|Adverse Event|1
848135|NCT01659996|2791940|P2|Overall Study|Adverse Event|0
848136|NCT01659996|2791941|P1|Overall Study|Adverse Event|0
848137|NCT01659996|2791939|P3|Overall Study|Lost to Follow-up|2
848138|NCT01659996|2791940|P2|Overall Study|Lost to Follow-up|3
848139|NCT01659996|2791941|P1|Overall Study|Lost to Follow-up|1
848140|NCT01659996|2791939|P3|Overall Study|Protocol Violation|3
848141|NCT01659996|2791940|P2|Overall Study|Protocol Violation|3
848142|NCT01659996|2791941|P1|Overall Study|Protocol Violation|3
848143|NCT01659853|2791973|P2|Washout , 3 to 7 Days|Protocol Violation|0
848144|NCT01659853|2791974|P1|Washout , 3 to 7 Days|Protocol Violation|1
848145|NCT01659853|2791973|P2|Washout , 3 to 7 Days|Adverse Event|0
848146|NCT01659853|2791974|P1|Washout , 3 to 7 Days|Adverse Event|1
848147|NCT01659736|2791984|P2|3-month Follow-up|Lost to Follow-up|1
848148|NCT01659736|2791985|P1|3-month Follow-up|Lost to Follow-up|0
848149|NCT01659736|2791984|P2|Treatment Period|Withdrawal by Subject|0
848150|NCT01659736|2791985|P1|Treatment Period|Withdrawal by Subject|1
848151|NCT01659736|2791984|P2|Treatment Period|Protocol Violation|1
848152|NCT01659736|2791985|P1|Treatment Period|Protocol Violation|3
848153|NCT01659736|2791984|P2|Treatment Period|Adverse Event|1
848154|NCT01659736|2791985|P1|Treatment Period|Adverse Event|1
848155|NCT01659567|2791999|P1|Overall Study|Other|13
848156|NCT01659567|2791999|P1|Overall Study|Progression of the main disease|1
848157|NCT01659567|2791999|P1|Overall Study|Withdrawal by Subject|64
848158|NCT01659567|2791999|P1|Overall Study|Good result at early stage of treatment|5
848159|NCT01659567|2791999|P1|Overall Study|Adverse Event|12
848160|NCT01659567|2791999|P1|Overall Study|Switched to Pegferon|6
848161|NCT01659567|2791999|P1|Overall Study|Lack of Efficacy|22
848162|NCT01659554|2792016|P1|Overall Study|Study Termination|4
848163|NCT01659320|2792023|P1|Overall Study|Physician Decision|1
848164|NCT01659320|2792023|P1|Overall Study|Withdrawal by Subject|2
848165|NCT01659125|2792042|P1|Overall Study|Failed to Start Treatment|2
848166|NCT01659125|2792042|P1|Overall Study|Time Constraints|2
848167|NCT01659125|2792042|P1|Overall Study|Technical Problem|1
848168|NCT01659125|2792042|P1|Overall Study|Lost to Follow-up|7
848169|NCT01659125|2792042|P1|Overall Study|Withdrawal by Subject|2
848170|NCT01659021|2792049|P2|Overall Study|Still on Study|1
848171|NCT01659021|2792050|P1|Overall Study|Still on Study|34
848172|NCT01659021|2792049|P2|Overall Study|Withdrawal by Subject|16
848173|NCT01659021|2792050|P1|Overall Study|Withdrawal by Subject|18
848174|NCT01659021|2792049|P2|Overall Study|Physician Decision|16
848175|NCT01659021|2792050|P1|Overall Study|Physician Decision|32
848176|NCT01659021|2792049|P2|Overall Study|Other?|1
848177|NCT01659021|2792050|P1|Overall Study|Other?|1
848178|NCT01659021|2792049|P2|Overall Study|Lost to Follow-up|0
848179|NCT01659021|2792050|P1|Overall Study|Lost to Follow-up|1
848180|NCT01659021|2792049|P2|Overall Study|Adverse Event|3
848181|NCT01659021|2792050|P1|Overall Study|Adverse Event|2
848182|NCT01658943|2792068|P2|Overall Study|Withdrew prior to beginning protocol Tx|0
848183|NCT01658943|2792069|P1|Overall Study|Withdrew prior to beginning protocol Tx|1
848184|NCT01658943|2792068|P2|Overall Study|Not eligible|9
848185|NCT01658943|2792069|P1|Overall Study|Not eligible|7
848186|NCT01658943|2792068|P2|Overall Study|not protocol specified|1
848187|NCT01658943|2792069|P1|Overall Study|not protocol specified|4
848188|NCT01658943|2792068|P2|Overall Study|Death|2
848189|NCT01658943|2792069|P1|Overall Study|Death|4
848190|NCT01658943|2792068|P2|Overall Study|Progression/Relapse|40
848191|NCT01658943|2792069|P1|Overall Study|Progression/Relapse|39
848192|NCT01658943|2792068|P2|Overall Study|Withdrawal by Subject|2
848193|NCT01658943|2792069|P1|Overall Study|Withdrawal by Subject|9
848194|NCT01658943|2792068|P2|Overall Study|Adverse Event|13
848195|NCT01658943|2792069|P1|Overall Study|Adverse Event|6
848196|NCT01658904|2792084|P3|Overall Study|Principal Investigator discretion|0
848197|NCT01658904|2792085|P2|Overall Study|Principal Investigator discretion|0
848198|NCT01658904|2792086|P1|Overall Study|Principal Investigator discretion|2
848199|NCT01658813|2792112|P1|Overall Study|Disease progression|3
848200|NCT01658735|2792123|P3|Overall Study|Withdrawal by Subject|3
848201|NCT01658735|2792124|P2|Overall Study|Withdrawal by Subject|5
848202|NCT01658735|2792125|P1|Overall Study|Withdrawal by Subject|3
848203|NCT01658735|2792123|P3|Overall Study|Protocol Violation|0
848204|NCT01658735|2792124|P2|Overall Study|Protocol Violation|1
848205|NCT01658735|2792125|P1|Overall Study|Protocol Violation|0
848206|NCT01658735|2792123|P3|Overall Study|Lost to Follow-up|0
848207|NCT01658735|2792124|P2|Overall Study|Lost to Follow-up|1
848208|NCT01658735|2792125|P1|Overall Study|Lost to Follow-up|1
848209|NCT01658735|2792123|P3|Overall Study|Lack of Efficacy|1
848210|NCT01658735|2792124|P2|Overall Study|Lack of Efficacy|0
848211|NCT01658735|2792125|P1|Overall Study|Lack of Efficacy|1
848212|NCT01658579|2792167|P4|Treatment Period B|Other|1
848213|NCT01658579|2792168|P3|Treatment Period B|Other|0
848214|NCT01658579|2792169|P2|Treatment Period B|Other|0
848215|NCT01658579|2792170|P1|Treatment Period B|Other|0
848216|NCT01658579|2792167|P4|Treatment Period A|Adverse Event|0
848217|NCT01658579|2792168|P3|Treatment Period A|Adverse Event|0
848218|NCT01658579|2792169|P2|Treatment Period A|Adverse Event|0
848219|NCT01658579|2792170|P1|Treatment Period A|Adverse Event|1
848220|NCT01658579|2792167|P4|Treatment Period A|Other|1
848221|NCT01658579|2792168|P3|Treatment Period A|Other|1
848222|NCT01658579|2792169|P2|Treatment Period A|Other|0
848223|NCT01658579|2792170|P1|Treatment Period A|Other|0
848224|NCT01658514|2792198|P3|Overall Study|Protocol Violation|2
848225|NCT01658514|2792199|P2|Overall Study|Protocol Violation|0
848226|NCT01658514|2792200|P1|Overall Study|Protocol Violation|1
848227|NCT01658436|2792211|P2|Overall Study|Death|0
848228|NCT01658436|2792212|P1|Overall Study|Death|1
848229|NCT01658436|2792211|P2|Overall Study|Subject/guardian decision|1
848230|NCT01658436|2792212|P1|Overall Study|Subject/guardian decision|0
848231|NCT01658436|2792211|P2|Overall Study|Study terminated by sponsor|1
848232|NCT01658436|2792212|P1|Overall Study|Study terminated by sponsor|0
848233|NCT01658436|2792211|P2|Overall Study|Progressive disease|4
848234|NCT01658436|2792212|P1|Overall Study|Progressive disease|12
848235|NCT01658436|2792211|P2|Overall Study|Physician Decision|0
848236|NCT01658436|2792212|P1|Overall Study|Physician Decision|1
848237|NCT01658436|2792211|P2|Overall Study|Adverse Event|5
848238|NCT01658436|2792212|P1|Overall Study|Adverse Event|6
848239|NCT01658072|2792234|P2|Overall Study|Protocol Violation|2
848240|NCT01658072|2792235|P1|Overall Study|Protocol Violation|4
848241|NCT01658020|2792243|P2|Overall Study|Protocol Violation|1
848242|NCT01658020|2792244|P1|Overall Study|Protocol Violation|0
848243|NCT01658020|2792243|P2|Overall Study|Withdrawal by Subject|5
848244|NCT01658020|2792244|P1|Overall Study|Withdrawal by Subject|4
848245|NCT01658020|2792243|P2|Overall Study|Lost to Follow-up|0
848246|NCT01658020|2792244|P1|Overall Study|Lost to Follow-up|1
848247|NCT01658020|2792243|P2|Overall Study|Adverse Event|3
848248|NCT01658020|2792244|P1|Overall Study|Adverse Event|3
848249|NCT01657903|2792260|P1|Overall Study|Withdrawal by Subject|1
848250|NCT01657903|2792260|P1|Overall Study|Lost to Follow-up|1
848251|NCT01657877|2792282|P1|Overall Study|Other Reason|2
848252|NCT01657877|2792282|P1|Overall Study|Adverse Event|2
848253|NCT01657877|2792282|P1|Overall Study|Protocol Violation|6
848254|NCT01657877|2792282|P1|Overall Study|Withdrawal by Subject|4
848255|NCT01657799|2792302|P3|Overall Study|Other|49
848256|NCT01657799|2792303|P2|Overall Study|Other|62
848257|NCT01657799|2792304|P1|Overall Study|Other|52
848258|NCT01657799|2792302|P3|Overall Study|Radiographic & Clinical Progression|15
848259|NCT01657799|2792303|P2|Overall Study|Radiographic & Clinical Progression|11
848260|NCT01657799|2792304|P1|Overall Study|Radiographic & Clinical Progression|16
848261|NCT01657799|2792302|P3|Overall Study|Progressive Disease Clinical|7
848262|NCT01657799|2792303|P2|Overall Study|Progressive Disease Clinical|4
848263|NCT01657799|2792304|P1|Overall Study|Progressive Disease Clinical|7
848264|NCT01657799|2792302|P3|Overall Study|Disease Progression|4
848265|NCT01657799|2792303|P2|Overall Study|Disease Progression|4
848266|NCT01657799|2792304|P1|Overall Study|Disease Progression|2
848267|NCT01657799|2792302|P3|Overall Study|Lost to Follow-up|1
848268|NCT01657799|2792303|P2|Overall Study|Lost to Follow-up|0
848269|NCT01657799|2792304|P1|Overall Study|Lost to Follow-up|1
848270|NCT01657799|2792302|P3|Overall Study|Withdrawal by Subject|10
848271|NCT01657799|2792303|P2|Overall Study|Withdrawal by Subject|10
848272|NCT01657799|2792304|P1|Overall Study|Withdrawal by Subject|13
848273|NCT01657799|2792302|P3|Overall Study|Adverse Event Not Related to Progression|4
848274|NCT01657799|2792303|P2|Overall Study|Adverse Event Not Related to Progression|4
848275|NCT01657799|2792304|P1|Overall Study|Adverse Event Not Related to Progression|5
848276|NCT01657799|2792302|P3|Overall Study|Adverse Event Related to progression|12
848277|NCT01657799|2792303|P2|Overall Study|Adverse Event Related to progression|8
848278|NCT01657799|2792304|P1|Overall Study|Adverse Event Related to progression|6
848279|NCT01657461|2792328|P2|Overall Study|Withdrawal by Subject|3
848280|NCT01657461|2792329|P1|Overall Study|Withdrawal by Subject|1
848281|NCT01657461|2792328|P2|Overall Study|Physician Decision|2
848282|NCT01657461|2792329|P1|Overall Study|Physician Decision|0
848283|NCT01657461|2792328|P2|Overall Study|Lost to Follow-up|3
848284|NCT01657461|2792329|P1|Overall Study|Lost to Follow-up|0
848285|NCT01657461|2792328|P2|Overall Study|Death|12
848286|NCT01657461|2792329|P1|Overall Study|Death|9
848287|NCT01657370|2792359|P6|Overall Study|Lost to Follow-up|1
848288|NCT01657370|2792360|P5|Overall Study|Lost to Follow-up|0
848289|NCT01657370|2792361|P4|Overall Study|Lost to Follow-up|0
848290|NCT01657370|2792362|P3|Overall Study|Lost to Follow-up|1
848291|NCT01657370|2792363|P2|Overall Study|Lost to Follow-up|0
848292|NCT01657370|2792364|P1|Overall Study|Lost to Follow-up|2
848293|NCT01657370|2792359|P6|Overall Study|Protocol Violation|0
848294|NCT01657370|2792360|P5|Overall Study|Protocol Violation|0
848295|NCT01657370|2792361|P4|Overall Study|Protocol Violation|1
848296|NCT01657370|2792362|P3|Overall Study|Protocol Violation|1
848297|NCT01657370|2792363|P2|Overall Study|Protocol Violation|1
848298|NCT01657370|2792364|P1|Overall Study|Protocol Violation|1
848299|NCT01657370|2792359|P6|Overall Study|Adverse Event|0
848300|NCT01657370|2792360|P5|Overall Study|Adverse Event|1
848301|NCT01657370|2792361|P4|Overall Study|Adverse Event|0
848302|NCT01657370|2792362|P3|Overall Study|Adverse Event|0
848303|NCT01657370|2792363|P2|Overall Study|Adverse Event|0
848304|NCT01657370|2792364|P1|Overall Study|Adverse Event|0
848305|NCT01657370|2792359|P6|Overall Study|Lack of Qualifying Event|2
848306|NCT01657370|2792360|P5|Overall Study|Lack of Qualifying Event|1
848307|NCT01657370|2792361|P4|Overall Study|Lack of Qualifying Event|2
848308|NCT01657370|2792362|P3|Overall Study|Lack of Qualifying Event|3
848309|NCT01657370|2792363|P2|Overall Study|Lack of Qualifying Event|0
848310|NCT01657370|2792364|P1|Overall Study|Lack of Qualifying Event|1
848311|NCT01657370|2792359|P6|Overall Study|Physician Decision|0
848312|NCT01657370|2792360|P5|Overall Study|Physician Decision|5
848313|NCT01657370|2792361|P4|Overall Study|Physician Decision|2
848314|NCT01657370|2792362|P3|Overall Study|Physician Decision|1
848315|NCT01657370|2792363|P2|Overall Study|Physician Decision|3
848316|NCT01657370|2792364|P1|Overall Study|Physician Decision|2
848317|NCT01657370|2792359|P6|Overall Study|Withdrawal by Subject|1
848318|NCT01657370|2792360|P5|Overall Study|Withdrawal by Subject|0
848319|NCT01657370|2792361|P4|Overall Study|Withdrawal by Subject|0
848320|NCT01657370|2792362|P3|Overall Study|Withdrawal by Subject|1
848321|NCT01657370|2792363|P2|Overall Study|Withdrawal by Subject|0
848322|NCT01657370|2792364|P1|Overall Study|Withdrawal by Subject|0
848323|NCT01657305|2792446|P1|Overall Study|Did not Adhere to Protocol/Procedures|4
848324|NCT01657305|2792446|P1|Overall Study|Lost to Follow-up|1
848325|NCT01657305|2792446|P1|Overall Study|Adverse Event|1
848326|NCT01657305|2792446|P1|Overall Study|Withdrawal by Subject|4
848327|NCT01657305|2792446|P1|Overall Study|Lack of Wound Closure at Day 28|15
848328|NCT01657292|2792496|P1|Overall Study|Change of therapy|1
848329|NCT01657292|2792496|P1|Overall Study|Violation of eligibility criteria|1
848330|NCT01657292|2792496|P1|Overall Study|Withdrawal by Subject|2
848331|NCT01657292|2792496|P1|Overall Study|Adverse Event|6
848332|NCT01657266|2792505|P2|Overall Study|Adverse Event|3
848333|NCT01657266|2792506|P1|Overall Study|Adverse Event|2
848334|NCT01657266|2792505|P2|Overall Study|Lost to Follow-up|2
848335|NCT01657266|2792506|P1|Overall Study|Lost to Follow-up|2
848336|NCT01657253|2792528|P2|Overall Study|Adverse Event|1
848337|NCT01657253|2792529|P1|Overall Study|Adverse Event|0
848338|NCT01657253|2792528|P2|Overall Study|Withdrawal by Subject|12
848339|NCT01657253|2792529|P1|Overall Study|Withdrawal by Subject|11
848340|NCT01657253|2792528|P2|Overall Study|Lost to Follow-up|5
848341|NCT01657253|2792529|P1|Overall Study|Lost to Follow-up|6
848342|NCT01657032|2792541|P2|Overall Study|Lost to Follow-up|7
848343|NCT01657032|2792542|P1|Overall Study|Lost to Follow-up|0
848344|NCT01657019|2792568|P1|Overall Study|Not Specified|58
848345|NCT01657019|2792568|P1|Overall Study|Lack of Efficacy|3
848346|NCT01657019|2792568|P1|Overall Study|Protocol Violation|6
848347|NCT01657019|2792568|P1|Overall Study|Lost to Follow-up|48
848348|NCT01657019|2792568|P1|Overall Study|Adverse Event|55
848349|NCT01657019|2792568|P1|Overall Study|Withdrawal by Subject|65
848350|NCT01656967|2792582|P2|Overall Study|unsuccessful ETT insertion|2
848351|NCT01656967|2792583|P1|Overall Study|unsuccessful ETT insertion|3
848352|NCT01656967|2792582|P2|Overall Study|faulty monitor|0
848353|NCT01656967|2792583|P1|Overall Study|faulty monitor|1
848354|NCT01656889|2792609|P2|Post Treatment Follow-Up, 3 Months|Site Closure|1
848355|NCT01656889|2792610|P1|Post Treatment Follow-Up, 3 Months|Site Closure|0
848356|NCT01656889|2792609|P2|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1
848357|NCT01656889|2792610|P1|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2
848358|NCT01656889|2792609|P2|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2
848359|NCT01656889|2792610|P1|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1
848360|NCT01656889|2792609|P2|Post Treatment Follow-Up, 3 Months|Death|5
848361|NCT01656889|2792610|P1|Post Treatment Follow-Up, 3 Months|Death|1
848362|NCT01656889|2792609|P2|Treatment Period, 12 Weeks|Moved out of the area|2
848363|NCT01656889|2792610|P1|Treatment Period, 12 Weeks|Moved out of the area|0
848364|NCT01656889|2792609|P2|Treatment Period, 12 Weeks|Protocol Violation|1
848365|NCT01656889|2792610|P1|Treatment Period, 12 Weeks|Protocol Violation|0
848366|NCT01656889|2792609|P2|Treatment Period, 12 Weeks|Withdrawal by Subject|2
848367|NCT01656889|2792610|P1|Treatment Period, 12 Weeks|Withdrawal by Subject|1
848368|NCT01656889|2792609|P2|Treatment Period, 12 Weeks|Lost to Follow-up|1
848369|NCT01656889|2792610|P1|Treatment Period, 12 Weeks|Lost to Follow-up|1
848370|NCT01656889|2792609|P2|Treatment Period, 12 Weeks|Death|1
848371|NCT01656889|2792610|P1|Treatment Period, 12 Weeks|Death|0
848372|NCT01656889|2792609|P2|Treatment Period, 12 Weeks|Adverse Event|4
848373|NCT01656889|2792610|P1|Treatment Period, 12 Weeks|Adverse Event|10
848374|NCT01656850|2792630|P2|First Intervention (3 Months)|Withdrawal by Subject|4
848375|NCT01656850|2792631|P1|First Intervention (3 Months)|Withdrawal by Subject|3
848376|NCT01656759|2792722|P2|Overall Study|Protocol Violation|3
848377|NCT01656759|2792723|P1|Overall Study|Protocol Violation|2
848378|NCT01656434|2792754|P2|Overall Study|Withdrawal by Subject|7
848379|NCT01656434|2792755|P1|Overall Study|Withdrawal by Subject|64
848380|NCT01656434|2792754|P2|Overall Study|Participant withdrew consent|9
848381|NCT01656434|2792755|P1|Overall Study|Participant withdrew consent|28
848382|NCT01656434|2792754|P2|Overall Study|Participant moved|12
848383|NCT01656434|2792755|P1|Overall Study|Participant moved|40
848384|NCT01656434|2792754|P2|Overall Study|Non-compliance with protocol|15
848385|NCT01656434|2792755|P1|Overall Study|Non-compliance with protocol|39
848386|NCT01656434|2792754|P2|Overall Study|Part. discontinued; unrelated to drug|10
848387|NCT01656434|2792755|P1|Overall Study|Part. discontinued; unrelated to drug|55
848388|NCT01656434|2792754|P2|Overall Study|Participant discontinued; drug related|4
848389|NCT01656434|2792755|P1|Overall Study|Participant discontinued; drug related|13
848390|NCT01656434|2792754|P2|Overall Study|Study terminated by sponsor|348
848391|NCT01656434|2792755|P1|Overall Study|Study terminated by sponsor|1501
848392|NCT01656434|2792754|P2|Overall Study|Non-compliance with study drug|9
848393|NCT01656434|2792755|P1|Overall Study|Non-compliance with study drug|48
848394|NCT01656434|2792754|P2|Overall Study|Physician Decision|2
848395|NCT01656434|2792755|P1|Overall Study|Physician Decision|7
848396|NCT01656434|2792754|P2|Overall Study|Pregnancy|10
848397|NCT01656434|2792755|P1|Overall Study|Pregnancy|45
848398|NCT01656434|2792754|P2|Overall Study|Pregnancy wish|6
848399|NCT01656434|2792755|P1|Overall Study|Pregnancy wish|18
848400|NCT01656434|2792754|P2|Overall Study|Protocol Violation|0
848401|NCT01656434|2792755|P1|Overall Study|Protocol Violation|7
848402|NCT01656434|2792754|P2|Overall Study|Screen failure|0
848403|NCT01656434|2792755|P1|Overall Study|Screen failure|2
848404|NCT01656434|2792754|P2|Overall Study|Site discontinued study participation|9
848405|NCT01656434|2792755|P1|Overall Study|Site discontinued study participation|24
848406|NCT01656434|2792754|P2|Overall Study|Lost to Follow-up|76
848407|NCT01656434|2792755|P1|Overall Study|Lost to Follow-up|309
848408|NCT01656434|2792754|P2|Overall Study|Enrollment terminated at trial site|0
848409|NCT01656434|2792755|P1|Overall Study|Enrollment terminated at trial site|2
848410|NCT01656434|2792754|P2|Overall Study|Adverse Event|63
848411|NCT01656434|2792755|P1|Overall Study|Adverse Event|199
848412|NCT01656408|2792781|P10|Overall Study|Physician Decision|3
848413|NCT01656408|2792782|P9|Overall Study|Physician Decision|1
848414|NCT01656408|2792783|P8|Overall Study|Physician Decision|1
848415|NCT01656408|2792784|P7|Overall Study|Physician Decision|0
848416|NCT01656408|2792785|P6|Overall Study|Physician Decision|1
848417|NCT01656408|2792786|P5|Overall Study|Physician Decision|1
848418|NCT01656408|2792787|P4|Overall Study|Physician Decision|0
848419|NCT01656408|2792788|P3|Overall Study|Physician Decision|1
848420|NCT01656408|2792789|P2|Overall Study|Physician Decision|0
848421|NCT01656408|2792790|P1|Overall Study|Physician Decision|1
848422|NCT01656408|2792781|P10|Overall Study|Adverse Event|0
848423|NCT01656408|2792782|P9|Overall Study|Adverse Event|1
848424|NCT01656408|2792783|P8|Overall Study|Adverse Event|0
848425|NCT01656408|2792784|P7|Overall Study|Adverse Event|1
848426|NCT01656408|2792785|P6|Overall Study|Adverse Event|1
848427|NCT01656408|2792786|P5|Overall Study|Adverse Event|0
848428|NCT01656408|2792787|P4|Overall Study|Adverse Event|0
848429|NCT01656408|2792788|P3|Overall Study|Adverse Event|1
848430|NCT01656408|2792789|P2|Overall Study|Adverse Event|0
848431|NCT01656408|2792790|P1|Overall Study|Adverse Event|0
848432|NCT01656395|2792985|P8|Overall Study|Withdrawal by Subject|0
848433|NCT01656395|2792986|P7|Overall Study|Withdrawal by Subject|0
848434|NCT01656395|2792987|P6|Overall Study|Withdrawal by Subject|3
848435|NCT01656395|2792988|P5|Overall Study|Withdrawal by Subject|0
848436|NCT01656395|2792989|P4|Overall Study|Withdrawal by Subject|2
848437|NCT01656395|2792990|P3|Overall Study|Withdrawal by Subject|4
848438|NCT01656395|2792991|P2|Overall Study|Withdrawal by Subject|1
848439|NCT01656395|2792992|P1|Overall Study|Withdrawal by Subject|3
848440|NCT01656395|2792985|P8|Overall Study|Screen Failure|0
848441|NCT01656395|2792986|P7|Overall Study|Screen Failure|0
848442|NCT01656395|2792987|P6|Overall Study|Screen Failure|8
848443|NCT01656395|2792988|P5|Overall Study|Screen Failure|0
848444|NCT01656395|2792989|P4|Overall Study|Screen Failure|1
848445|NCT01656395|2792990|P3|Overall Study|Screen Failure|7
848446|NCT01656395|2792991|P2|Overall Study|Screen Failure|1
848447|NCT01656395|2792992|P1|Overall Study|Screen Failure|2
848448|NCT01656395|2792985|P8|Overall Study|Protocol Violation|0
848449|NCT01656395|2792986|P7|Overall Study|Protocol Violation|0
848450|NCT01656395|2792987|P6|Overall Study|Protocol Violation|10
848451|NCT01656395|2792988|P5|Overall Study|Protocol Violation|4
848452|NCT01656395|2792989|P4|Overall Study|Protocol Violation|2
848453|NCT01656395|2792990|P3|Overall Study|Protocol Violation|9
848454|NCT01656395|2792991|P2|Overall Study|Protocol Violation|6
848455|NCT01656395|2792992|P1|Overall Study|Protocol Violation|6
848456|NCT01656395|2792985|P8|Overall Study|Progressive Disease|0
848457|NCT01656395|2792986|P7|Overall Study|Progressive Disease|0
848458|NCT01656395|2792987|P6|Overall Study|Progressive Disease|1
848459|NCT01656395|2792988|P5|Overall Study|Progressive Disease|0
848460|NCT01656395|2792989|P4|Overall Study|Progressive Disease|0
848461|NCT01656395|2792990|P3|Overall Study|Progressive Disease|0
848462|NCT01656395|2792991|P2|Overall Study|Progressive Disease|0
848463|NCT01656395|2792992|P1|Overall Study|Progressive Disease|0
848464|NCT01656395|2792985|P8|Overall Study|Pregnancy|0
848465|NCT01656395|2792986|P7|Overall Study|Pregnancy|0
848466|NCT01656395|2792987|P6|Overall Study|Pregnancy|0
848467|NCT01656395|2792988|P5|Overall Study|Pregnancy|0
848468|NCT01656395|2792989|P4|Overall Study|Pregnancy|0
848469|NCT01656395|2792990|P3|Overall Study|Pregnancy|1
848470|NCT01656395|2792991|P2|Overall Study|Pregnancy|0
848471|NCT01656395|2792992|P1|Overall Study|Pregnancy|0
848472|NCT01656395|2792985|P8|Overall Study|Physician Decision|0
848473|NCT01656395|2792986|P7|Overall Study|Physician Decision|0
848474|NCT01656395|2792987|P6|Overall Study|Physician Decision|3
848475|NCT01656395|2792988|P5|Overall Study|Physician Decision|3
848476|NCT01656395|2792989|P4|Overall Study|Physician Decision|2
848477|NCT01656395|2792990|P3|Overall Study|Physician Decision|3
848478|NCT01656395|2792991|P2|Overall Study|Physician Decision|3
848479|NCT01656395|2792992|P1|Overall Study|Physician Decision|2
848480|NCT01656395|2792985|P8|Overall Study|Other|0
848481|NCT01656395|2792986|P7|Overall Study|Other|0
848482|NCT01656395|2792987|P6|Overall Study|Other|1
848483|NCT01656395|2792988|P5|Overall Study|Other|0
848484|NCT01656395|2792989|P4|Overall Study|Other|0
848485|NCT01656395|2792990|P3|Overall Study|Other|1
848486|NCT01656395|2792991|P2|Overall Study|Other|0
848487|NCT01656395|2792992|P1|Overall Study|Other|0
848488|NCT01656395|2792985|P8|Overall Study|Non-Compliance with Study Drug|0
848489|NCT01656395|2792986|P7|Overall Study|Non-Compliance with Study Drug|0
848490|NCT01656395|2792987|P6|Overall Study|Non-Compliance with Study Drug|1
848491|NCT01656395|2792988|P5|Overall Study|Non-Compliance with Study Drug|1
848492|NCT01656395|2792989|P4|Overall Study|Non-Compliance with Study Drug|0
848493|NCT01656395|2792990|P3|Overall Study|Non-Compliance with Study Drug|0
848494|NCT01656395|2792991|P2|Overall Study|Non-Compliance with Study Drug|1
848495|NCT01656395|2792992|P1|Overall Study|Non-Compliance with Study Drug|1
848496|NCT01656395|2792985|P8|Overall Study|Lost to Follow-up|0
848497|NCT01656395|2792986|P7|Overall Study|Lost to Follow-up|0
848498|NCT01656395|2792987|P6|Overall Study|Lost to Follow-up|0
848499|NCT01656395|2792988|P5|Overall Study|Lost to Follow-up|0
848500|NCT01656395|2792989|P4|Overall Study|Lost to Follow-up|0
848501|NCT01656395|2792990|P3|Overall Study|Lost to Follow-up|0
848502|NCT01656395|2792991|P2|Overall Study|Lost to Follow-up|0
848503|NCT01656395|2792992|P1|Overall Study|Lost to Follow-up|1
848504|NCT01656395|2792985|P8|Overall Study|Lack of Efficacy|0
848505|NCT01656395|2792986|P7|Overall Study|Lack of Efficacy|0
848506|NCT01656395|2792987|P6|Overall Study|Lack of Efficacy|6
848507|NCT01656395|2792988|P5|Overall Study|Lack of Efficacy|1
848508|NCT01656395|2792989|P4|Overall Study|Lack of Efficacy|1
848509|NCT01656395|2792990|P3|Overall Study|Lack of Efficacy|6
848510|NCT01656395|2792991|P2|Overall Study|Lack of Efficacy|8
848511|NCT01656395|2792992|P1|Overall Study|Lack of Efficacy|1
848512|NCT01656395|2792985|P8|Overall Study|Adverse Event|0
848513|NCT01656395|2792986|P7|Overall Study|Adverse Event|0
848514|NCT01656395|2792987|P6|Overall Study|Adverse Event|7
848515|NCT01656395|2792988|P5|Overall Study|Adverse Event|5
848516|NCT01656395|2792989|P4|Overall Study|Adverse Event|4
848517|NCT01656395|2792990|P3|Overall Study|Adverse Event|5
848518|NCT01656395|2792991|P2|Overall Study|Adverse Event|14
848519|NCT01656395|2792992|P1|Overall Study|Adverse Event|1
848520|NCT01656304|2793078|P1|Overall Study|Ineligible, uncontrolled hypertension|1
848521|NCT01656161|2793119|P1|Overall Study|Withdrawal by Subject|1
848522|NCT01656161|2793119|P1|Overall Study|Protocol Violation|1
848523|NCT01656161|2793119|P1|Overall Study|Adverse Event|2
848524|NCT01656161|2793119|P1|Overall Study|Death|3
848525|NCT01655823|2793142|P5|Overall Study|Withdrawal by Subject|0
848526|NCT01655823|2793143|P4|Overall Study|Withdrawal by Subject|1
848527|NCT01655823|2793144|P3|Overall Study|Withdrawal by Subject|0
848528|NCT01655823|2793145|P2|Overall Study|Withdrawal by Subject|1
848529|NCT01655823|2793146|P1|Overall Study|Withdrawal by Subject|0
848530|NCT01655823|2793142|P5|Overall Study|Lost to Follow-up|1
848531|NCT01655823|2793143|P4|Overall Study|Lost to Follow-up|0
848532|NCT01655823|2793144|P3|Overall Study|Lost to Follow-up|0
848533|NCT01655823|2793145|P2|Overall Study|Lost to Follow-up|1
848534|NCT01655823|2793146|P1|Overall Study|Lost to Follow-up|0
848535|NCT01655498|2793164|P1|Overall Study|Withdrawal by Subject|1
848536|NCT01655498|2793164|P1|Overall Study|Protocol Violation|2
848537|NCT01655498|2793164|P1|Overall Study|Unrelated health issue|2
848538|NCT01655381|2793171|P1|Overall Study|Insufficient Treatment Response|1
848539|NCT01655381|2793171|P1|Overall Study|Moved to Another City|1
848540|NCT01655381|2793171|P1|Overall Study|Investigator Decision|1
848541|NCT01655069|2793211|P4|Overall Study|Withdrawal by Subject|0
848542|NCT01655069|2793212|P3|Overall Study|Withdrawal by Subject|0
848543|NCT01655069|2793213|P2|Overall Study|Withdrawal by Subject|3
848544|NCT01655069|2793214|P1|Overall Study|Withdrawal by Subject|2
848545|NCT01655069|2793211|P4|Overall Study|No Treatment Needed|0
848546|NCT01655069|2793212|P3|Overall Study|No Treatment Needed|0
848547|NCT01655069|2793213|P2|Overall Study|No Treatment Needed|1
848548|NCT01655069|2793214|P1|Overall Study|No Treatment Needed|0
848549|NCT01655069|2793211|P4|Overall Study|Lack of Efficacy|0
848550|NCT01655069|2793212|P3|Overall Study|Lack of Efficacy|0
848551|NCT01655069|2793213|P2|Overall Study|Lack of Efficacy|1
848552|NCT01655069|2793214|P1|Overall Study|Lack of Efficacy|0
848553|NCT01655069|2793211|P4|Overall Study|Adverse Event|3
848554|NCT01655069|2793212|P3|Overall Study|Adverse Event|2
848555|NCT01655069|2793213|P2|Overall Study|Adverse Event|7
848556|NCT01655069|2793214|P1|Overall Study|Adverse Event|6
848557|NCT01655069|2793211|P4|Overall Study|Physician Decision|1
848558|NCT01655069|2793212|P3|Overall Study|Physician Decision|0
848559|NCT01655069|2793213|P2|Overall Study|Physician Decision|0
848560|NCT01655069|2793214|P1|Overall Study|Physician Decision|0
848561|NCT01654666|2793274|P3|Overall Study|Withdrawal by Subject|1
848562|NCT01654666|2793275|P2|Overall Study|Withdrawal by Subject|4
848563|NCT01654666|2793276|P1|Overall Study|Withdrawal by Subject|4
848564|NCT01654666|2793274|P3|Overall Study|Lost to Follow-up|5
848565|NCT01654666|2793275|P2|Overall Study|Lost to Follow-up|5
848566|NCT01654666|2793276|P1|Overall Study|Lost to Follow-up|4
848567|NCT01654666|2793274|P3|Overall Study|Protocol Violation|8
848568|NCT01654666|2793275|P2|Overall Study|Protocol Violation|4
848569|NCT01654666|2793276|P1|Overall Study|Protocol Violation|7
848570|NCT01654601|2793301|P2|2nd Administration|Protocol Violation|1
848571|NCT01654601|2793302|P1|2nd Administration|Protocol Violation|0
848572|NCT01654601|2793301|P2|2nd Administration|Adverse Event|0
848573|NCT01654601|2793302|P1|2nd Administration|Adverse Event|1
848574|NCT01654601|2793301|P2|1st Administration|Protocol Violation|2
848575|NCT01654601|2793302|P1|1st Administration|Protocol Violation|0
848576|NCT01654601|2793301|P2|1st Administration|Withdrawal by Subject|0
848577|NCT01654601|2793302|P1|1st Administration|Withdrawal by Subject|2
848578|NCT01654549|2793316|P2|Overall Study|H.pylori eradication not successful|1
848579|NCT01654549|2793317|P1|Overall Study|H.pylori eradication not successful|0
848580|NCT01654536|2793329|P2|Overall Study|Withdrawal by Subject|25
848581|NCT01654536|2793330|P1|Overall Study|Withdrawal by Subject|27
848582|NCT01654536|2793329|P2|Overall Study|Physician Decision|8
848583|NCT01654536|2793330|P1|Overall Study|Physician Decision|12
848584|NCT01654536|2793329|P2|Overall Study|Lost to Follow-up|5
848585|NCT01654536|2793330|P1|Overall Study|Lost to Follow-up|5
848586|NCT01654523|2793366|P1|Overall Study|Withdrawal by Subject|1
848587|NCT01654302|2793372|P2|Second Intervention (Day 7)|Lost to Follow-up|1
848588|NCT01654302|2793373|P1|Second Intervention (Day 7)|Lost to Follow-up|1
848589|NCT01654289|2793382|P3|Overall Study|Withdrew from intervention only|0
848590|NCT01654289|2793383|P2|Overall Study|Withdrew from intervention only|20
848591|NCT01654289|2793384|P1|Overall Study|Withdrew from intervention only|17
848592|NCT01654289|2793382|P3|Overall Study|Withdrawal by Subject|5
848593|NCT01654289|2793383|P2|Overall Study|Withdrawal by Subject|8
848594|NCT01654289|2793384|P1|Overall Study|Withdrawal by Subject|10
848595|NCT01654276|2793422|P1|Overall Study|Withdrawal by Subject|1
848596|NCT01654276|2793422|P1|Overall Study|Lost to Follow-up|4
848597|NCT01654276|2793422|P1|Overall Study|Lack of Efficacy|1
848598|NCT01654250|2793476|P2|Overall Study|Lost to Follow-up|0
848599|NCT01654250|2793477|P1|Overall Study|Lost to Follow-up|1
848600|NCT01654224|2793494|P2|Overall Study|Insufficient blood sample|2
848601|NCT01654224|2793495|P1|Overall Study|Insufficient blood sample|3
848602|NCT01654224|2793494|P2|Overall Study|Did not receive allocation|8
848603|NCT01654224|2793495|P1|Overall Study|Did not receive allocation|1
848604|NCT01654224|2793494|P2|Overall Study|Lost to Follow-up|2
848605|NCT01654224|2793495|P1|Overall Study|Lost to Follow-up|2
848606|NCT01653912|2793520|P6|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1
848607|NCT01653912|2793521|P5|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
848608|NCT01653912|2793522|P4|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
848609|NCT01653912|2793523|P3|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
848610|NCT01653912|2793524|P2|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
848611|NCT01653912|2793525|P1|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
848612|NCT01653912|2793520|P6|Phase 2: GSK2110183 125 mg|Clinical Progression|6
848613|NCT01653912|2793521|P5|Phase 2: GSK2110183 125 mg|Clinical Progression|0
848614|NCT01653912|2793522|P4|Phase 2: GSK2110183 125 mg|Clinical Progression|0
848615|NCT01653912|2793523|P3|Phase 2: GSK2110183 125 mg|Clinical Progression|0
848616|NCT01653912|2793524|P2|Phase 2: GSK2110183 125 mg|Clinical Progression|0
848617|NCT01653912|2793525|P1|Phase 2: GSK2110183 125 mg|Clinical Progression|0
848618|NCT01653912|2793520|P6|Phase 2: GSK2110183 125 mg|Adverse Event|1
848619|NCT01653912|2793521|P5|Phase 2: GSK2110183 125 mg|Adverse Event|0
848620|NCT01653912|2793522|P4|Phase 2: GSK2110183 125 mg|Adverse Event|0
848621|NCT01653912|2793523|P3|Phase 2: GSK2110183 125 mg|Adverse Event|0
848622|NCT01653912|2793524|P2|Phase 2: GSK2110183 125 mg|Adverse Event|0
848623|NCT01653912|2793525|P1|Phase 2: GSK2110183 125 mg|Adverse Event|0
848624|NCT01653912|2793520|P6|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
848625|NCT01653912|2793521|P5|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
848626|NCT01653912|2793522|P4|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1
848627|NCT01653912|2793523|P3|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
848628|NCT01653912|2793524|P2|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
848629|NCT01653912|2793525|P1|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
848630|NCT01653912|2793520|P6|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
848631|NCT01653912|2793521|P5|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
848632|NCT01653912|2793522|P4|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1
848633|NCT01653912|2793523|P3|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
848634|NCT01653912|2793524|P2|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
848635|NCT01653912|2793525|P1|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
848636|NCT01653912|2793520|P6|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
848637|NCT01653912|2793521|P5|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
848638|NCT01653912|2793522|P4|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
848639|NCT01653912|2793523|P3|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2
848640|NCT01653912|2793524|P2|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
848641|NCT01653912|2793525|P1|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
848642|NCT01653912|2793520|P6|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
848643|NCT01653912|2793521|P5|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
848644|NCT01653912|2793522|P4|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
848645|NCT01653912|2793523|P3|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
848646|NCT01653912|2793524|P2|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1
848647|NCT01653912|2793525|P1|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
848648|NCT01653782|2793543|P3|Overall Study|Lost to Follow-up|2
848649|NCT01653782|2793544|P2|Overall Study|Lost to Follow-up|3
848650|NCT01653782|2793545|P1|Overall Study|Lost to Follow-up|7
848651|NCT01653782|2793543|P3|Overall Study|Withdrawal by Subject|4
848652|NCT01653782|2793544|P2|Overall Study|Withdrawal by Subject|15
848653|NCT01653782|2793545|P1|Overall Study|Withdrawal by Subject|9
848654|NCT01653743|2793555|P2|Overall Study|Investigator discretion|0
848655|NCT01653743|2793556|P1|Overall Study|Investigator discretion|3
848656|NCT01653743|2793555|P2|Overall Study|Withdrawal by Subject|0
848657|NCT01653743|2793556|P1|Overall Study|Withdrawal by Subject|1
848658|NCT01653327|2793616|P1|Overall Study|Withdrawal by Subject|1
848659|NCT01653262|2793624|P1|Overall Study|AE, non-serious non-fatal|1
848660|NCT01653262|2793624|P1|Overall Study|SAE, non-fatal|1
848661|NCT01653262|2793624|P1|Overall Study|Lack of Efficacy|1
848662|NCT01653158|2793637|P8|Overall Study|Withdrawal by Subject|0
848663|NCT01653158|2793638|P7|Overall Study|Withdrawal by Subject|0
848664|NCT01653158|2793639|P6|Overall Study|Withdrawal by Subject|0
848665|NCT01653158|2793640|P5|Overall Study|Withdrawal by Subject|0
848666|NCT01653158|2793641|P4|Overall Study|Withdrawal by Subject|0
848667|NCT01653158|2793642|P3|Overall Study|Withdrawal by Subject|0
848668|NCT01653158|2793643|P2|Overall Study|Withdrawal by Subject|0
848669|NCT01653158|2793644|P1|Overall Study|Withdrawal by Subject|1
848670|NCT01653158|2793637|P8|Overall Study|Progressive disease|9
848671|NCT01653158|2793638|P7|Overall Study|Progressive disease|2
848672|NCT01653158|2793639|P6|Overall Study|Progressive disease|1
848673|NCT01653158|2793640|P5|Overall Study|Progressive disease|1
848674|NCT01653158|2793641|P4|Overall Study|Progressive disease|0
848675|NCT01653158|2793642|P3|Overall Study|Progressive disease|0
848676|NCT01653158|2793643|P2|Overall Study|Progressive disease|0
848677|NCT01653158|2793644|P1|Overall Study|Progressive disease|0
848678|NCT01653158|2793637|P8|Overall Study|Other|1
848679|NCT01653158|2793638|P7|Overall Study|Other|0
848680|NCT01653158|2793639|P6|Overall Study|Other|0
848681|NCT01653158|2793640|P5|Overall Study|Other|0
848682|NCT01653158|2793641|P4|Overall Study|Other|0
848683|NCT01653158|2793642|P3|Overall Study|Other|0
848684|NCT01653158|2793643|P2|Overall Study|Other|0
848685|NCT01653158|2793644|P1|Overall Study|Other|0
848686|NCT01653158|2793637|P8|Overall Study|Adverse Event|3
848687|NCT01653158|2793638|P7|Overall Study|Adverse Event|0
848688|NCT01653158|2793639|P6|Overall Study|Adverse Event|0
848689|NCT01653158|2793640|P5|Overall Study|Adverse Event|0
848690|NCT01653158|2793641|P4|Overall Study|Adverse Event|1
848691|NCT01653158|2793642|P3|Overall Study|Adverse Event|0
848692|NCT01653158|2793643|P2|Overall Study|Adverse Event|0
848693|NCT01653158|2793644|P1|Overall Study|Adverse Event|0
848694|NCT01653158|2793637|P8|Overall Study|Death|2
848695|NCT01653158|2793638|P7|Overall Study|Death|0
848696|NCT01653158|2793639|P6|Overall Study|Death|0
848697|NCT01653158|2793640|P5|Overall Study|Death|0
848698|NCT01653158|2793641|P4|Overall Study|Death|1
848699|NCT01653158|2793642|P3|Overall Study|Death|0
848700|NCT01653158|2793643|P2|Overall Study|Death|0
848701|NCT01653158|2793644|P1|Overall Study|Death|0
848702|NCT01653132|2793916|P2|First Intervention|Protocol Violation|0
848703|NCT01653132|2793917|P1|First Intervention|Protocol Violation|1
848704|NCT01652885|2793967|P1|Overall Study|Adverse Event|1
848705|NCT01652872|2793994|P2|Overall Study|Withdrawal by Subject|84
848706|NCT01652872|2793995|P1|Overall Study|Withdrawal by Subject|76
848707|NCT01652872|2793994|P2|Overall Study|Decision by sponsor|7
848708|NCT01652872|2793995|P1|Overall Study|Decision by sponsor|5
848709|NCT01652872|2793994|P2|Overall Study|Lost to Follow-up|23
848710|NCT01652872|2793995|P1|Overall Study|Lost to Follow-up|28
848711|NCT01652872|2793994|P2|Overall Study|Death|39
848712|NCT01652872|2793995|P1|Overall Study|Death|36
848713|NCT01652729|2794012|P3|Overall Study|Administrative|0
848714|NCT01652729|2794013|P2|Overall Study|Administrative|0
848715|NCT01652729|2794014|P1|Overall Study|Administrative|1
848716|NCT01652729|2794012|P3|Overall Study|Lost to Follow-up|3
848717|NCT01652729|2794013|P2|Overall Study|Lost to Follow-up|6
848718|NCT01652729|2794014|P1|Overall Study|Lost to Follow-up|6
848719|NCT01652729|2794012|P3|Overall Study|Protocol Violation|0
848720|NCT01652729|2794013|P2|Overall Study|Protocol Violation|0
848721|NCT01652729|2794014|P1|Overall Study|Protocol Violation|1
848722|NCT01652729|2794012|P3|Overall Study|Physician Decision|1
848723|NCT01652729|2794013|P2|Overall Study|Physician Decision|0
848724|NCT01652729|2794014|P1|Overall Study|Physician Decision|1
848725|NCT01652729|2794012|P3|Overall Study|Adverse Event|3
848726|NCT01652729|2794013|P2|Overall Study|Adverse Event|0
848727|NCT01652729|2794014|P1|Overall Study|Adverse Event|4
848728|NCT01652729|2794012|P3|Overall Study|Withdrawal by Subject|7
848729|NCT01652729|2794013|P2|Overall Study|Withdrawal by Subject|7
848730|NCT01652729|2794014|P1|Overall Study|Withdrawal by Subject|14
848731|NCT01652716|2794036|P2|Overall Study|Withdrawal by Subject|18
848732|NCT01652716|2794037|P1|Overall Study|Withdrawal by Subject|33
848733|NCT01652716|2794036|P2|Overall Study|Adverse Event|10
848734|NCT01652716|2794037|P1|Overall Study|Adverse Event|7
848735|NCT01652716|2794036|P2|Overall Study|Protocol Violation|1
848736|NCT01652716|2794037|P1|Overall Study|Protocol Violation|2
848737|NCT01652716|2794036|P2|Overall Study|Lost to Follow-up|11
848738|NCT01652716|2794037|P1|Overall Study|Lost to Follow-up|12
848739|NCT01652716|2794036|P2|Overall Study|Investigator decision|4
848740|NCT01652716|2794037|P1|Overall Study|Investigator decision|1
848741|NCT01652716|2794036|P2|Overall Study|Administrative|2
848742|NCT01652716|2794037|P1|Overall Study|Administrative|0
848743|NCT01652716|2794036|P2|Overall Study|Loss of glucose control|0
848744|NCT01652716|2794037|P1|Overall Study|Loss of glucose control|1
848745|NCT01652703|2794057|P6|Overall Study|Other|1
848746|NCT01652703|2794058|P5|Overall Study|Other|1
848747|NCT01652703|2794059|P4|Overall Study|Other|1
848748|NCT01652703|2794060|P3|Overall Study|Other|0
848749|NCT01652703|2794061|P2|Overall Study|Other|0
848750|NCT01652703|2794062|P1|Overall Study|Other|0
848751|NCT01652703|2794057|P6|Overall Study|Withdrawal by Subject|1
848752|NCT01652703|2794058|P5|Overall Study|Withdrawal by Subject|0
848753|NCT01652703|2794059|P4|Overall Study|Withdrawal by Subject|1
848754|NCT01652703|2794060|P3|Overall Study|Withdrawal by Subject|3
848755|NCT01652703|2794061|P2|Overall Study|Withdrawal by Subject|1
848756|NCT01652703|2794062|P1|Overall Study|Withdrawal by Subject|0
848757|NCT01652690|2794120|P2|Overall Study|Death|2
848758|NCT01652690|2794121|P1|Overall Study|Death|5
848759|NCT01652690|2794120|P2|Overall Study|Lost to Follow-up|6
848760|NCT01652690|2794121|P1|Overall Study|Lost to Follow-up|6
848761|NCT01652690|2794120|P2|Overall Study|Other|9
848762|NCT01652690|2794121|P1|Overall Study|Other|8
848763|NCT01652690|2794120|P2|Overall Study|Withdrawal by Subject|4
848764|NCT01652690|2794121|P1|Overall Study|Withdrawal by Subject|16
848765|NCT01652664|2794155|P2|Overall Study|Inadequate IOP control|0
848766|NCT01652664|2794156|P1|Overall Study|Inadequate IOP control|1
848767|NCT01652664|2794155|P2|Overall Study|Treatment Failure|1
848768|NCT01652664|2794156|P1|Overall Study|Treatment Failure|5
848769|NCT01652573|2794165|P2|Overall Study|Adverse Event|1
848770|NCT01652573|2794166|P1|Overall Study|Adverse Event|0
848771|NCT01652287|2794221|P2|Overall Study|Withdrawal by Subject|0
848772|NCT01652287|2794222|P1|Overall Study|Withdrawal by Subject|2
848773|NCT01651949|2794253|P3|Overall Study|Withdrawal by Subject|9
848774|NCT01651949|2794254|P2|Overall Study|Withdrawal by Subject|18
848775|NCT01651949|2794255|P1|Overall Study|Withdrawal by Subject|17
848776|NCT01651949|2794253|P3|Overall Study|Screen failure|0
848777|NCT01651949|2794254|P2|Overall Study|Screen failure|2
848778|NCT01651949|2794255|P1|Overall Study|Screen failure|2
848779|NCT01651949|2794253|P3|Overall Study|Adverse Event|1
848780|NCT01651949|2794254|P2|Overall Study|Adverse Event|2
848781|NCT01651949|2794255|P1|Overall Study|Adverse Event|0
848782|NCT01651949|2794253|P3|Overall Study|Physician Decision|0
848783|NCT01651949|2794254|P2|Overall Study|Physician Decision|2
848784|NCT01651949|2794255|P1|Overall Study|Physician Decision|0
848785|NCT01651949|2794253|P3|Overall Study|Protocol Violation|1
848786|NCT01651949|2794254|P2|Overall Study|Protocol Violation|2
848787|NCT01651949|2794255|P1|Overall Study|Protocol Violation|0
848788|NCT01651949|2794253|P3|Overall Study|Lost to Follow-up|20
848789|NCT01651949|2794254|P2|Overall Study|Lost to Follow-up|56
848790|NCT01651949|2794255|P1|Overall Study|Lost to Follow-up|30
848791|NCT01651949|2794253|P3|Overall Study|Unknown status|0
848792|NCT01651949|2794254|P2|Overall Study|Unknown status|4
848793|NCT01651949|2794255|P1|Overall Study|Unknown status|4
848794|NCT01651936|2794275|P3|Extension Study|Study terminated by sponsor|13
848795|NCT01651936|2794276|P2|Extension Study|Study terminated by sponsor|0
848796|NCT01651936|2794277|P1|Extension Study|Study terminated by sponsor|0
848797|NCT01651936|2794275|P3|Extension Study|Lack of Efficacy|1
848798|NCT01651936|2794276|P2|Extension Study|Lack of Efficacy|0
848799|NCT01651936|2794277|P1|Extension Study|Lack of Efficacy|0
848800|NCT01651936|2794275|P3|Base Study|Study terminated by sponsor|0
848801|NCT01651936|2794276|P2|Base Study|Study terminated by sponsor|16
848802|NCT01651936|2794277|P1|Base Study|Study terminated by sponsor|21
848803|NCT01651936|2794275|P3|Base Study|Early Escape|0
848804|NCT01651936|2794276|P2|Base Study|Early Escape|8
848805|NCT01651936|2794277|P1|Base Study|Early Escape|2
848806|NCT01651936|2794275|P3|Base Study|Withdrawal by Subject|0
848807|NCT01651936|2794276|P2|Base Study|Withdrawal by Subject|1
848808|NCT01651936|2794277|P1|Base Study|Withdrawal by Subject|1
848809|NCT01651936|2794275|P3|Base Study|Adverse Event|0
848810|NCT01651936|2794276|P2|Base Study|Adverse Event|0
848811|NCT01651936|2794277|P1|Base Study|Adverse Event|3
848812|NCT01651780|2794347|P2|Overall Study|Physician decision: Day 30 visit <23 day|5
848813|NCT01651780|2794348|P1|Overall Study|Physician decision: Day 30 visit <23 day|1
848814|NCT01651780|2794347|P2|Overall Study|Lost to Follow-up|2
848815|NCT01651780|2794348|P1|Overall Study|Lost to Follow-up|1
848816|NCT01651780|2794347|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
848817|NCT01651780|2794348|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
848818|NCT01651780|2794347|P2|Overall Study|Withdrawal by Subject|0
848819|NCT01651780|2794348|P1|Overall Study|Withdrawal by Subject|2
848820|NCT01651780|2794347|P2|Overall Study|Reason Not Specified: No 30-day visit|2
848821|NCT01651780|2794348|P1|Overall Study|Reason Not Specified: No 30-day visit|2
848822|NCT01651780|2794347|P2|Overall Study|Physician decision: No 30-day visit|1
848823|NCT01651780|2794348|P1|Overall Study|Physician decision: No 30-day visit|2
848824|NCT01651403|2794380|P2|Overall Study|Subjects Randomized and Not Treated|1
848825|NCT01651403|2794381|P1|Overall Study|Subjects Randomized and Not Treated|0
848826|NCT01651403|2794380|P2|Overall Study|Investigator Decision|0
848827|NCT01651403|2794381|P1|Overall Study|Investigator Decision|1
848828|NCT01651403|2794380|P2|Overall Study|Withdrew Consent/Assent|5
848829|NCT01651403|2794381|P1|Overall Study|Withdrew Consent/Assent|5
848830|NCT01651403|2794380|P2|Overall Study|Subject Noncompliance|1
848831|NCT01651403|2794381|P1|Overall Study|Subject Noncompliance|1
848832|NCT01651403|2794380|P2|Overall Study|Continuing Study|22
848833|NCT01651403|2794381|P1|Overall Study|Continuing Study|48
848834|NCT01651260|2794427|P1|Overall Study|unable to apply product|3
848835|NCT01651208|2794434|P2|Overall Study|Lost to Follow-up|16
848836|NCT01651208|2794435|P1|Overall Study|Lost to Follow-up|14
848837|NCT01651039|2794450|P1|Overall Study|Progressive Disease|22
848838|NCT01651039|2794450|P1|Overall Study|Withdrawal by Subject|1
848839|NCT01651039|2794450|P1|Overall Study|Physician Decision|2
848840|NCT01651039|2794450|P1|Overall Study|Non-evaluables|5
848841|NCT01651000|2794463|P2|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1
848842|NCT01651000|2794464|P1|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0
848843|NCT01651000|2794463|P2|Overall Study|Administrative reason|0
848844|NCT01651000|2794464|P1|Overall Study|Administrative reason|1
848845|NCT01651000|2794463|P2|Overall Study|Physician Decision|0
848846|NCT01651000|2794464|P1|Overall Study|Physician Decision|1
848847|NCT01651000|2794463|P2|Overall Study|Lack of Efficacy|1
848848|NCT01651000|2794464|P1|Overall Study|Lack of Efficacy|1
848849|NCT01651000|2794463|P2|Overall Study|Subject noncompliance|3
848850|NCT01651000|2794464|P1|Overall Study|Subject noncompliance|0
848851|NCT01651000|2794463|P2|Overall Study|Withdrawal by Subject|10
848852|NCT01651000|2794464|P1|Overall Study|Withdrawal by Subject|2
848853|NCT01651000|2794463|P2|Overall Study|Protocol Violation|3
848854|NCT01651000|2794464|P1|Overall Study|Protocol Violation|0
848855|NCT01651000|2794463|P2|Overall Study|Lost to Follow-up|2
848856|NCT01651000|2794464|P1|Overall Study|Lost to Follow-up|3
848857|NCT01651000|2794463|P2|Overall Study|Adverse Event|8
848858|NCT01651000|2794464|P1|Overall Study|Adverse Event|2
848859|NCT01650831|2794485|P1|Overall Study|Screen failure|1
848860|NCT01650805|2794495|P2|Overall Study|Withdrawal by Subject|0
848861|NCT01650805|2794496|P1|Overall Study|Withdrawal by Subject|1
848862|NCT01650779|2794506|P1|Overall Study|Withdrawal by Subject|1
848863|NCT01650636|2794515|P2|Washout up to 9 Months|Lost to Follow-up|1
848864|NCT01650636|2794516|P1|Washout up to 9 Months|Lost to Follow-up|2
848865|NCT01650636|2794515|P2|Washout up to 9 Months|Withdrawal by Subject|2
848866|NCT01650636|2794516|P1|Washout up to 9 Months|Withdrawal by Subject|4
848867|NCT01650636|2794515|P2|Washout up to 5 Months|Lost to Follow-up|8
848868|NCT01650636|2794516|P1|Washout up to 5 Months|Lost to Follow-up|2
848869|NCT01650636|2794515|P2|Washout up to 5 Months|Death|0
848870|NCT01650636|2794516|P1|Washout up to 5 Months|Death|1
848871|NCT01650636|2794515|P2|Washout up to 5 Months|Physician Decision|2
848872|NCT01650636|2794516|P1|Washout up to 5 Months|Physician Decision|2
848873|NCT01650636|2794515|P2|Washout up to 5 Months|Withdrawal by Subject|8
848874|NCT01650636|2794516|P1|Washout up to 5 Months|Withdrawal by Subject|4
848875|NCT01650519|2794549|P2|Overall Study|Withdrawal by Subject|0
848876|NCT01650519|2794550|P1|Overall Study|Withdrawal by Subject|1
848877|NCT01650285|2794611|P1|Overall Study|Adverse Event|1
848878|NCT01650246|2794616|P1|Overall Study|Lack of Efficacy|30
848879|NCT01650246|2794616|P1|Overall Study|Death|1
848880|NCT01650246|2794616|P1|Overall Study|Withdrawal by Subject|26
848881|NCT01650246|2794616|P1|Overall Study|Lost to Follow-up|5
848882|NCT01650246|2794616|P1|Overall Study|Sponsor terminated study|53
848883|NCT01650246|2794616|P1|Overall Study|Protocol Violation|5
848884|NCT01650246|2794616|P1|Overall Study|Adverse Event|23
848885|NCT01649856|2794623|P2|Overall Study|Not Specified|5
848886|NCT01649856|2794624|P1|Overall Study|Not Specified|20
848887|NCT01649856|2794623|P2|Overall Study|Lack of Compliance|1
848888|NCT01649856|2794624|P1|Overall Study|Lack of Compliance|6
848889|NCT01649856|2794623|P2|Overall Study|Lost to Follow-up|16
848890|NCT01649856|2794624|P1|Overall Study|Lost to Follow-up|20
848891|NCT01649856|2794623|P2|Overall Study|Stable or Progressed Disease|3
848892|NCT01649856|2794624|P1|Overall Study|Stable or Progressed Disease|5
848893|NCT01649856|2794623|P2|Overall Study|Death|34
848894|NCT01649856|2794624|P1|Overall Study|Death|69
848895|NCT01649856|2794623|P2|Overall Study|Treatment Failure|1
848896|NCT01649856|2794624|P1|Overall Study|Treatment Failure|1
848897|NCT01649856|2794623|P2|Overall Study|Protocol Violation|4
848898|NCT01649856|2794624|P1|Overall Study|Protocol Violation|4
848899|NCT01649856|2794623|P2|Overall Study|Withdrawal by Subject|14
848900|NCT01649856|2794624|P1|Overall Study|Withdrawal by Subject|14
848901|NCT01649804|2794656|P1|Overall Study|Administrative/Other|8
848902|NCT01649791|2794668|P1|Overall Study|Adverse Event|1
848903|NCT01649791|2794668|P1|Overall Study|Disease Progression|2
848904|NCT01649765|2794677|P2|Overall Study|Withdrawal by Subject|1
848905|NCT01649765|2794678|P1|Overall Study|Withdrawal by Subject|2
848906|NCT01649765|2794677|P2|Overall Study|Protocol Violation|0
848907|NCT01649765|2794678|P1|Overall Study|Protocol Violation|1
848908|NCT01649765|2794677|P2|Overall Study|Physician Decision|3
848909|NCT01649765|2794678|P1|Overall Study|Physician Decision|0
848910|NCT01649765|2794677|P2|Overall Study|Lack of Efficacy|1
848911|NCT01649765|2794678|P1|Overall Study|Lack of Efficacy|1
848912|NCT01649765|2794677|P2|Overall Study|Adverse Event|3
848913|NCT01649765|2794678|P1|Overall Study|Adverse Event|5
848914|NCT01649557|2794729|P3|Overall Study|Lack of Efficacy|0
848915|NCT01649557|2794730|P2|Overall Study|Lack of Efficacy|0
848916|NCT01649557|2794731|P1|Overall Study|Lack of Efficacy|5
848917|NCT01649557|2794729|P3|Overall Study|Protocol deviation|0
848918|NCT01649557|2794730|P2|Overall Study|Protocol deviation|2
848919|NCT01649557|2794731|P1|Overall Study|Protocol deviation|0
848920|NCT01649557|2794729|P3|Overall Study|Withdrawal by Subject|4
848921|NCT01649557|2794730|P2|Overall Study|Withdrawal by Subject|5
848922|NCT01649557|2794731|P1|Overall Study|Withdrawal by Subject|15
848923|NCT01649557|2794729|P3|Overall Study|Physician Decision|1
848924|NCT01649557|2794730|P2|Overall Study|Physician Decision|2
848925|NCT01649557|2794731|P1|Overall Study|Physician Decision|8
848926|NCT01649557|2794729|P3|Overall Study|Met withdrawal criteria|0
848927|NCT01649557|2794730|P2|Overall Study|Met withdrawal criteria|0
848928|NCT01649557|2794731|P1|Overall Study|Met withdrawal criteria|4
848929|NCT01649557|2794729|P3|Overall Study|Adverse Event|1
848930|NCT01649557|2794730|P2|Overall Study|Adverse Event|5
848931|NCT01649557|2794731|P1|Overall Study|Adverse Event|7
848932|NCT01649557|2794729|P3|Overall Study|Lost to Follow-up|3
848933|NCT01649557|2794730|P2|Overall Study|Lost to Follow-up|0
848934|NCT01649557|2794731|P1|Overall Study|Lost to Follow-up|5
848935|NCT01649297|2794793|P5|Overall Study|For other reason|0
848936|NCT01649297|2794794|P4|Overall Study|For other reason|0
848937|NCT01649297|2794795|P3|Overall Study|For other reason|2
848938|NCT01649297|2794796|P2|Overall Study|For other reason|1
848939|NCT01649297|2794797|P1|Overall Study|For other reason|4
848940|NCT01649297|2794793|P5|Overall Study|Patient withdrawal (not due to AE)|1
848941|NCT01649297|2794794|P4|Overall Study|Patient withdrawal (not due to AE)|1
848942|NCT01649297|2794795|P3|Overall Study|Patient withdrawal (not due to AE)|4
848943|NCT01649297|2794796|P2|Overall Study|Patient withdrawal (not due to AE)|6
848944|NCT01649297|2794797|P1|Overall Study|Patient withdrawal (not due to AE)|3
848945|NCT01649297|2794793|P5|Overall Study|Lost to Follow-up|0
848946|NCT01649297|2794794|P4|Overall Study|Lost to Follow-up|3
848947|NCT01649297|2794795|P3|Overall Study|Lost to Follow-up|4
848948|NCT01649297|2794796|P2|Overall Study|Lost to Follow-up|1
848949|NCT01649297|2794797|P1|Overall Study|Lost to Follow-up|1
848950|NCT01649297|2794793|P5|Overall Study|Non compliant with Protocol|1
848951|NCT01649297|2794794|P4|Overall Study|Non compliant with Protocol|2
848952|NCT01649297|2794795|P3|Overall Study|Non compliant with Protocol|3
848953|NCT01649297|2794796|P2|Overall Study|Non compliant with Protocol|0
848954|NCT01649297|2794797|P1|Overall Study|Non compliant with Protocol|1
848955|NCT01649297|2794793|P5|Overall Study|Lack of Efficacy|1
848956|NCT01649297|2794794|P4|Overall Study|Lack of Efficacy|0
848957|NCT01649297|2794795|P3|Overall Study|Lack of Efficacy|0
848958|NCT01649297|2794796|P2|Overall Study|Lack of Efficacy|0
848959|NCT01649297|2794797|P1|Overall Study|Lack of Efficacy|0
848960|NCT01649297|2794793|P5|Overall Study|Adverse Event|1
848961|NCT01649297|2794794|P4|Overall Study|Adverse Event|13
848962|NCT01649297|2794795|P3|Overall Study|Adverse Event|4
848963|NCT01649297|2794796|P2|Overall Study|Adverse Event|5
848964|NCT01649297|2794797|P1|Overall Study|Adverse Event|5
848965|NCT01649271|2794816|P2|Overall Study|Other than stated above|0
848966|NCT01649271|2794817|P1|Overall Study|Other than stated above|1
848967|NCT01649271|2794816|P2|Overall Study|Withdrawal by Subject|0
848968|NCT01649271|2794817|P1|Overall Study|Withdrawal by Subject|1
848969|NCT01649271|2794816|P2|Overall Study|Other Adverse Event|2
848970|NCT01649271|2794817|P1|Overall Study|Other Adverse Event|0
848971|NCT01649271|2794816|P2|Overall Study|Progressive disease|5
848972|NCT01649271|2794817|P1|Overall Study|Progressive disease|4
848973|NCT01649232|2794832|P2|Overall Study|Physician Decision|0
848974|NCT01649232|2794833|P1|Overall Study|Physician Decision|2
848975|NCT01648790|2794885|P5|Treatment 3|Withdrawal by Subject|0
848976|NCT01648790|2794886|P4|Treatment 3|Withdrawal by Subject|1
848977|NCT01648790|2794887|P3|Treatment 3|Withdrawal by Subject|0
848978|NCT01648790|2794888|P2|Treatment 3|Withdrawal by Subject|0
848979|NCT01648790|2794889|P1|Treatment 3|Withdrawal by Subject|0
848980|NCT01648699|2794910|P1|Overall Study|Unspecified/unable to complete 4 visits|2
848981|NCT01648699|2794910|P1|Overall Study|Lost to Follow-up|2
848982|NCT01648699|2794910|P1|Overall Study|Death|1
848983|NCT01648582|2794939|P3|Overall Study|Sponsor Decision|1
848984|NCT01648582|2794940|P2|Overall Study|Sponsor Decision|1
848985|NCT01648582|2794941|P1|Overall Study|Sponsor Decision|0
848986|NCT01648582|2794939|P3|Overall Study|Death|0
848987|NCT01648582|2794940|P2|Overall Study|Death|0
848988|NCT01648582|2794941|P1|Overall Study|Death|1
848989|NCT01648582|2794939|P3|Overall Study|Physician Decision|3
848990|NCT01648582|2794940|P2|Overall Study|Physician Decision|1
848991|NCT01648582|2794941|P1|Overall Study|Physician Decision|0
848992|NCT01648582|2794939|P3|Overall Study|Withdrawal by Subject|17
848993|NCT01648582|2794940|P2|Overall Study|Withdrawal by Subject|17
848994|NCT01648582|2794941|P1|Overall Study|Withdrawal by Subject|15
848995|NCT01648582|2794939|P3|Overall Study|Protocol Violation|1
848996|NCT01648582|2794940|P2|Overall Study|Protocol Violation|2
848997|NCT01648582|2794941|P1|Overall Study|Protocol Violation|1
848998|NCT01648582|2794939|P3|Overall Study|Lost to Follow-up|8
848999|NCT01648582|2794940|P2|Overall Study|Lost to Follow-up|6
849000|NCT01648582|2794941|P1|Overall Study|Lost to Follow-up|9
849001|NCT01648582|2794939|P3|Overall Study|Adverse Event|2
849002|NCT01648582|2794940|P2|Overall Study|Adverse Event|11
849003|NCT01648582|2794941|P1|Overall Study|Adverse Event|6
849004|NCT01648348|2795044|P6|Overall Study|Replaced for MTD analysis|0
849005|NCT01648348|2795045|P5|Overall Study|Replaced for MTD analysis|0
849006|NCT01648348|2795046|P4|Overall Study|Replaced for MTD analysis|0
849007|NCT01648348|2795047|P3|Overall Study|Replaced for MTD analysis|1
849008|NCT01648348|2795048|P2|Overall Study|Replaced for MTD analysis|0
849009|NCT01648348|2795049|P1|Overall Study|Replaced for MTD analysis|1
849010|NCT01648348|2795044|P6|Overall Study|Cancel|6
849011|NCT01648348|2795045|P5|Overall Study|Cancel|3
849012|NCT01648348|2795046|P4|Overall Study|Cancel|0
849013|NCT01648348|2795047|P3|Overall Study|Cancel|0
849014|NCT01648348|2795048|P2|Overall Study|Cancel|0
849015|NCT01648348|2795049|P1|Overall Study|Cancel|1
849016|NCT01648283|2795125|P1|Overall Study|Withdrawal by Subject|14
849017|NCT01648140|2795135|P4|Overall Study|Lost to Follow-up|0
849018|NCT01648140|2795136|P3|Overall Study|Lost to Follow-up|2
849019|NCT01648140|2795137|P2|Overall Study|Lost to Follow-up|1
849020|NCT01648140|2795138|P1|Overall Study|Lost to Follow-up|2
849021|NCT01648140|2795135|P4|Overall Study|Withdrawal by Subject|2
849022|NCT01648140|2795136|P3|Overall Study|Withdrawal by Subject|3
849023|NCT01648140|2795137|P2|Overall Study|Withdrawal by Subject|3
849024|NCT01648140|2795138|P1|Overall Study|Withdrawal by Subject|2
849025|NCT01648140|2795135|P4|Overall Study|Adverse Event|0
849026|NCT01648140|2795136|P3|Overall Study|Adverse Event|2
849027|NCT01648140|2795137|P2|Overall Study|Adverse Event|1
849028|NCT01648140|2795138|P1|Overall Study|Adverse Event|3
849029|NCT01648140|2795135|P4|Overall Study|Lack of Efficacy|0
849030|NCT01648140|2795136|P3|Overall Study|Lack of Efficacy|1
849031|NCT01648140|2795137|P2|Overall Study|Lack of Efficacy|7
849032|NCT01648140|2795138|P1|Overall Study|Lack of Efficacy|4
849033|NCT01648140|2795135|P4|Overall Study|Physician Decision|0
849034|NCT01648140|2795136|P3|Overall Study|Physician Decision|0
849035|NCT01648140|2795137|P2|Overall Study|Physician Decision|0
849036|NCT01648140|2795138|P1|Overall Study|Physician Decision|1
849037|NCT01648101|2795303|P3|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
849038|NCT01648101|2795304|P2|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1
849039|NCT01648101|2795305|P1|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
849040|NCT01648101|2795303|P3|Transition Phase (4 Weeks)|Study Terminated|0
849041|NCT01648101|2795304|P2|Transition Phase (4 Weeks)|Study Terminated|0
849042|NCT01648101|2795305|P1|Transition Phase (4 Weeks)|Study Terminated|1
849043|NCT01648101|2795303|P3|Transition Phase (4 Weeks)|Withdrawal by Subject|2
849044|NCT01648101|2795304|P2|Transition Phase (4 Weeks)|Withdrawal by Subject|0
849045|NCT01648101|2795305|P1|Transition Phase (4 Weeks)|Withdrawal by Subject|0
849046|NCT01648101|2795303|P3|Transition Phase (4 Weeks)|Lack of Efficacy|0
849047|NCT01648101|2795304|P2|Transition Phase (4 Weeks)|Lack of Efficacy|2
849048|NCT01648101|2795305|P1|Transition Phase (4 Weeks)|Lack of Efficacy|0
849049|NCT01648101|2795303|P3|Transition Phase (4 Weeks)|Adverse Event|2
849050|NCT01648101|2795304|P2|Transition Phase (4 Weeks)|Adverse Event|3
849051|NCT01648101|2795305|P1|Transition Phase (4 Weeks)|Adverse Event|4
849052|NCT01648101|2795303|P3|Maintenance Phase (12 Weeks)|Adverse Event|4
849053|NCT01648101|2795304|P2|Maintenance Phase (12 Weeks)|Adverse Event|3
849054|NCT01648101|2795305|P1|Maintenance Phase (12 Weeks)|Adverse Event|1
849055|NCT01648101|2795303|P3|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
849056|NCT01648101|2795304|P2|Maintenance Phase (12 Weeks)|Lack of Efficacy|0
849057|NCT01648101|2795305|P1|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
849058|NCT01648101|2795303|P3|Maintenance Phase (12 Weeks)|Withdrew Consent|1
849059|NCT01648101|2795304|P2|Maintenance Phase (12 Weeks)|Withdrew Consent|0
849060|NCT01648101|2795305|P1|Maintenance Phase (12 Weeks)|Withdrew Consent|1
849061|NCT01648101|2795303|P3|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1
849062|NCT01648101|2795304|P2|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
849063|NCT01648101|2795305|P1|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
849064|NCT01648101|2795303|P3|Titration Phase (4 Weeks)|Adverse Event|3
849065|NCT01648101|2795304|P2|Titration Phase (4 Weeks)|Adverse Event|2
849066|NCT01648101|2795305|P1|Titration Phase (4 Weeks)|Adverse Event|0
849067|NCT01648101|2795303|P3|Titration Phase (4 Weeks)|Protocol Violation|2
849068|NCT01648101|2795304|P2|Titration Phase (4 Weeks)|Protocol Violation|1
849069|NCT01648101|2795305|P1|Titration Phase (4 Weeks)|Protocol Violation|2
849070|NCT01647711|2795392|P5|Overall Study|Other reason not defined|0
849071|NCT01647711|2795393|P4|Overall Study|Other reason not defined|1
849072|NCT01647711|2795394|P3|Overall Study|Other reason not defined|1
849073|NCT01647711|2795395|P2|Overall Study|Other reason not defined|1
849074|NCT01647711|2795396|P1|Overall Study|Other reason not defined|0
849075|NCT01647711|2795392|P5|Overall Study|Refused to continue taking medication|1
849076|NCT01647711|2795393|P4|Overall Study|Refused to continue taking medication|2
849077|NCT01647711|2795394|P3|Overall Study|Refused to continue taking medication|0
849078|NCT01647711|2795395|P2|Overall Study|Refused to continue taking medication|0
849079|NCT01647711|2795396|P1|Overall Study|Refused to continue taking medication|0
849080|NCT01647711|2795392|P5|Overall Study|Protocol Violation|1
849081|NCT01647711|2795393|P4|Overall Study|Protocol Violation|0
849082|NCT01647711|2795394|P3|Overall Study|Protocol Violation|0
849083|NCT01647711|2795395|P2|Overall Study|Protocol Violation|0
849084|NCT01647711|2795396|P1|Overall Study|Protocol Violation|0
849085|NCT01647711|2795392|P5|Overall Study|Other adverse event|2
849086|NCT01647711|2795393|P4|Overall Study|Other adverse event|0
849087|NCT01647711|2795394|P3|Overall Study|Other adverse event|2
849088|NCT01647711|2795395|P2|Overall Study|Other adverse event|0
849089|NCT01647711|2795396|P1|Overall Study|Other adverse event|0
849090|NCT01647711|2795392|P5|Overall Study|Progressive disease|2
849091|NCT01647711|2795393|P4|Overall Study|Progressive disease|8
849092|NCT01647711|2795394|P3|Overall Study|Progressive disease|6
849093|NCT01647711|2795395|P2|Overall Study|Progressive disease|2
849094|NCT01647711|2795396|P1|Overall Study|Progressive disease|6
849095|NCT01647542|2795424|P3|Overall Study|Death|1
849096|NCT01647542|2795425|P2|Overall Study|Death|0
849097|NCT01647542|2795426|P1|Overall Study|Death|0
849098|NCT01647542|2795424|P3|Overall Study|Lack of Efficacy|0
849099|NCT01647542|2795425|P2|Overall Study|Lack of Efficacy|1
849100|NCT01647542|2795426|P1|Overall Study|Lack of Efficacy|1
849101|NCT01647542|2795424|P3|Overall Study|Study Termination|65
849102|NCT01647542|2795425|P2|Overall Study|Study Termination|61
849103|NCT01647542|2795426|P1|Overall Study|Study Termination|64
849104|NCT01647542|2795424|P3|Overall Study|Withdrawal by Subject|0
849105|NCT01647542|2795425|P2|Overall Study|Withdrawal by Subject|4
849106|NCT01647542|2795426|P1|Overall Study|Withdrawal by Subject|6
849107|NCT01647542|2795424|P3|Overall Study|Lost to Follow-up|2
849108|NCT01647542|2795425|P2|Overall Study|Lost to Follow-up|2
849109|NCT01647542|2795426|P1|Overall Study|Lost to Follow-up|0
849110|NCT01647542|2795424|P3|Overall Study|Adverse Event|4
849111|NCT01647542|2795425|P2|Overall Study|Adverse Event|5
849112|NCT01647542|2795426|P1|Overall Study|Adverse Event|4
849113|NCT01647542|2795424|P3|Overall Study|Major Protocol Deviation|0
849114|NCT01647542|2795425|P2|Overall Study|Major Protocol Deviation|0
849115|NCT01647542|2795426|P1|Overall Study|Major Protocol Deviation|1
849116|NCT01647282|2795460|P2|Overall Study|Physician Decision|5
849117|NCT01647282|2795461|P1|Overall Study|Physician Decision|7
849118|NCT01646827|2795482|P2|Overall Study|Withdrawal by Subject|0
849119|NCT01646827|2795483|P1|Overall Study|Withdrawal by Subject|1
849120|NCT01646827|2795482|P2|Overall Study|Physician Decision|2
849121|NCT01646827|2795483|P1|Overall Study|Physician Decision|1
849122|NCT01646827|2795482|P2|Overall Study|Lost to Follow-up|3
849123|NCT01646827|2795483|P1|Overall Study|Lost to Follow-up|0
849124|NCT01646398|2795570|P2|Overall Study|Withdrawal by Subject|0
849125|NCT01646398|2795571|P1|Overall Study|Withdrawal by Subject|1
849126|NCT01646385|2795587|P2|Overall Study|Switched to alternate biologic|649
849127|NCT01646385|2795588|P1|Overall Study|Switched to alternate biologic|636
849128|NCT01646385|2795587|P2|Overall Study|Death|222
849129|NCT01646385|2795588|P1|Overall Study|Death|202
849130|NCT01646320|2795631|P2|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2
849131|NCT01646320|2795632|P1|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0
849132|NCT01646320|2795631|P2|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1
849133|NCT01646320|2795632|P1|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0
849134|NCT01646320|2795631|P2|Long-term Period (Weeks 24 to 52)|Adverse Event|2
849135|NCT01646320|2795632|P1|Long-term Period (Weeks 24 to 52)|Adverse Event|4
849136|NCT01646320|2795631|P2|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2
849137|NCT01646320|2795632|P1|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0
849138|NCT01646320|2795631|P2|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0
849139|NCT01646320|2795632|P1|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2
849140|NCT01646320|2795631|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0
849141|NCT01646320|2795632|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2
849142|NCT01646320|2795631|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
849143|NCT01646320|2795632|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
849144|NCT01646320|2795631|P2|Short-term Period (Day 1 to Week 24)|Not specified|0
849145|NCT01646320|2795632|P1|Short-term Period (Day 1 to Week 24)|Not specified|1
849146|NCT01646320|2795631|P2|Short-term Period (Day 1 to Week 24)|Not reported|2
849147|NCT01646320|2795632|P1|Short-term Period (Day 1 to Week 24)|Not reported|2
849148|NCT01646320|2795631|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1
849149|NCT01646320|2795632|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
849150|NCT01646320|2795631|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|0
849151|NCT01646320|2795632|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|3
849152|NCT01646268|2795648|P2|Overall Study|Other|0
849153|NCT01646268|2795649|P1|Overall Study|Other|2
849154|NCT01646268|2795648|P2|Overall Study|Withdrawal by Subject|5
849155|NCT01646268|2795649|P1|Overall Study|Withdrawal by Subject|2
849156|NCT01646268|2795648|P2|Overall Study|Protocol Violation|1
849157|NCT01646268|2795649|P1|Overall Study|Protocol Violation|0
849158|NCT01646268|2795648|P2|Overall Study|Lack of Efficacy|3
849159|NCT01646268|2795649|P1|Overall Study|Lack of Efficacy|1
849160|NCT01646268|2795648|P2|Overall Study|Adverse Event|7
849161|NCT01646268|2795649|P1|Overall Study|Adverse Event|6
849162|NCT01646255|2795663|P2|Overall Study|Inclusion Criteria Deviation|0
849163|NCT01646255|2795664|P1|Overall Study|Inclusion Criteria Deviation|1
849164|NCT01646255|2795663|P2|Overall Study|Compliance is not well|0
849165|NCT01646255|2795664|P1|Overall Study|Compliance is not well|1
849166|NCT01646255|2795663|P2|Overall Study|Withdrawal by Subject|6
849167|NCT01646255|2795664|P1|Overall Study|Withdrawal by Subject|10
849168|NCT01646255|2795663|P2|Overall Study|Lack of Efficacy|0
849169|NCT01646255|2795664|P1|Overall Study|Lack of Efficacy|2
849170|NCT01646255|2795663|P2|Overall Study|Adverse Event|8
849171|NCT01646255|2795664|P1|Overall Study|Adverse Event|7
849172|NCT01646216|2795696|P2|Overall Study|Investigator decision|1
849173|NCT01646216|2795697|P1|Overall Study|Investigator decision|1
849174|NCT01646216|2795696|P2|Overall Study|Did not complete training|2
849175|NCT01646216|2795697|P1|Overall Study|Did not complete training|0
849176|NCT01646216|2795696|P2|Overall Study|Baseline step length difference (<5cm)|10
849177|NCT01646216|2795697|P1|Overall Study|Baseline step length difference (<5cm)|10
849178|NCT01646177|2795720|P4|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
849179|NCT01646177|2795721|P3|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
849180|NCT01646177|2795722|P2|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
849181|NCT01646177|2795723|P1|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3
849182|NCT01646177|2795720|P4|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1
849183|NCT01646177|2795721|P3|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2
849184|NCT01646177|2795722|P2|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
849185|NCT01646177|2795723|P1|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
849186|NCT01646177|2795720|P4|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
849187|NCT01646177|2795721|P3|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
849188|NCT01646177|2795722|P2|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
849189|NCT01646177|2795723|P1|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
849190|NCT01646177|2795720|P4|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
849191|NCT01646177|2795721|P3|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
849192|NCT01646177|2795722|P2|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2
849193|NCT01646177|2795723|P1|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3
849194|NCT01646177|2795720|P4|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7
849195|NCT01646177|2795721|P3|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8
849196|NCT01646177|2795722|P2|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3
849197|NCT01646177|2795723|P1|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1
849198|NCT01646177|2795720|P4|Blinded Induction Dosing (Week 0-12)|Adverse Event|8
849199|NCT01646177|2795721|P3|Blinded Induction Dosing (Week 0-12)|Adverse Event|9
849200|NCT01646177|2795722|P2|Blinded Induction Dosing (Week 0-12)|Adverse Event|4
849201|NCT01646177|2795723|P1|Blinded Induction Dosing (Week 0-12)|Adverse Event|2
849202|NCT01646138|2795817|P5|Overall Study|Lost to Follow-up|2
849203|NCT01646138|2795818|P4|Overall Study|Lost to Follow-up|0
849204|NCT01646138|2795819|P3|Overall Study|Lost to Follow-up|0
849205|NCT01646138|2795820|P2|Overall Study|Lost to Follow-up|0
849206|NCT01646138|2795821|P1|Overall Study|Lost to Follow-up|0
849207|NCT01646125|2795835|P2|Overall Study|Subject/Guardian decision|1
849208|NCT01646125|2795836|P1|Overall Study|Subject/Guardian decision|1
849209|NCT01646125|2795835|P2|Overall Study|Study terminated by sponsor|1
849210|NCT01646125|2795836|P1|Overall Study|Study terminated by sponsor|2
849211|NCT01646125|2795835|P2|Overall Study|Progressive disease|16
849212|NCT01646125|2795836|P1|Overall Study|Progressive disease|22
849213|NCT01646125|2795835|P2|Overall Study|Physician Decision|3
849214|NCT01646125|2795836|P1|Overall Study|Physician Decision|1
849215|NCT01646125|2795835|P2|Overall Study|Death|1
849216|NCT01646125|2795836|P1|Overall Study|Death|1
849217|NCT01646125|2795835|P2|Overall Study|Adverse Event|1
849218|NCT01646125|2795836|P1|Overall Study|Adverse Event|2
849219|NCT01646125|2795835|P2|Overall Study|Untreated|5
849220|NCT01646125|2795836|P1|Overall Study|Untreated|2
849221|NCT01646073|2795861|P2|Period B (12 Weeks)|Lost to Follow-up|1
849222|NCT01646073|2795862|P1|Period B (12 Weeks)|Lost to Follow-up|0
849223|NCT01646073|2795861|P2|Period B (12 Weeks)|Withdrawal by Subject|5
849224|NCT01646073|2795862|P1|Period B (12 Weeks)|Withdrawal by Subject|1
849225|NCT01646073|2795861|P2|Period B (12 Weeks)|Adverse Event|7
849226|NCT01646073|2795862|P1|Period B (12 Weeks)|Adverse Event|0
849227|NCT01646073|2795861|P2|Period A (12 Weeks)|Not Specified|1
849228|NCT01646073|2795862|P1|Period A (12 Weeks)|Not Specified|0
849229|NCT01646073|2795861|P2|Period A (12 Weeks)|Protocol Violation|1
849230|NCT01646073|2795862|P1|Period A (12 Weeks)|Protocol Violation|0
849231|NCT01646073|2795861|P2|Period A (12 Weeks)|Lack of Efficacy|0
849232|NCT01646073|2795862|P1|Period A (12 Weeks)|Lack of Efficacy|1
849233|NCT01646073|2795861|P2|Period A (12 Weeks)|Withdrawal by Subject|1
849234|NCT01646073|2795862|P1|Period A (12 Weeks)|Withdrawal by Subject|1
849235|NCT01646073|2795861|P2|Period A (12 Weeks)|Adverse Event|2
849236|NCT01646073|2795862|P1|Period A (12 Weeks)|Adverse Event|0
849237|NCT01646021|2795903|P2|Overall Study|Withdrawal by Subject|15
849238|NCT01646021|2795904|P1|Overall Study|Withdrawal by Subject|10
849239|NCT01646021|2795903|P2|Overall Study|Lost to Follow-up|2
849240|NCT01646021|2795904|P1|Overall Study|Lost to Follow-up|2
849241|NCT01646021|2795903|P2|Overall Study|Study Terminated by Sponsor|41
849242|NCT01646021|2795904|P1|Overall Study|Study Terminated by Sponsor|50
849243|NCT01646021|2795903|P2|Overall Study|Death|83
849244|NCT01646021|2795904|P1|Overall Study|Death|77
849245|NCT01645930|2795941|P1|Overall Study|Reason not Defined|1
849246|NCT01645930|2795941|P1|Overall Study|Withdrawal by Participant|2
849247|NCT01645930|2795941|P1|Overall Study|Unsatisfactory Therapeutic Response|2
849248|NCT01645930|2795941|P1|Overall Study|Adverse Event|4
849249|NCT01645930|2795941|P1|Overall Study|Progressive Disease|12
849250|NCT01645930|2795941|P1|Overall Study|Participants Ongoing on Study Treatment|22
849251|NCT01645735|2795958|P2|Overall Study|Adverse Event|1
849252|NCT01645735|2795959|P1|Overall Study|Adverse Event|0
849253|NCT01645735|2795958|P2|Overall Study|Protocol Violation|0
849254|NCT01645735|2795959|P1|Overall Study|Protocol Violation|1
849255|NCT01645735|2795958|P2|Overall Study|Withdrawal by Subject|0
849256|NCT01645735|2795959|P1|Overall Study|Withdrawal by Subject|1
849257|NCT01645735|2795958|P2|Overall Study|Physician Decision|0
849258|NCT01645735|2795959|P1|Overall Study|Physician Decision|2
849259|NCT01645280|2796001|P5|Overall Study|Treatment not completed/Completed f/u|2
849260|NCT01645280|2796002|P4|Overall Study|Treatment not completed/Completed f/u|0
849261|NCT01645280|2796003|P3|Overall Study|Treatment not completed/Completed f/u|2
849262|NCT01645280|2796004|P2|Overall Study|Treatment not completed/Completed f/u|1
849263|NCT01645280|2796005|P1|Overall Study|Treatment not completed/Completed f/u|1
849264|NCT01645280|2796001|P5|Overall Study|Other|0
849265|NCT01645280|2796002|P4|Overall Study|Other|0
849266|NCT01645280|2796003|P3|Overall Study|Other|2
849267|NCT01645280|2796004|P2|Overall Study|Other|1
849268|NCT01645280|2796005|P1|Overall Study|Other|1
849269|NCT01645280|2796001|P5|Overall Study|Lost to Follow-up|1
849270|NCT01645280|2796002|P4|Overall Study|Lost to Follow-up|2
849271|NCT01645280|2796003|P3|Overall Study|Lost to Follow-up|0
849272|NCT01645280|2796004|P2|Overall Study|Lost to Follow-up|0
849273|NCT01645280|2796005|P1|Overall Study|Lost to Follow-up|0
849274|NCT01645280|2796001|P5|Overall Study|Withdrawal by Subject|5
849275|NCT01645280|2796002|P4|Overall Study|Withdrawal by Subject|4
849276|NCT01645280|2796003|P3|Overall Study|Withdrawal by Subject|2
849277|NCT01645280|2796004|P2|Overall Study|Withdrawal by Subject|0
849278|NCT01645280|2796005|P1|Overall Study|Withdrawal by Subject|4
849279|NCT01645280|2796001|P5|Overall Study|Death|0
849280|NCT01645280|2796002|P4|Overall Study|Death|0
849281|NCT01645280|2796003|P3|Overall Study|Death|0
849282|NCT01645280|2796004|P2|Overall Study|Death|1
849283|NCT01645280|2796005|P1|Overall Study|Death|0
849284|NCT01645176|2796033|P1|Overall Study|did not complete final MRI|1
849285|NCT01645176|2796033|P1|Overall Study|Lack of Efficacy|4
849286|NCT01645111|2796037|P1|Overall Study|Did not require Clevidipine|15
849287|NCT01644734|2796076|P1|Overall Study|Missing documentation|238
849288|NCT01644734|2796076|P1|Overall Study|Reasons other than stated above|7
849289|NCT01644734|2796076|P1|Overall Study|Lost to Follow-up|17
849290|NCT01644734|2796076|P1|Overall Study|Adverse Event|4
849291|NCT01644643|2796090|P4|Overall Study|Other Eligibility criteria|2
849292|NCT01644643|2796091|P3|Overall Study|Other Eligibility criteria|0
849293|NCT01644643|2796092|P2|Overall Study|Other Eligibility criteria|0
849294|NCT01644643|2796093|P1|Overall Study|Other Eligibility criteria|0
849295|NCT01644643|2796090|P4|Overall Study|Withdrawal by Subject|1
849296|NCT01644643|2796091|P3|Overall Study|Withdrawal by Subject|2
849297|NCT01644643|2796092|P2|Overall Study|Withdrawal by Subject|0
849298|NCT01644643|2796093|P1|Overall Study|Withdrawal by Subject|1
849299|NCT01644643|2796090|P4|Overall Study|Lost to Follow-up|4
849300|NCT01644643|2796091|P3|Overall Study|Lost to Follow-up|0
849301|NCT01644643|2796092|P2|Overall Study|Lost to Follow-up|0
849302|NCT01644643|2796093|P1|Overall Study|Lost to Follow-up|0
849303|NCT01644643|2796090|P4|Overall Study|Death|3
849304|NCT01644643|2796091|P3|Overall Study|Death|3
849305|NCT01644643|2796092|P2|Overall Study|Death|0
849306|NCT01644643|2796093|P1|Overall Study|Death|1
849307|NCT01644617|2796258|P3|Overall Study|Adverse Event|6
849308|NCT01644617|2796259|P2|Overall Study|Adverse Event|0
849309|NCT01644617|2796260|P1|Overall Study|Adverse Event|3
849310|NCT01644617|2796258|P3|Overall Study|Lost to Follow-up|0
849311|NCT01644617|2796259|P2|Overall Study|Lost to Follow-up|1
849312|NCT01644617|2796260|P1|Overall Study|Lost to Follow-up|0
849313|NCT01644617|2796258|P3|Overall Study|Withdrawal by Subject|1
849314|NCT01644617|2796259|P2|Overall Study|Withdrawal by Subject|4
849315|NCT01644617|2796260|P1|Overall Study|Withdrawal by Subject|3
849316|NCT01644500|2796313|P3|Overall Study|Physician Decision|1
849317|NCT01644500|2796314|P2|Overall Study|Physician Decision|1
849318|NCT01644500|2796315|P1|Overall Study|Physician Decision|1
849319|NCT01644500|2796313|P3|Overall Study|Withdrawal by Subject|12
849320|NCT01644500|2796314|P2|Overall Study|Withdrawal by Subject|12
849321|NCT01644500|2796315|P1|Overall Study|Withdrawal by Subject|11
849322|NCT01644500|2796313|P3|Overall Study|Protocol Violation|0
849323|NCT01644500|2796314|P2|Overall Study|Protocol Violation|1
849324|NCT01644500|2796315|P1|Overall Study|Protocol Violation|1
849325|NCT01644500|2796313|P3|Overall Study|Lost to Follow-up|0
849326|NCT01644500|2796314|P2|Overall Study|Lost to Follow-up|8
849327|NCT01644500|2796315|P1|Overall Study|Lost to Follow-up|3
849328|NCT01644500|2796313|P3|Overall Study|Death|0
849329|NCT01644500|2796314|P2|Overall Study|Death|1
849330|NCT01644500|2796315|P1|Overall Study|Death|0
849331|NCT01644500|2796313|P3|Overall Study|Adverse Event|2
849332|NCT01644500|2796314|P2|Overall Study|Adverse Event|1
849333|NCT01644500|2796315|P1|Overall Study|Adverse Event|6
849334|NCT01644474|2796385|P2|Overall Study|Protocol Violation|0
849335|NCT01644474|2796386|P1|Overall Study|Protocol Violation|1
849336|NCT01644474|2796385|P2|Overall Study|Site scheduling error|1
849337|NCT01644474|2796386|P1|Overall Study|Site scheduling error|1
849338|NCT01644474|2796385|P2|Overall Study|Adverse Event|5
849339|NCT01644474|2796386|P1|Overall Study|Adverse Event|4
849340|NCT01644474|2796385|P2|Overall Study|Participant moved|1
849341|NCT01644474|2796386|P1|Overall Study|Participant moved|0
849342|NCT01644474|2796385|P2|Overall Study|Consent withdrawn by participant|1
849343|NCT01644474|2796386|P1|Overall Study|Consent withdrawn by participant|0
849344|NCT01644474|2796385|P2|Overall Study|Poor compliance to protocol|0
849345|NCT01644474|2796386|P1|Overall Study|Poor compliance to protocol|1
849346|NCT01644188|2796570|P2|Overall Study|Other than specified above|7
849347|NCT01644188|2796571|P1|Overall Study|Other than specified above|6
849348|NCT01644188|2796570|P2|Overall Study|Site closure|1
849349|NCT01644188|2796571|P1|Overall Study|Site closure|1
849350|NCT01644188|2796570|P2|Overall Study|Last visit outside protocol visit window|16
849351|NCT01644188|2796571|P1|Overall Study|Last visit outside protocol visit window|14
849352|NCT01644188|2796570|P2|Overall Study|Death|3
849353|NCT01644188|2796571|P1|Overall Study|Death|4
849354|NCT01644188|2796570|P2|Overall Study|Lost to Follow-up|0
849355|NCT01644188|2796571|P1|Overall Study|Lost to Follow-up|1
849356|NCT01644188|2796570|P2|Overall Study|Selection criteria finally not met|0
849357|NCT01644188|2796571|P1|Overall Study|Selection criteria finally not met|2
849358|NCT01644188|2796570|P2|Overall Study|Consent withdrawn by participant|7
849359|NCT01644188|2796571|P1|Overall Study|Consent withdrawn by participant|14
849360|NCT01644188|2796570|P2|Overall Study|Related to auto-injector administration|2
849361|NCT01644188|2796571|P1|Overall Study|Related to auto-injector administration|2
849362|NCT01644188|2796570|P2|Overall Study|Participant moved|2
849363|NCT01644188|2796571|P1|Overall Study|Participant moved|7
849364|NCT01644188|2796570|P2|Overall Study|Physician Decision|3
849365|NCT01644188|2796571|P1|Overall Study|Physician Decision|1
849366|NCT01644188|2796570|P2|Overall Study|Poor compliance to protocol|14
849367|NCT01644188|2796571|P1|Overall Study|Poor compliance to protocol|26
849368|NCT01644188|2796570|P2|Overall Study|Adverse Event|20
849369|NCT01644188|2796571|P1|Overall Study|Adverse Event|44
849370|NCT01644175|2796629|P2|Overall Study|Other than specified above|3
849371|NCT01644175|2796630|P1|Overall Study|Other than specified above|0
849372|NCT01644175|2796629|P2|Overall Study|Lost to Follow-up|0
849373|NCT01644175|2796630|P1|Overall Study|Lost to Follow-up|1
849374|NCT01644175|2796629|P2|Overall Study|Site closure|2
849375|NCT01644175|2796630|P1|Overall Study|Site closure|2
849376|NCT01644175|2796629|P2|Overall Study|Selection criteria finally not met|1
849377|NCT01644175|2796630|P1|Overall Study|Selection criteria finally not met|0
849378|NCT01644175|2796629|P2|Overall Study|Last visit outside protocol visit window|11
849379|NCT01644175|2796630|P1|Overall Study|Last visit outside protocol visit window|4
849380|NCT01644175|2796629|P2|Overall Study|Related to Autoinjector Administration|1
849381|NCT01644175|2796630|P1|Overall Study|Related to Autoinjector Administration|2
849382|NCT01644175|2796629|P2|Overall Study|Consent withdrawn by participant|4
849383|NCT01644175|2796630|P1|Overall Study|Consent withdrawn by participant|3
849384|NCT01644175|2796629|P2|Overall Study|Participant Moved|2
849385|NCT01644175|2796630|P1|Overall Study|Participant Moved|1
849386|NCT01644175|2796629|P2|Overall Study|Physician Decision|2
849387|NCT01644175|2796630|P1|Overall Study|Physician Decision|1
849388|NCT01644175|2796629|P2|Overall Study|Poor compliance to protocol|10
849389|NCT01644175|2796630|P1|Overall Study|Poor compliance to protocol|9
849390|NCT01644175|2796629|P2|Overall Study|Death|2
849391|NCT01644175|2796630|P1|Overall Study|Death|1
849392|NCT01644175|2796629|P2|Overall Study|Adverse Event|13
849393|NCT01644175|2796630|P1|Overall Study|Adverse Event|8
849394|NCT01644175|2796629|P2|Overall Study|Randomized But Not Treated|2
849395|NCT01644175|2796630|P1|Overall Study|Randomized But Not Treated|0
849396|NCT01643928|2796690|P5|Overall Study|Adverse Event|2
849397|NCT01643928|2796691|P4|Overall Study|Adverse Event|1
849398|NCT01643928|2796692|P3|Overall Study|Adverse Event|0
849399|NCT01643928|2796693|P2|Overall Study|Adverse Event|1
849400|NCT01643928|2796694|P1|Overall Study|Adverse Event|2
849401|NCT01643928|2796690|P5|Overall Study|Other|0
849402|NCT01643928|2796691|P4|Overall Study|Other|0
849403|NCT01643928|2796692|P3|Overall Study|Other|1
849404|NCT01643928|2796693|P2|Overall Study|Other|1
849405|NCT01643928|2796694|P1|Overall Study|Other|5
849406|NCT01643928|2796690|P5|Overall Study|Pregnancy|0
849407|NCT01643928|2796691|P4|Overall Study|Pregnancy|1
849408|NCT01643928|2796692|P3|Overall Study|Pregnancy|0
849409|NCT01643928|2796693|P2|Overall Study|Pregnancy|0
849410|NCT01643928|2796694|P1|Overall Study|Pregnancy|0
849411|NCT01643928|2796690|P5|Overall Study|Withdrawal by Subject|0
849412|NCT01643928|2796691|P4|Overall Study|Withdrawal by Subject|1
849413|NCT01643928|2796692|P3|Overall Study|Withdrawal by Subject|0
849414|NCT01643928|2796693|P2|Overall Study|Withdrawal by Subject|0
849415|NCT01643928|2796694|P1|Overall Study|Withdrawal by Subject|2
849416|NCT01643928|2796690|P5|Overall Study|Lost to Follow-up|0
849417|NCT01643928|2796691|P4|Overall Study|Lost to Follow-up|0
849418|NCT01643928|2796692|P3|Overall Study|Lost to Follow-up|2
849419|NCT01643928|2796693|P2|Overall Study|Lost to Follow-up|0
849420|NCT01643928|2796694|P1|Overall Study|Lost to Follow-up|1
849421|NCT01643798|2796989|P2|Pretreatment 1 and Stimulation|Withdrawal by Subject|0
849422|NCT01643798|2796990|P1|Pretreatment 1 and Stimulation|Withdrawal by Subject|1
849423|NCT01643668|2797001|P1|Overall Study|Death|1
849424|NCT01643044|2797041|P2|Overall Study|Delivered outside of hospital|2
849425|NCT01643044|2797042|P1|Overall Study|Delivered outside of hospital|1
849426|NCT01643044|2797041|P2|Overall Study|Miscarried baby|2
849427|NCT01643044|2797042|P1|Overall Study|Miscarried baby|2
849428|NCT01643044|2797041|P2|Overall Study|Lost to Follow-up|1
849429|NCT01643044|2797042|P1|Overall Study|Lost to Follow-up|1
849430|NCT01642914|2797051|P3|Overall Study|Other Reason|0
849431|NCT01642914|2797052|P2|Overall Study|Other Reason|0
849432|NCT01642914|2797053|P1|Overall Study|Other Reason|1
849433|NCT01642914|2797051|P3|Overall Study|Lost to Follow-up|7
849434|NCT01642914|2797052|P2|Overall Study|Lost to Follow-up|3
849435|NCT01642914|2797053|P1|Overall Study|Lost to Follow-up|5
849436|NCT01642914|2797051|P3|Overall Study|Withdrawal by Subject|10
849437|NCT01642914|2797052|P2|Overall Study|Withdrawal by Subject|5
849438|NCT01642914|2797053|P1|Overall Study|Withdrawal by Subject|5
849439|NCT01642914|2797051|P3|Overall Study|Protocol Violation|6
849440|NCT01642914|2797052|P2|Overall Study|Protocol Violation|13
849441|NCT01642914|2797053|P1|Overall Study|Protocol Violation|15
849442|NCT01642914|2797051|P3|Overall Study|Lack of Efficacy|2
849443|NCT01642914|2797052|P2|Overall Study|Lack of Efficacy|4
849444|NCT01642914|2797053|P1|Overall Study|Lack of Efficacy|9
849445|NCT01642914|2797051|P3|Overall Study|Adverse Event|15
849446|NCT01642914|2797052|P2|Overall Study|Adverse Event|7
849447|NCT01642914|2797053|P1|Overall Study|Adverse Event|11
849448|NCT01642732|2797128|P1|Overall Study|Withdrawal by Subject|1
849449|NCT01642615|2797133|P3|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1
849450|NCT01642615|2797134|P2|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
849451|NCT01642615|2797135|P1|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
849452|NCT01642615|2797133|P3|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
849453|NCT01642615|2797134|P2|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1
849454|NCT01642615|2797135|P1|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
849455|NCT01642615|2797133|P3|Double Blind Maintenance Phase|Voluntary Withdrawal|2
849456|NCT01642615|2797134|P2|Double Blind Maintenance Phase|Voluntary Withdrawal|5
849457|NCT01642615|2797135|P1|Double Blind Maintenance Phase|Voluntary Withdrawal|0
849458|NCT01642615|2797133|P3|Double Blind Maintenance Phase|Lack of Efficacy|3
849459|NCT01642615|2797134|P2|Double Blind Maintenance Phase|Lack of Efficacy|1
849460|NCT01642615|2797135|P1|Double Blind Maintenance Phase|Lack of Efficacy|0
849461|NCT01642615|2797133|P3|Open Label Maintenance Phase|Did not receive treatment|0
849462|NCT01642615|2797134|P2|Open Label Maintenance Phase|Did not receive treatment|0
849463|NCT01642615|2797135|P1|Open Label Maintenance Phase|Did not receive treatment|1
849464|NCT01642615|2797133|P3|Open Label Maintenance Phase|Voluntary Withdrawal|0
849465|NCT01642615|2797134|P2|Open Label Maintenance Phase|Voluntary Withdrawal|0
849466|NCT01642615|2797135|P1|Open Label Maintenance Phase|Voluntary Withdrawal|1
849467|NCT01642615|2797133|P3|Open Label Maintenance Phase|Lost to Follow-up|0
849468|NCT01642615|2797134|P2|Open Label Maintenance Phase|Lost to Follow-up|0
849469|NCT01642615|2797135|P1|Open Label Maintenance Phase|Lost to Follow-up|1
849470|NCT01642615|2797133|P3|Open Label Maintenance Phase|Major Protocol Deviation|0
849471|NCT01642615|2797134|P2|Open Label Maintenance Phase|Major Protocol Deviation|0
849472|NCT01642615|2797135|P1|Open Label Maintenance Phase|Major Protocol Deviation|1
849473|NCT01642615|2797133|P3|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
849474|NCT01642615|2797134|P2|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
849475|NCT01642615|2797135|P1|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1
849476|NCT01642602|2797149|P1|Overall Study|Adverse Event|2
849477|NCT01642589|2797156|P2|Overall Study|Withdrawal by Subject|1
849478|NCT01642589|2797157|P1|Overall Study|Withdrawal by Subject|1
849479|NCT01642407|2797196|P1|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1
849480|NCT01642407|2797196|P1|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1
849481|NCT01642407|2797196|P1|Part 1 (Screening Till Week 16)|Insufficient clinical response|3
849482|NCT01642277|2797243|P2|Overall Study|Withdrawal by Subject|0
849483|NCT01642277|2797244|P1|Overall Study|Withdrawal by Subject|11
849484|NCT01642277|2797243|P2|Overall Study|Protocol Violation|0
849485|NCT01642277|2797244|P1|Overall Study|Protocol Violation|1
849486|NCT01642277|2797243|P2|Overall Study|Physician Decision|0
849487|NCT01642277|2797244|P1|Overall Study|Physician Decision|2
849488|NCT01642277|2797243|P2|Overall Study|Adverse Event|0
849489|NCT01642277|2797244|P1|Overall Study|Adverse Event|10
849490|NCT01642212|2797276|P5|Open-label Extension|Not Specified|1
849491|NCT01642212|2797277|P4|Open-label Extension|Not Specified|0
849492|NCT01642212|2797278|P3|Open-label Extension|Not Specified|0
849493|NCT01642212|2797279|P2|Open-label Extension|Not Specified|0
849494|NCT01642212|2797280|P1|Open-label Extension|Not Specified|0
849495|NCT01642212|2797276|P5|Open-label Extension|Lost to Follow-up|1
849496|NCT01642212|2797277|P4|Open-label Extension|Lost to Follow-up|0
849497|NCT01642212|2797278|P3|Open-label Extension|Lost to Follow-up|0
849498|NCT01642212|2797279|P2|Open-label Extension|Lost to Follow-up|0
849499|NCT01642212|2797280|P1|Open-label Extension|Lost to Follow-up|0
849500|NCT01642212|2797276|P5|Open-label Extension|Consent Withdrawn|2
849501|NCT01642212|2797277|P4|Open-label Extension|Consent Withdrawn|0
849502|NCT01642212|2797278|P3|Open-label Extension|Consent Withdrawn|0
849503|NCT01642212|2797279|P2|Open-label Extension|Consent Withdrawn|0
849504|NCT01642212|2797280|P1|Open-label Extension|Consent Withdrawn|0
849505|NCT01642212|2797276|P5|Open-label Extension|Sponsor Decision|4
849506|NCT01642212|2797277|P4|Open-label Extension|Sponsor Decision|7
849507|NCT01642212|2797278|P3|Open-label Extension|Sponsor Decision|0
849508|NCT01642212|2797279|P2|Open-label Extension|Sponsor Decision|0
849509|NCT01642212|2797280|P1|Open-label Extension|Sponsor Decision|0
849510|NCT01642212|2797276|P5|Open-label Extension|Adverse Event|0
849511|NCT01642212|2797277|P4|Open-label Extension|Adverse Event|3
849512|NCT01642212|2797278|P3|Open-label Extension|Adverse Event|0
849513|NCT01642212|2797279|P2|Open-label Extension|Adverse Event|0
849514|NCT01642212|2797280|P1|Open-label Extension|Adverse Event|0
849515|NCT01642212|2797276|P5|Double-blind Treatment|Adverse Event|0
849516|NCT01642212|2797277|P4|Double-blind Treatment|Adverse Event|0
849517|NCT01642212|2797278|P3|Double-blind Treatment|Adverse Event|1
849518|NCT01642212|2797279|P2|Double-blind Treatment|Adverse Event|0
849519|NCT01642212|2797280|P1|Double-blind Treatment|Adverse Event|0
849520|NCT01642212|2797276|P5|Double-blind Treatment|Non-compliance|0
849521|NCT01642212|2797277|P4|Double-blind Treatment|Non-compliance|0
849522|NCT01642212|2797278|P3|Double-blind Treatment|Non-compliance|0
849523|NCT01642212|2797279|P2|Double-blind Treatment|Non-compliance|1
849524|NCT01642212|2797280|P1|Double-blind Treatment|Non-compliance|0
849525|NCT01642212|2797276|P5|Double-blind Treatment|Not Specified|0
849526|NCT01642212|2797277|P4|Double-blind Treatment|Not Specified|0
849527|NCT01642212|2797278|P3|Double-blind Treatment|Not Specified|1
849528|NCT01642212|2797279|P2|Double-blind Treatment|Not Specified|2
849529|NCT01642212|2797280|P1|Double-blind Treatment|Not Specified|0
849530|NCT01642212|2797276|P5|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
849531|NCT01642212|2797277|P4|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
849532|NCT01642212|2797278|P3|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
849533|NCT01642212|2797279|P2|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
849534|NCT01642212|2797280|P1|Single-blind Baseline|Did Not Meet Eligibility Criteria|26
849535|NCT01642004|2797375|P2|Treatment|Missing from data|1
849536|NCT01642004|2797376|P1|Treatment|Missing from data|0
849537|NCT01642004|2797375|P2|Treatment|Other|2
849538|NCT01642004|2797376|P1|Treatment|Other|1
849539|NCT01642004|2797375|P2|Treatment|No longer meets study criteria|2
849540|NCT01642004|2797376|P1|Treatment|No longer meets study criteria|1
849541|NCT01642004|2797375|P2|Treatment|Poor/non-compliance|0
849542|NCT01642004|2797376|P1|Treatment|Poor/non-compliance|1
849543|NCT01642004|2797375|P2|Treatment|Maximum clinical benefit|7
849544|NCT01642004|2797376|P1|Treatment|Maximum clinical benefit|2
849545|NCT01642004|2797375|P2|Treatment|Withdrawal by Subject|9
849546|NCT01642004|2797376|P1|Treatment|Withdrawal by Subject|5
849547|NCT01642004|2797375|P2|Treatment|Adverse event unrelated to study drug|13
849548|NCT01642004|2797376|P1|Treatment|Adverse event unrelated to study drug|6
849549|NCT01642004|2797375|P2|Treatment|Death|0
849550|NCT01642004|2797376|P1|Treatment|Death|1
849551|NCT01642004|2797375|P2|Treatment|Study drug toxicity|13
849552|NCT01642004|2797376|P1|Treatment|Study drug toxicity|5
849553|NCT01642004|2797375|P2|Treatment|Disease progression|80
849554|NCT01642004|2797376|P1|Treatment|Disease progression|88
849555|NCT01642004|2797375|P2|Randomization|No longer meets study criteria|2
849556|NCT01642004|2797376|P1|Randomization|No longer meets study criteria|2
849557|NCT01642004|2797375|P2|Randomization|Withdrawal by Subject|6
849558|NCT01642004|2797376|P1|Randomization|Withdrawal by Subject|1
849559|NCT01642004|2797375|P2|Randomization|Adverse Event unrelated to study drug|0
849560|NCT01642004|2797376|P1|Randomization|Adverse Event unrelated to study drug|1
849561|NCT01641991|2797410|P4|Overall Study|no longer eligible|4
849562|NCT01641991|2797411|P3|Overall Study|no longer eligible|0
849563|NCT01641991|2797412|P2|Overall Study|no longer eligible|1
849564|NCT01641991|2797413|P1|Overall Study|no longer eligible|2
849565|NCT01641991|2797410|P4|Overall Study|Pregnancy|0
849566|NCT01641991|2797411|P3|Overall Study|Pregnancy|1
849567|NCT01641991|2797412|P2|Overall Study|Pregnancy|0
849568|NCT01641991|2797413|P1|Overall Study|Pregnancy|0
849569|NCT01641991|2797410|P4|Overall Study|Protocol Violation|0
849570|NCT01641991|2797411|P3|Overall Study|Protocol Violation|3
849571|NCT01641991|2797412|P2|Overall Study|Protocol Violation|1
849572|NCT01641991|2797413|P1|Overall Study|Protocol Violation|1
849573|NCT01641991|2797410|P4|Overall Study|Lost to Follow-up|1
849574|NCT01641991|2797411|P3|Overall Study|Lost to Follow-up|3
849575|NCT01641991|2797412|P2|Overall Study|Lost to Follow-up|2
849576|NCT01641991|2797413|P1|Overall Study|Lost to Follow-up|0
849577|NCT01641991|2797410|P4|Overall Study|Adverse Event|1
849578|NCT01641991|2797411|P3|Overall Study|Adverse Event|2
849579|NCT01641991|2797412|P2|Overall Study|Adverse Event|1
849580|NCT01641991|2797413|P1|Overall Study|Adverse Event|2
849581|NCT01641991|2797410|P4|Overall Study|Withdrawal by Subject|5
849582|NCT01641991|2797411|P3|Overall Study|Withdrawal by Subject|1
849583|NCT01641991|2797412|P2|Overall Study|Withdrawal by Subject|2
849584|NCT01641991|2797413|P1|Overall Study|Withdrawal by Subject|4
849585|NCT01641991|2797410|P4|Overall Study|Physician Decision|5
849586|NCT01641991|2797411|P3|Overall Study|Physician Decision|7
849587|NCT01641991|2797412|P2|Overall Study|Physician Decision|1
849588|NCT01641991|2797413|P1|Overall Study|Physician Decision|0
849589|NCT01641952|2797497|P1|Overall Study|Adverse Event|6
849590|NCT01641952|2797497|P1|Overall Study|Lost to Follow-up|28
849591|NCT01641939|2797513|P3|Overall Study|Study Terminated by Sponsor|3
849592|NCT01641939|2797514|P2|Overall Study|Study Terminated by Sponsor|28
849593|NCT01641939|2797515|P1|Overall Study|Study Terminated by Sponsor|10
849594|NCT01641939|2797513|P3|Overall Study|Withdrawal by Subject|5
849595|NCT01641939|2797514|P2|Overall Study|Withdrawal by Subject|11
849596|NCT01641939|2797515|P1|Overall Study|Withdrawal by Subject|14
849597|NCT01641939|2797513|P3|Overall Study|Lost to Follow-up|1
849598|NCT01641939|2797514|P2|Overall Study|Lost to Follow-up|2
849599|NCT01641939|2797515|P1|Overall Study|Lost to Follow-up|3
849600|NCT01641939|2797513|P3|Overall Study|Death|61
849601|NCT01641939|2797514|P2|Overall Study|Death|187
849602|NCT01641939|2797515|P1|Overall Study|Death|90
849603|NCT01641926|2797558|P4|Overall Study|Not Treated|0
849604|NCT01641926|2797559|P3|Overall Study|Not Treated|1
849605|NCT01641926|2797560|P2|Overall Study|Not Treated|1
849606|NCT01641926|2797561|P1|Overall Study|Not Treated|1
849607|NCT01641926|2797558|P4|Overall Study|Withdrawal by Subject|1
849608|NCT01641926|2797559|P3|Overall Study|Withdrawal by Subject|6
849609|NCT01641926|2797560|P2|Overall Study|Withdrawal by Subject|5
849610|NCT01641926|2797561|P1|Overall Study|Withdrawal by Subject|13
849611|NCT01641926|2797558|P4|Overall Study|Protocol Violation|1
849612|NCT01641926|2797559|P3|Overall Study|Protocol Violation|0
849613|NCT01641926|2797560|P2|Overall Study|Protocol Violation|0
849614|NCT01641926|2797561|P1|Overall Study|Protocol Violation|1
849615|NCT01641926|2797558|P4|Overall Study|Physician Decision|1
849616|NCT01641926|2797559|P3|Overall Study|Physician Decision|0
849617|NCT01641926|2797560|P2|Overall Study|Physician Decision|5
849618|NCT01641926|2797561|P1|Overall Study|Physician Decision|6
849619|NCT01641926|2797558|P4|Overall Study|Lost to Follow-up|0
849620|NCT01641926|2797559|P3|Overall Study|Lost to Follow-up|1
849621|NCT01641926|2797560|P2|Overall Study|Lost to Follow-up|2
849622|NCT01641926|2797561|P1|Overall Study|Lost to Follow-up|2
849623|NCT01641926|2797558|P4|Overall Study|Adverse Event|1
849624|NCT01641926|2797559|P3|Overall Study|Adverse Event|3
849625|NCT01641926|2797560|P2|Overall Study|Adverse Event|2
849626|NCT01641926|2797561|P1|Overall Study|Adverse Event|5
849627|NCT01641900|2797589|P2|Overall Study|Withdrawal by Subject|2
849628|NCT01641900|2797590|P1|Overall Study|Withdrawal by Subject|2
849629|NCT01641861|2797602|P2|Overall Study|Died due to drowning|1
849630|NCT01641861|2797603|P1|Overall Study|Died due to drowning|0
849631|NCT01641861|2797602|P2|Overall Study|Lost the tooth due to normal exfoliation|8
849632|NCT01641861|2797603|P1|Overall Study|Lost the tooth due to normal exfoliation|14
849633|NCT01641861|2797602|P2|Overall Study|Lost to Follow-up|16
849634|NCT01641861|2797603|P1|Overall Study|Lost to Follow-up|21
849635|NCT01641822|2797624|P3|Comparative Phase|Protocol-specified criteria for withdraw|1
849636|NCT01641822|2797625|P2|Comparative Phase|Protocol-specified criteria for withdraw|1
849637|NCT01641822|2797626|P1|Comparative Phase|Protocol-specified criteria for withdraw|0
849638|NCT01641822|2797624|P3|Comparative Phase|Withdrew consent|7
849639|NCT01641822|2797625|P2|Comparative Phase|Withdrew consent|3
849640|NCT01641822|2797626|P1|Comparative Phase|Withdrew consent|0
849641|NCT01641822|2797624|P3|Comparative Phase|Adverse event, serious fatal|0
849642|NCT01641822|2797625|P2|Comparative Phase|Adverse event, serious fatal|1
849643|NCT01641822|2797626|P1|Comparative Phase|Adverse event, serious fatal|0
849644|NCT01641822|2797624|P3|Comparative Phase|Pregnancy|1
849645|NCT01641822|2797625|P2|Comparative Phase|Pregnancy|0
849646|NCT01641822|2797626|P1|Comparative Phase|Pregnancy|0
849647|NCT01641822|2797624|P3|Comparative Phase|Investigator's discretion|1
849648|NCT01641822|2797625|P2|Comparative Phase|Investigator's discretion|0
849649|NCT01641822|2797626|P1|Comparative Phase|Investigator's discretion|0
849650|NCT01641822|2797624|P3|Comparative Phase|Noncompliance with study drug|0
849651|NCT01641822|2797625|P2|Comparative Phase|Noncompliance with study drug|1
849652|NCT01641822|2797626|P1|Comparative Phase|Noncompliance with study drug|0
849653|NCT01641822|2797624|P3|Run-in Phase|Protocol-specified criteria for withdraw|0
849654|NCT01641822|2797625|P2|Run-in Phase|Protocol-specified criteria for withdraw|0
849655|NCT01641822|2797626|P1|Run-in Phase|Protocol-specified criteria for withdraw|9
849656|NCT01641822|2797624|P3|Run-in Phase|Withdrew consent|0
849657|NCT01641822|2797625|P2|Run-in Phase|Withdrew consent|0
849658|NCT01641822|2797626|P1|Run-in Phase|Withdrew consent|1
849659|NCT01641822|2797624|P3|Run-in Phase|Adverse Event|0
849660|NCT01641822|2797625|P2|Run-in Phase|Adverse Event|0
849661|NCT01641822|2797626|P1|Run-in Phase|Adverse Event|3
849662|NCT01641822|2797624|P3|Run-in Phase|Noncompliance with study drug|0
849663|NCT01641822|2797625|P2|Run-in Phase|Noncompliance with study drug|0
849664|NCT01641822|2797626|P1|Run-in Phase|Noncompliance with study drug|1
849665|NCT01641692|2797643|P8|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
849666|NCT01641692|2797644|P7|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
849667|NCT01641692|2797645|P6|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
849668|NCT01641692|2797646|P5|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
849669|NCT01641692|2797647|P4|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
849670|NCT01641692|2797648|P3|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
849671|NCT01641692|2797649|P2|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
849672|NCT01641692|2797650|P1|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
849673|NCT01641692|2797643|P8|Washout Period 3 or Follow-up|Protocol Violation|0
849674|NCT01641692|2797644|P7|Washout Period 3 or Follow-up|Protocol Violation|0
849675|NCT01641692|2797645|P6|Washout Period 3 or Follow-up|Protocol Violation|1
849676|NCT01641692|2797646|P5|Washout Period 3 or Follow-up|Protocol Violation|0
849677|NCT01641692|2797647|P4|Washout Period 3 or Follow-up|Protocol Violation|0
849678|NCT01641692|2797648|P3|Washout Period 3 or Follow-up|Protocol Violation|0
849679|NCT01641692|2797649|P2|Washout Period 3 or Follow-up|Protocol Violation|0
849680|NCT01641692|2797650|P1|Washout Period 3 or Follow-up|Protocol Violation|0
849681|NCT01641692|2797643|P8|Treatment Period 3|Lost to Follow-up|0
849682|NCT01641692|2797644|P7|Treatment Period 3|Lost to Follow-up|0
849683|NCT01641692|2797645|P6|Treatment Period 3|Lost to Follow-up|0
849684|NCT01641692|2797646|P5|Treatment Period 3|Lost to Follow-up|0
849685|NCT01641692|2797647|P4|Treatment Period 3|Lost to Follow-up|0
849686|NCT01641692|2797648|P3|Treatment Period 3|Lost to Follow-up|0
849687|NCT01641692|2797649|P2|Treatment Period 3|Lost to Follow-up|1
849688|NCT01641692|2797650|P1|Treatment Period 3|Lost to Follow-up|0
849689|NCT01641692|2797643|P8|Treatment Period 3|Protocol-defined Stopping Criteria|0
849690|NCT01641692|2797644|P7|Treatment Period 3|Protocol-defined Stopping Criteria|1
849691|NCT01641692|2797645|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
849692|NCT01641692|2797646|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
849693|NCT01641692|2797647|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
849694|NCT01641692|2797648|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
849695|NCT01641692|2797649|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
849696|NCT01641692|2797650|P1|Treatment Period 3|Protocol-defined Stopping Criteria|0
849697|NCT01641692|2797643|P8|Treatment Period 3|Protocol Violation|0
849698|NCT01641692|2797644|P7|Treatment Period 3|Protocol Violation|0
849699|NCT01641692|2797645|P6|Treatment Period 3|Protocol Violation|0
849700|NCT01641692|2797646|P5|Treatment Period 3|Protocol Violation|0
849701|NCT01641692|2797647|P4|Treatment Period 3|Protocol Violation|0
849702|NCT01641692|2797648|P3|Treatment Period 3|Protocol Violation|1
849703|NCT01641692|2797649|P2|Treatment Period 3|Protocol Violation|0
849704|NCT01641692|2797650|P1|Treatment Period 3|Protocol Violation|0
849705|NCT01641692|2797643|P8|Treatment Period 3|Adverse Event|0
849706|NCT01641692|2797644|P7|Treatment Period 3|Adverse Event|1
849707|NCT01641692|2797645|P6|Treatment Period 3|Adverse Event|0
849708|NCT01641692|2797646|P5|Treatment Period 3|Adverse Event|0
849709|NCT01641692|2797647|P4|Treatment Period 3|Adverse Event|0
849710|NCT01641692|2797648|P3|Treatment Period 3|Adverse Event|0
849711|NCT01641692|2797649|P2|Treatment Period 3|Adverse Event|0
849712|NCT01641692|2797650|P1|Treatment Period 3|Adverse Event|0
849713|NCT01641692|2797643|P8|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
849714|NCT01641692|2797644|P7|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
849715|NCT01641692|2797645|P6|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
849716|NCT01641692|2797646|P5|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
849717|NCT01641692|2797647|P4|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
849718|NCT01641692|2797648|P3|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
849719|NCT01641692|2797649|P2|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
849720|NCT01641692|2797650|P1|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
849721|NCT01641692|2797643|P8|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
849722|NCT01641692|2797644|P7|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1
849723|NCT01641692|2797645|P6|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
849724|NCT01641692|2797646|P5|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3
849725|NCT01641692|2797647|P4|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
849726|NCT01641692|2797648|P3|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
849727|NCT01641692|2797649|P2|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
849728|NCT01641692|2797650|P1|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
849729|NCT01641692|2797643|P8|Treatment Period 2|Withdrawal by Subject|1
849730|NCT01641692|2797644|P7|Treatment Period 2|Withdrawal by Subject|0
849731|NCT01641692|2797645|P6|Treatment Period 2|Withdrawal by Subject|1
849732|NCT01641692|2797646|P5|Treatment Period 2|Withdrawal by Subject|0
849733|NCT01641692|2797647|P4|Treatment Period 2|Withdrawal by Subject|0
849734|NCT01641692|2797648|P3|Treatment Period 2|Withdrawal by Subject|0
849735|NCT01641692|2797649|P2|Treatment Period 2|Withdrawal by Subject|0
849736|NCT01641692|2797650|P1|Treatment Period 2|Withdrawal by Subject|1
849737|NCT01641692|2797643|P8|Treatment Period 2|Lost to Follow-up|0
849738|NCT01641692|2797644|P7|Treatment Period 2|Lost to Follow-up|0
849739|NCT01641692|2797645|P6|Treatment Period 2|Lost to Follow-up|1
849740|NCT01641692|2797646|P5|Treatment Period 2|Lost to Follow-up|0
849741|NCT01641692|2797647|P4|Treatment Period 2|Lost to Follow-up|0
849742|NCT01641692|2797648|P3|Treatment Period 2|Lost to Follow-up|0
849743|NCT01641692|2797649|P2|Treatment Period 2|Lost to Follow-up|0
849744|NCT01641692|2797650|P1|Treatment Period 2|Lost to Follow-up|0
849745|NCT01641692|2797643|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
849746|NCT01641692|2797644|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
849747|NCT01641692|2797645|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
849748|NCT01641692|2797646|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
849749|NCT01641692|2797647|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
849750|NCT01641692|2797648|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
849751|NCT01641692|2797649|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
849752|NCT01641692|2797650|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
849753|NCT01641692|2797643|P8|Treatment Period 2|Lack of Efficacy|0
849754|NCT01641692|2797644|P7|Treatment Period 2|Lack of Efficacy|0
849755|NCT01641692|2797645|P6|Treatment Period 2|Lack of Efficacy|0
849756|NCT01641692|2797646|P5|Treatment Period 2|Lack of Efficacy|0
849757|NCT01641692|2797647|P4|Treatment Period 2|Lack of Efficacy|0
849758|NCT01641692|2797648|P3|Treatment Period 2|Lack of Efficacy|0
849759|NCT01641692|2797649|P2|Treatment Period 2|Lack of Efficacy|0
849760|NCT01641692|2797650|P1|Treatment Period 2|Lack of Efficacy|1
849761|NCT01641692|2797643|P8|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
849762|NCT01641692|2797644|P7|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
849763|NCT01641692|2797645|P6|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
849764|NCT01641692|2797646|P5|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
849765|NCT01641692|2797647|P4|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
849766|NCT01641692|2797648|P3|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
849767|NCT01641692|2797649|P2|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
849768|NCT01641692|2797650|P1|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
849769|NCT01641692|2797643|P8|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
849770|NCT01641692|2797644|P7|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
849771|NCT01641692|2797645|P6|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
849772|NCT01641692|2797646|P5|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
849773|NCT01641692|2797647|P4|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
849774|NCT01641692|2797648|P3|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
849775|NCT01641692|2797649|P2|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
849776|NCT01641692|2797650|P1|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
849777|NCT01641692|2797643|P8|Washout Period 1 (12-14 Days)|Protocol Violation|0
849778|NCT01641692|2797644|P7|Washout Period 1 (12-14 Days)|Protocol Violation|1
849779|NCT01641692|2797645|P6|Washout Period 1 (12-14 Days)|Protocol Violation|0
849780|NCT01641692|2797646|P5|Washout Period 1 (12-14 Days)|Protocol Violation|0
849781|NCT01641692|2797647|P4|Washout Period 1 (12-14 Days)|Protocol Violation|0
849782|NCT01641692|2797648|P3|Washout Period 1 (12-14 Days)|Protocol Violation|0
849783|NCT01641692|2797649|P2|Washout Period 1 (12-14 Days)|Protocol Violation|0
849784|NCT01641692|2797650|P1|Washout Period 1 (12-14 Days)|Protocol Violation|0
849785|NCT01641692|2797643|P8|Washout Period 1 (12-14 Days)|Adverse Event|0
849786|NCT01641692|2797644|P7|Washout Period 1 (12-14 Days)|Adverse Event|0
849787|NCT01641692|2797645|P6|Washout Period 1 (12-14 Days)|Adverse Event|0
849788|NCT01641692|2797646|P5|Washout Period 1 (12-14 Days)|Adverse Event|0
849789|NCT01641692|2797647|P4|Washout Period 1 (12-14 Days)|Adverse Event|0
849790|NCT01641692|2797648|P3|Washout Period 1 (12-14 Days)|Adverse Event|0
849791|NCT01641692|2797649|P2|Washout Period 1 (12-14 Days)|Adverse Event|0
849792|NCT01641692|2797650|P1|Washout Period 1 (12-14 Days)|Adverse Event|2
849793|NCT01641692|2797643|P8|Treatment Period 1|Withdrawal by Subject|1
849794|NCT01641692|2797644|P7|Treatment Period 1|Withdrawal by Subject|0
849795|NCT01641692|2797645|P6|Treatment Period 1|Withdrawal by Subject|2
849796|NCT01641692|2797646|P5|Treatment Period 1|Withdrawal by Subject|0
849797|NCT01641692|2797647|P4|Treatment Period 1|Withdrawal by Subject|0
849798|NCT01641692|2797648|P3|Treatment Period 1|Withdrawal by Subject|0
849799|NCT01641692|2797649|P2|Treatment Period 1|Withdrawal by Subject|0
849800|NCT01641692|2797650|P1|Treatment Period 1|Withdrawal by Subject|0
849801|NCT01641692|2797643|P8|Treatment Period 1|Physician Decision|0
849802|NCT01641692|2797644|P7|Treatment Period 1|Physician Decision|0
849803|NCT01641692|2797645|P6|Treatment Period 1|Physician Decision|0
849804|NCT01641692|2797646|P5|Treatment Period 1|Physician Decision|1
849805|NCT01641692|2797647|P4|Treatment Period 1|Physician Decision|0
849806|NCT01641692|2797648|P3|Treatment Period 1|Physician Decision|0
849807|NCT01641692|2797649|P2|Treatment Period 1|Physician Decision|0
849808|NCT01641692|2797650|P1|Treatment Period 1|Physician Decision|0
849809|NCT01641692|2797643|P8|Treatment Period 1|Lost to Follow-up|0
849810|NCT01641692|2797644|P7|Treatment Period 1|Lost to Follow-up|0
849811|NCT01641692|2797645|P6|Treatment Period 1|Lost to Follow-up|0
849812|NCT01641692|2797646|P5|Treatment Period 1|Lost to Follow-up|0
849813|NCT01641692|2797647|P4|Treatment Period 1|Lost to Follow-up|0
849814|NCT01641692|2797648|P3|Treatment Period 1|Lost to Follow-up|1
849815|NCT01641692|2797649|P2|Treatment Period 1|Lost to Follow-up|0
849816|NCT01641692|2797650|P1|Treatment Period 1|Lost to Follow-up|0
849817|NCT01641692|2797643|P8|Treatment Period 1|Protocol-defined Stopping Criteria|1
849818|NCT01641692|2797644|P7|Treatment Period 1|Protocol-defined Stopping Criteria|0
849819|NCT01641692|2797645|P6|Treatment Period 1|Protocol-defined Stopping Criteria|0
849820|NCT01641692|2797646|P5|Treatment Period 1|Protocol-defined Stopping Criteria|1
849821|NCT01641692|2797647|P4|Treatment Period 1|Protocol-defined Stopping Criteria|0
849822|NCT01641692|2797648|P3|Treatment Period 1|Protocol-defined Stopping Criteria|0
849823|NCT01641692|2797649|P2|Treatment Period 1|Protocol-defined Stopping Criteria|0
849824|NCT01641692|2797650|P1|Treatment Period 1|Protocol-defined Stopping Criteria|0
849825|NCT01641692|2797643|P8|Treatment Period 1|Protocol Violation|0
849826|NCT01641692|2797644|P7|Treatment Period 1|Protocol Violation|0
849827|NCT01641692|2797645|P6|Treatment Period 1|Protocol Violation|0
849828|NCT01641692|2797646|P5|Treatment Period 1|Protocol Violation|2
849829|NCT01641692|2797647|P4|Treatment Period 1|Protocol Violation|0
849830|NCT01641692|2797648|P3|Treatment Period 1|Protocol Violation|0
849831|NCT01641692|2797649|P2|Treatment Period 1|Protocol Violation|0
849832|NCT01641692|2797650|P1|Treatment Period 1|Protocol Violation|1
849833|NCT01641692|2797643|P8|Treatment Period 1|Lack of Efficacy|1
849834|NCT01641692|2797644|P7|Treatment Period 1|Lack of Efficacy|0
849835|NCT01641692|2797645|P6|Treatment Period 1|Lack of Efficacy|0
849836|NCT01641692|2797646|P5|Treatment Period 1|Lack of Efficacy|0
849837|NCT01641692|2797647|P4|Treatment Period 1|Lack of Efficacy|0
849838|NCT01641692|2797648|P3|Treatment Period 1|Lack of Efficacy|0
849839|NCT01641692|2797649|P2|Treatment Period 1|Lack of Efficacy|0
849840|NCT01641692|2797650|P1|Treatment Period 1|Lack of Efficacy|0
849841|NCT01641692|2797643|P8|Treatment Period 1|Adverse Event|0
849842|NCT01641692|2797644|P7|Treatment Period 1|Adverse Event|0
849843|NCT01641692|2797645|P6|Treatment Period 1|Adverse Event|0
849844|NCT01641692|2797646|P5|Treatment Period 1|Adverse Event|0
849845|NCT01641692|2797647|P4|Treatment Period 1|Adverse Event|0
849846|NCT01641692|2797648|P3|Treatment Period 1|Adverse Event|0
849847|NCT01641692|2797649|P2|Treatment Period 1|Adverse Event|0
849848|NCT01641692|2797650|P1|Treatment Period 1|Adverse Event|1
849849|NCT01641640|2797850|P1|Overall Study|Adverse Event|1
849850|NCT01641640|2797850|P1|Overall Study|Withdrawal by Subject|2
849851|NCT01641640|2797850|P1|Overall Study|Lost to Follow-up|3
849852|NCT01641640|2797850|P1|Overall Study|Efficacy failure|29
849853|NCT01641640|2797850|P1|Overall Study|Enrolled but not treated|1
849854|NCT01641471|2797861|P2|Overall Study|Protocol Violation|4
849855|NCT01641471|2797862|P1|Overall Study|Protocol Violation|2
849856|NCT01641471|2797861|P2|Overall Study|Lost to Follow-up|4
849857|NCT01641471|2797862|P1|Overall Study|Lost to Follow-up|2
849858|NCT01641471|2797861|P2|Overall Study|Withdrawal by Subject|19
849859|NCT01641471|2797862|P1|Overall Study|Withdrawal by Subject|19
849860|NCT01641367|2797880|P6|Overall Study|Lost to Follow-up|0
849861|NCT01641367|2797881|P5|Overall Study|Lost to Follow-up|2
849862|NCT01641367|2797882|P4|Overall Study|Lost to Follow-up|0
849863|NCT01641367|2797883|P3|Overall Study|Lost to Follow-up|2
849864|NCT01641367|2797884|P2|Overall Study|Lost to Follow-up|0
849865|NCT01641367|2797885|P1|Overall Study|Lost to Follow-up|16
849866|NCT01641367|2797880|P6|Overall Study|Death|1
849867|NCT01641367|2797881|P5|Overall Study|Death|1
849868|NCT01641367|2797882|P4|Overall Study|Death|0
849869|NCT01641367|2797883|P3|Overall Study|Death|2
849870|NCT01641367|2797884|P2|Overall Study|Death|1
849871|NCT01641367|2797885|P1|Overall Study|Death|18
849872|NCT01641237|2797900|P4|Period III|Lost to Follow-up|0
849873|NCT01641237|2797901|P3|Period III|Lost to Follow-up|0
849874|NCT01641237|2797902|P2|Period III|Lost to Follow-up|0
849875|NCT01641237|2797903|P1|Period III|Lost to Follow-up|1
849876|NCT01641237|2797900|P4|Period II|Withdrawal by Subject|0
849877|NCT01641237|2797901|P3|Period II|Withdrawal by Subject|0
849878|NCT01641237|2797902|P2|Period II|Withdrawal by Subject|0
849879|NCT01641237|2797903|P1|Period II|Withdrawal by Subject|1
849880|NCT01641159|2797927|P2|Overall Study|Withdrawal by Subject|1
849881|NCT01641159|2797928|P1|Overall Study|Withdrawal by Subject|0
849882|NCT01641159|2797927|P2|Overall Study|Lost to Follow-up|1
849883|NCT01641159|2797928|P1|Overall Study|Lost to Follow-up|2
849884|NCT01641133|2797939|P3|Overall Study|Lost to Follow-up|2
849885|NCT01641133|2797940|P2|Overall Study|Lost to Follow-up|2
849886|NCT01641133|2797941|P1|Overall Study|Lost to Follow-up|0
849887|NCT01641133|2797939|P3|Overall Study|Withdrawal by Subject|3
849888|NCT01641133|2797940|P2|Overall Study|Withdrawal by Subject|3
849889|NCT01641133|2797941|P1|Overall Study|Withdrawal by Subject|5
849890|NCT01641133|2797939|P3|Overall Study|Adverse Event|1
849891|NCT01641133|2797940|P2|Overall Study|Adverse Event|0
849892|NCT01641133|2797941|P1|Overall Study|Adverse Event|0
849893|NCT01641133|2797939|P3|Overall Study|Migrated/moved from study area|1
849894|NCT01641133|2797940|P2|Overall Study|Migrated/moved from study area|3
849895|NCT01641133|2797941|P1|Overall Study|Migrated/moved from study area|5
849896|NCT01641133|2797939|P3|Overall Study|Protocol Violation|1
849897|NCT01641133|2797940|P2|Overall Study|Protocol Violation|1
849898|NCT01641133|2797941|P1|Overall Study|Protocol Violation|0
849899|NCT01641081|2797991|P10|Period 5|Adverse Event|0
849900|NCT01641081|2797992|P9|Period 5|Adverse Event|0
849901|NCT01641081|2797993|P8|Period 5|Adverse Event|0
849902|NCT01641081|2797994|P7|Period 5|Adverse Event|0
849903|NCT01641081|2797995|P6|Period 5|Adverse Event|0
849904|NCT01641081|2797996|P5|Period 5|Adverse Event|0
849905|NCT01641081|2797997|P4|Period 5|Adverse Event|0
849906|NCT01641081|2797998|P3|Period 5|Adverse Event|2
849907|NCT01641081|2797999|P2|Period 5|Adverse Event|0
849908|NCT01641081|2798000|P1|Period 5|Adverse Event|0
849909|NCT01641081|2797991|P10|Period 4|Adverse Event|0
849910|NCT01641081|2797992|P9|Period 4|Adverse Event|0
849911|NCT01641081|2797993|P8|Period 4|Adverse Event|0
849912|NCT01641081|2797994|P7|Period 4|Adverse Event|0
849913|NCT01641081|2797995|P6|Period 4|Adverse Event|0
849914|NCT01641081|2797996|P5|Period 4|Adverse Event|0
849915|NCT01641081|2797997|P4|Period 4|Adverse Event|1
849916|NCT01641081|2797998|P3|Period 4|Adverse Event|0
849917|NCT01641081|2797999|P2|Period 4|Adverse Event|1
849918|NCT01641081|2798000|P1|Period 4|Adverse Event|0
849919|NCT01641081|2797991|P10|Period 3|Withdrawal by Subject|0
849920|NCT01641081|2797992|P9|Period 3|Withdrawal by Subject|1
849921|NCT01641081|2797993|P8|Period 3|Withdrawal by Subject|0
849922|NCT01641081|2797994|P7|Period 3|Withdrawal by Subject|0
849923|NCT01641081|2797995|P6|Period 3|Withdrawal by Subject|0
849924|NCT01641081|2797996|P5|Period 3|Withdrawal by Subject|0
849925|NCT01641081|2797997|P4|Period 3|Withdrawal by Subject|0
849926|NCT01641081|2797998|P3|Period 3|Withdrawal by Subject|0
849927|NCT01641081|2797999|P2|Period 3|Withdrawal by Subject|0
849928|NCT01641081|2798000|P1|Period 3|Withdrawal by Subject|0
849929|NCT01641081|2797991|P10|Period 3|Adverse Event|0
849930|NCT01641081|2797992|P9|Period 3|Adverse Event|0
849931|NCT01641081|2797993|P8|Period 3|Adverse Event|0
849932|NCT01641081|2797994|P7|Period 3|Adverse Event|0
849933|NCT01641081|2797995|P6|Period 3|Adverse Event|0
849934|NCT01641081|2797996|P5|Period 3|Adverse Event|0
849935|NCT01641081|2797997|P4|Period 3|Adverse Event|0
849936|NCT01641081|2797998|P3|Period 3|Adverse Event|1
849937|NCT01641081|2797999|P2|Period 3|Adverse Event|0
849938|NCT01641081|2798000|P1|Period 3|Adverse Event|0
849939|NCT01641081|2797991|P10|Period 2|Protocol Violation|0
849940|NCT01641081|2797992|P9|Period 2|Protocol Violation|0
849941|NCT01641081|2797993|P8|Period 2|Protocol Violation|0
849942|NCT01641081|2797994|P7|Period 2|Protocol Violation|0
849943|NCT01641081|2797995|P6|Period 2|Protocol Violation|0
849944|NCT01641081|2797996|P5|Period 2|Protocol Violation|0
849945|NCT01641081|2797997|P4|Period 2|Protocol Violation|0
849946|NCT01641081|2797998|P3|Period 2|Protocol Violation|0
849947|NCT01641081|2797999|P2|Period 2|Protocol Violation|0
849948|NCT01641081|2798000|P1|Period 2|Protocol Violation|1
849949|NCT01641081|2797991|P10|Period 2|Withdrawal by Subject|0
849950|NCT01641081|2797992|P9|Period 2|Withdrawal by Subject|0
849951|NCT01641081|2797993|P8|Period 2|Withdrawal by Subject|0
849952|NCT01641081|2797994|P7|Period 2|Withdrawal by Subject|2
849953|NCT01641081|2797995|P6|Period 2|Withdrawal by Subject|0
849954|NCT01641081|2797996|P5|Period 2|Withdrawal by Subject|0
849955|NCT01641081|2797997|P4|Period 2|Withdrawal by Subject|1
849956|NCT01641081|2797998|P3|Period 2|Withdrawal by Subject|0
849957|NCT01641081|2797999|P2|Period 2|Withdrawal by Subject|0
849958|NCT01641081|2798000|P1|Period 2|Withdrawal by Subject|0
849959|NCT01641081|2797991|P10|Period 2|Adverse Event|0
849960|NCT01641081|2797992|P9|Period 2|Adverse Event|0
849961|NCT01641081|2797993|P8|Period 2|Adverse Event|0
849962|NCT01641081|2797994|P7|Period 2|Adverse Event|0
849963|NCT01641081|2797995|P6|Period 2|Adverse Event|1
849964|NCT01641081|2797996|P5|Period 2|Adverse Event|0
849965|NCT01641081|2797997|P4|Period 2|Adverse Event|0
849966|NCT01641081|2797998|P3|Period 2|Adverse Event|0
849967|NCT01641081|2797999|P2|Period 2|Adverse Event|0
849968|NCT01641081|2798000|P1|Period 2|Adverse Event|0
849969|NCT01641081|2797991|P10|Period 1|Adverse Event|0
849970|NCT01641081|2797992|P9|Period 1|Adverse Event|0
849971|NCT01641081|2797993|P8|Period 1|Adverse Event|2
849972|NCT01641081|2797994|P7|Period 1|Adverse Event|0
849973|NCT01641081|2797995|P6|Period 1|Adverse Event|0
849974|NCT01641081|2797996|P5|Period 1|Adverse Event|0
849975|NCT01641081|2797997|P4|Period 1|Adverse Event|0
849976|NCT01641081|2797998|P3|Period 1|Adverse Event|0
849977|NCT01641081|2797999|P2|Period 1|Adverse Event|0
849978|NCT01641081|2798000|P1|Period 1|Adverse Event|1
849979|NCT01641081|2797991|P10|Period 1|Protocol Violation|0
849980|NCT01641081|2797992|P9|Period 1|Protocol Violation|0
849981|NCT01641081|2797993|P8|Period 1|Protocol Violation|1
849982|NCT01641081|2797994|P7|Period 1|Protocol Violation|0
849983|NCT01641081|2797995|P6|Period 1|Protocol Violation|0
849984|NCT01641081|2797996|P5|Period 1|Protocol Violation|1
849985|NCT01641081|2797997|P4|Period 1|Protocol Violation|0
849986|NCT01641081|2797998|P3|Period 1|Protocol Violation|0
849987|NCT01641081|2797999|P2|Period 1|Protocol Violation|0
849988|NCT01641081|2798000|P1|Period 1|Protocol Violation|0
849989|NCT01641081|2797991|P10|Period 1|Sponsor request (potential unblinding)|0
849990|NCT01641081|2797992|P9|Period 1|Sponsor request (potential unblinding)|0
849991|NCT01641081|2797993|P8|Period 1|Sponsor request (potential unblinding)|0
849992|NCT01641081|2797994|P7|Period 1|Sponsor request (potential unblinding)|1
849993|NCT01641081|2797995|P6|Period 1|Sponsor request (potential unblinding)|0
849994|NCT01641081|2797996|P5|Period 1|Sponsor request (potential unblinding)|0
849995|NCT01641081|2797997|P4|Period 1|Sponsor request (potential unblinding)|0
849996|NCT01641081|2797998|P3|Period 1|Sponsor request (potential unblinding)|0
849997|NCT01641081|2797999|P2|Period 1|Sponsor request (potential unblinding)|0
849998|NCT01641081|2798000|P1|Period 1|Sponsor request (potential unblinding)|0
849999|NCT01640964|2798069|P3|Overall Study|Protocol Deviation|2
850000|NCT01640964|2798070|P2|Overall Study|Protocol Deviation|1
850001|NCT01640964|2798071|P1|Overall Study|Protocol Deviation|1
850002|NCT01640964|2798069|P3|Overall Study|Lost to Follow-up|1
850003|NCT01640964|2798070|P2|Overall Study|Lost to Follow-up|0
850004|NCT01640964|2798071|P1|Overall Study|Lost to Follow-up|0
850005|NCT01640951|2798094|P8|Overall Study|Death|2
850006|NCT01640951|2798095|P7|Overall Study|Death|0
850007|NCT01640951|2798096|P6|Overall Study|Death|0
850008|NCT01640951|2798097|P5|Overall Study|Death|0
850009|NCT01640951|2798098|P4|Overall Study|Death|0
850010|NCT01640951|2798099|P3|Overall Study|Death|1
850011|NCT01640951|2798100|P2|Overall Study|Death|1
850012|NCT01640951|2798101|P1|Overall Study|Death|0
850013|NCT01640951|2798094|P8|Overall Study|Subject/Guardian decision|4
850014|NCT01640951|2798095|P7|Overall Study|Subject/Guardian decision|5
850015|NCT01640951|2798096|P6|Overall Study|Subject/Guardian decision|19
850016|NCT01640951|2798097|P5|Overall Study|Subject/Guardian decision|7
850017|NCT01640951|2798098|P4|Overall Study|Subject/Guardian decision|15
850018|NCT01640951|2798099|P3|Overall Study|Subject/Guardian decision|13
850019|NCT01640951|2798100|P2|Overall Study|Subject/Guardian decision|4
850020|NCT01640951|2798101|P1|Overall Study|Subject/Guardian decision|12
850021|NCT01640951|2798094|P8|Overall Study|Protocol Deviation|0
850022|NCT01640951|2798095|P7|Overall Study|Protocol Deviation|0
850023|NCT01640951|2798096|P6|Overall Study|Protocol Deviation|1
850024|NCT01640951|2798097|P5|Overall Study|Protocol Deviation|0
850025|NCT01640951|2798098|P4|Overall Study|Protocol Deviation|1
850026|NCT01640951|2798099|P3|Overall Study|Protocol Deviation|2
850027|NCT01640951|2798100|P2|Overall Study|Protocol Deviation|1
850028|NCT01640951|2798101|P1|Overall Study|Protocol Deviation|0
850029|NCT01640951|2798094|P8|Overall Study|Pregnancy|0
850030|NCT01640951|2798095|P7|Overall Study|Pregnancy|2
850031|NCT01640951|2798096|P6|Overall Study|Pregnancy|0
850032|NCT01640951|2798097|P5|Overall Study|Pregnancy|0
850033|NCT01640951|2798098|P4|Overall Study|Pregnancy|4
850034|NCT01640951|2798099|P3|Overall Study|Pregnancy|0
850035|NCT01640951|2798100|P2|Overall Study|Pregnancy|0
850036|NCT01640951|2798101|P1|Overall Study|Pregnancy|3
850037|NCT01640951|2798094|P8|Overall Study|Physician Decision|0
850038|NCT01640951|2798095|P7|Overall Study|Physician Decision|3
850039|NCT01640951|2798096|P6|Overall Study|Physician Decision|3
850040|NCT01640951|2798097|P5|Overall Study|Physician Decision|2
850041|NCT01640951|2798098|P4|Overall Study|Physician Decision|2
850042|NCT01640951|2798099|P3|Overall Study|Physician Decision|2
850043|NCT01640951|2798100|P2|Overall Study|Physician Decision|5
850044|NCT01640951|2798101|P1|Overall Study|Physician Decision|2
850045|NCT01640951|2798094|P8|Overall Study|Non-compliance with study treatment|0
850046|NCT01640951|2798095|P7|Overall Study|Non-compliance with study treatment|1
850047|NCT01640951|2798096|P6|Overall Study|Non-compliance with study treatment|4
850048|NCT01640951|2798097|P5|Overall Study|Non-compliance with study treatment|1
850049|NCT01640951|2798098|P4|Overall Study|Non-compliance with study treatment|1
850050|NCT01640951|2798099|P3|Overall Study|Non-compliance with study treatment|1
850051|NCT01640951|2798100|P2|Overall Study|Non-compliance with study treatment|0
850052|NCT01640951|2798101|P1|Overall Study|Non-compliance with study treatment|0
850053|NCT01640951|2798094|P8|Overall Study|Lost to Follow-up|1
850054|NCT01640951|2798095|P7|Overall Study|Lost to Follow-up|1
850055|NCT01640951|2798096|P6|Overall Study|Lost to Follow-up|3
850056|NCT01640951|2798097|P5|Overall Study|Lost to Follow-up|2
850057|NCT01640951|2798098|P4|Overall Study|Lost to Follow-up|2
850058|NCT01640951|2798099|P3|Overall Study|Lost to Follow-up|6
850059|NCT01640951|2798100|P2|Overall Study|Lost to Follow-up|0
850060|NCT01640951|2798101|P1|Overall Study|Lost to Follow-up|1
850061|NCT01640951|2798094|P8|Overall Study|Lack of Efficacy|6
850062|NCT01640951|2798095|P7|Overall Study|Lack of Efficacy|5
850063|NCT01640951|2798096|P6|Overall Study|Lack of Efficacy|6
850064|NCT01640951|2798097|P5|Overall Study|Lack of Efficacy|0
850065|NCT01640951|2798098|P4|Overall Study|Lack of Efficacy|14
850066|NCT01640951|2798099|P3|Overall Study|Lack of Efficacy|7
850067|NCT01640951|2798100|P2|Overall Study|Lack of Efficacy|1
850068|NCT01640951|2798101|P1|Overall Study|Lack of Efficacy|20
850069|NCT01640951|2798094|P8|Overall Study|Adverse Event|3
850070|NCT01640951|2798095|P7|Overall Study|Adverse Event|1
850071|NCT01640951|2798096|P6|Overall Study|Adverse Event|11
850072|NCT01640951|2798097|P5|Overall Study|Adverse Event|1
850073|NCT01640951|2798098|P4|Overall Study|Adverse Event|6
850074|NCT01640951|2798099|P3|Overall Study|Adverse Event|10
850075|NCT01640951|2798100|P2|Overall Study|Adverse Event|3
850076|NCT01640951|2798101|P1|Overall Study|Adverse Event|8
850077|NCT01640925|2798203|P2|Overall Study|Previously enrolled in this trial|11
850078|NCT01640925|2798204|P1|Overall Study|Previously enrolled in this trial|13
850079|NCT01640925|2798203|P2|Overall Study|Withdrawal by Subject|0
850080|NCT01640925|2798204|P1|Overall Study|Withdrawal by Subject|1
850081|NCT01640873|2798218|P2|Overall Study|Protocol Violation|1
850082|NCT01640873|2798219|P1|Overall Study|Protocol Violation|2
850083|NCT01640353|2798292|P1|Overall Study|Physician Decision|1
850084|NCT01640353|2798292|P1|Overall Study|Lost to Follow-up|12
850085|NCT01640353|2798292|P1|Overall Study|Early site termination|3
850086|NCT01640353|2798292|P1|Overall Study|Death|2
850087|NCT01640353|2798292|P1|Overall Study|Withdrawal by Subject|5
850088|NCT01640353|2798292|P1|Overall Study|Withdrawn from analysis at term site|12
850089|NCT01640353|2798292|P1|Overall Study|Withdrew prior to treatment|10
850090|NCT01640314|2798340|P2|Overall Study|Protocol Violation|1
850091|NCT01640314|2798341|P1|Overall Study|Protocol Violation|0
850092|NCT01640184|2798379|P3|Overall Study|Protocol Violation|1
850093|NCT01640184|2798380|P2|Overall Study|Protocol Violation|0
850094|NCT01640184|2798381|P1|Overall Study|Protocol Violation|0
850095|NCT01640184|2798379|P3|Overall Study|Withdrawal by Subject|1
850096|NCT01640184|2798380|P2|Overall Study|Withdrawal by Subject|1
850097|NCT01640184|2798381|P1|Overall Study|Withdrawal by Subject|0
850098|NCT01640184|2798379|P3|Overall Study|Physician Decision|0
850099|NCT01640184|2798380|P2|Overall Study|Physician Decision|0
850100|NCT01640184|2798381|P1|Overall Study|Physician Decision|3
850101|NCT01640184|2798379|P3|Overall Study|Lost to Follow-up|0
850102|NCT01640184|2798380|P2|Overall Study|Lost to Follow-up|1
850103|NCT01640184|2798381|P1|Overall Study|Lost to Follow-up|4
850104|NCT01640184|2798379|P3|Overall Study|Death|0
850105|NCT01640184|2798380|P2|Overall Study|Death|0
850106|NCT01640184|2798381|P1|Overall Study|Death|1
850107|NCT01640054|2798410|P1|Overall Study|Adverse Event|2
850108|NCT01640054|2798410|P1|Overall Study|Lack of Efficacy|3
850109|NCT01640054|2798410|P1|Overall Study|Study-specific disc criteria|1
850110|NCT01639833|2798420|P2|Overall Study|Withdrawal by Subject|2
850111|NCT01639833|2798421|P1|Overall Study|Withdrawal by Subject|2
850112|NCT01639833|2798420|P2|Overall Study|Death|2
850113|NCT01639833|2798421|P1|Overall Study|Death|4
850114|NCT01639755|2798429|P1|Overall Study|Patient had device explantation|4
850115|NCT01639755|2798429|P1|Overall Study|Study Ongoing|15
850116|NCT01639742|2798437|P1|Overall Study|Lost to Follow-up|1
850117|NCT01639742|2798437|P1|Overall Study|Study Ongoing|17
850118|NCT01639729|2798445|P6|Overall Study|Withdrawal by Subject|0
850119|NCT01639729|2798446|P5|Overall Study|Withdrawal by Subject|0
850120|NCT01639729|2798447|P4|Overall Study|Withdrawal by Subject|1
850121|NCT01639729|2798448|P3|Overall Study|Withdrawal by Subject|1
850122|NCT01639729|2798449|P2|Overall Study|Withdrawal by Subject|0
850123|NCT01639729|2798450|P1|Overall Study|Withdrawal by Subject|1
850124|NCT01639703|2798472|P1|Overall Study|Other reason|7
850125|NCT01639703|2798472|P1|Overall Study|Withdrawal by Subject|5
850126|NCT01639560|2798515|P2|Overall Study|Adverse Event|2
850127|NCT01639560|2798516|P1|Overall Study|Adverse Event|0
850128|NCT01639560|2798515|P2|Overall Study|Lost to Follow-up|11
850129|NCT01639560|2798516|P1|Overall Study|Lost to Follow-up|9
850130|NCT01639560|2798515|P2|Overall Study|Lack of Efficacy|2
850131|NCT01639560|2798516|P1|Overall Study|Lack of Efficacy|1
850132|NCT01639560|2798515|P2|Overall Study|Withdrawal by Subject|14
850133|NCT01639560|2798516|P1|Overall Study|Withdrawal by Subject|9
850134|NCT01639495|2798528|P1|Overall Study|No radiofrequency energy applied|2
850135|NCT01639495|2798528|P1|Overall Study|Not meeting inclusion/exclusion criteria|4
850136|NCT01639495|2798528|P1|Overall Study|Consented but didn’t have study catheter|4
850137|NCT01639495|2798528|P1|Overall Study|Lost to Follow-up|6
850138|NCT01639469|2798538|P2|Overall Study|Lost to Follow-up|1
850139|NCT01639469|2798539|P1|Overall Study|Lost to Follow-up|1
850140|NCT01639469|2798538|P2|Overall Study|Death|2
850141|NCT01639469|2798539|P1|Overall Study|Death|4
850142|NCT01639144|2798644|P2|Overall Study|Met postoperative exclusion criteria|3
850143|NCT01639144|2798645|P1|Overall Study|Met postoperative exclusion criteria|4
850144|NCT01639144|2798644|P2|Overall Study|Physician Decision|0
850145|NCT01639144|2798645|P1|Overall Study|Physician Decision|2
850146|NCT01639144|2798644|P2|Overall Study|Withdrawal by Subject|2
850147|NCT01639144|2798645|P1|Overall Study|Withdrawal by Subject|4
850148|NCT01639040|2798653|P2|Overall Study|Adverse Event|0
850149|NCT01639040|2798654|P1|Overall Study|Adverse Event|1
850150|NCT01639001|2798672|P2|Overall Study|Death|35
850151|NCT01639001|2798673|P1|Overall Study|Death|35
850152|NCT01639001|2798672|P2|Overall Study|Lost to Follow-up|0
850153|NCT01639001|2798673|P1|Overall Study|Lost to Follow-up|1
850154|NCT01639001|2798672|P2|Overall Study|Refused further follow-up|6
850155|NCT01639001|2798673|P1|Overall Study|Refused further follow-up|3
850156|NCT01639001|2798672|P2|Overall Study|Ongoing at date of cutoff|60
850157|NCT01639001|2798673|P1|Overall Study|Ongoing at date of cutoff|65
850158|NCT01639001|2798672|P2|Overall Study|Randomized but not treated|2
850159|NCT01639001|2798673|P1|Overall Study|Randomized but not treated|0
850160|NCT01638819|2798719|P2|Overall Study|Lost to Follow-up|0
850161|NCT01638819|2798720|P1|Overall Study|Lost to Follow-up|1
850162|NCT01638546|2798735|P2|Overall Study|Adverse Event|3
850163|NCT01638546|2798736|P1|Overall Study|Adverse Event|1
850164|NCT01638000|2798782|P2|Overall Study|Miscellaneous|2
850165|NCT01638000|2798783|P1|Overall Study|Miscellaneous|2
850166|NCT01638000|2798782|P2|Overall Study|Withdrawal by Subject|24
850167|NCT01638000|2798783|P1|Overall Study|Withdrawal by Subject|21
850168|NCT01638000|2798782|P2|Overall Study|Protocol Violation|13
850169|NCT01638000|2798783|P1|Overall Study|Protocol Violation|11
850170|NCT01638000|2798782|P2|Overall Study|Lack of Efficacy|6
850171|NCT01638000|2798783|P1|Overall Study|Lack of Efficacy|5
850172|NCT01638000|2798782|P2|Overall Study|Adverse Event|16
850173|NCT01638000|2798783|P1|Overall Study|Adverse Event|14
850174|NCT01638000|2798782|P2|Overall Study|Randomized but Never Received Drug|10
850175|NCT01638000|2798783|P1|Overall Study|Randomized but Never Received Drug|7
850176|NCT01637961|2798881|P1|Overall Study|Ineligible: inadequate pathology|1
850177|NCT01637961|2798881|P1|Overall Study|Ineligible: wrong primary|1
850178|NCT01637922|2798913|P2|Overall Study|Lost to Follow-up|0
850179|NCT01637922|2798914|P1|Overall Study|Lost to Follow-up|2
850180|NCT01637922|2798913|P2|Overall Study|Withdrawal by Subject|3
850181|NCT01637922|2798914|P1|Overall Study|Withdrawal by Subject|0
850182|NCT01637922|2798913|P2|Overall Study|Protocol Violation|1
850183|NCT01637922|2798914|P1|Overall Study|Protocol Violation|0
850184|NCT01637922|2798913|P2|Overall Study|Adverse Event|1
850185|NCT01637922|2798914|P1|Overall Study|Adverse Event|0
850186|NCT01637584|2798943|P2|Overall Study|Withdrawal by Subject|3
850187|NCT01637584|2798944|P1|Overall Study|Withdrawal by Subject|1
850188|NCT01637272|2798951|P1|Overall Study|Protocol Violation|2
850189|NCT01637272|2798951|P1|Overall Study|Administrative problems|1
850190|NCT01637272|2798951|P1|Overall Study|completed core, did not enter ext. phase|4
850191|NCT01637272|2798951|P1|Overall Study|Lost to Follow-up|2
850192|NCT01637272|2798951|P1|Overall Study|Withdrawal by Subject|3
850193|NCT01637272|2798951|P1|Overall Study|Unsatisfactory therapeutic effect|2
850194|NCT01637272|2798951|P1|Overall Study|Adverse Event|6
850195|NCT01637077|2799031|P2|Overall Study|No cycle 1 questionnaire data|0
850196|NCT01637077|2799032|P1|Overall Study|No cycle 1 questionnaire data|2
850197|NCT01637077|2799031|P2|Overall Study|Withdrawal by Subject|0
850198|NCT01637077|2799032|P1|Overall Study|Withdrawal by Subject|1
850199|NCT01637077|2799031|P2|Overall Study|Cancel|1
850200|NCT01637077|2799032|P1|Overall Study|Cancel|1
850201|NCT01636986|2799060|P2|Overall Study|Corneal Staining|1
850202|NCT01636986|2799061|P1|Overall Study|Corneal Staining|0
850203|NCT01636986|2799060|P2|Overall Study|Withdrawal by Subject|1
850204|NCT01636986|2799061|P1|Overall Study|Withdrawal by Subject|0
850205|NCT01636960|2799067|P1|Maintenance Phase|Progressive disease|1
850206|NCT01636960|2799067|P1|Maintenance Phase|Adverse Event|3
850207|NCT01636960|2799067|P1|Maintenance Phase|Continued drug after regulatory approval|3
850208|NCT01636960|2799067|P1|Induction Phase|Adverse Event|2
850209|NCT01636947|2799075|P2|Overall Study|Did Not Meet Eligibility Criteria|4
850210|NCT01636947|2799076|P1|Overall Study|Did Not Meet Eligibility Criteria|1
850211|NCT01636947|2799075|P2|Overall Study|Adverse Event|1
850212|NCT01636947|2799076|P1|Overall Study|Adverse Event|1
850213|NCT01636947|2799075|P2|Overall Study|Withdrawal by Subject|3
850214|NCT01636947|2799076|P1|Overall Study|Withdrawal by Subject|3
850215|NCT01636947|2799075|P2|Overall Study|Protocol Violation|1
850216|NCT01636947|2799076|P1|Overall Study|Protocol Violation|1
850217|NCT01636947|2799075|P2|Overall Study|Lost to Follow-up|0
850218|NCT01636947|2799076|P1|Overall Study|Lost to Follow-up|4
850219|NCT01636947|2799075|P2|Overall Study|Not Treated|2
850220|NCT01636947|2799076|P1|Overall Study|Not Treated|2
850221|NCT01636778|2799100|P3|Follow-up Period After Part 2|Withdrawal by Subject|2
850222|NCT01636778|2799101|P2|Follow-up Period After Part 2|Withdrawal by Subject|0
850223|NCT01636778|2799102|P1|Follow-up Period After Part 2|Withdrawal by Subject|0
850224|NCT01636778|2799100|P3|Follow-up Period After Part 2|Not entered FU period after withdrawal|1
850225|NCT01636778|2799101|P2|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
850226|NCT01636778|2799102|P1|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
850227|NCT01636778|2799100|P3|Follow-up Period After Part 2|Other|1
850228|NCT01636778|2799101|P2|Follow-up Period After Part 2|Other|0
850229|NCT01636778|2799102|P1|Follow-up Period After Part 2|Other|0
850230|NCT01636778|2799100|P3|Antiviral Treatment Period (Part 2)|Physician Decision|0
850231|NCT01636778|2799101|P2|Antiviral Treatment Period (Part 2)|Physician Decision|2
850232|NCT01636778|2799102|P1|Antiviral Treatment Period (Part 2)|Physician Decision|0
850233|NCT01636778|2799100|P3|Antiviral Treatment Period (Part 2)|Protocol Violation|0
850234|NCT01636778|2799101|P2|Antiviral Treatment Period (Part 2)|Protocol Violation|1
850235|NCT01636778|2799102|P1|Antiviral Treatment Period (Part 2)|Protocol Violation|0
850236|NCT01636778|2799100|P3|Antiviral Treatment Period (Part 2)|Adverse Event|0
850237|NCT01636778|2799101|P2|Antiviral Treatment Period (Part 2)|Adverse Event|7
850238|NCT01636778|2799102|P1|Antiviral Treatment Period (Part 2)|Adverse Event|0
850239|NCT01636778|2799100|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
850240|NCT01636778|2799101|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
850241|NCT01636778|2799102|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1
850242|NCT01636778|2799100|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
850243|NCT01636778|2799101|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
850244|NCT01636778|2799102|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3
850245|NCT01636713|2799173|P3|Overall Study|Met Protocol-defined Stopping Criteria|4
850246|NCT01636713|2799174|P2|Overall Study|Met Protocol-defined Stopping Criteria|2
850247|NCT01636713|2799175|P1|Overall Study|Met Protocol-defined Stopping Criteria|2
850248|NCT01636713|2799173|P3|Overall Study|Withdrawal by Subject|8
850249|NCT01636713|2799174|P2|Overall Study|Withdrawal by Subject|4
850250|NCT01636713|2799175|P1|Overall Study|Withdrawal by Subject|5
850251|NCT01636713|2799173|P3|Overall Study|Lost to Follow-up|1
850252|NCT01636713|2799174|P2|Overall Study|Lost to Follow-up|0
850253|NCT01636713|2799175|P1|Overall Study|Lost to Follow-up|0
850254|NCT01636713|2799173|P3|Overall Study|Protocol Violation|1
850255|NCT01636713|2799174|P2|Overall Study|Protocol Violation|0
850256|NCT01636713|2799175|P1|Overall Study|Protocol Violation|3
850257|NCT01636713|2799173|P3|Overall Study|Lack of Efficacy|2
850258|NCT01636713|2799174|P2|Overall Study|Lack of Efficacy|6
850259|NCT01636713|2799175|P1|Overall Study|Lack of Efficacy|6
850260|NCT01636713|2799173|P3|Overall Study|Adverse Event|7
850261|NCT01636713|2799174|P2|Overall Study|Adverse Event|16
850262|NCT01636713|2799175|P1|Overall Study|Adverse Event|16
850263|NCT01636687|2799192|P5|Follow-up Period|Withdrawal by Subject|1
850264|NCT01636687|2799193|P4|Follow-up Period|Withdrawal by Subject|0
850265|NCT01636687|2799194|P3|Follow-up Period|Withdrawal by Subject|0
850266|NCT01636687|2799195|P2|Follow-up Period|Withdrawal by Subject|0
850267|NCT01636687|2799196|P1|Follow-up Period|Withdrawal by Subject|1
850268|NCT01636687|2799192|P5|Extension Period|Withdrawal by Subject|0
850269|NCT01636687|2799193|P4|Extension Period|Withdrawal by Subject|1
850270|NCT01636687|2799194|P3|Extension Period|Withdrawal by Subject|1
850271|NCT01636687|2799195|P2|Extension Period|Withdrawal by Subject|0
850272|NCT01636687|2799196|P1|Extension Period|Withdrawal by Subject|1
850273|NCT01636687|2799192|P5|Extension Period|study terminated by sponsor|0
850274|NCT01636687|2799193|P4|Extension Period|study terminated by sponsor|23
850275|NCT01636687|2799194|P3|Extension Period|study terminated by sponsor|17
850276|NCT01636687|2799195|P2|Extension Period|study terminated by sponsor|50
850277|NCT01636687|2799196|P1|Extension Period|study terminated by sponsor|33
850278|NCT01636687|2799192|P5|Extension Period|Physician Decision|0
850279|NCT01636687|2799193|P4|Extension Period|Physician Decision|1
850280|NCT01636687|2799194|P3|Extension Period|Physician Decision|0
850281|NCT01636687|2799195|P2|Extension Period|Physician Decision|0
850282|NCT01636687|2799196|P1|Extension Period|Physician Decision|1
850283|NCT01636687|2799192|P5|Extension Period|Lost to Follow-up|0
850284|NCT01636687|2799193|P4|Extension Period|Lost to Follow-up|0
850285|NCT01636687|2799194|P3|Extension Period|Lost to Follow-up|1
850286|NCT01636687|2799195|P2|Extension Period|Lost to Follow-up|0
850287|NCT01636687|2799196|P1|Extension Period|Lost to Follow-up|1
850288|NCT01636687|2799192|P5|Extension Period|Lack of Efficacy|0
850289|NCT01636687|2799193|P4|Extension Period|Lack of Efficacy|1
850290|NCT01636687|2799194|P3|Extension Period|Lack of Efficacy|2
850291|NCT01636687|2799195|P2|Extension Period|Lack of Efficacy|0
850292|NCT01636687|2799196|P1|Extension Period|Lack of Efficacy|7
850293|NCT01636687|2799192|P5|Extension Period|Adverse Event|0
850294|NCT01636687|2799193|P4|Extension Period|Adverse Event|1
850295|NCT01636687|2799194|P3|Extension Period|Adverse Event|2
850296|NCT01636687|2799195|P2|Extension Period|Adverse Event|3
850297|NCT01636687|2799196|P1|Extension Period|Adverse Event|4
850298|NCT01636687|2799192|P5|Extension Period|technical problems|0
850299|NCT01636687|2799193|P4|Extension Period|technical problems|1
850300|NCT01636687|2799194|P3|Extension Period|technical problems|2
850301|NCT01636687|2799195|P2|Extension Period|technical problems|1
850302|NCT01636687|2799196|P1|Extension Period|technical problems|0
850303|NCT01636687|2799192|P5|Maintenance Period|Physician Decision|1
850304|NCT01636687|2799193|P4|Maintenance Period|Physician Decision|0
850305|NCT01636687|2799194|P3|Maintenance Period|Physician Decision|0
850306|NCT01636687|2799195|P2|Maintenance Period|Physician Decision|0
850307|NCT01636687|2799196|P1|Maintenance Period|Physician Decision|0
850308|NCT01636687|2799192|P5|Maintenance Period|Lost to Follow-up|1
850309|NCT01636687|2799193|P4|Maintenance Period|Lost to Follow-up|0
850310|NCT01636687|2799194|P3|Maintenance Period|Lost to Follow-up|0
850311|NCT01636687|2799195|P2|Maintenance Period|Lost to Follow-up|1
850312|NCT01636687|2799196|P1|Maintenance Period|Lost to Follow-up|1
850313|NCT01636687|2799192|P5|Maintenance Period|Lack of Efficacy|0
850314|NCT01636687|2799193|P4|Maintenance Period|Lack of Efficacy|0
850315|NCT01636687|2799194|P3|Maintenance Period|Lack of Efficacy|0
850316|NCT01636687|2799195|P2|Maintenance Period|Lack of Efficacy|1
850317|NCT01636687|2799196|P1|Maintenance Period|Lack of Efficacy|4
850318|NCT01636687|2799192|P5|Maintenance Period|Adverse Event|0
850319|NCT01636687|2799193|P4|Maintenance Period|Adverse Event|0
850320|NCT01636687|2799194|P3|Maintenance Period|Adverse Event|0
850321|NCT01636687|2799195|P2|Maintenance Period|Adverse Event|0
850322|NCT01636687|2799196|P1|Maintenance Period|Adverse Event|1
850323|NCT01636687|2799192|P5|Maintenance Period|Withdrawal by Subject|0
850324|NCT01636687|2799193|P4|Maintenance Period|Withdrawal by Subject|0
850325|NCT01636687|2799194|P3|Maintenance Period|Withdrawal by Subject|2
850326|NCT01636687|2799195|P2|Maintenance Period|Withdrawal by Subject|0
850327|NCT01636687|2799196|P1|Maintenance Period|Withdrawal by Subject|2
850328|NCT01636687|2799192|P5|Induction Period|Physician Decision|0
850329|NCT01636687|2799193|P4|Induction Period|Physician Decision|0
850330|NCT01636687|2799194|P3|Induction Period|Physician Decision|0
850331|NCT01636687|2799195|P2|Induction Period|Physician Decision|0
850332|NCT01636687|2799196|P1|Induction Period|Physician Decision|1
850333|NCT01636687|2799192|P5|Induction Period|Lack of Efficacy|1
850334|NCT01636687|2799193|P4|Induction Period|Lack of Efficacy|0
850335|NCT01636687|2799194|P3|Induction Period|Lack of Efficacy|0
850336|NCT01636687|2799195|P2|Induction Period|Lack of Efficacy|0
850337|NCT01636687|2799196|P1|Induction Period|Lack of Efficacy|0
850338|NCT01636687|2799192|P5|Induction Period|Adverse Event|1
850339|NCT01636687|2799193|P4|Induction Period|Adverse Event|0
850340|NCT01636687|2799194|P3|Induction Period|Adverse Event|0
850341|NCT01636687|2799195|P2|Induction Period|Adverse Event|0
850342|NCT01636687|2799196|P1|Induction Period|Adverse Event|1
850343|NCT01636687|2799192|P5|Induction Period|Withdrawal by Subject|0
850344|NCT01636687|2799193|P4|Induction Period|Withdrawal by Subject|0
850345|NCT01636687|2799194|P3|Induction Period|Withdrawal by Subject|0
850346|NCT01636687|2799195|P2|Induction Period|Withdrawal by Subject|0
850347|NCT01636687|2799196|P1|Induction Period|Withdrawal by Subject|1
850348|NCT01636362|2799337|P1|Overall Study|Withdrawal by Subject|1
850349|NCT01636362|2799337|P1|Overall Study|Subject healed, not returning|1
850350|NCT01636362|2799337|P1|Overall Study|Physician Decision|6
850351|NCT01636258|2799364|P2|Overall Study|Lost to Follow-up|0
850352|NCT01636258|2799365|P1|Overall Study|Lost to Follow-up|1
850353|NCT01636076|2799405|P2|Overall Study|Withdrawal by Subject|10
850354|NCT01636076|2799406|P1|Overall Study|Withdrawal by Subject|7
850355|NCT01636076|2799405|P2|Overall Study|Adverse Event|11
850356|NCT01636076|2799406|P1|Overall Study|Adverse Event|6
850357|NCT01636076|2799405|P2|Overall Study|Non-compliance with study treatment|1
850358|NCT01636076|2799406|P1|Overall Study|Non-compliance with study treatment|1
850359|NCT01636076|2799405|P2|Overall Study|Physician Decision|1
850360|NCT01636076|2799406|P1|Overall Study|Physician Decision|1
850361|NCT01636076|2799405|P2|Overall Study|Lost to Follow-up|0
850362|NCT01636076|2799406|P1|Overall Study|Lost to Follow-up|1
850363|NCT01636076|2799405|P2|Overall Study|Lack of Efficacy|1
850364|NCT01636076|2799406|P1|Overall Study|Lack of Efficacy|0
850365|NCT01636076|2799405|P2|Overall Study|Terminated by sponsor|1
850366|NCT01636076|2799406|P1|Overall Study|Terminated by sponsor|1
850367|NCT01635933|2799477|P2|Overall Study|No longer had transportation|1
850368|NCT01635933|2799478|P1|Overall Study|No longer had transportation|0
850369|NCT01635933|2799477|P2|Overall Study|Noncompliance|1
850370|NCT01635933|2799478|P1|Overall Study|Noncompliance|0
850371|NCT01635933|2799477|P2|Overall Study|Subject decision|1
850372|NCT01635933|2799478|P1|Overall Study|Subject decision|1
850373|NCT01635933|2799477|P2|Overall Study|Lost to Follow-up|5
850374|NCT01635933|2799478|P1|Overall Study|Lost to Follow-up|0
850375|NCT01635933|2799477|P2|Overall Study|Adverse Event|0
850376|NCT01635933|2799478|P1|Overall Study|Adverse Event|1
850377|NCT01635920|2799490|P2|Overall Study|Subject decision|0
850378|NCT01635920|2799491|P1|Overall Study|Subject decision|2
850379|NCT01635920|2799490|P2|Overall Study|Lost to Follow-up|1
850380|NCT01635920|2799491|P1|Overall Study|Lost to Follow-up|0
850381|NCT01635920|2799490|P2|Overall Study|Adverse Event|0
850382|NCT01635920|2799491|P1|Overall Study|Adverse Event|1
850383|NCT01635855|2799504|P1|Overall Study|Withdrawal by Subject|4
850384|NCT01635764|2799513|P1|Overall Study|Not Specified|28
850385|NCT01635764|2799513|P1|Overall Study|Lost to Follow-up|53
850386|NCT01635764|2799513|P1|Overall Study|Withdrew Consent|67
850387|NCT01635764|2799513|P1|Overall Study|Protocol Deviation|1
850388|NCT01635764|2799513|P1|Overall Study|Exceed Protocol-specified Interventions|2
850389|NCT01635764|2799513|P1|Overall Study|Lack of Efficacy|76
850390|NCT01635764|2799513|P1|Overall Study|Adverse Event|46
850391|NCT01635218|2799579|P3|Overall Study|Lost to Follow-up|6
850392|NCT01635218|2799580|P2|Overall Study|Lost to Follow-up|7
850393|NCT01635218|2799581|P1|Overall Study|Lost to Follow-up|3
850394|NCT01634854|2799616|P2|Overall Study|Cesarean delivery|7
850395|NCT01634854|2799617|P1|Overall Study|Cesarean delivery|2
850396|NCT01634659|2799637|P2|Period 2 - Second 8 Days of Wear|Physician Decision|0
850397|NCT01634659|2799638|P1|Period 2 - Second 8 Days of Wear|Physician Decision|1
850398|NCT01634659|2799637|P2|Period 2 - Second 8 Days of Wear|Adverse Event|0
850399|NCT01634659|2799638|P1|Period 2 - Second 8 Days of Wear|Adverse Event|2
850400|NCT01634555|2799668|P1|Overall Study|Ongoing receiving treatment|13
850401|NCT01634555|2799668|P1|Overall Study|Physician Decision|1
850402|NCT01634555|2799668|P1|Overall Study|Adverse Event|3
850403|NCT01634360|2799678|P2|Overall Study|Study termination by sponsor|44
850404|NCT01634360|2799679|P1|Overall Study|Study termination by sponsor|18
850405|NCT01634360|2799678|P2|Overall Study|Not specified|20
850406|NCT01634360|2799679|P1|Overall Study|Not specified|3
850407|NCT01634360|2799678|P2|Overall Study|Lack of Efficacy|14
850408|NCT01634360|2799679|P1|Overall Study|Lack of Efficacy|4
850409|NCT01634360|2799678|P2|Overall Study|Protocol Violation|1
850410|NCT01634360|2799679|P1|Overall Study|Protocol Violation|1
850411|NCT01634360|2799678|P2|Overall Study|subject withdrew consent|23
850412|NCT01634360|2799679|P1|Overall Study|subject withdrew consent|13
850413|NCT01634360|2799678|P2|Overall Study|Adverse Event|34
850414|NCT01634360|2799679|P1|Overall Study|Adverse Event|10
850415|NCT01634243|2799708|P2|Overall Study|Lack of Efficacy|0
850416|NCT01634243|2799709|P1|Overall Study|Lack of Efficacy|1
850417|NCT01634243|2799708|P2|Overall Study|Adverse Event|5
850418|NCT01634243|2799709|P1|Overall Study|Adverse Event|5
850419|NCT01634165|2799735|P4|Period 2|Adverse Event|0
850420|NCT01634165|2799736|P3|Period 2|Adverse Event|0
850421|NCT01634165|2799737|P2|Period 2|Adverse Event|1
850422|NCT01634165|2799738|P1|Period 2|Adverse Event|0
850423|NCT01634152|2799771|P3|Overall Study|Other reason not defined above|1
850424|NCT01634152|2799772|P2|Overall Study|Other reason not defined above|0
850425|NCT01634152|2799773|P1|Overall Study|Other reason not defined above|1
850426|NCT01634152|2799771|P3|Overall Study|Not treated|0
850427|NCT01634152|2799772|P2|Overall Study|Not treated|1
850428|NCT01634152|2799773|P1|Overall Study|Not treated|0
850429|NCT01634152|2799771|P3|Overall Study|Consent withdrawn not due to AE|1
850430|NCT01634152|2799772|P2|Overall Study|Consent withdrawn not due to AE|0
850431|NCT01634152|2799773|P1|Overall Study|Consent withdrawn not due to AE|1
850432|NCT01634152|2799771|P3|Overall Study|Adverse Event|2
850433|NCT01634152|2799772|P2|Overall Study|Adverse Event|0
850434|NCT01634152|2799773|P1|Overall Study|Adverse Event|2
850435|NCT01634139|2799856|P3|Overall Study|Not treated|0
850436|NCT01634139|2799857|P2|Overall Study|Not treated|1
850437|NCT01634139|2799858|P1|Overall Study|Not treated|1
850438|NCT01634139|2799856|P3|Overall Study|Lost to Follow-up|0
850439|NCT01634139|2799857|P2|Overall Study|Lost to Follow-up|2
850440|NCT01634139|2799858|P1|Overall Study|Lost to Follow-up|0
850441|NCT01634139|2799856|P3|Overall Study|Other|3
850442|NCT01634139|2799857|P2|Overall Study|Other|0
850443|NCT01634139|2799858|P1|Overall Study|Other|4
850444|NCT01634139|2799856|P3|Overall Study|Consent withdrawn not due to AE|2
850445|NCT01634139|2799857|P2|Overall Study|Consent withdrawn not due to AE|3
850446|NCT01634139|2799858|P1|Overall Study|Consent withdrawn not due to AE|4
850447|NCT01634139|2799856|P3|Overall Study|Non compliant with protocol|0
850448|NCT01634139|2799857|P2|Overall Study|Non compliant with protocol|0
850449|NCT01634139|2799858|P1|Overall Study|Non compliant with protocol|1
850450|NCT01634113|2799959|P3|Overall Study|Not treated|1
850451|NCT01634113|2799960|P2|Overall Study|Not treated|0
850452|NCT01634113|2799961|P1|Overall Study|Not treated|0
850453|NCT01634100|2800005|P6|Overall Study|Withdrawal by Subject|0
850454|NCT01634100|2800006|P5|Overall Study|Withdrawal by Subject|0
850455|NCT01634100|2800007|P4|Overall Study|Withdrawal by Subject|0
850456|NCT01634100|2800008|P3|Overall Study|Withdrawal by Subject|1
850457|NCT01634100|2800009|P2|Overall Study|Withdrawal by Subject|0
850458|NCT01634100|2800010|P1|Overall Study|Withdrawal by Subject|1
850459|NCT01633944|2800026|P3|Double-blind Treatment Phase|Not specified|0
850460|NCT01633944|2800027|P2|Double-blind Treatment Phase|Not specified|7
850461|NCT01633944|2800028|P1|Double-blind Treatment Phase|Not specified|0
850462|NCT01633944|2800026|P3|Double-blind Treatment Phase|Not exposed to DB study medication|0
850463|NCT01633944|2800027|P2|Double-blind Treatment Phase|Not exposed to DB study medication|1
850464|NCT01633944|2800028|P1|Double-blind Treatment Phase|Not exposed to DB study medication|0
850465|NCT01633944|2800026|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
850466|NCT01633944|2800027|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3
850467|NCT01633944|2800028|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
850468|NCT01633944|2800026|P3|Double-blind Treatment Phase|Lost to Follow-up|9
850469|NCT01633944|2800027|P2|Double-blind Treatment Phase|Lost to Follow-up|4
850470|NCT01633944|2800028|P1|Double-blind Treatment Phase|Lost to Follow-up|0
850471|NCT01633944|2800026|P3|Double-blind Treatment Phase|Protocol Violation|10
850472|NCT01633944|2800027|P2|Double-blind Treatment Phase|Protocol Violation|7
850473|NCT01633944|2800028|P1|Double-blind Treatment Phase|Protocol Violation|0
850474|NCT01633944|2800026|P3|Double-blind Treatment Phase|Withdrawal by Subject|8
850475|NCT01633944|2800027|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
850476|NCT01633944|2800028|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
850477|NCT01633944|2800026|P3|Double-blind Treatment Phase|Lack of Efficacy|23
850478|NCT01633944|2800027|P2|Double-blind Treatment Phase|Lack of Efficacy|8
850479|NCT01633944|2800028|P1|Double-blind Treatment Phase|Lack of Efficacy|0
850480|NCT01633944|2800026|P3|Double-blind Treatment Phase|Adverse Event|7
850481|NCT01633944|2800027|P2|Double-blind Treatment Phase|Adverse Event|13
850482|NCT01633944|2800028|P1|Double-blind Treatment Phase|Adverse Event|0
850483|NCT01633944|2800026|P3|Open-label Titration Phase|Not specified|0
850484|NCT01633944|2800027|P2|Open-label Titration Phase|Not specified|0
850485|NCT01633944|2800028|P1|Open-label Titration Phase|Not specified|68
850486|NCT01633944|2800026|P3|Open-label Titration Phase|Lost to Follow-up|0
850487|NCT01633944|2800027|P2|Open-label Titration Phase|Lost to Follow-up|0
850488|NCT01633944|2800028|P1|Open-label Titration Phase|Lost to Follow-up|22
850489|NCT01633944|2800026|P3|Open-label Titration Phase|Protocol Violation|0
850490|NCT01633944|2800027|P2|Open-label Titration Phase|Protocol Violation|0
850491|NCT01633944|2800028|P1|Open-label Titration Phase|Protocol Violation|24
850492|NCT01633944|2800026|P3|Open-label Titration Phase|Withdrawal by Subject|0
850493|NCT01633944|2800027|P2|Open-label Titration Phase|Withdrawal by Subject|0
850494|NCT01633944|2800028|P1|Open-label Titration Phase|Withdrawal by Subject|34
850495|NCT01633944|2800026|P3|Open-label Titration Phase|Lack of Efficacy|0
850496|NCT01633944|2800027|P2|Open-label Titration Phase|Lack of Efficacy|0
850497|NCT01633944|2800028|P1|Open-label Titration Phase|Lack of Efficacy|33
850498|NCT01633944|2800026|P3|Open-label Titration Phase|Adverse Event|0
850499|NCT01633944|2800027|P2|Open-label Titration Phase|Adverse Event|0
850500|NCT01633944|2800028|P1|Open-label Titration Phase|Adverse Event|109
850501|NCT01633788|2800096|P4|Overall Study|Other Reasons|7
850502|NCT01633788|2800097|P3|Overall Study|Other Reasons|3
850503|NCT01633788|2800098|P2|Overall Study|Other Reasons|2
850504|NCT01633788|2800099|P1|Overall Study|Other Reasons|0
850505|NCT01633788|2800096|P4|Overall Study|Protocol Violation|0
850506|NCT01633788|2800097|P3|Overall Study|Protocol Violation|1
850507|NCT01633788|2800098|P2|Overall Study|Protocol Violation|0
850508|NCT01633788|2800099|P1|Overall Study|Protocol Violation|1
850509|NCT01633788|2800096|P4|Overall Study|Personal Reasons|3
850510|NCT01633788|2800097|P3|Overall Study|Personal Reasons|1
850511|NCT01633788|2800098|P2|Overall Study|Personal Reasons|1
850512|NCT01633788|2800099|P1|Overall Study|Personal Reasons|3
850513|NCT01633788|2800096|P4|Overall Study|Lost to Follow-up|0
850514|NCT01633788|2800097|P3|Overall Study|Lost to Follow-up|2
850515|NCT01633788|2800098|P2|Overall Study|Lost to Follow-up|2
850516|NCT01633788|2800099|P1|Overall Study|Lost to Follow-up|2
850517|NCT01633788|2800096|P4|Overall Study|Adverse Event|3
850518|NCT01633788|2800097|P3|Overall Study|Adverse Event|3
850519|NCT01633788|2800098|P2|Overall Study|Adverse Event|3
850520|NCT01633788|2800099|P1|Overall Study|Adverse Event|1
850521|NCT01632904|2800143|P2|Overall Study|Reason for discontinuation not available|1
850522|NCT01632904|2800144|P1|Overall Study|Reason for discontinuation not available|0
850523|NCT01632904|2800143|P2|Overall Study|Disease Progression|1
850524|NCT01632904|2800144|P1|Overall Study|Disease Progression|0
850525|NCT01632904|2800143|P2|Overall Study|Subject decision|2
850526|NCT01632904|2800144|P1|Overall Study|Subject decision|3
850527|NCT01632904|2800143|P2|Overall Study|Physician Decision|1
850528|NCT01632904|2800144|P1|Overall Study|Physician Decision|0
850529|NCT01632904|2800143|P2|Overall Study|Adverse Event|1
850530|NCT01632904|2800144|P1|Overall Study|Adverse Event|4
850531|NCT01632878|2800155|P1|Treatment|no information on study completion|43
850532|NCT01632878|2800155|P1|Treatment|missing information|4
850533|NCT01632878|2800155|P1|Treatment|Physician Decision|34
850534|NCT01632878|2800155|P1|Treatment|Withdrawal by Subject|36
850535|NCT01632878|2800155|P1|Treatment|Lost to Follow-up|41
850536|NCT01632878|2800155|P1|Screening|Physician Decision|268
850537|NCT01632800|2800159|P1|Overall Study|Subject did not fit in apparatus|1
850538|NCT01632579|2800226|P9|Period 2 (Second Intervention)|Adverse Event|0
850539|NCT01632579|2800227|P8|Period 2 (Second Intervention)|Adverse Event|0
850540|NCT01632579|2800228|P7|Period 2 (Second Intervention)|Adverse Event|0
850541|NCT01632579|2800229|P6|Period 2 (Second Intervention)|Adverse Event|0
850542|NCT01632579|2800230|P5|Period 2 (Second Intervention)|Adverse Event|0
850543|NCT01632579|2800231|P4|Period 2 (Second Intervention)|Adverse Event|0
850544|NCT01632579|2800232|P3|Period 2 (Second Intervention)|Adverse Event|0
850545|NCT01632579|2800233|P2|Period 2 (Second Intervention)|Adverse Event|0
850546|NCT01632579|2800234|P1|Period 2 (Second Intervention)|Adverse Event|1
850547|NCT01632579|2800226|P9|Washout Period|Adverse Event|0
850548|NCT01632579|2800227|P8|Washout Period|Adverse Event|0
850549|NCT01632579|2800228|P7|Washout Period|Adverse Event|0
850550|NCT01632579|2800229|P6|Washout Period|Adverse Event|0
850551|NCT01632579|2800230|P5|Washout Period|Adverse Event|0
850552|NCT01632579|2800231|P4|Washout Period|Adverse Event|0
850553|NCT01632579|2800232|P3|Washout Period|Adverse Event|0
850554|NCT01632579|2800233|P2|Washout Period|Adverse Event|0
850555|NCT01632579|2800234|P1|Washout Period|Adverse Event|1
850556|NCT01632345|2800309|P7|Treatment: Part II|Withdrawal by Subject|2
850557|NCT01632345|2800310|P6|Treatment: Part II|Withdrawal by Subject|2
850558|NCT01632345|2800311|P5|Treatment: Part II|Withdrawal by Subject|0
850559|NCT01632345|2800312|P4|Treatment: Part II|Withdrawal by Subject|0
850560|NCT01632345|2800313|P3|Treatment: Part II|Withdrawal by Subject|0
850561|NCT01632345|2800314|P2|Treatment: Part II|Withdrawal by Subject|0
850562|NCT01632345|2800315|P1|Treatment: Part II|Withdrawal by Subject|0
850563|NCT01632345|2800309|P7|Treatment: Part II|Non-Compliance with Study Drug|0
850564|NCT01632345|2800310|P6|Treatment: Part II|Non-Compliance with Study Drug|3
850565|NCT01632345|2800311|P5|Treatment: Part II|Non-Compliance with Study Drug|0
850566|NCT01632345|2800312|P4|Treatment: Part II|Non-Compliance with Study Drug|0
850567|NCT01632345|2800313|P3|Treatment: Part II|Non-Compliance with Study Drug|0
850568|NCT01632345|2800314|P2|Treatment: Part II|Non-Compliance with Study Drug|0
850569|NCT01632345|2800315|P1|Treatment: Part II|Non-Compliance with Study Drug|0
850570|NCT01632345|2800309|P7|Treatment: Part II|Lost to Follow-up|1
850571|NCT01632345|2800310|P6|Treatment: Part II|Lost to Follow-up|3
850572|NCT01632345|2800311|P5|Treatment: Part II|Lost to Follow-up|0
850573|NCT01632345|2800312|P4|Treatment: Part II|Lost to Follow-up|0
850574|NCT01632345|2800313|P3|Treatment: Part II|Lost to Follow-up|0
850575|NCT01632345|2800314|P2|Treatment: Part II|Lost to Follow-up|0
850576|NCT01632345|2800315|P1|Treatment: Part II|Lost to Follow-up|0
850577|NCT01632345|2800309|P7|Treatment: Part II|Adverse Event|8
850578|NCT01632345|2800310|P6|Treatment: Part II|Adverse Event|3
850579|NCT01632345|2800311|P5|Treatment: Part II|Adverse Event|0
850580|NCT01632345|2800312|P4|Treatment: Part II|Adverse Event|0
850581|NCT01632345|2800313|P3|Treatment: Part II|Adverse Event|0
850582|NCT01632345|2800314|P2|Treatment: Part II|Adverse Event|0
850583|NCT01632345|2800315|P1|Treatment: Part II|Adverse Event|0
850584|NCT01632345|2800309|P7|Treatment: Part I|Withdrawal by Subject|0
850585|NCT01632345|2800310|P6|Treatment: Part I|Withdrawal by Subject|0
850586|NCT01632345|2800311|P5|Treatment: Part I|Withdrawal by Subject|4
850587|NCT01632345|2800312|P4|Treatment: Part I|Withdrawal by Subject|1
850588|NCT01632345|2800313|P3|Treatment: Part I|Withdrawal by Subject|4
850589|NCT01632345|2800314|P2|Treatment: Part I|Withdrawal by Subject|4
850590|NCT01632345|2800315|P1|Treatment: Part I|Withdrawal by Subject|3
850591|NCT01632345|2800309|P7|Treatment: Part I|Protocol Deviation|0
850592|NCT01632345|2800310|P6|Treatment: Part I|Protocol Deviation|0
850593|NCT01632345|2800311|P5|Treatment: Part I|Protocol Deviation|0
850594|NCT01632345|2800312|P4|Treatment: Part I|Protocol Deviation|1
850595|NCT01632345|2800313|P3|Treatment: Part I|Protocol Deviation|1
850596|NCT01632345|2800314|P2|Treatment: Part I|Protocol Deviation|0
850597|NCT01632345|2800315|P1|Treatment: Part I|Protocol Deviation|0
850598|NCT01632345|2800309|P7|Treatment: Part I|Pregnancy|0
850599|NCT01632345|2800310|P6|Treatment: Part I|Pregnancy|0
850600|NCT01632345|2800311|P5|Treatment: Part I|Pregnancy|0
850601|NCT01632345|2800312|P4|Treatment: Part I|Pregnancy|0
850602|NCT01632345|2800313|P3|Treatment: Part I|Pregnancy|0
850603|NCT01632345|2800314|P2|Treatment: Part I|Pregnancy|1
850604|NCT01632345|2800315|P1|Treatment: Part I|Pregnancy|0
850605|NCT01632345|2800309|P7|Treatment: Part I|Physician Decision|0
850606|NCT01632345|2800310|P6|Treatment: Part I|Physician Decision|0
850607|NCT01632345|2800311|P5|Treatment: Part I|Physician Decision|1
850608|NCT01632345|2800312|P4|Treatment: Part I|Physician Decision|0
850609|NCT01632345|2800313|P3|Treatment: Part I|Physician Decision|0
850610|NCT01632345|2800314|P2|Treatment: Part I|Physician Decision|1
850611|NCT01632345|2800315|P1|Treatment: Part I|Physician Decision|2
850612|NCT01632345|2800309|P7|Treatment: Part I|Non-Compliance with Study Drug|0
850613|NCT01632345|2800310|P6|Treatment: Part I|Non-Compliance with Study Drug|0
850614|NCT01632345|2800311|P5|Treatment: Part I|Non-Compliance with Study Drug|0
850615|NCT01632345|2800312|P4|Treatment: Part I|Non-Compliance with Study Drug|1
850616|NCT01632345|2800313|P3|Treatment: Part I|Non-Compliance with Study Drug|2
850617|NCT01632345|2800314|P2|Treatment: Part I|Non-Compliance with Study Drug|2
850618|NCT01632345|2800315|P1|Treatment: Part I|Non-Compliance with Study Drug|3
850619|NCT01632345|2800309|P7|Treatment: Part I|Lost to Follow-up|0
850620|NCT01632345|2800310|P6|Treatment: Part I|Lost to Follow-up|0
850621|NCT01632345|2800311|P5|Treatment: Part I|Lost to Follow-up|4
850622|NCT01632345|2800312|P4|Treatment: Part I|Lost to Follow-up|3
850623|NCT01632345|2800313|P3|Treatment: Part I|Lost to Follow-up|1
850624|NCT01632345|2800314|P2|Treatment: Part I|Lost to Follow-up|2
850625|NCT01632345|2800315|P1|Treatment: Part I|Lost to Follow-up|3
850626|NCT01632345|2800309|P7|Treatment: Part I|Lack of Efficacy|0
850627|NCT01632345|2800310|P6|Treatment: Part I|Lack of Efficacy|0
850628|NCT01632345|2800311|P5|Treatment: Part I|Lack of Efficacy|1
850629|NCT01632345|2800312|P4|Treatment: Part I|Lack of Efficacy|1
850630|NCT01632345|2800313|P3|Treatment: Part I|Lack of Efficacy|0
850631|NCT01632345|2800314|P2|Treatment: Part I|Lack of Efficacy|1
850632|NCT01632345|2800315|P1|Treatment: Part I|Lack of Efficacy|0
850633|NCT01632345|2800309|P7|Treatment: Part I|Adverse Event|0
850634|NCT01632345|2800310|P6|Treatment: Part I|Adverse Event|0
850635|NCT01632345|2800311|P5|Treatment: Part I|Adverse Event|3
850636|NCT01632345|2800312|P4|Treatment: Part I|Adverse Event|1
850637|NCT01632345|2800313|P3|Treatment: Part I|Adverse Event|2
850638|NCT01632345|2800314|P2|Treatment: Part I|Adverse Event|4
850639|NCT01632345|2800315|P1|Treatment: Part I|Adverse Event|1
850640|NCT01632306|2800377|P3|Overall Study|Protocol Violation|0
850641|NCT01632306|2800378|P2|Overall Study|Protocol Violation|0
850642|NCT01632306|2800379|P1|Overall Study|Protocol Violation|1
850643|NCT01632280|2800395|P2|Overall Study|Withdrawal by Subject|0
850644|NCT01632280|2800396|P1|Overall Study|Withdrawal by Subject|1
850645|NCT01632150|2800419|P1|Overall Study|Moved to compassionate program|2
850646|NCT01632150|2800419|P1|Overall Study|Patient underwent autologous transplant|1
850647|NCT01632150|2800419|P1|Overall Study|Withdrawal by Subject|2
850648|NCT01632150|2800419|P1|Overall Study|Unrelated adverse event|7
850649|NCT01632150|2800419|P1|Overall Study|Study drug toxicity|1
850650|NCT01632150|2800419|P1|Overall Study|Disease progression|27
850651|NCT01632020|2800428|P2|Overall Study|Adverse Event|0
850652|NCT01632020|2800429|P1|Overall Study|Adverse Event|1
850653|NCT01632020|2800428|P2|Overall Study|Withdrawal by Subject|0
850654|NCT01632020|2800429|P1|Overall Study|Withdrawal by Subject|1
850655|NCT01631864|2800448|P2|Overall Study|Adverse Event|3
850656|NCT01631864|2800449|P1|Overall Study|Adverse Event|2
850657|NCT01631864|2800448|P2|Overall Study|Withdrawal by Subject|1
850658|NCT01631864|2800449|P1|Overall Study|Withdrawal by Subject|0
850659|NCT01631825|2800461|P1|Overall Study|Physician Decision|2
850660|NCT01631825|2800461|P1|Overall Study|Discontinuation criteria|1
850661|NCT01631825|2800461|P1|Overall Study|Protocol Violation|4
850662|NCT01631825|2800461|P1|Overall Study|Withdrawal by Subject|9
850663|NCT01631825|2800461|P1|Overall Study|Lack of Efficacy|7
850664|NCT01631825|2800461|P1|Overall Study|Adverse Event|42
850665|NCT01631812|2800481|P1|Overall Study|Physician Decision|3
850666|NCT01631812|2800481|P1|Overall Study|Withdrawal by Subject|4
850667|NCT01631812|2800481|P1|Overall Study|Lack of Efficacy|5
850668|NCT01631812|2800481|P1|Overall Study|Adverse Event|25
850669|NCT01631747|2800491|P2|One Year Infant Outcomes|Patient Refused|9
850670|NCT01631747|2800492|P1|One Year Infant Outcomes|Patient Refused|13
850671|NCT01631747|2800491|P2|Live Birth|Stillbirth|1
850672|NCT01631747|2800492|P1|Live Birth|Stillbirth|1
850673|NCT01631747|2800491|P2|Live Birth|MIscarriage|0
850674|NCT01631747|2800492|P1|Live Birth|MIscarriage|2
850675|NCT01631747|2800491|P2|Live Birth|Pregnancy Termination|0
850676|NCT01631747|2800492|P1|Live Birth|Pregnancy Termination|1
850677|NCT01631747|2800491|P2|Randomization Through End of Pregnancy|Lost to Follow-up|0
850678|NCT01631747|2800492|P1|Randomization Through End of Pregnancy|Lost to Follow-up|1
850679|NCT01631435|2800669|P1|Overall Study|incomplete study procedure|5
850680|NCT01631435|2800669|P1|Overall Study|Withdrawal by Subject|2
850681|NCT01631435|2800669|P1|Overall Study|Adverse Event|2
850682|NCT01631227|2800683|P2|Overall Study|administrative|1
850683|NCT01631227|2800684|P1|Overall Study|administrative|2
850684|NCT01631227|2800683|P2|Overall Study|Adverse Event|0
850685|NCT01631227|2800684|P1|Overall Study|Adverse Event|1
850686|NCT01631227|2800683|P2|Overall Study|withdrawn consent|21
850687|NCT01631227|2800684|P1|Overall Study|withdrawn consent|27
850688|NCT01630811|2800737|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
850689|NCT01630811|2800738|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
850690|NCT01630616|2800765|P6|Overall Study|Withdrawal by Subject|0
850691|NCT01630616|2800766|P5|Overall Study|Withdrawal by Subject|0
850692|NCT01630616|2800767|P4|Overall Study|Withdrawal by Subject|2
850693|NCT01630616|2800768|P3|Overall Study|Withdrawal by Subject|0
850694|NCT01630616|2800769|P2|Overall Study|Withdrawal by Subject|0
850695|NCT01630616|2800770|P1|Overall Study|Withdrawal by Subject|0
850696|NCT01630616|2800765|P6|Overall Study|Adverse Event|0
850697|NCT01630616|2800766|P5|Overall Study|Adverse Event|0
850698|NCT01630616|2800767|P4|Overall Study|Adverse Event|1
850699|NCT01630616|2800768|P3|Overall Study|Adverse Event|0
850700|NCT01630616|2800769|P2|Overall Study|Adverse Event|0
850701|NCT01630616|2800770|P1|Overall Study|Adverse Event|0
850702|NCT01630135|2800845|P2|Overall Study|Protocol-defined Stopping Criteria Met|2
850703|NCT01630135|2800846|P1|Overall Study|Protocol-defined Stopping Criteria Met|0
850704|NCT01629953|2800909|P2|Overall Study|Lost to Follow-up|14
850705|NCT01629953|2800910|P1|Overall Study|Lost to Follow-up|10
850706|NCT01629953|2800909|P2|Overall Study|Death|1
850707|NCT01629953|2800910|P1|Overall Study|Death|3
850708|NCT01629823|2800930|P3|Washout Period|Protocol Violation|0
850709|NCT01629823|2800931|P2|Washout Period|Protocol Violation|1
850710|NCT01629823|2800932|P1|Washout Period|Protocol Violation|0
850711|NCT01629823|2800930|P3|Washout Period|Pregnancy|0
850712|NCT01629823|2800931|P2|Washout Period|Pregnancy|0
850713|NCT01629823|2800932|P1|Washout Period|Pregnancy|1
850714|NCT01629823|2800930|P3|Washout Period|Safety|0
850715|NCT01629823|2800931|P2|Washout Period|Safety|5
850716|NCT01629823|2800932|P1|Washout Period|Safety|2
850717|NCT01629823|2800930|P3|Trial Period|Failed to hold medication|1
850718|NCT01629823|2800931|P2|Trial Period|Failed to hold medication|0
850719|NCT01629823|2800932|P1|Trial Period|Failed to hold medication|0
850720|NCT01629823|2800930|P3|Trial Period|Out-of-window visit|0
850721|NCT01629823|2800931|P2|Trial Period|Out-of-window visit|2
850722|NCT01629823|2800932|P1|Trial Period|Out-of-window visit|0
850723|NCT01629823|2800930|P3|Trial Period|Adverse Event|0
850724|NCT01629823|2800931|P2|Trial Period|Adverse Event|1
850725|NCT01629823|2800932|P1|Trial Period|Adverse Event|0
850726|NCT01629823|2800930|P3|Trial Period|Pregnancy|0
850727|NCT01629823|2800931|P2|Trial Period|Pregnancy|0
850728|NCT01629823|2800932|P1|Trial Period|Pregnancy|1
850729|NCT01629823|2800930|P3|Trial Period|Pre-diluent FEV₁ predicted <70%|1
850730|NCT01629823|2800931|P2|Trial Period|Pre-diluent FEV₁ predicted <70%|1
850731|NCT01629823|2800932|P1|Trial Period|Pre-diluent FEV₁ predicted <70%|1
850732|NCT01629823|2800930|P3|Trial Period|Missed visit|8
850733|NCT01629823|2800931|P2|Trial Period|Missed visit|9
850734|NCT01629823|2800932|P1|Trial Period|Missed visit|11
850735|NCT01629706|2800967|P1|Phase 2 Habitual|Lost to Follow Up after Dispense|1
850736|NCT01629706|2800967|P1|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1
850737|NCT01629706|2800967|P1|Phase 2 Habitual|Relocation prior to Dispense|1
850738|NCT01629706|2800967|P1|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1
850739|NCT01629706|2800967|P1|Phase 2 Habitual|Screen Failure|6
850740|NCT01629706|2800967|P1|Phase 1 PureVision|No Solution-Induced Corneal Staining|3
850741|NCT01629706|2800967|P1|Phase 1 PureVision|Inconvenience prior to Dispense|1
850742|NCT01629706|2800967|P1|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1
850743|NCT01629706|2800967|P1|Phase 1 PureVision|Screen Failure|4
850744|NCT01629693|2800995|P2|Overall Study|Subject decision unrelated to AE|1
850745|NCT01629693|2800996|P1|Overall Study|Subject decision unrelated to AE|0
850746|NCT01629693|2800995|P2|Overall Study|Poor comfort of study lenses|2
850747|NCT01629693|2800996|P1|Overall Study|Poor comfort of study lenses|0
850748|NCT01629693|2800995|P2|Overall Study|Investigator decision|1
850749|NCT01629693|2800996|P1|Overall Study|Investigator decision|0
850750|NCT01629693|2800995|P2|Overall Study|Adverse Event|0
850751|NCT01629693|2800996|P1|Overall Study|Adverse Event|1
850752|NCT01629693|2800995|P2|Overall Study|Withdrawal by Subject|2
850753|NCT01629693|2800996|P1|Overall Study|Withdrawal by Subject|2
850754|NCT01629693|2800995|P2|Overall Study|Lost to Follow-up|4
850755|NCT01629693|2800996|P1|Overall Study|Lost to Follow-up|2
850756|NCT01629667|2801005|P3|Overall Study|Code break|0
850757|NCT01629667|2801006|P2|Overall Study|Code break|0
850758|NCT01629667|2801007|P1|Overall Study|Code break|1
850759|NCT01629667|2801005|P3|Overall Study|Enrolled in another clinical study|0
850760|NCT01629667|2801006|P2|Overall Study|Enrolled in another clinical study|1
850761|NCT01629667|2801007|P1|Overall Study|Enrolled in another clinical study|0
850762|NCT01629667|2801005|P3|Overall Study|Site error in safety follow-up|1
850763|NCT01629667|2801006|P2|Overall Study|Site error in safety follow-up|0
850764|NCT01629667|2801007|P1|Overall Study|Site error in safety follow-up|0
850765|NCT01629667|2801005|P3|Overall Study|Started other medicine|1
850766|NCT01629667|2801006|P2|Overall Study|Started other medicine|0
850767|NCT01629667|2801007|P1|Overall Study|Started other medicine|1
850768|NCT01629667|2801005|P3|Overall Study|Early tretmt termntd, cmpltd safety f-up|8
850769|NCT01629667|2801006|P2|Overall Study|Early tretmt termntd, cmpltd safety f-up|11
850770|NCT01629667|2801007|P1|Overall Study|Early tretmt termntd, cmpltd safety f-up|9
850771|NCT01629667|2801005|P3|Overall Study|Requiring lung transplant|3
850772|NCT01629667|2801006|P2|Overall Study|Requiring lung transplant|1
850773|NCT01629667|2801007|P1|Overall Study|Requiring lung transplant|2
850774|NCT01629667|2801005|P3|Overall Study|Ongoing AE worsening right heart failure|0
850775|NCT01629667|2801006|P2|Overall Study|Ongoing AE worsening right heart failure|1
850776|NCT01629667|2801007|P1|Overall Study|Ongoing AE worsening right heart failure|0
850777|NCT01629667|2801005|P3|Overall Study|Randomized, not treated|0
850778|NCT01629667|2801006|P2|Overall Study|Randomized, not treated|1
850779|NCT01629667|2801007|P1|Overall Study|Randomized, not treated|2
850780|NCT01629667|2801005|P3|Overall Study|Death|3
850781|NCT01629667|2801006|P2|Overall Study|Death|5
850782|NCT01629667|2801007|P1|Overall Study|Death|1
850783|NCT01629667|2801005|P3|Overall Study|Withdrawal by Subject|28
850784|NCT01629667|2801006|P2|Overall Study|Withdrawal by Subject|20
850785|NCT01629667|2801007|P1|Overall Study|Withdrawal by Subject|31
850786|NCT01629667|2801005|P3|Overall Study|Lost to Follow-up|1
850787|NCT01629667|2801006|P2|Overall Study|Lost to Follow-up|1
850788|NCT01629667|2801007|P1|Overall Study|Lost to Follow-up|0
850789|NCT01629589|2801091|P2|Overall Study|Did not receive study vaccine|1
850790|NCT01629589|2801092|P1|Overall Study|Did not receive study vaccine|0
850791|NCT01629589|2801091|P2|Overall Study|Withdrawal by Subject|3
850792|NCT01629589|2801092|P1|Overall Study|Withdrawal by Subject|2
850793|NCT01629589|2801091|P2|Overall Study|Lost to Follow-up|1
850794|NCT01629589|2801092|P1|Overall Study|Lost to Follow-up|2
850795|NCT01629589|2801091|P2|Overall Study|Protocol Violation|2
850796|NCT01629589|2801092|P1|Overall Study|Protocol Violation|4
850797|NCT01628965|2801131|P1|Overall Study|Discontinuation criteria|8
850798|NCT01628965|2801131|P1|Overall Study|Lost to Follow-up|1
850799|NCT01628965|2801131|P1|Overall Study|Withdrawal by Subject|3
850800|NCT01628965|2801131|P1|Overall Study|Lack of Efficacy|7
850801|NCT01628965|2801131|P1|Overall Study|Adverse Event|30
850802|NCT01628926|2801140|P3|Overall Study|Physician Decision|1
850803|NCT01628926|2801141|P2|Overall Study|Physician Decision|2
850804|NCT01628926|2801142|P1|Overall Study|Physician Decision|2
850805|NCT01628926|2801140|P3|Overall Study|Discontinuation criteria|0
850806|NCT01628926|2801141|P2|Overall Study|Discontinuation criteria|4
850807|NCT01628926|2801142|P1|Overall Study|Discontinuation criteria|3
850808|NCT01628926|2801140|P3|Overall Study|Protocol Violation|0
850809|NCT01628926|2801141|P2|Overall Study|Protocol Violation|1
850810|NCT01628926|2801142|P1|Overall Study|Protocol Violation|0
850811|NCT01628926|2801140|P3|Overall Study|Withdrawal by Subject|2
850812|NCT01628926|2801141|P2|Overall Study|Withdrawal by Subject|4
850813|NCT01628926|2801142|P1|Overall Study|Withdrawal by Subject|6
850814|NCT01628926|2801140|P3|Overall Study|Lack of Efficacy|5
850815|NCT01628926|2801141|P2|Overall Study|Lack of Efficacy|1
850816|NCT01628926|2801142|P1|Overall Study|Lack of Efficacy|2
850817|NCT01628926|2801140|P3|Overall Study|Adverse Event|9
850818|NCT01628926|2801141|P2|Overall Study|Adverse Event|11
850819|NCT01628926|2801142|P1|Overall Study|Adverse Event|13
850820|NCT01628913|2801191|P2|Overall Study|Physician Decision|3
850821|NCT01628913|2801192|P1|Overall Study|Physician Decision|1
850822|NCT01628913|2801191|P2|Overall Study|Withdrawal by Subject|0
850823|NCT01628913|2801192|P1|Overall Study|Withdrawal by Subject|1
850824|NCT01628913|2801191|P2|Overall Study|study terminated by Sponsor|9
850825|NCT01628913|2801192|P1|Overall Study|study terminated by Sponsor|4
850826|NCT01628913|2801191|P2|Overall Study|Death|0
850827|NCT01628913|2801192|P1|Overall Study|Death|1
850828|NCT01628913|2801191|P2|Overall Study|Protocol Violation|0
850829|NCT01628913|2801192|P1|Overall Study|Protocol Violation|1
850830|NCT01628913|2801191|P2|Overall Study|Disease Progression|14
850831|NCT01628913|2801192|P1|Overall Study|Disease Progression|11
850832|NCT01628913|2801191|P2|Overall Study|Adverse Event|5
850833|NCT01628913|2801192|P1|Overall Study|Adverse Event|12
850834|NCT01628848|2801206|P2|Overall Study|Physician Decision|1
850835|NCT01628848|2801207|P1|Overall Study|Physician Decision|3
850836|NCT01628848|2801206|P2|Overall Study|Withdrawal by Subject|2
850837|NCT01628848|2801207|P1|Overall Study|Withdrawal by Subject|0
850838|NCT01628848|2801206|P2|Overall Study|Lack of Efficacy|4
850839|NCT01628848|2801207|P1|Overall Study|Lack of Efficacy|0
850840|NCT01628848|2801206|P2|Overall Study|Adverse Event|7
850841|NCT01628848|2801207|P1|Overall Study|Adverse Event|9
850842|NCT01628692|2801241|P6|Overall Study|Completed 12 Week only|1
850843|NCT01628692|2801242|P5|Overall Study|Completed 12 Week only|0
850844|NCT01628692|2801243|P4|Overall Study|Completed 12 Week only|0
850845|NCT01628692|2801244|P3|Overall Study|Completed 12 Week only|0
850846|NCT01628692|2801245|P2|Overall Study|Completed 12 Week only|0
850847|NCT01628692|2801246|P1|Overall Study|Completed 12 Week only|0
850848|NCT01628692|2801241|P6|Overall Study|Administrative reason by sponsor|1
850849|NCT01628692|2801242|P5|Overall Study|Administrative reason by sponsor|0
850850|NCT01628692|2801243|P4|Overall Study|Administrative reason by sponsor|0
850851|NCT01628692|2801244|P3|Overall Study|Administrative reason by sponsor|0
850852|NCT01628692|2801245|P2|Overall Study|Administrative reason by sponsor|0
850853|NCT01628692|2801246|P1|Overall Study|Administrative reason by sponsor|0
850854|NCT01628692|2801241|P6|Overall Study|Poor compliance/noncompliance|0
850855|NCT01628692|2801242|P5|Overall Study|Poor compliance/noncompliance|0
850856|NCT01628692|2801243|P4|Overall Study|Poor compliance/noncompliance|0
850857|NCT01628692|2801244|P3|Overall Study|Poor compliance/noncompliance|0
850858|NCT01628692|2801245|P2|Overall Study|Poor compliance/noncompliance|0
850859|NCT01628692|2801246|P1|Overall Study|Poor compliance/noncompliance|1
850860|NCT01628692|2801241|P6|Overall Study|Death|0
850861|NCT01628692|2801242|P5|Overall Study|Death|0
850862|NCT01628692|2801243|P4|Overall Study|Death|0
850863|NCT01628692|2801244|P3|Overall Study|Death|0
850864|NCT01628692|2801245|P2|Overall Study|Death|1
850865|NCT01628692|2801246|P1|Overall Study|Death|0
850866|NCT01628692|2801241|P6|Overall Study|Withdrawal by Subject|0
850867|NCT01628692|2801242|P5|Overall Study|Withdrawal by Subject|0
850868|NCT01628692|2801243|P4|Overall Study|Withdrawal by Subject|0
850869|NCT01628692|2801244|P3|Overall Study|Withdrawal by Subject|1
850870|NCT01628692|2801245|P2|Overall Study|Withdrawal by Subject|1
850871|NCT01628692|2801246|P1|Overall Study|Withdrawal by Subject|0
850872|NCT01628692|2801241|P6|Overall Study|Adverse Event|0
850873|NCT01628692|2801242|P5|Overall Study|Adverse Event|0
850874|NCT01628692|2801243|P4|Overall Study|Adverse Event|0
850875|NCT01628692|2801244|P3|Overall Study|Adverse Event|2
850876|NCT01628692|2801245|P2|Overall Study|Adverse Event|0
850877|NCT01628692|2801246|P1|Overall Study|Adverse Event|2
850878|NCT01628692|2801241|P6|Overall Study|Lack of Efficacy|7
850879|NCT01628692|2801242|P5|Overall Study|Lack of Efficacy|4
850880|NCT01628692|2801243|P4|Overall Study|Lack of Efficacy|1
850881|NCT01628692|2801244|P3|Overall Study|Lack of Efficacy|5
850882|NCT01628692|2801245|P2|Overall Study|Lack of Efficacy|4
850883|NCT01628692|2801246|P1|Overall Study|Lack of Efficacy|4
850884|NCT01628510|2801314|P2|Overall Study|Death|1
850885|NCT01628510|2801315|P1|Overall Study|Death|3
850886|NCT01628510|2801314|P2|Overall Study|Withdrawal by Subject|4
850887|NCT01628510|2801315|P1|Overall Study|Withdrawal by Subject|0
850888|NCT01628367|2801325|P2|Overall Study|Adverse Event|0
850889|NCT01628367|2801326|P1|Overall Study|Adverse Event|1
850890|NCT01628198|2801345|P1|Overall Study|Screen failure|1
850891|NCT01628198|2801345|P1|Overall Study|Withdrawal by Subject|10
850892|NCT01628198|2801345|P1|Overall Study|Lost to Follow-up|7
850893|NCT01628120|2801358|P1|Overall Study|Use of Standard of Care|1
850894|NCT01628120|2801358|P1|Overall Study|Kidney Transplant|2
850895|NCT01628120|2801358|P1|Overall Study|Moved or Relocated|5
850896|NCT01628120|2801358|P1|Overall Study|Missed Study Drug More than 2 Weeks|3
850897|NCT01628120|2801358|P1|Overall Study|Switched Dialysis Method|2
850898|NCT01628120|2801358|P1|Overall Study|Sponsor Decision|5
850899|NCT01628120|2801358|P1|Overall Study|Not Treated|3
850900|NCT01628120|2801358|P1|Overall Study|Non-compliant with Study Procedures|1
850901|NCT01628120|2801358|P1|Overall Study|Not met Inclusion/Exclusion Criteria|2
850902|NCT01628120|2801358|P1|Overall Study|Lost to Follow-up|1
850903|NCT01628120|2801358|P1|Overall Study|Adverse Event|12
850904|NCT01628120|2801358|P1|Overall Study|Withdrawal by Subject|7
850905|NCT01628107|2801383|P1|Overall Study|Use of Standard of Care|9
850906|NCT01628107|2801383|P1|Overall Study|Kidney Transplant|9
850907|NCT01628107|2801383|P1|Overall Study|Relocated|8
850908|NCT01628107|2801383|P1|Overall Study|Missed Study Drug More than 2 Weeks|7
850909|NCT01628107|2801383|P1|Overall Study|Sponsor Decision|11
850910|NCT01628107|2801383|P1|Overall Study|Not Treated|8
850911|NCT01628107|2801383|P1|Overall Study|Non-compliant with Study Procedures|10
850912|NCT01628107|2801383|P1|Overall Study|Not met Inclusion/Exclusion Criteria|1
850913|NCT01628107|2801383|P1|Overall Study|Physician Decision|2
850914|NCT01628107|2801383|P1|Overall Study|Adverse Event|33
850915|NCT01628107|2801383|P1|Overall Study|Lost to Follow-up|4
850916|NCT01628107|2801383|P1|Overall Study|Withdrawal by Subject|17
850917|NCT01627899|2801433|P1|Overall Study|Study terminated early by sponsor.|5
850918|NCT01627860|2801443|P2|Overall Study|Protocol Violation|0
850919|NCT01627860|2801444|P1|Overall Study|Protocol Violation|1
850920|NCT01627860|2801443|P2|Overall Study|Seizure frequency doubled|1
850921|NCT01627860|2801444|P1|Overall Study|Seizure frequency doubled|0
850922|NCT01627860|2801443|P2|Overall Study|Withdrawal by Subject|1
850923|NCT01627860|2801444|P1|Overall Study|Withdrawal by Subject|2
850924|NCT01627860|2801443|P2|Overall Study|Adverse Event|4
850925|NCT01627860|2801444|P1|Overall Study|Adverse Event|9
850926|NCT01627782|2801458|P4|Overall Study|Randomized But Not Treated|0
850927|NCT01627782|2801459|P3|Overall Study|Randomized But Not Treated|0
850928|NCT01627782|2801460|P2|Overall Study|Randomized But Not Treated|0
850929|NCT01627782|2801461|P1|Overall Study|Randomized But Not Treated|1
850930|NCT01627782|2801458|P4|Overall Study|Other|3
850931|NCT01627782|2801459|P3|Overall Study|Other|0
850932|NCT01627782|2801460|P2|Overall Study|Other|2
850933|NCT01627782|2801461|P1|Overall Study|Other|0
850934|NCT01627782|2801458|P4|Overall Study|Withdrawal by Subject|0
850935|NCT01627782|2801459|P3|Overall Study|Withdrawal by Subject|0
850936|NCT01627782|2801460|P2|Overall Study|Withdrawal by Subject|1
850937|NCT01627782|2801461|P1|Overall Study|Withdrawal by Subject|2
850938|NCT01627782|2801458|P4|Overall Study|Protocol Violation|0
850939|NCT01627782|2801459|P3|Overall Study|Protocol Violation|0
850940|NCT01627782|2801460|P2|Overall Study|Protocol Violation|0
850941|NCT01627782|2801461|P1|Overall Study|Protocol Violation|1
850942|NCT01627782|2801458|P4|Overall Study|Lack of Efficacy|2
850943|NCT01627782|2801459|P3|Overall Study|Lack of Efficacy|15
850944|NCT01627782|2801460|P2|Overall Study|Lack of Efficacy|1
850945|NCT01627782|2801461|P1|Overall Study|Lack of Efficacy|11
850946|NCT01627782|2801458|P4|Overall Study|Adverse Event|1
850947|NCT01627782|2801459|P3|Overall Study|Adverse Event|0
850948|NCT01627782|2801460|P2|Overall Study|Adverse Event|2
850949|NCT01627782|2801461|P1|Overall Study|Adverse Event|1
850950|NCT01627561|2801519|P2|Overall Study|Withdrawal by Subject|2
850951|NCT01627561|2801520|P1|Overall Study|Withdrawal by Subject|0
850952|NCT01627561|2801519|P2|Overall Study|Migrated/moved from study area|1
850953|NCT01627561|2801520|P1|Overall Study|Migrated/moved from study area|0
850954|NCT01627340|2801568|P2|Overall Study|Withdrawal by Subject|0
850955|NCT01627340|2801569|P1|Overall Study|Withdrawal by Subject|2
850956|NCT01627340|2801568|P2|Overall Study|Pregnancy|0
850957|NCT01627340|2801569|P1|Overall Study|Pregnancy|1
850958|NCT01627340|2801568|P2|Overall Study|Lost to Follow-up|4
850959|NCT01627340|2801569|P1|Overall Study|Lost to Follow-up|8
850960|NCT01627340|2801568|P2|Overall Study|Adverse Event|0
850961|NCT01627340|2801569|P1|Overall Study|Adverse Event|1
850962|NCT01627327|2801587|P2|Overall Study|Withdrawal by Subject|3
850963|NCT01627327|2801588|P1|Overall Study|Withdrawal by Subject|3
850964|NCT01627327|2801587|P2|Overall Study|Physician Decision|0
850965|NCT01627327|2801588|P1|Overall Study|Physician Decision|1
850966|NCT01627327|2801587|P2|Overall Study|Lost to Follow-up|3
850967|NCT01627327|2801588|P1|Overall Study|Lost to Follow-up|1
850968|NCT01627327|2801587|P2|Overall Study|Protocol Violation|10
850969|NCT01627327|2801588|P1|Overall Study|Protocol Violation|4
850970|NCT01627327|2801587|P2|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9
850971|NCT01627327|2801588|P1|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4
850972|NCT01627327|2801587|P2|Overall Study|Lack of Efficacy-No Sub-Reason|2
850973|NCT01627327|2801588|P1|Overall Study|Lack of Efficacy-No Sub-Reason|0
850974|NCT01627327|2801587|P2|Overall Study|Adverse Event|12
850975|NCT01627327|2801588|P1|Overall Study|Adverse Event|6
850976|NCT01627249|2801601|P3|Overall Study|Missed Visit|0
850977|NCT01627249|2801602|P2|Overall Study|Missed Visit|1
850978|NCT01627249|2801603|P1|Overall Study|Missed Visit|1
850979|NCT01627249|2801601|P3|Overall Study|Withdrawal by Subject|9
850980|NCT01627249|2801602|P2|Overall Study|Withdrawal by Subject|6
850981|NCT01627249|2801603|P1|Overall Study|Withdrawal by Subject|12
850982|NCT01627249|2801601|P3|Overall Study|Death|3
850983|NCT01627249|2801602|P2|Overall Study|Death|5
850984|NCT01627249|2801603|P1|Overall Study|Death|3
850985|NCT01626690|2801724|P2|Overall Study|Adverse Event|0
850986|NCT01626690|2801725|P1|Overall Study|Adverse Event|1
850987|NCT01626690|2801724|P2|Overall Study|Protocol Violation|0
850988|NCT01626690|2801725|P1|Overall Study|Protocol Violation|1
850989|NCT01626456|2801764|P2|Overall Study|Incarceration|2
850990|NCT01626456|2801765|P1|Overall Study|Incarceration|0
850991|NCT01626456|2801764|P2|Overall Study|Site Closure|3
850992|NCT01626456|2801765|P1|Overall Study|Site Closure|2
850993|NCT01626456|2801764|P2|Overall Study|Protocol Violation|1
850994|NCT01626456|2801765|P1|Overall Study|Protocol Violation|1
850995|NCT01626456|2801764|P2|Overall Study|Physician Decision|4
850996|NCT01626456|2801765|P1|Overall Study|Physician Decision|1
850997|NCT01626456|2801764|P2|Overall Study|Lack of Efficacy|7
850998|NCT01626456|2801765|P1|Overall Study|Lack of Efficacy|6
850999|NCT01626456|2801764|P2|Overall Study|Lost to Follow-up|27
851000|NCT01626456|2801765|P1|Overall Study|Lost to Follow-up|2
851001|NCT01626456|2801764|P2|Overall Study|Adverse Event|27
851002|NCT01626456|2801765|P1|Overall Study|Adverse Event|2
851003|NCT01626456|2801764|P2|Overall Study|Withdrawal by Subject|46
851004|NCT01626456|2801765|P1|Overall Study|Withdrawal by Subject|21
851005|NCT01626391|2801795|P2|Overall Study|Withdrawal by Subject|0
851006|NCT01626391|2801796|P1|Overall Study|Withdrawal by Subject|1
851007|NCT01626391|2801795|P2|Overall Study|Physician Decision|0
851008|NCT01626391|2801796|P1|Overall Study|Physician Decision|1
851009|NCT01626352|2801802|P1|Overall Study|Never Treated|1
851010|NCT01626352|2801802|P1|Overall Study|Non-Compliance|1
851011|NCT01626352|2801802|P1|Overall Study|Withdrawal by Subject|1
851012|NCT01626352|2801802|P1|Overall Study|Death|2
851013|NCT01626352|2801802|P1|Overall Study|Intercurrent Illness|2
851014|NCT01626352|2801802|P1|Overall Study|Disease Progression|3
851015|NCT01626118|2801816|P4|Overall Study|Investigator Decision|0
851016|NCT01626118|2801817|P3|Overall Study|Investigator Decision|0
851017|NCT01626118|2801818|P2|Overall Study|Investigator Decision|1
851018|NCT01626118|2801819|P1|Overall Study|Investigator Decision|0
851019|NCT01626118|2801816|P4|Overall Study|Adverse Event|0
851020|NCT01626118|2801817|P3|Overall Study|Adverse Event|1
851021|NCT01626118|2801818|P2|Overall Study|Adverse Event|1
851022|NCT01626118|2801819|P1|Overall Study|Adverse Event|0
851023|NCT01626118|2801816|P4|Overall Study|Lost to Follow-up|0
851024|NCT01626118|2801817|P3|Overall Study|Lost to Follow-up|0
851025|NCT01626118|2801818|P2|Overall Study|Lost to Follow-up|0
851026|NCT01626118|2801819|P1|Overall Study|Lost to Follow-up|1
851027|NCT01626118|2801816|P4|Overall Study|Lack of Efficacy|3
851028|NCT01626118|2801817|P3|Overall Study|Lack of Efficacy|1
851029|NCT01626118|2801818|P2|Overall Study|Lack of Efficacy|0
851030|NCT01626118|2801819|P1|Overall Study|Lack of Efficacy|1
851031|NCT01625910|2801865|P2|Overall Study|Lost to Follow-up|4
851032|NCT01625910|2801866|P1|Overall Study|Lost to Follow-up|3
851033|NCT01625845|2801876|P2|Overall Study|Withdrawal by Subject|0
851034|NCT01625845|2801877|P1|Overall Study|Withdrawal by Subject|2
851035|NCT01625845|2801876|P2|Overall Study|Lost to Follow-up|1
851036|NCT01625845|2801877|P1|Overall Study|Lost to Follow-up|2
851037|NCT01625845|2801876|P2|Overall Study|Adverse Event|2
851038|NCT01625845|2801877|P1|Overall Study|Adverse Event|1
851039|NCT01625689|2801897|P2|Overall Study|Migration|1
851040|NCT01625689|2801898|P1|Overall Study|Migration|2
851041|NCT01625377|2801953|P2|Overall Study|Abnormal laboratory values|0
851042|NCT01625377|2801954|P1|Overall Study|Abnormal laboratory values|1
851043|NCT01625377|2801953|P2|Overall Study|Unsatisfactory therapeutic effect|1
851044|NCT01625377|2801954|P1|Overall Study|Unsatisfactory therapeutic effect|0
851045|NCT01625377|2801953|P2|Overall Study|Graft loss|0
851046|NCT01625377|2801954|P1|Overall Study|Graft loss|1
851047|NCT01625377|2801953|P2|Overall Study|Adverse Event|16
851048|NCT01625377|2801954|P1|Overall Study|Adverse Event|3
851049|NCT01625377|2801953|P2|Overall Study|Protocol Violation|3
851050|NCT01625377|2801954|P1|Overall Study|Protocol Violation|0
851051|NCT01625377|2801953|P2|Overall Study|Administrative Problem|1
851052|NCT01625377|2801954|P1|Overall Study|Administrative Problem|1
851053|NCT01625377|2801953|P2|Overall Study|Death|1
851054|NCT01625377|2801954|P1|Overall Study|Death|1
851055|NCT01625338|2801987|P3|Overall Study|Study Discontinued by Sponsor|1
851056|NCT01625338|2801988|P2|Overall Study|Study Discontinued by Sponsor|0
851057|NCT01625338|2801989|P1|Overall Study|Study Discontinued by Sponsor|0
851058|NCT01625338|2801987|P3|Overall Study|Adverse Event|1
851059|NCT01625338|2801988|P2|Overall Study|Adverse Event|0
851060|NCT01625338|2801989|P1|Overall Study|Adverse Event|1
851061|NCT01625338|2801987|P3|Overall Study|Subject Withdrew Consent|2
851062|NCT01625338|2801988|P2|Overall Study|Subject Withdrew Consent|0
851063|NCT01625338|2801989|P1|Overall Study|Subject Withdrew Consent|1
851064|NCT01625338|2801987|P3|Overall Study|Investigator Decision|1
851065|NCT01625338|2801988|P2|Overall Study|Investigator Decision|2
851066|NCT01625338|2801989|P1|Overall Study|Investigator Decision|0
851067|NCT01625338|2801987|P3|Overall Study|Lost to Follow-up|2
851068|NCT01625338|2801988|P2|Overall Study|Lost to Follow-up|3
851069|NCT01625338|2801989|P1|Overall Study|Lost to Follow-up|3
851070|NCT01625338|2801987|P3|Overall Study|Efficacy Failure|31
851071|NCT01625338|2801988|P2|Overall Study|Efficacy Failure|39
851072|NCT01625338|2801989|P1|Overall Study|Efficacy Failure|27
851073|NCT01625338|2801987|P3|Overall Study|Enrolled but not Treated|1
851074|NCT01625338|2801988|P2|Overall Study|Enrolled but not Treated|0
851075|NCT01625338|2801989|P1|Overall Study|Enrolled but not Treated|0
851076|NCT01625182|2802016|P2|Overall Study|Lack of Efficacy|8
851077|NCT01625182|2802017|P1|Overall Study|Lack of Efficacy|12
851078|NCT01625182|2802016|P2|Overall Study|Withdrawal by Subject|1
851079|NCT01625182|2802017|P1|Overall Study|Withdrawal by Subject|5
851080|NCT01625182|2802016|P2|Overall Study|Adverse Event|0
851081|NCT01625182|2802017|P1|Overall Study|Adverse Event|2
851082|NCT01625182|2802016|P2|Overall Study|Protocol deviation|2
851083|NCT01625182|2802017|P1|Overall Study|Protocol deviation|0
851084|NCT01625182|2802016|P2|Overall Study|Administrative problems|0
851085|NCT01625182|2802017|P1|Overall Study|Administrative problems|1
851086|NCT01625091|2802054|P2|Post-intervention|Study termination|1
851087|NCT01625091|2802055|P1|Post-intervention|Study termination|2
851088|NCT01625091|2802054|P2|Post-intervention|Lost to Follow-up|0
851089|NCT01625091|2802055|P1|Post-intervention|Lost to Follow-up|2
851090|NCT01625091|2802054|P2|Post-intervention|Death|1
851091|NCT01625091|2802055|P1|Post-intervention|Death|0
851092|NCT01625091|2802054|P2|Intervention|Study termination|3
851093|NCT01625091|2802055|P1|Intervention|Study termination|2
851094|NCT01625091|2802054|P2|Intervention|Lost to Follow-up|4
851095|NCT01625091|2802055|P1|Intervention|Lost to Follow-up|4
851096|NCT01625091|2802054|P2|Intervention|Adverse Event|2
851097|NCT01625091|2802055|P1|Intervention|Adverse Event|0
851098|NCT01625091|2802054|P2|Intervention|Withdrawal by Subject|1
851099|NCT01625091|2802055|P1|Intervention|Withdrawal by Subject|4
851100|NCT01625091|2802054|P2|Intervention|Death|1
851101|NCT01625091|2802055|P1|Intervention|Death|1
851102|NCT01624974|2802069|P2|Period V of Treatment (4 Weeks)|Adverse Event|0
851103|NCT01624974|2802070|P1|Period V of Treatment (4 Weeks)|Adverse Event|1
851104|NCT01624974|2802069|P2|Period V of Treatment (4 Weeks)|Physician Decision|0
851105|NCT01624974|2802070|P1|Period V of Treatment (4 Weeks)|Physician Decision|3
851106|NCT01624974|2802069|P2|Period V of Treatment (4 Weeks)|Lack of Efficacy|0
851107|NCT01624974|2802070|P1|Period V of Treatment (4 Weeks)|Lack of Efficacy|1
851108|NCT01624974|2802069|P2|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1
851109|NCT01624974|2802070|P1|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0
851110|NCT01624974|2802069|P2|Period IV Washout (4 Weeks)|Adverse Event|0
851111|NCT01624974|2802070|P1|Period IV Washout (4 Weeks)|Adverse Event|2
851112|NCT01624974|2802069|P2|Period IV Washout (4 Weeks)|Withdrawal by Subject|1
851113|NCT01624974|2802070|P1|Period IV Washout (4 Weeks)|Withdrawal by Subject|0
851114|NCT01624974|2802069|P2|Period IV Washout (4 Weeks)|Lack of Efficacy|1
851115|NCT01624974|2802070|P1|Period IV Washout (4 Weeks)|Lack of Efficacy|1
851116|NCT01624974|2802069|P2|Period III of Treatment (4 Weeks)|Adverse Event|1
851117|NCT01624974|2802070|P1|Period III of Treatment (4 Weeks)|Adverse Event|0
851118|NCT01624974|2802069|P2|Period III of Treatment (4 Weeks)|Protocol Violation|0
851119|NCT01624974|2802070|P1|Period III of Treatment (4 Weeks)|Protocol Violation|1
851120|NCT01624974|2802069|P2|Period III of Treatment (4 Weeks)|Physician Decision|3
851121|NCT01624974|2802070|P1|Period III of Treatment (4 Weeks)|Physician Decision|5
851122|NCT01624974|2802069|P2|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2
851123|NCT01624974|2802070|P1|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1
851124|NCT01624974|2802069|P2|Period III of Treatment (4 Weeks)|Lack of Efficacy|2
851125|NCT01624974|2802070|P1|Period III of Treatment (4 Weeks)|Lack of Efficacy|0
851126|NCT01624870|2802111|P1|Overall Study|Lost to follow up|1
851127|NCT01624870|2802111|P1|Overall Study|CoreValve not implanted|6
851128|NCT01624870|2802111|P1|Overall Study|Withdrawal by Subject|1
851129|NCT01624870|2802111|P1|Overall Study|Death|19
851130|NCT01624467|2802127|P1|Overall Study|Subject Withdrew from Treatment|1
851131|NCT01624467|2802127|P1|Overall Study|Per Sponsor Requirement|1
851132|NCT01624467|2802127|P1|Overall Study|Progressive Disease|19
851133|NCT01624467|2802127|P1|Overall Study|Adverse Event|7
851134|NCT01624467|2802127|P1|Overall Study|Lost to Follow-up|1
851135|NCT01624467|2802127|P1|Overall Study|Withdrawal by Subject|2
851136|NCT01624259|2802166|P2|Overall Study|Abnormal laboratory measure|0
851137|NCT01624259|2802167|P1|Overall Study|Abnormal laboratory measure|3
851138|NCT01624259|2802166|P2|Overall Study|Lost to Follow-up|3
851139|NCT01624259|2802167|P1|Overall Study|Lost to Follow-up|2
851140|NCT01624259|2802166|P2|Overall Study|Physician Decision|1
851141|NCT01624259|2802167|P1|Overall Study|Physician Decision|1
851142|NCT01624259|2802166|P2|Overall Study|Withdrawal by Subject|7
851143|NCT01624259|2802167|P1|Overall Study|Withdrawal by Subject|5
851144|NCT01624259|2802166|P2|Overall Study|Protocol Violation|2
851145|NCT01624259|2802167|P1|Overall Study|Protocol Violation|1
851146|NCT01624259|2802166|P2|Overall Study|Adverse Event|18
851147|NCT01624259|2802167|P1|Overall Study|Adverse Event|18
851148|NCT01624233|2802216|P1|Period 6: Follow-up|Withdrawal by Subject|3
851149|NCT01624233|2802216|P1|Period 6: Follow-up|Physician Decision|1
851150|NCT01624233|2802216|P1|Period 6: Follow-up|Lack of Efficacy|2
851151|NCT01624233|2802216|P1|Period 6: Follow-up|Adverse Event|3
851152|NCT01624233|2802216|P1|Period 5 - Retreatment Period|Withdrawal by Subject|3
851153|NCT01624233|2802216|P1|Period 5 - Retreatment Period|Physician Decision|1
851154|NCT01624233|2802216|P1|Period 5 - Retreatment Period|Lack of Efficacy|1
851155|NCT01624233|2802216|P1|Period 5 - Retreatment Period|Adverse Event|5
851156|NCT01624233|2802216|P1|Period 4 - Drug Free Period|Relapsed|61
851157|NCT01624233|2802216|P1|Period 3 - Maintenance|Withdrawal by Subject|2
851158|NCT01624233|2802216|P1|Period 3 - Maintenance|Physician Decision|2
851159|NCT01624233|2802216|P1|Period 3 - Maintenance|Lack of Efficacy|1
851160|NCT01624233|2802216|P1|Period 3 - Maintenance|Adverse Event|2
851161|NCT01624233|2802216|P1|Period 2 - Induction|Adverse Event|1
851162|NCT01624194|2802248|P2|Overall Study|Withdrawal by Subject|0
851163|NCT01624194|2802249|P1|Overall Study|Withdrawal by Subject|1
851164|NCT01624194|2802248|P2|Overall Study|Lost to Follow-up|0
851165|NCT01624194|2802249|P1|Overall Study|Lost to Follow-up|1
851166|NCT01623830|2802323|P2|Overall Study|Exclusion from Study|2
851167|NCT01623830|2802324|P1|Overall Study|Exclusion from Study|1
851168|NCT01623830|2802323|P2|Overall Study|Withdrawal by Subject|7
851169|NCT01623830|2802324|P1|Overall Study|Withdrawal by Subject|6
851170|NCT01623596|2802358|P2|Overall Study|Lack of Efficacy|3
851171|NCT01623596|2802359|P1|Overall Study|Lack of Efficacy|5
851172|NCT01623596|2802358|P2|Overall Study|Protocol Violation|6
851173|NCT01623596|2802359|P1|Overall Study|Protocol Violation|0
851174|NCT01623596|2802358|P2|Overall Study|Patient no longer requires study drug|0
851175|NCT01623596|2802359|P1|Overall Study|Patient no longer requires study drug|1
851176|NCT01623596|2802358|P2|Overall Study|Withdrawal by Subject|31
851177|NCT01623596|2802359|P1|Overall Study|Withdrawal by Subject|13
851178|NCT01623596|2802358|P2|Overall Study|Lost to Follow-up|16
851179|NCT01623596|2802359|P1|Overall Study|Lost to Follow-up|12
851180|NCT01623596|2802358|P2|Overall Study|Death|2
851181|NCT01623596|2802359|P1|Overall Study|Death|0
851182|NCT01623596|2802358|P2|Overall Study|Adverse Event|29
851183|NCT01623596|2802359|P1|Overall Study|Adverse Event|20
851184|NCT01623596|2802358|P2|Overall Study|Administrative problems|13
851185|NCT01623596|2802359|P1|Overall Study|Administrative problems|9
851186|NCT01623596|2802358|P2|Overall Study|Abnormal laboratory values|0
851187|NCT01623596|2802359|P1|Overall Study|Abnormal laboratory values|2
851188|NCT01623310|2802402|P1|Overall Study|Investigators Discretion-Noncompliant|1
851189|NCT01623310|2802402|P1|Overall Study|Diagnoses of bilateral cateracts|1
851190|NCT01623310|2802402|P1|Overall Study|Became potentially child-bearing|1
851191|NCT01623310|2802402|P1|Overall Study|Withdrawal by Subject|25
851192|NCT01623310|2802402|P1|Overall Study|Protocol Violation|6
851193|NCT01623310|2802402|P1|Overall Study|Lack of Efficacy|6
851194|NCT01623310|2802402|P1|Overall Study|Lost to Follow-up|18
851195|NCT01623310|2802402|P1|Overall Study|Adverse Event|21
851196|NCT01623271|2802411|P1|Overall Study|Withdrawal by Subject|2
851197|NCT01623154|2802415|P1|Overall Study|Did not drink Pranactin Citric|4
851198|NCT01623115|2802423|P2|Overall Study|Other than specified above|3
851199|NCT01623115|2802424|P1|Overall Study|Other than specified above|0
851200|NCT01623115|2802423|P2|Overall Study|Death|4
851201|NCT01623115|2802424|P1|Overall Study|Death|0
851202|NCT01623115|2802423|P2|Overall Study|Site closure|7
851203|NCT01623115|2802424|P1|Overall Study|Site closure|1
851204|NCT01623115|2802423|P2|Overall Study|Last visit outside protocol visit window|26
851205|NCT01623115|2802424|P1|Overall Study|Last visit outside protocol visit window|14
851206|NCT01623115|2802423|P2|Overall Study|Related to study drug administration|2
851207|NCT01623115|2802424|P1|Overall Study|Related to study drug administration|0
851208|NCT01623115|2802423|P2|Overall Study|Consent withdrawn by participant|6
851209|NCT01623115|2802424|P1|Overall Study|Consent withdrawn by participant|2
851210|NCT01623115|2802423|P2|Overall Study|Poor compliance to protocol|10
851211|NCT01623115|2802424|P1|Overall Study|Poor compliance to protocol|4
851212|NCT01623115|2802423|P2|Overall Study|Adverse Event|13
851213|NCT01623115|2802424|P1|Overall Study|Adverse Event|10
851214|NCT01623115|2802423|P2|Overall Study|Participants moved|5
851215|NCT01623115|2802424|P1|Overall Study|Participants moved|1
851216|NCT01623115|2802423|P2|Overall Study|Physician Decision|0
851217|NCT01623115|2802424|P1|Overall Study|Physician Decision|1
851218|NCT01623115|2802423|P2|Overall Study|Randomized but not treated|1
851219|NCT01623115|2802424|P1|Overall Study|Randomized but not treated|0
851220|NCT01623050|2802484|P1|Overall Study|Lost to Follow-up|9
851221|NCT01622673|2802498|P6|Treatment Period 3|Protocol Violation|0
851222|NCT01622673|2802499|P5|Treatment Period 3|Protocol Violation|0
851223|NCT01622673|2802500|P4|Treatment Period 3|Protocol Violation|0
851224|NCT01622673|2802501|P3|Treatment Period 3|Protocol Violation|0
851225|NCT01622673|2802502|P2|Treatment Period 3|Protocol Violation|1
851226|NCT01622673|2802503|P1|Treatment Period 3|Protocol Violation|0
851227|NCT01622673|2802498|P6|Treatment Period 2|Withdrawal by Subject|0
851228|NCT01622673|2802499|P5|Treatment Period 2|Withdrawal by Subject|0
851229|NCT01622673|2802500|P4|Treatment Period 2|Withdrawal by Subject|1
851230|NCT01622673|2802501|P3|Treatment Period 2|Withdrawal by Subject|0
851231|NCT01622673|2802502|P2|Treatment Period 2|Withdrawal by Subject|0
851232|NCT01622673|2802503|P1|Treatment Period 2|Withdrawal by Subject|0
851233|NCT01622673|2802498|P6|Treatment Period 1|Protocol Violation|0
851234|NCT01622673|2802499|P5|Treatment Period 1|Protocol Violation|0
851235|NCT01622673|2802500|P4|Treatment Period 1|Protocol Violation|0
851236|NCT01622673|2802501|P3|Treatment Period 1|Protocol Violation|0
851237|NCT01622673|2802502|P2|Treatment Period 1|Protocol Violation|1
851238|NCT01622673|2802503|P1|Treatment Period 1|Protocol Violation|0
851239|NCT01622673|2802498|P6|Treatment Period 1|Withdrawal by Subject|0
851240|NCT01622673|2802499|P5|Treatment Period 1|Withdrawal by Subject|0
851241|NCT01622673|2802500|P4|Treatment Period 1|Withdrawal by Subject|1
851242|NCT01622673|2802501|P3|Treatment Period 1|Withdrawal by Subject|0
851243|NCT01622673|2802502|P2|Treatment Period 1|Withdrawal by Subject|0
851244|NCT01622673|2802503|P1|Treatment Period 1|Withdrawal by Subject|0
851245|NCT01622660|2802538|P1|Overall Study|Adverse Event|1
851246|NCT01622348|2802545|P3|Overall Study|Withdrawal by Subject|1
851247|NCT01622348|2802546|P2|Overall Study|Withdrawal by Subject|0
851248|NCT01622348|2802547|P1|Overall Study|Withdrawal by Subject|1
851249|NCT01622231|2802586|P1|Overall Study|Withdrawal by Subject|1
851250|NCT01622231|2802586|P1|Overall Study|Physician Decision|1
851251|NCT01621880|2802616|P2|Overall Study|Withdrawal by Subject|4
851252|NCT01621880|2802617|P1|Overall Study|Withdrawal by Subject|5
851253|NCT01621880|2802616|P2|Overall Study|Adverse Event|1
851254|NCT01621880|2802617|P1|Overall Study|Adverse Event|5
851255|NCT01621802|2802631|P6|Overall Study|Lost to Follow-up|11
851256|NCT01621802|2802632|P5|Overall Study|Lost to Follow-up|31
851257|NCT01621802|2802633|P4|Overall Study|Lost to Follow-up|7
851258|NCT01621802|2802634|P3|Overall Study|Lost to Follow-up|24
851259|NCT01621802|2802635|P2|Overall Study|Lost to Follow-up|16
851260|NCT01621802|2802636|P1|Overall Study|Lost to Follow-up|36
851261|NCT01621802|2802631|P6|Overall Study|Others|0
851262|NCT01621802|2802632|P5|Overall Study|Others|1
851263|NCT01621802|2802633|P4|Overall Study|Others|2
851264|NCT01621802|2802634|P3|Overall Study|Others|3
851265|NCT01621802|2802635|P2|Overall Study|Others|3
851266|NCT01621802|2802636|P1|Overall Study|Others|3
851267|NCT01621802|2802631|P6|Overall Study|Migrated/moved from study area|0
851268|NCT01621802|2802632|P5|Overall Study|Migrated/moved from study area|1
851269|NCT01621802|2802633|P4|Overall Study|Migrated/moved from study area|0
851270|NCT01621802|2802634|P3|Overall Study|Migrated/moved from study area|2
851271|NCT01621802|2802635|P2|Overall Study|Migrated/moved from study area|0
851272|NCT01621802|2802636|P1|Overall Study|Migrated/moved from study area|0
851273|NCT01621802|2802631|P6|Overall Study|Withdrawal by Subject|0
851274|NCT01621802|2802632|P5|Overall Study|Withdrawal by Subject|2
851275|NCT01621802|2802633|P4|Overall Study|Withdrawal by Subject|2
851276|NCT01621802|2802634|P3|Overall Study|Withdrawal by Subject|4
851277|NCT01621802|2802635|P2|Overall Study|Withdrawal by Subject|4
851278|NCT01621802|2802636|P1|Overall Study|Withdrawal by Subject|8
851279|NCT01621802|2802631|P6|Overall Study|Protocol Violation|1
851280|NCT01621802|2802632|P5|Overall Study|Protocol Violation|0
851281|NCT01621802|2802633|P4|Overall Study|Protocol Violation|0
851282|NCT01621802|2802634|P3|Overall Study|Protocol Violation|0
851283|NCT01621802|2802635|P2|Overall Study|Protocol Violation|0
851284|NCT01621802|2802636|P1|Overall Study|Protocol Violation|0
851285|NCT01621191|2802807|P1|Overall Study|Site Removed From Study|1
851286|NCT01621191|2802807|P1|Overall Study|Lost to Follow-up|1
851287|NCT01621191|2802807|P1|Overall Study|Lack of Efficacy|6
851288|NCT01621191|2802807|P1|Overall Study|Withdrawal by Subject|8
851289|NCT01621191|2802807|P1|Overall Study|Adverse Event|9
851290|NCT01621178|2802821|P3|Overall Study|Physician Decision|7
851291|NCT01621178|2802822|P2|Overall Study|Physician Decision|2
851292|NCT01621178|2802823|P1|Overall Study|Physician Decision|5
851293|NCT01621178|2802821|P3|Overall Study|Withdrawal by Subject|18
851294|NCT01621178|2802822|P2|Overall Study|Withdrawal by Subject|17
851295|NCT01621178|2802823|P1|Overall Study|Withdrawal by Subject|14
851296|NCT01621178|2802821|P3|Overall Study|Lost to Follow-up|1
851297|NCT01621178|2802822|P2|Overall Study|Lost to Follow-up|2
851298|NCT01621178|2802823|P1|Overall Study|Lost to Follow-up|1
851299|NCT01621178|2802821|P3|Overall Study|Death|2
851300|NCT01621178|2802822|P2|Overall Study|Death|7
851301|NCT01621178|2802823|P1|Overall Study|Death|6
851302|NCT01621178|2802821|P3|Overall Study|Adverse Event|8
851303|NCT01621178|2802822|P2|Overall Study|Adverse Event|2
851304|NCT01621178|2802823|P1|Overall Study|Adverse Event|5
851305|NCT01621126|2802915|P1|Overall Study|Physician Decision|6
851306|NCT01620983|2802937|P3|Overall Study|Physician Decision|5
851307|NCT01620983|2802938|P2|Overall Study|Physician Decision|10
851308|NCT01620983|2802939|P1|Overall Study|Physician Decision|3
851309|NCT01620983|2802937|P3|Overall Study|Death|0
851310|NCT01620983|2802938|P2|Overall Study|Death|0
851311|NCT01620983|2802939|P1|Overall Study|Death|2
851312|NCT01620983|2802937|P3|Overall Study|Withdrawal by Subject|1
851313|NCT01620983|2802938|P2|Overall Study|Withdrawal by Subject|8
851314|NCT01620983|2802939|P1|Overall Study|Withdrawal by Subject|6
851315|NCT01620983|2802937|P3|Overall Study|Lost to Follow-up|9
851316|NCT01620983|2802938|P2|Overall Study|Lost to Follow-up|4
851317|NCT01620983|2802939|P1|Overall Study|Lost to Follow-up|8
851318|NCT01620762|2802968|P3|Overall Study|Use of prohibted therapies|1
851319|NCT01620762|2802969|P2|Overall Study|Use of prohibted therapies|1
851320|NCT01620762|2802970|P1|Overall Study|Use of prohibted therapies|0
851321|NCT01620762|2802968|P3|Overall Study|Non-specified|5
851322|NCT01620762|2802969|P2|Overall Study|Non-specified|6
851323|NCT01620762|2802970|P1|Overall Study|Non-specified|3
851324|NCT01620762|2802968|P3|Overall Study|Subject deterioration|1
851325|NCT01620762|2802969|P2|Overall Study|Subject deterioration|1
851326|NCT01620762|2802970|P1|Overall Study|Subject deterioration|0
851327|NCT01620762|2802968|P3|Overall Study|Protocol deviation|6
851328|NCT01620762|2802969|P2|Overall Study|Protocol deviation|1
851329|NCT01620762|2802970|P1|Overall Study|Protocol deviation|1
851330|NCT01620762|2802968|P3|Overall Study|Lost to Follow-up|10
851331|NCT01620762|2802969|P2|Overall Study|Lost to Follow-up|17
851332|NCT01620762|2802970|P1|Overall Study|Lost to Follow-up|11
851333|NCT01620762|2802968|P3|Overall Study|Withdrawal by Subject|27
851334|NCT01620762|2802969|P2|Overall Study|Withdrawal by Subject|26
851335|NCT01620762|2802970|P1|Overall Study|Withdrawal by Subject|23
851336|NCT01620762|2802968|P3|Overall Study|Adverse Event|2
851337|NCT01620762|2802969|P2|Overall Study|Adverse Event|5
851338|NCT01620762|2802970|P1|Overall Study|Adverse Event|9
851339|NCT01620762|2802968|P3|Overall Study|Protocol Violation|1
851340|NCT01620762|2802969|P2|Overall Study|Protocol Violation|1
851341|NCT01620762|2802970|P1|Overall Study|Protocol Violation|1
851342|NCT01620528|2803016|P3|Post-Treatment Follow-Up Period|Not Specified|2
851343|NCT01620528|2803017|P2|Post-Treatment Follow-Up Period|Not Specified|4
851344|NCT01620528|2803018|P1|Post-Treatment Follow-Up Period|Not Specified|6
851345|NCT01620528|2803016|P3|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4
851346|NCT01620528|2803017|P2|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3
851347|NCT01620528|2803018|P1|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8
851348|NCT01620528|2803016|P3|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
851349|NCT01620528|2803017|P2|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
851350|NCT01620528|2803018|P1|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0
851351|NCT01620528|2803016|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|4
851352|NCT01620528|2803017|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|2
851353|NCT01620528|2803018|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|3
851354|NCT01620528|2803016|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
851355|NCT01620528|2803017|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|7
851356|NCT01620528|2803018|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
851357|NCT01620528|2803016|P3|Treatment Period|Exclusionary Medication Received|0
851358|NCT01620528|2803017|P2|Treatment Period|Exclusionary Medication Received|1
851359|NCT01620528|2803018|P1|Treatment Period|Exclusionary Medication Received|0
851360|NCT01620528|2803016|P3|Treatment Period|Surgery/Invasive Intervention|3
851361|NCT01620528|2803017|P2|Treatment Period|Surgery/Invasive Intervention|1
851362|NCT01620528|2803018|P1|Treatment Period|Surgery/Invasive Intervention|5
851363|NCT01620528|2803016|P3|Treatment Period|Pregnancy|2
851364|NCT01620528|2803017|P2|Treatment Period|Pregnancy|2
851365|NCT01620528|2803018|P1|Treatment Period|Pregnancy|7
851366|NCT01620528|2803016|P3|Treatment Period|Subject Noncompliant|2
851367|NCT01620528|2803017|P2|Treatment Period|Subject Noncompliant|2
851368|NCT01620528|2803018|P1|Treatment Period|Subject Noncompliant|11
851369|NCT01620528|2803016|P3|Treatment Period|Not Specified|7
851370|NCT01620528|2803017|P2|Treatment Period|Not Specified|5
851371|NCT01620528|2803018|P1|Treatment Period|Not Specified|9
851372|NCT01620528|2803016|P3|Treatment Period|Lost to Follow-up|14
851373|NCT01620528|2803017|P2|Treatment Period|Lost to Follow-up|8
851374|NCT01620528|2803018|P1|Treatment Period|Lost to Follow-up|16
851375|NCT01620528|2803016|P3|Treatment Period|Adverse Event|21
851376|NCT01620528|2803017|P2|Treatment Period|Adverse Event|13
851377|NCT01620528|2803018|P1|Treatment Period|Adverse Event|17
851378|NCT01620528|2803016|P3|Treatment Period|Withdrawal by Subject|16
851379|NCT01620528|2803017|P2|Treatment Period|Withdrawal by Subject|21
851380|NCT01620528|2803018|P1|Treatment Period|Withdrawal by Subject|35
851381|NCT01620528|2803016|P3|Treatment Period|Did Not Receive Study Drug|1
851382|NCT01620528|2803017|P2|Treatment Period|Did Not Receive Study Drug|0
851383|NCT01620528|2803018|P1|Treatment Period|Did Not Receive Study Drug|0
851384|NCT01620489|2803358|P2|Overall Study|Unclassified|2
851385|NCT01620489|2803359|P1|Overall Study|Unclassified|1
851386|NCT01620489|2803358|P2|Overall Study|Withdrawal Criteria|25
851387|NCT01620489|2803359|P1|Overall Study|Withdrawal Criteria|17
851388|NCT01620489|2803358|P2|Overall Study|Protocol Violation|3
851389|NCT01620489|2803359|P1|Overall Study|Protocol Violation|0
851390|NCT01620489|2803358|P2|Overall Study|Adverse Event|4
851391|NCT01620489|2803359|P1|Overall Study|Adverse Event|17
851392|NCT01620255|2803380|P5|Overall Study|Withdrawn at discretion of investigator|1
851393|NCT01620255|2803381|P4|Overall Study|Withdrawn at discretion of investigator|0
851394|NCT01620255|2803382|P3|Overall Study|Withdrawn at discretion of investigator|0
851395|NCT01620255|2803383|P2|Overall Study|Withdrawn at discretion of investigator|0
851396|NCT01620255|2803384|P1|Overall Study|Withdrawn at discretion of investigator|0
851397|NCT01620255|2803380|P5|Overall Study|Adverse Event|1
851398|NCT01620255|2803381|P4|Overall Study|Adverse Event|1
851399|NCT01620255|2803382|P3|Overall Study|Adverse Event|0
851400|NCT01620255|2803383|P2|Overall Study|Adverse Event|4
851401|NCT01620255|2803384|P1|Overall Study|Adverse Event|0
851402|NCT01620255|2803380|P5|Overall Study|Non-compliance|0
851403|NCT01620255|2803381|P4|Overall Study|Non-compliance|0
851404|NCT01620255|2803382|P3|Overall Study|Non-compliance|0
851405|NCT01620255|2803383|P2|Overall Study|Non-compliance|1
851406|NCT01620255|2803384|P1|Overall Study|Non-compliance|0
851407|NCT01620255|2803380|P5|Overall Study|Participant underwent fecal transplant|0
851408|NCT01620255|2803381|P4|Overall Study|Participant underwent fecal transplant|0
851409|NCT01620255|2803382|P3|Overall Study|Participant underwent fecal transplant|1
851410|NCT01620255|2803383|P2|Overall Study|Participant underwent fecal transplant|0
851411|NCT01620255|2803384|P1|Overall Study|Participant underwent fecal transplant|0
851412|NCT01620255|2803380|P5|Overall Study|Withdrawal by Subject|4
851413|NCT01620255|2803381|P4|Overall Study|Withdrawal by Subject|2
851414|NCT01620255|2803382|P3|Overall Study|Withdrawal by Subject|1
851415|NCT01620255|2803383|P2|Overall Study|Withdrawal by Subject|1
851416|NCT01620255|2803384|P1|Overall Study|Withdrawal by Subject|4
851417|NCT01620177|2803461|P1|Overall Study|Randomized, Not Active due to Scheduling|1
851418|NCT01620177|2803461|P1|Overall Study|Physician Decision|2
851419|NCT01620177|2803461|P1|Overall Study|Lost to Follow-up|7
851420|NCT01620177|2803461|P1|Overall Study|Withdrawal by Subject|26
851421|NCT01620177|2803461|P1|Overall Study|Failure at Screening Visit|43
851422|NCT01620138|2803486|P2|Overall Study|Adverse Event|0
851423|NCT01620138|2803487|P1|Overall Study|Adverse Event|2
851424|NCT01620138|2803486|P2|Overall Study|Lack of Efficacy|0
851425|NCT01620138|2803487|P1|Overall Study|Lack of Efficacy|1
851426|NCT01620138|2803486|P2|Overall Study|Withdrawal by Subject|0
851427|NCT01620138|2803487|P1|Overall Study|Withdrawal by Subject|3
851428|NCT01620086|2803495|P3|Overall Study|Physician Decision|0
851429|NCT01620086|2803496|P2|Overall Study|Physician Decision|0
851430|NCT01620086|2803497|P1|Overall Study|Physician Decision|1
851431|NCT01620086|2803495|P3|Overall Study|failed study criteria|0
851432|NCT01620086|2803496|P2|Overall Study|failed study criteria|4
851433|NCT01620086|2803497|P1|Overall Study|failed study criteria|1
851434|NCT01620086|2803495|P3|Overall Study|Withdrawal by Subject|0
851435|NCT01620086|2803496|P2|Overall Study|Withdrawal by Subject|3
851436|NCT01620086|2803497|P1|Overall Study|Withdrawal by Subject|3
851437|NCT01620060|2803516|P1|Overall Study|Per Sponsor Decision|2
851438|NCT01620060|2803516|P1|Overall Study|Family emergency|1
851439|NCT01620060|2803516|P1|Overall Study|Did not comply with Study Produre|1
851440|NCT01620060|2803516|P1|Overall Study|Withdrawal by Subject|1
851441|NCT01620060|2803516|P1|Overall Study|Protocol Violation|1
851442|NCT01620060|2803516|P1|Overall Study|Adverse Event|9
851443|NCT01619878|2803554|P1|Follow-up at 12 Months of Age|Death|2
851444|NCT01619878|2803554|P1|Follow-up at 12 Months of Age|Lost to Follow-up|1
851445|NCT01619878|2803554|P1|6 Week Follow-up Phase|Adverse Event|1
851446|NCT01619800|2803568|P2|Overall Study|study terminated|0
851447|NCT01619800|2803569|P1|Overall Study|study terminated|2
851448|NCT01619787|2803577|P1|Overall Study|Lost to Follow-up|5
851449|NCT01619579|2803594|P2|Overall Study|Withdrawal by Subject|3
851450|NCT01619579|2803595|P1|Overall Study|Withdrawal by Subject|0
851451|NCT01619423|2803609|P4|Part 1 (Dose Escalation)|High basal Mn|0
851452|NCT01619423|2803610|P3|Part 1 (Dose Escalation)|High basal Mn|0
851453|NCT01619423|2803611|P2|Part 1 (Dose Escalation)|High basal Mn|2
851454|NCT01619423|2803612|P1|Part 1 (Dose Escalation)|High basal Mn|0
851455|NCT01619085|2803623|P1|Overall Study|Ongoing on trial|27
851456|NCT01619085|2803623|P1|Overall Study|Not treated|1
851457|NCT01619085|2803623|P1|Overall Study|Other than specified|94
851458|NCT01619085|2803623|P1|Overall Study|Withdrawal by Subject|15
851459|NCT01619085|2803623|P1|Overall Study|Lost to Follow-up|10
851460|NCT01619085|2803623|P1|Overall Study|Protocol Violation|10
851461|NCT01619085|2803623|P1|Overall Study|Adverse Event|212
851462|NCT01619059|2803629|P2|Long-Term (LT) Treatment Period|Not Met Study Criteria|1
851463|NCT01619059|2803630|P1|Long-Term (LT) Treatment Period|Not Met Study Criteria|0
851464|NCT01619059|2803629|P2|Long-Term (LT) Treatment Period|Lost to Follow-up|2
851465|NCT01619059|2803630|P1|Long-Term (LT) Treatment Period|Lost to Follow-up|2
851466|NCT01619059|2803629|P2|Long-Term (LT) Treatment Period|Death|0
851467|NCT01619059|2803630|P1|Long-Term (LT) Treatment Period|Death|1
851468|NCT01619059|2803629|P2|Long-Term (LT) Treatment Period|Withdrawal by Subject|2
851469|NCT01619059|2803630|P1|Long-Term (LT) Treatment Period|Withdrawal by Subject|3
851470|NCT01619059|2803629|P2|Long-Term (LT) Treatment Period|Adverse Event|3
851471|NCT01619059|2803630|P1|Long-Term (LT) Treatment Period|Adverse Event|2
851472|NCT01619059|2803629|P2|Long-Term (LT) Treatment Period|Lack of Efficacy|1
851473|NCT01619059|2803630|P1|Long-Term (LT) Treatment Period|Lack of Efficacy|0
851474|NCT01619059|2803629|P2|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2
851475|NCT01619059|2803630|P1|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1
851476|NCT01619059|2803629|P2|Short-Term (ST) Treatment Period|Lost to Follow-up|4
851477|NCT01619059|2803630|P1|Short-Term (ST) Treatment Period|Lost to Follow-up|2
851478|NCT01619059|2803629|P2|Short-Term (ST) Treatment Period|Withdrawal by Subject|5
851479|NCT01619059|2803630|P1|Short-Term (ST) Treatment Period|Withdrawal by Subject|2
851480|NCT01619059|2803629|P2|Short-Term (ST) Treatment Period|Adverse Event|0
851481|NCT01619059|2803630|P1|Short-Term (ST) Treatment Period|Adverse Event|1
851482|NCT01618968|2803646|P4|Overall Study|Death|1
851483|NCT01618968|2803647|P3|Overall Study|Death|0
851484|NCT01618968|2803648|P2|Overall Study|Death|0
851485|NCT01618968|2803649|P1|Overall Study|Death|0
851486|NCT01618968|2803646|P4|Overall Study|Adverse Event|0
851487|NCT01618968|2803647|P3|Overall Study|Adverse Event|0
851488|NCT01618968|2803648|P2|Overall Study|Adverse Event|0
851489|NCT01618968|2803649|P1|Overall Study|Adverse Event|1
851490|NCT01618864|2803716|P1|Overall Study|Lost to Follow-up|2
851491|NCT01618864|2803716|P1|Overall Study|Withdrawal by Subject|2
851492|NCT01618838|2803725|P1|Overall Study|slow accrual, trial closed prematurely.|4
851493|NCT01618708|2803733|P2|Overall Study|Randomized but not treated|2
851494|NCT01618708|2803734|P1|Overall Study|Randomized but not treated|3
851495|NCT01618708|2803733|P2|Overall Study|Other than specified above|1
851496|NCT01618708|2803734|P1|Overall Study|Other than specified above|1
851497|NCT01618708|2803733|P2|Overall Study|Technical problems|0
851498|NCT01618708|2803734|P1|Overall Study|Technical problems|2
851499|NCT01618708|2803733|P2|Overall Study|Lack of Efficacy|8
851500|NCT01618708|2803734|P1|Overall Study|Lack of Efficacy|8
851501|NCT01618708|2803733|P2|Overall Study|Withdrawal by Subject|22
851502|NCT01618708|2803734|P1|Overall Study|Withdrawal by Subject|17
851503|NCT01618708|2803733|P2|Overall Study|Lost to Follow-up|3
851504|NCT01618708|2803734|P1|Overall Study|Lost to Follow-up|3
851505|NCT01618708|2803733|P2|Overall Study|Adverse Event|10
851506|NCT01618708|2803734|P1|Overall Study|Adverse Event|10
851507|NCT01618669|2803748|P2|Overall Study|Miscellaneous Reason|1
851508|NCT01618669|2803749|P1|Overall Study|Miscellaneous Reason|0
851509|NCT01618669|2803748|P2|Overall Study|Withdrawal by Subject|9
851510|NCT01618669|2803749|P1|Overall Study|Withdrawal by Subject|9
851511|NCT01618669|2803748|P2|Overall Study|Protocol Violation|3
851512|NCT01618669|2803749|P1|Overall Study|Protocol Violation|5
851513|NCT01618669|2803748|P2|Overall Study|Adverse Event|7
851514|NCT01618669|2803749|P1|Overall Study|Adverse Event|16
851515|NCT01618669|2803748|P2|Overall Study|Randomized but Never Received Study Drug|2
851516|NCT01618669|2803749|P1|Overall Study|Randomized but Never Received Study Drug|3
851517|NCT01618669|2803748|P2|Overall Study|Lost to Follow-up|1
851518|NCT01618669|2803749|P1|Overall Study|Lost to Follow-up|1
851519|NCT01618266|2803806|P1|Overall Study|Protocol Violation|43
851520|NCT01618266|2803806|P1|Overall Study|Lack of Efficacy|23
851521|NCT01618266|2803806|P1|Overall Study|Other reasons|11
851522|NCT01618266|2803806|P1|Overall Study|Treatment satisfaction|10
851523|NCT01618266|2803806|P1|Overall Study|Lost to Follow-up|9
851524|NCT01618214|2803843|P2|Overall Study|Unclassified|5
851525|NCT01618214|2803844|P1|Overall Study|Unclassified|4
851526|NCT01618214|2803843|P2|Overall Study|Withdrawal Criteria|2
851527|NCT01618214|2803844|P1|Overall Study|Withdrawal Criteria|1
851528|NCT01618214|2803843|P2|Overall Study|Protocol Violation|4
851529|NCT01618214|2803844|P1|Overall Study|Protocol Violation|1
851530|NCT01618214|2803843|P2|Overall Study|Lack of Efficacy|1
851531|NCT01618214|2803844|P1|Overall Study|Lack of Efficacy|1
851532|NCT01618214|2803843|P2|Overall Study|Adverse Event|1
851533|NCT01618214|2803844|P1|Overall Study|Adverse Event|3
851534|NCT01618162|2803860|P2|Overall Study|Unclassified|13
851535|NCT01618162|2803861|P1|Overall Study|Unclassified|14
851536|NCT01618162|2803860|P2|Overall Study|Withdrawal Criteria|10
851537|NCT01618162|2803861|P1|Overall Study|Withdrawal Criteria|2
851538|NCT01618162|2803860|P2|Overall Study|Adverse Event|2
851539|NCT01618162|2803861|P1|Overall Study|Adverse Event|9
851540|NCT01618162|2803860|P2|Overall Study|Protocol Violation|10
851541|NCT01618162|2803861|P1|Overall Study|Protocol Violation|13
851542|NCT01618019|2803881|P2|Overall Study|Withdrawal by Subject|14
851543|NCT01618019|2803882|P1|Overall Study|Withdrawal by Subject|14
851544|NCT01617967|2803908|P6|Overall Study|Dosing Suspended by Sponsor|0
851545|NCT01617967|2803909|P5|Overall Study|Dosing Suspended by Sponsor|0
851546|NCT01617967|2803910|P4|Overall Study|Dosing Suspended by Sponsor|0
851547|NCT01617967|2803911|P3|Overall Study|Dosing Suspended by Sponsor|0
851548|NCT01617967|2803912|P2|Overall Study|Dosing Suspended by Sponsor|0
851549|NCT01617967|2803913|P1|Overall Study|Dosing Suspended by Sponsor|1
851550|NCT01617967|2803908|P6|Overall Study|Withdrawal by Subject|1
851551|NCT01617967|2803909|P5|Overall Study|Withdrawal by Subject|0
851552|NCT01617967|2803910|P4|Overall Study|Withdrawal by Subject|0
851553|NCT01617967|2803911|P3|Overall Study|Withdrawal by Subject|0
851554|NCT01617967|2803912|P2|Overall Study|Withdrawal by Subject|0
851555|NCT01617967|2803913|P1|Overall Study|Withdrawal by Subject|0
851556|NCT01617967|2803908|P6|Overall Study|Protocol Violation|0
851557|NCT01617967|2803909|P5|Overall Study|Protocol Violation|0
851558|NCT01617967|2803910|P4|Overall Study|Protocol Violation|1
851559|NCT01617967|2803911|P3|Overall Study|Protocol Violation|0
851560|NCT01617967|2803912|P2|Overall Study|Protocol Violation|0
851561|NCT01617967|2803913|P1|Overall Study|Protocol Violation|0
851562|NCT01617681|2803967|P5|Period 2 Open Label|Withdrawal by Subject|3
851563|NCT01617681|2803968|P4|Period 2 Open Label|Withdrawal by Subject|0
851564|NCT01617681|2803969|P3|Period 2 Open Label|Withdrawal by Subject|0
851565|NCT01617681|2803970|P2|Period 2 Open Label|Withdrawal by Subject|0
851566|NCT01617681|2803971|P1|Period 2 Open Label|Withdrawal by Subject|0
851567|NCT01617681|2803967|P5|Period 2 Open Label|Adverse Event|3
851568|NCT01617681|2803968|P4|Period 2 Open Label|Adverse Event|0
851569|NCT01617681|2803969|P3|Period 2 Open Label|Adverse Event|0
851570|NCT01617681|2803970|P2|Period 2 Open Label|Adverse Event|0
851571|NCT01617681|2803971|P1|Period 2 Open Label|Adverse Event|0
851572|NCT01617681|2803967|P5|Period 1 Double Blind|Withdrawal by Subject|0
851573|NCT01617681|2803968|P4|Period 1 Double Blind|Withdrawal by Subject|0
851574|NCT01617681|2803969|P3|Period 1 Double Blind|Withdrawal by Subject|1
851575|NCT01617681|2803970|P2|Period 1 Double Blind|Withdrawal by Subject|1
851576|NCT01617681|2803971|P1|Period 1 Double Blind|Withdrawal by Subject|1
851577|NCT01617681|2803967|P5|Period 1 Double Blind|Adverse Event|0
851578|NCT01617681|2803968|P4|Period 1 Double Blind|Adverse Event|2
851579|NCT01617681|2803969|P3|Period 1 Double Blind|Adverse Event|0
851580|NCT01617681|2803970|P2|Period 1 Double Blind|Adverse Event|0
851581|NCT01617681|2803971|P1|Period 1 Double Blind|Adverse Event|2
851582|NCT01617668|2803992|P4|Overall Study|Subject/guardian decision|1
851583|NCT01617668|2803993|P3|Overall Study|Subject/guardian decision|2
851584|NCT01617668|2803994|P2|Overall Study|Subject/guardian decision|3
851585|NCT01617668|2803995|P1|Overall Study|Subject/guardian decision|1
851586|NCT01617668|2803992|P4|Overall Study|Progressive Disease|9
851587|NCT01617668|2803993|P3|Overall Study|Progressive Disease|6
851588|NCT01617668|2803994|P2|Overall Study|Progressive Disease|4
851589|NCT01617668|2803995|P1|Overall Study|Progressive Disease|4
851590|NCT01617668|2803992|P4|Overall Study|Physician Decision|0
851591|NCT01617668|2803993|P3|Overall Study|Physician Decision|3
851592|NCT01617668|2803994|P2|Overall Study|Physician Decision|2
851593|NCT01617668|2803995|P1|Overall Study|Physician Decision|1
851594|NCT01617668|2803992|P4|Overall Study|Adverse Event|5
851595|NCT01617668|2803993|P3|Overall Study|Adverse Event|12
851596|NCT01617668|2803994|P2|Overall Study|Adverse Event|0
851597|NCT01617668|2803995|P1|Overall Study|Adverse Event|7
851598|NCT01617655|2804036|P2|Overall Study|Other than specified above|2
851599|NCT01617655|2804037|P1|Overall Study|Other than specified above|1
851600|NCT01617655|2804036|P2|Overall Study|Site closure|5
851601|NCT01617655|2804037|P1|Overall Study|Site closure|3
851602|NCT01617655|2804036|P2|Overall Study|Last visit outside protocol visit window|10
851603|NCT01617655|2804037|P1|Overall Study|Last visit outside protocol visit window|1
851604|NCT01617655|2804036|P2|Overall Study|Consent withdrawn by participant|1
851605|NCT01617655|2804037|P1|Overall Study|Consent withdrawn by participant|1
851606|NCT01617655|2804036|P2|Overall Study|Participants moved|4
851607|NCT01617655|2804037|P1|Overall Study|Participants moved|0
851608|NCT01617655|2804036|P2|Overall Study|Poor compliance to protocol|4
851609|NCT01617655|2804037|P1|Overall Study|Poor compliance to protocol|1
851610|NCT01617655|2804036|P2|Overall Study|Adverse Event|3
851611|NCT01617655|2804037|P1|Overall Study|Adverse Event|2
851612|NCT01617629|2804097|P1|Overall Study|Participant Withdrew Consent|2
851613|NCT01617629|2804097|P1|Overall Study|Reason Not Specified|1
851614|NCT01617629|2804097|P1|Overall Study|Investigator's Clinical Judgement|1
851615|NCT01617629|2804097|P1|Overall Study|Death|2
851616|NCT01617460|2804125|P1|Overall Study|Withdrawal by Subject|9
851617|NCT01617460|2804125|P1|Overall Study|Protocol Violation|5
851618|NCT01617460|2804125|P1|Overall Study|Physician Decision|16
851619|NCT01617460|2804125|P1|Overall Study|Adverse Event|10
851620|NCT01617447|2804131|P2|Overall Study|Physician Decision|2
851621|NCT01617447|2804132|P1|Overall Study|Physician Decision|0
851622|NCT01617447|2804131|P2|Overall Study|Adverse Event|1
851623|NCT01617447|2804132|P1|Overall Study|Adverse Event|0
851624|NCT01617434|2804140|P2|Overall Study|Unclassified|4
851625|NCT01617434|2804141|P1|Overall Study|Unclassified|3
851626|NCT01617434|2804140|P2|Overall Study|Withdrawal Criteria|37
851627|NCT01617434|2804141|P1|Overall Study|Withdrawal Criteria|12
851628|NCT01617434|2804140|P2|Overall Study|Protocol Violation|7
851629|NCT01617434|2804141|P1|Overall Study|Protocol Violation|8
851630|NCT01617434|2804140|P2|Overall Study|Adverse Event|3
851631|NCT01617434|2804141|P1|Overall Study|Adverse Event|12
851632|NCT01617187|2804173|P4|Treatment Through Study Completion|Protocol Violation|1
851633|NCT01617187|2804174|P3|Treatment Through Study Completion|Protocol Violation|0
851634|NCT01617187|2804175|P2|Treatment Through Study Completion|Protocol Violation|0
851635|NCT01617187|2804176|P1|Treatment Through Study Completion|Protocol Violation|1
851636|NCT01617187|2804173|P4|Treatment Through Study Completion|Withdrawal by Subject|6
851637|NCT01617187|2804174|P3|Treatment Through Study Completion|Withdrawal by Subject|3
851638|NCT01617187|2804175|P2|Treatment Through Study Completion|Withdrawal by Subject|8
851639|NCT01617187|2804176|P1|Treatment Through Study Completion|Withdrawal by Subject|5
851640|NCT01617187|2804173|P4|Treatment Through Study Completion|Lost to Follow-up|2
851641|NCT01617187|2804174|P3|Treatment Through Study Completion|Lost to Follow-up|2
851642|NCT01617187|2804175|P2|Treatment Through Study Completion|Lost to Follow-up|2
851643|NCT01617187|2804176|P1|Treatment Through Study Completion|Lost to Follow-up|4
851644|NCT01617187|2804173|P4|Treatment Through Study Completion|Adverse Event|1
851645|NCT01617187|2804174|P3|Treatment Through Study Completion|Adverse Event|0
851646|NCT01617187|2804175|P2|Treatment Through Study Completion|Adverse Event|1
851647|NCT01617187|2804176|P1|Treatment Through Study Completion|Adverse Event|1
851648|NCT01617187|2804173|P4|Randomization Through Start Treatment|Not Treated: Completed study in database|0
851649|NCT01617187|2804174|P3|Randomization Through Start Treatment|Not Treated: Completed study in database|0
851650|NCT01617187|2804175|P2|Randomization Through Start Treatment|Not Treated: Completed study in database|0
851651|NCT01617187|2804176|P1|Randomization Through Start Treatment|Not Treated: Completed study in database|1
851652|NCT01617187|2804173|P4|Randomization Through Start Treatment|Not Treated: Adverse Event|1
851653|NCT01617187|2804174|P3|Randomization Through Start Treatment|Not Treated: Adverse Event|0
851654|NCT01617187|2804175|P2|Randomization Through Start Treatment|Not Treated: Adverse Event|0
851655|NCT01617187|2804176|P1|Randomization Through Start Treatment|Not Treated: Adverse Event|0
851656|NCT01617187|2804173|P4|Randomization Through Start Treatment|Not Treated: Administrative Reason|1
851657|NCT01617187|2804174|P3|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
851658|NCT01617187|2804175|P2|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
851659|NCT01617187|2804176|P1|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
851660|NCT01617070|2804273|P1|BH4 and LNAA (4 Weeks)|started medication interfere with study|1
851661|NCT01617005|2804291|P1|Overall Study|Lack of motivation for treatment|1
851662|NCT01617005|2804291|P1|Overall Study|Pregnancy|1
851663|NCT01616953|2804300|P2|Overall Study|lack of bone and soft tissue|0
851664|NCT01616953|2804301|P1|Overall Study|lack of bone and soft tissue|1
851665|NCT01616953|2804300|P2|Overall Study|Lost to Follow-up|0
851666|NCT01616953|2804301|P1|Overall Study|Lost to Follow-up|1
851667|NCT01616771|2804309|P1|Smaller Sized GVL for 5 Sec|lack of GVL size|4
851668|NCT01616693|2804322|P4|Blood Analyzed for Immunogenicity|Protocol Violation|1
851669|NCT01616693|2804323|P3|Blood Analyzed for Immunogenicity|Protocol Violation|6
851670|NCT01616693|2804324|P2|Blood Analyzed for Immunogenicity|Protocol Violation|2
851671|NCT01616693|2804325|P1|Blood Analyzed for Immunogenicity|Protocol Violation|4
851672|NCT01616693|2804322|P4|Received Both Vaccines|Lost to Follow-up|4
851673|NCT01616693|2804323|P3|Received Both Vaccines|Lost to Follow-up|4
851674|NCT01616693|2804324|P2|Received Both Vaccines|Lost to Follow-up|3
851675|NCT01616693|2804325|P1|Received Both Vaccines|Lost to Follow-up|4
851676|NCT01616693|2804322|P4|Received Both Vaccines|Withdrawal by Subject|15
851677|NCT01616693|2804323|P3|Received Both Vaccines|Withdrawal by Subject|8
851678|NCT01616693|2804324|P2|Received Both Vaccines|Withdrawal by Subject|7
851679|NCT01616693|2804325|P1|Received Both Vaccines|Withdrawal by Subject|7
851680|NCT01616693|2804322|P4|Received Both Vaccines|Adverse Event|0
851681|NCT01616693|2804323|P3|Received Both Vaccines|Adverse Event|0
851682|NCT01616693|2804324|P2|Received Both Vaccines|Adverse Event|0
851683|NCT01616693|2804325|P1|Received Both Vaccines|Adverse Event|2
851684|NCT01616693|2804322|P4|Evaluated for Safety|Physician Decision|0
851685|NCT01616693|2804323|P3|Evaluated for Safety|Physician Decision|1
851686|NCT01616693|2804324|P2|Evaluated for Safety|Physician Decision|0
851687|NCT01616693|2804325|P1|Evaluated for Safety|Physician Decision|1
851688|NCT01616459|2804391|P4|Overall Study|Other reason|0
851689|NCT01616459|2804392|P3|Overall Study|Other reason|1
851690|NCT01616459|2804393|P2|Overall Study|Other reason|1
851691|NCT01616459|2804394|P1|Overall Study|Other reason|0
851692|NCT01616459|2804391|P4|Overall Study|Withdrawal by Subject|4
851693|NCT01616459|2804392|P3|Overall Study|Withdrawal by Subject|4
851694|NCT01616459|2804393|P2|Overall Study|Withdrawal by Subject|4
851695|NCT01616459|2804394|P1|Overall Study|Withdrawal by Subject|2
851696|NCT01616459|2804391|P4|Overall Study|Protocol Violation|2
851697|NCT01616459|2804392|P3|Overall Study|Protocol Violation|0
851698|NCT01616459|2804393|P2|Overall Study|Protocol Violation|0
851699|NCT01616459|2804394|P1|Overall Study|Protocol Violation|0
851700|NCT01616459|2804391|P4|Overall Study|Lost to Follow-up|2
851701|NCT01616459|2804392|P3|Overall Study|Lost to Follow-up|3
851702|NCT01616459|2804393|P2|Overall Study|Lost to Follow-up|11
851703|NCT01616459|2804394|P1|Overall Study|Lost to Follow-up|1
851704|NCT01616459|2804391|P4|Overall Study|Adverse Event|0
851705|NCT01616459|2804392|P3|Overall Study|Adverse Event|2
851706|NCT01616459|2804393|P2|Overall Study|Adverse Event|1
851707|NCT01616459|2804394|P1|Overall Study|Adverse Event|1
851708|NCT01616173|2804483|P3|Overall Study|Lost to Follow-up|0
851709|NCT01616173|2804484|P2|Overall Study|Lost to Follow-up|2
851710|NCT01616173|2804485|P1|Overall Study|Lost to Follow-up|0
851711|NCT01615939|2804518|P2|Overall Study|Lost to Follow-up|0
851712|NCT01615939|2804519|P1|Overall Study|Lost to Follow-up|5
851713|NCT01615822|2804532|P3|Period 2|Lost to Follow-up|2
851714|NCT01615822|2804533|P2|Period 2|Lost to Follow-up|1
851715|NCT01615822|2804534|P1|Period 2|Lost to Follow-up|0
851716|NCT01615822|2804532|P3|Period 1|Adverse Event|0
851717|NCT01615822|2804533|P2|Period 1|Adverse Event|1
851718|NCT01615822|2804534|P1|Period 1|Adverse Event|1
851719|NCT01615822|2804532|P3|Period 1|Withdrawal by Subject|0
851720|NCT01615822|2804533|P2|Period 1|Withdrawal by Subject|1
851721|NCT01615822|2804534|P1|Period 1|Withdrawal by Subject|0
851722|NCT01615328|2804622|P2|Overall Study|Lost to Follow-up|5
851723|NCT01615328|2804623|P1|Overall Study|Lost to Follow-up|3
851724|NCT01615263|2804635|P2|Overall Study|Post-randomization exclusion|2
851725|NCT01615263|2804636|P1|Overall Study|Post-randomization exclusion|0
851726|NCT01615198|2804650|P2|Overall Study|Adverse Event|5
851727|NCT01615198|2804651|P1|Overall Study|Adverse Event|11
851728|NCT01615198|2804650|P2|Overall Study|Lack of Efficacy|6
851729|NCT01615198|2804651|P1|Overall Study|Lack of Efficacy|1
851730|NCT01615198|2804650|P2|Overall Study|Lost to Follow-up|1
851731|NCT01615198|2804651|P1|Overall Study|Lost to Follow-up|1
851732|NCT01615198|2804650|P2|Overall Study|Physician Decision|1
851733|NCT01615198|2804651|P1|Overall Study|Physician Decision|5
851734|NCT01615198|2804650|P2|Overall Study|Protocol deviation|1
851735|NCT01615198|2804651|P1|Overall Study|Protocol deviation|1
851736|NCT01615198|2804650|P2|Overall Study|Withdrawal by Subject|5
851737|NCT01615198|2804651|P1|Overall Study|Withdrawal by Subject|5
851738|NCT01615029|2804684|P5|Overall Study|Ongoing|23
851739|NCT01615029|2804685|P4|Overall Study|Ongoing|2
851740|NCT01615029|2804686|P3|Overall Study|Ongoing|3
851741|NCT01615029|2804687|P2|Overall Study|Ongoing|2
851742|NCT01615029|2804688|P1|Overall Study|Ongoing|1
851743|NCT01615029|2804684|P5|Overall Study|Physician Decision|1
851744|NCT01615029|2804685|P4|Overall Study|Physician Decision|0
851745|NCT01615029|2804686|P3|Overall Study|Physician Decision|0
851746|NCT01615029|2804687|P2|Overall Study|Physician Decision|0
851747|NCT01615029|2804688|P1|Overall Study|Physician Decision|0
851748|NCT01615029|2804684|P5|Overall Study|Progressive disease|5
851749|NCT01615029|2804685|P4|Overall Study|Progressive disease|1
851750|NCT01615029|2804686|P3|Overall Study|Progressive disease|1
851751|NCT01615029|2804687|P2|Overall Study|Progressive disease|1
851752|NCT01615029|2804688|P1|Overall Study|Progressive disease|2
851753|NCT01615029|2804684|P5|Overall Study|Lost to Follow-up|1
851754|NCT01615029|2804685|P4|Overall Study|Lost to Follow-up|0
851755|NCT01615029|2804686|P3|Overall Study|Lost to Follow-up|0
851756|NCT01615029|2804687|P2|Overall Study|Lost to Follow-up|0
851757|NCT01615029|2804688|P1|Overall Study|Lost to Follow-up|0
851758|NCT01615029|2804684|P5|Overall Study|Death|1
851759|NCT01615029|2804685|P4|Overall Study|Death|0
851760|NCT01615029|2804686|P3|Overall Study|Death|0
851761|NCT01615029|2804687|P2|Overall Study|Death|0
851762|NCT01615029|2804688|P1|Overall Study|Death|0
851763|NCT01615029|2804684|P5|Overall Study|Adverse Event|1
851764|NCT01615029|2804685|P4|Overall Study|Adverse Event|0
851765|NCT01615029|2804686|P3|Overall Study|Adverse Event|0
851766|NCT01615029|2804687|P2|Overall Study|Adverse Event|0
851767|NCT01615029|2804688|P1|Overall Study|Adverse Event|0
851768|NCT01614886|2804756|P2|Overall Study|Protocol deviation|2
851769|NCT01614886|2804757|P1|Overall Study|Protocol deviation|0
851770|NCT01614886|2804756|P2|Overall Study|Death|0
851771|NCT01614886|2804757|P1|Overall Study|Death|1
851772|NCT01614886|2804756|P2|Overall Study|Withdrawal by Subject|4
851773|NCT01614886|2804757|P1|Overall Study|Withdrawal by Subject|4
851774|NCT01614886|2804756|P2|Overall Study|Adverse Event|20
851775|NCT01614886|2804757|P1|Overall Study|Adverse Event|15
851776|NCT01614795|2804775|P4|Overall Study|Ineligible|0
851777|NCT01614795|2804776|P3|Overall Study|Ineligible|0
851778|NCT01614795|2804777|P2|Overall Study|Ineligible|1
851779|NCT01614795|2804778|P1|Overall Study|Ineligible|0
851780|NCT01614795|2804775|P4|Overall Study|Withdrawal by Subject|2
851781|NCT01614795|2804776|P3|Overall Study|Withdrawal by Subject|0
851782|NCT01614795|2804777|P2|Overall Study|Withdrawal by Subject|1
851783|NCT01614795|2804778|P1|Overall Study|Withdrawal by Subject|0
851784|NCT01614795|2804775|P4|Overall Study|Physician Decision|1
851785|NCT01614795|2804776|P3|Overall Study|Physician Decision|1
851786|NCT01614795|2804777|P2|Overall Study|Physician Decision|0
851787|NCT01614795|2804778|P1|Overall Study|Physician Decision|1
851788|NCT01614795|2804775|P4|Overall Study|Lack of Efficacy|8
851789|NCT01614795|2804776|P3|Overall Study|Lack of Efficacy|9
851790|NCT01614795|2804777|P2|Overall Study|Lack of Efficacy|10
851791|NCT01614795|2804778|P1|Overall Study|Lack of Efficacy|10
851792|NCT01614795|2804775|P4|Overall Study|Adverse Event|1
851793|NCT01614795|2804776|P3|Overall Study|Adverse Event|1
851794|NCT01614795|2804777|P2|Overall Study|Adverse Event|0
851795|NCT01614795|2804778|P1|Overall Study|Adverse Event|0
851796|NCT01614769|2804798|P6|Period 3|Withdrawal by Subject|0
851797|NCT01614769|2804799|P5|Period 3|Withdrawal by Subject|0
851798|NCT01614769|2804800|P4|Period 3|Withdrawal by Subject|0
851799|NCT01614769|2804801|P3|Period 3|Withdrawal by Subject|1
851800|NCT01614769|2804802|P2|Period 3|Withdrawal by Subject|0
851801|NCT01614769|2804803|P1|Period 3|Withdrawal by Subject|0
851802|NCT01614769|2804798|P6|Period 1|Withdrawal by Subject|0
851803|NCT01614769|2804799|P5|Period 1|Withdrawal by Subject|0
851804|NCT01614769|2804800|P4|Period 1|Withdrawal by Subject|0
851805|NCT01614769|2804801|P3|Period 1|Withdrawal by Subject|0
851806|NCT01614769|2804802|P2|Period 1|Withdrawal by Subject|0
851807|NCT01614769|2804803|P1|Period 1|Withdrawal by Subject|1
851808|NCT01614769|2804798|P6|Period 1|Protocol Violation|0
851809|NCT01614769|2804799|P5|Period 1|Protocol Violation|0
851810|NCT01614769|2804800|P4|Period 1|Protocol Violation|1
851811|NCT01614769|2804801|P3|Period 1|Protocol Violation|0
851812|NCT01614769|2804802|P2|Period 1|Protocol Violation|0
851813|NCT01614769|2804803|P1|Period 1|Protocol Violation|0
851814|NCT01614769|2804798|P6|Period 1|Discontinued due to Hypoglycemia|1
851815|NCT01614769|2804799|P5|Period 1|Discontinued due to Hypoglycemia|0
851816|NCT01614769|2804800|P4|Period 1|Discontinued due to Hypoglycemia|1
851817|NCT01614769|2804801|P3|Period 1|Discontinued due to Hypoglycemia|0
851818|NCT01614769|2804802|P2|Period 1|Discontinued due to Hypoglycemia|0
851819|NCT01614769|2804803|P1|Period 1|Discontinued due to Hypoglycemia|0
851820|NCT01614600|2804825|P1|Overall Study|Protocol deviation|1
851821|NCT01614600|2804825|P1|Overall Study|Unable to remove lens at the end of day|1
851822|NCT01614600|2804825|P1|Overall Study|Discomfort|1
851823|NCT01614600|2804825|P1|Overall Study|Unacceptable fit|1
851824|NCT01614470|2804856|P3|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0
851825|NCT01614470|2804857|P2|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
851826|NCT01614470|2804858|P1|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
851827|NCT01614470|2804856|P3|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
851828|NCT01614470|2804857|P2|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
851829|NCT01614470|2804858|P1|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
851830|NCT01614457|2804880|P2|Overall Study|Pregnancy (Self or Partner)|0
851831|NCT01614457|2804881|P1|Overall Study|Pregnancy (Self or Partner)|1
851832|NCT01614457|2804880|P2|Overall Study|Non-Compliance|0
851833|NCT01614457|2804881|P1|Overall Study|Non-Compliance|1
851834|NCT01614249|2804899|P2|Overall Study|Lost to Follow-up|23
851835|NCT01614249|2804900|P1|Overall Study|Lost to Follow-up|11
851836|NCT01614093|2804914|P1|Overall Study|Withdrawal by Subject|1
851837|NCT01613716|2804927|P1|Overall Study|Lost to Follow-up|4
851838|NCT01613716|2804927|P1|Overall Study|screen failures|3
851839|NCT01613599|2804932|P1|Overall Study|Reason not specified|3
851840|NCT01613599|2804932|P1|Overall Study|Withdrawal by Subject|8
851841|NCT01613599|2804932|P1|Overall Study|Lost to Follow-up|5
851842|NCT01613599|2804932|P1|Overall Study|Death|9
851843|NCT01613417|2804947|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|7
851844|NCT01613417|2804948|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|13
851845|NCT01613378|2804985|P1|Overall Study|Other Reason|4
851846|NCT01613378|2804985|P1|Overall Study|Lost to Follow-up|1
851847|NCT01613378|2804985|P1|Overall Study|Death|2
851848|NCT01613378|2804985|P1|Overall Study|Withdrawal by Subject|8
851849|NCT01613378|2804985|P1|Overall Study|Adverse Event|11
851850|NCT01613378|2804985|P1|Overall Study|Lack of Efficacy|13
851851|NCT01613326|2805015|P2|Overall Study|Protocol Violation|1
851852|NCT01613326|2805016|P1|Overall Study|Protocol Violation|0
851853|NCT01613326|2805015|P2|Overall Study|Administrative|2
851854|NCT01613326|2805016|P1|Overall Study|Administrative|0
851855|NCT01613326|2805015|P2|Overall Study|Lost to Follow-up|1
851856|NCT01613326|2805016|P1|Overall Study|Lost to Follow-up|0
851857|NCT01613326|2805015|P2|Overall Study|Lack of Efficacy|1
851858|NCT01613326|2805016|P1|Overall Study|Lack of Efficacy|0
851859|NCT01613326|2805015|P2|Overall Study|inability to use device|0
851860|NCT01613326|2805016|P1|Overall Study|inability to use device|1
851861|NCT01613326|2805015|P2|Overall Study|Abnormal test procedure result(s)|0
851862|NCT01613326|2805016|P1|Overall Study|Abnormal test procedure result(s)|2
851863|NCT01613326|2805015|P2|Overall Study|Withdrawal by Subject|4
851864|NCT01613326|2805016|P1|Overall Study|Withdrawal by Subject|3
851865|NCT01613326|2805015|P2|Overall Study|Adverse Event|5
851866|NCT01613326|2805016|P1|Overall Study|Adverse Event|7
851867|NCT01613248|2805073|P6|Overall Study|Pregnancy|0
851868|NCT01613248|2805074|P5|Overall Study|Pregnancy|0
851869|NCT01613248|2805075|P4|Overall Study|Pregnancy|1
851870|NCT01613248|2805076|P3|Overall Study|Pregnancy|0
851871|NCT01613248|2805077|P2|Overall Study|Pregnancy|0
851872|NCT01613248|2805078|P1|Overall Study|Pregnancy|0
851873|NCT01613248|2805073|P6|Overall Study|Lack of Qualifying Event|18
851874|NCT01613248|2805074|P5|Overall Study|Lack of Qualifying Event|15
851875|NCT01613248|2805075|P4|Overall Study|Lack of Qualifying Event|11
851876|NCT01613248|2805076|P3|Overall Study|Lack of Qualifying Event|10
851877|NCT01613248|2805077|P2|Overall Study|Lack of Qualifying Event|11
851878|NCT01613248|2805078|P1|Overall Study|Lack of Qualifying Event|9
851879|NCT01613248|2805073|P6|Overall Study|Physician Decision|6
851880|NCT01613248|2805074|P5|Overall Study|Physician Decision|7
851881|NCT01613248|2805075|P4|Overall Study|Physician Decision|4
851882|NCT01613248|2805076|P3|Overall Study|Physician Decision|9
851883|NCT01613248|2805077|P2|Overall Study|Physician Decision|8
851884|NCT01613248|2805078|P1|Overall Study|Physician Decision|8
851885|NCT01613248|2805073|P6|Overall Study|Study Terminated by Sponsor|11
851886|NCT01613248|2805074|P5|Overall Study|Study Terminated by Sponsor|9
851887|NCT01613248|2805075|P4|Overall Study|Study Terminated by Sponsor|8
851888|NCT01613248|2805076|P3|Overall Study|Study Terminated by Sponsor|8
851889|NCT01613248|2805077|P2|Overall Study|Study Terminated by Sponsor|6
851890|NCT01613248|2805078|P1|Overall Study|Study Terminated by Sponsor|4
851891|NCT01613248|2805073|P6|Overall Study|Lost to Follow-up|2
851892|NCT01613248|2805074|P5|Overall Study|Lost to Follow-up|4
851893|NCT01613248|2805075|P4|Overall Study|Lost to Follow-up|8
851894|NCT01613248|2805076|P3|Overall Study|Lost to Follow-up|4
851895|NCT01613248|2805077|P2|Overall Study|Lost to Follow-up|7
851896|NCT01613248|2805078|P1|Overall Study|Lost to Follow-up|5
851897|NCT01613248|2805073|P6|Overall Study|Withdrawal by Subject|1
851898|NCT01613248|2805074|P5|Overall Study|Withdrawal by Subject|0
851899|NCT01613248|2805075|P4|Overall Study|Withdrawal by Subject|5
851900|NCT01613248|2805076|P3|Overall Study|Withdrawal by Subject|2
851901|NCT01613248|2805077|P2|Overall Study|Withdrawal by Subject|2
851902|NCT01613248|2805078|P1|Overall Study|Withdrawal by Subject|3
851903|NCT01613248|2805073|P6|Overall Study|Adverse Event|0
851904|NCT01613248|2805074|P5|Overall Study|Adverse Event|0
851905|NCT01613248|2805075|P4|Overall Study|Adverse Event|1
851906|NCT01613248|2805076|P3|Overall Study|Adverse Event|0
851907|NCT01613248|2805077|P2|Overall Study|Adverse Event|0
851908|NCT01613248|2805078|P1|Overall Study|Adverse Event|0
851909|NCT01613131|2805178|P2|Overall Study|Withdrawal by Subject|5
851910|NCT01613131|2805179|P1|Overall Study|Withdrawal by Subject|3
851911|NCT01613027|2805207|P1|Overall Study|Patient’s Decision Due to Adverse Event|1
851912|NCT01613027|2805207|P1|Overall Study|Lack of Efficacy|1
851913|NCT01613027|2805207|P1|Overall Study|Switched Physician|1
851914|NCT01613027|2805207|P1|Overall Study|Lost to Follow-up|5
851915|NCT01612858|2805250|P2|Overall Study|Withdrawal by Subject|1
851916|NCT01612858|2805251|P1|Overall Study|Withdrawal by Subject|5
851917|NCT01612702|2805315|P2|Overall Study|Protocol Violation|11
851918|NCT01612702|2805316|P1|Overall Study|Protocol Violation|11
851919|NCT01612676|2805330|P4|Overall Study|Protocol Violation|0
851920|NCT01612676|2805331|P3|Overall Study|Protocol Violation|0
851921|NCT01612676|2805332|P2|Overall Study|Protocol Violation|1
851922|NCT01612676|2805333|P1|Overall Study|Protocol Violation|0
851923|NCT01612676|2805330|P4|Overall Study|Adverse Event|3
851924|NCT01612676|2805331|P3|Overall Study|Adverse Event|1
851925|NCT01612676|2805332|P2|Overall Study|Adverse Event|3
851926|NCT01612676|2805333|P1|Overall Study|Adverse Event|2
851927|NCT01612156|2805431|P2|Overall Study|Protocol Violation|0
851928|NCT01612156|2805432|P1|Overall Study|Protocol Violation|2
851929|NCT01612000|2805444|P4|Overall Study|Withdrawal by Subject|2
851930|NCT01612000|2805445|P3|Overall Study|Withdrawal by Subject|2
851931|NCT01612000|2805446|P2|Overall Study|Withdrawal by Subject|1
851932|NCT01612000|2805447|P1|Overall Study|Withdrawal by Subject|3
851933|NCT01612000|2805444|P4|Overall Study|Physician Decision|0
851934|NCT01612000|2805445|P3|Overall Study|Physician Decision|1
851935|NCT01612000|2805446|P2|Overall Study|Physician Decision|0
851936|NCT01612000|2805447|P1|Overall Study|Physician Decision|0
851937|NCT01612000|2805444|P4|Overall Study|Lost to Follow-up|8
851938|NCT01612000|2805445|P3|Overall Study|Lost to Follow-up|4
851939|NCT01612000|2805446|P2|Overall Study|Lost to Follow-up|4
851940|NCT01612000|2805447|P1|Overall Study|Lost to Follow-up|6
851941|NCT01611974|2805472|P3|Overall Study|Withdrawal by Subject|4
851942|NCT01611974|2805473|P2|Overall Study|Withdrawal by Subject|1
851943|NCT01611974|2805474|P1|Overall Study|Withdrawal by Subject|0
851944|NCT01611974|2805472|P3|Overall Study|Physician Decision|2
851945|NCT01611974|2805473|P2|Overall Study|Physician Decision|1
851946|NCT01611974|2805474|P1|Overall Study|Physician Decision|5
851947|NCT01611974|2805472|P3|Overall Study|Lost to Follow-up|0
851948|NCT01611974|2805473|P2|Overall Study|Lost to Follow-up|1
851949|NCT01611974|2805474|P1|Overall Study|Lost to Follow-up|0
851950|NCT01611974|2805472|P3|Overall Study|Death|10
851951|NCT01611974|2805473|P2|Overall Study|Death|12
851952|NCT01611974|2805474|P1|Overall Study|Death|10
851953|NCT01611883|2805520|P2|Overall Study|Adverse Event|1
851954|NCT01611883|2805521|P1|Overall Study|Adverse Event|1
851955|NCT01611857|2805547|P2|Overall Study|Withdrawal by Subject|2
851956|NCT01611857|2805548|P1|Overall Study|Withdrawal by Subject|0
851957|NCT01611792|2805560|P2|Followup: at 6 Months|Lost to Follow-up|13
851958|NCT01611792|2805561|P1|Followup: at 6 Months|Lost to Follow-up|6
851959|NCT01611792|2805560|P2|Initial Period: Time 0|unable to schedule 10 consecutive appts|9
851960|NCT01611792|2805561|P1|Initial Period: Time 0|unable to schedule 10 consecutive appts|12
851961|NCT01611558|2805615|P1|Maintenance Phase|Study drug toxicity|1
851962|NCT01611558|2805615|P1|Maintenance Phase|Withdrawal by Subject|1
851963|NCT01611558|2805615|P1|Induction Phase|Death|1
851964|NCT01611558|2805615|P1|Induction Phase|Adverse event unrelated to study drug|1
851965|NCT01611558|2805615|P1|Induction Phase|Not reported|5
851966|NCT01611558|2805615|P1|Induction Phase|Disease progression|14
851967|NCT01611558|2805615|P1|Induction Phase|Study drug toxicity|17
851968|NCT01611259|2805621|P1|Overall Study|Withdrawal by Subject|7
851969|NCT01611259|2805621|P1|Overall Study|Adverse Event|4
851970|NCT01611259|2805621|P1|Overall Study|Lack of Efficacy|2
851971|NCT01611259|2805621|P1|Overall Study|Physician Decision|1
851972|NCT01611194|2805627|P2|Overall Study|drug use|1
851973|NCT01611194|2805628|P1|Overall Study|drug use|0
851974|NCT01611194|2805627|P2|Overall Study|Withdrawal by Subject|1
851975|NCT01611194|2805628|P1|Overall Study|Withdrawal by Subject|0
851976|NCT01611194|2805627|P2|Overall Study|Lost to Follow-up|1
851977|NCT01611194|2805628|P1|Overall Study|Lost to Follow-up|0
851978|NCT01610791|2805664|P1|Overall Study|Not determined|5
851979|NCT01610791|2805664|P1|Overall Study|Death|1
851980|NCT01610791|2805664|P1|Overall Study|Adverse event and Investigator decision|1
851981|NCT01610791|2805664|P1|Overall Study|Physician Decision|1
851982|NCT01610791|2805664|P1|Overall Study|Adverse Event|6
851983|NCT01610791|2805664|P1|Overall Study|Lost to Follow-up|7
851984|NCT01610713|2805687|P2|Overall Study|Lost to Follow-up|1
851985|NCT01610713|2805688|P1|Overall Study|Lost to Follow-up|0
851986|NCT01610713|2805687|P2|Overall Study|adv. to use original dose/amitriptyline|0
851987|NCT01610713|2805688|P1|Overall Study|adv. to use original dose/amitriptyline|1
851988|NCT01610713|2805687|P2|Overall Study|low mood and poor motivation|0
851989|NCT01610713|2805688|P1|Overall Study|low mood and poor motivation|1
851990|NCT01610713|2805687|P2|Overall Study|Lack of Efficacy|0
851991|NCT01610713|2805688|P1|Overall Study|Lack of Efficacy|1
851992|NCT01610713|2805687|P2|Overall Study|Adverse Event|0
851993|NCT01610713|2805688|P1|Overall Study|Adverse Event|3
851994|NCT01610700|2805746|P2|Overall Study|subject took one dose of street cannabis|1
851995|NCT01610700|2805747|P1|Overall Study|subject took one dose of street cannabis|0
851996|NCT01610700|2805746|P2|Overall Study|Withdrawal by Subject|1
851997|NCT01610700|2805747|P1|Overall Study|Withdrawal by Subject|0
851998|NCT01610700|2805746|P2|Overall Study|Adverse Event|1
851999|NCT01610700|2805747|P1|Overall Study|Adverse Event|3
852000|NCT01610687|2805801|P1|Overall Study|Felt more alter without study medication|1
852001|NCT01610687|2805801|P1|Overall Study|Cannabis affecting job|1
852002|NCT01610687|2805801|P1|Overall Study|Death|1
852003|NCT01610687|2805801|P1|Overall Study|Unable to make journey|1
852004|NCT01610687|2805801|P1|Overall Study|Symptom control without study medication|2
852005|NCT01610687|2805801|P1|Overall Study|Lost to Follow-up|4
852006|NCT01610687|2805801|P1|Overall Study|Withdrawal by Subject|7
852007|NCT01610687|2805801|P1|Overall Study|Moved out of area|6
852008|NCT01610687|2805801|P1|Overall Study|Adverse Event|18
852009|NCT01610687|2805801|P1|Overall Study|Lack of Efficacy|26
852010|NCT01610596|2805814|P2|Overall Study|Lost to Follow-up|1
852011|NCT01610596|2805815|P1|Overall Study|Lost to Follow-up|0
852012|NCT01610557|2805873|P5|Post-36-Week Extension Phase|Withdrawal by Subject|3
852013|NCT01610557|2805874|P4|Post-36-Week Extension Phase|Withdrawal by Subject|0
852014|NCT01610557|2805875|P3|Post-36-Week Extension Phase|Withdrawal by Subject|0
852015|NCT01610557|2805876|P2|Post-36-Week Extension Phase|Withdrawal by Subject|0
852016|NCT01610557|2805877|P1|Post-36-Week Extension Phase|Withdrawal by Subject|0
852017|NCT01610557|2805873|P5|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
852018|NCT01610557|2805874|P4|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
852019|NCT01610557|2805875|P3|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
852020|NCT01610557|2805876|P2|36-Week Randomized Crossover Phase|Withdrawal by Subject|1
852021|NCT01610557|2805877|P1|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
852022|NCT01610492|2805890|P1|Overall Study|Other:Treatment stopped due to remission|1
852023|NCT01610492|2805890|P1|Overall Study|Other: Reached stopping criteria|1
852024|NCT01610492|2805890|P1|Overall Study|Lack of Efficacy|3
852025|NCT01610492|2805890|P1|Overall Study|Adverse Event|1
852026|NCT01610414|2805941|P2|After Month 25|Study end not reached|53
852027|NCT01610414|2805942|P1|After Month 25|Study end not reached|48
852028|NCT01610414|2805941|P2|Month 13 - Month 25|Other reasons for withdrawal|7
852029|NCT01610414|2805942|P1|Month 13 - Month 25|Other reasons for withdrawal|6
852030|NCT01610414|2805941|P2|Month 13 - Month 25|Lost to Follow-up|9
852031|NCT01610414|2805942|P1|Month 13 - Month 25|Lost to Follow-up|5
852032|NCT01610414|2805941|P2|Month 13 - Month 25|Protocol Violation|2
852033|NCT01610414|2805942|P1|Month 13 - Month 25|Protocol Violation|0
852034|NCT01610414|2805941|P2|Month 13 - Month 25|Migrated/moved from study area|2
852035|NCT01610414|2805942|P1|Month 13 - Month 25|Migrated/moved from study area|4
852036|NCT01610414|2805941|P2|Month 13 - Month 25|Withdrawal by Subject|8
852037|NCT01610414|2805942|P1|Month 13 - Month 25|Withdrawal by Subject|7
852038|NCT01610414|2805941|P2|Month 13 - Month 25|Adverse Event|4
852039|NCT01610414|2805942|P1|Month 13 - Month 25|Adverse Event|8
852040|NCT01610414|2805941|P2|Month 13 - Month 25|Serious Adverse Event|38
852041|NCT01610414|2805942|P1|Month 13 - Month 25|Serious Adverse Event|35
852042|NCT01610414|2805941|P2|Study Start - Month 13|Other reasons for withdrawal|4
852043|NCT01610414|2805942|P1|Study Start - Month 13|Other reasons for withdrawal|3
852044|NCT01610414|2805941|P2|Study Start - Month 13|Suspected HZ episode|3
852045|NCT01610414|2805942|P1|Study Start - Month 13|Suspected HZ episode|1
852046|NCT01610414|2805941|P2|Study Start - Month 13|Lost to Follow-up|6
852047|NCT01610414|2805942|P1|Study Start - Month 13|Lost to Follow-up|4
852048|NCT01610414|2805941|P2|Study Start - Month 13|Migrated/moved from study area|4
852049|NCT01610414|2805942|P1|Study Start - Month 13|Migrated/moved from study area|2
852050|NCT01610414|2805941|P2|Study Start - Month 13|Withdrawal by Subject|30
852051|NCT01610414|2805942|P1|Study Start - Month 13|Withdrawal by Subject|23
852052|NCT01610414|2805941|P2|Study Start - Month 13|Protocol Violation|1
852053|NCT01610414|2805942|P1|Study Start - Month 13|Protocol Violation|3
852054|NCT01610414|2805941|P2|Study Start - Month 13|Adverse Event|14
852055|NCT01610414|2805942|P1|Study Start - Month 13|Adverse Event|14
852056|NCT01610414|2805941|P2|Study Start - Month 13|Serious Adverse Event|67
852057|NCT01610414|2805942|P1|Study Start - Month 13|Serious Adverse Event|65
852058|NCT01610297|2805971|P1|Overall Study|Lost to Follow-up|1
852059|NCT01610167|2805982|P3|Overall Study|Scheduling conflict.|2
852060|NCT01610167|2805983|P2|Overall Study|Scheduling conflict.|0
852061|NCT01610167|2805984|P1|Overall Study|Scheduling conflict.|0
852062|NCT01610076|2806021|P2|Overall Study|Lost to Follow-up|4
852063|NCT01610076|2806022|P1|Overall Study|Lost to Follow-up|3
852064|NCT01610076|2806021|P2|Overall Study|Technical issue with video|1
852065|NCT01610076|2806022|P1|Overall Study|Technical issue with video|0
852066|NCT01610063|2806033|P2|Overall Study|Lost to Follow-up|20
852067|NCT01610063|2806034|P1|Overall Study|Lost to Follow-up|42
852068|NCT01610037|2806057|P3|Treatment and Follow up Period|Lost to Follow-up|4
852069|NCT01610037|2806058|P2|Treatment and Follow up Period|Lost to Follow-up|6
852070|NCT01610037|2806059|P1|Treatment and Follow up Period|Lost to Follow-up|1
852071|NCT01610037|2806057|P3|Treatment and Follow up Period|Administrative problems|2
852072|NCT01610037|2806058|P2|Treatment and Follow up Period|Administrative problems|3
852073|NCT01610037|2806059|P1|Treatment and Follow up Period|Administrative problems|1
852074|NCT01610037|2806057|P3|Treatment and Follow up Period|Death|4
852075|NCT01610037|2806058|P2|Treatment and Follow up Period|Death|5
852076|NCT01610037|2806059|P1|Treatment and Follow up Period|Death|10
852077|NCT01610037|2806057|P3|Treatment and Follow up Period|Subject withdrew consent|16
852078|NCT01610037|2806058|P2|Treatment and Follow up Period|Subject withdrew consent|14
852079|NCT01610037|2806059|P1|Treatment and Follow up Period|Subject withdrew consent|13
852080|NCT01610037|2806057|P3|All Patients|Abnormal test procedure result(s)|3
852081|NCT01610037|2806058|P2|All Patients|Abnormal test procedure result(s)|1
852082|NCT01610037|2806059|P1|All Patients|Abnormal test procedure result(s)|0
852083|NCT01610037|2806057|P3|All Patients|Lost to Follow-up|0
852084|NCT01610037|2806058|P2|All Patients|Lost to Follow-up|0
852085|NCT01610037|2806059|P1|All Patients|Lost to Follow-up|1
852086|NCT01610037|2806057|P3|All Patients|Administrative problems|4
852087|NCT01610037|2806058|P2|All Patients|Administrative problems|4
852088|NCT01610037|2806059|P1|All Patients|Administrative problems|1
852089|NCT01610037|2806057|P3|All Patients|Abnormal laboratory value|0
852090|NCT01610037|2806058|P2|All Patients|Abnormal laboratory value|1
852091|NCT01610037|2806059|P1|All Patients|Abnormal laboratory value|1
852092|NCT01610037|2806057|P3|All Patients|Protocol deviation|3
852093|NCT01610037|2806058|P2|All Patients|Protocol deviation|3
852094|NCT01610037|2806059|P1|All Patients|Protocol deviation|4
852095|NCT01610037|2806057|P3|All Patients|Death|1
852096|NCT01610037|2806058|P2|All Patients|Death|2
852097|NCT01610037|2806059|P1|All Patients|Death|4
852098|NCT01610037|2806057|P3|All Patients|Unsatisfactory therapeutic effect|27
852099|NCT01610037|2806058|P2|All Patients|Unsatisfactory therapeutic effect|8
852100|NCT01610037|2806059|P1|All Patients|Unsatisfactory therapeutic effect|9
852101|NCT01610037|2806057|P3|All Patients|Withdrawal by Subject|20
852102|NCT01610037|2806058|P2|All Patients|Withdrawal by Subject|10
852103|NCT01610037|2806059|P1|All Patients|Withdrawal by Subject|12
852104|NCT01610037|2806057|P3|All Patients|Adverse Event|26
852105|NCT01610037|2806058|P2|All Patients|Adverse Event|22
852106|NCT01610037|2806059|P1|All Patients|Adverse Event|27
852107|NCT01609933|2806109|P1|Overall Study|Withdrawal by Subject|3
852108|NCT01609933|2806109|P1|Overall Study|Adverse Event|1
852109|NCT01609790|2806119|P3|Overall Study|Protocol Violation|8
852110|NCT01609790|2806120|P2|Overall Study|Protocol Violation|7
852111|NCT01609790|2806121|P1|Overall Study|Protocol Violation|1
852112|NCT01609582|2806140|P2|Overall Study|Randomized, but not treated|3
852113|NCT01609582|2806141|P1|Overall Study|Randomized, but not treated|0
852114|NCT01609582|2806140|P2|Overall Study|Other|10
852115|NCT01609582|2806141|P1|Overall Study|Other|9
852116|NCT01609582|2806140|P2|Overall Study|Study Terminated by Sponsor|1548
852117|NCT01609582|2806141|P1|Overall Study|Study Terminated by Sponsor|1543
852118|NCT01609582|2806140|P2|Overall Study|Withdrawal by Subject|15
852119|NCT01609582|2806141|P1|Overall Study|Withdrawal by Subject|21
852120|NCT01609582|2806140|P2|Overall Study|Lost to Follow-up|10
852121|NCT01609582|2806141|P1|Overall Study|Lost to Follow-up|10
852122|NCT01609582|2806140|P2|Overall Study|Adverse Event|18
852123|NCT01609582|2806141|P1|Overall Study|Adverse Event|20
852124|NCT01609543|2806149|P1|Overall Study|Death|7
852125|NCT01609543|2806149|P1|Overall Study|Protocol Violation|1
852126|NCT01609543|2806149|P1|Overall Study|Withdrawal by Subject|1
852127|NCT01609543|2806149|P1|Overall Study|Adverse Event|5
852128|NCT01609543|2806149|P1|Overall Study|Disease Progression|28
852129|NCT01609478|2806158|P3|Overall Study|Withdrawal by Subject|2
852130|NCT01609478|2806159|P2|Overall Study|Withdrawal by Subject|0
852131|NCT01609478|2806160|P1|Overall Study|Withdrawal by Subject|2
852132|NCT01609478|2806158|P3|Overall Study|Physician Decision|1
852133|NCT01609478|2806159|P2|Overall Study|Physician Decision|0
852134|NCT01609478|2806160|P1|Overall Study|Physician Decision|1
852135|NCT01609478|2806158|P3|Overall Study|Non-Compliance with study treatment|0
852136|NCT01609478|2806159|P2|Overall Study|Non-Compliance with study treatment|0
852137|NCT01609478|2806160|P1|Overall Study|Non-Compliance with study treatment|1
852138|NCT01609478|2806158|P3|Overall Study|Protocol Deviation|1
852139|NCT01609478|2806159|P2|Overall Study|Protocol Deviation|1
852140|NCT01609478|2806160|P1|Overall Study|Protocol Deviation|0
852141|NCT01609478|2806158|P3|Overall Study|Adverse Event|5
852142|NCT01609478|2806159|P2|Overall Study|Adverse Event|1
852143|NCT01609478|2806160|P1|Overall Study|Adverse Event|3
852144|NCT01609257|2806235|P2|Overall Study|Non-compliance/Protocol deviation|6
852145|NCT01609257|2806236|P1|Overall Study|Non-compliance/Protocol deviation|4
852146|NCT01609257|2806235|P2|Overall Study|Voluntary Withdrawal by Subject|1
852147|NCT01609257|2806236|P1|Overall Study|Voluntary Withdrawal by Subject|0
852148|NCT01609257|2806235|P2|Overall Study|Lost to Follow-up|1
852149|NCT01609257|2806236|P1|Overall Study|Lost to Follow-up|2
852150|NCT01609062|2806308|P2|Extension Phase|Anticipated surgery & transition to EAP|1
852151|NCT01609062|2806309|P1|Extension Phase|Anticipated surgery & transition to EAP|0
852152|NCT01609062|2806308|P2|Extension Phase|Discontinued drug and then was pregnant|0
852153|NCT01609062|2806309|P1|Extension Phase|Discontinued drug and then was pregnant|1
852154|NCT01609062|2806308|P2|Extension Phase|Terminated by Sponsor|9
852155|NCT01609062|2806309|P1|Extension Phase|Terminated by Sponsor|14
852156|NCT01609023|2806352|P1|Overall Study|Personal reasons|1
852157|NCT01609023|2806352|P1|Overall Study|Death|2
852158|NCT01609023|2806352|P1|Overall Study|Physician Decision|2
852159|NCT01609023|2806352|P1|Overall Study|Disease progression|10
852160|NCT01609023|2806352|P1|Overall Study|Toxicity|3
852161|NCT01609023|2806352|P1|Overall Study|Lost to Follow-up|8
852162|NCT01609023|2806352|P1|Overall Study|Withdrawal by Subject|4
852163|NCT01609023|2806352|P1|Overall Study|Lack of Efficacy|3
852164|NCT01609010|2806364|P2|Overall Study|Lost to Follow-up|1
852165|NCT01609010|2806365|P1|Overall Study|Lost to Follow-up|1
852166|NCT01609010|2806364|P2|Overall Study|New cancer|0
852167|NCT01609010|2806365|P1|Overall Study|New cancer|1
852168|NCT01609010|2806364|P2|Overall Study|Protocol Violation|1
852169|NCT01609010|2806365|P1|Overall Study|Protocol Violation|1
852170|NCT01609010|2806364|P2|Overall Study|Pathology review|1
852171|NCT01609010|2806365|P1|Overall Study|Pathology review|2
852172|NCT01609010|2806364|P2|Overall Study|Other malignancy|0
852173|NCT01609010|2806365|P1|Overall Study|Other malignancy|1
852174|NCT01609010|2806364|P2|Overall Study|Not specified|0
852175|NCT01609010|2806365|P1|Overall Study|Not specified|2
852176|NCT01609010|2806364|P2|Overall Study|Withdrawal by Subject|2
852177|NCT01609010|2806365|P1|Overall Study|Withdrawal by Subject|2
852178|NCT01609010|2806364|P2|Overall Study|Adverse Event|6
852179|NCT01609010|2806365|P1|Overall Study|Adverse Event|3
852180|NCT01609010|2806364|P2|Overall Study|Progressive disease (PD)|10
852181|NCT01609010|2806365|P1|Overall Study|Progressive disease (PD)|8
852182|NCT01609010|2806364|P2|Overall Study|Stable disease (SD)|16
852183|NCT01609010|2806365|P1|Overall Study|Stable disease (SD)|22
852184|NCT01608724|2806426|P1|Overall Study|Safety reasons|1
852185|NCT01608724|2806426|P1|Overall Study|bood sugar too high, etc.|3
852186|NCT01608724|2806426|P1|Overall Study|Protocol Violation|6
852187|NCT01608724|2806426|P1|Overall Study|Adverse Event|29
852188|NCT01608724|2806426|P1|Overall Study|Study-specific discontinuation criteria|32
852189|NCT01608724|2806426|P1|Overall Study|Lost to Follow-up|41
852190|NCT01608724|2806426|P1|Overall Study|Withdrawal by Subject|131
852191|NCT01608321|2806458|P2|Overall Study|Withdrawal by Subject|0
852192|NCT01608321|2806459|P1|Overall Study|Withdrawal by Subject|1
852193|NCT01608308|2806467|P2|Overall Study|pretreatment medical and billing reasons|2
852194|NCT01608308|2806468|P1|Overall Study|pretreatment medical and billing reasons|0
852195|NCT01607593|2806697|P1|Overall Study|Other|4
852196|NCT01607593|2806697|P1|Overall Study|Continuation|33
852197|NCT01607593|2806697|P1|Overall Study|Lost to Follow-up|25
852198|NCT01607593|2806697|P1|Overall Study|Lack of Efficacy|16
852199|NCT01607593|2806697|P1|Overall Study|Adverse Event|15
852200|NCT01607554|2806703|P1|Overall Study|Disease progression|2
852201|NCT01607476|2806716|P3|Overall Study|Lost to Follow-up|2
852202|NCT01607476|2806717|P2|Overall Study|Lost to Follow-up|0
852203|NCT01607476|2806718|P1|Overall Study|Lost to Follow-up|0
852204|NCT01607476|2806716|P3|Overall Study|Withdrawal by Subject|1
852205|NCT01607476|2806717|P2|Overall Study|Withdrawal by Subject|0
852206|NCT01607476|2806718|P1|Overall Study|Withdrawal by Subject|1
852207|NCT01607398|2806812|P2|Overall Study|Severe COPD|0
852208|NCT01607398|2806813|P1|Overall Study|Severe COPD|2
852209|NCT01607398|2806812|P2|Overall Study|Adverse Event|2
852210|NCT01607398|2806813|P1|Overall Study|Adverse Event|0
852211|NCT01607346|2806857|P1|Overall Study|Adverse Event|3
852212|NCT01606800|2806942|P2|Overall Study|Missing completion status|0
852213|NCT01606800|2806943|P1|Overall Study|Missing completion status|2
852214|NCT01606800|2806942|P2|Overall Study|Participant withdrew consent|1
852215|NCT01606800|2806943|P1|Overall Study|Participant withdrew consent|0
852216|NCT01606800|2806942|P2|Overall Study|Adverse Event|1
852217|NCT01606800|2806943|P1|Overall Study|Adverse Event|3
852218|NCT01606787|2806951|P2|Overall Study|Surgery canceled|2
852219|NCT01606787|2806952|P1|Overall Study|Surgery canceled|0
852220|NCT01606787|2806951|P2|Overall Study|Withdrawal by Subject|5
852221|NCT01606787|2806952|P1|Overall Study|Withdrawal by Subject|4
852222|NCT01606761|2806963|P5|Safety Follow-up Period (Week 52-68)|Other|3
852223|NCT01606761|2806964|P4|Safety Follow-up Period (Week 52-68)|Other|1
852224|NCT01606761|2806965|P3|Safety Follow-up Period (Week 52-68)|Other|9
852225|NCT01606761|2806966|P2|Safety Follow-up Period (Week 52-68)|Other|3
852226|NCT01606761|2806967|P1|Safety Follow-up Period (Week 52-68)|Other|0
852227|NCT01606761|2806963|P5|Safety Follow-up Period (Week 52-68)|Death|1
852228|NCT01606761|2806964|P4|Safety Follow-up Period (Week 52-68)|Death|0
852229|NCT01606761|2806965|P3|Safety Follow-up Period (Week 52-68)|Death|0
852230|NCT01606761|2806966|P2|Safety Follow-up Period (Week 52-68)|Death|0
852231|NCT01606761|2806967|P1|Safety Follow-up Period (Week 52-68)|Death|0
852232|NCT01606761|2806963|P5|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3
852233|NCT01606761|2806964|P4|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1
852234|NCT01606761|2806965|P3|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
852235|NCT01606761|2806966|P2|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
852236|NCT01606761|2806967|P1|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4
852237|NCT01606761|2806963|P5|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
852238|NCT01606761|2806964|P4|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
852239|NCT01606761|2806965|P3|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2
852240|NCT01606761|2806966|P2|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
852241|NCT01606761|2806967|P1|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
852242|NCT01606761|2806963|P5|Week 24 to Week 52|Other|2
852243|NCT01606761|2806964|P4|Week 24 to Week 52|Other|2
852244|NCT01606761|2806965|P3|Week 24 to Week 52|Other|5
852245|NCT01606761|2806966|P2|Week 24 to Week 52|Other|1
852246|NCT01606761|2806967|P1|Week 24 to Week 52|Other|0
852247|NCT01606761|2806963|P5|Week 24 to Week 52|Physician Decision|0
852248|NCT01606761|2806964|P4|Week 24 to Week 52|Physician Decision|0
852249|NCT01606761|2806965|P3|Week 24 to Week 52|Physician Decision|1
852250|NCT01606761|2806966|P2|Week 24 to Week 52|Physician Decision|1
852251|NCT01606761|2806967|P1|Week 24 to Week 52|Physician Decision|0
852252|NCT01606761|2806963|P5|Week 24 to Week 52|Lack of Efficacy|3
852253|NCT01606761|2806964|P4|Week 24 to Week 52|Lack of Efficacy|10
852254|NCT01606761|2806965|P3|Week 24 to Week 52|Lack of Efficacy|7
852255|NCT01606761|2806966|P2|Week 24 to Week 52|Lack of Efficacy|13
852256|NCT01606761|2806967|P1|Week 24 to Week 52|Lack of Efficacy|0
852257|NCT01606761|2806963|P5|Week 24 to Week 52|Death|0
852258|NCT01606761|2806964|P4|Week 24 to Week 52|Death|1
852259|NCT01606761|2806965|P3|Week 24 to Week 52|Death|2
852260|NCT01606761|2806966|P2|Week 24 to Week 52|Death|0
852261|NCT01606761|2806967|P1|Week 24 to Week 52|Death|0
852262|NCT01606761|2806963|P5|Week 24 to Week 52|Adverse Event|15
852263|NCT01606761|2806964|P4|Week 24 to Week 52|Adverse Event|3
852264|NCT01606761|2806965|P3|Week 24 to Week 52|Adverse Event|14
852265|NCT01606761|2806966|P2|Week 24 to Week 52|Adverse Event|11
852266|NCT01606761|2806967|P1|Week 24 to Week 52|Adverse Event|0
852267|NCT01606761|2806963|P5|Week 24 to Week 52|Withdrawal by Subject|0
852268|NCT01606761|2806964|P4|Week 24 to Week 52|Withdrawal by Subject|0
852269|NCT01606761|2806965|P3|Week 24 to Week 52|Withdrawal by Subject|3
852270|NCT01606761|2806966|P2|Week 24 to Week 52|Withdrawal by Subject|6
852271|NCT01606761|2806967|P1|Week 24 to Week 52|Withdrawal by Subject|0
852272|NCT01606761|2806963|P5|Week 24 to Week 52|Lost to Follow-up|0
852273|NCT01606761|2806964|P4|Week 24 to Week 52|Lost to Follow-up|1
852274|NCT01606761|2806965|P3|Week 24 to Week 52|Lost to Follow-up|1
852275|NCT01606761|2806966|P2|Week 24 to Week 52|Lost to Follow-up|1
852276|NCT01606761|2806967|P1|Week 24 to Week 52|Lost to Follow-up|0
852277|NCT01606761|2806963|P5|Prior to Week 24|Other|0
852278|NCT01606761|2806964|P4|Prior to Week 24|Other|0
852279|NCT01606761|2806965|P3|Prior to Week 24|Other|5
852280|NCT01606761|2806966|P2|Prior to Week 24|Other|7
852281|NCT01606761|2806967|P1|Prior to Week 24|Other|4
852282|NCT01606761|2806963|P5|Prior to Week 24|Physician Decision|0
852283|NCT01606761|2806964|P4|Prior to Week 24|Physician Decision|0
852284|NCT01606761|2806965|P3|Prior to Week 24|Physician Decision|1
852285|NCT01606761|2806966|P2|Prior to Week 24|Physician Decision|3
852286|NCT01606761|2806967|P1|Prior to Week 24|Physician Decision|0
852287|NCT01606761|2806963|P5|Prior to Week 24|Lack of Efficacy|0
852288|NCT01606761|2806964|P4|Prior to Week 24|Lack of Efficacy|0
852289|NCT01606761|2806965|P3|Prior to Week 24|Lack of Efficacy|8
852290|NCT01606761|2806966|P2|Prior to Week 24|Lack of Efficacy|14
852291|NCT01606761|2806967|P1|Prior to Week 24|Lack of Efficacy|15
852292|NCT01606761|2806963|P5|Prior to Week 24|Adverse Event|0
852293|NCT01606761|2806964|P4|Prior to Week 24|Adverse Event|0
852294|NCT01606761|2806965|P3|Prior to Week 24|Adverse Event|22
852295|NCT01606761|2806966|P2|Prior to Week 24|Adverse Event|18
852296|NCT01606761|2806967|P1|Prior to Week 24|Adverse Event|11
852297|NCT01606761|2806963|P5|Prior to Week 24|Withdrawal by Subject|0
852298|NCT01606761|2806964|P4|Prior to Week 24|Withdrawal by Subject|0
852299|NCT01606761|2806965|P3|Prior to Week 24|Withdrawal by Subject|9
852300|NCT01606761|2806966|P2|Prior to Week 24|Withdrawal by Subject|10
852301|NCT01606761|2806967|P1|Prior to Week 24|Withdrawal by Subject|12
852302|NCT01606761|2806963|P5|Prior to Week 24|Lost to Follow-up|0
852303|NCT01606761|2806964|P4|Prior to Week 24|Lost to Follow-up|0
852304|NCT01606761|2806965|P3|Prior to Week 24|Lost to Follow-up|2
852305|NCT01606761|2806966|P2|Prior to Week 24|Lost to Follow-up|3
852306|NCT01606761|2806967|P1|Prior to Week 24|Lost to Follow-up|0
852307|NCT01606748|2806993|P2|Overall Study|Withdrawal by Subject|0
852308|NCT01606748|2806994|P1|Overall Study|Withdrawal by Subject|1
852309|NCT01606748|2806993|P2|Overall Study|Progressive Disease|0
852310|NCT01606748|2806994|P1|Overall Study|Progressive Disease|1
852311|NCT01606748|2806993|P2|Overall Study|Adverse Event|0
852312|NCT01606748|2806994|P1|Overall Study|Adverse Event|1
852313|NCT01606670|2807046|P1|Overall Study|Other Reason|2
852314|NCT01606670|2807046|P1|Overall Study|Withdrawal by Subject|3
852315|NCT01606670|2807046|P1|Overall Study|Lost to Follow-up|3
852316|NCT01606670|2807046|P1|Overall Study|Lack of Efficacy|2
852317|NCT01606670|2807046|P1|Overall Study|Adverse Event|6
852318|NCT01606319|2807056|P2|Overall Study|Adverse Event|4
852319|NCT01606319|2807057|P1|Overall Study|Adverse Event|1
852320|NCT01606319|2807056|P2|Overall Study|Lack of Efficacy|8
852321|NCT01606319|2807057|P1|Overall Study|Lack of Efficacy|6
852322|NCT01606319|2807056|P2|Overall Study|Physician Decision|2
852323|NCT01606319|2807057|P1|Overall Study|Physician Decision|1
852324|NCT01606319|2807056|P2|Overall Study|Withdrawal by Subject|12
852325|NCT01606319|2807057|P1|Overall Study|Withdrawal by Subject|9
852326|NCT01606319|2807056|P2|Overall Study|Lost to Follow-up|14
852327|NCT01606319|2807057|P1|Overall Study|Lost to Follow-up|17
852328|NCT01606306|2807075|P6|Overall Study|Physician Decision|0
852329|NCT01606306|2807076|P5|Overall Study|Physician Decision|0
852330|NCT01606306|2807077|P4|Overall Study|Physician Decision|0
852331|NCT01606306|2807078|P3|Overall Study|Physician Decision|0
852332|NCT01606306|2807079|P2|Overall Study|Physician Decision|2
852333|NCT01606306|2807080|P1|Overall Study|Physician Decision|1
852334|NCT01606306|2807075|P6|Overall Study|Withdrawal by Subject|4
852335|NCT01606306|2807076|P5|Overall Study|Withdrawal by Subject|5
852336|NCT01606306|2807077|P4|Overall Study|Withdrawal by Subject|4
852337|NCT01606306|2807078|P3|Overall Study|Withdrawal by Subject|4
852338|NCT01606306|2807079|P2|Overall Study|Withdrawal by Subject|3
852339|NCT01606306|2807080|P1|Overall Study|Withdrawal by Subject|4
852340|NCT01606306|2807075|P6|Overall Study|Lost to Follow-up|5
852341|NCT01606306|2807076|P5|Overall Study|Lost to Follow-up|3
852342|NCT01606306|2807077|P4|Overall Study|Lost to Follow-up|4
852343|NCT01606306|2807078|P3|Overall Study|Lost to Follow-up|5
852344|NCT01606306|2807079|P2|Overall Study|Lost to Follow-up|4
852345|NCT01606306|2807080|P1|Overall Study|Lost to Follow-up|7
852346|NCT01606306|2807075|P6|Overall Study|Adverse Event|0
852347|NCT01606306|2807076|P5|Overall Study|Adverse Event|2
852348|NCT01606306|2807077|P4|Overall Study|Adverse Event|1
852349|NCT01606306|2807078|P3|Overall Study|Adverse Event|1
852350|NCT01606306|2807079|P2|Overall Study|Adverse Event|0
852351|NCT01606306|2807080|P1|Overall Study|Adverse Event|1
852352|NCT01606306|2807075|P6|Overall Study|Lack of Efficacy|2
852353|NCT01606306|2807076|P5|Overall Study|Lack of Efficacy|1
852354|NCT01606306|2807077|P4|Overall Study|Lack of Efficacy|4
852355|NCT01606306|2807078|P3|Overall Study|Lack of Efficacy|4
852356|NCT01606306|2807079|P2|Overall Study|Lack of Efficacy|1
852357|NCT01606306|2807080|P1|Overall Study|Lack of Efficacy|2
852358|NCT01606254|2807090|P4|Overall Study|Adverse Event|1
852359|NCT01606254|2807091|P3|Overall Study|Adverse Event|0
852360|NCT01606254|2807092|P2|Overall Study|Adverse Event|1
852361|NCT01606254|2807093|P1|Overall Study|Adverse Event|1
852362|NCT01606254|2807090|P4|Overall Study|Withdrawal by Subject|2
852363|NCT01606254|2807091|P3|Overall Study|Withdrawal by Subject|0
852364|NCT01606254|2807092|P2|Overall Study|Withdrawal by Subject|3
852365|NCT01606254|2807093|P1|Overall Study|Withdrawal by Subject|1
852366|NCT01606228|2807175|P1|Overall Study|Adverse Event|1
852367|NCT01606228|2807175|P1|Overall Study|Lack of Efficacy|2
852368|NCT01606228|2807175|P1|Overall Study|Non-compliant|3
852369|NCT01606228|2807175|P1|Overall Study|Withdrawal by Subject|3
852370|NCT01606228|2807175|P1|Overall Study|Lost to Follow-up|20
852371|NCT01606202|2807192|P2|Overall Study|Problems with administration|1
852372|NCT01606202|2807193|P1|Overall Study|Problems with administration|0
852373|NCT01606202|2807192|P2|Overall Study|Personal problems|1
852374|NCT01606202|2807193|P1|Overall Study|Personal problems|0
852375|NCT01606202|2807192|P2|Overall Study|Withdrawal by Subject|1
852376|NCT01606202|2807193|P1|Overall Study|Withdrawal by Subject|2
852377|NCT01606202|2807192|P2|Overall Study|Adverse Event|0
852378|NCT01606202|2807193|P1|Overall Study|Adverse Event|5
852379|NCT01606189|2807225|P6|Third Intenvention (14-20 Days)|Withdrawal by Subject|1
852380|NCT01606189|2807226|P5|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
852381|NCT01606189|2807227|P4|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
852382|NCT01606189|2807228|P3|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
852383|NCT01606189|2807229|P2|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
852384|NCT01606189|2807230|P1|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
852385|NCT01606189|2807225|P6|Second Intenvention (14-20 Days)|Adverse Event|1
852386|NCT01606189|2807226|P5|Second Intenvention (14-20 Days)|Adverse Event|0
852387|NCT01606189|2807227|P4|Second Intenvention (14-20 Days)|Adverse Event|0
852388|NCT01606189|2807228|P3|Second Intenvention (14-20 Days)|Adverse Event|0
852389|NCT01606189|2807229|P2|Second Intenvention (14-20 Days)|Adverse Event|0
852390|NCT01606189|2807230|P1|Second Intenvention (14-20 Days)|Adverse Event|0
852391|NCT01606176|2807264|P2|Overall Study|Withdrawal by Subject|0
852392|NCT01606176|2807265|P1|Overall Study|Withdrawal by Subject|1
852393|NCT01606176|2807264|P2|Overall Study|Disease progression|0
852394|NCT01606176|2807265|P1|Overall Study|Disease progression|1
852395|NCT01606176|2807264|P2|Overall Study|Adverse Event|3
852396|NCT01606176|2807265|P1|Overall Study|Adverse Event|2
852397|NCT01606137|2807310|P1|Overall Study|Unable to collect consistent data|1
852398|NCT01606137|2807310|P1|Overall Study|Patient moving|1
852399|NCT01606137|2807310|P1|Overall Study|Unable to tolerate study med. taste|1
852400|NCT01606137|2807310|P1|Overall Study|Personal reasons|1
852401|NCT01606137|2807310|P1|Overall Study|Patient leaving country|1
852402|NCT01606137|2807310|P1|Overall Study|Wanted to try another treatment|1
852403|NCT01606137|2807310|P1|Overall Study|Not enough improvement|4
852404|NCT01606137|2807310|P1|Overall Study|Spray causes nausea|1
852405|NCT01606137|2807310|P1|Overall Study|Increased bilirubin|1
852406|NCT01606137|2807310|P1|Overall Study|multiple sclerosis less stable|1
852407|NCT01606137|2807310|P1|Overall Study|Issues with driving|4
852408|NCT01606137|2807310|P1|Overall Study|Decreased/no pain|4
852409|NCT01606137|2807310|P1|Overall Study|Death|1
852410|NCT01606137|2807310|P1|Overall Study|Patient non-compliance|9
852411|NCT01606137|2807310|P1|Overall Study|Protocol Violation|1
852412|NCT01606137|2807310|P1|Overall Study|Lost to Follow-up|15
852413|NCT01606137|2807310|P1|Overall Study|Lack of Efficacy|56
852414|NCT01606137|2807310|P1|Overall Study|Withdrawal by Subject|74
852415|NCT01606137|2807310|P1|Overall Study|Adverse Event|85
852416|NCT01606007|2807344|P3|Overall Study|Poor/Non-compliance|0
852417|NCT01606007|2807345|P2|Overall Study|Poor/Non-compliance|0
852418|NCT01606007|2807346|P1|Overall Study|Poor/Non-compliance|1
852419|NCT01606007|2807344|P3|Overall Study|Lost to Follow-up|5
852420|NCT01606007|2807345|P2|Overall Study|Lost to Follow-up|8
852421|NCT01606007|2807346|P1|Overall Study|Lost to Follow-up|6
852422|NCT01606007|2807344|P3|Overall Study|discontinue study treatment|1
852423|NCT01606007|2807345|P2|Overall Study|discontinue study treatment|2
852424|NCT01606007|2807346|P1|Overall Study|discontinue study treatment|0
852425|NCT01606007|2807344|P3|Overall Study|Adverse Event|1
852426|NCT01606007|2807345|P2|Overall Study|Adverse Event|1
852427|NCT01606007|2807346|P1|Overall Study|Adverse Event|0
852428|NCT01606007|2807344|P3|Overall Study|Withdrawal by Subject|1
852429|NCT01606007|2807345|P2|Overall Study|Withdrawal by Subject|6
852430|NCT01606007|2807346|P1|Overall Study|Withdrawal by Subject|8
852431|NCT01606007|2807344|P3|Overall Study|Pregnancy|1
852432|NCT01606007|2807345|P2|Overall Study|Pregnancy|1
852433|NCT01606007|2807346|P1|Overall Study|Pregnancy|0
852434|NCT01606007|2807344|P3|Overall Study|Reason 'Other' in the protocol|1
852435|NCT01606007|2807345|P2|Overall Study|Reason 'Other' in the protocol|1
852436|NCT01606007|2807346|P1|Overall Study|Reason 'Other' in the protocol|0
852437|NCT01605916|2807381|P5|Overall Study|Withdrawal by Subject|2
852438|NCT01605916|2807382|P4|Overall Study|Withdrawal by Subject|0
852439|NCT01605916|2807383|P3|Overall Study|Withdrawal by Subject|0
852440|NCT01605916|2807384|P2|Overall Study|Withdrawal by Subject|1
852441|NCT01605916|2807385|P1|Overall Study|Withdrawal by Subject|1
852442|NCT01605916|2807381|P5|Overall Study|Lack of Efficacy|4
852443|NCT01605916|2807382|P4|Overall Study|Lack of Efficacy|5
852444|NCT01605916|2807383|P3|Overall Study|Lack of Efficacy|3
852445|NCT01605916|2807384|P2|Overall Study|Lack of Efficacy|3
852446|NCT01605916|2807385|P1|Overall Study|Lack of Efficacy|2
852447|NCT01605916|2807381|P5|Overall Study|Adverse Event|0
852448|NCT01605916|2807382|P4|Overall Study|Adverse Event|1
852449|NCT01605916|2807383|P3|Overall Study|Adverse Event|0
852450|NCT01605916|2807384|P2|Overall Study|Adverse Event|0
852451|NCT01605916|2807385|P1|Overall Study|Adverse Event|1
852452|NCT01605877|2807482|P1|Overall Study|Withdrawal by Subject|1
852453|NCT01605825|2807546|P2|Overall Study|Non-Compliance with Protocol|0
852454|NCT01605825|2807547|P1|Overall Study|Non-Compliance with Protocol|3
852455|NCT01605825|2807546|P2|Overall Study|Non-Compliance -Investigational Drug|0
852456|NCT01605825|2807547|P1|Overall Study|Non-Compliance -Investigational Drug|3
852457|NCT01605825|2807546|P2|Overall Study|Withdrawal by Subject|1
852458|NCT01605825|2807547|P1|Overall Study|Withdrawal by Subject|0
852459|NCT01605825|2807546|P2|Overall Study|Adverse Event|2
852460|NCT01605825|2807547|P1|Overall Study|Adverse Event|4
852461|NCT01605799|2807555|P2|Overall Study|Withdrawal by Subject|1
852462|NCT01605799|2807556|P1|Overall Study|Withdrawal by Subject|2
852463|NCT01605617|2807571|P2|Washout Period of 4 Weeks|Study Terminated|1
852464|NCT01605617|2807572|P1|Washout Period of 4 Weeks|Study Terminated|2
852465|NCT01605617|2807571|P2|First Intervention|Adverse Event|1
852466|NCT01605617|2807572|P1|First Intervention|Adverse Event|0
852467|NCT01605461|2807631|P1|Overall Study|Withdrawal by Subject|1
852468|NCT01605461|2807631|P1|Overall Study|Lost to Follow-up|3
852469|NCT01605370|2807690|P2|Overall Study|Adverse Event|0
852470|NCT01605370|2807691|P1|Overall Study|Adverse Event|1
852471|NCT01605227|2807726|P2|Overall Study|Dose Held >6 weeks|1
852472|NCT01605227|2807727|P1|Overall Study|Dose Held >6 weeks|0
852473|NCT01605227|2807726|P2|Overall Study|Subject Decision|1
852474|NCT01605227|2807727|P1|Overall Study|Subject Decision|0
852475|NCT01605227|2807726|P2|Overall Study|Started New Therapy|0
852476|NCT01605227|2807727|P1|Overall Study|Started New Therapy|1
852477|NCT01605227|2807726|P2|Overall Study|Sponsor Decision|0
852478|NCT01605227|2807727|P1|Overall Study|Sponsor Decision|2
852479|NCT01605227|2807726|P2|Overall Study|Withdrawal by Subject|14
852480|NCT01605227|2807727|P1|Overall Study|Withdrawal by Subject|18
852481|NCT01605227|2807726|P2|Overall Study|Physician Decision|7
852482|NCT01605227|2807727|P1|Overall Study|Physician Decision|9
852483|NCT01605227|2807726|P2|Overall Study|Protocol Violation|0
852484|NCT01605227|2807727|P1|Overall Study|Protocol Violation|1
852485|NCT01605227|2807726|P2|Overall Study|Lost to Follow-up|0
852486|NCT01605227|2807727|P1|Overall Study|Lost to Follow-up|1
852487|NCT01605227|2807726|P2|Overall Study|Clinical Deterioration|133
852488|NCT01605227|2807727|P1|Overall Study|Clinical Deterioration|227
852489|NCT01605227|2807726|P2|Overall Study|Progressive Disease|128
852490|NCT01605227|2807727|P1|Overall Study|Progressive Disease|132
852491|NCT01605227|2807726|P2|Overall Study|Adverse Event|42
852492|NCT01605227|2807727|P1|Overall Study|Adverse Event|228
852493|NCT01605227|2807726|P2|Overall Study|Did not receive study treatment|3
852494|NCT01605227|2807727|P1|Overall Study|Did not receive study treatment|2
852495|NCT01605019|2807739|P2|Overall Study|pt did not meet transplant endpoint|0
852496|NCT01605019|2807740|P1|Overall Study|pt did not meet transplant endpoint|3
852497|NCT01604941|2807750|P6|Overall Study|Early Study Termination|0
852498|NCT01604941|2807751|P5|Overall Study|Early Study Termination|0
852499|NCT01604941|2807752|P4|Overall Study|Early Study Termination|3
852500|NCT01604941|2807753|P3|Overall Study|Early Study Termination|3
852501|NCT01604941|2807754|P2|Overall Study|Early Study Termination|2
852502|NCT01604941|2807755|P1|Overall Study|Early Study Termination|9
852503|NCT01604941|2807750|P6|Overall Study|Participant Decision|2
852504|NCT01604941|2807751|P5|Overall Study|Participant Decision|0
852505|NCT01604941|2807752|P4|Overall Study|Participant Decision|0
852506|NCT01604941|2807753|P3|Overall Study|Participant Decision|0
852507|NCT01604941|2807754|P2|Overall Study|Participant Decision|0
852508|NCT01604941|2807755|P1|Overall Study|Participant Decision|0
852509|NCT01604941|2807750|P6|Overall Study|Non-compliance|0
852510|NCT01604941|2807751|P5|Overall Study|Non-compliance|0
852511|NCT01604941|2807752|P4|Overall Study|Non-compliance|0
852512|NCT01604941|2807753|P3|Overall Study|Non-compliance|0
852513|NCT01604941|2807754|P2|Overall Study|Non-compliance|0
852514|NCT01604941|2807755|P1|Overall Study|Non-compliance|1
852515|NCT01604941|2807750|P6|Overall Study|Adverse Event|5
852516|NCT01604941|2807751|P5|Overall Study|Adverse Event|1
852517|NCT01604941|2807752|P4|Overall Study|Adverse Event|0
852518|NCT01604941|2807753|P3|Overall Study|Adverse Event|0
852519|NCT01604941|2807754|P2|Overall Study|Adverse Event|2
852520|NCT01604941|2807755|P1|Overall Study|Adverse Event|1
852521|NCT01604850|2807783|P2|Overall Study|Subject withdrew consent|0
852522|NCT01604850|2807784|P1|Overall Study|Subject withdrew consent|1
852523|NCT01604850|2807783|P2|Overall Study|Lost to Follow-up|0
852524|NCT01604850|2807784|P1|Overall Study|Lost to Follow-up|1
852525|NCT01604850|2807783|P2|Overall Study|Efficacy Failure|29
852526|NCT01604850|2807784|P1|Overall Study|Efficacy Failure|50
852527|NCT01604850|2807783|P2|Overall Study|Enrolled but never treated|1
852528|NCT01604850|2807784|P1|Overall Study|Enrolled but never treated|0
852529|NCT01604408|2807808|P2|Observation Period|Withdrawal by Subject|2
852530|NCT01604408|2807809|P1|Observation Period|Withdrawal by Subject|0
852531|NCT01604408|2807808|P2|Observation Period|Adverse Event|1
852532|NCT01604408|2807809|P1|Observation Period|Adverse Event|1
852533|NCT01604408|2807808|P2|Treatment Period 6|Sponsor decision|1
852534|NCT01604408|2807809|P1|Treatment Period 6|Sponsor decision|0
852535|NCT01604408|2807808|P2|Treatment Period 6|Adverse Event|0
852536|NCT01604408|2807809|P1|Treatment Period 6|Adverse Event|2
852537|NCT01604408|2807808|P2|Treatment Period 6|Lost to Follow-up|1
852538|NCT01604408|2807809|P1|Treatment Period 6|Lost to Follow-up|0
852539|NCT01604408|2807808|P2|Treatment Period 5|Adverse Event|0
852540|NCT01604408|2807809|P1|Treatment Period 5|Adverse Event|4
852541|NCT01604408|2807808|P2|Treatment Period 4|Adverse Event|1
852542|NCT01604408|2807809|P1|Treatment Period 4|Adverse Event|0
852543|NCT01604408|2807808|P2|Treatment Period 4|Withdrawal by Subject|1
852544|NCT01604408|2807809|P1|Treatment Period 4|Withdrawal by Subject|2
852545|NCT01604408|2807808|P2|Treatment Period 4|Death|0
852546|NCT01604408|2807809|P1|Treatment Period 4|Death|1
852547|NCT01604408|2807808|P2|Treatment Period 3|Sponsor Decision|0
852548|NCT01604408|2807809|P1|Treatment Period 3|Sponsor Decision|1
852549|NCT01604408|2807808|P2|Treatment Period 3|Withdrawal by Subject|1
852550|NCT01604408|2807809|P1|Treatment Period 3|Withdrawal by Subject|3
852551|NCT01604408|2807808|P2|Treatment Period 3|Adverse Event|3
852552|NCT01604408|2807809|P1|Treatment Period 3|Adverse Event|0
852553|NCT01604408|2807808|P2|Treatment Period 3|Protocol Violation|1
852554|NCT01604408|2807809|P1|Treatment Period 3|Protocol Violation|1
852555|NCT01604408|2807808|P2|Treatment Period 2|Adverse Event|1
852556|NCT01604408|2807809|P1|Treatment Period 2|Adverse Event|0
852557|NCT01604408|2807808|P2|Treatment Period 2|Protocol Violation|0
852558|NCT01604408|2807809|P1|Treatment Period 2|Protocol Violation|1
852559|NCT01604408|2807808|P2|Treatment Period 2|Withdrawal by Subject|1
852560|NCT01604408|2807809|P1|Treatment Period 2|Withdrawal by Subject|1
852561|NCT01604408|2807808|P2|Treatment Period 1|Protocol Violation|1
852562|NCT01604408|2807809|P1|Treatment Period 1|Protocol Violation|0
852563|NCT01604343|2807824|P5|Safety Follow-up Period (Week 104-120)|Other|14
852564|NCT01604343|2807825|P4|Safety Follow-up Period (Week 104-120)|Other|6
852565|NCT01604343|2807826|P3|Safety Follow-up Period (Week 104-120)|Other|20
852566|NCT01604343|2807827|P2|Safety Follow-up Period (Week 104-120)|Other|2
852567|NCT01604343|2807828|P1|Safety Follow-up Period (Week 104-120)|Other|15
852568|NCT01604343|2807824|P5|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14
852569|NCT01604343|2807825|P4|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3
852570|NCT01604343|2807826|P3|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11
852571|NCT01604343|2807827|P2|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4
852572|NCT01604343|2807828|P1|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12
852573|NCT01604343|2807824|P5|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
852574|NCT01604343|2807825|P4|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
852575|NCT01604343|2807826|P3|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2
852576|NCT01604343|2807827|P2|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
852577|NCT01604343|2807828|P1|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3
852578|NCT01604343|2807824|P5|Week 52 to Week 104|Other|3
852579|NCT01604343|2807825|P4|Week 52 to Week 104|Other|6
852580|NCT01604343|2807826|P3|Week 52 to Week 104|Other|11
852581|NCT01604343|2807827|P2|Week 52 to Week 104|Other|11
852582|NCT01604343|2807828|P1|Week 52 to Week 104|Other|0
852583|NCT01604343|2807824|P5|Week 52 to Week 104|Pregnancy|1
852584|NCT01604343|2807825|P4|Week 52 to Week 104|Pregnancy|2
852585|NCT01604343|2807826|P3|Week 52 to Week 104|Pregnancy|1
852586|NCT01604343|2807827|P2|Week 52 to Week 104|Pregnancy|0
852587|NCT01604343|2807828|P1|Week 52 to Week 104|Pregnancy|0
852588|NCT01604343|2807824|P5|Week 52 to Week 104|Physician Decision|2
852589|NCT01604343|2807825|P4|Week 52 to Week 104|Physician Decision|0
852590|NCT01604343|2807826|P3|Week 52 to Week 104|Physician Decision|0
852591|NCT01604343|2807827|P2|Week 52 to Week 104|Physician Decision|1
852592|NCT01604343|2807828|P1|Week 52 to Week 104|Physician Decision|0
852593|NCT01604343|2807824|P5|Week 52 to Week 104|Lack of Efficacy|3
852594|NCT01604343|2807825|P4|Week 52 to Week 104|Lack of Efficacy|2
852595|NCT01604343|2807826|P3|Week 52 to Week 104|Lack of Efficacy|11
852596|NCT01604343|2807827|P2|Week 52 to Week 104|Lack of Efficacy|6
852597|NCT01604343|2807828|P1|Week 52 to Week 104|Lack of Efficacy|0
852598|NCT01604343|2807824|P5|Week 52 to Week 104|Death|0
852599|NCT01604343|2807825|P4|Week 52 to Week 104|Death|5
852600|NCT01604343|2807826|P3|Week 52 to Week 104|Death|2
852601|NCT01604343|2807827|P2|Week 52 to Week 104|Death|4
852602|NCT01604343|2807828|P1|Week 52 to Week 104|Death|0
852603|NCT01604343|2807824|P5|Week 52 to Week 104|Adverse Event|27
852604|NCT01604343|2807825|P4|Week 52 to Week 104|Adverse Event|21
852605|NCT01604343|2807826|P3|Week 52 to Week 104|Adverse Event|26
852606|NCT01604343|2807827|P2|Week 52 to Week 104|Adverse Event|12
852607|NCT01604343|2807828|P1|Week 52 to Week 104|Adverse Event|0
852608|NCT01604343|2807824|P5|Week 52 to Week 104|Withdrawal by Subject|4
852609|NCT01604343|2807825|P4|Week 52 to Week 104|Withdrawal by Subject|8
852610|NCT01604343|2807826|P3|Week 52 to Week 104|Withdrawal by Subject|12
852611|NCT01604343|2807827|P2|Week 52 to Week 104|Withdrawal by Subject|7
852612|NCT01604343|2807828|P1|Week 52 to Week 104|Withdrawal by Subject|0
852613|NCT01604343|2807824|P5|Week 52 to Week 104|Lost to Follow-up|1
852614|NCT01604343|2807825|P4|Week 52 to Week 104|Lost to Follow-up|2
852615|NCT01604343|2807826|P3|Week 52 to Week 104|Lost to Follow-up|4
852616|NCT01604343|2807827|P2|Week 52 to Week 104|Lost to Follow-up|2
852617|NCT01604343|2807828|P1|Week 52 to Week 104|Lost to Follow-up|0
852618|NCT01604343|2807824|P5|Prior to W52 Administration(Through W52)|Other|6
852619|NCT01604343|2807825|P4|Prior to W52 Administration(Through W52)|Other|0
852620|NCT01604343|2807826|P3|Prior to W52 Administration(Through W52)|Other|10
852621|NCT01604343|2807827|P2|Prior to W52 Administration(Through W52)|Other|0
852622|NCT01604343|2807828|P1|Prior to W52 Administration(Through W52)|Other|15
852623|NCT01604343|2807824|P5|Prior to W52 Administration(Through W52)|Pregnancy|0
852624|NCT01604343|2807825|P4|Prior to W52 Administration(Through W52)|Pregnancy|0
852625|NCT01604343|2807826|P3|Prior to W52 Administration(Through W52)|Pregnancy|1
852626|NCT01604343|2807827|P2|Prior to W52 Administration(Through W52)|Pregnancy|0
852627|NCT01604343|2807828|P1|Prior to W52 Administration(Through W52)|Pregnancy|1
852628|NCT01604343|2807824|P5|Prior to W52 Administration(Through W52)|Physician Decision|2
852629|NCT01604343|2807825|P4|Prior to W52 Administration(Through W52)|Physician Decision|0
852630|NCT01604343|2807826|P3|Prior to W52 Administration(Through W52)|Physician Decision|1
852631|NCT01604343|2807827|P2|Prior to W52 Administration(Through W52)|Physician Decision|0
852632|NCT01604343|2807828|P1|Prior to W52 Administration(Through W52)|Physician Decision|4
852633|NCT01604343|2807824|P5|Prior to W52 Administration(Through W52)|Lack of Efficacy|14
852634|NCT01604343|2807825|P4|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
852635|NCT01604343|2807826|P3|Prior to W52 Administration(Through W52)|Lack of Efficacy|5
852636|NCT01604343|2807827|P2|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
852637|NCT01604343|2807828|P1|Prior to W52 Administration(Through W52)|Lack of Efficacy|24
852638|NCT01604343|2807824|P5|Prior to W52 Administration(Through W52)|Death|4
852639|NCT01604343|2807825|P4|Prior to W52 Administration(Through W52)|Death|0
852640|NCT01604343|2807826|P3|Prior to W52 Administration(Through W52)|Death|2
852641|NCT01604343|2807827|P2|Prior to W52 Administration(Through W52)|Death|0
852642|NCT01604343|2807828|P1|Prior to W52 Administration(Through W52)|Death|5
852643|NCT01604343|2807824|P5|Prior to W52 Administration(Through W52)|Adverse Event|42
852644|NCT01604343|2807825|P4|Prior to W52 Administration(Through W52)|Adverse Event|0
852645|NCT01604343|2807826|P3|Prior to W52 Administration(Through W52)|Adverse Event|41
852646|NCT01604343|2807827|P2|Prior to W52 Administration(Through W52)|Adverse Event|0
852647|NCT01604343|2807828|P1|Prior to W52 Administration(Through W52)|Adverse Event|25
852648|NCT01604343|2807824|P5|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16
852649|NCT01604343|2807825|P4|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
852650|NCT01604343|2807826|P3|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12
852651|NCT01604343|2807827|P2|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
852652|NCT01604343|2807828|P1|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19
852653|NCT01604343|2807824|P5|Prior to W52 Administration(Through W52)|Lost to Follow-up|3
852654|NCT01604343|2807825|P4|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
852655|NCT01604343|2807826|P3|Prior to W52 Administration(Through W52)|Lost to Follow-up|4
852656|NCT01604343|2807827|P2|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
852657|NCT01604343|2807828|P1|Prior to W52 Administration(Through W52)|Lost to Follow-up|5
852658|NCT01604278|2807939|P2|Overall Study|Protocol Deviation|3
852659|NCT01604278|2807940|P1|Overall Study|Protocol Deviation|5
852660|NCT01604278|2807939|P2|Overall Study|Adverse Event|5
852661|NCT01604278|2807940|P1|Overall Study|Adverse Event|3
852662|NCT01604278|2807939|P2|Overall Study|Withdrawal by Subject|3
852663|NCT01604278|2807940|P1|Overall Study|Withdrawal by Subject|3
852664|NCT01604278|2807939|P2|Overall Study|Administrative problems|1
852665|NCT01604278|2807940|P1|Overall Study|Administrative problems|2
852666|NCT01604278|2807939|P2|Overall Study|Lost to Follow-up|0
852667|NCT01604278|2807940|P1|Overall Study|Lost to Follow-up|1
852668|NCT01604278|2807939|P2|Overall Study|Lack of Efficacy|1
852669|NCT01604278|2807940|P1|Overall Study|Lack of Efficacy|0
852670|NCT01604265|2807966|P2|Overall Study|Withdrawal by Subject|0
852671|NCT01604265|2807967|P1|Overall Study|Withdrawal by Subject|1
852672|NCT01604265|2807966|P2|Overall Study|Adverse Event|0
852673|NCT01604265|2807967|P1|Overall Study|Adverse Event|1
852674|NCT01603875|2808078|P3|Overall Study|Protocol Violation|0
852675|NCT01603875|2808079|P2|Overall Study|Protocol Violation|1
852676|NCT01603875|2808080|P1|Overall Study|Protocol Violation|0
852677|NCT01603875|2808078|P3|Overall Study|Lost to Follow-up|6
852678|NCT01603875|2808079|P2|Overall Study|Lost to Follow-up|3
852679|NCT01603875|2808080|P1|Overall Study|Lost to Follow-up|4
852680|NCT01603875|2808078|P3|Overall Study|Preexisting rabies antibody|3
852681|NCT01603875|2808079|P2|Overall Study|Preexisting rabies antibody|4
852682|NCT01603875|2808080|P1|Overall Study|Preexisting rabies antibody|3
852683|NCT01603628|2808103|P3|Overall Study|Other Miscellaneous Reason|0
852684|NCT01603628|2808104|P2|Overall Study|Other Miscellaneous Reason|0
852685|NCT01603628|2808105|P1|Overall Study|Other Miscellaneous Reason|1
852686|NCT01603628|2808103|P3|Overall Study|Lost to Follow-up|0
852687|NCT01603628|2808104|P2|Overall Study|Lost to Follow-up|1
852688|NCT01603628|2808105|P1|Overall Study|Lost to Follow-up|0
852689|NCT01603628|2808103|P3|Overall Study|Protocol Violation|0
852690|NCT01603628|2808104|P2|Overall Study|Protocol Violation|1
852691|NCT01603628|2808105|P1|Overall Study|Protocol Violation|1
852692|NCT01603628|2808103|P3|Overall Study|Personal Reasons|2
852693|NCT01603628|2808104|P2|Overall Study|Personal Reasons|1
852694|NCT01603628|2808105|P1|Overall Study|Personal Reasons|1
852695|NCT01603602|2808125|P3|Overall Study|Personal Reasons|1
852696|NCT01603602|2808126|P2|Overall Study|Personal Reasons|0
852697|NCT01603602|2808127|P1|Overall Study|Personal Reasons|1
852698|NCT01603602|2808125|P3|Overall Study|Adverse Event|0
852699|NCT01603602|2808126|P2|Overall Study|Adverse Event|0
852700|NCT01603602|2808127|P1|Overall Study|Adverse Event|1
852701|NCT01603459|2808147|P1|Overall Study|Administrative reason|1
852702|NCT01603459|2808147|P1|Overall Study|Non-compliance|1
852703|NCT01603459|2808147|P1|Overall Study|Predefined discontinuation criteria|3
852704|NCT01603459|2808147|P1|Overall Study|Lost to Follow-up|3
852705|NCT01603459|2808147|P1|Overall Study|Withdrawal by Subject|5
852706|NCT01603459|2808147|P1|Overall Study|Adverse Event|5
852707|NCT01603394|2808298|P1|Overall Study|Adverse Event|1
852708|NCT01603355|2808313|P1|Overall Study|Lack of Efficacy|2
852709|NCT01603277|2808319|P2|Overall Study|Non-Compliance|1
852710|NCT01603277|2808320|P1|Overall Study|Non-Compliance|2
852711|NCT01603277|2808319|P2|Overall Study|Withdrawal by Subject|4
852712|NCT01603277|2808320|P1|Overall Study|Withdrawal by Subject|5
852713|NCT01603277|2808319|P2|Overall Study|Protocol Violation|10
852714|NCT01603277|2808320|P1|Overall Study|Protocol Violation|6
852715|NCT01603277|2808319|P2|Overall Study|Physician Decision|1
852716|NCT01603277|2808320|P1|Overall Study|Physician Decision|0
852717|NCT01603277|2808319|P2|Overall Study|Adverse Event|2
852718|NCT01603277|2808320|P1|Overall Study|Adverse Event|1
852719|NCT01603121|2808326|P2|Second Intervention, 10 Hours|Adverse Event|0
852720|NCT01603121|2808327|P1|Second Intervention, 10 Hours|Adverse Event|1
852721|NCT01603082|2808339|P2|Overall Study|Failed inclusion criterion after dosed|0
852722|NCT01603082|2808340|P1|Overall Study|Failed inclusion criterion after dosed|1
852723|NCT01603082|2808339|P2|Overall Study|Withdrawal by Subject|0
852724|NCT01603082|2808340|P1|Overall Study|Withdrawal by Subject|1
852725|NCT01603082|2808339|P2|Overall Study|Adverse Event|1
852726|NCT01603082|2808340|P1|Overall Study|Adverse Event|0
852727|NCT01603043|2808381|P2|Overall Study|Study Futility|3
852728|NCT01603043|2808382|P1|Overall Study|Study Futility|7
852729|NCT01602965|2808394|P2|Overall Study|Lost to Follow-up|2
852730|NCT01602965|2808395|P1|Overall Study|Lost to Follow-up|4
852731|NCT01602744|2808403|P2|Overall Study|Lost to Follow-up|8
852732|NCT01602744|2808404|P1|Overall Study|Lost to Follow-up|13
852733|NCT01602744|2808403|P2|Overall Study|Death|15
852734|NCT01602744|2808404|P1|Overall Study|Death|17
852735|NCT01602562|2808441|P2|Overall Study|Withdrawal by Subject|1
852736|NCT01602562|2808442|P1|Overall Study|Withdrawal by Subject|1
852737|NCT01602562|2808441|P2|Overall Study|Physician Decision|1
852738|NCT01602562|2808442|P1|Overall Study|Physician Decision|1
852739|NCT01602562|2808441|P2|Overall Study|Adverse Event|1
852740|NCT01602562|2808442|P1|Overall Study|Adverse Event|3
852741|NCT01602549|2808478|P2|Overall Study|Withdrawal by Subject|0
852742|NCT01602549|2808479|P1|Overall Study|Withdrawal by Subject|1
852743|NCT01602549|2808478|P2|Overall Study|Protocol Violation|1
852744|NCT01602549|2808479|P1|Overall Study|Protocol Violation|0
852745|NCT01602510|2808558|P3|Randomized Phase|Withdrawal by Subject|7
852746|NCT01602510|2808559|P2|Randomized Phase|Withdrawal by Subject|6
852747|NCT01602510|2808560|P1|Randomized Phase|Withdrawal by Subject|0
852748|NCT01602510|2808558|P3|Randomized Phase|Physician Decision|2
852749|NCT01602510|2808559|P2|Randomized Phase|Physician Decision|0
852750|NCT01602510|2808560|P1|Randomized Phase|Physician Decision|0
852751|NCT01602510|2808558|P3|Randomized Phase|Lost to Follow-up|3
852752|NCT01602510|2808559|P2|Randomized Phase|Lost to Follow-up|1
852753|NCT01602510|2808560|P1|Randomized Phase|Lost to Follow-up|0
852754|NCT01602510|2808558|P3|Randomized Phase|Met protocol-defined stopping criteria|48
852755|NCT01602510|2808559|P2|Randomized Phase|Met protocol-defined stopping criteria|58
852756|NCT01602510|2808560|P1|Randomized Phase|Met protocol-defined stopping criteria|0
852757|NCT01602510|2808558|P3|Randomized Phase|Protocol Violation|3
852758|NCT01602510|2808559|P2|Randomized Phase|Protocol Violation|3
852759|NCT01602510|2808560|P1|Randomized Phase|Protocol Violation|0
852760|NCT01602510|2808558|P3|Randomized Phase|Lack of Efficacy|4
852761|NCT01602510|2808559|P2|Randomized Phase|Lack of Efficacy|4
852762|NCT01602510|2808560|P1|Randomized Phase|Lack of Efficacy|0
852763|NCT01602510|2808558|P3|Randomized Phase|Adverse Event|6
852764|NCT01602510|2808559|P2|Randomized Phase|Adverse Event|2
852765|NCT01602510|2808560|P1|Randomized Phase|Adverse Event|0
852766|NCT01602510|2808558|P3|Open Label Phase|Withdrawal by Subject|0
852767|NCT01602510|2808559|P2|Open Label Phase|Withdrawal by Subject|0
852768|NCT01602510|2808560|P1|Open Label Phase|Withdrawal by Subject|57
852769|NCT01602510|2808558|P3|Open Label Phase|Physician Decision|0
852770|NCT01602510|2808559|P2|Open Label Phase|Physician Decision|0
852771|NCT01602510|2808560|P1|Open Label Phase|Physician Decision|19
852772|NCT01602510|2808558|P3|Open Label Phase|Lost to Follow-up|0
852773|NCT01602510|2808559|P2|Open Label Phase|Lost to Follow-up|0
852774|NCT01602510|2808560|P1|Open Label Phase|Lost to Follow-up|22
852775|NCT01602510|2808558|P3|Open Label Phase|Met protocol-defined stopping criteria|0
852776|NCT01602510|2808559|P2|Open Label Phase|Met protocol-defined stopping criteria|0
852777|NCT01602510|2808560|P1|Open Label Phase|Met protocol-defined stopping criteria|122
852778|NCT01602510|2808558|P3|Open Label Phase|Protocol Violation|0
852779|NCT01602510|2808559|P2|Open Label Phase|Protocol Violation|0
852780|NCT01602510|2808560|P1|Open Label Phase|Protocol Violation|15
852781|NCT01602510|2808558|P3|Open Label Phase|Lack of Efficacy|0
852782|NCT01602510|2808559|P2|Open Label Phase|Lack of Efficacy|0
852783|NCT01602510|2808560|P1|Open Label Phase|Lack of Efficacy|22
852784|NCT01602510|2808558|P3|Open Label Phase|Adverse Event|0
852785|NCT01602510|2808559|P2|Open Label Phase|Adverse Event|0
852786|NCT01602510|2808560|P1|Open Label Phase|Adverse Event|46
852787|NCT01602484|2808586|P2|Overall Study|Airway issues unrelated to study|1
852788|NCT01602484|2808587|P1|Overall Study|Airway issues unrelated to study|0
852789|NCT01602380|2808605|P2|Overall Study|Eligibility criteria not fulfilled|3
852790|NCT01602380|2808606|P1|Overall Study|Eligibility criteria not fulfilled|2
852791|NCT01602380|2808605|P2|Overall Study|Lost to Follow-up|1
852792|NCT01602380|2808606|P1|Overall Study|Lost to Follow-up|6
852793|NCT01602380|2808605|P2|Overall Study|Withdrawal by Subject|29
852794|NCT01602380|2808606|P1|Overall Study|Withdrawal by Subject|22
852795|NCT01602380|2808605|P2|Overall Study|Death|68
852796|NCT01602380|2808606|P1|Overall Study|Death|63
852797|NCT01602341|2808630|P2|Overall Study|Adverse Event|1
852798|NCT01602341|2808631|P1|Overall Study|Adverse Event|0
852799|NCT01602315|2808672|P7|Overall Study|Cross-over patients to combo treatment|0
852800|NCT01602315|2808673|P6|Overall Study|Cross-over patients to combo treatment|16
852801|NCT01602315|2808674|P5|Overall Study|Cross-over patients to combo treatment|0
852802|NCT01602315|2808675|P4|Overall Study|Cross-over patients to combo treatment|0
852803|NCT01602315|2808676|P3|Overall Study|Cross-over patients to combo treatment|0
852804|NCT01602315|2808677|P2|Overall Study|Cross-over patients to combo treatment|0
852805|NCT01602315|2808678|P1|Overall Study|Cross-over patients to combo treatment|0
852806|NCT01602315|2808672|P7|Overall Study|Subject/guardian decision|1
852807|NCT01602315|2808673|P6|Overall Study|Subject/guardian decision|0
852808|NCT01602315|2808674|P5|Overall Study|Subject/guardian decision|0
852809|NCT01602315|2808675|P4|Overall Study|Subject/guardian decision|0
852810|NCT01602315|2808676|P3|Overall Study|Subject/guardian decision|0
852811|NCT01602315|2808677|P2|Overall Study|Subject/guardian decision|0
852812|NCT01602315|2808678|P1|Overall Study|Subject/guardian decision|0
852813|NCT01602315|2808672|P7|Overall Study|Adverse Event|9
852814|NCT01602315|2808673|P6|Overall Study|Adverse Event|3
852815|NCT01602315|2808674|P5|Overall Study|Adverse Event|15
852816|NCT01602315|2808675|P4|Overall Study|Adverse Event|4
852817|NCT01602315|2808676|P3|Overall Study|Adverse Event|5
852818|NCT01602315|2808677|P2|Overall Study|Adverse Event|1
852819|NCT01602315|2808678|P1|Overall Study|Adverse Event|5
852820|NCT01602315|2808672|P7|Overall Study|Withdrawal by Subject|1
852821|NCT01602315|2808673|P6|Overall Study|Withdrawal by Subject|0
852822|NCT01602315|2808674|P5|Overall Study|Withdrawal by Subject|6
852823|NCT01602315|2808675|P4|Overall Study|Withdrawal by Subject|0
852824|NCT01602315|2808676|P3|Overall Study|Withdrawal by Subject|2
852825|NCT01602315|2808677|P2|Overall Study|Withdrawal by Subject|0
852826|NCT01602315|2808678|P1|Overall Study|Withdrawal by Subject|2
852827|NCT01602315|2808672|P7|Overall Study|Death|2
852828|NCT01602315|2808673|P6|Overall Study|Death|2
852829|NCT01602315|2808674|P5|Overall Study|Death|7
852830|NCT01602315|2808675|P4|Overall Study|Death|1
852831|NCT01602315|2808676|P3|Overall Study|Death|1
852832|NCT01602315|2808677|P2|Overall Study|Death|1
852833|NCT01602315|2808678|P1|Overall Study|Death|1
852834|NCT01602315|2808672|P7|Overall Study|Disease progression|15
852835|NCT01602315|2808673|P6|Overall Study|Disease progression|12
852836|NCT01602315|2808674|P5|Overall Study|Disease progression|41
852837|NCT01602315|2808675|P4|Overall Study|Disease progression|1
852838|NCT01602315|2808676|P3|Overall Study|Disease progression|10
852839|NCT01602315|2808677|P2|Overall Study|Disease progression|3
852840|NCT01602315|2808678|P1|Overall Study|Disease progression|6
852841|NCT01602315|2808672|P7|Overall Study|Physician Decision|1
852842|NCT01602315|2808673|P6|Overall Study|Physician Decision|1
852843|NCT01602315|2808674|P5|Overall Study|Physician Decision|2
852844|NCT01602315|2808675|P4|Overall Study|Physician Decision|0
852845|NCT01602315|2808676|P3|Overall Study|Physician Decision|0
852846|NCT01602315|2808677|P2|Overall Study|Physician Decision|0
852847|NCT01602315|2808678|P1|Overall Study|Physician Decision|2
852848|NCT01602315|2808672|P7|Overall Study|Protocol Violation|0
852849|NCT01602315|2808673|P6|Overall Study|Protocol Violation|1
852850|NCT01602315|2808674|P5|Overall Study|Protocol Violation|0
852851|NCT01602315|2808675|P4|Overall Study|Protocol Violation|0
852852|NCT01602315|2808676|P3|Overall Study|Protocol Violation|0
852853|NCT01602315|2808677|P2|Overall Study|Protocol Violation|0
852854|NCT01602315|2808678|P1|Overall Study|Protocol Violation|0
852855|NCT01602224|2808767|P3|Overall Study|Withdrawal by Subject|3
852856|NCT01602224|2808768|P2|Overall Study|Withdrawal by Subject|3
852857|NCT01602224|2808769|P1|Overall Study|Withdrawal by Subject|5
852858|NCT01602224|2808767|P3|Overall Study|Sponsor Decision|2
852859|NCT01602224|2808768|P2|Overall Study|Sponsor Decision|3
852860|NCT01602224|2808769|P1|Overall Study|Sponsor Decision|2
852861|NCT01602224|2808767|P3|Overall Study|Protocol Violation|0
852862|NCT01602224|2808768|P2|Overall Study|Protocol Violation|1
852863|NCT01602224|2808769|P1|Overall Study|Protocol Violation|0
852864|NCT01602224|2808767|P3|Overall Study|Lost to Follow-up|1
852865|NCT01602224|2808768|P2|Overall Study|Lost to Follow-up|0
852866|NCT01602224|2808769|P1|Overall Study|Lost to Follow-up|0
852867|NCT01602224|2808767|P3|Overall Study|Investigator Decison|0
852868|NCT01602224|2808768|P2|Overall Study|Investigator Decison|0
852869|NCT01602224|2808769|P1|Overall Study|Investigator Decison|1
852870|NCT01602224|2808767|P3|Overall Study|Adverse Event|0
852871|NCT01602224|2808768|P2|Overall Study|Adverse Event|1
852872|NCT01602224|2808769|P1|Overall Study|Adverse Event|0
852873|NCT01601847|2808858|P2|Overall Study|Lost to Follow-up|3
852874|NCT01601847|2808859|P1|Overall Study|Lost to Follow-up|1
852875|NCT01601847|2808858|P2|Overall Study|Withdrawal by Subject|7
852876|NCT01601847|2808859|P1|Overall Study|Withdrawal by Subject|11
852877|NCT01601847|2808858|P2|Overall Study|Death|0
852878|NCT01601847|2808859|P1|Overall Study|Death|1
852879|NCT01601821|2808871|P2|Overall Study|Other|1
852880|NCT01601821|2808872|P1|Overall Study|Other|5
852881|NCT01601821|2808871|P2|Overall Study|Study Events|1
852882|NCT01601821|2808872|P1|Overall Study|Study Events|7
852883|NCT01601821|2808871|P2|Overall Study|Graft Loss|6
852884|NCT01601821|2808872|P1|Overall Study|Graft Loss|6
852885|NCT01601821|2808871|P2|Overall Study|Withdrawal by Subject|0
852886|NCT01601821|2808872|P1|Overall Study|Withdrawal by Subject|1
852887|NCT01601821|2808871|P2|Overall Study|Lost to Follow-up|14
852888|NCT01601821|2808872|P1|Overall Study|Lost to Follow-up|6
852889|NCT01601821|2808871|P2|Overall Study|Protocol Violation|2
852890|NCT01601821|2808872|P1|Overall Study|Protocol Violation|2
852891|NCT01601821|2808871|P2|Overall Study|Death|5
852892|NCT01601821|2808872|P1|Overall Study|Death|2
852893|NCT01601704|2808908|P2|Overall Study|Randomized but not dispensed study med|4
852894|NCT01601704|2808909|P1|Overall Study|Randomized but not dispensed study med|1
852895|NCT01601626|2808930|P3|Overall Study|Not Willing to Adhere to Requirements|0
852896|NCT01601626|2808931|P2|Overall Study|Not Willing to Adhere to Requirements|0
852897|NCT01601626|2808932|P1|Overall Study|Not Willing to Adhere to Requirements|1
852898|NCT01601626|2808930|P3|Overall Study|Withdrawal by Subject|1
852899|NCT01601626|2808931|P2|Overall Study|Withdrawal by Subject|1
852900|NCT01601626|2808932|P1|Overall Study|Withdrawal by Subject|0
852901|NCT01601626|2808930|P3|Overall Study|Unable to Get to Clinic|0
852902|NCT01601626|2808931|P2|Overall Study|Unable to Get to Clinic|1
852903|NCT01601626|2808932|P1|Overall Study|Unable to Get to Clinic|0
852904|NCT01601626|2808930|P3|Overall Study|Lost to Follow-up|0
852905|NCT01601626|2808931|P2|Overall Study|Lost to Follow-up|2
852906|NCT01601626|2808932|P1|Overall Study|Lost to Follow-up|1
852907|NCT01601626|2808930|P3|Overall Study|Death|1
852908|NCT01601626|2808931|P2|Overall Study|Death|1
852909|NCT01601626|2808932|P1|Overall Study|Death|1
852910|NCT01601470|2809015|P1|Period 2 - LCZ696|Physician Decision|1
852911|NCT01601132|2809086|P1|Overall Study|Protocol deviation|1
852912|NCT01601132|2809086|P1|Overall Study|Patient withdrew consent|1
852913|NCT01600885|2809120|P2|First Period|moved out of area|0
852914|NCT01600885|2809121|P1|First Period|moved out of area|1
852915|NCT01600885|2809120|P2|First Period|Adverse Event|1
852916|NCT01600885|2809121|P1|First Period|Adverse Event|1
852917|NCT01600716|2809138|P2|Overall Study|Adverse Event|1
852918|NCT01600716|2809139|P1|Overall Study|Adverse Event|1
852919|NCT01600716|2809138|P2|Overall Study|Lack of Efficacy|1
852920|NCT01600716|2809139|P1|Overall Study|Lack of Efficacy|2
852921|NCT01600716|2809138|P2|Overall Study|Pregnancy|0
852922|NCT01600716|2809139|P1|Overall Study|Pregnancy|1
852923|NCT01600716|2809138|P2|Overall Study|Lost to Follow-up|2
852924|NCT01600716|2809139|P1|Overall Study|Lost to Follow-up|0
852925|NCT01600716|2809138|P2|Overall Study|Personal Reasons|2
852926|NCT01600716|2809139|P1|Overall Study|Personal Reasons|0
852927|NCT01600716|2809138|P2|Overall Study|Other Reasons|1
852928|NCT01600716|2809139|P1|Overall Study|Other Reasons|3
852929|NCT01600586|2809179|P2|Overall Study|Physician Decision|3
852930|NCT01600586|2809180|P1|Overall Study|Physician Decision|3
852931|NCT01600326|2809232|P2|Overall Study|Lost to Follow-up|1
852932|NCT01600326|2809233|P1|Overall Study|Lost to Follow-up|1
852933|NCT01600092|2809309|P2|Overall Study|Randomized but not vaccinated|3
852934|NCT01600092|2809310|P1|Overall Study|Randomized but not vaccinated|3
852935|NCT01600092|2809309|P2|Overall Study|Physician Decision|1
852936|NCT01600092|2809310|P1|Overall Study|Physician Decision|1
852937|NCT01600092|2809309|P2|Overall Study|Withdrawal by parent/guardian|6
852938|NCT01600092|2809310|P1|Overall Study|Withdrawal by parent/guardian|8
852939|NCT01600092|2809309|P2|Overall Study|Lost to Follow-up|6
852940|NCT01600092|2809310|P1|Overall Study|Lost to Follow-up|4
852941|NCT01600092|2809309|P2|Overall Study|Adverse Event|0
852942|NCT01600092|2809310|P1|Overall Study|Adverse Event|2
852943|NCT01600053|2809324|P1|Overall Study|trial will not meet the interim endpoint|9
852944|NCT01600053|2809324|P1|Overall Study|Adverse Event|2
852945|NCT01600014|2809329|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0
852946|NCT01600014|2809330|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1
852947|NCT01600014|2809329|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0
852948|NCT01600014|2809330|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1
852949|NCT01600014|2809329|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0
852950|NCT01600014|2809330|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1
852951|NCT01600014|2809329|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3
852952|NCT01600014|2809330|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1
852953|NCT01600014|2809329|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
852954|NCT01600014|2809330|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
852955|NCT01600014|2809329|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0
852956|NCT01600014|2809330|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5
852957|NCT01600014|2809329|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0
852958|NCT01600014|2809330|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1
852959|NCT01600014|2809329|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1
852960|NCT01600014|2809330|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2
852961|NCT01600014|2809329|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3
852962|NCT01600014|2809330|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1
852963|NCT01600014|2809329|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2
852964|NCT01600014|2809330|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1
852965|NCT01600014|2809329|P2|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0
852966|NCT01600014|2809330|P1|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8
852967|NCT01600014|2809329|P2|1. Cycle & Observation Period D1 to W52|Protocol Violation|0
852968|NCT01600014|2809330|P1|1. Cycle & Observation Period D1 to W52|Protocol Violation|6
852969|NCT01600014|2809329|P2|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0
852970|NCT01600014|2809330|P1|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14
852971|NCT01600014|2809329|P2|1. Cycle & Observation Period D1 to W52|Other|0
852972|NCT01600014|2809330|P1|1. Cycle & Observation Period D1 to W52|Other|27
852973|NCT01600014|2809329|P2|1. Cycle & Observation Period D1 to W52|Adverse Event|0
852974|NCT01600014|2809330|P1|1. Cycle & Observation Period D1 to W52|Adverse Event|6
852975|NCT01600014|2809329|P2|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0
852976|NCT01600014|2809330|P1|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203
852977|NCT01600014|2809329|P2|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0
852978|NCT01600014|2809330|P1|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24
852979|NCT01599806|2809358|P2|Overall Study|Other Eligibility criteria|9
852980|NCT01599806|2809359|P1|Overall Study|Other Eligibility criteria|11
852981|NCT01599806|2809358|P2|Overall Study|Withdrawal by Subject|12
852982|NCT01599806|2809359|P1|Overall Study|Withdrawal by Subject|12
852983|NCT01599806|2809358|P2|Overall Study|Lost to Follow-up|20
852984|NCT01599806|2809359|P1|Overall Study|Lost to Follow-up|20
852985|NCT01599650|2809492|P3|Overall Study|Adverse Event|4
852986|NCT01599650|2809493|P2|Overall Study|Adverse Event|8
852987|NCT01599650|2809494|P1|Overall Study|Adverse Event|3
852988|NCT01599650|2809492|P3|Overall Study|Withdrawal by Subject|10
852989|NCT01599650|2809493|P2|Overall Study|Withdrawal by Subject|11
852990|NCT01599650|2809494|P1|Overall Study|Withdrawal by Subject|11
852991|NCT01599650|2809492|P3|Overall Study|Lost to Follow-up|3
852992|NCT01599650|2809493|P2|Overall Study|Lost to Follow-up|3
852993|NCT01599650|2809494|P1|Overall Study|Lost to Follow-up|3
852994|NCT01599650|2809492|P3|Overall Study|Death|2
852995|NCT01599650|2809493|P2|Overall Study|Death|1
852996|NCT01599650|2809494|P1|Overall Study|Death|2
852997|NCT01599650|2809492|P3|Overall Study|Protocol Violation|0
852998|NCT01599650|2809493|P2|Overall Study|Protocol Violation|3
852999|NCT01599650|2809494|P1|Overall Study|Protocol Violation|0
853000|NCT01599650|2809492|P3|Overall Study|Physician Decision|7
853001|NCT01599650|2809493|P2|Overall Study|Physician Decision|0
853002|NCT01599650|2809494|P1|Overall Study|Physician Decision|2
853003|NCT01599650|2809492|P3|Overall Study|Administrative issue|1
853004|NCT01599650|2809493|P2|Overall Study|Administrative issue|0
853005|NCT01599650|2809494|P1|Overall Study|Administrative issue|1
853006|NCT01599637|2809533|P3|Overall Study|Adverse Event|0
853007|NCT01599637|2809534|P2|Overall Study|Adverse Event|0
853008|NCT01599637|2809535|P1|Overall Study|Adverse Event|1
853009|NCT01599637|2809533|P3|Overall Study|administrative problems|0
853010|NCT01599637|2809534|P2|Overall Study|administrative problems|2
853011|NCT01599637|2809535|P1|Overall Study|administrative problems|0
853012|NCT01599585|2809582|P2|Overall Study|randomized did not start treatment|3
853013|NCT01599585|2809583|P1|Overall Study|randomized did not start treatment|3
853014|NCT01599585|2809582|P2|Overall Study|Lost to Follow-up|5
853015|NCT01599585|2809583|P1|Overall Study|Lost to Follow-up|3
853016|NCT01599585|2809582|P2|Overall Study|Withdrawal by Subject|9
853017|NCT01599585|2809583|P1|Overall Study|Withdrawal by Subject|16
853018|NCT01599325|2809621|P1|Overall Study|Other|2
853019|NCT01599325|2809621|P1|Overall Study|Lack of Therapeutic Effect|9
853020|NCT01599325|2809621|P1|Overall Study|Protocol Violation|1
853021|NCT01599325|2809621|P1|Overall Study|Death|13
853022|NCT01599325|2809621|P1|Overall Study|Withdrawal by Subject|20
853023|NCT01599325|2809621|P1|Overall Study|Disease Progression|7
853024|NCT01599325|2809621|P1|Overall Study|Adverse Event|5
853025|NCT01599234|2809643|P2|Overall Study|Pregnancy|1
853026|NCT01599234|2809644|P1|Overall Study|Pregnancy|0
853027|NCT01599234|2809643|P2|Overall Study|Contra-indication discovered|1
853028|NCT01599234|2809644|P1|Overall Study|Contra-indication discovered|0
853029|NCT01599234|2809643|P2|Overall Study|Patient would not stop driving|0
853030|NCT01599234|2809644|P1|Overall Study|Patient would not stop driving|1
853031|NCT01599234|2809643|P2|Overall Study|Death|0
853032|NCT01599234|2809644|P1|Overall Study|Death|1
853033|NCT01599234|2809643|P2|Overall Study|Sponsor request as creatinine levels <50|1
853034|NCT01599234|2809644|P1|Overall Study|Sponsor request as creatinine levels <50|0
853035|NCT01599234|2809643|P2|Overall Study|Unable to operate spray|0
853036|NCT01599234|2809644|P1|Overall Study|Unable to operate spray|1
853037|NCT01599234|2809643|P2|Overall Study|Lack of Efficacy|4
853038|NCT01599234|2809644|P1|Overall Study|Lack of Efficacy|2
853039|NCT01599234|2809643|P2|Overall Study|Lost to Follow-up|2
853040|NCT01599234|2809644|P1|Overall Study|Lost to Follow-up|1
853041|NCT01599234|2809643|P2|Overall Study|Withdrawal by Subject|1
853042|NCT01599234|2809644|P1|Overall Study|Withdrawal by Subject|2
853043|NCT01599234|2809643|P2|Overall Study|Adverse Event|5
853044|NCT01599234|2809644|P1|Overall Study|Adverse Event|9
853045|NCT01599104|2809669|P3|Overall Study|Adverse Event|12
853046|NCT01599104|2809670|P2|Overall Study|Adverse Event|6
853047|NCT01599104|2809671|P1|Overall Study|Adverse Event|7
853048|NCT01599104|2809669|P3|Overall Study|Lack of Efficacy|10
853049|NCT01599104|2809670|P2|Overall Study|Lack of Efficacy|4
853050|NCT01599104|2809671|P1|Overall Study|Lack of Efficacy|4
853051|NCT01599104|2809669|P3|Overall Study|Non-compliance with study treatment|0
853052|NCT01599104|2809670|P2|Overall Study|Non-compliance with study treatment|1
853053|NCT01599104|2809671|P1|Overall Study|Non-compliance with study treatment|0
853054|NCT01599104|2809669|P3|Overall Study|Physician Decision|2
853055|NCT01599104|2809670|P2|Overall Study|Physician Decision|2
853056|NCT01599104|2809671|P1|Overall Study|Physician Decision|3
853057|NCT01599104|2809669|P3|Overall Study|Technical Problems|0
853058|NCT01599104|2809670|P2|Overall Study|Technical Problems|0
853059|NCT01599104|2809671|P1|Overall Study|Technical Problems|1
853060|NCT01599104|2809669|P3|Overall Study|Withdrawal by Subject|2
853061|NCT01599104|2809670|P2|Overall Study|Withdrawal by Subject|1
853062|NCT01599104|2809671|P1|Overall Study|Withdrawal by Subject|1
853063|NCT01598987|2809709|P1|Baseline to 24 Month|Lost to Follow-up|1
853064|NCT01598987|2809709|P1|Baseline to 24 Month|Administrative problems|2
853065|NCT01598987|2809709|P1|Baseline to 24 Month|Withdrawal by Subject|5
853066|NCT01598987|2809709|P1|Baseline to Month 12|Withdrawal by Subject|4
853067|NCT01598987|2809709|P1|Baseline to Month 12|Administrative problems|2
853068|NCT01598896|2809745|P2|Overall Study|Lack of Efficacy|1
853069|NCT01598896|2809746|P1|Overall Study|Lack of Efficacy|0
853070|NCT01598896|2809745|P2|Overall Study|Withdrawal by Subject|1
853071|NCT01598896|2809746|P1|Overall Study|Withdrawal by Subject|0
853072|NCT01598662|2809792|P2|Overall Study|IUD expelled before month 6|2
853073|NCT01598662|2809793|P1|Overall Study|IUD expelled before month 6|0
853074|NCT01598662|2809792|P2|Overall Study|Physician Decision|2
853075|NCT01598662|2809793|P1|Overall Study|Physician Decision|1
853076|NCT01598662|2809792|P2|Overall Study|Lost to Follow-up|17
853077|NCT01598662|2809793|P1|Overall Study|Lost to Follow-up|10
853078|NCT01598610|2809799|P1|Overall Study|Adverse Event|1
853079|NCT01598532|2809816|P1|Overall Study|Did not meet inclusion criteria|8
853080|NCT01598532|2809816|P1|Overall Study|Lost to Follow-up|3
853081|NCT01598506|2809825|P1|Overall Study|Withdrawal by Subject|2
853082|NCT01598311|2809845|P2|Overall Study|Assigned to CB but received vancomycin|0
853083|NCT01598311|2809846|P1|Overall Study|Assigned to CB but received vancomycin|1
853084|NCT01598311|2809845|P2|Overall Study|Treated but no confirmed CDAD|8
853085|NCT01598311|2809846|P1|Overall Study|Treated but no confirmed CDAD|9
853086|NCT01598311|2809845|P2|Overall Study|Randomized but never treated|5
853087|NCT01598311|2809846|P1|Overall Study|Randomized but never treated|8
853088|NCT01598311|2809845|P2|Overall Study|No reason provided.|5
853089|NCT01598311|2809846|P1|Overall Study|No reason provided.|0
853090|NCT01598311|2809845|P2|Overall Study|Withdrawal by Subject|13
853091|NCT01598311|2809846|P1|Overall Study|Withdrawal by Subject|9
853092|NCT01598311|2809845|P2|Overall Study|Lost to Follow-up|12
853093|NCT01598311|2809846|P1|Overall Study|Lost to Follow-up|7
853094|NCT01598311|2809845|P2|Overall Study|Adverse Event|13
853095|NCT01598311|2809846|P1|Overall Study|Adverse Event|9
853096|NCT01598311|2809845|P2|Overall Study|Physician Decision|5
853097|NCT01598311|2809846|P1|Overall Study|Physician Decision|4
853098|NCT01598298|2809862|P2|Overall Study|Other reason (not protocol specified)|0
853099|NCT01598298|2809863|P1|Overall Study|Other reason (not protocol specified)|4
853100|NCT01598298|2809862|P2|Overall Study|Withdrawal by Subject|15
853101|NCT01598298|2809863|P1|Overall Study|Withdrawal by Subject|10
853102|NCT01598298|2809862|P2|Overall Study|Progression/relapse|2
853103|NCT01598298|2809863|P1|Overall Study|Progression/relapse|0
853104|NCT01598298|2809862|P2|Overall Study|Adverse Event|19
853105|NCT01598298|2809863|P1|Overall Study|Adverse Event|21
853106|NCT01598298|2809862|P2|Overall Study|Not eligible|5
853107|NCT01598298|2809863|P1|Overall Study|Not eligible|5
853108|NCT01598129|2809894|P1|Overall Study|Withdrawal by Subject|1
853109|NCT01598129|2809894|P1|Overall Study|Deterioration of WHO status to WHO 4|2
853110|NCT01598129|2809894|P1|Overall Study|Disease progression|6
853111|NCT01597908|2809926|P2|Overall Study|Ongoing|202
853112|NCT01597908|2809927|P1|Overall Study|Ongoing|236
853113|NCT01597908|2809926|P2|Overall Study|Withdrawal by Subject|18
853114|NCT01597908|2809927|P1|Overall Study|Withdrawal by Subject|10
853115|NCT01597908|2809926|P2|Overall Study|Physician Decision|1
853116|NCT01597908|2809927|P1|Overall Study|Physician Decision|2
853117|NCT01597908|2809926|P2|Overall Study|Lost to Follow-up|9
853118|NCT01597908|2809927|P1|Overall Study|Lost to Follow-up|4
853119|NCT01597908|2809926|P2|Overall Study|Death|122
853120|NCT01597908|2809927|P1|Overall Study|Death|100
853121|NCT01597791|2809954|P2|Overall Study|Protocol Violation|1
853122|NCT01597791|2809955|P1|Overall Study|Protocol Violation|0
853123|NCT01597791|2809954|P2|Overall Study|Subject withdrawal|1
853124|NCT01597791|2809955|P1|Overall Study|Subject withdrawal|0
853125|NCT01597791|2809954|P2|Overall Study|Cesarean Section|7
853126|NCT01597791|2809955|P1|Overall Study|Cesarean Section|6
853127|NCT01597791|2809954|P2|Overall Study|Physician Decision|1
853128|NCT01597791|2809955|P1|Overall Study|Physician Decision|2
853129|NCT01597635|2809964|P3|Part B|Withdrawal by Subject|0
853130|NCT01597635|2809965|P2|Part B|Withdrawal by Subject|1
853131|NCT01597635|2809966|P1|Part B|Withdrawal by Subject|0
853132|NCT01597635|2809964|P3|Part B|Protocol-defined stopping criteria|3
853133|NCT01597635|2809965|P2|Part B|Protocol-defined stopping criteria|4
853134|NCT01597635|2809966|P1|Part B|Protocol-defined stopping criteria|0
853135|NCT01597635|2809964|P3|Part B|Protocol Violation|0
853136|NCT01597635|2809965|P2|Part B|Protocol Violation|1
853137|NCT01597635|2809966|P1|Part B|Protocol Violation|0
853138|NCT01597635|2809964|P3|Part B|Adverse Event|1
853139|NCT01597635|2809965|P2|Part B|Adverse Event|0
853140|NCT01597635|2809966|P1|Part B|Adverse Event|0
853141|NCT01597635|2809964|P3|Part A|Adverse Event|0
853142|NCT01597635|2809965|P2|Part A|Adverse Event|0
853143|NCT01597635|2809966|P1|Part A|Adverse Event|3
853144|NCT01597596|2810031|P2|Overall Study|Physician Decision|1
853145|NCT01597596|2810032|P1|Overall Study|Physician Decision|0
853146|NCT01597596|2810031|P2|Overall Study|Study terminated by sponsor|0
853147|NCT01597596|2810032|P1|Overall Study|Study terminated by sponsor|1
853148|NCT01597505|2810046|P2|Overall Study|Missing|0
853149|NCT01597505|2810047|P1|Overall Study|Missing|1
853150|NCT01597505|2810046|P2|Overall Study|Other|6
853151|NCT01597505|2810047|P1|Overall Study|Other|5
853152|NCT01597505|2810046|P2|Overall Study|Withdrawal by Subject|18
853153|NCT01597505|2810047|P1|Overall Study|Withdrawal by Subject|10
853154|NCT01597505|2810046|P2|Overall Study|Lost to Follow-up|2
853155|NCT01597505|2810047|P1|Overall Study|Lost to Follow-up|4
853156|NCT01597505|2810046|P2|Overall Study|Adverse Event|7
853157|NCT01597505|2810047|P1|Overall Study|Adverse Event|19
853158|NCT01597505|2810046|P2|Overall Study|Physician Decision|0
853159|NCT01597505|2810047|P1|Overall Study|Physician Decision|5
853160|NCT01597492|2810081|P2|Overall Study|Other Reason|0
853161|NCT01597492|2810082|P1|Overall Study|Other Reason|2
853162|NCT01597492|2810081|P2|Overall Study|Lost to Follow-up|2
853163|NCT01597492|2810082|P1|Overall Study|Lost to Follow-up|0
853164|NCT01597492|2810081|P2|Overall Study|Adverse Event|0
853165|NCT01597492|2810082|P1|Overall Study|Adverse Event|3
853166|NCT01597492|2810081|P2|Overall Study|Withdrawal by Subject|2
853167|NCT01597492|2810082|P1|Overall Study|Withdrawal by Subject|1
853168|NCT01597479|2810090|P2|Overall Study|Lost to Follow-up|0
853169|NCT01597479|2810091|P1|Overall Study|Lost to Follow-up|1
853170|NCT01597479|2810090|P2|Overall Study|Protocol Violation|0
853171|NCT01597479|2810091|P1|Overall Study|Protocol Violation|1
853172|NCT01597375|2810377|P2|Second Intervention|Failed to react at both Aspirin|1
853173|NCT01597375|2810378|P1|Second Intervention|Failed to react at both Aspirin|1
853174|NCT01597375|2810377|P2|Washout (2 Weeks)|Adverse Event|0
853175|NCT01597375|2810378|P1|Washout (2 Weeks)|Adverse Event|1
853176|NCT01597375|2810377|P2|First Intervention (4 Weeks)|Lost to Follow-up|1
853177|NCT01597375|2810378|P1|First Intervention (4 Weeks)|Lost to Follow-up|0
853178|NCT01597375|2810377|P2|First Intervention (4 Weeks)|Needed surgery|0
853179|NCT01597375|2810378|P1|First Intervention (4 Weeks)|Needed surgery|1
853180|NCT01597375|2810377|P2|First Intervention (4 Weeks)|Uncontrolled Asthma|0
853181|NCT01597375|2810378|P1|First Intervention (4 Weeks)|Uncontrolled Asthma|1
853182|NCT01597245|2810399|P13|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
853183|NCT01597245|2810400|P12|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
853184|NCT01597245|2810401|P11|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1
853185|NCT01597245|2810402|P10|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
853186|NCT01597245|2810403|P9|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
853187|NCT01597245|2810404|P8|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
853188|NCT01597245|2810405|P7|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
853189|NCT01597245|2810406|P6|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
853190|NCT01597245|2810407|P5|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
853191|NCT01597245|2810408|P4|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
853192|NCT01597245|2810409|P3|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
853193|NCT01597245|2810410|P2|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
853194|NCT01597245|2810411|P1|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
853195|NCT01597245|2810399|P13|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
853196|NCT01597245|2810400|P12|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
853197|NCT01597245|2810401|P11|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
853198|NCT01597245|2810402|P10|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
853199|NCT01597245|2810403|P9|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
853200|NCT01597245|2810404|P8|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
853201|NCT01597245|2810405|P7|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
853202|NCT01597245|2810406|P6|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
853203|NCT01597245|2810407|P5|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
853204|NCT01597245|2810408|P4|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
853205|NCT01597245|2810409|P3|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
853206|NCT01597245|2810410|P2|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
853207|NCT01597245|2810411|P1|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
853208|NCT01597245|2810399|P13|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
853209|NCT01597245|2810400|P12|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
853210|NCT01597245|2810401|P11|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
853211|NCT01597245|2810402|P10|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
853212|NCT01597245|2810403|P9|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
853213|NCT01597245|2810404|P8|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
853214|NCT01597245|2810405|P7|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4
853215|NCT01597245|2810406|P6|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
853216|NCT01597245|2810407|P5|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3
853217|NCT01597245|2810408|P4|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
853218|NCT01597245|2810409|P3|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
853219|NCT01597245|2810410|P2|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
853220|NCT01597245|2810411|P1|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
853221|NCT01597245|2810399|P13|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
853222|NCT01597245|2810400|P12|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
853223|NCT01597245|2810401|P11|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2
853224|NCT01597245|2810402|P10|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
853225|NCT01597245|2810403|P9|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3
853226|NCT01597245|2810404|P8|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
853227|NCT01597245|2810405|P7|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
853228|NCT01597245|2810406|P6|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
853229|NCT01597245|2810407|P5|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
853230|NCT01597245|2810408|P4|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
853231|NCT01597245|2810409|P3|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
853232|NCT01597245|2810410|P2|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
853233|NCT01597245|2810411|P1|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
853234|NCT01597245|2810399|P13|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
853235|NCT01597245|2810400|P12|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5
853236|NCT01597245|2810401|P11|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6
853237|NCT01597245|2810402|P10|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
853238|NCT01597245|2810403|P9|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
853239|NCT01597245|2810404|P8|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
853240|NCT01597245|2810405|P7|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
853241|NCT01597245|2810406|P6|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
853242|NCT01597245|2810407|P5|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
853243|NCT01597245|2810408|P4|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
853244|NCT01597245|2810409|P3|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
853245|NCT01597245|2810410|P2|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
853246|NCT01597245|2810411|P1|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
853247|NCT01597245|2810399|P13|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
853248|NCT01597245|2810400|P12|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
853249|NCT01597245|2810401|P11|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
853250|NCT01597245|2810402|P10|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
853251|NCT01597245|2810403|P9|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
853252|NCT01597245|2810404|P8|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
853253|NCT01597245|2810405|P7|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
853254|NCT01597245|2810406|P6|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
853255|NCT01597245|2810407|P5|Maintenance Period (Week 12 to Week 60)|Adverse Event|4
853256|NCT01597245|2810408|P4|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
853257|NCT01597245|2810409|P3|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
853258|NCT01597245|2810410|P2|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
853259|NCT01597245|2810411|P1|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
853260|NCT01597245|2810399|P13|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4
853261|NCT01597245|2810400|P12|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10
853262|NCT01597245|2810401|P11|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2
853263|NCT01597245|2810402|P10|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
853264|NCT01597245|2810403|P9|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3
853265|NCT01597245|2810404|P8|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
853266|NCT01597245|2810405|P7|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1
853267|NCT01597245|2810406|P6|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
853268|NCT01597245|2810407|P5|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
853269|NCT01597245|2810408|P4|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
853270|NCT01597245|2810409|P3|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
853271|NCT01597245|2810410|P2|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
853272|NCT01597245|2810411|P1|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
853273|NCT01597245|2810399|P13|Maintenance Period (Week 12 to Week 60)|Relapsed|0
853274|NCT01597245|2810400|P12|Maintenance Period (Week 12 to Week 60)|Relapsed|0
853275|NCT01597245|2810401|P11|Maintenance Period (Week 12 to Week 60)|Relapsed|0
853276|NCT01597245|2810402|P10|Maintenance Period (Week 12 to Week 60)|Relapsed|111
853277|NCT01597245|2810403|P9|Maintenance Period (Week 12 to Week 60)|Relapsed|0
853278|NCT01597245|2810404|P8|Maintenance Period (Week 12 to Week 60)|Relapsed|2
853279|NCT01597245|2810405|P7|Maintenance Period (Week 12 to Week 60)|Relapsed|21
853280|NCT01597245|2810406|P6|Maintenance Period (Week 12 to Week 60)|Relapsed|80
853281|NCT01597245|2810407|P5|Maintenance Period (Week 12 to Week 60)|Relapsed|148
853282|NCT01597245|2810408|P4|Maintenance Period (Week 12 to Week 60)|Relapsed|0
853283|NCT01597245|2810409|P3|Maintenance Period (Week 12 to Week 60)|Relapsed|0
853284|NCT01597245|2810410|P2|Maintenance Period (Week 12 to Week 60)|Relapsed|0
853285|NCT01597245|2810411|P1|Maintenance Period (Week 12 to Week 60)|Relapsed|0
853286|NCT01597245|2810399|P13|Maintenance Period (Week 12 to Week 60)|On study treatment|0
853287|NCT01597245|2810400|P12|Maintenance Period (Week 12 to Week 60)|On study treatment|0
853288|NCT01597245|2810401|P11|Maintenance Period (Week 12 to Week 60)|On study treatment|0
853289|NCT01597245|2810402|P10|Maintenance Period (Week 12 to Week 60)|On study treatment|0
853290|NCT01597245|2810403|P9|Maintenance Period (Week 12 to Week 60)|On study treatment|0
853291|NCT01597245|2810404|P8|Maintenance Period (Week 12 to Week 60)|On study treatment|0
853292|NCT01597245|2810405|P7|Maintenance Period (Week 12 to Week 60)|On study treatment|1
853293|NCT01597245|2810406|P6|Maintenance Period (Week 12 to Week 60)|On study treatment|1
853294|NCT01597245|2810407|P5|Maintenance Period (Week 12 to Week 60)|On study treatment|0
853295|NCT01597245|2810408|P4|Maintenance Period (Week 12 to Week 60)|On study treatment|0
853296|NCT01597245|2810409|P3|Maintenance Period (Week 12 to Week 60)|On study treatment|0
853297|NCT01597245|2810410|P2|Maintenance Period (Week 12 to Week 60)|On study treatment|0
853298|NCT01597245|2810411|P1|Maintenance Period (Week 12 to Week 60)|On study treatment|0
853299|NCT01597245|2810399|P13|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
853300|NCT01597245|2810400|P12|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
853301|NCT01597245|2810401|P11|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
853302|NCT01597245|2810402|P10|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
853303|NCT01597245|2810403|P9|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
853304|NCT01597245|2810404|P8|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
853305|NCT01597245|2810405|P7|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
853306|NCT01597245|2810406|P6|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
853307|NCT01597245|2810407|P5|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
853308|NCT01597245|2810408|P4|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
853309|NCT01597245|2810409|P3|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1
853310|NCT01597245|2810410|P2|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
853311|NCT01597245|2810411|P1|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
853312|NCT01597245|2810399|P13|Induction Period (Week 0 - Week 12)|Physician Decision|0
853313|NCT01597245|2810400|P12|Induction Period (Week 0 - Week 12)|Physician Decision|0
853314|NCT01597245|2810401|P11|Induction Period (Week 0 - Week 12)|Physician Decision|0
853315|NCT01597245|2810402|P10|Induction Period (Week 0 - Week 12)|Physician Decision|0
853316|NCT01597245|2810403|P9|Induction Period (Week 0 - Week 12)|Physician Decision|0
853317|NCT01597245|2810404|P8|Induction Period (Week 0 - Week 12)|Physician Decision|0
853318|NCT01597245|2810405|P7|Induction Period (Week 0 - Week 12)|Physician Decision|0
853319|NCT01597245|2810406|P6|Induction Period (Week 0 - Week 12)|Physician Decision|0
853320|NCT01597245|2810407|P5|Induction Period (Week 0 - Week 12)|Physician Decision|0
853321|NCT01597245|2810408|P4|Induction Period (Week 0 - Week 12)|Physician Decision|1
853322|NCT01597245|2810409|P3|Induction Period (Week 0 - Week 12)|Physician Decision|0
853489|NCT01594749|2811057|P2|Overall Study|Not Treated|10
853323|NCT01597245|2810410|P2|Induction Period (Week 0 - Week 12)|Physician Decision|0
853324|NCT01597245|2810411|P1|Induction Period (Week 0 - Week 12)|Physician Decision|1
853325|NCT01597245|2810399|P13|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
853326|NCT01597245|2810400|P12|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
853327|NCT01597245|2810401|P11|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
853328|NCT01597245|2810402|P10|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
853329|NCT01597245|2810403|P9|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
853330|NCT01597245|2810404|P8|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
853331|NCT01597245|2810405|P7|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
853332|NCT01597245|2810406|P6|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
853333|NCT01597245|2810407|P5|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
853334|NCT01597245|2810408|P4|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
853335|NCT01597245|2810409|P3|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2
853336|NCT01597245|2810410|P2|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5
853337|NCT01597245|2810411|P1|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1
853338|NCT01597245|2810399|P13|Induction Period (Week 0 - Week 12)|Protocol Violation|0
853339|NCT01597245|2810400|P12|Induction Period (Week 0 - Week 12)|Protocol Violation|0
853340|NCT01597245|2810401|P11|Induction Period (Week 0 - Week 12)|Protocol Violation|0
853341|NCT01597245|2810402|P10|Induction Period (Week 0 - Week 12)|Protocol Violation|0
853342|NCT01597245|2810403|P9|Induction Period (Week 0 - Week 12)|Protocol Violation|0
853343|NCT01597245|2810404|P8|Induction Period (Week 0 - Week 12)|Protocol Violation|0
853344|NCT01597245|2810405|P7|Induction Period (Week 0 - Week 12)|Protocol Violation|0
853345|NCT01597245|2810406|P6|Induction Period (Week 0 - Week 12)|Protocol Violation|0
853346|NCT01597245|2810407|P5|Induction Period (Week 0 - Week 12)|Protocol Violation|0
853347|NCT01597245|2810408|P4|Induction Period (Week 0 - Week 12)|Protocol Violation|2
853348|NCT01597245|2810409|P3|Induction Period (Week 0 - Week 12)|Protocol Violation|5
853349|NCT01597245|2810410|P2|Induction Period (Week 0 - Week 12)|Protocol Violation|4
853350|NCT01597245|2810411|P1|Induction Period (Week 0 - Week 12)|Protocol Violation|2
853351|NCT01597245|2810399|P13|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
853352|NCT01597245|2810400|P12|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
853353|NCT01597245|2810401|P11|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
853354|NCT01597245|2810402|P10|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
853355|NCT01597245|2810403|P9|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
853356|NCT01597245|2810404|P8|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
853357|NCT01597245|2810405|P7|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
853358|NCT01597245|2810406|P6|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
853359|NCT01597245|2810407|P5|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
853360|NCT01597245|2810408|P4|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
853361|NCT01597245|2810409|P3|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6
853362|NCT01597245|2810410|P2|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8
853363|NCT01597245|2810411|P1|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
853364|NCT01597245|2810399|P13|Induction Period (Week 0 - Week 12)|Adverse Event|0
853365|NCT01597245|2810400|P12|Induction Period (Week 0 - Week 12)|Adverse Event|0
853366|NCT01597245|2810401|P11|Induction Period (Week 0 - Week 12)|Adverse Event|0
853367|NCT01597245|2810402|P10|Induction Period (Week 0 - Week 12)|Adverse Event|0
853368|NCT01597245|2810403|P9|Induction Period (Week 0 - Week 12)|Adverse Event|0
853369|NCT01597245|2810404|P8|Induction Period (Week 0 - Week 12)|Adverse Event|0
853370|NCT01597245|2810405|P7|Induction Period (Week 0 - Week 12)|Adverse Event|0
853371|NCT01597245|2810406|P6|Induction Period (Week 0 - Week 12)|Adverse Event|0
853372|NCT01597245|2810407|P5|Induction Period (Week 0 - Week 12)|Adverse Event|0
853373|NCT01597245|2810408|P4|Induction Period (Week 0 - Week 12)|Adverse Event|4
853374|NCT01597245|2810409|P3|Induction Period (Week 0 - Week 12)|Adverse Event|5
853375|NCT01597245|2810410|P2|Induction Period (Week 0 - Week 12)|Adverse Event|5
853376|NCT01597245|2810411|P1|Induction Period (Week 0 - Week 12)|Adverse Event|1
853377|NCT01597050|2810534|P2|Overall Study|Withdrawal by Subject|0
853378|NCT01597050|2810535|P1|Overall Study|Withdrawal by Subject|1
853379|NCT01596972|2810543|P2|Overall Study|Withdrawal by Subject|1
853380|NCT01596972|2810544|P1|Overall Study|Withdrawal by Subject|0
853381|NCT01596972|2810543|P2|Overall Study|Lost to Follow-up|4
853382|NCT01596972|2810544|P1|Overall Study|Lost to Follow-up|0
853383|NCT01596972|2810543|P2|Overall Study|Physician Decision|9
853384|NCT01596972|2810544|P1|Overall Study|Physician Decision|1
853385|NCT01596582|2810567|P2|Overall Study|Missing all outcome data|1
853386|NCT01596582|2810568|P1|Overall Study|Missing all outcome data|1
853387|NCT01596582|2810567|P2|Overall Study|Deemed ineligible after study visit|6
853388|NCT01596582|2810568|P1|Overall Study|Deemed ineligible after study visit|3
853389|NCT01596504|2810595|P3|Overall Study|Withdrawal by Subject|0
853390|NCT01596504|2810596|P2|Overall Study|Withdrawal by Subject|0
853391|NCT01596504|2810597|P1|Overall Study|Withdrawal by Subject|1
853392|NCT01596504|2810595|P3|Overall Study|Adverse Event|1
853393|NCT01596504|2810596|P2|Overall Study|Adverse Event|2
853394|NCT01596504|2810597|P1|Overall Study|Adverse Event|1
853395|NCT01596504|2810595|P3|Overall Study|Participant's Private Reason|0
853396|NCT01596504|2810596|P2|Overall Study|Participant's Private Reason|1
853397|NCT01596504|2810597|P1|Overall Study|Participant's Private Reason|0
853398|NCT01596335|2810655|P2|Overall Study|exacerbation of primary disease|9
853399|NCT01596335|2810656|P1|Overall Study|exacerbation of primary disease|5
853400|NCT01596127|2810692|P1|Overall Study|Patient Ineligible|1
853401|NCT01596062|2810704|P3|Overall Study|Lack of Efficacy|1
853402|NCT01596062|2810705|P2|Overall Study|Lack of Efficacy|0
853403|NCT01596062|2810706|P1|Overall Study|Lack of Efficacy|0
853404|NCT01596062|2810704|P3|Overall Study|Adverse Event|2
853405|NCT01596062|2810705|P2|Overall Study|Adverse Event|0
853406|NCT01596062|2810706|P1|Overall Study|Adverse Event|1
853407|NCT01595646|2810770|P3|Overall Study|Withdrawal by Subject|0
853408|NCT01595646|2810771|P2|Overall Study|Withdrawal by Subject|0
853409|NCT01595646|2810772|P1|Overall Study|Withdrawal by Subject|1
853410|NCT01595438|2810794|P2|Overall Study|Other Eligibility criteria|9
853411|NCT01595438|2810795|P1|Overall Study|Other Eligibility criteria|11
853412|NCT01595438|2810794|P2|Overall Study|Withdrawal by Subject|12
853413|NCT01595438|2810795|P1|Overall Study|Withdrawal by Subject|12
853414|NCT01595438|2810794|P2|Overall Study|Lost to Follow-up|20
853415|NCT01595438|2810795|P1|Overall Study|Lost to Follow-up|20
853416|NCT01595009|2810963|P4|Extension|Adverse Event|1
853417|NCT01595009|2810964|P3|Extension|Adverse Event|0
853418|NCT01595009|2810965|P2|Extension|Adverse Event|0
853419|NCT01595009|2810966|P1|Extension|Adverse Event|0
853420|NCT01595009|2810963|P4|Extension|Disease progression|7
853421|NCT01595009|2810964|P3|Extension|Disease progression|4
853422|NCT01595009|2810965|P2|Extension|Disease progression|0
853423|NCT01595009|2810966|P1|Extension|Disease progression|0
853424|NCT01595009|2810963|P4|Extension|Patients completed per protocol|2
853425|NCT01595009|2810964|P3|Extension|Patients completed per protocol|0
853426|NCT01595009|2810965|P2|Extension|Patients completed per protocol|0
853427|NCT01595009|2810966|P1|Extension|Patients completed per protocol|0
853428|NCT01595009|2810963|P4|Extension|Administrative problems|1
853429|NCT01595009|2810964|P3|Extension|Administrative problems|0
853430|NCT01595009|2810965|P2|Extension|Administrative problems|0
853431|NCT01595009|2810966|P1|Extension|Administrative problems|0
853432|NCT01595009|2810963|P4|Core|Administrative problems|0
853433|NCT01595009|2810964|P3|Core|Administrative problems|0
853434|NCT01595009|2810965|P2|Core|Administrative problems|1
853435|NCT01595009|2810966|P1|Core|Administrative problems|0
853436|NCT01595009|2810963|P4|Core|Protocol deviation|0
853437|NCT01595009|2810964|P3|Core|Protocol deviation|0
853438|NCT01595009|2810965|P2|Core|Protocol deviation|1
853439|NCT01595009|2810966|P1|Core|Protocol deviation|0
853440|NCT01595009|2810963|P4|Core|Lost to Follow-up|0
853441|NCT01595009|2810964|P3|Core|Lost to Follow-up|0
853442|NCT01595009|2810965|P2|Core|Lost to Follow-up|2
853443|NCT01595009|2810966|P1|Core|Lost to Follow-up|1
853444|NCT01595009|2810963|P4|Core|Death|0
853445|NCT01595009|2810964|P3|Core|Death|0
853446|NCT01595009|2810965|P2|Core|Death|6
853447|NCT01595009|2810966|P1|Core|Death|3
853448|NCT01595009|2810963|P4|Core|Withdrawal by Subject|0
853449|NCT01595009|2810964|P3|Core|Withdrawal by Subject|0
853450|NCT01595009|2810965|P2|Core|Withdrawal by Subject|17
853451|NCT01595009|2810966|P1|Core|Withdrawal by Subject|4
853452|NCT01595009|2810963|P4|Core|Disease progression|0
853453|NCT01595009|2810964|P3|Core|Disease progression|0
853454|NCT01595009|2810965|P2|Core|Disease progression|26
853455|NCT01595009|2810966|P1|Core|Disease progression|14
853456|NCT01595009|2810963|P4|Core|Adverse Event|0
853457|NCT01595009|2810964|P3|Core|Adverse Event|0
853458|NCT01595009|2810965|P2|Core|Adverse Event|23
853459|NCT01595009|2810966|P1|Core|Adverse Event|19
853460|NCT01595009|2810963|P4|Core|Patients completed per protocol|0
853461|NCT01595009|2810964|P3|Core|Patients completed per protocol|0
853462|NCT01595009|2810965|P2|Core|Patients completed per protocol|44
853463|NCT01595009|2810966|P1|Core|Patients completed per protocol|85
853464|NCT01594970|2811001|P3|Overall Study|Lost to Follow-up|37
853465|NCT01594970|2811002|P2|Overall Study|Lost to Follow-up|54
853466|NCT01594970|2811003|P1|Overall Study|Lost to Follow-up|54
853467|NCT01594970|2811001|P3|Overall Study|Adverse Event|23
853468|NCT01594970|2811002|P2|Overall Study|Adverse Event|23
853469|NCT01594970|2811003|P1|Overall Study|Adverse Event|17
853470|NCT01594970|2811001|P3|Overall Study|Non-Adverse Event Related|6
853471|NCT01594970|2811002|P2|Overall Study|Non-Adverse Event Related|5
853472|NCT01594970|2811003|P1|Overall Study|Non-Adverse Event Related|4
853473|NCT01594853|2811022|P2|Overall Study|noncompliance with exercise|1
853474|NCT01594853|2811023|P1|Overall Study|noncompliance with exercise|0
853475|NCT01594853|2811022|P2|Overall Study|Lost to Follow-up|1
853476|NCT01594853|2811023|P1|Overall Study|Lost to Follow-up|1
853477|NCT01594853|2811022|P2|Overall Study|Withdrawal by Subject|1
853478|NCT01594853|2811023|P1|Overall Study|Withdrawal by Subject|1
853479|NCT01594827|2811031|P2|Overall Study|Physician Decision|0
853480|NCT01594827|2811032|P1|Overall Study|Physician Decision|3
853481|NCT01594827|2811031|P2|Overall Study|Adverse Event|0
853482|NCT01594827|2811032|P1|Overall Study|Adverse Event|1
853483|NCT01594762|2811044|P2|Overall Study|Lost to Follow-up|10
853484|NCT01594762|2811045|P1|Overall Study|Lost to Follow-up|10
853485|NCT01594762|2811044|P2|Overall Study|Withdrawal by Subject|0
853486|NCT01594762|2811045|P1|Overall Study|Withdrawal by Subject|1
853487|NCT01594749|2811057|P2|Overall Study|Lost Source Documentation|0
853488|NCT01594749|2811058|P1|Overall Study|Lost Source Documentation|1
853490|NCT01594749|2811058|P1|Overall Study|Not Treated|4
853491|NCT01594749|2811057|P2|Overall Study|Death|3
853492|NCT01594749|2811058|P1|Overall Study|Death|9
853493|NCT01594749|2811057|P2|Overall Study|Lost to Follow-up|0
853494|NCT01594749|2811058|P1|Overall Study|Lost to Follow-up|1
853495|NCT01594749|2811057|P2|Overall Study|Non-compliance with Protocol|1
853496|NCT01594749|2811058|P1|Overall Study|Non-compliance with Protocol|0
853497|NCT01594749|2811057|P2|Overall Study|Physician Decision|1
853498|NCT01594749|2811058|P1|Overall Study|Physician Decision|1
853499|NCT01594749|2811057|P2|Overall Study|Protocol Violation|0
853500|NCT01594749|2811058|P1|Overall Study|Protocol Violation|2
853501|NCT01594749|2811057|P2|Overall Study|Withdrawal by Subject|2
853502|NCT01594749|2811058|P1|Overall Study|Withdrawal by Subject|2
853503|NCT01594749|2811057|P2|Overall Study|Adverse Event|1
853504|NCT01594749|2811058|P1|Overall Study|Adverse Event|2
853505|NCT01594411|2811187|P1|Overall Study|Lost to Follow-up|2
853506|NCT01594125|2811241|P5|Overall Study|Progressive Disease|7
853507|NCT01594125|2811242|P4|Overall Study|Progressive Disease|3
853508|NCT01594125|2811243|P3|Overall Study|Progressive Disease|3
853509|NCT01594125|2811244|P2|Overall Study|Progressive Disease|12
853510|NCT01594125|2811245|P1|Overall Study|Progressive Disease|3
853511|NCT01594125|2811241|P5|Overall Study|Withdrawal by Subject|0
853512|NCT01594125|2811242|P4|Overall Study|Withdrawal by Subject|1
853513|NCT01594125|2811243|P3|Overall Study|Withdrawal by Subject|0
853514|NCT01594125|2811244|P2|Overall Study|Withdrawal by Subject|0
853515|NCT01594125|2811245|P1|Overall Study|Withdrawal by Subject|1
853516|NCT01593787|2811305|P3|Overall Study|Adverse Event|0
853517|NCT01593787|2811306|P2|Overall Study|Adverse Event|0
853518|NCT01593787|2811307|P1|Overall Study|Adverse Event|1
853519|NCT01592864|2811394|P2|Overall Study|Withdrawal by Subject|1
853520|NCT01592864|2811395|P1|Overall Study|Withdrawal by Subject|0
853521|NCT01592786|2811456|P1|Overall Study|Other|3
853522|NCT01592786|2811456|P1|Overall Study|Lost to Follow-up|19
853523|NCT01592786|2811456|P1|Overall Study|Withdrawal by Subject|23
853524|NCT01592786|2811456|P1|Overall Study|Protocol Violation|14
853525|NCT01592786|2811456|P1|Overall Study|Lack of Efficacy|19
853526|NCT01592786|2811456|P1|Overall Study|Adverse Event|60
853527|NCT01592773|2811460|P1|Overall Study|Other Reason|1
853528|NCT01592773|2811460|P1|Overall Study|Inclusion/exclusion not meet|1
853529|NCT01592773|2811460|P1|Overall Study|Protocol Violation|2
853530|NCT01592773|2811460|P1|Overall Study|Lack of Efficacy|9
853531|NCT01592773|2811460|P1|Overall Study|Adverse Event|17
853532|NCT01592773|2811460|P1|Overall Study|Lost to Follow-up|19
853533|NCT01592773|2811460|P1|Overall Study|Withdrawal by Subject|35
853534|NCT01592773|2811460|P1|Overall Study|Study Terminated by Sponsor|582
853535|NCT01592760|2811467|P3|24-hour Follow-Up|Lost to Follow-up|2
853536|NCT01592760|2811468|P2|24-hour Follow-Up|Lost to Follow-up|3
853537|NCT01592760|2811469|P1|24-hour Follow-Up|Lost to Follow-up|4
853538|NCT01592708|2811512|P2|Overall Study|Protocol Violation|0
853539|NCT01592708|2811513|P1|Overall Study|Protocol Violation|3
853540|NCT01592695|2811529|P2|Overall Study|Lost to Follow-up|4
853541|NCT01592695|2811530|P1|Overall Study|Lost to Follow-up|8
853542|NCT01592383|2811572|P1|Overall Study|Adverse Event|1
853543|NCT01592344|2811583|P2|Overall Study|not available at primary outcome visit|4
853544|NCT01592344|2811584|P1|Overall Study|not available at primary outcome visit|2
853545|NCT01592344|2811583|P2|Overall Study|Lack of Efficacy|0
853546|NCT01592344|2811584|P1|Overall Study|Lack of Efficacy|1
853547|NCT01592344|2811583|P2|Overall Study|Adverse Event|1
853548|NCT01592344|2811584|P1|Overall Study|Adverse Event|1
853549|NCT01592292|2811598|P4|Overall Study|Not specified|1
853550|NCT01592292|2811599|P3|Overall Study|Not specified|2
853551|NCT01592292|2811600|P2|Overall Study|Not specified|1
853552|NCT01592292|2811601|P1|Overall Study|Not specified|1
853553|NCT01592292|2811598|P4|Overall Study|Withdrew consent|0
853554|NCT01592292|2811599|P3|Overall Study|Withdrew consent|0
853555|NCT01592292|2811600|P2|Overall Study|Withdrew consent|1
853556|NCT01592292|2811601|P1|Overall Study|Withdrew consent|2
853557|NCT01592292|2811598|P4|Overall Study|Follow-up loss|0
853558|NCT01592292|2811599|P3|Overall Study|Follow-up loss|1
853559|NCT01592292|2811600|P2|Overall Study|Follow-up loss|3
853560|NCT01592292|2811601|P1|Overall Study|Follow-up loss|3
853561|NCT01592240|2811640|P7|Overall Study|Did Not Meet Entrance Criteria|0
853562|NCT01592240|2811641|P6|Overall Study|Did Not Meet Entrance Criteria|0
853563|NCT01592240|2811642|P5|Overall Study|Did Not Meet Entrance Criteria|0
853564|NCT01592240|2811643|P4|Overall Study|Did Not Meet Entrance Criteria|0
853565|NCT01592240|2811644|P3|Overall Study|Did Not Meet Entrance Criteria|1
853566|NCT01592240|2811645|P2|Overall Study|Did Not Meet Entrance Criteria|0
853567|NCT01592240|2811646|P1|Overall Study|Did Not Meet Entrance Criteria|1
853568|NCT01592240|2811640|P7|Overall Study|Other|1
853569|NCT01592240|2811641|P6|Overall Study|Other|0
853570|NCT01592240|2811642|P5|Overall Study|Other|0
853571|NCT01592240|2811643|P4|Overall Study|Other|1
853572|NCT01592240|2811644|P3|Overall Study|Other|1
853573|NCT01592240|2811645|P2|Overall Study|Other|3
853574|NCT01592240|2811646|P1|Overall Study|Other|0
853575|NCT01592240|2811640|P7|Overall Study|Withdrawal by Subject|2
853576|NCT01592240|2811641|P6|Overall Study|Withdrawal by Subject|0
853577|NCT01592240|2811642|P5|Overall Study|Withdrawal by Subject|3
853578|NCT01592240|2811643|P4|Overall Study|Withdrawal by Subject|1
853579|NCT01592240|2811644|P3|Overall Study|Withdrawal by Subject|4
853580|NCT01592240|2811645|P2|Overall Study|Withdrawal by Subject|4
853581|NCT01592240|2811646|P1|Overall Study|Withdrawal by Subject|0
853582|NCT01592240|2811640|P7|Overall Study|Protocol Violation|0
853583|NCT01592240|2811641|P6|Overall Study|Protocol Violation|1
853584|NCT01592240|2811642|P5|Overall Study|Protocol Violation|0
853585|NCT01592240|2811643|P4|Overall Study|Protocol Violation|0
853586|NCT01592240|2811644|P3|Overall Study|Protocol Violation|0
853587|NCT01592240|2811645|P2|Overall Study|Protocol Violation|0
853588|NCT01592240|2811646|P1|Overall Study|Protocol Violation|0
853589|NCT01592240|2811640|P7|Overall Study|Lost to Follow-up|0
853590|NCT01592240|2811641|P6|Overall Study|Lost to Follow-up|2
853591|NCT01592240|2811642|P5|Overall Study|Lost to Follow-up|3
853592|NCT01592240|2811643|P4|Overall Study|Lost to Follow-up|0
853593|NCT01592240|2811644|P3|Overall Study|Lost to Follow-up|1
853594|NCT01592240|2811645|P2|Overall Study|Lost to Follow-up|3
853595|NCT01592240|2811646|P1|Overall Study|Lost to Follow-up|1
853596|NCT01592240|2811640|P7|Overall Study|Death|0
853597|NCT01592240|2811641|P6|Overall Study|Death|0
853598|NCT01592240|2811642|P5|Overall Study|Death|0
853599|NCT01592240|2811643|P4|Overall Study|Death|0
853600|NCT01592240|2811644|P3|Overall Study|Death|0
853601|NCT01592240|2811645|P2|Overall Study|Death|1
853602|NCT01592240|2811646|P1|Overall Study|Death|0
853603|NCT01592240|2811640|P7|Overall Study|Adverse Event|0
853604|NCT01592240|2811641|P6|Overall Study|Adverse Event|0
853605|NCT01592240|2811642|P5|Overall Study|Adverse Event|1
853606|NCT01592240|2811643|P4|Overall Study|Adverse Event|1
853607|NCT01592240|2811644|P3|Overall Study|Adverse Event|0
853608|NCT01592240|2811645|P2|Overall Study|Adverse Event|0
853609|NCT01592240|2811646|P1|Overall Study|Adverse Event|1
853610|NCT01592045|2811839|P2|Overall Study|Moved out of country|0
853611|NCT01592045|2811840|P1|Overall Study|Moved out of country|2
853612|NCT01592045|2811839|P2|Overall Study|Withdrawal by Subject|0
853613|NCT01592045|2811840|P1|Overall Study|Withdrawal by Subject|1
853614|NCT01592045|2811839|P2|Overall Study|Adverse Event|1
853615|NCT01592045|2811840|P1|Overall Study|Adverse Event|1
853616|NCT01592045|2811839|P2|Overall Study|Disease Progression|1
853617|NCT01592045|2811840|P1|Overall Study|Disease Progression|1
853618|NCT01591863|2811858|P1|Overall Study|Lack of Efficacy|1
853619|NCT01591863|2811858|P1|Overall Study|recurrence|9
853620|NCT01591863|2811858|P1|Overall Study|Withdrawal by Subject|1
853621|NCT01591863|2811858|P1|Overall Study|Adverse Event|3
853622|NCT01591681|2811896|P1|Overall Study|Failed to use system during run-in|1
853623|NCT01591681|2811896|P1|Overall Study|Didn't meet min hypoglycemia requirement|3
853624|NCT01591616|2811922|P1|Overall Study|Withdrawal by Subject|1
853625|NCT01591499|2812063|P4|Second Intervention (up to 24 Days)|Lost to Follow-up|3
853626|NCT01591499|2812064|P3|Second Intervention (up to 24 Days)|Lost to Follow-up|1
853627|NCT01591499|2812065|P2|Second Intervention (up to 24 Days)|Lost to Follow-up|3
853628|NCT01591499|2812066|P1|Second Intervention (up to 24 Days)|Lost to Follow-up|4
853629|NCT01591499|2812063|P4|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
853630|NCT01591499|2812064|P3|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
853631|NCT01591499|2812065|P2|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
853632|NCT01591499|2812066|P1|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
853633|NCT01591499|2812063|P4|Baseline Visit|Withdrawal by Subject|2
853634|NCT01591499|2812064|P3|Baseline Visit|Withdrawal by Subject|0
853635|NCT01591499|2812065|P2|Baseline Visit|Withdrawal by Subject|2
853636|NCT01591499|2812066|P1|Baseline Visit|Withdrawal by Subject|0
853637|NCT01591460|2812132|P1|Overall Study|Protocol Violation|1
853638|NCT01591460|2812132|P1|Overall Study|Withdrawal by Subject|1
853639|NCT01591460|2812132|P1|Overall Study|Participant Refusal|3
853640|NCT01591460|2812132|P1|Overall Study|Noncompliance|1
853641|NCT01591460|2812132|P1|Overall Study|Lost to Follow-up|1
853642|NCT01591460|2812132|P1|Overall Study|Treatment Discontinued by Error|1
853643|NCT01591460|2812132|P1|Overall Study|Rebound or Breakthrough|3
853644|NCT01591460|2812132|P1|Overall Study|Futility Rule (Week 24)|3
853645|NCT01591460|2812132|P1|Overall Study|Futility Rule (Week 12)|7
853646|NCT01591460|2812132|P1|Overall Study|Adverse Event or Intercurrent Illness|5
853647|NCT01591382|2812223|P2|Overall Study|Participant Opted for Morphine PCA|1
853648|NCT01591382|2812224|P1|Overall Study|Participant Opted for Morphine PCA|1
853649|NCT01591382|2812223|P2|Overall Study|Discharged Prior to Study Completion|1
853650|NCT01591382|2812224|P1|Overall Study|Discharged Prior to Study Completion|2
853651|NCT01591096|2812269|P1|Overall Study|Adverse Event|1
853652|NCT01590888|2812354|P3|Overall Study|Lost to Follow-up|0
853653|NCT01590888|2812355|P2|Overall Study|Lost to Follow-up|0
853654|NCT01590888|2812356|P1|Overall Study|Lost to Follow-up|1
853655|NCT01590888|2812354|P3|Overall Study|Adverse Event|1
853656|NCT01590888|2812355|P2|Overall Study|Adverse Event|0
853657|NCT01590888|2812356|P1|Overall Study|Adverse Event|3
853658|NCT01590810|2812416|P5|Overall Study|Physician Decision|0
853659|NCT01590810|2812417|P4|Overall Study|Physician Decision|0
853660|NCT01590810|2812418|P3|Overall Study|Physician Decision|1
853661|NCT01590810|2812419|P2|Overall Study|Physician Decision|1
853662|NCT01590810|2812420|P1|Overall Study|Physician Decision|0
853663|NCT01590797|2812565|P2|Overall Study|Other Protocol Specified Criteria|4
853664|NCT01590797|2812566|P1|Overall Study|Other Protocol Specified Criteria|2
853665|NCT01590797|2812565|P2|Overall Study|Withdrawal by Subject|5
853666|NCT01590797|2812566|P1|Overall Study|Withdrawal by Subject|7
853667|NCT01590797|2812565|P2|Overall Study|Protocol Violation|1
853668|NCT01590797|2812566|P1|Overall Study|Protocol Violation|4
853669|NCT01590797|2812565|P2|Overall Study|Lost to Follow-up|1
853670|NCT01590797|2812566|P1|Overall Study|Lost to Follow-up|0
853671|NCT01590797|2812565|P2|Overall Study|Lack of Efficacy|2
853672|NCT01590797|2812566|P1|Overall Study|Lack of Efficacy|0
853673|NCT01590797|2812565|P2|Overall Study|Adverse Event|3
853674|NCT01590797|2812566|P1|Overall Study|Adverse Event|4
853675|NCT01590771|2812582|P2|Overall Study|Adverse Event|7
853676|NCT01590771|2812583|P1|Overall Study|Adverse Event|3
853677|NCT01590771|2812582|P2|Overall Study|Lack of Efficacy|0
853678|NCT01590771|2812583|P1|Overall Study|Lack of Efficacy|1
853679|NCT01590771|2812582|P2|Overall Study|Lost to Follow-up|1
853680|NCT01590771|2812583|P1|Overall Study|Lost to Follow-up|1
853681|NCT01590771|2812582|P2|Overall Study|Protocol Violation|2
853682|NCT01590771|2812583|P1|Overall Study|Protocol Violation|1
853683|NCT01590771|2812582|P2|Overall Study|Withdrawal by Subject|15
853684|NCT01590771|2812583|P1|Overall Study|Withdrawal by Subject|8
853685|NCT01590771|2812582|P2|Overall Study|Other Protocol Specified Criteria|14
853686|NCT01590771|2812583|P1|Overall Study|Other Protocol Specified Criteria|5
853687|NCT01590758|2812611|P2|Overall Study|Lost to Follow-up|2
853688|NCT01590758|2812612|P1|Overall Study|Lost to Follow-up|4
853689|NCT01590758|2812611|P2|Overall Study|Physician Decision|2
853690|NCT01590758|2812612|P1|Overall Study|Physician Decision|1
853691|NCT01590758|2812611|P2|Overall Study|Withdrawal by Subject|3
853692|NCT01590758|2812612|P1|Overall Study|Withdrawal by Subject|0
853693|NCT01590563|2812622|P1|Overall Study|simple uterine hyperplasia - not related|1
853694|NCT01590212|2812650|P3|Overall Study|Lost to Follow-up|3
853695|NCT01590212|2812651|P2|Overall Study|Lost to Follow-up|2
853696|NCT01590212|2812652|P1|Overall Study|Lost to Follow-up|1
853697|NCT01590212|2812650|P3|Overall Study|Withdrawal by Subject|2
853698|NCT01590212|2812651|P2|Overall Study|Withdrawal by Subject|2
853699|NCT01590212|2812652|P1|Overall Study|Withdrawal by Subject|2
853700|NCT01589822|2812696|P3|Overall Study|Missed 90 day visit|1
853701|NCT01589822|2812697|P2|Overall Study|Missed 90 day visit|1
853702|NCT01589822|2812698|P1|Overall Study|Missed 90 day visit|2
853703|NCT01589822|2812696|P3|Overall Study|Death|0
853704|NCT01589822|2812697|P2|Overall Study|Death|0
853705|NCT01589822|2812698|P1|Overall Study|Death|1
853706|NCT01589822|2812696|P3|Overall Study|Withdrawal by Subject|0
853707|NCT01589822|2812697|P2|Overall Study|Withdrawal by Subject|2
853708|NCT01589822|2812698|P1|Overall Study|Withdrawal by Subject|1
853709|NCT01589653|2812717|P2|Overall Study|Unclassified|3
853710|NCT01589653|2812718|P1|Overall Study|Unclassified|0
853711|NCT01589653|2812717|P2|Overall Study|Withdrawal criteria|7
853712|NCT01589653|2812718|P1|Overall Study|Withdrawal criteria|4
853713|NCT01589653|2812717|P2|Overall Study|Protocol Violation|1
853714|NCT01589653|2812718|P1|Overall Study|Protocol Violation|3
853715|NCT01589497|2812766|P4|Overall Study|Pre-entry overnight sputum< 10ML|0
853716|NCT01589497|2812767|P3|Overall Study|Pre-entry overnight sputum< 10ML|1
853717|NCT01589497|2812768|P2|Overall Study|Pre-entry overnight sputum< 10ML|0
853718|NCT01589497|2812769|P1|Overall Study|Pre-entry overnight sputum< 10ML|0
853719|NCT01589497|2812766|P4|Overall Study|Death|0
853720|NCT01589497|2812767|P3|Overall Study|Death|0
853721|NCT01589497|2812768|P2|Overall Study|Death|0
853722|NCT01589497|2812769|P1|Overall Study|Death|1
853723|NCT01589497|2812766|P4|Overall Study|Withdrawal by Subject|1
853724|NCT01589497|2812767|P3|Overall Study|Withdrawal by Subject|0
853725|NCT01589497|2812768|P2|Overall Study|Withdrawal by Subject|1
853726|NCT01589497|2812769|P1|Overall Study|Withdrawal by Subject|0
853727|NCT01589445|2812875|P1|002 (Metformin)-3 Months|Husbands of female patients refrained|2
853728|NCT01589445|2812875|P1|002 (Metformin)-3 Months|Adverse Event|2
853729|NCT01589445|2812875|P1|002 (Metformin)-3 Months|Protocol Violation|2
853730|NCT01589445|2812875|P1|002 (Metformin)-3 Months|Lost to Follow-up|2
853731|NCT01589445|2812875|P1|002 (Metformin)-3 Months|Lack of Efficacy|1
853732|NCT01589445|2812875|P1|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2
853733|NCT01589445|2812875|P1|001 (Pioglitazone) -3 Months|Lack of Efficacy|1
853734|NCT01589445|2812875|P1|001 (Pioglitazone) -3 Months|Lost to Follow-up|2
853735|NCT01589445|2812875|P1|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1
853736|NCT01589445|2812875|P1|001 (Pioglitazone) -3 Months|Protocol Violation|1
853737|NCT01589237|2812895|P4|Part B (Planned for 78 Week-terminated)|Physician Decision|1
853738|NCT01589237|2812896|P3|Part B (Planned for 78 Week-terminated)|Physician Decision|0
853739|NCT01589237|2812897|P2|Part B (Planned for 78 Week-terminated)|Physician Decision|0
853740|NCT01589237|2812898|P1|Part B (Planned for 78 Week-terminated)|Physician Decision|0
853741|NCT01589237|2812895|P4|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3
853742|NCT01589237|2812896|P3|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4
853743|NCT01589237|2812897|P2|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
853744|NCT01589237|2812898|P1|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
853745|NCT01589237|2812895|P4|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
853746|NCT01589237|2812896|P3|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
853747|NCT01589237|2812897|P2|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1
853748|NCT01589237|2812898|P1|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
853749|NCT01589237|2812895|P4|Part A (52 Weeks)|Subject/guardian decision|0
853750|NCT01589237|2812896|P3|Part A (52 Weeks)|Subject/guardian decision|2
853751|NCT01589237|2812897|P2|Part A (52 Weeks)|Subject/guardian decision|3
853752|NCT01589237|2812898|P1|Part A (52 Weeks)|Subject/guardian decision|2
853753|NCT01588951|2812947|P3|Overall Study|Ineligible in retrospect|1
853754|NCT01588951|2812948|P2|Overall Study|Ineligible in retrospect|0
853755|NCT01588951|2812949|P1|Overall Study|Ineligible in retrospect|0
853756|NCT01588548|2812980|P6|Overall Study|Condition Under Investigation Worsened|3
853757|NCT01588548|2812981|P5|Overall Study|Condition Under Investigation Worsened|3
853758|NCT01588548|2812982|P4|Overall Study|Condition Under Investigation Worsened|4
853759|NCT01588548|2812983|P3|Overall Study|Condition Under Investigation Worsened|4
853760|NCT01588548|2812984|P2|Overall Study|Condition Under Investigation Worsened|6
853761|NCT01588548|2812985|P1|Overall Study|Condition Under Investigation Worsened|3
853762|NCT01588548|2812980|P6|Overall Study|Adverse Event|0
853763|NCT01588548|2812981|P5|Overall Study|Adverse Event|1
853764|NCT01588548|2812982|P4|Overall Study|Adverse Event|2
853765|NCT01588548|2812983|P3|Overall Study|Adverse Event|1
853766|NCT01588548|2812984|P2|Overall Study|Adverse Event|0
853767|NCT01588548|2812985|P1|Overall Study|Adverse Event|0
853768|NCT01588548|2812980|P6|Overall Study|Withdrawal by Subject|3
853769|NCT01588548|2812981|P5|Overall Study|Withdrawal by Subject|2
853770|NCT01588548|2812982|P4|Overall Study|Withdrawal by Subject|1
853771|NCT01588548|2812983|P3|Overall Study|Withdrawal by Subject|1
853772|NCT01588548|2812984|P2|Overall Study|Withdrawal by Subject|1
853773|NCT01588548|2812985|P1|Overall Study|Withdrawal by Subject|0
853774|NCT01588496|2813002|P3|Overall Study|Withdrawal by Subject|0
853775|NCT01588496|2813003|P2|Overall Study|Withdrawal by Subject|1
853776|NCT01588496|2813004|P1|Overall Study|Withdrawal by Subject|0
853777|NCT01588405|2813054|P1|Overall Study|Clinical Worsening|1
853778|NCT01588405|2813054|P1|Overall Study|Adverse Event|1
853779|NCT01588353|2813081|P3|Step3|Adverse Event|2
853780|NCT01588353|2813082|P2|Step3|Adverse Event|0
853781|NCT01588353|2813083|P1|Step3|Adverse Event|0
853782|NCT01588353|2813081|P3|Step2|Withdrawal by Subject|0
853783|NCT01588353|2813082|P2|Step2|Withdrawal by Subject|1
853784|NCT01588353|2813083|P1|Step2|Withdrawal by Subject|0
853785|NCT01588106|2813126|P2|Overall Study|Withdrawal by Subject|4
853786|NCT01588106|2813127|P1|Overall Study|Withdrawal by Subject|5
853787|NCT01587989|2813135|P3|Randomized Study Treatment|Physician Decision|1
853788|NCT01587989|2813136|P2|Randomized Study Treatment|Physician Decision|0
853789|NCT01587989|2813137|P1|Randomized Study Treatment|Physician Decision|0
853790|NCT01587989|2813135|P3|Randomized Study Treatment|Screening failure|0
853791|NCT01587989|2813136|P2|Randomized Study Treatment|Screening failure|1
853792|NCT01587989|2813137|P1|Randomized Study Treatment|Screening failure|0
853793|NCT01587989|2813135|P3|Randomized Study Treatment|Withdrawal by Subject|0
853794|NCT01587989|2813136|P2|Randomized Study Treatment|Withdrawal by Subject|1
853795|NCT01587989|2813137|P1|Randomized Study Treatment|Withdrawal by Subject|0
853796|NCT01587989|2813135|P3|12-Week Open-Label Run-In Period|No EULAR Response|0
853797|NCT01587989|2813136|P2|12-Week Open-Label Run-In Period|No EULAR Response|0
853798|NCT01587989|2813137|P1|12-Week Open-Label Run-In Period|No EULAR Response|4
853799|NCT01587989|2813135|P3|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
853800|NCT01587989|2813136|P2|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
853801|NCT01587989|2813137|P1|12-Week Open-Label Run-In Period|Withdrawal by Subject|1
853802|NCT01587989|2813135|P3|12-Week Open-Label Run-In Period|Physician Decision|0
853803|NCT01587989|2813136|P2|12-Week Open-Label Run-In Period|Physician Decision|0
853804|NCT01587989|2813137|P1|12-Week Open-Label Run-In Period|Physician Decision|7
853805|NCT01587924|2813202|P4|Overall Study|Withdrawal by Subject|0
853806|NCT01587924|2813203|P3|Overall Study|Withdrawal by Subject|1
853807|NCT01587924|2813204|P2|Overall Study|Withdrawal by Subject|1
853808|NCT01587924|2813205|P1|Overall Study|Withdrawal by Subject|0
853809|NCT01587924|2813202|P4|Overall Study|Met Hemoglobin stopping criteria|0
853810|NCT01587924|2813203|P3|Overall Study|Met Hemoglobin stopping criteria|1
853811|NCT01587924|2813204|P2|Overall Study|Met Hemoglobin stopping criteria|0
853812|NCT01587924|2813205|P1|Overall Study|Met Hemoglobin stopping criteria|2
853813|NCT01587924|2813202|P4|Overall Study|Protocol Violation|1
853814|NCT01587924|2813203|P3|Overall Study|Protocol Violation|2
853815|NCT01587924|2813204|P2|Overall Study|Protocol Violation|1
853816|NCT01587924|2813205|P1|Overall Study|Protocol Violation|2
853817|NCT01587924|2813202|P4|Overall Study|Adverse Event|0
853818|NCT01587924|2813203|P3|Overall Study|Adverse Event|0
853819|NCT01587924|2813204|P2|Overall Study|Adverse Event|2
853820|NCT01587924|2813205|P1|Overall Study|Adverse Event|0
853821|NCT01587898|2813306|P4|Overall Study|Met haemoglobin stopping criteria|0
853822|NCT01587898|2813307|P3|Overall Study|Met haemoglobin stopping criteria|1
853823|NCT01587898|2813308|P2|Overall Study|Met haemoglobin stopping criteria|1
853824|NCT01587898|2813309|P1|Overall Study|Met haemoglobin stopping criteria|1
853825|NCT01587898|2813306|P4|Overall Study|Withdrawal by Subject|0
853826|NCT01587898|2813307|P3|Overall Study|Withdrawal by Subject|0
853827|NCT01587898|2813308|P2|Overall Study|Withdrawal by Subject|1
853828|NCT01587898|2813309|P1|Overall Study|Withdrawal by Subject|2
853829|NCT01587898|2813306|P4|Overall Study|Lost to Follow-up|1
853830|NCT01587898|2813307|P3|Overall Study|Lost to Follow-up|0
853831|NCT01587898|2813308|P2|Overall Study|Lost to Follow-up|0
853832|NCT01587898|2813309|P1|Overall Study|Lost to Follow-up|0
853833|NCT01587898|2813306|P4|Overall Study|Protocol Violation|1
853834|NCT01587898|2813307|P3|Overall Study|Protocol Violation|1
853835|NCT01587898|2813308|P2|Overall Study|Protocol Violation|2
853836|NCT01587898|2813309|P1|Overall Study|Protocol Violation|0
853837|NCT01587898|2813306|P4|Overall Study|Adverse Event|0
853838|NCT01587898|2813307|P3|Overall Study|Adverse Event|0
853839|NCT01587898|2813308|P2|Overall Study|Adverse Event|1
853840|NCT01587898|2813309|P1|Overall Study|Adverse Event|1
853841|NCT01587885|2813485|P2|Treatment Period 1|Protocol Violation|2
853842|NCT01587885|2813486|P1|Treatment Period 1|Protocol Violation|0
853843|NCT01587885|2813485|P2|Treatment Period 1|Failure to Return|1
853844|NCT01587885|2813486|P1|Treatment Period 1|Failure to Return|0
853845|NCT01587651|2813502|P3|Overall Study|Withdrawal by Subject|0
853846|NCT01587651|2813503|P2|Overall Study|Withdrawal by Subject|1
853847|NCT01587651|2813504|P1|Overall Study|Withdrawal by Subject|0
853848|NCT01587651|2813502|P3|Overall Study|Protocol Violation|1
853849|NCT01587651|2813503|P2|Overall Study|Protocol Violation|1
853850|NCT01587651|2813504|P1|Overall Study|Protocol Violation|0
853851|NCT01587651|2813502|P3|Overall Study|Adverse Event|0
853852|NCT01587651|2813503|P2|Overall Study|Adverse Event|1
853853|NCT01587651|2813504|P1|Overall Study|Adverse Event|0
853854|NCT01587274|2813534|P3|Overall Study|Lost to Follow-up|3
853855|NCT01587274|2813535|P2|Overall Study|Lost to Follow-up|5
853856|NCT01587274|2813536|P1|Overall Study|Lost to Follow-up|4
853857|NCT01587118|2813544|P1|Overall Study|nonresponse|1
853858|NCT01587118|2813544|P1|Overall Study|Relocation|1
853859|NCT01587118|2813544|P1|Overall Study|Lost to Follow-up|2
853860|NCT01587118|2813544|P1|Overall Study|Adverse Event|3
853861|NCT01587079|2813568|P1|Overall Study|Adverse Event|14
853862|NCT01587079|2813568|P1|Overall Study|Withdrawal by Subject|7
853863|NCT01587079|2813568|P1|Overall Study|Physician Decision|2
853864|NCT01587079|2813568|P1|Overall Study|Lost to Follow-up|2
853865|NCT01587079|2813568|P1|Overall Study|Protocol Violation|5
853866|NCT01587079|2813568|P1|Overall Study|Protocol-specified criteria|9
853867|NCT01587014|2813699|P1|Overall Study|Death|2
853868|NCT01587001|2813706|P2|Overall Study|Insufficient samples to complete testing|1
853869|NCT01587001|2813707|P1|Overall Study|Insufficient samples to complete testing|4
853870|NCT01587001|2813706|P2|Overall Study|Lost to Follow-up|0
853871|NCT01587001|2813707|P1|Overall Study|Lost to Follow-up|2
853872|NCT01586819|2813755|P2|Overall Study|Withdrawal by Subject|0
853873|NCT01586819|2813756|P1|Overall Study|Withdrawal by Subject|1
853874|NCT01586806|2813767|P3|Overall Study|Lost to Follow-up|2
853875|NCT01586806|2813768|P2|Overall Study|Lost to Follow-up|3
853876|NCT01586806|2813769|P1|Overall Study|Lost to Follow-up|2
853877|NCT01586806|2813767|P3|Overall Study|Withdrawal by Subject|0
853878|NCT01586806|2813768|P2|Overall Study|Withdrawal by Subject|0
853879|NCT01586806|2813769|P1|Overall Study|Withdrawal by Subject|1
853880|NCT01586806|2813767|P3|Overall Study|Protocol Violation|0
853881|NCT01586806|2813768|P2|Overall Study|Protocol Violation|1
853882|NCT01586806|2813769|P1|Overall Study|Protocol Violation|0
853883|NCT01586364|2813789|P1|Overall Study|Other-Not specified|1
853884|NCT01586364|2813789|P1|Overall Study|Other-PI discretion, site closing|2
853885|NCT01586364|2813789|P1|Overall Study|Other-Site closure due to PI illness|1
853886|NCT01586364|2813789|P1|Overall Study|Other-Subject wasn't getting much relief|1
853887|NCT01586364|2813789|P1|Overall Study|Other-Did not feel better post-treatment|1
853888|NCT01586364|2813789|P1|Overall Study|Lack of Efficacy|1
853889|NCT01586364|2813789|P1|Overall Study|Protocol Violation|16
853890|NCT01586364|2813789|P1|Overall Study|Lost to Follow-up|17
853891|NCT01586364|2813789|P1|Overall Study|Adverse Event|37
853892|NCT01586364|2813789|P1|Overall Study|Withdrawal by Subject|40
853893|NCT01586338|2813842|P1|Overall Study|Other|1
853894|NCT01586338|2813842|P1|Overall Study|Withdrawal by participant|3
853895|NCT01586338|2813842|P1|Overall Study|Lost to Follow-up|1
853896|NCT01586338|2813842|P1|Overall Study|Adverse Event|3
853897|NCT01586195|2813865|P1|Overall Study|Reason not specified|9
853898|NCT01586195|2813865|P1|Overall Study|Started new anti-melanoma therapy|1
853899|NCT01586195|2813865|P1|Overall Study|Withdrawal of Consent|5
853900|NCT01586195|2813865|P1|Overall Study|Death|11
853901|NCT01586156|2813879|P3|Overall Study|Pregnancy|0
853902|NCT01586156|2813880|P2|Overall Study|Pregnancy|1
853903|NCT01586156|2813881|P1|Overall Study|Pregnancy|0
853904|NCT01585987|2813919|P2|Treated|Poor/Non-Compliance|1
853905|NCT01585987|2813920|P1|Treated|Poor/Non-Compliance|0
853906|NCT01585987|2813919|P2|Treated|Subject Request|1
853907|NCT01585987|2813920|P1|Treated|Subject Request|0
853908|NCT01585987|2813919|P2|Treated|Non-Specified|2
853909|NCT01585987|2813920|P1|Treated|Non-Specified|1
853910|NCT01585987|2813919|P2|Treated|Maximum Clinical Benefit|1
853911|NCT01585987|2813920|P1|Treated|Maximum Clinical Benefit|0
853912|NCT01585987|2813919|P2|Treated|Lost to Follow-up|1
853913|NCT01585987|2813920|P1|Treated|Lost to Follow-up|0
853914|NCT01585987|2813919|P2|Treated|Death|0
853915|NCT01585987|2813920|P1|Treated|Death|1
853916|NCT01585987|2813919|P2|Treated|Withdrawal by Subject|2
853917|NCT01585987|2813920|P1|Treated|Withdrawal by Subject|1
853918|NCT01585987|2813919|P2|Treated|Adverse Event|0
853919|NCT01585987|2813920|P1|Treated|Adverse Event|3
853920|NCT01585987|2813919|P2|Treated|Study Drug Toxicity|5
853921|NCT01585987|2813920|P1|Treated|Study Drug Toxicity|9
853922|NCT01585987|2813919|P2|Treated|Disease Progression|36
853923|NCT01585987|2813920|P1|Treated|Disease Progression|39
853924|NCT01585987|2813919|P2|Randomized|No longer met criteria|2
853925|NCT01585987|2813920|P1|Randomized|No longer met criteria|0
853926|NCT01585987|2813919|P2|Randomized|Withdrawal by Subject|4
853927|NCT01585987|2813920|P1|Randomized|Withdrawal by Subject|0
853928|NCT01585961|2813935|P1|Overall Study|Ablation cancelled for slow-heal wound|1
853929|NCT01585961|2813935|P1|Overall Study|Lost to Follow-up|23
853930|NCT01585961|2813935|P1|Overall Study|Withdrawal by Subject|1
853931|NCT01585961|2813935|P1|Overall Study|Decision to use non-study catheter|1
853932|NCT01585961|2813935|P1|Overall Study|Physician Decision|1
853933|NCT01585961|2813935|P1|Overall Study|Death|6
853934|NCT01585766|2814013|P6|Overall Study|Physician Decision|0
853935|NCT01585766|2814014|P5|Overall Study|Physician Decision|0
853936|NCT01585766|2814015|P4|Overall Study|Physician Decision|0
853937|NCT01585766|2814016|P3|Overall Study|Physician Decision|1
853938|NCT01585766|2814017|P2|Overall Study|Physician Decision|0
853939|NCT01585766|2814018|P1|Overall Study|Physician Decision|0
853940|NCT01585766|2814013|P6|Overall Study|Death|0
853941|NCT01585766|2814014|P5|Overall Study|Death|0
853942|NCT01585766|2814015|P4|Overall Study|Death|0
853943|NCT01585766|2814016|P3|Overall Study|Death|0
853944|NCT01585766|2814017|P2|Overall Study|Death|1
853945|NCT01585766|2814018|P1|Overall Study|Death|0
853946|NCT01585766|2814013|P6|Overall Study|Withdrawal by Subject|0
853947|NCT01585766|2814014|P5|Overall Study|Withdrawal by Subject|0
853948|NCT01585766|2814015|P4|Overall Study|Withdrawal by Subject|0
853949|NCT01585766|2814016|P3|Overall Study|Withdrawal by Subject|1
853950|NCT01585766|2814017|P2|Overall Study|Withdrawal by Subject|1
853951|NCT01585766|2814018|P1|Overall Study|Withdrawal by Subject|0
853952|NCT01585584|2814122|P1|Overall Study|Physician Decision|2
853953|NCT01585584|2814122|P1|Overall Study|Withdrawal by Subject|1
853954|NCT01585584|2814122|P1|Overall Study|Lack of Efficacy|1
853955|NCT01585558|2814129|P3|Overall Study|Lack of Efficacy|1
853956|NCT01585558|2814130|P2|Overall Study|Lack of Efficacy|0
853957|NCT01585558|2814131|P1|Overall Study|Lack of Efficacy|0
853958|NCT01585558|2814129|P3|Overall Study|Protocol Violation|2
853959|NCT01585558|2814130|P2|Overall Study|Protocol Violation|3
853960|NCT01585558|2814131|P1|Overall Study|Protocol Violation|4
853961|NCT01585558|2814129|P3|Overall Study|Adverse Event|1
853962|NCT01585558|2814130|P2|Overall Study|Adverse Event|4
853963|NCT01585558|2814131|P1|Overall Study|Adverse Event|3
853964|NCT01585558|2814129|P3|Overall Study|Lost to Follow-up|3
853965|NCT01585558|2814130|P2|Overall Study|Lost to Follow-up|0
853966|NCT01585558|2814131|P1|Overall Study|Lost to Follow-up|2
853967|NCT01585558|2814129|P3|Overall Study|Withdrawal by Subject|8
853968|NCT01585558|2814130|P2|Overall Study|Withdrawal by Subject|5
853969|NCT01585558|2814131|P1|Overall Study|Withdrawal by Subject|4
853970|NCT01585428|2814365|P2|Overall Study|Death during treatment|0
853971|NCT01585428|2814366|P1|Overall Study|Death during treatment|1
853972|NCT01585272|2814390|P1|Overall Study|Withdrawal by Subject|10
853973|NCT01585272|2814390|P1|Overall Study|Protocol Violation|7
853974|NCT01585272|2814390|P1|Overall Study|Adverse Event|22
853975|NCT01585246|2814403|P5|Overall Study|Other|0
853976|NCT01585246|2814404|P4|Overall Study|Other|1
853977|NCT01585246|2814405|P3|Overall Study|Other|1
853978|NCT01585246|2814406|P2|Overall Study|Other|1
853979|NCT01585246|2814407|P1|Overall Study|Other|0
853980|NCT01585246|2814403|P5|Overall Study|Withdrawal by Subject|1
853981|NCT01585246|2814404|P4|Overall Study|Withdrawal by Subject|2
853982|NCT01585246|2814405|P3|Overall Study|Withdrawal by Subject|1
853983|NCT01585246|2814406|P2|Overall Study|Withdrawal by Subject|0
853984|NCT01585246|2814407|P1|Overall Study|Withdrawal by Subject|0
853985|NCT01585246|2814403|P5|Overall Study|Protocol Violation|1
853986|NCT01585246|2814404|P4|Overall Study|Protocol Violation|0
853987|NCT01585246|2814405|P3|Overall Study|Protocol Violation|0
853988|NCT01585246|2814406|P2|Overall Study|Protocol Violation|0
853989|NCT01585246|2814407|P1|Overall Study|Protocol Violation|0
853990|NCT01585246|2814403|P5|Overall Study|Lost to Follow-up|0
853991|NCT01585246|2814404|P4|Overall Study|Lost to Follow-up|1
853992|NCT01585246|2814405|P3|Overall Study|Lost to Follow-up|2
853993|NCT01585246|2814406|P2|Overall Study|Lost to Follow-up|0
853994|NCT01585246|2814407|P1|Overall Study|Lost to Follow-up|0
853995|NCT01585168|2814428|P4|Overall Study|Lost to Follow-up|1
853996|NCT01585168|2814429|P3|Overall Study|Lost to Follow-up|1
853997|NCT01585168|2814430|P2|Overall Study|Lost to Follow-up|1
853998|NCT01585168|2814431|P1|Overall Study|Lost to Follow-up|3
853999|NCT01585038|2814466|P2|Overall Study|Adverse Event|2
854000|NCT01585038|2814467|P1|Overall Study|Adverse Event|2
854001|NCT01584843|2814483|P6|Second Treatment Period|Withdrawal by Subject|1
854002|NCT01584843|2814484|P5|Second Treatment Period|Withdrawal by Subject|0
854003|NCT01584843|2814485|P4|Second Treatment Period|Withdrawal by Subject|0
854004|NCT01584843|2814486|P3|Second Treatment Period|Withdrawal by Subject|0
854005|NCT01584843|2814487|P2|Second Treatment Period|Withdrawal by Subject|0
854006|NCT01584843|2814488|P1|Second Treatment Period|Withdrawal by Subject|0
854007|NCT01584843|2814483|P6|First Treatment Period|Met Protocol-defined Stopping Criteria|1
854008|NCT01584843|2814484|P5|First Treatment Period|Met Protocol-defined Stopping Criteria|0
854009|NCT01584843|2814485|P4|First Treatment Period|Met Protocol-defined Stopping Criteria|0
854010|NCT01584843|2814486|P3|First Treatment Period|Met Protocol-defined Stopping Criteria|0
854011|NCT01584843|2814487|P2|First Treatment Period|Met Protocol-defined Stopping Criteria|0
854012|NCT01584843|2814488|P1|First Treatment Period|Met Protocol-defined Stopping Criteria|0
854013|NCT01584843|2814483|P6|First Treatment Period|Protocol Violation|1
854014|NCT01584843|2814484|P5|First Treatment Period|Protocol Violation|0
854015|NCT01584843|2814485|P4|First Treatment Period|Protocol Violation|0
854016|NCT01584843|2814486|P3|First Treatment Period|Protocol Violation|0
854017|NCT01584843|2814487|P2|First Treatment Period|Protocol Violation|0
854018|NCT01584843|2814488|P1|First Treatment Period|Protocol Violation|0
854019|NCT01584843|2814483|P6|First Treatment Period|Adverse Event|0
854020|NCT01584843|2814484|P5|First Treatment Period|Adverse Event|0
854021|NCT01584843|2814485|P4|First Treatment Period|Adverse Event|0
854022|NCT01584843|2814486|P3|First Treatment Period|Adverse Event|1
854023|NCT01584843|2814487|P2|First Treatment Period|Adverse Event|0
854024|NCT01584843|2814488|P1|First Treatment Period|Adverse Event|0
854025|NCT01584648|2814599|P2|Overall Study|Ongoing|147
854026|NCT01584648|2814600|P1|Overall Study|Ongoing|154
854027|NCT01584648|2814599|P2|Overall Study|Death|55
854028|NCT01584648|2814600|P1|Overall Study|Death|40
854029|NCT01584648|2814599|P2|Overall Study|Withdrawal by Subject|5
854030|NCT01584648|2814600|P1|Overall Study|Withdrawal by Subject|11
854031|NCT01584648|2814599|P2|Overall Study|Physician Decision|2
854032|NCT01584648|2814600|P1|Overall Study|Physician Decision|2
854033|NCT01584648|2814599|P2|Overall Study|Lost to Follow-up|3
854034|NCT01584648|2814600|P1|Overall Study|Lost to Follow-up|4
854035|NCT01584232|2814728|P2|Overall Study|Lost to Follow-up|0
854036|NCT01584232|2814729|P1|Overall Study|Lost to Follow-up|1
854037|NCT01584232|2814728|P2|Overall Study|Physician Decision|1
854038|NCT01584232|2814729|P1|Overall Study|Physician Decision|2
854039|NCT01584232|2814728|P2|Overall Study|Withdrawal by Subject|1
854040|NCT01584232|2814729|P1|Overall Study|Withdrawal by Subject|2
854041|NCT01584232|2814728|P2|Overall Study|Adverse Event|1
854042|NCT01584232|2814729|P1|Overall Study|Adverse Event|3
854043|NCT01583530|2814775|P6|Overall Study|Lack of compliance|0
854044|NCT01583530|2814776|P5|Overall Study|Lack of compliance|1
854045|NCT01583530|2814777|P4|Overall Study|Lack of compliance|0
854046|NCT01583530|2814778|P3|Overall Study|Lack of compliance|0
854047|NCT01583530|2814779|P2|Overall Study|Lack of compliance|0
854048|NCT01583530|2814780|P1|Overall Study|Lack of compliance|0
854049|NCT01583530|2814775|P6|Overall Study|Lost to Follow-up|0
854050|NCT01583530|2814776|P5|Overall Study|Lost to Follow-up|3
854051|NCT01583530|2814777|P4|Overall Study|Lost to Follow-up|0
854052|NCT01583530|2814778|P3|Overall Study|Lost to Follow-up|0
854053|NCT01583530|2814779|P2|Overall Study|Lost to Follow-up|0
854054|NCT01583530|2814780|P1|Overall Study|Lost to Follow-up|0
854055|NCT01583530|2814775|P6|Overall Study|Withdrawal by Subject|2
854056|NCT01583530|2814776|P5|Overall Study|Withdrawal by Subject|1
854057|NCT01583530|2814777|P4|Overall Study|Withdrawal by Subject|1
854058|NCT01583530|2814778|P3|Overall Study|Withdrawal by Subject|0
854059|NCT01583530|2814779|P2|Overall Study|Withdrawal by Subject|3
854060|NCT01583530|2814780|P1|Overall Study|Withdrawal by Subject|0
854061|NCT01583530|2814775|P6|Overall Study|Adverse Event|1
854062|NCT01583530|2814776|P5|Overall Study|Adverse Event|0
854063|NCT01583530|2814777|P4|Overall Study|Adverse Event|0
854064|NCT01583530|2814778|P3|Overall Study|Adverse Event|0
854065|NCT01583530|2814779|P2|Overall Study|Adverse Event|0
854066|NCT01583530|2814780|P1|Overall Study|Adverse Event|0
854067|NCT01583374|2814842|P3|Overall Study|Other|0
854068|NCT01583374|2814843|P2|Overall Study|Other|1
854069|NCT01583374|2814844|P1|Overall Study|Other|0
854070|NCT01583374|2814842|P3|Overall Study|Protocol Violation|3
854071|NCT01583374|2814843|P2|Overall Study|Protocol Violation|0
854072|NCT01583374|2814844|P1|Overall Study|Protocol Violation|0
854073|NCT01583374|2814842|P3|Overall Study|Lost to Follow-up|0
854074|NCT01583374|2814843|P2|Overall Study|Lost to Follow-up|2
854075|NCT01583374|2814844|P1|Overall Study|Lost to Follow-up|1
854076|NCT01583374|2814842|P3|Overall Study|Withdrawal by Subject|5
854077|NCT01583374|2814843|P2|Overall Study|Withdrawal by Subject|3
854078|NCT01583374|2814844|P1|Overall Study|Withdrawal by Subject|8
854079|NCT01583374|2814842|P3|Overall Study|Non-compliance with study drug|0
854080|NCT01583374|2814843|P2|Overall Study|Non-compliance with study drug|1
854081|NCT01583374|2814844|P1|Overall Study|Non-compliance with study drug|1
854082|NCT01583374|2814842|P3|Overall Study|Lack of Efficacy|5
854083|NCT01583374|2814843|P2|Overall Study|Lack of Efficacy|2
854084|NCT01583374|2814844|P1|Overall Study|Lack of Efficacy|3
854085|NCT01583374|2814842|P3|Overall Study|Adverse Event|12
854086|NCT01583374|2814843|P2|Overall Study|Adverse Event|7
854087|NCT01583374|2814844|P1|Overall Study|Adverse Event|6
854088|NCT01583218|2814856|P2|Overall Study|Withdraw of consent on day of random|0
854089|NCT01583218|2814857|P1|Overall Study|Withdraw of consent on day of random|1
854090|NCT01583218|2814856|P2|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1
854091|NCT01583218|2814857|P1|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0
854092|NCT01583218|2814856|P2|Overall Study|Patient was randomized due to mistake|0
854093|NCT01583218|2814857|P1|Overall Study|Patient was randomized due to mistake|1
854094|NCT01583218|2814856|P2|Overall Study|Patient was early terminated from study|1
854095|NCT01583218|2814857|P1|Overall Study|Patient was early terminated from study|0
854096|NCT01583218|2814856|P2|Overall Study|Patient deemed ineligible after random|0
854097|NCT01583218|2814857|P1|Overall Study|Patient deemed ineligible after random|2
854098|NCT01583218|2814856|P2|Overall Study|Patient was assessed via phone in person|0
854099|NCT01583218|2814857|P1|Overall Study|Patient was assessed via phone in person|1
854100|NCT01583218|2814856|P2|Overall Study|Patient randomized but not dosed|16
854101|NCT01583218|2814857|P1|Overall Study|Patient randomized but not dosed|17
854102|NCT01583218|2814856|P2|Overall Study|Patient did not wish to attend visits|1
854103|NCT01583218|2814857|P1|Overall Study|Patient did not wish to attend visits|0
854104|NCT01583218|2814856|P2|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2
854105|NCT01583218|2814857|P1|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0
854106|NCT01583218|2814856|P2|Overall Study|Cannot contact patient directly|2
854107|NCT01583218|2814857|P1|Overall Study|Cannot contact patient directly|1
854108|NCT01583218|2814856|P2|Overall Study|Patient /Family decision|0
854109|NCT01583218|2814857|P1|Overall Study|Patient /Family decision|3
854110|NCT01583218|2814856|P2|Overall Study|Adverse event or serious adverse event|3
854111|NCT01583218|2814857|P1|Overall Study|Adverse event or serious adverse event|3
854112|NCT01583218|2814856|P2|Overall Study|Lost to Follow-up|17
854113|NCT01583218|2814857|P1|Overall Study|Lost to Follow-up|11
854114|NCT01583218|2814856|P2|Overall Study|Death|211
854115|NCT01583218|2814857|P1|Overall Study|Death|206
854116|NCT01583218|2814856|P2|Overall Study|Withdrawal by Subject|29
854117|NCT01583218|2814857|P1|Overall Study|Withdrawal by Subject|43
854118|NCT01583166|2814877|P2|Overall Study|Withdrawal by Subject|6
854119|NCT01583166|2814878|P1|Overall Study|Withdrawal by Subject|4
854120|NCT01582971|2814901|P2|Overall Study|Other|13
854121|NCT01582971|2814902|P1|Overall Study|Other|15
854122|NCT01582971|2814901|P2|Overall Study|Withdrawal by Subject|2
854123|NCT01582971|2814902|P1|Overall Study|Withdrawal by Subject|4
854124|NCT01582971|2814901|P2|Overall Study|Lost to Follow-up|21
854125|NCT01582971|2814902|P1|Overall Study|Lost to Follow-up|18
854126|NCT01582971|2814901|P2|Overall Study|Death|1
854127|NCT01582971|2814902|P1|Overall Study|Death|2
854128|NCT01582945|2814920|P1|Overall Study|Scheduling conflicts|1
854129|NCT01582945|2814920|P1|Overall Study|Intolerable side-effects|1
854130|NCT01582854|2814934|P2|Overall Study|Other Miscellaneous Reason|0
854131|NCT01582854|2814935|P1|Overall Study|Other Miscellaneous Reason|1
854132|NCT01582854|2814934|P2|Overall Study|General Anaesthesia|1
854133|NCT01582854|2814935|P1|Overall Study|General Anaesthesia|0
854134|NCT01582854|2814934|P2|Overall Study|Carotid or Neurosurgery|1
854135|NCT01582854|2814935|P1|Overall Study|Carotid or Neurosurgery|0
854136|NCT01582854|2814934|P2|Overall Study|Disallowed Concomitant Medication|2
854137|NCT01582854|2814935|P1|Overall Study|Disallowed Concomitant Medication|3
854138|NCT01582854|2814934|P2|Overall Study|Recurrent Stroke|8
854139|NCT01582854|2814935|P1|Overall Study|Recurrent Stroke|13
854140|NCT01582854|2814934|P2|Overall Study|Physician Decision|1
854141|NCT01582854|2814935|P1|Overall Study|Physician Decision|0
854142|NCT01582854|2814934|P2|Overall Study|Lost to Follow-up|2
854143|NCT01582854|2814935|P1|Overall Study|Lost to Follow-up|1
854144|NCT01582854|2814934|P2|Overall Study|Withdrawal by Participant|11
854145|NCT01582854|2814935|P1|Overall Study|Withdrawal by Participant|8
854146|NCT01582854|2814934|P2|Overall Study|Adverse Event|3
854147|NCT01582854|2814935|P1|Overall Study|Adverse Event|2
854148|NCT01582854|2814934|P2|Overall Study|Death|5
854149|NCT01582854|2814935|P1|Overall Study|Death|8
854150|NCT01582789|2814963|P2|Second Intervention (14 Days)|Withdrawal by Subject|0
854151|NCT01582789|2814964|P1|Second Intervention (14 Days)|Withdrawal by Subject|1
854152|NCT01582451|2815024|P2|Overall Study|Sponsor Decision|0
854153|NCT01582451|2815025|P1|Overall Study|Sponsor Decision|1
854154|NCT01582451|2815024|P2|Overall Study|Physician Decision|0
854155|NCT01582451|2815025|P1|Overall Study|Physician Decision|3
854156|NCT01582451|2815024|P2|Overall Study|Withdrawal by Subject|9
854157|NCT01582451|2815025|P1|Overall Study|Withdrawal by Subject|13
854158|NCT01582451|2815024|P2|Overall Study|Protocol Violation|3
854159|NCT01582451|2815025|P1|Overall Study|Protocol Violation|11
854160|NCT01582451|2815024|P2|Overall Study|Lost to Follow-up|2
854161|NCT01582451|2815025|P1|Overall Study|Lost to Follow-up|0
854162|NCT01582451|2815024|P2|Overall Study|Death|3
854163|NCT01582451|2815025|P1|Overall Study|Death|3
854164|NCT01582451|2815024|P2|Overall Study|Adverse Event|3
854165|NCT01582451|2815025|P1|Overall Study|Adverse Event|1
854166|NCT01582308|2815067|P10|Period 4|Physician Decision|1
854167|NCT01582308|2815068|P9|Period 4|Physician Decision|0
854168|NCT01582308|2815069|P8|Period 4|Physician Decision|0
854169|NCT01582308|2815070|P7|Period 4|Physician Decision|0
854170|NCT01582308|2815071|P6|Period 4|Physician Decision|1
854171|NCT01582308|2815072|P5|Period 4|Physician Decision|0
854172|NCT01582308|2815073|P4|Period 4|Physician Decision|0
854173|NCT01582308|2815074|P3|Period 4|Physician Decision|0
854174|NCT01582308|2815075|P2|Period 4|Physician Decision|0
854175|NCT01582308|2815076|P1|Period 4|Physician Decision|1
854176|NCT01582308|2815067|P10|10-day Washout Following Period 1|Physician Decision|0
854177|NCT01582308|2815068|P9|10-day Washout Following Period 1|Physician Decision|0
854178|NCT01582308|2815069|P8|10-day Washout Following Period 1|Physician Decision|0
854179|NCT01582308|2815070|P7|10-day Washout Following Period 1|Physician Decision|0
854180|NCT01582308|2815071|P6|10-day Washout Following Period 1|Physician Decision|0
854181|NCT01582308|2815072|P5|10-day Washout Following Period 1|Physician Decision|1
854182|NCT01582308|2815073|P4|10-day Washout Following Period 1|Physician Decision|0
854183|NCT01582308|2815074|P3|10-day Washout Following Period 1|Physician Decision|0
854184|NCT01582308|2815075|P2|10-day Washout Following Period 1|Physician Decision|0
854185|NCT01582308|2815076|P1|10-day Washout Following Period 1|Physician Decision|0
854186|NCT01582308|2815067|P10|Period 1|Withdrawal by Subject|0
854187|NCT01582308|2815068|P9|Period 1|Withdrawal by Subject|0
854188|NCT01582308|2815069|P8|Period 1|Withdrawal by Subject|0
854189|NCT01582308|2815070|P7|Period 1|Withdrawal by Subject|1
854190|NCT01582308|2815071|P6|Period 1|Withdrawal by Subject|0
854191|NCT01582308|2815072|P5|Period 1|Withdrawal by Subject|0
854192|NCT01582308|2815073|P4|Period 1|Withdrawal by Subject|0
854193|NCT01582308|2815074|P3|Period 1|Withdrawal by Subject|0
854194|NCT01582308|2815075|P2|Period 1|Withdrawal by Subject|0
854195|NCT01582308|2815076|P1|Period 1|Withdrawal by Subject|0
854196|NCT01582282|2815104|P3|Overall Study|fasting blood glucose outside Protocol|0
854197|NCT01582282|2815105|P2|Overall Study|fasting blood glucose outside Protocol|1
854198|NCT01582282|2815106|P1|Overall Study|fasting blood glucose outside Protocol|0
854199|NCT01582282|2815104|P3|Overall Study|Lost to Follow-up|0
854200|NCT01582282|2815105|P2|Overall Study|Lost to Follow-up|0
854201|NCT01582282|2815106|P1|Overall Study|Lost to Follow-up|1
854202|NCT01582282|2815104|P3|Overall Study|Adverse Event|0
854203|NCT01582282|2815105|P2|Overall Study|Adverse Event|1
854204|NCT01582282|2815106|P1|Overall Study|Adverse Event|1
854205|NCT01582243|2815129|P1|Overall Study|Lost to Follow-up|1
854206|NCT01582243|2815129|P1|Overall Study|Adverse Event|1
854207|NCT01582243|2815129|P1|Overall Study|Withdrawal by Subject|1
854208|NCT01582178|2815140|P2|Overall Study|Physician Decision|5
854209|NCT01582178|2815141|P1|Overall Study|Physician Decision|6
854210|NCT01582100|2815162|P1|Overall Study|Withdrawal by Subject|1
854211|NCT01582100|2815162|P1|Overall Study|Adverse Event|1
854212|NCT01582061|2815168|P2|Overall Study|Lost to Follow-up|0
854213|NCT01582061|2815169|P1|Overall Study|Lost to Follow-up|1
854214|NCT01582061|2815168|P2|Overall Study|condition no longer requires study drug|0
854215|NCT01582061|2815169|P1|Overall Study|condition no longer requires study drug|1
854216|NCT01582061|2815168|P2|Overall Study|Death|1
854217|NCT01582061|2815169|P1|Overall Study|Death|0
854218|NCT01582061|2815168|P2|Overall Study|Abnormal laboratory value(s)|0
854219|NCT01582061|2815169|P1|Overall Study|Abnormal laboratory value(s)|1
854220|NCT01582061|2815168|P2|Overall Study|Withdrawal by Subject|4
854221|NCT01582061|2815169|P1|Overall Study|Withdrawal by Subject|10
854222|NCT01582061|2815168|P2|Overall Study|Adverse Event|8
854223|NCT01582061|2815169|P1|Overall Study|Adverse Event|12
854224|NCT01582061|2815168|P2|Overall Study|Lack of Efficacy|23
854225|NCT01582061|2815169|P1|Overall Study|Lack of Efficacy|3
854226|NCT01582009|2815219|P1|Overall Study|Physician Decision|1
854227|NCT01582009|2815219|P1|Overall Study|Withdrawal by Subject|1
854228|NCT01581931|2815227|P2|Washout|Adverse Event|1
854229|NCT01581931|2815228|P1|Washout|Adverse Event|0
854230|NCT01581684|2815281|P10|Overall Study|Other reason not defined|0
854231|NCT01581684|2815282|P9|Overall Study|Other reason not defined|1
854232|NCT01581684|2815283|P8|Overall Study|Other reason not defined|0
854233|NCT01581684|2815284|P7|Overall Study|Other reason not defined|0
854234|NCT01581684|2815285|P6|Overall Study|Other reason not defined|0
854235|NCT01581684|2815286|P5|Overall Study|Other reason not defined|0
854236|NCT01581684|2815287|P4|Overall Study|Other reason not defined|0
854237|NCT01581684|2815288|P3|Overall Study|Other reason not defined|0
854238|NCT01581684|2815289|P2|Overall Study|Other reason not defined|0
854239|NCT01581684|2815290|P1|Overall Study|Other reason not defined|0
854240|NCT01581619|2815386|P1|Overall Study|Lost to Follow-up|1
854241|NCT01581619|2815386|P1|Overall Study|Withdrawal by Subject|1
854242|NCT01581307|2815539|P1|Overall Study|Withdrawal by Subject|1
854243|NCT01581281|2815548|P3|Overall Study|Early Study Closure|12
854244|NCT01581281|2815549|P2|Overall Study|Early Study Closure|6
854245|NCT01581281|2815550|P1|Overall Study|Early Study Closure|15
854246|NCT01581021|2815572|P2|Overall Study|Lack of Efficacy|1
854247|NCT01581021|2815573|P1|Overall Study|Lack of Efficacy|0
854248|NCT01581021|2815572|P2|Overall Study|Lenke 6 Classification|1
854249|NCT01581021|2815573|P1|Overall Study|Lenke 6 Classification|0
854250|NCT01581021|2815572|P2|Overall Study|Not Randomized|2
854251|NCT01581021|2815573|P1|Overall Study|Not Randomized|1
854252|NCT01581021|2815572|P2|Overall Study|Neuromuscular|1
854253|NCT01581021|2815573|P1|Overall Study|Neuromuscular|2
854254|NCT01581021|2815572|P2|Overall Study|More than 2 hooks in thoracic|0
854255|NCT01581021|2815573|P1|Overall Study|More than 2 hooks in thoracic|3
854256|NCT01581021|2815572|P2|Overall Study|Lost to Follow-up|6
854257|NCT01581021|2815573|P1|Overall Study|Lost to Follow-up|4
854258|NCT01580995|2815600|P2|Overall Study|Lost to Follow-up|2
854259|NCT01580995|2815601|P1|Overall Study|Lost to Follow-up|2
854260|NCT01580488|2815654|P1|Overall Study|Withdrawal by Subject|1
854261|NCT01580020|2815810|P4|Overall Study|Lost to Follow-up|0
854262|NCT01580020|2815811|P3|Overall Study|Lost to Follow-up|1
854263|NCT01580020|2815812|P2|Overall Study|Lost to Follow-up|0
854264|NCT01580020|2815813|P1|Overall Study|Lost to Follow-up|0
854265|NCT01580020|2815810|P4|Overall Study|Administrative Problems|0
854266|NCT01580020|2815811|P3|Overall Study|Administrative Problems|1
854267|NCT01580020|2815812|P2|Overall Study|Administrative Problems|0
854268|NCT01580020|2815813|P1|Overall Study|Administrative Problems|0
854269|NCT01580020|2815810|P4|Overall Study|Adverse Event|1
854270|NCT01580020|2815811|P3|Overall Study|Adverse Event|1
854271|NCT01580020|2815812|P2|Overall Study|Adverse Event|1
854272|NCT01580020|2815813|P1|Overall Study|Adverse Event|1
854273|NCT01580020|2815810|P4|Overall Study|Withdrawal by Subject|0
854274|NCT01580020|2815811|P3|Overall Study|Withdrawal by Subject|1
854275|NCT01580020|2815812|P2|Overall Study|Withdrawal by Subject|1
854276|NCT01580020|2815813|P1|Overall Study|Withdrawal by Subject|0
854277|NCT01580020|2815810|P4|Overall Study|Lack of Efficacy|1
854278|NCT01580020|2815811|P3|Overall Study|Lack of Efficacy|0
854279|NCT01580020|2815812|P2|Overall Study|Lack of Efficacy|5
854280|NCT01580020|2815813|P1|Overall Study|Lack of Efficacy|0
854281|NCT01579916|2815857|P2|Overall Study|Death|0
854282|NCT01579916|2815858|P1|Overall Study|Death|1
854283|NCT01579916|2815857|P2|Overall Study|Withdrawal by Subject|1
854284|NCT01579916|2815858|P1|Overall Study|Withdrawal by Subject|1
854285|NCT01579916|2815857|P2|Overall Study|Lost to Follow-up|1
854286|NCT01579916|2815858|P1|Overall Study|Lost to Follow-up|6
854287|NCT01579812|2815884|P1|Overall Study|Withdrawal by Subject|6
854288|NCT01579812|2815884|P1|Overall Study|Noncompliance|3
854289|NCT01579812|2815884|P1|Overall Study|Patient choice|3
854290|NCT01579812|2815884|P1|Overall Study|Ineligible after treatment start|40
854291|NCT01579578|2815918|P2|Overall Study|Ongoing|0
854292|NCT01579578|2815919|P1|Overall Study|Ongoing|3
854293|NCT01579578|2815918|P2|Overall Study|Eligibility criteria|9
854294|NCT01579578|2815919|P1|Overall Study|Eligibility criteria|3
854295|NCT01579578|2815918|P2|Overall Study|Withdrawal by Subject|1
854296|NCT01579578|2815919|P1|Overall Study|Withdrawal by Subject|2
854297|NCT01579578|2815918|P2|Overall Study|Lost to Follow-up|1
854298|NCT01579578|2815919|P1|Overall Study|Lost to Follow-up|1
854299|NCT01579578|2815918|P2|Overall Study|Death|1
854300|NCT01579578|2815919|P1|Overall Study|Death|4
854301|NCT01579565|2815931|P2|Treated|declined to return for final visit|1
854302|NCT01579565|2815932|P1|Treated|declined to return for final visit|0
854303|NCT01579565|2815931|P2|Treated|Lost to Follow-up|1
854304|NCT01579565|2815932|P1|Treated|Lost to Follow-up|2
854305|NCT01579565|2815931|P2|Treated|Physician Decision|1
854306|NCT01579565|2815932|P1|Treated|Physician Decision|0
854307|NCT01579565|2815931|P2|Randomized|prohibited preoperative medication|1
854308|NCT01579565|2815932|P1|Randomized|prohibited preoperative medication|0
854309|NCT01579565|2815931|P2|Randomized|prohibited preoperative eating|0
854310|NCT01579565|2815932|P1|Randomized|prohibited preoperative eating|1
854311|NCT01579565|2815931|P2|Randomized|inadequate preoperative pupil dilation|1
854312|NCT01579565|2815932|P1|Randomized|inadequate preoperative pupil dilation|0
854313|NCT01579565|2815931|P2|Randomized|Withdrawal by Subject|0
854314|NCT01579565|2815932|P1|Randomized|Withdrawal by Subject|3
854315|NCT01579565|2815931|P2|Randomized|Adverse Event|3
854316|NCT01579565|2815932|P1|Randomized|Adverse Event|1
854317|NCT01579474|2815966|P6|Overall Study|Withdrawal by Subject|0
854318|NCT01579474|2815967|P5|Overall Study|Withdrawal by Subject|0
854319|NCT01579474|2815968|P4|Overall Study|Withdrawal by Subject|0
854320|NCT01579474|2815969|P3|Overall Study|Withdrawal by Subject|0
854321|NCT01579474|2815970|P2|Overall Study|Withdrawal by Subject|0
854322|NCT01579474|2815971|P1|Overall Study|Withdrawal by Subject|1
854323|NCT01579474|2815966|P6|Overall Study|Lack of Efficacy|0
854324|NCT01579474|2815967|P5|Overall Study|Lack of Efficacy|1
854325|NCT01579474|2815968|P4|Overall Study|Lack of Efficacy|0
854326|NCT01579474|2815969|P3|Overall Study|Lack of Efficacy|0
854327|NCT01579474|2815970|P2|Overall Study|Lack of Efficacy|0
854328|NCT01579474|2815971|P1|Overall Study|Lack of Efficacy|1
854329|NCT01579474|2815966|P6|Overall Study|Adverse Event|1
854330|NCT01579474|2815967|P5|Overall Study|Adverse Event|0
854331|NCT01579474|2815968|P4|Overall Study|Adverse Event|0
854332|NCT01579474|2815969|P3|Overall Study|Adverse Event|2
854333|NCT01579474|2815970|P2|Overall Study|Adverse Event|13
854334|NCT01579474|2815971|P1|Overall Study|Adverse Event|1
854335|NCT01579318|2816045|P1|Overall Study|Disease Progression|1
854336|NCT01579006|2816140|P1|Overall Study|Scheduled surgery|1
854337|NCT01579006|2816140|P1|Overall Study|Due to participant's health fund|1
854338|NCT01579006|2816140|P1|Overall Study|Non-compliance|3
854339|NCT01579006|2816140|P1|Overall Study|Withdrawal by Subject|5
854340|NCT01579006|2816140|P1|Overall Study|Adverse Event|13
854341|NCT01579006|2816140|P1|Overall Study|Lack of Efficacy|10
854342|NCT01578850|2816199|P3|Period 2|Unspecified Reasons|0
854343|NCT01578850|2816200|P2|Period 2|Unspecified Reasons|1
854344|NCT01578850|2816201|P1|Period 2|Unspecified Reasons|0
854345|NCT01578850|2816199|P3|Period 2|Study Terminated by Sponsor|4
854346|NCT01578850|2816200|P2|Period 2|Study Terminated by Sponsor|5
854347|NCT01578850|2816201|P1|Period 2|Study Terminated by Sponsor|0
854348|NCT01578850|2816199|P3|Period 2|Withdrawal by Subject|2
854349|NCT01578850|2816200|P2|Period 2|Withdrawal by Subject|2
854350|NCT01578850|2816201|P1|Period 2|Withdrawal by Subject|0
854351|NCT01578850|2816199|P3|Period 2|Lost to Follow-up|2
854352|NCT01578850|2816200|P2|Period 2|Lost to Follow-up|1
854353|NCT01578850|2816201|P1|Period 2|Lost to Follow-up|0
854354|NCT01578850|2816199|P3|Period 2|Adverse Event|6
854355|NCT01578850|2816200|P2|Period 2|Adverse Event|3
854356|NCT01578850|2816201|P1|Period 2|Adverse Event|0
854357|NCT01578850|2816199|P3|Period 2|Insufficient Clinical Response|0
854358|NCT01578850|2816200|P2|Period 2|Insufficient Clinical Response|1
854359|NCT01578850|2816201|P1|Period 2|Insufficient Clinical Response|0
854360|NCT01578850|2816199|P3|Period 1|Study Terminated by Sponsor|0
854361|NCT01578850|2816200|P2|Period 1|Study Terminated by Sponsor|0
854362|NCT01578850|2816201|P1|Period 1|Study Terminated by Sponsor|3
854363|NCT01578850|2816199|P3|Period 1|Withdrawal by Subject|0
854364|NCT01578850|2816200|P2|Period 1|Withdrawal by Subject|0
854365|NCT01578850|2816201|P1|Period 1|Withdrawal by Subject|9
854366|NCT01578850|2816199|P3|Period 1|Does Not Meet Entrance Criteria|0
854367|NCT01578850|2816200|P2|Period 1|Does Not Meet Entrance Criteria|0
854368|NCT01578850|2816201|P1|Period 1|Does Not Meet Entrance Criteria|12
854369|NCT01578850|2816199|P3|Period 1|Death|0
854370|NCT01578850|2816200|P2|Period 1|Death|0
854371|NCT01578850|2816201|P1|Period 1|Death|1
854372|NCT01578850|2816199|P3|Period 1|Adverse Event|0
854373|NCT01578850|2816200|P2|Period 1|Adverse Event|0
854374|NCT01578850|2816201|P1|Period 1|Adverse Event|11
854375|NCT01578850|2816199|P3|Period 1|Insufficient Clinical Response|0
854376|NCT01578850|2816200|P2|Period 1|Insufficient Clinical Response|0
854377|NCT01578850|2816201|P1|Period 1|Insufficient Clinical Response|1
854378|NCT01578785|2816253|P2|Overall Study|Study terminated by sponsor|118
854379|NCT01578785|2816254|P1|Overall Study|Study terminated by sponsor|59
854380|NCT01578785|2816253|P2|Overall Study|Withdrawal by Subject|1
854381|NCT01578785|2816254|P1|Overall Study|Withdrawal by Subject|0
854382|NCT01578499|2816286|P2|Overall Study|Participants on Study Treatment|0
854383|NCT01578499|2816287|P1|Overall Study|Participants on Study Treatment|3
854384|NCT01578499|2816286|P2|Overall Study|Participants in Follow-up|39
854385|NCT01578499|2816287|P1|Overall Study|Participants in Follow-up|42
854386|NCT01578499|2816286|P2|Overall Study|Reason not Specified|1
854387|NCT01578499|2816287|P1|Overall Study|Reason not Specified|0
854388|NCT01578499|2816286|P2|Overall Study|Lost to Follow-up|1
854389|NCT01578499|2816287|P1|Overall Study|Lost to Follow-up|2
854390|NCT01578499|2816286|P2|Overall Study|Withdrawal by Participant|10
854391|NCT01578499|2816287|P1|Overall Study|Withdrawal by Participant|8
854392|NCT01578499|2816286|P2|Overall Study|Death|14
854393|NCT01578499|2816287|P1|Overall Study|Death|11
854394|NCT01578486|2816321|P1|Overall Study|Withdrawal by Subject|2
854395|NCT01578486|2816321|P1|Overall Study|Physician Decision|3
854396|NCT01578330|2816332|P1|Overall Study|Protocol Violation|5
854397|NCT01578330|2816332|P1|Overall Study|Adverse Event|2
854398|NCT01578187|2816348|P1|Usability Phase|Withdrawal by Subject|1
854399|NCT01577758|2816382|P8|mCRC Expansion Phase|Progression Disease|19
854400|NCT01577758|2816383|P7|mCRC Expansion Phase|Progression Disease|0
854401|NCT01577758|2816384|P6|mCRC Expansion Phase|Progression Disease|0
854402|NCT01577758|2816385|P5|mCRC Expansion Phase|Progression Disease|0
854403|NCT01577758|2816386|P4|mCRC Expansion Phase|Progression Disease|0
854404|NCT01577758|2816387|P3|mCRC Expansion Phase|Progression Disease|0
854405|NCT01577758|2816388|P2|mCRC Expansion Phase|Progression Disease|0
854406|NCT01577758|2816389|P1|mCRC Expansion Phase|Progression Disease|0
854407|NCT01577758|2816382|P8|mCRC Expansion Phase|Withdrawal by Subject|2
854408|NCT01577758|2816383|P7|mCRC Expansion Phase|Withdrawal by Subject|0
854409|NCT01577758|2816384|P6|mCRC Expansion Phase|Withdrawal by Subject|0
854410|NCT01577758|2816385|P5|mCRC Expansion Phase|Withdrawal by Subject|0
854411|NCT01577758|2816386|P4|mCRC Expansion Phase|Withdrawal by Subject|0
854412|NCT01577758|2816387|P3|mCRC Expansion Phase|Withdrawal by Subject|0
854413|NCT01577758|2816388|P2|mCRC Expansion Phase|Withdrawal by Subject|0
854414|NCT01577758|2816389|P1|mCRC Expansion Phase|Withdrawal by Subject|0
854415|NCT01577758|2816382|P8|mCRC Expansion Phase|Symptomatic Deterioration|4
854416|NCT01577758|2816383|P7|mCRC Expansion Phase|Symptomatic Deterioration|0
854417|NCT01577758|2816384|P6|mCRC Expansion Phase|Symptomatic Deterioration|0
854418|NCT01577758|2816385|P5|mCRC Expansion Phase|Symptomatic Deterioration|0
854419|NCT01577758|2816386|P4|mCRC Expansion Phase|Symptomatic Deterioration|0
854420|NCT01577758|2816387|P3|mCRC Expansion Phase|Symptomatic Deterioration|0
854421|NCT01577758|2816388|P2|mCRC Expansion Phase|Symptomatic Deterioration|0
854422|NCT01577758|2816389|P1|mCRC Expansion Phase|Symptomatic Deterioration|0
854423|NCT01577758|2816382|P8|Dose Escalation Phase|Progression Disease|0
854424|NCT01577758|2816383|P7|Dose Escalation Phase|Progression Disease|0
854425|NCT01577758|2816384|P6|Dose Escalation Phase|Progression Disease|0
854426|NCT01577758|2816385|P5|Dose Escalation Phase|Progression Disease|5
854427|NCT01577758|2816386|P4|Dose Escalation Phase|Progression Disease|2
854428|NCT01577758|2816387|P3|Dose Escalation Phase|Progression Disease|1
854429|NCT01577758|2816388|P2|Dose Escalation Phase|Progression Disease|2
854430|NCT01577758|2816389|P1|Dose Escalation Phase|Progression Disease|2
854431|NCT01577758|2816382|P8|Dose Escalation Phase|Withdrawal by Subject|0
854432|NCT01577758|2816383|P7|Dose Escalation Phase|Withdrawal by Subject|0
854433|NCT01577758|2816384|P6|Dose Escalation Phase|Withdrawal by Subject|1
854434|NCT01577758|2816385|P5|Dose Escalation Phase|Withdrawal by Subject|0
854435|NCT01577758|2816386|P4|Dose Escalation Phase|Withdrawal by Subject|0
854436|NCT01577758|2816387|P3|Dose Escalation Phase|Withdrawal by Subject|0
854437|NCT01577758|2816388|P2|Dose Escalation Phase|Withdrawal by Subject|0
854438|NCT01577758|2816389|P1|Dose Escalation Phase|Withdrawal by Subject|0
854439|NCT01577758|2816382|P8|Dose Escalation Phase|Symptomatic Deterioration|0
854440|NCT01577758|2816383|P7|Dose Escalation Phase|Symptomatic Deterioration|0
854441|NCT01577758|2816384|P6|Dose Escalation Phase|Symptomatic Deterioration|1
854442|NCT01577758|2816385|P5|Dose Escalation Phase|Symptomatic Deterioration|1
854443|NCT01577758|2816386|P4|Dose Escalation Phase|Symptomatic Deterioration|0
854444|NCT01577758|2816387|P3|Dose Escalation Phase|Symptomatic Deterioration|1
854445|NCT01577758|2816388|P2|Dose Escalation Phase|Symptomatic Deterioration|0
854446|NCT01577758|2816389|P1|Dose Escalation Phase|Symptomatic Deterioration|0
854447|NCT01577758|2816382|P8|Dose Escalation Phase|Adverse Event|0
854448|NCT01577758|2816383|P7|Dose Escalation Phase|Adverse Event|1
854449|NCT01577758|2816384|P6|Dose Escalation Phase|Adverse Event|2
854450|NCT01577758|2816385|P5|Dose Escalation Phase|Adverse Event|0
854451|NCT01577758|2816386|P4|Dose Escalation Phase|Adverse Event|0
854452|NCT01577758|2816387|P3|Dose Escalation Phase|Adverse Event|0
854453|NCT01577758|2816388|P2|Dose Escalation Phase|Adverse Event|0
854454|NCT01577758|2816389|P1|Dose Escalation Phase|Adverse Event|0
854455|NCT01577745|2816428|P6|Overall Study|Alternative Therapy|0
854456|NCT01577745|2816429|P5|Overall Study|Alternative Therapy|1
854457|NCT01577745|2816430|P4|Overall Study|Alternative Therapy|1
854458|NCT01577745|2816431|P3|Overall Study|Alternative Therapy|0
854459|NCT01577745|2816432|P2|Overall Study|Alternative Therapy|0
854460|NCT01577745|2816433|P1|Overall Study|Alternative Therapy|0
854461|NCT01577745|2816428|P6|Overall Study|Lost to Follow-up|1
854462|NCT01577745|2816429|P5|Overall Study|Lost to Follow-up|0
854463|NCT01577745|2816430|P4|Overall Study|Lost to Follow-up|0
854464|NCT01577745|2816431|P3|Overall Study|Lost to Follow-up|0
854465|NCT01577745|2816432|P2|Overall Study|Lost to Follow-up|0
854466|NCT01577745|2816433|P1|Overall Study|Lost to Follow-up|0
854467|NCT01577745|2816428|P6|Overall Study|Physician Decision|0
854468|NCT01577745|2816429|P5|Overall Study|Physician Decision|1
854469|NCT01577745|2816430|P4|Overall Study|Physician Decision|1
854470|NCT01577745|2816431|P3|Overall Study|Physician Decision|0
854471|NCT01577745|2816432|P2|Overall Study|Physician Decision|0
854472|NCT01577745|2816433|P1|Overall Study|Physician Decision|0
854473|NCT01577745|2816428|P6|Overall Study|Death|3
854474|NCT01577745|2816429|P5|Overall Study|Death|1
854475|NCT01577745|2816430|P4|Overall Study|Death|1
854476|NCT01577745|2816431|P3|Overall Study|Death|2
854477|NCT01577745|2816432|P2|Overall Study|Death|2
854478|NCT01577745|2816433|P1|Overall Study|Death|3
854479|NCT01577745|2816428|P6|Overall Study|Withdrawal by Subject|0
854480|NCT01577745|2816429|P5|Overall Study|Withdrawal by Subject|2
854481|NCT01577745|2816430|P4|Overall Study|Withdrawal by Subject|3
854482|NCT01577745|2816431|P3|Overall Study|Withdrawal by Subject|0
854483|NCT01577745|2816432|P2|Overall Study|Withdrawal by Subject|1
854484|NCT01577745|2816433|P1|Overall Study|Withdrawal by Subject|0
854485|NCT01577381|2816617|P4|Overall Study|Ongoing at Date of Cut-Off|0
854486|NCT01577381|2816618|P3|Overall Study|Ongoing at Date of Cut-Off|1
854487|NCT01577381|2816619|P2|Overall Study|Ongoing at Date of Cut-Off|2
854488|NCT01577381|2816620|P1|Overall Study|Ongoing at Date of Cut-Off|0
854489|NCT01577381|2816617|P4|Overall Study|Discontinued|2
854490|NCT01577381|2816618|P3|Overall Study|Discontinued|2
854491|NCT01577381|2816619|P2|Overall Study|Discontinued|1
854492|NCT01577381|2816620|P1|Overall Study|Discontinued|2
854493|NCT01577186|2816758|P1|Overall Study|Other|2
854494|NCT01577186|2816758|P1|Overall Study|Non-Compliant|8
854495|NCT01577186|2816758|P1|Overall Study|Ineligible to Continue|15
854496|NCT01577186|2816758|P1|Overall Study|Insufficient Response|18
854497|NCT01577186|2816758|P1|Overall Study|Withdrawal by Subject|35
854498|NCT01577186|2816758|P1|Overall Study|Lost to Follow-up|28
854499|NCT01577186|2816758|P1|Overall Study|Death|1
854500|NCT01577186|2816758|P1|Overall Study|Adverse Event|23
854501|NCT01577160|2816766|P1|Overall Study|Other|9
854502|NCT01577160|2816766|P1|Overall Study|Subject Uncooperative|7
854503|NCT01577160|2816766|P1|Overall Study|Withdrawal by Subject|18
854504|NCT01577160|2816766|P1|Overall Study|Lost to Follow-up|40
854505|NCT01577160|2816766|P1|Overall Study|Lack of Efficacy|15
854506|NCT01577160|2816766|P1|Overall Study|Adverse Event|9
854507|NCT01576718|2816812|P7|Treatment Period|Noncompliance to study medication|1
854508|NCT01576718|2816813|P6|Treatment Period|Noncompliance to study medication|1
854509|NCT01576718|2816814|P5|Treatment Period|Noncompliance to study medication|0
854510|NCT01576718|2816815|P4|Treatment Period|Noncompliance to study medication|0
854511|NCT01576718|2816816|P3|Treatment Period|Noncompliance to study medication|0
854512|NCT01576718|2816817|P2|Treatment Period|Noncompliance to study medication|0
854513|NCT01576718|2816818|P1|Treatment Period|Noncompliance to study medication|0
854514|NCT01576718|2816812|P7|Treatment Period|Lost to Follow-up|0
854515|NCT01576718|2816813|P6|Treatment Period|Lost to Follow-up|0
854516|NCT01576718|2816814|P5|Treatment Period|Lost to Follow-up|1
854517|NCT01576718|2816815|P4|Treatment Period|Lost to Follow-up|0
854518|NCT01576718|2816816|P3|Treatment Period|Lost to Follow-up|0
854519|NCT01576718|2816817|P2|Treatment Period|Lost to Follow-up|0
854520|NCT01576718|2816818|P1|Treatment Period|Lost to Follow-up|0
854521|NCT01576718|2816812|P7|Treatment Period|Met stopping criteria|15
854522|NCT01576718|2816813|P6|Treatment Period|Met stopping criteria|33
854523|NCT01576718|2816814|P5|Treatment Period|Met stopping criteria|16
854524|NCT01576718|2816815|P4|Treatment Period|Met stopping criteria|19
854525|NCT01576718|2816816|P3|Treatment Period|Met stopping criteria|13
854526|NCT01576718|2816817|P2|Treatment Period|Met stopping criteria|16
854527|NCT01576718|2816818|P1|Treatment Period|Met stopping criteria|0
854528|NCT01576718|2816812|P7|Treatment Period|Sponsor request|0
854529|NCT01576718|2816813|P6|Treatment Period|Sponsor request|1
854530|NCT01576718|2816814|P5|Treatment Period|Sponsor request|0
854531|NCT01576718|2816815|P4|Treatment Period|Sponsor request|0
854532|NCT01576718|2816816|P3|Treatment Period|Sponsor request|0
854533|NCT01576718|2816817|P2|Treatment Period|Sponsor request|1
854534|NCT01576718|2816818|P1|Treatment Period|Sponsor request|0
854535|NCT01576718|2816812|P7|Treatment Period|Protocol Violation|12
854536|NCT01576718|2816813|P6|Treatment Period|Protocol Violation|8
854537|NCT01576718|2816814|P5|Treatment Period|Protocol Violation|6
854538|NCT01576718|2816815|P4|Treatment Period|Protocol Violation|10
854539|NCT01576718|2816816|P3|Treatment Period|Protocol Violation|4
854540|NCT01576718|2816817|P2|Treatment Period|Protocol Violation|5
854541|NCT01576718|2816818|P1|Treatment Period|Protocol Violation|0
854542|NCT01576718|2816812|P7|Treatment Period|Physician Decision|0
854543|NCT01576718|2816813|P6|Treatment Period|Physician Decision|0
854544|NCT01576718|2816814|P5|Treatment Period|Physician Decision|1
854545|NCT01576718|2816815|P4|Treatment Period|Physician Decision|1
854546|NCT01576718|2816816|P3|Treatment Period|Physician Decision|1
854547|NCT01576718|2816817|P2|Treatment Period|Physician Decision|1
854548|NCT01576718|2816818|P1|Treatment Period|Physician Decision|0
854549|NCT01576718|2816812|P7|Treatment Period|Withdrawal by Subject|2
854550|NCT01576718|2816813|P6|Treatment Period|Withdrawal by Subject|4
854551|NCT01576718|2816814|P5|Treatment Period|Withdrawal by Subject|2
854552|NCT01576718|2816815|P4|Treatment Period|Withdrawal by Subject|0
854553|NCT01576718|2816816|P3|Treatment Period|Withdrawal by Subject|1
854554|NCT01576718|2816817|P2|Treatment Period|Withdrawal by Subject|1
854555|NCT01576718|2816818|P1|Treatment Period|Withdrawal by Subject|0
854556|NCT01576718|2816812|P7|Treatment Period|Adverse Event|0
854557|NCT01576718|2816813|P6|Treatment Period|Adverse Event|1
854558|NCT01576718|2816814|P5|Treatment Period|Adverse Event|1
854559|NCT01576718|2816815|P4|Treatment Period|Adverse Event|1
854560|NCT01576718|2816816|P3|Treatment Period|Adverse Event|1
854561|NCT01576718|2816817|P2|Treatment Period|Adverse Event|1
854562|NCT01576718|2816818|P1|Treatment Period|Adverse Event|0
854563|NCT01576718|2816812|P7|Pre-Assignment Period (Run-In Placebo)|Not specified|0
854564|NCT01576718|2816813|P6|Pre-Assignment Period (Run-In Placebo)|Not specified|0
854565|NCT01576718|2816814|P5|Pre-Assignment Period (Run-In Placebo)|Not specified|0
854566|NCT01576718|2816815|P4|Pre-Assignment Period (Run-In Placebo)|Not specified|0
854567|NCT01576718|2816816|P3|Pre-Assignment Period (Run-In Placebo)|Not specified|0
854568|NCT01576718|2816817|P2|Pre-Assignment Period (Run-In Placebo)|Not specified|0
854569|NCT01576718|2816818|P1|Pre-Assignment Period (Run-In Placebo)|Not specified|15
854570|NCT01576718|2816812|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
854571|NCT01576718|2816813|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
854572|NCT01576718|2816814|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
854573|NCT01576718|2816815|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
854574|NCT01576718|2816816|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
854575|NCT01576718|2816817|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
854576|NCT01576718|2816818|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2
854577|NCT01576718|2816812|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
854578|NCT01576718|2816813|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
854579|NCT01576718|2816814|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
854580|NCT01576718|2816815|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
854581|NCT01576718|2816816|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
854582|NCT01576718|2816817|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
854583|NCT01576718|2816818|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166
854584|NCT01576718|2816812|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
854585|NCT01576718|2816813|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
854586|NCT01576718|2816814|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
854587|NCT01576718|2816815|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
854588|NCT01576718|2816816|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
854589|NCT01576718|2816817|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
854590|NCT01576718|2816818|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17
854591|NCT01576718|2816812|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
854592|NCT01576718|2816813|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
854593|NCT01576718|2816814|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
854594|NCT01576718|2816815|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
854595|NCT01576718|2816816|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
854596|NCT01576718|2816817|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
854597|NCT01576718|2816818|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49
854598|NCT01576549|2816910|P1|Overall Study|Sponsor Decision|2
854599|NCT01576406|2816933|P6|Overall Study|Other|0
854600|NCT01576406|2816934|P5|Overall Study|Other|0
854601|NCT01576406|2816935|P4|Overall Study|Other|2
854602|NCT01576406|2816936|P3|Overall Study|Other|2
854603|NCT01576406|2816937|P2|Overall Study|Other|0
854604|NCT01576406|2816938|P1|Overall Study|Other|0
854605|NCT01576406|2816933|P6|Overall Study|Withdrawal the consent|3
854606|NCT01576406|2816934|P5|Overall Study|Withdrawal the consent|1
854607|NCT01576406|2816935|P4|Overall Study|Withdrawal the consent|1
854608|NCT01576406|2816936|P3|Overall Study|Withdrawal the consent|5
854609|NCT01576406|2816937|P2|Overall Study|Withdrawal the consent|2
854610|NCT01576406|2816938|P1|Overall Study|Withdrawal the consent|2
854611|NCT01576406|2816933|P6|Overall Study|Non-clinical trial supply of Crizotinib|0
854612|NCT01576406|2816934|P5|Overall Study|Non-clinical trial supply of Crizotinib|0
854613|NCT01576406|2816935|P4|Overall Study|Non-clinical trial supply of Crizotinib|1
854614|NCT01576406|2816936|P3|Overall Study|Non-clinical trial supply of Crizotinib|1
854615|NCT01576406|2816937|P2|Overall Study|Non-clinical trial supply of Crizotinib|0
854616|NCT01576406|2816938|P1|Overall Study|Non-clinical trial supply of Crizotinib|0
854617|NCT01576406|2816933|P6|Overall Study|Death|9
854618|NCT01576406|2816934|P5|Overall Study|Death|7
854619|NCT01576406|2816935|P4|Overall Study|Death|5
854620|NCT01576406|2816936|P3|Overall Study|Death|8
854621|NCT01576406|2816937|P2|Overall Study|Death|4
854622|NCT01576406|2816938|P1|Overall Study|Death|3
854623|NCT01576406|2816933|P6|Overall Study|Lost to Follow-up|0
854624|NCT01576406|2816934|P5|Overall Study|Lost to Follow-up|0
854625|NCT01576406|2816935|P4|Overall Study|Lost to Follow-up|0
854626|NCT01576406|2816936|P3|Overall Study|Lost to Follow-up|0
854627|NCT01576406|2816937|P2|Overall Study|Lost to Follow-up|2
854628|NCT01576406|2816938|P1|Overall Study|Lost to Follow-up|1
854629|NCT01576367|2817186|P1|Overall Study|Moved to commercial use after 6 months|1
854630|NCT01576367|2817186|P1|Overall Study|Unsatisfactory therapeutic effect|2
854631|NCT01576341|2817194|P1|Overall Study|Other|12
854632|NCT01576341|2817194|P1|Overall Study|Protocol Violation|12
854633|NCT01576341|2817194|P1|Overall Study|Kidney transplantation|10
854634|NCT01576341|2817194|P1|Overall Study|Lost to Follow-up|2
854635|NCT01576341|2817194|P1|Overall Study|Physician Decision|2
854636|NCT01576341|2817194|P1|Overall Study|Death|21
854637|NCT01576341|2817194|P1|Overall Study|Adverse Event|10
854638|NCT01576341|2817194|P1|Overall Study|Withdrawal by Subject|24
854639|NCT01576159|2817215|P4|Overall Study|Protocol Violation|0
854640|NCT01576159|2817216|P3|Overall Study|Protocol Violation|0
854641|NCT01576159|2817217|P2|Overall Study|Protocol Violation|0
854642|NCT01576159|2817218|P1|Overall Study|Protocol Violation|1
854643|NCT01576159|2817215|P4|Overall Study|Lost to Follow-up|1
854644|NCT01576159|2817216|P3|Overall Study|Lost to Follow-up|0
854645|NCT01576159|2817217|P2|Overall Study|Lost to Follow-up|0
854646|NCT01576159|2817218|P1|Overall Study|Lost to Follow-up|0
854647|NCT01576159|2817215|P4|Overall Study|Physician Decision|0
854648|NCT01576159|2817216|P3|Overall Study|Physician Decision|1
854649|NCT01576159|2817217|P2|Overall Study|Physician Decision|0
854650|NCT01576159|2817218|P1|Overall Study|Physician Decision|0
854651|NCT01576159|2817215|P4|Overall Study|Withdrawal by Subject|0
854652|NCT01576159|2817216|P3|Overall Study|Withdrawal by Subject|0
854653|NCT01576159|2817217|P2|Overall Study|Withdrawal by Subject|1
854654|NCT01576159|2817218|P1|Overall Study|Withdrawal by Subject|0
854655|NCT01576146|2817236|P1|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1
854656|NCT01576146|2817236|P1|Extension Period 2|Renal Transplant|1
854657|NCT01576146|2817236|P1|Extension Period 2|Adverse Event|1
854658|NCT01576146|2817236|P1|Extension Period 2|Death|1
854659|NCT01576146|2817236|P1|Extension Period 2|Sponsor Decision|13
854660|NCT01576146|2817236|P1|Extension Period 1|Renal Transplant|1
854661|NCT01576146|2817236|P1|Extension Period 1|Parathyroidectomy|1
854662|NCT01576146|2817236|P1|Extension Period 1|Lost to Follow-up|1
854663|NCT01576146|2817236|P1|Extension Period 1|Withdrawal by Subject|1
854664|NCT01576146|2817236|P1|Extension Period 1|Physician Decision|2
854665|NCT01576146|2817236|P1|Extension Period 1|Death|2
854666|NCT01576146|2817236|P1|Extension Period 1|Adverse Event|2
854667|NCT01576042|2817269|P2|Overall Study|Physician Decision|0
854668|NCT01576042|2817270|P1|Overall Study|Physician Decision|2
854669|NCT01575899|2817306|P3|Overall Study|Protocol Violation|0
854670|NCT01575899|2817307|P2|Overall Study|Protocol Violation|1
854671|NCT01575899|2817308|P1|Overall Study|Protocol Violation|2
854672|NCT01575899|2817306|P3|Overall Study|Lost to Follow-up|2
854673|NCT01575899|2817307|P2|Overall Study|Lost to Follow-up|4
854674|NCT01575899|2817308|P1|Overall Study|Lost to Follow-up|3
854675|NCT01575873|2817322|P4|Overall Study|Other|2
854676|NCT01575873|2817323|P3|Overall Study|Other|4
854677|NCT01575873|2817324|P2|Overall Study|Other|0
854678|NCT01575873|2817325|P1|Overall Study|Other|0
854679|NCT01575873|2817322|P4|Overall Study|Requirement for Alternative Therapy|1
854680|NCT01575873|2817323|P3|Overall Study|Requirement for Alternative Therapy|1
854681|NCT01575873|2817324|P2|Overall Study|Requirement for Alternative Therapy|0
854682|NCT01575873|2817325|P1|Overall Study|Requirement for Alternative Therapy|0
854683|NCT01575873|2817322|P4|Overall Study|Protocol deviation|1
854684|NCT01575873|2817323|P3|Overall Study|Protocol deviation|0
854685|NCT01575873|2817324|P2|Overall Study|Protocol deviation|1
854686|NCT01575873|2817325|P1|Overall Study|Protocol deviation|0
854687|NCT01575873|2817322|P4|Overall Study|Administrative decision|0
854688|NCT01575873|2817323|P3|Overall Study|Administrative decision|1
854689|NCT01575873|2817324|P2|Overall Study|Administrative decision|1
854690|NCT01575873|2817325|P1|Overall Study|Administrative decision|1
854691|NCT01575873|2817322|P4|Overall Study|Noncompliance|3
854692|NCT01575873|2817323|P3|Overall Study|Noncompliance|4
854693|NCT01575873|2817324|P2|Overall Study|Noncompliance|2
854694|NCT01575873|2817325|P1|Overall Study|Noncompliance|1
854695|NCT01575873|2817322|P4|Overall Study|Death|9
854696|NCT01575873|2817323|P3|Overall Study|Death|8
854697|NCT01575873|2817324|P2|Overall Study|Death|2
854698|NCT01575873|2817325|P1|Overall Study|Death|3
854699|NCT01575873|2817322|P4|Overall Study|Lost to Follow-up|5
854700|NCT01575873|2817323|P3|Overall Study|Lost to Follow-up|13
854701|NCT01575873|2817324|P2|Overall Study|Lost to Follow-up|3
854702|NCT01575873|2817325|P1|Overall Study|Lost to Follow-up|1
854703|NCT01575873|2817322|P4|Overall Study|Adverse Event|12
854704|NCT01575873|2817323|P3|Overall Study|Adverse Event|9
854705|NCT01575873|2817324|P2|Overall Study|Adverse Event|7
854706|NCT01575873|2817325|P1|Overall Study|Adverse Event|7
854707|NCT01575873|2817322|P4|Overall Study|Withdrawal by Subject|34
854708|NCT01575873|2817323|P3|Overall Study|Withdrawal by Subject|34
854709|NCT01575873|2817324|P2|Overall Study|Withdrawal by Subject|20
854710|NCT01575873|2817325|P1|Overall Study|Withdrawal by Subject|15
854711|NCT01575834|2817351|P2|Overall Study|Requirement for Alternative Therapy|4
854712|NCT01575834|2817352|P1|Overall Study|Requirement for Alternative Therapy|2
854713|NCT01575834|2817351|P2|Overall Study|Protocol Deviation|3
854714|NCT01575834|2817352|P1|Overall Study|Protocol Deviation|4
854715|NCT01575834|2817351|P2|Overall Study|Ineligibility Determined|8
854716|NCT01575834|2817352|P1|Overall Study|Ineligibility Determined|5
854717|NCT01575834|2817351|P2|Overall Study|Administrative decision|33
854718|NCT01575834|2817352|P1|Overall Study|Administrative decision|15
854719|NCT01575834|2817351|P2|Overall Study|Noncompliance|27
854720|NCT01575834|2817352|P1|Overall Study|Noncompliance|52
854721|NCT01575834|2817351|P2|Overall Study|Lost to Follow-up|68
854722|NCT01575834|2817352|P1|Overall Study|Lost to Follow-up|55
854723|NCT01575834|2817351|P2|Overall Study|Adverse Event|61
854724|NCT01575834|2817352|P1|Overall Study|Adverse Event|63
854725|NCT01575834|2817351|P2|Overall Study|Other|70
854726|NCT01575834|2817352|P1|Overall Study|Other|70
854727|NCT01575834|2817351|P2|Overall Study|Death|74
854728|NCT01575834|2817352|P1|Overall Study|Death|81
854729|NCT01575834|2817351|P2|Overall Study|Withdrawal by Subject|390
854730|NCT01575834|2817352|P1|Overall Study|Withdrawal by Subject|352
854731|NCT01575808|2817404|P2|Overall Study|Withdrawal by Subject|0
854732|NCT01575808|2817405|P1|Overall Study|Withdrawal by Subject|1
854733|NCT01575808|2817404|P2|Overall Study|Death|0
854734|NCT01575808|2817405|P1|Overall Study|Death|2
854735|NCT01575769|2817452|P1|Overall Study|Study terminated by sponsor|40
854736|NCT01575769|2817452|P1|Overall Study|Adverse Event|1
854737|NCT01575561|2817510|P1|Overall Study|administration|1
854738|NCT01575561|2817510|P1|Overall Study|Withdrawal by Subject|11
854739|NCT01575561|2817510|P1|Overall Study|Protocol Violation|4
854740|NCT01575561|2817510|P1|Overall Study|Lost to Follow-up|6
854741|NCT01575561|2817510|P1|Overall Study|Lack of Efficacy|8
854742|NCT01575561|2817510|P1|Overall Study|Adverse Event|9
854743|NCT01575197|2817540|P3|Overall Study|Protocol Violation|1
854744|NCT01575197|2817541|P2|Overall Study|Protocol Violation|1
854745|NCT01575197|2817542|P1|Overall Study|Protocol Violation|2
854746|NCT01575197|2817540|P3|Overall Study|Withdrawal by Subject|1
854747|NCT01575197|2817541|P2|Overall Study|Withdrawal by Subject|1
854748|NCT01575197|2817542|P1|Overall Study|Withdrawal by Subject|0
854749|NCT01575197|2817540|P3|Overall Study|Lost to Follow-up|0
854750|NCT01575197|2817541|P2|Overall Study|Lost to Follow-up|1
854751|NCT01575197|2817542|P1|Overall Study|Lost to Follow-up|0
854752|NCT01575197|2817540|P3|Overall Study|SAE|0
854753|NCT01575197|2817541|P2|Overall Study|SAE|1
854754|NCT01575197|2817542|P1|Overall Study|SAE|0
854755|NCT01575197|2817540|P3|Overall Study|Migration out of study area|4
854756|NCT01575197|2817541|P2|Overall Study|Migration out of study area|5
854757|NCT01575197|2817542|P1|Overall Study|Migration out of study area|1
854758|NCT01575054|2817570|P2|Overall Study|Adverse Event|8
854759|NCT01575054|2817571|P1|Overall Study|Adverse Event|9
854760|NCT01575054|2817570|P2|Overall Study|Lost to Follow-up|3
854761|NCT01575054|2817571|P1|Overall Study|Lost to Follow-up|3
854762|NCT01575054|2817570|P2|Overall Study|Personal Reasons|11
854763|NCT01575054|2817571|P1|Overall Study|Personal Reasons|10
854764|NCT01575054|2817570|P2|Overall Study|Protocol Violation|1
854765|NCT01575054|2817571|P1|Overall Study|Protocol Violation|2
854766|NCT01575054|2817570|P2|Overall Study|Other Reasons|3
854767|NCT01575054|2817571|P1|Overall Study|Other Reasons|5
854768|NCT01575028|2817587|P2|Overall Study|Physician Decision|1
854769|NCT01575028|2817588|P1|Overall Study|Physician Decision|0
854770|NCT01574703|2817598|P4|Overall Study|Death|0
854771|NCT01574703|2817599|P3|Overall Study|Death|1
854772|NCT01574703|2817600|P2|Overall Study|Death|1
854773|NCT01574703|2817601|P1|Overall Study|Death|2
854774|NCT01574703|2817598|P4|Overall Study|Lost to Follow-up|35
854775|NCT01574703|2817599|P3|Overall Study|Lost to Follow-up|46
854776|NCT01574703|2817600|P2|Overall Study|Lost to Follow-up|41
854777|NCT01574703|2817601|P1|Overall Study|Lost to Follow-up|43
854778|NCT01574703|2817598|P4|Overall Study|Met Withdrawal Criteria|0
854779|NCT01574703|2817599|P3|Overall Study|Met Withdrawal Criteria|1
854780|NCT01574703|2817600|P2|Overall Study|Met Withdrawal Criteria|1
854781|NCT01574703|2817601|P1|Overall Study|Met Withdrawal Criteria|0
854782|NCT01574703|2817598|P4|Overall Study|Withdrawal by Subject|61
854783|NCT01574703|2817599|P3|Overall Study|Withdrawal by Subject|36
854784|NCT01574703|2817600|P2|Overall Study|Withdrawal by Subject|52
854785|NCT01574703|2817601|P1|Overall Study|Withdrawal by Subject|53
854786|NCT01574703|2817598|P4|Overall Study|Unspecified Reason|16
854787|NCT01574703|2817599|P3|Overall Study|Unspecified Reason|20
854788|NCT01574703|2817600|P2|Overall Study|Unspecified Reason|15
854789|NCT01574703|2817601|P1|Overall Study|Unspecified Reason|27
854790|NCT01574703|2817598|P4|Overall Study|Protocol Violation|1
854791|NCT01574703|2817599|P3|Overall Study|Protocol Violation|0
854792|NCT01574703|2817600|P2|Overall Study|Protocol Violation|0
854793|NCT01574703|2817601|P1|Overall Study|Protocol Violation|0
854794|NCT01574703|2817598|P4|Overall Study|Adverse Event|1
854795|NCT01574703|2817599|P3|Overall Study|Adverse Event|1
854796|NCT01574703|2817600|P2|Overall Study|Adverse Event|2
854797|NCT01574703|2817601|P1|Overall Study|Adverse Event|0
854798|NCT01574651|2817645|P2|Overall Study|Withdrawal by Subject|10
854799|NCT01574651|2817646|P1|Overall Study|Withdrawal by Subject|9
854800|NCT01574651|2817645|P2|Overall Study|Protocol Violation|5
854801|NCT01574651|2817646|P1|Overall Study|Protocol Violation|3
854802|NCT01574651|2817645|P2|Overall Study|Unsatisfactory therapeutic effect|0
854803|NCT01574651|2817646|P1|Overall Study|Unsatisfactory therapeutic effect|6
854804|NCT01574651|2817645|P2|Overall Study|Abnormal test procedure result(s)|1
854805|NCT01574651|2817646|P1|Overall Study|Abnormal test procedure result(s)|1
854806|NCT01574651|2817645|P2|Overall Study|Abnormal laboratory value(s)|0
854807|NCT01574651|2817646|P1|Overall Study|Abnormal laboratory value(s)|1
854808|NCT01574651|2817645|P2|Overall Study|Adverse Event|27
854809|NCT01574651|2817646|P1|Overall Study|Adverse Event|36
854810|NCT01574651|2817645|P2|Overall Study|Patient's inability to use the device|1
854811|NCT01574651|2817646|P1|Overall Study|Patient's inability to use the device|0
854812|NCT01574651|2817645|P2|Overall Study|Death|3
854813|NCT01574651|2817646|P1|Overall Study|Death|3
854814|NCT01574651|2817645|P2|Overall Study|Administrative problems|1
854815|NCT01574651|2817646|P1|Overall Study|Administrative problems|0
854816|NCT01574651|2817645|P2|Overall Study|Lost to Follow-up|4
854817|NCT01574651|2817646|P1|Overall Study|Lost to Follow-up|2
854818|NCT01574612|2817668|P1|Overall Study|Lost to Follow-up|2
854819|NCT01574612|2817668|P1|Overall Study|Withdrawal by Subject|1
854820|NCT01574612|2817668|P1|Overall Study|non compliant with drug|2
854821|NCT01574612|2817668|P1|Overall Study|Adverse Event|3
854822|NCT01574326|2817674|P2|Overall Study|Other: Mainly kidney transplant|8
854823|NCT01574326|2817675|P1|Overall Study|Other: Mainly kidney transplant|8
854824|NCT01574326|2817674|P2|Overall Study|Adverse Event|3
854825|NCT01574326|2817675|P1|Overall Study|Adverse Event|1
854826|NCT01574326|2817674|P2|Overall Study|Physician Decision|3
854827|NCT01574326|2817675|P1|Overall Study|Physician Decision|5
854828|NCT01574326|2817674|P2|Overall Study|Withdrawal by Participant|4
854829|NCT01574326|2817675|P1|Overall Study|Withdrawal by Participant|2
854830|NCT01574326|2817674|P2|Overall Study|Randomized but not treated|1
854831|NCT01574326|2817675|P1|Overall Study|Randomized but not treated|0
854832|NCT01574248|2817688|P2|Overall Study|Missing primary endpoint data|0
854833|NCT01574248|2817689|P1|Overall Study|Missing primary endpoint data|1
854834|NCT01574248|2817688|P2|Overall Study|Withdrawal by Subject|0
854835|NCT01574248|2817689|P1|Overall Study|Withdrawal by Subject|2
854836|NCT01574079|2817738|P2|Overall Study|Lost to Follow-up|0
854837|NCT01574079|2817739|P1|Overall Study|Lost to Follow-up|1
854838|NCT01574079|2817738|P2|Overall Study|Physician Decision|2
854839|NCT01574079|2817739|P1|Overall Study|Physician Decision|0
854840|NCT01573910|2817751|P2|Overall Study|Patient decision unrelated to Advs Event|11
854841|NCT01573910|2817752|P1|Overall Study|Patient decision unrelated to Advs Event|11
854842|NCT01573910|2817751|P2|Overall Study|Protocol Violation|0
854843|NCT01573910|2817752|P1|Overall Study|Protocol Violation|3
854844|NCT01573910|2817751|P2|Overall Study|Withdrawal by Subject|1
854845|NCT01573910|2817752|P1|Overall Study|Withdrawal by Subject|0
854846|NCT01573910|2817751|P2|Overall Study|Lost to Follow-up|1
854847|NCT01573910|2817752|P1|Overall Study|Lost to Follow-up|2
854848|NCT01573910|2817751|P2|Overall Study|Adverse Event|4
854849|NCT01573910|2817752|P1|Overall Study|Adverse Event|4
854850|NCT01573767|2817764|P4|Overall Study|Withdrawal by Subject|0
854851|NCT01573767|2817765|P3|Overall Study|Withdrawal by Subject|0
854852|NCT01573767|2817766|P2|Overall Study|Withdrawal by Subject|1
854853|NCT01573767|2817767|P1|Overall Study|Withdrawal by Subject|0
854854|NCT01573767|2817764|P4|Overall Study|Physician Decision|2
854855|NCT01573767|2817765|P3|Overall Study|Physician Decision|0
854856|NCT01573767|2817766|P2|Overall Study|Physician Decision|2
854857|NCT01573767|2817767|P1|Overall Study|Physician Decision|1
854858|NCT01573767|2817764|P4|Overall Study|Lost to Follow-up|1
854859|NCT01573767|2817765|P3|Overall Study|Lost to Follow-up|1
854860|NCT01573767|2817766|P2|Overall Study|Lost to Follow-up|1
854861|NCT01573767|2817767|P1|Overall Study|Lost to Follow-up|0
854862|NCT01573767|2817764|P4|Overall Study|Protocol Violation|3
854863|NCT01573767|2817765|P3|Overall Study|Protocol Violation|1
854864|NCT01573767|2817766|P2|Overall Study|Protocol Violation|1
854865|NCT01573767|2817767|P1|Overall Study|Protocol Violation|3
854866|NCT01573767|2817764|P4|Overall Study|Lack of Efficacy|17
854867|NCT01573767|2817765|P3|Overall Study|Lack of Efficacy|12
854868|NCT01573767|2817766|P2|Overall Study|Lack of Efficacy|15
854869|NCT01573767|2817767|P1|Overall Study|Lack of Efficacy|18
854870|NCT01573767|2817764|P4|Overall Study|Adverse Event|1
854871|NCT01573767|2817765|P3|Overall Study|Adverse Event|0
854872|NCT01573767|2817766|P2|Overall Study|Adverse Event|1
854873|NCT01573767|2817767|P1|Overall Study|Adverse Event|0
854874|NCT01573624|2817801|P7|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
854875|NCT01573624|2817802|P6|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
854876|NCT01573624|2817803|P5|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
854877|NCT01573624|2817804|P4|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
854878|NCT01573624|2817805|P3|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
854879|NCT01573624|2817806|P2|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
854880|NCT01573624|2817807|P1|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1
854881|NCT01573624|2817801|P7|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
854882|NCT01573624|2817802|P6|Period 6 : Follow-up Period (7 Days)|Adverse Event|1
854883|NCT01573624|2817803|P5|Period 6 : Follow-up Period (7 Days)|Adverse Event|2
854884|NCT01573624|2817804|P4|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
854885|NCT01573624|2817805|P3|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
854886|NCT01573624|2817806|P2|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
854887|NCT01573624|2817807|P1|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
854888|NCT01573624|2817801|P7|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
854889|NCT01573624|2817802|P6|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
854890|NCT01573624|2817803|P5|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
854891|NCT01573624|2817804|P4|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
854892|NCT01573624|2817805|P3|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
854893|NCT01573624|2817806|P2|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
854894|NCT01573624|2817807|P1|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1
854895|NCT01573624|2817801|P7|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
854896|NCT01573624|2817802|P6|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
854897|NCT01573624|2817803|P5|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
854898|NCT01573624|2817804|P4|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
854899|NCT01573624|2817805|P3|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
854900|NCT01573624|2817806|P2|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
854901|NCT01573624|2817807|P1|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
854902|NCT01573624|2817801|P7|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4
854903|NCT01573624|2817802|P6|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
854904|NCT01573624|2817803|P5|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
854905|NCT01573624|2817804|P4|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
854906|NCT01573624|2817805|P3|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
854907|NCT01573624|2817806|P2|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
854908|NCT01573624|2817807|P1|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2
854909|NCT01573624|2817801|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
854910|NCT01573624|2817802|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
854911|NCT01573624|2817803|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
854912|NCT01573624|2817804|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
854913|NCT01573624|2817805|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
854914|NCT01573624|2817806|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
854915|NCT01573624|2817807|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
854916|NCT01573624|2817801|P7|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
854917|NCT01573624|2817802|P6|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
854918|NCT01573624|2817803|P5|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
854919|NCT01573624|2817804|P4|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
854920|NCT01573624|2817805|P3|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
854921|NCT01573624|2817806|P2|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
854922|NCT01573624|2817807|P1|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
854923|NCT01573624|2817801|P7|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
854924|NCT01573624|2817802|P6|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
854925|NCT01573624|2817803|P5|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
854926|NCT01573624|2817804|P4|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
854927|NCT01573624|2817805|P3|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
854928|NCT01573624|2817806|P2|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1
854929|NCT01573624|2817807|P1|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
854930|NCT01573624|2817801|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
854931|NCT01573624|2817802|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
854932|NCT01573624|2817803|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
854933|NCT01573624|2817804|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
854934|NCT01573624|2817805|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
854935|NCT01573624|2817806|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1
854936|NCT01573624|2817807|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
854937|NCT01573624|2817801|P7|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
854938|NCT01573624|2817802|P6|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
854939|NCT01573624|2817803|P5|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
854940|NCT01573624|2817804|P4|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
854941|NCT01573624|2817805|P3|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
854942|NCT01573624|2817806|P2|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
854943|NCT01573624|2817807|P1|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
854944|NCT01573624|2817801|P7|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
854945|NCT01573624|2817802|P6|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
854946|NCT01573624|2817803|P5|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
854947|NCT01573624|2817804|P4|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
854948|NCT01573624|2817805|P3|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
854949|NCT01573624|2817806|P2|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
854950|NCT01573624|2817807|P1|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
854951|NCT01573624|2817801|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
854952|NCT01573624|2817802|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
854953|NCT01573624|2817803|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
854954|NCT01573624|2817804|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
854955|NCT01573624|2817805|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
854956|NCT01573624|2817806|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
854957|NCT01573624|2817807|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1
854958|NCT01573624|2817801|P7|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
854959|NCT01573624|2817802|P6|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
854960|NCT01573624|2817803|P5|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
854961|NCT01573624|2817804|P4|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
854962|NCT01573624|2817805|P3|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
854963|NCT01573624|2817806|P2|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
854964|NCT01573624|2817807|P1|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
854965|NCT01573624|2817801|P7|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
854966|NCT01573624|2817802|P6|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
854967|NCT01573624|2817803|P5|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
854968|NCT01573624|2817804|P4|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
854969|NCT01573624|2817805|P3|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
854970|NCT01573624|2817806|P2|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
854971|NCT01573624|2817807|P1|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1
854972|NCT01573624|2817801|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
854973|NCT01573624|2817802|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2
854974|NCT01573624|2817803|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
854975|NCT01573624|2817804|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
854976|NCT01573624|2817805|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
854977|NCT01573624|2817806|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1
854978|NCT01573624|2817807|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
854979|NCT01573624|2817801|P7|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0
854980|NCT01573624|2817802|P6|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
854981|NCT01573624|2817803|P5|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3
854982|NCT01573624|2817804|P4|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1
854983|NCT01573624|2817805|P3|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
854984|NCT01573624|2817806|P2|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4
854985|NCT01573624|2817807|P1|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5
854986|NCT01573624|2817801|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
854987|NCT01573624|2817802|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
854988|NCT01573624|2817803|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
854989|NCT01573624|2817804|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
854990|NCT01573624|2817805|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
854991|NCT01573624|2817806|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
854992|NCT01573624|2817807|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
854993|NCT01573624|2817801|P7|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
854994|NCT01573624|2817802|P6|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
854995|NCT01573624|2817803|P5|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
854996|NCT01573624|2817804|P4|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2
854997|NCT01573624|2817805|P3|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
854998|NCT01573624|2817806|P2|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
854999|NCT01573624|2817807|P1|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
855000|NCT01573624|2817801|P7|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
855001|NCT01573624|2817802|P6|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1
855002|NCT01573624|2817803|P5|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
855003|NCT01573624|2817804|P4|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
855004|NCT01573624|2817805|P3|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
855005|NCT01573624|2817806|P2|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
855006|NCT01573624|2817807|P1|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
855007|NCT01573624|2817801|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
855008|NCT01573624|2817802|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
855009|NCT01573624|2817803|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
855010|NCT01573624|2817804|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
855011|NCT01573624|2817805|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2
855012|NCT01573624|2817806|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
855013|NCT01573624|2817807|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
855014|NCT01573624|2817801|P7|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
855015|NCT01573624|2817802|P6|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
855016|NCT01573624|2817803|P5|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
855017|NCT01573624|2817804|P4|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
855018|NCT01573624|2817805|P3|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
855019|NCT01573624|2817806|P2|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
855020|NCT01573624|2817807|P1|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
855021|NCT01573624|2817801|P7|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
855022|NCT01573624|2817802|P6|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1
855023|NCT01573624|2817803|P5|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
855024|NCT01573624|2817804|P4|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
855025|NCT01573624|2817805|P3|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
855026|NCT01573624|2817806|P2|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
855027|NCT01573624|2817807|P1|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
855028|NCT01573624|2817801|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
855029|NCT01573624|2817802|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
855030|NCT01573624|2817803|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
855031|NCT01573624|2817804|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
855032|NCT01573624|2817805|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
855033|NCT01573624|2817806|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
855034|NCT01573624|2817807|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
855035|NCT01573624|2817801|P7|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
855036|NCT01573624|2817802|P6|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2
855037|NCT01573624|2817803|P5|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
855038|NCT01573624|2817804|P4|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
855039|NCT01573624|2817805|P3|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
855040|NCT01573624|2817806|P2|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
855041|NCT01573624|2817807|P1|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
855042|NCT01573624|2817801|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
855043|NCT01573624|2817802|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
855044|NCT01573624|2817803|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
855045|NCT01573624|2817804|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
855046|NCT01573624|2817805|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
855047|NCT01573624|2817806|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
855048|NCT01573624|2817807|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1
855049|NCT01573624|2817801|P7|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
855050|NCT01573624|2817802|P6|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0
855051|NCT01573624|2817803|P5|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2
855052|NCT01573624|2817804|P4|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
855053|NCT01573624|2817805|P3|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6
855054|NCT01573624|2817806|P2|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3
855055|NCT01573624|2817807|P1|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4
855056|NCT01573624|2817801|P7|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
855057|NCT01573624|2817802|P6|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
855058|NCT01573624|2817803|P5|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
855059|NCT01573624|2817804|P4|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
855060|NCT01573624|2817805|P3|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
855061|NCT01573624|2817806|P2|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
855062|NCT01573624|2817807|P1|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
855063|NCT01573000|2817896|P2|Long-Term Follow-Up|Lost to Follow-up|1
855064|NCT01573000|2817897|P1|Long-Term Follow-Up|Lost to Follow-up|0
855065|NCT01573000|2817896|P2|Long-Term Follow-Up|Death|0
855066|NCT01573000|2817897|P1|Long-Term Follow-Up|Death|3
855067|NCT01573000|2817896|P2|Crossover Phase|Death|3
855068|NCT01573000|2817897|P1|Crossover Phase|Death|0
855069|NCT01573000|2817896|P2|Crossover Phase|Lost to Follow-up|2
855070|NCT01573000|2817897|P1|Crossover Phase|Lost to Follow-up|0
855071|NCT01573000|2817896|P2|Crossover Phase|Lack of Efficacy|13
855072|NCT01573000|2817897|P1|Crossover Phase|Lack of Efficacy|0
855073|NCT01573000|2817896|P2|Dosimetric and Therapeutic Treatment|Received Other Treatment|0
855074|NCT01573000|2817897|P1|Dosimetric and Therapeutic Treatment|Received Other Treatment|2
855075|NCT01573000|2817896|P2|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0
855076|NCT01573000|2817897|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2
855077|NCT01573000|2817896|P2|Dosimetric and Therapeutic Treatment|Death|1
855078|NCT01573000|2817897|P1|Dosimetric and Therapeutic Treatment|Death|0
855079|NCT01573000|2817896|P2|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
855080|NCT01573000|2817897|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4
855081|NCT01573000|2817896|P2|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32
855082|NCT01573000|2817897|P1|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27
855083|NCT01572948|2817993|P2|Overall Study|unable to contact|1
855084|NCT01572948|2817994|P1|Overall Study|unable to contact|0
855085|NCT01572948|2817993|P2|Overall Study|Lost to Follow-up|0
855086|NCT01572948|2817994|P1|Overall Study|Lost to Follow-up|1
855087|NCT01572844|2818010|P2|Overall Study|Physician Decision|1
855088|NCT01572844|2818011|P1|Overall Study|Physician Decision|1
855089|NCT01572792|2818029|P5|Extension Study|Site termination/COPD exacerbation/other|6
855090|NCT01572792|2818030|P4|Extension Study|Site termination/COPD exacerbation/other|6
855091|NCT01572792|2818031|P3|Extension Study|Site termination/COPD exacerbation/other|4
855092|NCT01572792|2818032|P2|Extension Study|Site termination/COPD exacerbation/other|8
855093|NCT01572792|2818033|P1|Extension Study|Site termination/COPD exacerbation/other|3
855094|NCT01572792|2818029|P5|Extension Study|Adverse Event|4
855095|NCT01572792|2818030|P4|Extension Study|Adverse Event|6
855096|NCT01572792|2818031|P3|Extension Study|Adverse Event|5
855097|NCT01572792|2818032|P2|Extension Study|Adverse Event|6
855098|NCT01572792|2818033|P1|Extension Study|Adverse Event|7
855099|NCT01572792|2818029|P5|Extension Study|Lack of Efficacy|2
855100|NCT01572792|2818030|P4|Extension Study|Lack of Efficacy|2
855101|NCT01572792|2818031|P3|Extension Study|Lack of Efficacy|3
855102|NCT01572792|2818032|P2|Extension Study|Lack of Efficacy|3
855103|NCT01572792|2818033|P1|Extension Study|Lack of Efficacy|2
855104|NCT01572792|2818029|P5|Extension Study|Protocol Violation|3
855105|NCT01572792|2818030|P4|Extension Study|Protocol Violation|4
855106|NCT01572792|2818031|P3|Extension Study|Protocol Violation|3
855107|NCT01572792|2818032|P2|Extension Study|Protocol Violation|4
855108|NCT01572792|2818033|P1|Extension Study|Protocol Violation|0
855109|NCT01572792|2818029|P5|Extension Study|Withdrawal by Subject|14
855110|NCT01572792|2818030|P4|Extension Study|Withdrawal by Subject|8
855111|NCT01572792|2818031|P3|Extension Study|Withdrawal by Subject|11
855112|NCT01572792|2818032|P2|Extension Study|Withdrawal by Subject|6
855113|NCT01572792|2818033|P1|Extension Study|Withdrawal by Subject|7
855114|NCT01572792|2818029|P5|Extension Study|Lost to Follow-up|3
855115|NCT01572792|2818030|P4|Extension Study|Lost to Follow-up|3
855116|NCT01572792|2818031|P3|Extension Study|Lost to Follow-up|0
855117|NCT01572792|2818032|P2|Extension Study|Lost to Follow-up|2
855118|NCT01572792|2818033|P1|Extension Study|Lost to Follow-up|6
855119|NCT01572792|2818029|P5|Lead-in Study|Site termination/COPD exacerbation/other|9
855120|NCT01572792|2818030|P4|Lead-in Study|Site termination/COPD exacerbation/other|9
855121|NCT01572792|2818031|P3|Lead-in Study|Site termination/COPD exacerbation/other|8
855122|NCT01572792|2818032|P2|Lead-in Study|Site termination/COPD exacerbation/other|10
855123|NCT01572792|2818033|P1|Lead-in Study|Site termination/COPD exacerbation/other|14
855124|NCT01572792|2818029|P5|Lead-in Study|Adverse Event|14
855125|NCT01572792|2818030|P4|Lead-in Study|Adverse Event|16
855126|NCT01572792|2818031|P3|Lead-in Study|Adverse Event|22
855127|NCT01572792|2818032|P2|Lead-in Study|Adverse Event|21
855128|NCT01572792|2818033|P1|Lead-in Study|Adverse Event|21
855129|NCT01572792|2818029|P5|Lead-in Study|Lack of Efficacy|10
855130|NCT01572792|2818030|P4|Lead-in Study|Lack of Efficacy|8
855131|NCT01572792|2818031|P3|Lead-in Study|Lack of Efficacy|4
855132|NCT01572792|2818032|P2|Lead-in Study|Lack of Efficacy|5
855133|NCT01572792|2818033|P1|Lead-in Study|Lack of Efficacy|20
855134|NCT01572792|2818029|P5|Lead-in Study|Protocol Violation|21
855135|NCT01572792|2818030|P4|Lead-in Study|Protocol Violation|13
855136|NCT01572792|2818031|P3|Lead-in Study|Protocol Violation|12
855137|NCT01572792|2818032|P2|Lead-in Study|Protocol Violation|10
855138|NCT01572792|2818033|P1|Lead-in Study|Protocol Violation|19
855139|NCT01572792|2818029|P5|Lead-in Study|Withdrawal by Subject|11
855140|NCT01572792|2818030|P4|Lead-in Study|Withdrawal by Subject|24
855141|NCT01572792|2818031|P3|Lead-in Study|Withdrawal by Subject|12
855142|NCT01572792|2818032|P2|Lead-in Study|Withdrawal by Subject|11
855143|NCT01572792|2818033|P1|Lead-in Study|Withdrawal by Subject|22
855144|NCT01572792|2818029|P5|Lead-in Study|Lost to Follow-up|4
855145|NCT01572792|2818030|P4|Lead-in Study|Lost to Follow-up|2
855146|NCT01572792|2818031|P3|Lead-in Study|Lost to Follow-up|4
855147|NCT01572792|2818032|P2|Lead-in Study|Lost to Follow-up|9
855148|NCT01572792|2818033|P1|Lead-in Study|Lost to Follow-up|5
855149|NCT01572740|2818082|P2|Overall Study|unclassified|3
855150|NCT01572740|2818083|P1|Overall Study|unclassified|4
855151|NCT01572740|2818082|P2|Overall Study|Withdrawal by Subject|1
855152|NCT01572740|2818083|P1|Overall Study|Withdrawal by Subject|1
855153|NCT01572740|2818082|P2|Overall Study|Adverse Event|1
855154|NCT01572740|2818083|P1|Overall Study|Adverse Event|1
855155|NCT01572727|2818113|P2|Overall Study|Untreated|7
855156|NCT01572727|2818114|P1|Overall Study|Untreated|4
855157|NCT01572727|2818113|P2|Overall Study|Death|2
855158|NCT01572727|2818114|P1|Overall Study|Death|2
855159|NCT01572727|2818113|P2|Overall Study|Parent/guardian decision|9
855160|NCT01572727|2818114|P1|Overall Study|Parent/guardian decision|14
855161|NCT01572727|2818113|P2|Overall Study|Study terminated by sponsor|83
855162|NCT01572727|2818114|P1|Overall Study|Study terminated by sponsor|61
855163|NCT01572727|2818113|P2|Overall Study|Protocol Violation|1
855164|NCT01572727|2818114|P1|Overall Study|Protocol Violation|0
855165|NCT01572727|2818113|P2|Overall Study|Progressive disease|82
855166|NCT01572727|2818114|P1|Overall Study|Progressive disease|59
855167|NCT01572727|2818113|P2|Overall Study|Physician Decision|9
855168|NCT01572727|2818114|P1|Overall Study|Physician Decision|23
855169|NCT01572727|2818113|P2|Overall Study|Lost to Follow-up|1
855170|NCT01572727|2818114|P1|Overall Study|Lost to Follow-up|1
855171|NCT01572727|2818113|P2|Overall Study|Adverse Event|15
855172|NCT01572727|2818114|P1|Overall Study|Adverse Event|43
855173|NCT01572675|2818136|P2|Overall Study|Lost to Follow-up|27
855174|NCT01572675|2818137|P1|Overall Study|Lost to Follow-up|22
855175|NCT01572675|2818136|P2|Overall Study|Missing data|4
855176|NCT01572675|2818137|P1|Overall Study|Missing data|1
855177|NCT01572675|2818136|P2|Overall Study|Rheumatologist new evaluation|1
855178|NCT01572675|2818137|P1|Overall Study|Rheumatologist new evaluation|0
855179|NCT01572675|2818136|P2|Overall Study|Unknown reason|1
855180|NCT01572675|2818137|P1|Overall Study|Unknown reason|1
855181|NCT01572675|2818136|P2|Overall Study|Other disease detected|1
855182|NCT01572675|2818137|P1|Overall Study|Other disease detected|1
855183|NCT01572675|2818136|P2|Overall Study|Death unrelated to coxibs|1
855184|NCT01572675|2818137|P1|Overall Study|Death unrelated to coxibs|1
855185|NCT01572675|2818136|P2|Overall Study|Physician Decision|2
855186|NCT01572675|2818137|P1|Overall Study|Physician Decision|2
855187|NCT01572675|2818136|P2|Overall Study|Withdrawal by Subject|1
855188|NCT01572675|2818137|P1|Overall Study|Withdrawal by Subject|5
855189|NCT01572675|2818136|P2|Overall Study|Surgical intervention|6
855190|NCT01572675|2818137|P1|Overall Study|Surgical intervention|3
855191|NCT01572675|2818136|P2|Overall Study|Improved symptoms|2
855192|NCT01572675|2818137|P1|Overall Study|Improved symptoms|8
855193|NCT01572675|2818136|P2|Overall Study|Intolerance|5
855194|NCT01572675|2818137|P1|Overall Study|Intolerance|6
855195|NCT01572675|2818136|P2|Overall Study|Lack of Efficacy|31
855196|NCT01572675|2818137|P1|Overall Study|Lack of Efficacy|31
855197|NCT01572675|2818136|P2|Overall Study|Recovery|23
855198|NCT01572675|2818137|P1|Overall Study|Recovery|16
855199|NCT01572675|2818136|P2|Overall Study|End of prescribed treatment|118
855200|NCT01572675|2818137|P1|Overall Study|End of prescribed treatment|140
855201|NCT01572389|2818236|P2|Overall Study|Only A1C or Assessment was Collected|2
855202|NCT01572389|2818237|P1|Overall Study|Only A1C or Assessment was Collected|6
855203|NCT01572389|2818236|P2|Overall Study|Lost to Follow-up|14
855204|NCT01572389|2818237|P1|Overall Study|Lost to Follow-up|25
855205|NCT01572389|2818236|P2|Overall Study|Withdrawal by Subject|2
855206|NCT01572389|2818237|P1|Overall Study|Withdrawal by Subject|14
855207|NCT01572389|2818236|P2|Overall Study|Death|3
855208|NCT01572389|2818237|P1|Overall Study|Death|1
855209|NCT01571453|2818278|P2|Overall Study|Administrative or other reason(s)|3
855210|NCT01571453|2818279|P1|Overall Study|Administrative or other reason(s)|4
855211|NCT01571453|2818278|P2|Overall Study|Lost to Follow-up|2
855212|NCT01571453|2818279|P1|Overall Study|Lost to Follow-up|4
855213|NCT01571453|2818278|P2|Overall Study|Withdrawal of consent|13
855214|NCT01571453|2818279|P1|Overall Study|Withdrawal of consent|5
855215|NCT01571453|2818278|P2|Overall Study|Protocol Violation|5
855216|NCT01571453|2818279|P1|Overall Study|Protocol Violation|1
855217|NCT01571453|2818278|P2|Overall Study|Non-compliance|4
855218|NCT01571453|2818279|P1|Overall Study|Non-compliance|2
855219|NCT01571453|2818278|P2|Overall Study|Lack of Efficacy|3
855220|NCT01571453|2818279|P1|Overall Study|Lack of Efficacy|8
855221|NCT01571453|2818278|P2|Overall Study|Adverse Event|32
855222|NCT01571453|2818279|P1|Overall Study|Adverse Event|14
855223|NCT01571362|2818295|P3|Double-Blind Treatment Period|Other - unspecified|1
855224|NCT01571362|2818296|P2|Double-Blind Treatment Period|Other - unspecified|6
855225|NCT01571362|2818297|P1|Double-Blind Treatment Period|Other - unspecified|0
855226|NCT01571362|2818295|P3|Double-Blind Treatment Period|Insufficient clinical response|4
855227|NCT01571362|2818296|P2|Double-Blind Treatment Period|Insufficient clinical response|16
855228|NCT01571362|2818297|P1|Double-Blind Treatment Period|Insufficient clinical response|0
855229|NCT01571362|2818295|P3|Double-Blind Treatment Period|Lost to Follow-up|6
855230|NCT01571362|2818296|P2|Double-Blind Treatment Period|Lost to Follow-up|3
855231|NCT01571362|2818297|P1|Double-Blind Treatment Period|Lost to Follow-up|0
855232|NCT01571362|2818295|P3|Double-Blind Treatment Period|Adverse Event|14
855233|NCT01571362|2818296|P2|Double-Blind Treatment Period|Adverse Event|9
855234|NCT01571362|2818297|P1|Double-Blind Treatment Period|Adverse Event|0
855235|NCT01571362|2818295|P3|Double-Blind Treatment Period|Protocol Violation|9
855236|NCT01571362|2818296|P2|Double-Blind Treatment Period|Protocol Violation|8
855237|NCT01571362|2818297|P1|Double-Blind Treatment Period|Protocol Violation|0
855238|NCT01571362|2818295|P3|Double-Blind Treatment Period|Withdrawal by Subject|5
855239|NCT01571362|2818296|P2|Double-Blind Treatment Period|Withdrawal by Subject|11
855240|NCT01571362|2818297|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
855241|NCT01571362|2818295|P3|Open-Label Conversion + Titration Period|Other - unspecified|0
855242|NCT01571362|2818296|P2|Open-Label Conversion + Titration Period|Other - unspecified|0
855243|NCT01571362|2818297|P1|Open-Label Conversion + Titration Period|Other - unspecified|3
855244|NCT01571362|2818295|P3|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
855245|NCT01571362|2818296|P2|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
855246|NCT01571362|2818297|P1|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41
855247|NCT01571362|2818295|P3|Open-Label Conversion + Titration Period|Lost to Follow-up|0
855248|NCT01571362|2818296|P2|Open-Label Conversion + Titration Period|Lost to Follow-up|0
855249|NCT01571362|2818297|P1|Open-Label Conversion + Titration Period|Lost to Follow-up|10
855250|NCT01571362|2818295|P3|Open-Label Conversion + Titration Period|Adverse Event|0
855251|NCT01571362|2818296|P2|Open-Label Conversion + Titration Period|Adverse Event|0
855252|NCT01571362|2818297|P1|Open-Label Conversion + Titration Period|Adverse Event|57
855253|NCT01571362|2818295|P3|Open-Label Conversion + Titration Period|Protocol Violation|0
855254|NCT01571362|2818296|P2|Open-Label Conversion + Titration Period|Protocol Violation|0
855255|NCT01571362|2818297|P1|Open-Label Conversion + Titration Period|Protocol Violation|7
855256|NCT01571362|2818295|P3|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
855257|NCT01571362|2818296|P2|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
855258|NCT01571362|2818297|P1|Open-Label Conversion + Titration Period|Withdrawal by Subject|11
855259|NCT01571284|2818467|P1|Overall Study|Other than specified above|80
855260|NCT01571284|2818467|P1|Overall Study|Enrolled but not treated|2
855261|NCT01571284|2818467|P1|Overall Study|Lost to Follow-up|3
855262|NCT01571284|2818467|P1|Overall Study|Participant's decision|84
855263|NCT01571232|2818490|P2|Overall Study|Withdrawal by Subject|0
855264|NCT01571232|2818491|P1|Overall Study|Withdrawal by Subject|1
855265|NCT01571232|2818490|P2|Overall Study|Lost to Follow-up|1
855266|NCT01571232|2818491|P1|Overall Study|Lost to Follow-up|0
855267|NCT01570751|2818503|P2|Period B (16 Weeks)|Protocol Violation|1
855268|NCT01570751|2818504|P1|Period B (16 Weeks)|Protocol Violation|0
855269|NCT01570751|2818503|P2|Period B (16 Weeks)|Adverse Event|0
855270|NCT01570751|2818504|P1|Period B (16 Weeks)|Adverse Event|1
855271|NCT01570751|2818503|P2|Period A (16 Weeks)|Unclassified|3
855272|NCT01570751|2818504|P1|Period A (16 Weeks)|Unclassified|2
855273|NCT01570751|2818503|P2|Period A (16 Weeks)|Withdrawal criteria|1
855274|NCT01570751|2818504|P1|Period A (16 Weeks)|Withdrawal criteria|0
855275|NCT01570751|2818503|P2|Period A (16 Weeks)|Protocol Violation|1
855276|NCT01570751|2818504|P1|Period A (16 Weeks)|Protocol Violation|1
855277|NCT01570686|2818522|P2|Overall Study|Unsatisfactory therapeutic effect|1
855278|NCT01570686|2818523|P1|Overall Study|Unsatisfactory therapeutic effect|2
855279|NCT01570686|2818522|P2|Overall Study|Withdrawal by Subject|4
855280|NCT01570686|2818523|P1|Overall Study|Withdrawal by Subject|4
855281|NCT01570686|2818522|P2|Overall Study|Protocol Deviation|0
855282|NCT01570686|2818523|P1|Overall Study|Protocol Deviation|3
855283|NCT01570686|2818522|P2|Overall Study|Lost to Follow-up|3
855284|NCT01570686|2818523|P1|Overall Study|Lost to Follow-up|4
855285|NCT01570686|2818522|P2|Overall Study|Adverse Event|6
855286|NCT01570686|2818523|P1|Overall Study|Adverse Event|8
855287|NCT01570686|2818522|P2|Overall Study|Administrative problems|1
855288|NCT01570686|2818523|P1|Overall Study|Administrative problems|0
855289|NCT01570686|2818522|P2|Overall Study|Abnormal test procedure result(s)|1
855290|NCT01570686|2818523|P1|Overall Study|Abnormal test procedure result(s)|1
855291|NCT01570309|2818559|P2|Overall Study|Withdrawal by Subject|3
855292|NCT01570309|2818560|P1|Overall Study|Withdrawal by Subject|3
855293|NCT01570244|2818574|P1|Microgynon+Faldaprevir|Adverse Event|1
855294|NCT01570192|2818596|P2|Overall Study|Physician Decision|1
855295|NCT01570192|2818597|P1|Overall Study|Physician Decision|0
855296|NCT01570192|2818596|P2|Overall Study|changed to palliative care|0
855297|NCT01570192|2818597|P1|Overall Study|changed to palliative care|1
855298|NCT01570192|2818596|P2|Overall Study|no qualifying organism|12
855299|NCT01570192|2818597|P1|Overall Study|no qualifying organism|6
855300|NCT01569841|2818635|P2|Period A (6 Weeks)|Withdrawal by Subject|1
855301|NCT01569841|2818636|P1|Period A (6 Weeks)|Withdrawal by Subject|0
855302|NCT01569763|2818725|P2|Overall Study|Adverse Event|0
855303|NCT01569763|2818726|P1|Overall Study|Adverse Event|1
855304|NCT01569763|2818725|P2|Overall Study|Lack of Efficacy|7
855305|NCT01569763|2818726|P1|Overall Study|Lack of Efficacy|2
855306|NCT01569568|2818763|P2|Overall Study|Physician Decision|2
855307|NCT01569568|2818764|P1|Overall Study|Physician Decision|0
855308|NCT01569464|2818787|P2|Overall Study|Other|1
855309|NCT01569464|2818788|P1|Overall Study|Other|1
855310|NCT01569464|2818787|P2|Overall Study|Withdrawal by Subject|1
855311|NCT01569464|2818788|P1|Overall Study|Withdrawal by Subject|1
855312|NCT01569464|2818787|P2|Overall Study|Lost to Follow-up|3
855313|NCT01569464|2818788|P1|Overall Study|Lost to Follow-up|2
855314|NCT01569464|2818787|P2|Overall Study|Protocol Violation|0
855315|NCT01569464|2818788|P1|Overall Study|Protocol Violation|1
855316|NCT01569464|2818787|P2|Overall Study|Lack of Efficacy|0
855317|NCT01569464|2818788|P1|Overall Study|Lack of Efficacy|1
855318|NCT01569464|2818787|P2|Overall Study|Adverse Event|0
855319|NCT01569464|2818788|P1|Overall Study|Adverse Event|4
855320|NCT01569438|2818855|P2|Overall Study|Protocol Violation|0
855321|NCT01569438|2818856|P1|Overall Study|Protocol Violation|1
855322|NCT01569438|2818855|P2|Overall Study|Withdrawal by Subject|1
855323|NCT01569438|2818856|P1|Overall Study|Withdrawal by Subject|0
855324|NCT01569438|2818855|P2|Overall Study|Lack of Efficacy|1
855325|NCT01569438|2818856|P1|Overall Study|Lack of Efficacy|1
855326|NCT01569438|2818855|P2|Overall Study|Adverse Event|7
855327|NCT01569438|2818856|P1|Overall Study|Adverse Event|0
855328|NCT01569295|2818870|P2|Overall Study|Lost to Follow-up|0
855329|NCT01569295|2818871|P1|Overall Study|Lost to Follow-up|1
855330|NCT01569295|2818870|P2|Overall Study|Other Anticancer/Experimental Therapy|1
855331|NCT01569295|2818871|P1|Overall Study|Other Anticancer/Experimental Therapy|2
855332|NCT01569295|2818870|P2|Overall Study|Noncompliance with Study Drug|0
855333|NCT01569295|2818871|P1|Overall Study|Noncompliance with Study Drug|3
855334|NCT01569295|2818870|P2|Overall Study|Other|3
855335|NCT01569295|2818871|P1|Overall Study|Other|4
855336|NCT01569295|2818870|P2|Overall Study|Physician Decision|19
855337|NCT01569295|2818871|P1|Overall Study|Physician Decision|7
855338|NCT01569295|2818870|P2|Overall Study|Withdrawal by Subject|8
855339|NCT01569295|2818871|P1|Overall Study|Withdrawal by Subject|20
855340|NCT01569295|2818870|P2|Overall Study|Adverse Event|13
855341|NCT01569295|2818871|P1|Overall Study|Adverse Event|27
855342|NCT01569295|2818870|P2|Overall Study|Ongoing in Study|23
855343|NCT01569295|2818871|P1|Overall Study|Ongoing in Study|70
855344|NCT01569152|2818908|P3|Safety Extension, Period 3|Study terminated by Sponsor|47
855345|NCT01569152|2818909|P2|Safety Extension, Period 3|Study terminated by Sponsor|0
855346|NCT01569152|2818910|P1|Safety Extension, Period 3|Study terminated by Sponsor|0
855347|NCT01569152|2818908|P3|Safety Extension, Period 3|Physician Decision|2
855348|NCT01569152|2818909|P2|Safety Extension, Period 3|Physician Decision|0
855349|NCT01569152|2818910|P1|Safety Extension, Period 3|Physician Decision|0
855350|NCT01569152|2818908|P3|Safety Extension, Period 3|Withdrawal by Subject|2
855351|NCT01569152|2818909|P2|Safety Extension, Period 3|Withdrawal by Subject|0
855352|NCT01569152|2818910|P1|Safety Extension, Period 3|Withdrawal by Subject|0
855353|NCT01569152|2818908|P3|Safety Extension, Period 3|Adverse Event|4
855354|NCT01569152|2818909|P2|Safety Extension, Period 3|Adverse Event|0
855355|NCT01569152|2818910|P1|Safety Extension, Period 3|Adverse Event|0
855356|NCT01569152|2818908|P3|Phase IIa, Period 1|Withdrawal by Subject|0
855357|NCT01569152|2818909|P2|Phase IIa, Period 1|Withdrawal by Subject|1
855358|NCT01569152|2818910|P1|Phase IIa, Period 1|Withdrawal by Subject|2
855359|NCT01569152|2818908|P3|Phase IIa, Period 1|Protocol Violation|0
855360|NCT01569152|2818909|P2|Phase IIa, Period 1|Protocol Violation|1
855361|NCT01569152|2818910|P1|Phase IIa, Period 1|Protocol Violation|0
855362|NCT01569152|2818908|P3|Phase IIa, Period 1|Study Terminated by Sponsor|0
855363|NCT01569152|2818909|P2|Phase IIa, Period 1|Study Terminated by Sponsor|8
855364|NCT01569152|2818910|P1|Phase IIa, Period 1|Study Terminated by Sponsor|9
855365|NCT01569152|2818908|P3|Phase IIa, Period 1|Lost to Follow-up|0
855366|NCT01569152|2818909|P2|Phase IIa, Period 1|Lost to Follow-up|0
855367|NCT01569152|2818910|P1|Phase IIa, Period 1|Lost to Follow-up|1
855368|NCT01569152|2818908|P3|Phase IIa, Period 1|Adverse Event|0
855369|NCT01569152|2818909|P2|Phase IIa, Period 1|Adverse Event|0
855370|NCT01569152|2818910|P1|Phase IIa, Period 1|Adverse Event|4
855371|NCT01569152|2818908|P3|Phase IIa, Period 1|Early Escape|0
855372|NCT01569152|2818909|P2|Phase IIa, Period 1|Early Escape|22
855373|NCT01569152|2818910|P1|Phase IIa, Period 1|Early Escape|5
855374|NCT01569074|2819046|P5|Overall Study|Adverse Event|0
855375|NCT01569074|2819047|P4|Overall Study|Adverse Event|0
855376|NCT01569074|2819048|P3|Overall Study|Adverse Event|3
855377|NCT01569074|2819049|P2|Overall Study|Adverse Event|0
855378|NCT01569074|2819050|P1|Overall Study|Adverse Event|1
855379|NCT01569074|2819046|P5|Overall Study|eg change in circumstances|1
855380|NCT01569074|2819047|P4|Overall Study|eg change in circumstances|1
855381|NCT01569074|2819048|P3|Overall Study|eg change in circumstances|0
855382|NCT01569074|2819049|P2|Overall Study|eg change in circumstances|2
855383|NCT01569074|2819050|P1|Overall Study|eg change in circumstances|0
855384|NCT01569074|2819046|P5|Overall Study|Severe non-compliance to protocol|0
855385|NCT01569074|2819047|P4|Overall Study|Severe non-compliance to protocol|0
855386|NCT01569074|2819048|P3|Overall Study|Severe non-compliance to protocol|1
855387|NCT01569074|2819049|P2|Overall Study|Severe non-compliance to protocol|0
855388|NCT01569074|2819050|P1|Overall Study|Severe non-compliance to protocol|0
855389|NCT01569074|2819046|P5|Overall Study|Study-specific discontinuation criteria|0
855390|NCT01569074|2819047|P4|Overall Study|Study-specific discontinuation criteria|0
855391|NCT01569074|2819048|P3|Overall Study|Study-specific discontinuation criteria|0
855392|NCT01569074|2819049|P2|Overall Study|Study-specific discontinuation criteria|1
855393|NCT01569074|2819050|P1|Overall Study|Study-specific discontinuation criteria|0
855394|NCT01569074|2819046|P5|Overall Study|Study stopped|7
855395|NCT01569074|2819047|P4|Overall Study|Study stopped|7
855396|NCT01569074|2819048|P3|Overall Study|Study stopped|8
855397|NCT01569074|2819049|P2|Overall Study|Study stopped|6
855398|NCT01569074|2819050|P1|Overall Study|Study stopped|6
855399|NCT01569022|2819106|P2|Second Intervention|Lost to Follow-up|2
855400|NCT01569022|2819107|P1|Second Intervention|Lost to Follow-up|2
855401|NCT01569022|2819106|P2|First Intervention|Lost to Follow-up|1
855402|NCT01569022|2819107|P1|First Intervention|Lost to Follow-up|2
855403|NCT01568892|2819143|P2|Open-label Phase|Lost to Follow-up|1
855404|NCT01568892|2819144|P1|Open-label Phase|Lost to Follow-up|0
855405|NCT01568892|2819143|P2|Open-label Phase|Lack of Efficacy|2
855406|NCT01568892|2819144|P1|Open-label Phase|Lack of Efficacy|4
855407|NCT01568892|2819143|P2|Open-label Phase|Adverse Event|0
855408|NCT01568892|2819144|P1|Open-label Phase|Adverse Event|2
855409|NCT01568866|2819214|P2|Overall Study|Randomized but Not Dosed|1
855410|NCT01568866|2819215|P1|Overall Study|Randomized but Not Dosed|9
855411|NCT01568866|2819214|P2|Overall Study|Lost to Follow-up|0
855412|NCT01568866|2819215|P1|Overall Study|Lost to Follow-up|1
855413|NCT01568866|2819214|P2|Overall Study|Protocol Non-compliance|4
855414|NCT01568866|2819215|P1|Overall Study|Protocol Non-compliance|2
855415|NCT01568866|2819214|P2|Overall Study|Death|18
855416|NCT01568866|2819215|P1|Overall Study|Death|10
855417|NCT01568866|2819214|P2|Overall Study|Withdrawal by Subject|11
855418|NCT01568866|2819215|P1|Overall Study|Withdrawal by Subject|19
855419|NCT01568866|2819214|P2|Overall Study|Physician Decision|32
855420|NCT01568866|2819215|P1|Overall Study|Physician Decision|40
855421|NCT01568866|2819214|P2|Overall Study|Patient Request|71
855422|NCT01568866|2819215|P1|Overall Study|Patient Request|55
855423|NCT01568866|2819214|P2|Overall Study|Adverse Event|96
855424|NCT01568866|2819215|P1|Overall Study|Adverse Event|94
855425|NCT01568866|2819214|P2|Overall Study|Disease Progression|183
855426|NCT01568866|2819215|P1|Overall Study|Disease Progression|208
855427|NCT01568593|2819246|P2|Overall Study|Adverse Event|2
855428|NCT01568593|2819247|P1|Overall Study|Adverse Event|3
855429|NCT01568593|2819246|P2|Overall Study|Lack of Efficacy|1
855430|NCT01568593|2819247|P1|Overall Study|Lack of Efficacy|4
855431|NCT01568112|2819267|P4|Overall Study|Withdrawal by Physician|1
855432|NCT01568112|2819268|P3|Overall Study|Withdrawal by Physician|1
855433|NCT01568112|2819269|P2|Overall Study|Withdrawal by Physician|0
855434|NCT01568112|2819270|P1|Overall Study|Withdrawal by Physician|1
855435|NCT01568112|2819267|P4|Overall Study|Withdrawal by Subject|7
855436|NCT01568112|2819268|P3|Overall Study|Withdrawal by Subject|0
855437|NCT01568112|2819269|P2|Overall Study|Withdrawal by Subject|3
855438|NCT01568112|2819270|P1|Overall Study|Withdrawal by Subject|2
855439|NCT01568112|2819267|P4|Overall Study|Lost to Follow-up|1
855440|NCT01568112|2819268|P3|Overall Study|Lost to Follow-up|0
855441|NCT01568112|2819269|P2|Overall Study|Lost to Follow-up|0
855442|NCT01568112|2819270|P1|Overall Study|Lost to Follow-up|0
855443|NCT01568112|2819267|P4|Overall Study|Withdrew due to Adverse Event|3
855444|NCT01568112|2819268|P3|Overall Study|Withdrew due to Adverse Event|6
855445|NCT01568112|2819269|P2|Overall Study|Withdrew due to Adverse Event|4
855446|NCT01568112|2819270|P1|Overall Study|Withdrew due to Adverse Event|2
855447|NCT01568112|2819267|P4|Overall Study|Randomized But Not Treated|0
855448|NCT01568112|2819268|P3|Overall Study|Randomized But Not Treated|0
855449|NCT01568112|2819269|P2|Overall Study|Randomized But Not Treated|1
855450|NCT01568112|2819270|P1|Overall Study|Randomized But Not Treated|0
855451|NCT01568047|2819428|P4|Overall Study|Adverse Event|1
855452|NCT01568047|2819429|P3|Overall Study|Adverse Event|1
855453|NCT01568047|2819430|P2|Overall Study|Adverse Event|0
855454|NCT01568047|2819431|P1|Overall Study|Adverse Event|0
855455|NCT01568047|2819428|P4|Overall Study|Withdrawal by Subject|0
855456|NCT01568047|2819429|P3|Overall Study|Withdrawal by Subject|0
855457|NCT01568047|2819430|P2|Overall Study|Withdrawal by Subject|1
855458|NCT01568047|2819431|P1|Overall Study|Withdrawal by Subject|0
855459|NCT01568047|2819428|P4|Overall Study|Ineligibility|0
855460|NCT01568047|2819429|P3|Overall Study|Ineligibility|0
855461|NCT01568047|2819430|P2|Overall Study|Ineligibility|0
855462|NCT01568047|2819431|P1|Overall Study|Ineligibility|1
855463|NCT01568034|2819449|P4|Overall Study|Withdrawal by Subject|0
855464|NCT01568034|2819450|P3|Overall Study|Withdrawal by Subject|0
855465|NCT01568034|2819451|P2|Overall Study|Withdrawal by Subject|0
855466|NCT01568034|2819452|P1|Overall Study|Withdrawal by Subject|1
855467|NCT01567865|2819501|P4|Evaluated for Immunogenicity|Missing blood sample|28
855468|NCT01567865|2819502|P3|Evaluated for Immunogenicity|Missing blood sample|16
855469|NCT01567865|2819503|P2|Evaluated for Immunogenicity|Missing blood sample|24
855470|NCT01567865|2819504|P1|Evaluated for Immunogenicity|Missing blood sample|17
855471|NCT01567865|2819501|P4|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2
855472|NCT01567865|2819502|P3|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3
855473|NCT01567865|2819503|P2|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1
855474|NCT01567865|2819504|P1|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0
855475|NCT01567852|2819534|P2|Overall Study|ECT discontinued|1
855476|NCT01567852|2819535|P1|Overall Study|ECT discontinued|1
855477|NCT01567852|2819534|P2|Overall Study|Withdrawal by Subject|6
855478|NCT01567852|2819535|P1|Overall Study|Withdrawal by Subject|3
855479|NCT01567826|2819553|P2|Overall Study|Lost to Follow-up|2
855480|NCT01567826|2819554|P1|Overall Study|Lost to Follow-up|3
855481|NCT01567527|2819580|P5|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5
855482|NCT01567527|2819581|P4|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8
855483|NCT01567527|2819582|P3|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
855484|NCT01567527|2819583|P2|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
855485|NCT01567527|2819584|P1|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
855486|NCT01567527|2819580|P5|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35
855487|NCT01567527|2819581|P4|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19
855488|NCT01567527|2819582|P3|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
855489|NCT01567527|2819583|P2|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
855490|NCT01567527|2819584|P1|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
855491|NCT01567527|2819580|P5|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3
855492|NCT01567527|2819581|P4|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1
855493|NCT01567527|2819582|P3|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
855494|NCT01567527|2819583|P2|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
855495|NCT01567527|2819584|P1|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
855496|NCT01567527|2819580|P5|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10
855497|NCT01567527|2819581|P4|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13
855498|NCT01567527|2819582|P3|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
855499|NCT01567527|2819583|P2|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
855500|NCT01567527|2819584|P1|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
855501|NCT01567527|2819580|P5|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1
855502|NCT01567527|2819581|P4|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7
855503|NCT01567527|2819582|P3|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
855504|NCT01567527|2819583|P2|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
855505|NCT01567527|2819584|P1|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
855506|NCT01567527|2819580|P5|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7
855507|NCT01567527|2819581|P4|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4
855508|NCT01567527|2819582|P3|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
855509|NCT01567527|2819583|P2|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
855510|NCT01567527|2819584|P1|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
855511|NCT01567527|2819580|P5|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33
855512|NCT01567527|2819581|P4|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16
855513|NCT01567527|2819582|P3|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
855514|NCT01567527|2819583|P2|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
855515|NCT01567527|2819584|P1|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
855516|NCT01567527|2819580|P5|Double-blind, Placebo-controlled Phase|Protocol deviation|1
855517|NCT01567527|2819581|P4|Double-blind, Placebo-controlled Phase|Protocol deviation|1
855518|NCT01567527|2819582|P3|Double-blind, Placebo-controlled Phase|Protocol deviation|0
855519|NCT01567527|2819583|P2|Double-blind, Placebo-controlled Phase|Protocol deviation|0
855520|NCT01567527|2819584|P1|Double-blind, Placebo-controlled Phase|Protocol deviation|0
855521|NCT01567527|2819580|P5|IM Depot Stabilization.|Withdrawn by the investigator|0
855522|NCT01567527|2819581|P4|IM Depot Stabilization.|Withdrawn by the investigator|0
855523|NCT01567527|2819582|P3|IM Depot Stabilization.|Withdrawn by the investigator|6
855524|NCT01567527|2819583|P2|IM Depot Stabilization.|Withdrawn by the investigator|0
855525|NCT01567527|2819584|P1|IM Depot Stabilization.|Withdrawn by the investigator|0
855526|NCT01567527|2819580|P5|IM Depot Stabilization.|Adverse Event|0
855527|NCT01567527|2819581|P4|IM Depot Stabilization.|Adverse Event|0
855528|NCT01567527|2819582|P3|IM Depot Stabilization.|Adverse Event|37
855529|NCT01567527|2819583|P2|IM Depot Stabilization.|Adverse Event|0
855530|NCT01567527|2819584|P1|IM Depot Stabilization.|Adverse Event|0
855531|NCT01567527|2819580|P5|IM Depot Stabilization.|Lack of Efficacy|0
855532|NCT01567527|2819581|P4|IM Depot Stabilization.|Lack of Efficacy|0
855533|NCT01567527|2819582|P3|IM Depot Stabilization.|Lack of Efficacy|7
855534|NCT01567527|2819583|P2|IM Depot Stabilization.|Lack of Efficacy|0
855535|NCT01567527|2819584|P1|IM Depot Stabilization.|Lack of Efficacy|0
855536|NCT01567527|2819580|P5|IM Depot Stabilization.|Lost to Follow-up|0
855537|NCT01567527|2819581|P4|IM Depot Stabilization.|Lost to Follow-up|0
855538|NCT01567527|2819582|P3|IM Depot Stabilization.|Lost to Follow-up|21
855539|NCT01567527|2819583|P2|IM Depot Stabilization.|Lost to Follow-up|0
855540|NCT01567527|2819584|P1|IM Depot Stabilization.|Lost to Follow-up|0
855541|NCT01567527|2819580|P5|IM Depot Stabilization.|Sponsor discontinued study|0
855542|NCT01567527|2819581|P4|IM Depot Stabilization.|Sponsor discontinued study|0
855543|NCT01567527|2819582|P3|IM Depot Stabilization.|Sponsor discontinued study|1
855544|NCT01567527|2819583|P2|IM Depot Stabilization.|Sponsor discontinued study|0
855545|NCT01567527|2819584|P1|IM Depot Stabilization.|Sponsor discontinued study|0
855546|NCT01567527|2819580|P5|IM Depot Stabilization.|Withdrawal by Subject|0
855547|NCT01567527|2819581|P4|IM Depot Stabilization.|Withdrawal by Subject|0
855548|NCT01567527|2819582|P3|IM Depot Stabilization.|Withdrawal by Subject|56
855549|NCT01567527|2819583|P2|IM Depot Stabilization.|Withdrawal by Subject|0
855550|NCT01567527|2819584|P1|IM Depot Stabilization.|Withdrawal by Subject|0
855551|NCT01567527|2819580|P5|IM Depot Stabilization.|Met withdrawal criteria|0
855552|NCT01567527|2819581|P4|IM Depot Stabilization.|Met withdrawal criteria|0
855553|NCT01567527|2819582|P3|IM Depot Stabilization.|Met withdrawal criteria|26
855554|NCT01567527|2819583|P2|IM Depot Stabilization.|Met withdrawal criteria|0
855555|NCT01567527|2819584|P1|IM Depot Stabilization.|Met withdrawal criteria|0
855556|NCT01567527|2819580|P5|IM Depot Stabilization.|Protocol deviation|0
855557|NCT01567527|2819581|P4|IM Depot Stabilization.|Protocol deviation|0
855558|NCT01567527|2819582|P3|IM Depot Stabilization.|Protocol deviation|5
855559|NCT01567527|2819583|P2|IM Depot Stabilization.|Protocol deviation|0
855560|NCT01567527|2819584|P1|IM Depot Stabilization.|Protocol deviation|0
855561|NCT01567527|2819580|P5|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
855562|NCT01567527|2819581|P4|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
855563|NCT01567527|2819582|P3|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
855564|NCT01567527|2819583|P2|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2
855565|NCT01567527|2819584|P1|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
855566|NCT01567527|2819580|P5|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
855567|NCT01567527|2819581|P4|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
855568|NCT01567527|2819582|P3|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
855569|NCT01567527|2819583|P2|Oral Aripiprazole Stabilization Phase.|Adverse Event|63
855570|NCT01567527|2819584|P1|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
855571|NCT01567527|2819580|P5|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
855572|NCT01567527|2819581|P4|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
855573|NCT01567527|2819582|P3|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
855574|NCT01567527|2819583|P2|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12
855575|NCT01567527|2819584|P1|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
855576|NCT01567527|2819580|P5|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
855577|NCT01567527|2819581|P4|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
855578|NCT01567527|2819582|P3|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
855579|NCT01567527|2819583|P2|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44
855580|NCT01567527|2819584|P1|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
855581|NCT01567527|2819580|P5|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
855582|NCT01567527|2819581|P4|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
855583|NCT01567527|2819582|P3|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
855584|NCT01567527|2819583|P2|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45
855585|NCT01567527|2819584|P1|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
855586|NCT01567527|2819580|P5|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
855587|NCT01567527|2819581|P4|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
855588|NCT01567527|2819582|P3|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
855589|NCT01567527|2819583|P2|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41
855590|NCT01567527|2819584|P1|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
855591|NCT01567527|2819580|P5|Conversion Phase.|Withdrawn by the investigator|0
855592|NCT01567527|2819581|P4|Conversion Phase.|Withdrawn by the investigator|0
855593|NCT01567527|2819582|P3|Conversion Phase.|Withdrawn by the investigator|0
855594|NCT01567527|2819583|P2|Conversion Phase.|Withdrawn by the investigator|0
855595|NCT01567527|2819584|P1|Conversion Phase.|Withdrawn by the investigator|3
855596|NCT01567527|2819580|P5|Conversion Phase.|Adverse Event|0
855597|NCT01567527|2819581|P4|Conversion Phase.|Adverse Event|0
855598|NCT01567527|2819582|P3|Conversion Phase.|Adverse Event|0
855599|NCT01567527|2819583|P2|Conversion Phase.|Adverse Event|0
855600|NCT01567527|2819584|P1|Conversion Phase.|Adverse Event|33
855601|NCT01567527|2819580|P5|Conversion Phase.|Lack of Efficacy|0
855602|NCT01567527|2819581|P4|Conversion Phase.|Lack of Efficacy|0
855603|NCT01567527|2819582|P3|Conversion Phase.|Lack of Efficacy|0
855604|NCT01567527|2819583|P2|Conversion Phase.|Lack of Efficacy|0
855605|NCT01567527|2819584|P1|Conversion Phase.|Lack of Efficacy|2
855606|NCT01567527|2819580|P5|Conversion Phase.|Lost to Follow-up|0
855607|NCT01567527|2819581|P4|Conversion Phase.|Lost to Follow-up|0
855608|NCT01567527|2819582|P3|Conversion Phase.|Lost to Follow-up|0
855609|NCT01567527|2819583|P2|Conversion Phase.|Lost to Follow-up|0
855610|NCT01567527|2819584|P1|Conversion Phase.|Lost to Follow-up|16
855611|NCT01567527|2819580|P5|Conversion Phase.|Withdrawal by Subject|0
855612|NCT01567527|2819581|P4|Conversion Phase.|Withdrawal by Subject|0
855613|NCT01567527|2819582|P3|Conversion Phase.|Withdrawal by Subject|0
855614|NCT01567527|2819583|P2|Conversion Phase.|Withdrawal by Subject|0
855615|NCT01567527|2819584|P1|Conversion Phase.|Withdrawal by Subject|32
855616|NCT01567527|2819580|P5|Conversion Phase.|Met withdrawal criteria|0
855617|NCT01567527|2819581|P4|Conversion Phase.|Met withdrawal criteria|0
855618|NCT01567527|2819582|P3|Conversion Phase.|Met withdrawal criteria|0
855619|NCT01567527|2819583|P2|Conversion Phase.|Met withdrawal criteria|0
855620|NCT01567527|2819584|P1|Conversion Phase.|Met withdrawal criteria|10
855621|NCT01567527|2819580|P5|Conversion Phase.|Protocol deviation|0
855622|NCT01567527|2819581|P4|Conversion Phase.|Protocol deviation|0
855623|NCT01567527|2819582|P3|Conversion Phase.|Protocol deviation|0
855624|NCT01567527|2819583|P2|Conversion Phase.|Protocol deviation|0
855625|NCT01567527|2819584|P1|Conversion Phase.|Protocol deviation|3
855626|NCT01567462|2819601|P2|Overall Study|Withdrawal by Subject|7
855627|NCT01567462|2819602|P1|Overall Study|Withdrawal by Subject|4
855628|NCT01567163|2819619|P1|Overall Study|Lost to Follow-up|2
855629|NCT01567163|2819619|P1|Overall Study|Progressive Disease|2
855630|NCT01566981|2819659|P2|Overall Study|Lost to Follow-up|8
855631|NCT01566981|2819660|P1|Overall Study|Lost to Follow-up|5
855632|NCT01566773|2819689|P1|Overall Study|Physician Decision|2
855633|NCT01566773|2819689|P1|Overall Study|Adverse Event|10
855634|NCT01566773|2819689|P1|Overall Study|Administrative reason|1
855635|NCT01566773|2819689|P1|Overall Study|Withdrawal by Subject|9
855636|NCT01566773|2819689|P1|Overall Study|Protocol Violation|4
855637|NCT01566773|2819689|P1|Overall Study|Protocol specified criteria|4
855638|NCT01566721|2819898|P2|Overall Study|Withdrew Prior to Treatment|1
855639|NCT01566721|2819899|P1|Overall Study|Withdrew Prior to Treatment|3
855640|NCT01566721|2819898|P2|Overall Study|Not Specified|4
855641|NCT01566721|2819899|P1|Overall Study|Not Specified|10
855642|NCT01566721|2819898|P2|Overall Study|Death|3
855643|NCT01566721|2819899|P1|Overall Study|Death|6
855644|NCT01566721|2819898|P2|Overall Study|Lost to Follow-up|0
855645|NCT01566721|2819899|P1|Overall Study|Lost to Follow-up|18
855646|NCT01566721|2819898|P2|Overall Study|Disease Progression/Recurrence|28
855647|NCT01566721|2819899|P1|Overall Study|Disease Progression/Recurrence|123
855648|NCT01566721|2819898|P2|Overall Study|Withdrawal by Subject|15
855649|NCT01566721|2819899|P1|Overall Study|Withdrawal by Subject|58
855650|NCT01566721|2819898|P2|Overall Study|Ongoing Study|659
855651|NCT01566721|2819899|P1|Overall Study|Ongoing Study|1649
855652|NCT01566604|2819981|P2|Overall Study|Withdrawal by Subject|6
855653|NCT01566604|2819982|P1|Overall Study|Withdrawal by Subject|9
855654|NCT01566604|2819981|P2|Overall Study|Adverse Event|2
855655|NCT01566604|2819982|P1|Overall Study|Adverse Event|4
855656|NCT01566604|2819981|P2|Overall Study|Death|1
855657|NCT01566604|2819982|P1|Overall Study|Death|4
855658|NCT01566604|2819981|P2|Overall Study|Abnormal laboratory value|0
855659|NCT01566604|2819982|P1|Overall Study|Abnormal laboratory value|2
855660|NCT01566604|2819981|P2|Overall Study|Protocol deviation|0
855661|NCT01566604|2819982|P1|Overall Study|Protocol deviation|2
855662|NCT01566604|2819981|P2|Overall Study|Lack of Efficacy|2
855663|NCT01566604|2819982|P1|Overall Study|Lack of Efficacy|1
855664|NCT01566604|2819981|P2|Overall Study|Administrative problems|0
855665|NCT01566604|2819982|P1|Overall Study|Administrative problems|1
855666|NCT01566604|2819981|P2|Overall Study|Patient's inability to use the device|0
855667|NCT01566604|2819982|P1|Overall Study|Patient's inability to use the device|1
855668|NCT01566435|2820138|P1|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1
855669|NCT01566149|2820211|P2|Overall Study|Withdrawal by Subject|0
855670|NCT01566149|2820212|P1|Overall Study|Withdrawal by Subject|1
855671|NCT01566149|2820211|P2|Overall Study|Protocol Violation|1
855672|NCT01566149|2820212|P1|Overall Study|Protocol Violation|0
855673|NCT01566149|2820211|P2|Overall Study|Non-compliance with study medication|0
855674|NCT01566149|2820212|P1|Overall Study|Non-compliance with study medication|2
855675|NCT01566149|2820211|P2|Overall Study|Adverse Event|1
855676|NCT01566149|2820212|P1|Overall Study|Adverse Event|0
855677|NCT01565993|2820245|P2|Overall Study|Physician Decision|3
855678|NCT01565993|2820246|P1|Overall Study|Physician Decision|0
855679|NCT01565980|2820254|P2|Overall Study|Withdrawal by Subject|3
855680|NCT01565980|2820255|P1|Overall Study|Withdrawal by Subject|0
855681|NCT01565980|2820254|P2|Overall Study|stopped medical treatment|0
855682|NCT01565980|2820255|P1|Overall Study|stopped medical treatment|1
855683|NCT01565980|2820254|P2|Overall Study|health complications|1
855684|NCT01565980|2820255|P1|Overall Study|health complications|1
855685|NCT01565980|2820254|P2|Overall Study|Lost to Follow-up|0
855686|NCT01565980|2820255|P1|Overall Study|Lost to Follow-up|1
855687|NCT01565980|2820254|P2|Overall Study|Death|0
855688|NCT01565980|2820255|P1|Overall Study|Death|1
855689|NCT01565941|2820275|P2|Overall Study|Randomized; did not receive intevention|2
855690|NCT01565941|2820276|P1|Overall Study|Randomized; did not receive intevention|8
855691|NCT01565941|2820275|P2|Overall Study|Withdrawn by parent/guardian|2
855692|NCT01565941|2820276|P1|Overall Study|Withdrawn by parent/guardian|3
855693|NCT01565889|2820355|P6|Part B|Lost to Follow-up|1
855694|NCT01565889|2820356|P5|Part B|Lost to Follow-up|0
855695|NCT01565889|2820357|P4|Part B|Lost to Follow-up|0
855696|NCT01565889|2820358|P3|Part B|Lost to Follow-up|0
855697|NCT01565889|2820359|P2|Part B|Lost to Follow-up|0
855698|NCT01565889|2820360|P1|Part B|Lost to Follow-up|0
855699|NCT01565889|2820355|P6|Part B|Lack of Efficacy|2
855700|NCT01565889|2820356|P5|Part B|Lack of Efficacy|0
855701|NCT01565889|2820357|P4|Part B|Lack of Efficacy|0
855702|NCT01565889|2820358|P3|Part B|Lack of Efficacy|0
855703|NCT01565889|2820359|P2|Part B|Lack of Efficacy|0
855704|NCT01565889|2820360|P1|Part B|Lack of Efficacy|0
855705|NCT01565889|2820355|P6|Part B|Withdrawal by Subject|1
855706|NCT01565889|2820356|P5|Part B|Withdrawal by Subject|0
855707|NCT01565889|2820357|P4|Part B|Withdrawal by Subject|0
855708|NCT01565889|2820358|P3|Part B|Withdrawal by Subject|0
855709|NCT01565889|2820359|P2|Part B|Withdrawal by Subject|0
855710|NCT01565889|2820360|P1|Part B|Withdrawal by Subject|0
855711|NCT01565889|2820355|P6|Part A|Withdrawal by Subject|0
855712|NCT01565889|2820356|P5|Part A|Withdrawal by Subject|0
855713|NCT01565889|2820357|P4|Part A|Withdrawal by Subject|0
855714|NCT01565889|2820358|P3|Part A|Withdrawal by Subject|0
855715|NCT01565889|2820359|P2|Part A|Withdrawal by Subject|0
855716|NCT01565889|2820360|P1|Part A|Withdrawal by Subject|1
855717|NCT01565850|2820391|P2|Overall Study|Withdrew Consent|2
855718|NCT01565850|2820392|P1|Overall Study|Withdrew Consent|4
855719|NCT01565850|2820391|P2|Overall Study|Participant noncompliance|0
855720|NCT01565850|2820392|P1|Overall Study|Participant noncompliance|2
855721|NCT01565850|2820391|P2|Overall Study|Investigator’s Discretion|1
855722|NCT01565850|2820392|P1|Overall Study|Investigator’s Discretion|2
855723|NCT01565850|2820391|P2|Overall Study|Lost to Follow-up|4
855724|NCT01565850|2820392|P1|Overall Study|Lost to Follow-up|12
855725|NCT01565850|2820391|P2|Overall Study|Adverse Event|1
855726|NCT01565850|2820392|P1|Overall Study|Adverse Event|0
855727|NCT01565707|2820412|P4|Overall Study|Miscellaneous|2
855728|NCT01565707|2820413|P3|Overall Study|Miscellaneous|0
855729|NCT01565707|2820414|P2|Overall Study|Miscellaneous|1
855730|NCT01565707|2820415|P1|Overall Study|Miscellaneous|1
855731|NCT01565707|2820412|P4|Overall Study|Randomized but not evaluable|0
855732|NCT01565707|2820413|P3|Overall Study|Randomized but not evaluable|0
855733|NCT01565707|2820414|P2|Overall Study|Randomized but not evaluable|0
855734|NCT01565707|2820415|P1|Overall Study|Randomized but not evaluable|2
855735|NCT01565707|2820412|P4|Overall Study|Withdrawal by Subject|1
855736|NCT01565707|2820413|P3|Overall Study|Withdrawal by Subject|1
855737|NCT01565707|2820414|P2|Overall Study|Withdrawal by Subject|1
855738|NCT01565707|2820415|P1|Overall Study|Withdrawal by Subject|3
855739|NCT01565707|2820412|P4|Overall Study|Protocol Violation|1
855740|NCT01565707|2820413|P3|Overall Study|Protocol Violation|0
855741|NCT01565707|2820414|P2|Overall Study|Protocol Violation|0
855742|NCT01565707|2820415|P1|Overall Study|Protocol Violation|1
855743|NCT01565707|2820412|P4|Overall Study|Lost to Follow-up|0
855744|NCT01565707|2820413|P3|Overall Study|Lost to Follow-up|0
855745|NCT01565707|2820414|P2|Overall Study|Lost to Follow-up|0
855746|NCT01565707|2820415|P1|Overall Study|Lost to Follow-up|1
855747|NCT01565707|2820412|P4|Overall Study|Adverse Event|1
855748|NCT01565707|2820413|P3|Overall Study|Adverse Event|2
855749|NCT01565707|2820414|P2|Overall Study|Adverse Event|6
855750|NCT01565707|2820415|P1|Overall Study|Adverse Event|1
855751|NCT01565642|2820508|P2|Overall Study|Withdrawal by Subject|1
855752|NCT01565642|2820509|P1|Overall Study|Withdrawal by Subject|2
855753|NCT01565564|2820544|P2|Overall Study|Lost to Follow-up|1
855754|NCT01565564|2820545|P1|Overall Study|Lost to Follow-up|5
855755|NCT01565343|2820595|P3|Overall Study|Administrative decision/technical issues|0
855756|NCT01565343|2820596|P2|Overall Study|Administrative decision/technical issues|0
855757|NCT01565343|2820597|P1|Overall Study|Administrative decision/technical issues|1
855758|NCT01565291|2820627|P2|Overall Study|Withdrawal by Subject|0
855759|NCT01565291|2820628|P1|Overall Study|Withdrawal by Subject|1
855760|NCT01565148|2820640|P4|Overall Study|Physician Decision|0
855761|NCT01565148|2820641|P3|Overall Study|Physician Decision|0
855762|NCT01565148|2820642|P2|Overall Study|Physician Decision|5
855763|NCT01565148|2820643|P1|Overall Study|Physician Decision|2
855764|NCT01565148|2820640|P4|Overall Study|Death|0
855765|NCT01565148|2820641|P3|Overall Study|Death|1
855766|NCT01565148|2820642|P2|Overall Study|Death|0
855767|NCT01565148|2820643|P1|Overall Study|Death|0
855768|NCT01565148|2820640|P4|Overall Study|Rescue Therapy|8
855769|NCT01565148|2820641|P3|Overall Study|Rescue Therapy|5
855770|NCT01565148|2820642|P2|Overall Study|Rescue Therapy|5
855771|NCT01565148|2820643|P1|Overall Study|Rescue Therapy|8
855772|NCT01565148|2820640|P4|Overall Study|Lost to Follow-up|3
855773|NCT01565148|2820641|P3|Overall Study|Lost to Follow-up|0
855774|NCT01565148|2820642|P2|Overall Study|Lost to Follow-up|4
855775|NCT01565148|2820643|P1|Overall Study|Lost to Follow-up|4
855776|NCT01565148|2820640|P4|Overall Study|Withdrawal by Subject|2
855777|NCT01565148|2820641|P3|Overall Study|Withdrawal by Subject|1
855778|NCT01565148|2820642|P2|Overall Study|Withdrawal by Subject|1
855779|NCT01565148|2820643|P1|Overall Study|Withdrawal by Subject|1
855780|NCT01565083|2820679|P2|Overall Study|Other|5
855781|NCT01565083|2820680|P1|Overall Study|Other|3
855782|NCT01565083|2820679|P2|Overall Study|Death|23
855783|NCT01565083|2820680|P1|Overall Study|Death|22
855784|NCT01565083|2820679|P2|Overall Study|Lost to Follow-up|7
855785|NCT01565083|2820680|P1|Overall Study|Lost to Follow-up|2
855786|NCT01565083|2820679|P2|Overall Study|Withdrawal by Subject|4
855787|NCT01565083|2820680|P1|Overall Study|Withdrawal by Subject|6
855788|NCT01564862|2820717|P3|Overall Study|Other reason(s)|0
855789|NCT01564862|2820718|P2|Overall Study|Other reason(s)|0
855790|NCT01564862|2820719|P1|Overall Study|Other reason(s)|1
855791|NCT01564862|2820717|P3|Overall Study|Lack of Efficacy|6
855792|NCT01564862|2820718|P2|Overall Study|Lack of Efficacy|5
855793|NCT01564862|2820719|P1|Overall Study|Lack of Efficacy|1
855794|NCT01564862|2820717|P3|Overall Study|Voluntary Withdrawal|8
855795|NCT01564862|2820718|P2|Overall Study|Voluntary Withdrawal|6
855796|NCT01564862|2820719|P1|Overall Study|Voluntary Withdrawal|9
855797|NCT01564862|2820717|P3|Overall Study|Lost to Follow-up|6
855798|NCT01564862|2820718|P2|Overall Study|Lost to Follow-up|8
855799|NCT01564862|2820719|P1|Overall Study|Lost to Follow-up|10
855800|NCT01564862|2820717|P3|Overall Study|Major Protocol Deviation|4
855801|NCT01564862|2820718|P2|Overall Study|Major Protocol Deviation|3
855802|NCT01564862|2820719|P1|Overall Study|Major Protocol Deviation|3
855803|NCT01564862|2820717|P3|Overall Study|Pretreatment Event or Adverse Event|6
855804|NCT01564862|2820718|P2|Overall Study|Pretreatment Event or Adverse Event|12
855805|NCT01564862|2820719|P1|Overall Study|Pretreatment Event or Adverse Event|6
855806|NCT01564784|2820770|P2|Overall Study|Death|126
855807|NCT01564784|2820771|P1|Overall Study|Death|131
855808|NCT01564784|2820770|P2|Overall Study|Lost to Follow-up|1
855809|NCT01564784|2820771|P1|Overall Study|Lost to Follow-up|1
855810|NCT01564784|2820770|P2|Overall Study|Subject refused further follow-up|6
855811|NCT01564784|2820771|P1|Overall Study|Subject refused further follow-up|1
855812|NCT01564784|2820770|P2|Overall Study|Other|0
855813|NCT01564784|2820771|P1|Overall Study|Other|1
855814|NCT01564758|2820798|P1|Overall Study|Other|3
855815|NCT01564758|2820798|P1|Overall Study|Adverse Event|3
855816|NCT01564758|2820798|P1|Overall Study|Death|8
855817|NCT01564732|2820805|P2|Overall Study|Early termination by the study sponsor|5
855818|NCT01564732|2820806|P1|Overall Study|Early termination by the study sponsor|6
855819|NCT01564537|2820841|P2|Overall Study|Other Miscellaneous Reasons|2
855820|NCT01564537|2820842|P1|Overall Study|Other Miscellaneous Reasons|1
855821|NCT01564537|2820841|P2|Overall Study|Lost to Follow-up|0
855822|NCT01564537|2820842|P1|Overall Study|Lost to Follow-up|1
855823|NCT01564537|2820841|P2|Overall Study|Withdrawal by Participant|4
855824|NCT01564537|2820842|P1|Overall Study|Withdrawal by Participant|4
855825|NCT01564459|2820865|P3|Double-blind Treatment|Adverse Event|1
855826|NCT01564459|2820866|P2|Double-blind Treatment|Adverse Event|0
855827|NCT01564459|2820867|P1|Double-blind Treatment|Adverse Event|0
855828|NCT01564459|2820865|P3|Run-In|Withdrawal by Subject|0
855829|NCT01564459|2820866|P2|Run-In|Withdrawal by Subject|0
855830|NCT01564459|2820867|P1|Run-In|Withdrawal by Subject|1
855831|NCT01564459|2820865|P3|Run-In|Protocol Violation|0
855832|NCT01564459|2820866|P2|Run-In|Protocol Violation|0
855833|NCT01564459|2820867|P1|Run-In|Protocol Violation|1
855834|NCT01564459|2820865|P3|Run-In|Non-compliance with study drug|0
855835|NCT01564459|2820866|P2|Run-In|Non-compliance with study drug|0
855836|NCT01564459|2820867|P1|Run-In|Non-compliance with study drug|2
855837|NCT01564459|2820865|P3|Run-In|Lost to Follow-up|0
855838|NCT01564459|2820866|P2|Run-In|Lost to Follow-up|0
855839|NCT01564459|2820867|P1|Run-In|Lost to Follow-up|1
855840|NCT01564459|2820865|P3|Run-In|Adverse Event|0
855841|NCT01564459|2820866|P2|Run-In|Adverse Event|0
855842|NCT01564459|2820867|P1|Run-In|Adverse Event|7
855843|NCT01564407|2820891|P5|Overall Study|funding lost, study ended|0
855844|NCT01564407|2820892|P4|Overall Study|funding lost, study ended|1
855845|NCT01564407|2820893|P3|Overall Study|funding lost, study ended|0
855846|NCT01564407|2820894|P2|Overall Study|funding lost, study ended|0
855847|NCT01564407|2820895|P1|Overall Study|funding lost, study ended|0
855848|NCT01564407|2820891|P5|Overall Study|Withdrawal by Subject|0
855849|NCT01564407|2820892|P4|Overall Study|Withdrawal by Subject|0
855850|NCT01564407|2820893|P3|Overall Study|Withdrawal by Subject|0
855851|NCT01564407|2820894|P2|Overall Study|Withdrawal by Subject|1
855852|NCT01564407|2820895|P1|Overall Study|Withdrawal by Subject|0
855853|NCT01564407|2820891|P5|Overall Study|Lost to Follow-up|0
855854|NCT01564407|2820892|P4|Overall Study|Lost to Follow-up|0
855855|NCT01564407|2820893|P3|Overall Study|Lost to Follow-up|0
855856|NCT01564407|2820894|P2|Overall Study|Lost to Follow-up|1
855857|NCT01564407|2820895|P1|Overall Study|Lost to Follow-up|0
855858|NCT01564394|2820936|P2|Overall Study|Withdrawal by Subject|10
855859|NCT01564394|2820937|P1|Overall Study|Withdrawal by Subject|6
855860|NCT01564277|2820951|P2|Overall Study|Physician Decision|0
855861|NCT01564277|2820952|P1|Overall Study|Physician Decision|1
855862|NCT01564277|2820951|P2|Overall Study|Protocol Violation|1
855863|NCT01564277|2820952|P1|Overall Study|Protocol Violation|0
855864|NCT01563978|2820970|P2|Overall Study|Adverse Event|2
855865|NCT01563978|2820971|P1|Overall Study|Adverse Event|1
855866|NCT01563978|2820970|P2|Overall Study|Dev. of study specific discont. criteria|0
855867|NCT01563978|2820971|P1|Overall Study|Dev. of study specific discont. criteria|1
855868|NCT01563978|2820970|P2|Overall Study|Lost to Follow-up|0
855869|NCT01563978|2820971|P1|Overall Study|Lost to Follow-up|1
855870|NCT01563978|2820970|P2|Overall Study|Physician Decision|0
855871|NCT01563978|2820971|P1|Overall Study|Physician Decision|1
855872|NCT01563913|2820997|P2|Overall Study|Spouse Passed Away|0
855873|NCT01563913|2820998|P1|Overall Study|Spouse Passed Away|1
855874|NCT01563913|2820997|P2|Overall Study|Physician Decision|0
855875|NCT01563913|2820998|P1|Overall Study|Physician Decision|1
855876|NCT01563536|2821010|P2|Overall Study|Lost to Follow-up|0
855877|NCT01563536|2821011|P1|Overall Study|Lost to Follow-up|1
855878|NCT01563536|2821010|P2|Overall Study|Withdrawal by Subject|2
855879|NCT01563536|2821011|P1|Overall Study|Withdrawal by Subject|0
855880|NCT01563185|2821070|P1|Overall Study|Non-Compliance with study drug|1
855881|NCT01563185|2821070|P1|Overall Study|Withdrawal by Subject|1
855882|NCT01563172|2821084|P1|Overall Study|Other (Not specified)|1
855883|NCT01563172|2821084|P1|Overall Study|Other (Protocol deviation)|5
855884|NCT01563172|2821084|P1|Overall Study|Lost to Follow-up|2
855885|NCT01563172|2821084|P1|Overall Study|Adverse Event|5
855886|NCT01563029|2821190|P5|Overall Study|Withdrawal by Subject|3
855887|NCT01563029|2821191|P4|Overall Study|Withdrawal by Subject|4
855888|NCT01563029|2821192|P3|Overall Study|Withdrawal by Subject|3
855889|NCT01563029|2821193|P2|Overall Study|Withdrawal by Subject|1
855890|NCT01563029|2821194|P1|Overall Study|Withdrawal by Subject|4
855891|NCT01563029|2821190|P5|Overall Study|Physician Decision|2
855892|NCT01563029|2821191|P4|Overall Study|Physician Decision|4
855893|NCT01563029|2821192|P3|Overall Study|Physician Decision|2
855894|NCT01563029|2821193|P2|Overall Study|Physician Decision|5
855895|NCT01563029|2821194|P1|Overall Study|Physician Decision|3
855896|NCT01563029|2821190|P5|Overall Study|Lost to Follow-up|1
855897|NCT01563029|2821191|P4|Overall Study|Lost to Follow-up|1
855898|NCT01563029|2821192|P3|Overall Study|Lost to Follow-up|1
855899|NCT01563029|2821193|P2|Overall Study|Lost to Follow-up|0
855900|NCT01563029|2821194|P1|Overall Study|Lost to Follow-up|1
855901|NCT01563029|2821190|P5|Overall Study|Protocol defined stopping criteria|0
855902|NCT01563029|2821191|P4|Overall Study|Protocol defined stopping criteria|0
855903|NCT01563029|2821192|P3|Overall Study|Protocol defined stopping criteria|0
855904|NCT01563029|2821193|P2|Overall Study|Protocol defined stopping criteria|0
855905|NCT01563029|2821194|P1|Overall Study|Protocol defined stopping criteria|1
855906|NCT01563029|2821190|P5|Overall Study|Protocol Violation|3
855907|NCT01563029|2821191|P4|Overall Study|Protocol Violation|1
855908|NCT01563029|2821192|P3|Overall Study|Protocol Violation|3
855909|NCT01563029|2821193|P2|Overall Study|Protocol Violation|2
855910|NCT01563029|2821194|P1|Overall Study|Protocol Violation|1
855911|NCT01563029|2821190|P5|Overall Study|Lack of Efficacy|19
855912|NCT01563029|2821191|P4|Overall Study|Lack of Efficacy|21
855913|NCT01563029|2821192|P3|Overall Study|Lack of Efficacy|23
855914|NCT01563029|2821193|P2|Overall Study|Lack of Efficacy|16
855915|NCT01563029|2821194|P1|Overall Study|Lack of Efficacy|42
855916|NCT01563029|2821190|P5|Overall Study|Adverse Event|1
855917|NCT01563029|2821191|P4|Overall Study|Adverse Event|2
855918|NCT01563029|2821192|P3|Overall Study|Adverse Event|1
855919|NCT01563029|2821193|P2|Overall Study|Adverse Event|0
855920|NCT01563029|2821194|P1|Overall Study|Adverse Event|1
855921|NCT01562873|2821260|P2|Overall Study|Clinical PD and adverse event|0
855922|NCT01562873|2821261|P1|Overall Study|Clinical PD and adverse event|1
855923|NCT01562873|2821260|P2|Overall Study|Clinical Disease Progression|0
855924|NCT01562873|2821261|P1|Overall Study|Clinical Disease Progression|9
855925|NCT01562873|2821260|P2|Overall Study|Adverse Event|0
855926|NCT01562873|2821261|P1|Overall Study|Adverse Event|1
855927|NCT01562873|2821260|P2|Overall Study|Disease Progression per RECIST|0
855928|NCT01562873|2821261|P1|Overall Study|Disease Progression per RECIST|10
855929|NCT01562743|2821273|P1|Overall Study|Physician Decision|2
855930|NCT01562743|2821273|P1|Overall Study|Lost to Follow-up|2
855931|NCT01562743|2821273|P1|Overall Study|Discontinuation criteria|2
855932|NCT01562743|2821273|P1|Overall Study|Protocol Violation|1
855933|NCT01562743|2821273|P1|Overall Study|Withdrawal by Subject|13
855934|NCT01562743|2821273|P1|Overall Study|Lack of Efficacy|3
855935|NCT01562743|2821273|P1|Overall Study|Adverse Event|29
855936|NCT01562613|2821292|P1|Overall Study|Withdrawal by Subject|2
855937|NCT01562613|2821292|P1|Overall Study|Lost to Follow-up|2
855938|NCT01562548|2821302|P4|Overall Study|Lost to Follow-up|0
855939|NCT01562548|2821303|P3|Overall Study|Lost to Follow-up|1
855940|NCT01562548|2821304|P2|Overall Study|Lost to Follow-up|0
855941|NCT01562548|2821305|P1|Overall Study|Lost to Follow-up|0
855942|NCT01562444|2821358|P3|Overall Study|Protocol forbidden medication|0
855943|NCT01562444|2821359|P2|Overall Study|Protocol forbidden medication|0
855944|NCT01562444|2821360|P1|Overall Study|Protocol forbidden medication|1
855945|NCT01562444|2821358|P3|Overall Study|Protocol forbidden concomitant vaccine|1
855946|NCT01562444|2821359|P2|Overall Study|Protocol forbidden concomitant vaccine|0
855947|NCT01562444|2821360|P1|Overall Study|Protocol forbidden concomitant vaccine|1
855948|NCT01562444|2821358|P3|Overall Study|Unavailable serological results|2
855949|NCT01562444|2821359|P2|Overall Study|Unavailable serological results|2
855950|NCT01562444|2821360|P1|Overall Study|Unavailable serological results|0
855951|NCT01562444|2821358|P3|Overall Study|Did not comply with blood draw schedule|1
855952|NCT01562444|2821359|P2|Overall Study|Did not comply with blood draw schedule|0
855953|NCT01562444|2821360|P1|Overall Study|Did not comply with blood draw schedule|1
855954|NCT01562444|2821358|P3|Overall Study|Did not meet entry criteria|3
855955|NCT01562444|2821359|P2|Overall Study|Did not meet entry criteria|0
855956|NCT01562444|2821360|P1|Overall Study|Did not meet entry criteria|2
855957|NCT01562327|2821626|P1|Overall Study|Infusion not received at 6 month window|4
855958|NCT01562327|2821626|P1|Overall Study|Participant drop-out|1
855959|NCT01562327|2821626|P1|Overall Study|Lack of Efficacy|1
855960|NCT01562327|2821626|P1|Overall Study|Adverse Event|2
855961|NCT01562314|2821656|P2|Overall Study|Withdrawal by Subject|1
855962|NCT01562314|2821657|P1|Overall Study|Withdrawal by Subject|0
855963|NCT01562314|2821656|P2|Overall Study|Met Withdrawal Criteria|2
855964|NCT01562314|2821657|P1|Overall Study|Met Withdrawal Criteria|3
855965|NCT01562314|2821656|P2|Overall Study|Adverse Event|5
855966|NCT01562314|2821657|P1|Overall Study|Adverse Event|10
855967|NCT01562275|2821714|P13|Stage 2|Progression of Disease|4
855968|NCT01562275|2821715|P12|Stage 2|Progression of Disease|12
855969|NCT01562275|2821716|P11|Stage 2|Progression of Disease|0
855970|NCT01562275|2821717|P10|Stage 2|Progression of Disease|0
855971|NCT01562275|2821718|P9|Stage 2|Progression of Disease|0
855972|NCT01562275|2821719|P8|Stage 2|Progression of Disease|0
855973|NCT01562275|2821720|P7|Stage 2|Progression of Disease|0
855974|NCT01562275|2821721|P6|Stage 2|Progression of Disease|0
855975|NCT01562275|2821722|P5|Stage 2|Progression of Disease|0
855976|NCT01562275|2821723|P4|Stage 2|Progression of Disease|0
855977|NCT01562275|2821724|P3|Stage 2|Progression of Disease|0
855978|NCT01562275|2821725|P2|Stage 2|Progression of Disease|0
855979|NCT01562275|2821726|P1|Stage 2|Progression of Disease|0
855980|NCT01562275|2821714|P13|Stage 2|Death|1
855981|NCT01562275|2821715|P12|Stage 2|Death|2
855982|NCT01562275|2821716|P11|Stage 2|Death|0
855983|NCT01562275|2821717|P10|Stage 2|Death|0
855984|NCT01562275|2821718|P9|Stage 2|Death|0
855985|NCT01562275|2821719|P8|Stage 2|Death|0
855986|NCT01562275|2821720|P7|Stage 2|Death|0
855987|NCT01562275|2821721|P6|Stage 2|Death|0
855988|NCT01562275|2821722|P5|Stage 2|Death|0
855989|NCT01562275|2821723|P4|Stage 2|Death|0
855990|NCT01562275|2821724|P3|Stage 2|Death|0
855991|NCT01562275|2821725|P2|Stage 2|Death|0
855992|NCT01562275|2821726|P1|Stage 2|Death|0
855993|NCT01562275|2821714|P13|Stage 1|Withdrawal by Subject|0
855994|NCT01562275|2821715|P12|Stage 1|Withdrawal by Subject|0
855995|NCT01562275|2821716|P11|Stage 1|Withdrawal by Subject|0
855996|NCT01562275|2821717|P10|Stage 1|Withdrawal by Subject|1
855997|NCT01562275|2821718|P9|Stage 1|Withdrawal by Subject|0
855998|NCT01562275|2821719|P8|Stage 1|Withdrawal by Subject|0
855999|NCT01562275|2821720|P7|Stage 1|Withdrawal by Subject|1
856000|NCT01562275|2821721|P6|Stage 1|Withdrawal by Subject|0
856001|NCT01562275|2821722|P5|Stage 1|Withdrawal by Subject|0
856002|NCT01562275|2821723|P4|Stage 1|Withdrawal by Subject|2
856003|NCT01562275|2821724|P3|Stage 1|Withdrawal by Subject|0
856004|NCT01562275|2821725|P2|Stage 1|Withdrawal by Subject|1
856005|NCT01562275|2821726|P1|Stage 1|Withdrawal by Subject|0
856006|NCT01562275|2821714|P13|Stage 1|Progression of Disease|0
856007|NCT01562275|2821715|P12|Stage 1|Progression of Disease|0
856008|NCT01562275|2821716|P11|Stage 1|Progression of Disease|3
856009|NCT01562275|2821717|P10|Stage 1|Progression of Disease|5
856010|NCT01562275|2821718|P9|Stage 1|Progression of Disease|2
856011|NCT01562275|2821719|P8|Stage 1|Progression of Disease|7
856012|NCT01562275|2821720|P7|Stage 1|Progression of Disease|1
856013|NCT01562275|2821721|P6|Stage 1|Progression of Disease|4
856014|NCT01562275|2821722|P5|Stage 1|Progression of Disease|2
856015|NCT01562275|2821723|P4|Stage 1|Progression of Disease|1
856016|NCT01562275|2821724|P3|Stage 1|Progression of Disease|2
856017|NCT01562275|2821725|P2|Stage 1|Progression of Disease|6
856018|NCT01562275|2821726|P1|Stage 1|Progression of Disease|2
856019|NCT01562275|2821714|P13|Stage 1|Physician Decision|0
856020|NCT01562275|2821715|P12|Stage 1|Physician Decision|0
856021|NCT01562275|2821716|P11|Stage 1|Physician Decision|0
856022|NCT01562275|2821717|P10|Stage 1|Physician Decision|0
856023|NCT01562275|2821718|P9|Stage 1|Physician Decision|1
856024|NCT01562275|2821719|P8|Stage 1|Physician Decision|0
856025|NCT01562275|2821720|P7|Stage 1|Physician Decision|1
856026|NCT01562275|2821721|P6|Stage 1|Physician Decision|0
856027|NCT01562275|2821722|P5|Stage 1|Physician Decision|1
856028|NCT01562275|2821723|P4|Stage 1|Physician Decision|0
856029|NCT01562275|2821724|P3|Stage 1|Physician Decision|0
856030|NCT01562275|2821725|P2|Stage 1|Physician Decision|0
856031|NCT01562275|2821726|P1|Stage 1|Physician Decision|0
856032|NCT01562275|2821714|P13|Stage 1|Non Compliance|0
856033|NCT01562275|2821715|P12|Stage 1|Non Compliance|0
856034|NCT01562275|2821716|P11|Stage 1|Non Compliance|0
856035|NCT01562275|2821717|P10|Stage 1|Non Compliance|0
856036|NCT01562275|2821718|P9|Stage 1|Non Compliance|0
856037|NCT01562275|2821719|P8|Stage 1|Non Compliance|0
856038|NCT01562275|2821720|P7|Stage 1|Non Compliance|0
856039|NCT01562275|2821721|P6|Stage 1|Non Compliance|0
856040|NCT01562275|2821722|P5|Stage 1|Non Compliance|0
856041|NCT01562275|2821723|P4|Stage 1|Non Compliance|0
856042|NCT01562275|2821724|P3|Stage 1|Non Compliance|1
856043|NCT01562275|2821725|P2|Stage 1|Non Compliance|0
856044|NCT01562275|2821726|P1|Stage 1|Non Compliance|0
856045|NCT01562275|2821714|P13|Stage 1|Death|0
856046|NCT01562275|2821715|P12|Stage 1|Death|0
856047|NCT01562275|2821716|P11|Stage 1|Death|0
856048|NCT01562275|2821717|P10|Stage 1|Death|0
856049|NCT01562275|2821718|P9|Stage 1|Death|0
856050|NCT01562275|2821719|P8|Stage 1|Death|0
856051|NCT01562275|2821720|P7|Stage 1|Death|0
856052|NCT01562275|2821721|P6|Stage 1|Death|0
856053|NCT01562275|2821722|P5|Stage 1|Death|0
856054|NCT01562275|2821723|P4|Stage 1|Death|0
856055|NCT01562275|2821724|P3|Stage 1|Death|0
856056|NCT01562275|2821725|P2|Stage 1|Death|0
856057|NCT01562275|2821726|P1|Stage 1|Death|1
856058|NCT01562275|2821714|P13|Stage 1|Adverse Event|0
856059|NCT01562275|2821715|P12|Stage 1|Adverse Event|0
856060|NCT01562275|2821716|P11|Stage 1|Adverse Event|0
856061|NCT01562275|2821717|P10|Stage 1|Adverse Event|1
856062|NCT01562275|2821718|P9|Stage 1|Adverse Event|0
856063|NCT01562275|2821719|P8|Stage 1|Adverse Event|0
856064|NCT01562275|2821720|P7|Stage 1|Adverse Event|0
856065|NCT01562275|2821721|P6|Stage 1|Adverse Event|0
856066|NCT01562275|2821722|P5|Stage 1|Adverse Event|1
856067|NCT01562275|2821723|P4|Stage 1|Adverse Event|1
856068|NCT01562275|2821724|P3|Stage 1|Adverse Event|0
856069|NCT01562275|2821725|P2|Stage 1|Adverse Event|0
856070|NCT01562275|2821726|P1|Stage 1|Adverse Event|0
856071|NCT01561976|2821871|P6|Washout Period 2 (7 Days)|Non-compliance|0
856072|NCT01561976|2821872|P5|Washout Period 2 (7 Days)|Non-compliance|0
856073|NCT01561976|2821873|P4|Washout Period 2 (7 Days)|Non-compliance|0
856074|NCT01561976|2821874|P3|Washout Period 2 (7 Days)|Non-compliance|1
856075|NCT01561976|2821875|P2|Washout Period 2 (7 Days)|Non-compliance|0
856076|NCT01561976|2821876|P1|Washout Period 2 (7 Days)|Non-compliance|1
856077|NCT01561976|2821871|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|1
856078|NCT01561976|2821872|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
856079|NCT01561976|2821873|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
856080|NCT01561976|2821874|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|0
856081|NCT01561976|2821875|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
856082|NCT01561976|2821876|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
856083|NCT01561976|2821871|P6|Washout Period 1 (7 Days)|Adverse Event|0
856084|NCT01561976|2821872|P5|Washout Period 1 (7 Days)|Adverse Event|0
856085|NCT01561976|2821873|P4|Washout Period 1 (7 Days)|Adverse Event|1
856086|NCT01561976|2821874|P3|Washout Period 1 (7 Days)|Adverse Event|0
856087|NCT01561976|2821875|P2|Washout Period 1 (7 Days)|Adverse Event|0
856088|NCT01561976|2821876|P1|Washout Period 1 (7 Days)|Adverse Event|0
856089|NCT01561976|2821871|P6|Period 1|Adverse Event|0
856090|NCT01561976|2821872|P5|Period 1|Adverse Event|0
856091|NCT01561976|2821873|P4|Period 1|Adverse Event|0
856092|NCT01561976|2821874|P3|Period 1|Adverse Event|1
856093|NCT01561976|2821875|P2|Period 1|Adverse Event|0
856094|NCT01561976|2821876|P1|Period 1|Adverse Event|0
856095|NCT01561898|2821909|P4|Overall Study|Physician Decision|1
856096|NCT01561898|2821910|P3|Overall Study|Physician Decision|7
856097|NCT01561898|2821911|P2|Overall Study|Physician Decision|5
856098|NCT01561898|2821912|P1|Overall Study|Physician Decision|1
856099|NCT01561898|2821909|P4|Overall Study|Adverse Event|9
856100|NCT01561898|2821910|P3|Overall Study|Adverse Event|14
856101|NCT01561898|2821911|P2|Overall Study|Adverse Event|19
856102|NCT01561898|2821912|P1|Overall Study|Adverse Event|1
856103|NCT01561898|2821909|P4|Overall Study|Lost to Follow-up|0
856104|NCT01561898|2821910|P3|Overall Study|Lost to Follow-up|1
856105|NCT01561898|2821911|P2|Overall Study|Lost to Follow-up|0
856106|NCT01561898|2821912|P1|Overall Study|Lost to Follow-up|0
856107|NCT01561898|2821909|P4|Overall Study|Worsening of complications|0
856108|NCT01561898|2821910|P3|Overall Study|Worsening of complications|0
856109|NCT01561898|2821911|P2|Overall Study|Worsening of complications|1
856110|NCT01561898|2821912|P1|Overall Study|Worsening of complications|0
856111|NCT01561898|2821909|P4|Overall Study|Lack of Efficacy|5
856112|NCT01561898|2821910|P3|Overall Study|Lack of Efficacy|10
856113|NCT01561898|2821911|P2|Overall Study|Lack of Efficacy|8
856114|NCT01561898|2821912|P1|Overall Study|Lack of Efficacy|0
856115|NCT01561898|2821909|P4|Overall Study|Withdrawal by Subject|5
856116|NCT01561898|2821910|P3|Overall Study|Withdrawal by Subject|12
856117|NCT01561898|2821911|P2|Overall Study|Withdrawal by Subject|8
856118|NCT01561898|2821912|P1|Overall Study|Withdrawal by Subject|0
856119|NCT01561755|2821926|P2|Overall Study|Lost to Follow-up|1
856120|NCT01561755|2821927|P1|Overall Study|Lost to Follow-up|0
856121|NCT01561560|2821979|P2|Second Two Weeks of Wear|Adverse Event|1
856122|NCT01561560|2821980|P1|Second Two Weeks of Wear|Adverse Event|0
856123|NCT01561560|2821979|P2|First Two Weeks of Wear|Adverse Event|1
856124|NCT01561560|2821980|P1|First Two Weeks of Wear|Adverse Event|0
856125|NCT01561560|2821979|P2|First Two Weeks of Wear|Time/job conflict|1
856126|NCT01561560|2821980|P1|First Two Weeks of Wear|Time/job conflict|0
856127|NCT01561430|2822011|P4|Overall Study|Sponsor Decision|12
856128|NCT01561430|2822012|P3|Overall Study|Sponsor Decision|13
856129|NCT01561430|2822013|P2|Overall Study|Sponsor Decision|14
856130|NCT01561430|2822014|P1|Overall Study|Sponsor Decision|1
856131|NCT01561430|2822011|P4|Overall Study|Physician Decision|0
856132|NCT01561430|2822012|P3|Overall Study|Physician Decision|0
856133|NCT01561430|2822013|P2|Overall Study|Physician Decision|1
856134|NCT01561430|2822014|P1|Overall Study|Physician Decision|0
856135|NCT01561430|2822011|P4|Overall Study|Withdrawal by Subject|0
856136|NCT01561430|2822012|P3|Overall Study|Withdrawal by Subject|1
856137|NCT01561430|2822013|P2|Overall Study|Withdrawal by Subject|0
856138|NCT01561430|2822014|P1|Overall Study|Withdrawal by Subject|0
856139|NCT01561430|2822011|P4|Overall Study|Adverse Event|1
856140|NCT01561430|2822012|P3|Overall Study|Adverse Event|3
856141|NCT01561430|2822013|P2|Overall Study|Adverse Event|0
856142|NCT01561430|2822014|P1|Overall Study|Adverse Event|0
856143|NCT01561313|2822054|P2|Overall Study|Adverse event and withdrawal by subject|0
856144|NCT01561313|2822055|P1|Overall Study|Adverse event and withdrawal by subject|1
856145|NCT01561313|2822054|P2|Overall Study|Withdrawal by Subject|0
856146|NCT01561313|2822055|P1|Overall Study|Withdrawal by Subject|1
856147|NCT01561300|2822073|P2|Run in on Placebo|Adverse Event|0
856148|NCT01561300|2822074|P1|Run in on Placebo|Adverse Event|1
856149|NCT01561079|2822085|P1|Overall Study|Protocol Violation|2
856150|NCT01561079|2822085|P1|Overall Study|Withdrawal by Subject|59
856151|NCT01561079|2822085|P1|Overall Study|Physician Decision|17
856152|NCT01560988|2822128|P2|Washout (Six Weeks)|Lost to Follow-up|2
856153|NCT01560988|2822129|P1|Washout (Six Weeks)|Lost to Follow-up|2
856154|NCT01560988|2822128|P2|First Intervention (Six Weeks)|Withdrawal by Subject|0
856155|NCT01560988|2822129|P1|First Intervention (Six Weeks)|Withdrawal by Subject|3
856156|NCT01560988|2822128|P2|First Intervention (Six Weeks)|Lost to Follow-up|4
856157|NCT01560988|2822129|P1|First Intervention (Six Weeks)|Lost to Follow-up|7
856158|NCT01560819|2822167|P2|Overall Study|Physician Decision|0
856159|NCT01560819|2822168|P1|Overall Study|Physician Decision|1
856160|NCT01560507|2822175|P3|Overall Study|Withdrawal by Subject|0
856161|NCT01560507|2822176|P2|Overall Study|Withdrawal by Subject|1
856162|NCT01560507|2822177|P1|Overall Study|Withdrawal by Subject|1
856163|NCT01560507|2822175|P3|Overall Study|Lost to Follow-up|2
856164|NCT01560507|2822176|P2|Overall Study|Lost to Follow-up|1
856165|NCT01560507|2822177|P1|Overall Study|Lost to Follow-up|3
856166|NCT01560429|2822190|P2|Overall Study|Protocol Violation|6
856167|NCT01560429|2822191|P1|Overall Study|Protocol Violation|3
856168|NCT01560403|2822201|P2|Overall Study|Lost to Follow-up|1
856169|NCT01560403|2822202|P1|Overall Study|Lost to Follow-up|0
856170|NCT01560234|2822237|P8|Overall Study|Lost to Follow-up|2
856171|NCT01560234|2822238|P7|Overall Study|Lost to Follow-up|0
856172|NCT01560234|2822239|P6|Overall Study|Lost to Follow-up|2
856173|NCT01560234|2822240|P5|Overall Study|Lost to Follow-up|0
856174|NCT01560234|2822241|P4|Overall Study|Lost to Follow-up|0
856175|NCT01560234|2822242|P3|Overall Study|Lost to Follow-up|1
856176|NCT01560234|2822243|P2|Overall Study|Lost to Follow-up|0
856177|NCT01560234|2822244|P1|Overall Study|Lost to Follow-up|3
856178|NCT01559935|2822322|P1|Maintenance Phase|Non-compliance|2
856179|NCT01559935|2822322|P1|Maintenance Phase|Withdrawal by Subject|5
856180|NCT01559935|2822322|P1|Maintenance Phase|Lack of Efficacy|18
856181|NCT01559935|2822322|P1|Maintenance Phase|Toxicity|1
856182|NCT01559935|2822322|P1|Maintenance Phase|Remains on study|28
856183|NCT01559935|2822322|P1|BiRD Phase|Withdrawal by Subject|2
856184|NCT01559935|2822322|P1|BiRD Phase|Lack of Efficacy|1
856185|NCT01559935|2822322|P1|BiRD Phase|Toxicity|1
856186|NCT01559935|2822322|P1|Car Phase|non-compliance|1
856187|NCT01559935|2822322|P1|Car Phase|Insurance|1
856188|NCT01559935|2822322|P1|Car Phase|Per protocol|1
856189|NCT01559935|2822322|P1|Car Phase|Withdrawal by Subject|2
856190|NCT01559935|2822322|P1|Car Phase|Physician Decision|1
856191|NCT01559935|2822322|P1|Car Phase|Lost to Follow-up|1
856192|NCT01559935|2822322|P1|Car Phase|Lack of Efficacy|2
856193|NCT01559935|2822322|P1|Car Phase|Death|1
856194|NCT01559935|2822322|P1|Car Phase|Toxicity|4
856195|NCT01559844|2822358|P1|Overall Study|No Longer A Transplant Candidate|3
856196|NCT01559844|2822358|P1|Overall Study|Efficacy Failure|10
856197|NCT01559844|2822358|P1|Overall Study|Death|5
856198|NCT01559844|2822358|P1|Overall Study|Consent Withdrawn|7
856199|NCT01559675|2822371|P2|Overall Study|2nd operation on same patient excluded|12
856200|NCT01559675|2822372|P1|Overall Study|2nd operation on same patient excluded|14
856201|NCT01559675|2822371|P2|Overall Study|Protocol Violation|2
856202|NCT01559675|2822372|P1|Overall Study|Protocol Violation|1
856203|NCT01559454|2822403|P2|Overall Study|Lack of Efficacy|1
856204|NCT01559454|2822404|P1|Overall Study|Lack of Efficacy|0
856205|NCT01559454|2822403|P2|Overall Study|Protocol Violation|1
856206|NCT01559454|2822404|P1|Overall Study|Protocol Violation|0
856207|NCT01559454|2822403|P2|Overall Study|Physician Decision|1
856208|NCT01559454|2822404|P1|Overall Study|Physician Decision|0
856209|NCT01559454|2822403|P2|Overall Study|Withdrawal by Subject|1
856210|NCT01559454|2822404|P1|Overall Study|Withdrawal by Subject|0
856211|NCT01559454|2822403|P2|Overall Study|Lost to Follow-up|2
856212|NCT01559454|2822404|P1|Overall Study|Lost to Follow-up|3
856213|NCT01559311|2822423|P3|Overall Study|Adverse Event|1
856214|NCT01559311|2822424|P2|Overall Study|Adverse Event|0
856215|NCT01559311|2822425|P1|Overall Study|Adverse Event|0
856216|NCT01559311|2822423|P3|Overall Study|Lost to Follow-up|2
856217|NCT01559311|2822424|P2|Overall Study|Lost to Follow-up|3
856218|NCT01559311|2822425|P1|Overall Study|Lost to Follow-up|0
856219|NCT01559311|2822423|P3|Overall Study|Death|3
856220|NCT01559311|2822424|P2|Overall Study|Death|2
856221|NCT01559311|2822425|P1|Overall Study|Death|0
856222|NCT01559311|2822423|P3|Overall Study|Withdrawal by Subject|0
856223|NCT01559311|2822424|P2|Overall Study|Withdrawal by Subject|1
856224|NCT01559311|2822425|P1|Overall Study|Withdrawal by Subject|2
856225|NCT01559311|2822423|P3|Overall Study|Difficulty in cannulating the lateral ve|0
856226|NCT01559311|2822424|P2|Overall Study|Difficulty in cannulating the lateral ve|0
856227|NCT01559311|2822425|P1|Overall Study|Difficulty in cannulating the lateral ve|1
856228|NCT01559311|2822423|P3|Overall Study|Protocol Violation|2
856229|NCT01559311|2822424|P2|Overall Study|Protocol Violation|0
856230|NCT01559311|2822425|P1|Overall Study|Protocol Violation|0
856231|NCT01559116|2822436|P1|Overall Study|other than stated above|9
856232|NCT01559116|2822436|P1|Overall Study|Withdrawal by Subject|4
856233|NCT01559116|2822436|P1|Overall Study|Protocol Violation|1
856234|NCT01559116|2822436|P1|Overall Study|Lost to Follow-up|1
856235|NCT01559116|2822436|P1|Overall Study|Lack of Efficacy|1
856236|NCT01559116|2822436|P1|Overall Study|Adverse Event|10
856237|NCT01559012|2822519|P2|Overall Study|Withdrawal by Subject|1
856238|NCT01559012|2822520|P1|Overall Study|Withdrawal by Subject|0
856239|NCT01558739|2822556|P1|Overall Study|Protocol Violation|1
856240|NCT01558739|2822556|P1|Overall Study|Disease Progression|4
856241|NCT01558739|2822556|P1|Overall Study|Death|3
856242|NCT01558739|2822556|P1|Overall Study|Withdrawal by Subject|2
856243|NCT01558739|2822556|P1|Overall Study|Adverse Event|7
856244|NCT01558674|2822581|P2|Part 1|Withdrawal by Subject|0
856245|NCT01558674|2822582|P1|Part 1|Withdrawal by Subject|1
856246|NCT01558674|2822581|P2|Part 1|Study Terminated by Sponsor|0
856247|NCT01558674|2822582|P1|Part 1|Study Terminated by Sponsor|10
856248|NCT01558596|2822635|P2|Overall Study|Protocol Violation|0
856249|NCT01558596|2822636|P1|Overall Study|Protocol Violation|1
856250|NCT01558596|2822635|P2|Overall Study|surgery elsewhere or cancelled|1
856251|NCT01558596|2822636|P1|Overall Study|surgery elsewhere or cancelled|1
856252|NCT01558596|2822635|P2|Overall Study|Withdrawal by Subject|0
856253|NCT01558596|2822636|P1|Overall Study|Withdrawal by Subject|1
856254|NCT01558297|2822651|P3|Overall Study|Withdrawal by Subject|1
856255|NCT01558297|2822652|P2|Overall Study|Withdrawal by Subject|2
856256|NCT01558297|2822653|P1|Overall Study|Withdrawal by Subject|2
856257|NCT01558271|2822670|P3|Overall Study|Physician Decision|1
856258|NCT01558271|2822671|P2|Overall Study|Physician Decision|2
856259|NCT01558271|2822672|P1|Overall Study|Physician Decision|0
856260|NCT01558271|2822670|P3|Overall Study|Withdrawal by Subject|12
856261|NCT01558271|2822671|P2|Overall Study|Withdrawal by Subject|6
856262|NCT01558271|2822672|P1|Overall Study|Withdrawal by Subject|10
856263|NCT01558271|2822670|P3|Overall Study|Protocol Violation|0
856264|NCT01558271|2822671|P2|Overall Study|Protocol Violation|0
856265|NCT01558271|2822672|P1|Overall Study|Protocol Violation|1
856266|NCT01558271|2822670|P3|Overall Study|Lost to Follow-up|0
856267|NCT01558271|2822671|P2|Overall Study|Lost to Follow-up|0
856268|NCT01558271|2822672|P1|Overall Study|Lost to Follow-up|1
856269|NCT01558271|2822670|P3|Overall Study|Adverse Event|4
856270|NCT01558271|2822671|P2|Overall Study|Adverse Event|3
856271|NCT01558271|2822672|P1|Overall Study|Adverse Event|6
856272|NCT01558089|2822738|P1|Overall Study|Withdrawal by Subject|6
856273|NCT01558089|2822738|P1|Overall Study|Lost to Follow-up|5
856274|NCT01558089|2822738|P1|Overall Study|Lack of Efficacy|1
856275|NCT01558089|2822738|P1|Overall Study|Adverse Event|1
856276|NCT01557946|2822759|P2|Overall Study|Adverse Event|0
856277|NCT01557946|2822760|P1|Overall Study|Adverse Event|3
856278|NCT01557920|2822766|P2|Overall Study|Lack of Efficacy|0
856279|NCT01557920|2822767|P1|Overall Study|Lack of Efficacy|1
856280|NCT01557920|2822766|P2|Overall Study|Withdrawal by Subject|3
856281|NCT01557920|2822767|P1|Overall Study|Withdrawal by Subject|2
856282|NCT01557842|2822830|P2|Overall Study|Not Ablated|0
856283|NCT01557842|2822831|P1|Overall Study|Not Ablated|2
856284|NCT01557842|2822830|P2|Overall Study|Study Terminated by Sponsor|4
856285|NCT01557842|2822831|P1|Overall Study|Study Terminated by Sponsor|3
856286|NCT01557842|2822830|P2|Overall Study|Not Meet Inclusion/Exclusion Criteria|0
856287|NCT01557842|2822831|P1|Overall Study|Not Meet Inclusion/Exclusion Criteria|3
856288|NCT01557842|2822830|P2|Overall Study|Lack of Efficacy|1
856289|NCT01557842|2822831|P1|Overall Study|Lack of Efficacy|0
856290|NCT01557842|2822830|P2|Overall Study|Death|0
856291|NCT01557842|2822831|P1|Overall Study|Death|1
856292|NCT01557842|2822830|P2|Overall Study|Lost to Follow-up|1
856293|NCT01557842|2822831|P1|Overall Study|Lost to Follow-up|0
856294|NCT01557751|2822839|P1|Overall Study|Physician Decision|3
856295|NCT01557582|2822884|P1|Overall Study|Operator error|2
856296|NCT01557582|2822884|P1|Overall Study|Protocol Violation|4
856297|NCT01557569|2822892|P2|Overall Study|noncompliance with rules of residential|1
856298|NCT01557569|2822893|P1|Overall Study|noncompliance with rules of residential|0
856299|NCT01557569|2822892|P2|Overall Study|Withdrawal by Subject|5
856300|NCT01557569|2822893|P1|Overall Study|Withdrawal by Subject|3
856301|NCT01557569|2822892|P2|Overall Study|high blood pressure|1
856302|NCT01557569|2822893|P1|Overall Study|high blood pressure|0
856303|NCT01557569|2822892|P2|Overall Study|Adverse Event|0
856304|NCT01557569|2822893|P1|Overall Study|Adverse Event|2
856305|NCT01557504|2822901|P2|Overall Study|Physician Decision|0
856306|NCT01557504|2822902|P1|Overall Study|Physician Decision|1
856307|NCT01557348|2822927|P2|Overall Study|Administrative|11
856308|NCT01557348|2822928|P1|Overall Study|Administrative|18
856309|NCT01557348|2822927|P2|Overall Study|Lost to Follow-up|22
856310|NCT01557348|2822928|P1|Overall Study|Lost to Follow-up|26
856311|NCT01557348|2822927|P2|Overall Study|Withdrawal by Subject|4
856312|NCT01557348|2822928|P1|Overall Study|Withdrawal by Subject|5
856313|NCT01557348|2822927|P2|Overall Study|Insufficient Therapeutic Response|28
856314|NCT01557348|2822928|P1|Overall Study|Insufficient Therapeutic Response|13
856315|NCT01557348|2822927|P2|Overall Study|Death|4
856316|NCT01557348|2822928|P1|Overall Study|Death|7
856317|NCT01557348|2822927|P2|Overall Study|Infusion reaction event|5
856318|NCT01557348|2822928|P1|Overall Study|Infusion reaction event|5
856319|NCT01557348|2822927|P2|Overall Study|Adverse Event|16
856320|NCT01557348|2822928|P1|Overall Study|Adverse Event|6
856321|NCT01557283|2823045|P1|Overall Study|Other|6
856322|NCT01557283|2823045|P1|Overall Study|Worsening of psoriasis|1
856323|NCT01557283|2823045|P1|Overall Study|Participant’s weight too high for dose|1
856324|NCT01557283|2823045|P1|Overall Study|Withdrawal by Subject|1
856325|NCT01557283|2823045|P1|Overall Study|Non-compliance|1
856326|NCT01557283|2823045|P1|Overall Study|Lack of Efficacy|1
856327|NCT01557283|2823045|P1|Overall Study|Adverse Event|7
856328|NCT01557283|2823045|P1|Overall Study|Non-responder|19
856329|NCT01557283|2823045|P1|Overall Study|Lost to Follow-up|7
856330|NCT01557166|2823057|P2|Overall Study|Unclassified|5
856331|NCT01557166|2823058|P1|Overall Study|Unclassified|2
856332|NCT01557166|2823057|P2|Overall Study|Psychiatric disorder|0
856333|NCT01557166|2823058|P1|Overall Study|Psychiatric disorder|1
856334|NCT01557166|2823057|P2|Overall Study|Target dose not tolerated|0
856335|NCT01557166|2823058|P1|Overall Study|Target dose not tolerated|1
856336|NCT01557166|2823057|P2|Overall Study|Withdrawn consent|20
856337|NCT01557166|2823058|P1|Overall Study|Withdrawn consent|12
856338|NCT01557166|2823057|P2|Overall Study|Protocol Violation|5
856339|NCT01557166|2823058|P1|Overall Study|Protocol Violation|8
856340|NCT01557166|2823057|P2|Overall Study|Lack of Efficacy|1
856341|NCT01557166|2823058|P1|Overall Study|Lack of Efficacy|2
856342|NCT01557166|2823057|P2|Overall Study|Adverse Event|6
856343|NCT01557166|2823058|P1|Overall Study|Adverse Event|20
856344|NCT01556997|2823073|P3|Overall Study|Not specified|7
856345|NCT01556997|2823074|P2|Overall Study|Not specified|3
856346|NCT01556997|2823075|P1|Overall Study|Not specified|2
856347|NCT01556997|2823073|P3|Overall Study|Withdrawal by Subject|8
856348|NCT01556997|2823074|P2|Overall Study|Withdrawal by Subject|6
856349|NCT01556997|2823075|P1|Overall Study|Withdrawal by Subject|7
856350|NCT01556997|2823073|P3|Overall Study|Physician Decision|1
856351|NCT01556997|2823074|P2|Overall Study|Physician Decision|1
856352|NCT01556997|2823075|P1|Overall Study|Physician Decision|1
856353|NCT01556997|2823073|P3|Overall Study|Lost to Follow-up|4
856354|NCT01556997|2823074|P2|Overall Study|Lost to Follow-up|6
856355|NCT01556997|2823075|P1|Overall Study|Lost to Follow-up|6
856356|NCT01556997|2823073|P3|Overall Study|Adverse Event|12
856357|NCT01556997|2823074|P2|Overall Study|Adverse Event|12
856358|NCT01556997|2823075|P1|Overall Study|Adverse Event|10
856359|NCT01556932|2823086|P2|Time Point 60 Minutes|Withdrawal by Subject|1
856360|NCT01556932|2823087|P1|Time Point 60 Minutes|Withdrawal by Subject|1
856361|NCT01556763|2823113|P3|Overall Study|Withdrawal by Subject|0
856362|NCT01556763|2823114|P2|Overall Study|Withdrawal by Subject|1
856363|NCT01556763|2823115|P1|Overall Study|Withdrawal by Subject|0
856364|NCT01556165|2823301|P2|Overall Study|Withdrawal of Consent|1
856365|NCT01556165|2823302|P1|Overall Study|Withdrawal of Consent|7
856366|NCT01556165|2823301|P2|Overall Study|Protocol Violation|3
856367|NCT01556165|2823302|P1|Overall Study|Protocol Violation|0
856368|NCT01556165|2823301|P2|Overall Study|Adverse Event|3
856369|NCT01556165|2823302|P1|Overall Study|Adverse Event|5
856370|NCT01555983|2823332|P6|Overall Study|Withdrawal by Subject|1
856371|NCT01555983|2823333|P5|Overall Study|Withdrawal by Subject|1
856372|NCT01555983|2823334|P4|Overall Study|Withdrawal by Subject|0
856373|NCT01555983|2823335|P3|Overall Study|Withdrawal by Subject|0
856374|NCT01555983|2823336|P2|Overall Study|Withdrawal by Subject|0
856375|NCT01555983|2823337|P1|Overall Study|Withdrawal by Subject|1
856376|NCT01555931|2823347|P2|Overall Study|Lost to Follow-up|5
856377|NCT01555931|2823348|P1|Overall Study|Lost to Follow-up|2
856378|NCT01555463|2823384|P2|Follow up|Other reason|3
856379|NCT01555463|2823385|P1|Follow up|Other reason|3
856380|NCT01555463|2823384|P2|Follow up|Protocol Violation|4
856381|NCT01555463|2823385|P1|Follow up|Protocol Violation|2
856382|NCT01555463|2823384|P2|Follow up|Lost to Follow-up|10
856383|NCT01555463|2823385|P1|Follow up|Lost to Follow-up|9
856384|NCT01555463|2823384|P2|Follow up|Withdrawal by Subject|22
856385|NCT01555463|2823385|P1|Follow up|Withdrawal by Subject|22
856386|NCT01555463|2823384|P2|Follow up|Death|1
856387|NCT01555463|2823385|P1|Follow up|Death|0
856388|NCT01555463|2823384|P2|Follow up|Adverse Event|5
856389|NCT01555463|2823385|P1|Follow up|Adverse Event|2
856390|NCT01555463|2823384|P2|Treatment|Other reason|3
856391|NCT01555463|2823385|P1|Treatment|Other reason|2
856392|NCT01555463|2823384|P2|Treatment|Protocol Violation|5
856393|NCT01555463|2823385|P1|Treatment|Protocol Violation|4
856394|NCT01555463|2823384|P2|Treatment|Lost to Follow-up|23
856395|NCT01555463|2823385|P1|Treatment|Lost to Follow-up|28
856396|NCT01555463|2823384|P2|Treatment|Withdrawal by Subject|36
856397|NCT01555463|2823385|P1|Treatment|Withdrawal by Subject|24
856398|NCT01555463|2823384|P2|Treatment|Adverse Event|12
856399|NCT01555463|2823385|P1|Treatment|Adverse Event|6
856400|NCT01555164|2823427|P2|Overall Study|Subject Withdrew Consent|11
856401|NCT01555164|2823428|P1|Overall Study|Subject Withdrew Consent|6
856402|NCT01555164|2823427|P2|Overall Study|Subject Non-compliance|6
856403|NCT01555164|2823428|P1|Overall Study|Subject Non-compliance|14
856404|NCT01555164|2823427|P2|Overall Study|Protocol Violation|5
856405|NCT01555164|2823428|P1|Overall Study|Protocol Violation|9
856406|NCT01555164|2823427|P2|Overall Study|Lost to Follow-up|3
856407|NCT01555164|2823428|P1|Overall Study|Lost to Follow-up|4
856408|NCT01555164|2823427|P2|Overall Study|Investigator's Discretion|2
856409|NCT01555164|2823428|P1|Overall Study|Investigator's Discretion|2
856410|NCT01555164|2823427|P2|Overall Study|Hyperglycemia|1
856411|NCT01555164|2823428|P1|Overall Study|Hyperglycemia|0
856412|NCT01555164|2823427|P2|Overall Study|Adverse Event|7
856413|NCT01555164|2823428|P1|Overall Study|Adverse Event|5
856414|NCT01555151|2823442|P4|Overall Study|Lost to Follow-up|1
856415|NCT01555151|2823443|P3|Overall Study|Lost to Follow-up|0
856416|NCT01555151|2823444|P2|Overall Study|Lost to Follow-up|0
856417|NCT01555151|2823445|P1|Overall Study|Lost to Follow-up|0
856418|NCT01555151|2823442|P4|Overall Study|Adverse Event|2
856419|NCT01555151|2823443|P3|Overall Study|Adverse Event|1
856420|NCT01555151|2823444|P2|Overall Study|Adverse Event|2
856421|NCT01555151|2823445|P1|Overall Study|Adverse Event|1
856422|NCT01555151|2823442|P4|Overall Study|Protocol Violation|5
856423|NCT01555151|2823443|P3|Overall Study|Protocol Violation|3
856424|NCT01555151|2823444|P2|Overall Study|Protocol Violation|3
856425|NCT01555151|2823445|P1|Overall Study|Protocol Violation|3
856426|NCT01555151|2823442|P4|Overall Study|Administrative|0
856427|NCT01555151|2823443|P3|Overall Study|Administrative|2
856428|NCT01555151|2823444|P2|Overall Study|Administrative|1
856429|NCT01555151|2823445|P1|Overall Study|Administrative|3
856430|NCT01555151|2823442|P4|Overall Study|Withdrawal by Subject|2
856431|NCT01555151|2823443|P3|Overall Study|Withdrawal by Subject|0
856432|NCT01555151|2823444|P2|Overall Study|Withdrawal by Subject|2
856433|NCT01555151|2823445|P1|Overall Study|Withdrawal by Subject|6
856434|NCT01555138|2823498|P2|Overall Study|Adverse Event|14
856435|NCT01555138|2823499|P1|Overall Study|Adverse Event|14
856436|NCT01555138|2823498|P2|Overall Study|Withdrawal by Subject|15
856437|NCT01555138|2823499|P1|Overall Study|Withdrawal by Subject|16
856438|NCT01555138|2823498|P2|Overall Study|Administrative problems|0
856439|NCT01555138|2823499|P1|Overall Study|Administrative problems|8
856440|NCT01555138|2823498|P2|Overall Study|Protocol Violation|3
856441|NCT01555138|2823499|P1|Overall Study|Protocol Violation|5
856442|NCT01555138|2823498|P2|Overall Study|Lack of Efficacy|2
856443|NCT01555138|2823499|P1|Overall Study|Lack of Efficacy|2
856444|NCT01555138|2823498|P2|Overall Study|Abnormal Lab reults|3
856445|NCT01555138|2823499|P1|Overall Study|Abnormal Lab reults|1
856446|NCT01555138|2823498|P2|Overall Study|Lost to Follow-up|0
856447|NCT01555138|2823499|P1|Overall Study|Lost to Follow-up|1
856448|NCT01555138|2823498|P2|Overall Study|Death|1
856449|NCT01555138|2823499|P1|Overall Study|Death|0
856450|NCT01555125|2823528|P5|Follow-Up Period|Subject / guardian decision|0
856451|NCT01555125|2823529|P4|Follow-Up Period|Subject / guardian decision|1
856452|NCT01555125|2823530|P3|Follow-Up Period|Subject / guardian decision|1
856453|NCT01555125|2823531|P2|Follow-Up Period|Subject / guardian decision|1
856454|NCT01555125|2823532|P1|Follow-Up Period|Subject / guardian decision|3
856455|NCT01555125|2823528|P5|Follow-Up Period|Lost to Follow-up|0
856456|NCT01555125|2823529|P4|Follow-Up Period|Lost to Follow-up|0
856457|NCT01555125|2823530|P3|Follow-Up Period|Lost to Follow-up|0
856458|NCT01555125|2823531|P2|Follow-Up Period|Lost to Follow-up|0
856459|NCT01555125|2823532|P1|Follow-Up Period|Lost to Follow-up|1
856460|NCT01555125|2823528|P5|Extension|Technical Problems|0
856461|NCT01555125|2823529|P4|Extension|Technical Problems|1
856462|NCT01555125|2823530|P3|Extension|Technical Problems|0
856463|NCT01555125|2823531|P2|Extension|Technical Problems|0
856464|NCT01555125|2823532|P1|Extension|Technical Problems|1
856465|NCT01555125|2823528|P5|Extension|Subject/guardian decision|0
856466|NCT01555125|2823529|P4|Extension|Subject/guardian decision|0
856467|NCT01555125|2823530|P3|Extension|Subject/guardian decision|1
856468|NCT01555125|2823531|P2|Extension|Subject/guardian decision|9
856469|NCT01555125|2823532|P1|Extension|Subject/guardian decision|1
856470|NCT01555125|2823528|P5|Extension|Study terminated by sponsor|0
856471|NCT01555125|2823529|P4|Extension|Study terminated by sponsor|20
856472|NCT01555125|2823530|P3|Extension|Study terminated by sponsor|16
856473|NCT01555125|2823531|P2|Extension|Study terminated by sponsor|33
856474|NCT01555125|2823532|P1|Extension|Study terminated by sponsor|32
856475|NCT01555125|2823528|P5|Extension|Lost to Follow-up|0
856476|NCT01555125|2823529|P4|Extension|Lost to Follow-up|0
856477|NCT01555125|2823530|P3|Extension|Lost to Follow-up|2
856478|NCT01555125|2823531|P2|Extension|Lost to Follow-up|1
856479|NCT01555125|2823532|P1|Extension|Lost to Follow-up|2
856480|NCT01555125|2823528|P5|Extension|Lack of Efficacy|0
856481|NCT01555125|2823529|P4|Extension|Lack of Efficacy|0
856482|NCT01555125|2823530|P3|Extension|Lack of Efficacy|3
856483|NCT01555125|2823531|P2|Extension|Lack of Efficacy|6
856484|NCT01555125|2823532|P1|Extension|Lack of Efficacy|7
856485|NCT01555125|2823528|P5|Extension|Protocol deviation|0
856486|NCT01555125|2823529|P4|Extension|Protocol deviation|0
856487|NCT01555125|2823530|P3|Extension|Protocol deviation|0
856488|NCT01555125|2823531|P2|Extension|Protocol deviation|0
856489|NCT01555125|2823532|P1|Extension|Protocol deviation|1
856490|NCT01555125|2823528|P5|Extension|Adverse Event|0
856491|NCT01555125|2823529|P4|Extension|Adverse Event|1
856492|NCT01555125|2823530|P3|Extension|Adverse Event|1
856493|NCT01555125|2823531|P2|Extension|Adverse Event|2
856494|NCT01555125|2823532|P1|Extension|Adverse Event|1
856495|NCT01555125|2823528|P5|Maintenance Period|Death|0
856496|NCT01555125|2823529|P4|Maintenance Period|Death|1
856497|NCT01555125|2823530|P3|Maintenance Period|Death|0
856498|NCT01555125|2823531|P2|Maintenance Period|Death|0
856499|NCT01555125|2823532|P1|Maintenance Period|Death|0
856500|NCT01555125|2823528|P5|Maintenance Period|Physician Decision|0
856501|NCT01555125|2823529|P4|Maintenance Period|Physician Decision|0
856502|NCT01555125|2823530|P3|Maintenance Period|Physician Decision|1
856503|NCT01555125|2823531|P2|Maintenance Period|Physician Decision|0
856504|NCT01555125|2823532|P1|Maintenance Period|Physician Decision|0
856505|NCT01555125|2823528|P5|Maintenance Period|Lack of Efficacy|0
856506|NCT01555125|2823529|P4|Maintenance Period|Lack of Efficacy|0
856507|NCT01555125|2823530|P3|Maintenance Period|Lack of Efficacy|3
856508|NCT01555125|2823531|P2|Maintenance Period|Lack of Efficacy|1
856509|NCT01555125|2823532|P1|Maintenance Period|Lack of Efficacy|6
856510|NCT01555125|2823528|P5|Maintenance Period|Lost to Follow-up|0
856511|NCT01555125|2823529|P4|Maintenance Period|Lost to Follow-up|1
856512|NCT01555125|2823530|P3|Maintenance Period|Lost to Follow-up|0
856513|NCT01555125|2823531|P2|Maintenance Period|Lost to Follow-up|0
856514|NCT01555125|2823532|P1|Maintenance Period|Lost to Follow-up|2
856515|NCT01555125|2823528|P5|Maintenance Period|Subject / guardian decision|0
856516|NCT01555125|2823529|P4|Maintenance Period|Subject / guardian decision|0
856517|NCT01555125|2823530|P3|Maintenance Period|Subject / guardian decision|0
856518|NCT01555125|2823531|P2|Maintenance Period|Subject / guardian decision|2
856519|NCT01555125|2823532|P1|Maintenance Period|Subject / guardian decision|1
856520|NCT01555125|2823528|P5|Maintenance Period|Adverse Event|0
856521|NCT01555125|2823529|P4|Maintenance Period|Adverse Event|0
856522|NCT01555125|2823530|P3|Maintenance Period|Adverse Event|0
856523|NCT01555125|2823531|P2|Maintenance Period|Adverse Event|1
856524|NCT01555125|2823532|P1|Maintenance Period|Adverse Event|1
856525|NCT01555125|2823528|P5|Induction Period|Death|0
856526|NCT01555125|2823529|P4|Induction Period|Death|0
856527|NCT01555125|2823530|P3|Induction Period|Death|0
856528|NCT01555125|2823531|P2|Induction Period|Death|0
856529|NCT01555125|2823532|P1|Induction Period|Death|1
856530|NCT01555125|2823528|P5|Induction Period|Subject / guardian decision|2
856531|NCT01555125|2823529|P4|Induction Period|Subject / guardian decision|0
856532|NCT01555125|2823530|P3|Induction Period|Subject / guardian decision|0
856533|NCT01555125|2823531|P2|Induction Period|Subject / guardian decision|0
856534|NCT01555125|2823532|P1|Induction Period|Subject / guardian decision|0
856535|NCT01555125|2823528|P5|Induction Period|Adverse Event|1
856536|NCT01555125|2823529|P4|Induction Period|Adverse Event|0
856537|NCT01555125|2823530|P3|Induction Period|Adverse Event|0
856538|NCT01555125|2823531|P2|Induction Period|Adverse Event|1
856539|NCT01555125|2823532|P1|Induction Period|Adverse Event|0
856540|NCT01555125|2823528|P5|Induction Period|Lost to Follow-up|0
856541|NCT01555125|2823529|P4|Induction Period|Lost to Follow-up|0
856542|NCT01555125|2823530|P3|Induction Period|Lost to Follow-up|0
856543|NCT01555125|2823531|P2|Induction Period|Lost to Follow-up|2
856544|NCT01555125|2823532|P1|Induction Period|Lost to Follow-up|0
856545|NCT01555073|2823625|P4|Overall Study|Lost to Follow-up|5
856546|NCT01555073|2823626|P3|Overall Study|Lost to Follow-up|0
856547|NCT01555073|2823627|P2|Overall Study|Lost to Follow-up|2
856548|NCT01555073|2823628|P1|Overall Study|Lost to Follow-up|1
856549|NCT01555021|2823644|P2|Overall Study|Lost to Follow-up|2
856550|NCT01555021|2823645|P1|Overall Study|Lost to Follow-up|1
856551|NCT01554904|2823670|P1|Overall Study|Had sleep apnea on Home Study 1|1
856552|NCT01554904|2823670|P1|Overall Study|Withdrawal by Subject|3
856553|NCT01554579|2823690|P2|Overall Study|Withdrawal by Subject|1
856554|NCT01554579|2823691|P1|Overall Study|Withdrawal by Subject|2
856555|NCT01554579|2823690|P2|Overall Study|Lack of Efficacy|1
856556|NCT01554579|2823691|P1|Overall Study|Lack of Efficacy|2
856557|NCT01554579|2823690|P2|Overall Study|Adverse Event|25
856558|NCT01554579|2823691|P1|Overall Study|Adverse Event|6
856559|NCT01554241|2823705|P4|Overall Study|Withdrawal by Subject|0
856560|NCT01554241|2823706|P3|Overall Study|Withdrawal by Subject|2
856561|NCT01554241|2823707|P2|Overall Study|Withdrawal by Subject|0
856562|NCT01554241|2823708|P1|Overall Study|Withdrawal by Subject|0
856563|NCT01554241|2823705|P4|Overall Study|protocol specified change in eGFR|0
856564|NCT01554241|2823706|P3|Overall Study|protocol specified change in eGFR|1
856565|NCT01554241|2823707|P2|Overall Study|protocol specified change in eGFR|0
856566|NCT01554241|2823708|P1|Overall Study|protocol specified change in eGFR|0
856567|NCT01554241|2823705|P4|Overall Study|protocol specified renal stone|1
856568|NCT01554241|2823706|P3|Overall Study|protocol specified renal stone|0
856569|NCT01554241|2823707|P2|Overall Study|protocol specified renal stone|0
856570|NCT01554241|2823708|P1|Overall Study|protocol specified renal stone|0
856571|NCT01554241|2823705|P4|Overall Study|Death|0
856572|NCT01554241|2823706|P3|Overall Study|Death|1
856573|NCT01554241|2823707|P2|Overall Study|Death|1
856574|NCT01554241|2823708|P1|Overall Study|Death|3
856575|NCT01554176|2823724|P5|Run-out Phase|Protocol Violation|0
856576|NCT01554176|2823725|P4|Run-out Phase|Protocol Violation|1
856577|NCT01554176|2823726|P3|Run-out Phase|Protocol Violation|0
856578|NCT01554176|2823727|P2|Run-out Phase|Protocol Violation|0
856579|NCT01554176|2823728|P1|Run-out Phase|Protocol Violation|0
856580|NCT01554176|2823724|P5|Treatment Phase|Lost to Follow-up|0
856581|NCT01554176|2823725|P4|Treatment Phase|Lost to Follow-up|0
856582|NCT01554176|2823726|P3|Treatment Phase|Lost to Follow-up|0
856583|NCT01554176|2823727|P2|Treatment Phase|Lost to Follow-up|0
856584|NCT01554176|2823728|P1|Treatment Phase|Lost to Follow-up|3
856585|NCT01554176|2823724|P5|Treatment Phase|Withdrawal by Subject|0
856586|NCT01554176|2823725|P4|Treatment Phase|Withdrawal by Subject|0
856587|NCT01554176|2823726|P3|Treatment Phase|Withdrawal by Subject|0
856588|NCT01554176|2823727|P2|Treatment Phase|Withdrawal by Subject|0
856589|NCT01554176|2823728|P1|Treatment Phase|Withdrawal by Subject|1
856590|NCT01554176|2823724|P5|Treatment Phase|Non-compliance with study drug|0
856591|NCT01554176|2823725|P4|Treatment Phase|Non-compliance with study drug|0
856592|NCT01554176|2823726|P3|Treatment Phase|Non-compliance with study drug|0
856593|NCT01554176|2823727|P2|Treatment Phase|Non-compliance with study drug|0
856594|NCT01554176|2823728|P1|Treatment Phase|Non-compliance with study drug|1
856595|NCT01554176|2823724|P5|Treatment Phase|Adverse event, non-fatal|0
856596|NCT01554176|2823725|P4|Treatment Phase|Adverse event, non-fatal|0
856597|NCT01554176|2823726|P3|Treatment Phase|Adverse event, non-fatal|0
856598|NCT01554176|2823727|P2|Treatment Phase|Adverse event, non-fatal|1
856599|NCT01554176|2823728|P1|Treatment Phase|Adverse event, non-fatal|1
856600|NCT01554176|2823724|P5|Treatment Phase|Lack of Efficacy|0
856601|NCT01554176|2823725|P4|Treatment Phase|Lack of Efficacy|0
856602|NCT01554176|2823726|P3|Treatment Phase|Lack of Efficacy|0
856603|NCT01554176|2823727|P2|Treatment Phase|Lack of Efficacy|1
856604|NCT01554176|2823728|P1|Treatment Phase|Lack of Efficacy|0
856605|NCT01554176|2823724|P5|Treatment Phase|Physician Decision|0
856606|NCT01554176|2823725|P4|Treatment Phase|Physician Decision|0
856607|NCT01554176|2823726|P3|Treatment Phase|Physician Decision|0
856608|NCT01554176|2823727|P2|Treatment Phase|Physician Decision|1
856609|NCT01554176|2823728|P1|Treatment Phase|Physician Decision|1
856610|NCT01554176|2823724|P5|Treatment Phase|Protocol Violation|0
856611|NCT01554176|2823725|P4|Treatment Phase|Protocol Violation|0
856612|NCT01554176|2823726|P3|Treatment Phase|Protocol Violation|0
856613|NCT01554176|2823727|P2|Treatment Phase|Protocol Violation|2
856614|NCT01554176|2823728|P1|Treatment Phase|Protocol Violation|1
856615|NCT01554163|2823755|P2|Overall Study|Not Treated|0
856616|NCT01554163|2823756|P1|Overall Study|Not Treated|1
856617|NCT01554163|2823755|P2|Overall Study|Withdrawal by Subject|5
856618|NCT01554163|2823756|P1|Overall Study|Withdrawal by Subject|1
856619|NCT01554163|2823755|P2|Overall Study|Protocol Violation|4
856620|NCT01554163|2823756|P1|Overall Study|Protocol Violation|0
856621|NCT01554163|2823755|P2|Overall Study|Non-Compliance With Study Drug|1
856622|NCT01554163|2823756|P1|Overall Study|Non-Compliance With Study Drug|1
856623|NCT01554163|2823755|P2|Overall Study|Lost to Follow-up|0
856624|NCT01554163|2823756|P1|Overall Study|Lost to Follow-up|1
856625|NCT01554163|2823755|P2|Overall Study|Lack of Efficacy|0
856626|NCT01554163|2823756|P1|Overall Study|Lack of Efficacy|1
856627|NCT01554163|2823755|P2|Overall Study|Adverse Event|0
856628|NCT01554163|2823756|P1|Overall Study|Adverse Event|3
856629|NCT01553916|2823774|P1|Overall Study|Pre-treatment MRI metastatic disease|1
856630|NCT01553916|2823774|P1|Overall Study|Withdrawal by Subject|2
856631|NCT01553851|2823791|P1|Overall Study|constipation|1
856632|NCT01553851|2823791|P1|Overall Study|Adverse Event|2
856633|NCT01553747|2823806|P3|Overall Study|Physician decision: lack of efficacy|3
856634|NCT01553747|2823807|P2|Overall Study|Physician decision: lack of efficacy|5
856635|NCT01553747|2823808|P1|Overall Study|Physician decision: lack of efficacy|1
856636|NCT01553747|2823806|P3|Overall Study|Sponsor decision, specify|0
856637|NCT01553747|2823807|P2|Overall Study|Sponsor decision, specify|5
856638|NCT01553747|2823808|P1|Overall Study|Sponsor decision, specify|7
856639|NCT01553747|2823806|P3|Overall Study|Lost to Follow-up|6
856640|NCT01553747|2823807|P2|Overall Study|Lost to Follow-up|5
856641|NCT01553747|2823808|P1|Overall Study|Lost to Follow-up|11
856642|NCT01553747|2823806|P3|Overall Study|Physician decision: other|7
856643|NCT01553747|2823807|P2|Overall Study|Physician decision: other|8
856644|NCT01553747|2823808|P1|Overall Study|Physician decision: other|10
856645|NCT01553747|2823806|P3|Overall Study|Adverse event or SAE|19
856646|NCT01553747|2823807|P2|Overall Study|Adverse event or SAE|28
856647|NCT01553747|2823808|P1|Overall Study|Adverse event or SAE|32
856648|NCT01553747|2823806|P3|Overall Study|Voluntarily withdrew|74
856649|NCT01553747|2823807|P2|Overall Study|Voluntarily withdrew|66
856650|NCT01553747|2823808|P1|Overall Study|Voluntarily withdrew|70
856651|NCT01553747|2823806|P3|Overall Study|Protocol Violation|0
856652|NCT01553747|2823807|P2|Overall Study|Protocol Violation|2
856653|NCT01553747|2823808|P1|Overall Study|Protocol Violation|0
856654|NCT01553591|2823870|P3|Overall Study|Randomized and never dispensed drug|0
856655|NCT01553591|2823871|P2|Overall Study|Randomized and never dispensed drug|1
856656|NCT01553591|2823872|P1|Overall Study|Randomized and never dispensed drug|0
856657|NCT01553591|2823870|P3|Overall Study|Sponsor decision|3
856658|NCT01553591|2823871|P2|Overall Study|Sponsor decision|0
856659|NCT01553591|2823872|P1|Overall Study|Sponsor decision|1
856660|NCT01553591|2823870|P3|Overall Study|Protocol Violation|4
856661|NCT01553591|2823871|P2|Overall Study|Protocol Violation|4
856662|NCT01553591|2823872|P1|Overall Study|Protocol Violation|3
856663|NCT01553591|2823870|P3|Overall Study|Physician decision: lack of efficacy|7
856664|NCT01553591|2823871|P2|Overall Study|Physician decision: lack of efficacy|3
856665|NCT01553591|2823872|P1|Overall Study|Physician decision: lack of efficacy|2
856666|NCT01553591|2823870|P3|Overall Study|Physician decision: other|16
856667|NCT01553591|2823871|P2|Overall Study|Physician decision: other|14
856668|NCT01553591|2823872|P1|Overall Study|Physician decision: other|11
856669|NCT01553591|2823870|P3|Overall Study|Lost to Follow-up|16
856670|NCT01553591|2823871|P2|Overall Study|Lost to Follow-up|23
856671|NCT01553591|2823872|P1|Overall Study|Lost to Follow-up|25
856672|NCT01553591|2823870|P3|Overall Study|Adverse Event|16
856673|NCT01553591|2823871|P2|Overall Study|Adverse Event|45
856674|NCT01553591|2823872|P1|Overall Study|Adverse Event|36
856675|NCT01553591|2823870|P3|Overall Study|Voluntarily withdrew|96
856676|NCT01553591|2823871|P2|Overall Study|Voluntarily withdrew|79
856677|NCT01553591|2823872|P1|Overall Study|Voluntarily withdrew|94
856678|NCT01553318|2823932|P2|Overall Study|Protocol Violation|2
856679|NCT01553318|2823933|P1|Overall Study|Protocol Violation|3
856680|NCT01553188|2823970|P4|Overall Study|Intercurrent illness and adverse event|0
856681|NCT01553188|2823971|P3|Overall Study|Intercurrent illness and adverse event|2
856682|NCT01553188|2823972|P2|Overall Study|Intercurrent illness and adverse event|1
856683|NCT01553188|2823973|P1|Overall Study|Intercurrent illness and adverse event|0
856684|NCT01553188|2823970|P4|Overall Study|Patient choice|0
856685|NCT01553188|2823971|P3|Overall Study|Patient choice|0
856686|NCT01553188|2823972|P2|Overall Study|Patient choice|0
856687|NCT01553188|2823973|P1|Overall Study|Patient choice|1
856688|NCT01553136|2823997|P2|Overall Study|Scheduling Difficulties|4
856689|NCT01553136|2823998|P1|Overall Study|Scheduling Difficulties|5
856690|NCT01553136|2823997|P2|Overall Study|Physician Decision|3
856691|NCT01553136|2823998|P1|Overall Study|Physician Decision|2
856692|NCT01553136|2823997|P2|Overall Study|Lost to Follow-up|10
856693|NCT01553136|2823998|P1|Overall Study|Lost to Follow-up|4
856694|NCT01553136|2823997|P2|Overall Study|Withdrawal by Subject|3
856695|NCT01553136|2823998|P1|Overall Study|Withdrawal by Subject|2
856696|NCT01553136|2823997|P2|Overall Study|Adverse Event|2
856697|NCT01553136|2823998|P1|Overall Study|Adverse Event|3
856698|NCT01552954|2824078|P2|Overall Study|diagnosed DM|0
856699|NCT01552954|2824079|P1|Overall Study|diagnosed DM|1
856700|NCT01552954|2824078|P2|Overall Study|Protocol Violation|2
856701|NCT01552954|2824079|P1|Overall Study|Protocol Violation|1
856702|NCT01552954|2824078|P2|Overall Study|Withdrawal by Subject|1
856703|NCT01552954|2824079|P1|Overall Study|Withdrawal by Subject|1
856704|NCT01552954|2824078|P2|Overall Study|Lost to Follow-up|1
856705|NCT01552954|2824079|P1|Overall Study|Lost to Follow-up|1
856706|NCT01552954|2824078|P2|Overall Study|Adverse Event|2
856707|NCT01552954|2824079|P1|Overall Study|Adverse Event|1
856708|NCT01552928|2824095|P4|Period 3|Adverse Event|0
856709|NCT01552928|2824096|P3|Period 3|Adverse Event|1
856710|NCT01552928|2824097|P2|Period 3|Adverse Event|0
856711|NCT01552928|2824098|P1|Period 3|Adverse Event|0
856712|NCT01552915|2824145|P3|Overall Study|Not specified|6
856713|NCT01552915|2824146|P2|Overall Study|Not specified|0
856714|NCT01552915|2824147|P1|Overall Study|Not specified|2
856715|NCT01552915|2824145|P3|Overall Study|Lack of Efficacy|4
856716|NCT01552915|2824146|P2|Overall Study|Lack of Efficacy|1
856717|NCT01552915|2824147|P1|Overall Study|Lack of Efficacy|8
856718|NCT01552915|2824145|P3|Overall Study|Protocol Violation|4
856719|NCT01552915|2824146|P2|Overall Study|Protocol Violation|4
856720|NCT01552915|2824147|P1|Overall Study|Protocol Violation|0
856721|NCT01552915|2824145|P3|Overall Study|Withdrawal by Subject|5
856722|NCT01552915|2824146|P2|Overall Study|Withdrawal by Subject|4
856723|NCT01552915|2824147|P1|Overall Study|Withdrawal by Subject|6
856724|NCT01552915|2824145|P3|Overall Study|Lost to Follow-up|5
856725|NCT01552915|2824146|P2|Overall Study|Lost to Follow-up|6
856726|NCT01552915|2824147|P1|Overall Study|Lost to Follow-up|4
856727|NCT01552915|2824145|P3|Overall Study|Adverse Event|3
856728|NCT01552915|2824146|P2|Overall Study|Adverse Event|14
856729|NCT01552915|2824147|P1|Overall Study|Adverse Event|3
856730|NCT01552902|2824170|P3|Overall Study|Other|3
856731|NCT01552902|2824171|P2|Overall Study|Other|4
856732|NCT01552902|2824172|P1|Overall Study|Other|3
856733|NCT01552902|2824170|P3|Overall Study|Lost to Follow-up|6
856734|NCT01552902|2824171|P2|Overall Study|Lost to Follow-up|3
856735|NCT01552902|2824172|P1|Overall Study|Lost to Follow-up|1
856736|NCT01552902|2824170|P3|Overall Study|Withdrawal by Subject|6
856737|NCT01552902|2824171|P2|Overall Study|Withdrawal by Subject|9
856738|NCT01552902|2824172|P1|Overall Study|Withdrawal by Subject|1
856739|NCT01552902|2824170|P3|Overall Study|Lack of Efficacy|1
856740|NCT01552902|2824171|P2|Overall Study|Lack of Efficacy|3
856741|NCT01552902|2824172|P1|Overall Study|Lack of Efficacy|4
856742|NCT01552902|2824170|P3|Overall Study|Protocol Violation|3
856743|NCT01552902|2824171|P2|Overall Study|Protocol Violation|3
856744|NCT01552902|2824172|P1|Overall Study|Protocol Violation|3
856745|NCT01552902|2824170|P3|Overall Study|Adverse Event|14
856746|NCT01552902|2824171|P2|Overall Study|Adverse Event|15
856747|NCT01552902|2824172|P1|Overall Study|Adverse Event|1
856748|NCT01552772|2824222|P1|Overall Study|Protocol Deviation|1
856749|NCT01552772|2824222|P1|Overall Study|Adverse Event|1
856750|NCT01552772|2824222|P1|Overall Study|Lost to Follow-up|2
856751|NCT01552694|2824238|P2|Overall Study|Protocol Violation|1
856752|NCT01552694|2824239|P1|Overall Study|Protocol Violation|0
856753|NCT01552694|2824238|P2|Overall Study|Lost to Follow-up|1
856754|NCT01552694|2824239|P1|Overall Study|Lost to Follow-up|0
856755|NCT01552681|2824255|P2|Overall Study|Subject moved away|1
856756|NCT01552681|2824256|P1|Overall Study|Subject moved away|0
856757|NCT01552681|2824255|P2|Overall Study|Physician Decision|0
856758|NCT01552681|2824256|P1|Overall Study|Physician Decision|1
856759|NCT01552681|2824255|P2|Overall Study|Withdrawal by Subject|0
856760|NCT01552681|2824256|P1|Overall Study|Withdrawal by Subject|4
856761|NCT01552603|2824304|P1|Overall Study|Physician Decision|1
856762|NCT01552408|2824311|P2|Overall Study|Withdrawal by Subject|1
856763|NCT01552408|2824312|P1|Overall Study|Withdrawal by Subject|2
856764|NCT01552408|2824311|P2|Overall Study|Relocation|1
856765|NCT01552408|2824312|P1|Overall Study|Relocation|0
856766|NCT01552408|2824311|P2|Overall Study|Lost to Follow-up|0
856767|NCT01552408|2824312|P1|Overall Study|Lost to Follow-up|2
856768|NCT01552057|2824358|P2|Overall Study|Physician Decision|0
856769|NCT01552057|2824359|P1|Overall Study|Physician Decision|1
856770|NCT01552057|2824358|P2|Overall Study|Entry Criteria Not Met|2
856771|NCT01552057|2824359|P1|Overall Study|Entry Criteria Not Met|2
856772|NCT01552057|2824358|P2|Overall Study|Withdrawal by Subject|8
856773|NCT01552057|2824359|P1|Overall Study|Withdrawal by Subject|5
856774|NCT01552057|2824358|P2|Overall Study|Lack of Efficacy|23
856775|NCT01552057|2824359|P1|Overall Study|Lack of Efficacy|8
856776|NCT01552057|2824358|P2|Overall Study|Adverse Event|15
856777|NCT01552057|2824359|P1|Overall Study|Adverse Event|14
856778|NCT01551758|2824425|P2|Overall Study|Withdrawal by Subject|17
856779|NCT01551758|2824426|P1|Overall Study|Withdrawal by Subject|14
856780|NCT01551758|2824425|P2|Overall Study|Physician Decision|3
856781|NCT01551758|2824426|P1|Overall Study|Physician Decision|9
856782|NCT01551758|2824425|P2|Overall Study|Lost to Follow-up|25
856783|NCT01551758|2824426|P1|Overall Study|Lost to Follow-up|29
856784|NCT01551758|2824425|P2|Overall Study|Met Protocol-defined stopping criteria|10
856785|NCT01551758|2824426|P1|Overall Study|Met Protocol-defined stopping criteria|8
856786|NCT01551758|2824425|P2|Overall Study|Protocol Violation|6
856787|NCT01551758|2824426|P1|Overall Study|Protocol Violation|5
856788|NCT01551758|2824425|P2|Overall Study|Lack of Efficacy|1
856789|NCT01551758|2824426|P1|Overall Study|Lack of Efficacy|0
856790|NCT01551758|2824425|P2|Overall Study|Adverse Event|43
856791|NCT01551758|2824426|P1|Overall Study|Adverse Event|29
856792|NCT01551745|2824464|P1|Overall Study|Disease Progression|2
856793|NCT01551745|2824464|P1|Overall Study|Withdrawal by Subject|1
856794|NCT01551693|2824473|P2|Overall Study|Withdrawal by Subject|1
856795|NCT01551693|2824474|P1|Overall Study|Withdrawal by Subject|0
856796|NCT01551693|2824473|P2|Overall Study|Adverse Event|1
856797|NCT01551693|2824474|P1|Overall Study|Adverse Event|0
856798|NCT01551693|2824473|P2|Overall Study|Disease Progression|0
856799|NCT01551693|2824474|P1|Overall Study|Disease Progression|1
856800|NCT01551355|2824490|P6|Overall Study|Lost to Follow-up|6
856801|NCT01551355|2824491|P5|Overall Study|Lost to Follow-up|9
856802|NCT01551355|2824492|P4|Overall Study|Lost to Follow-up|24
856803|NCT01551355|2824493|P3|Overall Study|Lost to Follow-up|34
856804|NCT01551355|2824494|P2|Overall Study|Lost to Follow-up|49
856805|NCT01551355|2824495|P1|Overall Study|Lost to Follow-up|51
856806|NCT01551303|2824509|P2|Overall Study|failed awareness check on vision test|7
856807|NCT01551303|2824510|P1|Overall Study|failed awareness check on vision test|4
856808|NCT01551173|2824524|P2|Overall Study|Not specified|3
856809|NCT01551173|2824525|P1|Overall Study|Not specified|5
856810|NCT01551173|2824524|P2|Overall Study|Lost to Follow-up|7
856811|NCT01551173|2824525|P1|Overall Study|Lost to Follow-up|5
856812|NCT01551173|2824524|P2|Overall Study|Adverse Event|6
856813|NCT01551173|2824525|P1|Overall Study|Adverse Event|7
856814|NCT01551173|2824524|P2|Overall Study|Withdrawal by Subject|16
856815|NCT01551173|2824525|P1|Overall Study|Withdrawal by Subject|11
856816|NCT01550965|2824602|P1|Overall Study|Not Specified|13
856817|NCT01550965|2824602|P1|Overall Study|Lack of Efficacy|59
856818|NCT01550965|2824602|P1|Overall Study|Lost to Follow-up|2
856819|NCT01550965|2824602|P1|Overall Study|Withdrawal by Subject|10
856820|NCT01550965|2824602|P1|Overall Study|Adverse Event|26
856821|NCT01550757|2824646|P4|Overall Study|Withdrawal by Subject|1
856822|NCT01550757|2824647|P3|Overall Study|Withdrawal by Subject|3
856823|NCT01550757|2824648|P2|Overall Study|Withdrawal by Subject|0
856824|NCT01550757|2824649|P1|Overall Study|Withdrawal by Subject|2
856825|NCT01550757|2824646|P4|Overall Study|Lost to Follow-up|53
856826|NCT01550757|2824647|P3|Overall Study|Lost to Follow-up|42
856827|NCT01550757|2824648|P2|Overall Study|Lost to Follow-up|14
856828|NCT01550757|2824649|P1|Overall Study|Lost to Follow-up|21
856829|NCT01550744|2824659|P3|Double-Blind|Other|10
856830|NCT01550744|2824660|P2|Double-Blind|Other|2
856831|NCT01550744|2824661|P1|Double-Blind|Other|0
856832|NCT01550744|2824659|P3|Double-Blind|Pregnancy|3
856833|NCT01550744|2824660|P2|Double-Blind|Pregnancy|0
856834|NCT01550744|2824661|P1|Double-Blind|Pregnancy|0
856835|NCT01550744|2824659|P3|Double-Blind|Protocol Violation|4
856836|NCT01550744|2824660|P2|Double-Blind|Protocol Violation|0
856837|NCT01550744|2824661|P1|Double-Blind|Protocol Violation|0
856838|NCT01550744|2824659|P3|Double-Blind|Lack of Efficacy|8
856839|NCT01550744|2824660|P2|Double-Blind|Lack of Efficacy|2
856840|NCT01550744|2824661|P1|Double-Blind|Lack of Efficacy|0
856841|NCT01550744|2824659|P3|Double-Blind|Death|0
856842|NCT01550744|2824660|P2|Double-Blind|Death|1
856843|NCT01550744|2824661|P1|Double-Blind|Death|0
856844|NCT01550744|2824659|P3|Double-Blind|Adverse Event|15
856845|NCT01550744|2824660|P2|Double-Blind|Adverse Event|4
856846|NCT01550744|2824661|P1|Double-Blind|Adverse Event|0
856847|NCT01550744|2824659|P3|Double-Blind|Withdrawal by Subject|15
856848|NCT01550744|2824660|P2|Double-Blind|Withdrawal by Subject|2
856849|NCT01550744|2824661|P1|Double-Blind|Withdrawal by Subject|0
856850|NCT01550744|2824659|P3|Double-Blind|Lost to Follow-up|12
856851|NCT01550744|2824660|P2|Double-Blind|Lost to Follow-up|6
856852|NCT01550744|2824661|P1|Double-Blind|Lost to Follow-up|0
856853|NCT01550744|2824659|P3|Open-Label|Other|0
856854|NCT01550744|2824660|P2|Open-Label|Other|0
856855|NCT01550744|2824661|P1|Open-Label|Other|1
856856|NCT01550744|2824659|P3|Open-Label|Static PGA-cleared/minimal not achieved|0
856857|NCT01550744|2824660|P2|Open-Label|Static PGA-cleared/minimal not achieved|0
856858|NCT01550744|2824661|P1|Open-Label|Static PGA-cleared/minimal not achieved|58
856859|NCT01550744|2824659|P3|Open-Label|Not all 3 study drug injections received|0
856860|NCT01550744|2824660|P2|Open-Label|Not all 3 study drug injections received|0
856861|NCT01550744|2824661|P1|Open-Label|Not all 3 study drug injections received|2
856862|NCT01550744|2824659|P3|Open-Label|Protocol Violation|0
856863|NCT01550744|2824660|P2|Open-Label|Protocol Violation|0
856864|NCT01550744|2824661|P1|Open-Label|Protocol Violation|4
856865|NCT01550744|2824659|P3|Open-Label|Lack of Efficacy|0
856866|NCT01550744|2824660|P2|Open-Label|Lack of Efficacy|0
856867|NCT01550744|2824661|P1|Open-Label|Lack of Efficacy|4
856868|NCT01550744|2824659|P3|Open-Label|Adverse Event|0
856869|NCT01550744|2824660|P2|Open-Label|Adverse Event|0
856870|NCT01550744|2824661|P1|Open-Label|Adverse Event|11
856871|NCT01550744|2824659|P3|Open-Label|Withdrawal by Subject|0
856872|NCT01550744|2824660|P2|Open-Label|Withdrawal by Subject|0
856873|NCT01550744|2824661|P1|Open-Label|Withdrawal by Subject|13
856874|NCT01550744|2824659|P3|Open-Label|Lost to Follow-up|0
856875|NCT01550744|2824660|P2|Open-Label|Lost to Follow-up|0
856876|NCT01550744|2824661|P1|Open-Label|Lost to Follow-up|7
856877|NCT01550289|2824719|P2|Overall Study|Withdrawal by Subject|3
856878|NCT01550289|2824720|P1|Overall Study|Withdrawal by Subject|11
856879|NCT01550289|2824719|P2|Overall Study|Lost to Follow-up|1
856880|NCT01550289|2824720|P1|Overall Study|Lost to Follow-up|1
856881|NCT01550289|2824719|P2|Overall Study|Protocol Violation|0
856882|NCT01550289|2824720|P1|Overall Study|Protocol Violation|1
856883|NCT01549964|2824796|P4|80-Week Extension Period|Pretreatment Event/Adverse Event|2
856884|NCT01549964|2824797|P3|80-Week Extension Period|Pretreatment Event/Adverse Event|1
856885|NCT01549964|2824798|P2|80-Week Extension Period|Pretreatment Event/Adverse Event|0
856886|NCT01549964|2824799|P1|80-Week Extension Period|Pretreatment Event/Adverse Event|0
856887|NCT01549964|2824796|P4|80-Week Extension Period|Lost to Follow-up|1
856888|NCT01549964|2824797|P3|80-Week Extension Period|Lost to Follow-up|2
856889|NCT01549964|2824798|P2|80-Week Extension Period|Lost to Follow-up|0
856890|NCT01549964|2824799|P1|80-Week Extension Period|Lost to Follow-up|1
856891|NCT01549964|2824796|P4|80-Week Extension Period|Voluntary Withdrawal|2
856892|NCT01549964|2824797|P3|80-Week Extension Period|Voluntary Withdrawal|4
856893|NCT01549964|2824798|P2|80-Week Extension Period|Voluntary Withdrawal|1
856894|NCT01549964|2824799|P1|80-Week Extension Period|Voluntary Withdrawal|0
856895|NCT01549964|2824796|P4|80-Week Extension Period|Study Terminated by Sponsor|132
856896|NCT01549964|2824797|P3|80-Week Extension Period|Study Terminated by Sponsor|132
856897|NCT01549964|2824798|P2|80-Week Extension Period|Study Terminated by Sponsor|137
856898|NCT01549964|2824799|P1|80-Week Extension Period|Study Terminated by Sponsor|65
856899|NCT01549964|2824796|P4|80-Week Extension Period|Pregnancy|0
856900|NCT01549964|2824797|P3|80-Week Extension Period|Pregnancy|1
856901|NCT01549964|2824798|P2|80-Week Extension Period|Pregnancy|0
856902|NCT01549964|2824799|P1|80-Week Extension Period|Pregnancy|0
856903|NCT01549964|2824796|P4|24-Week Treatment Period|Completion Status Unknown|0
856904|NCT01549964|2824797|P3|24-Week Treatment Period|Completion Status Unknown|1
856905|NCT01549964|2824798|P2|24-Week Treatment Period|Completion Status Unknown|0
856906|NCT01549964|2824799|P1|24-Week Treatment Period|Completion Status Unknown|1
856907|NCT01549964|2824796|P4|24-Week Treatment Period|Randomized but Not Treated|1
856908|NCT01549964|2824797|P3|24-Week Treatment Period|Randomized but Not Treated|0
856909|NCT01549964|2824798|P2|24-Week Treatment Period|Randomized but Not Treated|0
856910|NCT01549964|2824799|P1|24-Week Treatment Period|Randomized but Not Treated|0
856911|NCT01549964|2824796|P4|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
856912|NCT01549964|2824797|P3|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1
856913|NCT01549964|2824798|P2|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
856914|NCT01549964|2824799|P1|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
856915|NCT01549964|2824796|P4|24-Week Treatment Period|Other|0
856916|NCT01549964|2824797|P3|24-Week Treatment Period|Other|1
856917|NCT01549964|2824798|P2|24-Week Treatment Period|Other|0
856918|NCT01549964|2824799|P1|24-Week Treatment Period|Other|1
856919|NCT01549964|2824796|P4|24-Week Treatment Period|Lack of Efficacy|1
856920|NCT01549964|2824797|P3|24-Week Treatment Period|Lack of Efficacy|1
856921|NCT01549964|2824798|P2|24-Week Treatment Period|Lack of Efficacy|0
856922|NCT01549964|2824799|P1|24-Week Treatment Period|Lack of Efficacy|1
856923|NCT01549964|2824796|P4|24-Week Treatment Period|Lost to Follow-up|2
856924|NCT01549964|2824797|P3|24-Week Treatment Period|Lost to Follow-up|1
856925|NCT01549964|2824798|P2|24-Week Treatment Period|Lost to Follow-up|0
856926|NCT01549964|2824799|P1|24-Week Treatment Period|Lost to Follow-up|1
856927|NCT01549964|2824796|P4|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
856928|NCT01549964|2824797|P3|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
856929|NCT01549964|2824798|P2|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
856930|NCT01549964|2824799|P1|24-Week Treatment Period|Pretreatment Event/Adverse Event|1
856931|NCT01549964|2824796|P4|24-Week Treatment Period|Voluntary Withdrawal|8
856932|NCT01549964|2824797|P3|24-Week Treatment Period|Voluntary Withdrawal|3
856933|NCT01549964|2824798|P2|24-Week Treatment Period|Voluntary Withdrawal|3
856934|NCT01549964|2824799|P1|24-Week Treatment Period|Voluntary Withdrawal|6
856935|NCT01549964|2824796|P4|24-Week Treatment Period|Study Terminated by Sponsor|105
856936|NCT01549964|2824797|P3|24-Week Treatment Period|Study Terminated by Sponsor|104
856937|NCT01549964|2824798|P2|24-Week Treatment Period|Study Terminated by Sponsor|104
856938|NCT01549964|2824799|P1|24-Week Treatment Period|Study Terminated by Sponsor|50
856939|NCT01549951|2824817|P1|Overall Study|Other|2
856940|NCT01549951|2824817|P1|Overall Study|Symptomatic deterioration|1
856941|NCT01549951|2824817|P1|Overall Study|Progressive disease|29
856942|NCT01549951|2824817|P1|Overall Study|Unsatisfactory therapeutic response|1
856943|NCT01549951|2824817|P1|Overall Study|Withdrawal by Subject|2
856944|NCT01549951|2824817|P1|Overall Study|Adverse Event|15
856945|NCT01549873|2824844|P2|Overall Study|Physician Decision|1
856946|NCT01549873|2824845|P1|Overall Study|Physician Decision|0
856947|NCT01549860|2824857|P2|Overall Study|Physician Decision|1
856948|NCT01549860|2824858|P1|Overall Study|Physician Decision|1
856949|NCT01549860|2824857|P2|Overall Study|Withdrawal by Subject|0
856950|NCT01549860|2824858|P1|Overall Study|Withdrawal by Subject|1
856951|NCT01549613|2824870|P2|Overall Study|Lost to Follow-up|11
856952|NCT01549613|2824871|P1|Overall Study|Lost to Follow-up|11
856953|NCT01549392|2824890|P2|Overall Study|Withdrawal by Subject|0
856954|NCT01549392|2824891|P1|Overall Study|Withdrawal by Subject|1
856955|NCT01549275|2824910|P2|Overall Study|Lost to Follow-up|0
856956|NCT01549275|2824911|P1|Overall Study|Lost to Follow-up|1
856957|NCT01549041|2824934|P2|Overall Study|Adverse Event|4
856958|NCT01549041|2824935|P1|Overall Study|Adverse Event|0
856959|NCT01549041|2824934|P2|Overall Study|Lack of Efficacy|4
856960|NCT01549041|2824935|P1|Overall Study|Lack of Efficacy|2
856961|NCT01549002|2824945|P2|Overall Study|Moderate sedation required|2
856962|NCT01549002|2824946|P1|Overall Study|Moderate sedation required|0
856963|NCT01549002|2824945|P2|Overall Study|Excessive pain|2
856964|NCT01549002|2824946|P1|Overall Study|Excessive pain|0
856965|NCT01548638|2825019|P1|Overall Study|Withdrawal by Subject|1
856966|NCT01548638|2825019|P1|Overall Study|Protocol Violation|3
856967|NCT01548573|2825029|P1|Overall Study|Withdrawal by Subject|2
856968|NCT01548573|2825029|P1|Overall Study|Death|3
856969|NCT01548417|2825038|P2|Overall Study|Withdrawal by Subject|2
856970|NCT01548417|2825039|P1|Overall Study|Withdrawal by Subject|0
856971|NCT01548404|2825049|P2|Overall Study|Other than specified above|2
856972|NCT01548404|2825050|P1|Overall Study|Other than specified above|0
856973|NCT01548404|2825049|P2|Overall Study|Withdrawal by Subject|3
856974|NCT01548404|2825050|P1|Overall Study|Withdrawal by Subject|0
856975|NCT01548404|2825049|P2|Overall Study|Lost to Follow-up|0
856976|NCT01548404|2825050|P1|Overall Study|Lost to Follow-up|2
856977|NCT01548404|2825049|P2|Overall Study|Inadequate response to study treatment|7
856978|NCT01548404|2825050|P1|Overall Study|Inadequate response to study treatment|23
856979|NCT01548404|2825049|P2|Overall Study|Physician Decision|1
856980|NCT01548404|2825050|P1|Overall Study|Physician Decision|2
856981|NCT01548404|2825049|P2|Overall Study|Adverse Event|1
856982|NCT01548404|2825050|P1|Overall Study|Adverse Event|3
856983|NCT01548287|2825076|P5|Randomized Period|Adverse Event|0
856984|NCT01548287|2825077|P4|Randomized Period|Adverse Event|0
856985|NCT01548287|2825078|P3|Randomized Period|Adverse Event|5
856986|NCT01548287|2825079|P2|Randomized Period|Adverse Event|2
856987|NCT01548287|2825080|P1|Randomized Period|Adverse Event|0
856988|NCT01548287|2825076|P5|Randomized Period|Did not meet inclusion criteria|0
856989|NCT01548287|2825077|P4|Randomized Period|Did not meet inclusion criteria|0
856990|NCT01548287|2825078|P3|Randomized Period|Did not meet inclusion criteria|2
856991|NCT01548287|2825079|P2|Randomized Period|Did not meet inclusion criteria|0
856992|NCT01548287|2825080|P1|Randomized Period|Did not meet inclusion criteria|0
856993|NCT01548287|2825076|P5|Screening|Did not meet eligibility criteria|74
856994|NCT01548287|2825077|P4|Screening|Did not meet eligibility criteria|0
856995|NCT01548287|2825078|P3|Screening|Did not meet eligibility criteria|0
856996|NCT01548287|2825079|P2|Screening|Did not meet eligibility criteria|0
856997|NCT01548287|2825080|P1|Screening|Did not meet eligibility criteria|0
856998|NCT01548287|2825076|P5|Screening|No reason provided|9
856999|NCT01548287|2825077|P4|Screening|No reason provided|0
857000|NCT01548287|2825078|P3|Screening|No reason provided|0
857001|NCT01548287|2825079|P2|Screening|No reason provided|0
857002|NCT01548287|2825080|P1|Screening|No reason provided|0
857003|NCT01547728|2825137|P1|Overall Study|Screen failure|39
857004|NCT01547728|2825137|P1|Overall Study|Drug not ready for subject|1
857005|NCT01547728|2825137|P1|Overall Study|Change in procedure and equipment|1
857006|NCT01547598|2825246|P2|Overall Study|Other Miscellaneous Reasons|1
857007|NCT01547598|2825247|P1|Overall Study|Other Miscellaneous Reasons|2
857008|NCT01547598|2825246|P2|Overall Study|Protocol Violation|1
857009|NCT01547598|2825247|P1|Overall Study|Protocol Violation|1
857010|NCT01547598|2825246|P2|Overall Study|Adverse Event|1
857011|NCT01547598|2825247|P1|Overall Study|Adverse Event|1
857012|NCT01547598|2825246|P2|Overall Study|Lost to Follow-up|1
857013|NCT01547598|2825247|P1|Overall Study|Lost to Follow-up|1
857014|NCT01547598|2825246|P2|Overall Study|Withdrew consent|1
857015|NCT01547598|2825247|P1|Overall Study|Withdrew consent|1
857016|NCT01547390|2825264|P2|Overall Study|Adverse Event|0
857017|NCT01547390|2825265|P1|Overall Study|Adverse Event|3
857018|NCT01547390|2825264|P2|Overall Study|Lost to Follow-up|2
857019|NCT01547390|2825265|P1|Overall Study|Lost to Follow-up|0
857020|NCT01547390|2825264|P2|Overall Study|termination of pregnancy|1
857021|NCT01547390|2825265|P1|Overall Study|termination of pregnancy|0
857022|NCT01547390|2825264|P2|Overall Study|Withdrawal by Subject|7
857023|NCT01547390|2825265|P1|Overall Study|Withdrawal by Subject|10
857024|NCT01547299|2825275|P2|Overall Study|Withdrawal by Subject|2
857025|NCT01547299|2825276|P1|Overall Study|Withdrawal by Subject|2
857026|NCT01547286|2825342|P1|Overall Study|Physician Decision|1
857027|NCT01547286|2825342|P1|Overall Study|Did not meet all eligibility criteria|1
857028|NCT01547130|2825362|P2|Overall Study|Lost to Follow-up|5
857029|NCT01547130|2825363|P1|Overall Study|Lost to Follow-up|9
857030|NCT01546922|2825386|P2|Second Period of 10 Weeks|Withdrawal by Subject|2
857031|NCT01546922|2825387|P1|Second Period of 10 Weeks|Withdrawal by Subject|0
857032|NCT01546922|2825386|P2|Second Period of 10 Weeks|Protocol Violation|1
857033|NCT01546922|2825387|P1|Second Period of 10 Weeks|Protocol Violation|3
857034|NCT01546922|2825386|P2|First Period of 10 Weeks|Investigator's judgment|0
857035|NCT01546922|2825387|P1|First Period of 10 Weeks|Investigator's judgment|1
857036|NCT01546922|2825386|P2|First Period of 10 Weeks|Withdrawal by Subject|1
857037|NCT01546922|2825387|P1|First Period of 10 Weeks|Withdrawal by Subject|1
857038|NCT01546922|2825386|P2|First Period of 10 Weeks|Protocol Violation|1
857039|NCT01546922|2825387|P1|First Period of 10 Weeks|Protocol Violation|3
857040|NCT01546883|2825393|P1|Overall Study|other unrelated illness|1
857041|NCT01546883|2825393|P1|Overall Study|early closure of study|2
857042|NCT01546883|2825393|P1|Overall Study|Lost to Follow-up|2
857043|NCT01546883|2825393|P1|Overall Study|Adverse Event|4
857044|NCT01546883|2825393|P1|Overall Study|Withdrawal by Subject|3
857045|NCT01546688|2825399|P2|Overall Study|Lack of Efficacy|0
857046|NCT01546688|2825400|P1|Overall Study|Lack of Efficacy|1
857047|NCT01546688|2825399|P2|Overall Study|Withdrawal by Subject|1
857048|NCT01546688|2825400|P1|Overall Study|Withdrawal by Subject|2
857049|NCT01546688|2825399|P2|Overall Study|Adverse Event|4
857050|NCT01546688|2825400|P1|Overall Study|Adverse Event|0
857051|NCT01546649|2825432|P2|Overall Study|Withdrawal by Subject|2
857052|NCT01546649|2825433|P1|Overall Study|Withdrawal by Subject|1
857053|NCT01546649|2825432|P2|Overall Study|Discovery of secondary cancer|1
857054|NCT01546649|2825433|P1|Overall Study|Discovery of secondary cancer|0
857055|NCT01546649|2825432|P2|Overall Study|Recurrence|1
857056|NCT01546649|2825433|P1|Overall Study|Recurrence|1
857057|NCT01546649|2825432|P2|Overall Study|Lack of Efficacy|0
857058|NCT01546649|2825433|P1|Overall Study|Lack of Efficacy|1
857059|NCT01546649|2825432|P2|Overall Study|Protocol Violation|0
857060|NCT01546649|2825433|P1|Overall Study|Protocol Violation|1
857061|NCT01546649|2825432|P2|Overall Study|Adverse Event|5
857062|NCT01546649|2825433|P1|Overall Study|Adverse Event|4
857063|NCT01546623|2825468|P2|Overall Study|Did Not Receive Study Drug|1
857064|NCT01546623|2825469|P1|Overall Study|Did Not Receive Study Drug|1
857065|NCT01546623|2825468|P2|Overall Study|High Prostate specific antigen|1
857066|NCT01546623|2825469|P1|Overall Study|High Prostate specific antigen|2
857067|NCT01546623|2825468|P2|Overall Study|Major Protocol Deviation|1
857068|NCT01546623|2825469|P1|Overall Study|Major Protocol Deviation|1
857069|NCT01546623|2825468|P2|Overall Study|Adverse Event|3
857070|NCT01546623|2825469|P1|Overall Study|Adverse Event|2
857071|NCT01546519|2825499|P4|Overall Study|Withdrawal by Subject|0
857072|NCT01546519|2825500|P3|Overall Study|Withdrawal by Subject|0
857073|NCT01546519|2825501|P2|Overall Study|Withdrawal by Subject|0
857074|NCT01546519|2825502|P1|Overall Study|Withdrawal by Subject|1
857075|NCT01546519|2825499|P4|Overall Study|Physician Decision|3
857076|NCT01546519|2825500|P3|Overall Study|Physician Decision|2
857077|NCT01546519|2825501|P2|Overall Study|Physician Decision|5
857078|NCT01546519|2825502|P1|Overall Study|Physician Decision|6
857079|NCT01546519|2825499|P4|Overall Study|related to disease progression|1
857080|NCT01546519|2825500|P3|Overall Study|related to disease progression|2
857081|NCT01546519|2825501|P2|Overall Study|related to disease progression|2
857082|NCT01546519|2825502|P1|Overall Study|related to disease progression|2
857083|NCT01546519|2825499|P4|Overall Study|Death|1
857084|NCT01546519|2825500|P3|Overall Study|Death|3
857085|NCT01546519|2825501|P2|Overall Study|Death|1
857086|NCT01546519|2825502|P1|Overall Study|Death|0
857087|NCT01546519|2825499|P4|Overall Study|Adverse Event|1
857088|NCT01546519|2825500|P3|Overall Study|Adverse Event|1
857089|NCT01546519|2825501|P2|Overall Study|Adverse Event|0
857090|NCT01546519|2825502|P1|Overall Study|Adverse Event|0
857091|NCT01546207|2825567|P1|Overall Study|Death|1
857092|NCT01546168|2825582|P2|Overall Study|ineligible after signing consent|0
857093|NCT01546168|2825583|P1|Overall Study|ineligible after signing consent|2
857094|NCT01546168|2825582|P2|Overall Study|Withdrawal by Subject|0
857095|NCT01546168|2825583|P1|Overall Study|Withdrawal by Subject|1
857096|NCT01546168|2825582|P2|Overall Study|Lost to Follow-up|0
857097|NCT01546168|2825583|P1|Overall Study|Lost to Follow-up|1
857098|NCT01546155|2825595|P1|Overall Study|could not tolerate long scan duration|3
857099|NCT01546142|2825601|P2|Overall Study|Subject Randomized but Not Treated|0
857100|NCT01546142|2825602|P1|Overall Study|Subject Randomized but Not Treated|1
857101|NCT01546142|2825601|P2|Overall Study|Consent Withdrawn (Subject Discomfort)|0
857102|NCT01546142|2825602|P1|Overall Study|Consent Withdrawn (Subject Discomfort)|1
857103|NCT01546142|2825601|P2|Overall Study|Lost to Follow-up|15
857104|NCT01546142|2825602|P1|Overall Study|Lost to Follow-up|20
857105|NCT01546142|2825601|P2|Overall Study|Adverse Event|3
857106|NCT01546142|2825602|P1|Overall Study|Adverse Event|6
857107|NCT01546142|2825601|P2|Overall Study|Subject Noncompliance|1
857108|NCT01546142|2825602|P1|Overall Study|Subject Noncompliance|1
857109|NCT01546142|2825601|P2|Overall Study|Consent Withdrawn (Subject Convenience)|15
857110|NCT01546142|2825602|P1|Overall Study|Consent Withdrawn (Subject Convenience)|15
857111|NCT01546038|2825620|P9|Overall Study|: Randomized, not treated|3
857112|NCT01546038|2825621|P8|Overall Study|: Randomized, not treated|4
857113|NCT01546038|2825622|P7|Overall Study|: Randomized, not treated|2
857114|NCT01546038|2825623|P6|Overall Study|: Randomized, not treated|0
857115|NCT01546038|2825624|P5|Overall Study|: Randomized, not treated|0
857116|NCT01546038|2825625|P4|Overall Study|: Randomized, not treated|0
857117|NCT01546038|2825626|P3|Overall Study|: Randomized, not treated|0
857118|NCT01546038|2825627|P2|Overall Study|: Randomized, not treated|0
857119|NCT01546038|2825628|P1|Overall Study|: Randomized, not treated|0
857120|NCT01546038|2825620|P9|Overall Study|: Study ongoing at cutoff date|1
857121|NCT01546038|2825621|P8|Overall Study|: Study ongoing at cutoff date|16
857122|NCT01546038|2825622|P7|Overall Study|: Study ongoing at cutoff date|24
857123|NCT01546038|2825623|P6|Overall Study|: Study ongoing at cutoff date|2
857124|NCT01546038|2825624|P5|Overall Study|: Study ongoing at cutoff date|8
857125|NCT01546038|2825625|P4|Overall Study|: Study ongoing at cutoff date|0
857126|NCT01546038|2825626|P3|Overall Study|: Study ongoing at cutoff date|0
857127|NCT01546038|2825627|P2|Overall Study|: Study ongoing at cutoff date|0
857128|NCT01546038|2825628|P1|Overall Study|: Study ongoing at cutoff date|1
857129|NCT01546038|2825620|P9|Overall Study|Withdrawal by Subject|0
857130|NCT01546038|2825621|P8|Overall Study|Withdrawal by Subject|3
857131|NCT01546038|2825622|P7|Overall Study|Withdrawal by Subject|3
857132|NCT01546038|2825623|P6|Overall Study|Withdrawal by Subject|1
857133|NCT01546038|2825624|P5|Overall Study|Withdrawal by Subject|0
857134|NCT01546038|2825625|P4|Overall Study|Withdrawal by Subject|1
857135|NCT01546038|2825626|P3|Overall Study|Withdrawal by Subject|0
857136|NCT01546038|2825627|P2|Overall Study|Withdrawal by Subject|0
857137|NCT01546038|2825628|P1|Overall Study|Withdrawal by Subject|1
857138|NCT01546038|2825620|P9|Overall Study|Lost to Follow-up|0
857139|NCT01546038|2825621|P8|Overall Study|Lost to Follow-up|1
857140|NCT01546038|2825622|P7|Overall Study|Lost to Follow-up|1
857141|NCT01546038|2825623|P6|Overall Study|Lost to Follow-up|0
857142|NCT01546038|2825624|P5|Overall Study|Lost to Follow-up|1
857143|NCT01546038|2825625|P4|Overall Study|Lost to Follow-up|0
857144|NCT01546038|2825626|P3|Overall Study|Lost to Follow-up|0
857145|NCT01546038|2825627|P2|Overall Study|Lost to Follow-up|0
857146|NCT01546038|2825628|P1|Overall Study|Lost to Follow-up|0
857147|NCT01546038|2825620|P9|Overall Study|Death|40
857148|NCT01546038|2825621|P8|Overall Study|Death|64
857149|NCT01546038|2825622|P7|Overall Study|Death|41
857150|NCT01546038|2825623|P6|Overall Study|Death|3
857151|NCT01546038|2825624|P5|Overall Study|Death|7
857152|NCT01546038|2825625|P4|Overall Study|Death|2
857153|NCT01546038|2825626|P3|Overall Study|Death|4
857154|NCT01546038|2825627|P2|Overall Study|Death|6
857155|NCT01546038|2825628|P1|Overall Study|Death|15
857156|NCT01545388|2825954|P3|Overall Study|Not specified|0
857157|NCT01545388|2825955|P2|Overall Study|Not specified|1
857158|NCT01545388|2825956|P1|Overall Study|Not specified|1
857159|NCT01545388|2825954|P3|Overall Study|Withdrawal by Subject|2
857160|NCT01545388|2825955|P2|Overall Study|Withdrawal by Subject|4
857161|NCT01545388|2825956|P1|Overall Study|Withdrawal by Subject|1
857162|NCT01545388|2825954|P3|Overall Study|Participant moved or relocated|0
857163|NCT01545388|2825955|P2|Overall Study|Participant moved or relocated|0
857164|NCT01545388|2825956|P1|Overall Study|Participant moved or relocated|1
857165|NCT01545388|2825954|P3|Overall Study|Lack of Efficacy|5
857166|NCT01545388|2825955|P2|Overall Study|Lack of Efficacy|2
857167|NCT01545388|2825956|P1|Overall Study|Lack of Efficacy|3
857168|NCT01545388|2825954|P3|Overall Study|Adverse Event|1
857169|NCT01545388|2825955|P2|Overall Study|Adverse Event|4
857170|NCT01545388|2825956|P1|Overall Study|Adverse Event|2
857171|NCT01545375|2825975|P2|Overall Study|Withdrawal by Subject|55
857172|NCT01545375|2825976|P1|Overall Study|Withdrawal by Subject|58
857173|NCT01545375|2825975|P2|Overall Study|Protocol Violation|3
857174|NCT01545375|2825976|P1|Overall Study|Protocol Violation|3
857175|NCT01545375|2825975|P2|Overall Study|Lost to Follow-up|31
857176|NCT01545375|2825976|P1|Overall Study|Lost to Follow-up|34
857177|NCT01545375|2825975|P2|Overall Study|Adverse Event|1
857178|NCT01545375|2825976|P1|Overall Study|Adverse Event|2
857179|NCT01545076|2826083|P5|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
857180|NCT01545076|2826084|P4|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3
857181|NCT01545076|2826085|P3|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2
857182|NCT01545076|2826086|P2|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8
857183|NCT01545076|2826087|P1|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
857184|NCT01545076|2826083|P5|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
857185|NCT01545076|2826084|P4|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
857186|NCT01545076|2826085|P3|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
857187|NCT01545076|2826086|P2|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
857188|NCT01545076|2826087|P1|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
857189|NCT01545076|2826083|P5|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
857190|NCT01545076|2826084|P4|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32
857191|NCT01545076|2826085|P3|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18
857192|NCT01545076|2826086|P2|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10
857193|NCT01545076|2826087|P1|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
857194|NCT01545076|2826083|P5|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
857195|NCT01545076|2826084|P4|IgPro20 Subcutaneous Treatment Period|Physician Decision|1
857196|NCT01545076|2826085|P3|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
857197|NCT01545076|2826086|P2|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
857198|NCT01545076|2826087|P1|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
857199|NCT01545076|2826083|P5|IgPro10 Restabilization Period|Withdrawal by Subject|0
857200|NCT01545076|2826084|P4|IgPro10 Restabilization Period|Withdrawal by Subject|0
857201|NCT01545076|2826085|P3|IgPro10 Restabilization Period|Withdrawal by Subject|0
857202|NCT01545076|2826086|P2|IgPro10 Restabilization Period|Withdrawal by Subject|0
857203|NCT01545076|2826087|P1|IgPro10 Restabilization Period|Withdrawal by Subject|7
857204|NCT01545076|2826083|P5|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
857205|NCT01545076|2826084|P4|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
857206|NCT01545076|2826085|P3|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
857207|NCT01545076|2826086|P2|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
857208|NCT01545076|2826087|P1|IgPro10 Restabilization Period|Failure to meet randomization criteria|22
857209|NCT01545076|2826083|P5|IgPro10 Restabilization Period|Protocol Violation|0
857210|NCT01545076|2826084|P4|IgPro10 Restabilization Period|Protocol Violation|0
857211|NCT01545076|2826085|P3|IgPro10 Restabilization Period|Protocol Violation|0
857212|NCT01545076|2826086|P2|IgPro10 Restabilization Period|Protocol Violation|0
857213|NCT01545076|2826087|P1|IgPro10 Restabilization Period|Protocol Violation|1
857214|NCT01545076|2826083|P5|IgPro10 Restabilization Period|Physician Decision|0
857215|NCT01545076|2826084|P4|IgPro10 Restabilization Period|Physician Decision|0
857216|NCT01545076|2826085|P3|IgPro10 Restabilization Period|Physician Decision|0
857217|NCT01545076|2826086|P2|IgPro10 Restabilization Period|Physician Decision|0
857218|NCT01545076|2826087|P1|IgPro10 Restabilization Period|Physician Decision|2
857219|NCT01545076|2826083|P5|IgPro10 Restabilization Period|Adverse Event|0
857220|NCT01545076|2826084|P4|IgPro10 Restabilization Period|Adverse Event|0
857221|NCT01545076|2826085|P3|IgPro10 Restabilization Period|Adverse Event|0
857222|NCT01545076|2826086|P2|IgPro10 Restabilization Period|Adverse Event|0
857223|NCT01545076|2826087|P1|IgPro10 Restabilization Period|Adverse Event|4
857224|NCT01544920|2826158|P2|Overall Study|Withdrawal by Subject|4
857225|NCT01544920|2826159|P1|Overall Study|Withdrawal by Subject|4
857226|NCT01544920|2826158|P2|Overall Study|Physician Decision|1
857227|NCT01544920|2826159|P1|Overall Study|Physician Decision|4
857228|NCT01544920|2826158|P2|Overall Study|Protocol Violation|2
857229|NCT01544920|2826159|P1|Overall Study|Protocol Violation|0
857230|NCT01544920|2826158|P2|Overall Study|Lost to Follow-up|12
857231|NCT01544920|2826159|P1|Overall Study|Lost to Follow-up|11
857232|NCT01544920|2826158|P2|Overall Study|Death|1
857233|NCT01544920|2826159|P1|Overall Study|Death|0
857234|NCT01544920|2826158|P2|Overall Study|Adverse Event|3
857235|NCT01544920|2826159|P1|Overall Study|Adverse Event|0
857236|NCT01544582|2826170|P4|Analysis Population|Participant in Jail|0
857237|NCT01544582|2826171|P3|Analysis Population|Participant in Jail|1
857238|NCT01544582|2826172|P2|Analysis Population|Participant in Jail|0
857239|NCT01544582|2826173|P1|Analysis Population|Participant in Jail|0
857240|NCT01544582|2826170|P4|Analysis Population|Programmed Surgery|0
857241|NCT01544582|2826171|P3|Analysis Population|Programmed Surgery|0
857242|NCT01544582|2826172|P2|Analysis Population|Programmed Surgery|1
857243|NCT01544582|2826173|P1|Analysis Population|Programmed Surgery|0
857244|NCT01544582|2826170|P4|Analysis Population|Poor Participant Compliance|0
857245|NCT01544582|2826171|P3|Analysis Population|Poor Participant Compliance|0
857246|NCT01544582|2826172|P2|Analysis Population|Poor Participant Compliance|1
857247|NCT01544582|2826173|P1|Analysis Population|Poor Participant Compliance|0
857248|NCT01544582|2826170|P4|Analysis Population|Poor Adherence|0
857249|NCT01544582|2826171|P3|Analysis Population|Poor Adherence|1
857250|NCT01544582|2826172|P2|Analysis Population|Poor Adherence|0
857251|NCT01544582|2826173|P1|Analysis Population|Poor Adherence|0
857252|NCT01544582|2826170|P4|Analysis Population|No Social Insurance|0
857253|NCT01544582|2826171|P3|Analysis Population|No Social Insurance|1
857254|NCT01544582|2826172|P2|Analysis Population|No Social Insurance|0
857255|NCT01544582|2826173|P1|Analysis Population|No Social Insurance|0
857256|NCT01544582|2826170|P4|Analysis Population|Liver Transplantation|0
857257|NCT01544582|2826171|P3|Analysis Population|Liver Transplantation|1
857258|NCT01544582|2826172|P2|Analysis Population|Liver Transplantation|0
857259|NCT01544582|2826173|P1|Analysis Population|Liver Transplantation|0
857260|NCT01544582|2826170|P4|Analysis Population|Intolerance|0
857261|NCT01544582|2826171|P3|Analysis Population|Intolerance|0
857262|NCT01544582|2826172|P2|Analysis Population|Intolerance|1
857263|NCT01544582|2826173|P1|Analysis Population|Intolerance|0
857264|NCT01544582|2826170|P4|Analysis Population|Did Not Meet Inclusion Criteria|0
857265|NCT01544582|2826171|P3|Analysis Population|Did Not Meet Inclusion Criteria|3
857266|NCT01544582|2826172|P2|Analysis Population|Did Not Meet Inclusion Criteria|0
857267|NCT01544582|2826173|P1|Analysis Population|Did Not Meet Inclusion Criteria|0
857268|NCT01544582|2826170|P4|Analysis Population|Bad Tolerance to Treatment|0
857269|NCT01544582|2826171|P3|Analysis Population|Bad Tolerance to Treatment|2
857270|NCT01544582|2826172|P2|Analysis Population|Bad Tolerance to Treatment|0
857271|NCT01544582|2826173|P1|Analysis Population|Bad Tolerance to Treatment|0
857272|NCT01544582|2826170|P4|Analysis Population|Lost to Follow-up|5
857273|NCT01544582|2826171|P3|Analysis Population|Lost to Follow-up|6
857274|NCT01544582|2826172|P2|Analysis Population|Lost to Follow-up|6
857275|NCT01544582|2826173|P1|Analysis Population|Lost to Follow-up|0
857276|NCT01544582|2826170|P4|Analysis Population|New Contraindication-Alcohol Abuse|1
857277|NCT01544582|2826171|P3|Analysis Population|New Contraindication-Alcohol Abuse|0
857278|NCT01544582|2826172|P2|Analysis Population|New Contraindication-Alcohol Abuse|0
857279|NCT01544582|2826173|P1|Analysis Population|New Contraindication-Alcohol Abuse|0
857280|NCT01544582|2826170|P4|Analysis Population|Effectiveness Reason|12
857281|NCT01544582|2826171|P3|Analysis Population|Effectiveness Reason|29
857282|NCT01544582|2826172|P2|Analysis Population|Effectiveness Reason|48
857283|NCT01544582|2826173|P1|Analysis Population|Effectiveness Reason|0
857284|NCT01544582|2826170|P4|Analysis Population|Safety Reason|8
857285|NCT01544582|2826171|P3|Analysis Population|Safety Reason|31
857286|NCT01544582|2826172|P2|Analysis Population|Safety Reason|33
857287|NCT01544582|2826173|P1|Analysis Population|Safety Reason|0
857288|NCT01544582|2826170|P4|Analysis Population|Physician Decision|9
857289|NCT01544582|2826171|P3|Analysis Population|Physician Decision|10
857290|NCT01544582|2826172|P2|Analysis Population|Physician Decision|13
857291|NCT01544582|2826173|P1|Analysis Population|Physician Decision|0
857292|NCT01544582|2826170|P4|Analysis Population|Participant Refuses to Continue Study|4
857293|NCT01544582|2826171|P3|Analysis Population|Participant Refuses to Continue Study|17
857294|NCT01544582|2826172|P2|Analysis Population|Participant Refuses to Continue Study|15
857295|NCT01544582|2826173|P1|Analysis Population|Participant Refuses to Continue Study|0
857296|NCT01544582|2826170|P4|Screening/Eligibility|Eligibility Criteria Not Met|0
857297|NCT01544582|2826171|P3|Screening/Eligibility|Eligibility Criteria Not Met|0
857298|NCT01544582|2826172|P2|Screening/Eligibility|Eligibility Criteria Not Met|0
857299|NCT01544582|2826173|P1|Screening/Eligibility|Eligibility Criteria Not Met|33
857300|NCT01544582|2826170|P4|Screening/Eligibility|Initiated Different CHC Treatment|0
857301|NCT01544582|2826171|P3|Screening/Eligibility|Initiated Different CHC Treatment|0
857302|NCT01544582|2826172|P2|Screening/Eligibility|Initiated Different CHC Treatment|0
857303|NCT01544582|2826173|P1|Screening/Eligibility|Initiated Different CHC Treatment|1
857304|NCT01544478|2826231|P1|Overall Study|Withdrawal by Subject|52
857305|NCT01544478|2826231|P1|Overall Study|Pregnancy|1
857306|NCT01544478|2826231|P1|Overall Study|Physician Decision|15
857307|NCT01544478|2826231|P1|Overall Study|Lost to Follow-up|48
857308|NCT01544478|2826231|P1|Overall Study|Death|1
857309|NCT01544478|2826231|P1|Overall Study|Adverse Event|1
857310|NCT01544348|2826274|P8|Overall Study|Physician Decision|0
857311|NCT01544348|2826275|P7|Overall Study|Physician Decision|0
857312|NCT01544348|2826276|P6|Overall Study|Physician Decision|1
857313|NCT01544348|2826277|P5|Overall Study|Physician Decision|0
857314|NCT01544348|2826278|P4|Overall Study|Physician Decision|0
857315|NCT01544348|2826279|P3|Overall Study|Physician Decision|0
857316|NCT01544348|2826280|P2|Overall Study|Physician Decision|0
857317|NCT01544348|2826281|P1|Overall Study|Physician Decision|0
857318|NCT01544348|2826274|P8|Overall Study|Withdrawal by Subject|0
857319|NCT01544348|2826275|P7|Overall Study|Withdrawal by Subject|1
857320|NCT01544348|2826276|P6|Overall Study|Withdrawal by Subject|2
857321|NCT01544348|2826277|P5|Overall Study|Withdrawal by Subject|1
857322|NCT01544348|2826278|P4|Overall Study|Withdrawal by Subject|0
857323|NCT01544348|2826279|P3|Overall Study|Withdrawal by Subject|0
857324|NCT01544348|2826280|P2|Overall Study|Withdrawal by Subject|0
857325|NCT01544348|2826281|P1|Overall Study|Withdrawal by Subject|1
857326|NCT01544348|2826274|P8|Overall Study|Lost to Follow-up|0
857327|NCT01544348|2826275|P7|Overall Study|Lost to Follow-up|1
857328|NCT01544348|2826276|P6|Overall Study|Lost to Follow-up|0
857329|NCT01544348|2826277|P5|Overall Study|Lost to Follow-up|0
857330|NCT01544348|2826278|P4|Overall Study|Lost to Follow-up|0
857331|NCT01544348|2826279|P3|Overall Study|Lost to Follow-up|0
857332|NCT01544348|2826280|P2|Overall Study|Lost to Follow-up|0
857333|NCT01544348|2826281|P1|Overall Study|Lost to Follow-up|1
857334|NCT01544309|2826323|P2|Overall Study|Administered prohibit prior medication|0
857335|NCT01544309|2826324|P1|Overall Study|Administered prohibit prior medication|1
857336|NCT01544309|2826323|P2|Overall Study|Not performed pre-dose examination|2
857337|NCT01544309|2826324|P1|Overall Study|Not performed pre-dose examination|1
857338|NCT01544309|2826323|P2|Overall Study|Physician Decision|1
857339|NCT01544309|2826324|P1|Overall Study|Physician Decision|4
857340|NCT01544309|2826323|P2|Overall Study|Protocol Violation|1
857341|NCT01544309|2826324|P1|Overall Study|Protocol Violation|2
857342|NCT01544309|2826323|P2|Overall Study|Withdrawal by Subject|7
857343|NCT01544309|2826324|P1|Overall Study|Withdrawal by Subject|12
857344|NCT01544179|2826362|P2|Overall Study|Eligibility criteria not fulfilled|0
857345|NCT01544179|2826363|P1|Overall Study|Eligibility criteria not fulfilled|1
857346|NCT01544179|2826362|P2|Overall Study|Withdrawal by Subject|7
857347|NCT01544179|2826363|P1|Overall Study|Withdrawal by Subject|12
857348|NCT01544179|2826362|P2|Overall Study|Adverse Event|1
857349|NCT01544179|2826363|P1|Overall Study|Adverse Event|0
857350|NCT01544179|2826362|P2|Overall Study|Lost to Follow-up|1
857351|NCT01544179|2826363|P1|Overall Study|Lost to Follow-up|0
857352|NCT01544179|2826362|P2|Overall Study|Death|37
857353|NCT01544179|2826363|P1|Overall Study|Death|50
857354|NCT01544153|2826456|P4|Overall Study|Non-smoker|0
857355|NCT01544153|2826457|P3|Overall Study|Non-smoker|1
857356|NCT01544153|2826458|P2|Overall Study|Non-smoker|0
857357|NCT01544153|2826459|P1|Overall Study|Non-smoker|0
857358|NCT01544153|2826456|P4|Overall Study|Under 18|0
857359|NCT01544153|2826457|P3|Overall Study|Under 18|0
857360|NCT01544153|2826458|P2|Overall Study|Under 18|1
857361|NCT01544153|2826459|P1|Overall Study|Under 18|0
857362|NCT01544114|2826476|P3|Overall Study|Protocol Violation|0
857363|NCT01544114|2826477|P2|Overall Study|Protocol Violation|1
857364|NCT01544114|2826478|P1|Overall Study|Protocol Violation|0
857365|NCT01544114|2826476|P3|Overall Study|Adverse Event|2
857366|NCT01544114|2826477|P2|Overall Study|Adverse Event|1
857367|NCT01544114|2826478|P1|Overall Study|Adverse Event|1
857368|NCT01544114|2826476|P3|Overall Study|Lost to Follow-up|0
857369|NCT01544114|2826477|P2|Overall Study|Lost to Follow-up|2
857370|NCT01544114|2826478|P1|Overall Study|Lost to Follow-up|0
857371|NCT01544114|2826476|P3|Overall Study|Withdrawal by Subject|3
857372|NCT01544114|2826477|P2|Overall Study|Withdrawal by Subject|0
857373|NCT01544114|2826478|P1|Overall Study|Withdrawal by Subject|0
857374|NCT01543958|2826561|P1|Overall Study|ART initiation|1
857375|NCT01543958|2826561|P1|Overall Study|Loss to follow-up|3
857376|NCT01543828|2826616|P2|Treatment 2|Lost to Follow-up|0
857377|NCT01543828|2826617|P1|Treatment 2|Lost to Follow-up|1
857378|NCT01543685|2826630|P5|Overall Study|Adverse Event|2
857379|NCT01543685|2826631|P4|Overall Study|Adverse Event|0
857380|NCT01543685|2826632|P3|Overall Study|Adverse Event|0
857381|NCT01543685|2826633|P2|Overall Study|Adverse Event|1
857382|NCT01543685|2826634|P1|Overall Study|Adverse Event|2
857383|NCT01543685|2826630|P5|Overall Study|Lack of Efficacy|2
857384|NCT01543685|2826631|P4|Overall Study|Lack of Efficacy|0
857385|NCT01543685|2826632|P3|Overall Study|Lack of Efficacy|2
857386|NCT01543685|2826633|P2|Overall Study|Lack of Efficacy|2
857387|NCT01543685|2826634|P1|Overall Study|Lack of Efficacy|1
857388|NCT01543503|2826706|P2|Overall Study|Screen failure|0
857389|NCT01543503|2826707|P1|Overall Study|Screen failure|1
857390|NCT01543503|2826706|P2|Overall Study|Participant went to United States|0
857391|NCT01543503|2826707|P1|Overall Study|Participant went to United States|1
857392|NCT01543503|2826706|P2|Overall Study|Participant consented to another study|2
857393|NCT01543503|2826707|P1|Overall Study|Participant consented to another study|0
857394|NCT01543503|2826706|P2|Overall Study|Moved to other rheumatologic site|1
857395|NCT01543503|2826707|P1|Overall Study|Moved to other rheumatologic site|0
857396|NCT01543503|2826706|P2|Overall Study|Participant did not attend a visit|0
857397|NCT01543503|2826707|P1|Overall Study|Participant did not attend a visit|1
857398|NCT01543503|2826706|P2|Overall Study|Site stopped participation|1
857399|NCT01543503|2826707|P1|Overall Study|Site stopped participation|5
857400|NCT01543503|2826706|P2|Overall Study|Participant recruited after closing date|1
857401|NCT01543503|2826707|P1|Overall Study|Participant recruited after closing date|0
857402|NCT01543503|2826706|P2|Overall Study|Investigator did not wish to participate|1
857403|NCT01543503|2826707|P1|Overall Study|Investigator did not wish to participate|1
857404|NCT01543503|2826706|P2|Overall Study|Participant decision to stop treatment|0
857405|NCT01543503|2826707|P1|Overall Study|Participant decision to stop treatment|1
857406|NCT01543503|2826706|P2|Overall Study|Participant moved to Scotland|0
857407|NCT01543503|2826707|P1|Overall Study|Participant moved to Scotland|1
857408|NCT01543503|2826706|P2|Overall Study|Participant transferred to another city|0
857409|NCT01543503|2826707|P1|Overall Study|Participant transferred to another city|1
857410|NCT01543503|2826706|P2|Overall Study|Participant will not return for visits|2
857411|NCT01543503|2826707|P1|Overall Study|Participant will not return for visits|0
857412|NCT01543503|2826706|P2|Overall Study|Participant moved to another city|0
857413|NCT01543503|2826707|P1|Overall Study|Participant moved to another city|2
857414|NCT01543503|2826706|P2|Overall Study|Incorrect medication received|0
857415|NCT01543503|2826707|P1|Overall Study|Incorrect medication received|1
857416|NCT01543503|2826706|P2|Overall Study|Refused to continue treatment|0
857417|NCT01543503|2826707|P1|Overall Study|Refused to continue treatment|7
857418|NCT01543503|2826706|P2|Overall Study|Participant did not complete last visit|2
857419|NCT01543503|2826707|P1|Overall Study|Participant did not complete last visit|0
857420|NCT01543503|2826706|P2|Overall Study|Probable overlap of RA with fibromyalgia|0
857421|NCT01543503|2826707|P1|Overall Study|Probable overlap of RA with fibromyalgia|1
857422|NCT01543503|2826706|P2|Overall Study|Intolerance to the biologic treatment|1
857423|NCT01543503|2826707|P1|Overall Study|Intolerance to the biologic treatment|0
857424|NCT01543503|2826706|P2|Overall Study|Change of jobs|1
857425|NCT01543503|2826707|P1|Overall Study|Change of jobs|0
857426|NCT01543503|2826706|P2|Overall Study|Participant withdrew informed consent|10
857427|NCT01543503|2826707|P1|Overall Study|Participant withdrew informed consent|8
857428|NCT01543503|2826706|P2|Overall Study|Lack of Efficacy|16
857429|NCT01543503|2826707|P1|Overall Study|Lack of Efficacy|4
857430|NCT01543503|2826706|P2|Overall Study|Adverse Event|13
857431|NCT01543503|2826707|P1|Overall Study|Adverse Event|9
857432|NCT01543503|2826706|P2|Overall Study|Lost to Follow-up|36
857433|NCT01543503|2826707|P1|Overall Study|Lost to Follow-up|32
857434|NCT01543204|2826751|P1|Overall Study|Lost to Follow-up|1
857435|NCT01543204|2826751|P1|Overall Study|Requirement for Alternative Therapy|1
857436|NCT01543204|2826751|P1|Overall Study|Withdrawal by Subject|4
857437|NCT01543204|2826751|P1|Overall Study|Adverse Event|1
857438|NCT01543204|2826751|P1|Overall Study|Non-compliance|1
857439|NCT01542788|2826843|P2|Overall Study|Withdrawal by Subject|0
857440|NCT01542788|2826844|P1|Overall Study|Withdrawal by Subject|1
857441|NCT01542788|2826843|P2|Overall Study|Physician Decision|0
857442|NCT01542788|2826844|P1|Overall Study|Physician Decision|1
857443|NCT01542788|2826843|P2|Overall Study|Protocol Violation|0
857444|NCT01542788|2826844|P1|Overall Study|Protocol Violation|2
857445|NCT01542788|2826843|P2|Overall Study|Death|0
857446|NCT01542788|2826844|P1|Overall Study|Death|3
857447|NCT01542788|2826843|P2|Overall Study|Lost to Follow-up|0
857448|NCT01542788|2826844|P1|Overall Study|Lost to Follow-up|5
857449|NCT01542788|2826843|P2|Overall Study|Lack of Efficacy|71
857450|NCT01542788|2826844|P1|Overall Study|Lack of Efficacy|41
857451|NCT01542788|2826843|P2|Overall Study|Randomized but Not Treated|0
857452|NCT01542788|2826844|P1|Overall Study|Randomized but Not Treated|2
857453|NCT01542632|2826883|P6|Overall Study|Sponsor/Investigator Decision|0
857454|NCT01542632|2826884|P5|Overall Study|Sponsor/Investigator Decision|1
857455|NCT01542632|2826885|P4|Overall Study|Sponsor/Investigator Decision|0
857456|NCT01542632|2826886|P3|Overall Study|Sponsor/Investigator Decision|0
857457|NCT01542632|2826887|P2|Overall Study|Sponsor/Investigator Decision|0
857458|NCT01542632|2826888|P1|Overall Study|Sponsor/Investigator Decision|0
857459|NCT01542632|2826883|P6|Overall Study|Lost to Follow-up|0
857460|NCT01542632|2826884|P5|Overall Study|Lost to Follow-up|0
857461|NCT01542632|2826885|P4|Overall Study|Lost to Follow-up|0
857462|NCT01542632|2826886|P3|Overall Study|Lost to Follow-up|0
857463|NCT01542632|2826887|P2|Overall Study|Lost to Follow-up|1
857464|NCT01542632|2826888|P1|Overall Study|Lost to Follow-up|0
857465|NCT01542632|2826883|P6|Overall Study|Adverse Event|0
857466|NCT01542632|2826884|P5|Overall Study|Adverse Event|0
857467|NCT01542632|2826885|P4|Overall Study|Adverse Event|0
857468|NCT01542632|2826886|P3|Overall Study|Adverse Event|1
857469|NCT01542632|2826887|P2|Overall Study|Adverse Event|0
857470|NCT01542632|2826888|P1|Overall Study|Adverse Event|0
857471|NCT01542632|2826883|P6|Overall Study|Withdrawal of Consent|0
857472|NCT01542632|2826884|P5|Overall Study|Withdrawal of Consent|3
857473|NCT01542632|2826885|P4|Overall Study|Withdrawal of Consent|2
857474|NCT01542632|2826886|P3|Overall Study|Withdrawal of Consent|0
857475|NCT01542632|2826887|P2|Overall Study|Withdrawal of Consent|0
857476|NCT01542632|2826888|P1|Overall Study|Withdrawal of Consent|0
857477|NCT01542528|2826945|P2|Overall Study|Withdrawal by Subject|6
857478|NCT01542528|2826946|P1|Overall Study|Withdrawal by Subject|9
857479|NCT01542528|2826945|P2|Overall Study|Physician Decision|0
857480|NCT01542528|2826946|P1|Overall Study|Physician Decision|1
857481|NCT01542528|2826945|P2|Overall Study|Lost to Follow-up|1
857482|NCT01542528|2826946|P1|Overall Study|Lost to Follow-up|2
857483|NCT01542034|2827015|P2|Overall Study|Lost to Follow-up|6
857484|NCT01542034|2827016|P1|Overall Study|Lost to Follow-up|7
857485|NCT01542034|2827015|P2|Overall Study|Adverse Event|2
857486|NCT01542034|2827016|P1|Overall Study|Adverse Event|2
857487|NCT01542034|2827015|P2|Overall Study|Subject Noncompliance|0
857488|NCT01542034|2827016|P1|Overall Study|Subject Noncompliance|1
857489|NCT01542034|2827015|P2|Overall Study|Administrative decision|3
857490|NCT01542034|2827016|P1|Overall Study|Administrative decision|0
857491|NCT01542034|2827015|P2|Overall Study|Consent Withdrawn (Subject Convenience)|12
857492|NCT01542034|2827016|P1|Overall Study|Consent Withdrawn (Subject Convenience)|20
857493|NCT01541969|2827030|P2|Open Label Extension (12-36 Weeks)|Adverse Event|3
857494|NCT01541969|2827031|P1|Open Label Extension (12-36 Weeks)|Adverse Event|2
857495|NCT01541969|2827030|P2|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8
857496|NCT01541969|2827031|P1|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6
857497|NCT01541969|2827030|P2|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
857498|NCT01541969|2827031|P1|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
857499|NCT01541969|2827030|P2|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0
857500|NCT01541969|2827031|P1|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1
857501|NCT01541969|2827030|P2|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
857502|NCT01541969|2827031|P1|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
857503|NCT01541969|2827030|P2|Double-blind (0-12 Weeks)|Adverse Event|0
857504|NCT01541969|2827031|P1|Double-blind (0-12 Weeks)|Adverse Event|2
857505|NCT01541969|2827030|P2|Double-blind (0-12 Weeks)|Lost to Follow-up|0
857506|NCT01541969|2827031|P1|Double-blind (0-12 Weeks)|Lost to Follow-up|1
857507|NCT01541969|2827030|P2|Double-blind (0-12 Weeks)|Withdrawal by Subject|0
857508|NCT01541969|2827031|P1|Double-blind (0-12 Weeks)|Withdrawal by Subject|2
857509|NCT01541969|2827030|P2|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
857510|NCT01541969|2827031|P1|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
857511|NCT01541969|2827030|P2|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1
857512|NCT01541969|2827031|P1|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0
857513|NCT01541930|2827047|P1|Overall Study|Withdrawal by Subject|1
857514|NCT01541917|2827069|P2|Overall Study|Withdrawal by Subject|7
857515|NCT01541917|2827070|P1|Overall Study|Withdrawal by Subject|13
857516|NCT01541917|2827069|P2|Overall Study|Lost to Follow-up|2
857517|NCT01541917|2827070|P1|Overall Study|Lost to Follow-up|2
857518|NCT01541865|2827099|P1|Overall Study|Protocol Violation|1
857519|NCT01541865|2827099|P1|Overall Study|Adverse Event|1
857520|NCT01541865|2827099|P1|Overall Study|Withdrawal by Subject|9
857521|NCT01541865|2827099|P1|Overall Study|Lost to Follow-up|11
857522|NCT01541826|2827117|P3|Overall Study|Withdrawal by Subject|0
857523|NCT01541826|2827118|P2|Overall Study|Withdrawal by Subject|0
857524|NCT01541826|2827119|P1|Overall Study|Withdrawal by Subject|2
857525|NCT01541826|2827117|P3|Overall Study|Lost to Follow-up|0
857526|NCT01541826|2827118|P2|Overall Study|Lost to Follow-up|3
857527|NCT01541826|2827119|P1|Overall Study|Lost to Follow-up|2
857528|NCT01541644|2827201|P1|Overall Study|Withdrawal by Subject|3
857529|NCT01541397|2827220|P2|Overall Study|Study ended prior to data collection|2
857530|NCT01541397|2827221|P1|Overall Study|Study ended prior to data collection|4
857531|NCT01541371|2827246|P1|Overall Study|Other|6
857532|NCT01541371|2827246|P1|Overall Study|Study medication non-compliance|3
857533|NCT01541371|2827246|P1|Overall Study|Protocol Violation|6
857534|NCT01541371|2827246|P1|Overall Study|Lack of Efficacy|12
857535|NCT01541371|2827246|P1|Overall Study|Adverse Event|15
857536|NCT01541371|2827246|P1|Overall Study|Lost to Follow-up|21
857537|NCT01541371|2827246|P1|Overall Study|Withdrawal by Subject|14
857538|NCT01541254|2827275|P1|Overall Study|alternate stent used|1
857539|NCT01541254|2827275|P1|Overall Study|stent not required|1
857540|NCT01541254|2827275|P1|Overall Study|GI bleed prior to procedure|1
857541|NCT01541254|2827275|P1|Overall Study|enrolled after study closed|1
857542|NCT01541254|2827275|P1|Overall Study|excluded - metal allergy|1
857543|NCT01541254|2827275|P1|Overall Study|Withdrawal by Subject|1
857544|NCT01540981|2827282|P2|Overall Study|Withdrawal by Subject|0
857545|NCT01540981|2827283|P1|Overall Study|Withdrawal by Subject|1
857546|NCT01540851|2827293|P2|Overall Study|Withdrawal by Subject|3
857547|NCT01540851|2827294|P1|Overall Study|Withdrawal by Subject|7
857548|NCT01540851|2827293|P2|Overall Study|Lost to Follow-up|15
857549|NCT01540851|2827294|P1|Overall Study|Lost to Follow-up|14
857550|NCT01540487|2827441|P2|Overall Study|Protocol Violation|0
857551|NCT01540487|2827442|P1|Overall Study|Protocol Violation|1
857552|NCT01539759|2827577|P2|Overall Study|Lost to Follow-up|8
857553|NCT01539759|2827578|P1|Overall Study|Lost to Follow-up|6
857554|NCT01539642|2827590|P2|Overall Study|Withdrawal by Subject|2
857555|NCT01539642|2827591|P1|Overall Study|Withdrawal by Subject|2
857556|NCT01539642|2827590|P2|Overall Study|Adverse Event|4
857557|NCT01539642|2827591|P1|Overall Study|Adverse Event|6
857558|NCT01539642|2827590|P2|Overall Study|Patient ready for early discharge|7
857559|NCT01539642|2827591|P1|Overall Study|Patient ready for early discharge|8
857560|NCT01539642|2827590|P2|Overall Study|Lack of Efficacy|18
857561|NCT01539642|2827591|P1|Overall Study|Lack of Efficacy|20
857562|NCT01539538|2827608|P2|Overall Study|PCA no longer required or PCA problem|7
857563|NCT01539538|2827609|P1|Overall Study|PCA no longer required or PCA problem|3
857564|NCT01539538|2827608|P2|Overall Study|Withdrawal by Subject|3
857565|NCT01539538|2827609|P1|Overall Study|Withdrawal by Subject|2
857566|NCT01539538|2827608|P2|Overall Study|Lack of Efficacy|16
857567|NCT01539538|2827609|P1|Overall Study|Lack of Efficacy|13
857568|NCT01539538|2827608|P2|Overall Study|Adverse Event|18
857569|NCT01539538|2827609|P1|Overall Study|Adverse Event|13
857570|NCT01539525|2827618|P3|Overall Study|Protocol Violation|4
857571|NCT01539525|2827619|P2|Overall Study|Protocol Violation|1
857572|NCT01539525|2827620|P1|Overall Study|Protocol Violation|1
857573|NCT01539525|2827618|P3|Overall Study|Withdrawal by Subject|2
857574|NCT01539525|2827619|P2|Overall Study|Withdrawal by Subject|3
857575|NCT01539525|2827620|P1|Overall Study|Withdrawal by Subject|0
857576|NCT01539525|2827618|P3|Overall Study|Lost to Follow-up|11
857577|NCT01539525|2827619|P2|Overall Study|Lost to Follow-up|12
857578|NCT01539525|2827620|P1|Overall Study|Lost to Follow-up|19
857579|NCT01539512|2827639|P2|Overall Study|Richter's Transformation|0
857580|NCT01539512|2827640|P1|Overall Study|Richter's Transformation|1
857581|NCT01539512|2827639|P2|Overall Study|Withdrawal by Subject|5
857582|NCT01539512|2827640|P1|Overall Study|Withdrawal by Subject|12
857583|NCT01539512|2827639|P2|Overall Study|Physician Decision|1
857584|NCT01539512|2827640|P1|Overall Study|Physician Decision|1
857585|NCT01539512|2827639|P2|Overall Study|Adverse Event|7
857586|NCT01539512|2827640|P1|Overall Study|Adverse Event|9
857587|NCT01539317|2827656|P2|Overall Study|Screening Error. Deleted from analysis.|0
857588|NCT01539317|2827657|P1|Overall Study|Screening Error. Deleted from analysis.|1
857589|NCT01539083|2827687|P3|After Randomization (TP and VTP)|Progressive Disease|2
857590|NCT01539083|2827688|P2|After Randomization (TP and VTP)|Progressive Disease|3
857591|NCT01539083|2827689|P1|After Randomization (TP and VTP)|Progressive Disease|0
857592|NCT01539083|2827687|P3|After Randomization (TP and VTP)|Death|6
857593|NCT01539083|2827688|P2|After Randomization (TP and VTP)|Death|4
857594|NCT01539083|2827689|P1|After Randomization (TP and VTP)|Death|0
857595|NCT01539083|2827687|P3|After Randomization (TP and VTP)|Adverse Event|0
857596|NCT01539083|2827688|P2|After Randomization (TP and VTP)|Adverse Event|1
857597|NCT01539083|2827689|P1|After Randomization (TP and VTP)|Adverse Event|0
857598|NCT01539083|2827687|P3|After Randomization (TP and VTP)|Withdrawal by Subject|1
857599|NCT01539083|2827688|P2|After Randomization (TP and VTP)|Withdrawal by Subject|3
857600|NCT01539083|2827689|P1|After Randomization (TP and VTP)|Withdrawal by Subject|0
857601|NCT01539083|2827687|P3|After Randomization (TP and VTP)|Lost to Follow-up|2
857602|NCT01539083|2827688|P2|After Randomization (TP and VTP)|Lost to Follow-up|2
857603|NCT01539083|2827689|P1|After Randomization (TP and VTP)|Lost to Follow-up|0
857604|NCT01539083|2827687|P3|Before Randomization (VCD Induction)|Other|0
857605|NCT01539083|2827688|P2|Before Randomization (VCD Induction)|Other|0
857606|NCT01539083|2827689|P1|Before Randomization (VCD Induction)|Other|5
857607|NCT01539083|2827687|P3|Before Randomization (VCD Induction)|Progressive Disease|0
857608|NCT01539083|2827688|P2|Before Randomization (VCD Induction)|Progressive Disease|0
857609|NCT01539083|2827689|P1|Before Randomization (VCD Induction)|Progressive Disease|8
857610|NCT01539083|2827687|P3|Before Randomization (VCD Induction)|Physician Decision|0
857611|NCT01539083|2827688|P2|Before Randomization (VCD Induction)|Physician Decision|0
857612|NCT01539083|2827689|P1|Before Randomization (VCD Induction)|Physician Decision|14
857613|NCT01539083|2827687|P3|Before Randomization (VCD Induction)|Protocol Violation|0
857614|NCT01539083|2827688|P2|Before Randomization (VCD Induction)|Protocol Violation|0
857615|NCT01539083|2827689|P1|Before Randomization (VCD Induction)|Protocol Violation|2
857616|NCT01539083|2827687|P3|Before Randomization (VCD Induction)|Death|0
857617|NCT01539083|2827688|P2|Before Randomization (VCD Induction)|Death|0
857618|NCT01539083|2827689|P1|Before Randomization (VCD Induction)|Death|6
857619|NCT01539083|2827687|P3|Before Randomization (VCD Induction)|Adverse Event|0
857620|NCT01539083|2827688|P2|Before Randomization (VCD Induction)|Adverse Event|0
857621|NCT01539083|2827689|P1|Before Randomization (VCD Induction)|Adverse Event|14
857622|NCT01539083|2827687|P3|Before Randomization (VCD Induction)|Withdrawal by Subject|0
857623|NCT01539083|2827688|P2|Before Randomization (VCD Induction)|Withdrawal by Subject|0
857624|NCT01539083|2827689|P1|Before Randomization (VCD Induction)|Withdrawal by Subject|4
857625|NCT01538719|2827733|P2|Overall Study|Lost to Follow-up|0
857626|NCT01538719|2827734|P1|Overall Study|Lost to Follow-up|2
857627|NCT01538472|2827757|P1|Overall Study|Death|1
857628|NCT01538472|2827757|P1|Overall Study|Disease Progression|3
857629|NCT01538199|2827768|P4|Overall Study|Lack of Efficacy|0
857630|NCT01538199|2827769|P3|Overall Study|Lack of Efficacy|0
857631|NCT01538199|2827770|P2|Overall Study|Lack of Efficacy|1
857632|NCT01538199|2827771|P1|Overall Study|Lack of Efficacy|0
857633|NCT01538199|2827768|P4|Overall Study|participant did not have time|2
857634|NCT01538199|2827769|P3|Overall Study|participant did not have time|0
857635|NCT01538199|2827770|P2|Overall Study|participant did not have time|0
857636|NCT01538199|2827771|P1|Overall Study|participant did not have time|1
857637|NCT01538199|2827768|P4|Overall Study|Lost to Follow-up|0
857638|NCT01538199|2827769|P3|Overall Study|Lost to Follow-up|1
857639|NCT01538199|2827770|P2|Overall Study|Lost to Follow-up|2
857640|NCT01538199|2827771|P1|Overall Study|Lost to Follow-up|1
857641|NCT01537783|2827823|P2|Overall Study|Lost to Follow-up|2
857642|NCT01537783|2827824|P1|Overall Study|Lost to Follow-up|11
857643|NCT01537549|2827875|P1|Overall Study|Withdrawal by Subject|2
857644|NCT01537549|2827875|P1|Overall Study|Lost to Follow-up|1
857645|NCT01537432|2827883|P2|Overall Study|Unsatisfactory therapeutic effect|0
857646|NCT01537432|2827884|P1|Overall Study|Unsatisfactory therapeutic effect|1
857647|NCT01537432|2827883|P2|Overall Study|Adverse Event|0
857648|NCT01537432|2827884|P1|Overall Study|Adverse Event|1
857649|NCT01537432|2827883|P2|Overall Study|Administrative problems|0
857650|NCT01537432|2827884|P1|Overall Study|Administrative problems|1
857651|NCT01537432|2827883|P2|Overall Study|Withdrawal by Subject|1
857652|NCT01537432|2827884|P1|Overall Study|Withdrawal by Subject|0
857653|NCT01537432|2827883|P2|Overall Study|Lost to Follow-up|1
857654|NCT01537432|2827884|P1|Overall Study|Lost to Follow-up|3
857655|NCT01537393|2827907|P2|Overall Study|Censored (severe event unrelated to PT)|1
857656|NCT01537393|2827908|P1|Overall Study|Censored (severe event unrelated to PT)|1
857657|NCT01537393|2827907|P2|Overall Study|Failure - Not regrafted|6
857658|NCT01537393|2827908|P1|Overall Study|Failure - Not regrafted|2
857659|NCT01537393|2827907|P2|Overall Study|Failure - Regrafted|43
857660|NCT01537393|2827908|P1|Overall Study|Failure - Regrafted|28
857661|NCT01537393|2827907|P2|Overall Study|Lost to Follow-up|48
857662|NCT01537393|2827908|P1|Overall Study|Lost to Follow-up|53
857663|NCT01537393|2827907|P2|Overall Study|Withdrawal by Subject|17
857664|NCT01537393|2827908|P1|Overall Study|Withdrawal by Subject|18
857665|NCT01537393|2827907|P2|Overall Study|Death|32
857666|NCT01537393|2827908|P1|Overall Study|Death|20
857667|NCT01537393|2827907|P2|Overall Study|Exclude prior to study|44
857668|NCT01537393|2827908|P1|Overall Study|Exclude prior to study|32
857669|NCT01537302|2827944|P1|Overall Study|Withdrawal by Subject|1
857670|NCT01537302|2827944|P1|Overall Study|Lost to Follow-up|1
857671|NCT01537198|2827951|P1|Overall Study|Not Specified|111
857672|NCT01537198|2827951|P1|Overall Study|No Further Visits to the Clinic|37
857673|NCT01537198|2827951|P1|Overall Study|Adverse Event|4
857674|NCT01537198|2827951|P1|Overall Study|RSV infection|2
857675|NCT01537133|2827980|P4|Overall Study|Lost to Follow-up|0
857676|NCT01537133|2827981|P3|Overall Study|Lost to Follow-up|0
857677|NCT01537133|2827982|P2|Overall Study|Lost to Follow-up|0
857678|NCT01537133|2827983|P1|Overall Study|Lost to Follow-up|1
857679|NCT01537133|2827980|P4|Overall Study|Withdrawal by Subject|0
857680|NCT01537133|2827981|P3|Overall Study|Withdrawal by Subject|0
857681|NCT01537133|2827982|P2|Overall Study|Withdrawal by Subject|0
857682|NCT01537133|2827983|P1|Overall Study|Withdrawal by Subject|2
857683|NCT01537120|2827999|P1|3 Weeks Placebo|Withdrawal by Subject|1
857684|NCT01537120|2827999|P1|8 Weeks Washout|Inclusion/exclusion criteria not met|1
857685|NCT01537081|2828012|P3|Overall Study|Assigned but never dosed|0
857686|NCT01537081|2828013|P2|Overall Study|Assigned but never dosed|0
857687|NCT01537081|2828014|P1|Overall Study|Assigned but never dosed|1
857688|NCT01537081|2828012|P3|Overall Study|Sponsor decision|0
857689|NCT01537081|2828013|P2|Overall Study|Sponsor decision|1
857690|NCT01537081|2828014|P1|Overall Study|Sponsor decision|0
857691|NCT01537081|2828012|P3|Overall Study|Physician Decision|0
857692|NCT01537081|2828013|P2|Overall Study|Physician Decision|6
857693|NCT01537081|2828014|P1|Overall Study|Physician Decision|5
857694|NCT01537081|2828012|P3|Overall Study|Withdrawal by Subject|3
857695|NCT01537081|2828013|P2|Overall Study|Withdrawal by Subject|11
857696|NCT01537081|2828014|P1|Overall Study|Withdrawal by Subject|6
857697|NCT01537081|2828012|P3|Overall Study|Protocol Violation|2
857698|NCT01537081|2828013|P2|Overall Study|Protocol Violation|2
857699|NCT01537081|2828014|P1|Overall Study|Protocol Violation|3
857700|NCT01537081|2828012|P3|Overall Study|Lost to Follow-up|9
857701|NCT01537081|2828013|P2|Overall Study|Lost to Follow-up|15
857702|NCT01537081|2828014|P1|Overall Study|Lost to Follow-up|17
857703|NCT01537081|2828012|P3|Overall Study|Lack of Efficacy|0
857704|NCT01537081|2828013|P2|Overall Study|Lack of Efficacy|1
857705|NCT01537081|2828014|P1|Overall Study|Lack of Efficacy|2
857706|NCT01537081|2828012|P3|Overall Study|Adverse Event|2
857707|NCT01537081|2828013|P2|Overall Study|Adverse Event|2
857708|NCT01537081|2828014|P1|Overall Study|Adverse Event|5
857709|NCT01537068|2828027|P2|Overall Study|Lack of Efficacy|0
857710|NCT01537068|2828028|P1|Overall Study|Lack of Efficacy|1
857711|NCT01537068|2828027|P2|Overall Study|Withdrawal by Subject|1
857712|NCT01537068|2828028|P1|Overall Study|Withdrawal by Subject|1
857713|NCT01537068|2828027|P2|Overall Study|Adverse Event|1
857714|NCT01537068|2828028|P1|Overall Study|Adverse Event|0
857715|NCT01537068|2828027|P2|Overall Study|Lost to Follow-up|1
857716|NCT01537068|2828028|P1|Overall Study|Lost to Follow-up|2
857717|NCT01537042|2828040|P2|Overall Study|Other|1
857718|NCT01537042|2828041|P1|Overall Study|Other|0
857719|NCT01537042|2828040|P2|Overall Study|Protocol Violation|1
857720|NCT01537042|2828041|P1|Overall Study|Protocol Violation|0
857721|NCT01537042|2828040|P2|Overall Study|Lack of Efficacy|1
857722|NCT01537042|2828041|P1|Overall Study|Lack of Efficacy|0
857723|NCT01537042|2828040|P2|Overall Study|Adverse Event|2
857724|NCT01537042|2828041|P1|Overall Study|Adverse Event|0
857725|NCT01536951|2828083|P9|Second Intervention and Washout Period 2|Adverse Event|0
857726|NCT01536951|2828084|P8|Second Intervention and Washout Period 2|Adverse Event|1
857727|NCT01536951|2828085|P7|Second Intervention and Washout Period 2|Adverse Event|0
857728|NCT01536951|2828086|P6|Second Intervention and Washout Period 2|Adverse Event|0
857729|NCT01536951|2828087|P5|Second Intervention and Washout Period 2|Adverse Event|0
857730|NCT01536951|2828088|P4|Second Intervention and Washout Period 2|Adverse Event|0
857731|NCT01536951|2828089|P3|Second Intervention and Washout Period 2|Adverse Event|0
857732|NCT01536951|2828090|P2|Second Intervention and Washout Period 2|Adverse Event|0
857733|NCT01536951|2828091|P1|Second Intervention and Washout Period 2|Adverse Event|0
857734|NCT01536951|2828083|P9|First Intervention and Washout Period 1|Withdrawal by Subject|0
857735|NCT01536951|2828084|P8|First Intervention and Washout Period 1|Withdrawal by Subject|0
857736|NCT01536951|2828085|P7|First Intervention and Washout Period 1|Withdrawal by Subject|0
857737|NCT01536951|2828086|P6|First Intervention and Washout Period 1|Withdrawal by Subject|0
857738|NCT01536951|2828087|P5|First Intervention and Washout Period 1|Withdrawal by Subject|0
857739|NCT01536951|2828088|P4|First Intervention and Washout Period 1|Withdrawal by Subject|0
857740|NCT01536951|2828089|P3|First Intervention and Washout Period 1|Withdrawal by Subject|1
857741|NCT01536951|2828090|P2|First Intervention and Washout Period 1|Withdrawal by Subject|0
857742|NCT01536951|2828091|P1|First Intervention and Washout Period 1|Withdrawal by Subject|0
857743|NCT01536860|2828148|P3|Washout Period (3 Days)|Lost to Follow-up|0
857744|NCT01536860|2828149|P2|Washout Period (3 Days)|Lost to Follow-up|0
857745|NCT01536860|2828150|P1|Washout Period (3 Days)|Lost to Follow-up|1
857746|NCT01536704|2828158|P4|Washout Period 3|Adverse Event|0
857747|NCT01536704|2828159|P3|Washout Period 3|Adverse Event|1
857748|NCT01536704|2828160|P2|Washout Period 3|Adverse Event|0
857749|NCT01536704|2828161|P1|Washout Period 3|Adverse Event|0
857750|NCT01536704|2828158|P4|Period 3|Adverse Event|1
857751|NCT01536704|2828159|P3|Period 3|Adverse Event|0
857752|NCT01536704|2828160|P2|Period 3|Adverse Event|0
857753|NCT01536704|2828161|P1|Period 3|Adverse Event|0
857754|NCT01536704|2828158|P4|Washout Period 2|Withdrawal by Subject|1
857755|NCT01536704|2828159|P3|Washout Period 2|Withdrawal by Subject|0
857756|NCT01536704|2828160|P2|Washout Period 2|Withdrawal by Subject|0
857757|NCT01536704|2828161|P1|Washout Period 2|Withdrawal by Subject|0
857758|NCT01536704|2828158|P4|Washout Period 2|Adverse Event|0
857759|NCT01536704|2828159|P3|Washout Period 2|Adverse Event|0
857760|NCT01536704|2828160|P2|Washout Period 2|Adverse Event|0
857761|NCT01536704|2828161|P1|Washout Period 2|Adverse Event|1
857762|NCT01536704|2828158|P4|Washout Period 1|Withdrawal by Subject|0
857763|NCT01536704|2828159|P3|Washout Period 1|Withdrawal by Subject|0
857764|NCT01536704|2828160|P2|Washout Period 1|Withdrawal by Subject|2
857765|NCT01536704|2828161|P1|Washout Period 1|Withdrawal by Subject|1
857766|NCT01536587|2828191|P1|Overall Study|Adverse Event|2
857767|NCT01536574|2828230|P2|Overall Study|Lack of Efficacy|0
857768|NCT01536574|2828231|P1|Overall Study|Lack of Efficacy|1
857769|NCT01536574|2828230|P2|Overall Study|Withdrawal by Subject|2
857770|NCT01536574|2828231|P1|Overall Study|Withdrawal by Subject|1
857771|NCT01536574|2828230|P2|Overall Study|Adverse Event|5
857772|NCT01536574|2828231|P1|Overall Study|Adverse Event|4
857773|NCT01536561|2828249|P1|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13
857774|NCT01536561|2828249|P1|Dosimetric and Therapeutic Treatment|Death|2
857775|NCT01536561|2828249|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1
857776|NCT01536561|2828249|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
857777|NCT01536561|2828249|P1|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2
857778|NCT01536561|2828249|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|40
857779|NCT01536418|2828326|P2|Overall Study|Withdrawal by Subject|3
857780|NCT01536418|2828327|P1|Overall Study|Withdrawal by Subject|5
857781|NCT01536418|2828326|P2|Overall Study|Met Liver Chemistry Stopping criteria|0
857782|NCT01536418|2828327|P1|Overall Study|Met Liver Chemistry Stopping criteria|1
857783|NCT01536418|2828326|P2|Overall Study|Adverse Event|4
857784|NCT01536418|2828327|P1|Overall Study|Adverse Event|9
857785|NCT01536418|2828326|P2|Overall Study|Lack of Efficacy|16
857786|NCT01536418|2828327|P1|Overall Study|Lack of Efficacy|10
857787|NCT01536418|2828326|P2|Overall Study|Study closed/terminated|37
857788|NCT01536418|2828327|P1|Overall Study|Study closed/terminated|41
857789|NCT01536418|2828326|P2|Overall Study|Physician Decision|3
857790|NCT01536418|2828327|P1|Overall Study|Physician Decision|1
857791|NCT01536418|2828326|P2|Overall Study|Protocol Violation|3
857792|NCT01536418|2828327|P1|Overall Study|Protocol Violation|2
857793|NCT01536405|2828347|P2|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
857794|NCT01536405|2828348|P1|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
857795|NCT01536405|2828347|P2|Visit 4 to Extended Study Follow-up|Adverse Event|1
857796|NCT01536405|2828348|P1|Visit 4 to Extended Study Follow-up|Adverse Event|0
857797|NCT01536405|2828347|P2|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2
857798|NCT01536405|2828348|P1|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0
857799|NCT01536405|2828347|P2|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14
857800|NCT01536405|2828348|P1|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16
857801|NCT01536405|2828347|P2|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0
857802|NCT01536405|2828348|P1|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1
857803|NCT01536405|2828347|P2|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2
857804|NCT01536405|2828348|P1|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3
857805|NCT01536405|2828347|P2|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
857806|NCT01536405|2828348|P1|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
857807|NCT01536405|2828347|P2|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10
857808|NCT01536405|2828348|P1|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9
857809|NCT01536405|2828347|P2|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
857810|NCT01536405|2828348|P1|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
857811|NCT01536405|2828347|P2|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13
857812|NCT01536405|2828348|P1|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17
857813|NCT01536405|2828347|P2|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22
857814|NCT01536405|2828348|P1|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20
857815|NCT01536405|2828347|P2|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18
857816|NCT01536405|2828348|P1|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12
857817|NCT01536405|2828347|P2|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4
857818|NCT01536405|2828348|P1|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8
857819|NCT01536379|2828386|P2|Overall Study|Withdrawal by Subject|1
857820|NCT01536379|2828387|P1|Overall Study|Withdrawal by Subject|1
857821|NCT01536379|2828386|P2|Overall Study|Adverse Event|2
857822|NCT01536379|2828387|P1|Overall Study|Adverse Event|1
857823|NCT01536262|2828479|P3|Overall Study|Other than stated above|0
857824|NCT01536262|2828480|P2|Overall Study|Other than stated above|0
857825|NCT01536262|2828481|P1|Overall Study|Other than stated above|1
857826|NCT01536262|2828479|P3|Overall Study|Withdrawal by Subject|0
857827|NCT01536262|2828480|P2|Overall Study|Withdrawal by Subject|1
857828|NCT01536262|2828481|P1|Overall Study|Withdrawal by Subject|1
857829|NCT01536262|2828479|P3|Overall Study|Adverse Event|2
857830|NCT01536262|2828480|P2|Overall Study|Adverse Event|1
857831|NCT01536262|2828481|P1|Overall Study|Adverse Event|6
857832|NCT01536171|2828523|P1|Overall Study|Withdrawal by Subject|1
857833|NCT01536145|2828528|P11|Overall Study|Adverse Event|3
857834|NCT01536145|2828529|P10|Overall Study|Adverse Event|0
857835|NCT01536145|2828530|P9|Overall Study|Adverse Event|0
857836|NCT01536145|2828531|P8|Overall Study|Adverse Event|2
857837|NCT01536145|2828532|P7|Overall Study|Adverse Event|0
857838|NCT01536145|2828533|P6|Overall Study|Adverse Event|0
857839|NCT01536145|2828534|P5|Overall Study|Adverse Event|0
857840|NCT01536145|2828535|P4|Overall Study|Adverse Event|0
857841|NCT01536145|2828536|P3|Overall Study|Adverse Event|0
857842|NCT01536145|2828537|P2|Overall Study|Adverse Event|0
857843|NCT01536145|2828538|P1|Overall Study|Adverse Event|0
857844|NCT01536145|2828528|P11|Overall Study|Death|0
857845|NCT01536145|2828529|P10|Overall Study|Death|0
857846|NCT01536145|2828530|P9|Overall Study|Death|0
857847|NCT01536145|2828531|P8|Overall Study|Death|0
857848|NCT01536145|2828532|P7|Overall Study|Death|1
857849|NCT01536145|2828533|P6|Overall Study|Death|0
857850|NCT01536145|2828534|P5|Overall Study|Death|0
857851|NCT01536145|2828535|P4|Overall Study|Death|0
857852|NCT01536145|2828536|P3|Overall Study|Death|0
857853|NCT01536145|2828537|P2|Overall Study|Death|0
857854|NCT01536145|2828538|P1|Overall Study|Death|0
857855|NCT01536145|2828528|P11|Overall Study|Other|2
857856|NCT01536145|2828529|P10|Overall Study|Other|3
857857|NCT01536145|2828530|P9|Overall Study|Other|0
857858|NCT01536145|2828531|P8|Overall Study|Other|0
857859|NCT01536145|2828532|P7|Overall Study|Other|0
857860|NCT01536145|2828533|P6|Overall Study|Other|0
857861|NCT01536145|2828534|P5|Overall Study|Other|1
857862|NCT01536145|2828535|P4|Overall Study|Other|0
857863|NCT01536145|2828536|P3|Overall Study|Other|0
857864|NCT01536145|2828537|P2|Overall Study|Other|0
857865|NCT01536145|2828538|P1|Overall Study|Other|0
857866|NCT01536145|2828528|P11|Overall Study|Withdrawal by Subject|2
857867|NCT01536145|2828529|P10|Overall Study|Withdrawal by Subject|0
857868|NCT01536145|2828530|P9|Overall Study|Withdrawal by Subject|2
857869|NCT01536145|2828531|P8|Overall Study|Withdrawal by Subject|0
857870|NCT01536145|2828532|P7|Overall Study|Withdrawal by Subject|0
857871|NCT01536145|2828533|P6|Overall Study|Withdrawal by Subject|1
857872|NCT01536145|2828534|P5|Overall Study|Withdrawal by Subject|0
857873|NCT01536145|2828535|P4|Overall Study|Withdrawal by Subject|0
857874|NCT01536145|2828536|P3|Overall Study|Withdrawal by Subject|1
857875|NCT01536145|2828537|P2|Overall Study|Withdrawal by Subject|0
857876|NCT01536145|2828538|P1|Overall Study|Withdrawal by Subject|0
857877|NCT01536145|2828528|P11|Overall Study|Progressive disease|3
857878|NCT01536145|2828529|P10|Overall Study|Progressive disease|3
857879|NCT01536145|2828530|P9|Overall Study|Progressive disease|1
857880|NCT01536145|2828531|P8|Overall Study|Progressive disease|2
857881|NCT01536145|2828532|P7|Overall Study|Progressive disease|1
857882|NCT01536145|2828533|P6|Overall Study|Progressive disease|2
857883|NCT01536145|2828534|P5|Overall Study|Progressive disease|1
857884|NCT01536145|2828535|P4|Overall Study|Progressive disease|2
857885|NCT01536145|2828536|P3|Overall Study|Progressive disease|1
857886|NCT01536145|2828537|P2|Overall Study|Progressive disease|4
857887|NCT01536145|2828538|P1|Overall Study|Progressive disease|3
857888|NCT01536119|2828645|P2|Overall Study|Lost to Follow-up|14
857889|NCT01536119|2828646|P1|Overall Study|Lost to Follow-up|17
857890|NCT01536093|2828672|P2|Overall Study|Withdrawal by Subject|1
857891|NCT01536093|2828673|P1|Overall Study|Withdrawal by Subject|0
857892|NCT01536093|2828672|P2|Overall Study|absence of maternal colostrum|0
857893|NCT01536093|2828673|P1|Overall Study|absence of maternal colostrum|2
857894|NCT01536093|2828672|P2|Overall Study|Death|2
857895|NCT01536093|2828673|P1|Overall Study|Death|1
857896|NCT01536067|2828689|P1|Overall Study|Disease Progression|1
857897|NCT01536015|2828702|P2|Overall Study|Study closure|5
857898|NCT01536015|2828703|P1|Overall Study|Study closure|5
857899|NCT01536015|2828702|P2|Overall Study|Inclusion Criterion not met|0
857900|NCT01536015|2828703|P1|Overall Study|Inclusion Criterion not met|2
857901|NCT01536015|2828702|P2|Overall Study|Lost to Follow-up|1
857902|NCT01536015|2828703|P1|Overall Study|Lost to Follow-up|0
857903|NCT01536015|2828702|P2|Overall Study|Adverse Event|4
857904|NCT01536015|2828703|P1|Overall Study|Adverse Event|1
857905|NCT01535807|2828741|P2|Overall Study|Data collection error|1
857906|NCT01535807|2828742|P1|Overall Study|Data collection error|1
857907|NCT01535807|2828741|P2|Overall Study|Withdrawal by Subject|1
857908|NCT01535807|2828742|P1|Overall Study|Withdrawal by Subject|1
857909|NCT01535729|2828748|P1|Overall Study|No participant record available|5
857910|NCT01535729|2828748|P1|Overall Study|Not treated|9
857911|NCT01535729|2828748|P1|Overall Study|Screening failure|1
857912|NCT01535729|2828748|P1|Overall Study|Protocol Violation|11
857913|NCT01535729|2828748|P1|Overall Study|NSCLC grade IV histology not confirmed|20
857914|NCT01535729|2828748|P1|Overall Study|No previous chemotherapy|33
857915|NCT01535729|2828748|P1|Overall Study|Did not sign informed consent|1
857916|NCT01535729|2828748|P1|Overall Study|Other|19
857917|NCT01535729|2828748|P1|Overall Study|Death|52
857918|NCT01535729|2828748|P1|Overall Study|Lost to Follow-up|8
857919|NCT01535729|2828748|P1|Overall Study|Discontinued treatment|25
857920|NCT01535729|2828748|P1|Overall Study|Disease progression|230
857921|NCT01535729|2828748|P1|Overall Study|Withdrawal by Subject|2
857922|NCT01535638|2828789|P6|Treatment 3 (Single Dose)|Protocol Violation|0
857923|NCT01535638|2828790|P5|Treatment 3 (Single Dose)|Protocol Violation|0
857924|NCT01535638|2828791|P4|Treatment 3 (Single Dose)|Protocol Violation|1
857925|NCT01535638|2828792|P3|Treatment 3 (Single Dose)|Protocol Violation|0
857926|NCT01535638|2828793|P2|Treatment 3 (Single Dose)|Protocol Violation|0
857927|NCT01535638|2828794|P1|Treatment 3 (Single Dose)|Protocol Violation|0
857928|NCT01535638|2828789|P6|Treatment 1 (Single Dose)|Protocol Violation|1
857929|NCT01535638|2828790|P5|Treatment 1 (Single Dose)|Protocol Violation|0
857930|NCT01535638|2828791|P4|Treatment 1 (Single Dose)|Protocol Violation|0
857931|NCT01535638|2828792|P3|Treatment 1 (Single Dose)|Protocol Violation|0
857932|NCT01535638|2828793|P2|Treatment 1 (Single Dose)|Protocol Violation|0
857933|NCT01535638|2828794|P1|Treatment 1 (Single Dose)|Protocol Violation|0
857934|NCT01535599|2828808|P2|Overall Study|Noncompliance|1
857935|NCT01535599|2828809|P1|Overall Study|Noncompliance|0
857936|NCT01535599|2828808|P2|Overall Study|Stopped medication|1
857937|NCT01535599|2828809|P1|Overall Study|Stopped medication|0
857938|NCT01535599|2828808|P2|Overall Study|Other|0
857939|NCT01535599|2828809|P1|Overall Study|Other|1
857940|NCT01535599|2828808|P2|Overall Study|Did not use product|0
857941|NCT01535599|2828809|P1|Overall Study|Did not use product|1
857942|NCT01535599|2828808|P2|Overall Study|Randomized in Error|4
857943|NCT01535599|2828809|P1|Overall Study|Randomized in Error|2
857944|NCT01535599|2828808|P2|Overall Study|BL Culture + for Yeast//Fungi|1
857945|NCT01535599|2828809|P1|Overall Study|BL Culture + for Yeast//Fungi|0
857946|NCT01535599|2828808|P2|Overall Study|BL Culture + for Group A Strep|1
857947|NCT01535599|2828809|P1|Overall Study|BL Culture + for Group A Strep|0
857948|NCT01535599|2828808|P2|Overall Study|Treatment Failure|66
857949|NCT01535599|2828809|P1|Overall Study|Treatment Failure|33
857950|NCT01535599|2828808|P2|Overall Study|Subj Decision Unrelated to Adverse Event|3
857951|NCT01535599|2828809|P1|Overall Study|Subj Decision Unrelated to Adverse Event|4
857952|NCT01535599|2828808|P2|Overall Study|Lost to Follow-up|4
857953|NCT01535599|2828809|P1|Overall Study|Lost to Follow-up|3
857954|NCT01535599|2828808|P2|Overall Study|Adverse Event|15
857955|NCT01535599|2828809|P1|Overall Study|Adverse Event|6
857956|NCT01535560|2828821|P2|Overall Study|Randomized in Error|1
857957|NCT01535560|2828822|P1|Overall Study|Randomized in Error|0
857958|NCT01535560|2828821|P2|Overall Study|Other|1
857959|NCT01535560|2828822|P1|Overall Study|Other|0
857960|NCT01535560|2828821|P2|Overall Study|Treatment Failure|83
857961|NCT01535560|2828822|P1|Overall Study|Treatment Failure|21
857962|NCT01535560|2828821|P2|Overall Study|Subj Decision Unrel to an Adverse Event|1
857963|NCT01535560|2828822|P1|Overall Study|Subj Decision Unrel to an Adverse Event|3
857964|NCT01535560|2828821|P2|Overall Study|Lost to Follow-up|3
857965|NCT01535560|2828822|P1|Overall Study|Lost to Follow-up|1
857966|NCT01535560|2828821|P2|Overall Study|Adverse Event|7
857967|NCT01535560|2828822|P1|Overall Study|Adverse Event|12
857968|NCT01535287|2828867|P2|Overall Study|drug not prepared in time|6
857969|NCT01535287|2828868|P1|Overall Study|drug not prepared in time|5
857970|NCT01535261|2828884|P1|Overall Study|Adverse Event|12
857971|NCT01535261|2828884|P1|Overall Study|Withdrawal by Subject|14
857972|NCT01535261|2828884|P1|Overall Study|Lost to Follow-up|8
857973|NCT01535261|2828884|P1|Overall Study|Death|5
857974|NCT01535261|2828884|P1|Overall Study|Protocol Violation|3
857975|NCT01535261|2828884|P1|Overall Study|Physician Decision|8
857976|NCT01535235|2828897|P2|Overall Study|Adverse Event|0
857977|NCT01535235|2828898|P1|Overall Study|Adverse Event|1
857978|NCT01535222|2828912|P6|Overall Study|Inclusion/exclusion|0
857979|NCT01535222|2828913|P5|Overall Study|Inclusion/exclusion|0
857980|NCT01535222|2828914|P4|Overall Study|Inclusion/exclusion|0
857981|NCT01535222|2828915|P3|Overall Study|Inclusion/exclusion|1
857982|NCT01535222|2828916|P2|Overall Study|Inclusion/exclusion|0
857983|NCT01535222|2828917|P1|Overall Study|Inclusion/exclusion|0
857984|NCT01535040|2828948|P2|Overall Study|Multiple Reasons|1
857985|NCT01535040|2828949|P1|Overall Study|Multiple Reasons|1
857986|NCT01535040|2828948|P2|Overall Study|Toxicity|5
857987|NCT01535040|2828949|P1|Overall Study|Toxicity|7
857988|NCT01535040|2828948|P2|Overall Study|Never Started|4
857989|NCT01535040|2828949|P1|Overall Study|Never Started|9
857990|NCT01535040|2828948|P2|Overall Study|Withdrawal by Subject|10
857991|NCT01535040|2828949|P1|Overall Study|Withdrawal by Subject|13
857992|NCT01535040|2828948|P2|Overall Study|Physician Decision|1
857993|NCT01535040|2828949|P1|Overall Study|Physician Decision|0
857994|NCT01534962|2829046|P4|Overall Study|Discontinued at AF recurrence|31
857995|NCT01534962|2829047|P3|Overall Study|Discontinued at AF recurrence|24
857996|NCT01534962|2829048|P2|Overall Study|Discontinued at AF recurrence|26
857997|NCT01534962|2829049|P1|Overall Study|Discontinued at AF recurrence|35
857998|NCT01534962|2829046|P4|Overall Study|Randomized but did not start treatment|1
857999|NCT01534962|2829047|P3|Overall Study|Randomized but did not start treatment|0
858000|NCT01534962|2829048|P2|Overall Study|Randomized but did not start treatment|0
858001|NCT01534962|2829049|P1|Overall Study|Randomized but did not start treatment|2
858002|NCT01534676|2829106|P2|Overall Study|Study closed due to poor enrollment|1
858003|NCT01534676|2829107|P1|Overall Study|Study closed due to poor enrollment|2
858004|NCT01534637|2829113|P1|Overall Study|Liver Mets before treatment|1
858005|NCT01534637|2829113|P1|Overall Study|Adverse Event|1
858006|NCT01534637|2829113|P1|Overall Study|Withdrawal by Subject|1
858007|NCT01534637|2829113|P1|Overall Study|Lack of Efficacy|3
858008|NCT01534637|2829113|P1|Overall Study|Physician Decision|3
858009|NCT01534533|2829123|P4|Overall Study|Withdrawal by Subject|1
858010|NCT01534533|2829124|P3|Overall Study|Withdrawal by Subject|4
858011|NCT01534533|2829125|P2|Overall Study|Withdrawal by Subject|3
858012|NCT01534533|2829126|P1|Overall Study|Withdrawal by Subject|5
858013|NCT01534533|2829123|P4|Overall Study|Lost to Follow-up|3
858014|NCT01534533|2829124|P3|Overall Study|Lost to Follow-up|4
858015|NCT01534533|2829125|P2|Overall Study|Lost to Follow-up|0
858016|NCT01534533|2829126|P1|Overall Study|Lost to Follow-up|3
858017|NCT01534520|2829154|P2|Overall Study|Adverse Event|1
858018|NCT01534520|2829155|P1|Overall Study|Adverse Event|0
858019|NCT01534351|2829189|P3|Overall Study|Study Terminated Early|0
858020|NCT01534351|2829190|P2|Overall Study|Study Terminated Early|0
858021|NCT01534351|2829191|P1|Overall Study|Study Terminated Early|1
858022|NCT01534260|2829210|P2|Overall Study|No treatment, per protocol|1
858023|NCT01534260|2829211|P1|Overall Study|No treatment, per protocol|0
858024|NCT01534260|2829210|P2|Overall Study|Physician Decision|1
858025|NCT01534260|2829211|P1|Overall Study|Physician Decision|3
858026|NCT01534260|2829210|P2|Overall Study|Disease Progression|6
858027|NCT01534260|2829211|P1|Overall Study|Disease Progression|8
858028|NCT01534260|2829210|P2|Overall Study|Withdrawal by Subject|3
858029|NCT01534260|2829211|P1|Overall Study|Withdrawal by Subject|1
858030|NCT01534260|2829210|P2|Overall Study|Lack of Efficacy|1
858031|NCT01534260|2829211|P1|Overall Study|Lack of Efficacy|1
858032|NCT01534260|2829210|P2|Overall Study|Death|0
858033|NCT01534260|2829211|P1|Overall Study|Death|2
858034|NCT01534260|2829210|P2|Overall Study|Adverse Event|8
858035|NCT01534260|2829211|P1|Overall Study|Adverse Event|1
858036|NCT01534208|2829221|P2|Overall Study|Needed prohibited meds|0
858037|NCT01534208|2829222|P1|Overall Study|Needed prohibited meds|1
858038|NCT01534208|2829221|P2|Overall Study|PCP decision|0
858039|NCT01534208|2829222|P1|Overall Study|PCP decision|1
858040|NCT01534208|2829221|P2|Overall Study|Eligibility error|0
858041|NCT01534208|2829222|P1|Overall Study|Eligibility error|3
858042|NCT01534208|2829221|P2|Overall Study|Lab assessment|1
858043|NCT01534208|2829222|P1|Overall Study|Lab assessment|2
858044|NCT01534208|2829221|P2|Overall Study|Subject relocation|0
858045|NCT01534208|2829222|P1|Overall Study|Subject relocation|2
858046|NCT01534208|2829221|P2|Overall Study|Sponsor decision|1
858047|NCT01534208|2829222|P1|Overall Study|Sponsor decision|4
858048|NCT01534208|2829221|P2|Overall Study|Protocol Violation|2
858049|NCT01534208|2829222|P1|Overall Study|Protocol Violation|2
858050|NCT01534208|2829221|P2|Overall Study|Lack of Efficacy|3
858051|NCT01534208|2829222|P1|Overall Study|Lack of Efficacy|0
858052|NCT01534208|2829221|P2|Overall Study|Physician Decision|0
858053|NCT01534208|2829222|P1|Overall Study|Physician Decision|2
858054|NCT01534208|2829221|P2|Overall Study|Adverse Event|8
858055|NCT01534208|2829222|P1|Overall Study|Adverse Event|15
858056|NCT01534208|2829221|P2|Overall Study|Withdrawal by Subject|20
858057|NCT01534208|2829222|P1|Overall Study|Withdrawal by Subject|6
858058|NCT01534208|2829221|P2|Overall Study|Lost to Follow-up|14
858059|NCT01534208|2829222|P1|Overall Study|Lost to Follow-up|19
858060|NCT01534182|2829240|P2|Overall Study|Adverse Event|3
858061|NCT01534182|2829241|P1|Overall Study|Adverse Event|7
858062|NCT01534182|2829240|P2|Overall Study|Withdrawal by Subject|7
858063|NCT01534182|2829241|P1|Overall Study|Withdrawal by Subject|4
858064|NCT01534182|2829240|P2|Overall Study|Administrative problems|0
858065|NCT01534182|2829241|P1|Overall Study|Administrative problems|1
858066|NCT01534078|2829272|P1|Overall Study|Withdrawal by Subject|1
858067|NCT01534078|2829272|P1|Overall Study|Death|1
858068|NCT01533935|2829300|P5|Overall Study|Other reason not defined above|1
858069|NCT01533935|2829301|P4|Overall Study|Other reason not defined above|0
858070|NCT01533935|2829302|P3|Overall Study|Other reason not defined above|1
858071|NCT01533935|2829303|P2|Overall Study|Other reason not defined above|0
858072|NCT01533935|2829304|P1|Overall Study|Other reason not defined above|1
858073|NCT01533935|2829300|P5|Overall Study|Withdrawal by Subject|4
858074|NCT01533935|2829301|P4|Overall Study|Withdrawal by Subject|2
858075|NCT01533935|2829302|P3|Overall Study|Withdrawal by Subject|5
858076|NCT01533935|2829303|P2|Overall Study|Withdrawal by Subject|4
858077|NCT01533935|2829304|P1|Overall Study|Withdrawal by Subject|0
858078|NCT01533935|2829300|P5|Overall Study|Lost to Follow-up|0
858079|NCT01533935|2829301|P4|Overall Study|Lost to Follow-up|0
858080|NCT01533935|2829302|P3|Overall Study|Lost to Follow-up|1
858081|NCT01533935|2829303|P2|Overall Study|Lost to Follow-up|0
858082|NCT01533935|2829304|P1|Overall Study|Lost to Follow-up|0
858083|NCT01533935|2829300|P5|Overall Study|Protocol Violation|0
858084|NCT01533935|2829301|P4|Overall Study|Protocol Violation|0
858085|NCT01533935|2829302|P3|Overall Study|Protocol Violation|0
858086|NCT01533935|2829303|P2|Overall Study|Protocol Violation|2
858087|NCT01533935|2829304|P1|Overall Study|Protocol Violation|0
858088|NCT01533935|2829300|P5|Overall Study|Adverse Event|3
858089|NCT01533935|2829301|P4|Overall Study|Adverse Event|5
858090|NCT01533935|2829302|P3|Overall Study|Adverse Event|1
858091|NCT01533935|2829303|P2|Overall Study|Adverse Event|7
858092|NCT01533935|2829304|P1|Overall Study|Adverse Event|5
858093|NCT01533922|2829331|P5|Overall Study|Other reason not defined above|0
858094|NCT01533922|2829332|P4|Overall Study|Other reason not defined above|0
858095|NCT01533922|2829333|P3|Overall Study|Other reason not defined above|1
858096|NCT01533922|2829334|P2|Overall Study|Other reason not defined above|0
858097|NCT01533922|2829335|P1|Overall Study|Other reason not defined above|2
858098|NCT01533922|2829331|P5|Overall Study|Withdrawal by Subject|1
858099|NCT01533922|2829332|P4|Overall Study|Withdrawal by Subject|2
858100|NCT01533922|2829333|P3|Overall Study|Withdrawal by Subject|2
858101|NCT01533922|2829334|P2|Overall Study|Withdrawal by Subject|1
858102|NCT01533922|2829335|P1|Overall Study|Withdrawal by Subject|3
858103|NCT01533922|2829331|P5|Overall Study|Protocol Violation|1
858104|NCT01533922|2829332|P4|Overall Study|Protocol Violation|0
858105|NCT01533922|2829333|P3|Overall Study|Protocol Violation|0
858106|NCT01533922|2829334|P2|Overall Study|Protocol Violation|3
858107|NCT01533922|2829335|P1|Overall Study|Protocol Violation|0
858108|NCT01533922|2829331|P5|Overall Study|Lack of Efficacy|0
858109|NCT01533922|2829332|P4|Overall Study|Lack of Efficacy|0
858110|NCT01533922|2829333|P3|Overall Study|Lack of Efficacy|1
858111|NCT01533922|2829334|P2|Overall Study|Lack of Efficacy|0
858112|NCT01533922|2829335|P1|Overall Study|Lack of Efficacy|0
858113|NCT01533922|2829331|P5|Overall Study|Adverse Event|4
858114|NCT01533922|2829332|P4|Overall Study|Adverse Event|3
858115|NCT01533922|2829333|P3|Overall Study|Adverse Event|6
858116|NCT01533922|2829334|P2|Overall Study|Adverse Event|8
858117|NCT01533922|2829335|P1|Overall Study|Adverse Event|5
858118|NCT01533688|2829380|P3|Overall Study|Had colonoscopy at outside hospital|2
858119|NCT01533688|2829381|P2|Overall Study|Had colonoscopy at outside hospital|3
858120|NCT01533688|2829382|P1|Overall Study|Had colonoscopy at outside hospital|2
858121|NCT01533688|2829380|P3|Overall Study|Medically unstable|3
858122|NCT01533688|2829381|P2|Overall Study|Medically unstable|3
858123|NCT01533688|2829382|P1|Overall Study|Medically unstable|1
858124|NCT01533688|2829380|P3|Overall Study|Withdrawal by Subject|3
858125|NCT01533688|2829381|P2|Overall Study|Withdrawal by Subject|4
858126|NCT01533688|2829382|P1|Overall Study|Withdrawal by Subject|5
858127|NCT01533493|2829414|P2|Overall Study|Lost to Follow-up|0
858128|NCT01533493|2829415|P1|Overall Study|Lost to Follow-up|2
858129|NCT01533493|2829414|P2|Overall Study|Withdrawal by Subject|2
858130|NCT01533493|2829415|P1|Overall Study|Withdrawal by Subject|1
858131|NCT01533493|2829414|P2|Overall Study|Adverse Event|1
858132|NCT01533493|2829415|P1|Overall Study|Adverse Event|2
858133|NCT01533428|2829423|P2|Overall Study|Withdrawal by Subject|6
858134|NCT01533428|2829424|P1|Overall Study|Withdrawal by Subject|7
858135|NCT01533428|2829423|P2|Overall Study|Lost to Follow-up|1
858136|NCT01533428|2829424|P1|Overall Study|Lost to Follow-up|2
858137|NCT01533428|2829423|P2|Overall Study|Adverse Event|1
858138|NCT01533428|2829424|P1|Overall Study|Adverse Event|0
858139|NCT01533246|2829470|P1|Overall Study|Withdrawal by Subject|1
858140|NCT01533246|2829470|P1|Overall Study|Adverse Event|1
858141|NCT01533181|2829481|P2|Overall Study|Patient withdrawal pre-active treatment|0
858142|NCT01533181|2829482|P1|Overall Study|Patient withdrawal pre-active treatment|1
858143|NCT01533181|2829481|P2|Overall Study|Disease progression pre-active treatment|1
858144|NCT01533181|2829482|P1|Overall Study|Disease progression pre-active treatment|0
858145|NCT01532999|2829599|P2|Overall Study|New job|2
858146|NCT01532999|2829600|P1|Overall Study|New job|0
858147|NCT01532999|2829599|P2|Overall Study|incarcerated|1
858148|NCT01532999|2829600|P1|Overall Study|incarcerated|0
858149|NCT01532999|2829599|P2|Overall Study|Adverse Event|1
858150|NCT01532999|2829600|P1|Overall Study|Adverse Event|0
858151|NCT01532999|2829599|P2|Overall Study|no show for week 9 assessments|4
858152|NCT01532999|2829600|P1|Overall Study|no show for week 9 assessments|6
858153|NCT01532999|2829599|P2|Overall Study|substantial noncompliance|0
858154|NCT01532999|2829600|P1|Overall Study|substantial noncompliance|2
858155|NCT01532999|2829599|P2|Overall Study|should not have been randomized|0
858156|NCT01532999|2829600|P1|Overall Study|should not have been randomized|1
858157|NCT01532999|2829599|P2|Overall Study|Relocated|0
858158|NCT01532999|2829600|P1|Overall Study|Relocated|2
858159|NCT01532999|2829599|P2|Overall Study|Withdrawal by Subject|0
858160|NCT01532999|2829600|P1|Overall Study|Withdrawal by Subject|5
858161|NCT01532999|2829599|P2|Overall Study|Physician Decision|2
858162|NCT01532999|2829600|P1|Overall Study|Physician Decision|1
858163|NCT01532999|2829599|P2|Overall Study|Lost to Follow-up|8
858164|NCT01532999|2829600|P1|Overall Study|Lost to Follow-up|14
858165|NCT01532934|2829682|P2|Overall Study|In controlled environment|2
858166|NCT01532934|2829683|P1|Overall Study|In controlled environment|3
858167|NCT01532934|2829682|P2|Overall Study|Lost to Follow-up|11
858168|NCT01532934|2829683|P1|Overall Study|Lost to Follow-up|11
858169|NCT01532921|2829693|P1|Overall Study|Device was explanted during procedure|1
858170|NCT01532921|2829693|P1|Overall Study|Physician Decision|7
858171|NCT01532921|2829693|P1|Overall Study|Lost to Follow-up|3
858172|NCT01532921|2829693|P1|Overall Study|Withdrawal by Subject|2
858173|NCT01532921|2829693|P1|Overall Study|Death|3
858174|NCT01532869|2829715|P2|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
858175|NCT01532869|2829716|P1|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
858176|NCT01532869|2829715|P2|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
858177|NCT01532869|2829716|P1|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
858178|NCT01532869|2829715|P2|Open-label Period (Week 48 to Week 96)|Non-compliance|0
858179|NCT01532869|2829716|P1|Open-label Period (Week 48 to Week 96)|Non-compliance|1
858180|NCT01532869|2829715|P2|Open-label Period (Week 48 to Week 96)|Adverse Event|1
858181|NCT01532869|2829716|P1|Open-label Period (Week 48 to Week 96)|Adverse Event|4
858182|NCT01532869|2829715|P2|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0
858183|NCT01532869|2829716|P1|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1
858184|NCT01532869|2829715|P2|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3
858185|NCT01532869|2829716|P1|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5
858186|NCT01532869|2829715|P2|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1
858187|NCT01532869|2829716|P1|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0
858188|NCT01532869|2829715|P2|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0
858189|NCT01532869|2829716|P1|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1
858190|NCT01532869|2829715|P2|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1
858191|NCT01532869|2829716|P1|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0
858192|NCT01532869|2829715|P2|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5
858193|NCT01532869|2829716|P1|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4
858194|NCT01532869|2829715|P2|Blinded-Treatment Period (Up to Week 48)|Death|3
858195|NCT01532869|2829716|P1|Blinded-Treatment Period (Up to Week 48)|Death|0
858196|NCT01532869|2829715|P2|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2
858197|NCT01532869|2829716|P1|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4
858198|NCT01532869|2829715|P2|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
858199|NCT01532869|2829716|P1|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
858200|NCT01532869|2829715|P2|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0
858201|NCT01532869|2829716|P1|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1
858202|NCT01532869|2829715|P2|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1
858203|NCT01532869|2829716|P1|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0
858204|NCT01532869|2829715|P2|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3
858205|NCT01532869|2829716|P1|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2
858206|NCT01532869|2829715|P2|Blinded-Treatment Period (Up to Week 24)|Death|1
858207|NCT01532869|2829716|P1|Blinded-Treatment Period (Up to Week 24)|Death|0
858208|NCT01532570|2829782|P4|Overall Study|Withdrawal by Subject|0
858209|NCT01532570|2829783|P3|Overall Study|Withdrawal by Subject|0
858210|NCT01532570|2829784|P2|Overall Study|Withdrawal by Subject|1
858211|NCT01532570|2829785|P1|Overall Study|Withdrawal by Subject|0
858212|NCT01532570|2829782|P4|Overall Study|Lack of Efficacy|0
858213|NCT01532570|2829783|P3|Overall Study|Lack of Efficacy|0
858214|NCT01532570|2829784|P2|Overall Study|Lack of Efficacy|0
858215|NCT01532570|2829785|P1|Overall Study|Lack of Efficacy|1
858216|NCT01532414|2829830|P3|Overall Study|Withdrawn by sponsor|0
858217|NCT01532414|2829831|P2|Overall Study|Withdrawn by sponsor|0
858218|NCT01532414|2829832|P1|Overall Study|Withdrawn by sponsor|1
858219|NCT01532414|2829830|P3|Overall Study|Unable to complete 24 hour PK|1
858220|NCT01532414|2829831|P2|Overall Study|Unable to complete 24 hour PK|0
858221|NCT01532414|2829832|P1|Overall Study|Unable to complete 24 hour PK|0
858222|NCT01532414|2829830|P3|Overall Study|Adverse Event|1
858223|NCT01532414|2829831|P2|Overall Study|Adverse Event|1
858224|NCT01532414|2829832|P1|Overall Study|Adverse Event|0
858225|NCT01532414|2829830|P3|Overall Study|No V6 semen sample|0
858226|NCT01532414|2829831|P2|Overall Study|No V6 semen sample|1
858227|NCT01532414|2829832|P1|Overall Study|No V6 semen sample|0
858228|NCT01532414|2829830|P3|Overall Study|Withdrawal by Subject|0
858229|NCT01532414|2829831|P2|Overall Study|Withdrawal by Subject|0
858230|NCT01532414|2829832|P1|Overall Study|Withdrawal by Subject|3
858231|NCT01532414|2829830|P3|Overall Study|Lost to Follow-up|1
858232|NCT01532414|2829831|P2|Overall Study|Lost to Follow-up|0
858233|NCT01532414|2829832|P1|Overall Study|Lost to Follow-up|3
858234|NCT01531998|2829898|P1|Overall Study|Withdrawal by Subject|3
858235|NCT01531725|2829903|P1|Overall Study|Protocol Violation|5
858236|NCT01531673|2829921|P13|Overall Study|Other|0
858237|NCT01531673|2829922|P12|Overall Study|Other|0
858238|NCT01531673|2829923|P11|Overall Study|Other|0
858239|NCT01531673|2829924|P10|Overall Study|Other|1
858240|NCT01531673|2829925|P9|Overall Study|Other|0
858241|NCT01531673|2829926|P8|Overall Study|Other|0
858242|NCT01531673|2829927|P7|Overall Study|Other|0
858243|NCT01531673|2829928|P6|Overall Study|Other|0
858244|NCT01531673|2829929|P5|Overall Study|Other|0
858245|NCT01531673|2829930|P4|Overall Study|Other|1
858246|NCT01531673|2829931|P3|Overall Study|Other|0
858247|NCT01531673|2829932|P2|Overall Study|Other|0
858248|NCT01531673|2829933|P1|Overall Study|Other|0
858249|NCT01531673|2829921|P13|Overall Study|Lost to Follow-up|0
858250|NCT01531673|2829922|P12|Overall Study|Lost to Follow-up|0
858251|NCT01531673|2829923|P11|Overall Study|Lost to Follow-up|0
858252|NCT01531673|2829924|P10|Overall Study|Lost to Follow-up|0
858253|NCT01531673|2829925|P9|Overall Study|Lost to Follow-up|0
858254|NCT01531673|2829926|P8|Overall Study|Lost to Follow-up|0
858255|NCT01531673|2829927|P7|Overall Study|Lost to Follow-up|0
858256|NCT01531673|2829928|P6|Overall Study|Lost to Follow-up|0
858257|NCT01531673|2829929|P5|Overall Study|Lost to Follow-up|1
858258|NCT01531673|2829930|P4|Overall Study|Lost to Follow-up|0
858259|NCT01531673|2829931|P3|Overall Study|Lost to Follow-up|0
858260|NCT01531673|2829932|P2|Overall Study|Lost to Follow-up|0
858261|NCT01531673|2829933|P1|Overall Study|Lost to Follow-up|0
858262|NCT01531673|2829921|P13|Overall Study|Adverse Event|0
858263|NCT01531673|2829922|P12|Overall Study|Adverse Event|0
858264|NCT01531673|2829923|P11|Overall Study|Adverse Event|0
858265|NCT01531673|2829924|P10|Overall Study|Adverse Event|0
858266|NCT01531673|2829925|P9|Overall Study|Adverse Event|0
858267|NCT01531673|2829926|P8|Overall Study|Adverse Event|0
858268|NCT01531673|2829927|P7|Overall Study|Adverse Event|0
858269|NCT01531673|2829928|P6|Overall Study|Adverse Event|0
858270|NCT01531673|2829929|P5|Overall Study|Adverse Event|0
858271|NCT01531673|2829930|P4|Overall Study|Adverse Event|0
858272|NCT01531673|2829931|P3|Overall Study|Adverse Event|0
858273|NCT01531673|2829932|P2|Overall Study|Adverse Event|1
858274|NCT01531673|2829933|P1|Overall Study|Adverse Event|0
858275|NCT01531673|2829921|P13|Overall Study|Non-Compliance|0
858276|NCT01531673|2829922|P12|Overall Study|Non-Compliance|0
858277|NCT01531673|2829923|P11|Overall Study|Non-Compliance|0
858278|NCT01531673|2829924|P10|Overall Study|Non-Compliance|0
858279|NCT01531673|2829925|P9|Overall Study|Non-Compliance|0
858280|NCT01531673|2829926|P8|Overall Study|Non-Compliance|0
858281|NCT01531673|2829927|P7|Overall Study|Non-Compliance|0
858282|NCT01531673|2829928|P6|Overall Study|Non-Compliance|1
858283|NCT01531673|2829929|P5|Overall Study|Non-Compliance|0
858284|NCT01531673|2829930|P4|Overall Study|Non-Compliance|0
858285|NCT01531673|2829931|P3|Overall Study|Non-Compliance|0
858286|NCT01531673|2829932|P2|Overall Study|Non-Compliance|0
858287|NCT01531673|2829933|P1|Overall Study|Non-Compliance|0
858288|NCT01531387|2830044|P2|Overall Study|Early termination of study|11
858289|NCT01531387|2830045|P1|Overall Study|Early termination of study|11
858290|NCT01531205|2830137|P1|Overall Study|Did not proceed to surgery|1
858291|NCT01531153|2830149|P3|Overall Study|Withdrawal by Subject|15
858292|NCT01531153|2830150|P2|Overall Study|Withdrawal by Subject|9
858293|NCT01531153|2830151|P1|Overall Study|Withdrawal by Subject|10
858294|NCT01530997|2830207|P1|Overall Study|Withdrawal by Subject|1
858295|NCT01530997|2830207|P1|Overall Study|Physician Decision|1
858296|NCT01530464|2830251|P2|Washout (24h)|Withdrawal by Subject|1
858297|NCT01530464|2830252|P1|Washout (24h)|Withdrawal by Subject|0
858298|NCT01530464|2830251|P2|Washout (24h)|Withdrawal by Subject|0
858299|NCT01530464|2830252|P1|Washout (24h)|Withdrawal by Subject|1
858300|NCT01530334|2830304|P1|Overall Study|Progressive disease|47
858301|NCT01530334|2830304|P1|Overall Study|unknown reason|1
858302|NCT01530334|2830304|P1|Overall Study|Adverse Event|3
858303|NCT01530087|2830351|P1|Overall Study|Physician Decision|2
858304|NCT01529645|2830373|P10|Overall Study|Withdrawal by Subject|0
858305|NCT01529645|2830374|P9|Overall Study|Withdrawal by Subject|0
858306|NCT01529645|2830375|P8|Overall Study|Withdrawal by Subject|0
858307|NCT01529645|2830376|P7|Overall Study|Withdrawal by Subject|0
858308|NCT01529645|2830377|P6|Overall Study|Withdrawal by Subject|1
858309|NCT01529645|2830378|P5|Overall Study|Withdrawal by Subject|1
858310|NCT01529645|2830379|P4|Overall Study|Withdrawal by Subject|1
858311|NCT01529645|2830380|P3|Overall Study|Withdrawal by Subject|0
858312|NCT01529645|2830381|P2|Overall Study|Withdrawal by Subject|0
858313|NCT01529645|2830382|P1|Overall Study|Withdrawal by Subject|2
858314|NCT01529645|2830373|P10|Overall Study|SAE - Premature contractions|0
858315|NCT01529645|2830374|P9|Overall Study|SAE - Premature contractions|0
858316|NCT01529645|2830375|P8|Overall Study|SAE - Premature contractions|0
858317|NCT01529645|2830376|P7|Overall Study|SAE - Premature contractions|0
858318|NCT01529645|2830377|P6|Overall Study|SAE - Premature contractions|0
858319|NCT01529645|2830378|P5|Overall Study|SAE - Premature contractions|0
858320|NCT01529645|2830379|P4|Overall Study|SAE - Premature contractions|0
858321|NCT01529645|2830380|P3|Overall Study|SAE - Premature contractions|1
858322|NCT01529645|2830381|P2|Overall Study|SAE - Premature contractions|0
858323|NCT01529645|2830382|P1|Overall Study|SAE - Premature contractions|0
858324|NCT01529645|2830373|P10|Overall Study|Lost to Follow-up|0
858325|NCT01529645|2830374|P9|Overall Study|Lost to Follow-up|1
858326|NCT01529645|2830375|P8|Overall Study|Lost to Follow-up|0
858327|NCT01529645|2830376|P7|Overall Study|Lost to Follow-up|2
858328|NCT01529645|2830377|P6|Overall Study|Lost to Follow-up|0
858329|NCT01529645|2830378|P5|Overall Study|Lost to Follow-up|1
858330|NCT01529645|2830379|P4|Overall Study|Lost to Follow-up|1
858331|NCT01529645|2830380|P3|Overall Study|Lost to Follow-up|1
858332|NCT01529645|2830381|P2|Overall Study|Lost to Follow-up|1
858333|NCT01529645|2830382|P1|Overall Study|Lost to Follow-up|0
858334|NCT01529632|2830480|P2|Overall Study|Adverse Event|1
858335|NCT01529632|2830481|P1|Overall Study|Adverse Event|1
858336|NCT01529632|2830480|P2|Overall Study|Protocol Violation|1
858337|NCT01529632|2830481|P1|Overall Study|Protocol Violation|0
858338|NCT01529632|2830480|P2|Overall Study|Administrative problem|1
858339|NCT01529632|2830481|P1|Overall Study|Administrative problem|2
858340|NCT01529515|2830501|P4|DOUBLE BLIND PHASE|Other|2
858341|NCT01529515|2830502|P3|DOUBLE BLIND PHASE|Other|9
858342|NCT01529515|2830503|P2|DOUBLE BLIND PHASE|Other|0
858343|NCT01529515|2830504|P1|DOUBLE BLIND PHASE|Other|0
858344|NCT01529515|2830501|P4|DOUBLE BLIND PHASE|Protocol Violation|0
858345|NCT01529515|2830502|P3|DOUBLE BLIND PHASE|Protocol Violation|1
858346|NCT01529515|2830503|P2|DOUBLE BLIND PHASE|Protocol Violation|0
858347|NCT01529515|2830504|P1|DOUBLE BLIND PHASE|Protocol Violation|0
858348|NCT01529515|2830501|P4|DOUBLE BLIND PHASE|Withdrawal by Subject|7
858349|NCT01529515|2830502|P3|DOUBLE BLIND PHASE|Withdrawal by Subject|10
858350|NCT01529515|2830503|P2|DOUBLE BLIND PHASE|Withdrawal by Subject|0
858351|NCT01529515|2830504|P1|DOUBLE BLIND PHASE|Withdrawal by Subject|0
858352|NCT01529515|2830501|P4|DOUBLE BLIND PHASE|Pregnancy|0
858353|NCT01529515|2830502|P3|DOUBLE BLIND PHASE|Pregnancy|1
858354|NCT01529515|2830503|P2|DOUBLE BLIND PHASE|Pregnancy|0
858355|NCT01529515|2830504|P1|DOUBLE BLIND PHASE|Pregnancy|0
858356|NCT01529515|2830501|P4|DOUBLE BLIND PHASE|Lost to Follow-up|3
858357|NCT01529515|2830502|P3|DOUBLE BLIND PHASE|Lost to Follow-up|1
858358|NCT01529515|2830503|P2|DOUBLE BLIND PHASE|Lost to Follow-up|0
858359|NCT01529515|2830504|P1|DOUBLE BLIND PHASE|Lost to Follow-up|0
858360|NCT01529515|2830501|P4|DOUBLE BLIND PHASE|Adverse Event|0
858361|NCT01529515|2830502|P3|DOUBLE BLIND PHASE|Adverse Event|1
858362|NCT01529515|2830503|P2|DOUBLE BLIND PHASE|Adverse Event|0
858363|NCT01529515|2830504|P1|DOUBLE BLIND PHASE|Adverse Event|0
858364|NCT01529515|2830501|P4|MAINTENANCE PHASE|Other|0
858365|NCT01529515|2830502|P3|MAINTENANCE PHASE|Other|0
858366|NCT01529515|2830503|P2|MAINTENANCE PHASE|Other|10
858367|NCT01529515|2830504|P1|MAINTENANCE PHASE|Other|0
858368|NCT01529515|2830501|P4|MAINTENANCE PHASE|Failed Randomization Criteria|0
858369|NCT01529515|2830502|P3|MAINTENANCE PHASE|Failed Randomization Criteria|0
858370|NCT01529515|2830503|P2|MAINTENANCE PHASE|Failed Randomization Criteria|13
858371|NCT01529515|2830504|P1|MAINTENANCE PHASE|Failed Randomization Criteria|0
858372|NCT01529515|2830501|P4|MAINTENANCE PHASE|Withdrawal by Subject|0
858373|NCT01529515|2830502|P3|MAINTENANCE PHASE|Withdrawal by Subject|0
858374|NCT01529515|2830503|P2|MAINTENANCE PHASE|Withdrawal by Subject|15
858375|NCT01529515|2830504|P1|MAINTENANCE PHASE|Withdrawal by Subject|0
858376|NCT01529515|2830501|P4|MAINTENANCE PHASE|Protocol Violation|0
858377|NCT01529515|2830502|P3|MAINTENANCE PHASE|Protocol Violation|0
858378|NCT01529515|2830503|P2|MAINTENANCE PHASE|Protocol Violation|12
858379|NCT01529515|2830504|P1|MAINTENANCE PHASE|Protocol Violation|0
858380|NCT01529515|2830501|P4|MAINTENANCE PHASE|Lost to Follow-up|0
858381|NCT01529515|2830502|P3|MAINTENANCE PHASE|Lost to Follow-up|0
858382|NCT01529515|2830503|P2|MAINTENANCE PHASE|Lost to Follow-up|5
858383|NCT01529515|2830504|P1|MAINTENANCE PHASE|Lost to Follow-up|0
858384|NCT01529515|2830501|P4|MAINTENANCE PHASE|Lack of Efficacy|0
858385|NCT01529515|2830502|P3|MAINTENANCE PHASE|Lack of Efficacy|0
858386|NCT01529515|2830503|P2|MAINTENANCE PHASE|Lack of Efficacy|9
858387|NCT01529515|2830504|P1|MAINTENANCE PHASE|Lack of Efficacy|0
858388|NCT01529515|2830501|P4|MAINTENANCE PHASE|Adverse Event|0
858389|NCT01529515|2830502|P3|MAINTENANCE PHASE|Adverse Event|0
858390|NCT01529515|2830503|P2|MAINTENANCE PHASE|Adverse Event|10
858391|NCT01529515|2830504|P1|MAINTENANCE PHASE|Adverse Event|0
858392|NCT01529515|2830501|P4|TRANSITION PHASE|Other|0
858393|NCT01529515|2830502|P3|TRANSITION PHASE|Other|0
858394|NCT01529515|2830503|P2|TRANSITION PHASE|Other|0
858395|NCT01529515|2830504|P1|TRANSITION PHASE|Other|9
858396|NCT01529515|2830501|P4|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
858397|NCT01529515|2830502|P3|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
858398|NCT01529515|2830503|P2|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
858399|NCT01529515|2830504|P1|TRANSITION PHASE|Failed Maintenance Phase Criteria|8
858400|NCT01529515|2830501|P4|TRANSITION PHASE|Withdrawal by Subject|0
858401|NCT01529515|2830502|P3|TRANSITION PHASE|Withdrawal by Subject|0
858402|NCT01529515|2830503|P2|TRANSITION PHASE|Withdrawal by Subject|0
858403|NCT01529515|2830504|P1|TRANSITION PHASE|Withdrawal by Subject|51
858404|NCT01529515|2830501|P4|TRANSITION PHASE|Protocol Violation|0
858405|NCT01529515|2830502|P3|TRANSITION PHASE|Protocol Violation|0
858406|NCT01529515|2830503|P2|TRANSITION PHASE|Protocol Violation|0
858407|NCT01529515|2830504|P1|TRANSITION PHASE|Protocol Violation|4
858408|NCT01529515|2830501|P4|TRANSITION PHASE|Lost to Follow-up|0
858409|NCT01529515|2830502|P3|TRANSITION PHASE|Lost to Follow-up|0
858410|NCT01529515|2830503|P2|TRANSITION PHASE|Lost to Follow-up|0
858411|NCT01529515|2830504|P1|TRANSITION PHASE|Lost to Follow-up|19
858412|NCT01529515|2830501|P4|TRANSITION PHASE|Lack of Efficacy|0
858413|NCT01529515|2830502|P3|TRANSITION PHASE|Lack of Efficacy|0
858414|NCT01529515|2830503|P2|TRANSITION PHASE|Lack of Efficacy|0
858415|NCT01529515|2830504|P1|TRANSITION PHASE|Lack of Efficacy|19
858416|NCT01529515|2830501|P4|TRANSITION PHASE|Death|0
858417|NCT01529515|2830502|P3|TRANSITION PHASE|Death|0
858418|NCT01529515|2830503|P2|TRANSITION PHASE|Death|0
858419|NCT01529515|2830504|P1|TRANSITION PHASE|Death|1
858420|NCT01529515|2830501|P4|TRANSITION PHASE|Adverse Event|0
858421|NCT01529515|2830502|P3|TRANSITION PHASE|Adverse Event|0
858422|NCT01529515|2830503|P2|TRANSITION PHASE|Adverse Event|0
858423|NCT01529515|2830504|P1|TRANSITION PHASE|Adverse Event|16
858424|NCT01529385|2830551|P2|Overall Study|Lost to Follow-up|1
858425|NCT01529385|2830552|P1|Overall Study|Lost to Follow-up|2
858426|NCT01529346|2830581|P5|Overall Study|Other|0
858427|NCT01529346|2830582|P4|Overall Study|Other|0
858428|NCT01529346|2830583|P3|Overall Study|Other|1
858429|NCT01529346|2830584|P2|Overall Study|Other|1
858430|NCT01529346|2830585|P1|Overall Study|Other|0
858431|NCT01529346|2830581|P5|Overall Study|Lost to Follow-up|0
858432|NCT01529346|2830582|P4|Overall Study|Lost to Follow-up|0
858433|NCT01529346|2830583|P3|Overall Study|Lost to Follow-up|1
858434|NCT01529346|2830584|P2|Overall Study|Lost to Follow-up|0
858435|NCT01529346|2830585|P1|Overall Study|Lost to Follow-up|2
858436|NCT01529268|2830673|P2|Overall Study|Moved|0
858437|NCT01529268|2830674|P1|Overall Study|Moved|3
858438|NCT01529268|2830673|P2|Overall Study|Lost to Follow-up|3
858439|NCT01529268|2830674|P1|Overall Study|Lost to Follow-up|9
858440|NCT01529112|2830736|P2|Overall Study|Withdrawal by Subject|3
858441|NCT01529112|2830737|P1|Overall Study|Withdrawal by Subject|7
858442|NCT01529112|2830736|P2|Overall Study|Protocol Violation|0
858443|NCT01529112|2830737|P1|Overall Study|Protocol Violation|1
858444|NCT01529112|2830736|P2|Overall Study|Death|38
858445|NCT01529112|2830737|P1|Overall Study|Death|59
858446|NCT01529112|2830736|P2|Overall Study|Adverse Event|0
858447|NCT01529112|2830737|P1|Overall Study|Adverse Event|2
858448|NCT01528969|2830764|P2|Overall Study|absent from the school at baseline|0
858449|NCT01528969|2830765|P1|Overall Study|absent from the school at baseline|2
858450|NCT01528787|2830798|P4|Overall Study|Family Emergency|0
858451|NCT01528787|2830799|P3|Overall Study|Family Emergency|1
858452|NCT01528787|2830800|P2|Overall Study|Family Emergency|0
858453|NCT01528787|2830801|P1|Overall Study|Family Emergency|0
858454|NCT01528787|2830798|P4|Overall Study|Withdrawal by Subject|1
858455|NCT01528787|2830799|P3|Overall Study|Withdrawal by Subject|0
858456|NCT01528787|2830800|P2|Overall Study|Withdrawal by Subject|0
858457|NCT01528787|2830801|P1|Overall Study|Withdrawal by Subject|0
858458|NCT01528735|2830813|P2|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0
858459|NCT01528735|2830814|P1|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1
858460|NCT01528735|2830813|P2|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
858461|NCT01528735|2830814|P1|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
858462|NCT01528709|2830916|P2|Overall Study|allergy|0
858463|NCT01528709|2830917|P1|Overall Study|allergy|1
858464|NCT01528709|2830916|P2|Overall Study|Withdrawal by Subject|15
858465|NCT01528709|2830917|P1|Overall Study|Withdrawal by Subject|10
858466|NCT01528709|2830916|P2|Overall Study|Death|0
858467|NCT01528709|2830917|P1|Overall Study|Death|2
858468|NCT01528696|2830927|P2|Overall Study|See detailed description|19
858469|NCT01528696|2830928|P1|Overall Study|See detailed description|18
858470|NCT01528605|2830944|P6|Overall Study|Death|0
858471|NCT01528605|2830945|P5|Overall Study|Death|0
858472|NCT01528605|2830946|P4|Overall Study|Death|0
858473|NCT01528605|2830947|P3|Overall Study|Death|0
858474|NCT01528605|2830948|P2|Overall Study|Death|0
858475|NCT01528605|2830949|P1|Overall Study|Death|1
858476|NCT01528605|2830944|P6|Overall Study|Lost to Follow-up|0
858477|NCT01528605|2830945|P5|Overall Study|Lost to Follow-up|0
858478|NCT01528605|2830946|P4|Overall Study|Lost to Follow-up|1
858479|NCT01528605|2830947|P3|Overall Study|Lost to Follow-up|1
858480|NCT01528605|2830948|P2|Overall Study|Lost to Follow-up|0
858481|NCT01528605|2830949|P1|Overall Study|Lost to Follow-up|1
858482|NCT01528345|2830979|P2|Overall Study|Subject/Guardian Decision|0
858483|NCT01528345|2830980|P1|Overall Study|Subject/Guardian Decision|5
858484|NCT01528345|2830979|P2|Overall Study|Study Terminated by Sponsor|8
858485|NCT01528345|2830980|P1|Overall Study|Study Terminated by Sponsor|4
858486|NCT01528345|2830979|P2|Overall Study|Progressive Disease|40
858487|NCT01528345|2830980|P1|Overall Study|Progressive Disease|26
858488|NCT01528345|2830979|P2|Overall Study|Non-compliance with study treatment|0
858489|NCT01528345|2830980|P1|Overall Study|Non-compliance with study treatment|1
858490|NCT01528345|2830979|P2|Overall Study|Death|1
858491|NCT01528345|2830980|P1|Overall Study|Death|1
858492|NCT01528345|2830979|P2|Overall Study|Adverse Event|1
858493|NCT01528345|2830980|P1|Overall Study|Adverse Event|10
858494|NCT01527500|2831119|P2|Part B|Adverse Event|0
858495|NCT01527500|2831120|P1|Part B|Adverse Event|1
858496|NCT01527500|2831119|P2|Part A|Withdrawal by Subject|0
858497|NCT01527500|2831120|P1|Part A|Withdrawal by Subject|2
858498|NCT01527500|2831119|P2|Part A|Protocol Deviation|2
858499|NCT01527500|2831120|P1|Part A|Protocol Deviation|9
858500|NCT01527500|2831119|P2|Part A|Lost to Follow-up|1
858501|NCT01527500|2831120|P1|Part A|Lost to Follow-up|0
858502|NCT01527500|2831119|P2|Part A|Death|1
858503|NCT01527500|2831120|P1|Part A|Death|4
858504|NCT01527500|2831119|P2|Part A|Adverse Event|2
858505|NCT01527500|2831120|P1|Part A|Adverse Event|4
858506|NCT01527500|2831119|P2|Part A|Administrative|7
858507|NCT01527500|2831120|P1|Part A|Administrative|11
858508|NCT01527487|2831150|P2|Overall Study|Death|1
858509|NCT01527487|2831151|P1|Overall Study|Death|0
858510|NCT01527487|2831150|P2|Overall Study|Adverse Event|1
858511|NCT01527487|2831151|P1|Overall Study|Adverse Event|1
858512|NCT01527487|2831150|P2|Overall Study|Disease Progression|1
858513|NCT01527487|2831151|P1|Overall Study|Disease Progression|4
858514|NCT01527487|2831150|P2|Overall Study|MD Discretion/Lack of Efficacy|4
858515|NCT01527487|2831151|P1|Overall Study|MD Discretion/Lack of Efficacy|3
858516|NCT01527370|2831163|P1|Overall Study|Death|1
858517|NCT01527370|2831163|P1|Overall Study|Physician Decision|1
858518|NCT01527370|2831163|P1|Overall Study|Withdrawal by Subject|4
858519|NCT01527110|2831180|P1|Overall Study|Adverse Event|1
858520|NCT01527006|2831227|P2|Extension Phase|Not Specified|3
858521|NCT01527006|2831228|P1|Extension Phase|Not Specified|0
858522|NCT01527006|2831227|P2|Extension Phase|Inadequate therapeutic effect|1
858523|NCT01527006|2831228|P1|Extension Phase|Inadequate therapeutic effect|1
858524|NCT01527006|2831227|P2|Extension Phase|Subject Choice|1
858525|NCT01527006|2831228|P1|Extension Phase|Subject Choice|1
858526|NCT01527006|2831227|P2|Extension Phase|Lost to Follow-up|1
858527|NCT01527006|2831228|P1|Extension Phase|Lost to Follow-up|0
858528|NCT01527006|2831227|P2|Extension Phase|Adverse Event|2
858529|NCT01527006|2831228|P1|Extension Phase|Adverse Event|4
858530|NCT01527006|2831227|P2|Core Study|Not Specified|2
858531|NCT01527006|2831228|P1|Core Study|Not Specified|0
858532|NCT01527006|2831227|P2|Core Study|Withdrawal by Subject|1
858533|NCT01527006|2831228|P1|Core Study|Withdrawal by Subject|0
858534|NCT01527006|2831227|P2|Core Study|Inadequate Therapeutic Effect|0
858535|NCT01527006|2831228|P1|Core Study|Inadequate Therapeutic Effect|1
858536|NCT01527006|2831227|P2|Core Study|Subject Choice|0
858537|NCT01527006|2831228|P1|Core Study|Subject Choice|1
858538|NCT01527006|2831227|P2|Core Study|Lost to Follow-up|1
858539|NCT01527006|2831228|P1|Core Study|Lost to Follow-up|0
858540|NCT01527006|2831227|P2|Core Study|Adverse Event|2
858541|NCT01527006|2831228|P1|Core Study|Adverse Event|0
858542|NCT01526889|2831297|P2|Treatment Extension Period|Administrative problems|0
858543|NCT01526889|2831298|P1|Treatment Extension Period|Administrative problems|1
858544|NCT01526889|2831297|P2|Treatment Period|Adverse Event|0
858545|NCT01526889|2831298|P1|Treatment Period|Adverse Event|2
858546|NCT01526785|2831319|P1|Overall Study|Withdrawal by Subject|2
858547|NCT01526785|2831319|P1|Overall Study|Physician Decision|1
858548|NCT01526785|2831319|P1|Overall Study|Death|2
858549|NCT01526785|2831319|P1|Overall Study|Study Terminated by Sponsor|8
858550|NCT01526733|2831329|P2|Phase 1|Withdrawal by Subject|1
858551|NCT01526733|2831330|P1|Phase 1|Withdrawal by Subject|1
858552|NCT01526733|2831329|P2|Phase 1|Protocol Violation|0
858553|NCT01526733|2831330|P1|Phase 1|Protocol Violation|1
858554|NCT01526551|2831369|P1|Overall Study|Lack of returned parental consent form|424
858555|NCT01526148|2831416|P2|Overall Study|Incarcerated|2
858556|NCT01526148|2831417|P1|Overall Study|Incarcerated|0
858557|NCT01526148|2831416|P2|Overall Study|Moved out of state|0
858558|NCT01526148|2831417|P1|Overall Study|Moved out of state|1
858559|NCT01526148|2831416|P2|Overall Study|Unable to discontinue concomitant med|0
858560|NCT01526148|2831417|P1|Overall Study|Unable to discontinue concomitant med|1
858561|NCT01526148|2831416|P2|Overall Study|Unstable Medical Condition|0
858562|NCT01526148|2831417|P1|Overall Study|Unstable Medical Condition|1
858563|NCT01526148|2831416|P2|Overall Study|Withdrawal by Subject|0
858564|NCT01526148|2831417|P1|Overall Study|Withdrawal by Subject|2
858565|NCT01526148|2831416|P2|Overall Study|Lost to Follow-up|6
858566|NCT01526148|2831417|P1|Overall Study|Lost to Follow-up|3
858567|NCT01526148|2831416|P2|Overall Study|Adverse Event|5
858568|NCT01526148|2831417|P1|Overall Study|Adverse Event|6
858569|NCT01525849|2831441|P2|Overall Study|Anatomic exclusion criteria identified|3
858570|NCT01525849|2831442|P1|Overall Study|Anatomic exclusion criteria identified|0
858571|NCT01525849|2831441|P2|Overall Study|Unrelated medical issue (not treated)|2
858572|NCT01525849|2831442|P1|Overall Study|Unrelated medical issue (not treated)|1
858573|NCT01525849|2831441|P2|Overall Study|Withdrawal by Subject|9
858574|NCT01525849|2831442|P1|Overall Study|Withdrawal by Subject|1
858575|NCT01525849|2831441|P2|Overall Study|Lost to Follow-up|2
858576|NCT01525849|2831442|P1|Overall Study|Lost to Follow-up|3
858577|NCT01525641|2831498|P1|Overall Study|Other than stated above|7
858578|NCT01525641|2831498|P1|Overall Study|Lost to follow-up (Changing hospital)|19
858579|NCT01525641|2831498|P1|Overall Study|Lost to follow-up (Unknown reason)|10
858580|NCT01525641|2831498|P1|Overall Study|Lost to follow-up (relocation)|1
858581|NCT01525641|2831498|P1|Overall Study|Improvement|5
858582|NCT01525641|2831498|P1|Overall Study|Lack of Efficacy|24
858583|NCT01525641|2831498|P1|Overall Study|Adverse Event|73
858584|NCT01525641|2831498|P1|Overall Study|No visit since the first visit|16
858585|NCT01525641|2831498|P1|Overall Study|Case report form not collected|25
858586|NCT01525628|2831512|P5|Overall Study|Other reason not defined above|0
858587|NCT01525628|2831513|P4|Overall Study|Other reason not defined above|3
858588|NCT01525628|2831514|P3|Overall Study|Other reason not defined above|0
858589|NCT01525628|2831515|P2|Overall Study|Other reason not defined above|0
858590|NCT01525628|2831516|P1|Overall Study|Other reason not defined above|0
858591|NCT01525628|2831512|P5|Overall Study|Withdrawal by Subject|0
858592|NCT01525628|2831513|P4|Overall Study|Withdrawal by Subject|0
858593|NCT01525628|2831514|P3|Overall Study|Withdrawal by Subject|0
858594|NCT01525628|2831515|P2|Overall Study|Withdrawal by Subject|1
858595|NCT01525628|2831516|P1|Overall Study|Withdrawal by Subject|0
858596|NCT01525628|2831512|P5|Overall Study|Lost to Follow-up|0
858597|NCT01525628|2831513|P4|Overall Study|Lost to Follow-up|0
858598|NCT01525628|2831514|P3|Overall Study|Lost to Follow-up|0
858599|NCT01525628|2831515|P2|Overall Study|Lost to Follow-up|1
858600|NCT01525628|2831516|P1|Overall Study|Lost to Follow-up|1
858601|NCT01525628|2831512|P5|Overall Study|Protocol Violation|0
858602|NCT01525628|2831513|P4|Overall Study|Protocol Violation|0
858603|NCT01525628|2831514|P3|Overall Study|Protocol Violation|1
858604|NCT01525628|2831515|P2|Overall Study|Protocol Violation|0
858605|NCT01525628|2831516|P1|Overall Study|Protocol Violation|0
858606|NCT01525628|2831512|P5|Overall Study|Lack of Efficacy|2
858607|NCT01525628|2831513|P4|Overall Study|Lack of Efficacy|1
858608|NCT01525628|2831514|P3|Overall Study|Lack of Efficacy|2
858609|NCT01525628|2831515|P2|Overall Study|Lack of Efficacy|2
858610|NCT01525628|2831516|P1|Overall Study|Lack of Efficacy|0
858611|NCT01525628|2831512|P5|Overall Study|Adverse Event|1
858612|NCT01525628|2831513|P4|Overall Study|Adverse Event|0
858613|NCT01525628|2831514|P3|Overall Study|Adverse Event|2
858614|NCT01525628|2831515|P2|Overall Study|Adverse Event|1
858615|NCT01525628|2831516|P1|Overall Study|Adverse Event|1
858616|NCT01525615|2831583|P3|Overall Study|Other reason not described above|1
858617|NCT01525615|2831584|P2|Overall Study|Other reason not described above|0
858618|NCT01525615|2831585|P1|Overall Study|Other reason not described above|1
858619|NCT01525615|2831583|P3|Overall Study|Withdrawal by Subject|0
858620|NCT01525615|2831584|P2|Overall Study|Withdrawal by Subject|0
858621|NCT01525615|2831585|P1|Overall Study|Withdrawal by Subject|1
858622|NCT01525615|2831583|P3|Overall Study|Lost to Follow-up|0
858623|NCT01525615|2831584|P2|Overall Study|Lost to Follow-up|0
858624|NCT01525615|2831585|P1|Overall Study|Lost to Follow-up|1
858625|NCT01525615|2831583|P3|Overall Study|Adverse Event|5
858626|NCT01525615|2831584|P2|Overall Study|Adverse Event|7
858627|NCT01525615|2831585|P1|Overall Study|Adverse Event|11
858628|NCT01525550|2831641|P2|Overall Study|Ongoing|23
858629|NCT01525550|2831642|P1|Overall Study|Ongoing|45
858630|NCT01525550|2831641|P2|Overall Study|Other Unspecified|2
858631|NCT01525550|2831642|P1|Overall Study|Other Unspecified|0
858632|NCT01525550|2831641|P2|Overall Study|Death|19
858633|NCT01525550|2831642|P1|Overall Study|Death|10
858634|NCT01525550|2831641|P2|Overall Study|Lost to Follow-up|1
858635|NCT01525550|2831642|P1|Overall Study|Lost to Follow-up|4
858636|NCT01525550|2831641|P2|Overall Study|Withdrawal by Subject|0
858637|NCT01525550|2831642|P1|Overall Study|Withdrawal by Subject|2
858638|NCT01525407|2831713|P2|Overall Study|Delay in Transplant|0
858639|NCT01525407|2831714|P1|Overall Study|Delay in Transplant|1
858640|NCT01525407|2831713|P2|Overall Study|Transplant was delayed|1
858641|NCT01525407|2831714|P1|Overall Study|Transplant was delayed|0
858642|NCT01525407|2831713|P2|Overall Study|Withdrawal by Subject|1
858643|NCT01525407|2831714|P1|Overall Study|Withdrawal by Subject|0
858644|NCT01525407|2831713|P2|Overall Study|Change in recipient treatment plan|2
858645|NCT01525407|2831714|P1|Overall Study|Change in recipient treatment plan|2
858646|NCT01525238|2831746|P3|Overall Study|Withdrawal by Subject|0
858647|NCT01525238|2831747|P2|Overall Study|Withdrawal by Subject|0
858648|NCT01525238|2831748|P1|Overall Study|Withdrawal by Subject|1
858649|NCT01525225|2831813|P1|Enrollment|Not Specified|1
858650|NCT01525225|2831813|P1|Enrollment|No longer met study criteria|1
858651|NCT01524978|2831838|P11|Overall Study|Death|17
858652|NCT01524978|2831839|P10|Overall Study|Death|6
858653|NCT01524978|2831840|P9|Overall Study|Death|5
858654|NCT01524978|2831841|P8|Overall Study|Death|9
858655|NCT01524978|2831842|P7|Overall Study|Death|1
858656|NCT01524978|2831843|P6|Overall Study|Death|4
858657|NCT01524978|2831844|P5|Overall Study|Death|4
858658|NCT01524978|2831845|P4|Overall Study|Death|24
858659|NCT01524978|2831846|P3|Overall Study|Death|5
858660|NCT01524978|2831847|P2|Overall Study|Death|2
858661|NCT01524978|2831848|P1|Overall Study|Death|34
858662|NCT01524978|2831838|P11|Overall Study|Lost to Follow-up|1
858663|NCT01524978|2831839|P10|Overall Study|Lost to Follow-up|1
858664|NCT01524978|2831840|P9|Overall Study|Lost to Follow-up|1
858665|NCT01524978|2831841|P8|Overall Study|Lost to Follow-up|0
858666|NCT01524978|2831842|P7|Overall Study|Lost to Follow-up|2
858667|NCT01524978|2831843|P6|Overall Study|Lost to Follow-up|1
858668|NCT01524978|2831844|P5|Overall Study|Lost to Follow-up|1
858669|NCT01524978|2831845|P4|Overall Study|Lost to Follow-up|0
858670|NCT01524978|2831846|P3|Overall Study|Lost to Follow-up|3
858671|NCT01524978|2831847|P2|Overall Study|Lost to Follow-up|0
858672|NCT01524978|2831848|P1|Overall Study|Lost to Follow-up|0
858673|NCT01524978|2831838|P11|Overall Study|Withdrawal by Subject|5
858674|NCT01524978|2831839|P10|Overall Study|Withdrawal by Subject|0
858675|NCT01524978|2831840|P9|Overall Study|Withdrawal by Subject|4
858676|NCT01524978|2831841|P8|Overall Study|Withdrawal by Subject|2
858677|NCT01524978|2831842|P7|Overall Study|Withdrawal by Subject|6
858678|NCT01524978|2831843|P6|Overall Study|Withdrawal by Subject|1
858679|NCT01524978|2831844|P5|Overall Study|Withdrawal by Subject|3
858680|NCT01524978|2831845|P4|Overall Study|Withdrawal by Subject|1
858681|NCT01524978|2831846|P3|Overall Study|Withdrawal by Subject|1
858682|NCT01524978|2831847|P2|Overall Study|Withdrawal by Subject|0
858683|NCT01524978|2831848|P1|Overall Study|Withdrawal by Subject|12
858684|NCT01524978|2831838|P11|Overall Study|Other|5
858685|NCT01524978|2831839|P10|Overall Study|Other|2
858686|NCT01524978|2831840|P9|Overall Study|Other|2
858687|NCT01524978|2831841|P8|Overall Study|Other|1
858688|NCT01524978|2831842|P7|Overall Study|Other|17
858689|NCT01524978|2831843|P6|Overall Study|Other|3
858690|NCT01524978|2831844|P5|Overall Study|Other|1
858691|NCT01524978|2831845|P4|Overall Study|Other|2
858692|NCT01524978|2831846|P3|Overall Study|Other|1
858693|NCT01524978|2831847|P2|Overall Study|Other|2
858694|NCT01524978|2831848|P1|Overall Study|Other|16
858695|NCT01524913|2831976|P3|Overall Study|Lost to Follow-up|0
858696|NCT01524913|2831977|P2|Overall Study|Lost to Follow-up|0
858697|NCT01524913|2831978|P1|Overall Study|Lost to Follow-up|4
858698|NCT01524900|2832000|P5|Overall Study|No reason documented|0
858699|NCT01524900|2832001|P4|Overall Study|No reason documented|1
858700|NCT01524900|2832002|P3|Overall Study|No reason documented|0
858701|NCT01524900|2832003|P2|Overall Study|No reason documented|1
858702|NCT01524900|2832004|P1|Overall Study|No reason documented|2
858703|NCT01524900|2832000|P5|Overall Study|Other reason than stated above|0
858704|NCT01524900|2832001|P4|Overall Study|Other reason than stated above|0
858705|NCT01524900|2832002|P3|Overall Study|Other reason than stated above|0
858706|NCT01524900|2832003|P2|Overall Study|Other reason than stated above|1
858707|NCT01524900|2832004|P1|Overall Study|Other reason than stated above|1
858708|NCT01524900|2832000|P5|Overall Study|Lost to Follow-up|0
858709|NCT01524900|2832001|P4|Overall Study|Lost to Follow-up|0
858710|NCT01524900|2832002|P3|Overall Study|Lost to Follow-up|1
858711|NCT01524900|2832003|P2|Overall Study|Lost to Follow-up|12
858712|NCT01524900|2832004|P1|Overall Study|Lost to Follow-up|3
858713|NCT01524887|2832049|P3|Overall Study|Use of prohibited medication|0
858714|NCT01524887|2832050|P2|Overall Study|Use of prohibited medication|0
858715|NCT01524887|2832051|P1|Overall Study|Use of prohibited medication|1
858716|NCT01524887|2832049|P3|Overall Study|Withdrawal by Caregiver|2
858717|NCT01524887|2832050|P2|Overall Study|Withdrawal by Caregiver|0
858718|NCT01524887|2832051|P1|Overall Study|Withdrawal by Caregiver|0
858719|NCT01524887|2832049|P3|Overall Study|Study termination|79
858720|NCT01524887|2832050|P2|Overall Study|Study termination|87
858721|NCT01524887|2832051|P1|Overall Study|Study termination|73
858722|NCT01524887|2832049|P3|Overall Study|Protocol Violation|1
858723|NCT01524887|2832050|P2|Overall Study|Protocol Violation|0
858724|NCT01524887|2832051|P1|Overall Study|Protocol Violation|0
858725|NCT01524887|2832049|P3|Overall Study|Adverse Event|1
858726|NCT01524887|2832050|P2|Overall Study|Adverse Event|1
858727|NCT01524887|2832051|P1|Overall Study|Adverse Event|5
858728|NCT01524887|2832049|P3|Overall Study|Withdrawal by Subject|3
858729|NCT01524887|2832050|P2|Overall Study|Withdrawal by Subject|2
858730|NCT01524887|2832051|P1|Overall Study|Withdrawal by Subject|6
858731|NCT01524796|2832095|P1|Overall Study|Adverse Event and Lack of Efficacy|1
858732|NCT01524796|2832095|P1|Overall Study|Switch to carbamazapine|1
858733|NCT01524796|2832095|P1|Overall Study|Nervous about confidentiality|1
858734|NCT01524796|2832095|P1|Overall Study|Gall stone surgery|1
858735|NCT01524796|2832095|P1|Overall Study|Deterioration of pains|1
858736|NCT01524796|2832095|P1|Overall Study|Move|1
858737|NCT01524796|2832095|P1|Overall Study|Withdrawal by Subject|4
858738|NCT01524796|2832095|P1|Overall Study|The price|1
858739|NCT01524796|2832095|P1|Overall Study|Lost to Follow-up|1
858740|NCT01524796|2832095|P1|Overall Study|Lack of Efficacy|3
858741|NCT01524796|2832095|P1|Overall Study|Adverse Event|13
858742|NCT01524783|2832110|P2|Randomized and Treated|Death|1
858743|NCT01524783|2832111|P1|Randomized and Treated|Death|4
858744|NCT01524783|2832110|P2|Randomized and Treated|Protocol Violation|1
858745|NCT01524783|2832111|P1|Randomized and Treated|Protocol Violation|1
858746|NCT01524783|2832110|P2|Randomized and Treated|Withdrawal by Subject|5
858747|NCT01524783|2832111|P1|Randomized and Treated|Withdrawal by Subject|15
858748|NCT01524783|2832110|P2|Randomized and Treated|Disease Progression|70
858749|NCT01524783|2832111|P1|Randomized and Treated|Disease Progression|76
858750|NCT01524783|2832110|P2|Randomized and Treated|Adverse Event|7
858751|NCT01524783|2832111|P1|Randomized and Treated|Adverse Event|59
858752|NCT01524783|2832110|P2|Randomized But Not Treated|Randomized, did not receive drug|0
858753|NCT01524783|2832111|P1|Randomized But Not Treated|Randomized, did not receive drug|2
858754|NCT01524770|2832133|P2|First Intervention|Protocol Violation|0
858755|NCT01524770|2832134|P1|First Intervention|Protocol Violation|1
858756|NCT01524770|2832133|P2|First Intervention|Adverse Event|1
858757|NCT01524770|2832134|P1|First Intervention|Adverse Event|1
858758|NCT01524770|2832133|P2|First Intervention|Withdrawal by Subject|0
858759|NCT01524770|2832134|P1|First Intervention|Withdrawal by Subject|1
858760|NCT01524692|2832144|P1|Overall Study|Withdrawal by Subject|3
858761|NCT01524627|2832154|P2|Overall Study|Lost to Follow-up|1
858762|NCT01524627|2832155|P1|Overall Study|Lost to Follow-up|1
858763|NCT01524627|2832154|P2|Overall Study|Physician Decision|1
858764|NCT01524627|2832155|P1|Overall Study|Physician Decision|0
858765|NCT01524198|2832182|P2|Overall Study|Withdrawal by Subject|10
858766|NCT01524198|2832183|P1|Overall Study|Withdrawal by Subject|15
858767|NCT01524198|2832182|P2|Overall Study|Protocol Violation|6
858768|NCT01524198|2832183|P1|Overall Study|Protocol Violation|8
858769|NCT01524133|2832194|P3|Overall Study 52 Weeks|Lost to Follow-up|15
858770|NCT01524133|2832195|P2|Overall Study 52 Weeks|Lost to Follow-up|15
858771|NCT01524133|2832196|P1|Overall Study 52 Weeks|Lost to Follow-up|16
858772|NCT01524133|2832194|P3|Overall Study 52 Weeks|Physician Decision|2
858773|NCT01524133|2832195|P2|Overall Study 52 Weeks|Physician Decision|0
858774|NCT01524133|2832196|P1|Overall Study 52 Weeks|Physician Decision|1
858775|NCT01524133|2832194|P3|Overall Study 52 Weeks|Withdrawal by Subject|10
858776|NCT01524133|2832195|P2|Overall Study 52 Weeks|Withdrawal by Subject|5
858777|NCT01524133|2832196|P1|Overall Study 52 Weeks|Withdrawal by Subject|4
858778|NCT01524133|2832194|P3|Treatment Phase|Lost to Follow-up|2
858779|NCT01524133|2832195|P2|Treatment Phase|Lost to Follow-up|1
858780|NCT01524133|2832196|P1|Treatment Phase|Lost to Follow-up|0
858781|NCT01524133|2832194|P3|Treatment Phase|Physician Decision|3
858782|NCT01524133|2832195|P2|Treatment Phase|Physician Decision|3
858783|NCT01524133|2832196|P1|Treatment Phase|Physician Decision|6
858784|NCT01524133|2832194|P3|Treatment Phase|Withdrawal by Subject|31
858785|NCT01524133|2832195|P2|Treatment Phase|Withdrawal by Subject|28
858786|NCT01524133|2832196|P1|Treatment Phase|Withdrawal by Subject|13
858787|NCT01523886|2832239|P2|Overall Study|surgery cancelled|1
858788|NCT01523886|2832240|P1|Overall Study|surgery cancelled|0
858789|NCT01523873|2832246|P1|Overall Study|Protocol Violation|422
858790|NCT01523756|2832333|P2|Test Period 2|Withdrawal by Subject|1
858791|NCT01523756|2832334|P1|Test Period 2|Withdrawal by Subject|0
858792|NCT01523756|2832333|P2|Test Period 1|Adverse Event|0
858793|NCT01523756|2832334|P1|Test Period 1|Adverse Event|1
858794|NCT01523756|2832333|P2|Baseline Period|Adverse Event|1
858795|NCT01523756|2832334|P1|Baseline Period|Adverse Event|0
858796|NCT01523743|2832342|P2|Period 2|Adverse Event|0
858797|NCT01523743|2832343|P1|Period 2|Adverse Event|1
858798|NCT01523743|2832342|P2|Period 2|Withdrawal by Subject|2
858799|NCT01523743|2832343|P1|Period 2|Withdrawal by Subject|0
858800|NCT01523743|2832342|P2|Period 1|Felt unable to empty bladder|0
858801|NCT01523743|2832343|P1|Period 1|Felt unable to empty bladder|1
858802|NCT01523743|2832342|P2|Period 1|Lack of Efficacy|0
858803|NCT01523743|2832343|P1|Period 1|Lack of Efficacy|1
858804|NCT01523743|2832342|P2|Period 1|Lost to Follow-up|0
858805|NCT01523743|2832343|P1|Period 1|Lost to Follow-up|1
858806|NCT01523743|2832342|P2|Period 1|Withdrawal by Subject|2
858807|NCT01523743|2832343|P1|Period 1|Withdrawal by Subject|6
858808|NCT01523743|2832342|P2|Period 1|Adverse Event|0
858809|NCT01523743|2832343|P1|Period 1|Adverse Event|1
858810|NCT01523587|2832366|P2|Overall Study|Randomised but not treated|2
858811|NCT01523587|2832367|P1|Overall Study|Randomised but not treated|6
858812|NCT01523587|2832366|P2|Overall Study|no reason given|3
858813|NCT01523587|2832367|P1|Overall Study|no reason given|2
858814|NCT01523587|2832366|P2|Overall Study|Withdrawal by Subject|12
858815|NCT01523587|2832367|P1|Overall Study|Withdrawal by Subject|23
858816|NCT01523587|2832366|P2|Overall Study|Lost to Follow-up|2
858817|NCT01523587|2832367|P1|Overall Study|Lost to Follow-up|2
858818|NCT01523587|2832366|P2|Overall Study|Non Compliance with protocol|1
858819|NCT01523587|2832367|P1|Overall Study|Non Compliance with protocol|2
858820|NCT01523587|2832366|P2|Overall Study|Adverse Event|34
858821|NCT01523587|2832367|P1|Overall Study|Adverse Event|52
858822|NCT01523457|2832408|P2|Overall Study|Withdrawal by Subject|2
858823|NCT01523457|2832409|P1|Overall Study|Withdrawal by Subject|7
858824|NCT01523392|2832427|P2|Washout Period - 10 to 14 Days|Adverse Event|0
858825|NCT01523392|2832428|P1|Washout Period - 10 to 14 Days|Adverse Event|1
858826|NCT01523392|2832427|P2|Treatment Period 1|Did not complete 7-9 days of treatment.|0
858827|NCT01523392|2832428|P1|Treatment Period 1|Did not complete 7-9 days of treatment.|1
858828|NCT01523392|2832427|P2|Treatment Period 1|Withdrawal by Subject|0
858829|NCT01523392|2832428|P1|Treatment Period 1|Withdrawal by Subject|2
858830|NCT01523366|2832444|P2|Treatment Period 2|Not completed at least 7 days treatment|0
858831|NCT01523366|2832445|P1|Treatment Period 2|Not completed at least 7 days treatment|1
858832|NCT01523366|2832444|P2|Treatment Period 1|Withdrawal by Subject|0
858833|NCT01523366|2832445|P1|Treatment Period 1|Withdrawal by Subject|1
858834|NCT01523301|2832461|P2|Overall Study|Other Reason|2
858835|NCT01523301|2832462|P1|Overall Study|Other Reason|0
858836|NCT01523301|2832461|P2|Overall Study|Withdrawal by Subject|8
858837|NCT01523301|2832462|P1|Overall Study|Withdrawal by Subject|6
858838|NCT01523301|2832461|P2|Overall Study|Lost to Follow-up|0
858839|NCT01523301|2832462|P1|Overall Study|Lost to Follow-up|1
858840|NCT01523301|2832461|P2|Overall Study|Protocol Violation|4
858841|NCT01523301|2832462|P1|Overall Study|Protocol Violation|3
858842|NCT01523301|2832461|P2|Overall Study|Lack of Efficacy|2
858843|NCT01523301|2832462|P1|Overall Study|Lack of Efficacy|0
858844|NCT01523301|2832461|P2|Overall Study|Adverse Event|16
858845|NCT01523301|2832462|P1|Overall Study|Adverse Event|25
858846|NCT01522976|2832483|P3|Overall Study|Not protocol specified|27
858847|NCT01522976|2832484|P2|Overall Study|Not protocol specified|27
858848|NCT01522976|2832485|P1|Overall Study|Not protocol specified|22
858849|NCT01522976|2832483|P3|Overall Study|Refusal unrelated to adverse event|14
858850|NCT01522976|2832484|P2|Overall Study|Refusal unrelated to adverse event|13
858851|NCT01522976|2832485|P1|Overall Study|Refusal unrelated to adverse event|10
858852|NCT01522976|2832483|P3|Overall Study|Adverse Event|18
858853|NCT01522976|2832484|P2|Overall Study|Adverse Event|7
858854|NCT01522976|2832485|P1|Overall Study|Adverse Event|17
858855|NCT01522976|2832483|P3|Overall Study|Disease progression|25
858856|NCT01522976|2832484|P2|Overall Study|Disease progression|30
858857|NCT01522976|2832485|P1|Overall Study|Disease progression|28
858858|NCT01522976|2832483|P3|Overall Study|Still on treatment|6
858859|NCT01522976|2832484|P2|Overall Study|Still on treatment|9
858860|NCT01522976|2832485|P1|Overall Study|Still on treatment|9
858861|NCT01522976|2832483|P3|Overall Study|Death|2
858862|NCT01522976|2832484|P2|Overall Study|Death|6
858863|NCT01522976|2832485|P1|Overall Study|Death|7
858864|NCT01522976|2832483|P3|Overall Study|Ineligible|1
858865|NCT01522976|2832484|P2|Overall Study|Ineligible|0
858866|NCT01522976|2832485|P1|Overall Study|Ineligible|4
858867|NCT01522456|2832565|P1|Overall Study|Tolerability Assessment|1
858868|NCT01522456|2832565|P1|Overall Study|Pregnancy|1
858869|NCT01522456|2832565|P1|Overall Study|Withdrawal by Subject|2
858870|NCT01522456|2832565|P1|Overall Study|Lost to Follow-up|2
858871|NCT01522456|2832565|P1|Overall Study|Adverse Event|2
858872|NCT01522443|2832628|P2|Overall Study|Other|3
858873|NCT01522443|2832629|P1|Overall Study|Other|1
858874|NCT01522443|2832628|P2|Overall Study|No study treatment given|1
858875|NCT01522443|2832629|P1|Overall Study|No study treatment given|1
858876|NCT01522443|2832628|P2|Overall Study|Withdrawal by Subject|8
858877|NCT01522443|2832629|P1|Overall Study|Withdrawal by Subject|5
858878|NCT01522443|2832628|P2|Overall Study|Adverse Event|15
858879|NCT01522443|2832629|P1|Overall Study|Adverse Event|10
858880|NCT01522443|2832628|P2|Overall Study|No longer receiving clinical benefit|28
858881|NCT01522443|2832629|P1|Overall Study|No longer receiving clinical benefit|36
858882|NCT01522235|2832646|P2|Overall Study|Physician Decision|1
858883|NCT01522235|2832647|P1|Overall Study|Physician Decision|1
858884|NCT01521923|2832683|P4|Overall Study|AE, captured in Period 1|1
858885|NCT01521923|2832684|P3|Overall Study|AE, captured in Period 1|0
858886|NCT01521923|2832685|P2|Overall Study|AE, captured in Period 1|1
858887|NCT01521923|2832686|P1|Overall Study|AE, captured in Period 1|0
858888|NCT01521923|2832683|P4|Overall Study|Other|6
858889|NCT01521923|2832684|P3|Overall Study|Other|3
858890|NCT01521923|2832685|P2|Overall Study|Other|1
858891|NCT01521923|2832686|P1|Overall Study|Other|2
858892|NCT01521923|2832683|P4|Overall Study|Withdrawal by Subject|2
858893|NCT01521923|2832684|P3|Overall Study|Withdrawal by Subject|1
858894|NCT01521923|2832685|P2|Overall Study|Withdrawal by Subject|1
858895|NCT01521923|2832686|P1|Overall Study|Withdrawal by Subject|1
858896|NCT01521923|2832683|P4|Overall Study|Lost to Follow-up|1
858897|NCT01521923|2832684|P3|Overall Study|Lost to Follow-up|2
858898|NCT01521923|2832685|P2|Overall Study|Lost to Follow-up|0
858899|NCT01521923|2832686|P1|Overall Study|Lost to Follow-up|1
858900|NCT01521923|2832683|P4|Overall Study|Protocol Violation|0
858901|NCT01521923|2832684|P3|Overall Study|Protocol Violation|1
858902|NCT01521923|2832685|P2|Overall Study|Protocol Violation|0
858903|NCT01521923|2832686|P1|Overall Study|Protocol Violation|0
858904|NCT01521923|2832683|P4|Overall Study|Lack of Efficacy|0
858905|NCT01521923|2832684|P3|Overall Study|Lack of Efficacy|0
858906|NCT01521923|2832685|P2|Overall Study|Lack of Efficacy|1
858907|NCT01521923|2832686|P1|Overall Study|Lack of Efficacy|1
858908|NCT01521923|2832683|P4|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1
858909|NCT01521923|2832684|P3|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
858910|NCT01521923|2832685|P2|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
858911|NCT01521923|2832686|P1|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
858912|NCT01521923|2832683|P4|Overall Study|AE, non-serious, non-fatal|2
858913|NCT01521923|2832684|P3|Overall Study|AE, non-serious, non-fatal|6
858914|NCT01521923|2832685|P2|Overall Study|AE, non-serious, non-fatal|3
858915|NCT01521923|2832686|P1|Overall Study|AE, non-serious, non-fatal|1
858916|NCT01521923|2832683|P4|Overall Study|SAE, non-fatal|0
858917|NCT01521923|2832684|P3|Overall Study|SAE, non-fatal|2
858918|NCT01521923|2832685|P2|Overall Study|SAE, non-fatal|2
858919|NCT01521923|2832686|P1|Overall Study|SAE, non-fatal|0
858920|NCT01521923|2832683|P4|Overall Study|AE, serious fatal|0
858921|NCT01521923|2832684|P3|Overall Study|AE, serious fatal|0
858922|NCT01521923|2832685|P2|Overall Study|AE, serious fatal|0
858923|NCT01521923|2832686|P1|Overall Study|AE, serious fatal|1
858924|NCT01521897|2832806|P1|Overall Study|Lost to Follow-up|5
858925|NCT01521897|2832806|P1|Overall Study|Protocol Violation|18
858926|NCT01521884|2832818|P1|Overall Study|Lost to Follow-up|4
858927|NCT01521884|2832818|P1|Overall Study|Participant non-eligible|1
858928|NCT01521884|2832818|P1|Overall Study|Protocol Violation|3
858929|NCT01521884|2832818|P1|Overall Study|Physician Decision|2
858930|NCT01521884|2832818|P1|Overall Study|Withdrawal by Subject|1
858931|NCT01521884|2832818|P1|Overall Study|Pregnancy|1
858932|NCT01521884|2832818|P1|Overall Study|Adverse Event|5
858933|NCT01521884|2832818|P1|Overall Study|Non Responders|10
858934|NCT01521559|2832915|P2|Overall Study|Other|2
858935|NCT01521559|2832916|P1|Overall Study|Other|1
858936|NCT01521559|2832915|P2|Overall Study|Protocol Violation|0
858937|NCT01521559|2832916|P1|Overall Study|Protocol Violation|1
858938|NCT01521559|2832915|P2|Overall Study|Lost to Follow-up|1
858939|NCT01521559|2832916|P1|Overall Study|Lost to Follow-up|3
858940|NCT01521559|2832915|P2|Overall Study|Withdrawal by Subject|11
858941|NCT01521559|2832916|P1|Overall Study|Withdrawal by Subject|9
858942|NCT01521559|2832915|P2|Overall Study|Death|0
858943|NCT01521559|2832916|P1|Overall Study|Death|1
858944|NCT01521559|2832915|P2|Overall Study|Adverse Event|4
858945|NCT01521559|2832916|P1|Overall Study|Adverse Event|0
858946|NCT01521507|2832939|P2|Stage 2: Observational Design|Physician Decision|0
858947|NCT01521507|2832940|P1|Stage 2: Observational Design|Physician Decision|1
858948|NCT01521507|2832939|P2|Stage 2: Observational Design|Withdrawal by Subject|1
858949|NCT01521507|2832940|P1|Stage 2: Observational Design|Withdrawal by Subject|3
858950|NCT01521507|2832939|P2|Stage 2: Observational Design|Device did not fit, No Treatment|1
858951|NCT01521507|2832940|P1|Stage 2: Observational Design|Device did not fit, No Treatment|0
858952|NCT01521507|2832939|P2|Stage 1: Randomized Design|Lost to Follow-up|2
858953|NCT01521507|2832940|P1|Stage 1: Randomized Design|Lost to Follow-up|0
858954|NCT01521507|2832939|P2|Stage 1: Randomized Design|Withdrawal by Subject|3
858955|NCT01521507|2832940|P1|Stage 1: Randomized Design|Withdrawal by Subject|1
858956|NCT01521507|2832939|P2|Stage 1: Randomized Design|Device did not fit, No Treatment|0
858957|NCT01521507|2832940|P1|Stage 1: Randomized Design|Device did not fit, No Treatment|2
858958|NCT01521494|2832962|P5|Overall Study|Physician Decision|2
858959|NCT01521494|2832963|P4|Overall Study|Physician Decision|0
858960|NCT01521494|2832964|P3|Overall Study|Physician Decision|0
858961|NCT01521494|2832965|P2|Overall Study|Physician Decision|0
858962|NCT01521494|2832966|P1|Overall Study|Physician Decision|0
858963|NCT01521494|2832962|P5|Overall Study|Decrease in serum calcium|1
858964|NCT01521494|2832963|P4|Overall Study|Decrease in serum calcium|1
858965|NCT01521494|2832964|P3|Overall Study|Decrease in serum calcium|0
858966|NCT01521494|2832965|P2|Overall Study|Decrease in serum calcium|0
858967|NCT01521494|2832966|P1|Overall Study|Decrease in serum calcium|0
858968|NCT01521494|2832962|P5|Overall Study|Decrease in serum phosphate|0
858969|NCT01521494|2832963|P4|Overall Study|Decrease in serum phosphate|12
858970|NCT01521494|2832964|P3|Overall Study|Decrease in serum phosphate|3
858971|NCT01521494|2832965|P2|Overall Study|Decrease in serum phosphate|2
858972|NCT01521494|2832966|P1|Overall Study|Decrease in serum phosphate|0
858973|NCT01521494|2832962|P5|Overall Study|Withdrawal by Subject|0
858974|NCT01521494|2832963|P4|Overall Study|Withdrawal by Subject|2
858975|NCT01521494|2832964|P3|Overall Study|Withdrawal by Subject|0
858976|NCT01521494|2832965|P2|Overall Study|Withdrawal by Subject|1
858977|NCT01521494|2832966|P1|Overall Study|Withdrawal by Subject|1
858978|NCT01521494|2832962|P5|Overall Study|Lack of Efficacy|2
858979|NCT01521494|2832963|P4|Overall Study|Lack of Efficacy|0
858980|NCT01521494|2832964|P3|Overall Study|Lack of Efficacy|0
858981|NCT01521494|2832965|P2|Overall Study|Lack of Efficacy|0
858982|NCT01521494|2832966|P1|Overall Study|Lack of Efficacy|0
858983|NCT01521494|2832962|P5|Overall Study|Adverse Event|2
858984|NCT01521494|2832963|P4|Overall Study|Adverse Event|6
858985|NCT01521494|2832964|P3|Overall Study|Adverse Event|9
858986|NCT01521494|2832965|P2|Overall Study|Adverse Event|2
858987|NCT01521494|2832966|P1|Overall Study|Adverse Event|1
858988|NCT01521364|2832988|P1|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1
858989|NCT01521364|2832988|P1|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1
858990|NCT01520987|2833064|P8|Overall Study|Withdrawal by Subject|0
858991|NCT01520987|2833065|P7|Overall Study|Withdrawal by Subject|0
858992|NCT01520987|2833066|P6|Overall Study|Withdrawal by Subject|1
858993|NCT01520987|2833067|P5|Overall Study|Withdrawal by Subject|0
858994|NCT01520987|2833068|P4|Overall Study|Withdrawal by Subject|0
858995|NCT01520987|2833069|P3|Overall Study|Withdrawal by Subject|0
858996|NCT01520987|2833070|P2|Overall Study|Withdrawal by Subject|0
858997|NCT01520987|2833071|P1|Overall Study|Withdrawal by Subject|1
858998|NCT01520922|2833131|P2|Survival Follow-up|Withdrawal by Subject|0
858999|NCT01520922|2833132|P1|Survival Follow-up|Withdrawal by Subject|1
859000|NCT01520922|2833131|P2|Follow up|Lost to Follow-up|1
859001|NCT01520922|2833132|P1|Follow up|Lost to Follow-up|0
859002|NCT01520922|2833131|P2|Treatment Phase|Adverse Event|5
859003|NCT01520922|2833132|P1|Treatment Phase|Adverse Event|3
859004|NCT01520922|2833131|P2|Treatment Phase|Progression|2
859005|NCT01520922|2833132|P1|Treatment Phase|Progression|0
859006|NCT01520922|2833131|P2|Treatment Phase|Physician Decision|1
859007|NCT01520922|2833132|P1|Treatment Phase|Physician Decision|2
859008|NCT01520909|2833194|P3|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1
859009|NCT01520909|2833195|P2|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
859010|NCT01520909|2833196|P1|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
859011|NCT01520909|2833194|P3|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2
859012|NCT01520909|2833195|P2|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
859013|NCT01520909|2833196|P1|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
859014|NCT01520909|2833194|P3|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4
859015|NCT01520909|2833195|P2|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
859016|NCT01520909|2833196|P1|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
859017|NCT01520909|2833194|P3|Part 1 (Randomized Period)|Adverse Event|0
859018|NCT01520909|2833195|P2|Part 1 (Randomized Period)|Adverse Event|2
859019|NCT01520909|2833196|P1|Part 1 (Randomized Period)|Adverse Event|1
859020|NCT01520714|2833313|P2|Overall Study|Lack of Efficacy|1
859021|NCT01520714|2833314|P1|Overall Study|Lack of Efficacy|0
859022|NCT01520714|2833313|P2|Overall Study|Adverse Event|2
859023|NCT01520714|2833314|P1|Overall Study|Adverse Event|0
859024|NCT01520714|2833313|P2|Overall Study|Protocol Violation|3
859025|NCT01520714|2833314|P1|Overall Study|Protocol Violation|0
859026|NCT01520506|2833339|P1|Overall Study|Withdrawal by Subject|1
859027|NCT01520506|2833339|P1|Overall Study|Lost to Follow-up|1
859028|NCT01520506|2833339|P1|Overall Study|Missed Visit|4
859029|NCT01520402|2833394|P1|Overall Study|Physician Decision|3
859030|NCT01520402|2833394|P1|Overall Study|Withdrawal by Subject|2
859031|NCT01520363|2833407|P2|Overall Study|Withdrawal by Subject|0
859032|NCT01520363|2833408|P1|Overall Study|Withdrawal by Subject|2
859033|NCT01519960|2833494|P3|Overall Study|Lost to Follow-up|0
859034|NCT01519960|2833495|P2|Overall Study|Lost to Follow-up|1
859035|NCT01519960|2833496|P1|Overall Study|Lost to Follow-up|0
859036|NCT01519960|2833494|P3|Overall Study|Withdrawal by Subject|0
859037|NCT01519960|2833495|P2|Overall Study|Withdrawal by Subject|4
859038|NCT01519960|2833496|P1|Overall Study|Withdrawal by Subject|0
859039|NCT01519960|2833494|P3|Overall Study|Adverse Event|0
859040|NCT01519960|2833495|P2|Overall Study|Adverse Event|1
859041|NCT01519960|2833496|P1|Overall Study|Adverse Event|0
859042|NCT01519960|2833494|P3|Overall Study|Ongoing/Switched to PEG-IFN|0
859043|NCT01519960|2833495|P2|Overall Study|Ongoing/Switched to PEG-IFN|33
859044|NCT01519960|2833496|P1|Overall Study|Ongoing/Switched to PEG-IFN|0
859045|NCT01519960|2833494|P3|Overall Study|Ongoing in Follow-Up|10
859046|NCT01519960|2833495|P2|Overall Study|Ongoing in Follow-Up|11
859047|NCT01519960|2833496|P1|Overall Study|Ongoing in Follow-Up|101
859048|NCT01519934|2833602|P1|Overall Study|Lost to Follow-up|3
859049|NCT01519921|2833611|P2|Overall Study|High alanine aminotransferase (ALT)|1
859050|NCT01519921|2833612|P1|Overall Study|High alanine aminotransferase (ALT)|0
859051|NCT01519921|2833611|P2|Overall Study|Treatment refusal|1
859052|NCT01519921|2833612|P1|Overall Study|Treatment refusal|2
859053|NCT01519921|2833611|P2|Overall Study|Lost to Follow-up|1
859054|NCT01519921|2833612|P1|Overall Study|Lost to Follow-up|2
859055|NCT01519921|2833611|P2|Overall Study|Withdrawal by Subject|0
859056|NCT01519921|2833612|P1|Overall Study|Withdrawal by Subject|3
859057|NCT01519921|2833611|P2|Overall Study|Lack of Efficacy|3
859058|NCT01519921|2833612|P1|Overall Study|Lack of Efficacy|4
859059|NCT01519921|2833611|P2|Overall Study|Adverse Event|9
859060|NCT01519921|2833612|P1|Overall Study|Adverse Event|10
859061|NCT01519817|2833661|P4|Overall Study|Off study due to infection|1
859062|NCT01519817|2833662|P3|Overall Study|Off study due to infection|0
859063|NCT01519817|2833663|P2|Overall Study|Off study due to infection|0
859064|NCT01519817|2833664|P1|Overall Study|Off study due to infection|0
859065|NCT01519817|2833661|P4|Overall Study|Withdrawal by Subject|0
859066|NCT01519817|2833662|P3|Overall Study|Withdrawal by Subject|0
859067|NCT01519817|2833663|P2|Overall Study|Withdrawal by Subject|0
859068|NCT01519817|2833664|P1|Overall Study|Withdrawal by Subject|1
859069|NCT01519791|2833704|P2|Overall Study|Lost to Follow-up|14
859070|NCT01519791|2833705|P1|Overall Study|Lost to Follow-up|6
859071|NCT01519791|2833704|P2|Overall Study|Withdrawal by Subject|37
859072|NCT01519791|2833705|P1|Overall Study|Withdrawal by Subject|15
859073|NCT01519791|2833704|P2|Overall Study|AE, non-serious non-fatal|31
859074|NCT01519791|2833705|P1|Overall Study|AE, non-serious non-fatal|12
859075|NCT01519791|2833704|P2|Overall Study|SAE, fatal + SAE, non-fatal|1
859076|NCT01519791|2833705|P1|Overall Study|SAE, fatal + SAE, non-fatal|0
859077|NCT01519791|2833704|P2|Overall Study|AE, serious fatal|1
859078|NCT01519791|2833705|P1|Overall Study|AE, serious fatal|0
859079|NCT01519791|2833704|P2|Overall Study|SAE, non-fatal|22
859080|NCT01519791|2833705|P1|Overall Study|SAE, non-fatal|6
859081|NCT01519791|2833704|P2|Overall Study|Lack of Efficacy|20
859082|NCT01519791|2833705|P1|Overall Study|Lack of Efficacy|16
859083|NCT01519791|2833704|P2|Overall Study|subjects randomized in error|0
859084|NCT01519791|2833705|P1|Overall Study|subjects randomized in error|2
859085|NCT01519791|2833704|P2|Overall Study|Other Reason|222
859086|NCT01519791|2833705|P1|Overall Study|Other Reason|87
859087|NCT01519791|2833704|P2|Overall Study|Protocol Violation|19
859088|NCT01519791|2833705|P1|Overall Study|Protocol Violation|6
859089|NCT01519791|2833704|P2|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1
859090|NCT01519791|2833705|P1|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2
859091|NCT01519778|2833769|P1|Overall Study|Physician Decision|1
859092|NCT01519778|2833769|P1|Overall Study|Lost to Follow-up|10
859093|NCT01519778|2833769|P1|Overall Study|Withdrawal by Subject|3
859094|NCT01519765|2833775|P2|Overall Study|Withdrawal by Subject|1
859095|NCT01519765|2833776|P1|Overall Study|Withdrawal by Subject|0
859096|NCT01519765|2833775|P2|Overall Study|Protocol Violation|0
859097|NCT01519765|2833776|P1|Overall Study|Protocol Violation|1
859098|NCT01519765|2833775|P2|Overall Study|Lack of Efficacy|0
859099|NCT01519765|2833776|P1|Overall Study|Lack of Efficacy|2
859100|NCT01519765|2833775|P2|Overall Study|Adverse Event|1
859101|NCT01519765|2833776|P1|Overall Study|Adverse Event|0
859102|NCT01519700|2833854|P4|Overall Study|Other Reason|4
859103|NCT01519700|2833855|P3|Overall Study|Other Reason|0
859104|NCT01519700|2833856|P2|Overall Study|Other Reason|2
859105|NCT01519700|2833857|P1|Overall Study|Other Reason|2
859106|NCT01519700|2833854|P4|Overall Study|Withdrawal by Subject|2
859107|NCT01519700|2833855|P3|Overall Study|Withdrawal by Subject|3
859108|NCT01519700|2833856|P2|Overall Study|Withdrawal by Subject|3
859109|NCT01519700|2833857|P1|Overall Study|Withdrawal by Subject|5
859110|NCT01519700|2833854|P4|Overall Study|Physician Decision|0
859111|NCT01519700|2833855|P3|Overall Study|Physician Decision|3
859112|NCT01519700|2833856|P2|Overall Study|Physician Decision|1
859113|NCT01519700|2833857|P1|Overall Study|Physician Decision|1
859114|NCT01519700|2833854|P4|Overall Study|Lost to Follow-up|1
859115|NCT01519700|2833855|P3|Overall Study|Lost to Follow-up|1
859116|NCT01519700|2833856|P2|Overall Study|Lost to Follow-up|0
859117|NCT01519700|2833857|P1|Overall Study|Lost to Follow-up|0
859118|NCT01519700|2833854|P4|Overall Study|Death|0
859119|NCT01519700|2833855|P3|Overall Study|Death|0
859120|NCT01519700|2833856|P2|Overall Study|Death|0
859121|NCT01519700|2833857|P1|Overall Study|Death|1
859122|NCT01519674|2833892|P3|Overall Study|Unsclassified|3
859123|NCT01519674|2833893|P2|Overall Study|Unsclassified|4
859124|NCT01519674|2833894|P1|Overall Study|Unsclassified|10
859125|NCT01519674|2833892|P3|Overall Study|Withdrawal Criteria|7
859126|NCT01519674|2833893|P2|Overall Study|Withdrawal Criteria|2
859127|NCT01519674|2833894|P1|Overall Study|Withdrawal Criteria|7
859128|NCT01519674|2833892|P3|Overall Study|Protocol Violation|1
859129|NCT01519674|2833893|P2|Overall Study|Protocol Violation|3
859130|NCT01519674|2833894|P1|Overall Study|Protocol Violation|0
859131|NCT01519674|2833892|P3|Overall Study|Lack of Efficacy|1
859132|NCT01519674|2833893|P2|Overall Study|Lack of Efficacy|1
859133|NCT01519674|2833894|P1|Overall Study|Lack of Efficacy|1
859134|NCT01519674|2833892|P3|Overall Study|Adverse Event|0
859135|NCT01519674|2833893|P2|Overall Study|Adverse Event|3
859136|NCT01519674|2833894|P1|Overall Study|Adverse Event|3
859137|NCT01519661|2833932|P1|Overall Study|Adverse Event|29
859138|NCT01519661|2833932|P1|Overall Study|Lack of Efficacy|6
859139|NCT01519661|2833932|P1|Overall Study|Withdrawal by Subject|17
859140|NCT01519661|2833932|P1|Overall Study|Lost to Follow-up|3
859141|NCT01519661|2833932|P1|Overall Study|Protocol deviation|6
859142|NCT01519518|2833958|P2|Overall Study|Consent not available|10
859143|NCT01519518|2833959|P1|Overall Study|Consent not available|7
859144|NCT01519427|2833984|P1|Overall Study|disease progression|2
859145|NCT01519323|2834016|P2|Overall Study|Study terminated by sponsor|1
859146|NCT01519323|2834017|P1|Overall Study|Study terminated by sponsor|0
859147|NCT01519323|2834016|P2|Overall Study|Death|2
859148|NCT01519323|2834017|P1|Overall Study|Death|3
859149|NCT01519245|2834077|P2|Overall Study|Met exclusion criteria, not analysed|2
859150|NCT01519245|2834078|P1|Overall Study|Met exclusion criteria, not analysed|1
859151|NCT01519206|2834090|P1|Overall Study|Missed Visit|2
859152|NCT01519206|2834090|P1|Overall Study|Lost to Follow-up|3
859153|NCT01519167|2834104|P2|Overall Study|Physician Decision|1
859154|NCT01519167|2834105|P1|Overall Study|Physician Decision|0
859155|NCT01519167|2834104|P2|Overall Study|Medical condition changes&deep sedation|2
859156|NCT01519167|2834105|P1|Overall Study|Medical condition changes&deep sedation|0
859157|NCT01519167|2834104|P2|Overall Study|Lack of Efficacy|1
859158|NCT01519167|2834105|P1|Overall Study|Lack of Efficacy|0
859159|NCT01519167|2834104|P2|Overall Study|Adverse Event|1
859160|NCT01519167|2834105|P1|Overall Study|Adverse Event|0
859161|NCT01519167|2834104|P2|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3
859162|NCT01519167|2834105|P1|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0
859163|NCT01519089|2834131|P2|Overall Study|Not received study drug|1
859164|NCT01519089|2834132|P1|Overall Study|Not received study drug|0
859165|NCT01519089|2834131|P2|Overall Study|Other|6
859166|NCT01519089|2834132|P1|Overall Study|Other|2
859167|NCT01519089|2834131|P2|Overall Study|Withdrawal by Subject|2
859168|NCT01519089|2834132|P1|Overall Study|Withdrawal by Subject|0
859169|NCT01519089|2834131|P2|Overall Study|Lost to Follow-up|0
859170|NCT01519089|2834132|P1|Overall Study|Lost to Follow-up|1
859171|NCT01519089|2834131|P2|Overall Study|Lack of Efficacy|2
859172|NCT01519089|2834132|P1|Overall Study|Lack of Efficacy|0
859173|NCT01519089|2834131|P2|Overall Study|Adverse Event|4
859174|NCT01519089|2834132|P1|Overall Study|Adverse Event|4
859175|NCT01518946|2834253|P3|Randomized Phase (First Intervention)|Not specified|0
859176|NCT01518946|2834254|P2|Randomized Phase (First Intervention)|Not specified|1
859177|NCT01518946|2834255|P1|Randomized Phase (First Intervention)|Not specified|0
859178|NCT01518946|2834253|P3|Open-label Phase|Not specified|0
859179|NCT01518946|2834254|P2|Open-label Phase|Not specified|0
859180|NCT01518946|2834255|P1|Open-label Phase|Not specified|4
859181|NCT01518374|2834266|P1|Overall Study|Lost to Follow-up|2
859182|NCT01518374|2834266|P1|Overall Study|Protocol Violation|3
859183|NCT01518374|2834266|P1|Overall Study|Withdrawal by Subject|2
859184|NCT01518322|2834270|P1|Overall Study|FeNO measurement was missing|13
859185|NCT01518257|2834291|P2|Overall Study|Other Miscellaneous Reason|0
859186|NCT01518257|2834292|P1|Overall Study|Other Miscellaneous Reason|1
859187|NCT01518257|2834291|P2|Overall Study|Lost to Follow-up|0
859188|NCT01518257|2834292|P1|Overall Study|Lost to Follow-up|1
859189|NCT01518244|2834314|P1|Overall Study|Adverse Event|3
859190|NCT01518192|2834322|P3|Overall Study|Lost to Follow-up|35
859191|NCT01518192|2834323|P2|Overall Study|Lost to Follow-up|26
859192|NCT01518192|2834324|P1|Overall Study|Lost to Follow-up|29
859193|NCT01518153|2834345|P3|Donor Lymphocyte Infusion|Death|1
859194|NCT01518153|2834346|P2|Donor Lymphocyte Infusion|Death|2
859195|NCT01518153|2834347|P1|Donor Lymphocyte Infusion|Death|0
859196|NCT01518153|2834345|P3|Stem Cell Transplant|Adverse Event|0
859197|NCT01518153|2834346|P2|Stem Cell Transplant|Adverse Event|0
859198|NCT01518153|2834347|P1|Stem Cell Transplant|Adverse Event|1
859199|NCT01518153|2834345|P3|Stem Cell Transplant|Secondary graft failure|0
859200|NCT01518153|2834346|P2|Stem Cell Transplant|Secondary graft failure|0
859201|NCT01518153|2834347|P1|Stem Cell Transplant|Secondary graft failure|1
859202|NCT01518153|2834345|P3|Stem Cell Transplant|Death|0
859203|NCT01518153|2834346|P2|Stem Cell Transplant|Death|0
859204|NCT01518153|2834347|P1|Stem Cell Transplant|Death|2
859205|NCT01518153|2834345|P3|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
859206|NCT01518153|2834346|P2|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
859207|NCT01518153|2834347|P1|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5
859208|NCT01517984|2834358|P4|Overall Study|Ineligible for randomization|0
859209|NCT01517984|2834359|P3|Overall Study|Ineligible for randomization|0
859210|NCT01517984|2834360|P2|Overall Study|Ineligible for randomization|14
859211|NCT01517984|2834361|P1|Overall Study|Ineligible for randomization|0
859212|NCT01517984|2834358|P4|Overall Study|Screen Failure|0
859213|NCT01517984|2834359|P3|Overall Study|Screen Failure|0
859214|NCT01517984|2834360|P2|Overall Study|Screen Failure|0
859215|NCT01517984|2834361|P1|Overall Study|Screen Failure|4
859216|NCT01517984|2834358|P4|Overall Study|Withdrawal by Subject|1
859217|NCT01517984|2834359|P3|Overall Study|Withdrawal by Subject|4
859218|NCT01517984|2834360|P2|Overall Study|Withdrawal by Subject|8
859219|NCT01517984|2834361|P1|Overall Study|Withdrawal by Subject|1
859220|NCT01517984|2834358|P4|Overall Study|Lost to Follow-up|0
859221|NCT01517984|2834359|P3|Overall Study|Lost to Follow-up|0
859222|NCT01517984|2834360|P2|Overall Study|Lost to Follow-up|1
859223|NCT01517984|2834361|P1|Overall Study|Lost to Follow-up|0
859224|NCT01517893|2834387|P2|Overall Study|Withdrawal by Subject|0
859225|NCT01517893|2834388|P1|Overall Study|Withdrawal by Subject|3
859226|NCT01517867|2834410|P2|Overall Study|Still in treatment at study end|3
859227|NCT01517867|2834411|P1|Overall Study|Still in treatment at study end|0
859228|NCT01517867|2834410|P2|Overall Study|Withdrawal by Subject|30
859229|NCT01517867|2834411|P1|Overall Study|Withdrawal by Subject|34
859230|NCT01517867|2834410|P2|Overall Study|never started treatment|32
859231|NCT01517867|2834411|P1|Overall Study|never started treatment|29
859232|NCT01517750|2834423|P4|Overall Study|Lost to Follow-up|1
859233|NCT01517750|2834424|P3|Overall Study|Lost to Follow-up|4
859234|NCT01517750|2834425|P2|Overall Study|Lost to Follow-up|2
859235|NCT01517750|2834426|P1|Overall Study|Lost to Follow-up|1
859236|NCT01517412|2834463|P2|Overall Study|Other than specified above|5
859237|NCT01517412|2834464|P1|Overall Study|Other than specified above|8
859238|NCT01517412|2834463|P2|Overall Study|Poor compliance to protocol|3
859239|NCT01517412|2834464|P1|Overall Study|Poor compliance to protocol|8
859240|NCT01517412|2834463|P2|Overall Study|Lack of Efficacy|5
859241|NCT01517412|2834464|P1|Overall Study|Lack of Efficacy|10
859242|NCT01517412|2834463|P2|Overall Study|Adverse Event|11
859243|NCT01517412|2834464|P1|Overall Study|Adverse Event|10
859244|NCT01517373|2834493|P6|Treatment Period|Medication error without AEs|2
859245|NCT01517373|2834494|P5|Treatment Period|Medication error without AEs|0
859246|NCT01517373|2834495|P4|Treatment Period|Medication error without AEs|1
859247|NCT01517373|2834496|P3|Treatment Period|Medication error without AEs|2
859248|NCT01517373|2834497|P2|Treatment Period|Medication error without AEs|0
859249|NCT01517373|2834498|P1|Treatment Period|Medication error without AEs|0
859250|NCT01517373|2834493|P6|Treatment Period|Lack of Efficacy|0
859251|NCT01517373|2834494|P5|Treatment Period|Lack of Efficacy|2
859252|NCT01517373|2834495|P4|Treatment Period|Lack of Efficacy|3
859253|NCT01517373|2834496|P3|Treatment Period|Lack of Efficacy|1
859254|NCT01517373|2834497|P2|Treatment Period|Lack of Efficacy|1
859255|NCT01517373|2834498|P1|Treatment Period|Lack of Efficacy|0
859256|NCT01517373|2834493|P6|Treatment Period|Protocol Violation|0
859257|NCT01517373|2834494|P5|Treatment Period|Protocol Violation|1
859258|NCT01517373|2834495|P4|Treatment Period|Protocol Violation|0
859259|NCT01517373|2834496|P3|Treatment Period|Protocol Violation|0
859260|NCT01517373|2834497|P2|Treatment Period|Protocol Violation|0
859261|NCT01517373|2834498|P1|Treatment Period|Protocol Violation|0
859262|NCT01517373|2834493|P6|Treatment Period|Other|0
859263|NCT01517373|2834494|P5|Treatment Period|Other|1
859264|NCT01517373|2834495|P4|Treatment Period|Other|0
859265|NCT01517373|2834496|P3|Treatment Period|Other|0
859266|NCT01517373|2834497|P2|Treatment Period|Other|0
859267|NCT01517373|2834498|P1|Treatment Period|Other|0
859268|NCT01517373|2834493|P6|Treatment Period|Withdrawal by Subject|3
859269|NCT01517373|2834494|P5|Treatment Period|Withdrawal by Subject|2
859270|NCT01517373|2834495|P4|Treatment Period|Withdrawal by Subject|2
859271|NCT01517373|2834496|P3|Treatment Period|Withdrawal by Subject|2
859272|NCT01517373|2834497|P2|Treatment Period|Withdrawal by Subject|3
859273|NCT01517373|2834498|P1|Treatment Period|Withdrawal by Subject|0
859274|NCT01517373|2834493|P6|Treatment Period|Lost to Follow-up|0
859275|NCT01517373|2834494|P5|Treatment Period|Lost to Follow-up|0
859276|NCT01517373|2834495|P4|Treatment Period|Lost to Follow-up|1
859277|NCT01517373|2834496|P3|Treatment Period|Lost to Follow-up|1
859278|NCT01517373|2834497|P2|Treatment Period|Lost to Follow-up|0
859279|NCT01517373|2834498|P1|Treatment Period|Lost to Follow-up|0
859280|NCT01517373|2834493|P6|Treatment Period|Adverse Event|2
859281|NCT01517373|2834494|P5|Treatment Period|Adverse Event|0
859282|NCT01517373|2834495|P4|Treatment Period|Adverse Event|0
859283|NCT01517373|2834496|P3|Treatment Period|Adverse Event|0
859284|NCT01517373|2834497|P2|Treatment Period|Adverse Event|0
859285|NCT01517373|2834498|P1|Treatment Period|Adverse Event|0
859286|NCT01517373|2834493|P6|Run-in Period|Other|0
859287|NCT01517373|2834494|P5|Run-in Period|Other|0
859288|NCT01517373|2834495|P4|Run-in Period|Other|0
859289|NCT01517373|2834496|P3|Run-in Period|Other|0
859290|NCT01517373|2834497|P2|Run-in Period|Other|0
859291|NCT01517373|2834498|P1|Run-in Period|Other|1
859292|NCT01517373|2834493|P6|Run-in Period|Sponsor Decision|0
859293|NCT01517373|2834494|P5|Run-in Period|Sponsor Decision|0
859294|NCT01517373|2834495|P4|Run-in Period|Sponsor Decision|0
859295|NCT01517373|2834496|P3|Run-in Period|Sponsor Decision|0
859296|NCT01517373|2834497|P2|Run-in Period|Sponsor Decision|0
859297|NCT01517373|2834498|P1|Run-in Period|Sponsor Decision|3
859298|NCT01517373|2834493|P6|Run-in Period|Withdrawal by Subject|0
859299|NCT01517373|2834494|P5|Run-in Period|Withdrawal by Subject|0
859300|NCT01517373|2834495|P4|Run-in Period|Withdrawal by Subject|0
859301|NCT01517373|2834496|P3|Run-in Period|Withdrawal by Subject|0
859302|NCT01517373|2834497|P2|Run-in Period|Withdrawal by Subject|0
859303|NCT01517373|2834498|P1|Run-in Period|Withdrawal by Subject|12
859304|NCT01517373|2834493|P6|Run-in Period|Lost to Follow-up|0
859305|NCT01517373|2834494|P5|Run-in Period|Lost to Follow-up|0
859306|NCT01517373|2834495|P4|Run-in Period|Lost to Follow-up|0
859307|NCT01517373|2834496|P3|Run-in Period|Lost to Follow-up|0
859308|NCT01517373|2834497|P2|Run-in Period|Lost to Follow-up|0
859309|NCT01517373|2834498|P1|Run-in Period|Lost to Follow-up|1
859310|NCT01517373|2834493|P6|Run-in Period|Did not meet eligibility criteria|0
859311|NCT01517373|2834494|P5|Run-in Period|Did not meet eligibility criteria|0
859312|NCT01517373|2834495|P4|Run-in Period|Did not meet eligibility criteria|0
859313|NCT01517373|2834496|P3|Run-in Period|Did not meet eligibility criteria|0
859314|NCT01517373|2834497|P2|Run-in Period|Did not meet eligibility criteria|0
859315|NCT01517373|2834498|P1|Run-in Period|Did not meet eligibility criteria|34
859316|NCT01517373|2834493|P6|Run-in Period|Adverse Event|0
859317|NCT01517373|2834494|P5|Run-in Period|Adverse Event|0
859318|NCT01517373|2834495|P4|Run-in Period|Adverse Event|0
859319|NCT01517373|2834496|P3|Run-in Period|Adverse Event|0
859320|NCT01517373|2834497|P2|Run-in Period|Adverse Event|0
859321|NCT01517373|2834498|P1|Run-in Period|Adverse Event|5
859322|NCT01517373|2834493|P6|Run-in Period|Death|0
859323|NCT01517373|2834494|P5|Run-in Period|Death|0
859324|NCT01517373|2834495|P4|Run-in Period|Death|0
859325|NCT01517373|2834496|P3|Run-in Period|Death|0
859326|NCT01517373|2834497|P2|Run-in Period|Death|0
859327|NCT01517373|2834498|P1|Run-in Period|Death|1
859328|NCT01517295|2834568|P2|Overall Study|Physician Decision|0
859329|NCT01517295|2834569|P1|Overall Study|Physician Decision|1
859330|NCT01517282|2834583|P4|Overall Study|Physician Decision|0
859331|NCT01517282|2834584|P3|Overall Study|Physician Decision|0
859332|NCT01517282|2834585|P2|Overall Study|Physician Decision|0
859333|NCT01517282|2834586|P1|Overall Study|Physician Decision|1
859334|NCT01517282|2834583|P4|Overall Study|Consent withdrawn|1
859335|NCT01517282|2834584|P3|Overall Study|Consent withdrawn|1
859336|NCT01517282|2834585|P2|Overall Study|Consent withdrawn|1
859337|NCT01517282|2834586|P1|Overall Study|Consent withdrawn|0
859338|NCT01517178|2834620|P2|Period 2|E.g. study termination|2
859339|NCT01517178|2834621|P1|Period 2|E.g. study termination|2
859340|NCT01517178|2834620|P2|Period 2|Withdrawal by Subject|0
859341|NCT01517178|2834621|P1|Period 2|Withdrawal by Subject|3
859342|NCT01517178|2834620|P2|Period 2|Adverse Event|0
859343|NCT01517178|2834621|P1|Period 2|Adverse Event|1
859344|NCT01517178|2834620|P2|Period 1|Withdrawal by Subject|1
859345|NCT01517178|2834621|P1|Period 1|Withdrawal by Subject|0
859346|NCT01517178|2834620|P2|Period 1|E.g. study termination|1
859347|NCT01517178|2834621|P1|Period 1|E.g. study termination|3
859348|NCT01517178|2834620|P2|Period 1|Lack of Efficacy|1
859349|NCT01517178|2834621|P1|Period 1|Lack of Efficacy|0
859350|NCT01517178|2834620|P2|Period 1|Adverse Event|2
859351|NCT01517178|2834621|P1|Period 1|Adverse Event|1
859352|NCT01516970|2834640|P2|Overall Study|Other|7
859353|NCT01516970|2834641|P1|Overall Study|Other|9
859354|NCT01516970|2834640|P2|Overall Study|Withdrawal by Subject|1
859355|NCT01516970|2834641|P1|Overall Study|Withdrawal by Subject|1
859356|NCT01516970|2834640|P2|Overall Study|Adverse Event|5
859357|NCT01516970|2834641|P1|Overall Study|Adverse Event|1
859358|NCT01516970|2834640|P2|Overall Study|Lost to Follow-up|8
859359|NCT01516970|2834641|P1|Overall Study|Lost to Follow-up|7
859360|NCT01516892|2834653|P1|Overall Study|Missing|1
859361|NCT01516892|2834653|P1|Overall Study|Other Miscellaneous Reasons|43
859362|NCT01516892|2834653|P1|Overall Study|Protocol Violation|60
859363|NCT01516892|2834653|P1|Overall Study|Subject Withdrew Consent|92
859364|NCT01516892|2834653|P1|Overall Study|Lost to Follow-up|82
859365|NCT01516892|2834653|P1|Overall Study|Pregnancy|5
859366|NCT01516892|2834653|P1|Overall Study|Lack of Efficacy|35
859367|NCT01516892|2834653|P1|Overall Study|Adverse Event|25
859368|NCT01516879|2834661|P2|Overall Study|Other|10
859369|NCT01516879|2834662|P1|Overall Study|Other|5
859370|NCT01516879|2834661|P2|Overall Study|Lost to Follow-up|11
859371|NCT01516879|2834662|P1|Overall Study|Lost to Follow-up|2
859372|NCT01516879|2834661|P2|Overall Study|Death|2
859373|NCT01516879|2834662|P1|Overall Study|Death|0
859374|NCT01516879|2834661|P2|Overall Study|Withdrawal by Subject|11
859375|NCT01516879|2834662|P1|Overall Study|Withdrawal by Subject|9
859376|NCT01516749|2834696|P1|Follow-up Off Therapy|Lost to Follow-up|1
859377|NCT01516749|2834696|P1|Active Therapy|Lost to Follow-up|1
859378|NCT01516736|2834705|P2|Overall Study|Other (not specified)|1
859379|NCT01516736|2834706|P1|Overall Study|Other (not specified)|0
859380|NCT01516736|2834705|P2|Overall Study|Protocol Violation|1
859381|NCT01516736|2834706|P1|Overall Study|Protocol Violation|0
859382|NCT01516736|2834705|P2|Overall Study|Lack of Efficacy|0
859383|NCT01516736|2834706|P1|Overall Study|Lack of Efficacy|1
859384|NCT01516736|2834705|P2|Overall Study|Physician Decision|1
859385|NCT01516736|2834706|P1|Overall Study|Physician Decision|2
859386|NCT01516736|2834705|P2|Overall Study|Death|1
859387|NCT01516736|2834706|P1|Overall Study|Death|3
859388|NCT01516736|2834705|P2|Overall Study|Adverse Event|5
859389|NCT01516736|2834706|P1|Overall Study|Adverse Event|4
859390|NCT01516736|2834705|P2|Overall Study|Withdrawal by Subject|4
859391|NCT01516736|2834706|P1|Overall Study|Withdrawal by Subject|10
859392|NCT01516437|2834743|P4|Overall Study|Reason not specified|1
859393|NCT01516437|2834744|P3|Overall Study|Reason not specified|1
859394|NCT01516437|2834745|P2|Overall Study|Reason not specified|0
859395|NCT01516437|2834746|P1|Overall Study|Reason not specified|0
859396|NCT01516034|2834818|P1|Overall Study|Lack of Efficacy|7
859397|NCT01516034|2834818|P1|Overall Study|Physician Decision|1
859398|NCT01516008|2834825|P3|Overall Study|Reason not specified|1
859399|NCT01516008|2834826|P2|Overall Study|Reason not specified|0
859400|NCT01516008|2834827|P1|Overall Study|Reason not specified|0
859401|NCT01516008|2834825|P3|Overall Study|Protocol Violation|0
859402|NCT01516008|2834826|P2|Overall Study|Protocol Violation|0
859403|NCT01516008|2834827|P1|Overall Study|Protocol Violation|1
859404|NCT01516008|2834825|P3|Overall Study|Lack of Efficacy|10
859405|NCT01516008|2834826|P2|Overall Study|Lack of Efficacy|14
859406|NCT01516008|2834827|P1|Overall Study|Lack of Efficacy|44
859407|NCT01516008|2834825|P3|Overall Study|Adverse Event|7
859408|NCT01516008|2834826|P2|Overall Study|Adverse Event|2
859409|NCT01516008|2834827|P1|Overall Study|Adverse Event|0
859410|NCT01515865|2834923|P3|Part B (Open-label)|Not Specified|0
859411|NCT01515865|2834924|P2|Part B (Open-label)|Not Specified|0
859412|NCT01515865|2834925|P1|Part B (Open-label)|Not Specified|1
859413|NCT01515865|2834923|P3|Part B (Open-label)|Withdrawal by Subject|0
859414|NCT01515865|2834924|P2|Part B (Open-label)|Withdrawal by Subject|0
859415|NCT01515865|2834925|P1|Part B (Open-label)|Withdrawal by Subject|1
859416|NCT01515865|2834923|P3|Part A (Open-label)|Not Specified|0
859417|NCT01515865|2834924|P2|Part A (Open-label)|Not Specified|0
859418|NCT01515865|2834925|P1|Part A (Open-label)|Not Specified|3
859419|NCT01515423|2834993|P3|DOUBLE BLIND|Blind broken by investigator|0
859420|NCT01515423|2834994|P2|DOUBLE BLIND|Blind broken by investigator|1
859421|NCT01515423|2834995|P1|DOUBLE BLIND|Blind broken by investigator|0
859422|NCT01515423|2834993|P3|DOUBLE BLIND|Other|12
859423|NCT01515423|2834994|P2|DOUBLE BLIND|Other|6
859424|NCT01515423|2834995|P1|DOUBLE BLIND|Other|0
859425|NCT01515423|2834993|P3|DOUBLE BLIND|Withdrawal by Subject|53
859426|NCT01515423|2834994|P2|DOUBLE BLIND|Withdrawal by Subject|50
859427|NCT01515423|2834995|P1|DOUBLE BLIND|Withdrawal by Subject|0
859428|NCT01515423|2834993|P3|DOUBLE BLIND|Pregnancy|0
859429|NCT01515423|2834994|P2|DOUBLE BLIND|Pregnancy|2
859430|NCT01515423|2834995|P1|DOUBLE BLIND|Pregnancy|0
859431|NCT01515423|2834993|P3|DOUBLE BLIND|Lost to Follow-up|12
859432|NCT01515423|2834994|P2|DOUBLE BLIND|Lost to Follow-up|7
859433|NCT01515423|2834995|P1|DOUBLE BLIND|Lost to Follow-up|0
859434|NCT01515423|2834993|P3|DOUBLE BLIND|Death|2
859435|NCT01515423|2834994|P2|DOUBLE BLIND|Death|1
859436|NCT01515423|2834995|P1|DOUBLE BLIND|Death|0
859437|NCT01515423|2834993|P3|DOUBLE BLIND|Adverse Event|13
859438|NCT01515423|2834994|P2|DOUBLE BLIND|Adverse Event|15
859439|NCT01515423|2834995|P1|DOUBLE BLIND|Adverse Event|0
859440|NCT01515423|2834993|P3|Open Label Phase|Other|0
859441|NCT01515423|2834994|P2|Open Label Phase|Other|0
859442|NCT01515423|2834995|P1|Open Label Phase|Other|28
859443|NCT01515423|2834993|P3|Open Label Phase|excluded from DB Phase|0
859444|NCT01515423|2834994|P2|Open Label Phase|excluded from DB Phase|0
859445|NCT01515423|2834995|P1|Open Label Phase|excluded from DB Phase|70
859446|NCT01515423|2834993|P3|Open Label Phase|Withdrawal by Subject|0
859447|NCT01515423|2834994|P2|Open Label Phase|Withdrawal by Subject|0
859448|NCT01515423|2834995|P1|Open Label Phase|Withdrawal by Subject|118
859449|NCT01515423|2834993|P3|Open Label Phase|Lost to Follow-up|0
859450|NCT01515423|2834994|P2|Open Label Phase|Lost to Follow-up|0
859451|NCT01515423|2834995|P1|Open Label Phase|Lost to Follow-up|21
859452|NCT01515423|2834993|P3|Open Label Phase|Lack of Efficacy|0
859453|NCT01515423|2834994|P2|Open Label Phase|Lack of Efficacy|0
859454|NCT01515423|2834995|P1|Open Label Phase|Lack of Efficacy|117
859455|NCT01515423|2834993|P3|Open Label Phase|Death|0
859456|NCT01515423|2834994|P2|Open Label Phase|Death|0
859457|NCT01515423|2834995|P1|Open Label Phase|Death|2
859458|NCT01515423|2834993|P3|Open Label Phase|Adverse Event|0
859459|NCT01515423|2834994|P2|Open Label Phase|Adverse Event|0
859460|NCT01515423|2834995|P1|Open Label Phase|Adverse Event|57
859461|NCT01515306|2835036|P2|Overall Study|Ongoing receiving treatment|14
859462|NCT01515306|2835037|P1|Overall Study|Ongoing receiving treatment|9
859463|NCT01515306|2835036|P2|Overall Study|Progressive Disease|0
859464|NCT01515306|2835037|P1|Overall Study|Progressive Disease|1
859465|NCT01515306|2835036|P2|Overall Study|Adverse Event|0
859466|NCT01515306|2835037|P1|Overall Study|Adverse Event|2
859467|NCT01515189|2835050|P2|First Re-Induction Phase|Other|0
859468|NCT01515189|2835051|P1|First Re-Induction Phase|Other|1
859469|NCT01515189|2835050|P2|First Re-Induction Phase|No longer meets study criteria|0
859470|NCT01515189|2835051|P1|First Re-Induction Phase|No longer meets study criteria|1
859471|NCT01515189|2835050|P2|First Re-Induction Phase|Withdrawal by Subject|1
859472|NCT01515189|2835051|P1|First Re-Induction Phase|Withdrawal by Subject|1
859473|NCT01515189|2835050|P2|First Re-Induction Phase|Study drug toxicity|0
859474|NCT01515189|2835051|P1|First Re-Induction Phase|Study drug toxicity|5
859475|NCT01515189|2835050|P2|First Re-Induction Phase|Disease progression|14
859476|NCT01515189|2835051|P1|First Re-Induction Phase|Disease progression|6
859477|NCT01515189|2835050|P2|Induction|Other|4
859478|NCT01515189|2835051|P1|Induction|Other|0
859479|NCT01515189|2835050|P2|Induction|Lost to Follow-up|0
859480|NCT01515189|2835051|P1|Induction|Lost to Follow-up|1
859481|NCT01515189|2835050|P2|Induction|No longer meets study criteria|2
859482|NCT01515189|2835051|P1|Induction|No longer meets study criteria|0
859483|NCT01515189|2835050|P2|Induction|Withdrawal by Subject|9
859484|NCT01515189|2835051|P1|Induction|Withdrawal by Subject|3
859485|NCT01515189|2835050|P2|Induction|Adverse Event|9
859486|NCT01515189|2835051|P1|Induction|Adverse Event|14
859487|NCT01515189|2835050|P2|Induction|Death|17
859488|NCT01515189|2835051|P1|Induction|Death|24
859489|NCT01515189|2835050|P2|Induction|Study drug toxicity|36
859490|NCT01515189|2835051|P1|Induction|Study drug toxicity|86
859491|NCT01515189|2835050|P2|Induction|Disease Progression|155
859492|NCT01515189|2835051|P1|Induction|Disease Progression|109
859493|NCT01514864|2835139|P2|Overall Study|Study drug toxicity|0
859494|NCT01514864|2835140|P1|Overall Study|Study drug toxicity|2
859495|NCT01514864|2835139|P2|Overall Study|Disease progression|5
859496|NCT01514864|2835140|P1|Overall Study|Disease progression|7
859497|NCT01514760|2835165|P1|Overall Study|Lost to Follow-up|2
859498|NCT01514682|2835178|P2|Overall Study|Physician Decision|3
859499|NCT01514682|2835179|P1|Overall Study|Physician Decision|4
859500|NCT01514682|2835178|P2|Overall Study|Withdrawal by Subject|3
859501|NCT01514682|2835179|P1|Overall Study|Withdrawal by Subject|2
859502|NCT01514461|2835213|P3|Overall Study|Death|0
859503|NCT01514461|2835214|P2|Overall Study|Death|0
859504|NCT01514461|2835215|P1|Overall Study|Death|1
859505|NCT01514461|2835213|P3|Overall Study|Patient/guardian decision|1
859506|NCT01514461|2835214|P2|Overall Study|Patient/guardian decision|1
859507|NCT01514461|2835215|P1|Overall Study|Patient/guardian decision|1
859508|NCT01514461|2835213|P3|Overall Study|Physician Decision|0
859509|NCT01514461|2835214|P2|Overall Study|Physician Decision|1
859510|NCT01514461|2835215|P1|Overall Study|Physician Decision|1
859511|NCT01514461|2835213|P3|Overall Study|Adverse Event|3
859512|NCT01514461|2835214|P2|Overall Study|Adverse Event|1
859513|NCT01514461|2835215|P1|Overall Study|Adverse Event|2
859514|NCT01514448|2835254|P2|Overall Study|New Cancer Therapy|0
859515|NCT01514448|2835255|P1|Overall Study|New Cancer Therapy|1
859516|NCT01514448|2835254|P2|Overall Study|Lost to Follow-up|0
859517|NCT01514448|2835255|P1|Overall Study|Lost to Follow-up|2
859518|NCT01514448|2835254|P2|Overall Study|Withdrawal by Subject|0
859519|NCT01514448|2835255|P1|Overall Study|Withdrawal by Subject|2
859520|NCT01514448|2835254|P2|Overall Study|Death|8
859521|NCT01514448|2835255|P1|Overall Study|Death|7
859522|NCT01514422|2835270|P1|Overall Study|Lost to Follow-up|1
859523|NCT01514357|2835278|P2|Overall Study|Withdrawal by Subject|0
859524|NCT01514357|2835279|P1|Overall Study|Withdrawal by Subject|2
859525|NCT01514357|2835278|P2|Overall Study|Screen failure|0
859526|NCT01514357|2835279|P1|Overall Study|Screen failure|2
859527|NCT01514240|2835297|P2|Overall Study|Subject Decision|7
859528|NCT01514240|2835298|P1|Overall Study|Subject Decision|2
859529|NCT01514240|2835297|P2|Overall Study|Adverse Event|4
859530|NCT01514240|2835298|P1|Overall Study|Adverse Event|4
859531|NCT01514136|2835411|P8|Test Period 2; Test C*|Protocol Violation|0
859532|NCT01514136|2835412|P7|Test Period 2; Test C*|Protocol Violation|1
859533|NCT01514136|2835413|P6|Test Period 2; Test C*|Protocol Violation|0
859534|NCT01514136|2835414|P5|Test Period 2; Test C*|Protocol Violation|0
859535|NCT01514136|2835415|P4|Test Period 2; Test C*|Protocol Violation|0
859536|NCT01514136|2835416|P3|Test Period 2; Test C*|Protocol Violation|0
859537|NCT01514136|2835417|P2|Test Period 2; Test C*|Protocol Violation|0
859538|NCT01514136|2835418|P1|Test Period 2; Test C*|Protocol Violation|0
859539|NCT01514136|2835411|P8|Test Period 2; Test C*|holiday|0
859540|NCT01514136|2835412|P7|Test Period 2; Test C*|holiday|1
859541|NCT01514136|2835413|P6|Test Period 2; Test C*|holiday|0
859542|NCT01514136|2835414|P5|Test Period 2; Test C*|holiday|0
859543|NCT01514136|2835415|P4|Test Period 2; Test C*|holiday|0
859544|NCT01514136|2835416|P3|Test Period 2; Test C*|holiday|0
859545|NCT01514136|2835417|P2|Test Period 2; Test C*|holiday|0
859546|NCT01514136|2835418|P1|Test Period 2; Test C*|holiday|0
859547|NCT01514136|2835411|P8|Test Period 2; Test C*|Withdrawal by Subject|0
859548|NCT01514136|2835412|P7|Test Period 2; Test C*|Withdrawal by Subject|1
859549|NCT01514136|2835413|P6|Test Period 2; Test C*|Withdrawal by Subject|0
859550|NCT01514136|2835414|P5|Test Period 2; Test C*|Withdrawal by Subject|0
859551|NCT01514136|2835415|P4|Test Period 2; Test C*|Withdrawal by Subject|0
859552|NCT01514136|2835416|P3|Test Period 2; Test C*|Withdrawal by Subject|0
859553|NCT01514136|2835417|P2|Test Period 2; Test C*|Withdrawal by Subject|0
859554|NCT01514136|2835418|P1|Test Period 2; Test C*|Withdrawal by Subject|0
859555|NCT01514136|2835411|P8|Test Period 2; Test B*|Withdrawal by Subject|0
859556|NCT01514136|2835412|P7|Test Period 2; Test B*|Withdrawal by Subject|0
859557|NCT01514136|2835413|P6|Test Period 2; Test B*|Withdrawal by Subject|2
859558|NCT01514136|2835414|P5|Test Period 2; Test B*|Withdrawal by Subject|0
859559|NCT01514136|2835415|P4|Test Period 2; Test B*|Withdrawal by Subject|0
859560|NCT01514136|2835416|P3|Test Period 2; Test B*|Withdrawal by Subject|0
859561|NCT01514136|2835417|P2|Test Period 2; Test B*|Withdrawal by Subject|0
859562|NCT01514136|2835418|P1|Test Period 2; Test B*|Withdrawal by Subject|0
859563|NCT01514136|2835411|P8|Test Period 2; Test A*|Holiday|0
859564|NCT01514136|2835412|P7|Test Period 2; Test A*|Holiday|0
859565|NCT01514136|2835413|P6|Test Period 2; Test A*|Holiday|0
859566|NCT01514136|2835414|P5|Test Period 2; Test A*|Holiday|1
859567|NCT01514136|2835415|P4|Test Period 2; Test A*|Holiday|0
859568|NCT01514136|2835416|P3|Test Period 2; Test A*|Holiday|0
859569|NCT01514136|2835417|P2|Test Period 2; Test A*|Holiday|0
859570|NCT01514136|2835418|P1|Test Period 2; Test A*|Holiday|0
859571|NCT01514136|2835411|P8|Test Period 2; Test A*|Adverse Event|0
859572|NCT01514136|2835412|P7|Test Period 2; Test A*|Adverse Event|0
859573|NCT01514136|2835413|P6|Test Period 2; Test A*|Adverse Event|0
859574|NCT01514136|2835414|P5|Test Period 2; Test A*|Adverse Event|1
859575|NCT01514136|2835415|P4|Test Period 2; Test A*|Adverse Event|0
859576|NCT01514136|2835416|P3|Test Period 2; Test A*|Adverse Event|0
859577|NCT01514136|2835417|P2|Test Period 2; Test A*|Adverse Event|0
859578|NCT01514136|2835418|P1|Test Period 2; Test A*|Adverse Event|0
859579|NCT01514136|2835411|P8|Test Period 1; Test D|Subject took a break due to holiday|0
859580|NCT01514136|2835412|P7|Test Period 1; Test D|Subject took a break due to holiday|0
859581|NCT01514136|2835413|P6|Test Period 1; Test D|Subject took a break due to holiday|0
859582|NCT01514136|2835414|P5|Test Period 1; Test D|Subject took a break due to holiday|0
859583|NCT01514136|2835415|P4|Test Period 1; Test D|Subject took a break due to holiday|2
859584|NCT01514136|2835416|P3|Test Period 1; Test D|Subject took a break due to holiday|0
859585|NCT01514136|2835417|P2|Test Period 1; Test D|Subject took a break due to holiday|0
859586|NCT01514136|2835418|P1|Test Period 1; Test D|Subject took a break due to holiday|0
859587|NCT01514136|2835411|P8|Test Period 1; Test B|Withdrawal by Subject|0
859588|NCT01514136|2835412|P7|Test Period 1; Test B|Withdrawal by Subject|0
859589|NCT01514136|2835413|P6|Test Period 1; Test B|Withdrawal by Subject|0
859590|NCT01514136|2835414|P5|Test Period 1; Test B|Withdrawal by Subject|0
859591|NCT01514136|2835415|P4|Test Period 1; Test B|Withdrawal by Subject|0
859592|NCT01514136|2835416|P3|Test Period 1; Test B|Withdrawal by Subject|0
859593|NCT01514136|2835417|P2|Test Period 1; Test B|Withdrawal by Subject|1
859594|NCT01514136|2835418|P1|Test Period 1; Test B|Withdrawal by Subject|0
859595|NCT01514136|2835411|P8|Test Period 1; Test A|Break from study holiday|0
859596|NCT01514136|2835412|P7|Test Period 1; Test A|Break from study holiday|0
859597|NCT01514136|2835413|P6|Test Period 1; Test A|Break from study holiday|0
859598|NCT01514136|2835414|P5|Test Period 1; Test A|Break from study holiday|0
859599|NCT01514136|2835415|P4|Test Period 1; Test A|Break from study holiday|0
859600|NCT01514136|2835416|P3|Test Period 1; Test A|Break from study holiday|0
859601|NCT01514136|2835417|P2|Test Period 1; Test A|Break from study holiday|0
859602|NCT01514136|2835418|P1|Test Period 1; Test A|Break from study holiday|2
859603|NCT01514136|2835411|P8|Test Period 1; Test A|Protocol Violation|0
859604|NCT01514136|2835412|P7|Test Period 1; Test A|Protocol Violation|0
859605|NCT01514136|2835413|P6|Test Period 1; Test A|Protocol Violation|0
859606|NCT01514136|2835414|P5|Test Period 1; Test A|Protocol Violation|0
859607|NCT01514136|2835415|P4|Test Period 1; Test A|Protocol Violation|0
859608|NCT01514136|2835416|P3|Test Period 1; Test A|Protocol Violation|0
859609|NCT01514136|2835417|P2|Test Period 1; Test A|Protocol Violation|0
859610|NCT01514136|2835418|P1|Test Period 1; Test A|Protocol Violation|1
859611|NCT01513590|2835486|P2|Overall Study|Unclassified|10
859612|NCT01513590|2835487|P1|Overall Study|Unclassified|5
859613|NCT01513590|2835486|P2|Overall Study|Withdrawal Criteria|0
859614|NCT01513590|2835487|P1|Overall Study|Withdrawal Criteria|3
859615|NCT01513590|2835486|P2|Overall Study|Adverse Event|3
859616|NCT01513590|2835487|P1|Overall Study|Adverse Event|2
859617|NCT01513473|2835511|P2|Extension Trial (26 Weeks)|Withdrawal by Subject|5
859618|NCT01513473|2835512|P1|Extension Trial (26 Weeks)|Withdrawal by Subject|1
859619|NCT01513473|2835511|P2|Extension Trial (26 Weeks)|Adverse Event|1
859620|NCT01513473|2835512|P1|Extension Trial (26 Weeks)|Adverse Event|0
859621|NCT01513473|2835511|P2|Main Trial (26 Weeks)|Unclassified|2
859622|NCT01513473|2835512|P1|Main Trial (26 Weeks)|Unclassified|0
859623|NCT01513473|2835511|P2|Main Trial (26 Weeks)|Withdrawal by Subject|7
859624|NCT01513473|2835512|P1|Main Trial (26 Weeks)|Withdrawal by Subject|4
859625|NCT01513473|2835511|P2|Main Trial (26 Weeks)|Adverse Event|2
859626|NCT01513473|2835512|P1|Main Trial (26 Weeks)|Adverse Event|0
859627|NCT01513460|2835539|P3|Overall Study|Abnormal test procedure|0
859628|NCT01513460|2835540|P2|Overall Study|Abnormal test procedure|0
859629|NCT01513460|2835541|P1|Overall Study|Abnormal test procedure|1
859630|NCT01513460|2835539|P3|Overall Study|Adverse Event|23
859631|NCT01513460|2835540|P2|Overall Study|Adverse Event|18
859632|NCT01513460|2835541|P1|Overall Study|Adverse Event|16
859633|NCT01513460|2835539|P3|Overall Study|Withdrawal by Subject|21
859634|NCT01513460|2835540|P2|Overall Study|Withdrawal by Subject|8
859635|NCT01513460|2835541|P1|Overall Study|Withdrawal by Subject|7
859636|NCT01513460|2835539|P3|Overall Study|Protocol deviations|3
859637|NCT01513460|2835540|P2|Overall Study|Protocol deviations|4
859638|NCT01513460|2835541|P1|Overall Study|Protocol deviations|3
859639|NCT01513460|2835539|P3|Overall Study|Lack of Efficacy|5
859640|NCT01513460|2835540|P2|Overall Study|Lack of Efficacy|2
859641|NCT01513460|2835541|P1|Overall Study|Lack of Efficacy|1
859642|NCT01513460|2835539|P3|Overall Study|Abnormal laboratory value|1
859643|NCT01513460|2835540|P2|Overall Study|Abnormal laboratory value|0
859644|NCT01513460|2835541|P1|Overall Study|Abnormal laboratory value|1
859645|NCT01513460|2835539|P3|Overall Study|Lost to Follow-up|2
859646|NCT01513460|2835540|P2|Overall Study|Lost to Follow-up|0
859647|NCT01513460|2835541|P1|Overall Study|Lost to Follow-up|0
859648|NCT01513460|2835539|P3|Overall Study|Death|1
859649|NCT01513460|2835540|P2|Overall Study|Death|0
859650|NCT01513460|2835541|P1|Overall Study|Death|0
859651|NCT01513330|2835576|P2|Standard Care First,|Other|0
859652|NCT01513330|2835577|P1|Standard Care First,|Other|1
859653|NCT01513330|2835576|P2|Standard Care First,|Withdrawal by Subject|2
859654|NCT01513330|2835577|P1|Standard Care First,|Withdrawal by Subject|1
859655|NCT01513330|2835576|P2|Standard Care First,|Lack of Efficacy|2
859656|NCT01513330|2835577|P1|Standard Care First,|Lack of Efficacy|2
859657|NCT01513330|2835576|P2|SenSura Mio First,|Other|0
859658|NCT01513330|2835577|P1|SenSura Mio First,|Other|1
859659|NCT01513330|2835576|P2|SenSura Mio First,|Withdrawal by Subject|1
859660|NCT01513330|2835577|P1|SenSura Mio First,|Withdrawal by Subject|1
859661|NCT01513330|2835576|P2|SenSura Mio First,|Lack of Efficacy|1
859662|NCT01513330|2835577|P1|SenSura Mio First,|Lack of Efficacy|0
859663|NCT01513330|2835576|P2|SenSura Mio First,|Adverse Event|0
859664|NCT01513330|2835577|P1|SenSura Mio First,|Adverse Event|2
859665|NCT01513317|2835585|P2|Overall Study|Not specified|1
859666|NCT01513317|2835586|P1|Overall Study|Not specified|0
859667|NCT01513317|2835585|P2|Overall Study|Study terminated by sponsor|18
859668|NCT01513317|2835586|P1|Overall Study|Study terminated by sponsor|18
859669|NCT01513317|2835585|P2|Overall Study|Death|1
859670|NCT01513317|2835586|P1|Overall Study|Death|1
859671|NCT01513317|2835585|P2|Overall Study|Withdrawal by Subject|4
859672|NCT01513317|2835586|P1|Overall Study|Withdrawal by Subject|15
859673|NCT01513291|2835604|P5|Run-out Period|Withdrawal by Subject|0
859674|NCT01513291|2835605|P4|Run-out Period|Withdrawal by Subject|1
859675|NCT01513291|2835606|P3|Run-out Period|Withdrawal by Subject|0
859676|NCT01513291|2835607|P2|Run-out Period|Withdrawal by Subject|0
859677|NCT01513291|2835608|P1|Run-out Period|Withdrawal by Subject|0
859678|NCT01513291|2835604|P5|Run-out Period|Lost to Follow-up|0
859679|NCT01513291|2835605|P4|Run-out Period|Lost to Follow-up|1
859680|NCT01513291|2835606|P3|Run-out Period|Lost to Follow-up|0
859681|NCT01513291|2835607|P2|Run-out Period|Lost to Follow-up|0
859682|NCT01513291|2835608|P1|Run-out Period|Lost to Follow-up|0
859683|NCT01513291|2835604|P5|Treatment Period|Randomized not treated|0
859684|NCT01513291|2835605|P4|Treatment Period|Randomized not treated|0
859685|NCT01513291|2835606|P3|Treatment Period|Randomized not treated|0
859686|NCT01513291|2835607|P2|Treatment Period|Randomized not treated|2
859687|NCT01513291|2835608|P1|Treatment Period|Randomized not treated|0
859688|NCT01513291|2835604|P5|Treatment Period|Withdrawal by Subject|0
859689|NCT01513291|2835605|P4|Treatment Period|Withdrawal by Subject|0
859690|NCT01513291|2835606|P3|Treatment Period|Withdrawal by Subject|0
859691|NCT01513291|2835607|P2|Treatment Period|Withdrawal by Subject|5
859692|NCT01513291|2835608|P1|Treatment Period|Withdrawal by Subject|8
859693|NCT01513291|2835604|P5|Treatment Period|Protocol Violation|0
859694|NCT01513291|2835605|P4|Treatment Period|Protocol Violation|0
859695|NCT01513291|2835606|P3|Treatment Period|Protocol Violation|0
859696|NCT01513291|2835607|P2|Treatment Period|Protocol Violation|2
859697|NCT01513291|2835608|P1|Treatment Period|Protocol Violation|1
859698|NCT01513291|2835604|P5|Treatment Period|Physician Decision|0
859699|NCT01513291|2835605|P4|Treatment Period|Physician Decision|0
859700|NCT01513291|2835606|P3|Treatment Period|Physician Decision|0
859701|NCT01513291|2835607|P2|Treatment Period|Physician Decision|0
859702|NCT01513291|2835608|P1|Treatment Period|Physician Decision|1
859703|NCT01513291|2835604|P5|Treatment Period|Lost to Follow-up|0
859704|NCT01513291|2835605|P4|Treatment Period|Lost to Follow-up|0
859705|NCT01513291|2835606|P3|Treatment Period|Lost to Follow-up|0
859706|NCT01513291|2835607|P2|Treatment Period|Lost to Follow-up|3
859707|NCT01513291|2835608|P1|Treatment Period|Lost to Follow-up|2
859708|NCT01513291|2835604|P5|Treatment Period|Lack of Efficacy|0
859709|NCT01513291|2835605|P4|Treatment Period|Lack of Efficacy|0
859710|NCT01513291|2835606|P3|Treatment Period|Lack of Efficacy|0
859711|NCT01513291|2835607|P2|Treatment Period|Lack of Efficacy|0
859712|NCT01513291|2835608|P1|Treatment Period|Lack of Efficacy|3
859713|NCT01513291|2835604|P5|Treatment Period|Adverse Event|0
859714|NCT01513291|2835605|P4|Treatment Period|Adverse Event|0
859715|NCT01513291|2835606|P3|Treatment Period|Adverse Event|0
859716|NCT01513291|2835607|P2|Treatment Period|Adverse Event|4
859717|NCT01513291|2835608|P1|Treatment Period|Adverse Event|8
859718|NCT01513239|2835636|P6|Period 2: 9 Month Extension Phase|Technical Problems|1
859719|NCT01513239|2835637|P5|Period 2: 9 Month Extension Phase|Technical Problems|1
859720|NCT01513239|2835638|P4|Period 2: 9 Month Extension Phase|Technical Problems|0
859721|NCT01513239|2835639|P3|Period 2: 9 Month Extension Phase|Technical Problems|0
859722|NCT01513239|2835640|P2|Period 2: 9 Month Extension Phase|Technical Problems|0
859723|NCT01513239|2835641|P1|Period 2: 9 Month Extension Phase|Technical Problems|0
859724|NCT01513239|2835636|P6|Period 2: 9 Month Extension Phase|Physician Decision|0
859725|NCT01513239|2835637|P5|Period 2: 9 Month Extension Phase|Physician Decision|0
859726|NCT01513239|2835638|P4|Period 2: 9 Month Extension Phase|Physician Decision|1
859727|NCT01513239|2835639|P3|Period 2: 9 Month Extension Phase|Physician Decision|0
859728|NCT01513239|2835640|P2|Period 2: 9 Month Extension Phase|Physician Decision|0
859729|NCT01513239|2835641|P1|Period 2: 9 Month Extension Phase|Physician Decision|0
859730|NCT01513239|2835636|P6|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
859731|NCT01513239|2835637|P5|Period 2: 9 Month Extension Phase|Lost to Follow-up|1
859732|NCT01513239|2835638|P4|Period 2: 9 Month Extension Phase|Lost to Follow-up|2
859733|NCT01513239|2835639|P3|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
859734|NCT01513239|2835640|P2|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
859735|NCT01513239|2835641|P1|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
859736|NCT01513239|2835636|P6|Period 2: 9 Month Extension Phase|Death|2
859737|NCT01513239|2835637|P5|Period 2: 9 Month Extension Phase|Death|5
859738|NCT01513239|2835638|P4|Period 2: 9 Month Extension Phase|Death|2
859739|NCT01513239|2835639|P3|Period 2: 9 Month Extension Phase|Death|0
859740|NCT01513239|2835640|P2|Period 2: 9 Month Extension Phase|Death|0
859741|NCT01513239|2835641|P1|Period 2: 9 Month Extension Phase|Death|0
859742|NCT01513239|2835636|P6|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2
859743|NCT01513239|2835637|P5|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3
859744|NCT01513239|2835638|P4|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5
859745|NCT01513239|2835639|P3|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
859746|NCT01513239|2835640|P2|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
859747|NCT01513239|2835641|P1|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
859748|NCT01513239|2835636|P6|Period 1: Main Phase|Withdrawal by Subject|0
859749|NCT01513239|2835637|P5|Period 1: Main Phase|Withdrawal by Subject|0
859750|NCT01513239|2835638|P4|Period 1: Main Phase|Withdrawal by Subject|0
859751|NCT01513239|2835639|P3|Period 1: Main Phase|Withdrawal by Subject|42
859752|NCT01513239|2835640|P2|Period 1: Main Phase|Withdrawal by Subject|29
859753|NCT01513239|2835641|P1|Period 1: Main Phase|Withdrawal by Subject|27
859754|NCT01513239|2835636|P6|Period 1: Main Phase|Technical Problems|0
859755|NCT01513239|2835637|P5|Period 1: Main Phase|Technical Problems|0
859756|NCT01513239|2835638|P4|Period 1: Main Phase|Technical Problems|0
859757|NCT01513239|2835639|P3|Period 1: Main Phase|Technical Problems|0
859758|NCT01513239|2835640|P2|Period 1: Main Phase|Technical Problems|2
859759|NCT01513239|2835641|P1|Period 1: Main Phase|Technical Problems|1
859760|NCT01513239|2835636|P6|Period 1: Main Phase|Protocol Violation|0
859761|NCT01513239|2835637|P5|Period 1: Main Phase|Protocol Violation|0
859762|NCT01513239|2835638|P4|Period 1: Main Phase|Protocol Violation|0
859763|NCT01513239|2835639|P3|Period 1: Main Phase|Protocol Violation|2
859764|NCT01513239|2835640|P2|Period 1: Main Phase|Protocol Violation|2
859765|NCT01513239|2835641|P1|Period 1: Main Phase|Protocol Violation|2
859766|NCT01513239|2835636|P6|Period 1: Main Phase|Physician Decision|0
859767|NCT01513239|2835637|P5|Period 1: Main Phase|Physician Decision|0
859768|NCT01513239|2835638|P4|Period 1: Main Phase|Physician Decision|0
859769|NCT01513239|2835639|P3|Period 1: Main Phase|Physician Decision|4
859770|NCT01513239|2835640|P2|Period 1: Main Phase|Physician Decision|4
859771|NCT01513239|2835641|P1|Period 1: Main Phase|Physician Decision|4
859772|NCT01513239|2835636|P6|Period 1: Main Phase|Lost to Follow-up|0
859773|NCT01513239|2835637|P5|Period 1: Main Phase|Lost to Follow-up|0
859774|NCT01513239|2835638|P4|Period 1: Main Phase|Lost to Follow-up|0
859775|NCT01513239|2835639|P3|Period 1: Main Phase|Lost to Follow-up|6
859776|NCT01513239|2835640|P2|Period 1: Main Phase|Lost to Follow-up|10
859777|NCT01513239|2835641|P1|Period 1: Main Phase|Lost to Follow-up|11
859778|NCT01513239|2835636|P6|Period 1: Main Phase|Death|0
859779|NCT01513239|2835637|P5|Period 1: Main Phase|Death|0
859780|NCT01513239|2835638|P4|Period 1: Main Phase|Death|0
859781|NCT01513239|2835639|P3|Period 1: Main Phase|Death|32
859782|NCT01513239|2835640|P2|Period 1: Main Phase|Death|22
859783|NCT01513239|2835641|P1|Period 1: Main Phase|Death|29
859784|NCT01513239|2835636|P6|Period 1: Main Phase|Adverse Event|0
859785|NCT01513239|2835637|P5|Period 1: Main Phase|Adverse Event|0
859786|NCT01513239|2835638|P4|Period 1: Main Phase|Adverse Event|0
859787|NCT01513239|2835639|P3|Period 1: Main Phase|Adverse Event|2
859788|NCT01513239|2835640|P2|Period 1: Main Phase|Adverse Event|1
859789|NCT01513239|2835641|P1|Period 1: Main Phase|Adverse Event|1
859790|NCT01513148|2835694|P2|Overall Study|Protocol Violation|2
859791|NCT01513148|2835695|P1|Overall Study|Protocol Violation|2
859792|NCT01512979|2835762|P2|Overall Study|Reason other than stated above|9
859793|NCT01512979|2835763|P1|Overall Study|Reason other than stated above|13
859794|NCT01512979|2835762|P2|Overall Study|Withdrawal by Subject|2
859795|NCT01512979|2835763|P1|Overall Study|Withdrawal by Subject|1
859796|NCT01512979|2835762|P2|Overall Study|Lost to Follow-up|5
859797|NCT01512979|2835763|P1|Overall Study|Lost to Follow-up|2
859798|NCT01512979|2835762|P2|Overall Study|Protocol Violation|4
859799|NCT01512979|2835763|P1|Overall Study|Protocol Violation|1
859800|NCT01512979|2835762|P2|Overall Study|Adverse Event|2
859801|NCT01512979|2835763|P1|Overall Study|Adverse Event|2
859802|NCT01512745|2835827|P2|Overall Study|Protocol Violation|0
859803|NCT01512745|2835828|P1|Overall Study|Protocol Violation|1
859804|NCT01512745|2835827|P2|Overall Study|Lack of Efficacy|2
859805|NCT01512745|2835828|P1|Overall Study|Lack of Efficacy|2
859806|NCT01512745|2835827|P2|Overall Study|Lost to Follow-up|0
859807|NCT01512745|2835828|P1|Overall Study|Lost to Follow-up|4
859808|NCT01512745|2835827|P2|Overall Study|Withdrawal by Subject|2
859809|NCT01512745|2835828|P1|Overall Study|Withdrawal by Subject|2
859810|NCT01512745|2835827|P2|Overall Study|Death|13
859811|NCT01512745|2835828|P1|Overall Study|Death|9
859812|NCT01512745|2835827|P2|Overall Study|Adverse Event|3
859813|NCT01512745|2835828|P1|Overall Study|Adverse Event|22
859814|NCT01512693|2835844|P2|Overall Study|Withdrawal by Subject|1
859815|NCT01512693|2835845|P1|Overall Study|Withdrawal by Subject|0
859816|NCT01512368|2835872|P1|Overall Study|Protocol Violation|3
859817|NCT01512160|2835930|P4|Overall Study|Withdrawal by Subject|1
859818|NCT01512160|2835931|P3|Overall Study|Withdrawal by Subject|0
859819|NCT01512160|2835932|P2|Overall Study|Withdrawal by Subject|0
859820|NCT01512160|2835933|P1|Overall Study|Withdrawal by Subject|1
859821|NCT01512160|2835930|P4|Overall Study|Lost to Follow-up|0
859822|NCT01512160|2835931|P3|Overall Study|Lost to Follow-up|0
859823|NCT01512160|2835932|P2|Overall Study|Lost to Follow-up|0
859824|NCT01512160|2835933|P1|Overall Study|Lost to Follow-up|1
859825|NCT01512108|2836025|P2|Overall Study|Unclassified|3
859826|NCT01512108|2836026|P1|Overall Study|Unclassified|11
859827|NCT01512108|2836025|P2|Overall Study|Withdrawal Criteria|0
859828|NCT01512108|2836026|P1|Overall Study|Withdrawal Criteria|1
859829|NCT01512108|2836025|P2|Overall Study|Protocol Violation|2
859830|NCT01512108|2836026|P1|Overall Study|Protocol Violation|1
859831|NCT01512108|2836025|P2|Overall Study|Adverse Event|4
859832|NCT01512108|2836026|P1|Overall Study|Adverse Event|9
859833|NCT01511939|2836052|P3|Overall Study|Withdrawal by Subject|0
859834|NCT01511939|2836053|P2|Overall Study|Withdrawal by Subject|1
859835|NCT01511939|2836054|P1|Overall Study|Withdrawal by Subject|2
859836|NCT01511536|2836083|P3|Phase 2|Other|9
859837|NCT01511536|2836084|P2|Phase 2|Other|0
859838|NCT01511536|2836085|P1|Phase 2|Other|0
859839|NCT01511536|2836083|P3|Phase 1|Other|0
859840|NCT01511536|2836084|P2|Phase 1|Other|1
859841|NCT01511536|2836085|P1|Phase 1|Other|0
859842|NCT01511445|2836107|P2|Overall Study|Protocol Violation|0
859843|NCT01511445|2836108|P1|Overall Study|Protocol Violation|1
859844|NCT01511445|2836107|P2|Overall Study|Protocol Violation|3
859845|NCT01511445|2836108|P1|Overall Study|Protocol Violation|1
859846|NCT01511445|2836107|P2|Overall Study|Lost to Follow-up|1
859847|NCT01511445|2836108|P1|Overall Study|Lost to Follow-up|3
859848|NCT01511250|2836136|P10|Overall Study|Protocol Violation|0
859849|NCT01511250|2836137|P9|Overall Study|Protocol Violation|0
859850|NCT01511250|2836138|P8|Overall Study|Protocol Violation|0
859851|NCT01511250|2836139|P7|Overall Study|Protocol Violation|0
859852|NCT01511250|2836140|P6|Overall Study|Protocol Violation|0
859853|NCT01511250|2836141|P5|Overall Study|Protocol Violation|0
859854|NCT01511250|2836142|P4|Overall Study|Protocol Violation|0
859855|NCT01511250|2836143|P3|Overall Study|Protocol Violation|1
859856|NCT01511250|2836144|P2|Overall Study|Protocol Violation|2
859857|NCT01511250|2836145|P1|Overall Study|Protocol Violation|0
859858|NCT01511250|2836136|P10|Overall Study|Lost to Follow-up|5
859859|NCT01511250|2836137|P9|Overall Study|Lost to Follow-up|13
859860|NCT01511250|2836138|P8|Overall Study|Lost to Follow-up|3
859861|NCT01511250|2836139|P7|Overall Study|Lost to Follow-up|2
859862|NCT01511250|2836140|P6|Overall Study|Lost to Follow-up|0
859863|NCT01511250|2836141|P5|Overall Study|Lost to Follow-up|0
859864|NCT01511250|2836142|P4|Overall Study|Lost to Follow-up|3
859865|NCT01511250|2836143|P3|Overall Study|Lost to Follow-up|3
859866|NCT01511250|2836144|P2|Overall Study|Lost to Follow-up|3
859867|NCT01511250|2836145|P1|Overall Study|Lost to Follow-up|7
859868|NCT01511250|2836136|P10|Overall Study|Sponsor/Investigator Decision|0
859869|NCT01511250|2836137|P9|Overall Study|Sponsor/Investigator Decision|0
859870|NCT01511250|2836138|P8|Overall Study|Sponsor/Investigator Decision|0
859871|NCT01511250|2836139|P7|Overall Study|Sponsor/Investigator Decision|0
859872|NCT01511250|2836140|P6|Overall Study|Sponsor/Investigator Decision|0
859873|NCT01511250|2836141|P5|Overall Study|Sponsor/Investigator Decision|0
859874|NCT01511250|2836142|P4|Overall Study|Sponsor/Investigator Decision|0
859875|NCT01511250|2836143|P3|Overall Study|Sponsor/Investigator Decision|0
859876|NCT01511250|2836144|P2|Overall Study|Sponsor/Investigator Decision|0
859877|NCT01511250|2836145|P1|Overall Study|Sponsor/Investigator Decision|1
859878|NCT01511250|2836136|P10|Overall Study|Withdrawal of Consent|0
859879|NCT01511250|2836137|P9|Overall Study|Withdrawal of Consent|1
859880|NCT01511250|2836138|P8|Overall Study|Withdrawal of Consent|1
859881|NCT01511250|2836139|P7|Overall Study|Withdrawal of Consent|0
859882|NCT01511250|2836140|P6|Overall Study|Withdrawal of Consent|0
859883|NCT01511250|2836141|P5|Overall Study|Withdrawal of Consent|0
859884|NCT01511250|2836142|P4|Overall Study|Withdrawal of Consent|0
859885|NCT01511250|2836143|P3|Overall Study|Withdrawal of Consent|0
859886|NCT01511250|2836144|P2|Overall Study|Withdrawal of Consent|0
859887|NCT01511250|2836145|P1|Overall Study|Withdrawal of Consent|1
859888|NCT01511107|2836293|P2|Overall Study|Withdrawal by Subject|20
859889|NCT01511107|2836294|P1|Overall Study|Withdrawal by Subject|9
859890|NCT01511107|2836293|P2|Overall Study|Lost to Follow-up|19
859891|NCT01511107|2836294|P1|Overall Study|Lost to Follow-up|10
859892|NCT01511107|2836293|P2|Overall Study|Ineligible|2
859893|NCT01511107|2836294|P1|Overall Study|Ineligible|3
859894|NCT01510912|2836372|P1|Overall Study|Other, including joint replacement|5
859895|NCT01510912|2836372|P1|Overall Study|Lost to Follow-up|26
859896|NCT01510912|2836372|P1|Overall Study|Protocol Violation|27
859897|NCT01510912|2836372|P1|Overall Study|Physician Decision|1
859898|NCT01510912|2836372|P1|Overall Study|Withdrawal by Subject|49
859899|NCT01510912|2836372|P1|Overall Study|Non-compliance with trial drug|23
859900|NCT01510912|2836372|P1|Overall Study|Lack of Efficacy|12
859901|NCT01510912|2836372|P1|Overall Study|Adverse Event|99
859902|NCT01510769|2836388|P3|Overall Study|Death|0
859903|NCT01510769|2836389|P2|Overall Study|Death|1
859904|NCT01510769|2836390|P1|Overall Study|Death|1
859905|NCT01510769|2836388|P3|Overall Study|Withdrawal by Subject|3
859906|NCT01510769|2836389|P2|Overall Study|Withdrawal by Subject|4
859907|NCT01510769|2836390|P1|Overall Study|Withdrawal by Subject|3
859908|NCT01510769|2836388|P3|Overall Study|Lost to Follow-up|5
859909|NCT01510769|2836389|P2|Overall Study|Lost to Follow-up|1
859910|NCT01510769|2836390|P1|Overall Study|Lost to Follow-up|5
859911|NCT01510769|2836388|P3|Overall Study|Protocol Violation|9
859912|NCT01510769|2836389|P2|Overall Study|Protocol Violation|10
859913|NCT01510769|2836390|P1|Overall Study|Protocol Violation|11
859914|NCT01510769|2836388|P3|Overall Study|Gout Flare|1
859915|NCT01510769|2836389|P2|Overall Study|Gout Flare|3
859916|NCT01510769|2836390|P1|Overall Study|Gout Flare|0
859917|NCT01510769|2836388|P3|Overall Study|Adverse Event|4
859918|NCT01510769|2836389|P2|Overall Study|Adverse Event|6
859919|NCT01510769|2836390|P1|Overall Study|Adverse Event|7
859920|NCT01510756|2836407|P1|Overall Study|Physician Decision|1
859921|NCT01510756|2836407|P1|Overall Study|Lack of Efficacy|2
859922|NCT01510756|2836407|P1|Overall Study|Death|1
859923|NCT01510717|2836415|P2|Overall Study|Withdrawal by Subject|2
859924|NCT01510717|2836416|P1|Overall Study|Withdrawal by Subject|0
859925|NCT01510717|2836415|P2|Overall Study|Lost to Follow-up|1
859926|NCT01510717|2836416|P1|Overall Study|Lost to Follow-up|0
859927|NCT01510717|2836415|P2|Overall Study|Death|0
859928|NCT01510717|2836416|P1|Overall Study|Death|1
859929|NCT01510717|2836415|P2|Overall Study|Adverse Event|2
859930|NCT01510717|2836416|P1|Overall Study|Adverse Event|1
859931|NCT01510158|2836536|P3|Overall Study|Death|0
859932|NCT01510158|2836537|P2|Overall Study|Death|0
859933|NCT01510158|2836538|P1|Overall Study|Death|1
859934|NCT01510158|2836536|P3|Overall Study|Withdrawal by Subject|10
859935|NCT01510158|2836537|P2|Overall Study|Withdrawal by Subject|13
859936|NCT01510158|2836538|P1|Overall Study|Withdrawal by Subject|10
859937|NCT01510158|2836536|P3|Overall Study|Lost to Follow-up|9
859938|NCT01510158|2836537|P2|Overall Study|Lost to Follow-up|16
859939|NCT01510158|2836538|P1|Overall Study|Lost to Follow-up|13
859940|NCT01510158|2836536|P3|Overall Study|Sponsor terminated study.|2
859941|NCT01510158|2836537|P2|Overall Study|Sponsor terminated study.|0
859942|NCT01510158|2836538|P1|Overall Study|Sponsor terminated study.|2
859943|NCT01510158|2836536|P3|Overall Study|Protocol Violation|24
859944|NCT01510158|2836537|P2|Overall Study|Protocol Violation|16
859945|NCT01510158|2836538|P1|Overall Study|Protocol Violation|17
859946|NCT01510158|2836536|P3|Overall Study|Gout flare|0
859947|NCT01510158|2836537|P2|Overall Study|Gout flare|0
859948|NCT01510158|2836538|P1|Overall Study|Gout flare|1
859949|NCT01510158|2836536|P3|Overall Study|Adverse Event|5
859950|NCT01510158|2836537|P2|Overall Study|Adverse Event|8
859951|NCT01510158|2836538|P1|Overall Study|Adverse Event|7
859952|NCT01510145|2836552|P1|Overall Study|Relative reported subject withdrew|1
859953|NCT01510145|2836552|P1|Overall Study|Withdrawal by Subject|6
859954|NCT01510145|2836552|P1|Overall Study|Lost to Follow-up|5
859955|NCT01510145|2836552|P1|Overall Study|Adverse Event|6
859956|NCT01510028|2836561|P4|Overall Study|Lack of Efficacy|0
859957|NCT01510028|2836562|P3|Overall Study|Lack of Efficacy|0
859958|NCT01510028|2836563|P2|Overall Study|Lack of Efficacy|0
859959|NCT01510028|2836564|P1|Overall Study|Lack of Efficacy|1
859960|NCT01509664|2836707|P2|Overall Study|Lost to Follow-up|21
859961|NCT01509664|2836708|P1|Overall Study|Lost to Follow-up|15
859962|NCT01509079|2836819|P2|Overall Study|started an excluded medication|1
859963|NCT01509079|2836820|P1|Overall Study|started an excluded medication|0
859964|NCT01509079|2836819|P2|Overall Study|Lack of Efficacy|2
859965|NCT01509079|2836820|P1|Overall Study|Lack of Efficacy|0
859966|NCT01509053|2836836|P1|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3
859967|NCT01509053|2836836|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1
859968|NCT01509053|2836836|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1
859969|NCT01509053|2836836|P1|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13
859970|NCT01509053|2836836|P1|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1
859971|NCT01509053|2836836|P1|Oral Aripirazole (Phase A)|Sponsor discontinued study|11
859972|NCT01508936|2836898|P2|Overall Study|Data from 2 sites deemed invalid|11
859973|NCT01508936|2836899|P1|Overall Study|Data from 2 sites deemed invalid|4
859974|NCT01508936|2836898|P2|Overall Study|Not specified|5
859975|NCT01508936|2836899|P1|Overall Study|Not specified|0
859976|NCT01508936|2836898|P2|Overall Study|Lost to Follow-up|9
859977|NCT01508936|2836899|P1|Overall Study|Lost to Follow-up|2
859978|NCT01508936|2836898|P2|Overall Study|Protocol Violation|3
859979|NCT01508936|2836899|P1|Overall Study|Protocol Violation|2
859980|NCT01508936|2836898|P2|Overall Study|Withdrawal by Subject|18
859981|NCT01508936|2836899|P1|Overall Study|Withdrawal by Subject|4
859982|NCT01508936|2836898|P2|Overall Study|Lack of Efficacy|1
859983|NCT01508936|2836899|P1|Overall Study|Lack of Efficacy|0
859984|NCT01508936|2836898|P2|Overall Study|Adverse Event|32
859985|NCT01508936|2836899|P1|Overall Study|Adverse Event|11
859986|NCT01508910|2836938|P4|Treatment|Sponsor Decision|1
859987|NCT01508910|2836939|P3|Treatment|Sponsor Decision|0
859988|NCT01508910|2836940|P2|Treatment|Sponsor Decision|0
859989|NCT01508910|2836941|P1|Treatment|Sponsor Decision|0
859990|NCT01508910|2836938|P4|Treatment|Withdrawal by Subject|1
859991|NCT01508910|2836939|P3|Treatment|Withdrawal by Subject|6
859992|NCT01508910|2836940|P2|Treatment|Withdrawal by Subject|1
859993|NCT01508910|2836941|P1|Treatment|Withdrawal by Subject|0
859994|NCT01508910|2836938|P4|Treatment|Lost to Follow-up|1
859995|NCT01508910|2836939|P3|Treatment|Lost to Follow-up|2
859996|NCT01508910|2836940|P2|Treatment|Lost to Follow-up|0
859997|NCT01508910|2836941|P1|Treatment|Lost to Follow-up|0
859998|NCT01508910|2836938|P4|Treatment|Death|0
859999|NCT01508910|2836939|P3|Treatment|Death|2
860000|NCT01508910|2836940|P2|Treatment|Death|3
860001|NCT01508910|2836941|P1|Treatment|Death|2
860002|NCT01508702|2836974|P2|Overall Study|Withdrawal by Subject|7
860003|NCT01508702|2836975|P1|Overall Study|Withdrawal by Subject|11
860004|NCT01508702|2836974|P2|Overall Study|Lost to Follow-up|2
860005|NCT01508702|2836975|P1|Overall Study|Lost to Follow-up|1
860006|NCT01508702|2836974|P2|Overall Study|Protocol Violation|1
860007|NCT01508702|2836975|P1|Overall Study|Protocol Violation|2
860008|NCT01508702|2836974|P2|Overall Study|Gout flare|0
860009|NCT01508702|2836975|P1|Overall Study|Gout flare|2
860010|NCT01508702|2836974|P2|Overall Study|Adverse Event|3
860011|NCT01508702|2836975|P1|Overall Study|Adverse Event|7
860012|NCT01508676|2836983|P2|Phase II (2 Weeks)|Medication Exclusion|0
860013|NCT01508676|2836984|P1|Phase II (2 Weeks)|Medication Exclusion|1
860014|NCT01508676|2836983|P2|Phase II (2 Weeks)|Skin Sensitivity|1
860015|NCT01508676|2836984|P1|Phase II (2 Weeks)|Skin Sensitivity|0
860016|NCT01508676|2836983|P2|Phase I (2 Weeks)|Positive Drug Screen|2
860017|NCT01508676|2836984|P1|Phase I (2 Weeks)|Positive Drug Screen|0
860018|NCT01508676|2836983|P2|Phase I (2 Weeks)|Wrong Pain Type|0
860019|NCT01508676|2836984|P1|Phase I (2 Weeks)|Wrong Pain Type|1
860020|NCT01508676|2836983|P2|Phase I (2 Weeks)|Medication Exclusion|1
860021|NCT01508676|2836984|P1|Phase I (2 Weeks)|Medication Exclusion|1
860022|NCT01508325|2837005|P2|Overall Study|Other|2
860023|NCT01508325|2837006|P1|Overall Study|Other|2
860024|NCT01508325|2837005|P2|Overall Study|Lost to Follow-up|6
860025|NCT01508325|2837006|P1|Overall Study|Lost to Follow-up|5
860026|NCT01508325|2837005|P2|Overall Study|Adverse Event|0
860027|NCT01508325|2837006|P1|Overall Study|Adverse Event|1
860028|NCT01508325|2837005|P2|Overall Study|Physician Decision|1
860029|NCT01508325|2837006|P1|Overall Study|Physician Decision|2
860030|NCT01508325|2837005|P2|Overall Study|Protocol Violation|3
860031|NCT01508325|2837006|P1|Overall Study|Protocol Violation|0
860032|NCT01508325|2837005|P2|Overall Study|Withdrawal by Subject|9
860033|NCT01508325|2837006|P1|Overall Study|Withdrawal by Subject|8
860034|NCT01508169|2837036|P2|Overall Study|Lost to Follow-up|2
860035|NCT01508169|2837037|P1|Overall Study|Lost to Follow-up|1
860036|NCT01508169|2837036|P2|Overall Study|Withdrawal by Subject|0
860037|NCT01508169|2837037|P1|Overall Study|Withdrawal by Subject|1
860038|NCT01508169|2837036|P2|Overall Study|Adverse Event|0
860039|NCT01508169|2837037|P1|Overall Study|Adverse Event|1
860040|NCT01508130|2837051|P2|Overall Study|Administrative|3
860041|NCT01508130|2837052|P1|Overall Study|Administrative|14
860042|NCT01508130|2837051|P2|Overall Study|Insufficient therapeutic response|23
860043|NCT01508130|2837052|P1|Overall Study|Insufficient therapeutic response|74
860044|NCT01508130|2837051|P2|Overall Study|Subject’s substantial non-compliance|9
860045|NCT01508130|2837052|P1|Overall Study|Subject’s substantial non-compliance|25
860046|NCT01508130|2837051|P2|Overall Study|Withdrawal by Subject|3
860047|NCT01508130|2837052|P1|Overall Study|Withdrawal by Subject|3
860048|NCT01508130|2837051|P2|Overall Study|Lost to Follow-up|2
860049|NCT01508130|2837052|P1|Overall Study|Lost to Follow-up|25
860050|NCT01508130|2837051|P2|Overall Study|Protocol Violation|0
860051|NCT01508130|2837052|P1|Overall Study|Protocol Violation|2
860052|NCT01508130|2837051|P2|Overall Study|Death|1
860053|NCT01508130|2837052|P1|Overall Study|Death|3
860054|NCT01508130|2837051|P2|Overall Study|Adverse Event|28
860055|NCT01508130|2837052|P1|Overall Study|Adverse Event|81
860056|NCT01507896|2837120|P1|Overall Study|The surgery was denied by the sponsor.|1
860057|NCT01507896|2837120|P1|Overall Study|Withdrawal by Subject|1
860058|NCT01507831|2837163|P2|Overall Study|Other|6
860059|NCT01507831|2837164|P1|Overall Study|Other|3
860060|NCT01507831|2837163|P2|Overall Study|Potential lost to follow-up|0
860061|NCT01507831|2837164|P1|Overall Study|Potential lost to follow-up|3
860062|NCT01507831|2837163|P2|Overall Study|Site closure|3
860063|NCT01507831|2837164|P1|Overall Study|Site closure|0
860064|NCT01507831|2837163|P2|Overall Study|Selection criteria finally not met|1
860065|NCT01507831|2837164|P1|Overall Study|Selection criteria finally not met|0
860066|NCT01507831|2837163|P2|Overall Study|Last visit outside protocol visit window|143
860067|NCT01507831|2837164|P1|Overall Study|Last visit outside protocol visit window|51
860068|NCT01507831|2837163|P2|Overall Study|Related to study drug administration|14
860069|NCT01507831|2837164|P1|Overall Study|Related to study drug administration|5
860070|NCT01507831|2837163|P2|Overall Study|Consent withdrawn by participant|72
860071|NCT01507831|2837164|P1|Overall Study|Consent withdrawn by participant|34
860072|NCT01507831|2837163|P2|Overall Study|Participant moved|19
860073|NCT01507831|2837164|P1|Overall Study|Participant moved|5
860074|NCT01507831|2837163|P2|Overall Study|Physician Decision|4
860075|NCT01507831|2837164|P1|Overall Study|Physician Decision|0
860076|NCT01507831|2837163|P2|Overall Study|Poor compliance to protocol|60
860077|NCT01507831|2837164|P1|Overall Study|Poor compliance to protocol|38
860078|NCT01507831|2837163|P2|Overall Study|Death|2
860079|NCT01507831|2837164|P1|Overall Study|Death|6
860080|NCT01507831|2837163|P2|Overall Study|Adverse Event|113
860081|NCT01507831|2837164|P1|Overall Study|Adverse Event|48
860082|NCT01507831|2837163|P2|Overall Study|Randomized but not treated|3
860083|NCT01507831|2837164|P1|Overall Study|Randomized but not treated|0
860084|NCT01507662|2837234|P2|Overall Study|Proxy interview done|3
860085|NCT01507662|2837235|P1|Overall Study|Proxy interview done|2
860086|NCT01507662|2837234|P2|Overall Study|Lost to Follow-up|523
860087|NCT01507662|2837235|P1|Overall Study|Lost to Follow-up|498
860088|NCT01507662|2837234|P2|Overall Study|Withdrawal by Subject|287
860089|NCT01507662|2837235|P1|Overall Study|Withdrawal by Subject|290
860090|NCT01507662|2837234|P2|Overall Study|Death|18
860091|NCT01507662|2837235|P1|Overall Study|Death|26
860092|NCT01507246|2837260|P2|Overall Study|Required different surgical procedures|1
860093|NCT01507246|2837261|P1|Overall Study|Required different surgical procedures|2
860094|NCT01507090|2837359|P1|Overall Study|incomplete dataset|18
860095|NCT01507051|2837398|P4|Overall Study|Adverse Event|0
860096|NCT01507051|2837399|P3|Overall Study|Adverse Event|0
860097|NCT01507051|2837400|P2|Overall Study|Adverse Event|0
860098|NCT01507051|2837401|P1|Overall Study|Adverse Event|1
860099|NCT01507051|2837398|P4|Overall Study|Physician Decision|1
860100|NCT01507051|2837399|P3|Overall Study|Physician Decision|0
860101|NCT01507051|2837400|P2|Overall Study|Physician Decision|0
860102|NCT01507051|2837401|P1|Overall Study|Physician Decision|0
860103|NCT01507051|2837398|P4|Overall Study|Withdrawal by Subject|6
860104|NCT01507051|2837399|P3|Overall Study|Withdrawal by Subject|1
860105|NCT01507051|2837400|P2|Overall Study|Withdrawal by Subject|3
860106|NCT01507051|2837401|P1|Overall Study|Withdrawal by Subject|1
860107|NCT01506960|2837519|P1|Overall Study|Did not meet angiographic criteria|47
860108|NCT01506947|2837525|P1|Overall Study|Did Not Meet Eligibility Criteria|3
860109|NCT01506947|2837525|P1|Overall Study|Death|1
860110|NCT01506947|2837525|P1|Overall Study|Adverse Event|5
860111|NCT01506947|2837525|P1|Overall Study|Lost to Follow-up|7
860112|NCT01506908|2837543|P2|Overall Study|Adverse Event|0
860113|NCT01506908|2837544|P1|Overall Study|Adverse Event|1
860114|NCT01506882|2837562|P2|Overall Study|Other Reason|0
860115|NCT01506882|2837563|P1|Overall Study|Other Reason|2
860116|NCT01506882|2837562|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
860117|NCT01506882|2837563|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
860118|NCT01506882|2837562|P2|Overall Study|AE, non-serious non-fatal|1
860119|NCT01506882|2837563|P1|Overall Study|AE, non-serious non-fatal|3
860120|NCT01506882|2837562|P2|Overall Study|SAE, non-fatal|0
860121|NCT01506882|2837563|P1|Overall Study|SAE, non-fatal|2
860122|NCT01506882|2837562|P2|Overall Study|Withdrawal by Subject|3
860123|NCT01506882|2837563|P1|Overall Study|Withdrawal by Subject|9
860124|NCT01506882|2837562|P2|Overall Study|Lost to Follow-up|0
860125|NCT01506882|2837563|P1|Overall Study|Lost to Follow-up|1
860126|NCT01506882|2837562|P2|Overall Study|Lack of Efficacy|3
860127|NCT01506882|2837563|P1|Overall Study|Lack of Efficacy|4
860128|NCT01506726|2837577|P2|Overall Study|Adverse Event|2
860129|NCT01506726|2837578|P1|Overall Study|Adverse Event|1
860130|NCT01506596|2837618|P1|Overall Study|ineligible pathology|1
860131|NCT01506479|2837629|P3|Overall Study|Adverse Event|0
860132|NCT01506479|2837630|P2|Overall Study|Adverse Event|1
860133|NCT01506479|2837631|P1|Overall Study|Adverse Event|0
860134|NCT01506479|2837629|P3|Overall Study|Missing assessment|0
860135|NCT01506479|2837630|P2|Overall Study|Missing assessment|0
860136|NCT01506479|2837631|P1|Overall Study|Missing assessment|1
860137|NCT01506479|2837629|P3|Overall Study|Withdrawal by Subject|1
860138|NCT01506479|2837630|P2|Overall Study|Withdrawal by Subject|2
860139|NCT01506479|2837631|P1|Overall Study|Withdrawal by Subject|1
860140|NCT01506479|2837629|P3|Overall Study|Lost to Follow-up|2
860141|NCT01506479|2837630|P2|Overall Study|Lost to Follow-up|2
860142|NCT01506479|2837631|P1|Overall Study|Lost to Follow-up|1
860143|NCT01506323|2837649|P2|Overall Study|Started another treatment|0
860144|NCT01506323|2837650|P1|Overall Study|Started another treatment|1
860145|NCT01506323|2837649|P2|Overall Study|Schedule or Transportation conflict|0
860146|NCT01506323|2837650|P1|Overall Study|Schedule or Transportation conflict|8
860147|NCT01506323|2837649|P2|Overall Study|Moved out of area|2
860148|NCT01506323|2837650|P1|Overall Study|Moved out of area|5
860149|NCT01506323|2837649|P2|Overall Study|Lack of Efficacy|3
860150|NCT01506323|2837650|P1|Overall Study|Lack of Efficacy|1
860151|NCT01506323|2837649|P2|Overall Study|Withdrawal by Subject|4
860152|NCT01506323|2837650|P1|Overall Study|Withdrawal by Subject|4
860153|NCT01506323|2837649|P2|Overall Study|Lost to Follow-up|4
860154|NCT01506323|2837650|P1|Overall Study|Lost to Follow-up|5
860155|NCT01506193|2837679|P3|Overall Study|Lost to Follow-up|3
860156|NCT01506193|2837680|P2|Overall Study|Lost to Follow-up|3
860157|NCT01506193|2837681|P1|Overall Study|Lost to Follow-up|8
860158|NCT01506193|2837679|P3|Overall Study|Withdrawal by Subject|8
860159|NCT01506193|2837680|P2|Overall Study|Withdrawal by Subject|1
860160|NCT01506193|2837681|P1|Overall Study|Withdrawal by Subject|5
860161|NCT01506193|2837679|P3|Overall Study|Adverse event, non-fatal|1
860162|NCT01506193|2837680|P2|Overall Study|Adverse event, non-fatal|0
860163|NCT01506193|2837681|P1|Overall Study|Adverse event, non-fatal|0
860164|NCT01506193|2837679|P3|Overall Study|Migrated/moved from study area|1
860165|NCT01506193|2837680|P2|Overall Study|Migrated/moved from study area|0
860166|NCT01506193|2837681|P1|Overall Study|Migrated/moved from study area|0
860167|NCT01506193|2837679|P3|Overall Study|Protocol Violation|1
860168|NCT01506193|2837680|P2|Overall Study|Protocol Violation|0
860169|NCT01506193|2837681|P1|Overall Study|Protocol Violation|1
860170|NCT01505881|2837714|P2|Overall Study|Withdrawal by Subject|0
860171|NCT01505881|2837715|P1|Overall Study|Withdrawal by Subject|2
860172|NCT01505881|2837714|P2|Overall Study|Lost to Follow-up|0
860173|NCT01505881|2837715|P1|Overall Study|Lost to Follow-up|2
860174|NCT01505881|2837714|P2|Overall Study|Adverse Event|1
860175|NCT01505881|2837715|P1|Overall Study|Adverse Event|0
860176|NCT01505647|2837821|P2|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2
860177|NCT01505647|2837822|P1|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1
860178|NCT01505647|2837821|P2|Day 43 Through Day 182 Follow-up|Death|1
860179|NCT01505647|2837822|P1|Day 43 Through Day 182 Follow-up|Death|0
860180|NCT01505647|2837821|P2|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0
860181|NCT01505647|2837822|P1|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1
860182|NCT01505647|2837821|P2|Day 1 Through Day 42 Follow-up|Physician Decision|0
860183|NCT01505647|2837822|P1|Day 1 Through Day 42 Follow-up|Physician Decision|1
860184|NCT01505647|2837821|P2|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0
860185|NCT01505647|2837822|P1|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1
860186|NCT01505608|2837838|P2|Phase II|Protocol Violation|1
860187|NCT01505608|2837839|P1|Phase II|Protocol Violation|0
860188|NCT01505608|2837838|P2|Phase II|Lack of Efficacy|1
860189|NCT01505608|2837839|P1|Phase II|Lack of Efficacy|2
860190|NCT01505608|2837838|P2|Phase I|Withdrawal by Subject|1
860191|NCT01505608|2837839|P1|Phase I|Withdrawal by Subject|0
860192|NCT01505608|2837838|P2|Phase I|Adverse Event|1
860193|NCT01505608|2837839|P1|Phase I|Adverse Event|0
860194|NCT01505608|2837838|P2|Phase I|Lack of Efficacy|4
860195|NCT01505608|2837839|P1|Phase I|Lack of Efficacy|0
860196|NCT01505530|2837858|P3|Overall Study|entry criteria not met|0
860197|NCT01505530|2837859|P2|Overall Study|entry criteria not met|1
860198|NCT01505530|2837860|P1|Overall Study|entry criteria not met|0
860199|NCT01505530|2837858|P3|Overall Study|Death|5
860200|NCT01505530|2837859|P2|Overall Study|Death|6
860201|NCT01505530|2837860|P1|Overall Study|Death|7
860202|NCT01505530|2837858|P3|Overall Study|Sponsor Decision|7
860203|NCT01505530|2837859|P2|Overall Study|Sponsor Decision|8
860204|NCT01505530|2837860|P1|Overall Study|Sponsor Decision|1
860205|NCT01505530|2837858|P3|Overall Study|Physician Decision|5
860206|NCT01505530|2837859|P2|Overall Study|Physician Decision|2
860207|NCT01505530|2837860|P1|Overall Study|Physician Decision|6
860208|NCT01505530|2837858|P3|Overall Study|Withdrawal by Subject|6
860209|NCT01505530|2837859|P2|Overall Study|Withdrawal by Subject|8
860210|NCT01505530|2837860|P1|Overall Study|Withdrawal by Subject|7
860211|NCT01505530|2837858|P3|Overall Study|Adverse Event|0
860212|NCT01505530|2837859|P2|Overall Study|Adverse Event|1
860213|NCT01505530|2837860|P1|Overall Study|Adverse Event|1
860214|NCT01505530|2837858|P3|Overall Study|Progressive Disease|18
860215|NCT01505530|2837859|P2|Overall Study|Progressive Disease|17
860216|NCT01505530|2837860|P1|Overall Study|Progressive Disease|19
860217|NCT01505387|2837920|P2|Overall Study|Withdrawal by Subject|1
860218|NCT01505387|2837921|P1|Overall Study|Withdrawal by Subject|1
860219|NCT01505387|2837920|P2|Overall Study|Protocol Violation|0
860220|NCT01505387|2837921|P1|Overall Study|Protocol Violation|1
860221|NCT01505374|2837927|P2|Overall Study|Lost to Follow-up|0
860222|NCT01505374|2837928|P1|Overall Study|Lost to Follow-up|1
860223|NCT01505114|2837963|P4|Overall Study|investigator decision|0
860224|NCT01505114|2837964|P3|Overall Study|investigator decision|1
860225|NCT01505114|2837965|P2|Overall Study|investigator decision|0
860226|NCT01505114|2837966|P1|Overall Study|investigator decision|1
860227|NCT01505114|2837963|P4|Overall Study|staff safety concerns|1
860228|NCT01505114|2837964|P3|Overall Study|staff safety concerns|0
860229|NCT01505114|2837965|P2|Overall Study|staff safety concerns|0
860230|NCT01505114|2837966|P1|Overall Study|staff safety concerns|0
860231|NCT01505114|2837963|P4|Overall Study|inadvertent enrollment due to peanut all|1
860232|NCT01505114|2837964|P3|Overall Study|inadvertent enrollment due to peanut all|0
860233|NCT01505114|2837965|P2|Overall Study|inadvertent enrollment due to peanut all|0
860234|NCT01505114|2837966|P1|Overall Study|inadvertent enrollment due to peanut all|0
860235|NCT01505114|2837963|P4|Overall Study|relocated|3
860236|NCT01505114|2837964|P3|Overall Study|relocated|2
860237|NCT01505114|2837965|P2|Overall Study|relocated|2
860238|NCT01505114|2837966|P1|Overall Study|relocated|4
860239|NCT01505114|2837963|P4|Overall Study|Lost to Follow-up|7
860240|NCT01505114|2837964|P3|Overall Study|Lost to Follow-up|8
860241|NCT01505114|2837965|P2|Overall Study|Lost to Follow-up|5
860242|NCT01505114|2837966|P1|Overall Study|Lost to Follow-up|11
860243|NCT01505114|2837963|P4|Overall Study|unable to adhere to visit schedule|3
860244|NCT01505114|2837964|P3|Overall Study|unable to adhere to visit schedule|3
860245|NCT01505114|2837965|P2|Overall Study|unable to adhere to visit schedule|2
860246|NCT01505114|2837966|P1|Overall Study|unable to adhere to visit schedule|3
860247|NCT01505114|2837963|P4|Overall Study|Death|1
860248|NCT01505114|2837964|P3|Overall Study|Death|0
860249|NCT01505114|2837965|P2|Overall Study|Death|0
860250|NCT01505114|2837966|P1|Overall Study|Death|1
860251|NCT01505114|2837963|P4|Overall Study|Withdrawal by Subject|7
860252|NCT01505114|2837964|P3|Overall Study|Withdrawal by Subject|4
860253|NCT01505114|2837965|P2|Overall Study|Withdrawal by Subject|4
860254|NCT01505114|2837966|P1|Overall Study|Withdrawal by Subject|5
860255|NCT01504971|2837980|P1|Overall Study|Physician Decision|13
860256|NCT01504867|2838009|P2|Overall Study|Consent revoked|1
860257|NCT01504867|2838010|P1|Overall Study|Consent revoked|5
860258|NCT01504867|2838009|P2|Overall Study|Inclusion criteria not met|2
860259|NCT01504867|2838010|P1|Overall Study|Inclusion criteria not met|2
860260|NCT01504204|2838047|P2|Overall Study|Lost to Follow-up|1
860261|NCT01504204|2838048|P1|Overall Study|Lost to Follow-up|1
860262|NCT01503164|2838105|P2|Overall Study|Withdrawal by Subject|1
860263|NCT01503164|2838106|P1|Overall Study|Withdrawal by Subject|2
860264|NCT01503021|2838136|P2|Overall Study|Moved, received transplant, etc.|7
860265|NCT01503021|2838137|P1|Overall Study|Moved, received transplant, etc.|5
860266|NCT01503021|2838136|P2|Overall Study|Withdrawal by Subject|8
860267|NCT01503021|2838137|P1|Overall Study|Withdrawal by Subject|9
860268|NCT01503021|2838136|P2|Overall Study|Protocol Violation|3
860269|NCT01503021|2838137|P1|Overall Study|Protocol Violation|1
860270|NCT01503021|2838136|P2|Overall Study|Physician Decision|0
860271|NCT01503021|2838137|P1|Overall Study|Physician Decision|3
860272|NCT01503021|2838136|P2|Overall Study|Lost to Follow-up|0
860273|NCT01503021|2838137|P1|Overall Study|Lost to Follow-up|2
860274|NCT01503021|2838136|P2|Overall Study|Death|2
860275|NCT01503021|2838137|P1|Overall Study|Death|0
860276|NCT01503021|2838136|P2|Overall Study|Adverse Event|6
860277|NCT01503021|2838137|P1|Overall Study|Adverse Event|7
860278|NCT01502956|2838186|P2|Overall Study|Withdrawal by Subject|10
860279|NCT01502956|2838187|P1|Overall Study|Withdrawal by Subject|8
860280|NCT01502956|2838186|P2|Overall Study|Physician Decision|3
860281|NCT01502956|2838187|P1|Overall Study|Physician Decision|2
860282|NCT01502956|2838186|P2|Overall Study|Lost to Follow-up|11
860283|NCT01502956|2838187|P1|Overall Study|Lost to Follow-up|14
860284|NCT01502956|2838186|P2|Overall Study|Death|2
860285|NCT01502956|2838187|P1|Overall Study|Death|0
860286|NCT01502709|2838245|P2|Overall Study|Lost to Follow-up|0
860287|NCT01502709|2838246|P1|Overall Study|Lost to Follow-up|4
860288|NCT01502644|2838259|P4|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
860289|NCT01502644|2838260|P3|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
860290|NCT01502644|2838261|P2|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
860291|NCT01502644|2838262|P1|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
860292|NCT01502644|2838259|P4|Assigned to NA Groups|Drop Out due to Side Effects|7
860293|NCT01502644|2838260|P3|Assigned to NA Groups|Drop Out due to Side Effects|2
860294|NCT01502644|2838261|P2|Assigned to NA Groups|Drop Out due to Side Effects|6
860295|NCT01502644|2838262|P1|Assigned to NA Groups|Drop Out due to Side Effects|0
860296|NCT01502644|2838259|P4|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
860297|NCT01502644|2838260|P3|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
860298|NCT01502644|2838261|P2|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
860299|NCT01502644|2838262|P1|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6
860300|NCT01502644|2838259|P4|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
860301|NCT01502644|2838260|P3|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
860302|NCT01502644|2838261|P2|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
860303|NCT01502644|2838262|P1|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2
860304|NCT01502644|2838259|P4|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
860305|NCT01502644|2838260|P3|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
860306|NCT01502644|2838261|P2|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
860307|NCT01502644|2838262|P1|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1
860308|NCT01502423|2838272|P2|Overall Study|Withdrawal by Subject|1
860309|NCT01502423|2838273|P1|Overall Study|Withdrawal by Subject|0
860310|NCT01502410|2838295|P4|Overall Study|Withdrawal by Subject|0
860311|NCT01502410|2838296|P3|Overall Study|Withdrawal by Subject|0
860312|NCT01502410|2838297|P2|Overall Study|Withdrawal by Subject|0
860313|NCT01502410|2838298|P1|Overall Study|Withdrawal by Subject|2
860314|NCT01502410|2838295|P4|Overall Study|Physician Decision|0
860315|NCT01502410|2838296|P3|Overall Study|Physician Decision|0
860316|NCT01502410|2838297|P2|Overall Study|Physician Decision|1
860317|NCT01502410|2838298|P1|Overall Study|Physician Decision|0
860318|NCT01502410|2838295|P4|Overall Study|Lack of Efficacy|0
860319|NCT01502410|2838296|P3|Overall Study|Lack of Efficacy|0
860320|NCT01502410|2838297|P2|Overall Study|Lack of Efficacy|7
860321|NCT01502410|2838298|P1|Overall Study|Lack of Efficacy|7
860322|NCT01502410|2838295|P4|Overall Study|Adverse Event|0
860323|NCT01502410|2838296|P3|Overall Study|Adverse Event|0
860324|NCT01502410|2838297|P2|Overall Study|Adverse Event|2
860325|NCT01502410|2838298|P1|Overall Study|Adverse Event|1
860326|NCT01502371|2838316|P5|Overall Study|Excluded Medication|1
860327|NCT01502371|2838317|P4|Overall Study|Excluded Medication|0
860328|NCT01502371|2838318|P3|Overall Study|Excluded Medication|1
860329|NCT01502371|2838319|P2|Overall Study|Excluded Medication|1
860330|NCT01502371|2838320|P1|Overall Study|Excluded Medication|0
860331|NCT01502371|2838316|P5|Overall Study|Protocol Violation|10
860332|NCT01502371|2838317|P4|Overall Study|Protocol Violation|5
860333|NCT01502371|2838318|P3|Overall Study|Protocol Violation|6
860334|NCT01502371|2838319|P2|Overall Study|Protocol Violation|5
860335|NCT01502371|2838320|P1|Overall Study|Protocol Violation|9
860336|NCT01502371|2838316|P5|Overall Study|Technical Problems|1
860337|NCT01502371|2838317|P4|Overall Study|Technical Problems|4
860338|NCT01502371|2838318|P3|Overall Study|Technical Problems|2
860339|NCT01502371|2838319|P2|Overall Study|Technical Problems|0
860340|NCT01502371|2838320|P1|Overall Study|Technical Problems|1
860341|NCT01502371|2838316|P5|Overall Study|Noncompliance with Study Drug|1
860342|NCT01502371|2838317|P4|Overall Study|Noncompliance with Study Drug|2
860343|NCT01502371|2838318|P3|Overall Study|Noncompliance with Study Drug|1
860344|NCT01502371|2838319|P2|Overall Study|Noncompliance with Study Drug|0
860345|NCT01502371|2838320|P1|Overall Study|Noncompliance with Study Drug|0
860346|NCT01502371|2838316|P5|Overall Study|Physician Decision|1
860347|NCT01502371|2838317|P4|Overall Study|Physician Decision|0
860348|NCT01502371|2838318|P3|Overall Study|Physician Decision|0
860349|NCT01502371|2838319|P2|Overall Study|Physician Decision|0
860350|NCT01502371|2838320|P1|Overall Study|Physician Decision|3
860351|NCT01502371|2838316|P5|Overall Study|Lack of Efficacy|4
860352|NCT01502371|2838317|P4|Overall Study|Lack of Efficacy|2
860353|NCT01502371|2838318|P3|Overall Study|Lack of Efficacy|2
860354|NCT01502371|2838319|P2|Overall Study|Lack of Efficacy|3
860355|NCT01502371|2838320|P1|Overall Study|Lack of Efficacy|3
860356|NCT01502371|2838316|P5|Overall Study|Treatment Failure|30
860357|NCT01502371|2838317|P4|Overall Study|Treatment Failure|19
860358|NCT01502371|2838318|P3|Overall Study|Treatment Failure|12
860359|NCT01502371|2838319|P2|Overall Study|Treatment Failure|20
860360|NCT01502371|2838320|P1|Overall Study|Treatment Failure|22
860361|NCT01502371|2838316|P5|Overall Study|Adverse Event|3
860362|NCT01502371|2838317|P4|Overall Study|Adverse Event|4
860363|NCT01502371|2838318|P3|Overall Study|Adverse Event|0
860364|NCT01502371|2838319|P2|Overall Study|Adverse Event|1
860365|NCT01502371|2838320|P1|Overall Study|Adverse Event|2
860366|NCT01502371|2838316|P5|Overall Study|Withdrawal by Subject|1
860367|NCT01502371|2838317|P4|Overall Study|Withdrawal by Subject|1
860368|NCT01502371|2838318|P3|Overall Study|Withdrawal by Subject|1
860369|NCT01502371|2838319|P2|Overall Study|Withdrawal by Subject|2
860370|NCT01502371|2838320|P1|Overall Study|Withdrawal by Subject|1
860371|NCT01502228|2838360|P1|Overall Study|Death|1
860372|NCT01502033|2838365|P1|Overall Study|1 participant went back to school|1
860373|NCT01502033|2838365|P1|Overall Study|1 participant had worsening depression|1
860374|NCT01502033|2838365|P1|Overall Study|1 participant had scalp discomfort|1
860375|NCT01501955|2838373|P2|Overall Study|Adverse Event|3
860376|NCT01501955|2838374|P1|Overall Study|Adverse Event|1
860377|NCT01501955|2838373|P2|Overall Study|Withdrawal by Subject|0
860378|NCT01501955|2838374|P1|Overall Study|Withdrawal by Subject|1
860379|NCT01501110|2838438|P2|Overall Study|Death|1
860380|NCT01501110|2838439|P1|Overall Study|Death|0
860381|NCT01500720|2838472|P2|Overall Study|Other|8
860382|NCT01500720|2838473|P1|Overall Study|Other|4
860383|NCT01500720|2838472|P2|Overall Study|Randomized But Not Treated|1
860384|NCT01500720|2838473|P1|Overall Study|Randomized But Not Treated|1
860385|NCT01500694|2838487|P2|Overall Study|Other|3
860386|NCT01500694|2838488|P1|Overall Study|Other|9
860387|NCT01500694|2838487|P2|Overall Study|Lack of Efficacy|5
860388|NCT01500694|2838488|P1|Overall Study|Lack of Efficacy|14
860389|NCT01500694|2838487|P2|Overall Study|Lost to Follow-up|3
860390|NCT01500694|2838488|P1|Overall Study|Lost to Follow-up|2
860391|NCT01500694|2838487|P2|Overall Study|Withdrawal by Subject|14
860392|NCT01500694|2838488|P1|Overall Study|Withdrawal by Subject|23
860393|NCT01500694|2838487|P2|Overall Study|Protocol Violation|1
860394|NCT01500694|2838488|P1|Overall Study|Protocol Violation|0
860395|NCT01500694|2838487|P2|Overall Study|Adverse Event|3
860396|NCT01500694|2838488|P1|Overall Study|Adverse Event|4
860397|NCT01500629|2838514|P2|Washout Period of 14 to 30 Days|Pregnancy|0
860398|NCT01500629|2838515|P1|Washout Period of 14 to 30 Days|Pregnancy|1
860399|NCT01500434|2838599|P1|Overall Study|Missed 12-month follow-up|5
860400|NCT01500434|2838599|P1|Overall Study|Withdrawal by Subject|1
860401|NCT01500434|2838599|P1|Overall Study|Death|1
860402|NCT01500382|2838632|P4|Washout Period|Study site went out of business|0
860403|NCT01500382|2838633|P3|Washout Period|Study site went out of business|1
860404|NCT01500382|2838634|P2|Washout Period|Study site went out of business|0
860405|NCT01500382|2838635|P1|Washout Period|Study site went out of business|0
860406|NCT01500317|2838660|P3|Overall Study|Withdrawal by Subject|0
860407|NCT01500317|2838661|P2|Overall Study|Withdrawal by Subject|2
860408|NCT01500317|2838662|P1|Overall Study|Withdrawal by Subject|3
860409|NCT01500278|2838684|P2|Week 13 - Week 104|Adverse Event|54
860410|NCT01500278|2838685|P1|Week 13 - Week 104|Adverse Event|54
860411|NCT01500278|2838684|P2|Week 13 - Week 104|Death|4
860412|NCT01500278|2838685|P1|Week 13 - Week 104|Death|2
860413|NCT01500278|2838684|P2|Week 13 - Week 104|Not completed|1
860414|NCT01500278|2838685|P1|Week 13 - Week 104|Not completed|0
860415|NCT01500278|2838684|P2|Week 13 - Week 104|Personal reason|1
860416|NCT01500278|2838685|P1|Week 13 - Week 104|Personal reason|0
860417|NCT01500278|2838684|P2|Week 13 - Week 104|Medical monitor decision|2
860418|NCT01500278|2838685|P1|Week 13 - Week 104|Medical monitor decision|0
860419|NCT01500278|2838684|P2|Week 13 - Week 104|Sponsor decision|2
860420|NCT01500278|2838685|P1|Week 13 - Week 104|Sponsor decision|0
860421|NCT01500278|2838684|P2|Week 13 - Week 104|Relocation|1
860422|NCT01500278|2838685|P1|Week 13 - Week 104|Relocation|0
860423|NCT01500278|2838684|P2|Week 13 - Week 104|Abnormal questionable chest X-ray|2
860424|NCT01500278|2838685|P1|Week 13 - Week 104|Abnormal questionable chest X-ray|0
860425|NCT01500278|2838684|P2|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0
860426|NCT01500278|2838685|P1|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1
860427|NCT01500278|2838684|P2|Week 13 - Week 104|Principal investigator retiring|0
860428|NCT01500278|2838685|P1|Week 13 - Week 104|Principal investigator retiring|1
860429|NCT01500278|2838684|P2|Week 13 - Week 104|Protocol deviation|0
860430|NCT01500278|2838685|P1|Week 13 - Week 104|Protocol deviation|1
860431|NCT01500278|2838684|P2|Week 13 - Week 104|Exclusion criteria not met|0
860432|NCT01500278|2838685|P1|Week 13 - Week 104|Exclusion criteria not met|1
860433|NCT01500278|2838684|P2|Week 13 - Week 104|Withdrawn in error|0
860434|NCT01500278|2838685|P1|Week 13 - Week 104|Withdrawn in error|1
860435|NCT01500278|2838684|P2|Week 13 - Week 104|Sponsor request|0
860436|NCT01500278|2838685|P1|Week 13 - Week 104|Sponsor request|4
860437|NCT01500278|2838684|P2|Week 13 - Week 104|False positive test|2
860438|NCT01500278|2838685|P1|Week 13 - Week 104|False positive test|1
860439|NCT01500278|2838684|P2|Week 13 - Week 104|Recurrent infections|0
860440|NCT01500278|2838685|P1|Week 13 - Week 104|Recurrent infections|1
860441|NCT01500278|2838684|P2|Week 13 - Week 104|Non/bad compliance|5
860442|NCT01500278|2838685|P1|Week 13 - Week 104|Non/bad compliance|7
860443|NCT01500278|2838684|P2|Week 13 - Week 104|Week 24 Non-Responder|16
860444|NCT01500278|2838685|P1|Week 13 - Week 104|Week 24 Non-Responder|20
860445|NCT01500278|2838684|P2|Week 13 - Week 104|Withdrawal by Subject|13
860446|NCT01500278|2838685|P1|Week 13 - Week 104|Withdrawal by Subject|22
860447|NCT01500278|2838684|P2|Week 13 - Week 104|Lost to Follow-up|5
860448|NCT01500278|2838685|P1|Week 13 - Week 104|Lost to Follow-up|6
860449|NCT01500278|2838684|P2|Week 13 - Week 104|Protocol Violation|6
860450|NCT01500278|2838685|P1|Week 13 - Week 104|Protocol Violation|6
860451|NCT01500278|2838684|P2|Week 13 - Week 104|Lack of Efficacy|12
860452|NCT01500278|2838685|P1|Week 13 - Week 104|Lack of Efficacy|11
860453|NCT01500278|2838684|P2|Week 0 - Week 12|Adverse event (AE), not fatal|8
860454|NCT01500278|2838685|P1|Week 0 - Week 12|Adverse event (AE), not fatal|7
860455|NCT01500278|2838684|P2|Week 0 - Week 12|Other serious disease|1
860456|NCT01500278|2838685|P1|Week 0 - Week 12|Other serious disease|0
860457|NCT01500278|2838684|P2|Week 0 - Week 12|Personal reason|1
860458|NCT01500278|2838685|P1|Week 0 - Week 12|Personal reason|0
860459|NCT01500278|2838684|P2|Week 0 - Week 12|Sponsor decision|0
860460|NCT01500278|2838685|P1|Week 0 - Week 12|Sponsor decision|1
860461|NCT01500278|2838684|P2|Week 0 - Week 12|Prior history of serious disease|0
860462|NCT01500278|2838685|P1|Week 0 - Week 12|Prior history of serious disease|1
860463|NCT01500278|2838684|P2|Week 0 - Week 12|Investigator decision|0
860464|NCT01500278|2838685|P1|Week 0 - Week 12|Investigator decision|1
860465|NCT01500278|2838684|P2|Week 0 - Week 12|Exclusion criteria not met|0
860466|NCT01500278|2838685|P1|Week 0 - Week 12|Exclusion criteria not met|1
860467|NCT01500278|2838684|P2|Week 0 - Week 12|Patient decision|0
860468|NCT01500278|2838685|P1|Week 0 - Week 12|Patient decision|1
860469|NCT01500278|2838684|P2|Week 0 - Week 12|Protocol violation on screening X-ray|0
860470|NCT01500278|2838685|P1|Week 0 - Week 12|Protocol violation on screening X-ray|1
860471|NCT01500278|2838684|P2|Week 0 - Week 12|Withdrawal by Subject|2
860472|NCT01500278|2838685|P1|Week 0 - Week 12|Withdrawal by Subject|7
860473|NCT01500278|2838684|P2|Week 0 - Week 12|Lost to Follow-up|1
860474|NCT01500278|2838685|P1|Week 0 - Week 12|Lost to Follow-up|1
860475|NCT01500278|2838684|P2|Week 0 - Week 12|Protocol Violation|16
860476|NCT01500278|2838685|P1|Week 0 - Week 12|Protocol Violation|10
860477|NCT01500278|2838684|P2|Week 0 - Week 12|Lack of Efficacy|1
860478|NCT01500278|2838685|P1|Week 0 - Week 12|Lack of Efficacy|0
860479|NCT01500252|2838709|P2|Overall Study|Lost to Follow-up|4
860480|NCT01500252|2838710|P1|Overall Study|Lost to Follow-up|5
860481|NCT01500252|2838709|P2|Overall Study|Death|2
860482|NCT01500252|2838710|P1|Overall Study|Death|4
860483|NCT01500226|2838736|P2|Overall Study|Other Reasons|16
860484|NCT01500226|2838737|P1|Overall Study|Other Reasons|19
860485|NCT01500226|2838736|P2|Overall Study|Lost to Follow-up|5
860486|NCT01500226|2838737|P1|Overall Study|Lost to Follow-up|9
860487|NCT01500226|2838736|P2|Overall Study|Lack of Efficacy|30
860488|NCT01500226|2838737|P1|Overall Study|Lack of Efficacy|14
860489|NCT01500226|2838736|P2|Overall Study|Physician Decision|15
860490|NCT01500226|2838737|P1|Overall Study|Physician Decision|17
860491|NCT01500226|2838736|P2|Overall Study|Protocol Violation|39
860492|NCT01500226|2838737|P1|Overall Study|Protocol Violation|53
860493|NCT01500226|2838736|P2|Overall Study|Disease Progression|14
860494|NCT01500226|2838737|P1|Overall Study|Disease Progression|16
860495|NCT01500226|2838736|P2|Overall Study|Death|4
860496|NCT01500226|2838737|P1|Overall Study|Death|12
860497|NCT01500226|2838736|P2|Overall Study|Withdrawal by Subject|96
860498|NCT01500226|2838737|P1|Overall Study|Withdrawal by Subject|93
860499|NCT01500226|2838736|P2|Overall Study|Chemo Completed or Change in Therapy|237
860500|NCT01500226|2838737|P1|Overall Study|Chemo Completed or Change in Therapy|235
860501|NCT01500226|2838736|P2|Overall Study|Adverse Event|38
860502|NCT01500226|2838737|P1|Overall Study|Adverse Event|31
860503|NCT01500213|2838749|P2|Overall Study|Other Reasons|5
860504|NCT01500213|2838750|P1|Overall Study|Other Reasons|7
860505|NCT01500213|2838749|P2|Overall Study|Lost to Follow-up|6
860506|NCT01500213|2838750|P1|Overall Study|Lost to Follow-up|3
860507|NCT01500213|2838749|P2|Overall Study|Lack of Efficacy|7
860508|NCT01500213|2838750|P1|Overall Study|Lack of Efficacy|9
860509|NCT01500213|2838749|P2|Overall Study|Physician Decision|10
860510|NCT01500213|2838750|P1|Overall Study|Physician Decision|12
860511|NCT01500213|2838749|P2|Overall Study|Protocol Violation|19
860512|NCT01500213|2838750|P1|Overall Study|Protocol Violation|19
860513|NCT01500213|2838749|P2|Overall Study|Disease Progression|21
860514|NCT01500213|2838750|P1|Overall Study|Disease Progression|13
860515|NCT01500213|2838749|P2|Overall Study|Death|3
860516|NCT01500213|2838750|P1|Overall Study|Death|7
860517|NCT01500213|2838749|P2|Overall Study|Withdrawal by Subject|37
860518|NCT01500213|2838750|P1|Overall Study|Withdrawal by Subject|28
860519|NCT01500213|2838749|P2|Overall Study|Chemo Completed or Change in Therapy|81
860520|NCT01500213|2838750|P1|Overall Study|Chemo Completed or Change in Therapy|84
860521|NCT01500213|2838749|P2|Overall Study|Adverse Event|35
860522|NCT01500213|2838750|P1|Overall Study|Adverse Event|35
860523|NCT01500135|2838762|P2|Overall Study|Patient Unable to Make Follow-up Visit|1
860524|NCT01500135|2838763|P1|Overall Study|Patient Unable to Make Follow-up Visit|0
860525|NCT01500135|2838762|P2|Overall Study|Participant was a Safety Concern|0
860526|NCT01500135|2838763|P1|Overall Study|Participant was a Safety Concern|1
860527|NCT01500135|2838762|P2|Overall Study|Patient Missed Scheduled Appointments|1
860528|NCT01500135|2838763|P1|Overall Study|Patient Missed Scheduled Appointments|0
860529|NCT01500135|2838762|P2|Overall Study|Principal Investigator (PI) Discretion|0
860530|NCT01500135|2838763|P1|Overall Study|Principal Investigator (PI) Discretion|1
860531|NCT01500135|2838762|P2|Overall Study|Fatal Adverse Event (AE)|5
860532|NCT01500135|2838763|P1|Overall Study|Fatal Adverse Event (AE)|5
860533|NCT01500135|2838762|P2|Overall Study|Lost to Follow-up|4
860534|NCT01500135|2838763|P1|Overall Study|Lost to Follow-up|6
860535|NCT01500135|2838762|P2|Overall Study|Withdrawal of Consent|0
860536|NCT01500135|2838763|P1|Overall Study|Withdrawal of Consent|4
860537|NCT01500096|2838790|P4|Overall Study|Lost to Follow-up|2
860538|NCT01500096|2838791|P3|Overall Study|Lost to Follow-up|0
860539|NCT01500096|2838792|P2|Overall Study|Lost to Follow-up|0
860540|NCT01500096|2838793|P1|Overall Study|Lost to Follow-up|1
860541|NCT01500083|2838849|P2|Overall Study|Other Reasons|5
860542|NCT01500083|2838850|P1|Overall Study|Other Reasons|2
860543|NCT01500083|2838849|P2|Overall Study|Investigator Discretion|8
860544|NCT01500083|2838850|P1|Overall Study|Investigator Discretion|3
860545|NCT01500083|2838849|P2|Overall Study|Disease Progression|10
860546|NCT01500083|2838850|P1|Overall Study|Disease Progression|2
860547|NCT01500083|2838849|P2|Overall Study|Withdrawal of Consent|1
860548|NCT01500083|2838850|P1|Overall Study|Withdrawal of Consent|0
860549|NCT01500083|2838849|P2|Overall Study|Lost to Follow-up|0
860550|NCT01500083|2838850|P1|Overall Study|Lost to Follow-up|1
860551|NCT01500083|2838849|P2|Overall Study|Death|2
860552|NCT01500083|2838850|P1|Overall Study|Death|0
860553|NCT01500083|2838849|P2|Overall Study|Adverse Event|17
860554|NCT01500083|2838850|P1|Overall Study|Adverse Event|4
860555|NCT01500057|2838858|P2|Overall Study|Lost to Follow-up|4
860556|NCT01500057|2838859|P1|Overall Study|Lost to Follow-up|6
860557|NCT01500031|2838869|P1|Overall Study|Withdrawal by Subject|4
860558|NCT01500031|2838869|P1|Overall Study|Death|1
860559|NCT01499849|2838904|P2|Overall Study|Other Reasons|30
860560|NCT01499849|2838905|P1|Overall Study|Other Reasons|27
860561|NCT01499849|2838904|P2|Overall Study|Lost to Follow-up|3
860562|NCT01499849|2838905|P1|Overall Study|Lost to Follow-up|6
860563|NCT01499849|2838904|P2|Overall Study|Lack of Efficacy|4
860564|NCT01499849|2838905|P1|Overall Study|Lack of Efficacy|3
860565|NCT01499849|2838904|P2|Overall Study|Physician Decision|19
860566|NCT01499849|2838905|P1|Overall Study|Physician Decision|20
860567|NCT01499849|2838904|P2|Overall Study|Protocol Violation|11
860568|NCT01499849|2838905|P1|Overall Study|Protocol Violation|11
860569|NCT01499849|2838904|P2|Overall Study|Disease Progression|10
860570|NCT01499849|2838905|P1|Overall Study|Disease Progression|11
860571|NCT01499849|2838904|P2|Overall Study|Death|7
860572|NCT01499849|2838905|P1|Overall Study|Death|5
860573|NCT01499849|2838904|P2|Overall Study|Withdrawal by Subject|43
860574|NCT01499849|2838905|P1|Overall Study|Withdrawal by Subject|43
860575|NCT01499849|2838904|P2|Overall Study|Chemo completed or Change in Therapy|67
860576|NCT01499849|2838905|P1|Overall Study|Chemo completed or Change in Therapy|70
860577|NCT01499849|2838904|P2|Overall Study|Adverse Event|32
860578|NCT01499849|2838905|P1|Overall Study|Adverse Event|28
860579|NCT01499810|2838915|P1|Overall Study|Withdrawal by Subject|1
860580|NCT01499810|2838915|P1|Overall Study|Protocol Violation|1
860581|NCT01499810|2838915|P1|Overall Study|Lost to Follow-up|10
860582|NCT01499667|2838965|P3|Overall Study|Lack of Efficacy|0
860583|NCT01499667|2838966|P2|Overall Study|Lack of Efficacy|0
860584|NCT01499667|2838967|P1|Overall Study|Lack of Efficacy|2
860585|NCT01499667|2838965|P3|Overall Study|Withdrawal by Subject|1
860586|NCT01499667|2838966|P2|Overall Study|Withdrawal by Subject|1
860587|NCT01499667|2838967|P1|Overall Study|Withdrawal by Subject|2
860588|NCT01499667|2838965|P3|Overall Study|Adverse Event|2
860589|NCT01499667|2838966|P2|Overall Study|Adverse Event|2
860590|NCT01499667|2838967|P1|Overall Study|Adverse Event|0
860591|NCT01499667|2838965|P3|Overall Study|Protocol Violation|2
860592|NCT01499667|2838966|P2|Overall Study|Protocol Violation|3
860593|NCT01499667|2838967|P1|Overall Study|Protocol Violation|1
860594|NCT01499667|2838965|P3|Overall Study|administrative problems|5
860595|NCT01499667|2838966|P2|Overall Study|administrative problems|5
860596|NCT01499667|2838967|P1|Overall Study|administrative problems|4
860597|NCT01499576|2839015|P1|Overall Study|Withdrawal by Subject|9
860598|NCT01499576|2839015|P1|Overall Study|Physician Decision|12
860599|NCT01499355|2839029|P4|Double-Blind Period|Lost to Follow-up|0
860600|NCT01499355|2839030|P3|Double-Blind Period|Lost to Follow-up|0
860601|NCT01499355|2839031|P2|Double-Blind Period|Lost to Follow-up|1
860602|NCT01499355|2839032|P1|Double-Blind Period|Lost to Follow-up|0
860603|NCT01499355|2839029|P4|Double-Blind Period|Consent Withdrawn|2
860604|NCT01499355|2839030|P3|Double-Blind Period|Consent Withdrawn|1
860605|NCT01499355|2839031|P2|Double-Blind Period|Consent Withdrawn|0
860606|NCT01499355|2839032|P1|Double-Blind Period|Consent Withdrawn|0
860607|NCT01499355|2839029|P4|Double-Blind Period|Investigator Decision|3
860608|NCT01499355|2839030|P3|Double-Blind Period|Investigator Decision|3
860609|NCT01499355|2839031|P2|Double-Blind Period|Investigator Decision|0
860610|NCT01499355|2839032|P1|Double-Blind Period|Investigator Decision|0
860611|NCT01499355|2839029|P4|Double-Blind Period|Death|0
860612|NCT01499355|2839030|P3|Double-Blind Period|Death|0
860613|NCT01499355|2839031|P2|Double-Blind Period|Death|1
860614|NCT01499355|2839032|P1|Double-Blind Period|Death|0
860615|NCT01499355|2839029|P4|Double-Blind Period|Not Specified|2
860616|NCT01499355|2839030|P3|Double-Blind Period|Not Specified|2
860617|NCT01499355|2839031|P2|Double-Blind Period|Not Specified|1
860618|NCT01499355|2839032|P1|Double-Blind Period|Not Specified|0
860619|NCT01499355|2839029|P4|Double-Blind Period|Study Termination|14
860620|NCT01499355|2839030|P3|Double-Blind Period|Study Termination|16
860621|NCT01499355|2839031|P2|Double-Blind Period|Study Termination|18
860622|NCT01499355|2839032|P1|Double-Blind Period|Study Termination|0
860623|NCT01499355|2839029|P4|Double-Blind Period|Adverse Event|2
860624|NCT01499355|2839030|P3|Double-Blind Period|Adverse Event|3
860625|NCT01499355|2839031|P2|Double-Blind Period|Adverse Event|2
860626|NCT01499355|2839032|P1|Double-Blind Period|Adverse Event|0
860627|NCT01499355|2839029|P4|Run-In Period|Adverse Event|0
860628|NCT01499355|2839030|P3|Run-In Period|Adverse Event|0
860629|NCT01499355|2839031|P2|Run-In Period|Adverse Event|0
860630|NCT01499355|2839032|P1|Run-In Period|Adverse Event|8
860631|NCT01499355|2839029|P4|Run-In Period|Consent Withdrawn|0
860632|NCT01499355|2839030|P3|Run-In Period|Consent Withdrawn|0
860633|NCT01499355|2839031|P2|Run-In Period|Consent Withdrawn|0
860634|NCT01499355|2839032|P1|Run-In Period|Consent Withdrawn|1
860635|NCT01499355|2839029|P4|Run-In Period|Investigator Decision|0
860636|NCT01499355|2839030|P3|Run-In Period|Investigator Decision|0
860637|NCT01499355|2839031|P2|Run-In Period|Investigator Decision|0
860638|NCT01499355|2839032|P1|Run-In Period|Investigator Decision|2
860639|NCT01499355|2839029|P4|Run-In Period|Death|0
860640|NCT01499355|2839030|P3|Run-In Period|Death|0
860641|NCT01499355|2839031|P2|Run-In Period|Death|0
860642|NCT01499355|2839032|P1|Run-In Period|Death|2
860643|NCT01499355|2839029|P4|Run-In Period|Not Specified|0
860644|NCT01499355|2839030|P3|Run-In Period|Not Specified|0
860645|NCT01499355|2839031|P2|Run-In Period|Not Specified|0
860646|NCT01499355|2839032|P1|Run-In Period|Not Specified|3
860647|NCT01499355|2839029|P4|Run-In Period|Study Termination|0
860648|NCT01499355|2839030|P3|Run-In Period|Study Termination|0
860649|NCT01499355|2839031|P2|Run-In Period|Study Termination|0
860650|NCT01499355|2839032|P1|Run-In Period|Study Termination|15
860651|NCT01499303|2839065|P2|Overall Study|Other|1
860652|NCT01499303|2839066|P1|Overall Study|Other|0
860653|NCT01499303|2839065|P2|Overall Study|Adverse Event|4
860654|NCT01499303|2839066|P1|Overall Study|Adverse Event|1
860655|NCT01499303|2839065|P2|Overall Study|Withdrawal by Subject|1
860656|NCT01499303|2839066|P1|Overall Study|Withdrawal by Subject|0
860657|NCT01499303|2839065|P2|Overall Study|Ongoing|1
860658|NCT01499303|2839066|P1|Overall Study|Ongoing|2
860659|NCT01499290|2839074|P2|Overall Study|Adverse Event|7
860660|NCT01499290|2839075|P1|Overall Study|Adverse Event|14
860661|NCT01499290|2839074|P2|Overall Study|Lack of Efficacy|8
860662|NCT01499290|2839075|P1|Overall Study|Lack of Efficacy|7
860663|NCT01499290|2839074|P2|Overall Study|Condition improved/subject recovered|0
860664|NCT01499290|2839075|P1|Overall Study|Condition improved/subject recovered|1
860665|NCT01499290|2839074|P2|Overall Study|Not specified in study report|5
860666|NCT01499290|2839075|P1|Overall Study|Not specified in study report|11
860667|NCT01499290|2839074|P2|Overall Study|Withdrawal by Subject|15
860668|NCT01499290|2839075|P1|Overall Study|Withdrawal by Subject|22
860669|NCT01499277|2839125|P2|Overall Study|Lack of therapeutic response and other|7
860670|NCT01499277|2839126|P1|Overall Study|Lack of therapeutic response and other|8
860671|NCT01499277|2839125|P2|Overall Study|Withdrawal by Subject|6
860672|NCT01499277|2839126|P1|Overall Study|Withdrawal by Subject|16
860673|NCT01499277|2839125|P2|Overall Study|Protocol Violation|3
860674|NCT01499277|2839126|P1|Overall Study|Protocol Violation|2
860675|NCT01499277|2839125|P2|Overall Study|Lost to Follow-up|8
860676|NCT01499277|2839126|P1|Overall Study|Lost to Follow-up|15
860677|NCT01499277|2839125|P2|Overall Study|Death|2
860678|NCT01499277|2839126|P1|Overall Study|Death|3
860679|NCT01499277|2839125|P2|Overall Study|Adverse Event|6
860680|NCT01499277|2839126|P1|Overall Study|Adverse Event|3
860681|NCT01499199|2839148|P1|Overall Study|Lack of Efficacy|1
860682|NCT01499199|2839148|P1|Overall Study|Adverse Event|1
860683|NCT01499160|2839177|P1|Overall Study|Withdrawal by Subject|1
860684|NCT01499160|2839177|P1|Overall Study|Adverse Event|1
860685|NCT01499134|2839200|P2|Overall Study|Withdrawal by Subject|1
860686|NCT01499134|2839201|P1|Overall Study|Withdrawal by Subject|0
860687|NCT01499095|2839223|P2|Overall Study|Perceived Lack of Efficacy|1
860688|NCT01499095|2839224|P1|Overall Study|Perceived Lack of Efficacy|1
860689|NCT01499095|2839223|P2|Overall Study|Change in Injection Schedule|0
860690|NCT01499095|2839224|P1|Overall Study|Change in Injection Schedule|2
860691|NCT01499095|2839223|P2|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1
860692|NCT01499095|2839224|P1|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2
860693|NCT01499095|2839223|P2|Overall Study|Hypoglycemia|1
860694|NCT01499095|2839224|P1|Overall Study|Hypoglycemia|3
860695|NCT01499095|2839223|P2|Overall Study|Insulin Dropped Below Authorized Dose|5
860696|NCT01499095|2839224|P1|Overall Study|Insulin Dropped Below Authorized Dose|0
860697|NCT01499095|2839223|P2|Overall Study|Lost to Follow-up|4
860698|NCT01499095|2839224|P1|Overall Study|Lost to Follow-up|6
860699|NCT01499095|2839223|P2|Overall Study|Diverse Reasons|25
860700|NCT01499095|2839224|P1|Overall Study|Diverse Reasons|22
860701|NCT01499095|2839223|P2|Overall Study|Received Rescue Therapy|40
860702|NCT01499095|2839224|P1|Overall Study|Received Rescue Therapy|32
860703|NCT01499095|2839223|P2|Overall Study|Protocol Violation|7
860704|NCT01499095|2839224|P1|Overall Study|Protocol Violation|6
860705|NCT01499095|2839223|P2|Overall Study|Lack of Efficacy|1
860706|NCT01499095|2839224|P1|Overall Study|Lack of Efficacy|2
860707|NCT01499095|2839223|P2|Overall Study|Adverse Event|7
860708|NCT01499095|2839224|P1|Overall Study|Adverse Event|12
860709|NCT01499095|2839223|P2|Overall Study|Randomized But Not Treated|1
860710|NCT01499095|2839224|P1|Overall Study|Randomized But Not Treated|1
860711|NCT01499082|2839254|P2|Overall Study|Lost to Follow-up|3
860712|NCT01499082|2839255|P1|Overall Study|Lost to Follow-up|1
860713|NCT01499082|2839254|P2|Overall Study|Hypoglycemia|3
860714|NCT01499082|2839255|P1|Overall Study|Hypoglycemia|2
860715|NCT01499082|2839254|P2|Overall Study|Site Closure for Noncompliance|2
860716|NCT01499082|2839255|P1|Overall Study|Site Closure for Noncompliance|5
860717|NCT01499082|2839254|P2|Overall Study|Diverse Reasons|14
860718|NCT01499082|2839255|P1|Overall Study|Diverse Reasons|18
860719|NCT01499082|2839254|P2|Overall Study|Protocol Violation|8
860720|NCT01499082|2839255|P1|Overall Study|Protocol Violation|6
860721|NCT01499082|2839254|P2|Overall Study|Lack of Efficacy|1
860722|NCT01499082|2839255|P1|Overall Study|Lack of Efficacy|1
860723|NCT01499082|2839254|P2|Overall Study|Adverse Event|16
860724|NCT01499082|2839255|P1|Overall Study|Adverse Event|12
860725|NCT01499082|2839254|P2|Overall Study|Randomized but not Treated|1
860726|NCT01499082|2839255|P1|Overall Study|Randomized but not Treated|0
860727|NCT01498822|2839305|P2|Overall Study|Lost to Follow-up|3
860728|NCT01498822|2839306|P1|Overall Study|Lost to Follow-up|8
860729|NCT01498822|2839305|P2|Overall Study|Withdrawal by Subject|25
860730|NCT01498822|2839306|P1|Overall Study|Withdrawal by Subject|15
860731|NCT01498822|2839305|P2|Overall Study|Adverse Event, serious fatal|1
860732|NCT01498822|2839306|P1|Overall Study|Adverse Event, serious fatal|1
860733|NCT01498822|2839305|P2|Overall Study|SAE, non-fatal|2
860734|NCT01498822|2839306|P1|Overall Study|SAE, non-fatal|2
860735|NCT01498822|2839305|P2|Overall Study|AE, non-serious non-fatal|17
860736|NCT01498822|2839306|P1|Overall Study|AE, non-serious non-fatal|8
860737|NCT01498822|2839305|P2|Overall Study|Lack of Efficacy|2
860738|NCT01498822|2839306|P1|Overall Study|Lack of Efficacy|7
860739|NCT01498822|2839305|P2|Overall Study|Other Reason|2
860740|NCT01498822|2839306|P1|Overall Study|Other Reason|5
860741|NCT01498822|2839305|P2|Overall Study|Protocol Violation|4
860742|NCT01498822|2839306|P1|Overall Study|Protocol Violation|8
860743|NCT01498692|2839333|P1|Overall Study|Missed 12-month visit|3
860744|NCT01498692|2839333|P1|Overall Study|Withdrawal by Subject|1
860745|NCT01498692|2839333|P1|Overall Study|Death|4
860746|NCT01498679|2839364|P2|Overall Study|Withdrawal by Subject|4
860747|NCT01498679|2839365|P1|Overall Study|Withdrawal by Subject|12
860748|NCT01498679|2839364|P2|Overall Study|Physician Decision|2
860749|NCT01498679|2839365|P1|Overall Study|Physician Decision|0
860750|NCT01498679|2839364|P2|Overall Study|Protocol Violation|0
860751|NCT01498679|2839365|P1|Overall Study|Protocol Violation|4
860752|NCT01498679|2839364|P2|Overall Study|Lack of Efficacy|12
860753|NCT01498679|2839365|P1|Overall Study|Lack of Efficacy|72
860754|NCT01498679|2839364|P2|Overall Study|Adverse Event|4
860755|NCT01498679|2839365|P1|Overall Study|Adverse Event|1
860756|NCT01498653|2839381|P2|Overall Study|Withdrawal by Subject|3
860757|NCT01498653|2839382|P1|Overall Study|Withdrawal by Subject|2
860758|NCT01498653|2839381|P2|Overall Study|Physician Decision|0
860759|NCT01498653|2839382|P1|Overall Study|Physician Decision|2
860760|NCT01498653|2839381|P2|Overall Study|Lost to Follow-up|0
860761|NCT01498653|2839382|P1|Overall Study|Lost to Follow-up|1
860762|NCT01498653|2839381|P2|Overall Study|Protocol Violation|4
860763|NCT01498653|2839382|P1|Overall Study|Protocol Violation|0
860764|NCT01498653|2839381|P2|Overall Study|Lack of Efficacy|26
860765|NCT01498653|2839382|P1|Overall Study|Lack of Efficacy|12
860766|NCT01498653|2839381|P2|Overall Study|Adverse Event|2
860767|NCT01498653|2839382|P1|Overall Study|Adverse Event|2
860768|NCT01498640|2839396|P1|Overall Study|not specified|3
860769|NCT01498640|2839396|P1|Overall Study|Death|1
860770|NCT01498640|2839396|P1|Overall Study|Lost to Follow-up|1
860771|NCT01498575|2839426|P2|On the Road Driving Assessment (ODA)|Protocol Violation|18
860772|NCT01498575|2839427|P1|On the Road Driving Assessment (ODA)|Protocol Violation|23
860773|NCT01498575|2839426|P2|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6
860774|NCT01498575|2839427|P1|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19
860775|NCT01498575|2839426|P2|Overall Sample|Withdrawal by Subject|14
860776|NCT01498575|2839427|P1|Overall Sample|Withdrawal by Subject|60
860777|NCT01498458|2839444|P1|Overall Study|Physician Decision|3
860778|NCT01498458|2839444|P1|Overall Study|Adverse Event|4
860779|NCT01498185|2839499|P5|Overall Study|No longer met criteria, etc|2
860780|NCT01498185|2839500|P4|Overall Study|No longer met criteria, etc|0
860781|NCT01498185|2839501|P3|Overall Study|No longer met criteria, etc|0
860782|NCT01498185|2839502|P2|Overall Study|No longer met criteria, etc|0
860783|NCT01498185|2839503|P1|Overall Study|No longer met criteria, etc|0
860784|NCT01498185|2839499|P5|Overall Study|Withdrawal by Subject|1
860785|NCT01498185|2839500|P4|Overall Study|Withdrawal by Subject|2
860786|NCT01498185|2839501|P3|Overall Study|Withdrawal by Subject|0
860787|NCT01498185|2839502|P2|Overall Study|Withdrawal by Subject|1
860788|NCT01498185|2839503|P1|Overall Study|Withdrawal by Subject|1
860789|NCT01498185|2839499|P5|Overall Study|Adverse Event|0
860790|NCT01498185|2839500|P4|Overall Study|Adverse Event|1
860791|NCT01498185|2839501|P3|Overall Study|Adverse Event|0
860792|NCT01498185|2839502|P2|Overall Study|Adverse Event|0
860793|NCT01498185|2839503|P1|Overall Study|Adverse Event|0
860794|NCT01498120|2839543|P1|Overall Study|Other|4
860795|NCT01498120|2839543|P1|Overall Study|AE, non-serious non-fatal|3
860796|NCT01498120|2839543|P1|Overall Study|Withdrawal by Subject|5
860797|NCT01498120|2839543|P1|Overall Study|Lost to Follow-up|1
860798|NCT01498068|2839550|P2|Overall Study|Withdrawal by Subject|1
860799|NCT01498068|2839551|P1|Overall Study|Withdrawal by Subject|1
860800|NCT01497938|2839569|P2|Overall Study|Device Violation|0
860801|NCT01497938|2839570|P1|Overall Study|Device Violation|1
860802|NCT01497938|2839569|P2|Overall Study|Withdrawal by Subject|0
860803|NCT01497938|2839570|P1|Overall Study|Withdrawal by Subject|4
860804|NCT01497938|2839569|P2|Overall Study|Physician Decision|1
860805|NCT01497938|2839570|P1|Overall Study|Physician Decision|0
860806|NCT01497938|2839569|P2|Overall Study|Adverse Event|1
860807|NCT01497938|2839570|P1|Overall Study|Adverse Event|0
860808|NCT01497899|2839582|P4|Open-Label Extension Phase|Lost to Follow-up|5
860809|NCT01497899|2839583|P3|Open-Label Extension Phase|Lost to Follow-up|5
860810|NCT01497899|2839584|P2|Open-Label Extension Phase|Lost to Follow-up|3
860811|NCT01497899|2839585|P1|Open-Label Extension Phase|Lost to Follow-up|9
860812|NCT01497899|2839582|P4|Open-Label Extension Phase|Protocol Violation|0
860813|NCT01497899|2839583|P3|Open-Label Extension Phase|Protocol Violation|1
860814|NCT01497899|2839584|P2|Open-Label Extension Phase|Protocol Violation|0
860815|NCT01497899|2839585|P1|Open-Label Extension Phase|Protocol Violation|0
860816|NCT01497899|2839582|P4|Open-Label Extension Phase|Pregnancy|0
860817|NCT01497899|2839583|P3|Open-Label Extension Phase|Pregnancy|1
860818|NCT01497899|2839584|P2|Open-Label Extension Phase|Pregnancy|1
860819|NCT01497899|2839585|P1|Open-Label Extension Phase|Pregnancy|0
860820|NCT01497899|2839582|P4|Open-Label Extension Phase|Withdrew Consent|0
860821|NCT01497899|2839583|P3|Open-Label Extension Phase|Withdrew Consent|2
860822|NCT01497899|2839584|P2|Open-Label Extension Phase|Withdrew Consent|3
860823|NCT01497899|2839585|P1|Open-Label Extension Phase|Withdrew Consent|8
860824|NCT01497899|2839582|P4|Open-Label Extension Phase|Death|0
860825|NCT01497899|2839583|P3|Open-Label Extension Phase|Death|0
860826|NCT01497899|2839584|P2|Open-Label Extension Phase|Death|0
860827|NCT01497899|2839585|P1|Open-Label Extension Phase|Death|1
860828|NCT01497899|2839582|P4|Open-Label Extension Phase|Adverse Event|0
860829|NCT01497899|2839583|P3|Open-Label Extension Phase|Adverse Event|0
860830|NCT01497899|2839584|P2|Open-Label Extension Phase|Adverse Event|0
860831|NCT01497899|2839585|P1|Open-Label Extension Phase|Adverse Event|1
860832|NCT01497899|2839582|P4|Double-Blind Phase|Subject Non-Compliance|0
860833|NCT01497899|2839583|P3|Double-Blind Phase|Subject Non-Compliance|0
860834|NCT01497899|2839584|P2|Double-Blind Phase|Subject Non-Compliance|1
860835|NCT01497899|2839585|P1|Double-Blind Phase|Subject Non-Compliance|0
860836|NCT01497899|2839582|P4|Double-Blind Phase|Lost to Follow-up|0
860837|NCT01497899|2839583|P3|Double-Blind Phase|Lost to Follow-up|0
860838|NCT01497899|2839584|P2|Double-Blind Phase|Lost to Follow-up|2
860839|NCT01497899|2839585|P1|Double-Blind Phase|Lost to Follow-up|3
860840|NCT01497899|2839582|P4|Double-Blind Phase|Withdrew Consent|0
860841|NCT01497899|2839583|P3|Double-Blind Phase|Withdrew Consent|0
860842|NCT01497899|2839584|P2|Double-Blind Phase|Withdrew Consent|1
860843|NCT01497899|2839585|P1|Double-Blind Phase|Withdrew Consent|0
860844|NCT01497899|2839582|P4|Double-Blind Phase|Investigator's Discretion|0
860845|NCT01497899|2839583|P3|Double-Blind Phase|Investigator's Discretion|0
860846|NCT01497899|2839584|P2|Double-Blind Phase|Investigator's Discretion|0
860847|NCT01497899|2839585|P1|Double-Blind Phase|Investigator's Discretion|1
860848|NCT01497899|2839582|P4|Double-Blind Phase|Lack of Efficacy|0
860849|NCT01497899|2839583|P3|Double-Blind Phase|Lack of Efficacy|0
860850|NCT01497899|2839584|P2|Double-Blind Phase|Lack of Efficacy|1
860851|NCT01497899|2839585|P1|Double-Blind Phase|Lack of Efficacy|0
860852|NCT01497899|2839582|P4|Double-Blind Phase|Adverse Event|0
860853|NCT01497899|2839583|P3|Double-Blind Phase|Adverse Event|0
860854|NCT01497899|2839584|P2|Double-Blind Phase|Adverse Event|0
860855|NCT01497899|2839585|P1|Double-Blind Phase|Adverse Event|1
860856|NCT01497899|2839582|P4|Double-Blind Phase|Randomized but not Treated|0
860857|NCT01497899|2839583|P3|Double-Blind Phase|Randomized but not Treated|0
860858|NCT01497899|2839584|P2|Double-Blind Phase|Randomized but not Treated|0
860859|NCT01497899|2839585|P1|Double-Blind Phase|Randomized but not Treated|1
860860|NCT01497366|2839652|P2|Overall Study|Randomized but not treated|21
860861|NCT01497366|2839653|P1|Overall Study|Randomized but not treated|7
860862|NCT01497366|2839652|P2|Overall Study|Death|1
860863|NCT01497366|2839653|P1|Overall Study|Death|1
860864|NCT01497366|2839652|P2|Overall Study|Other|0
860865|NCT01497366|2839653|P1|Overall Study|Other|5
860866|NCT01497366|2839652|P2|Overall Study|Initiated Non-protocol HCV Treatment|0
860867|NCT01497366|2839653|P1|Overall Study|Initiated Non-protocol HCV Treatment|7
860868|NCT01497366|2839652|P2|Overall Study|Withdrawal by Subject|6
860869|NCT01497366|2839653|P1|Overall Study|Withdrawal by Subject|6
860870|NCT01497366|2839652|P2|Overall Study|Lost to Follow-up|10
860871|NCT01497366|2839653|P1|Overall Study|Lost to Follow-up|11
860872|NCT01497366|2839652|P2|Overall Study|Virologic failure|50
860873|NCT01497366|2839653|P1|Overall Study|Virologic failure|2
860874|NCT01497275|2839671|P1|Overall Study|Adverse Event|1
860875|NCT01497275|2839671|P1|Overall Study|Death|1
860876|NCT01497262|2839678|P1|Overall Study|Protocol Violation|1
860877|NCT01497262|2839678|P1|Overall Study|Adverse Event|2
860878|NCT01497262|2839678|P1|Overall Study|Withdrawal by Subject|2
860879|NCT01497262|2839678|P1|Overall Study|Physician Decision|1
860880|NCT01497262|2839678|P1|Overall Study|Abnormal Test Procedure Result|1
860881|NCT01497262|2839678|P1|Overall Study|Abnormal Lab Values|4
860882|NCT01497197|2839685|P2|Overall Study|Other|1
860883|NCT01497197|2839686|P1|Overall Study|Other|3
860884|NCT01497197|2839685|P2|Overall Study|All embryos discarded|3
860885|NCT01497197|2839686|P1|Overall Study|All embryos discarded|0
860886|NCT01497197|2839685|P2|Overall Study|Intention to freeze all embryos|1
860887|NCT01497197|2839686|P1|Overall Study|Intention to freeze all embryos|0
860888|NCT01497197|2839685|P2|Overall Study|No fertilisation|5
860889|NCT01497197|2839686|P1|Overall Study|No fertilisation|6
860890|NCT01497197|2839685|P2|Overall Study|No oocytes retrieved|2
860891|NCT01497197|2839686|P1|Overall Study|No oocytes retrieved|3
860892|NCT01497197|2839685|P2|Overall Study|Risk of OHSS|0
860893|NCT01497197|2839686|P1|Overall Study|Risk of OHSS|1
860894|NCT01497197|2839685|P2|Overall Study|Excessive/lack of response to treatment|0
860895|NCT01497197|2839686|P1|Overall Study|Excessive/lack of response to treatment|1
860896|NCT01497197|2839685|P2|Overall Study|Withdrawal by Subject|1
860897|NCT01497197|2839686|P1|Overall Study|Withdrawal by Subject|2
860898|NCT01497197|2839685|P2|Overall Study|Protocol Violation|2
860899|NCT01497197|2839686|P1|Overall Study|Protocol Violation|0
860900|NCT01497197|2839685|P2|Overall Study|Lost to Follow-up|0
860901|NCT01497197|2839686|P1|Overall Study|Lost to Follow-up|1
860902|NCT01496846|2839727|P6|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
860903|NCT01496846|2839728|P5|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
860904|NCT01496846|2839729|P4|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
860905|NCT01496846|2839730|P3|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
860906|NCT01496846|2839731|P2|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
860907|NCT01496846|2839732|P1|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
860908|NCT01496807|2839743|P1|Overall Study|Change in diagnosis|1
860909|NCT01496807|2839743|P1|Overall Study|Participant preference/toxicity|8
860910|NCT01496807|2839743|P1|Overall Study|Progressive Disease|21
860911|NCT01496469|2839755|P2|Overall Study|Other|1
860912|NCT01496469|2839756|P1|Overall Study|Other|1
860913|NCT01496469|2839755|P2|Overall Study|BP exceeds protocol limits|2
860914|NCT01496469|2839756|P1|Overall Study|BP exceeds protocol limits|1
860915|NCT01496469|2839755|P2|Overall Study|Withdrawal by Subject|4
860916|NCT01496469|2839756|P1|Overall Study|Withdrawal by Subject|4
860917|NCT01496469|2839755|P2|Overall Study|Lost to Follow-up|1
860918|NCT01496469|2839756|P1|Overall Study|Lost to Follow-up|1
860919|NCT01496469|2839755|P2|Overall Study|Protocol Violation|0
860920|NCT01496469|2839756|P1|Overall Study|Protocol Violation|2
860921|NCT01496469|2839755|P2|Overall Study|Adverse Event|0
860922|NCT01496469|2839756|P1|Overall Study|Adverse Event|1
860923|NCT01496456|2839766|P1|Overall Study|Lost to Follow-up|7
860924|NCT01496456|2839766|P1|Overall Study|Protocol Violation|1
860925|NCT01496430|2839779|P3|Overall Study|Other|0
860926|NCT01496430|2839780|P2|Overall Study|Other|0
860927|NCT01496430|2839781|P1|Overall Study|Other|2
860928|NCT01496430|2839779|P3|Overall Study|Principal Investigator Discretion|1
860929|NCT01496430|2839780|P2|Overall Study|Principal Investigator Discretion|1
860930|NCT01496430|2839781|P1|Overall Study|Principal Investigator Discretion|0
860931|NCT01496430|2839779|P3|Overall Study|Voluntary Withdrawal|6
860932|NCT01496430|2839780|P2|Overall Study|Voluntary Withdrawal|1
860933|NCT01496430|2839781|P1|Overall Study|Voluntary Withdrawal|2
860934|NCT01496430|2839779|P3|Overall Study|Lost to Follow-up|1
860935|NCT01496430|2839780|P2|Overall Study|Lost to Follow-up|3
860936|NCT01496430|2839781|P1|Overall Study|Lost to Follow-up|2
860937|NCT01496430|2839779|P3|Overall Study|Major Protocol Deviation|1
860938|NCT01496430|2839780|P2|Overall Study|Major Protocol Deviation|0
860939|NCT01496430|2839781|P1|Overall Study|Major Protocol Deviation|0
860940|NCT01496430|2839779|P3|Overall Study|Adverse Event|1
860941|NCT01496430|2839780|P2|Overall Study|Adverse Event|0
860942|NCT01496430|2839781|P1|Overall Study|Adverse Event|0
860943|NCT01496287|2839893|P1|Overall Study|Incomplete anesthesia|5
860944|NCT01496287|2839893|P1|Overall Study|Lost to Follow-up|1
860945|NCT01496274|2839903|P2|Overall Study|Lost to Follow-up|3
860946|NCT01496274|2839904|P1|Overall Study|Lost to Follow-up|0
860947|NCT01496274|2839903|P2|Overall Study|Withdrawal by Subject|0
860948|NCT01496274|2839904|P1|Overall Study|Withdrawal by Subject|2
860949|NCT01496274|2839903|P2|Overall Study|Adverse Event|1
860950|NCT01496274|2839904|P1|Overall Study|Adverse Event|1
860951|NCT01496274|2839903|P2|Overall Study|Protocol Violation|1
860952|NCT01496274|2839904|P1|Overall Study|Protocol Violation|0
860953|NCT01496183|2839949|P2|Overall Study|Withdrawal by Subject|1
860954|NCT01496183|2839950|P1|Overall Study|Withdrawal by Subject|0
860955|NCT01496183|2839949|P2|Overall Study|Physician Decision|1
860956|NCT01496183|2839950|P1|Overall Study|Physician Decision|3
860957|NCT01496066|2840002|P2|Overall Study|Death|4
860958|NCT01496066|2840003|P1|Overall Study|Death|1
860959|NCT01496066|2840002|P2|Overall Study|Explant|0
860960|NCT01496066|2840003|P1|Overall Study|Explant|3
860961|NCT01496066|2840002|P2|Overall Study|Lost to Follow-up|5
860962|NCT01496066|2840003|P1|Overall Study|Lost to Follow-up|8
860963|NCT01495975|2840065|P2|Overall Study|Lost to Follow-up|0
860964|NCT01495975|2840066|P1|Overall Study|Lost to Follow-up|1
860965|NCT01495793|2840190|P1|Overall Study|Violation of inclusion criteria|1
860966|NCT01495793|2840190|P1|Overall Study|Lost to Follow-up|1
860967|NCT01495702|2840203|P2|Randomized Phase|Protocol Violation|1
860968|NCT01495702|2840204|P1|Randomized Phase|Protocol Violation|3
860969|NCT01495702|2840203|P2|Randomized Phase|Participant Noncompliance|0
860970|NCT01495702|2840204|P1|Randomized Phase|Participant Noncompliance|1
860971|NCT01495702|2840203|P2|Randomized Phase|Lost to Follow-up|3
860972|NCT01495702|2840204|P1|Randomized Phase|Lost to Follow-up|4
860973|NCT01495702|2840203|P2|Randomized Phase|Withdrew Consent|18
860974|NCT01495702|2840204|P1|Randomized Phase|Withdrew Consent|10
860975|NCT01495702|2840203|P2|Randomized Phase|Investigators Discretion|0
860976|NCT01495702|2840204|P1|Randomized Phase|Investigators Discretion|2
860977|NCT01495702|2840203|P2|Randomized Phase|Lack of Efficacy|0
860978|NCT01495702|2840204|P1|Randomized Phase|Lack of Efficacy|2
860979|NCT01495702|2840203|P2|Randomized Phase|Death|0
860980|NCT01495702|2840204|P1|Randomized Phase|Death|1
860981|NCT01495702|2840203|P2|Randomized Phase|Adverse Event|2
860982|NCT01495702|2840204|P1|Randomized Phase|Adverse Event|2
860983|NCT01495702|2840203|P2|Randomized Phase|Randomized But Not Treated|4
860984|NCT01495702|2840204|P1|Randomized Phase|Randomized But Not Treated|1
860985|NCT01495000|2840282|P2|Overall Study|Withdrawal by Subject|10
860986|NCT01495000|2840283|P1|Overall Study|Withdrawal by Subject|10
860987|NCT01495000|2840282|P2|Overall Study|Protocol Violation|0
860988|NCT01495000|2840283|P1|Overall Study|Protocol Violation|1
860989|NCT01495000|2840282|P2|Overall Study|Lost to Follow-up|2
860990|NCT01495000|2840283|P1|Overall Study|Lost to Follow-up|2
860991|NCT01494987|2840325|P2|Overall Study|Subject Withdrew Consent|3
860992|NCT01494987|2840326|P1|Overall Study|Subject Withdrew Consent|2
860993|NCT01494987|2840325|P2|Overall Study|Subject Non-Compliance|10
860994|NCT01494987|2840326|P1|Overall Study|Subject Non-Compliance|9
860995|NCT01494987|2840325|P2|Overall Study|Protocol Violation|3
860996|NCT01494987|2840326|P1|Overall Study|Protocol Violation|3
860997|NCT01494987|2840325|P2|Overall Study|Lost to Follow-up|1
860998|NCT01494987|2840326|P1|Overall Study|Lost to Follow-up|1
860999|NCT01494987|2840325|P2|Overall Study|Investigator's Discretion|2
861000|NCT01494987|2840326|P1|Overall Study|Investigator's Discretion|1
861001|NCT01494987|2840325|P2|Overall Study|Hyperglycemia|4
861002|NCT01494987|2840326|P1|Overall Study|Hyperglycemia|6
861003|NCT01494987|2840325|P2|Overall Study|Adverse Event|5
861004|NCT01494987|2840326|P1|Overall Study|Adverse Event|6
861005|NCT01494818|2840340|P2|Overall Study|Lost to Follow-up|0
861006|NCT01494818|2840341|P1|Overall Study|Lost to Follow-up|1
861007|NCT01494818|2840340|P2|Overall Study|Relocation|2
861008|NCT01494818|2840341|P1|Overall Study|Relocation|1
861009|NCT01494649|2840372|P2|Overall Study|Lost to Follow-up|1
861010|NCT01494649|2840373|P1|Overall Study|Lost to Follow-up|0
861011|NCT01494610|2840389|P2|Period 4|Protocol Violation|0
861012|NCT01494610|2840390|P1|Period 4|Protocol Violation|1
861013|NCT01494610|2840389|P2|Period 3|Withdrawal by Subject|0
861014|NCT01494610|2840390|P1|Period 3|Withdrawal by Subject|1
861015|NCT01494610|2840389|P2|Period 3|Adverse Event|0
861016|NCT01494610|2840390|P1|Period 3|Adverse Event|1
861017|NCT01494610|2840389|P2|Period 1|Withdrawal by Subject|1
861018|NCT01494610|2840390|P1|Period 1|Withdrawal by Subject|1
861019|NCT01494584|2840458|P1|Overall Study|Study Closed/Terminated|1
861020|NCT01494532|2840590|P6|Overall Study|Withdrawal by Subject|0
861021|NCT01494532|2840591|P5|Overall Study|Withdrawal by Subject|2
861022|NCT01494532|2840592|P4|Overall Study|Withdrawal by Subject|3
861023|NCT01494532|2840593|P3|Overall Study|Withdrawal by Subject|4
861024|NCT01494532|2840594|P2|Overall Study|Withdrawal by Subject|1
861025|NCT01494532|2840595|P1|Overall Study|Withdrawal by Subject|3
861026|NCT01494532|2840590|P6|Overall Study|Physician Decision|0
861027|NCT01494532|2840591|P5|Overall Study|Physician Decision|0
861028|NCT01494532|2840592|P4|Overall Study|Physician Decision|2
861029|NCT01494532|2840593|P3|Overall Study|Physician Decision|1
861030|NCT01494532|2840594|P2|Overall Study|Physician Decision|1
861031|NCT01494532|2840595|P1|Overall Study|Physician Decision|0
861032|NCT01494532|2840590|P6|Overall Study|Lost to Follow-up|0
861033|NCT01494532|2840591|P5|Overall Study|Lost to Follow-up|0
861034|NCT01494532|2840592|P4|Overall Study|Lost to Follow-up|2
861035|NCT01494532|2840593|P3|Overall Study|Lost to Follow-up|0
861036|NCT01494532|2840594|P2|Overall Study|Lost to Follow-up|0
861037|NCT01494532|2840595|P1|Overall Study|Lost to Follow-up|1
861038|NCT01494532|2840590|P6|Overall Study|Protocol-defined stopping criteria|0
861039|NCT01494532|2840591|P5|Overall Study|Protocol-defined stopping criteria|0
861040|NCT01494532|2840592|P4|Overall Study|Protocol-defined stopping criteria|0
861041|NCT01494532|2840593|P3|Overall Study|Protocol-defined stopping criteria|1
861042|NCT01494532|2840594|P2|Overall Study|Protocol-defined stopping criteria|0
861043|NCT01494532|2840595|P1|Overall Study|Protocol-defined stopping criteria|0
861044|NCT01494532|2840590|P6|Overall Study|Protocol deviation|0
861045|NCT01494532|2840591|P5|Overall Study|Protocol deviation|3
861046|NCT01494532|2840592|P4|Overall Study|Protocol deviation|2
861047|NCT01494532|2840593|P3|Overall Study|Protocol deviation|3
861048|NCT01494532|2840594|P2|Overall Study|Protocol deviation|1
861049|NCT01494532|2840595|P1|Overall Study|Protocol deviation|2
861050|NCT01494532|2840590|P6|Overall Study|Lack of Efficacy|0
861051|NCT01494532|2840591|P5|Overall Study|Lack of Efficacy|2
861052|NCT01494532|2840592|P4|Overall Study|Lack of Efficacy|0
861053|NCT01494532|2840593|P3|Overall Study|Lack of Efficacy|0
861054|NCT01494532|2840594|P2|Overall Study|Lack of Efficacy|0
861055|NCT01494532|2840595|P1|Overall Study|Lack of Efficacy|0
861056|NCT01494532|2840590|P6|Overall Study|Adverse Event|0
861057|NCT01494532|2840591|P5|Overall Study|Adverse Event|5
861058|NCT01494532|2840592|P4|Overall Study|Adverse Event|6
861059|NCT01494532|2840593|P3|Overall Study|Adverse Event|8
861060|NCT01494532|2840594|P2|Overall Study|Adverse Event|1
861061|NCT01494532|2840595|P1|Overall Study|Adverse Event|4
861062|NCT01494506|2840750|P3|Overall Study|Other|1
861063|NCT01494506|2840751|P2|Overall Study|Other|3
861064|NCT01494506|2840752|P1|Overall Study|Other|0
861065|NCT01494506|2840750|P3|Overall Study|Sponsor Decision|1
861066|NCT01494506|2840751|P2|Overall Study|Sponsor Decision|0
861067|NCT01494506|2840752|P1|Overall Study|Sponsor Decision|0
861068|NCT01494506|2840750|P3|Overall Study|Clinical Deterioration|13
861069|NCT01494506|2840751|P2|Overall Study|Clinical Deterioration|17
861070|NCT01494506|2840752|P1|Overall Study|Clinical Deterioration|21
861071|NCT01494506|2840750|P3|Overall Study|Withdrawal by Subject|14
861072|NCT01494506|2840751|P2|Overall Study|Withdrawal by Subject|20
861073|NCT01494506|2840752|P1|Overall Study|Withdrawal by Subject|17
861074|NCT01494506|2840750|P3|Overall Study|Physician Decision|4
861075|NCT01494506|2840751|P2|Overall Study|Physician Decision|5
861076|NCT01494506|2840752|P1|Overall Study|Physician Decision|7
861077|NCT01494506|2840750|P3|Overall Study|Death|2
861078|NCT01494506|2840751|P2|Overall Study|Death|5
861079|NCT01494506|2840752|P1|Overall Study|Death|9
861080|NCT01494506|2840750|P3|Overall Study|Adverse Event|11
861081|NCT01494506|2840751|P2|Overall Study|Adverse Event|10
861082|NCT01494506|2840752|P1|Overall Study|Adverse Event|17
861083|NCT01494506|2840750|P3|Overall Study|Lack of Efficacy|57
861084|NCT01494506|2840751|P2|Overall Study|Lack of Efficacy|83
861085|NCT01494506|2840752|P1|Overall Study|Lack of Efficacy|77
861086|NCT01494467|2840789|P2|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2
861087|NCT01494467|2840790|P1|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8
861088|NCT01494467|2840789|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
861089|NCT01494467|2840790|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26
861090|NCT01494467|2840789|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|5
861091|NCT01494467|2840790|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|3
861092|NCT01494467|2840789|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24
861093|NCT01494467|2840790|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32
861094|NCT01494467|2840789|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|5
861095|NCT01494467|2840790|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|3
861096|NCT01494467|2840789|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
861097|NCT01494467|2840790|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1
861098|NCT01494467|2840789|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|0
861099|NCT01494467|2840790|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|2
861100|NCT01494467|2840789|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
861101|NCT01494467|2840790|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
861102|NCT01494467|2840789|P2|Part A Vehicle Control (12 Weeks)|Other|1
861103|NCT01494467|2840790|P1|Part A Vehicle Control (12 Weeks)|Other|1
861104|NCT01494467|2840789|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
861105|NCT01494467|2840790|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
861106|NCT01494467|2840789|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|0
861107|NCT01494467|2840790|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|4
861108|NCT01494467|2840789|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8
861109|NCT01494467|2840790|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9
861110|NCT01494467|2840789|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
861111|NCT01494467|2840790|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|6
861112|NCT01494467|2840789|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
861113|NCT01494467|2840790|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|1
861114|NCT01494350|2840806|P1|Overall Study|Worsening of lesion|1
861115|NCT01494298|2840816|P2|Overall Study|Protocol Violation|8
861116|NCT01494298|2840817|P1|Overall Study|Protocol Violation|2
861117|NCT01494038|2840829|P2|Overall Study|Death|4
861118|NCT01494038|2840830|P1|Overall Study|Death|2
861119|NCT01494038|2840829|P2|Overall Study|Not willing to adhere to reqs|9
861120|NCT01494038|2840830|P1|Overall Study|Not willing to adhere to reqs|2
861121|NCT01494038|2840829|P2|Overall Study|Not able to get to clinic|15
861122|NCT01494038|2840830|P1|Overall Study|Not able to get to clinic|21
861123|NCT01494038|2840829|P2|Overall Study|Withdrawal by Subject|34
861124|NCT01494038|2840830|P1|Overall Study|Withdrawal by Subject|44
861125|NCT01494038|2840829|P2|Overall Study|Lost to Follow-up|20
861126|NCT01494038|2840830|P1|Overall Study|Lost to Follow-up|18
861127|NCT01494038|2840829|P2|Overall Study|Protocol Violation|1
861128|NCT01494038|2840830|P1|Overall Study|Protocol Violation|1
861129|NCT01493960|2840918|P2|Overall Study|Non-specified|4
861130|NCT01493960|2840919|P1|Overall Study|Non-specified|4
861131|NCT01493960|2840918|P2|Overall Study|Withdrawal by Subject|4
861132|NCT01493960|2840919|P1|Overall Study|Withdrawal by Subject|10
861133|NCT01493960|2840918|P2|Overall Study|Protocol Violation|0
861134|NCT01493960|2840919|P1|Overall Study|Protocol Violation|3
861135|NCT01493960|2840918|P2|Overall Study|Lack of Efficacy|9
861136|NCT01493960|2840919|P1|Overall Study|Lack of Efficacy|15
861137|NCT01493960|2840918|P2|Overall Study|Adverse Event|1
861138|NCT01493960|2840919|P1|Overall Study|Adverse Event|0
861139|NCT01493778|2840950|P1|Overall Study|treatment ongoing|1
861140|NCT01493778|2840950|P1|Overall Study|unclassified|2
861141|NCT01493687|2840978|P2|Part C Safety Follow up (4 Weeks)|Adverse Event|1
861142|NCT01493687|2840979|P1|Part C Safety Follow up (4 Weeks)|Adverse Event|0
861143|NCT01493687|2840978|P2|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1
861144|NCT01493687|2840979|P1|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5
861145|NCT01493687|2840978|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
861146|NCT01493687|2840979|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16
861147|NCT01493687|2840978|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|0
861148|NCT01493687|2840979|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|1
861149|NCT01493687|2840978|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16
861150|NCT01493687|2840979|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27
861151|NCT01493687|2840978|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|4
861152|NCT01493687|2840979|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|5
861153|NCT01493687|2840978|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
861154|NCT01493687|2840979|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2
861155|NCT01493687|2840978|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|1
861156|NCT01493687|2840979|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|5
861157|NCT01493687|2840978|P2|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
861158|NCT01493687|2840979|P1|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
861159|NCT01493687|2840978|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
861160|NCT01493687|2840979|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7
861161|NCT01493687|2840978|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|1
861162|NCT01493687|2840979|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|2
861163|NCT01493687|2840978|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7
861164|NCT01493687|2840979|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18
861165|NCT01493687|2840978|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
861166|NCT01493687|2840979|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|7
861167|NCT01493687|2840978|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
861168|NCT01493687|2840979|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
861169|NCT01493687|2840978|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
861170|NCT01493687|2840979|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|2
861171|NCT01493557|2840998|P3|Adding the Second Strategy|Withdrawal by Subject|0
861172|NCT01493557|2840999|P2|Adding the Second Strategy|Withdrawal by Subject|1
861173|NCT01493557|2841000|P1|Adding the Second Strategy|Withdrawal by Subject|0
861174|NCT01493557|2840998|P3|Adding the Second Strategy|Other adverse event|0
861175|NCT01493557|2840999|P2|Adding the Second Strategy|Other adverse event|2
861176|NCT01493557|2841000|P1|Adding the Second Strategy|Other adverse event|1
861177|NCT01493557|2840998|P3|Adding the Second Strategy|Worsening of events associate with GIS|0
861178|NCT01493557|2840999|P2|Adding the Second Strategy|Worsening of events associate with GIS|1
861179|NCT01493557|2841000|P1|Adding the Second Strategy|Worsening of events associate with GIS|1
861180|NCT01493557|2840998|P3|Randomized to Management Strategies|Other than stated above|0
861181|NCT01493557|2840999|P2|Randomized to Management Strategies|Other than stated above|3
861182|NCT01493557|2841000|P1|Randomized to Management Strategies|Other than stated above|1
861183|NCT01493557|2840998|P3|Randomized to Management Strategies|Withdrawal by Subject|0
861184|NCT01493557|2840999|P2|Randomized to Management Strategies|Withdrawal by Subject|1
861185|NCT01493557|2841000|P1|Randomized to Management Strategies|Withdrawal by Subject|0
861186|NCT01493557|2840998|P3|Randomized to Management Strategies|Protocol Violation|0
861187|NCT01493557|2840999|P2|Randomized to Management Strategies|Protocol Violation|0
861188|NCT01493557|2841000|P1|Randomized to Management Strategies|Protocol Violation|3
861189|NCT01493557|2840998|P3|Randomized to Management Strategies|Other adverse event|0
861190|NCT01493557|2840999|P2|Randomized to Management Strategies|Other adverse event|5
861191|NCT01493557|2841000|P1|Randomized to Management Strategies|Other adverse event|8
861192|NCT01493557|2840998|P3|Randomized to Management Strategies|Worsening of events associate with GIS|0
861193|NCT01493557|2840999|P2|Randomized to Management Strategies|Worsening of events associate with GIS|2
861194|NCT01493557|2841000|P1|Randomized to Management Strategies|Worsening of events associate with GIS|3
861195|NCT01493557|2840998|P3|Not Randomized to Management Strategies|Other than stated above|21
861196|NCT01493557|2840999|P2|Not Randomized to Management Strategies|Other than stated above|0
861197|NCT01493557|2841000|P1|Not Randomized to Management Strategies|Other than stated above|0
861198|NCT01493557|2840998|P3|Not Randomized to Management Strategies|Early termination|34
861199|NCT01493557|2840999|P2|Not Randomized to Management Strategies|Early termination|0
861200|NCT01493557|2841000|P1|Not Randomized to Management Strategies|Early termination|0
861201|NCT01493557|2840998|P3|Not Randomized to Management Strategies|Withdrawal by Subject|10
861202|NCT01493557|2840999|P2|Not Randomized to Management Strategies|Withdrawal by Subject|0
861203|NCT01493557|2841000|P1|Not Randomized to Management Strategies|Withdrawal by Subject|0
861204|NCT01493557|2840998|P3|Not Randomized to Management Strategies|Lost to Follow-up|4
861205|NCT01493557|2840999|P2|Not Randomized to Management Strategies|Lost to Follow-up|0
861206|NCT01493557|2841000|P1|Not Randomized to Management Strategies|Lost to Follow-up|0
861207|NCT01493557|2840998|P3|Not Randomized to Management Strategies|Protocol Violation|1
861208|NCT01493557|2840999|P2|Not Randomized to Management Strategies|Protocol Violation|0
861209|NCT01493557|2841000|P1|Not Randomized to Management Strategies|Protocol Violation|0
861210|NCT01493557|2840998|P3|Not Randomized to Management Strategies|Other adverse event|54
861211|NCT01493557|2840999|P2|Not Randomized to Management Strategies|Other adverse event|0
861212|NCT01493557|2841000|P1|Not Randomized to Management Strategies|Other adverse event|0
861213|NCT01493557|2840998|P3|Not Randomized to Management Strategies|Worsening of other pre−existing disease|9
861214|NCT01493557|2840999|P2|Not Randomized to Management Strategies|Worsening of other pre−existing disease|0
861215|NCT01493557|2841000|P1|Not Randomized to Management Strategies|Worsening of other pre−existing disease|0
861216|NCT01493557|2840998|P3|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1
861217|NCT01493557|2840999|P2|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
861218|NCT01493557|2841000|P1|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
861219|NCT01493531|2841028|P3|Overall Study|Death|0
861220|NCT01493531|2841029|P2|Overall Study|Death|1
861221|NCT01493531|2841030|P1|Overall Study|Death|0
861222|NCT01493531|2841028|P3|Overall Study|Withdrawal by Subject|11
861223|NCT01493531|2841029|P2|Overall Study|Withdrawal by Subject|13
861224|NCT01493531|2841030|P1|Overall Study|Withdrawal by Subject|16
861225|NCT01493531|2841028|P3|Overall Study|Lost to Follow-up|11
861226|NCT01493531|2841029|P2|Overall Study|Lost to Follow-up|7
861227|NCT01493531|2841030|P1|Overall Study|Lost to Follow-up|5
861228|NCT01493531|2841028|P3|Overall Study|Sponsor terminated study|3
861229|NCT01493531|2841029|P2|Overall Study|Sponsor terminated study|2
861230|NCT01493531|2841030|P1|Overall Study|Sponsor terminated study|5
861231|NCT01493531|2841028|P3|Overall Study|Protocol Violation|12
861232|NCT01493531|2841029|P2|Overall Study|Protocol Violation|15
861233|NCT01493531|2841030|P1|Overall Study|Protocol Violation|8
861234|NCT01493531|2841028|P3|Overall Study|Gout flare|2
861235|NCT01493531|2841029|P2|Overall Study|Gout flare|0
861236|NCT01493531|2841030|P1|Overall Study|Gout flare|3
861237|NCT01493531|2841028|P3|Overall Study|Adverse Event|9
861238|NCT01493531|2841029|P2|Overall Study|Adverse Event|12
861239|NCT01493531|2841030|P1|Overall Study|Adverse Event|4
861240|NCT01493427|2841044|P1|Overall Study|Other|2
861241|NCT01493427|2841044|P1|Overall Study|Inability to Follow Instructions|2
861242|NCT01493427|2841044|P1|Overall Study|Lost to Follow-up|2
861243|NCT01493427|2841044|P1|Overall Study|Personal Reasons|4
861244|NCT01493427|2841044|P1|Overall Study|Adverse Event|10
861245|NCT01493284|2841049|P1|Overall Study|Withdrawal by Subject|32
861246|NCT01493284|2841049|P1|Overall Study|Death|29
861247|NCT01493089|2841071|P2|Overall Study|Physician Decision|1
861248|NCT01493089|2841072|P1|Overall Study|Physician Decision|0
861249|NCT01493089|2841071|P2|Overall Study|Withdrawal by Subject|0
861250|NCT01493089|2841072|P1|Overall Study|Withdrawal by Subject|1
861251|NCT01493089|2841071|P2|Overall Study|Protocol Violation|2
861252|NCT01493089|2841072|P1|Overall Study|Protocol Violation|2
861253|NCT01492439|2841171|P2|Overall Study|Withdrew from RTE|9
861254|NCT01492439|2841172|P1|Overall Study|Withdrew from RTE|4
861255|NCT01492426|2841220|P2|Follow-Up|Lost to Follow-up|6
861256|NCT01492426|2841221|P1|Follow-Up|Lost to Follow-up|12
861257|NCT01492426|2841220|P2|Follow-Up|Participant Withdrew Consent|1
861258|NCT01492426|2841221|P1|Follow-Up|Participant Withdrew Consent|6
861259|NCT01492426|2841220|P2|Follow-Up|Other|2
861260|NCT01492426|2841221|P1|Follow-Up|Other|4
861261|NCT01492426|2841220|P2|Follow-Up|Death|0
861262|NCT01492426|2841221|P1|Follow-Up|Death|1
861263|NCT01492426|2841220|P2|Follow-Up|Protocol Requires no Follow-Up|1
861264|NCT01492426|2841221|P1|Follow-Up|Protocol Requires no Follow-Up|2
861265|NCT01492426|2841220|P2|Treatment|Participant does not meet study criteria|0
861266|NCT01492426|2841221|P1|Treatment|Participant does not meet study criteria|1
861267|NCT01492426|2841220|P2|Treatment|Lost to Follow-up|4
861268|NCT01492426|2841221|P1|Treatment|Lost to Follow-up|9
861269|NCT01492426|2841220|P2|Treatment|Subject requested discontinue study drug|3
861270|NCT01492426|2841221|P1|Treatment|Subject requested discontinue study drug|7
861271|NCT01492426|2841220|P2|Treatment|Poor compliance/noncompliance|0
861272|NCT01492426|2841221|P1|Treatment|Poor compliance/noncompliance|1
861273|NCT01492426|2841220|P2|Treatment|Participant withdrew consent|2
861274|NCT01492426|2841221|P1|Treatment|Participant withdrew consent|1
861275|NCT01492426|2841220|P2|Treatment|Lack of Efficacy|5
861276|NCT01492426|2841221|P1|Treatment|Lack of Efficacy|38
861277|NCT01492426|2841220|P2|Treatment|Adverse Event|25
861278|NCT01492426|2841221|P1|Treatment|Adverse Event|25
861279|NCT01492426|2841220|P2|Treatment|Other|0
861280|NCT01492426|2841221|P1|Treatment|Other|1
861281|NCT01492426|2841220|P2|Treatment|Death|1
861282|NCT01492426|2841221|P1|Treatment|Death|0
861283|NCT01492400|2841239|P2|Overall Study|Adverse Event|5
861284|NCT01492400|2841240|P1|Overall Study|Adverse Event|10
861285|NCT01492400|2841239|P2|Overall Study|Lack of Efficacy|1
861286|NCT01492400|2841240|P1|Overall Study|Lack of Efficacy|1
861287|NCT01492400|2841239|P2|Overall Study|Pregnancy|1
861288|NCT01492400|2841240|P1|Overall Study|Pregnancy|0
861289|NCT01492400|2841239|P2|Overall Study|Lost to Follow-up|1
861290|NCT01492400|2841240|P1|Overall Study|Lost to Follow-up|3
861291|NCT01492400|2841239|P2|Overall Study|Personal Reasons|5
861292|NCT01492400|2841240|P1|Overall Study|Personal Reasons|0
861293|NCT01492400|2841239|P2|Overall Study|Miscellaneous Reasons|3
861294|NCT01492400|2841240|P1|Overall Study|Miscellaneous Reasons|2
861295|NCT01492088|2841264|P3|Overall Study|Alive at Last Follow-up|11
861296|NCT01492088|2841265|P2|Overall Study|Alive at Last Follow-up|6
861297|NCT01492088|2841266|P1|Overall Study|Alive at Last Follow-up|0
861298|NCT01492088|2841264|P3|Overall Study|Completed Post Treatment Followup (PTFU)|1
861299|NCT01492088|2841265|P2|Overall Study|Completed Post Treatment Followup (PTFU)|0
861300|NCT01492088|2841266|P1|Overall Study|Completed Post Treatment Followup (PTFU)|2
861301|NCT01492088|2841264|P3|Overall Study|Death|2
861302|NCT01492088|2841265|P2|Overall Study|Death|6
861303|NCT01492088|2841266|P1|Overall Study|Death|1
861304|NCT01492088|2841264|P3|Overall Study|Withdrawal by Patient|0
861305|NCT01492088|2841265|P2|Overall Study|Withdrawal by Patient|2
861306|NCT01492088|2841266|P1|Overall Study|Withdrawal by Patient|0
861307|NCT01491919|2841347|P3|Overall Study|Insufficient PK sampling|1
861308|NCT01491919|2841348|P2|Overall Study|Insufficient PK sampling|2
861309|NCT01491919|2841349|P1|Overall Study|Insufficient PK sampling|1
861310|NCT01491802|2841420|P2|Overall Study|Withdrawal by Subject|1
861311|NCT01491802|2841421|P1|Overall Study|Withdrawal by Subject|0
861312|NCT01491802|2841420|P2|Overall Study|Adverse Event|1
861313|NCT01491802|2841421|P1|Overall Study|Adverse Event|1
861314|NCT01491737|2841448|P2|Overall Study|Reason not specified|3
861315|NCT01491737|2841449|P1|Overall Study|Reason not specified|2
861316|NCT01491737|2841448|P2|Overall Study|Death|28
861317|NCT01491737|2841449|P1|Overall Study|Death|33
861318|NCT01491737|2841448|P2|Overall Study|Lost to Follow-up|6
861319|NCT01491737|2841449|P1|Overall Study|Lost to Follow-up|1
861320|NCT01491737|2841448|P2|Overall Study|Withdrawal of consent|13
861321|NCT01491737|2841449|P1|Overall Study|Withdrawal of consent|13
861322|NCT01491672|2841472|P3|Overall Study|Death|0
861323|NCT01491672|2841473|P2|Overall Study|Death|4
861324|NCT01491672|2841474|P1|Overall Study|Death|0
861325|NCT01491672|2841472|P3|Overall Study|Protocol deviation|0
861326|NCT01491672|2841473|P2|Overall Study|Protocol deviation|1
861327|NCT01491672|2841474|P1|Overall Study|Protocol deviation|0
861328|NCT01491672|2841472|P3|Overall Study|Disease progression|6
861329|NCT01491672|2841473|P2|Overall Study|Disease progression|34
861330|NCT01491672|2841474|P1|Overall Study|Disease progression|42
861331|NCT01491672|2841472|P3|Overall Study|Adverse Event|4
861332|NCT01491672|2841473|P2|Overall Study|Adverse Event|10
861333|NCT01491672|2841474|P1|Overall Study|Adverse Event|8
861334|NCT01491672|2841472|P3|Overall Study|Withdrawal by Subject|0
861335|NCT01491672|2841473|P2|Overall Study|Withdrawal by Subject|7
861336|NCT01491672|2841474|P1|Overall Study|Withdrawal by Subject|6
861337|NCT01491672|2841472|P3|Overall Study|Lost to Follow-up|1
861338|NCT01491672|2841473|P2|Overall Study|Lost to Follow-up|4
861339|NCT01491672|2841474|P1|Overall Study|Lost to Follow-up|0
861340|NCT01491607|2841511|P1|Overall Study|Withdrawal by Subject|3
861341|NCT01491607|2841511|P1|Overall Study|Lost to Follow-up|7
861342|NCT01491178|2841616|P1|Overall Study|Other than specified above|657
861343|NCT01491178|2841616|P1|Overall Study|To take a contraindication|20
861344|NCT01491178|2841616|P1|Overall Study|Lost to follow−up (changing hospital)|545
861345|NCT01491178|2841616|P1|Overall Study|Lost to follow−up (unknown reason)|287
861346|NCT01491178|2841616|P1|Overall Study|To conduct invasive treatment|59
861347|NCT01491178|2841616|P1|Overall Study|Improvement of NVAF|210
861348|NCT01491178|2841616|P1|Overall Study|Adverse Event|1016
861349|NCT01491035|2841725|P8|Overall Study|Lost to Follow-up|0
861350|NCT01491035|2841726|P7|Overall Study|Lost to Follow-up|0
861351|NCT01491035|2841727|P6|Overall Study|Lost to Follow-up|0
861352|NCT01491035|2841728|P5|Overall Study|Lost to Follow-up|1
861353|NCT01491035|2841729|P4|Overall Study|Lost to Follow-up|0
861354|NCT01491035|2841730|P3|Overall Study|Lost to Follow-up|0
861355|NCT01491035|2841731|P2|Overall Study|Lost to Follow-up|0
861356|NCT01491035|2841732|P1|Overall Study|Lost to Follow-up|0
861357|NCT01490866|2841833|P1|Axitinib Maintenance Therapy|Intercurrent illness|2
861358|NCT01490866|2841833|P1|Axitinib Maintenance Therapy|Protocol Violation|2
861359|NCT01490866|2841833|P1|Axitinib Maintenance Therapy|Withdrawal by Subject|3
861360|NCT01490866|2841833|P1|Axitinib Maintenance Therapy|Adverse Event|12
861361|NCT01490866|2841833|P1|Axitinib Maintenance Therapy|Disease Progression|30
861362|NCT01490866|2841833|P1|FOLFOX/Bevacizumab Treatment|Physician Decision|2
861363|NCT01490866|2841833|P1|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1
861364|NCT01490866|2841833|P1|FOLFOX/Bevacizumab Treatment|Protocol Violation|1
861365|NCT01490866|2841833|P1|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5
861366|NCT01490866|2841833|P1|FOLFOX/Bevacizumab Treatment|Adverse Event|6
861367|NCT01490866|2841833|P1|FOLFOX/Bevacizumab Treatment|Disease Progression|6
861368|NCT01490840|2841844|P2|Phase 2|Adverse Event|1
861369|NCT01490840|2841845|P1|Phase 2|Adverse Event|1
861370|NCT01490840|2841844|P2|Phase 2|Lost to Follow-up|1
861371|NCT01490840|2841845|P1|Phase 2|Lost to Follow-up|1
861372|NCT01490840|2841844|P2|Phase 2|Permanent interruption of fingolimod|1
861373|NCT01490840|2841845|P1|Phase 2|Permanent interruption of fingolimod|0
861374|NCT01490840|2841844|P2|Phase 2|Withdrawal by Subject|3
861375|NCT01490840|2841845|P1|Phase 2|Withdrawal by Subject|4
861376|NCT01490840|2841844|P2|Phase 1|Visit 6a omitted|0
861377|NCT01490840|2841845|P1|Phase 1|Visit 6a omitted|1
861378|NCT01490840|2841844|P2|Phase 1|Withdrawal by Subject|5
861379|NCT01490840|2841845|P1|Phase 1|Withdrawal by Subject|6
861380|NCT01490840|2841844|P2|Phase 1|Adverse Event|1
861381|NCT01490840|2841845|P1|Phase 1|Adverse Event|2
861382|NCT01490840|2841844|P2|Phase 1|Lost to Follow-up|0
861383|NCT01490840|2841845|P1|Phase 1|Lost to Follow-up|1
861384|NCT01490814|2841869|P2|Overall Study|Withdrawal by Subject|5
861385|NCT01490814|2841870|P1|Overall Study|Withdrawal by Subject|0
861386|NCT01490814|2841869|P2|Overall Study|Physician Decision|0
861387|NCT01490814|2841870|P1|Overall Study|Physician Decision|1
861388|NCT01490814|2841869|P2|Overall Study|Inclusion/Exclusion Criteria Violation|3
861389|NCT01490814|2841870|P1|Overall Study|Inclusion/Exclusion Criteria Violation|3
861390|NCT01490697|2841908|P2|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2
861391|NCT01490697|2841909|P1|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1
861392|NCT01490632|2841929|P20|Part D: Re-Treatment Period|Withdrawal by Subject|1
861393|NCT01490632|2841930|P19|Part D: Re-Treatment Period|Withdrawal by Subject|1
861394|NCT01490632|2841931|P18|Part D: Re-Treatment Period|Withdrawal by Subject|1
861395|NCT01490632|2841932|P17|Part D: Re-Treatment Period|Withdrawal by Subject|0
861396|NCT01490632|2841933|P16|Part D: Re-Treatment Period|Withdrawal by Subject|0
861397|NCT01490632|2841934|P15|Part D: Re-Treatment Period|Withdrawal by Subject|0
861398|NCT01490632|2841935|P14|Part D: Re-Treatment Period|Withdrawal by Subject|0
861399|NCT01490632|2841936|P13|Part D: Re-Treatment Period|Withdrawal by Subject|0
861400|NCT01490632|2841937|P12|Part D: Re-Treatment Period|Withdrawal by Subject|0
861401|NCT01490632|2841938|P11|Part D: Re-Treatment Period|Withdrawal by Subject|0
861402|NCT01490632|2841939|P10|Part D: Re-Treatment Period|Withdrawal by Subject|0
861403|NCT01490632|2841940|P9|Part D: Re-Treatment Period|Withdrawal by Subject|0
861404|NCT01490632|2841941|P8|Part D: Re-Treatment Period|Withdrawal by Subject|0
861405|NCT01490632|2841942|P7|Part D: Re-Treatment Period|Withdrawal by Subject|0
861406|NCT01490632|2841943|P6|Part D: Re-Treatment Period|Withdrawal by Subject|0
861407|NCT01490632|2841944|P5|Part D: Re-Treatment Period|Withdrawal by Subject|0
861408|NCT01490632|2841945|P4|Part D: Re-Treatment Period|Withdrawal by Subject|0
861409|NCT01490632|2841946|P3|Part D: Re-Treatment Period|Withdrawal by Subject|0
861410|NCT01490632|2841947|P2|Part D: Re-Treatment Period|Withdrawal by Subject|0
861411|NCT01490632|2841948|P1|Part D: Re-Treatment Period|Withdrawal by Subject|0
861412|NCT01490632|2841929|P20|Part D: Re-Treatment Period|Protocol Violation|0
861413|NCT01490632|2841930|P19|Part D: Re-Treatment Period|Protocol Violation|1
861414|NCT01490632|2841931|P18|Part D: Re-Treatment Period|Protocol Violation|0
861415|NCT01490632|2841932|P17|Part D: Re-Treatment Period|Protocol Violation|0
861416|NCT01490632|2841933|P16|Part D: Re-Treatment Period|Protocol Violation|0
861417|NCT01490632|2841934|P15|Part D: Re-Treatment Period|Protocol Violation|0
861418|NCT01490632|2841935|P14|Part D: Re-Treatment Period|Protocol Violation|0
861419|NCT01490632|2841936|P13|Part D: Re-Treatment Period|Protocol Violation|0
861420|NCT01490632|2841937|P12|Part D: Re-Treatment Period|Protocol Violation|0
861421|NCT01490632|2841938|P11|Part D: Re-Treatment Period|Protocol Violation|0
861422|NCT01490632|2841939|P10|Part D: Re-Treatment Period|Protocol Violation|0
861423|NCT01490632|2841940|P9|Part D: Re-Treatment Period|Protocol Violation|0
861424|NCT01490632|2841941|P8|Part D: Re-Treatment Period|Protocol Violation|0
861425|NCT01490632|2841942|P7|Part D: Re-Treatment Period|Protocol Violation|0
861426|NCT01490632|2841943|P6|Part D: Re-Treatment Period|Protocol Violation|0
861427|NCT01490632|2841944|P5|Part D: Re-Treatment Period|Protocol Violation|0
861428|NCT01490632|2841945|P4|Part D: Re-Treatment Period|Protocol Violation|0
861429|NCT01490632|2841946|P3|Part D: Re-Treatment Period|Protocol Violation|0
861430|NCT01490632|2841947|P2|Part D: Re-Treatment Period|Protocol Violation|0
861431|NCT01490632|2841948|P1|Part D: Re-Treatment Period|Protocol Violation|0
861432|NCT01490632|2841929|P20|Part D: Re-Treatment Period|Physician Decision|1
861433|NCT01490632|2841930|P19|Part D: Re-Treatment Period|Physician Decision|1
861434|NCT01490632|2841931|P18|Part D: Re-Treatment Period|Physician Decision|0
861435|NCT01490632|2841932|P17|Part D: Re-Treatment Period|Physician Decision|0
861436|NCT01490632|2841933|P16|Part D: Re-Treatment Period|Physician Decision|0
861437|NCT01490632|2841934|P15|Part D: Re-Treatment Period|Physician Decision|0
861438|NCT01490632|2841935|P14|Part D: Re-Treatment Period|Physician Decision|0
861439|NCT01490632|2841936|P13|Part D: Re-Treatment Period|Physician Decision|0
861440|NCT01490632|2841937|P12|Part D: Re-Treatment Period|Physician Decision|0
861441|NCT01490632|2841938|P11|Part D: Re-Treatment Period|Physician Decision|0
861442|NCT01490632|2841939|P10|Part D: Re-Treatment Period|Physician Decision|0
861443|NCT01490632|2841940|P9|Part D: Re-Treatment Period|Physician Decision|0
861444|NCT01490632|2841941|P8|Part D: Re-Treatment Period|Physician Decision|0
861445|NCT01490632|2841942|P7|Part D: Re-Treatment Period|Physician Decision|0
861446|NCT01490632|2841943|P6|Part D: Re-Treatment Period|Physician Decision|0
861527|NCT01490632|2841944|P5|Part D: Re-Treatment Period|Adverse Event|0
861447|NCT01490632|2841944|P5|Part D: Re-Treatment Period|Physician Decision|0
861448|NCT01490632|2841945|P4|Part D: Re-Treatment Period|Physician Decision|0
861449|NCT01490632|2841946|P3|Part D: Re-Treatment Period|Physician Decision|0
861450|NCT01490632|2841947|P2|Part D: Re-Treatment Period|Physician Decision|0
861451|NCT01490632|2841948|P1|Part D: Re-Treatment Period|Physician Decision|0
861452|NCT01490632|2841929|P20|Part D: Re-Treatment Period|Lost to Follow-up|0
861453|NCT01490632|2841930|P19|Part D: Re-Treatment Period|Lost to Follow-up|1
861454|NCT01490632|2841931|P18|Part D: Re-Treatment Period|Lost to Follow-up|0
861455|NCT01490632|2841932|P17|Part D: Re-Treatment Period|Lost to Follow-up|0
861456|NCT01490632|2841933|P16|Part D: Re-Treatment Period|Lost to Follow-up|0
861457|NCT01490632|2841934|P15|Part D: Re-Treatment Period|Lost to Follow-up|0
861458|NCT01490632|2841935|P14|Part D: Re-Treatment Period|Lost to Follow-up|0
861459|NCT01490632|2841936|P13|Part D: Re-Treatment Period|Lost to Follow-up|0
861460|NCT01490632|2841937|P12|Part D: Re-Treatment Period|Lost to Follow-up|0
861461|NCT01490632|2841938|P11|Part D: Re-Treatment Period|Lost to Follow-up|0
861462|NCT01490632|2841939|P10|Part D: Re-Treatment Period|Lost to Follow-up|0
861463|NCT01490632|2841940|P9|Part D: Re-Treatment Period|Lost to Follow-up|0
861464|NCT01490632|2841941|P8|Part D: Re-Treatment Period|Lost to Follow-up|0
861465|NCT01490632|2841942|P7|Part D: Re-Treatment Period|Lost to Follow-up|0
861466|NCT01490632|2841943|P6|Part D: Re-Treatment Period|Lost to Follow-up|0
861467|NCT01490632|2841944|P5|Part D: Re-Treatment Period|Lost to Follow-up|0
861468|NCT01490632|2841945|P4|Part D: Re-Treatment Period|Lost to Follow-up|0
861469|NCT01490632|2841946|P3|Part D: Re-Treatment Period|Lost to Follow-up|0
861470|NCT01490632|2841947|P2|Part D: Re-Treatment Period|Lost to Follow-up|0
861471|NCT01490632|2841948|P1|Part D: Re-Treatment Period|Lost to Follow-up|0
861472|NCT01490632|2841929|P20|Part D: Re-Treatment Period|Lack of Efficacy|2
861473|NCT01490632|2841930|P19|Part D: Re-Treatment Period|Lack of Efficacy|1
861474|NCT01490632|2841931|P18|Part D: Re-Treatment Period|Lack of Efficacy|3
861475|NCT01490632|2841932|P17|Part D: Re-Treatment Period|Lack of Efficacy|0
861476|NCT01490632|2841933|P16|Part D: Re-Treatment Period|Lack of Efficacy|0
861477|NCT01490632|2841934|P15|Part D: Re-Treatment Period|Lack of Efficacy|0
861478|NCT01490632|2841935|P14|Part D: Re-Treatment Period|Lack of Efficacy|0
861479|NCT01490632|2841936|P13|Part D: Re-Treatment Period|Lack of Efficacy|0
861480|NCT01490632|2841937|P12|Part D: Re-Treatment Period|Lack of Efficacy|0
861481|NCT01490632|2841938|P11|Part D: Re-Treatment Period|Lack of Efficacy|0
861482|NCT01490632|2841939|P10|Part D: Re-Treatment Period|Lack of Efficacy|0
861483|NCT01490632|2841940|P9|Part D: Re-Treatment Period|Lack of Efficacy|0
861484|NCT01490632|2841941|P8|Part D: Re-Treatment Period|Lack of Efficacy|0
861485|NCT01490632|2841942|P7|Part D: Re-Treatment Period|Lack of Efficacy|0
861486|NCT01490632|2841943|P6|Part D: Re-Treatment Period|Lack of Efficacy|0
861487|NCT01490632|2841944|P5|Part D: Re-Treatment Period|Lack of Efficacy|0
861488|NCT01490632|2841945|P4|Part D: Re-Treatment Period|Lack of Efficacy|0
861489|NCT01490632|2841946|P3|Part D: Re-Treatment Period|Lack of Efficacy|0
861490|NCT01490632|2841947|P2|Part D: Re-Treatment Period|Lack of Efficacy|0
861491|NCT01490632|2841948|P1|Part D: Re-Treatment Period|Lack of Efficacy|0
861492|NCT01490632|2841929|P20|Part D: Re-Treatment Period|Death|0
861493|NCT01490632|2841930|P19|Part D: Re-Treatment Period|Death|1
861494|NCT01490632|2841931|P18|Part D: Re-Treatment Period|Death|0
861495|NCT01490632|2841932|P17|Part D: Re-Treatment Period|Death|0
861496|NCT01490632|2841933|P16|Part D: Re-Treatment Period|Death|0
861497|NCT01490632|2841934|P15|Part D: Re-Treatment Period|Death|0
861498|NCT01490632|2841935|P14|Part D: Re-Treatment Period|Death|0
861499|NCT01490632|2841936|P13|Part D: Re-Treatment Period|Death|0
861500|NCT01490632|2841937|P12|Part D: Re-Treatment Period|Death|0
861501|NCT01490632|2841938|P11|Part D: Re-Treatment Period|Death|0
861502|NCT01490632|2841939|P10|Part D: Re-Treatment Period|Death|0
861503|NCT01490632|2841940|P9|Part D: Re-Treatment Period|Death|0
861504|NCT01490632|2841941|P8|Part D: Re-Treatment Period|Death|0
861505|NCT01490632|2841942|P7|Part D: Re-Treatment Period|Death|0
861506|NCT01490632|2841943|P6|Part D: Re-Treatment Period|Death|0
861507|NCT01490632|2841944|P5|Part D: Re-Treatment Period|Death|0
861508|NCT01490632|2841945|P4|Part D: Re-Treatment Period|Death|0
861509|NCT01490632|2841946|P3|Part D: Re-Treatment Period|Death|0
861510|NCT01490632|2841947|P2|Part D: Re-Treatment Period|Death|0
861511|NCT01490632|2841948|P1|Part D: Re-Treatment Period|Death|0
861512|NCT01490632|2841929|P20|Part D: Re-Treatment Period|Adverse Event|3
861513|NCT01490632|2841930|P19|Part D: Re-Treatment Period|Adverse Event|1
861514|NCT01490632|2841931|P18|Part D: Re-Treatment Period|Adverse Event|1
861515|NCT01490632|2841932|P17|Part D: Re-Treatment Period|Adverse Event|0
861516|NCT01490632|2841933|P16|Part D: Re-Treatment Period|Adverse Event|0
861517|NCT01490632|2841934|P15|Part D: Re-Treatment Period|Adverse Event|0
861518|NCT01490632|2841935|P14|Part D: Re-Treatment Period|Adverse Event|0
861519|NCT01490632|2841936|P13|Part D: Re-Treatment Period|Adverse Event|0
861520|NCT01490632|2841937|P12|Part D: Re-Treatment Period|Adverse Event|0
861521|NCT01490632|2841938|P11|Part D: Re-Treatment Period|Adverse Event|0
861522|NCT01490632|2841939|P10|Part D: Re-Treatment Period|Adverse Event|0
861523|NCT01490632|2841940|P9|Part D: Re-Treatment Period|Adverse Event|0
861524|NCT01490632|2841941|P8|Part D: Re-Treatment Period|Adverse Event|0
861525|NCT01490632|2841942|P7|Part D: Re-Treatment Period|Adverse Event|0
861526|NCT01490632|2841943|P6|Part D: Re-Treatment Period|Adverse Event|0
861528|NCT01490632|2841945|P4|Part D: Re-Treatment Period|Adverse Event|0
861529|NCT01490632|2841946|P3|Part D: Re-Treatment Period|Adverse Event|0
861530|NCT01490632|2841947|P2|Part D: Re-Treatment Period|Adverse Event|0
861531|NCT01490632|2841948|P1|Part D: Re-Treatment Period|Adverse Event|0
861532|NCT01490632|2841929|P20|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
861533|NCT01490632|2841930|P19|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
861534|NCT01490632|2841931|P18|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
861535|NCT01490632|2841932|P17|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
861536|NCT01490632|2841933|P16|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34
861537|NCT01490632|2841934|P15|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14
861538|NCT01490632|2841935|P14|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9
861539|NCT01490632|2841936|P13|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5
861540|NCT01490632|2841937|P12|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
861541|NCT01490632|2841938|P11|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
861542|NCT01490632|2841939|P10|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
861543|NCT01490632|2841940|P9|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
861544|NCT01490632|2841941|P8|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
861545|NCT01490632|2841942|P7|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
861546|NCT01490632|2841943|P6|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
861547|NCT01490632|2841944|P5|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
861548|NCT01490632|2841945|P4|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
861549|NCT01490632|2841946|P3|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
861550|NCT01490632|2841947|P2|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
861551|NCT01490632|2841948|P1|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
861552|NCT01490632|2841929|P20|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
861553|NCT01490632|2841930|P19|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
861554|NCT01490632|2841931|P18|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
861555|NCT01490632|2841932|P17|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
861556|NCT01490632|2841933|P16|Part C: Washout or Step-Down Period|Withdrawal by Subject|1
861557|NCT01490632|2841934|P15|Part C: Washout or Step-Down Period|Withdrawal by Subject|2
861558|NCT01490632|2841935|P14|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
861559|NCT01490632|2841936|P13|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
861560|NCT01490632|2841937|P12|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
861561|NCT01490632|2841938|P11|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
861562|NCT01490632|2841939|P10|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
861563|NCT01490632|2841940|P9|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
861564|NCT01490632|2841941|P8|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
861565|NCT01490632|2841942|P7|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
861566|NCT01490632|2841943|P6|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
861567|NCT01490632|2841944|P5|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
861568|NCT01490632|2841945|P4|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
861569|NCT01490632|2841946|P3|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
861570|NCT01490632|2841947|P2|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
861571|NCT01490632|2841948|P1|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
861572|NCT01490632|2841929|P20|Part C: Washout or Step-Down Period|Lost to Follow-up|0
861573|NCT01490632|2841930|P19|Part C: Washout or Step-Down Period|Lost to Follow-up|0
861574|NCT01490632|2841931|P18|Part C: Washout or Step-Down Period|Lost to Follow-up|0
861575|NCT01490632|2841932|P17|Part C: Washout or Step-Down Period|Lost to Follow-up|0
861576|NCT01490632|2841933|P16|Part C: Washout or Step-Down Period|Lost to Follow-up|0
861577|NCT01490632|2841934|P15|Part C: Washout or Step-Down Period|Lost to Follow-up|0
861578|NCT01490632|2841935|P14|Part C: Washout or Step-Down Period|Lost to Follow-up|1
861579|NCT01490632|2841936|P13|Part C: Washout or Step-Down Period|Lost to Follow-up|0
861580|NCT01490632|2841937|P12|Part C: Washout or Step-Down Period|Lost to Follow-up|0
861581|NCT01490632|2841938|P11|Part C: Washout or Step-Down Period|Lost to Follow-up|0
861582|NCT01490632|2841939|P10|Part C: Washout or Step-Down Period|Lost to Follow-up|0
861583|NCT01490632|2841940|P9|Part C: Washout or Step-Down Period|Lost to Follow-up|0
861584|NCT01490632|2841941|P8|Part C: Washout or Step-Down Period|Lost to Follow-up|0
861585|NCT01490632|2841942|P7|Part C: Washout or Step-Down Period|Lost to Follow-up|0
861586|NCT01490632|2841943|P6|Part C: Washout or Step-Down Period|Lost to Follow-up|0
861587|NCT01490632|2841944|P5|Part C: Washout or Step-Down Period|Lost to Follow-up|0
861588|NCT01490632|2841945|P4|Part C: Washout or Step-Down Period|Lost to Follow-up|0
861589|NCT01490632|2841946|P3|Part C: Washout or Step-Down Period|Lost to Follow-up|0
861590|NCT01490632|2841947|P2|Part C: Washout or Step-Down Period|Lost to Follow-up|0
861591|NCT01490632|2841948|P1|Part C: Washout or Step-Down Period|Lost to Follow-up|0
861592|NCT01490632|2841929|P20|Part C: Washout or Step-Down Period|Adverse Event|0
861593|NCT01490632|2841930|P19|Part C: Washout or Step-Down Period|Adverse Event|0
861594|NCT01490632|2841931|P18|Part C: Washout or Step-Down Period|Adverse Event|0
861595|NCT01490632|2841932|P17|Part C: Washout or Step-Down Period|Adverse Event|0
861596|NCT01490632|2841933|P16|Part C: Washout or Step-Down Period|Adverse Event|2
861597|NCT01490632|2841934|P15|Part C: Washout or Step-Down Period|Adverse Event|2
861598|NCT01490632|2841935|P14|Part C: Washout or Step-Down Period|Adverse Event|0
861599|NCT01490632|2841936|P13|Part C: Washout or Step-Down Period|Adverse Event|0
861600|NCT01490632|2841937|P12|Part C: Washout or Step-Down Period|Adverse Event|0
861601|NCT01490632|2841938|P11|Part C: Washout or Step-Down Period|Adverse Event|0
861602|NCT01490632|2841939|P10|Part C: Washout or Step-Down Period|Adverse Event|0
861603|NCT01490632|2841940|P9|Part C: Washout or Step-Down Period|Adverse Event|0
861604|NCT01490632|2841941|P8|Part C: Washout or Step-Down Period|Adverse Event|0
861605|NCT01490632|2841942|P7|Part C: Washout or Step-Down Period|Adverse Event|0
861606|NCT01490632|2841943|P6|Part C: Washout or Step-Down Period|Adverse Event|0
861607|NCT01490632|2841944|P5|Part C: Washout or Step-Down Period|Adverse Event|0
861608|NCT01490632|2841945|P4|Part C: Washout or Step-Down Period|Adverse Event|0
861609|NCT01490632|2841946|P3|Part C: Washout or Step-Down Period|Adverse Event|0
861610|NCT01490632|2841947|P2|Part C: Washout or Step-Down Period|Adverse Event|0
861611|NCT01490632|2841948|P1|Part C: Washout or Step-Down Period|Adverse Event|0
861612|NCT01490632|2841929|P20|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
861613|NCT01490632|2841930|P19|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
861614|NCT01490632|2841931|P18|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
861615|NCT01490632|2841932|P17|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
861616|NCT01490632|2841933|P16|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
861617|NCT01490632|2841934|P15|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
861618|NCT01490632|2841935|P14|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
861619|NCT01490632|2841936|P13|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
861620|NCT01490632|2841937|P12|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5
861621|NCT01490632|2841938|P11|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16
861622|NCT01490632|2841939|P10|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19
861623|NCT01490632|2841940|P9|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8
861624|NCT01490632|2841941|P8|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
861625|NCT01490632|2841942|P7|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
861626|NCT01490632|2841943|P6|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1
861627|NCT01490632|2841944|P5|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
861628|NCT01490632|2841945|P4|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
861629|NCT01490632|2841946|P3|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
861630|NCT01490632|2841947|P2|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
861631|NCT01490632|2841948|P1|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
861632|NCT01490632|2841929|P20|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
861633|NCT01490632|2841930|P19|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
861634|NCT01490632|2841931|P18|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
861635|NCT01490632|2841932|P17|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
861636|NCT01490632|2841933|P16|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
861637|NCT01490632|2841934|P15|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
861638|NCT01490632|2841935|P14|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
861639|NCT01490632|2841936|P13|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
861640|NCT01490632|2841937|P12|Part B: Extension or Step-Up Period|Withdrawal by Subject|2
861641|NCT01490632|2841938|P11|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
861642|NCT01490632|2841939|P10|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
861643|NCT01490632|2841940|P9|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
861644|NCT01490632|2841941|P8|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
861645|NCT01490632|2841942|P7|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
861646|NCT01490632|2841943|P6|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
861647|NCT01490632|2841944|P5|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
861648|NCT01490632|2841945|P4|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
861649|NCT01490632|2841946|P3|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
861650|NCT01490632|2841947|P2|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
861651|NCT01490632|2841948|P1|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
861652|NCT01490632|2841929|P20|Part B: Extension or Step-Up Period|Sponsor Decision|0
861653|NCT01490632|2841930|P19|Part B: Extension or Step-Up Period|Sponsor Decision|0
861654|NCT01490632|2841931|P18|Part B: Extension or Step-Up Period|Sponsor Decision|0
861655|NCT01490632|2841932|P17|Part B: Extension or Step-Up Period|Sponsor Decision|0
861656|NCT01490632|2841933|P16|Part B: Extension or Step-Up Period|Sponsor Decision|0
861657|NCT01490632|2841934|P15|Part B: Extension or Step-Up Period|Sponsor Decision|0
861658|NCT01490632|2841935|P14|Part B: Extension or Step-Up Period|Sponsor Decision|0
861659|NCT01490632|2841936|P13|Part B: Extension or Step-Up Period|Sponsor Decision|0
861660|NCT01490632|2841937|P12|Part B: Extension or Step-Up Period|Sponsor Decision|0
861661|NCT01490632|2841938|P11|Part B: Extension or Step-Up Period|Sponsor Decision|0
861662|NCT01490632|2841939|P10|Part B: Extension or Step-Up Period|Sponsor Decision|0
861663|NCT01490632|2841940|P9|Part B: Extension or Step-Up Period|Sponsor Decision|0
861664|NCT01490632|2841941|P8|Part B: Extension or Step-Up Period|Sponsor Decision|0
861665|NCT01490632|2841942|P7|Part B: Extension or Step-Up Period|Sponsor Decision|0
861666|NCT01490632|2841943|P6|Part B: Extension or Step-Up Period|Sponsor Decision|1
861667|NCT01490632|2841944|P5|Part B: Extension or Step-Up Period|Sponsor Decision|0
861668|NCT01490632|2841945|P4|Part B: Extension or Step-Up Period|Sponsor Decision|0
861669|NCT01490632|2841946|P3|Part B: Extension or Step-Up Period|Sponsor Decision|0
861670|NCT01490632|2841947|P2|Part B: Extension or Step-Up Period|Sponsor Decision|0
861671|NCT01490632|2841948|P1|Part B: Extension or Step-Up Period|Sponsor Decision|0
861672|NCT01490632|2841929|P20|Part B: Extension or Step-Up Period|Physician Decision|0
861673|NCT01490632|2841930|P19|Part B: Extension or Step-Up Period|Physician Decision|0
861674|NCT01490632|2841931|P18|Part B: Extension or Step-Up Period|Physician Decision|0
861675|NCT01490632|2841932|P17|Part B: Extension or Step-Up Period|Physician Decision|0
861676|NCT01490632|2841933|P16|Part B: Extension or Step-Up Period|Physician Decision|0
861677|NCT01490632|2841934|P15|Part B: Extension or Step-Up Period|Physician Decision|0
861678|NCT01490632|2841935|P14|Part B: Extension or Step-Up Period|Physician Decision|0
861679|NCT01490632|2841936|P13|Part B: Extension or Step-Up Period|Physician Decision|0
861680|NCT01490632|2841937|P12|Part B: Extension or Step-Up Period|Physician Decision|0
861681|NCT01490632|2841938|P11|Part B: Extension or Step-Up Period|Physician Decision|0
861682|NCT01490632|2841939|P10|Part B: Extension or Step-Up Period|Physician Decision|0
861683|NCT01490632|2841940|P9|Part B: Extension or Step-Up Period|Physician Decision|0
861684|NCT01490632|2841941|P8|Part B: Extension or Step-Up Period|Physician Decision|0
861685|NCT01490632|2841942|P7|Part B: Extension or Step-Up Period|Physician Decision|1
861686|NCT01490632|2841943|P6|Part B: Extension or Step-Up Period|Physician Decision|0
861687|NCT01490632|2841944|P5|Part B: Extension or Step-Up Period|Physician Decision|0
861688|NCT01490632|2841945|P4|Part B: Extension or Step-Up Period|Physician Decision|0
861689|NCT01490632|2841946|P3|Part B: Extension or Step-Up Period|Physician Decision|0
861690|NCT01490632|2841947|P2|Part B: Extension or Step-Up Period|Physician Decision|0
861691|NCT01490632|2841948|P1|Part B: Extension or Step-Up Period|Physician Decision|0
861692|NCT01490632|2841929|P20|Part B: Extension or Step-Up Period|Lost to Follow-up|0
861693|NCT01490632|2841930|P19|Part B: Extension or Step-Up Period|Lost to Follow-up|0
861694|NCT01490632|2841931|P18|Part B: Extension or Step-Up Period|Lost to Follow-up|0
861695|NCT01490632|2841932|P17|Part B: Extension or Step-Up Period|Lost to Follow-up|0
861696|NCT01490632|2841933|P16|Part B: Extension or Step-Up Period|Lost to Follow-up|0
861697|NCT01490632|2841934|P15|Part B: Extension or Step-Up Period|Lost to Follow-up|0
861698|NCT01490632|2841935|P14|Part B: Extension or Step-Up Period|Lost to Follow-up|0
861699|NCT01490632|2841936|P13|Part B: Extension or Step-Up Period|Lost to Follow-up|0
861700|NCT01490632|2841937|P12|Part B: Extension or Step-Up Period|Lost to Follow-up|0
861701|NCT01490632|2841938|P11|Part B: Extension or Step-Up Period|Lost to Follow-up|0
861702|NCT01490632|2841939|P10|Part B: Extension or Step-Up Period|Lost to Follow-up|1
861703|NCT01490632|2841940|P9|Part B: Extension or Step-Up Period|Lost to Follow-up|0
861704|NCT01490632|2841941|P8|Part B: Extension or Step-Up Period|Lost to Follow-up|0
861705|NCT01490632|2841942|P7|Part B: Extension or Step-Up Period|Lost to Follow-up|2
861706|NCT01490632|2841943|P6|Part B: Extension or Step-Up Period|Lost to Follow-up|0
861707|NCT01490632|2841944|P5|Part B: Extension or Step-Up Period|Lost to Follow-up|0
861708|NCT01490632|2841945|P4|Part B: Extension or Step-Up Period|Lost to Follow-up|0
861709|NCT01490632|2841946|P3|Part B: Extension or Step-Up Period|Lost to Follow-up|0
861710|NCT01490632|2841947|P2|Part B: Extension or Step-Up Period|Lost to Follow-up|0
861711|NCT01490632|2841948|P1|Part B: Extension or Step-Up Period|Lost to Follow-up|0
861712|NCT01490632|2841929|P20|Part B: Extension or Step-Up Period|Lack of Efficacy|0
861713|NCT01490632|2841930|P19|Part B: Extension or Step-Up Period|Lack of Efficacy|0
861714|NCT01490632|2841931|P18|Part B: Extension or Step-Up Period|Lack of Efficacy|0
861715|NCT01490632|2841932|P17|Part B: Extension or Step-Up Period|Lack of Efficacy|0
861716|NCT01490632|2841933|P16|Part B: Extension or Step-Up Period|Lack of Efficacy|0
861717|NCT01490632|2841934|P15|Part B: Extension or Step-Up Period|Lack of Efficacy|0
861718|NCT01490632|2841935|P14|Part B: Extension or Step-Up Period|Lack of Efficacy|0
861719|NCT01490632|2841936|P13|Part B: Extension or Step-Up Period|Lack of Efficacy|0
861720|NCT01490632|2841937|P12|Part B: Extension or Step-Up Period|Lack of Efficacy|0
861721|NCT01490632|2841938|P11|Part B: Extension or Step-Up Period|Lack of Efficacy|1
861722|NCT01490632|2841939|P10|Part B: Extension or Step-Up Period|Lack of Efficacy|3
861723|NCT01490632|2841940|P9|Part B: Extension or Step-Up Period|Lack of Efficacy|1
861724|NCT01490632|2841941|P8|Part B: Extension or Step-Up Period|Lack of Efficacy|0
861725|NCT01490632|2841942|P7|Part B: Extension or Step-Up Period|Lack of Efficacy|1
861726|NCT01490632|2841943|P6|Part B: Extension or Step-Up Period|Lack of Efficacy|0
861727|NCT01490632|2841944|P5|Part B: Extension or Step-Up Period|Lack of Efficacy|0
861728|NCT01490632|2841945|P4|Part B: Extension or Step-Up Period|Lack of Efficacy|0
861729|NCT01490632|2841946|P3|Part B: Extension or Step-Up Period|Lack of Efficacy|0
861730|NCT01490632|2841947|P2|Part B: Extension or Step-Up Period|Lack of Efficacy|0
861731|NCT01490632|2841948|P1|Part B: Extension or Step-Up Period|Lack of Efficacy|0
861732|NCT01490632|2841929|P20|Part B: Extension or Step-Up Period|Adverse Event|0
861733|NCT01490632|2841930|P19|Part B: Extension or Step-Up Period|Adverse Event|0
861734|NCT01490632|2841931|P18|Part B: Extension or Step-Up Period|Adverse Event|0
861735|NCT01490632|2841932|P17|Part B: Extension or Step-Up Period|Adverse Event|0
861736|NCT01490632|2841933|P16|Part B: Extension or Step-Up Period|Adverse Event|0
861737|NCT01490632|2841934|P15|Part B: Extension or Step-Up Period|Adverse Event|0
861738|NCT01490632|2841935|P14|Part B: Extension or Step-Up Period|Adverse Event|0
861739|NCT01490632|2841936|P13|Part B: Extension or Step-Up Period|Adverse Event|0
861740|NCT01490632|2841937|P12|Part B: Extension or Step-Up Period|Adverse Event|1
861741|NCT01490632|2841938|P11|Part B: Extension or Step-Up Period|Adverse Event|3
861742|NCT01490632|2841939|P10|Part B: Extension or Step-Up Period|Adverse Event|2
861743|NCT01490632|2841940|P9|Part B: Extension or Step-Up Period|Adverse Event|0
861744|NCT01490632|2841941|P8|Part B: Extension or Step-Up Period|Adverse Event|0
861745|NCT01490632|2841942|P7|Part B: Extension or Step-Up Period|Adverse Event|2
861746|NCT01490632|2841943|P6|Part B: Extension or Step-Up Period|Adverse Event|2
861747|NCT01490632|2841944|P5|Part B: Extension or Step-Up Period|Adverse Event|0
861748|NCT01490632|2841945|P4|Part B: Extension or Step-Up Period|Adverse Event|0
861749|NCT01490632|2841946|P3|Part B: Extension or Step-Up Period|Adverse Event|0
861750|NCT01490632|2841947|P2|Part B: Extension or Step-Up Period|Adverse Event|0
861751|NCT01490632|2841948|P1|Part B: Extension or Step-Up Period|Adverse Event|0
861752|NCT01490632|2841929|P20|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
861753|NCT01490632|2841930|P19|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
861754|NCT01490632|2841931|P18|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
861755|NCT01490632|2841932|P17|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
861756|NCT01490632|2841933|P16|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
861757|NCT01490632|2841934|P15|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
861758|NCT01490632|2841935|P14|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
861759|NCT01490632|2841936|P13|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
861760|NCT01490632|2841937|P12|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
861761|NCT01490632|2841938|P11|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
861762|NCT01490632|2841939|P10|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
861763|NCT01490632|2841940|P9|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
861764|NCT01490632|2841941|P8|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
861765|NCT01490632|2841942|P7|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
861766|NCT01490632|2841943|P6|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
861767|NCT01490632|2841944|P5|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9
861768|NCT01490632|2841945|P4|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
861769|NCT01490632|2841946|P3|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
861770|NCT01490632|2841947|P2|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
861771|NCT01490632|2841948|P1|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
861772|NCT01490632|2841929|P20|Part A: Initial Treatment Period|Withdrawal by Subject|0
861773|NCT01490632|2841930|P19|Part A: Initial Treatment Period|Withdrawal by Subject|0
861774|NCT01490632|2841931|P18|Part A: Initial Treatment Period|Withdrawal by Subject|0
861775|NCT01490632|2841932|P17|Part A: Initial Treatment Period|Withdrawal by Subject|0
861776|NCT01490632|2841933|P16|Part A: Initial Treatment Period|Withdrawal by Subject|0
861777|NCT01490632|2841934|P15|Part A: Initial Treatment Period|Withdrawal by Subject|0
861778|NCT01490632|2841935|P14|Part A: Initial Treatment Period|Withdrawal by Subject|0
861779|NCT01490632|2841936|P13|Part A: Initial Treatment Period|Withdrawal by Subject|0
861780|NCT01490632|2841937|P12|Part A: Initial Treatment Period|Withdrawal by Subject|0
861781|NCT01490632|2841938|P11|Part A: Initial Treatment Period|Withdrawal by Subject|0
861782|NCT01490632|2841939|P10|Part A: Initial Treatment Period|Withdrawal by Subject|0
861783|NCT01490632|2841940|P9|Part A: Initial Treatment Period|Withdrawal by Subject|0
861784|NCT01490632|2841941|P8|Part A: Initial Treatment Period|Withdrawal by Subject|0
861785|NCT01490632|2841942|P7|Part A: Initial Treatment Period|Withdrawal by Subject|0
861786|NCT01490632|2841943|P6|Part A: Initial Treatment Period|Withdrawal by Subject|0
861787|NCT01490632|2841944|P5|Part A: Initial Treatment Period|Withdrawal by Subject|2
861788|NCT01490632|2841945|P4|Part A: Initial Treatment Period|Withdrawal by Subject|1
861789|NCT01490632|2841946|P3|Part A: Initial Treatment Period|Withdrawal by Subject|0
861790|NCT01490632|2841947|P2|Part A: Initial Treatment Period|Withdrawal by Subject|2
861791|NCT01490632|2841948|P1|Part A: Initial Treatment Period|Withdrawal by Subject|2
861792|NCT01490632|2841929|P20|Part A: Initial Treatment Period|Sponsor Decision|0
861793|NCT01490632|2841930|P19|Part A: Initial Treatment Period|Sponsor Decision|0
861794|NCT01490632|2841931|P18|Part A: Initial Treatment Period|Sponsor Decision|0
861795|NCT01490632|2841932|P17|Part A: Initial Treatment Period|Sponsor Decision|0
861796|NCT01490632|2841933|P16|Part A: Initial Treatment Period|Sponsor Decision|0
861797|NCT01490632|2841934|P15|Part A: Initial Treatment Period|Sponsor Decision|0
861798|NCT01490632|2841935|P14|Part A: Initial Treatment Period|Sponsor Decision|0
861799|NCT01490632|2841936|P13|Part A: Initial Treatment Period|Sponsor Decision|0
861800|NCT01490632|2841937|P12|Part A: Initial Treatment Period|Sponsor Decision|0
861801|NCT01490632|2841938|P11|Part A: Initial Treatment Period|Sponsor Decision|0
861802|NCT01490632|2841939|P10|Part A: Initial Treatment Period|Sponsor Decision|0
861803|NCT01490632|2841940|P9|Part A: Initial Treatment Period|Sponsor Decision|0
861804|NCT01490632|2841941|P8|Part A: Initial Treatment Period|Sponsor Decision|0
861805|NCT01490632|2841942|P7|Part A: Initial Treatment Period|Sponsor Decision|0
861806|NCT01490632|2841943|P6|Part A: Initial Treatment Period|Sponsor Decision|0
861807|NCT01490632|2841944|P5|Part A: Initial Treatment Period|Sponsor Decision|0
861808|NCT01490632|2841945|P4|Part A: Initial Treatment Period|Sponsor Decision|0
861809|NCT01490632|2841946|P3|Part A: Initial Treatment Period|Sponsor Decision|0
861810|NCT01490632|2841947|P2|Part A: Initial Treatment Period|Sponsor Decision|0
861811|NCT01490632|2841948|P1|Part A: Initial Treatment Period|Sponsor Decision|2
861812|NCT01490632|2841929|P20|Part A: Initial Treatment Period|Physician Decision|0
861813|NCT01490632|2841930|P19|Part A: Initial Treatment Period|Physician Decision|0
861814|NCT01490632|2841931|P18|Part A: Initial Treatment Period|Physician Decision|0
861815|NCT01490632|2841932|P17|Part A: Initial Treatment Period|Physician Decision|0
861816|NCT01490632|2841933|P16|Part A: Initial Treatment Period|Physician Decision|0
861817|NCT01490632|2841934|P15|Part A: Initial Treatment Period|Physician Decision|0
861818|NCT01490632|2841935|P14|Part A: Initial Treatment Period|Physician Decision|0
861819|NCT01490632|2841936|P13|Part A: Initial Treatment Period|Physician Decision|0
861820|NCT01490632|2841937|P12|Part A: Initial Treatment Period|Physician Decision|0
861821|NCT01490632|2841938|P11|Part A: Initial Treatment Period|Physician Decision|0
861822|NCT01490632|2841939|P10|Part A: Initial Treatment Period|Physician Decision|0
861823|NCT01490632|2841940|P9|Part A: Initial Treatment Period|Physician Decision|0
861824|NCT01490632|2841941|P8|Part A: Initial Treatment Period|Physician Decision|0
861825|NCT01490632|2841942|P7|Part A: Initial Treatment Period|Physician Decision|0
861826|NCT01490632|2841943|P6|Part A: Initial Treatment Period|Physician Decision|0
861827|NCT01490632|2841944|P5|Part A: Initial Treatment Period|Physician Decision|0
861828|NCT01490632|2841945|P4|Part A: Initial Treatment Period|Physician Decision|1
861829|NCT01490632|2841946|P3|Part A: Initial Treatment Period|Physician Decision|0
861830|NCT01490632|2841947|P2|Part A: Initial Treatment Period|Physician Decision|1
861831|NCT01490632|2841948|P1|Part A: Initial Treatment Period|Physician Decision|0
861832|NCT01490632|2841929|P20|Part A: Initial Treatment Period|Lost to Follow-up|0
861833|NCT01490632|2841930|P19|Part A: Initial Treatment Period|Lost to Follow-up|0
861834|NCT01490632|2841931|P18|Part A: Initial Treatment Period|Lost to Follow-up|0
861835|NCT01490632|2841932|P17|Part A: Initial Treatment Period|Lost to Follow-up|0
861836|NCT01490632|2841933|P16|Part A: Initial Treatment Period|Lost to Follow-up|0
861837|NCT01490632|2841934|P15|Part A: Initial Treatment Period|Lost to Follow-up|0
861838|NCT01490632|2841935|P14|Part A: Initial Treatment Period|Lost to Follow-up|0
861839|NCT01490632|2841936|P13|Part A: Initial Treatment Period|Lost to Follow-up|0
861840|NCT01490632|2841937|P12|Part A: Initial Treatment Period|Lost to Follow-up|0
861841|NCT01490632|2841938|P11|Part A: Initial Treatment Period|Lost to Follow-up|0
861842|NCT01490632|2841939|P10|Part A: Initial Treatment Period|Lost to Follow-up|0
861843|NCT01490632|2841940|P9|Part A: Initial Treatment Period|Lost to Follow-up|0
861844|NCT01490632|2841941|P8|Part A: Initial Treatment Period|Lost to Follow-up|0
861845|NCT01490632|2841942|P7|Part A: Initial Treatment Period|Lost to Follow-up|0
861846|NCT01490632|2841943|P6|Part A: Initial Treatment Period|Lost to Follow-up|0
861847|NCT01490632|2841944|P5|Part A: Initial Treatment Period|Lost to Follow-up|2
861848|NCT01490632|2841945|P4|Part A: Initial Treatment Period|Lost to Follow-up|1
861849|NCT01490632|2841946|P3|Part A: Initial Treatment Period|Lost to Follow-up|1
861850|NCT01490632|2841947|P2|Part A: Initial Treatment Period|Lost to Follow-up|0
861851|NCT01490632|2841948|P1|Part A: Initial Treatment Period|Lost to Follow-up|0
861852|NCT01490632|2841929|P20|Part A: Initial Treatment Period|Lack of Efficacy|0
861853|NCT01490632|2841930|P19|Part A: Initial Treatment Period|Lack of Efficacy|0
861854|NCT01490632|2841931|P18|Part A: Initial Treatment Period|Lack of Efficacy|0
861855|NCT01490632|2841932|P17|Part A: Initial Treatment Period|Lack of Efficacy|0
861856|NCT01490632|2841933|P16|Part A: Initial Treatment Period|Lack of Efficacy|0
861857|NCT01490632|2841934|P15|Part A: Initial Treatment Period|Lack of Efficacy|0
861858|NCT01490632|2841935|P14|Part A: Initial Treatment Period|Lack of Efficacy|0
861859|NCT01490632|2841936|P13|Part A: Initial Treatment Period|Lack of Efficacy|0
861860|NCT01490632|2841937|P12|Part A: Initial Treatment Period|Lack of Efficacy|0
861861|NCT01490632|2841938|P11|Part A: Initial Treatment Period|Lack of Efficacy|0
861862|NCT01490632|2841939|P10|Part A: Initial Treatment Period|Lack of Efficacy|0
861863|NCT01490632|2841940|P9|Part A: Initial Treatment Period|Lack of Efficacy|0
861864|NCT01490632|2841941|P8|Part A: Initial Treatment Period|Lack of Efficacy|0
861865|NCT01490632|2841942|P7|Part A: Initial Treatment Period|Lack of Efficacy|0
861866|NCT01490632|2841943|P6|Part A: Initial Treatment Period|Lack of Efficacy|0
861867|NCT01490632|2841944|P5|Part A: Initial Treatment Period|Lack of Efficacy|0
861868|NCT01490632|2841945|P4|Part A: Initial Treatment Period|Lack of Efficacy|2
861869|NCT01490632|2841946|P3|Part A: Initial Treatment Period|Lack of Efficacy|2
861870|NCT01490632|2841947|P2|Part A: Initial Treatment Period|Lack of Efficacy|1
861871|NCT01490632|2841948|P1|Part A: Initial Treatment Period|Lack of Efficacy|3
861872|NCT01490632|2841929|P20|Part A: Initial Treatment Period|Adverse Event|0
861873|NCT01490632|2841930|P19|Part A: Initial Treatment Period|Adverse Event|0
861874|NCT01490632|2841931|P18|Part A: Initial Treatment Period|Adverse Event|0
861875|NCT01490632|2841932|P17|Part A: Initial Treatment Period|Adverse Event|0
861876|NCT01490632|2841933|P16|Part A: Initial Treatment Period|Adverse Event|0
861877|NCT01490632|2841934|P15|Part A: Initial Treatment Period|Adverse Event|0
861878|NCT01490632|2841935|P14|Part A: Initial Treatment Period|Adverse Event|0
861879|NCT01490632|2841936|P13|Part A: Initial Treatment Period|Adverse Event|0
861880|NCT01490632|2841937|P12|Part A: Initial Treatment Period|Adverse Event|0
861881|NCT01490632|2841938|P11|Part A: Initial Treatment Period|Adverse Event|0
861882|NCT01490632|2841939|P10|Part A: Initial Treatment Period|Adverse Event|0
861883|NCT01490632|2841940|P9|Part A: Initial Treatment Period|Adverse Event|0
861884|NCT01490632|2841941|P8|Part A: Initial Treatment Period|Adverse Event|0
861885|NCT01490632|2841942|P7|Part A: Initial Treatment Period|Adverse Event|0
861886|NCT01490632|2841943|P6|Part A: Initial Treatment Period|Adverse Event|0
861887|NCT01490632|2841944|P5|Part A: Initial Treatment Period|Adverse Event|4
861888|NCT01490632|2841945|P4|Part A: Initial Treatment Period|Adverse Event|4
861889|NCT01490632|2841946|P3|Part A: Initial Treatment Period|Adverse Event|2
861890|NCT01490632|2841947|P2|Part A: Initial Treatment Period|Adverse Event|0
861891|NCT01490632|2841948|P1|Part A: Initial Treatment Period|Adverse Event|0
861892|NCT01490294|2842103|P4|Overall Study|Adverse Event|0
861893|NCT01490294|2842104|P3|Overall Study|Adverse Event|0
861894|NCT01490294|2842105|P2|Overall Study|Adverse Event|0
861895|NCT01490294|2842106|P1|Overall Study|Adverse Event|1
861896|NCT01490294|2842103|P4|Overall Study|Prematurely discontinuation|1
861897|NCT01490294|2842104|P3|Overall Study|Prematurely discontinuation|1
861898|NCT01490294|2842105|P2|Overall Study|Prematurely discontinuation|0
861899|NCT01490294|2842106|P1|Overall Study|Prematurely discontinuation|4
861900|NCT01490190|2842340|P1|Overall Study|Ring expulsion|2
861901|NCT01490190|2842340|P1|Overall Study|Inconvenience|1
861902|NCT01490190|2842340|P1|Overall Study|Relocation|1
861903|NCT01490190|2842340|P1|Overall Study|Lost to Follow-up|13
861904|NCT01490190|2842340|P1|Overall Study|Protocol Violation|5
861905|NCT01490190|2842340|P1|Overall Study|Adverse Event|17
861906|NCT01490190|2842340|P1|Overall Study|Withdrawal by Subject|9
861907|NCT01490125|2842367|P6|Period III|Lack of Efficacy|0
861908|NCT01490125|2842368|P5|Period III|Lack of Efficacy|1
861909|NCT01490125|2842369|P4|Period III|Lack of Efficacy|0
861910|NCT01490125|2842370|P3|Period III|Lack of Efficacy|0
861911|NCT01490125|2842371|P2|Period III|Lack of Efficacy|0
861912|NCT01490125|2842372|P1|Period III|Lack of Efficacy|0
861913|NCT01490125|2842367|P6|Period III|Death|0
861914|NCT01490125|2842368|P5|Period III|Death|0
861915|NCT01490125|2842369|P4|Period III|Death|1
861916|NCT01490125|2842370|P3|Period III|Death|0
861917|NCT01490125|2842371|P2|Period III|Death|0
861918|NCT01490125|2842372|P1|Period III|Death|0
861919|NCT01490125|2842367|P6|Period III|Adverse Event|0
861920|NCT01490125|2842368|P5|Period III|Adverse Event|0
861921|NCT01490125|2842369|P4|Period III|Adverse Event|1
861922|NCT01490125|2842370|P3|Period III|Adverse Event|0
861923|NCT01490125|2842371|P2|Period III|Adverse Event|1
861924|NCT01490125|2842372|P1|Period III|Adverse Event|3
861925|NCT01490125|2842367|P6|Period II|Withdrawal by Subject|0
861926|NCT01490125|2842368|P5|Period II|Withdrawal by Subject|0
861927|NCT01490125|2842369|P4|Period II|Withdrawal by Subject|0
861928|NCT01490125|2842370|P3|Period II|Withdrawal by Subject|0
861929|NCT01490125|2842371|P2|Period II|Withdrawal by Subject|0
861930|NCT01490125|2842372|P1|Period II|Withdrawal by Subject|1
861931|NCT01490125|2842367|P6|Period II|Lost to Follow-up|0
861932|NCT01490125|2842368|P5|Period II|Lost to Follow-up|0
861933|NCT01490125|2842369|P4|Period II|Lost to Follow-up|0
861934|NCT01490125|2842370|P3|Period II|Lost to Follow-up|0
861935|NCT01490125|2842371|P2|Period II|Lost to Follow-up|1
861936|NCT01490125|2842372|P1|Period II|Lost to Follow-up|0
861937|NCT01490125|2842367|P6|Period II|Protocol Violation|0
861938|NCT01490125|2842368|P5|Period II|Protocol Violation|0
861939|NCT01490125|2842369|P4|Period II|Protocol Violation|1
861940|NCT01490125|2842370|P3|Period II|Protocol Violation|1
861941|NCT01490125|2842371|P2|Period II|Protocol Violation|0
861942|NCT01490125|2842372|P1|Period II|Protocol Violation|0
861943|NCT01490125|2842367|P6|Period II|Adverse Event|2
861944|NCT01490125|2842368|P5|Period II|Adverse Event|4
861945|NCT01490125|2842369|P4|Period II|Adverse Event|2
861946|NCT01490125|2842370|P3|Period II|Adverse Event|2
861947|NCT01490125|2842371|P2|Period II|Adverse Event|3
861948|NCT01490125|2842372|P1|Period II|Adverse Event|2
861949|NCT01490125|2842367|P6|Period I|Withdrawal by Subject|1
861950|NCT01490125|2842368|P5|Period I|Withdrawal by Subject|2
861951|NCT01490125|2842369|P4|Period I|Withdrawal by Subject|1
861952|NCT01490125|2842370|P3|Period I|Withdrawal by Subject|2
861953|NCT01490125|2842371|P2|Period I|Withdrawal by Subject|3
861954|NCT01490125|2842372|P1|Period I|Withdrawal by Subject|1
861955|NCT01490125|2842367|P6|Period I|Protocol Violation|0
861956|NCT01490125|2842368|P5|Period I|Protocol Violation|0
861957|NCT01490125|2842369|P4|Period I|Protocol Violation|1
861958|NCT01490125|2842370|P3|Period I|Protocol Violation|1
861959|NCT01490125|2842371|P2|Period I|Protocol Violation|1
861960|NCT01490125|2842372|P1|Period I|Protocol Violation|1
861961|NCT01490125|2842367|P6|Period I|Adverse Event|4
861962|NCT01490125|2842368|P5|Period I|Adverse Event|2
861963|NCT01490125|2842369|P4|Period I|Adverse Event|3
861964|NCT01490125|2842370|P3|Period I|Adverse Event|1
861965|NCT01490125|2842371|P2|Period I|Adverse Event|1
861966|NCT01490125|2842372|P1|Period I|Adverse Event|4
861967|NCT01490086|2842400|P5|Overall Study|Subject left hospital|0
861968|NCT01490086|2842401|P4|Overall Study|Subject left hospital|1
861969|NCT01490086|2842402|P3|Overall Study|Subject left hospital|0
861970|NCT01490086|2842403|P2|Overall Study|Subject left hospital|1
861971|NCT01490086|2842404|P1|Overall Study|Subject left hospital|0
861972|NCT01490086|2842400|P5|Overall Study|Subject uncontrollable and abusive|0
861973|NCT01490086|2842401|P4|Overall Study|Subject uncontrollable and abusive|0
861974|NCT01490086|2842402|P3|Overall Study|Subject uncontrollable and abusive|0
861975|NCT01490086|2842403|P2|Overall Study|Subject uncontrollable and abusive|1
861976|NCT01490086|2842404|P1|Overall Study|Subject uncontrollable and abusive|0
861977|NCT01490086|2842400|P5|Overall Study|Worsening of symptoms|0
861978|NCT01490086|2842401|P4|Overall Study|Worsening of symptoms|1
861979|NCT01490086|2842402|P3|Overall Study|Worsening of symptoms|0
861980|NCT01490086|2842403|P2|Overall Study|Worsening of symptoms|1
861981|NCT01490086|2842404|P1|Overall Study|Worsening of symptoms|0
861982|NCT01490086|2842400|P5|Overall Study|Lack of Efficacy|8
861983|NCT01490086|2842401|P4|Overall Study|Lack of Efficacy|0
861984|NCT01490086|2842402|P3|Overall Study|Lack of Efficacy|1
861985|NCT01490086|2842403|P2|Overall Study|Lack of Efficacy|3
861986|NCT01490086|2842404|P1|Overall Study|Lack of Efficacy|0
861987|NCT01490086|2842400|P5|Overall Study|Adverse Event|0
861988|NCT01490086|2842401|P4|Overall Study|Adverse Event|2
861989|NCT01490086|2842402|P3|Overall Study|Adverse Event|1
861990|NCT01490086|2842403|P2|Overall Study|Adverse Event|0
861991|NCT01490086|2842404|P1|Overall Study|Adverse Event|0
861992|NCT01490086|2842400|P5|Overall Study|Physician Decision|1
861993|NCT01490086|2842401|P4|Overall Study|Physician Decision|3
861994|NCT01490086|2842402|P3|Overall Study|Physician Decision|2
861995|NCT01490086|2842403|P2|Overall Study|Physician Decision|4
861996|NCT01490086|2842404|P1|Overall Study|Physician Decision|3
861997|NCT01490086|2842400|P5|Overall Study|Lost to Follow-up|1
861998|NCT01490086|2842401|P4|Overall Study|Lost to Follow-up|0
861999|NCT01490086|2842402|P3|Overall Study|Lost to Follow-up|0
862000|NCT01490086|2842403|P2|Overall Study|Lost to Follow-up|0
862001|NCT01490086|2842404|P1|Overall Study|Lost to Follow-up|0
862002|NCT01490086|2842400|P5|Overall Study|Abnormal laboratory findings|0
862003|NCT01490086|2842401|P4|Overall Study|Abnormal laboratory findings|0
862004|NCT01490086|2842402|P3|Overall Study|Abnormal laboratory findings|0
862005|NCT01490086|2842403|P2|Overall Study|Abnormal laboratory findings|0
862006|NCT01490086|2842404|P1|Overall Study|Abnormal laboratory findings|1
862007|NCT01490086|2842400|P5|Overall Study|Non-compliance|0
862008|NCT01490086|2842401|P4|Overall Study|Non-compliance|0
862009|NCT01490086|2842402|P3|Overall Study|Non-compliance|0
862010|NCT01490086|2842403|P2|Overall Study|Non-compliance|1
862011|NCT01490086|2842404|P1|Overall Study|Non-compliance|0
862012|NCT01490086|2842400|P5|Overall Study|Consent withdrawn|1
862013|NCT01490086|2842401|P4|Overall Study|Consent withdrawn|0
862014|NCT01490086|2842402|P3|Overall Study|Consent withdrawn|3
862015|NCT01490086|2842403|P2|Overall Study|Consent withdrawn|4
862016|NCT01490086|2842404|P1|Overall Study|Consent withdrawn|4
862017|NCT01490060|2842438|P4|Cycle 2|Adverse Event Related to Chemotherapy|0
862018|NCT01490060|2842439|P3|Cycle 2|Adverse Event Related to Chemotherapy|0
862019|NCT01490060|2842440|P2|Cycle 2|Adverse Event Related to Chemotherapy|0
862020|NCT01490060|2842441|P1|Cycle 2|Adverse Event Related to Chemotherapy|1
862021|NCT01490060|2842438|P4|Cycle 2|Non-Compliance|0
862022|NCT01490060|2842439|P3|Cycle 2|Non-Compliance|1
862023|NCT01490060|2842440|P2|Cycle 2|Non-Compliance|0
862024|NCT01490060|2842441|P1|Cycle 2|Non-Compliance|0
862025|NCT01490060|2842438|P4|Cycle 2|Change of Treatment|0
862026|NCT01490060|2842439|P3|Cycle 2|Change of Treatment|0
862027|NCT01490060|2842440|P2|Cycle 2|Change of Treatment|1
862028|NCT01490060|2842441|P1|Cycle 2|Change of Treatment|1
862029|NCT01490060|2842438|P4|Cycle 1|Treatment at Another Facility|1
862030|NCT01490060|2842439|P3|Cycle 1|Treatment at Another Facility|0
862031|NCT01490060|2842440|P2|Cycle 1|Treatment at Another Facility|0
862032|NCT01490060|2842441|P1|Cycle 1|Treatment at Another Facility|0
862033|NCT01490060|2842438|P4|Cycle 1|Withdrawal by Subject|1
862034|NCT01490060|2842439|P3|Cycle 1|Withdrawal by Subject|0
862035|NCT01490060|2842440|P2|Cycle 1|Withdrawal by Subject|0
862036|NCT01490060|2842441|P1|Cycle 1|Withdrawal by Subject|0
862037|NCT01490060|2842438|P4|Cycle 1|Insurance Denied|0
862038|NCT01490060|2842439|P3|Cycle 1|Insurance Denied|2
862039|NCT01490060|2842440|P2|Cycle 1|Insurance Denied|0
862040|NCT01490060|2842441|P1|Cycle 1|Insurance Denied|0
862041|NCT01490060|2842438|P4|Cycle 1|Change of Treatment|1
862042|NCT01490060|2842439|P3|Cycle 1|Change of Treatment|1
862043|NCT01490060|2842440|P2|Cycle 1|Change of Treatment|1
862044|NCT01490060|2842441|P1|Cycle 1|Change of Treatment|0
862045|NCT01489956|2842470|P3|Overall Study|Withdrawal by Subject|1
862046|NCT01489956|2842471|P2|Overall Study|Withdrawal by Subject|0
862047|NCT01489956|2842472|P1|Overall Study|Withdrawal by Subject|0
862048|NCT01489956|2842470|P3|Overall Study|Lost to Follow-up|0
862049|NCT01489956|2842471|P2|Overall Study|Lost to Follow-up|0
862050|NCT01489956|2842472|P1|Overall Study|Lost to Follow-up|1
862051|NCT01489891|2842509|P2|Overall Study|Endoscopy failure|0
862052|NCT01489891|2842510|P1|Overall Study|Endoscopy failure|1
862053|NCT01489527|2842648|P2|Overall Study|Not compliant|0
862054|NCT01489527|2842649|P1|Overall Study|Not compliant|1
862055|NCT01489527|2842648|P2|Overall Study|Procedures|0
862056|NCT01489527|2842649|P1|Overall Study|Procedures|1
862057|NCT01489527|2842648|P2|Overall Study|Lost to Follow-up|1
862058|NCT01489527|2842649|P1|Overall Study|Lost to Follow-up|5
862059|NCT01489527|2842648|P2|Overall Study|Withdrawal by Subject|4
862060|NCT01489527|2842649|P1|Overall Study|Withdrawal by Subject|0
862061|NCT01489527|2842648|P2|Overall Study|Participant moved|7
862062|NCT01489527|2842649|P1|Overall Study|Participant moved|6
862063|NCT01489527|2842648|P2|Overall Study|Pregnancy|14
862064|NCT01489527|2842649|P1|Overall Study|Pregnancy|9
862065|NCT01489358|2842666|P3|Overall Study|Lost to Follow-up|2
862066|NCT01489358|2842667|P2|Overall Study|Lost to Follow-up|0
862067|NCT01489358|2842668|P1|Overall Study|Lost to Follow-up|0
862068|NCT01489254|2842718|P4|Open-label Extension Part|Other reasons for not completing study|5
862069|NCT01489254|2842719|P3|Open-label Extension Part|Other reasons for not completing study|0
862070|NCT01489254|2842720|P2|Open-label Extension Part|Other reasons for not completing study|0
862071|NCT01489254|2842721|P1|Open-label Extension Part|Other reasons for not completing study|0
862072|NCT01489254|2842718|P4|Open-label Extension Part|Lost to Follow-up|9
862073|NCT01489254|2842719|P3|Open-label Extension Part|Lost to Follow-up|0
862074|NCT01489254|2842720|P2|Open-label Extension Part|Lost to Follow-up|0
862075|NCT01489254|2842721|P1|Open-label Extension Part|Lost to Follow-up|0
862076|NCT01489254|2842718|P4|Open-label Extension Part|Protocol Violation|1
862077|NCT01489254|2842719|P3|Open-label Extension Part|Protocol Violation|0
862078|NCT01489254|2842720|P2|Open-label Extension Part|Protocol Violation|0
862079|NCT01489254|2842721|P1|Open-label Extension Part|Protocol Violation|0
862080|NCT01489254|2842718|P4|Open-label Extension Part|Withdrawal by Subject|30
862081|NCT01489254|2842719|P3|Open-label Extension Part|Withdrawal by Subject|0
862082|NCT01489254|2842720|P2|Open-label Extension Part|Withdrawal by Subject|0
862083|NCT01489254|2842721|P1|Open-label Extension Part|Withdrawal by Subject|0
862084|NCT01489254|2842718|P4|Open-label Extension Part|Pregnancy|3
862085|NCT01489254|2842719|P3|Open-label Extension Part|Pregnancy|0
862086|NCT01489254|2842720|P2|Open-label Extension Part|Pregnancy|0
862087|NCT01489254|2842721|P1|Open-label Extension Part|Pregnancy|0
862088|NCT01489254|2842718|P4|Open-label Extension Part|Adverse Event|10
862089|NCT01489254|2842719|P3|Open-label Extension Part|Adverse Event|0
862090|NCT01489254|2842720|P2|Open-label Extension Part|Adverse Event|0
862091|NCT01489254|2842721|P1|Open-label Extension Part|Adverse Event|0
862092|NCT01489254|2842718|P4|Double-blind Part|Other reasons for not completing study|0
862093|NCT01489254|2842719|P3|Double-blind Part|Other reasons for not completing study|0
862094|NCT01489254|2842720|P2|Double-blind Part|Other reasons for not completing study|6
862095|NCT01489254|2842721|P1|Double-blind Part|Other reasons for not completing study|4
862096|NCT01489254|2842718|P4|Double-blind Part|Lost to Follow-up|0
862097|NCT01489254|2842719|P3|Double-blind Part|Lost to Follow-up|0
862098|NCT01489254|2842720|P2|Double-blind Part|Lost to Follow-up|2
862099|NCT01489254|2842721|P1|Double-blind Part|Lost to Follow-up|1
862100|NCT01489254|2842718|P4|Double-blind Part|Withdrawal by Subject|0
862101|NCT01489254|2842719|P3|Double-blind Part|Withdrawal by Subject|1
862102|NCT01489254|2842720|P2|Double-blind Part|Withdrawal by Subject|20
862103|NCT01489254|2842721|P1|Double-blind Part|Withdrawal by Subject|12
862104|NCT01489254|2842718|P4|Double-blind Part|Pregnancy|0
862105|NCT01489254|2842719|P3|Double-blind Part|Pregnancy|0
862106|NCT01489254|2842720|P2|Double-blind Part|Pregnancy|3
862107|NCT01489254|2842721|P1|Double-blind Part|Pregnancy|1
862108|NCT01489254|2842718|P4|Double-blind Part|Adverse Event|0
862109|NCT01489254|2842719|P3|Double-blind Part|Adverse Event|2
862110|NCT01489254|2842720|P2|Double-blind Part|Adverse Event|2
862111|NCT01489254|2842721|P1|Double-blind Part|Adverse Event|7
862112|NCT01489189|2842732|P2|Overall Study|Missed Visit|4
862113|NCT01489189|2842733|P1|Overall Study|Missed Visit|1
862114|NCT01489189|2842732|P2|Overall Study|Death|8
862115|NCT01489189|2842733|P1|Overall Study|Death|10
862116|NCT01489189|2842732|P2|Overall Study|Withdrawal by Subject|23
862117|NCT01489189|2842733|P1|Overall Study|Withdrawal by Subject|20
862118|NCT01488994|2842760|P2|Overall Study|Withdrawal by Subject|1
862119|NCT01488994|2842761|P1|Overall Study|Withdrawal by Subject|0
862120|NCT01488578|2842888|P1|Overall Study|Protocol Violation|1836
862121|NCT01488487|2842922|P1|Overall Study|Withdrawal by Subject|2
862122|NCT01488487|2842922|P1|Overall Study|Death|1
862123|NCT01488487|2842922|P1|Overall Study|Adverse Event|6
862124|NCT01488448|2842931|P2|Overall Study|Protocol Violation|3
862125|NCT01488448|2842932|P1|Overall Study|Protocol Violation|4
862126|NCT01488448|2842931|P2|Overall Study|Physician Decision|9
862127|NCT01488448|2842932|P1|Overall Study|Physician Decision|4
862128|NCT01488448|2842931|P2|Overall Study|Adverse Event|4
862129|NCT01488448|2842932|P1|Overall Study|Adverse Event|9
862130|NCT01488448|2842931|P2|Overall Study|Withdrawal by Subject|1
862131|NCT01488448|2842932|P1|Overall Study|Withdrawal by Subject|3
862132|NCT01488370|2842974|P3|Overall Study|Protocol Violation|1
862133|NCT01488370|2842975|P2|Overall Study|Protocol Violation|1
862134|NCT01488370|2842976|P1|Overall Study|Protocol Violation|0
862135|NCT01488097|2843035|P1|Overall Study|Lost to Follow-up|1
862136|NCT01488071|2843048|P2|Overall Study|Administrative or Other Reason(s)|4
862137|NCT01488071|2843049|P1|Overall Study|Administrative or Other Reason(s)|5
862138|NCT01488071|2843048|P2|Overall Study|Lost to Follow-up|0
862139|NCT01488071|2843049|P1|Overall Study|Lost to Follow-up|1
862140|NCT01488071|2843048|P2|Overall Study|Withdrawal of Consent|12
862141|NCT01488071|2843049|P1|Overall Study|Withdrawal of Consent|14
862142|NCT01488071|2843048|P2|Overall Study|Protocol Violation|7
862143|NCT01488071|2843049|P1|Overall Study|Protocol Violation|5
862144|NCT01488071|2843048|P2|Overall Study|Non-compliance with study drug|0
862145|NCT01488071|2843049|P1|Overall Study|Non-compliance with study drug|2
862146|NCT01488071|2843048|P2|Overall Study|Lack of Efficacy|17
862147|NCT01488071|2843049|P1|Overall Study|Lack of Efficacy|11
862148|NCT01488071|2843048|P2|Overall Study|Adverse Event|23
862149|NCT01488071|2843049|P1|Overall Study|Adverse Event|15
862150|NCT01487863|2843129|P2|Overall Study|Death|19
862151|NCT01487863|2843130|P1|Overall Study|Death|19
862152|NCT01487577|2843147|P1|Overall Study|Became ineligible after signing consent|1
862153|NCT01487525|2843161|P2|Overall Study|Withdrawal by Subject|1
862154|NCT01487525|2843162|P1|Overall Study|Withdrawal by Subject|0
862155|NCT01487265|2843178|P1|Overall Study|Still on Treatment|1
862156|NCT01487265|2843178|P1|Overall Study|Death|2
862157|NCT01487265|2843178|P1|Overall Study|Disease Progression|21
862158|NCT01487265|2843178|P1|Overall Study|Withdrawal by Subject|5
862159|NCT01487265|2843178|P1|Overall Study|Adverse Event|8
862160|NCT01487161|2843190|P4|Overall Study|missing data|0
862161|NCT01487161|2843191|P3|Overall Study|missing data|0
862162|NCT01487161|2843192|P2|Overall Study|missing data|1
862163|NCT01487161|2843193|P1|Overall Study|missing data|0
862164|NCT01487161|2843190|P4|Overall Study|Withdrawal by Subject|2
862165|NCT01487161|2843191|P3|Overall Study|Withdrawal by Subject|1
862166|NCT01487161|2843192|P2|Overall Study|Withdrawal by Subject|1
862167|NCT01487161|2843193|P1|Overall Study|Withdrawal by Subject|1
862168|NCT01487161|2843190|P4|Overall Study|Adverse Event|0
862169|NCT01487161|2843191|P3|Overall Study|Adverse Event|0
862170|NCT01487161|2843192|P2|Overall Study|Adverse Event|0
862171|NCT01487161|2843193|P1|Overall Study|Adverse Event|1
862172|NCT01486966|2843258|P2|Overall Study|Withdrawal by Subject|1
862173|NCT01486966|2843259|P1|Overall Study|Withdrawal by Subject|0
862174|NCT01486966|2843258|P2|Overall Study|Adverse Event|1
862175|NCT01486966|2843259|P1|Overall Study|Adverse Event|0
862176|NCT01486927|2843283|P1|Overall Study|Subject did not reach 6 mo of treatment|1
862177|NCT01486927|2843283|P1|Overall Study|Withdrawal by Subject|8
862178|NCT01486927|2843283|P1|Overall Study|50 Exposure days not reached|2
862179|NCT01486927|2843283|P1|Overall Study|Physician Decision|1
862180|NCT01486927|2843283|P1|Overall Study|Knee surgery (prior to surgery substudy)|1
862181|NCT01486758|2843321|P2|Overall Study|Lost to Follow-up|1
862182|NCT01486758|2843322|P1|Overall Study|Lost to Follow-up|0
862183|NCT01486446|2843389|P2|Overall Study|Adverse Event|0
862184|NCT01486446|2843390|P1|Overall Study|Adverse Event|1
862185|NCT01486316|2843413|P4|Overall Study|Death|0
862186|NCT01486316|2843414|P3|Overall Study|Death|0
862187|NCT01486316|2843415|P2|Overall Study|Death|1
862188|NCT01486316|2843416|P1|Overall Study|Death|0
862189|NCT01486316|2843413|P4|Overall Study|Physician Decision|0
862190|NCT01486316|2843414|P3|Overall Study|Physician Decision|1
862191|NCT01486316|2843415|P2|Overall Study|Physician Decision|0
862192|NCT01486316|2843416|P1|Overall Study|Physician Decision|0
862193|NCT01486316|2843413|P4|Overall Study|Withdrawal by Subject|0
862194|NCT01486316|2843414|P3|Overall Study|Withdrawal by Subject|3
862195|NCT01486316|2843415|P2|Overall Study|Withdrawal by Subject|0
862196|NCT01486316|2843416|P1|Overall Study|Withdrawal by Subject|1
862197|NCT01486316|2843413|P4|Overall Study|Not meeting eligibility criteria|0
862198|NCT01486316|2843414|P3|Overall Study|Not meeting eligibility criteria|1
862199|NCT01486316|2843415|P2|Overall Study|Not meeting eligibility criteria|0
862200|NCT01486316|2843416|P1|Overall Study|Not meeting eligibility criteria|0
862201|NCT01486316|2843413|P4|Overall Study|Device explanted with/without re-implant|2
862202|NCT01486316|2843414|P3|Overall Study|Device explanted with/without re-implant|0
862203|NCT01486316|2843415|P2|Overall Study|Device explanted with/without re-implant|2
862204|NCT01486316|2843416|P1|Overall Study|Device explanted with/without re-implant|3
862205|NCT01486238|2843428|P2|Overall Study|Lost to Follow-up|3
862206|NCT01486238|2843429|P1|Overall Study|Lost to Follow-up|0
862207|NCT01486238|2843428|P2|Overall Study|Withdrawal by Subject|1
862208|NCT01486238|2843429|P1|Overall Study|Withdrawal by Subject|2
862209|NCT01486238|2843428|P2|Overall Study|Death|2
862210|NCT01486238|2843429|P1|Overall Study|Death|0
862211|NCT01486199|2843437|P2|Two Year Period Between Study Days|Physician Decision|0
862212|NCT01486199|2843438|P1|Two Year Period Between Study Days|Physician Decision|1
862213|NCT01485991|2843458|P2|Overall Study|randomized but not treated|2
862214|NCT01485991|2843459|P1|Overall Study|randomized but not treated|6
862215|NCT01485991|2843458|P2|Overall Study|Withdrawal by Subject|20
862216|NCT01485991|2843459|P1|Overall Study|Withdrawal by Subject|13
862217|NCT01485991|2843458|P2|Overall Study|Lost to Follow-up|10
862218|NCT01485991|2843459|P1|Overall Study|Lost to Follow-up|13
862219|NCT01485991|2843458|P2|Overall Study|Adverse Event|4
862220|NCT01485991|2843459|P1|Overall Study|Adverse Event|0
862221|NCT01485887|2843469|P1|Overall Study|Primary disease markedly improved|1
862222|NCT01485887|2843469|P1|Overall Study|Deterioration of primary disease|1
862223|NCT01485887|2843469|P1|Overall Study|Adverse Event|8
862224|NCT01485887|2843469|P1|Overall Study|Withdrawal by Subject|2
862225|NCT01485796|2843481|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2
862226|NCT01485796|2843481|P1|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3
862227|NCT01485796|2843481|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6
862228|NCT01485796|2843481|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1
862229|NCT01485796|2843481|P1|Period 2: Epoch 2|Switch to safety follow-up|26
862230|NCT01485796|2843481|P1|Period 2: Epoch 2|Adverse Event|3
862231|NCT01485796|2843481|P1|Period 2: Epoch 2|Withdrawal by Subject|6
862232|NCT01485796|2843481|P1|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1
862233|NCT01485640|2843503|P1|Overall Study|Terminated by Sponsor|95
862234|NCT01485640|2843503|P1|Overall Study|Withdrawal by Subject|14
862235|NCT01485640|2843503|P1|Overall Study|Protocol Violation|1
862236|NCT01485640|2843503|P1|Overall Study|Lack of Efficacy|2
862237|NCT01485640|2843503|P1|Overall Study|Adverse Event|10
862238|NCT01485536|2843508|P1|Overall Study|Adverse Event|1
862239|NCT01485536|2843508|P1|Overall Study|Withdrawal by Subject|3
862240|NCT01485354|2843517|P1|Overall Study|Withdrawal by Subject|5
862241|NCT01485172|2843531|P6|Overall Study|Withdrawal by Subject|1
862242|NCT01485172|2843532|P5|Overall Study|Withdrawal by Subject|1
862243|NCT01485172|2843533|P4|Overall Study|Withdrawal by Subject|1
862244|NCT01485172|2843534|P3|Overall Study|Withdrawal by Subject|0
862245|NCT01485172|2843535|P2|Overall Study|Withdrawal by Subject|0
862246|NCT01485172|2843536|P1|Overall Study|Withdrawal by Subject|2
862247|NCT01485172|2843531|P6|Overall Study|Physician Decision|0
862248|NCT01485172|2843532|P5|Overall Study|Physician Decision|1
862249|NCT01485172|2843533|P4|Overall Study|Physician Decision|0
862250|NCT01485172|2843534|P3|Overall Study|Physician Decision|0
862251|NCT01485172|2843535|P2|Overall Study|Physician Decision|0
862252|NCT01485172|2843536|P1|Overall Study|Physician Decision|0
862253|NCT01485172|2843531|P6|Overall Study|Lost to Follow-up|1
862254|NCT01485172|2843532|P5|Overall Study|Lost to Follow-up|0
862255|NCT01485172|2843533|P4|Overall Study|Lost to Follow-up|0
862256|NCT01485172|2843534|P3|Overall Study|Lost to Follow-up|1
862257|NCT01485172|2843535|P2|Overall Study|Lost to Follow-up|0
862258|NCT01485172|2843536|P1|Overall Study|Lost to Follow-up|0
862259|NCT01485172|2843531|P6|Overall Study|Protocol defined stopping criteria|0
862260|NCT01485172|2843532|P5|Overall Study|Protocol defined stopping criteria|1
862261|NCT01485172|2843533|P4|Overall Study|Protocol defined stopping criteria|0
862262|NCT01485172|2843534|P3|Overall Study|Protocol defined stopping criteria|0
862263|NCT01485172|2843535|P2|Overall Study|Protocol defined stopping criteria|0
862264|NCT01485172|2843536|P1|Overall Study|Protocol defined stopping criteria|1
862265|NCT01485172|2843531|P6|Overall Study|Protocol Violation|0
862266|NCT01485172|2843532|P5|Overall Study|Protocol Violation|1
862267|NCT01485172|2843533|P4|Overall Study|Protocol Violation|5
862268|NCT01485172|2843534|P3|Overall Study|Protocol Violation|4
862269|NCT01485172|2843535|P2|Overall Study|Protocol Violation|0
862270|NCT01485172|2843536|P1|Overall Study|Protocol Violation|0
862271|NCT01485172|2843531|P6|Overall Study|Lack of Efficacy|0
862272|NCT01485172|2843532|P5|Overall Study|Lack of Efficacy|0
862273|NCT01485172|2843533|P4|Overall Study|Lack of Efficacy|0
862274|NCT01485172|2843534|P3|Overall Study|Lack of Efficacy|0
862275|NCT01485172|2843535|P2|Overall Study|Lack of Efficacy|0
862276|NCT01485172|2843536|P1|Overall Study|Lack of Efficacy|2
862277|NCT01485172|2843531|P6|Overall Study|Adverse Event|2
862278|NCT01485172|2843532|P5|Overall Study|Adverse Event|1
862279|NCT01485172|2843533|P4|Overall Study|Adverse Event|2
862280|NCT01485172|2843534|P3|Overall Study|Adverse Event|2
862281|NCT01485172|2843535|P2|Overall Study|Adverse Event|1
862282|NCT01485172|2843536|P1|Overall Study|Adverse Event|2
862283|NCT01485094|2843613|P3|Overall Study|Withdrawal by Subject|0
862284|NCT01485094|2843614|P2|Overall Study|Withdrawal by Subject|1
862285|NCT01485094|2843615|P1|Overall Study|Withdrawal by Subject|1
862286|NCT01485094|2843613|P3|Overall Study|Lost to Follow-up|0
862287|NCT01485094|2843614|P2|Overall Study|Lost to Follow-up|0
862288|NCT01485094|2843615|P1|Overall Study|Lost to Follow-up|1
862289|NCT01485094|2843613|P3|Overall Study|Adverse Event|1
862290|NCT01485094|2843614|P2|Overall Study|Adverse Event|1
862291|NCT01485094|2843615|P1|Overall Study|Adverse Event|1
862292|NCT01484977|2843656|P1|Overall Study|Lack of Compliance|1
862293|NCT01484977|2843656|P1|Overall Study|Low White Blood Cell Count|1
862294|NCT01484977|2843656|P1|Overall Study|Moving Overseas|1
862295|NCT01484977|2843656|P1|Overall Study|Subject Protocol Non-compliant|1
862296|NCT01484977|2843656|P1|Overall Study|Withdrawal by Subject|4
862297|NCT01484977|2843656|P1|Overall Study|Lost to Follow-up|1
862298|NCT01484977|2843656|P1|Overall Study|Protocol Violation|6
862299|NCT01484977|2843656|P1|Overall Study|Lack of Efficacy|4
862300|NCT01484977|2843656|P1|Overall Study|Adverse Event|8
862301|NCT01484951|2843660|P1|Overall Study|Non-Compliance|1
862302|NCT01484951|2843660|P1|Overall Study|Personal Reasons|1
862303|NCT01484951|2843660|P1|Overall Study|Adverse Event|3
862304|NCT01484938|2843665|P1|Overall Study|Noncompliance|1
862305|NCT01484938|2843665|P1|Overall Study|Lost to Follow-up|1
862306|NCT01484938|2843665|P1|Overall Study|Adverse Event|2
862307|NCT01484912|2843672|P2|Overall Study|Physician Decision|1
862308|NCT01484912|2843673|P1|Overall Study|Physician Decision|0
862309|NCT01484912|2843672|P2|Overall Study|Withdrawal by Subject|0
862310|NCT01484912|2843673|P1|Overall Study|Withdrawal by Subject|1
862311|NCT01484873|2843683|P1|Overall Study|Withdrawal by Subject|2
862312|NCT01484834|2843695|P4|Overall Study|Lost to Follow-up|4
862313|NCT01484834|2843696|P3|Overall Study|Lost to Follow-up|1
862314|NCT01484834|2843697|P2|Overall Study|Lost to Follow-up|8
862315|NCT01484834|2843698|P1|Overall Study|Lost to Follow-up|5
862316|NCT01484561|2843739|P2|Overall Study|Adverse Event|4
862317|NCT01484561|2843740|P1|Overall Study|Adverse Event|1
862318|NCT01484561|2843739|P2|Overall Study|Not specified|1
862319|NCT01484561|2843740|P1|Overall Study|Not specified|1
862320|NCT01484561|2843739|P2|Overall Study|Withdrawal by Subject|0
862321|NCT01484561|2843740|P1|Overall Study|Withdrawal by Subject|3
862322|NCT01484561|2843739|P2|Overall Study|Lost to Follow-up|0
862323|NCT01484561|2843740|P1|Overall Study|Lost to Follow-up|1
862324|NCT01484561|2843739|P2|Overall Study|Lack of Efficacy|1
862325|NCT01484561|2843740|P1|Overall Study|Lack of Efficacy|3
862326|NCT01484496|2843830|P4|Period 2|Other|6
862327|NCT01484496|2843831|P3|Period 2|Other|9
862328|NCT01484496|2843832|P2|Period 2|Other|0
862329|NCT01484496|2843833|P1|Period 2|Other|0
862330|NCT01484496|2843830|P4|Period 2|Adverse Event|13
862331|NCT01484496|2843831|P3|Period 2|Adverse Event|5
862332|NCT01484496|2843832|P2|Period 2|Adverse Event|0
862333|NCT01484496|2843833|P1|Period 2|Adverse Event|0
862334|NCT01484496|2843830|P4|Period 2|Lack of Efficacy|3
862335|NCT01484496|2843831|P3|Period 2|Lack of Efficacy|1
862336|NCT01484496|2843832|P2|Period 2|Lack of Efficacy|0
862337|NCT01484496|2843833|P1|Period 2|Lack of Efficacy|0
862338|NCT01484496|2843830|P4|Period 1|Unable to Visit Site|0
862339|NCT01484496|2843831|P3|Period 1|Unable to Visit Site|0
862340|NCT01484496|2843832|P2|Period 1|Unable to Visit Site|2
862341|NCT01484496|2843833|P1|Period 1|Unable to Visit Site|0
862342|NCT01484496|2843830|P4|Period 1|Lack of Compliance|0
862343|NCT01484496|2843831|P3|Period 1|Lack of Compliance|0
862344|NCT01484496|2843832|P2|Period 1|Lack of Compliance|1
862345|NCT01484496|2843833|P1|Period 1|Lack of Compliance|2
862346|NCT01484496|2843830|P4|Period 1|Treatment Failure|0
862347|NCT01484496|2843831|P3|Period 1|Treatment Failure|0
862348|NCT01484496|2843832|P2|Period 1|Treatment Failure|6
862349|NCT01484496|2843833|P1|Period 1|Treatment Failure|3
862350|NCT01484496|2843830|P4|Period 1|Positive Pregnancy|0
862351|NCT01484496|2843831|P3|Period 1|Positive Pregnancy|0
862352|NCT01484496|2843832|P2|Period 1|Positive Pregnancy|6
862353|NCT01484496|2843833|P1|Period 1|Positive Pregnancy|1
862354|NCT01484496|2843830|P4|Period 1|Lost to Follow-up|0
862355|NCT01484496|2843831|P3|Period 1|Lost to Follow-up|0
862356|NCT01484496|2843832|P2|Period 1|Lost to Follow-up|6
862357|NCT01484496|2843833|P1|Period 1|Lost to Follow-up|2
862358|NCT01484496|2843830|P4|Period 1|Withdrawal by Subject|0
862359|NCT01484496|2843831|P3|Period 1|Withdrawal by Subject|0
862360|NCT01484496|2843832|P2|Period 1|Withdrawal by Subject|12
862361|NCT01484496|2843833|P1|Period 1|Withdrawal by Subject|15
862362|NCT01484496|2843830|P4|Period 1|Adverse Event|0
862363|NCT01484496|2843831|P3|Period 1|Adverse Event|0
862364|NCT01484496|2843832|P2|Period 1|Adverse Event|40
862365|NCT01484496|2843833|P1|Period 1|Adverse Event|25
862366|NCT01484496|2843830|P4|Period 1|Lack of Efficacy|0
862367|NCT01484496|2843831|P3|Period 1|Lack of Efficacy|0
862368|NCT01484496|2843832|P2|Period 1|Lack of Efficacy|15
862369|NCT01484496|2843833|P1|Period 1|Lack of Efficacy|10
862370|NCT01484496|2843830|P4|Period 1|Physician Decision|0
862371|NCT01484496|2843831|P3|Period 1|Physician Decision|0
862372|NCT01484496|2843832|P2|Period 1|Physician Decision|1
862373|NCT01484496|2843833|P1|Period 1|Physician Decision|5
862374|NCT01484496|2843830|P4|Period 1|Protocol Violation|0
862375|NCT01484496|2843831|P3|Period 1|Protocol Violation|0
862376|NCT01484496|2843832|P2|Period 1|Protocol Violation|4
862377|NCT01484496|2843833|P1|Period 1|Protocol Violation|3
862378|NCT01484197|2843866|P4|Treatment Period 2|Subject withdrew consent|1
862379|NCT01484197|2843867|P3|Treatment Period 2|Subject withdrew consent|0
862380|NCT01484197|2843868|P2|Treatment Period 2|Subject withdrew consent|0
862381|NCT01484197|2843869|P1|Treatment Period 2|Subject withdrew consent|0
862382|NCT01484197|2843866|P4|Treatment Period 1|Adverse Event|0
862383|NCT01484197|2843867|P3|Treatment Period 1|Adverse Event|0
862384|NCT01484197|2843868|P2|Treatment Period 1|Adverse Event|0
862385|NCT01484197|2843869|P1|Treatment Period 1|Adverse Event|1
862386|NCT01484132|2843952|P1|Overall Study|No post-treatment urine sample collected|10
862387|NCT01484132|2843952|P1|Overall Study|No pre-treatment urine sample collected|1
862388|NCT01484132|2843952|P1|Overall Study|Ineligible|1
862389|NCT01484132|2843952|P1|Overall Study|Difficulty with time commitment|2
862390|NCT01484132|2843952|P1|Overall Study|Lost to Follow-up|8
862391|NCT01484054|2843960|P2|Period 1|Withdrawal by Subject|1
862392|NCT01484054|2843961|P1|Period 1|Withdrawal by Subject|0
862393|NCT01484028|2843979|P4|Period 1|Lens Discomfort|0
862394|NCT01484028|2843980|P3|Period 1|Lens Discomfort|0
862395|NCT01484028|2843981|P2|Period 1|Lens Discomfort|1
862396|NCT01484028|2843982|P1|Period 1|Lens Discomfort|0
862397|NCT01484028|2843979|P4|Period 1|Non-Compliance to Protocol|1
862398|NCT01484028|2843980|P3|Period 1|Non-Compliance to Protocol|0
862399|NCT01484028|2843981|P2|Period 1|Non-Compliance to Protocol|1
862400|NCT01484028|2843982|P1|Period 1|Non-Compliance to Protocol|0
862401|NCT01484028|2843979|P4|Period 1|Lost to Follow-up|0
862402|NCT01484028|2843980|P3|Period 1|Lost to Follow-up|0
862403|NCT01484028|2843981|P2|Period 1|Lost to Follow-up|1
862404|NCT01484028|2843982|P1|Period 1|Lost to Follow-up|0
862405|NCT01483937|2844075|P2|Overall Study|Withdrawal by Subject|3
862406|NCT01483937|2844076|P1|Overall Study|Withdrawal by Subject|4
862407|NCT01483924|2844103|P5|Overall Study|Sponsor concern over ECG result|0
862408|NCT01483924|2844104|P4|Overall Study|Sponsor concern over ECG result|1
862409|NCT01483924|2844105|P3|Overall Study|Sponsor concern over ECG result|0
862410|NCT01483924|2844106|P2|Overall Study|Sponsor concern over ECG result|0
862411|NCT01483924|2844107|P1|Overall Study|Sponsor concern over ECG result|0
862412|NCT01483924|2844103|P5|Overall Study|Non-compliance|1
862413|NCT01483924|2844104|P4|Overall Study|Non-compliance|1
862414|NCT01483924|2844105|P3|Overall Study|Non-compliance|0
862415|NCT01483924|2844106|P2|Overall Study|Non-compliance|0
862416|NCT01483924|2844107|P1|Overall Study|Non-compliance|0
862417|NCT01483924|2844103|P5|Overall Study|Adverse Event|0
862418|NCT01483924|2844104|P4|Overall Study|Adverse Event|1
862419|NCT01483924|2844105|P3|Overall Study|Adverse Event|1
862420|NCT01483924|2844106|P2|Overall Study|Adverse Event|0
862421|NCT01483924|2844107|P1|Overall Study|Adverse Event|0
862422|NCT01483924|2844103|P5|Overall Study|Withdrawal by Subject|1
862423|NCT01483924|2844104|P4|Overall Study|Withdrawal by Subject|1
862424|NCT01483924|2844105|P3|Overall Study|Withdrawal by Subject|0
862425|NCT01483924|2844106|P2|Overall Study|Withdrawal by Subject|0
862426|NCT01483924|2844107|P1|Overall Study|Withdrawal by Subject|2
862427|NCT01483820|2844155|P1|Overall Study|Death|1
862428|NCT01483820|2844155|P1|Overall Study|Adverse Event|1
862429|NCT01483820|2844155|P1|Overall Study|Lack of Efficacy|6
862430|NCT01483651|2844164|P6|Overall Study|Withdrawal by Subject|1
862431|NCT01483651|2844165|P5|Overall Study|Withdrawal by Subject|0
862432|NCT01483651|2844166|P4|Overall Study|Withdrawal by Subject|0
862433|NCT01483651|2844167|P3|Overall Study|Withdrawal by Subject|1
862434|NCT01483651|2844168|P2|Overall Study|Withdrawal by Subject|1
862435|NCT01483651|2844169|P1|Overall Study|Withdrawal by Subject|0
862436|NCT01483625|2844179|P2|Overall Study|Due to other reason|0
862437|NCT01483625|2844180|P1|Overall Study|Due to other reason|1
862438|NCT01483625|2844179|P2|Overall Study|Refused to continue medication|1
862439|NCT01483625|2844180|P1|Overall Study|Refused to continue medication|2
862440|NCT01483625|2844179|P2|Overall Study|Adverse Event|1
862441|NCT01483625|2844180|P1|Overall Study|Adverse Event|1
862442|NCT01483599|2844203|P14|After Controlled Period(Week 16-Week 40)|Other|0
862443|NCT01483599|2844204|P13|After Controlled Period(Week 16-Week 40)|Other|1
862444|NCT01483599|2844205|P12|After Controlled Period(Week 16-Week 40)|Other|0
862445|NCT01483599|2844206|P11|After Controlled Period(Week 16-Week 40)|Other|0
862446|NCT01483599|2844207|P10|After Controlled Period(Week 16-Week 40)|Other|4
862447|NCT01483599|2844208|P9|After Controlled Period(Week 16-Week 40)|Other|0
862448|NCT01483599|2844209|P8|After Controlled Period(Week 16-Week 40)|Other|1
862449|NCT01483599|2844210|P7|After Controlled Period(Week 16-Week 40)|Other|0
862450|NCT01483599|2844211|P6|After Controlled Period(Week 16-Week 40)|Other|0
862451|NCT01483599|2844212|P5|After Controlled Period(Week 16-Week 40)|Other|0
862452|NCT01483599|2844213|P4|After Controlled Period(Week 16-Week 40)|Other|0
862453|NCT01483599|2844214|P3|After Controlled Period(Week 16-Week 40)|Other|0
862454|NCT01483599|2844215|P2|After Controlled Period(Week 16-Week 40)|Other|0
862455|NCT01483599|2844216|P1|After Controlled Period(Week 16-Week 40)|Other|0
862456|NCT01483599|2844203|P14|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4
862457|NCT01483599|2844204|P13|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1
862458|NCT01483599|2844205|P12|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
862459|NCT01483599|2844206|P11|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
862460|NCT01483599|2844207|P10|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
862461|NCT01483599|2844208|P9|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5
862462|NCT01483599|2844209|P8|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
862463|NCT01483599|2844210|P7|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
862464|NCT01483599|2844211|P6|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
862465|NCT01483599|2844212|P5|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
862466|NCT01483599|2844213|P4|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
862467|NCT01483599|2844214|P3|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
862468|NCT01483599|2844215|P2|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
862469|NCT01483599|2844216|P1|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
862470|NCT01483599|2844203|P14|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
862471|NCT01483599|2844204|P13|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
862472|NCT01483599|2844205|P12|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
862473|NCT01483599|2844206|P11|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2
862474|NCT01483599|2844207|P10|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
862475|NCT01483599|2844208|P9|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
862476|NCT01483599|2844209|P8|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
862477|NCT01483599|2844210|P7|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
862478|NCT01483599|2844211|P6|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
862479|NCT01483599|2844212|P5|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
862480|NCT01483599|2844213|P4|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
862481|NCT01483599|2844214|P3|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
862482|NCT01483599|2844215|P2|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
862483|NCT01483599|2844216|P1|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
862484|NCT01483599|2844203|P14|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
862485|NCT01483599|2844204|P13|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
862486|NCT01483599|2844205|P12|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
862487|NCT01483599|2844206|P11|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
862488|NCT01483599|2844207|P10|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
862489|NCT01483599|2844208|P9|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
862490|NCT01483599|2844209|P8|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
862491|NCT01483599|2844210|P7|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
862492|NCT01483599|2844211|P6|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
862493|NCT01483599|2844212|P5|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
862494|NCT01483599|2844213|P4|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
862495|NCT01483599|2844214|P3|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
862496|NCT01483599|2844215|P2|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
862497|NCT01483599|2844216|P1|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
862498|NCT01483599|2844203|P14|After Controlled Period(Week 16-Week 40)|Adverse Event|1
862499|NCT01483599|2844204|P13|After Controlled Period(Week 16-Week 40)|Adverse Event|1
862500|NCT01483599|2844205|P12|After Controlled Period(Week 16-Week 40)|Adverse Event|0
862501|NCT01483599|2844206|P11|After Controlled Period(Week 16-Week 40)|Adverse Event|0
862502|NCT01483599|2844207|P10|After Controlled Period(Week 16-Week 40)|Adverse Event|0
862503|NCT01483599|2844208|P9|After Controlled Period(Week 16-Week 40)|Adverse Event|1
862504|NCT01483599|2844209|P8|After Controlled Period(Week 16-Week 40)|Adverse Event|1
862505|NCT01483599|2844210|P7|After Controlled Period(Week 16-Week 40)|Adverse Event|0
862506|NCT01483599|2844211|P6|After Controlled Period(Week 16-Week 40)|Adverse Event|0
862507|NCT01483599|2844212|P5|After Controlled Period(Week 16-Week 40)|Adverse Event|0
862508|NCT01483599|2844213|P4|After Controlled Period(Week 16-Week 40)|Adverse Event|0
862509|NCT01483599|2844214|P3|After Controlled Period(Week 16-Week 40)|Adverse Event|0
862510|NCT01483599|2844215|P2|After Controlled Period(Week 16-Week 40)|Adverse Event|0
862511|NCT01483599|2844216|P1|After Controlled Period(Week 16-Week 40)|Adverse Event|0
862512|NCT01483599|2844203|P14|After Controlled Period(Week 16-Week 40)|Death|0
862513|NCT01483599|2844204|P13|After Controlled Period(Week 16-Week 40)|Death|0
862514|NCT01483599|2844205|P12|After Controlled Period(Week 16-Week 40)|Death|0
862515|NCT01483599|2844206|P11|After Controlled Period(Week 16-Week 40)|Death|0
862516|NCT01483599|2844207|P10|After Controlled Period(Week 16-Week 40)|Death|0
862517|NCT01483599|2844208|P9|After Controlled Period(Week 16-Week 40)|Death|1
862518|NCT01483599|2844209|P8|After Controlled Period(Week 16-Week 40)|Death|0
862519|NCT01483599|2844210|P7|After Controlled Period(Week 16-Week 40)|Death|0
862520|NCT01483599|2844211|P6|After Controlled Period(Week 16-Week 40)|Death|0
862521|NCT01483599|2844212|P5|After Controlled Period(Week 16-Week 40)|Death|0
862522|NCT01483599|2844213|P4|After Controlled Period(Week 16-Week 40)|Death|0
862523|NCT01483599|2844214|P3|After Controlled Period(Week 16-Week 40)|Death|0
862524|NCT01483599|2844215|P2|After Controlled Period(Week 16-Week 40)|Death|0
862525|NCT01483599|2844216|P1|After Controlled Period(Week 16-Week 40)|Death|0
862526|NCT01483599|2844203|P14|Controlled Period (CP) (up to Week 16)|Other|0
862527|NCT01483599|2844204|P13|Controlled Period (CP) (up to Week 16)|Other|0
862528|NCT01483599|2844205|P12|Controlled Period (CP) (up to Week 16)|Other|0
862529|NCT01483599|2844206|P11|Controlled Period (CP) (up to Week 16)|Other|0
862530|NCT01483599|2844207|P10|Controlled Period (CP) (up to Week 16)|Other|0
862531|NCT01483599|2844208|P9|Controlled Period (CP) (up to Week 16)|Other|0
862532|NCT01483599|2844209|P8|Controlled Period (CP) (up to Week 16)|Other|0
862533|NCT01483599|2844210|P7|Controlled Period (CP) (up to Week 16)|Other|0
862534|NCT01483599|2844211|P6|Controlled Period (CP) (up to Week 16)|Other|0
862535|NCT01483599|2844212|P5|Controlled Period (CP) (up to Week 16)|Other|1
862536|NCT01483599|2844213|P4|Controlled Period (CP) (up to Week 16)|Other|1
862537|NCT01483599|2844214|P3|Controlled Period (CP) (up to Week 16)|Other|0
862538|NCT01483599|2844215|P2|Controlled Period (CP) (up to Week 16)|Other|2
862539|NCT01483599|2844216|P1|Controlled Period (CP) (up to Week 16)|Other|0
862540|NCT01483599|2844203|P14|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
862541|NCT01483599|2844204|P13|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
862542|NCT01483599|2844205|P12|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
862543|NCT01483599|2844206|P11|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
862544|NCT01483599|2844207|P10|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
862545|NCT01483599|2844208|P9|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
862546|NCT01483599|2844209|P8|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
862547|NCT01483599|2844210|P7|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
862548|NCT01483599|2844211|P6|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
862549|NCT01483599|2844212|P5|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
862550|NCT01483599|2844213|P4|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
862551|NCT01483599|2844214|P3|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
862552|NCT01483599|2844215|P2|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
862553|NCT01483599|2844216|P1|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1
862554|NCT01483599|2844203|P14|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
862555|NCT01483599|2844204|P13|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
862556|NCT01483599|2844205|P12|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
862557|NCT01483599|2844206|P11|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
862558|NCT01483599|2844207|P10|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
862729|NCT01481116|2844775|P2|Overall Study|Non-Compliant With Study Drug|1
862559|NCT01483599|2844208|P9|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
862560|NCT01483599|2844209|P8|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
862561|NCT01483599|2844210|P7|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
862562|NCT01483599|2844211|P6|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
862563|NCT01483599|2844212|P5|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
862564|NCT01483599|2844213|P4|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
862565|NCT01483599|2844214|P3|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
862566|NCT01483599|2844215|P2|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
862567|NCT01483599|2844216|P1|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
862568|NCT01483599|2844203|P14|Controlled Period (CP) (up to Week 16)|Adverse Event|0
862569|NCT01483599|2844204|P13|Controlled Period (CP) (up to Week 16)|Adverse Event|0
862570|NCT01483599|2844205|P12|Controlled Period (CP) (up to Week 16)|Adverse Event|0
862571|NCT01483599|2844206|P11|Controlled Period (CP) (up to Week 16)|Adverse Event|0
862572|NCT01483599|2844207|P10|Controlled Period (CP) (up to Week 16)|Adverse Event|0
862573|NCT01483599|2844208|P9|Controlled Period (CP) (up to Week 16)|Adverse Event|0
862574|NCT01483599|2844209|P8|Controlled Period (CP) (up to Week 16)|Adverse Event|0
862575|NCT01483599|2844210|P7|Controlled Period (CP) (up to Week 16)|Adverse Event|3
862576|NCT01483599|2844211|P6|Controlled Period (CP) (up to Week 16)|Adverse Event|4
862577|NCT01483599|2844212|P5|Controlled Period (CP) (up to Week 16)|Adverse Event|1
862578|NCT01483599|2844213|P4|Controlled Period (CP) (up to Week 16)|Adverse Event|1
862579|NCT01483599|2844214|P3|Controlled Period (CP) (up to Week 16)|Adverse Event|0
862580|NCT01483599|2844215|P2|Controlled Period (CP) (up to Week 16)|Adverse Event|0
862581|NCT01483599|2844216|P1|Controlled Period (CP) (up to Week 16)|Adverse Event|2
862582|NCT01483183|2844306|P10|Overall Study|Withdrawal by Subject|1
862583|NCT01483183|2844307|P9|Overall Study|Withdrawal by Subject|0
862584|NCT01483183|2844308|P8|Overall Study|Withdrawal by Subject|0
862585|NCT01483183|2844309|P7|Overall Study|Withdrawal by Subject|0
862586|NCT01483183|2844310|P6|Overall Study|Withdrawal by Subject|0
862587|NCT01483183|2844311|P5|Overall Study|Withdrawal by Subject|0
862588|NCT01483183|2844312|P4|Overall Study|Withdrawal by Subject|0
862589|NCT01483183|2844313|P3|Overall Study|Withdrawal by Subject|0
862590|NCT01483183|2844314|P2|Overall Study|Withdrawal by Subject|0
862591|NCT01483183|2844315|P1|Overall Study|Withdrawal by Subject|0
862592|NCT01483183|2844306|P10|Overall Study|Physician Decision|0
862593|NCT01483183|2844307|P9|Overall Study|Physician Decision|0
862594|NCT01483183|2844308|P8|Overall Study|Physician Decision|0
862595|NCT01483183|2844309|P7|Overall Study|Physician Decision|2
862596|NCT01483183|2844310|P6|Overall Study|Physician Decision|0
862597|NCT01483183|2844311|P5|Overall Study|Physician Decision|0
862598|NCT01483183|2844312|P4|Overall Study|Physician Decision|0
862599|NCT01483183|2844313|P3|Overall Study|Physician Decision|0
862600|NCT01483183|2844314|P2|Overall Study|Physician Decision|0
862601|NCT01483183|2844315|P1|Overall Study|Physician Decision|0
862602|NCT01483118|2844385|P2|Overall Study|Lost to Follow-up|16
862603|NCT01483118|2844386|P1|Overall Study|Lost to Follow-up|12
862604|NCT01482962|2844398|P2|Overall Study|Did not Receive Study Drug|6
862605|NCT01482962|2844399|P1|Overall Study|Did not Receive Study Drug|1
862606|NCT01482962|2844398|P2|Overall Study|Study Terminated by Sponsor|2
862607|NCT01482962|2844399|P1|Overall Study|Study Terminated by Sponsor|5
862608|NCT01482962|2844398|P2|Overall Study|Other Reason|5
862609|NCT01482962|2844399|P1|Overall Study|Other Reason|1
862610|NCT01482962|2844398|P2|Overall Study|Hematopoietic Stem Cell Transplant|9
862611|NCT01482962|2844399|P1|Overall Study|Hematopoietic Stem Cell Transplant|3
862612|NCT01482962|2844398|P2|Overall Study|Withdrawal by Participant|13
862613|NCT01482962|2844399|P1|Overall Study|Withdrawal by Participant|8
862614|NCT01482962|2844398|P2|Overall Study|Adverse Event|22
862615|NCT01482962|2844399|P1|Overall Study|Adverse Event|18
862616|NCT01482962|2844398|P2|Overall Study|Unsatisfactory Therapeutic Response|23
862617|NCT01482962|2844399|P1|Overall Study|Unsatisfactory Therapeutic Response|37
862618|NCT01482962|2844398|P2|Overall Study|Progressive Disease|53
862619|NCT01482962|2844399|P1|Overall Study|Progressive Disease|65
862620|NCT01482910|2844432|P2|Overall Study|Death|0
862621|NCT01482910|2844433|P1|Overall Study|Death|1
862622|NCT01482910|2844432|P2|Overall Study|Withdrawal by Subject|2
862623|NCT01482910|2844433|P1|Overall Study|Withdrawal by Subject|7
862624|NCT01482910|2844432|P2|Overall Study|Protocol Violation|1
862625|NCT01482910|2844433|P1|Overall Study|Protocol Violation|1
862626|NCT01482910|2844432|P2|Overall Study|Lost to Follow-up|1
862627|NCT01482910|2844433|P1|Overall Study|Lost to Follow-up|0
862628|NCT01482910|2844432|P2|Overall Study|Adverse Event|5
862629|NCT01482910|2844433|P1|Overall Study|Adverse Event|6
862630|NCT01482884|2844445|P2|Overall Study|Withdrawal by Subject|13
862631|NCT01482884|2844446|P1|Overall Study|Withdrawal by Subject|8
862632|NCT01482884|2844445|P2|Overall Study|Adverse Event|1
862633|NCT01482884|2844446|P1|Overall Study|Adverse Event|2
862634|NCT01482884|2844445|P2|Overall Study|Lack of Efficacy|1
862635|NCT01482884|2844446|P1|Overall Study|Lack of Efficacy|0
862636|NCT01482884|2844445|P2|Overall Study|Lost to Follow-up|2
862637|NCT01482884|2844446|P1|Overall Study|Lost to Follow-up|2
862638|NCT01482884|2844445|P2|Overall Study|Protocol Violation|0
862639|NCT01482884|2844446|P1|Overall Study|Protocol Violation|1
862640|NCT01482884|2844445|P2|Overall Study|Medical decision due to lack of efficacy|1
862730|NCT01481116|2844776|P1|Overall Study|Non-Compliant With Study Drug|0
862641|NCT01482884|2844446|P1|Overall Study|Medical decision due to lack of efficacy|0
862642|NCT01482819|2844472|P1|Overall Study|Lost to Follow-up|2
862643|NCT01482767|2844492|P2|Overall Study|Nurse error|0
862644|NCT01482767|2844493|P1|Overall Study|Nurse error|1
862645|NCT01482767|2844492|P2|Overall Study|Ineligible|5
862646|NCT01482767|2844493|P1|Overall Study|Ineligible|0
862647|NCT01482767|2844492|P2|Overall Study|Alternate HCV treatment|8
862648|NCT01482767|2844493|P1|Overall Study|Alternate HCV treatment|7
862649|NCT01482767|2844492|P2|Overall Study|Non-adherence to study requirements|7
862650|NCT01482767|2844493|P1|Overall Study|Non-adherence to study requirements|4
862651|NCT01482767|2844492|P2|Overall Study|Site closure|14
862652|NCT01482767|2844493|P1|Overall Study|Site closure|22
862653|NCT01482767|2844492|P2|Overall Study|Adverse Event|3
862654|NCT01482767|2844493|P1|Overall Study|Adverse Event|0
862655|NCT01482767|2844492|P2|Overall Study|Lost to Follow-up|6
862656|NCT01482767|2844493|P1|Overall Study|Lost to Follow-up|12
862657|NCT01482767|2844492|P2|Overall Study|Withdrawal by Subject|5
862658|NCT01482767|2844493|P1|Overall Study|Withdrawal by Subject|7
862659|NCT01482767|2844492|P2|Overall Study|Death|1
862660|NCT01482767|2844493|P1|Overall Study|Death|1
862661|NCT01482429|2844515|P2|Protocol|Protocol Violation|0
862662|NCT01482429|2844516|P1|Protocol|Protocol Violation|275
862663|NCT01482429|2844515|P2|Care Usual|Lost to Follow-up|1
862664|NCT01482429|2844516|P1|Care Usual|Lost to Follow-up|0
862665|NCT01482429|2844515|P2|Care Usual|Protocol Violation|172
862666|NCT01482429|2844516|P1|Care Usual|Protocol Violation|0
862667|NCT01482312|2844528|P3|Period 2, 90 Minutes of Wear|Other|0
862668|NCT01482312|2844529|P2|Period 2, 90 Minutes of Wear|Other|0
862669|NCT01482312|2844530|P1|Period 2, 90 Minutes of Wear|Other|1
862670|NCT01482312|2844528|P3|Period 1, 90 Minutes of Wear|Other|0
862671|NCT01482312|2844529|P2|Period 1, 90 Minutes of Wear|Other|0
862672|NCT01482312|2844530|P1|Period 1, 90 Minutes of Wear|Other|1
862673|NCT01482221|2844544|P3|Overall Study|Physician Decision|0
862674|NCT01482221|2844545|P2|Overall Study|Physician Decision|1
862675|NCT01482221|2844546|P1|Overall Study|Physician Decision|0
862676|NCT01482221|2844544|P3|Overall Study|Incorrect randomization|0
862677|NCT01482221|2844545|P2|Overall Study|Incorrect randomization|1
862678|NCT01482221|2844546|P1|Overall Study|Incorrect randomization|0
862679|NCT01482221|2844544|P3|Overall Study|Withdrawal by Subject|12
862680|NCT01482221|2844545|P2|Overall Study|Withdrawal by Subject|7
862681|NCT01482221|2844546|P1|Overall Study|Withdrawal by Subject|10
862682|NCT01482221|2844544|P3|Overall Study|Adverse Event|3
862683|NCT01482221|2844545|P2|Overall Study|Adverse Event|7
862684|NCT01482221|2844546|P1|Overall Study|Adverse Event|1
862685|NCT01482221|2844544|P3|Overall Study|Severe Non-Compliance to Protocol|1
862686|NCT01482221|2844545|P2|Overall Study|Severe Non-Compliance to Protocol|0
862687|NCT01482221|2844546|P1|Overall Study|Severe Non-Compliance to Protocol|1
862688|NCT01482221|2844544|P3|Overall Study|Condition under Investigation Worsened|4
862689|NCT01482221|2844545|P2|Overall Study|Condition under Investigation Worsened|2
862690|NCT01482221|2844546|P1|Overall Study|Condition under Investigation Worsened|3
862691|NCT01482221|2844544|P3|Overall Study|Study-Specific Withdrawal Criteria|1
862692|NCT01482221|2844545|P2|Overall Study|Study-Specific Withdrawal Criteria|0
862693|NCT01482221|2844546|P1|Overall Study|Study-Specific Withdrawal Criteria|2
862694|NCT01482221|2844544|P3|Overall Study|Lost to Follow-up|1
862695|NCT01482221|2844545|P2|Overall Study|Lost to Follow-up|2
862696|NCT01482221|2844546|P1|Overall Study|Lost to Follow-up|3
862697|NCT01482221|2844544|P3|Overall Study|Lack of Efficacy|1
862698|NCT01482221|2844545|P2|Overall Study|Lack of Efficacy|0
862699|NCT01482221|2844546|P1|Overall Study|Lack of Efficacy|1
862700|NCT01482169|2844587|P1|Overall Study|Physician Decision|2
862701|NCT01482065|2844629|P2|Overall Study|Withdrawal by Subject|1
862702|NCT01482065|2844630|P1|Overall Study|Withdrawal by Subject|0
862703|NCT01481896|2844651|P1|Overall Study|Lost to Follow-up|12
862704|NCT01481779|2844667|P2|Overall Study|Sponsor Decision|1
862705|NCT01481779|2844668|P1|Overall Study|Sponsor Decision|3
862706|NCT01481779|2844667|P2|Overall Study|Physician Decision|4
862707|NCT01481779|2844668|P1|Overall Study|Physician Decision|13
862708|NCT01481779|2844667|P2|Overall Study|Withdrawal by Subject|13
862709|NCT01481779|2844668|P1|Overall Study|Withdrawal by Subject|26
862710|NCT01481779|2844667|P2|Overall Study|Protocol Violation|3
862711|NCT01481779|2844668|P1|Overall Study|Protocol Violation|2
862712|NCT01481779|2844667|P2|Overall Study|Lost to Follow-up|2
862713|NCT01481779|2844668|P1|Overall Study|Lost to Follow-up|3
862714|NCT01481779|2844667|P2|Overall Study|Adverse Event|5
862715|NCT01481779|2844668|P1|Overall Study|Adverse Event|23
862716|NCT01481324|2844753|P3|Overall Study|Missing Data|2
862717|NCT01481324|2844754|P2|Overall Study|Missing Data|2
862718|NCT01481324|2844755|P1|Overall Study|Missing Data|0
862719|NCT01481116|2844774|P3|Overall Study|Hypoglycemic Event|0
862720|NCT01481116|2844775|P2|Overall Study|Hypoglycemic Event|0
862721|NCT01481116|2844776|P1|Overall Study|Hypoglycemic Event|4
862722|NCT01481116|2844774|P3|Overall Study|Death|0
862723|NCT01481116|2844775|P2|Overall Study|Death|1
862724|NCT01481116|2844776|P1|Overall Study|Death|2
862725|NCT01481116|2844774|P3|Overall Study|Investigator's Discretion|0
862726|NCT01481116|2844775|P2|Overall Study|Investigator's Discretion|0
862727|NCT01481116|2844776|P1|Overall Study|Investigator's Discretion|2
862728|NCT01481116|2844774|P3|Overall Study|Non-Compliant With Study Drug|1
862731|NCT01481116|2844774|P3|Overall Study|Sponsor Decision|3
862732|NCT01481116|2844775|P2|Overall Study|Sponsor Decision|1
862733|NCT01481116|2844776|P1|Overall Study|Sponsor Decision|0
862734|NCT01481116|2844774|P3|Overall Study|Investigator Decision|1
862735|NCT01481116|2844775|P2|Overall Study|Investigator Decision|2
862736|NCT01481116|2844776|P1|Overall Study|Investigator Decision|3
862737|NCT01481116|2844774|P3|Overall Study|Participant Moved Out of Country|1
862738|NCT01481116|2844775|P2|Overall Study|Participant Moved Out of Country|0
862739|NCT01481116|2844776|P1|Overall Study|Participant Moved Out of Country|1
862740|NCT01481116|2844774|P3|Overall Study|Participant Moved Out of Area|1
862741|NCT01481116|2844775|P2|Overall Study|Participant Moved Out of Area|0
862742|NCT01481116|2844776|P1|Overall Study|Participant Moved Out of Area|2
862743|NCT01481116|2844774|P3|Overall Study|Participant Started Taking Glipizide|0
862744|NCT01481116|2844775|P2|Overall Study|Participant Started Taking Glipizide|0
862745|NCT01481116|2844776|P1|Overall Study|Participant Started Taking Glipizide|1
862746|NCT01481116|2844774|P3|Overall Study|Other|0
862747|NCT01481116|2844775|P2|Overall Study|Other|1
862748|NCT01481116|2844776|P1|Overall Study|Other|1
862749|NCT01481116|2844774|P3|Overall Study|Contraindications|0
862750|NCT01481116|2844775|P2|Overall Study|Contraindications|1
862751|NCT01481116|2844776|P1|Overall Study|Contraindications|1
862752|NCT01481116|2844774|P3|Overall Study|Lack of Efficacy|1
862753|NCT01481116|2844775|P2|Overall Study|Lack of Efficacy|3
862754|NCT01481116|2844776|P1|Overall Study|Lack of Efficacy|3
862755|NCT01481116|2844774|P3|Overall Study|Pregnancy|1
862756|NCT01481116|2844775|P2|Overall Study|Pregnancy|0
862757|NCT01481116|2844776|P1|Overall Study|Pregnancy|0
862758|NCT01481116|2844774|P3|Overall Study|Study Termination|713
862759|NCT01481116|2844775|P2|Overall Study|Study Termination|729
862760|NCT01481116|2844776|P1|Overall Study|Study Termination|730
862761|NCT01481116|2844774|P3|Overall Study|Withdrawal by Subject|37
862762|NCT01481116|2844775|P2|Overall Study|Withdrawal by Subject|33
862763|NCT01481116|2844776|P1|Overall Study|Withdrawal by Subject|37
862764|NCT01481116|2844774|P3|Overall Study|Lost to Follow-up|11
862765|NCT01481116|2844775|P2|Overall Study|Lost to Follow-up|12
862766|NCT01481116|2844776|P1|Overall Study|Lost to Follow-up|8
862767|NCT01481116|2844774|P3|Overall Study|Major Protocol Deviation|1
862768|NCT01481116|2844775|P2|Overall Study|Major Protocol Deviation|7
862769|NCT01481116|2844776|P1|Overall Study|Major Protocol Deviation|3
862770|NCT01481116|2844774|P3|Overall Study|Adverse Event|42
862771|NCT01481116|2844775|P2|Overall Study|Adverse Event|26
862772|NCT01481116|2844776|P1|Overall Study|Adverse Event|26
862773|NCT01480674|2844807|P1|Overall Study|visit not done|10
862774|NCT01480674|2844807|P1|Overall Study|Lost to Follow-up|2
862775|NCT01480674|2844807|P1|Overall Study|Death|23
862776|NCT01480596|2844821|P2|Overall Study|MG exacerbation or change in medication|2
862777|NCT01480596|2844822|P1|Overall Study|MG exacerbation or change in medication|2
862778|NCT01480596|2844821|P2|Overall Study|Adverse Event|0
862779|NCT01480596|2844822|P1|Overall Study|Adverse Event|3
862780|NCT01480284|2844870|P2|Overall Study|Physician Decision|0
862781|NCT01480284|2844871|P1|Overall Study|Physician Decision|1
862782|NCT01480284|2844870|P2|Overall Study|Lost to Follow-up|0
862783|NCT01480284|2844871|P1|Overall Study|Lost to Follow-up|1
862784|NCT01480284|2844870|P2|Overall Study|Study closed/terminated|0
862785|NCT01480284|2844871|P1|Overall Study|Study closed/terminated|3
862786|NCT01480284|2844870|P2|Overall Study|Adverse Event|0
862787|NCT01480284|2844871|P1|Overall Study|Adverse Event|1
862788|NCT01480284|2844870|P2|Overall Study|Withdrawal by Subject|0
862789|NCT01480284|2844871|P1|Overall Study|Withdrawal by Subject|2
862790|NCT01480076|2844954|P1|Overall Study|Not Specified|52
862791|NCT01480076|2844954|P1|Overall Study|Investigator Decision|13
862792|NCT01480076|2844954|P1|Overall Study|Lost to Follow-up|7
862793|NCT01480076|2844954|P1|Overall Study|Withdrawal by Subject|105
862794|NCT01480076|2844954|P1|Overall Study|Non-compliance With Study Protocol|15
862795|NCT01480076|2844954|P1|Overall Study|Disease Progression|5
862796|NCT01480076|2844954|P1|Overall Study|Death|2
862797|NCT01480076|2844954|P1|Overall Study|Adverse Event|39
862798|NCT01480076|2844954|P1|Overall Study|Run-in Failure|52
862799|NCT01479868|2845084|P1|Overall Study|Initiation of new HCV Therapy|1
862800|NCT01479868|2845084|P1|Overall Study|Sponsor's Decision|1
862801|NCT01479868|2845084|P1|Overall Study|Withdrawal by Subject|1
862802|NCT01479868|2845084|P1|Overall Study|Protocol Violation|1
862803|NCT01479868|2845084|P1|Overall Study|Lost to Follow-up|4
862804|NCT01479868|2845084|P1|Overall Study|Adverse Event|1
862805|NCT01479777|2845099|P1|Overall Study|Physician Decision|2
862806|NCT01479764|2845111|P2|Treated|Lost to Follow-up|2
862807|NCT01479764|2845112|P1|Treated|Lost to Follow-up|0
862808|NCT01479764|2845111|P2|Randomized|Withdrawal by Subject|0
862809|NCT01479764|2845112|P1|Randomized|Withdrawal by Subject|1
862810|NCT01479764|2845111|P2|Randomized|Adverse Event|1
862811|NCT01479764|2845112|P1|Randomized|Adverse Event|1
862812|NCT01479621|2845135|P7|Treatment Period|Met stopping criteria|6
862813|NCT01479621|2845136|P6|Treatment Period|Met stopping criteria|20
862814|NCT01479621|2845137|P5|Treatment Period|Met stopping criteria|9
862815|NCT01479621|2845138|P4|Treatment Period|Met stopping criteria|4
862816|NCT01479621|2845139|P3|Treatment Period|Met stopping criteria|7
862817|NCT01479621|2845140|P2|Treatment Period|Met stopping criteria|8
862818|NCT01479621|2845141|P1|Treatment Period|Met stopping criteria|0
862819|NCT01479621|2845135|P7|Treatment Period|Lost to Follow-up|1
862820|NCT01479621|2845136|P6|Treatment Period|Lost to Follow-up|2
862821|NCT01479621|2845137|P5|Treatment Period|Lost to Follow-up|2
862822|NCT01479621|2845138|P4|Treatment Period|Lost to Follow-up|0
862823|NCT01479621|2845139|P3|Treatment Period|Lost to Follow-up|1
862824|NCT01479621|2845140|P2|Treatment Period|Lost to Follow-up|0
862825|NCT01479621|2845141|P1|Treatment Period|Lost to Follow-up|0
862826|NCT01479621|2845135|P7|Treatment Period|Sponsor request subject to be withdrawn|3
862827|NCT01479621|2845136|P6|Treatment Period|Sponsor request subject to be withdrawn|1
862828|NCT01479621|2845137|P5|Treatment Period|Sponsor request subject to be withdrawn|1
862829|NCT01479621|2845138|P4|Treatment Period|Sponsor request subject to be withdrawn|1
862830|NCT01479621|2845139|P3|Treatment Period|Sponsor request subject to be withdrawn|3
862831|NCT01479621|2845140|P2|Treatment Period|Sponsor request subject to be withdrawn|2
862832|NCT01479621|2845141|P1|Treatment Period|Sponsor request subject to be withdrawn|0
862833|NCT01479621|2845135|P7|Treatment Period|Pregnancy|0
862834|NCT01479621|2845136|P6|Treatment Period|Pregnancy|0
862835|NCT01479621|2845137|P5|Treatment Period|Pregnancy|0
862836|NCT01479621|2845138|P4|Treatment Period|Pregnancy|0
862837|NCT01479621|2845139|P3|Treatment Period|Pregnancy|2
862838|NCT01479621|2845140|P2|Treatment Period|Pregnancy|0
862839|NCT01479621|2845141|P1|Treatment Period|Pregnancy|0
862840|NCT01479621|2845135|P7|Treatment Period|Protocol Violation|6
862841|NCT01479621|2845136|P6|Treatment Period|Protocol Violation|10
862842|NCT01479621|2845137|P5|Treatment Period|Protocol Violation|2
862843|NCT01479621|2845138|P4|Treatment Period|Protocol Violation|5
862844|NCT01479621|2845139|P3|Treatment Period|Protocol Violation|6
862845|NCT01479621|2845140|P2|Treatment Period|Protocol Violation|9
862846|NCT01479621|2845141|P1|Treatment Period|Protocol Violation|0
862847|NCT01479621|2845135|P7|Treatment Period|Non-compliance to study drug|1
862848|NCT01479621|2845136|P6|Treatment Period|Non-compliance to study drug|0
862849|NCT01479621|2845137|P5|Treatment Period|Non-compliance to study drug|0
862850|NCT01479621|2845138|P4|Treatment Period|Non-compliance to study drug|0
862851|NCT01479621|2845139|P3|Treatment Period|Non-compliance to study drug|0
862852|NCT01479621|2845140|P2|Treatment Period|Non-compliance to study drug|1
862853|NCT01479621|2845141|P1|Treatment Period|Non-compliance to study drug|0
862854|NCT01479621|2845135|P7|Treatment Period|Physician Decision|0
862855|NCT01479621|2845136|P6|Treatment Period|Physician Decision|1
862856|NCT01479621|2845137|P5|Treatment Period|Physician Decision|1
862857|NCT01479621|2845138|P4|Treatment Period|Physician Decision|0
862858|NCT01479621|2845139|P3|Treatment Period|Physician Decision|0
862859|NCT01479621|2845140|P2|Treatment Period|Physician Decision|0
862860|NCT01479621|2845141|P1|Treatment Period|Physician Decision|0
862861|NCT01479621|2845135|P7|Treatment Period|Withdrawal by Subject|1
862862|NCT01479621|2845136|P6|Treatment Period|Withdrawal by Subject|5
862863|NCT01479621|2845137|P5|Treatment Period|Withdrawal by Subject|5
862864|NCT01479621|2845138|P4|Treatment Period|Withdrawal by Subject|2
862865|NCT01479621|2845139|P3|Treatment Period|Withdrawal by Subject|2
862866|NCT01479621|2845140|P2|Treatment Period|Withdrawal by Subject|4
862867|NCT01479621|2845141|P1|Treatment Period|Withdrawal by Subject|0
862868|NCT01479621|2845135|P7|Treatment Period|Adverse Event|2
862869|NCT01479621|2845136|P6|Treatment Period|Adverse Event|2
862870|NCT01479621|2845137|P5|Treatment Period|Adverse Event|1
862871|NCT01479621|2845138|P4|Treatment Period|Adverse Event|0
862872|NCT01479621|2845139|P3|Treatment Period|Adverse Event|0
862873|NCT01479621|2845140|P2|Treatment Period|Adverse Event|0
862874|NCT01479621|2845141|P1|Treatment Period|Adverse Event|0
862875|NCT01479621|2845135|P7|Pre-Assignment Period (Run-In Placebo)|Not specified|0
862876|NCT01479621|2845136|P6|Pre-Assignment Period (Run-In Placebo)|Not specified|0
862877|NCT01479621|2845137|P5|Pre-Assignment Period (Run-In Placebo)|Not specified|0
862878|NCT01479621|2845138|P4|Pre-Assignment Period (Run-In Placebo)|Not specified|0
862879|NCT01479621|2845139|P3|Pre-Assignment Period (Run-In Placebo)|Not specified|0
862880|NCT01479621|2845140|P2|Pre-Assignment Period (Run-In Placebo)|Not specified|0
862881|NCT01479621|2845141|P1|Pre-Assignment Period (Run-In Placebo)|Not specified|15
862882|NCT01479621|2845135|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
862883|NCT01479621|2845136|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
862884|NCT01479621|2845137|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
862885|NCT01479621|2845138|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
862886|NCT01479621|2845139|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
862887|NCT01479621|2845140|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
862888|NCT01479621|2845141|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7
862889|NCT01479621|2845135|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
862890|NCT01479621|2845136|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
862891|NCT01479621|2845137|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
862892|NCT01479621|2845138|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
862893|NCT01479621|2845139|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
862894|NCT01479621|2845140|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
862895|NCT01479621|2845141|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153
862896|NCT01479621|2845135|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
862897|NCT01479621|2845136|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
862898|NCT01479621|2845137|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
862899|NCT01479621|2845138|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
862900|NCT01479621|2845139|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
862901|NCT01479621|2845140|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
862902|NCT01479621|2845141|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19
862903|NCT01479621|2845135|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
862904|NCT01479621|2845136|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
862905|NCT01479621|2845137|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
862906|NCT01479621|2845138|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
862907|NCT01479621|2845139|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
862908|NCT01479621|2845140|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
862909|NCT01479621|2845141|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93
862910|NCT01479595|2845229|P2|Overall Study|Adverse Event|1
862911|NCT01479595|2845230|P1|Overall Study|Adverse Event|2
862912|NCT01479595|2845229|P2|Overall Study|Protocol deviation|1
862913|NCT01479595|2845230|P1|Overall Study|Protocol deviation|0
862914|NCT01479530|2845275|P2|Overall Study|Withdrawal of Consent|2
862915|NCT01479530|2845276|P1|Overall Study|Withdrawal of Consent|3
862916|NCT01479530|2845275|P2|Overall Study|Protocol Violation|3
862917|NCT01479530|2845276|P1|Overall Study|Protocol Violation|2
862918|NCT01479530|2845275|P2|Overall Study|Lack of Efficacy|1
862919|NCT01479530|2845276|P1|Overall Study|Lack of Efficacy|0
862920|NCT01479530|2845275|P2|Overall Study|Adverse Event|6
862921|NCT01479530|2845276|P1|Overall Study|Adverse Event|5
862922|NCT01479374|2845356|P3|Overall Study|Other|5
862923|NCT01479374|2845357|P2|Overall Study|Other|4
862924|NCT01479374|2845358|P1|Overall Study|Other|0
862925|NCT01479374|2845356|P3|Overall Study|Decision Unrelated to Adverse Event|0
862926|NCT01479374|2845357|P2|Overall Study|Decision Unrelated to Adverse Event|1
862927|NCT01479374|2845358|P1|Overall Study|Decision Unrelated to Adverse Event|0
862928|NCT01479374|2845356|P3|Overall Study|Lost to Follow-up|0
862929|NCT01479374|2845357|P2|Overall Study|Lost to Follow-up|2
862930|NCT01479374|2845358|P1|Overall Study|Lost to Follow-up|1
862931|NCT01479374|2845356|P3|Overall Study|Adverse Event|0
862932|NCT01479374|2845357|P2|Overall Study|Adverse Event|1
862933|NCT01479374|2845358|P1|Overall Study|Adverse Event|2
862934|NCT01478971|2845444|P1|Peginesatide Treatment Period|Other|4
862935|NCT01478971|2845444|P1|Peginesatide Treatment Period|Lost to Follow-up|4
862936|NCT01478971|2845444|P1|Peginesatide Treatment Period|Death|4
862937|NCT01478971|2845444|P1|Peginesatide Treatment Period|Withdrawal by Subject|1
862938|NCT01478971|2845444|P1|Peginesatide Treatment Period|Adverse Event|1
862939|NCT01478971|2845444|P1|Standard of Care Period|Other|4
862940|NCT01478971|2845444|P1|Standard of Care Period|Lost to Follow-up|9
862941|NCT01478971|2845444|P1|Standard of Care Period|Death|8
862942|NCT01478971|2845444|P1|Standard of Care Period|Withdrawal by Subject|3
862943|NCT01478971|2845444|P1|Standard of Care Period|Adverse Event|1
862944|NCT01478958|2845461|P3|Overall Study|Unable to comply|2
862945|NCT01478958|2845462|P2|Overall Study|Unable to comply|0
862946|NCT01478958|2845463|P1|Overall Study|Unable to comply|0
862947|NCT01478958|2845461|P3|Overall Study|Re-located|0
862948|NCT01478958|2845462|P2|Overall Study|Re-located|1
862949|NCT01478958|2845463|P1|Overall Study|Re-located|0
862950|NCT01478958|2845461|P3|Overall Study|Weight loss|0
862951|NCT01478958|2845462|P2|Overall Study|Weight loss|0
862952|NCT01478958|2845463|P1|Overall Study|Weight loss|1
862953|NCT01478958|2845461|P3|Overall Study|Withdrawal by Subject|1
862954|NCT01478958|2845462|P2|Overall Study|Withdrawal by Subject|1
862955|NCT01478958|2845463|P1|Overall Study|Withdrawal by Subject|1
862956|NCT01478828|2845471|P1|Overall Study|Adverse Event|1
862957|NCT01478620|2845476|P1|Overall Study|Lost to Follow-up|6
862958|NCT01478594|2845482|P2|Overall Study|Study Closed by Sponsor|5
862959|NCT01478594|2845483|P1|Overall Study|Study Closed by Sponsor|8
862960|NCT01478594|2845482|P2|Overall Study|Withdrawal by Subject|3
862961|NCT01478594|2845483|P1|Overall Study|Withdrawal by Subject|9
862962|NCT01478594|2845482|P2|Overall Study|Lost to Follow-up|1
862963|NCT01478594|2845483|P1|Overall Study|Lost to Follow-up|3
862964|NCT01478594|2845482|P2|Overall Study|Death|18
862965|NCT01478594|2845483|P1|Overall Study|Death|45
862966|NCT01478594|2845482|P2|Overall Study|Randomized but Never Received Study Drug|1
862967|NCT01478594|2845483|P1|Overall Study|Randomized but Never Received Study Drug|0
862968|NCT01478373|2845608|P1|Survival Phase|Progressive Disease|27
862969|NCT01478373|2845608|P1|Survival Phase|crossover to another study|2
862970|NCT01478373|2845608|P1|Survival Phase|Protocol Violation|1
862971|NCT01478373|2845608|P1|Survival Phase|Adverse Event|8
862972|NCT01478373|2845608|P1|Treatment Phase|Protocol Violation|1
862973|NCT01478360|2845621|P2|Overall Study|Administrative problems|2
862974|NCT01478360|2845622|P1|Overall Study|Administrative problems|1
862975|NCT01478360|2845621|P2|Overall Study|Adverse Event|1
862976|NCT01478360|2845622|P1|Overall Study|Adverse Event|0
862977|NCT01478360|2845621|P2|Overall Study|Lost to Follow-up|0
862978|NCT01478360|2845622|P1|Overall Study|Lost to Follow-up|1
862979|NCT01478347|2845628|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4
862980|NCT01478347|2845628|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4
862981|NCT01478347|2845628|P1|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1
862982|NCT01478113|2845646|P2|Overall Study|Physician Decision|0
862983|NCT01478113|2845647|P1|Overall Study|Physician Decision|1
862984|NCT01478113|2845646|P2|Overall Study|Withdrawal by Subject|1
862985|NCT01478113|2845647|P1|Overall Study|Withdrawal by Subject|0
862986|NCT01478087|2845665|P1|Overall Study|due to sponsor closing study|1
862987|NCT01478048|2845672|P2|Overall Study|no longer meets study criteria|0
862988|NCT01478048|2845673|P1|Overall Study|no longer meets study criteria|1
862989|NCT01478048|2845672|P2|Overall Study|poor/non-compliance|1
862990|NCT01478048|2845673|P1|Overall Study|poor/non-compliance|0
862991|NCT01478048|2845672|P2|Overall Study|non-specified|4
862992|NCT01478048|2845673|P1|Overall Study|non-specified|6
862993|NCT01478048|2845672|P2|Overall Study|Withdrawal by Subject|5
862994|NCT01478048|2845673|P1|Overall Study|Withdrawal by Subject|2
862995|NCT01478048|2845672|P2|Overall Study|subject request to discontinue treatment|5
862996|NCT01478048|2845673|P1|Overall Study|subject request to discontinue treatment|3
862997|NCT01478048|2845672|P2|Overall Study|Adverse Event|11
862998|NCT01478048|2845673|P1|Overall Study|Adverse Event|2
862999|NCT01478048|2845672|P2|Overall Study|study drug toxicity|14
863000|NCT01478048|2845673|P1|Overall Study|study drug toxicity|11
863001|NCT01478048|2845672|P2|Overall Study|Disease Progression|35
863002|NCT01478048|2845673|P1|Overall Study|Disease Progression|52
863003|NCT01477892|2845702|P2|Overall Study|Withdrawal by Subject|2
863004|NCT01477892|2845703|P1|Overall Study|Withdrawal by Subject|0
863005|NCT01477853|2845714|P3|Phase B|Study terminated by sponsor|11
863006|NCT01477853|2845715|P2|Phase B|Study terminated by sponsor|10
863007|NCT01477853|2845716|P1|Phase B|Study terminated by sponsor|12
863008|NCT01477853|2845714|P3|Phase B|Lost to Follow-up|0
863009|NCT01477853|2845715|P2|Phase B|Lost to Follow-up|1
863010|NCT01477853|2845716|P1|Phase B|Lost to Follow-up|0
863011|NCT01477853|2845714|P3|Phase A|Study terminated by sponsor|39
863012|NCT01477853|2845715|P2|Phase A|Study terminated by sponsor|40
863013|NCT01477853|2845716|P1|Phase A|Study terminated by sponsor|37
863014|NCT01477853|2845714|P3|Phase A|Physician Decision|1
863015|NCT01477853|2845715|P2|Phase A|Physician Decision|0
863016|NCT01477853|2845716|P1|Phase A|Physician Decision|1
863017|NCT01477853|2845714|P3|Phase A|Lost to Follow-up|2
863018|NCT01477853|2845715|P2|Phase A|Lost to Follow-up|3
863019|NCT01477853|2845716|P1|Phase A|Lost to Follow-up|4
863020|NCT01477853|2845714|P3|Phase A|Adverse Event|2
863021|NCT01477853|2845715|P2|Phase A|Adverse Event|2
863022|NCT01477853|2845716|P1|Phase A|Adverse Event|1
863023|NCT01477749|2845783|P1|Overall Study|Physician Decision|4
863024|NCT01477333|2845891|P1|Overall Study|Clinical Deterioration|1
863025|NCT01477333|2845891|P1|Overall Study|Withdrawal by Subject|1
863026|NCT01477333|2845891|P1|Overall Study|Adverse Event|1
863027|NCT01476722|2845934|P1|Overall Study|Adverse Event|1
863028|NCT01476696|2845941|P3|Overall Study|Withdrawal by Subject|0
863029|NCT01476696|2845942|P2|Overall Study|Withdrawal by Subject|0
863030|NCT01476696|2845943|P1|Overall Study|Withdrawal by Subject|1
863031|NCT01476696|2845941|P3|Overall Study|Sponsor decision|0
863032|NCT01476696|2845942|P2|Overall Study|Sponsor decision|1
863033|NCT01476696|2845943|P1|Overall Study|Sponsor decision|2
863034|NCT01476475|2845959|P2|Overall Study|Other reasons|2
863035|NCT01476475|2845960|P1|Overall Study|Other reasons|4
863036|NCT01476475|2845959|P2|Overall Study|Poor compliance to protocol|1
863037|NCT01476475|2845960|P1|Overall Study|Poor compliance to protocol|1
863038|NCT01476475|2845959|P2|Overall Study|Adverse Event|0
863039|NCT01476475|2845960|P1|Overall Study|Adverse Event|6
863040|NCT01475851|2846389|P2|Overall Study|Protocol defined stopping criteria|0
863041|NCT01475851|2846390|P1|Overall Study|Protocol defined stopping criteria|1
863042|NCT01475838|2846418|P2|Extension Phase|Participant Noncompliance|0
863043|NCT01475838|2846419|P1|Extension Phase|Participant Noncompliance|1
863044|NCT01475838|2846418|P2|Randomized Phase|Protocol Violation|4
863045|NCT01475838|2846419|P1|Randomized Phase|Protocol Violation|9
863046|NCT01475838|2846418|P2|Randomized Phase|Participant Noncompliance|5
863047|NCT01475838|2846419|P1|Randomized Phase|Participant Noncompliance|1
863048|NCT01475838|2846418|P2|Randomized Phase|Lost to Follow-up|4
863049|NCT01475838|2846419|P1|Randomized Phase|Lost to Follow-up|3
863050|NCT01475838|2846418|P2|Randomized Phase|Withdrew Consent|14
863051|NCT01475838|2846419|P1|Randomized Phase|Withdrew Consent|10
863052|NCT01475838|2846418|P2|Randomized Phase|Investigators Discretion|2
863053|NCT01475838|2846419|P1|Randomized Phase|Investigators Discretion|1
863054|NCT01475838|2846418|P2|Randomized Phase|Pregnancy|1
863055|NCT01475838|2846419|P1|Randomized Phase|Pregnancy|0
863056|NCT01475838|2846418|P2|Randomized Phase|Adverse Event|1
863057|NCT01475838|2846419|P1|Randomized Phase|Adverse Event|6
863058|NCT01475838|2846418|P2|Randomized Phase|Randomized but Not Treated|5
863059|NCT01475838|2846419|P1|Randomized Phase|Randomized but Not Treated|0
863060|NCT01475734|2846434|P2|Overall Study|Physician Decision|1
863061|NCT01475734|2846435|P1|Overall Study|Physician Decision|0
863062|NCT01475734|2846434|P2|Overall Study|Protocol Violation|0
863063|NCT01475734|2846435|P1|Overall Study|Protocol Violation|1
863064|NCT01475734|2846434|P2|Overall Study|Withdrawal by Subject|0
863065|NCT01475734|2846435|P1|Overall Study|Withdrawal by Subject|1
863066|NCT01475721|2846463|P2|Overall Study|Withdrawal by Subject|8
863067|NCT01475721|2846464|P1|Overall Study|Withdrawal by Subject|8
863068|NCT01475721|2846463|P2|Overall Study|Death|6
863069|NCT01475721|2846464|P1|Overall Study|Death|3
863159|NCT01475461|2846544|P6|Run-in Period|Not meet eligibility criteria|0
863070|NCT01475487|2846519|P2|Overall Study|had to leave early for personal reasons|1
863071|NCT01475487|2846520|P1|Overall Study|had to leave early for personal reasons|2
863072|NCT01475474|2846532|P1|Baseline Period - 4 Weeks|Withdrawal by Subject|2
863073|NCT01475474|2846532|P1|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4
863074|NCT01475461|2846543|P7|Treatment Period|Adverse Event|0
863075|NCT01475461|2846544|P6|Treatment Period|Adverse Event|0
863076|NCT01475461|2846545|P5|Treatment Period|Adverse Event|0
863077|NCT01475461|2846546|P4|Treatment Period|Adverse Event|1
863078|NCT01475461|2846547|P3|Treatment Period|Adverse Event|0
863079|NCT01475461|2846548|P2|Treatment Period|Adverse Event|0
863080|NCT01475461|2846549|P1|Treatment Period|Adverse Event|0
863081|NCT01475461|2846543|P7|Treatment Period|Medication Error|0
863082|NCT01475461|2846544|P6|Treatment Period|Medication Error|0
863083|NCT01475461|2846545|P5|Treatment Period|Medication Error|0
863084|NCT01475461|2846546|P4|Treatment Period|Medication Error|1
863085|NCT01475461|2846547|P3|Treatment Period|Medication Error|0
863086|NCT01475461|2846548|P2|Treatment Period|Medication Error|0
863087|NCT01475461|2846549|P1|Treatment Period|Medication Error|0
863088|NCT01475461|2846543|P7|Treatment Period|Lack of Efficacy|0
863089|NCT01475461|2846544|P6|Treatment Period|Lack of Efficacy|1
863090|NCT01475461|2846545|P5|Treatment Period|Lack of Efficacy|1
863091|NCT01475461|2846546|P4|Treatment Period|Lack of Efficacy|2
863092|NCT01475461|2846547|P3|Treatment Period|Lack of Efficacy|0
863093|NCT01475461|2846548|P2|Treatment Period|Lack of Efficacy|2
863094|NCT01475461|2846549|P1|Treatment Period|Lack of Efficacy|0
863095|NCT01475461|2846543|P7|Treatment Period|Protocol Violation|1
863096|NCT01475461|2846544|P6|Treatment Period|Protocol Violation|0
863097|NCT01475461|2846545|P5|Treatment Period|Protocol Violation|0
863098|NCT01475461|2846546|P4|Treatment Period|Protocol Violation|0
863099|NCT01475461|2846547|P3|Treatment Period|Protocol Violation|0
863100|NCT01475461|2846548|P2|Treatment Period|Protocol Violation|1
863101|NCT01475461|2846549|P1|Treatment Period|Protocol Violation|0
863102|NCT01475461|2846543|P7|Treatment Period|Other|0
863103|NCT01475461|2846544|P6|Treatment Period|Other|0
863104|NCT01475461|2846545|P5|Treatment Period|Other|0
863105|NCT01475461|2846546|P4|Treatment Period|Other|0
863106|NCT01475461|2846547|P3|Treatment Period|Other|0
863107|NCT01475461|2846548|P2|Treatment Period|Other|1
863108|NCT01475461|2846549|P1|Treatment Period|Other|0
863109|NCT01475461|2846543|P7|Treatment Period|Withdrawal by Subject|0
863110|NCT01475461|2846544|P6|Treatment Period|Withdrawal by Subject|2
863111|NCT01475461|2846545|P5|Treatment Period|Withdrawal by Subject|2
863112|NCT01475461|2846546|P4|Treatment Period|Withdrawal by Subject|0
863113|NCT01475461|2846547|P3|Treatment Period|Withdrawal by Subject|2
863114|NCT01475461|2846548|P2|Treatment Period|Withdrawal by Subject|2
863115|NCT01475461|2846549|P1|Treatment Period|Withdrawal by Subject|0
863116|NCT01475461|2846543|P7|Treatment Period|Lost to Follow-up|1
863117|NCT01475461|2846544|P6|Treatment Period|Lost to Follow-up|2
863118|NCT01475461|2846545|P5|Treatment Period|Lost to Follow-up|1
863119|NCT01475461|2846546|P4|Treatment Period|Lost to Follow-up|3
863120|NCT01475461|2846547|P3|Treatment Period|Lost to Follow-up|2
863121|NCT01475461|2846548|P2|Treatment Period|Lost to Follow-up|3
863122|NCT01475461|2846549|P1|Treatment Period|Lost to Follow-up|0
863123|NCT01475461|2846543|P7|Treatment Period|Death|0
863124|NCT01475461|2846544|P6|Treatment Period|Death|0
863125|NCT01475461|2846545|P5|Treatment Period|Death|0
863126|NCT01475461|2846546|P4|Treatment Period|Death|1
863127|NCT01475461|2846547|P3|Treatment Period|Death|0
863128|NCT01475461|2846548|P2|Treatment Period|Death|0
863129|NCT01475461|2846549|P1|Treatment Period|Death|0
863130|NCT01475461|2846543|P7|Run-in Period|Protocol Violation|0
863131|NCT01475461|2846544|P6|Run-in Period|Protocol Violation|0
863132|NCT01475461|2846545|P5|Run-in Period|Protocol Violation|0
863133|NCT01475461|2846546|P4|Run-in Period|Protocol Violation|0
863134|NCT01475461|2846547|P3|Run-in Period|Protocol Violation|0
863135|NCT01475461|2846548|P2|Run-in Period|Protocol Violation|0
863136|NCT01475461|2846549|P1|Run-in Period|Protocol Violation|4
863137|NCT01475461|2846543|P7|Run-in Period|Other|0
863138|NCT01475461|2846544|P6|Run-in Period|Other|0
863139|NCT01475461|2846545|P5|Run-in Period|Other|0
863140|NCT01475461|2846546|P4|Run-in Period|Other|0
863141|NCT01475461|2846547|P3|Run-in Period|Other|0
863142|NCT01475461|2846548|P2|Run-in Period|Other|0
863143|NCT01475461|2846549|P1|Run-in Period|Other|3
863144|NCT01475461|2846543|P7|Run-in Period|Withdrawal by Subject|0
863145|NCT01475461|2846544|P6|Run-in Period|Withdrawal by Subject|0
863146|NCT01475461|2846545|P5|Run-in Period|Withdrawal by Subject|0
863147|NCT01475461|2846546|P4|Run-in Period|Withdrawal by Subject|0
863148|NCT01475461|2846547|P3|Run-in Period|Withdrawal by Subject|0
863149|NCT01475461|2846548|P2|Run-in Period|Withdrawal by Subject|0
863150|NCT01475461|2846549|P1|Run-in Period|Withdrawal by Subject|11
863151|NCT01475461|2846543|P7|Run-in Period|Lost to Follow-up|0
863152|NCT01475461|2846544|P6|Run-in Period|Lost to Follow-up|0
863153|NCT01475461|2846545|P5|Run-in Period|Lost to Follow-up|0
863154|NCT01475461|2846546|P4|Run-in Period|Lost to Follow-up|0
863155|NCT01475461|2846547|P3|Run-in Period|Lost to Follow-up|0
863156|NCT01475461|2846548|P2|Run-in Period|Lost to Follow-up|0
863157|NCT01475461|2846549|P1|Run-in Period|Lost to Follow-up|7
863158|NCT01475461|2846543|P7|Run-in Period|Not meet eligibility criteria|0
863160|NCT01475461|2846545|P5|Run-in Period|Not meet eligibility criteria|0
863161|NCT01475461|2846546|P4|Run-in Period|Not meet eligibility criteria|0
863162|NCT01475461|2846547|P3|Run-in Period|Not meet eligibility criteria|0
863163|NCT01475461|2846548|P2|Run-in Period|Not meet eligibility criteria|0
863164|NCT01475461|2846549|P1|Run-in Period|Not meet eligibility criteria|16
863165|NCT01475331|2846629|P2|Overall Study|cyst found to be prohibitively small|1
863166|NCT01475331|2846630|P1|Overall Study|cyst found to be prohibitively small|0
863167|NCT01475331|2846629|P2|Overall Study|Sign of malignancy during the procedure|0
863168|NCT01475331|2846630|P1|Overall Study|Sign of malignancy during the procedure|2
863169|NCT01475331|2846629|P2|Overall Study|Loss of needle positioning due pt. cough|0
863170|NCT01475331|2846630|P1|Overall Study|Loss of needle positioning due pt. cough|1
863171|NCT01475331|2846629|P2|Overall Study|excessive main duct communication|1
863172|NCT01475331|2846630|P1|Overall Study|excessive main duct communication|1
863173|NCT01475331|2846629|P2|Overall Study|Osteophyte obstruction of the proximal|0
863174|NCT01475331|2846630|P1|Overall Study|Osteophyte obstruction of the proximal|1
863175|NCT01475253|2846682|P4|Randomized, Blinded Study|Lost to Follow-up|0
863176|NCT01475253|2846683|P3|Randomized, Blinded Study|Lost to Follow-up|0
863177|NCT01475253|2846684|P2|Randomized, Blinded Study|Lost to Follow-up|0
863178|NCT01475253|2846685|P1|Randomized, Blinded Study|Lost to Follow-up|1
863179|NCT01475253|2846682|P4|Randomized, Blinded Study|Withdrawal by Subject|0
863180|NCT01475253|2846683|P3|Randomized, Blinded Study|Withdrawal by Subject|0
863181|NCT01475253|2846684|P2|Randomized, Blinded Study|Withdrawal by Subject|1
863182|NCT01475253|2846685|P1|Randomized, Blinded Study|Withdrawal by Subject|1
863183|NCT01475214|2846714|P3|Overall Study|Withdrawal by Subject|1
863184|NCT01475214|2846715|P2|Overall Study|Withdrawal by Subject|4
863185|NCT01475214|2846716|P1|Overall Study|Withdrawal by Subject|2
863186|NCT01475214|2846714|P3|Overall Study|Physician Decision|0
863187|NCT01475214|2846715|P2|Overall Study|Physician Decision|0
863188|NCT01475214|2846716|P1|Overall Study|Physician Decision|2
863189|NCT01475214|2846714|P3|Overall Study|Lost to Follow-up|1
863190|NCT01475214|2846715|P2|Overall Study|Lost to Follow-up|0
863191|NCT01475214|2846716|P1|Overall Study|Lost to Follow-up|1
863192|NCT01475097|2846741|P2|Overall Study|Protocol Violation|1
863193|NCT01475097|2846742|P1|Overall Study|Protocol Violation|1
863194|NCT01475071|2846750|P1|Overall Study|Lost to Follow-up|1
863195|NCT01475071|2846750|P1|Overall Study|Withdrawal by Subject|6
863196|NCT01475071|2846750|P1|Overall Study|Physician Decision|1
863197|NCT01474993|2846760|P2|Overall Study|Adverse Event|1
863198|NCT01474993|2846761|P1|Overall Study|Adverse Event|0
863199|NCT01474993|2846760|P2|Overall Study|Lost to Follow-up|2
863200|NCT01474993|2846761|P1|Overall Study|Lost to Follow-up|1
863201|NCT01474876|2846803|P3|Overall Study|Investigator's decision and pt request|0
863202|NCT01474876|2846804|P2|Overall Study|Investigator's decision and pt request|0
863203|NCT01474876|2846805|P1|Overall Study|Investigator's decision and pt request|1
863204|NCT01474876|2846803|P3|Overall Study|Patient's request|0
863205|NCT01474876|2846804|P2|Overall Study|Patient's request|5
863206|NCT01474876|2846805|P1|Overall Study|Patient's request|19
863207|NCT01474876|2846803|P3|Overall Study|Investigator's decision|0
863208|NCT01474876|2846804|P2|Overall Study|Investigator's decision|6
863209|NCT01474876|2846805|P1|Overall Study|Investigator's decision|28
863210|NCT01474876|2846803|P3|Overall Study|Lost to Follow-up|0
863211|NCT01474876|2846804|P2|Overall Study|Lost to Follow-up|4
863212|NCT01474876|2846805|P1|Overall Study|Lost to Follow-up|5
863213|NCT01474876|2846803|P3|Overall Study|Serious Adverse Event|0
863214|NCT01474876|2846804|P2|Overall Study|Serious Adverse Event|3
863215|NCT01474876|2846805|P1|Overall Study|Serious Adverse Event|2
863216|NCT01474876|2846803|P3|Overall Study|Adverse Event|0
863217|NCT01474876|2846804|P2|Overall Study|Adverse Event|5
863218|NCT01474876|2846805|P1|Overall Study|Adverse Event|11
863219|NCT01474772|2846851|P2|Follow-up|AE not Related to Study Drug|1
863220|NCT01474772|2846852|P1|Follow-up|AE not Related to Study Drug|0
863221|NCT01474772|2846851|P2|Period 2|Reason not Specified|2
863222|NCT01474772|2846852|P1|Period 2|Reason not Specified|0
863223|NCT01474772|2846851|P2|Period 2|Lost to Follow-up|1
863224|NCT01474772|2846852|P1|Period 2|Lost to Follow-up|1
863225|NCT01474772|2846851|P2|Period 2|Withdrawal by Subject|4
863226|NCT01474772|2846852|P1|Period 2|Withdrawal by Subject|3
863227|NCT01474772|2846851|P2|Period 2|Lack of Efficacy|0
863228|NCT01474772|2846852|P1|Period 2|Lack of Efficacy|1
863229|NCT01474772|2846851|P2|Period 2|AE not Related to Study Drug|1
863230|NCT01474772|2846852|P1|Period 2|AE not Related to Study Drug|4
863231|NCT01474772|2846851|P2|Period 2|AE Related to Study Drug|1
863232|NCT01474772|2846852|P1|Period 2|AE Related to Study Drug|0
863233|NCT01474772|2846851|P2|Period 2|Death|1
863234|NCT01474772|2846852|P1|Period 2|Death|0
863235|NCT01474772|2846851|P2|Washout|Reason not Specified|1
863236|NCT01474772|2846852|P1|Washout|Reason not Specified|0
863237|NCT01474772|2846851|P2|Washout|Lost to Follow-up|1
863238|NCT01474772|2846852|P1|Washout|Lost to Follow-up|0
863239|NCT01474772|2846851|P2|Washout|Withdrawal by Subject|0
863240|NCT01474772|2846852|P1|Washout|Withdrawal by Subject|1
863241|NCT01474772|2846851|P2|Washout|AE not Related to Study Drug|0
863242|NCT01474772|2846852|P1|Washout|AE not Related to Study Drug|2
863243|NCT01474772|2846851|P2|Period 1|Reason not Specified|1
863244|NCT01474772|2846852|P1|Period 1|Reason not Specified|1
863245|NCT01474772|2846851|P2|Period 1|Lost to Follow-up|0
863246|NCT01474772|2846852|P1|Period 1|Lost to Follow-up|1
863247|NCT01474772|2846851|P2|Period 1|Withdrawal by Subject|1
863248|NCT01474772|2846852|P1|Period 1|Withdrawal by Subject|3
863249|NCT01474772|2846851|P2|Period 1|AE not Related to Study Drug|0
863250|NCT01474772|2846852|P1|Period 1|AE not Related to Study Drug|1
863251|NCT01474772|2846851|P2|Period 1|Adverse Event (AE) Related to Study Drug|1
863252|NCT01474772|2846852|P1|Period 1|Adverse Event (AE) Related to Study Drug|6
863253|NCT01474746|2846902|P2|Overall Study|Withdrawal by Subject|1
863254|NCT01474746|2846903|P1|Overall Study|Withdrawal by Subject|2
863255|NCT01474746|2846902|P2|Overall Study|Lost to Follow-up|1
863256|NCT01474746|2846903|P1|Overall Study|Lost to Follow-up|1
863257|NCT01474681|2846967|P4|Overall Study|Death|6
863258|NCT01474681|2846968|P3|Overall Study|Death|2
863259|NCT01474681|2846969|P2|Overall Study|Death|3
863260|NCT01474681|2846970|P1|Overall Study|Death|0
863261|NCT01474551|2847021|P1|Overall Study|Death|1
863262|NCT01474538|2847027|P2|Treatment Period 2|Protocol Violation|0
863263|NCT01474538|2847028|P1|Treatment Period 2|Protocol Violation|1
863264|NCT01474538|2847027|P2|Treatment Period 2|Physician Decision|1
863265|NCT01474538|2847028|P1|Treatment Period 2|Physician Decision|0
863266|NCT01474538|2847027|P2|Treatment Period 2|Sponsor decision|0
863267|NCT01474538|2847028|P1|Treatment Period 2|Sponsor decision|1
863268|NCT01474538|2847027|P2|Treatment Period 2|Withdrawal by Subject|0
863269|NCT01474538|2847028|P1|Treatment Period 2|Withdrawal by Subject|2
863270|NCT01474538|2847027|P2|Treatment Period 2|Adverse Event|1
863271|NCT01474538|2847028|P1|Treatment Period 2|Adverse Event|1
863272|NCT01474538|2847027|P2|Treatment Period 2|Death|0
863273|NCT01474538|2847028|P1|Treatment Period 2|Death|1
863274|NCT01474538|2847027|P2|Treatment Period 1|Protocol Violation|1
863275|NCT01474538|2847028|P1|Treatment Period 1|Protocol Violation|0
863276|NCT01474538|2847027|P2|Treatment Period 1|Withdrawal by Subject|3
863277|NCT01474538|2847028|P1|Treatment Period 1|Withdrawal by Subject|1
863278|NCT01474538|2847027|P2|Treatment Period 1|Physician Decision|0
863279|NCT01474538|2847028|P1|Treatment Period 1|Physician Decision|1
863280|NCT01474538|2847027|P2|Treatment Period 1|Death|0
863281|NCT01474538|2847028|P1|Treatment Period 1|Death|1
863282|NCT01474512|2847045|P10|Maintenance Period|Treated but Discontinued in Induction|0
863283|NCT01474512|2847046|P9|Maintenance Period|Treated but Discontinued in Induction|0
863284|NCT01474512|2847047|P8|Maintenance Period|Treated but Discontinued in Induction|0
863285|NCT01474512|2847048|P7|Maintenance Period|Treated but Discontinued in Induction|0
863286|NCT01474512|2847049|P6|Maintenance Period|Treated but Discontinued in Induction|0
863287|NCT01474512|2847050|P5|Maintenance Period|Treated but Discontinued in Induction|1
863288|NCT01474512|2847051|P4|Maintenance Period|Treated but Discontinued in Induction|0
863289|NCT01474512|2847052|P3|Maintenance Period|Treated but Discontinued in Induction|0
863290|NCT01474512|2847053|P2|Maintenance Period|Treated but Discontinued in Induction|0
863291|NCT01474512|2847054|P1|Maintenance Period|Treated but Discontinued in Induction|0
863292|NCT01474512|2847045|P10|Maintenance Period|Protocol Violation|1
863293|NCT01474512|2847046|P9|Maintenance Period|Protocol Violation|0
863294|NCT01474512|2847047|P8|Maintenance Period|Protocol Violation|1
863295|NCT01474512|2847048|P7|Maintenance Period|Protocol Violation|0
863296|NCT01474512|2847049|P6|Maintenance Period|Protocol Violation|0
863297|NCT01474512|2847050|P5|Maintenance Period|Protocol Violation|0
863298|NCT01474512|2847051|P4|Maintenance Period|Protocol Violation|1
863299|NCT01474512|2847052|P3|Maintenance Period|Protocol Violation|0
863300|NCT01474512|2847053|P2|Maintenance Period|Protocol Violation|0
863301|NCT01474512|2847054|P1|Maintenance Period|Protocol Violation|0
863302|NCT01474512|2847045|P10|Maintenance Period|Lack of Efficacy|12
863303|NCT01474512|2847046|P9|Maintenance Period|Lack of Efficacy|11
863304|NCT01474512|2847047|P8|Maintenance Period|Lack of Efficacy|11
863305|NCT01474512|2847048|P7|Maintenance Period|Lack of Efficacy|0
863306|NCT01474512|2847049|P6|Maintenance Period|Lack of Efficacy|0
863307|NCT01474512|2847050|P5|Maintenance Period|Lack of Efficacy|0
863308|NCT01474512|2847051|P4|Maintenance Period|Lack of Efficacy|1
863309|NCT01474512|2847052|P3|Maintenance Period|Lack of Efficacy|0
863310|NCT01474512|2847053|P2|Maintenance Period|Lack of Efficacy|0
863311|NCT01474512|2847054|P1|Maintenance Period|Lack of Efficacy|0
863312|NCT01474512|2847045|P10|Maintenance Period|Clinical Relapse|0
863313|NCT01474512|2847046|P9|Maintenance Period|Clinical Relapse|0
863314|NCT01474512|2847047|P8|Maintenance Period|Clinical Relapse|0
863315|NCT01474512|2847048|P7|Maintenance Period|Clinical Relapse|0
863316|NCT01474512|2847049|P6|Maintenance Period|Clinical Relapse|0
863317|NCT01474512|2847050|P5|Maintenance Period|Clinical Relapse|0
863318|NCT01474512|2847051|P4|Maintenance Period|Clinical Relapse|1
863319|NCT01474512|2847052|P3|Maintenance Period|Clinical Relapse|0
863320|NCT01474512|2847053|P2|Maintenance Period|Clinical Relapse|0
863321|NCT01474512|2847054|P1|Maintenance Period|Clinical Relapse|0
863322|NCT01474512|2847045|P10|Maintenance Period|Investigator Decision|0
863323|NCT01474512|2847046|P9|Maintenance Period|Investigator Decision|0
863324|NCT01474512|2847047|P8|Maintenance Period|Investigator Decision|2
863325|NCT01474512|2847048|P7|Maintenance Period|Investigator Decision|0
863326|NCT01474512|2847049|P6|Maintenance Period|Investigator Decision|1
863327|NCT01474512|2847050|P5|Maintenance Period|Investigator Decision|0
863328|NCT01474512|2847051|P4|Maintenance Period|Investigator Decision|0
863329|NCT01474512|2847052|P3|Maintenance Period|Investigator Decision|0
863330|NCT01474512|2847053|P2|Maintenance Period|Investigator Decision|0
863331|NCT01474512|2847054|P1|Maintenance Period|Investigator Decision|0
863332|NCT01474512|2847045|P10|Maintenance Period|Death|0
863333|NCT01474512|2847046|P9|Maintenance Period|Death|0
863334|NCT01474512|2847047|P8|Maintenance Period|Death|0
863335|NCT01474512|2847048|P7|Maintenance Period|Death|0
863336|NCT01474512|2847049|P6|Maintenance Period|Death|2
863337|NCT01474512|2847050|P5|Maintenance Period|Death|0
863338|NCT01474512|2847051|P4|Maintenance Period|Death|0
863339|NCT01474512|2847052|P3|Maintenance Period|Death|0
863340|NCT01474512|2847053|P2|Maintenance Period|Death|0
863341|NCT01474512|2847054|P1|Maintenance Period|Death|0
863342|NCT01474512|2847045|P10|Maintenance Period|Lost to Follow-up|1
863343|NCT01474512|2847046|P9|Maintenance Period|Lost to Follow-up|1
863344|NCT01474512|2847047|P8|Maintenance Period|Lost to Follow-up|2
863345|NCT01474512|2847048|P7|Maintenance Period|Lost to Follow-up|0
863346|NCT01474512|2847049|P6|Maintenance Period|Lost to Follow-up|0
863347|NCT01474512|2847050|P5|Maintenance Period|Lost to Follow-up|3
863348|NCT01474512|2847051|P4|Maintenance Period|Lost to Follow-up|3
863349|NCT01474512|2847052|P3|Maintenance Period|Lost to Follow-up|0
863350|NCT01474512|2847053|P2|Maintenance Period|Lost to Follow-up|0
863351|NCT01474512|2847054|P1|Maintenance Period|Lost to Follow-up|0
863352|NCT01474512|2847045|P10|Maintenance Period|Withdrawal by Subject|1
863353|NCT01474512|2847046|P9|Maintenance Period|Withdrawal by Subject|3
863354|NCT01474512|2847047|P8|Maintenance Period|Withdrawal by Subject|6
863355|NCT01474512|2847048|P7|Maintenance Period|Withdrawal by Subject|1
863356|NCT01474512|2847049|P6|Maintenance Period|Withdrawal by Subject|3
863357|NCT01474512|2847050|P5|Maintenance Period|Withdrawal by Subject|2
863358|NCT01474512|2847051|P4|Maintenance Period|Withdrawal by Subject|6
863359|NCT01474512|2847052|P3|Maintenance Period|Withdrawal by Subject|0
863360|NCT01474512|2847053|P2|Maintenance Period|Withdrawal by Subject|0
863361|NCT01474512|2847054|P1|Maintenance Period|Withdrawal by Subject|0
863362|NCT01474512|2847045|P10|Maintenance Period|Adverse Event|3
863363|NCT01474512|2847046|P9|Maintenance Period|Adverse Event|1
863364|NCT01474512|2847047|P8|Maintenance Period|Adverse Event|19
863365|NCT01474512|2847048|P7|Maintenance Period|Adverse Event|0
863366|NCT01474512|2847049|P6|Maintenance Period|Adverse Event|7
863367|NCT01474512|2847050|P5|Maintenance Period|Adverse Event|2
863368|NCT01474512|2847051|P4|Maintenance Period|Adverse Event|4
863369|NCT01474512|2847052|P3|Maintenance Period|Adverse Event|0
863370|NCT01474512|2847053|P2|Maintenance Period|Adverse Event|0
863371|NCT01474512|2847054|P1|Maintenance Period|Adverse Event|0
863372|NCT01474512|2847045|P10|Maintenance Period|Relapsed (sPGA ≥3)|0
863373|NCT01474512|2847046|P9|Maintenance Period|Relapsed (sPGA ≥3)|0
863374|NCT01474512|2847047|P8|Maintenance Period|Relapsed (sPGA ≥3)|0
863375|NCT01474512|2847048|P7|Maintenance Period|Relapsed (sPGA ≥3)|9
863376|NCT01474512|2847049|P6|Maintenance Period|Relapsed (sPGA ≥3)|39
863377|NCT01474512|2847050|P5|Maintenance Period|Relapsed (sPGA ≥3)|111
863378|NCT01474512|2847051|P4|Maintenance Period|Relapsed (sPGA ≥3)|186
863379|NCT01474512|2847052|P3|Maintenance Period|Relapsed (sPGA ≥3)|0
863380|NCT01474512|2847053|P2|Maintenance Period|Relapsed (sPGA ≥3)|0
863381|NCT01474512|2847054|P1|Maintenance Period|Relapsed (sPGA ≥3)|0
863382|NCT01474512|2847045|P10|Induction Period|Lost to Follow-up|0
863383|NCT01474512|2847046|P9|Induction Period|Lost to Follow-up|0
863384|NCT01474512|2847047|P8|Induction Period|Lost to Follow-up|0
863385|NCT01474512|2847048|P7|Induction Period|Lost to Follow-up|0
863386|NCT01474512|2847049|P6|Induction Period|Lost to Follow-up|0
863387|NCT01474512|2847050|P5|Induction Period|Lost to Follow-up|0
863388|NCT01474512|2847051|P4|Induction Period|Lost to Follow-up|0
863389|NCT01474512|2847052|P3|Induction Period|Lost to Follow-up|2
863390|NCT01474512|2847053|P2|Induction Period|Lost to Follow-up|0
863391|NCT01474512|2847054|P1|Induction Period|Lost to Follow-up|1
863392|NCT01474512|2847045|P10|Induction Period|Sponsor Decision|0
863393|NCT01474512|2847046|P9|Induction Period|Sponsor Decision|0
863394|NCT01474512|2847047|P8|Induction Period|Sponsor Decision|0
863395|NCT01474512|2847048|P7|Induction Period|Sponsor Decision|0
863396|NCT01474512|2847049|P6|Induction Period|Sponsor Decision|0
863397|NCT01474512|2847050|P5|Induction Period|Sponsor Decision|0
863398|NCT01474512|2847051|P4|Induction Period|Sponsor Decision|0
863399|NCT01474512|2847052|P3|Induction Period|Sponsor Decision|1
863400|NCT01474512|2847053|P2|Induction Period|Sponsor Decision|1
863401|NCT01474512|2847054|P1|Induction Period|Sponsor Decision|1
863402|NCT01474512|2847045|P10|Induction Period|Protocol Violation|0
863403|NCT01474512|2847046|P9|Induction Period|Protocol Violation|0
863404|NCT01474512|2847047|P8|Induction Period|Protocol Violation|0
863405|NCT01474512|2847048|P7|Induction Period|Protocol Violation|0
863406|NCT01474512|2847049|P6|Induction Period|Protocol Violation|0
863407|NCT01474512|2847050|P5|Induction Period|Protocol Violation|0
863408|NCT01474512|2847051|P4|Induction Period|Protocol Violation|0
863409|NCT01474512|2847052|P3|Induction Period|Protocol Violation|0
863410|NCT01474512|2847053|P2|Induction Period|Protocol Violation|6
863411|NCT01474512|2847054|P1|Induction Period|Protocol Violation|3
863412|NCT01474512|2847045|P10|Induction Period|Withdrawal by Subject|0
863413|NCT01474512|2847046|P9|Induction Period|Withdrawal by Subject|0
863414|NCT01474512|2847047|P8|Induction Period|Withdrawal by Subject|0
863415|NCT01474512|2847048|P7|Induction Period|Withdrawal by Subject|0
863416|NCT01474512|2847049|P6|Induction Period|Withdrawal by Subject|0
863417|NCT01474512|2847050|P5|Induction Period|Withdrawal by Subject|0
863418|NCT01474512|2847051|P4|Induction Period|Withdrawal by Subject|0
863419|NCT01474512|2847052|P3|Induction Period|Withdrawal by Subject|5
863420|NCT01474512|2847053|P2|Induction Period|Withdrawal by Subject|6
863421|NCT01474512|2847054|P1|Induction Period|Withdrawal by Subject|6
863422|NCT01474512|2847045|P10|Induction Period|Lack of Efficacy|0
863423|NCT01474512|2847046|P9|Induction Period|Lack of Efficacy|0
863424|NCT01474512|2847047|P8|Induction Period|Lack of Efficacy|0
863425|NCT01474512|2847048|P7|Induction Period|Lack of Efficacy|0
863426|NCT01474512|2847049|P6|Induction Period|Lack of Efficacy|0
863427|NCT01474512|2847050|P5|Induction Period|Lack of Efficacy|0
863428|NCT01474512|2847051|P4|Induction Period|Lack of Efficacy|0
863429|NCT01474512|2847052|P3|Induction Period|Lack of Efficacy|0
863430|NCT01474512|2847053|P2|Induction Period|Lack of Efficacy|1
863431|NCT01474512|2847054|P1|Induction Period|Lack of Efficacy|7
863432|NCT01474512|2847045|P10|Induction Period|Adverse Event|0
863433|NCT01474512|2847046|P9|Induction Period|Adverse Event|0
863434|NCT01474512|2847047|P8|Induction Period|Adverse Event|0
863435|NCT01474512|2847048|P7|Induction Period|Adverse Event|0
863436|NCT01474512|2847049|P6|Induction Period|Adverse Event|0
863437|NCT01474512|2847050|P5|Induction Period|Adverse Event|0
863438|NCT01474512|2847051|P4|Induction Period|Adverse Event|0
863439|NCT01474512|2847052|P3|Induction Period|Adverse Event|10
863440|NCT01474512|2847053|P2|Induction Period|Adverse Event|10
863441|NCT01474512|2847054|P1|Induction Period|Adverse Event|6
863442|NCT01474434|2847123|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
863443|NCT01474434|2847124|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
863444|NCT01474434|2847125|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
863445|NCT01474434|2847126|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1
863446|NCT01474434|2847123|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1
863447|NCT01474434|2847124|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
863448|NCT01474434|2847125|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
863449|NCT01474434|2847126|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
863450|NCT01474434|2847123|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
863451|NCT01474434|2847124|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
863452|NCT01474434|2847125|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
863453|NCT01474434|2847126|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
863454|NCT01474317|2847168|P1|Overall Study|Subject ineligible for study|1
863455|NCT01474317|2847168|P1|Overall Study|Adverse Event|1
863456|NCT01474291|2847177|P1|Overall Study|Death|2
863457|NCT01474291|2847177|P1|Overall Study|No Reason Reported|10
863458|NCT01474291|2847177|P1|Overall Study|Patient No Longer Wanted to Participate|12
863459|NCT01474291|2847177|P1|Overall Study|Lost to Follow-up|29
863460|NCT01474291|2847177|P1|Overall Study|Adverse Event|53
863461|NCT01474291|2847177|P1|Overall Study|Lack of Treatment Efficacy|88
863462|NCT01474291|2847177|P1|Overall Study|Not Evaluable for Efficacy|26
863463|NCT01474239|2847221|P2|Overall Study|Withdrawal for Economic Reason|0
863464|NCT01474239|2847222|P1|Overall Study|Withdrawal for Economic Reason|1
863465|NCT01474239|2847221|P2|Overall Study|Clinical Disease Progression|1
863466|NCT01474239|2847222|P1|Overall Study|Clinical Disease Progression|7
863467|NCT01474239|2847221|P2|Overall Study|Death|1
863468|NCT01474239|2847222|P1|Overall Study|Death|1
863469|NCT01474239|2847221|P2|Overall Study|Withdrawal by Subject|2
863470|NCT01474239|2847222|P1|Overall Study|Withdrawal by Subject|1
863471|NCT01474239|2847221|P2|Overall Study|Adverse Event|3
863472|NCT01474239|2847222|P1|Overall Study|Adverse Event|12
863473|NCT01474239|2847221|P2|Overall Study|Disease Progression|25
863474|NCT01474239|2847222|P1|Overall Study|Disease Progression|37
863475|NCT01473953|2847416|P5|Overall Study|Other|0
863476|NCT01473953|2847417|P4|Overall Study|Other|0
863477|NCT01473953|2847418|P3|Overall Study|Other|0
863478|NCT01473953|2847419|P2|Overall Study|Other|0
863479|NCT01473953|2847420|P1|Overall Study|Other|1
863480|NCT01473836|2847462|P1|Overall Study|Does not meet entrance criteria|1
863481|NCT01473836|2847462|P1|Overall Study|Lack of Efficacy|1
863482|NCT01473836|2847462|P1|Overall Study|Adverse Event|4
863483|NCT01473758|2847473|P4|Cycle 2|Adverse Event|0
863484|NCT01473758|2847474|P3|Cycle 2|Adverse Event|5
863485|NCT01473758|2847475|P2|Cycle 2|Adverse Event|0
863486|NCT01473758|2847476|P1|Cycle 2|Adverse Event|0
863487|NCT01473758|2847473|P4|Cycle 1|Withdrawal by Subject|0
863488|NCT01473758|2847474|P3|Cycle 1|Withdrawal by Subject|0
863489|NCT01473758|2847475|P2|Cycle 1|Withdrawal by Subject|1
863490|NCT01473758|2847476|P1|Cycle 1|Withdrawal by Subject|1
863491|NCT01473758|2847473|P4|Cycle 1|Adverse Event|0
863492|NCT01473758|2847474|P3|Cycle 1|Adverse Event|0
863493|NCT01473758|2847475|P2|Cycle 1|Adverse Event|2
863494|NCT01473758|2847476|P1|Cycle 1|Adverse Event|10
863495|NCT01473732|2847613|P2|Overall Study|Death|0
863496|NCT01473732|2847614|P1|Overall Study|Death|1
863497|NCT01473732|2847613|P2|Overall Study|Adverse Event|0
863498|NCT01473732|2847614|P1|Overall Study|Adverse Event|1
863499|NCT01473602|2847622|P2|Overall Study|Physician Decision|0
863500|NCT01473602|2847623|P1|Overall Study|Physician Decision|1
863501|NCT01473602|2847622|P2|Overall Study|Withdrawal by Subject|4
863502|NCT01473602|2847623|P1|Overall Study|Withdrawal by Subject|5
863503|NCT01473602|2847622|P2|Overall Study|Lost to Follow-up|1
863504|NCT01473602|2847623|P1|Overall Study|Lost to Follow-up|1
863505|NCT01473602|2847622|P2|Overall Study|Death|1
863506|NCT01473602|2847623|P1|Overall Study|Death|0
863507|NCT01473602|2847622|P2|Overall Study|Adverse Event|2
863508|NCT01473602|2847623|P1|Overall Study|Adverse Event|1
863509|NCT01473589|2847659|P2|Overall Study|Entry criteria not met|1
863510|NCT01473589|2847660|P1|Overall Study|Entry criteria not met|0
863511|NCT01473589|2847659|P2|Overall Study|Physician Decision|1
863512|NCT01473589|2847660|P1|Overall Study|Physician Decision|0
863513|NCT01473589|2847659|P2|Overall Study|Withdrawal by Subject|11
863514|NCT01473589|2847660|P1|Overall Study|Withdrawal by Subject|5
863515|NCT01473589|2847659|P2|Overall Study|Protocol Violation|0
863516|NCT01473589|2847660|P1|Overall Study|Protocol Violation|1
863517|NCT01473589|2847659|P2|Overall Study|Lost to Follow-up|2
863518|NCT01473589|2847660|P1|Overall Study|Lost to Follow-up|2
863519|NCT01473589|2847659|P2|Overall Study|Death|0
863520|NCT01473589|2847660|P1|Overall Study|Death|2
863521|NCT01473589|2847659|P2|Overall Study|Adverse Event|1
863522|NCT01473589|2847660|P1|Overall Study|Adverse Event|1
863523|NCT01473563|2847694|P1|Overall Study|Lost to FU post tx discontinuation|1
863524|NCT01473524|2847716|P3|Overall Study|Withdrawal by Subject|1
863525|NCT01473524|2847717|P2|Overall Study|Withdrawal by Subject|1
863526|NCT01473524|2847718|P1|Overall Study|Withdrawal by Subject|2
863527|NCT01473524|2847716|P3|Overall Study|Death|0
863528|NCT01473524|2847717|P2|Overall Study|Death|0
863529|NCT01473524|2847718|P1|Overall Study|Death|1
863530|NCT01473524|2847716|P3|Overall Study|Adverse Event|2
863531|NCT01473524|2847717|P2|Overall Study|Adverse Event|8
863532|NCT01473524|2847718|P1|Overall Study|Adverse Event|4
863533|NCT01473420|2847751|P2|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0
863534|NCT01473420|2847752|P1|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1
863535|NCT01473420|2847751|P2|Maintenance Period (16 Weeks)|Sponsor's Decision|0
863536|NCT01473420|2847752|P1|Maintenance Period (16 Weeks)|Sponsor's Decision|1
863537|NCT01473420|2847751|P2|Maintenance Period (16 Weeks)|Long term hospitalization|1
863538|NCT01473420|2847752|P1|Maintenance Period (16 Weeks)|Long term hospitalization|0
863539|NCT01473420|2847751|P2|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0
863540|NCT01473420|2847752|P1|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1
863541|NCT01473420|2847751|P2|Maintenance Period (16 Weeks)|Site closure|1
863542|NCT01473420|2847752|P1|Maintenance Period (16 Weeks)|Site closure|3
863543|NCT01473420|2847751|P2|Maintenance Period (16 Weeks)|Withdrawal by Subject|6
863544|NCT01473420|2847752|P1|Maintenance Period (16 Weeks)|Withdrawal by Subject|4
863545|NCT01473420|2847751|P2|Maintenance Period (16 Weeks)|Lost to Follow-up|2
863546|NCT01473420|2847752|P1|Maintenance Period (16 Weeks)|Lost to Follow-up|1
863547|NCT01473420|2847751|P2|Maintenance Period (16 Weeks)|Kidney transplant|1
863548|NCT01473420|2847752|P1|Maintenance Period (16 Weeks)|Kidney transplant|3
863549|NCT01473420|2847751|P2|Maintenance Period (16 Weeks)|Did not meet criteria|2
863550|NCT01473420|2847752|P1|Maintenance Period (16 Weeks)|Did not meet criteria|0
863551|NCT01473420|2847751|P2|Maintenance Period (16 Weeks)|Physician Decision|2
863552|NCT01473420|2847752|P1|Maintenance Period (16 Weeks)|Physician Decision|1
863553|NCT01473420|2847751|P2|Maintenance Period (16 Weeks)|Adverse Event|2
863554|NCT01473420|2847752|P1|Maintenance Period (16 Weeks)|Adverse Event|3
863555|NCT01473420|2847751|P2|Titration Period (18 Weeks)|Did not meet criteria|32
863556|NCT01473420|2847752|P1|Titration Period (18 Weeks)|Did not meet criteria|32
863557|NCT01473420|2847751|P2|Titration Period (18 Weeks)|Adverse Event|6
863558|NCT01473420|2847752|P1|Titration Period (18 Weeks)|Adverse Event|4
863559|NCT01473407|2847836|P2|Overall Study|Site Closure|0
863560|NCT01473407|2847837|P1|Overall Study|Site Closure|1
863561|NCT01473407|2847836|P2|Overall Study|Sponsor's Decision|10
863562|NCT01473407|2847837|P1|Overall Study|Sponsor's Decision|10
863563|NCT01473407|2847836|P2|Overall Study|Transfer to Another Facility/Unit|3
863564|NCT01473407|2847837|P1|Overall Study|Transfer to Another Facility/Unit|4
863565|NCT01473407|2847836|P2|Overall Study|Temperature Excursion|3
863566|NCT01473407|2847837|P1|Overall Study|Temperature Excursion|2
863567|NCT01473407|2847836|P2|Overall Study|Patient Lost Green Card Status|0
863568|NCT01473407|2847837|P1|Overall Study|Patient Lost Green Card Status|1
863569|NCT01473407|2847836|P2|Overall Study|Patient Received Aranesp|0
863570|NCT01473407|2847837|P1|Overall Study|Patient Received Aranesp|1
863571|NCT01473407|2847836|P2|Overall Study|Elevated Hemoglobin|0
863572|NCT01473407|2847837|P1|Overall Study|Elevated Hemoglobin|1
863573|NCT01473407|2847836|P2|Overall Study|Vacation/Travel|1
863574|NCT01473407|2847837|P1|Overall Study|Vacation/Travel|1
863575|NCT01473407|2847836|P2|Overall Study|Kidney Transplant|6
863576|NCT01473407|2847837|P1|Overall Study|Kidney Transplant|7
863577|NCT01473407|2847836|P2|Overall Study|Withdrawal by Subject|7
863578|NCT01473407|2847837|P1|Overall Study|Withdrawal by Subject|4
863579|NCT01473407|2847836|P2|Overall Study|Randomization Error|1
863580|NCT01473407|2847837|P1|Overall Study|Randomization Error|3
863581|NCT01473407|2847836|P2|Overall Study|Adverse Event|8
863582|NCT01473407|2847837|P1|Overall Study|Adverse Event|8
863583|NCT01473407|2847836|P2|Overall Study|Lost to Follow-up|4
863584|NCT01473407|2847837|P1|Overall Study|Lost to Follow-up|10
863585|NCT01473407|2847836|P2|Overall Study|Physician Decision|4
863586|NCT01473407|2847837|P1|Overall Study|Physician Decision|1
863587|NCT01473394|2847891|P2|Overall Study|Lost to Follow-up|11
863588|NCT01473394|2847892|P1|Overall Study|Lost to Follow-up|9
863589|NCT01473394|2847891|P2|Overall Study|Withdrew Consent|10
863590|NCT01473394|2847892|P1|Overall Study|Withdrew Consent|12
863591|NCT01473394|2847891|P2|Overall Study|Protocol Violation|5
863592|NCT01473394|2847892|P1|Overall Study|Protocol Violation|7
863593|NCT01473394|2847891|P2|Overall Study|Insufficient Therapeutic Response|1
863594|NCT01473394|2847892|P1|Overall Study|Insufficient Therapeutic Response|4
863595|NCT01473394|2847891|P2|Overall Study|Adverse Event|16
863596|NCT01473394|2847892|P1|Overall Study|Adverse Event|13
863597|NCT01473381|2847906|P4|Overall Study|Other Reasons|3
863598|NCT01473381|2847907|P3|Overall Study|Other Reasons|1
863599|NCT01473381|2847908|P2|Overall Study|Other Reasons|0
863600|NCT01473381|2847909|P1|Overall Study|Other Reasons|0
863601|NCT01473381|2847906|P4|Overall Study|Lost to Follow-up|23
863602|NCT01473381|2847907|P3|Overall Study|Lost to Follow-up|35
863603|NCT01473381|2847908|P2|Overall Study|Lost to Follow-up|28
863604|NCT01473381|2847909|P1|Overall Study|Lost to Follow-up|25
863605|NCT01473381|2847906|P4|Overall Study|Withdrawal of Consent|26
863606|NCT01473381|2847907|P3|Overall Study|Withdrawal of Consent|20
863607|NCT01473381|2847908|P2|Overall Study|Withdrawal of Consent|21
863608|NCT01473381|2847909|P1|Overall Study|Withdrawal of Consent|20
863609|NCT01473381|2847906|P4|Overall Study|Protocol Violation|17
863610|NCT01473381|2847907|P3|Overall Study|Protocol Violation|19
863611|NCT01473381|2847908|P2|Overall Study|Protocol Violation|23
863612|NCT01473381|2847909|P1|Overall Study|Protocol Violation|17
863613|NCT01473381|2847906|P4|Overall Study|Insufficient Therapeutic Response|3
863614|NCT01473381|2847907|P3|Overall Study|Insufficient Therapeutic Response|2
863615|NCT01473381|2847908|P2|Overall Study|Insufficient Therapeutic Response|1
863616|NCT01473381|2847909|P1|Overall Study|Insufficient Therapeutic Response|10
863617|NCT01473381|2847906|P4|Overall Study|Adverse Event|17
863618|NCT01473381|2847907|P3|Overall Study|Adverse Event|25
863619|NCT01473381|2847908|P2|Overall Study|Adverse Event|20
863620|NCT01473381|2847909|P1|Overall Study|Adverse Event|8
863621|NCT01472965|2847991|P2|Overall Study|Withdrawal by Subject|0
863622|NCT01472965|2847992|P1|Overall Study|Withdrawal by Subject|1
863623|NCT01472939|2848012|P4|Overall Study|Withdrawal by Subject|4
863624|NCT01472939|2848013|P3|Overall Study|Withdrawal by Subject|1
863625|NCT01472939|2848014|P2|Overall Study|Withdrawal by Subject|3
863626|NCT01472939|2848015|P1|Overall Study|Withdrawal by Subject|9
863627|NCT01472939|2848012|P4|Overall Study|Protocol Violation|1
863628|NCT01472939|2848013|P3|Overall Study|Protocol Violation|0
863629|NCT01472939|2848014|P2|Overall Study|Protocol Violation|3
863630|NCT01472939|2848015|P1|Overall Study|Protocol Violation|3
863631|NCT01472939|2848012|P4|Overall Study|Withdrawal By PI|0
863632|NCT01472939|2848013|P3|Overall Study|Withdrawal By PI|0
863633|NCT01472939|2848014|P2|Overall Study|Withdrawal By PI|0
863634|NCT01472939|2848015|P1|Overall Study|Withdrawal By PI|1
863635|NCT01472939|2848012|P4|Overall Study|Prohibited Medication|0
863636|NCT01472939|2848013|P3|Overall Study|Prohibited Medication|0
863637|NCT01472939|2848014|P2|Overall Study|Prohibited Medication|1
863638|NCT01472939|2848015|P1|Overall Study|Prohibited Medication|0
863639|NCT01472939|2848012|P4|Overall Study|Clinically Significant Pre-Dose ECG|0
863640|NCT01472939|2848013|P3|Overall Study|Clinically Significant Pre-Dose ECG|1
863641|NCT01472939|2848014|P2|Overall Study|Clinically Significant Pre-Dose ECG|0
863642|NCT01472939|2848015|P1|Overall Study|Clinically Significant Pre-Dose ECG|0
863643|NCT01472939|2848012|P4|Overall Study|Lost to Follow-up|0
863644|NCT01472939|2848013|P3|Overall Study|Lost to Follow-up|2
863645|NCT01472939|2848014|P2|Overall Study|Lost to Follow-up|0
863646|NCT01472939|2848015|P1|Overall Study|Lost to Follow-up|3
863647|NCT01472939|2848012|P4|Overall Study|Lack of Efficacy|1
863648|NCT01472939|2848013|P3|Overall Study|Lack of Efficacy|0
863649|NCT01472939|2848014|P2|Overall Study|Lack of Efficacy|0
863650|NCT01472939|2848015|P1|Overall Study|Lack of Efficacy|1
863651|NCT01472939|2848012|P4|Overall Study|Adverse Event|14
863652|NCT01472939|2848013|P3|Overall Study|Adverse Event|7
863653|NCT01472939|2848014|P2|Overall Study|Adverse Event|7
863654|NCT01472939|2848015|P1|Overall Study|Adverse Event|3
863655|NCT01472835|2848059|P2|Overall Study|Lost to Follow-up|0
863656|NCT01472835|2848060|P1|Overall Study|Lost to Follow-up|2
863657|NCT01472380|2848138|P1|1 Day Period Between Dosing|Protocol Violation|1
863658|NCT01472380|2848138|P1|Efavirenz Alone|Withdrawal by Subject|1
863659|NCT01472341|2848149|P1|Overall Study|Death|9
863660|NCT01472341|2848149|P1|Overall Study|Laboratory parameters unavailable|25
863661|NCT01472341|2848149|P1|Overall Study|Lost to Follow-up|52
863662|NCT01472341|2848149|P1|Overall Study|Withdrawal by Subject|39
863663|NCT01472341|2848149|P1|Overall Study|Started therapy with a DPP-IV/GLP-1|92
863664|NCT01472341|2848149|P1|Overall Study|Started insulin therapy|55
863665|NCT01472289|2848155|P1|Overall Study|Death|2
863666|NCT01472185|2848167|P2|Overall Study|Subject Withdrew Consent|3
863667|NCT01472185|2848168|P1|Overall Study|Subject Withdrew Consent|6
863668|NCT01472185|2848167|P2|Overall Study|Subject Noncompliance|15
863669|NCT01472185|2848168|P1|Overall Study|Subject Noncompliance|8
863670|NCT01472185|2848167|P2|Overall Study|Protocol Violation|1
863671|NCT01472185|2848168|P1|Overall Study|Protocol Violation|5
863672|NCT01472185|2848167|P2|Overall Study|Lost to Follow-up|1
863673|NCT01472185|2848168|P1|Overall Study|Lost to Follow-up|4
863674|NCT01472185|2848167|P2|Overall Study|Investigator’s Discretion|1
863675|NCT01472185|2848168|P1|Overall Study|Investigator’s Discretion|3
863676|NCT01472185|2848167|P2|Overall Study|Hyperglycemia|2
863677|NCT01472185|2848168|P1|Overall Study|Hyperglycemia|5
863678|NCT01472185|2848167|P2|Overall Study|Adverse Event Other than Hyperglycemia|10
863679|NCT01472185|2848168|P1|Overall Study|Adverse Event Other than Hyperglycemia|3
863680|NCT01472185|2848167|P2|Overall Study|Randomized but Not Treated|1
863681|NCT01472185|2848168|P1|Overall Study|Randomized but Not Treated|0
863682|NCT01471782|2848188|P6|Overall Study|Death|1
863683|NCT01471782|2848189|P5|Overall Study|Death|0
863684|NCT01471782|2848190|P4|Overall Study|Death|0
863685|NCT01471782|2848191|P3|Overall Study|Death|0
863686|NCT01471782|2848192|P2|Overall Study|Death|0
863687|NCT01471782|2848193|P1|Overall Study|Death|0
863688|NCT01471782|2848188|P6|Overall Study|Withdrawal by Parent/Guardian|0
863689|NCT01471782|2848189|P5|Overall Study|Withdrawal by Parent/Guardian|1
863690|NCT01471782|2848190|P4|Overall Study|Withdrawal by Parent/Guardian|0
863691|NCT01471782|2848191|P3|Overall Study|Withdrawal by Parent/Guardian|0
863692|NCT01471782|2848192|P2|Overall Study|Withdrawal by Parent/Guardian|0
863693|NCT01471782|2848193|P1|Overall Study|Withdrawal by Parent/Guardian|0
863694|NCT01471782|2848188|P6|Overall Study|Physician Decision|8
863695|NCT01471782|2848189|P5|Overall Study|Physician Decision|3
863696|NCT01471782|2848190|P4|Overall Study|Physician Decision|0
863697|NCT01471782|2848191|P3|Overall Study|Physician Decision|0
863698|NCT01471782|2848192|P2|Overall Study|Physician Decision|0
863699|NCT01471782|2848193|P1|Overall Study|Physician Decision|0
863700|NCT01471782|2848188|P6|Overall Study|Disease Relapse|1
863701|NCT01471782|2848189|P5|Overall Study|Disease Relapse|2
863702|NCT01471782|2848190|P4|Overall Study|Disease Relapse|1
863703|NCT01471782|2848191|P3|Overall Study|Disease Relapse|0
863704|NCT01471782|2848192|P2|Overall Study|Disease Relapse|0
863705|NCT01471782|2848193|P1|Overall Study|Disease Relapse|0
863706|NCT01471782|2848188|P6|Overall Study|Change of Chemotherapy|4
863707|NCT01471782|2848189|P5|Overall Study|Change of Chemotherapy|1
863708|NCT01471782|2848190|P4|Overall Study|Change of Chemotherapy|0
863709|NCT01471782|2848191|P3|Overall Study|Change of Chemotherapy|0
863710|NCT01471782|2848192|P2|Overall Study|Change of Chemotherapy|1
863711|NCT01471782|2848193|P1|Overall Study|Change of Chemotherapy|1
863712|NCT01471782|2848188|P6|Overall Study|Other|5
863713|NCT01471782|2848189|P5|Overall Study|Other|6
863714|NCT01471782|2848190|P4|Overall Study|Other|1
863715|NCT01471782|2848191|P3|Overall Study|Other|1
863716|NCT01471782|2848192|P2|Overall Study|Other|0
863717|NCT01471782|2848193|P1|Overall Study|Other|0
863718|NCT01471782|2848188|P6|Overall Study|Adverse Event|1
863719|NCT01471782|2848189|P5|Overall Study|Adverse Event|3
863720|NCT01471782|2848190|P4|Overall Study|Adverse Event|2
863721|NCT01471782|2848191|P3|Overall Study|Adverse Event|2
863722|NCT01471782|2848192|P2|Overall Study|Adverse Event|1
863723|NCT01471782|2848193|P1|Overall Study|Adverse Event|1
863724|NCT01471782|2848188|P6|Overall Study|Lack of Efficacy|18
863725|NCT01471782|2848189|P5|Overall Study|Lack of Efficacy|5
863726|NCT01471782|2848190|P4|Overall Study|Lack of Efficacy|1
863727|NCT01471782|2848191|P3|Overall Study|Lack of Efficacy|1
863728|NCT01471782|2848192|P2|Overall Study|Lack of Efficacy|2
863729|NCT01471782|2848193|P1|Overall Study|Lack of Efficacy|1
863730|NCT01471782|2848188|P6|Overall Study|Hematopoietic Stem Cell Transplantation|3
863731|NCT01471782|2848189|P5|Overall Study|Hematopoietic Stem Cell Transplantation|5
863732|NCT01471782|2848190|P4|Overall Study|Hematopoietic Stem Cell Transplantation|0
863733|NCT01471782|2848191|P3|Overall Study|Hematopoietic Stem Cell Transplantation|1
863734|NCT01471782|2848192|P2|Overall Study|Hematopoietic Stem Cell Transplantation|2
863735|NCT01471782|2848193|P1|Overall Study|Hematopoietic Stem Cell Transplantation|2
863736|NCT01471691|2848247|P2|Overall Study|Lack of Efficacy|1
863737|NCT01471691|2848248|P1|Overall Study|Lack of Efficacy|0
863738|NCT01471379|2848257|P3|Overall Study|Study terminated|0
863739|NCT01471379|2848258|P2|Overall Study|Study terminated|1
863740|NCT01471379|2848259|P1|Overall Study|Study terminated|0
863741|NCT01471379|2848257|P3|Overall Study|Adverse Event|0
863742|NCT01471379|2848258|P2|Overall Study|Adverse Event|0
863743|NCT01471379|2848259|P1|Overall Study|Adverse Event|1
863744|NCT01471353|2848279|P1|Overall Study|remain on study|3
863745|NCT01471340|2848290|P2|Overall Study|Invalid informed consent|0
863746|NCT01471340|2848291|P1|Overall Study|Invalid informed consent|1
863747|NCT01471340|2848290|P2|Overall Study|Investigational site closure|1
863748|NCT01471340|2848291|P1|Overall Study|Investigational site closure|0
863749|NCT01471340|2848290|P2|Overall Study|Lost to Follow-up|1
863750|NCT01471340|2848291|P1|Overall Study|Lost to Follow-up|0
863751|NCT01471340|2848290|P2|Overall Study|Death|4
863752|NCT01471340|2848291|P1|Overall Study|Death|5
863753|NCT01471574|2848314|P4|Follow-up Period|Follow-up no longer required|0
863754|NCT01471574|2848315|P3|Follow-up Period|Follow-up no longer required|0
863755|NCT01471574|2848316|P2|Follow-up Period|Follow-up no longer required|1
863756|NCT01471574|2848317|P1|Follow-up Period|Follow-up no longer required|0
863757|NCT01471574|2848314|P4|Follow-up Period|Death|0
863758|NCT01471574|2848315|P3|Follow-up Period|Death|1
863759|NCT01471574|2848316|P2|Follow-up Period|Death|0
863760|NCT01471574|2848317|P1|Follow-up Period|Death|0
863761|NCT01471574|2848314|P4|Follow-up Period|Lost to Follow-up|2
863762|NCT01471574|2848315|P3|Follow-up Period|Lost to Follow-up|3
863763|NCT01471574|2848316|P2|Follow-up Period|Lost to Follow-up|1
863764|NCT01471574|2848317|P1|Follow-up Period|Lost to Follow-up|4
863765|NCT01471574|2848314|P4|Follow-up Period|Withdrawal by Subject|1
863766|NCT01471574|2848315|P3|Follow-up Period|Withdrawal by Subject|3
863767|NCT01471574|2848316|P2|Follow-up Period|Withdrawal by Subject|0
863768|NCT01471574|2848317|P1|Follow-up Period|Withdrawal by Subject|3
863769|NCT01471574|2848314|P4|Treatment Period|Not specified|0
863770|NCT01471574|2848315|P3|Treatment Period|Not specified|0
863771|NCT01471574|2848316|P2|Treatment Period|Not specified|0
863772|NCT01471574|2848317|P1|Treatment Period|Not specified|1
863773|NCT01471574|2848314|P4|Treatment Period|Patient no Longer Meets Study Criteria|0
863774|NCT01471574|2848315|P3|Treatment Period|Patient no Longer Meets Study Criteria|0
863775|NCT01471574|2848316|P2|Treatment Period|Patient no Longer Meets Study Criteria|0
863776|NCT01471574|2848317|P1|Treatment Period|Patient no Longer Meets Study Criteria|1
863777|NCT01471574|2848314|P4|Treatment Period|Lost to Follow-up|0
863778|NCT01471574|2848315|P3|Treatment Period|Lost to Follow-up|2
863779|NCT01471574|2848316|P2|Treatment Period|Lost to Follow-up|2
863780|NCT01471574|2848317|P1|Treatment Period|Lost to Follow-up|1
863781|NCT01471574|2848314|P4|Treatment Period|Patient Requested Discontinue Study drug|1
863782|NCT01471574|2848315|P3|Treatment Period|Patient Requested Discontinue Study drug|1
863783|NCT01471574|2848316|P2|Treatment Period|Patient Requested Discontinue Study drug|0
863784|NCT01471574|2848317|P1|Treatment Period|Patient Requested Discontinue Study drug|4
863785|NCT01471574|2848314|P4|Treatment Period|Withdrawal by Subject|0
863786|NCT01471574|2848315|P3|Treatment Period|Withdrawal by Subject|1
863787|NCT01471574|2848316|P2|Treatment Period|Withdrawal by Subject|1
863788|NCT01471574|2848317|P1|Treatment Period|Withdrawal by Subject|5
863789|NCT01471574|2848314|P4|Treatment Period|Adverse Event|1
863790|NCT01471574|2848315|P3|Treatment Period|Adverse Event|6
863791|NCT01471574|2848316|P2|Treatment Period|Adverse Event|3
863792|NCT01471574|2848317|P1|Treatment Period|Adverse Event|7
863793|NCT01471574|2848314|P4|Treatment Period|Lack of Efficacy|1
863794|NCT01471574|2848315|P3|Treatment Period|Lack of Efficacy|14
863795|NCT01471574|2848316|P2|Treatment Period|Lack of Efficacy|4
863796|NCT01471574|2848317|P1|Treatment Period|Lack of Efficacy|12
863797|NCT01471197|2848348|P2|Overall Study|Study Drug Toxicity|0
863798|NCT01471197|2848349|P1|Overall Study|Study Drug Toxicity|1
863799|NCT01471197|2848348|P2|Overall Study|Death|0
863800|NCT01471197|2848349|P1|Overall Study|Death|1
863801|NCT01471197|2848348|P2|Overall Study|Disease Progression|2
863802|NCT01471197|2848349|P1|Overall Study|Disease Progression|4
863803|NCT01471171|2848359|P2|Treatment Period 2|Adverse Event|0
863804|NCT01471171|2848360|P1|Treatment Period 2|Adverse Event|1
863805|NCT01471171|2848359|P2|Treatment Period 1|Adverse Event|1
863806|NCT01471171|2848360|P1|Treatment Period 1|Adverse Event|4
863807|NCT01471015|2848378|P3|Overall Study|Death|1
863808|NCT01471015|2848379|P2|Overall Study|Death|1
863809|NCT01471015|2848380|P1|Overall Study|Death|0
863810|NCT01470599|2848422|P2|Overall Study|Adverse event not related to study drug|5
863811|NCT01470599|2848423|P1|Overall Study|Adverse event not related to study drug|1
863812|NCT01470599|2848422|P2|Overall Study|Insufficient clinical response|27
863813|NCT01470599|2848423|P1|Overall Study|Insufficient clinical response|6
863814|NCT01470599|2848422|P2|Overall Study|Adverse event related to study drug|5
863815|NCT01470599|2848423|P1|Overall Study|Adverse event related to study drug|2
863816|NCT01470599|2848422|P2|Overall Study|Protocol Violation|1
863817|NCT01470599|2848423|P1|Overall Study|Protocol Violation|3
863818|NCT01470599|2848422|P2|Overall Study|Other|0
863819|NCT01470599|2848423|P1|Overall Study|Other|1
863820|NCT01470599|2848422|P2|Overall Study|Withdrawal by Subject|4
863821|NCT01470599|2848423|P1|Overall Study|Withdrawal by Subject|3
863822|NCT01470599|2848422|P2|Overall Study|Lost to Follow-up|1
863823|NCT01470599|2848423|P1|Overall Study|Lost to Follow-up|2
863824|NCT01470599|2848422|P2|Overall Study|Did not meet entrance criteria|0
863825|NCT01470599|2848423|P1|Overall Study|Did not meet entrance criteria|1
863826|NCT01470469|2848487|P2|Overall Study|Not specified|1
863827|NCT01470469|2848488|P1|Overall Study|Not specified|2
863828|NCT01470469|2848487|P2|Overall Study|Protocol Violation|1
863829|NCT01470469|2848488|P1|Overall Study|Protocol Violation|1
863830|NCT01470469|2848487|P2|Overall Study|Lost to Follow-up|2
863831|NCT01470469|2848488|P1|Overall Study|Lost to Follow-up|2
863832|NCT01470469|2848487|P2|Overall Study|Adverse Event|7
863833|NCT01470469|2848488|P1|Overall Study|Adverse Event|0
863834|NCT01470469|2848487|P2|Overall Study|Lack of Efficacy|7
863835|NCT01470469|2848488|P1|Overall Study|Lack of Efficacy|1
863836|NCT01470469|2848487|P2|Overall Study|Withdrawal by Subject|6
863837|NCT01470469|2848488|P1|Overall Study|Withdrawal by Subject|4
863838|NCT01470417|2848508|P2|Overall Study|Disease progression|2
863839|NCT01470417|2848509|P1|Overall Study|Disease progression|0
863840|NCT01470326|2848521|P1|Overall Study|No Visit After 1st Day of Treatment|119
863841|NCT01470326|2848521|P1|Overall Study|No Drug Administration Information|2
863842|NCT01470326|2848521|P1|Overall Study|Protocol Violation|32
863843|NCT01470248|2848532|P1|Overall Study|Withdrawal by Subject|1
863844|NCT01470144|2848588|P1|Overall Study|Patient’s and investigator’s decision|1
863845|NCT01470144|2848588|P1|Overall Study|Lung transplant|6
863846|NCT01470144|2848588|P1|Overall Study|Death|1
863847|NCT01470144|2848588|P1|Overall Study|Adverse Event|2
863848|NCT01470001|2848693|P2|Overall Study|Withdrawal by Subject|1
863849|NCT01470001|2848694|P1|Overall Study|Withdrawal by Subject|2
863850|NCT01470001|2848693|P2|Overall Study|Physician Decision|0
863851|NCT01470001|2848694|P1|Overall Study|Physician Decision|2
863852|NCT01470001|2848693|P2|Overall Study|Lost to Follow-up|1
863853|NCT01470001|2848694|P1|Overall Study|Lost to Follow-up|1
863854|NCT01469819|2848704|P1|Overall Study|Technical malfunction of SmartPill data|3
863855|NCT01469819|2848704|P1|Overall Study|Could not swallow SmartPill|2
863856|NCT01469819|2848704|P1|Overall Study|Did not meet inclusionary criteria|2
863857|NCT01469819|2848704|P1|Overall Study|Withdrawal by Subject|1
863858|NCT01469637|2848728|P2|Second Intervention|Incarcerated|0
863859|NCT01469637|2848729|P1|Second Intervention|Incarcerated|1
863860|NCT01469637|2848728|P2|First Intervention|Unacceptable behavior|1
863861|NCT01469637|2848729|P1|First Intervention|Unacceptable behavior|0
863862|NCT01469546|2848737|P1|Received 5 mg Dose|Physician Decision|3
863863|NCT01469546|2848737|P1|Received 5 mg Dose|Progressive Disease|3
863864|NCT01469546|2848737|P1|Received 5 mg Dose|Protocol Violation|2
863865|NCT01469546|2848737|P1|Received 5 mg Dose|Death|2
863866|NCT01469546|2848737|P1|Received 5 mg Dose|Adverse Event|13
863867|NCT01469377|2848747|P3|Overall Study|Other Miscellaneous Reasons|0
863868|NCT01469377|2848748|P2|Overall Study|Other Miscellaneous Reasons|0
863869|NCT01469377|2848749|P1|Overall Study|Other Miscellaneous Reasons|2
863870|NCT01469377|2848747|P3|Overall Study|Insufficient Therapeutic Response|0
863871|NCT01469377|2848748|P2|Overall Study|Insufficient Therapeutic Response|4
863872|NCT01469377|2848749|P1|Overall Study|Insufficient Therapeutic Response|3
863873|NCT01469377|2848747|P3|Overall Study|Adverse Event|36
863874|NCT01469377|2848748|P2|Overall Study|Adverse Event|18
863875|NCT01469377|2848749|P1|Overall Study|Adverse Event|8
863876|NCT01469377|2848747|P3|Overall Study|Withdrawal of Consent|15
863877|NCT01469377|2848748|P2|Overall Study|Withdrawal of Consent|14
863878|NCT01469377|2848749|P1|Overall Study|Withdrawal of Consent|12
863879|NCT01469377|2848747|P3|Overall Study|Lost to Follow-up|5
863880|NCT01469377|2848748|P2|Overall Study|Lost to Follow-up|2
863881|NCT01469377|2848749|P1|Overall Study|Lost to Follow-up|3
863882|NCT01469377|2848747|P3|Overall Study|Protocol Deviation|10
863883|NCT01469377|2848748|P2|Overall Study|Protocol Deviation|10
863884|NCT01469377|2848749|P1|Overall Study|Protocol Deviation|7
863885|NCT01469364|2848760|P1|Overall Study|Withdrawal by Subject|1
863886|NCT01469364|2848760|P1|Overall Study|Adverse Event|1
863887|NCT01469221|2848811|P3|Double Blind Phase|Sponsor Terminate Study|0
863888|NCT01469221|2848812|P2|Double Blind Phase|Sponsor Terminate Study|16
863889|NCT01469221|2848813|P1|Double Blind Phase|Sponsor Terminate Study|12
863890|NCT01469221|2848811|P3|Double Blind Phase|Physician Decision|0
863891|NCT01469221|2848812|P2|Double Blind Phase|Physician Decision|1
863892|NCT01469221|2848813|P1|Double Blind Phase|Physician Decision|1
863893|NCT01469221|2848811|P3|Double Blind Phase|Protocol Violation|0
863894|NCT01469221|2848812|P2|Double Blind Phase|Protocol Violation|0
863895|NCT01469221|2848813|P1|Double Blind Phase|Protocol Violation|1
863896|NCT01469182|2848824|P2|Overall Study|Did not meet Protocol Eligibility|0
863897|NCT01469182|2848825|P1|Overall Study|Did not meet Protocol Eligibility|3
863898|NCT01469182|2848824|P2|Overall Study|Protocol Violation|2
863899|NCT01469182|2848825|P1|Overall Study|Protocol Violation|4
863900|NCT01469182|2848824|P2|Overall Study|Withdrawal by Subject|1
863901|NCT01469182|2848825|P1|Overall Study|Withdrawal by Subject|4
863902|NCT01469182|2848824|P2|Overall Study|Lost to Follow-up|0
863903|NCT01469182|2848825|P1|Overall Study|Lost to Follow-up|3
863904|NCT01469182|2848824|P2|Overall Study|Adverse Event|3
863905|NCT01469182|2848825|P1|Overall Study|Adverse Event|21
863906|NCT01469065|2848852|P5|Overall Study|Not specified|0
863907|NCT01469065|2848853|P4|Overall Study|Not specified|0
863908|NCT01469065|2848854|P3|Overall Study|Not specified|0
863909|NCT01469065|2848855|P2|Overall Study|Not specified|1
863910|NCT01469065|2848856|P1|Overall Study|Not specified|0
863911|NCT01469065|2848852|P5|Overall Study|Lack of Efficacy|1
863912|NCT01469065|2848853|P4|Overall Study|Lack of Efficacy|0
863913|NCT01469065|2848854|P3|Overall Study|Lack of Efficacy|0
863914|NCT01469065|2848855|P2|Overall Study|Lack of Efficacy|0
863915|NCT01469065|2848856|P1|Overall Study|Lack of Efficacy|0
863916|NCT01469052|2848952|P6|Overall Study|Other|0
863917|NCT01469052|2848953|P5|Overall Study|Other|1
863918|NCT01469052|2848954|P4|Overall Study|Other|0
863919|NCT01469052|2848955|P3|Overall Study|Other|0
863920|NCT01469052|2848956|P2|Overall Study|Other|1
863921|NCT01469052|2848957|P1|Overall Study|Other|0
863922|NCT01469052|2848952|P6|Overall Study|Moved to rollover protocol|1
863923|NCT01469052|2848953|P5|Overall Study|Moved to rollover protocol|0
863924|NCT01469052|2848954|P4|Overall Study|Moved to rollover protocol|0
863925|NCT01469052|2848955|P3|Overall Study|Moved to rollover protocol|1
863926|NCT01469052|2848956|P2|Overall Study|Moved to rollover protocol|0
863927|NCT01469052|2848957|P1|Overall Study|Moved to rollover protocol|1
863928|NCT01469052|2848952|P6|Overall Study|Lack of Efficacy|2
863929|NCT01469052|2848953|P5|Overall Study|Lack of Efficacy|0
863930|NCT01469052|2848954|P4|Overall Study|Lack of Efficacy|0
863931|NCT01469052|2848955|P3|Overall Study|Lack of Efficacy|0
863932|NCT01469052|2848956|P2|Overall Study|Lack of Efficacy|0
863933|NCT01469052|2848957|P1|Overall Study|Lack of Efficacy|0
863934|NCT01469052|2848952|P6|Overall Study|Progressive disease|2
863935|NCT01469052|2848953|P5|Overall Study|Progressive disease|7
863936|NCT01469052|2848954|P4|Overall Study|Progressive disease|3
863937|NCT01469052|2848955|P3|Overall Study|Progressive disease|5
863938|NCT01469052|2848956|P2|Overall Study|Progressive disease|0
863939|NCT01469052|2848957|P1|Overall Study|Progressive disease|3
863940|NCT01469052|2848952|P6|Overall Study|Adverse Event|1
863941|NCT01469052|2848953|P5|Overall Study|Adverse Event|0
863942|NCT01469052|2848954|P4|Overall Study|Adverse Event|2
863943|NCT01469052|2848955|P3|Overall Study|Adverse Event|0
863944|NCT01469052|2848956|P2|Overall Study|Adverse Event|3
863945|NCT01469052|2848957|P1|Overall Study|Adverse Event|2
863946|NCT01469013|2849022|P13|Part B (Extension Period)|Withdrawal by Subject|3
863947|NCT01469013|2849023|P12|Part B (Extension Period)|Withdrawal by Subject|0
863948|NCT01469013|2849024|P11|Part B (Extension Period)|Withdrawal by Subject|1
863949|NCT01469013|2849025|P10|Part B (Extension Period)|Withdrawal by Subject|0
863950|NCT01469013|2849026|P9|Part B (Extension Period)|Withdrawal by Subject|1
863951|NCT01469013|2849027|P8|Part B (Extension Period)|Withdrawal by Subject|0
863952|NCT01469013|2849028|P7|Part B (Extension Period)|Withdrawal by Subject|0
863953|NCT01469013|2849029|P6|Part B (Extension Period)|Withdrawal by Subject|0
863954|NCT01469013|2849030|P5|Part B (Extension Period)|Withdrawal by Subject|0
863955|NCT01469013|2849031|P4|Part B (Extension Period)|Withdrawal by Subject|0
863956|NCT01469013|2849032|P3|Part B (Extension Period)|Withdrawal by Subject|0
863957|NCT01469013|2849033|P2|Part B (Extension Period)|Withdrawal by Subject|0
863958|NCT01469013|2849034|P1|Part B (Extension Period)|Withdrawal by Subject|0
863959|NCT01469013|2849022|P13|Part B (Extension Period)|Adverse Event|3
863960|NCT01469013|2849023|P12|Part B (Extension Period)|Adverse Event|6
863961|NCT01469013|2849024|P11|Part B (Extension Period)|Adverse Event|1
863962|NCT01469013|2849025|P10|Part B (Extension Period)|Adverse Event|3
863963|NCT01469013|2849026|P9|Part B (Extension Period)|Adverse Event|3
863964|NCT01469013|2849027|P8|Part B (Extension Period)|Adverse Event|5
863965|NCT01469013|2849028|P7|Part B (Extension Period)|Adverse Event|5
863966|NCT01469013|2849029|P6|Part B (Extension Period)|Adverse Event|2
863967|NCT01469013|2849030|P5|Part B (Extension Period)|Adverse Event|0
863968|NCT01469013|2849031|P4|Part B (Extension Period)|Adverse Event|0
863969|NCT01469013|2849032|P3|Part B (Extension Period)|Adverse Event|0
863970|NCT01469013|2849033|P2|Part B (Extension Period)|Adverse Event|0
863971|NCT01469013|2849034|P1|Part B (Extension Period)|Adverse Event|0
863972|NCT01469013|2849022|P13|Part A (Treatment Period)|Withdrawal by Subject|0
863973|NCT01469013|2849023|P12|Part A (Treatment Period)|Withdrawal by Subject|0
863974|NCT01469013|2849024|P11|Part A (Treatment Period)|Withdrawal by Subject|0
863975|NCT01469013|2849025|P10|Part A (Treatment Period)|Withdrawal by Subject|0
863976|NCT01469013|2849026|P9|Part A (Treatment Period)|Withdrawal by Subject|0
863977|NCT01469013|2849027|P8|Part A (Treatment Period)|Withdrawal by Subject|0
863978|NCT01469013|2849028|P7|Part A (Treatment Period)|Withdrawal by Subject|0
863979|NCT01469013|2849029|P6|Part A (Treatment Period)|Withdrawal by Subject|0
863980|NCT01469013|2849030|P5|Part A (Treatment Period)|Withdrawal by Subject|0
863981|NCT01469013|2849031|P4|Part A (Treatment Period)|Withdrawal by Subject|0
863982|NCT01469013|2849032|P3|Part A (Treatment Period)|Withdrawal by Subject|1
863983|NCT01469013|2849033|P2|Part A (Treatment Period)|Withdrawal by Subject|0
863984|NCT01469013|2849034|P1|Part A (Treatment Period)|Withdrawal by Subject|0
863985|NCT01469013|2849022|P13|Part A (Treatment Period)|Adverse Event|0
863986|NCT01469013|2849023|P12|Part A (Treatment Period)|Adverse Event|0
863987|NCT01469013|2849024|P11|Part A (Treatment Period)|Adverse Event|0
863988|NCT01469013|2849025|P10|Part A (Treatment Period)|Adverse Event|0
863989|NCT01469013|2849026|P9|Part A (Treatment Period)|Adverse Event|0
863990|NCT01469013|2849027|P8|Part A (Treatment Period)|Adverse Event|0
863991|NCT01469013|2849028|P7|Part A (Treatment Period)|Adverse Event|0
863992|NCT01469013|2849029|P6|Part A (Treatment Period)|Adverse Event|0
863993|NCT01469013|2849030|P5|Part A (Treatment Period)|Adverse Event|1
863994|NCT01469013|2849031|P4|Part A (Treatment Period)|Adverse Event|0
863995|NCT01469013|2849032|P3|Part A (Treatment Period)|Adverse Event|0
863996|NCT01469013|2849033|P2|Part A (Treatment Period)|Adverse Event|0
863997|NCT01469013|2849034|P1|Part A (Treatment Period)|Adverse Event|1
863998|NCT01469000|2849119|P2|Overall Study|On treatment, not yet died or PD|7
863999|NCT01469000|2849120|P1|Overall Study|On treatment, not yet died or PD|23
864000|NCT01469000|2849119|P2|Overall Study|Entry Criteria Not Met|0
864001|NCT01469000|2849120|P1|Overall Study|Entry Criteria Not Met|1
864002|NCT01469000|2849119|P2|Overall Study|Physician Decision|1
864003|NCT01469000|2849120|P1|Overall Study|Physician Decision|0
864004|NCT01469000|2849119|P2|Overall Study|Withdrawal by Subject|1
864005|NCT01469000|2849120|P1|Overall Study|Withdrawal by Subject|9
864006|NCT01468987|2849136|P2|Overall Study|Sponsor Decision|0
864007|NCT01468987|2849137|P1|Overall Study|Sponsor Decision|1
864008|NCT01468987|2849136|P2|Overall Study|Physician Decision|15
864009|NCT01468987|2849137|P1|Overall Study|Physician Decision|8
864010|NCT01468987|2849136|P2|Overall Study|Withdrawal by Subject|28
864011|NCT01468987|2849137|P1|Overall Study|Withdrawal by Subject|28
864012|NCT01468987|2849136|P2|Overall Study|Protocol Violation|2
864013|NCT01468987|2849137|P1|Overall Study|Protocol Violation|8
864014|NCT01468987|2849136|P2|Overall Study|Lost to Follow-up|5
864015|NCT01468987|2849137|P1|Overall Study|Lost to Follow-up|10
864016|NCT01468987|2849136|P2|Overall Study|Death|1
864017|NCT01468987|2849137|P1|Overall Study|Death|4
864018|NCT01468987|2849136|P2|Overall Study|Adverse Event|9
864019|NCT01468987|2849137|P1|Overall Study|Adverse Event|12
864020|NCT01468818|2849200|P1|Overall Study|Death during treatment|2
864021|NCT01468311|2849258|P1|Overall Study|Withdrawal by Subject|1
864022|NCT01468311|2849258|P1|Overall Study|mobilization failure|1
864023|NCT01468233|2849270|P6|Treatment Period 2|Not specified|0
864024|NCT01468233|2849271|P5|Treatment Period 2|Not specified|1
864025|NCT01468233|2849272|P4|Treatment Period 2|Not specified|0
864026|NCT01468233|2849273|P3|Treatment Period 2|Not specified|3
864027|NCT01468233|2849274|P2|Treatment Period 2|Not specified|0
864028|NCT01468233|2849275|P1|Treatment Period 2|Not specified|0
864029|NCT01468233|2849270|P6|Treatment Period 2|Lost to Follow-up|0
864030|NCT01468233|2849271|P5|Treatment Period 2|Lost to Follow-up|2
864031|NCT01468233|2849272|P4|Treatment Period 2|Lost to Follow-up|0
864032|NCT01468233|2849273|P3|Treatment Period 2|Lost to Follow-up|3
864033|NCT01468233|2849274|P2|Treatment Period 2|Lost to Follow-up|0
864034|NCT01468233|2849275|P1|Treatment Period 2|Lost to Follow-up|0
864035|NCT01468233|2849270|P6|Treatment Period 2|Loss/absence of response (per protocol)|20
864036|NCT01468233|2849271|P5|Treatment Period 2|Loss/absence of response (per protocol)|22
864037|NCT01468233|2849272|P4|Treatment Period 2|Loss/absence of response (per protocol)|25
864038|NCT01468233|2849273|P3|Treatment Period 2|Loss/absence of response (per protocol)|84
864039|NCT01468233|2849274|P2|Treatment Period 2|Loss/absence of response (per protocol)|0
864040|NCT01468233|2849275|P1|Treatment Period 2|Loss/absence of response (per protocol)|0
864041|NCT01468233|2849270|P6|Treatment Period 2|Withdrawal by Subject|1
864042|NCT01468233|2849271|P5|Treatment Period 2|Withdrawal by Subject|1
864043|NCT01468233|2849272|P4|Treatment Period 2|Withdrawal by Subject|1
864044|NCT01468233|2849273|P3|Treatment Period 2|Withdrawal by Subject|9
864045|NCT01468233|2849274|P2|Treatment Period 2|Withdrawal by Subject|0
864046|NCT01468233|2849275|P1|Treatment Period 2|Withdrawal by Subject|0
864047|NCT01468233|2849270|P6|Treatment Period 2|Lack of Efficacy|1
864048|NCT01468233|2849271|P5|Treatment Period 2|Lack of Efficacy|0
864049|NCT01468233|2849272|P4|Treatment Period 2|Lack of Efficacy|2
864050|NCT01468233|2849273|P3|Treatment Period 2|Lack of Efficacy|9
864051|NCT01468233|2849274|P2|Treatment Period 2|Lack of Efficacy|0
864052|NCT01468233|2849275|P1|Treatment Period 2|Lack of Efficacy|0
864053|NCT01468233|2849270|P6|Treatment Period 2|Adverse Event|1
864054|NCT01468233|2849271|P5|Treatment Period 2|Adverse Event|2
864055|NCT01468233|2849272|P4|Treatment Period 2|Adverse Event|0
864056|NCT01468233|2849273|P3|Treatment Period 2|Adverse Event|3
864057|NCT01468233|2849274|P2|Treatment Period 2|Adverse Event|0
864058|NCT01468233|2849275|P1|Treatment Period 2|Adverse Event|0
864059|NCT01468233|2849270|P6|Treatment Period 1|Not specified|0
864060|NCT01468233|2849271|P5|Treatment Period 1|Not specified|0
864061|NCT01468233|2849272|P4|Treatment Period 1|Not specified|0
864062|NCT01468233|2849273|P3|Treatment Period 1|Not specified|0
864063|NCT01468233|2849274|P2|Treatment Period 1|Not specified|1
864064|NCT01468233|2849275|P1|Treatment Period 1|Not specified|1
864065|NCT01468233|2849270|P6|Treatment Period 1|Lost to Follow-up|0
864066|NCT01468233|2849271|P5|Treatment Period 1|Lost to Follow-up|0
864067|NCT01468233|2849272|P4|Treatment Period 1|Lost to Follow-up|0
864068|NCT01468233|2849273|P3|Treatment Period 1|Lost to Follow-up|0
864069|NCT01468233|2849274|P2|Treatment Period 1|Lost to Follow-up|0
864070|NCT01468233|2849275|P1|Treatment Period 1|Lost to Follow-up|3
864071|NCT01468233|2849270|P6|Treatment Period 1|Withdrawal by Subject|0
864072|NCT01468233|2849271|P5|Treatment Period 1|Withdrawal by Subject|0
864073|NCT01468233|2849272|P4|Treatment Period 1|Withdrawal by Subject|0
864074|NCT01468233|2849273|P3|Treatment Period 1|Withdrawal by Subject|0
864075|NCT01468233|2849274|P2|Treatment Period 1|Withdrawal by Subject|4
864076|NCT01468233|2849275|P1|Treatment Period 1|Withdrawal by Subject|3
864077|NCT01468233|2849270|P6|Treatment Period 1|Adverse Event|0
864078|NCT01468233|2849271|P5|Treatment Period 1|Adverse Event|0
864079|NCT01468233|2849272|P4|Treatment Period 1|Adverse Event|0
864080|NCT01468233|2849273|P3|Treatment Period 1|Adverse Event|0
864081|NCT01468233|2849274|P2|Treatment Period 1|Adverse Event|3
864082|NCT01468233|2849275|P1|Treatment Period 1|Adverse Event|5
864083|NCT01468207|2849297|P6|Treatment Period 2|Not specified|2
864084|NCT01468207|2849298|P5|Treatment Period 2|Not specified|1
864085|NCT01468207|2849299|P4|Treatment Period 2|Not specified|1
864086|NCT01468207|2849300|P3|Treatment Period 2|Not specified|5
864087|NCT01468207|2849301|P2|Treatment Period 2|Not specified|0
864088|NCT01468207|2849302|P1|Treatment Period 2|Not specified|0
864089|NCT01468207|2849297|P6|Treatment Period 2|Lost to Follow-up|0
864090|NCT01468207|2849298|P5|Treatment Period 2|Lost to Follow-up|0
864091|NCT01468207|2849299|P4|Treatment Period 2|Lost to Follow-up|1
864092|NCT01468207|2849300|P3|Treatment Period 2|Lost to Follow-up|5
864093|NCT01468207|2849301|P2|Treatment Period 2|Lost to Follow-up|0
864094|NCT01468207|2849302|P1|Treatment Period 2|Lost to Follow-up|0
864095|NCT01468207|2849297|P6|Treatment Period 2|Loss/abscence of response (per protocol)|13
864096|NCT01468207|2849298|P5|Treatment Period 2|Loss/abscence of response (per protocol)|18
864097|NCT01468207|2849299|P4|Treatment Period 2|Loss/abscence of response (per protocol)|23
864098|NCT01468207|2849300|P3|Treatment Period 2|Loss/abscence of response (per protocol)|30
864099|NCT01468207|2849301|P2|Treatment Period 2|Loss/abscence of response (per protocol)|0
864100|NCT01468207|2849302|P1|Treatment Period 2|Loss/abscence of response (per protocol)|0
864101|NCT01468207|2849297|P6|Treatment Period 2|Withdrawal by Subject|2
864102|NCT01468207|2849298|P5|Treatment Period 2|Withdrawal by Subject|0
864103|NCT01468207|2849299|P4|Treatment Period 2|Withdrawal by Subject|0
864104|NCT01468207|2849300|P3|Treatment Period 2|Withdrawal by Subject|5
864105|NCT01468207|2849301|P2|Treatment Period 2|Withdrawal by Subject|0
864106|NCT01468207|2849302|P1|Treatment Period 2|Withdrawal by Subject|0
864107|NCT01468207|2849297|P6|Treatment Period 2|Lack of Efficacy|2
864108|NCT01468207|2849298|P5|Treatment Period 2|Lack of Efficacy|0
864109|NCT01468207|2849299|P4|Treatment Period 2|Lack of Efficacy|1
864110|NCT01468207|2849300|P3|Treatment Period 2|Lack of Efficacy|1
864111|NCT01468207|2849301|P2|Treatment Period 2|Lack of Efficacy|0
864112|NCT01468207|2849302|P1|Treatment Period 2|Lack of Efficacy|0
864113|NCT01468207|2849297|P6|Treatment Period 2|Adverse Event|1
864114|NCT01468207|2849298|P5|Treatment Period 2|Adverse Event|2
864115|NCT01468207|2849299|P4|Treatment Period 2|Adverse Event|1
864116|NCT01468207|2849300|P3|Treatment Period 2|Adverse Event|6
864117|NCT01468207|2849301|P2|Treatment Period 2|Adverse Event|0
864118|NCT01468207|2849302|P1|Treatment Period 2|Adverse Event|0
864119|NCT01468207|2849297|P6|Treatment Period 1|Not specified|0
864120|NCT01468207|2849298|P5|Treatment Period 1|Not specified|0
864121|NCT01468207|2849299|P4|Treatment Period 1|Not specified|0
864122|NCT01468207|2849300|P3|Treatment Period 1|Not specified|0
864123|NCT01468207|2849301|P2|Treatment Period 1|Not specified|2
864124|NCT01468207|2849302|P1|Treatment Period 1|Not specified|0
864125|NCT01468207|2849297|P6|Treatment Period 1|Lost to Follow-up|0
864126|NCT01468207|2849298|P5|Treatment Period 1|Lost to Follow-up|0
864127|NCT01468207|2849299|P4|Treatment Period 1|Lost to Follow-up|0
864128|NCT01468207|2849300|P3|Treatment Period 1|Lost to Follow-up|0
864129|NCT01468207|2849301|P2|Treatment Period 1|Lost to Follow-up|1
864130|NCT01468207|2849302|P1|Treatment Period 1|Lost to Follow-up|2
864131|NCT01468207|2849297|P6|Treatment Period 1|Withdrawal by Subject|0
864132|NCT01468207|2849298|P5|Treatment Period 1|Withdrawal by Subject|0
864133|NCT01468207|2849299|P4|Treatment Period 1|Withdrawal by Subject|0
864134|NCT01468207|2849300|P3|Treatment Period 1|Withdrawal by Subject|0
864135|NCT01468207|2849301|P2|Treatment Period 1|Withdrawal by Subject|4
864136|NCT01468207|2849302|P1|Treatment Period 1|Withdrawal by Subject|5
864137|NCT01468207|2849297|P6|Treatment Period 1|Protocol Violation|0
864138|NCT01468207|2849298|P5|Treatment Period 1|Protocol Violation|0
864139|NCT01468207|2849299|P4|Treatment Period 1|Protocol Violation|0
864140|NCT01468207|2849300|P3|Treatment Period 1|Protocol Violation|0
864141|NCT01468207|2849301|P2|Treatment Period 1|Protocol Violation|1
864142|NCT01468207|2849302|P1|Treatment Period 1|Protocol Violation|1
864143|NCT01468207|2849297|P6|Treatment Period 1|Adverse Event|0
864144|NCT01468207|2849298|P5|Treatment Period 1|Adverse Event|0
864145|NCT01468207|2849299|P4|Treatment Period 1|Adverse Event|0
864146|NCT01468207|2849300|P3|Treatment Period 1|Adverse Event|0
864147|NCT01468207|2849301|P2|Treatment Period 1|Adverse Event|0
864148|NCT01468207|2849302|P1|Treatment Period 1|Adverse Event|1
864149|NCT01468181|2849327|P5|Overall Study|Withdrawal by Subject|0
864150|NCT01468181|2849328|P4|Overall Study|Withdrawal by Subject|0
864151|NCT01468181|2849329|P3|Overall Study|Withdrawal by Subject|0
864152|NCT01468181|2849330|P2|Overall Study|Withdrawal by Subject|1
864153|NCT01468181|2849331|P1|Overall Study|Withdrawal by Subject|0
864154|NCT01468181|2849327|P5|Overall Study|Lost to Follow-up|1
864155|NCT01468181|2849328|P4|Overall Study|Lost to Follow-up|0
864156|NCT01468181|2849329|P3|Overall Study|Lost to Follow-up|1
864157|NCT01468181|2849330|P2|Overall Study|Lost to Follow-up|0
864158|NCT01468181|2849331|P1|Overall Study|Lost to Follow-up|0
864159|NCT01468181|2849327|P5|Overall Study|Physician Decision|1
864160|NCT01468181|2849328|P4|Overall Study|Physician Decision|1
864161|NCT01468181|2849329|P3|Overall Study|Physician Decision|0
864162|NCT01468181|2849330|P2|Overall Study|Physician Decision|0
864163|NCT01468181|2849331|P1|Overall Study|Physician Decision|0
864164|NCT01468181|2849327|P5|Overall Study|Protocol Violation|1
864165|NCT01468181|2849328|P4|Overall Study|Protocol Violation|0
864166|NCT01468181|2849329|P3|Overall Study|Protocol Violation|1
864167|NCT01468181|2849330|P2|Overall Study|Protocol Violation|0
864168|NCT01468181|2849331|P1|Overall Study|Protocol Violation|2
864169|NCT01468181|2849327|P5|Overall Study|Adverse Event|2
864170|NCT01468181|2849328|P4|Overall Study|Adverse Event|2
864171|NCT01468181|2849329|P3|Overall Study|Adverse Event|6
864172|NCT01468181|2849330|P2|Overall Study|Adverse Event|1
864173|NCT01468181|2849331|P1|Overall Study|Adverse Event|8
864174|NCT01468077|2849380|P2|Overall Study|Physician Decision|0
864175|NCT01468077|2849381|P1|Overall Study|Physician Decision|1
864176|NCT01468077|2849380|P2|Overall Study|Lack of Efficacy|1
864177|NCT01468077|2849381|P1|Overall Study|Lack of Efficacy|1
864178|NCT01468077|2849380|P2|Overall Study|Adverse Event|2
864179|NCT01468077|2849381|P1|Overall Study|Adverse Event|2
864180|NCT01467960|2849439|P6|Overall Study|Enrollment of patients (PD) in 09/2013|30
864181|NCT01467960|2849440|P5|Overall Study|Enrollment of patients (PD) in 09/2013|30
864182|NCT01467960|2849441|P4|Overall Study|Enrollment of patients (PD) in 09/2013|30
864183|NCT01467960|2849442|P3|Overall Study|Enrollment of patients (PD) in 09/2013|0
864184|NCT01467960|2849443|P2|Overall Study|Enrollment of patients (PD) in 09/2013|0
864185|NCT01467960|2849444|P1|Overall Study|Enrollment of patients (PD) in 09/2013|0
864186|NCT01467713|2849503|P4|Overall Study|Reason not Specified|7
864187|NCT01467713|2849504|P3|Overall Study|Reason not Specified|8
864188|NCT01467713|2849505|P2|Overall Study|Reason not Specified|11
864189|NCT01467713|2849506|P1|Overall Study|Reason not Specified|6
864190|NCT01467713|2849503|P4|Overall Study|Relapse|35
864191|NCT01467713|2849504|P3|Overall Study|Relapse|28
864192|NCT01467713|2849505|P2|Overall Study|Relapse|25
864193|NCT01467713|2849506|P1|Overall Study|Relapse|35
864194|NCT01467713|2849503|P4|Overall Study|Pregnancy|3
864195|NCT01467713|2849504|P3|Overall Study|Pregnancy|1
864196|NCT01467713|2849505|P2|Overall Study|Pregnancy|1
864197|NCT01467713|2849506|P1|Overall Study|Pregnancy|0
864198|NCT01467713|2849503|P4|Overall Study|Study Termination|29
864199|NCT01467713|2849504|P3|Overall Study|Study Termination|28
864200|NCT01467713|2849505|P2|Overall Study|Study Termination|33
864201|NCT01467713|2849506|P1|Overall Study|Study Termination|23
864202|NCT01467713|2849503|P4|Overall Study|Voluntary Withdrawal|20
864203|NCT01467713|2849504|P3|Overall Study|Voluntary Withdrawal|21
864204|NCT01467713|2849505|P2|Overall Study|Voluntary Withdrawal|14
864205|NCT01467713|2849506|P1|Overall Study|Voluntary Withdrawal|18
864206|NCT01467713|2849503|P4|Overall Study|Lost to Follow-up|9
864207|NCT01467713|2849504|P3|Overall Study|Lost to Follow-up|6
864208|NCT01467713|2849505|P2|Overall Study|Lost to Follow-up|12
864209|NCT01467713|2849506|P1|Overall Study|Lost to Follow-up|9
864210|NCT01467713|2849503|P4|Overall Study|Major Protocol Deviation|1
864211|NCT01467713|2849504|P3|Overall Study|Major Protocol Deviation|4
864212|NCT01467713|2849505|P2|Overall Study|Major Protocol Deviation|4
864213|NCT01467713|2849506|P1|Overall Study|Major Protocol Deviation|2
864214|NCT01467713|2849503|P4|Overall Study|Pretreatment Event or Adverse Event|5
864215|NCT01467713|2849504|P3|Overall Study|Pretreatment Event or Adverse Event|6
864216|NCT01467713|2849505|P2|Overall Study|Pretreatment Event or Adverse Event|4
864217|NCT01467713|2849506|P1|Overall Study|Pretreatment Event or Adverse Event|9
864218|NCT01467700|2849560|P4|Overall Study|Reason not Specified|8
864219|NCT01467700|2849561|P3|Overall Study|Reason not Specified|2
864220|NCT01467700|2849562|P2|Overall Study|Reason not Specified|3
864221|NCT01467700|2849563|P1|Overall Study|Reason not Specified|1
864222|NCT01467700|2849560|P4|Overall Study|Lack of Efficacy|1
864223|NCT01467700|2849561|P3|Overall Study|Lack of Efficacy|2
864224|NCT01467700|2849562|P2|Overall Study|Lack of Efficacy|0
864225|NCT01467700|2849563|P1|Overall Study|Lack of Efficacy|2
864226|NCT01467700|2849560|P4|Overall Study|Pregnancy|0
864227|NCT01467700|2849561|P3|Overall Study|Pregnancy|1
864228|NCT01467700|2849562|P2|Overall Study|Pregnancy|1
864229|NCT01467700|2849563|P1|Overall Study|Pregnancy|0
864230|NCT01467700|2849560|P4|Overall Study|Study Termination|7
864231|NCT01467700|2849561|P3|Overall Study|Study Termination|10
864232|NCT01467700|2849562|P2|Overall Study|Study Termination|5
864233|NCT01467700|2849563|P1|Overall Study|Study Termination|6
864234|NCT01467700|2849560|P4|Overall Study|Voluntary Withdrawal|2
864235|NCT01467700|2849561|P3|Overall Study|Voluntary Withdrawal|6
864236|NCT01467700|2849562|P2|Overall Study|Voluntary Withdrawal|7
864237|NCT01467700|2849563|P1|Overall Study|Voluntary Withdrawal|5
864238|NCT01467700|2849560|P4|Overall Study|Lost to Follow-up|3
864239|NCT01467700|2849561|P3|Overall Study|Lost to Follow-up|2
864240|NCT01467700|2849562|P2|Overall Study|Lost to Follow-up|5
864241|NCT01467700|2849563|P1|Overall Study|Lost to Follow-up|6
864242|NCT01467700|2849560|P4|Overall Study|Major Protocol Deviation|3
864243|NCT01467700|2849561|P3|Overall Study|Major Protocol Deviation|2
864244|NCT01467700|2849562|P2|Overall Study|Major Protocol Deviation|3
864245|NCT01467700|2849563|P1|Overall Study|Major Protocol Deviation|3
864246|NCT01467700|2849560|P4|Overall Study|Pretreatment Event or Adverse Event|3
864247|NCT01467700|2849561|P3|Overall Study|Pretreatment Event or Adverse Event|2
864248|NCT01467700|2849562|P2|Overall Study|Pretreatment Event or Adverse Event|4
864249|NCT01467700|2849563|P1|Overall Study|Pretreatment Event or Adverse Event|6
864250|NCT01467661|2849605|P1|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1
864251|NCT01467661|2849605|P1|Overall Study|Lack of Efficacy|3
864252|NCT01467661|2849605|P1|Overall Study|Withdrawal by Subject|1
864253|NCT01467661|2849605|P1|Overall Study|Adverse Event|16
864254|NCT01467583|2849625|P3|Overall Study|Protocol Violation|2
864255|NCT01467583|2849626|P2|Overall Study|Protocol Violation|0
864256|NCT01467583|2849627|P1|Overall Study|Protocol Violation|0
864257|NCT01467583|2849625|P3|Overall Study|Withdrawal by Subject|0
864258|NCT01467583|2849626|P2|Overall Study|Withdrawal by Subject|0
864259|NCT01467583|2849627|P1|Overall Study|Withdrawal by Subject|1
864260|NCT01467583|2849625|P3|Overall Study|Death|0
864261|NCT01467583|2849626|P2|Overall Study|Death|1
864262|NCT01467583|2849627|P1|Overall Study|Death|1
864263|NCT01467570|2849640|P2|Overall Study|Lost to Follow-up|9
864264|NCT01467570|2849641|P1|Overall Study|Lost to Follow-up|8
864265|NCT01467505|2849678|P2|Overall Study|Study Terminated by Sponsor|3
864266|NCT01467505|2849679|P1|Overall Study|Study Terminated by Sponsor|28
864267|NCT01467505|2849678|P2|Overall Study|Withdrawal by Subject|0
864268|NCT01467505|2849679|P1|Overall Study|Withdrawal by Subject|4
864269|NCT01467505|2849678|P2|Overall Study|Adverse Event|0
864270|NCT01467505|2849679|P1|Overall Study|Adverse Event|1
864271|NCT01467492|2849711|P2|Overall Study|Enrolled But Not Treated|0
864272|NCT01467492|2849712|P1|Overall Study|Enrolled But Not Treated|1
864273|NCT01467492|2849711|P2|Overall Study|Undefined|0
864274|NCT01467492|2849712|P1|Overall Study|Undefined|2
864275|NCT01467492|2849711|P2|Overall Study|Lost to Follow-up|2
864276|NCT01467492|2849712|P1|Overall Study|Lost to Follow-up|3
864277|NCT01467492|2849711|P2|Overall Study|Adverse Event|3
864278|NCT01467492|2849712|P1|Overall Study|Adverse Event|4
864279|NCT01467492|2849711|P2|Overall Study|Study Terminated by Sponsor|4
864280|NCT01467492|2849712|P1|Overall Study|Study Terminated by Sponsor|6
864281|NCT01467492|2849711|P2|Overall Study|Withdrawal by Subject|4
864282|NCT01467492|2849712|P1|Overall Study|Withdrawal by Subject|6
864283|NCT01467479|2849736|P3|Overall Study|Other|0
864284|NCT01467479|2849737|P2|Overall Study|Other|0
864285|NCT01467479|2849738|P1|Overall Study|Other|1
864286|NCT01467479|2849736|P3|Overall Study|Study Terminated by Sponsor|3
864287|NCT01467479|2849737|P2|Overall Study|Study Terminated by Sponsor|3
864288|NCT01467479|2849738|P1|Overall Study|Study Terminated by Sponsor|1
864289|NCT01467479|2849736|P3|Overall Study|Withdrawal of Consent|7
864290|NCT01467479|2849737|P2|Overall Study|Withdrawal of Consent|7
864291|NCT01467479|2849738|P1|Overall Study|Withdrawal of Consent|3
864292|NCT01467479|2849736|P3|Overall Study|Lost to Follow-up|3
864293|NCT01467479|2849737|P2|Overall Study|Lost to Follow-up|5
864294|NCT01467479|2849738|P1|Overall Study|Lost to Follow-up|2
864295|NCT01467479|2849736|P3|Overall Study|Death|1
864296|NCT01467479|2849737|P2|Overall Study|Death|0
864297|NCT01467479|2849738|P1|Overall Study|Death|0
864298|NCT01467479|2849736|P3|Overall Study|Adverse Event|0
864299|NCT01467479|2849737|P2|Overall Study|Adverse Event|2
864300|NCT01467479|2849738|P1|Overall Study|Adverse Event|1
864301|NCT01467479|2849736|P3|Overall Study|No Study Medication|2
864302|NCT01467479|2849737|P2|Overall Study|No Study Medication|0
864303|NCT01467479|2849738|P1|Overall Study|No Study Medication|1
864304|NCT01467466|2849769|P4|Overall Study|No Endpoint Blood Draw|43
864305|NCT01467466|2849770|P3|Overall Study|No Endpoint Blood Draw|51
864306|NCT01467466|2849771|P2|Overall Study|No Endpoint Blood Draw|32
864307|NCT01467466|2849772|P1|Overall Study|No Endpoint Blood Draw|38
864308|NCT01467466|2849769|P4|Overall Study|Procedure Cancelled|29
864309|NCT01467466|2849770|P3|Overall Study|Procedure Cancelled|25
864310|NCT01467466|2849771|P2|Overall Study|Procedure Cancelled|45
864311|NCT01467466|2849772|P1|Overall Study|Procedure Cancelled|46
864312|NCT01467466|2849769|P4|Overall Study|Revoked Consent Prior To Procedure|5
864313|NCT01467466|2849770|P3|Overall Study|Revoked Consent Prior To Procedure|15
864314|NCT01467466|2849771|P2|Overall Study|Revoked Consent Prior To Procedure|9
864315|NCT01467466|2849772|P1|Overall Study|Revoked Consent Prior To Procedure|10
864316|NCT01467466|2849769|P4|Overall Study|Withdrawal by Subject|11
864317|NCT01467466|2849770|P3|Overall Study|Withdrawal by Subject|13
864318|NCT01467466|2849771|P2|Overall Study|Withdrawal by Subject|18
864319|NCT01467466|2849772|P1|Overall Study|Withdrawal by Subject|15
864320|NCT01467427|2849784|P2|Overall Study|Not continuing in extension phase|2
864321|NCT01467427|2849785|P1|Overall Study|Not continuing in extension phase|0
864322|NCT01467427|2849784|P2|Overall Study|Entered extension phase|11
864323|NCT01467427|2849785|P1|Overall Study|Entered extension phase|11
864324|NCT01467427|2849784|P2|Overall Study|Withdrawal by Subject|0
864325|NCT01467427|2849785|P1|Overall Study|Withdrawal by Subject|1
864326|NCT01467076|2849806|P3|Overall Study|Lost to Follow-up|0
864327|NCT01467076|2849807|P2|Overall Study|Lost to Follow-up|0
864328|NCT01467076|2849808|P1|Overall Study|Lost to Follow-up|1
864329|NCT01466881|2849825|P1|Overall Study|Other reason not protocol specified|5
864330|NCT01466881|2849825|P1|Overall Study|Death|4
864331|NCT01466881|2849825|P1|Overall Study|Progression/relapse|20
864332|NCT01466881|2849825|P1|Overall Study|Adverse Event|6
864333|NCT01466881|2849825|P1|Overall Study|Ineligible|5
864334|NCT01466790|2849842|P8|Overall Study|Withdrawal by Subject|1
864335|NCT01466790|2849843|P7|Overall Study|Withdrawal by Subject|1
864336|NCT01466790|2849844|P6|Overall Study|Withdrawal by Subject|0
864337|NCT01466790|2849845|P5|Overall Study|Withdrawal by Subject|1
864338|NCT01466790|2849846|P4|Overall Study|Withdrawal by Subject|0
864339|NCT01466790|2849847|P3|Overall Study|Withdrawal by Subject|0
864340|NCT01466790|2849848|P2|Overall Study|Withdrawal by Subject|1
864341|NCT01466790|2849849|P1|Overall Study|Withdrawal by Subject|1
864342|NCT01466790|2849842|P8|Overall Study|Lost to Follow-up|0
864343|NCT01466790|2849843|P7|Overall Study|Lost to Follow-up|0
864344|NCT01466790|2849844|P6|Overall Study|Lost to Follow-up|0
864345|NCT01466790|2849845|P5|Overall Study|Lost to Follow-up|0
864346|NCT01466790|2849846|P4|Overall Study|Lost to Follow-up|0
864347|NCT01466790|2849847|P3|Overall Study|Lost to Follow-up|0
864348|NCT01466790|2849848|P2|Overall Study|Lost to Follow-up|0
864349|NCT01466790|2849849|P1|Overall Study|Lost to Follow-up|2
864350|NCT01466790|2849842|P8|Overall Study|Adverse Event|0
864351|NCT01466790|2849843|P7|Overall Study|Adverse Event|0
864352|NCT01466790|2849844|P6|Overall Study|Adverse Event|0
864353|NCT01466790|2849845|P5|Overall Study|Adverse Event|2
864354|NCT01466790|2849846|P4|Overall Study|Adverse Event|0
864355|NCT01466790|2849847|P3|Overall Study|Adverse Event|0
864356|NCT01466790|2849848|P2|Overall Study|Adverse Event|0
864357|NCT01466790|2849849|P1|Overall Study|Adverse Event|1
864358|NCT01466673|2849934|P2|Overall Study|Adverse Event|1
864359|NCT01466673|2849935|P1|Overall Study|Adverse Event|2
864360|NCT01466673|2849934|P2|Overall Study|Lost to Follow-up|5
864361|NCT01466673|2849935|P1|Overall Study|Lost to Follow-up|3
864362|NCT01466673|2849934|P2|Overall Study|Non-compliance with study treatment|0
864363|NCT01466673|2849935|P1|Overall Study|Non-compliance with study treatment|2
864364|NCT01466660|2849961|P2|Overall Study|Other reason not defined above|6
864365|NCT01466660|2849962|P1|Overall Study|Other reason not defined above|3
864366|NCT01466660|2849961|P2|Overall Study|Refused continuation of trial medication|3
864367|NCT01466660|2849962|P1|Overall Study|Refused continuation of trial medication|4
864368|NCT01466660|2849961|P2|Overall Study|Protocol Violation|1
864369|NCT01466660|2849962|P1|Overall Study|Protocol Violation|1
864370|NCT01466660|2849961|P2|Overall Study|Other adverse event|17
864371|NCT01466660|2849962|P1|Overall Study|Other adverse event|18
864372|NCT01466660|2849961|P2|Overall Study|Worsening of underlying cancer disease|2
864373|NCT01466660|2849962|P1|Overall Study|Worsening of underlying cancer disease|5
864374|NCT01466660|2849961|P2|Overall Study|Progressive Disease (RECIST 1.1)|122
864375|NCT01466660|2849962|P1|Overall Study|Progressive Disease (RECIST 1.1)|115
864376|NCT01466595|2849988|P2|Overall Study|Withdrawal by Subject|1
864377|NCT01466595|2849989|P1|Overall Study|Withdrawal by Subject|0
864378|NCT01466491|2850083|P4|Overall Study|Missing Data|0
864379|NCT01466491|2850084|P3|Overall Study|Missing Data|1
864380|NCT01466491|2850085|P2|Overall Study|Missing Data|0
864381|NCT01466491|2850086|P1|Overall Study|Missing Data|0
864382|NCT01466491|2850083|P4|Overall Study|Protocol Violation|0
864383|NCT01466491|2850084|P3|Overall Study|Protocol Violation|2
864384|NCT01466491|2850085|P2|Overall Study|Protocol Violation|3
864385|NCT01466491|2850086|P1|Overall Study|Protocol Violation|0
864386|NCT01466387|2850106|P6|Overall Study|Protocol Violation|0
864387|NCT01466387|2850107|P5|Overall Study|Protocol Violation|0
864388|NCT01466387|2850108|P4|Overall Study|Protocol Violation|1
864389|NCT01466387|2850109|P3|Overall Study|Protocol Violation|0
864390|NCT01466387|2850110|P2|Overall Study|Protocol Violation|0
864391|NCT01466387|2850111|P1|Overall Study|Protocol Violation|1
864392|NCT01466387|2850106|P6|Overall Study|Lost to Follow-up|1
864393|NCT01466387|2850107|P5|Overall Study|Lost to Follow-up|0
864394|NCT01466387|2850108|P4|Overall Study|Lost to Follow-up|0
864395|NCT01466387|2850109|P3|Overall Study|Lost to Follow-up|0
864396|NCT01466387|2850110|P2|Overall Study|Lost to Follow-up|0
864397|NCT01466387|2850111|P1|Overall Study|Lost to Follow-up|0
864398|NCT01466387|2850106|P6|Overall Study|Adverse Event|0
864399|NCT01466387|2850107|P5|Overall Study|Adverse Event|0
864400|NCT01466387|2850108|P4|Overall Study|Adverse Event|1
864401|NCT01466387|2850109|P3|Overall Study|Adverse Event|1
864402|NCT01466387|2850110|P2|Overall Study|Adverse Event|0
864403|NCT01466387|2850111|P1|Overall Study|Adverse Event|0
864404|NCT01466348|2850172|P2|Period I - First Intervention|Withdrawal by Subject|1
864405|NCT01466348|2850173|P1|Period I - First Intervention|Withdrawal by Subject|0
864406|NCT01466270|2850201|P2|Overall Study|Multiple|1
864407|NCT01466270|2850202|P1|Overall Study|Multiple|1
864408|NCT01466270|2850201|P2|Overall Study|Toxicity|1
864409|NCT01466270|2850202|P1|Overall Study|Toxicity|4
864410|NCT01466270|2850201|P2|Overall Study|Progression|0
864411|NCT01466270|2850202|P1|Overall Study|Progression|1
864412|NCT01466270|2850201|P2|Overall Study|Lost to Follow-up|3
864413|NCT01466270|2850202|P1|Overall Study|Lost to Follow-up|1
864414|NCT01466270|2850201|P2|Overall Study|Physician Decision|0
864415|NCT01466270|2850202|P1|Overall Study|Physician Decision|1
864416|NCT01466270|2850201|P2|Overall Study|Withdrawal by Subject|1
864417|NCT01466270|2850202|P1|Overall Study|Withdrawal by Subject|4
864418|NCT01466192|2850214|P1|Overall Study|Withdrawal by Subject|3
864419|NCT01466192|2850214|P1|Overall Study|Physician Decision|1
864420|NCT01466179|2850218|P1|Overall Study|Other|3
864421|NCT01466179|2850218|P1|Overall Study|Protocol Violation|2
864422|NCT01466179|2850218|P1|Overall Study|Withdrawal by Subject|7
864423|NCT01466179|2850218|P1|Overall Study|Death|7
864424|NCT01466179|2850218|P1|Overall Study|Lack of Efficacy|14
864425|NCT01466179|2850218|P1|Overall Study|Disease relapse|23
864426|NCT01466179|2850218|P1|Overall Study|Adverse Event|32
864427|NCT01466179|2850218|P1|Overall Study|Progressive disease|43
864428|NCT01466179|2850218|P1|Overall Study|Physician Decision|46
864429|NCT01466179|2850218|P1|Overall Study|Ongoing in core study|2
864430|NCT01466153|2850241|P3|Overall Study|Other-Unspecified|2
864431|NCT01466153|2850242|P2|Overall Study|Other-Unspecified|4
864432|NCT01466153|2850243|P1|Overall Study|Other-Unspecified|6
864433|NCT01466153|2850241|P3|Overall Study|Randomized-Not Treated|4
864434|NCT01466153|2850242|P2|Overall Study|Randomized-Not Treated|3
864435|NCT01466153|2850243|P1|Overall Study|Randomized-Not Treated|2
864436|NCT01466153|2850241|P3|Overall Study|Investigator Discretion|2
864437|NCT01466153|2850242|P2|Overall Study|Investigator Discretion|2
864438|NCT01466153|2850243|P1|Overall Study|Investigator Discretion|3
864439|NCT01466153|2850241|P3|Overall Study|Withdrawal of Consent|0
864440|NCT01466153|2850242|P2|Overall Study|Withdrawal of Consent|0
864441|NCT01466153|2850243|P1|Overall Study|Withdrawal of Consent|2
864442|NCT01466153|2850241|P3|Overall Study|Adverse Event|17
864443|NCT01466153|2850242|P2|Overall Study|Adverse Event|13
864444|NCT01466153|2850243|P1|Overall Study|Adverse Event|14
864445|NCT01466153|2850241|P3|Overall Study|Disease Progression|0
864446|NCT01466153|2850242|P2|Overall Study|Disease Progression|2
864447|NCT01466153|2850243|P1|Overall Study|Disease Progression|2
864448|NCT01466062|2850298|P1|Overall Study|Withdrawal by Subject|1
864449|NCT01466062|2850298|P1|Overall Study|Adverse Event|1
864450|NCT01465997|2850321|P2|Overall Study|subject left participation SP0993|1
864451|NCT01465997|2850322|P1|Overall Study|subject left participation SP0993|0
864452|NCT01465997|2850321|P2|Overall Study|decision by site staff|1
864453|NCT01465997|2850322|P1|Overall Study|decision by site staff|0
864454|NCT01465997|2850321|P2|Overall Study|withdrew before follow-up|13
864455|NCT01465997|2850322|P1|Overall Study|withdrew before follow-up|0
864456|NCT01465997|2850321|P2|Overall Study|local lab unblinded site|0
864457|NCT01465997|2850322|P1|Overall Study|local lab unblinded site|1
864458|NCT01465997|2850321|P2|Overall Study|subject withdrew consent|0
864459|NCT01465997|2850322|P1|Overall Study|subject withdrew consent|1
864460|NCT01465997|2850321|P2|Overall Study|sponsor's decision|1
864461|NCT01465997|2850322|P1|Overall Study|sponsor's decision|1
864462|NCT01465997|2850321|P2|Overall Study|Death|1
864463|NCT01465997|2850322|P1|Overall Study|Death|0
864464|NCT01465997|2850321|P2|Overall Study|investigator's decision|1
864465|NCT01465997|2850322|P1|Overall Study|investigator's decision|1
864466|NCT01465997|2850321|P2|Overall Study|Withdrawal by Subject|35
864467|NCT01465997|2850322|P1|Overall Study|Withdrawal by Subject|32
864468|NCT01465997|2850321|P2|Overall Study|Lost to Follow-up|9
864469|NCT01465997|2850322|P1|Overall Study|Lost to Follow-up|6
864470|NCT01465997|2850321|P2|Overall Study|Protocol Violation|4
864471|NCT01465997|2850322|P1|Overall Study|Protocol Violation|1
864472|NCT01465997|2850321|P2|Overall Study|Lack of Efficacy|1
864473|NCT01465997|2850322|P1|Overall Study|Lack of Efficacy|13
864474|NCT01465997|2850321|P2|Overall Study|Adverse Event|22
864475|NCT01465997|2850322|P1|Overall Study|Adverse Event|12
864476|NCT01465958|2850332|P2|Subcutaneous (SC) Phase|Adverse Event|1
864477|NCT01465958|2850333|P1|Subcutaneous (SC) Phase|Adverse Event|0
864478|NCT01465958|2850332|P2|Run-in Phase|Protocol Violation|0
864479|NCT01465958|2850333|P1|Run-in Phase|Protocol Violation|1
864480|NCT01465802|2850346|P5|Overall Study|Death|2
864481|NCT01465802|2850347|P4|Overall Study|Death|10
864482|NCT01465802|2850348|P3|Overall Study|Death|0
864483|NCT01465802|2850349|P2|Overall Study|Death|12
864484|NCT01465802|2850350|P1|Overall Study|Death|15
864485|NCT01465802|2850346|P5|Overall Study|Reason not specified|2
864486|NCT01465802|2850347|P4|Overall Study|Reason not specified|10
864487|NCT01465802|2850348|P3|Overall Study|Reason not specified|0
864488|NCT01465802|2850349|P2|Overall Study|Reason not specified|4
864489|NCT01465802|2850350|P1|Overall Study|Reason not specified|9
864490|NCT01465802|2850346|P5|Overall Study|Lost to Follow-up|0
864491|NCT01465802|2850347|P4|Overall Study|Lost to Follow-up|0
864492|NCT01465802|2850348|P3|Overall Study|Lost to Follow-up|0
864493|NCT01465802|2850349|P2|Overall Study|Lost to Follow-up|1
864494|NCT01465802|2850350|P1|Overall Study|Lost to Follow-up|1
864495|NCT01465802|2850346|P5|Overall Study|Withdrawal by Subject|1
864496|NCT01465802|2850347|P4|Overall Study|Withdrawal by Subject|8
864497|NCT01465802|2850348|P3|Overall Study|Withdrawal by Subject|0
864498|NCT01465802|2850349|P2|Overall Study|Withdrawal by Subject|7
864499|NCT01465802|2850350|P1|Overall Study|Withdrawal by Subject|7
864500|NCT01465802|2850346|P5|Overall Study|Study terminated by sponsor|7
864501|NCT01465802|2850347|P4|Overall Study|Study terminated by sponsor|1
864502|NCT01465802|2850348|P3|Overall Study|Study terminated by sponsor|0
864503|NCT01465802|2850349|P2|Overall Study|Study terminated by sponsor|0
864504|NCT01465802|2850350|P1|Overall Study|Study terminated by sponsor|1
864505|NCT01465763|2850402|P3|Overall Study|Death|0
864506|NCT01465763|2850403|P2|Overall Study|Death|0
864507|NCT01465763|2850404|P1|Overall Study|Death|1
864508|NCT01465763|2850402|P3|Overall Study|Protocol Violation|1
864509|NCT01465763|2850403|P2|Overall Study|Protocol Violation|1
864510|NCT01465763|2850404|P1|Overall Study|Protocol Violation|4
864511|NCT01465763|2850402|P3|Overall Study|Other|0
864512|NCT01465763|2850403|P2|Overall Study|Other|0
864513|NCT01465763|2850404|P1|Overall Study|Other|2
864514|NCT01465763|2850402|P3|Overall Study|Adverse Event|1
864515|NCT01465763|2850403|P2|Overall Study|Adverse Event|0
864516|NCT01465763|2850404|P1|Overall Study|Adverse Event|9
864517|NCT01465763|2850402|P3|Overall Study|Insufficient Clinical Response|1
864518|NCT01465763|2850403|P2|Overall Study|Insufficient Clinical Response|0
864519|NCT01465763|2850404|P1|Overall Study|Insufficient Clinical Response|11
864520|NCT01465763|2850402|P3|Overall Study|Withdrawal by Subject|1
864521|NCT01465763|2850403|P2|Overall Study|Withdrawal by Subject|0
864522|NCT01465763|2850404|P1|Overall Study|Withdrawal by Subject|4
864523|NCT01465386|2850474|P1|Overall Study|Adverse Event|1
864524|NCT01465386|2850474|P1|Overall Study|Lack of Efficacy|3
864525|NCT01465347|2850478|P2|Overall Study|Admitted to hospice|1
864526|NCT01465347|2850479|P1|Overall Study|Admitted to hospice|0
864527|NCT01465347|2850478|P2|Overall Study|Physician Decision|1
864528|NCT01465347|2850479|P1|Overall Study|Physician Decision|0
864529|NCT01465347|2850478|P2|Overall Study|Withdrawal by Subject|1
864530|NCT01465347|2850479|P1|Overall Study|Withdrawal by Subject|1
864531|NCT01465230|2850489|P1|Overall Study|Withdrawal by Subject|2
864532|NCT01465178|2850495|P2|Overall Study|Withdrawal by Subject|0
864533|NCT01465178|2850496|P1|Overall Study|Withdrawal by Subject|1
864534|NCT01465022|2850520|P3|Overall Study|Not Randomized|70
864535|NCT01465022|2850521|P2|Overall Study|Not Randomized|0
864536|NCT01465022|2850522|P1|Overall Study|Not Randomized|0
864537|NCT01465022|2850520|P3|Overall Study|Breastfeeding discontinuation before 8 w|0
864538|NCT01465022|2850521|P2|Overall Study|Breastfeeding discontinuation before 8 w|9
864539|NCT01465022|2850522|P1|Overall Study|Breastfeeding discontinuation before 8 w|8
864540|NCT01465022|2850520|P3|Overall Study|Lost to Follow-up|0
864541|NCT01465022|2850521|P2|Overall Study|Lost to Follow-up|14
864542|NCT01465022|2850522|P1|Overall Study|Lost to Follow-up|15
864543|NCT01464931|2850556|P2|Overall Study|Withdrawal by Subject|0
864544|NCT01464931|2850557|P1|Overall Study|Withdrawal by Subject|1
864545|NCT01464879|2850594|P1|Overall Study|Non-compliance|1
864546|NCT01464879|2850594|P1|Overall Study|Physician Decision|1
864547|NCT01464827|2850655|P14|Overall Study|Not Treated|2
864548|NCT01464827|2850656|P13|Overall Study|Not Treated|0
864549|NCT01464827|2850657|P12|Overall Study|Not Treated|1
864550|NCT01464827|2850658|P11|Overall Study|Not Treated|0
864551|NCT01464827|2850659|P10|Overall Study|Not Treated|2
864552|NCT01464827|2850660|P9|Overall Study|Not Treated|0
864553|NCT01464827|2850661|P8|Overall Study|Not Treated|0
864554|NCT01464827|2850662|P7|Overall Study|Not Treated|1
864555|NCT01464827|2850663|P6|Overall Study|Not Treated|0
864556|NCT01464827|2850664|P5|Overall Study|Not Treated|1
864557|NCT01464827|2850665|P4|Overall Study|Not Treated|0
864558|NCT01464827|2850666|P3|Overall Study|Not Treated|0
864559|NCT01464827|2850667|P2|Overall Study|Not Treated|2
864560|NCT01464827|2850668|P1|Overall Study|Not Treated|0
864561|NCT01464827|2850655|P14|Overall Study|Other|0
864562|NCT01464827|2850656|P13|Overall Study|Other|1
864563|NCT01464827|2850657|P12|Overall Study|Other|0
864564|NCT01464827|2850658|P11|Overall Study|Other|2
864565|NCT01464827|2850659|P10|Overall Study|Other|1
864566|NCT01464827|2850660|P9|Overall Study|Other|3
864567|NCT01464827|2850661|P8|Overall Study|Other|0
864568|NCT01464827|2850662|P7|Overall Study|Other|1
864569|NCT01464827|2850663|P6|Overall Study|Other|0
864570|NCT01464827|2850664|P5|Overall Study|Other|3
864571|NCT01464827|2850665|P4|Overall Study|Other|2
864572|NCT01464827|2850666|P3|Overall Study|Other|0
864573|NCT01464827|2850667|P2|Overall Study|Other|3
864574|NCT01464827|2850668|P1|Overall Study|Other|2
864575|NCT01464827|2850655|P14|Overall Study|Lost to Follow-up|1
864576|NCT01464827|2850656|P13|Overall Study|Lost to Follow-up|0
864577|NCT01464827|2850657|P12|Overall Study|Lost to Follow-up|1
864578|NCT01464827|2850658|P11|Overall Study|Lost to Follow-up|0
864579|NCT01464827|2850659|P10|Overall Study|Lost to Follow-up|0
864580|NCT01464827|2850660|P9|Overall Study|Lost to Follow-up|0
864581|NCT01464827|2850661|P8|Overall Study|Lost to Follow-up|2
864582|NCT01464827|2850662|P7|Overall Study|Lost to Follow-up|2
864583|NCT01464827|2850663|P6|Overall Study|Lost to Follow-up|1
864584|NCT01464827|2850664|P5|Overall Study|Lost to Follow-up|3
864585|NCT01464827|2850665|P4|Overall Study|Lost to Follow-up|2
864586|NCT01464827|2850666|P3|Overall Study|Lost to Follow-up|0
864587|NCT01464827|2850667|P2|Overall Study|Lost to Follow-up|2
864588|NCT01464827|2850668|P1|Overall Study|Lost to Follow-up|0
864589|NCT01464827|2850655|P14|Overall Study|Withdrawal by Subject|0
864590|NCT01464827|2850656|P13|Overall Study|Withdrawal by Subject|0
864591|NCT01464827|2850657|P12|Overall Study|Withdrawal by Subject|0
864592|NCT01464827|2850658|P11|Overall Study|Withdrawal by Subject|0
864593|NCT01464827|2850659|P10|Overall Study|Withdrawal by Subject|0
864594|NCT01464827|2850660|P9|Overall Study|Withdrawal by Subject|0
864595|NCT01464827|2850661|P8|Overall Study|Withdrawal by Subject|1
864596|NCT01464827|2850662|P7|Overall Study|Withdrawal by Subject|0
864597|NCT01464827|2850663|P6|Overall Study|Withdrawal by Subject|0
864598|NCT01464827|2850664|P5|Overall Study|Withdrawal by Subject|1
864599|NCT01464827|2850665|P4|Overall Study|Withdrawal by Subject|0
864600|NCT01464827|2850666|P3|Overall Study|Withdrawal by Subject|0
864601|NCT01464827|2850667|P2|Overall Study|Withdrawal by Subject|0
864602|NCT01464827|2850668|P1|Overall Study|Withdrawal by Subject|1
864603|NCT01464827|2850655|P14|Overall Study|Adverse Event|0
864604|NCT01464827|2850656|P13|Overall Study|Adverse Event|1
864605|NCT01464827|2850657|P12|Overall Study|Adverse Event|0
864606|NCT01464827|2850658|P11|Overall Study|Adverse Event|0
864607|NCT01464827|2850659|P10|Overall Study|Adverse Event|0
864608|NCT01464827|2850660|P9|Overall Study|Adverse Event|0
864609|NCT01464827|2850661|P8|Overall Study|Adverse Event|0
864610|NCT01464827|2850662|P7|Overall Study|Adverse Event|0
864611|NCT01464827|2850663|P6|Overall Study|Adverse Event|0
864612|NCT01464827|2850664|P5|Overall Study|Adverse Event|0
864613|NCT01464827|2850665|P4|Overall Study|Adverse Event|0
864614|NCT01464827|2850666|P3|Overall Study|Adverse Event|0
864615|NCT01464827|2850667|P2|Overall Study|Adverse Event|0
864616|NCT01464827|2850668|P1|Overall Study|Adverse Event|0
864617|NCT01464788|2850715|P3|Overall Study|Patient had hemorrhage after tPA started|0
864618|NCT01464788|2850716|P2|Overall Study|Patient had hemorrhage after tPA started|1
864619|NCT01464788|2850717|P1|Overall Study|Patient had hemorrhage after tPA started|0
864620|NCT01464788|2850715|P3|Overall Study|Lost to Follow-up|0
864621|NCT01464788|2850716|P2|Overall Study|Lost to Follow-up|1
864622|NCT01464788|2850717|P1|Overall Study|Lost to Follow-up|0
864623|NCT01464619|2850730|P2|Overall Study|Lost to Follow-up|4
864624|NCT01464619|2850731|P1|Overall Study|Lost to Follow-up|3
864625|NCT01464424|2850751|P2|Period 1, First 6 Weeks|Adverse Event|1
864626|NCT01464424|2850752|P1|Period 1, First 6 Weeks|Adverse Event|0
864627|NCT01464346|2850772|P3|Overall Study|Withdrawal by Subject|1
864628|NCT01464346|2850773|P2|Overall Study|Withdrawal by Subject|0
864629|NCT01464346|2850774|P1|Overall Study|Withdrawal by Subject|0
864630|NCT01464307|2850785|P2|Open-Label Extension Period|Predefined discontinuation criteria|0
864631|NCT01464307|2850786|P1|Open-Label Extension Period|Predefined discontinuation criteria|6
864632|NCT01464307|2850785|P2|Open-Label Extension Period|Non-compliance|0
864633|NCT01464307|2850786|P1|Open-Label Extension Period|Non-compliance|9
864634|NCT01464307|2850785|P2|Open-Label Extension Period|Lost to Follow-up|0
864635|NCT01464307|2850786|P1|Open-Label Extension Period|Lost to Follow-up|1
864636|NCT01464307|2850785|P2|Open-Label Extension Period|Death|0
864637|NCT01464307|2850786|P1|Open-Label Extension Period|Death|1
864638|NCT01464307|2850785|P2|Open-Label Extension Period|Lack of Efficacy|0
864639|NCT01464307|2850786|P1|Open-Label Extension Period|Lack of Efficacy|5
864640|NCT01464307|2850785|P2|Open-Label Extension Period|Withdrawal by Subject|0
864641|NCT01464307|2850786|P1|Open-Label Extension Period|Withdrawal by Subject|14
864642|NCT01464307|2850785|P2|Open-Label Extension Period|Adverse Event|0
864643|NCT01464307|2850786|P1|Open-Label Extension Period|Adverse Event|15
864644|NCT01464307|2850785|P2|Main Period|Predefined discontinuation criteria|1
864645|NCT01464307|2850786|P1|Main Period|Predefined discontinuation criteria|2
864646|NCT01464307|2850785|P2|Main Period|Withdrawal by Subject|2
864647|NCT01464307|2850786|P1|Main Period|Withdrawal by Subject|5
864648|NCT01464307|2850785|P2|Main Period|Lack of Efficacy|0
864649|NCT01464307|2850786|P1|Main Period|Lack of Efficacy|2
864650|NCT01464307|2850785|P2|Main Period|Adverse Event|1
864651|NCT01464307|2850786|P1|Main Period|Adverse Event|6
864652|NCT01464307|2850785|P2|Main Period|Death|1
864653|NCT01464307|2850786|P1|Main Period|Death|0
864654|NCT01464255|2850801|P2|Overall Study|unresolve corneal staining|1
864655|NCT01464255|2850802|P1|Overall Study|unresolve corneal staining|0
864656|NCT01464021|2850847|P1|Overall Study|various|11
864657|NCT01464021|2850847|P1|Overall Study|Lack of Efficacy|1
864658|NCT01464021|2850847|P1|Overall Study|Lost to Follow-up|1
864659|NCT01464021|2850847|P1|Overall Study|Withdrawal by Subject|13
864660|NCT01463982|2850863|P4|Overall Study|Treatment delay over 5 week|0
864661|NCT01463982|2850864|P3|Overall Study|Treatment delay over 5 week|1
864662|NCT01463982|2850865|P2|Overall Study|Treatment delay over 5 week|0
864663|NCT01463982|2850866|P1|Overall Study|Treatment delay over 5 week|0
864664|NCT01463982|2850863|P4|Overall Study|Withdrawal by Subject|0
864665|NCT01463982|2850864|P3|Overall Study|Withdrawal by Subject|1
864666|NCT01463982|2850865|P2|Overall Study|Withdrawal by Subject|1
864667|NCT01463982|2850866|P1|Overall Study|Withdrawal by Subject|0
864668|NCT01463878|2850882|P2|Overall Study|no longer met criteria for tube feed|2
864669|NCT01463878|2850883|P1|Overall Study|no longer met criteria for tube feed|2
864670|NCT01463696|2850897|P8|Overall Study|Not Treated|0
864671|NCT01463696|2850898|P7|Overall Study|Not Treated|1
864672|NCT01463696|2850899|P6|Overall Study|Not Treated|0
864673|NCT01463696|2850900|P5|Overall Study|Not Treated|0
864674|NCT01463696|2850901|P4|Overall Study|Not Treated|0
864675|NCT01463696|2850902|P3|Overall Study|Not Treated|0
864676|NCT01463696|2850903|P2|Overall Study|Not Treated|0
864677|NCT01463696|2850904|P1|Overall Study|Not Treated|0
864678|NCT01463696|2850897|P8|Overall Study|Withdrawal by Subject|0
864679|NCT01463696|2850898|P7|Overall Study|Withdrawal by Subject|2
864680|NCT01463696|2850899|P6|Overall Study|Withdrawal by Subject|1
864681|NCT01463696|2850900|P5|Overall Study|Withdrawal by Subject|1
864682|NCT01463696|2850901|P4|Overall Study|Withdrawal by Subject|1
864683|NCT01463696|2850902|P3|Overall Study|Withdrawal by Subject|0
864684|NCT01463696|2850903|P2|Overall Study|Withdrawal by Subject|0
864685|NCT01463696|2850904|P1|Overall Study|Withdrawal by Subject|0
864686|NCT01463696|2850897|P8|Overall Study|Progressive Disease|2
864687|NCT01463696|2850898|P7|Overall Study|Progressive Disease|4
864688|NCT01463696|2850899|P6|Overall Study|Progressive Disease|1
864689|NCT01463696|2850900|P5|Overall Study|Progressive Disease|0
864690|NCT01463696|2850901|P4|Overall Study|Progressive Disease|1
864691|NCT01463696|2850902|P3|Overall Study|Progressive Disease|0
864692|NCT01463696|2850903|P2|Overall Study|Progressive Disease|1
864693|NCT01463696|2850904|P1|Overall Study|Progressive Disease|0
864694|NCT01463696|2850897|P8|Overall Study|Lost to Follow-up|0
864695|NCT01463696|2850898|P7|Overall Study|Lost to Follow-up|0
864696|NCT01463696|2850899|P6|Overall Study|Lost to Follow-up|0
864697|NCT01463696|2850900|P5|Overall Study|Lost to Follow-up|0
864698|NCT01463696|2850901|P4|Overall Study|Lost to Follow-up|0
864699|NCT01463696|2850902|P3|Overall Study|Lost to Follow-up|1
864700|NCT01463696|2850903|P2|Overall Study|Lost to Follow-up|0
864701|NCT01463696|2850904|P1|Overall Study|Lost to Follow-up|0
864702|NCT01463696|2850897|P8|Overall Study|Adverse Event|2
864703|NCT01463696|2850898|P7|Overall Study|Adverse Event|3
864704|NCT01463696|2850899|P6|Overall Study|Adverse Event|1
864705|NCT01463696|2850900|P5|Overall Study|Adverse Event|0
864706|NCT01463696|2850901|P4|Overall Study|Adverse Event|2
864707|NCT01463696|2850902|P3|Overall Study|Adverse Event|0
864708|NCT01463696|2850903|P2|Overall Study|Adverse Event|1
864709|NCT01463696|2850904|P1|Overall Study|Adverse Event|0
864710|NCT01463683|2850957|P3|Overall Study|Withdrawal by Subject|2
864711|NCT01463683|2850958|P2|Overall Study|Withdrawal by Subject|17
864712|NCT01463683|2850959|P1|Overall Study|Withdrawal by Subject|5
864713|NCT01463683|2850957|P3|Overall Study|Pregnancy|1
864714|NCT01463683|2850958|P2|Overall Study|Pregnancy|2
864715|NCT01463683|2850959|P1|Overall Study|Pregnancy|2
864716|NCT01463683|2850957|P3|Overall Study|Physician Decision|1
864717|NCT01463683|2850958|P2|Overall Study|Physician Decision|3
864718|NCT01463683|2850959|P1|Overall Study|Physician Decision|0
864719|NCT01463683|2850957|P3|Overall Study|Lost to Follow-up|7
864720|NCT01463683|2850958|P2|Overall Study|Lost to Follow-up|9
864721|NCT01463683|2850959|P1|Overall Study|Lost to Follow-up|10
864722|NCT01463683|2850957|P3|Overall Study|Adverse Event|0
864723|NCT01463683|2850958|P2|Overall Study|Adverse Event|0
864724|NCT01463683|2850959|P1|Overall Study|Adverse Event|2
864725|NCT01463631|2850976|P4|Overall Study|Progressive Disease|5
864726|NCT01463631|2850977|P3|Overall Study|Progressive Disease|0
864727|NCT01463631|2850978|P2|Overall Study|Progressive Disease|0
864728|NCT01463631|2850979|P1|Overall Study|Progressive Disease|0
864729|NCT01463631|2850976|P4|Overall Study|Death|0
864730|NCT01463631|2850977|P3|Overall Study|Death|1
864731|NCT01463631|2850978|P2|Overall Study|Death|0
864732|NCT01463631|2850979|P1|Overall Study|Death|0
864733|NCT01463631|2850976|P4|Overall Study|Withdrawal by Subject|1
864734|NCT01463631|2850977|P3|Overall Study|Withdrawal by Subject|0
864735|NCT01463631|2850978|P2|Overall Study|Withdrawal by Subject|0
864736|NCT01463631|2850979|P1|Overall Study|Withdrawal by Subject|0
864737|NCT01463527|2851001|P2|Overall Study|Crying >20% of sedation|6
864738|NCT01463527|2851002|P1|Overall Study|Crying >20% of sedation|5
864739|NCT01463527|2851001|P2|Overall Study|Protocol Violation|1
864740|NCT01463527|2851002|P1|Overall Study|Protocol Violation|1
864741|NCT01463293|2851025|P3|Overall Study|Other|2
864742|NCT01463293|2851026|P2|Overall Study|Other|0
864743|NCT01463293|2851027|P1|Overall Study|Other|0
864744|NCT01463293|2851025|P3|Overall Study|Withdrawal by Subject|5
864745|NCT01463293|2851026|P2|Overall Study|Withdrawal by Subject|10
864746|NCT01463293|2851027|P1|Overall Study|Withdrawal by Subject|4
864747|NCT01463293|2851025|P3|Overall Study|Adverse Event|0
864748|NCT01463293|2851026|P2|Overall Study|Adverse Event|2
864749|NCT01463293|2851027|P1|Overall Study|Adverse Event|1
864750|NCT01463293|2851025|P3|Overall Study|Lost to Follow-up|5
864751|NCT01463293|2851026|P2|Overall Study|Lost to Follow-up|4
864752|NCT01463293|2851027|P1|Overall Study|Lost to Follow-up|1
864753|NCT01463111|2851050|P1|Overall Study|Physician Decision|2
864754|NCT01463111|2851050|P1|Overall Study|Lost to Follow-up|5
864755|NCT01463111|2851050|P1|Overall Study|Withdrawal by Subject|2
864756|NCT01463033|2851060|P2|Overall Study|Death|2
864757|NCT01463033|2851061|P1|Overall Study|Death|3
864758|NCT01463033|2851060|P2|Overall Study|Lost to Follow-up|4
864759|NCT01463033|2851061|P1|Overall Study|Lost to Follow-up|4
864760|NCT01463007|2851068|P1|Overall Study|Physician Decision|1
864761|NCT01462942|2851079|P5|Overall Study|Protocol Violation|6
864762|NCT01462942|2851080|P4|Overall Study|Protocol Violation|9
864763|NCT01462942|2851081|P3|Overall Study|Protocol Violation|9
864764|NCT01462942|2851082|P2|Overall Study|Protocol Violation|6
864765|NCT01462942|2851083|P1|Overall Study|Protocol Violation|4
864766|NCT01462942|2851079|P5|Overall Study|Lost to Follow-up|1
864767|NCT01462942|2851080|P4|Overall Study|Lost to Follow-up|1
864768|NCT01462942|2851081|P3|Overall Study|Lost to Follow-up|1
864769|NCT01462942|2851082|P2|Overall Study|Lost to Follow-up|1
864770|NCT01462942|2851083|P1|Overall Study|Lost to Follow-up|0
864771|NCT01462942|2851079|P5|Overall Study|Lack of Efficacy|3
864772|NCT01462942|2851080|P4|Overall Study|Lack of Efficacy|5
864773|NCT01462942|2851081|P3|Overall Study|Lack of Efficacy|4
864774|NCT01462942|2851082|P2|Overall Study|Lack of Efficacy|0
864775|NCT01462942|2851083|P1|Overall Study|Lack of Efficacy|6
864776|NCT01462942|2851079|P5|Overall Study|Withdrawal by Subject|19
864777|NCT01462942|2851080|P4|Overall Study|Withdrawal by Subject|16
864778|NCT01462942|2851081|P3|Overall Study|Withdrawal by Subject|14
864779|NCT01462942|2851082|P2|Overall Study|Withdrawal by Subject|10
864780|NCT01462942|2851083|P1|Overall Study|Withdrawal by Subject|14
864781|NCT01462942|2851079|P5|Overall Study|Other, including COPD exacerbation|5
864782|NCT01462942|2851080|P4|Overall Study|Other, including COPD exacerbation|8
864783|NCT01462942|2851081|P3|Overall Study|Other, including COPD exacerbation|2
864784|NCT01462942|2851082|P2|Overall Study|Other, including COPD exacerbation|5
864785|NCT01462942|2851083|P1|Overall Study|Other, including COPD exacerbation|3
864786|NCT01462942|2851079|P5|Overall Study|Adverse Event|11
864787|NCT01462942|2851080|P4|Overall Study|Adverse Event|11
864788|NCT01462942|2851081|P3|Overall Study|Adverse Event|10
864789|NCT01462942|2851082|P2|Overall Study|Adverse Event|12
864790|NCT01462942|2851083|P1|Overall Study|Adverse Event|7
864791|NCT01462929|2851113|P3|Overall Study|Lack of Efficacy|1
864792|NCT01462929|2851114|P2|Overall Study|Lack of Efficacy|0
864793|NCT01462929|2851115|P1|Overall Study|Lack of Efficacy|0
864794|NCT01462929|2851113|P3|Overall Study|Withdrawal by Subject|0
864795|NCT01462929|2851114|P2|Overall Study|Withdrawal by Subject|1
864796|NCT01462929|2851115|P1|Overall Study|Withdrawal by Subject|2
864797|NCT01462929|2851113|P3|Overall Study|Adverse Event|4
864798|NCT01462929|2851114|P2|Overall Study|Adverse Event|3
864799|NCT01462929|2851115|P1|Overall Study|Adverse Event|3
864800|NCT01462695|2851156|P2|Overall Study|Inevaluable (did not receive study drug)|0
864801|NCT01462695|2851157|P1|Overall Study|Inevaluable (did not receive study drug)|1
864802|NCT01462695|2851156|P2|Overall Study|Withdrawal by Subject|0
864803|NCT01462695|2851157|P1|Overall Study|Withdrawal by Subject|2
864804|NCT01462695|2851156|P2|Overall Study|Physician Decision|0
864805|NCT01462695|2851157|P1|Overall Study|Physician Decision|5
864806|NCT01462695|2851156|P2|Overall Study|Lack of Efficacy|12
864807|NCT01462695|2851157|P1|Overall Study|Lack of Efficacy|6
864808|NCT01462695|2851156|P2|Overall Study|Death|0
864809|NCT01462695|2851157|P1|Overall Study|Death|2
864810|NCT01462695|2851156|P2|Overall Study|Adverse Event|1
864811|NCT01462695|2851157|P1|Overall Study|Adverse Event|1
864812|NCT01462435|2851185|P4|Overall Study|Lost to Follow-up|1
864813|NCT01462435|2851186|P3|Overall Study|Lost to Follow-up|0
864814|NCT01462435|2851187|P2|Overall Study|Lost to Follow-up|0
864815|NCT01462435|2851188|P1|Overall Study|Lost to Follow-up|0
864816|NCT01462435|2851185|P4|Overall Study|Withdrawal by Subject|1
864817|NCT01462435|2851186|P3|Overall Study|Withdrawal by Subject|0
864818|NCT01462435|2851187|P2|Overall Study|Withdrawal by Subject|0
864819|NCT01462435|2851188|P1|Overall Study|Withdrawal by Subject|0
864820|NCT01462435|2851185|P4|Overall Study|Physician Decision|0
864821|NCT01462435|2851186|P3|Overall Study|Physician Decision|1
864822|NCT01462435|2851187|P2|Overall Study|Physician Decision|0
864823|NCT01462435|2851188|P1|Overall Study|Physician Decision|0
864824|NCT01462435|2851185|P4|Overall Study|Lack of Efficacy|3
864825|NCT01462435|2851186|P3|Overall Study|Lack of Efficacy|0
864826|NCT01462435|2851187|P2|Overall Study|Lack of Efficacy|0
864827|NCT01462435|2851188|P1|Overall Study|Lack of Efficacy|1
864828|NCT01462370|2851226|P2|Overall Study|Withdrawal by Subject|3
864829|NCT01462370|2851227|P1|Overall Study|Withdrawal by Subject|0
864830|NCT01462370|2851226|P2|Overall Study|Physician Decision|1
864831|NCT01462370|2851227|P1|Overall Study|Physician Decision|0
864832|NCT01462370|2851226|P2|Overall Study|Lack of Qualifying Event|1
864833|NCT01462370|2851227|P1|Overall Study|Lack of Qualifying Event|1
864834|NCT01462357|2851262|P3|Month 24|Migrated/moved from study area|0
864835|NCT01462357|2851263|P2|Month 24|Migrated/moved from study area|2
864836|NCT01462357|2851264|P1|Month 24|Migrated/moved from study area|0
864837|NCT01462357|2851262|P3|Month 24|Lost to Follow-up|6
864838|NCT01462357|2851263|P2|Month 24|Lost to Follow-up|4
864839|NCT01462357|2851264|P1|Month 24|Lost to Follow-up|2
864840|NCT01462357|2851262|P3|Month 24|Withdrawal by Subject|3
864841|NCT01462357|2851263|P2|Month 24|Withdrawal by Subject|8
864842|NCT01462357|2851264|P1|Month 24|Withdrawal by Subject|2
864843|NCT01462357|2851262|P3|Month 18|Other|1
864844|NCT01462357|2851263|P2|Month 18|Other|1
864845|NCT01462357|2851264|P1|Month 18|Other|0
864846|NCT01462357|2851262|P3|Month 18|Lost to Follow-up|5
864847|NCT01462357|2851263|P2|Month 18|Lost to Follow-up|4
864848|NCT01462357|2851264|P1|Month 18|Lost to Follow-up|1
864849|NCT01462357|2851262|P3|Month 18|Withdrawal by Subject|3
864850|NCT01462357|2851263|P2|Month 18|Withdrawal by Subject|6
864851|NCT01462357|2851264|P1|Month 18|Withdrawal by Subject|2
864852|NCT01462357|2851262|P3|Month 12|Lost to Follow-up|5
864853|NCT01462357|2851263|P2|Month 12|Lost to Follow-up|4
864854|NCT01462357|2851264|P1|Month 12|Lost to Follow-up|1
864855|NCT01462357|2851262|P3|Month 12|Withdrawal by Subject|3
864856|NCT01462357|2851263|P2|Month 12|Withdrawal by Subject|6
864857|NCT01462357|2851264|P1|Month 12|Withdrawal by Subject|2
864858|NCT01462357|2851262|P3|Month 7|Withdrawal by Subject|6
864859|NCT01462357|2851263|P2|Month 7|Withdrawal by Subject|5
864860|NCT01462357|2851264|P1|Month 7|Withdrawal by Subject|1
864861|NCT01462344|2851337|P2|Overall Study|Lost to Follow-up|7
864862|NCT01462344|2851338|P1|Overall Study|Lost to Follow-up|7
864863|NCT01462344|2851337|P2|Overall Study|Protocol Violation|53
864864|NCT01462344|2851338|P1|Overall Study|Protocol Violation|68
864865|NCT01462344|2851337|P2|Overall Study|Lack of Efficacy|6
864866|NCT01462344|2851338|P1|Overall Study|Lack of Efficacy|5
864867|NCT01462344|2851337|P2|Overall Study|Asthma Exacerbation|35
864868|NCT01462344|2851338|P1|Overall Study|Asthma Exacerbation|34
864869|NCT01462344|2851337|P2|Overall Study|Adverse Event|23
864870|NCT01462344|2851338|P1|Overall Study|Adverse Event|24
864871|NCT01462344|2851337|P2|Overall Study|Withdrawal by Subject|226
864872|NCT01462344|2851338|P1|Overall Study|Withdrawal by Subject|245
864873|NCT01462318|2851360|P3|Extension Phase|Adverse Event|22
864874|NCT01462318|2851361|P2|Extension Phase|Adverse Event|0
864875|NCT01462318|2851362|P1|Extension Phase|Adverse Event|0
864876|NCT01462318|2851360|P3|Extension Phase|Investigator Decision|5
864877|NCT01462318|2851361|P2|Extension Phase|Investigator Decision|0
864878|NCT01462318|2851362|P1|Extension Phase|Investigator Decision|0
864879|NCT01462318|2851360|P3|Extension Phase|Withdrawal by Subject|15
864880|NCT01462318|2851361|P2|Extension Phase|Withdrawal by Subject|0
864881|NCT01462318|2851362|P1|Extension Phase|Withdrawal by Subject|0
864882|NCT01462318|2851360|P3|Extension Phase|Disease Progression|1
864883|NCT01462318|2851361|P2|Extension Phase|Disease Progression|0
864884|NCT01462318|2851362|P1|Extension Phase|Disease Progression|0
864885|NCT01462318|2851360|P3|Extension Phase|Not Specified|1
864886|NCT01462318|2851361|P2|Extension Phase|Not Specified|0
864887|NCT01462318|2851362|P1|Extension Phase|Not Specified|0
864888|NCT01462318|2851360|P3|Extension Phase|Lost to Follow-up|1
864889|NCT01462318|2851361|P2|Extension Phase|Lost to Follow-up|0
864890|NCT01462318|2851362|P1|Extension Phase|Lost to Follow-up|0
864891|NCT01462318|2851360|P3|Main Study / TP-DI Study|Adverse Event|0
864892|NCT01462318|2851361|P2|Main Study / TP-DI Study|Adverse Event|0
864893|NCT01462318|2851362|P1|Main Study / TP-DI Study|Adverse Event|4
864894|NCT01462318|2851360|P3|Main Study / TP-DI Study|Withdrawal by Subject|0
864895|NCT01462318|2851361|P2|Main Study / TP-DI Study|Withdrawal by Subject|0
864896|NCT01462318|2851362|P1|Main Study / TP-DI Study|Withdrawal by Subject|2
864897|NCT01462318|2851360|P3|Main Study / TP-DI Study|Not Specified|0
864898|NCT01462318|2851361|P2|Main Study / TP-DI Study|Not Specified|0
864899|NCT01462318|2851362|P1|Main Study / TP-DI Study|Not Specified|2
864900|NCT01462266|2851450|P2|Overall Study|Screen failure|1
864901|NCT01462266|2851451|P1|Overall Study|Screen failure|1
864902|NCT01462266|2851450|P2|Overall Study|Withdrawal by Subject|2
864903|NCT01462266|2851451|P1|Overall Study|Withdrawal by Subject|7
864904|NCT01462266|2851450|P2|Overall Study|Protocol Violation|3
864905|NCT01462266|2851451|P1|Overall Study|Protocol Violation|1
864906|NCT01462266|2851450|P2|Overall Study|Physician Decision|5
864907|NCT01462266|2851451|P1|Overall Study|Physician Decision|2
864908|NCT01462266|2851450|P2|Overall Study|Creatinine and eGFR, excluded medication|4
864909|NCT01462266|2851451|P1|Overall Study|Creatinine and eGFR, excluded medication|8
864910|NCT01462266|2851450|P2|Overall Study|Non-compliance with study drug|0
864911|NCT01462266|2851451|P1|Overall Study|Non-compliance with study drug|3
864912|NCT01462266|2851450|P2|Overall Study|Lost to Follow-up|3
864913|NCT01462266|2851451|P1|Overall Study|Lost to Follow-up|4
864914|NCT01462266|2851450|P2|Overall Study|Lack of Efficacy|2
864915|NCT01462266|2851451|P1|Overall Study|Lack of Efficacy|0
864916|NCT01462266|2851450|P2|Overall Study|Death|1
864917|NCT01462266|2851451|P1|Overall Study|Death|2
864918|NCT01462266|2851450|P2|Overall Study|Adverse Event|6
864919|NCT01462266|2851451|P1|Overall Study|Adverse Event|7
864920|NCT01462227|2851467|P4|Second Assignment|Protocol Violation|0
864921|NCT01462227|2851468|P3|Second Assignment|Protocol Violation|1
864922|NCT01462227|2851469|P2|Second Assignment|Protocol Violation|1
864923|NCT01462227|2851470|P1|Second Assignment|Protocol Violation|0
864924|NCT01462227|2851467|P4|Second Assignment|Lost to Follow-up|0
864925|NCT01462227|2851468|P3|Second Assignment|Lost to Follow-up|0
864926|NCT01462227|2851469|P2|Second Assignment|Lost to Follow-up|0
864927|NCT01462227|2851470|P1|Second Assignment|Lost to Follow-up|1
864928|NCT01462162|2851488|P1|Overall Study|Other|2
864929|NCT01462162|2851488|P1|Overall Study|Abnormal laboratory parameters|1
864930|NCT01462162|2851488|P1|Overall Study|Lack of Efficacy|4
864931|NCT01462162|2851488|P1|Overall Study|Adverse Event|5
864932|NCT01462084|2851513|P2|Overall Study|Protocol Violation|1
864933|NCT01462084|2851514|P1|Overall Study|Protocol Violation|1
864934|NCT01462084|2851513|P2|Overall Study|Withdrawal by Subject|0
864935|NCT01462084|2851514|P1|Overall Study|Withdrawal by Subject|1
864936|NCT01462045|2851525|P3|Overall Study|Family matter|0
864937|NCT01462045|2851526|P2|Overall Study|Family matter|1
864938|NCT01462045|2851527|P1|Overall Study|Family matter|0
864939|NCT01461993|2851541|P3|Overall Study|Other|6
864940|NCT01461993|2851542|P2|Overall Study|Other|15
864941|NCT01461993|2851543|P1|Overall Study|Other|13
864942|NCT01461993|2851541|P3|Overall Study|Did not meet entrance criteria|0
864943|NCT01461993|2851542|P2|Overall Study|Did not meet entrance criteria|3
864944|NCT01461993|2851543|P1|Overall Study|Did not meet entrance criteria|2
864945|NCT01461993|2851541|P3|Overall Study|No longer met eligibility criteria|10
864946|NCT01461993|2851542|P2|Overall Study|No longer met eligibility criteria|18
864947|NCT01461993|2851543|P1|Overall Study|No longer met eligibility criteria|13
864948|NCT01461993|2851541|P3|Overall Study|Adverse Event|3
864949|NCT01461993|2851542|P2|Overall Study|Adverse Event|11
864950|NCT01461993|2851543|P1|Overall Study|Adverse Event|9
864951|NCT01461993|2851541|P3|Overall Study|Protocol Violation|7
864952|NCT01461993|2851542|P2|Overall Study|Protocol Violation|9
864953|NCT01461993|2851543|P1|Overall Study|Protocol Violation|10
864954|NCT01461993|2851541|P3|Overall Study|Lost to Follow-up|22
864955|NCT01461993|2851542|P2|Overall Study|Lost to Follow-up|48
864956|NCT01461993|2851543|P1|Overall Study|Lost to Follow-up|44
864957|NCT01461993|2851541|P3|Overall Study|Withdrawal by Subject|16
864958|NCT01461993|2851542|P2|Overall Study|Withdrawal by Subject|53
864959|NCT01461993|2851543|P1|Overall Study|Withdrawal by Subject|60
864960|NCT01461980|2851568|P3|Overall Study|Randomized but not vaccinated|7
864961|NCT01461980|2851569|P2|Overall Study|Randomized but not vaccinated|8
864962|NCT01461980|2851570|P1|Overall Study|Randomized but not vaccinated|4
864963|NCT01461980|2851568|P3|Overall Study|No longer willing to participate|54
864964|NCT01461980|2851569|P2|Overall Study|No longer willing to participate|38
864965|NCT01461980|2851570|P1|Overall Study|No longer willing to participate|52
864966|NCT01461980|2851568|P3|Overall Study|Lost to Follow-up|51
864967|NCT01461980|2851569|P2|Overall Study|Lost to Follow-up|53
864968|NCT01461980|2851570|P1|Overall Study|Lost to Follow-up|52
864969|NCT01461980|2851568|P3|Overall Study|No longer meets eligibility criteria|19
864970|NCT01461980|2851569|P2|Overall Study|No longer meets eligibility criteria|9
864971|NCT01461980|2851570|P1|Overall Study|No longer meets eligibility criteria|18
864972|NCT01461980|2851568|P3|Overall Study|Protocol Violation|16
864973|NCT01461980|2851569|P2|Overall Study|Protocol Violation|19
864974|NCT01461980|2851570|P1|Overall Study|Protocol Violation|12
864975|NCT01461980|2851568|P3|Overall Study|Adverse Event|6
864976|NCT01461980|2851569|P2|Overall Study|Adverse Event|5
864977|NCT01461980|2851570|P1|Overall Study|Adverse Event|12
864978|NCT01461980|2851568|P3|Overall Study|Medication error|6
864979|NCT01461980|2851569|P2|Overall Study|Medication error|5
864980|NCT01461980|2851570|P1|Overall Study|Medication error|7
864981|NCT01461980|2851568|P3|Overall Study|Other|6
864982|NCT01461980|2851569|P2|Overall Study|Other|8
864983|NCT01461980|2851570|P1|Overall Study|Other|9
864984|NCT01461811|2851632|P2|Overall Study|Noncompliance|1
864985|NCT01461811|2851633|P1|Overall Study|Noncompliance|1
864986|NCT01461811|2851632|P2|Overall Study|Subject decision unrelated to an AE|1
864987|NCT01461811|2851633|P1|Overall Study|Subject decision unrelated to an AE|1
864988|NCT01461811|2851632|P2|Overall Study|Adverse Event|1
864989|NCT01461811|2851633|P1|Overall Study|Adverse Event|2
864990|NCT01461707|2851672|P2|Overall Study|Withdrawal by Subject|0
864991|NCT01461707|2851673|P1|Overall Study|Withdrawal by Subject|1
864992|NCT01461551|2851710|P3|Overall Study|Physician Decision|2
864993|NCT01461551|2851711|P2|Overall Study|Physician Decision|1
864994|NCT01461551|2851712|P1|Overall Study|Physician Decision|2
864995|NCT01461538|2851723|P3|Overall Study|Withdrawal by Subject|0
864996|NCT01461538|2851724|P2|Overall Study|Withdrawal by Subject|1
864997|NCT01461538|2851725|P1|Overall Study|Withdrawal by Subject|1
864998|NCT01461538|2851723|P3|Overall Study|Study Stopped by Sponsor|0
864999|NCT01461538|2851724|P2|Overall Study|Study Stopped by Sponsor|1
865000|NCT01461538|2851725|P1|Overall Study|Study Stopped by Sponsor|2
865001|NCT01461538|2851723|P3|Overall Study|Death|2
865002|NCT01461538|2851724|P2|Overall Study|Death|6
865003|NCT01461538|2851725|P1|Overall Study|Death|15
865004|NCT01461369|2851794|P3|Overall Study|Withdrawal by Subject|2
865005|NCT01461369|2851795|P2|Overall Study|Withdrawal by Subject|3
865006|NCT01461369|2851796|P1|Overall Study|Withdrawal by Subject|1
865007|NCT01461369|2851794|P3|Overall Study|Protocol Violation|2
865008|NCT01461369|2851795|P2|Overall Study|Protocol Violation|2
865009|NCT01461369|2851796|P1|Overall Study|Protocol Violation|1
865010|NCT01461369|2851794|P3|Overall Study|Adverse Event|4
865011|NCT01461369|2851795|P2|Overall Study|Adverse Event|12
865012|NCT01461369|2851796|P1|Overall Study|Adverse Event|9
865013|NCT01461369|2851794|P3|Overall Study|Lost to Follow-up|3
865014|NCT01461369|2851795|P2|Overall Study|Lost to Follow-up|0
865015|NCT01461369|2851796|P1|Overall Study|Lost to Follow-up|0
865016|NCT01461369|2851794|P3|Overall Study|Lack of Efficacy|6
865017|NCT01461369|2851795|P2|Overall Study|Lack of Efficacy|0
865018|NCT01461369|2851796|P1|Overall Study|Lack of Efficacy|2
865019|NCT01461096|2851821|P2|Overall Study|Lost to Follow-up|4
865020|NCT01461096|2851822|P1|Overall Study|Lost to Follow-up|8
865021|NCT01461096|2851821|P2|Overall Study|Subj not willing to adhere to reqs|4
865022|NCT01461096|2851822|P1|Overall Study|Subj not willing to adhere to reqs|3
865023|NCT01461096|2851821|P2|Overall Study|Withdrawal by Subject|3
865024|NCT01461096|2851822|P1|Overall Study|Withdrawal by Subject|5
865025|NCT01461096|2851821|P2|Overall Study|Site is closing|30
865026|NCT01461096|2851822|P1|Overall Study|Site is closing|27
865027|NCT01461096|2851821|P2|Overall Study|Subj not able to get to clinic|13
865028|NCT01461096|2851822|P1|Overall Study|Subj not able to get to clinic|15
865029|NCT01461096|2851821|P2|Overall Study|Severe debilitation, unable to continue|1
865030|NCT01461096|2851822|P1|Overall Study|Severe debilitation, unable to continue|1
865031|NCT01461096|2851821|P2|Overall Study|Death|6
865032|NCT01461096|2851822|P1|Overall Study|Death|3
865033|NCT01461057|2851838|P2|Overall Study|Study Terminated by Sponsor|0
865034|NCT01461057|2851839|P1|Overall Study|Study Terminated by Sponsor|2
865035|NCT01461057|2851838|P2|Overall Study|Progression of Disease|0
865036|NCT01461057|2851839|P1|Overall Study|Progression of Disease|1
865037|NCT01461057|2851838|P2|Overall Study|Adverse Event|1
865038|NCT01461057|2851839|P1|Overall Study|Adverse Event|0
865039|NCT01461057|2851838|P2|Overall Study|Physician Decision|2
865040|NCT01461057|2851839|P1|Overall Study|Physician Decision|0
865041|NCT01461057|2851838|P2|Overall Study|Withdrawal by Subject|3
865042|NCT01461057|2851839|P1|Overall Study|Withdrawal by Subject|2
865043|NCT01461057|2851838|P2|Overall Study|Death|9
865044|NCT01461057|2851839|P1|Overall Study|Death|10
865045|NCT01461044|2851849|P2|Overall Study|Lost to Follow-up|5
865046|NCT01461044|2851850|P1|Overall Study|Lost to Follow-up|12
865047|NCT01461044|2851849|P2|Overall Study|Death|35
865048|NCT01461044|2851850|P1|Overall Study|Death|58
865049|NCT01460628|2851961|P1|Overall Study|Withdrawal by Subject|2
865050|NCT01460628|2851961|P1|Overall Study|Adverse Event|3
865051|NCT01460446|2851973|P2|Overall Study|Other Reasons Incl. Lost for Follow-Up|3
865052|NCT01460446|2851974|P1|Overall Study|Other Reasons Incl. Lost for Follow-Up|0
865053|NCT01460446|2851973|P2|Overall Study|Pregnancy|0
865054|NCT01460446|2851974|P1|Overall Study|Pregnancy|1
865055|NCT01460446|2851973|P2|Overall Study|Surgery/Illness|1
865056|NCT01460446|2851974|P1|Overall Study|Surgery/Illness|1
865057|NCT01460446|2851973|P2|Overall Study|Non-compliance & Consent Withdrawn|3
865058|NCT01460446|2851974|P1|Overall Study|Non-compliance & Consent Withdrawn|1
865059|NCT01460446|2851973|P2|Overall Study|Consent Withdrawn|4
865060|NCT01460446|2851974|P1|Overall Study|Consent Withdrawn|0
865061|NCT01460446|2851973|P2|Overall Study|Non-compliance|9
865062|NCT01460446|2851974|P1|Overall Study|Non-compliance|2
865063|NCT01460407|2852001|P2|Period 2: Day 6 to Day 14|Adverse Event|1
865064|NCT01460407|2852002|P1|Period 2: Day 6 to Day 14|Adverse Event|0
865065|NCT01460381|2852015|P2|Period 2 (Days 8-15)|Lost to Follow-up|0
865066|NCT01460381|2852016|P1|Period 2 (Days 8-15)|Lost to Follow-up|1
865067|NCT01460368|2852032|P7|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
865068|NCT01460368|2852033|P6|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
865069|NCT01460368|2852034|P5|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
865070|NCT01460368|2852035|P4|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
865071|NCT01460368|2852036|P3|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
865072|NCT01460368|2852037|P2|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
865154|NCT01459913|2852151|P4|Overall Study|Physician Decision|0
865073|NCT01460368|2852038|P1|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
865074|NCT01460368|2852032|P7|Part B: Washout (up to 15 Days)|Protocol Violation|0
865075|NCT01460368|2852033|P6|Part B: Washout (up to 15 Days)|Protocol Violation|0
865076|NCT01460368|2852034|P5|Part B: Washout (up to 15 Days)|Protocol Violation|0
865077|NCT01460368|2852035|P4|Part B: Washout (up to 15 Days)|Protocol Violation|0
865078|NCT01460368|2852036|P3|Part B: Washout (up to 15 Days)|Protocol Violation|1
865079|NCT01460368|2852037|P2|Part B: Washout (up to 15 Days)|Protocol Violation|0
865080|NCT01460368|2852038|P1|Part B: Washout (up to 15 Days)|Protocol Violation|0
865081|NCT01460368|2852032|P7|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
865082|NCT01460368|2852033|P6|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
865083|NCT01460368|2852034|P5|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
865084|NCT01460368|2852035|P4|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
865085|NCT01460368|2852036|P3|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
865086|NCT01460368|2852037|P2|Part B: Second Intervention (Period 2)|Lost to Follow-up|1
865087|NCT01460368|2852038|P1|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
865088|NCT01460368|2852032|P7|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
865089|NCT01460368|2852033|P6|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
865090|NCT01460368|2852034|P5|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
865091|NCT01460368|2852035|P4|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
865092|NCT01460368|2852036|P3|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
865093|NCT01460368|2852037|P2|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
865094|NCT01460368|2852038|P1|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
865095|NCT01460368|2852032|P7|Part B: First Intervention (Period 1)|Lost to Follow-up|0
865096|NCT01460368|2852033|P6|Part B: First Intervention (Period 1)|Lost to Follow-up|0
865097|NCT01460368|2852034|P5|Part B: First Intervention (Period 1)|Lost to Follow-up|1
865098|NCT01460368|2852035|P4|Part B: First Intervention (Period 1)|Lost to Follow-up|0
865099|NCT01460368|2852036|P3|Part B: First Intervention (Period 1)|Lost to Follow-up|0
865100|NCT01460368|2852037|P2|Part B: First Intervention (Period 1)|Lost to Follow-up|0
865101|NCT01460368|2852038|P1|Part B: First Intervention (Period 1)|Lost to Follow-up|0
865102|NCT01460342|2852050|P2|Overall Study|Lack of Efficacy|0
865103|NCT01460342|2852051|P1|Overall Study|Lack of Efficacy|1
865104|NCT01460342|2852050|P2|Overall Study|Physician Decision|3
865105|NCT01460342|2852051|P1|Overall Study|Physician Decision|1
865106|NCT01460342|2852050|P2|Overall Study|Withdrawal by Subject|4
865107|NCT01460342|2852051|P1|Overall Study|Withdrawal by Subject|3
865108|NCT01460342|2852050|P2|Overall Study|Protocol Violation|1
865109|NCT01460342|2852051|P1|Overall Study|Protocol Violation|0
865110|NCT01460342|2852050|P2|Overall Study|Lost to Follow-up|2
865111|NCT01460342|2852051|P1|Overall Study|Lost to Follow-up|1
865112|NCT01460342|2852050|P2|Overall Study|Adverse Event|4
865113|NCT01460342|2852051|P1|Overall Study|Adverse Event|5
865114|NCT01460290|2852082|P1|Overall Study|Elevated liver function|1
865115|NCT01460290|2852082|P1|Overall Study|Adverse Event|3
865116|NCT01460160|2852109|P2|Follow-up|Lost to Follow-up|0
865117|NCT01460160|2852110|P1|Follow-up|Lost to Follow-up|1
865118|NCT01460160|2852109|P2|Follow-up|Death|2
865119|NCT01460160|2852110|P1|Follow-up|Death|7
865120|NCT01460160|2852109|P2|Follow-up|Withdrawal by Subject|0
865121|NCT01460160|2852110|P1|Follow-up|Withdrawal by Subject|3
865122|NCT01460160|2852109|P2|Treatment|Subject refused to continue Chemo|0
865123|NCT01460160|2852110|P1|Treatment|Subject refused to continue Chemo|1
865124|NCT01460160|2852109|P2|Treatment|Family did not wish to restart after SCT|0
865125|NCT01460160|2852110|P1|Treatment|Family did not wish to restart after SCT|1
865126|NCT01460160|2852109|P2|Treatment|PI decision to pursue other options|1
865127|NCT01460160|2852110|P1|Treatment|PI decision to pursue other options|1
865128|NCT01460160|2852109|P2|Treatment|PI not to follow protocol therapy|0
865129|NCT01460160|2852110|P1|Treatment|PI not to follow protocol therapy|1
865130|NCT01460160|2852109|P2|Treatment|PI decision to not re-initiate after SCT|2
865131|NCT01460160|2852110|P1|Treatment|PI decision to not re-initiate after SCT|2
865132|NCT01460160|2852109|P2|Treatment|Death|2
865133|NCT01460160|2852110|P1|Treatment|Death|0
865134|NCT01460160|2852109|P2|Treatment|Withdrawal by Subject|0
865135|NCT01460160|2852110|P1|Treatment|Withdrawal by Subject|4
865136|NCT01460160|2852109|P2|Treatment|Adverse Event|0
865137|NCT01460160|2852110|P1|Treatment|Adverse Event|8
865138|NCT01460160|2852109|P2|Treatment|Study Drug Toxicity|0
865139|NCT01460160|2852110|P1|Treatment|Study Drug Toxicity|2
865140|NCT01460160|2852109|P2|Treatment|Lack of Efficacy|0
865141|NCT01460160|2852110|P1|Treatment|Lack of Efficacy|3
865142|NCT01459913|2852151|P4|Overall Study|Did Not Meet Inclusion Criteria|1
865143|NCT01459913|2852152|P3|Overall Study|Did Not Meet Inclusion Criteria|0
865144|NCT01459913|2852153|P2|Overall Study|Did Not Meet Inclusion Criteria|0
865145|NCT01459913|2852154|P1|Overall Study|Did Not Meet Inclusion Criteria|0
865146|NCT01459913|2852151|P4|Overall Study|Other|1
865147|NCT01459913|2852152|P3|Overall Study|Other|3
865148|NCT01459913|2852153|P2|Overall Study|Other|0
865149|NCT01459913|2852154|P1|Overall Study|Other|0
865150|NCT01459913|2852151|P4|Overall Study|Study Terminated by Sponsor|11
865151|NCT01459913|2852152|P3|Overall Study|Study Terminated by Sponsor|9
865152|NCT01459913|2852153|P2|Overall Study|Study Terminated by Sponsor|15
865153|NCT01459913|2852154|P1|Overall Study|Study Terminated by Sponsor|30
865155|NCT01459913|2852152|P3|Overall Study|Physician Decision|0
865156|NCT01459913|2852153|P2|Overall Study|Physician Decision|1
865157|NCT01459913|2852154|P1|Overall Study|Physician Decision|0
865158|NCT01459913|2852151|P4|Overall Study|Non- Compliance|3
865159|NCT01459913|2852152|P3|Overall Study|Non- Compliance|0
865160|NCT01459913|2852153|P2|Overall Study|Non- Compliance|0
865161|NCT01459913|2852154|P1|Overall Study|Non- Compliance|0
865162|NCT01459913|2852151|P4|Overall Study|Death|1
865163|NCT01459913|2852152|P3|Overall Study|Death|0
865164|NCT01459913|2852153|P2|Overall Study|Death|0
865165|NCT01459913|2852154|P1|Overall Study|Death|0
865166|NCT01459913|2852151|P4|Overall Study|Lost to Follow-up|8
865167|NCT01459913|2852152|P3|Overall Study|Lost to Follow-up|1
865168|NCT01459913|2852153|P2|Overall Study|Lost to Follow-up|4
865169|NCT01459913|2852154|P1|Overall Study|Lost to Follow-up|7
865170|NCT01459913|2852151|P4|Overall Study|Withdrawal by Subject|5
865171|NCT01459913|2852152|P3|Overall Study|Withdrawal by Subject|0
865172|NCT01459913|2852153|P2|Overall Study|Withdrawal by Subject|0
865173|NCT01459913|2852154|P1|Overall Study|Withdrawal by Subject|4
865174|NCT01459913|2852151|P4|Overall Study|Adverse Event|3
865175|NCT01459913|2852152|P3|Overall Study|Adverse Event|0
865176|NCT01459913|2852153|P2|Overall Study|Adverse Event|0
865177|NCT01459913|2852154|P1|Overall Study|Adverse Event|0
865178|NCT01459796|2852185|P2|Overall Study|Decision by the sponsor|108
865179|NCT01459796|2852186|P1|Overall Study|Decision by the sponsor|75
865180|NCT01459796|2852185|P2|Overall Study|Reason unspecified|2
865181|NCT01459796|2852186|P1|Overall Study|Reason unspecified|1
865182|NCT01459796|2852185|P2|Overall Study|Lost to Follow-up|4
865183|NCT01459796|2852186|P1|Overall Study|Lost to Follow-up|5
865184|NCT01459796|2852185|P2|Overall Study|Withdrawal by Subject|3
865185|NCT01459796|2852186|P1|Overall Study|Withdrawal by Subject|6
865186|NCT01459796|2852185|P2|Overall Study|Adverse Event|5
865187|NCT01459796|2852186|P1|Overall Study|Adverse Event|5
865188|NCT01459796|2852185|P2|Overall Study|Non compliance with protocol|4
865189|NCT01459796|2852186|P1|Overall Study|Non compliance with protocol|2
865190|NCT01459783|2852204|P2|6 Months to 12 Months|Study ended before 12-month follow-up|17
865191|NCT01459783|2852205|P1|6 Months to 12 Months|Study ended before 12-month follow-up|11
865192|NCT01459783|2852204|P2|6 Months to 12 Months|Lost to Follow-up|7
865193|NCT01459783|2852205|P1|6 Months to 12 Months|Lost to Follow-up|2
865194|NCT01459783|2852204|P2|6 Months to 12 Months|Withdrawal by Subject|5
865195|NCT01459783|2852205|P1|6 Months to 12 Months|Withdrawal by Subject|6
865196|NCT01459783|2852204|P2|6 Months to 12 Months|Death|1
865197|NCT01459783|2852205|P1|6 Months to 12 Months|Death|0
865198|NCT01459783|2852204|P2|Baseline to 6 Months|Lost to Follow-up|14
865199|NCT01459783|2852205|P1|Baseline to 6 Months|Lost to Follow-up|19
865200|NCT01459783|2852204|P2|Baseline to 6 Months|Withdrawal by Subject|6
865201|NCT01459783|2852205|P1|Baseline to 6 Months|Withdrawal by Subject|12
865202|NCT01459783|2852204|P2|Baseline to 6 Months|Death|0
865203|NCT01459783|2852205|P1|Baseline to 6 Months|Death|1
865204|NCT01459068|2852417|P2|Overall Study|Death|1
865205|NCT01459068|2852418|P1|Overall Study|Death|0
865206|NCT01459068|2852417|P2|Overall Study|Lost to Follow-up|15
865207|NCT01459068|2852418|P1|Overall Study|Lost to Follow-up|31
865208|NCT01459068|2852417|P2|Overall Study|Withdrawal by Subject|18
865209|NCT01459068|2852418|P1|Overall Study|Withdrawal by Subject|8
865210|NCT01459016|2852434|P1|Overall Study|Amendment Discontinuation Criteria|4
865211|NCT01459016|2852434|P1|Overall Study|Withdrawal by Subject|11
865212|NCT01458951|2852462|P3|Overall Study|Insufficient Clinical Response|11
865213|NCT01458951|2852463|P2|Overall Study|Insufficient Clinical Response|0
865214|NCT01458951|2852464|P1|Overall Study|Insufficient Clinical Response|17
865215|NCT01458951|2852462|P3|Overall Study|Adverse Event|2
865216|NCT01458951|2852463|P2|Overall Study|Adverse Event|0
865217|NCT01458951|2852464|P1|Overall Study|Adverse Event|7
865218|NCT01458951|2852462|P3|Overall Study|Withdrawal by Subject|2
865219|NCT01458951|2852463|P2|Overall Study|Withdrawal by Subject|0
865220|NCT01458951|2852464|P1|Overall Study|Withdrawal by Subject|2
865221|NCT01458951|2852462|P3|Overall Study|Protocol Violation|0
865222|NCT01458951|2852463|P2|Overall Study|Protocol Violation|1
865223|NCT01458951|2852464|P1|Overall Study|Protocol Violation|5
865224|NCT01458951|2852462|P3|Overall Study|Other|0
865225|NCT01458951|2852463|P2|Overall Study|Other|0
865226|NCT01458951|2852464|P1|Overall Study|Other|1
865227|NCT01458639|2852489|P1|Overall Study|Inability to obtain subject blood sample|1
865228|NCT01458639|2852489|P1|Overall Study|Equipment issue|1
865229|NCT01458639|2852489|P1|Overall Study|Physician Decision|4
865230|NCT01458587|2852501|P2|Overall Study|Withdrawal by Subject|0
865231|NCT01458587|2852502|P1|Overall Study|Withdrawal by Subject|1
865232|NCT01458574|2852665|P3|Overall Study|Randomized but not treated|0
865233|NCT01458574|2852666|P2|Overall Study|Randomized but not treated|1
865234|NCT01458574|2852667|P1|Overall Study|Randomized but not treated|0
865235|NCT01458574|2852665|P3|Overall Study|Other|0
865236|NCT01458574|2852666|P2|Overall Study|Other|1
865237|NCT01458574|2852667|P1|Overall Study|Other|2
865238|NCT01458574|2852665|P3|Overall Study|Withdrawal by Subject|5
865239|NCT01458574|2852666|P2|Overall Study|Withdrawal by Subject|3
865240|NCT01458574|2852667|P1|Overall Study|Withdrawal by Subject|6
865241|NCT01458574|2852665|P3|Overall Study|Protocol Violation|0
865242|NCT01458574|2852666|P2|Overall Study|Protocol Violation|1
865243|NCT01458574|2852667|P1|Overall Study|Protocol Violation|0
865244|NCT01458574|2852665|P3|Overall Study|Pregnancy|0
865245|NCT01458574|2852666|P2|Overall Study|Pregnancy|1
865246|NCT01458574|2852667|P1|Overall Study|Pregnancy|1
865247|NCT01458574|2852665|P3|Overall Study|Lost to Follow-up|1
865248|NCT01458574|2852666|P2|Overall Study|Lost to Follow-up|2
865249|NCT01458574|2852667|P1|Overall Study|Lost to Follow-up|3
865250|NCT01458574|2852665|P3|Overall Study|Lack of Efficacy|132
865251|NCT01458574|2852666|P2|Overall Study|Lack of Efficacy|53
865252|NCT01458574|2852667|P1|Overall Study|Lack of Efficacy|70
865253|NCT01458574|2852665|P3|Overall Study|Adverse Event|7
865254|NCT01458574|2852666|P2|Overall Study|Adverse Event|9
865255|NCT01458574|2852667|P1|Overall Study|Adverse Event|5
865256|NCT01458535|2852797|P6|Overall Study|Adverse Event|0
865257|NCT01458535|2852798|P5|Overall Study|Adverse Event|0
865258|NCT01458535|2852799|P4|Overall Study|Adverse Event|1
865259|NCT01458535|2852800|P3|Overall Study|Adverse Event|0
865260|NCT01458535|2852801|P2|Overall Study|Adverse Event|0
865261|NCT01458535|2852802|P1|Overall Study|Adverse Event|0
865262|NCT01458535|2852797|P6|Overall Study|Lost to Follow-up|2
865263|NCT01458535|2852798|P5|Overall Study|Lost to Follow-up|2
865264|NCT01458535|2852799|P4|Overall Study|Lost to Follow-up|3
865265|NCT01458535|2852800|P3|Overall Study|Lost to Follow-up|0
865266|NCT01458535|2852801|P2|Overall Study|Lost to Follow-up|2
865267|NCT01458535|2852802|P1|Overall Study|Lost to Follow-up|0
865268|NCT01458535|2852797|P6|Overall Study|Withdrawal by Subject|1
865269|NCT01458535|2852798|P5|Overall Study|Withdrawal by Subject|1
865270|NCT01458535|2852799|P4|Overall Study|Withdrawal by Subject|0
865271|NCT01458535|2852800|P3|Overall Study|Withdrawal by Subject|2
865272|NCT01458535|2852801|P2|Overall Study|Withdrawal by Subject|0
865273|NCT01458535|2852802|P1|Overall Study|Withdrawal by Subject|0
865274|NCT01458535|2852797|P6|Overall Study|Other|1
865275|NCT01458535|2852798|P5|Overall Study|Other|1
865276|NCT01458535|2852799|P4|Overall Study|Other|0
865277|NCT01458535|2852800|P3|Overall Study|Other|0
865278|NCT01458535|2852801|P2|Overall Study|Other|0
865279|NCT01458535|2852802|P1|Overall Study|Other|0
865280|NCT01458522|2852854|P2|Overall Study|Physician Decision|9
865281|NCT01458522|2852855|P1|Overall Study|Physician Decision|1
865282|NCT01458522|2852854|P2|Overall Study|Withdrawal by Subject|2
865283|NCT01458522|2852855|P1|Overall Study|Withdrawal by Subject|2
865284|NCT01458392|2852884|P3|Overall Study|Patient unwilling to comply with protoco|2
865285|NCT01458392|2852885|P2|Overall Study|Patient unwilling to comply with protoco|0
865286|NCT01458392|2852886|P1|Overall Study|Patient unwilling to comply with protoco|0
865287|NCT01458392|2852884|P3|Overall Study|At the discretion of the sponsor|7
865288|NCT01458392|2852885|P2|Overall Study|At the discretion of the sponsor|2
865289|NCT01458392|2852886|P1|Overall Study|At the discretion of the sponsor|0
865290|NCT01458392|2852884|P3|Overall Study|Death|22
865291|NCT01458392|2852885|P2|Overall Study|Death|11
865292|NCT01458392|2852886|P1|Overall Study|Death|2
865293|NCT01458275|2852918|P3|Overall Study|Withdrawal by Subject|1
865294|NCT01458275|2852919|P2|Overall Study|Withdrawal by Subject|2
865295|NCT01458275|2852920|P1|Overall Study|Withdrawal by Subject|3
865296|NCT01458275|2852918|P3|Overall Study|Protocol Violation|2
865297|NCT01458275|2852919|P2|Overall Study|Protocol Violation|5
865298|NCT01458275|2852920|P1|Overall Study|Protocol Violation|5
865299|NCT01458275|2852918|P3|Overall Study|Lost to Follow-up|5
865300|NCT01458275|2852919|P2|Overall Study|Lost to Follow-up|2
865301|NCT01458275|2852920|P1|Overall Study|Lost to Follow-up|3
865302|NCT01458275|2852918|P3|Overall Study|Adverse Event|1
865303|NCT01458275|2852919|P2|Overall Study|Adverse Event|4
865304|NCT01458275|2852920|P1|Overall Study|Adverse Event|3
865305|NCT01458249|2852962|P1|Overall Study|Ongoing|1
865306|NCT01458249|2852962|P1|Overall Study|Not specified|2
865307|NCT01458249|2852962|P1|Overall Study|Adverse Event|4
865308|NCT01458249|2852962|P1|Overall Study|Not treated|1
865309|NCT01458210|2852981|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1
865310|NCT01458210|2852981|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2
865311|NCT01458210|2852981|P1|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2
865312|NCT01458210|2852981|P1|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2
865313|NCT01458171|2852998|P1|Overall Study|Adverse Event|1
865314|NCT01458119|2853019|P1|Overall Study|Non-compliance With Study Drug|3
865315|NCT01458119|2853019|P1|Overall Study|Consent Withdrawn by Participant|8
865316|NCT01458119|2853019|P1|Overall Study|Adverse Event|1
865317|NCT01458119|2853019|P1|Overall Study|Death|2
865318|NCT01458119|2853019|P1|Overall Study|Pregnancy|1
865319|NCT01458119|2853019|P1|Overall Study|Withdrawal Due to Nonamenable Mutation|1
865320|NCT01458119|2853019|P1|Overall Study|Physician Decision|4
865321|NCT01458106|2853026|P2|Overall Study|Withdrawn Per Protocol|1
865322|NCT01458106|2853027|P1|Overall Study|Withdrawn Per Protocol|0
865323|NCT01458106|2853026|P2|Overall Study|Pre-rFVIIIFc Adverse Event|0
865324|NCT01458106|2853027|P1|Overall Study|Pre-rFVIIIFc Adverse Event|1
865325|NCT01458106|2853026|P2|Overall Study|Withdrawal by Subject|0
865326|NCT01458106|2853027|P1|Overall Study|Withdrawal by Subject|2
865327|NCT01457950|2853104|P4|Open-Label Phase|Withdrawal by Subject|0
865328|NCT01457950|2853105|P3|Open-Label Phase|Withdrawal by Subject|2
865329|NCT01457950|2853106|P2|Open-Label Phase|Withdrawal by Subject|0
865330|NCT01457950|2853107|P1|Open-Label Phase|Withdrawal by Subject|0
865331|NCT01457950|2853104|P4|Open-Label Phase|Protocol Violation|1
865332|NCT01457950|2853105|P3|Open-Label Phase|Protocol Violation|0
865333|NCT01457950|2853106|P2|Open-Label Phase|Protocol Violation|0
865334|NCT01457950|2853107|P1|Open-Label Phase|Protocol Violation|0
865335|NCT01457950|2853104|P4|Open-Label Phase|Adverse Event|1
865336|NCT01457950|2853105|P3|Open-Label Phase|Adverse Event|0
865337|NCT01457950|2853106|P2|Open-Label Phase|Adverse Event|0
865338|NCT01457950|2853107|P1|Open-Label Phase|Adverse Event|0
865339|NCT01457950|2853104|P4|Double-Blind Phase|Withdrawal by Subject|0
865340|NCT01457950|2853105|P3|Double-Blind Phase|Withdrawal by Subject|0
865341|NCT01457950|2853106|P2|Double-Blind Phase|Withdrawal by Subject|2
865342|NCT01457950|2853107|P1|Double-Blind Phase|Withdrawal by Subject|6
865343|NCT01457950|2853104|P4|Double-Blind Phase|Protocol Violation|0
865344|NCT01457950|2853105|P3|Double-Blind Phase|Protocol Violation|0
865345|NCT01457950|2853106|P2|Double-Blind Phase|Protocol Violation|1
865346|NCT01457950|2853107|P1|Double-Blind Phase|Protocol Violation|2
865347|NCT01457950|2853104|P4|Double-Blind Phase|Continuation Criteria Not Met|0
865348|NCT01457950|2853105|P3|Double-Blind Phase|Continuation Criteria Not Met|0
865349|NCT01457950|2853106|P2|Double-Blind Phase|Continuation Criteria Not Met|0
865350|NCT01457950|2853107|P1|Double-Blind Phase|Continuation Criteria Not Met|1
865351|NCT01457924|2853186|P5|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
865352|NCT01457924|2853187|P4|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2
865353|NCT01457924|2853188|P3|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
865354|NCT01457924|2853189|P2|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0
865355|NCT01457924|2853190|P1|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
865356|NCT01457924|2853186|P5|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5
865357|NCT01457924|2853187|P4|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
865358|NCT01457924|2853188|P3|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2
865359|NCT01457924|2853189|P2|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4
865360|NCT01457924|2853190|P1|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
865361|NCT01457924|2853186|P5|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
865362|NCT01457924|2853187|P4|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
865363|NCT01457924|2853188|P3|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
865364|NCT01457924|2853189|P2|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
865365|NCT01457924|2853190|P1|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
865366|NCT01457924|2853186|P5|FUP (Weeks 24-48)|Withdrawal by Subject|2
865367|NCT01457924|2853187|P4|FUP (Weeks 24-48)|Withdrawal by Subject|0
865368|NCT01457924|2853188|P3|FUP (Weeks 24-48)|Withdrawal by Subject|0
865369|NCT01457924|2853189|P2|FUP (Weeks 24-48)|Withdrawal by Subject|1
865370|NCT01457924|2853190|P1|FUP (Weeks 24-48)|Withdrawal by Subject|2
865371|NCT01457924|2853186|P5|FUP (Weeks 24-48)|Lost to Follow-up|0
865372|NCT01457924|2853187|P4|FUP (Weeks 24-48)|Lost to Follow-up|1
865373|NCT01457924|2853188|P3|FUP (Weeks 24-48)|Lost to Follow-up|0
865374|NCT01457924|2853189|P2|FUP (Weeks 24-48)|Lost to Follow-up|0
865375|NCT01457924|2853190|P1|FUP (Weeks 24-48)|Lost to Follow-up|0
865376|NCT01457924|2853186|P5|FUP (Weeks 24-48)|Physician Decision|0
865377|NCT01457924|2853187|P4|FUP (Weeks 24-48)|Physician Decision|0
865378|NCT01457924|2853188|P3|FUP (Weeks 24-48)|Physician Decision|1
865379|NCT01457924|2853189|P2|FUP (Weeks 24-48)|Physician Decision|0
865380|NCT01457924|2853190|P1|FUP (Weeks 24-48)|Physician Decision|1
865381|NCT01457924|2853186|P5|FUP (Weeks 24-48)|Adverse Event|0
865382|NCT01457924|2853187|P4|FUP (Weeks 24-48)|Adverse Event|0
865383|NCT01457924|2853188|P3|FUP (Weeks 24-48)|Adverse Event|1
865384|NCT01457924|2853189|P2|FUP (Weeks 24-48)|Adverse Event|0
865385|NCT01457924|2853190|P1|FUP (Weeks 24-48)|Adverse Event|0
865386|NCT01457924|2853186|P5|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2
865387|NCT01457924|2853187|P4|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
865388|NCT01457924|2853188|P3|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
865389|NCT01457924|2853189|P2|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
865390|NCT01457924|2853190|P1|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
865391|NCT01457924|2853186|P5|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
865392|NCT01457924|2853187|P4|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
865393|NCT01457924|2853188|P3|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
865394|NCT01457924|2853189|P2|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
865395|NCT01457924|2853190|P1|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
865396|NCT01457924|2853186|P5|Treatment Phase (Weeks 0-24)|Protocol Violation|0
865397|NCT01457924|2853187|P4|Treatment Phase (Weeks 0-24)|Protocol Violation|0
865398|NCT01457924|2853188|P3|Treatment Phase (Weeks 0-24)|Protocol Violation|1
865399|NCT01457924|2853189|P2|Treatment Phase (Weeks 0-24)|Protocol Violation|0
865400|NCT01457924|2853190|P1|Treatment Phase (Weeks 0-24)|Protocol Violation|1
865401|NCT01457924|2853186|P5|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
865402|NCT01457924|2853187|P4|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
865403|NCT01457924|2853188|P3|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
865404|NCT01457924|2853189|P2|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
865405|NCT01457924|2853190|P1|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1
865406|NCT01457924|2853186|P5|Treatment Phase (Weeks 0-24)|Physician Decision|1
865407|NCT01457924|2853187|P4|Treatment Phase (Weeks 0-24)|Physician Decision|0
865408|NCT01457924|2853188|P3|Treatment Phase (Weeks 0-24)|Physician Decision|0
865409|NCT01457924|2853189|P2|Treatment Phase (Weeks 0-24)|Physician Decision|0
865410|NCT01457924|2853190|P1|Treatment Phase (Weeks 0-24)|Physician Decision|0
865411|NCT01457924|2853186|P5|Treatment Phase (Weeks 0-24)|Adverse Event|2
865412|NCT01457924|2853187|P4|Treatment Phase (Weeks 0-24)|Adverse Event|0
865413|NCT01457924|2853188|P3|Treatment Phase (Weeks 0-24)|Adverse Event|1
865414|NCT01457924|2853189|P2|Treatment Phase (Weeks 0-24)|Adverse Event|4
865415|NCT01457924|2853190|P1|Treatment Phase (Weeks 0-24)|Adverse Event|0
865416|NCT01457846|2853260|P2|Overall Study|Lost to Follow-up|0
865417|NCT01457846|2853261|P1|Overall Study|Lost to Follow-up|1
865418|NCT01457846|2853260|P2|Overall Study|Withdrawal by Subject|1
865419|NCT01457846|2853261|P1|Overall Study|Withdrawal by Subject|1
865420|NCT01457846|2853260|P2|Overall Study|Unclassified reason for not completed|10
865421|NCT01457846|2853261|P1|Overall Study|Unclassified reason for not completed|11
865422|NCT01457846|2853260|P2|Overall Study|Death|16
865423|NCT01457846|2853261|P1|Overall Study|Death|27
865424|NCT01457846|2853260|P2|Overall Study|Did not receive treatment|1
865425|NCT01457846|2853261|P1|Overall Study|Did not receive treatment|0
865426|NCT01457846|2853260|P2|Overall Study|Death before treatment|2
865427|NCT01457846|2853261|P1|Overall Study|Death before treatment|1
865428|NCT01457703|2853277|P2|Overall Study|Withdrawal by Subject|4
865429|NCT01457703|2853278|P1|Overall Study|Withdrawal by Subject|1
865430|NCT01457703|2853277|P2|Overall Study|Screen Failure|7
865431|NCT01457703|2853278|P1|Overall Study|Screen Failure|5
865432|NCT01457339|2853389|P2|Period 6 (250 mg)|Personal appointment|1
865433|NCT01457339|2853390|P1|Period 6 (250 mg)|Personal appointment|0
865434|NCT01457339|2853389|P2|Period 6 (250 mg)|Family Emergency|0
865435|NCT01457339|2853390|P1|Period 6 (250 mg)|Family Emergency|1
865436|NCT01457339|2853389|P2|Period 5 (200 mg)|Met stopping criteria for PANSS score|1
865437|NCT01457339|2853390|P1|Period 5 (200 mg)|Met stopping criteria for PANSS score|0
865438|NCT01457339|2853389|P2|Period 3 (100 mg)|Adverse Event|1
865439|NCT01457339|2853390|P1|Period 3 (100 mg)|Adverse Event|0
865440|NCT01457053|2853556|P2|Overall Study|Unable to undergo selected treatment|1
865441|NCT01457053|2853557|P1|Overall Study|Unable to undergo selected treatment|1
865442|NCT01457014|2853563|P4|First Night|Withdrawal by Subject|0
865443|NCT01457014|2853564|P3|First Night|Withdrawal by Subject|0
865444|NCT01457014|2853565|P2|First Night|Withdrawal by Subject|0
865445|NCT01457014|2853566|P1|First Night|Withdrawal by Subject|3
865446|NCT01457014|2853563|P4|First Night|Didn't meet inclusion/exclusion criteria|0
865447|NCT01457014|2853564|P3|First Night|Didn't meet inclusion/exclusion criteria|0
865448|NCT01457014|2853565|P2|First Night|Didn't meet inclusion/exclusion criteria|0
865449|NCT01457014|2853566|P1|First Night|Didn't meet inclusion/exclusion criteria|37
865450|NCT01456962|2853583|P2|Overall Study|Lost to Follow-up|1
865451|NCT01456962|2853584|P1|Overall Study|Lost to Follow-up|2
865452|NCT01456936|2853594|P4|Overall Study|Randomized but not treated|21
865453|NCT01456936|2853595|P3|Overall Study|Randomized but not treated|16
865454|NCT01456936|2853596|P2|Overall Study|Randomized but not treated|28
865455|NCT01456936|2853597|P1|Overall Study|Randomized but not treated|21
865456|NCT01456936|2853594|P4|Overall Study|Death|3
865457|NCT01456936|2853595|P3|Overall Study|Death|1
865458|NCT01456936|2853596|P2|Overall Study|Death|3
865459|NCT01456936|2853597|P1|Overall Study|Death|0
865460|NCT01456936|2853594|P4|Overall Study|Adverse event (study drug unrelated)|9
865461|NCT01456936|2853595|P3|Overall Study|Adverse event (study drug unrelated)|9
865462|NCT01456936|2853596|P2|Overall Study|Adverse event (study drug unrelated)|7
865463|NCT01456936|2853597|P1|Overall Study|Adverse event (study drug unrelated)|9
865464|NCT01456936|2853594|P4|Overall Study|Adverse event (study drug)|17
865465|NCT01456936|2853595|P3|Overall Study|Adverse event (study drug)|26
865466|NCT01456936|2853596|P2|Overall Study|Adverse event (study drug)|21
865467|NCT01456936|2853597|P1|Overall Study|Adverse event (study drug)|25
865468|NCT01456936|2853594|P4|Overall Study|Medication error|1
865469|NCT01456936|2853595|P3|Overall Study|Medication error|0
865470|NCT01456936|2853596|P2|Overall Study|Medication error|1
865471|NCT01456936|2853597|P1|Overall Study|Medication error|0
865472|NCT01456936|2853594|P4|Overall Study|Lost to Follow-up|127
865473|NCT01456936|2853595|P3|Overall Study|Lost to Follow-up|144
865474|NCT01456936|2853596|P2|Overall Study|Lost to Follow-up|126
865475|NCT01456936|2853597|P1|Overall Study|Lost to Follow-up|135
865476|NCT01456936|2853594|P4|Overall Study|No longer willing to participate|248
865477|NCT01456936|2853595|P3|Overall Study|No longer willing to participate|224
865478|NCT01456936|2853596|P2|Overall Study|No longer willing to participate|218
865479|NCT01456936|2853597|P1|Overall Study|No longer willing to participate|195
865480|NCT01456936|2853594|P4|Overall Study|Insufficient clinical response|13
865481|NCT01456936|2853595|P3|Overall Study|Insufficient clinical response|14
865482|NCT01456936|2853596|P2|Overall Study|Insufficient clinical response|4
865483|NCT01456936|2853597|P1|Overall Study|Insufficient clinical response|4
865484|NCT01456936|2853594|P4|Overall Study|Pregnancy|1
865485|NCT01456936|2853595|P3|Overall Study|Pregnancy|0
865486|NCT01456936|2853596|P2|Overall Study|Pregnancy|0
865487|NCT01456936|2853597|P1|Overall Study|Pregnancy|1
865488|NCT01456936|2853594|P4|Overall Study|Protocol Violation|5
865489|NCT01456936|2853595|P3|Overall Study|Protocol Violation|5
865490|NCT01456936|2853596|P2|Overall Study|Protocol Violation|2
865491|NCT01456936|2853597|P1|Overall Study|Protocol Violation|4
865492|NCT01456936|2853594|P4|Overall Study|No longer meets eligibility criteria|5
865493|NCT01456936|2853595|P3|Overall Study|No longer meets eligibility criteria|6
865494|NCT01456936|2853596|P2|Overall Study|No longer meets eligibility criteria|8
865495|NCT01456936|2853597|P1|Overall Study|No longer meets eligibility criteria|4
865496|NCT01456936|2853594|P4|Overall Study|Other reason|33
865497|NCT01456936|2853595|P3|Overall Study|Other reason|36
865498|NCT01456936|2853596|P2|Overall Study|Other reason|30
865499|NCT01456936|2853597|P1|Overall Study|Other reason|41
865500|NCT01456780|2853706|P3|Overall Study|Lost to Follow-up|0
865501|NCT01456780|2853707|P2|Overall Study|Lost to Follow-up|3
865502|NCT01456780|2853708|P1|Overall Study|Lost to Follow-up|3
865503|NCT01456195|2853741|P3|Overall Study|Other Reasons|3
865504|NCT01456195|2853742|P2|Overall Study|Other Reasons|1
865505|NCT01456195|2853743|P1|Overall Study|Other Reasons|2
865506|NCT01456195|2853741|P3|Overall Study|Lack of Efficacy|0
865507|NCT01456195|2853742|P2|Overall Study|Lack of Efficacy|1
865508|NCT01456195|2853743|P1|Overall Study|Lack of Efficacy|0
865509|NCT01456195|2853741|P3|Overall Study|Voluntary Withdrawal|7
865510|NCT01456195|2853742|P2|Overall Study|Voluntary Withdrawal|3
865511|NCT01456195|2853743|P1|Overall Study|Voluntary Withdrawal|5
865512|NCT01456195|2853741|P3|Overall Study|Lost to Follow-up|3
865513|NCT01456195|2853742|P2|Overall Study|Lost to Follow-up|1
865514|NCT01456195|2853743|P1|Overall Study|Lost to Follow-up|3
865515|NCT01456195|2853741|P3|Overall Study|Pretreatment Event/Adverse Event|1
865516|NCT01456195|2853742|P2|Overall Study|Pretreatment Event/Adverse Event|4
865517|NCT01456195|2853743|P1|Overall Study|Pretreatment Event/Adverse Event|1
865518|NCT01456169|2853763|P3|Overall Study|Other|0
865519|NCT01456169|2853764|P2|Overall Study|Other|1
865520|NCT01456169|2853765|P1|Overall Study|Other|1
865521|NCT01456169|2853763|P3|Overall Study|Lack of Efficacy|0
865522|NCT01456169|2853764|P2|Overall Study|Lack of Efficacy|0
865523|NCT01456169|2853765|P1|Overall Study|Lack of Efficacy|2
865524|NCT01456169|2853763|P3|Overall Study|Voluntary Withdrawal|2
865525|NCT01456169|2853764|P2|Overall Study|Voluntary Withdrawal|0
865526|NCT01456169|2853765|P1|Overall Study|Voluntary Withdrawal|3
865527|NCT01456169|2853763|P3|Overall Study|Major Protocol Deviation|3
865528|NCT01456169|2853764|P2|Overall Study|Major Protocol Deviation|2
865529|NCT01456169|2853765|P1|Overall Study|Major Protocol Deviation|3
865530|NCT01456169|2853763|P3|Overall Study|Adverse Event|7
865531|NCT01456169|2853764|P2|Overall Study|Adverse Event|2
865532|NCT01456169|2853765|P1|Overall Study|Adverse Event|1
865533|NCT01456130|2853825|P1|Overall Study|Other|1
865534|NCT01456130|2853825|P1|Overall Study|Lack of Efficacy|4
865535|NCT01456130|2853825|P1|Overall Study|Voluntary Withdrawal|1
865536|NCT01456130|2853825|P1|Overall Study|Adverse Event|4
865537|NCT01456052|2853835|P3|Overall Study|Treatment Failure|1
865538|NCT01456052|2853836|P2|Overall Study|Treatment Failure|1
865539|NCT01456052|2853837|P1|Overall Study|Treatment Failure|0
865540|NCT01456052|2853835|P3|Overall Study|Physician Decision|1
865541|NCT01456052|2853836|P2|Overall Study|Physician Decision|0
865542|NCT01456052|2853837|P1|Overall Study|Physician Decision|1
865543|NCT01456052|2853835|P3|Overall Study|Protocol Violation|0
865544|NCT01456052|2853836|P2|Overall Study|Protocol Violation|1
865545|NCT01456052|2853837|P1|Overall Study|Protocol Violation|0
865546|NCT01456052|2853835|P3|Overall Study|Consent withdrawn|1
865547|NCT01456052|2853836|P2|Overall Study|Consent withdrawn|2
865548|NCT01456052|2853837|P1|Overall Study|Consent withdrawn|0
865549|NCT01456052|2853835|P3|Overall Study|Adverse Event|2
865550|NCT01456052|2853836|P2|Overall Study|Adverse Event|1
865551|NCT01456052|2853837|P1|Overall Study|Adverse Event|1
865552|NCT01456039|2853857|P3|Phase 2 (Second Step)|Other|1
865553|NCT01456039|2853858|P2|Phase 2 (Second Step)|Other|0
865554|NCT01456039|2853859|P1|Phase 2 (Second Step)|Other|0
865555|NCT01456039|2853857|P3|Phase 2 (Second Step)|Protocol Violation|1
865556|NCT01456039|2853858|P2|Phase 2 (Second Step)|Protocol Violation|0
865557|NCT01456039|2853859|P1|Phase 2 (Second Step)|Protocol Violation|0
865558|NCT01456039|2853857|P3|Phase 2 (Second Step)|Withdrawal by Subject|4
865559|NCT01456039|2853858|P2|Phase 2 (Second Step)|Withdrawal by Subject|0
865560|NCT01456039|2853859|P1|Phase 2 (Second Step)|Withdrawal by Subject|0
865561|NCT01456039|2853857|P3|Phase 2 (Second Step)|Adverse Event|10
865562|NCT01456039|2853858|P2|Phase 2 (Second Step)|Adverse Event|0
865563|NCT01456039|2853859|P1|Phase 2 (Second Step)|Adverse Event|0
865564|NCT01456039|2853857|P3|Phase 2 (Second Step)|Disease Progression|17
865565|NCT01456039|2853858|P2|Phase 2 (Second Step)|Disease Progression|0
865566|NCT01456039|2853859|P1|Phase 2 (Second Step)|Disease Progression|0
865567|NCT01456039|2853857|P3|Phase 1 (First Step)|Not specified|0
865568|NCT01456039|2853858|P2|Phase 1 (First Step)|Not specified|1
865569|NCT01456039|2853859|P1|Phase 1 (First Step)|Not specified|0
865570|NCT01456039|2853857|P3|Phase 1 (First Step)|Adverse Event|0
865571|NCT01456039|2853858|P2|Phase 1 (First Step)|Adverse Event|3
865572|NCT01456039|2853859|P1|Phase 1 (First Step)|Adverse Event|0
865573|NCT01456039|2853857|P3|Phase 1 (First Step)|Withdrawal by Subject|0
865574|NCT01456039|2853858|P2|Phase 1 (First Step)|Withdrawal by Subject|2
865575|NCT01456039|2853859|P1|Phase 1 (First Step)|Withdrawal by Subject|1
865576|NCT01456039|2853857|P3|Phase 1 (First Step)|Disease Progression|0
865577|NCT01456039|2853858|P2|Phase 1 (First Step)|Disease Progression|1
865578|NCT01456039|2853859|P1|Phase 1 (First Step)|Disease Progression|1
865579|NCT01455428|2854002|P2|Overall Study|Other|4
865580|NCT01455428|2854003|P1|Overall Study|Other|2
865581|NCT01455428|2854002|P2|Overall Study|Did not receive treatment|1
865582|NCT01455428|2854003|P1|Overall Study|Did not receive treatment|1
865583|NCT01455428|2854002|P2|Overall Study|Insufficient clinical response|2
865584|NCT01455428|2854003|P1|Overall Study|Insufficient clinical response|0
865585|NCT01455428|2854002|P2|Overall Study|Did not meet entrance criteria|2
865586|NCT01455428|2854003|P1|Overall Study|Did not meet entrance criteria|0
865587|NCT01455428|2854002|P2|Overall Study|Withdrawal by Subject|5
865588|NCT01455428|2854003|P1|Overall Study|Withdrawal by Subject|2
865589|NCT01455428|2854002|P2|Overall Study|Lost to Follow-up|1
865590|NCT01455428|2854003|P1|Overall Study|Lost to Follow-up|1
865591|NCT01455428|2854002|P2|Overall Study|Adverse Event|2
865592|NCT01455428|2854003|P1|Overall Study|Adverse Event|6
865593|NCT01455428|2854002|P2|Overall Study|Protocol Violation|1
865594|NCT01455428|2854003|P1|Overall Study|Protocol Violation|2
865595|NCT01455415|2854059|P2|Follow-up|Unspecified Reason|0
865596|NCT01455415|2854060|P1|Follow-up|Unspecified Reason|1
865597|NCT01455415|2854059|P2|Follow-up|Withdrawal by Subject|0
865598|NCT01455415|2854060|P1|Follow-up|Withdrawal by Subject|2
865599|NCT01455415|2854059|P2|Follow-up|Lack of Efficacy|1
865600|NCT01455415|2854060|P1|Follow-up|Lack of Efficacy|0
865601|NCT01455415|2854059|P2|Follow-up|AE Related to Study Drug|1
865602|NCT01455415|2854060|P1|Follow-up|AE Related to Study Drug|0
865603|NCT01455415|2854059|P2|Period 2|Protocol Violation|0
865604|NCT01455415|2854060|P1|Period 2|Protocol Violation|2
865605|NCT01455415|2854059|P2|Period 2|Unspecified Reason|3
865606|NCT01455415|2854060|P1|Period 2|Unspecified Reason|2
865607|NCT01455415|2854059|P2|Period 2|Withdrawal by Subject|3
865608|NCT01455415|2854060|P1|Period 2|Withdrawal by Subject|2
865609|NCT01455415|2854059|P2|Period 2|Lack of Efficacy|0
865610|NCT01455415|2854060|P1|Period 2|Lack of Efficacy|2
865611|NCT01455415|2854059|P2|Period 2|AE Not Related to Study Drug|1
865612|NCT01455415|2854060|P1|Period 2|AE Not Related to Study Drug|2
865613|NCT01455415|2854059|P2|Period 2|Lost to Follow-up|1
865614|NCT01455415|2854060|P1|Period 2|Lost to Follow-up|2
865615|NCT01455415|2854059|P2|Period 2|AE Related to Study Drug|2
865616|NCT01455415|2854060|P1|Period 2|AE Related to Study Drug|1
865617|NCT01455415|2854059|P2|Washout|Protocol Violation|1
865618|NCT01455415|2854060|P1|Washout|Protocol Violation|0
865619|NCT01455415|2854059|P2|Washout|Unspecified Reason|2
865620|NCT01455415|2854060|P1|Washout|Unspecified Reason|1
865621|NCT01455415|2854059|P2|Washout|AE Not Related to Study Drug|3
865622|NCT01455415|2854060|P1|Washout|AE Not Related to Study Drug|2
865623|NCT01455415|2854059|P2|Washout|Drug Error not Associated to AE|1
865624|NCT01455415|2854060|P1|Washout|Drug Error not Associated to AE|2
865625|NCT01455415|2854059|P2|Washout|Lost to Follow-up|0
865626|NCT01455415|2854060|P1|Washout|Lost to Follow-up|1
865627|NCT01455415|2854059|P2|Washout|AE Related to Study Drug|0
865628|NCT01455415|2854060|P1|Washout|AE Related to Study Drug|2
865629|NCT01455415|2854059|P2|Period 1|Protocol Violation|2
865630|NCT01455415|2854060|P1|Period 1|Protocol Violation|0
865631|NCT01455415|2854059|P2|Period 1|Unspecified Reason|1
865632|NCT01455415|2854060|P1|Period 1|Unspecified Reason|1
865633|NCT01455415|2854059|P2|Period 1|Withdrawal by Subject|5
865634|NCT01455415|2854060|P1|Period 1|Withdrawal by Subject|4
865635|NCT01455415|2854059|P2|Period 1|AE Not Related to Study Drug|6
865636|NCT01455415|2854060|P1|Period 1|AE Not Related to Study Drug|2
865637|NCT01455415|2854059|P2|Period 1|Drug Error not Associated to AE|1
865638|NCT01455415|2854060|P1|Period 1|Drug Error not Associated to AE|0
865639|NCT01455415|2854059|P2|Period 1|Lost To Follow-up Related to Study Drug|3
865640|NCT01455415|2854060|P1|Period 1|Lost To Follow-up Related to Study Drug|3
865641|NCT01455415|2854059|P2|Period 1|Adverse Event (AE) Related to Study Drug|6
865642|NCT01455415|2854060|P1|Period 1|Adverse Event (AE) Related to Study Drug|9
865643|NCT01455220|2854110|P1|Overall Study|screen fail|30
865644|NCT01455194|2854120|P4|Overall Study|Miscellaneous|4
865645|NCT01455194|2854121|P3|Overall Study|Miscellaneous|1
865646|NCT01455194|2854122|P2|Overall Study|Miscellaneous|5
865647|NCT01455194|2854123|P1|Overall Study|Miscellaneous|4
865648|NCT01455194|2854120|P4|Overall Study|Discontinuation criterion fulfilled|2
865649|NCT01455194|2854121|P3|Overall Study|Discontinuation criterion fulfilled|0
865650|NCT01455194|2854122|P2|Overall Study|Discontinuation criterion fulfilled|2
865651|NCT01455194|2854123|P1|Overall Study|Discontinuation criterion fulfilled|3
865652|NCT01455194|2854120|P4|Overall Study|Pregnancy|0
865653|NCT01455194|2854121|P3|Overall Study|Pregnancy|1
865654|NCT01455194|2854122|P2|Overall Study|Pregnancy|1
865655|NCT01455194|2854123|P1|Overall Study|Pregnancy|0
865656|NCT01455194|2854120|P4|Overall Study|Lost to Follow-up|1
865657|NCT01455194|2854121|P3|Overall Study|Lost to Follow-up|1
865658|NCT01455194|2854122|P2|Overall Study|Lost to Follow-up|0
865659|NCT01455194|2854123|P1|Overall Study|Lost to Follow-up|2
865660|NCT01455194|2854120|P4|Overall Study|Withdrawal by Subject|9
865661|NCT01455194|2854121|P3|Overall Study|Withdrawal by Subject|12
865662|NCT01455194|2854122|P2|Overall Study|Withdrawal by Subject|16
865663|NCT01455194|2854123|P1|Overall Study|Withdrawal by Subject|21
865664|NCT01455194|2854120|P4|Overall Study|Adverse Event|3
865665|NCT01455194|2854121|P3|Overall Study|Adverse Event|1
865666|NCT01455194|2854122|P2|Overall Study|Adverse Event|1
865667|NCT01455194|2854123|P1|Overall Study|Adverse Event|1
865668|NCT01455194|2854120|P4|Overall Study|Deterioration in asthma|9
865669|NCT01455194|2854121|P3|Overall Study|Deterioration in asthma|14
865670|NCT01455194|2854122|P2|Overall Study|Deterioration in asthma|6
865671|NCT01455194|2854123|P1|Overall Study|Deterioration in asthma|12
865672|NCT01455194|2854120|P4|Overall Study|Randomisation Failure|0
865673|NCT01455194|2854121|P3|Overall Study|Randomisation Failure|0
865674|NCT01455194|2854122|P2|Overall Study|Randomisation Failure|0
865675|NCT01455194|2854123|P1|Overall Study|Randomisation Failure|90
865676|NCT01455194|2854120|P4|Overall Study|Screen Failure|0
865677|NCT01455194|2854121|P3|Overall Study|Screen Failure|0
865678|NCT01455194|2854122|P2|Overall Study|Screen Failure|0
865679|NCT01455194|2854123|P1|Overall Study|Screen Failure|20
865680|NCT01455012|2854186|P2|Overall Study|Unknown reason|0
865681|NCT01455012|2854187|P1|Overall Study|Unknown reason|2
865682|NCT01455012|2854186|P2|Overall Study|Withdrawal by Subject|1
865683|NCT01455012|2854187|P1|Overall Study|Withdrawal by Subject|3
865684|NCT01455012|2854186|P2|Overall Study|Lack of Efficacy|1
865685|NCT01455012|2854187|P1|Overall Study|Lack of Efficacy|6
865686|NCT01455012|2854186|P2|Overall Study|Adverse Event|2
865687|NCT01455012|2854187|P1|Overall Study|Adverse Event|0
865688|NCT01454934|2854254|P2|Overall Study|Ongoing, survival follow-up|2
865689|NCT01454934|2854255|P1|Overall Study|Ongoing, survival follow-up|1
865690|NCT01454934|2854254|P2|Overall Study|Not treated|2
865691|NCT01454934|2854255|P1|Overall Study|Not treated|1
865692|NCT01454934|2854254|P2|Overall Study|Not specified|16
865693|NCT01454934|2854255|P1|Overall Study|Not specified|5
865694|NCT01454934|2854254|P2|Overall Study|Clinical progression|25
865695|NCT01454934|2854255|P1|Overall Study|Clinical progression|28
865696|NCT01454934|2854254|P2|Overall Study|Withdrawn consent|5
865697|NCT01454934|2854255|P1|Overall Study|Withdrawn consent|2
865698|NCT01454934|2854254|P2|Overall Study|Lost to Follow-up|1
865699|NCT01454934|2854255|P1|Overall Study|Lost to Follow-up|0
865700|NCT01454934|2854254|P2|Overall Study|Withdrawal by Subject|15
865701|NCT01454934|2854255|P1|Overall Study|Withdrawal by Subject|11
865702|NCT01454934|2854254|P2|Overall Study|Adverse Event|24
865703|NCT01454934|2854255|P1|Overall Study|Adverse Event|28
865704|NCT01454934|2854254|P2|Overall Study|Disease progression|180
865705|NCT01454934|2854255|P1|Overall Study|Disease progression|194
865706|NCT01454830|2854267|P2|Overall Study|Withdrawal - no polysomnography|2
865707|NCT01454830|2854268|P1|Overall Study|Withdrawal - no polysomnography|3
865708|NCT01454830|2854267|P2|Overall Study|Post-allocation Exclude-other treatment|7
865709|NCT01454830|2854268|P1|Overall Study|Post-allocation Exclude-other treatment|6
865710|NCT01454830|2854267|P2|Overall Study|Post-allocation Exclude-refused PAP|2
865711|NCT01454830|2854268|P1|Overall Study|Post-allocation Exclude-refused PAP|0
865712|NCT01454830|2854267|P2|Overall Study|Post-allocation Exclude- AHI<10|12
865713|NCT01454830|2854268|P1|Overall Study|Post-allocation Exclude- AHI<10|18
865714|NCT01454830|2854267|P2|Overall Study|Withdrawal by Subject|4
865715|NCT01454830|2854268|P1|Overall Study|Withdrawal by Subject|4
865716|NCT01454778|2854299|P1|Overall Study|Death|1
865717|NCT01454778|2854299|P1|Overall Study|Lost to Follow-up|2
865718|NCT01454739|2854310|P2|Overall Study|Adverse Event|1
865719|NCT01454739|2854311|P1|Overall Study|Adverse Event|0
865720|NCT01454739|2854310|P2|Overall Study|Lost to Follow-up|1
865721|NCT01454739|2854311|P1|Overall Study|Lost to Follow-up|0
865722|NCT01454739|2854310|P2|Overall Study|Physician Decision|5
865723|NCT01454739|2854311|P1|Overall Study|Physician Decision|0
865724|NCT01454739|2854310|P2|Overall Study|Other|5
865725|NCT01454739|2854311|P1|Overall Study|Other|3
865726|NCT01454739|2854310|P2|Overall Study|Withdrawal by Subject|6
865727|NCT01454739|2854311|P1|Overall Study|Withdrawal by Subject|2
865728|NCT01454739|2854310|P2|Overall Study|Protocol Violation|3
865729|NCT01454739|2854311|P1|Overall Study|Protocol Violation|2
865730|NCT01454726|2854340|P2|Overall Study|Withdrawal by Subject|1
865731|NCT01454726|2854341|P1|Overall Study|Withdrawal by Subject|0
865732|NCT01454583|2854350|P3|3rd Year|Lost to Follow-up|297
865733|NCT01454583|2854351|P2|3rd Year|Lost to Follow-up|512
865734|NCT01454583|2854352|P1|3rd Year|Lost to Follow-up|1959
865735|NCT01454583|2854350|P3|2nd Year|Lost to Follow-up|737
865736|NCT01454583|2854351|P2|2nd Year|Lost to Follow-up|1049
865737|NCT01454583|2854352|P1|2nd Year|Lost to Follow-up|3965
865738|NCT01454583|2854350|P3|1st Year|Lost to Follow-up|180
865739|NCT01454583|2854351|P2|1st Year|Lost to Follow-up|318
865740|NCT01454583|2854352|P1|1st Year|Lost to Follow-up|1057
865741|NCT01454531|2854420|P1|Overall Study|Other|1
865742|NCT01454531|2854420|P1|Overall Study|Delay in IMP administration|1
865743|NCT01454531|2854420|P1|Overall Study|Physician Decision|1
865744|NCT01454531|2854420|P1|Overall Study|Lost to Follow-up|1
865745|NCT01454531|2854420|P1|Overall Study|Withdrawal by Subject|5
865746|NCT01454531|2854420|P1|Overall Study|Adverse Event|14
865747|NCT01454401|2854456|P1|Overall Study|non-adherence|1
865748|NCT01454401|2854456|P1|Overall Study|osteomyelitis|2
865749|NCT01454401|2854456|P1|Overall Study|hospitalised|1
865750|NCT01454401|2854456|P1|Overall Study|Death|1
865751|NCT01454284|2854463|P2|Overall Study|Sponsor Decision|2
865752|NCT01454284|2854464|P1|Overall Study|Sponsor Decision|0
865753|NCT01454284|2854463|P2|Overall Study|Physician Decision|11
865754|NCT01454284|2854464|P1|Overall Study|Physician Decision|16
865755|NCT01454284|2854463|P2|Overall Study|Withdrawal by Subject|36
865756|NCT01454284|2854464|P1|Overall Study|Withdrawal by Subject|58
865757|NCT01454284|2854463|P2|Overall Study|Protocol Violation|6
865758|NCT01454284|2854464|P1|Overall Study|Protocol Violation|9
865759|NCT01454284|2854463|P2|Overall Study|Lost to Follow-up|8
865760|NCT01454284|2854464|P1|Overall Study|Lost to Follow-up|13
865761|NCT01454284|2854463|P2|Overall Study|Death|3
865762|NCT01454284|2854464|P1|Overall Study|Death|0
865763|NCT01454284|2854463|P2|Overall Study|Adverse Event|7
865764|NCT01454284|2854464|P1|Overall Study|Adverse Event|20
865765|NCT01454076|2854523|P5|Overall Study|Adverse Event|2
865766|NCT01454076|2854524|P4|Overall Study|Adverse Event|0
865767|NCT01454076|2854525|P3|Overall Study|Adverse Event|7
865768|NCT01454076|2854526|P2|Overall Study|Adverse Event|2
865769|NCT01454076|2854527|P1|Overall Study|Adverse Event|8
865770|NCT01454076|2854523|P5|Overall Study|Withdrawal by Subject|2
865771|NCT01454076|2854524|P4|Overall Study|Withdrawal by Subject|1
865772|NCT01454076|2854525|P3|Overall Study|Withdrawal by Subject|2
865773|NCT01454076|2854526|P2|Overall Study|Withdrawal by Subject|4
865774|NCT01454076|2854527|P1|Overall Study|Withdrawal by Subject|3
865775|NCT01454076|2854523|P5|Overall Study|Other|2
865776|NCT01454076|2854524|P4|Overall Study|Other|1
865777|NCT01454076|2854525|P3|Overall Study|Other|0
865778|NCT01454076|2854526|P2|Overall Study|Other|0
865779|NCT01454076|2854527|P1|Overall Study|Other|2
865780|NCT01454063|2854580|P2|Randomized|Protocol Violation|1
865781|NCT01454063|2854581|P1|Randomized|Protocol Violation|0
865782|NCT01454063|2854580|P2|Randomized|Adverse Event|1
865783|NCT01454063|2854581|P1|Randomized|Adverse Event|1
865784|NCT01453998|2854602|P3|After Protocol Amendment 2.|Withdrawal by Subject|0
865785|NCT01453998|2854603|P2|After Protocol Amendment 2.|Withdrawal by Subject|0
865786|NCT01453998|2854604|P1|After Protocol Amendment 2.|Withdrawal by Subject|1
865787|NCT01453946|2854669|P1|Overall Study|Adverse Event|3
865788|NCT01453946|2854669|P1|Overall Study|Lack of Efficacy|3
865789|NCT01453946|2854669|P1|Overall Study|Protocol Violation|2
865790|NCT01453946|2854669|P1|Overall Study|Did not receive drug for the taper phase|1
865791|NCT01453855|2854686|P2|Overall Study|Other|1
865792|NCT01453855|2854687|P1|Overall Study|Other|0
865793|NCT01453855|2854686|P2|Overall Study|Inadequate Control of IOP|5
865794|NCT01453855|2854687|P1|Overall Study|Inadequate Control of IOP|1
865795|NCT01453855|2854686|P2|Overall Study|Noncompliance|0
865796|NCT01453855|2854687|P1|Overall Study|Noncompliance|1
865797|NCT01453855|2854686|P2|Overall Study|Patient Decision Unrel to Adverse Event|3
865798|NCT01453855|2854687|P1|Overall Study|Patient Decision Unrel to Adverse Event|3
865799|NCT01453855|2854686|P2|Overall Study|Lost to Follow-up|1
865800|NCT01453855|2854687|P1|Overall Study|Lost to Follow-up|2
865801|NCT01453855|2854686|P2|Overall Study|Adverse Event|4
865802|NCT01453855|2854687|P1|Overall Study|Adverse Event|3
865803|NCT01453725|2854695|P2|Overall Study|Physician Decision|1
865804|NCT01453725|2854696|P1|Overall Study|Physician Decision|1
865805|NCT01453725|2854695|P2|Overall Study|Pregnancy|0
865806|NCT01453725|2854696|P1|Overall Study|Pregnancy|1
865807|NCT01453725|2854695|P2|Overall Study|Pregnancy Wish|2
865808|NCT01453725|2854696|P1|Overall Study|Pregnancy Wish|0
865809|NCT01453725|2854695|P2|Overall Study|Withdrawal by Subject|3
865810|NCT01453725|2854696|P1|Overall Study|Withdrawal by Subject|2
865811|NCT01453725|2854695|P2|Overall Study|Protocol Violation|0
865812|NCT01453725|2854696|P1|Overall Study|Protocol Violation|1
865813|NCT01453725|2854695|P2|Overall Study|Non-compliance With Protocol|2
865814|NCT01453725|2854696|P1|Overall Study|Non-compliance With Protocol|1
865815|NCT01453725|2854695|P2|Overall Study|Lost to Follow-up|0
865816|NCT01453725|2854696|P1|Overall Study|Lost to Follow-up|4
865817|NCT01453725|2854695|P2|Overall Study|Adverse Event|3
865818|NCT01453725|2854696|P1|Overall Study|Adverse Event|3
865819|NCT01453595|2854719|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
865820|NCT01453595|2854720|P2|Overall Study|Dose Limiting Toxicity (DLT)|1
865821|NCT01453595|2854721|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
865822|NCT01453374|2854840|P1|Overall Study|Incarcerated|2
865823|NCT01453374|2854840|P1|Overall Study|Withdrawal by Subject|5
865824|NCT01453374|2854840|P1|Overall Study|Lost to Follow-up|3
865825|NCT01453374|2854840|P1|Overall Study|Lack of Efficacy|1
865826|NCT01453374|2854840|P1|Overall Study|Adverse Event|7
865827|NCT01453361|2854856|P1|Overall Study|Screen-Failures|10
865828|NCT01453361|2854856|P1|Overall Study|Disease Progression|6
865829|NCT01453348|2854864|P3|Overall Study|Protocol Violation|0
865830|NCT01453348|2854865|P2|Overall Study|Protocol Violation|0
865831|NCT01453348|2854866|P1|Overall Study|Protocol Violation|1
865832|NCT01453348|2854864|P3|Overall Study|Withdrawal by Subject|0
865833|NCT01453348|2854865|P2|Overall Study|Withdrawal by Subject|1
865834|NCT01453348|2854866|P1|Overall Study|Withdrawal by Subject|0
865835|NCT01453348|2854864|P3|Overall Study|Death|1
865836|NCT01453348|2854865|P2|Overall Study|Death|0
865837|NCT01453348|2854866|P1|Overall Study|Death|0
865838|NCT01453296|2854882|P2|Treatment Period 2|Withdrawal by Subject|0
865839|NCT01453296|2854883|P1|Treatment Period 2|Withdrawal by Subject|1
865840|NCT01453296|2854882|P2|Treatment Period 2|Adverse Event|0
865841|NCT01453296|2854883|P1|Treatment Period 2|Adverse Event|1
865842|NCT01453296|2854882|P2|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0
865843|NCT01453296|2854883|P1|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1
865844|NCT01453296|2854882|P2|Treatment Period 1|Adverse Event|1
865845|NCT01453296|2854883|P1|Treatment Period 1|Adverse Event|0
865846|NCT01453205|2854950|P3|Overall Study|Other|35
865847|NCT01453205|2854951|P2|Overall Study|Other|27
865848|NCT01453205|2854952|P1|Overall Study|Other|45
865849|NCT01453205|2854950|P3|Overall Study|Death|18
865850|NCT01453205|2854951|P2|Overall Study|Death|22
865851|NCT01453205|2854952|P1|Overall Study|Death|24
865852|NCT01453205|2854950|P3|Overall Study|Withdrawal by Subject|0
865853|NCT01453205|2854951|P2|Overall Study|Withdrawal by Subject|3
865854|NCT01453205|2854952|P1|Overall Study|Withdrawal by Subject|8
865855|NCT01453205|2854950|P3|Overall Study|Lost to Follow-up|1
865856|NCT01453205|2854951|P2|Overall Study|Lost to Follow-up|0
865857|NCT01453205|2854952|P1|Overall Study|Lost to Follow-up|3
865858|NCT01453153|2855028|P3|Overall Study|Adverse Event|1
865859|NCT01453153|2855029|P2|Overall Study|Adverse Event|1
865860|NCT01453153|2855030|P1|Overall Study|Adverse Event|1
865861|NCT01453153|2855028|P3|Overall Study|Withdrawal by Subject|2
865862|NCT01453153|2855029|P2|Overall Study|Withdrawal by Subject|1
865863|NCT01453153|2855030|P1|Overall Study|Withdrawal by Subject|0
865864|NCT01453153|2855028|P3|Overall Study|Progressive Disease|16
865865|NCT01453153|2855029|P2|Overall Study|Progressive Disease|2
865866|NCT01453153|2855030|P1|Overall Study|Progressive Disease|3
865867|NCT01453153|2855028|P3|Overall Study|Physician Decision|1
865868|NCT01453153|2855029|P2|Overall Study|Physician Decision|0
865869|NCT01453153|2855030|P1|Overall Study|Physician Decision|0
865870|NCT01453049|2855112|P2|Overall Study|Randomized in Error|0
865871|NCT01453049|2855113|P1|Overall Study|Randomized in Error|1
865872|NCT01453049|2855112|P2|Overall Study|Withdrawal by Subject|0
865873|NCT01453049|2855113|P1|Overall Study|Withdrawal by Subject|1
865874|NCT01453049|2855112|P2|Overall Study|Withdrawn When Sponsor Terminated Study|36
865875|NCT01453049|2855113|P1|Overall Study|Withdrawn When Sponsor Terminated Study|35
865876|NCT01453049|2855112|P2|Overall Study|Lost to Follow-up|1
865877|NCT01453049|2855113|P1|Overall Study|Lost to Follow-up|2
865878|NCT01453049|2855112|P2|Overall Study|Protocol Violation|5
865879|NCT01453049|2855113|P1|Overall Study|Protocol Violation|2
865880|NCT01453036|2855186|P3|Overall Study|Lost to Follow-up|31
865881|NCT01453036|2855187|P2|Overall Study|Lost to Follow-up|115
865882|NCT01453036|2855188|P1|Overall Study|Lost to Follow-up|26
865883|NCT01453023|2855196|P2|Treatment Period 2|Protocol Violation|1
865884|NCT01453023|2855197|P1|Treatment Period 2|Protocol Violation|0
865885|NCT01453023|2855196|P2|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1
865886|NCT01453023|2855197|P1|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0
865887|NCT01453023|2855196|P2|Treatment Period (TP) 1|Protocol Violation|0
865888|NCT01453023|2855197|P1|Treatment Period (TP) 1|Protocol Violation|1
865889|NCT01452529|2855271|P3|Double-blind (DB) Period|Administrative|7
865890|NCT01452529|2855272|P2|Double-blind (DB) Period|Administrative|11
865891|NCT01452529|2855273|P1|Double-blind (DB) Period|Administrative|0
865892|NCT01452529|2855271|P3|Double-blind (DB) Period|Confirmed or suspected diversion|3
865893|NCT01452529|2855272|P2|Double-blind (DB) Period|Confirmed or suspected diversion|2
865894|NCT01452529|2855273|P1|Double-blind (DB) Period|Confirmed or suspected diversion|0
865895|NCT01452529|2855271|P3|Double-blind (DB) Period|Lack of Efficacy|44
865896|NCT01452529|2855272|P2|Double-blind (DB) Period|Lack of Efficacy|16
865897|NCT01452529|2855273|P1|Double-blind (DB) Period|Lack of Efficacy|0
865898|NCT01452529|2855271|P3|Double-blind (DB) Period|Lost to Follow-up|3
865899|NCT01452529|2855272|P2|Double-blind (DB) Period|Lost to Follow-up|5
865900|NCT01452529|2855273|P1|Double-blind (DB) Period|Lost to Follow-up|0
865901|NCT01452529|2855271|P3|Double-blind (DB) Period|Withdrawal by Subject|14
865902|NCT01452529|2855272|P2|Double-blind (DB) Period|Withdrawal by Subject|15
865903|NCT01452529|2855273|P1|Double-blind (DB) Period|Withdrawal by Subject|0
865904|NCT01452529|2855271|P3|Double-blind (DB) Period|Adverse Event|11
865905|NCT01452529|2855272|P2|Double-blind (DB) Period|Adverse Event|18
865906|NCT01452529|2855273|P1|Double-blind (DB) Period|Adverse Event|0
865907|NCT01452529|2855271|P3|Run-in Period|Did not qualify for Double-Blind Phase|0
865908|NCT01452529|2855272|P2|Run-in Period|Did not qualify for Double-Blind Phase|0
865909|NCT01452529|2855273|P1|Run-in Period|Did not qualify for Double-Blind Phase|59
865910|NCT01452529|2855271|P3|Run-in Period|Administrative|0
865911|NCT01452529|2855272|P2|Run-in Period|Administrative|0
865912|NCT01452529|2855273|P1|Run-in Period|Administrative|21
865913|NCT01452529|2855271|P3|Run-in Period|Confirmed or suspected diversion|0
865914|NCT01452529|2855272|P2|Run-in Period|Confirmed or suspected diversion|0
865915|NCT01452529|2855273|P1|Run-in Period|Confirmed or suspected diversion|23
865916|NCT01452529|2855271|P3|Run-in Period|Lack of Efficacy|0
865917|NCT01452529|2855272|P2|Run-in Period|Lack of Efficacy|0
865918|NCT01452529|2855273|P1|Run-in Period|Lack of Efficacy|46
865919|NCT01452529|2855271|P3|Run-in Period|Lost to Follow-up|0
865920|NCT01452529|2855272|P2|Run-in Period|Lost to Follow-up|0
865921|NCT01452529|2855273|P1|Run-in Period|Lost to Follow-up|19
865922|NCT01452529|2855271|P3|Run-in Period|Withdrawal by Subject|0
865923|NCT01452529|2855272|P2|Run-in Period|Withdrawal by Subject|0
865924|NCT01452529|2855273|P1|Run-in Period|Withdrawal by Subject|49
865925|NCT01452529|2855271|P3|Run-in Period|Adverse Event|0
865926|NCT01452529|2855272|P2|Run-in Period|Adverse Event|0
865927|NCT01452529|2855273|P1|Run-in Period|Adverse Event|96
865928|NCT01452347|2855295|P2|Overall Study|Other reason not defined above|0
865929|NCT01452347|2855296|P1|Overall Study|Other reason not defined above|2
865930|NCT01452347|2855295|P2|Overall Study|Not treated|3
865931|NCT01452347|2855296|P1|Overall Study|Not treated|6
865932|NCT01452347|2855295|P2|Overall Study|Withdrawal by Subject|3
865933|NCT01452347|2855296|P1|Overall Study|Withdrawal by Subject|3
865934|NCT01452347|2855295|P2|Overall Study|Lost to Follow-up|0
865935|NCT01452347|2855296|P1|Overall Study|Lost to Follow-up|2
865936|NCT01452347|2855295|P2|Overall Study|Non compliance protocol|0
865937|NCT01452347|2855296|P1|Overall Study|Non compliance protocol|2
865938|NCT01452347|2855295|P2|Overall Study|Adverse Event|1
865939|NCT01452347|2855296|P1|Overall Study|Adverse Event|2
865940|NCT01452152|2855328|P3|Overall Study|Study termination by sponsor|4
865941|NCT01452152|2855329|P2|Overall Study|Study termination by sponsor|0
865942|NCT01452152|2855330|P1|Overall Study|Study termination by sponsor|5
865943|NCT01451931|2855402|P3|Overall Study|Withdrawal by Subject|22
865944|NCT01451931|2855403|P2|Overall Study|Withdrawal by Subject|22
865945|NCT01451931|2855404|P1|Overall Study|Withdrawal by Subject|16
865946|NCT01451931|2855402|P3|Overall Study|Lost to Follow-up|21
865947|NCT01451931|2855403|P2|Overall Study|Lost to Follow-up|36
865948|NCT01451931|2855404|P1|Overall Study|Lost to Follow-up|17
865949|NCT01451827|2855428|P4|Overall Study|Withdrawal by Subject|1
865950|NCT01451827|2855429|P3|Overall Study|Withdrawal by Subject|1
865951|NCT01451827|2855430|P2|Overall Study|Withdrawal by Subject|0
865952|NCT01451827|2855431|P1|Overall Study|Withdrawal by Subject|0
865953|NCT01451827|2855428|P4|Overall Study|Participant met withdrawal criteria|0
865954|NCT01451827|2855429|P3|Overall Study|Participant met withdrawal criteria|0
865955|NCT01451827|2855430|P2|Overall Study|Participant met withdrawal criteria|2
865956|NCT01451827|2855431|P1|Overall Study|Participant met withdrawal criteria|0
865957|NCT01451827|2855428|P4|Overall Study|Lost to Follow-up|2
865958|NCT01451827|2855429|P3|Overall Study|Lost to Follow-up|0
865959|NCT01451827|2855430|P2|Overall Study|Lost to Follow-up|3
865960|NCT01451827|2855431|P1|Overall Study|Lost to Follow-up|0
865961|NCT01451827|2855428|P4|Overall Study|Protocol deviation|0
865962|NCT01451827|2855429|P3|Overall Study|Protocol deviation|0
865963|NCT01451827|2855430|P2|Overall Study|Protocol deviation|0
865964|NCT01451827|2855431|P1|Overall Study|Protocol deviation|1
865965|NCT01451827|2855428|P4|Overall Study|Adverse Event|1
865966|NCT01451827|2855429|P3|Overall Study|Adverse Event|1
865967|NCT01451827|2855430|P2|Overall Study|Adverse Event|0
865968|NCT01451827|2855431|P1|Overall Study|Adverse Event|2
865969|NCT01451814|2855451|P2|Overall Study|Lost to Follow-up|4
865970|NCT01451814|2855452|P1|Overall Study|Lost to Follow-up|5
865971|NCT01451814|2855451|P2|Overall Study|Withdrawal by Subject|1
865972|NCT01451814|2855452|P1|Overall Study|Withdrawal by Subject|1
865973|NCT01451762|2855484|P3|Overall Study|Lost to Follow-up|6
865974|NCT01451762|2855485|P2|Overall Study|Lost to Follow-up|6
865975|NCT01451762|2855486|P1|Overall Study|Lost to Follow-up|3
865976|NCT01451749|2855496|P2|Overall Study|Withdrawal by Subject|1
865977|NCT01451749|2855497|P1|Overall Study|Withdrawal by Subject|0
865978|NCT01451749|2855496|P2|Overall Study|Adverse Event|0
865979|NCT01451749|2855497|P1|Overall Study|Adverse Event|2
865980|NCT01451749|2855496|P2|Overall Study|Meet the exclusion criteria,and|1
865981|NCT01451749|2855497|P1|Overall Study|Meet the exclusion criteria,and|1
865982|NCT01451749|2855496|P2|Overall Study|Lost to Follow-up|5
865983|NCT01451749|2855497|P1|Overall Study|Lost to Follow-up|15
865984|NCT01451749|2855496|P2|Overall Study|Protocol Violation|7
865985|NCT01451749|2855497|P1|Overall Study|Protocol Violation|14
865986|NCT01451723|2855509|P2|Overall Study|study halted|5
865987|NCT01451723|2855510|P1|Overall Study|study halted|6
865988|NCT01451645|2855520|P2|Overall Study|Lost to Follow-up|3
865989|NCT01451645|2855521|P1|Overall Study|Lost to Follow-up|4
865990|NCT01451645|2855520|P2|Overall Study|Withdrawal by Subject|2
865991|NCT01451645|2855521|P1|Overall Study|Withdrawal by Subject|4
865992|NCT01451645|2855520|P2|Overall Study|Adverse Event|3
865993|NCT01451645|2855521|P1|Overall Study|Adverse Event|0
865994|NCT01451645|2855520|P2|Overall Study|Protocol Violation|0
865995|NCT01451645|2855521|P1|Overall Study|Protocol Violation|1
865996|NCT01451606|2855592|P2|Overall Study|Withdrawal by Subject|3
865997|NCT01451606|2855593|P1|Overall Study|Withdrawal by Subject|4
865998|NCT01451554|2855603|P2|Overall Study|Withdrawal by Subject|9
865999|NCT01451554|2855604|P1|Overall Study|Withdrawal by Subject|14
866000|NCT01451541|2855615|P3|Overall Study|randomization error, noncompliance|8
866001|NCT01451541|2855616|P2|Overall Study|randomization error, noncompliance|10
866002|NCT01451541|2855617|P1|Overall Study|randomization error, noncompliance|11
866003|NCT01451541|2855615|P3|Overall Study|Withdrawal by Subject|6
866004|NCT01451541|2855616|P2|Overall Study|Withdrawal by Subject|8
866005|NCT01451541|2855617|P1|Overall Study|Withdrawal by Subject|15
866006|NCT01451541|2855615|P3|Overall Study|Lost to Follow-up|7
866007|NCT01451541|2855616|P2|Overall Study|Lost to Follow-up|4
866008|NCT01451541|2855617|P1|Overall Study|Lost to Follow-up|4
866009|NCT01451541|2855615|P3|Overall Study|Lack of Efficacy|0
866010|NCT01451541|2855616|P2|Overall Study|Lack of Efficacy|0
866011|NCT01451541|2855617|P1|Overall Study|Lack of Efficacy|2
866012|NCT01451541|2855615|P3|Overall Study|Adverse Event|6
866013|NCT01451541|2855616|P2|Overall Study|Adverse Event|3
866014|NCT01451541|2855617|P1|Overall Study|Adverse Event|4
866015|NCT01451437|2855675|P9|Overall Study|Withdrawal by Subject|0
866016|NCT01451437|2855676|P8|Overall Study|Withdrawal by Subject|0
866017|NCT01451437|2855677|P7|Overall Study|Withdrawal by Subject|1
866018|NCT01451437|2855678|P6|Overall Study|Withdrawal by Subject|0
866019|NCT01451437|2855679|P5|Overall Study|Withdrawal by Subject|1
866020|NCT01451437|2855680|P4|Overall Study|Withdrawal by Subject|0
866021|NCT01451437|2855681|P3|Overall Study|Withdrawal by Subject|0
866022|NCT01451437|2855682|P2|Overall Study|Withdrawal by Subject|0
866023|NCT01451437|2855683|P1|Overall Study|Withdrawal by Subject|0
866024|NCT01451437|2855675|P9|Overall Study|Protocol Violation|0
866025|NCT01451437|2855676|P8|Overall Study|Protocol Violation|0
866026|NCT01451437|2855677|P7|Overall Study|Protocol Violation|1
866027|NCT01451437|2855678|P6|Overall Study|Protocol Violation|0
866028|NCT01451437|2855679|P5|Overall Study|Protocol Violation|0
866029|NCT01451437|2855680|P4|Overall Study|Protocol Violation|0
866030|NCT01451437|2855681|P3|Overall Study|Protocol Violation|0
866031|NCT01451437|2855682|P2|Overall Study|Protocol Violation|0
866032|NCT01451437|2855683|P1|Overall Study|Protocol Violation|0
866033|NCT01451437|2855675|P9|Overall Study|Disease Progression|3
866034|NCT01451437|2855676|P8|Overall Study|Disease Progression|1
866035|NCT01451437|2855677|P7|Overall Study|Disease Progression|3
866036|NCT01451437|2855678|P6|Overall Study|Disease Progression|2
866037|NCT01451437|2855679|P5|Overall Study|Disease Progression|3
866038|NCT01451437|2855680|P4|Overall Study|Disease Progression|1
866039|NCT01451437|2855681|P3|Overall Study|Disease Progression|1
866040|NCT01451437|2855682|P2|Overall Study|Disease Progression|0
866041|NCT01451437|2855683|P1|Overall Study|Disease Progression|0
866042|NCT01451437|2855675|P9|Overall Study|Physician Decision|0
866043|NCT01451437|2855676|P8|Overall Study|Physician Decision|0
866044|NCT01451437|2855677|P7|Overall Study|Physician Decision|0
866045|NCT01451437|2855678|P6|Overall Study|Physician Decision|0
866046|NCT01451437|2855679|P5|Overall Study|Physician Decision|0
866047|NCT01451437|2855680|P4|Overall Study|Physician Decision|0
866048|NCT01451437|2855681|P3|Overall Study|Physician Decision|2
866049|NCT01451437|2855682|P2|Overall Study|Physician Decision|1
866050|NCT01451437|2855683|P1|Overall Study|Physician Decision|1
866051|NCT01451437|2855675|P9|Overall Study|Adverse Event|1
866052|NCT01451437|2855676|P8|Overall Study|Adverse Event|2
866053|NCT01451437|2855677|P7|Overall Study|Adverse Event|1
866054|NCT01451437|2855678|P6|Overall Study|Adverse Event|1
866055|NCT01451437|2855679|P5|Overall Study|Adverse Event|0
866056|NCT01451437|2855680|P4|Overall Study|Adverse Event|0
866057|NCT01451437|2855681|P3|Overall Study|Adverse Event|0
866058|NCT01451437|2855682|P2|Overall Study|Adverse Event|0
866059|NCT01451437|2855683|P1|Overall Study|Adverse Event|0
866060|NCT01451424|2855815|P4|Overall Study|Adverse Event|1
866061|NCT01451424|2855816|P3|Overall Study|Adverse Event|0
866062|NCT01451424|2855817|P2|Overall Study|Adverse Event|0
866063|NCT01451424|2855818|P1|Overall Study|Adverse Event|0
866064|NCT01451424|2855815|P4|Overall Study|Physician Decision|1
866065|NCT01451424|2855816|P3|Overall Study|Physician Decision|1
866066|NCT01451424|2855817|P2|Overall Study|Physician Decision|0
866067|NCT01451424|2855818|P1|Overall Study|Physician Decision|0
866068|NCT01451424|2855815|P4|Overall Study|Lost to Follow-up|1
866069|NCT01451424|2855816|P3|Overall Study|Lost to Follow-up|0
866070|NCT01451424|2855817|P2|Overall Study|Lost to Follow-up|1
866071|NCT01451424|2855818|P1|Overall Study|Lost to Follow-up|0
866072|NCT01451424|2855815|P4|Overall Study|Withdrawal by Subject|2
866073|NCT01451424|2855816|P3|Overall Study|Withdrawal by Subject|0
866074|NCT01451424|2855817|P2|Overall Study|Withdrawal by Subject|1
866075|NCT01451424|2855818|P1|Overall Study|Withdrawal by Subject|1
866076|NCT01451398|2855876|P2|Overall Study|Lack of Efficacy|1
866077|NCT01451398|2855877|P1|Overall Study|Lack of Efficacy|0
866078|NCT01451398|2855876|P2|Overall Study|Adverse Event + Elevated Fasting Glucose|1
866079|NCT01451398|2855877|P1|Overall Study|Adverse Event + Elevated Fasting Glucose|0
866080|NCT01451398|2855876|P2|Overall Study|Moved out of country|1
866081|NCT01451398|2855877|P1|Overall Study|Moved out of country|0
866082|NCT01451398|2855876|P2|Overall Study|Non-compliance with protocol|1
866083|NCT01451398|2855877|P1|Overall Study|Non-compliance with protocol|1
866084|NCT01451398|2855876|P2|Overall Study|Non-compliance with study drug|3
866085|NCT01451398|2855877|P1|Overall Study|Non-compliance with study drug|1
866086|NCT01451398|2855876|P2|Overall Study|Lost to Follow-up|4
866087|NCT01451398|2855877|P1|Overall Study|Lost to Follow-up|6
866088|NCT01451398|2855876|P2|Overall Study|Withdrawal by Subject|14
866089|NCT01451398|2855877|P1|Overall Study|Withdrawal by Subject|10
866090|NCT01451398|2855876|P2|Overall Study|Physician Decision|1
866091|NCT01451398|2855877|P1|Overall Study|Physician Decision|1
866092|NCT01451398|2855876|P2|Overall Study|Protocol Violation|2
866093|NCT01451398|2855877|P1|Overall Study|Protocol Violation|1
866094|NCT01451398|2855876|P2|Overall Study|Adverse Event|9
866095|NCT01451398|2855877|P1|Overall Study|Adverse Event|7
866096|NCT01451203|2855911|P2|Post-treatment Period|Investigator decision|1
866097|NCT01451203|2855912|P1|Post-treatment Period|Investigator decision|0
866098|NCT01451203|2855911|P2|Post-treatment Period|Adverse Event|1
866099|NCT01451203|2855912|P1|Post-treatment Period|Adverse Event|0
866100|NCT01451203|2855911|P2|Post-treatment Period|Lack of Efficacy|28
866101|NCT01451203|2855912|P1|Post-treatment Period|Lack of Efficacy|12
866102|NCT01451203|2855911|P2|Post-treatment Period|Consent withdrawn|4
866103|NCT01451203|2855912|P1|Post-treatment Period|Consent withdrawn|2
866104|NCT01451203|2855911|P2|Double-blind Treatment Period|Investigator decision|0
866105|NCT01451203|2855912|P1|Double-blind Treatment Period|Investigator decision|2
866106|NCT01451203|2855911|P2|Double-blind Treatment Period|Violation of eligibility criteria|0
866107|NCT01451203|2855912|P1|Double-blind Treatment Period|Violation of eligibility criteria|1
866108|NCT01451203|2855911|P2|Double-blind Treatment Period|Missing study medication ≥6 times|0
866109|NCT01451203|2855912|P1|Double-blind Treatment Period|Missing study medication ≥6 times|1
866110|NCT01451203|2855911|P2|Double-blind Treatment Period|Adverse Event|9
866111|NCT01451203|2855912|P1|Double-blind Treatment Period|Adverse Event|6
866112|NCT01451203|2855911|P2|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1
866113|NCT01451203|2855912|P1|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0
866114|NCT01451203|2855911|P2|Double-blind Treatment Period|Lack of Efficacy|36
866115|NCT01451203|2855912|P1|Double-blind Treatment Period|Lack of Efficacy|71
866116|NCT01451203|2855911|P2|Double-blind Treatment Period|Consent Withdrawn|2
866117|NCT01451203|2855912|P1|Double-blind Treatment Period|Consent Withdrawn|3
866118|NCT01451203|2855911|P2|Double-blind Treatment Period|Did not receive treatment|2
866119|NCT01451203|2855912|P1|Double-blind Treatment Period|Did not receive treatment|1
866120|NCT01450813|2855945|P4|Overall Study|Physician Decision|3
866121|NCT01450813|2855946|P3|Overall Study|Physician Decision|0
866122|NCT01450813|2855947|P2|Overall Study|Physician Decision|1
866123|NCT01450813|2855948|P1|Overall Study|Physician Decision|1
866124|NCT01450800|2855962|P2|Overall Study|Protocol Violation|3
866125|NCT01450800|2855963|P1|Overall Study|Protocol Violation|1
866126|NCT01450761|2855998|P2|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3
866127|NCT01450761|2855999|P1|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2
866128|NCT01450761|2855998|P2|Treatment With Blinded Study Therapy|Poor/non-compliance|0
866129|NCT01450761|2855999|P1|Treatment With Blinded Study Therapy|Poor/non-compliance|1
866130|NCT01450761|2855998|P2|Treatment With Blinded Study Therapy|Not reported|2
866131|NCT01450761|2855999|P1|Treatment With Blinded Study Therapy|Not reported|2
866132|NCT01450761|2855998|P2|Treatment With Blinded Study Therapy|No longer meets study criteria|2
866133|NCT01450761|2855999|P1|Treatment With Blinded Study Therapy|No longer meets study criteria|1
866134|NCT01450761|2855998|P2|Treatment With Blinded Study Therapy|Maximum clinical benefit|2
866135|NCT01450761|2855999|P1|Treatment With Blinded Study Therapy|Maximum clinical benefit|1
866136|NCT01450761|2855998|P2|Treatment With Blinded Study Therapy|Lost to Follow-up|1
866137|NCT01450761|2855999|P1|Treatment With Blinded Study Therapy|Lost to Follow-up|2
866138|NCT01450761|2855998|P2|Treatment With Blinded Study Therapy|Other/Unspecified|4
866139|NCT01450761|2855999|P1|Treatment With Blinded Study Therapy|Other/Unspecified|5
866140|NCT01450761|2855998|P2|Treatment With Blinded Study Therapy|Death|6
866141|NCT01450761|2855999|P1|Treatment With Blinded Study Therapy|Death|5
866142|NCT01450761|2855998|P2|Treatment With Blinded Study Therapy|Withdrawal by Subject|5
866143|NCT01450761|2855999|P1|Treatment With Blinded Study Therapy|Withdrawal by Subject|12
866144|NCT01450761|2855998|P2|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8
866145|NCT01450761|2855999|P1|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15
866146|NCT01450761|2855998|P2|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19
866147|NCT01450761|2855999|P1|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27
866148|NCT01450761|2855998|P2|Treatment With Blinded Study Therapy|Study drug toxicity|9
866149|NCT01450761|2855999|P1|Treatment With Blinded Study Therapy|Study drug toxicity|87
866150|NCT01450761|2855998|P2|Treatment With Blinded Study Therapy|Disease progression|415
866151|NCT01450761|2855999|P1|Treatment With Blinded Study Therapy|Disease progression|318
866152|NCT01450761|2855998|P2|Lead-in Chemotherapy|Lost to Follow-up|0
866153|NCT01450761|2855999|P1|Lead-in Chemotherapy|Lost to Follow-up|2
866154|NCT01450761|2855998|P2|Lead-in Chemotherapy|Other|2
866155|NCT01450761|2855999|P1|Lead-in Chemotherapy|Other|2
866156|NCT01450761|2855998|P2|Lead-in Chemotherapy|Death|3
866157|NCT01450761|2855999|P1|Lead-in Chemotherapy|Death|3
866158|NCT01450761|2855998|P2|Lead-in Chemotherapy|No longer meets study criteria|7
866159|NCT01450761|2855999|P1|Lead-in Chemotherapy|No longer meets study criteria|3
866160|NCT01450761|2855998|P2|Lead-in Chemotherapy|Study drug toxicity|10
866161|NCT01450761|2855999|P1|Lead-in Chemotherapy|Study drug toxicity|6
866162|NCT01450761|2855998|P2|Lead-in Chemotherapy|Withdrawal by Subject|12
866163|NCT01450761|2855999|P1|Lead-in Chemotherapy|Withdrawal by Subject|14
866164|NCT01450761|2855998|P2|Lead-in Chemotherapy|Adverse event unrelated to study drug|19
866165|NCT01450761|2855999|P1|Lead-in Chemotherapy|Adverse event unrelated to study drug|21
866166|NCT01450761|2855998|P2|Lead-in Chemotherapy|Disease progression|32
866167|NCT01450761|2855999|P1|Lead-in Chemotherapy|Disease progression|33
866168|NCT01450761|2855998|P2|Randomization|Other|1
866169|NCT01450761|2855999|P1|Randomization|Other|0
866170|NCT01450761|2855998|P2|Randomization|Adverse Event unrelated to study drug|0
866171|NCT01450761|2855999|P1|Randomization|Adverse Event unrelated to study drug|1
866172|NCT01450761|2855998|P2|Randomization|Disease progression|2
866173|NCT01450761|2855999|P1|Randomization|Disease progression|0
866174|NCT01450761|2855998|P2|Randomization|Withdrawal by Subject|0
866175|NCT01450761|2855999|P1|Randomization|Withdrawal by Subject|2
866176|NCT01450761|2855998|P2|Randomization|Subject no longer meets study criteria|2
866177|NCT01450761|2855999|P1|Randomization|Subject no longer meets study criteria|1
866178|NCT01450696|2856011|P2|Overall Study|Study Terminated by Sponsor|58
866179|NCT01450696|2856012|P1|Overall Study|Study Terminated by Sponsor|53
866180|NCT01450696|2856011|P2|Overall Study|Withdrawal by Subject|2
866181|NCT01450696|2856012|P1|Overall Study|Withdrawal by Subject|13
866182|NCT01450696|2856011|P2|Overall Study|Non-Compliance|0
866183|NCT01450696|2856012|P1|Overall Study|Non-Compliance|1
866184|NCT01450696|2856011|P2|Overall Study|Lost to Follow-up|3
866185|NCT01450696|2856012|P1|Overall Study|Lost to Follow-up|3
866186|NCT01450696|2856011|P2|Overall Study|Death|84
866187|NCT01450696|2856012|P1|Overall Study|Death|77
866188|NCT01450696|2856011|P2|Overall Study|Never Treated|1
866189|NCT01450696|2856012|P1|Overall Study|Never Treated|1
866190|NCT01450683|2856034|P1|Overall Study|Adverse Event|2
866191|NCT01450631|2856040|P2|Overall Study|Withdrawal by Subject|0
866192|NCT01450631|2856041|P1|Overall Study|Withdrawal by Subject|1
866193|NCT01450631|2856040|P2|Overall Study|Lost to Follow-up|4
866194|NCT01450631|2856041|P1|Overall Study|Lost to Follow-up|2
866195|NCT01450098|2856171|P2|Period 3|Withdrawal by Subject|2
866196|NCT01450098|2856172|P1|Period 3|Withdrawal by Subject|0
866197|NCT01450098|2856171|P2|Period 3|Protocol Violation|1
866198|NCT01450098|2856172|P1|Period 3|Protocol Violation|0
866199|NCT01450007|2856191|P3|Overall Study|Adverse Event|0
866200|NCT01450007|2856192|P2|Overall Study|Adverse Event|1
866201|NCT01450007|2856193|P1|Overall Study|Adverse Event|0
866202|NCT01450007|2856191|P3|Overall Study|Protocol Violation|1
866203|NCT01450007|2856192|P2|Overall Study|Protocol Violation|1
866204|NCT01450007|2856193|P1|Overall Study|Protocol Violation|0
866205|NCT01450007|2856191|P3|Overall Study|Late exclusion before treatment|2
866206|NCT01450007|2856192|P2|Overall Study|Late exclusion before treatment|3
866207|NCT01450007|2856193|P1|Overall Study|Late exclusion before treatment|2
866208|NCT01449955|2856212|P2|Overall Study|Withdrawal by Subject|2
866209|NCT01449955|2856213|P1|Overall Study|Withdrawal by Subject|1
866210|NCT01449929|2856241|P3|Extension Phase Approximately 3 Years|Lost to Follow-up|4
866211|NCT01449929|2856242|P2|Extension Phase Approximately 3 Years|Lost to Follow-up|0
866212|NCT01449929|2856243|P1|Extension Phase Approximately 3 Years|Lost to Follow-up|0
866213|NCT01449929|2856241|P3|Extension Phase Approximately 3 Years|Lack of Efficacy|2
866214|NCT01449929|2856242|P2|Extension Phase Approximately 3 Years|Lack of Efficacy|0
866215|NCT01449929|2856243|P1|Extension Phase Approximately 3 Years|Lack of Efficacy|0
866216|NCT01449929|2856241|P3|Extension Phase Approximately 3 Years|Adverse Event|2
866217|NCT01449929|2856242|P2|Extension Phase Approximately 3 Years|Adverse Event|0
866218|NCT01449929|2856243|P1|Extension Phase Approximately 3 Years|Adverse Event|0
866219|NCT01449929|2856241|P3|Randomization Phase 96 Week|Other: study closed/terminated|0
866220|NCT01449929|2856242|P2|Randomization Phase 96 Week|Other: study closed/terminated|1
866221|NCT01449929|2856243|P1|Randomization Phase 96 Week|Other: study closed/terminated|0
866222|NCT01449929|2856241|P3|Randomization Phase 96 Week|Physician Decision|0
866223|NCT01449929|2856242|P2|Randomization Phase 96 Week|Physician Decision|3
866224|NCT01449929|2856243|P1|Randomization Phase 96 Week|Physician Decision|2
866225|NCT01449929|2856241|P3|Randomization Phase 96 Week|Withdrawal by Subject|0
866226|NCT01449929|2856242|P2|Randomization Phase 96 Week|Withdrawal by Subject|8
866227|NCT01449929|2856243|P1|Randomization Phase 96 Week|Withdrawal by Subject|2
866228|NCT01449929|2856241|P3|Randomization Phase 96 Week|Lost to Follow-up|0
866229|NCT01449929|2856242|P2|Randomization Phase 96 Week|Lost to Follow-up|18
866230|NCT01449929|2856243|P1|Randomization Phase 96 Week|Lost to Follow-up|15
866231|NCT01449929|2856241|P3|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
866232|NCT01449929|2856242|P2|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
866233|NCT01449929|2856243|P1|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1
866234|NCT01449929|2856241|P3|Randomization Phase 96 Week|Protocol Violation|0
866235|NCT01449929|2856242|P2|Randomization Phase 96 Week|Protocol Violation|6
866236|NCT01449929|2856243|P1|Randomization Phase 96 Week|Protocol Violation|5
866237|NCT01449929|2856241|P3|Randomization Phase 96 Week|Lack of Efficacy|0
866238|NCT01449929|2856242|P2|Randomization Phase 96 Week|Lack of Efficacy|4
866239|NCT01449929|2856243|P1|Randomization Phase 96 Week|Lack of Efficacy|3
866240|NCT01449929|2856241|P3|Randomization Phase 96 Week|Adverse Event|0
866241|NCT01449929|2856242|P2|Randomization Phase 96 Week|Adverse Event|13
866242|NCT01449929|2856243|P1|Randomization Phase 96 Week|Adverse Event|5
866243|NCT01449812|2856283|P3|Overall Study|Lost to Follow-up|0
866244|NCT01449812|2856284|P2|Overall Study|Lost to Follow-up|0
866245|NCT01449812|2856285|P1|Overall Study|Lost to Follow-up|1
866246|NCT01449812|2856283|P3|Overall Study|Withdrawal by Subject|1
866247|NCT01449812|2856284|P2|Overall Study|Withdrawal by Subject|0
866248|NCT01449812|2856285|P1|Overall Study|Withdrawal by Subject|0
866249|NCT01449812|2856283|P3|Overall Study|Migrated/moved from study area|0
866250|NCT01449812|2856284|P2|Overall Study|Migrated/moved from study area|0
866251|NCT01449812|2856285|P1|Overall Study|Migrated/moved from study area|1
866252|NCT01449721|2856400|P2|Overall Study|Physician Decision|1
866253|NCT01449721|2856401|P1|Overall Study|Physician Decision|0
866254|NCT01449721|2856400|P2|Overall Study|Physician Decision|1
866255|NCT01449721|2856401|P1|Overall Study|Physician Decision|0
866256|NCT01449708|2856413|P2|Overall Study|respiratory failure|0
866257|NCT01449708|2856414|P1|Overall Study|respiratory failure|1
866258|NCT01449708|2856413|P2|Overall Study|surgical complication|2
866259|NCT01449708|2856414|P1|Overall Study|surgical complication|1
866260|NCT01449708|2856413|P2|Overall Study|Protocol Violation|1
866261|NCT01449708|2856414|P1|Overall Study|Protocol Violation|0
866262|NCT01449682|2856425|P2|Overall Study|Adverse Event|0
866263|NCT01449682|2856426|P1|Overall Study|Adverse Event|1
866264|NCT01449682|2856425|P2|Overall Study|Death|1
866265|NCT01449682|2856426|P1|Overall Study|Death|0
866266|NCT01449539|2856438|P1|Overall Study|Toxicity not study related|1
866267|NCT01449539|2856438|P1|Overall Study|Withdrawal by Subject|3
866268|NCT01449526|2856444|P2|Overall Study|Cannot maintain visits|1
866269|NCT01449526|2856445|P1|Overall Study|Cannot maintain visits|0
866270|NCT01449526|2856444|P2|Overall Study|Lack of Motivation|1
866271|NCT01449526|2856445|P1|Overall Study|Lack of Motivation|0
866272|NCT01449526|2856444|P2|Overall Study|Symptoms/complaints|1
866273|NCT01449526|2856445|P1|Overall Study|Symptoms/complaints|0
866274|NCT01449526|2856444|P2|Overall Study|Withdrawal by Subject|1
866275|NCT01449526|2856445|P1|Overall Study|Withdrawal by Subject|1
866276|NCT01449526|2856444|P2|Overall Study|Lost to Follow-up|2
866277|NCT01449526|2856445|P1|Overall Study|Lost to Follow-up|1
866278|NCT01449461|2856514|P6|Overall Study|Reason not specified|1
866279|NCT01449461|2856515|P5|Overall Study|Reason not specified|0
866280|NCT01449461|2856516|P4|Overall Study|Reason not specified|3
866281|NCT01449461|2856517|P3|Overall Study|Reason not specified|0
866282|NCT01449461|2856518|P2|Overall Study|Reason not specified|1
866283|NCT01449461|2856519|P1|Overall Study|Reason not specified|0
866284|NCT01449461|2856514|P6|Overall Study|Clinical progressive disease|3
866285|NCT01449461|2856515|P5|Overall Study|Clinical progressive disease|3
866286|NCT01449461|2856516|P4|Overall Study|Clinical progressive disease|0
866287|NCT01449461|2856517|P3|Overall Study|Clinical progressive disease|0
866288|NCT01449461|2856518|P2|Overall Study|Clinical progressive disease|1
866289|NCT01449461|2856519|P1|Overall Study|Clinical progressive disease|2
866290|NCT01449461|2856514|P6|Overall Study|Documented progressive disease|5
866291|NCT01449461|2856515|P5|Overall Study|Documented progressive disease|21
866292|NCT01449461|2856516|P4|Overall Study|Documented progressive disease|11
866293|NCT01449461|2856517|P3|Overall Study|Documented progressive disease|14
866294|NCT01449461|2856518|P2|Overall Study|Documented progressive disease|6
866295|NCT01449461|2856519|P1|Overall Study|Documented progressive disease|4
866296|NCT01449461|2856514|P6|Overall Study|Death|1
866297|NCT01449461|2856515|P5|Overall Study|Death|4
866298|NCT01449461|2856516|P4|Overall Study|Death|0
866299|NCT01449461|2856517|P3|Overall Study|Death|0
866300|NCT01449461|2856518|P2|Overall Study|Death|1
866301|NCT01449461|2856519|P1|Overall Study|Death|0
866302|NCT01449461|2856514|P6|Overall Study|Adverse Event|3
866303|NCT01449461|2856515|P5|Overall Study|Adverse Event|3
866304|NCT01449461|2856516|P4|Overall Study|Adverse Event|3
866305|NCT01449461|2856517|P3|Overall Study|Adverse Event|2
866306|NCT01449461|2856518|P2|Overall Study|Adverse Event|3
866307|NCT01449461|2856519|P1|Overall Study|Adverse Event|0
866308|NCT01449461|2856514|P6|Overall Study|Ongoing|2
866309|NCT01449461|2856515|P5|Overall Study|Ongoing|17
866310|NCT01449461|2856516|P4|Overall Study|Ongoing|15
866311|NCT01449461|2856517|P3|Overall Study|Ongoing|2
866312|NCT01449461|2856518|P2|Overall Study|Ongoing|6
866313|NCT01449461|2856519|P1|Overall Study|Ongoing|0
866314|NCT01449370|2856656|P25|Overall Study|Death|1
866315|NCT01449370|2856657|P24|Overall Study|Death|0
866316|NCT01449370|2856658|P23|Overall Study|Death|0
866317|NCT01449370|2856659|P22|Overall Study|Death|0
866318|NCT01449370|2856660|P21|Overall Study|Death|0
866319|NCT01449370|2856661|P20|Overall Study|Death|0
866320|NCT01449370|2856662|P19|Overall Study|Death|0
866321|NCT01449370|2856663|P18|Overall Study|Death|0
866322|NCT01449370|2856664|P17|Overall Study|Death|0
866323|NCT01449370|2856665|P16|Overall Study|Death|0
866324|NCT01449370|2856666|P15|Overall Study|Death|0
866325|NCT01449370|2856667|P14|Overall Study|Death|0
866326|NCT01449370|2856668|P13|Overall Study|Death|0
866327|NCT01449370|2856669|P12|Overall Study|Death|0
866328|NCT01449370|2856670|P11|Overall Study|Death|0
866329|NCT01449370|2856671|P10|Overall Study|Death|0
866330|NCT01449370|2856672|P9|Overall Study|Death|0
866331|NCT01449370|2856673|P8|Overall Study|Death|0
866332|NCT01449370|2856674|P7|Overall Study|Death|0
866333|NCT01449370|2856675|P6|Overall Study|Death|0
866334|NCT01449370|2856676|P5|Overall Study|Death|0
866335|NCT01449370|2856677|P4|Overall Study|Death|0
866336|NCT01449370|2856678|P3|Overall Study|Death|0
866337|NCT01449370|2856679|P2|Overall Study|Death|0
866338|NCT01449370|2856680|P1|Overall Study|Death|0
866339|NCT01449370|2856656|P25|Overall Study|Medication Prohibited by Protocol|0
866340|NCT01449370|2856657|P24|Overall Study|Medication Prohibited by Protocol|1
866341|NCT01449370|2856658|P23|Overall Study|Medication Prohibited by Protocol|0
866342|NCT01449370|2856659|P22|Overall Study|Medication Prohibited by Protocol|0
866343|NCT01449370|2856660|P21|Overall Study|Medication Prohibited by Protocol|0
866344|NCT01449370|2856661|P20|Overall Study|Medication Prohibited by Protocol|0
866345|NCT01449370|2856662|P19|Overall Study|Medication Prohibited by Protocol|0
866346|NCT01449370|2856663|P18|Overall Study|Medication Prohibited by Protocol|0
866347|NCT01449370|2856664|P17|Overall Study|Medication Prohibited by Protocol|0
866348|NCT01449370|2856665|P16|Overall Study|Medication Prohibited by Protocol|0
866349|NCT01449370|2856666|P15|Overall Study|Medication Prohibited by Protocol|0
866350|NCT01449370|2856667|P14|Overall Study|Medication Prohibited by Protocol|0
866351|NCT01449370|2856668|P13|Overall Study|Medication Prohibited by Protocol|0
866352|NCT01449370|2856669|P12|Overall Study|Medication Prohibited by Protocol|0
866353|NCT01449370|2856670|P11|Overall Study|Medication Prohibited by Protocol|0
866354|NCT01449370|2856671|P10|Overall Study|Medication Prohibited by Protocol|0
866355|NCT01449370|2856672|P9|Overall Study|Medication Prohibited by Protocol|0
866356|NCT01449370|2856673|P8|Overall Study|Medication Prohibited by Protocol|0
866357|NCT01449370|2856674|P7|Overall Study|Medication Prohibited by Protocol|0
866358|NCT01449370|2856675|P6|Overall Study|Medication Prohibited by Protocol|0
866359|NCT01449370|2856676|P5|Overall Study|Medication Prohibited by Protocol|0
866360|NCT01449370|2856677|P4|Overall Study|Medication Prohibited by Protocol|0
866361|NCT01449370|2856678|P3|Overall Study|Medication Prohibited by Protocol|0
866362|NCT01449370|2856679|P2|Overall Study|Medication Prohibited by Protocol|0
866363|NCT01449370|2856680|P1|Overall Study|Medication Prohibited by Protocol|0
866364|NCT01449370|2856656|P25|Overall Study|Other|0
866365|NCT01449370|2856657|P24|Overall Study|Other|1
866366|NCT01449370|2856658|P23|Overall Study|Other|1
866367|NCT01449370|2856659|P22|Overall Study|Other|0
866368|NCT01449370|2856660|P21|Overall Study|Other|0
866369|NCT01449370|2856661|P20|Overall Study|Other|0
866370|NCT01449370|2856662|P19|Overall Study|Other|0
866371|NCT01449370|2856663|P18|Overall Study|Other|0
866372|NCT01449370|2856664|P17|Overall Study|Other|0
866373|NCT01449370|2856665|P16|Overall Study|Other|0
866374|NCT01449370|2856666|P15|Overall Study|Other|0
866375|NCT01449370|2856667|P14|Overall Study|Other|0
866376|NCT01449370|2856668|P13|Overall Study|Other|0
866377|NCT01449370|2856669|P12|Overall Study|Other|0
866378|NCT01449370|2856670|P11|Overall Study|Other|0
866379|NCT01449370|2856671|P10|Overall Study|Other|1
866380|NCT01449370|2856672|P9|Overall Study|Other|1
866381|NCT01449370|2856673|P8|Overall Study|Other|0
866382|NCT01449370|2856674|P7|Overall Study|Other|0
866383|NCT01449370|2856675|P6|Overall Study|Other|0
866384|NCT01449370|2856676|P5|Overall Study|Other|0
866385|NCT01449370|2856677|P4|Overall Study|Other|0
866386|NCT01449370|2856678|P3|Overall Study|Other|0
866387|NCT01449370|2856679|P2|Overall Study|Other|0
866388|NCT01449370|2856680|P1|Overall Study|Other|0
866389|NCT01449370|2856656|P25|Overall Study|Lost to Follow-up|0
866390|NCT01449370|2856657|P24|Overall Study|Lost to Follow-up|0
866391|NCT01449370|2856658|P23|Overall Study|Lost to Follow-up|0
866392|NCT01449370|2856659|P22|Overall Study|Lost to Follow-up|0
866393|NCT01449370|2856660|P21|Overall Study|Lost to Follow-up|1
866394|NCT01449370|2856661|P20|Overall Study|Lost to Follow-up|0
866395|NCT01449370|2856662|P19|Overall Study|Lost to Follow-up|0
866396|NCT01449370|2856663|P18|Overall Study|Lost to Follow-up|0
866397|NCT01449370|2856664|P17|Overall Study|Lost to Follow-up|0
866398|NCT01449370|2856665|P16|Overall Study|Lost to Follow-up|0
866399|NCT01449370|2856666|P15|Overall Study|Lost to Follow-up|0
866400|NCT01449370|2856667|P14|Overall Study|Lost to Follow-up|0
866401|NCT01449370|2856668|P13|Overall Study|Lost to Follow-up|0
866402|NCT01449370|2856669|P12|Overall Study|Lost to Follow-up|0
866403|NCT01449370|2856670|P11|Overall Study|Lost to Follow-up|0
866404|NCT01449370|2856671|P10|Overall Study|Lost to Follow-up|0
866405|NCT01449370|2856672|P9|Overall Study|Lost to Follow-up|0
866406|NCT01449370|2856673|P8|Overall Study|Lost to Follow-up|0
866407|NCT01449370|2856674|P7|Overall Study|Lost to Follow-up|0
866408|NCT01449370|2856675|P6|Overall Study|Lost to Follow-up|0
866409|NCT01449370|2856676|P5|Overall Study|Lost to Follow-up|0
866410|NCT01449370|2856677|P4|Overall Study|Lost to Follow-up|0
866411|NCT01449370|2856678|P3|Overall Study|Lost to Follow-up|0
866412|NCT01449370|2856679|P2|Overall Study|Lost to Follow-up|0
866413|NCT01449370|2856680|P1|Overall Study|Lost to Follow-up|0
866414|NCT01449370|2856656|P25|Overall Study|Participant Decision|1
866415|NCT01449370|2856657|P24|Overall Study|Participant Decision|0
866416|NCT01449370|2856658|P23|Overall Study|Participant Decision|0
866417|NCT01449370|2856659|P22|Overall Study|Participant Decision|1
866418|NCT01449370|2856660|P21|Overall Study|Participant Decision|0
866419|NCT01449370|2856661|P20|Overall Study|Participant Decision|0
866420|NCT01449370|2856662|P19|Overall Study|Participant Decision|1
866421|NCT01449370|2856663|P18|Overall Study|Participant Decision|0
866422|NCT01449370|2856664|P17|Overall Study|Participant Decision|3
866423|NCT01449370|2856665|P16|Overall Study|Participant Decision|1
866424|NCT01449370|2856666|P15|Overall Study|Participant Decision|0
866425|NCT01449370|2856667|P14|Overall Study|Participant Decision|1
866426|NCT01449370|2856668|P13|Overall Study|Participant Decision|1
866427|NCT01449370|2856669|P12|Overall Study|Participant Decision|0
866428|NCT01449370|2856670|P11|Overall Study|Participant Decision|0
866429|NCT01449370|2856671|P10|Overall Study|Participant Decision|0
866430|NCT01449370|2856672|P9|Overall Study|Participant Decision|1
866431|NCT01449370|2856673|P8|Overall Study|Participant Decision|1
866432|NCT01449370|2856674|P7|Overall Study|Participant Decision|0
866433|NCT01449370|2856675|P6|Overall Study|Participant Decision|0
866434|NCT01449370|2856676|P5|Overall Study|Participant Decision|0
866435|NCT01449370|2856677|P4|Overall Study|Participant Decision|0
866436|NCT01449370|2856678|P3|Overall Study|Participant Decision|0
866437|NCT01449370|2856679|P2|Overall Study|Participant Decision|0
866438|NCT01449370|2856680|P1|Overall Study|Participant Decision|0
866439|NCT01449370|2856656|P25|Overall Study|Adverse Event|3
866440|NCT01449370|2856657|P24|Overall Study|Adverse Event|1
866441|NCT01449370|2856658|P23|Overall Study|Adverse Event|0
866442|NCT01449370|2856659|P22|Overall Study|Adverse Event|1
866443|NCT01449370|2856660|P21|Overall Study|Adverse Event|0
866444|NCT01449370|2856661|P20|Overall Study|Adverse Event|1
866445|NCT01449370|2856662|P19|Overall Study|Adverse Event|1
866446|NCT01449370|2856663|P18|Overall Study|Adverse Event|0
866447|NCT01449370|2856664|P17|Overall Study|Adverse Event|0
866448|NCT01449370|2856665|P16|Overall Study|Adverse Event|1
866449|NCT01449370|2856666|P15|Overall Study|Adverse Event|0
866450|NCT01449370|2856667|P14|Overall Study|Adverse Event|2
866451|NCT01449370|2856668|P13|Overall Study|Adverse Event|0
866452|NCT01449370|2856669|P12|Overall Study|Adverse Event|0
866453|NCT01449370|2856670|P11|Overall Study|Adverse Event|0
866454|NCT01449370|2856671|P10|Overall Study|Adverse Event|1
866455|NCT01449370|2856672|P9|Overall Study|Adverse Event|1
866456|NCT01449370|2856673|P8|Overall Study|Adverse Event|0
866457|NCT01449370|2856674|P7|Overall Study|Adverse Event|0
866458|NCT01449370|2856675|P6|Overall Study|Adverse Event|0
866459|NCT01449370|2856676|P5|Overall Study|Adverse Event|0
866460|NCT01449370|2856677|P4|Overall Study|Adverse Event|1
866461|NCT01449370|2856678|P3|Overall Study|Adverse Event|0
866462|NCT01449370|2856679|P2|Overall Study|Adverse Event|2
866463|NCT01449370|2856680|P1|Overall Study|Adverse Event|1
866464|NCT01449370|2856656|P25|Overall Study|Disease Progression|3
866465|NCT01449370|2856657|P24|Overall Study|Disease Progression|7
866466|NCT01449370|2856658|P23|Overall Study|Disease Progression|3
866467|NCT01449370|2856659|P22|Overall Study|Disease Progression|2
866468|NCT01449370|2856660|P21|Overall Study|Disease Progression|5
866469|NCT01449370|2856661|P20|Overall Study|Disease Progression|2
866470|NCT01449370|2856662|P19|Overall Study|Disease Progression|1
866471|NCT01449370|2856663|P18|Overall Study|Disease Progression|3
866472|NCT01449370|2856664|P17|Overall Study|Disease Progression|4
866473|NCT01449370|2856665|P16|Overall Study|Disease Progression|1
866474|NCT01449370|2856666|P15|Overall Study|Disease Progression|3
866475|NCT01449370|2856667|P14|Overall Study|Disease Progression|8
866476|NCT01449370|2856668|P13|Overall Study|Disease Progression|2
866477|NCT01449370|2856669|P12|Overall Study|Disease Progression|3
866478|NCT01449370|2856670|P11|Overall Study|Disease Progression|3
866479|NCT01449370|2856671|P10|Overall Study|Disease Progression|1
866480|NCT01449370|2856672|P9|Overall Study|Disease Progression|9
866481|NCT01449370|2856673|P8|Overall Study|Disease Progression|2
866482|NCT01449370|2856674|P7|Overall Study|Disease Progression|3
866483|NCT01449370|2856675|P6|Overall Study|Disease Progression|3
866484|NCT01449370|2856676|P5|Overall Study|Disease Progression|3
866485|NCT01449370|2856677|P4|Overall Study|Disease Progression|3
866486|NCT01449370|2856678|P3|Overall Study|Disease Progression|8
866487|NCT01449370|2856679|P2|Overall Study|Disease Progression|4
866488|NCT01449370|2856680|P1|Overall Study|Disease Progression|5
866489|NCT01449279|2857058|P1|Overall Study|Toxicity|2
866490|NCT01449279|2857058|P1|Overall Study|Lack of Efficacy|5
866491|NCT01449006|2857083|P2|Overall Study|Protocol Violation|0
866492|NCT01449006|2857084|P1|Overall Study|Protocol Violation|1
866493|NCT01449006|2857083|P2|Overall Study|Withdrawal by Subject|0
866494|NCT01449006|2857084|P1|Overall Study|Withdrawal by Subject|1
866495|NCT01449006|2857083|P2|Overall Study|Lost to Follow-up|0
866496|NCT01449006|2857084|P1|Overall Study|Lost to Follow-up|1
866497|NCT01448850|2857098|P2|Overall Study|Other|12
866498|NCT01448850|2857099|P1|Overall Study|Other|15
866499|NCT01448850|2857098|P2|Overall Study|Lost to Follow-up|1
866500|NCT01448850|2857099|P1|Overall Study|Lost to Follow-up|3
866501|NCT01448850|2857098|P2|Overall Study|Withdrawal by Subject|21
866502|NCT01448850|2857099|P1|Overall Study|Withdrawal by Subject|13
866503|NCT01448850|2857098|P2|Overall Study|Death|6
866504|NCT01448850|2857099|P1|Overall Study|Death|3
866505|NCT01448707|2857124|P2|Overall Study|Other|4
866506|NCT01448707|2857125|P1|Overall Study|Other|7
866507|NCT01448707|2857124|P2|Overall Study|Withdrawal by Subject|7
866508|NCT01448707|2857125|P1|Overall Study|Withdrawal by Subject|6
866509|NCT01448707|2857124|P2|Overall Study|Lost to Follow-up|6
866510|NCT01448707|2857125|P1|Overall Study|Lost to Follow-up|2
866511|NCT01448707|2857124|P2|Overall Study|Adverse Event|1
866512|NCT01448707|2857125|P1|Overall Study|Adverse Event|3
866513|NCT01448616|2857146|P4|Study Drug (Treatment Phase)|Withdrawal by Subject|2
866514|NCT01448616|2857147|P3|Study Drug (Treatment Phase)|Withdrawal by Subject|2
866515|NCT01448616|2857148|P2|Study Drug (Treatment Phase)|Withdrawal by Subject|1
866516|NCT01448616|2857149|P1|Study Drug (Treatment Phase)|Withdrawal by Subject|0
866517|NCT01448616|2857146|P4|Study Drug (Treatment Phase)|Never initiated study drug|2
866518|NCT01448616|2857147|P3|Study Drug (Treatment Phase)|Never initiated study drug|1
866519|NCT01448616|2857148|P2|Study Drug (Treatment Phase)|Never initiated study drug|0
866520|NCT01448616|2857149|P1|Study Drug (Treatment Phase)|Never initiated study drug|0
866521|NCT01448616|2857146|P4|Study Drug (Treatment Phase)|Adverse Event|0
866522|NCT01448616|2857147|P3|Study Drug (Treatment Phase)|Adverse Event|1
866523|NCT01448616|2857148|P2|Study Drug (Treatment Phase)|Adverse Event|1
866524|NCT01448616|2857149|P1|Study Drug (Treatment Phase)|Adverse Event|0
866525|NCT01448616|2857146|P4|Lead-In (Observational Phase)|Collected <90% of required swabs|0
866526|NCT01448616|2857147|P3|Lead-In (Observational Phase)|Collected <90% of required swabs|0
866527|NCT01448616|2857148|P2|Lead-In (Observational Phase)|Collected <90% of required swabs|0
866528|NCT01448616|2857149|P1|Lead-In (Observational Phase)|Collected <90% of required swabs|6
866529|NCT01448616|2857146|P4|Lead-In (Observational Phase)|Collected no genital swabs|0
866530|NCT01448616|2857147|P3|Lead-In (Observational Phase)|Collected no genital swabs|0
866531|NCT01448616|2857148|P2|Lead-In (Observational Phase)|Collected no genital swabs|0
866532|NCT01448616|2857149|P1|Lead-In (Observational Phase)|Collected no genital swabs|3
866533|NCT01448213|2857196|P2|Overall Study|Protocol Violation|2
866534|NCT01448213|2857197|P1|Overall Study|Protocol Violation|1
866535|NCT01448213|2857196|P2|Overall Study|Adverse Event|10
866536|NCT01448213|2857197|P1|Overall Study|Adverse Event|4
866537|NCT01448213|2857196|P2|Overall Study|Lost to Follow-up|10
866538|NCT01448213|2857197|P1|Overall Study|Lost to Follow-up|12
866539|NCT01448057|2857207|P2|Overall Study|Withdrawal by Subject|0
866540|NCT01448057|2857208|P1|Overall Study|Withdrawal by Subject|2
866541|NCT01448057|2857207|P2|Overall Study|Adverse Event|2
866542|NCT01448057|2857208|P1|Overall Study|Adverse Event|0
866543|NCT01448057|2857207|P2|Overall Study|Lost to Follow-up|0
866544|NCT01448057|2857208|P1|Overall Study|Lost to Follow-up|3
866545|NCT01448057|2857207|P2|Overall Study|Protocol Violation|2
866546|NCT01448057|2857208|P1|Overall Study|Protocol Violation|3
866547|NCT01448044|2857218|P2|Follow Up Period|not specified|11
866548|NCT01448044|2857219|P1|Follow Up Period|not specified|5
866549|NCT01448044|2857218|P2|Follow Up Period|Lost to Follow-up|2
866550|NCT01448044|2857219|P1|Follow Up Period|Lost to Follow-up|6
866551|NCT01448044|2857218|P2|Follow Up Period|Withdrawal by Subject|1
866552|NCT01448044|2857219|P1|Follow Up Period|Withdrawal by Subject|1
866553|NCT01448044|2857218|P2|Treatment Period|Other reason|0
866554|NCT01448044|2857219|P1|Treatment Period|Other reason|2
866555|NCT01448044|2857218|P2|Treatment Period|Lost to Follow-up|1
866556|NCT01448044|2857219|P1|Treatment Period|Lost to Follow-up|2
866557|NCT01448044|2857218|P2|Treatment Period|Participant does not meet study criteria|0
866558|NCT01448044|2857219|P1|Treatment Period|Participant does not meet study criteria|1
866559|NCT01448044|2857218|P2|Treatment Period|Completed 24 weeks treatment period only|0
866560|NCT01448044|2857219|P1|Treatment Period|Completed 24 weeks treatment period only|8
866561|NCT01448044|2857218|P2|Treatment Period|Subject requested discontinue study drug|0
866562|NCT01448044|2857219|P1|Treatment Period|Subject requested discontinue study drug|1
866563|NCT01448044|2857218|P2|Treatment Period|Lack of Efficacy|12
866564|NCT01448044|2857219|P1|Treatment Period|Lack of Efficacy|5
866565|NCT01448044|2857218|P2|Treatment Period|Adverse Event|3
866566|NCT01448044|2857219|P1|Treatment Period|Adverse Event|4
866567|NCT01447927|2857235|P2|Overall Study|Withdrawal by Subject|0
866568|NCT01447927|2857236|P1|Overall Study|Withdrawal by Subject|1
866569|NCT01447927|2857235|P2|Overall Study|Adverse Event|3
866570|NCT01447927|2857236|P1|Overall Study|Adverse Event|4
866571|NCT01447719|2857266|P1|Overall Study|Family withdrew autopsy consent|7
866572|NCT01447719|2857266|P1|Overall Study|Withdrawal by Subject|2
866573|NCT01447719|2857266|P1|Overall Study|Subject still living at end of study|79
866574|NCT01447719|2857266|P1|Overall Study|Invalid image or not imaged|3
866575|NCT01447719|2857266|P1|Overall Study|Image acquisition failure|2
866576|NCT01447576|2857292|P1|Overall Study|Physician Decision|6
866577|NCT01447576|2857292|P1|Overall Study|Lack of Efficacy|68
866578|NCT01447576|2857292|P1|Overall Study|Protocol deviation|83
866579|NCT01447576|2857292|P1|Overall Study|Withdrawal by Subject|100
866580|NCT01447576|2857292|P1|Overall Study|Participant met withdrawal criteria|40
866581|NCT01447576|2857292|P1|Overall Study|Adverse Event|127
866582|NCT01447576|2857292|P1|Overall Study|Lost to Follow-up|52
866583|NCT01447446|2857325|P6|Overall Study|Reason not Specified|0
866584|NCT01447446|2857326|P5|Overall Study|Reason not Specified|1
866585|NCT01447446|2857327|P4|Overall Study|Reason not Specified|1
866586|NCT01447446|2857328|P3|Overall Study|Reason not Specified|1
866587|NCT01447446|2857329|P2|Overall Study|Reason not Specified|1
866588|NCT01447446|2857330|P1|Overall Study|Reason not Specified|1
866589|NCT01447446|2857325|P6|Overall Study|New Treatment Started|0
866590|NCT01447446|2857326|P5|Overall Study|New Treatment Started|2
866591|NCT01447446|2857327|P4|Overall Study|New Treatment Started|0
866592|NCT01447446|2857328|P3|Overall Study|New Treatment Started|1
866593|NCT01447446|2857329|P2|Overall Study|New Treatment Started|2
866594|NCT01447446|2857330|P1|Overall Study|New Treatment Started|8
866595|NCT01447446|2857325|P6|Overall Study|SVR12 Assessment|5
866596|NCT01447446|2857326|P5|Overall Study|SVR12 Assessment|5
866597|NCT01447446|2857327|P4|Overall Study|SVR12 Assessment|1
866598|NCT01447446|2857328|P3|Overall Study|SVR12 Assessment|2
866599|NCT01447446|2857329|P2|Overall Study|SVR12 Assessment|1
866600|NCT01447446|2857330|P1|Overall Study|SVR12 Assessment|13
866601|NCT01447446|2857325|P6|Overall Study|Administrative/Other|4
866602|NCT01447446|2857326|P5|Overall Study|Administrative/Other|33
866603|NCT01447446|2857327|P4|Overall Study|Administrative/Other|2
866604|NCT01447446|2857328|P3|Overall Study|Administrative/Other|10
866605|NCT01447446|2857329|P2|Overall Study|Administrative/Other|9
866606|NCT01447446|2857330|P1|Overall Study|Administrative/Other|34
866607|NCT01447446|2857325|P6|Overall Study|Insuff. VR/TRT too Short to Expect VR|14
866608|NCT01447446|2857326|P5|Overall Study|Insuff. VR/TRT too Short to Expect VR|92
866609|NCT01447446|2857327|P4|Overall Study|Insuff. VR/TRT too Short to Expect VR|21
866610|NCT01447446|2857328|P3|Overall Study|Insuff. VR/TRT too Short to Expect VR|52
866611|NCT01447446|2857329|P2|Overall Study|Insuff. VR/TRT too Short to Expect VR|71
866612|NCT01447446|2857330|P1|Overall Study|Insuff. VR/TRT too Short to Expect VR|300
866613|NCT01447446|2857325|P6|Overall Study|Failure to Return/Consent Withdrawn|9
866614|NCT01447446|2857326|P5|Overall Study|Failure to Return/Consent Withdrawn|69
866615|NCT01447446|2857327|P4|Overall Study|Failure to Return/Consent Withdrawn|7
866616|NCT01447446|2857328|P3|Overall Study|Failure to Return/Consent Withdrawn|31
866617|NCT01447446|2857329|P2|Overall Study|Failure to Return/Consent Withdrawn|78
866618|NCT01447446|2857330|P1|Overall Study|Failure to Return/Consent Withdrawn|357
866619|NCT01447446|2857325|P6|Overall Study|Adverse Event|0
866620|NCT01447446|2857326|P5|Overall Study|Adverse Event|2
866621|NCT01447446|2857327|P4|Overall Study|Adverse Event|0
866622|NCT01447446|2857328|P3|Overall Study|Adverse Event|1
866623|NCT01447446|2857329|P2|Overall Study|Adverse Event|0
866624|NCT01447446|2857330|P1|Overall Study|Adverse Event|3
866625|NCT01447446|2857325|P6|Overall Study|Death|0
866626|NCT01447446|2857326|P5|Overall Study|Death|7
866627|NCT01447446|2857327|P4|Overall Study|Death|1
866628|NCT01447446|2857328|P3|Overall Study|Death|2
866629|NCT01447446|2857329|P2|Overall Study|Death|3
866630|NCT01447446|2857330|P1|Overall Study|Death|6
866631|NCT01447433|2857420|P2|Overall Study|Protocol Violation|1
866632|NCT01447433|2857421|P1|Overall Study|Protocol Violation|1
866633|NCT01447433|2857420|P2|Overall Study|Withdrawal by Subject|3
866634|NCT01447433|2857421|P1|Overall Study|Withdrawal by Subject|3
866635|NCT01447433|2857420|P2|Overall Study|Lost to Follow-up|2
866636|NCT01447433|2857421|P1|Overall Study|Lost to Follow-up|0
866637|NCT01447420|2857448|P3|Overall Study|Lack of Efficacy|8
866638|NCT01447420|2857449|P2|Overall Study|Lack of Efficacy|19
866639|NCT01447420|2857450|P1|Overall Study|Lack of Efficacy|1
866640|NCT01447420|2857448|P3|Overall Study|Withdrawal by Subject|0
866641|NCT01447420|2857449|P2|Overall Study|Withdrawal by Subject|1
866642|NCT01447420|2857450|P1|Overall Study|Withdrawal by Subject|4
866643|NCT01447420|2857448|P3|Overall Study|Protocol Violation|0
866644|NCT01447420|2857449|P2|Overall Study|Protocol Violation|3
866645|NCT01447420|2857450|P1|Overall Study|Protocol Violation|3
866646|NCT01447420|2857448|P3|Overall Study|Adverse Event|2
866647|NCT01447420|2857449|P2|Overall Study|Adverse Event|4
866648|NCT01447420|2857450|P1|Overall Study|Adverse Event|2
866649|NCT01446874|2857566|P3|Overall Study|Withdrawal by Subject|4
866650|NCT01446874|2857567|P2|Overall Study|Withdrawal by Subject|0
866651|NCT01446874|2857568|P1|Overall Study|Withdrawal by Subject|0
866652|NCT01446874|2857566|P3|Overall Study|Antibiotics for pre-op infection|2
866653|NCT01446874|2857567|P2|Overall Study|Antibiotics for pre-op infection|0
866654|NCT01446874|2857568|P1|Overall Study|Antibiotics for pre-op infection|0
866655|NCT01446874|2857566|P3|Overall Study|Non-compliance|0
866656|NCT01446874|2857567|P2|Overall Study|Non-compliance|4
866657|NCT01446874|2857568|P1|Overall Study|Non-compliance|0
866658|NCT01446874|2857566|P3|Overall Study|No surgery/No qualifying surgery|12
866659|NCT01446874|2857567|P2|Overall Study|No surgery/No qualifying surgery|0
866660|NCT01446874|2857568|P1|Overall Study|No surgery/No qualifying surgery|1
866661|NCT01446874|2857566|P3|Overall Study|Not eligible|0
866662|NCT01446874|2857567|P2|Overall Study|Not eligible|0
866663|NCT01446874|2857568|P1|Overall Study|Not eligible|1
866664|NCT01446796|2857594|P2|Overall Study|Withdrawal by Subject|0
866665|NCT01446796|2857595|P1|Overall Study|Withdrawal by Subject|1
866666|NCT01446419|2857620|P2|Overall Study|Terminated per protocol|0
866667|NCT01446419|2857621|P1|Overall Study|Terminated per protocol|3
866668|NCT01446419|2857620|P2|Overall Study|Withdrawal by Subject|1
866669|NCT01446419|2857621|P1|Overall Study|Withdrawal by Subject|1
866670|NCT01446419|2857620|P2|Overall Study|Death|0
866671|NCT01446419|2857621|P1|Overall Study|Death|1
866672|NCT01446289|2857635|P4|Overall Study|Withdrawal by Subject|0
866673|NCT01446289|2857636|P3|Overall Study|Withdrawal by Subject|1
866674|NCT01446289|2857637|P2|Overall Study|Withdrawal by Subject|0
866675|NCT01446289|2857638|P1|Overall Study|Withdrawal by Subject|1
866676|NCT01446237|2857681|P1|Overall Study|Withdrawal by Subject|7
866677|NCT01446237|2857681|P1|Overall Study|Lost to Follow-up|2
866678|NCT01446237|2857681|P1|Overall Study|Adverse Event|1
866679|NCT01446159|2857693|P4|Overall Study|Not specified|13
866680|NCT01446159|2857694|P3|Overall Study|Not specified|14
866681|NCT01446159|2857695|P2|Overall Study|Not specified|0
866682|NCT01446159|2857696|P1|Overall Study|Not specified|0
866683|NCT01446159|2857693|P4|Overall Study|Death|36
866684|NCT01446159|2857694|P3|Overall Study|Death|43
866685|NCT01446159|2857695|P2|Overall Study|Death|3
866686|NCT01446159|2857696|P1|Overall Study|Death|2
866687|NCT01446159|2857693|P4|Overall Study|Lost to Follow-up|2
866688|NCT01446159|2857694|P3|Overall Study|Lost to Follow-up|1
866689|NCT01446159|2857695|P2|Overall Study|Lost to Follow-up|0
866690|NCT01446159|2857696|P1|Overall Study|Lost to Follow-up|0
866691|NCT01446159|2857693|P4|Overall Study|Withdrawal by Subject|11
866692|NCT01446159|2857694|P3|Overall Study|Withdrawal by Subject|14
866693|NCT01446159|2857695|P2|Overall Study|Withdrawal by Subject|0
866694|NCT01446159|2857696|P1|Overall Study|Withdrawal by Subject|1
866695|NCT01446042|2857771|P3|Overall Study|Other reasons|1
866696|NCT01446042|2857772|P2|Overall Study|Other reasons|1
866697|NCT01446042|2857773|P1|Overall Study|Other reasons|2
866698|NCT01446042|2857771|P3|Overall Study|Lost to Follow-up|0
866699|NCT01446042|2857772|P2|Overall Study|Lost to Follow-up|0
866700|NCT01446042|2857773|P1|Overall Study|Lost to Follow-up|5
866701|NCT01446042|2857771|P3|Overall Study|Adverse Event|4
866702|NCT01446042|2857772|P2|Overall Study|Adverse Event|0
866703|NCT01446042|2857773|P1|Overall Study|Adverse Event|1
866704|NCT01446042|2857771|P3|Overall Study|Withdrawal by Subject|4
866705|NCT01446042|2857772|P2|Overall Study|Withdrawal by Subject|2
866706|NCT01446042|2857773|P1|Overall Study|Withdrawal by Subject|12
866707|NCT01446003|2857784|P2|Period 2|Adverse Event|0
866708|NCT01446003|2857785|P1|Period 2|Adverse Event|1
866709|NCT01446003|2857784|P2|Period 1|Protocol Violation|0
866710|NCT01446003|2857785|P1|Period 1|Protocol Violation|2
866711|NCT01445951|2857806|P3|Overall Study|Cough|0
866712|NCT01445951|2857807|P2|Overall Study|Cough|1
866713|NCT01445951|2857808|P1|Overall Study|Cough|0
866714|NCT01445951|2857806|P3|Overall Study|Sponsor decision - subject travel|0
866715|NCT01445951|2857807|P2|Overall Study|Sponsor decision - subject travel|1
866716|NCT01445951|2857808|P1|Overall Study|Sponsor decision - subject travel|0
866717|NCT01445951|2857806|P3|Overall Study|Non-compliance with protocol|0
866718|NCT01445951|2857807|P2|Overall Study|Non-compliance with protocol|1
866719|NCT01445951|2857808|P1|Overall Study|Non-compliance with protocol|0
866720|NCT01445951|2857806|P3|Overall Study|Non-compliance with study drug|0
866721|NCT01445951|2857807|P2|Overall Study|Non-compliance with study drug|2
866722|NCT01445951|2857808|P1|Overall Study|Non-compliance with study drug|1
866723|NCT01445951|2857806|P3|Overall Study|Death|1
866724|NCT01445951|2857807|P2|Overall Study|Death|0
866725|NCT01445951|2857808|P1|Overall Study|Death|0
866726|NCT01445951|2857806|P3|Overall Study|Pregnancy|4
866727|NCT01445951|2857807|P2|Overall Study|Pregnancy|1
866728|NCT01445951|2857808|P1|Overall Study|Pregnancy|0
866729|NCT01445951|2857806|P3|Overall Study|Lost to Follow-up|4
866730|NCT01445951|2857807|P2|Overall Study|Lost to Follow-up|2
866731|NCT01445951|2857808|P1|Overall Study|Lost to Follow-up|1
866732|NCT01445951|2857806|P3|Overall Study|Physician Decision|0
866733|NCT01445951|2857807|P2|Overall Study|Physician Decision|1
866734|NCT01445951|2857808|P1|Overall Study|Physician Decision|3
866735|NCT01445951|2857806|P3|Overall Study|Withdrawal by Subject|8
866736|NCT01445951|2857807|P2|Overall Study|Withdrawal by Subject|16
866737|NCT01445951|2857808|P1|Overall Study|Withdrawal by Subject|21
866738|NCT01445951|2857806|P3|Overall Study|Protocol Violation|2
866739|NCT01445951|2857807|P2|Overall Study|Protocol Violation|2
866740|NCT01445951|2857808|P1|Overall Study|Protocol Violation|2
866741|NCT01445951|2857806|P3|Overall Study|Adverse Event|0
866742|NCT01445951|2857807|P2|Overall Study|Adverse Event|9
866743|NCT01445951|2857808|P1|Overall Study|Adverse Event|16
866744|NCT01445847|2857876|P2|Overall Study|Missed Data|0
866745|NCT01445847|2857877|P1|Overall Study|Missed Data|1
866746|NCT01445847|2857876|P2|Overall Study|Protocol Violation|14
866747|NCT01445847|2857877|P1|Overall Study|Protocol Violation|13
866748|NCT01445769|2857883|P1|Overall Study|Lost to Follow-up|5
866749|NCT01445769|2857883|P1|Overall Study|Disease Progression|1
866750|NCT01445769|2857883|P1|Overall Study|Consent Withdrawn|2
866751|NCT01445678|2857903|P2|Overall Study|Withdrawal by Subject|5
866752|NCT01445678|2857904|P1|Overall Study|Withdrawal by Subject|9
866753|NCT01445678|2857903|P2|Overall Study|Protocol Violation|1
866754|NCT01445678|2857904|P1|Overall Study|Protocol Violation|1
866755|NCT01445678|2857903|P2|Overall Study|Lost to Follow-up|5
866756|NCT01445678|2857904|P1|Overall Study|Lost to Follow-up|8
866757|NCT01445678|2857903|P2|Overall Study|Lack of Efficacy|2
866758|NCT01445678|2857904|P1|Overall Study|Lack of Efficacy|0
866759|NCT01445678|2857903|P2|Overall Study|Adverse Event|8
866760|NCT01445678|2857904|P1|Overall Study|Adverse Event|12
866761|NCT01445652|2857922|P2|Overall Study|Adverse Event|0
866762|NCT01445652|2857923|P1|Overall Study|Adverse Event|1
866763|NCT01445652|2857922|P2|Overall Study|Failed teach session|0
866764|NCT01445652|2857923|P1|Overall Study|Failed teach session|2
866765|NCT01445652|2857922|P2|Overall Study|Failed to attend scheduled visit|3
866766|NCT01445652|2857923|P1|Overall Study|Failed to attend scheduled visit|2
866767|NCT01445652|2857922|P2|Overall Study|Not comfortable in lenses|0
866768|NCT01445652|2857923|P1|Overall Study|Not comfortable in lenses|5
866769|NCT01445613|2857941|P1|1-year Follow-up|Received a non-study stent|2
866770|NCT01445613|2857941|P1|1-year Follow-up|Physician Decision|2
866771|NCT01445613|2857941|P1|1-year Follow-up|Death|30
866772|NCT01445613|2857941|P1|1-year Follow-up|Lost to Follow-up|2
866773|NCT01445613|2857941|P1|1-year Follow-up|Missed visit|29
866774|NCT01445613|2857941|P1|1-year Follow-up|Withdrawal by Subject|12
866775|NCT01445613|2857941|P1|30-day Follow-up|Death|3
866776|NCT01445613|2857941|P1|30-day Follow-up|Missed visit|23
866777|NCT01445613|2857941|P1|30-day Follow-up|Physician Decision|3
866778|NCT01445613|2857941|P1|30-day Follow-up|Withdrawal by Subject|6
866779|NCT01445548|2857959|P1|Overall Study|Adverse Event|1
866780|NCT01445301|2857983|P3|Overall Study|Withdrawal by Subject|4
866781|NCT01445301|2857984|P2|Overall Study|Withdrawal by Subject|6
866782|NCT01445301|2857985|P1|Overall Study|Withdrawal by Subject|5
866783|NCT01445301|2857983|P3|Overall Study|Physician Decision|0
866784|NCT01445301|2857984|P2|Overall Study|Physician Decision|2
866785|NCT01445301|2857985|P1|Overall Study|Physician Decision|0
866786|NCT01445301|2857983|P3|Overall Study|Protocol-Defined Stopping Criteria|1
866787|NCT01445301|2857984|P2|Overall Study|Protocol-Defined Stopping Criteria|1
866788|NCT01445301|2857985|P1|Overall Study|Protocol-Defined Stopping Criteria|0
866789|NCT01445301|2857983|P3|Overall Study|Protocol Violation|0
866790|NCT01445301|2857984|P2|Overall Study|Protocol Violation|0
866791|NCT01445301|2857985|P1|Overall Study|Protocol Violation|1
866792|NCT01445301|2857983|P3|Overall Study|Lack of Efficacy|0
866793|NCT01445301|2857984|P2|Overall Study|Lack of Efficacy|1
866794|NCT01445301|2857985|P1|Overall Study|Lack of Efficacy|0
866795|NCT01445301|2857983|P3|Overall Study|Adverse Event|4
866796|NCT01445301|2857984|P2|Overall Study|Adverse Event|25
866797|NCT01445301|2857985|P1|Overall Study|Adverse Event|15
866798|NCT01444898|2858055|P1|Overall Study|Withdrawal by Subject|1
866799|NCT01444781|2858070|P3|Overall Study|Withdrawal by Subject|2
866800|NCT01444781|2858071|P2|Overall Study|Withdrawal by Subject|1
866801|NCT01444781|2858072|P1|Overall Study|Withdrawal by Subject|3
866802|NCT01444781|2858070|P3|Overall Study|Lost to Follow-up|1
866803|NCT01444781|2858071|P2|Overall Study|Lost to Follow-up|3
866804|NCT01444781|2858072|P1|Overall Study|Lost to Follow-up|0
866805|NCT01444742|2858110|P1|Overall Study|Death|1
866806|NCT01444651|2858117|P2|Overall Study|Missing data|1
866807|NCT01444651|2858118|P1|Overall Study|Missing data|1
866808|NCT01444651|2858117|P2|Overall Study|Non-fasting|1
866809|NCT01444651|2858118|P1|Overall Study|Non-fasting|2
866810|NCT01444651|2858117|P2|Overall Study|Lost to Follow-up|5
866811|NCT01444651|2858118|P1|Overall Study|Lost to Follow-up|5
866812|NCT01444651|2858117|P2|Overall Study|Adverse Event|2
866813|NCT01444651|2858118|P1|Overall Study|Adverse Event|3
866814|NCT01444456|2858134|P1|Overall Study|Not treated|104
866815|NCT01444456|2858134|P1|Overall Study|Other|18
866816|NCT01444456|2858134|P1|Overall Study|Ineligibility determined|23
866817|NCT01444456|2858134|P1|Overall Study|Death|73
866818|NCT01444456|2858134|P1|Overall Study|Lost to Follow-up|37
866819|NCT01444456|2858134|P1|Overall Study|Physician Decision|9
866820|NCT01444456|2858134|P1|Overall Study|Withdrawal by Subject|21
866821|NCT01444430|2858145|P2|Overall Study|CRF termination module not completed.|1
866822|NCT01444430|2858146|P1|Overall Study|CRF termination module not completed.|0
866823|NCT01444430|2858145|P2|Overall Study|Lost to Follow-up|0
866824|NCT01444430|2858146|P1|Overall Study|Lost to Follow-up|2
866825|NCT01444430|2858145|P2|Overall Study|Death|8
866826|NCT01444430|2858146|P1|Overall Study|Death|6
866827|NCT01444430|2858145|P2|Overall Study|Withdrawal by Subject|72
866828|NCT01444430|2858146|P1|Overall Study|Withdrawal by Subject|53
866829|NCT01444417|2858168|P2|Overall Study|Withdrawal by Subject|0
866830|NCT01444417|2858169|P1|Overall Study|Withdrawal by Subject|2
866831|NCT01444417|2858168|P2|Overall Study|Ineligibility Determined|1
866832|NCT01444417|2858169|P1|Overall Study|Ineligibility Determined|0
866833|NCT01444391|2858185|P1|Overall Study|Death|1
866834|NCT01444378|2858193|P1|Overall Study|Missed Visits|10
866835|NCT01444378|2858193|P1|Overall Study|Administrative Closure Of The Study|2
866836|NCT01444378|2858193|P1|Overall Study|Death|3
866837|NCT01444378|2858193|P1|Overall Study|Withdrawal by Subject|1
866838|NCT01444378|2858193|P1|Overall Study|Lost to Follow-up|1
866839|NCT01444300|2858305|P2|Overall Study|Adverse Event|0
866840|NCT01444300|2858306|P1|Overall Study|Adverse Event|4
866841|NCT01444092|2858338|P1|Overall Study|Other Eligibility criteria|7
866842|NCT01444092|2858338|P1|Overall Study|Withdrawal by Subject|1
866843|NCT01444092|2858338|P1|Overall Study|Protocol Violation|1
866844|NCT01444092|2858338|P1|Overall Study|Adverse Event|8
866845|NCT01444027|2858347|P3|Overall Study|Lost to Follow-up|14
866846|NCT01444027|2858348|P2|Overall Study|Lost to Follow-up|20
866847|NCT01444027|2858349|P1|Overall Study|Lost to Follow-up|26
866848|NCT01444027|2858347|P3|Overall Study|Withdrawal by Subject|24
866849|NCT01444027|2858348|P2|Overall Study|Withdrawal by Subject|10
866850|NCT01444027|2858349|P1|Overall Study|Withdrawal by Subject|4
866851|NCT01443923|2858371|P2|Overall Study|Adverse Event|0
866852|NCT01443923|2858372|P1|Overall Study|Adverse Event|1
866853|NCT01443858|2858389|P3|Overall Study|Lost to Follow-up|2
866854|NCT01443858|2858390|P2|Overall Study|Lost to Follow-up|5
866855|NCT01443858|2858391|P1|Overall Study|Lost to Follow-up|5
866856|NCT01443858|2858389|P3|Overall Study|Lack of Efficacy|0
866857|NCT01443858|2858390|P2|Overall Study|Lack of Efficacy|0
866858|NCT01443858|2858391|P1|Overall Study|Lack of Efficacy|1
866859|NCT01443858|2858389|P3|Overall Study|Withdrawal by Subject|5
866860|NCT01443858|2858390|P2|Overall Study|Withdrawal by Subject|8
866861|NCT01443858|2858391|P1|Overall Study|Withdrawal by Subject|9
866862|NCT01443845|2858413|P2|Overall Study|Lost to Follow-up|13
866863|NCT01443845|2858414|P1|Overall Study|Lost to Follow-up|9
866864|NCT01443845|2858413|P2|Overall Study|Military Conflict - Site Terminated|21
866865|NCT01443845|2858414|P1|Overall Study|Military Conflict - Site Terminated|20
866866|NCT01443845|2858413|P2|Overall Study|Withdrawal by Subject|67
866867|NCT01443845|2858414|P1|Overall Study|Withdrawal by Subject|63
866868|NCT01443845|2858413|P2|Overall Study|Adverse Event|138
866869|NCT01443845|2858414|P1|Overall Study|Adverse Event|64
866870|NCT01443845|2858413|P2|Overall Study|Lack of Efficacy|5
866871|NCT01443845|2858414|P1|Overall Study|Lack of Efficacy|10
866872|NCT01443845|2858413|P2|Overall Study|Deterioration in pulmonary function|4
866873|NCT01443845|2858414|P1|Overall Study|Deterioration in pulmonary function|1
866874|NCT01443845|2858413|P2|Overall Study|Other reasons, such as COPD exacerbation|44
866875|NCT01443845|2858414|P1|Overall Study|Other reasons, such as COPD exacerbation|44
866876|NCT01443845|2858413|P2|Overall Study|Protocol Violation|45
866877|NCT01443845|2858414|P1|Overall Study|Protocol Violation|43
866878|NCT01443403|2858435|P4|Overall Study|Other - Miscellaneous|1
866879|NCT01443403|2858436|P3|Overall Study|Other - Miscellaneous|0
866880|NCT01443403|2858437|P2|Overall Study|Other - Miscellaneous|0
866881|NCT01443403|2858438|P1|Overall Study|Other - Miscellaneous|1
866882|NCT01443403|2858435|P4|Overall Study|Use of Prohibited Treatment|0
866883|NCT01443403|2858436|P3|Overall Study|Use of Prohibited Treatment|0
866884|NCT01443403|2858437|P2|Overall Study|Use of Prohibited Treatment|3
866885|NCT01443403|2858438|P1|Overall Study|Use of Prohibited Treatment|2
866886|NCT01443403|2858435|P4|Overall Study|Protocol Violation|1
866887|NCT01443403|2858436|P3|Overall Study|Protocol Violation|1
866888|NCT01443403|2858437|P2|Overall Study|Protocol Violation|1
866889|NCT01443403|2858438|P1|Overall Study|Protocol Violation|2
866890|NCT01443403|2858435|P4|Overall Study|Lost to Follow-up|1
866891|NCT01443403|2858436|P3|Overall Study|Lost to Follow-up|0
866892|NCT01443403|2858437|P2|Overall Study|Lost to Follow-up|0
866893|NCT01443403|2858438|P1|Overall Study|Lost to Follow-up|0
866894|NCT01443403|2858435|P4|Overall Study|Withdrawal by Subject|1
866895|NCT01443403|2858436|P3|Overall Study|Withdrawal by Subject|2
866896|NCT01443403|2858437|P2|Overall Study|Withdrawal by Subject|1
866897|NCT01443403|2858438|P1|Overall Study|Withdrawal by Subject|0
866898|NCT01443403|2858435|P4|Overall Study|Adverse Event|5
866899|NCT01443403|2858436|P3|Overall Study|Adverse Event|4
866900|NCT01443403|2858437|P2|Overall Study|Adverse Event|1
866901|NCT01443403|2858438|P1|Overall Study|Adverse Event|1
866902|NCT01443364|2858585|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
866903|NCT01443364|2858585|P1|Overall Study|AE, non-serious non-fatal|8
866904|NCT01443364|2858585|P1|Overall Study|SAE, non-fatal|6
866905|NCT01443364|2858585|P1|Overall Study|Other Reason|4
866906|NCT01443364|2858585|P1|Overall Study|Withdrawal by Subject|5
866907|NCT01443364|2858585|P1|Overall Study|Lost to Follow-up|3
866908|NCT01443364|2858585|P1|Overall Study|Lack of Efficacy|14
866909|NCT01443130|2858714|P6|Overall Study|Death of Subject's Infant|0
866910|NCT01443130|2858715|P5|Overall Study|Death of Subject's Infant|0
866911|NCT01443130|2858716|P4|Overall Study|Death of Subject's Infant|0
866912|NCT01443130|2858717|P3|Overall Study|Death of Subject's Infant|11
866913|NCT01443130|2858718|P2|Overall Study|Death of Subject's Infant|10
866914|NCT01443130|2858719|P1|Overall Study|Death of Subject's Infant|5
866915|NCT01443130|2858714|P6|Overall Study|Withdrawal by Subject|2
866916|NCT01443130|2858715|P5|Overall Study|Withdrawal by Subject|7
866917|NCT01443130|2858716|P4|Overall Study|Withdrawal by Subject|7
866918|NCT01443130|2858717|P3|Overall Study|Withdrawal by Subject|12
866919|NCT01443130|2858718|P2|Overall Study|Withdrawal by Subject|14
866920|NCT01443130|2858719|P1|Overall Study|Withdrawal by Subject|15
866921|NCT01443130|2858714|P6|Overall Study|Protocol Violation|3
866922|NCT01443130|2858715|P5|Overall Study|Protocol Violation|2
866923|NCT01443130|2858716|P4|Overall Study|Protocol Violation|2
866924|NCT01443130|2858717|P3|Overall Study|Protocol Violation|3
866925|NCT01443130|2858718|P2|Overall Study|Protocol Violation|1
866926|NCT01443130|2858719|P1|Overall Study|Protocol Violation|2
866927|NCT01443130|2858714|P6|Overall Study|Adverse Event|0
866928|NCT01443130|2858715|P5|Overall Study|Adverse Event|0
866929|NCT01443130|2858716|P4|Overall Study|Adverse Event|0
866930|NCT01443130|2858717|P3|Overall Study|Adverse Event|1
866931|NCT01443130|2858718|P2|Overall Study|Adverse Event|1
866932|NCT01443130|2858719|P1|Overall Study|Adverse Event|2
866933|NCT01443130|2858714|P6|Overall Study|Death|8
866934|NCT01443130|2858715|P5|Overall Study|Death|10
866935|NCT01443130|2858716|P4|Overall Study|Death|7
866936|NCT01443130|2858717|P3|Overall Study|Death|0
866937|NCT01443130|2858718|P2|Overall Study|Death|1
866938|NCT01443130|2858719|P1|Overall Study|Death|0
866939|NCT01443130|2858714|P6|Overall Study|Lost to Follow-up|21
866940|NCT01443130|2858715|P5|Overall Study|Lost to Follow-up|25
866941|NCT01443130|2858716|P4|Overall Study|Lost to Follow-up|23
866942|NCT01443130|2858717|P3|Overall Study|Lost to Follow-up|50
866943|NCT01443130|2858718|P2|Overall Study|Lost to Follow-up|42
866944|NCT01443130|2858719|P1|Overall Study|Lost to Follow-up|44
866945|NCT01443078|2858769|P1|Overall Study|Patient had brain mets|1
866946|NCT01443078|2858769|P1|Overall Study|Withdrawal by Subject|1
866947|NCT01443078|2858769|P1|Overall Study|Responded to neoadjuvant platinum txt|27
866948|NCT01443026|2858776|P2|Overall Study|Lost to Follow-up|1
866949|NCT01443026|2858777|P1|Overall Study|Lost to Follow-up|2
866950|NCT01443026|2858776|P2|Overall Study|Withdrawal by Subject|3
866951|NCT01443026|2858777|P1|Overall Study|Withdrawal by Subject|0
866952|NCT01443026|2858776|P2|Overall Study|Death|1
866953|NCT01443026|2858777|P1|Overall Study|Death|0
866954|NCT01443026|2858776|P2|Overall Study|Physician Decision|0
866955|NCT01443026|2858777|P1|Overall Study|Physician Decision|1
866956|NCT01442779|2858792|P1|Overall Study|Non-compliance|1
866957|NCT01442779|2858792|P1|Overall Study|Death|3
866958|NCT01442779|2858792|P1|Overall Study|Withdrawal by Subject|3
866959|NCT01442714|2858798|P1|Overall Study|Withdrawal by Subject|1
866960|NCT01442714|2858798|P1|Overall Study|Death|11
866961|NCT01442688|2858806|P2|Second Intervention|Adverse Event|0
866962|NCT01442688|2858807|P1|Second Intervention|Adverse Event|1
866963|NCT01442688|2858806|P2|First Intervention|subject incarcerated|0
866964|NCT01442688|2858807|P1|First Intervention|subject incarcerated|1
866965|NCT01442688|2858806|P2|First Intervention|Withdrawal by Subject|0
866966|NCT01442688|2858807|P1|First Intervention|Withdrawal by Subject|1
866967|NCT01442675|2858815|P1|Overall Study|Withdrawal by Subject|4
866968|NCT01442675|2858815|P1|Overall Study|Lost to Follow-up|2
866969|NCT01442675|2858815|P1|Overall Study|Protocol Violation|6
866970|NCT01442493|2858827|P2|Overall Study|withdrawn from study|2
866971|NCT01442493|2858828|P1|Overall Study|withdrawn from study|3
866972|NCT01442376|2858849|P3|Overall Study|Not eligible for subsequent cycles|0
866973|NCT01442376|2858850|P2|Overall Study|Not eligible for subsequent cycles|2
866974|NCT01442376|2858851|P1|Overall Study|Not eligible for subsequent cycles|1
866975|NCT01442376|2858849|P3|Overall Study|Patients not treated|1
866976|NCT01442376|2858850|P2|Overall Study|Patients not treated|3
866977|NCT01442376|2858851|P1|Overall Study|Patients not treated|2
866978|NCT01442376|2858849|P3|Overall Study|Withdrawal of consent|1
866979|NCT01442376|2858850|P2|Overall Study|Withdrawal of consent|0
866980|NCT01442376|2858851|P1|Overall Study|Withdrawal of consent|0
866981|NCT01442376|2858849|P3|Overall Study|Death|1
866982|NCT01442376|2858850|P2|Overall Study|Death|1
866983|NCT01442376|2858851|P1|Overall Study|Death|0
866984|NCT01442376|2858849|P3|Overall Study|Adverse Event|2
866985|NCT01442376|2858850|P2|Overall Study|Adverse Event|3
866986|NCT01442376|2858851|P1|Overall Study|Adverse Event|0
866987|NCT01442181|2858864|P2|Overall Study|atrial fibrillation not noted|1
866988|NCT01442181|2858865|P1|Overall Study|atrial fibrillation not noted|0
866989|NCT01442181|2858864|P2|Overall Study|patient in an additional study|0
866990|NCT01442181|2858865|P1|Overall Study|patient in an additional study|1
866991|NCT01442181|2858864|P2|Overall Study|Lost to Follow-up|1
866992|NCT01442181|2858865|P1|Overall Study|Lost to Follow-up|1
866993|NCT01442181|2858864|P2|Overall Study|low ejection factor|1
866994|NCT01442181|2858865|P1|Overall Study|low ejection factor|0
866995|NCT01442181|2858864|P2|Overall Study|no insurance for surgery|0
866996|NCT01442181|2858865|P1|Overall Study|no insurance for surgery|1
866997|NCT01442181|2858864|P2|Overall Study|patient refused surgery|0
866998|NCT01442181|2858865|P1|Overall Study|patient refused surgery|1
866999|NCT01442155|2858889|P1|Overall Study|Lost to Follow-up|2
867000|NCT01442155|2858889|P1|Overall Study|Adverse Event|2
867001|NCT01442155|2858889|P1|Overall Study|Recurrence|26
867002|NCT01442155|2858889|P1|Overall Study|Complete remission|35
867003|NCT01442103|2858905|P1|Overall Study|Lost to Follow-up|2
867004|NCT01442064|2858915|P6|Overall Study|Condition mandated other intervention|2
867005|NCT01442064|2858916|P5|Overall Study|Condition mandated other intervention|0
867006|NCT01442064|2858917|P4|Overall Study|Condition mandated other intervention|0
867007|NCT01442064|2858918|P3|Overall Study|Condition mandated other intervention|2
867008|NCT01442064|2858919|P2|Overall Study|Condition mandated other intervention|1
867009|NCT01442064|2858920|P1|Overall Study|Condition mandated other intervention|1
867010|NCT01442064|2858915|P6|Overall Study|Subject non-compliance|2
867011|NCT01442064|2858916|P5|Overall Study|Subject non-compliance|0
867012|NCT01442064|2858917|P4|Overall Study|Subject non-compliance|0
867013|NCT01442064|2858918|P3|Overall Study|Subject non-compliance|0
867014|NCT01442064|2858919|P2|Overall Study|Subject non-compliance|0
867015|NCT01442064|2858920|P1|Overall Study|Subject non-compliance|0
867016|NCT01442064|2858915|P6|Overall Study|Sponsor decision|87
867017|NCT01442064|2858916|P5|Overall Study|Sponsor decision|95
867018|NCT01442064|2858917|P4|Overall Study|Sponsor decision|88
867019|NCT01442064|2858918|P3|Overall Study|Sponsor decision|92
867020|NCT01442064|2858919|P2|Overall Study|Sponsor decision|88
867021|NCT01442064|2858920|P1|Overall Study|Sponsor decision|82
867022|NCT01442064|2858915|P6|Overall Study|Withdrawal by Subject|1
867023|NCT01442064|2858916|P5|Overall Study|Withdrawal by Subject|2
867024|NCT01442064|2858917|P4|Overall Study|Withdrawal by Subject|2
867025|NCT01442064|2858918|P3|Overall Study|Withdrawal by Subject|2
867026|NCT01442064|2858919|P2|Overall Study|Withdrawal by Subject|3
867027|NCT01442064|2858920|P1|Overall Study|Withdrawal by Subject|6
867028|NCT01442064|2858915|P6|Overall Study|Physician Decision|1
867029|NCT01442064|2858916|P5|Overall Study|Physician Decision|3
867030|NCT01442064|2858917|P4|Overall Study|Physician Decision|3
867031|NCT01442064|2858918|P3|Overall Study|Physician Decision|2
867032|NCT01442064|2858919|P2|Overall Study|Physician Decision|1
867033|NCT01442064|2858920|P1|Overall Study|Physician Decision|1
867034|NCT01442064|2858915|P6|Overall Study|Lost to Follow-up|3
867035|NCT01442064|2858916|P5|Overall Study|Lost to Follow-up|3
867036|NCT01442064|2858917|P4|Overall Study|Lost to Follow-up|1
867037|NCT01442064|2858918|P3|Overall Study|Lost to Follow-up|1
867038|NCT01442064|2858919|P2|Overall Study|Lost to Follow-up|5
867039|NCT01442064|2858920|P1|Overall Study|Lost to Follow-up|5
867040|NCT01442064|2858915|P6|Overall Study|Death|3
867041|NCT01442064|2858916|P5|Overall Study|Death|1
867042|NCT01442064|2858917|P4|Overall Study|Death|3
867043|NCT01442064|2858918|P3|Overall Study|Death|3
867044|NCT01442064|2858919|P2|Overall Study|Death|1
867045|NCT01442064|2858920|P1|Overall Study|Death|0
867046|NCT01442064|2858915|P6|Overall Study|Adverse Event|0
867047|NCT01442064|2858916|P5|Overall Study|Adverse Event|2
867048|NCT01442064|2858917|P4|Overall Study|Adverse Event|1
867049|NCT01442064|2858918|P3|Overall Study|Adverse Event|2
867050|NCT01442064|2858919|P2|Overall Study|Adverse Event|2
867051|NCT01442064|2858920|P1|Overall Study|Adverse Event|2
867052|NCT01442038|2858957|P2|Overall Study|Study Terminated By Sponsor|3
867053|NCT01442038|2858958|P1|Overall Study|Study Terminated By Sponsor|2
867054|NCT01442038|2858957|P2|Overall Study|Investigator's Discretion|16
867055|NCT01442038|2858958|P1|Overall Study|Investigator's Discretion|13
867056|NCT01442038|2858957|P2|Overall Study|Protocol Deviation|20
867057|NCT01442038|2858958|P1|Overall Study|Protocol Deviation|9
867058|NCT01442038|2858957|P2|Overall Study|Adverse Event|15
867059|NCT01442038|2858958|P1|Overall Study|Adverse Event|26
867060|NCT01442038|2858957|P2|Overall Study|Lost to Follow-up|51
867061|NCT01442038|2858958|P1|Overall Study|Lost to Follow-up|37
867062|NCT01442038|2858957|P2|Overall Study|Participant Withdrew Consent|102
867063|NCT01442038|2858958|P1|Overall Study|Participant Withdrew Consent|137
867064|NCT01442038|2858957|P2|Overall Study|Investigator-Initiated Early Closure|43
867065|NCT01442038|2858958|P1|Overall Study|Investigator-Initiated Early Closure|44
867066|NCT01442038|2858957|P2|Overall Study|Death|29
867067|NCT01442038|2858958|P1|Overall Study|Death|35
867068|NCT01441973|2858972|P2|Overall Study|Participant withdrew consent|1
867069|NCT01441973|2858973|P1|Overall Study|Participant withdrew consent|0
867070|NCT01441973|2858972|P2|Overall Study|Administrative reason by sponsor|5
867071|NCT01441973|2858973|P1|Overall Study|Administrative reason by sponsor|3
867072|NCT01441973|2858972|P2|Overall Study|Poor compliance/noncompliance|1
867073|NCT01441973|2858973|P1|Overall Study|Poor compliance/noncompliance|0
867074|NCT01441973|2858972|P2|Overall Study|Participant request to discontinue|1
867075|NCT01441973|2858973|P1|Overall Study|Participant request to discontinue|1
867076|NCT01441973|2858972|P2|Overall Study|Adverse event unrelated to study drug|2
867077|NCT01441973|2858973|P1|Overall Study|Adverse event unrelated to study drug|3
867078|NCT01441973|2858972|P2|Overall Study|Disease progression|6
867079|NCT01441973|2858973|P1|Overall Study|Disease progression|8
867080|NCT01441960|2858995|P2|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0
867081|NCT01441960|2858996|P1|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1
867082|NCT01441960|2858995|P2|First Neuromuscular Blocking Agent:|Protocol Violation|1
867083|NCT01441960|2858996|P1|First Neuromuscular Blocking Agent:|Protocol Violation|1
867084|NCT01441960|2858995|P2|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5
867085|NCT01441960|2858996|P1|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6
867086|NCT01441765|2859021|P2|Overall Study|Death|0
867087|NCT01441765|2859022|P1|Overall Study|Death|1
867088|NCT01441596|2859039|P3|Overall Study|Not treated|1
867089|NCT01441596|2859040|P2|Overall Study|Not treated|1
867090|NCT01441596|2859041|P1|Overall Study|Not treated|0
867091|NCT01441596|2859039|P3|Overall Study|Withdrawal by Subject|2
867092|NCT01441596|2859040|P2|Overall Study|Withdrawal by Subject|0
867093|NCT01441596|2859041|P1|Overall Study|Withdrawal by Subject|4
867094|NCT01441596|2859039|P3|Overall Study|Other reason not defined below|1
867095|NCT01441596|2859040|P2|Overall Study|Other reason not defined below|2
867096|NCT01441596|2859041|P1|Overall Study|Other reason not defined below|0
867097|NCT01441440|2859088|P3|Overall Study|Difficllty in keeping the schedule|0
867098|NCT01441440|2859089|P2|Overall Study|Difficllty in keeping the schedule|1
867099|NCT01441440|2859090|P1|Overall Study|Difficllty in keeping the schedule|1
867100|NCT01441440|2859088|P3|Overall Study|Work-related matter|0
867101|NCT01441440|2859089|P2|Overall Study|Work-related matter|1
867102|NCT01441440|2859090|P1|Overall Study|Work-related matter|0
867103|NCT01441440|2859088|P3|Overall Study|Moving|1
867104|NCT01441440|2859089|P2|Overall Study|Moving|1
867105|NCT01441440|2859090|P1|Overall Study|Moving|0
867106|NCT01441440|2859088|P3|Overall Study|Lack of Efficacy|1
867107|NCT01441440|2859089|P2|Overall Study|Lack of Efficacy|0
867108|NCT01441440|2859090|P1|Overall Study|Lack of Efficacy|1
867109|NCT01441440|2859088|P3|Overall Study|Pregnancy|0
867110|NCT01441440|2859089|P2|Overall Study|Pregnancy|0
867111|NCT01441440|2859090|P1|Overall Study|Pregnancy|1
867112|NCT01441440|2859088|P3|Overall Study|Withdrawal by Subject|9
867113|NCT01441440|2859089|P2|Overall Study|Withdrawal by Subject|9
867114|NCT01441440|2859090|P1|Overall Study|Withdrawal by Subject|11
867115|NCT01441440|2859088|P3|Overall Study|Lost to Follow-up|1
867116|NCT01441440|2859089|P2|Overall Study|Lost to Follow-up|2
867117|NCT01441440|2859090|P1|Overall Study|Lost to Follow-up|0
867118|NCT01441440|2859088|P3|Overall Study|Adverse Event|9
867119|NCT01441440|2859089|P2|Overall Study|Adverse Event|9
867120|NCT01441440|2859090|P1|Overall Study|Adverse Event|2
867121|NCT01441440|2859088|P3|Overall Study|Death|1
867122|NCT01441440|2859089|P2|Overall Study|Death|0
867123|NCT01441440|2859090|P1|Overall Study|Death|1
867124|NCT01441414|2859113|P1|Overall Study|Subject refused further follow-up|1
867125|NCT01441414|2859113|P1|Overall Study|Study terminated by sponsor|2
867126|NCT01441414|2859113|P1|Overall Study|Other reasons|3
867127|NCT01441414|2859113|P1|Overall Study|Participant died|9
867128|NCT01441180|2859192|P3|Overall Study|Discontinued|2
867129|NCT01441180|2859193|P2|Overall Study|Discontinued|0
867130|NCT01441180|2859194|P1|Overall Study|Discontinued|0
867131|NCT01441180|2859192|P3|Overall Study|Lost to Follow-up|1
867132|NCT01441180|2859193|P2|Overall Study|Lost to Follow-up|1
867133|NCT01441180|2859194|P1|Overall Study|Lost to Follow-up|1
867134|NCT01441102|2859205|P1|Overall Study|Withdrawal by Subject|2
867135|NCT01441102|2859205|P1|Overall Study|Adverse Event|1
867136|NCT01440972|2859249|P2|Overall Study|Withdrawal by Subject|2
867137|NCT01440972|2859250|P1|Overall Study|Withdrawal by Subject|3
867138|NCT01440946|2859274|P2|Overall Study|Physician Decision|0
867139|NCT01440946|2859275|P1|Overall Study|Physician Decision|1
867140|NCT01440946|2859274|P2|Overall Study|Lost to Follow-up|1
867141|NCT01440946|2859275|P1|Overall Study|Lost to Follow-up|1
867142|NCT01440881|2859314|P2|Overall Study|Death|1
867143|NCT01440881|2859315|P1|Overall Study|Death|0
867144|NCT01440816|2859329|P2|Overall Study|To Be Seen By Local Oncologist|2
867145|NCT01440816|2859330|P1|Overall Study|To Be Seen By Local Oncologist|1
867146|NCT01440816|2859329|P2|Overall Study|Disease Progression|9
867147|NCT01440816|2859330|P1|Overall Study|Disease Progression|0
867148|NCT01440647|2859373|P2|Overall Study|Death|3
867149|NCT01440647|2859374|P1|Overall Study|Death|2
867150|NCT01440595|2859393|P3|Overall Study|Study terminated by sponsor.|1
867151|NCT01440595|2859394|P2|Overall Study|Study terminated by sponsor.|2
867152|NCT01440595|2859395|P1|Overall Study|Study terminated by sponsor.|1
867153|NCT01440595|2859393|P3|Overall Study|Lost to Follow-up|0
867154|NCT01440595|2859394|P2|Overall Study|Lost to Follow-up|1
867155|NCT01440595|2859395|P1|Overall Study|Lost to Follow-up|0
867156|NCT01440569|2859415|P2|Open-Label Rollover Phase|Subject Non-Compliance|1
867157|NCT01440569|2859416|P1|Open-Label Rollover Phase|Subject Non-Compliance|1
867158|NCT01440569|2859415|P2|Open-Label Rollover Phase|Lost to Follow-up|3
867159|NCT01440569|2859416|P1|Open-Label Rollover Phase|Lost to Follow-up|26
867160|NCT01440569|2859415|P2|Open-Label Rollover Phase|Withdrew Consent|1
867161|NCT01440569|2859416|P1|Open-Label Rollover Phase|Withdrew Consent|11
867162|NCT01440569|2859415|P2|Open-Label Rollover Phase|Investigator’s Discretion|1
867163|NCT01440569|2859416|P1|Open-Label Rollover Phase|Investigator’s Discretion|3
867164|NCT01440569|2859415|P2|Open-Label Rollover Phase|Lack of Efficacy|0
867165|NCT01440569|2859416|P1|Open-Label Rollover Phase|Lack of Efficacy|2
867166|NCT01440569|2859415|P2|Open-Label Rollover Phase|Pregnancy|0
867167|NCT01440569|2859416|P1|Open-Label Rollover Phase|Pregnancy|1
867168|NCT01440569|2859415|P2|Open-Label Rollover Phase|Adverse Event|0
867169|NCT01440569|2859416|P1|Open-Label Rollover Phase|Adverse Event|3
867170|NCT01440569|2859415|P2|Main Study|Protocol Violation|0
867171|NCT01440569|2859416|P1|Main Study|Protocol Violation|1
867172|NCT01440569|2859415|P2|Main Study|Subject Non-Compliance|0
867173|NCT01440569|2859416|P1|Main Study|Subject Non-Compliance|3
867174|NCT01440569|2859415|P2|Main Study|Lost to Follow-up|2
867175|NCT01440569|2859416|P1|Main Study|Lost to Follow-up|13
867176|NCT01440569|2859415|P2|Main Study|Withdrew Consent|1
867177|NCT01440569|2859416|P1|Main Study|Withdrew Consent|7
867178|NCT01440569|2859415|P2|Main Study|Investigator's Discretion|1
867179|NCT01440569|2859416|P1|Main Study|Investigator's Discretion|1
867180|NCT01440569|2859415|P2|Main Study|Pregnancy|0
867181|NCT01440569|2859416|P1|Main Study|Pregnancy|1
867182|NCT01440569|2859415|P2|Main Study|Adverse Event|0
867183|NCT01440569|2859416|P1|Main Study|Adverse Event|9
867184|NCT01440569|2859415|P2|Main Study|Enrolled but not treated|0
867185|NCT01440569|2859416|P1|Main Study|Enrolled but not treated|1
867186|NCT01440517|2859451|P1|Overall Study|Subject withdrawn prior to dosing|1
867187|NCT01440374|2859482|P4|Part 3: Extension|Physician Decision|14
867188|NCT01440374|2859483|P3|Part 3: Extension|Physician Decision|0
867189|NCT01440374|2859484|P2|Part 3: Extension|Physician Decision|0
867190|NCT01440374|2859485|P1|Part 3: Extension|Physician Decision|0
867191|NCT01440374|2859482|P4|Part 3: Extension|Adverse Event|13
867192|NCT01440374|2859483|P3|Part 3: Extension|Adverse Event|0
867193|NCT01440374|2859484|P2|Part 3: Extension|Adverse Event|0
867194|NCT01440374|2859485|P1|Part 3: Extension|Adverse Event|0
867195|NCT01440374|2859482|P4|Part 3: Extension|Withdrawal by Subject|5
867196|NCT01440374|2859483|P3|Part 3: Extension|Withdrawal by Subject|0
867197|NCT01440374|2859484|P2|Part 3: Extension|Withdrawal by Subject|0
867198|NCT01440374|2859485|P1|Part 3: Extension|Withdrawal by Subject|0
867199|NCT01440374|2859482|P4|Part 2; Double-blind Phase|Not treated|0
867200|NCT01440374|2859483|P3|Part 2; Double-blind Phase|Not treated|1
867201|NCT01440374|2859484|P2|Part 2; Double-blind Phase|Not treated|0
867202|NCT01440374|2859485|P1|Part 2; Double-blind Phase|Not treated|0
867203|NCT01440374|2859482|P4|Part 2; Double-blind Phase|Adverse Event|0
867204|NCT01440374|2859483|P3|Part 2; Double-blind Phase|Adverse Event|31
867205|NCT01440374|2859484|P2|Part 2; Double-blind Phase|Adverse Event|7
867206|NCT01440374|2859485|P1|Part 2; Double-blind Phase|Adverse Event|0
867207|NCT01440374|2859482|P4|Part 2; Double-blind Phase|Lack of Efficacy|0
867208|NCT01440374|2859483|P3|Part 2; Double-blind Phase|Lack of Efficacy|0
867209|NCT01440374|2859484|P2|Part 2; Double-blind Phase|Lack of Efficacy|1
867210|NCT01440374|2859485|P1|Part 2; Double-blind Phase|Lack of Efficacy|0
867211|NCT01440374|2859482|P4|Part 2; Double-blind Phase|Protocol Violation|0
867212|NCT01440374|2859483|P3|Part 2; Double-blind Phase|Protocol Violation|1
867213|NCT01440374|2859484|P2|Part 2; Double-blind Phase|Protocol Violation|0
867214|NCT01440374|2859485|P1|Part 2; Double-blind Phase|Protocol Violation|0
867215|NCT01440374|2859482|P4|Part 2; Double-blind Phase|Withdrawal by Subject|0
867216|NCT01440374|2859483|P3|Part 2; Double-blind Phase|Withdrawal by Subject|5
867217|NCT01440374|2859484|P2|Part 2; Double-blind Phase|Withdrawal by Subject|4
867218|NCT01440374|2859485|P1|Part 2; Double-blind Phase|Withdrawal by Subject|0
867219|NCT01440374|2859482|P4|Part 2; Double-blind Phase|Physician Decision|0
867220|NCT01440374|2859483|P3|Part 2; Double-blind Phase|Physician Decision|17
867221|NCT01440374|2859484|P2|Part 2; Double-blind Phase|Physician Decision|8
867222|NCT01440374|2859485|P1|Part 2; Double-blind Phase|Physician Decision|0
867223|NCT01440374|2859482|P4|Part 1: Open-label Phase|Physician Decision|0
867224|NCT01440374|2859483|P3|Part 1: Open-label Phase|Physician Decision|0
867225|NCT01440374|2859484|P2|Part 1: Open-label Phase|Physician Decision|0
867226|NCT01440374|2859485|P1|Part 1: Open-label Phase|Physician Decision|1
867227|NCT01440374|2859482|P4|Part 1: Open-label Phase|Adverse Event|0
867228|NCT01440374|2859483|P3|Part 1: Open-label Phase|Adverse Event|0
867229|NCT01440374|2859484|P2|Part 1: Open-label Phase|Adverse Event|0
867230|NCT01440374|2859485|P1|Part 1: Open-label Phase|Adverse Event|5
867231|NCT01440322|2859520|P2|Overall Study|Other Non-Product Related|0
867232|NCT01440322|2859521|P1|Overall Study|Other Non-Product Related|1
867233|NCT01440322|2859520|P2|Overall Study|Unrelated Medical Problem|1
867234|NCT01440322|2859521|P1|Overall Study|Unrelated Medical Problem|0
867235|NCT01440322|2859520|P2|Overall Study|Other Product Related|0
867236|NCT01440322|2859521|P1|Overall Study|Other Product Related|1
867237|NCT01440322|2859520|P2|Overall Study|Unacceptable Subjective Vision|0
867238|NCT01440322|2859521|P1|Overall Study|Unacceptable Subjective Vision|1
867239|NCT01440322|2859520|P2|Overall Study|Symptoms and Problems|0
867240|NCT01440322|2859521|P1|Overall Study|Symptoms and Problems|1
867241|NCT01440322|2859520|P2|Overall Study|Biomicroscopy|0
867242|NCT01440322|2859521|P1|Overall Study|Biomicroscopy|1
867243|NCT01440322|2859520|P2|Overall Study|Discomfort|0
867244|NCT01440322|2859521|P1|Overall Study|Discomfort|2
867245|NCT01440283|2859543|P1|Overall Study|Physician Decision|3
867246|NCT01440283|2859543|P1|Overall Study|Withdrawal by Subject|4
867247|NCT01440283|2859543|P1|Overall Study|Death|3
867248|NCT01440101|2859558|P3|Overall Study|Not Specified|0
867249|NCT01440101|2859559|P2|Overall Study|Not Specified|1
867250|NCT01440101|2859560|P1|Overall Study|Not Specified|0
867251|NCT01440101|2859558|P3|Overall Study|Withdrawal by Subject|1
867252|NCT01440101|2859559|P2|Overall Study|Withdrawal by Subject|3
867253|NCT01440101|2859560|P1|Overall Study|Withdrawal by Subject|0
867254|NCT01440101|2859558|P3|Overall Study|Adverse Event|0
867255|NCT01440101|2859559|P2|Overall Study|Adverse Event|0
867256|NCT01440101|2859560|P1|Overall Study|Adverse Event|2
867257|NCT01440049|2859593|P1|Overall Study|Adverse Event|5
867258|NCT01439971|2859625|P5|Overall Study|Required number in cohort dosed|1
867259|NCT01439971|2859626|P4|Overall Study|Required number in cohort dosed|0
867260|NCT01439971|2859627|P3|Overall Study|Required number in cohort dosed|2
867261|NCT01439971|2859628|P2|Overall Study|Required number in cohort dosed|1
867262|NCT01439971|2859629|P1|Overall Study|Required number in cohort dosed|0
867263|NCT01439945|2859809|P4|Double-Blind Treatment Phase|Ineligible|1
867264|NCT01439945|2859810|P3|Double-Blind Treatment Phase|Ineligible|0
867265|NCT01439945|2859811|P2|Double-Blind Treatment Phase|Ineligible|2
867266|NCT01439945|2859812|P1|Double-Blind Treatment Phase|Ineligible|1
867267|NCT01439945|2859809|P4|Double-Blind Treatment Phase|Withdrawal by Subject|1
867268|NCT01439945|2859810|P3|Double-Blind Treatment Phase|Withdrawal by Subject|3
867269|NCT01439945|2859811|P2|Double-Blind Treatment Phase|Withdrawal by Subject|3
867270|NCT01439945|2859812|P1|Double-Blind Treatment Phase|Withdrawal by Subject|3
867271|NCT01439867|2859837|P2|Overall Study|Protocol-specified Criteria|0
867272|NCT01439867|2859838|P1|Overall Study|Protocol-specified Criteria|1
867273|NCT01439867|2859837|P2|Overall Study|Administrative Decision|5
867274|NCT01439867|2859838|P1|Overall Study|Administrative Decision|4
867275|NCT01439867|2859837|P2|Overall Study|Withdrawal by Subject|2
867276|NCT01439867|2859838|P1|Overall Study|Withdrawal by Subject|1
867277|NCT01439867|2859837|P2|Overall Study|Non-compliance|1
867278|NCT01439867|2859838|P1|Overall Study|Non-compliance|0
867279|NCT01439724|2859879|P2|Overall Study|missing consultation|8
867280|NCT01439724|2859880|P1|Overall Study|missing consultation|9
867281|NCT01439711|2859886|P1|Overall Study|No MRI|9
867282|NCT01439711|2859886|P1|Overall Study|Noncompliance|3
867283|NCT01439711|2859886|P1|Overall Study|Progression During Active Tx|3
867284|NCT01439711|2859886|P1|Overall Study|Withdrawal by Subject|3
867285|NCT01439711|2859886|P1|Overall Study|Adverse Event|5
867286|NCT01439711|2859886|P1|Overall Study|Progression Prior to Beginning Tx|1
867287|NCT01439711|2859886|P1|Overall Study|Cancel|3
867288|NCT01439711|2859886|P1|Overall Study|Ineligible|13
867289|NCT01439373|2859920|P2|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0
867290|NCT01439373|2859921|P1|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2
867291|NCT01439373|2859920|P2|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1
867292|NCT01439373|2859921|P1|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0
867293|NCT01439360|2859964|P2|Overall Study|Withdrawal by Subject|129
867294|NCT01439360|2859965|P1|Overall Study|Withdrawal by Subject|140
867295|NCT01439360|2859964|P2|Overall Study|Protocol Violation|0
867296|NCT01439360|2859965|P1|Overall Study|Protocol Violation|1
867297|NCT01439360|2859964|P2|Overall Study|Others|5
867298|NCT01439360|2859965|P1|Overall Study|Others|10
867299|NCT01439360|2859964|P2|Overall Study|Lost to Follow-up|58
867300|NCT01439360|2859965|P1|Overall Study|Lost to Follow-up|43
867301|NCT01439360|2859964|P2|Overall Study|Adverse Event|16
867302|NCT01439360|2859965|P1|Overall Study|Adverse Event|4
867303|NCT01439282|2860015|P2|Overall Study|Not specified|1
867304|NCT01439282|2860016|P1|Overall Study|Not specified|1
867305|NCT01439282|2860015|P2|Overall Study|Withdrawal by Subject|0
867306|NCT01439282|2860016|P1|Overall Study|Withdrawal by Subject|2
867307|NCT01439282|2860015|P2|Overall Study|Adverse Event|0
867308|NCT01439282|2860016|P1|Overall Study|Adverse Event|5
867309|NCT01439204|2860026|P2|Overall Study|poor/non-compliance|0
867310|NCT01439204|2860027|P1|Overall Study|poor/non-compliance|3
867311|NCT01439204|2860026|P2|Overall Study|No longer meets study criteria|0
867312|NCT01439204|2860027|P1|Overall Study|No longer meets study criteria|1
867313|NCT01439204|2860026|P2|Overall Study|Lost to Follow-up|2
867314|NCT01439204|2860027|P1|Overall Study|Lost to Follow-up|0
867315|NCT01439204|2860026|P2|Overall Study|Withdrawal by Subject|1
867316|NCT01439204|2860027|P1|Overall Study|Withdrawal by Subject|0
867317|NCT01439165|2860061|P2|Overall Study|Withdrawal by Subject|1
867318|NCT01439165|2860062|P1|Overall Study|Withdrawal by Subject|7
867319|NCT01439165|2860061|P2|Overall Study|Lost to Follow-up|1
867320|NCT01439165|2860062|P1|Overall Study|Lost to Follow-up|11
867321|NCT01439165|2860061|P2|Overall Study|Protocol Violation|0
867322|NCT01439165|2860062|P1|Overall Study|Protocol Violation|3
867323|NCT01439126|2860076|P2|Overall Study|Other-Miscellaneous|12
867324|NCT01439126|2860077|P1|Overall Study|Other-Miscellaneous|12
867325|NCT01439126|2860076|P2|Overall Study|Other-Use of prohibited treatment|2
867326|NCT01439126|2860077|P1|Overall Study|Other-Use of prohibited treatment|0
867327|NCT01439126|2860076|P2|Overall Study|Lost to Follow-up|3
867328|NCT01439126|2860077|P1|Overall Study|Lost to Follow-up|6
867329|NCT01439126|2860076|P2|Overall Study|Protocol Violation|4
867330|NCT01439126|2860077|P1|Overall Study|Protocol Violation|6
867331|NCT01439126|2860076|P2|Overall Study|Withdrawal by Subject|21
867332|NCT01439126|2860077|P1|Overall Study|Withdrawal by Subject|5
867333|NCT01439126|2860076|P2|Overall Study|Adverse Event|0
867334|NCT01439126|2860077|P1|Overall Study|Adverse Event|2
867335|NCT01439074|2860099|P2|Overall Study|Other|4
867336|NCT01439074|2860100|P1|Overall Study|Other|4
867337|NCT01439074|2860099|P2|Overall Study|Withdrawal by Subject|5
867338|NCT01439074|2860100|P1|Overall Study|Withdrawal by Subject|1
867339|NCT01439074|2860099|P2|Overall Study|Subject shedding|0
867340|NCT01439074|2860100|P1|Overall Study|Subject shedding|1
867341|NCT01439074|2860099|P2|Overall Study|Lost to Follow-up|4
867342|NCT01439074|2860100|P1|Overall Study|Lost to Follow-up|3
867343|NCT01438996|2860119|P3|Overall Study|Not meeting Inclusion Criteria|0
867344|NCT01438996|2860120|P2|Overall Study|Not meeting Inclusion Criteria|1
867345|NCT01438996|2860121|P1|Overall Study|Not meeting Inclusion Criteria|4
867346|NCT01438840|2860155|P3|Extension Phase|Not specified|1
867347|NCT01438840|2860156|P2|Extension Phase|Not specified|0
867348|NCT01438840|2860157|P1|Extension Phase|Not specified|0
867349|NCT01438840|2860155|P3|Extension Phase|Lack of Efficacy|2
867350|NCT01438840|2860156|P2|Extension Phase|Lack of Efficacy|0
867351|NCT01438840|2860157|P1|Extension Phase|Lack of Efficacy|0
867352|NCT01438840|2860155|P3|Extension Phase|Withdrawal by Subject|3
867353|NCT01438840|2860156|P2|Extension Phase|Withdrawal by Subject|0
867354|NCT01438840|2860157|P1|Extension Phase|Withdrawal by Subject|0
867355|NCT01438840|2860155|P3|Extension Phase|Lost to Follow-up|1
867356|NCT01438840|2860156|P2|Extension Phase|Lost to Follow-up|0
867357|NCT01438840|2860157|P1|Extension Phase|Lost to Follow-up|0
867358|NCT01438840|2860155|P3|Extension Phase|Adverse Event|3
867359|NCT01438840|2860156|P2|Extension Phase|Adverse Event|0
867360|NCT01438840|2860157|P1|Extension Phase|Adverse Event|0
867361|NCT01438840|2860155|P3|Core Study|Withdrawal of consent|0
867362|NCT01438840|2860156|P2|Core Study|Withdrawal of consent|0
867363|NCT01438840|2860157|P1|Core Study|Withdrawal of consent|1
867364|NCT01438840|2860155|P3|Core Study|Lack of Efficacy|0
867365|NCT01438840|2860156|P2|Core Study|Lack of Efficacy|7
867366|NCT01438840|2860157|P1|Core Study|Lack of Efficacy|15
867367|NCT01438840|2860155|P3|Core Study|Adverse Event|0
867368|NCT01438840|2860156|P2|Core Study|Adverse Event|3
867369|NCT01438840|2860157|P1|Core Study|Adverse Event|0
867370|NCT01438814|2860170|P2|Overall Study|Not specified|4
867371|NCT01438814|2860171|P1|Overall Study|Not specified|2
867372|NCT01438814|2860170|P2|Overall Study|Withdrawal by Subject|2
867373|NCT01438814|2860171|P1|Overall Study|Withdrawal by Subject|4
867374|NCT01438814|2860170|P2|Overall Study|Lost to Follow-up|3
867375|NCT01438814|2860171|P1|Overall Study|Lost to Follow-up|4
867376|NCT01438814|2860170|P2|Overall Study|Protocol Violation|2
867377|NCT01438814|2860171|P1|Overall Study|Protocol Violation|1
867378|NCT01438814|2860170|P2|Overall Study|Adverse Event|3
867379|NCT01438814|2860171|P1|Overall Study|Adverse Event|3
867380|NCT01438541|2860207|P1|Overall Study|discharge from the hospital|5
867381|NCT01438541|2860207|P1|Overall Study|Withdrawal by Subject|1
867382|NCT01438541|2860207|P1|Overall Study|Physician Decision|1
867383|NCT01438489|2860216|P3|Overall Study|Inadequate venous access|0
867384|NCT01438489|2860217|P2|Overall Study|Inadequate venous access|2
867385|NCT01438489|2860218|P1|Overall Study|Inadequate venous access|0
867386|NCT01438489|2860216|P3|Overall Study|Did not complete all 3 follow-up visits|2
867387|NCT01438489|2860217|P2|Overall Study|Did not complete all 3 follow-up visits|5
867388|NCT01438489|2860218|P1|Overall Study|Did not complete all 3 follow-up visits|2
867389|NCT01438489|2860216|P3|Overall Study|Received prohibited medication|0
867390|NCT01438489|2860217|P2|Overall Study|Received prohibited medication|0
867391|NCT01438489|2860218|P1|Overall Study|Received prohibited medication|1
867392|NCT01438489|2860216|P3|Overall Study|AE/SAEs|1
867393|NCT01438489|2860217|P2|Overall Study|AE/SAEs|1
867394|NCT01438489|2860218|P1|Overall Study|AE/SAEs|2
867395|NCT01438489|2860216|P3|Overall Study|Investigator decision|0
867396|NCT01438489|2860217|P2|Overall Study|Investigator decision|1
867397|NCT01438489|2860218|P1|Overall Study|Investigator decision|0
867398|NCT01438489|2860216|P3|Overall Study|Subject choice/Subject moved|1
867399|NCT01438489|2860217|P2|Overall Study|Subject choice/Subject moved|1
867400|NCT01438489|2860218|P1|Overall Study|Subject choice/Subject moved|2
867401|NCT01438489|2860216|P3|Overall Study|Sponsor decision|4
867402|NCT01438489|2860217|P2|Overall Study|Sponsor decision|1
867403|NCT01438489|2860218|P1|Overall Study|Sponsor decision|4
867404|NCT01438489|2860216|P3|Overall Study|Death|1
867405|NCT01438489|2860217|P2|Overall Study|Death|0
867406|NCT01438489|2860218|P1|Overall Study|Death|0
867407|NCT01438489|2860216|P3|Overall Study|Withdrawal by Subject|8
867408|NCT01438489|2860217|P2|Overall Study|Withdrawal by Subject|3
867409|NCT01438489|2860218|P1|Overall Study|Withdrawal by Subject|11
867410|NCT01438489|2860216|P3|Overall Study|Lost to Follow-up|2
867411|NCT01438489|2860217|P2|Overall Study|Lost to Follow-up|2
867412|NCT01438489|2860218|P1|Overall Study|Lost to Follow-up|4
867413|NCT01438424|2860261|P1|Overall Study|Participant noncompliance|20
867414|NCT01438424|2860261|P1|Overall Study|No longer met inclusion criteria|1
867415|NCT01438424|2860261|P1|Overall Study|Pregnancy|7
867416|NCT01438424|2860261|P1|Overall Study|Need for drug prohibited by protocol|14
867417|NCT01438424|2860261|P1|Overall Study|Abnormal laboratory test result|14
867418|NCT01438424|2860261|P1|Overall Study|Lost to Follow-up|17
867419|NCT01438424|2860261|P1|Overall Study|Adverse Event|17
867420|NCT01438424|2860261|P1|Overall Study|Death|22
867421|NCT01438424|2860261|P1|Overall Study|Progression of chronic hepatitis B|22
867422|NCT01438424|2860261|P1|Overall Study|Withdrawal by Subject|104
867423|NCT01438424|2860261|P1|Overall Study|Not identified|55
867424|NCT01438424|2860261|P1|Overall Study|Minimal virologic response|95
867425|NCT01438424|2860261|P1|Overall Study|Continuing treatment|29
867426|NCT01438307|2860299|P2|Overall Study|Death|1
867427|NCT01438307|2860300|P1|Overall Study|Death|1
867428|NCT01438294|2860314|P2|Overall Study|Lost to Follow-up|7
867429|NCT01438294|2860315|P1|Overall Study|Lost to Follow-up|3
867430|NCT01438177|2860358|P1|Overall Study|Initiation of new therapy|1
867431|NCT01438177|2860358|P1|Overall Study|Withdrawal by Subject|1
867432|NCT01438151|2860364|P1|Overall Study|study terminated|8
867433|NCT01438060|2860370|P2|On Study Beyond Week 140|Other Reason|3
867434|NCT01438060|2860371|P1|On Study Beyond Week 140|Other Reason|0
867435|NCT01438060|2860370|P2|On Study Beyond Week 140|Death|1
867436|NCT01438060|2860371|P1|On Study Beyond Week 140|Death|0
867437|NCT01438060|2860370|P2|On Study Beyond Week 140|Withdrawal by Subject|1
867438|NCT01438060|2860371|P1|On Study Beyond Week 140|Withdrawal by Subject|0
867439|NCT01438060|2860370|P2|On Study Beyond Week 140|Lack of Efficacy|1
867440|NCT01438060|2860371|P1|On Study Beyond Week 140|Lack of Efficacy|0
867441|NCT01438060|2860370|P2|On Study Beyond Week 140|Adverse Event|2
867442|NCT01438060|2860371|P1|On Study Beyond Week 140|Adverse Event|0
867443|NCT01438060|2860370|P2|Extension Phase: Week 10 to Week 130|Other Reason|15
867444|NCT01438060|2860371|P1|Extension Phase: Week 10 to Week 130|Other Reason|7
867445|NCT01438060|2860370|P2|Extension Phase: Week 10 to Week 130|Death|12
867446|NCT01438060|2860371|P1|Extension Phase: Week 10 to Week 130|Death|22
867447|NCT01438060|2860370|P2|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0
867448|NCT01438060|2860371|P1|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2
867449|NCT01438060|2860370|P2|Extension Phase: Week 10 to Week 130|Participant Unreliability|0
867450|NCT01438060|2860371|P1|Extension Phase: Week 10 to Week 130|Participant Unreliability|1
867451|NCT01438060|2860370|P2|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5
867452|NCT01438060|2860371|P1|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3
867453|NCT01438060|2860370|P2|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
867454|NCT01438060|2860371|P1|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
867455|NCT01438060|2860370|P2|Extension Phase: Week 10 to Week 130|Adverse Event|16
867456|NCT01438060|2860371|P1|Extension Phase: Week 10 to Week 130|Adverse Event|15
867457|NCT01438060|2860370|P2|Acute Phase: Double-blind, 10 Weeks|Other Reason|0
867458|NCT01438060|2860371|P1|Acute Phase: Double-blind, 10 Weeks|Other Reason|1
867459|NCT01438060|2860370|P2|Acute Phase: Double-blind, 10 Weeks|Death|2
867460|NCT01438060|2860371|P1|Acute Phase: Double-blind, 10 Weeks|Death|0
867461|NCT01438060|2860370|P2|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0
867462|NCT01438060|2860371|P1|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1
867463|NCT01438060|2860370|P2|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4
867464|NCT01438060|2860371|P1|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3
867465|NCT01438060|2860370|P2|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3
867466|NCT01438060|2860371|P1|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6
867467|NCT01438060|2860370|P2|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9
867468|NCT01438060|2860371|P1|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7
867469|NCT01437995|2860452|P3|Overall Study|Lost to Follow-up|20
867470|NCT01437995|2860453|P2|Overall Study|Lost to Follow-up|18
867471|NCT01437995|2860454|P1|Overall Study|Lost to Follow-up|11
867472|NCT01437943|2860476|P2|Overall Study|Adverse Event|0
867473|NCT01437943|2860477|P1|Overall Study|Adverse Event|2
867474|NCT01437943|2860476|P2|Overall Study|Subject expressed pregnancy plans|0
867475|NCT01437943|2860477|P1|Overall Study|Subject expressed pregnancy plans|1
867476|NCT01437943|2860476|P2|Overall Study|Aliskiren trials terminated by Novartis|2
867477|NCT01437943|2860477|P1|Overall Study|Aliskiren trials terminated by Novartis|4
867478|NCT01437878|2860485|P2|Overall Study|Withdrawal by Subject|0
867479|NCT01437878|2860486|P1|Overall Study|Withdrawal by Subject|1
867480|NCT01437540|2860528|P2|Overall Study|Withdrawal by Subject|15
867481|NCT01437540|2860529|P1|Overall Study|Withdrawal by Subject|31
867482|NCT01437540|2860528|P2|Overall Study|Adverse Event|13
867483|NCT01437540|2860529|P1|Overall Study|Adverse Event|26
867484|NCT01437540|2860528|P2|Overall Study|Protocol Violation|12
867485|NCT01437540|2860529|P1|Overall Study|Protocol Violation|24
867486|NCT01437540|2860528|P2|Overall Study|Lack of Efficacy|11
867487|NCT01437540|2860529|P1|Overall Study|Lack of Efficacy|23
867488|NCT01437540|2860528|P2|Overall Study|Lost to Follow-up|5
867489|NCT01437540|2860529|P1|Overall Study|Lost to Follow-up|3
867490|NCT01437540|2860528|P2|Overall Study|COPD exacerbation|3
867491|NCT01437540|2860529|P1|Overall Study|COPD exacerbation|13
867492|NCT01437540|2860528|P2|Overall Study|Not listed below|6
867493|NCT01437540|2860529|P1|Overall Study|Not listed below|7
867494|NCT01437423|2860559|P1|Overall Study|Off label usage|3
867495|NCT01437423|2860559|P1|Overall Study|Lost to Follow-up|12
867496|NCT01437397|2860571|P5|Overall Study|Site termination/COPD exacerbation/other|14
867497|NCT01437397|2860572|P4|Overall Study|Site termination/COPD exacerbation/other|9
867498|NCT01437397|2860573|P3|Overall Study|Site termination/COPD exacerbation/other|9
867499|NCT01437397|2860574|P2|Overall Study|Site termination/COPD exacerbation/other|8
867500|NCT01437397|2860575|P1|Overall Study|Site termination/COPD exacerbation/other|10
867501|NCT01437397|2860571|P5|Overall Study|Adverse Event|21
867502|NCT01437397|2860572|P4|Overall Study|Adverse Event|14
867503|NCT01437397|2860573|P3|Overall Study|Adverse Event|16
867504|NCT01437397|2860574|P2|Overall Study|Adverse Event|22
867505|NCT01437397|2860575|P1|Overall Study|Adverse Event|21
867506|NCT01437397|2860571|P5|Overall Study|Lack of Efficacy|20
867507|NCT01437397|2860572|P4|Overall Study|Lack of Efficacy|10
867508|NCT01437397|2860573|P3|Overall Study|Lack of Efficacy|8
867509|NCT01437397|2860574|P2|Overall Study|Lack of Efficacy|4
867510|NCT01437397|2860575|P1|Overall Study|Lack of Efficacy|5
867511|NCT01437397|2860571|P5|Overall Study|Protocol Violation|19
867512|NCT01437397|2860572|P4|Overall Study|Protocol Violation|21
867513|NCT01437397|2860573|P3|Overall Study|Protocol Violation|13
867514|NCT01437397|2860574|P2|Overall Study|Protocol Violation|12
867515|NCT01437397|2860575|P1|Overall Study|Protocol Violation|10
867516|NCT01437397|2860571|P5|Overall Study|Withdrawal by Subject|22
867517|NCT01437397|2860572|P4|Overall Study|Withdrawal by Subject|11
867518|NCT01437397|2860573|P3|Overall Study|Withdrawal by Subject|24
867519|NCT01437397|2860574|P2|Overall Study|Withdrawal by Subject|12
867520|NCT01437397|2860575|P1|Overall Study|Withdrawal by Subject|11
867521|NCT01437397|2860571|P5|Overall Study|Lost to Follow-up|5
867522|NCT01437397|2860572|P4|Overall Study|Lost to Follow-up|4
867523|NCT01437397|2860573|P3|Overall Study|Lost to Follow-up|2
867524|NCT01437397|2860574|P2|Overall Study|Lost to Follow-up|4
867525|NCT01437397|2860575|P1|Overall Study|Lost to Follow-up|9
867526|NCT01437319|2860602|P3|Phase II|Protocol Violation|0
867527|NCT01437319|2860603|P2|Phase II|Protocol Violation|1
867528|NCT01437319|2860604|P1|Phase II|Protocol Violation|0
867529|NCT01437319|2860602|P3|Phase II|Study related symptoms/complaints|19
867530|NCT01437319|2860603|P2|Phase II|Study related symptoms/complaints|28
867531|NCT01437319|2860604|P1|Phase II|Study related symptoms/complaints|0
867532|NCT01437319|2860602|P3|Phase II|Lost to Follow-up|2
867533|NCT01437319|2860603|P2|Phase II|Lost to Follow-up|7
867534|NCT01437319|2860604|P1|Phase II|Lost to Follow-up|0
867535|NCT01437319|2860602|P3|Phase II|Withdrawal by Subject|16
867536|NCT01437319|2860603|P2|Phase II|Withdrawal by Subject|8
867537|NCT01437319|2860604|P1|Phase II|Withdrawal by Subject|0
867538|NCT01437319|2860602|P3|Phase I|Withdrawal by Subject|0
867539|NCT01437319|2860603|P2|Phase I|Withdrawal by Subject|0
867540|NCT01437319|2860604|P1|Phase I|Withdrawal by Subject|25
867541|NCT01437319|2860602|P3|Phase I|Study related symptoms/complaints|0
867542|NCT01437319|2860603|P2|Phase I|Study related symptoms/complaints|0
867543|NCT01437319|2860604|P1|Phase I|Study related symptoms/complaints|27
867544|NCT01437319|2860602|P3|Phase I|Protocol Violation|0
867545|NCT01437319|2860603|P2|Phase I|Protocol Violation|0
867546|NCT01437319|2860604|P1|Phase I|Protocol Violation|1
867547|NCT01437319|2860602|P3|Phase I|Lost to Follow-up|0
867548|NCT01437319|2860603|P2|Phase I|Lost to Follow-up|0
867549|NCT01437319|2860604|P1|Phase I|Lost to Follow-up|2
867550|NCT01437267|2860619|P6|Overall Study|Protocol Violation|0
867551|NCT01437267|2860620|P5|Overall Study|Protocol Violation|0
867552|NCT01437267|2860621|P4|Overall Study|Protocol Violation|0
867553|NCT01437267|2860622|P3|Overall Study|Protocol Violation|0
867554|NCT01437267|2860623|P2|Overall Study|Protocol Violation|1
867555|NCT01437267|2860624|P1|Overall Study|Protocol Violation|0
867556|NCT01437267|2860619|P6|Overall Study|Withdrawal by Subject|0
867557|NCT01437267|2860620|P5|Overall Study|Withdrawal by Subject|0
867558|NCT01437267|2860621|P4|Overall Study|Withdrawal by Subject|1
867559|NCT01437267|2860622|P3|Overall Study|Withdrawal by Subject|0
867560|NCT01437267|2860623|P2|Overall Study|Withdrawal by Subject|0
867561|NCT01437267|2860624|P1|Overall Study|Withdrawal by Subject|0
867562|NCT01437111|2860667|P1|Overall Study|Protocol Violation|1
867563|NCT01437111|2860667|P1|Overall Study|Lost to Follow-up|5
867564|NCT01437111|2860667|P1|Overall Study|Physician Decision|1
867565|NCT01437111|2860667|P1|Overall Study|Not reported|5
867566|NCT01437111|2860667|P1|Overall Study|Withdrawal by Subject|4
867567|NCT01437111|2860667|P1|Overall Study|Adverse Event|2
867568|NCT01436643|2860745|P4|Core Phase (16 Weeks)|Protocol Violation|0
867569|NCT01436643|2860746|P3|Core Phase (16 Weeks)|Protocol Violation|1
867570|NCT01436643|2860747|P2|Core Phase (16 Weeks)|Protocol Violation|1
867571|NCT01436643|2860748|P1|Core Phase (16 Weeks)|Protocol Violation|1
867572|NCT01436643|2860745|P4|Core Phase (16 Weeks)|Abnormal Test result|0
867573|NCT01436643|2860746|P3|Core Phase (16 Weeks)|Abnormal Test result|1
867574|NCT01436643|2860747|P2|Core Phase (16 Weeks)|Abnormal Test result|0
867575|NCT01436643|2860748|P1|Core Phase (16 Weeks)|Abnormal Test result|0
867576|NCT01436643|2860745|P4|Core Phase (16 Weeks)|Adverse Event|0
867577|NCT01436643|2860746|P3|Core Phase (16 Weeks)|Adverse Event|1
867578|NCT01436643|2860747|P2|Core Phase (16 Weeks)|Adverse Event|3
867579|NCT01436643|2860748|P1|Core Phase (16 Weeks)|Adverse Event|0
867580|NCT01436643|2860745|P4|2-week Pre-treatment|Protocol Violation|4
867581|NCT01436643|2860746|P3|2-week Pre-treatment|Protocol Violation|0
867582|NCT01436643|2860747|P2|2-week Pre-treatment|Protocol Violation|0
867583|NCT01436643|2860748|P1|2-week Pre-treatment|Protocol Violation|0
867584|NCT01436643|2860745|P4|2-week Pre-treatment|Adverse Event|5
867585|NCT01436643|2860746|P3|2-week Pre-treatment|Adverse Event|0
867586|NCT01436643|2860747|P2|2-week Pre-treatment|Adverse Event|0
867587|NCT01436643|2860748|P1|2-week Pre-treatment|Adverse Event|0
867588|NCT01436643|2860745|P4|2-week Pre-treatment|Abnormal test result|1
867589|NCT01436643|2860746|P3|2-week Pre-treatment|Abnormal test result|0
867590|NCT01436643|2860747|P2|2-week Pre-treatment|Abnormal test result|0
867591|NCT01436643|2860748|P1|2-week Pre-treatment|Abnormal test result|0
867592|NCT01436500|2860783|P5|Overall Study|not specified|0
867593|NCT01436500|2860784|P4|Overall Study|not specified|1
867594|NCT01436500|2860785|P3|Overall Study|not specified|0
867595|NCT01436500|2860786|P2|Overall Study|not specified|1
867596|NCT01436500|2860787|P1|Overall Study|not specified|0
867597|NCT01436500|2860783|P5|Overall Study|discontinued study drug|0
867598|NCT01436500|2860784|P4|Overall Study|discontinued study drug|0
867599|NCT01436500|2860785|P3|Overall Study|discontinued study drug|0
867600|NCT01436500|2860786|P2|Overall Study|discontinued study drug|0
867601|NCT01436500|2860787|P1|Overall Study|discontinued study drug|1
867602|NCT01436500|2860783|P5|Overall Study|initiation of dialysis|1
867603|NCT01436500|2860784|P4|Overall Study|initiation of dialysis|0
867604|NCT01436500|2860785|P3|Overall Study|initiation of dialysis|0
867605|NCT01436500|2860786|P2|Overall Study|initiation of dialysis|0
867606|NCT01436500|2860787|P1|Overall Study|initiation of dialysis|0
867607|NCT01436500|2860783|P5|Overall Study|liver transplant|0
867608|NCT01436500|2860784|P4|Overall Study|liver transplant|0
867609|NCT01436500|2860785|P3|Overall Study|liver transplant|0
867610|NCT01436500|2860786|P2|Overall Study|liver transplant|0
867611|NCT01436500|2860787|P1|Overall Study|liver transplant|1
867612|NCT01436500|2860783|P5|Overall Study|Physician Decision|0
867613|NCT01436500|2860784|P4|Overall Study|Physician Decision|0
867614|NCT01436500|2860785|P3|Overall Study|Physician Decision|1
867615|NCT01436500|2860786|P2|Overall Study|Physician Decision|0
867616|NCT01436500|2860787|P1|Overall Study|Physician Decision|0
867617|NCT01436500|2860783|P5|Overall Study|Withdrawal by Subject|2
867618|NCT01436500|2860784|P4|Overall Study|Withdrawal by Subject|0
867619|NCT01436500|2860785|P3|Overall Study|Withdrawal by Subject|2
867620|NCT01436500|2860786|P2|Overall Study|Withdrawal by Subject|0
867621|NCT01436500|2860787|P1|Overall Study|Withdrawal by Subject|0
867622|NCT01436500|2860783|P5|Overall Study|Adverse Event|1
867623|NCT01436500|2860784|P4|Overall Study|Adverse Event|0
867624|NCT01436500|2860785|P3|Overall Study|Adverse Event|2
867625|NCT01436500|2860786|P2|Overall Study|Adverse Event|2
867626|NCT01436500|2860787|P1|Overall Study|Adverse Event|0
867627|NCT01436500|2860783|P5|Overall Study|Death|0
867628|NCT01436500|2860784|P4|Overall Study|Death|0
867629|NCT01436500|2860785|P3|Overall Study|Death|0
867630|NCT01436500|2860786|P2|Overall Study|Death|0
867631|NCT01436500|2860787|P1|Overall Study|Death|1
867632|NCT01436370|2860837|P8|Overall Study|Lost to Follow-up|0
867633|NCT01436370|2860838|P7|Overall Study|Lost to Follow-up|0
867634|NCT01436370|2860839|P6|Overall Study|Lost to Follow-up|0
867635|NCT01436370|2860840|P5|Overall Study|Lost to Follow-up|1
867636|NCT01436370|2860841|P4|Overall Study|Lost to Follow-up|0
867637|NCT01436370|2860842|P3|Overall Study|Lost to Follow-up|0
867638|NCT01436370|2860843|P2|Overall Study|Lost to Follow-up|0
867639|NCT01436370|2860844|P1|Overall Study|Lost to Follow-up|0
867640|NCT01436305|2860925|P3|Overall Study|Withdrawal by Subject|0
867641|NCT01436305|2860926|P2|Overall Study|Withdrawal by Subject|3
867642|NCT01436305|2860927|P1|Overall Study|Withdrawal by Subject|1
867643|NCT01436305|2860925|P3|Overall Study|Lost to Follow-up|0
867644|NCT01436305|2860926|P2|Overall Study|Lost to Follow-up|1
867645|NCT01436305|2860927|P1|Overall Study|Lost to Follow-up|0
867646|NCT01436305|2860925|P3|Overall Study|Death|0
867647|NCT01436305|2860926|P2|Overall Study|Death|0
867648|NCT01436305|2860927|P1|Overall Study|Death|1
867649|NCT01436253|2861054|P1|Overall Study|Not meeting all eligibility criteria|117
867650|NCT01436253|2861054|P1|Overall Study|Lost to Follow-up|182
867651|NCT01436201|2861059|P1|Overall Study|Protocol Violation|1
867652|NCT01436201|2861059|P1|Overall Study|Withdrawal by Subject|1
867653|NCT01436201|2861059|P1|Overall Study|Adverse Event|2
867654|NCT01436175|2861069|P1|Overall Study|Other|826
867655|NCT01436175|2861069|P1|Overall Study|Met blood pressure or pulse withdrawal|63
867656|NCT01436175|2861069|P1|Overall Study|Lack of Efficacy|24
867657|NCT01436175|2861069|P1|Overall Study|Lost to Follow-up|89
867658|NCT01436175|2861069|P1|Overall Study|Withdrawal by Subject|108
867659|NCT01436175|2861069|P1|Overall Study|Protocol Violation|49
867660|NCT01436175|2861069|P1|Overall Study|Adverse Event|111
867661|NCT01436162|2861096|P3|Randomized Phase|Not Specified|4
867662|NCT01436162|2861097|P2|Randomized Phase|Not Specified|5
867663|NCT01436162|2861098|P1|Randomized Phase|Not Specified|2
867664|NCT01436162|2861096|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0
867665|NCT01436162|2861097|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
867666|NCT01436162|2861098|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4
867667|NCT01436162|2861096|P3|Randomized Phase|Lack of Efficacy|1
867668|NCT01436162|2861097|P2|Randomized Phase|Lack of Efficacy|1
867669|NCT01436162|2861098|P1|Randomized Phase|Lack of Efficacy|0
867670|NCT01436162|2861096|P3|Randomized Phase|Lost to Follow-up|4
867671|NCT01436162|2861097|P2|Randomized Phase|Lost to Follow-up|5
867672|NCT01436162|2861098|P1|Randomized Phase|Lost to Follow-up|17
867673|NCT01436162|2861096|P3|Randomized Phase|Withdrawal by Subject|8
867674|NCT01436162|2861097|P2|Randomized Phase|Withdrawal by Subject|9
867675|NCT01436162|2861098|P1|Randomized Phase|Withdrawal by Subject|16
867676|NCT01436162|2861096|P3|Randomized Phase|Protocol Violation|2
867677|NCT01436162|2861097|P2|Randomized Phase|Protocol Violation|4
867678|NCT01436162|2861098|P1|Randomized Phase|Protocol Violation|4
867679|NCT01436162|2861096|P3|Randomized Phase|Adverse Event|6
867680|NCT01436162|2861097|P2|Randomized Phase|Adverse Event|5
867681|NCT01436162|2861098|P1|Randomized Phase|Adverse Event|1
867682|NCT01436162|2861096|P3|Single-blind Lead-in Phase|Not Specified|0
867683|NCT01436162|2861097|P2|Single-blind Lead-in Phase|Not Specified|0
867684|NCT01436162|2861098|P1|Single-blind Lead-in Phase|Not Specified|107
867685|NCT01436162|2861096|P3|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
867686|NCT01436162|2861097|P2|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
867687|NCT01436162|2861098|P1|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13
867688|NCT01436162|2861096|P3|Single-blind Lead-in Phase|Lost to Follow-up|0
867689|NCT01436162|2861097|P2|Single-blind Lead-in Phase|Lost to Follow-up|0
867690|NCT01436162|2861098|P1|Single-blind Lead-in Phase|Lost to Follow-up|43
867691|NCT01436162|2861096|P3|Single-blind Lead-in Phase|Withdrawal by Subject|0
867692|NCT01436162|2861097|P2|Single-blind Lead-in Phase|Withdrawal by Subject|0
867693|NCT01436162|2861098|P1|Single-blind Lead-in Phase|Withdrawal by Subject|69
867694|NCT01436162|2861096|P3|Single-blind Lead-in Phase|Protocol Violation|0
867695|NCT01436162|2861097|P2|Single-blind Lead-in Phase|Protocol Violation|0
867696|NCT01436162|2861098|P1|Single-blind Lead-in Phase|Protocol Violation|24
867697|NCT01436162|2861096|P3|Single-blind Lead-in Phase|Adverse Event|0
867698|NCT01436162|2861097|P2|Single-blind Lead-in Phase|Adverse Event|0
867699|NCT01436162|2861098|P1|Single-blind Lead-in Phase|Adverse Event|26
867700|NCT01436149|2861132|P3|Randomized Phase|Not Specified|11
867701|NCT01436149|2861133|P2|Randomized Phase|Not Specified|5
867702|NCT01436149|2861134|P1|Randomized Phase|Not Specified|12
867703|NCT01436149|2861132|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
867704|NCT01436149|2861133|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
867705|NCT01436149|2861134|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
867706|NCT01436149|2861132|P3|Randomized Phase|Lack of Efficacy|1
867707|NCT01436149|2861133|P2|Randomized Phase|Lack of Efficacy|0
867708|NCT01436149|2861134|P1|Randomized Phase|Lack of Efficacy|0
867709|NCT01436149|2861132|P3|Randomized Phase|Lost to Follow-up|6
867710|NCT01436149|2861133|P2|Randomized Phase|Lost to Follow-up|5
867711|NCT01436149|2861134|P1|Randomized Phase|Lost to Follow-up|34
867712|NCT01436149|2861132|P3|Randomized Phase|Withdrawal by Subject|10
867713|NCT01436149|2861133|P2|Randomized Phase|Withdrawal by Subject|10
867714|NCT01436149|2861134|P1|Randomized Phase|Withdrawal by Subject|16
867715|NCT01436149|2861132|P3|Randomized Phase|Protocol Violation|0
867716|NCT01436149|2861133|P2|Randomized Phase|Protocol Violation|5
867717|NCT01436149|2861134|P1|Randomized Phase|Protocol Violation|4
867718|NCT01436149|2861132|P3|Randomized Phase|Adverse Event|11
867719|NCT01436149|2861133|P2|Randomized Phase|Adverse Event|10
867720|NCT01436149|2861134|P1|Randomized Phase|Adverse Event|9
867721|NCT01436149|2861132|P3|Antidepressant Lead-in Phase|Not Specified|0
867722|NCT01436149|2861133|P2|Antidepressant Lead-in Phase|Not Specified|0
867723|NCT01436149|2861134|P1|Antidepressant Lead-in Phase|Not Specified|119
867724|NCT01436149|2861132|P3|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
867725|NCT01436149|2861133|P2|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
867726|NCT01436149|2861134|P1|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22
867727|NCT01436149|2861132|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
867728|NCT01436149|2861133|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
867729|NCT01436149|2861134|P1|Antidepressant Lead-in Phase|Lost to Follow-up|96
867730|NCT01436149|2861132|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
867731|NCT01436149|2861133|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
867732|NCT01436149|2861134|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|61
867733|NCT01436149|2861132|P3|Antidepressant Lead-in Phase|Protocol Violation|0
867734|NCT01436149|2861133|P2|Antidepressant Lead-in Phase|Protocol Violation|0
867735|NCT01436149|2861134|P1|Antidepressant Lead-in Phase|Protocol Violation|29
867736|NCT01436149|2861132|P3|Antidepressant Lead-in Phase|Adverse Event|0
867737|NCT01436149|2861133|P2|Antidepressant Lead-in Phase|Adverse Event|0
867738|NCT01436149|2861134|P1|Antidepressant Lead-in Phase|Adverse Event|39
867739|NCT01436110|2861165|P3|Overall Study|Did Not Receive Trial Medication|3
867740|NCT01436110|2861166|P2|Overall Study|Did Not Receive Trial Medication|0
867741|NCT01436110|2861167|P1|Overall Study|Did Not Receive Trial Medication|1
867742|NCT01436110|2861165|P3|Overall Study|Protocol Violation|1
867743|NCT01436110|2861166|P2|Overall Study|Protocol Violation|1
867744|NCT01436110|2861167|P1|Overall Study|Protocol Violation|3
867745|NCT01436110|2861165|P3|Overall Study|Lost to Follow-up|3
867746|NCT01436110|2861166|P2|Overall Study|Lost to Follow-up|1
867747|NCT01436110|2861167|P1|Overall Study|Lost to Follow-up|1
867748|NCT01436110|2861165|P3|Overall Study|Physician Decision|1
867749|NCT01436110|2861166|P2|Overall Study|Physician Decision|1
867750|NCT01436110|2861167|P1|Overall Study|Physician Decision|3
867751|NCT01436110|2861165|P3|Overall Study|Adverse Event|2
867752|NCT01436110|2861166|P2|Overall Study|Adverse Event|1
867753|NCT01436110|2861167|P1|Overall Study|Adverse Event|2
867754|NCT01436110|2861165|P3|Overall Study|Withdrawal by Subject|4
867755|NCT01436110|2861166|P2|Overall Study|Withdrawal by Subject|8
867756|NCT01436110|2861167|P1|Overall Study|Withdrawal by Subject|6
867757|NCT01436110|2861165|P3|Overall Study|Lack of Efficacy|9
867758|NCT01436110|2861166|P2|Overall Study|Lack of Efficacy|14
867759|NCT01436110|2861167|P1|Overall Study|Lack of Efficacy|23
867760|NCT01436084|2861190|P1|Overall Study|Early Closure of Study|1
867761|NCT01436084|2861190|P1|Overall Study|Withdrawal by Subject|1
867762|NCT01436084|2861190|P1|Overall Study|Disease Progression|2
867763|NCT01436071|2861196|P2|Overall Study|Did Not Receive Trial Medication|3
867764|NCT01436071|2861197|P1|Overall Study|Did Not Receive Trial Medication|3
867765|NCT01436071|2861196|P2|Overall Study|Withdrawal by Subject|2
867766|NCT01436071|2861197|P1|Overall Study|Withdrawal by Subject|2
867767|NCT01436071|2861196|P2|Overall Study|Physician Decision|0
867768|NCT01436071|2861197|P1|Overall Study|Physician Decision|1
867769|NCT01436071|2861196|P2|Overall Study|Lost to Follow-up|1
867770|NCT01436071|2861197|P1|Overall Study|Lost to Follow-up|3
867771|NCT01436071|2861196|P2|Overall Study|Protocol Violation|1
867772|NCT01436071|2861197|P1|Overall Study|Protocol Violation|0
867773|NCT01436071|2861196|P2|Overall Study|Lack of Efficacy|7
867774|NCT01436071|2861197|P1|Overall Study|Lack of Efficacy|16
867775|NCT01436071|2861196|P2|Overall Study|Adverse Event|0
867776|NCT01436071|2861197|P1|Overall Study|Adverse Event|1
867777|NCT01435928|2861239|P3|Double Blind Phase - 28 Weeks|Administrative|2
867778|NCT01435928|2861240|P2|Double Blind Phase - 28 Weeks|Administrative|5
867779|NCT01435928|2861241|P1|Double Blind Phase - 28 Weeks|Administrative|0
867780|NCT01435928|2861239|P3|Double Blind Phase - 28 Weeks|Relapse criteria met|58
867781|NCT01435928|2861240|P2|Double Blind Phase - 28 Weeks|Relapse criteria met|43
867782|NCT01435928|2861241|P1|Double Blind Phase - 28 Weeks|Relapse criteria met|0
867783|NCT01435928|2861239|P3|Double Blind Phase - 28 Weeks|Terminated at study completion|39
867784|NCT01435928|2861240|P2|Double Blind Phase - 28 Weeks|Terminated at study completion|47
867785|NCT01435928|2861241|P1|Double Blind Phase - 28 Weeks|Terminated at study completion|0
867786|NCT01435928|2861239|P3|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12
867787|NCT01435928|2861240|P2|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5
867788|NCT01435928|2861241|P1|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0
867789|NCT01435928|2861239|P3|Double Blind Phase - 28 Weeks|Protocol Violation|4
867790|NCT01435928|2861240|P2|Double Blind Phase - 28 Weeks|Protocol Violation|11
867791|NCT01435928|2861241|P1|Double Blind Phase - 28 Weeks|Protocol Violation|0
867792|NCT01435928|2861239|P3|Double Blind Phase - 28 Weeks|Lost to Follow-up|5
867793|NCT01435928|2861240|P2|Double Blind Phase - 28 Weeks|Lost to Follow-up|2
867794|NCT01435928|2861241|P1|Double Blind Phase - 28 Weeks|Lost to Follow-up|0
867795|NCT01435928|2861239|P3|Double Blind Phase - 28 Weeks|Adverse Event|1
867796|NCT01435928|2861240|P2|Double Blind Phase - 28 Weeks|Adverse Event|3
867797|NCT01435928|2861241|P1|Double Blind Phase - 28 Weeks|Adverse Event|0
867798|NCT01435928|2861239|P3|Open Label Phase - up to 24 Weeks|Administrative|0
867799|NCT01435928|2861240|P2|Open Label Phase - up to 24 Weeks|Administrative|0
867800|NCT01435928|2861241|P1|Open Label Phase - up to 24 Weeks|Administrative|14
867801|NCT01435928|2861239|P3|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
867802|NCT01435928|2861240|P2|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
867803|NCT01435928|2861241|P1|Open Label Phase - up to 24 Weeks|Terminated at study completion|6
867804|NCT01435928|2861239|P3|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
867805|NCT01435928|2861240|P2|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
867806|NCT01435928|2861241|P1|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44
867807|NCT01435928|2861239|P3|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
867808|NCT01435928|2861240|P2|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
867809|NCT01435928|2861241|P1|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96
867810|NCT01435928|2861239|P3|Open Label Phase - up to 24 Weeks|Protocol Violation|0
867811|NCT01435928|2861240|P2|Open Label Phase - up to 24 Weeks|Protocol Violation|0
867812|NCT01435928|2861241|P1|Open Label Phase - up to 24 Weeks|Protocol Violation|39
867813|NCT01435928|2861239|P3|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
867814|NCT01435928|2861240|P2|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
867815|NCT01435928|2861241|P1|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60
867816|NCT01435928|2861239|P3|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
867817|NCT01435928|2861240|P2|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
867818|NCT01435928|2861241|P1|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46
867819|NCT01435928|2861239|P3|Open Label Phase - up to 24 Weeks|Death|0
867820|NCT01435928|2861240|P2|Open Label Phase - up to 24 Weeks|Death|0
867821|NCT01435928|2861241|P1|Open Label Phase - up to 24 Weeks|Death|1
867822|NCT01435928|2861239|P3|Open Label Phase - up to 24 Weeks|Adverse Event|0
867823|NCT01435928|2861240|P2|Open Label Phase - up to 24 Weeks|Adverse Event|0
867824|NCT01435928|2861241|P1|Open Label Phase - up to 24 Weeks|Adverse Event|83
867825|NCT01435798|2861268|P1|Overall Study|Withdrawal by Subject|1
867826|NCT01435772|2861285|P3|Overall Study|Other - study termination|10
867827|NCT01435772|2861286|P2|Overall Study|Other - study termination|2
867828|NCT01435772|2861287|P1|Overall Study|Other - study termination|2
867829|NCT01435772|2861285|P3|Overall Study|Withdrawal by Subject|3
867830|NCT01435772|2861286|P2|Overall Study|Withdrawal by Subject|1
867831|NCT01435772|2861287|P1|Overall Study|Withdrawal by Subject|0
867832|NCT01435772|2861285|P3|Overall Study|Adverse Event|2
867833|NCT01435772|2861286|P2|Overall Study|Adverse Event|0
867834|NCT01435772|2861287|P1|Overall Study|Adverse Event|1
867835|NCT01435759|2861337|P6|Double-blind Phase|Not Specified|0
867836|NCT01435759|2861338|P5|Double-blind Phase|Not Specified|0
867837|NCT01435759|2861339|P4|Double-blind Phase|Not Specified|2
867838|NCT01435759|2861340|P3|Double-blind Phase|Not Specified|0
867839|NCT01435759|2861341|P2|Double-blind Phase|Not Specified|2
867840|NCT01435759|2861342|P1|Double-blind Phase|Not Specified|8
867841|NCT01435759|2861337|P6|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
867842|NCT01435759|2861338|P5|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3
867843|NCT01435759|2861339|P4|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
867844|NCT01435759|2861340|P3|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
867845|NCT01435759|2861341|P2|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
867846|NCT01435759|2861342|P1|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1
867847|NCT01435759|2861337|P6|Double-blind Phase|Lost to Follow-up|3
867848|NCT01435759|2861338|P5|Double-blind Phase|Lost to Follow-up|3
867849|NCT01435759|2861339|P4|Double-blind Phase|Lost to Follow-up|0
867850|NCT01435759|2861340|P3|Double-blind Phase|Lost to Follow-up|2
867851|NCT01435759|2861341|P2|Double-blind Phase|Lost to Follow-up|1
867852|NCT01435759|2861342|P1|Double-blind Phase|Lost to Follow-up|31
867853|NCT01435759|2861337|P6|Double-blind Phase|Withdrawal by Subject|2
867854|NCT01435759|2861338|P5|Double-blind Phase|Withdrawal by Subject|2
867855|NCT01435759|2861339|P4|Double-blind Phase|Withdrawal by Subject|4
867856|NCT01435759|2861340|P3|Double-blind Phase|Withdrawal by Subject|3
867857|NCT01435759|2861341|P2|Double-blind Phase|Withdrawal by Subject|4
867858|NCT01435759|2861342|P1|Double-blind Phase|Withdrawal by Subject|17
867859|NCT01435759|2861337|P6|Double-blind Phase|Protocol Violation|1
867860|NCT01435759|2861338|P5|Double-blind Phase|Protocol Violation|0
867861|NCT01435759|2861339|P4|Double-blind Phase|Protocol Violation|2
867862|NCT01435759|2861340|P3|Double-blind Phase|Protocol Violation|1
867863|NCT01435759|2861341|P2|Double-blind Phase|Protocol Violation|0
867864|NCT01435759|2861342|P1|Double-blind Phase|Protocol Violation|2
867865|NCT01435759|2861337|P6|Double-blind Phase|Adverse Event|3
867866|NCT01435759|2861338|P5|Double-blind Phase|Adverse Event|1
867867|NCT01435759|2861339|P4|Double-blind Phase|Adverse Event|1
867868|NCT01435759|2861340|P3|Double-blind Phase|Adverse Event|1
867869|NCT01435759|2861341|P2|Double-blind Phase|Adverse Event|0
867870|NCT01435759|2861342|P1|Double-blind Phase|Adverse Event|7
867871|NCT01435759|2861337|P6|Antidepressant Lead-in Phase|Not Specified|0
867872|NCT01435759|2861338|P5|Antidepressant Lead-in Phase|Not Specified|0
867873|NCT01435759|2861339|P4|Antidepressant Lead-in Phase|Not Specified|0
867874|NCT01435759|2861340|P3|Antidepressant Lead-in Phase|Not Specified|0
867875|NCT01435759|2861341|P2|Antidepressant Lead-in Phase|Not Specified|0
867876|NCT01435759|2861342|P1|Antidepressant Lead-in Phase|Not Specified|119
867877|NCT01435759|2861337|P6|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
867878|NCT01435759|2861338|P5|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
867879|NCT01435759|2861339|P4|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
867880|NCT01435759|2861340|P3|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
867881|NCT01435759|2861341|P2|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
867882|NCT01435759|2861342|P1|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10
867883|NCT01435759|2861337|P6|Antidepressant Lead-in Phase|Lost to Follow-up|0
867884|NCT01435759|2861338|P5|Antidepressant Lead-in Phase|Lost to Follow-up|0
867885|NCT01435759|2861339|P4|Antidepressant Lead-in Phase|Lost to Follow-up|0
867886|NCT01435759|2861340|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
867887|NCT01435759|2861341|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
867888|NCT01435759|2861342|P1|Antidepressant Lead-in Phase|Lost to Follow-up|83
867889|NCT01435759|2861337|P6|Antidepressant Lead-in Phase|Withdrawal by Subject|0
867890|NCT01435759|2861338|P5|Antidepressant Lead-in Phase|Withdrawal by Subject|0
867891|NCT01435759|2861339|P4|Antidepressant Lead-in Phase|Withdrawal by Subject|0
867892|NCT01435759|2861340|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
867893|NCT01435759|2861341|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
867894|NCT01435759|2861342|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|74
867895|NCT01435759|2861337|P6|Antidepressant Lead-in Phase|Protocol Violation|0
867896|NCT01435759|2861338|P5|Antidepressant Lead-in Phase|Protocol Violation|0
867897|NCT01435759|2861339|P4|Antidepressant Lead-in Phase|Protocol Violation|0
867898|NCT01435759|2861340|P3|Antidepressant Lead-in Phase|Protocol Violation|0
867899|NCT01435759|2861341|P2|Antidepressant Lead-in Phase|Protocol Violation|0
867900|NCT01435759|2861342|P1|Antidepressant Lead-in Phase|Protocol Violation|16
867901|NCT01435759|2861337|P6|Antidepressant Lead-in Phase|Adverse Event|0
867902|NCT01435759|2861338|P5|Antidepressant Lead-in Phase|Adverse Event|0
867903|NCT01435759|2861339|P4|Antidepressant Lead-in Phase|Adverse Event|0
867904|NCT01435759|2861340|P3|Antidepressant Lead-in Phase|Adverse Event|0
867905|NCT01435759|2861341|P2|Antidepressant Lead-in Phase|Adverse Event|0
867906|NCT01435759|2861342|P1|Antidepressant Lead-in Phase|Adverse Event|40
867907|NCT01435655|2861369|P1|Overall Study|Other|1
867908|NCT01435655|2861369|P1|Overall Study|Death|2
867909|NCT01435616|2861383|P2|Overall Study|Sponsor Decision|0
867910|NCT01435616|2861384|P1|Overall Study|Sponsor Decision|1
867911|NCT01435616|2861383|P2|Overall Study|Physician Decision|7
867912|NCT01435616|2861384|P1|Overall Study|Physician Decision|20
867913|NCT01435616|2861383|P2|Overall Study|Withdrawal by Subject|24
867914|NCT01435616|2861384|P1|Overall Study|Withdrawal by Subject|66
867915|NCT01435616|2861383|P2|Overall Study|Protocol Violation|13
867916|NCT01435616|2861384|P1|Overall Study|Protocol Violation|16
867917|NCT01435616|2861383|P2|Overall Study|Lost to Follow-up|13
867918|NCT01435616|2861384|P1|Overall Study|Lost to Follow-up|22
867919|NCT01435616|2861383|P2|Overall Study|Death|2
867920|NCT01435616|2861384|P1|Overall Study|Death|7
867921|NCT01435616|2861383|P2|Overall Study|Adverse Event|21
867922|NCT01435616|2861384|P1|Overall Study|Adverse Event|39
867923|NCT01435577|2861439|P2|Overall Study|Alternative treatment started|1
867924|NCT01435577|2861440|P1|Overall Study|Alternative treatment started|0
867925|NCT01435577|2861439|P2|Overall Study|Lack of Efficacy|51
867926|NCT01435577|2861440|P1|Overall Study|Lack of Efficacy|7
867927|NCT01435577|2861439|P2|Overall Study|Adverse Event|0
867928|NCT01435577|2861440|P1|Overall Study|Adverse Event|10
867929|NCT01435460|2861490|P2|Overall Study|Did not meet eligibility criteria|0
867930|NCT01435460|2861491|P1|Overall Study|Did not meet eligibility criteria|2
867931|NCT01435460|2861490|P2|Overall Study|Protocol Violation|1
867932|NCT01435460|2861491|P1|Overall Study|Protocol Violation|0
867933|NCT01435460|2861490|P2|Overall Study|Withdrawal by Subject|3
867934|NCT01435460|2861491|P1|Overall Study|Withdrawal by Subject|1
867935|NCT01435460|2861490|P2|Overall Study|Lost to Follow-up|1
867936|NCT01435460|2861491|P1|Overall Study|Lost to Follow-up|6
867937|NCT01435460|2861490|P2|Overall Study|Adverse Event|1
867938|NCT01435460|2861491|P1|Overall Study|Adverse Event|2
867939|NCT01435382|2861507|P4|Overall Study|Withdrawal by Subject|1
867940|NCT01435382|2861508|P3|Overall Study|Withdrawal by Subject|0
867941|NCT01435382|2861509|P2|Overall Study|Withdrawal by Subject|2
867942|NCT01435382|2861510|P1|Overall Study|Withdrawal by Subject|0
867943|NCT01435382|2861507|P4|Overall Study|Lost to Follow-up|0
867944|NCT01435382|2861508|P3|Overall Study|Lost to Follow-up|1
867945|NCT01435382|2861509|P2|Overall Study|Lost to Follow-up|0
867946|NCT01435382|2861510|P1|Overall Study|Lost to Follow-up|1
867947|NCT01435265|2861618|P2|Overall Study|Lost to Follow-up|1
867948|NCT01435265|2861619|P1|Overall Study|Lost to Follow-up|0
867949|NCT01435122|2861633|P1|Overall Study|Early withdrawal due to toxicity|8
867950|NCT01435031|2861642|P1|ITT at 4 Years|Lost to Follow-up|1
867951|NCT01435031|2861642|P1|ITT at 4 Years|Withdrawal by Subject|2
867952|NCT01435031|2861642|P1|ITT at 4 Years|Death|4
867953|NCT01435031|2861642|P1|ITT at 3 Years|Lost to Follow-up|4
867954|NCT01435031|2861642|P1|ITT at 3 Years|Withdrawal by Subject|2
867955|NCT01435031|2861642|P1|ITT at 3 Years|Death|5
867956|NCT01435031|2861642|P1|ITT at 2 Years|Lost to Follow-up|4
867957|NCT01435031|2861642|P1|ITT at 2 Years|Withdrawal by Subject|2
867958|NCT01435031|2861642|P1|ITT at 2 Years|Death|7
867959|NCT01435031|2861642|P1|ITT at 1 Year|Lost to Follow-up|6
867960|NCT01435031|2861642|P1|ITT at 1 Year|Withdrawal by Subject|2
867961|NCT01435031|2861642|P1|ITT at 1 Year|Death|1
867962|NCT01435031|2861642|P1|ITT at 6 Months|Lost to Follow-up|3
867963|NCT01435031|2861642|P1|ITT at 6 Months|Death|2
867964|NCT01435031|2861642|P1|ITT at 1 Month|Lost to Follow-up|4
867965|NCT01435031|2861642|P1|ITT at 1 Month|Death|1
867966|NCT01435031|2861642|P1|ITT at 1 Month|Withdrawal by Subject|1
867967|NCT01434823|2861742|P2|Overall Study|Incomplete data in medical record|7
867968|NCT01434823|2861743|P1|Overall Study|Incomplete data in medical record|4
867969|NCT01434693|2861763|P4|Overall Study|Lost to Follow-up|0
867970|NCT01434693|2861764|P3|Overall Study|Lost to Follow-up|0
867971|NCT01434693|2861765|P2|Overall Study|Lost to Follow-up|0
867972|NCT01434693|2861766|P1|Overall Study|Lost to Follow-up|1
867973|NCT01434693|2861763|P4|Overall Study|Withdrawal by Subject|1
867974|NCT01434693|2861764|P3|Overall Study|Withdrawal by Subject|1
867975|NCT01434693|2861765|P2|Overall Study|Withdrawal by Subject|0
867976|NCT01434693|2861766|P1|Overall Study|Withdrawal by Subject|1
867977|NCT01434693|2861763|P4|Overall Study|Adverse Event|0
867978|NCT01434693|2861764|P3|Overall Study|Adverse Event|0
867979|NCT01434693|2861765|P2|Overall Study|Adverse Event|0
867980|NCT01434693|2861766|P1|Overall Study|Adverse Event|1
867981|NCT01434680|2861780|P4|Overall Study|Protocol Violation|0
867982|NCT01434680|2861781|P3|Overall Study|Protocol Violation|0
867983|NCT01434680|2861782|P2|Overall Study|Protocol Violation|1
867984|NCT01434680|2861783|P1|Overall Study|Protocol Violation|1
867985|NCT01434680|2861780|P4|Overall Study|Lost to Follow-up|0
867986|NCT01434680|2861781|P3|Overall Study|Lost to Follow-up|0
867987|NCT01434680|2861782|P2|Overall Study|Lost to Follow-up|1
867988|NCT01434680|2861783|P1|Overall Study|Lost to Follow-up|1
867989|NCT01434680|2861780|P4|Overall Study|Withdrawal by Subject|0
867990|NCT01434680|2861781|P3|Overall Study|Withdrawal by Subject|2
867991|NCT01434680|2861782|P2|Overall Study|Withdrawal by Subject|0
867992|NCT01434680|2861783|P1|Overall Study|Withdrawal by Subject|1
867993|NCT01434667|2861800|P2|Overall Study|Lost to Follow-up|10
867994|NCT01434667|2861801|P1|Overall Study|Lost to Follow-up|5
867995|NCT01434654|2861827|P2|Overall Study|Lost to Follow-up|0
867996|NCT01434654|2861828|P1|Overall Study|Lost to Follow-up|1
867997|NCT01434654|2861827|P2|Overall Study|Withdrawal by Subject|0
867998|NCT01434654|2861828|P1|Overall Study|Withdrawal by Subject|1
867999|NCT01434290|2861875|P2|Overall Study|No protocol treatment|4
868000|NCT01434290|2861876|P1|Overall Study|No protocol treatment|2
868001|NCT01434290|2861875|P2|Overall Study|Protocol Violation|3
868002|NCT01434290|2861876|P1|Overall Study|Protocol Violation|6
868003|NCT01433978|2861949|P3|Extension Phase|Study Terminated by Sponsor|4
868004|NCT01433978|2861950|P2|Extension Phase|Study Terminated by Sponsor|0
868005|NCT01433978|2861951|P1|Extension Phase|Study Terminated by Sponsor|0
868006|NCT01433978|2861949|P3|Extension Phase|Lack of Efficacy|1
868007|NCT01433978|2861950|P2|Extension Phase|Lack of Efficacy|0
868008|NCT01433978|2861951|P1|Extension Phase|Lack of Efficacy|0
868009|NCT01433978|2861949|P3|Extension Phase|Adverse Event, Non-Fatal|1
868010|NCT01433978|2861950|P2|Extension Phase|Adverse Event, Non-Fatal|0
868011|NCT01433978|2861951|P1|Extension Phase|Adverse Event, Non-Fatal|0
868012|NCT01433978|2861949|P3|Core Study|Study Terminated by Sponsor|0
868013|NCT01433978|2861950|P2|Core Study|Study Terminated by Sponsor|9
868014|NCT01433978|2861951|P1|Core Study|Study Terminated by Sponsor|6
868015|NCT01433978|2861949|P3|Core Study|Lack of Efficacy|0
868016|NCT01433978|2861950|P2|Core Study|Lack of Efficacy|1
868017|NCT01433978|2861951|P1|Core Study|Lack of Efficacy|5
868018|NCT01433978|2861949|P3|Core Study|Adverse Event, Non-Fatal|0
868019|NCT01433978|2861950|P2|Core Study|Adverse Event, Non-Fatal|1
868020|NCT01433978|2861951|P1|Core Study|Adverse Event, Non-Fatal|0
868021|NCT01433549|2862008|P2|Phase 2: Second Study Product|Adverse Event|1
868022|NCT01433549|2862009|P1|Phase 2: Second Study Product|Adverse Event|0
868023|NCT01433471|2862019|P2|Overall Study|Withdrawal by Subject|1
868024|NCT01433471|2862020|P1|Overall Study|Withdrawal by Subject|0
868025|NCT01433354|2862036|P1|Overall Study|Subject Withdrew Consent|3
868026|NCT01433354|2862036|P1|Overall Study|Lack of Efficacy|17
868027|NCT01433354|2862036|P1|Overall Study|Protocol Violation|2
868028|NCT01433354|2862036|P1|Overall Study|Administrative problems|90
868029|NCT01433354|2862036|P1|Overall Study|Lost to Follow-up|1
868030|NCT01433354|2862036|P1|Overall Study|Adverse Event|6
868031|NCT01433263|2862052|P2|Overall Study|Withdrawal by Subject|7
868032|NCT01433263|2862053|P1|Overall Study|Withdrawal by Subject|10
868033|NCT01433263|2862052|P2|Overall Study|Protocol Deviation|0
868034|NCT01433263|2862053|P1|Overall Study|Protocol Deviation|1
868035|NCT01433263|2862052|P2|Overall Study|Lost to Follow-up|1
868036|NCT01433263|2862053|P1|Overall Study|Lost to Follow-up|0
868037|NCT01433263|2862052|P2|Overall Study|Death|3
868038|NCT01433263|2862053|P1|Overall Study|Death|5
868039|NCT01433263|2862052|P2|Overall Study|Adverse Event|1
868040|NCT01433263|2862053|P1|Overall Study|Adverse Event|3
868041|NCT01433250|2862082|P2|Overall Study|Withdrawal by Subject|2
868042|NCT01433250|2862083|P1|Overall Study|Withdrawal by Subject|3
868043|NCT01433250|2862082|P2|Overall Study|Protocol Violation|1
868044|NCT01433250|2862083|P1|Overall Study|Protocol Violation|0
868045|NCT01433172|2862102|P3|Overall Study|Death|0
868046|NCT01433172|2862103|P2|Overall Study|Death|2
868047|NCT01433172|2862104|P1|Overall Study|Death|0
868048|NCT01433172|2862102|P3|Overall Study|Disease Progression|1
868049|NCT01433172|2862103|P2|Overall Study|Disease Progression|0
868050|NCT01433172|2862104|P1|Overall Study|Disease Progression|0
868051|NCT01433172|2862102|P3|Overall Study|Withdrawal by Subject|0
868052|NCT01433172|2862103|P2|Overall Study|Withdrawal by Subject|1
868053|NCT01433172|2862104|P1|Overall Study|Withdrawal by Subject|0
868054|NCT01433159|2862116|P2|Overall Study|Protocol Violation|1
868055|NCT01433159|2862117|P1|Overall Study|Protocol Violation|0
868056|NCT01433159|2862116|P2|Overall Study|Physician Decision|0
868057|NCT01433159|2862117|P1|Overall Study|Physician Decision|1
868058|NCT01433159|2862116|P2|Overall Study|Adverse Event|0
868059|NCT01433159|2862117|P1|Overall Study|Adverse Event|1
868060|NCT01433055|2862149|P2|Overall Study|Severely elevated triglycerides at entry|0
868061|NCT01433055|2862150|P1|Overall Study|Severely elevated triglycerides at entry|1
868062|NCT01433055|2862149|P2|Overall Study|Diagnosed with cancer unrelated to study|0
868063|NCT01433055|2862150|P1|Overall Study|Diagnosed with cancer unrelated to study|1
868064|NCT01432938|2862172|P2|Second Intervention|Adverse Event|0
868065|NCT01432938|2862173|P1|Second Intervention|Adverse Event|1
868066|NCT01432938|2862172|P2|First Intervention|Physician Decision|0
868067|NCT01432938|2862173|P1|First Intervention|Physician Decision|1
868068|NCT01432938|2862172|P2|First Intervention|Protocol Violation|0
868069|NCT01432938|2862173|P1|First Intervention|Protocol Violation|1
868070|NCT01432756|2862203|P4|Overall Study|Lost to Follow-up|1
868071|NCT01432756|2862204|P3|Overall Study|Lost to Follow-up|2
868072|NCT01432756|2862205|P2|Overall Study|Lost to Follow-up|0
868073|NCT01432756|2862206|P1|Overall Study|Lost to Follow-up|1
868074|NCT01432626|2862214|P1|Overall Study|Imaging agent not available|1
868075|NCT01432626|2862214|P1|Overall Study|Only 1 image competed|2
868076|NCT01432626|2862214|P1|Overall Study|Withdrawal by Subject|2
868077|NCT01432626|2862214|P1|Overall Study|LV function recovered|2
868078|NCT01432600|2862221|P3|Overall Study|Rapid PD, allocated intv. not rec'd|1
868079|NCT01432600|2862222|P2|Overall Study|Rapid PD, allocated intv. not rec'd|1
868080|NCT01432600|2862223|P1|Overall Study|Rapid PD, allocated intv. not rec'd|0
868081|NCT01432574|2862239|P1|Overall Study|Not interested|1
868082|NCT01432574|2862239|P1|Overall Study|Moved|2
868083|NCT01432457|2862285|P3|Overall Study|Did not take study drug|3
868084|NCT01432457|2862286|P2|Overall Study|Did not take study drug|6
868085|NCT01432457|2862287|P1|Overall Study|Did not take study drug|6
868086|NCT01432457|2862285|P3|Overall Study|Reasons not defined|4
868087|NCT01432457|2862286|P2|Overall Study|Reasons not defined|3
868088|NCT01432457|2862287|P1|Overall Study|Reasons not defined|2
868089|NCT01432457|2862285|P3|Overall Study|Withdrawal by Subject|9
868090|NCT01432457|2862286|P2|Overall Study|Withdrawal by Subject|11
868091|NCT01432457|2862287|P1|Overall Study|Withdrawal by Subject|6
868092|NCT01432457|2862285|P3|Overall Study|Protocol Violation|6
868093|NCT01432457|2862286|P2|Overall Study|Protocol Violation|2
868094|NCT01432457|2862287|P1|Overall Study|Protocol Violation|3
868095|NCT01432457|2862285|P3|Overall Study|Lost to Follow-up|20
868096|NCT01432457|2862286|P2|Overall Study|Lost to Follow-up|15
868097|NCT01432457|2862287|P1|Overall Study|Lost to Follow-up|11
868098|NCT01432457|2862285|P3|Overall Study|Lack of Efficacy|1
868099|NCT01432457|2862286|P2|Overall Study|Lack of Efficacy|1
868100|NCT01432457|2862287|P1|Overall Study|Lack of Efficacy|2
868101|NCT01432457|2862285|P3|Overall Study|Adverse Event|16
868102|NCT01432457|2862286|P2|Overall Study|Adverse Event|10
868103|NCT01432457|2862287|P1|Overall Study|Adverse Event|7
868104|NCT01432444|2862316|P3|Extension Phase|Withdrawal by Subject|13
868105|NCT01432444|2862317|P2|Extension Phase|Withdrawal by Subject|0
868106|NCT01432444|2862318|P1|Extension Phase|Withdrawal by Subject|0
868107|NCT01432444|2862316|P3|Extension Phase|Physician Decision|1
868108|NCT01432444|2862317|P2|Extension Phase|Physician Decision|0
868109|NCT01432444|2862318|P1|Extension Phase|Physician Decision|0
868110|NCT01432444|2862316|P3|Extension Phase|Met Withdrawal Criteria|144
868111|NCT01432444|2862317|P2|Extension Phase|Met Withdrawal Criteria|0
868112|NCT01432444|2862318|P1|Extension Phase|Met Withdrawal Criteria|0
868113|NCT01432444|2862316|P3|Extension Phase|Sponsor Discontinued Trial|7
868114|NCT01432444|2862317|P2|Extension Phase|Sponsor Discontinued Trial|0
868115|NCT01432444|2862318|P1|Extension Phase|Sponsor Discontinued Trial|0
868116|NCT01432444|2862316|P3|Extension Phase|Adverse Event|10
868117|NCT01432444|2862317|P2|Extension Phase|Adverse Event|0
868118|NCT01432444|2862318|P1|Extension Phase|Adverse Event|0
868119|NCT01432444|2862316|P3|Extension Phase|Lost to Follow-up|17
868120|NCT01432444|2862317|P2|Extension Phase|Lost to Follow-up|0
868121|NCT01432444|2862318|P1|Extension Phase|Lost to Follow-up|0
868122|NCT01432444|2862316|P3|Treatment Phase|Lack of Efficacy|0
868123|NCT01432444|2862317|P2|Treatment Phase|Lack of Efficacy|10
868124|NCT01432444|2862318|P1|Treatment Phase|Lack of Efficacy|0
868125|NCT01432444|2862316|P3|Treatment Phase|Protocol Deviation|0
868126|NCT01432444|2862317|P2|Treatment Phase|Protocol Deviation|3
868127|NCT01432444|2862318|P1|Treatment Phase|Protocol Deviation|0
868128|NCT01432444|2862316|P3|Treatment Phase|Withdrawal by Subject|0
868129|NCT01432444|2862317|P2|Treatment Phase|Withdrawal by Subject|41
868130|NCT01432444|2862318|P1|Treatment Phase|Withdrawal by Subject|0
868131|NCT01432444|2862316|P3|Treatment Phase|Physician Decision|0
868132|NCT01432444|2862317|P2|Treatment Phase|Physician Decision|5
868133|NCT01432444|2862318|P1|Treatment Phase|Physician Decision|0
868134|NCT01432444|2862316|P3|Treatment Phase|Met Withdrawal Criteria|0
868135|NCT01432444|2862317|P2|Treatment Phase|Met Withdrawal Criteria|11
868136|NCT01432444|2862318|P1|Treatment Phase|Met Withdrawal Criteria|0
868137|NCT01432444|2862316|P3|Treatment Phase|Adverse Event|0
868138|NCT01432444|2862317|P2|Treatment Phase|Adverse Event|37
868139|NCT01432444|2862318|P1|Treatment Phase|Adverse Event|0
868140|NCT01432444|2862316|P3|Treatment Phase|Lost to Follow-up|0
868141|NCT01432444|2862317|P2|Treatment Phase|Lost to Follow-up|33
868142|NCT01432444|2862318|P1|Treatment Phase|Lost to Follow-up|0
868143|NCT01432444|2862316|P3|Tolerability/Cross-titration Phase|Lack of Efficacy|0
868144|NCT01432444|2862317|P2|Tolerability/Cross-titration Phase|Lack of Efficacy|0
868145|NCT01432444|2862318|P1|Tolerability/Cross-titration Phase|Lack of Efficacy|5
868146|NCT01432444|2862316|P3|Tolerability/Cross-titration Phase|Protocol Deviation|0
868147|NCT01432444|2862317|P2|Tolerability/Cross-titration Phase|Protocol Deviation|0
868148|NCT01432444|2862318|P1|Tolerability/Cross-titration Phase|Protocol Deviation|1
868149|NCT01432444|2862316|P3|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
868150|NCT01432444|2862317|P2|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
868151|NCT01432444|2862318|P1|Tolerability/Cross-titration Phase|Withdrawal by Subject|15
868152|NCT01432444|2862316|P3|Tolerability/Cross-titration Phase|Physician Decision|0
868153|NCT01432444|2862317|P2|Tolerability/Cross-titration Phase|Physician Decision|0
868154|NCT01432444|2862318|P1|Tolerability/Cross-titration Phase|Physician Decision|8
868155|NCT01432444|2862316|P3|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
868156|NCT01432444|2862317|P2|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
868157|NCT01432444|2862318|P1|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5
868158|NCT01432444|2862316|P3|Tolerability/Cross-titration Phase|Adverse Event|0
868159|NCT01432444|2862317|P2|Tolerability/Cross-titration Phase|Adverse Event|0
868160|NCT01432444|2862318|P1|Tolerability/Cross-titration Phase|Adverse Event|16
868161|NCT01432444|2862316|P3|Tolerability/Cross-titration Phase|Lost to Follow-up|0
868162|NCT01432444|2862317|P2|Tolerability/Cross-titration Phase|Lost to Follow-up|0
868163|NCT01432444|2862318|P1|Tolerability/Cross-titration Phase|Lost to Follow-up|10
868164|NCT01432366|2862344|P1|Overall Study|Other|14
868165|NCT01432366|2862344|P1|Overall Study|Investigator Forget to Complete Visits|1
868166|NCT01432366|2862344|P1|Overall Study|Site Closed|20
868167|NCT01432366|2862344|P1|Overall Study|Lack of Efficacy|1
868168|NCT01432366|2862344|P1|Overall Study|Lost to Follow-up|13
868169|NCT01432366|2862344|P1|Overall Study|Pregnancy|1
868170|NCT01432366|2862344|P1|Overall Study|Withdrawal Due to Non-Compliance|3
868171|NCT01432366|2862344|P1|Overall Study|Adverse Event|8
868172|NCT01432366|2862344|P1|Overall Study|Non-Responder|7
868173|NCT01432327|2862366|P4|Posttest 1 Year|Allergic reaction|1
868174|NCT01432327|2862367|P3|Posttest 1 Year|Allergic reaction|1
868175|NCT01432327|2862368|P2|Posttest 1 Year|Allergic reaction|0
868176|NCT01432327|2862369|P1|Posttest 1 Year|Allergic reaction|0
868177|NCT01432327|2862366|P4|Posttest 1 Year|Lost to Follow-up|2
868178|NCT01432327|2862367|P3|Posttest 1 Year|Lost to Follow-up|4
868179|NCT01432327|2862368|P2|Posttest 1 Year|Lost to Follow-up|0
868180|NCT01432327|2862369|P1|Posttest 1 Year|Lost to Follow-up|0
868181|NCT01432327|2862366|P4|Posttest 1 Year|Measurement have to take place in future|20
868182|NCT01432327|2862367|P3|Posttest 1 Year|Measurement have to take place in future|15
868183|NCT01432327|2862368|P2|Posttest 1 Year|Measurement have to take place in future|28
868184|NCT01432327|2862369|P1|Posttest 1 Year|Measurement have to take place in future|24
868185|NCT01432327|2862366|P4|Posttest 6 Months|Withdrawal by Subject|0
868186|NCT01432327|2862367|P3|Posttest 6 Months|Withdrawal by Subject|1
868187|NCT01432327|2862368|P2|Posttest 6 Months|Withdrawal by Subject|0
868188|NCT01432327|2862369|P1|Posttest 6 Months|Withdrawal by Subject|0
868189|NCT01432327|2862366|P4|Posttest 6 Months|Allergic reaction|0
868190|NCT01432327|2862367|P3|Posttest 6 Months|Allergic reaction|1
868191|NCT01432327|2862368|P2|Posttest 6 Months|Allergic reaction|0
868192|NCT01432327|2862369|P1|Posttest 6 Months|Allergic reaction|0
868193|NCT01432327|2862366|P4|Posttest 6 Months|Lost to Follow-up|2
868194|NCT01432327|2862367|P3|Posttest 6 Months|Lost to Follow-up|3
868195|NCT01432327|2862368|P2|Posttest 6 Months|Lost to Follow-up|0
868196|NCT01432327|2862369|P1|Posttest 6 Months|Lost to Follow-up|0
868197|NCT01432327|2862366|P4|Posttest 3 Months|Allergic reaction|0
868198|NCT01432327|2862367|P3|Posttest 3 Months|Allergic reaction|0
868199|NCT01432327|2862368|P2|Posttest 3 Months|Allergic reaction|2
868200|NCT01432327|2862369|P1|Posttest 3 Months|Allergic reaction|0
868201|NCT01432327|2862366|P4|Posttest 3 Months|Lost to Follow-up|1
868202|NCT01432327|2862367|P3|Posttest 3 Months|Lost to Follow-up|2
868203|NCT01432327|2862368|P2|Posttest 3 Months|Lost to Follow-up|0
868204|NCT01432327|2862369|P1|Posttest 3 Months|Lost to Follow-up|1
868205|NCT01432327|2862366|P4|Posttest 3 Months|depression|0
868206|NCT01432327|2862367|P3|Posttest 3 Months|depression|0
868207|NCT01432327|2862368|P2|Posttest 3 Months|depression|0
868208|NCT01432327|2862369|P1|Posttest 3 Months|depression|3
868209|NCT01432275|2862379|P2|ADC With Calculator (10 Days)|Protocol Violation|1
868210|NCT01432275|2862380|P1|ADC With Calculator (10 Days)|Protocol Violation|0
868211|NCT01432275|2862379|P2|ADC With Calculator (10 Days)|Withdrawal by Subject|0
868212|NCT01432275|2862380|P1|ADC With Calculator (10 Days)|Withdrawal by Subject|2
868213|NCT01432275|2862379|P2|ADC With Calculator (10 Days)|Physician Decision|1
868214|NCT01432275|2862380|P1|ADC With Calculator (10 Days)|Physician Decision|1
868215|NCT01432275|2862379|P2|Second BG Meter System (7 Days)|Withdrawal by Subject|1
868216|NCT01432275|2862380|P1|Second BG Meter System (7 Days)|Withdrawal by Subject|0
868217|NCT01432275|2862379|P2|Second BG Meter System (7 Days)|Physician Decision|1
868218|NCT01432275|2862380|P1|Second BG Meter System (7 Days)|Physician Decision|0
868219|NCT01432275|2862379|P2|Second BG Meter System (7 Days)|Lost to Follow-up|0
868220|NCT01432275|2862380|P1|Second BG Meter System (7 Days)|Lost to Follow-up|1
868221|NCT01432275|2862379|P2|Second BG Meter System (7 Days)|Adverse Event|1
868222|NCT01432275|2862380|P1|Second BG Meter System (7 Days)|Adverse Event|1
868223|NCT01432275|2862379|P2|First BG Meter System (7 Days)|Withdrawal by Subject|1
868224|NCT01432275|2862380|P1|First BG Meter System (7 Days)|Withdrawal by Subject|0
868225|NCT01432275|2862379|P2|First BG Meter System (7 Days)|Adverse Event|2
868226|NCT01432275|2862380|P1|First BG Meter System (7 Days)|Adverse Event|0
868227|NCT01432262|2862389|P2|Overall Study|Withdrawal by Subject|1
868228|NCT01432262|2862390|P1|Overall Study|Withdrawal by Subject|2
868229|NCT01431976|2862484|P1|Overall Study|Withdrawal by Subject|1
868230|NCT01431976|2862484|P1|Overall Study|Physician Decision|1
868231|NCT01431976|2862484|P1|Overall Study|Met Protocol-defined Stopping Criteria|4
868232|NCT01431976|2862484|P1|Overall Study|Lack of Efficacy|2
868233|NCT01431976|2862484|P1|Overall Study|Adverse Event|6
868234|NCT01431963|2862495|P1|Overall Study|Withdrawal by Subject|3
868235|NCT01431963|2862495|P1|Overall Study|Physician Decision|4
868236|NCT01431963|2862495|P1|Overall Study|Protocol-defined Stopping Criteria|2
868237|NCT01431963|2862495|P1|Overall Study|Protocol Violation|1
868238|NCT01431963|2862495|P1|Overall Study|Lack of Efficacy|7
868239|NCT01431963|2862495|P1|Overall Study|Adverse Event|18
868240|NCT01431950|2862503|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
868241|NCT01431950|2862504|P1|Overall Study|Met Protocol-defined Stopping Criteria|0
868242|NCT01431950|2862503|P2|Overall Study|Lost to Follow-up|1
868243|NCT01431950|2862504|P1|Overall Study|Lost to Follow-up|0
868244|NCT01431950|2862503|P2|Overall Study|Lack of Efficacy|1
868245|NCT01431950|2862504|P1|Overall Study|Lack of Efficacy|2
868246|NCT01431950|2862503|P2|Overall Study|Physician Decision|1
868247|NCT01431950|2862504|P1|Overall Study|Physician Decision|2
868248|NCT01431950|2862503|P2|Overall Study|Adverse Event|2
868249|NCT01431950|2862504|P1|Overall Study|Adverse Event|2
868250|NCT01431950|2862503|P2|Overall Study|Protocol Violation|3
868251|NCT01431950|2862504|P1|Overall Study|Protocol Violation|2
868252|NCT01431950|2862503|P2|Overall Study|Withdrawal by Subject|3
868253|NCT01431950|2862504|P1|Overall Study|Withdrawal by Subject|4
868254|NCT01431950|2862503|P2|Overall Study|Study Site Closed/Terminated|3
868255|NCT01431950|2862504|P1|Overall Study|Study Site Closed/Terminated|7
868256|NCT01431716|2862542|P1|Overall Study|Withdrawal of consent|1
868257|NCT01431521|2862567|P4|Overall Study|Withdrawal by Subject|0
868258|NCT01431521|2862568|P3|Overall Study|Withdrawal by Subject|1
868259|NCT01431521|2862569|P2|Overall Study|Withdrawal by Subject|0
868260|NCT01431521|2862570|P1|Overall Study|Withdrawal by Subject|0
868261|NCT01431508|2862591|P1|Overall Study|Unable to Follow Protocol Procedures|1
868262|NCT01431508|2862591|P1|Overall Study|Lack of Efficacy|1
868263|NCT01431287|2862642|P5|Overall Study|not stated above|1
868264|NCT01431287|2862643|P4|Overall Study|not stated above|2
868265|NCT01431287|2862644|P3|Overall Study|not stated above|2
868266|NCT01431287|2862645|P2|Overall Study|not stated above|2
868267|NCT01431287|2862646|P1|Overall Study|not stated above|4
868268|NCT01431287|2862642|P5|Overall Study|Consent withdrawn not due to AE|29
868269|NCT01431287|2862643|P4|Overall Study|Consent withdrawn not due to AE|19
868270|NCT01431287|2862644|P3|Overall Study|Consent withdrawn not due to AE|34
868271|NCT01431287|2862645|P2|Overall Study|Consent withdrawn not due to AE|30
868272|NCT01431287|2862646|P1|Overall Study|Consent withdrawn not due to AE|29
868273|NCT01431287|2862642|P5|Overall Study|Lost to Follow-up|1
868274|NCT01431287|2862643|P4|Overall Study|Lost to Follow-up|3
868275|NCT01431287|2862644|P3|Overall Study|Lost to Follow-up|2
868276|NCT01431287|2862645|P2|Overall Study|Lost to Follow-up|3
868277|NCT01431287|2862646|P1|Overall Study|Lost to Follow-up|0
868278|NCT01431287|2862642|P5|Overall Study|Non compliant with protocol|5
868279|NCT01431287|2862643|P4|Overall Study|Non compliant with protocol|6
868280|NCT01431287|2862644|P3|Overall Study|Non compliant with protocol|5
868281|NCT01431287|2862645|P2|Overall Study|Non compliant with protocol|6
868282|NCT01431287|2862646|P1|Overall Study|Non compliant with protocol|6
868283|NCT01431287|2862642|P5|Overall Study|Adverse Event|41
868284|NCT01431287|2862643|P4|Overall Study|Adverse Event|33
868285|NCT01431287|2862644|P3|Overall Study|Adverse Event|53
868286|NCT01431287|2862645|P2|Overall Study|Adverse Event|57
868287|NCT01431287|2862646|P1|Overall Study|Adverse Event|59
868288|NCT01431287|2862642|P5|Overall Study|not treated|0
868289|NCT01431287|2862643|P4|Overall Study|not treated|0
868290|NCT01431287|2862644|P3|Overall Study|not treated|1
868291|NCT01431287|2862645|P2|Overall Study|not treated|0
868292|NCT01431287|2862646|P1|Overall Study|not treated|0
868293|NCT01431274|2862808|P5|Overall Study|Other reason not stated above|4
868294|NCT01431274|2862809|P4|Overall Study|Other reason not stated above|2
868295|NCT01431274|2862810|P3|Overall Study|Other reason not stated above|7
868296|NCT01431274|2862811|P2|Overall Study|Other reason not stated above|5
868297|NCT01431274|2862812|P1|Overall Study|Other reason not stated above|6
868298|NCT01431274|2862808|P5|Overall Study|Lost to Follow-up|0
868299|NCT01431274|2862809|P4|Overall Study|Lost to Follow-up|4
868300|NCT01431274|2862810|P3|Overall Study|Lost to Follow-up|1
868301|NCT01431274|2862811|P2|Overall Study|Lost to Follow-up|7
868302|NCT01431274|2862812|P1|Overall Study|Lost to Follow-up|6
868303|NCT01431274|2862808|P5|Overall Study|Non compliant with protocol|4
868304|NCT01431274|2862809|P4|Overall Study|Non compliant with protocol|4
868305|NCT01431274|2862810|P3|Overall Study|Non compliant with protocol|4
868306|NCT01431274|2862811|P2|Overall Study|Non compliant with protocol|8
868307|NCT01431274|2862812|P1|Overall Study|Non compliant with protocol|5
868308|NCT01431274|2862808|P5|Overall Study|Consent withdrawn not due to AE|11
868309|NCT01431274|2862809|P4|Overall Study|Consent withdrawn not due to AE|20
868310|NCT01431274|2862810|P3|Overall Study|Consent withdrawn not due to AE|17
868311|NCT01431274|2862811|P2|Overall Study|Consent withdrawn not due to AE|20
868312|NCT01431274|2862812|P1|Overall Study|Consent withdrawn not due to AE|29
868313|NCT01431274|2862808|P5|Overall Study|Adverse Event|37
868314|NCT01431274|2862809|P4|Overall Study|Adverse Event|30
868315|NCT01431274|2862810|P3|Overall Study|Adverse Event|43
868316|NCT01431274|2862811|P2|Overall Study|Adverse Event|37
868317|NCT01431274|2862812|P1|Overall Study|Adverse Event|51
868318|NCT01431144|2862990|P2|Overall Study|Implant mobility and removal|0
868319|NCT01431144|2862991|P1|Overall Study|Implant mobility and removal|2
868320|NCT01431079|2863010|P2|Overall Study|Lost to Follow-up|39
868321|NCT01431079|2863011|P1|Overall Study|Lost to Follow-up|35
868322|NCT01430754|2863090|P2|Run-In Phase|Lost to Follow-up|0
868323|NCT01430754|2863091|P1|Run-In Phase|Lost to Follow-up|1
868324|NCT01430754|2863090|P2|Run-In Phase|Withdrawal by Subject|0
868325|NCT01430754|2863091|P1|Run-In Phase|Withdrawal by Subject|2
868326|NCT01430754|2863090|P2|Run-In Phase|Other|0
868327|NCT01430754|2863091|P1|Run-In Phase|Other|2
868328|NCT01430754|2863090|P2|Run-In Phase|Adverse Event|0
868329|NCT01430754|2863091|P1|Run-In Phase|Adverse Event|2
868330|NCT01430754|2863090|P2|Run-In Phase|Protocol Violation|0
868331|NCT01430754|2863091|P1|Run-In Phase|Protocol Violation|6
868332|NCT01430754|2863090|P2|Run-In Phase|Circadian Period Ineligible|0
868333|NCT01430754|2863091|P1|Run-In Phase|Circadian Period Ineligible|24
868334|NCT01430624|2863149|P3|Overall Study|technical or eligibility|2
868335|NCT01430624|2863150|P2|Overall Study|technical or eligibility|5
868336|NCT01430624|2863151|P1|Overall Study|technical or eligibility|5
868337|NCT01430624|2863149|P3|Overall Study|Lost to Follow-up|27
868338|NCT01430624|2863150|P2|Overall Study|Lost to Follow-up|29
868339|NCT01430624|2863151|P1|Overall Study|Lost to Follow-up|23
868340|NCT01430611|2863182|P2|Overall Study|Withdrawal by Subject|14
868341|NCT01430611|2863183|P1|Overall Study|Withdrawal by Subject|15
868342|NCT01430611|2863182|P2|Overall Study|Lost to Follow-up|0
868343|NCT01430611|2863183|P1|Overall Study|Lost to Follow-up|1
868344|NCT01430611|2863182|P2|Overall Study|Protocol Violation|0
868345|NCT01430611|2863183|P1|Overall Study|Protocol Violation|1
868346|NCT01430611|2863182|P2|Overall Study|Adverse Event|1
868347|NCT01430611|2863183|P1|Overall Study|Adverse Event|0
868348|NCT01430585|2863201|P1|Overall Study|Other|7
868349|NCT01430585|2863201|P1|Overall Study|Study Terminated by Sponsor|3
868350|NCT01430585|2863201|P1|Overall Study|Objective Progression or Relapse|3
868351|NCT01430585|2863201|P1|Overall Study|Death|1
868352|NCT01430468|2863236|P2|Overall Study|Withdrawal by Subject|1
868353|NCT01430468|2863237|P1|Overall Study|Withdrawal by Subject|1
868354|NCT01430468|2863236|P2|Overall Study|Physician Decision|1
868355|NCT01430468|2863237|P1|Overall Study|Physician Decision|2
868356|NCT01430455|2863243|P1|Overall Study|Switched to follow-up phase|1
868357|NCT01430455|2863243|P1|Overall Study|Withdrawal by Subject|1
868358|NCT01430403|2863250|P3|Overall Study|Withdrawal by Subject|3
868359|NCT01430403|2863251|P2|Overall Study|Withdrawal by Subject|1
868360|NCT01430403|2863252|P1|Overall Study|Withdrawal by Subject|9
868361|NCT01430403|2863250|P3|Overall Study|Protocol Violation|2
868362|NCT01430403|2863251|P2|Overall Study|Protocol Violation|3
868363|NCT01430403|2863252|P1|Overall Study|Protocol Violation|2
868364|NCT01430403|2863250|P3|Overall Study|Physician Decision|0
868365|NCT01430403|2863251|P2|Overall Study|Physician Decision|0
868366|NCT01430403|2863252|P1|Overall Study|Physician Decision|1
868367|NCT01430403|2863250|P3|Overall Study|Lost to Follow-up|3
868368|NCT01430403|2863251|P2|Overall Study|Lost to Follow-up|5
868369|NCT01430403|2863252|P1|Overall Study|Lost to Follow-up|5
868370|NCT01430130|2863359|P1|Overall Study|Infection on Control Side of Incision|1
868371|NCT01430130|2863359|P1|Overall Study|Lost to Follow-up|1
868372|NCT01430104|2863365|P1|28-Day Teriparatide Treatment Period|Adverse Event|1
868373|NCT01429792|2863432|P1|Overall Study|Lost to Follow-up|88
868374|NCT01429792|2863432|P1|Overall Study|Withdrawal by Subject|70
868375|NCT01429792|2863432|P1|Overall Study|Positive HCV-RNA at Week 24|50
868376|NCT01429792|2863432|P1|Overall Study|Decrease of less than 2-log in HCV RNA|32
868377|NCT01429792|2863432|P1|Overall Study|Negative HCV-RNA at Week 12|4
868378|NCT01429792|2863432|P1|Overall Study|Negative HCV-RNA at Week 4|1
868379|NCT01429792|2863432|P1|Overall Study|Unknown Disposition|94
868380|NCT01429792|2863432|P1|Overall Study|Other Reasons|67
868381|NCT01429623|2863446|P2|Overall Study|No post baseline data|4
868382|NCT01429623|2863447|P1|Overall Study|No post baseline data|4
868383|NCT01429623|2863446|P2|Overall Study|Conversion to Alzheimer's disease|21
868384|NCT01429623|2863447|P1|Overall Study|Conversion to Alzheimer's disease|14
868385|NCT01429623|2863446|P2|Overall Study|Assorted|2
868386|NCT01429623|2863447|P1|Overall Study|Assorted|1
868387|NCT01429623|2863446|P2|Overall Study|Protocol Violation|2
868388|NCT01429623|2863447|P1|Overall Study|Protocol Violation|3
868389|NCT01429623|2863446|P2|Overall Study|Physician Decision|3
868390|NCT01429623|2863447|P1|Overall Study|Physician Decision|2
868391|NCT01429623|2863446|P2|Overall Study|Withdrawal by Subject|13
868392|NCT01429623|2863447|P1|Overall Study|Withdrawal by Subject|19
868393|NCT01429623|2863446|P2|Overall Study|Adverse Event|14
868394|NCT01429623|2863447|P1|Overall Study|Adverse Event|7
868395|NCT01429623|2863446|P2|Overall Study|Death|0
868396|NCT01429623|2863447|P1|Overall Study|Death|1
868397|NCT01429584|2863461|P2|Overall Study|Protocol Violation|1
868398|NCT01429584|2863462|P1|Overall Study|Protocol Violation|0
868399|NCT01429584|2863461|P2|Overall Study|Withdrawal by Subject|0
868400|NCT01429584|2863462|P1|Overall Study|Withdrawal by Subject|1
868401|NCT01429441|2863493|P2|Overall Study|Withdrawal by Subject|18
868402|NCT01429441|2863494|P1|Overall Study|Withdrawal by Subject|27
868403|NCT01429441|2863493|P2|Overall Study|Physician Decision|0
868404|NCT01429441|2863494|P1|Overall Study|Physician Decision|1
868405|NCT01429441|2863493|P2|Overall Study|Lost to Follow-up|2
868406|NCT01429441|2863494|P1|Overall Study|Lost to Follow-up|5
868407|NCT01429441|2863493|P2|Overall Study|Death|2
868408|NCT01429441|2863494|P1|Overall Study|Death|0
868409|NCT01429441|2863493|P2|Overall Study|Adverse Event|1
868410|NCT01429441|2863494|P1|Overall Study|Adverse Event|5
868411|NCT01429298|2863504|P2|Overall Study|Protocol Violation|6
868412|NCT01429298|2863505|P1|Overall Study|Protocol Violation|4
868413|NCT01429285|2863521|P2|Overall Study|Erroneously Enrolled Twice|2
868414|NCT01429285|2863522|P1|Overall Study|Erroneously Enrolled Twice|8
868415|NCT01429285|2863521|P2|Overall Study|Missing Data|3
868416|NCT01429285|2863522|P1|Overall Study|Missing Data|5
868417|NCT01429285|2863521|P2|Overall Study|Protocol Violation|4
868418|NCT01429285|2863522|P1|Overall Study|Protocol Violation|9
868419|NCT01429077|2863568|P2|Overall Study|Lost to Follow-up|3
868420|NCT01429077|2863569|P1|Overall Study|Lost to Follow-up|0
868421|NCT01429051|2863592|P1|Tolerability Phase|Other|2
868422|NCT01429051|2863592|P1|Tolerability Phase|Physician Decision|1
868423|NCT01429051|2863592|P1|Tolerability Phase|Withdrawal by Subject|5
868424|NCT01429051|2863592|P1|Tolerability Phase|Adverse Event|2
868425|NCT01429051|2863592|P1|Tolerability Phase|Death|5
868426|NCT01429051|2863592|P1|Efficacy Phase|Death|1
868427|NCT01429051|2863592|P1|Efficacy Phase|Adverse Event|1
868428|NCT01429051|2863592|P1|Titration Phase|Less than 3 BTP episodes per week|2
868429|NCT01429051|2863592|P1|Titration Phase|Unsuccessful titration at any dose|1
868430|NCT01429051|2863592|P1|Titration Phase|Physician Decision|1
868431|NCT01429051|2863592|P1|Titration Phase|Withdrawal by Subject|7
868432|NCT01429051|2863592|P1|Titration Phase|Death|1
868433|NCT01428882|2863615|P2|Overall Study|Protocol Violation|3
868434|NCT01428882|2863616|P1|Overall Study|Protocol Violation|4
868435|NCT01428882|2863615|P2|Overall Study|Lack of Efficacy|7
868436|NCT01428882|2863616|P1|Overall Study|Lack of Efficacy|2
868437|NCT01428713|2863639|P2|Overall Study|Adverse Event|2
868438|NCT01428713|2863640|P1|Overall Study|Adverse Event|0
868439|NCT01428713|2863639|P2|Overall Study|Withdrawal by Subject|1
868440|NCT01428713|2863640|P1|Overall Study|Withdrawal by Subject|1
868441|NCT01428713|2863639|P2|Overall Study|Non-compliance|2
868442|NCT01428713|2863640|P1|Overall Study|Non-compliance|2
868443|NCT01428661|2863649|P3|Open Label Extension|**Various|185
868444|NCT01428661|2863650|P2|Open Label Extension|**Various|0
868445|NCT01428661|2863651|P1|Open Label Extension|**Various|0
868446|NCT01428661|2863649|P3|Open Label Extension|Lack of Efficacy|24
868447|NCT01428661|2863650|P2|Open Label Extension|Lack of Efficacy|0
868448|NCT01428661|2863651|P1|Open Label Extension|Lack of Efficacy|0
868449|NCT01428661|2863649|P3|Open Label Extension|Withdrawal by Subject|49
868450|NCT01428661|2863650|P2|Open Label Extension|Withdrawal by Subject|0
868451|NCT01428661|2863651|P1|Open Label Extension|Withdrawal by Subject|0
868452|NCT01428661|2863649|P3|Open Label Extension|Lost to Follow-up|38
868453|NCT01428661|2863650|P2|Open Label Extension|Lost to Follow-up|0
868454|NCT01428661|2863651|P1|Open Label Extension|Lost to Follow-up|0
868455|NCT01428661|2863649|P3|Open Label Extension|Adverse Event|15
868456|NCT01428661|2863650|P2|Open Label Extension|Adverse Event|0
868457|NCT01428661|2863651|P1|Open Label Extension|Adverse Event|0
868458|NCT01428661|2863649|P3|Open Label Extension|Protocol Violation|9
868459|NCT01428661|2863650|P2|Open Label Extension|Protocol Violation|0
868460|NCT01428661|2863651|P1|Open Label Extension|Protocol Violation|0
868461|NCT01428661|2863649|P3|Double-Masked Phase|*Various|0
868462|NCT01428661|2863650|P2|Double-Masked Phase|*Various|6
868463|NCT01428661|2863651|P1|Double-Masked Phase|*Various|1
868464|NCT01428661|2863649|P3|Double-Masked Phase|Lack of Efficacy|0
868465|NCT01428661|2863650|P2|Double-Masked Phase|Lack of Efficacy|1
868466|NCT01428661|2863651|P1|Double-Masked Phase|Lack of Efficacy|2
868467|NCT01428661|2863649|P3|Double-Masked Phase|Withdrawal by Subject|0
868468|NCT01428661|2863650|P2|Double-Masked Phase|Withdrawal by Subject|20
868469|NCT01428661|2863651|P1|Double-Masked Phase|Withdrawal by Subject|18
868470|NCT01428661|2863649|P3|Double-Masked Phase|Lost to Follow-up|0
868471|NCT01428661|2863650|P2|Double-Masked Phase|Lost to Follow-up|14
868472|NCT01428661|2863651|P1|Double-Masked Phase|Lost to Follow-up|14
868473|NCT01428661|2863649|P3|Double-Masked Phase|Adverse Event|0
868474|NCT01428661|2863650|P2|Double-Masked Phase|Adverse Event|4
868475|NCT01428661|2863651|P1|Double-Masked Phase|Adverse Event|13
868476|NCT01428661|2863649|P3|Double-Masked Phase|Protocol Violation|0
868477|NCT01428661|2863650|P2|Double-Masked Phase|Protocol Violation|4
868478|NCT01428661|2863651|P1|Double-Masked Phase|Protocol Violation|9
868479|NCT01428583|2863659|P1|Overall Study|Other|6
868480|NCT01428583|2863659|P1|Overall Study|Sponsor’s request|3
868481|NCT01428583|2863659|P1|Overall Study|Confirmed positive urine drug test|8
868482|NCT01428583|2863659|P1|Overall Study|Non-compliant|25
868483|NCT01428583|2863659|P1|Overall Study|Physician Decision|12
868484|NCT01428583|2863659|P1|Overall Study|Protocol Violation|1
868485|NCT01428583|2863659|P1|Overall Study|Pregnancy|1
868486|NCT01428583|2863659|P1|Overall Study|Death|1
868487|NCT01428583|2863659|P1|Overall Study|Lost to Follow-up|17
868488|NCT01428583|2863659|P1|Overall Study|Lack of Efficacy|37
868489|NCT01428583|2863659|P1|Overall Study|Withdrawal by Subject|51
868490|NCT01428583|2863659|P1|Overall Study|Adverse Event|75
868491|NCT01428453|2863683|P2|Overall Study|Withdrawal by Subject|1
868492|NCT01428453|2863684|P1|Overall Study|Withdrawal by Subject|3
868493|NCT01428453|2863683|P2|Overall Study|Lost to Follow-up|1
868494|NCT01428453|2863684|P1|Overall Study|Lost to Follow-up|0
868495|NCT01428453|2863683|P2|Overall Study|Protocol Violation|0
868496|NCT01428453|2863684|P1|Overall Study|Protocol Violation|1
868497|NCT01428453|2863683|P2|Overall Study|Adverse Event|7
868498|NCT01428453|2863684|P1|Overall Study|Adverse Event|2
868499|NCT01428258|2863723|P2|Intervention 1|Withdrawal by Subject|0
868500|NCT01428258|2863724|P1|Intervention 1|Withdrawal by Subject|2
868501|NCT01428219|2863742|P1|Overall Study|25 patients enrolled, 3 were not treated|3
868502|NCT01428193|2863753|P1|Overall Study|Elevated screening liver enzymes|1
868503|NCT01428193|2863753|P1|Overall Study|Physician Decision|1
868504|NCT01428128|2863757|P1|Overall Study|Adverse Event|1
868505|NCT01428128|2863757|P1|Overall Study|Received Neulasta in one cycle|2
868506|NCT01428128|2863757|P1|Overall Study|Screen failure by p53|10
868507|NCT01428128|2863757|P1|Overall Study|Withdrawal by Subject|4
868508|NCT01428115|2863762|P1|Overall Study|Withdrawal by Subject|4
868509|NCT01428115|2863762|P1|Overall Study|Protocol Violation|3
868510|NCT01428115|2863762|P1|Overall Study|Pregnancy|1
868511|NCT01428115|2863762|P1|Overall Study|Lost to Follow-up|10
868512|NCT01428115|2863762|P1|Overall Study|Lack of Efficacy|3
868513|NCT01428076|2863777|P2|Overall Study|Adverse Event|1
868514|NCT01428076|2863778|P1|Overall Study|Adverse Event|0
868515|NCT01428063|2863789|P3|Overall Study|No longer meets study criteria|0
868516|NCT01428063|2863790|P2|Overall Study|No longer meets study criteria|1
868517|NCT01428063|2863791|P1|Overall Study|No longer meets study criteria|0
868518|NCT01428063|2863789|P3|Overall Study|Lost to Follow-up|0
868519|NCT01428063|2863790|P2|Overall Study|Lost to Follow-up|2
868520|NCT01428063|2863791|P1|Overall Study|Lost to Follow-up|0
868521|NCT01428063|2863789|P3|Overall Study|Adverse Event|0
868522|NCT01428063|2863790|P2|Overall Study|Adverse Event|3
868523|NCT01428063|2863791|P1|Overall Study|Adverse Event|2
868524|NCT01428063|2863789|P3|Overall Study|Lack of Efficacy|1
868525|NCT01428063|2863790|P2|Overall Study|Lack of Efficacy|4
868526|NCT01428063|2863791|P1|Overall Study|Lack of Efficacy|8
868527|NCT01427933|2863882|P2|Overall Study|Investigator's Decision|0
868528|NCT01427933|2863883|P1|Overall Study|Investigator's Decision|1
868529|NCT01427933|2863882|P2|Overall Study|Not Specified|0
868530|NCT01427933|2863883|P1|Overall Study|Not Specified|1
868531|NCT01427933|2863882|P2|Overall Study|Lost to Follow-up|5
868532|NCT01427933|2863883|P1|Overall Study|Lost to Follow-up|1
868533|NCT01427933|2863882|P2|Overall Study|Withdrawal by Subject|8
868534|NCT01427933|2863883|P1|Overall Study|Withdrawal by Subject|5
868535|NCT01427920|2863903|P2|Overall Study|Unclassified|8
868536|NCT01427920|2863904|P1|Overall Study|Unclassified|2
868537|NCT01427920|2863903|P2|Overall Study|Withdrawal Criteria|4
868538|NCT01427920|2863904|P1|Overall Study|Withdrawal Criteria|4
868539|NCT01427920|2863903|P2|Overall Study|Protocol Violation|3
868540|NCT01427920|2863904|P1|Overall Study|Protocol Violation|1
868541|NCT01427920|2863903|P2|Overall Study|Lack of Efficacy|0
868542|NCT01427920|2863904|P1|Overall Study|Lack of Efficacy|1
868543|NCT01427920|2863903|P2|Overall Study|Adverse Event|2
868544|NCT01427920|2863904|P1|Overall Study|Adverse Event|1
868545|NCT01427907|2863924|P2|Overall Study|Withdrawal by Subject|4
868546|NCT01427907|2863925|P1|Overall Study|Withdrawal by Subject|3
868547|NCT01427803|2863946|P2|Overall Study|did not take product|0
868548|NCT01427803|2863947|P1|Overall Study|did not take product|1
868549|NCT01427803|2863946|P2|Overall Study|Physician Decision|0
868550|NCT01427803|2863947|P1|Overall Study|Physician Decision|3
868551|NCT01427803|2863946|P2|Overall Study|Protocol Violation|0
868552|NCT01427803|2863947|P1|Overall Study|Protocol Violation|1
868553|NCT01427803|2863946|P2|Overall Study|Unable to complete full treatment period|0
868554|NCT01427803|2863947|P1|Overall Study|Unable to complete full treatment period|6
868555|NCT01427803|2863946|P2|Overall Study|Withdrawal by Subject|0
868556|NCT01427803|2863947|P1|Overall Study|Withdrawal by Subject|20
868557|NCT01427803|2863946|P2|Overall Study|Lost to Follow-up|26
868558|NCT01427803|2863947|P1|Overall Study|Lost to Follow-up|32
868559|NCT01427751|2863961|P2|Overall Study|Other miscellaneous reasons|4
868560|NCT01427751|2863962|P1|Overall Study|Other miscellaneous reasons|6
868561|NCT01427751|2863961|P2|Overall Study|Death|0
868562|NCT01427751|2863962|P1|Overall Study|Death|2
868563|NCT01427751|2863961|P2|Overall Study|Protocol Violation|4
868564|NCT01427751|2863962|P1|Overall Study|Protocol Violation|6
868565|NCT01427751|2863961|P2|Overall Study|Withdrawal of consent|2
868566|NCT01427751|2863962|P1|Overall Study|Withdrawal of consent|2
868567|NCT01427751|2863961|P2|Overall Study|Lost to Follow-up|1
868568|NCT01427751|2863962|P1|Overall Study|Lost to Follow-up|3
868569|NCT01427751|2863961|P2|Overall Study|No further treatment benefit expected|1
868570|NCT01427751|2863962|P1|Overall Study|No further treatment benefit expected|5
868571|NCT01427751|2863961|P2|Overall Study|Adverse Event|2
868572|NCT01427751|2863962|P1|Overall Study|Adverse Event|18
868573|NCT01427738|2863982|P2|Overall Study|Lost to Follow-up|5
868574|NCT01427738|2863983|P1|Overall Study|Lost to Follow-up|1
868575|NCT01427738|2863982|P2|Overall Study|Subject not willing to adhere to reqs|2
868576|NCT01427738|2863983|P1|Overall Study|Subject not willing to adhere to reqs|1
868577|NCT01427738|2863982|P2|Overall Study|Withdrawal by Subject|2
868578|NCT01427738|2863983|P1|Overall Study|Withdrawal by Subject|0
868579|NCT01427738|2863982|P2|Overall Study|Subject unable to get to clinic|2
868580|NCT01427738|2863983|P1|Overall Study|Subject unable to get to clinic|5
868581|NCT01427738|2863982|P2|Overall Study|Severe debilitation, unable to continue|1
868582|NCT01427738|2863983|P1|Overall Study|Severe debilitation, unable to continue|0
868583|NCT01427738|2863982|P2|Overall Study|Death|9
868584|NCT01427738|2863983|P1|Overall Study|Death|12
868585|NCT01427309|2864046|P4|Overall Study|Withdrawal by Subject|55
868586|NCT01427309|2864047|P3|Overall Study|Withdrawal by Subject|61
868587|NCT01427309|2864048|P2|Overall Study|Withdrawal by Subject|148
868588|NCT01427309|2864049|P1|Overall Study|Withdrawal by Subject|148
868589|NCT01427309|2864046|P4|Overall Study|Serious adverse event|61
868590|NCT01427309|2864047|P3|Overall Study|Serious adverse event|50
868591|NCT01427309|2864048|P2|Overall Study|Serious adverse event|45
868592|NCT01427309|2864049|P1|Overall Study|Serious adverse event|52
868593|NCT01427309|2864046|P4|Overall Study|Adverse Event|1
868594|NCT01427309|2864047|P3|Overall Study|Adverse Event|3
868595|NCT01427309|2864048|P2|Overall Study|Adverse Event|0
868596|NCT01427309|2864049|P1|Overall Study|Adverse Event|0
868597|NCT01427309|2864046|P4|Overall Study|Protocol Violation|124
868598|NCT01427309|2864047|P3|Overall Study|Protocol Violation|125
868599|NCT01427309|2864048|P2|Overall Study|Protocol Violation|69
868600|NCT01427309|2864049|P1|Overall Study|Protocol Violation|42
868601|NCT01427309|2864046|P4|Overall Study|Lost to Follow-up|135
868602|NCT01427309|2864047|P3|Overall Study|Lost to Follow-up|122
868603|NCT01427309|2864048|P2|Overall Study|Lost to Follow-up|145
868604|NCT01427309|2864049|P1|Overall Study|Lost to Follow-up|130
868605|NCT01426958|2864096|P1|Overall Study|Adverse Event|2
868606|NCT01426854|2864125|P2|Overall Study|Other|2
868607|NCT01426854|2864126|P1|Overall Study|Other|3
868608|NCT01426854|2864125|P2|Overall Study|Protocol Deviation|1
868609|NCT01426854|2864126|P1|Overall Study|Protocol Deviation|0
868610|NCT01426854|2864125|P2|Overall Study|Treatment Failure|16
868611|NCT01426854|2864126|P1|Overall Study|Treatment Failure|0
868612|NCT01426854|2864125|P2|Overall Study|Noncompliance|1
868613|NCT01426854|2864126|P1|Overall Study|Noncompliance|0
868614|NCT01426854|2864125|P2|Overall Study|Lost to Follow-up|0
868615|NCT01426854|2864126|P1|Overall Study|Lost to Follow-up|3
868616|NCT01426854|2864125|P2|Overall Study|Subject Decision Unrelated to AE|6
868617|NCT01426854|2864126|P1|Overall Study|Subject Decision Unrelated to AE|5
868618|NCT01426854|2864125|P2|Overall Study|Adverse Event|5
868619|NCT01426854|2864126|P1|Overall Study|Adverse Event|1
868620|NCT01426789|2864136|P6|Part 2|Adverse Event|0
868621|NCT01426789|2864137|P5|Part 2|Adverse Event|1
868622|NCT01426789|2864138|P4|Part 2|Adverse Event|0
868623|NCT01426789|2864139|P3|Part 2|Adverse Event|2
868624|NCT01426789|2864140|P2|Part 2|Adverse Event|0
868625|NCT01426789|2864141|P1|Part 2|Adverse Event|0
868626|NCT01426789|2864136|P6|Part 2|Lack of Efficacy|0
868627|NCT01426789|2864137|P5|Part 2|Lack of Efficacy|2
868628|NCT01426789|2864138|P4|Part 2|Lack of Efficacy|0
868629|NCT01426789|2864139|P3|Part 2|Lack of Efficacy|5
868630|NCT01426789|2864140|P2|Part 2|Lack of Efficacy|0
868631|NCT01426789|2864141|P1|Part 2|Lack of Efficacy|0
868632|NCT01426789|2864136|P6|Part 2|Withdrawal by Subject|0
868633|NCT01426789|2864137|P5|Part 2|Withdrawal by Subject|2
868634|NCT01426789|2864138|P4|Part 2|Withdrawal by Subject|1
868635|NCT01426789|2864139|P3|Part 2|Withdrawal by Subject|0
868636|NCT01426789|2864140|P2|Part 2|Withdrawal by Subject|0
868637|NCT01426789|2864141|P1|Part 2|Withdrawal by Subject|0
868638|NCT01426789|2864136|P6|Part 2|Lost to Follow-up|0
868639|NCT01426789|2864137|P5|Part 2|Lost to Follow-up|1
868640|NCT01426789|2864138|P4|Part 2|Lost to Follow-up|0
868641|NCT01426789|2864139|P3|Part 2|Lost to Follow-up|4
868642|NCT01426789|2864140|P2|Part 2|Lost to Follow-up|0
868643|NCT01426789|2864141|P1|Part 2|Lost to Follow-up|0
868644|NCT01426789|2864136|P6|Part 2|Administrative problems|0
868645|NCT01426789|2864137|P5|Part 2|Administrative problems|1
868646|NCT01426789|2864138|P4|Part 2|Administrative problems|0
868647|NCT01426789|2864139|P3|Part 2|Administrative problems|2
868648|NCT01426789|2864140|P2|Part 2|Administrative problems|0
868649|NCT01426789|2864141|P1|Part 2|Administrative problems|0
868650|NCT01426789|2864136|P6|Part 2|Death|0
868651|NCT01426789|2864137|P5|Part 2|Death|1
868652|NCT01426789|2864138|P4|Part 2|Death|0
868653|NCT01426789|2864139|P3|Part 2|Death|1
868654|NCT01426789|2864140|P2|Part 2|Death|0
868655|NCT01426789|2864141|P1|Part 2|Death|0
868656|NCT01426789|2864136|P6|Part 2|Protocol deviation|0
868657|NCT01426789|2864137|P5|Part 2|Protocol deviation|0
868658|NCT01426789|2864138|P4|Part 2|Protocol deviation|0
868659|NCT01426789|2864139|P3|Part 2|Protocol deviation|1
868660|NCT01426789|2864140|P2|Part 2|Protocol deviation|0
868661|NCT01426789|2864141|P1|Part 2|Protocol deviation|0
868662|NCT01426789|2864136|P6|Part 1|Adverse Event|0
868663|NCT01426789|2864137|P5|Part 1|Adverse Event|0
868664|NCT01426789|2864138|P4|Part 1|Adverse Event|0
868665|NCT01426789|2864139|P3|Part 1|Adverse Event|0
868666|NCT01426789|2864140|P2|Part 1|Adverse Event|0
868667|NCT01426789|2864141|P1|Part 1|Adverse Event|3
868668|NCT01426789|2864136|P6|Part 1|Lack of Efficacy|0
868669|NCT01426789|2864137|P5|Part 1|Lack of Efficacy|0
868670|NCT01426789|2864138|P4|Part 1|Lack of Efficacy|0
868671|NCT01426789|2864139|P3|Part 1|Lack of Efficacy|0
868672|NCT01426789|2864140|P2|Part 1|Lack of Efficacy|1
868673|NCT01426789|2864141|P1|Part 1|Lack of Efficacy|2
868674|NCT01426789|2864136|P6|Part 1|Lost to Follow-up|0
868675|NCT01426789|2864137|P5|Part 1|Lost to Follow-up|0
868676|NCT01426789|2864138|P4|Part 1|Lost to Follow-up|0
868677|NCT01426789|2864139|P3|Part 1|Lost to Follow-up|0
868678|NCT01426789|2864140|P2|Part 1|Lost to Follow-up|2
868679|NCT01426789|2864141|P1|Part 1|Lost to Follow-up|1
868680|NCT01426789|2864136|P6|Part 1|Protocol deviation|0
868681|NCT01426789|2864137|P5|Part 1|Protocol deviation|0
868682|NCT01426789|2864138|P4|Part 1|Protocol deviation|0
868683|NCT01426789|2864139|P3|Part 1|Protocol deviation|0
868684|NCT01426789|2864140|P2|Part 1|Protocol deviation|1
868685|NCT01426789|2864141|P1|Part 1|Protocol deviation|0
868686|NCT01426438|2864186|P2|Overall Study|Missed Scan|2
868687|NCT01426438|2864187|P1|Overall Study|Missed Scan|2
868688|NCT01426438|2864186|P2|Overall Study|Poor scan quality|2
868689|NCT01426438|2864187|P1|Overall Study|Poor scan quality|3
868690|NCT01426438|2864186|P2|Overall Study|Off study Treatment|3
868691|NCT01426438|2864187|P1|Overall Study|Off study Treatment|9
868692|NCT01426438|2864186|P2|Overall Study|Lost to Follow-up|3
868693|NCT01426438|2864187|P1|Overall Study|Lost to Follow-up|1
868694|NCT01426425|2864219|P1|Overall Study|Met inclusion/exclusion, not treated|2
868695|NCT01426425|2864219|P1|Overall Study|Inclusion/exclusion criteria not met|151
868696|NCT01426425|2864219|P1|Overall Study|Exited prior to EP study|22
868697|NCT01426386|2864231|P6|Overall Study|Personal reasons|0
868698|NCT01426386|2864232|P5|Overall Study|Personal reasons|1
868699|NCT01426386|2864233|P4|Overall Study|Personal reasons|0
868700|NCT01426386|2864234|P3|Overall Study|Personal reasons|0
868701|NCT01426386|2864235|P2|Overall Study|Personal reasons|0
868702|NCT01426386|2864236|P1|Overall Study|Personal reasons|0
868703|NCT01426386|2864231|P6|Overall Study|Poor response|0
868704|NCT01426386|2864232|P5|Overall Study|Poor response|1
868705|NCT01426386|2864233|P4|Overall Study|Poor response|0
868706|NCT01426386|2864234|P3|Overall Study|Poor response|2
868707|NCT01426386|2864235|P2|Overall Study|Poor response|1
868708|NCT01426386|2864236|P1|Overall Study|Poor response|2
868709|NCT01426386|2864231|P6|Overall Study|Did not attend scheduled visit|1
868710|NCT01426386|2864232|P5|Overall Study|Did not attend scheduled visit|2
868711|NCT01426386|2864233|P4|Overall Study|Did not attend scheduled visit|0
868712|NCT01426386|2864234|P3|Overall Study|Did not attend scheduled visit|0
868713|NCT01426386|2864235|P2|Overall Study|Did not attend scheduled visit|4
868714|NCT01426386|2864236|P1|Overall Study|Did not attend scheduled visit|1
868715|NCT01426386|2864231|P6|Overall Study|Adverse Event|0
868716|NCT01426386|2864232|P5|Overall Study|Adverse Event|0
868717|NCT01426386|2864233|P4|Overall Study|Adverse Event|0
868718|NCT01426386|2864234|P3|Overall Study|Adverse Event|0
868719|NCT01426386|2864235|P2|Overall Study|Adverse Event|1
868720|NCT01426386|2864236|P1|Overall Study|Adverse Event|0
868721|NCT01426373|2864292|P1|Overall Study|Miscellaneous Reasons|4
868722|NCT01426373|2864292|P1|Overall Study|Participant Convenience|10
868723|NCT01426373|2864292|P1|Overall Study|Lost to Follow-up|14
868724|NCT01426373|2864292|P1|Overall Study|Adverse Event|6
868725|NCT01426347|2864325|P2|Overall Study|Withdrawal by Subject|0
868726|NCT01426347|2864326|P1|Overall Study|Withdrawal by Subject|5
868727|NCT01426347|2864325|P2|Overall Study|Protocol Violation|0
868728|NCT01426347|2864326|P1|Overall Study|Protocol Violation|2
868729|NCT01426347|2864325|P2|Overall Study|Lost to Follow-up|3
868730|NCT01426347|2864326|P1|Overall Study|Lost to Follow-up|0
868731|NCT01426269|2864334|P3|Period 2: 40 Weeks|Relapsed|18
868732|NCT01426269|2864335|P2|Period 2: 40 Weeks|Relapsed|9
868733|NCT01426269|2864336|P1|Period 2: 40 Weeks|Relapsed|0
868734|NCT01426269|2864334|P3|Period 2: 40 Weeks|Site closed|5
868735|NCT01426269|2864335|P2|Period 2: 40 Weeks|Site closed|6
868736|NCT01426269|2864336|P1|Period 2: 40 Weeks|Site closed|0
868737|NCT01426269|2864334|P3|Period 2: 40 Weeks|Lost to Follow-up|6
868738|NCT01426269|2864335|P2|Period 2: 40 Weeks|Lost to Follow-up|8
868739|NCT01426269|2864336|P1|Period 2: 40 Weeks|Lost to Follow-up|0
868740|NCT01426269|2864334|P3|Period 2: 40 Weeks|Protocol Violation|5
868741|NCT01426269|2864335|P2|Period 2: 40 Weeks|Protocol Violation|5
868742|NCT01426269|2864336|P1|Period 2: 40 Weeks|Protocol Violation|0
868743|NCT01426269|2864334|P3|Period 2: 40 Weeks|Withdrawal by Subject|11
868744|NCT01426269|2864335|P2|Period 2: 40 Weeks|Withdrawal by Subject|9
868745|NCT01426269|2864336|P1|Period 2: 40 Weeks|Withdrawal by Subject|0
868746|NCT01426269|2864334|P3|Period 2: 40 Weeks|Adverse Event|2
868747|NCT01426269|2864335|P2|Period 2: 40 Weeks|Adverse Event|1
868748|NCT01426269|2864336|P1|Period 2: 40 Weeks|Adverse Event|0
868749|NCT01426269|2864334|P3|Eligibility for Period 2, Randomization|Qualified, opted out|0
868750|NCT01426269|2864335|P2|Eligibility for Period 2, Randomization|Qualified, opted out|0
868751|NCT01426269|2864336|P1|Eligibility for Period 2, Randomization|Qualified, opted out|8
868752|NCT01426269|2864334|P3|Eligibility for Period 2, Randomization|Did not qualify|0
868753|NCT01426269|2864335|P2|Eligibility for Period 2, Randomization|Did not qualify|0
868754|NCT01426269|2864336|P1|Eligibility for Period 2, Randomization|Did not qualify|42
868755|NCT01426269|2864334|P3|Period 1: 12 Weeks|Pregnancy|0
868756|NCT01426269|2864335|P2|Period 1: 12 Weeks|Pregnancy|0
868757|NCT01426269|2864336|P1|Period 1: 12 Weeks|Pregnancy|1
868758|NCT01426269|2864334|P3|Period 1: 12 Weeks|Lost to Follow-up|0
868759|NCT01426269|2864335|P2|Period 1: 12 Weeks|Lost to Follow-up|0
868760|NCT01426269|2864336|P1|Period 1: 12 Weeks|Lost to Follow-up|22
868761|NCT01426269|2864334|P3|Period 1: 12 Weeks|Protocol Violation|0
868762|NCT01426269|2864335|P2|Period 1: 12 Weeks|Protocol Violation|0
868763|NCT01426269|2864336|P1|Period 1: 12 Weeks|Protocol Violation|5
868764|NCT01426269|2864334|P3|Period 1: 12 Weeks|Withdrawal by Subject|0
868765|NCT01426269|2864335|P2|Period 1: 12 Weeks|Withdrawal by Subject|0
868766|NCT01426269|2864336|P1|Period 1: 12 Weeks|Withdrawal by Subject|22
868767|NCT01426269|2864334|P3|Period 1: 12 Weeks|Adverse Event|0
868768|NCT01426269|2864335|P2|Period 1: 12 Weeks|Adverse Event|0
868769|NCT01426269|2864336|P1|Period 1: 12 Weeks|Adverse Event|5
868770|NCT01426217|2864371|P2|Overall Study|lost sample|14
868771|NCT01426217|2864372|P1|Overall Study|lost sample|8
868772|NCT01426113|2864380|P2|Overall Study|Adverse Event|1
868773|NCT01426113|2864381|P1|Overall Study|Adverse Event|0
868774|NCT01426113|2864380|P2|Overall Study|Study Discontinued|1
868775|NCT01426113|2864381|P1|Overall Study|Study Discontinued|1
868776|NCT01426009|2864387|P1|Washout 4|Lost to Follow-up|1
868777|NCT01426009|2864387|P1|Period 4-Fourth Intervention (7 Days)|personal reasons|1
868778|NCT01426009|2864387|P1|Washout 3|personal reasons|1
868779|NCT01426009|2864387|P1|Washout 2|electrive surgery|1
868780|NCT01426009|2864387|P1|Period 2-Second Intervention (7 Days)|personal reasons|1
868781|NCT01426009|2864387|P1|Period 2-Second Intervention (7 Days)|Adverse Event|4
868782|NCT01426009|2864387|P1|Washout 1|Personal Reasons|1
868783|NCT01426009|2864387|P1|Washout 1|Withdrawal by Subject|1
868784|NCT01426009|2864387|P1|Period 1-First Intervention (7 Days)|Personal Reasons|1
868785|NCT01426009|2864387|P1|Period 1-First Intervention (7 Days)|Adverse Event|1
868786|NCT01425814|2864483|P6|Period 5|Stability criteria not fulfilled|1
868787|NCT01425814|2864484|P5|Period 5|Stability criteria not fulfilled|0
868788|NCT01425814|2864485|P4|Period 5|Stability criteria not fulfilled|0
868789|NCT01425814|2864486|P3|Period 5|Stability criteria not fulfilled|1
868790|NCT01425814|2864487|P2|Period 5|Stability criteria not fulfilled|0
868791|NCT01425814|2864488|P1|Period 5|Stability criteria not fulfilled|0
868792|NCT01425814|2864483|P6|Period 4|Adverse Event|0
868793|NCT01425814|2864484|P5|Period 4|Adverse Event|0
868794|NCT01425814|2864485|P4|Period 4|Adverse Event|0
868795|NCT01425814|2864486|P3|Period 4|Adverse Event|1
868796|NCT01425814|2864487|P2|Period 4|Adverse Event|0
868797|NCT01425814|2864488|P1|Period 4|Adverse Event|1
868798|NCT01425814|2864483|P6|Period 3|Adverse Event|1
868799|NCT01425814|2864484|P5|Period 3|Adverse Event|0
868800|NCT01425814|2864485|P4|Period 3|Adverse Event|0
868801|NCT01425814|2864486|P3|Period 3|Adverse Event|0
868802|NCT01425814|2864487|P2|Period 3|Adverse Event|0
868803|NCT01425814|2864488|P1|Period 3|Adverse Event|0
868804|NCT01425814|2864483|P6|Period 2|Stability criteria not fulfilled|0
868805|NCT01425814|2864484|P5|Period 2|Stability criteria not fulfilled|0
868806|NCT01425814|2864485|P4|Period 2|Stability criteria not fulfilled|0
868807|NCT01425814|2864486|P3|Period 2|Stability criteria not fulfilled|0
868808|NCT01425814|2864487|P2|Period 2|Stability criteria not fulfilled|1
868809|NCT01425814|2864488|P1|Period 2|Stability criteria not fulfilled|0
868810|NCT01425814|2864483|P6|Period 1|Stability criteria not fulfilled|0
868811|NCT01425814|2864484|P5|Period 1|Stability criteria not fulfilled|0
868812|NCT01425814|2864485|P4|Period 1|Stability criteria not fulfilled|0
868813|NCT01425814|2864486|P3|Period 1|Stability criteria not fulfilled|0
868814|NCT01425814|2864487|P2|Period 1|Stability criteria not fulfilled|1
868815|NCT01425814|2864488|P1|Period 1|Stability criteria not fulfilled|0
868816|NCT01425801|2864580|P6|Period 4|Not able to maintain visit schedule|0
868817|NCT01425801|2864581|P5|Period 4|Not able to maintain visit schedule|0
868818|NCT01425801|2864582|P4|Period 4|Not able to maintain visit schedule|0
868819|NCT01425801|2864583|P3|Period 4|Not able to maintain visit schedule|1
868820|NCT01425801|2864584|P2|Period 4|Not able to maintain visit schedule|0
868821|NCT01425801|2864585|P1|Period 4|Not able to maintain visit schedule|0
868822|NCT01425801|2864580|P6|Period 3|Stability criteria not fullfilled|0
868823|NCT01425801|2864581|P5|Period 3|Stability criteria not fullfilled|0
868824|NCT01425801|2864582|P4|Period 3|Stability criteria not fullfilled|0
868825|NCT01425801|2864583|P3|Period 3|Stability criteria not fullfilled|1
868826|NCT01425801|2864584|P2|Period 3|Stability criteria not fullfilled|0
868827|NCT01425801|2864585|P1|Period 3|Stability criteria not fullfilled|0
868828|NCT01425801|2864580|P6|Period 2|Withdrawal by Subject|0
868829|NCT01425801|2864581|P5|Period 2|Withdrawal by Subject|1
868830|NCT01425801|2864582|P4|Period 2|Withdrawal by Subject|0
868831|NCT01425801|2864583|P3|Period 2|Withdrawal by Subject|0
868832|NCT01425801|2864584|P2|Period 2|Withdrawal by Subject|0
868833|NCT01425801|2864585|P1|Period 2|Withdrawal by Subject|0
868834|NCT01425801|2864580|P6|Period 1|Withdrawal by Subject|0
868835|NCT01425801|2864581|P5|Period 1|Withdrawal by Subject|1
868836|NCT01425801|2864582|P4|Period 1|Withdrawal by Subject|0
868837|NCT01425801|2864583|P3|Period 1|Withdrawal by Subject|0
868838|NCT01425801|2864584|P2|Period 1|Withdrawal by Subject|0
868839|NCT01425801|2864585|P1|Period 1|Withdrawal by Subject|0
868840|NCT01425749|2864691|P2|Overall Study|progression of melanoma|1
868841|NCT01425749|2864692|P1|Overall Study|progression of melanoma|0
868842|NCT01425723|2864709|P2|Overall Study|Other|10
868843|NCT01425723|2864710|P1|Overall Study|Other|1
868844|NCT01425723|2864709|P2|Overall Study|Physician Decision|0
868845|NCT01425723|2864710|P1|Overall Study|Physician Decision|2
868846|NCT01425723|2864709|P2|Overall Study|Lost to Follow-up|3
868847|NCT01425723|2864710|P1|Overall Study|Lost to Follow-up|0
868848|NCT01425723|2864709|P2|Overall Study|Withdrawal by Subject|4
868849|NCT01425723|2864710|P1|Overall Study|Withdrawal by Subject|1
868850|NCT01425723|2864709|P2|Overall Study|Lack of Efficacy|1
868851|NCT01425723|2864710|P1|Overall Study|Lack of Efficacy|0
868852|NCT01425632|2864740|P3|Overall Study|Withdrawal by Subject|1
868853|NCT01425632|2864741|P2|Overall Study|Withdrawal by Subject|0
868854|NCT01425632|2864742|P1|Overall Study|Withdrawal by Subject|0
868855|NCT01425632|2864740|P3|Overall Study|Protocol Violation|2
868856|NCT01425632|2864741|P2|Overall Study|Protocol Violation|0
868857|NCT01425632|2864742|P1|Overall Study|Protocol Violation|0
868858|NCT01425632|2864740|P3|Overall Study|Physician Decision|0
868859|NCT01425632|2864741|P2|Overall Study|Physician Decision|0
868860|NCT01425632|2864742|P1|Overall Study|Physician Decision|1
868861|NCT01425632|2864740|P3|Overall Study|Adverse Event|1
868862|NCT01425632|2864741|P2|Overall Study|Adverse Event|1
868863|NCT01425632|2864742|P1|Overall Study|Adverse Event|0
868864|NCT01425528|2864752|P2|Overall Study|Withdrawal by Subject|1
868865|NCT01425528|2864753|P1|Overall Study|Withdrawal by Subject|1
868866|NCT01425463|2864761|P2|Overall Study|Unknown Reason|7
868867|NCT01425463|2864762|P1|Overall Study|Unknown Reason|4
868868|NCT01425463|2864761|P2|Overall Study|Withdrawal by Subject|5
868869|NCT01425463|2864762|P1|Overall Study|Withdrawal by Subject|7
868870|NCT01425463|2864761|P2|Overall Study|Lost to Follow-up|2
868871|NCT01425463|2864762|P1|Overall Study|Lost to Follow-up|5
868872|NCT01425463|2864761|P2|Overall Study|Protocol Violation|2
868873|NCT01425463|2864762|P1|Overall Study|Protocol Violation|2
868874|NCT01425463|2864761|P2|Overall Study|Lack of Efficacy|1
868875|NCT01425463|2864762|P1|Overall Study|Lack of Efficacy|1
868876|NCT01425463|2864761|P2|Overall Study|Adverse Event|7
868877|NCT01425463|2864762|P1|Overall Study|Adverse Event|5
868878|NCT01425359|2864778|P2|Overall Study|Did Not Meet Qualifying Criteria|5
868879|NCT01425359|2864779|P1|Overall Study|Did Not Meet Qualifying Criteria|3
868880|NCT01425359|2864778|P2|Overall Study|Investigator’s Discretion|0
868881|NCT01425359|2864779|P1|Overall Study|Investigator’s Discretion|2
868882|NCT01425359|2864778|P2|Overall Study|Subject Withdrew Consent|2
868883|NCT01425359|2864779|P1|Overall Study|Subject Withdrew Consent|1
868884|NCT01425359|2864778|P2|Overall Study|Protocol Violation|2
868885|NCT01425359|2864779|P1|Overall Study|Protocol Violation|1
868886|NCT01425359|2864778|P2|Overall Study|Unsatisfactory Response|0
868887|NCT01425359|2864779|P1|Overall Study|Unsatisfactory Response|1
868888|NCT01425359|2864778|P2|Overall Study|Death|1
868889|NCT01425359|2864779|P1|Overall Study|Death|0
868890|NCT01425359|2864778|P2|Overall Study|Revascularization|1
868891|NCT01425359|2864779|P1|Overall Study|Revascularization|0
868892|NCT01425359|2864778|P2|Overall Study|Adverse Event|8
868893|NCT01425359|2864779|P1|Overall Study|Adverse Event|9
868894|NCT01425359|2864778|P2|Overall Study|Randomized but Not Treated|3
868895|NCT01425359|2864779|P1|Overall Study|Randomized but Not Treated|2
868896|NCT01425268|2864810|P2|Overall Study|Physician Decision|0
868897|NCT01425268|2864811|P1|Overall Study|Physician Decision|1
868898|NCT01425268|2864810|P2|Overall Study|Sponsor Decision|0
868899|NCT01425268|2864811|P1|Overall Study|Sponsor Decision|5
868900|NCT01425268|2864810|P2|Overall Study|Withdrawal by Subject|0
868901|NCT01425268|2864811|P1|Overall Study|Withdrawal by Subject|2
868902|NCT01425203|2864832|P3|Crossover Phase|Other virologic failure criteria|3
868903|NCT01425203|2864833|P2|Crossover Phase|Other virologic failure criteria|0
868904|NCT01425203|2864834|P1|Crossover Phase|Other virologic failure criteria|0
868905|NCT01425203|2864832|P3|Crossover Phase|Failure at futility timepoint|3
868906|NCT01425203|2864833|P2|Crossover Phase|Failure at futility timepoint|0
868907|NCT01425203|2864834|P1|Crossover Phase|Failure at futility timepoint|0
868908|NCT01425203|2864832|P3|Treatment Phase|Did not receive treatment|0
868909|NCT01425203|2864833|P2|Treatment Phase|Did not receive treatment|1
868910|NCT01425203|2864834|P1|Treatment Phase|Did not receive treatment|0
868911|NCT01425203|2864832|P3|Treatment Phase|Unidentified reasons|0
868912|NCT01425203|2864833|P2|Treatment Phase|Unidentified reasons|5
868913|NCT01425203|2864834|P1|Treatment Phase|Unidentified reasons|11
868914|NCT01425203|2864832|P3|Treatment Phase|Other virologic failure criteria|0
868915|NCT01425203|2864833|P2|Treatment Phase|Other virologic failure criteria|3
868916|NCT01425203|2864834|P1|Treatment Phase|Other virologic failure criteria|5
868917|NCT01425203|2864832|P3|Treatment Phase|Failure at futility timepoint|0
868918|NCT01425203|2864833|P2|Treatment Phase|Failure at futility timepoint|27
868919|NCT01425203|2864834|P1|Treatment Phase|Failure at futility timepoint|8
868920|NCT01425203|2864832|P3|Treatment Phase|DC during PR Lead-in Phase|0
868921|NCT01425203|2864833|P2|Treatment Phase|DC during PR Lead-in Phase|1
868922|NCT01425203|2864834|P1|Treatment Phase|DC during PR Lead-in Phase|3
868923|NCT01425190|2864851|P3|Overall Study|Full dose not consumed.|0
868924|NCT01425190|2864852|P2|Overall Study|Full dose not consumed.|0
868925|NCT01425190|2864853|P1|Overall Study|Full dose not consumed.|1
868926|NCT01424930|2864889|P2|Overall Study|Reason not specified|6
868927|NCT01424930|2864890|P1|Overall Study|Reason not specified|0
868928|NCT01424930|2864889|P2|Overall Study|Screen Failure|1
868929|NCT01424930|2864890|P1|Overall Study|Screen Failure|0
868930|NCT01424930|2864889|P2|Overall Study|Progressive Disease|6
868931|NCT01424930|2864890|P1|Overall Study|Progressive Disease|3
868932|NCT01424930|2864889|P2|Overall Study|Death|0
868933|NCT01424930|2864890|P1|Overall Study|Death|1
868934|NCT01424930|2864889|P2|Overall Study|Adverse Event|1
868935|NCT01424930|2864890|P1|Overall Study|Adverse Event|0
868936|NCT01424813|2864904|P2|Overall Study|not specified|2
868937|NCT01424813|2864905|P1|Overall Study|not specified|1
868938|NCT01424813|2864904|P2|Overall Study|Protocol Violation|0
868939|NCT01424813|2864905|P1|Overall Study|Protocol Violation|1
868940|NCT01424813|2864904|P2|Overall Study|Withdrawal by Subject|0
868941|NCT01424813|2864905|P1|Overall Study|Withdrawal by Subject|3
868942|NCT01424644|2864925|P2|Overall Study|Unable to Classify|0
868943|NCT01424644|2864926|P1|Overall Study|Unable to Classify|1
868944|NCT01424644|2864925|P2|Overall Study|Administrative Reason|0
868945|NCT01424644|2864926|P1|Overall Study|Administrative Reason|1
868946|NCT01424644|2864925|P2|Overall Study|Protocol Violation|3
868947|NCT01424644|2864926|P1|Overall Study|Protocol Violation|4
868948|NCT01424644|2864925|P2|Overall Study|Lost to Follow-up|12
868949|NCT01424644|2864926|P1|Overall Study|Lost to Follow-up|16
868950|NCT01424644|2864925|P2|Overall Study|Withdrawal by Subject|12
868951|NCT01424644|2864926|P1|Overall Study|Withdrawal by Subject|9
868952|NCT01424644|2864925|P2|Overall Study|Adverse Event|0
868953|NCT01424644|2864926|P1|Overall Study|Adverse Event|2
868954|NCT01424566|2864940|P3|Double-blind Treatment|Lack of Efficacy|1
868955|NCT01424566|2864941|P2|Double-blind Treatment|Lack of Efficacy|1
868956|NCT01424566|2864942|P1|Double-blind Treatment|Lack of Efficacy|0
868957|NCT01424566|2864940|P3|Double-blind Treatment|Withdrawal by Investigator|1
868958|NCT01424566|2864941|P2|Double-blind Treatment|Withdrawal by Investigator|1
868959|NCT01424566|2864942|P1|Double-blind Treatment|Withdrawal by Investigator|0
868960|NCT01424566|2864940|P3|Double-blind Treatment|Withdrawal by Subject|0
868961|NCT01424566|2864941|P2|Double-blind Treatment|Withdrawal by Subject|2
868962|NCT01424566|2864942|P1|Double-blind Treatment|Withdrawal by Subject|0
868963|NCT01424566|2864940|P3|Double-blind Treatment|Adverse Event|13
868964|NCT01424566|2864941|P2|Double-blind Treatment|Adverse Event|21
868965|NCT01424566|2864942|P1|Double-blind Treatment|Adverse Event|0
868966|NCT01424566|2864940|P3|Single-blind Treatment|Did Not Administer Any Study Drug|0
868967|NCT01424566|2864941|P2|Single-blind Treatment|Did Not Administer Any Study Drug|0
868968|NCT01424566|2864942|P1|Single-blind Treatment|Did Not Administer Any Study Drug|2
868969|NCT01424566|2864940|P3|Single-blind Treatment|Met Exclusion Criteria|0
868970|NCT01424566|2864941|P2|Single-blind Treatment|Met Exclusion Criteria|0
868971|NCT01424566|2864942|P1|Single-blind Treatment|Met Exclusion Criteria|1
868972|NCT01424566|2864940|P3|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
868973|NCT01424566|2864941|P2|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
868974|NCT01424566|2864942|P1|Single-blind Treatment|Did Not Meet Inclusion Criteria|108
868975|NCT01424566|2864940|P3|Single-blind Treatment|Withdrawal by Investigator|0
868976|NCT01424566|2864941|P2|Single-blind Treatment|Withdrawal by Investigator|0
868977|NCT01424566|2864942|P1|Single-blind Treatment|Withdrawal by Investigator|2
868978|NCT01424566|2864940|P3|Single-blind Treatment|Withdrawal by Subject|0
868979|NCT01424566|2864941|P2|Single-blind Treatment|Withdrawal by Subject|0
868980|NCT01424566|2864942|P1|Single-blind Treatment|Withdrawal by Subject|16
868981|NCT01424566|2864940|P3|Single-blind Treatment|Adverse Event|0
868982|NCT01424566|2864941|P2|Single-blind Treatment|Adverse Event|0
868983|NCT01424566|2864942|P1|Single-blind Treatment|Adverse Event|71
868984|NCT01424514|2864969|P2|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0
868985|NCT01424514|2864970|P1|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1
868986|NCT01424514|2864969|P2|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
868987|NCT01424514|2864970|P1|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
868988|NCT01424501|2865015|P6|Overall Study|Lost to Follow-up|0
868989|NCT01424501|2865016|P5|Overall Study|Lost to Follow-up|0
868990|NCT01424501|2865017|P4|Overall Study|Lost to Follow-up|0
868991|NCT01424501|2865018|P3|Overall Study|Lost to Follow-up|1
868992|NCT01424501|2865019|P2|Overall Study|Lost to Follow-up|1
868993|NCT01424501|2865020|P1|Overall Study|Lost to Follow-up|0
868994|NCT01424501|2865015|P6|Overall Study|Withdrawal by Subject|0
868995|NCT01424501|2865016|P5|Overall Study|Withdrawal by Subject|0
868996|NCT01424501|2865017|P4|Overall Study|Withdrawal by Subject|0
868997|NCT01424501|2865018|P3|Overall Study|Withdrawal by Subject|1
868998|NCT01424501|2865019|P2|Overall Study|Withdrawal by Subject|0
868999|NCT01424501|2865020|P1|Overall Study|Withdrawal by Subject|1
869000|NCT01424306|2865184|P6|Overall Study|Protocol Violation|0
869001|NCT01424306|2865185|P5|Overall Study|Protocol Violation|1
869002|NCT01424306|2865186|P4|Overall Study|Protocol Violation|0
869003|NCT01424306|2865187|P3|Overall Study|Protocol Violation|0
869004|NCT01424306|2865188|P2|Overall Study|Protocol Violation|0
869005|NCT01424306|2865189|P1|Overall Study|Protocol Violation|0
869006|NCT01424228|2865238|P2|Overall Study|Unplanned journey|1
869007|NCT01424228|2865239|P1|Overall Study|Unplanned journey|0
869008|NCT01424228|2865238|P2|Overall Study|Worsening of symptoms|0
869009|NCT01424228|2865239|P1|Overall Study|Worsening of symptoms|1
869010|NCT01424228|2865238|P2|Overall Study|Non-compliance|0
869011|NCT01424228|2865239|P1|Overall Study|Non-compliance|2
869012|NCT01424228|2865238|P2|Overall Study|inclusion/exclusion criteria not met|2
869013|NCT01424228|2865239|P1|Overall Study|inclusion/exclusion criteria not met|2
869014|NCT01424228|2865238|P2|Overall Study|Lack of Efficacy|7
869015|NCT01424228|2865239|P1|Overall Study|Lack of Efficacy|5
869016|NCT01424228|2865238|P2|Overall Study|Sponsor's decision|12
869017|NCT01424228|2865239|P1|Overall Study|Sponsor's decision|9
869018|NCT01424228|2865238|P2|Overall Study|Adverse Event|14
869019|NCT01424228|2865239|P1|Overall Study|Adverse Event|10
869020|NCT01424228|2865238|P2|Overall Study|Withdrawal by Subject|11
869021|NCT01424228|2865239|P1|Overall Study|Withdrawal by Subject|27
869022|NCT01424189|2865279|P2|Overall Study|Death|1
869023|NCT01424189|2865280|P1|Overall Study|Death|3
869024|NCT01424189|2865279|P2|Overall Study|Subject moved|0
869025|NCT01424189|2865280|P1|Overall Study|Subject moved|1
869026|NCT01424189|2865279|P2|Overall Study|Withdrawal by Subject|4
869027|NCT01424189|2865280|P1|Overall Study|Withdrawal by Subject|4
869028|NCT01424189|2865279|P2|Overall Study|Lost to Follow-up|1
869029|NCT01424189|2865280|P1|Overall Study|Lost to Follow-up|4
869030|NCT01424189|2865279|P2|Overall Study|Adverse Event|0
869031|NCT01424189|2865280|P1|Overall Study|Adverse Event|1
869032|NCT01423916|2865321|P3|Overall Study|Protocol Deviation|0
869033|NCT01423916|2865322|P2|Overall Study|Protocol Deviation|0
869034|NCT01423916|2865323|P1|Overall Study|Protocol Deviation|1
869035|NCT01423916|2865321|P3|Overall Study|Withdrawal by Subject|3
869036|NCT01423916|2865322|P2|Overall Study|Withdrawal by Subject|10
869037|NCT01423916|2865323|P1|Overall Study|Withdrawal by Subject|3
869038|NCT01423916|2865321|P3|Overall Study|Physician Decision|1
869039|NCT01423916|2865322|P2|Overall Study|Physician Decision|0
869040|NCT01423916|2865323|P1|Overall Study|Physician Decision|1
869041|NCT01423916|2865321|P3|Overall Study|Met Withdrawal Criteria|1
869042|NCT01423916|2865322|P2|Overall Study|Met Withdrawal Criteria|1
869043|NCT01423916|2865323|P1|Overall Study|Met Withdrawal Criteria|1
869044|NCT01423916|2865321|P3|Overall Study|Adverse Event|2
869045|NCT01423916|2865322|P2|Overall Study|Adverse Event|9
869046|NCT01423916|2865323|P1|Overall Study|Adverse Event|5
869047|NCT01423812|2865379|P2|Overall Study|Withdrawal by Subject|2
869048|NCT01423812|2865380|P1|Overall Study|Withdrawal by Subject|1
869049|NCT01423812|2865379|P2|Overall Study|Lost to Follow-up|2
869050|NCT01423812|2865380|P1|Overall Study|Lost to Follow-up|2
869051|NCT01423617|2865408|P2|Overall Study|Lost to Follow-up|1
869052|NCT01423617|2865409|P1|Overall Study|Lost to Follow-up|0
869053|NCT01423604|2865426|P2|Randomized|Patient decision|9
869054|NCT01423604|2865427|P1|Randomized|Patient decision|5
869055|NCT01423604|2865426|P2|Randomized|Other - unspecified|31
869056|NCT01423604|2865427|P1|Randomized|Other - unspecified|37
869057|NCT01423604|2865426|P2|Randomized|Physician Decision|13
869058|NCT01423604|2865427|P1|Randomized|Physician Decision|16
869059|NCT01423604|2865426|P2|Randomized|Death|0
869060|NCT01423604|2865427|P1|Randomized|Death|1
869061|NCT01423604|2865426|P2|Randomized|Adverse Event|10
869062|NCT01423604|2865427|P1|Randomized|Adverse Event|4
869063|NCT01423604|2865426|P2|Safety Run-In|Patient decision|0
869064|NCT01423604|2865427|P1|Safety Run-In|Patient decision|1
869065|NCT01423604|2865426|P2|Safety Run-In|Disease progression|0
869066|NCT01423604|2865427|P1|Safety Run-In|Disease progression|3
869067|NCT01423604|2865426|P2|Safety Run-In|Physician Decision|0
869068|NCT01423604|2865427|P1|Safety Run-In|Physician Decision|1
869069|NCT01423604|2865426|P2|Safety Run-In|Death|0
869070|NCT01423604|2865427|P1|Safety Run-In|Death|1
869071|NCT01423604|2865426|P2|Safety Run-In|Adverse Event|0
869072|NCT01423604|2865427|P1|Safety Run-In|Adverse Event|3
869073|NCT01423253|2865442|P1|Overall Study|Withdrawal by Subject|2
869074|NCT01423253|2865442|P1|Overall Study|Protocol Violation|2
869075|NCT01423253|2865442|P1|Overall Study|Lost to Follow-up|1
869076|NCT01423253|2865442|P1|Overall Study|Lack of Efficacy|2
869077|NCT01423253|2865442|P1|Overall Study|Adverse Event|2
869078|NCT01423084|2865464|P2|Overall Study|Withdrawal by Subject|3
869079|NCT01423084|2865465|P1|Overall Study|Withdrawal by Subject|2
869080|NCT01423084|2865464|P2|Overall Study|Adverse Event|1
869081|NCT01423084|2865465|P1|Overall Study|Adverse Event|0
869082|NCT01422915|2865495|P1|Overall Study|Adverse Event|1
869083|NCT01422889|2865500|P1|Overall Study|No Data Entered for Study Stent|9
869084|NCT01422876|2865515|P10|Week 52|Death|0
869085|NCT01422876|2865516|P9|Week 52|Death|1
869086|NCT01422876|2865517|P8|Week 52|Death|3
869087|NCT01422876|2865518|P7|Week 52|Death|1
869088|NCT01422876|2865519|P6|Week 52|Death|0
869089|NCT01422876|2865520|P5|Week 52|Death|0
869090|NCT01422876|2865521|P4|Week 52|Death|1
869091|NCT01422876|2865522|P3|Week 52|Death|0
869092|NCT01422876|2865523|P2|Week 52|Death|1
869093|NCT01422876|2865524|P1|Week 52|Death|0
869094|NCT01422876|2865515|P10|Week 52|Consent withdrawn|9
869095|NCT01422876|2865516|P9|Week 52|Consent withdrawn|13
869096|NCT01422876|2865517|P8|Week 52|Consent withdrawn|12
869097|NCT01422876|2865518|P7|Week 52|Consent withdrawn|10
869098|NCT01422876|2865519|P6|Week 52|Consent withdrawn|12
869099|NCT01422876|2865520|P5|Week 52|Consent withdrawn|7
869100|NCT01422876|2865521|P4|Week 52|Consent withdrawn|12
869101|NCT01422876|2865522|P3|Week 52|Consent withdrawn|6
869102|NCT01422876|2865523|P2|Week 52|Consent withdrawn|4
869103|NCT01422876|2865524|P1|Week 52|Consent withdrawn|9
869104|NCT01422876|2865515|P10|Week 52|Lost to Follow-up|8
869105|NCT01422876|2865516|P9|Week 52|Lost to Follow-up|7
869106|NCT01422876|2865517|P8|Week 52|Lost to Follow-up|8
869107|NCT01422876|2865518|P7|Week 52|Lost to Follow-up|5
869108|NCT01422876|2865519|P6|Week 52|Lost to Follow-up|5
869109|NCT01422876|2865520|P5|Week 52|Lost to Follow-up|8
869110|NCT01422876|2865521|P4|Week 52|Lost to Follow-up|5
869111|NCT01422876|2865522|P3|Week 52|Lost to Follow-up|7
869112|NCT01422876|2865523|P2|Week 52|Lost to Follow-up|5
869113|NCT01422876|2865524|P1|Week 52|Lost to Follow-up|3
869114|NCT01422876|2865515|P10|Week 24|Death|0
869115|NCT01422876|2865516|P9|Week 24|Death|0
869116|NCT01422876|2865517|P8|Week 24|Death|0
869117|NCT01422876|2865518|P7|Week 24|Death|0
869118|NCT01422876|2865519|P6|Week 24|Death|0
869119|NCT01422876|2865520|P5|Week 24|Death|0
869120|NCT01422876|2865521|P4|Week 24|Death|0
869121|NCT01422876|2865522|P3|Week 24|Death|0
869122|NCT01422876|2865523|P2|Week 24|Death|1
869123|NCT01422876|2865524|P1|Week 24|Death|0
869124|NCT01422876|2865515|P10|Week 24|Consent withdrawn|6
869125|NCT01422876|2865516|P9|Week 24|Consent withdrawn|3
869126|NCT01422876|2865517|P8|Week 24|Consent withdrawn|4
869127|NCT01422876|2865518|P7|Week 24|Consent withdrawn|5
869128|NCT01422876|2865519|P6|Week 24|Consent withdrawn|6
869129|NCT01422876|2865520|P5|Week 24|Consent withdrawn|5
869130|NCT01422876|2865521|P4|Week 24|Consent withdrawn|4
869131|NCT01422876|2865522|P3|Week 24|Consent withdrawn|3
869132|NCT01422876|2865523|P2|Week 24|Consent withdrawn|1
869133|NCT01422876|2865524|P1|Week 24|Consent withdrawn|5
869134|NCT01422876|2865515|P10|Week 24|Lost to Follow-up|4
869135|NCT01422876|2865516|P9|Week 24|Lost to Follow-up|3
869136|NCT01422876|2865517|P8|Week 24|Lost to Follow-up|3
869137|NCT01422876|2865518|P7|Week 24|Lost to Follow-up|1
869138|NCT01422876|2865519|P6|Week 24|Lost to Follow-up|0
869139|NCT01422876|2865520|P5|Week 24|Lost to Follow-up|2
869140|NCT01422876|2865521|P4|Week 24|Lost to Follow-up|4
869141|NCT01422876|2865522|P3|Week 24|Lost to Follow-up|2
869142|NCT01422876|2865523|P2|Week 24|Lost to Follow-up|1
869143|NCT01422876|2865524|P1|Week 24|Lost to Follow-up|1
869144|NCT01422850|2865571|P1|Overall Study|Physician Decision|3
869145|NCT01422824|2865577|P1|Overall Study|Lost to Follow-up|37
869146|NCT01422824|2865577|P1|Overall Study|Case record form not evaluated|1
869147|NCT01422720|2865582|P1|Overall Study|Ineligibility|1
869148|NCT01422720|2865582|P1|Overall Study|Withdrawal by Subject|4
869149|NCT01422720|2865582|P1|Overall Study|Lack of Efficacy|1
869150|NCT01422720|2865582|P1|Overall Study|Adverse Event|16
869151|NCT01422538|2865593|P3|Overall Study|Missed visit|1
869152|NCT01422538|2865594|P2|Overall Study|Missed visit|1
869153|NCT01422538|2865595|P1|Overall Study|Missed visit|0
869154|NCT01422538|2865593|P3|Overall Study|Lost to Follow-up|1
869155|NCT01422538|2865594|P2|Overall Study|Lost to Follow-up|1
869156|NCT01422538|2865595|P1|Overall Study|Lost to Follow-up|0
869157|NCT01422408|2865639|P1|Overall Study|Withdrawal by Subject|3
869158|NCT01422408|2865639|P1|Overall Study|Adverse Event|1
869159|NCT01422382|2865668|P1|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1
869160|NCT01422304|2865684|P2|Overall Study|Not Treated|11
869161|NCT01422304|2865685|P1|Overall Study|Not Treated|3
869162|NCT01422304|2865684|P2|Overall Study|Did Not Meet Protocol Eligibility|2
869163|NCT01422304|2865685|P1|Overall Study|Did Not Meet Protocol Eligibility|0
869164|NCT01422304|2865684|P2|Overall Study|Withdrawal by Subject|2
869165|NCT01422304|2865685|P1|Overall Study|Withdrawal by Subject|4
869166|NCT01422304|2865684|P2|Overall Study|Protocol Violation|0
869167|NCT01422304|2865685|P1|Overall Study|Protocol Violation|1
869168|NCT01422304|2865684|P2|Overall Study|Never Entered Follow-up|1
869169|NCT01422304|2865685|P1|Overall Study|Never Entered Follow-up|2
869170|NCT01422304|2865684|P2|Overall Study|Lost to Follow-up|20
869171|NCT01422304|2865685|P1|Overall Study|Lost to Follow-up|14
869172|NCT01422304|2865684|P2|Overall Study|Adverse Event|1
869173|NCT01422304|2865685|P1|Overall Study|Adverse Event|0
869174|NCT01422239|2865717|P2|Overall Study|Lost to Follow-up|3
869175|NCT01422239|2865718|P1|Overall Study|Lost to Follow-up|4
869176|NCT01422213|2865740|P3|Overall Study|Administrative or Other Reason(s)|2
869177|NCT01422213|2865741|P2|Overall Study|Administrative or Other Reason(s)|4
869178|NCT01422213|2865742|P1|Overall Study|Administrative or Other Reason(s)|5
869179|NCT01422213|2865740|P3|Overall Study|Lost to Follow-up|5
869180|NCT01422213|2865741|P2|Overall Study|Lost to Follow-up|3
869181|NCT01422213|2865742|P1|Overall Study|Lost to Follow-up|3
869182|NCT01422213|2865740|P3|Overall Study|Withdrawal of Consent|5
869183|NCT01422213|2865741|P2|Overall Study|Withdrawal of Consent|3
869184|NCT01422213|2865742|P1|Overall Study|Withdrawal of Consent|7
869185|NCT01422213|2865740|P3|Overall Study|Protocol Violation|4
869186|NCT01422213|2865741|P2|Overall Study|Protocol Violation|2
869187|NCT01422213|2865742|P1|Overall Study|Protocol Violation|0
869188|NCT01422213|2865740|P3|Overall Study|Non-compliance with study drug|0
869189|NCT01422213|2865741|P2|Overall Study|Non-compliance with study drug|1
869190|NCT01422213|2865742|P1|Overall Study|Non-compliance with study drug|0
869191|NCT01422213|2865740|P3|Overall Study|Lack of Efficacy|2
869192|NCT01422213|2865741|P2|Overall Study|Lack of Efficacy|2
869193|NCT01422213|2865742|P1|Overall Study|Lack of Efficacy|10
869194|NCT01422213|2865740|P3|Overall Study|Adverse Event|11
869195|NCT01422213|2865741|P2|Overall Study|Adverse Event|7
869196|NCT01422213|2865742|P1|Overall Study|Adverse Event|8
869197|NCT01422187|2865803|P3|Overall Study|Lost to Follow-up|0
869198|NCT01422187|2865804|P2|Overall Study|Lost to Follow-up|1
869199|NCT01422187|2865805|P1|Overall Study|Lost to Follow-up|0
869200|NCT01422187|2865803|P3|Overall Study|Personal reason|0
869201|NCT01422187|2865804|P2|Overall Study|Personal reason|0
869202|NCT01422187|2865805|P1|Overall Study|Personal reason|1
869203|NCT01421719|2865836|P1|Overall Study|Withdrawal by Subject|4
869204|NCT01421667|2865845|P4|Overall Study|Lost to Follow-up|0
869205|NCT01421667|2865846|P3|Overall Study|Lost to Follow-up|0
869206|NCT01421667|2865847|P2|Overall Study|Lost to Follow-up|1
869207|NCT01421667|2865848|P1|Overall Study|Lost to Follow-up|0
869208|NCT01421667|2865845|P4|Overall Study|Withdrawal by Subject|1
869209|NCT01421667|2865846|P3|Overall Study|Withdrawal by Subject|2
869210|NCT01421667|2865847|P2|Overall Study|Withdrawal by Subject|1
869211|NCT01421667|2865848|P1|Overall Study|Withdrawal by Subject|0
869212|NCT01421641|2865909|P2|Overall Study|Protocol Violation|2
869213|NCT01421641|2865910|P1|Overall Study|Protocol Violation|2
869214|NCT01421511|2865932|P2|Overall Study|Death|1
869215|NCT01421511|2865933|P1|Overall Study|Death|1
869216|NCT01421511|2865932|P2|Overall Study|Withdrawal by Subject|5
869217|NCT01421511|2865933|P1|Overall Study|Withdrawal by Subject|6
869218|NCT01421511|2865932|P2|Overall Study|Physician Decision|1
869219|NCT01421511|2865933|P1|Overall Study|Physician Decision|0
869220|NCT01421511|2865932|P2|Overall Study|Randomized but didn't receive study drug|7
869221|NCT01421511|2865933|P1|Overall Study|Randomized but didn't receive study drug|1
869222|NCT01421511|2865932|P2|Overall Study|Lost to Follow-up|14
869223|NCT01421511|2865933|P1|Overall Study|Lost to Follow-up|11
869224|NCT01421459|2865983|P2|Overall Study|Withdrawal by Subject|16
869225|NCT01421459|2865984|P1|Overall Study|Withdrawal by Subject|12
869226|NCT01421459|2865983|P2|Overall Study|Protocol Violation|5
869227|NCT01421459|2865984|P1|Overall Study|Protocol Violation|8
869228|NCT01421459|2865983|P2|Overall Study|Physician Decision|9
869229|NCT01421459|2865984|P1|Overall Study|Physician Decision|9
869230|NCT01421459|2865983|P2|Overall Study|Lost to Follow-up|9
869231|NCT01421459|2865984|P1|Overall Study|Lost to Follow-up|8
869232|NCT01421459|2865983|P2|Overall Study|Lack of Efficacy|2
869233|NCT01421459|2865984|P1|Overall Study|Lack of Efficacy|1
869234|NCT01421459|2865983|P2|Overall Study|Death|1
869235|NCT01421459|2865984|P1|Overall Study|Death|1
869236|NCT01421459|2865983|P2|Overall Study|Adverse Event|10
869237|NCT01421459|2865984|P1|Overall Study|Adverse Event|6
869238|NCT01421342|2866025|P3|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7
869239|NCT01421342|2866026|P2|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0
869240|NCT01421342|2866027|P1|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6
869241|NCT01421342|2866025|P3|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
869242|NCT01421342|2866026|P2|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
869243|NCT01421342|2866027|P1|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
869244|NCT01421342|2866025|P3|Continuation of Treatment (Week 12 - 36)|Participant moved away|3
869245|NCT01421342|2866026|P2|Continuation of Treatment (Week 12 - 36)|Participant moved away|1
869246|NCT01421342|2866027|P1|Continuation of Treatment (Week 12 - 36)|Participant moved away|4
869247|NCT01421342|2866025|P3|Continuation of Treatment (Week 12 - 36)|End of Study Time|14
869248|NCT01421342|2866026|P2|Continuation of Treatment (Week 12 - 36)|End of Study Time|20
869249|NCT01421342|2866027|P1|Continuation of Treatment (Week 12 - 36)|End of Study Time|15
869250|NCT01421342|2866025|P3|Continuation of Treatment (Week 12 - 36)|Non-adherence|4
869251|NCT01421342|2866026|P2|Continuation of Treatment (Week 12 - 36)|Non-adherence|8
869252|NCT01421342|2866027|P1|Continuation of Treatment (Week 12 - 36)|Non-adherence|3
869253|NCT01421342|2866025|P3|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9
869254|NCT01421342|2866026|P2|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11
869255|NCT01421342|2866027|P1|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4
869256|NCT01421342|2866025|P3|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4
869257|NCT01421342|2866026|P2|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6
869258|NCT01421342|2866027|P1|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7
869259|NCT01421342|2866025|P3|Continuation of Treatment (Week 12 - 36)|Adverse Event|11
869260|NCT01421342|2866026|P2|Continuation of Treatment (Week 12 - 36)|Adverse Event|6
869261|NCT01421342|2866027|P1|Continuation of Treatment (Week 12 - 36)|Adverse Event|0
869262|NCT01421342|2866025|P3|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
869263|NCT01421342|2866026|P2|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5
869264|NCT01421342|2866027|P1|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
869265|NCT01421342|2866025|P3|Completed to Week 12 But Then Withdrawn|End of Study Time|2
869266|NCT01421342|2866026|P2|Completed to Week 12 But Then Withdrawn|End of Study Time|0
869267|NCT01421342|2866027|P1|Completed to Week 12 But Then Withdrawn|End of Study Time|0
869268|NCT01421342|2866025|P3|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4
869269|NCT01421342|2866026|P2|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
869270|NCT01421342|2866027|P1|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
869271|NCT01421342|2866025|P3|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
869272|NCT01421342|2866026|P2|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
869273|NCT01421342|2866027|P1|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1
869274|NCT01421342|2866025|P3|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2
869275|NCT01421342|2866026|P2|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0
869276|NCT01421342|2866027|P1|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1
869277|NCT01421342|2866025|P3|Completed to Week 12 But Then Withdrawn|Non-adherence|5
869278|NCT01421342|2866026|P2|Completed to Week 12 But Then Withdrawn|Non-adherence|4
869279|NCT01421342|2866027|P1|Completed to Week 12 But Then Withdrawn|Non-adherence|5
869280|NCT01421342|2866025|P3|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
869281|NCT01421342|2866026|P2|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
869282|NCT01421342|2866027|P1|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4
869283|NCT01421342|2866025|P3|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11
869284|NCT01421342|2866026|P2|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4
869285|NCT01421342|2866027|P1|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13
869286|NCT01421342|2866025|P3|Completed to Week 12 But Then Withdrawn|Adverse Event|6
869287|NCT01421342|2866026|P2|Completed to Week 12 But Then Withdrawn|Adverse Event|3
869288|NCT01421342|2866027|P1|Completed to Week 12 But Then Withdrawn|Adverse Event|4
869289|NCT01421342|2866025|P3|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12
869290|NCT01421342|2866026|P2|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10
869291|NCT01421342|2866027|P1|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7
869292|NCT01421342|2866025|P3|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88
869293|NCT01421342|2866026|P2|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93
869294|NCT01421342|2866027|P1|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111
869295|NCT01421342|2866025|P3|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4
869296|NCT01421342|2866026|P2|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9
869297|NCT01421342|2866027|P1|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8
869298|NCT01421342|2866025|P3|Acute Treatment Phase (12 Weeks)|Participant moved away|1
869299|NCT01421342|2866026|P2|Acute Treatment Phase (12 Weeks)|Participant moved away|6
869300|NCT01421342|2866027|P1|Acute Treatment Phase (12 Weeks)|Participant moved away|1
869301|NCT01421342|2866025|P3|Acute Treatment Phase (12 Weeks)|Dure to other illness|4
869302|NCT01421342|2866026|P2|Acute Treatment Phase (12 Weeks)|Dure to other illness|2
869303|NCT01421342|2866027|P1|Acute Treatment Phase (12 Weeks)|Dure to other illness|3
869304|NCT01421342|2866025|P3|Acute Treatment Phase (12 Weeks)|Non-adherence|13
869305|NCT01421342|2866026|P2|Acute Treatment Phase (12 Weeks)|Non-adherence|7
869306|NCT01421342|2866027|P1|Acute Treatment Phase (12 Weeks)|Non-adherence|15
869307|NCT01421342|2866025|P3|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21
869308|NCT01421342|2866026|P2|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18
869309|NCT01421342|2866027|P1|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6
869310|NCT01421342|2866025|P3|Acute Treatment Phase (12 Weeks)|Death|3
869311|NCT01421342|2866026|P2|Acute Treatment Phase (12 Weeks)|Death|0
869312|NCT01421342|2866027|P1|Acute Treatment Phase (12 Weeks)|Death|0
869313|NCT01421342|2866025|P3|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13
869314|NCT01421342|2866026|P2|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20
869315|NCT01421342|2866027|P1|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23
869316|NCT01421342|2866025|P3|Acute Treatment Phase (12 Weeks)|Adverse Event|27
869317|NCT01421342|2866026|P2|Acute Treatment Phase (12 Weeks)|Adverse Event|38
869318|NCT01421342|2866027|P1|Acute Treatment Phase (12 Weeks)|Adverse Event|53
869319|NCT01421342|2866025|P3|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13
869320|NCT01421342|2866026|P2|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28
869321|NCT01421342|2866027|P1|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49
869322|NCT01421303|2866044|P1|Overall Study|Withdrawal by Subject|1
869323|NCT01421303|2866044|P1|Overall Study|Other|7
869324|NCT01421303|2866044|P1|Overall Study|Non compliance with study procedure|1
869325|NCT01421303|2866044|P1|Overall Study|Lost to Follow-up|13
869326|NCT01421277|2866071|P2|Overall Study|Incomplete baseline data|31
869327|NCT01421277|2866072|P1|Overall Study|Incomplete baseline data|0
869328|NCT01421277|2866071|P2|Overall Study|Lack of qualifying event|61
869329|NCT01421277|2866072|P1|Overall Study|Lack of qualifying event|0
869330|NCT01421225|2866084|P2|Overall Study|Withdrawal by Subject|1
869331|NCT01421225|2866085|P1|Overall Study|Withdrawal by Subject|0
869332|NCT01421147|2866099|P2|Extension Period|Withdrawal by Subject|3
869333|NCT01421147|2866100|P1|Extension Period|Withdrawal by Subject|5
869334|NCT01421147|2866099|P2|Extension Period|Physician Decision|0
869335|NCT01421147|2866100|P1|Extension Period|Physician Decision|1
869336|NCT01421147|2866099|P2|Extension Period|Lost to Follow-up|5
869337|NCT01421147|2866100|P1|Extension Period|Lost to Follow-up|2
869338|NCT01421147|2866099|P2|Extension Period|Death|1
869339|NCT01421147|2866100|P1|Extension Period|Death|0
869340|NCT01421147|2866099|P2|Extension Period|Adverse Event|2
869341|NCT01421147|2866100|P1|Extension Period|Adverse Event|0
869342|NCT01421147|2866099|P2|Treatment Period|Withdrawal by Subject|5
869343|NCT01421147|2866100|P1|Treatment Period|Withdrawal by Subject|10
869344|NCT01421147|2866099|P2|Treatment Period|Physician Decision|2
869345|NCT01421147|2866100|P1|Treatment Period|Physician Decision|2
869346|NCT01421147|2866099|P2|Treatment Period|Lost to Follow-up|1
869347|NCT01421147|2866100|P1|Treatment Period|Lost to Follow-up|2
869348|NCT01421147|2866099|P2|Treatment Period|Adverse Event|3
869349|NCT01421147|2866100|P1|Treatment Period|Adverse Event|2
869350|NCT01421134|2866132|P2|Overall Study|Lost to Follow-up|1
869351|NCT01421134|2866133|P1|Overall Study|Lost to Follow-up|1
869352|NCT01421134|2866132|P2|Overall Study|Administrative|1
869353|NCT01421134|2866133|P1|Overall Study|Administrative|0
869354|NCT01421134|2866132|P2|Overall Study|Withdrawal by Subject|1
869355|NCT01421134|2866133|P1|Overall Study|Withdrawal by Subject|1
869356|NCT01421134|2866132|P2|Overall Study|Protocol Violation|3
869357|NCT01421134|2866133|P1|Overall Study|Protocol Violation|0
869358|NCT01421134|2866132|P2|Overall Study|Lack of Efficacy|4
869359|NCT01421134|2866133|P1|Overall Study|Lack of Efficacy|2
869360|NCT01421134|2866132|P2|Overall Study|Adverse Event|5
869361|NCT01421134|2866133|P1|Overall Study|Adverse Event|3
869362|NCT01420926|2866153|P2|Overall Study|Continues on active treatment|3
869363|NCT01420926|2866154|P1|Overall Study|Continues on active treatment|1
869364|NCT01420926|2866153|P2|Overall Study|Physician Decision|5
869365|NCT01420926|2866154|P1|Overall Study|Physician Decision|7
869366|NCT01420926|2866153|P2|Overall Study|Non-protocol treatment|20
869367|NCT01420926|2866154|P1|Overall Study|Non-protocol treatment|17
869368|NCT01420926|2866153|P2|Overall Study|Withdrawal by Subject|16
869369|NCT01420926|2866154|P1|Overall Study|Withdrawal by Subject|11
869370|NCT01420926|2866153|P2|Overall Study|Death|17
869371|NCT01420926|2866154|P1|Overall Study|Death|18
869372|NCT01420926|2866153|P2|Overall Study|Adverse Event|4
869373|NCT01420926|2866154|P1|Overall Study|Adverse Event|6
869374|NCT01420081|2866212|P9|Overall Study|Other Reasons|0
869375|NCT01420081|2866213|P8|Overall Study|Other Reasons|0
869376|NCT01420081|2866214|P7|Overall Study|Other Reasons|0
869377|NCT01420081|2866215|P6|Overall Study|Other Reasons|0
869378|NCT01420081|2866216|P5|Overall Study|Other Reasons|0
869379|NCT01420081|2866217|P4|Overall Study|Other Reasons|0
869380|NCT01420081|2866218|P3|Overall Study|Other Reasons|1
869381|NCT01420081|2866219|P2|Overall Study|Other Reasons|0
869382|NCT01420081|2866220|P1|Overall Study|Other Reasons|0
869383|NCT01420081|2866212|P9|Overall Study|Subject Refused Futher Follow-up|0
869384|NCT01420081|2866213|P8|Overall Study|Subject Refused Futher Follow-up|0
869385|NCT01420081|2866214|P7|Overall Study|Subject Refused Futher Follow-up|0
869386|NCT01420081|2866215|P6|Overall Study|Subject Refused Futher Follow-up|0
869387|NCT01420081|2866216|P5|Overall Study|Subject Refused Futher Follow-up|1
869388|NCT01420081|2866217|P4|Overall Study|Subject Refused Futher Follow-up|0
869389|NCT01420081|2866218|P3|Overall Study|Subject Refused Futher Follow-up|1
869390|NCT01420081|2866219|P2|Overall Study|Subject Refused Futher Follow-up|0
869391|NCT01420081|2866220|P1|Overall Study|Subject Refused Futher Follow-up|0
869392|NCT01420081|2866212|P9|Overall Study|Study Terminated by Sponsor|2
869393|NCT01420081|2866213|P8|Overall Study|Study Terminated by Sponsor|2
869394|NCT01420081|2866214|P7|Overall Study|Study Terminated by Sponsor|3
869395|NCT01420081|2866215|P6|Overall Study|Study Terminated by Sponsor|7
869396|NCT01420081|2866216|P5|Overall Study|Study Terminated by Sponsor|11
869397|NCT01420081|2866217|P4|Overall Study|Study Terminated by Sponsor|3
869398|NCT01420081|2866218|P3|Overall Study|Study Terminated by Sponsor|1
869399|NCT01420081|2866219|P2|Overall Study|Study Terminated by Sponsor|1
869400|NCT01420081|2866220|P1|Overall Study|Study Terminated by Sponsor|2
869401|NCT01420081|2866212|P9|Overall Study|Lost to Follow-up|0
869402|NCT01420081|2866213|P8|Overall Study|Lost to Follow-up|0
869403|NCT01420081|2866214|P7|Overall Study|Lost to Follow-up|0
869404|NCT01420081|2866215|P6|Overall Study|Lost to Follow-up|1
869405|NCT01420081|2866216|P5|Overall Study|Lost to Follow-up|1
869406|NCT01420081|2866217|P4|Overall Study|Lost to Follow-up|0
869407|NCT01420081|2866218|P3|Overall Study|Lost to Follow-up|0
869408|NCT01420081|2866219|P2|Overall Study|Lost to Follow-up|0
869409|NCT01420081|2866220|P1|Overall Study|Lost to Follow-up|0
869410|NCT01420081|2866212|P9|Overall Study|Death|1
869411|NCT01420081|2866213|P8|Overall Study|Death|1
869412|NCT01420081|2866214|P7|Overall Study|Death|0
869413|NCT01420081|2866215|P6|Overall Study|Death|12
869414|NCT01420081|2866216|P5|Overall Study|Death|7
869415|NCT01420081|2866217|P4|Overall Study|Death|0
869416|NCT01420081|2866218|P3|Overall Study|Death|8
869417|NCT01420081|2866219|P2|Overall Study|Death|0
869418|NCT01420081|2866220|P1|Overall Study|Death|1
869419|NCT01419769|2866350|P1|Overall Study|Not evaluable due to pigtail stents|1
869420|NCT01419769|2866350|P1|Overall Study|Did not receive the AXIOS stent|3
869421|NCT01419314|2866371|P2|Follow-up at Week 6 of the Trial|Lost to Follow-up|2
869422|NCT01419314|2866372|P1|Follow-up at Week 6 of the Trial|Lost to Follow-up|1
869423|NCT01419314|2866371|P2|Follow-up at Week 3 of the Trial|Lost to Follow-up|0
869424|NCT01419314|2866372|P1|Follow-up at Week 3 of the Trial|Lost to Follow-up|3
869425|NCT01419314|2866371|P2|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1
869426|NCT01419314|2866372|P1|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3
869427|NCT01419236|2866413|P2|Overall Study|Entry Criteria Not Met|0
869428|NCT01419236|2866414|P1|Overall Study|Entry Criteria Not Met|1
869429|NCT01419236|2866413|P2|Overall Study|Withdrawal by Subject|4
869430|NCT01419236|2866414|P1|Overall Study|Withdrawal by Subject|1
869431|NCT01419236|2866413|P2|Overall Study|Physician Decision|0
869432|NCT01419236|2866414|P1|Overall Study|Physician Decision|1
869433|NCT01419236|2866413|P2|Overall Study|Lost to Follow-up|0
869434|NCT01419236|2866414|P1|Overall Study|Lost to Follow-up|1
869435|NCT01419236|2866413|P2|Overall Study|Lack of Efficacy|1
869436|NCT01419236|2866414|P1|Overall Study|Lack of Efficacy|0
869437|NCT01419236|2866413|P2|Overall Study|Adverse Event|0
869438|NCT01419236|2866414|P1|Overall Study|Adverse Event|1
869439|NCT01419197|2866438|P2|Overall Study|Lost to Follow-up|4
869440|NCT01419197|2866439|P1|Overall Study|Lost to Follow-up|14
869441|NCT01419197|2866438|P2|Overall Study|Reason Not Specified|1
869442|NCT01419197|2866439|P1|Overall Study|Reason Not Specified|0
869443|NCT01419197|2866438|P2|Overall Study|Study Completed by Sponsor|34
869444|NCT01419197|2866439|P1|Overall Study|Study Completed by Sponsor|103
869445|NCT01419197|2866438|P2|Overall Study|Withdrawal by Subject|32
869446|NCT01419197|2866439|P1|Overall Study|Withdrawal by Subject|33
869447|NCT01419197|2866438|P2|Overall Study|Non-compliance|1
869448|NCT01419197|2866439|P1|Overall Study|Non-compliance|3
869449|NCT01419197|2866438|P2|Overall Study|Physician Decision|4
869450|NCT01419197|2866439|P1|Overall Study|Physician Decision|4
869451|NCT01419197|2866438|P2|Overall Study|Death|122
869452|NCT01419197|2866439|P1|Overall Study|Death|247
869453|NCT01419184|2866464|P2|Overall Study|Participant randomized, not treated|0
869454|NCT01419184|2866465|P1|Overall Study|Participant randomized, not treated|1
869455|NCT01419184|2866464|P2|Overall Study|No IRLOS-No adverse event treatment date|1
869456|NCT01419184|2866465|P1|Overall Study|No IRLOS-No adverse event treatment date|0
869457|NCT01419184|2866464|P2|Overall Study|No IRLOS-non trial antibiotic used|2
869458|NCT01419184|2866465|P1|Overall Study|No IRLOS-non trial antibiotic used|1
869459|NCT01419184|2866464|P2|Overall Study|No IRLOS-randomized, not treated|4
869460|NCT01419184|2866465|P1|Overall Study|No IRLOS-randomized, not treated|2
869461|NCT01419184|2866464|P2|Overall Study|No IRLOS-No in-patient end date reported|6
869462|NCT01419184|2866465|P1|Overall Study|No IRLOS-No in-patient end date reported|3
869463|NCT01419184|2866464|P2|Overall Study|Site data not available|2
869464|NCT01419184|2866465|P1|Overall Study|Site data not available|3
869465|NCT01418937|2866503|P1|Overall Study|Withdrawal by Subject|1
869466|NCT01418937|2866503|P1|Overall Study|Pregnancy|1
869467|NCT01418937|2866503|P1|Overall Study|Protocol Violation|1
869468|NCT01418937|2866503|P1|Overall Study|Lost to Follow-up|5
869469|NCT01418365|2866534|P2|Second Intervention|Withdrawal by Subject|1
869470|NCT01418365|2866535|P1|Second Intervention|Withdrawal by Subject|0
869471|NCT01418365|2866534|P2|First Intervention|Non-compliance|0
869472|NCT01418365|2866535|P1|First Intervention|Non-compliance|1
869473|NCT01418365|2866534|P2|First Intervention|Withdrawal by Subject|1
869474|NCT01418365|2866535|P1|First Intervention|Withdrawal by Subject|0
869475|NCT01418209|2866546|P3|Overall Study|Did not provide hot flash diary data|3
869476|NCT01418209|2866547|P2|Overall Study|Did not provide hot flash diary data|3
869477|NCT01418209|2866548|P1|Overall Study|Did not provide hot flash diary data|1
869478|NCT01418209|2866546|P3|Overall Study|Withdrawal by Subject|1
869479|NCT01418209|2866547|P2|Overall Study|Withdrawal by Subject|0
869480|NCT01418209|2866548|P1|Overall Study|Withdrawal by Subject|1
869481|NCT01417481|2866603|P2|First Intervention (8 Weeks)|Withdrawal by Subject|2
869482|NCT01417481|2866604|P1|First Intervention (8 Weeks)|Withdrawal by Subject|0
869483|NCT01417377|2866669|P1|Overall Study|Enrolled, but not treated|1
869484|NCT01417377|2866669|P1|Overall Study|Lost to Follow-up|12
869485|NCT01417195|2866678|P2|Overall Study|No transfer due to elevated progesterone|0
869486|NCT01417195|2866679|P1|Overall Study|No transfer due to elevated progesterone|1
869487|NCT01417195|2866678|P2|Overall Study|No transfer due to risk of OHSS|0
869488|NCT01417195|2866679|P1|Overall Study|No transfer due to risk of OHSS|1
869489|NCT01417195|2866678|P2|Overall Study|No embryos for transfer|1
869490|NCT01417195|2866679|P1|Overall Study|No embryos for transfer|0
869491|NCT01417195|2866678|P2|Overall Study|Stimulation failure|0
869492|NCT01417195|2866679|P1|Overall Study|Stimulation failure|1
869493|NCT01417156|2866695|P1|Overall Study|Protocol Violation|2
869494|NCT01417156|2866695|P1|Overall Study|Adverse Event|12
869495|NCT01417104|2866705|P2|Overall Study|Adverse Event|0
869496|NCT01417104|2866706|P1|Overall Study|Adverse Event|1
869497|NCT01417104|2866705|P2|Overall Study|Failure to make contact|1
869498|NCT01417104|2866706|P1|Overall Study|Failure to make contact|0
869499|NCT01417104|2866705|P2|Overall Study|Withdrawal by Subject|1
869500|NCT01417104|2866706|P1|Overall Study|Withdrawal by Subject|5
869501|NCT01417078|2866716|P1|Overall Study|Withdrawal by Subject|1
869502|NCT01417000|2866741|P2|Overall Study|Study Terminated by Sponsor|1
869503|NCT01417000|2866742|P1|Overall Study|Study Terminated by Sponsor|1
869504|NCT01417000|2866741|P2|Overall Study|Lost to Follow-up|0
869505|NCT01417000|2866742|P1|Overall Study|Lost to Follow-up|1
869506|NCT01417000|2866741|P2|Overall Study|Death|28
869507|NCT01417000|2866742|P1|Overall Study|Death|59
869508|NCT01416610|2866750|P1|Overall Study|Sufficient treatment duration (PCR neg.)|7
869509|NCT01416610|2866750|P1|Overall Study|Lost to Follow-up|7
869510|NCT01416610|2866750|P1|Overall Study|Withdrawal by Subject|13
869511|NCT01416610|2866750|P1|Overall Study|No reason given|5
869512|NCT01416610|2866750|P1|Overall Study|Lack of Efficacy|4
869513|NCT01416610|2866750|P1|Overall Study|Adverse Event -Patient decision|3
869514|NCT01416610|2866750|P1|Overall Study|Adverse Event|4
869515|NCT01416571|2866804|P1|Overall Study|Lost to Follow-up|2
869516|NCT01416389|2866833|P2|Overall Study|Started New Therapy|0
869517|NCT01416389|2866834|P1|Overall Study|Started New Therapy|2
869518|NCT01416389|2866833|P2|Overall Study|Lost to Follow-up|0
869519|NCT01416389|2866834|P1|Overall Study|Lost to Follow-up|1
869520|NCT01416272|2866851|P1|Overall Study|Study related complaints|1
869521|NCT01416272|2866851|P1|Overall Study|Lost to Follow-up|1
869522|NCT01416272|2866851|P1|Overall Study|Unacceptable distance visual acuity|2
869523|NCT01416181|2866859|P2|Part 2|Lost to Follow-up|2
869524|NCT01416181|2866860|P1|Part 2|Lost to Follow-up|2
869525|NCT01416181|2866859|P2|Part 2|Lack of Efficacy|1
869526|NCT01416181|2866860|P1|Part 2|Lack of Efficacy|4
869527|NCT01416181|2866859|P2|Part 2|Withdrawal by Subject|5
869528|NCT01416181|2866860|P1|Part 2|Withdrawal by Subject|14
869529|NCT01416181|2866859|P2|Part 2|Investigator Decision|7
869530|NCT01416181|2866860|P1|Part 2|Investigator Decision|6
869531|NCT01416181|2866859|P2|Part 2|Not Specified|267
869532|NCT01416181|2866860|P1|Part 2|Not Specified|234
869533|NCT01416181|2866859|P2|Part 2|Adverse Event|4
869534|NCT01416181|2866860|P1|Part 2|Adverse Event|11
869535|NCT01416181|2866859|P2|Part 1|Ongoing in Follow-Up|8
869536|NCT01416181|2866860|P1|Part 1|Ongoing in Follow-Up|14
869537|NCT01416181|2866859|P2|Part 1|Adverse Event|18
869538|NCT01416181|2866860|P1|Part 1|Adverse Event|15
869539|NCT01416181|2866859|P2|Part 1|Lost to Follow-up|1
869540|NCT01416181|2866860|P1|Part 1|Lost to Follow-up|1
869541|NCT01416181|2866859|P2|Part 1|Lack of Efficacy|8
869542|NCT01416181|2866860|P1|Part 1|Lack of Efficacy|16
869543|NCT01416181|2866859|P2|Part 1|Withdrawal by Subject|48
869544|NCT01416181|2866860|P1|Part 1|Withdrawal by Subject|74
869545|NCT01416181|2866859|P2|Part 1|Investigator Decision|6
869546|NCT01416181|2866860|P1|Part 1|Investigator Decision|7
869547|NCT01416181|2866859|P2|Part 1|Death|1
869548|NCT01416181|2866860|P1|Part 1|Death|0
869549|NCT01416181|2866859|P2|Part 1|Not Specified|24
869550|NCT01416181|2866860|P1|Part 1|Not Specified|10
869551|NCT01416155|2866922|P1|Overall Study|Not specified|7
869552|NCT01416155|2866922|P1|Overall Study|Investigator decision|8
869553|NCT01416155|2866922|P1|Overall Study|Withdrawal by Subject|33
869554|NCT01416155|2866922|P1|Overall Study|Positive for anti-BG00002 antibodies|2
869555|NCT01416155|2866922|P1|Overall Study|Adverse Event|8
869556|NCT01416142|2866929|P3|PureVision2 HD|Inability to maintain lens wear|1
869557|NCT01416142|2866930|P2|PureVision2 HD|Inability to maintain lens wear|0
869558|NCT01416142|2866931|P1|PureVision2 HD|Inability to maintain lens wear|0
869559|NCT01415986|2866958|P1|Overall Study|Lost to Follow-up|1
869560|NCT01415921|2866984|P2|Overall Study|Other|0
869561|NCT01415921|2866985|P1|Overall Study|Other|2
869562|NCT01415921|2866984|P2|Overall Study|Withdrawal by Subject|1
869563|NCT01415921|2866985|P1|Overall Study|Withdrawal by Subject|0
869564|NCT01415921|2866984|P2|Overall Study|Physician Decision|1
869565|NCT01415921|2866985|P1|Overall Study|Physician Decision|1
869566|NCT01415921|2866984|P2|Overall Study|Adverse Event|1
869567|NCT01415921|2866985|P1|Overall Study|Adverse Event|0
869568|NCT01415908|2866995|P2|Overall Study|Withdrawal by Subject|0
869569|NCT01415908|2866996|P1|Overall Study|Withdrawal by Subject|1
869570|NCT01415531|2867033|P2|Overall Study|Other Reasons|2
869571|NCT01415531|2867034|P1|Overall Study|Other Reasons|3
869572|NCT01415531|2867033|P2|Overall Study|Lack of Compliance|4
869573|NCT01415531|2867034|P1|Overall Study|Lack of Compliance|1
869574|NCT01415531|2867033|P2|Overall Study|Lost to Follow-up|14
869575|NCT01415531|2867034|P1|Overall Study|Lost to Follow-up|6
869576|NCT01415531|2867033|P2|Overall Study|Withdrawal by Subject|4
869577|NCT01415531|2867034|P1|Overall Study|Withdrawal by Subject|5
869578|NCT01415531|2867033|P2|Overall Study|Protocol Violation|1
869579|NCT01415531|2867034|P1|Overall Study|Protocol Violation|0
869580|NCT01415531|2867033|P2|Overall Study|Lack of Efficacy|2
869581|NCT01415531|2867034|P1|Overall Study|Lack of Efficacy|3
869582|NCT01415531|2867033|P2|Overall Study|Adverse Event|10
869583|NCT01415531|2867034|P1|Overall Study|Adverse Event|7
869584|NCT01415518|2867044|P2|Overall Study|Condition under Investigation Worsened|1
869585|NCT01415518|2867045|P1|Overall Study|Condition under Investigation Worsened|1
869586|NCT01415518|2867044|P2|Overall Study|Death|1
869587|NCT01415518|2867045|P1|Overall Study|Death|1
869588|NCT01415518|2867044|P2|Overall Study|Adverse Event|4
869589|NCT01415518|2867045|P1|Overall Study|Adverse Event|3
869590|NCT01415518|2867044|P2|Overall Study|Lost to Follow-up|5
869591|NCT01415518|2867045|P1|Overall Study|Lost to Follow-up|3
869592|NCT01415518|2867044|P2|Overall Study|Protocol Violation|8
869593|NCT01415518|2867045|P1|Overall Study|Protocol Violation|6
869594|NCT01415518|2867044|P2|Overall Study|Withdrawal by Subject|12
869595|NCT01415518|2867045|P1|Overall Study|Withdrawal by Subject|2
869596|NCT01415401|2867145|P1|Overall Study|Terminated by Sponsor|1
869597|NCT01415401|2867145|P1|Overall Study|DId not meet inclusion/exclusion criteri|1
869598|NCT01415401|2867145|P1|Overall Study|Adverse Event|5
869599|NCT01415349|2867150|P2|Treatment Period 1|Withdrawal by Subject|1
869600|NCT01415349|2867151|P1|Treatment Period 1|Withdrawal by Subject|0
869601|NCT01415349|2867150|P2|Treatment Period 1|Adverse Event|1
869602|NCT01415349|2867151|P1|Treatment Period 1|Adverse Event|0
869603|NCT01414855|2867163|P1|Overall Study|Withdrawal by Subject|7
869604|NCT01414855|2867163|P1|Overall Study|Lost to Follow-up|5
869605|NCT01414855|2867163|P1|Overall Study|Death|17
869606|NCT01414257|2867212|P1|Overall Study|Protocol Violation|10
869607|NCT01414257|2867212|P1|Overall Study|No Visit After First Day of Treatment|12
869608|NCT01414205|2867240|P2|Overall Study|Randomized but not Treated|1
869609|NCT01414205|2867241|P1|Overall Study|Randomized but not Treated|1
869610|NCT01414205|2867240|P2|Overall Study|Physician Decision|1
869611|NCT01414205|2867241|P1|Overall Study|Physician Decision|0
869612|NCT01414205|2867240|P2|Overall Study|Lost to Follow-up|4
869613|NCT01414205|2867241|P1|Overall Study|Lost to Follow-up|1
869614|NCT01414205|2867240|P2|Overall Study|Death|1
869615|NCT01414205|2867241|P1|Overall Study|Death|5
869616|NCT01414166|2867310|P2|Overall Study|Withdrawal by Subject|5
869617|NCT01414166|2867311|P1|Overall Study|Withdrawal by Subject|3
869618|NCT01414166|2867310|P2|Overall Study|Study terminated by Sponsor|75
869619|NCT01414166|2867311|P1|Overall Study|Study terminated by Sponsor|68
869620|NCT01414166|2867310|P2|Overall Study|Protocol Violation|0
869621|NCT01414166|2867311|P1|Overall Study|Protocol Violation|2
869622|NCT01414166|2867310|P2|Overall Study|Physician Decision|0
869623|NCT01414166|2867311|P1|Overall Study|Physician Decision|2
869624|NCT01414166|2867310|P2|Overall Study|Non-compliance with study drug|0
869625|NCT01414166|2867311|P1|Overall Study|Non-compliance with study drug|2
869626|NCT01414166|2867310|P2|Overall Study|Lost to Follow-up|1
869627|NCT01414166|2867311|P1|Overall Study|Lost to Follow-up|4
869628|NCT01414166|2867310|P2|Overall Study|Adverse Event|2
869629|NCT01414166|2867311|P1|Overall Study|Adverse Event|10
869630|NCT01414114|2867374|P1|Overall Study|Other|2
869631|NCT01414114|2867374|P1|Overall Study|Withdrawal by Subject|1
869632|NCT01414114|2867374|P1|Overall Study|Adverse Event|2
869633|NCT01413958|2867430|P2|Overall Study|Lost to Follow-up|1
869634|NCT01413958|2867431|P1|Overall Study|Lost to Follow-up|0
869635|NCT01413542|2867482|P4|Overall Study|Adverse Event|1
869636|NCT01413542|2867483|P3|Overall Study|Adverse Event|0
869637|NCT01413542|2867484|P2|Overall Study|Adverse Event|0
869638|NCT01413542|2867485|P1|Overall Study|Adverse Event|0
869639|NCT01413542|2867482|P4|Overall Study|Physician Decision|0
869640|NCT01413542|2867483|P3|Overall Study|Physician Decision|3
869641|NCT01413542|2867484|P2|Overall Study|Physician Decision|0
869642|NCT01413542|2867485|P1|Overall Study|Physician Decision|1
869643|NCT01413503|2867507|P1|Overall Study|Lost to Follow-up|1
869644|NCT01413360|2867511|P1|Overall Study|Adverse Event|1
869645|NCT01413360|2867511|P1|Overall Study|Lost to Follow-up|2
869646|NCT01413204|2867519|P3|Overall Study|Fasting plasma glucose level increased|10
869647|NCT01413204|2867520|P2|Overall Study|Fasting plasma glucose level increased|0
869648|NCT01413204|2867521|P1|Overall Study|Fasting plasma glucose level increased|1
869649|NCT01413204|2867519|P3|Overall Study|Clearly not eligible for the study|1
869650|NCT01413204|2867520|P2|Overall Study|Clearly not eligible for the study|0
869651|NCT01413204|2867521|P1|Overall Study|Clearly not eligible for the study|0
869652|NCT01413204|2867519|P3|Overall Study|Withdrawal by Subject|4
869653|NCT01413204|2867520|P2|Overall Study|Withdrawal by Subject|4
869654|NCT01413204|2867521|P1|Overall Study|Withdrawal by Subject|1
869655|NCT01413204|2867519|P3|Overall Study|Physician Decision|2
869656|NCT01413204|2867520|P2|Overall Study|Physician Decision|0
869657|NCT01413204|2867521|P1|Overall Study|Physician Decision|3
869658|NCT01413204|2867519|P3|Overall Study|Adverse Event|2
869659|NCT01413204|2867520|P2|Overall Study|Adverse Event|2
869660|NCT01413204|2867521|P1|Overall Study|Adverse Event|1
869661|NCT01413191|2867529|P1|Overall Study|Death|1
869662|NCT01413191|2867529|P1|Overall Study|Disease Progression|5
869663|NCT01413191|2867529|P1|Overall Study|Lost to Follow-up|5
869664|NCT01412983|2867533|P2|1st Period|Inability to maintain wear|1
869665|NCT01412983|2867534|P1|1st Period|Inability to maintain wear|0
869666|NCT01412983|2867533|P2|1st Period|Unacceptable lens movement|1
869667|NCT01412983|2867534|P1|1st Period|Unacceptable lens movement|0
869668|NCT01412983|2867533|P2|1st Period|Positive slit lamp finding|1
869669|NCT01412983|2867534|P1|1st Period|Positive slit lamp finding|0
869670|NCT01412983|2867533|P2|1st Period|Ineligible|1
869671|NCT01412983|2867534|P1|1st Period|Ineligible|0
869672|NCT01412957|2867544|P2|Overall Study|Death|133
869673|NCT01412957|2867545|P1|Overall Study|Death|136
869674|NCT01412957|2867544|P2|Overall Study|Lost to Follow-up|2
869675|NCT01412957|2867545|P1|Overall Study|Lost to Follow-up|7
869676|NCT01412957|2867544|P2|Overall Study|Withdrawal by Subject|22
869677|NCT01412957|2867545|P1|Overall Study|Withdrawal by Subject|6
869678|NCT01412944|2867567|P6|Entire: IV + Maintenance|Adverse Event|0
869679|NCT01412944|2867568|P5|Entire: IV + Maintenance|Adverse Event|0
869680|NCT01412944|2867569|P4|Entire: IV + Maintenance|Adverse Event|0
869681|NCT01412944|2867570|P3|Entire: IV + Maintenance|Adverse Event|0
869682|NCT01412944|2867571|P2|Entire: IV + Maintenance|Adverse Event|1
869683|NCT01412944|2867572|P1|Entire: IV + Maintenance|Adverse Event|0
869684|NCT01412944|2867567|P6|Entire: IV + Maintenance|Lack of Efficacy|0
869685|NCT01412944|2867568|P5|Entire: IV + Maintenance|Lack of Efficacy|0
869686|NCT01412944|2867569|P4|Entire: IV + Maintenance|Lack of Efficacy|0
869687|NCT01412944|2867570|P3|Entire: IV + Maintenance|Lack of Efficacy|0
869688|NCT01412944|2867571|P2|Entire: IV + Maintenance|Lack of Efficacy|1
869689|NCT01412944|2867572|P1|Entire: IV + Maintenance|Lack of Efficacy|0
869690|NCT01412944|2867567|P6|Entire: IV + Maintenance|Lost to Follow-up|0
869691|NCT01412944|2867568|P5|Entire: IV + Maintenance|Lost to Follow-up|0
869692|NCT01412944|2867569|P4|Entire: IV + Maintenance|Lost to Follow-up|0
869693|NCT01412944|2867570|P3|Entire: IV + Maintenance|Lost to Follow-up|0
869694|NCT01412944|2867571|P2|Entire: IV + Maintenance|Lost to Follow-up|1
869695|NCT01412944|2867572|P1|Entire: IV + Maintenance|Lost to Follow-up|0
869696|NCT01412944|2867567|P6|Entire: IV + Maintenance|Protocol deviation|0
869697|NCT01412944|2867568|P5|Entire: IV + Maintenance|Protocol deviation|0
869698|NCT01412944|2867569|P4|Entire: IV + Maintenance|Protocol deviation|0
869699|NCT01412944|2867570|P3|Entire: IV + Maintenance|Protocol deviation|0
869700|NCT01412944|2867571|P2|Entire: IV + Maintenance|Protocol deviation|1
869701|NCT01412944|2867572|P1|Entire: IV + Maintenance|Protocol deviation|0
869702|NCT01412944|2867567|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
869703|NCT01412944|2867568|P5|Entire: IV + Maintenance|Withdrawal by Subject|0
869704|NCT01412944|2867569|P4|Entire: IV + Maintenance|Withdrawal by Subject|0
869705|NCT01412944|2867570|P3|Entire: IV + Maintenance|Withdrawal by Subject|0
869706|NCT01412944|2867571|P2|Entire: IV + Maintenance|Withdrawal by Subject|1
869707|NCT01412944|2867572|P1|Entire: IV + Maintenance|Withdrawal by Subject|2
869708|NCT01412944|2867567|P6|Entire: IV + Maintenance|Lack of Efficacy|0
869709|NCT01412944|2867568|P5|Entire: IV + Maintenance|Lack of Efficacy|1
869710|NCT01412944|2867569|P4|Entire: IV + Maintenance|Lack of Efficacy|0
869711|NCT01412944|2867570|P3|Entire: IV + Maintenance|Lack of Efficacy|0
869712|NCT01412944|2867571|P2|Entire: IV + Maintenance|Lack of Efficacy|0
869713|NCT01412944|2867572|P1|Entire: IV + Maintenance|Lack of Efficacy|0
869714|NCT01412944|2867567|P6|Entire: IV + Maintenance|Lost to Follow-up|1
869715|NCT01412944|2867568|P5|Entire: IV + Maintenance|Lost to Follow-up|0
869716|NCT01412944|2867569|P4|Entire: IV + Maintenance|Lost to Follow-up|0
869717|NCT01412944|2867570|P3|Entire: IV + Maintenance|Lost to Follow-up|0
869718|NCT01412944|2867571|P2|Entire: IV + Maintenance|Lost to Follow-up|0
869719|NCT01412944|2867572|P1|Entire: IV + Maintenance|Lost to Follow-up|0
869720|NCT01412944|2867567|P6|Entire: IV + Maintenance|Protocol deviation|1
869721|NCT01412944|2867568|P5|Entire: IV + Maintenance|Protocol deviation|0
869722|NCT01412944|2867569|P4|Entire: IV + Maintenance|Protocol deviation|0
869723|NCT01412944|2867570|P3|Entire: IV + Maintenance|Protocol deviation|0
869724|NCT01412944|2867571|P2|Entire: IV + Maintenance|Protocol deviation|0
869725|NCT01412944|2867572|P1|Entire: IV + Maintenance|Protocol deviation|0
869726|NCT01412944|2867567|P6|Entire: IV + Maintenance|Adverse Event|0
869727|NCT01412944|2867568|P5|Entire: IV + Maintenance|Adverse Event|1
869728|NCT01412944|2867569|P4|Entire: IV + Maintenance|Adverse Event|0
869729|NCT01412944|2867570|P3|Entire: IV + Maintenance|Adverse Event|0
869730|NCT01412944|2867571|P2|Entire: IV + Maintenance|Adverse Event|0
869731|NCT01412944|2867572|P1|Entire: IV + Maintenance|Adverse Event|0
869732|NCT01412944|2867567|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
869733|NCT01412944|2867568|P5|Entire: IV + Maintenance|Withdrawal by Subject|1
869734|NCT01412944|2867569|P4|Entire: IV + Maintenance|Withdrawal by Subject|1
869735|NCT01412944|2867570|P3|Entire: IV + Maintenance|Withdrawal by Subject|1
869736|NCT01412944|2867571|P2|Entire: IV + Maintenance|Withdrawal by Subject|0
869737|NCT01412944|2867572|P1|Entire: IV + Maintenance|Withdrawal by Subject|0
869738|NCT01412944|2867567|P6|IV: Per CAIN457A2307|Lost to Follow-up|0
869739|NCT01412944|2867568|P5|IV: Per CAIN457A2307|Lost to Follow-up|0
869740|NCT01412944|2867569|P4|IV: Per CAIN457A2307|Lost to Follow-up|0
869741|NCT01412944|2867570|P3|IV: Per CAIN457A2307|Lost to Follow-up|0
869742|NCT01412944|2867571|P2|IV: Per CAIN457A2307|Lost to Follow-up|1
869743|NCT01412944|2867572|P1|IV: Per CAIN457A2307|Lost to Follow-up|0
869744|NCT01412944|2867567|P6|IV: Per CAIN457A2307|Protocol deviation|0
869745|NCT01412944|2867568|P5|IV: Per CAIN457A2307|Protocol deviation|0
869746|NCT01412944|2867569|P4|IV: Per CAIN457A2307|Protocol deviation|0
869747|NCT01412944|2867570|P3|IV: Per CAIN457A2307|Protocol deviation|0
869748|NCT01412944|2867571|P2|IV: Per CAIN457A2307|Protocol deviation|1
869749|NCT01412944|2867572|P1|IV: Per CAIN457A2307|Protocol deviation|0
869750|NCT01412944|2867567|P6|IV: Per CAIN457A2307|Withdrawal by Subject|0
869751|NCT01412944|2867568|P5|IV: Per CAIN457A2307|Withdrawal by Subject|0
869752|NCT01412944|2867569|P4|IV: Per CAIN457A2307|Withdrawal by Subject|0
869753|NCT01412944|2867570|P3|IV: Per CAIN457A2307|Withdrawal by Subject|0
869754|NCT01412944|2867571|P2|IV: Per CAIN457A2307|Withdrawal by Subject|0
869755|NCT01412944|2867572|P1|IV: Per CAIN457A2307|Withdrawal by Subject|1
869756|NCT01412944|2867567|P6|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1
869757|NCT01412944|2867568|P5|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
869758|NCT01412944|2867569|P4|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
869759|NCT01412944|2867570|P3|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
869760|NCT01412944|2867571|P2|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
869761|NCT01412944|2867572|P1|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
869762|NCT01412944|2867567|P6|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1
869763|NCT01412944|2867568|P5|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
869764|NCT01412944|2867569|P4|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
869765|NCT01412944|2867570|P3|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
869766|NCT01412944|2867571|P2|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
869767|NCT01412944|2867572|P1|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
869768|NCT01412944|2867567|P6|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
869769|NCT01412944|2867568|P5|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
869770|NCT01412944|2867569|P4|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
869771|NCT01412944|2867570|P3|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1
869772|NCT01412944|2867571|P2|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
869773|NCT01412944|2867572|P1|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
869774|NCT01412879|2867618|P3|Initial Registration (Induction Therapy)|Treatment not Given|0
869775|NCT01412879|2867619|P2|Initial Registration (Induction Therapy)|Treatment not Given|0
869776|NCT01412879|2867620|P1|Initial Registration (Induction Therapy)|Treatment not Given|1
869777|NCT01412879|2867618|P3|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0
869778|NCT01412879|2867619|P2|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1
869779|NCT01412879|2867620|P1|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6
869780|NCT01412879|2867618|P3|Initial Registration (Induction Therapy)|Progression/Relapse|0
869781|NCT01412879|2867619|P2|Initial Registration (Induction Therapy)|Progression/Relapse|1
869782|NCT01412879|2867620|P1|Initial Registration (Induction Therapy)|Progression/Relapse|0
869783|NCT01412879|2867618|P3|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0
869784|NCT01412879|2867619|P2|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3
869785|NCT01412879|2867620|P1|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1
869786|NCT01412879|2867618|P3|Initial Registration (Induction Therapy)|Adverse Event|0
869787|NCT01412879|2867619|P2|Initial Registration (Induction Therapy)|Adverse Event|3
869788|NCT01412879|2867620|P1|Initial Registration (Induction Therapy)|Adverse Event|5
869789|NCT01412801|2867640|P6|Overall Study|Relocated to another area|0
869790|NCT01412801|2867641|P5|Overall Study|Relocated to another area|0
869791|NCT01412801|2867642|P4|Overall Study|Relocated to another area|0
869792|NCT01412801|2867643|P3|Overall Study|Relocated to another area|2
869793|NCT01412801|2867644|P2|Overall Study|Relocated to another area|0
869794|NCT01412801|2867645|P1|Overall Study|Relocated to another area|0
869795|NCT01412801|2867640|P6|Overall Study|Withdrawal by Subject|0
869796|NCT01412801|2867641|P5|Overall Study|Withdrawal by Subject|0
869797|NCT01412801|2867642|P4|Overall Study|Withdrawal by Subject|0
869798|NCT01412801|2867643|P3|Overall Study|Withdrawal by Subject|1
869799|NCT01412801|2867644|P2|Overall Study|Withdrawal by Subject|2
869800|NCT01412801|2867645|P1|Overall Study|Withdrawal by Subject|3
869801|NCT01412801|2867640|P6|Overall Study|Lost to Follow-up|1
869802|NCT01412801|2867641|P5|Overall Study|Lost to Follow-up|1
869803|NCT01412801|2867642|P4|Overall Study|Lost to Follow-up|0
869804|NCT01412801|2867643|P3|Overall Study|Lost to Follow-up|4
869805|NCT01412801|2867644|P2|Overall Study|Lost to Follow-up|2
869806|NCT01412801|2867645|P1|Overall Study|Lost to Follow-up|1
869807|NCT01412801|2867640|P6|Overall Study|Death|2
869808|NCT01412801|2867641|P5|Overall Study|Death|2
869809|NCT01412801|2867642|P4|Overall Study|Death|4
869810|NCT01412801|2867643|P3|Overall Study|Death|0
869811|NCT01412801|2867644|P2|Overall Study|Death|1
869812|NCT01412801|2867645|P1|Overall Study|Death|0
869813|NCT01412424|2867804|P1|Extension Treatment Period|Patient Request|2
869814|NCT01412424|2867804|P1|Extension Treatment Period|Treatment Failure|2
869815|NCT01412424|2867804|P1|Extension Treatment Period|Adverse Event|2
869816|NCT01412424|2867804|P1|Core Treatment Period|Sponsor Request|1
869817|NCT01412424|2867804|P1|Core Treatment Period|Lost to Follow-up|2
869818|NCT01412424|2867804|P1|Core Treatment Period|Patient Request|5
869819|NCT01412424|2867804|P1|Core Treatment Period|Adverse Event|21
869820|NCT01412424|2867804|P1|Core Treatment Period|Treatment Failure|24
869821|NCT01412333|2867822|P2|Overall Study|Lost to Follow-up|6
869822|NCT01412333|2867823|P1|Overall Study|Lost to Follow-up|10
869823|NCT01412333|2867822|P2|Overall Study|Adverse Event|16
869824|NCT01412333|2867823|P1|Overall Study|Adverse Event|25
869825|NCT01412333|2867822|P2|Overall Study|Consent withdrawn by participant|12
869826|NCT01412333|2867823|P1|Overall Study|Consent withdrawn by participant|25
869827|NCT01412333|2867822|P2|Overall Study|Pregnancy|0
869828|NCT01412333|2867823|P1|Overall Study|Pregnancy|3
869829|NCT01412333|2867822|P2|Overall Study|Lack of Efficacy|6
869830|NCT01412333|2867823|P1|Overall Study|Lack of Efficacy|15
869831|NCT01412333|2867822|P2|Overall Study|Non-compliance|3
869832|NCT01412333|2867823|P1|Overall Study|Non-compliance|1
869833|NCT01412333|2867822|P2|Overall Study|Protocol Violation|1
869834|NCT01412333|2867823|P1|Overall Study|Protocol Violation|1
869835|NCT01412333|2867822|P2|Overall Study|Non-compliance with study drug|1
869836|NCT01412333|2867823|P1|Overall Study|Non-compliance with study drug|1
869837|NCT01412333|2867822|P2|Overall Study|Reason not specified|10
869838|NCT01412333|2867823|P1|Overall Study|Reason not specified|16
869839|NCT01412333|2867822|P2|Overall Study|Physician Decision|1
869840|NCT01412333|2867823|P1|Overall Study|Physician Decision|0
869841|NCT01412333|2867822|P2|Overall Study|Death|1
869842|NCT01412333|2867823|P1|Overall Study|Death|1
869843|NCT01412229|2867883|P1|Overall Study|Physician Decision|1
869844|NCT01412151|2867899|P1|Week 306 - 310 - Washout Period|Withdrawal by Subject|2
869845|NCT01412151|2867899|P1|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3
869846|NCT01412151|2867899|P1|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1
869847|NCT01412151|2867899|P1|Week 0 - 306 - Treatment Period|Death|1
869848|NCT01412060|2867910|P3|Double-blind Treatment Phase (DBP)|Relapse|25
869849|NCT01412060|2867911|P2|Double-blind Treatment Phase (DBP)|Relapse|47
869850|NCT01412060|2867912|P1|Double-blind Treatment Phase (DBP)|Relapse|0
869851|NCT01412060|2867910|P3|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27
869852|NCT01412060|2867911|P2|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11
869853|NCT01412060|2867912|P1|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0
869854|NCT01412060|2867910|P3|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5
869855|NCT01412060|2867911|P2|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6
869856|NCT01412060|2867912|P1|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0
869857|NCT01412060|2867910|P3|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15
869858|NCT01412060|2867911|P2|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10
869859|NCT01412060|2867912|P1|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0
869860|NCT01412060|2867910|P3|Double-blind Treatment Phase (DBP)|Protocol Violation|5
869861|NCT01412060|2867911|P2|Double-blind Treatment Phase (DBP)|Protocol Violation|4
869862|NCT01412060|2867912|P1|Double-blind Treatment Phase (DBP)|Protocol Violation|0
869863|NCT01412060|2867910|P3|Double-blind Treatment Phase (DBP)|Adverse Event|6
869864|NCT01412060|2867911|P2|Double-blind Treatment Phase (DBP)|Adverse Event|5
869865|NCT01412060|2867912|P1|Double-blind Treatment Phase (DBP)|Adverse Event|0
869866|NCT01412060|2867910|P3|Period Between SP and DBP|Other Miscellaneous Reasons|0
869867|NCT01412060|2867911|P2|Period Between SP and DBP|Other Miscellaneous Reasons|0
869868|NCT01412060|2867912|P1|Period Between SP and DBP|Other Miscellaneous Reasons|55
869869|NCT01412060|2867910|P3|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
869870|NCT01412060|2867911|P2|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
869871|NCT01412060|2867912|P1|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4
869872|NCT01412060|2867910|P3|Period Between SP and DBP|Lost to Follow-up|0
869873|NCT01412060|2867911|P2|Period Between SP and DBP|Lost to Follow-up|0
869874|NCT01412060|2867912|P1|Period Between SP and DBP|Lost to Follow-up|1
869875|NCT01412060|2867910|P3|Period Between SP and DBP|Withdrawal of Consent|0
869876|NCT01412060|2867911|P2|Period Between SP and DBP|Withdrawal of Consent|0
869877|NCT01412060|2867912|P1|Period Between SP and DBP|Withdrawal of Consent|2
869878|NCT01412060|2867910|P3|Period Between SP and DBP|Protocol Violation|0
869879|NCT01412060|2867911|P2|Period Between SP and DBP|Protocol Violation|0
869880|NCT01412060|2867912|P1|Period Between SP and DBP|Protocol Violation|2
869881|NCT01412060|2867910|P3|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
869882|NCT01412060|2867911|P2|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
869956|NCT01411852|2867945|P1|Hospital Intervention Phase|CPR administered|3
869883|NCT01412060|2867912|P1|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19
869884|NCT01412060|2867910|P3|Open-label Stabilization Period (SP)|Lost to Follow-up|0
869885|NCT01412060|2867911|P2|Open-label Stabilization Period (SP)|Lost to Follow-up|0
869886|NCT01412060|2867912|P1|Open-label Stabilization Period (SP)|Lost to Follow-up|9
869887|NCT01412060|2867910|P3|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
869888|NCT01412060|2867911|P2|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
869889|NCT01412060|2867912|P1|Open-label Stabilization Period (SP)|Withdrawal of Consent|40
869890|NCT01412060|2867910|P3|Open-label Stabilization Period (SP)|Protocol Violation|0
869891|NCT01412060|2867911|P2|Open-label Stabilization Period (SP)|Protocol Violation|0
869892|NCT01412060|2867912|P1|Open-label Stabilization Period (SP)|Protocol Violation|14
869893|NCT01412060|2867910|P3|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
869894|NCT01412060|2867911|P2|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
869895|NCT01412060|2867912|P1|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9
869896|NCT01412060|2867910|P3|Open-label Stabilization Period (SP)|Adverse Event|0
869897|NCT01412060|2867911|P2|Open-label Stabilization Period (SP)|Adverse Event|0
869898|NCT01412060|2867912|P1|Open-label Stabilization Period (SP)|Adverse Event|9
869899|NCT01412060|2867910|P3|Period Between RIP and SP|Other Miscellaneous Reasons|0
869900|NCT01412060|2867911|P2|Period Between RIP and SP|Other Miscellaneous Reasons|0
869901|NCT01412060|2867912|P1|Period Between RIP and SP|Other Miscellaneous Reasons|23
869902|NCT01412060|2867910|P3|Period Between RIP and SP|Lost to Follow-up|0
869903|NCT01412060|2867911|P2|Period Between RIP and SP|Lost to Follow-up|0
869904|NCT01412060|2867912|P1|Period Between RIP and SP|Lost to Follow-up|5
869905|NCT01412060|2867910|P3|Period Between RIP and SP|Withdrawal of Consent|0
869906|NCT01412060|2867911|P2|Period Between RIP and SP|Withdrawal of Consent|0
869907|NCT01412060|2867912|P1|Period Between RIP and SP|Withdrawal of Consent|1
869908|NCT01412060|2867910|P3|Period Between RIP and SP|Protocol Violation|0
869909|NCT01412060|2867911|P2|Period Between RIP and SP|Protocol Violation|0
869910|NCT01412060|2867912|P1|Period Between RIP and SP|Protocol Violation|2
869911|NCT01412060|2867910|P3|Period Between RIP and SP|Insufficient Therapeutic Response|0
869912|NCT01412060|2867911|P2|Period Between RIP and SP|Insufficient Therapeutic Response|0
869913|NCT01412060|2867912|P1|Period Between RIP and SP|Insufficient Therapeutic Response|19
869914|NCT01412060|2867910|P3|Period Between RIP and SP|Adverse Event|0
869915|NCT01412060|2867911|P2|Period Between RIP and SP|Adverse Event|0
869916|NCT01412060|2867912|P1|Period Between RIP and SP|Adverse Event|4
869917|NCT01412060|2867910|P3|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
869918|NCT01412060|2867911|P2|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
869919|NCT01412060|2867912|P1|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19
869920|NCT01412060|2867910|P3|Open-label Run-in Period (RIP)|Lost to Follow-up|0
869921|NCT01412060|2867911|P2|Open-label Run-in Period (RIP)|Lost to Follow-up|0
869922|NCT01412060|2867912|P1|Open-label Run-in Period (RIP)|Lost to Follow-up|32
869923|NCT01412060|2867910|P3|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
869924|NCT01412060|2867911|P2|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
869925|NCT01412060|2867912|P1|Open-label Run-in Period (RIP)|Withdrawal of Consent|117
869926|NCT01412060|2867910|P3|Open-label Run-in Period (RIP)|Protocol Violation|0
869927|NCT01412060|2867911|P2|Open-label Run-in Period (RIP)|Protocol Violation|0
869928|NCT01412060|2867912|P1|Open-label Run-in Period (RIP)|Protocol Violation|27
869929|NCT01412060|2867910|P3|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
869930|NCT01412060|2867911|P2|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
869931|NCT01412060|2867912|P1|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66
869932|NCT01412060|2867910|P3|Open-label Run-in Period (RIP)|Adverse Event|0
869933|NCT01412060|2867911|P2|Open-label Run-in Period (RIP)|Adverse Event|0
869934|NCT01412060|2867912|P1|Open-label Run-in Period (RIP)|Adverse Event|86
869935|NCT01411995|2867924|P2|Overall Study|Failed IUD insertion|1
869936|NCT01411995|2867925|P1|Overall Study|Failed IUD insertion|0
869937|NCT01411891|2867933|P2|Overall Study|Catheter dislodgement or loss to follow-|2
869938|NCT01411891|2867934|P1|Overall Study|Catheter dislodgement or loss to follow-|3
869939|NCT01411852|2867944|P2|Hospital Intervention Phase|Vascular access failed|0
869940|NCT01411852|2867945|P1|Hospital Intervention Phase|Vascular access failed|1
869941|NCT01411852|2867944|P2|Hospital Intervention Phase|Withdrawal by Subject|0
869942|NCT01411852|2867945|P1|Hospital Intervention Phase|Withdrawal by Subject|1
869943|NCT01411852|2867944|P2|Hospital Intervention Phase|Spinal cord injury|0
869944|NCT01411852|2867945|P1|Hospital Intervention Phase|Spinal cord injury|2
869945|NCT01411852|2867944|P2|Hospital Intervention Phase|Other ineligible|2
869946|NCT01411852|2867945|P1|Hospital Intervention Phase|Other ineligible|2
869947|NCT01411852|2867944|P2|Hospital Intervention Phase|Physician/hospital staff noncompliance|4
869948|NCT01411852|2867945|P1|Hospital Intervention Phase|Physician/hospital staff noncompliance|0
869949|NCT01411852|2867944|P2|Hospital Intervention Phase|Diagnosis of dehydration|1
869950|NCT01411852|2867945|P1|Hospital Intervention Phase|Diagnosis of dehydration|0
869951|NCT01411852|2867944|P2|Hospital Intervention Phase|Diagnosis of sepsis|2
869952|NCT01411852|2867945|P1|Hospital Intervention Phase|Diagnosis of sepsis|0
869953|NCT01411852|2867944|P2|Hospital Intervention Phase|Misunderstanding of protocol|1
869954|NCT01411852|2867945|P1|Hospital Intervention Phase|Misunderstanding of protocol|4
869955|NCT01411852|2867944|P2|Hospital Intervention Phase|CPR administered|1
869957|NCT01411852|2867944|P2|Hospital Intervention Phase|Miscommunication error|2
869958|NCT01411852|2867945|P1|Hospital Intervention Phase|Miscommunication error|1
869959|NCT01411852|2867944|P2|Hospital Intervention Phase|No qualifying SBP|1
869960|NCT01411852|2867945|P1|Hospital Intervention Phase|No qualifying SBP|5
869961|NCT01411852|2867944|P2|Hospital Intervention Phase|Severe head injury|4
869962|NCT01411852|2867945|P1|Hospital Intervention Phase|Severe head injury|5
869963|NCT01411852|2867944|P2|Prehospital Intervention Phase|Severe head injury with GCS≤8|0
869964|NCT01411852|2867945|P1|Prehospital Intervention Phase|Severe head injury with GCS≤8|5
869965|NCT01411852|2867944|P2|Prehospital Intervention Phase|Found to be under age|1
869966|NCT01411852|2867945|P1|Prehospital Intervention Phase|Found to be under age|0
869967|NCT01411852|2867944|P2|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
869968|NCT01411852|2867945|P1|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
869969|NCT01411852|2867944|P2|Prehospital Intervention Phase|No qualifying SBP|4
869970|NCT01411852|2867945|P1|Prehospital Intervention Phase|No qualifying SBP|5
869971|NCT01411839|2867990|P2|Overall Study|Lost to Follow-up|3
869972|NCT01411839|2867991|P1|Overall Study|Lost to Follow-up|4
869973|NCT01411774|2868003|P2|Overall Study|Withdrawal by Subject|3
869974|NCT01411774|2868004|P1|Overall Study|Withdrawal by Subject|0
869975|NCT01411228|2868079|P3|Overall Study|Withdrawal by Subject|0
869976|NCT01411228|2868080|P2|Overall Study|Withdrawal by Subject|0
869977|NCT01411228|2868081|P1|Overall Study|Withdrawal by Subject|1
869978|NCT01411228|2868079|P3|Overall Study|Lost to Follow-up|1
869979|NCT01411228|2868080|P2|Overall Study|Lost to Follow-up|0
869980|NCT01411228|2868081|P1|Overall Study|Lost to Follow-up|0
869981|NCT01411215|2868103|P2|Overall Study|Screen failure|1
869982|NCT01411215|2868104|P1|Overall Study|Screen failure|0
869983|NCT01411215|2868103|P2|Overall Study|Other|17
869984|NCT01411215|2868104|P1|Overall Study|Other|12
869985|NCT01411215|2868103|P2|Overall Study|Withdrawal by Subject|21
869986|NCT01411215|2868104|P1|Overall Study|Withdrawal by Subject|34
869987|NCT01411215|2868103|P2|Overall Study|Protocol Violation|5
869988|NCT01411215|2868104|P1|Overall Study|Protocol Violation|3
869989|NCT01411215|2868103|P2|Overall Study|Study terminated by sponsor|15
869990|NCT01411215|2868104|P1|Overall Study|Study terminated by sponsor|2
869991|NCT01411215|2868103|P2|Overall Study|Did not meet entrance criteria|1
869992|NCT01411215|2868104|P1|Overall Study|Did not meet entrance criteria|0
869993|NCT01411215|2868103|P2|Overall Study|Lost to Follow-up|18
869994|NCT01411215|2868104|P1|Overall Study|Lost to Follow-up|12
869995|NCT01411215|2868103|P2|Overall Study|Lack of Efficacy|4
869996|NCT01411215|2868104|P1|Overall Study|Lack of Efficacy|2
869997|NCT01411215|2868103|P2|Overall Study|Adverse Event|2
869998|NCT01411215|2868104|P1|Overall Study|Adverse Event|1
869999|NCT01411085|2868156|P1|Overall Study|Adverse Event|1
870000|NCT01411085|2868156|P1|Overall Study|Protocol Violation|1
870001|NCT01411085|2868156|P1|Overall Study|Physician Decision|1
870002|NCT01410604|2868167|P2|Overall Study|Physician Decision|1
870003|NCT01410604|2868168|P1|Overall Study|Physician Decision|0
870004|NCT01410604|2868167|P2|Overall Study|Lost to Follow-up|0
870005|NCT01410604|2868168|P1|Overall Study|Lost to Follow-up|1
870006|NCT01410604|2868167|P2|Overall Study|Adverse Event|1
870007|NCT01410604|2868168|P1|Overall Study|Adverse Event|2
870008|NCT01410474|2868209|P2|Overall Study|Withdrawal by Subject|1
870009|NCT01410474|2868210|P1|Overall Study|Withdrawal by Subject|0
870010|NCT01410448|2868233|P2|Overall Study|Death|3
870011|NCT01410448|2868234|P1|Overall Study|Death|2
870012|NCT01410448|2868233|P2|Overall Study|Protocol Violation|4
870013|NCT01410448|2868234|P1|Overall Study|Protocol Violation|0
870014|NCT01410448|2868233|P2|Overall Study|Withdrawal by Subject|2
870015|NCT01410448|2868234|P1|Overall Study|Withdrawal by Subject|3
870016|NCT01410448|2868233|P2|Overall Study|Lost to Follow-up|0
870017|NCT01410448|2868234|P1|Overall Study|Lost to Follow-up|1
870018|NCT01410448|2868233|P2|Overall Study|Administrative issues|1
870019|NCT01410448|2868234|P1|Overall Study|Administrative issues|2
870020|NCT01410448|2868233|P2|Overall Study|Graft loss|1
870021|NCT01410448|2868234|P1|Overall Study|Graft loss|4
870022|NCT01410448|2868233|P2|Overall Study|No conversion to everolimus|24
870023|NCT01410448|2868234|P1|Overall Study|No conversion to everolimus|0
870024|NCT01410357|2868299|P2|Overall Study|Lost to Follow-up|21
870025|NCT01410357|2868300|P1|Overall Study|Lost to Follow-up|23
870026|NCT01410357|2868299|P2|Overall Study|Withdrawal by Subject|2
870027|NCT01410357|2868300|P1|Overall Study|Withdrawal by Subject|1
870028|NCT01410357|2868299|P2|Overall Study|Death|1
870029|NCT01410357|2868300|P1|Overall Study|Death|2
870030|NCT01410240|2868361|P3|Overall Study|Missed week 6 assessments|1
870031|NCT01410240|2868362|P2|Overall Study|Missed week 6 assessments|1
870032|NCT01410240|2868363|P1|Overall Study|Missed week 6 assessments|1
870033|NCT01410240|2868361|P3|Overall Study|Physician Decision|1
870034|NCT01410240|2868362|P2|Overall Study|Physician Decision|0
870035|NCT01410240|2868363|P1|Overall Study|Physician Decision|0
870036|NCT01410227|2868434|P4|Overall Study|Met Excl. Criteria After Starting Study|0
870037|NCT01410227|2868435|P3|Overall Study|Met Excl. Criteria After Starting Study|1
870038|NCT01410227|2868436|P2|Overall Study|Met Excl. Criteria After Starting Study|0
870039|NCT01410227|2868437|P1|Overall Study|Met Excl. Criteria After Starting Study|0
870040|NCT01410227|2868434|P4|Overall Study|Pregnancy|1
870041|NCT01410227|2868435|P3|Overall Study|Pregnancy|0
870042|NCT01410227|2868436|P2|Overall Study|Pregnancy|0
870043|NCT01410227|2868437|P1|Overall Study|Pregnancy|0
870044|NCT01410227|2868434|P4|Overall Study|Withdrawal by Subject|0
870045|NCT01410227|2868435|P3|Overall Study|Withdrawal by Subject|1
870046|NCT01410227|2868436|P2|Overall Study|Withdrawal by Subject|0
870047|NCT01410227|2868437|P1|Overall Study|Withdrawal by Subject|3
870048|NCT01410227|2868434|P4|Overall Study|Adverse Event|0
870049|NCT01410227|2868435|P3|Overall Study|Adverse Event|0
870050|NCT01410227|2868436|P2|Overall Study|Adverse Event|0
870051|NCT01410227|2868437|P1|Overall Study|Adverse Event|1
870052|NCT01410110|2868509|P2|Overall Study|Withdrawal by Subject|2
870053|NCT01410110|2868510|P1|Overall Study|Withdrawal by Subject|4
870054|NCT01409993|2868559|P4|Overall Study|Lost to Follow-up|0
870055|NCT01409993|2868560|P3|Overall Study|Lost to Follow-up|0
870056|NCT01409993|2868561|P2|Overall Study|Lost to Follow-up|1
870057|NCT01409993|2868562|P1|Overall Study|Lost to Follow-up|0
870058|NCT01409993|2868559|P4|Overall Study|Withdrawal by Subject|4
870059|NCT01409993|2868560|P3|Overall Study|Withdrawal by Subject|0
870060|NCT01409993|2868561|P2|Overall Study|Withdrawal by Subject|0
870061|NCT01409993|2868562|P1|Overall Study|Withdrawal by Subject|0
870062|NCT01409993|2868559|P4|Overall Study|Adverse Event|1
870063|NCT01409993|2868560|P3|Overall Study|Adverse Event|3
870064|NCT01409993|2868561|P2|Overall Study|Adverse Event|4
870065|NCT01409993|2868562|P1|Overall Study|Adverse Event|4
870066|NCT01409837|2868582|P2|Overall Study|Physician Decision|1
870067|NCT01409837|2868583|P1|Overall Study|Physician Decision|0
870068|NCT01409837|2868582|P2|Overall Study|Lost to Follow-up|0
870069|NCT01409837|2868583|P1|Overall Study|Lost to Follow-up|1
870070|NCT01409837|2868582|P2|Overall Study|Withdrawal by Subject|1
870071|NCT01409837|2868583|P1|Overall Study|Withdrawal by Subject|2
870072|NCT01409707|2868608|P3|Overall Study|Withdrawal by Subject|16
870073|NCT01409707|2868609|P2|Overall Study|Withdrawal by Subject|17
870074|NCT01409707|2868610|P1|Overall Study|Withdrawal by Subject|5
870075|NCT01409564|2868622|P2|Overall Study|brain abnormalities found in T1 MR|2
870076|NCT01409564|2868623|P1|Overall Study|brain abnormalities found in T1 MR|1
870077|NCT01409564|2868622|P2|Overall Study|low medication compliance|3
870078|NCT01409564|2868623|P1|Overall Study|low medication compliance|4
870079|NCT01409434|2868641|P1|Overall Study|Protocol Violation|4
870080|NCT01409382|2868651|P2|Overall Study|Had a 2nd trimester loss after accident|0
870081|NCT01409382|2868652|P1|Overall Study|Had a 2nd trimester loss after accident|1
870082|NCT01409382|2868651|P2|Overall Study|Did not manage to get pregnant|70
870083|NCT01409382|2868652|P1|Overall Study|Did not manage to get pregnant|64
870084|NCT01409382|2868651|P2|Overall Study|Still pregnant when study ended|2
870085|NCT01409382|2868652|P1|Overall Study|Still pregnant when study ended|13
870086|NCT01409382|2868651|P2|Overall Study|Multiple pregnancy|4
870087|NCT01409382|2868652|P1|Overall Study|Multiple pregnancy|2
870088|NCT01409382|2868651|P2|Overall Study|Protocol Violation|3
870089|NCT01409382|2868652|P1|Overall Study|Protocol Violation|0
870090|NCT01409382|2868651|P2|Overall Study|Lost to Follow-up|1
870091|NCT01409382|2868652|P1|Overall Study|Lost to Follow-up|1
870092|NCT01408914|2868719|P3|Overall Study|Change in local TB/HIV norms|1
870093|NCT01408914|2868720|P2|Overall Study|Change in local TB/HIV norms|1
870094|NCT01408914|2868721|P1|Overall Study|Change in local TB/HIV norms|0
870095|NCT01408914|2868719|P3|Overall Study|Late exclusion|3
870096|NCT01408914|2868720|P2|Overall Study|Late exclusion|3
870097|NCT01408914|2868721|P1|Overall Study|Late exclusion|0
870098|NCT01408914|2868719|P3|Overall Study|Moved out of study jurisdiction|0
870099|NCT01408914|2868720|P2|Overall Study|Moved out of study jurisdiction|1
870100|NCT01408914|2868721|P1|Overall Study|Moved out of study jurisdiction|1
870101|NCT01408914|2868719|P3|Overall Study|Withdrawal by Subject|1
870102|NCT01408914|2868720|P2|Overall Study|Withdrawal by Subject|0
870103|NCT01408914|2868721|P1|Overall Study|Withdrawal by Subject|1
870104|NCT01408914|2868719|P3|Overall Study|Physician Decision|0
870105|NCT01408914|2868720|P2|Overall Study|Physician Decision|1
870106|NCT01408914|2868721|P1|Overall Study|Physician Decision|1
870107|NCT01408914|2868719|P3|Overall Study|Lost to Follow-up|2
870108|NCT01408914|2868720|P2|Overall Study|Lost to Follow-up|1
870109|NCT01408914|2868721|P1|Overall Study|Lost to Follow-up|4
870110|NCT01408914|2868719|P3|Overall Study|Could not complete tx in protocol period|6
870111|NCT01408914|2868720|P2|Overall Study|Could not complete tx in protocol period|5
870112|NCT01408914|2868721|P1|Overall Study|Could not complete tx in protocol period|5
870113|NCT01408888|2868735|P2|Second Intervention|Adverse Event|0
870114|NCT01408888|2868736|P1|Second Intervention|Adverse Event|1
870115|NCT01408888|2868735|P2|Second Intervention|Withdrawal by Subject|0
870116|NCT01408888|2868736|P1|Second Intervention|Withdrawal by Subject|1
870117|NCT01408888|2868735|P2|First Intervention|Withdrawal by Subject|2
870118|NCT01408888|2868736|P1|First Intervention|Withdrawal by Subject|0
870119|NCT01408888|2868735|P2|First Intervention|Adverse Event|1
870120|NCT01408888|2868736|P1|First Intervention|Adverse Event|0
870121|NCT01408732|2868764|P2|Overall Study|Withdrawal by Subject|2
870122|NCT01408732|2868765|P1|Overall Study|Withdrawal by Subject|2
870123|NCT01408706|2868822|P2|Overall Study|Physician Decision|0
870124|NCT01408706|2868823|P1|Overall Study|Physician Decision|1
870125|NCT01408641|2868835|P2|Overall Study|Physician Decision|0
870126|NCT01408641|2868836|P1|Overall Study|Physician Decision|1
870127|NCT01408628|2868844|P1|Completed 6 Month Follow-Up|Withdrawal by Subject|5
870128|NCT01408628|2868844|P1|Completed 6 Month Follow-Up|Protocol Violation|6
870129|NCT01408628|2868844|P1|Completed 6 Month Follow-Up|Lost to Follow-up|3
870130|NCT01408628|2868844|P1|Consented|Withdrawal by Subject|12
870131|NCT01408576|2868853|P3|Overall Study|Not specified|18
870132|NCT01408576|2868854|P2|Overall Study|Not specified|16
870133|NCT01408576|2868855|P1|Overall Study|Not specified|10
870134|NCT01408576|2868853|P3|Overall Study|AE, unknown type|0
870135|NCT01408576|2868854|P2|Overall Study|AE, unknown type|1
870136|NCT01408576|2868855|P1|Overall Study|AE, unknown type|0
870137|NCT01408576|2868853|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
870138|NCT01408576|2868854|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
870139|NCT01408576|2868855|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
870140|NCT01408576|2868853|P3|Overall Study|AE, non-serious non-fatal|11
870141|NCT01408576|2868854|P2|Overall Study|AE, non-serious non-fatal|19
870142|NCT01408576|2868855|P1|Overall Study|AE, non-serious non-fatal|12
870143|NCT01408576|2868853|P3|Overall Study|SAE, non-fatal|14
870144|NCT01408576|2868854|P2|Overall Study|SAE, non-fatal|23
870145|NCT01408576|2868855|P1|Overall Study|SAE, non-fatal|11
870146|NCT01408576|2868853|P3|Overall Study|AE, serious fatal|1
870147|NCT01408576|2868854|P2|Overall Study|AE, serious fatal|4
870148|NCT01408576|2868855|P1|Overall Study|AE, serious fatal|4
870149|NCT01408576|2868853|P3|Overall Study|Sponsor terminated study|330
870150|NCT01408576|2868854|P2|Overall Study|Sponsor terminated study|333
870151|NCT01408576|2868855|P1|Overall Study|Sponsor terminated study|89
870152|NCT01408576|2868853|P3|Overall Study|Withdrawal by Subject|66
870153|NCT01408576|2868854|P2|Overall Study|Withdrawal by Subject|60
870154|NCT01408576|2868855|P1|Overall Study|Withdrawal by Subject|34
870155|NCT01408576|2868853|P3|Overall Study|Lost to Follow-up|17
870156|NCT01408576|2868854|P2|Overall Study|Lost to Follow-up|9
870157|NCT01408576|2868855|P1|Overall Study|Lost to Follow-up|10
870158|NCT01408576|2868853|P3|Overall Study|Protocol Violation|2
870159|NCT01408576|2868854|P2|Overall Study|Protocol Violation|2
870160|NCT01408576|2868855|P1|Overall Study|Protocol Violation|1
870161|NCT01408576|2868853|P3|Overall Study|Lack of Efficacy|48
870162|NCT01408576|2868854|P2|Overall Study|Lack of Efficacy|30
870163|NCT01408576|2868855|P1|Overall Study|Lack of Efficacy|17
870164|NCT01408563|2868902|P1|Overall Study|Ineligible after consent/ registration|2
870165|NCT01408537|2868913|P1|Overall Study|Lost to Follow-up|3
870166|NCT01408537|2868913|P1|Overall Study|Protocol Violation|3
870167|NCT01408537|2868913|P1|Overall Study|Withdrawal by Subject|2
870168|NCT01408485|2868929|P1|Overall Study|Withdrawal by Subject|21
870169|NCT01408303|2868947|P3|Overall Study|Noncompliance|1
870170|NCT01408303|2868948|P2|Overall Study|Noncompliance|0
870171|NCT01408303|2868949|P1|Overall Study|Noncompliance|1
870172|NCT01408303|2868947|P3|Overall Study|Protocol Violation|0
870173|NCT01408303|2868948|P2|Overall Study|Protocol Violation|1
870174|NCT01408303|2868949|P1|Overall Study|Protocol Violation|0
870175|NCT01408303|2868947|P3|Overall Study|Withdrawal by Subject|1
870176|NCT01408303|2868948|P2|Overall Study|Withdrawal by Subject|3
870177|NCT01408303|2868949|P1|Overall Study|Withdrawal by Subject|2
870178|NCT01408303|2868947|P3|Overall Study|Lost to Follow-up|2
870179|NCT01408303|2868948|P2|Overall Study|Lost to Follow-up|1
870180|NCT01408303|2868949|P1|Overall Study|Lost to Follow-up|0
870181|NCT01408303|2868947|P3|Overall Study|Adverse Event|2
870182|NCT01408303|2868948|P2|Overall Study|Adverse Event|7
870183|NCT01408303|2868949|P1|Overall Study|Adverse Event|3
870184|NCT01408277|2868959|P2|Overall Study|Protocol Violation|0
870185|NCT01408277|2868960|P1|Overall Study|Protocol Violation|2
870186|NCT01408277|2868959|P2|Overall Study|Withdrawal by Subject|0
870187|NCT01408277|2868960|P1|Overall Study|Withdrawal by Subject|2
870188|NCT01408277|2868959|P2|Overall Study|Lost to Follow-up|0
870189|NCT01408277|2868960|P1|Overall Study|Lost to Follow-up|1
870190|NCT01408277|2868959|P2|Overall Study|Adverse Event|4
870191|NCT01408277|2868960|P1|Overall Study|Adverse Event|3
870192|NCT01408030|2868970|P4|Observation Phase (Off Drug)|Other|1
870193|NCT01408030|2868971|P3|Observation Phase (Off Drug)|Other|1
870194|NCT01408030|2868972|P2|Observation Phase (Off Drug)|Other|1
870195|NCT01408030|2868973|P1|Observation Phase (Off Drug)|Other|1
870196|NCT01408030|2868970|P4|Observation Phase (Off Drug)|Physician Decision|0
870197|NCT01408030|2868971|P3|Observation Phase (Off Drug)|Physician Decision|2
870198|NCT01408030|2868972|P2|Observation Phase (Off Drug)|Physician Decision|1
870199|NCT01408030|2868973|P1|Observation Phase (Off Drug)|Physician Decision|0
870200|NCT01408030|2868970|P4|Observation Phase (Off Drug)|Withdrawal by Subject|3
870201|NCT01408030|2868971|P3|Observation Phase (Off Drug)|Withdrawal by Subject|1
870202|NCT01408030|2868972|P2|Observation Phase (Off Drug)|Withdrawal by Subject|2
870203|NCT01408030|2868973|P1|Observation Phase (Off Drug)|Withdrawal by Subject|3
870204|NCT01408030|2868970|P4|Observation Phase (Off Drug)|Lost to Follow-up|0
870205|NCT01408030|2868971|P3|Observation Phase (Off Drug)|Lost to Follow-up|2
870206|NCT01408030|2868972|P2|Observation Phase (Off Drug)|Lost to Follow-up|2
870207|NCT01408030|2868973|P1|Observation Phase (Off Drug)|Lost to Follow-up|0
870208|NCT01408030|2868970|P4|Treatment Phase (on Drug)|Protocol Violation|0
870209|NCT01408030|2868971|P3|Treatment Phase (on Drug)|Protocol Violation|0
870210|NCT01408030|2868972|P2|Treatment Phase (on Drug)|Protocol Violation|1
870211|NCT01408030|2868973|P1|Treatment Phase (on Drug)|Protocol Violation|0
870212|NCT01408030|2868970|P4|Treatment Phase (on Drug)|Lack of Efficacy|3
870213|NCT01408030|2868971|P3|Treatment Phase (on Drug)|Lack of Efficacy|0
870214|NCT01408030|2868972|P2|Treatment Phase (on Drug)|Lack of Efficacy|6
870215|NCT01408030|2868973|P1|Treatment Phase (on Drug)|Lack of Efficacy|2
870216|NCT01408030|2868970|P4|Treatment Phase (on Drug)|Lost to Follow-up|0
870217|NCT01408030|2868971|P3|Treatment Phase (on Drug)|Lost to Follow-up|1
870218|NCT01408030|2868972|P2|Treatment Phase (on Drug)|Lost to Follow-up|0
870219|NCT01408030|2868973|P1|Treatment Phase (on Drug)|Lost to Follow-up|1
870220|NCT01407367|2869036|P2|Overall Study|Lost to Follow-up|2
870221|NCT01407367|2869037|P1|Overall Study|Lost to Follow-up|0
870222|NCT01407367|2869036|P2|Overall Study|Withdrawal by Subject|15
870223|NCT01407367|2869037|P1|Overall Study|Withdrawal by Subject|4
870224|NCT01407367|2869036|P2|Overall Study|Renal Replacement Therapy (RRT)|29
870225|NCT01407367|2869037|P1|Overall Study|Renal Replacement Therapy (RRT)|12
870226|NCT01407367|2869036|P2|Overall Study|Death|32
870227|NCT01407367|2869037|P1|Overall Study|Death|24
870228|NCT01407354|2869051|P2|First Intervention|Physician Decision|0
870229|NCT01407354|2869052|P1|First Intervention|Physician Decision|1
870230|NCT01407354|2869051|P2|First Intervention|Adverse Event|0
870231|NCT01407354|2869052|P1|First Intervention|Adverse Event|1
870232|NCT01407354|2869051|P2|First Intervention|Withdrawal by Subject|2
870233|NCT01407354|2869052|P1|First Intervention|Withdrawal by Subject|0
870234|NCT01407276|2869068|P8|Overall Study|Withdrawal by Subject|1
870235|NCT01407276|2869069|P7|Overall Study|Withdrawal by Subject|0
870236|NCT01407276|2869070|P6|Overall Study|Withdrawal by Subject|0
870237|NCT01407276|2869071|P5|Overall Study|Withdrawal by Subject|0
870238|NCT01407276|2869072|P4|Overall Study|Withdrawal by Subject|0
870239|NCT01407276|2869073|P3|Overall Study|Withdrawal by Subject|0
870240|NCT01407276|2869074|P2|Overall Study|Withdrawal by Subject|0
870241|NCT01407276|2869075|P1|Overall Study|Withdrawal by Subject|0
870242|NCT01406938|2869214|P6|Follow up|Lost to Follow-up|1
870243|NCT01406938|2869215|P5|Follow up|Lost to Follow-up|2
870244|NCT01406938|2869216|P4|Follow up|Lost to Follow-up|1
870245|NCT01406938|2869217|P3|Follow up|Lost to Follow-up|0
870246|NCT01406938|2869218|P2|Follow up|Lost to Follow-up|1
870247|NCT01406938|2869219|P1|Follow up|Lost to Follow-up|1
870248|NCT01406938|2869214|P6|Follow up|Physician Decision|1
870249|NCT01406938|2869215|P5|Follow up|Physician Decision|3
870250|NCT01406938|2869216|P4|Follow up|Physician Decision|0
870251|NCT01406938|2869217|P3|Follow up|Physician Decision|2
870252|NCT01406938|2869218|P2|Follow up|Physician Decision|0
870253|NCT01406938|2869219|P1|Follow up|Physician Decision|0
870254|NCT01406938|2869214|P6|Follow up|Protocol Violation|0
870255|NCT01406938|2869215|P5|Follow up|Protocol Violation|0
870256|NCT01406938|2869216|P4|Follow up|Protocol Violation|0
870257|NCT01406938|2869217|P3|Follow up|Protocol Violation|1
870258|NCT01406938|2869218|P2|Follow up|Protocol Violation|0
870259|NCT01406938|2869219|P1|Follow up|Protocol Violation|0
870260|NCT01406938|2869214|P6|Follow up|Patient/guardian decision|1
870261|NCT01406938|2869215|P5|Follow up|Patient/guardian decision|4
870262|NCT01406938|2869216|P4|Follow up|Patient/guardian decision|2
870263|NCT01406938|2869217|P3|Follow up|Patient/guardian decision|4
870264|NCT01406938|2869218|P2|Follow up|Patient/guardian decision|2
870265|NCT01406938|2869219|P1|Follow up|Patient/guardian decision|4
870266|NCT01406938|2869214|P6|Follow up|Lack of Efficacy|0
870267|NCT01406938|2869215|P5|Follow up|Lack of Efficacy|0
870268|NCT01406938|2869216|P4|Follow up|Lack of Efficacy|0
870269|NCT01406938|2869217|P3|Follow up|Lack of Efficacy|1
870270|NCT01406938|2869218|P2|Follow up|Lack of Efficacy|2
870271|NCT01406938|2869219|P1|Follow up|Lack of Efficacy|3
870272|NCT01406938|2869214|P6|Maintenance Period|Lack of Efficacy|5
870273|NCT01406938|2869215|P5|Maintenance Period|Lack of Efficacy|3
870274|NCT01406938|2869216|P4|Maintenance Period|Lack of Efficacy|1
870275|NCT01406938|2869217|P3|Maintenance Period|Lack of Efficacy|2
870276|NCT01406938|2869218|P2|Maintenance Period|Lack of Efficacy|0
870277|NCT01406938|2869219|P1|Maintenance Period|Lack of Efficacy|0
870278|NCT01406938|2869214|P6|Maintenance Period|Lost to Follow-up|0
870279|NCT01406938|2869215|P5|Maintenance Period|Lost to Follow-up|4
870280|NCT01406938|2869216|P4|Maintenance Period|Lost to Follow-up|0
870281|NCT01406938|2869217|P3|Maintenance Period|Lost to Follow-up|0
870282|NCT01406938|2869218|P2|Maintenance Period|Lost to Follow-up|0
870283|NCT01406938|2869219|P1|Maintenance Period|Lost to Follow-up|0
870284|NCT01406938|2869214|P6|Maintenance Period|Pregnancy|0
870285|NCT01406938|2869215|P5|Maintenance Period|Pregnancy|1
870286|NCT01406938|2869216|P4|Maintenance Period|Pregnancy|0
870287|NCT01406938|2869217|P3|Maintenance Period|Pregnancy|0
870288|NCT01406938|2869218|P2|Maintenance Period|Pregnancy|0
870289|NCT01406938|2869219|P1|Maintenance Period|Pregnancy|0
870290|NCT01406938|2869214|P6|Maintenance Period|Protocol Violation|2
870291|NCT01406938|2869215|P5|Maintenance Period|Protocol Violation|2
870292|NCT01406938|2869216|P4|Maintenance Period|Protocol Violation|2
870293|NCT01406938|2869217|P3|Maintenance Period|Protocol Violation|2
870294|NCT01406938|2869218|P2|Maintenance Period|Protocol Violation|0
870295|NCT01406938|2869219|P1|Maintenance Period|Protocol Violation|0
870296|NCT01406938|2869214|P6|Maintenance Period|Subject/guardian decision|7
870297|NCT01406938|2869215|P5|Maintenance Period|Subject/guardian decision|10
870298|NCT01406938|2869216|P4|Maintenance Period|Subject/guardian decision|7
870299|NCT01406938|2869217|P3|Maintenance Period|Subject/guardian decision|11
870300|NCT01406938|2869218|P2|Maintenance Period|Subject/guardian decision|0
870301|NCT01406938|2869219|P1|Maintenance Period|Subject/guardian decision|0
870302|NCT01406938|2869214|P6|Maintenance Period|Death|0
870303|NCT01406938|2869215|P5|Maintenance Period|Death|1
870304|NCT01406938|2869216|P4|Maintenance Period|Death|0
870305|NCT01406938|2869217|P3|Maintenance Period|Death|0
870306|NCT01406938|2869218|P2|Maintenance Period|Death|0
870307|NCT01406938|2869219|P1|Maintenance Period|Death|0
870308|NCT01406938|2869214|P6|Maintenance Period|Adverse Event|2
870309|NCT01406938|2869215|P5|Maintenance Period|Adverse Event|4
870310|NCT01406938|2869216|P4|Maintenance Period|Adverse Event|8
870311|NCT01406938|2869217|P3|Maintenance Period|Adverse Event|2
870312|NCT01406938|2869218|P2|Maintenance Period|Adverse Event|0
870313|NCT01406938|2869219|P1|Maintenance Period|Adverse Event|0
870314|NCT01406938|2869214|P6|Induction Period|Lost to Follow-up|0
870315|NCT01406938|2869215|P5|Induction Period|Lost to Follow-up|0
870316|NCT01406938|2869216|P4|Induction Period|Lost to Follow-up|0
870317|NCT01406938|2869217|P3|Induction Period|Lost to Follow-up|0
870318|NCT01406938|2869218|P2|Induction Period|Lost to Follow-up|3
870319|NCT01406938|2869219|P1|Induction Period|Lost to Follow-up|2
870320|NCT01406938|2869214|P6|Induction Period|Lack of Efficacy|0
870321|NCT01406938|2869215|P5|Induction Period|Lack of Efficacy|0
870322|NCT01406938|2869216|P4|Induction Period|Lack of Efficacy|0
870323|NCT01406938|2869217|P3|Induction Period|Lack of Efficacy|0
870324|NCT01406938|2869218|P2|Induction Period|Lack of Efficacy|0
870325|NCT01406938|2869219|P1|Induction Period|Lack of Efficacy|1
870326|NCT01406938|2869214|P6|Induction Period|Adverse Event|0
870327|NCT01406938|2869215|P5|Induction Period|Adverse Event|0
870328|NCT01406938|2869216|P4|Induction Period|Adverse Event|0
870329|NCT01406938|2869217|P3|Induction Period|Adverse Event|0
870330|NCT01406938|2869218|P2|Induction Period|Adverse Event|9
870331|NCT01406938|2869219|P1|Induction Period|Adverse Event|8
870332|NCT01406938|2869214|P6|Induction Period|Protocol deviation|0
870333|NCT01406938|2869215|P5|Induction Period|Protocol deviation|0
870334|NCT01406938|2869216|P4|Induction Period|Protocol deviation|0
870335|NCT01406938|2869217|P3|Induction Period|Protocol deviation|0
870336|NCT01406938|2869218|P2|Induction Period|Protocol deviation|0
870337|NCT01406938|2869219|P1|Induction Period|Protocol deviation|1
870338|NCT01406938|2869214|P6|Induction Period|Subject/guardian decision|0
870339|NCT01406938|2869215|P5|Induction Period|Subject/guardian decision|0
870340|NCT01406938|2869216|P4|Induction Period|Subject/guardian decision|0
870341|NCT01406938|2869217|P3|Induction Period|Subject/guardian decision|0
870342|NCT01406938|2869218|P2|Induction Period|Subject/guardian decision|8
870343|NCT01406938|2869219|P1|Induction Period|Subject/guardian decision|6
870344|NCT01406873|2869337|P2|Overall Study|Withdrawal by Subject|1
870345|NCT01406873|2869338|P1|Overall Study|Withdrawal by Subject|1
870346|NCT01406795|2869369|P1|Overall Study|Withdrawal by Subject|1
870347|NCT01406574|2869383|P4|Overall Study|Definite progression of primary disease|0
870348|NCT01406574|2869384|P3|Overall Study|Definite progression of primary disease|0
870349|NCT01406574|2869385|P2|Overall Study|Definite progression of primary disease|0
870350|NCT01406574|2869386|P1|Overall Study|Definite progression of primary disease|1
870351|NCT01406574|2869383|P4|Overall Study|Withdrawal by Subject|0
870352|NCT01406574|2869384|P3|Overall Study|Withdrawal by Subject|0
870353|NCT01406574|2869385|P2|Overall Study|Withdrawal by Subject|1
870354|NCT01406574|2869386|P1|Overall Study|Withdrawal by Subject|0
870355|NCT01406574|2869383|P4|Overall Study|Physician Decision|1
870356|NCT01406574|2869384|P3|Overall Study|Physician Decision|0
870357|NCT01406574|2869385|P2|Overall Study|Physician Decision|0
870358|NCT01406574|2869386|P1|Overall Study|Physician Decision|0
870359|NCT01406574|2869383|P4|Overall Study|Adverse Event|3
870360|NCT01406574|2869384|P3|Overall Study|Adverse Event|1
870361|NCT01406574|2869385|P2|Overall Study|Adverse Event|0
870362|NCT01406574|2869386|P1|Overall Study|Adverse Event|0
870363|NCT01406015|2869421|P2|Overall Study|Withdrawal by Subject|3
870364|NCT01406015|2869422|P1|Overall Study|Withdrawal by Subject|3
870365|NCT01405950|2869438|P4|Overall Study|Withdrawal by Subject|0
870366|NCT01405950|2869439|P3|Overall Study|Withdrawal by Subject|0
870367|NCT01405950|2869440|P2|Overall Study|Withdrawal by Subject|0
870368|NCT01405950|2869441|P1|Overall Study|Withdrawal by Subject|1
870369|NCT01405924|2869476|P1|Overall Study|Missing/Incomplete Data|2
870370|NCT01405924|2869476|P1|Overall Study|Protocol Violation|8
870371|NCT01405898|2869488|P2|Overall Study|Withdrawal by Subject|2
870372|NCT01405898|2869489|P1|Overall Study|Withdrawal by Subject|2
870373|NCT01405820|2869513|P6|Open-Label Treatment Period|Adverse Event|0
870374|NCT01405820|2869514|P5|Open-Label Treatment Period|Adverse Event|0
870375|NCT01405820|2869515|P4|Open-Label Treatment Period|Adverse Event|1
870376|NCT01405820|2869516|P3|Open-Label Treatment Period|Adverse Event|0
870377|NCT01405820|2869517|P2|Open-Label Treatment Period|Adverse Event|0
870378|NCT01405820|2869518|P1|Open-Label Treatment Period|Adverse Event|0
870379|NCT01405820|2869513|P6|Open-Label Treatment Period|Physician Decision|0
870380|NCT01405820|2869514|P5|Open-Label Treatment Period|Physician Decision|1
870381|NCT01405820|2869515|P4|Open-Label Treatment Period|Physician Decision|2
870382|NCT01405820|2869516|P3|Open-Label Treatment Period|Physician Decision|1
870383|NCT01405820|2869517|P2|Open-Label Treatment Period|Physician Decision|0
870384|NCT01405820|2869518|P1|Open-Label Treatment Period|Physician Decision|0
870385|NCT01405820|2869513|P6|Open-Label Treatment Period|Not Specified|1
870386|NCT01405820|2869514|P5|Open-Label Treatment Period|Not Specified|1
870387|NCT01405820|2869515|P4|Open-Label Treatment Period|Not Specified|1
870388|NCT01405820|2869516|P3|Open-Label Treatment Period|Not Specified|1
870389|NCT01405820|2869517|P2|Open-Label Treatment Period|Not Specified|1
870390|NCT01405820|2869518|P1|Open-Label Treatment Period|Not Specified|1
870391|NCT01405820|2869513|P6|Open-Label Treatment Period|Withdrawal by Subject|1
870392|NCT01405820|2869514|P5|Open-Label Treatment Period|Withdrawal by Subject|0
870393|NCT01405820|2869515|P4|Open-Label Treatment Period|Withdrawal by Subject|1
870394|NCT01405820|2869516|P3|Open-Label Treatment Period|Withdrawal by Subject|1
870395|NCT01405820|2869517|P2|Open-Label Treatment Period|Withdrawal by Subject|1
870396|NCT01405820|2869518|P1|Open-Label Treatment Period|Withdrawal by Subject|3
870397|NCT01405820|2869513|P6|Randomized Treatment Period|Withdrew Prior to Dosing|0
870398|NCT01405820|2869514|P5|Randomized Treatment Period|Withdrew Prior to Dosing|0
870399|NCT01405820|2869515|P4|Randomized Treatment Period|Withdrew Prior to Dosing|1
870400|NCT01405820|2869516|P3|Randomized Treatment Period|Withdrew Prior to Dosing|0
870401|NCT01405820|2869517|P2|Randomized Treatment Period|Withdrew Prior to Dosing|0
870402|NCT01405820|2869518|P1|Randomized Treatment Period|Withdrew Prior to Dosing|0
870403|NCT01405820|2869513|P6|Randomized Treatment Period|Death|0
870404|NCT01405820|2869514|P5|Randomized Treatment Period|Death|0
870405|NCT01405820|2869515|P4|Randomized Treatment Period|Death|1
870406|NCT01405820|2869516|P3|Randomized Treatment Period|Death|0
870407|NCT01405820|2869517|P2|Randomized Treatment Period|Death|0
870408|NCT01405820|2869518|P1|Randomized Treatment Period|Death|0
870409|NCT01405820|2869513|P6|Randomized Treatment Period|Treatment Arm Closed|28
870410|NCT01405820|2869514|P5|Randomized Treatment Period|Treatment Arm Closed|33
870411|NCT01405820|2869515|P4|Randomized Treatment Period|Treatment Arm Closed|36
870412|NCT01405820|2869516|P3|Randomized Treatment Period|Treatment Arm Closed|20
870413|NCT01405820|2869517|P2|Randomized Treatment Period|Treatment Arm Closed|0
870414|NCT01405820|2869518|P1|Randomized Treatment Period|Treatment Arm Closed|0
870415|NCT01405820|2869513|P6|Randomized Treatment Period|Incorrect Study Treatment|0
870416|NCT01405820|2869514|P5|Randomized Treatment Period|Incorrect Study Treatment|2
870417|NCT01405820|2869515|P4|Randomized Treatment Period|Incorrect Study Treatment|0
870418|NCT01405820|2869516|P3|Randomized Treatment Period|Incorrect Study Treatment|3
870419|NCT01405820|2869517|P2|Randomized Treatment Period|Incorrect Study Treatment|0
870420|NCT01405820|2869518|P1|Randomized Treatment Period|Incorrect Study Treatment|0
870421|NCT01405820|2869513|P6|Randomized Treatment Period|Rescue|8
870422|NCT01405820|2869514|P5|Randomized Treatment Period|Rescue|8
870423|NCT01405820|2869515|P4|Randomized Treatment Period|Rescue|10
870424|NCT01405820|2869516|P3|Randomized Treatment Period|Rescue|13
870425|NCT01405820|2869517|P2|Randomized Treatment Period|Rescue|1
870426|NCT01405820|2869518|P1|Randomized Treatment Period|Rescue|0
870427|NCT01405820|2869513|P6|Randomized Treatment Period|Physician Decision|0
870428|NCT01405820|2869514|P5|Randomized Treatment Period|Physician Decision|0
870429|NCT01405820|2869515|P4|Randomized Treatment Period|Physician Decision|0
870430|NCT01405820|2869516|P3|Randomized Treatment Period|Physician Decision|1
870431|NCT01405820|2869517|P2|Randomized Treatment Period|Physician Decision|2
870432|NCT01405820|2869518|P1|Randomized Treatment Period|Physician Decision|0
870433|NCT01405820|2869513|P6|Randomized Treatment Period|Not Specified|0
870434|NCT01405820|2869514|P5|Randomized Treatment Period|Not Specified|0
870435|NCT01405820|2869515|P4|Randomized Treatment Period|Not Specified|1
870436|NCT01405820|2869516|P3|Randomized Treatment Period|Not Specified|1
870437|NCT01405820|2869517|P2|Randomized Treatment Period|Not Specified|2
870438|NCT01405820|2869518|P1|Randomized Treatment Period|Not Specified|2
870439|NCT01405820|2869513|P6|Randomized Treatment Period|Withdrawal by Subject|0
870440|NCT01405820|2869514|P5|Randomized Treatment Period|Withdrawal by Subject|0
870441|NCT01405820|2869515|P4|Randomized Treatment Period|Withdrawal by Subject|2
870442|NCT01405820|2869516|P3|Randomized Treatment Period|Withdrawal by Subject|2
870443|NCT01405820|2869517|P2|Randomized Treatment Period|Withdrawal by Subject|2
870444|NCT01405820|2869518|P1|Randomized Treatment Period|Withdrawal by Subject|6
870445|NCT01405820|2869513|P6|Randomized Treatment Period|Adverse Event|1
870446|NCT01405820|2869514|P5|Randomized Treatment Period|Adverse Event|2
870447|NCT01405820|2869515|P4|Randomized Treatment Period|Adverse Event|0
870448|NCT01405820|2869516|P3|Randomized Treatment Period|Adverse Event|3
870449|NCT01405820|2869517|P2|Randomized Treatment Period|Adverse Event|3
870450|NCT01405820|2869518|P1|Randomized Treatment Period|Adverse Event|3
870451|NCT01405768|2869614|P2|Overall Study|Didn't complete questionnaire correctly|0
870452|NCT01405768|2869615|P1|Overall Study|Didn't complete questionnaire correctly|4
870453|NCT01405742|2869627|P2|Overall Study|Lost to Follow-up|0
870454|NCT01405742|2869628|P1|Overall Study|Lost to Follow-up|1
870455|NCT01405560|2869638|P1|Overall Study|Physician Decision|1
870456|NCT01405508|2869653|P4|Overall Study|AE, non-serious non-fatal|0
870457|NCT01405508|2869654|P3|Overall Study|AE, non-serious non-fatal|0
870458|NCT01405508|2869655|P2|Overall Study|AE, non-serious non-fatal|1
870459|NCT01405508|2869656|P1|Overall Study|AE, non-serious non-fatal|1
870460|NCT01405456|2869688|P2|Overall Study|Physician Decision|0
870461|NCT01405456|2869689|P1|Overall Study|Physician Decision|1
870462|NCT01405456|2869688|P2|Overall Study|Lost to Follow-up|1
870463|NCT01405456|2869689|P1|Overall Study|Lost to Follow-up|2
870464|NCT01405196|2869729|P4|Overall Study|Lost to Follow-up|1
870465|NCT01405196|2869730|P3|Overall Study|Lost to Follow-up|3
870466|NCT01405196|2869731|P2|Overall Study|Lost to Follow-up|2
870467|NCT01405196|2869732|P1|Overall Study|Lost to Follow-up|2
870468|NCT01405196|2869729|P4|Overall Study|Death|0
870469|NCT01405196|2869730|P3|Overall Study|Death|3
870470|NCT01405196|2869731|P2|Overall Study|Death|0
870471|NCT01405196|2869732|P1|Overall Study|Death|1
870472|NCT01405196|2869729|P4|Overall Study|Adverse Event|2
870473|NCT01405196|2869730|P3|Overall Study|Adverse Event|0
870474|NCT01405196|2869731|P2|Overall Study|Adverse Event|2
870475|NCT01405196|2869732|P1|Overall Study|Adverse Event|2
870476|NCT01405196|2869729|P4|Overall Study|Withdrawal by Subject|6
870477|NCT01405196|2869730|P3|Overall Study|Withdrawal by Subject|3
870478|NCT01405196|2869731|P2|Overall Study|Withdrawal by Subject|6
870479|NCT01405196|2869732|P1|Overall Study|Withdrawal by Subject|4
870480|NCT01405196|2869729|P4|Overall Study|Other|0
870481|NCT01405196|2869730|P3|Overall Study|Other|5
870482|NCT01405196|2869731|P2|Overall Study|Other|2
870483|NCT01405196|2869732|P1|Overall Study|Other|2
870484|NCT01405196|2869729|P4|Overall Study|Study Terminated by Sponsor|0
870485|NCT01405196|2869730|P3|Overall Study|Study Terminated by Sponsor|9
870486|NCT01405196|2869731|P2|Overall Study|Study Terminated by Sponsor|0
870487|NCT01405196|2869732|P1|Overall Study|Study Terminated by Sponsor|0
870488|NCT01405027|2869819|P2|Overall Study|Other or Unknown|25
870489|NCT01405027|2869820|P1|Overall Study|Other or Unknown|12
870490|NCT01405027|2869819|P2|Overall Study|Death|0
870491|NCT01405027|2869820|P1|Overall Study|Death|1
870492|NCT01405027|2869819|P2|Overall Study|Investigator judgement|2
870493|NCT01405027|2869820|P1|Overall Study|Investigator judgement|0
870494|NCT01405027|2869819|P2|Overall Study|Lost to Follow-up|24
870495|NCT01405027|2869820|P1|Overall Study|Lost to Follow-up|16
870496|NCT01405027|2869819|P2|Overall Study|Withdrawn consent|0
870497|NCT01405027|2869820|P1|Overall Study|Withdrawn consent|3
870498|NCT01404988|2869837|P3|Overall Study|Lost to Follow-up|1
870499|NCT01404988|2869838|P2|Overall Study|Lost to Follow-up|2
870500|NCT01404988|2869839|P1|Overall Study|Lost to Follow-up|1
870501|NCT01404988|2869837|P3|Overall Study|Withdrawal by Subject|0
870502|NCT01404988|2869838|P2|Overall Study|Withdrawal by Subject|2
870503|NCT01404988|2869839|P1|Overall Study|Withdrawal by Subject|2
870504|NCT01404988|2869837|P3|Overall Study|Adverse Event|0
870505|NCT01404988|2869838|P2|Overall Study|Adverse Event|0
870506|NCT01404988|2869839|P1|Overall Study|Adverse Event|1
870507|NCT01404988|2869837|P3|Overall Study|Death|2
870508|NCT01404988|2869838|P2|Overall Study|Death|0
870509|NCT01404988|2869839|P1|Overall Study|Death|2
870510|NCT01404234|2869967|P1|Overall Study|Withdrawal by Subject|2
870511|NCT01404208|2869983|P2|Overall Study|Discontinued|0
870512|NCT01404208|2869984|P1|Overall Study|Discontinued|3
870513|NCT01403987|2870049|P3|Overall Study|Residents forgot their secret PIN|18
870514|NCT01403987|2870050|P2|Overall Study|Residents forgot their secret PIN|17
870515|NCT01403987|2870051|P1|Overall Study|Residents forgot their secret PIN|18
870516|NCT01403805|2870067|P2|Overall Study|Death|1
870517|NCT01403805|2870068|P1|Overall Study|Death|0
870518|NCT01403805|2870067|P2|Overall Study|Lost to Follow-up|2
870519|NCT01403805|2870068|P1|Overall Study|Lost to Follow-up|0
870520|NCT01403805|2870067|P2|Overall Study|Withdrawal by Subject|4
870521|NCT01403805|2870068|P1|Overall Study|Withdrawal by Subject|0
870522|NCT01403194|2870112|P1|Overall Study|Lost to Follow-up|8
870523|NCT01403194|2870112|P1|Overall Study|Screen Failure|2
870524|NCT01403116|2870120|P2|Overall Study|unable to keep appointments|2
870525|NCT01403116|2870121|P1|Overall Study|unable to keep appointments|0
870526|NCT01403116|2870120|P2|Overall Study|Hct >54%|0
870527|NCT01403116|2870121|P1|Overall Study|Hct >54%|2
870528|NCT01403116|2870120|P2|Overall Study|undisclosed Hx of Prostate Ca|0
870529|NCT01403116|2870121|P1|Overall Study|undisclosed Hx of Prostate Ca|1
870530|NCT01403116|2870120|P2|Overall Study|Protocol Violation|1
870531|NCT01403116|2870121|P1|Overall Study|Protocol Violation|0
870532|NCT01403116|2870120|P2|Overall Study|Non-compliance of study drug|0
870533|NCT01403116|2870121|P1|Overall Study|Non-compliance of study drug|3
870534|NCT01403116|2870120|P2|Overall Study|Withdrawal by Subject|15
870535|NCT01403116|2870121|P1|Overall Study|Withdrawal by Subject|12
870536|NCT01403116|2870120|P2|Overall Study|Lost to Follow-up|5
870537|NCT01403116|2870121|P1|Overall Study|Lost to Follow-up|7
870538|NCT01403116|2870120|P2|Overall Study|Adverse Event|4
870539|NCT01403116|2870121|P1|Overall Study|Adverse Event|7
870540|NCT01403051|2870134|P2|Overall Study|Lost to Follow-up|5
870541|NCT01403051|2870135|P1|Overall Study|Lost to Follow-up|5
870542|NCT01403051|2870134|P2|Overall Study|Withdrawal by Subject|1
870543|NCT01403051|2870135|P1|Overall Study|Withdrawal by Subject|2
870544|NCT01403051|2870134|P2|Overall Study|Death|0
870545|NCT01403051|2870135|P1|Overall Study|Death|1
870546|NCT01403051|2870134|P2|Overall Study|Protocol Violation|0
870547|NCT01403051|2870135|P1|Overall Study|Protocol Violation|2
870548|NCT01402986|2870171|P4|Overall Study|Other|6
870549|NCT01402986|2870172|P3|Overall Study|Other|1
870550|NCT01402986|2870173|P2|Overall Study|Other|5
870551|NCT01402986|2870174|P1|Overall Study|Other|2
870552|NCT01402986|2870171|P4|Overall Study|Lost to Follow-up|1
870553|NCT01402986|2870172|P3|Overall Study|Lost to Follow-up|0
870554|NCT01402986|2870173|P2|Overall Study|Lost to Follow-up|0
870555|NCT01402986|2870174|P1|Overall Study|Lost to Follow-up|0
870556|NCT01402986|2870171|P4|Overall Study|Death|2
870557|NCT01402986|2870172|P3|Overall Study|Death|0
870558|NCT01402986|2870173|P2|Overall Study|Death|0
870559|NCT01402986|2870174|P1|Overall Study|Death|0
870560|NCT01402986|2870171|P4|Overall Study|Withdrawal by Subject|13
870561|NCT01402986|2870172|P3|Overall Study|Withdrawal by Subject|7
870562|NCT01402986|2870173|P2|Overall Study|Withdrawal by Subject|10
870563|NCT01402986|2870174|P1|Overall Study|Withdrawal by Subject|7
870564|NCT01402947|2870309|P2|First Intervention|Adverse Event|1
870565|NCT01402947|2870310|P1|First Intervention|Adverse Event|0
870566|NCT01402869|2870321|P3|Overall Study|Required Tooth Extraction|1
870567|NCT01402869|2870322|P2|Overall Study|Required Tooth Extraction|0
870568|NCT01402869|2870323|P1|Overall Study|Required Tooth Extraction|0
870569|NCT01402817|2870337|P1|Overall Study|Study Suspended by FDA|8
870570|NCT01402817|2870337|P1|Overall Study|Withdrawal by Subject|3
870571|NCT01402700|2870342|P1|Overall Study|Missed Visit|1
870572|NCT01402700|2870342|P1|Overall Study|Withdrawal by Subject|3
870573|NCT01402700|2870342|P1|Overall Study|Death|3
870574|NCT01402570|2870346|P1|Overall Study|Adverse Event|1
870575|NCT01402284|2870417|P1|Overall Study|Non compliance|2
870576|NCT01402284|2870417|P1|Overall Study|Disease progression on study|9
870577|NCT01402284|2870417|P1|Overall Study|Physician Decision|1
870578|NCT01402284|2870417|P1|Overall Study|Follows up at Memorial Sloan Kettering|2
870579|NCT01402284|2870417|P1|Overall Study|Withdrawal consent|1
870580|NCT01402102|2870499|P2|Overall Study|Withdrawal by Subject|2
870581|NCT01402102|2870500|P1|Overall Study|Withdrawal by Subject|0
870582|NCT01402102|2870499|P2|Overall Study|Insufficiency of compliance|1
870583|NCT01402102|2870500|P1|Overall Study|Insufficiency of compliance|1
870584|NCT01402102|2870499|P2|Overall Study|Protocol Violation|0
870585|NCT01402102|2870500|P1|Overall Study|Protocol Violation|1
870586|NCT01402063|2870520|P2|Overall Study|Withdrawal by Subject|3
870587|NCT01402063|2870521|P1|Overall Study|Withdrawal by Subject|3
870588|NCT01402011|2870530|P3|Nine Month Follow-up|Withdrawal by Subject|0
870589|NCT01402011|2870531|P2|Nine Month Follow-up|Withdrawal by Subject|1
870590|NCT01402011|2870532|P1|Nine Month Follow-up|Withdrawal by Subject|0
870591|NCT01402011|2870530|P3|Active Treatment Period|Withdrawal by Subject|0
870592|NCT01402011|2870531|P2|Active Treatment Period|Withdrawal by Subject|3
870593|NCT01402011|2870532|P1|Active Treatment Period|Withdrawal by Subject|1
870594|NCT01402011|2870530|P3|Delayed Treatment Period|Withdrawal by Subject|0
870595|NCT01402011|2870531|P2|Delayed Treatment Period|Withdrawal by Subject|0
870596|NCT01402011|2870532|P1|Delayed Treatment Period|Withdrawal by Subject|1
870597|NCT01401959|2870561|P3|Treated|Protocol Violation|0
870598|NCT01401959|2870562|P2|Treated|Protocol Violation|1
870599|NCT01401959|2870563|P1|Treated|Protocol Violation|0
870600|NCT01401959|2870561|P3|Treated|Withdrawal by Subject|2
870601|NCT01401959|2870562|P2|Treated|Withdrawal by Subject|2
870602|NCT01401959|2870563|P1|Treated|Withdrawal by Subject|1
870603|NCT01401959|2870561|P3|Treated|Adverse Event|2
870604|NCT01401959|2870562|P2|Treated|Adverse Event|3
870605|NCT01401959|2870563|P1|Treated|Adverse Event|4
870606|NCT01401959|2870561|P3|Treated|Disease Progression|1
870607|NCT01401959|2870562|P2|Treated|Disease Progression|2
870608|NCT01401959|2870563|P1|Treated|Disease Progression|2
870609|NCT01401959|2870561|P3|Enrolled|Withdrawal by Subject|0
870610|NCT01401959|2870562|P2|Enrolled|Withdrawal by Subject|0
870611|NCT01401959|2870563|P1|Enrolled|Withdrawal by Subject|1
870612|NCT01401842|2870600|P2|Overall Study|other/unknown|17
870613|NCT01401842|2870601|P1|Overall Study|other/unknown|28
870614|NCT01401842|2870600|P2|Overall Study|on profile|5
870615|NCT01401842|2870601|P1|Overall Study|on profile|9
870616|NCT01401842|2870600|P2|Overall Study|invalid follow-up strength data|4
870617|NCT01401842|2870601|P1|Overall Study|invalid follow-up strength data|1
870618|NCT01401842|2870600|P2|Overall Study|discharged from US Army|4
870619|NCT01401842|2870601|P1|Overall Study|discharged from US Army|3
870620|NCT01401842|2870600|P2|Overall Study|changed companies|34
870621|NCT01401842|2870601|P1|Overall Study|changed companies|20
870622|NCT01401842|2870600|P2|Overall Study|academic reason|1
870623|NCT01401842|2870601|P1|Overall Study|academic reason|4
870624|NCT01401842|2870600|P2|Overall Study|Withdrawal by Subject|2
870625|NCT01401842|2870601|P1|Overall Study|Withdrawal by Subject|3
870626|NCT01401647|2870618|P3|Overall Study|Lost to Follow-up|1
870627|NCT01401647|2870619|P2|Overall Study|Lost to Follow-up|3
870628|NCT01401647|2870620|P1|Overall Study|Lost to Follow-up|3
870629|NCT01401647|2870618|P3|Overall Study|Withdrawal by Subject|2
870630|NCT01401647|2870619|P2|Overall Study|Withdrawal by Subject|5
870631|NCT01401647|2870620|P1|Overall Study|Withdrawal by Subject|1
870632|NCT01401530|2870665|P3|Overall Study|Physician Decision|0
870633|NCT01401530|2870666|P2|Overall Study|Physician Decision|1
870634|NCT01401530|2870667|P1|Overall Study|Physician Decision|0
870635|NCT01401530|2870665|P3|Overall Study|Participant Choice|1
870636|NCT01401530|2870666|P2|Overall Study|Participant Choice|2
870637|NCT01401530|2870667|P1|Overall Study|Participant Choice|1
870638|NCT01401530|2870665|P3|Overall Study|Adverse Event|1
870639|NCT01401530|2870666|P2|Overall Study|Adverse Event|1
870640|NCT01401530|2870667|P1|Overall Study|Adverse Event|1
870641|NCT01401530|2870665|P3|Overall Study|Disease Progression|1
870642|NCT01401530|2870666|P2|Overall Study|Disease Progression|2
870643|NCT01401530|2870667|P1|Overall Study|Disease Progression|1
870644|NCT01401478|2870717|P1|Overall Study|Serious adverse event|1
870645|NCT01401478|2870717|P1|Overall Study|Low intact parathyroid hormone|1
870646|NCT01401478|2870717|P1|Overall Study|Hyperphosphatemia and adverse event|1
870647|NCT01401478|2870717|P1|Overall Study|Blood samples not available|1
870648|NCT01401478|2870717|P1|Overall Study|Withdrawal by Subject|3
870649|NCT01401478|2870717|P1|Overall Study|Kidney transplantation|3
870650|NCT01401478|2870717|P1|Overall Study|Lost to Follow-up|5
870651|NCT01401478|2870717|P1|Overall Study|Hyperphosphatemia|5
870652|NCT01401478|2870717|P1|Overall Study|Adverse Event|5
870653|NCT01401478|2870717|P1|Overall Study|Study drug not available|6
870654|NCT01401465|2870730|P2|Treatment Period 2|Withdrawal by Subject|1
870655|NCT01401465|2870731|P1|Treatment Period 2|Withdrawal by Subject|0
870656|NCT01401465|2870730|P2|Treatment Period 2|Lost to Follow-up|1
870657|NCT01401465|2870731|P1|Treatment Period 2|Lost to Follow-up|0
870658|NCT01401465|2870730|P2|Treatment Period 1|Scheduling Difficulties|1
870659|NCT01401465|2870731|P1|Treatment Period 1|Scheduling Difficulties|1
870660|NCT01401465|2870730|P2|Treatment Period 1|Inability to Meet Continuation Criteria|9
870661|NCT01401465|2870731|P1|Treatment Period 1|Inability to Meet Continuation Criteria|3
870662|NCT01401465|2870730|P2|Treatment Period 1|Non-Compliance to Study Drug|0
870663|NCT01401465|2870731|P1|Treatment Period 1|Non-Compliance to Study Drug|1
870664|NCT01401465|2870730|P2|Treatment Period 1|Withdrawal by Subject|4
870665|NCT01401465|2870731|P1|Treatment Period 1|Withdrawal by Subject|1
870666|NCT01401465|2870730|P2|Treatment Period 1|Protocol Violation|0
870667|NCT01401465|2870731|P1|Treatment Period 1|Protocol Violation|5
870668|NCT01401465|2870730|P2|Treatment Period 1|Pregnancy|1
870669|NCT01401465|2870731|P1|Treatment Period 1|Pregnancy|0
870670|NCT01401465|2870730|P2|Treatment Period 1|Adverse Event|1
870671|NCT01401465|2870731|P1|Treatment Period 1|Adverse Event|4
870672|NCT01401452|2870794|P1|Overall Study|Participant withdrew consent|1
870673|NCT01401452|2870794|P1|Overall Study|Subject chose to discontinue treatment|1
870674|NCT01401452|2870794|P1|Overall Study|Subject withdrew because of Tx success|1
870675|NCT01401452|2870794|P1|Overall Study|Unsatisfactory output|1
870676|NCT01401452|2870794|P1|Overall Study|Treatment failure|1
870677|NCT01401452|2870794|P1|Overall Study|Discontinuation for personal reasons|1
870678|NCT01401452|2870794|P1|Overall Study|Participant stopped Tx|2
870679|NCT01401452|2870794|P1|Overall Study|Psoriatic arthritis|1
870680|NCT01401452|2870794|P1|Overall Study|Subject's wife wants to get pregnant|1
870681|NCT01401452|2870794|P1|Overall Study|Subject moved to another city|1
870682|NCT01401452|2870794|P1|Overall Study|Subject didn't return for routine visits|1
870683|NCT01401452|2870794|P1|Overall Study|Subject did not come to follow up visits|2
870684|NCT01401452|2870794|P1|Overall Study|No more visits within the 36 wk followup|4
870685|NCT01401452|2870794|P1|Overall Study|Tx stopped by psychiatrist|1
870686|NCT01401452|2870794|P1|Overall Study|Tx stopped due to financial reasons|1
870687|NCT01401452|2870794|P1|Overall Study|Participant developed breast cancer|1
870688|NCT01401452|2870794|P1|Overall Study|Lack of Efficacy|30
870689|NCT01401452|2870794|P1|Overall Study|Lost to Follow-up|12
870690|NCT01401452|2870794|P1|Overall Study|Adverse reaction|9
870691|NCT01401361|2870806|P1|Overall Study|Subject/family decision post procedure|2
870692|NCT01401361|2870806|P1|Overall Study|Lost to Follow-up|3
870693|NCT01401361|2870806|P1|Overall Study|Physician Decision|1
870694|NCT01401361|2870806|P1|Overall Study|Lack of Efficacy|6
870695|NCT01401361|2870806|P1|Overall Study|Withdrawal by Subject|16
870696|NCT01401322|2870812|P1|Overall Study|Physician Decision|1
870697|NCT01401322|2870812|P1|Overall Study|Withdrawal by Subject|1
870698|NCT01401283|2870818|P2|Overall Study|suspicion of malignant hyperthermia|1
870699|NCT01401283|2870819|P1|Overall Study|suspicion of malignant hyperthermia|0
870700|NCT01401283|2870818|P2|Overall Study|no central venous access|1
870701|NCT01401283|2870819|P1|Overall Study|no central venous access|0
870702|NCT01401283|2870818|P2|Overall Study|preoperative arrhythmia|0
870703|NCT01401283|2870819|P1|Overall Study|preoperative arrhythmia|5
870704|NCT01401283|2870818|P2|Overall Study|surgery cancelled|8
870705|NCT01401283|2870819|P1|Overall Study|surgery cancelled|5
870706|NCT01401153|2870885|P2|Second Test Day|illness|5
870707|NCT01401153|2870886|P1|Second Test Day|illness|0
870708|NCT01401153|2870885|P2|First Test Day|Learning disabilities; illness|10
870709|NCT01401153|2870886|P1|First Test Day|Learning disabilities; illness|1
870710|NCT01401062|2870933|P2|Overall Study|Withdrawal by Subject|1
870711|NCT01401062|2870934|P1|Overall Study|Withdrawal by Subject|1
870712|NCT01401062|2870933|P2|Overall Study|Physician Decision|0
870713|NCT01401062|2870934|P1|Overall Study|Physician Decision|1
870714|NCT01401062|2870933|P2|Overall Study|Death|7
870715|NCT01401062|2870934|P1|Overall Study|Death|9
870716|NCT01401010|2870961|P2|Overall Study|Could not interpret assay results|0
870717|NCT01401010|2870962|P1|Overall Study|Could not interpret assay results|1
870718|NCT01400958|2870987|P2|Overall Study|Adverse Event|0
870719|NCT01400958|2870988|P1|Overall Study|Adverse Event|1
870720|NCT01400958|2870987|P2|Overall Study|Withdrawal by Subject|1
870721|NCT01400958|2870988|P1|Overall Study|Withdrawal by Subject|0
870722|NCT01400958|2870987|P2|Overall Study|Physician Decision|1
870723|NCT01400958|2870988|P1|Overall Study|Physician Decision|0
870724|NCT01400932|2870998|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
870725|NCT01400932|2870999|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
870726|NCT01400932|2870998|P2|Overall Study|Protocol Deviation|1
870727|NCT01400932|2870999|P1|Overall Study|Protocol Deviation|0
870728|NCT01400932|2870998|P2|Overall Study|Lost to Follow-up|0
870729|NCT01400932|2870999|P1|Overall Study|Lost to Follow-up|1
870730|NCT01400932|2870998|P2|Overall Study|Withdrawal by Subject|6
870731|NCT01400932|2870999|P1|Overall Study|Withdrawal by Subject|2
870732|NCT01400932|2870998|P2|Overall Study|Lack of Efficacy|3
870733|NCT01400932|2870999|P1|Overall Study|Lack of Efficacy|0
870734|NCT01400932|2870998|P2|Overall Study|Adverse Event|5
870735|NCT01400932|2870999|P1|Overall Study|Adverse Event|10
870736|NCT01400919|2871021|P1|Overall Study|Missed visit|2
870737|NCT01400919|2871021|P1|Overall Study|Lost to Follow-up|2
870738|NCT01400919|2871021|P1|Overall Study|Withdrawal by Subject|4
870739|NCT01400893|2871064|P2|Overall Study|Lost to Follow-up|6
870740|NCT01400893|2871065|P1|Overall Study|Lost to Follow-up|0
870741|NCT01400893|2871064|P2|Overall Study|Death|21
870742|NCT01400893|2871065|P1|Overall Study|Death|27
870743|NCT01400841|2871077|P1|Extended Study Phase (2 Years)|Adverse Event|2
870744|NCT01400841|2871077|P1|Initial Study Phase (6 Months)|Death|1
870745|NCT01400698|2871115|P6|Overall Study|Other|0
870746|NCT01400698|2871116|P5|Overall Study|Other|1
870747|NCT01400698|2871117|P4|Overall Study|Other|2
870748|NCT01400698|2871118|P3|Overall Study|Other|0
870749|NCT01400698|2871119|P2|Overall Study|Other|2
870750|NCT01400698|2871120|P1|Overall Study|Other|4
870751|NCT01400698|2871115|P6|Overall Study|Adverse Event|0
870752|NCT01400698|2871116|P5|Overall Study|Adverse Event|0
870753|NCT01400698|2871117|P4|Overall Study|Adverse Event|0
870754|NCT01400698|2871118|P3|Overall Study|Adverse Event|0
870755|NCT01400698|2871119|P2|Overall Study|Adverse Event|0
870756|NCT01400698|2871120|P1|Overall Study|Adverse Event|1
870757|NCT01400698|2871115|P6|Overall Study|Non-compliance|0
870758|NCT01400698|2871116|P5|Overall Study|Non-compliance|0
870759|NCT01400698|2871117|P4|Overall Study|Non-compliance|1
870760|NCT01400698|2871118|P3|Overall Study|Non-compliance|0
870761|NCT01400698|2871119|P2|Overall Study|Non-compliance|1
870762|NCT01400698|2871120|P1|Overall Study|Non-compliance|0
870763|NCT01400698|2871115|P6|Overall Study|Protocol Violation|0
870764|NCT01400698|2871116|P5|Overall Study|Protocol Violation|1
870765|NCT01400698|2871117|P4|Overall Study|Protocol Violation|0
870766|NCT01400698|2871118|P3|Overall Study|Protocol Violation|0
870767|NCT01400698|2871119|P2|Overall Study|Protocol Violation|1
870768|NCT01400698|2871120|P1|Overall Study|Protocol Violation|0
870769|NCT01400698|2871115|P6|Overall Study|Withdrawal by Subject|3
870770|NCT01400698|2871116|P5|Overall Study|Withdrawal by Subject|1
870771|NCT01400698|2871117|P4|Overall Study|Withdrawal by Subject|4
870772|NCT01400698|2871118|P3|Overall Study|Withdrawal by Subject|0
870773|NCT01400698|2871119|P2|Overall Study|Withdrawal by Subject|2
870774|NCT01400698|2871120|P1|Overall Study|Withdrawal by Subject|8
870775|NCT01400698|2871115|P6|Overall Study|Lost to Follow-up|3
870776|NCT01400698|2871116|P5|Overall Study|Lost to Follow-up|4
870777|NCT01400698|2871117|P4|Overall Study|Lost to Follow-up|1
870778|NCT01400698|2871118|P3|Overall Study|Lost to Follow-up|2
870779|NCT01400698|2871119|P2|Overall Study|Lost to Follow-up|5
870780|NCT01400698|2871120|P1|Overall Study|Lost to Follow-up|2
870781|NCT01400516|2871144|P2|Primary Trial|Withdrawal by Subject|2
870782|NCT01400516|2871145|P1|Primary Trial|Withdrawal by Subject|0
870783|NCT01400503|2871155|P1|Overall Study|Other|1
870784|NCT01400503|2871155|P1|Overall Study|Study Terminated by Sponsor|58
870785|NCT01400503|2871155|P1|Overall Study|Withdrawal by Subject|1
870786|NCT01400451|2871167|P3|Combination Treatment (or Intended)|Dose-limiting toxicity|0
870787|NCT01400451|2871168|P2|Combination Treatment (or Intended)|Dose-limiting toxicity|1
870788|NCT01400451|2871169|P1|Combination Treatment (or Intended)|Dose-limiting toxicity|0
870789|NCT01400451|2871167|P3|Combination Treatment (or Intended)|Disease Progression|1
870790|NCT01400451|2871168|P2|Combination Treatment (or Intended)|Disease Progression|1
870791|NCT01400451|2871169|P1|Combination Treatment (or Intended)|Disease Progression|3
870792|NCT01400451|2871167|P3|Combination Treatment (or Intended)|Adverse Event|0
870793|NCT01400451|2871168|P2|Combination Treatment (or Intended)|Adverse Event|0
870794|NCT01400451|2871169|P1|Combination Treatment (or Intended)|Adverse Event|1
870795|NCT01400451|2871167|P3|Combination Treatment (or Intended)|Drug Toxicity|0
870796|NCT01400451|2871168|P2|Combination Treatment (or Intended)|Drug Toxicity|1
870797|NCT01400451|2871169|P1|Combination Treatment (or Intended)|Drug Toxicity|0
870798|NCT01400451|2871167|P3|Combination Treatment (or Intended)|Withdrawal by Subject|1
870799|NCT01400451|2871168|P2|Combination Treatment (or Intended)|Withdrawal by Subject|1
870800|NCT01400451|2871169|P1|Combination Treatment (or Intended)|Withdrawal by Subject|2
870801|NCT01400425|2871183|P1|Overall Study|Withdrawal by Subject|10
870802|NCT01400412|2871196|P2|Overall Study|Never started study treatment|3
870803|NCT01400412|2871197|P1|Overall Study|Never started study treatment|0
870804|NCT01400412|2871196|P2|Overall Study|Unable to complete|3
870805|NCT01400412|2871197|P1|Overall Study|Unable to complete|3
870806|NCT01400412|2871196|P2|Overall Study|Withdrawal by Subject|4
870807|NCT01400412|2871197|P1|Overall Study|Withdrawal by Subject|3
870808|NCT01400412|2871196|P2|Overall Study|Lost to Follow-up|7
870809|NCT01400412|2871197|P1|Overall Study|Lost to Follow-up|4
870810|NCT01400243|2871243|P2|Overall Study|Protocol Violation|11
870811|NCT01400243|2871244|P1|Overall Study|Protocol Violation|8
870812|NCT01400139|2871266|P1|HYD Extension Period|Administrative|10
870813|NCT01400139|2871266|P1|HYD Extension Period|Withdrawal by Subject|5
870814|NCT01400139|2871266|P1|HYD Extension Period|Adverse Event|8
870815|NCT01400139|2871266|P1|HYD Core Study|Did not qualify for Maintenance Period|14
870816|NCT01400139|2871266|P1|HYD Core Study|Administrative|56
870817|NCT01400139|2871266|P1|HYD Core Study|Confirmed or suspected diversion|20
870818|NCT01400139|2871266|P1|HYD Core Study|Lost to Follow-up|39
870819|NCT01400139|2871266|P1|HYD Core Study|Withdrawal by Subject|114
870820|NCT01400139|2871266|P1|HYD Core Study|Lack of Efficacy|59
870821|NCT01400139|2871266|P1|HYD Core Study|Adverse Event|210
870822|NCT01400113|2871276|P2|Overall Study|Withdrawal by Subject|1
870823|NCT01400113|2871277|P1|Overall Study|Withdrawal by Subject|1
870824|NCT01399788|2871319|P2|First Intervention Period|Adverse Event|0
870825|NCT01399788|2871320|P1|First Intervention Period|Adverse Event|1
870826|NCT01399723|2871342|P2|Overall Study|Lost to Follow-up|1
870827|NCT01399723|2871343|P1|Overall Study|Lost to Follow-up|0
870828|NCT01399697|2871356|P3|Overall Study|Sponsor Decision|0
870829|NCT01399697|2871357|P2|Overall Study|Sponsor Decision|0
870830|NCT01399697|2871358|P1|Overall Study|Sponsor Decision|1
870831|NCT01399697|2871356|P3|Overall Study|Clinical RA remission|0
870832|NCT01399697|2871357|P2|Overall Study|Clinical RA remission|0
870833|NCT01399697|2871358|P1|Overall Study|Clinical RA remission|1
870834|NCT01399697|2871356|P3|Overall Study|Positive result for hepatitis B|0
870835|NCT01399697|2871357|P2|Overall Study|Positive result for hepatitis B|0
870836|NCT01399697|2871358|P1|Overall Study|Positive result for hepatitis B|1
870837|NCT01399697|2871356|P3|Overall Study|Inclusion Error|0
870838|NCT01399697|2871357|P2|Overall Study|Inclusion Error|0
870839|NCT01399697|2871358|P1|Overall Study|Inclusion Error|2
870840|NCT01399697|2871356|P3|Overall Study|Non-Compliant|0
870841|NCT01399697|2871357|P2|Overall Study|Non-Compliant|0
870842|NCT01399697|2871358|P1|Overall Study|Non-Compliant|1
870843|NCT01399697|2871356|P3|Overall Study|Protocol Violation|0
870844|NCT01399697|2871357|P2|Overall Study|Protocol Violation|0
870845|NCT01399697|2871358|P1|Overall Study|Protocol Violation|2
870846|NCT01399697|2871356|P3|Overall Study|Lack of Efficacy|1
870847|NCT01399697|2871357|P2|Overall Study|Lack of Efficacy|0
870848|NCT01399697|2871358|P1|Overall Study|Lack of Efficacy|9
870849|NCT01399697|2871356|P3|Overall Study|Investigator Decisión|2
870850|NCT01399697|2871357|P2|Overall Study|Investigator Decisión|0
870851|NCT01399697|2871358|P1|Overall Study|Investigator Decisión|1
870852|NCT01399697|2871356|P3|Overall Study|Withdrawal by Subject|0
870853|NCT01399697|2871357|P2|Overall Study|Withdrawal by Subject|0
870854|NCT01399697|2871358|P1|Overall Study|Withdrawal by Subject|8
870855|NCT01399697|2871356|P3|Overall Study|Lost to Follow-up|0
870856|NCT01399697|2871357|P2|Overall Study|Lost to Follow-up|0
870857|NCT01399697|2871358|P1|Overall Study|Lost to Follow-up|2
870858|NCT01399697|2871356|P3|Overall Study|Adverse Event|1
870859|NCT01399697|2871357|P2|Overall Study|Adverse Event|3
870860|NCT01399697|2871358|P1|Overall Study|Adverse Event|13
870861|NCT01399619|2871385|P4|Overall Study|Not treated|2
870862|NCT01399619|2871386|P3|Overall Study|Not treated|0
870863|NCT01399619|2871387|P2|Overall Study|Not treated|0
870864|NCT01399619|2871388|P1|Overall Study|Not treated|0
870865|NCT01399619|2871385|P4|Overall Study|Protocol Violation|1
870866|NCT01399619|2871386|P3|Overall Study|Protocol Violation|0
870867|NCT01399619|2871387|P2|Overall Study|Protocol Violation|0
870868|NCT01399619|2871388|P1|Overall Study|Protocol Violation|0
870869|NCT01399619|2871385|P4|Overall Study|Withdrawal by Subject|4
870870|NCT01399619|2871386|P3|Overall Study|Withdrawal by Subject|3
870871|NCT01399619|2871387|P2|Overall Study|Withdrawal by Subject|0
870872|NCT01399619|2871388|P1|Overall Study|Withdrawal by Subject|6
870873|NCT01399619|2871385|P4|Overall Study|Lack of Efficacy|0
870874|NCT01399619|2871386|P3|Overall Study|Lack of Efficacy|5
870875|NCT01399619|2871387|P2|Overall Study|Lack of Efficacy|0
870876|NCT01399619|2871388|P1|Overall Study|Lack of Efficacy|9
870877|NCT01399619|2871385|P4|Overall Study|Adverse Event|10
870878|NCT01399619|2871386|P3|Overall Study|Adverse Event|4
870879|NCT01399619|2871387|P2|Overall Study|Adverse Event|0
870880|NCT01399619|2871388|P1|Overall Study|Adverse Event|10
870881|NCT01399593|2871451|P2|Overall Study|Transplantectomy|1
870882|NCT01399593|2871452|P1|Overall Study|Transplantectomy|0
870883|NCT01399593|2871451|P2|Overall Study|Death|1
870884|NCT01399593|2871452|P1|Overall Study|Death|1
870885|NCT01399593|2871451|P2|Overall Study|Adverse Event|0
870886|NCT01399593|2871452|P1|Overall Study|Adverse Event|1
870887|NCT01399593|2871451|P2|Overall Study|Physician Decision|0
870888|NCT01399593|2871452|P1|Overall Study|Physician Decision|1
870889|NCT01399190|2871485|P1|Overall Study|Physician Decision|2
870890|NCT01399190|2871485|P1|Overall Study|Participant's Request|5
870891|NCT01399190|2871485|P1|Overall Study|Adverse Event|8
870892|NCT01399190|2871485|P1|Overall Study|Not Eligible for Final Analysis|5
870893|NCT01399125|2871493|P2|Overall Study|Protocol Deviation|2
870894|NCT01399125|2871494|P1|Overall Study|Protocol Deviation|5
870895|NCT01399125|2871493|P2|Overall Study|Death|1
870896|NCT01399125|2871494|P1|Overall Study|Death|0
870897|NCT01399125|2871493|P2|Overall Study|Administrative Problems|11
870898|NCT01399125|2871494|P1|Overall Study|Administrative Problems|7
870899|NCT01399125|2871493|P2|Overall Study|Lost to Follow-up|3
870900|NCT01399125|2871494|P1|Overall Study|Lost to Follow-up|2
870901|NCT01399125|2871493|P2|Overall Study|Withdrawal by Subject|8
870902|NCT01399125|2871494|P1|Overall Study|Withdrawal by Subject|5
870903|NCT01399125|2871493|P2|Overall Study|Unsatisfactory Therapeutic Effect|4
870904|NCT01399125|2871494|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
870905|NCT01399125|2871493|P2|Overall Study|Abnormal Lab values|1
870906|NCT01399125|2871494|P1|Overall Study|Abnormal Lab values|0
870907|NCT01399125|2871493|P2|Overall Study|Adverse Event|30
870908|NCT01399125|2871494|P1|Overall Study|Adverse Event|32
870909|NCT01399099|2871508|P1|Overall Study|Miscellaneous|4
870910|NCT01399099|2871508|P1|Overall Study|Infection|1
870911|NCT01399099|2871508|P1|Overall Study|Skin Irritation|13
870912|NCT01399099|2871508|P1|Overall Study|Protocol Violation|1
870913|NCT01399099|2871508|P1|Overall Study|Physician Decision|1
870914|NCT01399099|2871508|P1|Overall Study|Lost to Follow-up|11
870915|NCT01399047|2871515|P2|Overall Study|Withdrawal by Subject|1
870916|NCT01399047|2871516|P1|Overall Study|Withdrawal by Subject|0
870917|NCT01398956|2871544|P1|Overall Study|Subject moved a long distance|1
870918|NCT01398956|2871544|P1|Overall Study|Withdrawal Criteria No.3|1
870919|NCT01398956|2871544|P1|Overall Study|AE, non-serious non-fatal|4
870920|NCT01398956|2871544|P1|Overall Study|Withdrawal by Subject|4
870921|NCT01398787|2871576|P1|Overall Study|Adverse Event|1
870922|NCT01398514|2871594|P2|Overall Study|Failure to show a conditioned response|3
870923|NCT01398514|2871595|P1|Overall Study|Failure to show a conditioned response|4
870924|NCT01398514|2871594|P2|Overall Study|Physiologic non-responsiveness|3
870925|NCT01398514|2871595|P1|Overall Study|Physiologic non-responsiveness|1
870926|NCT01398514|2871594|P2|Overall Study|Non-compliance with study procedures|0
870927|NCT01398514|2871595|P1|Overall Study|Non-compliance with study procedures|2
870928|NCT01398514|2871594|P2|Overall Study|Adverse Event|0
870929|NCT01398514|2871595|P1|Overall Study|Adverse Event|1
870930|NCT01398410|2871630|P2|Overall Study|Not Specified|29
870931|NCT01398410|2871631|P1|Overall Study|Not Specified|36
870932|NCT01398410|2871630|P2|Overall Study|Inadequate Therapeutic Effect|0
870933|NCT01398410|2871631|P1|Overall Study|Inadequate Therapeutic Effect|2
870934|NCT01398410|2871630|P2|Overall Study|Participants Choice|11
870935|NCT01398410|2871631|P1|Overall Study|Participants Choice|8
870936|NCT01398410|2871630|P2|Overall Study|Adverse Event|16
870937|NCT01398410|2871631|P1|Overall Study|Adverse Event|12
870938|NCT01398358|2871642|P3|Overall Study|no longer eligible|1
870939|NCT01398358|2871643|P2|Overall Study|no longer eligible|0
870940|NCT01398358|2871644|P1|Overall Study|no longer eligible|1
870941|NCT01398358|2871642|P3|Overall Study|Withdrawal by Subject|2
870942|NCT01398358|2871643|P2|Overall Study|Withdrawal by Subject|2
870943|NCT01398358|2871644|P1|Overall Study|Withdrawal by Subject|3
870944|NCT01398358|2871642|P3|Overall Study|Lost to Follow-up|18
870945|NCT01398358|2871643|P2|Overall Study|Lost to Follow-up|21
870946|NCT01398358|2871644|P1|Overall Study|Lost to Follow-up|11
870947|NCT01398176|2871657|P2|Overall Study|Physician Decision|3
870948|NCT01398176|2871658|P1|Overall Study|Physician Decision|2
870949|NCT01398176|2871657|P2|Overall Study|Lost to Follow-up|3
870950|NCT01398176|2871658|P1|Overall Study|Lost to Follow-up|1
870951|NCT01397890|2871666|P2|Overall Study|Others|1
870952|NCT01397890|2871667|P1|Overall Study|Others|2
870953|NCT01397890|2871666|P2|Overall Study|Severe Non-Compliance to Protocol|1
870954|NCT01397890|2871667|P1|Overall Study|Severe Non-Compliance to Protocol|2
870955|NCT01397890|2871666|P2|Overall Study|Adverse Event|2
870956|NCT01397890|2871667|P1|Overall Study|Adverse Event|1
870957|NCT01397890|2871666|P2|Overall Study|Condition under Investigation Worsened|3
870958|NCT01397890|2871667|P1|Overall Study|Condition under Investigation Worsened|1
870959|NCT01397890|2871666|P2|Overall Study|Lost to Follow-up|4
870960|NCT01397890|2871667|P1|Overall Study|Lost to Follow-up|1
870961|NCT01397890|2871666|P2|Overall Study|Death|3
870962|NCT01397890|2871667|P1|Overall Study|Death|2
870963|NCT01397890|2871666|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
870964|NCT01397890|2871667|P1|Overall Study|Eligibility Criteria Not Fulfilled|7
870965|NCT01397890|2871666|P2|Overall Study|Withdrawal by Subject|11
870966|NCT01397890|2871667|P1|Overall Study|Withdrawal by Subject|7
870967|NCT01397825|2871738|P5|Overall Study|Withdrawal by Subject|0
870968|NCT01397825|2871739|P4|Overall Study|Withdrawal by Subject|1
870969|NCT01397825|2871740|P3|Overall Study|Withdrawal by Subject|5
870970|NCT01397825|2871741|P2|Overall Study|Withdrawal by Subject|0
870971|NCT01397825|2871742|P1|Overall Study|Withdrawal by Subject|1
870972|NCT01397825|2871738|P5|Overall Study|Adverse Event|0
870973|NCT01397825|2871739|P4|Overall Study|Adverse Event|1
870974|NCT01397825|2871740|P3|Overall Study|Adverse Event|5
870975|NCT01397825|2871741|P2|Overall Study|Adverse Event|1
870976|NCT01397825|2871742|P1|Overall Study|Adverse Event|0
870977|NCT01397825|2871738|P5|Overall Study|Symptomatic Deterioration|0
870978|NCT01397825|2871739|P4|Overall Study|Symptomatic Deterioration|0
870979|NCT01397825|2871740|P3|Overall Study|Symptomatic Deterioration|4
870980|NCT01397825|2871741|P2|Overall Study|Symptomatic Deterioration|0
870981|NCT01397825|2871742|P1|Overall Study|Symptomatic Deterioration|2
870982|NCT01397825|2871738|P5|Overall Study|Progressive Disease|0
870983|NCT01397825|2871739|P4|Overall Study|Progressive Disease|1
870984|NCT01397825|2871740|P3|Overall Study|Progressive Disease|11
870985|NCT01397825|2871741|P2|Overall Study|Progressive Disease|3
870986|NCT01397825|2871742|P1|Overall Study|Progressive Disease|10
870987|NCT01397786|2871812|P3|Phase B|Lack of Efficacy|14
870988|NCT01397786|2871813|P2|Phase B|Lack of Efficacy|7
870989|NCT01397786|2871814|P1|Phase B|Lack of Efficacy|22
870990|NCT01397786|2871812|P3|Phase B|Protocol Deviation|4
870991|NCT01397786|2871813|P2|Phase B|Protocol Deviation|2
870992|NCT01397786|2871814|P1|Phase B|Protocol Deviation|1
870993|NCT01397786|2871812|P3|Phase B|Withdrawal by Subject|30
870994|NCT01397786|2871813|P2|Phase B|Withdrawal by Subject|45
870995|NCT01397786|2871814|P1|Phase B|Withdrawal by Subject|102
870996|NCT01397786|2871812|P3|Phase B|Physician Decision|3
870997|NCT01397786|2871813|P2|Phase B|Physician Decision|1
870998|NCT01397786|2871814|P1|Phase B|Physician Decision|9
870999|NCT01397786|2871812|P3|Phase B|Subject Met Withdrawal Criteria|38
871000|NCT01397786|2871813|P2|Phase B|Subject Met Withdrawal Criteria|5
871001|NCT01397786|2871814|P1|Phase B|Subject Met Withdrawal Criteria|38
871002|NCT01397786|2871812|P3|Phase B|Adverse Event|27
871003|NCT01397786|2871813|P2|Phase B|Adverse Event|23
871004|NCT01397786|2871814|P1|Phase B|Adverse Event|109
871005|NCT01397786|2871812|P3|Phase B|Lost to Follow-up|22
871006|NCT01397786|2871813|P2|Phase B|Lost to Follow-up|12
871007|NCT01397786|2871814|P1|Phase B|Lost to Follow-up|22
871008|NCT01397786|2871812|P3|Phase A|Lack of Efficacy|1
871009|NCT01397786|2871813|P2|Phase A|Lack of Efficacy|0
871010|NCT01397786|2871814|P1|Phase A|Lack of Efficacy|0
871011|NCT01397786|2871812|P3|Phase A|Withdrawal by Subject|5
871012|NCT01397786|2871813|P2|Phase A|Withdrawal by Subject|0
871013|NCT01397786|2871814|P1|Phase A|Withdrawal by Subject|0
871014|NCT01397786|2871812|P3|Phase A|Physician Decision|1
871015|NCT01397786|2871813|P2|Phase A|Physician Decision|0
871016|NCT01397786|2871814|P1|Phase A|Physician Decision|0
871017|NCT01397786|2871812|P3|Phase A|Subject Met Withdrawal Criteria|7
871018|NCT01397786|2871813|P2|Phase A|Subject Met Withdrawal Criteria|0
871019|NCT01397786|2871814|P1|Phase A|Subject Met Withdrawal Criteria|0
871020|NCT01397786|2871812|P3|Phase A|Adverse Event|8
871021|NCT01397786|2871813|P2|Phase A|Adverse Event|0
871022|NCT01397786|2871814|P1|Phase A|Adverse Event|0
871023|NCT01397786|2871812|P3|Phase A|Lost to Follow-up|6
871024|NCT01397786|2871813|P2|Phase A|Lost to Follow-up|0
871025|NCT01397786|2871814|P1|Phase A|Lost to Follow-up|0
871026|NCT01397747|2871880|P1|Overall Study|FIT excluded|34
871027|NCT01397747|2871880|P1|Overall Study|Colonoscopy excluded|304
871028|NCT01397747|2871880|P1|Overall Study|Multitarget DNA test excluded|689
871029|NCT01397461|2871927|P3|Overall Study|Not treated|1
871030|NCT01397461|2871928|P2|Overall Study|Not treated|0
871031|NCT01397461|2871929|P1|Overall Study|Not treated|0
871032|NCT01397461|2871927|P3|Overall Study|Lack of Efficacy|0
871033|NCT01397461|2871928|P2|Overall Study|Lack of Efficacy|3
871034|NCT01397461|2871929|P1|Overall Study|Lack of Efficacy|0
871035|NCT01397461|2871927|P3|Overall Study|Lost to Follow-up|1
871036|NCT01397461|2871928|P2|Overall Study|Lost to Follow-up|2
871037|NCT01397461|2871929|P1|Overall Study|Lost to Follow-up|0
871038|NCT01397461|2871927|P3|Overall Study|Withdrawal by Subject|0
871039|NCT01397461|2871928|P2|Overall Study|Withdrawal by Subject|1
871040|NCT01397461|2871929|P1|Overall Study|Withdrawal by Subject|2
871041|NCT01397448|2871940|P3|Overall Study|Not specified|4
871042|NCT01397448|2871941|P2|Overall Study|Not specified|7
871043|NCT01397448|2871942|P1|Overall Study|Not specified|8
871044|NCT01397448|2871940|P3|Overall Study|Lack of Efficacy|5
871045|NCT01397448|2871941|P2|Overall Study|Lack of Efficacy|0
871046|NCT01397448|2871942|P1|Overall Study|Lack of Efficacy|2
871047|NCT01397448|2871940|P3|Overall Study|Withdrawal by Subject|3
871048|NCT01397448|2871941|P2|Overall Study|Withdrawal by Subject|4
871049|NCT01397448|2871942|P1|Overall Study|Withdrawal by Subject|4
871050|NCT01397448|2871940|P3|Overall Study|Adverse Event|6
871051|NCT01397448|2871941|P2|Overall Study|Adverse Event|4
871052|NCT01397448|2871942|P1|Overall Study|Adverse Event|4
871053|NCT01397422|2871957|P4|Overall Study|Increased bradykinesia related to PD|0
871054|NCT01397422|2871958|P3|Overall Study|Increased bradykinesia related to PD|0
871055|NCT01397422|2871959|P2|Overall Study|Increased bradykinesia related to PD|0
871056|NCT01397422|2871960|P1|Overall Study|Increased bradykinesia related to PD|1
871057|NCT01397422|2871957|P4|Overall Study|Withdrawal by Subject|0
871058|NCT01397422|2871958|P3|Overall Study|Withdrawal by Subject|0
871059|NCT01397422|2871959|P2|Overall Study|Withdrawal by Subject|0
871060|NCT01397422|2871960|P1|Overall Study|Withdrawal by Subject|1
871061|NCT01397422|2871957|P4|Overall Study|Adverse Event|8
871062|NCT01397422|2871958|P3|Overall Study|Adverse Event|3
871063|NCT01397422|2871959|P2|Overall Study|Adverse Event|3
871064|NCT01397422|2871960|P1|Overall Study|Adverse Event|0
871065|NCT01397409|2872000|P10|Stage 3|Other Miscellaneous Reasons|0
871066|NCT01397409|2872001|P9|Stage 3|Other Miscellaneous Reasons|0
871067|NCT01397409|2872002|P8|Stage 3|Other Miscellaneous Reasons|1
871068|NCT01397409|2872003|P7|Stage 3|Other Miscellaneous Reasons|0
871069|NCT01397409|2872004|P6|Stage 3|Other Miscellaneous Reasons|0
871070|NCT01397409|2872005|P5|Stage 3|Other Miscellaneous Reasons|0
871071|NCT01397409|2872006|P4|Stage 3|Other Miscellaneous Reasons|0
871072|NCT01397409|2872007|P3|Stage 3|Other Miscellaneous Reasons|0
871073|NCT01397409|2872008|P2|Stage 3|Other Miscellaneous Reasons|0
871074|NCT01397409|2872009|P1|Stage 3|Other Miscellaneous Reasons|0
871075|NCT01397409|2872000|P10|Stage 3|Adverse Event|0
871076|NCT01397409|2872001|P9|Stage 3|Adverse Event|0
871077|NCT01397409|2872002|P8|Stage 3|Adverse Event|1
871078|NCT01397409|2872003|P7|Stage 3|Adverse Event|0
871079|NCT01397409|2872004|P6|Stage 3|Adverse Event|0
871080|NCT01397409|2872005|P5|Stage 3|Adverse Event|0
871081|NCT01397409|2872006|P4|Stage 3|Adverse Event|0
871082|NCT01397409|2872007|P3|Stage 3|Adverse Event|0
871083|NCT01397409|2872008|P2|Stage 3|Adverse Event|0
871084|NCT01397409|2872009|P1|Stage 3|Adverse Event|0
871085|NCT01397409|2872000|P10|Stage 2|Other Miscellaneous Reasons|0
871086|NCT01397409|2872001|P9|Stage 2|Other Miscellaneous Reasons|0
871087|NCT01397409|2872002|P8|Stage 2|Other Miscellaneous Reasons|0
871088|NCT01397409|2872003|P7|Stage 2|Other Miscellaneous Reasons|0
871089|NCT01397409|2872004|P6|Stage 2|Other Miscellaneous Reasons|1
871090|NCT01397409|2872005|P5|Stage 2|Other Miscellaneous Reasons|1
871091|NCT01397409|2872006|P4|Stage 2|Other Miscellaneous Reasons|0
871092|NCT01397409|2872007|P3|Stage 2|Other Miscellaneous Reasons|0
871093|NCT01397409|2872008|P2|Stage 2|Other Miscellaneous Reasons|0
871094|NCT01397409|2872009|P1|Stage 2|Other Miscellaneous Reasons|0
871095|NCT01397409|2872000|P10|Stage 2|Personal Reasons|0
871096|NCT01397409|2872001|P9|Stage 2|Personal Reasons|0
871097|NCT01397409|2872002|P8|Stage 2|Personal Reasons|0
871098|NCT01397409|2872003|P7|Stage 2|Personal Reasons|0
871099|NCT01397409|2872004|P6|Stage 2|Personal Reasons|0
871100|NCT01397409|2872005|P5|Stage 2|Personal Reasons|1
871101|NCT01397409|2872006|P4|Stage 2|Personal Reasons|0
871102|NCT01397409|2872007|P3|Stage 2|Personal Reasons|0
871103|NCT01397409|2872008|P2|Stage 2|Personal Reasons|0
871104|NCT01397409|2872009|P1|Stage 2|Personal Reasons|0
871105|NCT01397409|2872000|P10|Stage 2|Adverse Event|0
871106|NCT01397409|2872001|P9|Stage 2|Adverse Event|0
871107|NCT01397409|2872002|P8|Stage 2|Adverse Event|0
871108|NCT01397409|2872003|P7|Stage 2|Adverse Event|0
871109|NCT01397409|2872004|P6|Stage 2|Adverse Event|3
871110|NCT01397409|2872005|P5|Stage 2|Adverse Event|6
871111|NCT01397409|2872006|P4|Stage 2|Adverse Event|0
871112|NCT01397409|2872007|P3|Stage 2|Adverse Event|0
871113|NCT01397409|2872008|P2|Stage 2|Adverse Event|0
871114|NCT01397409|2872009|P1|Stage 2|Adverse Event|0
871115|NCT01397253|2872049|P2|Overall Study|Reviewed by only 1 pharmacist|149
871116|NCT01397253|2872050|P1|Overall Study|Reviewed by only 1 pharmacist|126
871117|NCT01397084|2872056|P1|Overall Study|Used other proton pump inhibitor|1
871118|NCT01397084|2872056|P1|Overall Study|Lost to Follow-up|1
871119|NCT01397084|2872056|P1|Overall Study|Withdrawal by Subject|1
871120|NCT01397084|2872056|P1|Overall Study|Adverse Event|2
871121|NCT01397084|2872056|P1|Overall Study|Protocol Violation|2
871122|NCT01397084|2872056|P1|Overall Study|Severe Non-Compliance to Protocol|1
871123|NCT01396525|2872063|P1|Overall Study|Lost to Follow-up|4
871124|NCT01396525|2872063|P1|Overall Study|Death|14
871125|NCT01396525|2872063|P1|Overall Study|Withdrawal by Subject|8
871126|NCT01396512|2872163|P2|Overall Study|Withdrawal by Subject|1
871127|NCT01396512|2872164|P1|Overall Study|Withdrawal by Subject|0
871128|NCT01396447|2872180|P4|Overall Study|Other Miscellaneous Reasons|0
871129|NCT01396447|2872181|P3|Overall Study|Other Miscellaneous Reasons|1
871130|NCT01396447|2872182|P2|Overall Study|Other Miscellaneous Reasons|2
871131|NCT01396447|2872183|P1|Overall Study|Other Miscellaneous Reasons|0
871132|NCT01396447|2872180|P4|Overall Study|Lost to Follow-up|9
871133|NCT01396447|2872181|P3|Overall Study|Lost to Follow-up|7
871134|NCT01396447|2872182|P2|Overall Study|Lost to Follow-up|8
871135|NCT01396447|2872183|P1|Overall Study|Lost to Follow-up|4
871136|NCT01396447|2872180|P4|Overall Study|Withdrawal of Consent|15
871137|NCT01396447|2872181|P3|Overall Study|Withdrawal of Consent|4
871138|NCT01396447|2872182|P2|Overall Study|Withdrawal of Consent|9
871139|NCT01396447|2872183|P1|Overall Study|Withdrawal of Consent|11
871140|NCT01396447|2872180|P4|Overall Study|Protocol Violation|7
871141|NCT01396447|2872181|P3|Overall Study|Protocol Violation|3
871142|NCT01396447|2872182|P2|Overall Study|Protocol Violation|2
871143|NCT01396447|2872183|P1|Overall Study|Protocol Violation|5
871144|NCT01396447|2872180|P4|Overall Study|Insufficient Therapeutic Response|4
871145|NCT01396447|2872181|P3|Overall Study|Insufficient Therapeutic Response|2
871146|NCT01396447|2872182|P2|Overall Study|Insufficient Therapeutic Response|5
871147|NCT01396447|2872183|P1|Overall Study|Insufficient Therapeutic Response|5
871148|NCT01396447|2872180|P4|Overall Study|Adverse Event|17
871149|NCT01396447|2872181|P3|Overall Study|Adverse Event|12
871150|NCT01396447|2872182|P2|Overall Study|Adverse Event|12
871151|NCT01396447|2872183|P1|Overall Study|Adverse Event|15
871152|NCT01396447|2872180|P4|Overall Study|Did Not Receive Treatment|0
871153|NCT01396447|2872181|P3|Overall Study|Did Not Receive Treatment|1
871154|NCT01396447|2872182|P2|Overall Study|Did Not Receive Treatment|2
871155|NCT01396447|2872183|P1|Overall Study|Did Not Receive Treatment|3
871156|NCT01396434|2872200|P3|Overall Study|Other|0
871157|NCT01396434|2872201|P2|Overall Study|Other|0
871158|NCT01396434|2872202|P1|Overall Study|Other|10
871159|NCT01396434|2872200|P3|Overall Study|Lost to Follow-up|0
871160|NCT01396434|2872201|P2|Overall Study|Lost to Follow-up|0
871161|NCT01396434|2872202|P1|Overall Study|Lost to Follow-up|1
871162|NCT01396421|2872214|P4|Overall Study|Lack of Efficacy|18
871163|NCT01396421|2872215|P3|Overall Study|Lack of Efficacy|7
871164|NCT01396421|2872216|P2|Overall Study|Lack of Efficacy|17
871165|NCT01396421|2872217|P1|Overall Study|Lack of Efficacy|7
871166|NCT01396421|2872214|P4|Overall Study|Protocol Deviation|0
871167|NCT01396421|2872215|P3|Overall Study|Protocol Deviation|1
871168|NCT01396421|2872216|P2|Overall Study|Protocol Deviation|1
871169|NCT01396421|2872217|P1|Overall Study|Protocol Deviation|2
871170|NCT01396421|2872214|P4|Overall Study|Withdrawal by Subject|21
871171|NCT01396421|2872215|P3|Overall Study|Withdrawal by Subject|13
871172|NCT01396421|2872216|P2|Overall Study|Withdrawal by Subject|24
871173|NCT01396421|2872217|P1|Overall Study|Withdrawal by Subject|31
871174|NCT01396421|2872214|P4|Overall Study|Physician Decision|3
871175|NCT01396421|2872215|P3|Overall Study|Physician Decision|0
871176|NCT01396421|2872216|P2|Overall Study|Physician Decision|1
871177|NCT01396421|2872217|P1|Overall Study|Physician Decision|1
871178|NCT01396421|2872214|P4|Overall Study|Participant Met Withdrawal Criteria|0
871179|NCT01396421|2872215|P3|Overall Study|Participant Met Withdrawal Criteria|1
871180|NCT01396421|2872216|P2|Overall Study|Participant Met Withdrawal Criteria|0
871181|NCT01396421|2872217|P1|Overall Study|Participant Met Withdrawal Criteria|1
871182|NCT01396421|2872214|P4|Overall Study|Adverse Event|32
871183|NCT01396421|2872215|P3|Overall Study|Adverse Event|12
871184|NCT01396421|2872216|P2|Overall Study|Adverse Event|15
871185|NCT01396421|2872217|P1|Overall Study|Adverse Event|17
871186|NCT01396421|2872214|P4|Overall Study|Lost to Follow-up|1
871187|NCT01396421|2872215|P3|Overall Study|Lost to Follow-up|0
871188|NCT01396421|2872216|P2|Overall Study|Lost to Follow-up|0
871189|NCT01396421|2872217|P1|Overall Study|Lost to Follow-up|0
871190|NCT01396395|2872289|P2|Overall Study|Other|1
871191|NCT01396395|2872290|P1|Overall Study|Other|0
871192|NCT01396395|2872289|P2|Overall Study|Lost to Follow-up|11
871193|NCT01396395|2872290|P1|Overall Study|Lost to Follow-up|17
871194|NCT01396395|2872289|P2|Overall Study|Adverse Event|2
871195|NCT01396395|2872290|P1|Overall Study|Adverse Event|10
871196|NCT01396395|2872289|P2|Overall Study|Protocol Violation|1
871197|NCT01396395|2872290|P1|Overall Study|Protocol Violation|3
871198|NCT01396395|2872289|P2|Overall Study|Withdrawal by Subject|12
871199|NCT01396395|2872290|P1|Overall Study|Withdrawal by Subject|10
871200|NCT01396317|2872332|P2|Overall Study|Adverse Event|0
871201|NCT01396317|2872333|P1|Overall Study|Adverse Event|1
871202|NCT01396265|2872347|P1|Rifa+Afatinib|Withdrawal by Subject|1
871203|NCT01396187|2872436|P5|Overall Study|Other|1
871204|NCT01396187|2872437|P4|Overall Study|Other|0
871205|NCT01396187|2872438|P3|Overall Study|Other|0
871206|NCT01396187|2872439|P2|Overall Study|Other|1
871207|NCT01396187|2872440|P1|Overall Study|Other|1
871208|NCT01396187|2872436|P5|Overall Study|Withdrawal by Subject|0
871209|NCT01396187|2872437|P4|Overall Study|Withdrawal by Subject|0
871210|NCT01396187|2872438|P3|Overall Study|Withdrawal by Subject|1
871211|NCT01396187|2872439|P2|Overall Study|Withdrawal by Subject|1
871212|NCT01396187|2872440|P1|Overall Study|Withdrawal by Subject|0
871213|NCT01396187|2872436|P5|Overall Study|Adverse Event|0
871214|NCT01396187|2872437|P4|Overall Study|Adverse Event|0
871215|NCT01396187|2872438|P3|Overall Study|Adverse Event|0
871216|NCT01396187|2872439|P2|Overall Study|Adverse Event|1
871217|NCT01396187|2872440|P1|Overall Study|Adverse Event|0
871218|NCT01396161|2872540|P7|Overall Study|Other|1
871219|NCT01396161|2872541|P6|Overall Study|Other|0
871220|NCT01396161|2872542|P5|Overall Study|Other|0
871221|NCT01396161|2872543|P4|Overall Study|Other|0
871222|NCT01396161|2872544|P3|Overall Study|Other|0
871223|NCT01396161|2872545|P2|Overall Study|Other|0
871224|NCT01396161|2872546|P1|Overall Study|Other|0
871225|NCT01396161|2872540|P7|Overall Study|Withdrawal by Subject|0
871226|NCT01396161|2872541|P6|Overall Study|Withdrawal by Subject|0
871227|NCT01396161|2872542|P5|Overall Study|Withdrawal by Subject|1
871228|NCT01396161|2872543|P4|Overall Study|Withdrawal by Subject|0
871229|NCT01396161|2872544|P3|Overall Study|Withdrawal by Subject|0
871230|NCT01396161|2872545|P2|Overall Study|Withdrawal by Subject|0
871231|NCT01396161|2872546|P1|Overall Study|Withdrawal by Subject|0
871232|NCT01396148|2872599|P1|Overall Study|Patient Decision|1
871233|NCT01396083|2872626|P2|Overall Study|Lost to Follow-up|0
871234|NCT01396083|2872627|P1|Overall Study|Lost to Follow-up|1
871235|NCT01396083|2872626|P2|Overall Study|Administrative problems|0
871236|NCT01396083|2872627|P1|Overall Study|Administrative problems|1
871237|NCT01396083|2872626|P2|Overall Study|Abnormal laboratory value(s)|0
871238|NCT01396083|2872627|P1|Overall Study|Abnormal laboratory value(s)|1
871239|NCT01396083|2872626|P2|Overall Study|Protocol deviation(s)|1
871240|NCT01396083|2872627|P1|Overall Study|Protocol deviation(s)|0
871241|NCT01396083|2872626|P2|Overall Study|Consent withdrawn|5
871242|NCT01396083|2872627|P1|Overall Study|Consent withdrawn|4
871243|NCT01396083|2872626|P2|Overall Study|Unsatisfactory therapeutic effect|13
871244|NCT01396083|2872627|P1|Overall Study|Unsatisfactory therapeutic effect|2
871245|NCT01396083|2872626|P2|Overall Study|Adverse Event|28
871246|NCT01396083|2872627|P1|Overall Study|Adverse Event|2
871247|NCT01396070|2872651|P1|Overall Study|Lack of Efficacy|4
871248|NCT01396070|2872651|P1|Overall Study|Physician Decision|3
871249|NCT01396070|2872651|P1|Overall Study|Adverse Event|8
871250|NCT01396070|2872651|P1|Overall Study|Death|2
871251|NCT01396070|2872651|P1|Overall Study|Withdrawal by Subject|2
871252|NCT01396057|2872660|P2|Overall Study|Consent withdrawn|2
871253|NCT01396057|2872661|P1|Overall Study|Consent withdrawn|3
871254|NCT01396057|2872660|P2|Overall Study|Protocol deviation|4
871255|NCT01396057|2872661|P1|Overall Study|Protocol deviation|4
871256|NCT01396057|2872660|P2|Overall Study|Unsatisfactory therapeutic effect|6
871257|NCT01396057|2872661|P1|Overall Study|Unsatisfactory therapeutic effect|2
871258|NCT01396057|2872660|P2|Overall Study|Adverse Event|6
871259|NCT01396057|2872661|P1|Overall Study|Adverse Event|2
871260|NCT01396005|2872710|P2|Overall Study|Non-compliance with protocol|1
871261|NCT01396005|2872711|P1|Overall Study|Non-compliance with protocol|0
871262|NCT01396005|2872710|P2|Overall Study|Withdrawal by Subject|1
871263|NCT01396005|2872711|P1|Overall Study|Withdrawal by Subject|0
871264|NCT01395914|2872742|P2|Overall Study|Lost to Follow-up|2
871265|NCT01395914|2872743|P1|Overall Study|Lost to Follow-up|6
871266|NCT01395914|2872742|P2|Overall Study|Study drug-related AE|0
871267|NCT01395914|2872743|P1|Overall Study|Study drug-related AE|1
871268|NCT01395914|2872742|P2|Overall Study|Withdrawal by patient|14
871269|NCT01395914|2872743|P1|Overall Study|Withdrawal by patient|27
871270|NCT01395914|2872742|P2|Overall Study|Other|3
871271|NCT01395914|2872743|P1|Overall Study|Other|9
871272|NCT01395914|2872742|P2|Overall Study|Death|17
871273|NCT01395914|2872743|P1|Overall Study|Death|23
871274|NCT01395914|2872742|P2|Overall Study|Unrelated to study drug AE|1
871275|NCT01395914|2872743|P1|Overall Study|Unrelated to study drug AE|6
871276|NCT01395901|2872757|P2|Overall Study|Withdrawal of consent|0
871277|NCT01395901|2872758|P1|Overall Study|Withdrawal of consent|1
871278|NCT01395901|2872757|P2|Overall Study|Adverse Event|1
871279|NCT01395901|2872758|P1|Overall Study|Adverse Event|0
871280|NCT01395901|2872757|P2|Overall Study|Randomized but not received study drug|4
871281|NCT01395901|2872758|P1|Overall Study|Randomized but not received study drug|5
871282|NCT01395901|2872757|P2|Overall Study|Lost to Follow-up|0
871283|NCT01395901|2872758|P1|Overall Study|Lost to Follow-up|4
871284|NCT01395888|2872774|P3|Treatment Period (TP)|Withdrawal by Subject|3
871285|NCT01395888|2872775|P2|Treatment Period (TP)|Withdrawal by Subject|2
871286|NCT01395888|2872776|P1|Treatment Period (TP)|Withdrawal by Subject|0
871287|NCT01395888|2872774|P3|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
871288|NCT01395888|2872775|P2|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1
871289|NCT01395888|2872776|P1|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
871290|NCT01395888|2872774|P3|Treatment Period (TP)|Protocol Violation|5
871291|NCT01395888|2872775|P2|Treatment Period (TP)|Protocol Violation|1
871292|NCT01395888|2872776|P1|Treatment Period (TP)|Protocol Violation|0
871293|NCT01395888|2872774|P3|Treatment Period (TP)|Lack of Efficacy|3
871294|NCT01395888|2872775|P2|Treatment Period (TP)|Lack of Efficacy|4
871295|NCT01395888|2872776|P1|Treatment Period (TP)|Lack of Efficacy|0
871296|NCT01395888|2872774|P3|Treatment Period (TP)|Adverse Event|6
871297|NCT01395888|2872775|P2|Treatment Period (TP)|Adverse Event|7
871298|NCT01395888|2872776|P1|Treatment Period (TP)|Adverse Event|0
871299|NCT01395888|2872774|P3|2-week Run-in Period|Withdrawal by Subject|0
871300|NCT01395888|2872775|P2|2-week Run-in Period|Withdrawal by Subject|0
871301|NCT01395888|2872776|P1|2-week Run-in Period|Withdrawal by Subject|4
871302|NCT01395888|2872774|P3|2-week Run-in Period|Protocol Violation|0
871303|NCT01395888|2872775|P2|2-week Run-in Period|Protocol Violation|0
871304|NCT01395888|2872776|P1|2-week Run-in Period|Protocol Violation|2
871305|NCT01395888|2872774|P3|2-week Run-in Period|Lost to Follow-up|0
871306|NCT01395888|2872775|P2|2-week Run-in Period|Lost to Follow-up|0
871307|NCT01395888|2872776|P1|2-week Run-in Period|Lost to Follow-up|1
871308|NCT01395888|2872774|P3|2-week Run-in Period|Continuation Criteria Not Met|0
871309|NCT01395888|2872775|P2|2-week Run-in Period|Continuation Criteria Not Met|0
871310|NCT01395888|2872776|P1|2-week Run-in Period|Continuation Criteria Not Met|13
871311|NCT01395888|2872774|P3|2-week Run-in Period|Adverse Event|0
871312|NCT01395888|2872775|P2|2-week Run-in Period|Adverse Event|0
871313|NCT01395888|2872776|P1|2-week Run-in Period|Adverse Event|2
871314|NCT01395823|2872784|P2|Overall Study|Withdrawal by Subject|4
871315|NCT01395823|2872785|P1|Overall Study|Withdrawal by Subject|5
871316|NCT01395823|2872784|P2|Overall Study|GI symptoms|0
871317|NCT01395823|2872785|P1|Overall Study|GI symptoms|1
871318|NCT01395823|2872784|P2|Overall Study|Transplant|0
871319|NCT01395823|2872785|P1|Overall Study|Transplant|1
871320|NCT01395823|2872784|P2|Overall Study|Lost to Follow-up|0
871321|NCT01395823|2872785|P1|Overall Study|Lost to Follow-up|1
871322|NCT01395823|2872784|P2|Overall Study|Physician Decision|1
871323|NCT01395823|2872785|P1|Overall Study|Physician Decision|3
871324|NCT01395823|2872784|P2|Overall Study|Death|4
871325|NCT01395823|2872785|P1|Overall Study|Death|4
871326|NCT01395810|2872795|P4|Overall Study|Unclassified|0
871327|NCT01395810|2872796|P3|Overall Study|Unclassified|0
871328|NCT01395810|2872797|P2|Overall Study|Unclassified|0
871329|NCT01395810|2872798|P1|Overall Study|Unclassified|2
871330|NCT01395810|2872795|P4|Overall Study|Withdrawal criteria|0
871331|NCT01395810|2872796|P3|Overall Study|Withdrawal criteria|0
871332|NCT01395810|2872797|P2|Overall Study|Withdrawal criteria|2
871333|NCT01395810|2872798|P1|Overall Study|Withdrawal criteria|0
871334|NCT01395810|2872795|P4|Overall Study|Lack of Efficacy|0
871335|NCT01395810|2872796|P3|Overall Study|Lack of Efficacy|0
871336|NCT01395810|2872797|P2|Overall Study|Lack of Efficacy|1
871337|NCT01395810|2872798|P1|Overall Study|Lack of Efficacy|0
871338|NCT01395810|2872795|P4|Overall Study|Adverse Event|0
871339|NCT01395810|2872796|P3|Overall Study|Adverse Event|0
871340|NCT01395810|2872797|P2|Overall Study|Adverse Event|1
871341|NCT01395810|2872798|P1|Overall Study|Adverse Event|0
871342|NCT01395784|2872857|P1|Overall Study|Physician Decision|5
871343|NCT01395784|2872857|P1|Overall Study|Withdrawal by Subject|3
871344|NCT01395784|2872857|P1|Overall Study|Lost to Follow-up|7
871345|NCT01395758|2872864|P3|Open-label Treatment Period|Withdrawal by Subject|0
871346|NCT01395758|2872865|P2|Open-label Treatment Period|Withdrawal by Subject|0
871347|NCT01395758|2872866|P1|Open-label Treatment Period|Withdrawal by Subject|4
871348|NCT01395524|2872880|P3|Overall Study|Subject had spinal surgery|1
871349|NCT01395524|2872881|P2|Overall Study|Subject had spinal surgery|0
871350|NCT01395524|2872882|P1|Overall Study|Subject had spinal surgery|0
871351|NCT01395524|2872880|P3|Overall Study|Did not receive treatment|3
871352|NCT01395524|2872881|P2|Overall Study|Did not receive treatment|1
871353|NCT01395524|2872882|P1|Overall Study|Did not receive treatment|1
871354|NCT01395524|2872880|P3|Overall Study|Withdrawal by Subject|8
871355|NCT01395524|2872881|P2|Overall Study|Withdrawal by Subject|8
871356|NCT01395524|2872882|P1|Overall Study|Withdrawal by Subject|4
871357|NCT01395524|2872880|P3|Overall Study|Eligibility Criteria Not Fulfilled|0
871358|NCT01395524|2872881|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
871359|NCT01395524|2872882|P1|Overall Study|Eligibility Criteria Not Fulfilled|2
871360|NCT01395524|2872880|P3|Overall Study|Death|0
871361|NCT01395524|2872881|P2|Overall Study|Death|0
871362|NCT01395524|2872882|P1|Overall Study|Death|1
871363|NCT01395524|2872880|P3|Overall Study|Adverse Event|3
871364|NCT01395524|2872881|P2|Overall Study|Adverse Event|4
871365|NCT01395524|2872882|P1|Overall Study|Adverse Event|4
871366|NCT01395524|2872880|P3|Overall Study|Severe noncompliance with protocol|0
871367|NCT01395524|2872881|P2|Overall Study|Severe noncompliance with protocol|0
871368|NCT01395524|2872882|P1|Overall Study|Severe noncompliance with protocol|1
871369|NCT01395524|2872880|P3|Overall Study|Study-Specific Withdrawal Criteria|0
871370|NCT01395524|2872881|P2|Overall Study|Study-Specific Withdrawal Criteria|2
871371|NCT01395524|2872882|P1|Overall Study|Study-Specific Withdrawal Criteria|1
871372|NCT01395524|2872880|P3|Overall Study|Lost to Follow-up|1
871373|NCT01395524|2872881|P2|Overall Study|Lost to Follow-up|1
871374|NCT01395524|2872882|P1|Overall Study|Lost to Follow-up|3
871375|NCT01395524|2872880|P3|Overall Study|Non-compliance with study schedule|1
871376|NCT01395524|2872881|P2|Overall Study|Non-compliance with study schedule|0
871377|NCT01395524|2872882|P1|Overall Study|Non-compliance with study schedule|1
871378|NCT01395394|2872905|P3|Baseline Study Visit|Protocol Violation|0
871379|NCT01395394|2872906|P2|Baseline Study Visit|Protocol Violation|0
871380|NCT01395394|2872907|P1|Baseline Study Visit|Protocol Violation|1
871381|NCT01395368|2872918|P1|Overall Study|Withdrawal by Subject|2
871382|NCT01395368|2872918|P1|Overall Study|Physician Decision|14
871383|NCT01395030|2872938|P1|Overall Study|Did not complete FCH PET/CT|7
871384|NCT01395017|2872948|P2|Overall Study|Sponsor discontinued study|4
871385|NCT01395017|2872949|P1|Overall Study|Sponsor discontinued study|1
871386|NCT01395017|2872948|P2|Overall Study|Disease progression|58
871387|NCT01395017|2872949|P1|Overall Study|Disease progression|42
871388|NCT01395017|2872948|P2|Overall Study|Death|3
871389|NCT01395017|2872949|P1|Overall Study|Death|4
871390|NCT01395017|2872948|P2|Overall Study|Protocol deviation|2
871391|NCT01395017|2872949|P1|Overall Study|Protocol deviation|1
871392|NCT01395017|2872948|P2|Overall Study|Withdrawal by Subject|8
871393|NCT01395017|2872949|P1|Overall Study|Withdrawal by Subject|14
871394|NCT01395017|2872948|P2|Overall Study|Physician Decision|15
871395|NCT01395017|2872949|P1|Overall Study|Physician Decision|11
871396|NCT01395017|2872948|P2|Overall Study|Adverse Event|12
871397|NCT01395017|2872949|P1|Overall Study|Adverse Event|26
871398|NCT01395017|2872948|P2|Overall Study|Lost to Follow-up|0
871399|NCT01395017|2872949|P1|Overall Study|Lost to Follow-up|1
871400|NCT01394991|2872959|P2|Overall Study|Prematurely Termination of Trial|10
871401|NCT01394991|2872960|P1|Overall Study|Prematurely Termination of Trial|9
871402|NCT01394991|2872959|P2|Overall Study|Disease Progression|7
871403|NCT01394991|2872960|P1|Overall Study|Disease Progression|7
871404|NCT01394991|2872959|P2|Overall Study|Chemotherapy Termination|15
871405|NCT01394991|2872960|P1|Overall Study|Chemotherapy Termination|10
871406|NCT01394991|2872959|P2|Overall Study|Withdrawal by Subject|17
871407|NCT01394991|2872960|P1|Overall Study|Withdrawal by Subject|20
871408|NCT01394991|2872959|P2|Overall Study|Protocol Violation|1
871409|NCT01394991|2872960|P1|Overall Study|Protocol Violation|1
871410|NCT01394991|2872959|P2|Overall Study|Physician Decision|3
871411|NCT01394991|2872960|P1|Overall Study|Physician Decision|1
871412|NCT01394991|2872959|P2|Overall Study|Lost to Follow-up|8
871413|NCT01394991|2872960|P1|Overall Study|Lost to Follow-up|6
871414|NCT01394991|2872959|P2|Overall Study|Lack of Efficacy|7
871415|NCT01394991|2872960|P1|Overall Study|Lack of Efficacy|5
871416|NCT01394991|2872959|P2|Overall Study|Adverse Event|4
871417|NCT01394991|2872960|P1|Overall Study|Adverse Event|0
871418|NCT01394978|2872982|P2|Overall Study|Death|7
871419|NCT01394978|2872983|P1|Overall Study|Death|6
871420|NCT01394978|2872982|P2|Overall Study|Lost to Follow-up|20
871421|NCT01394978|2872983|P1|Overall Study|Lost to Follow-up|13
871422|NCT01394978|2872982|P2|Overall Study|Withdrawal by Subject|4
871423|NCT01394978|2872983|P1|Overall Study|Withdrawal by Subject|2
871424|NCT01394718|2873000|P2|Overall Study|Met protocol-specific stopping criteria|1
871425|NCT01394718|2873001|P1|Overall Study|Met protocol-specific stopping criteria|2
871426|NCT01394627|2873022|P2|Washout (1-3 Months)|concurrent enrollment in another study|0
871427|NCT01394627|2873023|P1|Washout (1-3 Months)|concurrent enrollment in another study|1
871428|NCT01394627|2873022|P2|First Intervention (1 Day)|poor intravenous access|1
871429|NCT01394627|2873023|P1|First Intervention (1 Day)|poor intravenous access|0
871430|NCT01394523|2873043|P3|Overall Study|Unable to place block|0
871431|NCT01394523|2873044|P2|Overall Study|Unable to place block|0
871432|NCT01394523|2873045|P1|Overall Study|Unable to place block|1
871433|NCT01394276|2873059|P1|Overall Study|Symptoms of concurrent diseases|1
871434|NCT01394276|2873059|P1|Overall Study|unavailability of drug at the Hospital|2
871435|NCT01394276|2873059|P1|Overall Study|Pregnancy|1
871436|NCT01394276|2873059|P1|Overall Study|Participant moved to another site|1
871437|NCT01394276|2873059|P1|Overall Study|Lost to Follow-up|5
871438|NCT01394276|2873059|P1|Overall Study|Insufficient compliance|9
871439|NCT01394276|2873059|P1|Overall Study|Insufficient therapeutic effect|17
871440|NCT01394276|2873059|P1|Overall Study|Remission of disease|2
871441|NCT01394276|2873059|P1|Overall Study|Not related AEs|9
871442|NCT01394276|2873059|P1|Overall Study|Related Adverse event (AEs)|15
871443|NCT01394250|2873083|P2|Successful IV Placement & Follow-Up|Withdrawal by Subject|11
871444|NCT01394250|2873084|P1|Successful IV Placement & Follow-Up|Withdrawal by Subject|6
871445|NCT01394250|2873083|P2|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13
871446|NCT01394250|2873084|P1|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14
871447|NCT01394185|2873098|P6|Overall Study|Protocol Violation|1
871448|NCT01394185|2873099|P5|Overall Study|Protocol Violation|0
871449|NCT01394185|2873100|P4|Overall Study|Protocol Violation|1
871450|NCT01394185|2873101|P3|Overall Study|Protocol Violation|0
871451|NCT01394185|2873102|P2|Overall Study|Protocol Violation|0
871452|NCT01394185|2873103|P1|Overall Study|Protocol Violation|1
871453|NCT01394185|2873098|P6|Overall Study|Change in protocol|0
871454|NCT01394185|2873099|P5|Overall Study|Change in protocol|3
871455|NCT01394185|2873100|P4|Overall Study|Change in protocol|0
871456|NCT01394185|2873101|P3|Overall Study|Change in protocol|0
871457|NCT01394185|2873102|P2|Overall Study|Change in protocol|0
871458|NCT01394185|2873103|P1|Overall Study|Change in protocol|3
871459|NCT01394185|2873098|P6|Overall Study|Withdrawal by Subject|0
871460|NCT01394185|2873099|P5|Overall Study|Withdrawal by Subject|1
871461|NCT01394185|2873100|P4|Overall Study|Withdrawal by Subject|0
871462|NCT01394185|2873101|P3|Overall Study|Withdrawal by Subject|0
871463|NCT01394185|2873102|P2|Overall Study|Withdrawal by Subject|0
871464|NCT01394185|2873103|P1|Overall Study|Withdrawal by Subject|2
871465|NCT01393964|2873141|P3|Overall Study|Subject to receive non-protocol therapy|1
871466|NCT01393964|2873142|P2|Overall Study|Subject to receive non-protocol therapy|0
871467|NCT01393964|2873143|P1|Overall Study|Subject to receive non-protocol therapy|0
871468|NCT01393964|2873141|P3|Overall Study|Subject converted to roll-over study|0
871469|NCT01393964|2873142|P2|Overall Study|Subject converted to roll-over study|1
871470|NCT01393964|2873143|P1|Overall Study|Subject converted to roll-over study|0
871471|NCT01393964|2873141|P3|Overall Study|Investigator removed subject from study|0
871472|NCT01393964|2873142|P2|Overall Study|Investigator removed subject from study|1
871473|NCT01393964|2873143|P1|Overall Study|Investigator removed subject from study|0
871474|NCT01393964|2873141|P3|Overall Study|Subject plateaued in terms of effect|0
871475|NCT01393964|2873142|P2|Overall Study|Subject plateaued in terms of effect|0
871476|NCT01393964|2873143|P1|Overall Study|Subject plateaued in terms of effect|1
871477|NCT01393964|2873141|P3|Overall Study|Subject switched to commercial supply|2
871478|NCT01393964|2873142|P2|Overall Study|Subject switched to commercial supply|0
871479|NCT01393964|2873143|P1|Overall Study|Subject switched to commercial supply|1
871480|NCT01393964|2873141|P3|Overall Study|Subject decided to move to transplant|0
871481|NCT01393964|2873142|P2|Overall Study|Subject decided to move to transplant|0
871482|NCT01393964|2873143|P1|Overall Study|Subject decided to move to transplant|1
871483|NCT01393964|2873141|P3|Overall Study|Subject request stop study treatment|0
871484|NCT01393964|2873142|P2|Overall Study|Subject request stop study treatment|1
871485|NCT01393964|2873143|P1|Overall Study|Subject request stop study treatment|0
871486|NCT01393964|2873141|P3|Overall Study|Adverse event unrelated to study drug|0
871487|NCT01393964|2873142|P2|Overall Study|Adverse event unrelated to study drug|3
871488|NCT01393964|2873143|P1|Overall Study|Adverse event unrelated to study drug|0
871489|NCT01393964|2873141|P3|Overall Study|Withdrawal by Subject|1
871490|NCT01393964|2873142|P2|Overall Study|Withdrawal by Subject|0
871491|NCT01393964|2873143|P1|Overall Study|Withdrawal by Subject|0
871492|NCT01393964|2873141|P3|Overall Study|Study drug toxicity|0
871493|NCT01393964|2873142|P2|Overall Study|Study drug toxicity|0
871494|NCT01393964|2873143|P1|Overall Study|Study drug toxicity|1
871495|NCT01393964|2873141|P3|Overall Study|Disease Progression|5
871496|NCT01393964|2873142|P2|Overall Study|Disease Progression|3
871497|NCT01393964|2873143|P1|Overall Study|Disease Progression|4
871498|NCT01393899|2873184|P3|Overall Study|Adverse Event|3
871499|NCT01393899|2873185|P2|Overall Study|Adverse Event|5
871500|NCT01393899|2873186|P1|Overall Study|Adverse Event|1
871501|NCT01393899|2873184|P3|Overall Study|Lack of Efficacy|16
871502|NCT01393899|2873185|P2|Overall Study|Lack of Efficacy|21
871503|NCT01393899|2873186|P1|Overall Study|Lack of Efficacy|26
871504|NCT01393899|2873184|P3|Overall Study|Does not meet entrance criteria|1
871505|NCT01393899|2873185|P2|Overall Study|Does not meet entrance criteria|0
871506|NCT01393899|2873186|P1|Overall Study|Does not meet entrance criteria|1
871507|NCT01393899|2873184|P3|Overall Study|Lost to Follow-up|1
871508|NCT01393899|2873185|P2|Overall Study|Lost to Follow-up|0
871509|NCT01393899|2873186|P1|Overall Study|Lost to Follow-up|0
871510|NCT01393899|2873184|P3|Overall Study|Withdrawal by Subject|1
871511|NCT01393899|2873185|P2|Overall Study|Withdrawal by Subject|2
871512|NCT01393899|2873186|P1|Overall Study|Withdrawal by Subject|2
871513|NCT01393899|2873184|P3|Overall Study|Other|0
871514|NCT01393899|2873185|P2|Overall Study|Other|0
871515|NCT01393899|2873186|P1|Overall Study|Other|1
871516|NCT01393899|2873184|P3|Overall Study|Study terminated by sponsor|1
871517|NCT01393899|2873185|P2|Overall Study|Study terminated by sponsor|0
871518|NCT01393899|2873186|P1|Overall Study|Study terminated by sponsor|1
871519|NCT01393743|2873240|P3|Extension Phase|Not specified|14
871520|NCT01393743|2873241|P2|Extension Phase|Not specified|0
871521|NCT01393743|2873242|P1|Extension Phase|Not specified|0
871522|NCT01393743|2873240|P3|Extension Phase|Pregnancy|1
871523|NCT01393743|2873241|P2|Extension Phase|Pregnancy|0
871524|NCT01393743|2873242|P1|Extension Phase|Pregnancy|0
871525|NCT01393743|2873240|P3|Extension Phase|Withdrawal by Subject|8
871526|NCT01393743|2873241|P2|Extension Phase|Withdrawal by Subject|0
871527|NCT01393743|2873242|P1|Extension Phase|Withdrawal by Subject|0
871528|NCT01393743|2873240|P3|Extension Phase|Inadequate therapeutic effect|7
871529|NCT01393743|2873241|P2|Extension Phase|Inadequate therapeutic effect|0
871530|NCT01393743|2873242|P1|Extension Phase|Inadequate therapeutic effect|0
871531|NCT01393743|2873240|P3|Extension Phase|Participant choice|16
871532|NCT01393743|2873241|P2|Extension Phase|Participant choice|0
871533|NCT01393743|2873242|P1|Extension Phase|Participant choice|0
871534|NCT01393743|2873240|P3|Extension Phase|Lost to Follow-up|2
871535|NCT01393743|2873241|P2|Extension Phase|Lost to Follow-up|0
871536|NCT01393743|2873242|P1|Extension Phase|Lost to Follow-up|0
871537|NCT01393743|2873240|P3|Extension Phase|Adverse Event|12
871538|NCT01393743|2873241|P2|Extension Phase|Adverse Event|0
871539|NCT01393743|2873242|P1|Extension Phase|Adverse Event|0
871540|NCT01393743|2873240|P3|Core Study|Inadequate therapeutic effect|0
871541|NCT01393743|2873241|P2|Core Study|Inadequate therapeutic effect|0
871542|NCT01393743|2873242|P1|Core Study|Inadequate therapeutic effect|2
871543|NCT01393743|2873240|P3|Core Study|Participant's Choice|0
871544|NCT01393743|2873241|P2|Core Study|Participant's Choice|3
871545|NCT01393743|2873242|P1|Core Study|Participant's Choice|2
871546|NCT01393743|2873240|P3|Core Study|Lost to Follow-up|0
871547|NCT01393743|2873241|P2|Core Study|Lost to Follow-up|1
871548|NCT01393743|2873242|P1|Core Study|Lost to Follow-up|1
871549|NCT01393743|2873240|P3|Core Study|Adverse Event|0
871550|NCT01393743|2873241|P2|Core Study|Adverse Event|9
871551|NCT01393743|2873242|P1|Core Study|Adverse Event|5
871552|NCT01393730|2873265|P1|Overall Study|Adverse Event|1
871553|NCT01393730|2873265|P1|Overall Study|Other|2
871554|NCT01393730|2873265|P1|Overall Study|Withdrawal by Subject|3
871555|NCT01393626|2873311|P4|Overall Study|Protocol Violation|0
871556|NCT01393626|2873312|P3|Overall Study|Protocol Violation|2
871557|NCT01393626|2873313|P2|Overall Study|Protocol Violation|0
871558|NCT01393626|2873314|P1|Overall Study|Protocol Violation|1
871559|NCT01393626|2873311|P4|Overall Study|Other|0
871560|NCT01393626|2873312|P3|Overall Study|Other|0
871561|NCT01393626|2873313|P2|Overall Study|Other|0
871562|NCT01393626|2873314|P1|Overall Study|Other|1
871563|NCT01393626|2873311|P4|Overall Study|Withdrawal by Subject|0
871564|NCT01393626|2873312|P3|Overall Study|Withdrawal by Subject|0
871565|NCT01393626|2873313|P2|Overall Study|Withdrawal by Subject|4
871566|NCT01393626|2873314|P1|Overall Study|Withdrawal by Subject|6
871567|NCT01393626|2873311|P4|Overall Study|Lost to Follow-up|0
871568|NCT01393626|2873312|P3|Overall Study|Lost to Follow-up|1
871569|NCT01393626|2873313|P2|Overall Study|Lost to Follow-up|1
871570|NCT01393626|2873314|P1|Overall Study|Lost to Follow-up|1
871571|NCT01393626|2873311|P4|Overall Study|Lack of Efficacy|1
871572|NCT01393626|2873312|P3|Overall Study|Lack of Efficacy|4
871573|NCT01393626|2873313|P2|Overall Study|Lack of Efficacy|6
871574|NCT01393626|2873314|P1|Overall Study|Lack of Efficacy|6
871575|NCT01393626|2873311|P4|Overall Study|Did not meet entrance criteria|0
871576|NCT01393626|2873312|P3|Overall Study|Did not meet entrance criteria|0
871577|NCT01393626|2873313|P2|Overall Study|Did not meet entrance criteria|0
871578|NCT01393626|2873314|P1|Overall Study|Did not meet entrance criteria|1
871579|NCT01393626|2873311|P4|Overall Study|Adverse Event|0
871580|NCT01393626|2873312|P3|Overall Study|Adverse Event|5
871581|NCT01393626|2873313|P2|Overall Study|Adverse Event|1
871582|NCT01393626|2873314|P1|Overall Study|Adverse Event|2
871583|NCT01393613|2873394|P4|Overall Study|Lack of Efficacy|21
871584|NCT01393613|2873395|P3|Overall Study|Lack of Efficacy|16
871585|NCT01393613|2873396|P2|Overall Study|Lack of Efficacy|20
871586|NCT01393613|2873397|P1|Overall Study|Lack of Efficacy|9
871587|NCT01393613|2873394|P4|Overall Study|Protocol Deviation|0
871588|NCT01393613|2873395|P3|Overall Study|Protocol Deviation|0
871589|NCT01393613|2873396|P2|Overall Study|Protocol Deviation|1
871590|NCT01393613|2873397|P1|Overall Study|Protocol Deviation|2
871591|NCT01393613|2873394|P4|Overall Study|Withdrawal by Subject|21
871592|NCT01393613|2873395|P3|Overall Study|Withdrawal by Subject|23
871593|NCT01393613|2873396|P2|Overall Study|Withdrawal by Subject|25
871594|NCT01393613|2873397|P1|Overall Study|Withdrawal by Subject|15
871595|NCT01393613|2873394|P4|Overall Study|Physician Decision|1
871596|NCT01393613|2873395|P3|Overall Study|Physician Decision|0
871597|NCT01393613|2873396|P2|Overall Study|Physician Decision|0
871598|NCT01393613|2873397|P1|Overall Study|Physician Decision|2
871599|NCT01393613|2873394|P4|Overall Study|Participant Met Withdrawal Criteria|1
871600|NCT01393613|2873395|P3|Overall Study|Participant Met Withdrawal Criteria|2
871601|NCT01393613|2873396|P2|Overall Study|Participant Met Withdrawal Criteria|0
871602|NCT01393613|2873397|P1|Overall Study|Participant Met Withdrawal Criteria|0
871603|NCT01393613|2873394|P4|Overall Study|Adverse Event|22
871604|NCT01393613|2873395|P3|Overall Study|Adverse Event|13
871605|NCT01393613|2873396|P2|Overall Study|Adverse Event|11
871606|NCT01393613|2873397|P1|Overall Study|Adverse Event|11
871686|NCT01392573|2873667|P1|Overall Study|Unclassified|9
871607|NCT01393600|2873459|P4|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
871608|NCT01393600|2873460|P3|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1
871609|NCT01393600|2873461|P2|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
871610|NCT01393600|2873462|P1|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
871611|NCT01393600|2873459|P4|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
871612|NCT01393600|2873460|P3|Treatment Period 2 (Day 15 to 28)|Physician Decision|1
871613|NCT01393600|2873461|P2|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
871614|NCT01393600|2873462|P1|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
871615|NCT01393600|2873459|P4|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
871616|NCT01393600|2873460|P3|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1
871617|NCT01393600|2873461|P2|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
871618|NCT01393600|2873462|P1|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
871619|NCT01393600|2873459|P4|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1
871620|NCT01393600|2873460|P3|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
871621|NCT01393600|2873461|P2|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
871622|NCT01393600|2873462|P1|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
871623|NCT01393600|2873459|P4|Treatment Period 1 (Day 1 to 14)|Adverse Event|1
871624|NCT01393600|2873460|P3|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
871625|NCT01393600|2873461|P2|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
871626|NCT01393600|2873462|P1|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
871627|NCT01393600|2873459|P4|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
871628|NCT01393600|2873460|P3|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1
871629|NCT01393600|2873461|P2|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
871630|NCT01393600|2873462|P1|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
871631|NCT01393600|2873459|P4|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
871632|NCT01393600|2873460|P3|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
871633|NCT01393600|2873461|P2|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1
871634|NCT01393600|2873462|P1|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
871635|NCT01393444|2873498|P1|Overall Study|Determined ineligible during screening.|2
871636|NCT01393444|2873498|P1|Overall Study|Withdrawal by Subject|1
871637|NCT01393405|2873503|P3|Maintenance Period Week|Lost to Follow-up|0
871638|NCT01393405|2873504|P2|Maintenance Period Week|Lost to Follow-up|1
871639|NCT01393405|2873505|P1|Maintenance Period Week|Lost to Follow-up|0
871640|NCT01393405|2873503|P3|Maintenance Period Week|Withdrawal by Subject|0
871641|NCT01393405|2873504|P2|Maintenance Period Week|Withdrawal by Subject|1
871642|NCT01393405|2873505|P1|Maintenance Period Week|Withdrawal by Subject|0
871643|NCT01393405|2873503|P3|Maintenance Period Week|Adverse Event|2
871644|NCT01393405|2873504|P2|Maintenance Period Week|Adverse Event|5
871645|NCT01393405|2873505|P1|Maintenance Period Week|Adverse Event|0
871646|NCT01393405|2873503|P3|Maintenance Period Week|Lack of Efficacy|22
871647|NCT01393405|2873504|P2|Maintenance Period Week|Lack of Efficacy|22
871648|NCT01393405|2873505|P1|Maintenance Period Week|Lack of Efficacy|0
871649|NCT01393405|2873503|P3|Induction Period (week1-16)|Withdrawal by Subject|0
871650|NCT01393405|2873504|P2|Induction Period (week1-16)|Withdrawal by Subject|0
871651|NCT01393405|2873505|P1|Induction Period (week1-16)|Withdrawal by Subject|9
871652|NCT01393405|2873503|P3|Induction Period (week1-16)|Adverse Event|0
871653|NCT01393405|2873504|P2|Induction Period (week1-16)|Adverse Event|0
871654|NCT01393405|2873505|P1|Induction Period (week1-16)|Adverse Event|16
871655|NCT01393405|2873503|P3|Induction Period (week1-16)|Lack of Efficacy|0
871656|NCT01393405|2873504|P2|Induction Period (week1-16)|Lack of Efficacy|0
871657|NCT01393405|2873505|P1|Induction Period (week1-16)|Lack of Efficacy|70
871658|NCT01393106|2873556|P1|Overall Study|Lack of Efficacy|1
871659|NCT01393106|2873556|P1|Overall Study|Withdrawal by Subject|1
871660|NCT01393106|2873556|P1|Overall Study|Adverse Event|3
871661|NCT01392963|2873575|P2|Week 24 Follow-up|Lost to Follow-up|0
871662|NCT01392963|2873576|P1|Week 24 Follow-up|Lost to Follow-up|2
871663|NCT01392963|2873575|P2|Week 0 (First Intervention)|Withdrawal by Subject|1
871664|NCT01392963|2873576|P1|Week 0 (First Intervention)|Withdrawal by Subject|0
871665|NCT01392963|2873575|P2|Week 0 (First Intervention)|Lost to Follow-up|1
871666|NCT01392963|2873576|P1|Week 0 (First Intervention)|Lost to Follow-up|0
871667|NCT01392742|2873584|P1|Overall Study|Missing information|13
871668|NCT01392742|2873584|P1|Overall Study|Other|3
871669|NCT01392742|2873584|P1|Overall Study|Protocol Violation|14
871670|NCT01392742|2873584|P1|Overall Study|Adverse event/intercurrent illness|17
871671|NCT01392742|2873584|P1|Overall Study|ITR and Protocol deviation|1
871672|NCT01392742|2873584|P1|Overall Study|Insufficient therapeutic response (ITR)|30
871673|NCT01392742|2873584|P1|Overall Study|Lost to Follow-up|34
871674|NCT01392742|2873584|P1|Overall Study|No treatment/no cooperation/withdrew|12
871675|NCT01392742|2873584|P1|Overall Study|Failure to return|35
871676|NCT01392742|2873584|P1|Overall Study|Premature study termination|42
871677|NCT01392677|2873630|P2|Overall Study|Other reason|2
871678|NCT01392677|2873631|P1|Overall Study|Other reason|3
871679|NCT01392677|2873630|P2|Overall Study|Incorrect enrollment|3
871680|NCT01392677|2873631|P1|Overall Study|Incorrect enrollment|2
871681|NCT01392677|2873630|P2|Overall Study|Withdrawal by Subject|2
871682|NCT01392677|2873631|P1|Overall Study|Withdrawal by Subject|0
871683|NCT01392677|2873630|P2|Overall Study|Adverse Event|1
871684|NCT01392677|2873631|P1|Overall Study|Adverse Event|3
871685|NCT01392573|2873666|P2|Overall Study|Unclassified|6
871687|NCT01392573|2873666|P2|Overall Study|Site closure|7
871688|NCT01392573|2873667|P1|Overall Study|Site closure|8
871689|NCT01392573|2873666|P2|Overall Study|Withdrawal Criteria|15
871690|NCT01392573|2873667|P1|Overall Study|Withdrawal Criteria|13
871691|NCT01392573|2873666|P2|Overall Study|Protocol Violation|2
871692|NCT01392573|2873667|P1|Overall Study|Protocol Violation|0
871693|NCT01392573|2873666|P2|Overall Study|Lack of Efficacy|2
871694|NCT01392573|2873667|P1|Overall Study|Lack of Efficacy|1
871695|NCT01392573|2873666|P2|Overall Study|Adverse Event|3
871696|NCT01392573|2873667|P1|Overall Study|Adverse Event|1
871697|NCT01392560|2873675|P1|Overall Study|discontinued during placebo run-in|2
871698|NCT01392560|2873675|P1|Overall Study|not entered|8
871699|NCT01392560|2873675|P1|Overall Study|Adverse Event|2
871700|NCT01392547|2873681|P1|Overall Study|Unclassified|1
871701|NCT01392547|2873681|P1|Overall Study|Withdrawal criteria|3
871702|NCT01392547|2873681|P1|Overall Study|Non-compliance|2
871703|NCT01392547|2873681|P1|Overall Study|Adverse Event|2
871704|NCT01392495|2873695|P1|Overall Study|Adverse Event|3
871705|NCT01392495|2873695|P1|Overall Study|Withdrawal by Subject|2
871706|NCT01392495|2873695|P1|Overall Study|Administrative problems|8
871707|NCT01392495|2873695|P1|Overall Study|Death|3
871708|NCT01392378|2873712|P5|Toddler Dose|Withdrawal by Parent|1
871709|NCT01392378|2873713|P4|Toddler Dose|Withdrawal by Parent|1
871710|NCT01392378|2873714|P3|Toddler Dose|Withdrawal by Parent|0
871711|NCT01392378|2873715|P2|Toddler Dose|Withdrawal by Parent|1
871712|NCT01392378|2873716|P1|Toddler Dose|Withdrawal by Parent|0
871713|NCT01392378|2873712|P5|Toddler Dose|Lost to Follow-up|0
871714|NCT01392378|2873713|P4|Toddler Dose|Lost to Follow-up|1
871715|NCT01392378|2873714|P3|Toddler Dose|Lost to Follow-up|0
871716|NCT01392378|2873715|P2|Toddler Dose|Lost to Follow-up|0
871717|NCT01392378|2873716|P1|Toddler Dose|Lost to Follow-up|0
871718|NCT01392378|2873712|P5|After Infant Series|Withdrawal by Parent|1
871719|NCT01392378|2873713|P4|After Infant Series|Withdrawal by Parent|0
871720|NCT01392378|2873714|P3|After Infant Series|Withdrawal by Parent|1
871721|NCT01392378|2873715|P2|After Infant Series|Withdrawal by Parent|1
871722|NCT01392378|2873716|P1|After Infant Series|Withdrawal by Parent|0
871723|NCT01392378|2873712|P5|After Infant Series|Lost to Follow-up|0
871724|NCT01392378|2873713|P4|After Infant Series|Lost to Follow-up|0
871725|NCT01392378|2873714|P3|After Infant Series|Lost to Follow-up|1
871726|NCT01392378|2873715|P2|After Infant Series|Lost to Follow-up|0
871727|NCT01392378|2873716|P1|After Infant Series|Lost to Follow-up|0
871728|NCT01392378|2873712|P5|Infant Series|Withdrawal by Parent|0
871729|NCT01392378|2873713|P4|Infant Series|Withdrawal by Parent|0
871730|NCT01392378|2873714|P3|Infant Series|Withdrawal by Parent|0
871731|NCT01392378|2873715|P2|Infant Series|Withdrawal by Parent|1
871732|NCT01392378|2873716|P1|Infant Series|Withdrawal by Parent|4
871733|NCT01392378|2873712|P5|Infant Series|Protocol Violation|0
871734|NCT01392378|2873713|P4|Infant Series|Protocol Violation|0
871735|NCT01392378|2873714|P3|Infant Series|Protocol Violation|0
871736|NCT01392378|2873715|P2|Infant Series|Protocol Violation|1
871737|NCT01392378|2873716|P1|Infant Series|Protocol Violation|0
871738|NCT01392378|2873712|P5|Infant Series|Lost to Follow-up|0
871739|NCT01392378|2873713|P4|Infant Series|Lost to Follow-up|1
871740|NCT01392378|2873714|P3|Infant Series|Lost to Follow-up|0
871741|NCT01392378|2873715|P2|Infant Series|Lost to Follow-up|0
871742|NCT01392378|2873716|P1|Infant Series|Lost to Follow-up|0
871743|NCT01392378|2873712|P5|Infant Series|Adverse Event|0
871744|NCT01392378|2873713|P4|Infant Series|Adverse Event|1
871745|NCT01392378|2873714|P3|Infant Series|Adverse Event|0
871746|NCT01392378|2873715|P2|Infant Series|Adverse Event|0
871747|NCT01392378|2873716|P1|Infant Series|Adverse Event|0
871748|NCT01392326|2873856|P3|Overall Study|Adverse Event|11
871749|NCT01392326|2873857|P2|Overall Study|Adverse Event|6
871750|NCT01392326|2873858|P1|Overall Study|Adverse Event|9
871751|NCT01392326|2873856|P3|Overall Study|Lack of Efficacy|15
871752|NCT01392326|2873857|P2|Overall Study|Lack of Efficacy|10
871753|NCT01392326|2873858|P1|Overall Study|Lack of Efficacy|14
871754|NCT01392326|2873856|P3|Overall Study|Lost to Follow-up|4
871755|NCT01392326|2873857|P2|Overall Study|Lost to Follow-up|3
871756|NCT01392326|2873858|P1|Overall Study|Lost to Follow-up|1
871757|NCT01392326|2873856|P3|Overall Study|Physician Decision|2
871758|NCT01392326|2873857|P2|Overall Study|Physician Decision|5
871759|NCT01392326|2873858|P1|Overall Study|Physician Decision|7
871760|NCT01392326|2873856|P3|Overall Study|Pregnancy|1
871761|NCT01392326|2873857|P2|Overall Study|Pregnancy|0
871762|NCT01392326|2873858|P1|Overall Study|Pregnancy|0
871763|NCT01392326|2873856|P3|Overall Study|Protocol Violation|0
871764|NCT01392326|2873857|P2|Overall Study|Protocol Violation|0
871765|NCT01392326|2873858|P1|Overall Study|Protocol Violation|2
871766|NCT01392326|2873856|P3|Overall Study|Withdrawal by Subject|15
871767|NCT01392326|2873857|P2|Overall Study|Withdrawal by Subject|11
871768|NCT01392326|2873858|P1|Overall Study|Withdrawal by Subject|12
871769|NCT01392326|2873856|P3|Overall Study|Death|0
871770|NCT01392326|2873857|P2|Overall Study|Death|0
871771|NCT01392326|2873858|P1|Overall Study|Death|2
871772|NCT01392300|2873895|P3|Open Label Extension (OLEX) Period|Lost to Follow-up|6
871773|NCT01392300|2873896|P2|Open Label Extension (OLEX) Period|Lost to Follow-up|0
871774|NCT01392300|2873897|P1|Open Label Extension (OLEX) Period|Lost to Follow-up|0
871775|NCT01392300|2873895|P3|Open Label Extension (OLEX) Period|Withdrawal by Subject|17
871776|NCT01392300|2873896|P2|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
871777|NCT01392300|2873897|P1|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
871778|NCT01392300|2873895|P3|Open Label Extension (OLEX) Period|Adverse Event|7
871779|NCT01392300|2873896|P2|Open Label Extension (OLEX) Period|Adverse Event|0
871780|NCT01392300|2873897|P1|Open Label Extension (OLEX) Period|Adverse Event|0
871781|NCT01392300|2873895|P3|Open Label Extension (OLEX) Period|Death|4
871782|NCT01392300|2873896|P2|Open Label Extension (OLEX) Period|Death|0
871783|NCT01392300|2873897|P1|Open Label Extension (OLEX) Period|Death|0
871784|NCT01392300|2873895|P3|Open Label Extension (OLEX) Period|Non-compliance|1
871785|NCT01392300|2873896|P2|Open Label Extension (OLEX) Period|Non-compliance|0
871786|NCT01392300|2873897|P1|Open Label Extension (OLEX) Period|Non-compliance|0
871787|NCT01392300|2873895|P3|Open Label Extension (OLEX) Period|Lack of Efficacy|3
871788|NCT01392300|2873896|P2|Open Label Extension (OLEX) Period|Lack of Efficacy|0
871789|NCT01392300|2873897|P1|Open Label Extension (OLEX) Period|Lack of Efficacy|0
871790|NCT01392300|2873895|P3|Open Label Extension (OLEX) Period|Protocol Violation|13
871791|NCT01392300|2873896|P2|Open Label Extension (OLEX) Period|Protocol Violation|0
871792|NCT01392300|2873897|P1|Open Label Extension (OLEX) Period|Protocol Violation|0
871793|NCT01392300|2873895|P3|Main Period (MP)|Non-compliance|0
871794|NCT01392300|2873896|P2|Main Period (MP)|Non-compliance|0
871795|NCT01392300|2873897|P1|Main Period (MP)|Non-compliance|1
871796|NCT01392300|2873895|P3|Main Period (MP)|Lost to Follow-up|0
871797|NCT01392300|2873896|P2|Main Period (MP)|Lost to Follow-up|3
871798|NCT01392300|2873897|P1|Main Period (MP)|Lost to Follow-up|3
871799|NCT01392300|2873895|P3|Main Period (MP)|Withdrawal by Subject|0
871800|NCT01392300|2873896|P2|Main Period (MP)|Withdrawal by Subject|1
871801|NCT01392300|2873897|P1|Main Period (MP)|Withdrawal by Subject|5
871802|NCT01392300|2873895|P3|Main Period (MP)|Predefined discontinuation criteria|0
871803|NCT01392300|2873896|P2|Main Period (MP)|Predefined discontinuation criteria|3
871804|NCT01392300|2873897|P1|Main Period (MP)|Predefined discontinuation criteria|2
871805|NCT01392170|2874002|P1|Overall Study|Ineligible|1
871806|NCT01392170|2874002|P1|Overall Study|Withdrawal by Subject|1
871807|NCT01391819|2874050|P1|Overall Study|Other|9
871808|NCT01391819|2874050|P1|Overall Study|Death|3
871809|NCT01391819|2874050|P1|Overall Study|Lost to Follow-up|252
871810|NCT01391819|2874050|P1|Overall Study|Migrated/moved from study area|82
871811|NCT01391819|2874050|P1|Overall Study|Withdrawal by Subject|56
871812|NCT01391663|2874081|P4|Overall Study|Withdrawal by Subject|0
871813|NCT01391663|2874082|P3|Overall Study|Withdrawal by Subject|1
871814|NCT01391663|2874083|P2|Overall Study|Withdrawal by Subject|0
871815|NCT01391663|2874084|P1|Overall Study|Withdrawal by Subject|0
871816|NCT01391546|2874128|P2|Overall Study|History of Herpes Zoster (HZ)|0
871817|NCT01391546|2874129|P1|Overall Study|History of Herpes Zoster (HZ)|1
871818|NCT01391507|2874151|P4|Overall Study|Protocol Violation|2
871819|NCT01391507|2874152|P3|Overall Study|Protocol Violation|1
871820|NCT01391507|2874153|P2|Overall Study|Protocol Violation|1
871821|NCT01391507|2874154|P1|Overall Study|Protocol Violation|2
871822|NCT01391507|2874151|P4|Overall Study|Lack of Efficacy|1
871823|NCT01391507|2874152|P3|Overall Study|Lack of Efficacy|0
871824|NCT01391507|2874153|P2|Overall Study|Lack of Efficacy|0
871825|NCT01391507|2874154|P1|Overall Study|Lack of Efficacy|0
871826|NCT01391507|2874151|P4|Overall Study|Withdrawal by Subject|1
871827|NCT01391507|2874152|P3|Overall Study|Withdrawal by Subject|1
871828|NCT01391507|2874153|P2|Overall Study|Withdrawal by Subject|2
871829|NCT01391507|2874154|P1|Overall Study|Withdrawal by Subject|1
871830|NCT01391507|2874151|P4|Overall Study|Adverse Event|2
871831|NCT01391507|2874152|P3|Overall Study|Adverse Event|2
871832|NCT01391507|2874153|P2|Overall Study|Adverse Event|1
871833|NCT01391507|2874154|P1|Overall Study|Adverse Event|1
871834|NCT01391507|2874151|P4|Overall Study|Death|1
871835|NCT01391507|2874152|P3|Overall Study|Death|0
871836|NCT01391507|2874153|P2|Overall Study|Death|0
871837|NCT01391507|2874154|P1|Overall Study|Death|0
871838|NCT01391000|2874333|P2|Overall Study|Lost to Follow-up|0
871839|NCT01391000|2874334|P1|Overall Study|Lost to Follow-up|2
871840|NCT01390948|2874347|P3|Overall Study|Withdrew consent from survival follow-up|0
871841|NCT01390948|2874348|P2|Overall Study|Withdrew consent from survival follow-up|5
871842|NCT01390948|2874349|P1|Overall Study|Withdrew consent from survival follow-up|3
871843|NCT01390948|2874347|P3|Overall Study|Ongoing|0
871844|NCT01390948|2874348|P2|Overall Study|Ongoing|6
871845|NCT01390948|2874349|P1|Overall Study|Ongoing|6
871846|NCT01390948|2874347|P3|Overall Study|Death|2
871847|NCT01390948|2874348|P2|Overall Study|Death|34
871848|NCT01390948|2874349|P1|Overall Study|Death|30
871849|NCT01390948|2874347|P3|Overall Study|Alive in follow-up|1
871850|NCT01390948|2874348|P2|Overall Study|Alive in follow-up|17
871851|NCT01390948|2874349|P1|Overall Study|Alive in follow-up|20
871852|NCT01390857|2874415|P1|Overall Study|No Visit after the First Visit|7
871853|NCT01390857|2874415|P1|Overall Study|Lost to Follow-up|1
871854|NCT01390857|2874415|P1|Overall Study|Protocol Violation|2
871855|NCT01390844|2874426|P4|Follow-Up Phase|Non-Medical Reasons|0
871856|NCT01390844|2874427|P3|Follow-Up Phase|Non-Medical Reasons|1
871857|NCT01390844|2874428|P2|Follow-Up Phase|Non-Medical Reasons|1
871858|NCT01390844|2874429|P1|Follow-Up Phase|Non-Medical Reasons|1
871859|NCT01390844|2874426|P4|Treatment Phase|Non-GCP Compliant|3
871860|NCT01390844|2874427|P3|Treatment Phase|Non-GCP Compliant|10
871861|NCT01390844|2874428|P2|Treatment Phase|Non-GCP Compliant|0
871862|NCT01390844|2874429|P1|Treatment Phase|Non-GCP Compliant|0
871863|NCT01390844|2874426|P4|Treatment Phase|Non-Medical Reasons|1
871864|NCT01390844|2874427|P3|Treatment Phase|Non-Medical Reasons|8
871865|NCT01390844|2874428|P2|Treatment Phase|Non-Medical Reasons|1
871866|NCT01390844|2874429|P1|Treatment Phase|Non-Medical Reasons|5
871867|NCT01390844|2874426|P4|Treatment Phase|Treatment Failure|13
871868|NCT01390844|2874427|P3|Treatment Phase|Treatment Failure|10
871869|NCT01390844|2874428|P2|Treatment Phase|Treatment Failure|25
871870|NCT01390844|2874429|P1|Treatment Phase|Treatment Failure|23
871871|NCT01390844|2874426|P4|Treatment Phase|Adverse Event|2
871872|NCT01390844|2874427|P3|Treatment Phase|Adverse Event|3
871873|NCT01390844|2874428|P2|Treatment Phase|Adverse Event|2
871874|NCT01390844|2874429|P1|Treatment Phase|Adverse Event|12
871875|NCT01390779|2874756|P1|Overall Study|Physician Decision|1
871876|NCT01390649|2874761|P1|Overall Study|Physician Decision|1
871877|NCT01390441|2874771|P5|Extension Period|Protocol Violation|0
871878|NCT01390441|2874772|P4|Extension Period|Protocol Violation|1
871879|NCT01390441|2874773|P3|Extension Period|Protocol Violation|0
871880|NCT01390441|2874774|P2|Extension Period|Protocol Violation|1
871881|NCT01390441|2874775|P1|Extension Period|Protocol Violation|3
871882|NCT01390441|2874771|P5|Treatment Period|Lost to Follow-up|0
871883|NCT01390441|2874772|P4|Treatment Period|Lost to Follow-up|0
871884|NCT01390441|2874773|P3|Treatment Period|Lost to Follow-up|0
871885|NCT01390441|2874774|P2|Treatment Period|Lost to Follow-up|0
871886|NCT01390441|2874775|P1|Treatment Period|Lost to Follow-up|1
871887|NCT01390441|2874771|P5|Treatment Period|Withdrawal by Subject|1
871888|NCT01390441|2874772|P4|Treatment Period|Withdrawal by Subject|0
871889|NCT01390441|2874773|P3|Treatment Period|Withdrawal by Subject|1
871890|NCT01390441|2874774|P2|Treatment Period|Withdrawal by Subject|0
871891|NCT01390441|2874775|P1|Treatment Period|Withdrawal by Subject|0
871892|NCT01390441|2874771|P5|Treatment Period|Adverse Event|2
871893|NCT01390441|2874772|P4|Treatment Period|Adverse Event|1
871894|NCT01390441|2874773|P3|Treatment Period|Adverse Event|1
871895|NCT01390441|2874774|P2|Treatment Period|Adverse Event|0
871896|NCT01390441|2874775|P1|Treatment Period|Adverse Event|0
871897|NCT01390441|2874771|P5|Treatment Period|Unknown due to early stopping of study|7
871898|NCT01390441|2874772|P4|Treatment Period|Unknown due to early stopping of study|11
871899|NCT01390441|2874773|P3|Treatment Period|Unknown due to early stopping of study|8
871900|NCT01390441|2874774|P2|Treatment Period|Unknown due to early stopping of study|0
871901|NCT01390441|2874775|P1|Treatment Period|Unknown due to early stopping of study|0
871902|NCT01390441|2874771|P5|Treatment Period|Lack of Efficacy|1
871903|NCT01390441|2874772|P4|Treatment Period|Lack of Efficacy|0
871904|NCT01390441|2874773|P3|Treatment Period|Lack of Efficacy|0
871905|NCT01390441|2874774|P2|Treatment Period|Lack of Efficacy|0
871906|NCT01390441|2874775|P1|Treatment Period|Lack of Efficacy|0
871907|NCT01390441|2874771|P5|Treatment Period|Physician Decision|0
871908|NCT01390441|2874772|P4|Treatment Period|Physician Decision|1
871909|NCT01390441|2874773|P3|Treatment Period|Physician Decision|0
871910|NCT01390441|2874774|P2|Treatment Period|Physician Decision|0
871911|NCT01390441|2874775|P1|Treatment Period|Physician Decision|0
871912|NCT01390441|2874771|P5|Treatment Period|Protocol Violation|0
871913|NCT01390441|2874772|P4|Treatment Period|Protocol Violation|0
871914|NCT01390441|2874773|P3|Treatment Period|Protocol Violation|0
871915|NCT01390441|2874774|P2|Treatment Period|Protocol Violation|1
871916|NCT01390441|2874775|P1|Treatment Period|Protocol Violation|0
871917|NCT01390428|2874840|P6|Overall Study|Withdrawal by Subject|0
871918|NCT01390428|2874841|P5|Overall Study|Withdrawal by Subject|0
871919|NCT01390428|2874842|P4|Overall Study|Withdrawal by Subject|0
871920|NCT01390428|2874843|P3|Overall Study|Withdrawal by Subject|1
871921|NCT01390428|2874844|P2|Overall Study|Withdrawal by Subject|0
871922|NCT01390428|2874845|P1|Overall Study|Withdrawal by Subject|0
871923|NCT01390428|2874840|P6|Overall Study|Elective Surgery|0
871924|NCT01390428|2874841|P5|Overall Study|Elective Surgery|1
871925|NCT01390428|2874842|P4|Overall Study|Elective Surgery|0
871926|NCT01390428|2874843|P3|Overall Study|Elective Surgery|0
871927|NCT01390428|2874844|P2|Overall Study|Elective Surgery|0
871928|NCT01390428|2874845|P1|Overall Study|Elective Surgery|0
871929|NCT01390402|2874908|P1|Overall Study|Disease Progression|4
871930|NCT01390402|2874908|P1|Overall Study|Death|1
871931|NCT01390389|2874914|P2|Overall Study|Screen Fail|1
871932|NCT01390389|2874915|P1|Overall Study|Screen Fail|2
871933|NCT01390389|2874914|P2|Overall Study|Withdrawal by Subject|0
871934|NCT01390389|2874915|P1|Overall Study|Withdrawal by Subject|2
871935|NCT01390181|2874963|P1|Overall Study|Study Terminated due to Low Accrual|3
871936|NCT01390181|2874963|P1|Overall Study|Lost to Follow-up|1
871937|NCT01390038|2874967|P1|Overall Study|Simpliciti System Removal|2
871938|NCT01390038|2874967|P1|Overall Study|Withdrawal by Subject|4
871939|NCT01390038|2874967|P1|Overall Study|Lost to Follow-up|1
871940|NCT01390038|2874967|P1|Overall Study|Death|1
871941|NCT01389973|2874977|P1|Overall Study|Other|10
871942|NCT01389973|2874977|P1|Overall Study|Trial Stopped by Sponsor|9
871943|NCT01389973|2874977|P1|Overall Study|Lost to Follow-up|1
871944|NCT01389882|2874987|P2|Overall Study|Withdrawal by Subject|1
871945|NCT01389882|2874988|P1|Overall Study|Withdrawal by Subject|0
871946|NCT01389882|2874987|P2|Overall Study|Respiratory rate > 80/min during study|3
871947|NCT01389882|2874988|P1|Overall Study|Respiratory rate > 80/min during study|1
871948|NCT01389817|2875076|P2|Overall Study|Withdrawal by Subject|0
871949|NCT01389817|2875077|P1|Overall Study|Withdrawal by Subject|2
871950|NCT01389817|2875076|P2|Overall Study|Lost to Follow-up|0
871951|NCT01389817|2875077|P1|Overall Study|Lost to Follow-up|1
871952|NCT01389817|2875076|P2|Overall Study|Physician Decision|0
871953|NCT01389817|2875077|P1|Overall Study|Physician Decision|1
871954|NCT01389752|2875094|P2|Study Period 2|Sponsor decision|0
871955|NCT01389752|2875095|P1|Study Period 2|Sponsor decision|1
871956|NCT01389752|2875094|P2|Study Period 1|Sponsor decision|2
871957|NCT01389752|2875095|P1|Study Period 1|Sponsor decision|0
871958|NCT01389596|2875108|P3|Overall Study|Other Unspecified|0
871959|NCT01389596|2875109|P2|Overall Study|Other Unspecified|1
871960|NCT01389596|2875110|P1|Overall Study|Other Unspecified|2
871961|NCT01389596|2875108|P3|Overall Study|Death|0
871962|NCT01389596|2875109|P2|Overall Study|Death|1
871963|NCT01389596|2875110|P1|Overall Study|Death|0
871964|NCT01389596|2875108|P3|Overall Study|Adverse Event|0
871965|NCT01389596|2875109|P2|Overall Study|Adverse Event|4
871966|NCT01389596|2875110|P1|Overall Study|Adverse Event|1
871967|NCT01389596|2875108|P3|Overall Study|Insufficient Clinical Response|5
871968|NCT01389596|2875109|P2|Overall Study|Insufficient Clinical Response|4
871969|NCT01389596|2875110|P1|Overall Study|Insufficient Clinical Response|3
871970|NCT01389596|2875108|P3|Overall Study|Withdrawal by Subject|2
871971|NCT01389596|2875109|P2|Overall Study|Withdrawal by Subject|2
871972|NCT01389596|2875110|P1|Overall Study|Withdrawal by Subject|1
871973|NCT01389596|2875108|P3|Overall Study|Protocol Violation|3
871974|NCT01389596|2875109|P2|Overall Study|Protocol Violation|4
871975|NCT01389596|2875110|P1|Overall Study|Protocol Violation|3
871976|NCT01389323|2875169|P1|Follow-up Period (up to 48 Weeks)|Other|3
871977|NCT01389323|2875169|P1|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2
871978|NCT01389323|2875169|P1|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22
871979|NCT01389323|2875169|P1|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10
871980|NCT01389323|2875169|P1|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2
871981|NCT01389323|2875169|P1|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5
871982|NCT01389323|2875169|P1|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10
871983|NCT01389323|2875169|P1|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7
871984|NCT01389323|2875169|P1|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6
871985|NCT01389323|2875169|P1|Treatment Period (up to 48 Weeks)|Adverse Event|24
871986|NCT01389323|2875169|P1|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41
871987|NCT01389102|2875232|P6|Overall Study|Investigator Judgement|0
871988|NCT01389102|2875233|P5|Overall Study|Investigator Judgement|0
871989|NCT01389102|2875234|P4|Overall Study|Investigator Judgement|0
871990|NCT01389102|2875235|P3|Overall Study|Investigator Judgement|0
871991|NCT01389102|2875236|P2|Overall Study|Investigator Judgement|1
871992|NCT01389102|2875237|P1|Overall Study|Investigator Judgement|0
871993|NCT01389102|2875232|P6|Overall Study|Unavailable due to husband's illness|0
871994|NCT01389102|2875233|P5|Overall Study|Unavailable due to husband's illness|0
871995|NCT01389102|2875234|P4|Overall Study|Unavailable due to husband's illness|0
871996|NCT01389102|2875235|P3|Overall Study|Unavailable due to husband's illness|0
871997|NCT01389102|2875236|P2|Overall Study|Unavailable due to husband's illness|1
871998|NCT01389102|2875237|P1|Overall Study|Unavailable due to husband's illness|0
871999|NCT01389102|2875232|P6|Overall Study|Subject Moved|0
872000|NCT01389102|2875233|P5|Overall Study|Subject Moved|0
872001|NCT01389102|2875234|P4|Overall Study|Subject Moved|0
872002|NCT01389102|2875235|P3|Overall Study|Subject Moved|1
872003|NCT01389102|2875236|P2|Overall Study|Subject Moved|0
872004|NCT01389102|2875237|P1|Overall Study|Subject Moved|2
872005|NCT01389102|2875232|P6|Overall Study|Subject Traveling Out of Country|0
872006|NCT01389102|2875233|P5|Overall Study|Subject Traveling Out of Country|0
872007|NCT01389102|2875234|P4|Overall Study|Subject Traveling Out of Country|1
872008|NCT01389102|2875235|P3|Overall Study|Subject Traveling Out of Country|0
872009|NCT01389102|2875236|P2|Overall Study|Subject Traveling Out of Country|0
872010|NCT01389102|2875237|P1|Overall Study|Subject Traveling Out of Country|0
872011|NCT01389102|2875232|P6|Overall Study|Withdrawal by Subject|3
872012|NCT01389102|2875233|P5|Overall Study|Withdrawal by Subject|3
872013|NCT01389102|2875234|P4|Overall Study|Withdrawal by Subject|2
872014|NCT01389102|2875235|P3|Overall Study|Withdrawal by Subject|9
872015|NCT01389102|2875236|P2|Overall Study|Withdrawal by Subject|4
872016|NCT01389102|2875237|P1|Overall Study|Withdrawal by Subject|7
872017|NCT01389102|2875232|P6|Overall Study|Protocol Violation|1
872018|NCT01389102|2875233|P5|Overall Study|Protocol Violation|1
872019|NCT01389102|2875234|P4|Overall Study|Protocol Violation|0
872020|NCT01389102|2875235|P3|Overall Study|Protocol Violation|3
872021|NCT01389102|2875236|P2|Overall Study|Protocol Violation|0
872022|NCT01389102|2875237|P1|Overall Study|Protocol Violation|0
872023|NCT01389102|2875232|P6|Overall Study|Lost to Follow-up|1
872024|NCT01389102|2875233|P5|Overall Study|Lost to Follow-up|4
872025|NCT01389102|2875234|P4|Overall Study|Lost to Follow-up|2
872026|NCT01389102|2875235|P3|Overall Study|Lost to Follow-up|1
872027|NCT01389102|2875236|P2|Overall Study|Lost to Follow-up|1
872028|NCT01389102|2875237|P1|Overall Study|Lost to Follow-up|4
872029|NCT01389102|2875232|P6|Overall Study|Hurricane Katrina|1
872030|NCT01389102|2875233|P5|Overall Study|Hurricane Katrina|3
872031|NCT01389102|2875234|P4|Overall Study|Hurricane Katrina|0
872032|NCT01389102|2875235|P3|Overall Study|Hurricane Katrina|3
872033|NCT01389102|2875236|P2|Overall Study|Hurricane Katrina|2
872034|NCT01389102|2875237|P1|Overall Study|Hurricane Katrina|4
872035|NCT01389102|2875232|P6|Overall Study|Adverse Event|2
872036|NCT01389102|2875233|P5|Overall Study|Adverse Event|2
872037|NCT01389102|2875234|P4|Overall Study|Adverse Event|2
872038|NCT01389102|2875235|P3|Overall Study|Adverse Event|2
872039|NCT01389102|2875236|P2|Overall Study|Adverse Event|3
872040|NCT01389102|2875237|P1|Overall Study|Adverse Event|1
872041|NCT01388907|2875315|P2|Overall Study|Adverse Event|0
872042|NCT01388907|2875316|P1|Overall Study|Adverse Event|2
872043|NCT01388816|2875332|P4|Overall Study|Protocol Violation|0
872044|NCT01388816|2875333|P3|Overall Study|Protocol Violation|2
872045|NCT01388816|2875334|P2|Overall Study|Protocol Violation|0
872046|NCT01388816|2875335|P1|Overall Study|Protocol Violation|0
872047|NCT01388816|2875332|P4|Overall Study|Withdrawal by Subject|0
872048|NCT01388816|2875333|P3|Overall Study|Withdrawal by Subject|1
872049|NCT01388816|2875334|P2|Overall Study|Withdrawal by Subject|1
872050|NCT01388816|2875335|P1|Overall Study|Withdrawal by Subject|2
872051|NCT01388816|2875332|P4|Overall Study|Lost to Follow-up|0
872052|NCT01388816|2875333|P3|Overall Study|Lost to Follow-up|0
872053|NCT01388816|2875334|P2|Overall Study|Lost to Follow-up|1
872054|NCT01388816|2875335|P1|Overall Study|Lost to Follow-up|0
872055|NCT01388816|2875332|P4|Overall Study|Adverse Event|0
872056|NCT01388816|2875333|P3|Overall Study|Adverse Event|0
872057|NCT01388816|2875334|P2|Overall Study|Adverse Event|2
872058|NCT01388816|2875335|P1|Overall Study|Adverse Event|0
872059|NCT01388790|2875364|P1|Overall Study|Ongoing at data cut−off date|8
872060|NCT01388647|2875375|P2|Overall Study|Adverse Event|2
872061|NCT01388647|2875376|P1|Overall Study|Adverse Event|1
872062|NCT01388530|2875387|P1|Overall Study|Lost to Follow-up|5
872063|NCT01388491|2875396|P2|Overall Study|Pregnancy|0
872064|NCT01388491|2875397|P1|Overall Study|Pregnancy|1
872065|NCT01388491|2875396|P2|Overall Study|Noncompliance|0
872066|NCT01388491|2875397|P1|Overall Study|Noncompliance|2
872067|NCT01388491|2875396|P2|Overall Study|Protocol Violation|0
872068|NCT01388491|2875397|P1|Overall Study|Protocol Violation|2
872069|NCT01388491|2875396|P2|Overall Study|Lost to Follow-up|3
872070|NCT01388491|2875397|P1|Overall Study|Lost to Follow-up|4
872071|NCT01388491|2875396|P2|Overall Study|Withdrawal by Subject|10
872072|NCT01388491|2875397|P1|Overall Study|Withdrawal by Subject|6
872073|NCT01388491|2875396|P2|Overall Study|Sponsor Request|7
872074|NCT01388491|2875397|P1|Overall Study|Sponsor Request|9
872075|NCT01388491|2875396|P2|Overall Study|Adverse Event|9
872076|NCT01388491|2875397|P1|Overall Study|Adverse Event|10
872077|NCT01388361|2875432|P3|Overall Study|Unclassified|1
872078|NCT01388361|2875433|P2|Overall Study|Unclassified|0
872079|NCT01388361|2875434|P1|Overall Study|Unclassified|0
872080|NCT01388361|2875432|P3|Overall Study|Withdrawal criteria|10
872081|NCT01388361|2875433|P2|Overall Study|Withdrawal criteria|7
872082|NCT01388361|2875434|P1|Overall Study|Withdrawal criteria|12
872083|NCT01388361|2875432|P3|Overall Study|Protocol Violation|2
872084|NCT01388361|2875433|P2|Overall Study|Protocol Violation|0
872085|NCT01388361|2875434|P1|Overall Study|Protocol Violation|0
872086|NCT01388361|2875432|P3|Overall Study|Adverse Event|1
872087|NCT01388361|2875433|P2|Overall Study|Adverse Event|5
872088|NCT01388361|2875434|P1|Overall Study|Adverse Event|0
872089|NCT01388166|2875451|P1|Overall Study|Others than specified above|13
872090|NCT01388166|2875451|P1|Overall Study|Lost to Follow-up|30
872091|NCT01388166|2875451|P1|Overall Study|Adverse Event|16
872092|NCT01387789|2875457|P1|Overall Study|Lost to Follow-up|1
872093|NCT01387789|2875457|P1|Overall Study|Lack of Efficacy|2
872094|NCT01387789|2875457|P1|Overall Study|Adverse Event|5
872095|NCT01387737|2875471|P2|Overall Study|Clearly not eligible for the study|3
872096|NCT01387737|2875472|P1|Overall Study|Clearly not eligible for the study|1
872097|NCT01387737|2875471|P2|Overall Study|Withdrawal by Subject|31
872098|NCT01387737|2875472|P1|Overall Study|Withdrawal by Subject|27
872099|NCT01387737|2875471|P2|Overall Study|Physician Decision|10
872100|NCT01387737|2875472|P1|Overall Study|Physician Decision|3
872101|NCT01387737|2875471|P2|Overall Study|Lack of Efficacy|0
872102|NCT01387737|2875472|P1|Overall Study|Lack of Efficacy|1
872103|NCT01387737|2875471|P2|Overall Study|Adverse Event|30
872104|NCT01387737|2875472|P1|Overall Study|Adverse Event|20
872105|NCT01387607|2875506|P2|Overall Study|Randomized, not treated|6
872106|NCT01387607|2875507|P1|Overall Study|Randomized, not treated|3
872107|NCT01387607|2875506|P2|Overall Study|Other|1
872108|NCT01387607|2875507|P1|Overall Study|Other|1
872109|NCT01387607|2875506|P2|Overall Study|Withdrawal by Subject|14
872110|NCT01387607|2875507|P1|Overall Study|Withdrawal by Subject|13
872111|NCT01387607|2875506|P2|Overall Study|Protocol Violation|5
872112|NCT01387607|2875507|P1|Overall Study|Protocol Violation|1
872113|NCT01387607|2875506|P2|Overall Study|No longer meets eligibility criteria|1
872114|NCT01387607|2875507|P1|Overall Study|No longer meets eligibility criteria|0
872115|NCT01387607|2875506|P2|Overall Study|Lost to Follow-up|1
872116|NCT01387607|2875507|P1|Overall Study|Lost to Follow-up|2
872117|NCT01387607|2875506|P2|Overall Study|Lack of Efficacy|6
872118|NCT01387607|2875507|P1|Overall Study|Lack of Efficacy|8
872119|NCT01387607|2875506|P2|Overall Study|Adverse Event|11
872120|NCT01387607|2875507|P1|Overall Study|Adverse Event|23
872121|NCT01387594|2875561|P2|Overall Study|Lost to Follow-up|1
872122|NCT01387594|2875562|P1|Overall Study|Lost to Follow-up|0
872123|NCT01387594|2875561|P2|Overall Study|Withdrawal by Subject|2
872124|NCT01387594|2875562|P1|Overall Study|Withdrawal by Subject|0
872125|NCT01387542|2875590|P1|Overall Study|Lost to Follow-up|1
872126|NCT01387542|2875590|P1|Overall Study|Non-compliant|1
872127|NCT01387542|2875590|P1|Overall Study|Insufficient response|1
872128|NCT01387542|2875590|P1|Overall Study|Changed diagnosis|1
872129|NCT01387542|2875590|P1|Overall Study|Withdrawal by Subject|1
872130|NCT01387542|2875590|P1|Overall Study|Adverse Event|3
872131|NCT01387347|2875608|P2|Overall Study|Lost to Follow-up|1
872132|NCT01387347|2875609|P1|Overall Study|Lost to Follow-up|2
872133|NCT01387282|2875621|P2|Overall Study|Lost to Follow-up|1
872134|NCT01387282|2875622|P1|Overall Study|Lost to Follow-up|4
872135|NCT01387282|2875621|P2|Overall Study|Study drug-related AE|2
872136|NCT01387282|2875622|P1|Overall Study|Study drug-related AE|2
872137|NCT01387282|2875621|P2|Overall Study|Withdrawal by patient|23
872138|NCT01387282|2875622|P1|Overall Study|Withdrawal by patient|33
872139|NCT01387282|2875621|P2|Overall Study|Unrelated AE|4
872140|NCT01387282|2875622|P1|Overall Study|Unrelated AE|6
872141|NCT01387282|2875621|P2|Overall Study|Other|1
872142|NCT01387282|2875622|P1|Overall Study|Other|5
872143|NCT01387282|2875621|P2|Overall Study|Death|16
872144|NCT01387282|2875622|P1|Overall Study|Death|47
872145|NCT01387269|2875638|P2|Overall Study|Lost to Follow-up|0
872146|NCT01387269|2875639|P1|Overall Study|Lost to Follow-up|1
872147|NCT01387269|2875638|P2|Overall Study|Study drug-related AE|0
872148|NCT01387269|2875639|P1|Overall Study|Study drug-related AE|1
872149|NCT01387269|2875638|P2|Overall Study|Withdrawal by patient|10
872150|NCT01387269|2875639|P1|Overall Study|Withdrawal by patient|32
872151|NCT01387269|2875638|P2|Overall Study|Unrelated AE|3
872152|NCT01387269|2875639|P1|Overall Study|Unrelated AE|12
872153|NCT01387269|2875638|P2|Overall Study|Other|7
872154|NCT01387269|2875639|P1|Overall Study|Other|8
872155|NCT01387269|2875638|P2|Overall Study|Death|20
872156|NCT01387269|2875639|P1|Overall Study|Death|38
872157|NCT01387230|2875656|P3|Overall Study|Withdrawal by Subject|0
872158|NCT01387230|2875657|P2|Overall Study|Withdrawal by Subject|1
872159|NCT01387230|2875658|P1|Overall Study|Withdrawal by Subject|4
872160|NCT01387230|2875656|P3|Overall Study|Lost to Follow-up|1
872161|NCT01387230|2875657|P2|Overall Study|Lost to Follow-up|0
872162|NCT01387230|2875658|P1|Overall Study|Lost to Follow-up|0
872163|NCT01387230|2875656|P3|Overall Study|Protocol-defined Stopping Criteria|5
872164|NCT01387230|2875657|P2|Overall Study|Protocol-defined Stopping Criteria|0
872165|NCT01387230|2875658|P1|Overall Study|Protocol-defined Stopping Criteria|6
872166|NCT01387230|2875656|P3|Overall Study|Lack of Efficacy|4
872167|NCT01387230|2875657|P2|Overall Study|Lack of Efficacy|5
872168|NCT01387230|2875658|P1|Overall Study|Lack of Efficacy|8
872169|NCT01387230|2875656|P3|Overall Study|Adverse Event|3
872170|NCT01387230|2875657|P2|Overall Study|Adverse Event|1
872171|NCT01387230|2875658|P1|Overall Study|Adverse Event|0
872172|NCT01387074|2875704|P1|Overall Study|Lack of Efficacy|1
872173|NCT01387074|2875704|P1|Overall Study|Lost to Follow-up|7
872174|NCT01387022|2875717|P2|Overall Study|Lost to Follow-up|3
872175|NCT01387022|2875718|P1|Overall Study|Lost to Follow-up|0
872176|NCT01387022|2875717|P2|Overall Study|Death|1
872177|NCT01387022|2875718|P1|Overall Study|Death|1
872178|NCT01386944|2875745|P1|Overall Study|Unspecified reason|8
872179|NCT01386944|2875745|P1|Overall Study|Lost to Follow-up|8
872180|NCT01386944|2875745|P1|Overall Study|Lack of Efficacy|14
872181|NCT01386944|2875745|P1|Overall Study|Adverse Event|26
872182|NCT01386788|2875755|P1|Overall Study|Lost to Follow-up|2
872183|NCT01386684|2875760|P1|Overall Study|Missing|3
872184|NCT01386684|2875760|P1|Overall Study|Protocol Violation|4
872185|NCT01386684|2875760|P1|Overall Study|Noncompliance|8
872186|NCT01386684|2875760|P1|Overall Study|Adverse Event|20
872187|NCT01386684|2875760|P1|Overall Study|Disease Progression|28
872188|NCT01386684|2875760|P1|Overall Study|Alternative Therapy Required|37
872189|NCT01386684|2875760|P1|Overall Study|Withdrawal of Consent|44
872190|NCT01386684|2875760|P1|Overall Study|Death|47
872191|NCT01386684|2875760|P1|Overall Study|Not Specified|51
872192|NCT01386684|2875760|P1|Overall Study|Lost to Follow-up|51
872193|NCT01386606|2875814|P4|Overall Study|T levels too high|0
872194|NCT01386606|2875815|P3|Overall Study|T levels too high|1
872195|NCT01386606|2875816|P2|Overall Study|T levels too high|1
872196|NCT01386606|2875817|P1|Overall Study|T levels too high|0
872197|NCT01386606|2875814|P4|Overall Study|Unable to draw PK|0
872198|NCT01386606|2875815|P3|Overall Study|Unable to draw PK|0
872199|NCT01386606|2875816|P2|Overall Study|Unable to draw PK|0
872200|NCT01386606|2875817|P1|Overall Study|Unable to draw PK|1
872201|NCT01386606|2875814|P4|Overall Study|Subject incarcerated|0
872202|NCT01386606|2875815|P3|Overall Study|Subject incarcerated|0
872203|NCT01386606|2875816|P2|Overall Study|Subject incarcerated|1
872204|NCT01386606|2875817|P1|Overall Study|Subject incarcerated|0
872205|NCT01386606|2875814|P4|Overall Study|Lost to Follow-up|0
872206|NCT01386606|2875815|P3|Overall Study|Lost to Follow-up|0
872207|NCT01386606|2875816|P2|Overall Study|Lost to Follow-up|0
872208|NCT01386606|2875817|P1|Overall Study|Lost to Follow-up|2
872209|NCT01386606|2875814|P4|Overall Study|Protocol Violation|1
872210|NCT01386606|2875815|P3|Overall Study|Protocol Violation|1
872211|NCT01386606|2875816|P2|Overall Study|Protocol Violation|0
872212|NCT01386606|2875817|P1|Overall Study|Protocol Violation|1
872213|NCT01386606|2875814|P4|Overall Study|Withdrawal by Subject|0
872214|NCT01386606|2875815|P3|Overall Study|Withdrawal by Subject|1
872215|NCT01386606|2875816|P2|Overall Study|Withdrawal by Subject|1
872216|NCT01386606|2875817|P1|Overall Study|Withdrawal by Subject|0
872217|NCT01386606|2875814|P4|Overall Study|Adverse Event|0
872218|NCT01386606|2875815|P3|Overall Study|Adverse Event|0
872219|NCT01386606|2875816|P2|Overall Study|Adverse Event|1
872220|NCT01386606|2875817|P1|Overall Study|Adverse Event|0
872221|NCT01386125|2875876|P2|Overall Study|Participant Leaving Country|0
872222|NCT01386125|2875877|P1|Overall Study|Participant Leaving Country|1
872223|NCT01386125|2875876|P2|Overall Study|Lack of Efficacy|1
872224|NCT01386125|2875877|P1|Overall Study|Lack of Efficacy|0
872225|NCT01386125|2875876|P2|Overall Study|Adverse Event|5
872226|NCT01386125|2875877|P1|Overall Study|Adverse Event|2
872227|NCT01386125|2875876|P2|Overall Study|Withdrawal by Subject|12
872228|NCT01386125|2875877|P1|Overall Study|Withdrawal by Subject|13
872229|NCT01386125|2875876|P2|Overall Study|Disease Progress|2
872230|NCT01386125|2875877|P1|Overall Study|Disease Progress|1
872231|NCT01386125|2875876|P2|Overall Study|Protocol Violation|7
872232|NCT01386125|2875877|P1|Overall Study|Protocol Violation|5
872233|NCT01386125|2875876|P2|Overall Study|Physician Decision|1
872234|NCT01386125|2875877|P1|Overall Study|Physician Decision|0
872235|NCT01386125|2875876|P2|Overall Study|Lost to Follow-up|9
872236|NCT01386125|2875877|P1|Overall Study|Lost to Follow-up|3
872237|NCT01386008|2875885|P1|Overall Study|Adverse Event|3
872238|NCT01386008|2875885|P1|Overall Study|exited w/o incident /study discontinued|17
872239|NCT01385995|2875894|P2|Period 1, 2 Months|Physician Decision|0
872240|NCT01385995|2875895|P1|Period 1, 2 Months|Physician Decision|1
872241|NCT01385748|2875912|P3|Overall Study|Adverse Event|1
872242|NCT01385748|2875913|P2|Overall Study|Adverse Event|2
872243|NCT01385748|2875914|P1|Overall Study|Adverse Event|4
872244|NCT01385748|2875912|P3|Overall Study|Not specified|1
872245|NCT01385748|2875913|P2|Overall Study|Not specified|7
872246|NCT01385748|2875914|P1|Overall Study|Not specified|1
872247|NCT01385748|2875912|P3|Overall Study|Noncompliance|6
872248|NCT01385748|2875913|P2|Overall Study|Noncompliance|1
872249|NCT01385748|2875914|P1|Overall Study|Noncompliance|3
872250|NCT01385748|2875912|P3|Overall Study|Withdrawal by Subject|5
872251|NCT01385748|2875913|P2|Overall Study|Withdrawal by Subject|4
872252|NCT01385748|2875914|P1|Overall Study|Withdrawal by Subject|7
872253|NCT01385566|2875999|P6|Overall Study|Withdrawal by Subject|0
872254|NCT01385566|2876000|P5|Overall Study|Withdrawal by Subject|0
872255|NCT01385566|2876001|P4|Overall Study|Withdrawal by Subject|1
872256|NCT01385566|2876002|P3|Overall Study|Withdrawal by Subject|0
872257|NCT01385566|2876003|P2|Overall Study|Withdrawal by Subject|0
872258|NCT01385566|2876004|P1|Overall Study|Withdrawal by Subject|0
872259|NCT01385566|2875999|P6|Overall Study|Lost to Follow-up|0
872260|NCT01385566|2876000|P5|Overall Study|Lost to Follow-up|0
872261|NCT01385566|2876001|P4|Overall Study|Lost to Follow-up|0
872262|NCT01385566|2876002|P3|Overall Study|Lost to Follow-up|0
872263|NCT01385566|2876003|P2|Overall Study|Lost to Follow-up|0
872264|NCT01385566|2876004|P1|Overall Study|Lost to Follow-up|1
872265|NCT01385371|2876058|P2|Overall Study|Administrative|2
872266|NCT01385371|2876059|P1|Overall Study|Administrative|2
872267|NCT01385371|2876058|P2|Overall Study|Protocol Violation|21
872268|NCT01385371|2876059|P1|Overall Study|Protocol Violation|25
872269|NCT01385371|2876058|P2|Overall Study|Withdrawal by Subject|39
872270|NCT01385371|2876059|P1|Overall Study|Withdrawal by Subject|52
872271|NCT01385371|2876058|P2|Overall Study|Lost to Follow-up|16
872272|NCT01385371|2876059|P1|Overall Study|Lost to Follow-up|16
872273|NCT01385371|2876058|P2|Overall Study|Adverse Event|19
872274|NCT01385371|2876059|P1|Overall Study|Adverse Event|54
872275|NCT01385202|2876107|P1|Overall Study|Withdrawn|1
872276|NCT01385202|2876107|P1|Overall Study|Not Eligible|11
872277|NCT01385202|2876107|P1|Overall Study|Lost to Follow-up|6
872278|NCT01385098|2876159|P1|Overall Study|Lost to Follow-up|4
872279|NCT01385098|2876159|P1|Overall Study|Adverse Event|10
872280|NCT01384760|2876181|P2|Overall Study|Protocol Violation|0
872281|NCT01384760|2876182|P1|Overall Study|Protocol Violation|16
872282|NCT01384760|2876181|P2|Overall Study|Lost to Follow-up|6
872283|NCT01384760|2876182|P1|Overall Study|Lost to Follow-up|0
872284|NCT01384734|2876195|P5|Overall Study|Physician Decision|0
872285|NCT01384734|2876196|P4|Overall Study|Physician Decision|0
872286|NCT01384734|2876197|P3|Overall Study|Physician Decision|0
872287|NCT01384734|2876198|P2|Overall Study|Physician Decision|0
872288|NCT01384734|2876199|P1|Overall Study|Physician Decision|1
872289|NCT01384734|2876195|P5|Overall Study|Early termination|1
872290|NCT01384734|2876196|P4|Overall Study|Early termination|0
872291|NCT01384734|2876197|P3|Overall Study|Early termination|0
872292|NCT01384734|2876198|P2|Overall Study|Early termination|0
872293|NCT01384734|2876199|P1|Overall Study|Early termination|0
872294|NCT01384734|2876195|P5|Overall Study|Adhesion problem|0
872295|NCT01384734|2876196|P4|Overall Study|Adhesion problem|1
872296|NCT01384734|2876197|P3|Overall Study|Adhesion problem|0
872297|NCT01384734|2876198|P2|Overall Study|Adhesion problem|0
872298|NCT01384734|2876199|P1|Overall Study|Adhesion problem|0
872299|NCT01384734|2876195|P5|Overall Study|Missed End of treatment visit|0
872300|NCT01384734|2876196|P4|Overall Study|Missed End of treatment visit|1
872301|NCT01384734|2876197|P3|Overall Study|Missed End of treatment visit|0
872302|NCT01384734|2876198|P2|Overall Study|Missed End of treatment visit|0
872303|NCT01384734|2876199|P1|Overall Study|Missed End of treatment visit|0
872304|NCT01384734|2876195|P5|Overall Study|As per Exclusion criteria|0
872305|NCT01384734|2876196|P4|Overall Study|As per Exclusion criteria|0
872306|NCT01384734|2876197|P3|Overall Study|As per Exclusion criteria|0
872307|NCT01384734|2876198|P2|Overall Study|As per Exclusion criteria|1
872308|NCT01384734|2876199|P1|Overall Study|As per Exclusion criteria|0
872309|NCT01384734|2876195|P5|Overall Study|Prison|0
872310|NCT01384734|2876196|P4|Overall Study|Prison|0
872311|NCT01384734|2876197|P3|Overall Study|Prison|1
872312|NCT01384734|2876198|P2|Overall Study|Prison|0
872313|NCT01384734|2876199|P1|Overall Study|Prison|0
872314|NCT01384734|2876195|P5|Overall Study|Unable to come back for visit|0
872315|NCT01384734|2876196|P4|Overall Study|Unable to come back for visit|1
872316|NCT01384734|2876197|P3|Overall Study|Unable to come back for visit|1
872317|NCT01384734|2876198|P2|Overall Study|Unable to come back for visit|0
872318|NCT01384734|2876199|P1|Overall Study|Unable to come back for visit|1
872319|NCT01384734|2876195|P5|Overall Study|Investigator relocating|1
872320|NCT01384734|2876196|P4|Overall Study|Investigator relocating|3
872321|NCT01384734|2876197|P3|Overall Study|Investigator relocating|0
872322|NCT01384734|2876198|P2|Overall Study|Investigator relocating|2
872323|NCT01384734|2876199|P1|Overall Study|Investigator relocating|0
872324|NCT01384734|2876195|P5|Overall Study|Withdrawal by Subject|9
872325|NCT01384734|2876196|P4|Overall Study|Withdrawal by Subject|7
872326|NCT01384734|2876197|P3|Overall Study|Withdrawal by Subject|6
872327|NCT01384734|2876198|P2|Overall Study|Withdrawal by Subject|5
872328|NCT01384734|2876199|P1|Overall Study|Withdrawal by Subject|5
872329|NCT01384734|2876195|P5|Overall Study|Sponsor terminated|1
872330|NCT01384734|2876196|P4|Overall Study|Sponsor terminated|0
872331|NCT01384734|2876197|P3|Overall Study|Sponsor terminated|0
872332|NCT01384734|2876198|P2|Overall Study|Sponsor terminated|0
872333|NCT01384734|2876199|P1|Overall Study|Sponsor terminated|0
872334|NCT01384734|2876195|P5|Overall Study|Pregnancy|1
872335|NCT01384734|2876196|P4|Overall Study|Pregnancy|0
872336|NCT01384734|2876197|P3|Overall Study|Pregnancy|0
872337|NCT01384734|2876198|P2|Overall Study|Pregnancy|1
872338|NCT01384734|2876199|P1|Overall Study|Pregnancy|0
872339|NCT01384734|2876195|P5|Overall Study|Non-compliance with study drug|2
872340|NCT01384734|2876196|P4|Overall Study|Non-compliance with study drug|0
872341|NCT01384734|2876197|P3|Overall Study|Non-compliance with study drug|6
872342|NCT01384734|2876198|P2|Overall Study|Non-compliance with study drug|2
872343|NCT01384734|2876199|P1|Overall Study|Non-compliance with study drug|1
872344|NCT01384734|2876195|P5|Overall Study|Lost to Follow-up|5
872345|NCT01384734|2876196|P4|Overall Study|Lost to Follow-up|8
872346|NCT01384734|2876197|P3|Overall Study|Lost to Follow-up|3
872347|NCT01384734|2876198|P2|Overall Study|Lost to Follow-up|3
872348|NCT01384734|2876199|P1|Overall Study|Lost to Follow-up|5
872349|NCT01384734|2876195|P5|Overall Study|Lack of Efficacy|2
872350|NCT01384734|2876196|P4|Overall Study|Lack of Efficacy|4
872351|NCT01384734|2876197|P3|Overall Study|Lack of Efficacy|4
872352|NCT01384734|2876198|P2|Overall Study|Lack of Efficacy|7
872353|NCT01384734|2876199|P1|Overall Study|Lack of Efficacy|3
872354|NCT01384734|2876195|P5|Overall Study|Continuation criteria not met|0
872355|NCT01384734|2876196|P4|Overall Study|Continuation criteria not met|1
872356|NCT01384734|2876197|P3|Overall Study|Continuation criteria not met|1
872357|NCT01384734|2876198|P2|Overall Study|Continuation criteria not met|0
872358|NCT01384734|2876199|P1|Overall Study|Continuation criteria not met|0
872359|NCT01384734|2876195|P5|Overall Study|Death|0
872360|NCT01384734|2876196|P4|Overall Study|Death|0
872361|NCT01384734|2876197|P3|Overall Study|Death|1
872362|NCT01384734|2876198|P2|Overall Study|Death|0
872363|NCT01384734|2876199|P1|Overall Study|Death|1
872364|NCT01384734|2876195|P5|Overall Study|Adverse Event|7
872365|NCT01384734|2876196|P4|Overall Study|Adverse Event|2
872366|NCT01384734|2876197|P3|Overall Study|Adverse Event|0
872367|NCT01384734|2876198|P2|Overall Study|Adverse Event|3
872368|NCT01384734|2876199|P1|Overall Study|Adverse Event|0
872369|NCT01384292|2876428|P3|Part B|Severe non-compliance to protocol|0
872370|NCT01384292|2876429|P2|Part B|Severe non-compliance to protocol|0
872371|NCT01384292|2876430|P1|Part B|Severe non-compliance to protocol|1
872372|NCT01384019|2876442|P2|Overall Study|MRI refusal|6
872373|NCT01384019|2876443|P1|Overall Study|MRI refusal|6
872374|NCT01384019|2876442|P2|Overall Study|Death|0
872375|NCT01384019|2876443|P1|Overall Study|Death|1
872376|NCT01384019|2876442|P2|Overall Study|Withdrawal by Subject|0
872377|NCT01384019|2876443|P1|Overall Study|Withdrawal by Subject|3
872378|NCT01383993|2876452|P3|Overall Study|Marketed voriconazole in post-therapy|0
872379|NCT01383993|2876453|P2|Overall Study|Marketed voriconazole in post-therapy|0
872380|NCT01383993|2876454|P1|Overall Study|Marketed voriconazole in post-therapy|2
872381|NCT01383993|2876452|P3|Overall Study|Withdrawal by Subject|1
872382|NCT01383993|2876453|P2|Overall Study|Withdrawal by Subject|0
872383|NCT01383993|2876454|P1|Overall Study|Withdrawal by Subject|0
872384|NCT01383993|2876452|P3|Overall Study|Adverse Event|0
872385|NCT01383993|2876453|P2|Overall Study|Adverse Event|1
872386|NCT01383993|2876454|P1|Overall Study|Adverse Event|1
872387|NCT01383954|2876501|P1|Overall Study|Reason Not Specified|9
872388|NCT01383954|2876501|P1|Overall Study|Adverse Event|1
872389|NCT01383954|2876501|P1|Overall Study|Electronic Diary Too Cumbersome to Use|2
872390|NCT01383954|2876501|P1|Overall Study|Lack of Efficacy|2
872391|NCT01383928|2876509|P3|Phase 2|Unsatisfactory therapeutic response|1
872392|NCT01383928|2876510|P2|Phase 2|Unsatisfactory therapeutic response|0
872393|NCT01383928|2876511|P1|Phase 2|Unsatisfactory therapeutic response|0
872394|NCT01383928|2876509|P3|Phase 2|Withdrawal by Subject|4
872395|NCT01383928|2876510|P2|Phase 2|Withdrawal by Subject|0
872396|NCT01383928|2876511|P1|Phase 2|Withdrawal by Subject|0
872397|NCT01383928|2876509|P3|Phase 2|Progressive Disease|5
872398|NCT01383928|2876510|P2|Phase 2|Progressive Disease|0
872399|NCT01383928|2876511|P1|Phase 2|Progressive Disease|0
872400|NCT01383928|2876509|P3|Phase 2|Other|4
872401|NCT01383928|2876510|P2|Phase 2|Other|0
872402|NCT01383928|2876511|P1|Phase 2|Other|0
872403|NCT01383928|2876509|P3|Phase 2|Adverse Event|8
872404|NCT01383928|2876510|P2|Phase 2|Adverse Event|0
872405|NCT01383928|2876511|P1|Phase 2|Adverse Event|0
872406|NCT01383928|2876509|P3|Phase 2|Autologous Stem Cell Transplantation|18
872407|NCT01383928|2876510|P2|Phase 2|Autologous Stem Cell Transplantation|0
872408|NCT01383928|2876511|P1|Phase 2|Autologous Stem Cell Transplantation|0
872409|NCT01383928|2876509|P3|Phase 1|Progressive Disease|0
872410|NCT01383928|2876510|P2|Phase 1|Progressive Disease|1
872411|NCT01383928|2876511|P1|Phase 1|Progressive Disease|1
872412|NCT01383928|2876509|P3|Phase 1|Other|0
872413|NCT01383928|2876510|P2|Phase 1|Other|3
872414|NCT01383928|2876511|P1|Phase 1|Other|1
872415|NCT01383928|2876509|P3|Phase 1|Adverse Event|0
872416|NCT01383928|2876510|P2|Phase 1|Adverse Event|2
872417|NCT01383928|2876511|P1|Phase 1|Adverse Event|1
872418|NCT01383928|2876509|P3|Phase 1|Autologous Stem Cell Transplantation|0
872419|NCT01383928|2876510|P2|Phase 1|Autologous Stem Cell Transplantation|1
872420|NCT01383928|2876511|P1|Phase 1|Autologous Stem Cell Transplantation|2
872421|NCT01383707|2876575|P1|Overall Study|Progressive disease|23
872422|NCT01383707|2876575|P1|Overall Study|Adverse Event|14
872423|NCT01383707|2876575|P1|Overall Study|Sponsor's decision|2
872424|NCT01383707|2876575|P1|Overall Study|Not specified|8
872425|NCT01383707|2876575|P1|Overall Study|Death|19
872426|NCT01383707|2876575|P1|Overall Study|Consent withdrawal|6
872427|NCT01383499|2876615|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
872428|NCT01383499|2876616|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
872429|NCT01383499|2876617|P2|Period 1 (4 Weeks)|Withdrawal by Subject|0
872430|NCT01383499|2876618|P1|Period 1 (4 Weeks)|Withdrawal by Subject|1
872431|NCT01383486|2876668|P1|Overall Study|Did not take any product|6
872432|NCT01383486|2876668|P1|Overall Study|Incomplete information for analysis|2
872433|NCT01383486|2876668|P1|Overall Study|Lost to Follow-up|10
872434|NCT01383356|2876745|P2|Period 1|Personal|2
872435|NCT01383356|2876746|P1|Period 1|Personal|0
872436|NCT01383356|2876745|P2|Period 1|Out of Range Mid-study-Test|1
872437|NCT01383356|2876746|P1|Period 1|Out of Range Mid-study-Test|0
872438|NCT01383356|2876745|P2|Period 1|Non-compliance|0
872439|NCT01383356|2876746|P1|Period 1|Non-compliance|3
872440|NCT01383356|2876745|P2|Period 1|Adverse Event|3
872441|NCT01383356|2876746|P1|Period 1|Adverse Event|5
872442|NCT01383317|2876758|P2|Overall Study|Adverse Event|1
872443|NCT01383317|2876759|P1|Overall Study|Adverse Event|0
872444|NCT01383317|2876758|P2|Overall Study|Death|0
872445|NCT01383317|2876759|P1|Overall Study|Death|1
872446|NCT01383317|2876758|P2|Overall Study|Lost to Follow-up|1
872447|NCT01383317|2876759|P1|Overall Study|Lost to Follow-up|2
872448|NCT01383174|2876801|P2|6 Month Assessment|Refused to complete|0
872449|NCT01383174|2876802|P1|6 Month Assessment|Refused to complete|4
872450|NCT01383174|2876801|P2|6 Month Assessment|Lost to Follow-up|1
872451|NCT01383174|2876802|P1|6 Month Assessment|Lost to Follow-up|1
872452|NCT01383174|2876801|P2|3 Month Assessment|Refused to complete|0
872453|NCT01383174|2876802|P1|3 Month Assessment|Refused to complete|4
872454|NCT01383174|2876801|P2|3 Month Assessment|Lost to Follow-up|0
872455|NCT01383174|2876802|P1|3 Month Assessment|Lost to Follow-up|2
872456|NCT01383174|2876801|P2|3 Month Assessment|Death|1
872457|NCT01383174|2876802|P1|3 Month Assessment|Death|0
872458|NCT01383161|2876828|P2|Overall Study|Lack of Efficacy|1
872459|NCT01383161|2876829|P1|Overall Study|Lack of Efficacy|0
872460|NCT01383161|2876828|P2|Overall Study|Withdrawal by Subject|2
872461|NCT01383161|2876829|P1|Overall Study|Withdrawal by Subject|0
872462|NCT01383161|2876828|P2|Overall Study|Adverse Event|1
872463|NCT01383161|2876829|P1|Overall Study|Adverse Event|5
872464|NCT01383096|2876848|P3|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
872465|NCT01383096|2876849|P2|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
872466|NCT01383096|2876850|P1|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1
872467|NCT01383096|2876848|P3|Fifth Intervention (8 Days)|Withdrawal by Subject|0
872468|NCT01383096|2876849|P2|Fifth Intervention (8 Days)|Withdrawal by Subject|0
872469|NCT01383096|2876850|P1|Fifth Intervention (8 Days)|Withdrawal by Subject|1
872470|NCT01383096|2876848|P3|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
872471|NCT01383096|2876849|P2|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
872472|NCT01383096|2876850|P1|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1
872473|NCT01383096|2876848|P3|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
872474|NCT01383096|2876849|P2|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
872475|NCT01383096|2876850|P1|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
872476|NCT01383096|2876848|P3|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
872477|NCT01383096|2876849|P2|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
872478|NCT01383096|2876850|P1|Third Intervention (8 Days)|QTcF was greater than 450 msec|1
872479|NCT01383096|2876848|P3|Third Intervention (8 Days)|Withdrawal by Subject|0
872480|NCT01383096|2876849|P2|Third Intervention (8 Days)|Withdrawal by Subject|0
872481|NCT01383096|2876850|P1|Third Intervention (8 Days)|Withdrawal by Subject|1
872482|NCT01383096|2876848|P3|Third Intervention (8 Days)|Adverse Event|0
872483|NCT01383096|2876849|P2|Third Intervention (8 Days)|Adverse Event|0
872484|NCT01383096|2876850|P1|Third Intervention (8 Days)|Adverse Event|1
872485|NCT01383096|2876848|P3|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
872486|NCT01383096|2876849|P2|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3
872487|NCT01383096|2876850|P1|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
872488|NCT01383096|2876848|P3|Third Intervention (8 Days)|Elevated AST|0
872489|NCT01383096|2876849|P2|Third Intervention (8 Days)|Elevated AST|1
872490|NCT01383096|2876850|P1|Third Intervention (8 Days)|Elevated AST|0
872491|NCT01383096|2876848|P3|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
872492|NCT01383096|2876849|P2|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
872493|NCT01383096|2876850|P1|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
872494|NCT01383096|2876848|P3|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
872495|NCT01383096|2876849|P2|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
872496|NCT01383096|2876850|P1|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
872497|NCT01382940|2876918|P1|Overall Study|Protocol Violation|20
872498|NCT01382940|2876918|P1|Overall Study|Withdrawal by Subject|23
872499|NCT01382940|2876918|P1|Overall Study|Physician Decision|7
872500|NCT01382940|2876918|P1|Overall Study|Lost to Follow-up|4
872501|NCT01382940|2876918|P1|Overall Study|Adverse Event|19
872502|NCT01382602|2876980|P2|Overall Study|Withdrawal by Subject|1
872503|NCT01382602|2876981|P1|Overall Study|Withdrawal by Subject|0
872504|NCT01382602|2876980|P2|Overall Study|Protocol Violation|3
872505|NCT01382602|2876981|P1|Overall Study|Protocol Violation|0
872506|NCT01382446|2876989|P2|Overall Study|Removal from Mechanical Ventilation|3
872507|NCT01382446|2876990|P1|Overall Study|Removal from Mechanical Ventilation|3
872508|NCT01382446|2876989|P2|Overall Study|Withdrawal by Subject|1
872509|NCT01382446|2876990|P1|Overall Study|Withdrawal by Subject|0
872510|NCT01382251|2877017|P2|Overall Study|Contacted after study closed|1
872511|NCT01382251|2877018|P1|Overall Study|Contacted after study closed|1
872512|NCT01382251|2877017|P2|Overall Study|Lost to Follow-up|4
872513|NCT01382251|2877018|P1|Overall Study|Lost to Follow-up|4
872514|NCT01382251|2877017|P2|Overall Study|Surgeries cancelled or delayed|16
872515|NCT01382251|2877018|P1|Overall Study|Surgeries cancelled or delayed|16
872516|NCT01382225|2877031|P2|Overall Study|Other|2
872517|NCT01382225|2877032|P1|Overall Study|Other|4
872518|NCT01382225|2877031|P2|Overall Study|Subject Withdrew Consent|2
872519|NCT01382225|2877032|P1|Overall Study|Subject Withdrew Consent|5
872520|NCT01382225|2877031|P2|Overall Study|Protocol Violation|1
872521|NCT01382225|2877032|P1|Overall Study|Protocol Violation|2
872522|NCT01382225|2877031|P2|Overall Study|Adverse Event|2
872523|NCT01382225|2877032|P1|Overall Study|Adverse Event|3
872524|NCT01382212|2877054|P1|Overall Study|Withdrew consent|1
872525|NCT01382212|2877054|P1|Overall Study|Kidney transplant|1
872526|NCT01381926|2877117|P2|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1
872527|NCT01381926|2877118|P1|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0
872528|NCT01381926|2877117|P2|Low/High Dose of 1st Treatment (2months)|Adverse Event|0
872529|NCT01381926|2877118|P1|Low/High Dose of 1st Treatment (2months)|Adverse Event|2
872530|NCT01381900|2877131|P3|Overall Study|Early withdraw|1
872531|NCT01381900|2877132|P2|Overall Study|Early withdraw|1
872532|NCT01381900|2877133|P1|Overall Study|Early withdraw|3
872533|NCT01381900|2877131|P3|Overall Study|Withdrawal by Subject|1
872534|NCT01381900|2877132|P2|Overall Study|Withdrawal by Subject|0
872535|NCT01381900|2877133|P1|Overall Study|Withdrawal by Subject|0
872536|NCT01381900|2877131|P3|Overall Study|Protocol Violation|1
872537|NCT01381900|2877132|P2|Overall Study|Protocol Violation|1
872538|NCT01381900|2877133|P1|Overall Study|Protocol Violation|0
872539|NCT01381900|2877131|P3|Overall Study|Physician Decision|1
872540|NCT01381900|2877132|P2|Overall Study|Physician Decision|1
872541|NCT01381900|2877133|P1|Overall Study|Physician Decision|0
872542|NCT01381900|2877131|P3|Overall Study|Noncompliance with study drug|1
872543|NCT01381900|2877132|P2|Overall Study|Noncompliance with study drug|0
872544|NCT01381900|2877133|P1|Overall Study|Noncompliance with study drug|0
872545|NCT01381900|2877131|P3|Overall Study|Adverse Event|7
872546|NCT01381900|2877132|P2|Overall Study|Adverse Event|6
872547|NCT01381900|2877133|P1|Overall Study|Adverse Event|4
872548|NCT01381900|2877131|P3|Overall Study|Subject meets glycemic withdrawal crit.|0
872549|NCT01381900|2877132|P2|Overall Study|Subject meets glycemic withdrawal crit.|0
872550|NCT01381900|2877133|P1|Overall Study|Subject meets glycemic withdrawal crit.|2
872551|NCT01381874|2877156|P3|Overall Study|Other|67
872552|NCT01381874|2877157|P2|Overall Study|Other|52
872553|NCT01381874|2877158|P1|Overall Study|Other|67
872554|NCT01381874|2877156|P3|Overall Study|Withdrawal by Subject|9
872555|NCT01381874|2877157|P2|Overall Study|Withdrawal by Subject|10
872556|NCT01381874|2877158|P1|Overall Study|Withdrawal by Subject|9
872557|NCT01381874|2877156|P3|Overall Study|Lost to Follow-up|0
872558|NCT01381874|2877157|P2|Overall Study|Lost to Follow-up|1
872559|NCT01381874|2877158|P1|Overall Study|Lost to Follow-up|1
872560|NCT01381679|2877184|P1|Overall Study|Lost to Follow-up|885
872561|NCT01381679|2877184|P1|Overall Study|Adverse Event|3
872562|NCT01381575|2877199|P3|Overall Study|Withdrawal by Subject|4
872563|NCT01381575|2877200|P2|Overall Study|Withdrawal by Subject|0
872564|NCT01381575|2877201|P1|Overall Study|Withdrawal by Subject|0
872565|NCT01381575|2877199|P3|Overall Study|Protocol Violation|1
872566|NCT01381575|2877200|P2|Overall Study|Protocol Violation|0
872567|NCT01381575|2877201|P1|Overall Study|Protocol Violation|0
872568|NCT01381575|2877199|P3|Overall Study|Lost to Follow-up|1
872569|NCT01381575|2877200|P2|Overall Study|Lost to Follow-up|0
872570|NCT01381575|2877201|P1|Overall Study|Lost to Follow-up|0
872571|NCT01381575|2877199|P3|Overall Study|Adverse Event|1
872572|NCT01381575|2877200|P2|Overall Study|Adverse Event|0
872573|NCT01381575|2877201|P1|Overall Study|Adverse Event|0
872574|NCT01381575|2877199|P3|Overall Study|Other|0
872575|NCT01381575|2877200|P2|Overall Study|Other|10
872576|NCT01381575|2877201|P1|Overall Study|Other|2
872577|NCT01381562|2877258|P3|Overall Study|Adverse Event|0
872578|NCT01381562|2877259|P2|Overall Study|Adverse Event|1
872579|NCT01381562|2877260|P1|Overall Study|Adverse Event|0
872580|NCT01381549|2877328|P3|Overall Study|Ineligible: No organisms isolated|1
872581|NCT01381549|2877329|P2|Overall Study|Ineligible: No organisms isolated|0
872582|NCT01381549|2877330|P1|Overall Study|Ineligible: No organisms isolated|0
872583|NCT01381016|2877456|P2|Overall Study|Physician Decision|2
872584|NCT01381016|2877457|P1|Overall Study|Physician Decision|0
872585|NCT01381016|2877456|P2|Overall Study|Withdrawal by Subject|1
872586|NCT01381016|2877457|P1|Overall Study|Withdrawal by Subject|0
872587|NCT01381016|2877456|P2|Overall Study|Screen Failure|2
872588|NCT01381016|2877457|P1|Overall Study|Screen Failure|2
872589|NCT01381016|2877456|P2|Overall Study|Lost to Follow-up|1
872590|NCT01381016|2877457|P1|Overall Study|Lost to Follow-up|1
872591|NCT01380834|2877467|P2|Overall Study|Physician Decision|0
872592|NCT01380834|2877468|P1|Overall Study|Physician Decision|1
872593|NCT01380782|2877480|P4|Overall Study|Withdrawal by Subject|1
872594|NCT01380782|2877481|P3|Overall Study|Withdrawal by Subject|1
872595|NCT01380782|2877482|P2|Overall Study|Withdrawal by Subject|0
872596|NCT01380782|2877483|P1|Overall Study|Withdrawal by Subject|0
872597|NCT01380782|2877480|P4|Overall Study|Physician Decision|0
872598|NCT01380782|2877481|P3|Overall Study|Physician Decision|0
872599|NCT01380782|2877482|P2|Overall Study|Physician Decision|0
872600|NCT01380782|2877483|P1|Overall Study|Physician Decision|1
872601|NCT01380782|2877480|P4|Overall Study|Lack of Efficacy|3
872602|NCT01380782|2877481|P3|Overall Study|Lack of Efficacy|10
872603|NCT01380782|2877482|P2|Overall Study|Lack of Efficacy|9
872604|NCT01380782|2877483|P1|Overall Study|Lack of Efficacy|10
872605|NCT01380782|2877480|P4|Overall Study|Death|0
872606|NCT01380782|2877481|P3|Overall Study|Death|0
872607|NCT01380782|2877482|P2|Overall Study|Death|0
872608|NCT01380782|2877483|P1|Overall Study|Death|1
872609|NCT01380782|2877480|P4|Overall Study|Adverse Event|0
872610|NCT01380782|2877481|P3|Overall Study|Adverse Event|0
872611|NCT01380782|2877482|P2|Overall Study|Adverse Event|1
872612|NCT01380782|2877483|P1|Overall Study|Adverse Event|0
872613|NCT01380769|2877506|P2|Overall Study|Protocol Violation|1
872614|NCT01380769|2877507|P1|Overall Study|Protocol Violation|0
872615|NCT01380769|2877506|P2|Overall Study|Adverse Event|1
872616|NCT01380769|2877507|P1|Overall Study|Adverse Event|1
872617|NCT01380769|2877506|P2|Overall Study|Physician Decision|1
872618|NCT01380769|2877507|P1|Overall Study|Physician Decision|1
872619|NCT01380769|2877506|P2|Overall Study|Withdrawal by Subject|11
872620|NCT01380769|2877507|P1|Overall Study|Withdrawal by Subject|7
872621|NCT01380730|2877568|P8|Overall Study|Death|0
872622|NCT01380730|2877569|P7|Overall Study|Death|0
872623|NCT01380730|2877570|P6|Overall Study|Death|0
872624|NCT01380730|2877571|P5|Overall Study|Death|1
872625|NCT01380730|2877572|P4|Overall Study|Death|0
872626|NCT01380730|2877573|P3|Overall Study|Death|0
872627|NCT01380730|2877574|P2|Overall Study|Death|0
872628|NCT01380730|2877575|P1|Overall Study|Death|0
872629|NCT01380379|2877642|P1|Overall Study|Pregnancy|1
872630|NCT01380327|2877655|P3|Overall Study|Questionable onset of epilepsy|1
872631|NCT01380327|2877656|P2|Overall Study|Questionable onset of epilepsy|0
872632|NCT01380327|2877657|P1|Overall Study|Questionable onset of epilepsy|0
872633|NCT01380327|2877655|P3|Overall Study|Housing situation precluded ability to k|1
872634|NCT01380327|2877656|P2|Overall Study|Housing situation precluded ability to k|0
872635|NCT01380327|2877657|P1|Overall Study|Housing situation precluded ability to k|0
872636|NCT01380327|2877655|P3|Overall Study|Withdrawal by Subject|1
872637|NCT01380327|2877656|P2|Overall Study|Withdrawal by Subject|0
872638|NCT01380327|2877657|P1|Overall Study|Withdrawal by Subject|0
872639|NCT01380327|2877655|P3|Overall Study|Protocol Violation|3
872640|NCT01380327|2877656|P2|Overall Study|Protocol Violation|2
872641|NCT01380327|2877657|P1|Overall Study|Protocol Violation|3
872642|NCT01380327|2877655|P3|Overall Study|Lost to Follow-up|1
872643|NCT01380327|2877656|P2|Overall Study|Lost to Follow-up|1
872644|NCT01380327|2877657|P1|Overall Study|Lost to Follow-up|0
872645|NCT01380145|2877688|P1|Overall Study|Progressive disease|4
872646|NCT01380093|2877696|P9|Treatment Phase: Third Intervention|Other|1
872647|NCT01380093|2877697|P8|Treatment Phase: Third Intervention|Other|0
872648|NCT01380093|2877698|P7|Treatment Phase: Third Intervention|Other|0
872649|NCT01380093|2877699|P6|Treatment Phase: Third Intervention|Other|0
872650|NCT01380093|2877700|P5|Treatment Phase: Third Intervention|Other|0
872651|NCT01380093|2877701|P4|Treatment Phase: Third Intervention|Other|0
872652|NCT01380093|2877702|P3|Treatment Phase: Third Intervention|Other|0
872653|NCT01380093|2877703|P2|Treatment Phase: Third Intervention|Other|0
872654|NCT01380093|2877704|P1|Treatment Phase: Third Intervention|Other|0
872655|NCT01380093|2877696|P9|Treatment Phase: Third Intervention|Non-compliance|1
872656|NCT01380093|2877697|P8|Treatment Phase: Third Intervention|Non-compliance|0
872657|NCT01380093|2877698|P7|Treatment Phase: Third Intervention|Non-compliance|0
872658|NCT01380093|2877699|P6|Treatment Phase: Third Intervention|Non-compliance|0
872659|NCT01380093|2877700|P5|Treatment Phase: Third Intervention|Non-compliance|0
872660|NCT01380093|2877701|P4|Treatment Phase: Third Intervention|Non-compliance|0
872661|NCT01380093|2877702|P3|Treatment Phase: Third Intervention|Non-compliance|0
872662|NCT01380093|2877703|P2|Treatment Phase: Third Intervention|Non-compliance|0
872663|NCT01380093|2877704|P1|Treatment Phase: Third Intervention|Non-compliance|0
872664|NCT01380093|2877696|P9|Treatment Phase: Second Intervention|Other|0
872665|NCT01380093|2877697|P8|Treatment Phase: Second Intervention|Other|0
872666|NCT01380093|2877698|P7|Treatment Phase: Second Intervention|Other|0
872667|NCT01380093|2877699|P6|Treatment Phase: Second Intervention|Other|0
872668|NCT01380093|2877700|P5|Treatment Phase: Second Intervention|Other|0
872669|NCT01380093|2877701|P4|Treatment Phase: Second Intervention|Other|1
872670|NCT01380093|2877702|P3|Treatment Phase: Second Intervention|Other|0
872671|NCT01380093|2877703|P2|Treatment Phase: Second Intervention|Other|0
872672|NCT01380093|2877704|P1|Treatment Phase: Second Intervention|Other|0
872673|NCT01380093|2877696|P9|Drug Discrimination Phase: Day 2|Sponsor decision|0
872674|NCT01380093|2877697|P8|Drug Discrimination Phase: Day 2|Sponsor decision|0
872675|NCT01380093|2877698|P7|Drug Discrimination Phase: Day 2|Sponsor decision|0
872676|NCT01380093|2877699|P6|Drug Discrimination Phase: Day 2|Sponsor decision|0
872677|NCT01380093|2877700|P5|Drug Discrimination Phase: Day 2|Sponsor decision|0
872678|NCT01380093|2877701|P4|Drug Discrimination Phase: Day 2|Sponsor decision|0
872679|NCT01380093|2877702|P3|Drug Discrimination Phase: Day 2|Sponsor decision|1
872680|NCT01380093|2877703|P2|Drug Discrimination Phase: Day 2|Sponsor decision|0
872681|NCT01380093|2877704|P1|Drug Discrimination Phase: Day 2|Sponsor decision|0
872682|NCT01380093|2877696|P9|Drug Discrimination Phase: Day 2|Backup participant|0
872683|NCT01380093|2877697|P8|Drug Discrimination Phase: Day 2|Backup participant|0
872684|NCT01380093|2877698|P7|Drug Discrimination Phase: Day 2|Backup participant|0
872685|NCT01380093|2877699|P6|Drug Discrimination Phase: Day 2|Backup participant|0
872686|NCT01380093|2877700|P5|Drug Discrimination Phase: Day 2|Backup participant|0
872687|NCT01380093|2877701|P4|Drug Discrimination Phase: Day 2|Backup participant|0
872688|NCT01380093|2877702|P3|Drug Discrimination Phase: Day 2|Backup participant|1
872689|NCT01380093|2877703|P2|Drug Discrimination Phase: Day 2|Backup participant|0
872690|NCT01380093|2877704|P1|Drug Discrimination Phase: Day 2|Backup participant|0
872691|NCT01380093|2877696|P9|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
872692|NCT01380093|2877697|P8|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
872693|NCT01380093|2877698|P7|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
872694|NCT01380093|2877699|P6|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
872695|NCT01380093|2877700|P5|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
872696|NCT01380093|2877701|P4|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
872697|NCT01380093|2877702|P3|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
872698|NCT01380093|2877703|P2|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
872699|NCT01380093|2877704|P1|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
872700|NCT01380093|2877696|P9|Drug Discrimination Phase: Day 2|Discrimination failure|0
872701|NCT01380093|2877697|P8|Drug Discrimination Phase: Day 2|Discrimination failure|0
872702|NCT01380093|2877698|P7|Drug Discrimination Phase: Day 2|Discrimination failure|0
872703|NCT01380093|2877699|P6|Drug Discrimination Phase: Day 2|Discrimination failure|0
872704|NCT01380093|2877700|P5|Drug Discrimination Phase: Day 2|Discrimination failure|0
872705|NCT01380093|2877701|P4|Drug Discrimination Phase: Day 2|Discrimination failure|0
872706|NCT01380093|2877702|P3|Drug Discrimination Phase: Day 2|Discrimination failure|9
872707|NCT01380093|2877703|P2|Drug Discrimination Phase: Day 2|Discrimination failure|4
872708|NCT01380093|2877704|P1|Drug Discrimination Phase: Day 2|Discrimination failure|0
872709|NCT01380093|2877696|P9|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
872710|NCT01380093|2877697|P8|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
872711|NCT01380093|2877698|P7|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
872712|NCT01380093|2877699|P6|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
872713|NCT01380093|2877700|P5|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
872714|NCT01380093|2877701|P4|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
872715|NCT01380093|2877702|P3|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
872716|NCT01380093|2877703|P2|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1
872717|NCT01380093|2877704|P1|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
872718|NCT01380093|2877696|P9|Drug Discrimination Phase: Day 2|Physician Decision|0
872719|NCT01380093|2877697|P8|Drug Discrimination Phase: Day 2|Physician Decision|0
872720|NCT01380093|2877698|P7|Drug Discrimination Phase: Day 2|Physician Decision|0
872721|NCT01380093|2877699|P6|Drug Discrimination Phase: Day 2|Physician Decision|0
872722|NCT01380093|2877700|P5|Drug Discrimination Phase: Day 2|Physician Decision|0
872723|NCT01380093|2877701|P4|Drug Discrimination Phase: Day 2|Physician Decision|0
872724|NCT01380093|2877702|P3|Drug Discrimination Phase: Day 2|Physician Decision|1
872725|NCT01380093|2877703|P2|Drug Discrimination Phase: Day 2|Physician Decision|3
872726|NCT01380093|2877704|P1|Drug Discrimination Phase: Day 2|Physician Decision|0
872727|NCT01380093|2877696|P9|Drug Discrimination Phase: Day 1|Discrimination failure|0
872728|NCT01380093|2877697|P8|Drug Discrimination Phase: Day 1|Discrimination failure|0
872729|NCT01380093|2877698|P7|Drug Discrimination Phase: Day 1|Discrimination failure|0
872730|NCT01380093|2877699|P6|Drug Discrimination Phase: Day 1|Discrimination failure|0
872731|NCT01380093|2877700|P5|Drug Discrimination Phase: Day 1|Discrimination failure|0
872732|NCT01380093|2877701|P4|Drug Discrimination Phase: Day 1|Discrimination failure|0
872733|NCT01380093|2877702|P3|Drug Discrimination Phase: Day 1|Discrimination failure|0
872734|NCT01380093|2877703|P2|Drug Discrimination Phase: Day 1|Discrimination failure|1
872735|NCT01380093|2877704|P1|Drug Discrimination Phase: Day 1|Discrimination failure|0
872736|NCT01380093|2877696|P9|Naloxone Challenge Phase|Screen failures|0
872737|NCT01380093|2877697|P8|Naloxone Challenge Phase|Screen failures|0
872738|NCT01380093|2877698|P7|Naloxone Challenge Phase|Screen failures|0
872739|NCT01380093|2877699|P6|Naloxone Challenge Phase|Screen failures|0
872740|NCT01380093|2877700|P5|Naloxone Challenge Phase|Screen failures|0
872741|NCT01380093|2877701|P4|Naloxone Challenge Phase|Screen failures|0
872742|NCT01380093|2877702|P3|Naloxone Challenge Phase|Screen failures|0
872743|NCT01380093|2877703|P2|Naloxone Challenge Phase|Screen failures|0
872744|NCT01380093|2877704|P1|Naloxone Challenge Phase|Screen failures|21
872745|NCT01380080|2877996|P2|Overall Study|Lost to Follow-up|0
872746|NCT01380080|2877997|P1|Overall Study|Lost to Follow-up|2
872747|NCT01380080|2877996|P2|Overall Study|Not willing to adhere to requirements|1
872748|NCT01380080|2877997|P1|Overall Study|Not willing to adhere to requirements|3
872749|NCT01380080|2877996|P2|Overall Study|Not able to get to clinic|0
872750|NCT01380080|2877997|P1|Overall Study|Not able to get to clinic|4
872751|NCT01380080|2877996|P2|Overall Study|Withdrawal by Subject|0
872752|NCT01380080|2877997|P1|Overall Study|Withdrawal by Subject|4
872753|NCT01380080|2877996|P2|Overall Study|Death|22
872754|NCT01380080|2877997|P1|Overall Study|Death|20
872755|NCT01379937|2878022|P4|Overall Study|Lost to Follow-up|0
872756|NCT01379937|2878023|P3|Overall Study|Lost to Follow-up|2
872757|NCT01379937|2878024|P2|Overall Study|Lost to Follow-up|2
872758|NCT01379937|2878025|P1|Overall Study|Lost to Follow-up|1
872759|NCT01379937|2878022|P4|Overall Study|Consent withdrawal|0
872760|NCT01379937|2878023|P3|Overall Study|Consent withdrawal|0
872761|NCT01379937|2878024|P2|Overall Study|Consent withdrawal|1
872762|NCT01379937|2878025|P1|Overall Study|Consent withdrawal|0
872763|NCT01379937|2878022|P4|Overall Study|Protocol Violation|1
872764|NCT01379937|2878023|P3|Overall Study|Protocol Violation|0
872765|NCT01379937|2878024|P2|Overall Study|Protocol Violation|0
872766|NCT01379937|2878025|P1|Overall Study|Protocol Violation|0
872767|NCT01379781|2878107|P2|Overall Study|Lost to Follow-up|8
872768|NCT01379781|2878108|P1|Overall Study|Lost to Follow-up|11
872769|NCT01379768|2878117|P3|Overall Study|Lost to Follow-up|0
872770|NCT01379768|2878118|P2|Overall Study|Lost to Follow-up|0
872771|NCT01379768|2878119|P1|Overall Study|Lost to Follow-up|2
872772|NCT01379768|2878117|P3|Overall Study|Adverse Event|0
872773|NCT01379768|2878118|P2|Overall Study|Adverse Event|1
872774|NCT01379768|2878119|P1|Overall Study|Adverse Event|1
872775|NCT01379703|2878142|P3|9 Months Through 18 Months|Reason Unknown|0
872776|NCT01379703|2878143|P2|9 Months Through 18 Months|Reason Unknown|23
872777|NCT01379703|2878144|P1|9 Months Through 18 Months|Reason Unknown|0
872778|NCT01379703|2878142|P3|9 Months Through 18 Months|Fatigue|0
872779|NCT01379703|2878143|P2|9 Months Through 18 Months|Fatigue|1
872780|NCT01379703|2878144|P1|9 Months Through 18 Months|Fatigue|0
872781|NCT01379703|2878142|P3|9 Months Through 18 Months|Tuberculosis/TB treatment|0
872782|NCT01379703|2878143|P2|9 Months Through 18 Months|Tuberculosis/TB treatment|2
872783|NCT01379703|2878144|P1|9 Months Through 18 Months|Tuberculosis/TB treatment|0
872784|NCT01379703|2878142|P3|9 Months Through 18 Months|Patient Noncompliance|0
872785|NCT01379703|2878143|P2|9 Months Through 18 Months|Patient Noncompliance|4
872786|NCT01379703|2878144|P1|9 Months Through 18 Months|Patient Noncompliance|0
872787|NCT01379703|2878142|P3|9 Months Through 18 Months|Treatment failure|0
872788|NCT01379703|2878143|P2|9 Months Through 18 Months|Treatment failure|5
872789|NCT01379703|2878144|P1|9 Months Through 18 Months|Treatment failure|0
872790|NCT01379703|2878142|P3|9 Months Through 18 Months|Adverse Event|0
872791|NCT01379703|2878143|P2|9 Months Through 18 Months|Adverse Event|6
872792|NCT01379703|2878144|P1|9 Months Through 18 Months|Adverse Event|0
872793|NCT01379703|2878142|P3|9 Months Through 18 Months|Withdrawal by Subject|0
872794|NCT01379703|2878143|P2|9 Months Through 18 Months|Withdrawal by Subject|11
872795|NCT01379703|2878144|P1|9 Months Through 18 Months|Withdrawal by Subject|0
872796|NCT01379703|2878142|P3|9 Months Through 18 Months|Lost to Follow-up|0
872797|NCT01379703|2878143|P2|9 Months Through 18 Months|Lost to Follow-up|178
872798|NCT01379703|2878144|P1|9 Months Through 18 Months|Lost to Follow-up|0
872799|NCT01379703|2878142|P3|Study Start Through 9 Months|Reason unknown|24
872800|NCT01379703|2878143|P2|Study Start Through 9 Months|Reason unknown|31
872801|NCT01379703|2878144|P1|Study Start Through 9 Months|Reason unknown|2
872802|NCT01379703|2878142|P3|Study Start Through 9 Months|Increased triglycerides|0
872803|NCT01379703|2878143|P2|Study Start Through 9 Months|Increased triglycerides|1
872804|NCT01379703|2878144|P1|Study Start Through 9 Months|Increased triglycerides|0
872805|NCT01379703|2878142|P3|Study Start Through 9 Months|Poor general condition|0
872806|NCT01379703|2878143|P2|Study Start Through 9 Months|Poor general condition|1
872807|NCT01379703|2878144|P1|Study Start Through 9 Months|Poor general condition|0
872808|NCT01379703|2878142|P3|Study Start Through 9 Months|Medication not available|1
872809|NCT01379703|2878143|P2|Study Start Through 9 Months|Medication not available|2
872810|NCT01379703|2878144|P1|Study Start Through 9 Months|Medication not available|0
872811|NCT01379703|2878142|P3|Study Start Through 9 Months|Tuberculosis/TB treatment|0
872812|NCT01379703|2878143|P2|Study Start Through 9 Months|Tuberculosis/TB treatment|4
872813|NCT01379703|2878144|P1|Study Start Through 9 Months|Tuberculosis/TB treatment|0
872814|NCT01379703|2878142|P3|Study Start Through 9 Months|Patient Noncompliance|1
872815|NCT01379703|2878143|P2|Study Start Through 9 Months|Patient Noncompliance|0
872816|NCT01379703|2878144|P1|Study Start Through 9 Months|Patient Noncompliance|0
872817|NCT01379703|2878142|P3|Study Start Through 9 Months|Treatment Failure|2
872818|NCT01379703|2878143|P2|Study Start Through 9 Months|Treatment Failure|2
872819|NCT01379703|2878144|P1|Study Start Through 9 Months|Treatment Failure|0
872820|NCT01379703|2878142|P3|Study Start Through 9 Months|Withdrawal by Subject|1
872821|NCT01379703|2878143|P2|Study Start Through 9 Months|Withdrawal by Subject|6
872822|NCT01379703|2878144|P1|Study Start Through 9 Months|Withdrawal by Subject|0
872823|NCT01379703|2878142|P3|Study Start Through 9 Months|Adverse Event|10
872824|NCT01379703|2878143|P2|Study Start Through 9 Months|Adverse Event|14
872825|NCT01379703|2878144|P1|Study Start Through 9 Months|Adverse Event|0
872826|NCT01379703|2878142|P3|Study Start Through 9 Months|Lost to Follow-up|104
872827|NCT01379703|2878143|P2|Study Start Through 9 Months|Lost to Follow-up|61
872828|NCT01379703|2878144|P1|Study Start Through 9 Months|Lost to Follow-up|2
872829|NCT01379534|2878244|P2|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0
872830|NCT01379534|2878245|P1|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1
872831|NCT01379534|2878244|P2|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1
872832|NCT01379534|2878245|P1|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0
872833|NCT01379534|2878244|P2|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0
872834|NCT01379534|2878245|P1|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3
872835|NCT01379534|2878244|P2|Tumor Assessment Follow-up (f/u) Phase|Death|1
872836|NCT01379534|2878245|P1|Tumor Assessment Follow-up (f/u) Phase|Death|0
872837|NCT01379534|2878244|P2|Treatment Phase|Adverse Event|7
872838|NCT01379534|2878245|P1|Treatment Phase|Adverse Event|7
872839|NCT01379534|2878244|P2|Treatment Phase|Progressive disease|22
872840|NCT01379534|2878245|P1|Treatment Phase|Progressive disease|13
872841|NCT01379534|2878244|P2|Treatment Phase|Withdrawal by Subject|2
872842|NCT01379534|2878245|P1|Treatment Phase|Withdrawal by Subject|2
872843|NCT01379521|2878265|P2|Post-Treatment Evaluations|Death|0
872844|NCT01379521|2878266|P1|Post-Treatment Evaluations|Death|1
872845|NCT01379521|2878265|P2|Post-Treatment Evaluations|Withdrawal by Subject|1
872846|NCT01379521|2878266|P1|Post-Treatment Evaluations|Withdrawal by Subject|2
872847|NCT01379521|2878265|P2|Post-Treatment Evaluations|Disease Progression|20
872848|NCT01379521|2878266|P1|Post-Treatment Evaluations|Disease Progression|22
872849|NCT01379521|2878265|P2|Overall Study -Treatment Period|Death|1
872850|NCT01379521|2878266|P1|Overall Study -Treatment Period|Death|2
872851|NCT01379521|2878265|P2|Overall Study -Treatment Period|Administrative Problems|0
872852|NCT01379521|2878266|P1|Overall Study -Treatment Period|Administrative Problems|1
872853|NCT01379521|2878265|P2|Overall Study -Treatment Period|Withdrawal by Subject|0
872854|NCT01379521|2878266|P1|Overall Study -Treatment Period|Withdrawal by Subject|3
872855|NCT01379521|2878265|P2|Overall Study -Treatment Period|Protocol Deviation|2
872856|NCT01379521|2878266|P1|Overall Study -Treatment Period|Protocol Deviation|0
872857|NCT01379521|2878265|P2|Overall Study -Treatment Period|New Cancer Therapy|0
872858|NCT01379521|2878266|P1|Overall Study -Treatment Period|New Cancer Therapy|1
872859|NCT01379521|2878265|P2|Overall Study -Treatment Period|Disease Progression|22
872860|NCT01379521|2878266|P1|Overall Study -Treatment Period|Disease Progression|23
872861|NCT01379521|2878265|P2|Overall Study -Treatment Period|Abnormal test procedure results|1
872862|NCT01379521|2878266|P1|Overall Study -Treatment Period|Abnormal test procedure results|0
872863|NCT01379521|2878265|P2|Overall Study -Treatment Period|Adverse Event|0
872864|NCT01379521|2878266|P1|Overall Study -Treatment Period|Adverse Event|3
872865|NCT01379508|2878288|P4|Extension Period Weeks 109-156|Protocol Violation|0
872866|NCT01379508|2878289|P3|Extension Period Weeks 109-156|Protocol Violation|0
872867|NCT01379508|2878290|P2|Extension Period Weeks 109-156|Protocol Violation|1
872868|NCT01379508|2878291|P1|Extension Period Weeks 109-156|Protocol Violation|2
872869|NCT01379508|2878288|P4|Extension Period Weeks 109-156|Administrative problems|0
872870|NCT01379508|2878289|P3|Extension Period Weeks 109-156|Administrative problems|1
872871|NCT01379508|2878290|P2|Extension Period Weeks 109-156|Administrative problems|0
872872|NCT01379508|2878291|P1|Extension Period Weeks 109-156|Administrative problems|3
872873|NCT01379508|2878288|P4|Extension Period Weeks 109-156|Lost to Follow-up|0
872874|NCT01379508|2878289|P3|Extension Period Weeks 109-156|Lost to Follow-up|5
872875|NCT01379508|2878290|P2|Extension Period Weeks 109-156|Lost to Follow-up|1
872876|NCT01379508|2878291|P1|Extension Period Weeks 109-156|Lost to Follow-up|6
872877|NCT01379508|2878288|P4|Extension Period Weeks 109-156|Withdrawal by Subject|0
872878|NCT01379508|2878289|P3|Extension Period Weeks 109-156|Withdrawal by Subject|8
872879|NCT01379508|2878290|P2|Extension Period Weeks 109-156|Withdrawal by Subject|1
872880|NCT01379508|2878291|P1|Extension Period Weeks 109-156|Withdrawal by Subject|8
872881|NCT01379508|2878288|P4|Treatment to Week 104|Protocol Violation|0
872882|NCT01379508|2878289|P3|Treatment to Week 104|Protocol Violation|1
872883|NCT01379508|2878290|P2|Treatment to Week 104|Protocol Violation|1
872884|NCT01379508|2878291|P1|Treatment to Week 104|Protocol Violation|1
872885|NCT01379508|2878288|P4|Treatment to Week 104|Administrative problems|0
872886|NCT01379508|2878289|P3|Treatment to Week 104|Administrative problems|0
872887|NCT01379508|2878290|P2|Treatment to Week 104|Administrative problems|1
872888|NCT01379508|2878291|P1|Treatment to Week 104|Administrative problems|3
872889|NCT01379508|2878288|P4|Treatment to Week 104|Lost to Follow-up|0
872890|NCT01379508|2878289|P3|Treatment to Week 104|Lost to Follow-up|3
872891|NCT01379508|2878290|P2|Treatment to Week 104|Lost to Follow-up|0
872892|NCT01379508|2878291|P1|Treatment to Week 104|Lost to Follow-up|5
872893|NCT01379508|2878288|P4|Treatment to Week 104|Withdrawal by Subject|0
872894|NCT01379508|2878289|P3|Treatment to Week 104|Withdrawal by Subject|4
872895|NCT01379508|2878290|P2|Treatment to Week 104|Withdrawal by Subject|1
872896|NCT01379508|2878291|P1|Treatment to Week 104|Withdrawal by Subject|6
872897|NCT01379508|2878288|P4|Treatment to Week 104|Abnormal test procedure result(s)|0
872898|NCT01379508|2878289|P3|Treatment to Week 104|Abnormal test procedure result(s)|0
872899|NCT01379508|2878290|P2|Treatment to Week 104|Abnormal test procedure result(s)|0
872900|NCT01379508|2878291|P1|Treatment to Week 104|Abnormal test procedure result(s)|1
872901|NCT01379508|2878288|P4|Treatment to Week 104|Abnormal lab value|0
872902|NCT01379508|2878289|P3|Treatment to Week 104|Abnormal lab value|0
872903|NCT01379508|2878290|P2|Treatment to Week 104|Abnormal lab value|0
872904|NCT01379508|2878291|P1|Treatment to Week 104|Abnormal lab value|1
872905|NCT01379508|2878288|P4|Treatment to Week 104|Adverse Event|0
872906|NCT01379508|2878289|P3|Treatment to Week 104|Adverse Event|5
872907|NCT01379508|2878290|P2|Treatment to Week 104|Adverse Event|0
872908|NCT01379508|2878291|P1|Treatment to Week 104|Adverse Event|2
872909|NCT01378975|2878369|P2|Overall Study|Withdrew Consent|3
872910|NCT01378975|2878370|P1|Overall Study|Withdrew Consent|4
872911|NCT01378975|2878369|P2|Overall Study|Lost to Follow-up|1
872912|NCT01378975|2878370|P1|Overall Study|Lost to Follow-up|4
872913|NCT01378975|2878369|P2|Overall Study|Investigator Request|0
872914|NCT01378975|2878370|P1|Overall Study|Investigator Request|1
872915|NCT01378975|2878369|P2|Overall Study|Death|46
872916|NCT01378975|2878370|P1|Overall Study|Death|77
872917|NCT01378962|2878396|P1|Overall Study|Other|2
872918|NCT01378962|2878396|P1|Overall Study|Lost to Follow-up|1
872919|NCT01378962|2878396|P1|Overall Study|Death|14
872920|NCT01378429|2878422|P2|Overall Study|Noncompliance with study drug|0
872921|NCT01378429|2878423|P1|Overall Study|Noncompliance with study drug|1
872922|NCT01378325|2878536|P2|Overall Study|Protocol Violation|1
872923|NCT01378325|2878537|P1|Overall Study|Protocol Violation|0
872924|NCT01378195|2878554|P2|Overall Study|Lost to Follow-up|18
872925|NCT01378195|2878555|P1|Overall Study|Lost to Follow-up|29
872926|NCT01378117|2878568|P3|Overall Study|discharged before med given|1
872927|NCT01378117|2878569|P2|Overall Study|discharged before med given|0
872928|NCT01378117|2878570|P1|Overall Study|discharged before med given|2
872929|NCT01378117|2878568|P3|Overall Study|withdrawal|2
872930|NCT01378117|2878569|P2|Overall Study|withdrawal|1
872931|NCT01378117|2878570|P1|Overall Study|withdrawal|2
872932|NCT01378104|2878580|P2|Overall Study|Withdrawal by Subject|13
872933|NCT01378104|2878581|P1|Overall Study|Withdrawal by Subject|12
872934|NCT01378104|2878580|P2|Overall Study|Lack of Efficacy|5
872935|NCT01378104|2878581|P1|Overall Study|Lack of Efficacy|7
872936|NCT01378104|2878580|P2|Overall Study|Adverse Event|8
872937|NCT01378104|2878581|P1|Overall Study|Adverse Event|8
872938|NCT01377987|2878626|P2|Washout (7 Days)|Withdrawal by Subject|1
872939|NCT01377987|2878627|P1|Washout (7 Days)|Withdrawal by Subject|1
872940|NCT01377922|2878645|P2|Overall Study|rescue tx after part 2, entered part 4|0
872941|NCT01377922|2878646|P1|Overall Study|rescue tx after part 2, entered part 4|1
872942|NCT01377480|2878731|P4|Overall Study|Not specified|6
872943|NCT01377480|2878732|P3|Overall Study|Not specified|7
872944|NCT01377480|2878733|P2|Overall Study|Not specified|0
872945|NCT01377480|2878734|P1|Overall Study|Not specified|0
872946|NCT01377480|2878731|P4|Overall Study|Serious adverse event|1
872947|NCT01377480|2878732|P3|Overall Study|Serious adverse event|1
872948|NCT01377480|2878733|P2|Overall Study|Serious adverse event|0
872949|NCT01377480|2878734|P1|Overall Study|Serious adverse event|0
872950|NCT01377480|2878731|P4|Overall Study|Withdrawal by Subject|0
872951|NCT01377480|2878732|P3|Overall Study|Withdrawal by Subject|1
872952|NCT01377480|2878733|P2|Overall Study|Withdrawal by Subject|0
872953|NCT01377480|2878734|P1|Overall Study|Withdrawal by Subject|0
872954|NCT01377480|2878731|P4|Overall Study|Evidence of drug-induced hepatotoxicity|0
872955|NCT01377480|2878732|P3|Overall Study|Evidence of drug-induced hepatotoxicity|1
872956|NCT01377480|2878733|P2|Overall Study|Evidence of drug-induced hepatotoxicity|1
872957|NCT01377480|2878734|P1|Overall Study|Evidence of drug-induced hepatotoxicity|0
872958|NCT01377480|2878731|P4|Overall Study|Protocol Violation|4
872959|NCT01377480|2878732|P3|Overall Study|Protocol Violation|0
872960|NCT01377480|2878733|P2|Overall Study|Protocol Violation|0
872961|NCT01377480|2878734|P1|Overall Study|Protocol Violation|0
872962|NCT01377233|2878815|P5|Double-blind|Administrative or other|1
872963|NCT01377233|2878816|P4|Double-blind|Administrative or other|1
872964|NCT01377233|2878817|P3|Double-blind|Administrative or other|0
872965|NCT01377233|2878818|P2|Double-blind|Administrative or other|0
872966|NCT01377233|2878819|P1|Double-blind|Administrative or other|0
872967|NCT01377233|2878815|P5|Double-blind|Withdrawal by Subject|0
872968|NCT01377233|2878816|P4|Double-blind|Withdrawal by Subject|1
872969|NCT01377233|2878817|P3|Double-blind|Withdrawal by Subject|0
872970|NCT01377233|2878818|P2|Double-blind|Withdrawal by Subject|0
872971|NCT01377233|2878819|P1|Double-blind|Withdrawal by Subject|0
872972|NCT01377233|2878815|P5|Double-blind|Protocol Violation|1
872973|NCT01377233|2878816|P4|Double-blind|Protocol Violation|0
872974|NCT01377233|2878817|P3|Double-blind|Protocol Violation|0
872975|NCT01377233|2878818|P2|Double-blind|Protocol Violation|0
872976|NCT01377233|2878819|P1|Double-blind|Protocol Violation|0
872977|NCT01377233|2878815|P5|Double-blind|Adverse Event|0
872978|NCT01377233|2878816|P4|Double-blind|Adverse Event|2
872979|NCT01377233|2878817|P3|Double-blind|Adverse Event|2
872980|NCT01377233|2878818|P2|Double-blind|Adverse Event|1
872981|NCT01377233|2878819|P1|Double-blind|Adverse Event|0
872982|NCT01377233|2878815|P5|Open-label|Withdrawal by Subject|0
872983|NCT01377233|2878816|P4|Open-label|Withdrawal by Subject|0
872984|NCT01377233|2878817|P3|Open-label|Withdrawal by Subject|0
872985|NCT01377233|2878818|P2|Open-label|Withdrawal by Subject|0
872986|NCT01377233|2878819|P1|Open-label|Withdrawal by Subject|3
872987|NCT01377233|2878815|P5|Open-label|Adverse Event|0
872988|NCT01377233|2878816|P4|Open-label|Adverse Event|0
872989|NCT01377233|2878817|P3|Open-label|Adverse Event|0
872990|NCT01377233|2878818|P2|Open-label|Adverse Event|0
872991|NCT01377233|2878819|P1|Open-label|Adverse Event|1
872992|NCT01377194|2878846|P3|Overall Study|Lost to Follow-up|11
872993|NCT01377194|2878847|P2|Overall Study|Lost to Follow-up|8
872994|NCT01377194|2878848|P1|Overall Study|Lost to Follow-up|14
872995|NCT01377194|2878846|P3|Overall Study|Withdrawal by Subject|7
872996|NCT01377194|2878847|P2|Overall Study|Withdrawal by Subject|10
872997|NCT01377194|2878848|P1|Overall Study|Withdrawal by Subject|8
872998|NCT01377194|2878846|P3|Overall Study|Protocol Violation|6
872999|NCT01377194|2878847|P2|Overall Study|Protocol Violation|10
873000|NCT01377194|2878848|P1|Overall Study|Protocol Violation|4
873001|NCT01377194|2878846|P3|Overall Study|Lack of Efficacy|3
873002|NCT01377194|2878847|P2|Overall Study|Lack of Efficacy|3
873003|NCT01377194|2878848|P1|Overall Study|Lack of Efficacy|3
873004|NCT01377194|2878846|P3|Overall Study|Adverse Event|19
873005|NCT01377194|2878847|P2|Overall Study|Adverse Event|12
873006|NCT01377194|2878848|P1|Overall Study|Adverse Event|3
873007|NCT01377012|2878862|P3|Extension Study, Weeks 104-260|Adverse Event|1
873008|NCT01377012|2878863|P2|Extension Study, Weeks 104-260|Adverse Event|2
873009|NCT01377012|2878864|P1|Extension Study, Weeks 104-260|Adverse Event|0
873010|NCT01377012|2878862|P3|Extension Study, Weeks 104-260|Lost to Follow-up|1
873011|NCT01377012|2878863|P2|Extension Study, Weeks 104-260|Lost to Follow-up|0
873012|NCT01377012|2878864|P1|Extension Study, Weeks 104-260|Lost to Follow-up|0
873013|NCT01377012|2878862|P3|Extension Study, Weeks 104-260|Physician Decision|0
873014|NCT01377012|2878863|P2|Extension Study, Weeks 104-260|Physician Decision|0
873015|NCT01377012|2878864|P1|Extension Study, Weeks 104-260|Physician Decision|1
873016|NCT01377012|2878862|P3|Extension Study, Weeks 104-260|Withdrawal by Subject|3
873017|NCT01377012|2878863|P2|Extension Study, Weeks 104-260|Withdrawal by Subject|0
873018|NCT01377012|2878864|P1|Extension Study, Weeks 104-260|Withdrawal by Subject|1
873019|NCT01377012|2878862|P3|Extension Study, Weeks 104-260|Study terminated by sponsor|63
873020|NCT01377012|2878863|P2|Extension Study, Weeks 104-260|Study terminated by sponsor|69
873021|NCT01377012|2878864|P1|Extension Study, Weeks 104-260|Study terminated by sponsor|52
873022|NCT01377012|2878862|P3|Extension Study, Weeks 104-260|Lack of Efficacy|0
873023|NCT01377012|2878863|P2|Extension Study, Weeks 104-260|Lack of Efficacy|0
873024|NCT01377012|2878864|P1|Extension Study, Weeks 104-260|Lack of Efficacy|3
873025|NCT01377012|2878862|P3|Core Study|Adverse Event|13
873026|NCT01377012|2878863|P2|Core Study|Adverse Event|14
873027|NCT01377012|2878864|P1|Core Study|Adverse Event|10
873028|NCT01377012|2878862|P3|Core Study|Death|1
873029|NCT01377012|2878863|P2|Core Study|Death|1
873030|NCT01377012|2878864|P1|Core Study|Death|1
873031|NCT01377012|2878862|P3|Core Study|Lack of Efficacy|37
873032|NCT01377012|2878863|P2|Core Study|Lack of Efficacy|28
873033|NCT01377012|2878864|P1|Core Study|Lack of Efficacy|41
873034|NCT01377012|2878862|P3|Core Study|Lost to Follow-up|4
873035|NCT01377012|2878863|P2|Core Study|Lost to Follow-up|5
873036|NCT01377012|2878864|P1|Core Study|Lost to Follow-up|7
873037|NCT01377012|2878862|P3|Core Study|No Longer require treatment|1
873038|NCT01377012|2878863|P2|Core Study|No Longer require treatment|0
873039|NCT01377012|2878864|P1|Core Study|No Longer require treatment|0
873040|NCT01377012|2878862|P3|Core Study|Non-Compliant with study treatment|1
873041|NCT01377012|2878863|P2|Core Study|Non-Compliant with study treatment|0
873042|NCT01377012|2878864|P1|Core Study|Non-Compliant with study treatment|0
873043|NCT01377012|2878862|P3|Core Study|Physician Decision|10
873044|NCT01377012|2878863|P2|Core Study|Physician Decision|4
873045|NCT01377012|2878864|P1|Core Study|Physician Decision|5
873046|NCT01377012|2878862|P3|Core Study|Pregnancy|1
873047|NCT01377012|2878863|P2|Core Study|Pregnancy|0
873048|NCT01377012|2878864|P1|Core Study|Pregnancy|0
873049|NCT01377012|2878862|P3|Core Study|Protocol Violation|2
873050|NCT01377012|2878863|P2|Core Study|Protocol Violation|3
873051|NCT01377012|2878864|P1|Core Study|Protocol Violation|7
873052|NCT01377012|2878862|P3|Core Study|Withdrawal by Subject|18
873053|NCT01377012|2878863|P2|Core Study|Withdrawal by Subject|23
873054|NCT01377012|2878864|P1|Core Study|Withdrawal by Subject|15
873055|NCT01377012|2878862|P3|Core Study|Technical problems|0
873056|NCT01377012|2878863|P2|Core Study|Technical problems|0
873057|NCT01377012|2878864|P1|Core Study|Technical problems|1
873058|NCT01377012|2878862|P3|Core Study|Study terminated by Sponsor|46
873059|NCT01377012|2878863|P2|Core Study|Study terminated by Sponsor|54
873060|NCT01377012|2878864|P1|Core Study|Study terminated by Sponsor|47
873061|NCT01376908|2878901|P2|Overall Study|Withdrawal by Subject|2
873062|NCT01376908|2878902|P1|Overall Study|Withdrawal by Subject|1
873063|NCT01376908|2878901|P2|Overall Study|Protocol Violation|1
873064|NCT01376908|2878902|P1|Overall Study|Protocol Violation|1
873065|NCT01376804|2878935|P1|Treatment Period|Patient did not receive study drug|1
873066|NCT01376804|2878935|P1|Treatment Period|Adverse Event|6
873067|NCT01376804|2878935|P1|Treatment Period|Withdrawal by Subject|1
873068|NCT01376700|2878946|P1|Overall Study|Low or high titer inhibitor|8
873069|NCT01376700|2878946|P1|Overall Study|Sponsor terminated study early|8
873070|NCT01376388|2879008|P1|Overall Study|Withdrawal by Subject|3
873071|NCT01376388|2879008|P1|Overall Study|Lack of Efficacy|2
873072|NCT01376388|2879008|P1|Overall Study|Adverse Event|13
873073|NCT01376349|2879046|P3|Raondomized Treatment|Alternative Treatment|1
873074|NCT01376349|2879047|P2|Raondomized Treatment|Alternative Treatment|0
873075|NCT01376349|2879048|P1|Raondomized Treatment|Alternative Treatment|0
873076|NCT01376349|2879046|P3|Raondomized Treatment|Unkown|1
873077|NCT01376349|2879047|P2|Raondomized Treatment|Unkown|2
873078|NCT01376349|2879048|P1|Raondomized Treatment|Unkown|1
873079|NCT01376349|2879046|P3|Raondomized Treatment|Adverse Event|14
873080|NCT01376349|2879047|P2|Raondomized Treatment|Adverse Event|17
873081|NCT01376349|2879048|P1|Raondomized Treatment|Adverse Event|13
873082|NCT01376349|2879046|P3|Raondomized Treatment|Withdrawal by Subject|13
873083|NCT01376349|2879047|P2|Raondomized Treatment|Withdrawal by Subject|16
873084|NCT01376349|2879048|P1|Raondomized Treatment|Withdrawal by Subject|10
873085|NCT01376323|2879062|P5|Overall Study|Withdrawal by Subject|0
873086|NCT01376323|2879063|P4|Overall Study|Withdrawal by Subject|0
873087|NCT01376323|2879064|P3|Overall Study|Withdrawal by Subject|1
873088|NCT01376323|2879065|P2|Overall Study|Withdrawal by Subject|1
873089|NCT01376323|2879066|P1|Overall Study|Withdrawal by Subject|0
873090|NCT01376323|2879062|P5|Overall Study|Physician Decision|1
873091|NCT01376323|2879063|P4|Overall Study|Physician Decision|1
873092|NCT01376323|2879064|P3|Overall Study|Physician Decision|2
873093|NCT01376323|2879065|P2|Overall Study|Physician Decision|0
873094|NCT01376323|2879066|P1|Overall Study|Physician Decision|1
873095|NCT01376323|2879062|P5|Overall Study|Lost to Follow-up|0
873096|NCT01376323|2879063|P4|Overall Study|Lost to Follow-up|2
873097|NCT01376323|2879064|P3|Overall Study|Lost to Follow-up|0
873098|NCT01376323|2879065|P2|Overall Study|Lost to Follow-up|0
873099|NCT01376323|2879066|P1|Overall Study|Lost to Follow-up|0
873100|NCT01376323|2879062|P5|Overall Study|Adverse Event|0
873101|NCT01376323|2879063|P4|Overall Study|Adverse Event|2
873102|NCT01376323|2879064|P3|Overall Study|Adverse Event|0
873103|NCT01376323|2879065|P2|Overall Study|Adverse Event|0
873104|NCT01376323|2879066|P1|Overall Study|Adverse Event|1
873105|NCT01376245|2879161|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
873106|NCT01376245|2879162|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
873107|NCT01376245|2879163|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
873108|NCT01376245|2879164|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
873109|NCT01376245|2879165|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
873110|NCT01376245|2879161|P5|24-week, Double-blind Treatment Period|Physician Decision|0
873111|NCT01376245|2879162|P4|24-week, Double-blind Treatment Period|Physician Decision|1
873112|NCT01376245|2879163|P3|24-week, Double-blind Treatment Period|Physician Decision|1
873113|NCT01376245|2879164|P2|24-week, Double-blind Treatment Period|Physician Decision|0
873114|NCT01376245|2879165|P1|24-week, Double-blind Treatment Period|Physician Decision|0
873115|NCT01376245|2879161|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
873116|NCT01376245|2879162|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|1
873117|NCT01376245|2879163|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
873118|NCT01376245|2879164|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|2
873119|NCT01376245|2879165|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
873120|NCT01376245|2879161|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
873121|NCT01376245|2879162|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1
873122|NCT01376245|2879163|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3
873123|NCT01376245|2879164|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2
873124|NCT01376245|2879165|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
873125|NCT01376245|2879161|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
873126|NCT01376245|2879162|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
873127|NCT01376245|2879163|P3|24-week, Double-blind Treatment Period|Protocol Violation|0
873128|NCT01376245|2879164|P2|24-week, Double-blind Treatment Period|Protocol Violation|2
873129|NCT01376245|2879165|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
873130|NCT01376245|2879161|P5|24-week, Double-blind Treatment Period|Lack of Efficacy|3
873131|NCT01376245|2879162|P4|24-week, Double-blind Treatment Period|Lack of Efficacy|4
873132|NCT01376245|2879163|P3|24-week, Double-blind Treatment Period|Lack of Efficacy|5
873133|NCT01376245|2879164|P2|24-week, Double-blind Treatment Period|Lack of Efficacy|4
873134|NCT01376245|2879165|P1|24-week, Double-blind Treatment Period|Lack of Efficacy|0
873135|NCT01376245|2879161|P5|24-week, Double-blind Treatment Period|Adverse Event|18
873136|NCT01376245|2879162|P4|24-week, Double-blind Treatment Period|Adverse Event|8
873137|NCT01376245|2879163|P3|24-week, Double-blind Treatment Period|Adverse Event|7
873138|NCT01376245|2879164|P2|24-week, Double-blind Treatment Period|Adverse Event|16
873139|NCT01376245|2879165|P1|24-week, Double-blind Treatment Period|Adverse Event|0
873140|NCT01376245|2879161|P5|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
873141|NCT01376245|2879162|P4|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
873142|NCT01376245|2879163|P3|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
873143|NCT01376245|2879164|P2|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
873144|NCT01376245|2879165|P1|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28
873145|NCT01376245|2879161|P5|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
873146|NCT01376245|2879162|P4|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
873147|NCT01376245|2879163|P3|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
873148|NCT01376245|2879164|P2|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
873149|NCT01376245|2879165|P1|2-wk Single-blind Placebo Run-in Period|Physician Decision|2
873150|NCT01376245|2879161|P5|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
873151|NCT01376245|2879162|P4|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
873152|NCT01376245|2879163|P3|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
873153|NCT01376245|2879164|P2|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
873154|NCT01376245|2879165|P1|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1
873155|NCT01376245|2879161|P5|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
873156|NCT01376245|2879162|P4|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
873157|NCT01376245|2879163|P3|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
873158|NCT01376245|2879164|P2|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
873159|NCT01376245|2879165|P1|2-wk Single-blind Placebo Run-in Period|Adverse Event|4
873160|NCT01376245|2879161|P5|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
873161|NCT01376245|2879162|P4|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
873162|NCT01376245|2879163|P3|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
873163|NCT01376245|2879164|P2|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
873164|NCT01376245|2879165|P1|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66
873165|NCT01376167|2879182|P3|Overall Study|Withdrawal by Subject|4
873166|NCT01376167|2879183|P2|Overall Study|Withdrawal by Subject|5
873167|NCT01376167|2879184|P1|Overall Study|Withdrawal by Subject|1
873168|NCT01376167|2879182|P3|Overall Study|Physician Decision|0
873169|NCT01376167|2879183|P2|Overall Study|Physician Decision|1
873170|NCT01376167|2879184|P1|Overall Study|Physician Decision|1
873171|NCT01376167|2879182|P3|Overall Study|Lost to Follow-up|2
873172|NCT01376167|2879183|P2|Overall Study|Lost to Follow-up|4
873173|NCT01376167|2879184|P1|Overall Study|Lost to Follow-up|2
873174|NCT01376089|2879255|P2|Overall Study|Patient received no contrast media|4
873175|NCT01376089|2879256|P1|Overall Study|Patient received no contrast media|3
873176|NCT01376037|2879279|P2|Overall Study|Lost to Follow-up|2
873177|NCT01376037|2879280|P1|Overall Study|Lost to Follow-up|0
873178|NCT01375777|2879308|P9|Overall Study|Other|1
873179|NCT01375777|2879309|P8|Overall Study|Other|0
873180|NCT01375777|2879310|P7|Overall Study|Other|0
873181|NCT01375777|2879311|P6|Overall Study|Other|0
873182|NCT01375777|2879312|P5|Overall Study|Other|0
873183|NCT01375777|2879313|P4|Overall Study|Other|0
873184|NCT01375777|2879314|P3|Overall Study|Other|0
873185|NCT01375777|2879315|P2|Overall Study|Other|1
873186|NCT01375777|2879316|P1|Overall Study|Other|1
873187|NCT01375777|2879308|P9|Overall Study|Lost to Follow-up|0
873188|NCT01375777|2879309|P8|Overall Study|Lost to Follow-up|0
873189|NCT01375777|2879310|P7|Overall Study|Lost to Follow-up|1
873190|NCT01375777|2879311|P6|Overall Study|Lost to Follow-up|0
873191|NCT01375777|2879312|P5|Overall Study|Lost to Follow-up|0
873192|NCT01375777|2879313|P4|Overall Study|Lost to Follow-up|0
873193|NCT01375777|2879314|P3|Overall Study|Lost to Follow-up|0
873194|NCT01375777|2879315|P2|Overall Study|Lost to Follow-up|0
873195|NCT01375777|2879316|P1|Overall Study|Lost to Follow-up|1
873196|NCT01375777|2879308|P9|Overall Study|Withdrawal by Subject|1
873197|NCT01375777|2879309|P8|Overall Study|Withdrawal by Subject|2
873198|NCT01375777|2879310|P7|Overall Study|Withdrawal by Subject|1
873199|NCT01375777|2879311|P6|Overall Study|Withdrawal by Subject|1
873200|NCT01375777|2879312|P5|Overall Study|Withdrawal by Subject|1
873201|NCT01375777|2879313|P4|Overall Study|Withdrawal by Subject|0
873202|NCT01375777|2879314|P3|Overall Study|Withdrawal by Subject|1
873203|NCT01375777|2879315|P2|Overall Study|Withdrawal by Subject|2
873204|NCT01375777|2879316|P1|Overall Study|Withdrawal by Subject|0
873205|NCT01375764|2879386|P5|Overall Study|Other|0
873206|NCT01375764|2879387|P4|Overall Study|Other|1
873207|NCT01375764|2879388|P3|Overall Study|Other|0
873208|NCT01375764|2879389|P2|Overall Study|Other|0
873209|NCT01375764|2879390|P1|Overall Study|Other|0
873210|NCT01375764|2879386|P5|Overall Study|Withdrawal by Subject|1
873211|NCT01375764|2879387|P4|Overall Study|Withdrawal by Subject|0
873212|NCT01375764|2879388|P3|Overall Study|Withdrawal by Subject|0
873213|NCT01375764|2879389|P2|Overall Study|Withdrawal by Subject|0
873214|NCT01375764|2879390|P1|Overall Study|Withdrawal by Subject|2
873215|NCT01375764|2879386|P5|Overall Study|Lost to Follow-up|0
873216|NCT01375764|2879387|P4|Overall Study|Lost to Follow-up|0
873217|NCT01375764|2879388|P3|Overall Study|Lost to Follow-up|0
873218|NCT01375764|2879389|P2|Overall Study|Lost to Follow-up|1
873219|NCT01375764|2879390|P1|Overall Study|Lost to Follow-up|0
873220|NCT01375751|2879436|P3|Overall Study|Other|0
873221|NCT01375751|2879437|P2|Overall Study|Other|1
873222|NCT01375751|2879438|P1|Overall Study|Other|0
873223|NCT01375608|2879482|P1|Overall Study|Withdrawal by Subject|2
873224|NCT01375374|2879491|P1|Overall Study|Adverse Event|1
873225|NCT01375075|2879547|P6|Overall Study|Withdrawal by Subject|1
873226|NCT01375075|2879548|P5|Overall Study|Withdrawal by Subject|0
873227|NCT01375075|2879549|P4|Overall Study|Withdrawal by Subject|0
873228|NCT01375075|2879550|P3|Overall Study|Withdrawal by Subject|0
873229|NCT01375075|2879551|P2|Overall Study|Withdrawal by Subject|1
873230|NCT01375075|2879552|P1|Overall Study|Withdrawal by Subject|0
873231|NCT01375075|2879547|P6|Overall Study|Entry Criterion Not Met|1
873232|NCT01375075|2879548|P5|Overall Study|Entry Criterion Not Met|0
873233|NCT01375075|2879549|P4|Overall Study|Entry Criterion Not Met|0
873234|NCT01375075|2879550|P3|Overall Study|Entry Criterion Not Met|0
873235|NCT01375075|2879551|P2|Overall Study|Entry Criterion Not Met|0
873236|NCT01375075|2879552|P1|Overall Study|Entry Criterion Not Met|1
873237|NCT01375075|2879547|P6|Overall Study|Adverse Event|1
873238|NCT01375075|2879548|P5|Overall Study|Adverse Event|0
873239|NCT01375075|2879549|P4|Overall Study|Adverse Event|1
873240|NCT01375075|2879550|P3|Overall Study|Adverse Event|3
873241|NCT01375075|2879551|P2|Overall Study|Adverse Event|0
873242|NCT01375075|2879552|P1|Overall Study|Adverse Event|0
873243|NCT01375049|2879636|P1|Overall Study|Protocol-Specified Withdrawal Criteria|45
873244|NCT01375049|2879636|P1|Overall Study|Withdrawal by Subject|2
873245|NCT01375049|2879636|P1|Overall Study|Lost to Follow-up|1
873246|NCT01375049|2879636|P1|Overall Study|Adverse Event|2
873247|NCT01374971|2879651|P1|Overall Study|Withdrawal by Subject|1
873248|NCT01374919|2879656|P1|Overall Study|Withdrawal by Subject|2
873249|NCT01374906|2879663|P2|Overall Study|Unsatisfactory therapeutic effect|19
873250|NCT01374906|2879664|P1|Overall Study|Unsatisfactory therapeutic effect|11
873251|NCT01374906|2879663|P2|Overall Study|Withdrawal by Subject|9
873252|NCT01374906|2879664|P1|Overall Study|Withdrawal by Subject|15
873253|NCT01374906|2879663|P2|Overall Study|Protocol Violation|2
873254|NCT01374906|2879664|P1|Overall Study|Protocol Violation|2
873255|NCT01374906|2879663|P2|Overall Study|Death|2
873256|NCT01374906|2879664|P1|Overall Study|Death|0
873257|NCT01374906|2879663|P2|Overall Study|Adverse Event|11
873258|NCT01374906|2879664|P1|Overall Study|Adverse Event|10
873259|NCT01374906|2879663|P2|Overall Study|Administrative problems|2
873260|NCT01374906|2879664|P1|Overall Study|Administrative problems|2
873261|NCT01374906|2879663|P2|Overall Study|Abnormal laboratory value(s)|3
873262|NCT01374906|2879664|P1|Overall Study|Abnormal laboratory value(s)|0
873263|NCT01374568|2879745|P2|Overall Study|Lab unable to analyze BTM|2
873264|NCT01374568|2879746|P1|Overall Study|Lab unable to analyze BTM|0
873265|NCT01374451|2879756|P2|Overall Study|Administrative problems|0
873266|NCT01374451|2879757|P1|Overall Study|Administrative problems|1
873267|NCT01374425|2879803|P2|Overall Study|Not Specified|43
873268|NCT01374425|2879804|P1|Overall Study|Not Specified|41
873269|NCT01374425|2879803|P2|Overall Study|Lost to Follow-up|1
873270|NCT01374425|2879804|P1|Overall Study|Lost to Follow-up|2
873271|NCT01374425|2879803|P2|Overall Study|Sponsor Decision|1
873272|NCT01374425|2879804|P1|Overall Study|Sponsor Decision|0
873273|NCT01374425|2879803|P2|Overall Study|Protocol Violation|3
873274|NCT01374425|2879804|P1|Overall Study|Protocol Violation|2
873275|NCT01374425|2879803|P2|Overall Study|Refused Treatment|24
873276|NCT01374425|2879804|P1|Overall Study|Refused Treatment|10
873277|NCT01374425|2879803|P2|Overall Study|Withdrawal by Subject|7
873278|NCT01374425|2879804|P1|Overall Study|Withdrawal by Subject|6
873279|NCT01374425|2879803|P2|Overall Study|Death (Adverse Event)|4
873280|NCT01374425|2879804|P1|Overall Study|Death (Adverse Event)|2
873281|NCT01374425|2879803|P2|Overall Study|Death (Progression of Disease)|0
873282|NCT01374425|2879804|P1|Overall Study|Death (Progression of Disease)|1
873283|NCT01374425|2879803|P2|Overall Study|Adverse Event|18
873284|NCT01374425|2879804|P1|Overall Study|Adverse Event|29
873285|NCT01374425|2879803|P2|Overall Study|Clinical Disease Progression|6
873286|NCT01374425|2879804|P1|Overall Study|Clinical Disease Progression|9
873287|NCT01374425|2879803|P2|Overall Study|Radiographic Disease Progression|81
873288|NCT01374425|2879804|P1|Overall Study|Radiographic Disease Progression|86
873289|NCT01374269|2879884|P2|Overall Study|closed research|2
873290|NCT01374269|2879885|P1|Overall Study|closed research|1
873291|NCT01374269|2879884|P2|Overall Study|Lost to Follow-up|3
873292|NCT01374269|2879885|P1|Overall Study|Lost to Follow-up|1
873293|NCT01374269|2879884|P2|Overall Study|Withdrawal by Subject|0
873294|NCT01374269|2879885|P1|Overall Study|Withdrawal by Subject|4
873295|NCT01374178|2880013|P2|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0
873296|NCT01374178|2880014|P1|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2
873297|NCT01374178|2880013|P2|Washout Period of at Least 7 Days|Withdrawal by Subject|0
873298|NCT01374178|2880014|P1|Washout Period of at Least 7 Days|Withdrawal by Subject|1
873299|NCT01374087|2880032|P2|Overall Study|Not provided|13
873300|NCT01374087|2880033|P1|Overall Study|Not provided|13
873301|NCT01374087|2880032|P2|Overall Study|Disease progression|2
873302|NCT01374087|2880033|P1|Overall Study|Disease progression|2
873303|NCT01374087|2880032|P2|Overall Study|Adverse Event|1
873304|NCT01374087|2880033|P1|Overall Study|Adverse Event|0
873305|NCT01373931|2880043|P2|Period 1|Withdrawal by Subject|2
873306|NCT01373931|2880044|P1|Period 1|Withdrawal by Subject|0
873307|NCT01373931|2880043|P2|Period 1|Adverse Event|0
873308|NCT01373931|2880044|P1|Period 1|Adverse Event|2
873309|NCT01373931|2880043|P2|Lead-in Period|Adverse Event|0
873310|NCT01373931|2880044|P1|Lead-in Period|Adverse Event|2
873311|NCT01373918|2880057|P2|Overall Study|Physician Decision|1
873312|NCT01373918|2880058|P1|Overall Study|Physician Decision|0
873313|NCT01373346|2880117|P1|Overall Study|Death|1
873314|NCT01373294|2880140|P2|Overall Study|Adverse Event|0
873315|NCT01373294|2880141|P1|Overall Study|Adverse Event|1
873316|NCT01373281|2880150|P2|Overall Study|Serious adverse event|1
873317|NCT01373281|2880151|P1|Overall Study|Serious adverse event|4
873318|NCT01373281|2880150|P2|Overall Study|Lost to Follow-up|1
873319|NCT01373281|2880151|P1|Overall Study|Lost to Follow-up|5
873320|NCT01373281|2880150|P2|Overall Study|Protocol Violation|2
873321|NCT01373281|2880151|P1|Overall Study|Protocol Violation|5
873322|NCT01373281|2880150|P2|Overall Study|Withdrawal by Subject|23
873323|NCT01373281|2880151|P1|Overall Study|Withdrawal by Subject|40
873324|NCT01373229|2880175|P1|Overall Study|Physician Decision|3
873325|NCT01373229|2880175|P1|Overall Study|Death|3
873326|NCT01373164|2880189|P5|Overall Study|Withdrawal by Subject|2
873327|NCT01373164|2880190|P4|Overall Study|Withdrawal by Subject|10
873328|NCT01373164|2880191|P3|Overall Study|Withdrawal by Subject|0
873329|NCT01373164|2880192|P2|Overall Study|Withdrawal by Subject|1
873330|NCT01373164|2880193|P1|Overall Study|Withdrawal by Subject|0
873331|NCT01373164|2880189|P5|Overall Study|Lost to Follow-up|0
873332|NCT01373164|2880190|P4|Overall Study|Lost to Follow-up|2
873333|NCT01373164|2880191|P3|Overall Study|Lost to Follow-up|1
873334|NCT01373164|2880192|P2|Overall Study|Lost to Follow-up|0
873335|NCT01373164|2880193|P1|Overall Study|Lost to Follow-up|0
873336|NCT01372995|2880227|P3|Overall Study|Physician Decision|1
873337|NCT01372995|2880228|P2|Overall Study|Physician Decision|0
873338|NCT01372995|2880229|P1|Overall Study|Physician Decision|0
873339|NCT01372995|2880227|P3|Overall Study|Spouse withdrew participant from study|0
873340|NCT01372995|2880228|P2|Overall Study|Spouse withdrew participant from study|1
873341|NCT01372995|2880229|P1|Overall Study|Spouse withdrew participant from study|0
873342|NCT01372878|2880276|P1|Overall Study|incomplete study procedure|104
873343|NCT01372878|2880276|P1|Overall Study|Protocol Violation|17
873344|NCT01372878|2880276|P1|Overall Study|Withdrawal by Subject|63
873345|NCT01372774|2880296|P2|Overall Study|Withdrawal prior to treatment|5
873346|NCT01372774|2880297|P1|Overall Study|Withdrawal prior to treatment|4
873347|NCT01372748|2880313|P2|Overall Study|Withdrawal by Subject|5
873348|NCT01372748|2880314|P1|Overall Study|Withdrawal by Subject|7
873349|NCT01372748|2880313|P2|Overall Study|Lost to Follow-up|34
873350|NCT01372748|2880314|P1|Overall Study|Lost to Follow-up|16
873351|NCT01372618|2880322|P1|Overall Study|PI Died. Study Terminated|9
873352|NCT01372605|2880330|P2|Overall Study|Changed medical home|0
873353|NCT01372605|2880331|P1|Overall Study|Changed medical home|2
873354|NCT01372605|2880330|P2|Overall Study|Moved|0
873355|NCT01372605|2880331|P1|Overall Study|Moved|3
873356|NCT01372605|2880330|P2|Overall Study|Withdrawal by Subject|7
873357|NCT01372605|2880331|P1|Overall Study|Withdrawal by Subject|4
873358|NCT01372605|2880330|P2|Overall Study|Lost to Follow-up|1
873359|NCT01372605|2880331|P1|Overall Study|Lost to Follow-up|2
873360|NCT01372605|2880330|P2|Overall Study|Death|2
873361|NCT01372605|2880331|P1|Overall Study|Death|1
873362|NCT01372501|2880357|P1|Overall Study|Device migration|1
873363|NCT01372501|2880357|P1|Overall Study|Adverse Event|4
873364|NCT01372410|2880380|P8|Treatment Period 3 (7 Days)|Protocol Deviation|0
873365|NCT01372410|2880381|P7|Treatment Period 3 (7 Days)|Protocol Deviation|0
873366|NCT01372410|2880382|P6|Treatment Period 3 (7 Days)|Protocol Deviation|1
873367|NCT01372410|2880383|P5|Treatment Period 3 (7 Days)|Protocol Deviation|0
873368|NCT01372410|2880384|P4|Treatment Period 3 (7 Days)|Protocol Deviation|0
873369|NCT01372410|2880385|P3|Treatment Period 3 (7 Days)|Protocol Deviation|0
873370|NCT01372410|2880386|P2|Treatment Period 3 (7 Days)|Protocol Deviation|0
873371|NCT01372410|2880387|P1|Treatment Period 3 (7 Days)|Protocol Deviation|0
873372|NCT01372410|2880380|P8|Treatment Period 3 (7 Days)|Adverse Event|0
873373|NCT01372410|2880381|P7|Treatment Period 3 (7 Days)|Adverse Event|0
873374|NCT01372410|2880382|P6|Treatment Period 3 (7 Days)|Adverse Event|0
873375|NCT01372410|2880383|P5|Treatment Period 3 (7 Days)|Adverse Event|0
873376|NCT01372410|2880384|P4|Treatment Period 3 (7 Days)|Adverse Event|0
873377|NCT01372410|2880385|P3|Treatment Period 3 (7 Days)|Adverse Event|1
873378|NCT01372410|2880386|P2|Treatment Period 3 (7 Days)|Adverse Event|0
873379|NCT01372410|2880387|P1|Treatment Period 3 (7 Days)|Adverse Event|0
873380|NCT01372410|2880380|P8|Washout Period 2 (10-14 Days)|Lack of Efficacy|1
873381|NCT01372410|2880381|P7|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
873382|NCT01372410|2880382|P6|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
873383|NCT01372410|2880383|P5|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
873384|NCT01372410|2880384|P4|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
873385|NCT01372410|2880385|P3|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
873386|NCT01372410|2880386|P2|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
873387|NCT01372410|2880387|P1|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
873388|NCT01372410|2880380|P8|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
873389|NCT01372410|2880381|P7|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
873390|NCT01372410|2880382|P6|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
873391|NCT01372410|2880383|P5|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
873392|NCT01372410|2880384|P4|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
873393|NCT01372410|2880385|P3|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
873394|NCT01372410|2880386|P2|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
873395|NCT01372410|2880387|P1|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
873396|NCT01372410|2880380|P8|Washout Period 2 (10-14 Days)|Adverse Event|0
873397|NCT01372410|2880381|P7|Washout Period 2 (10-14 Days)|Adverse Event|0
873398|NCT01372410|2880382|P6|Washout Period 2 (10-14 Days)|Adverse Event|0
873399|NCT01372410|2880383|P5|Washout Period 2 (10-14 Days)|Adverse Event|1
873400|NCT01372410|2880384|P4|Washout Period 2 (10-14 Days)|Adverse Event|0
873401|NCT01372410|2880385|P3|Washout Period 2 (10-14 Days)|Adverse Event|0
873402|NCT01372410|2880386|P2|Washout Period 2 (10-14 Days)|Adverse Event|0
873403|NCT01372410|2880387|P1|Washout Period 2 (10-14 Days)|Adverse Event|0
873404|NCT01372410|2880380|P8|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
873405|NCT01372410|2880381|P7|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
873406|NCT01372410|2880382|P6|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
873407|NCT01372410|2880383|P5|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
873408|NCT01372410|2880384|P4|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
873409|NCT01372410|2880385|P3|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
873410|NCT01372410|2880386|P2|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
873411|NCT01372410|2880387|P1|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
873412|NCT01372410|2880380|P8|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
873413|NCT01372410|2880381|P7|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1
873414|NCT01372410|2880382|P6|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
873415|NCT01372410|2880383|P5|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
873416|NCT01372410|2880384|P4|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
873417|NCT01372410|2880385|P3|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
873418|NCT01372410|2880386|P2|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
873419|NCT01372410|2880387|P1|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
873420|NCT01372410|2880380|P8|Treatment Period 1 (7 Days)|Lost to Follow-up|0
873421|NCT01372410|2880381|P7|Treatment Period 1 (7 Days)|Lost to Follow-up|0
873422|NCT01372410|2880382|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
873423|NCT01372410|2880383|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|1
873424|NCT01372410|2880384|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
873425|NCT01372410|2880385|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
873426|NCT01372410|2880386|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
873427|NCT01372410|2880387|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|0
873428|NCT01372410|2880380|P8|Treatment Period 1 (7 Days)|Adverse Event|0
873429|NCT01372410|2880381|P7|Treatment Period 1 (7 Days)|Adverse Event|1
873430|NCT01372410|2880382|P6|Treatment Period 1 (7 Days)|Adverse Event|0
873431|NCT01372410|2880383|P5|Treatment Period 1 (7 Days)|Adverse Event|0
873432|NCT01372410|2880384|P4|Treatment Period 1 (7 Days)|Adverse Event|0
873433|NCT01372410|2880385|P3|Treatment Period 1 (7 Days)|Adverse Event|0
873434|NCT01372410|2880386|P2|Treatment Period 1 (7 Days)|Adverse Event|1
873435|NCT01372410|2880387|P1|Treatment Period 1 (7 Days)|Adverse Event|0
873436|NCT01372410|2880380|P8|Treatment Period 1 (7 Days)|Lack of Efficacy|0
873437|NCT01372410|2880381|P7|Treatment Period 1 (7 Days)|Lack of Efficacy|0
873438|NCT01372410|2880382|P6|Treatment Period 1 (7 Days)|Lack of Efficacy|0
873439|NCT01372410|2880383|P5|Treatment Period 1 (7 Days)|Lack of Efficacy|1
873440|NCT01372410|2880384|P4|Treatment Period 1 (7 Days)|Lack of Efficacy|0
873441|NCT01372410|2880385|P3|Treatment Period 1 (7 Days)|Lack of Efficacy|0
873442|NCT01372410|2880386|P2|Treatment Period 1 (7 Days)|Lack of Efficacy|1
873443|NCT01372410|2880387|P1|Treatment Period 1 (7 Days)|Lack of Efficacy|1
873444|NCT01372384|2880424|P1|Overall Study|Progression of disease|3
873445|NCT01372150|2880447|P3|Overall Study|Randomized but not treated|0
873446|NCT01372150|2880448|P2|Overall Study|Randomized but not treated|1
873447|NCT01372150|2880449|P1|Overall Study|Randomized but not treated|0
873448|NCT01372150|2880447|P3|Overall Study|Adverse Event|2
873449|NCT01372150|2880448|P2|Overall Study|Adverse Event|1
873450|NCT01372150|2880449|P1|Overall Study|Adverse Event|2
873451|NCT01372150|2880447|P3|Overall Study|Other|2
873452|NCT01372150|2880448|P2|Overall Study|Other|0
873453|NCT01372150|2880449|P1|Overall Study|Other|1
873454|NCT01372150|2880447|P3|Overall Study|Withdrawal by Subject|2
873455|NCT01372150|2880448|P2|Overall Study|Withdrawal by Subject|7
873456|NCT01372150|2880449|P1|Overall Study|Withdrawal by Subject|2
873457|NCT01372150|2880447|P3|Overall Study|Protocol Violation|3
873458|NCT01372150|2880448|P2|Overall Study|Protocol Violation|0
873459|NCT01372150|2880449|P1|Overall Study|Protocol Violation|1
873460|NCT01372150|2880447|P3|Overall Study|Lost to Follow-up|6
873461|NCT01372150|2880448|P2|Overall Study|Lost to Follow-up|5
873462|NCT01372150|2880449|P1|Overall Study|Lost to Follow-up|4
873463|NCT01372150|2880447|P3|Overall Study|Lack of Efficacy|1
873464|NCT01372150|2880448|P2|Overall Study|Lack of Efficacy|0
873465|NCT01372150|2880449|P1|Overall Study|Lack of Efficacy|3
873466|NCT01371994|2880468|P2|Overall Study|Miscellaneous Reasons|4
873467|NCT01371994|2880469|P1|Overall Study|Miscellaneous Reasons|6
873468|NCT01371994|2880468|P2|Overall Study|Physician Decision|1
873469|NCT01371994|2880469|P1|Overall Study|Physician Decision|1
873470|NCT01371994|2880468|P2|Overall Study|Randomized but Never Received Study Drug|6
873471|NCT01371994|2880469|P1|Overall Study|Randomized but Never Received Study Drug|6
873472|NCT01371994|2880468|P2|Overall Study|Protocol Violation|17
873473|NCT01371994|2880469|P1|Overall Study|Protocol Violation|24
873474|NCT01371994|2880468|P2|Overall Study|Lost to Follow-up|1
873475|NCT01371994|2880469|P1|Overall Study|Lost to Follow-up|1
873476|NCT01371994|2880468|P2|Overall Study|Withdrawal by Subject|7
873477|NCT01371994|2880469|P1|Overall Study|Withdrawal by Subject|13
873478|NCT01371994|2880468|P2|Overall Study|Lack of Efficacy|0
873479|NCT01371994|2880469|P1|Overall Study|Lack of Efficacy|3
873480|NCT01371994|2880468|P2|Overall Study|Adverse Event|6
873481|NCT01371994|2880469|P1|Overall Study|Adverse Event|3
873482|NCT01371877|2880513|P2|Overall Study|3 for unknown reasons and 1 pregnant|4
873483|NCT01371877|2880514|P1|Overall Study|3 for unknown reasons and 1 pregnant|0
873484|NCT01371851|2880526|P2|Overall Study|Blood Pressure outside study parameters|0
873485|NCT01371851|2880527|P1|Overall Study|Blood Pressure outside study parameters|2
873486|NCT01371851|2880526|P2|Overall Study|non study related adverse event|0
873487|NCT01371851|2880527|P1|Overall Study|non study related adverse event|1
873488|NCT01371851|2880526|P2|Overall Study|was arrested and put in jail|1
873489|NCT01371851|2880527|P1|Overall Study|was arrested and put in jail|0
873490|NCT01371851|2880526|P2|Overall Study|Lost to Follow-up|8
873491|NCT01371851|2880527|P1|Overall Study|Lost to Follow-up|5
873492|NCT01371838|2880535|P2|Overall Study|Surgery|0
873493|NCT01371838|2880536|P1|Overall Study|Surgery|1
873494|NCT01371838|2880535|P2|Overall Study|Lack of therapeutic response|1
873495|NCT01371838|2880536|P1|Overall Study|Lack of therapeutic response|0
873496|NCT01371838|2880535|P2|Overall Study|Last follow-up visit not conducted|0
873497|NCT01371838|2880536|P1|Overall Study|Last follow-up visit not conducted|2
873498|NCT01371838|2880535|P2|Overall Study|Investigator Decision|8
873499|NCT01371838|2880536|P1|Overall Study|Investigator Decision|3
873500|NCT01371838|2880535|P2|Overall Study|Protocol Violation|0
873501|NCT01371838|2880536|P1|Overall Study|Protocol Violation|3
873502|NCT01371838|2880535|P2|Overall Study|Death|4
873503|NCT01371838|2880536|P1|Overall Study|Death|3
873504|NCT01371838|2880535|P2|Overall Study|Lost to Follow-up|20
873505|NCT01371838|2880536|P1|Overall Study|Lost to Follow-up|10
873506|NCT01371838|2880535|P2|Overall Study|Withdrawal by Subject|33
873507|NCT01371838|2880536|P1|Overall Study|Withdrawal by Subject|27
873508|NCT01371825|2880572|P1|Primary Efficacy Analysis Period|Death|3
873509|NCT01371747|2880607|P6|Overall Study|Other Reasons|1
873510|NCT01371747|2880608|P5|Overall Study|Other Reasons|0
873511|NCT01371747|2880609|P4|Overall Study|Other Reasons|0
873512|NCT01371747|2880610|P3|Overall Study|Other Reasons|2
873513|NCT01371747|2880611|P2|Overall Study|Other Reasons|1
873514|NCT01371747|2880612|P1|Overall Study|Other Reasons|2
873515|NCT01371747|2880607|P6|Overall Study|Withdrawal by Subject|4
873516|NCT01371747|2880608|P5|Overall Study|Withdrawal by Subject|2
873517|NCT01371747|2880609|P4|Overall Study|Withdrawal by Subject|2
873518|NCT01371747|2880610|P3|Overall Study|Withdrawal by Subject|5
873519|NCT01371747|2880611|P2|Overall Study|Withdrawal by Subject|12
873520|NCT01371747|2880612|P1|Overall Study|Withdrawal by Subject|6
873521|NCT01371747|2880607|P6|Overall Study|Physician Decision|0
873522|NCT01371747|2880608|P5|Overall Study|Physician Decision|1
873523|NCT01371747|2880609|P4|Overall Study|Physician Decision|0
873524|NCT01371747|2880610|P3|Overall Study|Physician Decision|0
873525|NCT01371747|2880611|P2|Overall Study|Physician Decision|0
873526|NCT01371747|2880612|P1|Overall Study|Physician Decision|0
873527|NCT01371747|2880607|P6|Overall Study|Non-Compliance|1
873528|NCT01371747|2880608|P5|Overall Study|Non-Compliance|0
873529|NCT01371747|2880609|P4|Overall Study|Non-Compliance|0
873530|NCT01371747|2880610|P3|Overall Study|Non-Compliance|3
873531|NCT01371747|2880611|P2|Overall Study|Non-Compliance|4
873532|NCT01371747|2880612|P1|Overall Study|Non-Compliance|3
873533|NCT01371747|2880607|P6|Overall Study|Protocol Violation|0
873534|NCT01371747|2880608|P5|Overall Study|Protocol Violation|0
873535|NCT01371747|2880609|P4|Overall Study|Protocol Violation|0
873536|NCT01371747|2880610|P3|Overall Study|Protocol Violation|1
873537|NCT01371747|2880611|P2|Overall Study|Protocol Violation|0
873538|NCT01371747|2880612|P1|Overall Study|Protocol Violation|0
873539|NCT01371747|2880607|P6|Overall Study|Low Serum Potassium Results|3
873540|NCT01371747|2880608|P5|Overall Study|Low Serum Potassium Results|0
873541|NCT01371747|2880609|P4|Overall Study|Low Serum Potassium Results|1
873542|NCT01371747|2880610|P3|Overall Study|Low Serum Potassium Results|1
873543|NCT01371747|2880611|P2|Overall Study|Low Serum Potassium Results|1
873544|NCT01371747|2880612|P1|Overall Study|Low Serum Potassium Results|1
873545|NCT01371747|2880607|P6|Overall Study|High Serum Potassium Results|2
873546|NCT01371747|2880608|P5|Overall Study|High Serum Potassium Results|0
873547|NCT01371747|2880609|P4|Overall Study|High Serum Potassium Results|2
873548|NCT01371747|2880610|P3|Overall Study|High Serum Potassium Results|1
873549|NCT01371747|2880611|P2|Overall Study|High Serum Potassium Results|1
873550|NCT01371747|2880612|P1|Overall Study|High Serum Potassium Results|1
873551|NCT01371747|2880607|P6|Overall Study|Abnormal Renal Function|1
873552|NCT01371747|2880608|P5|Overall Study|Abnormal Renal Function|0
873553|NCT01371747|2880609|P4|Overall Study|Abnormal Renal Function|1
873554|NCT01371747|2880610|P3|Overall Study|Abnormal Renal Function|0
873555|NCT01371747|2880611|P2|Overall Study|Abnormal Renal Function|2
873556|NCT01371747|2880612|P1|Overall Study|Abnormal Renal Function|0
873557|NCT01371747|2880607|P6|Overall Study|Death|0
873558|NCT01371747|2880608|P5|Overall Study|Death|2
873559|NCT01371747|2880609|P4|Overall Study|Death|1
873560|NCT01371747|2880610|P3|Overall Study|Death|4
873561|NCT01371747|2880611|P2|Overall Study|Death|0
873562|NCT01371747|2880612|P1|Overall Study|Death|1
873563|NCT01371747|2880607|P6|Overall Study|Adverse Event|2
873564|NCT01371747|2880608|P5|Overall Study|Adverse Event|2
873565|NCT01371747|2880609|P4|Overall Study|Adverse Event|2
873566|NCT01371747|2880610|P3|Overall Study|Adverse Event|7
873567|NCT01371747|2880611|P2|Overall Study|Adverse Event|2
873568|NCT01371747|2880612|P1|Overall Study|Adverse Event|4
873569|NCT01371734|2880677|P3|Overall Study|Lack of Efficacy|0
873570|NCT01371734|2880678|P2|Overall Study|Lack of Efficacy|2
873571|NCT01371734|2880679|P1|Overall Study|Lack of Efficacy|2
873572|NCT01371734|2880677|P3|Overall Study|Adverse Event|3
873573|NCT01371734|2880678|P2|Overall Study|Adverse Event|8
873574|NCT01371734|2880679|P1|Overall Study|Adverse Event|8
873575|NCT01371734|2880677|P3|Overall Study|Protocol Violation|2
873576|NCT01371734|2880678|P2|Overall Study|Protocol Violation|1
873577|NCT01371734|2880679|P1|Overall Study|Protocol Violation|3
873578|NCT01371734|2880677|P3|Overall Study|Lost to Follow-up|1
873579|NCT01371734|2880678|P2|Overall Study|Lost to Follow-up|3
873580|NCT01371734|2880679|P1|Overall Study|Lost to Follow-up|5
873581|NCT01371734|2880677|P3|Overall Study|Withdrawal by Subject|9
873582|NCT01371734|2880678|P2|Overall Study|Withdrawal by Subject|4
873583|NCT01371734|2880679|P1|Overall Study|Withdrawal by Subject|3
873584|NCT01371734|2880677|P3|Overall Study|Not specified|2
873585|NCT01371734|2880678|P2|Overall Study|Not specified|1
873586|NCT01371734|2880679|P1|Overall Study|Not specified|2
873587|NCT01371721|2880699|P3|Overall Study|Randomized but not treated|0
873588|NCT01371721|2880700|P2|Overall Study|Randomized but not treated|0
873589|NCT01371721|2880701|P1|Overall Study|Randomized but not treated|1
873590|NCT01371721|2880699|P3|Overall Study|Lack of Efficacy|3
873591|NCT01371721|2880700|P2|Overall Study|Lack of Efficacy|4
873592|NCT01371721|2880701|P1|Overall Study|Lack of Efficacy|2
873593|NCT01371721|2880699|P3|Overall Study|Not specified|0
873594|NCT01371721|2880700|P2|Overall Study|Not specified|3
873595|NCT01371721|2880701|P1|Overall Study|Not specified|2
873596|NCT01371721|2880699|P3|Overall Study|Withdrawal by Subject|11
873597|NCT01371721|2880700|P2|Overall Study|Withdrawal by Subject|7
873598|NCT01371721|2880701|P1|Overall Study|Withdrawal by Subject|5
873599|NCT01371721|2880699|P3|Overall Study|Lost to Follow-up|6
873600|NCT01371721|2880700|P2|Overall Study|Lost to Follow-up|2
873601|NCT01371721|2880701|P1|Overall Study|Lost to Follow-up|8
873602|NCT01371721|2880699|P3|Overall Study|Protocol Violation|5
873603|NCT01371721|2880700|P2|Overall Study|Protocol Violation|4
873604|NCT01371721|2880701|P1|Overall Study|Protocol Violation|6
873605|NCT01371721|2880699|P3|Overall Study|Adverse Event|5
873606|NCT01371721|2880700|P2|Overall Study|Adverse Event|4
873607|NCT01371721|2880701|P1|Overall Study|Adverse Event|5
873608|NCT01371708|2880734|P3|Overall Study|Started but did not receive treatment|1
873609|NCT01371708|2880735|P2|Overall Study|Started but did not receive treatment|0
873610|NCT01371708|2880736|P1|Overall Study|Started but did not receive treatment|1
873611|NCT01371708|2880734|P3|Overall Study|Adverse Event|12
873612|NCT01371708|2880735|P2|Overall Study|Adverse Event|8
873613|NCT01371708|2880736|P1|Overall Study|Adverse Event|5
873614|NCT01371708|2880734|P3|Overall Study|Not specified|4
873615|NCT01371708|2880735|P2|Overall Study|Not specified|2
873616|NCT01371708|2880736|P1|Overall Study|Not specified|3
873617|NCT01371708|2880734|P3|Overall Study|Medication error/not related to AE|0
873618|NCT01371708|2880735|P2|Overall Study|Medication error/not related to AE|1
873619|NCT01371708|2880736|P1|Overall Study|Medication error/not related to AE|0
873620|NCT01371708|2880734|P3|Overall Study|No longer willing to participate|13
873621|NCT01371708|2880735|P2|Overall Study|No longer willing to participate|7
873622|NCT01371708|2880736|P1|Overall Study|No longer willing to participate|7
873623|NCT01371708|2880734|P3|Overall Study|Protocol Violation|2
873624|NCT01371708|2880735|P2|Overall Study|Protocol Violation|1
873625|NCT01371708|2880736|P1|Overall Study|Protocol Violation|2
873626|NCT01371708|2880734|P3|Overall Study|Lost to Follow-up|7
873627|NCT01371708|2880735|P2|Overall Study|Lost to Follow-up|9
873628|NCT01371708|2880736|P1|Overall Study|Lost to Follow-up|5
873629|NCT01371708|2880734|P3|Overall Study|Insufficient clinical response|0
873630|NCT01371708|2880735|P2|Overall Study|Insufficient clinical response|2
873631|NCT01371708|2880736|P1|Overall Study|Insufficient clinical response|3
873632|NCT01371656|2880768|P2|Overall Study|Ineligible|3
873633|NCT01371656|2880769|P1|Overall Study|Ineligible|4
873634|NCT01371656|2880768|P2|Overall Study|Withdrawal by Subject|0
873635|NCT01371656|2880769|P1|Overall Study|Withdrawal by Subject|7
873636|NCT01371656|2880768|P2|Overall Study|Physician Decision|7
873637|NCT01371656|2880769|P1|Overall Study|Physician Decision|46
873638|NCT01371656|2880768|P2|Overall Study|Death|4
873639|NCT01371656|2880769|P1|Overall Study|Death|7
873640|NCT01371643|2880789|P2|Overall Study|Withdrawal by Subject|0
873641|NCT01371643|2880790|P1|Overall Study|Withdrawal by Subject|3
873642|NCT01371565|2880800|P1|Overall Study|Resection of neuroendocrine tumor|1
873643|NCT01371565|2880800|P1|Overall Study|Death|1
873644|NCT01371565|2880800|P1|Overall Study|Withdrawal by Subject|1
873645|NCT01371552|2880804|P6|Part 1, First 3 Days|Inconvenience|0
873646|NCT01371552|2880805|P5|Part 1, First 3 Days|Inconvenience|0
873647|NCT01371552|2880806|P4|Part 1, First 3 Days|Inconvenience|0
873648|NCT01371552|2880807|P3|Part 1, First 3 Days|Inconvenience|1
873649|NCT01371552|2880808|P2|Part 1, First 3 Days|Inconvenience|0
873650|NCT01371552|2880809|P1|Part 1, First 3 Days|Inconvenience|0
873651|NCT01371539|2880836|P2|Period Two: One Week|Time/job conflict|1
873652|NCT01371539|2880837|P1|Period Two: One Week|Time/job conflict|0
873653|NCT01371539|2880836|P2|Period Two: One Week|Unacceptable Objective Visual Acuity|1
873654|NCT01371539|2880837|P1|Period Two: One Week|Unacceptable Objective Visual Acuity|0
873655|NCT01371539|2880836|P2|Period Two: One Week|Lost to Follow-up|1
873656|NCT01371539|2880837|P1|Period Two: One Week|Lost to Follow-up|0
873657|NCT01371539|2880836|P2|Period One: One Week|Lost to Follow-up|1
873658|NCT01371539|2880837|P1|Period One: One Week|Lost to Follow-up|0
873659|NCT01371006|2880858|P2|Overall Study|Adverse Event|0
873660|NCT01371006|2880859|P1|Overall Study|Adverse Event|1
873661|NCT01370863|2880900|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
873662|NCT01370863|2880901|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
873663|NCT01370863|2880900|P2|Overall Study|Did not want second pH/MII monitoring|1
873664|NCT01370863|2880901|P1|Overall Study|Did not want second pH/MII monitoring|1
873665|NCT01370863|2880900|P2|Overall Study|Adverse Event|1
873666|NCT01370863|2880901|P1|Overall Study|Adverse Event|1
873667|NCT01370733|2880926|P2|Overall Study|Protocol Violation|3
873668|NCT01370733|2880927|P1|Overall Study|Protocol Violation|1
873669|NCT01370733|2880926|P2|Overall Study|Physician Decision|2
873670|NCT01370733|2880927|P1|Overall Study|Physician Decision|0
873671|NCT01370733|2880926|P2|Overall Study|Lack of Efficacy|5
873672|NCT01370733|2880927|P1|Overall Study|Lack of Efficacy|3
873673|NCT01370733|2880926|P2|Overall Study|Adverse Event|4
873674|NCT01370733|2880927|P1|Overall Study|Adverse Event|2
873675|NCT01370733|2880926|P2|Overall Study|Lost to Follow-up|0
873676|NCT01370733|2880927|P1|Overall Study|Lost to Follow-up|3
873677|NCT01370733|2880926|P2|Overall Study|Withdrawal by Subject|8
873678|NCT01370733|2880927|P1|Overall Study|Withdrawal by Subject|8
873679|NCT01370694|2880949|P1|Overall Study|Progressive disease|2
873680|NCT01370694|2880949|P1|Overall Study|Switched to rituximab|4
873681|NCT01370655|2880971|P12|Period 2|Withdrawal by Subject|0
873682|NCT01370655|2880972|P11|Period 2|Withdrawal by Subject|0
873683|NCT01370655|2880973|P10|Period 2|Withdrawal by Subject|0
873684|NCT01370655|2880974|P9|Period 2|Withdrawal by Subject|1
873685|NCT01370655|2880975|P8|Period 2|Withdrawal by Subject|0
873686|NCT01370655|2880976|P7|Period 2|Withdrawal by Subject|0
873687|NCT01370655|2880977|P6|Period 2|Withdrawal by Subject|0
873688|NCT01370655|2880978|P5|Period 2|Withdrawal by Subject|0
873689|NCT01370655|2880979|P4|Period 2|Withdrawal by Subject|0
873690|NCT01370655|2880980|P3|Period 2|Withdrawal by Subject|0
873691|NCT01370655|2880981|P2|Period 2|Withdrawal by Subject|0
873692|NCT01370655|2880982|P1|Period 2|Withdrawal by Subject|0
873693|NCT01370655|2880971|P12|Period 2|met protocol specified stopping criteria|0
873694|NCT01370655|2880972|P11|Period 2|met protocol specified stopping criteria|1
873695|NCT01370655|2880973|P10|Period 2|met protocol specified stopping criteria|0
873696|NCT01370655|2880974|P9|Period 2|met protocol specified stopping criteria|1
873697|NCT01370655|2880975|P8|Period 2|met protocol specified stopping criteria|0
873698|NCT01370655|2880976|P7|Period 2|met protocol specified stopping criteria|1
873699|NCT01370655|2880977|P6|Period 2|met protocol specified stopping criteria|0
873700|NCT01370655|2880978|P5|Period 2|met protocol specified stopping criteria|0
873701|NCT01370655|2880979|P4|Period 2|met protocol specified stopping criteria|0
873702|NCT01370655|2880980|P3|Period 2|met protocol specified stopping criteria|1
873703|NCT01370655|2880981|P2|Period 2|met protocol specified stopping criteria|0
873704|NCT01370655|2880982|P1|Period 2|met protocol specified stopping criteria|0
873705|NCT01370655|2880971|P12|Period 2|Adverse Event|0
873706|NCT01370655|2880972|P11|Period 2|Adverse Event|0
873707|NCT01370655|2880973|P10|Period 2|Adverse Event|0
873708|NCT01370655|2880974|P9|Period 2|Adverse Event|0
873709|NCT01370655|2880975|P8|Period 2|Adverse Event|1
873710|NCT01370655|2880976|P7|Period 2|Adverse Event|0
873711|NCT01370655|2880977|P6|Period 2|Adverse Event|0
873712|NCT01370655|2880978|P5|Period 2|Adverse Event|1
873713|NCT01370655|2880979|P4|Period 2|Adverse Event|0
873714|NCT01370655|2880980|P3|Period 2|Adverse Event|1
873715|NCT01370655|2880981|P2|Period 2|Adverse Event|0
873716|NCT01370655|2880982|P1|Period 2|Adverse Event|0
873717|NCT01370655|2880971|P12|Period 1|Adverse Event|0
873718|NCT01370655|2880972|P11|Period 1|Adverse Event|0
873719|NCT01370655|2880973|P10|Period 1|Adverse Event|0
873720|NCT01370655|2880974|P9|Period 1|Adverse Event|0
873721|NCT01370655|2880975|P8|Period 1|Adverse Event|0
873722|NCT01370655|2880976|P7|Period 1|Adverse Event|1
873723|NCT01370655|2880977|P6|Period 1|Adverse Event|0
873724|NCT01370655|2880978|P5|Period 1|Adverse Event|0
873725|NCT01370655|2880979|P4|Period 1|Adverse Event|0
873726|NCT01370655|2880980|P3|Period 1|Adverse Event|0
873727|NCT01370655|2880981|P2|Period 1|Adverse Event|0
873728|NCT01370655|2880982|P1|Period 1|Adverse Event|2
873729|NCT01370642|2881019|P3|Overall Study|Withdrawal by Subject|3
873730|NCT01370642|2881020|P2|Overall Study|Withdrawal by Subject|4
873731|NCT01370642|2881021|P1|Overall Study|Withdrawal by Subject|2
873732|NCT01370642|2881019|P3|Overall Study|Physician Decision|2
873733|NCT01370642|2881020|P2|Overall Study|Physician Decision|1
873734|NCT01370642|2881021|P1|Overall Study|Physician Decision|4
873735|NCT01370642|2881019|P3|Overall Study|Lost to Follow-up|1
873736|NCT01370642|2881020|P2|Overall Study|Lost to Follow-up|0
873737|NCT01370642|2881021|P1|Overall Study|Lost to Follow-up|0
873738|NCT01370642|2881019|P3|Overall Study|Detectable HCV RNA|22
873739|NCT01370642|2881020|P2|Overall Study|Detectable HCV RNA|0
873740|NCT01370642|2881021|P1|Overall Study|Detectable HCV RNA|0
873741|NCT01370642|2881019|P3|Overall Study|Adverse Event|1
873742|NCT01370642|2881020|P2|Overall Study|Adverse Event|1
873743|NCT01370642|2881021|P1|Overall Study|Adverse Event|2
873744|NCT01370616|2881052|P2|Overall Study|Withdrawal by Subject|34
873745|NCT01370616|2881053|P1|Overall Study|Withdrawal by Subject|34
873746|NCT01370616|2881052|P2|Overall Study|Technical Problems|5
873747|NCT01370616|2881053|P1|Overall Study|Technical Problems|3
873748|NCT01370616|2881052|P2|Overall Study|Recovery|0
873749|NCT01370616|2881053|P1|Overall Study|Recovery|1
873750|NCT01370616|2881052|P2|Overall Study|Progressive Disease|1
873751|NCT01370616|2881053|P1|Overall Study|Progressive Disease|0
873752|NCT01370616|2881052|P2|Overall Study|Physician Decision|6
873753|NCT01370616|2881053|P1|Overall Study|Physician Decision|6
873754|NCT01370616|2881052|P2|Overall Study|Lost to Follow-up|3
873755|NCT01370616|2881053|P1|Overall Study|Lost to Follow-up|0
873756|NCT01370616|2881052|P2|Overall Study|Lack of Efficacy|2
873757|NCT01370616|2881053|P1|Overall Study|Lack of Efficacy|6
873758|NCT01370616|2881052|P2|Overall Study|Death|0
873759|NCT01370616|2881053|P1|Overall Study|Death|1
873760|NCT01370616|2881052|P2|Overall Study|Adverse Event|16
873761|NCT01370616|2881053|P1|Overall Study|Adverse Event|11
873762|NCT01370603|2881077|P2|Period 2|Withdrawal by Subject|0
873763|NCT01370603|2881078|P1|Period 2|Withdrawal by Subject|1
873764|NCT01370603|2881077|P2|Period 2|Lost to Follow-up|0
873765|NCT01370603|2881078|P1|Period 2|Lost to Follow-up|1
873766|NCT01370603|2881077|P2|Period 2|Adverse Event|4
873767|NCT01370603|2881078|P1|Period 2|Adverse Event|1
873768|NCT01370603|2881077|P2|Crossover Washout|Non-compliance with Study Drug|2
873769|NCT01370603|2881078|P1|Crossover Washout|Non-compliance with Study Drug|0
873770|NCT01370603|2881077|P2|Crossover Washout|Withdrawal by Subject|1
873771|NCT01370603|2881078|P1|Crossover Washout|Withdrawal by Subject|4
873772|NCT01370603|2881077|P2|Crossover Washout|Protocol Violation|0
873773|NCT01370603|2881078|P1|Crossover Washout|Protocol Violation|1
873774|NCT01370603|2881077|P2|Crossover Washout|Lost to Follow-up|0
873775|NCT01370603|2881078|P1|Crossover Washout|Lost to Follow-up|2
873776|NCT01370603|2881077|P2|Crossover Washout|Adverse Event|1
873777|NCT01370603|2881078|P1|Crossover Washout|Adverse Event|2
873778|NCT01370603|2881077|P2|Period 1|Withdrawal by Subject|5
873779|NCT01370603|2881078|P1|Period 1|Withdrawal by Subject|5
873780|NCT01370603|2881077|P2|Period 1|Protocol Violation|2
873781|NCT01370603|2881078|P1|Period 1|Protocol Violation|2
873782|NCT01370603|2881077|P2|Period 1|Lost to Follow-up|0
873783|NCT01370603|2881078|P1|Period 1|Lost to Follow-up|2
873784|NCT01370603|2881077|P2|Period 1|Adverse Event|3
873785|NCT01370603|2881078|P1|Period 1|Adverse Event|5
873786|NCT01370590|2881096|P2|Period 2|Withdrawal by Subject|1
873787|NCT01370590|2881097|P1|Period 2|Withdrawal by Subject|1
873788|NCT01370590|2881096|P2|Period 2|Adverse Event|1
873789|NCT01370590|2881097|P1|Period 2|Adverse Event|0
873790|NCT01370590|2881096|P2|Crossover Washout Period|Withdrawal by Subject|2
873791|NCT01370590|2881097|P1|Crossover Washout Period|Withdrawal by Subject|2
873792|NCT01370590|2881096|P2|Crossover Washout Period|Non-compliance with Study Drug|0
873793|NCT01370590|2881097|P1|Crossover Washout Period|Non-compliance with Study Drug|1
873794|NCT01370590|2881096|P2|Crossover Washout Period|Lost to Follow-up|0
873795|NCT01370590|2881097|P1|Crossover Washout Period|Lost to Follow-up|2
873796|NCT01370590|2881096|P2|Crossover Washout Period|Adverse Event|4
873797|NCT01370590|2881097|P1|Crossover Washout Period|Adverse Event|1
873798|NCT01370590|2881096|P2|Period 1|Could not access randomization system|1
873799|NCT01370590|2881097|P1|Period 1|Could not access randomization system|0
873800|NCT01370590|2881096|P2|Period 1|Withdrawal by Subject|2
873801|NCT01370590|2881097|P1|Period 1|Withdrawal by Subject|4
873802|NCT01370590|2881096|P2|Period 1|Protocol Violation|2
873803|NCT01370590|2881097|P1|Period 1|Protocol Violation|2
873804|NCT01370590|2881096|P2|Period 1|Lost to Follow-up|2
873805|NCT01370590|2881097|P1|Period 1|Lost to Follow-up|2
873806|NCT01370590|2881096|P2|Period 1|Adverse Event|4
873807|NCT01370590|2881097|P1|Period 1|Adverse Event|8
873808|NCT01370538|2881125|P2|Overall Study|Lost to follow up|10
873809|NCT01370538|2881126|P1|Overall Study|Lost to follow up|6
873810|NCT01370538|2881125|P2|Overall Study|Development of study specific withdrawal|1
873811|NCT01370538|2881126|P1|Overall Study|Development of study specific withdrawal|1
873812|NCT01370538|2881125|P2|Overall Study|Protocol Violation|5
873813|NCT01370538|2881126|P1|Overall Study|Protocol Violation|8
873814|NCT01370538|2881125|P2|Overall Study|Adverse Event|0
873815|NCT01370538|2881126|P1|Overall Study|Adverse Event|1
873816|NCT01370538|2881125|P2|Overall Study|Eligibility criteria not fulfilled|1
873817|NCT01370538|2881126|P1|Overall Study|Eligibility criteria not fulfilled|0
873818|NCT01370538|2881125|P2|Overall Study|Voluntary Discontinuation by Subject|2
873819|NCT01370538|2881126|P1|Overall Study|Voluntary Discontinuation by Subject|3
873820|NCT01370525|2881142|P2|Overall Study|Lost to follow up|6
873821|NCT01370525|2881143|P1|Overall Study|Lost to follow up|2
873822|NCT01370525|2881142|P2|Overall Study|Protocol Violation|1
873823|NCT01370525|2881143|P1|Overall Study|Protocol Violation|2
873824|NCT01370525|2881142|P2|Overall Study|Adverse Event|1
873825|NCT01370525|2881143|P1|Overall Study|Adverse Event|0
873826|NCT01370525|2881142|P2|Overall Study|Eligibility criteria not fulfilled|0
873827|NCT01370525|2881143|P1|Overall Study|Eligibility criteria not fulfilled|2
873828|NCT01370525|2881142|P2|Overall Study|Voluntary Discontinuation by Subject|3
873829|NCT01370525|2881143|P1|Overall Study|Voluntary Discontinuation by Subject|2
873830|NCT01370499|2881159|P2|Overall Study|Sponsor Decision|15
873831|NCT01370499|2881160|P1|Overall Study|Sponsor Decision|41
873832|NCT01370499|2881159|P2|Overall Study|Withdrawal by Subject|7
873833|NCT01370499|2881160|P1|Overall Study|Withdrawal by Subject|18
873834|NCT01370499|2881159|P2|Overall Study|Protocol Violation|4
873835|NCT01370499|2881160|P1|Overall Study|Protocol Violation|5
873836|NCT01370499|2881159|P2|Overall Study|Physician Decision|3
873837|NCT01370499|2881160|P1|Overall Study|Physician Decision|3
873838|NCT01370499|2881159|P2|Overall Study|Lost to Follow-up|1
873839|NCT01370499|2881160|P1|Overall Study|Lost to Follow-up|2
873840|NCT01370499|2881159|P2|Overall Study|Lack of Efficacy|2
873841|NCT01370499|2881160|P1|Overall Study|Lack of Efficacy|4
873842|NCT01370499|2881159|P2|Overall Study|Adverse Event|12
873843|NCT01370499|2881160|P1|Overall Study|Adverse Event|38
873844|NCT01370408|2881202|P1|Overall Study|treatment failure|9
873845|NCT01370356|2881262|P2|Overall Study|AE Not Related to Study Drug|4
873846|NCT01370356|2881263|P1|Overall Study|AE Not Related to Study Drug|1
873847|NCT01370356|2881262|P2|Overall Study|Adverse event (AE) Related to Study Drug|9
873848|NCT01370356|2881263|P1|Overall Study|Adverse event (AE) Related to Study Drug|12
873849|NCT01370356|2881262|P2|Overall Study|Protocol Violation|3
873850|NCT01370356|2881263|P1|Overall Study|Protocol Violation|3
873851|NCT01370356|2881262|P2|Overall Study|Reason not specified|43
873852|NCT01370356|2881263|P1|Overall Study|Reason not specified|39
873853|NCT01370356|2881262|P2|Overall Study|Withdrawal by Subject|59
873854|NCT01370356|2881263|P1|Overall Study|Withdrawal by Subject|54
873855|NCT01370356|2881262|P2|Overall Study|Lost to Follow-up|81
873856|NCT01370356|2881263|P1|Overall Study|Lost to Follow-up|76
873857|NCT01370356|2881262|P2|Overall Study|Lack of Efficacy|28
873858|NCT01370356|2881263|P1|Overall Study|Lack of Efficacy|6
873859|NCT01370356|2881262|P2|Overall Study|Death|0
873860|NCT01370356|2881263|P1|Overall Study|Death|1
873861|NCT01370265|2881277|P2|First Intervention|Adverse Event|1
873862|NCT01370265|2881278|P1|First Intervention|Adverse Event|1
873863|NCT01370083|2881297|P2|Overall Study|Adverse Event|1
873864|NCT01370083|2881298|P1|Overall Study|Adverse Event|0
873865|NCT01370083|2881297|P2|Overall Study|Lost to Follow-up|0
873866|NCT01370083|2881298|P1|Overall Study|Lost to Follow-up|2
873867|NCT01370005|2881311|P3|Overall Study|Other reason not defined above|2
873868|NCT01370005|2881312|P2|Overall Study|Other reason not defined above|0
873869|NCT01370005|2881313|P1|Overall Study|Other reason not defined above|3
873870|NCT01370005|2881311|P3|Overall Study|Patient refusal to continue,not due toAE|0
873871|NCT01370005|2881312|P2|Overall Study|Patient refusal to continue,not due toAE|4
873872|NCT01370005|2881313|P1|Overall Study|Patient refusal to continue,not due toAE|5
873873|NCT01370005|2881311|P3|Overall Study|Lost to Follow-up|1
873874|NCT01370005|2881312|P2|Overall Study|Lost to Follow-up|1
873875|NCT01370005|2881313|P1|Overall Study|Lost to Follow-up|1
873876|NCT01370005|2881311|P3|Overall Study|Non compliant with protocol|2
873877|NCT01370005|2881312|P2|Overall Study|Non compliant with protocol|1
873878|NCT01370005|2881313|P1|Overall Study|Non compliant with protocol|0
873879|NCT01370005|2881311|P3|Overall Study|Lack of Efficacy|0
873880|NCT01370005|2881312|P2|Overall Study|Lack of Efficacy|0
873881|NCT01370005|2881313|P1|Overall Study|Lack of Efficacy|1
873882|NCT01370005|2881311|P3|Overall Study|Adverse Event|6
873883|NCT01370005|2881312|P2|Overall Study|Adverse Event|5
873884|NCT01370005|2881313|P1|Overall Study|Adverse Event|5
873885|NCT01370005|2881311|P3|Overall Study|Not treated|0
873886|NCT01370005|2881312|P2|Overall Study|Not treated|0
873887|NCT01370005|2881313|P1|Overall Study|Not treated|1
873888|NCT01369849|2881395|P3|Overall Study|Ineligible after receiving treatment|0
873889|NCT01369849|2881396|P2|Overall Study|Ineligible after receiving treatment|1
873890|NCT01369849|2881397|P1|Overall Study|Ineligible after receiving treatment|0
873891|NCT01369849|2881395|P3|Overall Study|Ineligible prior to treatment|1
873892|NCT01369849|2881396|P2|Overall Study|Ineligible prior to treatment|0
873893|NCT01369849|2881397|P1|Overall Study|Ineligible prior to treatment|0
873894|NCT01369784|2881419|P1|Overall Study|Protocol Violation|12
873895|NCT01369680|2881507|P4|Overall Study|Lost to Follow-up|2
873896|NCT01369680|2881508|P3|Overall Study|Lost to Follow-up|1
873897|NCT01369680|2881509|P2|Overall Study|Lost to Follow-up|0
873898|NCT01369680|2881510|P1|Overall Study|Lost to Follow-up|0
873899|NCT01369641|2881531|P1|Overall Study|Withdrawal by Subject|1
873900|NCT01369615|2881537|P2|Overall Study|Lost to Follow-up|1
873901|NCT01369615|2881538|P1|Overall Study|Lost to Follow-up|0
873902|NCT01369615|2881537|P2|Overall Study|Withdrawal by Subject|1
873903|NCT01369615|2881538|P1|Overall Study|Withdrawal by Subject|0
873904|NCT01369511|2881548|P4|Overall Study|Withdrawal by Subject|6
873905|NCT01369511|2881549|P3|Overall Study|Withdrawal by Subject|4
873906|NCT01369511|2881550|P2|Overall Study|Withdrawal by Subject|6
873907|NCT01369511|2881551|P1|Overall Study|Withdrawal by Subject|5
873908|NCT01369511|2881548|P4|Overall Study|Sponsor decision|0
873909|NCT01369511|2881549|P3|Overall Study|Sponsor decision|1
873910|NCT01369511|2881550|P2|Overall Study|Sponsor decision|0
873911|NCT01369511|2881551|P1|Overall Study|Sponsor decision|2
873912|NCT01369511|2881548|P4|Overall Study|Physician Decision|0
873913|NCT01369511|2881549|P3|Overall Study|Physician Decision|0
873914|NCT01369511|2881550|P2|Overall Study|Physician Decision|4
873915|NCT01369511|2881551|P1|Overall Study|Physician Decision|3
873916|NCT01369511|2881548|P4|Overall Study|Protocol Violation|2
873917|NCT01369511|2881549|P3|Overall Study|Protocol Violation|0
873918|NCT01369511|2881550|P2|Overall Study|Protocol Violation|1
873919|NCT01369511|2881551|P1|Overall Study|Protocol Violation|0
873920|NCT01369511|2881548|P4|Overall Study|Lost to Follow-up|2
873921|NCT01369511|2881549|P3|Overall Study|Lost to Follow-up|1
873922|NCT01369511|2881550|P2|Overall Study|Lost to Follow-up|1
873923|NCT01369511|2881551|P1|Overall Study|Lost to Follow-up|0
873924|NCT01369511|2881548|P4|Overall Study|Entry criteria not met|1
873925|NCT01369511|2881549|P3|Overall Study|Entry criteria not met|0
873926|NCT01369511|2881550|P2|Overall Study|Entry criteria not met|0
873927|NCT01369511|2881551|P1|Overall Study|Entry criteria not met|2
873928|NCT01369511|2881548|P4|Overall Study|Adverse Event|0
873929|NCT01369511|2881549|P3|Overall Study|Adverse Event|5
873930|NCT01369511|2881550|P2|Overall Study|Adverse Event|1
873931|NCT01369511|2881551|P1|Overall Study|Adverse Event|1
873932|NCT01369485|2881567|P2|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3
873933|NCT01369485|2881568|P1|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0
873934|NCT01369485|2881567|P2|Open Label Phase (Week 12 to Month 12)|Death|1
873935|NCT01369485|2881568|P1|Open Label Phase (Week 12 to Month 12)|Death|0
873936|NCT01369485|2881567|P2|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20
873937|NCT01369485|2881568|P1|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17
873938|NCT01369485|2881567|P2|Open Label Phase (Week 12 to Month 12)|Physician Decision|4
873939|NCT01369485|2881568|P1|Open Label Phase (Week 12 to Month 12)|Physician Decision|3
873940|NCT01369485|2881567|P2|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3
873941|NCT01369485|2881568|P1|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2
873942|NCT01369485|2881567|P2|Open Label Phase (Week 12 to Month 12)|Adverse Event|9
873943|NCT01369485|2881568|P1|Open Label Phase (Week 12 to Month 12)|Adverse Event|11
873944|NCT01369485|2881567|P2|Randomized Phase (Day 0 to Week 12)|expired patches|0
873945|NCT01369485|2881568|P1|Randomized Phase (Day 0 to Week 12)|expired patches|2
873946|NCT01369485|2881567|P2|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4
873947|NCT01369485|2881568|P1|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2
873948|NCT01369485|2881567|P2|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8
873949|NCT01369485|2881568|P1|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12
873950|NCT01369485|2881567|P2|Randomized Phase (Day 0 to Week 12)|Adverse Event|5
873951|NCT01369485|2881568|P1|Randomized Phase (Day 0 to Week 12)|Adverse Event|7
873952|NCT01369355|2881614|P6|Overall Study|Not Treated|0
873953|NCT01369355|2881615|P5|Overall Study|Not Treated|0
873954|NCT01369355|2881616|P4|Overall Study|Not Treated|0
873955|NCT01369355|2881617|P3|Overall Study|Not Treated|1
873956|NCT01369355|2881618|P2|Overall Study|Not Treated|0
873957|NCT01369355|2881619|P1|Overall Study|Not Treated|0
873958|NCT01369355|2881614|P6|Overall Study|Other|0
873959|NCT01369355|2881615|P5|Overall Study|Other|1
873960|NCT01369355|2881616|P4|Overall Study|Other|0
873961|NCT01369355|2881617|P3|Overall Study|Other|0
873962|NCT01369355|2881618|P2|Overall Study|Other|0
873963|NCT01369355|2881619|P1|Overall Study|Other|0
873964|NCT01369355|2881614|P6|Overall Study|Withdrawal by Subject|22
873965|NCT01369355|2881615|P5|Overall Study|Withdrawal by Subject|8
873966|NCT01369355|2881616|P4|Overall Study|Withdrawal by Subject|6
873967|NCT01369355|2881617|P3|Overall Study|Withdrawal by Subject|7
873968|NCT01369355|2881618|P2|Overall Study|Withdrawal by Subject|2
873969|NCT01369355|2881619|P1|Overall Study|Withdrawal by Subject|6
873970|NCT01369355|2881614|P6|Overall Study|Lost to Follow-up|6
873971|NCT01369355|2881615|P5|Overall Study|Lost to Follow-up|5
873972|NCT01369355|2881616|P4|Overall Study|Lost to Follow-up|2
873973|NCT01369355|2881617|P3|Overall Study|Lost to Follow-up|1
873974|NCT01369355|2881618|P2|Overall Study|Lost to Follow-up|0
873975|NCT01369355|2881619|P1|Overall Study|Lost to Follow-up|1
873976|NCT01369355|2881614|P6|Overall Study|Protocol Violation|2
873977|NCT01369355|2881615|P5|Overall Study|Protocol Violation|0
873978|NCT01369355|2881616|P4|Overall Study|Protocol Violation|0
873979|NCT01369355|2881617|P3|Overall Study|Protocol Violation|1
873980|NCT01369355|2881618|P2|Overall Study|Protocol Violation|1
873981|NCT01369355|2881619|P1|Overall Study|Protocol Violation|0
873982|NCT01369355|2881614|P6|Overall Study|Lack of Efficacy|217
873983|NCT01369355|2881615|P5|Overall Study|Lack of Efficacy|126
873984|NCT01369355|2881616|P4|Overall Study|Lack of Efficacy|15
873985|NCT01369355|2881617|P3|Overall Study|Lack of Efficacy|15
873986|NCT01369355|2881618|P2|Overall Study|Lack of Efficacy|14
873987|NCT01369355|2881619|P1|Overall Study|Lack of Efficacy|15
873988|NCT01369355|2881614|P6|Overall Study|Adverse Event|25
873989|NCT01369355|2881615|P5|Overall Study|Adverse Event|14
873990|NCT01369355|2881616|P4|Overall Study|Adverse Event|7
873991|NCT01369355|2881617|P3|Overall Study|Adverse Event|6
873992|NCT01369355|2881618|P2|Overall Study|Adverse Event|12
873993|NCT01369355|2881619|P1|Overall Study|Adverse Event|9
873994|NCT01369342|2881648|P3|Overall Study|Not Treated|0
873995|NCT01369342|2881649|P2|Overall Study|Not Treated|0
873996|NCT01369342|2881650|P1|Overall Study|Not Treated|1
873997|NCT01369342|2881648|P3|Overall Study|Lost to Follow-up|1
873998|NCT01369342|2881649|P2|Overall Study|Lost to Follow-up|2
873999|NCT01369342|2881650|P1|Overall Study|Lost to Follow-up|5
874000|NCT01369342|2881648|P3|Overall Study|Withdrawal by Subject|2
874001|NCT01369342|2881649|P2|Overall Study|Withdrawal by Subject|7
874002|NCT01369342|2881650|P1|Overall Study|Withdrawal by Subject|7
874003|NCT01369329|2881673|P3|Overall Study|Other|2
874004|NCT01369329|2881674|P2|Overall Study|Other|3
874005|NCT01369329|2881675|P1|Overall Study|Other|2
874006|NCT01369329|2881673|P3|Overall Study|Lost to Follow-up|2
874007|NCT01369329|2881674|P2|Overall Study|Lost to Follow-up|2
874008|NCT01369329|2881675|P1|Overall Study|Lost to Follow-up|2
874009|NCT01369329|2881673|P3|Overall Study|Withdrawal by Subject|10
874010|NCT01369329|2881674|P2|Overall Study|Withdrawal by Subject|6
874011|NCT01369329|2881675|P1|Overall Study|Withdrawal by Subject|8
874012|NCT01369225|2881701|P6|Overall Study|Adverse Event|0
874013|NCT01369225|2881702|P5|Overall Study|Adverse Event|1
874014|NCT01369225|2881703|P4|Overall Study|Adverse Event|1
874015|NCT01369225|2881704|P3|Overall Study|Adverse Event|0
874016|NCT01369225|2881705|P2|Overall Study|Adverse Event|0
874017|NCT01369225|2881706|P1|Overall Study|Adverse Event|0
874018|NCT01369225|2881701|P6|Overall Study|Other|0
874019|NCT01369225|2881702|P5|Overall Study|Other|1
874020|NCT01369225|2881703|P4|Overall Study|Other|0
874021|NCT01369225|2881704|P3|Overall Study|Other|0
874022|NCT01369225|2881705|P2|Overall Study|Other|0
874023|NCT01369225|2881706|P1|Overall Study|Other|1
874024|NCT01369225|2881701|P6|Overall Study|Does Not Meet Entrance Criteria|0
874025|NCT01369225|2881702|P5|Overall Study|Does Not Meet Entrance Criteria|0
874026|NCT01369225|2881703|P4|Overall Study|Does Not Meet Entrance Criteria|0
874027|NCT01369225|2881704|P3|Overall Study|Does Not Meet Entrance Criteria|1
874028|NCT01369225|2881705|P2|Overall Study|Does Not Meet Entrance Criteria|0
874029|NCT01369225|2881706|P1|Overall Study|Does Not Meet Entrance Criteria|0
874030|NCT01369225|2881701|P6|Overall Study|Withdrawal by Subject|0
874031|NCT01369225|2881702|P5|Overall Study|Withdrawal by Subject|0
874032|NCT01369225|2881703|P4|Overall Study|Withdrawal by Subject|1
874033|NCT01369225|2881704|P3|Overall Study|Withdrawal by Subject|2
874034|NCT01369225|2881705|P2|Overall Study|Withdrawal by Subject|0
874035|NCT01369225|2881706|P1|Overall Study|Withdrawal by Subject|1
874036|NCT01369199|2881798|P1|Overall Study|Lost to Follow-up|2
874037|NCT01369199|2881798|P1|Overall Study|Withdrawal by Subject|1
874038|NCT01368965|2881833|P1|Overall Study|Lost to Follow-up|12
874039|NCT01368900|2881842|P1|Overall Study|Lost to Follow-up|7
874040|NCT01368835|2881917|P1|Overall Study|Lost to Follow-up|11
874041|NCT01368835|2881917|P1|Overall Study|Inclusion criteria/photography quality|22
874042|NCT01368536|2881959|P3|Overall Study|Protocol deviation|1
874043|NCT01368536|2881960|P2|Overall Study|Protocol deviation|3
874044|NCT01368536|2881961|P1|Overall Study|Protocol deviation|0
874045|NCT01368536|2881959|P3|Overall Study|Administrative problems|35
874046|NCT01368536|2881960|P2|Overall Study|Administrative problems|39
874047|NCT01368536|2881961|P1|Overall Study|Administrative problems|34
874048|NCT01368536|2881959|P3|Overall Study|Lost to Follow-up|5
874049|NCT01368536|2881960|P2|Overall Study|Lost to Follow-up|3
874050|NCT01368536|2881961|P1|Overall Study|Lost to Follow-up|3
874051|NCT01368536|2881959|P3|Overall Study|Withdrawal by Subject|4
874052|NCT01368536|2881960|P2|Overall Study|Withdrawal by Subject|5
874053|NCT01368536|2881961|P1|Overall Study|Withdrawal by Subject|2
874054|NCT01368536|2881959|P3|Overall Study|No longer required study medication|1
874055|NCT01368536|2881960|P2|Overall Study|No longer required study medication|0
874056|NCT01368536|2881961|P1|Overall Study|No longer required study medication|0
874057|NCT01368536|2881959|P3|Overall Study|Unsatisfactory therapeutic effect|2
874058|NCT01368536|2881960|P2|Overall Study|Unsatisfactory therapeutic effect|2
874059|NCT01368536|2881961|P1|Overall Study|Unsatisfactory therapeutic effect|7
874060|NCT01368536|2881959|P3|Overall Study|Abnormal test procedure result(s)|1
874061|NCT01368536|2881960|P2|Overall Study|Abnormal test procedure result(s)|0
874062|NCT01368536|2881961|P1|Overall Study|Abnormal test procedure result(s)|0
874063|NCT01368536|2881959|P3|Overall Study|Abnormal laboratory value(s)|2
874064|NCT01368536|2881960|P2|Overall Study|Abnormal laboratory value(s)|1
874065|NCT01368536|2881961|P1|Overall Study|Abnormal laboratory value(s)|0
874066|NCT01368536|2881959|P3|Overall Study|Adverse Event|8
874067|NCT01368536|2881960|P2|Overall Study|Adverse Event|6
874068|NCT01368536|2881961|P1|Overall Study|Adverse Event|5
874069|NCT01368497|2881982|P1|Overall Study|Lost to Follow-up|2
874070|NCT01368432|2882010|P2|Overall Study|Lost to Follow-up|1
874071|NCT01368432|2882011|P1|Overall Study|Lost to Follow-up|0
874072|NCT01368406|2882045|P2|Overall Study|started working|3
874073|NCT01368406|2882046|P1|Overall Study|started working|2
874074|NCT01368406|2882045|P2|Overall Study|relapse of the disease|2
874075|NCT01368406|2882046|P1|Overall Study|relapse of the disease|3
874076|NCT01368406|2882045|P2|Overall Study|Withdrawal by Subject|4
874077|NCT01368406|2882046|P1|Overall Study|Withdrawal by Subject|8
874078|NCT01368406|2882045|P2|Overall Study|Lost to Follow-up|4
874079|NCT01368406|2882046|P1|Overall Study|Lost to Follow-up|8
874080|NCT01368276|2882054|P2|Overall Study|Death|10
874081|NCT01368276|2882055|P1|Overall Study|Death|1
874082|NCT01368211|2882092|P2|Second Platelets Transfusion|No need for additional transfusion|2
874083|NCT01368211|2882093|P1|Second Platelets Transfusion|No need for additional transfusion|1
874084|NCT01368081|2882121|P13|Overall Study|Other reason not defined above|3
874085|NCT01368081|2882122|P12|Overall Study|Other reason not defined above|0
874086|NCT01368081|2882123|P11|Overall Study|Other reason not defined above|0
874087|NCT01368081|2882124|P10|Overall Study|Other reason not defined above|1
874088|NCT01368081|2882125|P9|Overall Study|Other reason not defined above|0
874089|NCT01368081|2882126|P8|Overall Study|Other reason not defined above|0
874090|NCT01368081|2882127|P7|Overall Study|Other reason not defined above|2
874091|NCT01368081|2882128|P6|Overall Study|Other reason not defined above|1
874092|NCT01368081|2882129|P5|Overall Study|Other reason not defined above|0
874093|NCT01368081|2882130|P4|Overall Study|Other reason not defined above|1
874094|NCT01368081|2882131|P3|Overall Study|Other reason not defined above|0
874095|NCT01368081|2882132|P2|Overall Study|Other reason not defined above|0
874096|NCT01368081|2882133|P1|Overall Study|Other reason not defined above|2
874097|NCT01368081|2882121|P13|Overall Study|Withdrawal by Subject|0
874098|NCT01368081|2882122|P12|Overall Study|Withdrawal by Subject|2
874099|NCT01368081|2882123|P11|Overall Study|Withdrawal by Subject|3
874100|NCT01368081|2882124|P10|Overall Study|Withdrawal by Subject|4
874101|NCT01368081|2882125|P9|Overall Study|Withdrawal by Subject|5
874102|NCT01368081|2882126|P8|Overall Study|Withdrawal by Subject|2
874103|NCT01368081|2882127|P7|Overall Study|Withdrawal by Subject|4
874104|NCT01368081|2882128|P6|Overall Study|Withdrawal by Subject|3
874105|NCT01368081|2882129|P5|Overall Study|Withdrawal by Subject|0
874106|NCT01368081|2882130|P4|Overall Study|Withdrawal by Subject|1
874107|NCT01368081|2882131|P3|Overall Study|Withdrawal by Subject|1
874108|NCT01368081|2882132|P2|Overall Study|Withdrawal by Subject|4
874109|NCT01368081|2882133|P1|Overall Study|Withdrawal by Subject|4
874110|NCT01368081|2882121|P13|Overall Study|Lost to Follow-up|1
874111|NCT01368081|2882122|P12|Overall Study|Lost to Follow-up|0
874112|NCT01368081|2882123|P11|Overall Study|Lost to Follow-up|0
874113|NCT01368081|2882124|P10|Overall Study|Lost to Follow-up|0
874114|NCT01368081|2882125|P9|Overall Study|Lost to Follow-up|0
874115|NCT01368081|2882126|P8|Overall Study|Lost to Follow-up|0
874116|NCT01368081|2882127|P7|Overall Study|Lost to Follow-up|0
874117|NCT01368081|2882128|P6|Overall Study|Lost to Follow-up|0
874118|NCT01368081|2882129|P5|Overall Study|Lost to Follow-up|0
874119|NCT01368081|2882130|P4|Overall Study|Lost to Follow-up|0
874120|NCT01368081|2882131|P3|Overall Study|Lost to Follow-up|0
874121|NCT01368081|2882132|P2|Overall Study|Lost to Follow-up|0
874122|NCT01368081|2882133|P1|Overall Study|Lost to Follow-up|0
874123|NCT01368081|2882121|P13|Overall Study|Protocol Violation|0
874124|NCT01368081|2882122|P12|Overall Study|Protocol Violation|0
874125|NCT01368081|2882123|P11|Overall Study|Protocol Violation|0
874126|NCT01368081|2882124|P10|Overall Study|Protocol Violation|0
874127|NCT01368081|2882125|P9|Overall Study|Protocol Violation|0
874128|NCT01368081|2882126|P8|Overall Study|Protocol Violation|1
874129|NCT01368081|2882127|P7|Overall Study|Protocol Violation|0
874130|NCT01368081|2882128|P6|Overall Study|Protocol Violation|1
874131|NCT01368081|2882129|P5|Overall Study|Protocol Violation|0
874132|NCT01368081|2882130|P4|Overall Study|Protocol Violation|0
874133|NCT01368081|2882131|P3|Overall Study|Protocol Violation|0
874134|NCT01368081|2882132|P2|Overall Study|Protocol Violation|0
874135|NCT01368081|2882133|P1|Overall Study|Protocol Violation|0
874136|NCT01368081|2882121|P13|Overall Study|Lack of Efficacy|0
874137|NCT01368081|2882122|P12|Overall Study|Lack of Efficacy|0
874138|NCT01368081|2882123|P11|Overall Study|Lack of Efficacy|0
874139|NCT01368081|2882124|P10|Overall Study|Lack of Efficacy|0
874140|NCT01368081|2882125|P9|Overall Study|Lack of Efficacy|0
874141|NCT01368081|2882126|P8|Overall Study|Lack of Efficacy|2
874142|NCT01368081|2882127|P7|Overall Study|Lack of Efficacy|0
874143|NCT01368081|2882128|P6|Overall Study|Lack of Efficacy|0
874144|NCT01368081|2882129|P5|Overall Study|Lack of Efficacy|0
874145|NCT01368081|2882130|P4|Overall Study|Lack of Efficacy|1
874146|NCT01368081|2882131|P3|Overall Study|Lack of Efficacy|0
874147|NCT01368081|2882132|P2|Overall Study|Lack of Efficacy|1
874148|NCT01368081|2882133|P1|Overall Study|Lack of Efficacy|0
874149|NCT01368081|2882121|P13|Overall Study|Adverse Event|3
874150|NCT01368081|2882122|P12|Overall Study|Adverse Event|1
874151|NCT01368081|2882123|P11|Overall Study|Adverse Event|6
874152|NCT01368081|2882124|P10|Overall Study|Adverse Event|5
874153|NCT01368081|2882125|P9|Overall Study|Adverse Event|3
874154|NCT01368081|2882126|P8|Overall Study|Adverse Event|2
874155|NCT01368081|2882127|P7|Overall Study|Adverse Event|6
874156|NCT01368081|2882128|P6|Overall Study|Adverse Event|5
874157|NCT01368081|2882129|P5|Overall Study|Adverse Event|2
874158|NCT01368081|2882130|P4|Overall Study|Adverse Event|2
874159|NCT01368081|2882131|P3|Overall Study|Adverse Event|3
874160|NCT01368081|2882132|P2|Overall Study|Adverse Event|4
874161|NCT01368081|2882133|P1|Overall Study|Adverse Event|4
874162|NCT01368042|2882187|P1|Overall Study|Transplanted|1
874163|NCT01368042|2882187|P1|Overall Study|Lost to Follow-up|4
874164|NCT01368042|2882187|P1|Overall Study|Protocol Violation|11
874165|NCT01368042|2882187|P1|Overall Study|Death|14
874166|NCT01367886|2882207|P1|Overall Study|Death|1
874167|NCT01367886|2882207|P1|Overall Study|Lack of Efficacy|2
874168|NCT01367886|2882207|P1|Overall Study|Lost to Follow-up|4
874169|NCT01367847|2882257|P2|Overall Study|Withdrawal by Subject|2
874170|NCT01367847|2882258|P1|Overall Study|Withdrawal by Subject|2
874171|NCT01367834|2882274|P2|Overall Study|Study was ended.|1
874172|NCT01367834|2882275|P1|Overall Study|Study was ended.|0
874173|NCT01367834|2882274|P2|Overall Study|Withdrawal by Subject|2
874174|NCT01367834|2882275|P1|Overall Study|Withdrawal by Subject|2
874175|NCT01367704|2882299|P2|Overall Study|Lost to Follow-up|161
874176|NCT01367704|2882300|P1|Overall Study|Lost to Follow-up|47
874177|NCT01367457|2882313|P3|Overall Study|Suspected DP/suspected active infection|0
874178|NCT01367457|2882314|P2|Overall Study|Suspected DP/suspected active infection|0
874179|NCT01367457|2882315|P1|Overall Study|Suspected DP/suspected active infection|1
874180|NCT01367457|2882313|P3|Overall Study|Palliative. Overall decline|0
874181|NCT01367457|2882314|P2|Overall Study|Palliative. Overall decline|0
874182|NCT01367457|2882315|P1|Overall Study|Palliative. Overall decline|1
874183|NCT01367457|2882313|P3|Overall Study|Patient's Wish|0
874184|NCT01367457|2882314|P2|Overall Study|Patient's Wish|0
874185|NCT01367457|2882315|P1|Overall Study|Patient's Wish|1
874186|NCT01367457|2882313|P3|Overall Study|CD, Suspected disease progression (DP)|0
874187|NCT01367457|2882314|P2|Overall Study|CD, Suspected disease progression (DP)|0
874188|NCT01367457|2882315|P1|Overall Study|CD, Suspected disease progression (DP)|1
874189|NCT01367457|2882313|P3|Overall Study|Death from septic shock|0
874190|NCT01367457|2882314|P2|Overall Study|Death from septic shock|0
874191|NCT01367457|2882315|P1|Overall Study|Death from septic shock|1
874192|NCT01367457|2882313|P3|Overall Study|Lost to Follow-up|0
874193|NCT01367457|2882314|P2|Overall Study|Lost to Follow-up|0
874194|NCT01367457|2882315|P1|Overall Study|Lost to Follow-up|1
874195|NCT01367457|2882313|P3|Overall Study|Rejection of treatment|0
874196|NCT01367457|2882314|P2|Overall Study|Rejection of treatment|0
874197|NCT01367457|2882315|P1|Overall Study|Rejection of treatment|1
874198|NCT01367457|2882313|P3|Overall Study|Overall decline|0
874199|NCT01367457|2882314|P2|Overall Study|Overall decline|0
874200|NCT01367457|2882315|P1|Overall Study|Overall decline|1
874201|NCT01367457|2882313|P3|Overall Study|Intestinal obstruction with necrosis|0
874202|NCT01367457|2882314|P2|Overall Study|Intestinal obstruction with necrosis|0
874203|NCT01367457|2882315|P1|Overall Study|Intestinal obstruction with necrosis|1
874204|NCT01367457|2882313|P3|Overall Study|No clinical benefit|0
874205|NCT01367457|2882314|P2|Overall Study|No clinical benefit|0
874206|NCT01367457|2882315|P1|Overall Study|No clinical benefit|1
874207|NCT01367457|2882313|P3|Overall Study|Stabilisation + frequent infections|0
874208|NCT01367457|2882314|P2|Overall Study|Stabilisation + frequent infections|0
874209|NCT01367457|2882315|P1|Overall Study|Stabilisation + frequent infections|1
874210|NCT01367457|2882313|P3|Overall Study|Overall status worsens to grade 4|0
874211|NCT01367457|2882314|P2|Overall Study|Overall status worsens to grade 4|0
874212|NCT01367457|2882315|P1|Overall Study|Overall status worsens to grade 4|1
874213|NCT01367457|2882313|P3|Overall Study|Uncontrolled pain|0
874214|NCT01367457|2882314|P2|Overall Study|Uncontrolled pain|0
874215|NCT01367457|2882315|P1|Overall Study|Uncontrolled pain|1
874216|NCT01367457|2882313|P3|Overall Study|CD, associated leukaemia|0
874217|NCT01367457|2882314|P2|Overall Study|CD, associated leukaemia|0
874218|NCT01367457|2882315|P1|Overall Study|CD, associated leukaemia|1
874219|NCT01367457|2882313|P3|Overall Study|Withdrawal by Subject|0
874220|NCT01367457|2882314|P2|Overall Study|Withdrawal by Subject|0
874221|NCT01367457|2882315|P1|Overall Study|Withdrawal by Subject|1
874222|NCT01367457|2882313|P3|Overall Study|Choledocolithiasis and pancreatitis|0
874223|NCT01367457|2882314|P2|Overall Study|Choledocolithiasis and pancreatitis|0
874224|NCT01367457|2882315|P1|Overall Study|Choledocolithiasis and pancreatitis|1
874225|NCT01367457|2882313|P3|Overall Study|low grade toxicities + stable disease|0
874226|NCT01367457|2882314|P2|Overall Study|low grade toxicities + stable disease|0
874227|NCT01367457|2882315|P1|Overall Study|low grade toxicities + stable disease|1
874228|NCT01367457|2882313|P3|Overall Study|3 yr Temsirolimus treatment (no disease)|0
874229|NCT01367457|2882314|P2|Overall Study|3 yr Temsirolimus treatment (no disease)|0
874230|NCT01367457|2882315|P1|Overall Study|3 yr Temsirolimus treatment (no disease)|1
874231|NCT01367457|2882313|P3|Overall Study|Bleeding from cavernous haemangioma|0
874232|NCT01367457|2882314|P2|Overall Study|Bleeding from cavernous haemangioma|0
874233|NCT01367457|2882315|P1|Overall Study|Bleeding from cavernous haemangioma|1
874234|NCT01367457|2882313|P3|Overall Study|Investigator's opinion, stable disease|0
874235|NCT01367457|2882314|P2|Overall Study|Investigator's opinion, stable disease|0
874236|NCT01367457|2882315|P1|Overall Study|Investigator's opinion, stable disease|1
874237|NCT01367457|2882313|P3|Overall Study|Patient asks for rest + slow progression|0
874238|NCT01367457|2882314|P2|Overall Study|Patient asks for rest + slow progression|0
874239|NCT01367457|2882315|P1|Overall Study|Patient asks for rest + slow progression|1
874240|NCT01367457|2882313|P3|Overall Study|Progression|0
874241|NCT01367457|2882314|P2|Overall Study|Progression|0
874242|NCT01367457|2882315|P1|Overall Study|Progression|137
874243|NCT01367457|2882313|P3|Overall Study|Toxicity|0
874244|NCT01367457|2882314|P2|Overall Study|Toxicity|0
874245|NCT01367457|2882315|P1|Overall Study|Toxicity|16
874246|NCT01367457|2882313|P3|Overall Study|Progression and death|0
874247|NCT01367457|2882314|P2|Overall Study|Progression and death|0
874248|NCT01367457|2882315|P1|Overall Study|Progression and death|8
874249|NCT01367457|2882313|P3|Overall Study|Clinical decline (CD)|0
874250|NCT01367457|2882314|P2|Overall Study|Clinical decline (CD)|0
874251|NCT01367457|2882315|P1|Overall Study|Clinical decline (CD)|2
874252|NCT01367457|2882313|P3|Overall Study|Investigator's decision|0
874253|NCT01367457|2882314|P2|Overall Study|Investigator's decision|0
874254|NCT01367457|2882315|P1|Overall Study|Investigator's decision|2
874255|NCT01367457|2882313|P3|Overall Study|Death|0
874256|NCT01367457|2882314|P2|Overall Study|Death|0
874257|NCT01367457|2882315|P1|Overall Study|Death|2
874258|NCT01367249|2882337|P2|Overall Study|Not Specified|10
874259|NCT01367249|2882338|P1|Overall Study|Not Specified|3
874260|NCT01367249|2882337|P2|Overall Study|Withdrawal by Subject|6
874261|NCT01367249|2882338|P1|Overall Study|Withdrawal by Subject|6
874262|NCT01367158|2882357|P11|Overall Study|Protocol Violation|0
874263|NCT01367158|2882358|P10|Overall Study|Protocol Violation|0
874264|NCT01367158|2882359|P9|Overall Study|Protocol Violation|0
874265|NCT01367158|2882360|P8|Overall Study|Protocol Violation|0
874266|NCT01367158|2882361|P7|Overall Study|Protocol Violation|0
874267|NCT01367158|2882362|P6|Overall Study|Protocol Violation|0
874268|NCT01367158|2882363|P5|Overall Study|Protocol Violation|0
874269|NCT01367158|2882364|P4|Overall Study|Protocol Violation|0
874270|NCT01367158|2882365|P3|Overall Study|Protocol Violation|0
874271|NCT01367158|2882366|P2|Overall Study|Protocol Violation|1
874272|NCT01367158|2882367|P1|Overall Study|Protocol Violation|0
874273|NCT01367158|2882357|P11|Overall Study|Lost to Follow-up|1
874274|NCT01367158|2882358|P10|Overall Study|Lost to Follow-up|0
874275|NCT01367158|2882359|P9|Overall Study|Lost to Follow-up|0
874276|NCT01367158|2882360|P8|Overall Study|Lost to Follow-up|1
874277|NCT01367158|2882361|P7|Overall Study|Lost to Follow-up|0
874278|NCT01367158|2882362|P6|Overall Study|Lost to Follow-up|2
874279|NCT01367158|2882363|P5|Overall Study|Lost to Follow-up|0
874280|NCT01367158|2882364|P4|Overall Study|Lost to Follow-up|1
874281|NCT01367158|2882365|P3|Overall Study|Lost to Follow-up|0
874282|NCT01367158|2882366|P2|Overall Study|Lost to Follow-up|0
874283|NCT01367158|2882367|P1|Overall Study|Lost to Follow-up|0
874284|NCT01367158|2882357|P11|Overall Study|Withdrew consent|0
874285|NCT01367158|2882358|P10|Overall Study|Withdrew consent|0
874286|NCT01367158|2882359|P9|Overall Study|Withdrew consent|0
874287|NCT01367158|2882360|P8|Overall Study|Withdrew consent|1
874288|NCT01367158|2882361|P7|Overall Study|Withdrew consent|0
874289|NCT01367158|2882362|P6|Overall Study|Withdrew consent|0
874290|NCT01367158|2882363|P5|Overall Study|Withdrew consent|2
874291|NCT01367158|2882364|P4|Overall Study|Withdrew consent|0
874292|NCT01367158|2882365|P3|Overall Study|Withdrew consent|1
874293|NCT01367158|2882366|P2|Overall Study|Withdrew consent|2
874294|NCT01367158|2882367|P1|Overall Study|Withdrew consent|0
874295|NCT01367119|2882511|P2|Overall Study|Withdrawal by Subject|1
874296|NCT01367119|2882512|P1|Overall Study|Withdrawal by Subject|1
874297|NCT01367119|2882511|P2|Overall Study|Adverse Event|0
874298|NCT01367119|2882512|P1|Overall Study|Adverse Event|1
874299|NCT01366846|2882567|P4|Overall Study|Scheduling Conflicts|0
874300|NCT01366846|2882568|P3|Overall Study|Scheduling Conflicts|1
874301|NCT01366846|2882569|P2|Overall Study|Scheduling Conflicts|0
874302|NCT01366846|2882570|P1|Overall Study|Scheduling Conflicts|0
874303|NCT01366846|2882567|P4|Overall Study|Communication Difficulties|1
874304|NCT01366846|2882568|P3|Overall Study|Communication Difficulties|0
874305|NCT01366846|2882569|P2|Overall Study|Communication Difficulties|4
874306|NCT01366846|2882570|P1|Overall Study|Communication Difficulties|1
874307|NCT01366846|2882567|P4|Overall Study|Withdrawal by Subject|0
874308|NCT01366846|2882568|P3|Overall Study|Withdrawal by Subject|0
874309|NCT01366846|2882569|P2|Overall Study|Withdrawal by Subject|0
874310|NCT01366846|2882570|P1|Overall Study|Withdrawal by Subject|2
874311|NCT01366638|2882593|P3|Overall Study|Not specified|0
874312|NCT01366638|2882594|P2|Overall Study|Not specified|0
874313|NCT01366638|2882595|P1|Overall Study|Not specified|1
874314|NCT01366638|2882593|P3|Overall Study|Withdrawal by Subject|6
874315|NCT01366638|2882594|P2|Overall Study|Withdrawal by Subject|0
874316|NCT01366638|2882595|P1|Overall Study|Withdrawal by Subject|0
874317|NCT01366534|2882632|P3|Overall Study|Declined challenged|0
874318|NCT01366534|2882633|P2|Overall Study|Declined challenged|1
874319|NCT01366534|2882634|P1|Overall Study|Declined challenged|0
874320|NCT01366534|2882632|P3|Overall Study|Migrated|0
874321|NCT01366534|2882633|P2|Overall Study|Migrated|1
874322|NCT01366534|2882634|P1|Overall Study|Migrated|1
874323|NCT01366534|2882632|P3|Overall Study|Lost to Follow-up|0
874324|NCT01366534|2882633|P2|Overall Study|Lost to Follow-up|0
874325|NCT01366534|2882634|P1|Overall Study|Lost to Follow-up|1
874326|NCT01366521|2882684|P4|Overall Study|Withdrawal by Subject|0
874327|NCT01366521|2882685|P3|Overall Study|Withdrawal by Subject|0
874328|NCT01366521|2882686|P2|Overall Study|Withdrawal by Subject|1
874329|NCT01366521|2882687|P1|Overall Study|Withdrawal by Subject|0
874330|NCT01366521|2882684|P4|Overall Study|Physician Decision|0
874331|NCT01366521|2882685|P3|Overall Study|Physician Decision|1
874332|NCT01366521|2882686|P2|Overall Study|Physician Decision|0
874333|NCT01366521|2882687|P1|Overall Study|Physician Decision|0
874334|NCT01366521|2882684|P4|Overall Study|Protocol Violation|0
874335|NCT01366521|2882685|P3|Overall Study|Protocol Violation|1
874336|NCT01366521|2882686|P2|Overall Study|Protocol Violation|0
874337|NCT01366521|2882687|P1|Overall Study|Protocol Violation|0
874338|NCT01366521|2882684|P4|Overall Study|Adverse Event|0
874339|NCT01366521|2882685|P3|Overall Study|Adverse Event|0
874340|NCT01366521|2882686|P2|Overall Study|Adverse Event|0
874341|NCT01366521|2882687|P1|Overall Study|Adverse Event|1
874342|NCT01366443|2882762|P1|Overall Study|Under 18 yo|1
874343|NCT01366443|2882762|P1|Overall Study|Lost to Follow-up|2
874344|NCT01366209|2882776|P2|Overall Study|Withdrew consent|3
874345|NCT01366209|2882777|P1|Overall Study|Withdrew consent|4
874346|NCT01366209|2882776|P2|Overall Study|Sponsors decision|1
874347|NCT01366209|2882777|P1|Overall Study|Sponsors decision|0
874348|NCT01366209|2882776|P2|Overall Study|Physician Decision|0
874349|NCT01366209|2882777|P1|Overall Study|Physician Decision|1
874350|NCT01366209|2882776|P2|Overall Study|Lost to Follow-up|1
874351|NCT01366209|2882777|P1|Overall Study|Lost to Follow-up|2
874352|NCT01366209|2882776|P2|Overall Study|Lung transplantation|1
874353|NCT01366209|2882777|P1|Overall Study|Lung transplantation|6
874354|NCT01366209|2882776|P2|Overall Study|Death|19
874355|NCT01366209|2882777|P1|Overall Study|Death|12
874356|NCT01366209|2882776|P2|Overall Study|Withdrawal by Subject|4
874357|NCT01366209|2882777|P1|Overall Study|Withdrawal by Subject|4
874358|NCT01366209|2882776|P2|Overall Study|Adverse Event|7
874359|NCT01366209|2882777|P1|Overall Study|Adverse Event|6
874360|NCT01366092|2882800|P1|Overall Study|Withdrawal by Subject|1
874361|NCT01366092|2882800|P1|Overall Study|Physician Decision|1
874362|NCT01366092|2882800|P1|Overall Study|Progressive cGVHD|2
874363|NCT01365910|2882809|P1|Overall Study|pt did not get tx, nausea/vomiting|1
874364|NCT01365910|2882809|P1|Overall Study|other complicating disease|1
874365|NCT01365910|2882809|P1|Overall Study|Adverse Event|3
874366|NCT01365910|2882809|P1|Overall Study|disease progression|18
874367|NCT01365910|2882809|P1|Overall Study|Withdrawal by Subject|7
874368|NCT01365546|2882945|P1|Overall Study|Study termination|1
874369|NCT01365546|2882945|P1|Overall Study|Screen failure|9
874370|NCT01365546|2882945|P1|Overall Study|Withdrawal by Subject|1
874371|NCT01365507|2882955|P2|Overall Study|Unclassified|4
874372|NCT01365507|2882956|P1|Overall Study|Unclassified|1
874373|NCT01365507|2882955|P2|Overall Study|Withdrawal Criteria|5
874374|NCT01365507|2882956|P1|Overall Study|Withdrawal Criteria|8
874375|NCT01365494|2882972|P2|Overall Study|Lost to Follow-up|2
874376|NCT01365494|2882973|P1|Overall Study|Lost to Follow-up|1
874377|NCT01365494|2882972|P2|Overall Study|Withdrawal by Subject|1
874378|NCT01365494|2882973|P1|Overall Study|Withdrawal by Subject|0
874379|NCT01365494|2882972|P2|Overall Study|Adverse Event|0
874380|NCT01365494|2882973|P1|Overall Study|Adverse Event|1
874381|NCT01365481|2882989|P4|Overall Study|Unsatisfactory therapeutic effect|0
874382|NCT01365481|2882990|P3|Overall Study|Unsatisfactory therapeutic effect|1
874383|NCT01365481|2882991|P2|Overall Study|Unsatisfactory therapeutic effect|0
874384|NCT01365481|2882992|P1|Overall Study|Unsatisfactory therapeutic effect|0
874385|NCT01365481|2882989|P4|Overall Study|Protocol deviation|1
874386|NCT01365481|2882990|P3|Overall Study|Protocol deviation|0
874387|NCT01365481|2882991|P2|Overall Study|Protocol deviation|1
874388|NCT01365481|2882992|P1|Overall Study|Protocol deviation|0
874389|NCT01365481|2882989|P4|Overall Study|Administrative problems|0
874390|NCT01365481|2882990|P3|Overall Study|Administrative problems|0
874391|NCT01365481|2882991|P2|Overall Study|Administrative problems|1
874392|NCT01365481|2882992|P1|Overall Study|Administrative problems|0
874393|NCT01365481|2882989|P4|Overall Study|Abnormal laboratory value(s)|0
874394|NCT01365481|2882990|P3|Overall Study|Abnormal laboratory value(s)|0
874395|NCT01365481|2882991|P2|Overall Study|Abnormal laboratory value(s)|1
874396|NCT01365481|2882992|P1|Overall Study|Abnormal laboratory value(s)|0
874397|NCT01365481|2882989|P4|Overall Study|Lost to Follow-up|3
874398|NCT01365481|2882990|P3|Overall Study|Lost to Follow-up|2
874399|NCT01365481|2882991|P2|Overall Study|Lost to Follow-up|1
874400|NCT01365481|2882992|P1|Overall Study|Lost to Follow-up|1
874401|NCT01365481|2882989|P4|Overall Study|Withdrawal by Subject|1
874402|NCT01365481|2882990|P3|Overall Study|Withdrawal by Subject|1
874403|NCT01365481|2882991|P2|Overall Study|Withdrawal by Subject|2
874404|NCT01365481|2882992|P1|Overall Study|Withdrawal by Subject|0
874405|NCT01365481|2882989|P4|Overall Study|Adverse Event|2
874406|NCT01365481|2882990|P3|Overall Study|Adverse Event|0
874407|NCT01365481|2882991|P2|Overall Study|Adverse Event|9
874408|NCT01365481|2882992|P1|Overall Study|Adverse Event|6
874409|NCT01365468|2883012|P2|Overall Study|Lost to Follow-up|0
874410|NCT01365468|2883013|P1|Overall Study|Lost to Follow-up|2
874411|NCT01365468|2883012|P2|Overall Study|Disease progression|0
874412|NCT01365468|2883013|P1|Overall Study|Disease progression|1
874413|NCT01365468|2883012|P2|Overall Study|Physician Decision|0
874414|NCT01365468|2883013|P1|Overall Study|Physician Decision|1
874415|NCT01365455|2883028|P5|Maintenance Period|Subject/guardian decision|1
874416|NCT01365455|2883029|P4|Maintenance Period|Subject/guardian decision|4
874417|NCT01365455|2883030|P3|Maintenance Period|Subject/guardian decision|2
874418|NCT01365455|2883031|P2|Maintenance Period|Subject/guardian decision|6
874419|NCT01365455|2883032|P1|Maintenance Period|Subject/guardian decision|4
874420|NCT01365455|2883028|P5|Maintenance Period|Protocol deviation|0
874421|NCT01365455|2883029|P4|Maintenance Period|Protocol deviation|0
874422|NCT01365455|2883030|P3|Maintenance Period|Protocol deviation|0
874423|NCT01365455|2883031|P2|Maintenance Period|Protocol deviation|1
874424|NCT01365455|2883032|P1|Maintenance Period|Protocol deviation|1
874425|NCT01365455|2883028|P5|Maintenance Period|Pregnancy|2
874426|NCT01365455|2883029|P4|Maintenance Period|Pregnancy|0
874427|NCT01365455|2883030|P3|Maintenance Period|Pregnancy|0
874428|NCT01365455|2883031|P2|Maintenance Period|Pregnancy|4
874429|NCT01365455|2883032|P1|Maintenance Period|Pregnancy|0
874430|NCT01365455|2883028|P5|Maintenance Period|Physician Decision|1
874431|NCT01365455|2883029|P4|Maintenance Period|Physician Decision|0
874432|NCT01365455|2883030|P3|Maintenance Period|Physician Decision|0
874433|NCT01365455|2883031|P2|Maintenance Period|Physician Decision|1
874434|NCT01365455|2883032|P1|Maintenance Period|Physician Decision|0
874435|NCT01365455|2883028|P5|Maintenance Period|Non-compliance with study treatment|0
874436|NCT01365455|2883029|P4|Maintenance Period|Non-compliance with study treatment|1
874437|NCT01365455|2883030|P3|Maintenance Period|Non-compliance with study treatment|0
874438|NCT01365455|2883031|P2|Maintenance Period|Non-compliance with study treatment|0
874439|NCT01365455|2883032|P1|Maintenance Period|Non-compliance with study treatment|0
874440|NCT01365455|2883028|P5|Maintenance Period|Lost to Follow-up|3
874441|NCT01365455|2883029|P4|Maintenance Period|Lost to Follow-up|0
874442|NCT01365455|2883030|P3|Maintenance Period|Lost to Follow-up|0
874443|NCT01365455|2883031|P2|Maintenance Period|Lost to Follow-up|4
874444|NCT01365455|2883032|P1|Maintenance Period|Lost to Follow-up|2
874445|NCT01365455|2883028|P5|Maintenance Period|Lack of Efficacy|2
874446|NCT01365455|2883029|P4|Maintenance Period|Lack of Efficacy|2
874447|NCT01365455|2883030|P3|Maintenance Period|Lack of Efficacy|0
874448|NCT01365455|2883031|P2|Maintenance Period|Lack of Efficacy|2
874449|NCT01365455|2883032|P1|Maintenance Period|Lack of Efficacy|10
874450|NCT01365455|2883028|P5|Maintenance Period|Adverse Event|4
874451|NCT01365455|2883029|P4|Maintenance Period|Adverse Event|2
874452|NCT01365455|2883030|P3|Maintenance Period|Adverse Event|1
874453|NCT01365455|2883031|P2|Maintenance Period|Adverse Event|5
874454|NCT01365455|2883032|P1|Maintenance Period|Adverse Event|12
874455|NCT01365455|2883028|P5|Induction Period|Lost to Follow-up|0
874456|NCT01365455|2883029|P4|Induction Period|Lost to Follow-up|0
874457|NCT01365455|2883030|P3|Induction Period|Lost to Follow-up|3
874458|NCT01365455|2883031|P2|Induction Period|Lost to Follow-up|0
874459|NCT01365455|2883032|P1|Induction Period|Lost to Follow-up|0
874460|NCT01365455|2883028|P5|Induction Period|Subject/guardian decision|0
874461|NCT01365455|2883029|P4|Induction Period|Subject/guardian decision|0
874462|NCT01365455|2883030|P3|Induction Period|Subject/guardian decision|8
874463|NCT01365455|2883031|P2|Induction Period|Subject/guardian decision|1
874464|NCT01365455|2883032|P1|Induction Period|Subject/guardian decision|9
874465|NCT01365455|2883028|P5|Induction Period|Protocol deviation|0
874466|NCT01365455|2883029|P4|Induction Period|Protocol deviation|0
874467|NCT01365455|2883030|P3|Induction Period|Protocol deviation|1
874468|NCT01365455|2883031|P2|Induction Period|Protocol deviation|1
874469|NCT01365455|2883032|P1|Induction Period|Protocol deviation|0
874470|NCT01365455|2883028|P5|Induction Period|Pregnancy|0
874471|NCT01365455|2883029|P4|Induction Period|Pregnancy|0
874472|NCT01365455|2883030|P3|Induction Period|Pregnancy|0
874473|NCT01365455|2883031|P2|Induction Period|Pregnancy|1
874474|NCT01365455|2883032|P1|Induction Period|Pregnancy|0
874475|NCT01365455|2883028|P5|Induction Period|Lack of Efficacy|0
874476|NCT01365455|2883029|P4|Induction Period|Lack of Efficacy|0
874477|NCT01365455|2883030|P3|Induction Period|Lack of Efficacy|0
874478|NCT01365455|2883031|P2|Induction Period|Lack of Efficacy|1
874479|NCT01365455|2883032|P1|Induction Period|Lack of Efficacy|1
874480|NCT01365455|2883028|P5|Induction Period|Adverse Event|0
874481|NCT01365455|2883029|P4|Induction Period|Adverse Event|0
874482|NCT01365455|2883030|P3|Induction Period|Adverse Event|4
874483|NCT01365455|2883031|P2|Induction Period|Adverse Event|3
874484|NCT01365455|2883032|P1|Induction Period|Adverse Event|5
874485|NCT01365273|2883122|P2|Overall Study|Physician Decision|0
874486|NCT01365273|2883123|P1|Overall Study|Physician Decision|1
874487|NCT01365273|2883122|P2|Overall Study|Protocol Violation|1
874488|NCT01365273|2883123|P1|Overall Study|Protocol Violation|0
874489|NCT01365273|2883122|P2|Overall Study|Lost to Follow-up|0
874490|NCT01365273|2883123|P1|Overall Study|Lost to Follow-up|1
874491|NCT01365130|2883133|P1|Overall Study|Progression/worsening of Dx prior to txt|2
874492|NCT01365091|2883142|P4|Period 2|Adverse Event|0
874493|NCT01365091|2883143|P3|Period 2|Adverse Event|1
874494|NCT01365091|2883144|P2|Period 2|Adverse Event|0
874495|NCT01365091|2883145|P1|Period 2|Adverse Event|0
874496|NCT01365091|2883142|P4|Period 2|Withdrawal by Subject|0
874497|NCT01365091|2883143|P3|Period 2|Withdrawal by Subject|0
874498|NCT01365091|2883144|P2|Period 2|Withdrawal by Subject|0
874499|NCT01365091|2883145|P1|Period 2|Withdrawal by Subject|1
874500|NCT01365091|2883142|P4|Period 1|Personal reasons|0
874501|NCT01365091|2883143|P3|Period 1|Personal reasons|1
874502|NCT01365091|2883144|P2|Period 1|Personal reasons|0
874503|NCT01365091|2883145|P1|Period 1|Personal reasons|0
874504|NCT01365091|2883142|P4|Period 1|Withdrawal by Subject|0
874505|NCT01365091|2883143|P3|Period 1|Withdrawal by Subject|0
874506|NCT01365091|2883144|P2|Period 1|Withdrawal by Subject|1
874507|NCT01365091|2883145|P1|Period 1|Withdrawal by Subject|0
874508|NCT01365091|2883142|P4|Period 1|No longer met study criteria|0
874509|NCT01365091|2883143|P3|Period 1|No longer met study criteria|0
874510|NCT01365091|2883144|P2|Period 1|No longer met study criteria|1
874511|NCT01365091|2883145|P1|Period 1|No longer met study criteria|0
874512|NCT01365091|2883142|P4|Period 1|Positive test result for drugs of abuse|0
874513|NCT01365091|2883143|P3|Period 1|Positive test result for drugs of abuse|0
874514|NCT01365091|2883144|P2|Period 1|Positive test result for drugs of abuse|0
874515|NCT01365091|2883145|P1|Period 1|Positive test result for drugs of abuse|1
874516|NCT01365091|2883142|P4|Period 1|Adverse Event|3
874517|NCT01365091|2883143|P3|Period 1|Adverse Event|2
874518|NCT01365091|2883144|P2|Period 1|Adverse Event|0
874519|NCT01365091|2883145|P1|Period 1|Adverse Event|1
874520|NCT01365052|2883173|P2|Overall Study|Adverse Event|4
874521|NCT01365052|2883174|P1|Overall Study|Adverse Event|4
874522|NCT01365039|2883190|P2|Overall Study|Study related symptoms and complaints|0
874523|NCT01365039|2883191|P1|Overall Study|Study related symptoms and complaints|1
874524|NCT01364922|2883202|P3|Double-Blind (DB) Period|Other, Unspecified|0
874525|NCT01364922|2883203|P2|Double-Blind (DB) Period|Other, Unspecified|1
874526|NCT01364922|2883204|P1|Double-Blind (DB) Period|Other, Unspecified|0
874527|NCT01364922|2883202|P3|Double-Blind (DB) Period|Adverse Event|1
874528|NCT01364922|2883203|P2|Double-Blind (DB) Period|Adverse Event|0
874529|NCT01364922|2883204|P1|Double-Blind (DB) Period|Adverse Event|0
874530|NCT01364922|2883202|P3|Double-Blind (DB) Period|Subject Noncompliant|0
874531|NCT01364922|2883203|P2|Double-Blind (DB) Period|Subject Noncompliant|1
874532|NCT01364922|2883204|P1|Double-Blind (DB) Period|Subject Noncompliant|0
874533|NCT01364922|2883202|P3|Double-Blind (DB) Period|Lack of Efficacy|4
874534|NCT01364922|2883203|P2|Double-Blind (DB) Period|Lack of Efficacy|3
874535|NCT01364922|2883204|P1|Double-Blind (DB) Period|Lack of Efficacy|0
874536|NCT01364922|2883202|P3|Open-label (OL) Period|Other, Unspecified|0
874537|NCT01364922|2883203|P2|Open-label (OL) Period|Other, Unspecified|0
874538|NCT01364922|2883204|P1|Open-label (OL) Period|Other, Unspecified|1
874539|NCT01364922|2883202|P3|Open-label (OL) Period|Lost to Follow-up|0
874540|NCT01364922|2883203|P2|Open-label (OL) Period|Lost to Follow-up|0
874541|NCT01364922|2883204|P1|Open-label (OL) Period|Lost to Follow-up|1
874542|NCT01364922|2883202|P3|Open-label (OL) Period|Lack of Efficacy|0
874543|NCT01364922|2883203|P2|Open-label (OL) Period|Lack of Efficacy|0
874544|NCT01364922|2883204|P1|Open-label (OL) Period|Lack of Efficacy|3
874545|NCT01364922|2883202|P3|Open-label (OL) Period|Withdrawal by Subject|0
874546|NCT01364922|2883203|P2|Open-label (OL) Period|Withdrawal by Subject|0
874547|NCT01364922|2883204|P1|Open-label (OL) Period|Withdrawal by Subject|4
874548|NCT01364922|2883202|P3|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
874549|NCT01364922|2883203|P2|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
874550|NCT01364922|2883204|P1|Open-label (OL) Period|Did Not Meet Randomization Criteria|6
874551|NCT01364922|2883202|P3|Open-label (OL) Period|Adverse Event|0
874552|NCT01364922|2883203|P2|Open-label (OL) Period|Adverse Event|0
874553|NCT01364922|2883204|P1|Open-label (OL) Period|Adverse Event|7
874554|NCT01364870|2883226|P3|Overall Study|Protocol Violation|0
874555|NCT01364870|2883227|P2|Overall Study|Protocol Violation|0
874556|NCT01364870|2883228|P1|Overall Study|Protocol Violation|1
874557|NCT01364870|2883226|P3|Overall Study|Adverse Event|4
874558|NCT01364870|2883227|P2|Overall Study|Adverse Event|6
874559|NCT01364870|2883228|P1|Overall Study|Adverse Event|8
874560|NCT01364870|2883226|P3|Overall Study|Withdrawal by Subject|10
874561|NCT01364870|2883227|P2|Overall Study|Withdrawal by Subject|24
874562|NCT01364870|2883228|P1|Overall Study|Withdrawal by Subject|13
874563|NCT01364727|2883247|P1|Overall Study|Not Eligible|2
874564|NCT01364649|2883255|P2|Overall Study|Other|1
874565|NCT01364649|2883256|P1|Overall Study|Other|4
874566|NCT01364649|2883255|P2|Overall Study|Lost to Follow-up|13
874567|NCT01364649|2883256|P1|Overall Study|Lost to Follow-up|12
874568|NCT01364649|2883255|P2|Overall Study|Withdrawal of Consent|7
874569|NCT01364649|2883256|P1|Overall Study|Withdrawal of Consent|9
874570|NCT01364649|2883255|P2|Overall Study|Protocol Deviations|8
874571|NCT01364649|2883256|P1|Overall Study|Protocol Deviations|4
874572|NCT01364649|2883255|P2|Overall Study|Non-compliance with Investigational Drug|0
874573|NCT01364649|2883256|P1|Overall Study|Non-compliance with Investigational Drug|1
874574|NCT01364649|2883255|P2|Overall Study|Lack of Efficacy|0
874575|NCT01364649|2883256|P1|Overall Study|Lack of Efficacy|6
874576|NCT01364649|2883255|P2|Overall Study|Pretreatment Event or Adverse Event|14
874577|NCT01364649|2883256|P1|Overall Study|Pretreatment Event or Adverse Event|20
874578|NCT01364428|2883315|P2|Overall Study|Other|3
874579|NCT01364428|2883316|P1|Overall Study|Other|3
874580|NCT01364428|2883315|P2|Overall Study|Withdrawal Criteria|10
874581|NCT01364428|2883316|P1|Overall Study|Withdrawal Criteria|14
874582|NCT01364428|2883315|P2|Overall Study|Protocol Violation|0
874583|NCT01364428|2883316|P1|Overall Study|Protocol Violation|2
874584|NCT01364428|2883315|P2|Overall Study|Adverse Event|2
874585|NCT01364428|2883316|P1|Overall Study|Adverse Event|1
874586|NCT01364389|2883333|P3|Overall Study|Adverse Event|0
874587|NCT01364389|2883334|P2|Overall Study|Adverse Event|0
874588|NCT01364389|2883335|P1|Overall Study|Adverse Event|1
874589|NCT01364389|2883333|P3|Overall Study|Administrative problems|0
874590|NCT01364389|2883334|P2|Overall Study|Administrative problems|0
874591|NCT01364389|2883335|P1|Overall Study|Administrative problems|1
874592|NCT01364389|2883333|P3|Overall Study|Protocol deviation|1
874593|NCT01364389|2883334|P2|Overall Study|Protocol deviation|0
874594|NCT01364389|2883335|P1|Overall Study|Protocol deviation|0
874595|NCT01364389|2883333|P3|Overall Study|Withdrawal by Subject|0
874596|NCT01364389|2883334|P2|Overall Study|Withdrawal by Subject|1
874597|NCT01364389|2883335|P1|Overall Study|Withdrawal by Subject|0
874598|NCT01364298|2883354|P2|Overall Study|Other|3
874599|NCT01364298|2883355|P1|Overall Study|Other|1
874600|NCT01364298|2883354|P2|Overall Study|Withdrawal by Subject|3
874601|NCT01364298|2883355|P1|Overall Study|Withdrawal by Subject|3
874602|NCT01364298|2883354|P2|Overall Study|Lost to Follow-up|10
874603|NCT01364298|2883355|P1|Overall Study|Lost to Follow-up|5
874604|NCT01364298|2883354|P2|Overall Study|Lack of Efficacy|0
874605|NCT01364298|2883355|P1|Overall Study|Lack of Efficacy|1
874606|NCT01364298|2883354|P2|Overall Study|Lack of adherence to treatment|3
874607|NCT01364298|2883355|P1|Overall Study|Lack of adherence to treatment|1
874608|NCT01364298|2883354|P2|Overall Study|Adverse Event|4
874609|NCT01364298|2883355|P1|Overall Study|Adverse Event|3
874610|NCT01363986|2883410|P1|Overall Study|Disease progression|1
874611|NCT01363908|2883420|P2|Chronic Dosing (CD) Phase|Early study termination|3
874612|NCT01363908|2883421|P1|Chronic Dosing (CD) Phase|Early study termination|9
874613|NCT01363908|2883420|P2|Chronic Dosing (CD) Phase|Physician Decision|1
874614|NCT01363908|2883421|P1|Chronic Dosing (CD) Phase|Physician Decision|0
874615|NCT01363908|2883420|P2|Chronic Dosing (CD) Phase|Patient decision|1
874616|NCT01363908|2883421|P1|Chronic Dosing (CD) Phase|Patient decision|0
874617|NCT01363908|2883420|P2|Chronic Dosing (CD) Phase|Adverse Event|1
874618|NCT01363908|2883421|P1|Chronic Dosing (CD) Phase|Adverse Event|1
874619|NCT01363765|2883457|P2|Overall Study|smear during intervention|0
874620|NCT01363765|2883458|P1|Overall Study|smear during intervention|2170
874621|NCT01363765|2883457|P2|Overall Study|age not recorded (used for cross-linkage|354
874622|NCT01363765|2883458|P1|Overall Study|age not recorded (used for cross-linkage|117
874623|NCT01363765|2883457|P2|Overall Study|non-resident|76
874624|NCT01363765|2883458|P1|Overall Study|non-resident|156
874625|NCT01363765|2883457|P2|Overall Study|duplicate records|3177
874626|NCT01363765|2883458|P1|Overall Study|duplicate records|736
874627|NCT01363765|2883457|P2|Overall Study|non-diagnostic|1124
874628|NCT01363765|2883458|P1|Overall Study|non-diagnostic|2621
874629|NCT01363713|2883470|P1|Overall Study|Withdrawal by Subject|2
874630|NCT01363713|2883470|P1|Overall Study|Protocol Violation|3
874631|NCT01363713|2883470|P1|Overall Study|Adverse Event|1
874632|NCT01363700|2883479|P5|Epinastine vs Placebo Period1|Withdrawal by Subject|0
874633|NCT01363700|2883480|P4|Epinastine vs Placebo Period1|Withdrawal by Subject|0
874634|NCT01363700|2883481|P3|Epinastine vs Placebo Period1|Withdrawal by Subject|0
874635|NCT01363700|2883482|P2|Epinastine vs Placebo Period1|Withdrawal by Subject|1
874636|NCT01363700|2883483|P1|Epinastine vs Placebo Period1|Withdrawal by Subject|0
874637|NCT01363661|2883502|P2|Overall Study|Lost to Follow-up|1
874638|NCT01363661|2883503|P1|Overall Study|Lost to Follow-up|3
874639|NCT01363661|2883502|P2|Overall Study|Protocol Violation|0
874640|NCT01363661|2883503|P1|Overall Study|Protocol Violation|1
874641|NCT01363661|2883502|P2|Overall Study|Withdrawal by Subject|1
874642|NCT01363661|2883503|P1|Overall Study|Withdrawal by Subject|1
874643|NCT01363661|2883502|P2|Overall Study|Adverse Event|2
874644|NCT01363661|2883503|P1|Overall Study|Adverse Event|9
874645|NCT01363440|2883544|P3|Overall Study|Other|2
874646|NCT01363440|2883545|P2|Overall Study|Other|5
874647|NCT01363440|2883546|P1|Overall Study|Other|4
874648|NCT01363440|2883544|P3|Overall Study|Lost to Follow-up|5
874649|NCT01363440|2883545|P2|Overall Study|Lost to Follow-up|4
874650|NCT01363440|2883546|P1|Overall Study|Lost to Follow-up|2
874651|NCT01363440|2883544|P3|Overall Study|Withdrawal by Subject|11
874652|NCT01363440|2883545|P2|Overall Study|Withdrawal by Subject|11
874653|NCT01363440|2883546|P1|Overall Study|Withdrawal by Subject|9
874654|NCT01363440|2883544|P3|Overall Study|Death|5
874655|NCT01363440|2883545|P2|Overall Study|Death|7
874656|NCT01363440|2883546|P1|Overall Study|Death|3
874657|NCT01363440|2883544|P3|Overall Study|Adverse Event|4
874658|NCT01363440|2883545|P2|Overall Study|Adverse Event|4
874659|NCT01363440|2883546|P1|Overall Study|Adverse Event|5
874660|NCT01363349|2883592|P2|Overall Study|missing|2
874661|NCT01363349|2883593|P1|Overall Study|missing|1
874662|NCT01363349|2883592|P2|Overall Study|Not reported|37
874663|NCT01363349|2883593|P1|Overall Study|Not reported|36
874664|NCT01363349|2883592|P2|Overall Study|Lost to Follow-up|6
874665|NCT01363349|2883593|P1|Overall Study|Lost to Follow-up|5
874666|NCT01363349|2883592|P2|Overall Study|Withdrawal by Subject|6
874667|NCT01363349|2883593|P1|Overall Study|Withdrawal by Subject|14
874668|NCT01363349|2883592|P2|Overall Study|Non compliance/Protocol deviations|2
874669|NCT01363349|2883593|P1|Overall Study|Non compliance/Protocol deviations|2
874670|NCT01363349|2883592|P2|Overall Study|Lack of Efficacy|10
874671|NCT01363349|2883593|P1|Overall Study|Lack of Efficacy|3
874672|NCT01363349|2883592|P2|Overall Study|Adverse Event|7
874673|NCT01363349|2883593|P1|Overall Study|Adverse Event|6
874674|NCT01363297|2883604|P5|Overall Study|Death|30
874675|NCT01363297|2883605|P4|Overall Study|Death|10
874676|NCT01363297|2883606|P3|Overall Study|Death|6
874677|NCT01363297|2883607|P2|Overall Study|Death|6
874678|NCT01363297|2883608|P1|Overall Study|Death|3
874679|NCT01363297|2883604|P5|Overall Study|Not specified|1
874680|NCT01363297|2883605|P4|Overall Study|Not specified|0
874681|NCT01363297|2883606|P3|Overall Study|Not specified|0
874682|NCT01363297|2883607|P2|Overall Study|Not specified|0
874683|NCT01363297|2883608|P1|Overall Study|Not specified|0
874684|NCT01363076|2883711|P2|Overall Study|Withdrawal by Subject|1
874685|NCT01363076|2883712|P1|Overall Study|Withdrawal by Subject|0
874686|NCT01363011|2883744|P2|Extension Phase|Rolled Over to Another Gilead Study|1
874687|NCT01363011|2883745|P1|Extension Phase|Rolled Over to Another Gilead Study|2
874688|NCT01363011|2883744|P2|Extension Phase|Lost to Follow-up|2
874689|NCT01363011|2883745|P1|Extension Phase|Lost to Follow-up|0
874690|NCT01363011|2883744|P2|Extension Phase|Withdrew Consent|1
874691|NCT01363011|2883745|P1|Extension Phase|Withdrew Consent|0
874692|NCT01363011|2883744|P2|Extension Phase|Investigator's Discretion|2
874693|NCT01363011|2883745|P1|Extension Phase|Investigator's Discretion|2
874694|NCT01363011|2883744|P2|Extension Phase|Lack of Efficacy|1
874695|NCT01363011|2883745|P1|Extension Phase|Lack of Efficacy|0
874696|NCT01363011|2883744|P2|Extension Phase|Adverse Event|1
874697|NCT01363011|2883745|P1|Extension Phase|Adverse Event|1
874698|NCT01363011|2883744|P2|Main Study|Protocol Violation|1
874699|NCT01363011|2883745|P1|Main Study|Protocol Violation|0
874700|NCT01363011|2883744|P2|Main Study|Withdrew Consent|4
874701|NCT01363011|2883745|P1|Main Study|Withdrew Consent|1
874702|NCT01363011|2883744|P2|Main Study|Investigator's Discretion|1
874703|NCT01363011|2883745|P1|Main Study|Investigator's Discretion|1
874704|NCT01363011|2883744|P2|Main Study|Adverse Event|3
874705|NCT01363011|2883745|P1|Main Study|Adverse Event|2
874706|NCT01362608|2883887|P2|Overall Study|Adverse Event|2
874707|NCT01362608|2883888|P1|Overall Study|Adverse Event|0
874708|NCT01362608|2883887|P2|Overall Study|Lack of Efficacy|2
874709|NCT01362608|2883888|P1|Overall Study|Lack of Efficacy|0
874710|NCT01362608|2883887|P2|Overall Study|Withdrawal by Subject|2
874711|NCT01362608|2883888|P1|Overall Study|Withdrawal by Subject|1
874712|NCT01362608|2883887|P2|Overall Study|Lost to Follow-up|1
874713|NCT01362608|2883888|P1|Overall Study|Lost to Follow-up|3
874714|NCT01362608|2883887|P2|Overall Study|Protocol Violation|1
874715|NCT01362608|2883888|P1|Overall Study|Protocol Violation|0
874716|NCT01362530|2883926|P2|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0
874717|NCT01362530|2883927|P1|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18
874718|NCT01362530|2883926|P2|Optional Extension (Cycles 2-6)|Protocol Violation|0
874719|NCT01362530|2883927|P1|Optional Extension (Cycles 2-6)|Protocol Violation|4
874720|NCT01362530|2883926|P2|Optional Extension (Cycles 2-6)|Physician Decision|0
874721|NCT01362530|2883927|P1|Optional Extension (Cycles 2-6)|Physician Decision|19
874722|NCT01362530|2883926|P2|Optional Extension (Cycles 2-6)|Lost to Follow-up|0
874723|NCT01362530|2883927|P1|Optional Extension (Cycles 2-6)|Lost to Follow-up|1
874724|NCT01362530|2883926|P2|Optional Extension (Cycles 2-6)|Lack of Efficacy|0
874725|NCT01362530|2883927|P1|Optional Extension (Cycles 2-6)|Lack of Efficacy|1
874726|NCT01362530|2883926|P2|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0
874727|NCT01362530|2883927|P1|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4
874728|NCT01362530|2883926|P2|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0
874729|NCT01362530|2883927|P1|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25
874730|NCT01362530|2883926|P2|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0
874731|NCT01362530|2883927|P1|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51
874732|NCT01362530|2883926|P2|Optional Extension (Cycles 2-6)|Adverse Event|0
874733|NCT01362530|2883927|P1|Optional Extension (Cycles 2-6)|Adverse Event|2
874734|NCT01362530|2883926|P2|Base Study (Cycle 1)|Withdrawal by Subject|2
874735|NCT01362530|2883927|P1|Base Study (Cycle 1)|Withdrawal by Subject|1
874736|NCT01362530|2883926|P2|Base Study (Cycle 1)|Protocol Violation|0
874737|NCT01362530|2883927|P1|Base Study (Cycle 1)|Protocol Violation|2
874738|NCT01362530|2883926|P2|Base Study (Cycle 1)|Physician Decision|1
874739|NCT01362530|2883927|P1|Base Study (Cycle 1)|Physician Decision|0
874740|NCT01362530|2883926|P2|Base Study (Cycle 1)|Adverse Event|0
874741|NCT01362530|2883927|P1|Base Study (Cycle 1)|Adverse Event|2
874742|NCT01362517|2883940|P1|Overall Study|Lost to Follow-up|1
874743|NCT01362517|2883940|P1|Overall Study|Protocol Violation|1
874744|NCT01362491|2883951|P3|Overall Study|Ineligible|0
874745|NCT01362491|2883952|P2|Overall Study|Ineligible|0
874746|NCT01362491|2883953|P1|Overall Study|Ineligible|1
874747|NCT01362439|2884001|P1|Overall Study|Participant who withdrew consent|8
874748|NCT01362439|2884001|P1|Overall Study|Study medication non-compliant|1
874749|NCT01362439|2884001|P1|Overall Study|Lost to Follow-up|2
874750|NCT01362439|2884001|P1|Overall Study|Lack of Efficacy|3
874751|NCT01362439|2884001|P1|Overall Study|Adverse Event|1
874752|NCT01362348|2884016|P1|Overall Study|Study closed/terminated|5
874753|NCT01362348|2884016|P1|Overall Study|Protocol-defined stopping criteria|9
874754|NCT01362322|2884035|P2|Overall Study|Lost to Follow-up|6
874755|NCT01362322|2884036|P1|Overall Study|Lost to Follow-up|2
874756|NCT01362322|2884035|P2|Overall Study|Withdrawal by Subject|1
874757|NCT01362322|2884036|P1|Overall Study|Withdrawal by Subject|3
874758|NCT01362296|2884068|P4|Crossover Phase|Study Closed/Terminated|0
874759|NCT01362296|2884069|P3|Crossover Phase|Study Closed/Terminated|1
874760|NCT01362296|2884070|P2|Crossover Phase|Study Closed/Terminated|0
874761|NCT01362296|2884071|P1|Crossover Phase|Study Closed/Terminated|0
874762|NCT01362296|2884068|P4|Crossover Phase|Adverse Event|0
874763|NCT01362296|2884069|P3|Crossover Phase|Adverse Event|4
874764|NCT01362296|2884070|P2|Crossover Phase|Adverse Event|0
874765|NCT01362296|2884071|P1|Crossover Phase|Adverse Event|0
874766|NCT01362296|2884068|P4|Crossover Phase|Withdrawal by Subject|1
874767|NCT01362296|2884069|P3|Crossover Phase|Withdrawal by Subject|2
874768|NCT01362296|2884070|P2|Crossover Phase|Withdrawal by Subject|0
874769|NCT01362296|2884071|P1|Crossover Phase|Withdrawal by Subject|0
874770|NCT01362296|2884068|P4|Crossover Phase|PD including Death due to PD|1
874771|NCT01362296|2884069|P3|Crossover Phase|PD including Death due to PD|16
874772|NCT01362296|2884070|P2|Crossover Phase|PD including Death due to PD|0
874773|NCT01362296|2884071|P1|Crossover Phase|PD including Death due to PD|0
874774|NCT01362296|2884068|P4|Randomized Phase (RP)|Study Closed/Terminated|0
874775|NCT01362296|2884069|P3|Randomized Phase (RP)|Study Closed/Terminated|0
874776|NCT01362296|2884070|P2|Randomized Phase (RP)|Study Closed/Terminated|1
874777|NCT01362296|2884071|P1|Randomized Phase (RP)|Study Closed/Terminated|8
874778|NCT01362296|2884068|P4|Randomized Phase (RP)|Adverse Event|0
874779|NCT01362296|2884069|P3|Randomized Phase (RP)|Adverse Event|0
874780|NCT01362296|2884070|P2|Randomized Phase (RP)|Adverse Event|4
874781|NCT01362296|2884071|P1|Randomized Phase (RP)|Adverse Event|20
874782|NCT01362296|2884068|P4|Randomized Phase (RP)|Withdrawal by Subject|0
874783|NCT01362296|2884069|P3|Randomized Phase (RP)|Withdrawal by Subject|0
874784|NCT01362296|2884070|P2|Randomized Phase (RP)|Withdrawal by Subject|1
874785|NCT01362296|2884071|P1|Randomized Phase (RP)|Withdrawal by Subject|2
874786|NCT01362296|2884068|P4|Randomized Phase (RP)|Physician Decision|0
874787|NCT01362296|2884069|P3|Randomized Phase (RP)|Physician Decision|0
874788|NCT01362296|2884070|P2|Randomized Phase (RP)|Physician Decision|9
874789|NCT01362296|2884071|P1|Randomized Phase (RP)|Physician Decision|1
874790|NCT01362296|2884068|P4|Randomized Phase (RP)|PD including Death due to PD|0
874791|NCT01362296|2884069|P3|Randomized Phase (RP)|PD including Death due to PD|0
874792|NCT01362296|2884070|P2|Randomized Phase (RP)|PD including Death due to PD|28
874793|NCT01362296|2884071|P1|Randomized Phase (RP)|PD including Death due to PD|56
874794|NCT01362244|2884119|P2|Overall Study|Protocol Defined Stopping Criteria|1
874795|NCT01362244|2884120|P1|Overall Study|Protocol Defined Stopping Criteria|0
874796|NCT01362244|2884119|P2|Overall Study|Did not Meet Continuation Criteria|11
874797|NCT01362244|2884120|P1|Overall Study|Did not Meet Continuation Criteria|17
874798|NCT01362244|2884119|P2|Overall Study|Withdrawal by Subject|1
874799|NCT01362244|2884120|P1|Overall Study|Withdrawal by Subject|2
874800|NCT01362244|2884119|P2|Overall Study|Protocol Violation|1
874801|NCT01362244|2884120|P1|Overall Study|Protocol Violation|5
874802|NCT01362244|2884119|P2|Overall Study|Lost to Follow-up|2
874803|NCT01362244|2884120|P1|Overall Study|Lost to Follow-up|0
874804|NCT01362244|2884119|P2|Overall Study|Lack of Efficacy|11
874805|NCT01362244|2884120|P1|Overall Study|Lack of Efficacy|5
874806|NCT01362244|2884119|P2|Overall Study|Adverse Event|5
874807|NCT01362244|2884120|P1|Overall Study|Adverse Event|3
874808|NCT01362140|2884232|P2|Overall Study|Discontinued Without Receiving Treatment|1
874809|NCT01362140|2884233|P1|Overall Study|Discontinued Without Receiving Treatment|0
874810|NCT01362140|2884232|P2|Overall Study|Protocol-specified Criteria|2
874811|NCT01362140|2884233|P1|Overall Study|Protocol-specified Criteria|1
874812|NCT01362140|2884232|P2|Overall Study|Other|1
874813|NCT01362140|2884233|P1|Overall Study|Other|1
874814|NCT01362140|2884232|P2|Overall Study|Death|1
874815|NCT01362140|2884233|P1|Overall Study|Death|2
874816|NCT01362140|2884232|P2|Overall Study|Administrative Decision|1
874817|NCT01362140|2884233|P1|Overall Study|Administrative Decision|0
874818|NCT01362140|2884232|P2|Overall Study|Withdrawal by Subject|3
874819|NCT01362140|2884233|P1|Overall Study|Withdrawal by Subject|3
874820|NCT01362140|2884232|P2|Overall Study|Adverse Event|2
874821|NCT01362140|2884233|P1|Overall Study|Adverse Event|2
874822|NCT01362140|2884232|P2|Overall Study|Noncompliance|0
874823|NCT01362140|2884233|P1|Overall Study|Noncompliance|1
874824|NCT01362062|2884257|P2|Overall Study|Had significant improvement|0
874825|NCT01362062|2884258|P1|Overall Study|Had significant improvement|9
874826|NCT01362062|2884257|P2|Overall Study|Detected with Spondylo-arthritis|0
874827|NCT01362062|2884258|P1|Overall Study|Detected with Spondylo-arthritis|1
874828|NCT01362062|2884257|P2|Overall Study|Non-compliant participant|0
874829|NCT01362062|2884258|P1|Overall Study|Non-compliant participant|2
874830|NCT01362062|2884257|P2|Overall Study|Withdrawal by Subject|0
874831|NCT01362062|2884258|P1|Overall Study|Withdrawal by Subject|2
874832|NCT01362062|2884257|P2|Overall Study|Lost to Follow-up|0
874833|NCT01362062|2884258|P1|Overall Study|Lost to Follow-up|11
874834|NCT01362062|2884257|P2|Overall Study|Adverse Event|0
874835|NCT01362062|2884258|P1|Overall Study|Adverse Event|1
874836|NCT01362049|2884279|P4|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
874837|NCT01362049|2884280|P3|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2
874838|NCT01362049|2884281|P2|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
874839|NCT01362049|2884282|P1|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5
874840|NCT01362049|2884279|P4|Follow-Up at 7 Weeks|Lost to Follow-up|1
874841|NCT01362049|2884280|P3|Follow-Up at 7 Weeks|Lost to Follow-up|2
874842|NCT01362049|2884281|P2|Follow-Up at 7 Weeks|Lost to Follow-up|3
874843|NCT01362049|2884282|P1|Follow-Up at 7 Weeks|Lost to Follow-up|3
874844|NCT01361607|2884347|P2|Overall Study|Met Withdrawal Criteria|1
874845|NCT01361607|2884348|P1|Overall Study|Met Withdrawal Criteria|1
874846|NCT01361607|2884347|P2|Overall Study|Lost to Follow-up|0
874847|NCT01361607|2884348|P1|Overall Study|Lost to Follow-up|1
874848|NCT01361607|2884347|P2|Overall Study|Withdrawal by Investigator|3
874849|NCT01361607|2884348|P1|Overall Study|Withdrawal by Investigator|5
874850|NCT01361607|2884347|P2|Overall Study|Withdrawal by Subject|8
874851|NCT01361607|2884348|P1|Overall Study|Withdrawal by Subject|19
874852|NCT01361607|2884347|P2|Overall Study|Adverse Event|29
874853|NCT01361607|2884348|P1|Overall Study|Adverse Event|38
874854|NCT01361594|2884376|P2|Overall Study|Withdrawal by Subject|2
874855|NCT01361594|2884377|P1|Overall Study|Withdrawal by Subject|1
874856|NCT01361568|2884391|P6|Overall Study|Withdrawal by Subject|1
874857|NCT01361568|2884392|P5|Overall Study|Withdrawal by Subject|0
874858|NCT01361568|2884393|P4|Overall Study|Withdrawal by Subject|0
874859|NCT01361568|2884394|P3|Overall Study|Withdrawal by Subject|0
874860|NCT01361568|2884395|P2|Overall Study|Withdrawal by Subject|1
874861|NCT01361568|2884396|P1|Overall Study|Withdrawal by Subject|2
874862|NCT01361568|2884391|P6|Overall Study|Physician Decision|1
874863|NCT01361568|2884392|P5|Overall Study|Physician Decision|0
874864|NCT01361568|2884393|P4|Overall Study|Physician Decision|0
874865|NCT01361568|2884394|P3|Overall Study|Physician Decision|0
874866|NCT01361568|2884395|P2|Overall Study|Physician Decision|0
874867|NCT01361568|2884396|P1|Overall Study|Physician Decision|0
874868|NCT01361568|2884391|P6|Overall Study|Adverse Event|0
874869|NCT01361568|2884392|P5|Overall Study|Adverse Event|1
874870|NCT01361568|2884393|P4|Overall Study|Adverse Event|0
874871|NCT01361568|2884394|P3|Overall Study|Adverse Event|0
874872|NCT01361568|2884395|P2|Overall Study|Adverse Event|0
874873|NCT01361568|2884396|P1|Overall Study|Adverse Event|0
874874|NCT01361464|2884426|P1|Overall Study|Withdrawal by Subject|2
874875|NCT01361464|2884426|P1|Overall Study|Death|1
874876|NCT01361308|2884435|P2|Overall Study|Not Specified|1
874877|NCT01361308|2884436|P1|Overall Study|Not Specified|0
874878|NCT01361308|2884435|P2|Overall Study|Failed C-SSRS|2
874879|NCT01361308|2884436|P1|Overall Study|Failed C-SSRS|5
874880|NCT01361308|2884435|P2|Overall Study|Eligibility Criteria Not Met|3
874881|NCT01361308|2884436|P1|Overall Study|Eligibility Criteria Not Met|2
874882|NCT01361308|2884435|P2|Overall Study|Adverse Event|4
874883|NCT01361308|2884436|P1|Overall Study|Adverse Event|8
874884|NCT01361308|2884435|P2|Overall Study|Lost to Follow-up|4
874885|NCT01361308|2884436|P1|Overall Study|Lost to Follow-up|5
874886|NCT01361308|2884435|P2|Overall Study|Protocol Violation|0
874887|NCT01361308|2884436|P1|Overall Study|Protocol Violation|1
874888|NCT01361308|2884435|P2|Overall Study|Lack of Efficacy|0
874889|NCT01361308|2884436|P1|Overall Study|Lack of Efficacy|2
874890|NCT01361308|2884435|P2|Overall Study|Physician Decision|3
874891|NCT01361308|2884436|P1|Overall Study|Physician Decision|3
874892|NCT01361308|2884435|P2|Overall Study|Withdrawal by Subject|13
874893|NCT01361308|2884436|P1|Overall Study|Withdrawal by Subject|9
874894|NCT01361178|2884484|P2|Overall Study|Death|0
874895|NCT01361178|2884485|P1|Overall Study|Death|13
874896|NCT01361126|2884493|P2|Overall Study|Sponsor decision|2
874897|NCT01361126|2884494|P1|Overall Study|Sponsor decision|0
874898|NCT01361009|2884533|P1|Overall Study|Protocol Violation|116
874899|NCT01360996|2884543|P3|Overall Study|Noncompliant|0
874900|NCT01360996|2884544|P2|Overall Study|Noncompliant|0
874901|NCT01360996|2884545|P1|Overall Study|Noncompliant|2
874902|NCT01360996|2884543|P3|Overall Study|Withdrawal by Subject|2
874903|NCT01360996|2884544|P2|Overall Study|Withdrawal by Subject|3
874904|NCT01360996|2884545|P1|Overall Study|Withdrawal by Subject|4
874905|NCT01360866|2884568|P4|Overall Study|Lack of Efficacy|4
874906|NCT01360866|2884569|P3|Overall Study|Lack of Efficacy|30
874907|NCT01360866|2884570|P2|Overall Study|Lack of Efficacy|40
874908|NCT01360866|2884571|P1|Overall Study|Lack of Efficacy|30
874909|NCT01360866|2884568|P4|Overall Study|Protocol Deviation|2
874910|NCT01360866|2884569|P3|Overall Study|Protocol Deviation|61
874911|NCT01360866|2884570|P2|Overall Study|Protocol Deviation|33
874912|NCT01360866|2884571|P1|Overall Study|Protocol Deviation|25
874913|NCT01360866|2884568|P4|Overall Study|Withdrawal by participant|8
874914|NCT01360866|2884569|P3|Overall Study|Withdrawal by participant|168
874915|NCT01360866|2884570|P2|Overall Study|Withdrawal by participant|89
874916|NCT01360866|2884571|P1|Overall Study|Withdrawal by participant|79
874917|NCT01360866|2884568|P4|Overall Study|Withdrawn by Investigator|2
874918|NCT01360866|2884569|P3|Overall Study|Withdrawn by Investigator|31
874919|NCT01360866|2884570|P2|Overall Study|Withdrawn by Investigator|8
874920|NCT01360866|2884571|P1|Overall Study|Withdrawn by Investigator|9
874921|NCT01360866|2884568|P4|Overall Study|Paticipant met withdrawal criteria|0
874922|NCT01360866|2884569|P3|Overall Study|Paticipant met withdrawal criteria|54
874923|NCT01360866|2884570|P2|Overall Study|Paticipant met withdrawal criteria|28
874924|NCT01360866|2884571|P1|Overall Study|Paticipant met withdrawal criteria|11
874925|NCT01360866|2884568|P4|Overall Study|Adverse Event|6
874926|NCT01360866|2884569|P3|Overall Study|Adverse Event|134
874927|NCT01360866|2884570|P2|Overall Study|Adverse Event|61
874928|NCT01360866|2884571|P1|Overall Study|Adverse Event|56
874929|NCT01360866|2884568|P4|Overall Study|Lost to Follow-up|0
874930|NCT01360866|2884569|P3|Overall Study|Lost to Follow-up|41
874931|NCT01360866|2884570|P2|Overall Study|Lost to Follow-up|28
874932|NCT01360866|2884571|P1|Overall Study|Lost to Follow-up|11
874933|NCT01360840|2884600|P3|Overall Study|Ongoing at data cut-off|9
874934|NCT01360840|2884601|P2|Overall Study|Ongoing at data cut-off|10
874935|NCT01360840|2884602|P1|Overall Study|Ongoing at data cut-off|10
874936|NCT01360645|2884654|P4|Phase A+|Protocol Deviation|4
874937|NCT01360645|2884655|P3|Phase A+|Protocol Deviation|0
874938|NCT01360645|2884656|P2|Phase A+|Protocol Deviation|0
874939|NCT01360645|2884657|P1|Phase A+|Protocol Deviation|0
874940|NCT01360645|2884654|P4|Phase A+|Withdrawal by Subject|5
874941|NCT01360645|2884655|P3|Phase A+|Withdrawal by Subject|0
874942|NCT01360645|2884656|P2|Phase A+|Withdrawal by Subject|0
874943|NCT01360645|2884657|P1|Phase A+|Withdrawal by Subject|0
874944|NCT01360645|2884654|P4|Phase A+|Physician Decision|2
874945|NCT01360645|2884655|P3|Phase A+|Physician Decision|0
874946|NCT01360645|2884656|P2|Phase A+|Physician Decision|0
874947|NCT01360645|2884657|P1|Phase A+|Physician Decision|0
874948|NCT01360645|2884654|P4|Phase A+|Met Withdrawal Criteria|4
874949|NCT01360645|2884655|P3|Phase A+|Met Withdrawal Criteria|0
874950|NCT01360645|2884656|P2|Phase A+|Met Withdrawal Criteria|0
874951|NCT01360645|2884657|P1|Phase A+|Met Withdrawal Criteria|0
874952|NCT01360645|2884654|P4|Phase A+|Adverse Event|2
874953|NCT01360645|2884655|P3|Phase A+|Adverse Event|0
874954|NCT01360645|2884656|P2|Phase A+|Adverse Event|0
874955|NCT01360645|2884657|P1|Phase A+|Adverse Event|0
874956|NCT01360645|2884654|P4|Phase A+|Lost to Follow-up|7
874957|NCT01360645|2884655|P3|Phase A+|Lost to Follow-up|0
874958|NCT01360645|2884656|P2|Phase A+|Lost to Follow-up|0
874959|NCT01360645|2884657|P1|Phase A+|Lost to Follow-up|0
874960|NCT01360645|2884654|P4|Phase B (6 Weeks)|Protocol Deviation|0
874961|NCT01360645|2884655|P3|Phase B (6 Weeks)|Protocol Deviation|3
874962|NCT01360645|2884656|P2|Phase B (6 Weeks)|Protocol Deviation|1
874963|NCT01360645|2884657|P1|Phase B (6 Weeks)|Protocol Deviation|0
874964|NCT01360645|2884654|P4|Phase B (6 Weeks)|Withdrawal by Subject|0
874965|NCT01360645|2884655|P3|Phase B (6 Weeks)|Withdrawal by Subject|8
874966|NCT01360645|2884656|P2|Phase B (6 Weeks)|Withdrawal by Subject|3
874967|NCT01360645|2884657|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
874968|NCT01360645|2884654|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|0
874969|NCT01360645|2884655|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
874970|NCT01360645|2884656|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|3
874971|NCT01360645|2884657|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
874972|NCT01360645|2884654|P4|Phase B (6 Weeks)|Adverse Event|0
874973|NCT01360645|2884655|P3|Phase B (6 Weeks)|Adverse Event|0
874974|NCT01360645|2884656|P2|Phase B (6 Weeks)|Adverse Event|6
874975|NCT01360645|2884657|P1|Phase B (6 Weeks)|Adverse Event|0
874976|NCT01360645|2884654|P4|Phase B (6 Weeks)|Lost to Follow-up|0
874977|NCT01360645|2884655|P3|Phase B (6 Weeks)|Lost to Follow-up|0
874978|NCT01360645|2884656|P2|Phase B (6 Weeks)|Lost to Follow-up|1
874979|NCT01360645|2884657|P1|Phase B (6 Weeks)|Lost to Follow-up|0
874980|NCT01360645|2884654|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
874981|NCT01360645|2884655|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
874982|NCT01360645|2884656|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
874983|NCT01360645|2884657|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5
874984|NCT01360645|2884654|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
874985|NCT01360645|2884655|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
874986|NCT01360645|2884656|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
874987|NCT01360645|2884657|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24
874988|NCT01360645|2884654|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
874989|NCT01360645|2884655|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
874990|NCT01360645|2884656|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
874991|NCT01360645|2884657|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34
874992|NCT01360645|2884654|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
874993|NCT01360645|2884655|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
874994|NCT01360645|2884656|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
874995|NCT01360645|2884657|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16
874996|NCT01360645|2884654|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
874997|NCT01360645|2884655|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
874998|NCT01360645|2884656|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
874999|NCT01360645|2884657|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19
875000|NCT01360645|2884654|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
875001|NCT01360645|2884655|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
875002|NCT01360645|2884656|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
875003|NCT01360645|2884657|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16
875004|NCT01360632|2884712|P5|Phase A+|Protocol Deviation|3
875005|NCT01360632|2884713|P4|Phase A+|Protocol Deviation|0
875006|NCT01360632|2884714|P3|Phase A+|Protocol Deviation|0
875007|NCT01360632|2884715|P2|Phase A+|Protocol Deviation|0
875008|NCT01360632|2884716|P1|Phase A+|Protocol Deviation|0
875009|NCT01360632|2884712|P5|Phase A+|Withdrawal by Subject|8
875010|NCT01360632|2884713|P4|Phase A+|Withdrawal by Subject|0
875011|NCT01360632|2884714|P3|Phase A+|Withdrawal by Subject|0
875012|NCT01360632|2884715|P2|Phase A+|Withdrawal by Subject|0
875013|NCT01360632|2884716|P1|Phase A+|Withdrawal by Subject|0
875014|NCT01360632|2884712|P5|Phase A+|Physician Decision|3
875015|NCT01360632|2884713|P4|Phase A+|Physician Decision|0
875016|NCT01360632|2884714|P3|Phase A+|Physician Decision|0
875017|NCT01360632|2884715|P2|Phase A+|Physician Decision|0
875018|NCT01360632|2884716|P1|Phase A+|Physician Decision|0
875019|NCT01360632|2884712|P5|Phase A+|Met Withdrawal Criteria|7
875020|NCT01360632|2884713|P4|Phase A+|Met Withdrawal Criteria|0
875021|NCT01360632|2884714|P3|Phase A+|Met Withdrawal Criteria|0
875022|NCT01360632|2884715|P2|Phase A+|Met Withdrawal Criteria|0
875023|NCT01360632|2884716|P1|Phase A+|Met Withdrawal Criteria|0
875024|NCT01360632|2884712|P5|Phase A+|Adverse Event|2
875025|NCT01360632|2884713|P4|Phase A+|Adverse Event|0
875026|NCT01360632|2884714|P3|Phase A+|Adverse Event|0
875027|NCT01360632|2884715|P2|Phase A+|Adverse Event|0
875028|NCT01360632|2884716|P1|Phase A+|Adverse Event|0
875029|NCT01360632|2884712|P5|Phase A+|Lost to Follow-up|2
875030|NCT01360632|2884713|P4|Phase A+|Lost to Follow-up|0
875031|NCT01360632|2884714|P3|Phase A+|Lost to Follow-up|0
875032|NCT01360632|2884715|P2|Phase A+|Lost to Follow-up|0
875033|NCT01360632|2884716|P1|Phase A+|Lost to Follow-up|0
875034|NCT01360632|2884712|P5|Phase B (6 Weeks)|Lack of Efficacy|0
875035|NCT01360632|2884713|P4|Phase B (6 Weeks)|Lack of Efficacy|0
875036|NCT01360632|2884714|P3|Phase B (6 Weeks)|Lack of Efficacy|0
875037|NCT01360632|2884715|P2|Phase B (6 Weeks)|Lack of Efficacy|1
875038|NCT01360632|2884716|P1|Phase B (6 Weeks)|Lack of Efficacy|0
875039|NCT01360632|2884712|P5|Phase B (6 Weeks)|Protocol Deviation|0
875040|NCT01360632|2884713|P4|Phase B (6 Weeks)|Protocol Deviation|1
875041|NCT01360632|2884714|P3|Phase B (6 Weeks)|Protocol Deviation|4
875042|NCT01360632|2884715|P2|Phase B (6 Weeks)|Protocol Deviation|1
875043|NCT01360632|2884716|P1|Phase B (6 Weeks)|Protocol Deviation|0
875044|NCT01360632|2884712|P5|Phase B (6 Weeks)|Withdrawal by Subject|0
875045|NCT01360632|2884713|P4|Phase B (6 Weeks)|Withdrawal by Subject|7
875046|NCT01360632|2884714|P3|Phase B (6 Weeks)|Withdrawal by Subject|4
875047|NCT01360632|2884715|P2|Phase B (6 Weeks)|Withdrawal by Subject|4
875048|NCT01360632|2884716|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
875049|NCT01360632|2884712|P5|Phase B (6 Weeks)|Physician Decision|0
875050|NCT01360632|2884713|P4|Phase B (6 Weeks)|Physician Decision|1
875051|NCT01360632|2884714|P3|Phase B (6 Weeks)|Physician Decision|0
875052|NCT01360632|2884715|P2|Phase B (6 Weeks)|Physician Decision|0
875053|NCT01360632|2884716|P1|Phase B (6 Weeks)|Physician Decision|0
875054|NCT01360632|2884712|P5|Phase B (6 Weeks)|Met Withdrawal Criteria|0
875055|NCT01360632|2884713|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|1
875056|NCT01360632|2884714|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
875057|NCT01360632|2884715|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|0
875058|NCT01360632|2884716|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
875059|NCT01360632|2884712|P5|Phase B (6 Weeks)|Adverse Event|0
875060|NCT01360632|2884713|P4|Phase B (6 Weeks)|Adverse Event|3
875061|NCT01360632|2884714|P3|Phase B (6 Weeks)|Adverse Event|9
875062|NCT01360632|2884715|P2|Phase B (6 Weeks)|Adverse Event|3
875063|NCT01360632|2884716|P1|Phase B (6 Weeks)|Adverse Event|0
875064|NCT01360632|2884712|P5|Phase B (6 Weeks)|Lost to Follow-up|0
875065|NCT01360632|2884713|P4|Phase B (6 Weeks)|Lost to Follow-up|0
875066|NCT01360632|2884714|P3|Phase B (6 Weeks)|Lost to Follow-up|1
875067|NCT01360632|2884715|P2|Phase B (6 Weeks)|Lost to Follow-up|1
875068|NCT01360632|2884716|P1|Phase B (6 Weeks)|Lost to Follow-up|0
875069|NCT01360632|2884712|P5|Phase A (8 Weeks)|Protocol Deviation|0
875070|NCT01360632|2884713|P4|Phase A (8 Weeks)|Protocol Deviation|0
875071|NCT01360632|2884714|P3|Phase A (8 Weeks)|Protocol Deviation|0
875072|NCT01360632|2884715|P2|Phase A (8 Weeks)|Protocol Deviation|0
875073|NCT01360632|2884716|P1|Phase A (8 Weeks)|Protocol Deviation|39
875074|NCT01360632|2884712|P5|Phase A (8 Weeks)|Withdrawal by Subject|0
875075|NCT01360632|2884713|P4|Phase A (8 Weeks)|Withdrawal by Subject|0
875076|NCT01360632|2884714|P3|Phase A (8 Weeks)|Withdrawal by Subject|0
875077|NCT01360632|2884715|P2|Phase A (8 Weeks)|Withdrawal by Subject|0
875078|NCT01360632|2884716|P1|Phase A (8 Weeks)|Withdrawal by Subject|74
875079|NCT01360632|2884712|P5|Phase A (8 Weeks)|Physician Decision|0
875080|NCT01360632|2884713|P4|Phase A (8 Weeks)|Physician Decision|0
875081|NCT01360632|2884714|P3|Phase A (8 Weeks)|Physician Decision|0
875082|NCT01360632|2884715|P2|Phase A (8 Weeks)|Physician Decision|0
875083|NCT01360632|2884716|P1|Phase A (8 Weeks)|Physician Decision|10
875084|NCT01360632|2884712|P5|Phase A (8 Weeks)|Met Withdrawal Criteria|0
875085|NCT01360632|2884713|P4|Phase A (8 Weeks)|Met Withdrawal Criteria|0
875086|NCT01360632|2884714|P3|Phase A (8 Weeks)|Met Withdrawal Criteria|0
875087|NCT01360632|2884715|P2|Phase A (8 Weeks)|Met Withdrawal Criteria|0
875088|NCT01360632|2884716|P1|Phase A (8 Weeks)|Met Withdrawal Criteria|45
875089|NCT01360632|2884712|P5|Phase A (8 Weeks)|Adverse Event|0
875090|NCT01360632|2884713|P4|Phase A (8 Weeks)|Adverse Event|0
875091|NCT01360632|2884714|P3|Phase A (8 Weeks)|Adverse Event|0
875092|NCT01360632|2884715|P2|Phase A (8 Weeks)|Adverse Event|0
875093|NCT01360632|2884716|P1|Phase A (8 Weeks)|Adverse Event|60
875094|NCT01360632|2884712|P5|Phase A (8 Weeks)|Lost to Follow-up|0
875095|NCT01360632|2884713|P4|Phase A (8 Weeks)|Lost to Follow-up|0
875096|NCT01360632|2884714|P3|Phase A (8 Weeks)|Lost to Follow-up|0
875097|NCT01360632|2884715|P2|Phase A (8 Weeks)|Lost to Follow-up|0
875098|NCT01360632|2884716|P1|Phase A (8 Weeks)|Lost to Follow-up|27
875099|NCT01360554|2884795|P2|Overall Study|Randomized but not treated.|3
875100|NCT01360554|2884796|P1|Overall Study|Randomized but not treated.|3
875101|NCT01360554|2884795|P2|Overall Study|Other, not specified|0
875102|NCT01360554|2884796|P1|Overall Study|Other, not specified|1
875103|NCT01360554|2884795|P2|Overall Study|Study terminated by sponsor|37
875104|NCT01360554|2884796|P1|Overall Study|Study terminated by sponsor|49
875105|NCT01360554|2884795|P2|Overall Study|Withdrawal by Subject|24
875106|NCT01360554|2884796|P1|Overall Study|Withdrawal by Subject|23
875107|NCT01360554|2884795|P2|Overall Study|Lost to Follow-up|4
875108|NCT01360554|2884796|P1|Overall Study|Lost to Follow-up|4
875109|NCT01360554|2884795|P2|Overall Study|Death|371
875110|NCT01360554|2884796|P1|Overall Study|Death|359
875111|NCT01360021|2884848|P3|Overall Study|Adverse Event|3
875112|NCT01360021|2884849|P2|Overall Study|Adverse Event|3
875113|NCT01360021|2884850|P1|Overall Study|Adverse Event|2
875114|NCT01360021|2884848|P3|Overall Study|Withdrawal by Subject|2
875115|NCT01360021|2884849|P2|Overall Study|Withdrawal by Subject|0
875116|NCT01360021|2884850|P1|Overall Study|Withdrawal by Subject|4
875117|NCT01360021|2884848|P3|Overall Study|Protocol Violation|1
875118|NCT01360021|2884849|P2|Overall Study|Protocol Violation|0
875119|NCT01360021|2884850|P1|Overall Study|Protocol Violation|0
875120|NCT01360021|2884848|P3|Overall Study|Eligibility criteria + other|1
875121|NCT01360021|2884849|P2|Overall Study|Eligibility criteria + other|1
875122|NCT01360021|2884850|P1|Overall Study|Eligibility criteria + other|2
875123|NCT01359943|2884876|P3|Follow-up (Weeks 52 - 60)|Adverse Event|1
875124|NCT01359943|2884877|P2|Follow-up (Weeks 52 - 60)|Adverse Event|5
875125|NCT01359943|2884878|P1|Follow-up (Weeks 52 - 60)|Adverse Event|3
875126|NCT01359943|2884876|P3|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
875127|NCT01359943|2884877|P2|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1
875128|NCT01359943|2884878|P1|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
875129|NCT01359943|2884876|P3|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
875130|NCT01359943|2884877|P2|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
875131|NCT01359943|2884878|P1|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
875132|NCT01359943|2884876|P3|Follow-up (Weeks 52 - 60)|Protocol deviation|0
875133|NCT01359943|2884877|P2|Follow-up (Weeks 52 - 60)|Protocol deviation|1
875134|NCT01359943|2884878|P1|Follow-up (Weeks 52 - 60)|Protocol deviation|0
875135|NCT01359943|2884876|P3|Follow-up (Weeks 52 - 60)|Administrative problems|0
875136|NCT01359943|2884877|P2|Follow-up (Weeks 52 - 60)|Administrative problems|0
875137|NCT01359943|2884878|P1|Follow-up (Weeks 52 - 60)|Administrative problems|1
875138|NCT01359943|2884876|P3|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4
875139|NCT01359943|2884877|P2|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5
875140|NCT01359943|2884878|P1|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1
875141|NCT01359943|2884876|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1
875142|NCT01359943|2884877|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5
875143|NCT01359943|2884878|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3
875144|NCT01359943|2884876|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
875145|NCT01359943|2884877|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1
875146|NCT01359943|2884878|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
875147|NCT01359943|2884876|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
875148|NCT01359943|2884877|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
875149|NCT01359943|2884878|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
875150|NCT01359943|2884876|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
875151|NCT01359943|2884877|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1
875152|NCT01359943|2884878|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
875153|NCT01359943|2884876|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4
875154|NCT01359943|2884877|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3
875155|NCT01359943|2884878|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1
875156|NCT01359943|2884876|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
875157|NCT01359943|2884877|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
875158|NCT01359943|2884878|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1
875159|NCT01359943|2884876|P3|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
875160|NCT01359943|2884877|P2|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2
875161|NCT01359943|2884878|P1|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
875162|NCT01359943|2884876|P3|Double-blind (Weeks 0 - 16)|Adverse Event|0
875163|NCT01359943|2884877|P2|Double-blind (Weeks 0 - 16)|Adverse Event|2
875164|NCT01359943|2884878|P1|Double-blind (Weeks 0 - 16)|Adverse Event|1
875165|NCT01359943|2884876|P3|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
875166|NCT01359943|2884877|P2|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
875167|NCT01359943|2884878|P1|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1
875168|NCT01359904|2884926|P2|Overall Study|Withdrawal by Subject|0
875169|NCT01359904|2884927|P1|Overall Study|Withdrawal by Subject|1
875170|NCT01359644|2884981|P10|Follow-up Period|Lost to Follow-up|0
875171|NCT01359644|2884982|P9|Follow-up Period|Lost to Follow-up|0
875172|NCT01359644|2884983|P8|Follow-up Period|Lost to Follow-up|2
875173|NCT01359644|2884984|P7|Follow-up Period|Lost to Follow-up|1
875174|NCT01359644|2884985|P6|Follow-up Period|Lost to Follow-up|0
875175|NCT01359644|2884986|P5|Follow-up Period|Lost to Follow-up|0
875176|NCT01359644|2884987|P4|Follow-up Period|Lost to Follow-up|0
875177|NCT01359644|2884988|P3|Follow-up Period|Lost to Follow-up|0
875178|NCT01359644|2884989|P2|Follow-up Period|Lost to Follow-up|0
875179|NCT01359644|2884990|P1|Follow-up Period|Lost to Follow-up|0
875180|NCT01359644|2884981|P10|Follow-up Period|Withdrawal by Subject|0
875181|NCT01359644|2884982|P9|Follow-up Period|Withdrawal by Subject|0
875182|NCT01359644|2884983|P8|Follow-up Period|Withdrawal by Subject|0
875183|NCT01359644|2884984|P7|Follow-up Period|Withdrawal by Subject|0
875184|NCT01359644|2884985|P6|Follow-up Period|Withdrawal by Subject|1
875185|NCT01359644|2884986|P5|Follow-up Period|Withdrawal by Subject|0
875186|NCT01359644|2884987|P4|Follow-up Period|Withdrawal by Subject|0
875187|NCT01359644|2884988|P3|Follow-up Period|Withdrawal by Subject|0
875188|NCT01359644|2884989|P2|Follow-up Period|Withdrawal by Subject|0
875189|NCT01359644|2884990|P1|Follow-up Period|Withdrawal by Subject|0
875190|NCT01359644|2884981|P10|Treatment Period|Lost to Follow-up|0
875191|NCT01359644|2884982|P9|Treatment Period|Lost to Follow-up|0
875192|NCT01359644|2884983|P8|Treatment Period|Lost to Follow-up|0
875193|NCT01359644|2884984|P7|Treatment Period|Lost to Follow-up|0
875194|NCT01359644|2884985|P6|Treatment Period|Lost to Follow-up|1
875195|NCT01359644|2884986|P5|Treatment Period|Lost to Follow-up|0
875196|NCT01359644|2884987|P4|Treatment Period|Lost to Follow-up|0
875197|NCT01359644|2884988|P3|Treatment Period|Lost to Follow-up|0
875198|NCT01359644|2884989|P2|Treatment Period|Lost to Follow-up|0
875199|NCT01359644|2884990|P1|Treatment Period|Lost to Follow-up|0
875200|NCT01359644|2884981|P10|Treatment Period|Adverse Event|0
875201|NCT01359644|2884982|P9|Treatment Period|Adverse Event|0
875202|NCT01359644|2884983|P8|Treatment Period|Adverse Event|0
875203|NCT01359644|2884984|P7|Treatment Period|Adverse Event|0
875204|NCT01359644|2884985|P6|Treatment Period|Adverse Event|1
875205|NCT01359644|2884986|P5|Treatment Period|Adverse Event|0
875206|NCT01359644|2884987|P4|Treatment Period|Adverse Event|0
875207|NCT01359644|2884988|P3|Treatment Period|Adverse Event|1
875208|NCT01359644|2884989|P2|Treatment Period|Adverse Event|0
875209|NCT01359644|2884990|P1|Treatment Period|Adverse Event|0
875210|NCT01359644|2884981|P10|Treatment Period|Lack of Efficacy|0
875211|NCT01359644|2884982|P9|Treatment Period|Lack of Efficacy|0
875212|NCT01359644|2884983|P8|Treatment Period|Lack of Efficacy|0
875213|NCT01359644|2884984|P7|Treatment Period|Lack of Efficacy|0
875214|NCT01359644|2884985|P6|Treatment Period|Lack of Efficacy|0
875215|NCT01359644|2884986|P5|Treatment Period|Lack of Efficacy|0
875216|NCT01359644|2884987|P4|Treatment Period|Lack of Efficacy|0
875217|NCT01359644|2884988|P3|Treatment Period|Lack of Efficacy|0
875218|NCT01359644|2884989|P2|Treatment Period|Lack of Efficacy|1
875219|NCT01359644|2884990|P1|Treatment Period|Lack of Efficacy|0
875220|NCT01359449|2885034|P2|Overall Study|Withdrawal by Subject|2
875221|NCT01359449|2885035|P1|Overall Study|Withdrawal by Subject|3
875222|NCT01359449|2885034|P2|Overall Study|Protocol Violation|2
875223|NCT01359449|2885035|P1|Overall Study|Protocol Violation|0
875224|NCT01359449|2885034|P2|Overall Study|Lost to Follow-up|0
875225|NCT01359449|2885035|P1|Overall Study|Lost to Follow-up|1
875226|NCT01359254|2885081|P2|Overall Study|Death|0
875227|NCT01359254|2885082|P1|Overall Study|Death|1
875228|NCT01359150|2885092|P2|Overall Study|Other|0
875229|NCT01359150|2885093|P1|Overall Study|Other|1
875230|NCT01359150|2885092|P2|Overall Study|Adverse Event|3
875231|NCT01359150|2885093|P1|Overall Study|Adverse Event|4
875232|NCT01359150|2885092|P2|Overall Study|Withdrawal by Subject|1
875233|NCT01359150|2885093|P1|Overall Study|Withdrawal by Subject|1
875234|NCT01359150|2885092|P2|Overall Study|Lack of Efficacy|1
875235|NCT01359150|2885093|P1|Overall Study|Lack of Efficacy|1
875236|NCT01358968|2885130|P4|Continued Access Phase|Death|1
875237|NCT01358968|2885131|P3|Continued Access Phase|Death|1
875238|NCT01358968|2885132|P2|Continued Access Phase|Death|0
875239|NCT01358968|2885133|P1|Continued Access Phase|Death|0
875240|NCT01358968|2885130|P4|Continued Access Phase|Withdrawal by Subject|0
875241|NCT01358968|2885131|P3|Continued Access Phase|Withdrawal by Subject|3
875242|NCT01358968|2885132|P2|Continued Access Phase|Withdrawal by Subject|0
875243|NCT01358968|2885133|P1|Continued Access Phase|Withdrawal by Subject|0
875244|NCT01358968|2885130|P4|Continued Access Phase|Protocol Violation|2
875245|NCT01358968|2885131|P3|Continued Access Phase|Protocol Violation|0
875246|NCT01358968|2885132|P2|Continued Access Phase|Protocol Violation|0
875247|NCT01358968|2885133|P1|Continued Access Phase|Protocol Violation|0
875248|NCT01358968|2885130|P4|Continued Access Phase|Progression of Disease|4
875249|NCT01358968|2885131|P3|Continued Access Phase|Progression of Disease|8
875250|NCT01358968|2885132|P2|Continued Access Phase|Progression of Disease|0
875251|NCT01358968|2885133|P1|Continued Access Phase|Progression of Disease|0
875252|NCT01358968|2885130|P4|Period 2|Adverse Event|0
875253|NCT01358968|2885131|P3|Period 2|Adverse Event|0
875254|NCT01358968|2885132|P2|Period 2|Adverse Event|1
875255|NCT01358968|2885133|P1|Period 2|Adverse Event|0
875256|NCT01358877|2885149|P2|Overall Study|Other|129
875257|NCT01358877|2885150|P1|Overall Study|Other|142
875258|NCT01358877|2885149|P2|Overall Study|Ongoing follow-up for overall survival|5
875259|NCT01358877|2885150|P1|Overall Study|Ongoing follow-up for overall survival|7
875260|NCT01358877|2885149|P2|Overall Study|Ongoing follow-up for IDFS event|2073
875261|NCT01358877|2885150|P1|Overall Study|Ongoing follow-up for IDFS event|2084
875262|NCT01358877|2885149|P2|Overall Study|Ongoing follow-up for post-recurrence|108
875263|NCT01358877|2885150|P1|Overall Study|Ongoing follow-up for post-recurrence|87
875264|NCT01358877|2885149|P2|Overall Study|Death|89
875265|NCT01358877|2885150|P1|Overall Study|Death|80
875266|NCT01358864|2885220|P8|Overall Study|Not treated|0
875267|NCT01358864|2885221|P7|Overall Study|Not treated|1
875268|NCT01358864|2885222|P6|Overall Study|Not treated|0
875269|NCT01358864|2885223|P5|Overall Study|Not treated|0
875270|NCT01358864|2885224|P4|Overall Study|Not treated|0
875271|NCT01358864|2885225|P3|Overall Study|Not treated|0
875272|NCT01358864|2885226|P2|Overall Study|Not treated|0
875273|NCT01358864|2885227|P1|Overall Study|Not treated|0
875274|NCT01358864|2885220|P8|Overall Study|Other reason not defined above|0
875275|NCT01358864|2885221|P7|Overall Study|Other reason not defined above|2
875276|NCT01358864|2885222|P6|Overall Study|Other reason not defined above|0
875277|NCT01358864|2885223|P5|Overall Study|Other reason not defined above|0
875278|NCT01358864|2885224|P4|Overall Study|Other reason not defined above|0
875279|NCT01358864|2885225|P3|Overall Study|Other reason not defined above|0
875280|NCT01358864|2885226|P2|Overall Study|Other reason not defined above|0
875281|NCT01358864|2885227|P1|Overall Study|Other reason not defined above|2
875282|NCT01358864|2885220|P8|Overall Study|Withdrawal by Subject|3
875283|NCT01358864|2885221|P7|Overall Study|Withdrawal by Subject|1
875284|NCT01358864|2885222|P6|Overall Study|Withdrawal by Subject|1
875285|NCT01358864|2885223|P5|Overall Study|Withdrawal by Subject|0
875286|NCT01358864|2885224|P4|Overall Study|Withdrawal by Subject|0
875287|NCT01358864|2885225|P3|Overall Study|Withdrawal by Subject|2
875288|NCT01358864|2885226|P2|Overall Study|Withdrawal by Subject|4
875289|NCT01358864|2885227|P1|Overall Study|Withdrawal by Subject|3
875290|NCT01358864|2885220|P8|Overall Study|Lost to Follow-up|1
875291|NCT01358864|2885221|P7|Overall Study|Lost to Follow-up|0
875292|NCT01358864|2885222|P6|Overall Study|Lost to Follow-up|0
875293|NCT01358864|2885223|P5|Overall Study|Lost to Follow-up|0
875294|NCT01358864|2885224|P4|Overall Study|Lost to Follow-up|0
875295|NCT01358864|2885225|P3|Overall Study|Lost to Follow-up|1
875296|NCT01358864|2885226|P2|Overall Study|Lost to Follow-up|0
875297|NCT01358864|2885227|P1|Overall Study|Lost to Follow-up|0
875298|NCT01358864|2885220|P8|Overall Study|Lack of Efficacy|44
875299|NCT01358864|2885221|P7|Overall Study|Lack of Efficacy|49
875300|NCT01358864|2885222|P6|Overall Study|Lack of Efficacy|4
875301|NCT01358864|2885223|P5|Overall Study|Lack of Efficacy|7
875302|NCT01358864|2885224|P4|Overall Study|Lack of Efficacy|19
875303|NCT01358864|2885225|P3|Overall Study|Lack of Efficacy|4
875304|NCT01358864|2885226|P2|Overall Study|Lack of Efficacy|3
875305|NCT01358864|2885227|P1|Overall Study|Lack of Efficacy|26
875306|NCT01358864|2885220|P8|Overall Study|Adverse Event|7
875307|NCT01358864|2885221|P7|Overall Study|Adverse Event|12
875308|NCT01358864|2885222|P6|Overall Study|Adverse Event|8
875309|NCT01358864|2885223|P5|Overall Study|Adverse Event|4
875310|NCT01358864|2885224|P4|Overall Study|Adverse Event|0
875311|NCT01358864|2885225|P3|Overall Study|Adverse Event|9
875312|NCT01358864|2885226|P2|Overall Study|Adverse Event|6
875313|NCT01358864|2885227|P1|Overall Study|Adverse Event|0
875314|NCT01358825|2885318|P2|Overall Study|Blood sample not drawn|1
875315|NCT01358825|2885319|P1|Overall Study|Blood sample not drawn|0
875316|NCT01358760|2885343|P3|Overall Study|Entry criteria not met/Non-compliance|16
875317|NCT01358760|2885344|P2|Overall Study|Entry criteria not met/Non-compliance|12
875318|NCT01358760|2885345|P1|Overall Study|Entry criteria not met/Non-compliance|12
875319|NCT01358760|2885343|P3|Overall Study|Physician Decision|1
875320|NCT01358760|2885344|P2|Overall Study|Physician Decision|0
875321|NCT01358760|2885345|P1|Overall Study|Physician Decision|1
875322|NCT01358760|2885343|P3|Overall Study|Withdrawal by Subject|2
875323|NCT01358760|2885344|P2|Overall Study|Withdrawal by Subject|3
875324|NCT01358760|2885345|P1|Overall Study|Withdrawal by Subject|5
875325|NCT01358760|2885343|P3|Overall Study|Lost to Follow-up|3
875326|NCT01358760|2885344|P2|Overall Study|Lost to Follow-up|1
875327|NCT01358760|2885345|P1|Overall Study|Lost to Follow-up|1
875328|NCT01358760|2885343|P3|Overall Study|Adverse Event|3
875329|NCT01358760|2885344|P2|Overall Study|Adverse Event|4
875330|NCT01358760|2885345|P1|Overall Study|Adverse Event|3
875331|NCT01358734|2885380|P3|Overall Study|Not Specified|4
875332|NCT01358734|2885381|P2|Overall Study|Not Specified|5
875333|NCT01358734|2885382|P1|Overall Study|Not Specified|2
875334|NCT01358734|2885380|P3|Overall Study|Non-compliance with study drug|1
875335|NCT01358734|2885381|P2|Overall Study|Non-compliance with study drug|0
875336|NCT01358734|2885382|P1|Overall Study|Non-compliance with study drug|0
875337|NCT01358734|2885380|P3|Overall Study|Progressive Disease|13
875338|NCT01358734|2885381|P2|Overall Study|Progressive Disease|11
875339|NCT01358734|2885382|P1|Overall Study|Progressive Disease|5
875340|NCT01358734|2885380|P3|Overall Study|Death|2
875341|NCT01358734|2885381|P2|Overall Study|Death|7
875342|NCT01358734|2885382|P1|Overall Study|Death|3
875343|NCT01358734|2885380|P3|Overall Study|Withdrawal by Subject|3
875344|NCT01358734|2885381|P2|Overall Study|Withdrawal by Subject|6
875345|NCT01358734|2885382|P1|Overall Study|Withdrawal by Subject|1
875346|NCT01358734|2885380|P3|Overall Study|Lack of Efficacy|3
875347|NCT01358734|2885381|P2|Overall Study|Lack of Efficacy|1
875348|NCT01358734|2885382|P1|Overall Study|Lack of Efficacy|0
875349|NCT01358734|2885380|P3|Overall Study|Adverse Event|3
875350|NCT01358734|2885381|P2|Overall Study|Adverse Event|7
875351|NCT01358734|2885382|P1|Overall Study|Adverse Event|4
875352|NCT01358708|2885401|P2|Double-Blind Treatment Phase|Protocol Violation|0
875353|NCT01358708|2885402|P1|Double-Blind Treatment Phase|Protocol Violation|1
875354|NCT01358708|2885401|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
875355|NCT01358708|2885402|P1|Double-Blind Treatment Phase|Lost to Follow-up|2
875356|NCT01358578|2885425|P6|Follow-up Period|Physician Decision|0
875357|NCT01358578|2885426|P5|Follow-up Period|Physician Decision|0
875358|NCT01358578|2885427|P4|Follow-up Period|Physician Decision|2
875359|NCT01358578|2885428|P3|Follow-up Period|Physician Decision|0
875360|NCT01358578|2885429|P2|Follow-up Period|Physician Decision|1
875361|NCT01358578|2885430|P1|Follow-up Period|Physician Decision|1
875362|NCT01358578|2885425|P6|Follow-up Period|Withdrawal by Subject|0
875363|NCT01358578|2885426|P5|Follow-up Period|Withdrawal by Subject|0
875364|NCT01358578|2885427|P4|Follow-up Period|Withdrawal by Subject|12
875365|NCT01358578|2885428|P3|Follow-up Period|Withdrawal by Subject|1
875366|NCT01358578|2885429|P2|Follow-up Period|Withdrawal by Subject|3
875367|NCT01358578|2885430|P1|Follow-up Period|Withdrawal by Subject|3
875368|NCT01358578|2885425|P6|Follow-up Period|Pregnancy|0
875369|NCT01358578|2885426|P5|Follow-up Period|Pregnancy|0
875370|NCT01358578|2885427|P4|Follow-up Period|Pregnancy|0
875371|NCT01358578|2885428|P3|Follow-up Period|Pregnancy|0
875372|NCT01358578|2885429|P2|Follow-up Period|Pregnancy|0
875373|NCT01358578|2885430|P1|Follow-up Period|Pregnancy|1
875374|NCT01358578|2885425|P6|Follow-up Period|non- compliance with study treatment|0
875375|NCT01358578|2885426|P5|Follow-up Period|non- compliance with study treatment|0
875376|NCT01358578|2885427|P4|Follow-up Period|non- compliance with study treatment|0
875377|NCT01358578|2885428|P3|Follow-up Period|non- compliance with study treatment|0
875378|NCT01358578|2885429|P2|Follow-up Period|non- compliance with study treatment|0
875379|NCT01358578|2885430|P1|Follow-up Period|non- compliance with study treatment|1
875380|NCT01358578|2885425|P6|Follow-up Period|Lost to Follow-up|0
875381|NCT01358578|2885426|P5|Follow-up Period|Lost to Follow-up|0
875382|NCT01358578|2885427|P4|Follow-up Period|Lost to Follow-up|4
875383|NCT01358578|2885428|P3|Follow-up Period|Lost to Follow-up|0
875384|NCT01358578|2885429|P2|Follow-up Period|Lost to Follow-up|1
875385|NCT01358578|2885430|P1|Follow-up Period|Lost to Follow-up|0
875386|NCT01358578|2885425|P6|Follow-up Period|Lack of Efficacy|0
875387|NCT01358578|2885426|P5|Follow-up Period|Lack of Efficacy|0
875388|NCT01358578|2885427|P4|Follow-up Period|Lack of Efficacy|1
875389|NCT01358578|2885428|P3|Follow-up Period|Lack of Efficacy|4
875390|NCT01358578|2885429|P2|Follow-up Period|Lack of Efficacy|0
875391|NCT01358578|2885430|P1|Follow-up Period|Lack of Efficacy|3
875392|NCT01358578|2885425|P6|Follow-up Period|Adverse Event|0
875393|NCT01358578|2885426|P5|Follow-up Period|Adverse Event|0
875394|NCT01358578|2885427|P4|Follow-up Period|Adverse Event|0
875395|NCT01358578|2885428|P3|Follow-up Period|Adverse Event|0
875396|NCT01358578|2885429|P2|Follow-up Period|Adverse Event|1
875397|NCT01358578|2885430|P1|Follow-up Period|Adverse Event|1
875398|NCT01358578|2885425|P6|Maintenance Period|Withdrawal by Subject|3
875399|NCT01358578|2885426|P5|Maintenance Period|Withdrawal by Subject|6
875400|NCT01358578|2885427|P4|Maintenance Period|Withdrawal by Subject|15
875401|NCT01358578|2885428|P3|Maintenance Period|Withdrawal by Subject|2
875402|NCT01358578|2885429|P2|Maintenance Period|Withdrawal by Subject|7
875403|NCT01358578|2885430|P1|Maintenance Period|Withdrawal by Subject|12
875404|NCT01358578|2885425|P6|Maintenance Period|Protocol deviation|2
875405|NCT01358578|2885426|P5|Maintenance Period|Protocol deviation|2
875406|NCT01358578|2885427|P4|Maintenance Period|Protocol deviation|2
875407|NCT01358578|2885428|P3|Maintenance Period|Protocol deviation|0
875408|NCT01358578|2885429|P2|Maintenance Period|Protocol deviation|4
875409|NCT01358578|2885430|P1|Maintenance Period|Protocol deviation|7
875410|NCT01358578|2885425|P6|Maintenance Period|Pregnancy|0
875411|NCT01358578|2885426|P5|Maintenance Period|Pregnancy|0
875412|NCT01358578|2885427|P4|Maintenance Period|Pregnancy|0
875413|NCT01358578|2885428|P3|Maintenance Period|Pregnancy|0
875414|NCT01358578|2885429|P2|Maintenance Period|Pregnancy|0
875415|NCT01358578|2885430|P1|Maintenance Period|Pregnancy|1
875416|NCT01358578|2885425|P6|Maintenance Period|Physician Decision|0
875417|NCT01358578|2885426|P5|Maintenance Period|Physician Decision|0
875418|NCT01358578|2885427|P4|Maintenance Period|Physician Decision|1
875419|NCT01358578|2885428|P3|Maintenance Period|Physician Decision|0
875420|NCT01358578|2885429|P2|Maintenance Period|Physician Decision|1
875421|NCT01358578|2885430|P1|Maintenance Period|Physician Decision|0
875422|NCT01358578|2885425|P6|Maintenance Period|Non-compliance with study treatment|2
875423|NCT01358578|2885426|P5|Maintenance Period|Non-compliance with study treatment|1
875424|NCT01358578|2885427|P4|Maintenance Period|Non-compliance with study treatment|2
875425|NCT01358578|2885428|P3|Maintenance Period|Non-compliance with study treatment|0
875426|NCT01358578|2885429|P2|Maintenance Period|Non-compliance with study treatment|1
875427|NCT01358578|2885430|P1|Maintenance Period|Non-compliance with study treatment|3
875428|NCT01358578|2885425|P6|Maintenance Period|Lost to Follow-up|1
875429|NCT01358578|2885426|P5|Maintenance Period|Lost to Follow-up|1
875430|NCT01358578|2885427|P4|Maintenance Period|Lost to Follow-up|5
875431|NCT01358578|2885428|P3|Maintenance Period|Lost to Follow-up|0
875432|NCT01358578|2885429|P2|Maintenance Period|Lost to Follow-up|0
875433|NCT01358578|2885430|P1|Maintenance Period|Lost to Follow-up|4
875434|NCT01358578|2885425|P6|Maintenance Period|Lack of Efficacy|0
875435|NCT01358578|2885426|P5|Maintenance Period|Lack of Efficacy|3
875436|NCT01358578|2885427|P4|Maintenance Period|Lack of Efficacy|11
875437|NCT01358578|2885428|P3|Maintenance Period|Lack of Efficacy|0
875438|NCT01358578|2885429|P2|Maintenance Period|Lack of Efficacy|2
875439|NCT01358578|2885430|P1|Maintenance Period|Lack of Efficacy|10
875440|NCT01358578|2885425|P6|Maintenance Period|Adverse Event|3
875441|NCT01358578|2885426|P5|Maintenance Period|Adverse Event|4
875442|NCT01358578|2885427|P4|Maintenance Period|Adverse Event|6
875443|NCT01358578|2885428|P3|Maintenance Period|Adverse Event|0
875444|NCT01358578|2885429|P2|Maintenance Period|Adverse Event|7
875445|NCT01358578|2885430|P1|Maintenance Period|Adverse Event|2
875446|NCT01358578|2885425|P6|Induction Period|Withdrawal by Subject|0
875447|NCT01358578|2885426|P5|Induction Period|Withdrawal by Subject|0
875448|NCT01358578|2885427|P4|Induction Period|Withdrawal by Subject|6
875449|NCT01358578|2885428|P3|Induction Period|Withdrawal by Subject|10
875450|NCT01358578|2885429|P2|Induction Period|Withdrawal by Subject|5
875451|NCT01358578|2885430|P1|Induction Period|Withdrawal by Subject|5
875452|NCT01358578|2885425|P6|Induction Period|technical problems|0
875453|NCT01358578|2885426|P5|Induction Period|technical problems|0
875454|NCT01358578|2885427|P4|Induction Period|technical problems|1
875455|NCT01358578|2885428|P3|Induction Period|technical problems|1
875456|NCT01358578|2885429|P2|Induction Period|technical problems|0
875457|NCT01358578|2885430|P1|Induction Period|technical problems|0
875458|NCT01358578|2885425|P6|Induction Period|Protocol Deviation|0
875459|NCT01358578|2885426|P5|Induction Period|Protocol Deviation|0
875460|NCT01358578|2885427|P4|Induction Period|Protocol Deviation|3
875461|NCT01358578|2885428|P3|Induction Period|Protocol Deviation|0
875462|NCT01358578|2885429|P2|Induction Period|Protocol Deviation|5
875463|NCT01358578|2885430|P1|Induction Period|Protocol Deviation|3
875464|NCT01358578|2885425|P6|Induction Period|Physician Decision|0
875465|NCT01358578|2885426|P5|Induction Period|Physician Decision|0
875466|NCT01358578|2885427|P4|Induction Period|Physician Decision|0
875467|NCT01358578|2885428|P3|Induction Period|Physician Decision|2
875468|NCT01358578|2885429|P2|Induction Period|Physician Decision|1
875469|NCT01358578|2885430|P1|Induction Period|Physician Decision|2
875470|NCT01358578|2885425|P6|Induction Period|Lost to Follow-up|0
875471|NCT01358578|2885426|P5|Induction Period|Lost to Follow-up|0
875472|NCT01358578|2885427|P4|Induction Period|Lost to Follow-up|4
875473|NCT01358578|2885428|P3|Induction Period|Lost to Follow-up|1
875474|NCT01358578|2885429|P2|Induction Period|Lost to Follow-up|0
875475|NCT01358578|2885430|P1|Induction Period|Lost to Follow-up|0
875476|NCT01358578|2885425|P6|Induction Period|Lack of Efficacy|0
875477|NCT01358578|2885426|P5|Induction Period|Lack of Efficacy|0
875478|NCT01358578|2885427|P4|Induction Period|Lack of Efficacy|1
875479|NCT01358578|2885428|P3|Induction Period|Lack of Efficacy|9
875480|NCT01358578|2885429|P2|Induction Period|Lack of Efficacy|0
875481|NCT01358578|2885430|P1|Induction Period|Lack of Efficacy|0
875482|NCT01358578|2885425|P6|Induction Period|Adverse Event|0
875483|NCT01358578|2885426|P5|Induction Period|Adverse Event|0
875484|NCT01358578|2885427|P4|Induction Period|Adverse Event|6
875485|NCT01358578|2885428|P3|Induction Period|Adverse Event|2
875486|NCT01358578|2885429|P2|Induction Period|Adverse Event|4
875487|NCT01358578|2885430|P1|Induction Period|Adverse Event|2
875488|NCT01358526|2885482|P3|Double-blind Phase|Administrative|10
875489|NCT01358526|2885483|P2|Double-blind Phase|Administrative|6
875490|NCT01358526|2885484|P1|Double-blind Phase|Administrative|0
875491|NCT01358526|2885482|P3|Double-blind Phase|Confirmed or suspected diversion|6
875492|NCT01358526|2885483|P2|Double-blind Phase|Confirmed or suspected diversion|5
875493|NCT01358526|2885484|P1|Double-blind Phase|Confirmed or suspected diversion|0
875494|NCT01358526|2885482|P3|Double-blind Phase|Lack of Efficacy|73
875495|NCT01358526|2885483|P2|Double-blind Phase|Lack of Efficacy|31
875496|NCT01358526|2885484|P1|Double-blind Phase|Lack of Efficacy|0
875497|NCT01358526|2885482|P3|Double-blind Phase|Lost to Follow-up|1
875498|NCT01358526|2885483|P2|Double-blind Phase|Lost to Follow-up|4
875499|NCT01358526|2885484|P1|Double-blind Phase|Lost to Follow-up|0
875500|NCT01358526|2885482|P3|Double-blind Phase|Withdrawal by Subject|8
875501|NCT01358526|2885483|P2|Double-blind Phase|Withdrawal by Subject|10
875502|NCT01358526|2885484|P1|Double-blind Phase|Withdrawal by Subject|0
875503|NCT01358526|2885482|P3|Double-blind Phase|Adverse Event|23
875504|NCT01358526|2885483|P2|Double-blind Phase|Adverse Event|24
875505|NCT01358526|2885484|P1|Double-blind Phase|Adverse Event|0
875506|NCT01358526|2885482|P3|Open-label Titration Period|Did not qualify|0
875507|NCT01358526|2885483|P2|Open-label Titration Period|Did not qualify|0
875508|NCT01358526|2885484|P1|Open-label Titration Period|Did not qualify|178
875509|NCT01358526|2885482|P3|Open-label Titration Period|Administrative|0
875510|NCT01358526|2885483|P2|Open-label Titration Period|Administrative|0
875511|NCT01358526|2885484|P1|Open-label Titration Period|Administrative|8
875512|NCT01358526|2885482|P3|Open-label Titration Period|Confirmed or suspected diversion|0
875513|NCT01358526|2885483|P2|Open-label Titration Period|Confirmed or suspected diversion|0
875514|NCT01358526|2885484|P1|Open-label Titration Period|Confirmed or suspected diversion|16
875515|NCT01358526|2885482|P3|Open-label Titration Period|Lack of Efficacy|0
875516|NCT01358526|2885483|P2|Open-label Titration Period|Lack of Efficacy|0
875517|NCT01358526|2885484|P1|Open-label Titration Period|Lack of Efficacy|107
875518|NCT01358526|2885482|P3|Open-label Titration Period|Lost to Follow-up|0
875519|NCT01358526|2885483|P2|Open-label Titration Period|Lost to Follow-up|0
875520|NCT01358526|2885484|P1|Open-label Titration Period|Lost to Follow-up|25
875521|NCT01358526|2885482|P3|Open-label Titration Period|Withdrawal by Subject|0
875522|NCT01358526|2885483|P2|Open-label Titration Period|Withdrawal by Subject|0
875523|NCT01358526|2885484|P1|Open-label Titration Period|Withdrawal by Subject|65
875524|NCT01358526|2885482|P3|Open-label Titration Period|Adverse Event|0
875525|NCT01358526|2885483|P2|Open-label Titration Period|Adverse Event|0
875526|NCT01358526|2885484|P1|Open-label Titration Period|Adverse Event|95
875527|NCT01358357|2885501|P3|Double-Blind Phase|Administrative|0
875528|NCT01358357|2885502|P2|Double-Blind Phase|Administrative|1
875529|NCT01358357|2885503|P1|Double-Blind Phase|Administrative|0
875530|NCT01358357|2885501|P3|Double-Blind Phase|Recurrence of mood event|0
875531|NCT01358357|2885502|P2|Double-Blind Phase|Recurrence of mood event|64
875532|NCT01358357|2885503|P1|Double-Blind Phase|Recurrence of mood event|48
875533|NCT01358357|2885501|P3|Double-Blind Phase|Terminated at study completion|0
875534|NCT01358357|2885502|P2|Double-Blind Phase|Terminated at study completion|0
875535|NCT01358357|2885503|P1|Double-Blind Phase|Terminated at study completion|2
875536|NCT01358357|2885501|P3|Double-Blind Phase|Protocol Violation|0
875537|NCT01358357|2885502|P2|Double-Blind Phase|Protocol Violation|12
875538|NCT01358357|2885503|P1|Double-Blind Phase|Protocol Violation|16
875539|NCT01358357|2885501|P3|Double-Blind Phase|Protocol Violation|0
875540|NCT01358357|2885502|P2|Double-Blind Phase|Protocol Violation|11
875541|NCT01358357|2885503|P1|Double-Blind Phase|Protocol Violation|1
875542|NCT01358357|2885501|P3|Double-Blind Phase|Lost to Follow-up|0
875543|NCT01358357|2885502|P2|Double-Blind Phase|Lost to Follow-up|7
875544|NCT01358357|2885503|P1|Double-Blind Phase|Lost to Follow-up|5
875545|NCT01358357|2885501|P3|Double-Blind Phase|Adverse Event|0
875546|NCT01358357|2885502|P2|Double-Blind Phase|Adverse Event|5
875547|NCT01358357|2885503|P1|Double-Blind Phase|Adverse Event|8
875548|NCT01358357|2885501|P3|Open Label Phase|Mood episode|42
875549|NCT01358357|2885502|P2|Open Label Phase|Mood episode|0
875550|NCT01358357|2885503|P1|Open Label Phase|Mood episode|0
875551|NCT01358357|2885501|P3|Open Label Phase|Terminated at study completion|5
875552|NCT01358357|2885502|P2|Open Label Phase|Terminated at study completion|0
875553|NCT01358357|2885503|P1|Open Label Phase|Terminated at study completion|0
875554|NCT01358357|2885501|P3|Open Label Phase|Did not meet criteria for DB phase|16
875555|NCT01358357|2885502|P2|Open Label Phase|Did not meet criteria for DB phase|0
875556|NCT01358357|2885503|P1|Open Label Phase|Did not meet criteria for DB phase|0
875557|NCT01358357|2885501|P3|Open Label Phase|Withdrawal by Subject|112
875558|NCT01358357|2885502|P2|Open Label Phase|Withdrawal by Subject|0
875559|NCT01358357|2885503|P1|Open Label Phase|Withdrawal by Subject|0
875560|NCT01358357|2885501|P3|Open Label Phase|Protocol Violation|45
875561|NCT01358357|2885502|P2|Open Label Phase|Protocol Violation|0
875562|NCT01358357|2885503|P1|Open Label Phase|Protocol Violation|0
875563|NCT01358357|2885501|P3|Open Label Phase|Lost to Follow-up|76
875564|NCT01358357|2885502|P2|Open Label Phase|Lost to Follow-up|0
875565|NCT01358357|2885503|P1|Open Label Phase|Lost to Follow-up|0
875566|NCT01358357|2885501|P3|Open Label Phase|Lack of Efficacy|107
875567|NCT01358357|2885502|P2|Open Label Phase|Lack of Efficacy|0
875568|NCT01358357|2885503|P1|Open Label Phase|Lack of Efficacy|0
875569|NCT01358357|2885501|P3|Open Label Phase|Adverse Event|59
875570|NCT01358357|2885502|P2|Open Label Phase|Adverse Event|0
875571|NCT01358357|2885503|P1|Open Label Phase|Adverse Event|0
875572|NCT01358175|2885539|P3|Overall Study|Adverse Event|11
875573|NCT01358175|2885540|P2|Overall Study|Adverse Event|11
875574|NCT01358175|2885541|P1|Overall Study|Adverse Event|6
875575|NCT01358175|2885539|P3|Overall Study|Lack of Efficacy|6
875576|NCT01358175|2885540|P2|Overall Study|Lack of Efficacy|8
875577|NCT01358175|2885541|P1|Overall Study|Lack of Efficacy|3
875578|NCT01358175|2885539|P3|Overall Study|Lost to Follow-up|3
875579|NCT01358175|2885540|P2|Overall Study|Lost to Follow-up|1
875580|NCT01358175|2885541|P1|Overall Study|Lost to Follow-up|1
875581|NCT01358175|2885539|P3|Overall Study|Non Compliance with Study Treatment|1
875582|NCT01358175|2885540|P2|Overall Study|Non Compliance with Study Treatment|1
875583|NCT01358175|2885541|P1|Overall Study|Non Compliance with Study Treatment|0
875584|NCT01358175|2885539|P3|Overall Study|Physician Decision|0
875585|NCT01358175|2885540|P2|Overall Study|Physician Decision|0
875586|NCT01358175|2885541|P1|Overall Study|Physician Decision|1
875587|NCT01358175|2885539|P3|Overall Study|Pregnancy|0
875588|NCT01358175|2885540|P2|Overall Study|Pregnancy|1
875589|NCT01358175|2885541|P1|Overall Study|Pregnancy|0
875590|NCT01358175|2885539|P3|Overall Study|Technical issues|0
875591|NCT01358175|2885540|P2|Overall Study|Technical issues|1
875592|NCT01358175|2885541|P1|Overall Study|Technical issues|0
875593|NCT01358175|2885539|P3|Overall Study|Withdrawal by Subject|10
875594|NCT01358175|2885540|P2|Overall Study|Withdrawal by Subject|5
875595|NCT01358175|2885541|P1|Overall Study|Withdrawal by Subject|9
875596|NCT01358175|2885539|P3|Overall Study|Death|1
875597|NCT01358175|2885540|P2|Overall Study|Death|0
875598|NCT01358175|2885541|P1|Overall Study|Death|1
875599|NCT01357980|2885578|P4|Overall Study|Consent withdrawn|0
875600|NCT01357980|2885579|P3|Overall Study|Consent withdrawn|1
875601|NCT01357980|2885580|P2|Overall Study|Consent withdrawn|0
875602|NCT01357980|2885581|P1|Overall Study|Consent withdrawn|0
875603|NCT01357980|2885578|P4|Overall Study|Lack of Efficacy|0
875604|NCT01357980|2885579|P3|Overall Study|Lack of Efficacy|0
875605|NCT01357980|2885580|P2|Overall Study|Lack of Efficacy|1
875606|NCT01357980|2885581|P1|Overall Study|Lack of Efficacy|0
875607|NCT01357915|2885625|P2|Overall Study|Lost to Follow-up|0
875608|NCT01357915|2885626|P1|Overall Study|Lost to Follow-up|3
875609|NCT01357889|2885641|P2|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0
875610|NCT01357889|2885642|P1|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1
875611|NCT01357889|2885641|P2|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0
875612|NCT01357889|2885642|P1|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1
875613|NCT01357889|2885641|P2|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4
875614|NCT01357889|2885642|P1|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0
875615|NCT01357889|2885641|P2|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0
875616|NCT01357889|2885642|P1|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1
875617|NCT01357889|2885641|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
875618|NCT01357889|2885642|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
875619|NCT01357889|2885641|P2|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1
875620|NCT01357889|2885642|P1|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2
875621|NCT01357889|2885641|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2
875622|NCT01357889|2885642|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5
875623|NCT01357889|2885641|P2|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2
875624|NCT01357889|2885642|P1|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0
875625|NCT01357889|2885641|P2|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2
875626|NCT01357889|2885642|P1|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0
875627|NCT01357889|2885641|P2|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
875628|NCT01357889|2885642|P1|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
875629|NCT01357889|2885641|P2|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0
875630|NCT01357889|2885642|P1|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1
875631|NCT01357889|2885641|P2|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
875632|NCT01357889|2885642|P1|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
875633|NCT01357889|2885641|P2|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1
875634|NCT01357889|2885642|P1|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2
875635|NCT01357850|2885686|P4|Overall Study|Lost to Follow-up|0
875636|NCT01357850|2885687|P3|Overall Study|Lost to Follow-up|0
875637|NCT01357850|2885688|P2|Overall Study|Lost to Follow-up|0
875638|NCT01357850|2885689|P1|Overall Study|Lost to Follow-up|1
875639|NCT01357655|2885780|P2|Overall Study|Subject Withdrew Consent|0
875640|NCT01357655|2885781|P1|Overall Study|Subject Withdrew Consent|1
875641|NCT01357655|2885780|P2|Overall Study|Study Drug Toxicity|0
875642|NCT01357655|2885781|P1|Overall Study|Study Drug Toxicity|11
875643|NCT01357655|2885780|P2|Overall Study|Reason Unspecified|0
875644|NCT01357655|2885781|P1|Overall Study|Reason Unspecified|1
875645|NCT01357655|2885780|P2|Overall Study|Maximum Clinical Benefit|0
875646|NCT01357655|2885781|P1|Overall Study|Maximum Clinical Benefit|2
875647|NCT01357655|2885780|P2|Overall Study|Lost to Follow-up|0
875648|NCT01357655|2885781|P1|Overall Study|Lost to Follow-up|2
875649|NCT01357655|2885780|P2|Overall Study|Disease Progression|0
875650|NCT01357655|2885781|P1|Overall Study|Disease Progression|1
875651|NCT01357655|2885780|P2|Overall Study|Adverse Event Unrelated to Study Drug|0
875652|NCT01357655|2885781|P1|Overall Study|Adverse Event Unrelated to Study Drug|3
875653|NCT01357655|2885780|P2|Overall Study|Administrative Reason by Sponsor|0
875654|NCT01357655|2885781|P1|Overall Study|Administrative Reason by Sponsor|45
875655|NCT01357616|2885798|P2|Overall Study|Withdrawal by Subject|0
875656|NCT01357616|2885799|P1|Overall Study|Withdrawal by Subject|1
875657|NCT01357616|2885798|P2|Overall Study|Decision Unrelated to Adverse Event|1
875658|NCT01357616|2885799|P1|Overall Study|Decision Unrelated to Adverse Event|3
875659|NCT01357616|2885798|P2|Overall Study|Inadequate Control of IOP|2
875660|NCT01357616|2885799|P1|Overall Study|Inadequate Control of IOP|1
875661|NCT01357616|2885798|P2|Overall Study|Protocol Violation|2
875662|NCT01357616|2885799|P1|Overall Study|Protocol Violation|0
875663|NCT01357616|2885798|P2|Overall Study|Lost to Follow-up|3
875664|NCT01357616|2885799|P1|Overall Study|Lost to Follow-up|4
875665|NCT01357616|2885798|P2|Overall Study|Adverse Event|1
875666|NCT01357616|2885799|P1|Overall Study|Adverse Event|1
875667|NCT01357551|2885813|P2|Overall Study|Lost to Follow-up|6
875668|NCT01357551|2885814|P1|Overall Study|Lost to Follow-up|16
875669|NCT01357551|2885813|P2|Overall Study|Death|1
875670|NCT01357551|2885814|P1|Overall Study|Death|0
875671|NCT01357551|2885813|P2|Overall Study|Withdrawal by Subject|4
875672|NCT01357551|2885814|P1|Overall Study|Withdrawal by Subject|6
875673|NCT01357239|2885841|P4|Stratum II: Partially-Methylated|Subject withdrew consent|1
875674|NCT01357239|2885842|P3|Stratum II: Partially-Methylated|Subject withdrew consent|1
875675|NCT01357239|2885843|P2|Stratum II: Partially-Methylated|Subject withdrew consent|0
875676|NCT01357239|2885844|P1|Stratum II: Partially-Methylated|Subject withdrew consent|0
875677|NCT01357239|2885841|P4|Stratum II: Partially-Methylated|Adverse Event|1
875678|NCT01357239|2885842|P3|Stratum II: Partially-Methylated|Adverse Event|0
875679|NCT01357239|2885843|P2|Stratum II: Partially-Methylated|Adverse Event|0
875680|NCT01357239|2885844|P1|Stratum II: Partially-Methylated|Adverse Event|0
875681|NCT01357239|2885841|P4|Stratum I: Fully-Methylated|Adverse Event|0
875682|NCT01357239|2885842|P3|Stratum I: Fully-Methylated|Adverse Event|1
875683|NCT01357239|2885843|P2|Stratum I: Fully-Methylated|Adverse Event|0
875684|NCT01357239|2885844|P1|Stratum I: Fully-Methylated|Adverse Event|0
875685|NCT01357239|2885841|P4|Stratum: All Patients|Subject withdrew consent|1
875686|NCT01357239|2885842|P3|Stratum: All Patients|Subject withdrew consent|1
875687|NCT01357239|2885843|P2|Stratum: All Patients|Subject withdrew consent|0
875688|NCT01357239|2885844|P1|Stratum: All Patients|Subject withdrew consent|0
875689|NCT01357239|2885841|P4|Stratum: All Patients|Adverse Event|1
875690|NCT01357239|2885842|P3|Stratum: All Patients|Adverse Event|1
875691|NCT01357239|2885843|P2|Stratum: All Patients|Adverse Event|0
875692|NCT01357239|2885844|P1|Stratum: All Patients|Adverse Event|0
875693|NCT01357161|2885902|P3|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4
875694|NCT01357161|2885903|P2|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5
875695|NCT01357161|2885904|P1|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0
875696|NCT01357161|2885902|P3|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26
875697|NCT01357161|2885903|P2|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29
875698|NCT01357161|2885904|P1|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0
875699|NCT01357161|2885902|P3|Part 2 (Double-Blind Comparison)|Progressive Disease|3
875700|NCT01357161|2885903|P2|Part 2 (Double-Blind Comparison)|Progressive Disease|1
875701|NCT01357161|2885904|P1|Part 2 (Double-Blind Comparison)|Progressive Disease|0
875702|NCT01357161|2885902|P3|Part 2 (Double-Blind Comparison)|Physician Decision|4
875703|NCT01357161|2885903|P2|Part 2 (Double-Blind Comparison)|Physician Decision|1
875704|NCT01357161|2885904|P1|Part 2 (Double-Blind Comparison)|Physician Decision|0
875705|NCT01357161|2885902|P3|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6
875706|NCT01357161|2885903|P2|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1
875707|NCT01357161|2885904|P1|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0
875708|NCT01357161|2885902|P3|Part 2 (Double-Blind Comparison)|Death|19
875709|NCT01357161|2885903|P2|Part 2 (Double-Blind Comparison)|Death|22
875710|NCT01357161|2885904|P1|Part 2 (Double-Blind Comparison)|Death|0
875711|NCT01357161|2885902|P3|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
875712|NCT01357161|2885903|P2|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
875713|NCT01357161|2885904|P1|Part 1 (Open Label Run-in)|Withdrawal by Subject|1
875714|NCT01357161|2885902|P3|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
875715|NCT01357161|2885903|P2|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
875716|NCT01357161|2885904|P1|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5
875717|NCT01357161|2885902|P3|Part 1 (Open Label Run-in)|Physician Decision|0
875718|NCT01357161|2885903|P2|Part 1 (Open Label Run-in)|Physician Decision|0
875719|NCT01357161|2885904|P1|Part 1 (Open Label Run-in)|Physician Decision|1
875720|NCT01357161|2885902|P3|Part 1 (Open Label Run-in)|Lost to Follow-up|0
875721|NCT01357161|2885903|P2|Part 1 (Open Label Run-in)|Lost to Follow-up|0
875722|NCT01357161|2885904|P1|Part 1 (Open Label Run-in)|Lost to Follow-up|3
875723|NCT01357161|2885902|P3|Part 1 (Open Label Run-in)|Death|0
875724|NCT01357161|2885903|P2|Part 1 (Open Label Run-in)|Death|0
875725|NCT01357161|2885904|P1|Part 1 (Open Label Run-in)|Death|5
875726|NCT01356966|2885956|P2|Overall Study|Physician Decision|0
875727|NCT01356966|2885957|P1|Overall Study|Physician Decision|1
875728|NCT01356966|2885956|P2|Overall Study|Withdrawal by Subject|2
875729|NCT01356966|2885957|P1|Overall Study|Withdrawal by Subject|1
875730|NCT01356940|2885969|P2|Second Intervention (28 Days)|Withdrawal by Subject|0
875731|NCT01356940|2885970|P1|Second Intervention (28 Days)|Withdrawal by Subject|1
875732|NCT01356940|2885969|P2|First Intervention (28 Days)|Adverse Event|0
875733|NCT01356940|2885970|P1|First Intervention (28 Days)|Adverse Event|1
875734|NCT01356602|2885999|P3|Overall Study|Adverse Event|1
875735|NCT01356602|2886000|P2|Overall Study|Adverse Event|1
875736|NCT01356602|2886001|P1|Overall Study|Adverse Event|0
875737|NCT01356602|2885999|P3|Overall Study|Lack of Efficacy|4
875738|NCT01356602|2886000|P2|Overall Study|Lack of Efficacy|1
875739|NCT01356602|2886001|P1|Overall Study|Lack of Efficacy|0
875740|NCT01356602|2885999|P3|Overall Study|Withdrawal by Subject|7
875741|NCT01356602|2886000|P2|Overall Study|Withdrawal by Subject|3
875742|NCT01356602|2886001|P1|Overall Study|Withdrawal by Subject|4
875743|NCT01356602|2885999|P3|Overall Study|Lost to Follow-up|6
875744|NCT01356602|2886000|P2|Overall Study|Lost to Follow-up|5
875745|NCT01356602|2886001|P1|Overall Study|Lost to Follow-up|4
875746|NCT01356602|2885999|P3|Overall Study|Administrative Problems|5
875747|NCT01356602|2886000|P2|Overall Study|Administrative Problems|4
875748|NCT01356602|2886001|P1|Overall Study|Administrative Problems|1
875749|NCT01356602|2885999|P3|Overall Study|Protocol Deviation|1
875750|NCT01356602|2886000|P2|Overall Study|Protocol Deviation|1
875751|NCT01356602|2886001|P1|Overall Study|Protocol Deviation|0
875752|NCT01356589|2886060|P1|Overall Study|Dose data not recorded|2
875753|NCT01356589|2886060|P1|Overall Study|Enrolled, but not treated|3
875754|NCT01356407|2886117|P2|Overall Study|Not complete Endoscopy|2
875755|NCT01356407|2886118|P1|Overall Study|Not complete Endoscopy|2
875756|NCT01356407|2886117|P2|Overall Study|Could not afford IMP administration|1
875757|NCT01356407|2886118|P1|Overall Study|Could not afford IMP administration|0
875758|NCT01356407|2886117|P2|Overall Study|Patient Withdrew Consent|1
875759|NCT01356407|2886118|P1|Overall Study|Patient Withdrew Consent|2
875760|NCT01356407|2886117|P2|Overall Study|Lost to Follow-up|0
875761|NCT01356407|2886118|P1|Overall Study|Lost to Follow-up|2
875762|NCT01355679|2886190|P1|Overall Study|benign tumor types found at biopsy|2
875763|NCT01355627|2886199|P2|Overall Study|Other|1
875764|NCT01355627|2886200|P1|Overall Study|Other|1
875765|NCT01355627|2886199|P2|Overall Study|Fatal Adverse Event|23
875766|NCT01355627|2886200|P1|Overall Study|Fatal Adverse Event|19
875767|NCT01355627|2886199|P2|Overall Study|Lost to Follow-up|7
875768|NCT01355627|2886200|P1|Overall Study|Lost to Follow-up|8
875769|NCT01355627|2886199|P2|Overall Study|Request By the Patient to Discontinue|7
875770|NCT01355627|2886200|P1|Overall Study|Request By the Patient to Discontinue|5
875771|NCT01355523|2886239|P2|Overall Study|Adverse Event|2
875772|NCT01355523|2886240|P1|Overall Study|Adverse Event|0
875773|NCT01355523|2886239|P2|Overall Study|Protocol Violation|2
875774|NCT01355523|2886240|P1|Overall Study|Protocol Violation|0
875775|NCT01355523|2886239|P2|Overall Study|Lost to Follow-up|2
875776|NCT01355523|2886240|P1|Overall Study|Lost to Follow-up|0
875777|NCT01355523|2886239|P2|Overall Study|Withdrawal by Subject|4
875778|NCT01355523|2886240|P1|Overall Study|Withdrawal by Subject|1
875779|NCT01355302|2886316|P3|Phase 1b|Study terminated by sponsor|0
875780|NCT01355302|2886317|P2|Phase 1b|Study terminated by sponsor|0
875781|NCT01355302|2886318|P1|Phase 1b|Study terminated by sponsor|2
875782|NCT01355302|2886316|P3|Phase 1b|Death|0
875783|NCT01355302|2886317|P2|Phase 1b|Death|0
875784|NCT01355302|2886318|P1|Phase 1b|Death|4
875785|NCT01355289|2886333|P5|Open Label Extension|Not specified|3
875786|NCT01355289|2886334|P4|Open Label Extension|Not specified|0
875787|NCT01355289|2886335|P3|Open Label Extension|Not specified|0
875788|NCT01355289|2886336|P2|Open Label Extension|Not specified|0
875789|NCT01355289|2886337|P1|Open Label Extension|Not specified|0
875790|NCT01355289|2886333|P5|Open Label Extension|Inadequate Therapeutic Effect|29
875791|NCT01355289|2886334|P4|Open Label Extension|Inadequate Therapeutic Effect|0
875792|NCT01355289|2886335|P3|Open Label Extension|Inadequate Therapeutic Effect|0
875793|NCT01355289|2886336|P2|Open Label Extension|Inadequate Therapeutic Effect|0
875794|NCT01355289|2886337|P1|Open Label Extension|Inadequate Therapeutic Effect|0
875795|NCT01355289|2886333|P5|Open Label Extension|Lost to Follow-up|1
875796|NCT01355289|2886334|P4|Open Label Extension|Lost to Follow-up|0
875797|NCT01355289|2886335|P3|Open Label Extension|Lost to Follow-up|0
875798|NCT01355289|2886336|P2|Open Label Extension|Lost to Follow-up|0
875799|NCT01355289|2886337|P1|Open Label Extension|Lost to Follow-up|0
875800|NCT01355289|2886333|P5|Open Label Extension|Adverse Event, Non-Fatal|1
875801|NCT01355289|2886334|P4|Open Label Extension|Adverse Event, Non-Fatal|0
875802|NCT01355289|2886335|P3|Open Label Extension|Adverse Event, Non-Fatal|0
875803|NCT01355289|2886336|P2|Open Label Extension|Adverse Event, Non-Fatal|0
875804|NCT01355289|2886337|P1|Open Label Extension|Adverse Event, Non-Fatal|0
875805|NCT01355289|2886333|P5|Core Study|Not specified|0
875806|NCT01355289|2886334|P4|Core Study|Not specified|1
875807|NCT01355289|2886335|P3|Core Study|Not specified|0
875808|NCT01355289|2886336|P2|Core Study|Not specified|0
875809|NCT01355289|2886337|P1|Core Study|Not specified|0
875810|NCT01355289|2886333|P5|Core Study|Inadequate Therapeutic Effect|0
875811|NCT01355289|2886334|P4|Core Study|Inadequate Therapeutic Effect|1
875812|NCT01355289|2886335|P3|Core Study|Inadequate Therapeutic Effect|0
875813|NCT01355289|2886336|P2|Core Study|Inadequate Therapeutic Effect|0
875814|NCT01355289|2886337|P1|Core Study|Inadequate Therapeutic Effect|0
875815|NCT01355289|2886333|P5|Core Study|Adverse Event, Non-Fatal|0
875816|NCT01355289|2886334|P4|Core Study|Adverse Event, Non-Fatal|0
875817|NCT01355289|2886335|P3|Core Study|Adverse Event, Non-Fatal|0
875818|NCT01355289|2886336|P2|Core Study|Adverse Event, Non-Fatal|0
875819|NCT01355289|2886337|P1|Core Study|Adverse Event, Non-Fatal|1
875820|NCT01355081|2886390|P3|Overall Study|Non Compliance with Study Medication|0
875821|NCT01355081|2886391|P2|Overall Study|Non Compliance with Study Medication|1
875822|NCT01355081|2886392|P1|Overall Study|Non Compliance with Study Medication|0
875823|NCT01355081|2886390|P3|Overall Study|Lack of Efficacy|1
875824|NCT01355081|2886391|P2|Overall Study|Lack of Efficacy|1
875825|NCT01355081|2886392|P1|Overall Study|Lack of Efficacy|2
875826|NCT01355081|2886390|P3|Overall Study|Withdrawal of Consent|3
875827|NCT01355081|2886391|P2|Overall Study|Withdrawal of Consent|3
875828|NCT01355081|2886392|P1|Overall Study|Withdrawal of Consent|2
875829|NCT01355081|2886390|P3|Overall Study|Lost to Follow-up|1
875830|NCT01355081|2886391|P2|Overall Study|Lost to Follow-up|0
875831|NCT01355081|2886392|P1|Overall Study|Lost to Follow-up|0
875832|NCT01355081|2886390|P3|Overall Study|Major Protocol Deviation|0
875833|NCT01355081|2886391|P2|Overall Study|Major Protocol Deviation|1
875834|NCT01355081|2886392|P1|Overall Study|Major Protocol Deviation|0
875835|NCT01355081|2886390|P3|Overall Study|Pretreatment Event or Adverse Event|6
875836|NCT01355081|2886391|P2|Overall Study|Pretreatment Event or Adverse Event|4
875837|NCT01355081|2886392|P1|Overall Study|Pretreatment Event or Adverse Event|3
875838|NCT01355068|2886415|P2|First Intervention Period|Withdrawal by Subject|1
875839|NCT01355068|2886416|P1|First Intervention Period|Withdrawal by Subject|0
875840|NCT01355068|2886415|P2|First Intervention Period|Adverse Event|1
875841|NCT01355068|2886416|P1|First Intervention Period|Adverse Event|0
875842|NCT01354938|2886446|P1|Overall Study|Lost to Follow-up|1
875843|NCT01354899|2886452|P1|Overall Study|Protocol Violation|1
875844|NCT01354899|2886452|P1|Overall Study|discharge from the hospital|2
875845|NCT01354431|2886501|P3|Participants Treated|Withdrawal by Subject|1
875846|NCT01354431|2886502|P2|Participants Treated|Withdrawal by Subject|2
875847|NCT01354431|2886503|P1|Participants Treated|Withdrawal by Subject|1
875848|NCT01354431|2886501|P3|Participants Treated|Adverse Event|4
875849|NCT01354431|2886502|P2|Participants Treated|Adverse Event|2
875850|NCT01354431|2886503|P1|Participants Treated|Adverse Event|1
875851|NCT01354431|2886501|P3|Participants Treated|Death|0
875852|NCT01354431|2886502|P2|Participants Treated|Death|1
875853|NCT01354431|2886503|P1|Participants Treated|Death|0
875854|NCT01354431|2886501|P3|Participants Treated|Study Drug Toxicity|4
875855|NCT01354431|2886502|P2|Participants Treated|Study Drug Toxicity|7
875856|NCT01354431|2886503|P1|Participants Treated|Study Drug Toxicity|2
875857|NCT01354431|2886501|P3|Participants Treated|Disease Progression|41
875858|NCT01354431|2886502|P2|Participants Treated|Disease Progression|40
875859|NCT01354431|2886503|P1|Participants Treated|Disease Progression|49
875860|NCT01354431|2886501|P3|Participants Treated|Continuing Treatment|4
875861|NCT01354431|2886502|P2|Participants Treated|Continuing Treatment|2
875862|NCT01354431|2886503|P1|Participants Treated|Continuing Treatment|6
875863|NCT01354431|2886501|P3|Randomized to Enter Treatment Period|No longer met criteria|0
875864|NCT01354431|2886502|P2|Randomized to Enter Treatment Period|No longer met criteria|0
875865|NCT01354431|2886503|P1|Randomized to Enter Treatment Period|No longer met criteria|1
875866|NCT01354314|2886527|P4|Overall Study|Less than 90% Adherence|4
875867|NCT01354314|2886528|P3|Overall Study|Less than 90% Adherence|6
875868|NCT01354314|2886529|P2|Overall Study|Less than 90% Adherence|2
875869|NCT01354314|2886530|P1|Overall Study|Less than 90% Adherence|4
875870|NCT01354314|2886527|P4|Overall Study|Protocol Violation|0
875871|NCT01354314|2886528|P3|Overall Study|Protocol Violation|0
875872|NCT01354314|2886529|P2|Overall Study|Protocol Violation|1
875873|NCT01354314|2886530|P1|Overall Study|Protocol Violation|1
875874|NCT01354314|2886527|P4|Overall Study|Adverse Event|1
875875|NCT01354314|2886528|P3|Overall Study|Adverse Event|0
875876|NCT01354314|2886529|P2|Overall Study|Adverse Event|0
875877|NCT01354314|2886530|P1|Overall Study|Adverse Event|0
875878|NCT01354314|2886527|P4|Overall Study|Withdrawal by Subject|0
875879|NCT01354314|2886528|P3|Overall Study|Withdrawal by Subject|1
875880|NCT01354314|2886529|P2|Overall Study|Withdrawal by Subject|0
875881|NCT01354314|2886530|P1|Overall Study|Withdrawal by Subject|0
875882|NCT01354314|2886527|P4|Overall Study|Lost to Follow-up|1
875883|NCT01354314|2886528|P3|Overall Study|Lost to Follow-up|1
875884|NCT01354314|2886529|P2|Overall Study|Lost to Follow-up|0
875885|NCT01354314|2886530|P1|Overall Study|Lost to Follow-up|1
875886|NCT01354223|2886666|P2|Overall Study|Withdrawal by Subject|1
875887|NCT01354223|2886667|P1|Overall Study|Withdrawal by Subject|3
875888|NCT01354132|2886726|P2|1 Month Post Study Medication|Withdrawal by Subject|3
875889|NCT01354132|2886727|P1|1 Month Post Study Medication|Withdrawal by Subject|1
875890|NCT01354132|2886726|P2|Double Blind (Visits 1-7)|Withdrawal by Subject|11
875891|NCT01354132|2886727|P1|Double Blind (Visits 1-7)|Withdrawal by Subject|8
875892|NCT01354132|2886726|P2|Double Blind (Visits 1-7)|Adverse Event|0
875893|NCT01354132|2886727|P1|Double Blind (Visits 1-7)|Adverse Event|1
875894|NCT01354132|2886726|P2|Randomization|Withdrawal by Subject|1
875895|NCT01354132|2886727|P1|Randomization|Withdrawal by Subject|0
875896|NCT01354132|2886726|P2|Randomization|Physician Decision|0
875897|NCT01354132|2886727|P1|Randomization|Physician Decision|1
875898|NCT01354106|2886765|P1|Overall Study|Withdrawal by Subject|2
875899|NCT01354028|2886771|P2|Overall Study|No quiet alert state|1
875900|NCT01354028|2886772|P1|Overall Study|No quiet alert state|0
875901|NCT01354028|2886771|P2|Overall Study|Discharged before study start|2
875902|NCT01354028|2886772|P1|Overall Study|Discharged before study start|2
875903|NCT01354028|2886771|P2|Overall Study|Physician Decision|2
875904|NCT01354028|2886772|P1|Overall Study|Physician Decision|0
875905|NCT01353963|2886808|P1|Overall Study|Adverse Event|2
875906|NCT01353911|2886826|P8|Overall Study|Status Not Recorded|0
875907|NCT01353911|2886827|P7|Overall Study|Status Not Recorded|0
875908|NCT01353911|2886828|P6|Overall Study|Status Not Recorded|0
875909|NCT01353911|2886829|P5|Overall Study|Status Not Recorded|0
875910|NCT01353911|2886830|P4|Overall Study|Status Not Recorded|0
875911|NCT01353911|2886831|P3|Overall Study|Status Not Recorded|1
875912|NCT01353911|2886832|P2|Overall Study|Status Not Recorded|0
875913|NCT01353911|2886833|P1|Overall Study|Status Not Recorded|4
875914|NCT01353911|2886826|P8|Overall Study|Withdrawal by Subject|9
875915|NCT01353911|2886827|P7|Overall Study|Withdrawal by Subject|3
875916|NCT01353911|2886828|P6|Overall Study|Withdrawal by Subject|3
875917|NCT01353911|2886829|P5|Overall Study|Withdrawal by Subject|2
875918|NCT01353911|2886830|P4|Overall Study|Withdrawal by Subject|2
875919|NCT01353911|2886831|P3|Overall Study|Withdrawal by Subject|4
875920|NCT01353911|2886832|P2|Overall Study|Withdrawal by Subject|3
875921|NCT01353911|2886833|P1|Overall Study|Withdrawal by Subject|2
875922|NCT01353911|2886826|P8|Overall Study|Lost to Follow-up|6
875923|NCT01353911|2886827|P7|Overall Study|Lost to Follow-up|3
875924|NCT01353911|2886828|P6|Overall Study|Lost to Follow-up|4
875925|NCT01353911|2886829|P5|Overall Study|Lost to Follow-up|4
875926|NCT01353911|2886830|P4|Overall Study|Lost to Follow-up|0
875927|NCT01353911|2886831|P3|Overall Study|Lost to Follow-up|4
875928|NCT01353911|2886832|P2|Overall Study|Lost to Follow-up|6
875929|NCT01353911|2886833|P1|Overall Study|Lost to Follow-up|2
875930|NCT01353898|2886913|P6|Overall Study|Study site terminated|1
875931|NCT01353898|2886914|P5|Overall Study|Study site terminated|0
875932|NCT01353898|2886915|P4|Overall Study|Study site terminated|0
875933|NCT01353898|2886916|P3|Overall Study|Study site terminated|0
875934|NCT01353898|2886917|P2|Overall Study|Study site terminated|0
875935|NCT01353898|2886918|P1|Overall Study|Study site terminated|0
875936|NCT01353859|2886944|P1|Overall Study|Lack of Efficacy|1
875937|NCT01353859|2886944|P1|Overall Study|Adverse Event|3
875938|NCT01353664|2886957|P1|Overall Study|Disease Progression|16
875939|NCT01353664|2886957|P1|Overall Study|Other|3
875940|NCT01353586|2886963|P2|Overall Study|Neurological exam not done|1
875941|NCT01353586|2886964|P1|Overall Study|Neurological exam not done|0
875942|NCT01353586|2886963|P2|Overall Study|Never had insertion of study catheter|1
875943|NCT01353586|2886964|P1|Overall Study|Never had insertion of study catheter|4
875944|NCT01353586|2886963|P2|Overall Study|Procedure terminated prior to ablation|0
875945|NCT01353586|2886964|P1|Overall Study|Procedure terminated prior to ablation|3
876285|NCT01349907|2888201|P2|Overall Study|Administrative|1
875946|NCT01353508|2886982|P4|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
875947|NCT01353508|2886983|P3|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
875948|NCT01353508|2886984|P2|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
875949|NCT01353508|2886985|P1|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1
875950|NCT01353508|2886982|P4|Period 1 - First Intervention (7 Days)|Adverse Event|1
875951|NCT01353508|2886983|P3|Period 1 - First Intervention (7 Days)|Adverse Event|0
875952|NCT01353508|2886984|P2|Period 1 - First Intervention (7 Days)|Adverse Event|0
875953|NCT01353508|2886985|P1|Period 1 - First Intervention (7 Days)|Adverse Event|0
875954|NCT01353274|2887063|P1|Overall Study|No case report form (CRF) collected|28
875955|NCT01353222|2887073|P2|Overall Study|Site closed research department|0
875956|NCT01353222|2887074|P1|Overall Study|Site closed research department|1
875957|NCT01353222|2887073|P2|Overall Study|Study Terminated|37
875958|NCT01353222|2887074|P1|Overall Study|Study Terminated|31
875959|NCT01353222|2887073|P2|Overall Study|Withdrawal by Subject|5
875960|NCT01353222|2887074|P1|Overall Study|Withdrawal by Subject|8
875961|NCT01353222|2887073|P2|Overall Study|Death|30
875962|NCT01353222|2887074|P1|Overall Study|Death|30
875963|NCT01352845|2887108|P2|Overall Study|Death|0
875964|NCT01352845|2887109|P1|Overall Study|Death|3
875965|NCT01352845|2887108|P2|Overall Study|Protocol Violation|6
875966|NCT01352845|2887109|P1|Overall Study|Protocol Violation|12
875967|NCT01352845|2887108|P2|Overall Study|Other|7
875968|NCT01352845|2887109|P1|Overall Study|Other|17
875969|NCT01352845|2887108|P2|Overall Study|Adverse Event|6
875970|NCT01352845|2887109|P1|Overall Study|Adverse Event|22
875971|NCT01352845|2887108|P2|Overall Study|Pregnancy|7
875972|NCT01352845|2887109|P1|Overall Study|Pregnancy|27
875973|NCT01352845|2887108|P2|Overall Study|No Longer Meets Eligibility Criteria|11
875974|NCT01352845|2887109|P1|Overall Study|No Longer Meets Eligibility Criteria|24
875975|NCT01352845|2887108|P2|Overall Study|Withdrawal by Subject|16
875976|NCT01352845|2887109|P1|Overall Study|Withdrawal by Subject|48
875977|NCT01352845|2887108|P2|Overall Study|No Longer Willing to Participate|58
875978|NCT01352845|2887109|P1|Overall Study|No Longer Willing to Participate|205
875979|NCT01352845|2887108|P2|Overall Study|Lost to Follow-up|92
875980|NCT01352845|2887109|P1|Overall Study|Lost to Follow-up|313
875981|NCT01352793|2887198|P2|Overall Study|No longer meets eligibility criteria|15
875982|NCT01352793|2887199|P1|Overall Study|No longer meets eligibility criteria|25
875983|NCT01352793|2887198|P2|Overall Study|Randomized but not vaccinated|0
875984|NCT01352793|2887199|P1|Overall Study|Randomized but not vaccinated|8
875985|NCT01352793|2887198|P2|Overall Study|Death|0
875986|NCT01352793|2887199|P1|Overall Study|Death|1
875987|NCT01352793|2887198|P2|Overall Study|Medication error|2
875988|NCT01352793|2887199|P1|Overall Study|Medication error|2
875989|NCT01352793|2887198|P2|Overall Study|Other|7
875990|NCT01352793|2887199|P1|Overall Study|Other|25
875991|NCT01352793|2887198|P2|Overall Study|Pregnancy|8
875992|NCT01352793|2887199|P1|Overall Study|Pregnancy|26
875993|NCT01352793|2887198|P2|Overall Study|Physician Decision|0
875994|NCT01352793|2887199|P1|Overall Study|Physician Decision|1
875995|NCT01352793|2887198|P2|Overall Study|Adverse Event|10
875996|NCT01352793|2887199|P1|Overall Study|Adverse Event|44
875997|NCT01352793|2887198|P2|Overall Study|Protocol Violation|23
875998|NCT01352793|2887199|P1|Overall Study|Protocol Violation|44
875999|NCT01352793|2887198|P2|Overall Study|Withdrawal by Subject|55
876000|NCT01352793|2887199|P1|Overall Study|Withdrawal by Subject|120
876001|NCT01352793|2887198|P2|Overall Study|Lost to Follow-up|125
876002|NCT01352793|2887199|P1|Overall Study|Lost to Follow-up|289
876003|NCT01352741|2887223|P2|Open-Label Tapentadol Continuation Arm|Protocol Violation|0
876004|NCT01352741|2887224|P1|Open-Label Tapentadol Continuation Arm|Protocol Violation|1
876005|NCT01352741|2887223|P2|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0
876006|NCT01352741|2887224|P1|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2
876007|NCT01352741|2887223|P2|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0
876008|NCT01352741|2887224|P1|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1
876009|NCT01352741|2887223|P2|Open-Label Tapentadol Continuation Arm|Adverse Event|0
876010|NCT01352741|2887224|P1|Open-Label Tapentadol Continuation Arm|Adverse Event|4
876011|NCT01352741|2887223|P2|Double-blind Comparative Period|Not Specified|2
876012|NCT01352741|2887224|P1|Double-blind Comparative Period|Not Specified|1
876013|NCT01352741|2887223|P2|Double-blind Comparative Period|Withdrawal of consent|3
876014|NCT01352741|2887224|P1|Double-blind Comparative Period|Withdrawal of consent|8
876015|NCT01352741|2887223|P2|Double-blind Comparative Period|Death|1
876016|NCT01352741|2887224|P1|Double-blind Comparative Period|Death|0
876017|NCT01352741|2887223|P2|Double-blind Comparative Period|Lost to Follow-up|0
876018|NCT01352741|2887224|P1|Double-blind Comparative Period|Lost to Follow-up|1
876019|NCT01352741|2887223|P2|Double-blind Comparative Period|Adverse Event|17
876020|NCT01352741|2887224|P1|Double-blind Comparative Period|Adverse Event|16
876021|NCT01352741|2887223|P2|Double-blind Comparative Period|Lack of Efficacy|3
876022|NCT01352741|2887224|P1|Double-blind Comparative Period|Lack of Efficacy|0
876023|NCT01352741|2887223|P2|Double-blind Comparative Period|Protocol Violation|0
876024|NCT01352741|2887224|P1|Double-blind Comparative Period|Protocol Violation|2
876025|NCT01352741|2887223|P2|Open-label Tapentadol Titration Period|Not Specified|0
876026|NCT01352741|2887224|P1|Open-label Tapentadol Titration Period|Not Specified|4
876027|NCT01352741|2887223|P2|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0
876028|NCT01352741|2887224|P1|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5
876029|NCT01352741|2887223|P2|Open-label Tapentadol Titration Period|Withdrawal of consent|0
876030|NCT01352741|2887224|P1|Open-label Tapentadol Titration Period|Withdrawal of consent|7
876031|NCT01352741|2887223|P2|Open-label Tapentadol Titration Period|Adverse Event|0
876032|NCT01352741|2887224|P1|Open-label Tapentadol Titration Period|Adverse Event|34
876033|NCT01352741|2887223|P2|Open-label Tapentadol Titration Period|Lack of Efficacy|0
876034|NCT01352741|2887224|P1|Open-label Tapentadol Titration Period|Lack of Efficacy|19
876035|NCT01352741|2887223|P2|Open-label Tapentadol Titration Period|Protocol Violation|0
876036|NCT01352741|2887224|P1|Open-label Tapentadol Titration Period|Protocol Violation|4
876037|NCT01352715|2887318|P2|Overall Study|major ineligibility|1
876038|NCT01352715|2887319|P1|Overall Study|major ineligibility|2
876039|NCT01352715|2887318|P2|Overall Study|no final visit in closeout period|12
876040|NCT01352715|2887319|P1|Overall Study|no final visit in closeout period|15
876041|NCT01352715|2887318|P2|Overall Study|site closure|15
876042|NCT01352715|2887319|P1|Overall Study|site closure|16
876043|NCT01352715|2887318|P2|Overall Study|Withdrawal by Subject|8
876044|NCT01352715|2887319|P1|Overall Study|Withdrawal by Subject|4
876045|NCT01352715|2887318|P2|Overall Study|Lost to Follow-up|7
876046|NCT01352715|2887319|P1|Overall Study|Lost to Follow-up|5
876047|NCT01352715|2887318|P2|Overall Study|Death|3
876048|NCT01352715|2887319|P1|Overall Study|Death|3
876049|NCT01352585|2887341|P1|Overall Study|Not specified|7
876050|NCT01352585|2887341|P1|Overall Study|Lost to Follow-up|1
876051|NCT01352585|2887341|P1|Overall Study|Adverse Event|3
876052|NCT01352507|2887358|P2|Treatment Period 2|Lack of Efficacy|0
876053|NCT01352507|2887359|P1|Treatment Period 2|Lack of Efficacy|1
876054|NCT01352507|2887358|P2|Treatment Period 2|Withdrawal by Subject|3
876055|NCT01352507|2887359|P1|Treatment Period 2|Withdrawal by Subject|4
876056|NCT01352507|2887358|P2|Treatment Period 2|Entry Criteria Not Met|0
876057|NCT01352507|2887359|P1|Treatment Period 2|Entry Criteria Not Met|1
876058|NCT01352507|2887358|P2|Washout Period|Withdrawal by Subject|1
876059|NCT01352507|2887359|P1|Washout Period|Withdrawal by Subject|0
876060|NCT01352507|2887358|P2|Treatment Period 1|Physician Decision|0
876061|NCT01352507|2887359|P1|Treatment Period 1|Physician Decision|1
876062|NCT01352507|2887358|P2|Treatment Period 1|Withdrawal by Subject|5
876063|NCT01352507|2887359|P1|Treatment Period 1|Withdrawal by Subject|7
876064|NCT01352507|2887358|P2|Treatment Period 1|Lost to Follow-up|4
876065|NCT01352507|2887359|P1|Treatment Period 1|Lost to Follow-up|3
876066|NCT01352507|2887358|P2|Treatment Period 1|Adverse Event|0
876067|NCT01352507|2887359|P1|Treatment Period 1|Adverse Event|3
876068|NCT01352416|2887412|P4|Overall Study|Physician Decision|1
876069|NCT01352416|2887413|P3|Overall Study|Physician Decision|2
876070|NCT01352416|2887414|P2|Overall Study|Physician Decision|2
876071|NCT01352416|2887415|P1|Overall Study|Physician Decision|1
876072|NCT01352221|2887427|P4|Open-label Phase|Worsening of IBD|0
876073|NCT01352221|2887428|P3|Open-label Phase|Worsening of IBD|1
876074|NCT01352221|2887429|P2|Open-label Phase|Worsening of IBD|0
876075|NCT01352221|2887430|P1|Open-label Phase|Worsening of IBD|0
876076|NCT01352221|2887427|P4|Open-label Phase|Withdrawal by Subject|6
876077|NCT01352221|2887428|P3|Open-label Phase|Withdrawal by Subject|1
876078|NCT01352221|2887429|P2|Open-label Phase|Withdrawal by Subject|0
876079|NCT01352221|2887430|P1|Open-label Phase|Withdrawal by Subject|0
876080|NCT01352221|2887427|P4|Open-label Phase|Adverse Event|4
876081|NCT01352221|2887428|P3|Open-label Phase|Adverse Event|8
876082|NCT01352221|2887429|P2|Open-label Phase|Adverse Event|0
876083|NCT01352221|2887430|P1|Open-label Phase|Adverse Event|0
876084|NCT01352221|2887427|P4|Open-label Phase|Pregnancy|0
876085|NCT01352221|2887428|P3|Open-label Phase|Pregnancy|1
876086|NCT01352221|2887429|P2|Open-label Phase|Pregnancy|0
876087|NCT01352221|2887430|P1|Open-label Phase|Pregnancy|0
876088|NCT01352221|2887427|P4|Open-label Phase|Physician Decision|1
876089|NCT01352221|2887428|P3|Open-label Phase|Physician Decision|2
876090|NCT01352221|2887429|P2|Open-label Phase|Physician Decision|0
876091|NCT01352221|2887430|P1|Open-label Phase|Physician Decision|0
876092|NCT01352221|2887427|P4|Double-blind Phase|Protocol Violation|0
876093|NCT01352221|2887428|P3|Double-blind Phase|Protocol Violation|0
876094|NCT01352221|2887429|P2|Double-blind Phase|Protocol Violation|1
876095|NCT01352221|2887430|P1|Double-blind Phase|Protocol Violation|0
876096|NCT01352221|2887427|P4|Double-blind Phase|Lost to Follow-up|0
876097|NCT01352221|2887428|P3|Double-blind Phase|Lost to Follow-up|0
876098|NCT01352221|2887429|P2|Double-blind Phase|Lost to Follow-up|1
876099|NCT01352221|2887430|P1|Double-blind Phase|Lost to Follow-up|0
876100|NCT01352221|2887427|P4|Double-blind Phase|Withdrawal by Subject|0
876101|NCT01352221|2887428|P3|Double-blind Phase|Withdrawal by Subject|0
876102|NCT01352221|2887429|P2|Double-blind Phase|Withdrawal by Subject|5
876103|NCT01352221|2887430|P1|Double-blind Phase|Withdrawal by Subject|3
876104|NCT01352221|2887427|P4|Double-blind Phase|Adverse Event|0
876105|NCT01352221|2887428|P3|Double-blind Phase|Adverse Event|0
876106|NCT01352221|2887429|P2|Double-blind Phase|Adverse Event|4
876107|NCT01352221|2887430|P1|Double-blind Phase|Adverse Event|6
876108|NCT01352117|2887490|P2|Overall Study|Ineligible (no KS diagnosis)|0
876109|NCT01352117|2887491|P1|Overall Study|Ineligible (no KS diagnosis)|1
876110|NCT01352117|2887490|P2|Overall Study|Did not initiate study treatment|0
876111|NCT01352117|2887491|P1|Overall Study|Did not initiate study treatment|1
876112|NCT01352117|2887490|P2|Overall Study|Non-adherent to study requirements|0
876113|NCT01352117|2887491|P1|Overall Study|Non-adherent to study requirements|1
876114|NCT01352117|2887490|P2|Overall Study|Lost to Follow-up|4
876115|NCT01352117|2887491|P1|Overall Study|Lost to Follow-up|2
876116|NCT01352117|2887490|P2|Overall Study|Withdrawal by Subject|0
876117|NCT01352117|2887491|P1|Overall Study|Withdrawal by Subject|1
876118|NCT01352117|2887490|P2|Overall Study|Death|12
876119|NCT01352117|2887491|P1|Overall Study|Death|13
876120|NCT01352117|2887490|P2|Overall Study|On study|80
876121|NCT01352117|2887491|P1|Overall Study|On study|49
876122|NCT01351623|2887554|P1|Overall Study|Death|2
876123|NCT01351623|2887554|P1|Overall Study|Withdrawal by Subject|1
876124|NCT01351623|2887554|P1|Overall Study|Adverse Event|4
876125|NCT01351623|2887554|P1|Overall Study|Protocol Violation|2
876126|NCT01351415|2887580|P2|Overall Study|Never Started|5
876127|NCT01351415|2887581|P1|Overall Study|Never Started|5
876128|NCT01351415|2887580|P2|Overall Study|Reason unknown|2
876129|NCT01351415|2887581|P1|Overall Study|Reason unknown|0
876130|NCT01351415|2887580|P2|Overall Study|Physician Decision|3
876131|NCT01351415|2887581|P1|Overall Study|Physician Decision|2
876132|NCT01351415|2887580|P2|Overall Study|Death|187
876133|NCT01351415|2887581|P1|Overall Study|Death|190
876134|NCT01351415|2887580|P2|Overall Study|Lost to Follow-up|7
876135|NCT01351415|2887581|P1|Overall Study|Lost to Follow-up|5
876136|NCT01351415|2887580|P2|Overall Study|Trial termination by the Sponsor|19
876137|NCT01351415|2887581|P1|Overall Study|Trial termination by the Sponsor|28
876138|NCT01351415|2887580|P2|Overall Study|Withdrawal by Subject|17
876139|NCT01351415|2887581|P1|Overall Study|Withdrawal by Subject|15
876140|NCT01351025|2887659|P2|Week 24 - 44|unable to get to clinic|1
876141|NCT01351025|2887660|P1|Week 24 - 44|unable to get to clinic|1
876142|NCT01351025|2887659|P2|Week 24 - 44|Site closed|1
876143|NCT01351025|2887660|P1|Week 24 - 44|Site closed|0
876144|NCT01351025|2887659|P2|Week 24 - 44|Lost to Follow-up|2
876145|NCT01351025|2887660|P1|Week 24 - 44|Lost to Follow-up|0
876146|NCT01351025|2887659|P2|Week 0 - 20|Withdrawal by Subject|0
876147|NCT01351025|2887660|P1|Week 0 - 20|Withdrawal by Subject|1
876148|NCT01351025|2887659|P2|Week 0 - 20|Lost to Follow-up|1
876149|NCT01351025|2887660|P1|Week 0 - 20|Lost to Follow-up|2
876150|NCT01350999|2887693|P3|Overall Study|Difficulty Making it to Study Visit|5
876151|NCT01350999|2887694|P2|Overall Study|Difficulty Making it to Study Visit|1
876152|NCT01350999|2887695|P1|Overall Study|Difficulty Making it to Study Visit|1
876153|NCT01350999|2887693|P3|Overall Study|Voluntary withdrawal|6
876154|NCT01350999|2887694|P2|Overall Study|Voluntary withdrawal|4
876155|NCT01350999|2887695|P1|Overall Study|Voluntary withdrawal|3
876156|NCT01350999|2887693|P3|Overall Study|Adverse Event|10
876157|NCT01350999|2887694|P2|Overall Study|Adverse Event|9
876158|NCT01350999|2887695|P1|Overall Study|Adverse Event|4
876159|NCT01350973|2887733|P3|Overall Study|Voluntary Withdrawal|1
876160|NCT01350973|2887734|P2|Overall Study|Voluntary Withdrawal|1
876161|NCT01350973|2887735|P1|Overall Study|Voluntary Withdrawal|2
876162|NCT01350973|2887733|P3|Overall Study|Adverse Event|7
876163|NCT01350973|2887734|P2|Overall Study|Adverse Event|7
876164|NCT01350973|2887735|P1|Overall Study|Adverse Event|4
876165|NCT01350934|2887776|P2|Extension Study|Withdrawal by Subject|1
876166|NCT01350934|2887777|P1|Extension Study|Withdrawal by Subject|0
876167|NCT01350934|2887776|P2|Extension Study|Lack of Efficacy|1
876168|NCT01350934|2887777|P1|Extension Study|Lack of Efficacy|0
876169|NCT01350934|2887776|P2|Extension Study|Protocol Violation|1
876170|NCT01350934|2887777|P1|Extension Study|Protocol Violation|1
876171|NCT01350934|2887776|P2|Extension Study|Lost to Follow-up|0
876172|NCT01350934|2887777|P1|Extension Study|Lost to Follow-up|2
876173|NCT01350934|2887776|P2|Extension Study|Adverse Event|1
876174|NCT01350934|2887777|P1|Extension Study|Adverse Event|2
876175|NCT01350934|2887776|P2|Base Study|Non-Compliance With Study Drug|0
876176|NCT01350934|2887777|P1|Base Study|Non-Compliance With Study Drug|2
876177|NCT01350934|2887776|P2|Base Study|Withdrawal by Subject|2
876178|NCT01350934|2887777|P1|Base Study|Withdrawal by Subject|1
876179|NCT01350934|2887776|P2|Base Study|Protocol Violation|1
876180|NCT01350934|2887777|P1|Base Study|Protocol Violation|1
876181|NCT01350934|2887776|P2|Base Study|Lost to Follow-up|0
876182|NCT01350934|2887777|P1|Base Study|Lost to Follow-up|1
876183|NCT01350934|2887776|P2|Base Study|Adverse Event|0
876184|NCT01350934|2887777|P1|Base Study|Adverse Event|6
876185|NCT01350804|2887799|P4|Extension Study, Weeks 52 - 260|Adverse Event|3
876186|NCT01350804|2887800|P3|Extension Study, Weeks 52 - 260|Adverse Event|2
876187|NCT01350804|2887801|P2|Extension Study, Weeks 52 - 260|Adverse Event|1
876188|NCT01350804|2887802|P1|Extension Study, Weeks 52 - 260|Adverse Event|3
876189|NCT01350804|2887799|P4|Extension Study, Weeks 52 - 260|Lack of Efficacy|1
876190|NCT01350804|2887800|P3|Extension Study, Weeks 52 - 260|Lack of Efficacy|0
876191|NCT01350804|2887801|P2|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
876192|NCT01350804|2887802|P1|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
876193|NCT01350804|2887799|P4|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
876194|NCT01350804|2887800|P3|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
876195|NCT01350804|2887801|P2|Extension Study, Weeks 52 - 260|Lost to Follow-up|1
876196|NCT01350804|2887802|P1|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
876197|NCT01350804|2887799|P4|Extension Study, Weeks 52 - 260|Physician Decision|0
876198|NCT01350804|2887800|P3|Extension Study, Weeks 52 - 260|Physician Decision|2
876199|NCT01350804|2887801|P2|Extension Study, Weeks 52 - 260|Physician Decision|0
876200|NCT01350804|2887802|P1|Extension Study, Weeks 52 - 260|Physician Decision|1
876201|NCT01350804|2887799|P4|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16
876202|NCT01350804|2887800|P3|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64
876203|NCT01350804|2887801|P2|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
876204|NCT01350804|2887802|P1|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
876205|NCT01350804|2887799|P4|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3
876206|NCT01350804|2887800|P3|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4
876207|NCT01350804|2887801|P2|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6
876208|NCT01350804|2887802|P1|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5
876209|NCT01350804|2887799|P4|Core Study|Adverse Event|8
876210|NCT01350804|2887800|P3|Core Study|Adverse Event|8
876211|NCT01350804|2887801|P2|Core Study|Adverse Event|10
876212|NCT01350804|2887802|P1|Core Study|Adverse Event|8
876213|NCT01350804|2887799|P4|Core Study|Death|0
876214|NCT01350804|2887800|P3|Core Study|Death|1
876215|NCT01350804|2887801|P2|Core Study|Death|1
876216|NCT01350804|2887802|P1|Core Study|Death|1
876217|NCT01350804|2887799|P4|Core Study|Lack of Efficacy|5
876218|NCT01350804|2887800|P3|Core Study|Lack of Efficacy|18
876219|NCT01350804|2887801|P2|Core Study|Lack of Efficacy|19
876220|NCT01350804|2887802|P1|Core Study|Lack of Efficacy|16
876221|NCT01350804|2887799|P4|Core Study|Lost to Follow-up|1
876222|NCT01350804|2887800|P3|Core Study|Lost to Follow-up|2
876223|NCT01350804|2887801|P2|Core Study|Lost to Follow-up|0
876224|NCT01350804|2887802|P1|Core Study|Lost to Follow-up|3
876225|NCT01350804|2887799|P4|Core Study|Physician Decision|3
876226|NCT01350804|2887800|P3|Core Study|Physician Decision|1
876227|NCT01350804|2887801|P2|Core Study|Physician Decision|0
876228|NCT01350804|2887802|P1|Core Study|Physician Decision|1
876229|NCT01350804|2887799|P4|Core Study|Protocol deviation|0
876230|NCT01350804|2887800|P3|Core Study|Protocol deviation|1
876231|NCT01350804|2887801|P2|Core Study|Protocol deviation|0
876232|NCT01350804|2887802|P1|Core Study|Protocol deviation|1
876233|NCT01350804|2887799|P4|Core Study|Study terminated by Sponsor|2
876234|NCT01350804|2887800|P3|Core Study|Study terminated by Sponsor|0
876235|NCT01350804|2887801|P2|Core Study|Study terminated by Sponsor|0
876236|NCT01350804|2887802|P1|Core Study|Study terminated by Sponsor|0
876237|NCT01350804|2887799|P4|Core Study|Withdrawal by Subject|7
876238|NCT01350804|2887800|P3|Core Study|Withdrawal by Subject|16
876239|NCT01350804|2887801|P2|Core Study|Withdrawal by Subject|17
876240|NCT01350804|2887802|P1|Core Study|Withdrawal by Subject|11
876241|NCT01350544|2887899|P2|Overall Study|Lost to Follow-up|15
876242|NCT01350544|2887900|P1|Overall Study|Lost to Follow-up|18
876243|NCT01350544|2887899|P2|Overall Study|Incarceration|0
876244|NCT01350544|2887900|P1|Overall Study|Incarceration|1
876245|NCT01350544|2887899|P2|Overall Study|Withdrawal by Subject|1
876246|NCT01350544|2887900|P1|Overall Study|Withdrawal by Subject|0
876247|NCT01350544|2887899|P2|Overall Study|Medical Issues|1
876248|NCT01350544|2887900|P1|Overall Study|Medical Issues|1
876249|NCT01350544|2887899|P2|Overall Study|Moved out of LA County|2
876250|NCT01350544|2887900|P1|Overall Study|Moved out of LA County|2
876251|NCT01350544|2887899|P2|Overall Study|Death|2
876252|NCT01350544|2887900|P1|Overall Study|Death|1
876253|NCT01350544|2887899|P2|Overall Study|Administrative Withdrawal|1
876254|NCT01350544|2887900|P1|Overall Study|Administrative Withdrawal|0
876255|NCT01350414|2887915|P1|Overall Study|Physician Decision|2
876256|NCT01350414|2887915|P1|Overall Study|Withdrawal by Subject|4
876257|NCT01350414|2887915|P1|Overall Study|Lost to Follow-up|13
876258|NCT01350271|2887964|P3|Overall Study|Lost to Follow-up|26
876259|NCT01350271|2887965|P2|Overall Study|Lost to Follow-up|17
876260|NCT01350271|2887966|P1|Overall Study|Lost to Follow-up|21
876261|NCT01350141|2888008|P3|Overall Study|Randomized but not treated|0
876262|NCT01350141|2888009|P2|Overall Study|Randomized but not treated|0
876263|NCT01350141|2888010|P1|Overall Study|Randomized but not treated|1
876264|NCT01350141|2888008|P3|Overall Study|Withdrawal by Subject|0
876265|NCT01350141|2888009|P2|Overall Study|Withdrawal by Subject|0
876266|NCT01350141|2888010|P1|Overall Study|Withdrawal by Subject|1
876267|NCT01350141|2888008|P3|Overall Study|Lost to Follow-up|1
876268|NCT01350141|2888009|P2|Overall Study|Lost to Follow-up|0
876269|NCT01350141|2888010|P1|Overall Study|Lost to Follow-up|1
876270|NCT01350128|2888044|P1|Overall Study|Lost to Follow-up|2
876271|NCT01350128|2888044|P1|Overall Study|Physician Decision|1
876272|NCT01350128|2888044|P1|Overall Study|Protocol discontinuation criteria|8
876273|NCT01350128|2888044|P1|Overall Study|Withdrawal by Subject|3
876274|NCT01350115|2888108|P2|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0
876275|NCT01350115|2888109|P1|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1
876276|NCT01350115|2888108|P2|Long Term Follow-Up (All Patients)|Adverse Event|1
876277|NCT01350115|2888109|P1|Long Term Follow-Up (All Patients)|Adverse Event|0
876278|NCT01350115|2888108|P2|Long Term Follow-Up (All Patients)|Lost to Follow-up|1
876279|NCT01350115|2888109|P1|Long Term Follow-Up (All Patients)|Lost to Follow-up|0
876280|NCT01350102|2888125|P4|Overall Study|Adverse Event|0
876281|NCT01350102|2888126|P3|Overall Study|Adverse Event|1
876282|NCT01350102|2888127|P2|Overall Study|Adverse Event|0
876283|NCT01350102|2888128|P1|Overall Study|Adverse Event|0
876284|NCT01349959|2888165|P1|Overall Study|Patients are followed for survival|7
876286|NCT01349907|2888202|P1|Overall Study|Administrative|1
876287|NCT01349907|2888201|P2|Overall Study|Protocol Violation|13
876288|NCT01349907|2888202|P1|Overall Study|Protocol Violation|33
876289|NCT01349907|2888201|P2|Overall Study|Withdrawal by Subject|8
876290|NCT01349907|2888202|P1|Overall Study|Withdrawal by Subject|30
876291|NCT01349907|2888201|P2|Overall Study|Lost to Follow-up|6
876292|NCT01349907|2888202|P1|Overall Study|Lost to Follow-up|25
876293|NCT01349907|2888201|P2|Overall Study|Treatment failure|4
876294|NCT01349907|2888202|P1|Overall Study|Treatment failure|13
876295|NCT01349907|2888201|P2|Overall Study|Adverse Event|11
876296|NCT01349907|2888202|P1|Overall Study|Adverse Event|37
876297|NCT01349829|2888240|P2|Overall Study|Migrated/moved|7
876298|NCT01349829|2888241|P1|Overall Study|Migrated/moved|2
876299|NCT01349829|2888240|P2|Overall Study|Consent withdrawal|8
876300|NCT01349829|2888241|P1|Overall Study|Consent withdrawal|3
876301|NCT01349829|2888240|P2|Overall Study|Lost to Follow-up|8
876302|NCT01349829|2888241|P1|Overall Study|Lost to Follow-up|4
876303|NCT01349816|2888259|P1|Overall Study|Protocol-specified criteria|8
876304|NCT01349816|2888259|P1|Overall Study|Protocol Violation|1
876305|NCT01349816|2888259|P1|Overall Study|Lost to Follow-up|2
876306|NCT01349816|2888259|P1|Overall Study|Adverse Event|14
876307|NCT01349816|2888259|P1|Overall Study|Physician Decision|1
876308|NCT01349816|2888259|P1|Overall Study|Withdrawal by Subject|4
876309|NCT01349803|2888325|P4|Overall Study|Protocol-specified criteria|0
876310|NCT01349803|2888326|P3|Overall Study|Protocol-specified criteria|3
876311|NCT01349803|2888327|P2|Overall Study|Protocol-specified criteria|1
876312|NCT01349803|2888328|P1|Overall Study|Protocol-specified criteria|0
876313|NCT01349803|2888325|P4|Overall Study|Withdrawal by Subject|0
876314|NCT01349803|2888326|P3|Overall Study|Withdrawal by Subject|0
876315|NCT01349803|2888327|P2|Overall Study|Withdrawal by Subject|0
876316|NCT01349803|2888328|P1|Overall Study|Withdrawal by Subject|1
876317|NCT01349803|2888325|P4|Overall Study|Adverse Event|2
876318|NCT01349803|2888326|P3|Overall Study|Adverse Event|0
876319|NCT01349803|2888327|P2|Overall Study|Adverse Event|0
876320|NCT01349803|2888328|P1|Overall Study|Adverse Event|0
876321|NCT01349790|2888398|P1|Overall Study|Lost to Follow-up|1
876322|NCT01349790|2888398|P1|Overall Study|Adverse Event|1
876323|NCT01349790|2888398|P1|Overall Study|Withdrawal by Patient|2
876324|NCT01349790|2888398|P1|Overall Study|Death|2
876325|NCT01349790|2888398|P1|Overall Study|Investigator Judgement|3
876326|NCT01349660|2888420|P3|Overall Study|Declining Performance Status|1
876327|NCT01349660|2888421|P2|Overall Study|Declining Performance Status|0
876328|NCT01349660|2888422|P1|Overall Study|Declining Performance Status|0
876329|NCT01349660|2888420|P3|Overall Study|Study Compliance|1
876330|NCT01349660|2888421|P2|Overall Study|Study Compliance|0
876331|NCT01349660|2888422|P1|Overall Study|Study Compliance|0
876332|NCT01349660|2888420|P3|Overall Study|Non-Permitted Interventions|2
876333|NCT01349660|2888421|P2|Overall Study|Non-Permitted Interventions|0
876334|NCT01349660|2888422|P1|Overall Study|Non-Permitted Interventions|0
876335|NCT01349660|2888420|P3|Overall Study|Death|0
876336|NCT01349660|2888421|P2|Overall Study|Death|1
876337|NCT01349660|2888422|P1|Overall Study|Death|1
876338|NCT01349660|2888420|P3|Overall Study|Withdrawal by Subject|9
876339|NCT01349660|2888421|P2|Overall Study|Withdrawal by Subject|0
876340|NCT01349660|2888422|P1|Overall Study|Withdrawal by Subject|2
876341|NCT01349660|2888420|P3|Overall Study|Adverse Event|12
876342|NCT01349660|2888421|P2|Overall Study|Adverse Event|1
876343|NCT01349660|2888422|P1|Overall Study|Adverse Event|1
876344|NCT01349660|2888420|P3|Overall Study|Disease Progression|50
876345|NCT01349660|2888421|P2|Overall Study|Disease Progression|4
876346|NCT01349660|2888422|P1|Overall Study|Disease Progression|2
876347|NCT01349660|2888420|P3|Overall Study|Still Receiving Study Treatment|1
876348|NCT01349660|2888421|P2|Overall Study|Still Receiving Study Treatment|0
876349|NCT01349660|2888422|P1|Overall Study|Still Receiving Study Treatment|0
876350|NCT01349595|2888440|P2|Overall Study|Lack of funding|2
876351|NCT01349595|2888441|P1|Overall Study|Lack of funding|2
876352|NCT01349465|2888458|P2|Overall Study|Subject Ineligible To Continue The Trial|19
876353|NCT01349465|2888459|P1|Overall Study|Subject Ineligible To Continue The Trial|0
876354|NCT01349465|2888458|P2|Overall Study|Withdrawal by Subject|2
876355|NCT01349465|2888459|P1|Overall Study|Withdrawal by Subject|4
876356|NCT01349465|2888458|P2|Overall Study|Lost to Follow-up|1
876357|NCT01349465|2888459|P1|Overall Study|Lost to Follow-up|10
876358|NCT01349465|2888458|P2|Overall Study|Death|0
876359|NCT01349465|2888459|P1|Overall Study|Death|3
876360|NCT01349465|2888458|P2|Overall Study|Adverse Event|0
876361|NCT01349465|2888459|P1|Overall Study|Adverse Event|1
876362|NCT01349192|2888480|P2|Overall Study|Failure to adhere to Protocol|0
876363|NCT01349192|2888481|P1|Overall Study|Failure to adhere to Protocol|2
876364|NCT01349192|2888480|P2|Overall Study|Lost to Follow-up|3
876365|NCT01349192|2888481|P1|Overall Study|Lost to Follow-up|1
876366|NCT01349192|2888480|P2|Overall Study|Withdrawal by Subject|2
876367|NCT01349192|2888481|P1|Overall Study|Withdrawal by Subject|0
876368|NCT01349192|2888480|P2|Overall Study|Protocol Violation|1
876369|NCT01349192|2888481|P1|Overall Study|Protocol Violation|0
876370|NCT01348854|2888506|P2|Overall Study|Withdrawal by Subject|0
876371|NCT01348854|2888507|P1|Overall Study|Withdrawal by Subject|1
876372|NCT01348854|2888506|P2|Overall Study|Lost to Follow-up|1
876373|NCT01348854|2888507|P1|Overall Study|Lost to Follow-up|2
876374|NCT01348789|2888515|P1|Overall Study|Withdrawal by Subject|2
876375|NCT01348789|2888515|P1|Overall Study|Protocol Violation|2
876376|NCT01348776|2888526|P1|Overall Study|Lost to Follow-up|3
876377|NCT01348698|2888539|P1|Overall Study|PI decision to close study|68
876378|NCT01348698|2888539|P1|Overall Study|Death|3
876379|NCT01348698|2888539|P1|Overall Study|Does not meet lesion size criteria|1
876380|NCT01348425|2888564|P2|Overall Study|Imaging was not taken.|1
876381|NCT01348425|2888565|P1|Overall Study|Imaging was not taken.|1
876382|NCT01348347|2888573|P3|Overall Study|Progressive disease|5
876383|NCT01348347|2888574|P2|Overall Study|Progressive disease|5
876384|NCT01348347|2888575|P1|Overall Study|Progressive disease|2
876385|NCT01348347|2888573|P3|Overall Study|Withdrawal by Subject|1
876386|NCT01348347|2888574|P2|Overall Study|Withdrawal by Subject|1
876387|NCT01348347|2888575|P1|Overall Study|Withdrawal by Subject|1
876388|NCT01348165|2888606|P7|Overall Study|Adverse Event|1
876389|NCT01348165|2888607|P6|Overall Study|Adverse Event|0
876390|NCT01348165|2888608|P5|Overall Study|Adverse Event|0
876391|NCT01348165|2888609|P4|Overall Study|Adverse Event|0
876392|NCT01348165|2888610|P3|Overall Study|Adverse Event|0
876393|NCT01348165|2888611|P2|Overall Study|Adverse Event|0
876394|NCT01348165|2888612|P1|Overall Study|Adverse Event|0
876395|NCT01348139|2888741|P6|Period 1|Adverse Event|0
876396|NCT01348139|2888742|P5|Period 1|Adverse Event|0
876397|NCT01348139|2888743|P4|Period 1|Adverse Event|0
876398|NCT01348139|2888744|P3|Period 1|Adverse Event|0
876399|NCT01348139|2888745|P2|Period 1|Adverse Event|0
876400|NCT01348139|2888746|P1|Period 1|Adverse Event|1
876401|NCT01348100|2888827|P7|Overall Study|Administrative Problems|1
876402|NCT01348100|2888828|P6|Overall Study|Administrative Problems|1
876403|NCT01348100|2888829|P5|Overall Study|Administrative Problems|0
876404|NCT01348100|2888830|P4|Overall Study|Administrative Problems|0
876405|NCT01348100|2888831|P3|Overall Study|Administrative Problems|0
876406|NCT01348100|2888832|P2|Overall Study|Administrative Problems|0
876407|NCT01348100|2888833|P1|Overall Study|Administrative Problems|0
876408|NCT01348100|2888827|P7|Overall Study|Lost to Follow-up|1
876409|NCT01348100|2888828|P6|Overall Study|Lost to Follow-up|0
876410|NCT01348100|2888829|P5|Overall Study|Lost to Follow-up|0
876411|NCT01348100|2888830|P4|Overall Study|Lost to Follow-up|0
876412|NCT01348100|2888831|P3|Overall Study|Lost to Follow-up|0
876413|NCT01348100|2888832|P2|Overall Study|Lost to Follow-up|0
876414|NCT01348100|2888833|P1|Overall Study|Lost to Follow-up|0
876415|NCT01348100|2888827|P7|Overall Study|Unsatisfactory Therapeutic Effect|0
876416|NCT01348100|2888828|P6|Overall Study|Unsatisfactory Therapeutic Effect|1
876417|NCT01348100|2888829|P5|Overall Study|Unsatisfactory Therapeutic Effect|0
876418|NCT01348100|2888830|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
876419|NCT01348100|2888831|P3|Overall Study|Unsatisfactory Therapeutic Effect|0
876420|NCT01348100|2888832|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
876421|NCT01348100|2888833|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
876422|NCT01348100|2888827|P7|Overall Study|Protocol Deviation|0
876423|NCT01348100|2888828|P6|Overall Study|Protocol Deviation|0
876424|NCT01348100|2888829|P5|Overall Study|Protocol Deviation|0
876425|NCT01348100|2888830|P4|Overall Study|Protocol Deviation|1
876426|NCT01348100|2888831|P3|Overall Study|Protocol Deviation|0
876427|NCT01348100|2888832|P2|Overall Study|Protocol Deviation|0
876428|NCT01348100|2888833|P1|Overall Study|Protocol Deviation|0
876429|NCT01348100|2888827|P7|Overall Study|Subject Withdrew Consent|1
876430|NCT01348100|2888828|P6|Overall Study|Subject Withdrew Consent|0
876431|NCT01348100|2888829|P5|Overall Study|Subject Withdrew Consent|1
876432|NCT01348100|2888830|P4|Overall Study|Subject Withdrew Consent|0
876433|NCT01348100|2888831|P3|Overall Study|Subject Withdrew Consent|2
876434|NCT01348100|2888832|P2|Overall Study|Subject Withdrew Consent|0
876435|NCT01348100|2888833|P1|Overall Study|Subject Withdrew Consent|0
876436|NCT01348087|2888878|P1|Overall Study|Adverse Event|25
876437|NCT01348087|2888878|P1|Overall Study|Subject withdrew consent|7
876438|NCT01348087|2888878|P1|Overall Study|Lost to Follow-up|1
876439|NCT01348087|2888878|P1|Overall Study|protocol deviation|1
876440|NCT01348087|2888878|P1|Overall Study|Administrative problems|79
876441|NCT01348087|2888878|P1|Overall Study|Unsatisfactory therapeutic effect|35
876442|NCT01347931|2888892|P1|Standard Oxygen Therapy|Withdrawal by Subject|1
876443|NCT01347879|2888904|P2|Overall Study|Other|3
876444|NCT01347879|2888905|P1|Overall Study|Other|2
876445|NCT01347879|2888904|P2|Overall Study|Withdrawal by Subject|2
876446|NCT01347879|2888905|P1|Overall Study|Withdrawal by Subject|3
876447|NCT01347879|2888904|P2|Overall Study|Lost to Follow-up|0
876448|NCT01347879|2888905|P1|Overall Study|Lost to Follow-up|2
876449|NCT01347879|2888904|P2|Overall Study|Adverse Event|12
876450|NCT01347879|2888905|P1|Overall Study|Adverse Event|0
876451|NCT01347866|2888954|P17|Overall Study|Subject refused further follow-up|2
876452|NCT01347866|2888955|P16|Overall Study|Subject refused further follow-up|0
876453|NCT01347866|2888956|P15|Overall Study|Subject refused further follow-up|1
876454|NCT01347866|2888957|P14|Overall Study|Subject refused further follow-up|3
876455|NCT01347866|2888958|P13|Overall Study|Subject refused further follow-up|1
876456|NCT01347866|2888959|P12|Overall Study|Subject refused further follow-up|0
876457|NCT01347866|2888960|P11|Overall Study|Subject refused further follow-up|0
876458|NCT01347866|2888961|P10|Overall Study|Subject refused further follow-up|1
876459|NCT01347866|2888962|P9|Overall Study|Subject refused further follow-up|4
876460|NCT01347866|2888963|P8|Overall Study|Subject refused further follow-up|0
876461|NCT01347866|2888964|P7|Overall Study|Subject refused further follow-up|0
876462|NCT01347866|2888965|P6|Overall Study|Subject refused further follow-up|1
876463|NCT01347866|2888966|P5|Overall Study|Subject refused further follow-up|0
876464|NCT01347866|2888967|P4|Overall Study|Subject refused further follow-up|2
876465|NCT01347866|2888968|P3|Overall Study|Subject refused further follow-up|0
876466|NCT01347866|2888969|P2|Overall Study|Subject refused further follow-up|0
876467|NCT01347866|2888970|P1|Overall Study|Subject refused further follow-up|2
876468|NCT01347866|2888954|P17|Overall Study|Other|0
876469|NCT01347866|2888955|P16|Overall Study|Other|3
876470|NCT01347866|2888956|P15|Overall Study|Other|2
876471|NCT01347866|2888957|P14|Overall Study|Other|4
876472|NCT01347866|2888958|P13|Overall Study|Other|4
876473|NCT01347866|2888959|P12|Overall Study|Other|3
876474|NCT01347866|2888960|P11|Overall Study|Other|0
876475|NCT01347866|2888961|P10|Overall Study|Other|5
876476|NCT01347866|2888962|P9|Overall Study|Other|22
876477|NCT01347866|2888963|P8|Overall Study|Other|3
876478|NCT01347866|2888964|P7|Overall Study|Other|5
876479|NCT01347866|2888965|P6|Overall Study|Other|0
876480|NCT01347866|2888966|P5|Overall Study|Other|5
876481|NCT01347866|2888967|P4|Overall Study|Other|4
876482|NCT01347866|2888968|P3|Overall Study|Other|1
876483|NCT01347866|2888969|P2|Overall Study|Other|1
876484|NCT01347866|2888970|P1|Overall Study|Other|3
876485|NCT01347866|2888954|P17|Overall Study|Lost to Follow-up|0
876486|NCT01347866|2888955|P16|Overall Study|Lost to Follow-up|0
876487|NCT01347866|2888956|P15|Overall Study|Lost to Follow-up|0
876488|NCT01347866|2888957|P14|Overall Study|Lost to Follow-up|0
876489|NCT01347866|2888958|P13|Overall Study|Lost to Follow-up|0
876490|NCT01347866|2888959|P12|Overall Study|Lost to Follow-up|0
876491|NCT01347866|2888960|P11|Overall Study|Lost to Follow-up|0
876492|NCT01347866|2888961|P10|Overall Study|Lost to Follow-up|0
876493|NCT01347866|2888962|P9|Overall Study|Lost to Follow-up|1
876494|NCT01347866|2888963|P8|Overall Study|Lost to Follow-up|1
876495|NCT01347866|2888964|P7|Overall Study|Lost to Follow-up|0
876496|NCT01347866|2888965|P6|Overall Study|Lost to Follow-up|0
876497|NCT01347866|2888966|P5|Overall Study|Lost to Follow-up|0
876498|NCT01347866|2888967|P4|Overall Study|Lost to Follow-up|0
876499|NCT01347866|2888968|P3|Overall Study|Lost to Follow-up|0
876500|NCT01347866|2888969|P2|Overall Study|Lost to Follow-up|0
876501|NCT01347866|2888970|P1|Overall Study|Lost to Follow-up|0
876502|NCT01347866|2888954|P17|Overall Study|Death|0
876503|NCT01347866|2888955|P16|Overall Study|Death|1
876504|NCT01347866|2888956|P15|Overall Study|Death|0
876505|NCT01347866|2888957|P14|Overall Study|Death|0
876506|NCT01347866|2888958|P13|Overall Study|Death|2
876507|NCT01347866|2888959|P12|Overall Study|Death|1
876508|NCT01347866|2888960|P11|Overall Study|Death|3
876509|NCT01347866|2888961|P10|Overall Study|Death|1
876510|NCT01347866|2888962|P9|Overall Study|Death|4
876511|NCT01347866|2888963|P8|Overall Study|Death|0
876512|NCT01347866|2888964|P7|Overall Study|Death|1
876513|NCT01347866|2888965|P6|Overall Study|Death|2
876514|NCT01347866|2888966|P5|Overall Study|Death|2
876515|NCT01347866|2888967|P4|Overall Study|Death|1
876516|NCT01347866|2888968|P3|Overall Study|Death|0
876517|NCT01347866|2888969|P2|Overall Study|Death|0
876518|NCT01347866|2888970|P1|Overall Study|Death|0
876519|NCT01347840|2889344|P1|Overall Study|Withdrawal by Subject|1
876520|NCT01347762|2889371|P4|Overall Study|Withdrawal by Subject|3
876521|NCT01347762|2889372|P3|Overall Study|Withdrawal by Subject|3
876522|NCT01347762|2889373|P2|Overall Study|Withdrawal by Subject|1
876523|NCT01347762|2889374|P1|Overall Study|Withdrawal by Subject|4
876524|NCT01347762|2889371|P4|Overall Study|Lost to Follow-up|5
876525|NCT01347762|2889372|P3|Overall Study|Lost to Follow-up|6
876526|NCT01347762|2889373|P2|Overall Study|Lost to Follow-up|1
876527|NCT01347762|2889374|P1|Overall Study|Lost to Follow-up|0
876528|NCT01347710|2889400|P1|Overall Study|Other|3
876529|NCT01347710|2889400|P1|Overall Study|Physician Decision|2
876530|NCT01347710|2889400|P1|Overall Study|Lost to Follow-up|1
876531|NCT01347710|2889400|P1|Overall Study|issue with vitals prior to dosing|1
876532|NCT01347710|2889400|P1|Overall Study|Angio or SPECT not completed|18
876533|NCT01347710|2889400|P1|Overall Study|Adverse Event|4
876534|NCT01347710|2889400|P1|Overall Study|Withdrawal by Subject|2
876535|NCT01347580|2889422|P2|Overall Study|Had other reason|6
876536|NCT01347580|2889423|P1|Overall Study|Had other reason|9
876537|NCT01347580|2889422|P2|Overall Study|Lost to Follow-up|1
876538|NCT01347580|2889423|P1|Overall Study|Lost to Follow-up|3
876539|NCT01347580|2889422|P2|Overall Study|Protocol Violation|7
876540|NCT01347580|2889423|P1|Overall Study|Protocol Violation|10
876541|NCT01347580|2889422|P2|Overall Study|Death|19
876542|NCT01347580|2889423|P1|Overall Study|Death|30
876543|NCT01347580|2889422|P2|Overall Study|Withdrawal by Subject|23
876544|NCT01347580|2889423|P1|Overall Study|Withdrawal by Subject|13
876545|NCT01347554|2889453|P2|Overall Study|Lack of Efficacy|11
876546|NCT01347554|2889454|P1|Overall Study|Lack of Efficacy|7
876547|NCT01347112|2889491|P2|Overall Study|Lost to Follow-up|5
876548|NCT01347112|2889492|P1|Overall Study|Lost to Follow-up|3
876549|NCT01347112|2889491|P2|Overall Study|Withdrawal by Subject|7
876550|NCT01347112|2889492|P1|Overall Study|Withdrawal by Subject|1
876551|NCT01347086|2889512|P10|Overall Study|failed screening visit|1
876552|NCT01347086|2889513|P9|Overall Study|failed screening visit|0
876553|NCT01347086|2889514|P8|Overall Study|failed screening visit|1
876554|NCT01347086|2889515|P7|Overall Study|failed screening visit|1
876555|NCT01347086|2889516|P6|Overall Study|failed screening visit|0
876556|NCT01347086|2889517|P5|Overall Study|failed screening visit|0
876557|NCT01347086|2889518|P4|Overall Study|failed screening visit|0
876558|NCT01347086|2889519|P3|Overall Study|failed screening visit|1
876559|NCT01347086|2889520|P2|Overall Study|failed screening visit|0
876560|NCT01347086|2889521|P1|Overall Study|failed screening visit|0
876561|NCT01347073|2889620|P1|Overall Study|Liver Transplant|1
876562|NCT01347073|2889620|P1|Overall Study|Adverse Event|1
876563|NCT01346774|2889699|P2|Overall Study|Adverse Event|2
876564|NCT01346774|2889700|P1|Overall Study|Adverse Event|1
876565|NCT01346774|2889699|P2|Overall Study|Protocol Violation|3
876566|NCT01346774|2889700|P1|Overall Study|Protocol Violation|2
876567|NCT01346774|2889699|P2|Overall Study|Withdrawal by Subject|4
876568|NCT01346774|2889700|P1|Overall Study|Withdrawal by Subject|1
876569|NCT01346774|2889699|P2|Overall Study|Lost to Follow-up|4
876570|NCT01346774|2889700|P1|Overall Study|Lost to Follow-up|3
876571|NCT01346774|2889699|P2|Overall Study|Did not take a single dose|4
876572|NCT01346774|2889700|P1|Overall Study|Did not take a single dose|6
876573|NCT01346592|2889709|P3|Overall Study|Unable to Classify|6
876574|NCT01346592|2889710|P2|Overall Study|Unable to Classify|3
876575|NCT01346592|2889711|P1|Overall Study|Unable to Classify|7
876576|NCT01346592|2889709|P3|Overall Study|Administrative reason|0
876577|NCT01346592|2889710|P2|Overall Study|Administrative reason|0
876578|NCT01346592|2889711|P1|Overall Study|Administrative reason|1
876579|NCT01346592|2889709|P3|Overall Study|Inappropriate enrollment|1
876580|NCT01346592|2889710|P2|Overall Study|Inappropriate enrollment|1
876581|NCT01346592|2889711|P1|Overall Study|Inappropriate enrollment|3
876582|NCT01346592|2889709|P3|Overall Study|Withdrawal by Subject|38
876583|NCT01346592|2889710|P2|Overall Study|Withdrawal by Subject|51
876584|NCT01346592|2889711|P1|Overall Study|Withdrawal by Subject|77
876585|NCT01346592|2889709|P3|Overall Study|Adverse Event|0
876586|NCT01346592|2889710|P2|Overall Study|Adverse Event|1
876587|NCT01346592|2889711|P1|Overall Study|Adverse Event|0
876588|NCT01346592|2889709|P3|Overall Study|Death|4
876589|NCT01346592|2889710|P2|Overall Study|Death|3
876590|NCT01346592|2889711|P1|Overall Study|Death|1
876591|NCT01346592|2889709|P3|Overall Study|Protocol Violation|0
876592|NCT01346592|2889710|P2|Overall Study|Protocol Violation|1
876593|NCT01346592|2889711|P1|Overall Study|Protocol Violation|2
876594|NCT01346592|2889709|P3|Overall Study|Lost to Follow-up|29
876595|NCT01346592|2889710|P2|Overall Study|Lost to Follow-up|29
876596|NCT01346592|2889711|P1|Overall Study|Lost to Follow-up|62
876597|NCT01346540|2889803|P2|Overall Study|Adverse Event|4
876598|NCT01346540|2889804|P1|Overall Study|Adverse Event|0
876599|NCT01346540|2889803|P2|Overall Study|Progressive disease-RECIST 1.1 criteria|8
876600|NCT01346540|2889804|P1|Overall Study|Progressive disease-RECIST 1.1 criteria|3
876601|NCT01346514|2889815|P2|Overall Study|Death|4
876602|NCT01346514|2889816|P1|Overall Study|Death|3
876603|NCT01346514|2889815|P2|Overall Study|Withdrawal by Subject|3
876604|NCT01346514|2889816|P1|Overall Study|Withdrawal by Subject|7
876605|NCT01346514|2889815|P2|Overall Study|Lost to Follow-up|30
876606|NCT01346514|2889816|P1|Overall Study|Lost to Follow-up|19
876607|NCT01346501|2889836|P2|Overall Study|Not Specified|12
876608|NCT01346501|2889837|P1|Overall Study|Not Specified|8
876609|NCT01346501|2889836|P2|Overall Study|Initiated Other Biological Agents|1
876610|NCT01346501|2889837|P1|Overall Study|Initiated Other Biological Agents|3
876611|NCT01346475|2889870|P2|First Intervention|Lost to Follow-up|3
876612|NCT01346475|2889871|P1|First Intervention|Lost to Follow-up|4
876613|NCT01346410|2889883|P1|Overall Study|Death|1
876614|NCT01346293|2889900|P2|Overall Study|Other|0
876615|NCT01346293|2889901|P1|Overall Study|Other|1
876616|NCT01346293|2889900|P2|Overall Study|Withdrawal by Subject|4
876617|NCT01346293|2889901|P1|Overall Study|Withdrawal by Subject|15
876618|NCT01346293|2889900|P2|Overall Study|Lost to Follow-up|8
876619|NCT01346293|2889901|P1|Overall Study|Lost to Follow-up|21
876620|NCT01346293|2889900|P2|Overall Study|Protocol Violation|9
876621|NCT01346293|2889901|P1|Overall Study|Protocol Violation|30
876622|NCT01346189|2889931|P4|Overall Study|Travel|3
876623|NCT01346189|2889932|P3|Overall Study|Travel|0
876624|NCT01346189|2889933|P2|Overall Study|Travel|0
876625|NCT01346189|2889934|P1|Overall Study|Travel|0
876626|NCT01346189|2889931|P4|Overall Study|Non-health system primary care physician|0
876627|NCT01346189|2889932|P3|Overall Study|Non-health system primary care physician|0
876628|NCT01346189|2889933|P2|Overall Study|Non-health system primary care physician|5
876629|NCT01346189|2889934|P1|Overall Study|Non-health system primary care physician|0
876630|NCT01346189|2889931|P4|Overall Study|Death|0
876631|NCT01346189|2889932|P3|Overall Study|Death|0
876632|NCT01346189|2889933|P2|Overall Study|Death|3
876633|NCT01346189|2889934|P1|Overall Study|Death|0
876634|NCT01346189|2889931|P4|Overall Study|Other|3
876635|NCT01346189|2889932|P3|Overall Study|Other|7
876636|NCT01346189|2889933|P2|Overall Study|Other|4
876637|NCT01346189|2889934|P1|Overall Study|Other|2
876638|NCT01346189|2889931|P4|Overall Study|Moved|0
876639|NCT01346189|2889932|P3|Overall Study|Moved|4
876640|NCT01346189|2889933|P2|Overall Study|Moved|0
876641|NCT01346189|2889934|P1|Overall Study|Moved|3
876642|NCT01346189|2889931|P4|Overall Study|Physician Decision|0
876643|NCT01346189|2889932|P3|Overall Study|Physician Decision|0
876644|NCT01346189|2889933|P2|Overall Study|Physician Decision|0
876645|NCT01346189|2889934|P1|Overall Study|Physician Decision|4
876646|NCT01346189|2889931|P4|Overall Study|Withdrawal by Subject|5
876647|NCT01346189|2889932|P3|Overall Study|Withdrawal by Subject|3
876648|NCT01346189|2889933|P2|Overall Study|Withdrawal by Subject|5
876649|NCT01346189|2889934|P1|Overall Study|Withdrawal by Subject|7
876650|NCT01346176|2889951|P3|Completed Satisfaction Survey|Lost to Follow-up|4
876651|NCT01346176|2889952|P2|Completed Satisfaction Survey|Lost to Follow-up|4
876652|NCT01346176|2889953|P1|Completed Satisfaction Survey|Lost to Follow-up|3
876653|NCT01346176|2889951|P3|Completed Satisfaction Survey|Death|2
876654|NCT01346176|2889952|P2|Completed Satisfaction Survey|Death|0
876655|NCT01346176|2889953|P1|Completed Satisfaction Survey|Death|3
876656|NCT01346176|2889951|P3|Completed Advance Directive|Other reason did not complete AD|7
876657|NCT01346176|2889952|P2|Completed Advance Directive|Other reason did not complete AD|12
876658|NCT01346176|2889953|P1|Completed Advance Directive|Other reason did not complete AD|7
876659|NCT01346176|2889951|P3|Completed Advance Directive|Became Ineligible|1
876660|NCT01346176|2889952|P2|Completed Advance Directive|Became Ineligible|0
876661|NCT01346176|2889953|P1|Completed Advance Directive|Became Ineligible|3
876662|NCT01346176|2889951|P3|Completed Advance Directive|Death|2
876663|NCT01346176|2889952|P2|Completed Advance Directive|Death|2
876664|NCT01346176|2889953|P1|Completed Advance Directive|Death|3
876665|NCT01346176|2889951|P3|Recruited|Protocol Violation|0
876666|NCT01346176|2889952|P2|Recruited|Protocol Violation|0
876667|NCT01346176|2889953|P1|Recruited|Protocol Violation|1
876668|NCT01346059|2889982|P2|Overall Study|Withdrawal by Subject|0
876669|NCT01346059|2889983|P1|Overall Study|Withdrawal by Subject|1
876670|NCT01345929|2889995|P2|Overall Study|Patient withdrawal|1
876671|NCT01345929|2889996|P1|Overall Study|Patient withdrawal|0
876672|NCT01345929|2889995|P2|Overall Study|40,000 CFU/ML|0
876673|NCT01345929|2889996|P1|Overall Study|40,000 CFU/ML|1
876674|NCT01345929|2889995|P2|Overall Study|Didn't meet eligibility criteria|0
876675|NCT01345929|2889996|P1|Overall Study|Didn't meet eligibility criteria|2
876676|NCT01345929|2889995|P2|Overall Study|Adverse Event|1
876677|NCT01345929|2889996|P1|Overall Study|Adverse Event|0
876678|NCT01345929|2889995|P2|Overall Study|Lost to Follow-up|9
876679|NCT01345929|2889996|P1|Overall Study|Lost to Follow-up|9
876680|NCT01345929|2889995|P2|Overall Study|Withdrawal by Subject|8
876681|NCT01345929|2889996|P1|Overall Study|Withdrawal by Subject|9
876682|NCT01345786|2890008|P4|Overall Study|Lost to Follow-up|2
876683|NCT01345786|2890009|P3|Overall Study|Lost to Follow-up|0
876684|NCT01345786|2890010|P2|Overall Study|Lost to Follow-up|0
876685|NCT01345786|2890011|P1|Overall Study|Lost to Follow-up|0
876686|NCT01345786|2890008|P4|Overall Study|Administrative|0
876687|NCT01345786|2890009|P3|Overall Study|Administrative|0
876688|NCT01345786|2890010|P2|Overall Study|Administrative|5
876689|NCT01345786|2890011|P1|Overall Study|Administrative|3
876690|NCT01345786|2890008|P4|Overall Study|Noncompliance with protocol|0
876691|NCT01345786|2890009|P3|Overall Study|Noncompliance with protocol|1
876692|NCT01345786|2890010|P2|Overall Study|Noncompliance with protocol|0
876693|NCT01345786|2890011|P1|Overall Study|Noncompliance with protocol|1
876694|NCT01345786|2890008|P4|Overall Study|Subject withdrew consent|0
876695|NCT01345786|2890009|P3|Overall Study|Subject withdrew consent|1
876696|NCT01345786|2890010|P2|Overall Study|Subject withdrew consent|2
876697|NCT01345786|2890011|P1|Overall Study|Subject withdrew consent|2
876698|NCT01345786|2890008|P4|Overall Study|Adverse Event|1
876699|NCT01345786|2890009|P3|Overall Study|Adverse Event|3
876700|NCT01345786|2890010|P2|Overall Study|Adverse Event|1
876701|NCT01345786|2890011|P1|Overall Study|Adverse Event|0
876702|NCT01345682|2890091|P2|Overall Study|Reason other than those specified above|3
876703|NCT01345682|2890092|P1|Overall Study|Reason other than those specified above|4
876704|NCT01345682|2890091|P2|Overall Study|Not treated|1
876705|NCT01345682|2890092|P1|Overall Study|Not treated|2
876706|NCT01345682|2890091|P2|Overall Study|Refused to continue trial medication|9
876707|NCT01345682|2890092|P1|Overall Study|Refused to continue trial medication|16
876708|NCT01345682|2890091|P2|Overall Study|Lost to Follow-up|1
876709|NCT01345682|2890092|P1|Overall Study|Lost to Follow-up|0
876710|NCT01345682|2890091|P2|Overall Study|Non-compliance with protocol|1
876711|NCT01345682|2890092|P1|Overall Study|Non-compliance with protocol|0
876712|NCT01345682|2890091|P2|Overall Study|Adverse Event|41
876713|NCT01345682|2890092|P1|Overall Study|Adverse Event|51
876714|NCT01345682|2890091|P2|Overall Study|Worsening of underlying cancer disease|12
876715|NCT01345682|2890092|P1|Overall Study|Worsening of underlying cancer disease|23
876716|NCT01345682|2890091|P2|Overall Study|Progressive disease per RECIST|93
876717|NCT01345682|2890092|P1|Overall Study|Progressive disease per RECIST|226
876718|NCT01345669|2890126|P2|Overall Study|Other Reasons|60
876719|NCT01345669|2890127|P1|Overall Study|Other Reasons|111
876720|NCT01345669|2890126|P2|Overall Study|Withdrawal by Subject|13
876721|NCT01345669|2890127|P1|Overall Study|Withdrawal by Subject|52
876722|NCT01345669|2890126|P2|Overall Study|Lost to Follow-up|1
876723|NCT01345669|2890127|P1|Overall Study|Lost to Follow-up|1
876724|NCT01345669|2890126|P2|Overall Study|Protocol Violation|1
876725|NCT01345669|2890127|P1|Overall Study|Protocol Violation|3
876726|NCT01345669|2890126|P2|Overall Study|Adverse Event|9
876727|NCT01345669|2890127|P1|Overall Study|Adverse Event|63
876728|NCT01345669|2890126|P2|Overall Study|Second primary tumour|3
876729|NCT01345669|2890127|P1|Overall Study|Second primary tumour|4
876730|NCT01345669|2890126|P2|Overall Study|Primary tumour recurrence|32
876731|NCT01345669|2890127|P1|Overall Study|Primary tumour recurrence|53
876732|NCT01345630|2890145|P2|Overall Study|Insufficient clinical response|11
876733|NCT01345630|2890146|P1|Overall Study|Insufficient clinical response|48
876734|NCT01345630|2890145|P2|Overall Study|No longer willing to participate|12
876735|NCT01345630|2890146|P1|Overall Study|No longer willing to participate|9
876736|NCT01345630|2890145|P2|Overall Study|Withdrawn due to pregnancy|2
876737|NCT01345630|2890146|P1|Overall Study|Withdrawn due to pregnancy|1
876738|NCT01345630|2890145|P2|Overall Study|Other reasons|8
876739|NCT01345630|2890146|P1|Overall Study|Other reasons|6
876740|NCT01345630|2890145|P2|Overall Study|Study terminated by sponsor|285
876741|NCT01345630|2890146|P1|Overall Study|Study terminated by sponsor|254
876742|NCT01345630|2890145|P2|Overall Study|Medication error without associated AE|1
876743|NCT01345630|2890146|P1|Overall Study|Medication error without associated AE|0
876744|NCT01345630|2890145|P2|Overall Study|Protocol Violation|1
876745|NCT01345630|2890146|P1|Overall Study|Protocol Violation|4
876746|NCT01345630|2890145|P2|Overall Study|Lost to Follow-up|16
876747|NCT01345630|2890146|P1|Overall Study|Lost to Follow-up|17
876748|NCT01345630|2890145|P2|Overall Study|Adverse Event|23
876749|NCT01345630|2890146|P1|Overall Study|Adverse Event|22
876750|NCT01345591|2890202|P1|Overall Study|Lost to Follow-up|1
876751|NCT01345318|2890211|P1|Overall Study|Other|3
876752|NCT01345318|2890211|P1|Overall Study|Withdrawal by Subject|41
876753|NCT01345318|2890211|P1|Overall Study|Protocol Violation|1
876754|NCT01345318|2890211|P1|Overall Study|Lost to Follow-up|2
876755|NCT01345318|2890211|P1|Overall Study|Lack of Efficacy|17
876756|NCT01345318|2890211|P1|Overall Study|Adverse Event|16
876757|NCT01345292|2890219|P3|Overall Study|Withdrawal by Subject|1
876758|NCT01345292|2890220|P2|Overall Study|Withdrawal by Subject|0
876759|NCT01345292|2890221|P1|Overall Study|Withdrawal by Subject|2
876760|NCT01345253|2890252|P2|Overall Study|Withdrawal by Subject|19
876761|NCT01345253|2890253|P1|Overall Study|Withdrawal by Subject|9
876762|NCT01345253|2890252|P2|Overall Study|Physician Decision|12
876763|NCT01345253|2890253|P1|Overall Study|Physician Decision|4
876764|NCT01345253|2890252|P2|Overall Study|Lost to Follow-up|8
876765|NCT01345253|2890253|P1|Overall Study|Lost to Follow-up|3
876766|NCT01345253|2890252|P2|Overall Study|Met Protocol Defined Stopping Criteria|1
876767|NCT01345253|2890253|P1|Overall Study|Met Protocol Defined Stopping Criteria|6
876768|NCT01345253|2890252|P2|Overall Study|Protocol Violation|5
876769|NCT01345253|2890253|P1|Overall Study|Protocol Violation|1
876770|NCT01345253|2890252|P2|Overall Study|Lack of Efficacy|7
876771|NCT01345253|2890253|P1|Overall Study|Lack of Efficacy|11
876772|NCT01345253|2890252|P2|Overall Study|Adverse Event|27
876773|NCT01345253|2890253|P1|Overall Study|Adverse Event|22
876774|NCT01345240|2890272|P5|Overall Study|Serious Adverse Event|1
876775|NCT01345240|2890273|P4|Overall Study|Serious Adverse Event|2
876776|NCT01345240|2890274|P3|Overall Study|Serious Adverse Event|2
876777|NCT01345240|2890275|P2|Overall Study|Serious Adverse Event|2
876778|NCT01345240|2890276|P1|Overall Study|Serious Adverse Event|1
876779|NCT01345240|2890272|P5|Overall Study|Lost to Follow-up|6
876780|NCT01345240|2890273|P4|Overall Study|Lost to Follow-up|8
876781|NCT01345240|2890274|P3|Overall Study|Lost to Follow-up|8
876782|NCT01345240|2890275|P2|Overall Study|Lost to Follow-up|12
876783|NCT01345240|2890276|P1|Overall Study|Lost to Follow-up|1
876784|NCT01345188|2890369|P1|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1
876785|NCT01345188|2890369|P1|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2
876786|NCT01345162|2890381|P2|Overall Study|Protocol Violation|4
876787|NCT01345162|2890382|P1|Overall Study|Protocol Violation|2
876788|NCT01345123|2890391|P3|Overall Study|participants no longer with health plan|88
876789|NCT01345123|2890392|P2|Overall Study|participants no longer with health plan|85
876790|NCT01345123|2890393|P1|Overall Study|participants no longer with health plan|79
876791|NCT01345058|2890415|P2|Overall Study|Participant No-Show at Multiple Visits|0
876792|NCT01345058|2890416|P1|Overall Study|Participant No-Show at Multiple Visits|1
876793|NCT01345058|2890415|P2|Overall Study|Participant Stopped Taking Study Drug|0
876794|NCT01345058|2890416|P1|Overall Study|Participant Stopped Taking Study Drug|1
876795|NCT01345058|2890415|P2|Overall Study|Side Effects of Hair Loss and Itchiness|0
876796|NCT01345058|2890416|P1|Overall Study|Side Effects of Hair Loss and Itchiness|1
876797|NCT01345058|2890415|P2|Overall Study|Participant Reported Increase in Events|0
876798|NCT01345058|2890416|P1|Overall Study|Participant Reported Increase in Events|1
876799|NCT01345058|2890415|P2|Overall Study|Withdrawal by Subject|0
876800|NCT01345058|2890416|P1|Overall Study|Withdrawal by Subject|1
876801|NCT01345019|2890432|P2|Overall Study|Other|3
876802|NCT01345019|2890433|P1|Overall Study|Other|1
876803|NCT01345019|2890432|P2|Overall Study|Protocol Deviation|0
876804|NCT01345019|2890433|P1|Overall Study|Protocol Deviation|5
876805|NCT01345019|2890432|P2|Overall Study|Lost to Follow-up|2
876806|NCT01345019|2890433|P1|Overall Study|Lost to Follow-up|4
876807|NCT01345019|2890432|P2|Overall Study|Ineligibility Determined|6
876808|NCT01345019|2890433|P1|Overall Study|Ineligibility Determined|1
876809|NCT01345019|2890432|P2|Overall Study|Noncompliance|4
876810|NCT01345019|2890433|P1|Overall Study|Noncompliance|4
876811|NCT01345019|2890432|P2|Overall Study|Administrative Decision|5
876812|NCT01345019|2890433|P1|Overall Study|Administrative Decision|8
876813|NCT01345019|2890432|P2|Overall Study|Adverse Event|13
876814|NCT01345019|2890433|P1|Overall Study|Adverse Event|4
876815|NCT01345019|2890432|P2|Overall Study|Disease Progression|8
876816|NCT01345019|2890433|P1|Overall Study|Disease Progression|11
876817|NCT01345019|2890432|P2|Overall Study|Completed Survival Follow-up|4
876818|NCT01345019|2890433|P1|Overall Study|Completed Survival Follow-up|16
876819|NCT01345019|2890432|P2|Overall Study|Withdrawal by Subject|107
876820|NCT01345019|2890433|P1|Overall Study|Withdrawal by Subject|82
876821|NCT01345019|2890432|P2|Overall Study|Death|120
876822|NCT01345019|2890433|P1|Overall Study|Death|127
876823|NCT01344876|2890453|P5|Overall Study|Definite progression of primary disease|0
876824|NCT01344876|2890454|P4|Overall Study|Definite progression of primary disease|3
876825|NCT01344876|2890455|P3|Overall Study|Definite progression of primary disease|0
876826|NCT01344876|2890456|P2|Overall Study|Definite progression of primary disease|0
876827|NCT01344876|2890457|P1|Overall Study|Definite progression of primary disease|1
876828|NCT01344876|2890453|P5|Overall Study|Withdrawal by Subject|0
876829|NCT01344876|2890454|P4|Overall Study|Withdrawal by Subject|0
876830|NCT01344876|2890455|P3|Overall Study|Withdrawal by Subject|1
876831|NCT01344876|2890456|P2|Overall Study|Withdrawal by Subject|0
876832|NCT01344876|2890457|P1|Overall Study|Withdrawal by Subject|0
876833|NCT01344876|2890453|P5|Overall Study|Adverse Event|1
876834|NCT01344876|2890454|P4|Overall Study|Adverse Event|0
876835|NCT01344876|2890455|P3|Overall Study|Adverse Event|0
876836|NCT01344876|2890456|P2|Overall Study|Adverse Event|0
876837|NCT01344876|2890457|P1|Overall Study|Adverse Event|0
876838|NCT01344824|2890471|P1|Overall Study|Progression|15
876839|NCT01344824|2890471|P1|Overall Study|Other complicating disease|1
876840|NCT01344824|2890471|P1|Overall Study|Withdrawal by Subject|6
876841|NCT01344824|2890471|P1|Overall Study|Adverse Event|15
876842|NCT01344759|2890479|P2|Overall Study|Patients failed to reach sedation level|2
876843|NCT01344759|2890480|P1|Overall Study|Patients failed to reach sedation level|0
876844|NCT01344629|2890512|P2|Crossover Period 2|Withdrawal by Subject|1
876845|NCT01344629|2890513|P1|Crossover Period 2|Withdrawal by Subject|0
876846|NCT01344538|2890542|P2|Overall Study|Lost to Follow-up|0
876847|NCT01344538|2890543|P1|Overall Study|Lost to Follow-up|1
876848|NCT01344538|2890542|P2|Overall Study|Adverse Event|1
876849|NCT01344538|2890543|P1|Overall Study|Adverse Event|1
876850|NCT01344460|2890549|P1|Overall Study|Lost to Follow-up|2
876851|NCT01344460|2890549|P1|Overall Study|Withdrawal by Subject|1
876852|NCT01344447|2890594|P1|Overall Study|Error of power injector|1
876853|NCT01344447|2890594|P1|Overall Study|Bolus tracking failed|1
876854|NCT01344447|2890594|P1|Overall Study|MRA unsuccessful|1
876855|NCT01344447|2890594|P1|Overall Study|Physician Decision|1
876856|NCT01344447|2890594|P1|Overall Study|The contrast was not seen|1
876857|NCT01344447|2890594|P1|Overall Study|Withdrawal by Subject|1
876858|NCT01344447|2890594|P1|Overall Study|Protocol Violation|1
876859|NCT01344447|2890594|P1|Overall Study|Adverse Event|1
876860|NCT01344369|2890638|P2|Second Intervention|Emesis within 2 x Tmax|1
876861|NCT01344369|2890639|P1|Second Intervention|Emesis within 2 x Tmax|0
876862|NCT01344369|2890638|P2|Washout of 28 Days|Physician Decision|1
876863|NCT01344369|2890639|P1|Washout of 28 Days|Physician Decision|0
876864|NCT01344369|2890638|P2|Washout of 28 Days|Withdrawal by Subject|0
876865|NCT01344369|2890639|P1|Washout of 28 Days|Withdrawal by Subject|1
876866|NCT01344226|2890655|P1|Overall Study|Lack of Efficacy|3
876867|NCT01344226|2890655|P1|Overall Study|Withdrawal by Subject|3
876868|NCT01344226|2890655|P1|Overall Study|Protocol Violation|2
876869|NCT01344161|2890664|P2|Overall Study|Protocol Violation|1
876870|NCT01344161|2890665|P1|Overall Study|Protocol Violation|1
876871|NCT01344161|2890664|P2|Overall Study|Pregnancy|1
876872|NCT01344161|2890665|P1|Overall Study|Pregnancy|0
876873|NCT01344161|2890664|P2|Overall Study|Lost to Follow-up|1
876874|NCT01344161|2890665|P1|Overall Study|Lost to Follow-up|4
876875|NCT01344057|2890677|P1|Overall Study|Premature Withdrawal|1
876876|NCT01343901|2890684|P1|Overall Study|Participant decision|1
876877|NCT01343901|2890684|P1|Overall Study|Management by another medical team|11
876878|NCT01343901|2890684|P1|Overall Study|Lost to Follow-up|12
876879|NCT01343901|2890684|P1|Overall Study|Physician Decision|4
876880|NCT01343901|2890684|P1|Overall Study|Death|85
876881|NCT01343888|2890708|P3|Overall Study|other than stated above|1
876882|NCT01343888|2890709|P2|Overall Study|other than stated above|0
876883|NCT01343888|2890710|P1|Overall Study|other than stated above|0
876884|NCT01343888|2890708|P3|Overall Study|Withdrawal by Subject|2
876885|NCT01343888|2890709|P2|Overall Study|Withdrawal by Subject|4
876886|NCT01343888|2890710|P1|Overall Study|Withdrawal by Subject|4
876887|NCT01343888|2890708|P3|Overall Study|Protocol Violation|0
876888|NCT01343888|2890709|P2|Overall Study|Protocol Violation|2
876889|NCT01343888|2890710|P1|Overall Study|Protocol Violation|0
876890|NCT01343888|2890708|P3|Overall Study|Lost to Follow-up|1
876891|NCT01343888|2890709|P2|Overall Study|Lost to Follow-up|2
876892|NCT01343888|2890710|P1|Overall Study|Lost to Follow-up|0
876893|NCT01343888|2890708|P3|Overall Study|Lack of Efficacy|13
876894|NCT01343888|2890709|P2|Overall Study|Lack of Efficacy|9
876895|NCT01343888|2890710|P1|Overall Study|Lack of Efficacy|9
876896|NCT01343888|2890708|P3|Overall Study|Adverse Event|5
876897|NCT01343888|2890709|P2|Overall Study|Adverse Event|22
876898|NCT01343888|2890710|P1|Overall Study|Adverse Event|12
876899|NCT01343823|2890752|P4|Overall Study|Withdrawal by Subject|0
876900|NCT01343823|2890753|P3|Overall Study|Withdrawal by Subject|0
876901|NCT01343823|2890754|P2|Overall Study|Withdrawal by Subject|0
876902|NCT01343823|2890755|P1|Overall Study|Withdrawal by Subject|1
876903|NCT01343823|2890752|P4|Overall Study|Study Terminated|1
876904|NCT01343823|2890753|P3|Overall Study|Study Terminated|0
876905|NCT01343823|2890754|P2|Overall Study|Study Terminated|0
876906|NCT01343823|2890755|P1|Overall Study|Study Terminated|1
876907|NCT01343368|2890789|P2|Overall Study|Lost to Follow-up|0
876908|NCT01343368|2890790|P1|Overall Study|Lost to Follow-up|1
876909|NCT01343368|2890789|P2|Overall Study|Death|0
876910|NCT01343368|2890790|P1|Overall Study|Death|1
876911|NCT01343277|2890826|P2|Overall Study|Subsequent anticancer therapy|0
876912|NCT01343277|2890827|P1|Overall Study|Subsequent anticancer therapy|1
876913|NCT01343277|2890826|P2|Overall Study|Treatment ongoing|2
876914|NCT01343277|2890827|P1|Overall Study|Treatment ongoing|8
876915|NCT01343277|2890826|P2|Overall Study|Randomized not treated|21
876916|NCT01343277|2890827|P1|Overall Study|Randomized not treated|6
876917|NCT01343277|2890826|P2|Overall Study|Disease progression|138
876918|NCT01343277|2890827|P1|Overall Study|Disease progression|270
876919|NCT01343277|2890826|P2|Overall Study|Adverse Event|13
876920|NCT01343277|2890827|P1|Overall Study|Adverse Event|67
876921|NCT01343277|2890826|P2|Overall Study|Death|1
876922|NCT01343277|2890827|P1|Overall Study|Death|10
876923|NCT01343277|2890826|P2|Overall Study|Physician Decision|2
876924|NCT01343277|2890827|P1|Overall Study|Physician Decision|1
876925|NCT01343277|2890826|P2|Overall Study|Withdrawal by Subject|13
876926|NCT01343277|2890827|P1|Overall Study|Withdrawal by Subject|18
876927|NCT01343277|2890826|P2|Overall Study|Other|3
876928|NCT01343277|2890827|P1|Overall Study|Other|3
876929|NCT01343082|2890888|P3|Treatment Period , Switched to DE-111|Withdrawal by Subject|5
876930|NCT01343082|2890889|P2|Treatment Period , Switched to DE-111|Withdrawal by Subject|2
876931|NCT01343082|2890890|P1|Treatment Period , Switched to DE-111|Withdrawal by Subject|4
876932|NCT01343082|2890888|P3|Treatment Period , Switched to DE-111|Physician Decision|2
876933|NCT01343082|2890889|P2|Treatment Period , Switched to DE-111|Physician Decision|2
876934|NCT01343082|2890890|P1|Treatment Period , Switched to DE-111|Physician Decision|0
876935|NCT01343082|2890888|P3|Treatment Period , Switched to DE-111|Lack of Efficacy|2
876936|NCT01343082|2890889|P2|Treatment Period , Switched to DE-111|Lack of Efficacy|1
876937|NCT01343082|2890890|P1|Treatment Period , Switched to DE-111|Lack of Efficacy|0
876938|NCT01343082|2890888|P3|Treatment Period , Switched to DE-111|Adverse Event|3
876939|NCT01343082|2890889|P2|Treatment Period , Switched to DE-111|Adverse Event|4
876940|NCT01343082|2890890|P1|Treatment Period , Switched to DE-111|Adverse Event|1
876941|NCT01343082|2890888|P3|The run-in Period|Not meeting criteria|5
876942|NCT01343082|2890889|P2|The run-in Period|Not meeting criteria|4
876943|NCT01343082|2890890|P1|The run-in Period|Not meeting criteria|3
876944|NCT01343056|2890898|P4|Overall Study|Lost to Follow-up|9
876945|NCT01343056|2890899|P3|Overall Study|Lost to Follow-up|3
876946|NCT01343056|2890900|P2|Overall Study|Lost to Follow-up|5
876947|NCT01343056|2890901|P1|Overall Study|Lost to Follow-up|7
876948|NCT01342965|2890969|P2|Overall Study|Withdrawal by Subject|9
876949|NCT01342965|2890970|P1|Overall Study|Withdrawal by Subject|2
876950|NCT01342965|2890969|P2|Overall Study|Other Reasons- Unspecified|38
876951|NCT01342965|2890970|P1|Overall Study|Other Reasons- Unspecified|44
876952|NCT01342965|2890969|P2|Overall Study|Lost to Follow-up|3
876953|NCT01342965|2890970|P1|Overall Study|Lost to Follow-up|5
876954|NCT01342965|2890969|P2|Overall Study|Death|57
876955|NCT01342965|2890970|P1|Overall Study|Death|58
876956|NCT01342926|2890988|P4|Overall Study|Withdrawal by Subject|5
876957|NCT01342926|2890989|P3|Overall Study|Withdrawal by Subject|3
876958|NCT01342926|2890990|P2|Overall Study|Withdrawal by Subject|4
876959|NCT01342926|2890991|P1|Overall Study|Withdrawal by Subject|2
876960|NCT01342926|2890988|P4|Overall Study|Investigator Discretion|0
876961|NCT01342926|2890989|P3|Overall Study|Investigator Discretion|0
876962|NCT01342926|2890990|P2|Overall Study|Investigator Discretion|2
876963|NCT01342926|2890991|P1|Overall Study|Investigator Discretion|2
876964|NCT01342926|2890988|P4|Overall Study|Lost to Follow-up|0
876965|NCT01342926|2890989|P3|Overall Study|Lost to Follow-up|1
876966|NCT01342926|2890990|P2|Overall Study|Lost to Follow-up|1
876967|NCT01342926|2890991|P1|Overall Study|Lost to Follow-up|0
876968|NCT01342926|2890988|P4|Overall Study|Adverse Event|7
876969|NCT01342926|2890989|P3|Overall Study|Adverse Event|10
876970|NCT01342926|2890990|P2|Overall Study|Adverse Event|8
876971|NCT01342926|2890991|P1|Overall Study|Adverse Event|5
876972|NCT01342913|2891071|P3|Double-Blind Treatment Period|Withdrawal by Subject|2
876973|NCT01342913|2891072|P2|Double-Blind Treatment Period|Withdrawal by Subject|2
876974|NCT01342913|2891073|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
876975|NCT01342913|2891071|P3|Double-Blind Treatment Period|Physician Decision|0
876976|NCT01342913|2891072|P2|Double-Blind Treatment Period|Physician Decision|2
876977|NCT01342913|2891073|P1|Double-Blind Treatment Period|Physician Decision|0
876978|NCT01342913|2891071|P3|Double-Blind Treatment Period|Lost to Follow-up|3
876979|NCT01342913|2891072|P2|Double-Blind Treatment Period|Lost to Follow-up|1
876980|NCT01342913|2891073|P1|Double-Blind Treatment Period|Lost to Follow-up|0
876981|NCT01342913|2891071|P3|Double-Blind Treatment Period|Protocol Violation|9
876982|NCT01342913|2891072|P2|Double-Blind Treatment Period|Protocol Violation|6
876983|NCT01342913|2891073|P1|Double-Blind Treatment Period|Protocol Violation|0
876984|NCT01342913|2891071|P3|Double-Blind Treatment Period|Lack of Efficacy|3
876985|NCT01342913|2891072|P2|Double-Blind Treatment Period|Lack of Efficacy|2
876986|NCT01342913|2891073|P1|Double-Blind Treatment Period|Lack of Efficacy|0
876987|NCT01342913|2891071|P3|Double-Blind Treatment Period|Adverse Event|6
876988|NCT01342913|2891072|P2|Double-Blind Treatment Period|Adverse Event|3
876989|NCT01342913|2891073|P1|Double-Blind Treatment Period|Adverse Event|0
876990|NCT01342913|2891071|P3|2-week Run-in Period|Continuation Criteria Not Met|0
876991|NCT01342913|2891072|P2|2-week Run-in Period|Continuation Criteria Not Met|0
876992|NCT01342913|2891073|P1|2-week Run-in Period|Continuation Criteria Not Met|88
876993|NCT01342913|2891071|P3|2-week Run-in Period|Protocol Violation|0
876994|NCT01342913|2891072|P2|2-week Run-in Period|Protocol Violation|0
876995|NCT01342913|2891073|P1|2-week Run-in Period|Protocol Violation|5
876996|NCT01342913|2891071|P3|2-week Run-in Period|Adverse Event|0
876997|NCT01342913|2891072|P2|2-week Run-in Period|Adverse Event|0
876998|NCT01342913|2891073|P1|2-week Run-in Period|Adverse Event|2
876999|NCT01342913|2891071|P3|2-week Run-in Period|Withdrawal by Subject|0
877000|NCT01342913|2891072|P2|2-week Run-in Period|Withdrawal by Subject|0
877001|NCT01342913|2891073|P1|2-week Run-in Period|Withdrawal by Subject|7
877002|NCT01342913|2891071|P3|2-week Run-in Period|Physician Decision|0
877003|NCT01342913|2891072|P2|2-week Run-in Period|Physician Decision|0
877004|NCT01342913|2891073|P1|2-week Run-in Period|Physician Decision|6
877005|NCT01342913|2891071|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
877006|NCT01342913|2891072|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
877007|NCT01342913|2891073|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66
877008|NCT01342887|2891083|P1|Overall Study|Death|2
877009|NCT01342640|2891124|P1|Overall Study|Other|1
877010|NCT01342640|2891124|P1|Overall Study|Lost to Follow-up|21
877011|NCT01342640|2891124|P1|Overall Study|Protocol Violation|16
877012|NCT01342640|2891124|P1|Overall Study|Adverse Event|3
877013|NCT01342510|2891219|P4|Overall Study|Protocol Violation|11
877014|NCT01342510|2891220|P3|Overall Study|Protocol Violation|13
877015|NCT01342510|2891221|P2|Overall Study|Protocol Violation|6
877016|NCT01342510|2891222|P1|Overall Study|Protocol Violation|12
877017|NCT01342484|2891235|P3|Overall Study|Withdrawal by Subject|0
877018|NCT01342484|2891236|P2|Overall Study|Withdrawal by Subject|0
877019|NCT01342484|2891237|P1|Overall Study|Withdrawal by Subject|1
877020|NCT01342484|2891235|P3|Overall Study|Protocol Violation|1
877021|NCT01342484|2891236|P2|Overall Study|Protocol Violation|0
877022|NCT01342484|2891237|P1|Overall Study|Protocol Violation|0
877023|NCT01342484|2891235|P3|Overall Study|Other Reasons|0
877024|NCT01342484|2891236|P2|Overall Study|Other Reasons|0
877025|NCT01342484|2891237|P1|Overall Study|Other Reasons|1
877026|NCT01342445|2891293|P2|Overall Study|Experienced side effects|2
877027|NCT01342445|2891294|P1|Overall Study|Experienced side effects|0
877028|NCT01342341|2891310|P2|Overall Study|Lost to Follow-up|4
877029|NCT01342341|2891311|P1|Overall Study|Lost to Follow-up|4
877030|NCT01342211|2891322|P5|Overall Study|Randomized, but not Treated|1
877031|NCT01342211|2891323|P4|Overall Study|Randomized, but not Treated|0
877032|NCT01342211|2891324|P3|Overall Study|Randomized, but not Treated|0
877033|NCT01342211|2891325|P2|Overall Study|Randomized, but not Treated|2
877034|NCT01342211|2891326|P1|Overall Study|Randomized, but not Treated|0
877035|NCT01342211|2891322|P5|Overall Study|Withdrawal by Subject|0
877036|NCT01342211|2891323|P4|Overall Study|Withdrawal by Subject|1
877037|NCT01342211|2891324|P3|Overall Study|Withdrawal by Subject|0
877038|NCT01342211|2891325|P2|Overall Study|Withdrawal by Subject|0
877039|NCT01342211|2891326|P1|Overall Study|Withdrawal by Subject|0
877040|NCT01342211|2891322|P5|Overall Study|Adverse Event|1
877041|NCT01342211|2891323|P4|Overall Study|Adverse Event|0
877042|NCT01342211|2891324|P3|Overall Study|Adverse Event|0
877043|NCT01342211|2891325|P2|Overall Study|Adverse Event|0
877044|NCT01342211|2891326|P1|Overall Study|Adverse Event|0
877045|NCT01342211|2891322|P5|Overall Study|Lost to Follow-up|0
877046|NCT01342211|2891323|P4|Overall Study|Lost to Follow-up|1
877047|NCT01342211|2891324|P3|Overall Study|Lost to Follow-up|0
877048|NCT01342211|2891325|P2|Overall Study|Lost to Follow-up|0
877049|NCT01342211|2891326|P1|Overall Study|Lost to Follow-up|0
877050|NCT01342094|2891407|P2|Overall Study|Withdrawal by Subject|2
877051|NCT01342094|2891408|P1|Overall Study|Withdrawal by Subject|0
877052|NCT01342094|2891407|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
877053|NCT01342094|2891408|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
877054|NCT01342094|2891407|P2|Overall Study|Adverse Event|0
877055|NCT01342094|2891408|P1|Overall Study|Adverse Event|5
877056|NCT01342081|2891417|P3|Overall Study|Withdrawal by Subject|0
877057|NCT01342081|2891418|P2|Overall Study|Withdrawal by Subject|1
877058|NCT01342081|2891419|P1|Overall Study|Withdrawal by Subject|1
877059|NCT01342081|2891417|P3|Overall Study|Physician Decision|0
877060|NCT01342081|2891418|P2|Overall Study|Physician Decision|1
877061|NCT01342081|2891419|P1|Overall Study|Physician Decision|0
877062|NCT01342081|2891417|P3|Overall Study|Adverse Event|0
877063|NCT01342081|2891418|P2|Overall Study|Adverse Event|0
877064|NCT01342081|2891419|P1|Overall Study|Adverse Event|1
877065|NCT01342081|2891417|P3|Overall Study|Did not receive allocated intervention|1
877066|NCT01342081|2891418|P2|Overall Study|Did not receive allocated intervention|0
877067|NCT01342081|2891419|P1|Overall Study|Did not receive allocated intervention|0
877068|NCT01341990|2891438|P2|Overall Study|Withdrawal by Subject|0
877069|NCT01341990|2891439|P1|Overall Study|Withdrawal by Subject|2
877070|NCT01341990|2891438|P2|Overall Study|Torn Study Lens|0
877071|NCT01341990|2891439|P1|Overall Study|Torn Study Lens|1
877072|NCT01341990|2891438|P2|Overall Study|Adverse Event|1
877073|NCT01341990|2891439|P1|Overall Study|Adverse Event|0
877074|NCT01341782|2891463|P2|Overall Study|Other|0
877075|NCT01341782|2891464|P1|Overall Study|Other|5
877076|NCT01341782|2891463|P2|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
877077|NCT01341782|2891464|P1|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
877078|NCT01341782|2891463|P2|Overall Study|2 consecutive calcium values >11.5 mg/dL|1
877079|NCT01341782|2891464|P1|Overall Study|2 consecutive calcium values >11.5 mg/dL|0
877080|NCT01341782|2891463|P2|Overall Study|Missed 3 consecutive doses|4
877081|NCT01341782|2891464|P1|Overall Study|Missed 3 consecutive doses|0
877082|NCT01341782|2891463|P2|Overall Study|Withdrawal by Subject|5
877083|NCT01341782|2891464|P1|Overall Study|Withdrawal by Subject|6
877084|NCT01341782|2891463|P2|Overall Study|Adverse Event|1
877085|NCT01341782|2891464|P1|Overall Study|Adverse Event|1
877086|NCT01341587|2891504|P2|Overall Study|stopped using the meters|10
877087|NCT01341587|2891505|P1|Overall Study|stopped using the meters|2
877088|NCT01341587|2891504|P2|Overall Study|Lost to Follow-up|0
877089|NCT01341587|2891505|P1|Overall Study|Lost to Follow-up|2
877090|NCT01340976|2891540|P6|Overall Study|Adverse Event|0
877091|NCT01340976|2891541|P5|Overall Study|Adverse Event|0
877092|NCT01340976|2891542|P4|Overall Study|Adverse Event|0
877093|NCT01340976|2891543|P3|Overall Study|Adverse Event|0
877094|NCT01340976|2891544|P2|Overall Study|Adverse Event|1
877095|NCT01340976|2891545|P1|Overall Study|Adverse Event|0
877096|NCT01340976|2891540|P6|Overall Study|Other anemia treatment|1
877097|NCT01340976|2891541|P5|Overall Study|Other anemia treatment|0
877098|NCT01340976|2891542|P4|Overall Study|Other anemia treatment|1
877099|NCT01340976|2891543|P3|Overall Study|Other anemia treatment|2
877100|NCT01340976|2891544|P2|Overall Study|Other anemia treatment|0
877101|NCT01340976|2891545|P1|Overall Study|Other anemia treatment|1
877102|NCT01340976|2891540|P6|Overall Study|Withdrawal by Subject|0
877103|NCT01340976|2891541|P5|Overall Study|Withdrawal by Subject|1
877104|NCT01340976|2891542|P4|Overall Study|Withdrawal by Subject|1
877105|NCT01340976|2891543|P3|Overall Study|Withdrawal by Subject|0
877106|NCT01340976|2891544|P2|Overall Study|Withdrawal by Subject|0
877107|NCT01340976|2891545|P1|Overall Study|Withdrawal by Subject|0
877108|NCT01340976|2891540|P6|Overall Study|Dose Limiting Toxicity Stopping Rule|0
877109|NCT01340976|2891541|P5|Overall Study|Dose Limiting Toxicity Stopping Rule|0
877110|NCT01340976|2891542|P4|Overall Study|Dose Limiting Toxicity Stopping Rule|0
877111|NCT01340976|2891543|P3|Overall Study|Dose Limiting Toxicity Stopping Rule|0
877112|NCT01340976|2891544|P2|Overall Study|Dose Limiting Toxicity Stopping Rule|0
877113|NCT01340976|2891545|P1|Overall Study|Dose Limiting Toxicity Stopping Rule|1
877114|NCT01340976|2891540|P6|Overall Study|Death|0
877115|NCT01340976|2891541|P5|Overall Study|Death|0
877116|NCT01340976|2891542|P4|Overall Study|Death|0
877117|NCT01340976|2891543|P3|Overall Study|Death|0
877118|NCT01340976|2891544|P2|Overall Study|Death|1
877119|NCT01340976|2891545|P1|Overall Study|Death|0
877120|NCT01340976|2891540|P6|Overall Study|Physician Decision|0
877121|NCT01340976|2891541|P5|Overall Study|Physician Decision|1
877122|NCT01340976|2891542|P4|Overall Study|Physician Decision|1
877123|NCT01340976|2891543|P3|Overall Study|Physician Decision|1
877124|NCT01340976|2891544|P2|Overall Study|Physician Decision|0
877125|NCT01340976|2891545|P1|Overall Study|Physician Decision|2
877126|NCT01340937|2891583|P4|Period 3: Toddler Vaccinations|Technical problem|0
877127|NCT01340937|2891584|P3|Period 3: Toddler Vaccinations|Technical problem|1
877128|NCT01340937|2891585|P2|Period 3: Toddler Vaccinations|Technical problem|1
877129|NCT01340937|2891586|P1|Period 3: Toddler Vaccinations|Technical problem|1
877130|NCT01340937|2891583|P4|Period 3: Toddler Vaccinations|Protocol Violation|1
877131|NCT01340937|2891584|P3|Period 3: Toddler Vaccinations|Protocol Violation|0
877132|NCT01340937|2891585|P2|Period 3: Toddler Vaccinations|Protocol Violation|0
877133|NCT01340937|2891586|P1|Period 3: Toddler Vaccinations|Protocol Violation|0
877134|NCT01340937|2891583|P4|Period 3: Toddler Vaccinations|Lost to Follow-up|8
877135|NCT01340937|2891584|P3|Period 3: Toddler Vaccinations|Lost to Follow-up|7
877136|NCT01340937|2891585|P2|Period 3: Toddler Vaccinations|Lost to Follow-up|14
877137|NCT01340937|2891586|P1|Period 3: Toddler Vaccinations|Lost to Follow-up|6
877138|NCT01340937|2891583|P4|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
877139|NCT01340937|2891584|P3|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
877140|NCT01340937|2891585|P2|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
877141|NCT01340937|2891586|P1|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
877142|NCT01340937|2891583|P4|Period 2: Interim Period|Technical problems|3
877143|NCT01340937|2891584|P3|Period 2: Interim Period|Technical problems|6
877144|NCT01340937|2891585|P2|Period 2: Interim Period|Technical problems|4
877145|NCT01340937|2891586|P1|Period 2: Interim Period|Technical problems|4
877146|NCT01340937|2891583|P4|Period 2: Interim Period|Protocol Violation|3
877147|NCT01340937|2891584|P3|Period 2: Interim Period|Protocol Violation|6
877148|NCT01340937|2891585|P2|Period 2: Interim Period|Protocol Violation|3
877149|NCT01340937|2891586|P1|Period 2: Interim Period|Protocol Violation|5
877150|NCT01340937|2891583|P4|Period 2: Interim Period|Physician Decision|0
877151|NCT01340937|2891584|P3|Period 2: Interim Period|Physician Decision|1
877152|NCT01340937|2891585|P2|Period 2: Interim Period|Physician Decision|1
877153|NCT01340937|2891586|P1|Period 2: Interim Period|Physician Decision|0
877154|NCT01340937|2891583|P4|Period 2: Interim Period|Lost to Follow-up|23
877155|NCT01340937|2891584|P3|Period 2: Interim Period|Lost to Follow-up|53
877156|NCT01340937|2891585|P2|Period 2: Interim Period|Lost to Follow-up|48
877157|NCT01340937|2891586|P1|Period 2: Interim Period|Lost to Follow-up|29
877158|NCT01340937|2891583|P4|Period 2: Interim Period|Adverse Event|0
877159|NCT01340937|2891584|P3|Period 2: Interim Period|Adverse Event|1
877160|NCT01340937|2891585|P2|Period 2: Interim Period|Adverse Event|0
877161|NCT01340937|2891586|P1|Period 2: Interim Period|Adverse Event|1
877162|NCT01340937|2891583|P4|Period 2: Interim Period|Withdrawal by Subject|12
877163|NCT01340937|2891584|P3|Period 2: Interim Period|Withdrawal by Subject|17
877164|NCT01340937|2891585|P2|Period 2: Interim Period|Withdrawal by Subject|23
877165|NCT01340937|2891586|P1|Period 2: Interim Period|Withdrawal by Subject|28
877166|NCT01340937|2891583|P4|Period 1: Infant Series|Randomized but not vaccinated|1
877167|NCT01340937|2891584|P3|Period 1: Infant Series|Randomized but not vaccinated|2
877168|NCT01340937|2891585|P2|Period 1: Infant Series|Randomized but not vaccinated|5
877169|NCT01340937|2891586|P1|Period 1: Infant Series|Randomized but not vaccinated|0
877170|NCT01340937|2891583|P4|Period 1: Infant Series|Withdrawal by Subject|15
877171|NCT01340937|2891584|P3|Period 1: Infant Series|Withdrawal by Subject|30
877172|NCT01340937|2891585|P2|Period 1: Infant Series|Withdrawal by Subject|32
877173|NCT01340937|2891586|P1|Period 1: Infant Series|Withdrawal by Subject|33
877174|NCT01340937|2891583|P4|Period 1: Infant Series|Protocol Violation|3
877175|NCT01340937|2891584|P3|Period 1: Infant Series|Protocol Violation|4
877176|NCT01340937|2891585|P2|Period 1: Infant Series|Protocol Violation|4
877177|NCT01340937|2891586|P1|Period 1: Infant Series|Protocol Violation|1
877178|NCT01340937|2891583|P4|Period 1: Infant Series|Physician Decision|0
877179|NCT01340937|2891584|P3|Period 1: Infant Series|Physician Decision|1
877180|NCT01340937|2891585|P2|Period 1: Infant Series|Physician Decision|3
877181|NCT01340937|2891586|P1|Period 1: Infant Series|Physician Decision|2
877182|NCT01340937|2891583|P4|Period 1: Infant Series|Lost to Follow-up|13
877183|NCT01340937|2891584|P3|Period 1: Infant Series|Lost to Follow-up|12
877184|NCT01340937|2891585|P2|Period 1: Infant Series|Lost to Follow-up|14
877185|NCT01340937|2891586|P1|Period 1: Infant Series|Lost to Follow-up|20
877186|NCT01340937|2891583|P4|Period 1: Infant Series|Death|0
877187|NCT01340937|2891584|P3|Period 1: Infant Series|Death|2
877188|NCT01340937|2891585|P2|Period 1: Infant Series|Death|0
877189|NCT01340937|2891586|P1|Period 1: Infant Series|Death|2
877190|NCT01340937|2891583|P4|Period 1: Infant Series|Adverse Event|0
877191|NCT01340937|2891584|P3|Period 1: Infant Series|Adverse Event|4
877192|NCT01340937|2891585|P2|Period 1: Infant Series|Adverse Event|1
877193|NCT01340937|2891586|P1|Period 1: Infant Series|Adverse Event|0
877194|NCT01340937|2891583|P4|Period 1: Infant Series|Other protocol criterion not met|0
877195|NCT01340937|2891584|P3|Period 1: Infant Series|Other protocol criterion not met|1
877196|NCT01340937|2891585|P2|Period 1: Infant Series|Other protocol criterion not met|1
877197|NCT01340937|2891586|P1|Period 1: Infant Series|Other protocol criterion not met|0
877198|NCT01340872|2891745|P4|Open-label Phase|Worsening of IBD|0
877199|NCT01340872|2891746|P3|Open-label Phase|Worsening of IBD|1
877200|NCT01340872|2891747|P2|Open-label Phase|Worsening of IBD|0
877201|NCT01340872|2891748|P1|Open-label Phase|Worsening of IBD|0
877202|NCT01340872|2891745|P4|Open-label Phase|Withdrawal by Subject|6
877203|NCT01340872|2891746|P3|Open-label Phase|Withdrawal by Subject|1
877204|NCT01340872|2891747|P2|Open-label Phase|Withdrawal by Subject|0
877205|NCT01340872|2891748|P1|Open-label Phase|Withdrawal by Subject|0
877206|NCT01340872|2891745|P4|Open-label Phase|Adverse Event|4
877207|NCT01340872|2891746|P3|Open-label Phase|Adverse Event|8
877208|NCT01340872|2891747|P2|Open-label Phase|Adverse Event|0
877209|NCT01340872|2891748|P1|Open-label Phase|Adverse Event|0
877210|NCT01340872|2891745|P4|Open-label Phase|Pregnancy|0
877211|NCT01340872|2891746|P3|Open-label Phase|Pregnancy|1
877212|NCT01340872|2891747|P2|Open-label Phase|Pregnancy|0
877213|NCT01340872|2891748|P1|Open-label Phase|Pregnancy|0
877214|NCT01340872|2891745|P4|Open-label Phase|Physician Decision|1
877215|NCT01340872|2891746|P3|Open-label Phase|Physician Decision|2
877216|NCT01340872|2891747|P2|Open-label Phase|Physician Decision|0
877217|NCT01340872|2891748|P1|Open-label Phase|Physician Decision|0
877218|NCT01340872|2891745|P4|Double-blind Phase|Protocol Violation|0
877219|NCT01340872|2891746|P3|Double-blind Phase|Protocol Violation|0
877220|NCT01340872|2891747|P2|Double-blind Phase|Protocol Violation|1
877221|NCT01340872|2891748|P1|Double-blind Phase|Protocol Violation|0
877222|NCT01340872|2891745|P4|Double-blind Phase|Lost to Follow-up|0
877223|NCT01340872|2891746|P3|Double-blind Phase|Lost to Follow-up|0
877224|NCT01340872|2891747|P2|Double-blind Phase|Lost to Follow-up|1
877225|NCT01340872|2891748|P1|Double-blind Phase|Lost to Follow-up|0
877226|NCT01340872|2891745|P4|Double-blind Phase|Withdrawal by Subject|0
877227|NCT01340872|2891746|P3|Double-blind Phase|Withdrawal by Subject|0
877228|NCT01340872|2891747|P2|Double-blind Phase|Withdrawal by Subject|5
877229|NCT01340872|2891748|P1|Double-blind Phase|Withdrawal by Subject|3
877230|NCT01340872|2891745|P4|Double-blind Phase|Adverse Event|0
877231|NCT01340872|2891746|P3|Double-blind Phase|Adverse Event|0
877232|NCT01340872|2891747|P2|Double-blind Phase|Adverse Event|4
877233|NCT01340872|2891748|P1|Double-blind Phase|Adverse Event|6
877234|NCT01340794|2891808|P2|Overall Study|Withdrawal by Subject|1
877235|NCT01340794|2891809|P1|Overall Study|Withdrawal by Subject|0
877236|NCT01340768|2891825|P2|Overall Study|Other|0
877237|NCT01340768|2891826|P1|Overall Study|Other|2
877238|NCT01340768|2891825|P2|Overall Study|Withdrawal by Subject|1
877239|NCT01340768|2891826|P1|Overall Study|Withdrawal by Subject|5
877240|NCT01340768|2891825|P2|Overall Study|Lost to Follow-up|4
877241|NCT01340768|2891826|P1|Overall Study|Lost to Follow-up|10
877242|NCT01340664|2891837|P3|Overall Study|Not specified|2
877243|NCT01340664|2891838|P2|Overall Study|Not specified|2
877244|NCT01340664|2891839|P1|Overall Study|Not specified|1
877245|NCT01340664|2891837|P3|Overall Study|Creatinine or eGFR withdrawal criteria|2
877246|NCT01340664|2891838|P2|Overall Study|Creatinine or eGFR withdrawal criteria|1
877247|NCT01340664|2891839|P1|Overall Study|Creatinine or eGFR withdrawal criteria|0
877248|NCT01340664|2891837|P3|Overall Study|Glycemic withdrawal criteria|0
877249|NCT01340664|2891838|P2|Overall Study|Glycemic withdrawal criteria|0
877250|NCT01340664|2891839|P1|Overall Study|Glycemic withdrawal criteria|2
877251|NCT01340664|2891837|P3|Overall Study|Withdrawal by Subject|0
877252|NCT01340664|2891838|P2|Overall Study|Withdrawal by Subject|4
877253|NCT01340664|2891839|P1|Overall Study|Withdrawal by Subject|2
877254|NCT01340664|2891837|P3|Overall Study|Lost to Follow-up|2
877255|NCT01340664|2891838|P2|Overall Study|Lost to Follow-up|0
877256|NCT01340664|2891839|P1|Overall Study|Lost to Follow-up|2
877257|NCT01340664|2891837|P3|Overall Study|Adverse Event|7
877258|NCT01340664|2891838|P2|Overall Study|Adverse Event|1
877259|NCT01340664|2891839|P1|Overall Study|Adverse Event|0
877260|NCT01340651|2891856|P1|Overall Study|Commercial Supply per Sponsor|12
877261|NCT01340651|2891856|P1|Overall Study|Consent Withdrawn|2
877262|NCT01340651|2891856|P1|Overall Study|Adverse Event|3
877263|NCT01340625|2891872|P2|Washout Period of 28 Days|Withdrawal by Subject|0
877264|NCT01340625|2891873|P1|Washout Period of 28 Days|Withdrawal by Subject|1
877265|NCT01340625|2891872|P2|First Intervention|Adverse Event|0
877266|NCT01340625|2891873|P1|First Intervention|Adverse Event|1
877267|NCT01340495|2891978|P1|Overall Study|Withdrawal by Subject|1
877268|NCT01340300|2891988|P4|Overall Study|Unrelated sickness|1
877269|NCT01340300|2891989|P3|Overall Study|Unrelated sickness|0
877270|NCT01340300|2891990|P2|Overall Study|Unrelated sickness|2
877271|NCT01340300|2891991|P1|Overall Study|Unrelated sickness|0
877272|NCT01340300|2891988|P4|Overall Study|Physician Decision|0
877273|NCT01340300|2891989|P3|Overall Study|Physician Decision|0
877274|NCT01340300|2891990|P2|Overall Study|Physician Decision|1
877275|NCT01340300|2891991|P1|Overall Study|Physician Decision|0
877276|NCT01340300|2891988|P4|Overall Study|Adverse Event|0
877277|NCT01340300|2891989|P3|Overall Study|Adverse Event|4
877278|NCT01340300|2891990|P2|Overall Study|Adverse Event|0
877279|NCT01340300|2891991|P1|Overall Study|Adverse Event|1
877280|NCT01340300|2891988|P4|Overall Study|Withdrawal by Subject|3
877281|NCT01340300|2891989|P3|Overall Study|Withdrawal by Subject|6
877282|NCT01340300|2891990|P2|Overall Study|Withdrawal by Subject|6
877283|NCT01340300|2891991|P1|Overall Study|Withdrawal by Subject|5
877284|NCT01340300|2891988|P4|Overall Study|Lost to Follow-up|10
877285|NCT01340300|2891989|P3|Overall Study|Lost to Follow-up|5
877286|NCT01340300|2891990|P2|Overall Study|Lost to Follow-up|0
877287|NCT01340300|2891991|P1|Overall Study|Lost to Follow-up|3
877288|NCT01340209|2892024|P3|Overall Study|Other reason not defined above|4
877289|NCT01340209|2892025|P2|Overall Study|Other reason not defined above|5
877290|NCT01340209|2892026|P1|Overall Study|Other reason not defined above|3
877291|NCT01340209|2892024|P3|Overall Study|Withdrawal by Subject|1
877292|NCT01340209|2892025|P2|Overall Study|Withdrawal by Subject|0
877293|NCT01340209|2892026|P1|Overall Study|Withdrawal by Subject|0
877294|NCT01340209|2892024|P3|Overall Study|Protocol Violation|1
877295|NCT01340209|2892025|P2|Overall Study|Protocol Violation|2
877296|NCT01340209|2892026|P1|Overall Study|Protocol Violation|1
877297|NCT01340209|2892024|P3|Overall Study|Adverse Event|2
877298|NCT01340209|2892025|P2|Overall Study|Adverse Event|1
877299|NCT01340209|2892026|P1|Overall Study|Adverse Event|1
877300|NCT01340196|2892061|P1|Treat. Period 3 (Faldaprevir)|Adverse Event|2
877301|NCT01340066|2892101|P3|5 Week Double Blind Randomization Period|Withdrawal by Subject|1
877302|NCT01340066|2892102|P2|5 Week Double Blind Randomization Period|Withdrawal by Subject|2
877303|NCT01340066|2892103|P1|5 Week Double Blind Randomization Period|Withdrawal by Subject|0
877304|NCT01340066|2892101|P3|5 Week Double Blind Randomization Period|Physician Decision|0
877305|NCT01340066|2892102|P2|5 Week Double Blind Randomization Period|Physician Decision|1
877306|NCT01340066|2892103|P1|5 Week Double Blind Randomization Period|Physician Decision|0
877307|NCT01340066|2892101|P3|5 Week Double Blind Randomization Period|Adverse Event|2
877308|NCT01340066|2892102|P2|5 Week Double Blind Randomization Period|Adverse Event|2
877309|NCT01340066|2892103|P1|5 Week Double Blind Randomization Period|Adverse Event|0
877310|NCT01340066|2892101|P3|Placebo Run in Period|Screen Failures|0
877311|NCT01340066|2892102|P2|Placebo Run in Period|Screen Failures|0
877312|NCT01340066|2892103|P1|Placebo Run in Period|Screen Failures|27
877313|NCT01340027|2892122|P12|Overall Study|Miscellaneous|0
877314|NCT01340027|2892123|P11|Overall Study|Miscellaneous|1
877315|NCT01340027|2892124|P10|Overall Study|Miscellaneous|0
877316|NCT01340027|2892125|P9|Overall Study|Miscellaneous|0
877317|NCT01340027|2892126|P8|Overall Study|Miscellaneous|0
877318|NCT01340027|2892127|P7|Overall Study|Miscellaneous|0
877319|NCT01340027|2892128|P6|Overall Study|Miscellaneous|0
877320|NCT01340027|2892129|P5|Overall Study|Miscellaneous|0
877321|NCT01340027|2892130|P4|Overall Study|Miscellaneous|1
877322|NCT01340027|2892131|P3|Overall Study|Miscellaneous|0
877323|NCT01340027|2892132|P2|Overall Study|Miscellaneous|0
877324|NCT01340027|2892133|P1|Overall Study|Miscellaneous|0
877325|NCT01340027|2892122|P12|Overall Study|Withdrawal by Subject|1
877326|NCT01340027|2892123|P11|Overall Study|Withdrawal by Subject|0
877327|NCT01340027|2892124|P10|Overall Study|Withdrawal by Subject|2
877328|NCT01340027|2892125|P9|Overall Study|Withdrawal by Subject|1
877329|NCT01340027|2892126|P8|Overall Study|Withdrawal by Subject|4
877330|NCT01340027|2892127|P7|Overall Study|Withdrawal by Subject|3
877331|NCT01340027|2892128|P6|Overall Study|Withdrawal by Subject|2
877332|NCT01340027|2892129|P5|Overall Study|Withdrawal by Subject|3
877333|NCT01340027|2892130|P4|Overall Study|Withdrawal by Subject|3
877334|NCT01340027|2892131|P3|Overall Study|Withdrawal by Subject|1
877335|NCT01340027|2892132|P2|Overall Study|Withdrawal by Subject|3
877336|NCT01340027|2892133|P1|Overall Study|Withdrawal by Subject|4
877337|NCT01340027|2892122|P12|Overall Study|Protocol Violation|0
877338|NCT01340027|2892123|P11|Overall Study|Protocol Violation|0
877339|NCT01340027|2892124|P10|Overall Study|Protocol Violation|2
877340|NCT01340027|2892125|P9|Overall Study|Protocol Violation|2
877341|NCT01340027|2892126|P8|Overall Study|Protocol Violation|1
877342|NCT01340027|2892127|P7|Overall Study|Protocol Violation|0
877343|NCT01340027|2892128|P6|Overall Study|Protocol Violation|0
877344|NCT01340027|2892129|P5|Overall Study|Protocol Violation|6
877345|NCT01340027|2892130|P4|Overall Study|Protocol Violation|0
877346|NCT01340027|2892131|P3|Overall Study|Protocol Violation|0
877347|NCT01340027|2892132|P2|Overall Study|Protocol Violation|2
877348|NCT01340027|2892133|P1|Overall Study|Protocol Violation|1
877349|NCT01340027|2892122|P12|Overall Study|Lost to Follow-up|0
877350|NCT01340027|2892123|P11|Overall Study|Lost to Follow-up|0
877351|NCT01340027|2892124|P10|Overall Study|Lost to Follow-up|1
877352|NCT01340027|2892125|P9|Overall Study|Lost to Follow-up|0
877353|NCT01340027|2892126|P8|Overall Study|Lost to Follow-up|0
877354|NCT01340027|2892127|P7|Overall Study|Lost to Follow-up|1
877355|NCT01340027|2892128|P6|Overall Study|Lost to Follow-up|0
877356|NCT01340027|2892129|P5|Overall Study|Lost to Follow-up|0
877357|NCT01340027|2892130|P4|Overall Study|Lost to Follow-up|0
877358|NCT01340027|2892131|P3|Overall Study|Lost to Follow-up|0
877359|NCT01340027|2892132|P2|Overall Study|Lost to Follow-up|1
877360|NCT01340027|2892133|P1|Overall Study|Lost to Follow-up|0
877361|NCT01340027|2892122|P12|Overall Study|Lack of Efficacy|0
877362|NCT01340027|2892123|P11|Overall Study|Lack of Efficacy|0
877363|NCT01340027|2892124|P10|Overall Study|Lack of Efficacy|0
877364|NCT01340027|2892125|P9|Overall Study|Lack of Efficacy|1
877365|NCT01340027|2892126|P8|Overall Study|Lack of Efficacy|1
877366|NCT01340027|2892127|P7|Overall Study|Lack of Efficacy|1
877367|NCT01340027|2892128|P6|Overall Study|Lack of Efficacy|0
877368|NCT01340027|2892129|P5|Overall Study|Lack of Efficacy|0
877369|NCT01340027|2892130|P4|Overall Study|Lack of Efficacy|0
877370|NCT01340027|2892131|P3|Overall Study|Lack of Efficacy|0
877371|NCT01340027|2892132|P2|Overall Study|Lack of Efficacy|0
877372|NCT01340027|2892133|P1|Overall Study|Lack of Efficacy|0
877373|NCT01340027|2892122|P12|Overall Study|Adverse Event|3
877374|NCT01340027|2892123|P11|Overall Study|Adverse Event|1
877375|NCT01340027|2892124|P10|Overall Study|Adverse Event|1
877376|NCT01340027|2892125|P9|Overall Study|Adverse Event|4
877377|NCT01340027|2892126|P8|Overall Study|Adverse Event|1
877378|NCT01340027|2892127|P7|Overall Study|Adverse Event|2
877379|NCT01340027|2892128|P6|Overall Study|Adverse Event|2
877380|NCT01340027|2892129|P5|Overall Study|Adverse Event|1
877381|NCT01340027|2892130|P4|Overall Study|Adverse Event|0
877382|NCT01340027|2892131|P3|Overall Study|Adverse Event|2
877383|NCT01340027|2892132|P2|Overall Study|Adverse Event|1
877384|NCT01340027|2892133|P1|Overall Study|Adverse Event|0
877385|NCT01340027|2892122|P12|Overall Study|Randomized but Never Received Study Drug|0
877386|NCT01340027|2892123|P11|Overall Study|Randomized but Never Received Study Drug|0
877387|NCT01340027|2892124|P10|Overall Study|Randomized but Never Received Study Drug|0
877388|NCT01340027|2892125|P9|Overall Study|Randomized but Never Received Study Drug|0
877389|NCT01340027|2892126|P8|Overall Study|Randomized but Never Received Study Drug|0
877390|NCT01340027|2892127|P7|Overall Study|Randomized but Never Received Study Drug|0
877391|NCT01340027|2892128|P6|Overall Study|Randomized but Never Received Study Drug|0
877392|NCT01340027|2892129|P5|Overall Study|Randomized but Never Received Study Drug|0
877393|NCT01340027|2892130|P4|Overall Study|Randomized but Never Received Study Drug|0
877394|NCT01340027|2892131|P3|Overall Study|Randomized but Never Received Study Drug|1
877395|NCT01340027|2892132|P2|Overall Study|Randomized but Never Received Study Drug|0
877396|NCT01340027|2892133|P1|Overall Study|Randomized but Never Received Study Drug|0
877397|NCT01340014|2892509|P2|Period 2, Second 7 Days|Adverse Event|1
877398|NCT01340014|2892510|P1|Period 2, Second 7 Days|Adverse Event|0
877399|NCT01340014|2892509|P2|Period 1, First 7 Days|Personal Reasons|0
877400|NCT01340014|2892510|P1|Period 1, First 7 Days|Personal Reasons|1
877401|NCT01340014|2892509|P2|Period 1, First 7 Days|Adverse Event|0
877402|NCT01340014|2892510|P1|Period 1, First 7 Days|Adverse Event|1
877403|NCT01339923|2892531|P7|Overall Study|Withdrawal by Subject|2
877404|NCT01339923|2892532|P6|Overall Study|Withdrawal by Subject|3
877405|NCT01339923|2892533|P5|Overall Study|Withdrawal by Subject|4
877406|NCT01339923|2892534|P4|Overall Study|Withdrawal by Subject|1
877407|NCT01339923|2892535|P3|Overall Study|Withdrawal by Subject|6
877408|NCT01339923|2892536|P2|Overall Study|Withdrawal by Subject|11
877409|NCT01339923|2892537|P1|Overall Study|Withdrawal by Subject|7
877410|NCT01339923|2892531|P7|Overall Study|Unable to Classify|5
877411|NCT01339923|2892532|P6|Overall Study|Unable to Classify|1
877412|NCT01339923|2892533|P5|Overall Study|Unable to Classify|0
877413|NCT01339923|2892534|P4|Overall Study|Unable to Classify|0
877414|NCT01339923|2892535|P3|Overall Study|Unable to Classify|1
877415|NCT01339923|2892536|P2|Overall Study|Unable to Classify|0
877416|NCT01339923|2892537|P1|Overall Study|Unable to Classify|1
877417|NCT01339923|2892531|P7|Overall Study|Protocol Violation|1
877418|NCT01339923|2892532|P6|Overall Study|Protocol Violation|3
877419|NCT01339923|2892533|P5|Overall Study|Protocol Violation|0
877420|NCT01339923|2892534|P4|Overall Study|Protocol Violation|0
877421|NCT01339923|2892535|P3|Overall Study|Protocol Violation|0
877422|NCT01339923|2892536|P2|Overall Study|Protocol Violation|0
877423|NCT01339923|2892537|P1|Overall Study|Protocol Violation|0
877424|NCT01339923|2892531|P7|Overall Study|Lost to Follow-up|5
877425|NCT01339923|2892532|P6|Overall Study|Lost to Follow-up|1
877426|NCT01339923|2892533|P5|Overall Study|Lost to Follow-up|1
877427|NCT01339923|2892534|P4|Overall Study|Lost to Follow-up|3
877428|NCT01339923|2892535|P3|Overall Study|Lost to Follow-up|0
877429|NCT01339923|2892536|P2|Overall Study|Lost to Follow-up|4
877430|NCT01339923|2892537|P1|Overall Study|Lost to Follow-up|4
877431|NCT01339923|2892531|P7|Overall Study|Inappropriate Enrollment|0
877432|NCT01339923|2892532|P6|Overall Study|Inappropriate Enrollment|1
877433|NCT01339923|2892533|P5|Overall Study|Inappropriate Enrollment|0
877434|NCT01339923|2892534|P4|Overall Study|Inappropriate Enrollment|0
877435|NCT01339923|2892535|P3|Overall Study|Inappropriate Enrollment|0
877436|NCT01339923|2892536|P2|Overall Study|Inappropriate Enrollment|0
877437|NCT01339923|2892537|P1|Overall Study|Inappropriate Enrollment|1
877438|NCT01339923|2892531|P7|Overall Study|Adverse Event|1
877439|NCT01339923|2892532|P6|Overall Study|Adverse Event|0
877440|NCT01339923|2892533|P5|Overall Study|Adverse Event|0
877441|NCT01339923|2892534|P4|Overall Study|Adverse Event|0
877442|NCT01339923|2892535|P3|Overall Study|Adverse Event|1
877443|NCT01339923|2892536|P2|Overall Study|Adverse Event|1
877444|NCT01339923|2892537|P1|Overall Study|Adverse Event|1
877445|NCT01339910|2892608|P2|Overall Study|Disease relapse|4
877446|NCT01339910|2892609|P1|Overall Study|Disease relapse|1
877447|NCT01339910|2892608|P2|Overall Study|Physician Decision|0
877448|NCT01339910|2892609|P1|Overall Study|Physician Decision|1
877449|NCT01339910|2892608|P2|Overall Study|Withdrawal by Subject|0
877450|NCT01339910|2892609|P1|Overall Study|Withdrawal by Subject|1
877451|NCT01339897|2892647|P4|Overall Study|Adverse Event|1
877452|NCT01339897|2892648|P3|Overall Study|Adverse Event|0
877453|NCT01339897|2892649|P2|Overall Study|Adverse Event|0
877454|NCT01339897|2892650|P1|Overall Study|Adverse Event|1
877455|NCT01339832|2892676|P1|Overall Study|Death|11
877456|NCT01339832|2892676|P1|Overall Study|Lost to Follow-up|3
877457|NCT01339429|2892687|P1|Overall Study|Physician Decision|3
877458|NCT01339429|2892687|P1|Overall Study|Withdrawal by Subject|1
877459|NCT01339390|2892727|P2|Overall Study|Lost to Follow-up|127
877460|NCT01339390|2892728|P1|Overall Study|Lost to Follow-up|125
877461|NCT01339390|2892727|P2|Overall Study|Death|29
877462|NCT01339390|2892728|P1|Overall Study|Death|32
877463|NCT01339052|2892786|P2|Overall Study|Physician Decision|0
877464|NCT01339052|2892787|P1|Overall Study|Physician Decision|1
877465|NCT01339052|2892786|P2|Overall Study|Withdrawal by Subject|3
877466|NCT01339052|2892787|P1|Overall Study|Withdrawal by Subject|0
877467|NCT01339052|2892786|P2|Overall Study|Adverse Event|1
877468|NCT01339052|2892787|P1|Overall Study|Adverse Event|1
877469|NCT01339052|2892786|P2|Overall Study|Disease progression|46
877470|NCT01339052|2892787|P1|Overall Study|Disease progression|13
877471|NCT01339000|2892813|P2|Overall Study|study closed due to lack of drug supply|0
877472|NCT01339000|2892814|P1|Overall Study|study closed due to lack of drug supply|1
877473|NCT01338870|2892834|P6|Overall Study|Adverse Event|1
877474|NCT01338870|2892835|P5|Overall Study|Adverse Event|4
877475|NCT01338870|2892836|P4|Overall Study|Adverse Event|5
877476|NCT01338870|2892837|P3|Overall Study|Adverse Event|1
877477|NCT01338870|2892838|P2|Overall Study|Adverse Event|4
877478|NCT01338870|2892839|P1|Overall Study|Adverse Event|4
877479|NCT01338870|2892834|P6|Overall Study|Protocol Violation|1
877480|NCT01338870|2892835|P5|Overall Study|Protocol Violation|1
877481|NCT01338870|2892836|P4|Overall Study|Protocol Violation|2
877482|NCT01338870|2892837|P3|Overall Study|Protocol Violation|2
877483|NCT01338870|2892838|P2|Overall Study|Protocol Violation|2
877484|NCT01338870|2892839|P1|Overall Study|Protocol Violation|0
877485|NCT01338870|2892834|P6|Overall Study|Other|2
877486|NCT01338870|2892835|P5|Overall Study|Other|0
877487|NCT01338870|2892836|P4|Overall Study|Other|2
877488|NCT01338870|2892837|P3|Overall Study|Other|3
877489|NCT01338870|2892838|P2|Overall Study|Other|3
877490|NCT01338870|2892839|P1|Overall Study|Other|3
877491|NCT01338870|2892834|P6|Overall Study|Withdrawal by Subject|2
877492|NCT01338870|2892835|P5|Overall Study|Withdrawal by Subject|0
877493|NCT01338870|2892836|P4|Overall Study|Withdrawal by Subject|0
877494|NCT01338870|2892837|P3|Overall Study|Withdrawal by Subject|4
877495|NCT01338870|2892838|P2|Overall Study|Withdrawal by Subject|3
877496|NCT01338870|2892839|P1|Overall Study|Withdrawal by Subject|2
877497|NCT01338870|2892834|P6|Overall Study|Lost to Follow-up|0
877498|NCT01338870|2892835|P5|Overall Study|Lost to Follow-up|1
877499|NCT01338870|2892836|P4|Overall Study|Lost to Follow-up|0
877500|NCT01338870|2892837|P3|Overall Study|Lost to Follow-up|1
877501|NCT01338870|2892838|P2|Overall Study|Lost to Follow-up|0
877502|NCT01338870|2892839|P1|Overall Study|Lost to Follow-up|0
877503|NCT01338818|2892894|P1|Overall Study|Protocol Deviation|4
877504|NCT01338818|2892894|P1|Overall Study|Administrative problems|3
877505|NCT01338818|2892894|P1|Overall Study|Lost to Follow-up|4
877506|NCT01338818|2892894|P1|Overall Study|Withdrawal by Subject|11
877507|NCT01338818|2892894|P1|Overall Study|no longer require study drug|1
877508|NCT01338818|2892894|P1|Overall Study|Lack of Efficacy|5
877509|NCT01338818|2892894|P1|Overall Study|Adverse Event|8
877510|NCT01338792|2892900|P1|Overall Study|Withdrawal by Subject|1
877511|NCT01338792|2892900|P1|Overall Study|Death|1
877512|NCT01338792|2892900|P1|Overall Study|Adverse Event|2
877513|NCT01338636|2892915|P1|Overall Study|Withdrawn due to lack of improvement|8
877514|NCT01338610|2892929|P3|Overall Study|Adverse Event|0
877515|NCT01338610|2892930|P2|Overall Study|Adverse Event|0
877516|NCT01338610|2892931|P1|Overall Study|Adverse Event|3
877517|NCT01338610|2892929|P3|Overall Study|Protocol Violation|1
877518|NCT01338610|2892930|P2|Overall Study|Protocol Violation|0
877519|NCT01338610|2892931|P1|Overall Study|Protocol Violation|1
877520|NCT01338610|2892929|P3|Overall Study|Patient Decision Unrelated to Advs Event|0
877521|NCT01338610|2892930|P2|Overall Study|Patient Decision Unrelated to Advs Event|1
877522|NCT01338610|2892931|P1|Overall Study|Patient Decision Unrelated to Advs Event|1
877523|NCT01338493|2892938|P1|12 Months Follow up|Lost to Follow-up|9
877524|NCT01338493|2892938|P1|6 Months Follow up|Missed visit|8
877525|NCT01338493|2892938|P1|6 Months Follow up|Lost to Follow-up|11
877526|NCT01338493|2892938|P1|Discharge|Missed visit|1
877527|NCT01338493|2892938|P1|Discharge|Death|1
877528|NCT01338493|2892938|P1|Enrolled|Patient not implanted|4
877529|NCT01338493|2892938|P1|Enrolled|Withdrawal by Subject|1
877530|NCT01338415|2892945|P2|Overall Study|Other (administrative reason)|0
877531|NCT01338415|2892946|P1|Overall Study|Other (administrative reason)|1
877532|NCT01338415|2892945|P2|Overall Study|Other (PAH not the main etiology of PH)|2
877533|NCT01338415|2892946|P1|Overall Study|Other (PAH not the main etiology of PH)|0
877534|NCT01338415|2892945|P2|Overall Study|Withdrawal by Subject|1
877535|NCT01338415|2892946|P1|Overall Study|Withdrawal by Subject|1
877536|NCT01338415|2892945|P2|Overall Study|Adverse Event|6
877537|NCT01338415|2892946|P1|Overall Study|Adverse Event|8
877538|NCT01338298|2892968|P2|Overall Study|Non-adherence|0
877539|NCT01338298|2892969|P1|Overall Study|Non-adherence|1
877540|NCT01338298|2892968|P2|Overall Study|Depressive symptoms and nausea|0
877541|NCT01338298|2892969|P1|Overall Study|Depressive symptoms and nausea|1
877542|NCT01338298|2892968|P2|Overall Study|Positive symptom worsening|0
877543|NCT01338298|2892969|P1|Overall Study|Positive symptom worsening|1
877544|NCT01338298|2892968|P2|Overall Study|Administrative error|1
877545|NCT01338298|2892969|P1|Overall Study|Administrative error|0
877546|NCT01338298|2892968|P2|Overall Study|Abdominal Pain and scheduled surgery|1
877547|NCT01338298|2892969|P1|Overall Study|Abdominal Pain and scheduled surgery|0
877548|NCT01338298|2892968|P2|Overall Study|Withdrawal by Subject|1
877549|NCT01338298|2892969|P1|Overall Study|Withdrawal by Subject|1
877550|NCT01338025|2892979|P2|Overall Study|Found ineligible after starting|0
877551|NCT01338025|2892980|P1|Overall Study|Found ineligible after starting|1
877552|NCT01338025|2892979|P2|Overall Study|Withdrawal by Subject|2
877553|NCT01338025|2892980|P1|Overall Study|Withdrawal by Subject|0
877554|NCT01338025|2892979|P2|Overall Study|Unexpected closure of study|9
877555|NCT01338025|2892980|P1|Overall Study|Unexpected closure of study|10
877556|NCT01338012|2892992|P1|Overall Study|Study terminated|4
877557|NCT01338012|2892992|P1|Overall Study|Death|4
877558|NCT01337960|2892999|P3|Overall Study|Withdrawal by Subject|0
877559|NCT01337960|2893000|P2|Overall Study|Withdrawal by Subject|0
877560|NCT01337960|2893001|P1|Overall Study|Withdrawal by Subject|1
877561|NCT01337960|2892999|P3|Overall Study|Lost to Follow-up|0
877562|NCT01337960|2893000|P2|Overall Study|Lost to Follow-up|0
877563|NCT01337960|2893001|P1|Overall Study|Lost to Follow-up|1
877564|NCT01337674|2893034|P4|Treatment Period 2|Withdrawal by Subject|0
877565|NCT01337674|2893035|P3|Treatment Period 2|Withdrawal by Subject|1
877566|NCT01337674|2893036|P2|Treatment Period 2|Withdrawal by Subject|0
877567|NCT01337674|2893037|P1|Treatment Period 2|Withdrawal by Subject|0
877568|NCT01337674|2893034|P4|Treatment Period 1|Discontinued due to blood draws|1
877569|NCT01337674|2893035|P3|Treatment Period 1|Discontinued due to blood draws|0
877570|NCT01337674|2893036|P2|Treatment Period 1|Discontinued due to blood draws|0
877571|NCT01337674|2893037|P1|Treatment Period 1|Discontinued due to blood draws|0
877572|NCT01337674|2893034|P4|Treatment Period 1|Adverse Event|0
877573|NCT01337674|2893035|P3|Treatment Period 1|Adverse Event|0
877574|NCT01337674|2893036|P2|Treatment Period 1|Adverse Event|1
877575|NCT01337674|2893037|P1|Treatment Period 1|Adverse Event|0
877576|NCT01337635|2893055|P2|Overall Study|Lost to Follow-up|1
877577|NCT01337635|2893056|P1|Overall Study|Lost to Follow-up|0
877578|NCT01337297|2893104|P2|Overall Study|Lost to Follow-up|3
877579|NCT01337297|2893105|P1|Overall Study|Lost to Follow-up|1
877580|NCT01337297|2893104|P2|Overall Study|They entered to single anodal tDCS|3
877581|NCT01337297|2893105|P1|Overall Study|They entered to single anodal tDCS|4
877582|NCT01337167|2893113|P2|Toddler Vaccinations|Withdrawal by Subject|0
877583|NCT01337167|2893114|P1|Toddler Vaccinations|Withdrawal by Subject|3
877584|NCT01337167|2893113|P2|Toddler Vaccinations|Protocol Violation|1
877585|NCT01337167|2893114|P1|Toddler Vaccinations|Protocol Violation|0
877586|NCT01337167|2893113|P2|Toddler Vaccinations|Lost to Follow-up|12
877587|NCT01337167|2893114|P1|Toddler Vaccinations|Lost to Follow-up|11
877588|NCT01337167|2893113|P2|Interim Period|Other protocol criterion not met|1
877589|NCT01337167|2893114|P1|Interim Period|Other protocol criterion not met|0
877590|NCT01337167|2893113|P2|Interim Period|Withdrawal by Subject|10
877591|NCT01337167|2893114|P1|Interim Period|Withdrawal by Subject|18
877592|NCT01337167|2893113|P2|Interim Period|Protocol Violation|3
877593|NCT01337167|2893114|P1|Interim Period|Protocol Violation|5
877594|NCT01337167|2893113|P2|Interim Period|Physician Decision|3
877595|NCT01337167|2893114|P1|Interim Period|Physician Decision|6
877596|NCT01337167|2893113|P2|Interim Period|Non-compliance with study drug|0
877597|NCT01337167|2893114|P1|Interim Period|Non-compliance with study drug|1
877598|NCT01337167|2893113|P2|Interim Period|Lost to Follow-up|23
877599|NCT01337167|2893114|P1|Interim Period|Lost to Follow-up|51
877600|NCT01337167|2893113|P2|Infant Series|Randomized but not vaccinated|3
877601|NCT01337167|2893114|P1|Infant Series|Randomized but not vaccinated|5
877602|NCT01337167|2893113|P2|Infant Series|Withdrawal by Subject|4
877603|NCT01337167|2893114|P1|Infant Series|Withdrawal by Subject|15
877604|NCT01337167|2893113|P2|Infant Series|Protocol Violation|9
877605|NCT01337167|2893114|P1|Infant Series|Protocol Violation|22
877606|NCT01337167|2893113|P2|Infant Series|Physician Decision|1
877607|NCT01337167|2893114|P1|Infant Series|Physician Decision|3
877608|NCT01337167|2893113|P2|Infant Series|Non-compliance with study drug|1
877609|NCT01337167|2893114|P1|Infant Series|Non-compliance with study drug|2
877610|NCT01337167|2893113|P2|Infant Series|Lost to Follow-up|7
877611|NCT01337167|2893114|P1|Infant Series|Lost to Follow-up|13
877612|NCT01337167|2893113|P2|Infant Series|Death|1
877613|NCT01337167|2893114|P1|Infant Series|Death|1
877614|NCT01337167|2893113|P2|Infant Series|Adverse Event|1
877615|NCT01337167|2893114|P1|Infant Series|Adverse Event|1
877616|NCT01337115|2893182|P2|Overall Study|Protocol Violation|0
877617|NCT01337115|2893183|P1|Overall Study|Protocol Violation|2
877618|NCT01337089|2893195|P1|Overall Study|Lost to Follow-up|2
877619|NCT01337089|2893195|P1|Overall Study|Met Withdrawal Criteria|3
877620|NCT01337089|2893195|P1|Overall Study|Withdrawal by Investigator|33
877621|NCT01337089|2893195|P1|Overall Study|Withdrawal by Subject|129
877622|NCT01337089|2893195|P1|Overall Study|Adverse Event|237
877623|NCT01337050|2893210|P3|Overall Study|Participants refused further follow-up|7
877624|NCT01337050|2893211|P2|Overall Study|Participants refused further follow-up|7
877625|NCT01337050|2893212|P1|Overall Study|Participants refused further follow-up|0
877626|NCT01337050|2893210|P3|Overall Study|Other|8
877627|NCT01337050|2893211|P2|Overall Study|Other|6
877628|NCT01337050|2893212|P1|Overall Study|Other|4
877629|NCT01337050|2893210|P3|Overall Study|Death|4
877630|NCT01337050|2893211|P2|Overall Study|Death|0
877631|NCT01337050|2893212|P1|Overall Study|Death|0
877632|NCT01336972|2893273|P3|Overall Study|Adverse Event|0
877633|NCT01336972|2893274|P2|Overall Study|Adverse Event|1
877634|NCT01336972|2893275|P1|Overall Study|Adverse Event|1
877635|NCT01336894|2893337|P2|Follow-up|Study terminated prematurely|7
877636|NCT01336894|2893338|P1|Follow-up|Study terminated prematurely|2
877637|NCT01336764|2893358|P2|Overall Study|Withdrawal by Subject|5
877638|NCT01336764|2893359|P1|Overall Study|Withdrawal by Subject|5
877639|NCT01336738|2893370|P5|Overall Study|Other|4
877640|NCT01336738|2893371|P4|Overall Study|Other|3
877641|NCT01336738|2893372|P3|Overall Study|Other|2
877642|NCT01336738|2893373|P2|Overall Study|Other|3
877643|NCT01336738|2893374|P1|Overall Study|Other|3
877644|NCT01336738|2893370|P5|Overall Study|Withdrawal by Subject|1
877645|NCT01336738|2893371|P4|Overall Study|Withdrawal by Subject|1
877646|NCT01336738|2893372|P3|Overall Study|Withdrawal by Subject|2
877647|NCT01336738|2893373|P2|Overall Study|Withdrawal by Subject|0
877648|NCT01336738|2893374|P1|Overall Study|Withdrawal by Subject|2
877649|NCT01336738|2893370|P5|Overall Study|Protocol Violation|0
877650|NCT01336738|2893371|P4|Overall Study|Protocol Violation|0
877651|NCT01336738|2893372|P3|Overall Study|Protocol Violation|0
877652|NCT01336738|2893373|P2|Overall Study|Protocol Violation|1
877653|NCT01336738|2893374|P1|Overall Study|Protocol Violation|0
877654|NCT01336738|2893370|P5|Overall Study|Did not meet entrance criteria|0
877655|NCT01336738|2893371|P4|Overall Study|Did not meet entrance criteria|0
877656|NCT01336738|2893372|P3|Overall Study|Did not meet entrance criteria|0
877657|NCT01336738|2893373|P2|Overall Study|Did not meet entrance criteria|1
877658|NCT01336738|2893374|P1|Overall Study|Did not meet entrance criteria|0
877659|NCT01336738|2893370|P5|Overall Study|Lost to Follow-up|2
877660|NCT01336738|2893371|P4|Overall Study|Lost to Follow-up|2
877661|NCT01336738|2893372|P3|Overall Study|Lost to Follow-up|2
877662|NCT01336738|2893373|P2|Overall Study|Lost to Follow-up|1
877663|NCT01336738|2893374|P1|Overall Study|Lost to Follow-up|2
877664|NCT01336738|2893370|P5|Overall Study|Adverse Event|3
877665|NCT01336738|2893371|P4|Overall Study|Adverse Event|1
877666|NCT01336738|2893372|P3|Overall Study|Adverse Event|2
877667|NCT01336738|2893373|P2|Overall Study|Adverse Event|3
877668|NCT01336738|2893374|P1|Overall Study|Adverse Event|0
877669|NCT01336712|2893416|P1|Overall Study|Lack of Efficacy|1
877670|NCT01336712|2893416|P1|Overall Study|Death|2
877671|NCT01336647|2893429|P3|Overall Study|Lost to Follow-up|3
877672|NCT01336647|2893430|P2|Overall Study|Lost to Follow-up|1
877673|NCT01336647|2893431|P1|Overall Study|Lost to Follow-up|4
877674|NCT01336634|2893445|P3|Overall Study|Ongoing|24
877675|NCT01336634|2893446|P2|Overall Study|Ongoing|22
877676|NCT01336634|2893447|P1|Overall Study|Ongoing|15
877677|NCT01336634|2893445|P3|Overall Study|Physician Decision|0
877678|NCT01336634|2893446|P2|Overall Study|Physician Decision|1
877679|NCT01336634|2893447|P1|Overall Study|Physician Decision|1
877680|NCT01336634|2893445|P3|Overall Study|Withdrawal by Subject|1
877681|NCT01336634|2893446|P2|Overall Study|Withdrawal by Subject|0
877682|NCT01336634|2893447|P1|Overall Study|Withdrawal by Subject|6
877683|NCT01336634|2893445|P3|Overall Study|Lost to Follow-up|1
877684|NCT01336634|2893446|P2|Overall Study|Lost to Follow-up|1
877685|NCT01336634|2893447|P1|Overall Study|Lost to Follow-up|2
877686|NCT01336634|2893445|P3|Overall Study|Death|10
877687|NCT01336634|2893446|P2|Overall Study|Death|33
877688|NCT01336634|2893447|P1|Overall Study|Death|60
877689|NCT01336621|2893488|P1|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3
877690|NCT01336621|2893488|P1|SFUCP (up to 2.6 Years)|Physician Decision|1
877691|NCT01336621|2893488|P1|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3
877692|NCT01336621|2893488|P1|SFUCP (up to 2.6 Years)|Adverse Event|1
877693|NCT01336621|2893488|P1|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1
877694|NCT01336621|2893488|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9
877695|NCT01336621|2893488|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2
877696|NCT01336621|2893488|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22
877697|NCT01336621|2893488|P1|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2
877698|NCT01336621|2893488|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11
877699|NCT01336621|2893488|P1|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27
877700|NCT01336621|2893488|P1|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12
877701|NCT01336621|2893488|P1|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2
877702|NCT01336621|2893488|P1|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11
877703|NCT01336608|2893538|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|1
877704|NCT01336608|2893539|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|4
877705|NCT01336608|2893540|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
877706|NCT01336608|2893541|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
877707|NCT01336608|2893538|P4|24-week, Double-blind Treatment Period|Physician Decision|1
877708|NCT01336608|2893539|P3|24-week, Double-blind Treatment Period|Physician Decision|1
877709|NCT01336608|2893540|P2|24-week, Double-blind Treatment Period|Physician Decision|3
877710|NCT01336608|2893541|P1|24-week, Double-blind Treatment Period|Physician Decision|0
877711|NCT01336608|2893538|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
877712|NCT01336608|2893539|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
877713|NCT01336608|2893540|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
877714|NCT01336608|2893541|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
877715|NCT01336608|2893538|P4|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6
877716|NCT01336608|2893539|P3|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3
877717|NCT01336608|2893540|P2|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
877718|NCT01336608|2893541|P1|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
877719|NCT01336608|2893538|P4|24-week, Double-blind Treatment Period|Protocol Violation|3
877720|NCT01336608|2893539|P3|24-week, Double-blind Treatment Period|Protocol Violation|3
877721|NCT01336608|2893540|P2|24-week, Double-blind Treatment Period|Protocol Violation|4
877722|NCT01336608|2893541|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
877723|NCT01336608|2893538|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6
877724|NCT01336608|2893539|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
877725|NCT01336608|2893540|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
877726|NCT01336608|2893541|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
877727|NCT01336608|2893538|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
877728|NCT01336608|2893539|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
877729|NCT01336608|2893540|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
877730|NCT01336608|2893541|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
877731|NCT01336608|2893538|P4|24-week, Double-blind Treatment Period|Adverse Event|7
877732|NCT01336608|2893539|P3|24-week, Double-blind Treatment Period|Adverse Event|6
877733|NCT01336608|2893540|P2|24-week, Double-blind Treatment Period|Adverse Event|8
877734|NCT01336608|2893541|P1|24-week, Double-blind Treatment Period|Adverse Event|0
877735|NCT01336608|2893538|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
877736|NCT01336608|2893539|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
877737|NCT01336608|2893540|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
877738|NCT01336608|2893541|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|2
877739|NCT01336608|2893538|P4|2-week, Single-blind Run-In Period|Physician Decision|0
877740|NCT01336608|2893539|P3|2-week, Single-blind Run-In Period|Physician Decision|0
877741|NCT01336608|2893540|P2|2-week, Single-blind Run-In Period|Physician Decision|0
877742|NCT01336608|2893541|P1|2-week, Single-blind Run-In Period|Physician Decision|1
877743|NCT01336608|2893538|P4|2-week, Single-blind Run-In Period|Adverse Event|0
877744|NCT01336608|2893539|P3|2-week, Single-blind Run-In Period|Adverse Event|0
877745|NCT01336608|2893540|P2|2-week, Single-blind Run-In Period|Adverse Event|0
877746|NCT01336608|2893541|P1|2-week, Single-blind Run-In Period|Adverse Event|1
877747|NCT01336608|2893538|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
877748|NCT01336608|2893539|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
877749|NCT01336608|2893540|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
877750|NCT01336608|2893541|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|9
877751|NCT01336608|2893538|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
877752|NCT01336608|2893539|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
877753|NCT01336608|2893540|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
877754|NCT01336608|2893541|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102
877755|NCT01336569|2893555|P1|Overall Study|Lost to Follow-up|4
877756|NCT01336205|2893597|P2|Overall Study|Did not receive treatment|0
877757|NCT01336205|2893598|P1|Overall Study|Did not receive treatment|4
877758|NCT01336205|2893597|P2|Overall Study|Withdrawal by Subject|38
877759|NCT01336205|2893598|P1|Overall Study|Withdrawal by Subject|72
877760|NCT01336205|2893597|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
877761|NCT01336205|2893598|P1|Overall Study|Eligibility Criteria Not Fulfilled|9
877762|NCT01336205|2893597|P2|Overall Study|Death|1
877763|NCT01336205|2893598|P1|Overall Study|Death|1
877764|NCT01336205|2893597|P2|Overall Study|Adverse Event|6
877765|NCT01336205|2893598|P1|Overall Study|Adverse Event|56
877766|NCT01336205|2893597|P2|Overall Study|Severe noncompliance with protocol|2
877767|NCT01336205|2893598|P1|Overall Study|Severe noncompliance with protocol|9
877768|NCT01336205|2893597|P2|Overall Study|Lack of Efficacy|0
877769|NCT01336205|2893598|P1|Overall Study|Lack of Efficacy|4
877770|NCT01336205|2893597|P2|Overall Study|Study-Specific Withdrawal Criteria|7
877771|NCT01336205|2893598|P1|Overall Study|Study-Specific Withdrawal Criteria|16
877772|NCT01336205|2893597|P2|Overall Study|Lost to Follow-up|20
877773|NCT01336205|2893598|P1|Overall Study|Lost to Follow-up|40
877774|NCT01336205|2893597|P2|Overall Study|Other|9
877775|NCT01336205|2893598|P1|Overall Study|Other|22
877776|NCT01336023|2893626|P3|Week 27 to 52|Unclassified|9
877777|NCT01336023|2893627|P2|Week 27 to 52|Unclassified|18
877778|NCT01336023|2893628|P1|Week 27 to 52|Unclassified|13
877779|NCT01336023|2893626|P3|Week 27 to 52|Withdrawal Criteria|16
877780|NCT01336023|2893627|P2|Week 27 to 52|Withdrawal Criteria|19
877781|NCT01336023|2893628|P1|Week 27 to 52|Withdrawal Criteria|14
877782|NCT01336023|2893626|P3|Week 27 to 52|Protocol Violation|1
877783|NCT01336023|2893627|P2|Week 27 to 52|Protocol Violation|2
877784|NCT01336023|2893628|P1|Week 27 to 52|Protocol Violation|0
877785|NCT01336023|2893626|P3|Week 27 to 52|Adverse Event|2
877786|NCT01336023|2893627|P2|Week 27 to 52|Adverse Event|5
877787|NCT01336023|2893628|P1|Week 27 to 52|Adverse Event|1
877788|NCT01336023|2893626|P3|Week 0 to Week 26|Unclassified|9
877789|NCT01336023|2893627|P2|Week 0 to Week 26|Unclassified|16
877790|NCT01336023|2893628|P1|Week 0 to Week 26|Unclassified|5
877791|NCT01336023|2893626|P3|Week 0 to Week 26|Withdrawal Criteria|40
877792|NCT01336023|2893627|P2|Week 0 to Week 26|Withdrawal Criteria|69
877793|NCT01336023|2893628|P1|Week 0 to Week 26|Withdrawal Criteria|34
877794|NCT01336023|2893626|P3|Week 0 to Week 26|Protocol Violation|0
877795|NCT01336023|2893627|P2|Week 0 to Week 26|Protocol Violation|2
877796|NCT01336023|2893628|P1|Week 0 to Week 26|Protocol Violation|1
877797|NCT01336023|2893626|P3|Week 0 to Week 26|Lack of Efficacy|0
877798|NCT01336023|2893627|P2|Week 0 to Week 26|Lack of Efficacy|1
877799|NCT01336023|2893628|P1|Week 0 to Week 26|Lack of Efficacy|0
877800|NCT01336023|2893626|P3|Week 0 to Week 26|Adverse Event|24
877801|NCT01336023|2893627|P2|Week 0 to Week 26|Adverse Event|10
877802|NCT01336023|2893628|P1|Week 0 to Week 26|Adverse Event|8
877803|NCT01335997|2893649|P2|Period III|Lost to Follow-up|0
877804|NCT01335997|2893650|P1|Period III|Lost to Follow-up|1
877805|NCT01335997|2893649|P2|Period III|Protocol Violation|1
877806|NCT01335997|2893650|P1|Period III|Protocol Violation|0
877807|NCT01335997|2893649|P2|Period III|Study Terminated by Sponsor|76
877808|NCT01335997|2893650|P1|Period III|Study Terminated by Sponsor|77
877809|NCT01335997|2893649|P2|Period III|Adverse Event|2
877810|NCT01335997|2893650|P1|Period III|Adverse Event|0
877811|NCT01335997|2893649|P2|Period I and II|Physician Decision|1
877812|NCT01335997|2893650|P1|Period I and II|Physician Decision|2
877813|NCT01335997|2893649|P2|Period I and II|Protocol Violation|10
877814|NCT01335997|2893650|P1|Period I and II|Protocol Violation|9
877815|NCT01335997|2893649|P2|Period I and II|Study Terminated by Sponsor|415
877816|NCT01335997|2893650|P1|Period I and II|Study Terminated by Sponsor|406
877817|NCT01335997|2893649|P2|Period I and II|Withdrawal by Subject|4
877818|NCT01335997|2893650|P1|Period I and II|Withdrawal by Subject|9
877819|NCT01335997|2893649|P2|Period I and II|Lost to Follow-up|5
877820|NCT01335997|2893650|P1|Period I and II|Lost to Follow-up|3
877821|NCT01335997|2893649|P2|Period I and II|Noncompliance with Study Drug|1
877822|NCT01335997|2893650|P1|Period I and II|Noncompliance with Study Drug|1
877823|NCT01335997|2893649|P2|Period I and II|Adverse Event|43
877824|NCT01335997|2893650|P1|Period I and II|Adverse Event|63
877825|NCT01335971|2893663|P3|Overall Study|Did not complete bronchoscopy|1
877826|NCT01335971|2893664|P2|Overall Study|Did not complete bronchoscopy|1
877827|NCT01335971|2893665|P1|Overall Study|Did not complete bronchoscopy|1
877828|NCT01335971|2893663|P3|Overall Study|Withdrawal by Subject|0
877829|NCT01335971|2893664|P2|Overall Study|Withdrawal by Subject|0
877830|NCT01335971|2893665|P1|Overall Study|Withdrawal by Subject|1
877912|NCT01335685|2893977|P2|Overall Study|Reason not Specified|0
877831|NCT01335698|2893902|P5|Treatment Stage 2|Switched to another formulation|0
877832|NCT01335698|2893903|P4|Treatment Stage 2|Switched to another formulation|0
877833|NCT01335698|2893904|P3|Treatment Stage 2|Switched to another formulation|0
877834|NCT01335698|2893905|P2|Treatment Stage 2|Switched to another formulation|1
877835|NCT01335698|2893906|P1|Treatment Stage 2|Switched to another formulation|1
877836|NCT01335698|2893902|P5|Treatment Stage 2|Subject no longer meets study criteria|0
877837|NCT01335698|2893903|P4|Treatment Stage 2|Subject no longer meets study criteria|1
877838|NCT01335698|2893904|P3|Treatment Stage 2|Subject no longer meets study criteria|0
877839|NCT01335698|2893905|P2|Treatment Stage 2|Subject no longer meets study criteria|0
877840|NCT01335698|2893906|P1|Treatment Stage 2|Subject no longer meets study criteria|0
877841|NCT01335698|2893902|P5|Treatment Stage 2|Capsules received at state hospital|0
877842|NCT01335698|2893903|P4|Treatment Stage 2|Capsules received at state hospital|0
877843|NCT01335698|2893904|P3|Treatment Stage 2|Capsules received at state hospital|0
877844|NCT01335698|2893905|P2|Treatment Stage 2|Capsules received at state hospital|0
877845|NCT01335698|2893906|P1|Treatment Stage 2|Capsules received at state hospital|1
877846|NCT01335698|2893902|P5|Treatment Stage 2|Lost to Follow-up|0
877847|NCT01335698|2893903|P4|Treatment Stage 2|Lost to Follow-up|0
877848|NCT01335698|2893904|P3|Treatment Stage 2|Lost to Follow-up|0
877849|NCT01335698|2893905|P2|Treatment Stage 2|Lost to Follow-up|0
877850|NCT01335698|2893906|P1|Treatment Stage 2|Lost to Follow-up|1
877851|NCT01335698|2893902|P5|Treatment Stage 2|Poor compliance/noncompliance|1
877852|NCT01335698|2893903|P4|Treatment Stage 2|Poor compliance/noncompliance|3
877853|NCT01335698|2893904|P3|Treatment Stage 2|Poor compliance/noncompliance|1
877854|NCT01335698|2893905|P2|Treatment Stage 2|Poor compliance/noncompliance|0
877855|NCT01335698|2893906|P1|Treatment Stage 2|Poor compliance/noncompliance|1
877856|NCT01335698|2893902|P5|Treatment Stage 2|Withdrawal by Subject|0
877857|NCT01335698|2893903|P4|Treatment Stage 2|Withdrawal by Subject|0
877858|NCT01335698|2893904|P3|Treatment Stage 2|Withdrawal by Subject|1
877859|NCT01335698|2893905|P2|Treatment Stage 2|Withdrawal by Subject|1
877860|NCT01335698|2893906|P1|Treatment Stage 2|Withdrawal by Subject|3
877861|NCT01335698|2893902|P5|Treatment Stage 2|Adverse Event|0
877862|NCT01335698|2893903|P4|Treatment Stage 2|Adverse Event|3
877863|NCT01335698|2893904|P3|Treatment Stage 2|Adverse Event|0
877864|NCT01335698|2893905|P2|Treatment Stage 2|Adverse Event|0
877865|NCT01335698|2893906|P1|Treatment Stage 2|Adverse Event|2
877866|NCT01335698|2893902|P5|Treatment Stage 2|Lack of Efficacy|0
877867|NCT01335698|2893903|P4|Treatment Stage 2|Lack of Efficacy|1
877868|NCT01335698|2893904|P3|Treatment Stage 2|Lack of Efficacy|3
877869|NCT01335698|2893905|P2|Treatment Stage 2|Lack of Efficacy|1
877870|NCT01335698|2893906|P1|Treatment Stage 2|Lack of Efficacy|2
877871|NCT01335698|2893902|P5|Treatment Stage 1|Not specified|0
877872|NCT01335698|2893903|P4|Treatment Stage 1|Not specified|1
877873|NCT01335698|2893904|P3|Treatment Stage 1|Not specified|0
877874|NCT01335698|2893905|P2|Treatment Stage 1|Not specified|0
877875|NCT01335698|2893906|P1|Treatment Stage 1|Not specified|1
877876|NCT01335698|2893902|P5|Treatment Stage 1|No longer meets study criteria|0
877877|NCT01335698|2893903|P4|Treatment Stage 1|No longer meets study criteria|1
877878|NCT01335698|2893904|P3|Treatment Stage 1|No longer meets study criteria|0
877879|NCT01335698|2893905|P2|Treatment Stage 1|No longer meets study criteria|1
877880|NCT01335698|2893906|P1|Treatment Stage 1|No longer meets study criteria|1
877881|NCT01335698|2893902|P5|Treatment Stage 1|Poor compliance/noncompliance|0
877882|NCT01335698|2893903|P4|Treatment Stage 1|Poor compliance/noncompliance|2
877883|NCT01335698|2893904|P3|Treatment Stage 1|Poor compliance/noncompliance|0
877884|NCT01335698|2893905|P2|Treatment Stage 1|Poor compliance/noncompliance|1
877885|NCT01335698|2893906|P1|Treatment Stage 1|Poor compliance/noncompliance|0
877886|NCT01335698|2893902|P5|Treatment Stage 1|Lost to Follow-up|0
877887|NCT01335698|2893903|P4|Treatment Stage 1|Lost to Follow-up|0
877888|NCT01335698|2893904|P3|Treatment Stage 1|Lost to Follow-up|0
877889|NCT01335698|2893905|P2|Treatment Stage 1|Lost to Follow-up|1
877890|NCT01335698|2893906|P1|Treatment Stage 1|Lost to Follow-up|1
877891|NCT01335698|2893902|P5|Treatment Stage 1|Withdrawal by Subject|0
877892|NCT01335698|2893903|P4|Treatment Stage 1|Withdrawal by Subject|1
877893|NCT01335698|2893904|P3|Treatment Stage 1|Withdrawal by Subject|0
877894|NCT01335698|2893905|P2|Treatment Stage 1|Withdrawal by Subject|2
877895|NCT01335698|2893906|P1|Treatment Stage 1|Withdrawal by Subject|1
877896|NCT01335698|2893902|P5|Treatment Stage 1|Adverse Event|1
877897|NCT01335698|2893903|P4|Treatment Stage 1|Adverse Event|1
877898|NCT01335698|2893904|P3|Treatment Stage 1|Adverse Event|2
877899|NCT01335698|2893905|P2|Treatment Stage 1|Adverse Event|2
877900|NCT01335698|2893906|P1|Treatment Stage 1|Adverse Event|1
877901|NCT01335698|2893902|P5|Treatment Stage 1|Lack of Efficacy|1
877902|NCT01335698|2893903|P4|Treatment Stage 1|Lack of Efficacy|3
877903|NCT01335698|2893904|P3|Treatment Stage 1|Lack of Efficacy|3
877904|NCT01335698|2893905|P2|Treatment Stage 1|Lack of Efficacy|1
877905|NCT01335698|2893906|P1|Treatment Stage 1|Lack of Efficacy|3
877906|NCT01335685|2893971|P8|Overall Study|Reason not Specified|0
877907|NCT01335685|2893972|P7|Overall Study|Reason not Specified|0
877908|NCT01335685|2893973|P6|Overall Study|Reason not Specified|1
877909|NCT01335685|2893974|P5|Overall Study|Reason not Specified|0
877910|NCT01335685|2893975|P4|Overall Study|Reason not Specified|0
877911|NCT01335685|2893976|P3|Overall Study|Reason not Specified|1
877913|NCT01335685|2893978|P1|Overall Study|Reason not Specified|0
877914|NCT01335685|2893971|P8|Overall Study|Withdrawal by Subject|0
877915|NCT01335685|2893972|P7|Overall Study|Withdrawal by Subject|0
877916|NCT01335685|2893973|P6|Overall Study|Withdrawal by Subject|0
877917|NCT01335685|2893974|P5|Overall Study|Withdrawal by Subject|0
877918|NCT01335685|2893975|P4|Overall Study|Withdrawal by Subject|1
877919|NCT01335685|2893976|P3|Overall Study|Withdrawal by Subject|0
877920|NCT01335685|2893977|P2|Overall Study|Withdrawal by Subject|0
877921|NCT01335685|2893978|P1|Overall Study|Withdrawal by Subject|1
877922|NCT01335685|2893971|P8|Overall Study|Study Terminated by Sponsor|3
877923|NCT01335685|2893972|P7|Overall Study|Study Terminated by Sponsor|2
877924|NCT01335685|2893973|P6|Overall Study|Study Terminated by Sponsor|4
877925|NCT01335685|2893974|P5|Overall Study|Study Terminated by Sponsor|0
877926|NCT01335685|2893975|P4|Overall Study|Study Terminated by Sponsor|10
877927|NCT01335685|2893976|P3|Overall Study|Study Terminated by Sponsor|1
877928|NCT01335685|2893977|P2|Overall Study|Study Terminated by Sponsor|1
877929|NCT01335685|2893978|P1|Overall Study|Study Terminated by Sponsor|2
877930|NCT01335477|2894091|P2|Overall Study|Reason other than those stated above|2
877931|NCT01335477|2894092|P1|Overall Study|Reason other than those stated above|2
877932|NCT01335477|2894091|P2|Overall Study|Not treated|2
877933|NCT01335477|2894092|P1|Overall Study|Not treated|1
877934|NCT01335477|2894091|P2|Overall Study|Consent withdrawn, not due to AE|9
877935|NCT01335477|2894092|P1|Overall Study|Consent withdrawn, not due to AE|7
877936|NCT01335477|2894091|P2|Overall Study|Lost to Follow-up|2
877937|NCT01335477|2894092|P1|Overall Study|Lost to Follow-up|1
877938|NCT01335477|2894091|P2|Overall Study|Non compliant with protocol|2
877939|NCT01335477|2894092|P1|Overall Study|Non compliant with protocol|0
877940|NCT01335477|2894091|P2|Overall Study|Adverse Event|42
877941|NCT01335477|2894092|P1|Overall Study|Adverse Event|30
877942|NCT01335464|2894156|P2|Overall Study|Reason other than those stated above|1
877943|NCT01335464|2894157|P1|Overall Study|Reason other than those stated above|1
877944|NCT01335464|2894156|P2|Overall Study|Not treated|0
877945|NCT01335464|2894157|P1|Overall Study|Not treated|2
877946|NCT01335464|2894156|P2|Overall Study|Consent withdrawn, not due to AE|23
877947|NCT01335464|2894157|P1|Overall Study|Consent withdrawn, not due to AE|12
877948|NCT01335464|2894156|P2|Overall Study|Non compliant with protocol|0
877949|NCT01335464|2894157|P1|Overall Study|Non compliant with protocol|2
877950|NCT01335464|2894156|P2|Overall Study|Adverse Event|25
877951|NCT01335464|2894157|P1|Overall Study|Adverse Event|15
877952|NCT01334918|2894326|P2|Overall Study|Withdrawal by Subject|1
877953|NCT01334918|2894327|P1|Overall Study|Withdrawal by Subject|0
877954|NCT01334918|2894326|P2|Overall Study|Adverse Event|0
877955|NCT01334918|2894327|P1|Overall Study|Adverse Event|2
877956|NCT01334918|2894326|P2|Overall Study|Did not receive study drug|0
877957|NCT01334918|2894327|P1|Overall Study|Did not receive study drug|6
877958|NCT01334866|2894353|P1|Overall Study|medically necessary post-procedure|1
877959|NCT01334866|2894353|P1|Overall Study|medically necessary prior to procedure|2
877960|NCT01334866|2894353|P1|Overall Study|Physician Decision|3
877961|NCT01334866|2894353|P1|Overall Study|Lost to Follow-up|3
877962|NCT01334866|2894353|P1|Overall Study|Withdrawal by Subject|10
877963|NCT01334710|2894390|P1|Overall Study|Trial was terminated|3
877964|NCT01334606|2894395|P1|Overall Study|Study Terminated due to slow enrolment|18
877965|NCT01334554|2894403|P2|Overall Study|Adverse Event|2
877966|NCT01334554|2894404|P1|Overall Study|Adverse Event|4
877967|NCT01334515|2894414|P2|Overall Study|Withdrawal by Subject|1
877968|NCT01334515|2894415|P1|Overall Study|Withdrawal by Subject|1
877969|NCT01334515|2894414|P2|Overall Study|Physician Decision|1
877970|NCT01334515|2894415|P1|Overall Study|Physician Decision|1
877971|NCT01334515|2894414|P2|Overall Study|Lack of Efficacy|21
877972|NCT01334515|2894415|P1|Overall Study|Lack of Efficacy|8
877973|NCT01334515|2894414|P2|Overall Study|Death|0
877974|NCT01334515|2894415|P1|Overall Study|Death|1
877975|NCT01334515|2894414|P2|Overall Study|Adverse Event|6
877976|NCT01334515|2894415|P1|Overall Study|Adverse Event|1
877977|NCT01334125|2894453|P2|Overall Study|Lost to Follow-up|3
877978|NCT01334125|2894454|P1|Overall Study|Lost to Follow-up|3
877979|NCT01333956|2894470|P4|Overall Study|Withdrawal by Subject|0
877980|NCT01333956|2894471|P3|Overall Study|Withdrawal by Subject|1
877981|NCT01333956|2894472|P2|Overall Study|Withdrawal by Subject|2
877982|NCT01333956|2894473|P1|Overall Study|Withdrawal by Subject|0
877983|NCT01333956|2894470|P4|Overall Study|Unable to complete study procedure|1
877984|NCT01333956|2894471|P3|Overall Study|Unable to complete study procedure|0
877985|NCT01333956|2894472|P2|Overall Study|Unable to complete study procedure|0
877986|NCT01333956|2894473|P1|Overall Study|Unable to complete study procedure|1
877987|NCT01333956|2894470|P4|Overall Study|Lost to Follow-up|1
877988|NCT01333956|2894471|P3|Overall Study|Lost to Follow-up|0
877989|NCT01333956|2894472|P2|Overall Study|Lost to Follow-up|2
877990|NCT01333956|2894473|P1|Overall Study|Lost to Follow-up|1
877991|NCT01333943|2894509|P2|Overall Study|Known neuropathy|0
877992|NCT01333943|2894510|P1|Overall Study|Known neuropathy|1
877993|NCT01333865|2894526|P1|Overall Study|Adverse Event|2
877994|NCT01333722|2894546|P2|Overall Study|Withdrawal by Subject|1
877995|NCT01333722|2894547|P1|Overall Study|Withdrawal by Subject|0
877996|NCT01333722|2894546|P2|Overall Study|Lack of Efficacy|2
877997|NCT01333722|2894547|P1|Overall Study|Lack of Efficacy|0
877998|NCT01333501|2894572|P2|Overall Study|Withdrawn consent|12
877999|NCT01333501|2894573|P1|Overall Study|Withdrawn consent|3
878000|NCT01333501|2894572|P2|Overall Study|Unsatisfactory therapeutic effect|7
878001|NCT01333501|2894573|P1|Overall Study|Unsatisfactory therapeutic effect|1
878002|NCT01333501|2894572|P2|Overall Study|Abnormal laboratory value|1
878003|NCT01333501|2894573|P1|Overall Study|Abnormal laboratory value|2
878004|NCT01333501|2894572|P2|Overall Study|Adverse Event|1
878005|NCT01333501|2894573|P1|Overall Study|Adverse Event|3
878006|NCT01333475|2894640|P2|Overall Study|Toxicity|3
878007|NCT01333475|2894641|P1|Overall Study|Toxicity|1
878008|NCT01333475|2894640|P2|Overall Study|pt withdrew-need emergent radiation trmt|0
878009|NCT01333475|2894641|P1|Overall Study|pt withdrew-need emergent radiation trmt|1
878010|NCT01333397|2894667|P5|Overall Study|Lost to Follow-up|0
878011|NCT01333397|2894668|P4|Overall Study|Lost to Follow-up|1
878012|NCT01333397|2894669|P3|Overall Study|Lost to Follow-up|0
878013|NCT01333397|2894670|P2|Overall Study|Lost to Follow-up|0
878014|NCT01333397|2894671|P1|Overall Study|Lost to Follow-up|1
878015|NCT01333189|2894745|P2|Overall Study|Moved from region|1
878016|NCT01333189|2894746|P1|Overall Study|Moved from region|0
878017|NCT01333189|2894745|P2|Overall Study|Transportation difficulties|1
878018|NCT01333189|2894746|P1|Overall Study|Transportation difficulties|0
878019|NCT01333189|2894745|P2|Overall Study|Adverse Event|0
878020|NCT01333189|2894746|P1|Overall Study|Adverse Event|1
878021|NCT01333189|2894745|P2|Overall Study|Time constraints|0
878022|NCT01333189|2894746|P1|Overall Study|Time constraints|1
878023|NCT01333111|2894777|P3|Overall Study|Ineffective therapy|1
878024|NCT01333111|2894778|P2|Overall Study|Ineffective therapy|0
878025|NCT01333111|2894779|P1|Overall Study|Ineffective therapy|0
878026|NCT01333111|2894777|P3|Overall Study|Non-compliance|0
878027|NCT01333111|2894778|P2|Overall Study|Non-compliance|0
878028|NCT01333111|2894779|P1|Overall Study|Non-compliance|1
878029|NCT01333111|2894777|P3|Overall Study|withdrawal criteria|0
878030|NCT01333111|2894778|P2|Overall Study|withdrawal criteria|1
878031|NCT01333111|2894779|P1|Overall Study|withdrawal criteria|0
878032|NCT01333111|2894777|P3|Overall Study|unclassified|0
878033|NCT01333111|2894778|P2|Overall Study|unclassified|0
878034|NCT01333111|2894779|P1|Overall Study|unclassified|1
878035|NCT01333111|2894777|P3|Overall Study|personal reasons|1
878036|NCT01333111|2894778|P2|Overall Study|personal reasons|0
878037|NCT01333111|2894779|P1|Overall Study|personal reasons|0
878038|NCT01333111|2894777|P3|Overall Study|patient undergoing major surgery|0
878039|NCT01333111|2894778|P2|Overall Study|patient undergoing major surgery|2
878040|NCT01333111|2894779|P1|Overall Study|patient undergoing major surgery|0
878041|NCT01333072|2894805|P2|Overall Study|Physician Decision|0
878042|NCT01333072|2894806|P1|Overall Study|Physician Decision|1
878043|NCT01333072|2894805|P2|Overall Study|Adverse Event|4
878044|NCT01333072|2894806|P1|Overall Study|Adverse Event|2
878045|NCT01333072|2894805|P2|Overall Study|Lost to Follow-up|0
878046|NCT01333072|2894806|P1|Overall Study|Lost to Follow-up|3
878047|NCT01333059|2894814|P2|Overall Study|Protocol Violation|0
878048|NCT01333059|2894815|P1|Overall Study|Protocol Violation|3
878049|NCT01333059|2894814|P2|Overall Study|Physician Decision|3
878050|NCT01333059|2894815|P1|Overall Study|Physician Decision|3
878051|NCT01332994|2894825|P1|Overall Study|Not Specified|8
878052|NCT01332994|2894825|P1|Overall Study|Administrative Problem|2
878053|NCT01332994|2894825|P1|Overall Study|Withdrawal by Subject|15
878054|NCT01332994|2894825|P1|Overall Study|Protocol Violation|6
878055|NCT01332994|2894825|P1|Overall Study|Lost to Follow-up|4
878056|NCT01332994|2894825|P1|Overall Study|Lack of Efficacy|1
878057|NCT01332994|2894825|P1|Overall Study|Death|1
878058|NCT01332994|2894825|P1|Overall Study|Adverse Event|34
878059|NCT01332968|2894894|P8|Follow-Up Period|Lost to Follow-up|2
878060|NCT01332968|2894895|P7|Follow-Up Period|Lost to Follow-up|1
878061|NCT01332968|2894896|P6|Follow-Up Period|Lost to Follow-up|0
878062|NCT01332968|2894897|P5|Follow-Up Period|Lost to Follow-up|0
878063|NCT01332968|2894898|P4|Follow-Up Period|Lost to Follow-up|0
878064|NCT01332968|2894899|P3|Follow-Up Period|Lost to Follow-up|0
878065|NCT01332968|2894900|P2|Follow-Up Period|Lost to Follow-up|0
878066|NCT01332968|2894901|P1|Follow-Up Period|Lost to Follow-up|0
878067|NCT01332968|2894894|P8|Follow-Up Period|Withdrawal by Subject|2
878068|NCT01332968|2894895|P7|Follow-Up Period|Withdrawal by Subject|1
878069|NCT01332968|2894896|P6|Follow-Up Period|Withdrawal by Subject|0
878070|NCT01332968|2894897|P5|Follow-Up Period|Withdrawal by Subject|0
878071|NCT01332968|2894898|P4|Follow-Up Period|Withdrawal by Subject|0
878072|NCT01332968|2894899|P3|Follow-Up Period|Withdrawal by Subject|0
878073|NCT01332968|2894900|P2|Follow-Up Period|Withdrawal by Subject|0
878074|NCT01332968|2894901|P1|Follow-Up Period|Withdrawal by Subject|0
878075|NCT01332968|2894894|P8|Follow-Up Period|Follow-up ongoing|505
878076|NCT01332968|2894895|P7|Follow-Up Period|Follow-up ongoing|502
878077|NCT01332968|2894896|P6|Follow-Up Period|Follow-up ongoing|0
878078|NCT01332968|2894897|P5|Follow-Up Period|Follow-up ongoing|0
878079|NCT01332968|2894898|P4|Follow-Up Period|Follow-up ongoing|0
878080|NCT01332968|2894899|P3|Follow-Up Period|Follow-up ongoing|0
878081|NCT01332968|2894900|P2|Follow-Up Period|Follow-up ongoing|0
878082|NCT01332968|2894901|P1|Follow-Up Period|Follow-up ongoing|0
878083|NCT01332968|2894894|P8|Follow-Up Period|Death|22
878084|NCT01332968|2894895|P7|Follow-Up Period|Death|38
878085|NCT01332968|2894896|P6|Follow-Up Period|Death|0
878086|NCT01332968|2894897|P5|Follow-Up Period|Death|0
878087|NCT01332968|2894898|P4|Follow-Up Period|Death|0
878088|NCT01332968|2894899|P3|Follow-Up Period|Death|0
878089|NCT01332968|2894900|P2|Follow-Up Period|Death|0
878090|NCT01332968|2894901|P1|Follow-Up Period|Death|0
878091|NCT01332968|2894894|P8|Maintenance/Observation Period|Treatment ongoing|0
878092|NCT01332968|2894895|P7|Maintenance/Observation Period|Treatment ongoing|0
878093|NCT01332968|2894896|P6|Maintenance/Observation Period|Treatment ongoing|8
878094|NCT01332968|2894897|P5|Maintenance/Observation Period|Treatment ongoing|10
878095|NCT01332968|2894898|P4|Maintenance/Observation Period|Treatment ongoing|62
878096|NCT01332968|2894899|P3|Maintenance/Observation Period|Treatment ongoing|54
878097|NCT01332968|2894900|P2|Maintenance/Observation Period|Treatment ongoing|0
878098|NCT01332968|2894901|P1|Maintenance/Observation Period|Treatment ongoing|0
878099|NCT01332968|2894894|P8|Maintenance/Observation Period|Adverse Event|0
878100|NCT01332968|2894895|P7|Maintenance/Observation Period|Adverse Event|0
878101|NCT01332968|2894896|P6|Maintenance/Observation Period|Adverse Event|0
878102|NCT01332968|2894897|P5|Maintenance/Observation Period|Adverse Event|0
878103|NCT01332968|2894898|P4|Maintenance/Observation Period|Adverse Event|65
878104|NCT01332968|2894899|P3|Maintenance/Observation Period|Adverse Event|50
878105|NCT01332968|2894900|P2|Maintenance/Observation Period|Adverse Event|0
878106|NCT01332968|2894901|P1|Maintenance/Observation Period|Adverse Event|0
878107|NCT01332968|2894894|P8|Maintenance/Observation Period|Death|0
878108|NCT01332968|2894895|P7|Maintenance/Observation Period|Death|0
878109|NCT01332968|2894896|P6|Maintenance/Observation Period|Death|0
878110|NCT01332968|2894897|P5|Maintenance/Observation Period|Death|0
878111|NCT01332968|2894898|P4|Maintenance/Observation Period|Death|6
878112|NCT01332968|2894899|P3|Maintenance/Observation Period|Death|5
878113|NCT01332968|2894900|P2|Maintenance/Observation Period|Death|0
878114|NCT01332968|2894901|P1|Maintenance/Observation Period|Death|0
878115|NCT01332968|2894894|P8|Maintenance/Observation Period|Lost to Follow-up|0
878116|NCT01332968|2894895|P7|Maintenance/Observation Period|Lost to Follow-up|0
878117|NCT01332968|2894896|P6|Maintenance/Observation Period|Lost to Follow-up|0
878118|NCT01332968|2894897|P5|Maintenance/Observation Period|Lost to Follow-up|0
878119|NCT01332968|2894898|P4|Maintenance/Observation Period|Lost to Follow-up|2
878120|NCT01332968|2894899|P3|Maintenance/Observation Period|Lost to Follow-up|1
878121|NCT01332968|2894900|P2|Maintenance/Observation Period|Lost to Follow-up|0
878122|NCT01332968|2894901|P1|Maintenance/Observation Period|Lost to Follow-up|0
878123|NCT01332968|2894894|P8|Maintenance/Observation Period|Non-compliance|0
878124|NCT01332968|2894895|P7|Maintenance/Observation Period|Non-compliance|0
878125|NCT01332968|2894896|P6|Maintenance/Observation Period|Non-compliance|1
878126|NCT01332968|2894897|P5|Maintenance/Observation Period|Non-compliance|0
878127|NCT01332968|2894898|P4|Maintenance/Observation Period|Non-compliance|3
878128|NCT01332968|2894899|P3|Maintenance/Observation Period|Non-compliance|2
878129|NCT01332968|2894900|P2|Maintenance/Observation Period|Non-compliance|0
878130|NCT01332968|2894901|P1|Maintenance/Observation Period|Non-compliance|0
878131|NCT01332968|2894894|P8|Maintenance/Observation Period|Other|0
878132|NCT01332968|2894895|P7|Maintenance/Observation Period|Other|0
878133|NCT01332968|2894896|P6|Maintenance/Observation Period|Other|0
878134|NCT01332968|2894897|P5|Maintenance/Observation Period|Other|0
878135|NCT01332968|2894898|P4|Maintenance/Observation Period|Other|5
878136|NCT01332968|2894899|P3|Maintenance/Observation Period|Other|4
878137|NCT01332968|2894900|P2|Maintenance/Observation Period|Other|0
878138|NCT01332968|2894901|P1|Maintenance/Observation Period|Other|0
878139|NCT01332968|2894894|P8|Maintenance/Observation Period|Physician Decision|0
878140|NCT01332968|2894895|P7|Maintenance/Observation Period|Physician Decision|0
878141|NCT01332968|2894896|P6|Maintenance/Observation Period|Physician Decision|0
878142|NCT01332968|2894897|P5|Maintenance/Observation Period|Physician Decision|0
878143|NCT01332968|2894898|P4|Maintenance/Observation Period|Physician Decision|19
878144|NCT01332968|2894899|P3|Maintenance/Observation Period|Physician Decision|14
878145|NCT01332968|2894900|P2|Maintenance/Observation Period|Physician Decision|0
878146|NCT01332968|2894901|P1|Maintenance/Observation Period|Physician Decision|0
878147|NCT01332968|2894894|P8|Maintenance/Observation Period|Progressive disease|0
878148|NCT01332968|2894895|P7|Maintenance/Observation Period|Progressive disease|0
878149|NCT01332968|2894896|P6|Maintenance/Observation Period|Progressive disease|0
878150|NCT01332968|2894897|P5|Maintenance/Observation Period|Progressive disease|0
878151|NCT01332968|2894898|P4|Maintenance/Observation Period|Progressive disease|39
878152|NCT01332968|2894899|P3|Maintenance/Observation Period|Progressive disease|72
878153|NCT01332968|2894900|P2|Maintenance/Observation Period|Progressive disease|0
878154|NCT01332968|2894901|P1|Maintenance/Observation Period|Progressive disease|0
878155|NCT01332968|2894894|P8|Maintenance/Observation Period|Protocol Violation|0
878156|NCT01332968|2894895|P7|Maintenance/Observation Period|Protocol Violation|0
878157|NCT01332968|2894896|P6|Maintenance/Observation Period|Protocol Violation|0
878158|NCT01332968|2894897|P5|Maintenance/Observation Period|Protocol Violation|0
878159|NCT01332968|2894898|P4|Maintenance/Observation Period|Protocol Violation|1
878160|NCT01332968|2894899|P3|Maintenance/Observation Period|Protocol Violation|1
878161|NCT01332968|2894900|P2|Maintenance/Observation Period|Protocol Violation|0
878162|NCT01332968|2894901|P1|Maintenance/Observation Period|Protocol Violation|0
878163|NCT01332968|2894894|P8|Maintenance/Observation Period|Withdrawal by Subject|0
878164|NCT01332968|2894895|P7|Maintenance/Observation Period|Withdrawal by Subject|0
878165|NCT01332968|2894896|P6|Maintenance/Observation Period|Withdrawal by Subject|0
878166|NCT01332968|2894897|P5|Maintenance/Observation Period|Withdrawal by Subject|0
878167|NCT01332968|2894898|P4|Maintenance/Observation Period|Withdrawal by Subject|5
878168|NCT01332968|2894899|P3|Maintenance/Observation Period|Withdrawal by Subject|10
878169|NCT01332968|2894900|P2|Maintenance/Observation Period|Withdrawal by Subject|0
878170|NCT01332968|2894901|P1|Maintenance/Observation Period|Withdrawal by Subject|0
878171|NCT01332968|2894894|P8|Induction Period|Randomized, but not treated|0
878172|NCT01332968|2894895|P7|Induction Period|Randomized, but not treated|0
878173|NCT01332968|2894896|P6|Induction Period|Randomized, but not treated|0
878174|NCT01332968|2894897|P5|Induction Period|Randomized, but not treated|0
878175|NCT01332968|2894898|P4|Induction Period|Randomized, but not treated|0
878176|NCT01332968|2894899|P3|Induction Period|Randomized, but not treated|0
878177|NCT01332968|2894900|P2|Induction Period|Randomized, but not treated|7
878178|NCT01332968|2894901|P1|Induction Period|Randomized, but not treated|4
878179|NCT01332968|2894894|P8|Induction Period|Adverse Event|0
878180|NCT01332968|2894895|P7|Induction Period|Adverse Event|0
878181|NCT01332968|2894896|P6|Induction Period|Adverse Event|0
878182|NCT01332968|2894897|P5|Induction Period|Adverse Event|0
878183|NCT01332968|2894898|P4|Induction Period|Adverse Event|0
878184|NCT01332968|2894899|P3|Induction Period|Adverse Event|0
878185|NCT01332968|2894900|P2|Induction Period|Adverse Event|26
878186|NCT01332968|2894901|P1|Induction Period|Adverse Event|23
878187|NCT01332968|2894894|P8|Induction Period|Death|0
878188|NCT01332968|2894895|P7|Induction Period|Death|0
878189|NCT01332968|2894896|P6|Induction Period|Death|0
878190|NCT01332968|2894897|P5|Induction Period|Death|0
878191|NCT01332968|2894898|P4|Induction Period|Death|0
878192|NCT01332968|2894899|P3|Induction Period|Death|0
878193|NCT01332968|2894900|P2|Induction Period|Death|4
878194|NCT01332968|2894901|P1|Induction Period|Death|1
878195|NCT01332968|2894894|P8|Induction Period|Non-compliance|0
878196|NCT01332968|2894895|P7|Induction Period|Non-compliance|0
878197|NCT01332968|2894896|P6|Induction Period|Non-compliance|0
878198|NCT01332968|2894897|P5|Induction Period|Non-compliance|0
878199|NCT01332968|2894898|P4|Induction Period|Non-compliance|0
878200|NCT01332968|2894899|P3|Induction Period|Non-compliance|0
878201|NCT01332968|2894900|P2|Induction Period|Non-compliance|0
878202|NCT01332968|2894901|P1|Induction Period|Non-compliance|1
878203|NCT01332968|2894894|P8|Induction Period|Other|0
878204|NCT01332968|2894895|P7|Induction Period|Other|0
878205|NCT01332968|2894896|P6|Induction Period|Other|0
878206|NCT01332968|2894897|P5|Induction Period|Other|0
878207|NCT01332968|2894898|P4|Induction Period|Other|0
878208|NCT01332968|2894899|P3|Induction Period|Other|0
878209|NCT01332968|2894900|P2|Induction Period|Other|2
878210|NCT01332968|2894901|P1|Induction Period|Other|2
878211|NCT01332968|2894894|P8|Induction Period|Physician Decision|0
878212|NCT01332968|2894895|P7|Induction Period|Physician Decision|0
878213|NCT01332968|2894896|P6|Induction Period|Physician Decision|0
878214|NCT01332968|2894897|P5|Induction Period|Physician Decision|0
878215|NCT01332968|2894898|P4|Induction Period|Physician Decision|0
878216|NCT01332968|2894899|P3|Induction Period|Physician Decision|0
878217|NCT01332968|2894900|P2|Induction Period|Physician Decision|1
878218|NCT01332968|2894901|P1|Induction Period|Physician Decision|6
878219|NCT01332968|2894894|P8|Induction Period|Progressive disease|0
878220|NCT01332968|2894895|P7|Induction Period|Progressive disease|0
878221|NCT01332968|2894896|P6|Induction Period|Progressive disease|0
878222|NCT01332968|2894897|P5|Induction Period|Progressive disease|0
878223|NCT01332968|2894898|P4|Induction Period|Progressive disease|0
878224|NCT01332968|2894899|P3|Induction Period|Progressive disease|0
878225|NCT01332968|2894900|P2|Induction Period|Progressive disease|7
878226|NCT01332968|2894901|P1|Induction Period|Progressive disease|15
878227|NCT01332968|2894894|P8|Induction Period|Protocol Violation|0
878228|NCT01332968|2894895|P7|Induction Period|Protocol Violation|0
878229|NCT01332968|2894896|P6|Induction Period|Protocol Violation|0
878230|NCT01332968|2894897|P5|Induction Period|Protocol Violation|0
878231|NCT01332968|2894898|P4|Induction Period|Protocol Violation|0
878232|NCT01332968|2894899|P3|Induction Period|Protocol Violation|0
878233|NCT01332968|2894900|P2|Induction Period|Protocol Violation|4
878234|NCT01332968|2894901|P1|Induction Period|Protocol Violation|3
878235|NCT01332968|2894894|P8|Induction Period|Withdrawal by Subject|0
878236|NCT01332968|2894895|P7|Induction Period|Withdrawal by Subject|0
878237|NCT01332968|2894896|P6|Induction Period|Withdrawal by Subject|0
878238|NCT01332968|2894897|P5|Induction Period|Withdrawal by Subject|0
878239|NCT01332968|2894898|P4|Induction Period|Withdrawal by Subject|0
878240|NCT01332968|2894899|P3|Induction Period|Withdrawal by Subject|0
878241|NCT01332968|2894900|P2|Induction Period|Withdrawal by Subject|5
878242|NCT01332968|2894901|P1|Induction Period|Withdrawal by Subject|3
878243|NCT01332851|2894967|P2|Overall Study|Lost to Follow-up|11
878244|NCT01332851|2894968|P1|Overall Study|Lost to Follow-up|7
878245|NCT01332851|2894967|P2|Overall Study|Withdrawal by Subject|2
878246|NCT01332851|2894968|P1|Overall Study|Withdrawal by Subject|4
878247|NCT01332630|2895006|P1|Overall Study|Withdrawal by Subject|3
878248|NCT01332318|2895124|P4|Overall Study|Protocol Violation|1
878249|NCT01332318|2895125|P3|Overall Study|Protocol Violation|1
878250|NCT01332318|2895126|P2|Overall Study|Protocol Violation|0
878251|NCT01332318|2895127|P1|Overall Study|Protocol Violation|1
878252|NCT01332318|2895124|P4|Overall Study|Withdrawal by Subject|1
878253|NCT01332318|2895125|P3|Overall Study|Withdrawal by Subject|0
878254|NCT01332318|2895126|P2|Overall Study|Withdrawal by Subject|1
878255|NCT01332318|2895127|P1|Overall Study|Withdrawal by Subject|1
878256|NCT01332318|2895124|P4|Overall Study|Adverse Event|0
878257|NCT01332318|2895125|P3|Overall Study|Adverse Event|0
878258|NCT01332318|2895126|P2|Overall Study|Adverse Event|3
878259|NCT01332318|2895127|P1|Overall Study|Adverse Event|0
878260|NCT01332305|2895238|P5|Overall Study|Physician Decision|0
878261|NCT01332305|2895239|P4|Overall Study|Physician Decision|1
878262|NCT01332305|2895240|P3|Overall Study|Physician Decision|0
878263|NCT01332305|2895241|P2|Overall Study|Physician Decision|0
878264|NCT01332305|2895242|P1|Overall Study|Physician Decision|0
878265|NCT01332305|2895238|P5|Overall Study|Treatment Failure|0
878266|NCT01332305|2895239|P4|Overall Study|Treatment Failure|0
878267|NCT01332305|2895240|P3|Overall Study|Treatment Failure|0
878268|NCT01332305|2895241|P2|Overall Study|Treatment Failure|1
878269|NCT01332305|2895242|P1|Overall Study|Treatment Failure|1
878270|NCT01332305|2895238|P5|Overall Study|Withdrawal by Sponsor|1
878271|NCT01332305|2895239|P4|Overall Study|Withdrawal by Sponsor|1
878272|NCT01332305|2895240|P3|Overall Study|Withdrawal by Sponsor|0
878273|NCT01332305|2895241|P2|Overall Study|Withdrawal by Sponsor|0
878274|NCT01332305|2895242|P1|Overall Study|Withdrawal by Sponsor|1
878275|NCT01332305|2895238|P5|Overall Study|Protocol Violation|3
878276|NCT01332305|2895239|P4|Overall Study|Protocol Violation|0
878277|NCT01332305|2895240|P3|Overall Study|Protocol Violation|1
878278|NCT01332305|2895241|P2|Overall Study|Protocol Violation|2
878279|NCT01332305|2895242|P1|Overall Study|Protocol Violation|1
878280|NCT01332305|2895238|P5|Overall Study|Lost to Follow-up|3
878281|NCT01332305|2895239|P4|Overall Study|Lost to Follow-up|2
878282|NCT01332305|2895240|P3|Overall Study|Lost to Follow-up|3
878283|NCT01332305|2895241|P2|Overall Study|Lost to Follow-up|2
878284|NCT01332305|2895242|P1|Overall Study|Lost to Follow-up|0
878285|NCT01332305|2895238|P5|Overall Study|Withdrawal by Subject|0
878286|NCT01332305|2895239|P4|Overall Study|Withdrawal by Subject|1
878287|NCT01332305|2895240|P3|Overall Study|Withdrawal by Subject|4
878288|NCT01332305|2895241|P2|Overall Study|Withdrawal by Subject|5
878289|NCT01332305|2895242|P1|Overall Study|Withdrawal by Subject|6
878290|NCT01332305|2895238|P5|Overall Study|Adverse Event|5
878291|NCT01332305|2895239|P4|Overall Study|Adverse Event|3
878292|NCT01332305|2895240|P3|Overall Study|Adverse Event|6
878293|NCT01332305|2895241|P2|Overall Study|Adverse Event|4
878294|NCT01332305|2895242|P1|Overall Study|Adverse Event|1
878295|NCT01332292|2895264|P2|Treatment Period 2 (14 Days)|Physician Decision|1
878296|NCT01332292|2895265|P1|Treatment Period 2 (14 Days)|Physician Decision|1
878297|NCT01332292|2895264|P2|Treatment Period 1 (14 Days)|Protocol Violation|1
878298|NCT01332292|2895265|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
878299|NCT01332292|2895264|P2|Treatment Period 1 (14 Days)|Adverse Event|0
878300|NCT01332292|2895265|P1|Treatment Period 1 (14 Days)|Adverse Event|1
878301|NCT01332227|2895356|P2|Overall Study|Patient began prohibited medication|1
878302|NCT01332227|2895357|P1|Overall Study|Patient began prohibited medication|0
878303|NCT01332227|2895356|P2|Overall Study|Patient moved from area|0
878304|NCT01332227|2895357|P1|Overall Study|Patient moved from area|1
878305|NCT01332227|2895356|P2|Overall Study|Poor compliance/noncompliance|1
878306|NCT01332227|2895357|P1|Overall Study|Poor compliance/noncompliance|1
878307|NCT01332227|2895356|P2|Overall Study|Lack of Efficacy|1
878308|NCT01332227|2895357|P1|Overall Study|Lack of Efficacy|3
878309|NCT01332227|2895356|P2|Overall Study|Lost to Follow-up|0
878310|NCT01332227|2895357|P1|Overall Study|Lost to Follow-up|2
878311|NCT01332227|2895356|P2|Overall Study|Withdrawal by Subject|1
878312|NCT01332227|2895357|P1|Overall Study|Withdrawal by Subject|5
878313|NCT01332227|2895356|P2|Overall Study|Adverse Event|1
878314|NCT01332227|2895357|P1|Overall Study|Adverse Event|4
878315|NCT01332149|2895538|P2|Overall Study|Randomized but not treated|2
878316|NCT01332149|2895539|P1|Overall Study|Randomized but not treated|1
878317|NCT01332149|2895538|P2|Overall Study|Did not meet entrance criteria|4
878318|NCT01332149|2895539|P1|Overall Study|Did not meet entrance criteria|3
878319|NCT01332149|2895538|P2|Overall Study|Insufficient clinical response|7
878320|NCT01332149|2895539|P1|Overall Study|Insufficient clinical response|4
878321|NCT01332149|2895538|P2|Overall Study|Lost to Follow-up|1
878322|NCT01332149|2895539|P1|Overall Study|Lost to Follow-up|1
878323|NCT01332149|2895538|P2|Overall Study|Withdrawal by Subject|5
878324|NCT01332149|2895539|P1|Overall Study|Withdrawal by Subject|4
878325|NCT01332149|2895538|P2|Overall Study|Protocol Violation|3
878326|NCT01332149|2895539|P1|Overall Study|Protocol Violation|1
878327|NCT01332149|2895538|P2|Overall Study|Other unspecified|7
878328|NCT01332149|2895539|P1|Overall Study|Other unspecified|5
878329|NCT01332149|2895538|P2|Overall Study|Adverse Event|9
878330|NCT01332149|2895539|P1|Overall Study|Adverse Event|11
878331|NCT01332019|2895617|P2|Overall Study|Adverse Event|22
878332|NCT01332019|2895618|P1|Overall Study|Adverse Event|13
878333|NCT01332019|2895617|P2|Overall Study|Lost to Follow-up|7
878334|NCT01332019|2895618|P1|Overall Study|Lost to Follow-up|4
878335|NCT01332019|2895617|P2|Overall Study|Withdrawal by Subject|71
878336|NCT01332019|2895618|P1|Overall Study|Withdrawal by Subject|73
878337|NCT01332019|2895617|P2|Overall Study|Physician Decision|3
878338|NCT01332019|2895618|P1|Overall Study|Physician Decision|4
878339|NCT01332019|2895617|P2|Overall Study|Death|1
878340|NCT01332019|2895618|P1|Overall Study|Death|2
878341|NCT01332019|2895617|P2|Overall Study|Not Specified|18
878342|NCT01332019|2895618|P1|Overall Study|Not Specified|16
878343|NCT01332019|2895617|P2|Overall Study|Was Not Dosed|0
878344|NCT01332019|2895618|P1|Overall Study|Was Not Dosed|1
878345|NCT01331837|2895702|P2|Overall Study|Withdrawal by Subject|16
878346|NCT01331837|2895703|P1|Overall Study|Withdrawal by Subject|13
878347|NCT01331837|2895702|P2|Overall Study|Info not recorded|16
878348|NCT01331837|2895703|P1|Overall Study|Info not recorded|10
878349|NCT01331837|2895702|P2|Overall Study|Lost to Follow-up|1
878350|NCT01331837|2895703|P1|Overall Study|Lost to Follow-up|3
878351|NCT01331837|2895702|P2|Overall Study|Death|34
878352|NCT01331837|2895703|P1|Overall Study|Death|30
878353|NCT01331824|2895743|P1|Overall Study|Withdrawal by Subject|1
878354|NCT01331824|2895743|P1|Overall Study|Disease Progression|9
878355|NCT01331824|2895743|P1|Overall Study|Death|1
878356|NCT01331824|2895743|P1|Overall Study|Adverse Event|2
878357|NCT01331681|2895778|P3|Overall Study|Not Received Study Treatment|2
878358|NCT01331681|2895779|P2|Overall Study|Not Received Study Treatment|0
878359|NCT01331681|2895780|P1|Overall Study|Not Received Study Treatment|0
878360|NCT01331681|2895778|P3|Overall Study|Switching to other therapy|1
878361|NCT01331681|2895779|P2|Overall Study|Switching to other therapy|0
878362|NCT01331681|2895780|P1|Overall Study|Switching to other therapy|0
878363|NCT01331681|2895778|P3|Overall Study|Sponsor decision|0
878364|NCT01331681|2895779|P2|Overall Study|Sponsor decision|1
878365|NCT01331681|2895780|P1|Overall Study|Sponsor decision|1
878366|NCT01331681|2895778|P3|Overall Study|Therapeutic procedure required|0
878367|NCT01331681|2895779|P2|Overall Study|Therapeutic procedure required|0
878368|NCT01331681|2895780|P1|Overall Study|Therapeutic procedure required|1
878369|NCT01331681|2895778|P3|Overall Study|Physician Decision|4
878370|NCT01331681|2895779|P2|Overall Study|Physician Decision|0
878371|NCT01331681|2895780|P1|Overall Study|Physician Decision|2
878372|NCT01331681|2895778|P3|Overall Study|Lost to Follow-up|1
878373|NCT01331681|2895779|P2|Overall Study|Lost to Follow-up|4
878374|NCT01331681|2895780|P1|Overall Study|Lost to Follow-up|2
878375|NCT01331681|2895778|P3|Overall Study|Protocol Violation|0
878376|NCT01331681|2895779|P2|Overall Study|Protocol Violation|1
878377|NCT01331681|2895780|P1|Overall Study|Protocol Violation|1
878378|NCT01331681|2895778|P3|Overall Study|Withdrawal by Subject|15
878379|NCT01331681|2895779|P2|Overall Study|Withdrawal by Subject|8
878380|NCT01331681|2895780|P1|Overall Study|Withdrawal by Subject|12
878381|NCT01331681|2895778|P3|Overall Study|Lack of Efficacy|0
878382|NCT01331681|2895779|P2|Overall Study|Lack of Efficacy|1
878383|NCT01331681|2895780|P1|Overall Study|Lack of Efficacy|0
878384|NCT01331681|2895778|P3|Overall Study|Death|2
878385|NCT01331681|2895779|P2|Overall Study|Death|6
878386|NCT01331681|2895780|P1|Overall Study|Death|6
878387|NCT01331681|2895778|P3|Overall Study|Adverse Event|10
878388|NCT01331681|2895779|P2|Overall Study|Adverse Event|13
878389|NCT01331681|2895780|P1|Overall Study|Adverse Event|10
878390|NCT01331291|2895823|P2|Overall Study|Death|1
878391|NCT01331291|2895824|P1|Overall Study|Death|0
878392|NCT01331291|2895823|P2|Overall Study|Lack of Efficacy|8
878393|NCT01331291|2895824|P1|Overall Study|Lack of Efficacy|2
878394|NCT01331161|2895858|P2|Overall Study|Pregnancy|1
878395|NCT01331161|2895859|P1|Overall Study|Pregnancy|0
878396|NCT01331161|2895858|P2|Overall Study|Lost to Follow-up|1
878397|NCT01331161|2895859|P1|Overall Study|Lost to Follow-up|0
878398|NCT01331161|2895858|P2|Overall Study|Physician Decision|0
878399|NCT01331161|2895859|P1|Overall Study|Physician Decision|1
878400|NCT01331109|2895867|P1|Overall Study|Study Terminated by Sponsor|38
878401|NCT01331109|2895867|P1|Overall Study|Lost to Follow-up|1
878402|NCT01331109|2895867|P1|Overall Study|Withdrawal by Subject|7
878403|NCT01331109|2895867|P1|Overall Study|Protocol Violation|3
878404|NCT01331109|2895867|P1|Overall Study|Lack of Efficacy|2
878405|NCT01331109|2895867|P1|Overall Study|Adverse Event|6
878406|NCT01331005|2895879|P2|Overall Study|Withdrawal by Subject|3
878407|NCT01331005|2895880|P1|Overall Study|Withdrawal by Subject|2
878408|NCT01331005|2895879|P2|Overall Study|Lost to Follow-up|1
878409|NCT01331005|2895880|P1|Overall Study|Lost to Follow-up|2
878410|NCT01330914|2895945|P1|Overall Study|No longer eligible (sleeve gastrectomy)|3
878411|NCT01330914|2895945|P1|Overall Study|Withdrawal by Subject|4
878412|NCT01330628|2895951|P2|Overall Study|Didn't receive study treatment|0
878413|NCT01330628|2895952|P1|Overall Study|Didn't receive study treatment|1
878414|NCT01330628|2895951|P2|Overall Study|Withdrawn|6
878415|NCT01330628|2895952|P1|Overall Study|Withdrawn|18
878416|NCT01330628|2895951|P2|Overall Study|Adverse Event|25
878417|NCT01330628|2895952|P1|Overall Study|Adverse Event|44
878418|NCT01330628|2895951|P2|Overall Study|Lost to Follow-up|6
878419|NCT01330628|2895952|P1|Overall Study|Lost to Follow-up|5
878420|NCT01330628|2895951|P2|Overall Study|Death|3
878421|NCT01330628|2895952|P1|Overall Study|Death|2
878422|NCT01330433|2895962|P2|Overall Study|Lost to Follow-up|0
878423|NCT01330433|2895963|P1|Overall Study|Lost to Follow-up|1
878424|NCT01330433|2895962|P2|Overall Study|Death|3
878425|NCT01330433|2895963|P1|Overall Study|Death|1
878426|NCT01330381|2896002|P3|Open-label Treatment Period (16 Weeks)|Non-compliance|1
878427|NCT01330381|2896003|P2|Open-label Treatment Period (16 Weeks)|Non-compliance|0
878428|NCT01330381|2896004|P1|Open-label Treatment Period (16 Weeks)|Non-compliance|0
878429|NCT01330381|2896002|P3|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
878430|NCT01330381|2896003|P2|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0
878431|NCT01330381|2896004|P1|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
878432|NCT01330381|2896002|P3|Open-label Treatment Period (16 Weeks)|Adverse Event|0
878433|NCT01330381|2896003|P2|Open-label Treatment Period (16 Weeks)|Adverse Event|0
878434|NCT01330381|2896004|P1|Open-label Treatment Period (16 Weeks)|Adverse Event|2
878435|NCT01330381|2896002|P3|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16
878436|NCT01330381|2896003|P2|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0
878437|NCT01330381|2896004|P1|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7
878438|NCT01330381|2896002|P3|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
878439|NCT01330381|2896003|P2|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
878440|NCT01330381|2896004|P1|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
878441|NCT01330381|2896002|P3|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
878442|NCT01330381|2896003|P2|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
878443|NCT01330381|2896004|P1|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1
878444|NCT01330381|2896002|P3|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
878445|NCT01330381|2896003|P2|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
878446|NCT01330381|2896004|P1|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1
878447|NCT01330381|2896002|P3|Double-blind Treatment Period (8 Weeks)|Adverse Event|0
878448|NCT01330381|2896003|P2|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
878449|NCT01330381|2896004|P1|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
878450|NCT01330381|2896002|P3|Double-blind Treatment Period (8 Weeks)|Non-compliance|0
878451|NCT01330381|2896003|P2|Double-blind Treatment Period (8 Weeks)|Non-compliance|1
878452|NCT01330381|2896004|P1|Double-blind Treatment Period (8 Weeks)|Non-compliance|2
878453|NCT01330381|2896002|P3|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0
878454|NCT01330381|2896003|P2|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4
878455|NCT01330381|2896004|P1|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5
878456|NCT01330316|2896065|P2|Overall Study|other than above|1
878457|NCT01330316|2896066|P1|Overall Study|other than above|0
878458|NCT01330316|2896065|P2|Overall Study|Withdrawal by Subject|1
878459|NCT01330316|2896066|P1|Overall Study|Withdrawal by Subject|0
878460|NCT01330316|2896065|P2|Overall Study|Lost to Follow-up|1
878461|NCT01330316|2896066|P1|Overall Study|Lost to Follow-up|0
878462|NCT01330316|2896065|P2|Overall Study|Lack of Efficacy|10
878463|NCT01330316|2896066|P1|Overall Study|Lack of Efficacy|0
878464|NCT01330316|2896065|P2|Overall Study|Adverse Event|2
878465|NCT01330316|2896066|P1|Overall Study|Adverse Event|2
878466|NCT01330303|2896102|P2|Period 1|Withdrawal by Subject|1
878467|NCT01330303|2896103|P1|Period 1|Withdrawal by Subject|0
878468|NCT01330303|2896102|P2|Period 1|Protocol Violation|1
878469|NCT01330303|2896103|P1|Period 1|Protocol Violation|0
878470|NCT01330303|2896102|P2|Period 1|Adverse Event|0
878471|NCT01330303|2896103|P1|Period 1|Adverse Event|1
878472|NCT01330108|2896150|P1|Overall Study|Withdrawal by Subject|4
878473|NCT01330030|2896168|P2|Overall Study|Lost to Follow-up|17
878474|NCT01330030|2896169|P1|Overall Study|Lost to Follow-up|16
878475|NCT01330017|2896180|P5|Overall Study|Unknown Reason|2
878476|NCT01330017|2896181|P4|Overall Study|Unknown Reason|7
878477|NCT01330017|2896182|P3|Overall Study|Unknown Reason|5
878478|NCT01330017|2896183|P2|Overall Study|Unknown Reason|3
878479|NCT01330017|2896184|P1|Overall Study|Unknown Reason|5
878480|NCT01330017|2896180|P5|Overall Study|Protocol Violation|0
878481|NCT01330017|2896181|P4|Overall Study|Protocol Violation|1
878482|NCT01330017|2896182|P3|Overall Study|Protocol Violation|0
878483|NCT01330017|2896183|P2|Overall Study|Protocol Violation|0
878484|NCT01330017|2896184|P1|Overall Study|Protocol Violation|0
878485|NCT01330017|2896180|P5|Overall Study|Lost to Follow-up|0
878486|NCT01330017|2896181|P4|Overall Study|Lost to Follow-up|0
878487|NCT01330017|2896182|P3|Overall Study|Lost to Follow-up|1
878488|NCT01330017|2896183|P2|Overall Study|Lost to Follow-up|0
878489|NCT01330017|2896184|P1|Overall Study|Lost to Follow-up|0
878490|NCT01330017|2896180|P5|Overall Study|Withdrawal by Subject|1
878491|NCT01330017|2896181|P4|Overall Study|Withdrawal by Subject|0
878492|NCT01330017|2896182|P3|Overall Study|Withdrawal by Subject|1
878493|NCT01330017|2896183|P2|Overall Study|Withdrawal by Subject|0
878494|NCT01330017|2896184|P1|Overall Study|Withdrawal by Subject|0
878495|NCT01330017|2896180|P5|Overall Study|Adverse Event|0
878496|NCT01330017|2896181|P4|Overall Study|Adverse Event|4
878497|NCT01330017|2896182|P3|Overall Study|Adverse Event|1
878498|NCT01330017|2896183|P2|Overall Study|Adverse Event|1
878499|NCT01330017|2896184|P1|Overall Study|Adverse Event|0
878500|NCT01329978|2896233|P5|Rerandomization Treatment Period|Withdrawal by Subject|1
878501|NCT01329978|2896234|P4|Rerandomization Treatment Period|Withdrawal by Subject|0
878502|NCT01329978|2896235|P3|Rerandomization Treatment Period|Withdrawal by Subject|0
878503|NCT01329978|2896236|P2|Rerandomization Treatment Period|Withdrawal by Subject|0
878504|NCT01329978|2896237|P1|Rerandomization Treatment Period|Withdrawal by Subject|0
878505|NCT01329978|2896233|P5|Rerandomization Treatment Period|Lost to Follow-up|3
878506|NCT01329978|2896234|P4|Rerandomization Treatment Period|Lost to Follow-up|5
878507|NCT01329978|2896235|P3|Rerandomization Treatment Period|Lost to Follow-up|0
878508|NCT01329978|2896236|P2|Rerandomization Treatment Period|Lost to Follow-up|0
878509|NCT01329978|2896237|P1|Rerandomization Treatment Period|Lost to Follow-up|0
878510|NCT01329978|2896233|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
878511|NCT01329978|2896234|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
878512|NCT01329978|2896235|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
878513|NCT01329978|2896236|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1
878514|NCT01329978|2896237|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
878515|NCT01329978|2896233|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
878516|NCT01329978|2896234|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
878517|NCT01329978|2896235|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
878518|NCT01329978|2896236|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1
878519|NCT01329978|2896237|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
878520|NCT01329978|2896233|P5|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
878521|NCT01329978|2896234|P4|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
878522|NCT01329978|2896235|P3|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3
878523|NCT01329978|2896236|P2|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
878524|NCT01329978|2896237|P1|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
878525|NCT01329978|2896233|P5|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
878526|NCT01329978|2896234|P4|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
878527|NCT01329978|2896235|P3|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
878528|NCT01329978|2896236|P2|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8
878529|NCT01329978|2896237|P1|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
878530|NCT01329978|2896233|P5|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
878531|NCT01329978|2896234|P4|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
878532|NCT01329978|2896235|P3|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
878533|NCT01329978|2896236|P2|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2
878534|NCT01329978|2896237|P1|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1
878535|NCT01329939|2896311|P4|Overall Study|Adverse Event|3
878536|NCT01329939|2896312|P3|Overall Study|Adverse Event|0
878537|NCT01329939|2896313|P2|Overall Study|Adverse Event|0
878538|NCT01329939|2896314|P1|Overall Study|Adverse Event|0
878539|NCT01329939|2896311|P4|Overall Study|Withdrawal by Subject|0
878540|NCT01329939|2896312|P3|Overall Study|Withdrawal by Subject|0
878541|NCT01329939|2896313|P2|Overall Study|Withdrawal by Subject|1
878542|NCT01329939|2896314|P1|Overall Study|Withdrawal by Subject|0
878543|NCT01329939|2896311|P4|Overall Study|Lost to Follow-up|2
878544|NCT01329939|2896312|P3|Overall Study|Lost to Follow-up|1
878545|NCT01329939|2896313|P2|Overall Study|Lost to Follow-up|0
878546|NCT01329939|2896314|P1|Overall Study|Lost to Follow-up|3
878547|NCT01329562|2896378|P2|Overall Study|Physician Decision|1
878548|NCT01329562|2896379|P1|Overall Study|Physician Decision|0
878549|NCT01329562|2896378|P2|Overall Study|Subject withdrew due to personal issues.|2
878550|NCT01329562|2896379|P1|Overall Study|Subject withdrew due to personal issues.|3
878551|NCT01329562|2896378|P2|Overall Study|Lost to Follow-up|1
878552|NCT01329562|2896379|P1|Overall Study|Lost to Follow-up|1
878553|NCT01329562|2896378|P2|Overall Study|Protocol Violation|3
878554|NCT01329562|2896379|P1|Overall Study|Protocol Violation|5
878555|NCT01329549|2896428|P1|Overall Study|Adverse Event|1
878556|NCT01329549|2896428|P1|Overall Study|Withdrawal by Subject|1
878557|NCT01329419|2896439|P1|Overall Study|Protocol Violation|235
878558|NCT01329263|2896447|P2|Overall Study|Withdrawal by Subject|2
878559|NCT01329263|2896448|P1|Overall Study|Withdrawal by Subject|1
878560|NCT01329263|2896447|P2|Overall Study|Lost to Follow-up|21
878561|NCT01329263|2896448|P1|Overall Study|Lost to Follow-up|4
878562|NCT01329029|2896485|P2|Overall Study|Met Pre-defined Discontinuation Criteria|1
878563|NCT01329029|2896486|P1|Overall Study|Met Pre-defined Discontinuation Criteria|5
878564|NCT01329029|2896485|P2|Overall Study|Lost to Follow-up|5
878565|NCT01329029|2896486|P1|Overall Study|Lost to Follow-up|8
878566|NCT01329029|2896485|P2|Overall Study|Physician Decision|13
878567|NCT01329029|2896486|P1|Overall Study|Physician Decision|16
878568|NCT01329029|2896485|P2|Overall Study|COPD Exacerbation|18
878569|NCT01329029|2896486|P1|Overall Study|COPD Exacerbation|11
878570|NCT01329029|2896485|P2|Overall Study|Other|20
878571|NCT01329029|2896486|P1|Overall Study|Other|14
878572|NCT01329029|2896485|P2|Overall Study|Death|19
878573|NCT01329029|2896486|P1|Overall Study|Death|16
878574|NCT01329029|2896485|P2|Overall Study|Adverse Event|29
878575|NCT01329029|2896486|P1|Overall Study|Adverse Event|82
878576|NCT01329029|2896485|P2|Overall Study|Withdrawal by Subject|87
878577|NCT01329029|2896486|P1|Overall Study|Withdrawal by Subject|117
878578|NCT01328951|2896576|P2|Overall Study|Not Specified|6
878579|NCT01328951|2896577|P1|Overall Study|Not Specified|11
878580|NCT01328951|2896576|P2|Overall Study|Study Closed by the Sponsor|31
878581|NCT01328951|2896577|P1|Overall Study|Study Closed by the Sponsor|36
878582|NCT01328951|2896576|P2|Overall Study|Withdrawal by Subject|6
878583|NCT01328951|2896577|P1|Overall Study|Withdrawal by Subject|6
878584|NCT01328951|2896576|P2|Overall Study|Lost to Follow-up|7
878585|NCT01328951|2896577|P1|Overall Study|Lost to Follow-up|6
878586|NCT01328951|2896576|P2|Overall Study|Death|258
878587|NCT01328951|2896577|P1|Overall Study|Death|243
878588|NCT01328951|2896576|P2|Overall Study|Adverse Event|0
878589|NCT01328951|2896577|P1|Overall Study|Adverse Event|2
878590|NCT01328951|2896576|P2|Overall Study|Disease Progression|14
878591|NCT01328951|2896577|P1|Overall Study|Disease Progression|17
878592|NCT01328756|2896646|P1|Overall Study|Other|29
878593|NCT01328756|2896646|P1|Overall Study|Lost to Follow-up|5
878594|NCT01328756|2896646|P1|Overall Study|Withdrawal by Subject|41
878595|NCT01328756|2896646|P1|Overall Study|Lack of Efficacy|5
878596|NCT01328756|2896646|P1|Overall Study|Adverse Event|39
878597|NCT01328756|2896646|P1|Overall Study|Protocol Violation|4
878598|NCT01328717|2896663|P1|Overall Study|Adverse Event|1
878599|NCT01328574|2896668|P1|Overall Study|Refused further treatment|1
878600|NCT01328548|2896682|P2|Overall Study|Protocol Violation|0
878601|NCT01328548|2896683|P1|Overall Study|Protocol Violation|1
878602|NCT01328548|2896682|P2|Overall Study|Death|0
878603|NCT01328548|2896683|P1|Overall Study|Death|3
878604|NCT01328535|2896701|P1|Overall Study|Ineligible|1
878605|NCT01328496|2896712|P2|Overall Study|Significant Change in Health Status|0
878606|NCT01328496|2896713|P1|Overall Study|Significant Change in Health Status|1
878607|NCT01328444|2896731|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
878608|NCT01328444|2896732|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
878609|NCT01328444|2896733|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
878610|NCT01328444|2896734|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
878611|NCT01328444|2896735|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
878612|NCT01328444|2896736|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
878613|NCT01328444|2896731|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
878614|NCT01328444|2896732|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
878615|NCT01328444|2896733|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
878616|NCT01328444|2896734|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
878617|NCT01328444|2896735|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
878618|NCT01328444|2896736|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
878619|NCT01328444|2896731|P6|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
878620|NCT01328444|2896732|P5|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
878621|NCT01328444|2896733|P4|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
878622|NCT01328444|2896734|P3|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
878623|NCT01328444|2896735|P2|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
878624|NCT01328444|2896736|P1|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
878625|NCT01328444|2896731|P6|Treatment Period 2 (12 Weeks)|Protocol Violation|0
878626|NCT01328444|2896732|P5|Treatment Period 2 (12 Weeks)|Protocol Violation|1
878627|NCT01328444|2896733|P4|Treatment Period 2 (12 Weeks)|Protocol Violation|0
878628|NCT01328444|2896734|P3|Treatment Period 2 (12 Weeks)|Protocol Violation|0
878629|NCT01328444|2896735|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|0
878630|NCT01328444|2896736|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|1
878631|NCT01328444|2896731|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4
878632|NCT01328444|2896732|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
878633|NCT01328444|2896733|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
878634|NCT01328444|2896734|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
878635|NCT01328444|2896735|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
878636|NCT01328444|2896736|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5
878637|NCT01328444|2896731|P6|Treatment Period 2 (12 Weeks)|Adverse Event|0
878638|NCT01328444|2896732|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
878639|NCT01328444|2896733|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
878640|NCT01328444|2896734|P3|Treatment Period 2 (12 Weeks)|Adverse Event|1
878641|NCT01328444|2896735|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
878642|NCT01328444|2896736|P1|Treatment Period 2 (12 Weeks)|Adverse Event|5
878643|NCT01328444|2896731|P6|Washout Period (14 Days)|Withdrawal by Subject|1
878644|NCT01328444|2896732|P5|Washout Period (14 Days)|Withdrawal by Subject|0
878645|NCT01328444|2896733|P4|Washout Period (14 Days)|Withdrawal by Subject|0
878646|NCT01328444|2896734|P3|Washout Period (14 Days)|Withdrawal by Subject|0
878647|NCT01328444|2896735|P2|Washout Period (14 Days)|Withdrawal by Subject|0
878648|NCT01328444|2896736|P1|Washout Period (14 Days)|Withdrawal by Subject|0
878649|NCT01328444|2896731|P6|Washout Period (14 Days)|Lack of Efficacy|1
878650|NCT01328444|2896732|P5|Washout Period (14 Days)|Lack of Efficacy|0
878651|NCT01328444|2896733|P4|Washout Period (14 Days)|Lack of Efficacy|0
878652|NCT01328444|2896734|P3|Washout Period (14 Days)|Lack of Efficacy|0
878653|NCT01328444|2896735|P2|Washout Period (14 Days)|Lack of Efficacy|0
878654|NCT01328444|2896736|P1|Washout Period (14 Days)|Lack of Efficacy|0
878655|NCT01328444|2896731|P6|Washout Period (14 Days)|Adverse Event|2
878656|NCT01328444|2896732|P5|Washout Period (14 Days)|Adverse Event|1
878657|NCT01328444|2896733|P4|Washout Period (14 Days)|Adverse Event|1
878658|NCT01328444|2896734|P3|Washout Period (14 Days)|Adverse Event|0
878659|NCT01328444|2896735|P2|Washout Period (14 Days)|Adverse Event|1
878660|NCT01328444|2896736|P1|Washout Period (14 Days)|Adverse Event|1
878661|NCT01328444|2896731|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
878662|NCT01328444|2896732|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
878663|NCT01328444|2896733|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
878664|NCT01328444|2896734|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
878665|NCT01328444|2896735|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
878666|NCT01328444|2896736|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
878667|NCT01328444|2896731|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
878668|NCT01328444|2896732|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
878669|NCT01328444|2896733|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
878670|NCT01328444|2896734|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
878671|NCT01328444|2896735|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
878672|NCT01328444|2896736|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2
878673|NCT01328444|2896731|P6|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
878674|NCT01328444|2896732|P5|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2
878675|NCT01328444|2896733|P4|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
878676|NCT01328444|2896734|P3|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
878677|NCT01328444|2896735|P2|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1
878678|NCT01328444|2896736|P1|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
878679|NCT01328444|2896731|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|1
878680|NCT01328444|2896732|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|0
878681|NCT01328444|2896733|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
878682|NCT01328444|2896734|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|0
878683|NCT01328444|2896735|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
878684|NCT01328444|2896736|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|0
878685|NCT01328444|2896731|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
878686|NCT01328444|2896732|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
878687|NCT01328444|2896733|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
878688|NCT01328444|2896734|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
878689|NCT01328444|2896735|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
878690|NCT01328444|2896736|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
878691|NCT01328444|2896731|P6|Treatment Period 1 (12 Weeks)|Adverse Event|2
878692|NCT01328444|2896732|P5|Treatment Period 1 (12 Weeks)|Adverse Event|5
878693|NCT01328444|2896733|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
878694|NCT01328444|2896734|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
878695|NCT01328444|2896735|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
878696|NCT01328444|2896736|P1|Treatment Period 1 (12 Weeks)|Adverse Event|3
878697|NCT01328431|2896782|P2|12 Month (12M)|Lost to Follow-up|91
878698|NCT01328431|2896783|P1|12 Month (12M)|Lost to Follow-up|82
878699|NCT01328431|2896782|P2|12 Month (12M)|Death|6
878700|NCT01328431|2896783|P1|12 Month (12M)|Death|2
878701|NCT01328431|2896782|P2|3 Month (3M)|Lost to Follow-up|70
878702|NCT01328431|2896783|P1|3 Month (3M)|Lost to Follow-up|75
878703|NCT01328431|2896782|P2|3 Month (3M)|Death|2
878704|NCT01328431|2896783|P1|3 Month (3M)|Death|2
878705|NCT01328431|2896782|P2|1 Month (1M)|Lost to Follow-up|58
878706|NCT01328431|2896783|P1|1 Month (1M)|Lost to Follow-up|55
878707|NCT01328431|2896782|P2|Baseline|Protocol Violation|2
878708|NCT01328431|2896783|P1|Baseline|Protocol Violation|0
878709|NCT01328366|2896839|P1|Overall Study|Lost to Follow-up|7
878710|NCT01328366|2896839|P1|Overall Study|Withdrawal by Subject|2
878711|NCT01328366|2896839|P1|Overall Study|Death|1
878712|NCT01328249|2896859|P2|Overall Study|Protocol Violation|1
878713|NCT01328249|2896860|P1|Overall Study|Protocol Violation|0
878714|NCT01328249|2896859|P2|Overall Study|Subject choice|1
878715|NCT01328249|2896860|P1|Overall Study|Subject choice|1
878716|NCT01328249|2896859|P2|Overall Study|Moved before end of treatment visit|0
878717|NCT01328249|2896860|P1|Overall Study|Moved before end of treatment visit|1
878718|NCT01328249|2896859|P2|Overall Study|Withdrawal by Subject|1
878719|NCT01328249|2896860|P1|Overall Study|Withdrawal by Subject|1
878720|NCT01328249|2896859|P2|Overall Study|Disease progression|0
878721|NCT01328249|2896860|P1|Overall Study|Disease progression|1
878722|NCT01328249|2896859|P2|Overall Study|Adverse Event|0
878723|NCT01328249|2896860|P1|Overall Study|Adverse Event|3
878724|NCT01328080|2896946|P1|Overall Study|Lost to Follow-up|5
878725|NCT01328054|2896950|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2
878726|NCT01328054|2896951|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0
878727|NCT01328054|2896950|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1
878728|NCT01328054|2896951|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0
878729|NCT01328054|2896950|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2
878730|NCT01328054|2896951|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0
878731|NCT01328041|2896976|P1|Overall Study|Withdrawal by Subject|7
878732|NCT01328041|2896976|P1|Overall Study|Physician Decision|2
878733|NCT01328041|2896976|P1|Overall Study|Lost to Follow-up|7
878734|NCT01328041|2896976|P1|Overall Study|Protocol Violation|7
878735|NCT01328041|2896976|P1|Overall Study|Lack of Efficacy|27
878736|NCT01328041|2896976|P1|Overall Study|Adverse Event|7
878737|NCT01327885|2897025|P2|Overall Study|Ongoing|1
878738|NCT01327885|2897026|P1|Overall Study|Ongoing|1
878739|NCT01327885|2897025|P2|Overall Study|Not treated|1
878740|NCT01327885|2897026|P1|Overall Study|Not treated|1
878741|NCT01327885|2897025|P2|Overall Study|Withdrawal of consent from study|4
878742|NCT01327885|2897026|P1|Overall Study|Withdrawal of consent from study|2
878743|NCT01327885|2897025|P2|Overall Study|Not specified|6
878744|NCT01327885|2897026|P1|Overall Study|Not specified|8
878745|NCT01327885|2897025|P2|Overall Study|Subject choice|10
878746|NCT01327885|2897026|P1|Overall Study|Subject choice|5
878747|NCT01327885|2897025|P2|Overall Study|Adverse Event|10
878748|NCT01327885|2897026|P1|Overall Study|Adverse Event|14
878749|NCT01327885|2897025|P2|Overall Study|Clinical progression|27
878750|NCT01327885|2897026|P1|Overall Study|Clinical progression|24
878751|NCT01327885|2897025|P2|Overall Study|Disease progression-according to RECIST|165
878752|NCT01327885|2897026|P1|Overall Study|Disease progression-according to RECIST|173
878753|NCT01327703|2897038|P2|Second Treatment Period|Protocol Violation|1
878754|NCT01327703|2897039|P1|Second Treatment Period|Protocol Violation|0
878755|NCT01327703|2897038|P2|Second Treatment Period|Adverse Event|1
878756|NCT01327703|2897039|P1|Second Treatment Period|Adverse Event|1
878757|NCT01327651|2897095|P9|Post Study Follow-up|Lost to Follow-up|2
878758|NCT01327651|2897096|P8|Post Study Follow-up|Lost to Follow-up|1
878759|NCT01327651|2897097|P7|Post Study Follow-up|Lost to Follow-up|4
878760|NCT01327651|2897098|P6|Post Study Follow-up|Lost to Follow-up|0
878761|NCT01327651|2897099|P5|Post Study Follow-up|Lost to Follow-up|0
878762|NCT01327651|2897100|P4|Post Study Follow-up|Lost to Follow-up|0
878763|NCT01327651|2897101|P3|Post Study Follow-up|Lost to Follow-up|1
878764|NCT01327651|2897102|P2|Post Study Follow-up|Lost to Follow-up|1
878765|NCT01327651|2897103|P1|Post Study Follow-up|Lost to Follow-up|0
878766|NCT01327651|2897095|P9|Self-administered Dosing Period|Withdrawal by Subject|1
878767|NCT01327651|2897096|P8|Self-administered Dosing Period|Withdrawal by Subject|1
878768|NCT01327651|2897097|P7|Self-administered Dosing Period|Withdrawal by Subject|2
878769|NCT01327651|2897098|P6|Self-administered Dosing Period|Withdrawal by Subject|0
878770|NCT01327651|2897099|P5|Self-administered Dosing Period|Withdrawal by Subject|0
878771|NCT01327651|2897100|P4|Self-administered Dosing Period|Withdrawal by Subject|1
878772|NCT01327651|2897101|P3|Self-administered Dosing Period|Withdrawal by Subject|0
878773|NCT01327651|2897102|P2|Self-administered Dosing Period|Withdrawal by Subject|1
878774|NCT01327651|2897103|P1|Self-administered Dosing Period|Withdrawal by Subject|0
878775|NCT01327651|2897095|P9|Self-administered Dosing Period|Ineligible (retrospective result)|0
878776|NCT01327651|2897096|P8|Self-administered Dosing Period|Ineligible (retrospective result)|0
878777|NCT01327651|2897097|P7|Self-administered Dosing Period|Ineligible (retrospective result)|0
878778|NCT01327651|2897098|P6|Self-administered Dosing Period|Ineligible (retrospective result)|0
878779|NCT01327651|2897099|P5|Self-administered Dosing Period|Ineligible (retrospective result)|0
878780|NCT01327651|2897100|P4|Self-administered Dosing Period|Ineligible (retrospective result)|0
878781|NCT01327651|2897101|P3|Self-administered Dosing Period|Ineligible (retrospective result)|0
878782|NCT01327651|2897102|P2|Self-administered Dosing Period|Ineligible (retrospective result)|0
878783|NCT01327651|2897103|P1|Self-administered Dosing Period|Ineligible (retrospective result)|1
878784|NCT01327651|2897095|P9|Self-administered Dosing Period|Lost to Follow-up|10
878785|NCT01327651|2897096|P8|Self-administered Dosing Period|Lost to Follow-up|9
878786|NCT01327651|2897097|P7|Self-administered Dosing Period|Lost to Follow-up|8
878787|NCT01327651|2897098|P6|Self-administered Dosing Period|Lost to Follow-up|0
878788|NCT01327651|2897099|P5|Self-administered Dosing Period|Lost to Follow-up|3
878789|NCT01327651|2897100|P4|Self-administered Dosing Period|Lost to Follow-up|2
878790|NCT01327651|2897101|P3|Self-administered Dosing Period|Lost to Follow-up|4
878791|NCT01327651|2897102|P2|Self-administered Dosing Period|Lost to Follow-up|2
878792|NCT01327651|2897103|P1|Self-administered Dosing Period|Lost to Follow-up|3
878793|NCT01327599|2897222|P1|Overall Study|Withdrawal of Consent|1
878794|NCT01327599|2897222|P1|Overall Study|Could Not Attend Visit|1
878795|NCT01327599|2897222|P1|Overall Study|Adverse Event|1
878796|NCT01327547|2897232|P2|Overall Study|By investigator in subject’s interest|1
878797|NCT01327547|2897233|P1|Overall Study|By investigator in subject’s interest|0
878798|NCT01327547|2897232|P2|Overall Study|Non-compliance with study procedures|0
878799|NCT01327547|2897233|P1|Overall Study|Non-compliance with study procedures|1
878800|NCT01327547|2897232|P2|Overall Study|Required prohibited medication|0
878801|NCT01327547|2897233|P1|Overall Study|Required prohibited medication|2
878802|NCT01327547|2897232|P2|Overall Study|Non-compliance due to alcohol intake|1
878803|NCT01327547|2897233|P1|Overall Study|Non-compliance due to alcohol intake|0
878804|NCT01327547|2897232|P2|Overall Study|Protocol Violation|0
878805|NCT01327547|2897233|P1|Overall Study|Protocol Violation|1
878806|NCT01327547|2897232|P2|Overall Study|Does Not Meet Entrance Criteria|2
878807|NCT01327547|2897233|P1|Overall Study|Does Not Meet Entrance Criteria|2
878808|NCT01327547|2897232|P2|Overall Study|Withdrawal by Subject|7
878809|NCT01327547|2897233|P1|Overall Study|Withdrawal by Subject|3
878810|NCT01327547|2897232|P2|Overall Study|Non-Compliance With Study Treatment|2
878811|NCT01327547|2897233|P1|Overall Study|Non-Compliance With Study Treatment|0
878812|NCT01327547|2897232|P2|Overall Study|Lost to Follow-up|6
878813|NCT01327547|2897233|P1|Overall Study|Lost to Follow-up|6
878814|NCT01327547|2897232|P2|Overall Study|Death|2
878815|NCT01327547|2897233|P1|Overall Study|Death|1
878816|NCT01327547|2897232|P2|Overall Study|Adverse Event|1
878817|NCT01327547|2897233|P1|Overall Study|Adverse Event|4
878818|NCT01327495|2897301|P6|Overall Study|Physician Decision|0
878819|NCT01327495|2897302|P5|Overall Study|Physician Decision|2
878820|NCT01327495|2897303|P4|Overall Study|Physician Decision|0
878821|NCT01327495|2897304|P3|Overall Study|Physician Decision|0
878822|NCT01327495|2897305|P2|Overall Study|Physician Decision|0
878823|NCT01327495|2897306|P1|Overall Study|Physician Decision|0
878824|NCT01327495|2897301|P6|Overall Study|Withdrawal by Subject|0
878825|NCT01327495|2897302|P5|Overall Study|Withdrawal by Subject|1
878826|NCT01327495|2897303|P4|Overall Study|Withdrawal by Subject|0
878827|NCT01327495|2897304|P3|Overall Study|Withdrawal by Subject|1
878828|NCT01327495|2897305|P2|Overall Study|Withdrawal by Subject|1
878829|NCT01327495|2897306|P1|Overall Study|Withdrawal by Subject|0
878830|NCT01327495|2897301|P6|Overall Study|Adverse Event|2
878831|NCT01327495|2897302|P5|Overall Study|Adverse Event|0
878832|NCT01327495|2897303|P4|Overall Study|Adverse Event|0
878833|NCT01327495|2897304|P3|Overall Study|Adverse Event|1
878834|NCT01327495|2897305|P2|Overall Study|Adverse Event|1
878835|NCT01327495|2897306|P1|Overall Study|Adverse Event|2
878836|NCT01327482|2897398|P1|Overall Study|Adverse Event|1
878837|NCT01327339|2897403|P1|Overall Study|Protocol Violation|8
878838|NCT01327300|2897538|P2|Washout (3 Weeks)|Withdrawal by Subject|0
878839|NCT01327300|2897539|P1|Washout (3 Weeks)|Withdrawal by Subject|1
878840|NCT01327053|2897579|P2|Overall Study|Untreated|1
878841|NCT01327053|2897580|P1|Overall Study|Untreated|0
878842|NCT01327053|2897579|P2|Overall Study|Withdrawal by Subject|28
878843|NCT01327053|2897580|P1|Overall Study|Withdrawal by Subject|5
878844|NCT01327053|2897579|P2|Overall Study|Protocol Violation|1
878845|NCT01327053|2897580|P1|Overall Study|Protocol Violation|0
878846|NCT01327053|2897579|P2|Overall Study|Progressive Disease|6
878847|NCT01327053|2897580|P1|Overall Study|Progressive Disease|15
878848|NCT01327053|2897579|P2|Overall Study|Physician Decision|10
878849|NCT01327053|2897580|P1|Overall Study|Physician Decision|3
878850|NCT01327053|2897579|P2|Overall Study|Non-compliance with study treatment|3
878851|NCT01327053|2897580|P1|Overall Study|Non-compliance with study treatment|0
878852|NCT01327053|2897579|P2|Overall Study|Lost to Follow-up|4
878853|NCT01327053|2897580|P1|Overall Study|Lost to Follow-up|1
878854|NCT01327053|2897579|P2|Overall Study|Death|4
878855|NCT01327053|2897580|P1|Overall Study|Death|0
878856|NCT01327053|2897579|P2|Overall Study|Adverse Event|48
878857|NCT01327053|2897580|P1|Overall Study|Adverse Event|16
878858|NCT01326962|2897608|P1|Overall Study|Not Specified|2
878859|NCT01326962|2897608|P1|Overall Study|Lost to Follow-up|3
878860|NCT01326962|2897608|P1|Overall Study|Withdrawal by Subject|1
878861|NCT01326962|2897608|P1|Overall Study|Adverse Event|1
878862|NCT01326910|2897626|P2|Overall Study|Protocol Violation|1
878863|NCT01326910|2897627|P1|Overall Study|Protocol Violation|1
878864|NCT01326910|2897626|P2|Overall Study|Withdrawal by Subject|2
878865|NCT01326910|2897627|P1|Overall Study|Withdrawal by Subject|3
878866|NCT01326845|2897641|P2|Overall Study|Misisng|3
878867|NCT01326845|2897642|P1|Overall Study|Misisng|1
878868|NCT01326845|2897641|P2|Overall Study|Adverse Event|0
878869|NCT01326845|2897642|P1|Overall Study|Adverse Event|1
878870|NCT01326845|2897641|P2|Overall Study|Administrative Problems|2
878871|NCT01326845|2897642|P1|Overall Study|Administrative Problems|5
878872|NCT01326728|2897666|P2|Overall Study|Early closure of study|9
878873|NCT01326728|2897667|P1|Overall Study|Early closure of study|34
878874|NCT01326728|2897666|P2|Overall Study|Death|0
878875|NCT01326728|2897667|P1|Overall Study|Death|13
878876|NCT01326533|2897686|P2|Overall Study|Adverse Event|0
878877|NCT01326533|2897687|P1|Overall Study|Adverse Event|1
878878|NCT01326533|2897686|P2|Overall Study|Withdrawal by Subject|0
878879|NCT01326533|2897687|P1|Overall Study|Withdrawal by Subject|1
878880|NCT01326533|2897686|P2|Overall Study|Lost to Follow-up|0
878881|NCT01326533|2897687|P1|Overall Study|Lost to Follow-up|2
878882|NCT01326026|2897697|P2|Overall Study|Other|3
878883|NCT01326026|2897698|P1|Overall Study|Other|3
878884|NCT01326026|2897697|P2|Overall Study|Withdrawal Criteria|7
878885|NCT01326026|2897698|P1|Overall Study|Withdrawal Criteria|5
878886|NCT01326026|2897697|P2|Overall Study|Adverse Event|3
878887|NCT01326026|2897698|P1|Overall Study|Adverse Event|4
878888|NCT01325701|2897763|P2|Overall Study|Rollerover Extension Study|0
878889|NCT01325701|2897764|P1|Overall Study|Rollerover Extension Study|4
878890|NCT01325701|2897763|P2|Overall Study|Withdrawal by Subject|1
878891|NCT01325701|2897764|P1|Overall Study|Withdrawal by Subject|2
878892|NCT01325701|2897763|P2|Overall Study|Physician Decision|2
878893|NCT01325701|2897764|P1|Overall Study|Physician Decision|2
878894|NCT01325701|2897763|P2|Overall Study|Protocol Violation|0
878895|NCT01325701|2897764|P1|Overall Study|Protocol Violation|1
878896|NCT01325701|2897763|P2|Overall Study|Adverse Event|0
878897|NCT01325701|2897764|P1|Overall Study|Adverse Event|12
878898|NCT01325623|2897774|P1|Overall Study|Withdrawal by Subject|3
878899|NCT01325584|2897816|P1|Overall Study|Death|1
878900|NCT01325532|2897826|P2|Overall Study|Withdrawal by Subject|0
878901|NCT01325532|2897827|P1|Overall Study|Withdrawal by Subject|2
878902|NCT01325493|2897839|P2|Overall Study|Allergy|0
878903|NCT01325493|2897840|P1|Overall Study|Allergy|1
878904|NCT01325493|2897839|P2|Overall Study|loss of neuromonitoring signals|2
878905|NCT01325493|2897840|P1|Overall Study|loss of neuromonitoring signals|0
878906|NCT01325493|2897839|P2|Overall Study|Protocol Violation|1
878907|NCT01325493|2897840|P1|Overall Study|Protocol Violation|0
878908|NCT01325428|2897852|P1|Part B|Other reason not defined above|1
878909|NCT01325428|2897852|P1|Part B|Refused continue taking trial medication|2
878910|NCT01325428|2897852|P1|Part A|Other reason not defined above|2
878911|NCT01325428|2897852|P1|Part A|Refused continue taking trial medication|2
878912|NCT01325428|2897852|P1|Part A|Other adverse event|1
878913|NCT01325428|2897852|P1|Part A|Clinical signs, symptoms of progression|2
878914|NCT01325428|2897852|P1|Part A|Progressive disease according to RECIST|9
878915|NCT01325350|2897872|P5|Overall Study|Did Not Receive Treatment|1
878916|NCT01325350|2897873|P4|Overall Study|Did Not Receive Treatment|0
878917|NCT01325350|2897874|P3|Overall Study|Did Not Receive Treatment|1
878918|NCT01325350|2897875|P2|Overall Study|Did Not Receive Treatment|1
878919|NCT01325350|2897876|P1|Overall Study|Did Not Receive Treatment|0
878920|NCT01325350|2897872|P5|Overall Study|Withdrawal by Subject|0
878921|NCT01325350|2897873|P4|Overall Study|Withdrawal by Subject|1
878922|NCT01325350|2897874|P3|Overall Study|Withdrawal by Subject|1
878923|NCT01325350|2897875|P2|Overall Study|Withdrawal by Subject|0
878924|NCT01325350|2897876|P1|Overall Study|Withdrawal by Subject|0
878925|NCT01325350|2897872|P5|Overall Study|Protocol Violation|0
878926|NCT01325350|2897873|P4|Overall Study|Protocol Violation|1
878927|NCT01325350|2897874|P3|Overall Study|Protocol Violation|0
878928|NCT01325350|2897875|P2|Overall Study|Protocol Violation|0
878929|NCT01325350|2897876|P1|Overall Study|Protocol Violation|0
878930|NCT01325350|2897872|P5|Overall Study|Personal Reasons|3
878931|NCT01325350|2897873|P4|Overall Study|Personal Reasons|5
878932|NCT01325350|2897874|P3|Overall Study|Personal Reasons|6
878933|NCT01325350|2897875|P2|Overall Study|Personal Reasons|1
878934|NCT01325350|2897876|P1|Overall Study|Personal Reasons|2
878935|NCT01325350|2897872|P5|Overall Study|Lost to Follow-up|5
878936|NCT01325350|2897873|P4|Overall Study|Lost to Follow-up|1
878937|NCT01325350|2897874|P3|Overall Study|Lost to Follow-up|5
878938|NCT01325350|2897875|P2|Overall Study|Lost to Follow-up|0
878939|NCT01325350|2897876|P1|Overall Study|Lost to Follow-up|1
878940|NCT01325350|2897872|P5|Overall Study|Pregnancy|1
878941|NCT01325350|2897873|P4|Overall Study|Pregnancy|0
878942|NCT01325350|2897874|P3|Overall Study|Pregnancy|1
878943|NCT01325350|2897875|P2|Overall Study|Pregnancy|0
878944|NCT01325350|2897876|P1|Overall Study|Pregnancy|0
878945|NCT01325350|2897872|P5|Overall Study|Adverse Event|2
878946|NCT01325350|2897873|P4|Overall Study|Adverse Event|1
878947|NCT01325350|2897874|P3|Overall Study|Adverse Event|3
878948|NCT01325350|2897875|P2|Overall Study|Adverse Event|3
878949|NCT01325350|2897876|P1|Overall Study|Adverse Event|3
878950|NCT01325337|2897918|P5|Overall Study|Withdrawal by Subject|1
878951|NCT01325337|2897919|P4|Overall Study|Withdrawal by Subject|0
878952|NCT01325337|2897920|P3|Overall Study|Withdrawal by Subject|1
878953|NCT01325337|2897921|P2|Overall Study|Withdrawal by Subject|0
878954|NCT01325337|2897922|P1|Overall Study|Withdrawal by Subject|1
878955|NCT01325337|2897918|P5|Overall Study|Personal Reasons|3
878956|NCT01325337|2897919|P4|Overall Study|Personal Reasons|8
878957|NCT01325337|2897920|P3|Overall Study|Personal Reasons|4
878958|NCT01325337|2897921|P2|Overall Study|Personal Reasons|5
878959|NCT01325337|2897922|P1|Overall Study|Personal Reasons|2
878960|NCT01325337|2897918|P5|Overall Study|Lost to Follow-up|2
878961|NCT01325337|2897919|P4|Overall Study|Lost to Follow-up|1
878962|NCT01325337|2897920|P3|Overall Study|Lost to Follow-up|2
878963|NCT01325337|2897921|P2|Overall Study|Lost to Follow-up|2
878964|NCT01325337|2897922|P1|Overall Study|Lost to Follow-up|2
878965|NCT01325337|2897918|P5|Overall Study|Adverse Event|2
878966|NCT01325337|2897919|P4|Overall Study|Adverse Event|1
878967|NCT01325337|2897920|P3|Overall Study|Adverse Event|2
878968|NCT01325337|2897921|P2|Overall Study|Adverse Event|2
878969|NCT01325337|2897922|P1|Overall Study|Adverse Event|0
878970|NCT01324999|2898005|P1|Overall Study|Withdrawal by Subject|2
878971|NCT01324999|2898005|P1|Overall Study|Adverse Event|3
878972|NCT01324947|2898016|P1|Overall Study|1 discontinued before starting drug|1
878973|NCT01324947|2898016|P1|Overall Study|Withdrawal by Subject|3
878974|NCT01324947|2898016|P1|Overall Study|Progressive Disease|50
878975|NCT01324947|2898016|P1|Overall Study|Other|3
878976|NCT01324947|2898016|P1|Overall Study|Death|10
878977|NCT01324947|2898016|P1|Overall Study|Adverse Event|7
878978|NCT01324622|2898072|P2|Overall Study|Lack of Efficacy|0
878979|NCT01324622|2898073|P1|Overall Study|Lack of Efficacy|1
878980|NCT01324622|2898072|P2|Overall Study|Death|0
878981|NCT01324622|2898073|P1|Overall Study|Death|1
878982|NCT01324622|2898072|P2|Overall Study|Lost to Follow-up|7
878983|NCT01324622|2898073|P1|Overall Study|Lost to Follow-up|7
878984|NCT01324570|2898103|P2|Overall Study|Administrative|2
878985|NCT01324570|2898104|P1|Overall Study|Administrative|0
878986|NCT01324570|2898103|P2|Overall Study|Confirmed or suspected diversion|1
878987|NCT01324570|2898104|P1|Overall Study|Confirmed or suspected diversion|0
878988|NCT01324570|2898103|P2|Overall Study|Lack of Efficacy|1
878989|NCT01324570|2898104|P1|Overall Study|Lack of Efficacy|0
878990|NCT01324570|2898103|P2|Overall Study|Withdrawal by Subject|3
878991|NCT01324570|2898104|P1|Overall Study|Withdrawal by Subject|0
878992|NCT01324570|2898103|P2|Overall Study|Adverse Event|7
878993|NCT01324570|2898104|P1|Overall Study|Adverse Event|4
878994|NCT01324440|2898141|P2|Overall Study|Subject moved|1
878995|NCT01324440|2898142|P1|Overall Study|Subject moved|0
878996|NCT01324401|2898156|P2|Overall Study|Adverse Event|3
878997|NCT01324401|2898157|P1|Overall Study|Adverse Event|1
878998|NCT01324401|2898156|P2|Overall Study|Withdrawn before any treatment|3
878999|NCT01324401|2898157|P1|Overall Study|Withdrawn before any treatment|0
879000|NCT01324388|2898168|P4|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
879001|NCT01324388|2898169|P3|Part 2 of Study: Second Intervention|Withdrawal by Subject|1
879002|NCT01324388|2898170|P2|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
879003|NCT01324388|2898171|P1|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
879004|NCT01324388|2898168|P4|Part 2 of Study: First Intervention|Protocol Violation|1
879005|NCT01324388|2898169|P3|Part 2 of Study: First Intervention|Protocol Violation|0
879006|NCT01324388|2898170|P2|Part 2 of Study: First Intervention|Protocol Violation|0
879007|NCT01324388|2898171|P1|Part 2 of Study: First Intervention|Protocol Violation|0
879008|NCT01324388|2898168|P4|Part 1 of Study|Physician Decision|0
879009|NCT01324388|2898169|P3|Part 1 of Study|Physician Decision|0
879010|NCT01324388|2898170|P2|Part 1 of Study|Physician Decision|0
879011|NCT01324388|2898171|P1|Part 1 of Study|Physician Decision|1
879012|NCT01324388|2898168|P4|Part 1 of Study|Protocol Violation|0
879013|NCT01324388|2898169|P3|Part 1 of Study|Protocol Violation|0
879014|NCT01324388|2898170|P2|Part 1 of Study|Protocol Violation|2
879015|NCT01324388|2898171|P1|Part 1 of Study|Protocol Violation|1
879016|NCT01324388|2898168|P4|Part 1 of Study|Adverse Event|0
879017|NCT01324388|2898169|P3|Part 1 of Study|Adverse Event|0
879018|NCT01324388|2898170|P2|Part 1 of Study|Adverse Event|0
879019|NCT01324388|2898171|P1|Part 1 of Study|Adverse Event|2
879020|NCT01324349|2898192|P2|Overall Study|Withdrawal by Subject|1
879021|NCT01324349|2898193|P1|Overall Study|Withdrawal by Subject|0
879022|NCT01324349|2898192|P2|Overall Study|Death|1
879023|NCT01324349|2898193|P1|Overall Study|Death|1
879024|NCT01324323|2898203|P1|Overall Study|Withdrawal by Subject|1
879025|NCT01324310|2898223|P1|Overall Study|Disease Progression|1
879026|NCT01324310|2898223|P1|Overall Study|Adverse Event|1
879027|NCT01324271|2898243|P2|Overall Study|Physician Decision|0
879028|NCT01324271|2898244|P1|Overall Study|Physician Decision|1
879029|NCT01324271|2898243|P2|Overall Study|Lost to Follow-up|0
879030|NCT01324271|2898244|P1|Overall Study|Lost to Follow-up|3
879031|NCT01324102|2898267|P2|Overall Study|illness|6
879032|NCT01324102|2898268|P1|Overall Study|illness|1
879033|NCT01324024|2898275|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
879034|NCT01324024|2898276|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|2
879035|NCT01323972|2898314|P4|Overall Study|Lost to Follow-up|1
879036|NCT01323972|2898315|P3|Overall Study|Lost to Follow-up|1
879037|NCT01323972|2898316|P2|Overall Study|Lost to Follow-up|1
879038|NCT01323972|2898317|P1|Overall Study|Lost to Follow-up|0
879039|NCT01323972|2898314|P4|Overall Study|Migrated/moved from study area|0
879040|NCT01323972|2898315|P3|Overall Study|Migrated/moved from study area|0
879041|NCT01323972|2898316|P2|Overall Study|Migrated/moved from study area|2
879042|NCT01323972|2898317|P1|Overall Study|Migrated/moved from study area|1
879043|NCT01323972|2898314|P4|Overall Study|Withdrawal by Subject|0
879044|NCT01323972|2898315|P3|Overall Study|Withdrawal by Subject|1
879045|NCT01323972|2898316|P2|Overall Study|Withdrawal by Subject|0
879046|NCT01323972|2898317|P1|Overall Study|Withdrawal by Subject|1
879047|NCT01323920|2898410|P1|Overall Study|Withdrawal by Subject|1
879048|NCT01323920|2898410|P1|Overall Study|Death|5
879049|NCT01323790|2898451|P3|Overall Study|Severe non-compliance with protocol|2
879050|NCT01323790|2898452|P2|Overall Study|Severe non-compliance with protocol|2
879051|NCT01323790|2898453|P1|Overall Study|Severe non-compliance with protocol|2
879052|NCT01323790|2898451|P3|Overall Study|Did Not Receive Treatment|1
879053|NCT01323790|2898452|P2|Overall Study|Did Not Receive Treatment|0
879054|NCT01323790|2898453|P1|Overall Study|Did Not Receive Treatment|2
879055|NCT01323790|2898451|P3|Overall Study|Withdrawal by Subject|13
879056|NCT01323790|2898452|P2|Overall Study|Withdrawal by Subject|20
879057|NCT01323790|2898453|P1|Overall Study|Withdrawal by Subject|23
879058|NCT01323790|2898451|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
879059|NCT01323790|2898452|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
879060|NCT01323790|2898453|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
879061|NCT01323790|2898451|P3|Overall Study|Adverse Event|12
879062|NCT01323790|2898452|P2|Overall Study|Adverse Event|24
879063|NCT01323790|2898453|P1|Overall Study|Adverse Event|11
879064|NCT01323790|2898451|P3|Overall Study|Lack of Efficacy|3
879065|NCT01323790|2898452|P2|Overall Study|Lack of Efficacy|0
879066|NCT01323790|2898453|P1|Overall Study|Lack of Efficacy|3
879067|NCT01323790|2898451|P3|Overall Study|Study-Specific Withdrawal Criteria|3
879068|NCT01323790|2898452|P2|Overall Study|Study-Specific Withdrawal Criteria|3
879069|NCT01323790|2898453|P1|Overall Study|Study-Specific Withdrawal Criteria|0
879070|NCT01323790|2898451|P3|Overall Study|Lost to Follow-up|9
879071|NCT01323790|2898452|P2|Overall Study|Lost to Follow-up|9
879072|NCT01323790|2898453|P1|Overall Study|Lost to Follow-up|11
879073|NCT01323790|2898451|P3|Overall Study|Other|1
879074|NCT01323790|2898452|P2|Overall Study|Other|2
879075|NCT01323790|2898453|P1|Overall Study|Other|3
879076|NCT01323673|2898504|P2|Overall Study|Withdrawal by Subject|3
879077|NCT01323673|2898505|P1|Overall Study|Withdrawal by Subject|2
879078|NCT01323673|2898504|P2|Overall Study|Protocol Violation|0
879079|NCT01323673|2898505|P1|Overall Study|Protocol Violation|1
879080|NCT01323673|2898504|P2|Overall Study|Lost to Follow-up|1
879081|NCT01323673|2898505|P1|Overall Study|Lost to Follow-up|0
879082|NCT01323673|2898504|P2|Overall Study|Adverse Event|1
879083|NCT01323673|2898505|P1|Overall Study|Adverse Event|0
879084|NCT01323660|2898525|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
879085|NCT01323660|2898526|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
879086|NCT01323660|2898527|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
879087|NCT01323660|2898528|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
879088|NCT01323660|2898529|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
879089|NCT01323660|2898530|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
879090|NCT01323660|2898525|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
879091|NCT01323660|2898526|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
879092|NCT01323660|2898527|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
879093|NCT01323660|2898528|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
879094|NCT01323660|2898529|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
879095|NCT01323660|2898530|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
879096|NCT01323660|2898525|P6|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1
879097|NCT01323660|2898526|P5|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
879098|NCT01323660|2898527|P4|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
879099|NCT01323660|2898528|P3|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
879100|NCT01323660|2898529|P2|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
879101|NCT01323660|2898530|P1|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
879102|NCT01323660|2898525|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
879103|NCT01323660|2898526|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
879104|NCT01323660|2898527|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
879105|NCT01323660|2898528|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
879106|NCT01323660|2898529|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
879107|NCT01323660|2898530|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9
879108|NCT01323660|2898525|P6|Treatment Period 2 (12 Weeks)|Adverse Event|2
879109|NCT01323660|2898526|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
879110|NCT01323660|2898527|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
879111|NCT01323660|2898528|P3|Treatment Period 2 (12 Weeks)|Adverse Event|0
879112|NCT01323660|2898529|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
879113|NCT01323660|2898530|P1|Treatment Period 2 (12 Weeks)|Adverse Event|1
879114|NCT01323660|2898525|P6|Washout Period (14 Days)|Lack of Efficacy|2
879115|NCT01323660|2898526|P5|Washout Period (14 Days)|Lack of Efficacy|2
879116|NCT01323660|2898527|P4|Washout Period (14 Days)|Lack of Efficacy|3
879117|NCT01323660|2898528|P3|Washout Period (14 Days)|Lack of Efficacy|1
879118|NCT01323660|2898529|P2|Washout Period (14 Days)|Lack of Efficacy|0
879119|NCT01323660|2898530|P1|Washout Period (14 Days)|Lack of Efficacy|0
879120|NCT01323660|2898525|P6|Washout Period (14 Days)|Adverse Event|0
879121|NCT01323660|2898526|P5|Washout Period (14 Days)|Adverse Event|1
879122|NCT01323660|2898527|P4|Washout Period (14 Days)|Adverse Event|0
879123|NCT01323660|2898528|P3|Washout Period (14 Days)|Adverse Event|0
879124|NCT01323660|2898529|P2|Washout Period (14 Days)|Adverse Event|0
879125|NCT01323660|2898530|P1|Washout Period (14 Days)|Adverse Event|0
879126|NCT01323660|2898525|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
879127|NCT01323660|2898526|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3
879128|NCT01323660|2898527|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
879129|NCT01323660|2898528|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
879130|NCT01323660|2898529|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
879131|NCT01323660|2898530|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5
879132|NCT01323660|2898525|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
879133|NCT01323660|2898526|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
879134|NCT01323660|2898527|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
879135|NCT01323660|2898528|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
879136|NCT01323660|2898529|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
879137|NCT01323660|2898530|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
879138|NCT01323660|2898525|P6|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
879139|NCT01323660|2898526|P5|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1
879140|NCT01323660|2898527|P4|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
879141|NCT01323660|2898528|P3|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
879142|NCT01323660|2898529|P2|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
879143|NCT01323660|2898530|P1|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
879144|NCT01323660|2898525|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|2
879145|NCT01323660|2898526|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|1
879146|NCT01323660|2898527|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
879147|NCT01323660|2898528|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|1
879148|NCT01323660|2898529|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
879149|NCT01323660|2898530|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
879150|NCT01323660|2898525|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3
879151|NCT01323660|2898526|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
879152|NCT01323660|2898527|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
879153|NCT01323660|2898528|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
879154|NCT01323660|2898529|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
879155|NCT01323660|2898530|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
879156|NCT01323660|2898525|P6|Treatment Period 1 (12 Weeks)|Adverse Event|4
879157|NCT01323660|2898526|P5|Treatment Period 1 (12 Weeks)|Adverse Event|3
879158|NCT01323660|2898527|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
879159|NCT01323660|2898528|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
879160|NCT01323660|2898529|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
879161|NCT01323660|2898530|P1|Treatment Period 1 (12 Weeks)|Adverse Event|6
879162|NCT01323647|2898576|P2|Overall Study|Lost to Follow-up|0
879163|NCT01323647|2898577|P1|Overall Study|Lost to Follow-up|2
879164|NCT01323647|2898576|P2|Overall Study|Withdrawal by Subject|0
879165|NCT01323647|2898577|P1|Overall Study|Withdrawal by Subject|5
879166|NCT01323647|2898576|P2|Overall Study|Migrated/moved from study area|0
879167|NCT01323647|2898577|P1|Overall Study|Migrated/moved from study area|2
879168|NCT01323634|2898594|P3|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
879169|NCT01323634|2898595|P2|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
879170|NCT01323634|2898596|P1|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0
879171|NCT01323634|2898594|P3|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4
879172|NCT01323634|2898595|P2|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7
879173|NCT01323634|2898596|P1|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
879174|NCT01323634|2898594|P3|Double-Blind (DB) Treatment Period|Physician Decision|3
879175|NCT01323634|2898595|P2|Double-Blind (DB) Treatment Period|Physician Decision|2
879176|NCT01323634|2898596|P1|Double-Blind (DB) Treatment Period|Physician Decision|0
879177|NCT01323634|2898594|P3|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
879178|NCT01323634|2898595|P2|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
879179|NCT01323634|2898596|P1|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
879180|NCT01323634|2898594|P3|Double-Blind (DB) Treatment Period|Protocol Violation|7
879181|NCT01323634|2898595|P2|Double-Blind (DB) Treatment Period|Protocol Violation|6
879182|NCT01323634|2898596|P1|Double-Blind (DB) Treatment Period|Protocol Violation|0
879183|NCT01323634|2898594|P3|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
879184|NCT01323634|2898595|P2|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
879185|NCT01323634|2898596|P1|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
879186|NCT01323634|2898594|P3|Double-Blind (DB) Treatment Period|Adverse Event|4
879187|NCT01323634|2898595|P2|Double-Blind (DB) Treatment Period|Adverse Event|8
879188|NCT01323634|2898596|P1|Double-Blind (DB) Treatment Period|Adverse Event|0
879189|NCT01323634|2898594|P3|2-week Run-in Period|Adverse Event|0
879190|NCT01323634|2898595|P2|2-week Run-in Period|Adverse Event|0
879191|NCT01323634|2898596|P1|2-week Run-in Period|Adverse Event|1
879192|NCT01323634|2898594|P3|2-week Run-in Period|Protocol Violation|0
879193|NCT01323634|2898595|P2|2-week Run-in Period|Protocol Violation|0
879194|NCT01323634|2898596|P1|2-week Run-in Period|Protocol Violation|1
879195|NCT01323634|2898594|P3|2-week Run-in Period|Physician Decision|0
879196|NCT01323634|2898595|P2|2-week Run-in Period|Physician Decision|0
879197|NCT01323634|2898596|P1|2-week Run-in Period|Physician Decision|5
879198|NCT01323634|2898594|P3|2-week Run-in Period|Withdrawal by Subject|0
879199|NCT01323634|2898595|P2|2-week Run-in Period|Withdrawal by Subject|0
879200|NCT01323634|2898596|P1|2-week Run-in Period|Withdrawal by Subject|7
879201|NCT01323634|2898594|P3|2-week Run-in Period|Continuation Criteria not Met|0
879202|NCT01323634|2898595|P2|2-week Run-in Period|Continuation Criteria not Met|0
879203|NCT01323634|2898596|P1|2-week Run-in Period|Continuation Criteria not Met|73
879204|NCT01323634|2898594|P3|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
879205|NCT01323634|2898595|P2|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
879206|NCT01323634|2898596|P1|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125
879207|NCT01323621|2898606|P3|12-week, Double-blind Treatment Period|Withdrawal by Subject|4
879208|NCT01323621|2898607|P2|12-week, Double-blind Treatment Period|Withdrawal by Subject|5
879209|NCT01323621|2898608|P1|12-week, Double-blind Treatment Period|Withdrawal by Subject|0
879210|NCT01323621|2898606|P3|12-week, Double-blind Treatment Period|Physician Decision|1
879211|NCT01323621|2898607|P2|12-week, Double-blind Treatment Period|Physician Decision|2
879212|NCT01323621|2898608|P1|12-week, Double-blind Treatment Period|Physician Decision|0
879213|NCT01323621|2898606|P3|12-week, Double-blind Treatment Period|Lost to Follow-up|0
879214|NCT01323621|2898607|P2|12-week, Double-blind Treatment Period|Lost to Follow-up|1
879215|NCT01323621|2898608|P1|12-week, Double-blind Treatment Period|Lost to Follow-up|0
879216|NCT01323621|2898606|P3|12-week, Double-blind Treatment Period|Protocol Violation|4
879217|NCT01323621|2898607|P2|12-week, Double-blind Treatment Period|Protocol Violation|4
879218|NCT01323621|2898608|P1|12-week, Double-blind Treatment Period|Protocol Violation|0
879219|NCT01323621|2898606|P3|12-week, Double-blind Treatment Period|Lack of Efficacy|6
879220|NCT01323621|2898607|P2|12-week, Double-blind Treatment Period|Lack of Efficacy|2
879221|NCT01323621|2898608|P1|12-week, Double-blind Treatment Period|Lack of Efficacy|0
879222|NCT01323621|2898606|P3|12-week, Double-blind Treatment Period|Adverse Event|5
879223|NCT01323621|2898607|P2|12-week, Double-blind Treatment Period|Adverse Event|1
879224|NCT01323621|2898608|P1|12-week, Double-blind Treatment Period|Adverse Event|0
879225|NCT01323621|2898606|P3|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
879226|NCT01323621|2898607|P2|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
879227|NCT01323621|2898608|P1|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86
879228|NCT01323621|2898606|P3|2-week, Single-blind Run In Period|Lost to Follow-up|0
879229|NCT01323621|2898607|P2|2-week, Single-blind Run In Period|Lost to Follow-up|0
879230|NCT01323621|2898608|P1|2-week, Single-blind Run In Period|Lost to Follow-up|1
879231|NCT01323621|2898606|P3|2-week, Single-blind Run In Period|Protocol Violation|0
879232|NCT01323621|2898607|P2|2-week, Single-blind Run In Period|Protocol Violation|0
879233|NCT01323621|2898608|P1|2-week, Single-blind Run In Period|Protocol Violation|1
879234|NCT01323621|2898606|P3|2-week, Single-blind Run In Period|Withdrawal by Subject|0
879235|NCT01323621|2898607|P2|2-week, Single-blind Run In Period|Withdrawal by Subject|0
879236|NCT01323621|2898608|P1|2-week, Single-blind Run In Period|Withdrawal by Subject|12
879237|NCT01323621|2898606|P3|2-week, Single-blind Run In Period|Physician Decision|0
879238|NCT01323621|2898607|P2|2-week, Single-blind Run In Period|Physician Decision|0
879239|NCT01323621|2898608|P1|2-week, Single-blind Run In Period|Physician Decision|7
879240|NCT01323621|2898606|P3|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
879241|NCT01323621|2898607|P2|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
879242|NCT01323621|2898608|P1|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121
879243|NCT01323582|2898629|P2|Weeks 8-11 (Period 2)|Withdrawal by Subject|1
879244|NCT01323582|2898630|P1|Weeks 8-11 (Period 2)|Withdrawal by Subject|0
879245|NCT01323582|2898629|P2|Weeks 5-7 (Washout)|Withdrawal by Subject|1
879246|NCT01323582|2898630|P1|Weeks 5-7 (Washout)|Withdrawal by Subject|0
879247|NCT01323582|2898629|P2|Weeks 1-4 (First Period)|Withdrawal by Subject|2
879248|NCT01323582|2898630|P1|Weeks 1-4 (First Period)|Withdrawal by Subject|2
879249|NCT01323478|2898653|P1|Overall Study|Administrative or Other Reasons|8
879250|NCT01323478|2898653|P1|Overall Study|Withdrawal of Consent|1
879251|NCT01323478|2898653|P1|Overall Study|Protocol Violation|1
879252|NCT01323478|2898653|P1|Overall Study|Non-compliance With Study Product|3
879253|NCT01323478|2898653|P1|Overall Study|Lack of Efficacy|4
879254|NCT01323478|2898653|P1|Overall Study|Adverse Event|7
879255|NCT01323387|2898666|P1|Overall Study|Randomized but Never Treated|16
879256|NCT01323387|2898666|P1|Overall Study|Protocol Violation|12
879257|NCT01323387|2898666|P1|Overall Study|Revision|14
879258|NCT01323387|2898666|P1|Overall Study|Radiographic Data Unavailable|1
879259|NCT01323387|2898666|P1|Overall Study|Withdrawal by Subject|41
879260|NCT01323270|2898679|P2|Overall Study|Randomized, but not vaccinated|0
879261|NCT01323270|2898680|P1|Overall Study|Randomized, but not vaccinated|1
879262|NCT01323270|2898679|P2|Overall Study|Death|0
879263|NCT01323270|2898680|P1|Overall Study|Death|1
879264|NCT01323270|2898679|P2|Overall Study|Not eligible|1
879265|NCT01323270|2898680|P1|Overall Study|Not eligible|1
879266|NCT01323270|2898679|P2|Overall Study|Physician Decision|2
879267|NCT01323270|2898680|P1|Overall Study|Physician Decision|0
879268|NCT01323270|2898679|P2|Overall Study|Other|3
879269|NCT01323270|2898680|P1|Overall Study|Other|0
879270|NCT01323270|2898679|P2|Overall Study|Adverse Event|0
879271|NCT01323270|2898680|P1|Overall Study|Adverse Event|8
879272|NCT01323270|2898679|P2|Overall Study|Lost to Follow-up|6
879273|NCT01323270|2898680|P1|Overall Study|Lost to Follow-up|4
879274|NCT01323270|2898679|P2|Overall Study|Protocol Violation|7
879275|NCT01323270|2898680|P1|Overall Study|Protocol Violation|9
879276|NCT01323270|2898679|P2|Overall Study|Withdrawal by Subject|10
879277|NCT01323270|2898680|P1|Overall Study|Withdrawal by Subject|19
879278|NCT01323192|2898702|P2|Overall Study|Nonmedical reasons|1
879279|NCT01323192|2898703|P1|Overall Study|Nonmedical reasons|0
879280|NCT01323192|2898702|P2|Overall Study|Noncompliance with study medication|3
879281|NCT01323192|2898703|P1|Overall Study|Noncompliance with study medication|0
879282|NCT01323192|2898702|P2|Overall Study|Withdrawal by Subject|1
879283|NCT01323192|2898703|P1|Overall Study|Withdrawal by Subject|3
879284|NCT01323192|2898702|P2|Overall Study|Adverse Event|1
879285|NCT01323192|2898703|P1|Overall Study|Adverse Event|6
879286|NCT01322386|2898951|P2|Overall Study|Physician Decision|1
879287|NCT01322386|2898952|P1|Overall Study|Physician Decision|0
879288|NCT01322386|2898951|P2|Overall Study|Protocol Violation|1
879289|NCT01322386|2898952|P1|Overall Study|Protocol Violation|0
879290|NCT01322347|2898967|P2|Overall Study|moved/changed dialysis|4
879291|NCT01322347|2898968|P1|Overall Study|moved/changed dialysis|2
879292|NCT01322347|2898967|P2|Overall Study|study drug withheld > 12 wks|1
879293|NCT01322347|2898968|P1|Overall Study|study drug withheld > 12 wks|0
879294|NCT01322347|2898967|P2|Overall Study|kidney transplant|1
879295|NCT01322347|2898968|P1|Overall Study|kidney transplant|3
879296|NCT01322347|2898967|P2|Overall Study|ineligible|3
879297|NCT01322347|2898968|P1|Overall Study|ineligible|6
879298|NCT01322347|2898967|P2|Overall Study|sponsor decision|3
879299|NCT01322347|2898968|P1|Overall Study|sponsor decision|1
879300|NCT01322347|2898967|P2|Overall Study|blood transfusion|5
879301|NCT01322347|2898968|P1|Overall Study|blood transfusion|5
879302|NCT01322347|2898967|P2|Overall Study|non-protocol change to ESA or IV iron|6
879303|NCT01322347|2898968|P1|Overall Study|non-protocol change to ESA or IV iron|14
879304|NCT01322347|2898967|P2|Overall Study|Withdrawal by Subject|4
879305|NCT01322347|2898968|P1|Overall Study|Withdrawal by Subject|1
879306|NCT01322347|2898967|P2|Overall Study|Protocol Violation|2
879307|NCT01322347|2898968|P1|Overall Study|Protocol Violation|5
879308|NCT01322347|2898967|P2|Overall Study|Physician Decision|1
879309|NCT01322347|2898968|P1|Overall Study|Physician Decision|2
879310|NCT01322347|2898967|P2|Overall Study|Death|3
879311|NCT01322347|2898968|P1|Overall Study|Death|5
879312|NCT01322347|2898967|P2|Overall Study|Adverse Event|2
879313|NCT01322347|2898968|P1|Overall Study|Adverse Event|7
879314|NCT01322009|2899031|P2|Overall Study|ng tube discontinued|1
879315|NCT01322009|2899032|P1|Overall Study|ng tube discontinued|0
879316|NCT01322009|2899031|P2|Overall Study|Adverse Event|1
879317|NCT01322009|2899032|P1|Overall Study|Adverse Event|0
879318|NCT01322009|2899031|P2|Overall Study|Death|1
879319|NCT01322009|2899032|P1|Overall Study|Death|0
879320|NCT01321749|2899042|P2|Overall Study|Withdrawal by Subject|4
879321|NCT01321749|2899043|P1|Overall Study|Withdrawal by Subject|5
879322|NCT01321749|2899042|P2|Overall Study|Protocol Violation|7
879323|NCT01321749|2899043|P1|Overall Study|Protocol Violation|4
879324|NCT01321749|2899042|P2|Overall Study|Lost to Follow-up|11
879325|NCT01321749|2899043|P1|Overall Study|Lost to Follow-up|4
879326|NCT01321723|2899052|P3|Overall Study|Withdrawal by Subject|2
879327|NCT01321723|2899053|P2|Overall Study|Withdrawal by Subject|0
879328|NCT01321723|2899054|P1|Overall Study|Withdrawal by Subject|2
879329|NCT01321723|2899052|P3|Overall Study|Adverse Event|2
879330|NCT01321723|2899053|P2|Overall Study|Adverse Event|5
879331|NCT01321723|2899054|P1|Overall Study|Adverse Event|3
879332|NCT01321710|2899076|P3|Overall Study|Lost to Follow-up|0
879333|NCT01321710|2899077|P2|Overall Study|Lost to Follow-up|5
879334|NCT01321710|2899078|P1|Overall Study|Lost to Follow-up|4
879335|NCT01321697|2899093|P1|Overall Study|Study Terminated|7
879336|NCT01321606|2899099|P4|Overall Study|Lost to Follow-up|1
879337|NCT01321606|2899100|P3|Overall Study|Lost to Follow-up|0
879338|NCT01321606|2899101|P2|Overall Study|Lost to Follow-up|0
879339|NCT01321606|2899102|P1|Overall Study|Lost to Follow-up|0
879340|NCT01321554|2899122|P4|OOL Lenvatinib Treatment Period|Death|1
879341|NCT01321554|2899123|P3|OOL Lenvatinib Treatment Period|Death|1
879342|NCT01321554|2899124|P2|OOL Lenvatinib Treatment Period|Death|0
879343|NCT01321554|2899125|P1|OOL Lenvatinib Treatment Period|Death|0
879344|NCT01321554|2899122|P4|OOL Lenvatinib Treatment Period|Worsening disease|0
879345|NCT01321554|2899123|P3|OOL Lenvatinib Treatment Period|Worsening disease|1
879346|NCT01321554|2899124|P2|OOL Lenvatinib Treatment Period|Worsening disease|0
879347|NCT01321554|2899125|P1|OOL Lenvatinib Treatment Period|Worsening disease|0
879348|NCT01321554|2899122|P4|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
879349|NCT01321554|2899123|P3|OOL Lenvatinib Treatment Period|Lost to Follow-up|1
879350|NCT01321554|2899124|P2|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
879351|NCT01321554|2899125|P1|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
879352|NCT01321554|2899122|P4|OOL Lenvatinib Treatment Period|Not specified|0
879353|NCT01321554|2899123|P3|OOL Lenvatinib Treatment Period|Not specified|5
879354|NCT01321554|2899124|P2|OOL Lenvatinib Treatment Period|Not specified|0
879355|NCT01321554|2899125|P1|OOL Lenvatinib Treatment Period|Not specified|0
879356|NCT01321554|2899122|P4|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
879357|NCT01321554|2899123|P3|OOL Lenvatinib Treatment Period|Withdrawal by Subject|1
879358|NCT01321554|2899124|P2|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
879359|NCT01321554|2899125|P1|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
879360|NCT01321554|2899122|P4|OOL Lenvatinib Treatment Period|Participant choice|0
879361|NCT01321554|2899123|P3|OOL Lenvatinib Treatment Period|Participant choice|3
879362|NCT01321554|2899124|P2|OOL Lenvatinib Treatment Period|Participant choice|0
879363|NCT01321554|2899125|P1|OOL Lenvatinib Treatment Period|Participant choice|0
879364|NCT01321554|2899122|P4|OOL Lenvatinib Treatment Period|Adverse Event|1
879365|NCT01321554|2899123|P3|OOL Lenvatinib Treatment Period|Adverse Event|16
879366|NCT01321554|2899124|P2|OOL Lenvatinib Treatment Period|Adverse Event|0
879367|NCT01321554|2899125|P1|OOL Lenvatinib Treatment Period|Adverse Event|0
879368|NCT01321554|2899122|P4|Randomization Phase|Death|0
879369|NCT01321554|2899123|P3|Randomization Phase|Death|0
879370|NCT01321554|2899124|P2|Randomization Phase|Death|1
879371|NCT01321554|2899125|P1|Randomization Phase|Death|0
879372|NCT01321554|2899122|P4|Randomization Phase|Withdrawal by Subject|0
879373|NCT01321554|2899123|P3|Randomization Phase|Withdrawal by Subject|0
879374|NCT01321554|2899124|P2|Randomization Phase|Withdrawal by Subject|0
879375|NCT01321554|2899125|P1|Randomization Phase|Withdrawal by Subject|4
879376|NCT01321554|2899122|P4|Randomization Phase|Participant choice|0
879377|NCT01321554|2899123|P3|Randomization Phase|Participant choice|0
879378|NCT01321554|2899124|P2|Randomization Phase|Participant choice|0
879379|NCT01321554|2899125|P1|Randomization Phase|Participant choice|4
879380|NCT01321554|2899122|P4|Randomization Phase|Adverse Event|0
879381|NCT01321554|2899123|P3|Randomization Phase|Adverse Event|0
879382|NCT01321554|2899124|P2|Randomization Phase|Adverse Event|3
879383|NCT01321554|2899125|P1|Randomization Phase|Adverse Event|37
879384|NCT01321073|2899138|P1|Overall Study|Death|3
879385|NCT01321073|2899138|P1|Overall Study|Did not attempt implant|4
879386|NCT01321008|2899142|P1|Overall Study|Early Study Termination|1
879387|NCT01320943|2899148|P2|Overall Study|Randomized but not Treated|1
879388|NCT01320943|2899149|P1|Overall Study|Randomized but not Treated|0
879389|NCT01320943|2899148|P2|Overall Study|Physician Decision|1
879390|NCT01320943|2899149|P1|Overall Study|Physician Decision|0
879391|NCT01320943|2899148|P2|Overall Study|Lost to Follow-up|0
879392|NCT01320943|2899149|P1|Overall Study|Lost to Follow-up|1
879393|NCT01320735|2899183|P1|Overall Study|Investigator Unable to be Contacted|17
879394|NCT01320735|2899183|P1|Overall Study|No Decrease of Prostate Specific Antigen|7
879395|NCT01320735|2899183|P1|Overall Study|Not Specified|1
879396|NCT01320735|2899183|P1|Overall Study|Protocol Violation|1
879397|NCT01320735|2899183|P1|Overall Study|Progression/Hormone-Refractory Pca|55
879398|NCT01320735|2899183|P1|Overall Study|Administrative Reason|6
879399|NCT01320735|2899183|P1|Overall Study|Lost to Follow-up|13
879400|NCT01320735|2899183|P1|Overall Study|Withdrawal by Subject|3
879401|NCT01320735|2899183|P1|Overall Study|Adverse Event|3
879402|NCT01320722|2899205|P5|Overall Study|Withdrew due to Health Condition|1
879403|NCT01320722|2899206|P4|Overall Study|Withdrew due to Health Condition|0
879404|NCT01320722|2899207|P3|Overall Study|Withdrew due to Health Condition|0
879405|NCT01320722|2899208|P2|Overall Study|Withdrew due to Health Condition|0
879406|NCT01320722|2899209|P1|Overall Study|Withdrew due to Health Condition|0
879407|NCT01320722|2899205|P5|Overall Study|Started an Exclusionary Medication|1
879408|NCT01320722|2899206|P4|Overall Study|Started an Exclusionary Medication|0
879409|NCT01320722|2899207|P3|Overall Study|Started an Exclusionary Medication|0
879410|NCT01320722|2899208|P2|Overall Study|Started an Exclusionary Medication|0
879411|NCT01320722|2899209|P1|Overall Study|Started an Exclusionary Medication|0
879412|NCT01320722|2899205|P5|Overall Study|Pregnancy|0
879413|NCT01320722|2899206|P4|Overall Study|Pregnancy|1
879414|NCT01320722|2899207|P3|Overall Study|Pregnancy|0
879415|NCT01320722|2899208|P2|Overall Study|Pregnancy|0
879416|NCT01320722|2899209|P1|Overall Study|Pregnancy|0
879417|NCT01320722|2899205|P5|Overall Study|Not Compliant with Study Procedures|0
879418|NCT01320722|2899206|P4|Overall Study|Not Compliant with Study Procedures|4
879419|NCT01320722|2899207|P3|Overall Study|Not Compliant with Study Procedures|0
879420|NCT01320722|2899208|P2|Overall Study|Not Compliant with Study Procedures|0
879421|NCT01320722|2899209|P1|Overall Study|Not Compliant with Study Procedures|0
879422|NCT01320722|2899205|P5|Overall Study|Adverse Event|0
879423|NCT01320722|2899206|P4|Overall Study|Adverse Event|6
879424|NCT01320722|2899207|P3|Overall Study|Adverse Event|3
879425|NCT01320722|2899208|P2|Overall Study|Adverse Event|0
879426|NCT01320722|2899209|P1|Overall Study|Adverse Event|0
879427|NCT01320722|2899205|P5|Overall Study|Non-compliant with Medication|0
879428|NCT01320722|2899206|P4|Overall Study|Non-compliant with Medication|0
879429|NCT01320722|2899207|P3|Overall Study|Non-compliant with Medication|1
879430|NCT01320722|2899208|P2|Overall Study|Non-compliant with Medication|0
879431|NCT01320722|2899209|P1|Overall Study|Non-compliant with Medication|0
879432|NCT01320722|2899205|P5|Overall Study|Participant Developed a Rash|1
879433|NCT01320722|2899206|P4|Overall Study|Participant Developed a Rash|1
879434|NCT01320722|2899207|P3|Overall Study|Participant Developed a Rash|2
879435|NCT01320722|2899208|P2|Overall Study|Participant Developed a Rash|0
879436|NCT01320722|2899209|P1|Overall Study|Participant Developed a Rash|0
879437|NCT01320722|2899205|P5|Overall Study|Not Available for the 8 Week Visit|0
879438|NCT01320722|2899206|P4|Overall Study|Not Available for the 8 Week Visit|0
879439|NCT01320722|2899207|P3|Overall Study|Not Available for the 8 Week Visit|0
879440|NCT01320722|2899208|P2|Overall Study|Not Available for the 8 Week Visit|3
879441|NCT01320722|2899209|P1|Overall Study|Not Available for the 8 Week Visit|0
879442|NCT01320722|2899205|P5|Overall Study|Lost to Follow-up|3
879443|NCT01320722|2899206|P4|Overall Study|Lost to Follow-up|1
879444|NCT01320722|2899207|P3|Overall Study|Lost to Follow-up|0
879445|NCT01320722|2899208|P2|Overall Study|Lost to Follow-up|1
879446|NCT01320722|2899209|P1|Overall Study|Lost to Follow-up|0
879447|NCT01320722|2899205|P5|Overall Study|Did not Receive Intervention|2
879448|NCT01320722|2899206|P4|Overall Study|Did not Receive Intervention|1
879449|NCT01320722|2899207|P3|Overall Study|Did not Receive Intervention|1
879450|NCT01320722|2899208|P2|Overall Study|Did not Receive Intervention|2
879451|NCT01320722|2899209|P1|Overall Study|Did not Receive Intervention|3
879452|NCT01320683|2899246|P1|Overall Study|Positive antibody response|1
879453|NCT01320293|2899272|P1|Overall Study|Adverse Event|1
879454|NCT01320293|2899272|P1|Overall Study|Lack of Efficacy|1
879455|NCT01320202|2899280|P2|Overall Study|regained renal function|0
879456|NCT01320202|2899281|P1|Overall Study|regained renal function|1
879457|NCT01320202|2899280|P2|Overall Study|ineligible|0
879458|NCT01320202|2899281|P1|Overall Study|ineligible|3
879459|NCT01320202|2899280|P2|Overall Study|sponsor request|0
879460|NCT01320202|2899281|P1|Overall Study|sponsor request|2
879461|NCT01320202|2899280|P2|Overall Study|moved/changed dialysis|2
879462|NCT01320202|2899281|P1|Overall Study|moved/changed dialysis|5
879463|NCT01320202|2899280|P2|Overall Study|blood transfusion|7
879464|NCT01320202|2899281|P1|Overall Study|blood transfusion|1
879465|NCT01320202|2899280|P2|Overall Study|kidney transplant|2
879466|NCT01320202|2899281|P1|Overall Study|kidney transplant|1
879467|NCT01320202|2899280|P2|Overall Study|non-protocol change to ESA or IV iron|20
879468|NCT01320202|2899281|P1|Overall Study|non-protocol change to ESA or IV iron|17
879469|NCT01320202|2899280|P2|Overall Study|Withdrawal by Subject|3
879470|NCT01320202|2899281|P1|Overall Study|Withdrawal by Subject|10
879471|NCT01320202|2899280|P2|Overall Study|Protocol Violation|1
879472|NCT01320202|2899281|P1|Overall Study|Protocol Violation|2
879473|NCT01320202|2899280|P2|Overall Study|Physician Decision|1
879474|NCT01320202|2899281|P1|Overall Study|Physician Decision|3
879475|NCT01320202|2899280|P2|Overall Study|Lost to Follow-up|0
879476|NCT01320202|2899281|P1|Overall Study|Lost to Follow-up|1
879477|NCT01320202|2899280|P2|Overall Study|Death|3
879478|NCT01320202|2899281|P1|Overall Study|Death|5
879479|NCT01320202|2899280|P2|Overall Study|Adverse Event|5
879480|NCT01320202|2899281|P1|Overall Study|Adverse Event|5
879481|NCT01319877|2899345|P2|Overall Study|Reason Not Specified|5
879482|NCT01319877|2899346|P1|Overall Study|Reason Not Specified|4
879483|NCT01319877|2899345|P2|Overall Study|Withdrawal by Subject|1
879484|NCT01319877|2899346|P1|Overall Study|Withdrawal by Subject|0
879485|NCT01319877|2899345|P2|Overall Study|Disease Progression|2
879486|NCT01319877|2899346|P1|Overall Study|Disease Progression|2
879487|NCT01319877|2899345|P2|Overall Study|Physician Decision|0
879488|NCT01319877|2899346|P1|Overall Study|Physician Decision|2
879489|NCT01319877|2899345|P2|Overall Study|Lost to Follow-up|37
879490|NCT01319877|2899346|P1|Overall Study|Lost to Follow-up|100
879491|NCT01319721|2899496|P2|Overall Study|Lost to Follow-up|6
879492|NCT01319721|2899497|P1|Overall Study|Lost to Follow-up|1
879493|NCT01319422|2899550|P2|Overall Study|Withdrawal by Subject|0
879494|NCT01319422|2899551|P1|Overall Study|Withdrawal by Subject|1
879495|NCT01319383|2899569|P2|Overall Study|No in vivo response to interval doses|1
879496|NCT01319383|2899570|P1|Overall Study|No in vivo response to interval doses|0
879497|NCT01319383|2899569|P2|Overall Study|Lack of Efficacy|9
879498|NCT01319383|2899570|P1|Overall Study|Lack of Efficacy|5
879499|NCT01319383|2899569|P2|Overall Study|Physician Decision|0
879500|NCT01319383|2899570|P1|Overall Study|Physician Decision|3
879501|NCT01319383|2899569|P2|Overall Study|No ex vivo or in vivo response|0
879502|NCT01319383|2899570|P1|Overall Study|No ex vivo or in vivo response|4
879503|NCT01318993|2899609|P1|Overall Study|Withdrawal by Subject|24
879504|NCT01318993|2899609|P1|Overall Study|Physician Decision|13
879505|NCT01318993|2899609|P1|Overall Study|Lost to Follow-up|4
879506|NCT01318993|2899609|P1|Overall Study|Study closed or terminated|174
879507|NCT01318993|2899609|P1|Overall Study|Protocol based stopping criteria|6
879508|NCT01318993|2899609|P1|Overall Study|Protocol Violation|3
879509|NCT01318993|2899609|P1|Overall Study|Lack of Efficacy|121
879510|NCT01318993|2899609|P1|Overall Study|Adverse Event|53
879511|NCT01318915|2899630|P1|Overall Study|Lost to Follow-up|1
879512|NCT01318876|2899655|P1|Day 29 Survey|survey not completed-don't know why|1825
879513|NCT01318876|2899655|P1|Day 8 Survey|survey not completed-don't know why|1724
879514|NCT01318876|2899655|P1|Day 8 Survey|email address invalid|96
879515|NCT01318512|2899753|P1|Maintenance Period (6 Months)|Protocol Violation|9
879516|NCT01318512|2899753|P1|Maintenance Period (6 Months)|Death|2
879517|NCT01318499|2899772|P3|Overall Study|Not Specified|22
879518|NCT01318499|2899773|P2|Overall Study|Not Specified|10
879519|NCT01318499|2899774|P1|Overall Study|Not Specified|7
879520|NCT01318499|2899772|P3|Overall Study|Patient Did Not Use Study Medication|14
879521|NCT01318499|2899773|P2|Overall Study|Patient Did Not Use Study Medication|28
879522|NCT01318499|2899774|P1|Overall Study|Patient Did Not Use Study Medication|18
879523|NCT01318499|2899772|P3|Overall Study|Protocol Violation|2
879524|NCT01318499|2899773|P2|Overall Study|Protocol Violation|4
879525|NCT01318499|2899774|P1|Overall Study|Protocol Violation|2
879526|NCT01318499|2899772|P3|Overall Study|Treatment Failure|101
879527|NCT01318499|2899773|P2|Overall Study|Treatment Failure|19
879528|NCT01318499|2899774|P1|Overall Study|Treatment Failure|19
879529|NCT01318499|2899772|P3|Overall Study|Noncompliance|0
879530|NCT01318499|2899773|P2|Overall Study|Noncompliance|3
879531|NCT01318499|2899774|P1|Overall Study|Noncompliance|2
879532|NCT01318499|2899772|P3|Overall Study|Pt Decision Unrelated to Adverse Event|2
879533|NCT01318499|2899773|P2|Overall Study|Pt Decision Unrelated to Adverse Event|1
879534|NCT01318499|2899774|P1|Overall Study|Pt Decision Unrelated to Adverse Event|1
879535|NCT01318499|2899772|P3|Overall Study|Adverse Event|6
879536|NCT01318499|2899773|P2|Overall Study|Adverse Event|11
879537|NCT01318499|2899774|P1|Overall Study|Adverse Event|16
879538|NCT01318382|2899797|P1|Overall Study|Protocol Violation|1
879539|NCT01318382|2899797|P1|Overall Study|Device Malfunction|10
879540|NCT01318382|2899797|P1|Overall Study|Physician Decision|2
879541|NCT01318135|2899855|P8|Entered - Long-Term Extension Study|Use of Excluded Medications|1
879542|NCT01318135|2899856|P7|Entered - Long-Term Extension Study|Use of Excluded Medications|0
879543|NCT01318135|2899857|P6|Entered - Long-Term Extension Study|Use of Excluded Medications|0
879544|NCT01318135|2899858|P5|Entered - Long-Term Extension Study|Use of Excluded Medications|0
879545|NCT01318135|2899859|P4|Entered - Long-Term Extension Study|Use of Excluded Medications|0
879546|NCT01318135|2899860|P3|Entered - Long-Term Extension Study|Use of Excluded Medications|0
879547|NCT01318135|2899861|P2|Entered - Long-Term Extension Study|Use of Excluded Medications|0
879548|NCT01318135|2899862|P1|Entered - Long-Term Extension Study|Use of Excluded Medications|0
879549|NCT01318135|2899855|P8|Entered - Long-Term Extension Study|Lack of Efficacy|1
879550|NCT01318135|2899856|P7|Entered - Long-Term Extension Study|Lack of Efficacy|1
879551|NCT01318135|2899857|P6|Entered - Long-Term Extension Study|Lack of Efficacy|2
879552|NCT01318135|2899858|P5|Entered - Long-Term Extension Study|Lack of Efficacy|2
879553|NCT01318135|2899859|P4|Entered - Long-Term Extension Study|Lack of Efficacy|3
879554|NCT01318135|2899860|P3|Entered - Long-Term Extension Study|Lack of Efficacy|2
879555|NCT01318135|2899861|P2|Entered - Long-Term Extension Study|Lack of Efficacy|7
879556|NCT01318135|2899862|P1|Entered - Long-Term Extension Study|Lack of Efficacy|5
879557|NCT01318135|2899855|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|1
879558|NCT01318135|2899856|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|0
879559|NCT01318135|2899857|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|0
879560|NCT01318135|2899858|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|2
879561|NCT01318135|2899859|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|1
879562|NCT01318135|2899860|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|2
879563|NCT01318135|2899861|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
879564|NCT01318135|2899862|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
879565|NCT01318135|2899855|P8|Entered - Long-Term Extension Study|Protocol Violation|0
879566|NCT01318135|2899856|P7|Entered - Long-Term Extension Study|Protocol Violation|0
879567|NCT01318135|2899857|P6|Entered - Long-Term Extension Study|Protocol Violation|0
879568|NCT01318135|2899858|P5|Entered - Long-Term Extension Study|Protocol Violation|1
879569|NCT01318135|2899859|P4|Entered - Long-Term Extension Study|Protocol Violation|0
879570|NCT01318135|2899860|P3|Entered - Long-Term Extension Study|Protocol Violation|0
879571|NCT01318135|2899861|P2|Entered - Long-Term Extension Study|Protocol Violation|1
879572|NCT01318135|2899862|P1|Entered - Long-Term Extension Study|Protocol Violation|1
879573|NCT01318135|2899855|P8|Entered - Long-Term Extension Study|Adverse Event|0
879574|NCT01318135|2899856|P7|Entered - Long-Term Extension Study|Adverse Event|0
879575|NCT01318135|2899857|P6|Entered - Long-Term Extension Study|Adverse Event|2
879576|NCT01318135|2899858|P5|Entered - Long-Term Extension Study|Adverse Event|4
879577|NCT01318135|2899859|P4|Entered - Long-Term Extension Study|Adverse Event|3
879578|NCT01318135|2899860|P3|Entered - Long-Term Extension Study|Adverse Event|4
879579|NCT01318135|2899861|P2|Entered - Long-Term Extension Study|Adverse Event|3
879580|NCT01318135|2899862|P1|Entered - Long-Term Extension Study|Adverse Event|9
879581|NCT01318135|2899855|P8|Enrolled - Long-Term Extension Study|Treatment Complications|0
879582|NCT01318135|2899856|P7|Enrolled - Long-Term Extension Study|Treatment Complications|0
879583|NCT01318135|2899857|P6|Enrolled - Long-Term Extension Study|Treatment Complications|0
879584|NCT01318135|2899858|P5|Enrolled - Long-Term Extension Study|Treatment Complications|0
879585|NCT01318135|2899859|P4|Enrolled - Long-Term Extension Study|Treatment Complications|0
879586|NCT01318135|2899860|P3|Enrolled - Long-Term Extension Study|Treatment Complications|0
879587|NCT01318135|2899861|P2|Enrolled - Long-Term Extension Study|Treatment Complications|0
879588|NCT01318135|2899862|P1|Enrolled - Long-Term Extension Study|Treatment Complications|1
879589|NCT01318135|2899855|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
879590|NCT01318135|2899856|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
879591|NCT01318135|2899857|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
879592|NCT01318135|2899858|P5|Enrolled - Long-Term Extension Study|Adverse Event|0
879593|NCT01318135|2899859|P4|Enrolled - Long-Term Extension Study|Adverse Event|0
879594|NCT01318135|2899860|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
879595|NCT01318135|2899861|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
879596|NCT01318135|2899862|P1|Enrolled - Long-Term Extension Study|Adverse Event|1
879597|NCT01318122|2899994|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
879598|NCT01318122|2899995|P3|Entered - Long-Term Extension Study|Lack of Efficacy|3
879599|NCT01318122|2899996|P2|Entered - Long-Term Extension Study|Lack of Efficacy|2
879600|NCT01318122|2899997|P1|Entered - Long-Term Extension Study|Lack of Efficacy|0
879601|NCT01318122|2899994|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
879602|NCT01318122|2899995|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|1
879603|NCT01318122|2899996|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|3
879604|NCT01318122|2899997|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
879605|NCT01318122|2899994|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
879606|NCT01318122|2899995|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
879607|NCT01318122|2899996|P2|Entered - Long-Term Extension Study|Lost to Follow-up|0
879608|NCT01318122|2899997|P1|Entered - Long-Term Extension Study|Lost to Follow-up|1
879609|NCT01318122|2899994|P4|Entered - Long-Term Extension Study|Adverse Event|4
879610|NCT01318122|2899995|P3|Entered - Long-Term Extension Study|Adverse Event|2
879611|NCT01318122|2899996|P2|Entered - Long-Term Extension Study|Adverse Event|6
879612|NCT01318122|2899997|P1|Entered - Long-Term Extension Study|Adverse Event|6
879613|NCT01318122|2899994|P4|Enrolled - Long-Term Extension Study|Other|0
879614|NCT01318122|2899995|P3|Enrolled - Long-Term Extension Study|Other|0
879615|NCT01318122|2899996|P2|Enrolled - Long-Term Extension Study|Other|0
879616|NCT01318122|2899997|P1|Enrolled - Long-Term Extension Study|Other|1
879617|NCT01318122|2899994|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
879618|NCT01318122|2899995|P3|Enrolled - Long-Term Extension Study|Adverse Event|2
879619|NCT01318122|2899996|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
879620|NCT01318122|2899997|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
879621|NCT01318109|2900066|P3|Overall Study|Schedule Conflict|0
879622|NCT01318109|2900067|P2|Overall Study|Schedule Conflict|1
879623|NCT01318109|2900068|P1|Overall Study|Schedule Conflict|0
879624|NCT01318109|2900066|P3|Overall Study|Withdrawal by Subject|0
879625|NCT01318109|2900067|P2|Overall Study|Withdrawal by Subject|0
879626|NCT01318109|2900068|P1|Overall Study|Withdrawal by Subject|1
879627|NCT01318109|2900066|P3|Overall Study|Adverse Event|0
879628|NCT01318109|2900067|P2|Overall Study|Adverse Event|2
879629|NCT01318109|2900068|P1|Overall Study|Adverse Event|0
879630|NCT01318083|2900103|P3|Overall Study|Lack of Study Medication Compliance|0
879631|NCT01318083|2900104|P2|Overall Study|Lack of Study Medication Compliance|1
879632|NCT01318083|2900105|P1|Overall Study|Lack of Study Medication Compliance|0
879633|NCT01318083|2900103|P3|Overall Study|Treatment Complications|0
879634|NCT01318083|2900104|P2|Overall Study|Treatment Complications|0
879635|NCT01318083|2900105|P1|Overall Study|Treatment Complications|1
879636|NCT01318083|2900103|P3|Overall Study|Lack of Efficacy|1
879637|NCT01318083|2900104|P2|Overall Study|Lack of Efficacy|0
879638|NCT01318083|2900105|P1|Overall Study|Lack of Efficacy|0
879639|NCT01318083|2900103|P3|Overall Study|Withdrawal by Subject|2
879640|NCT01318083|2900104|P2|Overall Study|Withdrawal by Subject|0
879641|NCT01318083|2900105|P1|Overall Study|Withdrawal by Subject|1
879642|NCT01318083|2900103|P3|Overall Study|Adverse Event|2
879643|NCT01318083|2900104|P2|Overall Study|Adverse Event|1
879644|NCT01318083|2900105|P1|Overall Study|Adverse Event|4
879645|NCT01318070|2900140|P3|Overall Study|Principal Investigator Discretion|0
879646|NCT01318070|2900141|P2|Overall Study|Principal Investigator Discretion|0
879647|NCT01318070|2900142|P1|Overall Study|Principal Investigator Discretion|1
879648|NCT01318070|2900140|P3|Overall Study|Lack of Efficacy|1
879649|NCT01318070|2900141|P2|Overall Study|Lack of Efficacy|0
879650|NCT01318070|2900142|P1|Overall Study|Lack of Efficacy|0
879651|NCT01318070|2900140|P3|Overall Study|Withdrawal by Subject|1
879652|NCT01318070|2900141|P2|Overall Study|Withdrawal by Subject|1
879653|NCT01318070|2900142|P1|Overall Study|Withdrawal by Subject|0
879654|NCT01318070|2900140|P3|Overall Study|Adverse Event|5
879655|NCT01318070|2900141|P2|Overall Study|Adverse Event|1
879656|NCT01318070|2900142|P1|Overall Study|Adverse Event|1
879657|NCT01317797|2900195|P3|Overall Study|Withdrawal of Patient|1
879658|NCT01317797|2900196|P2|Overall Study|Withdrawal of Patient|0
879659|NCT01317797|2900197|P1|Overall Study|Withdrawal of Patient|0
879660|NCT01317797|2900195|P3|Overall Study|Other|0
879661|NCT01317797|2900196|P2|Overall Study|Other|1
879662|NCT01317797|2900197|P1|Overall Study|Other|0
879663|NCT01317641|2900274|P9|Overall Study|Withdrawal by Subject|0
879664|NCT01317641|2900275|P8|Overall Study|Withdrawal by Subject|0
879665|NCT01317641|2900276|P7|Overall Study|Withdrawal by Subject|1
879666|NCT01317641|2900277|P6|Overall Study|Withdrawal by Subject|0
879667|NCT01317641|2900278|P5|Overall Study|Withdrawal by Subject|0
879668|NCT01317641|2900279|P4|Overall Study|Withdrawal by Subject|0
879669|NCT01317641|2900280|P3|Overall Study|Withdrawal by Subject|0
879670|NCT01317641|2900281|P2|Overall Study|Withdrawal by Subject|0
879671|NCT01317641|2900282|P1|Overall Study|Withdrawal by Subject|0
879672|NCT01317641|2900274|P9|Overall Study|Disease progression|4
879673|NCT01317641|2900275|P8|Overall Study|Disease progression|3
879674|NCT01317641|2900276|P7|Overall Study|Disease progression|0
879675|NCT01317641|2900277|P6|Overall Study|Disease progression|0
879676|NCT01317641|2900278|P5|Overall Study|Disease progression|0
879677|NCT01317641|2900279|P4|Overall Study|Disease progression|0
879678|NCT01317641|2900280|P3|Overall Study|Disease progression|0
879679|NCT01317641|2900281|P2|Overall Study|Disease progression|0
879680|NCT01317641|2900282|P1|Overall Study|Disease progression|0
879681|NCT01317641|2900274|P9|Overall Study|Protocol Violation|0
879682|NCT01317641|2900275|P8|Overall Study|Protocol Violation|0
879683|NCT01317641|2900276|P7|Overall Study|Protocol Violation|0
879684|NCT01317641|2900277|P6|Overall Study|Protocol Violation|0
879685|NCT01317641|2900278|P5|Overall Study|Protocol Violation|0
879686|NCT01317641|2900279|P4|Overall Study|Protocol Violation|0
879687|NCT01317641|2900280|P3|Overall Study|Protocol Violation|0
879688|NCT01317641|2900281|P2|Overall Study|Protocol Violation|0
879689|NCT01317641|2900282|P1|Overall Study|Protocol Violation|1
879690|NCT01317641|2900274|P9|Overall Study|Adverse Event|0
879691|NCT01317641|2900275|P8|Overall Study|Adverse Event|1
879692|NCT01317641|2900276|P7|Overall Study|Adverse Event|2
879693|NCT01317641|2900277|P6|Overall Study|Adverse Event|0
879694|NCT01317641|2900278|P5|Overall Study|Adverse Event|0
879695|NCT01317641|2900279|P4|Overall Study|Adverse Event|1
879696|NCT01317641|2900280|P3|Overall Study|Adverse Event|0
879697|NCT01317641|2900281|P2|Overall Study|Adverse Event|1
879698|NCT01317641|2900282|P1|Overall Study|Adverse Event|0
879699|NCT01317641|2900274|P9|Overall Study|Not treated|1
879700|NCT01317641|2900275|P8|Overall Study|Not treated|1
879701|NCT01317641|2900276|P7|Overall Study|Not treated|0
879702|NCT01317641|2900277|P6|Overall Study|Not treated|0
879703|NCT01317641|2900278|P5|Overall Study|Not treated|0
879704|NCT01317641|2900279|P4|Overall Study|Not treated|0
879705|NCT01317641|2900280|P3|Overall Study|Not treated|0
879706|NCT01317641|2900281|P2|Overall Study|Not treated|0
879707|NCT01317641|2900282|P1|Overall Study|Not treated|0
879708|NCT01317615|2900384|P1|Overall Study|Adverse Event|7
879709|NCT01317615|2900384|P1|Overall Study|Abnormal laboratory value(s)|1
879710|NCT01317615|2900384|P1|Overall Study|Withdrawal by Subject|5
879711|NCT01317615|2900384|P1|Overall Study|Death|6
879712|NCT01317615|2900384|P1|Overall Study|New cancer therapy|5
879713|NCT01317615|2900384|P1|Overall Study|Disease progression|25
879714|NCT01317199|2900397|P4|Randomized Phase 2|Patient transferred to other facility|0
879715|NCT01317199|2900398|P3|Randomized Phase 2|Patient transferred to other facility|1
879716|NCT01317199|2900399|P2|Randomized Phase 2|Patient transferred to other facility|0
879717|NCT01317199|2900400|P1|Randomized Phase 2|Patient transferred to other facility|0
879718|NCT01317199|2900397|P4|Randomized Phase 2|Patient stopped taking study drug|1
879719|NCT01317199|2900398|P3|Randomized Phase 2|Patient stopped taking study drug|0
879720|NCT01317199|2900399|P2|Randomized Phase 2|Patient stopped taking study drug|0
879721|NCT01317199|2900400|P1|Randomized Phase 2|Patient stopped taking study drug|0
879722|NCT01317199|2900397|P4|Randomized Phase 2|Disenrolled before treatment|2
879723|NCT01317199|2900398|P3|Randomized Phase 2|Disenrolled before treatment|1
879724|NCT01317199|2900399|P2|Randomized Phase 2|Disenrolled before treatment|1
879725|NCT01317199|2900400|P1|Randomized Phase 2|Disenrolled before treatment|0
879726|NCT01317199|2900397|P4|Randomized Phase 2|Rising PSA, not as defined by protocol|2
879727|NCT01317199|2900398|P3|Randomized Phase 2|Rising PSA, not as defined by protocol|5
879728|NCT01317199|2900399|P2|Randomized Phase 2|Rising PSA, not as defined by protocol|2
879729|NCT01317199|2900400|P1|Randomized Phase 2|Rising PSA, not as defined by protocol|0
879730|NCT01317199|2900397|P4|Randomized Phase 2|Comorbidities|2
879731|NCT01317199|2900398|P3|Randomized Phase 2|Comorbidities|2
879732|NCT01317199|2900399|P2|Randomized Phase 2|Comorbidities|2
879733|NCT01317199|2900400|P1|Randomized Phase 2|Comorbidities|0
879734|NCT01317199|2900397|P4|Randomized Phase 2|Adverse Event|1
879735|NCT01317199|2900398|P3|Randomized Phase 2|Adverse Event|0
879736|NCT01317199|2900399|P2|Randomized Phase 2|Adverse Event|0
879737|NCT01317199|2900400|P1|Randomized Phase 2|Adverse Event|0
879738|NCT01317199|2900397|P4|Randomized Phase 2|Withdrawal by Subject|4
879739|NCT01317199|2900398|P3|Randomized Phase 2|Withdrawal by Subject|5
879740|NCT01317199|2900399|P2|Randomized Phase 2|Withdrawal by Subject|3
879741|NCT01317199|2900400|P1|Randomized Phase 2|Withdrawal by Subject|0
879742|NCT01317199|2900397|P4|Randomized Phase 2|Disease progression|5
879743|NCT01317199|2900398|P3|Randomized Phase 2|Disease progression|7
879744|NCT01317199|2900399|P2|Randomized Phase 2|Disease progression|3
879745|NCT01317199|2900400|P1|Randomized Phase 2|Disease progression|0
879746|NCT01317199|2900397|P4|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
879747|NCT01317199|2900398|P3|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
879748|NCT01317199|2900399|P2|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
879749|NCT01317199|2900400|P1|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1
879750|NCT01317199|2900397|P4|Dose-escalation Phase 1|Disease progression|0
879751|NCT01317199|2900398|P3|Dose-escalation Phase 1|Disease progression|0
879752|NCT01317199|2900399|P2|Dose-escalation Phase 1|Disease progression|0
879753|NCT01317199|2900400|P1|Dose-escalation Phase 1|Disease progression|1
879754|NCT01317199|2900397|P4|Dose-escalation Phase 1|Physician Decision|0
879755|NCT01317199|2900398|P3|Dose-escalation Phase 1|Physician Decision|0
879756|NCT01317199|2900399|P2|Dose-escalation Phase 1|Physician Decision|0
879757|NCT01317199|2900400|P1|Dose-escalation Phase 1|Physician Decision|5
879758|NCT01317160|2900429|P2|Overall Study|Withdrawal by Subject|2
879759|NCT01317160|2900430|P1|Overall Study|Withdrawal by Subject|0
879760|NCT01317160|2900429|P2|Overall Study|Lost to Follow-up|3
879761|NCT01317160|2900430|P1|Overall Study|Lost to Follow-up|3
879762|NCT01317160|2900429|P2|Overall Study|Incorrect inclusion|1
879763|NCT01317160|2900430|P1|Overall Study|Incorrect inclusion|1
879764|NCT01317004|2900455|P2|Overall Study|Adverse Event|3
879765|NCT01317004|2900456|P1|Overall Study|Adverse Event|3
879766|NCT01317004|2900455|P2|Overall Study|Protocol Violation|2
879767|NCT01317004|2900456|P1|Overall Study|Protocol Violation|0
879768|NCT01317004|2900455|P2|Overall Study|Withdrawal by Subject|4
879769|NCT01317004|2900456|P1|Overall Study|Withdrawal by Subject|1
879770|NCT01316939|2900477|P3|Overall Study|Protocol Violation|0
879771|NCT01316939|2900478|P2|Overall Study|Protocol Violation|1
879772|NCT01316939|2900479|P1|Overall Study|Protocol Violation|0
879773|NCT01316939|2900477|P3|Overall Study|Met Liver chemistry stopping criteria|1
879774|NCT01316939|2900478|P2|Overall Study|Met Liver chemistry stopping criteria|0
879775|NCT01316939|2900479|P1|Overall Study|Met Liver chemistry stopping criteria|1
879776|NCT01316939|2900477|P3|Overall Study|Lost to Follow-up|2
879777|NCT01316939|2900478|P2|Overall Study|Lost to Follow-up|0
879778|NCT01316939|2900479|P1|Overall Study|Lost to Follow-up|0
879779|NCT01316939|2900477|P3|Overall Study|Physician Decision|1
879780|NCT01316939|2900478|P2|Overall Study|Physician Decision|2
879781|NCT01316939|2900479|P1|Overall Study|Physician Decision|2
879782|NCT01316939|2900477|P3|Overall Study|Withdrawal by Subject|6
879783|NCT01316939|2900478|P2|Overall Study|Withdrawal by Subject|3
879784|NCT01316939|2900479|P1|Overall Study|Withdrawal by Subject|1
879785|NCT01316939|2900477|P3|Overall Study|Adverse Event|11
879786|NCT01316939|2900478|P2|Overall Study|Adverse Event|12
879787|NCT01316939|2900479|P1|Overall Study|Adverse Event|9
879788|NCT01316939|2900477|P3|Overall Study|Lack of Efficacy|25
879789|NCT01316939|2900478|P2|Overall Study|Lack of Efficacy|25
879790|NCT01316939|2900479|P1|Overall Study|Lack of Efficacy|24
879791|NCT01316939|2900477|P3|Overall Study|Study closed/terminated|23
879792|NCT01316939|2900478|P2|Overall Study|Study closed/terminated|25
879793|NCT01316939|2900479|P1|Overall Study|Study closed/terminated|26
879794|NCT01316913|2900574|P4|Overall Study|Withdrawal by Subject|6
879795|NCT01316913|2900575|P3|Overall Study|Withdrawal by Subject|10
879796|NCT01316913|2900576|P2|Overall Study|Withdrawal by Subject|9
879797|NCT01316913|2900577|P1|Overall Study|Withdrawal by Subject|10
879798|NCT01316913|2900574|P4|Overall Study|Lost to Follow-up|2
879799|NCT01316913|2900575|P3|Overall Study|Lost to Follow-up|0
879800|NCT01316913|2900576|P2|Overall Study|Lost to Follow-up|1
879801|NCT01316913|2900577|P1|Overall Study|Lost to Follow-up|0
879802|NCT01316913|2900574|P4|Overall Study|Protocol-defined Stopping Criteria|6
879803|NCT01316913|2900575|P3|Overall Study|Protocol-defined Stopping Criteria|11
879804|NCT01316913|2900576|P2|Overall Study|Protocol-defined Stopping Criteria|8
879805|NCT01316913|2900577|P1|Overall Study|Protocol-defined Stopping Criteria|7
879806|NCT01316913|2900574|P4|Overall Study|Protocol Violation|1
879807|NCT01316913|2900575|P3|Overall Study|Protocol Violation|4
879808|NCT01316913|2900576|P2|Overall Study|Protocol Violation|4
879809|NCT01316913|2900577|P1|Overall Study|Protocol Violation|1
879810|NCT01316913|2900574|P4|Overall Study|Lack of Efficacy|13
879811|NCT01316913|2900575|P3|Overall Study|Lack of Efficacy|9
879812|NCT01316913|2900576|P2|Overall Study|Lack of Efficacy|12
879813|NCT01316913|2900577|P1|Overall Study|Lack of Efficacy|22
879814|NCT01316913|2900574|P4|Overall Study|Adverse Event|11
879815|NCT01316913|2900575|P3|Overall Study|Adverse Event|15
879816|NCT01316913|2900576|P2|Overall Study|Adverse Event|20
879817|NCT01316913|2900577|P1|Overall Study|Adverse Event|17
879818|NCT01316900|2900599|P4|Overall Study|Withdrawal by Subject|9
879819|NCT01316900|2900600|P3|Overall Study|Withdrawal by Subject|6
879820|NCT01316900|2900601|P2|Overall Study|Withdrawal by Subject|8
879821|NCT01316900|2900602|P1|Overall Study|Withdrawal by Subject|7
879822|NCT01316900|2900599|P4|Overall Study|Lost to Follow-up|1
879823|NCT01316900|2900600|P3|Overall Study|Lost to Follow-up|1
879824|NCT01316900|2900601|P2|Overall Study|Lost to Follow-up|0
879825|NCT01316900|2900602|P1|Overall Study|Lost to Follow-up|1
879826|NCT01316900|2900599|P4|Overall Study|Protocol-defined Stopping Criteria|5
879827|NCT01316900|2900600|P3|Overall Study|Protocol-defined Stopping Criteria|10
879828|NCT01316900|2900601|P2|Overall Study|Protocol-defined Stopping Criteria|3
879829|NCT01316900|2900602|P1|Overall Study|Protocol-defined Stopping Criteria|2
879830|NCT01316900|2900599|P4|Overall Study|Protocol Violation|0
879831|NCT01316900|2900600|P3|Overall Study|Protocol Violation|4
879832|NCT01316900|2900601|P2|Overall Study|Protocol Violation|1
879833|NCT01316900|2900602|P1|Overall Study|Protocol Violation|7
879834|NCT01316900|2900599|P4|Overall Study|Lack of Efficacy|7
879835|NCT01316900|2900600|P3|Overall Study|Lack of Efficacy|5
879836|NCT01316900|2900601|P2|Overall Study|Lack of Efficacy|9
879837|NCT01316900|2900602|P1|Overall Study|Lack of Efficacy|17
879838|NCT01316900|2900599|P4|Overall Study|Adverse Event|9
879839|NCT01316900|2900600|P3|Overall Study|Adverse Event|15
879840|NCT01316900|2900601|P2|Overall Study|Adverse Event|10
879841|NCT01316900|2900602|P1|Overall Study|Adverse Event|10
879842|NCT01316887|2900623|P3|Overall Study|Withdrawal by Subject|15
879843|NCT01316887|2900624|P2|Overall Study|Withdrawal by Subject|16
879844|NCT01316887|2900625|P1|Overall Study|Withdrawal by Subject|8
879845|NCT01316887|2900623|P3|Overall Study|Lost to Follow-up|5
879846|NCT01316887|2900624|P2|Overall Study|Lost to Follow-up|7
879847|NCT01316887|2900625|P1|Overall Study|Lost to Follow-up|1
879848|NCT01316887|2900623|P3|Overall Study|Study Closed/Terminated|3
879849|NCT01316887|2900624|P2|Overall Study|Study Closed/Terminated|4
879850|NCT01316887|2900625|P1|Overall Study|Study Closed/Terminated|2
879851|NCT01316887|2900623|P3|Overall Study|Protocol-defined Stopping Criteria|36
879852|NCT01316887|2900624|P2|Overall Study|Protocol-defined Stopping Criteria|37
879853|NCT01316887|2900625|P1|Overall Study|Protocol-defined Stopping Criteria|8
879854|NCT01316887|2900623|P3|Overall Study|Protocol Violation|6
879855|NCT01316887|2900624|P2|Overall Study|Protocol Violation|6
879856|NCT01316887|2900625|P1|Overall Study|Protocol Violation|2
879857|NCT01316887|2900623|P3|Overall Study|Lack of Efficacy|1
879858|NCT01316887|2900624|P2|Overall Study|Lack of Efficacy|3
879859|NCT01316887|2900625|P1|Overall Study|Lack of Efficacy|9
879860|NCT01316887|2900623|P3|Overall Study|Adverse Event|17
879861|NCT01316887|2900624|P2|Overall Study|Adverse Event|21
879862|NCT01316887|2900625|P1|Overall Study|Adverse Event|13
879863|NCT01316692|2900750|P1|Overall Study|Disease Progression|7
879864|NCT01316692|2900750|P1|Overall Study|Adverse Event|5
879865|NCT01316614|2900759|P1|Overall Study|Medically unstable|1
879866|NCT01316614|2900759|P1|Overall Study|Inadequate number of passes|2
879867|NCT01316614|2900759|P1|Overall Study|Cystic lesion|5
879868|NCT01316614|2900759|P1|Overall Study|Cytology slides not available for review|4
879869|NCT01316614|2900759|P1|Overall Study|No solid lesion and FNA not indicated|25
879870|NCT01316575|2900776|P2|Overall Study|Required alternate treatment|1
879871|NCT01316575|2900777|P1|Overall Study|Required alternate treatment|0
879872|NCT01316575|2900776|P2|Overall Study|Withdrawal by Subject|0
879873|NCT01316575|2900777|P1|Overall Study|Withdrawal by Subject|2
879874|NCT01316419|2900800|P1|Overall Study|Lost to Follow-up|19
879875|NCT01316419|2900800|P1|Overall Study|Violated inclusion/exclusion criterion|143
879876|NCT01316419|2900800|P1|Overall Study|Not treated|103
879877|NCT01316380|2900826|P3|Overall Study|Not treated|0
879878|NCT01316380|2900827|P2|Overall Study|Not treated|0
879879|NCT01316380|2900828|P1|Overall Study|Not treated|1
879880|NCT01316380|2900826|P3|Overall Study|Other|1
879881|NCT01316380|2900827|P2|Overall Study|Other|1
879882|NCT01316380|2900828|P1|Overall Study|Other|0
879883|NCT01316380|2900826|P3|Overall Study|Withdrawal by Subject|0
879884|NCT01316380|2900827|P2|Overall Study|Withdrawal by Subject|2
879885|NCT01316380|2900828|P1|Overall Study|Withdrawal by Subject|1
879886|NCT01316380|2900826|P3|Overall Study|Protocol Violation|1
879887|NCT01316380|2900827|P2|Overall Study|Protocol Violation|0
879888|NCT01316380|2900828|P1|Overall Study|Protocol Violation|0
879889|NCT01316380|2900826|P3|Overall Study|Adverse Event|1
879890|NCT01316380|2900827|P2|Overall Study|Adverse Event|2
879891|NCT01316380|2900828|P1|Overall Study|Adverse Event|0
879892|NCT01316224|2900994|P1|Overall Study|Not Specified|1
879893|NCT01316224|2900994|P1|Overall Study|Adverse Event With Treatment Failure|1
879894|NCT01316224|2900994|P1|Overall Study|Withdrawal by Subject|1
879895|NCT01316224|2900994|P1|Overall Study|Lack of Efficacy|1
879896|NCT01316224|2900994|P1|Overall Study|Adverse Event|3
879897|NCT01316224|2900994|P1|Overall Study|Protocol Violation|3
879898|NCT01316055|2901011|P3|Overall Study|Lost to Follow-up|0
879899|NCT01316055|2901012|P2|Overall Study|Lost to Follow-up|0
879900|NCT01316055|2901013|P1|Overall Study|Lost to Follow-up|1
879901|NCT01315847|2901044|P2|Part III, Period 1|[11C]MK-4232 synthesis failure|1
879902|NCT01315847|2901045|P1|Part III, Period 1|[11C]MK-4232 synthesis failure|0
879903|NCT01315847|2901044|P2|Part I, Period 1|Reached maximum number of arterial lines|0
879904|NCT01315847|2901045|P1|Part I, Period 1|Reached maximum number of arterial lines|3
879905|NCT01315353|2901090|P3|Overall Study|Inadvertent randomization/assignment|2
879906|NCT01315353|2901091|P2|Overall Study|Inadvertent randomization/assignment|0
879907|NCT01315353|2901092|P1|Overall Study|Inadvertent randomization/assignment|0
879908|NCT01315353|2901090|P3|Overall Study|Taken off study by site in error|0
879909|NCT01315353|2901091|P2|Overall Study|Taken off study by site in error|1
879910|NCT01315353|2901092|P1|Overall Study|Taken off study by site in error|0
879911|NCT01315353|2901090|P3|Overall Study|Site closing|0
879912|NCT01315353|2901091|P2|Overall Study|Site closing|4
879913|NCT01315353|2901092|P1|Overall Study|Site closing|7
879914|NCT01315353|2901090|P3|Overall Study|Unwilling to adhere to requirements|4
879915|NCT01315353|2901091|P2|Overall Study|Unwilling to adhere to requirements|5
879916|NCT01315353|2901092|P1|Overall Study|Unwilling to adhere to requirements|5
879917|NCT01315353|2901090|P3|Overall Study|Lost to Follow-up|6
879918|NCT01315353|2901091|P2|Overall Study|Lost to Follow-up|6
879919|NCT01315353|2901092|P1|Overall Study|Lost to Follow-up|13
879920|NCT01315353|2901090|P3|Overall Study|Withdrawal by Subject|1
879921|NCT01315353|2901091|P2|Overall Study|Withdrawal by Subject|6
879922|NCT01315353|2901092|P1|Overall Study|Withdrawal by Subject|2
879923|NCT01315353|2901090|P3|Overall Study|Death|0
879924|NCT01315353|2901091|P2|Overall Study|Death|1
879925|NCT01315353|2901092|P1|Overall Study|Death|2
879926|NCT01315249|2901119|P2|Overall Study|Death|1
879927|NCT01315249|2901120|P1|Overall Study|Death|0
879928|NCT01315249|2901119|P2|Overall Study|Lost to Follow-up|2
879929|NCT01315249|2901120|P1|Overall Study|Lost to Follow-up|0
879930|NCT01315249|2901119|P2|Overall Study|Lack of Efficacy|1
879931|NCT01315249|2901120|P1|Overall Study|Lack of Efficacy|0
879932|NCT01315249|2901119|P2|Overall Study|inability to use device|0
879933|NCT01315249|2901120|P1|Overall Study|inability to use device|1
879934|NCT01315249|2901119|P2|Overall Study|Administrative problems|0
879935|NCT01315249|2901120|P1|Overall Study|Administrative problems|1
879936|NCT01315249|2901119|P2|Overall Study|Abnormal test results|2
879937|NCT01315249|2901120|P1|Overall Study|Abnormal test results|1
879938|NCT01315249|2901119|P2|Overall Study|Protocol Violation|5
879939|NCT01315249|2901120|P1|Overall Study|Protocol Violation|8
879940|NCT01315249|2901119|P2|Overall Study|Withdrawal by Subject|10
879941|NCT01315249|2901120|P1|Overall Study|Withdrawal by Subject|11
879942|NCT01315249|2901119|P2|Overall Study|Adverse Event|26
879943|NCT01315249|2901120|P1|Overall Study|Adverse Event|22
879944|NCT01315028|2901182|P2|Overall Study|Death|1
879945|NCT01315028|2901183|P1|Overall Study|Death|0
879946|NCT01315028|2901182|P2|Overall Study|Lost to Follow-up|0
879947|NCT01315028|2901183|P1|Overall Study|Lost to Follow-up|1
879948|NCT01314872|2901219|P15|Period 2|Lost to Follow-up|6
879949|NCT01314872|2901220|P14|Period 2|Lost to Follow-up|2
879950|NCT01314872|2901221|P13|Period 2|Lost to Follow-up|7
879951|NCT01314872|2901222|P12|Period 2|Lost to Follow-up|6
879952|NCT01314872|2901223|P11|Period 2|Lost to Follow-up|0
879953|NCT01314872|2901224|P10|Period 2|Lost to Follow-up|0
879954|NCT01314872|2901225|P9|Period 2|Lost to Follow-up|0
879955|NCT01314872|2901226|P8|Period 2|Lost to Follow-up|0
879956|NCT01314872|2901227|P7|Period 2|Lost to Follow-up|0
879957|NCT01314872|2901228|P6|Period 2|Lost to Follow-up|0
879958|NCT01314872|2901229|P5|Period 2|Lost to Follow-up|0
879959|NCT01314872|2901230|P4|Period 2|Lost to Follow-up|0
879960|NCT01314872|2901231|P3|Period 2|Lost to Follow-up|0
879961|NCT01314872|2901232|P2|Period 2|Lost to Follow-up|0
879962|NCT01314872|2901233|P1|Period 2|Lost to Follow-up|0
879963|NCT01314872|2901219|P15|Period 2|Withdrawal by Subject|4
879964|NCT01314872|2901220|P14|Period 2|Withdrawal by Subject|12
879965|NCT01314872|2901221|P13|Period 2|Withdrawal by Subject|17
879966|NCT01314872|2901222|P12|Period 2|Withdrawal by Subject|14
879967|NCT01314872|2901223|P11|Period 2|Withdrawal by Subject|0
879968|NCT01314872|2901224|P10|Period 2|Withdrawal by Subject|0
879969|NCT01314872|2901225|P9|Period 2|Withdrawal by Subject|0
879970|NCT01314872|2901226|P8|Period 2|Withdrawal by Subject|0
879971|NCT01314872|2901227|P7|Period 2|Withdrawal by Subject|0
879972|NCT01314872|2901228|P6|Period 2|Withdrawal by Subject|0
879973|NCT01314872|2901229|P5|Period 2|Withdrawal by Subject|0
879974|NCT01314872|2901230|P4|Period 2|Withdrawal by Subject|0
879975|NCT01314872|2901231|P3|Period 2|Withdrawal by Subject|0
879976|NCT01314872|2901232|P2|Period 2|Withdrawal by Subject|0
879977|NCT01314872|2901233|P1|Period 2|Withdrawal by Subject|0
879978|NCT01314872|2901219|P15|Period 2|Adverse event, non-fatal|9
879979|NCT01314872|2901220|P14|Period 2|Adverse event, non-fatal|24
879980|NCT01314872|2901221|P13|Period 2|Adverse event, non-fatal|16
879981|NCT01314872|2901222|P12|Period 2|Adverse event, non-fatal|13
879982|NCT01314872|2901223|P11|Period 2|Adverse event, non-fatal|0
879983|NCT01314872|2901224|P10|Period 2|Adverse event, non-fatal|0
879984|NCT01314872|2901225|P9|Period 2|Adverse event, non-fatal|0
879985|NCT01314872|2901226|P8|Period 2|Adverse event, non-fatal|0
879986|NCT01314872|2901227|P7|Period 2|Adverse event, non-fatal|0
879987|NCT01314872|2901228|P6|Period 2|Adverse event, non-fatal|0
879988|NCT01314872|2901229|P5|Period 2|Adverse event, non-fatal|0
879989|NCT01314872|2901230|P4|Period 2|Adverse event, non-fatal|0
879990|NCT01314872|2901231|P3|Period 2|Adverse event, non-fatal|0
879991|NCT01314872|2901232|P2|Period 2|Adverse event, non-fatal|0
879992|NCT01314872|2901233|P1|Period 2|Adverse event, non-fatal|0
879993|NCT01314872|2901219|P15|Period 2|Study terminated by Sponsor|0
879994|NCT01314872|2901220|P14|Period 2|Study terminated by Sponsor|3
879995|NCT01314872|2901221|P13|Period 2|Study terminated by Sponsor|2
879996|NCT01314872|2901222|P12|Period 2|Study terminated by Sponsor|2
879997|NCT01314872|2901223|P11|Period 2|Study terminated by Sponsor|0
879998|NCT01314872|2901224|P10|Period 2|Study terminated by Sponsor|0
879999|NCT01314872|2901225|P9|Period 2|Study terminated by Sponsor|0
880000|NCT01314872|2901226|P8|Period 2|Study terminated by Sponsor|0
880001|NCT01314872|2901227|P7|Period 2|Study terminated by Sponsor|0
880002|NCT01314872|2901228|P6|Period 2|Study terminated by Sponsor|0
880003|NCT01314872|2901229|P5|Period 2|Study terminated by Sponsor|0
880004|NCT01314872|2901230|P4|Period 2|Study terminated by Sponsor|0
880005|NCT01314872|2901231|P3|Period 2|Study terminated by Sponsor|0
880006|NCT01314872|2901232|P2|Period 2|Study terminated by Sponsor|0
880007|NCT01314872|2901233|P1|Period 2|Study terminated by Sponsor|0
880008|NCT01314872|2901219|P15|Period 2|Pregnancy|1
880009|NCT01314872|2901220|P14|Period 2|Pregnancy|0
880010|NCT01314872|2901221|P13|Period 2|Pregnancy|0
880011|NCT01314872|2901222|P12|Period 2|Pregnancy|0
880012|NCT01314872|2901223|P11|Period 2|Pregnancy|0
880013|NCT01314872|2901224|P10|Period 2|Pregnancy|0
880014|NCT01314872|2901225|P9|Period 2|Pregnancy|0
880015|NCT01314872|2901226|P8|Period 2|Pregnancy|0
880016|NCT01314872|2901227|P7|Period 2|Pregnancy|0
880017|NCT01314872|2901228|P6|Period 2|Pregnancy|0
880018|NCT01314872|2901229|P5|Period 2|Pregnancy|0
880019|NCT01314872|2901230|P4|Period 2|Pregnancy|0
880020|NCT01314872|2901231|P3|Period 2|Pregnancy|0
880021|NCT01314872|2901232|P2|Period 2|Pregnancy|0
880022|NCT01314872|2901233|P1|Period 2|Pregnancy|0
880023|NCT01314872|2901219|P15|Period 2|Lack of Efficacy|2
880024|NCT01314872|2901220|P14|Period 2|Lack of Efficacy|9
880025|NCT01314872|2901221|P13|Period 2|Lack of Efficacy|12
880026|NCT01314872|2901222|P12|Period 2|Lack of Efficacy|7
880027|NCT01314872|2901223|P11|Period 2|Lack of Efficacy|0
880028|NCT01314872|2901224|P10|Period 2|Lack of Efficacy|0
880029|NCT01314872|2901225|P9|Period 2|Lack of Efficacy|0
880030|NCT01314872|2901226|P8|Period 2|Lack of Efficacy|0
880031|NCT01314872|2901227|P7|Period 2|Lack of Efficacy|0
880032|NCT01314872|2901228|P6|Period 2|Lack of Efficacy|0
880033|NCT01314872|2901229|P5|Period 2|Lack of Efficacy|0
880034|NCT01314872|2901230|P4|Period 2|Lack of Efficacy|0
880035|NCT01314872|2901231|P3|Period 2|Lack of Efficacy|0
880036|NCT01314872|2901232|P2|Period 2|Lack of Efficacy|0
880037|NCT01314872|2901233|P1|Period 2|Lack of Efficacy|0
880038|NCT01314872|2901219|P15|Period 2|Non-compliance with study drug|2
880039|NCT01314872|2901220|P14|Period 2|Non-compliance with study drug|1
880040|NCT01314872|2901221|P13|Period 2|Non-compliance with study drug|3
880041|NCT01314872|2901222|P12|Period 2|Non-compliance with study drug|3
880042|NCT01314872|2901223|P11|Period 2|Non-compliance with study drug|0
880043|NCT01314872|2901224|P10|Period 2|Non-compliance with study drug|0
880044|NCT01314872|2901225|P9|Period 2|Non-compliance with study drug|0
880045|NCT01314872|2901226|P8|Period 2|Non-compliance with study drug|0
880046|NCT01314872|2901227|P7|Period 2|Non-compliance with study drug|0
880047|NCT01314872|2901228|P6|Period 2|Non-compliance with study drug|0
880048|NCT01314872|2901229|P5|Period 2|Non-compliance with study drug|0
880049|NCT01314872|2901230|P4|Period 2|Non-compliance with study drug|0
880050|NCT01314872|2901231|P3|Period 2|Non-compliance with study drug|0
880051|NCT01314872|2901232|P2|Period 2|Non-compliance with study drug|0
880052|NCT01314872|2901233|P1|Period 2|Non-compliance with study drug|0
880053|NCT01314872|2901219|P15|Period 2|Protocol Violation|0
880054|NCT01314872|2901220|P14|Period 2|Protocol Violation|2
880055|NCT01314872|2901221|P13|Period 2|Protocol Violation|3
880056|NCT01314872|2901222|P12|Period 2|Protocol Violation|3
880057|NCT01314872|2901223|P11|Period 2|Protocol Violation|0
880058|NCT01314872|2901224|P10|Period 2|Protocol Violation|0
880059|NCT01314872|2901225|P9|Period 2|Protocol Violation|0
880060|NCT01314872|2901226|P8|Period 2|Protocol Violation|0
880061|NCT01314872|2901227|P7|Period 2|Protocol Violation|0
880062|NCT01314872|2901228|P6|Period 2|Protocol Violation|0
880063|NCT01314872|2901229|P5|Period 2|Protocol Violation|0
880064|NCT01314872|2901230|P4|Period 2|Protocol Violation|0
880065|NCT01314872|2901231|P3|Period 2|Protocol Violation|0
880066|NCT01314872|2901232|P2|Period 2|Protocol Violation|0
880067|NCT01314872|2901233|P1|Period 2|Protocol Violation|0
880068|NCT01314872|2901219|P15|Treatment Period 1|Lost to Follow-up|0
880069|NCT01314872|2901220|P14|Treatment Period 1|Lost to Follow-up|0
880070|NCT01314872|2901221|P13|Treatment Period 1|Lost to Follow-up|0
880071|NCT01314872|2901222|P12|Treatment Period 1|Lost to Follow-up|0
880072|NCT01314872|2901223|P11|Treatment Period 1|Lost to Follow-up|0
880073|NCT01314872|2901224|P10|Treatment Period 1|Lost to Follow-up|0
880074|NCT01314872|2901225|P9|Treatment Period 1|Lost to Follow-up|1
880075|NCT01314872|2901226|P8|Treatment Period 1|Lost to Follow-up|1
880076|NCT01314872|2901227|P7|Treatment Period 1|Lost to Follow-up|1
880077|NCT01314872|2901228|P6|Treatment Period 1|Lost to Follow-up|1
880078|NCT01314872|2901229|P5|Treatment Period 1|Lost to Follow-up|1
880079|NCT01314872|2901230|P4|Treatment Period 1|Lost to Follow-up|2
880080|NCT01314872|2901231|P3|Treatment Period 1|Lost to Follow-up|2
880081|NCT01314872|2901232|P2|Treatment Period 1|Lost to Follow-up|1
880082|NCT01314872|2901233|P1|Treatment Period 1|Lost to Follow-up|0
880083|NCT01314872|2901219|P15|Treatment Period 1|Withdrawal by Subject|0
880084|NCT01314872|2901220|P14|Treatment Period 1|Withdrawal by Subject|0
880085|NCT01314872|2901221|P13|Treatment Period 1|Withdrawal by Subject|0
880086|NCT01314872|2901222|P12|Treatment Period 1|Withdrawal by Subject|0
880087|NCT01314872|2901223|P11|Treatment Period 1|Withdrawal by Subject|1
880088|NCT01314872|2901224|P10|Treatment Period 1|Withdrawal by Subject|2
880089|NCT01314872|2901225|P9|Treatment Period 1|Withdrawal by Subject|2
880090|NCT01314872|2901226|P8|Treatment Period 1|Withdrawal by Subject|2
880091|NCT01314872|2901227|P7|Treatment Period 1|Withdrawal by Subject|3
880092|NCT01314872|2901228|P6|Treatment Period 1|Withdrawal by Subject|1
880093|NCT01314872|2901229|P5|Treatment Period 1|Withdrawal by Subject|3
880094|NCT01314872|2901230|P4|Treatment Period 1|Withdrawal by Subject|2
880095|NCT01314872|2901231|P3|Treatment Period 1|Withdrawal by Subject|0
880096|NCT01314872|2901232|P2|Treatment Period 1|Withdrawal by Subject|1
880097|NCT01314872|2901233|P1|Treatment Period 1|Withdrawal by Subject|3
880098|NCT01314872|2901219|P15|Treatment Period 1|Adverse event, non-fatal|0
880099|NCT01314872|2901220|P14|Treatment Period 1|Adverse event, non-fatal|0
880100|NCT01314872|2901221|P13|Treatment Period 1|Adverse event, non-fatal|0
880101|NCT01314872|2901222|P12|Treatment Period 1|Adverse event, non-fatal|0
880102|NCT01314872|2901223|P11|Treatment Period 1|Adverse event, non-fatal|1
880103|NCT01314872|2901224|P10|Treatment Period 1|Adverse event, non-fatal|0
880104|NCT01314872|2901225|P9|Treatment Period 1|Adverse event, non-fatal|3
880105|NCT01314872|2901226|P8|Treatment Period 1|Adverse event, non-fatal|2
880106|NCT01314872|2901227|P7|Treatment Period 1|Adverse event, non-fatal|4
880107|NCT01314872|2901228|P6|Treatment Period 1|Adverse event, non-fatal|4
880108|NCT01314872|2901229|P5|Treatment Period 1|Adverse event, non-fatal|2
880109|NCT01314872|2901230|P4|Treatment Period 1|Adverse event, non-fatal|2
880110|NCT01314872|2901231|P3|Treatment Period 1|Adverse event, non-fatal|3
880111|NCT01314872|2901232|P2|Treatment Period 1|Adverse event, non-fatal|2
880112|NCT01314872|2901233|P1|Treatment Period 1|Adverse event, non-fatal|4
880113|NCT01314872|2901219|P15|Treatment Period 1|Lack of Efficacy|0
880114|NCT01314872|2901220|P14|Treatment Period 1|Lack of Efficacy|0
880115|NCT01314872|2901221|P13|Treatment Period 1|Lack of Efficacy|0
880116|NCT01314872|2901222|P12|Treatment Period 1|Lack of Efficacy|0
880117|NCT01314872|2901223|P11|Treatment Period 1|Lack of Efficacy|0
880118|NCT01314872|2901224|P10|Treatment Period 1|Lack of Efficacy|0
880119|NCT01314872|2901225|P9|Treatment Period 1|Lack of Efficacy|0
880120|NCT01314872|2901226|P8|Treatment Period 1|Lack of Efficacy|2
880121|NCT01314872|2901227|P7|Treatment Period 1|Lack of Efficacy|0
880122|NCT01314872|2901228|P6|Treatment Period 1|Lack of Efficacy|1
880123|NCT01314872|2901229|P5|Treatment Period 1|Lack of Efficacy|0
880124|NCT01314872|2901230|P4|Treatment Period 1|Lack of Efficacy|0
880125|NCT01314872|2901231|P3|Treatment Period 1|Lack of Efficacy|0
880126|NCT01314872|2901232|P2|Treatment Period 1|Lack of Efficacy|0
880127|NCT01314872|2901233|P1|Treatment Period 1|Lack of Efficacy|1
880128|NCT01314872|2901219|P15|Treatment Period 1|Physician Decision|0
880129|NCT01314872|2901220|P14|Treatment Period 1|Physician Decision|0
880130|NCT01314872|2901221|P13|Treatment Period 1|Physician Decision|0
880131|NCT01314872|2901222|P12|Treatment Period 1|Physician Decision|0
880132|NCT01314872|2901223|P11|Treatment Period 1|Physician Decision|0
880133|NCT01314872|2901224|P10|Treatment Period 1|Physician Decision|1
880134|NCT01314872|2901225|P9|Treatment Period 1|Physician Decision|0
880135|NCT01314872|2901226|P8|Treatment Period 1|Physician Decision|0
880136|NCT01314872|2901227|P7|Treatment Period 1|Physician Decision|0
880137|NCT01314872|2901228|P6|Treatment Period 1|Physician Decision|0
880138|NCT01314872|2901229|P5|Treatment Period 1|Physician Decision|0
880139|NCT01314872|2901230|P4|Treatment Period 1|Physician Decision|1
880140|NCT01314872|2901231|P3|Treatment Period 1|Physician Decision|0
880141|NCT01314872|2901232|P2|Treatment Period 1|Physician Decision|1
880142|NCT01314872|2901233|P1|Treatment Period 1|Physician Decision|0
880143|NCT01314872|2901219|P15|Treatment Period 1|Protocol Violation|0
880144|NCT01314872|2901220|P14|Treatment Period 1|Protocol Violation|0
880145|NCT01314872|2901221|P13|Treatment Period 1|Protocol Violation|0
880146|NCT01314872|2901222|P12|Treatment Period 1|Protocol Violation|0
880147|NCT01314872|2901223|P11|Treatment Period 1|Protocol Violation|1
880148|NCT01314872|2901224|P10|Treatment Period 1|Protocol Violation|1
880149|NCT01314872|2901225|P9|Treatment Period 1|Protocol Violation|0
880150|NCT01314872|2901226|P8|Treatment Period 1|Protocol Violation|0
880151|NCT01314872|2901227|P7|Treatment Period 1|Protocol Violation|0
880152|NCT01314872|2901228|P6|Treatment Period 1|Protocol Violation|0
880153|NCT01314872|2901229|P5|Treatment Period 1|Protocol Violation|1
880154|NCT01314872|2901230|P4|Treatment Period 1|Protocol Violation|0
880155|NCT01314872|2901231|P3|Treatment Period 1|Protocol Violation|1
880156|NCT01314872|2901232|P2|Treatment Period 1|Protocol Violation|1
880157|NCT01314872|2901233|P1|Treatment Period 1|Protocol Violation|2
880158|NCT01314716|2901337|P2|Open-Label Phase|Physician Decision|4
880159|NCT01314716|2901338|P1|Open-Label Phase|Physician Decision|5
880160|NCT01314716|2901337|P2|Open-Label Phase|Withdrawal by Subject|2
880161|NCT01314716|2901338|P1|Open-Label Phase|Withdrawal by Subject|1
880162|NCT01314716|2901337|P2|Open-Label Phase|Adverse Event|6
880163|NCT01314716|2901338|P1|Open-Label Phase|Adverse Event|4
880164|NCT01314716|2901337|P2|Double-Blind Phase|Physician Decision|1
880165|NCT01314716|2901338|P1|Double-Blind Phase|Physician Decision|0
880166|NCT01314716|2901337|P2|Double-Blind Phase|Sponsor request|2
880167|NCT01314716|2901338|P1|Double-Blind Phase|Sponsor request|1
880168|NCT01314716|2901337|P2|Double-Blind Phase|Lost to Follow-up|1
880169|NCT01314716|2901338|P1|Double-Blind Phase|Lost to Follow-up|0
880170|NCT01314716|2901337|P2|Double-Blind Phase|Withdrawal by Subject|6
880171|NCT01314716|2901338|P1|Double-Blind Phase|Withdrawal by Subject|5
880172|NCT01314716|2901337|P2|Double-Blind Phase|Adverse Event|4
880173|NCT01314716|2901338|P1|Double-Blind Phase|Adverse Event|10
880174|NCT01314716|2901337|P2|Double-Blind Phase|Randomized but not treated|1
880175|NCT01314716|2901338|P1|Double-Blind Phase|Randomized but not treated|1
880176|NCT01314703|2901350|P1|Overall Study|screen failure and closed enrollment|8
880177|NCT01314443|2901359|P4|Overall Study|Protocol Violation|1
880178|NCT01314443|2901360|P3|Overall Study|Protocol Violation|1
880179|NCT01314443|2901361|P2|Overall Study|Protocol Violation|2
880180|NCT01314443|2901362|P1|Overall Study|Protocol Violation|2
880181|NCT01314443|2901359|P4|Overall Study|Withdrawal by Subject|1
880182|NCT01314443|2901360|P3|Overall Study|Withdrawal by Subject|1
880183|NCT01314443|2901361|P2|Overall Study|Withdrawal by Subject|1
880184|NCT01314443|2901362|P1|Overall Study|Withdrawal by Subject|2
880185|NCT01314261|2901432|P4|Overall Study|Virologic Failure|1
880186|NCT01314261|2901433|P3|Overall Study|Virologic Failure|0
880187|NCT01314261|2901434|P2|Overall Study|Virologic Failure|1
880188|NCT01314261|2901435|P1|Overall Study|Virologic Failure|0
880189|NCT01314261|2901432|P4|Overall Study|Lost to Follow-up|2
880190|NCT01314261|2901433|P3|Overall Study|Lost to Follow-up|2
880191|NCT01314261|2901434|P2|Overall Study|Lost to Follow-up|0
880192|NCT01314261|2901435|P1|Overall Study|Lost to Follow-up|1
880193|NCT01314261|2901432|P4|Overall Study|Withdrawal by Subject|0
880194|NCT01314261|2901433|P3|Overall Study|Withdrawal by Subject|1
880195|NCT01314261|2901434|P2|Overall Study|Withdrawal by Subject|3
880196|NCT01314261|2901435|P1|Overall Study|Withdrawal by Subject|0
880197|NCT01314261|2901432|P4|Overall Study|Adverse Event|0
880198|NCT01314261|2901433|P3|Overall Study|Adverse Event|0
880199|NCT01314261|2901434|P2|Overall Study|Adverse Event|0
880200|NCT01314261|2901435|P1|Overall Study|Adverse Event|1
880201|NCT01314118|2901486|P1|Overall Study|Ongoing|62
880202|NCT01314118|2901486|P1|Overall Study|Other|2
880203|NCT01314118|2901486|P1|Overall Study|Withdrawal by Subject|11
880204|NCT01314118|2901486|P1|Overall Study|Protocol Violation|5
880205|NCT01314118|2901486|P1|Overall Study|Death|4
880206|NCT01314118|2901486|P1|Overall Study|Physician Decision|11
880207|NCT01314118|2901486|P1|Overall Study|Progressive disease|27
880208|NCT01314118|2901486|P1|Overall Study|Adverse Event|9
880209|NCT01314105|2901495|P2|Overall Study|Other Adverse Event|1
880210|NCT01314105|2901496|P1|Overall Study|Other Adverse Event|1
880211|NCT01314105|2901495|P2|Overall Study|Refused to continue taking medication|1
880212|NCT01314105|2901496|P1|Overall Study|Refused to continue taking medication|0
880213|NCT01314105|2901495|P2|Overall Study|Progressive Disease|10
880214|NCT01314105|2901496|P1|Overall Study|Progressive Disease|6
880215|NCT01313923|2901609|P1|Overall Study|Physician Decision|3
880216|NCT01313884|2901625|P1|Overall Study|Per insurance pvdr, pt can't be on cl tr|1
880217|NCT01313858|2901633|P3|Overall Study|Lost to Follow-up|47
880218|NCT01313858|2901634|P2|Overall Study|Lost to Follow-up|51
880219|NCT01313858|2901635|P1|Overall Study|Lost to Follow-up|35
880220|NCT01313858|2901633|P3|Overall Study|Premature Treatment Termination|191
880221|NCT01313858|2901634|P2|Overall Study|Premature Treatment Termination|219
880222|NCT01313858|2901635|P1|Overall Study|Premature Treatment Termination|251
880223|NCT01313780|2901658|P2|Overall Study|missing data|3
880224|NCT01313780|2901659|P1|Overall Study|missing data|3
880225|NCT01313780|2901658|P2|Overall Study|Protocol Violation|4
880226|NCT01313780|2901659|P1|Overall Study|Protocol Violation|10
880227|NCT01313780|2901658|P2|Overall Study|Withdrawal by Subject|8
880228|NCT01313780|2901659|P1|Overall Study|Withdrawal by Subject|2
880229|NCT01313780|2901658|P2|Overall Study|Adverse Event|11
880230|NCT01313780|2901659|P1|Overall Study|Adverse Event|6
880231|NCT01313780|2901658|P2|Overall Study|Lack of Efficacy|2
880232|NCT01313780|2901659|P1|Overall Study|Lack of Efficacy|4
880233|NCT01313728|2901667|P1|Informed Consent to Baseline|Withdrawal by Subject|1
880234|NCT01313689|2901687|P5|24-Week Randomization 2|Physician Decision|4
880235|NCT01313689|2901688|P4|24-Week Randomization 2|Physician Decision|0
880236|NCT01313689|2901689|P3|24-Week Randomization 2|Physician Decision|0
880237|NCT01313689|2901690|P2|24-Week Randomization 2|Physician Decision|0
880238|NCT01313689|2901691|P1|24-Week Randomization 2|Physician Decision|0
880239|NCT01313689|2901687|P5|24-Week Randomization 2|Withdrawal by Subject|3
880240|NCT01313689|2901688|P4|24-Week Randomization 2|Withdrawal by Subject|1
880241|NCT01313689|2901689|P3|24-Week Randomization 2|Withdrawal by Subject|1
880242|NCT01313689|2901690|P2|24-Week Randomization 2|Withdrawal by Subject|0
880243|NCT01313689|2901691|P1|24-Week Randomization 2|Withdrawal by Subject|0
880244|NCT01313689|2901687|P5|24-Week Randomization 2|Adverse Event|8
880245|NCT01313689|2901688|P4|24-Week Randomization 2|Adverse Event|0
880246|NCT01313689|2901689|P3|24-Week Randomization 2|Adverse Event|2
880247|NCT01313689|2901690|P2|24-Week Randomization 2|Adverse Event|0
880248|NCT01313689|2901691|P1|24-Week Randomization 2|Adverse Event|0
880249|NCT01313689|2901687|P5|24-Week Randomization 1|Withdrawal by Subject|0
880250|NCT01313689|2901688|P4|24-Week Randomization 1|Withdrawal by Subject|0
880251|NCT01313689|2901689|P3|24-Week Randomization 1|Withdrawal by Subject|0
880252|NCT01313689|2901690|P2|24-Week Randomization 1|Withdrawal by Subject|0
880253|NCT01313689|2901691|P1|24-Week Randomization 1|Withdrawal by Subject|5
880254|NCT01313689|2901687|P5|24-Week Randomization 1|Physician Decision|0
880255|NCT01313689|2901688|P4|24-Week Randomization 1|Physician Decision|0
880256|NCT01313689|2901689|P3|24-Week Randomization 1|Physician Decision|0
880257|NCT01313689|2901690|P2|24-Week Randomization 1|Physician Decision|5
880258|NCT01313689|2901691|P1|24-Week Randomization 1|Physician Decision|4
880259|NCT01313689|2901687|P5|24-Week Randomization 1|Adverse Event|0
880260|NCT01313689|2901688|P4|24-Week Randomization 1|Adverse Event|0
880261|NCT01313689|2901689|P3|24-Week Randomization 1|Adverse Event|0
880262|NCT01313689|2901690|P2|24-Week Randomization 1|Adverse Event|5
880263|NCT01313689|2901691|P1|24-Week Randomization 1|Adverse Event|10
880264|NCT01313676|2901770|P4|Overall Study|Missing|0
880265|NCT01313676|2901771|P3|Overall Study|Missing|1
880266|NCT01313676|2901772|P2|Overall Study|Missing|1
880267|NCT01313676|2901773|P1|Overall Study|Missing|1
880268|NCT01313676|2901770|P4|Overall Study|Investigator Site Closed|10
880269|NCT01313676|2901771|P3|Overall Study|Investigator Site Closed|15
880270|NCT01313676|2901772|P2|Overall Study|Investigator Site Closed|11
880271|NCT01313676|2901773|P1|Overall Study|Investigator Site Closed|12
880272|NCT01313676|2901770|P4|Overall Study|Sponsor Terminated Study Treatment|1
880273|NCT01313676|2901771|P3|Overall Study|Sponsor Terminated Study Treatment|0
880274|NCT01313676|2901772|P2|Overall Study|Sponsor Terminated Study Treatment|1
880275|NCT01313676|2901773|P1|Overall Study|Sponsor Terminated Study Treatment|1
880276|NCT01313676|2901770|P4|Overall Study|Decision by Participant or Proxy|492
880277|NCT01313676|2901771|P3|Overall Study|Decision by Participant or Proxy|515
880278|NCT01313676|2901772|P2|Overall Study|Decision by Participant or Proxy|527
880279|NCT01313676|2901773|P1|Overall Study|Decision by Participant or Proxy|643
880280|NCT01313676|2901770|P4|Overall Study|Physician Decision|48
880281|NCT01313676|2901771|P3|Overall Study|Physician Decision|62
880282|NCT01313676|2901772|P2|Overall Study|Physician Decision|64
880283|NCT01313676|2901773|P1|Overall Study|Physician Decision|53
880284|NCT01313676|2901770|P4|Overall Study|Lost to Follow-up|0
880285|NCT01313676|2901771|P3|Overall Study|Lost to Follow-up|1
880286|NCT01313676|2901772|P2|Overall Study|Lost to Follow-up|0
880287|NCT01313676|2901773|P1|Overall Study|Lost to Follow-up|0
880288|NCT01313676|2901770|P4|Overall Study|Study Closed/terminated|9
880289|NCT01313676|2901771|P3|Overall Study|Study Closed/terminated|9
880290|NCT01313676|2901772|P2|Overall Study|Study Closed/terminated|6
880291|NCT01313676|2901773|P1|Overall Study|Study Closed/terminated|7
880292|NCT01313676|2901770|P4|Overall Study|Met Protocol-Defined Stopping Critera|11
880293|NCT01313676|2901771|P3|Overall Study|Met Protocol-Defined Stopping Critera|2
880294|NCT01313676|2901772|P2|Overall Study|Met Protocol-Defined Stopping Critera|4
880295|NCT01313676|2901773|P1|Overall Study|Met Protocol-Defined Stopping Critera|3
880296|NCT01313676|2901770|P4|Overall Study|Protocol Violation|44
880297|NCT01313676|2901771|P3|Overall Study|Protocol Violation|46
880298|NCT01313676|2901772|P2|Overall Study|Protocol Violation|44
880299|NCT01313676|2901773|P1|Overall Study|Protocol Violation|37
880300|NCT01313676|2901770|P4|Overall Study|Lack of Efficacy|46
880301|NCT01313676|2901771|P3|Overall Study|Lack of Efficacy|65
880302|NCT01313676|2901772|P2|Overall Study|Lack of Efficacy|90
880303|NCT01313676|2901773|P1|Overall Study|Lack of Efficacy|98
880304|NCT01313676|2901770|P4|Overall Study|Adverse Event|333
880305|NCT01313676|2901771|P3|Overall Study|Adverse Event|372
880306|NCT01313676|2901772|P2|Overall Study|Adverse Event|365
880307|NCT01313676|2901773|P1|Overall Study|Adverse Event|395
880308|NCT01313663|2901793|P2|Overall Study|Withdrawal by Subject|1
880309|NCT01313663|2901794|P1|Overall Study|Withdrawal by Subject|2
880310|NCT01313663|2901793|P2|Overall Study|Physician Decision|2
880311|NCT01313663|2901794|P1|Overall Study|Physician Decision|0
880312|NCT01313663|2901793|P2|Overall Study|Lost to Follow-up|1
880313|NCT01313663|2901794|P1|Overall Study|Lost to Follow-up|0
880314|NCT01313663|2901793|P2|Overall Study|Study Closed/Terminated|4
880315|NCT01313663|2901794|P1|Overall Study|Study Closed/Terminated|2
880316|NCT01313650|2901832|P4|Overall Study|Met Protocol-defined Stopping Criteria|15
880317|NCT01313650|2901833|P3|Overall Study|Met Protocol-defined Stopping Criteria|24
880318|NCT01313650|2901834|P2|Overall Study|Met Protocol-defined Stopping Criteria|13
880319|NCT01313650|2901835|P1|Overall Study|Met Protocol-defined Stopping Criteria|9
880320|NCT01313650|2901832|P4|Overall Study|Protocol Violation|6
880321|NCT01313650|2901833|P3|Overall Study|Protocol Violation|5
880322|NCT01313650|2901834|P2|Overall Study|Protocol Violation|7
880323|NCT01313650|2901835|P1|Overall Study|Protocol Violation|4
880324|NCT01313650|2901832|P4|Overall Study|Withdrawal by Subject|15
880325|NCT01313650|2901833|P3|Overall Study|Withdrawal by Subject|15
880326|NCT01313650|2901834|P2|Overall Study|Withdrawal by Subject|20
880327|NCT01313650|2901835|P1|Overall Study|Withdrawal by Subject|16
880328|NCT01313650|2901832|P4|Overall Study|Lost to Follow-up|2
880329|NCT01313650|2901833|P3|Overall Study|Lost to Follow-up|3
880330|NCT01313650|2901834|P2|Overall Study|Lost to Follow-up|0
880331|NCT01313650|2901835|P1|Overall Study|Lost to Follow-up|1
880332|NCT01313650|2901832|P4|Overall Study|Lack of Efficacy|20
880333|NCT01313650|2901833|P3|Overall Study|Lack of Efficacy|32
880334|NCT01313650|2901834|P2|Overall Study|Lack of Efficacy|20
880335|NCT01313650|2901835|P1|Overall Study|Lack of Efficacy|37
880336|NCT01313650|2901832|P4|Overall Study|Adverse Event|23
880337|NCT01313650|2901833|P3|Overall Study|Adverse Event|24
880338|NCT01313650|2901834|P2|Overall Study|Adverse Event|34
880339|NCT01313650|2901835|P1|Overall Study|Adverse Event|9
880340|NCT01313637|2901861|P4|Overall Study|Withdrawal by Subject|15
880341|NCT01313637|2901862|P3|Overall Study|Withdrawal by Subject|18
880342|NCT01313637|2901863|P2|Overall Study|Withdrawal by Subject|13
880343|NCT01313637|2901864|P1|Overall Study|Withdrawal by Subject|11
880344|NCT01313637|2901861|P4|Overall Study|Lost to Follow-up|3
880345|NCT01313637|2901862|P3|Overall Study|Lost to Follow-up|1
880346|NCT01313637|2901863|P2|Overall Study|Lost to Follow-up|2
880347|NCT01313637|2901864|P1|Overall Study|Lost to Follow-up|0
880435|NCT01313221|2902091|P2|Overall Study|Lost to Follow-up|3
880348|NCT01313637|2901861|P4|Overall Study|Met Protocol- Defined Stopping Criteria|13
880349|NCT01313637|2901862|P3|Overall Study|Met Protocol- Defined Stopping Criteria|14
880350|NCT01313637|2901863|P2|Overall Study|Met Protocol- Defined Stopping Criteria|15
880351|NCT01313637|2901864|P1|Overall Study|Met Protocol- Defined Stopping Criteria|16
880352|NCT01313637|2901861|P4|Overall Study|Protocol Violation|5
880353|NCT01313637|2901862|P3|Overall Study|Protocol Violation|11
880354|NCT01313637|2901863|P2|Overall Study|Protocol Violation|3
880355|NCT01313637|2901864|P1|Overall Study|Protocol Violation|4
880356|NCT01313637|2901861|P4|Overall Study|Lack of Efficacy|24
880357|NCT01313637|2901862|P3|Overall Study|Lack of Efficacy|37
880358|NCT01313637|2901863|P2|Overall Study|Lack of Efficacy|38
880359|NCT01313637|2901864|P1|Overall Study|Lack of Efficacy|44
880360|NCT01313637|2901861|P4|Overall Study|Adverse Event|18
880361|NCT01313637|2901862|P3|Overall Study|Adverse Event|25
880362|NCT01313637|2901863|P2|Overall Study|Adverse Event|24
880363|NCT01313637|2901864|P1|Overall Study|Adverse Event|17
880364|NCT01313624|2901888|P2|Open-Label Phase|Lost to Follow-up|1
880365|NCT01313624|2901889|P1|Open-Label Phase|Lost to Follow-up|1
880366|NCT01313624|2901888|P2|Open-Label Phase|Withdrawal by Subject|2
880367|NCT01313624|2901889|P1|Open-Label Phase|Withdrawal by Subject|2
880368|NCT01313624|2901888|P2|Open-Label Phase|Adverse Event|10
880369|NCT01313624|2901889|P1|Open-Label Phase|Adverse Event|1
880370|NCT01313624|2901888|P2|Double-Blind Phase|Lack of Efficacy|0
880371|NCT01313624|2901889|P1|Double-Blind Phase|Lack of Efficacy|1
880372|NCT01313624|2901888|P2|Double-Blind Phase|Physician Decision|0
880373|NCT01313624|2901889|P1|Double-Blind Phase|Physician Decision|1
880374|NCT01313624|2901888|P2|Double-Blind Phase|Lost to Follow-up|2
880375|NCT01313624|2901889|P1|Double-Blind Phase|Lost to Follow-up|0
880376|NCT01313624|2901888|P2|Double-Blind Phase|Withdrawal by Subject|4
880377|NCT01313624|2901889|P1|Double-Blind Phase|Withdrawal by Subject|9
880378|NCT01313624|2901888|P2|Double-Blind Phase|Adverse Event|4
880379|NCT01313624|2901889|P1|Double-Blind Phase|Adverse Event|27
880380|NCT01313559|2901903|P2|Overall Study|Rising PSA|0
880381|NCT01313559|2901904|P1|Overall Study|Rising PSA|2
880382|NCT01313559|2901903|P2|Overall Study|Disease progression|0
880383|NCT01313559|2901904|P1|Overall Study|Disease progression|1
880384|NCT01313559|2901903|P2|Overall Study|Withdrawal by Subject|2
880385|NCT01313559|2901904|P1|Overall Study|Withdrawal by Subject|1
880386|NCT01313312|2902000|P1|Overall Study|Did Not Receive Treatment with Dysport®|4
880387|NCT01313312|2902000|P1|Overall Study|Subject Withdrawn Early in Error|4
880388|NCT01313312|2902000|P1|Overall Study|Observational Phase|1
880389|NCT01313312|2902000|P1|Overall Study|Investigator Decision|1
880390|NCT01313312|2902000|P1|Overall Study|Lack of Efficacy|3
880391|NCT01313312|2902000|P1|Overall Study|Withdrawal by Subject|18
880392|NCT01313312|2902000|P1|Overall Study|Adverse Event|5
880393|NCT01313299|2902047|P3|Overall Study|Lack of subject compliance|1
880394|NCT01313299|2902048|P2|Overall Study|Lack of subject compliance|0
880395|NCT01313299|2902049|P1|Overall Study|Lack of subject compliance|0
880396|NCT01313299|2902047|P3|Overall Study|Family reason and moved out of state|0
880397|NCT01313299|2902048|P2|Overall Study|Family reason and moved out of state|2
880398|NCT01313299|2902049|P1|Overall Study|Family reason and moved out of state|0
880399|NCT01313299|2902047|P3|Overall Study|Withdrawal by Subject|2
880400|NCT01313299|2902048|P2|Overall Study|Withdrawal by Subject|0
880401|NCT01313299|2902049|P1|Overall Study|Withdrawal by Subject|1
880402|NCT01313299|2902047|P3|Overall Study|Protocol Violation|0
880403|NCT01313299|2902048|P2|Overall Study|Protocol Violation|0
880404|NCT01313299|2902049|P1|Overall Study|Protocol Violation|2
880405|NCT01313299|2902047|P3|Overall Study|Lost to Follow-up|0
880406|NCT01313299|2902048|P2|Overall Study|Lost to Follow-up|0
880407|NCT01313299|2902049|P1|Overall Study|Lost to Follow-up|1
880408|NCT01313299|2902047|P3|Overall Study|Adverse Event|1
880409|NCT01313299|2902048|P2|Overall Study|Adverse Event|1
880410|NCT01313299|2902049|P1|Overall Study|Adverse Event|3
880411|NCT01313286|2902063|P2|Period 1|Withdrawal by Subject|0
880412|NCT01313286|2902064|P1|Period 1|Withdrawal by Subject|2
880413|NCT01313273|2902074|P2|Overall Study|Screening Chromogranin A-in normal range|1
880414|NCT01313273|2902075|P1|Overall Study|Screening Chromogranin A-in normal range|0
880415|NCT01313273|2902074|P2|Overall Study|Withdrawal by Subject|0
880416|NCT01313273|2902075|P1|Overall Study|Withdrawal by Subject|1
880417|NCT01313273|2902074|P2|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0
880418|NCT01313273|2902075|P1|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1
880419|NCT01313221|2902090|P3|Overall Study|Pregnancy|2
880420|NCT01313221|2902091|P2|Overall Study|Pregnancy|0
880421|NCT01313221|2902092|P1|Overall Study|Pregnancy|0
880422|NCT01313221|2902090|P3|Overall Study|Physician Decision|2
880423|NCT01313221|2902091|P2|Overall Study|Physician Decision|0
880424|NCT01313221|2902092|P1|Overall Study|Physician Decision|0
880425|NCT01313221|2902090|P3|Overall Study|Disease progression|2
880426|NCT01313221|2902091|P2|Overall Study|Disease progression|0
880427|NCT01313221|2902092|P1|Overall Study|Disease progression|0
880428|NCT01313221|2902090|P3|Overall Study|Adverse Event|7
880429|NCT01313221|2902091|P2|Overall Study|Adverse Event|0
880430|NCT01313221|2902092|P1|Overall Study|Adverse Event|0
880431|NCT01313221|2902090|P3|Overall Study|Other|0
880432|NCT01313221|2902091|P2|Overall Study|Other|0
880433|NCT01313221|2902092|P1|Overall Study|Other|1
880434|NCT01313221|2902090|P3|Overall Study|Lost to Follow-up|1
880436|NCT01313221|2902092|P1|Overall Study|Lost to Follow-up|6
880437|NCT01313221|2902090|P3|Overall Study|Requirement for alternative therapy|1
880438|NCT01313221|2902091|P2|Overall Study|Requirement for alternative therapy|1
880439|NCT01313221|2902092|P1|Overall Study|Requirement for alternative therapy|0
880440|NCT01313221|2902090|P3|Overall Study|Withdrawal by Subject|5
880441|NCT01313221|2902091|P2|Overall Study|Withdrawal by Subject|3
880442|NCT01313221|2902092|P1|Overall Study|Withdrawal by Subject|2
880443|NCT01313221|2902090|P3|Overall Study|Non-compliance|2
880444|NCT01313221|2902091|P2|Overall Study|Non-compliance|0
880445|NCT01313221|2902092|P1|Overall Study|Non-compliance|3
880446|NCT01313221|2902090|P3|Overall Study|Protocol Violation|1
880447|NCT01313221|2902091|P2|Overall Study|Protocol Violation|1
880448|NCT01313221|2902092|P1|Overall Study|Protocol Violation|0
880449|NCT01313208|2902144|P2|Open-label Phase (Weeks 13 - 24)|Other|0
880450|NCT01313208|2902145|P1|Open-label Phase (Weeks 13 - 24)|Other|2
880451|NCT01313208|2902144|P2|Open-label Phase (Weeks 13 - 24)|Adverse Event|0
880452|NCT01313208|2902145|P1|Open-label Phase (Weeks 13 - 24)|Adverse Event|1
880453|NCT01313208|2902144|P2|Open-label Phase (Weeks 13 - 24)|Noncompliance|2
880454|NCT01313208|2902145|P1|Open-label Phase (Weeks 13 - 24)|Noncompliance|0
880455|NCT01313208|2902144|P2|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1
880456|NCT01313208|2902145|P1|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3
880457|NCT01313208|2902144|P2|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0
880458|NCT01313208|2902145|P1|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1
880459|NCT01313208|2902144|P2|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0
880460|NCT01313208|2902145|P1|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1
880461|NCT01313208|2902144|P2|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1
880462|NCT01313208|2902145|P1|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0
880463|NCT01313208|2902144|P2|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2
880464|NCT01313208|2902145|P1|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1
880465|NCT01313208|2902144|P2|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2
880466|NCT01313208|2902145|P1|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3
880467|NCT01313182|2902235|P2|Overall Study|Protocol Violation|92
880468|NCT01313182|2902236|P1|Overall Study|Protocol Violation|66
880469|NCT01313117|2902242|P1|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
880470|NCT01313117|2902242|P1|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
880471|NCT01313078|2902249|P1|Overall Study|Withdrawal by Subject|1
880472|NCT01313078|2902249|P1|Overall Study|Discontinued study drug|1
880473|NCT01313078|2902249|P1|Overall Study|Death|1
880474|NCT01313039|2902254|P1|Overall Study|Adverse Event|1
880475|NCT01313039|2902254|P1|Overall Study|Physician Decision|1
880476|NCT01312961|2902260|P2|Overall Study|Other than specified above|3
880477|NCT01312961|2902261|P1|Overall Study|Other than specified above|2
880478|NCT01312961|2902260|P2|Overall Study|Poor compliance to protocol|0
880479|NCT01312961|2902261|P1|Overall Study|Poor compliance to protocol|1
880480|NCT01312961|2902260|P2|Overall Study|Lack of Efficacy|1
880481|NCT01312961|2902261|P1|Overall Study|Lack of Efficacy|11
880482|NCT01312961|2902260|P2|Overall Study|Adverse Event|3
880483|NCT01312961|2902261|P1|Overall Study|Adverse Event|3
880484|NCT01312909|2902297|P3|Overall Study|Entrance criteria not met|2
880485|NCT01312909|2902298|P2|Overall Study|Entrance criteria not met|0
880486|NCT01312909|2902299|P1|Overall Study|Entrance criteria not met|0
880487|NCT01312909|2902297|P3|Overall Study|Insufficient clinical response|1
880488|NCT01312909|2902298|P2|Overall Study|Insufficient clinical response|0
880489|NCT01312909|2902299|P1|Overall Study|Insufficient clinical response|0
880490|NCT01312909|2902297|P3|Overall Study|Lost to Follow-up|20
880491|NCT01312909|2902298|P2|Overall Study|Lost to Follow-up|17
880492|NCT01312909|2902299|P1|Overall Study|Lost to Follow-up|21
880493|NCT01312909|2902297|P3|Overall Study|Withdrawal by Subject|7
880494|NCT01312909|2902298|P2|Overall Study|Withdrawal by Subject|10
880495|NCT01312909|2902299|P1|Overall Study|Withdrawal by Subject|8
880496|NCT01312909|2902297|P3|Overall Study|Other|11
880497|NCT01312909|2902298|P2|Overall Study|Other|6
880498|NCT01312909|2902299|P1|Overall Study|Other|9
880499|NCT01312909|2902297|P3|Overall Study|Protocol Violation|2
880500|NCT01312909|2902298|P2|Overall Study|Protocol Violation|0
880501|NCT01312909|2902299|P1|Overall Study|Protocol Violation|2
880502|NCT01312909|2902297|P3|Overall Study|Adverse Event|3
880503|NCT01312909|2902298|P2|Overall Study|Adverse Event|0
880504|NCT01312909|2902299|P1|Overall Study|Adverse Event|1
880505|NCT01312909|2902297|P3|Overall Study|Randomized but not treated|1
880506|NCT01312909|2902298|P2|Overall Study|Randomized but not treated|3
880507|NCT01312909|2902299|P1|Overall Study|Randomized but not treated|1
880508|NCT01312467|2902439|P1|Overall Study|Ineligible|4
880509|NCT01312467|2902439|P1|Overall Study|Another medical condition|1
880510|NCT01312467|2902439|P1|Overall Study|Deported to country of origin|1
880511|NCT01312467|2902439|P1|Overall Study|Withdrawal by Subject|2
880512|NCT01312467|2902439|P1|Overall Study|Lost to Follow-up|1
880513|NCT01312467|2902439|P1|Overall Study|Adverse Event|4
880514|NCT01312428|2902448|P2|Overall Study|Study Termination|4
880515|NCT01312428|2902449|P1|Overall Study|Study Termination|3
880516|NCT01312129|2902494|P2|Second Intervention (24 Hours)|Lost to Follow-up|1
880517|NCT01312129|2902495|P1|Second Intervention (24 Hours)|Lost to Follow-up|0
880518|NCT01311661|2902580|P1|Overall Study|Withdrawal by Subject|2
880519|NCT01311661|2902580|P1|Overall Study|Protocol Violation|3
880520|NCT01311661|2902580|P1|Overall Study|Adverse Event|2
880521|NCT01311557|2902724|P2|Overall Study|Withdrawal by Subject|2
880522|NCT01311557|2902725|P1|Overall Study|Withdrawal by Subject|1
880523|NCT01311557|2902724|P2|Overall Study|Lost to Follow-up|1
880524|NCT01311557|2902725|P1|Overall Study|Lost to Follow-up|0
880525|NCT01311557|2902724|P2|Overall Study|Protocol Violation|2
880526|NCT01311557|2902725|P1|Overall Study|Protocol Violation|4
880527|NCT01311557|2902724|P2|Overall Study|Serious adverse event|1
880528|NCT01311557|2902725|P1|Overall Study|Serious adverse event|0
880529|NCT01311505|2902741|P2|First Intervention Period|Protocol Violation|1
880530|NCT01311505|2902742|P1|First Intervention Period|Protocol Violation|0
880531|NCT01311024|2902798|P2|Overall Study|Protocol Violation|22
880532|NCT01311024|2902799|P1|Overall Study|Protocol Violation|35
880533|NCT01310868|2902805|P1|Overall Study|Do not have histologically confirmed GBM|13
880534|NCT01310803|2902822|P2|Overall Study|Subject terminated by Sponsor|0
880535|NCT01310803|2902823|P1|Overall Study|Subject terminated by Sponsor|1
880536|NCT01310777|2902834|P3|Overall Study|Other|2
880537|NCT01310777|2902835|P2|Overall Study|Other|1
880538|NCT01310777|2902836|P1|Overall Study|Other|4
880539|NCT01310777|2902834|P3|Overall Study|Inadequate Control of IOP|10
880540|NCT01310777|2902835|P2|Overall Study|Inadequate Control of IOP|7
880541|NCT01310777|2902836|P1|Overall Study|Inadequate Control of IOP|5
880542|NCT01310777|2902834|P3|Overall Study|Patient's Decision Unrelated to AE|2
880543|NCT01310777|2902835|P2|Overall Study|Patient's Decision Unrelated to AE|1
880544|NCT01310777|2902836|P1|Overall Study|Patient's Decision Unrelated to AE|1
880545|NCT01310777|2902834|P3|Overall Study|Lost to Follow-up|1
880546|NCT01310777|2902835|P2|Overall Study|Lost to Follow-up|4
880547|NCT01310777|2902836|P1|Overall Study|Lost to Follow-up|0
880548|NCT01310777|2902834|P3|Overall Study|Adverse Event|15
880549|NCT01310777|2902835|P2|Overall Study|Adverse Event|1
880550|NCT01310777|2902836|P1|Overall Study|Adverse Event|23
880551|NCT01310699|2902846|P2|Overall Study|Patients did not complete tandem.|6
880552|NCT01310699|2902847|P1|Overall Study|Patients did not complete tandem.|4
880553|NCT01310413|2902874|P7|From Day U0 to Day U385|Lost to Follow-up|2
880554|NCT01310413|2902875|P6|From Day U0 to Day U385|Lost to Follow-up|0
880555|NCT01310413|2902876|P5|From Day U0 to Day U385|Lost to Follow-up|0
880556|NCT01310413|2902877|P4|From Day U0 to Day U385|Lost to Follow-up|0
880557|NCT01310413|2902878|P3|From Day U0 to Day U385|Lost to Follow-up|0
880558|NCT01310413|2902879|P2|From Day U0 to Day U385|Lost to Follow-up|0
880559|NCT01310413|2902880|P1|From Day U0 to Day U385|Lost to Follow-up|0
880560|NCT01310413|2902874|P7|From Day U0 to Day U385|Withdrawal by Subject|1
880561|NCT01310413|2902875|P6|From Day U0 to Day U385|Withdrawal by Subject|0
880562|NCT01310413|2902876|P5|From Day U0 to Day U385|Withdrawal by Subject|0
880563|NCT01310413|2902877|P4|From Day U0 to Day U385|Withdrawal by Subject|0
880564|NCT01310413|2902878|P3|From Day U0 to Day U385|Withdrawal by Subject|0
880565|NCT01310413|2902879|P2|From Day U0 to Day U385|Withdrawal by Subject|0
880566|NCT01310413|2902880|P1|From Day U0 to Day U385|Withdrawal by Subject|0
880567|NCT01310413|2902874|P7|Day 0 to Day 385|Other|0
880568|NCT01310413|2902875|P6|Day 0 to Day 385|Other|0
880569|NCT01310413|2902876|P5|Day 0 to Day 385|Other|0
880570|NCT01310413|2902877|P4|Day 0 to Day 385|Other|0
880571|NCT01310413|2902878|P3|Day 0 to Day 385|Other|3
880572|NCT01310413|2902879|P2|Day 0 to Day 385|Other|0
880573|NCT01310413|2902880|P1|Day 0 to Day 385|Other|1
880574|NCT01310413|2902874|P7|Day 0 to Day 385|Migrated/moved from study area|0
880575|NCT01310413|2902875|P6|Day 0 to Day 385|Migrated/moved from study area|0
880576|NCT01310413|2902876|P5|Day 0 to Day 385|Migrated/moved from study area|1
880577|NCT01310413|2902877|P4|Day 0 to Day 385|Migrated/moved from study area|1
880578|NCT01310413|2902878|P3|Day 0 to Day 385|Migrated/moved from study area|1
880579|NCT01310413|2902879|P2|Day 0 to Day 385|Migrated/moved from study area|3
880580|NCT01310413|2902880|P1|Day 0 to Day 385|Migrated/moved from study area|3
880581|NCT01310413|2902874|P7|Day 0 to Day 385|Lost to Follow-up|0
880582|NCT01310413|2902875|P6|Day 0 to Day 385|Lost to Follow-up|2
880583|NCT01310413|2902876|P5|Day 0 to Day 385|Lost to Follow-up|1
880584|NCT01310413|2902877|P4|Day 0 to Day 385|Lost to Follow-up|5
880585|NCT01310413|2902878|P3|Day 0 to Day 385|Lost to Follow-up|3
880586|NCT01310413|2902879|P2|Day 0 to Day 385|Lost to Follow-up|3
880587|NCT01310413|2902880|P1|Day 0 to Day 385|Lost to Follow-up|18
880588|NCT01310413|2902874|P7|Day 0 to Day 385|Withdrawal by Subject|0
880589|NCT01310413|2902875|P6|Day 0 to Day 385|Withdrawal by Subject|1
880590|NCT01310413|2902876|P5|Day 0 to Day 385|Withdrawal by Subject|1
880591|NCT01310413|2902877|P4|Day 0 to Day 385|Withdrawal by Subject|2
880592|NCT01310413|2902878|P3|Day 0 to Day 385|Withdrawal by Subject|0
880593|NCT01310413|2902879|P2|Day 0 to Day 385|Withdrawal by Subject|2
880594|NCT01310413|2902880|P1|Day 0 to Day 385|Withdrawal by Subject|5
880595|NCT01310127|2903062|P2|Overall Study|advanced psc cataract outlier|0
880596|NCT01310127|2903063|P1|Overall Study|advanced psc cataract outlier|1
880597|NCT01310127|2903062|P2|Overall Study|Protocol Violation|1
880598|NCT01310127|2903063|P1|Overall Study|Protocol Violation|1
880599|NCT01310036|2903075|P1|Overall Study|Adverse event or intercurrent illness|12
880600|NCT01310036|2903075|P1|Overall Study|Death|1
880601|NCT01310036|2903075|P1|Overall Study|Progression of Disease|164
880602|NCT01310036|2903075|P1|Overall Study|Refused Treatment/Did not Cooperate|4
880603|NCT01310036|2903075|P1|Overall Study|Withdrew Consent|11
880604|NCT01310036|2903075|P1|Overall Study|Administrative/other|10
880605|NCT01309997|2903088|P2|Overall Study|Withdrawal by Subject|1
880606|NCT01309997|2903089|P1|Overall Study|Withdrawal by Subject|1
880607|NCT01309997|2903088|P2|Overall Study|Lack of Efficacy|2
880608|NCT01309997|2903089|P1|Overall Study|Lack of Efficacy|2
880609|NCT01309997|2903088|P2|Overall Study|Death|3
880610|NCT01309997|2903089|P1|Overall Study|Death|1
880611|NCT01309997|2903088|P2|Overall Study|Adverse Event|0
880612|NCT01309997|2903089|P1|Overall Study|Adverse Event|1
880613|NCT01309919|2903113|P2|Overall Study|Did not receive a postpartum IUD|48
880614|NCT01309919|2903114|P1|Overall Study|Did not receive a postpartum IUD|17
880615|NCT01309893|2903126|P2|Week 2 - Crossover Intervention|Missed crossover visit|1
880616|NCT01309893|2903127|P1|Week 2 - Crossover Intervention|Missed crossover visit|0
880617|NCT01309893|2903126|P2|Week 2 - Crossover Intervention|Lost to Follow-up|0
880618|NCT01309893|2903127|P1|Week 2 - Crossover Intervention|Lost to Follow-up|1
880619|NCT01309841|2903151|P3|Overall Study|Severe non-compliance with protocol|2
880620|NCT01309841|2903152|P2|Overall Study|Severe non-compliance with protocol|5
880621|NCT01309841|2903153|P1|Overall Study|Severe non-compliance with protocol|0
880622|NCT01309841|2903151|P3|Overall Study|Did Not Receive Treatment|1
880623|NCT01309841|2903152|P2|Overall Study|Did Not Receive Treatment|0
880624|NCT01309841|2903153|P1|Overall Study|Did Not Receive Treatment|2
880625|NCT01309841|2903151|P3|Overall Study|Withdrawal by Subject|13
880626|NCT01309841|2903152|P2|Overall Study|Withdrawal by Subject|6
880627|NCT01309841|2903153|P1|Overall Study|Withdrawal by Subject|17
880628|NCT01309841|2903151|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
880629|NCT01309841|2903152|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
880630|NCT01309841|2903153|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
880631|NCT01309841|2903151|P3|Overall Study|Death|0
880632|NCT01309841|2903152|P2|Overall Study|Death|0
880633|NCT01309841|2903153|P1|Overall Study|Death|1
880634|NCT01309841|2903151|P3|Overall Study|Adverse Event|11
880635|NCT01309841|2903152|P2|Overall Study|Adverse Event|22
880636|NCT01309841|2903153|P1|Overall Study|Adverse Event|9
880637|NCT01309841|2903151|P3|Overall Study|Lack of Efficacy|2
880638|NCT01309841|2903152|P2|Overall Study|Lack of Efficacy|0
880639|NCT01309841|2903153|P1|Overall Study|Lack of Efficacy|0
880640|NCT01309841|2903151|P3|Overall Study|Study-Specific Withdrawal Criteria|2
880641|NCT01309841|2903152|P2|Overall Study|Study-Specific Withdrawal Criteria|1
880642|NCT01309841|2903153|P1|Overall Study|Study-Specific Withdrawal Criteria|3
880643|NCT01309841|2903151|P3|Overall Study|Lost to Follow-up|4
880644|NCT01309841|2903152|P2|Overall Study|Lost to Follow-up|6
880645|NCT01309841|2903153|P1|Overall Study|Lost to Follow-up|7
880646|NCT01309841|2903151|P3|Overall Study|Other|1
880647|NCT01309841|2903152|P2|Overall Study|Other|1
880648|NCT01309841|2903153|P1|Overall Study|Other|0
880649|NCT01309828|2903193|P2|Overall Study|Other|0
880650|NCT01309828|2903194|P1|Overall Study|Other|1
880651|NCT01309828|2903193|P2|Overall Study|Major Protocol Deviation|1
880652|NCT01309828|2903194|P1|Overall Study|Major Protocol Deviation|0
880653|NCT01309828|2903193|P2|Overall Study|Voluntary Withdrawal|4
880654|NCT01309828|2903194|P1|Overall Study|Voluntary Withdrawal|5
880655|NCT01309828|2903193|P2|Overall Study|Adverse Event|11
880656|NCT01309828|2903194|P1|Overall Study|Adverse Event|10
880657|NCT01309737|2903228|P5|Week 16 to 52|Other|0
880658|NCT01309737|2903229|P4|Week 16 to 52|Other|2
880659|NCT01309737|2903230|P3|Week 16 to 52|Other|0
880660|NCT01309737|2903231|P2|Week 16 to 52|Other|12
880661|NCT01309737|2903232|P1|Week 16 to 52|Other|10
880662|NCT01309737|2903228|P5|Week 16 to 52|Withdrawal by Subject|2
880663|NCT01309737|2903229|P4|Week 16 to 52|Withdrawal by Subject|0
880664|NCT01309737|2903230|P3|Week 16 to 52|Withdrawal by Subject|0
880665|NCT01309737|2903231|P2|Week 16 to 52|Withdrawal by Subject|6
880666|NCT01309737|2903232|P1|Week 16 to 52|Withdrawal by Subject|5
880667|NCT01309737|2903228|P5|Week 16 to 52|Lost to Follow-up|4
880668|NCT01309737|2903229|P4|Week 16 to 52|Lost to Follow-up|1
880669|NCT01309737|2903230|P3|Week 16 to 52|Lost to Follow-up|0
880670|NCT01309737|2903231|P2|Week 16 to 52|Lost to Follow-up|2
880671|NCT01309737|2903232|P1|Week 16 to 52|Lost to Follow-up|4
880672|NCT01309737|2903228|P5|Week 16 to 52|Lack of Efficacy|21
880673|NCT01309737|2903229|P4|Week 16 to 52|Lack of Efficacy|25
880674|NCT01309737|2903230|P3|Week 16 to 52|Lack of Efficacy|0
880675|NCT01309737|2903231|P2|Week 16 to 52|Lack of Efficacy|76
880676|NCT01309737|2903232|P1|Week 16 to 52|Lack of Efficacy|107
880677|NCT01309737|2903228|P5|Week 16 to 52|Adverse Event|5
880678|NCT01309737|2903229|P4|Week 16 to 52|Adverse Event|6
880679|NCT01309737|2903230|P3|Week 16 to 52|Adverse Event|0
880680|NCT01309737|2903231|P2|Week 16 to 52|Adverse Event|7
880681|NCT01309737|2903232|P1|Week 16 to 52|Adverse Event|7
880682|NCT01309737|2903228|P5|Week 16 to 52|Death|1
880683|NCT01309737|2903229|P4|Week 16 to 52|Death|0
880684|NCT01309737|2903230|P3|Week 16 to 52|Death|0
880685|NCT01309737|2903231|P2|Week 16 to 52|Death|0
880686|NCT01309737|2903232|P1|Week 16 to 52|Death|0
880687|NCT01309737|2903228|P5|Week 0 to 16|Randomized, but not treated|0
880688|NCT01309737|2903229|P4|Week 0 to 16|Randomized, but not treated|0
880689|NCT01309737|2903230|P3|Week 0 to 16|Randomized, but not treated|0
880690|NCT01309737|2903231|P2|Week 0 to 16|Randomized, but not treated|0
880691|NCT01309737|2903232|P1|Week 0 to 16|Randomized, but not treated|1
880692|NCT01309737|2903228|P5|Week 0 to 16|Other|0
880693|NCT01309737|2903229|P4|Week 0 to 16|Other|0
880694|NCT01309737|2903230|P3|Week 0 to 16|Other|4
880695|NCT01309737|2903231|P2|Week 0 to 16|Other|14
880696|NCT01309737|2903232|P1|Week 0 to 16|Other|10
880697|NCT01309737|2903228|P5|Week 0 to 16|Withdrawal by Subject|0
880698|NCT01309737|2903229|P4|Week 0 to 16|Withdrawal by Subject|0
880699|NCT01309737|2903230|P3|Week 0 to 16|Withdrawal by Subject|7
880700|NCT01309737|2903231|P2|Week 0 to 16|Withdrawal by Subject|6
880701|NCT01309737|2903232|P1|Week 0 to 16|Withdrawal by Subject|7
880702|NCT01309737|2903228|P5|Week 0 to 16|Lost to Follow-up|0
880703|NCT01309737|2903229|P4|Week 0 to 16|Lost to Follow-up|0
880704|NCT01309737|2903230|P3|Week 0 to 16|Lost to Follow-up|3
880705|NCT01309737|2903231|P2|Week 0 to 16|Lost to Follow-up|8
880706|NCT01309737|2903232|P1|Week 0 to 16|Lost to Follow-up|7
880707|NCT01309737|2903228|P5|Week 0 to 16|Lack of Efficacy|0
880708|NCT01309737|2903229|P4|Week 0 to 16|Lack of Efficacy|0
880709|NCT01309737|2903230|P3|Week 0 to 16|Lack of Efficacy|24
880710|NCT01309737|2903231|P2|Week 0 to 16|Lack of Efficacy|2
880711|NCT01309737|2903232|P1|Week 0 to 16|Lack of Efficacy|15
880712|NCT01309737|2903228|P5|Week 0 to 16|Adverse Event|0
880713|NCT01309737|2903229|P4|Week 0 to 16|Adverse Event|0
880714|NCT01309737|2903230|P3|Week 0 to 16|Adverse Event|5
880715|NCT01309737|2903231|P2|Week 0 to 16|Adverse Event|10
880716|NCT01309737|2903232|P1|Week 0 to 16|Adverse Event|11
880717|NCT01309737|2903228|P5|Week 0 to 16|Death|0
880718|NCT01309737|2903229|P4|Week 0 to 16|Death|0
880719|NCT01309737|2903230|P3|Week 0 to 16|Death|1
880720|NCT01309737|2903231|P2|Week 0 to 16|Death|0
880721|NCT01309737|2903232|P1|Week 0 to 16|Death|1
880722|NCT01309672|2903427|P1|Overall Study|Withdrawal by Subject|3
880723|NCT01309672|2903427|P1|Overall Study|Adverse Event|5
880724|NCT01309672|2903427|P1|Overall Study|Other|9
880725|NCT01309672|2903427|P1|Overall Study|Lack of Efficacy|20
880726|NCT01309659|2903437|P2|Overall Study|Protocol Violation|1
880727|NCT01309659|2903438|P1|Overall Study|Protocol Violation|0
880728|NCT01309386|2903543|P2|Overall Study|Adverse Event|8
880729|NCT01309386|2903544|P1|Overall Study|Adverse Event|5
880730|NCT01309386|2903543|P2|Overall Study|Lack of Efficacy|1
880731|NCT01309386|2903544|P1|Overall Study|Lack of Efficacy|3
880732|NCT01309386|2903543|P2|Overall Study|Physician Decision|1
880733|NCT01309386|2903544|P1|Overall Study|Physician Decision|1
880734|NCT01309386|2903543|P2|Overall Study|Progressive disease|11
880735|NCT01309386|2903544|P1|Overall Study|Progressive disease|9
880736|NCT01309386|2903543|P2|Overall Study|Withdrawal by Subject|0
880737|NCT01309386|2903544|P1|Overall Study|Withdrawal by Subject|2
880738|NCT01309386|2903543|P2|Overall Study|Other|0
880739|NCT01309386|2903544|P1|Overall Study|Other|2
880740|NCT01309308|2903592|P2|Overall Study|Lost to Follow-up|4
880741|NCT01309308|2903593|P1|Overall Study|Lost to Follow-up|6
880742|NCT01309282|2903601|P1|Overall Study|Lost to Follow-up|1
880743|NCT01309269|2903618|P1|Overall Study|Enrolled but not Treated|107
880744|NCT01309269|2903618|P1|Overall Study|Study Completion Data Not Recorded|95
880745|NCT01309269|2903618|P1|Overall Study|Other|1
880746|NCT01309269|2903618|P1|Overall Study|Other|256
880747|NCT01309269|2903618|P1|Overall Study|Administrative Problems|141
880748|NCT01309269|2903618|P1|Overall Study|Kidney Transplant|25
880749|NCT01309269|2903618|P1|Overall Study|Other Erythropoiesis-stimulating Agents|119
880750|NCT01309269|2903618|P1|Overall Study|Lack of Acceptance|15
880751|NCT01309269|2903618|P1|Overall Study|Withdrawal by Subject|25
880752|NCT01309269|2903618|P1|Overall Study|Adverse Event|56
880753|NCT01309243|2903626|P2|Extension Phase|Lost to Follow-up|0
880754|NCT01309243|2903627|P1|Extension Phase|Lost to Follow-up|6
880755|NCT01309243|2903626|P2|Randomized Phase Through Week 96|Protocol Violation|1
880756|NCT01309243|2903627|P1|Randomized Phase Through Week 96|Protocol Violation|1
880757|NCT01309243|2903626|P2|Randomized Phase Through Week 96|Subject Non-Compliance|7
880758|NCT01309243|2903627|P1|Randomized Phase Through Week 96|Subject Non-Compliance|9
880759|NCT01309243|2903626|P2|Randomized Phase Through Week 96|Lost to Follow-up|22
880760|NCT01309243|2903627|P1|Randomized Phase Through Week 96|Lost to Follow-up|23
880761|NCT01309243|2903626|P2|Randomized Phase Through Week 96|Withdrew Consent|18
880762|NCT01309243|2903627|P1|Randomized Phase Through Week 96|Withdrew Consent|12
880763|NCT01309243|2903626|P2|Randomized Phase Through Week 96|Investigators Discretion|6
880764|NCT01309243|2903627|P1|Randomized Phase Through Week 96|Investigators Discretion|3
880765|NCT01309243|2903626|P2|Randomized Phase Through Week 96|Lack of Efficacy|4
880766|NCT01309243|2903627|P1|Randomized Phase Through Week 96|Lack of Efficacy|16
880767|NCT01309243|2903626|P2|Randomized Phase Through Week 96|Pregnancy|0
880768|NCT01309243|2903627|P1|Randomized Phase Through Week 96|Pregnancy|2
880769|NCT01309243|2903626|P2|Randomized Phase Through Week 96|Death|1
880770|NCT01309243|2903627|P1|Randomized Phase Through Week 96|Death|0
880771|NCT01309243|2903626|P2|Randomized Phase Through Week 96|Adverse Event|43
880772|NCT01309243|2903627|P1|Randomized Phase Through Week 96|Adverse Event|12
880773|NCT01309243|2903626|P2|Randomized Phase Through Week 96|Randomized but not treated|7
880774|NCT01309243|2903627|P1|Randomized Phase Through Week 96|Randomized but not treated|6
880775|NCT01309204|2903653|P2|Overall Study|Other|1
880776|NCT01309204|2903654|P1|Overall Study|Other|4
880777|NCT01309204|2903653|P2|Overall Study|Inadequate control of IOP|4
880778|NCT01309204|2903654|P1|Overall Study|Inadequate control of IOP|4
880779|NCT01309204|2903653|P2|Overall Study|Subject's decision unrelated to an AE|10
880780|NCT01309204|2903654|P1|Overall Study|Subject's decision unrelated to an AE|9
880781|NCT01309204|2903653|P2|Overall Study|Lost to Follow-up|2
880782|NCT01309204|2903654|P1|Overall Study|Lost to Follow-up|2
880783|NCT01309204|2903653|P2|Overall Study|Adverse Event|58
880784|NCT01309204|2903654|P1|Overall Study|Adverse Event|48
880785|NCT01309100|2903660|P1|Overall Study|Positive Slit lamp finding|1
880786|NCT01309100|2903660|P1|Overall Study|Protocol Violation|1
880787|NCT01308788|2903708|P2|2-year Treatment|medication change by treating physician|11
880788|NCT01308788|2903709|P1|2-year Treatment|medication change by treating physician|4
880789|NCT01308762|2903744|P3|Overall Study|Protocol Violation|0
880790|NCT01308762|2903745|P2|Overall Study|Protocol Violation|1
880791|NCT01308762|2903746|P1|Overall Study|Protocol Violation|0
880792|NCT01308749|2903759|P2|Period 2: Open Label Treatment|Lost to Follow-up|1
880793|NCT01308749|2903760|P1|Period 2: Open Label Treatment|Lost to Follow-up|0
880794|NCT01308749|2903759|P2|Period 2: Open Label Treatment|Adverse Event|1
880795|NCT01308749|2903760|P1|Period 2: Open Label Treatment|Adverse Event|0
880796|NCT01308749|2903759|P2|Period 1: Double Blind Treatment|Adverse Event|0
880797|NCT01308749|2903760|P1|Period 1: Double Blind Treatment|Adverse Event|1
880798|NCT01308736|2903790|P2|Overall Study|Did not attend a single session|5
880799|NCT01308736|2903791|P1|Overall Study|Did not attend a single session|6
880800|NCT01308580|2903814|P2|Overall Study|Lost to Follow-up|7
880801|NCT01308580|2903815|P1|Overall Study|Lost to Follow-up|12
880802|NCT01308567|2903858|P3|Overall Study|Lost to Follow-up|4
880803|NCT01308567|2903859|P2|Overall Study|Lost to Follow-up|4
880804|NCT01308567|2903860|P1|Overall Study|Lost to Follow-up|2
880805|NCT01308476|2903900|P2|Overall Study|Other|0
880806|NCT01308476|2903901|P1|Overall Study|Other|1
880807|NCT01308476|2903900|P2|Overall Study|Lost to Follow-up|2
880808|NCT01308476|2903901|P1|Overall Study|Lost to Follow-up|2
880809|NCT01308463|2903921|P1|Overall Study|Revision|2
880810|NCT01308463|2903921|P1|Overall Study|Death|4
880811|NCT01308463|2903921|P1|Overall Study|Study Discontinued|23
880812|NCT01308424|2903934|P3|Randomization|Physician Decision|1
880813|NCT01308424|2903935|P2|Randomization|Physician Decision|1
880814|NCT01308424|2903936|P1|Randomization|Physician Decision|0
880815|NCT01308424|2903934|P3|Randomization|Lost to Follow-up|0
880816|NCT01308424|2903935|P2|Randomization|Lost to Follow-up|1
880817|NCT01308424|2903936|P1|Randomization|Lost to Follow-up|0
880818|NCT01308424|2903934|P3|Randomization|Adverse Event|1
880819|NCT01308424|2903935|P2|Randomization|Adverse Event|1
880820|NCT01308424|2903936|P1|Randomization|Adverse Event|0
880821|NCT01308424|2903934|P3|Baseline Eligibility|Screen Failures|0
880822|NCT01308424|2903935|P2|Baseline Eligibility|Screen Failures|0
880823|NCT01308424|2903936|P1|Baseline Eligibility|Screen Failures|71
880824|NCT01308008|2903945|P2|4 Weeks|Illness, disinterest, time|2
880825|NCT01308008|2903946|P1|4 Weeks|Illness, disinterest, time|9
880826|NCT01307891|2903962|P2|Overall Study|Progressive Disease|1
880827|NCT01307891|2903963|P1|Overall Study|Progressive Disease|3
880828|NCT01307787|2903975|P2|Overall Study|Withdrawal by Subject|0
880829|NCT01307787|2903976|P1|Overall Study|Withdrawal by Subject|2
880830|NCT01307449|2904041|P4|Overall Study|Adverse Event|0
880831|NCT01307449|2904042|P3|Overall Study|Adverse Event|0
880832|NCT01307449|2904043|P2|Overall Study|Adverse Event|0
880833|NCT01307449|2904044|P1|Overall Study|Adverse Event|1
880834|NCT01307423|2904077|P9|Long-term Safety Phase (Year 5)|Miscellaneous|1
880835|NCT01307423|2904078|P8|Long-term Safety Phase (Year 5)|Miscellaneous|1
880836|NCT01307423|2904079|P7|Long-term Safety Phase (Year 5)|Miscellaneous|0
880837|NCT01307423|2904080|P6|Long-term Safety Phase (Year 5)|Miscellaneous|0
880838|NCT01307423|2904081|P5|Long-term Safety Phase (Year 5)|Miscellaneous|0
880839|NCT01307423|2904082|P4|Long-term Safety Phase (Year 5)|Miscellaneous|0
880840|NCT01307423|2904083|P3|Long-term Safety Phase (Year 5)|Miscellaneous|2
880841|NCT01307423|2904084|P2|Long-term Safety Phase (Year 5)|Miscellaneous|0
880842|NCT01307423|2904085|P1|Long-term Safety Phase (Year 5)|Miscellaneous|0
880843|NCT01307423|2904077|P9|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
880844|NCT01307423|2904078|P8|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
880845|NCT01307423|2904079|P7|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
880846|NCT01307423|2904080|P6|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
880847|NCT01307423|2904081|P5|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
880848|NCT01307423|2904082|P4|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
880849|NCT01307423|2904083|P3|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
880850|NCT01307423|2904084|P2|Long-term Safety Phase (Year 5)|Lost to Follow-up|1
880851|NCT01307423|2904085|P1|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
880852|NCT01307423|2904077|P9|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
880853|NCT01307423|2904078|P8|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
880854|NCT01307423|2904079|P7|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
880855|NCT01307423|2904080|P6|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
880856|NCT01307423|2904081|P5|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
880857|NCT01307423|2904082|P4|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
880858|NCT01307423|2904083|P3|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
880859|NCT01307423|2904084|P2|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6
880860|NCT01307423|2904085|P1|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
880861|NCT01307423|2904077|P9|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
880862|NCT01307423|2904078|P8|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
880863|NCT01307423|2904079|P7|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
880864|NCT01307423|2904080|P6|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
880865|NCT01307423|2904081|P5|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
880866|NCT01307423|2904082|P4|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
880867|NCT01307423|2904083|P3|Long-term Safety Phase (Year 5)|Lack of Efficacy|1
880868|NCT01307423|2904084|P2|Long-term Safety Phase (Year 5)|Lack of Efficacy|2
880869|NCT01307423|2904085|P1|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
880870|NCT01307423|2904077|P9|Long-term Safety Phase (Year 5)|Adverse Event|1
880871|NCT01307423|2904078|P8|Long-term Safety Phase (Year 5)|Adverse Event|0
880872|NCT01307423|2904079|P7|Long-term Safety Phase (Year 5)|Adverse Event|0
880873|NCT01307423|2904080|P6|Long-term Safety Phase (Year 5)|Adverse Event|0
880874|NCT01307423|2904081|P5|Long-term Safety Phase (Year 5)|Adverse Event|0
880875|NCT01307423|2904082|P4|Long-term Safety Phase (Year 5)|Adverse Event|0
880876|NCT01307423|2904083|P3|Long-term Safety Phase (Year 5)|Adverse Event|1
880877|NCT01307423|2904084|P2|Long-term Safety Phase (Year 5)|Adverse Event|1
880878|NCT01307423|2904085|P1|Long-term Safety Phase (Year 5)|Adverse Event|0
880879|NCT01307423|2904077|P9|Long-term Safety Phase (Year 4)|Miscellaneous|0
880880|NCT01307423|2904078|P8|Long-term Safety Phase (Year 4)|Miscellaneous|1
880881|NCT01307423|2904079|P7|Long-term Safety Phase (Year 4)|Miscellaneous|0
880882|NCT01307423|2904080|P6|Long-term Safety Phase (Year 4)|Miscellaneous|0
880883|NCT01307423|2904081|P5|Long-term Safety Phase (Year 4)|Miscellaneous|0
880884|NCT01307423|2904082|P4|Long-term Safety Phase (Year 4)|Miscellaneous|0
880885|NCT01307423|2904083|P3|Long-term Safety Phase (Year 4)|Miscellaneous|0
880886|NCT01307423|2904084|P2|Long-term Safety Phase (Year 4)|Miscellaneous|0
880887|NCT01307423|2904085|P1|Long-term Safety Phase (Year 4)|Miscellaneous|0
880888|NCT01307423|2904077|P9|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
880889|NCT01307423|2904078|P8|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
880890|NCT01307423|2904079|P7|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
880891|NCT01307423|2904080|P6|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
880892|NCT01307423|2904081|P5|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
880893|NCT01307423|2904082|P4|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
880894|NCT01307423|2904083|P3|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
880895|NCT01307423|2904084|P2|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
880896|NCT01307423|2904085|P1|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
880897|NCT01307423|2904077|P9|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
880898|NCT01307423|2904078|P8|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1
880899|NCT01307423|2904079|P7|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
880900|NCT01307423|2904080|P6|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
880901|NCT01307423|2904081|P5|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
880902|NCT01307423|2904082|P4|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
880903|NCT01307423|2904083|P3|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
880904|NCT01307423|2904084|P2|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5
880905|NCT01307423|2904085|P1|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
880906|NCT01307423|2904077|P9|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
880907|NCT01307423|2904078|P8|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
880908|NCT01307423|2904079|P7|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
880909|NCT01307423|2904080|P6|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
880910|NCT01307423|2904081|P5|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
880911|NCT01307423|2904082|P4|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
880912|NCT01307423|2904083|P3|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
880913|NCT01307423|2904084|P2|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
880914|NCT01307423|2904085|P1|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
880915|NCT01307423|2904077|P9|Long-term Safety Phase (Year 4)|Adverse Event|0
880916|NCT01307423|2904078|P8|Long-term Safety Phase (Year 4)|Adverse Event|0
880917|NCT01307423|2904079|P7|Long-term Safety Phase (Year 4)|Adverse Event|0
880918|NCT01307423|2904080|P6|Long-term Safety Phase (Year 4)|Adverse Event|0
880919|NCT01307423|2904081|P5|Long-term Safety Phase (Year 4)|Adverse Event|0
880920|NCT01307423|2904082|P4|Long-term Safety Phase (Year 4)|Adverse Event|0
880921|NCT01307423|2904083|P3|Long-term Safety Phase (Year 4)|Adverse Event|0
880922|NCT01307423|2904084|P2|Long-term Safety Phase (Year 4)|Adverse Event|2
880923|NCT01307423|2904085|P1|Long-term Safety Phase (Year 4)|Adverse Event|0
880924|NCT01307423|2904077|P9|Long-term Safety Phase (Year 3)|Miscellaneous|0
880925|NCT01307423|2904078|P8|Long-term Safety Phase (Year 3)|Miscellaneous|1
880926|NCT01307423|2904079|P7|Long-term Safety Phase (Year 3)|Miscellaneous|0
880927|NCT01307423|2904080|P6|Long-term Safety Phase (Year 3)|Miscellaneous|0
880928|NCT01307423|2904081|P5|Long-term Safety Phase (Year 3)|Miscellaneous|0
880929|NCT01307423|2904082|P4|Long-term Safety Phase (Year 3)|Miscellaneous|0
880930|NCT01307423|2904083|P3|Long-term Safety Phase (Year 3)|Miscellaneous|0
880931|NCT01307423|2904084|P2|Long-term Safety Phase (Year 3)|Miscellaneous|1
880932|NCT01307423|2904085|P1|Long-term Safety Phase (Year 3)|Miscellaneous|0
880933|NCT01307423|2904077|P9|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
880934|NCT01307423|2904078|P8|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
880935|NCT01307423|2904079|P7|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
880936|NCT01307423|2904080|P6|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
881229|NCT01307033|2904331|P4|8-week Double-blind Period|Adverse Event|0
880937|NCT01307423|2904081|P5|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
880938|NCT01307423|2904082|P4|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
880939|NCT01307423|2904083|P3|Long-term Safety Phase (Year 3)|Lost to Follow-up|3
880940|NCT01307423|2904084|P2|Long-term Safety Phase (Year 3)|Lost to Follow-up|2
880941|NCT01307423|2904085|P1|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
880942|NCT01307423|2904077|P9|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
880943|NCT01307423|2904078|P8|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
880944|NCT01307423|2904079|P7|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
880945|NCT01307423|2904080|P6|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
880946|NCT01307423|2904081|P5|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
880947|NCT01307423|2904082|P4|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
880948|NCT01307423|2904083|P3|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8
880949|NCT01307423|2904084|P2|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
880950|NCT01307423|2904085|P1|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
880951|NCT01307423|2904077|P9|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
880952|NCT01307423|2904078|P8|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
880953|NCT01307423|2904079|P7|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
880954|NCT01307423|2904080|P6|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
880955|NCT01307423|2904081|P5|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
880956|NCT01307423|2904082|P4|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
880957|NCT01307423|2904083|P3|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
880958|NCT01307423|2904084|P2|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
880959|NCT01307423|2904085|P1|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
880960|NCT01307423|2904077|P9|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
880961|NCT01307423|2904078|P8|Long-term Safety Phase (Year 3)|Lack of Efficacy|1
880962|NCT01307423|2904079|P7|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
880963|NCT01307423|2904080|P6|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
880964|NCT01307423|2904081|P5|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
880965|NCT01307423|2904082|P4|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
880966|NCT01307423|2904083|P3|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
880967|NCT01307423|2904084|P2|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
880968|NCT01307423|2904085|P1|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
880969|NCT01307423|2904077|P9|Long-term Safety Phase (Year 3)|Adverse Event|4
880970|NCT01307423|2904078|P8|Long-term Safety Phase (Year 3)|Adverse Event|3
880971|NCT01307423|2904079|P7|Long-term Safety Phase (Year 3)|Adverse Event|0
880972|NCT01307423|2904080|P6|Long-term Safety Phase (Year 3)|Adverse Event|0
880973|NCT01307423|2904081|P5|Long-term Safety Phase (Year 3)|Adverse Event|0
880974|NCT01307423|2904082|P4|Long-term Safety Phase (Year 3)|Adverse Event|0
880975|NCT01307423|2904083|P3|Long-term Safety Phase (Year 3)|Adverse Event|2
880976|NCT01307423|2904084|P2|Long-term Safety Phase (Year 3)|Adverse Event|1
880977|NCT01307423|2904085|P1|Long-term Safety Phase (Year 3)|Adverse Event|0
880978|NCT01307423|2904077|P9|Long-term Safety Phase (Year 2)|Miscellaneous|1
880979|NCT01307423|2904078|P8|Long-term Safety Phase (Year 2)|Miscellaneous|1
880980|NCT01307423|2904079|P7|Long-term Safety Phase (Year 2)|Miscellaneous|0
880981|NCT01307423|2904080|P6|Long-term Safety Phase (Year 2)|Miscellaneous|0
880982|NCT01307423|2904081|P5|Long-term Safety Phase (Year 2)|Miscellaneous|0
880983|NCT01307423|2904082|P4|Long-term Safety Phase (Year 2)|Miscellaneous|0
880984|NCT01307423|2904083|P3|Long-term Safety Phase (Year 2)|Miscellaneous|0
880985|NCT01307423|2904084|P2|Long-term Safety Phase (Year 2)|Miscellaneous|1
880986|NCT01307423|2904085|P1|Long-term Safety Phase (Year 2)|Miscellaneous|0
880987|NCT01307423|2904077|P9|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2
880988|NCT01307423|2904078|P8|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
880989|NCT01307423|2904079|P7|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
880990|NCT01307423|2904080|P6|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
880991|NCT01307423|2904081|P5|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
880992|NCT01307423|2904082|P4|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
880993|NCT01307423|2904083|P3|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12
880994|NCT01307423|2904084|P2|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13
880995|NCT01307423|2904085|P1|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
880996|NCT01307423|2904077|P9|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
880997|NCT01307423|2904078|P8|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
880998|NCT01307423|2904079|P7|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
880999|NCT01307423|2904080|P6|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
881000|NCT01307423|2904081|P5|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
881001|NCT01307423|2904082|P4|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
881002|NCT01307423|2904083|P3|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1
881003|NCT01307423|2904084|P2|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
881004|NCT01307423|2904085|P1|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
881005|NCT01307423|2904077|P9|Long-term Safety Phase (Year 2)|Lack of Efficacy|3
881006|NCT01307423|2904078|P8|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
881007|NCT01307423|2904079|P7|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
881008|NCT01307423|2904080|P6|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
881009|NCT01307423|2904081|P5|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
881010|NCT01307423|2904082|P4|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
881011|NCT01307423|2904083|P3|Long-term Safety Phase (Year 2)|Lack of Efficacy|5
881012|NCT01307423|2904084|P2|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
881013|NCT01307423|2904085|P1|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
881014|NCT01307423|2904077|P9|Long-term Safety Phase (Year 2)|Adverse Event|1
881015|NCT01307423|2904078|P8|Long-term Safety Phase (Year 2)|Adverse Event|1
881016|NCT01307423|2904079|P7|Long-term Safety Phase (Year 2)|Adverse Event|0
881017|NCT01307423|2904080|P6|Long-term Safety Phase (Year 2)|Adverse Event|0
881018|NCT01307423|2904081|P5|Long-term Safety Phase (Year 2)|Adverse Event|0
881019|NCT01307423|2904082|P4|Long-term Safety Phase (Year 2)|Adverse Event|0
881020|NCT01307423|2904083|P3|Long-term Safety Phase (Year 2)|Adverse Event|7
881021|NCT01307423|2904084|P2|Long-term Safety Phase (Year 2)|Adverse Event|2
881022|NCT01307423|2904085|P1|Long-term Safety Phase (Year 2)|Adverse Event|0
881023|NCT01307423|2904077|P9|Active Treatment Phase (Week 25-52)|Protocol Violation|0
881024|NCT01307423|2904078|P8|Active Treatment Phase (Week 25-52)|Protocol Violation|0
881025|NCT01307423|2904079|P7|Active Treatment Phase (Week 25-52)|Protocol Violation|0
881026|NCT01307423|2904080|P6|Active Treatment Phase (Week 25-52)|Protocol Violation|1
881027|NCT01307423|2904081|P5|Active Treatment Phase (Week 25-52)|Protocol Violation|0
881028|NCT01307423|2904082|P4|Active Treatment Phase (Week 25-52)|Protocol Violation|0
881029|NCT01307423|2904083|P3|Active Treatment Phase (Week 25-52)|Protocol Violation|0
881030|NCT01307423|2904084|P2|Active Treatment Phase (Week 25-52)|Protocol Violation|0
881031|NCT01307423|2904085|P1|Active Treatment Phase (Week 25-52)|Protocol Violation|0
881032|NCT01307423|2904077|P9|Active Treatment Phase (Week 25-52)|Other|0
881033|NCT01307423|2904078|P8|Active Treatment Phase (Week 25-52)|Other|0
881034|NCT01307423|2904079|P7|Active Treatment Phase (Week 25-52)|Other|0
881035|NCT01307423|2904080|P6|Active Treatment Phase (Week 25-52)|Other|0
881036|NCT01307423|2904081|P5|Active Treatment Phase (Week 25-52)|Other|0
881037|NCT01307423|2904082|P4|Active Treatment Phase (Week 25-52)|Other|1
881038|NCT01307423|2904083|P3|Active Treatment Phase (Week 25-52)|Other|0
881039|NCT01307423|2904084|P2|Active Treatment Phase (Week 25-52)|Other|0
881040|NCT01307423|2904085|P1|Active Treatment Phase (Week 25-52)|Other|0
881041|NCT01307423|2904077|P9|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
881042|NCT01307423|2904078|P8|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
881043|NCT01307423|2904079|P7|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
881044|NCT01307423|2904080|P6|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
881045|NCT01307423|2904081|P5|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
881046|NCT01307423|2904082|P4|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2
881047|NCT01307423|2904083|P3|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
881048|NCT01307423|2904084|P2|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
881049|NCT01307423|2904085|P1|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
881050|NCT01307423|2904077|P9|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
881051|NCT01307423|2904078|P8|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
881052|NCT01307423|2904079|P7|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
881053|NCT01307423|2904080|P6|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
881054|NCT01307423|2904081|P5|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
881055|NCT01307423|2904082|P4|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
881056|NCT01307423|2904083|P3|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2
881057|NCT01307423|2904084|P2|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11
881058|NCT01307423|2904085|P1|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
881059|NCT01307423|2904077|P9|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
881060|NCT01307423|2904078|P8|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
881061|NCT01307423|2904079|P7|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
881062|NCT01307423|2904080|P6|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1
881063|NCT01307423|2904081|P5|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
881064|NCT01307423|2904082|P4|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
881065|NCT01307423|2904083|P3|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
881066|NCT01307423|2904084|P2|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
881067|NCT01307423|2904085|P1|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
881068|NCT01307423|2904077|P9|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
881069|NCT01307423|2904078|P8|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
881070|NCT01307423|2904079|P7|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
881071|NCT01307423|2904080|P6|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
881072|NCT01307423|2904081|P5|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1
881073|NCT01307423|2904082|P4|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3
881074|NCT01307423|2904083|P3|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
881075|NCT01307423|2904084|P2|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
881076|NCT01307423|2904085|P1|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
881077|NCT01307423|2904077|P9|Active Treatment Phase (Week 25-52)|Adverse Event|0
881078|NCT01307423|2904078|P8|Active Treatment Phase (Week 25-52)|Adverse Event|0
881079|NCT01307423|2904079|P7|Active Treatment Phase (Week 25-52)|Adverse Event|0
881230|NCT01307033|2904332|P3|8-week Double-blind Period|Adverse Event|0
881080|NCT01307423|2904080|P6|Active Treatment Phase (Week 25-52)|Adverse Event|0
881081|NCT01307423|2904081|P5|Active Treatment Phase (Week 25-52)|Adverse Event|2
881082|NCT01307423|2904082|P4|Active Treatment Phase (Week 25-52)|Adverse Event|2
881083|NCT01307423|2904083|P3|Active Treatment Phase (Week 25-52)|Adverse Event|2
881084|NCT01307423|2904084|P2|Active Treatment Phase (Week 25-52)|Adverse Event|3
881085|NCT01307423|2904085|P1|Active Treatment Phase (Week 25-52)|Adverse Event|0
881086|NCT01307423|2904077|P9|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
881087|NCT01307423|2904078|P8|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
881088|NCT01307423|2904079|P7|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
881089|NCT01307423|2904080|P6|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
881090|NCT01307423|2904081|P5|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
881091|NCT01307423|2904082|P4|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
881092|NCT01307423|2904083|P3|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
881093|NCT01307423|2904084|P2|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
881094|NCT01307423|2904085|P1|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
881095|NCT01307423|2904077|P9|Placebo-controlled Phase (Week 0 - 24)|Other|0
881096|NCT01307423|2904078|P8|Placebo-controlled Phase (Week 0 - 24)|Other|0
881097|NCT01307423|2904079|P7|Placebo-controlled Phase (Week 0 - 24)|Other|0
881098|NCT01307423|2904080|P6|Placebo-controlled Phase (Week 0 - 24)|Other|0
881099|NCT01307423|2904081|P5|Placebo-controlled Phase (Week 0 - 24)|Other|0
881100|NCT01307423|2904082|P4|Placebo-controlled Phase (Week 0 - 24)|Other|0
881101|NCT01307423|2904083|P3|Placebo-controlled Phase (Week 0 - 24)|Other|0
881102|NCT01307423|2904084|P2|Placebo-controlled Phase (Week 0 - 24)|Other|2
881103|NCT01307423|2904085|P1|Placebo-controlled Phase (Week 0 - 24)|Other|1
881104|NCT01307423|2904077|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
881105|NCT01307423|2904078|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
881106|NCT01307423|2904079|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
881107|NCT01307423|2904080|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
881108|NCT01307423|2904081|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
881109|NCT01307423|2904082|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
881110|NCT01307423|2904083|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
881111|NCT01307423|2904084|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
881112|NCT01307423|2904085|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
881113|NCT01307423|2904077|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
881114|NCT01307423|2904078|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
881115|NCT01307423|2904079|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
881116|NCT01307423|2904080|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
881117|NCT01307423|2904081|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
881118|NCT01307423|2904082|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
881119|NCT01307423|2904083|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
881120|NCT01307423|2904084|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
881121|NCT01307423|2904085|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5
881122|NCT01307423|2904077|P9|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
881123|NCT01307423|2904078|P8|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
881124|NCT01307423|2904079|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
881125|NCT01307423|2904080|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
881126|NCT01307423|2904081|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
881127|NCT01307423|2904082|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
881128|NCT01307423|2904083|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
881129|NCT01307423|2904084|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
881130|NCT01307423|2904085|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
881131|NCT01307423|2904077|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
881132|NCT01307423|2904078|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
881133|NCT01307423|2904079|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
881134|NCT01307423|2904080|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
881135|NCT01307423|2904081|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
881136|NCT01307423|2904082|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
881137|NCT01307423|2904083|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10
881138|NCT01307423|2904084|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
881139|NCT01307423|2904085|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8
881140|NCT01307423|2904077|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
881141|NCT01307423|2904078|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
881142|NCT01307423|2904079|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
881143|NCT01307423|2904080|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
881144|NCT01307423|2904081|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
881145|NCT01307423|2904082|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
881146|NCT01307423|2904083|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
881147|NCT01307423|2904084|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
881148|NCT01307423|2904085|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1
881149|NCT01307423|2904077|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
881231|NCT01307033|2904333|P2|8-week Double-blind Period|Adverse Event|0
881150|NCT01307423|2904078|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
881151|NCT01307423|2904079|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
881152|NCT01307423|2904080|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
881153|NCT01307423|2904081|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
881154|NCT01307423|2904082|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
881155|NCT01307423|2904083|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6
881156|NCT01307423|2904084|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
881157|NCT01307423|2904085|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
881158|NCT01307319|2904291|P3|Overall Study|Not specified|3
881159|NCT01307319|2904292|P2|Overall Study|Not specified|4
881160|NCT01307319|2904293|P1|Overall Study|Not specified|0
881161|NCT01307319|2904291|P3|Overall Study|Withdrawal by Subject|2
881162|NCT01307319|2904292|P2|Overall Study|Withdrawal by Subject|1
881163|NCT01307319|2904293|P1|Overall Study|Withdrawal by Subject|0
881164|NCT01307319|2904291|P3|Overall Study|Protocol Violation|0
881165|NCT01307319|2904292|P2|Overall Study|Protocol Violation|1
881166|NCT01307319|2904293|P1|Overall Study|Protocol Violation|1
881167|NCT01307319|2904291|P3|Overall Study|Lost to Follow-up|1
881168|NCT01307319|2904292|P2|Overall Study|Lost to Follow-up|0
881169|NCT01307319|2904293|P1|Overall Study|Lost to Follow-up|1
881170|NCT01307319|2904291|P3|Overall Study|Adverse Event|1
881171|NCT01307319|2904292|P2|Overall Study|Adverse Event|2
881172|NCT01307319|2904293|P1|Overall Study|Adverse Event|2
881173|NCT01307111|2904307|P2|1-2 Week IUD Check up|IUD expulsion/removal|2
881174|NCT01307111|2904308|P1|1-2 Week IUD Check up|IUD expulsion/removal|2
881175|NCT01307111|2904307|P2|IUD Insertion|Lost to Follow-up|0
881176|NCT01307111|2904308|P1|IUD Insertion|Lost to Follow-up|2
881177|NCT01307046|2904318|P2|Overall Study|Blood Pressure Withdrawal Criteria Met|3
881178|NCT01307046|2904319|P1|Overall Study|Blood Pressure Withdrawal Criteria Met|2
881179|NCT01307046|2904318|P2|Overall Study|Serum Potassium Withdrawal Criteria Met|2
881180|NCT01307046|2904319|P1|Overall Study|Serum Potassium Withdrawal Criteria Met|4
881181|NCT01307046|2904318|P2|Overall Study|Withdrawal by Subject|1
881182|NCT01307046|2904319|P1|Overall Study|Withdrawal by Subject|1
881183|NCT01307046|2904318|P2|Overall Study|Physician Decision|0
881184|NCT01307046|2904319|P1|Overall Study|Physician Decision|2
881185|NCT01307046|2904318|P2|Overall Study|Lack of Efficacy|2
881186|NCT01307046|2904319|P1|Overall Study|Lack of Efficacy|0
881187|NCT01307046|2904318|P2|Overall Study|Adverse Event|3
881188|NCT01307046|2904319|P1|Overall Study|Adverse Event|3
881189|NCT01307033|2904331|P4|44-week Open-label Extension|Death|1
881190|NCT01307033|2904332|P3|44-week Open-label Extension|Death|0
881191|NCT01307033|2904333|P2|44-week Open-label Extension|Death|0
881192|NCT01307033|2904334|P1|44-week Open-label Extension|Death|0
881193|NCT01307033|2904331|P4|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7
881194|NCT01307033|2904332|P3|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6
881195|NCT01307033|2904333|P2|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
881196|NCT01307033|2904334|P1|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
881197|NCT01307033|2904331|P4|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2
881198|NCT01307033|2904332|P3|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
881199|NCT01307033|2904333|P2|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
881200|NCT01307033|2904334|P1|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
881201|NCT01307033|2904331|P4|44-week Open-label Extension|Physician Decision|0
881202|NCT01307033|2904332|P3|44-week Open-label Extension|Physician Decision|1
881203|NCT01307033|2904333|P2|44-week Open-label Extension|Physician Decision|0
881204|NCT01307033|2904334|P1|44-week Open-label Extension|Physician Decision|0
881205|NCT01307033|2904331|P4|44-week Open-label Extension|Withdrawal by Subject|1
881206|NCT01307033|2904332|P3|44-week Open-label Extension|Withdrawal by Subject|2
881207|NCT01307033|2904333|P2|44-week Open-label Extension|Withdrawal by Subject|0
881208|NCT01307033|2904334|P1|44-week Open-label Extension|Withdrawal by Subject|0
881209|NCT01307033|2904331|P4|44-week Open-label Extension|Adverse Event|1
881210|NCT01307033|2904332|P3|44-week Open-label Extension|Adverse Event|2
881211|NCT01307033|2904333|P2|44-week Open-label Extension|Adverse Event|0
881212|NCT01307033|2904334|P1|44-week Open-label Extension|Adverse Event|0
881213|NCT01307033|2904331|P4|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
881214|NCT01307033|2904332|P3|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
881215|NCT01307033|2904333|P2|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3
881216|NCT01307033|2904334|P1|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6
881217|NCT01307033|2904331|P4|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
881218|NCT01307033|2904332|P3|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
881219|NCT01307033|2904333|P2|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3
881220|NCT01307033|2904334|P1|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
881221|NCT01307033|2904331|P4|8-week Double-blind Period|Lack of Efficacy|0
881222|NCT01307033|2904332|P3|8-week Double-blind Period|Lack of Efficacy|0
881223|NCT01307033|2904333|P2|8-week Double-blind Period|Lack of Efficacy|0
881224|NCT01307033|2904334|P1|8-week Double-blind Period|Lack of Efficacy|1
881225|NCT01307033|2904331|P4|8-week Double-blind Period|Withdrawal by Subject|0
881226|NCT01307033|2904332|P3|8-week Double-blind Period|Withdrawal by Subject|0
881227|NCT01307033|2904333|P2|8-week Double-blind Period|Withdrawal by Subject|1
881228|NCT01307033|2904334|P1|8-week Double-blind Period|Withdrawal by Subject|4
881232|NCT01307033|2904334|P1|8-week Double-blind Period|Adverse Event|2
881233|NCT01307020|2904356|P10|Overall Study|Electronic data capture failure|0
881234|NCT01307020|2904357|P9|Overall Study|Electronic data capture failure|0
881235|NCT01307020|2904358|P8|Overall Study|Electronic data capture failure|0
881236|NCT01307020|2904359|P7|Overall Study|Electronic data capture failure|0
881237|NCT01307020|2904360|P6|Overall Study|Electronic data capture failure|0
881238|NCT01307020|2904361|P5|Overall Study|Electronic data capture failure|0
881239|NCT01307020|2904362|P4|Overall Study|Electronic data capture failure|0
881240|NCT01307020|2904363|P3|Overall Study|Electronic data capture failure|0
881241|NCT01307020|2904364|P2|Overall Study|Electronic data capture failure|1
881242|NCT01307020|2904365|P1|Overall Study|Electronic data capture failure|0
881243|NCT01307020|2904356|P10|Overall Study|Lost to Follow-up|0
881244|NCT01307020|2904357|P9|Overall Study|Lost to Follow-up|0
881245|NCT01307020|2904358|P8|Overall Study|Lost to Follow-up|0
881246|NCT01307020|2904359|P7|Overall Study|Lost to Follow-up|1
881247|NCT01307020|2904360|P6|Overall Study|Lost to Follow-up|0
881248|NCT01307020|2904361|P5|Overall Study|Lost to Follow-up|0
881249|NCT01307020|2904362|P4|Overall Study|Lost to Follow-up|1
881250|NCT01307020|2904363|P3|Overall Study|Lost to Follow-up|1
881251|NCT01307020|2904364|P2|Overall Study|Lost to Follow-up|0
881252|NCT01307020|2904365|P1|Overall Study|Lost to Follow-up|0
881253|NCT01306968|2904420|P4|Overall Study|Withdrew over privacy concerns|1
881254|NCT01306968|2904421|P3|Overall Study|Withdrew over privacy concerns|0
881255|NCT01306968|2904422|P2|Overall Study|Withdrew over privacy concerns|0
881256|NCT01306968|2904423|P1|Overall Study|Withdrew over privacy concerns|0
881257|NCT01306968|2904420|P4|Overall Study|Withdrew - time commitment|2
881258|NCT01306968|2904421|P3|Overall Study|Withdrew - time commitment|0
881259|NCT01306968|2904422|P2|Overall Study|Withdrew - time commitment|0
881260|NCT01306968|2904423|P1|Overall Study|Withdrew - time commitment|0
881261|NCT01306968|2904420|P4|Overall Study|Relocated and left active duty|1
881262|NCT01306968|2904421|P3|Overall Study|Relocated and left active duty|1
881263|NCT01306968|2904422|P2|Overall Study|Relocated and left active duty|1
881264|NCT01306968|2904423|P1|Overall Study|Relocated and left active duty|0
881265|NCT01306968|2904420|P4|Overall Study|Physician Decision|0
881266|NCT01306968|2904421|P3|Overall Study|Physician Decision|0
881267|NCT01306968|2904422|P2|Overall Study|Physician Decision|1
881268|NCT01306968|2904423|P1|Overall Study|Physician Decision|0
881269|NCT01306968|2904420|P4|Overall Study|Lost to Follow-up|0
881270|NCT01306968|2904421|P3|Overall Study|Lost to Follow-up|0
881271|NCT01306968|2904422|P2|Overall Study|Lost to Follow-up|1
881272|NCT01306968|2904423|P1|Overall Study|Lost to Follow-up|1
881273|NCT01306877|2904447|P2|Overall Study|Physician Decision|1
881274|NCT01306877|2904448|P1|Overall Study|Physician Decision|0
881275|NCT01306877|2904447|P2|Overall Study|Lost to Follow-up|3
881276|NCT01306877|2904448|P1|Overall Study|Lost to Follow-up|3
881277|NCT01306643|2904466|P1|Overall Study|Other: Change in Eligibility Status|1
881278|NCT01306643|2904466|P1|Overall Study|Disease Progression|7
881279|NCT01306643|2904466|P1|Overall Study|Adverse Event|5
881280|NCT01306617|2904478|P3|Overall Study|Non-compliance|0
881281|NCT01306617|2904479|P2|Overall Study|Non-compliance|1
881282|NCT01306617|2904480|P1|Overall Study|Non-compliance|0
881283|NCT01306617|2904478|P3|Overall Study|Virologic Failure|5
881284|NCT01306617|2904479|P2|Overall Study|Virologic Failure|0
881285|NCT01306617|2904480|P1|Overall Study|Virologic Failure|0
881286|NCT01306617|2904478|P3|Overall Study|Adverse Event|0
881287|NCT01306617|2904479|P2|Overall Study|Adverse Event|0
881288|NCT01306617|2904480|P1|Overall Study|Adverse Event|1
881289|NCT01306305|2904523|P2|Overall Study|Withdrew consent|0
881290|NCT01306305|2904524|P1|Overall Study|Withdrew consent|1
881291|NCT01306305|2904523|P2|Overall Study|Lost to Follow-up|0
881292|NCT01306305|2904524|P1|Overall Study|Lost to Follow-up|1
881293|NCT01306253|2904561|P2|Overall Study|Lost to Follow-up|1
881294|NCT01306253|2904562|P1|Overall Study|Lost to Follow-up|1
881295|NCT01306214|2904579|P3|Overall Study|Not treated|1
881296|NCT01306214|2904580|P2|Overall Study|Not treated|1
881297|NCT01306214|2904581|P1|Overall Study|Not treated|1
881298|NCT01306214|2904579|P3|Overall Study|Withdrawal by Subject|16
881299|NCT01306214|2904580|P2|Overall Study|Withdrawal by Subject|22
881300|NCT01306214|2904581|P1|Overall Study|Withdrawal by Subject|24
881301|NCT01306214|2904579|P3|Overall Study|Lost to Follow-up|4
881302|NCT01306214|2904580|P2|Overall Study|Lost to Follow-up|5
881303|NCT01306214|2904581|P1|Overall Study|Lost to Follow-up|3
881304|NCT01306214|2904579|P3|Overall Study|Death|1
881305|NCT01306214|2904580|P2|Overall Study|Death|0
881306|NCT01306214|2904581|P1|Overall Study|Death|0
881307|NCT01306201|2904598|P1|Overall Study|Files unreadable|3
881308|NCT01306201|2904598|P1|Overall Study|Files could not be processed|3
881309|NCT01306201|2904598|P1|Overall Study|Arrhythmia|4
881310|NCT01306162|2904620|P4|Washout 1|Non-compliance to protocol|0
881311|NCT01306162|2904621|P3|Washout 1|Non-compliance to protocol|0
881312|NCT01306162|2904622|P2|Washout 1|Non-compliance to protocol|1
881313|NCT01306162|2904623|P1|Washout 1|Non-compliance to protocol|0
881314|NCT01306162|2904620|P4|Period 1|Adverse Event|1
881315|NCT01306162|2904621|P3|Period 1|Adverse Event|0
881316|NCT01306162|2904622|P2|Period 1|Adverse Event|0
881317|NCT01306162|2904623|P1|Period 1|Adverse Event|0
881318|NCT01306058|2904651|P1|Overall Study|Enrolled but did not get treatment|1
881319|NCT01306058|2904651|P1|Overall Study|Death|1
881320|NCT01306032|2904677|P6|Disease Progression/Crossover|other/symptomatic progression|0
881321|NCT01306032|2904678|P5|Disease Progression/Crossover|other/symptomatic progression|0
881322|NCT01306032|2904679|P4|Disease Progression/Crossover|other/symptomatic progression|2
881323|NCT01306032|2904680|P3|Disease Progression/Crossover|other/symptomatic progression|0
881324|NCT01306032|2904681|P2|Disease Progression/Crossover|other/symptomatic progression|2
881325|NCT01306032|2904682|P1|Disease Progression/Crossover|other/symptomatic progression|0
881326|NCT01306032|2904677|P6|Disease Progression/Crossover|Withdrawal by Subject|0
881327|NCT01306032|2904678|P5|Disease Progression/Crossover|Withdrawal by Subject|0
881328|NCT01306032|2904679|P4|Disease Progression/Crossover|Withdrawal by Subject|1
881329|NCT01306032|2904680|P3|Disease Progression/Crossover|Withdrawal by Subject|0
881330|NCT01306032|2904681|P2|Disease Progression/Crossover|Withdrawal by Subject|0
881331|NCT01306032|2904682|P1|Disease Progression/Crossover|Withdrawal by Subject|0
881332|NCT01306032|2904677|P6|First Intervention|Progressive disease|0
881333|NCT01306032|2904678|P5|First Intervention|Progressive disease|2
881334|NCT01306032|2904679|P4|First Intervention|Progressive disease|0
881335|NCT01306032|2904680|P3|First Intervention|Progressive disease|0
881336|NCT01306032|2904681|P2|First Intervention|Progressive disease|0
881337|NCT01306032|2904682|P1|First Intervention|Progressive disease|0
881338|NCT01306032|2904677|P6|First Intervention|Ineligible|1
881339|NCT01306032|2904678|P5|First Intervention|Ineligible|0
881340|NCT01306032|2904679|P4|First Intervention|Ineligible|0
881341|NCT01306032|2904680|P3|First Intervention|Ineligible|0
881342|NCT01306032|2904681|P2|First Intervention|Ineligible|0
881343|NCT01306032|2904682|P1|First Intervention|Ineligible|0
881344|NCT01306032|2904677|P6|First Intervention|Death|0
881345|NCT01306032|2904678|P5|First Intervention|Death|0
881346|NCT01306032|2904679|P4|First Intervention|Death|0
881347|NCT01306032|2904680|P3|First Intervention|Death|1
881348|NCT01306032|2904681|P2|First Intervention|Death|0
881349|NCT01306032|2904682|P1|First Intervention|Death|0
881350|NCT01306032|2904677|P6|First Intervention|Withdrawal by Subject|0
881351|NCT01306032|2904678|P5|First Intervention|Withdrawal by Subject|0
881352|NCT01306032|2904679|P4|First Intervention|Withdrawal by Subject|1
881353|NCT01306032|2904680|P3|First Intervention|Withdrawal by Subject|0
881354|NCT01306032|2904681|P2|First Intervention|Withdrawal by Subject|2
881355|NCT01306032|2904682|P1|First Intervention|Withdrawal by Subject|0
881356|NCT01306032|2904677|P6|First Intervention|Adverse Event|1
881357|NCT01306032|2904678|P5|First Intervention|Adverse Event|0
881358|NCT01306032|2904679|P4|First Intervention|Adverse Event|0
881359|NCT01306032|2904680|P3|First Intervention|Adverse Event|1
881360|NCT01306032|2904681|P2|First Intervention|Adverse Event|0
881361|NCT01306032|2904682|P1|First Intervention|Adverse Event|1
881362|NCT01305941|2904734|P1|Overall Study|Death|1
881363|NCT01305941|2904734|P1|Overall Study|Withdrawal by Subject|1
881364|NCT01305941|2904734|P1|Overall Study|Clinical decline|2
881365|NCT01305941|2904734|P1|Overall Study|Adverse Event|6
881366|NCT01305577|2904774|P3|Overall Study|Protocol Deviation|1
881367|NCT01305577|2904775|P2|Overall Study|Protocol Deviation|1
881368|NCT01305577|2904776|P1|Overall Study|Protocol Deviation|0
881369|NCT01305577|2904774|P3|Overall Study|Lost to Follow-up|2
881370|NCT01305577|2904775|P2|Overall Study|Lost to Follow-up|3
881371|NCT01305577|2904776|P1|Overall Study|Lost to Follow-up|4
881372|NCT01305577|2904774|P3|Overall Study|Withdrawal by Subject|6
881373|NCT01305577|2904775|P2|Overall Study|Withdrawal by Subject|5
881374|NCT01305577|2904776|P1|Overall Study|Withdrawal by Subject|7
881375|NCT01305577|2904774|P3|Overall Study|Adverse Event|1
881376|NCT01305577|2904775|P2|Overall Study|Adverse Event|2
881377|NCT01305577|2904776|P1|Overall Study|Adverse Event|2
881378|NCT01305564|2904805|P1|Overall Study|Physician Decision|3
881379|NCT01305564|2904805|P1|Overall Study|Withdrawal by Subject|1
881380|NCT01305564|2904805|P1|Overall Study|Lost to Follow-up|12
881381|NCT01305564|2904805|P1|Overall Study|Death|21
881382|NCT01305408|2904832|P2|Overall Study|Not specified|0
881383|NCT01305408|2904833|P1|Overall Study|Not specified|1
881384|NCT01305408|2904832|P2|Overall Study|Noncompliance with study procedures|1
881385|NCT01305408|2904833|P1|Overall Study|Noncompliance with study procedures|0
881386|NCT01305408|2904832|P2|Overall Study|Noncompliance with study medication|1
881387|NCT01305408|2904833|P1|Overall Study|Noncompliance with study medication|0
881388|NCT01305408|2904832|P2|Overall Study|Lost to Follow-up|3
881389|NCT01305408|2904833|P1|Overall Study|Lost to Follow-up|5
881390|NCT01305408|2904832|P2|Overall Study|Protocol Violation|6
881391|NCT01305408|2904833|P1|Overall Study|Protocol Violation|4
881392|NCT01305408|2904832|P2|Overall Study|Withdrawal by Subject|9
881393|NCT01305408|2904833|P1|Overall Study|Withdrawal by Subject|9
881394|NCT01305408|2904832|P2|Overall Study|Lack of Efficacy|4
881395|NCT01305408|2904833|P1|Overall Study|Lack of Efficacy|3
881396|NCT01305408|2904832|P2|Overall Study|Adverse Event|7
881397|NCT01305408|2904833|P1|Overall Study|Adverse Event|10
881398|NCT01305239|2904909|P1|Overall Study|Exemestane taken prior to inclusion only|1
881399|NCT01305239|2904909|P1|Overall Study|Adverse Event|22
881400|NCT01305200|2904939|P3|Overall Study|Death|0
881401|NCT01305200|2904940|P2|Overall Study|Death|2
881402|NCT01305200|2904941|P1|Overall Study|Death|0
881403|NCT01305200|2904939|P3|Overall Study|Ineligible|1
881404|NCT01305200|2904940|P2|Overall Study|Ineligible|2
881405|NCT01305200|2904941|P1|Overall Study|Ineligible|1
881406|NCT01305200|2904939|P3|Overall Study|Withdrawal by Subject|1
881407|NCT01305200|2904940|P2|Overall Study|Withdrawal by Subject|21
881408|NCT01305200|2904941|P1|Overall Study|Withdrawal by Subject|24
881409|NCT01305200|2904939|P3|Overall Study|Physician Decision|1
881410|NCT01305200|2904940|P2|Overall Study|Physician Decision|6
881411|NCT01305200|2904941|P1|Overall Study|Physician Decision|4
881412|NCT01305044|2904971|P2|Overall Study|Withdrawal by Subject|6
881413|NCT01305044|2904972|P1|Overall Study|Withdrawal by Subject|3
881414|NCT01304706|2905002|P1|Overall Study|Discontinued due to failed drug admin.|1
881415|NCT01304706|2905002|P1|Overall Study|Lost to Follow-up|7
881416|NCT01304706|2905002|P1|Overall Study|Withdrawal by Subject|3
881417|NCT01304706|2905002|P1|Overall Study|Death|3
881418|NCT01304706|2905002|P1|Overall Study|Lack of Efficacy|1
881419|NCT01304706|2905002|P1|Overall Study|Adverse Event|2
881420|NCT01304693|2905011|P5|Overall Study|Decision Unrelated to an Adverse Event|0
881421|NCT01304693|2905012|P4|Overall Study|Decision Unrelated to an Adverse Event|1
881422|NCT01304693|2905013|P3|Overall Study|Decision Unrelated to an Adverse Event|1
881423|NCT01304693|2905014|P2|Overall Study|Decision Unrelated to an Adverse Event|0
881424|NCT01304693|2905015|P1|Overall Study|Decision Unrelated to an Adverse Event|0
881425|NCT01304693|2905011|P5|Overall Study|Adverse Event|1
881426|NCT01304693|2905012|P4|Overall Study|Adverse Event|0
881427|NCT01304693|2905013|P3|Overall Study|Adverse Event|0
881428|NCT01304693|2905014|P2|Overall Study|Adverse Event|0
881429|NCT01304693|2905015|P1|Overall Study|Adverse Event|0
881430|NCT01304498|2905062|P2|Overall Study|Lost to Follow-up|1
881431|NCT01304498|2905063|P1|Overall Study|Lost to Follow-up|2
881432|NCT01304498|2905062|P2|Overall Study|Protocol Violation|0
881433|NCT01304498|2905063|P1|Overall Study|Protocol Violation|1
881434|NCT01304498|2905062|P2|Overall Study|Withdrawal by Subject|3
881435|NCT01304498|2905063|P1|Overall Study|Withdrawal by Subject|2
881436|NCT01304498|2905062|P2|Overall Study|Adverse Event|1
881437|NCT01304498|2905063|P1|Overall Study|Adverse Event|1
881438|NCT01304329|2905083|P6|Third Intervention (3 Days)|Adverse Event|0
881439|NCT01304329|2905084|P5|Third Intervention (3 Days)|Adverse Event|0
881440|NCT01304329|2905085|P4|Third Intervention (3 Days)|Adverse Event|0
881441|NCT01304329|2905086|P3|Third Intervention (3 Days)|Adverse Event|0
881442|NCT01304329|2905087|P2|Third Intervention (3 Days)|Adverse Event|1
881443|NCT01304329|2905088|P1|Third Intervention (3 Days)|Adverse Event|0
881444|NCT01304147|2905222|P2|Second Intervention (7days)|Withdrawal by Subject|1
881445|NCT01304147|2905223|P1|Second Intervention (7days)|Withdrawal by Subject|1
881446|NCT01303861|2905268|P4|Overall Study|Pregnancy|0
881447|NCT01303861|2905269|P3|Overall Study|Pregnancy|0
881448|NCT01303861|2905270|P2|Overall Study|Pregnancy|0
881449|NCT01303861|2905271|P1|Overall Study|Pregnancy|1
881450|NCT01303861|2905268|P4|Overall Study|Adverse Event|5
881451|NCT01303861|2905269|P3|Overall Study|Adverse Event|0
881452|NCT01303861|2905270|P2|Overall Study|Adverse Event|1
881453|NCT01303861|2905271|P1|Overall Study|Adverse Event|4
881454|NCT01303861|2905268|P4|Overall Study|Withdrawal by Subject|23
881455|NCT01303861|2905269|P3|Overall Study|Withdrawal by Subject|8
881456|NCT01303861|2905270|P2|Overall Study|Withdrawal by Subject|8
881457|NCT01303861|2905271|P1|Overall Study|Withdrawal by Subject|16
881458|NCT01303861|2905268|P4|Overall Study|Lack of Efficacy|0
881459|NCT01303861|2905269|P3|Overall Study|Lack of Efficacy|1
881460|NCT01303861|2905270|P2|Overall Study|Lack of Efficacy|2
881461|NCT01303861|2905271|P1|Overall Study|Lack of Efficacy|3
881462|NCT01303861|2905268|P4|Overall Study|Lost to Follow-up|31
881463|NCT01303861|2905269|P3|Overall Study|Lost to Follow-up|27
881464|NCT01303861|2905270|P2|Overall Study|Lost to Follow-up|14
881465|NCT01303861|2905271|P1|Overall Study|Lost to Follow-up|34
881466|NCT01303627|2905330|P2|Overall Study|the failure while performing URS|1
881467|NCT01303627|2905331|P1|Overall Study|the failure while performing URS|0
881468|NCT01303510|2905339|P2|Overall Study|Lost to Follow-up|0
881469|NCT01303510|2905340|P1|Overall Study|Lost to Follow-up|1
881470|NCT01303445|2905354|P2|Follow-up Period (14 Days)|Withdrawal by Subject|1
881471|NCT01303445|2905355|P1|Follow-up Period (14 Days)|Withdrawal by Subject|0
881472|NCT01303445|2905354|P2|Fourth Intervention (7 Days)|Withdrawal by Subject|0
881473|NCT01303445|2905355|P1|Fourth Intervention (7 Days)|Withdrawal by Subject|1
881474|NCT01303445|2905354|P2|Washout (14 Days)|Lost to Follow-up|2
881475|NCT01303445|2905355|P1|Washout (14 Days)|Lost to Follow-up|0
881476|NCT01303445|2905354|P2|Washout (14 Days)|Protocol Violation|0
881477|NCT01303445|2905355|P1|Washout (14 Days)|Protocol Violation|1
881478|NCT01303445|2905354|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
881479|NCT01303445|2905355|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
881480|NCT01303445|2905354|P2|Second Intervention (7 Days)|Adverse Event|2
881481|NCT01303445|2905355|P1|Second Intervention (7 Days)|Adverse Event|0
881482|NCT01303445|2905354|P2|First Intervention (7 Days)|Withdrawal by Subject|0
881483|NCT01303445|2905355|P1|First Intervention (7 Days)|Withdrawal by Subject|1
881484|NCT01303380|2905396|P1|Overall Study|Lack of compliance to study procedures|1
881485|NCT01303159|2905455|P1|Overall Study|Study Termination|7
881486|NCT01303159|2905455|P1|Overall Study|Death|16
881487|NCT01302964|2905473|P2|Overall Study|Adverse Event|0
881488|NCT01302964|2905474|P1|Overall Study|Adverse Event|1
881489|NCT01302938|2905484|P2|Overall Study|Adverse Event|0
881490|NCT01302938|2905485|P1|Overall Study|Adverse Event|1
881491|NCT01302938|2905484|P2|Overall Study|Withdrawal by Subject|0
881492|NCT01302938|2905485|P1|Overall Study|Withdrawal by Subject|1
881493|NCT01302899|2905530|P2|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1
881494|NCT01302899|2905531|P1|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0
881495|NCT01302899|2905530|P2|Period 2 (Weeks 7 to 12)|Protocol Deviation|0
881496|NCT01302899|2905531|P1|Period 2 (Weeks 7 to 12)|Protocol Deviation|1
881497|NCT01302691|2905611|P2|Overall Study|Protocol Violation|0
881498|NCT01302691|2905612|P1|Overall Study|Protocol Violation|1
881499|NCT01302691|2905611|P2|Overall Study|Physician Decision|1
881500|NCT01302691|2905612|P1|Overall Study|Physician Decision|0
881501|NCT01302691|2905611|P2|Overall Study|Blood Pressure/Potassium Criteria Met|4
881502|NCT01302691|2905612|P1|Overall Study|Blood Pressure/Potassium Criteria Met|6
881503|NCT01302691|2905611|P2|Overall Study|Lost to Follow-up|0
881504|NCT01302691|2905612|P1|Overall Study|Lost to Follow-up|1
881505|NCT01302691|2905611|P2|Overall Study|Death|1
881506|NCT01302691|2905612|P1|Overall Study|Death|0
881507|NCT01302691|2905611|P2|Overall Study|Adverse Event|0
881508|NCT01302691|2905612|P1|Overall Study|Adverse Event|2
881509|NCT01302548|2905632|P2|Overall Study|Lost to Follow-up|1
881510|NCT01302548|2905633|P1|Overall Study|Lost to Follow-up|2
881511|NCT01302418|2905683|P1|Overall Study|Non-evaluable|9
881512|NCT01302418|2905683|P1|Overall Study|Protocol Violation|9
881513|NCT01302392|2905689|P2|Overall Study|Withdrawal by Subject|1
881514|NCT01302392|2905690|P1|Overall Study|Withdrawal by Subject|6
881515|NCT01302392|2905689|P2|Overall Study|Lost to Follow-up|0
881516|NCT01302392|2905690|P1|Overall Study|Lost to Follow-up|1
881517|NCT01302366|2905710|P1|Overall Study|patient choice or noncompliance|5
881518|NCT01302119|2905718|P2|Overall Study|Non-specific|1
881519|NCT01302119|2905719|P1|Overall Study|Non-specific|4
881520|NCT01302119|2905718|P2|Overall Study|Non-compliance|2
881521|NCT01302119|2905719|P1|Overall Study|Non-compliance|4
881522|NCT01302119|2905718|P2|Overall Study|Adverse Event|1
881523|NCT01302119|2905719|P1|Overall Study|Adverse Event|2
881524|NCT01302119|2905718|P2|Overall Study|Lost to Follow-up|4
881525|NCT01302119|2905719|P1|Overall Study|Lost to Follow-up|10
881526|NCT01302119|2905718|P2|Overall Study|Withdrawal by Subject|20
881527|NCT01302119|2905719|P1|Overall Study|Withdrawal by Subject|30
881528|NCT01302067|2905734|P3|Overall Study|Adverse Event|45
881529|NCT01302067|2905735|P2|Overall Study|Adverse Event|14
881530|NCT01302067|2905736|P1|Overall Study|Adverse Event|27
881531|NCT01302067|2905734|P3|Overall Study|Protocol Violation|8
881532|NCT01302067|2905735|P2|Overall Study|Protocol Violation|0
881533|NCT01302067|2905736|P1|Overall Study|Protocol Violation|11
881534|NCT01302067|2905734|P3|Overall Study|Not specified|3
881535|NCT01302067|2905735|P2|Overall Study|Not specified|1
881536|NCT01302067|2905736|P1|Overall Study|Not specified|1
881537|NCT01302067|2905734|P3|Overall Study|Withdrawal by Subject|10
881538|NCT01302067|2905735|P2|Overall Study|Withdrawal by Subject|6
881539|NCT01302067|2905736|P1|Overall Study|Withdrawal by Subject|13
881540|NCT01302067|2905734|P3|Overall Study|Lost to Follow-up|15
881541|NCT01302067|2905735|P2|Overall Study|Lost to Follow-up|4
881542|NCT01302067|2905736|P1|Overall Study|Lost to Follow-up|9
881543|NCT01302067|2905734|P3|Overall Study|Lack of Efficacy|2
881544|NCT01302067|2905735|P2|Overall Study|Lack of Efficacy|4
881545|NCT01302067|2905736|P1|Overall Study|Lack of Efficacy|8
881546|NCT01302067|2905734|P3|Overall Study|Physician Decision|14
881547|NCT01302067|2905735|P2|Overall Study|Physician Decision|5
881548|NCT01302067|2905736|P1|Overall Study|Physician Decision|9
881549|NCT01302067|2905734|P3|Overall Study|Death|1
881550|NCT01302067|2905735|P2|Overall Study|Death|0
881551|NCT01302067|2905736|P1|Overall Study|Death|0
881552|NCT01302054|2905807|P3|Double-Blind Treatment Phase|Other|9
881553|NCT01302054|2905808|P2|Double-Blind Treatment Phase|Other|4
881554|NCT01302054|2905809|P1|Double-Blind Treatment Phase|Other|0
881555|NCT01302054|2905807|P3|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2
881556|NCT01302054|2905808|P2|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
881557|NCT01302054|2905809|P1|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
881558|NCT01302054|2905807|P3|Double-Blind Treatment Phase|Adverse Event|10
881559|NCT01302054|2905808|P2|Double-Blind Treatment Phase|Adverse Event|10
881560|NCT01302054|2905809|P1|Double-Blind Treatment Phase|Adverse Event|0
881561|NCT01302054|2905807|P3|Double-Blind Treatment Phase|Protocol Violation|6
881562|NCT01302054|2905808|P2|Double-Blind Treatment Phase|Protocol Violation|3
881563|NCT01302054|2905809|P1|Double-Blind Treatment Phase|Protocol Violation|0
881564|NCT01302054|2905807|P3|Double-Blind Treatment Phase|Withdrawal by Subject|14
881565|NCT01302054|2905808|P2|Double-Blind Treatment Phase|Withdrawal by Subject|6
881566|NCT01302054|2905809|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
881567|NCT01302054|2905807|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
881568|NCT01302054|2905808|P2|Double-Blind Treatment Phase|Lost to Follow-up|2
881569|NCT01302054|2905809|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
881570|NCT01302054|2905807|P3|Double-Blind Treatment Phase|Lack of Efficacy|4
881571|NCT01302054|2905808|P2|Double-Blind Treatment Phase|Lack of Efficacy|2
881572|NCT01302054|2905809|P1|Double-Blind Treatment Phase|Lack of Efficacy|0
881573|NCT01302054|2905807|P3|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
881574|NCT01302054|2905808|P2|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
881575|NCT01302054|2905809|P1|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2
881576|NCT01302054|2905807|P3|Tolterodine Open-Label Run-In Phase|Other|0
881577|NCT01302054|2905808|P2|Tolterodine Open-Label Run-In Phase|Other|0
881578|NCT01302054|2905809|P1|Tolterodine Open-Label Run-In Phase|Other|7
881579|NCT01302054|2905807|P3|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
881580|NCT01302054|2905808|P2|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
881581|NCT01302054|2905809|P1|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314
881582|NCT01302054|2905807|P3|Tolterodine Open-Label Run-In Phase|Adverse Event|0
881583|NCT01302054|2905808|P2|Tolterodine Open-Label Run-In Phase|Adverse Event|0
881584|NCT01302054|2905809|P1|Tolterodine Open-Label Run-In Phase|Adverse Event|13
881585|NCT01302054|2905807|P3|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
881586|NCT01302054|2905808|P2|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
881587|NCT01302054|2905809|P1|Tolterodine Open-Label Run-In Phase|Protocol Violation|8
881588|NCT01302054|2905807|P3|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
881589|NCT01302054|2905808|P2|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
881590|NCT01302054|2905809|P1|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16
881591|NCT01302054|2905807|P3|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
881592|NCT01302054|2905808|P2|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
881593|NCT01302054|2905809|P1|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17
881594|NCT01302054|2905807|P3|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
881595|NCT01302054|2905808|P2|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
881596|NCT01302054|2905809|P1|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4
881597|NCT01302041|2905836|P1|Overall Study|Other-Miscellaneous Reason|2
881598|NCT01302041|2905836|P1|Overall Study|Other-Transitioned to 9785-CL-0123|29
881599|NCT01302041|2905836|P1|Overall Study|Withdrawal by Subject|4
881600|NCT01302041|2905836|P1|Overall Study|Death|5
881601|NCT01301950|2905878|P2|Overall Study|Surgery was cancelled by patient|1
881602|NCT01301950|2905879|P1|Overall Study|Surgery was cancelled by patient|0
881603|NCT01301833|2905897|P4|Overall Study|Personal matter|0
881604|NCT01301833|2905898|P3|Overall Study|Personal matter|0
881605|NCT01301833|2905899|P2|Overall Study|Personal matter|0
881606|NCT01301833|2905900|P1|Overall Study|Personal matter|1
881607|NCT01301833|2905897|P4|Overall Study|Withdrawal by Subject|2
881608|NCT01301833|2905898|P3|Overall Study|Withdrawal by Subject|1
881609|NCT01301833|2905899|P2|Overall Study|Withdrawal by Subject|1
881610|NCT01301833|2905900|P1|Overall Study|Withdrawal by Subject|3
881611|NCT01301833|2905897|P4|Overall Study|Physician Decision|0
881612|NCT01301833|2905898|P3|Overall Study|Physician Decision|1
881613|NCT01301833|2905899|P2|Overall Study|Physician Decision|1
881614|NCT01301833|2905900|P1|Overall Study|Physician Decision|3
881615|NCT01301833|2905897|P4|Overall Study|Lack of Efficacy|0
881616|NCT01301833|2905898|P3|Overall Study|Lack of Efficacy|0
881617|NCT01301833|2905899|P2|Overall Study|Lack of Efficacy|1
881618|NCT01301833|2905900|P1|Overall Study|Lack of Efficacy|1
881619|NCT01301833|2905897|P4|Overall Study|Adverse Event|5
881620|NCT01301833|2905898|P3|Overall Study|Adverse Event|5
881621|NCT01301833|2905899|P2|Overall Study|Adverse Event|5
881622|NCT01301833|2905900|P1|Overall Study|Adverse Event|7
881623|NCT01301729|2905938|P1|Overall Study|Violated Selection Criteria|1
881624|NCT01301729|2905938|P1|Overall Study|Participant did not Return for Treatment|1
881625|NCT01301729|2905938|P1|Overall Study|Withdrawal by Subject|2
881626|NCT01301625|2905949|P1|Overall Study|Lost to Follow-up|1
881627|NCT01301625|2905949|P1|Overall Study|Expected|8
881628|NCT01301625|2905949|P1|Overall Study|Not Due|21
881629|NCT01301625|2905949|P1|Overall Study|Death|5
881630|NCT01301508|2906021|P2|Overall Study|Lost to Follow-up|1
881631|NCT01301508|2906022|P1|Overall Study|Lost to Follow-up|0
881632|NCT01301508|2906021|P2|Overall Study|Withdrawal by Subject|2
881633|NCT01301508|2906022|P1|Overall Study|Withdrawal by Subject|1
881634|NCT01301456|2906052|P12|Stage 2|Adverse Event|0
881635|NCT01301456|2906053|P11|Stage 2|Adverse Event|1
881636|NCT01301456|2906054|P10|Stage 2|Adverse Event|0
881637|NCT01301456|2906055|P9|Stage 2|Adverse Event|0
881638|NCT01301456|2906056|P8|Stage 2|Adverse Event|0
881639|NCT01301456|2906057|P7|Stage 2|Adverse Event|0
881640|NCT01301456|2906058|P6|Stage 2|Adverse Event|0
881641|NCT01301456|2906059|P5|Stage 2|Adverse Event|0
881642|NCT01301456|2906060|P4|Stage 2|Adverse Event|0
881643|NCT01301456|2906061|P3|Stage 2|Adverse Event|0
881644|NCT01301456|2906062|P2|Stage 2|Adverse Event|0
881645|NCT01301456|2906063|P1|Stage 2|Adverse Event|0
881646|NCT01301456|2906052|P12|Stage 1|Randomized but not treated|0
881647|NCT01301456|2906053|P11|Stage 1|Randomized but not treated|0
881648|NCT01301456|2906054|P10|Stage 1|Randomized but not treated|0
881649|NCT01301456|2906055|P9|Stage 1|Randomized but not treated|0
881650|NCT01301456|2906056|P8|Stage 1|Randomized but not treated|0
881651|NCT01301456|2906057|P7|Stage 1|Randomized but not treated|1
881652|NCT01301456|2906058|P6|Stage 1|Randomized but not treated|0
881653|NCT01301456|2906059|P5|Stage 1|Randomized but not treated|0
881654|NCT01301456|2906060|P4|Stage 1|Randomized but not treated|0
881655|NCT01301456|2906061|P3|Stage 1|Randomized but not treated|0
881656|NCT01301456|2906062|P2|Stage 1|Randomized but not treated|0
881657|NCT01301456|2906063|P1|Stage 1|Randomized but not treated|0
881658|NCT01301456|2906052|P12|Stage 1|Withdrawal by Subject|0
881659|NCT01301456|2906053|P11|Stage 1|Withdrawal by Subject|0
881660|NCT01301456|2906054|P10|Stage 1|Withdrawal by Subject|0
881661|NCT01301456|2906055|P9|Stage 1|Withdrawal by Subject|0
881662|NCT01301456|2906056|P8|Stage 1|Withdrawal by Subject|0
881663|NCT01301456|2906057|P7|Stage 1|Withdrawal by Subject|0
881664|NCT01301456|2906058|P6|Stage 1|Withdrawal by Subject|0
881665|NCT01301456|2906059|P5|Stage 1|Withdrawal by Subject|1
881666|NCT01301456|2906060|P4|Stage 1|Withdrawal by Subject|0
881667|NCT01301456|2906061|P3|Stage 1|Withdrawal by Subject|1
881668|NCT01301456|2906062|P2|Stage 1|Withdrawal by Subject|0
881669|NCT01301456|2906063|P1|Stage 1|Withdrawal by Subject|0
881670|NCT01301391|2906289|P1|Overall Study|Sponsor's decision|8
881671|NCT01301391|2906289|P1|Overall Study|Physician Decision|2
881672|NCT01301391|2906289|P1|Overall Study|Lost to Follow-up|3
881673|NCT01301391|2906289|P1|Overall Study|Death|13
881674|NCT01301274|2906301|P2|Overall Study|Physician Decision|1
881675|NCT01301274|2906302|P1|Overall Study|Physician Decision|2
881676|NCT01301092|2906317|P3|Overall Study|Lost to Follow-up|1
881677|NCT01301092|2906318|P2|Overall Study|Lost to Follow-up|0
881678|NCT01301092|2906319|P1|Overall Study|Lost to Follow-up|0
881679|NCT01301079|2906336|P2|Overall Study|Lost to Follow-up|2
881680|NCT01301079|2906337|P1|Overall Study|Lost to Follow-up|2
881681|NCT01301066|2906415|P2|Overall Study|Other|0
881682|NCT01301066|2906416|P1|Overall Study|Other|2
881683|NCT01301066|2906415|P2|Overall Study|Physician Decision|1
881684|NCT01301066|2906416|P1|Overall Study|Physician Decision|0
881685|NCT01301066|2906415|P2|Overall Study|Sponsor Decision|1
881686|NCT01301066|2906416|P1|Overall Study|Sponsor Decision|2
881687|NCT01301066|2906415|P2|Overall Study|Adverse Event|6
881688|NCT01301066|2906416|P1|Overall Study|Adverse Event|6
881689|NCT01301066|2906415|P2|Overall Study|Withdrawal by Subject|9
881690|NCT01301066|2906416|P1|Overall Study|Withdrawal by Subject|4
881691|NCT01301066|2906415|P2|Overall Study|Protocol Violation|7
881692|NCT01301066|2906416|P1|Overall Study|Protocol Violation|8
881693|NCT01301066|2906415|P2|Overall Study|Lost to Follow-up|11
881694|NCT01301066|2906416|P1|Overall Study|Lost to Follow-up|5
881695|NCT01301027|2906424|P2|Overall Study|Volume Overload|0
881696|NCT01301027|2906425|P1|Overall Study|Volume Overload|3
881697|NCT01301027|2906424|P2|Overall Study|Transplant|2
881698|NCT01301027|2906425|P1|Overall Study|Transplant|0
881699|NCT01301027|2906424|P2|Overall Study|Fracture|3
881700|NCT01301027|2906425|P1|Overall Study|Fracture|1
881701|NCT01301027|2906424|P2|Overall Study|Adverse Event|2
881702|NCT01301027|2906425|P1|Overall Study|Adverse Event|0
881703|NCT01301027|2906424|P2|Overall Study|Withdrawal by Subject|3
881704|NCT01301027|2906425|P1|Overall Study|Withdrawal by Subject|2
881705|NCT01301027|2906424|P2|Overall Study|Physician Decision|0
881706|NCT01301027|2906425|P1|Overall Study|Physician Decision|2
881707|NCT01301001|2906437|P2|Second Intervention|Withdrawal by Subject|0
881708|NCT01301001|2906438|P1|Second Intervention|Withdrawal by Subject|2
881709|NCT01301001|2906437|P2|Second Intervention|Adverse Event|0
881710|NCT01301001|2906438|P1|Second Intervention|Adverse Event|2
881711|NCT01301001|2906437|P2|First Intervention|Protocol Violation|1
881712|NCT01301001|2906438|P1|First Intervention|Protocol Violation|0
881713|NCT01301001|2906437|P2|First Intervention|Adverse Event|0
881714|NCT01301001|2906438|P1|First Intervention|Adverse Event|5
881715|NCT01301001|2906437|P2|First Intervention|Withdrawal by Subject|4
881716|NCT01301001|2906438|P1|First Intervention|Withdrawal by Subject|1
881717|NCT01301001|2906437|P2|First Intervention|Lost to Follow-up|4
881718|NCT01301001|2906438|P1|First Intervention|Lost to Follow-up|4
881719|NCT01300923|2906461|P2|Overall Study|Physician Decision|2
881720|NCT01300923|2906462|P1|Overall Study|Physician Decision|0
881721|NCT01300819|2906475|P2|Overall Study|Follow up call was not done|0
881722|NCT01300819|2906476|P1|Overall Study|Follow up call was not done|1
881723|NCT01300819|2906475|P2|Overall Study|Safety follow up not done by mistake|1
881724|NCT01300819|2906476|P1|Overall Study|Safety follow up not done by mistake|0
881725|NCT01300819|2906475|P2|Overall Study|Administrative reason|1
881726|NCT01300819|2906476|P1|Overall Study|Administrative reason|0
881727|NCT01300819|2906475|P2|Overall Study|Refusal to down titrate study drug|1
881728|NCT01300819|2906476|P1|Overall Study|Refusal to down titrate study drug|0
881729|NCT01300819|2906475|P2|Overall Study|Patient was 1 month late for Visit 10|1
881730|NCT01300819|2906476|P1|Overall Study|Patient was 1 month late for Visit 10|0
881731|NCT01300819|2906475|P2|Overall Study|Withdrawal by Subject|12
881732|NCT01300819|2906476|P1|Overall Study|Withdrawal by Subject|10
881733|NCT01300819|2906475|P2|Overall Study|Lack of Efficacy|1
881734|NCT01300819|2906476|P1|Overall Study|Lack of Efficacy|2
881735|NCT01300819|2906475|P2|Overall Study|Adverse Event|27
881736|NCT01300819|2906476|P1|Overall Study|Adverse Event|9
881737|NCT01300767|2906504|P1|Overall Study|Unacceptable fit|1
881738|NCT01300767|2906504|P1|Overall Study|Biomicroscopy|1
881739|NCT01300767|2906504|P1|Overall Study|Discomfort|2
881740|NCT01300741|2906532|P1|Overall Study|Discomfort|1
881741|NCT01300741|2906532|P1|Overall Study|Lost to Follow-up|1
881742|NCT01300741|2906532|P1|Overall Study|Lens deposits|1
881743|NCT01300728|2906562|P2|Overall Study|Physician Decision|0
881744|NCT01300728|2906563|P1|Overall Study|Physician Decision|1
881745|NCT01300728|2906562|P2|Overall Study|Withdrawal by Subject|1
881746|NCT01300728|2906563|P1|Overall Study|Withdrawal by Subject|1
881747|NCT01300650|2906577|P1|Overall Study|Adverse Event|1
881748|NCT01300546|2906604|P2|Overall Study|Adverse Event|1
881749|NCT01300546|2906605|P1|Overall Study|Adverse Event|0
881750|NCT01300546|2906604|P2|Overall Study|Lack of Efficacy|3
881751|NCT01300546|2906605|P1|Overall Study|Lack of Efficacy|0
881752|NCT01300546|2906604|P2|Overall Study|Lost to Follow-up|2
881753|NCT01300546|2906605|P1|Overall Study|Lost to Follow-up|0
881754|NCT01300546|2906604|P2|Overall Study|Withdrawal by Subject|0
881755|NCT01300546|2906605|P1|Overall Study|Withdrawal by Subject|1
881756|NCT01300455|2906635|P2|Washout|Withdrawal by Subject|0
881757|NCT01300455|2906636|P1|Washout|Withdrawal by Subject|1
881758|NCT01300351|2906656|P2|Overall Study|Withdrawal by Subject|10
881759|NCT01300351|2906657|P1|Overall Study|Withdrawal by Subject|7
881760|NCT01300351|2906656|P2|Overall Study|Adverse Event|4
881761|NCT01300351|2906657|P1|Overall Study|Adverse Event|0
881762|NCT01300351|2906656|P2|Overall Study|Lost to Follow-up|1
881763|NCT01300351|2906657|P1|Overall Study|Lost to Follow-up|0
881764|NCT01300351|2906656|P2|Overall Study|Ongoing treatment at data cut-off|23
881765|NCT01300351|2906657|P1|Overall Study|Ongoing treatment at data cut-off|27
881766|NCT01300351|2906656|P2|Overall Study|Did not receive treatment|0
881767|NCT01300351|2906657|P1|Overall Study|Did not receive treatment|2
881768|NCT01300338|2906673|P2|Overall Study|Lost to Follow-up|0
881769|NCT01300338|2906674|P1|Overall Study|Lost to Follow-up|5
881770|NCT01300286|2906682|P1|Overall Study|did not get dosed|1
881771|NCT01300260|2906692|P2|Period 2 of Study: Second Intervention|Adverse Event|1
881772|NCT01300260|2906693|P1|Period 2 of Study: Second Intervention|Adverse Event|0
881773|NCT01300260|2906692|P2|Period 1 of Study: First Intervention|Withdrawal by Subject|0
881774|NCT01300260|2906693|P1|Period 1 of Study: First Intervention|Withdrawal by Subject|1
881775|NCT01300260|2906692|P2|Period 1 of Study: First Intervention|Adverse Event|1
881776|NCT01300260|2906693|P1|Period 1 of Study: First Intervention|Adverse Event|0
881777|NCT01300247|2906725|P2|Overall Study|Non-Compliance|1
881778|NCT01300247|2906726|P1|Overall Study|Non-Compliance|0
881779|NCT01300247|2906725|P2|Overall Study|Withdrawal by Subject|0
881780|NCT01300247|2906726|P1|Overall Study|Withdrawal by Subject|1
881781|NCT01300247|2906725|P2|Overall Study|Lost to Follow-up|0
881782|NCT01300247|2906726|P1|Overall Study|Lost to Follow-up|2
881783|NCT01300247|2906725|P2|Overall Study|Death|1
881784|NCT01300247|2906726|P1|Overall Study|Death|1
881785|NCT01300234|2906758|P2|Overall Study|Participant refused return to hospital|0
881786|NCT01300234|2906759|P1|Overall Study|Participant refused return to hospital|1
881787|NCT01300234|2906758|P2|Overall Study|Participant stopped medication|1
881788|NCT01300234|2906759|P1|Overall Study|Participant stopped medication|1
881789|NCT01300234|2906758|P2|Overall Study|Participant reached stopping critera|0
881790|NCT01300234|2906759|P1|Overall Study|Participant reached stopping critera|2
881791|NCT01300234|2906758|P2|Overall Study|Pregnancy|1
881792|NCT01300234|2906759|P1|Overall Study|Pregnancy|2
881793|NCT01300234|2906758|P2|Overall Study|Lost to Follow-up|12
881794|NCT01300234|2906759|P1|Overall Study|Lost to Follow-up|14
881795|NCT01300234|2906758|P2|Overall Study|Withdrawal by Subject|9
881796|NCT01300234|2906759|P1|Overall Study|Withdrawal by Subject|5
881797|NCT01300234|2906758|P2|Overall Study|Protocol Violation|3
881798|NCT01300234|2906759|P1|Overall Study|Protocol Violation|2
881799|NCT01300234|2906758|P2|Overall Study|Adverse Event|1
881800|NCT01300234|2906759|P1|Overall Study|Adverse Event|1
881801|NCT01300052|2906795|P2|Overall Study|Protocol Violation|1
881802|NCT01300052|2906796|P1|Overall Study|Protocol Violation|1
881803|NCT01300052|2906795|P2|Overall Study|Withdrawal by Subject|2
881804|NCT01300052|2906796|P1|Overall Study|Withdrawal by Subject|2
881805|NCT01300052|2906795|P2|Overall Study|Adverse Event|0
881806|NCT01300052|2906796|P1|Overall Study|Adverse Event|3
881807|NCT01299961|2906814|P1|Overall Study|Lost to Follow-up|1
881808|NCT01299961|2906814|P1|Overall Study|Lack of Efficacy|2
881809|NCT01299961|2906814|P1|Overall Study|Adverse Event|3
881810|NCT01299909|2906823|P3|Overall Study|Lost to Follow-up|17
881811|NCT01299909|2906824|P2|Overall Study|Lost to Follow-up|18
881812|NCT01299909|2906825|P1|Overall Study|Lost to Follow-up|22
881813|NCT01299896|2906840|P2|Overall Study|Lost to Follow-up|11
881814|NCT01299896|2906841|P1|Overall Study|Lost to Follow-up|0
881815|NCT01299896|2906840|P2|Overall Study|Withdrawal by Subject|7
881816|NCT01299896|2906841|P1|Overall Study|Withdrawal by Subject|1
881817|NCT01299805|2906849|P2|Overall Study|Adverse Event|0
881818|NCT01299805|2906850|P1|Overall Study|Adverse Event|2
881819|NCT01299766|2906880|P2|Overall Study|Withdrawal by Subject|19
881820|NCT01299766|2906881|P1|Overall Study|Withdrawal by Subject|29
881821|NCT01299766|2906880|P2|Overall Study|Death|4
881822|NCT01299766|2906881|P1|Overall Study|Death|5
881823|NCT01299584|2906939|P1|Overall Study|Protocol Violation|9
881824|NCT01299571|2906946|P1|Overall Study|Protocol Violation|107
881825|NCT01299480|2906957|P5|Overall Study|Started, but not vaccinated|0
881826|NCT01299480|2906958|P4|Overall Study|Started, but not vaccinated|1
881827|NCT01299480|2906959|P3|Overall Study|Started, but not vaccinated|1
881828|NCT01299480|2906960|P2|Overall Study|Started, but not vaccinated|0
881829|NCT01299480|2906961|P1|Overall Study|Started, but not vaccinated|0
881830|NCT01299480|2906957|P5|Overall Study|Other|3
881831|NCT01299480|2906958|P4|Overall Study|Other|0
881832|NCT01299480|2906959|P3|Overall Study|Other|3
881833|NCT01299480|2906960|P2|Overall Study|Other|2
881834|NCT01299480|2906961|P1|Overall Study|Other|3
881835|NCT01299480|2906957|P5|Overall Study|Lost to Follow-up|2
881836|NCT01299480|2906958|P4|Overall Study|Lost to Follow-up|1
881837|NCT01299480|2906959|P3|Overall Study|Lost to Follow-up|2
881838|NCT01299480|2906960|P2|Overall Study|Lost to Follow-up|1
881839|NCT01299480|2906961|P1|Overall Study|Lost to Follow-up|3
881840|NCT01299480|2906957|P5|Overall Study|Physician Decision|0
881841|NCT01299480|2906958|P4|Overall Study|Physician Decision|2
881842|NCT01299480|2906959|P3|Overall Study|Physician Decision|0
881843|NCT01299480|2906960|P2|Overall Study|Physician Decision|1
881844|NCT01299480|2906961|P1|Overall Study|Physician Decision|1
881845|NCT01299480|2906957|P5|Overall Study|Withdrawal due to pregnancy|0
881846|NCT01299480|2906958|P4|Overall Study|Withdrawal due to pregnancy|0
881847|NCT01299480|2906959|P3|Overall Study|Withdrawal due to pregnancy|1
881848|NCT01299480|2906960|P2|Overall Study|Withdrawal due to pregnancy|1
881849|NCT01299480|2906961|P1|Overall Study|Withdrawal due to pregnancy|0
881850|NCT01299480|2906957|P5|Overall Study|Adverse Event|0
881851|NCT01299480|2906958|P4|Overall Study|Adverse Event|4
881852|NCT01299480|2906959|P3|Overall Study|Adverse Event|5
881853|NCT01299480|2906960|P2|Overall Study|Adverse Event|4
881854|NCT01299480|2906961|P1|Overall Study|Adverse Event|6
881855|NCT01299480|2906957|P5|Overall Study|Withdrawal by Subject|4
881856|NCT01299480|2906958|P4|Overall Study|Withdrawal by Subject|3
881857|NCT01299480|2906959|P3|Overall Study|Withdrawal by Subject|7
881858|NCT01299480|2906960|P2|Overall Study|Withdrawal by Subject|4
881859|NCT01299480|2906961|P1|Overall Study|Withdrawal by Subject|3
881860|NCT01299480|2906957|P5|Overall Study|Protocol Violation|1
881861|NCT01299480|2906958|P4|Overall Study|Protocol Violation|1
881862|NCT01299480|2906959|P3|Overall Study|Protocol Violation|8
881863|NCT01299480|2906960|P2|Overall Study|Protocol Violation|5
881864|NCT01299480|2906961|P1|Overall Study|Protocol Violation|7
881865|NCT01299480|2906957|P5|Overall Study|No longer willing to participate|10
881866|NCT01299480|2906958|P4|Overall Study|No longer willing to participate|13
881867|NCT01299480|2906959|P3|Overall Study|No longer willing to participate|14
881868|NCT01299480|2906960|P2|Overall Study|No longer willing to participate|17
881869|NCT01299480|2906961|P1|Overall Study|No longer willing to participate|19
881870|NCT01299389|2907163|P4|Post-observational|Other|6
881871|NCT01299389|2907164|P3|Post-observational|Other|12
881872|NCT01299389|2907165|P2|Post-observational|Other|0
881873|NCT01299389|2907166|P1|Post-observational|Other|0
881874|NCT01299389|2907163|P4|Double-blind|fail to meet “study population” criteria|0
881875|NCT01299389|2907164|P3|Double-blind|fail to meet “study population” criteria|0
881876|NCT01299389|2907165|P2|Double-blind|fail to meet “study population” criteria|1
881877|NCT01299389|2907166|P1|Double-blind|fail to meet “study population” criteria|0
881878|NCT01299389|2907163|P4|Double-blind|Other|0
881879|NCT01299389|2907164|P3|Double-blind|Other|0
881880|NCT01299389|2907165|P2|Double-blind|Other|1
881881|NCT01299389|2907166|P1|Double-blind|Other|1
881882|NCT01299389|2907163|P4|Double-blind|Withdrawal by Subject|0
881883|NCT01299389|2907164|P3|Double-blind|Withdrawal by Subject|0
881884|NCT01299389|2907165|P2|Double-blind|Withdrawal by Subject|13
881885|NCT01299389|2907166|P1|Double-blind|Withdrawal by Subject|16
881886|NCT01299389|2907163|P4|Double-blind|Lost to Follow-up|0
881887|NCT01299389|2907164|P3|Double-blind|Lost to Follow-up|0
881888|NCT01299389|2907165|P2|Double-blind|Lost to Follow-up|1
881889|NCT01299389|2907166|P1|Double-blind|Lost to Follow-up|2
881890|NCT01299389|2907163|P4|Double-blind|Lack of Efficacy|0
881891|NCT01299389|2907164|P3|Double-blind|Lack of Efficacy|0
881892|NCT01299389|2907165|P2|Double-blind|Lack of Efficacy|21
881893|NCT01299389|2907166|P1|Double-blind|Lack of Efficacy|45
881894|NCT01299389|2907163|P4|Double-blind|Adverse Event|0
881895|NCT01299389|2907164|P3|Double-blind|Adverse Event|0
881896|NCT01299389|2907165|P2|Double-blind|Adverse Event|27
881897|NCT01299389|2907166|P1|Double-blind|Adverse Event|45
881898|NCT01299376|2907188|P2|Extension (Weeks 9 to 52)|Physician Decision|0
881899|NCT01299376|2907189|P1|Extension (Weeks 9 to 52)|Physician Decision|1
881900|NCT01299376|2907188|P2|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9
881901|NCT01299376|2907189|P1|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4
881902|NCT01299376|2907188|P2|Extension (Weeks 9 to 52)|Lost to Follow-up|2
881903|NCT01299376|2907189|P1|Extension (Weeks 9 to 52)|Lost to Follow-up|1
881904|NCT01299376|2907188|P2|Extension (Weeks 9 to 52)|Adverse Event|3
881905|NCT01299376|2907189|P1|Extension (Weeks 9 to 52)|Adverse Event|2
881906|NCT01299376|2907188|P2|Extension (Weeks 9 to 52)|Withdrawal by Subject|1
881907|NCT01299376|2907189|P1|Extension (Weeks 9 to 52)|Withdrawal by Subject|2
881908|NCT01299376|2907188|P2|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
881909|NCT01299376|2907189|P1|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
881910|NCT01299376|2907188|P2|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0
881911|NCT01299376|2907189|P1|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1
881912|NCT01299376|2907188|P2|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7
881913|NCT01299376|2907189|P1|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4
881914|NCT01299376|2907188|P2|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1
881915|NCT01299376|2907189|P1|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0
881916|NCT01299376|2907188|P2|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1
881917|NCT01299376|2907189|P1|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0
881918|NCT01299376|2907188|P2|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2
881919|NCT01299376|2907189|P1|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1
881920|NCT01299272|2907232|P4|Double-blind (DB) Randomized Period|Sponsor Decision|1
881921|NCT01299272|2907233|P3|Double-blind (DB) Randomized Period|Sponsor Decision|1
881922|NCT01299272|2907234|P2|Double-blind (DB) Randomized Period|Sponsor Decision|0
881923|NCT01299272|2907235|P1|Double-blind (DB) Randomized Period|Sponsor Decision|0
881924|NCT01299272|2907232|P4|Double-blind (DB) Randomized Period|Physician Decision|1
881925|NCT01299272|2907233|P3|Double-blind (DB) Randomized Period|Physician Decision|2
881926|NCT01299272|2907234|P2|Double-blind (DB) Randomized Period|Physician Decision|0
881927|NCT01299272|2907235|P1|Double-blind (DB) Randomized Period|Physician Decision|0
881928|NCT01299272|2907232|P4|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10
881929|NCT01299272|2907233|P3|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4
881930|NCT01299272|2907234|P2|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
881931|NCT01299272|2907235|P1|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
881932|NCT01299272|2907232|P4|Double-blind (DB) Randomized Period|Lost to Follow-up|5
881933|NCT01299272|2907233|P3|Double-blind (DB) Randomized Period|Lost to Follow-up|5
881934|NCT01299272|2907234|P2|Double-blind (DB) Randomized Period|Lost to Follow-up|0
881935|NCT01299272|2907235|P1|Double-blind (DB) Randomized Period|Lost to Follow-up|0
881936|NCT01299272|2907232|P4|Double-blind (DB) Randomized Period|Protocol Violation|7
881937|NCT01299272|2907233|P3|Double-blind (DB) Randomized Period|Protocol Violation|8
881938|NCT01299272|2907234|P2|Double-blind (DB) Randomized Period|Protocol Violation|0
881939|NCT01299272|2907235|P1|Double-blind (DB) Randomized Period|Protocol Violation|0
881940|NCT01299272|2907232|P4|Double-blind (DB) Randomized Period|Adverse Event|9
881941|NCT01299272|2907233|P3|Double-blind (DB) Randomized Period|Adverse Event|8
881942|NCT01299272|2907234|P2|Double-blind (DB) Randomized Period|Adverse Event|0
881943|NCT01299272|2907235|P1|Double-blind (DB) Randomized Period|Adverse Event|0
881944|NCT01299272|2907232|P4|Double-blind (DB) Randomized Period|Lack of Efficacy|10
881945|NCT01299272|2907233|P3|Double-blind (DB) Randomized Period|Lack of Efficacy|20
881946|NCT01299272|2907234|P2|Double-blind (DB) Randomized Period|Lack of Efficacy|0
881947|NCT01299272|2907235|P1|Double-blind (DB) Randomized Period|Lack of Efficacy|0
881948|NCT01299272|2907232|P4|Double-blind (DB) Randomized Period|Withdrawal by Subject|15
881949|NCT01299272|2907233|P3|Double-blind (DB) Randomized Period|Withdrawal by Subject|22
881950|NCT01299272|2907234|P2|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
881951|NCT01299272|2907235|P1|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
881952|NCT01299272|2907232|P4|Stabilization Open-label (OL) Period|Physician Decision|0
881953|NCT01299272|2907233|P3|Stabilization Open-label (OL) Period|Physician Decision|0
881954|NCT01299272|2907234|P2|Stabilization Open-label (OL) Period|Physician Decision|3
881955|NCT01299272|2907235|P1|Stabilization Open-label (OL) Period|Physician Decision|0
881956|NCT01299272|2907232|P4|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
881957|NCT01299272|2907233|P3|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
881958|NCT01299272|2907234|P2|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6
881959|NCT01299272|2907235|P1|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
881960|NCT01299272|2907232|P4|Stabilization Open-label (OL) Period|Lost to Follow-up|0
881961|NCT01299272|2907233|P3|Stabilization Open-label (OL) Period|Lost to Follow-up|0
881962|NCT01299272|2907234|P2|Stabilization Open-label (OL) Period|Lost to Follow-up|9
881963|NCT01299272|2907235|P1|Stabilization Open-label (OL) Period|Lost to Follow-up|0
881964|NCT01299272|2907232|P4|Stabilization Open-label (OL) Period|Lack of Efficacy|0
881965|NCT01299272|2907233|P3|Stabilization Open-label (OL) Period|Lack of Efficacy|0
881966|NCT01299272|2907234|P2|Stabilization Open-label (OL) Period|Lack of Efficacy|11
881967|NCT01299272|2907235|P1|Stabilization Open-label (OL) Period|Lack of Efficacy|0
881968|NCT01299272|2907232|P4|Stabilization Open-label (OL) Period|Sponsor Decision|0
881969|NCT01299272|2907233|P3|Stabilization Open-label (OL) Period|Sponsor Decision|0
881970|NCT01299272|2907234|P2|Stabilization Open-label (OL) Period|Sponsor Decision|12
881971|NCT01299272|2907235|P1|Stabilization Open-label (OL) Period|Sponsor Decision|0
881972|NCT01299272|2907232|P4|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
881973|NCT01299272|2907233|P3|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
881974|NCT01299272|2907234|P2|Stabilization Open-label (OL) Period|Withdrawal by Subject|42
881975|NCT01299272|2907235|P1|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
881976|NCT01299272|2907232|P4|Stabilization Open-label (OL) Period|Adverse Event|0
881977|NCT01299272|2907233|P3|Stabilization Open-label (OL) Period|Adverse Event|0
881978|NCT01299272|2907234|P2|Stabilization Open-label (OL) Period|Adverse Event|42
881979|NCT01299272|2907235|P1|Stabilization Open-label (OL) Period|Adverse Event|0
881980|NCT01299272|2907232|P4|Stabilization Open-label (OL) Period|Protocol Violation|0
881981|NCT01299272|2907233|P3|Stabilization Open-label (OL) Period|Protocol Violation|0
881982|NCT01299272|2907234|P2|Stabilization Open-label (OL) Period|Protocol Violation|44
881983|NCT01299272|2907235|P1|Stabilization Open-label (OL) Period|Protocol Violation|0
881984|NCT01299272|2907232|P4|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
881985|NCT01299272|2907233|P3|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
881986|NCT01299272|2907234|P2|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80
881987|NCT01299272|2907235|P1|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
881988|NCT01299272|2907232|P4|Acute Open-label (OL) Period|Physician Decision|0
881989|NCT01299272|2907233|P3|Acute Open-label (OL) Period|Physician Decision|0
881990|NCT01299272|2907234|P2|Acute Open-label (OL) Period|Physician Decision|0
881991|NCT01299272|2907235|P1|Acute Open-label (OL) Period|Physician Decision|5
881992|NCT01299272|2907232|P4|Acute Open-label (OL) Period|Lack of Efficacy|0
881993|NCT01299272|2907233|P3|Acute Open-label (OL) Period|Lack of Efficacy|0
881994|NCT01299272|2907234|P2|Acute Open-label (OL) Period|Lack of Efficacy|0
881995|NCT01299272|2907235|P1|Acute Open-label (OL) Period|Lack of Efficacy|10
881996|NCT01299272|2907232|P4|Acute Open-label (OL) Period|Sponsor Decision|0
881997|NCT01299272|2907233|P3|Acute Open-label (OL) Period|Sponsor Decision|0
881998|NCT01299272|2907234|P2|Acute Open-label (OL) Period|Sponsor Decision|0
881999|NCT01299272|2907235|P1|Acute Open-label (OL) Period|Sponsor Decision|13
882000|NCT01299272|2907232|P4|Acute Open-label (OL) Period|Lost to Follow-up|0
882001|NCT01299272|2907233|P3|Acute Open-label (OL) Period|Lost to Follow-up|0
882002|NCT01299272|2907234|P2|Acute Open-label (OL) Period|Lost to Follow-up|0
882003|NCT01299272|2907235|P1|Acute Open-label (OL) Period|Lost to Follow-up|14
882004|NCT01299272|2907232|P4|Acute Open-label (OL) Period|Protocol Violation|0
882005|NCT01299272|2907233|P3|Acute Open-label (OL) Period|Protocol Violation|0
882006|NCT01299272|2907234|P2|Acute Open-label (OL) Period|Protocol Violation|0
882007|NCT01299272|2907235|P1|Acute Open-label (OL) Period|Protocol Violation|36
882008|NCT01299272|2907232|P4|Acute Open-label (OL) Period|Withdrawal by Subject|0
882009|NCT01299272|2907233|P3|Acute Open-label (OL) Period|Withdrawal by Subject|0
882010|NCT01299272|2907234|P2|Acute Open-label (OL) Period|Withdrawal by Subject|0
882011|NCT01299272|2907235|P1|Acute Open-label (OL) Period|Withdrawal by Subject|56
882012|NCT01299272|2907232|P4|Acute Open-label (OL) Period|Adverse Event|0
882013|NCT01299272|2907233|P3|Acute Open-label (OL) Period|Adverse Event|0
882014|NCT01299272|2907234|P2|Acute Open-label (OL) Period|Adverse Event|0
882015|NCT01299272|2907235|P1|Acute Open-label (OL) Period|Adverse Event|140
882016|NCT01299272|2907232|P4|Acute Open-label (OL) Period|Remission Criteria Not Met|0
882017|NCT01299272|2907233|P3|Acute Open-label (OL) Period|Remission Criteria Not Met|0
882018|NCT01299272|2907234|P2|Acute Open-label (OL) Period|Remission Criteria Not Met|0
882019|NCT01299272|2907235|P1|Acute Open-label (OL) Period|Remission Criteria Not Met|140
882020|NCT01299116|2907290|P3|Overall Study|Lost to Follow-up|11
882021|NCT01299116|2907291|P2|Overall Study|Lost to Follow-up|9
882022|NCT01299116|2907292|P1|Overall Study|Lost to Follow-up|65
882023|NCT01299025|2907337|P2|Overall Study|Lost to Follow-up|0
882024|NCT01299025|2907338|P1|Overall Study|Lost to Follow-up|1
882025|NCT01299025|2907337|P2|Overall Study|Withdrawal by Subject|1
882026|NCT01299025|2907338|P1|Overall Study|Withdrawal by Subject|2
882027|NCT01298778|2907352|P2|Overall Study|not meet inclusion/exclusion criteria|1
882028|NCT01298778|2907353|P1|Overall Study|not meet inclusion/exclusion criteria|0
882029|NCT01298778|2907352|P2|Overall Study|Protocol Violation|1
882030|NCT01298778|2907353|P1|Overall Study|Protocol Violation|0
882031|NCT01298778|2907352|P2|Overall Study|Withdrawal by Subject|1
882032|NCT01298778|2907353|P1|Overall Study|Withdrawal by Subject|0
882033|NCT01298778|2907352|P2|Overall Study|Incorrect use of VAS|0
882034|NCT01298778|2907353|P1|Overall Study|Incorrect use of VAS|1
882035|NCT01298778|2907352|P2|Overall Study|Lost to Follow-up|3
882036|NCT01298778|2907353|P1|Overall Study|Lost to Follow-up|2
882037|NCT01298765|2907373|P1|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46
882038|NCT01298765|2907373|P1|Long-Term Treatment Period|Physician Decision|1
882039|NCT01298765|2907373|P1|Long-Term Treatment Period|Withdrawal by Subject|19
882040|NCT01298765|2907373|P1|Long-Term Treatment Period|Lost to Follow-up|8
882041|NCT01298765|2907373|P1|Long-Term Treatment Period|Lack of Efficacy|6
882042|NCT01298765|2907373|P1|Long-Term Treatment Period|Adverse Event|19
882043|NCT01298765|2907373|P1|Titration Period|Other: Not Lack of Analgesic Effect|8
882044|NCT01298765|2907373|P1|Titration Period|Withdrawal by Subject|10
882045|NCT01298765|2907373|P1|Titration Period|Physician Decision|1
882046|NCT01298765|2907373|P1|Titration Period|Lost to Follow-up|9
882047|NCT01298765|2907373|P1|Titration Period|Lack of Efficacy|21
882048|NCT01298765|2907373|P1|Titration Period|Death|1
882049|NCT01298765|2907373|P1|Titration Period|Adverse Event|26
882050|NCT01298700|2907383|P2|Overall Study|Did not Receive Study Drug|5
882051|NCT01298700|2907384|P1|Overall Study|Did not Receive Study Drug|3
882052|NCT01298700|2907383|P2|Overall Study|Other Miscellaneous Reasons|15
882053|NCT01298700|2907384|P1|Overall Study|Other Miscellaneous Reasons|16
882054|NCT01298700|2907383|P2|Overall Study|Protocol Violation|4
882055|NCT01298700|2907384|P1|Overall Study|Protocol Violation|6
882056|NCT01298700|2907383|P2|Overall Study|Withdrawal by Subject|9
882057|NCT01298700|2907384|P1|Overall Study|Withdrawal by Subject|12
882058|NCT01298700|2907383|P2|Overall Study|Lost to Follow-up|2
882059|NCT01298700|2907384|P1|Overall Study|Lost to Follow-up|5
882060|NCT01298700|2907383|P2|Overall Study|Lack of Efficacy|14
882061|NCT01298700|2907384|P1|Overall Study|Lack of Efficacy|9
882062|NCT01298700|2907383|P2|Overall Study|Adverse Event|51
882063|NCT01298700|2907384|P1|Overall Study|Adverse Event|50
882064|NCT01298661|2907395|P3|Overall Study|Withdrawal by Subject|2
882065|NCT01298661|2907396|P2|Overall Study|Withdrawal by Subject|0
882066|NCT01298661|2907397|P1|Overall Study|Withdrawal by Subject|2
882067|NCT01298648|2907475|P1|Overall Study|Lost to Follow-up|21
882068|NCT01298648|2907475|P1|Overall Study|Withdrawal by Subject|2
882069|NCT01298570|2907486|P2|Overall Study|Ineligibility|1
882070|NCT01298570|2907487|P1|Overall Study|Ineligibility|0
882071|NCT01298570|2907486|P2|Overall Study|Death|1
882072|NCT01298570|2907487|P1|Overall Study|Death|0
882073|NCT01298570|2907486|P2|Overall Study|Symptomatic progression/deterioration|2
882074|NCT01298570|2907487|P1|Overall Study|Symptomatic progression/deterioration|3
882075|NCT01298570|2907486|P2|Overall Study|Surgery|1
882076|NCT01298570|2907487|P1|Overall Study|Surgery|2
882077|NCT01298570|2907486|P2|Overall Study|Other complicating disease|1
882078|NCT01298570|2907487|P1|Overall Study|Other complicating disease|2
882079|NCT01298570|2907486|P2|Overall Study|Physician Decision|2
882080|NCT01298570|2907487|P1|Overall Study|Physician Decision|4
882081|NCT01298570|2907486|P2|Overall Study|Treatment delay > 4 weeks|5
882082|NCT01298570|2907487|P1|Overall Study|Treatment delay > 4 weeks|4
882083|NCT01298570|2907486|P2|Overall Study|Withdrawal by Subject|6
882084|NCT01298570|2907487|P1|Overall Study|Withdrawal by Subject|21
882085|NCT01298570|2907486|P2|Overall Study|Adverse Event|2
882086|NCT01298570|2907487|P1|Overall Study|Adverse Event|20
882087|NCT01298570|2907486|P2|Overall Study|Disease progression, relapse during acti|40
882088|NCT01298570|2907487|P1|Overall Study|Disease progression, relapse during acti|64
882089|NCT01298531|2907514|P2|Overall Study|Not specified|1
882090|NCT01298531|2907515|P1|Overall Study|Not specified|2
882091|NCT01298531|2907514|P2|Overall Study|Does not meet entrance criteria|1
882092|NCT01298531|2907515|P1|Overall Study|Does not meet entrance criteria|0
882093|NCT01298531|2907514|P2|Overall Study|Adverse Event|3
882094|NCT01298531|2907515|P1|Overall Study|Adverse Event|4
882095|NCT01298531|2907514|P2|Overall Study|Protocol Violation|1
882096|NCT01298531|2907515|P1|Overall Study|Protocol Violation|1
882097|NCT01298531|2907514|P2|Overall Study|Lost to Follow-up|0
882098|NCT01298531|2907515|P1|Overall Study|Lost to Follow-up|2
882099|NCT01298531|2907514|P2|Overall Study|Lack of Efficacy|1
882100|NCT01298531|2907515|P1|Overall Study|Lack of Efficacy|0
882101|NCT01298518|2907644|P3|Overall Study|Withdrawal by Subject|1
882102|NCT01298518|2907645|P2|Overall Study|Withdrawal by Subject|0
882103|NCT01298518|2907646|P1|Overall Study|Withdrawal by Subject|0
882104|NCT01298492|2907698|P1|Overall Study|Adverse Event(Not Related to Study Drug)|18
882105|NCT01298492|2907698|P1|Overall Study|Adverse Event(Related to Study Drug)|8
882106|NCT01298492|2907698|P1|Overall Study|Protocol Violation|2
882107|NCT01298492|2907698|P1|Overall Study|Withdrawn Due to Pregnancy|1
882108|NCT01298492|2907698|P1|Overall Study|Other (Unspecified)|7
882109|NCT01298492|2907698|P1|Overall Study|Withdrawal by Subject|47
882110|NCT01298492|2907698|P1|Overall Study|Lost to Follow-up|12
882111|NCT01298492|2907698|P1|Overall Study|Insufficient Clinical Response|22
882112|NCT01298492|2907698|P1|Overall Study|Death|2
882113|NCT01298362|2907706|P2|Overall Study|Did not provide 12month BMD measurements|43
882114|NCT01298362|2907707|P1|Overall Study|Did not provide 12month BMD measurements|38
882115|NCT01298323|2907727|P2|Overall Study|Eligibility criteria not fulfilled|1
882116|NCT01298323|2907728|P1|Overall Study|Eligibility criteria not fulfilled|0
882117|NCT01298323|2907727|P2|Overall Study|Ongoing|55
882118|NCT01298323|2907728|P1|Overall Study|Ongoing|55
882119|NCT01298323|2907727|P2|Overall Study|Other|9
882120|NCT01298323|2907728|P1|Overall Study|Other|10
882121|NCT01298323|2907727|P2|Overall Study|Protocol Violation|0
882122|NCT01298323|2907728|P1|Overall Study|Protocol Violation|1
882123|NCT01298323|2907727|P2|Overall Study|Withdrawal by Subject|3
882124|NCT01298323|2907728|P1|Overall Study|Withdrawal by Subject|6
882125|NCT01298323|2907727|P2|Overall Study|Lost to Follow-up|0
882126|NCT01298323|2907728|P1|Overall Study|Lost to Follow-up|1
882127|NCT01298323|2907727|P2|Overall Study|Death|16
882128|NCT01298323|2907728|P1|Overall Study|Death|11
882129|NCT01298323|2907727|P2|Overall Study|Adverse Event|4
882130|NCT01298323|2907728|P1|Overall Study|Adverse Event|2
882131|NCT01297920|2907791|P3|Overall Study|Patient Did Not Meet Entrance Criteria|0
882132|NCT01297920|2907792|P2|Overall Study|Patient Did Not Meet Entrance Criteria|0
882133|NCT01297920|2907793|P1|Overall Study|Patient Did Not Meet Entrance Criteria|1
882134|NCT01297920|2907791|P3|Overall Study|Inadequate Control of IOP|17
882135|NCT01297920|2907792|P2|Overall Study|Inadequate Control of IOP|9
882136|NCT01297920|2907793|P1|Overall Study|Inadequate Control of IOP|7
882137|NCT01297920|2907791|P3|Overall Study|Protocol Violation|0
882138|NCT01297920|2907792|P2|Overall Study|Protocol Violation|3
882139|NCT01297920|2907793|P1|Overall Study|Protocol Violation|1
882140|NCT01297920|2907791|P3|Overall Study|Noncompliance|0
882141|NCT01297920|2907792|P2|Overall Study|Noncompliance|0
882142|NCT01297920|2907793|P1|Overall Study|Noncompliance|1
882143|NCT01297920|2907791|P3|Overall Study|Patient Decision Unrelated to AE|2
882144|NCT01297920|2907792|P2|Overall Study|Patient Decision Unrelated to AE|5
882145|NCT01297920|2907793|P1|Overall Study|Patient Decision Unrelated to AE|6
882146|NCT01297920|2907791|P3|Overall Study|Adverse Event|38
882147|NCT01297920|2907792|P2|Overall Study|Adverse Event|10
882148|NCT01297920|2907793|P1|Overall Study|Adverse Event|42
882149|NCT01297517|2907837|P3|Overall Study|Inadequate Control of IOP|2
882150|NCT01297517|2907838|P2|Overall Study|Inadequate Control of IOP|1
882151|NCT01297517|2907839|P1|Overall Study|Inadequate Control of IOP|1
882152|NCT01297517|2907837|P3|Overall Study|Protocol Violation|1
882153|NCT01297517|2907838|P2|Overall Study|Protocol Violation|1
882154|NCT01297517|2907839|P1|Overall Study|Protocol Violation|1
882155|NCT01297517|2907837|P3|Overall Study|Noncompliance|0
882156|NCT01297517|2907838|P2|Overall Study|Noncompliance|0
882157|NCT01297517|2907839|P1|Overall Study|Noncompliance|1
882158|NCT01297517|2907837|P3|Overall Study|Patient Decision Unrelated to AE|7
882159|NCT01297517|2907838|P2|Overall Study|Patient Decision Unrelated to AE|3
882160|NCT01297517|2907839|P1|Overall Study|Patient Decision Unrelated to AE|2
882161|NCT01297517|2907837|P3|Overall Study|Lost to Follow-up|1
882162|NCT01297517|2907838|P2|Overall Study|Lost to Follow-up|0
882163|NCT01297517|2907839|P1|Overall Study|Lost to Follow-up|1
882164|NCT01297517|2907837|P3|Overall Study|Adverse Event|16
882165|NCT01297517|2907838|P2|Overall Study|Adverse Event|7
882166|NCT01297517|2907839|P1|Overall Study|Adverse Event|21
882167|NCT01297504|2907847|P1|Overall Study|Protocol Violation|3
882168|NCT01297504|2907847|P1|Overall Study|Site Closure|3
882169|NCT01297504|2907847|P1|Overall Study|Withdrawal by Subject|9
882170|NCT01297504|2907847|P1|Overall Study|Lost to Follow-up|43
882171|NCT01297504|2907847|P1|Overall Study|Death|3
882172|NCT01297504|2907847|P1|Overall Study|No Study Visits|4
882173|NCT01297504|2907847|P1|Overall Study|Received Palivizumab in Previous Season|1
882174|NCT01297504|2907847|P1|Overall Study|Invalid Consent|1
882175|NCT01297491|2907861|P2|Overall Study|Death|1
882176|NCT01297491|2907862|P1|Overall Study|Death|2
882177|NCT01297491|2907861|P2|Overall Study|Patient/Guardian decision|4
882178|NCT01297491|2907862|P1|Overall Study|Patient/Guardian decision|3
882179|NCT01297491|2907861|P2|Overall Study|Progressive disease|20
882180|NCT01297491|2907862|P1|Overall Study|Progressive disease|11
882181|NCT01297491|2907861|P2|Overall Study|Physician Decision|2
882182|NCT01297491|2907862|P1|Overall Study|Physician Decision|3
882183|NCT01297491|2907861|P2|Overall Study|Adverse Event|6
882184|NCT01297491|2907862|P1|Overall Study|Adverse Event|11
882185|NCT01297465|2907880|P2|Overall Study|Intention to Freeze all Embryos|1
882186|NCT01297465|2907881|P1|Overall Study|Intention to Freeze all Embryos|0
882187|NCT01297465|2907880|P2|Overall Study|All Embryos Discarded|1
882188|NCT01297465|2907881|P1|Overall Study|All Embryos Discarded|0
882189|NCT01297465|2907880|P2|Overall Study|No Fertilization|4
882190|NCT01297465|2907881|P1|Overall Study|No Fertilization|6
882191|NCT01297465|2907880|P2|Overall Study|Poor oocyte quality|1
882192|NCT01297465|2907881|P1|Overall Study|Poor oocyte quality|0
882193|NCT01297465|2907880|P2|Overall Study|No Oocytes Retrieved|1
882194|NCT01297465|2907881|P1|Overall Study|No Oocytes Retrieved|1
882195|NCT01297465|2907880|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
882196|NCT01297465|2907881|P1|Overall Study|Ovarian hyperstimulation syndrome risk|0
882197|NCT01297465|2907880|P2|Overall Study|Lack of Ovarian Response|1
882198|NCT01297465|2907881|P1|Overall Study|Lack of Ovarian Response|1
882199|NCT01297322|2907934|P2|Overall Study|Withdrawal by Subject|1
882200|NCT01297322|2907935|P1|Overall Study|Withdrawal by Subject|0
882201|NCT01297322|2907934|P2|Overall Study|Lost to Follow-up|0
882202|NCT01297322|2907935|P1|Overall Study|Lost to Follow-up|1
882203|NCT01297270|2907963|P3|Overall Study|Not treated|0
882204|NCT01297270|2907964|P2|Overall Study|Not treated|1
882205|NCT01297270|2907965|P1|Overall Study|Not treated|0
882206|NCT01297270|2907963|P3|Overall Study|Other reason not defined above|1
882207|NCT01297270|2907964|P2|Overall Study|Other reason not defined above|3
882208|NCT01297270|2907965|P1|Overall Study|Other reason not defined above|3
882209|NCT01297270|2907963|P3|Overall Study|Withdrawal by Subject|7
882210|NCT01297270|2907964|P2|Overall Study|Withdrawal by Subject|15
882211|NCT01297270|2907965|P1|Overall Study|Withdrawal by Subject|7
882212|NCT01297270|2907963|P3|Overall Study|Protocol Violation|0
882213|NCT01297270|2907964|P2|Overall Study|Protocol Violation|2
882214|NCT01297270|2907965|P1|Overall Study|Protocol Violation|0
882215|NCT01297270|2907963|P3|Overall Study|Lost to Follow-up|1
882216|NCT01297270|2907964|P2|Overall Study|Lost to Follow-up|2
882217|NCT01297270|2907965|P1|Overall Study|Lost to Follow-up|1
882218|NCT01297270|2907963|P3|Overall Study|Lack of Efficacy|15
882219|NCT01297270|2907964|P2|Overall Study|Lack of Efficacy|17
882220|NCT01297270|2907965|P1|Overall Study|Lack of Efficacy|15
882221|NCT01297270|2907963|P3|Overall Study|Adverse Event|5
882222|NCT01297270|2907964|P2|Overall Study|Adverse Event|32
882223|NCT01297270|2907965|P1|Overall Study|Adverse Event|19
882224|NCT01297062|2908014|P7|Overall Study|Subject Decision|2
882225|NCT01297062|2908015|P6|Overall Study|Subject Decision|1
882226|NCT01297062|2908016|P5|Overall Study|Subject Decision|1
882227|NCT01297062|2908017|P4|Overall Study|Subject Decision|1
882228|NCT01297062|2908018|P3|Overall Study|Subject Decision|0
882229|NCT01297062|2908019|P2|Overall Study|Subject Decision|1
882230|NCT01297062|2908020|P1|Overall Study|Subject Decision|1
882231|NCT01297062|2908014|P7|Overall Study|Protocol Violation|0
882232|NCT01297062|2908015|P6|Overall Study|Protocol Violation|0
882233|NCT01297062|2908016|P5|Overall Study|Protocol Violation|1
882234|NCT01297062|2908017|P4|Overall Study|Protocol Violation|0
882235|NCT01297062|2908018|P3|Overall Study|Protocol Violation|0
882236|NCT01297062|2908019|P2|Overall Study|Protocol Violation|0
882237|NCT01297062|2908020|P1|Overall Study|Protocol Violation|0
882238|NCT01297062|2908014|P7|Overall Study|Physician Decision|6
882239|NCT01297062|2908015|P6|Overall Study|Physician Decision|0
882240|NCT01297062|2908016|P5|Overall Study|Physician Decision|0
882241|NCT01297062|2908017|P4|Overall Study|Physician Decision|0
882242|NCT01297062|2908018|P3|Overall Study|Physician Decision|1
882243|NCT01297062|2908019|P2|Overall Study|Physician Decision|0
882244|NCT01297062|2908020|P1|Overall Study|Physician Decision|1
882245|NCT01297062|2908014|P7|Overall Study|Adverse Event|0
882246|NCT01297062|2908015|P6|Overall Study|Adverse Event|0
882247|NCT01297062|2908016|P5|Overall Study|Adverse Event|0
882248|NCT01297062|2908017|P4|Overall Study|Adverse Event|0
882249|NCT01297062|2908018|P3|Overall Study|Adverse Event|1
882250|NCT01297062|2908019|P2|Overall Study|Adverse Event|0
882251|NCT01297062|2908020|P1|Overall Study|Adverse Event|2
882252|NCT01296698|2908082|P2|Overall Study|Study Terminated by Sponsor|12
882253|NCT01296698|2908083|P1|Overall Study|Study Terminated by Sponsor|209
882254|NCT01296698|2908082|P2|Overall Study|Difficulty Contacting Subject|0
882255|NCT01296698|2908083|P1|Overall Study|Difficulty Contacting Subject|2
882256|NCT01296698|2908082|P2|Overall Study|Withdrawal by Subject|0
882257|NCT01296698|2908083|P1|Overall Study|Withdrawal by Subject|12
882258|NCT01296698|2908082|P2|Overall Study|Lost to Follow-up|1
882259|NCT01296698|2908083|P1|Overall Study|Lost to Follow-up|19
882260|NCT01296698|2908082|P2|Overall Study|Death|0
882261|NCT01296698|2908083|P1|Overall Study|Death|1
882262|NCT01296698|2908082|P2|Overall Study|Adverse Event|0
882263|NCT01296698|2908083|P1|Overall Study|Adverse Event|1
882264|NCT01296672|2908137|P2|Overall Study|Lost to Follow-up|18
882265|NCT01296672|2908138|P1|Overall Study|Lost to Follow-up|73
882266|NCT01296568|2908159|P1|Continued Access Phase|Disease Progression|1
882267|NCT01296568|2908159|P1|Continued Access Phase|Withdrawal by Subject|1
882268|NCT01296568|2908159|P1|Continued Access Phase|Lost to Follow-up|1
882269|NCT01296412|2908175|P2|Overall Study|Withdrawal by Subject|13
882270|NCT01296412|2908176|P1|Overall Study|Withdrawal by Subject|10
882271|NCT01296412|2908175|P2|Overall Study|Pregnancy|1
882272|NCT01296412|2908176|P1|Overall Study|Pregnancy|0
882273|NCT01296412|2908175|P2|Overall Study|Physician Decision|3
882274|NCT01296412|2908176|P1|Overall Study|Physician Decision|1
882275|NCT01296412|2908175|P2|Overall Study|Other reason not specified|15
882276|NCT01296412|2908176|P1|Overall Study|Other reason not specified|20
882277|NCT01296412|2908175|P2|Overall Study|Non-compliance with study drug|2
882278|NCT01296412|2908176|P1|Overall Study|Non-compliance with study drug|1
882279|NCT01296412|2908175|P2|Overall Study|Lost to Follow-up|7
882280|NCT01296412|2908176|P1|Overall Study|Lost to Follow-up|10
882281|NCT01296412|2908175|P2|Overall Study|Lack of Efficacy|0
882282|NCT01296412|2908176|P1|Overall Study|Lack of Efficacy|1
882283|NCT01296412|2908175|P2|Overall Study|Adverse Event|29
882284|NCT01296412|2908176|P1|Overall Study|Adverse Event|8
882285|NCT01296152|2908206|P1|Overall Study|Unwilling to adhere to study requirement|1
882286|NCT01296035|2908233|P1|Overall Study|Withdrawal by Subject|1
882287|NCT01295905|2908240|P2|Overall Study|Met exclusion criteria|0
882288|NCT01295905|2908241|P1|Overall Study|Met exclusion criteria|1
882289|NCT01295905|2908240|P2|Overall Study|Did not meet inclusion criteria|0
882290|NCT01295905|2908241|P1|Overall Study|Did not meet inclusion criteria|1
882291|NCT01295814|2908275|P2|Overall Study|Withdrawal by Subject|0
882292|NCT01295814|2908276|P1|Overall Study|Withdrawal by Subject|2
882293|NCT01295814|2908275|P2|Overall Study|Lack of Efficacy|2
882294|NCT01295814|2908276|P1|Overall Study|Lack of Efficacy|0
882295|NCT01295671|2908293|P3|Overall Study|Withdrawal by Subject|0
882296|NCT01295671|2908294|P2|Overall Study|Withdrawal by Subject|1
882297|NCT01295671|2908295|P1|Overall Study|Withdrawal by Subject|3
882298|NCT01295671|2908293|P3|Overall Study|Lost to Follow-up|3
882299|NCT01295671|2908294|P2|Overall Study|Lost to Follow-up|6
882300|NCT01295671|2908295|P1|Overall Study|Lost to Follow-up|4
882301|NCT01295320|2908333|P1|Overall Study|Unable to travel|1
882302|NCT01295320|2908333|P1|Overall Study|Subject was bedridden|1
882303|NCT01295320|2908333|P1|Overall Study|Withdrawal by Subject|2
882304|NCT01295320|2908333|P1|Overall Study|Lost to Follow-up|4
882305|NCT01295320|2908333|P1|Overall Study|Adverse Event|2
882306|NCT01295281|2908350|P2|First Intervention (7 Days)|Death|1
882307|NCT01295281|2908351|P1|First Intervention (7 Days)|Death|0
882308|NCT01295034|2908389|P2|Overall Study|Lost to Follow-up|5
882309|NCT01295034|2908390|P1|Overall Study|Lost to Follow-up|5
882310|NCT01294917|2908398|P1|Overall Study|Inconvenience|1
882311|NCT01294917|2908398|P1|Overall Study|Relocation|5
882312|NCT01294800|2908408|P4|Overall Study|Did Not Meet Protocol Eligibility|0
882313|NCT01294800|2908409|P3|Overall Study|Did Not Meet Protocol Eligibility|1
882314|NCT01294800|2908410|P2|Overall Study|Did Not Meet Protocol Eligibility|1
882315|NCT01294800|2908411|P1|Overall Study|Did Not Meet Protocol Eligibility|2
882316|NCT01294800|2908408|P4|Overall Study|Non-compliance With Protocol|0
882317|NCT01294800|2908409|P3|Overall Study|Non-compliance With Protocol|1
882318|NCT01294800|2908410|P2|Overall Study|Non-compliance With Protocol|1
882319|NCT01294800|2908411|P1|Overall Study|Non-compliance With Protocol|0
882320|NCT01294800|2908408|P4|Overall Study|Lost to Follow-up|0
882321|NCT01294800|2908409|P3|Overall Study|Lost to Follow-up|1
882322|NCT01294800|2908410|P2|Overall Study|Lost to Follow-up|0
882323|NCT01294800|2908411|P1|Overall Study|Lost to Follow-up|0
882324|NCT01294800|2908408|P4|Overall Study|Subject Withdrew Consent|11
882325|NCT01294800|2908409|P3|Overall Study|Subject Withdrew Consent|2
882326|NCT01294800|2908410|P2|Overall Study|Subject Withdrew Consent|2
882327|NCT01294800|2908411|P1|Overall Study|Subject Withdrew Consent|2
882328|NCT01294800|2908408|P4|Overall Study|Adverse Event|5
882329|NCT01294800|2908409|P3|Overall Study|Adverse Event|12
882330|NCT01294800|2908410|P2|Overall Study|Adverse Event|6
882331|NCT01294800|2908411|P1|Overall Study|Adverse Event|7
882332|NCT01294787|2908437|P6|Period 3|Adverse Event|0
882333|NCT01294787|2908438|P5|Period 3|Adverse Event|1
882334|NCT01294787|2908439|P4|Period 3|Adverse Event|0
882335|NCT01294787|2908440|P3|Period 3|Adverse Event|0
882336|NCT01294787|2908441|P2|Period 3|Adverse Event|0
882337|NCT01294787|2908442|P1|Period 3|Adverse Event|0
882338|NCT01294787|2908437|P6|Period 2|No longer needs study drug|0
882339|NCT01294787|2908438|P5|Period 2|No longer needs study drug|0
882340|NCT01294787|2908439|P4|Period 2|No longer needs study drug|1
882341|NCT01294787|2908440|P3|Period 2|No longer needs study drug|0
882342|NCT01294787|2908441|P2|Period 2|No longer needs study drug|0
882343|NCT01294787|2908442|P1|Period 2|No longer needs study drug|0
882344|NCT01294787|2908437|P6|Period 2|Adverse Event|0
882345|NCT01294787|2908438|P5|Period 2|Adverse Event|0
882346|NCT01294787|2908439|P4|Period 2|Adverse Event|1
882347|NCT01294787|2908440|P3|Period 2|Adverse Event|0
882348|NCT01294787|2908441|P2|Period 2|Adverse Event|3
882349|NCT01294787|2908442|P1|Period 2|Adverse Event|0
882350|NCT01294787|2908437|P6|Period 1|Administrative problem|1
882351|NCT01294787|2908438|P5|Period 1|Administrative problem|0
882352|NCT01294787|2908439|P4|Period 1|Administrative problem|0
882353|NCT01294787|2908440|P3|Period 1|Administrative problem|1
882354|NCT01294787|2908441|P2|Period 1|Administrative problem|0
882355|NCT01294787|2908442|P1|Period 1|Administrative problem|0
882356|NCT01294787|2908437|P6|Period 1|Withdrawal by Subject|1
882357|NCT01294787|2908438|P5|Period 1|Withdrawal by Subject|1
882358|NCT01294787|2908439|P4|Period 1|Withdrawal by Subject|1
882359|NCT01294787|2908440|P3|Period 1|Withdrawal by Subject|0
882360|NCT01294787|2908441|P2|Period 1|Withdrawal by Subject|0
882361|NCT01294787|2908442|P1|Period 1|Withdrawal by Subject|0
882362|NCT01294787|2908437|P6|Period 1|Adverse Event|0
882363|NCT01294787|2908438|P5|Period 1|Adverse Event|1
882364|NCT01294787|2908439|P4|Period 1|Adverse Event|0
882365|NCT01294787|2908440|P3|Period 1|Adverse Event|0
882366|NCT01294787|2908441|P2|Period 1|Adverse Event|0
882367|NCT01294787|2908442|P1|Period 1|Adverse Event|0
882368|NCT01294696|2908533|P1|Overall Study|Site closure|52
882369|NCT01294696|2908533|P1|Overall Study|Missing BPI Response|7
882370|NCT01294696|2908533|P1|Overall Study|Protocol Violation|8
882371|NCT01294696|2908533|P1|Overall Study|Screening failures|7
882372|NCT01294683|2908547|P2|Post Crossover (Period III)|Withdrawal by Subject|2
882373|NCT01294683|2908548|P1|Post Crossover (Period III)|Withdrawal by Subject|3
882374|NCT01294683|2908547|P2|Post Crossover (Period III)|Study Terminated by Sponsor|21
882375|NCT01294683|2908548|P1|Post Crossover (Period III)|Study Terminated by Sponsor|23
882376|NCT01294683|2908547|P2|Post Crossover (Period III)|Lost to Follow-up|3
882377|NCT01294683|2908548|P1|Post Crossover (Period III)|Lost to Follow-up|1
882378|NCT01294683|2908547|P2|Post Crossover (Period III)|Adverse Event|6
882379|NCT01294683|2908548|P1|Post Crossover (Period III)|Adverse Event|6
882380|NCT01294683|2908547|P2|Precrossover (Periods I/II)|Withdrawal by Subject|9
882381|NCT01294683|2908548|P1|Precrossover (Periods I/II)|Withdrawal by Subject|11
882382|NCT01294683|2908547|P2|Precrossover (Periods I/II)|Technical Problems|1
882383|NCT01294683|2908548|P1|Precrossover (Periods I/II)|Technical Problems|0
882384|NCT01294683|2908547|P2|Precrossover (Periods I/II)|Study Terminated by Sponsor|192
882385|NCT01294683|2908548|P1|Precrossover (Periods I/II)|Study Terminated by Sponsor|187
882386|NCT01294683|2908547|P2|Precrossover (Periods I/II)|Protocol Violation|5
882387|NCT01294683|2908548|P1|Precrossover (Periods I/II)|Protocol Violation|5
882388|NCT01294683|2908547|P2|Precrossover (Periods I/II)|Physician Decision|0
882389|NCT01294683|2908548|P1|Precrossover (Periods I/II)|Physician Decision|1
882390|NCT01294683|2908547|P2|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
882391|NCT01294683|2908548|P1|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
882392|NCT01294683|2908547|P2|Precrossover (Periods I/II)|Lost to Follow-up|6
882393|NCT01294683|2908548|P1|Precrossover (Periods I/II)|Lost to Follow-up|3
882394|NCT01294683|2908547|P2|Precrossover (Periods I/II)|Adverse Event|52
882395|NCT01294683|2908548|P1|Precrossover (Periods I/II)|Adverse Event|49
882396|NCT01294644|2908601|P3|Overall Study|Miscellaneous Reason|4
882397|NCT01294644|2908602|P2|Overall Study|Miscellaneous Reason|1
882398|NCT01294644|2908603|P1|Overall Study|Miscellaneous Reason|2
882399|NCT01294644|2908601|P3|Overall Study|Lost to Follow-up|5
882400|NCT01294644|2908602|P2|Overall Study|Lost to Follow-up|2
882401|NCT01294644|2908603|P1|Overall Study|Lost to Follow-up|3
882402|NCT01294644|2908601|P3|Overall Study|Withdrawal by Subject|4
882403|NCT01294644|2908602|P2|Overall Study|Withdrawal by Subject|7
882404|NCT01294644|2908603|P1|Overall Study|Withdrawal by Subject|3
882405|NCT01294644|2908601|P3|Overall Study|Adverse Event|1
882406|NCT01294644|2908602|P2|Overall Study|Adverse Event|0
882407|NCT01294644|2908603|P1|Overall Study|Adverse Event|2
882408|NCT01294592|2908634|P2|Overall Study|Withdrawal by Subject|28
882409|NCT01294592|2908635|P1|Overall Study|Withdrawal by Subject|28
882410|NCT01294592|2908634|P2|Overall Study|Physician Decision|11
882411|NCT01294592|2908635|P1|Overall Study|Physician Decision|6
882412|NCT01294592|2908634|P2|Overall Study|Lost to Follow-up|9
882413|NCT01294592|2908635|P1|Overall Study|Lost to Follow-up|7
882414|NCT01294592|2908634|P2|Overall Study|Protocol Violation|7
882415|NCT01294592|2908635|P1|Overall Study|Protocol Violation|1
882416|NCT01294592|2908634|P2|Overall Study|Lack of Efficacy|5
882417|NCT01294592|2908635|P1|Overall Study|Lack of Efficacy|7
882418|NCT01294592|2908634|P2|Overall Study|Adverse Event|13
882419|NCT01294592|2908635|P1|Overall Study|Adverse Event|28
882420|NCT01294579|2908663|P1|Overall Study|Withdrawal by Subject|5
882421|NCT01294579|2908663|P1|Overall Study|Physician Decision|3
882422|NCT01294579|2908663|P1|Overall Study|Lost to Follow-up|1
882423|NCT01294579|2908663|P1|Overall Study|Study closed/terminated|3
882424|NCT01294579|2908663|P1|Overall Study|Adverse Event|11
882425|NCT01294579|2908663|P1|Overall Study|Disease progression|12
882426|NCT01294553|2908673|P1|Overall Study|Protocol Violation|268
882427|NCT01294553|2908673|P1|Overall Study|Duplicated Participants|1
882428|NCT01294514|2908679|P1|Overall Study|Excluded due to Arrhythmia|1
882429|NCT01294462|2908689|P2|Overall Study|Withdrawal by Subject|63
882430|NCT01294462|2908690|P1|Overall Study|Withdrawal by Subject|65
882431|NCT01294462|2908689|P2|Overall Study|Lost to Follow-up|0
882432|NCT01294462|2908690|P1|Overall Study|Lost to Follow-up|1
882433|NCT01294449|2908704|P2|Overall Study|Withdrawal by Subject|3
882434|NCT01294449|2908705|P1|Overall Study|Withdrawal by Subject|1
882435|NCT01294449|2908704|P2|Overall Study|Death|12
882436|NCT01294449|2908705|P1|Overall Study|Death|11
882437|NCT01294436|2908713|P2|Overall Study|poor/non-compliance|5
882438|NCT01294436|2908714|P1|Overall Study|poor/non-compliance|2
882439|NCT01294436|2908713|P2|Overall Study|subject no longer meets study criteria|20
882440|NCT01294436|2908714|P1|Overall Study|subject no longer meets study criteria|5
882441|NCT01294436|2908713|P2|Overall Study|Withdrawal by Subject|28
882442|NCT01294436|2908714|P1|Overall Study|Withdrawal by Subject|11
882443|NCT01294436|2908713|P2|Overall Study|Adverse Event|17
882444|NCT01294436|2908714|P1|Overall Study|Adverse Event|10
882445|NCT01294423|2908749|P3|Overall Study|poor/non-compliance|1
882446|NCT01294423|2908750|P2|Overall Study|poor/non-compliance|0
882447|NCT01294423|2908751|P1|Overall Study|poor/non-compliance|1
882448|NCT01294423|2908749|P3|Overall Study|subject no longer meets study criteria|2
882449|NCT01294423|2908750|P2|Overall Study|subject no longer meets study criteria|5
882450|NCT01294423|2908751|P1|Overall Study|subject no longer meets study criteria|2
882451|NCT01294423|2908749|P3|Overall Study|Withdrawal by Subject|2
882452|NCT01294423|2908750|P2|Overall Study|Withdrawal by Subject|2
882453|NCT01294423|2908751|P1|Overall Study|Withdrawal by Subject|1
882454|NCT01294423|2908749|P3|Overall Study|Adverse Event|3
882455|NCT01294423|2908750|P2|Overall Study|Adverse Event|2
882456|NCT01294423|2908751|P1|Overall Study|Adverse Event|1
882457|NCT01294397|2908765|P1|Overall Study|Administrative Decision|1
882458|NCT01294397|2908765|P1|Overall Study|Withdrawal by Subject|1
882459|NCT01294371|2908809|P1|Overall Study|Other|14
882460|NCT01294371|2908809|P1|Overall Study|Administrative Reason|1
882461|NCT01294371|2908809|P1|Overall Study|Lost to Follow-up|6
882462|NCT01294371|2908809|P1|Overall Study|Withdrawal by Subject|12
882463|NCT01294371|2908809|P1|Overall Study|Adverse Event|1
882464|NCT01294358|2908817|P5|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1
882465|NCT01294358|2908818|P4|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
882466|NCT01294358|2908819|P3|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
882467|NCT01294358|2908820|P2|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
882468|NCT01294358|2908821|P1|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
882469|NCT01294358|2908817|P5|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
882470|NCT01294358|2908818|P4|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1
882471|NCT01294358|2908819|P3|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
882472|NCT01294358|2908820|P2|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
882473|NCT01294358|2908821|P1|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
882474|NCT01294358|2908817|P5|Cohort 3: 12/1/11-10/6/12|Disease progression|0
882475|NCT01294358|2908818|P4|Cohort 3: 12/1/11-10/6/12|Disease progression|0
882476|NCT01294358|2908819|P3|Cohort 3: 12/1/11-10/6/12|Disease progression|2
882477|NCT01294358|2908820|P2|Cohort 3: 12/1/11-10/6/12|Disease progression|0
882478|NCT01294358|2908821|P1|Cohort 3: 12/1/11-10/6/12|Disease progression|0
882479|NCT01294358|2908817|P5|Cohort 2: 6/9/11-9/17/12|Disease progression|0
882480|NCT01294358|2908818|P4|Cohort 2: 6/9/11-9/17/12|Disease progression|0
882481|NCT01294358|2908819|P3|Cohort 2: 6/9/11-9/17/12|Disease progression|0
882482|NCT01294358|2908820|P2|Cohort 2: 6/9/11-9/17/12|Disease progression|2
882483|NCT01294358|2908821|P1|Cohort 2: 6/9/11-9/17/12|Disease progression|0
882484|NCT01294150|2908949|P2|Overall Study|Physician Decision|2
882485|NCT01294150|2908950|P1|Overall Study|Physician Decision|2
882486|NCT01294046|2908979|P1|Overall Study|Stimulation response inadqequate|1
882487|NCT01294046|2908979|P1|Overall Study|Eligibility criteria expanded|1
882488|NCT01294046|2908979|P1|Overall Study|Infection and surgical explant|1
882489|NCT01293968|2908994|P2|Overall Study|non-cooperation|3
882490|NCT01293968|2908995|P1|Overall Study|non-cooperation|3
882491|NCT01293695|2909015|P2|Overall Study|Lost to Follow-up|6
882492|NCT01293695|2909016|P1|Overall Study|Lost to Follow-up|8
882493|NCT01293695|2909015|P2|Overall Study|Withdrawal by Subject|1
882494|NCT01293695|2909016|P1|Overall Study|Withdrawal by Subject|7
882495|NCT01293539|2909030|P1|Overall Study|Physician Decision|1
882496|NCT01293240|2909034|P1|Overall Study|Noncompliance|2
882497|NCT01293084|2909049|P1|Overall Study|Withdrawal by Subject|2
882498|NCT01293084|2909049|P1|Overall Study|Physician Decision|3
882499|NCT01293032|2909061|P4|Treatment|Disease Progression, relapse|0
882500|NCT01293032|2909062|P3|Treatment|Disease Progression, relapse|0
882501|NCT01293032|2909063|P2|Treatment|Disease Progression, relapse|1
882502|NCT01293032|2909064|P1|Treatment|Disease Progression, relapse|0
882503|NCT01293032|2909061|P4|Treatment|Withdrawal by Subject|0
882504|NCT01293032|2909062|P3|Treatment|Withdrawal by Subject|0
882505|NCT01293032|2909063|P2|Treatment|Withdrawal by Subject|4
882506|NCT01293032|2909064|P1|Treatment|Withdrawal by Subject|2
882507|NCT01293032|2909061|P4|Treatment|Adverse Event|1
882508|NCT01293032|2909062|P3|Treatment|Adverse Event|1
882509|NCT01293032|2909063|P2|Treatment|Adverse Event|0
882510|NCT01293032|2909064|P1|Treatment|Adverse Event|0
882511|NCT01293032|2909061|P4|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
882512|NCT01293032|2909062|P3|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5
882513|NCT01293032|2909063|P2|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
882514|NCT01293032|2909064|P1|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
882515|NCT01293006|2909075|P4|Period 2|Lost to Follow-up|0
882516|NCT01293006|2909076|P3|Period 2|Lost to Follow-up|0
882517|NCT01293006|2909077|P2|Period 2|Lost to Follow-up|0
882518|NCT01293006|2909078|P1|Period 2|Lost to Follow-up|1
882519|NCT01292928|2909099|P1|Overall Study|Physician Decision|2
882520|NCT01292928|2909099|P1|Overall Study|Lost to Follow-up|6
882521|NCT01292928|2909099|P1|Overall Study|Withdrawal by Subject|8
882522|NCT01292928|2909099|P1|Overall Study|Death|8
882523|NCT01292876|2909116|P1|Overall Study|Physician Decision|4
882524|NCT01292837|2909122|P1|Overall Study|Further treatment determined|1
882525|NCT01292837|2909122|P1|Overall Study|Adverse Event|1
882526|NCT01292603|2909159|P6|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|10
882527|NCT01292603|2909160|P5|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|10
882528|NCT01292603|2909161|P4|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
882529|NCT01292603|2909162|P3|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
882530|NCT01292603|2909163|P2|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
882531|NCT01292603|2909164|P1|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
882532|NCT01292603|2909159|P6|Part 2: Survival Follow-UP|Death|3
882533|NCT01292603|2909160|P5|Part 2: Survival Follow-UP|Death|1
882534|NCT01292603|2909161|P4|Part 2: Survival Follow-UP|Death|0
882535|NCT01292603|2909162|P3|Part 2: Survival Follow-UP|Death|0
882536|NCT01292603|2909163|P2|Part 2: Survival Follow-UP|Death|0
882537|NCT01292603|2909164|P1|Part 2: Survival Follow-UP|Death|0
882538|NCT01292603|2909159|P6|Part 2: Regular Follow-Up|Noncompliance|0
882539|NCT01292603|2909160|P5|Part 2: Regular Follow-Up|Noncompliance|1
882540|NCT01292603|2909161|P4|Part 2: Regular Follow-Up|Noncompliance|0
882541|NCT01292603|2909162|P3|Part 2: Regular Follow-Up|Noncompliance|0
882542|NCT01292603|2909163|P2|Part 2: Regular Follow-Up|Noncompliance|0
882543|NCT01292603|2909164|P1|Part 2: Regular Follow-Up|Noncompliance|0
882544|NCT01292603|2909159|P6|Part 2: Regular Follow-Up|Disease Progression|4
882545|NCT01292603|2909160|P5|Part 2: Regular Follow-Up|Disease Progression|2
882546|NCT01292603|2909161|P4|Part 2: Regular Follow-Up|Disease Progression|0
882547|NCT01292603|2909162|P3|Part 2: Regular Follow-Up|Disease Progression|0
882548|NCT01292603|2909163|P2|Part 2: Regular Follow-Up|Disease Progression|0
882549|NCT01292603|2909164|P1|Part 2: Regular Follow-Up|Disease Progression|0
882550|NCT01292603|2909159|P6|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|72
882551|NCT01292603|2909160|P5|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|73
882552|NCT01292603|2909161|P4|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
882553|NCT01292603|2909162|P3|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
882554|NCT01292603|2909163|P2|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
882555|NCT01292603|2909164|P1|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
882556|NCT01292603|2909159|P6|Part 2: Regular Follow-Up|Death|2
882557|NCT01292603|2909160|P5|Part 2: Regular Follow-Up|Death|2
882558|NCT01292603|2909161|P4|Part 2: Regular Follow-Up|Death|0
882559|NCT01292603|2909162|P3|Part 2: Regular Follow-Up|Death|0
882560|NCT01292603|2909163|P2|Part 2: Regular Follow-Up|Death|0
882561|NCT01292603|2909164|P1|Part 2: Regular Follow-Up|Death|0
882562|NCT01292603|2909159|P6|Part 2: Dose Confirmation Period|Withdrawal by Subject|2
882563|NCT01292603|2909160|P5|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
882564|NCT01292603|2909161|P4|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
882565|NCT01292603|2909162|P3|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
882566|NCT01292603|2909163|P2|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
882567|NCT01292603|2909164|P1|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
882568|NCT01292603|2909159|P6|Part 2: Dose Confirmation Period|Protocol Violation|3
882569|NCT01292603|2909160|P5|Part 2: Dose Confirmation Period|Protocol Violation|5
882570|NCT01292603|2909161|P4|Part 2: Dose Confirmation Period|Protocol Violation|0
882571|NCT01292603|2909162|P3|Part 2: Dose Confirmation Period|Protocol Violation|0
882572|NCT01292603|2909163|P2|Part 2: Dose Confirmation Period|Protocol Violation|0
882573|NCT01292603|2909164|P1|Part 2: Dose Confirmation Period|Protocol Violation|0
882574|NCT01292603|2909159|P6|Part 2: Dose Confirmation Period|Adverse Event|9
882575|NCT01292603|2909160|P5|Part 2: Dose Confirmation Period|Adverse Event|7
882576|NCT01292603|2909161|P4|Part 2: Dose Confirmation Period|Adverse Event|0
882577|NCT01292603|2909162|P3|Part 2: Dose Confirmation Period|Adverse Event|0
882578|NCT01292603|2909163|P2|Part 2: Dose Confirmation Period|Adverse Event|0
882579|NCT01292603|2909164|P1|Part 2: Dose Confirmation Period|Adverse Event|0
882580|NCT01292603|2909159|P6|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
882581|NCT01292603|2909160|P5|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
882582|NCT01292603|2909161|P4|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
882583|NCT01292603|2909162|P3|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
882584|NCT01292603|2909163|P2|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
882585|NCT01292603|2909164|P1|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
882586|NCT01292603|2909159|P6|Part 2: Dose Confirmation Period|Physician Decision|0
882587|NCT01292603|2909160|P5|Part 2: Dose Confirmation Period|Physician Decision|2
882588|NCT01292603|2909161|P4|Part 2: Dose Confirmation Period|Physician Decision|0
882589|NCT01292603|2909162|P3|Part 2: Dose Confirmation Period|Physician Decision|0
882590|NCT01292603|2909163|P2|Part 2: Dose Confirmation Period|Physician Decision|0
882591|NCT01292603|2909164|P1|Part 2: Dose Confirmation Period|Physician Decision|0
882592|NCT01292603|2909159|P6|Part 2: Dose Confirmation Period|Death|0
882593|NCT01292603|2909160|P5|Part 2: Dose Confirmation Period|Death|1
882594|NCT01292603|2909161|P4|Part 2: Dose Confirmation Period|Death|0
882595|NCT01292603|2909162|P3|Part 2: Dose Confirmation Period|Death|0
882596|NCT01292603|2909163|P2|Part 2: Dose Confirmation Period|Death|0
882597|NCT01292603|2909164|P1|Part 2: Dose Confirmation Period|Death|0
882598|NCT01292603|2909159|P6|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|0
882599|NCT01292603|2909160|P5|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|0
882600|NCT01292603|2909161|P4|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|0
882601|NCT01292603|2909162|P3|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|1
882602|NCT01292603|2909163|P2|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|2
882603|NCT01292603|2909164|P1|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|3
882604|NCT01292603|2909159|P6|Part 1: Survival Follow-Up|Death|0
882605|NCT01292603|2909160|P5|Part 1: Survival Follow-Up|Death|0
882606|NCT01292603|2909161|P4|Part 1: Survival Follow-Up|Death|0
882607|NCT01292603|2909162|P3|Part 1: Survival Follow-Up|Death|1
882608|NCT01292603|2909163|P2|Part 1: Survival Follow-Up|Death|0
882609|NCT01292603|2909164|P1|Part 1: Survival Follow-Up|Death|1
882610|NCT01292603|2909159|P6|Part 1: Regular Follow-Up Period|Adverse Event|0
882611|NCT01292603|2909160|P5|Part 1: Regular Follow-Up Period|Adverse Event|0
882612|NCT01292603|2909161|P4|Part 1: Regular Follow-Up Period|Adverse Event|0
882613|NCT01292603|2909162|P3|Part 1: Regular Follow-Up Period|Adverse Event|0
882614|NCT01292603|2909163|P2|Part 1: Regular Follow-Up Period|Adverse Event|0
882615|NCT01292603|2909164|P1|Part 1: Regular Follow-Up Period|Adverse Event|1
882616|NCT01292603|2909159|P6|Part 1: Regular Follow-Up Period|Disease Progression|0
882617|NCT01292603|2909160|P5|Part 1: Regular Follow-Up Period|Disease Progression|0
882618|NCT01292603|2909161|P4|Part 1: Regular Follow-Up Period|Disease Progression|0
882619|NCT01292603|2909162|P3|Part 1: Regular Follow-Up Period|Disease Progression|2
882620|NCT01292603|2909163|P2|Part 1: Regular Follow-Up Period|Disease Progression|2
882621|NCT01292603|2909164|P1|Part 1: Regular Follow-Up Period|Disease Progression|3
882622|NCT01292603|2909159|P6|Part 1: Regular Follow-Up Period|Death|0
882623|NCT01292603|2909160|P5|Part 1: Regular Follow-Up Period|Death|0
882624|NCT01292603|2909161|P4|Part 1: Regular Follow-Up Period|Death|0
882625|NCT01292603|2909162|P3|Part 1: Regular Follow-Up Period|Death|2
882626|NCT01292603|2909163|P2|Part 1: Regular Follow-Up Period|Death|0
882627|NCT01292603|2909164|P1|Part 1: Regular Follow-Up Period|Death|1
882628|NCT01292603|2909159|P6|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|0
882629|NCT01292603|2909160|P5|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|0
882630|NCT01292603|2909161|P4|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|0
882631|NCT01292603|2909162|P3|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|19
882632|NCT01292603|2909163|P2|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|15
882633|NCT01292603|2909164|P1|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|11
882634|NCT01292603|2909159|P6|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
882635|NCT01292603|2909160|P5|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
882636|NCT01292603|2909161|P4|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1
882637|NCT01292603|2909162|P3|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
882638|NCT01292603|2909163|P2|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
882639|NCT01292603|2909164|P1|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
882640|NCT01292603|2909159|P6|Part 1: Pilot Dose Selection Period|Protocol Violation|0
882641|NCT01292603|2909160|P5|Part 1: Pilot Dose Selection Period|Protocol Violation|0
882642|NCT01292603|2909161|P4|Part 1: Pilot Dose Selection Period|Protocol Violation|2
882643|NCT01292603|2909162|P3|Part 1: Pilot Dose Selection Period|Protocol Violation|0
882644|NCT01292603|2909163|P2|Part 1: Pilot Dose Selection Period|Protocol Violation|0
882645|NCT01292603|2909164|P1|Part 1: Pilot Dose Selection Period|Protocol Violation|0
882646|NCT01292603|2909159|P6|Part 1: Pilot Dose Selection Period|Death|0
882647|NCT01292603|2909160|P5|Part 1: Pilot Dose Selection Period|Death|0
882648|NCT01292603|2909161|P4|Part 1: Pilot Dose Selection Period|Death|1
882649|NCT01292603|2909162|P3|Part 1: Pilot Dose Selection Period|Death|0
882650|NCT01292603|2909163|P2|Part 1: Pilot Dose Selection Period|Death|0
882651|NCT01292603|2909164|P1|Part 1: Pilot Dose Selection Period|Death|0
882652|NCT01292603|2909159|P6|Part 1: Pilot Dose Selection Period|Adverse Event|0
882653|NCT01292603|2909160|P5|Part 1: Pilot Dose Selection Period|Adverse Event|0
882654|NCT01292603|2909161|P4|Part 1: Pilot Dose Selection Period|Adverse Event|4
882655|NCT01292603|2909162|P3|Part 1: Pilot Dose Selection Period|Adverse Event|0
882656|NCT01292603|2909163|P2|Part 1: Pilot Dose Selection Period|Adverse Event|0
882657|NCT01292603|2909164|P1|Part 1: Pilot Dose Selection Period|Adverse Event|0
882658|NCT01292486|2909217|P1|Overall Study|Physician Decision|1
882659|NCT01292486|2909217|P1|Overall Study|Adverse Event|1
882660|NCT01292486|2909217|P1|Overall Study|Did not meet screening criteria|2
882661|NCT01292486|2909217|P1|Overall Study|Protocol Violation|2
882662|NCT01292473|2909231|P4|Overall Study|Disease Progression|6
882663|NCT01292473|2909232|P3|Overall Study|Disease Progression|3
882664|NCT01292473|2909233|P2|Overall Study|Disease Progression|1
882665|NCT01292473|2909234|P1|Overall Study|Disease Progression|0
882666|NCT01292473|2909231|P4|Overall Study|Physician Decision|0
882667|NCT01292473|2909232|P3|Overall Study|Physician Decision|0
882668|NCT01292473|2909233|P2|Overall Study|Physician Decision|1
882669|NCT01292473|2909234|P1|Overall Study|Physician Decision|0
882670|NCT01292473|2909231|P4|Overall Study|Withdrawal by Subject|3
882671|NCT01292473|2909232|P3|Overall Study|Withdrawal by Subject|3
882672|NCT01292473|2909233|P2|Overall Study|Withdrawal by Subject|4
882673|NCT01292473|2909234|P1|Overall Study|Withdrawal by Subject|3
882674|NCT01292473|2909231|P4|Overall Study|Lost to Follow-up|2
882675|NCT01292473|2909232|P3|Overall Study|Lost to Follow-up|2
882676|NCT01292473|2909233|P2|Overall Study|Lost to Follow-up|1
882677|NCT01292473|2909234|P1|Overall Study|Lost to Follow-up|1
882678|NCT01292473|2909231|P4|Overall Study|Adverse Event|1
882679|NCT01292473|2909232|P3|Overall Study|Adverse Event|1
882680|NCT01292473|2909233|P2|Overall Study|Adverse Event|0
882681|NCT01292473|2909234|P1|Overall Study|Adverse Event|1
882682|NCT01292239|2909293|P2|Overall Study|Withdrawal by Subject|6
882683|NCT01292239|2909294|P1|Overall Study|Withdrawal by Subject|3
882684|NCT01292239|2909293|P2|Overall Study|Not specified|1
882685|NCT01292239|2909294|P1|Overall Study|Not specified|1
882686|NCT01292226|2909315|P1|Overall Study|Not specified|2
882687|NCT01292226|2909315|P1|Overall Study|Withdrawal by Subject|1
882688|NCT01292226|2909315|P1|Overall Study|Protocol Violation|3
882689|NCT01292226|2909315|P1|Overall Study|Graft loss|1
882690|NCT01292226|2909315|P1|Overall Study|Death|1
882691|NCT01292226|2909315|P1|Overall Study|Adverse Event|5
882692|NCT01292187|2909348|P2|Overall Study|All other reasons|3
882693|NCT01292187|2909349|P1|Overall Study|All other reasons|1
882694|NCT01292187|2909348|P2|Overall Study|Withdrawal by Subject|5
882695|NCT01292187|2909349|P1|Overall Study|Withdrawal by Subject|6
882696|NCT01292187|2909348|P2|Overall Study|Adverse Event|5
882697|NCT01292187|2909349|P1|Overall Study|Adverse Event|10
882698|NCT01292057|2909384|P2|Overall Study|Lost to Follow-up|1
882699|NCT01292057|2909385|P1|Overall Study|Lost to Follow-up|1
882700|NCT01292057|2909384|P2|Overall Study|Protocol Violation|1
882701|NCT01292057|2909385|P1|Overall Study|Protocol Violation|1
882702|NCT01291277|2909457|P2|Overall Study|Lost to Follow-up|1
882703|NCT01291277|2909458|P1|Overall Study|Lost to Follow-up|3
882704|NCT01291277|2909457|P2|Overall Study|Death|2
882705|NCT01291277|2909458|P1|Overall Study|Death|2
882706|NCT01291225|2909470|P2|Overall Study|Lost to Follow-up|39
882707|NCT01291225|2909471|P1|Overall Study|Lost to Follow-up|85
882708|NCT01291173|2909485|P4|Overall Study|Excluded therapy|0
882709|NCT01291173|2909486|P3|Overall Study|Excluded therapy|1
882710|NCT01291173|2909487|P2|Overall Study|Excluded therapy|0
882711|NCT01291173|2909488|P1|Overall Study|Excluded therapy|0
882712|NCT01291173|2909485|P4|Overall Study|Subject was unblinded|0
882713|NCT01291173|2909486|P3|Overall Study|Subject was unblinded|1
882714|NCT01291173|2909487|P2|Overall Study|Subject was unblinded|0
882715|NCT01291173|2909488|P1|Overall Study|Subject was unblinded|0
882716|NCT01291173|2909485|P4|Overall Study|Lack of compliance|1
882717|NCT01291173|2909486|P3|Overall Study|Lack of compliance|0
882718|NCT01291173|2909487|P2|Overall Study|Lack of compliance|0
882719|NCT01291173|2909488|P1|Overall Study|Lack of compliance|0
882720|NCT01291173|2909485|P4|Overall Study|Unable to meet visit schedule|0
882721|NCT01291173|2909486|P3|Overall Study|Unable to meet visit schedule|1
882722|NCT01291173|2909487|P2|Overall Study|Unable to meet visit schedule|0
882723|NCT01291173|2909488|P1|Overall Study|Unable to meet visit schedule|0
882724|NCT01291173|2909485|P4|Overall Study|Lost to Follow-up|2
882725|NCT01291173|2909486|P3|Overall Study|Lost to Follow-up|3
882726|NCT01291173|2909487|P2|Overall Study|Lost to Follow-up|6
882727|NCT01291173|2909488|P1|Overall Study|Lost to Follow-up|4
882728|NCT01291173|2909485|P4|Overall Study|Withdrawal by Subject|2
882729|NCT01291173|2909486|P3|Overall Study|Withdrawal by Subject|4
882730|NCT01291173|2909487|P2|Overall Study|Withdrawal by Subject|4
882731|NCT01291173|2909488|P1|Overall Study|Withdrawal by Subject|6
882732|NCT01291173|2909485|P4|Overall Study|Protocol Violation|5
882733|NCT01291173|2909486|P3|Overall Study|Protocol Violation|2
882734|NCT01291173|2909487|P2|Overall Study|Protocol Violation|2
882735|NCT01291173|2909488|P1|Overall Study|Protocol Violation|7
882736|NCT01291173|2909485|P4|Overall Study|Adverse Event|3
882737|NCT01291173|2909486|P3|Overall Study|Adverse Event|1
882738|NCT01291173|2909487|P2|Overall Study|Adverse Event|3
882739|NCT01291173|2909488|P1|Overall Study|Adverse Event|0
882740|NCT01291017|2909597|P1|Overall Study|Withdrawal by Subject|3
882741|NCT01291017|2909597|P1|Overall Study|Lost to Follow-up|2
882742|NCT01290887|2909630|P2|Overall Study|Not specified|6
882743|NCT01290887|2909631|P1|Overall Study|Not specified|3
882744|NCT01290887|2909630|P2|Overall Study|Sponsor closure of study|476
882745|NCT01290887|2909631|P1|Overall Study|Sponsor closure of study|420
882746|NCT01290887|2909630|P2|Overall Study|Non-compliance to study medications|0
882747|NCT01290887|2909631|P1|Overall Study|Non-compliance to study medications|1
882748|NCT01290887|2909630|P2|Overall Study|Non-compliance to study procedures|1
882749|NCT01290887|2909631|P1|Overall Study|Non-compliance to study procedures|0
882750|NCT01290887|2909630|P2|Overall Study|Lost to Follow-up|4
882751|NCT01290887|2909631|P1|Overall Study|Lost to Follow-up|4
882752|NCT01290887|2909630|P2|Overall Study|Protocol Violation|1
882753|NCT01290887|2909631|P1|Overall Study|Protocol Violation|2
882754|NCT01290887|2909630|P2|Overall Study|Withdrawal by Subject|32
882755|NCT01290887|2909631|P1|Overall Study|Withdrawal by Subject|26
882756|NCT01290887|2909630|P2|Overall Study|Lack of Efficacy|5
882757|NCT01290887|2909631|P1|Overall Study|Lack of Efficacy|4
882758|NCT01290887|2909630|P2|Overall Study|Adverse Event|11
882759|NCT01290887|2909631|P1|Overall Study|Adverse Event|6
882760|NCT01290822|2909692|P1|Overall Study|Physician Decision|10
882761|NCT01290822|2909692|P1|Overall Study|Withdrawal by Subject|1
882762|NCT01290796|2909701|P1|Overall Study|Withdrawal by Sponsor|1
882763|NCT01290796|2909701|P1|Overall Study|Secondary Surgical Intervention|2
882764|NCT01290796|2909701|P1|Overall Study|Physician Decision|2
882765|NCT01290796|2909701|P1|Overall Study|Withdrawal by Subject|4
882766|NCT01290796|2909701|P1|Overall Study|Lost to Follow-up|21
882767|NCT01290757|2909717|P2|Overall Study|Other|1
882768|NCT01290757|2909718|P1|Overall Study|Other|0
882769|NCT01290757|2909717|P2|Overall Study|Protocol Violation|1
882770|NCT01290757|2909718|P1|Overall Study|Protocol Violation|1
882771|NCT01290757|2909717|P2|Overall Study|Adverse Event|0
882772|NCT01290757|2909718|P1|Overall Study|Adverse Event|1
882773|NCT01290731|2909734|P1|Overall Study|Withdrawal by Subject|1
882774|NCT01290718|2909746|P1|Overall Study|Early termination of the study|4
882775|NCT01290679|2909755|P2|Overall Study|Subject Entered Another Trial|5
882776|NCT01290679|2909756|P1|Overall Study|Subject Entered Another Trial|0
882777|NCT01290679|2909755|P2|Overall Study|Withdrawal by Subject|5
882778|NCT01290679|2909756|P1|Overall Study|Withdrawal by Subject|6
882779|NCT01290679|2909755|P2|Overall Study|Protocol Violation|1
882780|NCT01290679|2909756|P1|Overall Study|Protocol Violation|0
882781|NCT01290679|2909755|P2|Overall Study|Lost to Follow-up|10
882782|NCT01290679|2909756|P1|Overall Study|Lost to Follow-up|8
882783|NCT01290679|2909755|P2|Overall Study|Adverse Event|0
882784|NCT01290679|2909756|P1|Overall Study|Adverse Event|2
882785|NCT01290666|2909825|P1|Overall Study|Early Termination of Study|4
882786|NCT01290666|2909825|P1|Overall Study|Withdrawal by Subject|23
882787|NCT01290666|2909825|P1|Overall Study|Lost to Follow-up|11
882788|NCT01290601|2909878|P4|Overall Study|Protocol Violation|0
882789|NCT01290601|2909879|P3|Overall Study|Protocol Violation|0
882790|NCT01290601|2909880|P2|Overall Study|Protocol Violation|0
882791|NCT01290601|2909881|P1|Overall Study|Protocol Violation|1
882792|NCT01290601|2909878|P4|Overall Study|Other|0
882793|NCT01290601|2909879|P3|Overall Study|Other|0
882794|NCT01290601|2909880|P2|Overall Study|Other|0
882795|NCT01290601|2909881|P1|Overall Study|Other|1
882796|NCT01290601|2909878|P4|Overall Study|Lost to Follow-up|0
882797|NCT01290601|2909879|P3|Overall Study|Lost to Follow-up|0
882798|NCT01290601|2909880|P2|Overall Study|Lost to Follow-up|2
882799|NCT01290601|2909881|P1|Overall Study|Lost to Follow-up|7
882800|NCT01290601|2909878|P4|Overall Study|Lack of Efficacy|0
882801|NCT01290601|2909879|P3|Overall Study|Lack of Efficacy|0
882802|NCT01290601|2909880|P2|Overall Study|Lack of Efficacy|1
882803|NCT01290601|2909881|P1|Overall Study|Lack of Efficacy|2
882804|NCT01290601|2909878|P4|Overall Study|Adverse Event|0
882805|NCT01290601|2909879|P3|Overall Study|Adverse Event|0
882806|NCT01290601|2909880|P2|Overall Study|Adverse Event|2
882807|NCT01290601|2909881|P1|Overall Study|Adverse Event|0
882808|NCT01290341|2909913|P2|Overall Study|Negative baseline culture and others|11
882809|NCT01290341|2909914|P1|Overall Study|Negative baseline culture and others|44
882810|NCT01290341|2909913|P2|Overall Study|Withdrawal by Subject|5
882811|NCT01290341|2909914|P1|Overall Study|Withdrawal by Subject|19
882812|NCT01290341|2909913|P2|Overall Study|Lost to Follow-up|10
882813|NCT01290341|2909914|P1|Overall Study|Lost to Follow-up|21
882814|NCT01290341|2909913|P2|Overall Study|Adverse Event|0
882815|NCT01290341|2909914|P1|Overall Study|Adverse Event|1
882816|NCT01290341|2909913|P2|Overall Study|Protocol Violation|3
882817|NCT01290341|2909914|P1|Overall Study|Protocol Violation|7
882818|NCT01290315|2909926|P4|Overall Study|Withdrawal by Subject|0
882819|NCT01290315|2909927|P3|Overall Study|Withdrawal by Subject|0
882820|NCT01290315|2909928|P2|Overall Study|Withdrawal by Subject|1
882821|NCT01290315|2909929|P1|Overall Study|Withdrawal by Subject|1
882822|NCT01290315|2909926|P4|Overall Study|Lost to Follow-up|0
882823|NCT01290315|2909927|P3|Overall Study|Lost to Follow-up|0
882824|NCT01290315|2909928|P2|Overall Study|Lost to Follow-up|1
882825|NCT01290315|2909929|P1|Overall Study|Lost to Follow-up|0
882826|NCT01290315|2909926|P4|Overall Study|Selection criteria/compliance|2
882827|NCT01290315|2909927|P3|Overall Study|Selection criteria/compliance|0
882828|NCT01290315|2909928|P2|Overall Study|Selection criteria/compliance|1
882829|NCT01290315|2909929|P1|Overall Study|Selection criteria/compliance|2
882830|NCT01290315|2909926|P4|Overall Study|Adverse Event|3
882831|NCT01290315|2909927|P3|Overall Study|Adverse Event|0
882832|NCT01290315|2909928|P2|Overall Study|Adverse Event|0
882833|NCT01290315|2909929|P1|Overall Study|Adverse Event|0
882834|NCT01290263|2909951|P5|Overall Study|Participant Non-Compliance|1
882835|NCT01290263|2909952|P4|Overall Study|Participant Non-Compliance|1
882836|NCT01290263|2909953|P3|Overall Study|Participant Non-Compliance|0
882837|NCT01290263|2909954|P2|Overall Study|Participant Non-Compliance|0
882838|NCT01290263|2909955|P1|Overall Study|Participant Non-Compliance|0
882839|NCT01290263|2909951|P5|Overall Study|Withdrawal by Subject|2
882840|NCT01290263|2909952|P4|Overall Study|Withdrawal by Subject|1
882841|NCT01290263|2909953|P3|Overall Study|Withdrawal by Subject|0
882842|NCT01290263|2909954|P2|Overall Study|Withdrawal by Subject|1
882843|NCT01290263|2909955|P1|Overall Study|Withdrawal by Subject|3
882844|NCT01290263|2909951|P5|Overall Study|Lack of Efficacy|33
882845|NCT01290263|2909952|P4|Overall Study|Lack of Efficacy|24
882846|NCT01290263|2909953|P3|Overall Study|Lack of Efficacy|7
882847|NCT01290263|2909954|P2|Overall Study|Lack of Efficacy|2
882848|NCT01290263|2909955|P1|Overall Study|Lack of Efficacy|8
882849|NCT01290263|2909951|P5|Overall Study|Adverse Event|1
882850|NCT01290263|2909952|P4|Overall Study|Adverse Event|1
882851|NCT01290263|2909953|P3|Overall Study|Adverse Event|0
882852|NCT01290263|2909954|P2|Overall Study|Adverse Event|0
882853|NCT01290263|2909955|P1|Overall Study|Adverse Event|0
882854|NCT01290224|2909982|P1|Overall Study|Refused Further Treatment|4
882855|NCT01290224|2909982|P1|Overall Study|Adverse Event|1
882856|NCT01290094|2909993|P1|Overall Study|Lost to Follow-up|5
882857|NCT01290094|2909993|P1|Overall Study|Withdrawal by Subject|1
882858|NCT01290068|2910006|P2|Overall Study|Other|1
882859|NCT01290068|2910007|P1|Overall Study|Other|3
882860|NCT01290068|2910006|P2|Overall Study|Withdrawal by subject prior to implant|2
882861|NCT01290068|2910007|P1|Overall Study|Withdrawal by subject prior to implant|0
882862|NCT01290068|2910006|P2|Overall Study|Lost to Follow-up|0
882863|NCT01290068|2910007|P1|Overall Study|Lost to Follow-up|3
882864|NCT01290068|2910006|P2|Overall Study|Adverse Event|3
882865|NCT01290068|2910007|P1|Overall Study|Adverse Event|1
882866|NCT01290029|2910019|P1|Overall Study|Other|2
882867|NCT01289990|2910045|P13|Overall Study|Not treated|0
882868|NCT01289990|2910046|P12|Overall Study|Not treated|2
882869|NCT01289990|2910047|P11|Overall Study|Not treated|1
882870|NCT01289990|2910048|P10|Overall Study|Not treated|0
882871|NCT01289990|2910049|P9|Overall Study|Not treated|1
882872|NCT01289990|2910050|P8|Overall Study|Not treated|0
882873|NCT01289990|2910051|P7|Overall Study|Not treated|1
882874|NCT01289990|2910052|P6|Overall Study|Not treated|0
882875|NCT01289990|2910053|P5|Overall Study|Not treated|0
882876|NCT01289990|2910054|P4|Overall Study|Not treated|0
882877|NCT01289990|2910055|P3|Overall Study|Not treated|0
882878|NCT01289990|2910056|P2|Overall Study|Not treated|0
882879|NCT01289990|2910057|P1|Overall Study|Not treated|0
882880|NCT01289990|2910045|P13|Overall Study|did not continue in extension|56
882881|NCT01289990|2910046|P12|Overall Study|did not continue in extension|34
882882|NCT01289990|2910047|P11|Overall Study|did not continue in extension|45
882883|NCT01289990|2910048|P10|Overall Study|did not continue in extension|48
882884|NCT01289990|2910049|P9|Overall Study|did not continue in extension|44
882885|NCT01289990|2910050|P8|Overall Study|did not continue in extension|36
882886|NCT01289990|2910051|P7|Overall Study|did not continue in extension|54
882887|NCT01289990|2910052|P6|Overall Study|did not continue in extension|50
882888|NCT01289990|2910053|P5|Overall Study|did not continue in extension|48
882889|NCT01289990|2910054|P4|Overall Study|did not continue in extension|51
882890|NCT01289990|2910055|P3|Overall Study|did not continue in extension|51
882891|NCT01289990|2910056|P2|Overall Study|did not continue in extension|45
882892|NCT01289990|2910057|P1|Overall Study|did not continue in extension|41
882893|NCT01289990|2910045|P13|Overall Study|discontinued in preceding trial|24
882894|NCT01289990|2910046|P12|Overall Study|discontinued in preceding trial|17
882895|NCT01289990|2910047|P11|Overall Study|discontinued in preceding trial|17
882896|NCT01289990|2910048|P10|Overall Study|discontinued in preceding trial|21
882897|NCT01289990|2910049|P9|Overall Study|discontinued in preceding trial|17
882898|NCT01289990|2910050|P8|Overall Study|discontinued in preceding trial|8
882899|NCT01289990|2910051|P7|Overall Study|discontinued in preceding trial|18
882900|NCT01289990|2910052|P6|Overall Study|discontinued in preceding trial|12
882901|NCT01289990|2910053|P5|Overall Study|discontinued in preceding trial|11
882902|NCT01289990|2910054|P4|Overall Study|discontinued in preceding trial|17
882903|NCT01289990|2910055|P3|Overall Study|discontinued in preceding trial|41
882904|NCT01289990|2910056|P2|Overall Study|discontinued in preceding trial|20
882905|NCT01289990|2910057|P1|Overall Study|discontinued in preceding trial|18
882906|NCT01289990|2910045|P13|Overall Study|Withdrawal by Subject|16
882907|NCT01289990|2910046|P12|Overall Study|Withdrawal by Subject|13
882908|NCT01289990|2910047|P11|Overall Study|Withdrawal by Subject|11
882909|NCT01289990|2910048|P10|Overall Study|Withdrawal by Subject|13
882910|NCT01289990|2910049|P9|Overall Study|Withdrawal by Subject|12
882911|NCT01289990|2910050|P8|Overall Study|Withdrawal by Subject|9
882912|NCT01289990|2910051|P7|Overall Study|Withdrawal by Subject|13
882913|NCT01289990|2910052|P6|Overall Study|Withdrawal by Subject|7
882914|NCT01289990|2910053|P5|Overall Study|Withdrawal by Subject|8
882915|NCT01289990|2910054|P4|Overall Study|Withdrawal by Subject|13
882916|NCT01289990|2910055|P3|Overall Study|Withdrawal by Subject|12
882917|NCT01289990|2910056|P2|Overall Study|Withdrawal by Subject|14
882918|NCT01289990|2910057|P1|Overall Study|Withdrawal by Subject|15
882919|NCT01289990|2910045|P13|Overall Study|Lost to Follow-up|2
882920|NCT01289990|2910046|P12|Overall Study|Lost to Follow-up|1
882921|NCT01289990|2910047|P11|Overall Study|Lost to Follow-up|2
882922|NCT01289990|2910048|P10|Overall Study|Lost to Follow-up|4
882923|NCT01289990|2910049|P9|Overall Study|Lost to Follow-up|1
882924|NCT01289990|2910050|P8|Overall Study|Lost to Follow-up|2
882925|NCT01289990|2910051|P7|Overall Study|Lost to Follow-up|2
882926|NCT01289990|2910052|P6|Overall Study|Lost to Follow-up|4
882927|NCT01289990|2910053|P5|Overall Study|Lost to Follow-up|3
882928|NCT01289990|2910054|P4|Overall Study|Lost to Follow-up|5
882929|NCT01289990|2910055|P3|Overall Study|Lost to Follow-up|5
882930|NCT01289990|2910056|P2|Overall Study|Lost to Follow-up|2
882931|NCT01289990|2910057|P1|Overall Study|Lost to Follow-up|3
882932|NCT01289990|2910045|P13|Overall Study|Death|0
882933|NCT01289990|2910046|P12|Overall Study|Death|1
882934|NCT01289990|2910047|P11|Overall Study|Death|0
882935|NCT01289990|2910048|P10|Overall Study|Death|0
882936|NCT01289990|2910049|P9|Overall Study|Death|0
882937|NCT01289990|2910050|P8|Overall Study|Death|0
882938|NCT01289990|2910051|P7|Overall Study|Death|0
882939|NCT01289990|2910052|P6|Overall Study|Death|1
882940|NCT01289990|2910053|P5|Overall Study|Death|2
882941|NCT01289990|2910054|P4|Overall Study|Death|1
882942|NCT01289990|2910055|P3|Overall Study|Death|0
882943|NCT01289990|2910056|P2|Overall Study|Death|0
882944|NCT01289990|2910057|P1|Overall Study|Death|0
882945|NCT01289847|2910274|P1|Overall Study|Patient could not comply with visits|1
882946|NCT01289821|2910283|P1|Survival Follow-up Period|Clinical endpoint reached|16
882947|NCT01289821|2910283|P1|Survival Follow-up Period|Lost to Follow-up|1
882948|NCT01289821|2910283|P1|Survival Follow-up Period|Protocol Violation|1
882949|NCT01289821|2910283|P1|Safety Follow-up Period|Unspecified reason|1
882950|NCT01289821|2910283|P1|Safety Follow-up Period|Protocol Violation|3
882951|NCT01289821|2910283|P1|Safety Follow-up Period|Withdrawal by Subject|1
882952|NCT01289821|2910283|P1|Treatment Period|Therapeutic procedure required|1
882953|NCT01289821|2910283|P1|Treatment Period|Clinical Progression|2
882954|NCT01289821|2910283|P1|Treatment Period|Radiological Progression|43
882955|NCT01289821|2910283|P1|Treatment Period|Adverse Event|4
882956|NCT01289821|2910283|P1|Treatment Period|Physician Decision|3
882957|NCT01289821|2910283|P1|Treatment Period|Withdrawal by Subject|1
882958|NCT01289782|2910294|P2|Overall Study|Reason not specified|2
882959|NCT01289782|2910295|P1|Overall Study|Reason not specified|1
882960|NCT01289782|2910294|P2|Overall Study|Sponsor's Decision|0
882961|NCT01289782|2910295|P1|Overall Study|Sponsor's Decision|1
882962|NCT01289782|2910294|P2|Overall Study|Withdrawal by Subject|2
882963|NCT01289782|2910295|P1|Overall Study|Withdrawal by Subject|8
882964|NCT01289782|2910294|P2|Overall Study|Protocol Violation|1
882965|NCT01289782|2910295|P1|Overall Study|Protocol Violation|1
882966|NCT01289782|2910294|P2|Overall Study|Lost to Follow-up|7
882967|NCT01289782|2910295|P1|Overall Study|Lost to Follow-up|14
882968|NCT01289639|2910367|P3|Overall Study|Lost to Follow-up|0
882969|NCT01289639|2910368|P2|Overall Study|Lost to Follow-up|0
882970|NCT01289639|2910369|P1|Overall Study|Lost to Follow-up|1
882971|NCT01289574|2910395|P3|Overall Study|Subject wanted alternate treatment|0
882972|NCT01289574|2910396|P2|Overall Study|Subject wanted alternate treatment|1
882973|NCT01289574|2910397|P1|Overall Study|Subject wanted alternate treatment|0
882974|NCT01289574|2910395|P3|Overall Study|Adverse Event|0
882975|NCT01289574|2910396|P2|Overall Study|Adverse Event|1
882976|NCT01289574|2910397|P1|Overall Study|Adverse Event|0
882977|NCT01289574|2910395|P3|Overall Study|Withdrawal by Subject|1
882978|NCT01289574|2910396|P2|Overall Study|Withdrawal by Subject|1
882979|NCT01289574|2910397|P1|Overall Study|Withdrawal by Subject|1
882980|NCT01289574|2910395|P3|Overall Study|Lost to Follow-up|1
882981|NCT01289574|2910396|P2|Overall Study|Lost to Follow-up|0
882982|NCT01289574|2910397|P1|Overall Study|Lost to Follow-up|2
882983|NCT01289574|2910395|P3|Overall Study|Lack of Efficacy|1
882984|NCT01289574|2910396|P2|Overall Study|Lack of Efficacy|0
882985|NCT01289574|2910397|P1|Overall Study|Lack of Efficacy|4
882986|NCT01289418|2910469|P1|Day 29 Survey|participants did not complete the survey|2185
882987|NCT01289418|2910469|P1|Day 29 Survey|email address invalid|283
882988|NCT01289418|2910469|P1|Day 8 Survey|participants did not complete the survey|1935
882989|NCT01289418|2910469|P1|Day 8 Survey|email address invalid|283
882990|NCT01289210|2910505|P1|Overall Study|Adverse Event|1
882991|NCT01289119|2910515|P6|Overall Study|Other|0
882992|NCT01289119|2910516|P5|Overall Study|Other|0
882993|NCT01289119|2910517|P4|Overall Study|Other|0
882994|NCT01289119|2910518|P3|Overall Study|Other|1
882995|NCT01289119|2910519|P2|Overall Study|Other|0
882996|NCT01289119|2910520|P1|Overall Study|Other|1
882997|NCT01289119|2910515|P6|Overall Study|Lack of Efficacy|1
882998|NCT01289119|2910516|P5|Overall Study|Lack of Efficacy|1
882999|NCT01289119|2910517|P4|Overall Study|Lack of Efficacy|1
883000|NCT01289119|2910518|P3|Overall Study|Lack of Efficacy|1
883001|NCT01289119|2910519|P2|Overall Study|Lack of Efficacy|1
883002|NCT01289119|2910520|P1|Overall Study|Lack of Efficacy|0
883003|NCT01289119|2910515|P6|Overall Study|Pregnancy|0
883004|NCT01289119|2910516|P5|Overall Study|Pregnancy|0
883005|NCT01289119|2910517|P4|Overall Study|Pregnancy|0
883006|NCT01289119|2910518|P3|Overall Study|Pregnancy|0
883007|NCT01289119|2910519|P2|Overall Study|Pregnancy|1
883008|NCT01289119|2910520|P1|Overall Study|Pregnancy|0
883009|NCT01289119|2910515|P6|Overall Study|Withdrawal by Subject|1
883010|NCT01289119|2910516|P5|Overall Study|Withdrawal by Subject|1
883011|NCT01289119|2910517|P4|Overall Study|Withdrawal by Subject|3
883012|NCT01289119|2910518|P3|Overall Study|Withdrawal by Subject|4
883013|NCT01289119|2910519|P2|Overall Study|Withdrawal by Subject|2
883014|NCT01289119|2910520|P1|Overall Study|Withdrawal by Subject|4
883015|NCT01289119|2910515|P6|Overall Study|Lost to Follow-up|1
883016|NCT01289119|2910516|P5|Overall Study|Lost to Follow-up|0
883017|NCT01289119|2910517|P4|Overall Study|Lost to Follow-up|0
883018|NCT01289119|2910518|P3|Overall Study|Lost to Follow-up|0
883019|NCT01289119|2910519|P2|Overall Study|Lost to Follow-up|3
883020|NCT01289119|2910520|P1|Overall Study|Lost to Follow-up|0
883021|NCT01289119|2910515|P6|Overall Study|Major Protocol Deviation|1
883022|NCT01289119|2910516|P5|Overall Study|Major Protocol Deviation|2
883023|NCT01289119|2910517|P4|Overall Study|Major Protocol Deviation|0
883024|NCT01289119|2910518|P3|Overall Study|Major Protocol Deviation|3
883025|NCT01289119|2910519|P2|Overall Study|Major Protocol Deviation|1
883026|NCT01289119|2910520|P1|Overall Study|Major Protocol Deviation|2
883027|NCT01289119|2910515|P6|Overall Study|Adverse Event|0
883028|NCT01289119|2910516|P5|Overall Study|Adverse Event|1
883029|NCT01289119|2910517|P4|Overall Study|Adverse Event|2
883030|NCT01289119|2910518|P3|Overall Study|Adverse Event|0
883031|NCT01289119|2910519|P2|Overall Study|Adverse Event|1
883032|NCT01289119|2910520|P1|Overall Study|Adverse Event|2
883033|NCT01289041|2910641|P1|Overall Study|Death|1
883034|NCT01289041|2910641|P1|Overall Study|Withdrawal by Subject|3
883035|NCT01289041|2910641|P1|Overall Study|Progressive Disease|41
883036|NCT01289041|2910641|P1|Overall Study|Physician Decision|1
883037|NCT01289041|2910641|P1|Overall Study|Adverse Event|24
883038|NCT01289028|2910653|P1|Overall Study|Missing reason for discon|1
883039|NCT01289028|2910653|P1|Overall Study|Abnormal Lab Value|1
883040|NCT01289028|2910653|P1|Overall Study|New Cancer Therapy|2
883041|NCT01289028|2910653|P1|Overall Study|Lost to Follow-up|2
883042|NCT01289028|2910653|P1|Overall Study|No longer required|2
883043|NCT01289028|2910653|P1|Overall Study|Lack of Efficacy|2
883044|NCT01289028|2910653|P1|Overall Study|Death|4
883045|NCT01289028|2910653|P1|Overall Study|Withdrawal by Subject|6
883046|NCT01289028|2910653|P1|Overall Study|Adverse Event|14
883047|NCT01289028|2910653|P1|Overall Study|Progressive Disease|49
883048|NCT01289015|2910667|P2|Overall Study|Negative baseline culture and others|20
883049|NCT01289015|2910668|P1|Overall Study|Negative baseline culture and others|33
883050|NCT01289015|2910667|P2|Overall Study|Disease progression|0
883051|NCT01289015|2910668|P1|Overall Study|Disease progression|1
883052|NCT01289015|2910667|P2|Overall Study|Withdrawal by Subject|8
883053|NCT01289015|2910668|P1|Overall Study|Withdrawal by Subject|17
883054|NCT01289015|2910667|P2|Overall Study|Lost to Follow-up|17
883055|NCT01289015|2910668|P1|Overall Study|Lost to Follow-up|33
883056|NCT01289015|2910667|P2|Overall Study|Adverse Event|0
883057|NCT01289015|2910668|P1|Overall Study|Adverse Event|3
883058|NCT01289015|2910667|P2|Overall Study|Protocol Violation|9
883059|NCT01289015|2910668|P1|Overall Study|Protocol Violation|12
883060|NCT01288976|2910679|P3|Overall Study|Data unavailable|7
883061|NCT01288976|2910680|P2|Overall Study|Data unavailable|9
883062|NCT01288976|2910681|P1|Overall Study|Data unavailable|22
883063|NCT01288976|2910679|P3|Overall Study|Death|4
883064|NCT01288976|2910680|P2|Overall Study|Death|6
883065|NCT01288976|2910681|P1|Overall Study|Death|98
883066|NCT01288976|2910679|P3|Overall Study|Withdrawal by Subject|9
883067|NCT01288976|2910680|P2|Overall Study|Withdrawal by Subject|12
883068|NCT01288976|2910681|P1|Overall Study|Withdrawal by Subject|58
883069|NCT01288911|2910710|P2|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5
883070|NCT01288911|2910711|P1|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17
883071|NCT01288911|2910710|P2|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0
883072|NCT01288911|2910711|P1|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5
883073|NCT01288911|2910710|P2|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0
883074|NCT01288911|2910711|P1|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1
883075|NCT01288911|2910710|P2|Open-label Period (All Enzalutamide)|Progressive disease|3
883076|NCT01288911|2910711|P1|Open-label Period (All Enzalutamide)|Progressive disease|18
883077|NCT01288911|2910710|P2|Open-label Period (All Enzalutamide)|Lost to Follow-up|0
883078|NCT01288911|2910711|P1|Open-label Period (All Enzalutamide)|Lost to Follow-up|1
883079|NCT01288911|2910710|P2|Open-label Period (All Enzalutamide)|Death|1
883080|NCT01288911|2910711|P1|Open-label Period (All Enzalutamide)|Death|0
883081|NCT01288911|2910710|P2|Double-blind Period|Randomized but never received study drug|2
883082|NCT01288911|2910711|P1|Double-blind Period|Randomized but never received study drug|1
883083|NCT01288911|2910710|P2|Double-blind Period|Miscellaneous Reason|42
883084|NCT01288911|2910711|P1|Double-blind Period|Miscellaneous Reason|29
883085|NCT01288911|2910710|P2|Double-blind Period|Withdrawal by Subject|26
883086|NCT01288911|2910711|P1|Double-blind Period|Withdrawal by Subject|25
883087|NCT01288911|2910710|P2|Double-blind Period|Protocol Violation|0
883088|NCT01288911|2910711|P1|Double-blind Period|Protocol Violation|1
883089|NCT01288911|2910710|P2|Double-blind Period|Progressive Disease|103
883090|NCT01288911|2910711|P1|Double-blind Period|Progressive Disease|75
883091|NCT01288911|2910710|P2|Double-blind Period|Lost to Follow-up|2
883092|NCT01288911|2910711|P1|Double-blind Period|Lost to Follow-up|0
883093|NCT01288911|2910710|P2|Double-blind Period|Death|7
883094|NCT01288911|2910711|P1|Double-blind Period|Death|11
883095|NCT01288729|2910813|P2|Overall Study|Withdrawal by Subject|0
883096|NCT01288729|2910814|P1|Overall Study|Withdrawal by Subject|1
883097|NCT01288612|2910823|P3|Overall Study|Unable to intubate|0
883098|NCT01288612|2910824|P2|Overall Study|Unable to intubate|3
883099|NCT01288612|2910825|P1|Overall Study|Unable to intubate|0
883100|NCT01288612|2910823|P3|Overall Study|Declined|62
883101|NCT01288612|2910824|P2|Overall Study|Declined|63
883102|NCT01288612|2910825|P1|Overall Study|Declined|78
883103|NCT01288612|2910823|P3|Overall Study|Unable to contact|20
883104|NCT01288612|2910824|P2|Overall Study|Unable to contact|16
883105|NCT01288612|2910825|P1|Overall Study|Unable to contact|11
883106|NCT01288469|2910874|P3|Overall Study|Exclusion criteria finally met|0
883107|NCT01288469|2910875|P2|Overall Study|Exclusion criteria finally met|0
883108|NCT01288469|2910876|P1|Overall Study|Exclusion criteria finally met|1
883109|NCT01288469|2910874|P3|Overall Study|Consent withdrawn by subject|1
883110|NCT01288469|2910875|P2|Overall Study|Consent withdrawn by subject|1
883111|NCT01288469|2910876|P1|Overall Study|Consent withdrawn by subject|1
883112|NCT01288469|2910874|P3|Overall Study|Participant Moved|0
883113|NCT01288469|2910875|P2|Overall Study|Participant Moved|0
883114|NCT01288469|2910876|P1|Overall Study|Participant Moved|1
883115|NCT01288469|2910874|P3|Overall Study|Poor compliance to protocol|0
883116|NCT01288469|2910875|P2|Overall Study|Poor compliance to protocol|1
883117|NCT01288469|2910876|P1|Overall Study|Poor compliance to protocol|0
883118|NCT01288469|2910874|P3|Overall Study|Adverse Event|1
883119|NCT01288469|2910875|P2|Overall Study|Adverse Event|1
883120|NCT01288469|2910876|P1|Overall Study|Adverse Event|4
883121|NCT01288443|2910908|P6|Overall Study|Other than above|0
883122|NCT01288443|2910909|P5|Overall Study|Other than above|1
883123|NCT01288443|2910910|P4|Overall Study|Other than above|2
883124|NCT01288443|2910911|P3|Overall Study|Other than above|0
883125|NCT01288443|2910912|P2|Overall Study|Other than above|0
883126|NCT01288443|2910913|P1|Overall Study|Other than above|0
883127|NCT01288443|2910908|P6|Overall Study|Study drug auto-injector administration|1
883128|NCT01288443|2910909|P5|Overall Study|Study drug auto-injector administration|1
883129|NCT01288443|2910910|P4|Overall Study|Study drug auto-injector administration|0
883130|NCT01288443|2910911|P3|Overall Study|Study drug auto-injector administration|0
883131|NCT01288443|2910912|P2|Overall Study|Study drug auto-injector administration|0
883132|NCT01288443|2910913|P1|Overall Study|Study drug auto-injector administration|0
883133|NCT01288443|2910908|P6|Overall Study|Lost to Follow-up|0
883134|NCT01288443|2910909|P5|Overall Study|Lost to Follow-up|0
883135|NCT01288443|2910910|P4|Overall Study|Lost to Follow-up|0
883136|NCT01288443|2910911|P3|Overall Study|Lost to Follow-up|0
883137|NCT01288443|2910912|P2|Overall Study|Lost to Follow-up|1
883138|NCT01288443|2910913|P1|Overall Study|Lost to Follow-up|0
883139|NCT01288443|2910908|P6|Overall Study|Consent withdrawn by Participant|1
883140|NCT01288443|2910909|P5|Overall Study|Consent withdrawn by Participant|0
883141|NCT01288443|2910910|P4|Overall Study|Consent withdrawn by Participant|0
883142|NCT01288443|2910911|P3|Overall Study|Consent withdrawn by Participant|0
883143|NCT01288443|2910912|P2|Overall Study|Consent withdrawn by Participant|0
883144|NCT01288443|2910913|P1|Overall Study|Consent withdrawn by Participant|0
883145|NCT01288443|2910908|P6|Overall Study|Participant Moved|1
883146|NCT01288443|2910909|P5|Overall Study|Participant Moved|2
883147|NCT01288443|2910910|P4|Overall Study|Participant Moved|1
883148|NCT01288443|2910911|P3|Overall Study|Participant Moved|0
883149|NCT01288443|2910912|P2|Overall Study|Participant Moved|0
883150|NCT01288443|2910913|P1|Overall Study|Participant Moved|0
883151|NCT01288443|2910908|P6|Overall Study|Poor compliance to protocol|1
883152|NCT01288443|2910909|P5|Overall Study|Poor compliance to protocol|0
883153|NCT01288443|2910910|P4|Overall Study|Poor compliance to protocol|0
883154|NCT01288443|2910911|P3|Overall Study|Poor compliance to protocol|0
883155|NCT01288443|2910912|P2|Overall Study|Poor compliance to protocol|0
883156|NCT01288443|2910913|P1|Overall Study|Poor compliance to protocol|0
883157|NCT01288443|2910908|P6|Overall Study|Adverse Event|1
883158|NCT01288443|2910909|P5|Overall Study|Adverse Event|3
883159|NCT01288443|2910910|P4|Overall Study|Adverse Event|1
883160|NCT01288443|2910911|P3|Overall Study|Adverse Event|1
883161|NCT01288443|2910912|P2|Overall Study|Adverse Event|0
883162|NCT01288443|2910913|P1|Overall Study|Adverse Event|0
883163|NCT01288287|2910963|P1|Overall Study|Unknown Status|7
883164|NCT01288287|2910963|P1|Overall Study|Unknown Reason|1
883165|NCT01288287|2910963|P1|Overall Study|Other Reason|13
883166|NCT01288287|2910963|P1|Overall Study|Lack of Efficacy|13
883167|NCT01288287|2910963|P1|Overall Study|Withdrawal by Subject|4
883168|NCT01288287|2910963|P1|Overall Study|Lost to Follow-up|8
883169|NCT01288209|2910978|P2|Overall Study|Not specified|0
883170|NCT01288209|2910979|P1|Overall Study|Not specified|1
883171|NCT01288209|2910978|P2|Overall Study|Withdrawal by Subject|3
883172|NCT01288209|2910979|P1|Overall Study|Withdrawal by Subject|1
883173|NCT01288079|2911009|P4|Overall Study|Other or Study Termination|8
883174|NCT01288079|2911010|P3|Overall Study|Other or Study Termination|14
883175|NCT01288079|2911011|P2|Overall Study|Other or Study Termination|15
883176|NCT01288079|2911012|P1|Overall Study|Other or Study Termination|11
883177|NCT01288079|2911009|P4|Overall Study|Lost to Follow-up|0
883178|NCT01288079|2911010|P3|Overall Study|Lost to Follow-up|1
883179|NCT01288079|2911011|P2|Overall Study|Lost to Follow-up|1
883180|NCT01288079|2911012|P1|Overall Study|Lost to Follow-up|1
883181|NCT01288079|2911009|P4|Overall Study|Study-Specific Withdrawal Criteria|0
883182|NCT01288079|2911010|P3|Overall Study|Study-Specific Withdrawal Criteria|0
883183|NCT01288079|2911011|P2|Overall Study|Study-Specific Withdrawal Criteria|1
883184|NCT01288079|2911012|P1|Overall Study|Study-Specific Withdrawal Criteria|1
883185|NCT01288079|2911009|P4|Overall Study|Lack of Efficacy|2
883186|NCT01288079|2911010|P3|Overall Study|Lack of Efficacy|0
883187|NCT01288079|2911011|P2|Overall Study|Lack of Efficacy|2
883188|NCT01288079|2911012|P1|Overall Study|Lack of Efficacy|2
883189|NCT01288079|2911009|P4|Overall Study|Condition under Investigation Worsened|1
883190|NCT01288079|2911010|P3|Overall Study|Condition under Investigation Worsened|0
883191|NCT01288079|2911011|P2|Overall Study|Condition under Investigation Worsened|0
883192|NCT01288079|2911012|P1|Overall Study|Condition under Investigation Worsened|0
883193|NCT01288079|2911009|P4|Overall Study|Severe Non-Compliance to Protocol|3
883194|NCT01288079|2911010|P3|Overall Study|Severe Non-Compliance to Protocol|1
883195|NCT01288079|2911011|P2|Overall Study|Severe Non-Compliance to Protocol|3
883196|NCT01288079|2911012|P1|Overall Study|Severe Non-Compliance to Protocol|1
883197|NCT01288079|2911009|P4|Overall Study|Adverse Event|3
883198|NCT01288079|2911010|P3|Overall Study|Adverse Event|2
883199|NCT01288079|2911011|P2|Overall Study|Adverse Event|1
883200|NCT01288079|2911012|P1|Overall Study|Adverse Event|2
883201|NCT01288079|2911009|P4|Overall Study|Withdrawal by Subject|0
883202|NCT01288079|2911010|P3|Overall Study|Withdrawal by Subject|1
883203|NCT01288079|2911011|P2|Overall Study|Withdrawal by Subject|4
883204|NCT01288079|2911012|P1|Overall Study|Withdrawal by Subject|2
883205|NCT01288053|2911022|P1|Overall Study|Death|1
883206|NCT01287897|2911040|P4|Overall Study|Other|0
883207|NCT01287897|2911041|P3|Overall Study|Other|1
883208|NCT01287897|2911042|P2|Overall Study|Other|0
883209|NCT01287897|2911043|P1|Overall Study|Other|1
883210|NCT01287897|2911040|P4|Overall Study|Not meeting entrance criteria|0
883211|NCT01287897|2911041|P3|Overall Study|Not meeting entrance criteria|0
883212|NCT01287897|2911042|P2|Overall Study|Not meeting entrance criteria|1
883213|NCT01287897|2911043|P1|Overall Study|Not meeting entrance criteria|1
883214|NCT01287897|2911040|P4|Overall Study|Not consented properly|0
883215|NCT01287897|2911041|P3|Overall Study|Not consented properly|0
883216|NCT01287897|2911042|P2|Overall Study|Not consented properly|1
883217|NCT01287897|2911043|P1|Overall Study|Not consented properly|0
883218|NCT01287897|2911040|P4|Overall Study|Withdrawal by Subject|2
883219|NCT01287897|2911041|P3|Overall Study|Withdrawal by Subject|3
883220|NCT01287897|2911042|P2|Overall Study|Withdrawal by Subject|5
883221|NCT01287897|2911043|P1|Overall Study|Withdrawal by Subject|1
883222|NCT01287897|2911040|P4|Overall Study|Lost to Follow-up|0
883223|NCT01287897|2911041|P3|Overall Study|Lost to Follow-up|2
883224|NCT01287897|2911042|P2|Overall Study|Lost to Follow-up|0
883225|NCT01287897|2911043|P1|Overall Study|Lost to Follow-up|0
883226|NCT01287897|2911040|P4|Overall Study|Protocol Violation|1
883227|NCT01287897|2911041|P3|Overall Study|Protocol Violation|0
883228|NCT01287897|2911042|P2|Overall Study|Protocol Violation|1
883229|NCT01287897|2911043|P1|Overall Study|Protocol Violation|1
883230|NCT01287897|2911040|P4|Overall Study|Lack of Efficacy|0
883231|NCT01287897|2911041|P3|Overall Study|Lack of Efficacy|0
883232|NCT01287897|2911042|P2|Overall Study|Lack of Efficacy|0
883233|NCT01287897|2911043|P1|Overall Study|Lack of Efficacy|2
883234|NCT01287897|2911040|P4|Overall Study|Adverse Event|4
883235|NCT01287897|2911041|P3|Overall Study|Adverse Event|6
883236|NCT01287897|2911042|P2|Overall Study|Adverse Event|3
883237|NCT01287897|2911043|P1|Overall Study|Adverse Event|5
883238|NCT01287832|2911094|P2|Overall Study|Death|1
883239|NCT01287832|2911095|P1|Overall Study|Death|0
883240|NCT01287832|2911094|P2|Overall Study|Adverse Event|0
883241|NCT01287832|2911095|P1|Overall Study|Adverse Event|1
883242|NCT01287754|2911103|P2|Overall Study|Protocol Violation|3
883243|NCT01287754|2911104|P1|Overall Study|Protocol Violation|0
883244|NCT01287754|2911103|P2|Overall Study|Lost to Follow-up|6
883245|NCT01287754|2911104|P1|Overall Study|Lost to Follow-up|1
883246|NCT01287754|2911103|P2|Overall Study|Death|12
883247|NCT01287754|2911104|P1|Overall Study|Death|2
883248|NCT01287741|2911116|P2|Overall Study|Reason not specified|9
883249|NCT01287741|2911117|P1|Overall Study|Reason not specified|14
883250|NCT01287741|2911116|P2|Overall Study|Progressive disease|148
883251|NCT01287741|2911117|P1|Overall Study|Progressive disease|173
883252|NCT01287741|2911116|P2|Overall Study|Continued in the study|455
883253|NCT01287741|2911117|P1|Overall Study|Continued in the study|446
883254|NCT01287741|2911116|P2|Overall Study|Adverse Event|4
883255|NCT01287741|2911117|P1|Overall Study|Adverse Event|3
883256|NCT01287741|2911116|P2|Overall Study|Death|38
883257|NCT01287741|2911117|P1|Overall Study|Death|31
883258|NCT01287741|2911116|P2|Overall Study|Lost to Follow-up|8
883259|NCT01287741|2911117|P1|Overall Study|Lost to Follow-up|5
883260|NCT01287741|2911116|P2|Overall Study|Non-compliance|3
883261|NCT01287741|2911117|P1|Overall Study|Non-compliance|2
883262|NCT01287741|2911116|P2|Overall Study|Physician Decision|19
883263|NCT01287741|2911117|P1|Overall Study|Physician Decision|12
883264|NCT01287741|2911116|P2|Overall Study|Protocol Violation|0
883265|NCT01287741|2911117|P1|Overall Study|Protocol Violation|1
883266|NCT01287741|2911116|P2|Overall Study|Withdrawal by Subject|22
883267|NCT01287741|2911117|P1|Overall Study|Withdrawal by Subject|25
883268|NCT01287611|2911153|P2|Overall Study|Exclusion due to expanded Kerr incision|3
883269|NCT01287611|2911154|P1|Overall Study|Exclusion due to expanded Kerr incision|4
883270|NCT01287611|2911153|P2|Overall Study|Lost to Follow-up|16
883271|NCT01287611|2911154|P1|Overall Study|Lost to Follow-up|29
883272|NCT01287416|2911164|P2|6 Month Follow-up|Lost to Follow-up|2
883273|NCT01287416|2911165|P1|6 Month Follow-up|Lost to Follow-up|3
883274|NCT01287416|2911164|P2|Pre-post Training|Lost to Follow-up|1
883275|NCT01287416|2911165|P1|Pre-post Training|Lost to Follow-up|5
883276|NCT01287416|2911164|P2|Pre-post Training|Withdrawal by Subject|24
883277|NCT01287416|2911165|P1|Pre-post Training|Withdrawal by Subject|17
883278|NCT01287403|2911201|P1|1st Intervention (1 Day)|Adverse Event|1
883279|NCT01287364|2911217|P2|Overall Study|Other Reason|2
883280|NCT01287364|2911218|P1|Overall Study|Other Reason|4
883281|NCT01287364|2911217|P2|Overall Study|Protocol Violation|5
883282|NCT01287364|2911218|P1|Overall Study|Protocol Violation|5
883283|NCT01287364|2911217|P2|Overall Study|Adverse Event|3
883284|NCT01287364|2911218|P1|Overall Study|Adverse Event|0
883285|NCT01287221|2911240|P2|Overall Study|Withdrawal by Subject|1
883286|NCT01287221|2911241|P1|Overall Study|Withdrawal by Subject|0
883287|NCT01287221|2911240|P2|Overall Study|Adverse Event|3
883288|NCT01287221|2911241|P1|Overall Study|Adverse Event|3
883289|NCT01287221|2911240|P2|Overall Study|Lack of Perceived Benefit|1
883290|NCT01287221|2911241|P1|Overall Study|Lack of Perceived Benefit|1
883291|NCT01287195|2911276|P1|Overall Study|Withdrawal by Subject|2
883292|NCT01287117|2911291|P4|Overall Study|Disease Progression|5
883293|NCT01287117|2911292|P3|Overall Study|Disease Progression|6
883294|NCT01287117|2911293|P2|Overall Study|Disease Progression|5
883295|NCT01287117|2911294|P1|Overall Study|Disease Progression|10
883296|NCT01287117|2911291|P4|Overall Study|Patient/Legal Guardian's Decision|5
883297|NCT01287117|2911292|P3|Overall Study|Patient/Legal Guardian's Decision|8
883298|NCT01287117|2911293|P2|Overall Study|Patient/Legal Guardian's Decision|6
883299|NCT01287117|2911294|P1|Overall Study|Patient/Legal Guardian's Decision|2
883300|NCT01287117|2911291|P4|Overall Study|Physician Decision|1
883301|NCT01287117|2911292|P3|Overall Study|Physician Decision|1
883302|NCT01287117|2911293|P2|Overall Study|Physician Decision|1
883303|NCT01287117|2911294|P1|Overall Study|Physician Decision|0
883304|NCT01287117|2911291|P4|Overall Study|Lost to Follow-up|0
883305|NCT01287117|2911292|P3|Overall Study|Lost to Follow-up|0
883306|NCT01287117|2911293|P2|Overall Study|Lost to Follow-up|1
883307|NCT01287117|2911294|P1|Overall Study|Lost to Follow-up|1
883308|NCT01287117|2911291|P4|Overall Study|Adverse Event|1
883309|NCT01287117|2911292|P3|Overall Study|Adverse Event|1
883310|NCT01287117|2911293|P2|Overall Study|Adverse Event|1
883311|NCT01287117|2911294|P1|Overall Study|Adverse Event|2
883312|NCT01287065|2911340|P6|Treatment Period 1|Withdrawal by Subject|1
883313|NCT01287065|2911341|P5|Treatment Period 1|Withdrawal by Subject|0
883314|NCT01287065|2911342|P4|Treatment Period 1|Withdrawal by Subject|0
883315|NCT01287065|2911343|P3|Treatment Period 1|Withdrawal by Subject|0
883316|NCT01287065|2911344|P2|Treatment Period 1|Withdrawal by Subject|0
883317|NCT01287065|2911345|P1|Treatment Period 1|Withdrawal by Subject|0
883318|NCT01287065|2911340|P6|Treatment Period 1|Adverse Event|0
883319|NCT01287065|2911341|P5|Treatment Period 1|Adverse Event|1
883320|NCT01287065|2911342|P4|Treatment Period 1|Adverse Event|0
883321|NCT01287065|2911343|P3|Treatment Period 1|Adverse Event|0
883322|NCT01287065|2911344|P2|Treatment Period 1|Adverse Event|0
883323|NCT01287065|2911345|P1|Treatment Period 1|Adverse Event|0
883324|NCT01287039|2911364|P2|Overall Study|Lost to Follow-up|2
883325|NCT01287039|2911365|P1|Overall Study|Lost to Follow-up|3
883326|NCT01287039|2911364|P2|Overall Study|Withdrawal by Subject|11
883327|NCT01287039|2911365|P1|Overall Study|Withdrawal by Subject|14
883328|NCT01287039|2911364|P2|Overall Study|Adverse Event|4
883329|NCT01287039|2911365|P1|Overall Study|Adverse Event|7
883330|NCT01287039|2911364|P2|Overall Study|Change of residence|0
883331|NCT01287039|2911365|P1|Overall Study|Change of residence|1
883332|NCT01287039|2911364|P2|Overall Study|Death|0
883333|NCT01287039|2911365|P1|Overall Study|Death|1
883334|NCT01287039|2911364|P2|Overall Study|Problem with travel|1
883335|NCT01287039|2911365|P1|Overall Study|Problem with travel|0
883336|NCT01287039|2911364|P2|Overall Study|Noncompliance with study medication|1
883337|NCT01287039|2911365|P1|Overall Study|Noncompliance with study medication|0
883338|NCT01287039|2911364|P2|Overall Study|Excluded medication taken|0
883339|NCT01287039|2911365|P1|Overall Study|Excluded medication taken|1
883340|NCT01287039|2911364|P2|Overall Study|Protocol Violation|3
883341|NCT01287039|2911365|P1|Overall Study|Protocol Violation|2
883342|NCT01287039|2911364|P2|Overall Study|Elective surgery|1
883343|NCT01287039|2911365|P1|Overall Study|Elective surgery|0
883344|NCT01287039|2911364|P2|Overall Study|Change of location/residence|3
883345|NCT01287039|2911365|P1|Overall Study|Change of location/residence|0
883346|NCT01287039|2911364|P2|Overall Study|Noncompliance with study procedures|1
883347|NCT01287039|2911365|P1|Overall Study|Noncompliance with study procedures|0
883348|NCT01287013|2911398|P3|Overall Study|Non-evaluable|21
883349|NCT01287013|2911399|P2|Overall Study|Non-evaluable|5
883350|NCT01287013|2911400|P1|Overall Study|Non-evaluable|3
883351|NCT01286779|2911450|P1|Overall Study|Discontinued by sponsor|1
883352|NCT01286779|2911450|P1|Overall Study|Participant moved to another country|1
883353|NCT01286779|2911450|P1|Overall Study|Participant had scheduled surgery|1
883354|NCT01286779|2911450|P1|Overall Study|Physician Decision|2
883355|NCT01286779|2911450|P1|Overall Study|Protocol Violation|5
883356|NCT01286779|2911450|P1|Overall Study|Withdrawal by Subject|9
883357|NCT01286753|2911502|P2|Overall Study|Participant to Receive Radiotherapy|0
883684|NCT01283516|2913020|P1|Overall Study|Withdrawal by Subject|0
883358|NCT01286753|2911503|P1|Overall Study|Participant to Receive Radiotherapy|1
883359|NCT01286753|2911502|P2|Overall Study|Discontinued to Join Extension Study|4
883360|NCT01286753|2911503|P1|Overall Study|Discontinued to Join Extension Study|6
883361|NCT01286753|2911502|P2|Overall Study|Withdrawal of Consent|2
883362|NCT01286753|2911503|P1|Overall Study|Withdrawal of Consent|0
883363|NCT01286753|2911502|P2|Overall Study|Refused Treatment|0
883364|NCT01286753|2911503|P1|Overall Study|Refused Treatment|1
883365|NCT01286753|2911502|P2|Overall Study|Progression|13
883366|NCT01286753|2911503|P1|Overall Study|Progression|11
883367|NCT01286753|2911502|P2|Overall Study|Adverse Event|6
883368|NCT01286753|2911503|P1|Overall Study|Adverse Event|7
883369|NCT01286740|2911521|P1|Overall Study|Protocol Violation|1
883370|NCT01286740|2911521|P1|Overall Study|Enrolled but not treated|1
883371|NCT01286558|2911539|P2|Overall Study|Withdrawal by Subject|1
883372|NCT01286558|2911540|P1|Overall Study|Withdrawal by Subject|0
883373|NCT01286558|2911539|P2|Overall Study|Adverse Event|1
883374|NCT01286558|2911540|P1|Overall Study|Adverse Event|1
883375|NCT01286480|2911576|P2|Overall Study|Withdrawal by Subject|3
883376|NCT01286480|2911577|P1|Overall Study|Withdrawal by Subject|5
883377|NCT01286311|2911663|P2|Overall Study|Physician did not want outreach sent|0
883378|NCT01286311|2911664|P1|Overall Study|Physician did not want outreach sent|14
883379|NCT01286207|2911681|P3|Overall Study|Other|13
883380|NCT01286207|2911682|P2|Overall Study|Other|47
883381|NCT01286207|2911683|P1|Overall Study|Other|37
883382|NCT01286207|2911681|P3|Overall Study|Lack of Response|8
883383|NCT01286207|2911682|P2|Overall Study|Lack of Response|38
883384|NCT01286207|2911683|P1|Overall Study|Lack of Response|92
883385|NCT01286207|2911681|P3|Overall Study|Withdrawal by Subject|41
883386|NCT01286207|2911682|P2|Overall Study|Withdrawal by Subject|79
883387|NCT01286207|2911683|P1|Overall Study|Withdrawal by Subject|93
883388|NCT01286207|2911681|P3|Overall Study|Lost to Follow-up|20
883389|NCT01286207|2911682|P2|Overall Study|Lost to Follow-up|43
883390|NCT01286207|2911683|P1|Overall Study|Lost to Follow-up|49
883391|NCT01286207|2911681|P3|Overall Study|Adverse Event|8
883392|NCT01286207|2911682|P2|Overall Study|Adverse Event|41
883393|NCT01286207|2911683|P1|Overall Study|Adverse Event|27
883394|NCT01286168|2911703|P1|Overall Study|Surgical Drains Fell Out at Home|2
883395|NCT01286168|2911703|P1|Overall Study|Withdrawal by Subject|1
883396|NCT01286129|2911717|P2|Overall Study|Could not comply with study requirements|4
883397|NCT01286129|2911718|P1|Overall Study|Could not comply with study requirements|4
883398|NCT01286129|2911717|P2|Overall Study|Withdrawal by Subject|1
883399|NCT01286129|2911718|P1|Overall Study|Withdrawal by Subject|4
883400|NCT01286077|2911728|P2|Overall Study|refill medication not received in time|0
883401|NCT01286077|2911729|P1|Overall Study|refill medication not received in time|1
883402|NCT01286077|2911728|P2|Overall Study|Progression of disease|1
883403|NCT01286077|2911729|P1|Overall Study|Progression of disease|0
883404|NCT01286077|2911728|P2|Overall Study|Patient's decision to stop treatment|0
883405|NCT01286077|2911729|P1|Overall Study|Patient's decision to stop treatment|3
883406|NCT01286077|2911728|P2|Overall Study|The subject starts with alternative MMY|3
883407|NCT01286077|2911729|P1|Overall Study|The subject starts with alternative MMY|0
883408|NCT01286077|2911728|P2|Overall Study|Non-compliance|0
883409|NCT01286077|2911729|P1|Overall Study|Non-compliance|1
883410|NCT01286077|2911728|P2|Overall Study|Intercurrent illness|0
883411|NCT01286077|2911729|P1|Overall Study|Intercurrent illness|1
883412|NCT01286077|2911728|P2|Overall Study|Withdrawal by Subject|2
883413|NCT01286077|2911729|P1|Overall Study|Withdrawal by Subject|0
883414|NCT01286077|2911728|P2|Overall Study|Protocol Violation|1
883415|NCT01286077|2911729|P1|Overall Study|Protocol Violation|1
883416|NCT01286077|2911728|P2|Overall Study|Death|0
883417|NCT01286077|2911729|P1|Overall Study|Death|1
883418|NCT01286077|2911728|P2|Overall Study|Adverse Event|0
883419|NCT01286077|2911729|P1|Overall Study|Adverse Event|2
883420|NCT01286012|2911765|P2|Overall Study|peritoneal dialysis, randomized in error|3
883421|NCT01286012|2911766|P1|Overall Study|peritoneal dialysis, randomized in error|1
883422|NCT01286012|2911765|P2|Overall Study|Physician Decision|0
883423|NCT01286012|2911766|P1|Overall Study|Physician Decision|2
883424|NCT01286012|2911765|P2|Overall Study|Withdrawal by Subject|4
883425|NCT01286012|2911766|P1|Overall Study|Withdrawal by Subject|4
883426|NCT01286012|2911765|P2|Overall Study|Protocol Violation|1
883427|NCT01286012|2911766|P1|Overall Study|Protocol Violation|1
883428|NCT01286012|2911765|P2|Overall Study|Death|3
883429|NCT01286012|2911766|P1|Overall Study|Death|2
883430|NCT01286012|2911765|P2|Overall Study|Adverse Event|3
883431|NCT01286012|2911766|P1|Overall Study|Adverse Event|3
883432|NCT01285908|2911789|P3|Baseline Measurement|unable to tolerate procedure|0
883433|NCT01285908|2911790|P2|Baseline Measurement|unable to tolerate procedure|0
883434|NCT01285908|2911791|P1|Baseline Measurement|unable to tolerate procedure|1
883435|NCT01285908|2911789|P3|Baseline Measurement|History of stroke, exclusion criteria|0
883436|NCT01285908|2911790|P2|Baseline Measurement|History of stroke, exclusion criteria|0
883437|NCT01285908|2911791|P1|Baseline Measurement|History of stroke, exclusion criteria|1
883438|NCT01285908|2911789|P3|Baseline Measurement|unable to insert catheter|0
883439|NCT01285908|2911790|P2|Baseline Measurement|unable to insert catheter|0
883440|NCT01285908|2911791|P1|Baseline Measurement|unable to insert catheter|1
883441|NCT01285609|2911885|P2|Treated With Blinded Therapy|Worsening of general condition|1
883442|NCT01285609|2911886|P1|Treated With Blinded Therapy|Worsening of general condition|0
883443|NCT01285609|2911885|P2|Treated With Blinded Therapy|PI decision to discontinue|1
883444|NCT01285609|2911886|P1|Treated With Blinded Therapy|PI decision to discontinue|0
883445|NCT01285609|2911885|P2|Treated With Blinded Therapy|Investigator's assessment|0
883446|NCT01285609|2911886|P1|Treated With Blinded Therapy|Investigator's assessment|1
883447|NCT01285609|2911885|P2|Treated With Blinded Therapy|Participant hospitalized|0
883448|NCT01285609|2911886|P1|Treated With Blinded Therapy|Participant hospitalized|1
883449|NCT01285609|2911885|P2|Treated With Blinded Therapy|Participant started radiotherapy|0
883450|NCT01285609|2911886|P1|Treated With Blinded Therapy|Participant started radiotherapy|1
883451|NCT01285609|2911885|P2|Treated With Blinded Therapy|Participant refused participation|0
883452|NCT01285609|2911886|P1|Treated With Blinded Therapy|Participant refused participation|1
883453|NCT01285609|2911885|P2|Treated With Blinded Therapy|Physician and Patient decision|3
883454|NCT01285609|2911886|P1|Treated With Blinded Therapy|Physician and Patient decision|1
883455|NCT01285609|2911885|P2|Treated With Blinded Therapy|Administrative Reason by Sponsor|3
883456|NCT01285609|2911886|P1|Treated With Blinded Therapy|Administrative Reason by Sponsor|1
883457|NCT01285609|2911885|P2|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0
883458|NCT01285609|2911886|P1|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1
883459|NCT01285609|2911885|P2|Treated With Blinded Therapy|Poor/Non-Compliance|2
883460|NCT01285609|2911886|P1|Treated With Blinded Therapy|Poor/Non-Compliance|1
883461|NCT01285609|2911885|P2|Treated With Blinded Therapy|Not Reported|2
883462|NCT01285609|2911886|P1|Treated With Blinded Therapy|Not Reported|0
883463|NCT01285609|2911885|P2|Treated With Blinded Therapy|Maximum Clinical Benefit|4
883464|NCT01285609|2911886|P1|Treated With Blinded Therapy|Maximum Clinical Benefit|2
883465|NCT01285609|2911885|P2|Treated With Blinded Therapy|Death|3
883466|NCT01285609|2911886|P1|Treated With Blinded Therapy|Death|11
883467|NCT01285609|2911885|P2|Treated With Blinded Therapy|Withdrawal by Subject|7
883468|NCT01285609|2911886|P1|Treated With Blinded Therapy|Withdrawal by Subject|20
883469|NCT01285609|2911885|P2|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14
883470|NCT01285609|2911886|P1|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36
883471|NCT01285609|2911885|P2|Treated With Blinded Therapy|Study Drug Toxicity|14
883472|NCT01285609|2911886|P1|Treated With Blinded Therapy|Study Drug Toxicity|87
883473|NCT01285609|2911885|P2|Treated With Blinded Therapy|Progressive Disease|305
883474|NCT01285609|2911886|P1|Treated With Blinded Therapy|Progressive Disease|223
883475|NCT01285609|2911885|P2|Randomized|Randomized but not Treated|4
883476|NCT01285609|2911886|P1|Randomized|Randomized but not Treated|4
883477|NCT01285609|2911885|P2|Randomized|Undisclosed Reasons|0
883478|NCT01285609|2911886|P1|Randomized|Undisclosed Reasons|1
883479|NCT01285609|2911885|P2|Randomized|Subject No Longer Met Study Criteria|1
883480|NCT01285609|2911886|P1|Randomized|Subject No Longer Met Study Criteria|1
883481|NCT01285609|2911885|P2|Randomized|Withdrawal by Subject|11
883482|NCT01285609|2911886|P1|Randomized|Withdrawal by Subject|8
883483|NCT01285609|2911885|P2|Randomized|Death|7
883484|NCT01285609|2911886|P1|Randomized|Death|5
883485|NCT01285609|2911885|P2|Randomized|Study Drug Toxicity|14
883486|NCT01285609|2911886|P1|Randomized|Study Drug Toxicity|13
883487|NCT01285609|2911885|P2|Randomized|Adverse Event Unrelated to Study Drug|18
883488|NCT01285609|2911886|P1|Randomized|Adverse Event Unrelated to Study Drug|18
883489|NCT01285609|2911885|P2|Randomized|Progressive Disease|61
883490|NCT01285609|2911886|P1|Randomized|Progressive Disease|41
883491|NCT01285518|2911904|P8|Overall Study|Lost to Follow-up|0
883492|NCT01285518|2911905|P7|Overall Study|Lost to Follow-up|0
883493|NCT01285518|2911906|P6|Overall Study|Lost to Follow-up|1
883494|NCT01285518|2911907|P5|Overall Study|Lost to Follow-up|0
883495|NCT01285518|2911908|P4|Overall Study|Lost to Follow-up|0
883496|NCT01285518|2911909|P3|Overall Study|Lost to Follow-up|0
883497|NCT01285518|2911910|P2|Overall Study|Lost to Follow-up|0
883498|NCT01285518|2911911|P1|Overall Study|Lost to Follow-up|0
883499|NCT01285492|2912171|P2|Overall Study|Death|0
883500|NCT01285492|2912172|P1|Overall Study|Death|1
883501|NCT01285492|2912171|P2|Overall Study|Withdrawal by Subject|1
883502|NCT01285492|2912172|P1|Overall Study|Withdrawal by Subject|2
883503|NCT01285492|2912171|P2|Overall Study|Protocol Violation|0
883504|NCT01285492|2912172|P1|Overall Study|Protocol Violation|3
883505|NCT01285492|2912171|P2|Overall Study|Adverse Event|0
883506|NCT01285492|2912172|P1|Overall Study|Adverse Event|11
883507|NCT01285401|2912204|P2|Overall Study|Prematurely withdrawn from the study|29
883508|NCT01285401|2912205|P1|Overall Study|Prematurely withdrawn from the study|17
883509|NCT01285323|2912245|P2|Overall Study|Not specified|3
883510|NCT01285323|2912246|P1|Overall Study|Not specified|1
883511|NCT01285323|2912245|P2|Overall Study|Lost to Follow-up|1
883512|NCT01285323|2912246|P1|Overall Study|Lost to Follow-up|1
883513|NCT01285323|2912245|P2|Overall Study|Non-compliance with study procedures|3
883514|NCT01285323|2912246|P1|Overall Study|Non-compliance with study procedures|2
883515|NCT01285323|2912245|P2|Overall Study|Protocol Violation|2
883516|NCT01285323|2912246|P1|Overall Study|Protocol Violation|1
883517|NCT01285323|2912245|P2|Overall Study|Withdrawal by Subject|11
883518|NCT01285323|2912246|P1|Overall Study|Withdrawal by Subject|15
883519|NCT01285323|2912245|P2|Overall Study|Lack of Efficacy|2
883520|NCT01285323|2912246|P1|Overall Study|Lack of Efficacy|4
883521|NCT01285323|2912245|P2|Overall Study|Adverse Event|8
883522|NCT01285323|2912246|P1|Overall Study|Adverse Event|9
883523|NCT01285310|2912281|P5|Active Treatment Phase: Weeks 25-52|Non-compliance|0
883524|NCT01285310|2912282|P4|Active Treatment Phase: Weeks 25-52|Non-compliance|1
883525|NCT01285310|2912283|P3|Active Treatment Phase: Weeks 25-52|Non-compliance|1
883526|NCT01285310|2912284|P2|Active Treatment Phase: Weeks 25-52|Non-compliance|1
883527|NCT01285310|2912285|P1|Active Treatment Phase: Weeks 25-52|Non-compliance|0
883528|NCT01285310|2912281|P5|Active Treatment Phase: Weeks 25-52|Not Specified|0
883529|NCT01285310|2912282|P4|Active Treatment Phase: Weeks 25-52|Not Specified|0
883530|NCT01285310|2912283|P3|Active Treatment Phase: Weeks 25-52|Not Specified|0
883531|NCT01285310|2912284|P2|Active Treatment Phase: Weeks 25-52|Not Specified|1
883532|NCT01285310|2912285|P1|Active Treatment Phase: Weeks 25-52|Not Specified|0
883533|NCT01285310|2912281|P5|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15
883534|NCT01285310|2912282|P4|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6
883535|NCT01285310|2912283|P3|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19
883536|NCT01285310|2912284|P2|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21
883537|NCT01285310|2912285|P1|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0
883538|NCT01285310|2912281|P5|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
883539|NCT01285310|2912282|P4|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
883540|NCT01285310|2912283|P3|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
883541|NCT01285310|2912284|P2|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3
883542|NCT01285310|2912285|P1|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
883543|NCT01285310|2912281|P5|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
883544|NCT01285310|2912282|P4|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1
883545|NCT01285310|2912283|P3|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3
883546|NCT01285310|2912284|P2|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4
883547|NCT01285310|2912285|P1|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
883548|NCT01285310|2912281|P5|Active Treatment Phase: Weeks 25-52|Adverse Event|2
883549|NCT01285310|2912282|P4|Active Treatment Phase: Weeks 25-52|Adverse Event|0
883550|NCT01285310|2912283|P3|Active Treatment Phase: Weeks 25-52|Adverse Event|3
883551|NCT01285310|2912284|P2|Active Treatment Phase: Weeks 25-52|Adverse Event|2
883552|NCT01285310|2912285|P1|Active Treatment Phase: Weeks 25-52|Adverse Event|0
883553|NCT01285310|2912281|P5|Placebo Controlled Phase: Weeks 0-24|Not specified|0
883554|NCT01285310|2912282|P4|Placebo Controlled Phase: Weeks 0-24|Not specified|0
883555|NCT01285310|2912283|P3|Placebo Controlled Phase: Weeks 0-24|Not specified|1
883556|NCT01285310|2912284|P2|Placebo Controlled Phase: Weeks 0-24|Not specified|0
883557|NCT01285310|2912285|P1|Placebo Controlled Phase: Weeks 0-24|Not specified|1
883558|NCT01285310|2912281|P5|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
883559|NCT01285310|2912282|P4|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
883560|NCT01285310|2912283|P3|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
883561|NCT01285310|2912284|P2|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
883562|NCT01285310|2912285|P1|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
883563|NCT01285310|2912281|P5|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
883564|NCT01285310|2912282|P4|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
883565|NCT01285310|2912283|P3|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2
883566|NCT01285310|2912284|P2|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
883567|NCT01285310|2912285|P1|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
883568|NCT01285310|2912281|P5|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
883569|NCT01285310|2912282|P4|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
883570|NCT01285310|2912283|P3|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2
883571|NCT01285310|2912284|P2|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
883572|NCT01285310|2912285|P1|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1
883573|NCT01285310|2912281|P5|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
883574|NCT01285310|2912282|P4|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
883575|NCT01285310|2912283|P3|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3
883576|NCT01285310|2912284|P2|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7
883577|NCT01285310|2912285|P1|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1
883578|NCT01285310|2912281|P5|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
883579|NCT01285310|2912282|P4|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
883580|NCT01285310|2912283|P3|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6
883581|NCT01285310|2912284|P2|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4
883582|NCT01285310|2912285|P1|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3
883583|NCT01284959|2912550|P3|Overall Study|Adverse Event|1
883584|NCT01284959|2912551|P2|Overall Study|Adverse Event|0
883585|NCT01284959|2912552|P1|Overall Study|Adverse Event|0
883586|NCT01284959|2912550|P3|Overall Study|Withdrawal by Subject|0
883587|NCT01284959|2912551|P2|Overall Study|Withdrawal by Subject|0
883588|NCT01284959|2912552|P1|Overall Study|Withdrawal by Subject|1
883589|NCT01284634|2912582|P4|Overall Study|Adverse Event|1
883590|NCT01284634|2912583|P3|Overall Study|Adverse Event|2
883591|NCT01284634|2912584|P2|Overall Study|Adverse Event|0
883592|NCT01284634|2912585|P1|Overall Study|Adverse Event|1
883593|NCT01284621|2912615|P6|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
883594|NCT01284621|2912616|P5|Washout Period 1 (7 Days)|Required unexpected medical treatment|1
883595|NCT01284621|2912617|P4|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
883596|NCT01284621|2912618|P3|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
883597|NCT01284621|2912619|P2|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
883598|NCT01284621|2912620|P1|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
883599|NCT01284491|2912688|P1|Overall Study|Study termination|13
883600|NCT01284361|2912698|P1|Overall Study|Lost to Follow-up|2
883601|NCT01284361|2912698|P1|Overall Study|Adverse Event|1
883602|NCT01284361|2912698|P1|Overall Study|Protocol Violation|5
883603|NCT01284361|2912698|P1|Overall Study|Withdrawal by Subject|1
883604|NCT01284140|2912794|P2|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1
883605|NCT01284140|2912795|P1|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0
883606|NCT01284140|2912794|P2|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
883607|NCT01284140|2912795|P1|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
883608|NCT01284114|2912809|P1|Overall Study|dizziness|1
883609|NCT01284114|2912809|P1|Overall Study|Symptomatic hypotension|1
883610|NCT01284114|2912809|P1|Overall Study|From the results of ALLTITUDE study|1
883611|NCT01284114|2912809|P1|Overall Study|viral infection|1
883612|NCT01284062|2912821|P4|Overall Study|Site Closed|0
883613|NCT01284062|2912822|P3|Overall Study|Site Closed|1
883614|NCT01284062|2912823|P2|Overall Study|Site Closed|0
883615|NCT01284062|2912824|P1|Overall Study|Site Closed|0
883616|NCT01284062|2912821|P4|Overall Study|Other|1
883617|NCT01284062|2912822|P3|Overall Study|Other|0
883618|NCT01284062|2912823|P2|Overall Study|Other|0
883619|NCT01284062|2912824|P1|Overall Study|Other|0
883620|NCT01284062|2912821|P4|Overall Study|Withdrawal by Subject|5
883621|NCT01284062|2912822|P3|Overall Study|Withdrawal by Subject|2
883622|NCT01284062|2912823|P2|Overall Study|Withdrawal by Subject|1
883623|NCT01284062|2912824|P1|Overall Study|Withdrawal by Subject|3
883624|NCT01284062|2912821|P4|Overall Study|Protocol Violation|2
883625|NCT01284062|2912822|P3|Overall Study|Protocol Violation|0
883626|NCT01284062|2912823|P2|Overall Study|Protocol Violation|0
883627|NCT01284062|2912824|P1|Overall Study|Protocol Violation|1
883628|NCT01284062|2912821|P4|Overall Study|Medication error without adverse event|0
883629|NCT01284062|2912822|P3|Overall Study|Medication error without adverse event|1
883630|NCT01284062|2912823|P2|Overall Study|Medication error without adverse event|0
883631|NCT01284062|2912824|P1|Overall Study|Medication error without adverse event|0
883632|NCT01284062|2912821|P4|Overall Study|Lack of Efficacy|1
883633|NCT01284062|2912822|P3|Overall Study|Lack of Efficacy|2
883634|NCT01284062|2912823|P2|Overall Study|Lack of Efficacy|2
883635|NCT01284062|2912824|P1|Overall Study|Lack of Efficacy|3
883636|NCT01284062|2912821|P4|Overall Study|Adverse Event|5
883637|NCT01284062|2912822|P3|Overall Study|Adverse Event|0
883638|NCT01284062|2912823|P2|Overall Study|Adverse Event|5
883639|NCT01284062|2912824|P1|Overall Study|Adverse Event|4
883640|NCT01283971|2912898|P2|Overall Study|Administrative reasons|1
883641|NCT01283971|2912899|P1|Overall Study|Administrative reasons|1
883642|NCT01283971|2912898|P2|Overall Study|Failure to return|1
883643|NCT01283971|2912899|P1|Overall Study|Failure to return|0
883644|NCT01283971|2912898|P2|Overall Study|Refused treatment|1
883645|NCT01283971|2912899|P1|Overall Study|Refused treatment|3
883646|NCT01283971|2912898|P2|Overall Study|Protocol Violation|1
883647|NCT01283971|2912899|P1|Overall Study|Protocol Violation|5
883648|NCT01283971|2912898|P2|Overall Study|Insufficient therapeutic responses|3
883649|NCT01283971|2912899|P1|Overall Study|Insufficient therapeutic responses|3
883650|NCT01283971|2912898|P2|Overall Study|Adverse Event|5
883651|NCT01283971|2912899|P1|Overall Study|Adverse Event|3
883652|NCT01283581|2912946|P3|Overall Study|"Early termination"|1
883653|NCT01283581|2912947|P2|Overall Study|"Early termination"|0
883654|NCT01283581|2912948|P1|Overall Study|"Early termination"|0
883655|NCT01283581|2912946|P3|Overall Study|Investigator unblinded|1
883656|NCT01283581|2912947|P2|Overall Study|Investigator unblinded|0
883657|NCT01283581|2912948|P1|Overall Study|Investigator unblinded|0
883658|NCT01283581|2912946|P3|Overall Study|Noncompliance|0
883659|NCT01283581|2912947|P2|Overall Study|Noncompliance|0
883660|NCT01283581|2912948|P1|Overall Study|Noncompliance|1
883661|NCT01283581|2912946|P3|Overall Study|Protocol Violation|2
883662|NCT01283581|2912947|P2|Overall Study|Protocol Violation|1
883663|NCT01283581|2912948|P1|Overall Study|Protocol Violation|0
883664|NCT01283581|2912946|P3|Overall Study|Physician Decision|2
883665|NCT01283581|2912947|P2|Overall Study|Physician Decision|1
883666|NCT01283581|2912948|P1|Overall Study|Physician Decision|0
883667|NCT01283581|2912946|P3|Overall Study|Adverse Event|4
883668|NCT01283581|2912947|P2|Overall Study|Adverse Event|1
883669|NCT01283581|2912948|P1|Overall Study|Adverse Event|1
883670|NCT01283581|2912946|P3|Overall Study|Withdrawal by Subject|2
883671|NCT01283581|2912947|P2|Overall Study|Withdrawal by Subject|5
883672|NCT01283581|2912948|P1|Overall Study|Withdrawal by Subject|2
883673|NCT01283581|2912946|P3|Overall Study|Lost to Follow-up|8
883674|NCT01283581|2912947|P2|Overall Study|Lost to Follow-up|6
883675|NCT01283581|2912948|P1|Overall Study|Lost to Follow-up|8
883676|NCT01283516|2913012|P9|Overall Study|Withdrawal by Subject|11
883677|NCT01283516|2913013|P8|Overall Study|Withdrawal by Subject|0
883678|NCT01283516|2913014|P7|Overall Study|Withdrawal by Subject|0
883679|NCT01283516|2913015|P6|Overall Study|Withdrawal by Subject|0
883680|NCT01283516|2913016|P5|Overall Study|Withdrawal by Subject|1
883681|NCT01283516|2913017|P4|Overall Study|Withdrawal by Subject|0
883682|NCT01283516|2913018|P3|Overall Study|Withdrawal by Subject|0
883683|NCT01283516|2913019|P2|Overall Study|Withdrawal by Subject|0
883685|NCT01283516|2913012|P9|Overall Study|Disease Progression|81
883686|NCT01283516|2913013|P8|Overall Study|Disease Progression|2
883687|NCT01283516|2913014|P7|Overall Study|Disease Progression|6
883688|NCT01283516|2913015|P6|Overall Study|Disease Progression|7
883689|NCT01283516|2913016|P5|Overall Study|Disease Progression|12
883690|NCT01283516|2913017|P4|Overall Study|Disease Progression|3
883691|NCT01283516|2913018|P3|Overall Study|Disease Progression|2
883692|NCT01283516|2913019|P2|Overall Study|Disease Progression|2
883693|NCT01283516|2913020|P1|Overall Study|Disease Progression|2
883694|NCT01283516|2913012|P9|Overall Study|Death|6
883695|NCT01283516|2913013|P8|Overall Study|Death|1
883696|NCT01283516|2913014|P7|Overall Study|Death|0
883697|NCT01283516|2913015|P6|Overall Study|Death|1
883698|NCT01283516|2913016|P5|Overall Study|Death|0
883699|NCT01283516|2913017|P4|Overall Study|Death|0
883700|NCT01283516|2913018|P3|Overall Study|Death|0
883701|NCT01283516|2913019|P2|Overall Study|Death|0
883702|NCT01283516|2913020|P1|Overall Study|Death|0
883703|NCT01283516|2913012|P9|Overall Study|Adverse Event|24
883704|NCT01283516|2913013|P8|Overall Study|Adverse Event|0
883705|NCT01283516|2913014|P7|Overall Study|Adverse Event|2
883706|NCT01283516|2913015|P6|Overall Study|Adverse Event|0
883707|NCT01283516|2913016|P5|Overall Study|Adverse Event|0
883708|NCT01283516|2913017|P4|Overall Study|Adverse Event|0
883709|NCT01283516|2913018|P3|Overall Study|Adverse Event|0
883710|NCT01283516|2913019|P2|Overall Study|Adverse Event|0
883711|NCT01283516|2913020|P1|Overall Study|Adverse Event|0
883712|NCT01283464|2913044|P2|Overall Study|Physician Decision|0
883713|NCT01283464|2913045|P1|Overall Study|Physician Decision|1
883714|NCT01283464|2913044|P2|Overall Study|Withdrawal by Subject|0
883715|NCT01283464|2913045|P1|Overall Study|Withdrawal by Subject|1
883716|NCT01283464|2913044|P2|Overall Study|Lost to Follow-up|1
883717|NCT01283464|2913045|P1|Overall Study|Lost to Follow-up|0
883718|NCT01283334|2913051|P1|Overall Study|Physician Decision|1
883719|NCT01283334|2913051|P1|Overall Study|Adverse Event|4
883720|NCT01283334|2913051|P1|Overall Study|Inability to Swallow Everolimus Pills|1
883721|NCT01283334|2913051|P1|Overall Study|Withdrawal by Subject|1
883722|NCT01283282|2913074|P2|First Intervention (6 Weeks)|Lost to Follow-up|0
883723|NCT01283282|2913075|P1|First Intervention (6 Weeks)|Lost to Follow-up|1
883724|NCT01283282|2913074|P2|First Intervention (6 Weeks)|Withdrawal by Subject|3
883725|NCT01283282|2913075|P1|First Intervention (6 Weeks)|Withdrawal by Subject|2
883726|NCT01283282|2913074|P2|First Intervention (6 Weeks)|Physician Decision|1
883727|NCT01283282|2913075|P1|First Intervention (6 Weeks)|Physician Decision|0
883728|NCT01283152|2913095|P2|Overall Study|Refused HESA|0
883729|NCT01283152|2913096|P1|Overall Study|Refused HESA|1
883730|NCT01283152|2913095|P2|Overall Study|Discharged prior to 24 hr assessment|0
883731|NCT01283152|2913096|P1|Overall Study|Discharged prior to 24 hr assessment|1
883732|NCT01283139|2913110|P4|Overall Study|Participant randomized in error|0
883733|NCT01283139|2913111|P3|Overall Study|Participant randomized in error|1
883734|NCT01283139|2913112|P2|Overall Study|Participant randomized in error|0
883735|NCT01283139|2913113|P1|Overall Study|Participant randomized in error|0
883736|NCT01283139|2913110|P4|Overall Study|Missed follow-up visit|2
883737|NCT01283139|2913111|P3|Overall Study|Missed follow-up visit|2
883738|NCT01283139|2913112|P2|Overall Study|Missed follow-up visit|1
883739|NCT01283139|2913113|P1|Overall Study|Missed follow-up visit|0
883740|NCT01283139|2913110|P4|Overall Study|Pregnancy|0
883741|NCT01283139|2913111|P3|Overall Study|Pregnancy|1
883742|NCT01283139|2913112|P2|Overall Study|Pregnancy|1
883743|NCT01283139|2913113|P1|Overall Study|Pregnancy|0
883744|NCT01283139|2913110|P4|Overall Study|Participant's refusal to continue|1
883745|NCT01283139|2913111|P3|Overall Study|Participant's refusal to continue|1
883746|NCT01283139|2913112|P2|Overall Study|Participant's refusal to continue|3
883747|NCT01283139|2913113|P1|Overall Study|Participant's refusal to continue|0
883748|NCT01283139|2913110|P4|Overall Study|Early termination due to AE/SAE|0
883749|NCT01283139|2913111|P3|Overall Study|Early termination due to AE/SAE|0
883750|NCT01283139|2913112|P2|Overall Study|Early termination due to AE/SAE|1
883751|NCT01283139|2913113|P1|Overall Study|Early termination due to AE/SAE|1
883752|NCT01283139|2913110|P4|Overall Study|Lack of Efficacy|1
883753|NCT01283139|2913111|P3|Overall Study|Lack of Efficacy|2
883754|NCT01283139|2913112|P2|Overall Study|Lack of Efficacy|2
883755|NCT01283139|2913113|P1|Overall Study|Lack of Efficacy|1
883756|NCT01283139|2913110|P4|Overall Study|Death|2
883757|NCT01283139|2913111|P3|Overall Study|Death|2
883758|NCT01283139|2913112|P2|Overall Study|Death|0
883759|NCT01283139|2913113|P1|Overall Study|Death|2
883760|NCT01283139|2913110|P4|Overall Study|Withdrawal by Subject|8
883761|NCT01283139|2913111|P3|Overall Study|Withdrawal by Subject|6
883762|NCT01283139|2913112|P2|Overall Study|Withdrawal by Subject|8
883763|NCT01283139|2913113|P1|Overall Study|Withdrawal by Subject|8
883764|NCT01283139|2913110|P4|Overall Study|Lost to Follow-up|1
883765|NCT01283139|2913111|P3|Overall Study|Lost to Follow-up|3
883766|NCT01283139|2913112|P2|Overall Study|Lost to Follow-up|2
883767|NCT01283139|2913113|P1|Overall Study|Lost to Follow-up|5
883768|NCT01283035|2913155|P1|Overall Study|Subject later found ineligible|1
883769|NCT01282866|2913170|P1|Overall Study|Adverse Event|1
883770|NCT01282814|2913178|P2|Washout of 7 Days|Withdrawal by Subject|0
883771|NCT01282814|2913179|P1|Washout of 7 Days|Withdrawal by Subject|2
883772|NCT01282814|2913178|P2|First Intervention|Emesis During Dosing Interval|3
883773|NCT01282814|2913179|P1|First Intervention|Emesis During Dosing Interval|0
883774|NCT01282801|2913191|P2|Second Intervention|Emesis During Critical Breakfast|1
883775|NCT01282801|2913192|P1|Second Intervention|Emesis During Critical Breakfast|0
883776|NCT01282476|2913216|P1|Overall Study|Death|11
883777|NCT01282424|2913222|P1|Overall Study|Investigator Request|7
883778|NCT01282424|2913222|P1|Overall Study|Withdrew Consent|4
883779|NCT01282424|2913222|P1|Overall Study|Adverse Event|25
883780|NCT01282424|2913222|P1|Overall Study|Treatment Ongoing|40
883781|NCT01282372|2913239|P1|Overall Study|Adverse Event|12
883782|NCT01282372|2913239|P1|Overall Study|Refer Pre-Assignment Detail for Reason 2|1
883783|NCT01282372|2913239|P1|Overall Study|Presence of AE, Regression of Symptoms|1
883784|NCT01282372|2913239|P1|Overall Study|Presence of AE, Lack of Efficacy|1
883785|NCT01282372|2913239|P1|Overall Study|Death|1
883786|NCT01282372|2913239|P1|Overall Study|Refer Pre-Assignment Detail for Reason 1|4
883787|NCT01282372|2913239|P1|Overall Study|Withdrawal by Subject|11
883788|NCT01282372|2913239|P1|Overall Study|Lost to Follow-up|23
883789|NCT01282372|2913239|P1|Overall Study|Lack of Efficacy / Exacerbation|25
883790|NCT01282294|2913267|P1|Overall Study|Physician Decision|1
883791|NCT01282294|2913267|P1|Overall Study|Patient non-compliance|2
883792|NCT01282294|2913267|P1|Overall Study|Adverse Event|1
883793|NCT01282294|2913267|P1|Overall Study|Screening failure|1
883794|NCT01282294|2913267|P1|Overall Study|Lost to Follow-up|14
883795|NCT01282229|2913296|P1|Overall Study|Protocol Violation|2
883796|NCT01282203|2913326|P1|Overall Study|Adverse Event|1
883797|NCT01282164|2913348|P2|Overall Study|Lack of hypoglycemia during ITT|0
883798|NCT01282164|2913349|P1|Overall Study|Lack of hypoglycemia during ITT|1
883799|NCT01281917|2913400|P1|Overall Study|Withdrawal by Subject|1
883800|NCT01281865|2913412|P2|Overall Study|Lack of Efficacy|0
883801|NCT01281865|2913413|P1|Overall Study|Lack of Efficacy|1
883802|NCT01281865|2913412|P2|Overall Study|Withdrawal by Subject|0
883803|NCT01281865|2913413|P1|Overall Study|Withdrawal by Subject|1
883804|NCT01281865|2913412|P2|Overall Study|Adverse Event|1
883805|NCT01281865|2913413|P1|Overall Study|Adverse Event|1
883806|NCT01281839|2913421|P2|Overall Study|Reason not specified|1
883807|NCT01281839|2913422|P1|Overall Study|Reason not specified|0
883808|NCT01281839|2913421|P2|Overall Study|Withdrawal by Subject|10
883809|NCT01281839|2913422|P1|Overall Study|Withdrawal by Subject|4
883810|NCT01281839|2913421|P2|Overall Study|Lost to Follow-up|3
883811|NCT01281839|2913422|P1|Overall Study|Lost to Follow-up|6
883812|NCT01281644|2913483|P1|Overall Study|Withdrawal by Subject|2
883813|NCT01281644|2913483|P1|Overall Study|Lost to Follow-up|3
883814|NCT01281306|2913524|P7|Overall Study|Randomized in error|0
883815|NCT01281306|2913525|P6|Overall Study|Randomized in error|0
883816|NCT01281306|2913526|P5|Overall Study|Randomized in error|0
883817|NCT01281306|2913527|P4|Overall Study|Randomized in error|1
883818|NCT01281306|2913528|P3|Overall Study|Randomized in error|0
883819|NCT01281306|2913529|P2|Overall Study|Randomized in error|0
883820|NCT01281306|2913530|P1|Overall Study|Randomized in error|1
883821|NCT01281306|2913524|P7|Overall Study|Adverse Event|3
883822|NCT01281306|2913525|P6|Overall Study|Adverse Event|3
883823|NCT01281306|2913526|P5|Overall Study|Adverse Event|5
883824|NCT01281306|2913527|P4|Overall Study|Adverse Event|3
883825|NCT01281306|2913528|P3|Overall Study|Adverse Event|2
883826|NCT01281306|2913529|P2|Overall Study|Adverse Event|2
883827|NCT01281306|2913530|P1|Overall Study|Adverse Event|3
883828|NCT01281306|2913524|P7|Overall Study|Death|0
883829|NCT01281306|2913525|P6|Overall Study|Death|0
883830|NCT01281306|2913526|P5|Overall Study|Death|0
883831|NCT01281306|2913527|P4|Overall Study|Death|0
883832|NCT01281306|2913528|P3|Overall Study|Death|0
883833|NCT01281306|2913529|P2|Overall Study|Death|0
883834|NCT01281306|2913530|P1|Overall Study|Death|1
883835|NCT01281306|2913524|P7|Overall Study|Lost to Follow-up|1
883836|NCT01281306|2913525|P6|Overall Study|Lost to Follow-up|0
883837|NCT01281306|2913526|P5|Overall Study|Lost to Follow-up|0
883838|NCT01281306|2913527|P4|Overall Study|Lost to Follow-up|2
883839|NCT01281306|2913528|P3|Overall Study|Lost to Follow-up|0
883840|NCT01281306|2913529|P2|Overall Study|Lost to Follow-up|0
883841|NCT01281306|2913530|P1|Overall Study|Lost to Follow-up|1
883842|NCT01281306|2913524|P7|Overall Study|Condition no longer requires study drug|1
883843|NCT01281306|2913525|P6|Overall Study|Condition no longer requires study drug|1
883844|NCT01281306|2913526|P5|Overall Study|Condition no longer requires study drug|0
883845|NCT01281306|2913527|P4|Overall Study|Condition no longer requires study drug|0
883846|NCT01281306|2913528|P3|Overall Study|Condition no longer requires study drug|0
883847|NCT01281306|2913529|P2|Overall Study|Condition no longer requires study drug|0
883848|NCT01281306|2913530|P1|Overall Study|Condition no longer requires study drug|1
883849|NCT01281306|2913524|P7|Overall Study|Protocol deviation|0
883850|NCT01281306|2913525|P6|Overall Study|Protocol deviation|0
883851|NCT01281306|2913526|P5|Overall Study|Protocol deviation|1
883852|NCT01281306|2913527|P4|Overall Study|Protocol deviation|1
883853|NCT01281306|2913528|P3|Overall Study|Protocol deviation|1
883854|NCT01281306|2913529|P2|Overall Study|Protocol deviation|1
883855|NCT01281306|2913530|P1|Overall Study|Protocol deviation|0
883856|NCT01281306|2913524|P7|Overall Study|Withdrawal by Subject|1
883857|NCT01281306|2913525|P6|Overall Study|Withdrawal by Subject|3
883858|NCT01281306|2913526|P5|Overall Study|Withdrawal by Subject|1
883859|NCT01281306|2913527|P4|Overall Study|Withdrawal by Subject|4
883860|NCT01281306|2913528|P3|Overall Study|Withdrawal by Subject|2
883861|NCT01281306|2913529|P2|Overall Study|Withdrawal by Subject|0
883862|NCT01281306|2913530|P1|Overall Study|Withdrawal by Subject|1
883863|NCT01281306|2913524|P7|Overall Study|Lack of Efficacy|1
883864|NCT01281306|2913525|P6|Overall Study|Lack of Efficacy|0
883865|NCT01281306|2913526|P5|Overall Study|Lack of Efficacy|2
883866|NCT01281306|2913527|P4|Overall Study|Lack of Efficacy|0
883867|NCT01281306|2913528|P3|Overall Study|Lack of Efficacy|3
883868|NCT01281306|2913529|P2|Overall Study|Lack of Efficacy|1
883869|NCT01281306|2913530|P1|Overall Study|Lack of Efficacy|0
883870|NCT01281202|2913646|P2|Overall Study|Incarceration|3
883871|NCT01281202|2913647|P1|Overall Study|Incarceration|0
883872|NCT01281202|2913646|P2|Overall Study|Lost to Follow-up|13
883873|NCT01281202|2913647|P1|Overall Study|Lost to Follow-up|11
883874|NCT01281202|2913646|P2|Overall Study|Administrative|8
883875|NCT01281202|2913647|P1|Overall Study|Administrative|2
883876|NCT01281202|2913646|P2|Overall Study|Protocol Violation|10
883877|NCT01281202|2913647|P1|Overall Study|Protocol Violation|11
883878|NCT01281202|2913646|P2|Overall Study|Withdrawal by Subject|2
883879|NCT01281202|2913647|P1|Overall Study|Withdrawal by Subject|2
883880|NCT01281202|2913646|P2|Overall Study|Adverse Event|0
883881|NCT01281202|2913647|P1|Overall Study|Adverse Event|2
883882|NCT01281124|2913655|P1|Overall Study|Death|1
883883|NCT01280981|2913670|P1|Overall Study|Study site closure|1
883884|NCT01280981|2913670|P1|Overall Study|Elective surgery|2
883885|NCT01280981|2913670|P1|Overall Study|Withdrawal of consent|3
883886|NCT01280981|2913670|P1|Overall Study|Non-compliance with protocol|3
883887|NCT01280981|2913670|P1|Overall Study|Failed to return|45
883888|NCT01280981|2913670|P1|Overall Study|Irregular or discontinued menses|3
883889|NCT01280981|2913670|P1|Overall Study|Adverse Event|6
883890|NCT01280981|2913670|P1|Overall Study|Lost to Follow-up|3
883891|NCT01280981|2913670|P1|Overall Study|Lack of Efficacy|13
883892|NCT01280981|2913670|P1|Overall Study|Protocol Violation|2
883893|NCT01280981|2913670|P1|Overall Study|Withdrawal by Subject|11
883894|NCT01280968|2913681|P2|Overall Study|Unable to Smoke in Supine Position|0
883895|NCT01280968|2913682|P1|Overall Study|Unable to Smoke in Supine Position|1
883896|NCT01280968|2913681|P2|Overall Study|Pre-existing Neurological Condition|0
883897|NCT01280968|2913682|P1|Overall Study|Pre-existing Neurological Condition|1
883898|NCT01280968|2913681|P2|Overall Study|Scheduling Conflicts|1
883899|NCT01280968|2913682|P1|Overall Study|Scheduling Conflicts|1
883900|NCT01280968|2913681|P2|Overall Study|Adverse Event|0
883901|NCT01280968|2913682|P1|Overall Study|Adverse Event|1
883902|NCT01280968|2913681|P2|Overall Study|Anxiety|0
883903|NCT01280968|2913682|P1|Overall Study|Anxiety|2
883904|NCT01280968|2913681|P2|Overall Study|Commuting Problems|0
883905|NCT01280968|2913682|P1|Overall Study|Commuting Problems|2
883906|NCT01280968|2913681|P2|Overall Study|Unable to Follow Experimental Protocol|0
883907|NCT01280968|2913682|P1|Overall Study|Unable to Follow Experimental Protocol|2
883908|NCT01280968|2913681|P2|Overall Study|Lost to Follow-up|2
883909|NCT01280968|2913682|P1|Overall Study|Lost to Follow-up|8
883910|NCT01280955|2913698|P1|Overall Study|Withdrawal by Subject|1
883911|NCT01280955|2913698|P1|Overall Study|Death|2
883912|NCT01280903|2913742|P2|Overall Study|Lost to Follow-up|16
883913|NCT01280903|2913743|P1|Overall Study|Lost to Follow-up|23
883914|NCT01280656|2913856|P3|Overall Study|Other|7
883915|NCT01280656|2913857|P2|Overall Study|Other|7
883916|NCT01280656|2913858|P1|Overall Study|Other|1
883917|NCT01280656|2913856|P3|Overall Study|Treatment shortening (RGT)|5
883918|NCT01280656|2913857|P2|Overall Study|Treatment shortening (RGT)|4
883919|NCT01280656|2913858|P1|Overall Study|Treatment shortening (RGT)|0
883920|NCT01280656|2913856|P3|Overall Study|Lack of Efficacy|38
883921|NCT01280656|2913857|P2|Overall Study|Lack of Efficacy|22
883922|NCT01280656|2913858|P1|Overall Study|Lack of Efficacy|1
883923|NCT01280656|2913856|P3|Overall Study|Adverse Event|13
883924|NCT01280656|2913857|P2|Overall Study|Adverse Event|14
883925|NCT01280656|2913858|P1|Overall Study|Adverse Event|1
883926|NCT01280591|2913925|P4|Overall Study|Does not meet exclusion #27 criteria|1
883927|NCT01280591|2913926|P3|Overall Study|Does not meet exclusion #27 criteria|0
883928|NCT01280591|2913927|P2|Overall Study|Does not meet exclusion #27 criteria|0
883929|NCT01280591|2913928|P1|Overall Study|Does not meet exclusion #27 criteria|0
883930|NCT01280591|2913925|P4|Overall Study|Withdrawal by Subject|2
883931|NCT01280591|2913926|P3|Overall Study|Withdrawal by Subject|0
883932|NCT01280591|2913927|P2|Overall Study|Withdrawal by Subject|0
883933|NCT01280591|2913928|P1|Overall Study|Withdrawal by Subject|0
883934|NCT01280357|2914066|P1|Overall Study|IInsufficient data/No data supplied|12
883935|NCT01280357|2914066|P1|Overall Study|Excluded no internal monitoring|14
883936|NCT01280266|2914075|P2|First Intervention (Week 1-4)|Withdrawal by Subject|2
883937|NCT01280266|2914076|P1|First Intervention (Week 1-4)|Withdrawal by Subject|0
883938|NCT01280266|2914075|P2|First Intervention (Week 1-4)|Adverse Event|0
883939|NCT01280266|2914076|P1|First Intervention (Week 1-4)|Adverse Event|1
883940|NCT01279681|2914158|P2|Overall Study|Other Reason|2
883941|NCT01279681|2914159|P1|Overall Study|Other Reason|0
883942|NCT01279681|2914158|P2|Overall Study|Physician Decision|0
883943|NCT01279681|2914159|P1|Overall Study|Physician Decision|1
883944|NCT01279681|2914158|P2|Overall Study|Withdrawal Prior to Beginning Treatment|1
883945|NCT01279681|2914159|P1|Overall Study|Withdrawal Prior to Beginning Treatment|0
883946|NCT01279681|2914158|P2|Overall Study|Death|1
883947|NCT01279681|2914159|P1|Overall Study|Death|0
883948|NCT01279681|2914158|P2|Overall Study|Adverse Event|3
883949|NCT01279681|2914159|P1|Overall Study|Adverse Event|2
883950|NCT01279681|2914158|P2|Overall Study|Withdrawal by Subject|4
883951|NCT01279681|2914159|P1|Overall Study|Withdrawal by Subject|3
883952|NCT01279681|2914158|P2|Overall Study|Disease Progression|6
883953|NCT01279681|2914159|P1|Overall Study|Disease Progression|9
883954|NCT01279486|2914180|P1|Overall Study|Lost to Follow-up|1
883955|NCT01279447|2914186|P2|Overall Study|Lost to Follow-up|1
883956|NCT01279447|2914187|P1|Overall Study|Lost to Follow-up|3
883957|NCT01279200|2914214|P2|Overall Study|Adverse Event|0
883958|NCT01279200|2914215|P1|Overall Study|Adverse Event|1
883959|NCT01279200|2914214|P2|Overall Study|Lost to Follow-up|1
883960|NCT01279200|2914215|P1|Overall Study|Lost to Follow-up|0
883961|NCT01279200|2914214|P2|Overall Study|ultrasound screening failure|1
883962|NCT01279200|2914215|P1|Overall Study|ultrasound screening failure|0
883963|NCT01279200|2914214|P2|Overall Study|Inconvenience of ultrasound visit|1
883964|NCT01279200|2914215|P1|Overall Study|Inconvenience of ultrasound visit|0
883965|NCT01279200|2914214|P2|Overall Study|Patient withdrawal due to high cost|1
883966|NCT01279200|2914215|P1|Overall Study|Patient withdrawal due to high cost|0
883967|NCT01279200|2914214|P2|Overall Study|Withdrawal by Subject|3
883968|NCT01279200|2914215|P1|Overall Study|Withdrawal by Subject|1
883969|NCT01279070|2914253|P2|Overall Study|Acute exacerbation|1
883970|NCT01279070|2914254|P1|Overall Study|Acute exacerbation|3
883971|NCT01279070|2914253|P2|Overall Study|Withdrawal by Subject|3
883972|NCT01279070|2914254|P1|Overall Study|Withdrawal by Subject|2
883973|NCT01279044|2914273|P3|PHASE 2 - Randmonized Controlled Trial|Death|1
883974|NCT01279044|2914274|P2|PHASE 2 - Randmonized Controlled Trial|Death|0
883975|NCT01279044|2914275|P1|PHASE 2 - Randmonized Controlled Trial|Death|0
883976|NCT01279044|2914273|P3|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
883977|NCT01279044|2914274|P2|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8
883978|NCT01279044|2914275|P1|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
883979|NCT01279044|2914273|P3|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2
883980|NCT01279044|2914274|P2|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3
883981|NCT01279044|2914275|P1|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0
883982|NCT01278797|2914349|P2|Period 1|Protocol Violation|0
883983|NCT01278797|2914350|P1|Period 1|Protocol Violation|1
883984|NCT01278797|2914349|P2|Period 1|Adverse Event|1
883985|NCT01278797|2914350|P1|Period 1|Adverse Event|0
883986|NCT01278745|2914362|P4|Overall Study|Moves,enrollment in mx studies, et al.|1
883987|NCT01278745|2914363|P3|Overall Study|Moves,enrollment in mx studies, et al.|5
883988|NCT01278745|2914364|P2|Overall Study|Moves,enrollment in mx studies, et al.|0
883989|NCT01278745|2914365|P1|Overall Study|Moves,enrollment in mx studies, et al.|0
883990|NCT01278745|2914362|P4|Overall Study|Ineligible|61
883991|NCT01278745|2914363|P3|Overall Study|Ineligible|42
883992|NCT01278745|2914364|P2|Overall Study|Ineligible|0
883993|NCT01278745|2914365|P1|Overall Study|Ineligible|0
883994|NCT01278745|2914362|P4|Overall Study|Sponsor Decision|6
883995|NCT01278745|2914363|P3|Overall Study|Sponsor Decision|62
883996|NCT01278745|2914364|P2|Overall Study|Sponsor Decision|0
883997|NCT01278745|2914365|P1|Overall Study|Sponsor Decision|1
883998|NCT01278745|2914362|P4|Overall Study|Withdrawal by Subject|1
883999|NCT01278745|2914363|P3|Overall Study|Withdrawal by Subject|5
884000|NCT01278745|2914364|P2|Overall Study|Withdrawal by Subject|1
884001|NCT01278745|2914365|P1|Overall Study|Withdrawal by Subject|1
884002|NCT01278745|2914362|P4|Overall Study|Physician Decision|9
884003|NCT01278745|2914363|P3|Overall Study|Physician Decision|0
884004|NCT01278745|2914364|P2|Overall Study|Physician Decision|0
884005|NCT01278745|2914365|P1|Overall Study|Physician Decision|1
884006|NCT01278745|2914362|P4|Overall Study|Death|0
884007|NCT01278745|2914363|P3|Overall Study|Death|7
884008|NCT01278745|2914364|P2|Overall Study|Death|5
884009|NCT01278745|2914365|P1|Overall Study|Death|2
884010|NCT01278615|2914397|P1|Overall Study|Withdrawal by Subject|2
884011|NCT01278407|2914423|P5|Extension Phase|Not Specified|3
884012|NCT01278407|2914424|P4|Extension Phase|Not Specified|1
884013|NCT01278407|2914425|P3|Extension Phase|Not Specified|0
884014|NCT01278407|2914426|P2|Extension Phase|Not Specified|0
884015|NCT01278407|2914427|P1|Extension Phase|Not Specified|0
884016|NCT01278407|2914423|P5|Extension Phase|Participant's Choice|11
884017|NCT01278407|2914424|P4|Extension Phase|Participant's Choice|4
884018|NCT01278407|2914425|P3|Extension Phase|Participant's Choice|0
884019|NCT01278407|2914426|P2|Extension Phase|Participant's Choice|0
884020|NCT01278407|2914427|P1|Extension Phase|Participant's Choice|0
884021|NCT01278407|2914423|P5|Extension Phase|Adverse Event|16
884022|NCT01278407|2914424|P4|Extension Phase|Adverse Event|7
884023|NCT01278407|2914425|P3|Extension Phase|Adverse Event|0
884024|NCT01278407|2914426|P2|Extension Phase|Adverse Event|0
884025|NCT01278407|2914427|P1|Extension Phase|Adverse Event|0
884026|NCT01278407|2914423|P5|Confirmatory Phase|Not Specified|0
884027|NCT01278407|2914424|P4|Confirmatory Phase|Not Specified|0
884028|NCT01278407|2914425|P3|Confirmatory Phase|Not Specified|2
884029|NCT01278407|2914426|P2|Confirmatory Phase|Not Specified|1
884030|NCT01278407|2914427|P1|Confirmatory Phase|Not Specified|1
884031|NCT01278407|2914423|P5|Confirmatory Phase|Participant's Choice|0
884032|NCT01278407|2914424|P4|Confirmatory Phase|Participant's Choice|0
884033|NCT01278407|2914425|P3|Confirmatory Phase|Participant's Choice|3
884034|NCT01278407|2914426|P2|Confirmatory Phase|Participant's Choice|5
884035|NCT01278407|2914427|P1|Confirmatory Phase|Participant's Choice|3
884036|NCT01278407|2914423|P5|Confirmatory Phase|Adverse Event|0
884037|NCT01278407|2914424|P4|Confirmatory Phase|Adverse Event|0
884038|NCT01278407|2914425|P3|Confirmatory Phase|Adverse Event|1
884039|NCT01278407|2914426|P2|Confirmatory Phase|Adverse Event|10
884040|NCT01278407|2914427|P1|Confirmatory Phase|Adverse Event|5
884041|NCT01278394|2914440|P1|Overall Study|Lost to Follow-up|1
884042|NCT01278342|2914453|P3|Overall Study|Other|0
884043|NCT01278342|2914454|P2|Overall Study|Other|0
884044|NCT01278342|2914455|P1|Overall Study|Other|1
884045|NCT01278342|2914453|P3|Overall Study|Administrative problems|0
884046|NCT01278342|2914454|P2|Overall Study|Administrative problems|0
884047|NCT01278342|2914455|P1|Overall Study|Administrative problems|2
884048|NCT01278342|2914453|P3|Overall Study|Lost to Follow-up|0
884049|NCT01278342|2914454|P2|Overall Study|Lost to Follow-up|0
884050|NCT01278342|2914455|P1|Overall Study|Lost to Follow-up|1
884051|NCT01278342|2914453|P3|Overall Study|Physician Decision|0
884052|NCT01278342|2914454|P2|Overall Study|Physician Decision|1
884053|NCT01278342|2914455|P1|Overall Study|Physician Decision|0
884054|NCT01278173|2914475|P1|Overall Study|Withdrawal by Subject|1
884055|NCT01278173|2914475|P1|Overall Study|Protocol Violation|1
884056|NCT01278173|2914475|P1|Overall Study|Administrative or other reason|4
884057|NCT01278173|2914475|P1|Overall Study|Adverse Event|8
884058|NCT01278173|2914475|P1|Overall Study|Lack of Efficacy|13
884059|NCT01278160|2914482|P2|Overall Study|Unclassified|2
884060|NCT01278160|2914483|P1|Overall Study|Unclassified|1
884061|NCT01278160|2914482|P2|Overall Study|Withdrawal by Subject|2
884062|NCT01278160|2914483|P1|Overall Study|Withdrawal by Subject|3
884063|NCT01278160|2914482|P2|Overall Study|Lost to Follow-up|1
884064|NCT01278160|2914483|P1|Overall Study|Lost to Follow-up|0
884065|NCT01278160|2914482|P2|Overall Study|Adverse Event|1
884066|NCT01278160|2914483|P1|Overall Study|Adverse Event|1
884067|NCT01278030|2914499|P2|Overall Study|Withdrawal by Subject|4
884068|NCT01278030|2914500|P1|Overall Study|Withdrawal by Subject|8
884069|NCT01277887|2914508|P2|Post-Quit Treatment Phase|No longer interested in treatment|5
884070|NCT01277887|2914509|P1|Post-Quit Treatment Phase|No longer interested in treatment|3
884071|NCT01277887|2914508|P2|Pre-Quit Treatment Phase|Withdrawal by Subject|0
884072|NCT01277887|2914509|P1|Pre-Quit Treatment Phase|Withdrawal by Subject|2
884073|NCT01277887|2914508|P2|Pre-Quit Treatment Phase|No longer interested in treatment|0
884074|NCT01277887|2914509|P1|Pre-Quit Treatment Phase|No longer interested in treatment|1
884075|NCT01277861|2914521|P2|Overall Study|Physician Decision|2
884076|NCT01277861|2914522|P1|Overall Study|Physician Decision|2
884077|NCT01277822|2914534|P2|Overall Study|Participant moved|0
884078|NCT01277822|2914535|P1|Overall Study|Participant moved|1
884079|NCT01277822|2914534|P2|Overall Study|Contraindicated medication used|1
884080|NCT01277822|2914535|P1|Overall Study|Contraindicated medication used|2
884081|NCT01277822|2914534|P2|Overall Study|Lost to Follow-up|1
884082|NCT01277822|2914535|P1|Overall Study|Lost to Follow-up|2
884083|NCT01277822|2914534|P2|Overall Study|Protocol Violation|0
884084|NCT01277822|2914535|P1|Overall Study|Protocol Violation|1
884085|NCT01277822|2914534|P2|Overall Study|Physician Decision|1
884086|NCT01277822|2914535|P1|Overall Study|Physician Decision|1
884087|NCT01277822|2914534|P2|Overall Study|Withdrawal by Subject|7
884088|NCT01277822|2914535|P1|Overall Study|Withdrawal by Subject|6
884089|NCT01277822|2914534|P2|Overall Study|Adverse Event|1
884090|NCT01277822|2914535|P1|Overall Study|Adverse Event|2
884091|NCT01277757|2914555|P1|Overall Study|Withdrawal by Subject|1
884092|NCT01277757|2914555|P1|Overall Study|Disease Progression|1
884093|NCT01277718|2914562|P2|Period 2 - Second Intervention|Physician Decision|2
884094|NCT01277718|2914563|P1|Period 2 - Second Intervention|Physician Decision|0
884095|NCT01277718|2914562|P2|Period 2 - Second Intervention|Protocol Violation|1
884096|NCT01277718|2914563|P1|Period 2 - Second Intervention|Protocol Violation|0
884097|NCT01277666|2914577|P3|Overall Study|Death|1
884098|NCT01277666|2914578|P2|Overall Study|Death|0
884099|NCT01277666|2914579|P1|Overall Study|Death|0
884100|NCT01277666|2914577|P3|Overall Study|Withdrawal by Subject|6
884101|NCT01277666|2914578|P2|Overall Study|Withdrawal by Subject|8
884102|NCT01277666|2914579|P1|Overall Study|Withdrawal by Subject|7
884103|NCT01277666|2914577|P3|Overall Study|Lost to Follow-up|2
884104|NCT01277666|2914578|P2|Overall Study|Lost to Follow-up|1
884105|NCT01277666|2914579|P1|Overall Study|Lost to Follow-up|1
884106|NCT01277666|2914577|P3|Overall Study|Protocol Defined Stopping criteria|6
884107|NCT01277666|2914578|P2|Overall Study|Protocol Defined Stopping criteria|2
884108|NCT01277666|2914579|P1|Overall Study|Protocol Defined Stopping criteria|1
884109|NCT01277666|2914577|P3|Overall Study|Protocol Violation|2
884110|NCT01277666|2914578|P2|Overall Study|Protocol Violation|3
884111|NCT01277666|2914579|P1|Overall Study|Protocol Violation|2
884112|NCT01277666|2914577|P3|Overall Study|Lack of Efficacy|12
884113|NCT01277666|2914578|P2|Overall Study|Lack of Efficacy|20
884114|NCT01277666|2914579|P1|Overall Study|Lack of Efficacy|8
884115|NCT01277666|2914577|P3|Overall Study|Adverse Event|20
884116|NCT01277666|2914578|P2|Overall Study|Adverse Event|25
884117|NCT01277666|2914579|P1|Overall Study|Adverse Event|26
884118|NCT01277601|2914612|P4|Overall Study|Subject Terminated from Study by Sponsor|2
884119|NCT01277601|2914613|P3|Overall Study|Subject Terminated from Study by Sponsor|0
884120|NCT01277601|2914614|P2|Overall Study|Subject Terminated from Study by Sponsor|1
884121|NCT01277601|2914615|P1|Overall Study|Subject Terminated from Study by Sponsor|0
884122|NCT01277601|2914612|P4|Overall Study|Protocol Violation|0
884123|NCT01277601|2914613|P3|Overall Study|Protocol Violation|5
884124|NCT01277601|2914614|P2|Overall Study|Protocol Violation|2
884125|NCT01277601|2914615|P1|Overall Study|Protocol Violation|0
884126|NCT01277601|2914612|P4|Overall Study|Subject Never Dosed with Study Drug|1
884127|NCT01277601|2914613|P3|Overall Study|Subject Never Dosed with Study Drug|3
884128|NCT01277601|2914614|P2|Overall Study|Subject Never Dosed with Study Drug|2
884129|NCT01277601|2914615|P1|Overall Study|Subject Never Dosed with Study Drug|1
884130|NCT01277601|2914612|P4|Overall Study|Noncompliance with Study Drug|0
884131|NCT01277601|2914613|P3|Overall Study|Noncompliance with Study Drug|2
884132|NCT01277601|2914614|P2|Overall Study|Noncompliance with Study Drug|3
884133|NCT01277601|2914615|P1|Overall Study|Noncompliance with Study Drug|1
884134|NCT01277601|2914612|P4|Overall Study|Pregnancy|1
884135|NCT01277601|2914613|P3|Overall Study|Pregnancy|4
884136|NCT01277601|2914614|P2|Overall Study|Pregnancy|2
884137|NCT01277601|2914615|P1|Overall Study|Pregnancy|2
884138|NCT01277601|2914612|P4|Overall Study|Physician Decision|6
884139|NCT01277601|2914613|P3|Overall Study|Physician Decision|1
884140|NCT01277601|2914614|P2|Overall Study|Physician Decision|5
884141|NCT01277601|2914615|P1|Overall Study|Physician Decision|3
884142|NCT01277601|2914612|P4|Overall Study|Lost to Follow-up|2
884143|NCT01277601|2914613|P3|Overall Study|Lost to Follow-up|4
884144|NCT01277601|2914614|P2|Overall Study|Lost to Follow-up|9
884145|NCT01277601|2914615|P1|Overall Study|Lost to Follow-up|7
884146|NCT01277601|2914612|P4|Overall Study|Withdrawal by Subject|17
884147|NCT01277601|2914613|P3|Overall Study|Withdrawal by Subject|8
884148|NCT01277601|2914614|P2|Overall Study|Withdrawal by Subject|21
884149|NCT01277601|2914615|P1|Overall Study|Withdrawal by Subject|18
884150|NCT01277601|2914612|P4|Overall Study|Adverse Event|7
884151|NCT01277601|2914613|P3|Overall Study|Adverse Event|0
884152|NCT01277601|2914614|P2|Overall Study|Adverse Event|3
884153|NCT01277601|2914615|P1|Overall Study|Adverse Event|5
884154|NCT01277549|2914706|P2|Overall Study|Physician Decision|1
884155|NCT01277549|2914707|P1|Overall Study|Physician Decision|2
884156|NCT01277549|2914706|P2|Overall Study|Protocol Violation|1
884157|NCT01277549|2914707|P1|Overall Study|Protocol Violation|10
884158|NCT01277549|2914706|P2|Overall Study|Withdrawal by Subject|3
884159|NCT01277549|2914707|P1|Overall Study|Withdrawal by Subject|1
884160|NCT01277549|2914706|P2|Overall Study|Failed to meet eligibility criteria|9
884161|NCT01277549|2914707|P1|Overall Study|Failed to meet eligibility criteria|13
884162|NCT01277523|2914724|P3|Overall Study|Other Reason not Defined|0
884163|NCT01277523|2914725|P2|Overall Study|Other Reason not Defined|1
884164|NCT01277523|2914726|P1|Overall Study|Other Reason not Defined|0
884165|NCT01277523|2914724|P3|Overall Study|Protocol Violation|0
884166|NCT01277523|2914725|P2|Overall Study|Protocol Violation|0
884167|NCT01277523|2914726|P1|Overall Study|Protocol Violation|2
884168|NCT01277523|2914724|P3|Overall Study|Adverse Event|0
884169|NCT01277523|2914725|P2|Overall Study|Adverse Event|0
884170|NCT01277523|2914726|P1|Overall Study|Adverse Event|1
884171|NCT01277510|2914778|P2|Open-label Phase|Never received investigational product|0
884172|NCT01277510|2914779|P1|Open-label Phase|Never received investigational product|2
884173|NCT01277510|2914778|P2|Open-label Phase|Protocol-specified criteria|0
884174|NCT01277510|2914779|P1|Open-label Phase|Protocol-specified criteria|1
884175|NCT01277510|2914778|P2|Open-label Phase|Administrative decision|3
884176|NCT01277510|2914779|P1|Open-label Phase|Administrative decision|4
884177|NCT01277510|2914778|P2|Double-blind Phase|Other|1
884178|NCT01277510|2914779|P1|Double-blind Phase|Other|1
884179|NCT01277510|2914778|P2|Double-blind Phase|Protocol-specified criteria|6
884180|NCT01277510|2914779|P1|Double-blind Phase|Protocol-specified criteria|2
884181|NCT01277510|2914778|P2|Double-blind Phase|Death|1
884182|NCT01277510|2914779|P1|Double-blind Phase|Death|0
884183|NCT01277510|2914778|P2|Double-blind Phase|Administrative decision|9
884184|NCT01277510|2914779|P1|Double-blind Phase|Administrative decision|7
884185|NCT01277510|2914778|P2|Double-blind Phase|Withdrawal by Subject|0
884186|NCT01277510|2914779|P1|Double-blind Phase|Withdrawal by Subject|2
884187|NCT01277510|2914778|P2|Double-blind Phase|Adverse Event|0
884188|NCT01277510|2914779|P1|Double-blind Phase|Adverse Event|1
884189|NCT01277510|2914778|P2|Double-blind Phase|Non-compliance|1
884190|NCT01277510|2914779|P1|Double-blind Phase|Non-compliance|0
884191|NCT01277302|2914813|P3|8-Month Alternate Dose Regimen Period|Relocation|1
884192|NCT01277302|2914814|P2|8-Month Alternate Dose Regimen Period|Relocation|0
884193|NCT01277302|2914815|P1|8-Month Alternate Dose Regimen Period|Relocation|1
884194|NCT01277302|2914813|P3|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1
884195|NCT01277302|2914814|P2|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2
884196|NCT01277302|2914815|P1|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0
884197|NCT01277302|2914813|P3|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1
884198|NCT01277302|2914814|P2|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0
884199|NCT01277302|2914815|P1|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3
884200|NCT01277302|2914813|P3|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3
884201|NCT01277302|2914814|P2|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
884202|NCT01277302|2914815|P1|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
884203|NCT01277302|2914813|P3|8-Month Alternate Dose Regimen Period|Death|0
884204|NCT01277302|2914814|P2|8-Month Alternate Dose Regimen Period|Death|1
884205|NCT01277302|2914815|P1|8-Month Alternate Dose Regimen Period|Death|0
884206|NCT01277302|2914813|P3|7-Month Fixed Treatment Period|Subject Non-compliance|1
884207|NCT01277302|2914814|P2|7-Month Fixed Treatment Period|Subject Non-compliance|0
884208|NCT01277302|2914815|P1|7-Month Fixed Treatment Period|Subject Non-compliance|0
884209|NCT01277302|2914813|P3|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1
884210|NCT01277302|2914814|P2|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
884211|NCT01277302|2914815|P1|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
884212|NCT01277302|2914813|P3|7-Month Fixed Treatment Period|Lost to Follow-up|2
884213|NCT01277302|2914814|P2|7-Month Fixed Treatment Period|Lost to Follow-up|0
884214|NCT01277302|2914815|P1|7-Month Fixed Treatment Period|Lost to Follow-up|0
884215|NCT01277302|2914813|P3|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8
884216|NCT01277302|2914814|P2|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
884217|NCT01277302|2914815|P1|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
884218|NCT01277211|2914847|P2|Overall Study|Discontinued prior to treatment|13
884219|NCT01277211|2914848|P1|Overall Study|Discontinued prior to treatment|24
884220|NCT01277211|2914847|P2|Overall Study|Pregnancy wish|2
884221|NCT01277211|2914848|P1|Overall Study|Pregnancy wish|0
884222|NCT01277211|2914847|P2|Overall Study|Administrative|0
884223|NCT01277211|2914848|P1|Overall Study|Administrative|3
884224|NCT01277211|2914847|P2|Overall Study|Did not meet protocol eligibility|0
884225|NCT01277211|2914848|P1|Overall Study|Did not meet protocol eligibility|1
884226|NCT01277211|2914847|P2|Overall Study|Non-compliance with protocol|4
884227|NCT01277211|2914848|P1|Overall Study|Non-compliance with protocol|13
884228|NCT01277211|2914847|P2|Overall Study|Withdrew Consent|9
884229|NCT01277211|2914848|P1|Overall Study|Withdrew Consent|9
884230|NCT01277211|2914847|P2|Overall Study|Did not wish to continue|0
884231|NCT01277211|2914848|P1|Overall Study|Did not wish to continue|17
884232|NCT01277211|2914847|P2|Overall Study|Lost to Follow-up|9
884233|NCT01277211|2914848|P1|Overall Study|Lost to Follow-up|14
884234|NCT01277211|2914847|P2|Overall Study|Pregnancy|4
884235|NCT01277211|2914848|P1|Overall Study|Pregnancy|9
884236|NCT01277211|2914847|P2|Overall Study|Adverse Event|22
884237|NCT01277211|2914848|P1|Overall Study|Adverse Event|60
884238|NCT01277042|2914900|P2|Overall Study|Withdrawal by Subject|0
884239|NCT01277042|2914901|P1|Overall Study|Withdrawal by Subject|2
884240|NCT01277042|2914900|P2|Overall Study|Lost to Follow-up|2
884241|NCT01277042|2914901|P1|Overall Study|Lost to Follow-up|2
884242|NCT01277042|2914900|P2|Overall Study|Adverse Event|3
884243|NCT01277042|2914901|P1|Overall Study|Adverse Event|4
884244|NCT01276847|2914926|P3|Overall Study|Withdrawal by Subject|0
884245|NCT01276847|2914927|P2|Overall Study|Withdrawal by Subject|0
884246|NCT01276847|2914928|P1|Overall Study|Withdrawal by Subject|1
884247|NCT01276821|2914938|P2|Overall Study|Protocol Violation|1
884248|NCT01276821|2914939|P1|Overall Study|Protocol Violation|0
884249|NCT01276756|2914959|P2|Overall Study|Adverse Event|2
884250|NCT01276756|2914960|P1|Overall Study|Adverse Event|3
884251|NCT01276756|2914959|P2|Overall Study|Lost to Follow-up|0
884252|NCT01276756|2914960|P1|Overall Study|Lost to Follow-up|2
884253|NCT01276639|2915005|P5|Week 16 to 52|Other|3
884254|NCT01276639|2915006|P4|Week 16 to 52|Other|1
884255|NCT01276639|2915007|P3|Week 16 to 52|Other|0
884256|NCT01276639|2915008|P2|Week 16 to 52|Other|12
884257|NCT01276639|2915009|P1|Week 16 to 52|Other|10
884258|NCT01276639|2915005|P5|Week 16 to 52|Withdrawal by Subject|1
884259|NCT01276639|2915006|P4|Week 16 to 52|Withdrawal by Subject|0
884260|NCT01276639|2915007|P3|Week 16 to 52|Withdrawal by Subject|0
884261|NCT01276639|2915008|P2|Week 16 to 52|Withdrawal by Subject|4
884262|NCT01276639|2915009|P1|Week 16 to 52|Withdrawal by Subject|4
884263|NCT01276639|2915005|P5|Week 16 to 52|Lost to Follow-up|1
884264|NCT01276639|2915006|P4|Week 16 to 52|Lost to Follow-up|0
884265|NCT01276639|2915007|P3|Week 16 to 52|Lost to Follow-up|0
884266|NCT01276639|2915008|P2|Week 16 to 52|Lost to Follow-up|1
884267|NCT01276639|2915009|P1|Week 16 to 52|Lost to Follow-up|3
884268|NCT01276639|2915005|P5|Week 16 to 52|Lack of Efficacy|13
884269|NCT01276639|2915006|P4|Week 16 to 52|Lack of Efficacy|14
884270|NCT01276639|2915007|P3|Week 16 to 52|Lack of Efficacy|0
884271|NCT01276639|2915008|P2|Week 16 to 52|Lack of Efficacy|71
884272|NCT01276639|2915009|P1|Week 16 to 52|Lack of Efficacy|99
884273|NCT01276639|2915005|P5|Week 16 to 52|Adverse Event|3
884274|NCT01276639|2915006|P4|Week 16 to 52|Adverse Event|1
884275|NCT01276639|2915007|P3|Week 16 to 52|Adverse Event|0
884276|NCT01276639|2915008|P2|Week 16 to 52|Adverse Event|13
884277|NCT01276639|2915009|P1|Week 16 to 52|Adverse Event|10
884278|NCT01276639|2915005|P5|Week 16 to 52|Death|0
884279|NCT01276639|2915006|P4|Week 16 to 52|Death|0
884280|NCT01276639|2915007|P3|Week 16 to 52|Death|0
884281|NCT01276639|2915008|P2|Week 16 to 52|Death|0
884282|NCT01276639|2915009|P1|Week 16 to 52|Death|1
884283|NCT01276639|2915005|P5|Week 0 to 16|Randomized, But Not Treated|0
884284|NCT01276639|2915006|P4|Week 0 to 16|Randomized, But Not Treated|0
884285|NCT01276639|2915007|P3|Week 0 to 16|Randomized, But Not Treated|0
884286|NCT01276639|2915008|P2|Week 0 to 16|Randomized, But Not Treated|1
884287|NCT01276639|2915009|P1|Week 0 to 16|Randomized, But Not Treated|0
884288|NCT01276639|2915005|P5|Week 0 to 16|Other|0
884289|NCT01276639|2915006|P4|Week 0 to 16|Other|0
884290|NCT01276639|2915007|P3|Week 0 to 16|Other|2
884291|NCT01276639|2915008|P2|Week 0 to 16|Other|7
884292|NCT01276639|2915009|P1|Week 0 to 16|Other|7
884293|NCT01276639|2915005|P5|Week 0 to 16|Withdrawal by Subject|0
884294|NCT01276639|2915006|P4|Week 0 to 16|Withdrawal by Subject|0
884295|NCT01276639|2915007|P3|Week 0 to 16|Withdrawal by Subject|4
884296|NCT01276639|2915008|P2|Week 0 to 16|Withdrawal by Subject|5
884297|NCT01276639|2915009|P1|Week 0 to 16|Withdrawal by Subject|8
884298|NCT01276639|2915005|P5|Week 0 to 16|Lost to Follow-up|0
884299|NCT01276639|2915006|P4|Week 0 to 16|Lost to Follow-up|0
884300|NCT01276639|2915007|P3|Week 0 to 16|Lost to Follow-up|3
884301|NCT01276639|2915008|P2|Week 0 to 16|Lost to Follow-up|5
884302|NCT01276639|2915009|P1|Week 0 to 16|Lost to Follow-up|3
884303|NCT01276639|2915005|P5|Week 0 to 16|Lack of Efficacy|0
884304|NCT01276639|2915006|P4|Week 0 to 16|Lack of Efficacy|0
884305|NCT01276639|2915007|P3|Week 0 to 16|Lack of Efficacy|25
884306|NCT01276639|2915008|P2|Week 0 to 16|Lack of Efficacy|15
884307|NCT01276639|2915009|P1|Week 0 to 16|Lack of Efficacy|20
884308|NCT01276639|2915005|P5|Week 0 to 16|Adverse Event|0
884309|NCT01276639|2915006|P4|Week 0 to 16|Adverse Event|0
884310|NCT01276639|2915007|P3|Week 0 to 16|Adverse Event|11
884311|NCT01276639|2915008|P2|Week 0 to 16|Adverse Event|8
884312|NCT01276639|2915009|P1|Week 0 to 16|Adverse Event|11
884313|NCT01276639|2915005|P5|Week 0 to 16|Death|0
884314|NCT01276639|2915006|P4|Week 0 to 16|Death|0
884315|NCT01276639|2915007|P3|Week 0 to 16|Death|0
884316|NCT01276639|2915008|P2|Week 0 to 16|Death|0
884317|NCT01276639|2915009|P1|Week 0 to 16|Death|1
884318|NCT01276509|2915214|P4|Overall Study|Other|0
884319|NCT01276509|2915215|P3|Overall Study|Other|0
884320|NCT01276509|2915216|P2|Overall Study|Other|1
884321|NCT01276509|2915217|P1|Overall Study|Other|0
884322|NCT01276509|2915214|P4|Overall Study|Withdrawal by Subject|0
884323|NCT01276509|2915215|P3|Overall Study|Withdrawal by Subject|0
884324|NCT01276509|2915216|P2|Overall Study|Withdrawal by Subject|2
884325|NCT01276509|2915217|P1|Overall Study|Withdrawal by Subject|1
884326|NCT01276509|2915214|P4|Overall Study|Pregnancy|0
884327|NCT01276509|2915215|P3|Overall Study|Pregnancy|0
884328|NCT01276509|2915216|P2|Overall Study|Pregnancy|0
884329|NCT01276509|2915217|P1|Overall Study|Pregnancy|1
884330|NCT01276509|2915214|P4|Overall Study|Lack of Efficacy|2
884331|NCT01276509|2915215|P3|Overall Study|Lack of Efficacy|1
884332|NCT01276509|2915216|P2|Overall Study|Lack of Efficacy|1
884333|NCT01276509|2915217|P1|Overall Study|Lack of Efficacy|2
884334|NCT01276509|2915214|P4|Overall Study|Adverse Event|3
884335|NCT01276509|2915215|P3|Overall Study|Adverse Event|4
884336|NCT01276509|2915216|P2|Overall Study|Adverse Event|8
884337|NCT01276509|2915217|P1|Overall Study|Adverse Event|9
884338|NCT01276457|2915270|P2|Extension Study|Lack of Efficacy|1
884339|NCT01276457|2915271|P1|Extension Study|Lack of Efficacy|3
884340|NCT01276457|2915270|P2|Extension Study|Death|1
884341|NCT01276457|2915271|P1|Extension Study|Death|0
884342|NCT01276457|2915270|P2|Extension Study|Lost to Follow-up|0
884343|NCT01276457|2915271|P1|Extension Study|Lost to Follow-up|3
884344|NCT01276457|2915270|P2|Core Study|Lack of Efficacy|12
884345|NCT01276457|2915271|P1|Core Study|Lack of Efficacy|3
884346|NCT01276457|2915270|P2|Core Study|Death|2
884347|NCT01276457|2915271|P1|Core Study|Death|2
884348|NCT01276457|2915270|P2|Core Study|Administrative problems|1
884349|NCT01276457|2915271|P1|Core Study|Administrative problems|1
884350|NCT01276457|2915270|P2|Core Study|Lost to Follow-up|2
884351|NCT01276457|2915271|P1|Core Study|Lost to Follow-up|1
884352|NCT01276457|2915270|P2|Core Study|Adverse Event|3
884353|NCT01276457|2915271|P1|Core Study|Adverse Event|6
884354|NCT01276353|2915285|P2|Extension|Prohibited concomitant medications|1
884355|NCT01276353|2915286|P1|Extension|Prohibited concomitant medications|0
884356|NCT01276353|2915285|P2|Extension|Physician Decision|0
884357|NCT01276353|2915286|P1|Extension|Physician Decision|1
884358|NCT01276353|2915285|P2|Extension|Withdrawal of study drug 4 days in a row|1
884359|NCT01276353|2915286|P1|Extension|Withdrawal of study drug 4 days in a row|3
884360|NCT01276353|2915285|P2|Extension|Withdrawal by Subject|2
884361|NCT01276353|2915286|P1|Extension|Withdrawal by Subject|1
884362|NCT01276353|2915285|P2|Extension|Adverse Event|5
884363|NCT01276353|2915286|P1|Extension|Adverse Event|2
884364|NCT01276353|2915285|P2|Double-blind|Withdrawal by Subject|0
884365|NCT01276353|2915286|P1|Double-blind|Withdrawal by Subject|1
884366|NCT01276353|2915285|P2|Double-blind|Adverse Event|0
884367|NCT01276353|2915286|P1|Double-blind|Adverse Event|2
884368|NCT01276327|2915298|P2|Overall Study|Withdrawal by Subject|0
884369|NCT01276327|2915299|P1|Overall Study|Withdrawal by Subject|1
884370|NCT01276327|2915298|P2|Overall Study|Adverse Event|3
884371|NCT01276327|2915299|P1|Overall Study|Adverse Event|1
884372|NCT01276288|2915366|P4|Overall Study|not treated|0
884373|NCT01276288|2915367|P3|Overall Study|not treated|0
884374|NCT01276288|2915368|P2|Overall Study|not treated|0
884375|NCT01276288|2915369|P1|Overall Study|not treated|1
884376|NCT01276288|2915366|P4|Overall Study|Adverse Event|0
884377|NCT01276288|2915367|P3|Overall Study|Adverse Event|0
884378|NCT01276288|2915368|P2|Overall Study|Adverse Event|1
884379|NCT01276288|2915369|P1|Overall Study|Adverse Event|1
884380|NCT01276223|2915496|P3|Overall Study|Protocol Violation|0
884381|NCT01276223|2915497|P2|Overall Study|Protocol Violation|0
884382|NCT01276223|2915498|P1|Overall Study|Protocol Violation|1
884383|NCT01276223|2915496|P3|Overall Study|Pt Decision Unrelated to Adverse Event|0
884384|NCT01276223|2915497|P2|Overall Study|Pt Decision Unrelated to Adverse Event|0
884385|NCT01276223|2915498|P1|Overall Study|Pt Decision Unrelated to Adverse Event|3
884386|NCT01276223|2915496|P3|Overall Study|Not specified|1
884387|NCT01276223|2915497|P2|Overall Study|Not specified|0
884388|NCT01276223|2915498|P1|Overall Study|Not specified|0
884389|NCT01276223|2915496|P3|Overall Study|Lost to Follow-up|1
884390|NCT01276223|2915497|P2|Overall Study|Lost to Follow-up|0
884391|NCT01276223|2915498|P1|Overall Study|Lost to Follow-up|0
884392|NCT01276223|2915496|P3|Overall Study|Adverse Event|1
884393|NCT01276223|2915497|P2|Overall Study|Adverse Event|4
884394|NCT01276223|2915498|P1|Overall Study|Adverse Event|7
884395|NCT01276106|2915539|P4|Overall Study|Insufficient therapeutic effects|0
884396|NCT01276106|2915540|P3|Overall Study|Insufficient therapeutic effects|2
884397|NCT01276106|2915541|P2|Overall Study|Insufficient therapeutic effects|0
884398|NCT01276106|2915542|P1|Overall Study|Insufficient therapeutic effects|0
884399|NCT01276106|2915539|P4|Overall Study|Protocol Violation|2
884400|NCT01276106|2915540|P3|Overall Study|Protocol Violation|0
884401|NCT01276106|2915541|P2|Overall Study|Protocol Violation|1
884402|NCT01276106|2915542|P1|Overall Study|Protocol Violation|1
884403|NCT01276106|2915539|P4|Overall Study|Physician Decision|1
884404|NCT01276106|2915540|P3|Overall Study|Physician Decision|1
884405|NCT01276106|2915541|P2|Overall Study|Physician Decision|0
884406|NCT01276106|2915542|P1|Overall Study|Physician Decision|0
884407|NCT01276106|2915539|P4|Overall Study|Lost to Follow-up|0
884408|NCT01276106|2915540|P3|Overall Study|Lost to Follow-up|1
884409|NCT01276106|2915541|P2|Overall Study|Lost to Follow-up|1
884410|NCT01276106|2915542|P1|Overall Study|Lost to Follow-up|2
884411|NCT01276106|2915539|P4|Overall Study|Lack of Efficacy|1
884412|NCT01276106|2915540|P3|Overall Study|Lack of Efficacy|0
884413|NCT01276106|2915541|P2|Overall Study|Lack of Efficacy|1
884414|NCT01276106|2915542|P1|Overall Study|Lack of Efficacy|0
884415|NCT01276106|2915539|P4|Overall Study|Withdrawal by Subject|6
884416|NCT01276106|2915540|P3|Overall Study|Withdrawal by Subject|1
884417|NCT01276106|2915541|P2|Overall Study|Withdrawal by Subject|3
884418|NCT01276106|2915542|P1|Overall Study|Withdrawal by Subject|6
884419|NCT01276106|2915539|P4|Overall Study|Adverse Event|3
884420|NCT01276106|2915540|P3|Overall Study|Adverse Event|11
884421|NCT01276106|2915541|P2|Overall Study|Adverse Event|3
884422|NCT01276106|2915542|P1|Overall Study|Adverse Event|3
884423|NCT01276054|2915554|P2|Overall Study|No one to oversee trial after P.I. left|2
884424|NCT01276054|2915555|P1|Overall Study|No one to oversee trial after P.I. left|2
884425|NCT01275833|2915563|P2|Overall Study|Study terminated|1
884426|NCT01275833|2915564|P1|Overall Study|Study terminated|1
884427|NCT01275755|2915572|P2|Run-out Placebo Period|Lost to Follow-up|0
884428|NCT01275755|2915573|P1|Run-out Placebo Period|Lost to Follow-up|1
884429|NCT01275755|2915572|P2|Double-blind Treatment Period|Withdrawal by Subject|0
884430|NCT01275755|2915573|P1|Double-blind Treatment Period|Withdrawal by Subject|1
884431|NCT01275755|2915572|P2|Double-blind Treatment Period|Lost to Follow-up|1
884432|NCT01275755|2915573|P1|Double-blind Treatment Period|Lost to Follow-up|1
884433|NCT01275755|2915572|P2|Double-blind Treatment Period|Adverse Event|2
884434|NCT01275755|2915573|P1|Double-blind Treatment Period|Adverse Event|0
884435|NCT01275625|2915587|P1|Overall Study|Not specified|1
884436|NCT01275625|2915587|P1|Overall Study|Adverse Event|4
884437|NCT01275625|2915587|P1|Overall Study|Protocol Violation|1
884438|NCT01275625|2915587|P1|Overall Study|Withdrawal by Subject|3
884439|NCT01275625|2915587|P1|Overall Study|Lost to Follow-up|1
884440|NCT01275625|2915587|P1|Overall Study|Lack of Efficacy|2
884441|NCT01275625|2915587|P1|Overall Study|Death|1
884442|NCT01275430|2915605|P1|Overall Study|Inability to achieve maximum p-wave|1
884443|NCT01275430|2915605|P1|Overall Study|Device Malfunction|1
884444|NCT01275430|2915605|P1|Overall Study|No Contrast Injection|6
884445|NCT01275430|2915605|P1|Overall Study|Adverse Event|1
884446|NCT01275196|2915677|P2|Overall Study|Suboptimal response/treatment failure|6
884447|NCT01275196|2915678|P1|Overall Study|Suboptimal response/treatment failure|5
884448|NCT01275196|2915677|P2|Overall Study|Protocol Violation|0
884449|NCT01275196|2915678|P1|Overall Study|Protocol Violation|1
884450|NCT01275196|2915677|P2|Overall Study|Disease Progression|5
884451|NCT01275196|2915678|P1|Overall Study|Disease Progression|6
884452|NCT01275196|2915677|P2|Overall Study|Lost to Follow-up|0
884453|NCT01275196|2915678|P1|Overall Study|Lost to Follow-up|1
884454|NCT01275196|2915677|P2|Overall Study|Withdrawal by Subject|5
884455|NCT01275196|2915678|P1|Overall Study|Withdrawal by Subject|4
884456|NCT01275196|2915677|P2|Overall Study|Adverse Event|5
884457|NCT01275196|2915678|P1|Overall Study|Adverse Event|3
884458|NCT01275131|2915721|P4|Period 2 (Crossover)|Withdrawal by Subject|2
884459|NCT01275131|2915722|P3|Period 2 (Crossover)|Withdrawal by Subject|1
884460|NCT01275131|2915723|P2|Period 2 (Crossover)|Withdrawal by Subject|0
884461|NCT01275131|2915724|P1|Period 2 (Crossover)|Withdrawal by Subject|1
884462|NCT01275131|2915721|P4|Period 2 (Crossover)|Adverse Event|0
884463|NCT01275131|2915722|P3|Period 2 (Crossover)|Adverse Event|0
884464|NCT01275131|2915723|P2|Period 2 (Crossover)|Adverse Event|1
884465|NCT01275131|2915724|P1|Period 2 (Crossover)|Adverse Event|0
884466|NCT01275131|2915721|P4|Period 1|Physician Decision|0
884467|NCT01275131|2915722|P3|Period 1|Physician Decision|0
884468|NCT01275131|2915723|P2|Period 1|Physician Decision|0
884469|NCT01275131|2915724|P1|Period 1|Physician Decision|1
884470|NCT01275131|2915721|P4|Period 1|Withdrawal by Subject|2
884471|NCT01275131|2915722|P3|Period 1|Withdrawal by Subject|3
884472|NCT01275131|2915723|P2|Period 1|Withdrawal by Subject|0
884473|NCT01275131|2915724|P1|Period 1|Withdrawal by Subject|1
884474|NCT01275066|2915767|P3|Overall Study|Not Diagnosed w/ Disease|0
884475|NCT01275066|2915768|P2|Overall Study|Not Diagnosed w/ Disease|0
884476|NCT01275066|2915769|P1|Overall Study|Not Diagnosed w/ Disease|1
884477|NCT01275066|2915767|P3|Overall Study|Withdrawal by Subject|1
884478|NCT01275066|2915768|P2|Overall Study|Withdrawal by Subject|0
884479|NCT01275066|2915769|P1|Overall Study|Withdrawal by Subject|0
884480|NCT01274715|2915802|P1|Overall Study|After consent, met exclusion criteria.|1
884481|NCT01274715|2915802|P1|Overall Study|After consent, met exclusion criteria.|1
884482|NCT01274715|2915802|P1|Overall Study|After consent, met exclusion criteria.|1
884483|NCT01274715|2915802|P1|Overall Study|Lost to Follow-up|1
884484|NCT01274637|2915809|P2|Overall Study|Lost to Follow-up|1
884485|NCT01274637|2915810|P1|Overall Study|Lost to Follow-up|0
884486|NCT01274637|2915809|P2|Overall Study|Withdrawal by Subject|1
884487|NCT01274637|2915810|P1|Overall Study|Withdrawal by Subject|0
884488|NCT01274559|2915849|P2|Overall Study|Withdrawal by Subject|13
884489|NCT01274559|2915850|P1|Overall Study|Withdrawal by Subject|25
884490|NCT01274559|2915849|P2|Overall Study|Study Terminated by Sponsor|87
884491|NCT01274559|2915850|P1|Overall Study|Study Terminated by Sponsor|79
884492|NCT01274559|2915849|P2|Overall Study|Protocol Violation|23
884493|NCT01274559|2915850|P1|Overall Study|Protocol Violation|28
884494|NCT01274559|2915849|P2|Overall Study|Physician Decision|1
884495|NCT01274559|2915850|P1|Overall Study|Physician Decision|2
884496|NCT01274559|2915849|P2|Overall Study|Non-compliance with Study Drug|4
884497|NCT01274559|2915850|P1|Overall Study|Non-compliance with Study Drug|2
884498|NCT01274559|2915849|P2|Overall Study|Lost to Follow-up|3
884499|NCT01274559|2915850|P1|Overall Study|Lost to Follow-up|3
884500|NCT01274559|2915849|P2|Overall Study|Death|1
884501|NCT01274559|2915850|P1|Overall Study|Death|1
884502|NCT01274559|2915849|P2|Overall Study|Adverse Event|13
884503|NCT01274559|2915850|P1|Overall Study|Adverse Event|57
884504|NCT01274533|2915900|P1|Overall Study|Disease progression|2
884505|NCT01274533|2915900|P1|Overall Study|Non-compliance|1
884506|NCT01274533|2915900|P1|Overall Study|Withdrawal by Subject|1
884507|NCT01274429|2915905|P1|Overall Study|Study closed do to lack of funding|5
884508|NCT01274182|2915913|P3|Overall Study|Death|1
884509|NCT01274182|2915914|P2|Overall Study|Death|0
884510|NCT01274182|2915915|P1|Overall Study|Death|1
884511|NCT01274182|2915913|P3|Overall Study|Protocol Violation|0
884512|NCT01274182|2915914|P2|Overall Study|Protocol Violation|2
884513|NCT01274182|2915915|P1|Overall Study|Protocol Violation|3
884514|NCT01274182|2915913|P3|Overall Study|Lost to Follow-up|1
884515|NCT01274182|2915914|P2|Overall Study|Lost to Follow-up|3
884516|NCT01274182|2915915|P1|Overall Study|Lost to Follow-up|2
884517|NCT01274182|2915913|P3|Overall Study|Withdrawal by Subject|3
884518|NCT01274182|2915914|P2|Overall Study|Withdrawal by Subject|5
884519|NCT01274182|2915915|P1|Overall Study|Withdrawal by Subject|5
884520|NCT01274182|2915913|P3|Overall Study|Adverse Event|3
884521|NCT01274182|2915914|P2|Overall Study|Adverse Event|5
884522|NCT01274182|2915915|P1|Overall Study|Adverse Event|4
884523|NCT01274182|2915913|P3|Overall Study|Unsatisfactory therapeutic effect|4
884524|NCT01274182|2915914|P2|Overall Study|Unsatisfactory therapeutic effect|3
884525|NCT01274182|2915915|P1|Overall Study|Unsatisfactory therapeutic effect|6
884526|NCT01273883|2915956|P2|Second Intervention|Lack of Efficacy|0
884527|NCT01273883|2915957|P1|Second Intervention|Lack of Efficacy|1
884528|NCT01273883|2915956|P2|Second Intervention|Lost to Follow-up|1
884529|NCT01273883|2915957|P1|Second Intervention|Lost to Follow-up|1
884530|NCT01273883|2915956|P2|First Intervention|Adverse Event|1
884531|NCT01273883|2915957|P1|First Intervention|Adverse Event|2
884532|NCT01273818|2915983|P3|Overall Study|Physician Decision|9
884533|NCT01273818|2915984|P2|Overall Study|Physician Decision|2
884534|NCT01273818|2915985|P1|Overall Study|Physician Decision|13
884535|NCT01273805|2915995|P2|Overall Study|Radiologic PD or Symptom Deterioration|10
884536|NCT01273805|2915996|P1|Overall Study|Radiologic PD or Symptom Deterioration|10
884537|NCT01273623|2916027|P1|Overall Study|did not meet IVUS criteria|29
884538|NCT01273597|2916034|P1|Overall Study|Reason Not Reported|1
884539|NCT01273597|2916034|P1|Overall Study|Underwent Kidney Transplantation|2
884540|NCT01273597|2916034|P1|Overall Study|Adverse Event|5
884541|NCT01273519|2916049|P3|Overall Study|Not Specified|1
884542|NCT01273519|2916050|P2|Overall Study|Not Specified|1
884543|NCT01273519|2916051|P1|Overall Study|Not Specified|6
884544|NCT01273519|2916049|P3|Overall Study|Lack of Efficacy|4
884545|NCT01273519|2916050|P2|Overall Study|Lack of Efficacy|3
884546|NCT01273519|2916051|P1|Overall Study|Lack of Efficacy|8
884547|NCT01273519|2916049|P3|Overall Study|Lost to Follow-up|3
884548|NCT01273519|2916050|P2|Overall Study|Lost to Follow-up|1
884549|NCT01273519|2916051|P1|Overall Study|Lost to Follow-up|2
884550|NCT01273519|2916049|P3|Overall Study|Adverse Event|0
884551|NCT01273519|2916050|P2|Overall Study|Adverse Event|0
884552|NCT01273519|2916051|P1|Overall Study|Adverse Event|3
884553|NCT01273181|2916088|P4|Phase 2, Dose 2|Death during treatment|1
884554|NCT01273181|2916089|P3|Phase 2, Dose 2|Death during treatment|0
884555|NCT01273181|2916090|P2|Phase 2, Dose 2|Death during treatment|0
884556|NCT01273181|2916091|P1|Phase 2, Dose 2|Death during treatment|0
884557|NCT01273181|2916088|P4|Phase 2, Dose 1|Study termination|0
884558|NCT01273181|2916089|P3|Phase 2, Dose 1|Study termination|1
884559|NCT01273181|2916090|P2|Phase 2, Dose 1|Study termination|0
884560|NCT01273181|2916091|P1|Phase 2, Dose 1|Study termination|0
884561|NCT01273181|2916088|P4|Phase I, Dose 2|Death during treatment|0
884562|NCT01273181|2916089|P3|Phase I, Dose 2|Death during treatment|0
884563|NCT01273181|2916090|P2|Phase I, Dose 2|Death during treatment|1
884564|NCT01273181|2916091|P1|Phase I, Dose 2|Death during treatment|0
884565|NCT01273181|2916088|P4|Phase I, Dose 1|Study termination|0
884566|NCT01273181|2916089|P3|Phase I, Dose 1|Study termination|0
884567|NCT01273181|2916090|P2|Phase I, Dose 1|Study termination|0
884568|NCT01273181|2916091|P1|Phase I, Dose 1|Study termination|1
884569|NCT01273064|2916110|P5|Overall Study|Physician Decision|1
884570|NCT01273064|2916111|P4|Overall Study|Physician Decision|0
884571|NCT01273064|2916112|P3|Overall Study|Physician Decision|0
884572|NCT01273064|2916113|P2|Overall Study|Physician Decision|0
884573|NCT01273064|2916114|P1|Overall Study|Physician Decision|0
884574|NCT01273064|2916110|P5|Overall Study|Lost to Follow-up|0
884575|NCT01273064|2916111|P4|Overall Study|Lost to Follow-up|0
884576|NCT01273064|2916112|P3|Overall Study|Lost to Follow-up|0
884577|NCT01273064|2916113|P2|Overall Study|Lost to Follow-up|0
884578|NCT01273064|2916114|P1|Overall Study|Lost to Follow-up|1
884579|NCT01273064|2916110|P5|Overall Study|Study Termination|8
884580|NCT01273064|2916111|P4|Overall Study|Study Termination|16
884581|NCT01273064|2916112|P3|Overall Study|Study Termination|26
884582|NCT01273064|2916113|P2|Overall Study|Study Termination|27
884583|NCT01273064|2916114|P1|Overall Study|Study Termination|13
884584|NCT01273064|2916110|P5|Overall Study|Withdrawal by Subject|0
884585|NCT01273064|2916111|P4|Overall Study|Withdrawal by Subject|2
884586|NCT01273064|2916112|P3|Overall Study|Withdrawal by Subject|2
884587|NCT01273064|2916113|P2|Overall Study|Withdrawal by Subject|2
884588|NCT01273064|2916114|P1|Overall Study|Withdrawal by Subject|4
884589|NCT01273064|2916110|P5|Overall Study|Adverse Event|1
884590|NCT01273064|2916111|P4|Overall Study|Adverse Event|2
884591|NCT01273064|2916112|P3|Overall Study|Adverse Event|3
884592|NCT01273064|2916113|P2|Overall Study|Adverse Event|1
884593|NCT01273064|2916114|P1|Overall Study|Adverse Event|5
884594|NCT01273038|2916133|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
884595|NCT01273038|2916134|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
884596|NCT01273038|2916133|P2|Second Intervention (14 Days)|Adverse Event|1
884597|NCT01273038|2916134|P1|Second Intervention (14 Days)|Adverse Event|0
884598|NCT01272947|2916157|P2|Overall Study|Abnormal Laboratory Value|2
884599|NCT01272947|2916158|P1|Overall Study|Abnormal Laboratory Value|2
884600|NCT01272934|2916168|P2|Overall Study|Abnormal Laboratory Value|1
884601|NCT01272934|2916169|P1|Overall Study|Abnormal Laboratory Value|0
884602|NCT01272934|2916168|P2|Overall Study|Adverse Event|1
884603|NCT01272934|2916169|P1|Overall Study|Adverse Event|0
884604|NCT01272921|2916179|P2|Overall Study|Protocol Violation|1
884605|NCT01272921|2916180|P1|Overall Study|Protocol Violation|2
884606|NCT01272908|2916188|P1|Re-Treatment Period|Withdrawal by Subject|1
884607|NCT01272908|2916188|P1|Re-Treatment Period|Lack of Efficacy|3
884608|NCT01272908|2916188|P1|Re-Treatment Period|Adverse Event|2
884609|NCT01272908|2916188|P1|Initial Treatment Period|Withdrawal by Subject|1
884610|NCT01272908|2916188|P1|Initial Treatment Period|Protocol Violation|1
884611|NCT01272908|2916188|P1|Initial Treatment Period|Lack of Efficacy|5
884612|NCT01272908|2916188|P1|Initial Treatment Period|Adverse Event|1
884613|NCT01272869|2916228|P2|Period 2 (14 Days)|Adverse Event|0
884614|NCT01272869|2916229|P1|Period 2 (14 Days)|Adverse Event|1
884615|NCT01272804|2916256|P6|Overall Study|Adverse Event|1
884616|NCT01272804|2916257|P5|Overall Study|Adverse Event|2
884617|NCT01272804|2916258|P4|Overall Study|Adverse Event|0
884618|NCT01272804|2916259|P3|Overall Study|Adverse Event|0
884619|NCT01272804|2916260|P2|Overall Study|Adverse Event|0
884620|NCT01272804|2916261|P1|Overall Study|Adverse Event|1
884621|NCT01272661|2916419|P3|Overall Study|lost to followup/case closed/ no birth|72
884622|NCT01272661|2916420|P2|Overall Study|lost to followup/case closed/ no birth|209
884623|NCT01272661|2916421|P1|Overall Study|lost to followup/case closed/ no birth|126
884624|NCT01272635|2916446|P4|Overall Study|Lost to Follow-up|23
884625|NCT01272635|2916447|P3|Overall Study|Lost to Follow-up|31
884626|NCT01272635|2916448|P2|Overall Study|Lost to Follow-up|20
884627|NCT01272635|2916449|P1|Overall Study|Lost to Follow-up|31
884628|NCT01272232|2916533|P3|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0
884629|NCT01272232|2916534|P2|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
884630|NCT01272232|2916535|P1|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
884631|NCT01272232|2916533|P3|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4
884632|NCT01272232|2916534|P2|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7
884633|NCT01272232|2916535|P1|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9
884634|NCT01272232|2916533|P3|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
884635|NCT01272232|2916534|P2|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0
884636|NCT01272232|2916535|P1|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
884637|NCT01272232|2916533|P3|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
884638|NCT01272232|2916534|P2|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
884639|NCT01272232|2916535|P1|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1
884640|NCT01272232|2916533|P3|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0
884641|NCT01272232|2916534|P2|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
884642|NCT01272232|2916535|P1|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
884643|NCT01272232|2916533|P3|Weeks 0-56|Unclassified|12
884644|NCT01272232|2916534|P2|Weeks 0-56|Unclassified|7
884645|NCT01272232|2916535|P1|Weeks 0-56|Unclassified|16
884646|NCT01272232|2916533|P3|Weeks 0-56|Withdrawal criteria|37
884647|NCT01272232|2916534|P2|Weeks 0-56|Withdrawal criteria|14
884648|NCT01272232|2916535|P1|Weeks 0-56|Withdrawal criteria|32
884649|NCT01272232|2916533|P3|Weeks 0-56|Protocol Violation|13
884650|NCT01272232|2916534|P2|Weeks 0-56|Protocol Violation|8
884651|NCT01272232|2916535|P1|Weeks 0-56|Protocol Violation|12
884652|NCT01272232|2916533|P3|Weeks 0-56|Lack of Efficacy|3
884653|NCT01272232|2916534|P2|Weeks 0-56|Lack of Efficacy|0
884654|NCT01272232|2916535|P1|Weeks 0-56|Lack of Efficacy|0
884655|NCT01272232|2916533|P3|Weeks 0-56|Adverse Event|7
884656|NCT01272232|2916534|P2|Weeks 0-56|Adverse Event|18
884657|NCT01272232|2916535|P1|Weeks 0-56|Adverse Event|39
884658|NCT01272219|2916580|P6|Main + Extension Period: Week 0-172|Unclassified|51
884659|NCT01272219|2916581|P5|Main + Extension Period: Week 0-172|Unclassified|61
884660|NCT01272219|2916582|P4|Main + Extension Period: Week 0-172|Unclassified|0
884661|NCT01272219|2916583|P3|Main + Extension Period: Week 0-172|Unclassified|0
884662|NCT01272219|2916584|P2|Main + Extension Period: Week 0-172|Unclassified|0
884663|NCT01272219|2916585|P1|Main + Extension Period: Week 0-172|Unclassified|0
884664|NCT01272219|2916580|P6|Main + Extension Period: Week 0-172|Missing reason|0
884665|NCT01272219|2916581|P5|Main + Extension Period: Week 0-172|Missing reason|1
884666|NCT01272219|2916582|P4|Main + Extension Period: Week 0-172|Missing reason|0
884667|NCT01272219|2916583|P3|Main + Extension Period: Week 0-172|Missing reason|0
884668|NCT01272219|2916584|P2|Main + Extension Period: Week 0-172|Missing reason|0
884669|NCT01272219|2916585|P1|Main + Extension Period: Week 0-172|Missing reason|0
884670|NCT01272219|2916580|P6|Main + Extension Period: Week 0-172|Withdrawal criteria|256
884671|NCT01272219|2916581|P5|Main + Extension Period: Week 0-172|Withdrawal criteria|364
884672|NCT01272219|2916582|P4|Main + Extension Period: Week 0-172|Withdrawal criteria|0
884673|NCT01272219|2916583|P3|Main + Extension Period: Week 0-172|Withdrawal criteria|0
884674|NCT01272219|2916584|P2|Main + Extension Period: Week 0-172|Withdrawal criteria|0
884675|NCT01272219|2916585|P1|Main + Extension Period: Week 0-172|Withdrawal criteria|0
884676|NCT01272219|2916580|P6|Main + Extension Period: Week 0-172|Protocol Violation|36
884677|NCT01272219|2916581|P5|Main + Extension Period: Week 0-172|Protocol Violation|76
884678|NCT01272219|2916582|P4|Main + Extension Period: Week 0-172|Protocol Violation|0
884679|NCT01272219|2916583|P3|Main + Extension Period: Week 0-172|Protocol Violation|0
884680|NCT01272219|2916584|P2|Main + Extension Period: Week 0-172|Protocol Violation|0
884681|NCT01272219|2916585|P1|Main + Extension Period: Week 0-172|Protocol Violation|0
884682|NCT01272219|2916580|P6|Main + Extension Period: Week 0-172|Lack of Efficacy|36
884683|NCT01272219|2916581|P5|Main + Extension Period: Week 0-172|Lack of Efficacy|29
884684|NCT01272219|2916582|P4|Main + Extension Period: Week 0-172|Lack of Efficacy|0
884685|NCT01272219|2916583|P3|Main + Extension Period: Week 0-172|Lack of Efficacy|0
884686|NCT01272219|2916584|P2|Main + Extension Period: Week 0-172|Lack of Efficacy|0
884687|NCT01272219|2916585|P1|Main + Extension Period: Week 0-172|Lack of Efficacy|0
884688|NCT01272219|2916580|P6|Main + Extension Period: Week 0-172|Adverse Event|43
884689|NCT01272219|2916581|P5|Main + Extension Period: Week 0-172|Adverse Event|191
884690|NCT01272219|2916582|P4|Main + Extension Period: Week 0-172|Adverse Event|0
884691|NCT01272219|2916583|P3|Main + Extension Period: Week 0-172|Adverse Event|0
884692|NCT01272219|2916584|P2|Main + Extension Period: Week 0-172|Adverse Event|0
884693|NCT01272219|2916585|P1|Main + Extension Period: Week 0-172|Adverse Event|0
884694|NCT01272219|2916580|P6|Re-randomised Period: Week 56 to Week 68|Unclassified|0
884695|NCT01272219|2916581|P5|Re-randomised Period: Week 56 to Week 68|Unclassified|0
884696|NCT01272219|2916582|P4|Re-randomised Period: Week 56 to Week 68|Unclassified|2
884697|NCT01272219|2916583|P3|Re-randomised Period: Week 56 to Week 68|Unclassified|2
884698|NCT01272219|2916584|P2|Re-randomised Period: Week 56 to Week 68|Unclassified|1
884699|NCT01272219|2916585|P1|Re-randomised Period: Week 56 to Week 68|Unclassified|0
884700|NCT01272219|2916580|P6|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
884701|NCT01272219|2916581|P5|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
884702|NCT01272219|2916582|P4|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7
884703|NCT01272219|2916583|P3|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4
884704|NCT01272219|2916584|P2|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6
884705|NCT01272219|2916585|P1|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
884706|NCT01272219|2916580|P6|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
884707|NCT01272219|2916581|P5|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
884708|NCT01272219|2916582|P4|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3
884709|NCT01272219|2916583|P3|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
884710|NCT01272219|2916584|P2|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1
884711|NCT01272219|2916585|P1|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
884712|NCT01272219|2916580|P6|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
884713|NCT01272219|2916581|P5|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
884714|NCT01272219|2916582|P4|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1
884715|NCT01272219|2916583|P3|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
884716|NCT01272219|2916584|P2|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
884717|NCT01272219|2916585|P1|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
884718|NCT01272219|2916580|P6|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
884719|NCT01272219|2916581|P5|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
884720|NCT01272219|2916582|P4|Re-randomised Period: Week 56 to Week 68|Adverse Event|2
884721|NCT01272219|2916583|P3|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
884722|NCT01272219|2916584|P2|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
884723|NCT01272219|2916585|P1|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
884724|NCT01272219|2916580|P6|Main Period: Week 0 to Week 56|Unclassified|34
884725|NCT01272219|2916581|P5|Main Period: Week 0 to Week 56|Unclassified|42
884726|NCT01272219|2916582|P4|Main Period: Week 0 to Week 56|Unclassified|29
884727|NCT01272219|2916583|P3|Main Period: Week 0 to Week 56|Unclassified|0
884728|NCT01272219|2916584|P2|Main Period: Week 0 to Week 56|Unclassified|0
884729|NCT01272219|2916585|P1|Main Period: Week 0 to Week 56|Unclassified|36
884730|NCT01272219|2916580|P6|Main Period: Week 0 to Week 56|Withdrawal criteria|147
884731|NCT01272219|2916581|P5|Main Period: Week 0 to Week 56|Withdrawal criteria|172
884732|NCT01272219|2916582|P4|Main Period: Week 0 to Week 56|Withdrawal criteria|114
884733|NCT01272219|2916583|P3|Main Period: Week 0 to Week 56|Withdrawal criteria|0
884734|NCT01272219|2916584|P2|Main Period: Week 0 to Week 56|Withdrawal criteria|0
884735|NCT01272219|2916585|P1|Main Period: Week 0 to Week 56|Withdrawal criteria|122
884736|NCT01272219|2916580|P6|Main Period: Week 0 to Week 56|Protocol Violation|20
884737|NCT01272219|2916581|P5|Main Period: Week 0 to Week 56|Protocol Violation|40
884738|NCT01272219|2916582|P4|Main Period: Week 0 to Week 56|Protocol Violation|18
884739|NCT01272219|2916583|P3|Main Period: Week 0 to Week 56|Protocol Violation|0
884740|NCT01272219|2916584|P2|Main Period: Week 0 to Week 56|Protocol Violation|0
884741|NCT01272219|2916585|P1|Main Period: Week 0 to Week 56|Protocol Violation|25
884742|NCT01272219|2916580|P6|Main Period: Week 0 to Week 56|Lack of Efficacy|22
884743|NCT01272219|2916581|P5|Main Period: Week 0 to Week 56|Lack of Efficacy|12
884744|NCT01272219|2916582|P4|Main Period: Week 0 to Week 56|Lack of Efficacy|14
884745|NCT01272219|2916583|P3|Main Period: Week 0 to Week 56|Lack of Efficacy|0
884746|NCT01272219|2916584|P2|Main Period: Week 0 to Week 56|Lack of Efficacy|0
884747|NCT01272219|2916585|P1|Main Period: Week 0 to Week 56|Lack of Efficacy|11
884748|NCT01272219|2916580|P6|Main Period: Week 0 to Week 56|Adverse Event|29
884749|NCT01272219|2916581|P5|Main Period: Week 0 to Week 56|Adverse Event|152
884750|NCT01272219|2916582|P4|Main Period: Week 0 to Week 56|Adverse Event|16
884751|NCT01272219|2916583|P3|Main Period: Week 0 to Week 56|Adverse Event|0
884752|NCT01272219|2916584|P2|Main Period: Week 0 to Week 56|Adverse Event|0
884753|NCT01272219|2916585|P1|Main Period: Week 0 to Week 56|Adverse Event|86
884754|NCT01272193|2916619|P2|Overall Study|Unclassified|7
884755|NCT01272193|2916620|P1|Overall Study|Unclassified|8
884756|NCT01272193|2916619|P2|Overall Study|Withdrawal Criteria|1
884757|NCT01272193|2916620|P1|Overall Study|Withdrawal Criteria|1
884758|NCT01272193|2916619|P2|Overall Study|Lack of Efficacy|3
884759|NCT01272193|2916620|P1|Overall Study|Lack of Efficacy|0
884760|NCT01272193|2916619|P2|Overall Study|Adverse Event|1
884761|NCT01272193|2916620|P1|Overall Study|Adverse Event|1
884762|NCT01272180|2916640|P4|Overall Study|Protocol Violation|1
884763|NCT01272180|2916641|P3|Overall Study|Protocol Violation|0
884764|NCT01272180|2916642|P2|Overall Study|Protocol Violation|1
884765|NCT01272180|2916643|P1|Overall Study|Protocol Violation|0
884766|NCT01272180|2916640|P4|Overall Study|Inappropriate enrollment|1
884767|NCT01272180|2916641|P3|Overall Study|Inappropriate enrollment|1
884768|NCT01272180|2916642|P2|Overall Study|Inappropriate enrollment|0
884769|NCT01272180|2916643|P1|Overall Study|Inappropriate enrollment|0
884770|NCT01272180|2916640|P4|Overall Study|Lost to Follow-up|10
884771|NCT01272180|2916641|P3|Overall Study|Lost to Follow-up|8
884772|NCT01272180|2916642|P2|Overall Study|Lost to Follow-up|14
884773|NCT01272180|2916643|P1|Overall Study|Lost to Follow-up|15
884774|NCT01272180|2916640|P4|Overall Study|Withdrawal by Subject|2
884775|NCT01272180|2916641|P3|Overall Study|Withdrawal by Subject|3
884776|NCT01272180|2916642|P2|Overall Study|Withdrawal by Subject|6
884777|NCT01272180|2916643|P1|Overall Study|Withdrawal by Subject|2
884778|NCT01272180|2916640|P4|Overall Study|Adverse Event|0
884779|NCT01272180|2916641|P3|Overall Study|Adverse Event|1
884780|NCT01272180|2916642|P2|Overall Study|Adverse Event|0
884781|NCT01272180|2916643|P1|Overall Study|Adverse Event|0
884782|NCT01272011|2916692|P3|Overall Study|Withdrawal By Subject or Failed Screen|0
884783|NCT01272011|2916693|P2|Overall Study|Withdrawal By Subject or Failed Screen|2
884784|NCT01272011|2916694|P1|Overall Study|Withdrawal By Subject or Failed Screen|0
884785|NCT01271933|2916730|P3|Double-Blind Phase|Participant request-personal reason|0
884786|NCT01271933|2916731|P2|Double-Blind Phase|Participant request-personal reason|1
884787|NCT01271933|2916732|P1|Double-Blind Phase|Participant request-personal reason|0
884788|NCT01271933|2916730|P3|Double-Blind Phase|Adverse Event|0
884789|NCT01271933|2916731|P2|Double-Blind Phase|Adverse Event|3
884790|NCT01271933|2916732|P1|Double-Blind Phase|Adverse Event|0
884791|NCT01271933|2916730|P3|Double-Blind Phase|Withdrawal by Subject|1
884792|NCT01271933|2916731|P2|Double-Blind Phase|Withdrawal by Subject|6
884793|NCT01271933|2916732|P1|Double-Blind Phase|Withdrawal by Subject|0
884794|NCT01271933|2916730|P3|Double-Blind Phase|Lost to Follow-up|1
884795|NCT01271933|2916731|P2|Double-Blind Phase|Lost to Follow-up|1
884796|NCT01271933|2916732|P1|Double-Blind Phase|Lost to Follow-up|0
884797|NCT01271933|2916730|P3|Double-Blind Phase|Lack of Efficacy|9
884798|NCT01271933|2916731|P2|Double-Blind Phase|Lack of Efficacy|6
884799|NCT01271933|2916732|P1|Double-Blind Phase|Lack of Efficacy|0
884800|NCT01271933|2916730|P3|Double-Blind Phase|Randomized but not treated|1
884801|NCT01271933|2916731|P2|Double-Blind Phase|Randomized but not treated|0
884802|NCT01271933|2916732|P1|Double-Blind Phase|Randomized but not treated|0
884803|NCT01271933|2916730|P3|Single-Blind Phase|(Participant request-personal reason)|0
884804|NCT01271933|2916731|P2|Single-Blind Phase|(Participant request-personal reason)|0
884805|NCT01271933|2916732|P1|Single-Blind Phase|(Participant request-personal reason)|1
884806|NCT01271933|2916730|P3|Single-Blind Phase|(Protocol non-compliance)|0
884807|NCT01271933|2916731|P2|Single-Blind Phase|(Protocol non-compliance)|0
884808|NCT01271933|2916732|P1|Single-Blind Phase|(Protocol non-compliance)|2
884809|NCT01271933|2916730|P3|Single-Blind Phase|(Failed to meet dosing requirement)|0
884810|NCT01271933|2916731|P2|Single-Blind Phase|(Failed to meet dosing requirement)|0
884811|NCT01271933|2916732|P1|Single-Blind Phase|(Failed to meet dosing requirement)|1
884812|NCT01271933|2916730|P3|Single-Blind Phase|Adverse Event|0
884813|NCT01271933|2916731|P2|Single-Blind Phase|Adverse Event|0
884814|NCT01271933|2916732|P1|Single-Blind Phase|Adverse Event|52
884815|NCT01271933|2916730|P3|Single-Blind Phase|Protocol Violation|0
884816|NCT01271933|2916731|P2|Single-Blind Phase|Protocol Violation|0
884817|NCT01271933|2916732|P1|Single-Blind Phase|Protocol Violation|3
884818|NCT01271933|2916730|P3|Single-Blind Phase|Withdrawal by Subject|0
884819|NCT01271933|2916731|P2|Single-Blind Phase|Withdrawal by Subject|0
884820|NCT01271933|2916732|P1|Single-Blind Phase|Withdrawal by Subject|15
884821|NCT01271933|2916730|P3|Single-Blind Phase|Lost to Follow-up|0
884822|NCT01271933|2916731|P2|Single-Blind Phase|Lost to Follow-up|0
884823|NCT01271933|2916732|P1|Single-Blind Phase|Lost to Follow-up|10
884824|NCT01271933|2916730|P3|Single-Blind Phase|Lack of Efficacy|0
884825|NCT01271933|2916731|P2|Single-Blind Phase|Lack of Efficacy|0
884826|NCT01271933|2916732|P1|Single-Blind Phase|Lack of Efficacy|37
884827|NCT01271803|2916873|P12|Stage 2|Ongoing in the Study|14
884828|NCT01271803|2916874|P11|Stage 2|Ongoing in the Study|6
884829|NCT01271803|2916875|P10|Stage 2|Ongoing in the Study|0
884830|NCT01271803|2916876|P9|Stage 2|Ongoing in the Study|0
884831|NCT01271803|2916877|P8|Stage 2|Ongoing in the Study|0
884832|NCT01271803|2916878|P7|Stage 2|Ongoing in the Study|0
884833|NCT01271803|2916879|P6|Stage 2|Ongoing in the Study|0
884834|NCT01271803|2916880|P5|Stage 2|Ongoing in the Study|0
884835|NCT01271803|2916881|P4|Stage 2|Ongoing in the Study|0
884836|NCT01271803|2916882|P3|Stage 2|Ongoing in the Study|0
884837|NCT01271803|2916883|P2|Stage 2|Ongoing in the Study|0
884838|NCT01271803|2916884|P1|Stage 2|Ongoing in the Study|0
884839|NCT01271803|2916873|P12|Stage 2|Other|0
884840|NCT01271803|2916874|P11|Stage 2|Other|1
884841|NCT01271803|2916875|P10|Stage 2|Other|0
884842|NCT01271803|2916876|P9|Stage 2|Other|0
884843|NCT01271803|2916877|P8|Stage 2|Other|0
884844|NCT01271803|2916878|P7|Stage 2|Other|0
884845|NCT01271803|2916879|P6|Stage 2|Other|0
884846|NCT01271803|2916880|P5|Stage 2|Other|0
884847|NCT01271803|2916881|P4|Stage 2|Other|0
884848|NCT01271803|2916882|P3|Stage 2|Other|0
884849|NCT01271803|2916883|P2|Stage 2|Other|0
884850|NCT01271803|2916884|P1|Stage 2|Other|0
884851|NCT01271803|2916873|P12|Stage 2|Physician Decision|1
884852|NCT01271803|2916874|P11|Stage 2|Physician Decision|0
884853|NCT01271803|2916875|P10|Stage 2|Physician Decision|0
884854|NCT01271803|2916876|P9|Stage 2|Physician Decision|0
884855|NCT01271803|2916877|P8|Stage 2|Physician Decision|0
884856|NCT01271803|2916878|P7|Stage 2|Physician Decision|0
884857|NCT01271803|2916879|P6|Stage 2|Physician Decision|0
884858|NCT01271803|2916880|P5|Stage 2|Physician Decision|0
884859|NCT01271803|2916881|P4|Stage 2|Physician Decision|0
884860|NCT01271803|2916882|P3|Stage 2|Physician Decision|0
884861|NCT01271803|2916883|P2|Stage 2|Physician Decision|0
884862|NCT01271803|2916884|P1|Stage 2|Physician Decision|0
884863|NCT01271803|2916873|P12|Stage 2|Withdrawal by Subject|2
884864|NCT01271803|2916874|P11|Stage 2|Withdrawal by Subject|0
884865|NCT01271803|2916875|P10|Stage 2|Withdrawal by Subject|0
884866|NCT01271803|2916876|P9|Stage 2|Withdrawal by Subject|0
884867|NCT01271803|2916877|P8|Stage 2|Withdrawal by Subject|0
884868|NCT01271803|2916878|P7|Stage 2|Withdrawal by Subject|0
884869|NCT01271803|2916879|P6|Stage 2|Withdrawal by Subject|0
884870|NCT01271803|2916880|P5|Stage 2|Withdrawal by Subject|0
884871|NCT01271803|2916881|P4|Stage 2|Withdrawal by Subject|0
884872|NCT01271803|2916882|P3|Stage 2|Withdrawal by Subject|0
884873|NCT01271803|2916883|P2|Stage 2|Withdrawal by Subject|0
884874|NCT01271803|2916884|P1|Stage 2|Withdrawal by Subject|0
884875|NCT01271803|2916873|P12|Stage 2|Death|2
884876|NCT01271803|2916874|P11|Stage 2|Death|2
884877|NCT01271803|2916875|P10|Stage 2|Death|0
884878|NCT01271803|2916876|P9|Stage 2|Death|0
884879|NCT01271803|2916877|P8|Stage 2|Death|0
884880|NCT01271803|2916878|P7|Stage 2|Death|0
884881|NCT01271803|2916879|P6|Stage 2|Death|0
884882|NCT01271803|2916880|P5|Stage 2|Death|0
884883|NCT01271803|2916881|P4|Stage 2|Death|0
884884|NCT01271803|2916882|P3|Stage 2|Death|0
884885|NCT01271803|2916883|P2|Stage 2|Death|0
884886|NCT01271803|2916884|P1|Stage 2|Death|0
884887|NCT01271803|2916873|P12|Stage 2|Adverse Event|3
884888|NCT01271803|2916874|P11|Stage 2|Adverse Event|1
884889|NCT01271803|2916875|P10|Stage 2|Adverse Event|0
884890|NCT01271803|2916876|P9|Stage 2|Adverse Event|0
884891|NCT01271803|2916877|P8|Stage 2|Adverse Event|0
884892|NCT01271803|2916878|P7|Stage 2|Adverse Event|0
884893|NCT01271803|2916879|P6|Stage 2|Adverse Event|0
884894|NCT01271803|2916880|P5|Stage 2|Adverse Event|0
884895|NCT01271803|2916881|P4|Stage 2|Adverse Event|0
884896|NCT01271803|2916882|P3|Stage 2|Adverse Event|0
884897|NCT01271803|2916883|P2|Stage 2|Adverse Event|0
884898|NCT01271803|2916884|P1|Stage 2|Adverse Event|0
884899|NCT01271803|2916873|P12|Stage 2|Progressive disease|17
884900|NCT01271803|2916874|P11|Stage 2|Progressive disease|17
884901|NCT01271803|2916875|P10|Stage 2|Progressive disease|0
884902|NCT01271803|2916876|P9|Stage 2|Progressive disease|0
884903|NCT01271803|2916877|P8|Stage 2|Progressive disease|0
884904|NCT01271803|2916878|P7|Stage 2|Progressive disease|0
884905|NCT01271803|2916879|P6|Stage 2|Progressive disease|0
884906|NCT01271803|2916880|P5|Stage 2|Progressive disease|0
884907|NCT01271803|2916881|P4|Stage 2|Progressive disease|0
884908|NCT01271803|2916882|P3|Stage 2|Progressive disease|0
884909|NCT01271803|2916883|P2|Stage 2|Progressive disease|0
884910|NCT01271803|2916884|P1|Stage 2|Progressive disease|0
884911|NCT01271803|2916873|P12|Stage 1|Ongoing in the Study|0
884912|NCT01271803|2916874|P11|Stage 1|Ongoing in the Study|0
884913|NCT01271803|2916875|P10|Stage 1|Ongoing in the Study|0
884914|NCT01271803|2916876|P9|Stage 1|Ongoing in the Study|1
884915|NCT01271803|2916877|P8|Stage 1|Ongoing in the Study|1
884916|NCT01271803|2916878|P7|Stage 1|Ongoing in the Study|1
884917|NCT01271803|2916879|P6|Stage 1|Ongoing in the Study|0
884918|NCT01271803|2916880|P5|Stage 1|Ongoing in the Study|3
884919|NCT01271803|2916881|P4|Stage 1|Ongoing in the Study|1
884920|NCT01271803|2916882|P3|Stage 1|Ongoing in the Study|11
884921|NCT01271803|2916883|P2|Stage 1|Ongoing in the Study|1
884922|NCT01271803|2916884|P1|Stage 1|Ongoing in the Study|0
884923|NCT01271803|2916873|P12|Stage 1|Other|0
884924|NCT01271803|2916874|P11|Stage 1|Other|0
884925|NCT01271803|2916875|P10|Stage 1|Other|0
884926|NCT01271803|2916876|P9|Stage 1|Other|0
884927|NCT01271803|2916877|P8|Stage 1|Other|0
884928|NCT01271803|2916878|P7|Stage 1|Other|0
884929|NCT01271803|2916879|P6|Stage 1|Other|0
884930|NCT01271803|2916880|P5|Stage 1|Other|0
884931|NCT01271803|2916881|P4|Stage 1|Other|0
884932|NCT01271803|2916882|P3|Stage 1|Other|2
884933|NCT01271803|2916883|P2|Stage 1|Other|0
884934|NCT01271803|2916884|P1|Stage 1|Other|0
884935|NCT01271803|2916873|P12|Stage 1|Withdrawal by Subject|0
884936|NCT01271803|2916874|P11|Stage 1|Withdrawal by Subject|0
884937|NCT01271803|2916875|P10|Stage 1|Withdrawal by Subject|0
884938|NCT01271803|2916876|P9|Stage 1|Withdrawal by Subject|0
884939|NCT01271803|2916877|P8|Stage 1|Withdrawal by Subject|0
884940|NCT01271803|2916878|P7|Stage 1|Withdrawal by Subject|0
884941|NCT01271803|2916879|P6|Stage 1|Withdrawal by Subject|0
884942|NCT01271803|2916880|P5|Stage 1|Withdrawal by Subject|0
884943|NCT01271803|2916881|P4|Stage 1|Withdrawal by Subject|0
884944|NCT01271803|2916882|P3|Stage 1|Withdrawal by Subject|1
884945|NCT01271803|2916883|P2|Stage 1|Withdrawal by Subject|0
884946|NCT01271803|2916884|P1|Stage 1|Withdrawal by Subject|0
884947|NCT01271803|2916873|P12|Stage 1|Physician Decision|0
884948|NCT01271803|2916874|P11|Stage 1|Physician Decision|0
884949|NCT01271803|2916875|P10|Stage 1|Physician Decision|0
884950|NCT01271803|2916876|P9|Stage 1|Physician Decision|0
884951|NCT01271803|2916877|P8|Stage 1|Physician Decision|0
884952|NCT01271803|2916878|P7|Stage 1|Physician Decision|1
884953|NCT01271803|2916879|P6|Stage 1|Physician Decision|0
884954|NCT01271803|2916880|P5|Stage 1|Physician Decision|0
884955|NCT01271803|2916881|P4|Stage 1|Physician Decision|0
884956|NCT01271803|2916882|P3|Stage 1|Physician Decision|0
884957|NCT01271803|2916883|P2|Stage 1|Physician Decision|0
884958|NCT01271803|2916884|P1|Stage 1|Physician Decision|1
884959|NCT01271803|2916873|P12|Stage 1|Death|0
884960|NCT01271803|2916874|P11|Stage 1|Death|0
884961|NCT01271803|2916875|P10|Stage 1|Death|0
884962|NCT01271803|2916876|P9|Stage 1|Death|0
884963|NCT01271803|2916877|P8|Stage 1|Death|0
884964|NCT01271803|2916878|P7|Stage 1|Death|0
884965|NCT01271803|2916879|P6|Stage 1|Death|1
884966|NCT01271803|2916880|P5|Stage 1|Death|0
884967|NCT01271803|2916881|P4|Stage 1|Death|0
884968|NCT01271803|2916882|P3|Stage 1|Death|0
884969|NCT01271803|2916883|P2|Stage 1|Death|0
884970|NCT01271803|2916884|P1|Stage 1|Death|1
884971|NCT01271803|2916873|P12|Stage 1|Adverse Event|0
884972|NCT01271803|2916874|P11|Stage 1|Adverse Event|0
884973|NCT01271803|2916875|P10|Stage 1|Adverse Event|0
884974|NCT01271803|2916876|P9|Stage 1|Adverse Event|0
884975|NCT01271803|2916877|P8|Stage 1|Adverse Event|0
884976|NCT01271803|2916878|P7|Stage 1|Adverse Event|0
884977|NCT01271803|2916879|P6|Stage 1|Adverse Event|0
884978|NCT01271803|2916880|P5|Stage 1|Adverse Event|0
884979|NCT01271803|2916881|P4|Stage 1|Adverse Event|0
884980|NCT01271803|2916882|P3|Stage 1|Adverse Event|1
884981|NCT01271803|2916883|P2|Stage 1|Adverse Event|0
884982|NCT01271803|2916884|P1|Stage 1|Adverse Event|0
884983|NCT01271803|2916873|P12|Stage 1|Progressive disease|0
884984|NCT01271803|2916874|P11|Stage 1|Progressive disease|0
884985|NCT01271803|2916875|P10|Stage 1|Progressive disease|2
884986|NCT01271803|2916876|P9|Stage 1|Progressive disease|4
884987|NCT01271803|2916877|P8|Stage 1|Progressive disease|2
884988|NCT01271803|2916878|P7|Stage 1|Progressive disease|2
884989|NCT01271803|2916879|P6|Stage 1|Progressive disease|3
884990|NCT01271803|2916880|P5|Stage 1|Progressive disease|1
884991|NCT01271803|2916881|P4|Stage 1|Progressive disease|2
884992|NCT01271803|2916882|P3|Stage 1|Progressive disease|12
884993|NCT01271803|2916883|P2|Stage 1|Progressive disease|7
884994|NCT01271803|2916884|P1|Stage 1|Progressive disease|3
884995|NCT01271712|2917057|P2|Survival Follow-up|Ongoing survival follow-up|6
884996|NCT01271712|2917058|P1|Survival Follow-up|Ongoing survival follow-up|15
884997|NCT01271712|2917057|P2|Safety Follow-up|Progressive disease|0
884998|NCT01271712|2917058|P1|Safety Follow-up|Progressive disease|1
884999|NCT01271712|2917057|P2|Safety Follow-up|No follow-up|1
885000|NCT01271712|2917058|P1|Safety Follow-up|No follow-up|1
885001|NCT01271712|2917057|P2|Safety Follow-up|Ongoing safety follow-up|4
885002|NCT01271712|2917058|P1|Safety Follow-up|Ongoing safety follow-up|3
885003|NCT01271712|2917057|P2|Safety Follow-up|Protocol Violation|1
885004|NCT01271712|2917058|P1|Safety Follow-up|Protocol Violation|1
885005|NCT01271712|2917057|P2|Safety Follow-up|Withdrawal by Subject|2
885006|NCT01271712|2917058|P1|Safety Follow-up|Withdrawal by Subject|4
885007|NCT01271712|2917057|P2|Safety Follow-up|Death|7
885008|NCT01271712|2917058|P1|Safety Follow-up|Death|11
885009|NCT01271712|2917057|P2|Open Label Treatment|Switching to other therapy|1
885010|NCT01271712|2917058|P1|Open Label Treatment|Switching to other therapy|2
885011|NCT01271712|2917057|P2|Open Label Treatment|Protocol Violation|1
885012|NCT01271712|2917058|P1|Open Label Treatment|Protocol Violation|0
885013|NCT01271712|2917057|P2|Open Label Treatment|Non-compliance with study drug|0
885014|NCT01271712|2917058|P1|Open Label Treatment|Non-compliance with study drug|1
885015|NCT01271712|2917057|P2|Open Label Treatment|Ongoing with open-label treatment|1
885016|NCT01271712|2917058|P1|Open Label Treatment|Ongoing with open-label treatment|6
885017|NCT01271712|2917057|P2|Open Label Treatment|Progressive disease|31
885018|NCT01271712|2917058|P1|Open Label Treatment|Progressive disease|56
885019|NCT01271712|2917057|P2|Open Label Treatment|Adverse Event|8
885020|NCT01271712|2917058|P1|Open Label Treatment|Adverse Event|12
885021|NCT01271712|2917057|P2|Open Label Treatment|Physician Decision|0
885022|NCT01271712|2917058|P1|Open Label Treatment|Physician Decision|2
885023|NCT01271712|2917057|P2|Open Label Treatment|Withdrawal by Subject|11
885024|NCT01271712|2917058|P1|Open Label Treatment|Withdrawal by Subject|6
885025|NCT01271712|2917057|P2|Open Label Treatment|Death|5
885026|NCT01271712|2917058|P1|Open Label Treatment|Death|6
885027|NCT01271712|2917057|P2|Double Blind Treatment|receive no study drug|0
885028|NCT01271712|2917058|P1|Double Blind Treatment|receive no study drug|1
885029|NCT01271712|2917057|P2|Double Blind Treatment|Non compliance with study drug|0
885030|NCT01271712|2917058|P1|Double Blind Treatment|Non compliance with study drug|2
885031|NCT01271712|2917057|P2|Double Blind Treatment|Withdrawal by Subject|1
885032|NCT01271712|2917058|P1|Double Blind Treatment|Withdrawal by Subject|4
885033|NCT01271712|2917057|P2|Double Blind Treatment|Progressive disease|3
885034|NCT01271712|2917058|P1|Double Blind Treatment|Progressive disease|23
885035|NCT01271712|2917057|P2|Double Blind Treatment|Adverse Event|4
885036|NCT01271712|2917058|P1|Double Blind Treatment|Adverse Event|9
885037|NCT01271712|2917057|P2|Double Blind Treatment|Lack of Efficacy|0
885038|NCT01271712|2917058|P1|Double Blind Treatment|Lack of Efficacy|1
885039|NCT01271712|2917057|P2|Double Blind Treatment|Death|0
885040|NCT01271712|2917058|P1|Double Blind Treatment|Death|2
885041|NCT01271010|2917152|P1|Overall Study|Disease progression|27
885042|NCT01271010|2917152|P1|Overall Study|Withdrawal by Subject|18
885043|NCT01271010|2917152|P1|Overall Study|Progression and relapse of disease|1
885044|NCT01271010|2917152|P1|Overall Study|Death|2
885045|NCT01271010|2917152|P1|Overall Study|Protocol Violation|1
885046|NCT01271010|2917152|P1|Overall Study|Start of new CLL therapy|1
885047|NCT01271010|2917152|P1|Overall Study|Reason not specified|11
885048|NCT01270971|2917167|P2|Overall Study|Non-specific|3
885049|NCT01270971|2917168|P1|Overall Study|Non-specific|7
885050|NCT01270971|2917167|P2|Overall Study|Non compliance|2
885051|NCT01270971|2917168|P1|Overall Study|Non compliance|2
885052|NCT01270971|2917167|P2|Overall Study|Adverse Event|2
885053|NCT01270971|2917168|P1|Overall Study|Adverse Event|1
885054|NCT01270971|2917167|P2|Overall Study|Lost to Follow-up|5
885055|NCT01270971|2917168|P1|Overall Study|Lost to Follow-up|18
885056|NCT01270971|2917167|P2|Overall Study|Withdrawal by Subject|11
885057|NCT01270971|2917168|P1|Overall Study|Withdrawal by Subject|24
885058|NCT01270958|2917180|P1|Overall Study|Did not meet inclusion criteria for age|2
885059|NCT01270958|2917180|P1|Overall Study|Lost to Follow-up|2
885060|NCT01270880|2917209|P1|Overall Study|Never rec'd treatment, but registered.|1
885061|NCT01270841|2917239|P4|Overall Study|Enrolled in error|0
885062|NCT01270841|2917240|P3|Overall Study|Enrolled in error|0
885063|NCT01270841|2917241|P2|Overall Study|Enrolled in error|1
885064|NCT01270841|2917242|P1|Overall Study|Enrolled in error|0
885065|NCT01270841|2917239|P4|Overall Study|Protocol Violation|0
885066|NCT01270841|2917240|P3|Overall Study|Protocol Violation|0
885067|NCT01270841|2917241|P2|Overall Study|Protocol Violation|5
885068|NCT01270841|2917242|P1|Overall Study|Protocol Violation|1
885069|NCT01270841|2917239|P4|Overall Study|Did not qualify|5
885070|NCT01270841|2917240|P3|Overall Study|Did not qualify|4
885071|NCT01270841|2917241|P2|Overall Study|Did not qualify|3
885072|NCT01270841|2917242|P1|Overall Study|Did not qualify|6
885073|NCT01270841|2917239|P4|Overall Study|Physician Decision|0
885074|NCT01270841|2917240|P3|Overall Study|Physician Decision|0
885075|NCT01270841|2917241|P2|Overall Study|Physician Decision|1
885076|NCT01270841|2917242|P1|Overall Study|Physician Decision|0
885077|NCT01270841|2917239|P4|Overall Study|Lost to Follow-up|2
885078|NCT01270841|2917240|P3|Overall Study|Lost to Follow-up|4
885079|NCT01270841|2917241|P2|Overall Study|Lost to Follow-up|1
885080|NCT01270841|2917242|P1|Overall Study|Lost to Follow-up|3
885081|NCT01270841|2917239|P4|Overall Study|Withdrawal by Subject|3
885082|NCT01270841|2917240|P3|Overall Study|Withdrawal by Subject|3
885083|NCT01270841|2917241|P2|Overall Study|Withdrawal by Subject|2
885084|NCT01270841|2917242|P1|Overall Study|Withdrawal by Subject|3
885085|NCT01270841|2917239|P4|Overall Study|Adverse Event|3
885086|NCT01270841|2917240|P3|Overall Study|Adverse Event|0
885087|NCT01270841|2917241|P2|Overall Study|Adverse Event|1
885088|NCT01270841|2917242|P1|Overall Study|Adverse Event|0
885089|NCT01270828|2917266|P3|Double Blind Phase|Adverse event related to study drug|0
885090|NCT01270828|2917267|P2|Double Blind Phase|Adverse event related to study drug|7
885091|NCT01270828|2917268|P1|Double Blind Phase|Adverse event related to study drug|5
885092|NCT01270828|2917266|P3|Double Blind Phase|Adverse event not related to study drug|0
885093|NCT01270828|2917267|P2|Double Blind Phase|Adverse event not related to study drug|1
885094|NCT01270828|2917268|P1|Double Blind Phase|Adverse event not related to study drug|1
885095|NCT01270828|2917266|P3|Double Blind Phase|Lack of Efficacy|0
885096|NCT01270828|2917267|P2|Double Blind Phase|Lack of Efficacy|11
885097|NCT01270828|2917268|P1|Double Blind Phase|Lack of Efficacy|2
885098|NCT01270828|2917266|P3|Double Blind Phase|Lost to Follow-up|0
885099|NCT01270828|2917267|P2|Double Blind Phase|Lost to Follow-up|2
885100|NCT01270828|2917268|P1|Double Blind Phase|Lost to Follow-up|1
885101|NCT01270828|2917266|P3|Double Blind Phase|Withdrawal by Subject|0
885102|NCT01270828|2917267|P2|Double Blind Phase|Withdrawal by Subject|15
885103|NCT01270828|2917268|P1|Double Blind Phase|Withdrawal by Subject|6
885104|NCT01270828|2917266|P3|Double Blind Phase|Reason Unspecified|0
885105|NCT01270828|2917267|P2|Double Blind Phase|Reason Unspecified|4
885106|NCT01270828|2917268|P1|Double Blind Phase|Reason Unspecified|7
885107|NCT01270828|2917266|P3|Double Blind Phase|Protocol and GCP non-compliance|0
885108|NCT01270828|2917267|P2|Double Blind Phase|Protocol and GCP non-compliance|3
885109|NCT01270828|2917268|P1|Double Blind Phase|Protocol and GCP non-compliance|4
885110|NCT01270828|2917266|P3|Double Blind Phase|Protocol Violation|0
885111|NCT01270828|2917267|P2|Double Blind Phase|Protocol Violation|1
885112|NCT01270828|2917268|P1|Double Blind Phase|Protocol Violation|0
885113|NCT01270828|2917266|P3|Double Blind Phase|Death|0
885114|NCT01270828|2917267|P2|Double Blind Phase|Death|1
885115|NCT01270828|2917268|P1|Double Blind Phase|Death|0
885116|NCT01270828|2917266|P3|Pregabalin CR SB|Protocol Violation|8
885117|NCT01270828|2917267|P2|Pregabalin CR SB|Protocol Violation|0
885118|NCT01270828|2917268|P1|Pregabalin CR SB|Protocol Violation|0
885119|NCT01270828|2917266|P3|Pregabalin CR SB|Unrelated AE|8
885120|NCT01270828|2917267|P2|Pregabalin CR SB|Unrelated AE|0
885121|NCT01270828|2917268|P1|Pregabalin CR SB|Unrelated AE|0
885122|NCT01270828|2917266|P3|Pregabalin CR SB|Lost to Follow-up|10
885123|NCT01270828|2917267|P2|Pregabalin CR SB|Lost to Follow-up|0
885124|NCT01270828|2917268|P1|Pregabalin CR SB|Lost to Follow-up|0
885125|NCT01270828|2917266|P3|Pregabalin CR SB|Withdrawal by Subject|29
885126|NCT01270828|2917267|P2|Pregabalin CR SB|Withdrawal by Subject|0
885127|NCT01270828|2917268|P1|Pregabalin CR SB|Withdrawal by Subject|0
885128|NCT01270828|2917266|P3|Pregabalin CR SB|Lack of Efficacy|32
885129|NCT01270828|2917267|P2|Pregabalin CR SB|Lack of Efficacy|0
885130|NCT01270828|2917268|P1|Pregabalin CR SB|Lack of Efficacy|0
885131|NCT01270828|2917266|P3|Pregabalin CR SB|Related adverse event|46
885132|NCT01270828|2917267|P2|Pregabalin CR SB|Related adverse event|0
885133|NCT01270828|2917268|P1|Pregabalin CR SB|Related adverse event|0
885134|NCT01270828|2917266|P3|Pregabalin CR SB|Enrolled but not treated|5
885135|NCT01270828|2917267|P2|Pregabalin CR SB|Enrolled but not treated|0
885136|NCT01270828|2917268|P1|Pregabalin CR SB|Enrolled but not treated|0
885137|NCT01270828|2917266|P3|Pregabalin CR SB|Reason Unspecified|8
885138|NCT01270828|2917267|P2|Pregabalin CR SB|Reason Unspecified|0
885139|NCT01270828|2917268|P1|Pregabalin CR SB|Reason Unspecified|0
885140|NCT01270802|2917310|P2|Overall Study|Lost to Follow-up|1
885141|NCT01270802|2917311|P1|Overall Study|Lost to Follow-up|0
885142|NCT01270802|2917310|P2|Overall Study|Adverse Event|0
885143|NCT01270802|2917311|P1|Overall Study|Adverse Event|1
885144|NCT01270802|2917310|P2|Overall Study|Withdrawal by Subject|0
885145|NCT01270802|2917311|P1|Overall Study|Withdrawal by Subject|1
885146|NCT01270620|2917458|P2|Overall Study|Withdrawal by Subject|3
885147|NCT01270620|2917459|P1|Overall Study|Withdrawal by Subject|1
885148|NCT01270503|2917554|P1|Overall Study|Lost to Follow-up|1
885149|NCT01270464|2917562|P3|Overall Study|Not Specified|3
885150|NCT01270464|2917563|P2|Overall Study|Not Specified|1
885151|NCT01270464|2917564|P1|Overall Study|Not Specified|1
885152|NCT01270464|2917562|P3|Overall Study|Lost to Follow-up|1
885153|NCT01270464|2917563|P2|Overall Study|Lost to Follow-up|3
885154|NCT01270464|2917564|P1|Overall Study|Lost to Follow-up|2
885155|NCT01270464|2917562|P3|Overall Study|Withdrawal by Subject|4
885156|NCT01270464|2917563|P2|Overall Study|Withdrawal by Subject|1
885157|NCT01270464|2917564|P1|Overall Study|Withdrawal by Subject|2
885158|NCT01270464|2917562|P3|Overall Study|Adverse Event|7
885159|NCT01270464|2917563|P2|Overall Study|Adverse Event|1
885160|NCT01270464|2917564|P1|Overall Study|Adverse Event|9
885161|NCT01270464|2917562|P3|Overall Study|Lack of Efficacy|1
885162|NCT01270464|2917563|P2|Overall Study|Lack of Efficacy|3
885163|NCT01270464|2917564|P1|Overall Study|Lack of Efficacy|2
885164|NCT01270464|2917562|P3|Overall Study|Protocol Violation|2
885165|NCT01270464|2917563|P2|Overall Study|Protocol Violation|3
885166|NCT01270464|2917564|P1|Overall Study|Protocol Violation|4
885167|NCT01270256|2917613|P2|Overall Study|Withdrawal by Subject|0
885168|NCT01270256|2917614|P1|Overall Study|Withdrawal by Subject|1
885169|NCT01270139|2917623|P3|Overall Study|Lost to Follow-up|2
885170|NCT01270139|2917624|P2|Overall Study|Lost to Follow-up|9
885171|NCT01270139|2917625|P1|Overall Study|Lost to Follow-up|10
885172|NCT01270139|2917623|P3|Overall Study|Adverse Event|18
885173|NCT01270139|2917624|P2|Overall Study|Adverse Event|17
885174|NCT01270139|2917625|P1|Overall Study|Adverse Event|8
885175|NCT01269918|2917694|P2|Overall Study|Did not receive study drug|3
885176|NCT01269918|2917695|P1|Overall Study|Did not receive study drug|0
885177|NCT01269346|2917770|P1|Extension Phase|Started a prohibited con med|1
885178|NCT01269346|2917770|P1|Extension Phase|Clinical progression|1
885179|NCT01269346|2917770|P1|Extension Phase|Physician decision or participant choice|9
885180|NCT01269346|2917770|P1|Extension Phase|Disease progression|22
885181|NCT01269346|2917770|P1|Extension Phase|Withdrawal by Subject|4
885182|NCT01269346|2917770|P1|Extension Phase|Adverse Event|6
885183|NCT01269346|2917770|P1|Treatment Phase|Not specified|2
885184|NCT01269346|2917770|P1|Treatment Phase|Withdrawal by Subject|1
885185|NCT01269346|2917770|P1|Treatment Phase|Adverse Event|3
885186|NCT01269346|2917770|P1|Treatment Phase|Disease progression|3
885187|NCT01269125|2917781|P3|Overall Study|Lost to Follow-up|0
885188|NCT01269125|2917782|P2|Overall Study|Lost to Follow-up|0
885189|NCT01269125|2917783|P1|Overall Study|Lost to Follow-up|4
885190|NCT01269125|2917781|P3|Overall Study|Adverse Event|0
885191|NCT01269125|2917782|P2|Overall Study|Adverse Event|5
885192|NCT01269125|2917783|P1|Overall Study|Adverse Event|3
885193|NCT01268891|2917842|P2|Overall Study|Administrative or other reason(s)|0
885194|NCT01268891|2917843|P1|Overall Study|Administrative or other reason(s)|1
885195|NCT01268891|2917842|P2|Overall Study|Withdrawal of Consent|1
885196|NCT01268891|2917843|P1|Overall Study|Withdrawal of Consent|3
885197|NCT01268891|2917842|P2|Overall Study|Lack of Efficacy|0
885198|NCT01268891|2917843|P1|Overall Study|Lack of Efficacy|1
885199|NCT01268891|2917842|P2|Overall Study|Adverse Event|7
885200|NCT01268891|2917843|P1|Overall Study|Adverse Event|3
885201|NCT01268566|2917862|P1|Overall Study|Death|30
885202|NCT01268566|2917862|P1|Overall Study|Withdrawal by Subject|12
885203|NCT01268566|2917862|P1|Overall Study|Lost to Follow-up|1
885204|NCT01268501|2917889|P1|Overall Study|Handling Difficulties|2
885205|NCT01268501|2917889|P1|Overall Study|Unacceptable Subjective Vision|3
885206|NCT01268501|2917889|P1|Overall Study|Withdrawal by Subject|3
885207|NCT01268501|2917889|P1|Overall Study|Lost to Follow-up|1
885208|NCT01268488|2917893|P1|Overall Study|Physician Decision|2
885209|NCT01268488|2917893|P1|Overall Study|Adverse Event|3
885210|NCT01268306|2917900|P1|Overall Study|Lost to Follow-up|1
885211|NCT01268293|2917904|P1|Overall Study|Subject choice|1
885212|NCT01268293|2917904|P1|Overall Study|Adverse Event|1
885213|NCT01268293|2917904|P1|Overall Study|Disease progression|7
885214|NCT01268267|2917909|P1|Overall Study|Protocol Violation|1
885215|NCT01268150|2917930|P1|Extension Phase|Not specified|6
885216|NCT01268150|2917930|P1|Extension Phase|Disease progression|18
885217|NCT01268150|2917930|P1|Extension Phase|Adverse Event|3
885218|NCT01268150|2917930|P1|Treatment Phase|Not specified|4
885219|NCT01268150|2917930|P1|Treatment Phase|Withdrawal by Subject|3
885220|NCT01268150|2917930|P1|Treatment Phase|Adverse Event|3
885221|NCT01268150|2917930|P1|Treatment Phase|Progression of disease|18
885222|NCT01268098|2917949|P2|Overall Study|Adverse Event|0
885223|NCT01268098|2917950|P1|Overall Study|Adverse Event|1
885224|NCT01268046|2917962|P4|Overall Study|Lost to Follow-up|0
885225|NCT01268046|2917963|P3|Overall Study|Lost to Follow-up|1
885226|NCT01268046|2917964|P2|Overall Study|Lost to Follow-up|0
885227|NCT01268046|2917965|P1|Overall Study|Lost to Follow-up|0
885228|NCT01268046|2917962|P4|Overall Study|Withdrawal by Subject|1
885229|NCT01268046|2917963|P3|Overall Study|Withdrawal by Subject|0
885230|NCT01268046|2917964|P2|Overall Study|Withdrawal by Subject|0
885231|NCT01268046|2917965|P1|Overall Study|Withdrawal by Subject|1
885232|NCT01267994|2917975|P1|Overall Study|Adverse Event|2
885233|NCT01267825|2918013|P2|Overall Study|study terminated. no data collected.|0
885234|NCT01267825|2918014|P1|Overall Study|study terminated. no data collected.|1
885235|NCT01267266|2918080|P2|Lead-in Phase|Withdrawal by Subject|0
885236|NCT01267266|2918081|P1|Lead-in Phase|Withdrawal by Subject|1
885237|NCT01267266|2918080|P2|Lead-in Phase|Adverse Event|0
885238|NCT01267266|2918081|P1|Lead-in Phase|Adverse Event|2
885239|NCT01267266|2918080|P2|Lead-in Phase|Lack of Efficacy|0
885240|NCT01267266|2918081|P1|Lead-in Phase|Lack of Efficacy|20
885241|NCT01267266|2918080|P2|Enrollment Phase|Withdrawal by Subject|0
885242|NCT01267266|2918081|P1|Enrollment Phase|Withdrawal by Subject|2
885243|NCT01267253|2918094|P1|Overall Study|Inevaluable-never received study treatme|2
885244|NCT01267253|2918094|P1|Overall Study|Ineligible - required test not done|1
885245|NCT01267201|2918133|P6|Second Intervention Period|Withdrawal by Subject|0
885246|NCT01267201|2918134|P5|Second Intervention Period|Withdrawal by Subject|0
885247|NCT01267201|2918135|P4|Second Intervention Period|Withdrawal by Subject|0
885248|NCT01267201|2918136|P3|Second Intervention Period|Withdrawal by Subject|0
885249|NCT01267201|2918137|P2|Second Intervention Period|Withdrawal by Subject|1
885250|NCT01267201|2918138|P1|Second Intervention Period|Withdrawal by Subject|0
885251|NCT01267201|2918133|P6|First Intervention Period|Withdrawal by Subject|0
885252|NCT01267201|2918134|P5|First Intervention Period|Withdrawal by Subject|0
885253|NCT01267201|2918135|P4|First Intervention Period|Withdrawal by Subject|0
885254|NCT01267201|2918136|P3|First Intervention Period|Withdrawal by Subject|0
885255|NCT01267201|2918137|P2|First Intervention Period|Withdrawal by Subject|0
885256|NCT01267201|2918138|P1|First Intervention Period|Withdrawal by Subject|1
885257|NCT01267175|2918155|P1|Overall Study|Lost to Follow-up|1
885258|NCT01267175|2918155|P1|Overall Study|Withdrawal by Subject|1
885259|NCT01266967|2918227|P2|Overall Study|Withdrawal by Subject|3
885260|NCT01266967|2918228|P1|Overall Study|Withdrawal by Subject|3
885261|NCT01266967|2918227|P2|Overall Study|Physician Decision|1
885262|NCT01266967|2918228|P1|Overall Study|Physician Decision|0
885263|NCT01266967|2918227|P2|Overall Study|Lost to Follow-up|1
885264|NCT01266967|2918228|P1|Overall Study|Lost to Follow-up|2
885265|NCT01266967|2918227|P2|Overall Study|Study Closed/Terminated|17
885266|NCT01266967|2918228|P1|Overall Study|Study Closed/Terminated|15
885267|NCT01266967|2918227|P2|Overall Study|Death|61
885268|NCT01266967|2918228|P1|Overall Study|Death|69
885269|NCT01266876|2918280|P5|Overall Study|Adverse Event|0
885270|NCT01266876|2918281|P4|Overall Study|Adverse Event|1
885271|NCT01266876|2918282|P3|Overall Study|Adverse Event|0
885272|NCT01266876|2918283|P2|Overall Study|Adverse Event|0
885273|NCT01266876|2918284|P1|Overall Study|Adverse Event|0
885274|NCT01266850|2918391|P5|Overall Study|Site Closure|0
885275|NCT01266850|2918392|P4|Overall Study|Site Closure|1
885276|NCT01266850|2918393|P3|Overall Study|Site Closure|1
885277|NCT01266850|2918394|P2|Overall Study|Site Closure|1
885278|NCT01266850|2918395|P1|Overall Study|Site Closure|0
885279|NCT01266850|2918391|P5|Overall Study|Adverse Event|1
885280|NCT01266850|2918392|P4|Overall Study|Adverse Event|0
885281|NCT01266850|2918393|P3|Overall Study|Adverse Event|0
885282|NCT01266850|2918394|P2|Overall Study|Adverse Event|0
885283|NCT01266850|2918395|P1|Overall Study|Adverse Event|0
885284|NCT01266850|2918391|P5|Overall Study|Protocol Violation|2
885285|NCT01266850|2918392|P4|Overall Study|Protocol Violation|1
885286|NCT01266850|2918393|P3|Overall Study|Protocol Violation|0
885287|NCT01266850|2918394|P2|Overall Study|Protocol Violation|1
885288|NCT01266850|2918395|P1|Overall Study|Protocol Violation|0
885289|NCT01266850|2918391|P5|Overall Study|Physician Decision|3
885290|NCT01266850|2918392|P4|Overall Study|Physician Decision|4
885291|NCT01266850|2918393|P3|Overall Study|Physician Decision|4
885292|NCT01266850|2918394|P2|Overall Study|Physician Decision|6
885293|NCT01266850|2918395|P1|Overall Study|Physician Decision|3
885294|NCT01266850|2918391|P5|Overall Study|Withdrawal by Subject|12
885295|NCT01266850|2918392|P4|Overall Study|Withdrawal by Subject|9
885296|NCT01266850|2918393|P3|Overall Study|Withdrawal by Subject|6
885297|NCT01266850|2918394|P2|Overall Study|Withdrawal by Subject|9
885298|NCT01266850|2918395|P1|Overall Study|Withdrawal by Subject|8
885299|NCT01266850|2918391|P5|Overall Study|Lost to Follow-up|12
885300|NCT01266850|2918392|P4|Overall Study|Lost to Follow-up|13
885301|NCT01266850|2918393|P3|Overall Study|Lost to Follow-up|13
885302|NCT01266850|2918394|P2|Overall Study|Lost to Follow-up|19
885303|NCT01266850|2918395|P1|Overall Study|Lost to Follow-up|19
885304|NCT01266824|2918449|P2|Overall Study|Study terminated prior to completion|3
885305|NCT01266824|2918450|P1|Overall Study|Study terminated prior to completion|2
885306|NCT01266590|2918462|P1|Overall Study|Physician Decision|1
885307|NCT01266590|2918462|P1|Overall Study|Withdrawal by Subject|1
885308|NCT01266590|2918462|P1|Overall Study|Lost to Follow-up|1
885309|NCT01266590|2918462|P1|Overall Study|Adverse Event|3
885310|NCT01266317|2918482|P1|Overall Study|Withdrawal by Subject|2
885311|NCT01266291|2918487|P1|Overall Study|Adverse Event|1
885312|NCT01266265|2918494|P2|Overall Study|Clinical worsening|1
885313|NCT01266265|2918495|P1|Overall Study|Clinical worsening|1
885314|NCT01266265|2918494|P2|Overall Study|Site closed early|3
885315|NCT01266265|2918495|P1|Overall Study|Site closed early|4
885316|NCT01266265|2918494|P2|Overall Study|Lung transplant|5
885317|NCT01266265|2918495|P1|Overall Study|Lung transplant|6
885318|NCT01266265|2918494|P2|Overall Study|Non-compliance|5
885319|NCT01266265|2918495|P1|Overall Study|Non-compliance|8
885320|NCT01266265|2918494|P2|Overall Study|Enrolled in another clinical study|26
885321|NCT01266265|2918495|P1|Overall Study|Enrolled in another clinical study|15
885322|NCT01266265|2918494|P2|Overall Study|Stopped/changed PAH medication(s)|9
885323|NCT01266265|2918495|P1|Overall Study|Stopped/changed PAH medication(s)|16
885324|NCT01266265|2918494|P2|Overall Study|Transferred care to another provider|28
885325|NCT01266265|2918495|P1|Overall Study|Transferred care to another provider|22
885326|NCT01266265|2918494|P2|Overall Study|Respiratory-related adverse event|1
885327|NCT01266265|2918495|P1|Overall Study|Respiratory-related adverse event|2
885328|NCT01266265|2918494|P2|Overall Study|Withdrawal by Subject|11
885329|NCT01266265|2918495|P1|Overall Study|Withdrawal by Subject|13
885330|NCT01266265|2918494|P2|Overall Study|Lost to Follow-up|28
885331|NCT01266265|2918495|P1|Overall Study|Lost to Follow-up|23
885332|NCT01266265|2918494|P2|Overall Study|Death|73
885333|NCT01266265|2918495|P1|Overall Study|Death|95
885334|NCT01266161|2918503|P2|Overall Study|Vomited within 4 hours of dosing|0
885335|NCT01266161|2918504|P1|Overall Study|Vomited within 4 hours of dosing|3
885336|NCT01266161|2918503|P2|Overall Study|Lack of Efficacy|1
885337|NCT01266161|2918504|P1|Overall Study|Lack of Efficacy|0
885338|NCT01266161|2918503|P2|Overall Study|Ineligible|0
885339|NCT01266161|2918504|P1|Overall Study|Ineligible|1
885340|NCT01266148|2918536|P2|Overall Study|missing mGFR value + AE|0
885341|NCT01266148|2918537|P1|Overall Study|missing mGFR value + AE|1
885342|NCT01266148|2918536|P2|Overall Study|Death|3
885343|NCT01266148|2918537|P1|Overall Study|Death|2
885344|NCT01266148|2918536|P2|Overall Study|2 2R rejections|0
885345|NCT01266148|2918537|P1|Overall Study|2 2R rejections|1
885346|NCT01266148|2918536|P2|Overall Study|Ongoing rejection|0
885347|NCT01266148|2918537|P1|Overall Study|Ongoing rejection|1
885348|NCT01266148|2918536|P2|Overall Study|Adverse Event|0
885349|NCT01266148|2918537|P1|Overall Study|Adverse Event|2
885350|NCT01266122|2918565|P2|Overall Study|Lost to Follow-up|6
885351|NCT01266122|2918566|P1|Overall Study|Lost to Follow-up|6
885352|NCT01266070|2918574|P1|Overall Study|Protocol Violation|1
885353|NCT01266070|2918574|P1|Overall Study|Adverse Event|3
885354|NCT01266031|2918582|P3|Overall Study|Not treated|2
885355|NCT01266031|2918583|P2|Overall Study|Not treated|3
885356|NCT01266031|2918584|P1|Overall Study|Not treated|0
885357|NCT01266018|2918611|P2|Overall Study|Progressive disease|1
885358|NCT01266018|2918612|P1|Overall Study|Progressive disease|0
885359|NCT01266018|2918611|P2|Overall Study|Physician Decision|0
885360|NCT01266018|2918612|P1|Overall Study|Physician Decision|1
885361|NCT01265992|2918623|P1|Overall Study|Did not receive treatment|1
885362|NCT01265992|2918623|P1|Overall Study|Stopped treatment|3
885363|NCT01265992|2918623|P1|Overall Study|Administrative reasons|2
885364|NCT01265992|2918623|P1|Overall Study|Adverse Event|1
885365|NCT01265992|2918623|P1|Overall Study|Withdrawal by Subject|1
885366|NCT01265992|2918623|P1|Overall Study|Lost to Follow-up|1
885367|NCT01265953|2918651|P2|Overall Study|Non compliance|3
885368|NCT01265953|2918652|P1|Overall Study|Non compliance|5
885369|NCT01265875|2918664|P1|Overall Study|Uncooperative/unreliable|1
885370|NCT01265823|2918672|P1|Overall Study|Participant Request|1
885371|NCT01265823|2918672|P1|Overall Study|Protocol Violation|1
885372|NCT01265823|2918672|P1|Overall Study|Failure to Return|4
885373|NCT01265823|2918672|P1|Overall Study|Unsatisfactory Response Efficacy|1
885374|NCT01265797|2918701|P2|Open Label Month|Lost to Follow-up|1
885375|NCT01265797|2918702|P1|Open Label Month|Lost to Follow-up|0
885376|NCT01265797|2918701|P2|Blinded Month|Diary data incomplete|1
885377|NCT01265797|2918702|P1|Blinded Month|Diary data incomplete|0
885378|NCT01265797|2918701|P2|Blinded Month|Adverse Event|0
885379|NCT01265797|2918702|P1|Blinded Month|Adverse Event|2
885380|NCT01265797|2918701|P2|Blinded Month|Protocol Violation|1
885381|NCT01265797|2918702|P1|Blinded Month|Protocol Violation|2
885382|NCT01265797|2918701|P2|Blinded Month|Lost to Follow-up|0
885383|NCT01265797|2918702|P1|Blinded Month|Lost to Follow-up|1
885384|NCT01265797|2918701|P2|Blinded Month|Lack of Efficacy|0
885385|NCT01265797|2918702|P1|Blinded Month|Lack of Efficacy|5
885386|NCT01265797|2918701|P2|Run-in Month|1st seizure during run-in month|1
885387|NCT01265797|2918702|P1|Run-in Month|1st seizure during run-in month|0
885388|NCT01265797|2918701|P2|Run-in Month|Withdrawal by Subject|4
885389|NCT01265797|2918702|P1|Run-in Month|Withdrawal by Subject|0
885390|NCT01265784|2918733|P3|Overall Study|Incorrectly Randomized|1
885391|NCT01265784|2918734|P2|Overall Study|Incorrectly Randomized|0
885392|NCT01265784|2918735|P1|Overall Study|Incorrectly Randomized|0
885393|NCT01265784|2918733|P3|Overall Study|Protocol Violation|0
885394|NCT01265784|2918734|P2|Overall Study|Protocol Violation|0
885395|NCT01265784|2918735|P1|Overall Study|Protocol Violation|2
885396|NCT01265784|2918733|P3|Overall Study|Death|0
885397|NCT01265784|2918734|P2|Overall Study|Death|0
885398|NCT01265784|2918735|P1|Overall Study|Death|3
885399|NCT01265784|2918733|P3|Overall Study|Adverse Event|0
885400|NCT01265784|2918734|P2|Overall Study|Adverse Event|0
885401|NCT01265784|2918735|P1|Overall Study|Adverse Event|1
885402|NCT01265784|2918733|P3|Overall Study|Physician Decision|1
885403|NCT01265784|2918734|P2|Overall Study|Physician Decision|0
885404|NCT01265784|2918735|P1|Overall Study|Physician Decision|1
885405|NCT01265784|2918733|P3|Overall Study|Withdrawal by Subject|0
885406|NCT01265784|2918734|P2|Overall Study|Withdrawal by Subject|5
885407|NCT01265784|2918735|P1|Overall Study|Withdrawal by Subject|0
885408|NCT01265784|2918733|P3|Overall Study|Lost to Follow-up|2
885409|NCT01265784|2918734|P2|Overall Study|Lost to Follow-up|3
885410|NCT01265784|2918735|P1|Overall Study|Lost to Follow-up|5
885411|NCT01265719|2918803|P2|Overall Study|Adverse Event|0
885412|NCT01265719|2918804|P1|Overall Study|Adverse Event|2
885413|NCT01265719|2918803|P2|Overall Study|Lost to Follow-up|7
885414|NCT01265719|2918804|P1|Overall Study|Lost to Follow-up|2
885415|NCT01265719|2918803|P2|Overall Study|Withdrawal by Subject|3
885416|NCT01265719|2918804|P1|Overall Study|Withdrawal by Subject|8
885417|NCT01265719|2918803|P2|Overall Study|Other reasons|0
885418|NCT01265719|2918804|P1|Overall Study|Other reasons|2
885419|NCT01265719|2918803|P2|Overall Study|Does not meet entrance criteria|3
885420|NCT01265719|2918804|P1|Overall Study|Does not meet entrance criteria|0
885421|NCT01265615|2918855|P4|Overall Study|Protocol Violation|3
885422|NCT01265615|2918856|P3|Overall Study|Protocol Violation|4
885423|NCT01265615|2918857|P2|Overall Study|Protocol Violation|2
885424|NCT01265615|2918858|P1|Overall Study|Protocol Violation|2
885425|NCT01265563|2918909|P5|Overall Study|Withdrawal by Subject|2
885426|NCT01265563|2918910|P4|Overall Study|Withdrawal by Subject|0
885427|NCT01265563|2918911|P3|Overall Study|Withdrawal by Subject|1
885428|NCT01265563|2918912|P2|Overall Study|Withdrawal by Subject|1
885429|NCT01265563|2918913|P1|Overall Study|Withdrawal by Subject|0
885430|NCT01265511|2919013|P2|Overall Study|Met stopping rules|2
885431|NCT01265511|2919014|P1|Overall Study|Met stopping rules|0
885432|NCT01265511|2919013|P2|Overall Study|Lack of Efficacy|1
885433|NCT01265511|2919014|P1|Overall Study|Lack of Efficacy|2
885434|NCT01265498|2919028|P2|Overall Study|Protocol modified to eliminate wk72 bx|33
885435|NCT01265498|2919029|P1|Overall Study|Protocol modified to eliminate wk72 bx|31
885436|NCT01265420|2919165|P1|Overall Study|Lost to Follow-up|1
885437|NCT01265394|2919169|P1|Overall Study|Subjects withdrawn|37
885438|NCT01265056|2919176|P2|Follow up|Lost to Follow-up|3
885439|NCT01265056|2919177|P1|Follow up|Lost to Follow-up|7
885440|NCT01265056|2919176|P2|Initial Study Period|Withdrawal by Subject|1
885441|NCT01265056|2919177|P1|Initial Study Period|Withdrawal by Subject|1
885442|NCT01265056|2919176|P2|Initial Study Period|Withdrawal by Subject|1
885443|NCT01265056|2919177|P1|Initial Study Period|Withdrawal by Subject|1
885444|NCT01264939|2919208|P2|Overall Study|Disease Progression|11
885445|NCT01264939|2919209|P1|Overall Study|Disease Progression|8
885446|NCT01264939|2919208|P2|Overall Study|Patient/Guardian Decision|10
885447|NCT01264939|2919209|P1|Overall Study|Patient/Guardian Decision|8
885448|NCT01264939|2919208|P2|Overall Study|Physician Decision|1
885449|NCT01264939|2919209|P1|Overall Study|Physician Decision|1
885450|NCT01264939|2919208|P2|Overall Study|Lost to Follow-up|3
885451|NCT01264939|2919209|P1|Overall Study|Lost to Follow-up|0
885452|NCT01264939|2919208|P2|Overall Study|Adverse Event|3
885453|NCT01264939|2919209|P1|Overall Study|Adverse Event|1
885454|NCT01264887|2919235|P1|Overall Study|Not Specified|2
885455|NCT01264887|2919235|P1|Overall Study|Sponsor Decision Administrative Reasons|2
885456|NCT01264887|2919235|P1|Overall Study|Withdrawal by Subject|6
885457|NCT01264887|2919235|P1|Overall Study|Physician Decision|4
885458|NCT01264887|2919235|P1|Overall Study|Lack of Efficacy|5
885459|NCT01264887|2919235|P1|Overall Study|Death|7
885460|NCT01264887|2919235|P1|Overall Study|Adverse Event|5
885461|NCT01264835|2919246|P1|Overall Study|Lost to Follow-up|1
885462|NCT01264770|2919256|P6|Overall Study|Adverse Event|1
885463|NCT01264770|2919257|P5|Overall Study|Adverse Event|2
885464|NCT01264770|2919258|P4|Overall Study|Adverse Event|0
885465|NCT01264770|2919259|P3|Overall Study|Adverse Event|8
885466|NCT01264770|2919260|P2|Overall Study|Adverse Event|7
885467|NCT01264770|2919261|P1|Overall Study|Adverse Event|7
885468|NCT01264770|2919256|P6|Overall Study|Lost to Follow-up|0
885469|NCT01264770|2919257|P5|Overall Study|Lost to Follow-up|0
885470|NCT01264770|2919258|P4|Overall Study|Lost to Follow-up|1
885471|NCT01264770|2919259|P3|Overall Study|Lost to Follow-up|1
885472|NCT01264770|2919260|P2|Overall Study|Lost to Follow-up|0
885473|NCT01264770|2919261|P1|Overall Study|Lost to Follow-up|0
885474|NCT01264770|2919256|P6|Overall Study|Dev. of study specific discont. criteria|1
885475|NCT01264770|2919257|P5|Overall Study|Dev. of study specific discont. criteria|1
885476|NCT01264770|2919258|P4|Overall Study|Dev. of study specific discont. criteria|0
885477|NCT01264770|2919259|P3|Overall Study|Dev. of study specific discont. criteria|0
885478|NCT01264770|2919260|P2|Overall Study|Dev. of study specific discont. criteria|0
885479|NCT01264770|2919261|P1|Overall Study|Dev. of study specific discont. criteria|2
885480|NCT01264770|2919256|P6|Overall Study|Lack of therapeutic response|0
885481|NCT01264770|2919257|P5|Overall Study|Lack of therapeutic response|1
885482|NCT01264770|2919258|P4|Overall Study|Lack of therapeutic response|1
885483|NCT01264770|2919259|P3|Overall Study|Lack of therapeutic response|2
885484|NCT01264770|2919260|P2|Overall Study|Lack of therapeutic response|0
885485|NCT01264770|2919261|P1|Overall Study|Lack of therapeutic response|1
885486|NCT01264770|2919256|P6|Overall Study|Severe non-compliance to protocol|0
885487|NCT01264770|2919257|P5|Overall Study|Severe non-compliance to protocol|0
885488|NCT01264770|2919258|P4|Overall Study|Severe non-compliance to protocol|1
885489|NCT01264770|2919259|P3|Overall Study|Severe non-compliance to protocol|1
885490|NCT01264770|2919260|P2|Overall Study|Severe non-compliance to protocol|0
885491|NCT01264770|2919261|P1|Overall Study|Severe non-compliance to protocol|0
885492|NCT01264770|2919256|P6|Overall Study|e.g., change in circumstances|4
885493|NCT01264770|2919257|P5|Overall Study|e.g., change in circumstances|4
885494|NCT01264770|2919258|P4|Overall Study|e.g., change in circumstances|3
885495|NCT01264770|2919259|P3|Overall Study|e.g., change in circumstances|3
885496|NCT01264770|2919260|P2|Overall Study|e.g., change in circumstances|3
885497|NCT01264770|2919261|P1|Overall Study|e.g., change in circumstances|8
885498|NCT01264770|2919256|P6|Overall Study|Not reported|0
885499|NCT01264770|2919257|P5|Overall Study|Not reported|0
885500|NCT01264770|2919258|P4|Overall Study|Not reported|0
885501|NCT01264770|2919259|P3|Overall Study|Not reported|1
885502|NCT01264770|2919260|P2|Overall Study|Not reported|0
885503|NCT01264770|2919261|P1|Overall Study|Not reported|0
885504|NCT01264679|2919345|P1|Overall Study|Withdrawal by Subject|1
885505|NCT01264679|2919345|P1|Overall Study|Sponsor's Suspension of Dosing|2
885506|NCT01264679|2919345|P1|Overall Study|Physician Decision|1
885507|NCT01264679|2919345|P1|Overall Study|Participation in Another Clinical Trial|1
885508|NCT01264380|2919379|P3|Period C|Adverse Event|1
885509|NCT01264380|2919380|P2|Period C|Adverse Event|0
885510|NCT01264380|2919381|P1|Period C|Adverse Event|0
885511|NCT01264380|2919379|P3|Period C|Withdrawal by Subject|1
885512|NCT01264380|2919380|P2|Period C|Withdrawal by Subject|0
885513|NCT01264380|2919381|P1|Period C|Withdrawal by Subject|0
885514|NCT01264380|2919379|P3|Period C|Follow-up for survival status|6
885515|NCT01264380|2919380|P2|Period C|Follow-up for survival status|0
885516|NCT01264380|2919381|P1|Period C|Follow-up for survival status|0
885517|NCT01264380|2919379|P3|Period C|Death|2
885518|NCT01264380|2919380|P2|Period C|Death|0
885519|NCT01264380|2919381|P1|Period C|Death|0
885520|NCT01264380|2919379|P3|Period C|Disease Progression|4
885521|NCT01264380|2919380|P2|Period C|Disease Progression|0
885522|NCT01264380|2919381|P1|Period C|Disease Progression|0
885523|NCT01264081|2919402|P1|Started Treatment|Not complete cycle 1 due to death|1
885524|NCT01264081|2919402|P1|Started Treatment|Withdrawal by Subject|1
885525|NCT01264081|2919402|P1|Participants Screened|Screening failures|30
885526|NCT01264016|2919407|P1|Overall Study|Felt faint at sight of blood|1
885527|NCT01264016|2919407|P1|Overall Study|Withdrawal by Subject|1
885528|NCT01263925|2919415|P2|Overall Study|Withdrawal/ Not specified|1
885529|NCT01263925|2919416|P1|Overall Study|Withdrawal/ Not specified|0
885530|NCT01263925|2919415|P2|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2
885531|NCT01263925|2919416|P1|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1
885532|NCT01263925|2919415|P2|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
885533|NCT01263925|2919416|P1|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
885534|NCT01263925|2919415|P2|Overall Study|AE/ Withdrawal|4
885535|NCT01263925|2919416|P1|Overall Study|AE/ Withdrawal|1
885536|NCT01263925|2919415|P2|Overall Study|AE/ Unsatisfactory Compliance|2
885537|NCT01263925|2919416|P1|Overall Study|AE/ Unsatisfactory Compliance|2
885538|NCT01263925|2919415|P2|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
885539|NCT01263925|2919416|P1|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
885540|NCT01263925|2919415|P2|Overall Study|Lost to Follow-up|1
885541|NCT01263925|2919416|P1|Overall Study|Lost to Follow-up|3
885542|NCT01263925|2919415|P2|Overall Study|Not specified|4
885543|NCT01263925|2919416|P1|Overall Study|Not specified|4
885544|NCT01263925|2919415|P2|Overall Study|Withdrawal by Subject|8
885545|NCT01263925|2919416|P1|Overall Study|Withdrawal by Subject|6
885546|NCT01263925|2919415|P2|Overall Study|Unsatisfactory Compliance of Subject|5
885547|NCT01263925|2919416|P1|Overall Study|Unsatisfactory Compliance of Subject|8
885548|NCT01263925|2919415|P2|Overall Study|Adverse Event|22
885549|NCT01263925|2919416|P1|Overall Study|Adverse Event|23
885550|NCT01263925|2919415|P2|Overall Study|Lack of Efficacy|1
885551|NCT01263925|2919416|P1|Overall Study|Lack of Efficacy|0
885552|NCT01263925|2919415|P2|Overall Study|Protocol Violation|0
885553|NCT01263925|2919416|P1|Overall Study|Protocol Violation|1
885554|NCT01263873|2919450|P2|Overall Study|One provider unable to complete numbers|1
885555|NCT01263873|2919451|P1|Overall Study|One provider unable to complete numbers|1
885556|NCT01263704|2919492|P1|Overall Study|Principal Investigator (PI) decision|1
885557|NCT01263704|2919492|P1|Overall Study|Colon metastases|1
885558|NCT01263704|2919492|P1|Overall Study|Lost to Follow-up|1
885559|NCT01263704|2919492|P1|Overall Study|Eligibility criteria not fulfilled|1
885560|NCT01263704|2919492|P1|Overall Study|Patient withdrew consent|2
885561|NCT01263704|2919492|P1|Overall Study|Death|2
885562|NCT01263704|2919492|P1|Overall Study|Adverse Event|3
885563|NCT01263704|2919492|P1|Overall Study|Progressive disease|18
885564|NCT01263691|2919507|P6|Overall Study|Adverse Event|0
885565|NCT01263691|2919508|P5|Overall Study|Adverse Event|0
885566|NCT01263691|2919509|P4|Overall Study|Adverse Event|0
885567|NCT01263691|2919510|P3|Overall Study|Adverse Event|0
885568|NCT01263691|2919511|P2|Overall Study|Adverse Event|0
885569|NCT01263691|2919512|P1|Overall Study|Adverse Event|1
885570|NCT01263691|2919507|P6|Overall Study|Withdrawal by Subject|0
885571|NCT01263691|2919508|P5|Overall Study|Withdrawal by Subject|0
885572|NCT01263691|2919509|P4|Overall Study|Withdrawal by Subject|0
885573|NCT01263691|2919510|P3|Overall Study|Withdrawal by Subject|0
885574|NCT01263691|2919511|P2|Overall Study|Withdrawal by Subject|0
885575|NCT01263691|2919512|P1|Overall Study|Withdrawal by Subject|1
885576|NCT01263691|2919507|P6|Overall Study|Lost to Follow-up|0
885577|NCT01263691|2919508|P5|Overall Study|Lost to Follow-up|0
885578|NCT01263691|2919509|P4|Overall Study|Lost to Follow-up|1
885579|NCT01263691|2919510|P3|Overall Study|Lost to Follow-up|1
885580|NCT01263691|2919511|P2|Overall Study|Lost to Follow-up|0
885581|NCT01263691|2919512|P1|Overall Study|Lost to Follow-up|1
885582|NCT01263665|2919622|P1|Overall Study|Surgical Bypass|2
885583|NCT01263665|2919622|P1|Overall Study|Amputation above the ankle|1
885584|NCT01263665|2919622|P1|Overall Study|Death|2
885585|NCT01263665|2919622|P1|Overall Study|Lost to Follow-up|3
885586|NCT01263665|2919622|P1|Overall Study|Withdrew Consent|1
885587|NCT01263639|2919629|P2|Overall Study|Exclusion =Admission greater than 7 days|9
885588|NCT01263639|2919630|P1|Overall Study|Exclusion =Admission greater than 7 days|7
885589|NCT01263639|2919629|P2|Overall Study|Lost to Follow-up|70
885590|NCT01263639|2919630|P1|Overall Study|Lost to Follow-up|66
885591|NCT01263561|2919638|P2|Overall Study|Death|2
885592|NCT01263561|2919639|P1|Overall Study|Death|1
885593|NCT01263509|2919651|P4|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1
885594|NCT01263509|2919652|P3|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
885595|NCT01263509|2919653|P2|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
885596|NCT01263509|2919654|P1|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
885597|NCT01263509|2919651|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
885598|NCT01263509|2919652|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
885599|NCT01263509|2919653|P2|Entered - Long-Term Extension Study|Participant Unavailability|1
885600|NCT01263509|2919654|P1|Entered - Long-Term Extension Study|Participant Unavailability|1
885601|NCT01263509|2919651|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
885602|NCT01263509|2919652|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
885603|NCT01263509|2919653|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
885604|NCT01263509|2919654|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
885605|NCT01263509|2919651|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
885606|NCT01263509|2919652|P3|Entered - Long-Term Extension Study|Lack of Efficacy|1
885607|NCT01263509|2919653|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
885608|NCT01263509|2919654|P1|Entered - Long-Term Extension Study|Lack of Efficacy|1
885609|NCT01263509|2919651|P4|Entered - Long-Term Extension Study|Adverse Event|1
885610|NCT01263509|2919652|P3|Entered - Long-Term Extension Study|Adverse Event|4
885611|NCT01263509|2919653|P2|Entered - Long-Term Extension Study|Adverse Event|5
885612|NCT01263509|2919654|P1|Entered - Long-Term Extension Study|Adverse Event|5
885613|NCT01263496|2919783|P9|Entered - Long-Term Extension Study|Participant Unavailability|0
885614|NCT01263496|2919784|P8|Entered - Long-Term Extension Study|Participant Unavailability|1
885615|NCT01263496|2919785|P7|Entered - Long-Term Extension Study|Participant Unavailability|0
885616|NCT01263496|2919786|P6|Entered - Long-Term Extension Study|Participant Unavailability|0
885617|NCT01263496|2919787|P5|Entered - Long-Term Extension Study|Participant Unavailability|0
885618|NCT01263496|2919788|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
885619|NCT01263496|2919789|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
885620|NCT01263496|2919790|P2|Entered - Long-Term Extension Study|Participant Unavailability|0
885621|NCT01263496|2919791|P1|Entered - Long-Term Extension Study|Participant Unavailability|0
885622|NCT01263496|2919783|P9|Entered - Long-Term Extension Study|Lack of Efficacy|1
885623|NCT01263496|2919784|P8|Entered - Long-Term Extension Study|Lack of Efficacy|0
885624|NCT01263496|2919785|P7|Entered - Long-Term Extension Study|Lack of Efficacy|0
885625|NCT01263496|2919786|P6|Entered - Long-Term Extension Study|Lack of Efficacy|0
885626|NCT01263496|2919787|P5|Entered - Long-Term Extension Study|Lack of Efficacy|5
885627|NCT01263496|2919788|P4|Entered - Long-Term Extension Study|Lack of Efficacy|1
885628|NCT01263496|2919789|P3|Entered - Long-Term Extension Study|Lack of Efficacy|4
885629|NCT01263496|2919790|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
885630|NCT01263496|2919791|P1|Entered - Long-Term Extension Study|Lack of Efficacy|8
885631|NCT01263496|2919783|P9|Entered - Long-Term Extension Study|Withdrawal by Subject|1
885632|NCT01263496|2919784|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|0
885633|NCT01263496|2919785|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|1
885634|NCT01263496|2919786|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|1
885635|NCT01263496|2919787|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|4
885636|NCT01263496|2919788|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|2
885637|NCT01263496|2919789|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
885638|NCT01263496|2919790|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
885639|NCT01263496|2919791|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
885640|NCT01263496|2919783|P9|Entered - Long-Term Extension Study|Lost to Follow-up|0
885641|NCT01263496|2919784|P8|Entered - Long-Term Extension Study|Lost to Follow-up|0
885642|NCT01263496|2919785|P7|Entered - Long-Term Extension Study|Lost to Follow-up|0
885643|NCT01263496|2919786|P6|Entered - Long-Term Extension Study|Lost to Follow-up|0
885644|NCT01263496|2919787|P5|Entered - Long-Term Extension Study|Lost to Follow-up|0
885645|NCT01263496|2919788|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
885646|NCT01263496|2919789|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
885647|NCT01263496|2919790|P2|Entered - Long-Term Extension Study|Lost to Follow-up|2
885648|NCT01263496|2919791|P1|Entered - Long-Term Extension Study|Lost to Follow-up|0
885649|NCT01263496|2919783|P9|Entered - Long-Term Extension Study|Adverse Event|1
885650|NCT01263496|2919784|P8|Entered - Long-Term Extension Study|Adverse Event|0
885651|NCT01263496|2919785|P7|Entered - Long-Term Extension Study|Adverse Event|0
885652|NCT01263496|2919786|P6|Entered - Long-Term Extension Study|Adverse Event|0
885653|NCT01263496|2919787|P5|Entered - Long-Term Extension Study|Adverse Event|1
885654|NCT01263496|2919788|P4|Entered - Long-Term Extension Study|Adverse Event|3
885655|NCT01263496|2919789|P3|Entered - Long-Term Extension Study|Adverse Event|6
885656|NCT01263496|2919790|P2|Entered - Long-Term Extension Study|Adverse Event|5
885657|NCT01263496|2919791|P1|Entered - Long-Term Extension Study|Adverse Event|0
885658|NCT01263496|2919783|P9|Enrolled - Long-Term Extension Study|Adverse Event|0
885659|NCT01263496|2919784|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
885660|NCT01263496|2919785|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
885661|NCT01263496|2919786|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
885662|NCT01263496|2919787|P5|Enrolled - Long-Term Extension Study|Adverse Event|2
885663|NCT01263496|2919788|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
885664|NCT01263496|2919789|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
885665|NCT01263496|2919790|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
885666|NCT01263496|2919791|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
885667|NCT01263496|2919783|P9|Enrolled - Long-Term Extension Study|Protocol Violation|0
885668|NCT01263496|2919784|P8|Enrolled - Long-Term Extension Study|Protocol Violation|0
885669|NCT01263496|2919785|P7|Enrolled - Long-Term Extension Study|Protocol Violation|0
885670|NCT01263496|2919786|P6|Enrolled - Long-Term Extension Study|Protocol Violation|0
885671|NCT01263496|2919787|P5|Enrolled - Long-Term Extension Study|Protocol Violation|0
885672|NCT01263496|2919788|P4|Enrolled - Long-Term Extension Study|Protocol Violation|0
885673|NCT01263496|2919789|P3|Enrolled - Long-Term Extension Study|Protocol Violation|0
885674|NCT01263496|2919790|P2|Enrolled - Long-Term Extension Study|Protocol Violation|0
885675|NCT01263496|2919791|P1|Enrolled - Long-Term Extension Study|Protocol Violation|1
885676|NCT01263483|2920086|P3|Overall Study|Participant Unavailability|1
885677|NCT01263483|2920087|P2|Overall Study|Participant Unavailability|1
885678|NCT01263483|2920088|P1|Overall Study|Participant Unavailability|0
885679|NCT01263483|2920086|P3|Overall Study|Protocol Violation|1
885680|NCT01263483|2920087|P2|Overall Study|Protocol Violation|1
885681|NCT01263483|2920088|P1|Overall Study|Protocol Violation|0
885682|NCT01263483|2920086|P3|Overall Study|Lack of Efficacy|0
885683|NCT01263483|2920087|P2|Overall Study|Lack of Efficacy|0
885684|NCT01263483|2920088|P1|Overall Study|Lack of Efficacy|2
885685|NCT01263483|2920086|P3|Overall Study|Withdrawal by Subject|0
885686|NCT01263483|2920087|P2|Overall Study|Withdrawal by Subject|0
885687|NCT01263483|2920088|P1|Overall Study|Withdrawal by Subject|1
885688|NCT01263483|2920086|P3|Overall Study|Adverse Event|3
885689|NCT01263483|2920087|P2|Overall Study|Adverse Event|0
885690|NCT01263483|2920088|P1|Overall Study|Adverse Event|4
885691|NCT01263470|2920150|P6|Overall Study|Study Drug Non-compliance|0
885692|NCT01263470|2920151|P5|Overall Study|Study Drug Non-compliance|1
885693|NCT01263470|2920152|P4|Overall Study|Study Drug Non-compliance|0
885694|NCT01263470|2920153|P3|Overall Study|Study Drug Non-compliance|0
885695|NCT01263470|2920154|P2|Overall Study|Study Drug Non-compliance|0
885696|NCT01263470|2920155|P1|Overall Study|Study Drug Non-compliance|0
885697|NCT01263470|2920150|P6|Overall Study|Participant Unavailability|0
885698|NCT01263470|2920151|P5|Overall Study|Participant Unavailability|0
885699|NCT01263470|2920152|P4|Overall Study|Participant Unavailability|0
885700|NCT01263470|2920153|P3|Overall Study|Participant Unavailability|0
885701|NCT01263470|2920154|P2|Overall Study|Participant Unavailability|1
885702|NCT01263470|2920155|P1|Overall Study|Participant Unavailability|0
885703|NCT01263470|2920150|P6|Overall Study|Lack of Efficacy|0
885704|NCT01263470|2920151|P5|Overall Study|Lack of Efficacy|0
885705|NCT01263470|2920152|P4|Overall Study|Lack of Efficacy|0
885706|NCT01263470|2920153|P3|Overall Study|Lack of Efficacy|2
885707|NCT01263470|2920154|P2|Overall Study|Lack of Efficacy|0
885708|NCT01263470|2920155|P1|Overall Study|Lack of Efficacy|0
885709|NCT01263470|2920150|P6|Overall Study|Withdrawal by Subject|2
885710|NCT01263470|2920151|P5|Overall Study|Withdrawal by Subject|0
885711|NCT01263470|2920152|P4|Overall Study|Withdrawal by Subject|2
885712|NCT01263470|2920153|P3|Overall Study|Withdrawal by Subject|1
885713|NCT01263470|2920154|P2|Overall Study|Withdrawal by Subject|1
885714|NCT01263470|2920155|P1|Overall Study|Withdrawal by Subject|0
885715|NCT01263470|2920150|P6|Overall Study|Protocol Violation|1
885716|NCT01263470|2920151|P5|Overall Study|Protocol Violation|0
885717|NCT01263470|2920152|P4|Overall Study|Protocol Violation|0
885718|NCT01263470|2920153|P3|Overall Study|Protocol Violation|0
885719|NCT01263470|2920154|P2|Overall Study|Protocol Violation|1
885720|NCT01263470|2920155|P1|Overall Study|Protocol Violation|0
885721|NCT01263470|2920150|P6|Overall Study|Adverse Event|2
885722|NCT01263470|2920151|P5|Overall Study|Adverse Event|2
885723|NCT01263470|2920152|P4|Overall Study|Adverse Event|1
885724|NCT01263470|2920153|P3|Overall Study|Adverse Event|1
885725|NCT01263470|2920154|P2|Overall Study|Adverse Event|2
885726|NCT01263470|2920155|P1|Overall Study|Adverse Event|2
885727|NCT01263444|2920265|P1|Overall Study|Protocol Violation|1
885728|NCT01263444|2920265|P1|Overall Study|Withdrawal by Subject|1
885729|NCT01263444|2920265|P1|Overall Study|Adverse Event|8
885730|NCT01263223|2920402|P2|7-day Follow-up|Lost to Follow-up|0
885731|NCT01263223|2920403|P1|7-day Follow-up|Lost to Follow-up|1
885732|NCT01263223|2920402|P2|7-day Follow-up|Withdrawal by Subject|1
885733|NCT01263223|2920403|P1|7-day Follow-up|Withdrawal by Subject|0
885734|NCT01263223|2920402|P2|Period 2|Withdrawal by Subject|1
885735|NCT01263223|2920403|P1|Period 2|Withdrawal by Subject|0
885736|NCT01263197|2920426|P6|Third Intervention (Period 3)|Adverse Event|0
885737|NCT01263197|2920427|P5|Third Intervention (Period 3)|Adverse Event|0
885738|NCT01263197|2920428|P4|Third Intervention (Period 3)|Adverse Event|0
885739|NCT01263197|2920429|P3|Third Intervention (Period 3)|Adverse Event|0
885740|NCT01263197|2920430|P2|Third Intervention (Period 3)|Adverse Event|1
885741|NCT01263197|2920431|P1|Third Intervention (Period 3)|Adverse Event|0
885742|NCT01263197|2920426|P6|Washout Period 2|Protocol Violation|0
885743|NCT01263197|2920427|P5|Washout Period 2|Protocol Violation|0
885744|NCT01263197|2920428|P4|Washout Period 2|Protocol Violation|1
885745|NCT01263197|2920429|P3|Washout Period 2|Protocol Violation|0
885746|NCT01263197|2920430|P2|Washout Period 2|Protocol Violation|0
885747|NCT01263197|2920431|P1|Washout Period 2|Protocol Violation|0
885748|NCT01263197|2920426|P6|Washout Period 2|Physician Decision|1
885749|NCT01263197|2920427|P5|Washout Period 2|Physician Decision|0
885750|NCT01263197|2920428|P4|Washout Period 2|Physician Decision|0
885751|NCT01263197|2920429|P3|Washout Period 2|Physician Decision|0
885752|NCT01263197|2920430|P2|Washout Period 2|Physician Decision|0
885753|NCT01263197|2920431|P1|Washout Period 2|Physician Decision|0
885754|NCT01263197|2920426|P6|Washout Period 1|Protocol Violation|0
885755|NCT01263197|2920427|P5|Washout Period 1|Protocol Violation|1
885756|NCT01263197|2920428|P4|Washout Period 1|Protocol Violation|0
885757|NCT01263197|2920429|P3|Washout Period 1|Protocol Violation|0
885758|NCT01263197|2920430|P2|Washout Period 1|Protocol Violation|0
885759|NCT01263197|2920431|P1|Washout Period 1|Protocol Violation|0
885760|NCT01263197|2920426|P6|First Intervention (Period 1)|Adverse Event|1
885761|NCT01263197|2920427|P5|First Intervention (Period 1)|Adverse Event|0
885762|NCT01263197|2920428|P4|First Intervention (Period 1)|Adverse Event|0
885763|NCT01263197|2920429|P3|First Intervention (Period 1)|Adverse Event|0
885764|NCT01263197|2920430|P2|First Intervention (Period 1)|Adverse Event|0
885765|NCT01263197|2920431|P1|First Intervention (Period 1)|Adverse Event|0
885766|NCT01263119|2920474|P1|Overall Study|Adverse Event|2
885767|NCT01263119|2920474|P1|Overall Study|Protocol Violation|2
885768|NCT01263093|2920497|P2|Period 2|Adverse Event|0
885769|NCT01263093|2920498|P1|Period 2|Adverse Event|1
885770|NCT01263093|2920497|P2|Washout|Physician Decision|0
885771|NCT01263093|2920498|P1|Washout|Physician Decision|1
885772|NCT01263054|2920515|P2|Overall Study|Other|1
885773|NCT01263054|2920516|P1|Overall Study|Other|0
885774|NCT01263054|2920515|P2|Overall Study|Qualification Violation|0
885775|NCT01263054|2920516|P1|Overall Study|Qualification Violation|1
885776|NCT01263054|2920515|P2|Overall Study|Withdrawal by Subject|3
885777|NCT01263054|2920516|P1|Overall Study|Withdrawal by Subject|1
885778|NCT01263054|2920515|P2|Overall Study|Lost to Follow-up|2
885779|NCT01263054|2920516|P1|Overall Study|Lost to Follow-up|2
885780|NCT01263054|2920515|P2|Overall Study|Death|0
885781|NCT01263054|2920516|P1|Overall Study|Death|1
885782|NCT01263028|2920534|P1|Overall Study|Study terminated due to low enrollment.|4
885783|NCT01263028|2920534|P1|Overall Study|Adverse Event|1
885784|NCT01263028|2920534|P1|Overall Study|Withdrawal by Subject|1
885785|NCT01263015|2920544|P2|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7
885786|NCT01263015|2920545|P1|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3
885787|NCT01263015|2920544|P2|Open-label Phase: 48 Weeks Duration|Physician Decision|2
885788|NCT01263015|2920545|P1|Open-label Phase: 48 Weeks Duration|Physician Decision|0
885789|NCT01263015|2920544|P2|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
885790|NCT01263015|2920545|P1|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
885791|NCT01263015|2920544|P2|Open-label Phase: 48 Weeks Duration|Protocol Violation|2
885792|NCT01263015|2920545|P1|Open-label Phase: 48 Weeks Duration|Protocol Violation|3
885793|NCT01263015|2920544|P2|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2
885794|NCT01263015|2920545|P1|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7
885795|NCT01263015|2920544|P2|Open-label Phase: 48 Weeks Duration|Adverse Event|10
885796|NCT01263015|2920545|P1|Open-label Phase: 48 Weeks Duration|Adverse Event|3
885797|NCT01263015|2920544|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|2
885798|NCT01263015|2920545|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|1
885799|NCT01263015|2920544|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15
885800|NCT01263015|2920545|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9
885801|NCT01263015|2920544|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18
885802|NCT01263015|2920545|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17
885803|NCT01263015|2920544|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12
885804|NCT01263015|2920545|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14
885805|NCT01263015|2920544|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14
885806|NCT01263015|2920545|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18
885807|NCT01263015|2920544|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|48
885808|NCT01263015|2920545|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|13
885809|NCT01262989|2920571|P2|Period 2|Intercurrent disease|1
885810|NCT01262989|2920572|P1|Period 2|Intercurrent disease|0
885811|NCT01262989|2920571|P2|Period 1|Positive answer for exclusion criteria|1
885812|NCT01262989|2920572|P1|Period 1|Positive answer for exclusion criteria|0
885813|NCT01262989|2920571|P2|Period 1|Intercurrent disease|1
885814|NCT01262989|2920572|P1|Period 1|Intercurrent disease|0
885815|NCT01262989|2920571|P2|Period 1|Lost to Follow-up|1
885816|NCT01262989|2920572|P1|Period 1|Lost to Follow-up|1
885817|NCT01262976|2920588|P6|Up to Year 3|Other|0
885818|NCT01262976|2920589|P5|Up to Year 3|Other|0
885819|NCT01262976|2920590|P4|Up to Year 3|Other|0
885820|NCT01262976|2920591|P3|Up to Year 3|Other|0
885821|NCT01262976|2920592|P2|Up to Year 3|Other|0
885822|NCT01262976|2920593|P1|Up to Year 3|Other|3
885823|NCT01262976|2920588|P6|Up to Year 3|Subjects with unknown completion status|0
885824|NCT01262976|2920589|P5|Up to Year 3|Subjects with unknown completion status|0
885825|NCT01262976|2920590|P4|Up to Year 3|Subjects with unknown completion status|0
885826|NCT01262976|2920591|P3|Up to Year 3|Subjects with unknown completion status|1
885827|NCT01262976|2920592|P2|Up to Year 3|Subjects with unknown completion status|0
885828|NCT01262976|2920593|P1|Up to Year 3|Subjects with unknown completion status|0
885829|NCT01262976|2920588|P6|Up to Year 3|Lost to Follow-up|3
885830|NCT01262976|2920589|P5|Up to Year 3|Lost to Follow-up|1
885831|NCT01262976|2920590|P4|Up to Year 3|Lost to Follow-up|3
885832|NCT01262976|2920591|P3|Up to Year 3|Lost to Follow-up|4
885833|NCT01262976|2920592|P2|Up to Year 3|Lost to Follow-up|2
885834|NCT01262976|2920593|P1|Up to Year 3|Lost to Follow-up|2
885835|NCT01262976|2920588|P6|Up to Year 3|Migrated/moved from study area|1
885836|NCT01262976|2920589|P5|Up to Year 3|Migrated/moved from study area|1
885837|NCT01262976|2920590|P4|Up to Year 3|Migrated/moved from study area|2
885838|NCT01262976|2920591|P3|Up to Year 3|Migrated/moved from study area|0
885839|NCT01262976|2920592|P2|Up to Year 3|Migrated/moved from study area|0
885840|NCT01262976|2920593|P1|Up to Year 3|Migrated/moved from study area|0
885841|NCT01262976|2920588|P6|Up to Year 3|Withdrawal by Subject|0
885842|NCT01262976|2920589|P5|Up to Year 3|Withdrawal by Subject|0
885843|NCT01262976|2920590|P4|Up to Year 3|Withdrawal by Subject|0
885844|NCT01262976|2920591|P3|Up to Year 3|Withdrawal by Subject|0
885845|NCT01262976|2920592|P2|Up to Year 3|Withdrawal by Subject|0
885846|NCT01262976|2920593|P1|Up to Year 3|Withdrawal by Subject|1
885847|NCT01262976|2920588|P6|Up to Year 3|Serious Adverse Event|0
885848|NCT01262976|2920589|P5|Up to Year 3|Serious Adverse Event|0
885849|NCT01262976|2920590|P4|Up to Year 3|Serious Adverse Event|0
885850|NCT01262976|2920591|P3|Up to Year 3|Serious Adverse Event|2
885851|NCT01262976|2920592|P2|Up to Year 3|Serious Adverse Event|0
885852|NCT01262976|2920593|P1|Up to Year 3|Serious Adverse Event|0
885853|NCT01262976|2920588|P6|Up to Year 2|Other|0
885854|NCT01262976|2920589|P5|Up to Year 2|Other|0
885855|NCT01262976|2920590|P4|Up to Year 2|Other|0
885856|NCT01262976|2920591|P3|Up to Year 2|Other|0
885857|NCT01262976|2920592|P2|Up to Year 2|Other|0
885858|NCT01262976|2920593|P1|Up to Year 2|Other|3
885859|NCT01262976|2920588|P6|Up to Year 2|Subjects with unknown completion status|0
885860|NCT01262976|2920589|P5|Up to Year 2|Subjects with unknown completion status|0
885861|NCT01262976|2920590|P4|Up to Year 2|Subjects with unknown completion status|0
885862|NCT01262976|2920591|P3|Up to Year 2|Subjects with unknown completion status|1
885863|NCT01262976|2920592|P2|Up to Year 2|Subjects with unknown completion status|0
885864|NCT01262976|2920593|P1|Up to Year 2|Subjects with unknown completion status|0
885865|NCT01262976|2920588|P6|Up to Year 2|Lost to Follow-up|3
885866|NCT01262976|2920589|P5|Up to Year 2|Lost to Follow-up|3
885867|NCT01262976|2920590|P4|Up to Year 2|Lost to Follow-up|2
885868|NCT01262976|2920591|P3|Up to Year 2|Lost to Follow-up|2
885869|NCT01262976|2920592|P2|Up to Year 2|Lost to Follow-up|1
885870|NCT01262976|2920593|P1|Up to Year 2|Lost to Follow-up|1
885871|NCT01262976|2920588|P6|Up to Year 2|Migrated/moved from study area|2
885872|NCT01262976|2920589|P5|Up to Year 2|Migrated/moved from study area|1
885873|NCT01262976|2920590|P4|Up to Year 2|Migrated/moved from study area|2
885874|NCT01262976|2920591|P3|Up to Year 2|Migrated/moved from study area|0
885875|NCT01262976|2920592|P2|Up to Year 2|Migrated/moved from study area|0
885876|NCT01262976|2920593|P1|Up to Year 2|Migrated/moved from study area|0
885877|NCT01262976|2920588|P6|Up to Year 2|Withdrawal by Subject|0
885878|NCT01262976|2920589|P5|Up to Year 2|Withdrawal by Subject|0
885879|NCT01262976|2920590|P4|Up to Year 2|Withdrawal by Subject|0
885880|NCT01262976|2920591|P3|Up to Year 2|Withdrawal by Subject|0
885881|NCT01262976|2920592|P2|Up to Year 2|Withdrawal by Subject|0
885882|NCT01262976|2920593|P1|Up to Year 2|Withdrawal by Subject|1
885883|NCT01262976|2920588|P6|Up to Year 2|Serious Adverse Event|0
885884|NCT01262976|2920589|P5|Up to Year 2|Serious Adverse Event|0
885885|NCT01262976|2920590|P4|Up to Year 2|Serious Adverse Event|0
885886|NCT01262976|2920591|P3|Up to Year 2|Serious Adverse Event|2
885887|NCT01262976|2920592|P2|Up to Year 2|Serious Adverse Event|0
885888|NCT01262976|2920593|P1|Up to Year 2|Serious Adverse Event|0
885889|NCT01262976|2920588|P6|Up to Year 1|Subjects with unknown completion status|1
885890|NCT01262976|2920589|P5|Up to Year 1|Subjects with unknown completion status|0
885891|NCT01262976|2920590|P4|Up to Year 1|Subjects with unknown completion status|0
885892|NCT01262976|2920591|P3|Up to Year 1|Subjects with unknown completion status|1
885893|NCT01262976|2920592|P2|Up to Year 1|Subjects with unknown completion status|0
885894|NCT01262976|2920593|P1|Up to Year 1|Subjects with unknown completion status|0
885895|NCT01262976|2920588|P6|Up to Year 1|Other|1
885896|NCT01262976|2920589|P5|Up to Year 1|Other|2
885897|NCT01262976|2920590|P4|Up to Year 1|Other|0
885898|NCT01262976|2920591|P3|Up to Year 1|Other|0
885899|NCT01262976|2920592|P2|Up to Year 1|Other|1
885900|NCT01262976|2920593|P1|Up to Year 1|Other|3
885901|NCT01262976|2920588|P6|Up to Year 1|Lost to Follow-up|5
885902|NCT01262976|2920589|P5|Up to Year 1|Lost to Follow-up|6
885903|NCT01262976|2920590|P4|Up to Year 1|Lost to Follow-up|1
885904|NCT01262976|2920591|P3|Up to Year 1|Lost to Follow-up|0
885905|NCT01262976|2920592|P2|Up to Year 1|Lost to Follow-up|0
885906|NCT01262976|2920593|P1|Up to Year 1|Lost to Follow-up|4
885907|NCT01262976|2920588|P6|Up to Year 1|Migrated/moved from study area|2
885908|NCT01262976|2920589|P5|Up to Year 1|Migrated/moved from study area|3
885909|NCT01262976|2920590|P4|Up to Year 1|Migrated/moved from study area|3
885910|NCT01262976|2920591|P3|Up to Year 1|Migrated/moved from study area|0
885911|NCT01262976|2920592|P2|Up to Year 1|Migrated/moved from study area|0
885912|NCT01262976|2920593|P1|Up to Year 1|Migrated/moved from study area|1
885913|NCT01262976|2920588|P6|Up to Year 1|Withdrawal by Subject|0
885914|NCT01262976|2920589|P5|Up to Year 1|Withdrawal by Subject|0
885915|NCT01262976|2920590|P4|Up to Year 1|Withdrawal by Subject|0
885916|NCT01262976|2920591|P3|Up to Year 1|Withdrawal by Subject|0
885917|NCT01262976|2920592|P2|Up to Year 1|Withdrawal by Subject|0
885918|NCT01262976|2920593|P1|Up to Year 1|Withdrawal by Subject|1
885919|NCT01262976|2920588|P6|Up to Year 1|Serious Adverse Event|0
885920|NCT01262976|2920589|P5|Up to Year 1|Serious Adverse Event|0
885921|NCT01262976|2920590|P4|Up to Year 1|Serious Adverse Event|0
885922|NCT01262976|2920591|P3|Up to Year 1|Serious Adverse Event|2
885923|NCT01262976|2920592|P2|Up to Year 1|Serious Adverse Event|0
885924|NCT01262976|2920593|P1|Up to Year 1|Serious Adverse Event|0
885925|NCT01262976|2920588|P6|Up to Month 7|Other|0
885926|NCT01262976|2920589|P5|Up to Month 7|Other|0
885927|NCT01262976|2920590|P4|Up to Month 7|Other|0
885928|NCT01262976|2920591|P3|Up to Month 7|Other|2
885929|NCT01262976|2920592|P2|Up to Month 7|Other|0
885930|NCT01262976|2920593|P1|Up to Month 7|Other|3
885931|NCT01262976|2920588|P6|Up to Month 7|Lost to Follow-up|3
885932|NCT01262976|2920589|P5|Up to Month 7|Lost to Follow-up|1
885933|NCT01262976|2920590|P4|Up to Month 7|Lost to Follow-up|3
885934|NCT01262976|2920591|P3|Up to Month 7|Lost to Follow-up|1
885935|NCT01262976|2920592|P2|Up to Month 7|Lost to Follow-up|0
885936|NCT01262976|2920593|P1|Up to Month 7|Lost to Follow-up|1
885937|NCT01262976|2920588|P6|Up to Month 7|Migrated/moved from study area|1
885938|NCT01262976|2920589|P5|Up to Month 7|Migrated/moved from study area|1
885939|NCT01262976|2920590|P4|Up to Month 7|Migrated/moved from study area|3
885940|NCT01262976|2920591|P3|Up to Month 7|Migrated/moved from study area|1
885941|NCT01262976|2920592|P2|Up to Month 7|Migrated/moved from study area|0
885942|NCT01262976|2920593|P1|Up to Month 7|Migrated/moved from study area|0
885943|NCT01262976|2920588|P6|Up to Month 7|Withdrawal by Subject|0
885944|NCT01262976|2920589|P5|Up to Month 7|Withdrawal by Subject|0
885945|NCT01262976|2920590|P4|Up to Month 7|Withdrawal by Subject|0
885946|NCT01262976|2920591|P3|Up to Month 7|Withdrawal by Subject|0
885947|NCT01262976|2920592|P2|Up to Month 7|Withdrawal by Subject|0
885948|NCT01262976|2920593|P1|Up to Month 7|Withdrawal by Subject|1
885949|NCT01262976|2920588|P6|Up to Month 7|Serious Adverse Event|0
885950|NCT01262976|2920589|P5|Up to Month 7|Serious Adverse Event|0
885951|NCT01262976|2920590|P4|Up to Month 7|Serious Adverse Event|0
885952|NCT01262976|2920591|P3|Up to Month 7|Serious Adverse Event|2
885953|NCT01262976|2920592|P2|Up to Month 7|Serious Adverse Event|0
885954|NCT01262976|2920593|P1|Up to Month 7|Serious Adverse Event|0
885955|NCT01262976|2920588|P6|Up to Month 2|Other|2
885956|NCT01262976|2920589|P5|Up to Month 2|Other|0
885957|NCT01262976|2920590|P4|Up to Month 2|Other|1
885958|NCT01262976|2920591|P3|Up to Month 2|Other|0
885959|NCT01262976|2920592|P2|Up to Month 2|Other|0
885960|NCT01262976|2920593|P1|Up to Month 2|Other|1
885961|NCT01262976|2920588|P6|Up to Month 2|Lost to Follow-up|1
885962|NCT01262976|2920589|P5|Up to Month 2|Lost to Follow-up|1
885963|NCT01262976|2920590|P4|Up to Month 2|Lost to Follow-up|1
885964|NCT01262976|2920591|P3|Up to Month 2|Lost to Follow-up|0
885965|NCT01262976|2920592|P2|Up to Month 2|Lost to Follow-up|0
885966|NCT01262976|2920593|P1|Up to Month 2|Lost to Follow-up|1
885967|NCT01262976|2920588|P6|Up to Month 2|Migrated/moved from study area|1
885968|NCT01262976|2920589|P5|Up to Month 2|Migrated/moved from study area|1
885969|NCT01262976|2920590|P4|Up to Month 2|Migrated/moved from study area|0
885970|NCT01262976|2920591|P3|Up to Month 2|Migrated/moved from study area|0
885971|NCT01262976|2920592|P2|Up to Month 2|Migrated/moved from study area|1
885972|NCT01262976|2920593|P1|Up to Month 2|Migrated/moved from study area|0
885973|NCT01262976|2920588|P6|Up to Month 2|Withdrawal by Subject|0
885974|NCT01262976|2920589|P5|Up to Month 2|Withdrawal by Subject|0
885975|NCT01262976|2920590|P4|Up to Month 2|Withdrawal by Subject|0
885976|NCT01262976|2920591|P3|Up to Month 2|Withdrawal by Subject|0
885977|NCT01262976|2920592|P2|Up to Month 2|Withdrawal by Subject|0
885978|NCT01262976|2920593|P1|Up to Month 2|Withdrawal by Subject|1
885979|NCT01262976|2920588|P6|Up to Month 2|Serious Adverse Event|0
885980|NCT01262976|2920589|P5|Up to Month 2|Serious Adverse Event|0
885981|NCT01262976|2920590|P4|Up to Month 2|Serious Adverse Event|0
885982|NCT01262976|2920591|P3|Up to Month 2|Serious Adverse Event|1
885983|NCT01262976|2920592|P2|Up to Month 2|Serious Adverse Event|0
885984|NCT01262976|2920593|P1|Up to Month 2|Serious Adverse Event|0
885985|NCT01262898|2920749|P4|Overall Study|Withdrawal by Subject|0
885986|NCT01262898|2920750|P3|Overall Study|Withdrawal by Subject|0
885987|NCT01262898|2920751|P2|Overall Study|Withdrawal by Subject|1
885988|NCT01262898|2920752|P1|Overall Study|Withdrawal by Subject|1
885989|NCT01262898|2920749|P4|Overall Study|Lost to Follow-up|0
885990|NCT01262898|2920750|P3|Overall Study|Lost to Follow-up|0
885991|NCT01262898|2920751|P2|Overall Study|Lost to Follow-up|0
885992|NCT01262898|2920752|P1|Overall Study|Lost to Follow-up|1
885993|NCT01262898|2920749|P4|Overall Study|Protocol Violation|0
885994|NCT01262898|2920750|P3|Overall Study|Protocol Violation|0
885995|NCT01262898|2920751|P2|Overall Study|Protocol Violation|1
885996|NCT01262898|2920752|P1|Overall Study|Protocol Violation|1
885997|NCT01262872|2920880|P8|Step 2|Migrated/moved from study area|3
885998|NCT01262872|2920881|P7|Step 2|Migrated/moved from study area|2
885999|NCT01262872|2920882|P6|Step 2|Migrated/moved from study area|6
886000|NCT01262872|2920883|P5|Step 2|Migrated/moved from study area|2
886001|NCT01262872|2920884|P4|Step 2|Migrated/moved from study area|3
886002|NCT01262872|2920885|P3|Step 2|Migrated/moved from study area|4
886003|NCT01262872|2920886|P2|Step 2|Migrated/moved from study area|0
886004|NCT01262872|2920887|P1|Step 2|Migrated/moved from study area|0
886005|NCT01262872|2920880|P8|Step 2|Withdrawal by Subject|1
886006|NCT01262872|2920881|P7|Step 2|Withdrawal by Subject|2
886007|NCT01262872|2920882|P6|Step 2|Withdrawal by Subject|1
886008|NCT01262872|2920883|P5|Step 2|Withdrawal by Subject|3
886009|NCT01262872|2920884|P4|Step 2|Withdrawal by Subject|6
886010|NCT01262872|2920885|P3|Step 2|Withdrawal by Subject|4
886011|NCT01262872|2920886|P2|Step 2|Withdrawal by Subject|0
886012|NCT01262872|2920887|P1|Step 2|Withdrawal by Subject|0
886013|NCT01262872|2920880|P8|Step 2|Protocol Violation|1
886014|NCT01262872|2920881|P7|Step 2|Protocol Violation|3
886015|NCT01262872|2920882|P6|Step 2|Protocol Violation|0
886016|NCT01262872|2920883|P5|Step 2|Protocol Violation|0
886017|NCT01262872|2920884|P4|Step 2|Protocol Violation|0
886018|NCT01262872|2920885|P3|Step 2|Protocol Violation|1
886019|NCT01262872|2920886|P2|Step 2|Protocol Violation|0
886020|NCT01262872|2920887|P1|Step 2|Protocol Violation|0
886021|NCT01262872|2920880|P8|Step 2|Death|1
886022|NCT01262872|2920881|P7|Step 2|Death|2
886023|NCT01262872|2920882|P6|Step 2|Death|2
886024|NCT01262872|2920883|P5|Step 2|Death|0
886025|NCT01262872|2920884|P4|Step 2|Death|1
886026|NCT01262872|2920885|P3|Step 2|Death|0
886027|NCT01262872|2920886|P2|Step 2|Death|0
886028|NCT01262872|2920887|P1|Step 2|Death|0
886029|NCT01262820|2921149|P1|Overall Study|Drug held for 21+ days|1
886030|NCT01262820|2921149|P1|Overall Study|Lack of Efficacy|9
886031|NCT01262820|2921149|P1|Overall Study|Adverse Event|5
886032|NCT01262677|2921163|P3|Overall Study|Adverse Event (AE) related to study drug|3
886033|NCT01262677|2921164|P2|Overall Study|Adverse Event (AE) related to study drug|8
886034|NCT01262677|2921165|P1|Overall Study|Adverse Event (AE) related to study drug|3
886035|NCT01262677|2921163|P3|Overall Study|Protocol Violation|1
886036|NCT01262677|2921164|P2|Overall Study|Protocol Violation|1
886037|NCT01262677|2921165|P1|Overall Study|Protocol Violation|0
886038|NCT01262677|2921163|P3|Overall Study|Reason not provided|3
886039|NCT01262677|2921164|P2|Overall Study|Reason not provided|1
886040|NCT01262677|2921165|P1|Overall Study|Reason not provided|2
886041|NCT01262677|2921163|P3|Overall Study|No longer willing to participate|2
886042|NCT01262677|2921164|P2|Overall Study|No longer willing to participate|3
886043|NCT01262677|2921165|P1|Overall Study|No longer willing to participate|3
886044|NCT01262677|2921163|P3|Overall Study|Lost to Follow-up|2
886045|NCT01262677|2921164|P2|Overall Study|Lost to Follow-up|0
886046|NCT01262677|2921165|P1|Overall Study|Lost to Follow-up|1
886047|NCT01262677|2921163|P3|Overall Study|Insufficient clinical response|1
886048|NCT01262677|2921164|P2|Overall Study|Insufficient clinical response|0
886049|NCT01262677|2921165|P1|Overall Study|Insufficient clinical response|0
886050|NCT01262677|2921163|P3|Overall Study|Does not meet entrance criteria|0
886051|NCT01262677|2921164|P2|Overall Study|Does not meet entrance criteria|2
886052|NCT01262677|2921165|P1|Overall Study|Does not meet entrance criteria|0
886053|NCT01262651|2921256|P2|Overall Study|Met Withdrawal Criteria|0
886054|NCT01262651|2921257|P1|Overall Study|Met Withdrawal Criteria|1
886055|NCT01262651|2921256|P2|Overall Study|Withdrawal by Investigator|2
886056|NCT01262651|2921257|P1|Overall Study|Withdrawal by Investigator|2
886057|NCT01262651|2921256|P2|Overall Study|Withdrawal by Subject|11
886058|NCT01262651|2921257|P1|Overall Study|Withdrawal by Subject|15
886059|NCT01262651|2921256|P2|Overall Study|Adverse Event|35
886060|NCT01262651|2921257|P1|Overall Study|Adverse Event|40
886061|NCT01262573|2921298|P2|Overall Study|Withdrawal by Subject|1
886062|NCT01262573|2921299|P1|Overall Study|Withdrawal by Subject|0
886063|NCT01262560|2921310|P3|Overall Study|Protocol Violation|2
886064|NCT01262560|2921311|P2|Overall Study|Protocol Violation|1
886065|NCT01262560|2921312|P1|Overall Study|Protocol Violation|0
886066|NCT01262456|2921361|P3|1-Month Open-Label Extension Period|Other Reason|0
886067|NCT01262456|2921362|P2|1-Month Open-Label Extension Period|Other Reason|1
886068|NCT01262456|2921363|P1|1-Month Open-Label Extension Period|Other Reason|0
886069|NCT01262456|2921361|P3|1-Month Open-Label Extension Period|Protocol Violation|2
886070|NCT01262456|2921362|P2|1-Month Open-Label Extension Period|Protocol Violation|0
886071|NCT01262456|2921363|P1|1-Month Open-Label Extension Period|Protocol Violation|1
886072|NCT01262456|2921361|P3|1-Month Open-Label Extension Period|Adverse Event|2
886073|NCT01262456|2921362|P2|1-Month Open-Label Extension Period|Adverse Event|0
886074|NCT01262456|2921363|P1|1-Month Open-Label Extension Period|Adverse Event|2
886075|NCT01262456|2921361|P3|1-Month Open-Label Extension Period|Lost to Follow-up|0
886076|NCT01262456|2921362|P2|1-Month Open-Label Extension Period|Lost to Follow-up|1
886077|NCT01262456|2921363|P1|1-Month Open-Label Extension Period|Lost to Follow-up|0
886078|NCT01262456|2921361|P3|1-Month Open-Label Extension Period|Withdrawal by Subject|1
886079|NCT01262456|2921362|P2|1-Month Open-Label Extension Period|Withdrawal by Subject|1
886080|NCT01262456|2921363|P1|1-Month Open-Label Extension Period|Withdrawal by Subject|1
886081|NCT01262456|2921361|P3|3-Month Double-Blind Period|Protocol Violation|6
886082|NCT01262456|2921362|P2|3-Month Double-Blind Period|Protocol Violation|6
886083|NCT01262456|2921363|P1|3-Month Double-Blind Period|Protocol Violation|3
886084|NCT01262456|2921361|P3|3-Month Double-Blind Period|Adverse Event|8
886085|NCT01262456|2921362|P2|3-Month Double-Blind Period|Adverse Event|4
886086|NCT01262456|2921363|P1|3-Month Double-Blind Period|Adverse Event|6
886087|NCT01262456|2921361|P3|3-Month Double-Blind Period|Lost to Follow-up|3
886088|NCT01262456|2921362|P2|3-Month Double-Blind Period|Lost to Follow-up|5
886089|NCT01262456|2921363|P1|3-Month Double-Blind Period|Lost to Follow-up|4
886090|NCT01262456|2921361|P3|3-Month Double-Blind Period|Withdrawal by Subject|9
886091|NCT01262456|2921362|P2|3-Month Double-Blind Period|Withdrawal by Subject|8
886092|NCT01262456|2921363|P1|3-Month Double-Blind Period|Withdrawal by Subject|6
886093|NCT01262365|2921407|P3|Overall Study|Patient unavailable|1
886094|NCT01262365|2921408|P2|Overall Study|Patient unavailable|0
886095|NCT01262365|2921409|P1|Overall Study|Patient unavailable|0
886096|NCT01262365|2921407|P3|Overall Study|Cannot tolerate the protocol|0
886097|NCT01262365|2921408|P2|Overall Study|Cannot tolerate the protocol|1
886098|NCT01262365|2921409|P1|Overall Study|Cannot tolerate the protocol|0
886099|NCT01262365|2921407|P3|Overall Study|Toxicity related to study drug|0
886100|NCT01262365|2921408|P2|Overall Study|Toxicity related to study drug|1
886101|NCT01262365|2921409|P1|Overall Study|Toxicity related to study drug|0
886102|NCT01262365|2921407|P3|Overall Study|Patient pregnant|1
886103|NCT01262365|2921408|P2|Overall Study|Patient pregnant|0
886104|NCT01262365|2921409|P1|Overall Study|Patient pregnant|1
886105|NCT01262365|2921407|P3|Overall Study|Suspected pregnancy|0
886106|NCT01262365|2921408|P2|Overall Study|Suspected pregnancy|0
886107|NCT01262365|2921409|P1|Overall Study|Suspected pregnancy|1
886108|NCT01262365|2921407|P3|Overall Study|Non-compliance|2
886109|NCT01262365|2921408|P2|Overall Study|Non-compliance|0
886110|NCT01262365|2921409|P1|Overall Study|Non-compliance|1
886111|NCT01262365|2921407|P3|Overall Study|Randomization error|2
886112|NCT01262365|2921408|P2|Overall Study|Randomization error|0
886113|NCT01262365|2921409|P1|Overall Study|Randomization error|1
886114|NCT01262365|2921407|P3|Overall Study|sponsor decision|0
886115|NCT01262365|2921408|P2|Overall Study|sponsor decision|1
886116|NCT01262365|2921409|P1|Overall Study|sponsor decision|1
886117|NCT01262365|2921407|P3|Overall Study|Adverse Event|11
886118|NCT01262365|2921408|P2|Overall Study|Adverse Event|16
886119|NCT01262365|2921409|P1|Overall Study|Adverse Event|26
886120|NCT01262365|2921407|P3|Overall Study|Death|1
886121|NCT01262365|2921408|P2|Overall Study|Death|2
886122|NCT01262365|2921409|P1|Overall Study|Death|1
886123|NCT01262365|2921407|P3|Overall Study|Withdrawal by Subject|22
886124|NCT01262365|2921408|P2|Overall Study|Withdrawal by Subject|22
886125|NCT01262365|2921409|P1|Overall Study|Withdrawal by Subject|17
886126|NCT01262365|2921407|P3|Overall Study|Lost to Follow-up|6
886127|NCT01262365|2921408|P2|Overall Study|Lost to Follow-up|7
886128|NCT01262365|2921409|P1|Overall Study|Lost to Follow-up|3
886129|NCT01262365|2921407|P3|Overall Study|Protocol Violation|1
886130|NCT01262365|2921408|P2|Overall Study|Protocol Violation|1
886131|NCT01262365|2921409|P1|Overall Study|Protocol Violation|3
886132|NCT01262365|2921407|P3|Overall Study|Lack of Efficacy|47
886133|NCT01262365|2921408|P2|Overall Study|Lack of Efficacy|30
886134|NCT01262365|2921409|P1|Overall Study|Lack of Efficacy|35
886135|NCT01262352|2921434|P2|Washout|Extended Washout|1
886136|NCT01262352|2921435|P1|Washout|Extended Washout|0
886137|NCT01262352|2921434|P2|Washout|Adverse Event|1
886138|NCT01262352|2921435|P1|Washout|Adverse Event|1
886139|NCT01262352|2921434|P2|Period 1|Illness after randomization|0
886140|NCT01262352|2921435|P1|Period 1|Illness after randomization|1
886141|NCT01262287|2921453|P2|Overall Study|Lost to Follow-up|1
886142|NCT01262287|2921454|P1|Overall Study|Lost to Follow-up|2
886143|NCT01262092|2921515|P2|Gabapentin Taper|noncompliance - missed medications|0
886144|NCT01262092|2921516|P1|Gabapentin Taper|noncompliance - missed medications|1
886145|NCT01262092|2921515|P2|Buprenorphine Taper|noncompliance - missed medication|1
886146|NCT01262092|2921516|P1|Buprenorphine Taper|noncompliance - missed medication|1
886147|NCT01262092|2921515|P2|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0
886148|NCT01262092|2921516|P1|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1
886149|NCT01262092|2921515|P2|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1
886150|NCT01262092|2921516|P1|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2
886151|NCT01262027|2921522|P1|Overall Study|Protocol Violation|1
886152|NCT01262027|2921522|P1|Overall Study|Withdrawal by Subject|3
886153|NCT01262027|2921522|P1|Overall Study|Adverse Event|1
886154|NCT01261975|2921527|P1|Overall Study|Surgical complication|1
886155|NCT01261793|2921549|P3|Overall Study|Patient unable to start IV line|1
886156|NCT01261793|2921550|P2|Overall Study|Patient unable to start IV line|0
886157|NCT01261793|2921551|P1|Overall Study|Patient unable to start IV line|0
886158|NCT01261793|2921549|P3|Overall Study|Randomization error|0
886159|NCT01261793|2921550|P2|Overall Study|Randomization error|1
886160|NCT01261793|2921551|P1|Overall Study|Randomization error|0
886161|NCT01261793|2921549|P3|Overall Study|Patient withdrew after cardiology visit|0
886162|NCT01261793|2921550|P2|Overall Study|Patient withdrew after cardiology visit|1
886163|NCT01261793|2921551|P1|Overall Study|Patient withdrew after cardiology visit|0
886164|NCT01261793|2921549|P3|Overall Study|Lack of efficacy & patient not available|0
886165|NCT01261793|2921550|P2|Overall Study|Lack of efficacy & patient not available|1
886166|NCT01261793|2921551|P1|Overall Study|Lack of efficacy & patient not available|0
886167|NCT01261793|2921549|P3|Overall Study|Outside the study area|1
886168|NCT01261793|2921550|P2|Overall Study|Outside the study area|2
886169|NCT01261793|2921551|P1|Overall Study|Outside the study area|0
886170|NCT01261793|2921549|P3|Overall Study|Patient pregnant|0
886171|NCT01261793|2921550|P2|Overall Study|Patient pregnant|0
886172|NCT01261793|2921551|P1|Overall Study|Patient pregnant|1
886173|NCT01261793|2921549|P3|Overall Study|Patient non-compliance|1
886174|NCT01261793|2921550|P2|Overall Study|Patient non-compliance|0
886175|NCT01261793|2921551|P1|Overall Study|Patient non-compliance|1
886176|NCT01261793|2921549|P3|Overall Study|Suspected pregnancy|0
886177|NCT01261793|2921550|P2|Overall Study|Suspected pregnancy|1
886178|NCT01261793|2921551|P1|Overall Study|Suspected pregnancy|1
886179|NCT01261793|2921549|P3|Overall Study|Patient non-availability|1
886180|NCT01261793|2921550|P2|Overall Study|Patient non-availability|1
886181|NCT01261793|2921551|P1|Overall Study|Patient non-availability|1
886182|NCT01261793|2921549|P3|Overall Study|Adverse Event|19
886183|NCT01261793|2921550|P2|Overall Study|Adverse Event|24
886184|NCT01261793|2921551|P1|Overall Study|Adverse Event|9
886185|NCT01261793|2921549|P3|Overall Study|Death|0
886186|NCT01261793|2921550|P2|Overall Study|Death|1
886187|NCT01261793|2921551|P1|Overall Study|Death|3
886188|NCT01261793|2921549|P3|Overall Study|Withdrawal by Subject|14
886189|NCT01261793|2921550|P2|Overall Study|Withdrawal by Subject|14
886190|NCT01261793|2921551|P1|Overall Study|Withdrawal by Subject|12
886191|NCT01261793|2921549|P3|Overall Study|Lost to Follow-up|7
886192|NCT01261793|2921550|P2|Overall Study|Lost to Follow-up|3
886193|NCT01261793|2921551|P1|Overall Study|Lost to Follow-up|10
886194|NCT01261793|2921549|P3|Overall Study|Protocol Violation|6
886195|NCT01261793|2921550|P2|Overall Study|Protocol Violation|5
886196|NCT01261793|2921551|P1|Overall Study|Protocol Violation|3
886197|NCT01261793|2921549|P3|Overall Study|Lack of Efficacy|32
886198|NCT01261793|2921550|P2|Overall Study|Lack of Efficacy|37
886199|NCT01261793|2921551|P1|Overall Study|Lack of Efficacy|44
886200|NCT01261780|2921576|P2|Overall Study|Event not related to subject|2
886201|NCT01261780|2921577|P1|Overall Study|Event not related to subject|1
886202|NCT01261780|2921576|P2|Overall Study|Withdrawal by Subject|0
886203|NCT01261780|2921577|P1|Overall Study|Withdrawal by Subject|1
886204|NCT01261624|2921587|P2|Week 13 to Week 24|Insufficient Response|1
886205|NCT01261624|2921588|P1|Week 13 to Week 24|Insufficient Response|0
886206|NCT01261624|2921587|P2|Week 0 to Week 12|Insufficient Response|2
886207|NCT01261624|2921588|P1|Week 0 to Week 12|Insufficient Response|0
886208|NCT01261624|2921587|P2|Week 0 to Week 12|Disease Progression|1
886209|NCT01261624|2921588|P1|Week 0 to Week 12|Disease Progression|1
886210|NCT01261390|2921633|P4|Overall Study|Lost to Follow-up|6
886211|NCT01261390|2921634|P3|Overall Study|Lost to Follow-up|5
886212|NCT01261390|2921635|P2|Overall Study|Lost to Follow-up|6
886213|NCT01261390|2921636|P1|Overall Study|Lost to Follow-up|1
886214|NCT01261390|2921633|P4|Overall Study|Loss of Interest in the Study|0
886215|NCT01261390|2921634|P3|Overall Study|Loss of Interest in the Study|0
886216|NCT01261390|2921635|P2|Overall Study|Loss of Interest in the Study|1
886217|NCT01261390|2921636|P1|Overall Study|Loss of Interest in the Study|3
886218|NCT01261390|2921633|P4|Overall Study|Relocation|0
886219|NCT01261390|2921634|P3|Overall Study|Relocation|0
886220|NCT01261390|2921635|P2|Overall Study|Relocation|1
886221|NCT01261390|2921636|P1|Overall Study|Relocation|0
886222|NCT01261390|2921633|P4|Overall Study|Dissatisfaction with Treatment|2
886223|NCT01261390|2921634|P3|Overall Study|Dissatisfaction with Treatment|1
886224|NCT01261390|2921635|P2|Overall Study|Dissatisfaction with Treatment|1
886225|NCT01261390|2921636|P1|Overall Study|Dissatisfaction with Treatment|2
886226|NCT01261390|2921633|P4|Overall Study|Significant Concurrent Illness|0
886227|NCT01261390|2921634|P3|Overall Study|Significant Concurrent Illness|1
886228|NCT01261390|2921635|P2|Overall Study|Significant Concurrent Illness|0
886229|NCT01261390|2921636|P1|Overall Study|Significant Concurrent Illness|1
886230|NCT01261325|2921801|P3|Overall Study|AE, serious fatal|2
886231|NCT01261325|2921802|P2|Overall Study|AE, serious fatal|0
886232|NCT01261325|2921803|P1|Overall Study|AE, serious fatal|0
886233|NCT01261325|2921801|P3|Overall Study|Lost to Follow-up|3
886234|NCT01261325|2921802|P2|Overall Study|Lost to Follow-up|1
886235|NCT01261325|2921803|P1|Overall Study|Lost to Follow-up|0
886236|NCT01261325|2921801|P3|Overall Study|Protocol Violation|1
886237|NCT01261325|2921802|P2|Overall Study|Protocol Violation|3
886238|NCT01261325|2921803|P1|Overall Study|Protocol Violation|0
886239|NCT01261325|2921801|P3|Overall Study|Randomized in Error|1
886240|NCT01261325|2921802|P2|Overall Study|Randomized in Error|0
886241|NCT01261325|2921803|P1|Overall Study|Randomized in Error|0
886242|NCT01261325|2921801|P3|Overall Study|Screen Failure|0
886243|NCT01261325|2921802|P2|Overall Study|Screen Failure|0
886244|NCT01261325|2921803|P1|Overall Study|Screen Failure|1
886245|NCT01261325|2921801|P3|Overall Study|Erroneously Randomized|0
886246|NCT01261325|2921802|P2|Overall Study|Erroneously Randomized|0
886247|NCT01261325|2921803|P1|Overall Study|Erroneously Randomized|1
886248|NCT01261325|2921801|P3|Overall Study|Patient Randomized by Mistake|0
886249|NCT01261325|2921802|P2|Overall Study|Patient Randomized by Mistake|1
886250|NCT01261325|2921803|P1|Overall Study|Patient Randomized by Mistake|0
886251|NCT01261325|2921801|P3|Overall Study|Non Compliance|0
886252|NCT01261325|2921802|P2|Overall Study|Non Compliance|0
886253|NCT01261325|2921803|P1|Overall Study|Non Compliance|2
886254|NCT01261325|2921801|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
886255|NCT01261325|2921802|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
886256|NCT01261325|2921803|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
886257|NCT01261325|2921801|P3|Overall Study|AE, non-serious non-fatal|13
886258|NCT01261325|2921802|P2|Overall Study|AE, non-serious non-fatal|15
886259|NCT01261325|2921803|P1|Overall Study|AE, non-serious non-fatal|9
886260|NCT01261325|2921801|P3|Overall Study|SAE, non-fatal|1
886261|NCT01261325|2921802|P2|Overall Study|SAE, non-fatal|5
886262|NCT01261325|2921803|P1|Overall Study|SAE, non-fatal|1
886263|NCT01261325|2921801|P3|Overall Study|Withdrawal by Subject|4
886264|NCT01261325|2921802|P2|Overall Study|Withdrawal by Subject|2
886265|NCT01261325|2921803|P1|Overall Study|Withdrawal by Subject|2
886266|NCT01261325|2921801|P3|Overall Study|Lack of Efficacy|0
886267|NCT01261325|2921802|P2|Overall Study|Lack of Efficacy|1
886268|NCT01261325|2921803|P1|Overall Study|Lack of Efficacy|1
886269|NCT01261247|2921835|P1|Overall Study|Ineligible|2
886270|NCT01261000|2921848|P1|Overall Study|Screen failure|1
886271|NCT01260948|2921854|P2|Second Intervention|Emesis|1
886272|NCT01260948|2921855|P1|Second Intervention|Emesis|0
886273|NCT01260948|2921854|P2|Washout of 28 Days|Withdrawal by Subject|3
886274|NCT01260948|2921855|P1|Washout of 28 Days|Withdrawal by Subject|1
886275|NCT01260922|2921865|P2|Second Intervention|Emesis|2
886276|NCT01260922|2921866|P1|Second Intervention|Emesis|0
886277|NCT01260922|2921865|P2|Washout of 28 Days|Withdrawal by Subject|2
886278|NCT01260922|2921866|P1|Washout of 28 Days|Withdrawal by Subject|4
886279|NCT01260922|2921865|P2|First Intervention|Withdrawal by Subject|1
886280|NCT01260922|2921866|P1|First Intervention|Withdrawal by Subject|0
886281|NCT01260896|2921876|P2|First Intervention|Withdrawn Due to Emesis|0
886282|NCT01260896|2921877|P1|First Intervention|Withdrawn Due to Emesis|2
886283|NCT01260701|2921935|P1|Overall Study|Did not begin protocol therapy|1
886284|NCT01260701|2921935|P1|Overall Study|Ineligible|4
886285|NCT01260701|2921935|P1|Overall Study|Under review|1
886286|NCT01260701|2921935|P1|Overall Study|Not protocol specified|3
886287|NCT01260701|2921935|P1|Overall Study|Death|2
886288|NCT01260701|2921935|P1|Overall Study|Progression|53
886289|NCT01260701|2921935|P1|Overall Study|Withdrawal by Subject|2
886290|NCT01260701|2921935|P1|Overall Study|Adverse Event|9
886291|NCT01260584|2922016|P4|Period 2|Withdrawal by Subject|0
886292|NCT01260584|2922017|P3|Period 2|Withdrawal by Subject|0
886293|NCT01260584|2922018|P2|Period 2|Withdrawal by Subject|1
886294|NCT01260584|2922019|P1|Period 2|Withdrawal by Subject|0
886295|NCT01260584|2922016|P4|Period 2|Adverse Event|0
886296|NCT01260584|2922017|P3|Period 2|Adverse Event|2
886297|NCT01260584|2922018|P2|Period 2|Adverse Event|0
886298|NCT01260584|2922019|P1|Period 2|Adverse Event|1
886299|NCT01260584|2922016|P4|Period 2|Protocol Violation|1
886300|NCT01260584|2922017|P3|Period 2|Protocol Violation|3
886301|NCT01260584|2922018|P2|Period 2|Protocol Violation|2
886302|NCT01260584|2922019|P1|Period 2|Protocol Violation|0
886303|NCT01260584|2922016|P4|Period 1|Adverse Event|0
886304|NCT01260584|2922017|P3|Period 1|Adverse Event|1
886305|NCT01260584|2922018|P2|Period 1|Adverse Event|0
886306|NCT01260584|2922019|P1|Period 1|Adverse Event|0
886307|NCT01260584|2922016|P4|Period 1|Protocol Violation|1
886308|NCT01260584|2922017|P3|Period 1|Protocol Violation|1
886309|NCT01260584|2922018|P2|Period 1|Protocol Violation|0
886310|NCT01260584|2922019|P1|Period 1|Protocol Violation|0
886311|NCT01260467|2922062|P1|Overall Study|Withdrawal by Subject|2
886312|NCT01260350|2922094|P22|Overall Study|Did Not Complete Follow-up 12 Visit|0
886313|NCT01260350|2922095|P21|Overall Study|Did Not Complete Follow-up 12 Visit|0
886314|NCT01260350|2922096|P20|Overall Study|Did Not Complete Follow-up 12 Visit|0
886315|NCT01260350|2922097|P19|Overall Study|Did Not Complete Follow-up 12 Visit|0
886316|NCT01260350|2922098|P18|Overall Study|Did Not Complete Follow-up 12 Visit|0
886317|NCT01260350|2922099|P17|Overall Study|Did Not Complete Follow-up 12 Visit|0
886318|NCT01260350|2922100|P16|Overall Study|Did Not Complete Follow-up 12 Visit|0
886319|NCT01260350|2922101|P15|Overall Study|Did Not Complete Follow-up 12 Visit|0
886320|NCT01260350|2922102|P14|Overall Study|Did Not Complete Follow-up 12 Visit|0
886321|NCT01260350|2922103|P13|Overall Study|Did Not Complete Follow-up 12 Visit|0
886322|NCT01260350|2922104|P12|Overall Study|Did Not Complete Follow-up 12 Visit|0
886323|NCT01260350|2922105|P11|Overall Study|Did Not Complete Follow-up 12 Visit|0
886324|NCT01260350|2922106|P10|Overall Study|Did Not Complete Follow-up 12 Visit|0
886325|NCT01260350|2922107|P9|Overall Study|Did Not Complete Follow-up 12 Visit|1
886326|NCT01260350|2922108|P8|Overall Study|Did Not Complete Follow-up 12 Visit|0
886327|NCT01260350|2922109|P7|Overall Study|Did Not Complete Follow-up 12 Visit|0
886328|NCT01260350|2922110|P6|Overall Study|Did Not Complete Follow-up 12 Visit|0
886329|NCT01260350|2922111|P5|Overall Study|Did Not Complete Follow-up 12 Visit|0
886330|NCT01260350|2922112|P4|Overall Study|Did Not Complete Follow-up 12 Visit|0
886331|NCT01260350|2922113|P3|Overall Study|Did Not Complete Follow-up 12 Visit|0
886332|NCT01260350|2922114|P2|Overall Study|Did Not Complete Follow-up 12 Visit|0
886333|NCT01260350|2922115|P1|Overall Study|Did Not Complete Follow-up 12 Visit|0
886334|NCT01260350|2922094|P22|Overall Study|Lack of Efficacy|0
886335|NCT01260350|2922095|P21|Overall Study|Lack of Efficacy|3
886336|NCT01260350|2922096|P20|Overall Study|Lack of Efficacy|0
886337|NCT01260350|2922097|P19|Overall Study|Lack of Efficacy|0
886338|NCT01260350|2922098|P18|Overall Study|Lack of Efficacy|1
886339|NCT01260350|2922099|P17|Overall Study|Lack of Efficacy|0
886340|NCT01260350|2922100|P16|Overall Study|Lack of Efficacy|0
886341|NCT01260350|2922101|P15|Overall Study|Lack of Efficacy|0
886342|NCT01260350|2922102|P14|Overall Study|Lack of Efficacy|0
886343|NCT01260350|2922103|P13|Overall Study|Lack of Efficacy|0
886344|NCT01260350|2922104|P12|Overall Study|Lack of Efficacy|0
886345|NCT01260350|2922105|P11|Overall Study|Lack of Efficacy|0
886346|NCT01260350|2922106|P10|Overall Study|Lack of Efficacy|0
886347|NCT01260350|2922107|P9|Overall Study|Lack of Efficacy|0
886348|NCT01260350|2922108|P8|Overall Study|Lack of Efficacy|0
886349|NCT01260350|2922109|P7|Overall Study|Lack of Efficacy|0
886350|NCT01260350|2922110|P6|Overall Study|Lack of Efficacy|0
886351|NCT01260350|2922111|P5|Overall Study|Lack of Efficacy|0
886352|NCT01260350|2922112|P4|Overall Study|Lack of Efficacy|0
886353|NCT01260350|2922113|P3|Overall Study|Lack of Efficacy|0
886354|NCT01260350|2922114|P2|Overall Study|Lack of Efficacy|0
886355|NCT01260350|2922115|P1|Overall Study|Lack of Efficacy|0
886356|NCT01260311|2922322|P1|Overall Study|Fesoterodine Started Before Enrollment|1
886357|NCT01260311|2922322|P1|Overall Study|Medication Stopped|1
886358|NCT01260311|2922322|P1|Overall Study|Gone to Province|2
886359|NCT01260311|2922322|P1|Overall Study|Financial Constraints|77
886360|NCT01260311|2922322|P1|Overall Study|Withdrawal by Subject|6
886361|NCT01260311|2922322|P1|Overall Study|Lost to Follow-up|25
886362|NCT01260311|2922322|P1|Overall Study|Lack of Efficacy|4
886363|NCT01260311|2922322|P1|Overall Study|Adverse Event|11
886364|NCT01260194|2922353|P1|Overall Study|Withdrawal of Consent|1
886365|NCT01260181|2922365|P1|Overall Study|Decision of Investigator|1
886366|NCT01260142|2922380|P6|Treatment Period 1|Withdrawal by Subject|1
886367|NCT01260142|2922381|P5|Treatment Period 1|Withdrawal by Subject|0
886368|NCT01260142|2922382|P4|Treatment Period 1|Withdrawal by Subject|0
886369|NCT01260142|2922383|P3|Treatment Period 1|Withdrawal by Subject|0
886370|NCT01260142|2922384|P2|Treatment Period 1|Withdrawal by Subject|0
886371|NCT01260142|2922385|P1|Treatment Period 1|Withdrawal by Subject|0
886372|NCT01260142|2922380|P6|Treatment Period 1|Unexplained elevated sys. BP|0
886373|NCT01260142|2922381|P5|Treatment Period 1|Unexplained elevated sys. BP|1
886374|NCT01260142|2922382|P4|Treatment Period 1|Unexplained elevated sys. BP|0
886375|NCT01260142|2922383|P3|Treatment Period 1|Unexplained elevated sys. BP|0
886376|NCT01260142|2922384|P2|Treatment Period 1|Unexplained elevated sys. BP|0
886377|NCT01260142|2922385|P1|Treatment Period 1|Unexplained elevated sys. BP|0
886378|NCT01260142|2922380|P6|Treatment Period 1|Study on hold|2
886379|NCT01260142|2922381|P5|Treatment Period 1|Study on hold|1
886380|NCT01260142|2922382|P4|Treatment Period 1|Study on hold|0
886381|NCT01260142|2922383|P3|Treatment Period 1|Study on hold|0
886382|NCT01260142|2922384|P2|Treatment Period 1|Study on hold|1
886383|NCT01260142|2922385|P1|Treatment Period 1|Study on hold|1
886384|NCT01259856|2922437|P2|Overall Study|Unknown/missing|2
886385|NCT01259856|2922438|P1|Overall Study|Unknown/missing|2
886386|NCT01259856|2922437|P2|Overall Study|Transfer to another study|1
886387|NCT01259856|2922438|P1|Overall Study|Transfer to another study|0
886388|NCT01259856|2922437|P2|Overall Study|Patient developed other disease|1
886389|NCT01259856|2922438|P1|Overall Study|Patient developed other disease|0
886390|NCT01259856|2922437|P2|Overall Study|Study closure by sponsor|41
886391|NCT01259856|2922438|P1|Overall Study|Study closure by sponsor|40
886392|NCT01259856|2922437|P2|Overall Study|Treatment never started|6
886393|NCT01259856|2922438|P1|Overall Study|Treatment never started|0
886394|NCT01259856|2922437|P2|Overall Study|Withdrawal by Subject|10
886395|NCT01259856|2922438|P1|Overall Study|Withdrawal by Subject|9
886396|NCT01259856|2922437|P2|Overall Study|Physician Decision|1
886397|NCT01259856|2922438|P1|Overall Study|Physician Decision|2
886398|NCT01259856|2922437|P2|Overall Study|Lost to Follow-up|1
886399|NCT01259856|2922438|P1|Overall Study|Lost to Follow-up|1
886400|NCT01259856|2922437|P2|Overall Study|Lack of Efficacy|1
886401|NCT01259856|2922438|P1|Overall Study|Lack of Efficacy|3
886402|NCT01259856|2922437|P2|Overall Study|Death|1
886403|NCT01259856|2922438|P1|Overall Study|Death|0
886404|NCT01259856|2922437|P2|Overall Study|Adverse Event|9
886405|NCT01259856|2922438|P1|Overall Study|Adverse Event|12
886406|NCT01259726|2922462|P4|Overall Study|Lost to Follow-up|3
886407|NCT01259726|2922463|P3|Overall Study|Lost to Follow-up|1
886408|NCT01259726|2922464|P2|Overall Study|Lost to Follow-up|1
886409|NCT01259726|2922465|P1|Overall Study|Lost to Follow-up|1
886410|NCT01259726|2922462|P4|Overall Study|Withdrawal by Subject|1
886411|NCT01259726|2922463|P3|Overall Study|Withdrawal by Subject|2
886412|NCT01259726|2922464|P2|Overall Study|Withdrawal by Subject|3
886413|NCT01259726|2922465|P1|Overall Study|Withdrawal by Subject|1
886414|NCT01259726|2922462|P4|Overall Study|Physician Decision|1
886415|NCT01259726|2922463|P3|Overall Study|Physician Decision|1
886416|NCT01259726|2922464|P2|Overall Study|Physician Decision|0
886417|NCT01259726|2922465|P1|Overall Study|Physician Decision|2
886418|NCT01259726|2922462|P4|Overall Study|Death|0
886419|NCT01259726|2922463|P3|Overall Study|Death|0
886420|NCT01259726|2922464|P2|Overall Study|Death|0
886421|NCT01259726|2922465|P1|Overall Study|Death|1
886422|NCT01259713|2922497|P2|Overall Study|Subject Withdrew Consent|7
886423|NCT01259713|2922498|P1|Overall Study|Subject Withdrew Consent|12
886424|NCT01259713|2922497|P2|Overall Study|Protocol Violation|4
886425|NCT01259713|2922498|P1|Overall Study|Protocol Violation|5
886426|NCT01259713|2922497|P2|Overall Study|Lack of Efficacy|0
886427|NCT01259713|2922498|P1|Overall Study|Lack of Efficacy|2
886428|NCT01259713|2922497|P2|Overall Study|Investigators Discretion|6
886429|NCT01259713|2922498|P1|Overall Study|Investigators Discretion|14
886430|NCT01259713|2922497|P2|Overall Study|Death Not Related to IFI|1
886431|NCT01259713|2922498|P1|Overall Study|Death Not Related to IFI|8
886432|NCT01259713|2922497|P2|Overall Study|Adverse Event|23
886433|NCT01259713|2922498|P1|Overall Study|Adverse Event|54
886434|NCT01259492|2922545|P4|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7
886435|NCT01259492|2922546|P3|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3
886436|NCT01259492|2922547|P2|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6
886437|NCT01259492|2922548|P1|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5
886438|NCT01259492|2922545|P4|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
886439|NCT01259492|2922546|P3|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1
886440|NCT01259492|2922547|P2|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
886441|NCT01259492|2922548|P1|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
886442|NCT01259492|2922545|P4|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
886443|NCT01259492|2922546|P3|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6
886444|NCT01259492|2922547|P2|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4
886445|NCT01259492|2922548|P1|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
886446|NCT01259492|2922545|P4|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3
886447|NCT01259492|2922546|P3|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4
886448|NCT01259492|2922547|P2|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6
886449|NCT01259492|2922548|P1|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12
886450|NCT01259492|2922545|P4|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
886451|NCT01259492|2922546|P3|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
886452|NCT01259492|2922547|P2|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
886453|NCT01259492|2922548|P1|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1
886454|NCT01259492|2922545|P4|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62
886455|NCT01259492|2922546|P3|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29
886456|NCT01259492|2922547|P2|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42
886457|NCT01259492|2922548|P1|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28
886458|NCT01259492|2922545|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
886459|NCT01259492|2922546|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1
886460|NCT01259492|2922547|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
886461|NCT01259492|2922548|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
886462|NCT01259492|2922545|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1
886463|NCT01259492|2922546|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
886464|NCT01259492|2922547|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
886465|NCT01259492|2922548|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
886466|NCT01259492|2922545|P4|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
886467|NCT01259492|2922546|P3|Period 3 (Week 15 to End of Week 40)|Adverse Event|6
886468|NCT01259492|2922547|P2|Period 3 (Week 15 to End of Week 40)|Adverse Event|11
886469|NCT01259492|2922548|P1|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
886470|NCT01259492|2922545|P4|Period 2 (Week 10 to Week 14)|Protocol Violation|0
886471|NCT01259492|2922546|P3|Period 2 (Week 10 to Week 14)|Protocol Violation|1
886472|NCT01259492|2922547|P2|Period 2 (Week 10 to Week 14)|Protocol Violation|2
886473|NCT01259492|2922548|P1|Period 2 (Week 10 to Week 14)|Protocol Violation|0
886474|NCT01259492|2922545|P4|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
886475|NCT01259492|2922546|P3|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1
886476|NCT01259492|2922547|P2|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
886477|NCT01259492|2922548|P1|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
886478|NCT01259492|2922545|P4|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4
886479|NCT01259492|2922546|P3|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8
886480|NCT01259492|2922547|P2|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2
886481|NCT01259492|2922548|P1|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6
886482|NCT01259492|2922545|P4|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
886483|NCT01259492|2922546|P3|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
886484|NCT01259492|2922547|P2|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
886485|NCT01259492|2922548|P1|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
886486|NCT01259492|2922545|P4|Period 2 (Week 10 to Week 14)|Adverse Event|8
886487|NCT01259492|2922546|P3|Period 2 (Week 10 to Week 14)|Adverse Event|7
886488|NCT01259492|2922547|P2|Period 2 (Week 10 to Week 14)|Adverse Event|4
886489|NCT01259492|2922548|P1|Period 2 (Week 10 to Week 14)|Adverse Event|3
886490|NCT01259492|2922545|P4|Period 1 (9 Weeks)|Protocol Violation|1
886491|NCT01259492|2922546|P3|Period 1 (9 Weeks)|Protocol Violation|3
886492|NCT01259492|2922547|P2|Period 1 (9 Weeks)|Protocol Violation|6
886493|NCT01259492|2922548|P1|Period 1 (9 Weeks)|Protocol Violation|5
886494|NCT01259492|2922545|P4|Period 1 (9 Weeks)|Administrative Problems|2
886495|NCT01259492|2922546|P3|Period 1 (9 Weeks)|Administrative Problems|1
886496|NCT01259492|2922547|P2|Period 1 (9 Weeks)|Administrative Problems|1
886497|NCT01259492|2922548|P1|Period 1 (9 Weeks)|Administrative Problems|0
886498|NCT01259492|2922545|P4|Period 1 (9 Weeks)|Lost to Follow-up|4
886499|NCT01259492|2922546|P3|Period 1 (9 Weeks)|Lost to Follow-up|3
886500|NCT01259492|2922547|P2|Period 1 (9 Weeks)|Lost to Follow-up|6
886501|NCT01259492|2922548|P1|Period 1 (9 Weeks)|Lost to Follow-up|4
886502|NCT01259492|2922545|P4|Period 1 (9 Weeks)|Withdrawal by Subject|7
886503|NCT01259492|2922546|P3|Period 1 (9 Weeks)|Withdrawal by Subject|6
886504|NCT01259492|2922547|P2|Period 1 (9 Weeks)|Withdrawal by Subject|8
886505|NCT01259492|2922548|P1|Period 1 (9 Weeks)|Withdrawal by Subject|5
886506|NCT01259492|2922545|P4|Period 1 (9 Weeks)|Lack of Efficacy|11
886507|NCT01259492|2922546|P3|Period 1 (9 Weeks)|Lack of Efficacy|4
886508|NCT01259492|2922547|P2|Period 1 (9 Weeks)|Lack of Efficacy|2
886509|NCT01259492|2922548|P1|Period 1 (9 Weeks)|Lack of Efficacy|2
886510|NCT01259492|2922545|P4|Period 1 (9 Weeks)|Adverse Event|3
886511|NCT01259492|2922546|P3|Period 1 (9 Weeks)|Adverse Event|26
886512|NCT01259492|2922547|P2|Period 1 (9 Weeks)|Adverse Event|18
886513|NCT01259492|2922548|P1|Period 1 (9 Weeks)|Adverse Event|13
886514|NCT01259466|2922597|P2|Overall Study|Withdrawal by Subject|9
886515|NCT01259466|2922598|P1|Overall Study|Withdrawal by Subject|1
886516|NCT01259401|2922636|P2|4-month Follow-up|Lost to Follow-up|1
886517|NCT01259401|2922637|P1|4-month Follow-up|Lost to Follow-up|0
886518|NCT01259401|2922636|P2|4-month Follow-up|Death|1
886519|NCT01259401|2922637|P1|4-month Follow-up|Death|0
886520|NCT01259375|2922645|P1|Overall Study|Adverse Event|1
886521|NCT01259297|2922662|P8|Double Blind Randomized Period|Other reasons|1
886522|NCT01259297|2922663|P7|Double Blind Randomized Period|Other reasons|3
886523|NCT01259297|2922664|P6|Double Blind Randomized Period|Other reasons|2
886524|NCT01259297|2922665|P5|Double Blind Randomized Period|Other reasons|1
886525|NCT01259297|2922666|P4|Double Blind Randomized Period|Other reasons|0
886526|NCT01259297|2922667|P3|Double Blind Randomized Period|Other reasons|0
886527|NCT01259297|2922668|P2|Double Blind Randomized Period|Other reasons|1
886528|NCT01259297|2922669|P1|Double Blind Randomized Period|Other reasons|0
886529|NCT01259297|2922662|P8|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
886530|NCT01259297|2922663|P7|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
886531|NCT01259297|2922664|P6|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
886532|NCT01259297|2922665|P5|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
886533|NCT01259297|2922666|P4|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
886534|NCT01259297|2922667|P3|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0
886535|NCT01259297|2922668|P2|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
886536|NCT01259297|2922669|P1|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
886537|NCT01259297|2922662|P8|Double Blind Randomized Period|Death|1
886538|NCT01259297|2922663|P7|Double Blind Randomized Period|Death|2
886539|NCT01259297|2922664|P6|Double Blind Randomized Period|Death|5
886540|NCT01259297|2922665|P5|Double Blind Randomized Period|Death|1
886541|NCT01259297|2922666|P4|Double Blind Randomized Period|Death|2
886542|NCT01259297|2922667|P3|Double Blind Randomized Period|Death|1
886543|NCT01259297|2922668|P2|Double Blind Randomized Period|Death|1
886544|NCT01259297|2922669|P1|Double Blind Randomized Period|Death|1
886545|NCT01259284|2922700|P3|Overall Study|Study Termination|0
886546|NCT01259284|2922701|P2|Overall Study|Study Termination|0
886547|NCT01259284|2922702|P1|Overall Study|Study Termination|2
886548|NCT01259245|2922712|P2|Overall Study|Death|2
886549|NCT01259245|2922713|P1|Overall Study|Death|1
886550|NCT01259245|2922712|P2|Overall Study|Withdrawal by Subject|24
886551|NCT01259245|2922713|P1|Overall Study|Withdrawal by Subject|27
886552|NCT01259115|2922737|P2|Period 2|Adverse Event|0
886553|NCT01259115|2922738|P1|Period 2|Adverse Event|1
886554|NCT01259115|2922737|P2|Period 1|Lost to Follow-up|1
886555|NCT01259115|2922738|P1|Period 1|Lost to Follow-up|0
886556|NCT01259115|2922737|P2|Period 1|Protocol Violation|0
886557|NCT01259115|2922738|P1|Period 1|Protocol Violation|2
886558|NCT01259115|2922737|P2|Period 1|Adverse Event|0
886559|NCT01259115|2922738|P1|Period 1|Adverse Event|1
886560|NCT01259102|2922774|P5|Overall Study|Other|1
886561|NCT01259102|2922775|P4|Overall Study|Other|1
886562|NCT01259102|2922776|P3|Overall Study|Other|1
886563|NCT01259102|2922777|P2|Overall Study|Other|0
886564|NCT01259102|2922778|P1|Overall Study|Other|0
886565|NCT01259102|2922774|P5|Overall Study|Adverse Event|0
886566|NCT01259102|2922775|P4|Overall Study|Adverse Event|1
886567|NCT01259102|2922776|P3|Overall Study|Adverse Event|1
886568|NCT01259102|2922777|P2|Overall Study|Adverse Event|0
886569|NCT01259102|2922778|P1|Overall Study|Adverse Event|1
886570|NCT01259089|2922835|P6|Survival Follow up for Two Years|stopped being followed as study closed|4
886571|NCT01259089|2922836|P5|Survival Follow up for Two Years|stopped being followed as study closed|0
886572|NCT01259089|2922837|P4|Survival Follow up for Two Years|stopped being followed as study closed|0
886573|NCT01259089|2922838|P3|Survival Follow up for Two Years|stopped being followed as study closed|0
886574|NCT01259089|2922839|P2|Survival Follow up for Two Years|stopped being followed as study closed|0
886575|NCT01259089|2922840|P1|Survival Follow up for Two Years|stopped being followed as study closed|0
886576|NCT01259089|2922835|P6|Survival Follow up for Two Years|Lost to Follow-up|2
886577|NCT01259089|2922836|P5|Survival Follow up for Two Years|Lost to Follow-up|0
886578|NCT01259089|2922837|P4|Survival Follow up for Two Years|Lost to Follow-up|0
886579|NCT01259089|2922838|P3|Survival Follow up for Two Years|Lost to Follow-up|0
886580|NCT01259089|2922839|P2|Survival Follow up for Two Years|Lost to Follow-up|0
886581|NCT01259089|2922840|P1|Survival Follow up for Two Years|Lost to Follow-up|0
886582|NCT01259089|2922835|P6|Survival Follow up for Two Years|Death|13
886583|NCT01259089|2922836|P5|Survival Follow up for Two Years|Death|6
886584|NCT01259089|2922837|P4|Survival Follow up for Two Years|Death|3
886585|NCT01259089|2922838|P3|Survival Follow up for Two Years|Death|2
886586|NCT01259089|2922839|P2|Survival Follow up for Two Years|Death|2
886587|NCT01259089|2922840|P1|Survival Follow up for Two Years|Death|3
886588|NCT01259089|2922835|P6|Continued Treatment After 8 Weeks|Progressive disease|0
886589|NCT01259089|2922836|P5|Continued Treatment After 8 Weeks|Progressive disease|0
886590|NCT01259089|2922837|P4|Continued Treatment After 8 Weeks|Progressive disease|1
886591|NCT01259089|2922838|P3|Continued Treatment After 8 Weeks|Progressive disease|1
886592|NCT01259089|2922839|P2|Continued Treatment After 8 Weeks|Progressive disease|1
886593|NCT01259089|2922840|P1|Continued Treatment After 8 Weeks|Progressive disease|1
886594|NCT01259089|2922835|P6|Continued Treatment After 8 Weeks|Adverse Event|1
886595|NCT01259089|2922836|P5|Continued Treatment After 8 Weeks|Adverse Event|2
886596|NCT01259089|2922837|P4|Continued Treatment After 8 Weeks|Adverse Event|0
886597|NCT01259089|2922838|P3|Continued Treatment After 8 Weeks|Adverse Event|0
886598|NCT01259089|2922839|P2|Continued Treatment After 8 Weeks|Adverse Event|0
886599|NCT01259089|2922840|P1|Continued Treatment After 8 Weeks|Adverse Event|0
886600|NCT01259089|2922835|P6|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
886601|NCT01259089|2922836|P5|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
886602|NCT01259089|2922837|P4|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
886603|NCT01259089|2922838|P3|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
886604|NCT01259089|2922839|P2|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
886605|NCT01259089|2922840|P1|Continued Treatment After 8 Weeks|Withdrawal by Subject|1
886606|NCT01259089|2922835|P6|Confirmed Response at 8 Weeks|Progressive disease|7
886607|NCT01259089|2922836|P5|Confirmed Response at 8 Weeks|Progressive disease|3
886608|NCT01259089|2922837|P4|Confirmed Response at 8 Weeks|Progressive disease|1
886609|NCT01259089|2922838|P3|Confirmed Response at 8 Weeks|Progressive disease|1
886610|NCT01259089|2922839|P2|Confirmed Response at 8 Weeks|Progressive disease|0
886611|NCT01259089|2922840|P1|Confirmed Response at 8 Weeks|Progressive disease|0
886612|NCT01259089|2922835|P6|Confirmed Response at 8 Weeks|Adverse Event|2
886613|NCT01259089|2922836|P5|Confirmed Response at 8 Weeks|Adverse Event|1
886614|NCT01259089|2922837|P4|Confirmed Response at 8 Weeks|Adverse Event|0
886615|NCT01259089|2922838|P3|Confirmed Response at 8 Weeks|Adverse Event|0
886616|NCT01259089|2922839|P2|Confirmed Response at 8 Weeks|Adverse Event|0
886617|NCT01259089|2922840|P1|Confirmed Response at 8 Weeks|Adverse Event|0
886618|NCT01259089|2922835|P6|Confirmed Response at 8 Weeks|Withdrawal by Subject|1
886619|NCT01259089|2922836|P5|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
886620|NCT01259089|2922837|P4|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
886621|NCT01259089|2922838|P3|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
886622|NCT01259089|2922839|P2|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
886623|NCT01259089|2922840|P1|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
886624|NCT01259089|2922835|P6|Reached First Response at 4 Weeks|Adverse Event|1
886625|NCT01259089|2922836|P5|Reached First Response at 4 Weeks|Adverse Event|0
886626|NCT01259089|2922837|P4|Reached First Response at 4 Weeks|Adverse Event|0
886627|NCT01259089|2922838|P3|Reached First Response at 4 Weeks|Adverse Event|0
886628|NCT01259089|2922839|P2|Reached First Response at 4 Weeks|Adverse Event|0
886629|NCT01259089|2922840|P1|Reached First Response at 4 Weeks|Adverse Event|0
886630|NCT01259089|2922835|P6|Reached First Response at 4 Weeks|Patient not treated on study|1
886631|NCT01259089|2922836|P5|Reached First Response at 4 Weeks|Patient not treated on study|0
886632|NCT01259089|2922837|P4|Reached First Response at 4 Weeks|Patient not treated on study|0
886633|NCT01259089|2922838|P3|Reached First Response at 4 Weeks|Patient not treated on study|0
886634|NCT01259089|2922839|P2|Reached First Response at 4 Weeks|Patient not treated on study|0
886635|NCT01259089|2922840|P1|Reached First Response at 4 Weeks|Patient not treated on study|0
886636|NCT01259024|2922863|P1|Overall Study|Physician Decision|1
886637|NCT01258998|2922883|P1|Overall Study|Ineligible|1
886638|NCT01258803|2922916|P6|Treatment Period 3 (1 Dose)|Protocol Violation|0
886639|NCT01258803|2922917|P5|Treatment Period 3 (1 Dose)|Protocol Violation|0
886640|NCT01258803|2922918|P4|Treatment Period 3 (1 Dose)|Protocol Violation|0
886641|NCT01258803|2922919|P3|Treatment Period 3 (1 Dose)|Protocol Violation|1
886642|NCT01258803|2922920|P2|Treatment Period 3 (1 Dose)|Protocol Violation|0
886643|NCT01258803|2922921|P1|Treatment Period 3 (1 Dose)|Protocol Violation|0
886644|NCT01258803|2922916|P6|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
886645|NCT01258803|2922917|P5|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
886646|NCT01258803|2922918|P4|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
886647|NCT01258803|2922919|P3|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
886648|NCT01258803|2922920|P2|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1
886649|NCT01258803|2922921|P1|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
886650|NCT01258803|2922916|P6|Treatment Period 2 (1 Dose)|Protocol Violation|1
886651|NCT01258803|2922917|P5|Treatment Period 2 (1 Dose)|Protocol Violation|0
886652|NCT01258803|2922918|P4|Treatment Period 2 (1 Dose)|Protocol Violation|0
886653|NCT01258803|2922919|P3|Treatment Period 2 (1 Dose)|Protocol Violation|0
886654|NCT01258803|2922920|P2|Treatment Period 2 (1 Dose)|Protocol Violation|1
886655|NCT01258803|2922921|P1|Treatment Period 2 (1 Dose)|Protocol Violation|1
886656|NCT01258738|2922958|P2|Open-label Period|Withdrawn due to pregnancy|1
886657|NCT01258738|2922959|P1|Open-label Period|Withdrawn due to pregnancy|1
886658|NCT01258738|2922958|P2|Open-label Period|Other Reasons|1
886659|NCT01258738|2922959|P1|Open-label Period|Other Reasons|0
886660|NCT01258738|2922958|P2|Open-label Period|Adverse Event|5
886661|NCT01258738|2922959|P1|Open-label Period|Adverse Event|4
886662|NCT01258738|2922958|P2|Open-label Period|Protocol Violation|2
886663|NCT01258738|2922959|P1|Open-label Period|Protocol Violation|2
886664|NCT01258738|2922958|P2|Open-label Period|Withdrawal by Subject|6
886665|NCT01258738|2922959|P1|Open-label Period|Withdrawal by Subject|5
886666|NCT01258738|2922958|P2|Open-label Period|Lost to Follow-up|2
886667|NCT01258738|2922959|P1|Open-label Period|Lost to Follow-up|0
886668|NCT01258738|2922958|P2|Open-label Period|Insufficient clinical response|3
886669|NCT01258738|2922959|P1|Open-label Period|Insufficient clinical response|5
886670|NCT01258738|2922958|P2|Open-label Period|Did not meet inclusion criteria|1
886671|NCT01258738|2922959|P1|Open-label Period|Did not meet inclusion criteria|0
886672|NCT01258738|2922958|P2|Double-blind Period|Adverse Event|1
886673|NCT01258738|2922959|P1|Double-blind Period|Adverse Event|3
886674|NCT01258738|2922958|P2|Double-blind Period|Protocol Violation|1
886675|NCT01258738|2922959|P1|Double-blind Period|Protocol Violation|1
886676|NCT01258738|2922958|P2|Double-blind Period|Withdrawal by Subject|2
886677|NCT01258738|2922959|P1|Double-blind Period|Withdrawal by Subject|2
886678|NCT01258738|2922958|P2|Double-blind Period|Did not meet inclusion criteria|3
886679|NCT01258738|2922959|P1|Double-blind Period|Did not meet inclusion criteria|3
886680|NCT01258660|2923097|P2|Overall Study|Invalid for primary analysis data set|6
886681|NCT01258660|2923098|P1|Overall Study|Invalid for primary analysis data set|4
886682|NCT01258660|2923097|P2|Overall Study|Protocol Violation|1
886683|NCT01258660|2923098|P1|Overall Study|Protocol Violation|0
886684|NCT01258660|2923097|P2|Overall Study|due to relocation|0
886685|NCT01258660|2923098|P1|Overall Study|due to relocation|2
886686|NCT01258660|2923097|P2|Overall Study|Withdrawal by Subject|0
886687|NCT01258660|2923098|P1|Overall Study|Withdrawal by Subject|3
886688|NCT01258660|2923097|P2|Overall Study|Adverse Event|4
886689|NCT01258660|2923098|P1|Overall Study|Adverse Event|2
886690|NCT01258595|2923117|P2|Overall Study|Withdrawal by Subject|1
886691|NCT01258595|2923118|P1|Overall Study|Withdrawal by Subject|0
886692|NCT01258595|2923117|P2|Overall Study|Lost to Follow-up|0
886693|NCT01258595|2923118|P1|Overall Study|Lost to Follow-up|1
886694|NCT01258348|2923208|P5|Overall Study|Withdrawal by Subject|0
886695|NCT01258348|2923209|P4|Overall Study|Withdrawal by Subject|0
886696|NCT01258348|2923210|P3|Overall Study|Withdrawal by Subject|0
886697|NCT01258348|2923211|P2|Overall Study|Withdrawal by Subject|1
886698|NCT01258348|2923212|P1|Overall Study|Withdrawal by Subject|0
886699|NCT01258348|2923208|P5|Overall Study|Physician Decision|0
886700|NCT01258348|2923209|P4|Overall Study|Physician Decision|2
886701|NCT01258348|2923210|P3|Overall Study|Physician Decision|0
886702|NCT01258348|2923211|P2|Overall Study|Physician Decision|0
886703|NCT01258348|2923212|P1|Overall Study|Physician Decision|0
886704|NCT01258348|2923208|P5|Overall Study|Progressive Disease|2
886705|NCT01258348|2923209|P4|Overall Study|Progressive Disease|2
886706|NCT01258348|2923210|P3|Overall Study|Progressive Disease|0
886707|NCT01258348|2923211|P2|Overall Study|Progressive Disease|3
886708|NCT01258348|2923212|P1|Overall Study|Progressive Disease|0
886709|NCT01258348|2923208|P5|Overall Study|Adverse Event|4
886710|NCT01258348|2923209|P4|Overall Study|Adverse Event|2
886711|NCT01258348|2923210|P3|Overall Study|Adverse Event|3
886712|NCT01258348|2923211|P2|Overall Study|Adverse Event|1
886713|NCT01258348|2923212|P1|Overall Study|Adverse Event|1
886714|NCT01258101|2923269|P4|Overall Study|Other reason|8
886715|NCT01258101|2923270|P3|Overall Study|Other reason|1
886716|NCT01258101|2923271|P2|Overall Study|Other reason|8
886717|NCT01258101|2923272|P1|Overall Study|Other reason|7
886718|NCT01258101|2923269|P4|Overall Study|PCR positive at week 24|1
886719|NCT01258101|2923270|P3|Overall Study|PCR positive at week 24|0
886720|NCT01258101|2923271|P2|Overall Study|PCR positive at week 24|0
886721|NCT01258101|2923272|P1|Overall Study|PCR positive at week 24|0
886722|NCT01258101|2923269|P4|Overall Study|Lost to Follow-up|6
886723|NCT01258101|2923270|P3|Overall Study|Lost to Follow-up|0
886724|NCT01258101|2923271|P2|Overall Study|Lost to Follow-up|5
886725|NCT01258101|2923272|P1|Overall Study|Lost to Follow-up|5
886726|NCT01258101|2923269|P4|Overall Study|Patient´s compliance|2
886727|NCT01258101|2923270|P3|Overall Study|Patient´s compliance|1
886728|NCT01258101|2923271|P2|Overall Study|Patient´s compliance|3
886729|NCT01258101|2923272|P1|Overall Study|Patient´s compliance|4
886730|NCT01258101|2923269|P4|Overall Study|Patient is not able to attend visits|6
886731|NCT01258101|2923270|P3|Overall Study|Patient is not able to attend visits|7
886732|NCT01258101|2923271|P2|Overall Study|Patient is not able to attend visits|9
886733|NCT01258101|2923272|P1|Overall Study|Patient is not able to attend visits|8
886734|NCT01258101|2923269|P4|Overall Study|Informed consent has been withdrawn|1
886735|NCT01258101|2923270|P3|Overall Study|Informed consent has been withdrawn|1
886736|NCT01258101|2923271|P2|Overall Study|Informed consent has been withdrawn|2
886737|NCT01258101|2923272|P1|Overall Study|Informed consent has been withdrawn|2
886738|NCT01258101|2923269|P4|Overall Study|Extra exclusion criterion amended|1
886739|NCT01258101|2923270|P3|Overall Study|Extra exclusion criterion amended|1
886740|NCT01258101|2923271|P2|Overall Study|Extra exclusion criterion amended|1
886741|NCT01258101|2923272|P1|Overall Study|Extra exclusion criterion amended|2
886742|NCT01258101|2923269|P4|Overall Study|Adverse Event|0
886743|NCT01258101|2923270|P3|Overall Study|Adverse Event|0
886744|NCT01258101|2923271|P2|Overall Study|Adverse Event|6
886745|NCT01258101|2923272|P1|Overall Study|Adverse Event|5
886746|NCT01257737|2923402|P2|Overall Study|Withdrew from study|1
886747|NCT01257737|2923403|P1|Overall Study|Withdrew from study|0
886748|NCT01257737|2923402|P2|Overall Study|Relocation out of the country|1
886749|NCT01257737|2923403|P1|Overall Study|Relocation out of the country|0
886750|NCT01257737|2923402|P2|Overall Study|Liver transplant|0
886751|NCT01257737|2923403|P1|Overall Study|Liver transplant|1
886752|NCT01257737|2923402|P2|Overall Study|Lost to Follow-up|2
886753|NCT01257737|2923403|P1|Overall Study|Lost to Follow-up|1
886754|NCT01257581|2923424|P3|Overall Study|Death|4
886755|NCT01257581|2923425|P2|Overall Study|Death|2
886756|NCT01257581|2923426|P1|Overall Study|Death|2
886757|NCT01257581|2923424|P3|Overall Study|Early Termination|2
886758|NCT01257581|2923425|P2|Overall Study|Early Termination|1
886759|NCT01257581|2923426|P1|Overall Study|Early Termination|3
886760|NCT01257542|2923466|P2|Overall Study|Withdrawal by Subject|2
886761|NCT01257542|2923467|P1|Overall Study|Withdrawal by Subject|0
886762|NCT01257542|2923466|P2|Overall Study|Protocol Violation|5
886763|NCT01257542|2923467|P1|Overall Study|Protocol Violation|3
886764|NCT01257503|2923487|P2|Overall Study|strep culture positive at enrollment|0
886765|NCT01257503|2923488|P1|Overall Study|strep culture positive at enrollment|1
886766|NCT01257503|2923487|P2|Overall Study|Over 5 years old at enrollment|1
886767|NCT01257503|2923488|P1|Overall Study|Over 5 years old at enrollment|0
886768|NCT01257503|2923487|P2|Overall Study|Lost to Follow-up|10
886769|NCT01257503|2923488|P1|Overall Study|Lost to Follow-up|7
886770|NCT01257425|2923517|P2|Overall Study|Death|0
886771|NCT01257425|2923518|P1|Overall Study|Death|1
886772|NCT01257425|2923517|P2|Overall Study|Withdrawal by Subject|1
886773|NCT01257425|2923518|P1|Overall Study|Withdrawal by Subject|0
886774|NCT01257425|2923517|P2|Overall Study|Protocol Violation|1
886775|NCT01257425|2923518|P1|Overall Study|Protocol Violation|1
886776|NCT01257425|2923517|P2|Overall Study|Adverse Event|1
886777|NCT01257425|2923518|P1|Overall Study|Adverse Event|1
886778|NCT01257425|2923517|P2|Overall Study|Lack of Efficacy|3
886779|NCT01257425|2923518|P1|Overall Study|Lack of Efficacy|3
886780|NCT01257230|2923560|P3|Overall Study|Other reason not defined above|3
886781|NCT01257230|2923561|P2|Overall Study|Other reason not defined above|5
886782|NCT01257230|2923562|P1|Overall Study|Other reason not defined above|1
886783|NCT01257230|2923560|P3|Overall Study|Withdrawal by Subject|1
886784|NCT01257230|2923561|P2|Overall Study|Withdrawal by Subject|4
886785|NCT01257230|2923562|P1|Overall Study|Withdrawal by Subject|0
886786|NCT01257230|2923560|P3|Overall Study|Protocol Violation|1
886787|NCT01257230|2923561|P2|Overall Study|Protocol Violation|0
886788|NCT01257230|2923562|P1|Overall Study|Protocol Violation|3
886789|NCT01257230|2923560|P3|Overall Study|Lack of Efficacy|0
886790|NCT01257230|2923561|P2|Overall Study|Lack of Efficacy|1
886791|NCT01257230|2923562|P1|Overall Study|Lack of Efficacy|0
886792|NCT01257230|2923560|P3|Overall Study|Adverse Event|0
886793|NCT01257230|2923561|P2|Overall Study|Adverse Event|0
886794|NCT01257230|2923562|P1|Overall Study|Adverse Event|2
886795|NCT01257230|2923560|P3|Overall Study|Not Treated|1
886796|NCT01257230|2923561|P2|Overall Study|Not Treated|0
886797|NCT01257230|2923562|P1|Overall Study|Not Treated|0
886798|NCT01257204|2923639|P3|Follow-up Period (up to Week 48)|Other|5
886799|NCT01257204|2923640|P2|Follow-up Period (up to Week 48)|Other|0
886800|NCT01257204|2923641|P1|Follow-up Period (up to Week 48)|Other|0
886801|NCT01257204|2923639|P3|Follow-up Period (up to Week 48)|Lost to Follow-up|4
886802|NCT01257204|2923640|P2|Follow-up Period (up to Week 48)|Lost to Follow-up|4
886803|NCT01257204|2923641|P1|Follow-up Period (up to Week 48)|Lost to Follow-up|1
886804|NCT01257204|2923639|P3|Follow-up Period (up to Week 48)|Withdrawal by Subject|1
886805|NCT01257204|2923640|P2|Follow-up Period (up to Week 48)|Withdrawal by Subject|2
886806|NCT01257204|2923641|P1|Follow-up Period (up to Week 48)|Withdrawal by Subject|0
886807|NCT01257204|2923639|P3|Treatment Period (up to Week 24)|Participant's request to discontinue|2
886808|NCT01257204|2923640|P2|Treatment Period (up to Week 24)|Participant's request to discontinue|2
886809|NCT01257204|2923641|P1|Treatment Period (up to Week 24)|Participant's request to discontinue|1
886810|NCT01257204|2923639|P3|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1
886811|NCT01257204|2923640|P2|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
886812|NCT01257204|2923641|P1|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
886813|NCT01257204|2923639|P3|Treatment Period (up to Week 24)|Lost to Follow-up|0
886814|NCT01257204|2923640|P2|Treatment Period (up to Week 24)|Lost to Follow-up|2
886815|NCT01257204|2923641|P1|Treatment Period (up to Week 24)|Lost to Follow-up|0
886816|NCT01257204|2923639|P3|Treatment Period (up to Week 24)|Withdrawal by Subject|1
886817|NCT01257204|2923640|P2|Treatment Period (up to Week 24)|Withdrawal by Subject|0
886818|NCT01257204|2923641|P1|Treatment Period (up to Week 24)|Withdrawal by Subject|1
886819|NCT01257204|2923639|P3|Treatment Period (up to Week 24)|Adverse Event|2
886820|NCT01257204|2923640|P2|Treatment Period (up to Week 24)|Adverse Event|1
886821|NCT01257204|2923641|P1|Treatment Period (up to Week 24)|Adverse Event|3
886822|NCT01257204|2923639|P3|Treatment Period (up to Week 24)|Lack of Efficacy|3
886823|NCT01257204|2923640|P2|Treatment Period (up to Week 24)|Lack of Efficacy|1
886824|NCT01257204|2923641|P1|Treatment Period (up to Week 24)|Lack of Efficacy|0
886825|NCT01256684|2923752|P3|Overall Study|Entry criteria not met/non-compliance|6
886826|NCT01256684|2923753|P2|Overall Study|Entry criteria not met/non-compliance|7
886827|NCT01256684|2923754|P1|Overall Study|Entry criteria not met/non-compliance|4
886828|NCT01256684|2923752|P3|Overall Study|Lack of Efficacy|1
886829|NCT01256684|2923753|P2|Overall Study|Lack of Efficacy|1
886830|NCT01256684|2923754|P1|Overall Study|Lack of Efficacy|0
886831|NCT01256684|2923752|P3|Overall Study|Physician Decision|0
886832|NCT01256684|2923753|P2|Overall Study|Physician Decision|1
886833|NCT01256684|2923754|P1|Overall Study|Physician Decision|0
886834|NCT01256684|2923752|P3|Overall Study|Withdrawal by Subject|2
886835|NCT01256684|2923753|P2|Overall Study|Withdrawal by Subject|0
886836|NCT01256684|2923754|P1|Overall Study|Withdrawal by Subject|4
886837|NCT01256684|2923752|P3|Overall Study|Adverse Event|2
886838|NCT01256684|2923753|P2|Overall Study|Adverse Event|4
886839|NCT01256684|2923754|P1|Overall Study|Adverse Event|1
886840|NCT01256671|2923786|P1|Overall Study|Non-compliance/Sponsor Decision/Other|12
886841|NCT01256671|2923786|P1|Overall Study|Lack of Efficacy|4
886842|NCT01256671|2923786|P1|Overall Study|Physician Decision|3
886843|NCT01256671|2923786|P1|Overall Study|Withdrawal by Subject|31
886844|NCT01256671|2923786|P1|Overall Study|Lost to Follow-up|16
886845|NCT01256671|2923786|P1|Overall Study|Adverse Event|29
886846|NCT01256658|2923799|P2|Period 1|Death|44
886847|NCT01256658|2923800|P1|Period 1|Death|48
886848|NCT01256658|2923799|P2|Period 1|Withdrawal by Subject|43
886849|NCT01256658|2923800|P1|Period 1|Withdrawal by Subject|35
886850|NCT01256658|2923799|P2|Period 1|Lost to Follow-up|661
886851|NCT01256658|2923800|P1|Period 1|Lost to Follow-up|837
886852|NCT01256567|2923850|P1|Overall Study|Withdrawal by Subject|1
886853|NCT01256502|2923860|P1|Overall Study|Protocol deviation|1
886854|NCT01256502|2923860|P1|Overall Study|Personal reasons|5
886855|NCT01256502|2923860|P1|Overall Study|Had scaffold removed|4
886856|NCT01256476|2923872|P2|Overall Study|LDL-C elevation exceeding 250 mg/dL|1
886857|NCT01256476|2923873|P1|Overall Study|LDL-C elevation exceeding 250 mg/dL|0
886858|NCT01256476|2923872|P2|Overall Study|Subject non-compliance|1
886859|NCT01256476|2923873|P1|Overall Study|Subject non-compliance|0
886860|NCT01256476|2923872|P2|Overall Study|Physician Decision|1
886861|NCT01256476|2923873|P1|Overall Study|Physician Decision|0
886862|NCT01256476|2923872|P2|Overall Study|Persistent ALT or AST elevation|0
886863|NCT01256476|2923873|P1|Overall Study|Persistent ALT or AST elevation|1
886864|NCT01256476|2923872|P2|Overall Study|Lost to Follow-up|2
886865|NCT01256476|2923873|P1|Overall Study|Lost to Follow-up|1
886866|NCT01256476|2923872|P2|Overall Study|Withdrawal by Subject|1
886867|NCT01256476|2923873|P1|Overall Study|Withdrawal by Subject|2
886868|NCT01256476|2923872|P2|Overall Study|Adverse Event|1
886869|NCT01256476|2923873|P1|Overall Study|Adverse Event|2
886870|NCT01256450|2923881|P3|Double-blind Treatment|Not specified|12
886871|NCT01256450|2923882|P2|Double-blind Treatment|Not specified|9
886872|NCT01256450|2923883|P1|Double-blind Treatment|Not specified|0
886873|NCT01256450|2923881|P3|Double-blind Treatment|Opioid withdrawal symptoms|1
886874|NCT01256450|2923882|P2|Double-blind Treatment|Opioid withdrawal symptoms|0
886875|NCT01256450|2923883|P1|Double-blind Treatment|Opioid withdrawal symptoms|0
886876|NCT01256450|2923881|P3|Double-blind Treatment|Non-compliance|4
886877|NCT01256450|2923882|P2|Double-blind Treatment|Non-compliance|5
886878|NCT01256450|2923883|P1|Double-blind Treatment|Non-compliance|0
886879|NCT01256450|2923881|P3|Double-blind Treatment|Lack of analgesic effect|6
886880|NCT01256450|2923882|P2|Double-blind Treatment|Lack of analgesic effect|5
886881|NCT01256450|2923883|P1|Double-blind Treatment|Lack of analgesic effect|0
886882|NCT01256450|2923881|P3|Double-blind Treatment|Withdrawal by Subject|1
886883|NCT01256450|2923882|P2|Double-blind Treatment|Withdrawal by Subject|0
886884|NCT01256450|2923883|P1|Double-blind Treatment|Withdrawal by Subject|0
886885|NCT01256450|2923881|P3|Double-blind Treatment|Lost to Follow-up|7
886886|NCT01256450|2923882|P2|Double-blind Treatment|Lost to Follow-up|1
886887|NCT01256450|2923883|P1|Double-blind Treatment|Lost to Follow-up|0
886888|NCT01256450|2923881|P3|Double-blind Treatment|Adverse Event|6
886889|NCT01256450|2923882|P2|Double-blind Treatment|Adverse Event|8
886890|NCT01256450|2923883|P1|Double-blind Treatment|Adverse Event|0
886891|NCT01256450|2923881|P3|Open-label Titration|Not specified|0
886892|NCT01256450|2923882|P2|Open-label Titration|Not specified|0
886893|NCT01256450|2923883|P1|Open-label Titration|Not specified|13
886894|NCT01256450|2923881|P3|Open-label Titration|Screen failure|0
886895|NCT01256450|2923882|P2|Open-label Titration|Screen failure|0
886896|NCT01256450|2923883|P1|Open-label Titration|Screen failure|1
886897|NCT01256450|2923881|P3|Open-label Titration|Non-compliance|0
886898|NCT01256450|2923882|P2|Open-label Titration|Non-compliance|0
886899|NCT01256450|2923883|P1|Open-label Titration|Non-compliance|9
886900|NCT01256450|2923881|P3|Open-label Titration|Lack of analgesic effect|0
886901|NCT01256450|2923882|P2|Open-label Titration|Lack of analgesic effect|0
886902|NCT01256450|2923883|P1|Open-label Titration|Lack of analgesic effect|30
886903|NCT01256450|2923881|P3|Open-label Titration|Lost to Follow-up|0
886904|NCT01256450|2923882|P2|Open-label Titration|Lost to Follow-up|0
886905|NCT01256450|2923883|P1|Open-label Titration|Lost to Follow-up|7
886906|NCT01256450|2923881|P3|Open-label Titration|Adverse Event|0
886907|NCT01256450|2923882|P2|Open-label Titration|Adverse Event|0
886908|NCT01256450|2923883|P1|Open-label Titration|Adverse Event|39
886909|NCT01256411|2923941|P6|Extension by Mono or Combination Therapy|Lack of Efficacy|1
886910|NCT01256411|2923942|P5|Extension by Mono or Combination Therapy|Lack of Efficacy|1
886911|NCT01256411|2923943|P4|Extension by Mono or Combination Therapy|Lack of Efficacy|0
886912|NCT01256411|2923944|P3|Extension by Mono or Combination Therapy|Lack of Efficacy|0
886913|NCT01256411|2923945|P2|Extension by Mono or Combination Therapy|Lack of Efficacy|0
886914|NCT01256411|2923946|P1|Extension by Mono or Combination Therapy|Lack of Efficacy|0
886915|NCT01256411|2923941|P6|Extension by Mono or Combination Therapy|Withdrawal by Subject|1
886916|NCT01256411|2923942|P5|Extension by Mono or Combination Therapy|Withdrawal by Subject|7
886917|NCT01256411|2923943|P4|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
886918|NCT01256411|2923944|P3|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
886919|NCT01256411|2923945|P2|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
886920|NCT01256411|2923946|P1|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
886921|NCT01256411|2923941|P6|Extension by Mono or Combination Therapy|Lost to Follow-up|0
886922|NCT01256411|2923942|P5|Extension by Mono or Combination Therapy|Lost to Follow-up|3
886923|NCT01256411|2923943|P4|Extension by Mono or Combination Therapy|Lost to Follow-up|0
886924|NCT01256411|2923944|P3|Extension by Mono or Combination Therapy|Lost to Follow-up|0
886925|NCT01256411|2923945|P2|Extension by Mono or Combination Therapy|Lost to Follow-up|0
886926|NCT01256411|2923946|P1|Extension by Mono or Combination Therapy|Lost to Follow-up|0
886927|NCT01256411|2923941|P6|Extension by Mono or Combination Therapy|Protocol deviation|1
886928|NCT01256411|2923942|P5|Extension by Mono or Combination Therapy|Protocol deviation|0
886929|NCT01256411|2923943|P4|Extension by Mono or Combination Therapy|Protocol deviation|0
886930|NCT01256411|2923944|P3|Extension by Mono or Combination Therapy|Protocol deviation|0
886931|NCT01256411|2923945|P2|Extension by Mono or Combination Therapy|Protocol deviation|0
886932|NCT01256411|2923946|P1|Extension by Mono or Combination Therapy|Protocol deviation|0
886933|NCT01256411|2923941|P6|Extension by Mono or Combination Therapy|Adverse Event|1
886934|NCT01256411|2923942|P5|Extension by Mono or Combination Therapy|Adverse Event|6
886935|NCT01256411|2923943|P4|Extension by Mono or Combination Therapy|Adverse Event|0
886936|NCT01256411|2923944|P3|Extension by Mono or Combination Therapy|Adverse Event|0
886937|NCT01256411|2923945|P2|Extension by Mono or Combination Therapy|Adverse Event|0
886938|NCT01256411|2923946|P1|Extension by Mono or Combination Therapy|Adverse Event|0
886939|NCT01256411|2923941|P6|Extension by Maximum Treatment|Adverse Event|0
886940|NCT01256411|2923942|P5|Extension by Maximum Treatment|Adverse Event|0
886941|NCT01256411|2923943|P4|Extension by Maximum Treatment|Adverse Event|0
886942|NCT01256411|2923944|P3|Extension by Maximum Treatment|Adverse Event|1
886943|NCT01256411|2923945|P2|Extension by Maximum Treatment|Adverse Event|2
886944|NCT01256411|2923946|P1|Extension by Maximum Treatment|Adverse Event|4
886945|NCT01256411|2923941|P6|Extension by Maximum Treatment|Lack of Efficacy|0
886946|NCT01256411|2923942|P5|Extension by Maximum Treatment|Lack of Efficacy|0
886947|NCT01256411|2923943|P4|Extension by Maximum Treatment|Lack of Efficacy|0
886948|NCT01256411|2923944|P3|Extension by Maximum Treatment|Lack of Efficacy|1
886949|NCT01256411|2923945|P2|Extension by Maximum Treatment|Lack of Efficacy|0
886950|NCT01256411|2923946|P1|Extension by Maximum Treatment|Lack of Efficacy|1
886951|NCT01256411|2923941|P6|Extension by Maximum Treatment|Withdrawal by Subject|0
886952|NCT01256411|2923942|P5|Extension by Maximum Treatment|Withdrawal by Subject|0
886953|NCT01256411|2923943|P4|Extension by Maximum Treatment|Withdrawal by Subject|0
886954|NCT01256411|2923944|P3|Extension by Maximum Treatment|Withdrawal by Subject|1
886955|NCT01256411|2923945|P2|Extension by Maximum Treatment|Withdrawal by Subject|6
886956|NCT01256411|2923946|P1|Extension by Maximum Treatment|Withdrawal by Subject|1
886957|NCT01256411|2923941|P6|Extension by Maximum Treatment|Lost to Follow-up|0
886958|NCT01256411|2923942|P5|Extension by Maximum Treatment|Lost to Follow-up|0
886959|NCT01256411|2923943|P4|Extension by Maximum Treatment|Lost to Follow-up|0
886960|NCT01256411|2923944|P3|Extension by Maximum Treatment|Lost to Follow-up|0
886961|NCT01256411|2923945|P2|Extension by Maximum Treatment|Lost to Follow-up|2
886962|NCT01256411|2923946|P1|Extension by Maximum Treatment|Lost to Follow-up|1
886963|NCT01256411|2923941|P6|Extension by Maximum Treatment|Protocol deviation|0
886964|NCT01256411|2923942|P5|Extension by Maximum Treatment|Protocol deviation|0
886965|NCT01256411|2923943|P4|Extension by Maximum Treatment|Protocol deviation|0
886966|NCT01256411|2923944|P3|Extension by Maximum Treatment|Protocol deviation|1
886967|NCT01256411|2923945|P2|Extension by Maximum Treatment|Protocol deviation|0
886968|NCT01256411|2923946|P1|Extension by Maximum Treatment|Protocol deviation|0
886969|NCT01256385|2923972|P2|Overall Study|Withdrawal by Subject|2
886970|NCT01256385|2923973|P1|Overall Study|Withdrawal by Subject|2
886971|NCT01256385|2923972|P2|Overall Study|Physician Decision|1
886972|NCT01256385|2923973|P1|Overall Study|Physician Decision|1
886973|NCT01256294|2923993|P2|Overall Study|Protocol deviation|1
886974|NCT01256294|2923994|P1|Overall Study|Protocol deviation|2
886975|NCT01256294|2923993|P2|Overall Study|Withdrawal by Subject|1
886976|NCT01256294|2923994|P1|Overall Study|Withdrawal by Subject|1
886977|NCT01256294|2923993|P2|Overall Study|Adverse Event|0
886978|NCT01256294|2923994|P1|Overall Study|Adverse Event|1
886979|NCT01256190|2924016|P2|Overall Study|Lost to Follow-up|0
886980|NCT01256190|2924017|P1|Overall Study|Lost to Follow-up|2
886981|NCT01256177|2924033|P2|Overall Study|TG=593mg/dL, not fit to participate.|0
886982|NCT01256177|2924034|P1|Overall Study|TG=593mg/dL, not fit to participate.|1
886983|NCT01256177|2924033|P2|Overall Study|Lack of Efficacy|2
886984|NCT01256177|2924034|P1|Overall Study|Lack of Efficacy|11
886985|NCT01256177|2924033|P2|Overall Study|Condition under Investigation Worsened|0
886986|NCT01256177|2924034|P1|Overall Study|Condition under Investigation Worsened|1
886987|NCT01256177|2924033|P2|Overall Study|Severe Non-Compliance to Protocol|2
886988|NCT01256177|2924034|P1|Overall Study|Severe Non-Compliance to Protocol|4
886989|NCT01256177|2924033|P2|Overall Study|Adverse Event|9
886990|NCT01256177|2924034|P1|Overall Study|Adverse Event|8
886991|NCT01256177|2924033|P2|Overall Study|Lost to Follow-up|2
886992|NCT01256177|2924034|P1|Overall Study|Lost to Follow-up|2
886993|NCT01256177|2924033|P2|Overall Study|Withdrawal by Subject|22
886994|NCT01256177|2924034|P1|Overall Study|Withdrawal by Subject|23
886995|NCT01256060|2924090|P4|Overall Study|Lost to Follow-up|0
886996|NCT01256060|2924091|P3|Overall Study|Lost to Follow-up|0
886997|NCT01256060|2924092|P2|Overall Study|Lost to Follow-up|1
886998|NCT01256060|2924093|P1|Overall Study|Lost to Follow-up|0
886999|NCT01256008|2924112|P3|Overall Study|Withdrawal by Subject|10
887000|NCT01256008|2924113|P2|Overall Study|Withdrawal by Subject|3
887001|NCT01256008|2924114|P1|Overall Study|Withdrawal by Subject|2
887002|NCT01256008|2924112|P3|Overall Study|Lost to Follow-up|11
887003|NCT01256008|2924113|P2|Overall Study|Lost to Follow-up|4
887004|NCT01256008|2924114|P1|Overall Study|Lost to Follow-up|6
887005|NCT01255904|2924136|P2|Overall Study|Physician Decision|4
887006|NCT01255904|2924137|P1|Overall Study|Physician Decision|1
887007|NCT01255787|2924147|P4|Overall Study|Noncompliance with Study Drug|0
887008|NCT01255787|2924148|P3|Overall Study|Noncompliance with Study Drug|0
887009|NCT01255787|2924149|P2|Overall Study|Noncompliance with Study Drug|1
887010|NCT01255787|2924150|P1|Overall Study|Noncompliance with Study Drug|3
887011|NCT01255787|2924147|P4|Overall Study|Lack of Efficacy|2
887012|NCT01255787|2924148|P3|Overall Study|Lack of Efficacy|2
887013|NCT01255787|2924149|P2|Overall Study|Lack of Efficacy|2
887014|NCT01255787|2924150|P1|Overall Study|Lack of Efficacy|2
887015|NCT01255787|2924147|P4|Overall Study|Pregnancy|1
887016|NCT01255787|2924148|P3|Overall Study|Pregnancy|0
887017|NCT01255787|2924149|P2|Overall Study|Pregnancy|0
887018|NCT01255787|2924150|P1|Overall Study|Pregnancy|0
887019|NCT01255787|2924147|P4|Overall Study|Withdrawal of Consent|4
887020|NCT01255787|2924148|P3|Overall Study|Withdrawal of Consent|3
887021|NCT01255787|2924149|P2|Overall Study|Withdrawal of Consent|9
887022|NCT01255787|2924150|P1|Overall Study|Withdrawal of Consent|3
887023|NCT01255787|2924147|P4|Overall Study|Lost to Follow-up|2
887024|NCT01255787|2924148|P3|Overall Study|Lost to Follow-up|4
887025|NCT01255787|2924149|P2|Overall Study|Lost to Follow-up|2
887026|NCT01255787|2924150|P1|Overall Study|Lost to Follow-up|1
887027|NCT01255787|2924147|P4|Overall Study|Major Protocol Deviation|4
887028|NCT01255787|2924148|P3|Overall Study|Major Protocol Deviation|0
887029|NCT01255787|2924149|P2|Overall Study|Major Protocol Deviation|1
887030|NCT01255787|2924150|P1|Overall Study|Major Protocol Deviation|1
887031|NCT01255787|2924147|P4|Overall Study|Pretreatment Event or Adverse Event (AE)|9
887032|NCT01255787|2924148|P3|Overall Study|Pretreatment Event or Adverse Event (AE)|9
887033|NCT01255787|2924149|P2|Overall Study|Pretreatment Event or Adverse Event (AE)|2
887034|NCT01255787|2924150|P1|Overall Study|Pretreatment Event or Adverse Event (AE)|6
887035|NCT01255761|2924178|P2|Overall Study|Other Reasons|18
887036|NCT01255761|2924179|P1|Overall Study|Other Reasons|37
887037|NCT01255761|2924178|P2|Overall Study|Withdrawal by Subject|27
887038|NCT01255761|2924179|P1|Overall Study|Withdrawal by Subject|11
887039|NCT01255761|2924178|P2|Overall Study|Lost to Follow-up|8
887040|NCT01255761|2924179|P1|Overall Study|Lost to Follow-up|10
887041|NCT01255761|2924178|P2|Overall Study|Protocol Violation|5
887042|NCT01255761|2924179|P1|Overall Study|Protocol Violation|9
887043|NCT01255761|2924178|P2|Overall Study|Lack of Efficacy|74
887044|NCT01255761|2924179|P1|Overall Study|Lack of Efficacy|86
887045|NCT01255761|2924178|P2|Overall Study|Adverse Event|43
887046|NCT01255761|2924179|P1|Overall Study|Adverse Event|29
887047|NCT01255722|2924264|P3|Overall Study|beta-blocker contraindicated|0
887048|NCT01255722|2924265|P2|Overall Study|beta-blocker contraindicated|0
887049|NCT01255722|2924266|P1|Overall Study|beta-blocker contraindicated|2
887050|NCT01255722|2924264|P3|Overall Study|asymptomatic patient|0
887051|NCT01255722|2924265|P2|Overall Study|asymptomatic patient|0
887052|NCT01255722|2924266|P1|Overall Study|asymptomatic patient|1
887053|NCT01255722|2924264|P3|Overall Study|Adverse Event|1
887054|NCT01255722|2924265|P2|Overall Study|Adverse Event|1
887055|NCT01255722|2924266|P1|Overall Study|Adverse Event|0
887056|NCT01255631|2924291|P2|Overall Study|poor enrollment, no data analyzed|6
887057|NCT01255631|2924292|P1|Overall Study|poor enrollment, no data analyzed|9
887058|NCT01255592|2924310|P2|Overall Study|Other|1
887059|NCT01255592|2924311|P1|Overall Study|Other|0
887060|NCT01255592|2924310|P2|Overall Study|Withdrawal by Subject|0
887061|NCT01255592|2924311|P1|Overall Study|Withdrawal by Subject|1
887062|NCT01255592|2924310|P2|Overall Study|Adverse Event|0
887063|NCT01255592|2924311|P1|Overall Study|Adverse Event|5
887064|NCT01255436|2924374|P2|Overall Study|Death, stroke, or MI|3
887065|NCT01255436|2924375|P1|Overall Study|Death, stroke, or MI|4
887066|NCT01255436|2924374|P2|Overall Study|Lost to Follow-up|191
887067|NCT01255436|2924375|P1|Overall Study|Lost to Follow-up|178
887068|NCT01255423|2924389|P2|Overall Study|Use of prohibited medications|1
887069|NCT01255423|2924390|P1|Overall Study|Use of prohibited medications|0
887070|NCT01255423|2924389|P2|Overall Study|Abnormal Laboratory value|2
887071|NCT01255423|2924390|P1|Overall Study|Abnormal Laboratory value|3
887072|NCT01255306|2924406|P2|Overall Study|Physician Decision|1
887073|NCT01255306|2924407|P1|Overall Study|Physician Decision|1
887074|NCT01255163|2924418|P2|Overall Study|AstraZeneca stopped support of the study|3
887075|NCT01255163|2924419|P1|Overall Study|AstraZeneca stopped support of the study|1
887076|NCT01255163|2924418|P2|Overall Study|Adverse Event|2
887077|NCT01255163|2924419|P1|Overall Study|Adverse Event|0
887078|NCT01255163|2924418|P2|Overall Study|Lost to Follow-up|0
887079|NCT01255163|2924419|P1|Overall Study|Lost to Follow-up|2
887080|NCT01255163|2924418|P2|Overall Study|Withdrawal by Subject|0
887081|NCT01255163|2924419|P1|Overall Study|Withdrawal by Subject|1
887082|NCT01254890|2924448|P2|Overall Study|Disease Progression|5
887083|NCT01254890|2924449|P1|Overall Study|Disease Progression|0
887084|NCT01254890|2924448|P2|Overall Study|Withdrawal by Subject|2
887085|NCT01254890|2924449|P1|Overall Study|Withdrawal by Subject|1
887086|NCT01254890|2924448|P2|Overall Study|Ineligible|3
887087|NCT01254890|2924449|P1|Overall Study|Ineligible|0
887088|NCT01254747|2924511|P4|Overall Study|Discomfort|0
887089|NCT01254747|2924512|P3|Overall Study|Discomfort|0
887090|NCT01254747|2924513|P2|Overall Study|Discomfort|4
887091|NCT01254747|2924514|P1|Overall Study|Discomfort|0
887092|NCT01254747|2924511|P4|Overall Study|Biomicroscopy|0
887093|NCT01254747|2924512|P3|Overall Study|Biomicroscopy|1
887094|NCT01254747|2924513|P2|Overall Study|Biomicroscopy|0
887095|NCT01254747|2924514|P1|Overall Study|Biomicroscopy|0
887096|NCT01254747|2924511|P4|Overall Study|Lost to Follow-up|0
887097|NCT01254747|2924512|P3|Overall Study|Lost to Follow-up|1
887098|NCT01254747|2924513|P2|Overall Study|Lost to Follow-up|0
887099|NCT01254747|2924514|P1|Overall Study|Lost to Follow-up|0
887100|NCT01254747|2924511|P4|Overall Study|Symptoms and problems|0
887101|NCT01254747|2924512|P3|Overall Study|Symptoms and problems|1
887102|NCT01254747|2924513|P2|Overall Study|Symptoms and problems|2
887103|NCT01254747|2924514|P1|Overall Study|Symptoms and problems|0
887104|NCT01254747|2924511|P4|Overall Study|Difficult removal handling|0
887105|NCT01254747|2924512|P3|Overall Study|Difficult removal handling|1
887106|NCT01254747|2924513|P2|Overall Study|Difficult removal handling|0
887107|NCT01254747|2924514|P1|Overall Study|Difficult removal handling|0
887108|NCT01254747|2924511|P4|Overall Study|Unacceptable subjective vision|2
887109|NCT01254747|2924512|P3|Overall Study|Unacceptable subjective vision|0
887110|NCT01254747|2924513|P2|Overall Study|Unacceptable subjective vision|0
887111|NCT01254747|2924514|P1|Overall Study|Unacceptable subjective vision|0
887112|NCT01254721|2924554|P2|Overall Study|Wrongly randomization|1
887113|NCT01254721|2924555|P1|Overall Study|Wrongly randomization|0
887114|NCT01254721|2924554|P2|Overall Study|Withdrawal by Subject|11
887115|NCT01254721|2924555|P1|Overall Study|Withdrawal by Subject|8
887116|NCT01254721|2924554|P2|Overall Study|Adverse Event|3
887117|NCT01254721|2924555|P1|Overall Study|Adverse Event|2
887118|NCT01254721|2924554|P2|Overall Study|technical problum|0
887119|NCT01254721|2924555|P1|Overall Study|technical problum|1
887120|NCT01254721|2924554|P2|Overall Study|Death|1
887121|NCT01254721|2924555|P1|Overall Study|Death|0
887122|NCT01254721|2924554|P2|Overall Study|Lack of Efficacy|2
887123|NCT01254721|2924555|P1|Overall Study|Lack of Efficacy|4
887124|NCT01254721|2924554|P2|Overall Study|Lost to Follow-up|4
887125|NCT01254721|2924555|P1|Overall Study|Lost to Follow-up|0
887126|NCT01254669|2924565|P2|Overall Study|called to clinic during intervention|1
887127|NCT01254669|2924566|P1|Overall Study|called to clinic during intervention|1
887128|NCT01254669|2924565|P2|Overall Study|time constraint|2
887129|NCT01254669|2924566|P1|Overall Study|time constraint|2
887130|NCT01254669|2924565|P2|Overall Study|Withdrawal by Subject|1
887131|NCT01254669|2924566|P1|Overall Study|Withdrawal by Subject|0
887132|NCT01254656|2924577|P3|Overall Study|Death|0
887133|NCT01254656|2924578|P2|Overall Study|Death|1
887134|NCT01254656|2924579|P1|Overall Study|Death|0
887135|NCT01254656|2924577|P3|Overall Study|Adverse Event|0
887136|NCT01254656|2924578|P2|Overall Study|Adverse Event|1
887137|NCT01254656|2924579|P1|Overall Study|Adverse Event|1
887138|NCT01254656|2924577|P3|Overall Study|Pregnancy|2
887139|NCT01254656|2924578|P2|Overall Study|Pregnancy|0
887140|NCT01254656|2924579|P1|Overall Study|Pregnancy|0
887141|NCT01254656|2924577|P3|Overall Study|Withdrawal by Subject|1
887142|NCT01254656|2924578|P2|Overall Study|Withdrawal by Subject|2
887143|NCT01254656|2924579|P1|Overall Study|Withdrawal by Subject|2
887144|NCT01254656|2924577|P3|Overall Study|Lost to Follow-up|2
887145|NCT01254656|2924578|P2|Overall Study|Lost to Follow-up|0
887146|NCT01254656|2924579|P1|Overall Study|Lost to Follow-up|1
887147|NCT01254656|2924577|P3|Overall Study|Lack of Efficacy|0
887148|NCT01254656|2924578|P2|Overall Study|Lack of Efficacy|0
887149|NCT01254656|2924579|P1|Overall Study|Lack of Efficacy|3
887150|NCT01254656|2924577|P3|Overall Study|Discontinued due to termination of study|13
887151|NCT01254656|2924578|P2|Overall Study|Discontinued due to termination of study|39
887152|NCT01254656|2924579|P1|Overall Study|Discontinued due to termination of study|40
887153|NCT01254643|2924605|P1|Overall Study|Withdrawal by Subject|1
887154|NCT01254630|2924617|P4|Overall Study|Status not recorded|0
887155|NCT01254630|2924618|P3|Overall Study|Status not recorded|1
887156|NCT01254630|2924619|P2|Overall Study|Status not recorded|0
887157|NCT01254630|2924620|P1|Overall Study|Status not recorded|0
887158|NCT01254630|2924617|P4|Overall Study|Study terminated by sponsor|1010
887159|NCT01254630|2924618|P3|Overall Study|Study terminated by sponsor|0
887160|NCT01254630|2924619|P2|Overall Study|Study terminated by sponsor|994
887161|NCT01254630|2924620|P1|Overall Study|Study terminated by sponsor|0
887162|NCT01254630|2924617|P4|Overall Study|Withdrawal by Subject|89
887163|NCT01254630|2924618|P3|Overall Study|Withdrawal by Subject|188
887164|NCT01254630|2924619|P2|Overall Study|Withdrawal by Subject|94
887165|NCT01254630|2924620|P1|Overall Study|Withdrawal by Subject|201
887166|NCT01254630|2924617|P4|Overall Study|Physician Decision|7
887167|NCT01254630|2924618|P3|Overall Study|Physician Decision|16
887168|NCT01254630|2924619|P2|Overall Study|Physician Decision|8
887169|NCT01254630|2924620|P1|Overall Study|Physician Decision|24
887170|NCT01254630|2924617|P4|Overall Study|Lost to Follow-up|32
887171|NCT01254630|2924618|P3|Overall Study|Lost to Follow-up|89
887172|NCT01254630|2924619|P2|Overall Study|Lost to Follow-up|26
887173|NCT01254630|2924620|P1|Overall Study|Lost to Follow-up|80
887174|NCT01254630|2924617|P4|Overall Study|Death|139
887175|NCT01254630|2924618|P3|Overall Study|Death|478
887176|NCT01254630|2924619|P2|Overall Study|Death|151
887177|NCT01254630|2924620|P1|Overall Study|Death|461
887178|NCT01254630|2924617|P4|Overall Study|Adverse Event|8
887179|NCT01254630|2924618|P3|Overall Study|Adverse Event|40
887180|NCT01254630|2924619|P2|Overall Study|Adverse Event|15
887181|NCT01254630|2924620|P1|Overall Study|Adverse Event|36
887182|NCT01254604|2924640|P2|Overall Study|Adverse Event|2
887183|NCT01254604|2924641|P1|Overall Study|Adverse Event|3
887184|NCT01254604|2924640|P2|Overall Study|Withdrawal by Subject|4
887185|NCT01254604|2924641|P1|Overall Study|Withdrawal by Subject|2
887186|NCT01254604|2924640|P2|Overall Study|Protocol Violation|2
887187|NCT01254604|2924641|P1|Overall Study|Protocol Violation|2
887188|NCT01254604|2924640|P2|Overall Study|Lost to Follow-up|1
887189|NCT01254604|2924641|P1|Overall Study|Lost to Follow-up|1
887190|NCT01254565|2924659|P6|Overall Study|Other|0
887191|NCT01254565|2924660|P5|Overall Study|Other|0
887192|NCT01254565|2924661|P4|Overall Study|Other|1
887193|NCT01254565|2924662|P3|Overall Study|Other|0
887194|NCT01254565|2924663|P2|Overall Study|Other|0
887195|NCT01254565|2924664|P1|Overall Study|Other|0
887196|NCT01254565|2924659|P6|Overall Study|Did not Receive Treatment|4
887197|NCT01254565|2924660|P5|Overall Study|Did not Receive Treatment|3
887198|NCT01254565|2924661|P4|Overall Study|Did not Receive Treatment|0
887199|NCT01254565|2924662|P3|Overall Study|Did not Receive Treatment|0
887200|NCT01254565|2924663|P2|Overall Study|Did not Receive Treatment|1
887201|NCT01254565|2924664|P1|Overall Study|Did not Receive Treatment|1
887202|NCT01254565|2924659|P6|Overall Study|Non-compliance to Study Procedures|0
887203|NCT01254565|2924660|P5|Overall Study|Non-compliance to Study Procedures|1
887204|NCT01254565|2924661|P4|Overall Study|Non-compliance to Study Procedures|0
887205|NCT01254565|2924662|P3|Overall Study|Non-compliance to Study Procedures|0
887206|NCT01254565|2924663|P2|Overall Study|Non-compliance to Study Procedures|0
887207|NCT01254565|2924664|P1|Overall Study|Non-compliance to Study Procedures|0
887208|NCT01254409|2924718|P4|Overall Study|Adverse Event|0
887209|NCT01254409|2924719|P3|Overall Study|Adverse Event|0
887210|NCT01254409|2924720|P2|Overall Study|Adverse Event|1
887211|NCT01254409|2924721|P1|Overall Study|Adverse Event|0
887212|NCT01254344|2924790|P2|Overall Study|Withdrawal by Subject|6
887213|NCT01254344|2924791|P1|Overall Study|Withdrawal by Subject|3
887214|NCT01254344|2924790|P2|Overall Study|Protocol Violation|4
887215|NCT01254344|2924791|P1|Overall Study|Protocol Violation|1
887216|NCT01254344|2924790|P2|Overall Study|Physician Decision|4
887217|NCT01254344|2924791|P1|Overall Study|Physician Decision|7
887218|NCT01254344|2924790|P2|Overall Study|Adverse Event|5
887219|NCT01254344|2924791|P1|Overall Study|Adverse Event|2
887220|NCT01254331|2924799|P1|Extension Phase|Lost to Follow-up|3
887221|NCT01254331|2924799|P1|Extension Phase|Lack of Efficacy|1
887222|NCT01254331|2924799|P1|Initial Phase|Pregnancy|1
887223|NCT01254331|2924799|P1|Initial Phase|Withdrawal by Subject|1
887224|NCT01254331|2924799|P1|Initial Phase|Adverse Event|3
887225|NCT01254318|2924817|P1|Overall Study|Death|47
887226|NCT01254318|2924817|P1|Overall Study|Lost to Follow-up|5
887227|NCT01254305|2924826|P3|Overall Study|Other Reasons|2
887228|NCT01254305|2924827|P2|Overall Study|Other Reasons|0
887229|NCT01254305|2924828|P1|Overall Study|Other Reasons|0
887230|NCT01254305|2924826|P3|Overall Study|Lost to Follow-up|5
887231|NCT01254305|2924827|P2|Overall Study|Lost to Follow-up|6
887232|NCT01254305|2924828|P1|Overall Study|Lost to Follow-up|10
887233|NCT01254305|2924826|P3|Overall Study|Withdrawal by Subject|4
887234|NCT01254305|2924827|P2|Overall Study|Withdrawal by Subject|2
887235|NCT01254305|2924828|P1|Overall Study|Withdrawal by Subject|4
887236|NCT01254305|2924826|P3|Overall Study|Protocol Violation|3
887237|NCT01254305|2924827|P2|Overall Study|Protocol Violation|7
887238|NCT01254305|2924828|P1|Overall Study|Protocol Violation|1
887239|NCT01254305|2924826|P3|Overall Study|Lack of Efficacy|1
887240|NCT01254305|2924827|P2|Overall Study|Lack of Efficacy|0
887241|NCT01254305|2924828|P1|Overall Study|Lack of Efficacy|1
887242|NCT01254305|2924826|P3|Overall Study|Adverse Event|2
887243|NCT01254305|2924827|P2|Overall Study|Adverse Event|3
887244|NCT01254305|2924828|P1|Overall Study|Adverse Event|6
887245|NCT01254292|2924844|P2|LCS12 Extension Phase|Lost to Follow-up|0
887246|NCT01254292|2924845|P1|LCS12 Extension Phase|Lost to Follow-up|1
887247|NCT01254292|2924844|P2|LCS12 Extension Phase|Pregnancy|0
887248|NCT01254292|2924845|P1|LCS12 Extension Phase|Pregnancy|2
887249|NCT01254292|2924844|P2|LCS12 Extension Phase|Other unknown|0
887250|NCT01254292|2924845|P1|LCS12 Extension Phase|Other unknown|4
887251|NCT01254292|2924844|P2|LCS12 Extension Phase|Withdrawal by Subject|0
887252|NCT01254292|2924845|P1|LCS12 Extension Phase|Withdrawal by Subject|7
887253|NCT01254292|2924844|P2|LCS12 Extension Phase|Adverse Event|0
887254|NCT01254292|2924845|P1|LCS12 Extension Phase|Adverse Event|9
887255|NCT01254292|2924844|P2|LCS12 Extension Phase|Wish for pregnancy|0
887256|NCT01254292|2924845|P1|LCS12 Extension Phase|Wish for pregnancy|14
887257|NCT01254292|2924844|P2|Comparative Phase|Wish for pregnancy|6
887258|NCT01254292|2924845|P1|Comparative Phase|Wish for pregnancy|4
887259|NCT01254292|2924844|P2|Comparative Phase|Protocol Violation|2
887260|NCT01254292|2924845|P1|Comparative Phase|Protocol Violation|1
887261|NCT01254292|2924844|P2|Comparative Phase|Withdrawal by Subject|21
887262|NCT01254292|2924845|P1|Comparative Phase|Withdrawal by Subject|20
887263|NCT01254292|2924844|P2|Comparative Phase|Pregnancy|6
887264|NCT01254292|2924845|P1|Comparative Phase|Pregnancy|2
887265|NCT01254292|2924844|P2|Comparative Phase|Lost to Follow-up|21
887266|NCT01254292|2924845|P1|Comparative Phase|Lost to Follow-up|3
887267|NCT01254292|2924844|P2|Comparative Phase|Adverse Event|25
887268|NCT01254292|2924845|P1|Comparative Phase|Adverse Event|25
887269|NCT01254188|2924922|P1|Overall Study|per investigator discretion|20
887270|NCT01254188|2924922|P1|Overall Study|Adverse Event|43
887271|NCT01254188|2924922|P1|Overall Study|Withdrawal by Subject|7
887272|NCT01254188|2924922|P1|Overall Study|Lost to Follow-up|5
887273|NCT01254188|2924922|P1|Overall Study|Death|4
887274|NCT01254188|2924922|P1|Overall Study|Pregnancy|2
887275|NCT01254188|2924922|P1|Overall Study|Protocol Violation|6
887276|NCT01254188|2924922|P1|Overall Study|Disease Progression|6
887277|NCT01254045|2924933|P6|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
887278|NCT01254045|2924934|P5|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
887279|NCT01254045|2924935|P4|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
887280|NCT01254045|2924936|P3|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
887281|NCT01254045|2924937|P2|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
887282|NCT01254045|2924938|P1|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1
887283|NCT01253811|2924992|P1|Overall Study|Withdrawal criteria|1
887284|NCT01253577|2925023|P1|Overall Study|Lost to Follow-up|3
887285|NCT01253564|2925031|P1|Overall Study|Serious Adverse Event|1
887286|NCT01253564|2925031|P1|Overall Study|Withdrawal by Subject|1
887287|NCT01253564|2925031|P1|Overall Study|Disease Progression|22
887288|NCT01253447|2925075|P1|Overall Study|Adverse Event|2
887289|NCT01253421|2925085|P5|Drug+Scanning Visit|Physician Decision|1
887290|NCT01253421|2925086|P4|Drug+Scanning Visit|Physician Decision|0
887291|NCT01253421|2925087|P3|Drug+Scanning Visit|Physician Decision|0
887292|NCT01253421|2925088|P2|Drug+Scanning Visit|Physician Decision|0
887293|NCT01253421|2925089|P1|Drug+Scanning Visit|Physician Decision|0
887294|NCT01253421|2925085|P5|Assessment and Scheduling|Physician Decision|0
887295|NCT01253421|2925086|P4|Assessment and Scheduling|Physician Decision|0
887296|NCT01253421|2925087|P3|Assessment and Scheduling|Physician Decision|0
887297|NCT01253421|2925088|P2|Assessment and Scheduling|Physician Decision|0
887298|NCT01253421|2925089|P1|Assessment and Scheduling|Physician Decision|1
887299|NCT01253421|2925085|P5|Assessment and Scheduling|Withdrawal by Subject|0
887300|NCT01253421|2925086|P4|Assessment and Scheduling|Withdrawal by Subject|0
887301|NCT01253421|2925087|P3|Assessment and Scheduling|Withdrawal by Subject|0
887302|NCT01253421|2925088|P2|Assessment and Scheduling|Withdrawal by Subject|0
887303|NCT01253421|2925089|P1|Assessment and Scheduling|Withdrawal by Subject|7
887304|NCT01253421|2925085|P5|Assessment and Scheduling|Lost to Follow-up|0
887305|NCT01253421|2925086|P4|Assessment and Scheduling|Lost to Follow-up|0
887306|NCT01253421|2925087|P3|Assessment and Scheduling|Lost to Follow-up|0
887307|NCT01253421|2925088|P2|Assessment and Scheduling|Lost to Follow-up|0
887308|NCT01253421|2925089|P1|Assessment and Scheduling|Lost to Follow-up|17
887309|NCT01253421|2925085|P5|Assessment and Scheduling|Found to be Ineligible|0
887310|NCT01253421|2925086|P4|Assessment and Scheduling|Found to be Ineligible|0
887311|NCT01253421|2925087|P3|Assessment and Scheduling|Found to be Ineligible|0
887312|NCT01253421|2925088|P2|Assessment and Scheduling|Found to be Ineligible|0
887313|NCT01253421|2925089|P1|Assessment and Scheduling|Found to be Ineligible|74
887314|NCT01253408|2925138|P3|Overall Study|Adverse Event|0
887315|NCT01253408|2925139|P2|Overall Study|Adverse Event|1
887316|NCT01253408|2925140|P1|Overall Study|Adverse Event|0
887317|NCT01253369|2925163|P1|Overall Study|Not Evaluable|3
887318|NCT01253369|2925163|P1|Overall Study|Progressive disease|23
887319|NCT01253369|2925163|P1|Overall Study|Death|1
887320|NCT01253369|2925163|P1|Overall Study|Withdrawal by Subject|2
887321|NCT01253369|2925163|P1|Overall Study|Adverse Event|4
887322|NCT01253317|2925193|P1|Overall Study|Adverse Event|2
887323|NCT01253304|2925205|P4|Overall Study|Adverse Event|1
887324|NCT01253304|2925206|P3|Overall Study|Adverse Event|0
887325|NCT01253304|2925207|P2|Overall Study|Adverse Event|0
887326|NCT01253304|2925208|P1|Overall Study|Adverse Event|0
887327|NCT01253265|2925247|P5|Overall Study|Withdrawal by Subject|1
887328|NCT01253265|2925248|P4|Overall Study|Withdrawal by Subject|0
887329|NCT01253265|2925249|P3|Overall Study|Withdrawal by Subject|0
887330|NCT01253265|2925250|P2|Overall Study|Withdrawal by Subject|0
887331|NCT01253265|2925251|P1|Overall Study|Withdrawal by Subject|0
887332|NCT01253265|2925247|P5|Overall Study|Met Predefined Discontinuation Criteria|0
887333|NCT01253265|2925248|P4|Overall Study|Met Predefined Discontinuation Criteria|0
887334|NCT01253265|2925249|P3|Overall Study|Met Predefined Discontinuation Criteria|0
887335|NCT01253265|2925250|P2|Overall Study|Met Predefined Discontinuation Criteria|0
887336|NCT01253265|2925251|P1|Overall Study|Met Predefined Discontinuation Criteria|1
887337|NCT01253226|2925300|P5|Overall Study|Withdrawal by Subject|0
887338|NCT01253226|2925301|P4|Overall Study|Withdrawal by Subject|1
887339|NCT01253226|2925302|P3|Overall Study|Withdrawal by Subject|0
887340|NCT01253226|2925303|P2|Overall Study|Withdrawal by Subject|0
887341|NCT01253226|2925304|P1|Overall Study|Withdrawal by Subject|0
887342|NCT01253226|2925300|P5|Overall Study|Physician Decision|2
887343|NCT01253226|2925301|P4|Overall Study|Physician Decision|0
887344|NCT01253226|2925302|P3|Overall Study|Physician Decision|0
887345|NCT01253226|2925303|P2|Overall Study|Physician Decision|0
887346|NCT01253226|2925304|P1|Overall Study|Physician Decision|0
887347|NCT01253226|2925300|P5|Overall Study|Death|0
887348|NCT01253226|2925301|P4|Overall Study|Death|0
887349|NCT01253226|2925302|P3|Overall Study|Death|0
887350|NCT01253226|2925303|P2|Overall Study|Death|1
887351|NCT01253226|2925304|P1|Overall Study|Death|0
887352|NCT01253226|2925300|P5|Overall Study|Adverse Event|0
887353|NCT01253226|2925301|P4|Overall Study|Adverse Event|0
887354|NCT01253226|2925302|P3|Overall Study|Adverse Event|1
887355|NCT01253226|2925303|P2|Overall Study|Adverse Event|0
887356|NCT01253226|2925304|P1|Overall Study|Adverse Event|0
887357|NCT01253200|2925364|P5|Overall Study|Attempts|0
887358|NCT01253200|2925365|P4|Overall Study|Attempts|2
887359|NCT01253200|2925366|P3|Overall Study|Attempts|1
887360|NCT01253200|2925367|P2|Overall Study|Attempts|4
887361|NCT01253200|2925368|P1|Overall Study|Attempts|6
887362|NCT01253200|2925364|P5|Overall Study|intents|0
887363|NCT01253200|2925365|P4|Overall Study|intents|3
887364|NCT01253200|2925366|P3|Overall Study|intents|1
887365|NCT01253200|2925367|P2|Overall Study|intents|10
887366|NCT01253200|2925368|P1|Overall Study|intents|10
887367|NCT01253200|2925364|P5|Overall Study|Protocol Violation|5
887368|NCT01253200|2925365|P4|Overall Study|Protocol Violation|0
887369|NCT01253200|2925366|P3|Overall Study|Protocol Violation|0
887370|NCT01253200|2925367|P2|Overall Study|Protocol Violation|4
887371|NCT01253200|2925368|P1|Overall Study|Protocol Violation|1
887372|NCT01253200|2925364|P5|Overall Study|Withdrawal by Subject|0
887373|NCT01253200|2925365|P4|Overall Study|Withdrawal by Subject|0
887374|NCT01253200|2925366|P3|Overall Study|Withdrawal by Subject|0
887375|NCT01253200|2925367|P2|Overall Study|Withdrawal by Subject|0
887376|NCT01253200|2925368|P1|Overall Study|Withdrawal by Subject|2
887377|NCT01253200|2925364|P5|Overall Study|Lost to Follow-up|0
887378|NCT01253200|2925365|P4|Overall Study|Lost to Follow-up|0
887379|NCT01253200|2925366|P3|Overall Study|Lost to Follow-up|0
887380|NCT01253200|2925367|P2|Overall Study|Lost to Follow-up|1
887381|NCT01253200|2925368|P1|Overall Study|Lost to Follow-up|1
887382|NCT01253200|2925364|P5|Overall Study|Death|0
887383|NCT01253200|2925365|P4|Overall Study|Death|0
887384|NCT01253200|2925366|P3|Overall Study|Death|0
887385|NCT01253200|2925367|P2|Overall Study|Death|0
887386|NCT01253200|2925368|P1|Overall Study|Death|1
887387|NCT01253187|2925383|P6|Period 3|non-compliance|0
887388|NCT01253187|2925384|P5|Period 3|non-compliance|1
887389|NCT01253187|2925385|P4|Period 3|non-compliance|0
887390|NCT01253187|2925386|P3|Period 3|non-compliance|0
887391|NCT01253187|2925387|P2|Period 3|non-compliance|0
887392|NCT01253187|2925388|P1|Period 3|non-compliance|0
887393|NCT01253187|2925383|P6|Period 3|difficulty with blood sampling|0
887394|NCT01253187|2925384|P5|Period 3|difficulty with blood sampling|0
887395|NCT01253187|2925385|P4|Period 3|difficulty with blood sampling|0
887396|NCT01253187|2925386|P3|Period 3|difficulty with blood sampling|0
887397|NCT01253187|2925387|P2|Period 3|difficulty with blood sampling|1
887398|NCT01253187|2925388|P1|Period 3|difficulty with blood sampling|0
887399|NCT01253187|2925383|P6|Period 3|Pregnancy|0
887400|NCT01253187|2925384|P5|Period 3|Pregnancy|0
887401|NCT01253187|2925385|P4|Period 3|Pregnancy|0
887402|NCT01253187|2925386|P3|Period 3|Pregnancy|0
887403|NCT01253187|2925387|P2|Period 3|Pregnancy|0
887404|NCT01253187|2925388|P1|Period 3|Pregnancy|1
887405|NCT01253187|2925383|P6|Period 2|Withdrawal by Subject|0
887406|NCT01253187|2925384|P5|Period 2|Withdrawal by Subject|1
887407|NCT01253187|2925385|P4|Period 2|Withdrawal by Subject|0
887408|NCT01253187|2925386|P3|Period 2|Withdrawal by Subject|0
887409|NCT01253187|2925387|P2|Period 2|Withdrawal by Subject|0
887410|NCT01253187|2925388|P1|Period 2|Withdrawal by Subject|0
887411|NCT01253174|2925417|P6|Period 3|Pregnancy|0
887412|NCT01253174|2925418|P5|Period 3|Pregnancy|0
887413|NCT01253174|2925419|P4|Period 3|Pregnancy|0
887414|NCT01253174|2925420|P3|Period 3|Pregnancy|1
887415|NCT01253174|2925421|P2|Period 3|Pregnancy|0
887416|NCT01253174|2925422|P1|Period 3|Pregnancy|0
887417|NCT01253174|2925417|P6|Period 3|Withdrawal by Subject|0
887418|NCT01253174|2925418|P5|Period 3|Withdrawal by Subject|1
887419|NCT01253174|2925419|P4|Period 3|Withdrawal by Subject|0
887420|NCT01253174|2925420|P3|Period 3|Withdrawal by Subject|0
887421|NCT01253174|2925421|P2|Period 3|Withdrawal by Subject|1
887422|NCT01253174|2925422|P1|Period 3|Withdrawal by Subject|0
887423|NCT01253174|2925417|P6|Period 2|Adverse Event|0
887424|NCT01253174|2925418|P5|Period 2|Adverse Event|0
887425|NCT01253174|2925419|P4|Period 2|Adverse Event|0
887426|NCT01253174|2925420|P3|Period 2|Adverse Event|1
887427|NCT01253174|2925421|P2|Period 2|Adverse Event|0
887428|NCT01253174|2925422|P1|Period 2|Adverse Event|0
887429|NCT01253174|2925417|P6|Period 1|Randomized but not treated|0
887430|NCT01253174|2925418|P5|Period 1|Randomized but not treated|1
887431|NCT01253174|2925419|P4|Period 1|Randomized but not treated|0
887432|NCT01253174|2925420|P3|Period 1|Randomized but not treated|1
887433|NCT01253174|2925421|P2|Period 1|Randomized but not treated|1
887434|NCT01253174|2925422|P1|Period 1|Randomized but not treated|0
887435|NCT01253135|2925457|P1|Amended Protocol|Non-compliance|1
887436|NCT01253135|2925457|P1|Original Protocol|Protocol Amendment|15
887437|NCT01253044|2925476|P2|Overall Study|Lost to Follow-up|29
887438|NCT01253044|2925477|P1|Overall Study|Lost to Follow-up|38
887439|NCT01253018|2925487|P2|Overall Study|Withdrawal by Subject|1
887440|NCT01253018|2925488|P1|Overall Study|Withdrawal by Subject|1
887441|NCT01253018|2925487|P2|Overall Study|Robot Repair Issues|0
887442|NCT01253018|2925488|P1|Overall Study|Robot Repair Issues|2
887443|NCT01253018|2925487|P2|Overall Study|Lost to Follow-up|1
887444|NCT01253018|2925488|P1|Overall Study|Lost to Follow-up|1
887445|NCT01252966|2925502|P2|Overall Study|Withdrawal by Subject|3
887446|NCT01252966|2925503|P1|Overall Study|Withdrawal by Subject|7
887447|NCT01252966|2925502|P2|Overall Study|Lost to Follow-up|10
887448|NCT01252966|2925503|P1|Overall Study|Lost to Follow-up|16
887449|NCT01252953|2925519|P2|Overall Study|Lost to Follow-up|21
887450|NCT01252953|2925520|P1|Overall Study|Lost to Follow-up|22
887451|NCT01252953|2925519|P2|Overall Study|Withdrawal by Subject|17
887452|NCT01252953|2925520|P1|Overall Study|Withdrawal by Subject|16
887453|NCT01252940|2925534|P2|Extension Phase|Withdrawal by Subject|1
887454|NCT01252940|2925535|P1|Extension Phase|Withdrawal by Subject|1
887455|NCT01252940|2925534|P2|Extension Phase|Subject Non-compliance|0
887456|NCT01252940|2925535|P1|Extension Phase|Subject Non-compliance|1
887457|NCT01252940|2925534|P2|Extension Phase|Physician Decision|1
887458|NCT01252940|2925535|P1|Extension Phase|Physician Decision|0
887459|NCT01252940|2925534|P2|Extension Phase|Lost to Follow-up|0
887460|NCT01252940|2925535|P1|Extension Phase|Lost to Follow-up|5
887461|NCT01252940|2925534|P2|Extension Phase|Lack of Efficacy|0
887462|NCT01252940|2925535|P1|Extension Phase|Lack of Efficacy|1
887463|NCT01252940|2925534|P2|Extension Phase|Adverse Event|1
887464|NCT01252940|2925535|P1|Extension Phase|Adverse Event|2
887465|NCT01252940|2925534|P2|Main Study Phase|Subject Non-compliance|1
887466|NCT01252940|2925535|P1|Main Study Phase|Subject Non-compliance|1
887467|NCT01252940|2925534|P2|Main Study Phase|Withdrawal by Subject|5
887468|NCT01252940|2925535|P1|Main Study Phase|Withdrawal by Subject|6
887469|NCT01252940|2925534|P2|Main Study Phase|Protocol Violation|2
887470|NCT01252940|2925535|P1|Main Study Phase|Protocol Violation|4
887471|NCT01252940|2925534|P2|Main Study Phase|Physician Decision|0
887472|NCT01252940|2925535|P1|Main Study Phase|Physician Decision|1
887473|NCT01252940|2925534|P2|Main Study Phase|Lost to Follow-up|1
887474|NCT01252940|2925535|P1|Main Study Phase|Lost to Follow-up|6
887475|NCT01252940|2925534|P2|Main Study Phase|Lack of Efficacy|0
887476|NCT01252940|2925535|P1|Main Study Phase|Lack of Efficacy|1
887477|NCT01252940|2925534|P2|Main Study Phase|Adverse Event|1
887478|NCT01252940|2925535|P1|Main Study Phase|Adverse Event|3
887479|NCT01252940|2925534|P2|Main Study Phase|Randomized but not treated|2
887480|NCT01252940|2925535|P1|Main Study Phase|Randomized but not treated|4
887481|NCT01252810|2925566|P2|Overall Study|Various reasons|0
887482|NCT01252810|2925567|P1|Overall Study|Various reasons|8
887483|NCT01252810|2925566|P2|Overall Study|Physician Decision|1
887484|NCT01252810|2925567|P1|Overall Study|Physician Decision|2
887485|NCT01252810|2925566|P2|Overall Study|Lost to Follow-up|1
887486|NCT01252810|2925567|P1|Overall Study|Lost to Follow-up|0
887487|NCT01252810|2925566|P2|Overall Study|Withdrawal by Subject|1
887488|NCT01252810|2925567|P1|Overall Study|Withdrawal by Subject|4
887489|NCT01252355|2925599|P3|Overall Study|Other Than Above|7
887490|NCT01252355|2925600|P2|Overall Study|Other Than Above|7
887491|NCT01252355|2925601|P1|Overall Study|Other Than Above|8
887492|NCT01252355|2925599|P3|Overall Study|Randomized but not Treated|0
887493|NCT01252355|2925600|P2|Overall Study|Randomized but not Treated|0
887494|NCT01252355|2925601|P1|Overall Study|Randomized but not Treated|2
887495|NCT01252355|2925599|P3|Overall Study|Sponsor Early Termination of Study|146
887496|NCT01252355|2925600|P2|Overall Study|Sponsor Early Termination of Study|149
887497|NCT01252355|2925601|P1|Overall Study|Sponsor Early Termination of Study|149
887498|NCT01252355|2925599|P3|Overall Study|Progressive Disease|0
887499|NCT01252355|2925600|P2|Overall Study|Progressive Disease|0
887500|NCT01252355|2925601|P1|Overall Study|Progressive Disease|2
887501|NCT01252355|2925599|P3|Overall Study|Poor Compliance to Protocol|1
887502|NCT01252355|2925600|P2|Overall Study|Poor Compliance to Protocol|1
887503|NCT01252355|2925601|P1|Overall Study|Poor Compliance to Protocol|1
887504|NCT01252355|2925599|P3|Overall Study|Lost to Follow-up|1
887505|NCT01252355|2925600|P2|Overall Study|Lost to Follow-up|0
887506|NCT01252355|2925601|P1|Overall Study|Lost to Follow-up|0
887507|NCT01252355|2925599|P3|Overall Study|Lack of Efficacy|2
887508|NCT01252355|2925600|P2|Overall Study|Lack of Efficacy|4
887509|NCT01252355|2925601|P1|Overall Study|Lack of Efficacy|6
887510|NCT01252355|2925599|P3|Overall Study|Adverse Event|22
887511|NCT01252355|2925600|P2|Overall Study|Adverse Event|17
887512|NCT01252355|2925601|P1|Overall Study|Adverse Event|9
887513|NCT01252290|2925639|P1|Overall Study|Withdrawal by Subject|1
887514|NCT01252251|2925655|P1|Overall Study|Withdrawal by Subject|1
887515|NCT01252238|2925667|P3|Overall Study|Sponsor terminated study|4
887516|NCT01252238|2925668|P2|Overall Study|Sponsor terminated study|4
887517|NCT01252238|2925669|P1|Overall Study|Sponsor terminated study|4
887518|NCT01252186|2925686|P3|Overall Study|Other - Miscellaneous Reasons|7
887519|NCT01252186|2925687|P2|Overall Study|Other - Miscellaneous Reasons|5
887520|NCT01252186|2925688|P1|Overall Study|Other - Miscellaneous Reasons|5
887521|NCT01252186|2925686|P3|Overall Study|Lost to Follow-up|11
887522|NCT01252186|2925687|P2|Overall Study|Lost to Follow-up|10
887523|NCT01252186|2925688|P1|Overall Study|Lost to Follow-up|10
887524|NCT01252186|2925686|P3|Overall Study|Sponsor Request|0
887525|NCT01252186|2925687|P2|Overall Study|Sponsor Request|1
887526|NCT01252186|2925688|P1|Overall Study|Sponsor Request|2
887527|NCT01252186|2925686|P3|Overall Study|Pregnancy|0
887528|NCT01252186|2925687|P2|Overall Study|Pregnancy|2
887529|NCT01252186|2925688|P1|Overall Study|Pregnancy|2
887530|NCT01252186|2925686|P3|Overall Study|Protocol Violation|1
887531|NCT01252186|2925687|P2|Overall Study|Protocol Violation|0
887532|NCT01252186|2925688|P1|Overall Study|Protocol Violation|0
887533|NCT01252186|2925686|P3|Overall Study|Non-compliance|4
887534|NCT01252186|2925687|P2|Overall Study|Non-compliance|3
887535|NCT01252186|2925688|P1|Overall Study|Non-compliance|0
887536|NCT01252186|2925686|P3|Overall Study|Physician Decision|1
887537|NCT01252186|2925687|P2|Overall Study|Physician Decision|0
887538|NCT01252186|2925688|P1|Overall Study|Physician Decision|0
887539|NCT01252186|2925686|P3|Overall Study|Withdrawal by Subject|2
887540|NCT01252186|2925687|P2|Overall Study|Withdrawal by Subject|5
887541|NCT01252186|2925688|P1|Overall Study|Withdrawal by Subject|2
887542|NCT01252186|2925686|P3|Overall Study|Adverse Event|8
887543|NCT01252186|2925687|P2|Overall Study|Adverse Event|6
887544|NCT01252186|2925688|P1|Overall Study|Adverse Event|9
887545|NCT01252134|2925761|P6|Period 1, 8 Hours|Personal Reasons|0
887546|NCT01252134|2925762|P5|Period 1, 8 Hours|Personal Reasons|0
887547|NCT01252134|2925763|P4|Period 1, 8 Hours|Personal Reasons|0
887548|NCT01252134|2925764|P3|Period 1, 8 Hours|Personal Reasons|1
887549|NCT01252134|2925765|P2|Period 1, 8 Hours|Personal Reasons|1
887550|NCT01252134|2925766|P1|Period 1, 8 Hours|Personal Reasons|0
887551|NCT01252095|2925785|P2|Overall Study|Disease progression|0
887552|NCT01252095|2925786|P1|Overall Study|Disease progression|1
887553|NCT01251952|2925804|P1|Overall Study|Adverse Event|1
887554|NCT01251770|2925810|P2|Overall Study|Protocol Violation|7
887555|NCT01251770|2925811|P1|Overall Study|Protocol Violation|13
887556|NCT01251653|2925862|P9|Overall Study|Other reason not mentioned above|0
887557|NCT01251653|2925863|P8|Overall Study|Other reason not mentioned above|2
887558|NCT01251653|2925864|P7|Overall Study|Other reason not mentioned above|0
887559|NCT01251653|2925865|P6|Overall Study|Other reason not mentioned above|0
887560|NCT01251653|2925866|P5|Overall Study|Other reason not mentioned above|0
887561|NCT01251653|2925867|P4|Overall Study|Other reason not mentioned above|0
887562|NCT01251653|2925868|P3|Overall Study|Other reason not mentioned above|0
887563|NCT01251653|2925869|P2|Overall Study|Other reason not mentioned above|0
887564|NCT01251653|2925870|P1|Overall Study|Other reason not mentioned above|0
887565|NCT01251653|2925862|P9|Overall Study|Withdrawal by Subject|0
887566|NCT01251653|2925863|P8|Overall Study|Withdrawal by Subject|1
887567|NCT01251653|2925864|P7|Overall Study|Withdrawal by Subject|0
887568|NCT01251653|2925865|P6|Overall Study|Withdrawal by Subject|1
887569|NCT01251653|2925866|P5|Overall Study|Withdrawal by Subject|1
887570|NCT01251653|2925867|P4|Overall Study|Withdrawal by Subject|0
887571|NCT01251653|2925868|P3|Overall Study|Withdrawal by Subject|1
887572|NCT01251653|2925869|P2|Overall Study|Withdrawal by Subject|0
887573|NCT01251653|2925870|P1|Overall Study|Withdrawal by Subject|1
887574|NCT01251653|2925862|P9|Overall Study|Adverse Event|1
887575|NCT01251653|2925863|P8|Overall Study|Adverse Event|2
887576|NCT01251653|2925864|P7|Overall Study|Adverse Event|2
887577|NCT01251653|2925865|P6|Overall Study|Adverse Event|0
887578|NCT01251653|2925866|P5|Overall Study|Adverse Event|1
887579|NCT01251653|2925867|P4|Overall Study|Adverse Event|1
887580|NCT01251653|2925868|P3|Overall Study|Adverse Event|2
887581|NCT01251653|2925869|P2|Overall Study|Adverse Event|0
887582|NCT01251653|2925870|P1|Overall Study|Adverse Event|1
887583|NCT01251653|2925862|P9|Overall Study|Dose-limiting toxicity|0
887584|NCT01251653|2925863|P8|Overall Study|Dose-limiting toxicity|0
887585|NCT01251653|2925864|P7|Overall Study|Dose-limiting toxicity|2
887586|NCT01251653|2925865|P6|Overall Study|Dose-limiting toxicity|0
887587|NCT01251653|2925866|P5|Overall Study|Dose-limiting toxicity|0
887588|NCT01251653|2925867|P4|Overall Study|Dose-limiting toxicity|1
887589|NCT01251653|2925868|P3|Overall Study|Dose-limiting toxicity|1
887590|NCT01251653|2925869|P2|Overall Study|Dose-limiting toxicity|1
887591|NCT01251653|2925870|P1|Overall Study|Dose-limiting toxicity|0
887592|NCT01251653|2925862|P9|Overall Study|Progressive Disease|5
887593|NCT01251653|2925863|P8|Overall Study|Progressive Disease|7
887594|NCT01251653|2925864|P7|Overall Study|Progressive Disease|14
887595|NCT01251653|2925865|P6|Overall Study|Progressive Disease|17
887596|NCT01251653|2925866|P5|Overall Study|Progressive Disease|0
887597|NCT01251653|2925867|P4|Overall Study|Progressive Disease|4
887598|NCT01251653|2925868|P3|Overall Study|Progressive Disease|16
887599|NCT01251653|2925869|P2|Overall Study|Progressive Disease|7
887600|NCT01251653|2925870|P1|Overall Study|Progressive Disease|1
887601|NCT01251614|2925998|P3|Overall Study|Lost to Follow-up|0
887602|NCT01251614|2925999|P2|Overall Study|Lost to Follow-up|1
887603|NCT01251614|2926000|P1|Overall Study|Lost to Follow-up|0
887604|NCT01251614|2925998|P3|Overall Study|Withdrawal by Subject|1
887605|NCT01251614|2925999|P2|Overall Study|Withdrawal by Subject|2
887606|NCT01251614|2926000|P1|Overall Study|Withdrawal by Subject|0
887607|NCT01251614|2925998|P3|Overall Study|Loss of Disease Control|0
887608|NCT01251614|2925999|P2|Overall Study|Loss of Disease Control|1
887609|NCT01251614|2926000|P1|Overall Study|Loss of Disease Control|0
887610|NCT01251614|2925998|P3|Overall Study|Pregnancy|2
887611|NCT01251614|2925999|P2|Overall Study|Pregnancy|0
887612|NCT01251614|2926000|P1|Overall Study|Pregnancy|0
887613|NCT01251614|2925998|P3|Overall Study|Clearing of Psoriatic Lesions|0
887614|NCT01251614|2925999|P2|Overall Study|Clearing of Psoriatic Lesions|0
887615|NCT01251614|2926000|P1|Overall Study|Clearing of Psoriatic Lesions|1
887616|NCT01251614|2925998|P3|Overall Study|Lack of Efficacy|4
887617|NCT01251614|2925999|P2|Overall Study|Lack of Efficacy|9
887618|NCT01251614|2926000|P1|Overall Study|Lack of Efficacy|1
887619|NCT01251614|2925998|P3|Overall Study|Adverse Event|1
887620|NCT01251614|2925999|P2|Overall Study|Adverse Event|0
887621|NCT01251614|2926000|P1|Overall Study|Adverse Event|1
887622|NCT01251380|2926107|P1|Overall Study|Lost to Follow-up|2
887623|NCT01251380|2926107|P1|Overall Study|Adverse Event|1
887624|NCT01251380|2926107|P1|Overall Study|Lack of Efficacy|1
887625|NCT01251380|2926107|P1|Overall Study|Withdrawal by Subject|6
887626|NCT01251380|2926107|P1|Overall Study|Other (Not otherwise specified)|12
887627|NCT01251367|2926131|P1|Overall Study|End of Study Visit Performed in Error|1
887628|NCT01251367|2926131|P1|Overall Study|Subject had Personal or Medical Issues|4
887629|NCT01251367|2926131|P1|Overall Study|No Study Drug Available|1
887630|NCT01251367|2926131|P1|Overall Study|Subject Required Alternative Treatment|7
887631|NCT01251367|2926131|P1|Overall Study|Lost to Follow-up|5
887632|NCT01251367|2926131|P1|Overall Study|Withdrawal by Subject|36
887633|NCT01251367|2926131|P1|Overall Study|Adverse Event|19
887634|NCT01251367|2926131|P1|Overall Study|Lack of Efficacy|2
887635|NCT01251367|2926131|P1|Overall Study|Protocol Violation|1
887636|NCT01251354|2926166|P1|Overall Study|Disease Progression|4
887637|NCT01251354|2926166|P1|Overall Study|Investigator's Decision|1
887638|NCT01251354|2926166|P1|Overall Study|Adverse Event|1
887639|NCT01251276|2926209|P2|Overall Study|Lost to Follow-up|1
887640|NCT01251276|2926210|P1|Overall Study|Lost to Follow-up|0
887641|NCT01251276|2926209|P2|Overall Study|Protocol Violation|0
887642|NCT01251276|2926210|P1|Overall Study|Protocol Violation|1
887643|NCT01251146|2926228|P2|Overall Study|Lost to Follow-up|10
887644|NCT01251146|2926229|P1|Overall Study|Lost to Follow-up|3
887645|NCT01251120|2926251|P2|Overall Study|Lack of Efficacy|1
887646|NCT01251120|2926252|P1|Overall Study|Lack of Efficacy|0
887647|NCT01250925|2926317|P3|Overall Study|Adverse Event|1
887648|NCT01250925|2926318|P2|Overall Study|Adverse Event|0
887649|NCT01250925|2926319|P1|Overall Study|Adverse Event|0
887650|NCT01250925|2926317|P3|Overall Study|Physician Decision|1
887651|NCT01250925|2926318|P2|Overall Study|Physician Decision|2
887652|NCT01250925|2926319|P1|Overall Study|Physician Decision|0
887653|NCT01250925|2926317|P3|Overall Study|Protocol Violation|0
887654|NCT01250925|2926318|P2|Overall Study|Protocol Violation|0
887655|NCT01250925|2926319|P1|Overall Study|Protocol Violation|2
887656|NCT01250925|2926317|P3|Overall Study|Withdrawal by Subject|0
887657|NCT01250925|2926318|P2|Overall Study|Withdrawal by Subject|0
887658|NCT01250925|2926319|P1|Overall Study|Withdrawal by Subject|2
887659|NCT01250925|2926317|P3|Overall Study|Lost to Follow-up|0
887660|NCT01250925|2926318|P2|Overall Study|Lost to Follow-up|1
887661|NCT01250925|2926319|P1|Overall Study|Lost to Follow-up|1
887662|NCT01250873|2926364|P1|Overall Study|Adverse Event|3
887663|NCT01250769|2926396|P4|Overall Study|Adverse Event|0
887664|NCT01250769|2926397|P3|Overall Study|Adverse Event|1
887665|NCT01250769|2926398|P2|Overall Study|Adverse Event|0
887666|NCT01250769|2926399|P1|Overall Study|Adverse Event|0
887667|NCT01250769|2926396|P4|Overall Study|Withdrawal by Subject|0
887668|NCT01250769|2926397|P3|Overall Study|Withdrawal by Subject|1
887669|NCT01250769|2926398|P2|Overall Study|Withdrawal by Subject|1
887670|NCT01250769|2926399|P1|Overall Study|Withdrawal by Subject|0
887671|NCT01250756|2926431|P2|After Toddler Dose|Adverse Event|1
887672|NCT01250756|2926432|P1|After Toddler Dose|Adverse Event|0
887673|NCT01250756|2926431|P2|Toddler Dose|Adverse Event|1
887674|NCT01250756|2926432|P1|Toddler Dose|Adverse Event|0
887675|NCT01250756|2926431|P2|After Infant Series|Other|1
887676|NCT01250756|2926432|P1|After Infant Series|Other|2
887677|NCT01250756|2926431|P2|After Infant Series|Withdrawal by Subject|1
887678|NCT01250756|2926432|P1|After Infant Series|Withdrawal by Subject|4
887679|NCT01250756|2926431|P2|After Infant Series|Adverse Event|2
887680|NCT01250756|2926432|P1|After Infant Series|Adverse Event|5
887681|NCT01250756|2926431|P2|Infant Series|Other|0
887682|NCT01250756|2926432|P1|Infant Series|Other|22
887683|NCT01250756|2926431|P2|Infant Series|Randomized, Not Vaccinated|2
887684|NCT01250756|2926432|P1|Infant Series|Randomized, Not Vaccinated|2
887685|NCT01250756|2926431|P2|Infant Series|Withdrawal by Subject|5
887686|NCT01250756|2926432|P1|Infant Series|Withdrawal by Subject|4
887687|NCT01250509|2926549|P2|Overall Study|Lost to Follow-up|2
887688|NCT01250509|2926550|P1|Overall Study|Lost to Follow-up|5
887689|NCT01250418|2926564|P2|Overall Study|monitor data failure|1
887690|NCT01250418|2926565|P1|Overall Study|monitor data failure|1
887691|NCT01250379|2926573|P2|Overall Study|Participant noncompliance|0
887692|NCT01250379|2926574|P1|Overall Study|Participant noncompliance|2
887693|NCT01250379|2926573|P2|Overall Study|Not specified|4
887694|NCT01250379|2926574|P1|Overall Study|Not specified|0
887695|NCT01250379|2926573|P2|Overall Study|Adverse Event|4
887696|NCT01250379|2926574|P1|Overall Study|Adverse Event|5
887697|NCT01250379|2926573|P2|Overall Study|Lost to Follow-up|6
887698|NCT01250379|2926574|P1|Overall Study|Lost to Follow-up|9
887699|NCT01250379|2926573|P2|Overall Study|Protocol Violation|8
887700|NCT01250379|2926574|P1|Overall Study|Protocol Violation|2
887701|NCT01250379|2926573|P2|Overall Study|Physician Decision|3
887702|NCT01250379|2926574|P1|Overall Study|Physician Decision|11
887703|NCT01250379|2926573|P2|Overall Study|Withdrawal by Subject|20
887704|NCT01250379|2926574|P1|Overall Study|Withdrawal by Subject|32
887705|NCT01250379|2926573|P2|Overall Study|Death|148
887706|NCT01250379|2926574|P1|Overall Study|Death|141
887707|NCT01250171|2926679|P3|Overall Study|Administrative reasons|0
887708|NCT01250171|2926680|P2|Overall Study|Administrative reasons|0
887709|NCT01250171|2926681|P1|Overall Study|Administrative reasons|1
887710|NCT01250145|2926712|P2|Overall Study|Withdrawal by Subject|4
887711|NCT01250145|2926713|P1|Overall Study|Withdrawal by Subject|0
887712|NCT01250145|2926712|P2|Overall Study|Adverse Event|1
887713|NCT01250145|2926713|P1|Overall Study|Adverse Event|2
887714|NCT01250119|2926733|P2|Treatment Phase|Unknown reason|4
887715|NCT01250119|2926734|P1|Treatment Phase|Unknown reason|0
887716|NCT01250119|2926733|P2|Treatment Phase|Adverse Event|2
887717|NCT01250119|2926734|P1|Treatment Phase|Adverse Event|0
887718|NCT01250119|2926733|P2|Treatment Phase|Withdrawal by Subject|1
887719|NCT01250119|2926734|P1|Treatment Phase|Withdrawal by Subject|0
887720|NCT01250119|2926733|P2|Treatment Phase|Death|2
887721|NCT01250119|2926734|P1|Treatment Phase|Death|0
887722|NCT01250119|2926733|P2|Treatment Phase|Progressive Disease|32
887723|NCT01250119|2926734|P1|Treatment Phase|Progressive Disease|0
887724|NCT01250119|2926733|P2|Diagnostic Phase|Participants Not Tested|0
887725|NCT01250119|2926734|P1|Diagnostic Phase|Participants Not Tested|44
887726|NCT01250119|2926733|P2|Diagnostic Phase|Failed to Produce a Test Results|0
887727|NCT01250119|2926734|P1|Diagnostic Phase|Failed to Produce a Test Results|69
887728|NCT01250054|2926749|P2|Period 2, One Week of Wear|Unacceptable subjective vision|0
887729|NCT01250054|2926750|P1|Period 2, One Week of Wear|Unacceptable subjective vision|1
887730|NCT01250002|2926758|P2|Overall Study|Change to open surgical procedure|3
887731|NCT01250002|2926759|P1|Overall Study|Change to open surgical procedure|4
887732|NCT01249833|2926824|P2|Overall Study|Lost to Follow-up|1
887733|NCT01249833|2926825|P1|Overall Study|Lost to Follow-up|0
887734|NCT01249664|2926839|P2|Overall Study|Adverse Event|0
887735|NCT01249664|2926840|P1|Overall Study|Adverse Event|1
887736|NCT01249664|2926839|P2|Overall Study|Withdrawal by Subject|0
887737|NCT01249664|2926840|P1|Overall Study|Withdrawal by Subject|5
887738|NCT01249651|2926890|P1|Overall Study|Sponsor Decision|1
887739|NCT01249651|2926890|P1|Overall Study|Protocol Violation|1
887740|NCT01249651|2926890|P1|Overall Study|Adverse Event|1
887741|NCT01249651|2926890|P1|Overall Study|Withdrawal by Subject|4
887742|NCT01249417|2926900|P3|Treatment Phase - ITT Population|Lost to Follow-up|1
887743|NCT01249417|2926901|P2|Treatment Phase - ITT Population|Lost to Follow-up|1
887744|NCT01249417|2926902|P1|Treatment Phase - ITT Population|Lost to Follow-up|0
887745|NCT01249417|2926900|P3|Treatment Phase - ITT Population|Withdrawal by Subject|1
887746|NCT01249417|2926901|P2|Treatment Phase - ITT Population|Withdrawal by Subject|3
887747|NCT01249417|2926902|P1|Treatment Phase - ITT Population|Withdrawal by Subject|1
887748|NCT01249417|2926900|P3|Treatment Phase - ITT Population|Adverse Event|1
887749|NCT01249417|2926901|P2|Treatment Phase - ITT Population|Adverse Event|0
887750|NCT01249417|2926902|P1|Treatment Phase - ITT Population|Adverse Event|0
887751|NCT01249417|2926900|P3|Treatment Phase - ITT Population|Not specified|1
887752|NCT01249417|2926901|P2|Treatment Phase - ITT Population|Not specified|0
887753|NCT01249417|2926902|P1|Treatment Phase - ITT Population|Not specified|0
887754|NCT01249417|2926900|P3|Randomised Population|No MAS score at baseline and/or Week 4|2
887755|NCT01249417|2926901|P2|Randomised Population|No MAS score at baseline and/or Week 4|1
887756|NCT01249417|2926902|P1|Randomised Population|No MAS score at baseline and/or Week 4|1
887757|NCT01249417|2926900|P3|Randomised Population|Study treatment not received|2
887758|NCT01249417|2926901|P2|Randomised Population|Study treatment not received|0
887759|NCT01249417|2926902|P1|Randomised Population|Study treatment not received|0
887760|NCT01249404|2926919|P3|Overall Study|Non compliance to visit schedule|0
887761|NCT01249404|2926920|P2|Overall Study|Non compliance to visit schedule|1
887762|NCT01249404|2926921|P1|Overall Study|Non compliance to visit schedule|0
887763|NCT01249404|2926919|P3|Overall Study|Botulinum toxin (BTX) in upper limb|1
887764|NCT01249404|2926920|P2|Overall Study|Botulinum toxin (BTX) in upper limb|2
887765|NCT01249404|2926921|P1|Overall Study|Botulinum toxin (BTX) in upper limb|1
887766|NCT01249404|2926919|P3|Overall Study|Withdrawal by Subject|0
887767|NCT01249404|2926920|P2|Overall Study|Withdrawal by Subject|2
887768|NCT01249404|2926921|P1|Overall Study|Withdrawal by Subject|2
887769|NCT01249404|2926919|P3|Overall Study|Adverse Event|2
887770|NCT01249404|2926920|P2|Overall Study|Adverse Event|2
887771|NCT01249404|2926921|P1|Overall Study|Adverse Event|2
887772|NCT01249404|2926919|P3|Overall Study|No MAS Score at baseline and/or Week 4|2
887773|NCT01249404|2926920|P2|Overall Study|No MAS Score at baseline and/or Week 4|0
887774|NCT01249404|2926921|P1|Overall Study|No MAS Score at baseline and/or Week 4|2
887775|NCT01249404|2926919|P3|Overall Study|Study treatment not received|2
887776|NCT01249404|2926920|P2|Overall Study|Study treatment not received|1
887777|NCT01249404|2926921|P1|Overall Study|Study treatment not received|0
887778|NCT01249365|2926998|P1|Overall Study|Lost to Follow-up|1
887779|NCT01249274|2927006|P2|Overall Study|Received inpatient substance treatment|2
887780|NCT01249274|2927007|P1|Overall Study|Received inpatient substance treatment|1
887781|NCT01249274|2927006|P2|Overall Study|Lost to Follow-up|4
887782|NCT01249274|2927007|P1|Overall Study|Lost to Follow-up|3
887783|NCT01249261|2927033|P2|Overall Study|Withdrawal by Subject|0
887784|NCT01249261|2927034|P1|Overall Study|Withdrawal by Subject|1
887785|NCT01249157|2927062|P1|Overall Study|Withdrawal by Subject|1
887786|NCT01249131|2927066|P6|Washout Period of 10 Days|Adverse Event|0
887787|NCT01249131|2927067|P5|Washout Period of 10 Days|Adverse Event|1
887788|NCT01249131|2927068|P4|Washout Period of 10 Days|Adverse Event|0
887789|NCT01249131|2927069|P3|Washout Period of 10 Days|Adverse Event|0
887790|NCT01249131|2927070|P2|Washout Period of 10 Days|Adverse Event|0
887791|NCT01249131|2927071|P1|Washout Period of 10 Days|Adverse Event|0
887792|NCT01249118|2927091|P3|First Washout Period|Physician Decision|0
887793|NCT01249118|2927092|P2|First Washout Period|Physician Decision|1
887794|NCT01249118|2927093|P1|First Washout Period|Physician Decision|0
887795|NCT01249092|2927127|P1|Overall Study|Unable to tolerate expected SE -nausea|1
887796|NCT01249092|2927127|P1|Overall Study|Expected side effect of nausea/dyspepsia|1
887797|NCT01248949|2927138|P5|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
887798|NCT01248949|2927139|P4|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
887799|NCT01248949|2927140|P3|Overall Study|Lesion In ThoracicSpine Requires Therapy|1
887800|NCT01248949|2927141|P2|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
887801|NCT01248949|2927142|P1|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
887802|NCT01248949|2927138|P5|Overall Study|Pi Discretion Due To Hospitalisation|0
887803|NCT01248949|2927139|P4|Overall Study|Pi Discretion Due To Hospitalisation|0
887804|NCT01248949|2927140|P3|Overall Study|Pi Discretion Due To Hospitalisation|0
887805|NCT01248949|2927141|P2|Overall Study|Pi Discretion Due To Hospitalisation|1
887806|NCT01248949|2927142|P1|Overall Study|Pi Discretion Due To Hospitalisation|0
887807|NCT01248949|2927138|P5|Overall Study|Pi Decision Due To Declining Status|0
887808|NCT01248949|2927139|P4|Overall Study|Pi Decision Due To Declining Status|0
887809|NCT01248949|2927140|P3|Overall Study|Pi Decision Due To Declining Status|1
887810|NCT01248949|2927141|P2|Overall Study|Pi Decision Due To Declining Status|0
887811|NCT01248949|2927142|P1|Overall Study|Pi Decision Due To Declining Status|0
887812|NCT01248949|2927138|P5|Overall Study|Per Sponsor Request o Discontinue Drug|0
887813|NCT01248949|2927139|P4|Overall Study|Per Sponsor Request o Discontinue Drug|0
887814|NCT01248949|2927140|P3|Overall Study|Per Sponsor Request o Discontinue Drug|0
887815|NCT01248949|2927141|P2|Overall Study|Per Sponsor Request o Discontinue Drug|0
887816|NCT01248949|2927142|P1|Overall Study|Per Sponsor Request o Discontinue Drug|1
887817|NCT01248949|2927138|P5|Overall Study|Participant Went To Hospice|0
887818|NCT01248949|2927139|P4|Overall Study|Participant Went To Hospice|0
887819|NCT01248949|2927140|P3|Overall Study|Participant Went To Hospice|1
887820|NCT01248949|2927141|P2|Overall Study|Participant Went To Hospice|0
887821|NCT01248949|2927142|P1|Overall Study|Participant Went To Hospice|0
887822|NCT01248949|2927138|P5|Overall Study|Entered Hospice And Refused Follow Up|1
887823|NCT01248949|2927139|P4|Overall Study|Entered Hospice And Refused Follow Up|0
887824|NCT01248949|2927140|P3|Overall Study|Entered Hospice And Refused Follow Up|0
887825|NCT01248949|2927141|P2|Overall Study|Entered Hospice And Refused Follow Up|0
887826|NCT01248949|2927142|P1|Overall Study|Entered Hospice And Refused Follow Up|0
887827|NCT01248949|2927138|P5|Overall Study|Palliative Radiation To Brain Metastases|0
887828|NCT01248949|2927139|P4|Overall Study|Palliative Radiation To Brain Metastases|0
887829|NCT01248949|2927140|P3|Overall Study|Palliative Radiation To Brain Metastases|0
887830|NCT01248949|2927141|P2|Overall Study|Palliative Radiation To Brain Metastases|0
887831|NCT01248949|2927142|P1|Overall Study|Palliative Radiation To Brain Metastases|1
887832|NCT01248949|2927138|P5|Overall Study|Alternative Therapy.|0
887833|NCT01248949|2927139|P4|Overall Study|Alternative Therapy.|0
887834|NCT01248949|2927140|P3|Overall Study|Alternative Therapy.|0
887835|NCT01248949|2927141|P2|Overall Study|Alternative Therapy.|0
887836|NCT01248949|2927142|P1|Overall Study|Alternative Therapy.|1
887837|NCT01248949|2927138|P5|Overall Study|Alternative Therapy|0
887838|NCT01248949|2927139|P4|Overall Study|Alternative Therapy|0
887839|NCT01248949|2927140|P3|Overall Study|Alternative Therapy|0
887840|NCT01248949|2927141|P2|Overall Study|Alternative Therapy|0
887841|NCT01248949|2927142|P1|Overall Study|Alternative Therapy|1
887842|NCT01248949|2927138|P5|Overall Study|Death|2
887843|NCT01248949|2927139|P4|Overall Study|Death|6
887844|NCT01248949|2927140|P3|Overall Study|Death|21
887845|NCT01248949|2927141|P2|Overall Study|Death|7
887846|NCT01248949|2927142|P1|Overall Study|Death|22
887847|NCT01248949|2927138|P5|Overall Study|Withdrawal by Subject|1
887848|NCT01248949|2927139|P4|Overall Study|Withdrawal by Subject|3
887849|NCT01248949|2927140|P3|Overall Study|Withdrawal by Subject|11
887850|NCT01248949|2927141|P2|Overall Study|Withdrawal by Subject|3
887851|NCT01248949|2927142|P1|Overall Study|Withdrawal by Subject|5
887852|NCT01248949|2927138|P5|Overall Study|Lost to Follow-up|0
887853|NCT01248949|2927139|P4|Overall Study|Lost to Follow-up|1
887854|NCT01248949|2927140|P3|Overall Study|Lost to Follow-up|2
887855|NCT01248949|2927141|P2|Overall Study|Lost to Follow-up|2
887856|NCT01248949|2927142|P1|Overall Study|Lost to Follow-up|2
887857|NCT01248936|2927254|P1|Overall Study|Other reason|3
887858|NCT01248936|2927254|P1|Overall Study|Refused Treatment|1
887859|NCT01248936|2927254|P1|Overall Study|Lost to Follow-up|7
887860|NCT01248936|2927254|P1|Overall Study|Adverse Event|8
887861|NCT01248936|2927254|P1|Overall Study|Withdrawal of Consent|20
887862|NCT01248936|2927254|P1|Overall Study|Death|26
887863|NCT01248936|2927254|P1|Overall Study|Progression of Disease|50
887864|NCT01248936|2927254|P1|Overall Study|Sponsor Decision|259
887865|NCT01248884|2927267|P3|Overall Study|Adverse Event|0
887866|NCT01248884|2927268|P2|Overall Study|Adverse Event|0
887867|NCT01248884|2927269|P1|Overall Study|Adverse Event|1
887868|NCT01248884|2927267|P3|Overall Study|Withdrawal by Subject|1
887869|NCT01248884|2927268|P2|Overall Study|Withdrawal by Subject|3
887870|NCT01248884|2927269|P1|Overall Study|Withdrawal by Subject|1
887871|NCT01248793|2927327|P2|Overall Study|Withdrawal by Subject|3
887872|NCT01248793|2927328|P1|Overall Study|Withdrawal by Subject|3
887873|NCT01248793|2927327|P2|Overall Study|Protocol Violation|1
887874|NCT01248793|2927328|P1|Overall Study|Protocol Violation|0
887875|NCT01248793|2927327|P2|Overall Study|Adverse Event|1
887876|NCT01248793|2927328|P1|Overall Study|Adverse Event|1
887877|NCT01248793|2927327|P2|Overall Study|Lost to Follow-up|1
887878|NCT01248793|2927328|P1|Overall Study|Lost to Follow-up|0
887879|NCT01248780|2927342|P2|Overall Study|Not treated|1
887880|NCT01248780|2927343|P1|Overall Study|Not treated|0
887881|NCT01248780|2927342|P2|Overall Study|Withdrawal by Subject|4
887882|NCT01248780|2927343|P1|Overall Study|Withdrawal by Subject|4
887883|NCT01248780|2927342|P2|Overall Study|Protocol Violation|1
887884|NCT01248780|2927343|P1|Overall Study|Protocol Violation|1
887885|NCT01248780|2927342|P2|Overall Study|Adverse Event|7
887886|NCT01248780|2927343|P1|Overall Study|Adverse Event|2
887887|NCT01248780|2927342|P2|Overall Study|Death|1
887888|NCT01248780|2927343|P1|Overall Study|Death|0
887889|NCT01248780|2927342|P2|Overall Study|Lost to Follow-up|1
887890|NCT01248780|2927343|P1|Overall Study|Lost to Follow-up|0
887891|NCT01248780|2927342|P2|Overall Study|Lack of Efficacy|0
887892|NCT01248780|2927343|P1|Overall Study|Lack of Efficacy|2
887893|NCT01248728|2927357|P2|Overall Study|Lack of Efficacy|0
887894|NCT01248728|2927358|P1|Overall Study|Lack of Efficacy|1
887895|NCT01248728|2927357|P2|Overall Study|Withdrawal by Subject|1
887896|NCT01248728|2927358|P1|Overall Study|Withdrawal by Subject|2
887897|NCT01248728|2927357|P2|Overall Study|Adverse Event|1
887898|NCT01248728|2927358|P1|Overall Study|Adverse Event|1
887899|NCT01248715|2927374|P2|Overall Study|Not influenza positive|510
887900|NCT01248715|2927375|P1|Overall Study|Not influenza positive|501
887901|NCT01248468|2927396|P3|Overall Study|Withdrawal by Subject|0
887902|NCT01248468|2927397|P2|Overall Study|Withdrawal by Subject|2
887903|NCT01248468|2927398|P1|Overall Study|Withdrawal by Subject|4
887904|NCT01248468|2927396|P3|Overall Study|Pregnancy|0
887905|NCT01248468|2927397|P2|Overall Study|Pregnancy|0
887906|NCT01248468|2927398|P1|Overall Study|Pregnancy|1
887907|NCT01248468|2927396|P3|Overall Study|Lost to Follow-up|4
887908|NCT01248468|2927397|P2|Overall Study|Lost to Follow-up|12
887909|NCT01248468|2927398|P1|Overall Study|Lost to Follow-up|9
887910|NCT01248468|2927396|P3|Overall Study|Administrative problem|0
887911|NCT01248468|2927397|P2|Overall Study|Administrative problem|0
887912|NCT01248468|2927398|P1|Overall Study|Administrative problem|1
887913|NCT01248455|2927415|P1|Overall Study|switched to alternate treatment|1
887914|NCT01248364|2927460|P4|Overall Study|Adverse Event|0
887915|NCT01248364|2927461|P3|Overall Study|Adverse Event|0
887916|NCT01248364|2927462|P2|Overall Study|Adverse Event|1
887917|NCT01248364|2927463|P1|Overall Study|Adverse Event|0
887918|NCT01248130|2927526|P2|Overall Study|Ineligible|0
887919|NCT01248130|2927527|P1|Overall Study|Ineligible|1
887920|NCT01248130|2927526|P2|Overall Study|Protocol Violation|0
887921|NCT01248130|2927527|P1|Overall Study|Protocol Violation|1
887922|NCT01248065|2927537|P2|Overall Study|Other|5
887923|NCT01248065|2927538|P1|Overall Study|Other|3
887924|NCT01248065|2927537|P2|Overall Study|Third treatment failure event|1
887925|NCT01248065|2927538|P1|Overall Study|Third treatment failure event|3
887926|NCT01248065|2927537|P2|Overall Study|Adverse Event|0
887927|NCT01248065|2927538|P1|Overall Study|Adverse Event|3
887928|NCT01248065|2927537|P2|Overall Study|Withdrawal by Subject|11
887929|NCT01248065|2927538|P1|Overall Study|Withdrawal by Subject|14
887930|NCT01248065|2927537|P2|Overall Study|Lost to Follow-up|5
887931|NCT01248065|2927538|P1|Overall Study|Lost to Follow-up|3
887932|NCT01248013|2927548|P1|Overall Study|Withdrawal by Subject|14
887933|NCT01247922|2927563|P1|Overall Study|Disease progression|4
887934|NCT01247350|2927661|P5|Overall Study|Entry criteria not met|1
887935|NCT01247350|2927662|P4|Overall Study|Entry criteria not met|0
887936|NCT01247350|2927663|P3|Overall Study|Entry criteria not met|0
887937|NCT01247350|2927664|P2|Overall Study|Entry criteria not met|0
887938|NCT01247350|2927665|P1|Overall Study|Entry criteria not met|0
887939|NCT01247350|2927661|P5|Overall Study|Withdrawal by Subject|0
887940|NCT01247350|2927662|P4|Overall Study|Withdrawal by Subject|1
887941|NCT01247350|2927663|P3|Overall Study|Withdrawal by Subject|0
887942|NCT01247350|2927664|P2|Overall Study|Withdrawal by Subject|0
887943|NCT01247350|2927665|P1|Overall Study|Withdrawal by Subject|0
887944|NCT01247350|2927661|P5|Overall Study|Adverse Event|0
887945|NCT01247350|2927662|P4|Overall Study|Adverse Event|0
887946|NCT01247350|2927663|P3|Overall Study|Adverse Event|1
887947|NCT01247350|2927664|P2|Overall Study|Adverse Event|0
887948|NCT01247350|2927665|P1|Overall Study|Adverse Event|0
887949|NCT01247324|2927723|P2|Overall Study|Lost to Follow-up|1
887950|NCT01247324|2927724|P1|Overall Study|Lost to Follow-up|1
887951|NCT01247324|2927723|P2|Overall Study|Adverse Event|13
887952|NCT01247324|2927724|P1|Overall Study|Adverse Event|25
887953|NCT01247324|2927723|P2|Overall Study|Consent withdrawn by participant|8
887954|NCT01247324|2927724|P1|Overall Study|Consent withdrawn by participant|13
887955|NCT01247324|2927723|P2|Overall Study|Reason not specified|8
887956|NCT01247324|2927724|P1|Overall Study|Reason not specified|11
887957|NCT01247324|2927723|P2|Overall Study|Protocol Violation|2
887958|NCT01247324|2927724|P1|Overall Study|Protocol Violation|1
887959|NCT01247324|2927723|P2|Overall Study|Pregnancy|3
887960|NCT01247324|2927724|P1|Overall Study|Pregnancy|2
887961|NCT01247324|2927723|P2|Overall Study|Non-compliance|0
887962|NCT01247324|2927724|P1|Overall Study|Non-compliance|2
887963|NCT01247324|2927723|P2|Overall Study|Lack of Efficacy|8
887964|NCT01247324|2927724|P1|Overall Study|Lack of Efficacy|12
887965|NCT01247324|2927723|P2|Overall Study|Non-compliance with study drug|0
887966|NCT01247324|2927724|P1|Overall Study|Non-compliance with study drug|3
887967|NCT01247324|2927723|P2|Overall Study|Physician Decision|1
887968|NCT01247324|2927724|P1|Overall Study|Physician Decision|0
887969|NCT01247324|2927723|P2|Overall Study|Death|0
887970|NCT01247324|2927724|P1|Overall Study|Death|1
887971|NCT01247090|2927817|P3|Overall Study|Withdrawal by Subject|0
887972|NCT01247090|2927818|P2|Overall Study|Withdrawal by Subject|1
887973|NCT01247090|2927819|P1|Overall Study|Withdrawal by Subject|0
887974|NCT01247090|2927817|P3|Overall Study|Physician Decision|0
887975|NCT01247090|2927818|P2|Overall Study|Physician Decision|0
887976|NCT01247090|2927819|P1|Overall Study|Physician Decision|1
887977|NCT01246999|2927848|P4|Overall Study|Withdrawal by Subject|2
887978|NCT01246999|2927849|P3|Overall Study|Withdrawal by Subject|0
887979|NCT01246999|2927850|P2|Overall Study|Withdrawal by Subject|0
887980|NCT01246999|2927851|P1|Overall Study|Withdrawal by Subject|0
887981|NCT01246999|2927848|P4|Overall Study|Lost to Follow-up|0
887982|NCT01246999|2927849|P3|Overall Study|Lost to Follow-up|0
887983|NCT01246999|2927850|P2|Overall Study|Lost to Follow-up|1
887984|NCT01246999|2927851|P1|Overall Study|Lost to Follow-up|0
887985|NCT01246973|2927886|P2|Overall Study|Withdrawal by Subject|13
887986|NCT01246973|2927887|P1|Overall Study|Withdrawal by Subject|7
887987|NCT01246973|2927886|P2|Overall Study|Adverse Event|9
887988|NCT01246973|2927887|P1|Overall Study|Adverse Event|16
887989|NCT01246973|2927886|P2|Overall Study|Other|25
887990|NCT01246973|2927887|P1|Overall Study|Other|38
887991|NCT01246960|2927897|P2|Overall Study|Withdrawal (by participant or physician)|3
887992|NCT01246960|2927898|P1|Overall Study|Withdrawal (by participant or physician)|3
887993|NCT01246960|2927897|P2|Overall Study|Lost to Follow-up|1
887994|NCT01246960|2927898|P1|Overall Study|Lost to Follow-up|3
887995|NCT01246206|2928006|P1|Overall Study|Patient did not receive study regiments.|1
887996|NCT01246011|2928029|P3|Overall Study|Withdrawal by Subject|1
887997|NCT01246011|2928030|P2|Overall Study|Withdrawal by Subject|0
887998|NCT01246011|2928031|P1|Overall Study|Withdrawal by Subject|0
887999|NCT01246011|2928029|P3|Overall Study|If needed warfarin clinically, withdrawn|3
888000|NCT01246011|2928030|P2|Overall Study|If needed warfarin clinically, withdrawn|0
888001|NCT01246011|2928031|P1|Overall Study|If needed warfarin clinically, withdrawn|0
888002|NCT01245764|2928046|P4|Study Phase A|Lost to Follow-up|0
888003|NCT01245764|2928047|P3|Study Phase A|Lost to Follow-up|5
888004|NCT01245764|2928048|P2|Study Phase A|Lost to Follow-up|0
888005|NCT01245764|2928049|P1|Study Phase A|Lost to Follow-up|0
888006|NCT01245764|2928046|P4|Study Phase A|Protocol Violation|2
888007|NCT01245764|2928047|P3|Study Phase A|Protocol Violation|2
888008|NCT01245764|2928048|P2|Study Phase A|Protocol Violation|3
888009|NCT01245764|2928049|P1|Study Phase A|Protocol Violation|6
888010|NCT01245764|2928046|P4|Study Phase A|Other|1
888011|NCT01245764|2928047|P3|Study Phase A|Other|3
888012|NCT01245764|2928048|P2|Study Phase A|Other|2
888013|NCT01245764|2928049|P1|Study Phase A|Other|3
888014|NCT01245751|2928087|P4|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
888015|NCT01245751|2928088|P3|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
888016|NCT01245751|2928089|P2|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4
888017|NCT01245751|2928090|P1|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
888018|NCT01245751|2928087|P4|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2
888019|NCT01245751|2928088|P3|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
888020|NCT01245751|2928089|P2|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
888021|NCT01245751|2928090|P1|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
888022|NCT01245751|2928087|P4|Part 1: Day 1 to Week 52 (1 Year)|Death|0
888023|NCT01245751|2928088|P3|Part 1: Day 1 to Week 52 (1 Year)|Death|0
888024|NCT01245751|2928089|P2|Part 1: Day 1 to Week 52 (1 Year)|Death|1
888025|NCT01245751|2928090|P1|Part 1: Day 1 to Week 52 (1 Year)|Death|2
888026|NCT01245387|2928184|P1|Overall Study|Missing discontinuation status|369
888027|NCT01245387|2928184|P1|Overall Study|Other|131
888028|NCT01245387|2928184|P1|Overall Study|Death|3
888029|NCT01245387|2928184|P1|Overall Study|Adverse Event|9
888030|NCT01245387|2928184|P1|Overall Study|Lack of Efficacy|195
888031|NCT01245387|2928184|P1|Overall Study|Lost to Follow-up|106
888032|NCT01245374|2928233|P1|Overall Study|Withdrawal by Subject|3
888033|NCT01245374|2928233|P1|Overall Study|Protocol Violation|1
888034|NCT01245283|2928256|P3|Overall Study|Lost to Follow-up|11
888035|NCT01245283|2928257|P2|Overall Study|Lost to Follow-up|11
888036|NCT01245283|2928258|P1|Overall Study|Lost to Follow-up|14
888037|NCT01245140|2928303|P2|Overall Study|Refused Treatment/Did Not Coopera|1
888038|NCT01245140|2928304|P1|Overall Study|Refused Treatment/Did Not Coopera|0
888039|NCT01245140|2928303|P2|Overall Study|Withdrawal by Subject|1
888040|NCT01245140|2928304|P1|Overall Study|Withdrawal by Subject|0
888041|NCT01245140|2928303|P2|Overall Study|Protocol Violation|1
888042|NCT01245140|2928304|P1|Overall Study|Protocol Violation|0
888043|NCT01245140|2928303|P2|Overall Study|Lack of Efficacy|4
888044|NCT01245140|2928304|P1|Overall Study|Lack of Efficacy|2
888045|NCT01245140|2928303|P2|Overall Study|Adverse Event|3
888046|NCT01245140|2928304|P1|Overall Study|Adverse Event|1
888047|NCT01245101|2928360|P2|Period 3 (Treatment)|Withdrawal by Subject|0
888048|NCT01245101|2928361|P1|Period 3 (Treatment)|Withdrawal by Subject|1
888049|NCT01245101|2928360|P2|Period 2 (Washout)|Withdrawal by Subject|0
888050|NCT01245101|2928361|P1|Period 2 (Washout)|Withdrawal by Subject|1
888051|NCT01245101|2928360|P2|Period 1 (Treatment)|Withdrawal by Subject|0
888052|NCT01245101|2928361|P1|Period 1 (Treatment)|Withdrawal by Subject|2
888053|NCT01245062|2928371|P3|Cross-over Phase|Study closed/ terminated|11
888054|NCT01245062|2928372|P2|Cross-over Phase|Study closed/ terminated|0
888055|NCT01245062|2928373|P1|Cross-over Phase|Study closed/ terminated|0
888056|NCT01245062|2928371|P3|Cross-over Phase|Withdrew Consent|4
888057|NCT01245062|2928372|P2|Cross-over Phase|Withdrew Consent|0
888058|NCT01245062|2928373|P1|Cross-over Phase|Withdrew Consent|0
888059|NCT01245062|2928371|P3|Cross-over Phase|Physician Decision|1
888060|NCT01245062|2928372|P2|Cross-over Phase|Physician Decision|0
888061|NCT01245062|2928373|P1|Cross-over Phase|Physician Decision|0
888062|NCT01245062|2928371|P3|Cross-over Phase|Lost to Follow-up|1
888063|NCT01245062|2928372|P2|Cross-over Phase|Lost to Follow-up|0
888064|NCT01245062|2928373|P1|Cross-over Phase|Lost to Follow-up|0
888065|NCT01245062|2928371|P3|Randomization and Crossover Phase|Study closed/ terminated|0
888066|NCT01245062|2928372|P2|Randomization and Crossover Phase|Study closed/ terminated|14
888067|NCT01245062|2928373|P1|Randomization and Crossover Phase|Study closed/ terminated|23
888068|NCT01245062|2928371|P3|Randomization and Crossover Phase|Withdrew Consent|0
888069|NCT01245062|2928372|P2|Randomization and Crossover Phase|Withdrew Consent|11
888070|NCT01245062|2928373|P1|Randomization and Crossover Phase|Withdrew Consent|12
888071|NCT01245062|2928371|P3|Randomization and Crossover Phase|Physician Decision|0
888072|NCT01245062|2928372|P2|Randomization and Crossover Phase|Physician Decision|4
888073|NCT01245062|2928373|P1|Randomization and Crossover Phase|Physician Decision|2
888074|NCT01245062|2928371|P3|Randomization and Crossover Phase|Lost to Follow-up|0
888075|NCT01245062|2928372|P2|Randomization and Crossover Phase|Lost to Follow-up|2
888076|NCT01245062|2928373|P1|Randomization and Crossover Phase|Lost to Follow-up|4
888077|NCT01245049|2928411|P2|Overall Study|Lost to Follow-up|2
888078|NCT01245049|2928412|P1|Overall Study|Lost to Follow-up|1
888079|NCT01245049|2928411|P2|Overall Study|Withdrawal by Subject|1
888080|NCT01245049|2928412|P1|Overall Study|Withdrawal by Subject|0
888081|NCT01245049|2928411|P2|Overall Study|Migrated/moved from study area|1
888082|NCT01245049|2928412|P1|Overall Study|Migrated/moved from study area|0
888083|NCT01244984|2928465|P3|Overall Study|Withdrawal by Subject|2
888084|NCT01244984|2928466|P2|Overall Study|Withdrawal by Subject|2
888085|NCT01244984|2928467|P1|Overall Study|Withdrawal by Subject|1
888086|NCT01244984|2928465|P3|Overall Study|Protocol Defined Stopping Criteria|0
888087|NCT01244984|2928466|P2|Overall Study|Protocol Defined Stopping Criteria|1
888088|NCT01244984|2928467|P1|Overall Study|Protocol Defined Stopping Criteria|1
888089|NCT01244984|2928465|P3|Overall Study|Protocol Violation|0
888090|NCT01244984|2928466|P2|Overall Study|Protocol Violation|0
888091|NCT01244984|2928467|P1|Overall Study|Protocol Violation|1
888092|NCT01244984|2928465|P3|Overall Study|Adverse Event|2
888093|NCT01244984|2928466|P2|Overall Study|Adverse Event|11
888094|NCT01244984|2928467|P1|Overall Study|Adverse Event|2
888095|NCT01244906|2928541|P1|Overall Study|Progression of disease post treatment|6
888096|NCT01244906|2928541|P1|Overall Study|Death|2
888097|NCT01244893|2928550|P2|1-Week Follow Up|Lost to Follow-up|0
888098|NCT01244893|2928551|P1|1-Week Follow Up|Lost to Follow-up|1
888099|NCT01244893|2928550|P2|Baseline|Protocol Violation|1
888100|NCT01244893|2928551|P1|Baseline|Protocol Violation|0
888101|NCT01244828|2928563|P1|Overall Study|Other reason (not specified)|1
888102|NCT01244828|2928563|P1|Overall Study|Lost to Follow-up|2
888103|NCT01244828|2928563|P1|Overall Study|Lack of Efficacy|7
888104|NCT01244828|2928563|P1|Overall Study|Withdrawal by Subject|31
888105|NCT01244828|2928563|P1|Overall Study|Adverse Event|37
888106|NCT01244815|2928579|P4|Overall Study|Did Not Meet Protocol Eligibility|0
888107|NCT01244815|2928580|P3|Overall Study|Did Not Meet Protocol Eligibility|0
888108|NCT01244815|2928581|P2|Overall Study|Did Not Meet Protocol Eligibility|1
888109|NCT01244815|2928582|P1|Overall Study|Did Not Meet Protocol Eligibility|0
888110|NCT01244815|2928579|P4|Overall Study|Protocol Violation|1
888111|NCT01244815|2928580|P3|Overall Study|Protocol Violation|3
888112|NCT01244815|2928581|P2|Overall Study|Protocol Violation|4
888113|NCT01244815|2928582|P1|Overall Study|Protocol Violation|7
888114|NCT01244815|2928579|P4|Overall Study|Withdrawal by Subject|3
888115|NCT01244815|2928580|P3|Overall Study|Withdrawal by Subject|0
888116|NCT01244815|2928581|P2|Overall Study|Withdrawal by Subject|2
888117|NCT01244815|2928582|P1|Overall Study|Withdrawal by Subject|0
888118|NCT01244815|2928579|P4|Overall Study|Lost to Follow-up|2
888119|NCT01244815|2928580|P3|Overall Study|Lost to Follow-up|3
888120|NCT01244815|2928581|P2|Overall Study|Lost to Follow-up|2
888121|NCT01244815|2928582|P1|Overall Study|Lost to Follow-up|3
888122|NCT01244815|2928579|P4|Overall Study|Treatment Failure|1
888123|NCT01244815|2928580|P3|Overall Study|Treatment Failure|0
888124|NCT01244815|2928581|P2|Overall Study|Treatment Failure|0
888125|NCT01244815|2928582|P1|Overall Study|Treatment Failure|0
888126|NCT01244815|2928579|P4|Overall Study|Adverse Event|5
888127|NCT01244815|2928580|P3|Overall Study|Adverse Event|5
888128|NCT01244815|2928581|P2|Overall Study|Adverse Event|7
888129|NCT01244815|2928582|P1|Overall Study|Adverse Event|4
888130|NCT01244815|2928579|P4|Overall Study|Not Treated|0
888131|NCT01244815|2928580|P3|Overall Study|Not Treated|0
888132|NCT01244815|2928581|P2|Overall Study|Not Treated|1
888133|NCT01244815|2928582|P1|Overall Study|Not Treated|0
888134|NCT01244620|2928669|P4|Overall Study|Study terminated|4
888135|NCT01244620|2928670|P3|Overall Study|Study terminated|4
888136|NCT01244620|2928671|P2|Overall Study|Study terminated|4
888137|NCT01244620|2928672|P1|Overall Study|Study terminated|4
888138|NCT01244516|2928731|P3|Period 2 (1-week to 2-week Visit)|Poor Comfort|1
888139|NCT01244516|2928732|P2|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
888140|NCT01244516|2928733|P1|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
888141|NCT01244516|2928731|P3|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
888142|NCT01244516|2928732|P2|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1
888143|NCT01244516|2928733|P1|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
888144|NCT01244516|2928731|P3|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
888145|NCT01244516|2928732|P2|Period 2 (1-week to 2-week Visit)|Protocol Violation|0
888146|NCT01244516|2928733|P1|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
888147|NCT01244516|2928731|P3|Period 2 (1-week to 2-week Visit)|Adverse Event|0
888148|NCT01244516|2928732|P2|Period 2 (1-week to 2-week Visit)|Adverse Event|0
888149|NCT01244516|2928733|P1|Period 2 (1-week to 2-week Visit)|Adverse Event|2
888150|NCT01244516|2928731|P3|Period 1 (Baseline to 1-week Visit)|Poor comfort|1
888151|NCT01244516|2928732|P2|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
888152|NCT01244516|2928733|P1|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
888153|NCT01244516|2928731|P3|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
888154|NCT01244516|2928732|P2|Period 1 (Baseline to 1-week Visit)|Poor Vision|1
888155|NCT01244516|2928733|P1|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
888156|NCT01244516|2928731|P3|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2
888157|NCT01244516|2928732|P2|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5
888158|NCT01244516|2928733|P1|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4
888159|NCT01244490|2928754|P3|Overall Study|Not specified|1
888160|NCT01244490|2928755|P2|Overall Study|Not specified|0
888161|NCT01244490|2928756|P1|Overall Study|Not specified|0
888162|NCT01244490|2928754|P3|Overall Study|Lost to Follow-up|3
888163|NCT01244490|2928755|P2|Overall Study|Lost to Follow-up|6
888164|NCT01244490|2928756|P1|Overall Study|Lost to Follow-up|0
888165|NCT01244490|2928754|P3|Overall Study|Adverse Event|5
888166|NCT01244490|2928755|P2|Overall Study|Adverse Event|9
888167|NCT01244490|2928756|P1|Overall Study|Adverse Event|1
888168|NCT01244490|2928754|P3|Overall Study|Withdrawal by Subject|9
888169|NCT01244490|2928755|P2|Overall Study|Withdrawal by Subject|4
888170|NCT01244490|2928756|P1|Overall Study|Withdrawal by Subject|4
888171|NCT01244490|2928754|P3|Overall Study|Lack of Efficacy|5
888172|NCT01244490|2928755|P2|Overall Study|Lack of Efficacy|5
888173|NCT01244490|2928756|P1|Overall Study|Lack of Efficacy|14
888174|NCT01244425|2928824|P2|Overall Study|Adverse Event|1
888175|NCT01244425|2928825|P1|Overall Study|Adverse Event|1
888176|NCT01244425|2928824|P2|Overall Study|Withdrawal by Subject|2
888177|NCT01244425|2928825|P1|Overall Study|Withdrawal by Subject|2
888178|NCT01244126|2928857|P3|Overall Study|Protocol Violation|9
888179|NCT01244126|2928858|P2|Overall Study|Protocol Violation|3
888180|NCT01244126|2928859|P1|Overall Study|Protocol Violation|3
888181|NCT01244061|2928872|P2|Overall Study|Randomized but not treated|2
888182|NCT01244061|2928873|P1|Overall Study|Randomized but not treated|2
888183|NCT01244061|2928872|P2|Overall Study|Adverse Event|2
888184|NCT01244061|2928873|P1|Overall Study|Adverse Event|5
888185|NCT01244061|2928872|P2|Overall Study|Protocol Violation|1
888186|NCT01244061|2928873|P1|Overall Study|Protocol Violation|1
888187|NCT01244061|2928872|P2|Overall Study|Not specified|19
888188|NCT01244061|2928873|P1|Overall Study|Not specified|8
888189|NCT01244061|2928872|P2|Overall Study|Withdrawal by Subject|46
888190|NCT01244061|2928873|P1|Overall Study|Withdrawal by Subject|29
888191|NCT01244061|2928872|P2|Overall Study|Lost to Follow-up|30
888192|NCT01244061|2928873|P1|Overall Study|Lost to Follow-up|34
888193|NCT01244061|2928872|P2|Overall Study|Lack of Efficacy|3
888194|NCT01244061|2928873|P1|Overall Study|Lack of Efficacy|1
888195|NCT01244061|2928872|P2|Overall Study|Did not meet entrance criteria|0
888196|NCT01244061|2928873|P1|Overall Study|Did not meet entrance criteria|1
888197|NCT01244061|2928872|P2|Overall Study|Death|0
888198|NCT01244061|2928873|P1|Overall Study|Death|1
888199|NCT01243944|2928898|P2|Overall Study|Physician Decision|2
888200|NCT01243944|2928899|P1|Overall Study|Physician Decision|2
888201|NCT01243944|2928898|P2|Overall Study|Patient decision|5
888202|NCT01243944|2928899|P1|Overall Study|Patient decision|6
888203|NCT01243944|2928898|P2|Overall Study|Disease progression|1
888204|NCT01243944|2928899|P1|Overall Study|Disease progression|5
888205|NCT01243944|2928898|P2|Overall Study|Lack of Efficacy|98
888206|NCT01243944|2928899|P1|Overall Study|Lack of Efficacy|0
888207|NCT01243944|2928898|P2|Overall Study|Adverse Event|2
888208|NCT01243944|2928899|P1|Overall Study|Adverse Event|4
888209|NCT01243892|2928923|P2|Overall Study|Did not meet eligibility criteria|0
888210|NCT01243892|2928924|P1|Overall Study|Did not meet eligibility criteria|2
888211|NCT01243775|2928934|P1|Overall Study|Withdrawal by Subject|2
888212|NCT01243762|2928948|P7|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
888213|NCT01243762|2928949|P6|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
888214|NCT01243762|2928950|P5|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
888215|NCT01243762|2928951|P4|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
888216|NCT01243762|2928952|P3|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
888217|NCT01243762|2928953|P2|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
888218|NCT01243762|2928954|P1|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
888219|NCT01243762|2928948|P7|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
888220|NCT01243762|2928949|P6|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
888221|NCT01243762|2928950|P5|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
888222|NCT01243762|2928951|P4|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
888223|NCT01243762|2928952|P3|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
888224|NCT01243762|2928953|P2|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
888225|NCT01243762|2928954|P1|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
888226|NCT01243762|2928948|P7|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
888227|NCT01243762|2928949|P6|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
888228|NCT01243762|2928950|P5|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2
888229|NCT01243762|2928951|P4|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
888230|NCT01243762|2928952|P3|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
888231|NCT01243762|2928953|P2|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
888232|NCT01243762|2928954|P1|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
888233|NCT01243762|2928948|P7|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3
888234|NCT01243762|2928949|P6|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
888235|NCT01243762|2928950|P5|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
888236|NCT01243762|2928951|P4|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
888237|NCT01243762|2928952|P3|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
888238|NCT01243762|2928953|P2|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1
888239|NCT01243762|2928954|P1|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
888240|NCT01243762|2928948|P7|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
888241|NCT01243762|2928949|P6|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
888242|NCT01243762|2928950|P5|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
888243|NCT01243762|2928951|P4|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
888244|NCT01243762|2928952|P3|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
888245|NCT01243762|2928953|P2|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3
888246|NCT01243762|2928954|P1|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
888247|NCT01243762|2928948|P7|Part 1 (Dose Escalation/MTD)|Progressive Disease|0
888248|NCT01243762|2928949|P6|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
888249|NCT01243762|2928950|P5|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
888250|NCT01243762|2928951|P4|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
888251|NCT01243762|2928952|P3|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
888252|NCT01243762|2928953|P2|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
888253|NCT01243762|2928954|P1|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
888254|NCT01243762|2928948|P7|Part 1 (Dose Escalation/MTD)|Physician Decision|0
888255|NCT01243762|2928949|P6|Part 1 (Dose Escalation/MTD)|Physician Decision|0
888256|NCT01243762|2928950|P5|Part 1 (Dose Escalation/MTD)|Physician Decision|0
888257|NCT01243762|2928951|P4|Part 1 (Dose Escalation/MTD)|Physician Decision|1
888258|NCT01243762|2928952|P3|Part 1 (Dose Escalation/MTD)|Physician Decision|0
888259|NCT01243762|2928953|P2|Part 1 (Dose Escalation/MTD)|Physician Decision|1
888260|NCT01243762|2928954|P1|Part 1 (Dose Escalation/MTD)|Physician Decision|0
888261|NCT01243762|2928948|P7|Part 1 (Dose Escalation/MTD)|Adverse Event|0
888262|NCT01243762|2928949|P6|Part 1 (Dose Escalation/MTD)|Adverse Event|1
888263|NCT01243762|2928950|P5|Part 1 (Dose Escalation/MTD)|Adverse Event|1
888264|NCT01243762|2928951|P4|Part 1 (Dose Escalation/MTD)|Adverse Event|0
888265|NCT01243762|2928952|P3|Part 1 (Dose Escalation/MTD)|Adverse Event|0
888266|NCT01243762|2928953|P2|Part 1 (Dose Escalation/MTD)|Adverse Event|2
888267|NCT01243762|2928954|P1|Part 1 (Dose Escalation/MTD)|Adverse Event|0
888268|NCT01243671|2928973|P1|Overall Study|Not Specified|1
888269|NCT01243671|2928973|P1|Overall Study|Anti-adalimumab antibody positive|1
888270|NCT01243671|2928973|P1|Overall Study|Adverse Event|3
888271|NCT01243411|2929050|P1|Overall Study|Other|8
888272|NCT01243411|2929050|P1|Overall Study|Adverse Event|5
888273|NCT01243411|2929050|P1|Overall Study|Lost to Follow-up|10
888274|NCT01243411|2929050|P1|Overall Study|Withdrawal by Subject|18
888275|NCT01243268|2929155|P1|Overall Study|Duplicate subject|2
888276|NCT01243268|2929155|P1|Overall Study|Deviation with contract date|7
888277|NCT01243268|2929155|P1|Overall Study|Protocol Violation|51
888278|NCT01243268|2929155|P1|Overall Study|Lost to Follow-up|4
888279|NCT01243242|2929165|P2|Overall Study|non compliance|0
888280|NCT01243242|2929166|P1|Overall Study|non compliance|1
888281|NCT01243242|2929165|P2|Overall Study|sponsor decision|1
888282|NCT01243242|2929166|P1|Overall Study|sponsor decision|0
888283|NCT01243242|2929165|P2|Overall Study|Physician Decision|1
888284|NCT01243242|2929166|P1|Overall Study|Physician Decision|0
888285|NCT01243242|2929165|P2|Overall Study|Withdrawal by Subject|1
888286|NCT01243242|2929166|P1|Overall Study|Withdrawal by Subject|1
888287|NCT01243242|2929165|P2|Overall Study|Adverse Event|1
888288|NCT01243242|2929166|P1|Overall Study|Adverse Event|1
888289|NCT01243177|2929180|P2|Overall Study|Other Reason|12
888290|NCT01243177|2929181|P1|Overall Study|Other Reason|11
888291|NCT01243177|2929180|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
888292|NCT01243177|2929181|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
888293|NCT01243177|2929180|P2|Overall Study|SAE, fatal + SAE, non-fatal|0
888294|NCT01243177|2929181|P1|Overall Study|SAE, fatal + SAE, non-fatal|1
888295|NCT01243177|2929180|P2|Overall Study|AE, non-serious non-fatal|58
888296|NCT01243177|2929181|P1|Overall Study|AE, non-serious non-fatal|40
888297|NCT01243177|2929180|P2|Overall Study|SAE, non-fatal|9
888298|NCT01243177|2929181|P1|Overall Study|SAE, non-fatal|7
888299|NCT01243177|2929180|P2|Overall Study|AE, serious fatal|1
888300|NCT01243177|2929181|P1|Overall Study|AE, serious fatal|0
888301|NCT01243177|2929180|P2|Overall Study|Withdrawal by Subject|38
888302|NCT01243177|2929181|P1|Overall Study|Withdrawal by Subject|46
888303|NCT01243177|2929180|P2|Overall Study|Lost to Follow-up|18
888304|NCT01243177|2929181|P1|Overall Study|Lost to Follow-up|15
888305|NCT01243177|2929180|P2|Overall Study|Protocol Violation|10
888306|NCT01243177|2929181|P1|Overall Study|Protocol Violation|11
888307|NCT01243177|2929180|P2|Overall Study|Lack of Efficacy|31
888308|NCT01243177|2929181|P1|Overall Study|Lack of Efficacy|47
888309|NCT01242813|2929202|P1|Overall Study|Lost to Follow-up|2
888310|NCT01242748|2929224|P2|Overall Study|Miscellaneous reasons|3
888311|NCT01242748|2929225|P1|Overall Study|Miscellaneous reasons|8
888312|NCT01242748|2929224|P2|Overall Study|Withdrawal by Subject|2
888313|NCT01242748|2929225|P1|Overall Study|Withdrawal by Subject|10
888314|NCT01242748|2929224|P2|Overall Study|Protocol Violation|0
888315|NCT01242748|2929225|P1|Overall Study|Protocol Violation|1
888316|NCT01242748|2929224|P2|Overall Study|Physician Decision|2
888317|NCT01242748|2929225|P1|Overall Study|Physician Decision|3
888318|NCT01242748|2929224|P2|Overall Study|Lost to Follow-up|2
888319|NCT01242748|2929225|P1|Overall Study|Lost to Follow-up|6
888320|NCT01242748|2929224|P2|Overall Study|Adverse Event|5
888321|NCT01242748|2929225|P1|Overall Study|Adverse Event|10
888322|NCT01242514|2929265|P3|Overall Study|Adverse Event|19
888323|NCT01242514|2929266|P2|Overall Study|Adverse Event|18
888324|NCT01242514|2929267|P1|Overall Study|Adverse Event|129
888325|NCT01242514|2929265|P3|Overall Study|Lost to Follow-up|4
888326|NCT01242514|2929266|P2|Overall Study|Lost to Follow-up|5
888327|NCT01242514|2929267|P1|Overall Study|Lost to Follow-up|14
888328|NCT01242514|2929265|P3|Overall Study|Dev. of study specific discont. criteria|5
888329|NCT01242514|2929266|P2|Overall Study|Dev. of study specific discont. criteria|3
888330|NCT01242514|2929267|P1|Overall Study|Dev. of study specific discont. criteria|21
888331|NCT01242514|2929265|P3|Overall Study|Lack of therapeutic response|10
888332|NCT01242514|2929266|P2|Overall Study|Lack of therapeutic response|16
888333|NCT01242514|2929267|P1|Overall Study|Lack of therapeutic response|99
888334|NCT01242514|2929265|P3|Overall Study|Severe non-compliance to protocol|1
888335|NCT01242514|2929266|P2|Overall Study|Severe non-compliance to protocol|2
888336|NCT01242514|2929267|P1|Overall Study|Severe non-compliance to protocol|5
888337|NCT01242514|2929265|P3|Overall Study|Subject decision|2
888338|NCT01242514|2929266|P2|Overall Study|Subject decision|8
888339|NCT01242514|2929267|P1|Overall Study|Subject decision|33
888340|NCT01242514|2929265|P3|Overall Study|e.g., project closure|171
888341|NCT01242514|2929266|P2|Overall Study|e.g., project closure|305
888342|NCT01242514|2929267|P1|Overall Study|e.g., project closure|1042
888343|NCT01242371|2929286|P2|Overall Study|Protocol Violation|3
888344|NCT01242371|2929287|P1|Overall Study|Protocol Violation|0
888345|NCT01242371|2929286|P2|Overall Study|Withdrawal by Subject|2
888346|NCT01242371|2929287|P1|Overall Study|Withdrawal by Subject|2
888347|NCT01242176|2929293|P2|Washout Period of 7 Days|Non-compliant with protocol|0
888348|NCT01242176|2929294|P1|Washout Period of 7 Days|Non-compliant with protocol|1
888349|NCT01242176|2929293|P2|Washout Period of 7 Days|Adverse Event|2
888350|NCT01242176|2929294|P1|Washout Period of 7 Days|Adverse Event|0
888351|NCT01242111|2929304|P1|Overall Study|Did not consent to MOR-100 follow-up|1
888352|NCT01242111|2929304|P1|Overall Study|Withdrawal by Subject|1
888353|NCT01242111|2929304|P1|Overall Study|Adverse Event|1
888354|NCT01242085|2929316|P3|Overall Study|medically unable to have surgery|0
888355|NCT01242085|2929317|P2|Overall Study|medically unable to have surgery|5
888356|NCT01242085|2929318|P1|Overall Study|medically unable to have surgery|4
888357|NCT01242085|2929316|P3|Overall Study|Withdrawal by Subject|0
888358|NCT01242085|2929317|P2|Overall Study|Withdrawal by Subject|2
888359|NCT01242085|2929318|P1|Overall Study|Withdrawal by Subject|4
888360|NCT01242020|2929328|P2|Overall Study|Failed screening|0
888361|NCT01242020|2929329|P1|Overall Study|Failed screening|1
888362|NCT01242020|2929328|P2|Overall Study|Withdrawal by Subject|0
888363|NCT01242020|2929329|P1|Overall Study|Withdrawal by Subject|2
888364|NCT01241760|2929359|P2|Overall Study|Not specified|1
888365|NCT01241760|2929360|P1|Overall Study|Not specified|1
888366|NCT01241760|2929359|P2|Overall Study|Switch To Commercially Available Medicat|4
888367|NCT01241760|2929360|P1|Overall Study|Switch To Commercially Available Medicat|1
888368|NCT01241760|2929359|P2|Overall Study|Withdrawal by Subject|13
888369|NCT01241760|2929360|P1|Overall Study|Withdrawal by Subject|13
888370|NCT01241760|2929359|P2|Overall Study|Lost to Follow-up|22
888371|NCT01241760|2929360|P1|Overall Study|Lost to Follow-up|18
888372|NCT01241760|2929359|P2|Overall Study|Adverse Event|0
888373|NCT01241760|2929360|P1|Overall Study|Adverse Event|1
888374|NCT01241591|2929383|P4|Overall Study|Adverse Event|4
888375|NCT01241591|2929384|P3|Overall Study|Adverse Event|12
888376|NCT01241591|2929385|P2|Overall Study|Adverse Event|11
888377|NCT01241591|2929386|P1|Overall Study|Adverse Event|3
888378|NCT01241591|2929383|P4|Overall Study|Not specified|1
888379|NCT01241591|2929384|P3|Overall Study|Not specified|0
888380|NCT01241591|2929385|P2|Overall Study|Not specified|1
888381|NCT01241591|2929386|P1|Overall Study|Not specified|0
888382|NCT01241591|2929383|P4|Overall Study|Withdrawal by Subject|2
888383|NCT01241591|2929384|P3|Overall Study|Withdrawal by Subject|2
888384|NCT01241591|2929385|P2|Overall Study|Withdrawal by Subject|4
888385|NCT01241591|2929386|P1|Overall Study|Withdrawal by Subject|6
888386|NCT01241591|2929383|P4|Overall Study|Screen Failure|0
888387|NCT01241591|2929384|P3|Overall Study|Screen Failure|1
888388|NCT01241591|2929385|P2|Overall Study|Screen Failure|2
888389|NCT01241591|2929386|P1|Overall Study|Screen Failure|3
888390|NCT01241591|2929383|P4|Overall Study|Lost to Follow-up|2
888391|NCT01241591|2929384|P3|Overall Study|Lost to Follow-up|2
888392|NCT01241591|2929385|P2|Overall Study|Lost to Follow-up|2
888393|NCT01241591|2929386|P1|Overall Study|Lost to Follow-up|1
888394|NCT01241591|2929383|P4|Overall Study|Protocol Violation|0
888395|NCT01241591|2929384|P3|Overall Study|Protocol Violation|3
888396|NCT01241591|2929385|P2|Overall Study|Protocol Violation|2
888397|NCT01241591|2929386|P1|Overall Study|Protocol Violation|5
888398|NCT01241591|2929383|P4|Overall Study|Lack of Efficacy|3
888399|NCT01241591|2929384|P3|Overall Study|Lack of Efficacy|2
888400|NCT01241591|2929385|P2|Overall Study|Lack of Efficacy|2
888401|NCT01241591|2929386|P1|Overall Study|Lack of Efficacy|5
888402|NCT01241552|2929589|P4|Overall Study|Lost to Follow-up|16
888403|NCT01241552|2929590|P3|Overall Study|Lost to Follow-up|15
888404|NCT01241552|2929591|P2|Overall Study|Lost to Follow-up|11
888405|NCT01241552|2929592|P1|Overall Study|Lost to Follow-up|2
888406|NCT01241552|2929589|P4|Overall Study|Physician Decision|3
888407|NCT01241552|2929590|P3|Overall Study|Physician Decision|2
888408|NCT01241552|2929591|P2|Overall Study|Physician Decision|4
888409|NCT01241552|2929592|P1|Overall Study|Physician Decision|2
888410|NCT01241552|2929589|P4|Overall Study|Withdrawal by Subject|15
888411|NCT01241552|2929590|P3|Overall Study|Withdrawal by Subject|14
888412|NCT01241552|2929591|P2|Overall Study|Withdrawal by Subject|15
888413|NCT01241552|2929592|P1|Overall Study|Withdrawal by Subject|7
888414|NCT01241552|2929589|P4|Overall Study|Protocol Violation|1
888415|NCT01241552|2929590|P3|Overall Study|Protocol Violation|6
888416|NCT01241552|2929591|P2|Overall Study|Protocol Violation|2
888417|NCT01241552|2929592|P1|Overall Study|Protocol Violation|0
888418|NCT01241552|2929589|P4|Overall Study|Progressive Disease|2
888419|NCT01241552|2929590|P3|Overall Study|Progressive Disease|1
888420|NCT01241552|2929591|P2|Overall Study|Progressive Disease|0
888421|NCT01241552|2929592|P1|Overall Study|Progressive Disease|0
888422|NCT01241552|2929589|P4|Overall Study|Technical Problems|2
888423|NCT01241552|2929590|P3|Overall Study|Technical Problems|2
888424|NCT01241552|2929591|P2|Overall Study|Technical Problems|0
888425|NCT01241552|2929592|P1|Overall Study|Technical Problems|2
888426|NCT01241552|2929589|P4|Overall Study|Adverse Event|0
888427|NCT01241552|2929590|P3|Overall Study|Adverse Event|0
888428|NCT01241552|2929591|P2|Overall Study|Adverse Event|1
888429|NCT01241552|2929592|P1|Overall Study|Adverse Event|1
888430|NCT01241552|2929589|P4|Overall Study|Death|25
888431|NCT01241552|2929590|P3|Overall Study|Death|20
888432|NCT01241552|2929591|P2|Overall Study|Death|30
888433|NCT01241552|2929592|P1|Overall Study|Death|26
888434|NCT01241552|2929589|P4|Overall Study|Lack of Efficacy|0
888435|NCT01241552|2929590|P3|Overall Study|Lack of Efficacy|0
888436|NCT01241552|2929591|P2|Overall Study|Lack of Efficacy|0
888437|NCT01241552|2929592|P1|Overall Study|Lack of Efficacy|1
888438|NCT01241461|2929687|P2|Overall Study|Progressive Disease|6
888439|NCT01241461|2929688|P1|Overall Study|Progressive Disease|3
888440|NCT01241448|2929708|P4|Overall Study|Excluded due to data integrity issues|2
888441|NCT01241448|2929709|P3|Overall Study|Excluded due to data integrity issues|2
888442|NCT01241448|2929710|P2|Overall Study|Excluded due to data integrity issues|2
888443|NCT01241448|2929711|P1|Overall Study|Excluded due to data integrity issues|3
888444|NCT01241448|2929708|P4|Overall Study|Withdrawal by Subject|6
888445|NCT01241448|2929709|P3|Overall Study|Withdrawal by Subject|3
888446|NCT01241448|2929710|P2|Overall Study|Withdrawal by Subject|5
888447|NCT01241448|2929711|P1|Overall Study|Withdrawal by Subject|4
888448|NCT01241448|2929708|P4|Overall Study|Sponsor Decision|6
888449|NCT01241448|2929709|P3|Overall Study|Sponsor Decision|12
888450|NCT01241448|2929710|P2|Overall Study|Sponsor Decision|14
888451|NCT01241448|2929711|P1|Overall Study|Sponsor Decision|17
888452|NCT01241448|2929708|P4|Overall Study|Protocol Violation|6
888453|NCT01241448|2929709|P3|Overall Study|Protocol Violation|3
888454|NCT01241448|2929710|P2|Overall Study|Protocol Violation|5
888455|NCT01241448|2929711|P1|Overall Study|Protocol Violation|10
888456|NCT01241448|2929708|P4|Overall Study|Physician Decision|0
888457|NCT01241448|2929709|P3|Overall Study|Physician Decision|0
888458|NCT01241448|2929710|P2|Overall Study|Physician Decision|2
888459|NCT01241448|2929711|P1|Overall Study|Physician Decision|0
888460|NCT01241448|2929708|P4|Overall Study|Lost to Follow-up|1
888461|NCT01241448|2929709|P3|Overall Study|Lost to Follow-up|1
888462|NCT01241448|2929710|P2|Overall Study|Lost to Follow-up|1
888463|NCT01241448|2929711|P1|Overall Study|Lost to Follow-up|2
888464|NCT01241448|2929708|P4|Overall Study|Adverse Event|2
888465|NCT01241448|2929709|P3|Overall Study|Adverse Event|2
888466|NCT01241448|2929710|P2|Overall Study|Adverse Event|0
888467|NCT01241448|2929711|P1|Overall Study|Adverse Event|1
888468|NCT01241292|2929802|P2|Overall Study|Participant Discontinued Treatment|2
888469|NCT01241292|2929803|P1|Overall Study|Participant Discontinued Treatment|0
888470|NCT01241292|2929802|P2|Overall Study|Study Drug Toxicity|1
888471|NCT01241292|2929803|P1|Overall Study|Study Drug Toxicity|0
888472|NCT01241292|2929802|P2|Overall Study|Disease Progression|0
888473|NCT01241292|2929803|P1|Overall Study|Disease Progression|2
888474|NCT01241292|2929802|P2|Overall Study|Administrative Reason by Sponsor|0
888475|NCT01241292|2929803|P1|Overall Study|Administrative Reason by Sponsor|1
888476|NCT01241279|2929827|P2|Overall Study|Lost to Follow-up|1
888477|NCT01241279|2929828|P1|Overall Study|Lost to Follow-up|0
888478|NCT01241240|2929838|P2|Overall Study|Personal Reasons|1
888479|NCT01241240|2929839|P1|Overall Study|Personal Reasons|1
888480|NCT01241240|2929838|P2|Overall Study|Lost to Follow-up|4
888481|NCT01241240|2929839|P1|Overall Study|Lost to Follow-up|2
888482|NCT01241240|2929838|P2|Overall Study|Adverse Event|4
888483|NCT01241240|2929839|P1|Overall Study|Adverse Event|5
888484|NCT01240915|2929857|P9|Overall Study|Insufficient Clinical Response|3
888485|NCT01240915|2929858|P8|Overall Study|Insufficient Clinical Response|0
888486|NCT01240915|2929859|P7|Overall Study|Insufficient Clinical Response|6
888487|NCT01240915|2929860|P6|Overall Study|Insufficient Clinical Response|3
888488|NCT01240915|2929861|P5|Overall Study|Insufficient Clinical Response|1
888489|NCT01240915|2929862|P4|Overall Study|Insufficient Clinical Response|0
888490|NCT01240915|2929863|P3|Overall Study|Insufficient Clinical Response|0
888491|NCT01240915|2929864|P2|Overall Study|Insufficient Clinical Response|0
888492|NCT01240915|2929865|P1|Overall Study|Insufficient Clinical Response|0
888493|NCT01240915|2929857|P9|Overall Study|Other|0
888494|NCT01240915|2929858|P8|Overall Study|Other|0
888495|NCT01240915|2929859|P7|Overall Study|Other|0
888496|NCT01240915|2929860|P6|Overall Study|Other|0
888497|NCT01240915|2929861|P5|Overall Study|Other|2
888498|NCT01240915|2929862|P4|Overall Study|Other|0
888499|NCT01240915|2929863|P3|Overall Study|Other|0
888500|NCT01240915|2929864|P2|Overall Study|Other|0
888501|NCT01240915|2929865|P1|Overall Study|Other|0
888502|NCT01240915|2929857|P9|Overall Study|Withdrawal by Subject|3
888503|NCT01240915|2929858|P8|Overall Study|Withdrawal by Subject|3
888504|NCT01240915|2929859|P7|Overall Study|Withdrawal by Subject|2
888505|NCT01240915|2929860|P6|Overall Study|Withdrawal by Subject|4
888506|NCT01240915|2929861|P5|Overall Study|Withdrawal by Subject|0
888507|NCT01240915|2929862|P4|Overall Study|Withdrawal by Subject|2
888508|NCT01240915|2929863|P3|Overall Study|Withdrawal by Subject|0
888509|NCT01240915|2929864|P2|Overall Study|Withdrawal by Subject|1
888510|NCT01240915|2929865|P1|Overall Study|Withdrawal by Subject|2
888511|NCT01240915|2929857|P9|Overall Study|Lost to Follow-up|1
888512|NCT01240915|2929858|P8|Overall Study|Lost to Follow-up|1
888513|NCT01240915|2929859|P7|Overall Study|Lost to Follow-up|0
888514|NCT01240915|2929860|P6|Overall Study|Lost to Follow-up|1
888515|NCT01240915|2929861|P5|Overall Study|Lost to Follow-up|1
888516|NCT01240915|2929862|P4|Overall Study|Lost to Follow-up|0
888517|NCT01240915|2929863|P3|Overall Study|Lost to Follow-up|0
888518|NCT01240915|2929864|P2|Overall Study|Lost to Follow-up|0
888519|NCT01240915|2929865|P1|Overall Study|Lost to Follow-up|0
888520|NCT01240915|2929857|P9|Overall Study|Adverse Event|1
888521|NCT01240915|2929858|P8|Overall Study|Adverse Event|0
888522|NCT01240915|2929859|P7|Overall Study|Adverse Event|0
888523|NCT01240915|2929860|P6|Overall Study|Adverse Event|2
888524|NCT01240915|2929861|P5|Overall Study|Adverse Event|0
888525|NCT01240915|2929862|P4|Overall Study|Adverse Event|1
888526|NCT01240915|2929863|P3|Overall Study|Adverse Event|0
888527|NCT01240915|2929864|P2|Overall Study|Adverse Event|0
888528|NCT01240915|2929865|P1|Overall Study|Adverse Event|0
888529|NCT01240863|2930139|P3|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
888530|NCT01240863|2930140|P2|Double-blind Treatment Period (12 Weeks)|Physician Decision|1
888531|NCT01240863|2930141|P1|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
888532|NCT01240863|2930139|P3|Double-blind Treatment Period (12 Weeks)|Not specified|5
888533|NCT01240863|2930140|P2|Double-blind Treatment Period (12 Weeks)|Not specified|1
888534|NCT01240863|2930141|P1|Double-blind Treatment Period (12 Weeks)|Not specified|0
888535|NCT01240863|2930139|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
888536|NCT01240863|2930140|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
888537|NCT01240863|2930141|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0
888538|NCT01240863|2930139|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11
888539|NCT01240863|2930140|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9
888540|NCT01240863|2930141|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
888541|NCT01240863|2930139|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14
888542|NCT01240863|2930140|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
888543|NCT01240863|2930141|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
888544|NCT01240863|2930139|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5
888545|NCT01240863|2930140|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3
888546|NCT01240863|2930141|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
888547|NCT01240863|2930139|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
888548|NCT01240863|2930140|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
888549|NCT01240863|2930141|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
888550|NCT01240863|2930139|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|10
888551|NCT01240863|2930140|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|4
888552|NCT01240863|2930141|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
888553|NCT01240863|2930139|P3|Open-label Titration Period|Not specified|0
888554|NCT01240863|2930140|P2|Open-label Titration Period|Not specified|0
888555|NCT01240863|2930141|P1|Open-label Titration Period|Not specified|7
888556|NCT01240863|2930139|P3|Open-label Titration Period|Dropped out prior to dosing|0
888557|NCT01240863|2930140|P2|Open-label Titration Period|Dropped out prior to dosing|0
888558|NCT01240863|2930141|P1|Open-label Titration Period|Dropped out prior to dosing|2
888559|NCT01240863|2930139|P3|Open-label Titration Period|Noncompliance to study procedures|0
888560|NCT01240863|2930140|P2|Open-label Titration Period|Noncompliance to study procedures|0
888561|NCT01240863|2930141|P1|Open-label Titration Period|Noncompliance to study procedures|3
888562|NCT01240863|2930139|P3|Open-label Titration Period|Noncompliance to study drug admin|0
888563|NCT01240863|2930140|P2|Open-label Titration Period|Noncompliance to study drug admin|0
888564|NCT01240863|2930141|P1|Open-label Titration Period|Noncompliance to study drug admin|3
888565|NCT01240863|2930139|P3|Open-label Titration Period|Protocol Violation|0
888566|NCT01240863|2930140|P2|Open-label Titration Period|Protocol Violation|0
888567|NCT01240863|2930141|P1|Open-label Titration Period|Protocol Violation|7
888568|NCT01240863|2930139|P3|Open-label Titration Period|Withdrawal by Subject|0
888569|NCT01240863|2930140|P2|Open-label Titration Period|Withdrawal by Subject|0
888570|NCT01240863|2930141|P1|Open-label Titration Period|Withdrawal by Subject|9
888571|NCT01240863|2930139|P3|Open-label Titration Period|Lack of Efficacy|0
888572|NCT01240863|2930140|P2|Open-label Titration Period|Lack of Efficacy|0
888573|NCT01240863|2930141|P1|Open-label Titration Period|Lack of Efficacy|19
888574|NCT01240863|2930139|P3|Open-label Titration Period|Adverse Event|0
888575|NCT01240863|2930140|P2|Open-label Titration Period|Adverse Event|0
888576|NCT01240863|2930141|P1|Open-label Titration Period|Adverse Event|47
888577|NCT01240811|2930203|P3|Overall Study|Withdrawal by Subject|1
888578|NCT01240811|2930204|P2|Overall Study|Withdrawal by Subject|0
888579|NCT01240811|2930205|P1|Overall Study|Withdrawal by Subject|0
888580|NCT01240811|2930203|P3|Overall Study|Physician Decision|0
888581|NCT01240811|2930204|P2|Overall Study|Physician Decision|1
888582|NCT01240811|2930205|P1|Overall Study|Physician Decision|0
888583|NCT01240785|2930221|P2|Overall Study|Protocol Violation|3
888584|NCT01240785|2930222|P1|Overall Study|Protocol Violation|0
888585|NCT01240785|2930221|P2|Overall Study|Lost to Follow-up|0
888586|NCT01240785|2930222|P1|Overall Study|Lost to Follow-up|1
888587|NCT01240746|2930253|P3|Overall Study|Withdrawal by Subject|59
888588|NCT01240746|2930254|P2|Overall Study|Withdrawal by Subject|13
888589|NCT01240746|2930255|P1|Overall Study|Withdrawal by Subject|10
888590|NCT01240746|2930253|P3|Overall Study|Protocol Violation|72
888591|NCT01240746|2930254|P2|Overall Study|Protocol Violation|15
888592|NCT01240746|2930255|P1|Overall Study|Protocol Violation|24
888593|NCT01240746|2930253|P3|Overall Study|Lost to Follow-up|102
888594|NCT01240746|2930254|P2|Overall Study|Lost to Follow-up|20
888595|NCT01240746|2930255|P1|Overall Study|Lost to Follow-up|23
888596|NCT01240746|2930253|P3|Overall Study|Adverse Event|10
888597|NCT01240746|2930254|P2|Overall Study|Adverse Event|0
888598|NCT01240746|2930255|P1|Overall Study|Adverse Event|2
888599|NCT01240590|2930310|P5|Phase II|Refused further treatment|1
888600|NCT01240590|2930311|P4|Phase II|Refused further treatment|2
888601|NCT01240590|2930312|P3|Phase II|Refused further treatment|0
888602|NCT01240590|2930313|P2|Phase II|Refused further treatment|0
888603|NCT01240590|2930314|P1|Phase II|Refused further treatment|0
888604|NCT01240590|2930310|P5|Phase I|Refused further treatment|0
888605|NCT01240590|2930311|P4|Phase I|Refused further treatment|0
888606|NCT01240590|2930312|P3|Phase I|Refused further treatment|3
888607|NCT01240590|2930313|P2|Phase I|Refused further treatment|0
888608|NCT01240590|2930314|P1|Phase I|Refused further treatment|0
888609|NCT01240551|2930342|P2|Overall Study|Lost to Follow-up|1
888610|NCT01240551|2930343|P1|Overall Study|Lost to Follow-up|1
888611|NCT01240551|2930342|P2|Overall Study|Refused further treatment|2
888612|NCT01240551|2930343|P1|Overall Study|Refused further treatment|3
888613|NCT01240382|2930353|P2|Overall Study|Fear of adverse events|1
888614|NCT01240382|2930354|P1|Overall Study|Fear of adverse events|0
888615|NCT01240382|2930353|P2|Overall Study|Lack of Efficacy|2
888616|NCT01240382|2930354|P1|Overall Study|Lack of Efficacy|0
888617|NCT01240382|2930353|P2|Overall Study|Adverse Event|1
888618|NCT01240382|2930354|P1|Overall Study|Adverse Event|2
888619|NCT01240356|2930364|P2|Overall Study|MRI contraindication|0
888620|NCT01240356|2930365|P1|Overall Study|MRI contraindication|1
888621|NCT01240356|2930364|P2|Overall Study|Withdrawal by Subject|0
888622|NCT01240356|2930365|P1|Overall Study|Withdrawal by Subject|2
888623|NCT01240200|2930384|P2|12-week Crossover Phase - Period 1|Withdrawal by Subject|1
888624|NCT01240200|2930385|P1|12-week Crossover Phase - Period 1|Withdrawal by Subject|2
888625|NCT01240135|2930403|P2|Period Two, 14 Days of Wear|Adverse Event|1
888626|NCT01240135|2930404|P1|Period Two, 14 Days of Wear|Adverse Event|0
888627|NCT01240135|2930403|P2|Period Two, 14 Days of Wear|Withdrawal by Subject|1
888628|NCT01240135|2930404|P1|Period Two, 14 Days of Wear|Withdrawal by Subject|1
888629|NCT01239992|2930421|P1|Overall Study|Withdrawal by Subject|2
888630|NCT01239797|2930430|P2|Treated Participants|Poor/Non-compliance|1
888631|NCT01239797|2930431|P1|Treated Participants|Poor/Non-compliance|0
888632|NCT01239797|2930430|P2|Treated Participants|Subject No Longer Meets Study Criteria|1
888633|NCT01239797|2930431|P1|Treated Participants|Subject No Longer Meets Study Criteria|1
888634|NCT01239797|2930430|P2|Treated Participants|Death|1
888635|NCT01239797|2930431|P1|Treated Participants|Death|1
888636|NCT01239797|2930430|P2|Treated Participants|Non-specified|11
888637|NCT01239797|2930431|P1|Treated Participants|Non-specified|1
888638|NCT01239797|2930430|P2|Treated Participants|Withdrawal by Subject|23
888639|NCT01239797|2930431|P1|Treated Participants|Withdrawal by Subject|27
888640|NCT01239797|2930430|P2|Treated Participants|Adverse Event Unrelated to Study Drug|32
888641|NCT01239797|2930431|P1|Treated Participants|Adverse Event Unrelated to Study Drug|22
888642|NCT01239797|2930430|P2|Treated Participants|Study Drug Toxicity|44
888643|NCT01239797|2930431|P1|Treated Participants|Study Drug Toxicity|30
888644|NCT01239797|2930430|P2|Treated Participants|Disease Progression|161
888645|NCT01239797|2930431|P1|Treated Participants|Disease Progression|153
888646|NCT01239745|2930439|P1|Overall Study|Adverse Event|1
888647|NCT01239745|2930439|P1|Overall Study|Study terminated by sponsor|45
888648|NCT01239732|2930450|P1|Overall Study|Other|19
888649|NCT01239732|2930450|P1|Overall Study|Treatment failure|2
888650|NCT01239732|2930450|P1|Overall Study|Investigator's decision|4
888651|NCT01239732|2930450|P1|Overall Study|Study termination by sponsor|2
888652|NCT01239732|2930450|P1|Overall Study|Participant non compliance|5
888653|NCT01239732|2930450|P1|Overall Study|Protocol Violation|3
888654|NCT01239732|2930450|P1|Overall Study|Adverse Event|6
888655|NCT01239732|2930450|P1|Overall Study|Withdrawal by Subject|87
888656|NCT01239732|2930450|P1|Overall Study|Death|226
888657|NCT01239732|2930450|P1|Overall Study|Termination of study per protocol|667
888658|NCT01239680|2930463|P2|Overall Study|Withdrawal by Subject|0
888659|NCT01239680|2930464|P1|Overall Study|Withdrawal by Subject|2
888660|NCT01239394|2930487|P1|Overall Study|Adverse Event|1
888661|NCT01239381|2930494|P1|Overall Study|Withdrawal by Subject|1
888662|NCT01239381|2930494|P1|Overall Study|Protocol Violation|1
888663|NCT01239368|2930514|P10|Overall Study|Death|0
888664|NCT01239368|2930515|P9|Overall Study|Death|0
888665|NCT01239368|2930516|P8|Overall Study|Death|0
888666|NCT01239368|2930517|P7|Overall Study|Death|1
888667|NCT01239368|2930518|P6|Overall Study|Death|0
888668|NCT01239368|2930519|P5|Overall Study|Death|0
888669|NCT01239368|2930520|P4|Overall Study|Death|0
888670|NCT01239368|2930521|P3|Overall Study|Death|0
888671|NCT01239368|2930522|P2|Overall Study|Death|0
888672|NCT01239368|2930523|P1|Overall Study|Death|0
888673|NCT01239368|2930514|P10|Overall Study|Refused further treatment|1
888674|NCT01239368|2930515|P9|Overall Study|Refused further treatment|0
888675|NCT01239368|2930516|P8|Overall Study|Refused further treatment|0
888676|NCT01239368|2930517|P7|Overall Study|Refused further treatment|0
888677|NCT01239368|2930518|P6|Overall Study|Refused further treatment|0
888678|NCT01239368|2930519|P5|Overall Study|Refused further treatment|0
888679|NCT01239368|2930520|P4|Overall Study|Refused further treatment|0
888680|NCT01239368|2930521|P3|Overall Study|Refused further treatment|0
888681|NCT01239368|2930522|P2|Overall Study|Refused further treatment|0
888682|NCT01239368|2930523|P1|Overall Study|Refused further treatment|0
888683|NCT01239368|2930514|P10|Overall Study|Disease progression on study|2
888684|NCT01239368|2930515|P9|Overall Study|Disease progression on study|0
888685|NCT01239368|2930516|P8|Overall Study|Disease progression on study|0
888686|NCT01239368|2930517|P7|Overall Study|Disease progression on study|5
888687|NCT01239368|2930518|P6|Overall Study|Disease progression on study|2
888688|NCT01239368|2930519|P5|Overall Study|Disease progression on study|4
888689|NCT01239368|2930520|P4|Overall Study|Disease progression on study|1
888690|NCT01239368|2930521|P3|Overall Study|Disease progression on study|1
888691|NCT01239368|2930522|P2|Overall Study|Disease progression on study|1
888692|NCT01239368|2930523|P1|Overall Study|Disease progression on study|1
888693|NCT01239368|2930514|P10|Overall Study|Principal investigator discretion|1
888694|NCT01239368|2930515|P9|Overall Study|Principal investigator discretion|0
888695|NCT01239368|2930516|P8|Overall Study|Principal investigator discretion|0
888696|NCT01239368|2930517|P7|Overall Study|Principal investigator discretion|0
888697|NCT01239368|2930518|P6|Overall Study|Principal investigator discretion|2
888698|NCT01239368|2930519|P5|Overall Study|Principal investigator discretion|1
888699|NCT01239368|2930520|P4|Overall Study|Principal investigator discretion|0
888700|NCT01239368|2930521|P3|Overall Study|Principal investigator discretion|0
888701|NCT01239368|2930522|P2|Overall Study|Principal investigator discretion|0
888702|NCT01239368|2930523|P1|Overall Study|Principal investigator discretion|1
888703|NCT01239342|2930575|P2|Overall Study|Reason Unknown|1
888704|NCT01239342|2930576|P1|Overall Study|Reason Unknown|1
888705|NCT01239342|2930575|P2|Overall Study|Withdrawal by Subject|5
888706|NCT01239342|2930576|P1|Overall Study|Withdrawal by Subject|1
888707|NCT01239342|2930575|P2|Overall Study|Adverse Event|0
888708|NCT01239342|2930576|P1|Overall Study|Adverse Event|1
888709|NCT01239316|2930592|P1|Overall Study|Adverse Event|1
888710|NCT01239316|2930592|P1|Overall Study|Progression/Relapse|11
888711|NCT01239121|2930607|P3|Overall Study|Withdrawal by Subject|0
888712|NCT01239121|2930608|P2|Overall Study|Withdrawal by Subject|4
888713|NCT01239121|2930609|P1|Overall Study|Withdrawal by Subject|2
888714|NCT01239043|2930631|P2|Overall Study|Protocol Violation|1
888715|NCT01239043|2930632|P1|Overall Study|Protocol Violation|2
888716|NCT01238991|2930660|P10|Overall Study|Admission to a nursing home|0
888717|NCT01238991|2930661|P9|Overall Study|Admission to a nursing home|0
888718|NCT01238991|2930662|P8|Overall Study|Admission to a nursing home|0
888719|NCT01238991|2930663|P7|Overall Study|Admission to a nursing home|0
888720|NCT01238991|2930664|P6|Overall Study|Admission to a nursing home|0
888721|NCT01238991|2930665|P5|Overall Study|Admission to a nursing home|0
888722|NCT01238991|2930666|P4|Overall Study|Admission to a nursing home|0
888723|NCT01238991|2930667|P3|Overall Study|Admission to a nursing home|1
888724|NCT01238991|2930668|P2|Overall Study|Admission to a nursing home|0
888725|NCT01238991|2930669|P1|Overall Study|Admission to a nursing home|1
888726|NCT01238991|2930660|P10|Overall Study|Caregiver's request|0
888727|NCT01238991|2930661|P9|Overall Study|Caregiver's request|1
888728|NCT01238991|2930662|P8|Overall Study|Caregiver's request|0
888729|NCT01238991|2930663|P7|Overall Study|Caregiver's request|0
888730|NCT01238991|2930664|P6|Overall Study|Caregiver's request|0
888731|NCT01238991|2930665|P5|Overall Study|Caregiver's request|0
888732|NCT01238991|2930666|P4|Overall Study|Caregiver's request|0
888733|NCT01238991|2930667|P3|Overall Study|Caregiver's request|0
888734|NCT01238991|2930668|P2|Overall Study|Caregiver's request|0
888735|NCT01238991|2930669|P1|Overall Study|Caregiver's request|0
888736|NCT01238991|2930660|P10|Overall Study|Study Terminated by Sponsor|2
888737|NCT01238991|2930661|P9|Overall Study|Study Terminated by Sponsor|2
888738|NCT01238991|2930662|P8|Overall Study|Study Terminated by Sponsor|4
888739|NCT01238991|2930663|P7|Overall Study|Study Terminated by Sponsor|7
888740|NCT01238991|2930664|P6|Overall Study|Study Terminated by Sponsor|0
888741|NCT01238991|2930665|P5|Overall Study|Study Terminated by Sponsor|1
888742|NCT01238991|2930666|P4|Overall Study|Study Terminated by Sponsor|0
888743|NCT01238991|2930667|P3|Overall Study|Study Terminated by Sponsor|0
888744|NCT01238991|2930668|P2|Overall Study|Study Terminated by Sponsor|0
888745|NCT01238991|2930669|P1|Overall Study|Study Terminated by Sponsor|0
888746|NCT01238991|2930660|P10|Overall Study|Withdrawal by Subject|0
888747|NCT01238991|2930661|P9|Overall Study|Withdrawal by Subject|0
888748|NCT01238991|2930662|P8|Overall Study|Withdrawal by Subject|0
888749|NCT01238991|2930663|P7|Overall Study|Withdrawal by Subject|0
888750|NCT01238991|2930664|P6|Overall Study|Withdrawal by Subject|0
888751|NCT01238991|2930665|P5|Overall Study|Withdrawal by Subject|0
888752|NCT01238991|2930666|P4|Overall Study|Withdrawal by Subject|0
888753|NCT01238991|2930667|P3|Overall Study|Withdrawal by Subject|1
888754|NCT01238991|2930668|P2|Overall Study|Withdrawal by Subject|0
888755|NCT01238991|2930669|P1|Overall Study|Withdrawal by Subject|0
888756|NCT01238991|2930660|P10|Overall Study|Lack of Efficacy|0
888757|NCT01238991|2930661|P9|Overall Study|Lack of Efficacy|1
888758|NCT01238991|2930662|P8|Overall Study|Lack of Efficacy|0
888759|NCT01238991|2930663|P7|Overall Study|Lack of Efficacy|0
888760|NCT01238991|2930664|P6|Overall Study|Lack of Efficacy|0
888761|NCT01238991|2930665|P5|Overall Study|Lack of Efficacy|0
888762|NCT01238991|2930666|P4|Overall Study|Lack of Efficacy|0
888763|NCT01238991|2930667|P3|Overall Study|Lack of Efficacy|1
888764|NCT01238991|2930668|P2|Overall Study|Lack of Efficacy|0
888765|NCT01238991|2930669|P1|Overall Study|Lack of Efficacy|0
888766|NCT01238991|2930660|P10|Overall Study|Death|0
888767|NCT01238991|2930661|P9|Overall Study|Death|0
888768|NCT01238991|2930662|P8|Overall Study|Death|0
888769|NCT01238991|2930663|P7|Overall Study|Death|0
888770|NCT01238991|2930664|P6|Overall Study|Death|0
888771|NCT01238991|2930665|P5|Overall Study|Death|0
888772|NCT01238991|2930666|P4|Overall Study|Death|1
888773|NCT01238991|2930667|P3|Overall Study|Death|0
888774|NCT01238991|2930668|P2|Overall Study|Death|0
888775|NCT01238991|2930669|P1|Overall Study|Death|0
888776|NCT01238991|2930660|P10|Overall Study|Adverse Event|0
888777|NCT01238991|2930661|P9|Overall Study|Adverse Event|0
888778|NCT01238991|2930662|P8|Overall Study|Adverse Event|1
888779|NCT01238991|2930663|P7|Overall Study|Adverse Event|1
888780|NCT01238991|2930664|P6|Overall Study|Adverse Event|0
888781|NCT01238991|2930665|P5|Overall Study|Adverse Event|1
888782|NCT01238991|2930666|P4|Overall Study|Adverse Event|1
888783|NCT01238991|2930667|P3|Overall Study|Adverse Event|3
888784|NCT01238991|2930668|P2|Overall Study|Adverse Event|0
888785|NCT01238991|2930669|P1|Overall Study|Adverse Event|1
888786|NCT01238900|2930756|P1|<12 Months Post Stent Removal|persistent stricture after stenting|1
888787|NCT01238900|2930756|P1|<12 Months Post Stent Removal|Lost to Follow-up|4
888788|NCT01238861|2930770|P6|Overall Study|Withdrawal by Subject|9
888789|NCT01238861|2930771|P5|Overall Study|Withdrawal by Subject|10
888790|NCT01238861|2930772|P4|Overall Study|Withdrawal by Subject|8
888791|NCT01238861|2930773|P3|Overall Study|Withdrawal by Subject|4
888792|NCT01238861|2930774|P2|Overall Study|Withdrawal by Subject|5
888793|NCT01238861|2930775|P1|Overall Study|Withdrawal by Subject|6
888794|NCT01238861|2930770|P6|Overall Study|Adverse Event|0
888795|NCT01238861|2930771|P5|Overall Study|Adverse Event|0
888796|NCT01238861|2930772|P4|Overall Study|Adverse Event|0
888797|NCT01238861|2930773|P3|Overall Study|Adverse Event|0
888798|NCT01238861|2930774|P2|Overall Study|Adverse Event|1
888799|NCT01238861|2930775|P1|Overall Study|Adverse Event|0
888800|NCT01238861|2930770|P6|Overall Study|Lack of compliance|1
888801|NCT01238861|2930771|P5|Overall Study|Lack of compliance|0
888802|NCT01238861|2930772|P4|Overall Study|Lack of compliance|0
888803|NCT01238861|2930773|P3|Overall Study|Lack of compliance|0
888804|NCT01238861|2930774|P2|Overall Study|Lack of compliance|0
888805|NCT01238861|2930775|P1|Overall Study|Lack of compliance|0
888806|NCT01238861|2930770|P6|Overall Study|Serious adverse event|1
888807|NCT01238861|2930771|P5|Overall Study|Serious adverse event|0
888808|NCT01238861|2930772|P4|Overall Study|Serious adverse event|0
888809|NCT01238861|2930773|P3|Overall Study|Serious adverse event|0
888810|NCT01238861|2930774|P2|Overall Study|Serious adverse event|0
888811|NCT01238861|2930775|P1|Overall Study|Serious adverse event|0
888812|NCT01238861|2930770|P6|Overall Study|Unable to continue visits|1
888813|NCT01238861|2930771|P5|Overall Study|Unable to continue visits|0
888814|NCT01238861|2930772|P4|Overall Study|Unable to continue visits|1
888815|NCT01238861|2930773|P3|Overall Study|Unable to continue visits|0
888816|NCT01238861|2930774|P2|Overall Study|Unable to continue visits|0
888817|NCT01238861|2930775|P1|Overall Study|Unable to continue visits|0
888818|NCT01238861|2930770|P6|Overall Study|Personal problems|0
888819|NCT01238861|2930771|P5|Overall Study|Personal problems|0
888820|NCT01238861|2930772|P4|Overall Study|Personal problems|1
888821|NCT01238861|2930773|P3|Overall Study|Personal problems|0
888822|NCT01238861|2930774|P2|Overall Study|Personal problems|0
888823|NCT01238861|2930775|P1|Overall Study|Personal problems|0
888824|NCT01238861|2930770|P6|Overall Study|Strongyloides stercoralis antibodies +|0
888825|NCT01238861|2930771|P5|Overall Study|Strongyloides stercoralis antibodies +|0
888826|NCT01238861|2930772|P4|Overall Study|Strongyloides stercoralis antibodies +|1
888827|NCT01238861|2930773|P3|Overall Study|Strongyloides stercoralis antibodies +|0
888828|NCT01238861|2930774|P2|Overall Study|Strongyloides stercoralis antibodies +|0
888829|NCT01238861|2930775|P1|Overall Study|Strongyloides stercoralis antibodies +|0
888830|NCT01238861|2930770|P6|Overall Study|Subject moved out of state/area|0
888831|NCT01238861|2930771|P5|Overall Study|Subject moved out of state/area|0
888832|NCT01238861|2930772|P4|Overall Study|Subject moved out of state/area|1
888833|NCT01238861|2930773|P3|Overall Study|Subject moved out of state/area|1
888834|NCT01238861|2930774|P2|Overall Study|Subject moved out of state/area|0
888835|NCT01238861|2930775|P1|Overall Study|Subject moved out of state/area|0
888836|NCT01238861|2930770|P6|Overall Study|Subject traveled to Argentina by 1 year|0
888837|NCT01238861|2930771|P5|Overall Study|Subject traveled to Argentina by 1 year|0
888838|NCT01238861|2930772|P4|Overall Study|Subject traveled to Argentina by 1 year|0
888839|NCT01238861|2930773|P3|Overall Study|Subject traveled to Argentina by 1 year|1
888840|NCT01238861|2930774|P2|Overall Study|Subject traveled to Argentina by 1 year|0
888841|NCT01238861|2930775|P1|Overall Study|Subject traveled to Argentina by 1 year|0
888842|NCT01238861|2930770|P6|Overall Study|Incorrect enrollment/randomization|0
888843|NCT01238861|2930771|P5|Overall Study|Incorrect enrollment/randomization|1
888844|NCT01238861|2930772|P4|Overall Study|Incorrect enrollment/randomization|0
888845|NCT01238861|2930773|P3|Overall Study|Incorrect enrollment/randomization|1
888846|NCT01238861|2930774|P2|Overall Study|Incorrect enrollment/randomization|0
888847|NCT01238861|2930775|P1|Overall Study|Incorrect enrollment/randomization|0
888848|NCT01238861|2930770|P6|Overall Study|Did not meet entry ACQ-6 criteria|1
888849|NCT01238861|2930771|P5|Overall Study|Did not meet entry ACQ-6 criteria|1
888850|NCT01238861|2930772|P4|Overall Study|Did not meet entry ACQ-6 criteria|0
888851|NCT01238861|2930773|P3|Overall Study|Did not meet entry ACQ-6 criteria|1
888852|NCT01238861|2930774|P2|Overall Study|Did not meet entry ACQ-6 criteria|0
888853|NCT01238861|2930775|P1|Overall Study|Did not meet entry ACQ-6 criteria|0
888854|NCT01238861|2930770|P6|Overall Study|Unplanned surgery|0
888855|NCT01238861|2930771|P5|Overall Study|Unplanned surgery|0
888856|NCT01238861|2930772|P4|Overall Study|Unplanned surgery|0
888857|NCT01238861|2930773|P3|Overall Study|Unplanned surgery|0
888858|NCT01238861|2930774|P2|Overall Study|Unplanned surgery|0
888859|NCT01238861|2930775|P1|Overall Study|Unplanned surgery|1
888860|NCT01238861|2930770|P6|Overall Study|Lost to Follow-up|2
888861|NCT01238861|2930771|P5|Overall Study|Lost to Follow-up|1
888862|NCT01238861|2930772|P4|Overall Study|Lost to Follow-up|1
888863|NCT01238861|2930773|P3|Overall Study|Lost to Follow-up|3
888864|NCT01238861|2930774|P2|Overall Study|Lost to Follow-up|2
888865|NCT01238861|2930775|P1|Overall Study|Lost to Follow-up|4
888866|NCT01238848|2930855|P2|Overall Study|Physician Decision|5
888867|NCT01238848|2930856|P1|Overall Study|Physician Decision|13
888868|NCT01238822|2930864|P1|Overall Study|COULD NOT SWALLOW PILLS|3
888869|NCT01238588|2930891|P1|Overall Study|Physician Decision|2
888870|NCT01238588|2930891|P1|Overall Study|Withdrawal by Subject|1
888871|NCT01238575|2930904|P2|Overall Study|Adverse Event|0
888872|NCT01238575|2930905|P1|Overall Study|Adverse Event|2
888873|NCT01238575|2930904|P2|Overall Study|Lack of Efficacy|4
888874|NCT01238575|2930905|P1|Overall Study|Lack of Efficacy|2
888875|NCT01238211|2930989|P1|Overall Study|Investigator/Patient Decision|3
888876|NCT01238211|2930989|P1|Overall Study|Non-protocol treatment|4
888877|NCT01238211|2930989|P1|Overall Study|Withdrawal by Subject|7
888878|NCT01238211|2930989|P1|Overall Study|Relapse/Progression|2
888879|NCT01238211|2930989|P1|Overall Study|Death|4
888880|NCT01238211|2930989|P1|Overall Study|Adverse Event|7
888881|NCT01238211|2930989|P1|Overall Study|Continues active treatment|31
888882|NCT01237678|2930996|P3|Phase II|Randomized but were not treated|3
888883|NCT01237678|2930997|P2|Phase II|Randomized but were not treated|4
888884|NCT01237678|2930998|P1|Phase II|Randomized but were not treated|0
888885|NCT01237678|2930996|P3|Phase II|Sponsor Decision/Study Closed|7
888886|NCT01237678|2930997|P2|Phase II|Sponsor Decision/Study Closed|18
888887|NCT01237678|2930998|P1|Phase II|Sponsor Decision/Study Closed|0
888888|NCT01237678|2930996|P3|Phase II|Completed Cycles 4-6|21
888889|NCT01237678|2930997|P2|Phase II|Completed Cycles 4-6|11
888890|NCT01237678|2930998|P1|Phase II|Completed Cycles 4-6|0
888891|NCT01237678|2930996|P3|Phase II|Withdrawal by Subject|5
888892|NCT01237678|2930997|P2|Phase II|Withdrawal by Subject|1
888893|NCT01237678|2930998|P1|Phase II|Withdrawal by Subject|0
888894|NCT01237678|2930996|P3|Phase II|Lack of Efficacy|3
888895|NCT01237678|2930997|P2|Phase II|Lack of Efficacy|25
888896|NCT01237678|2930998|P1|Phase II|Lack of Efficacy|0
888897|NCT01237678|2930996|P3|Phase II|Death|2
888898|NCT01237678|2930997|P2|Phase II|Death|0
888899|NCT01237678|2930998|P1|Phase II|Death|0
888900|NCT01237678|2930996|P3|Phase II|Adverse Event|9
888901|NCT01237678|2930997|P2|Phase II|Adverse Event|39
888902|NCT01237678|2930998|P1|Phase II|Adverse Event|0
888903|NCT01237678|2930996|P3|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
888904|NCT01237678|2930997|P2|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
888905|NCT01237678|2930998|P1|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1
888906|NCT01237678|2930996|P3|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
888907|NCT01237678|2930997|P2|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
888908|NCT01237678|2930998|P1|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3
888909|NCT01237678|2930996|P3|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
888910|NCT01237678|2930997|P2|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
888911|NCT01237678|2930998|P1|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24
888912|NCT01237678|2930996|P3|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
888913|NCT01237678|2930997|P2|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
888914|NCT01237678|2930998|P1|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5
888915|NCT01237587|2931043|P2|Taper Phase|Withdrawal by Subject|1
888916|NCT01237587|2931044|P1|Taper Phase|Withdrawal by Subject|0
888917|NCT01237587|2931043|P2|Taper Phase|Sponsor Decision|0
888918|NCT01237587|2931044|P1|Taper Phase|Sponsor Decision|1
888919|NCT01237587|2931043|P2|Taper Phase|Parent/Guardian Decision|2
888920|NCT01237587|2931044|P1|Taper Phase|Parent/Guardian Decision|0
888921|NCT01237587|2931043|P2|Taper Phase|Lack of Efficacy|5
888922|NCT01237587|2931044|P1|Taper Phase|Lack of Efficacy|2
888923|NCT01237587|2931043|P2|Taper Phase|Protocol Violation|0
888924|NCT01237587|2931044|P1|Taper Phase|Protocol Violation|2
888925|NCT01237587|2931043|P2|Taper Phase|Adverse Event|2
888926|NCT01237587|2931044|P1|Taper Phase|Adverse Event|0
888927|NCT01237587|2931043|P2|Open Label Treatment (Extension Phase)|Physician Decision|4
888928|NCT01237587|2931044|P1|Open Label Treatment (Extension Phase)|Physician Decision|4
888929|NCT01237587|2931043|P2|Open Label Treatment (Extension Phase)|Sponsor Decision|0
888930|NCT01237587|2931044|P1|Open Label Treatment (Extension Phase)|Sponsor Decision|1
888931|NCT01237587|2931043|P2|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5
888932|NCT01237587|2931044|P1|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0
888933|NCT01237587|2931043|P2|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4
888934|NCT01237587|2931044|P1|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2
888935|NCT01237587|2931043|P2|Open Label Treatment (Extension Phase)|Lack of Efficacy|4
888936|NCT01237587|2931044|P1|Open Label Treatment (Extension Phase)|Lack of Efficacy|2
888937|NCT01237587|2931043|P2|Open Label Treatment (Extension Phase)|Adverse Event|5
888938|NCT01237587|2931044|P1|Open Label Treatment (Extension Phase)|Adverse Event|5
888939|NCT01237587|2931043|P2|Open Label Treatment (Extension Phase)|Lost to Follow-up|3
888940|NCT01237587|2931044|P1|Open Label Treatment (Extension Phase)|Lost to Follow-up|4
888941|NCT01237587|2931043|P2|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4
888942|NCT01237587|2931044|P1|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3
888943|NCT01237587|2931043|P2|Double Blind Treatment (Acute Phase)|Protocol Violation|3
888944|NCT01237587|2931044|P1|Double Blind Treatment (Acute Phase)|Protocol Violation|4
888945|NCT01237587|2931043|P2|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4
888946|NCT01237587|2931044|P1|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2
888947|NCT01237587|2931043|P2|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3
888948|NCT01237587|2931044|P1|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2
888949|NCT01237587|2931043|P2|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3
888950|NCT01237587|2931044|P1|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1
888951|NCT01237587|2931043|P2|Double Blind Treatment (Acute Phase)|Adverse Event|1
888952|NCT01237587|2931044|P1|Double Blind Treatment (Acute Phase)|Adverse Event|5
888953|NCT01237340|2931096|P1|Overall Study|Early termination of the trial|36
888954|NCT01237340|2931096|P1|Overall Study|Withdrawal by Subject|1
888955|NCT01237340|2931096|P1|Overall Study|Adverse Event|3
888956|NCT01237327|2931110|P2|Overall Study|Lost to Follow-up|0
888957|NCT01237327|2931111|P1|Overall Study|Lost to Follow-up|3
888958|NCT01237327|2931110|P2|Overall Study|Withdrawal by Subject|3
888959|NCT01237327|2931111|P1|Overall Study|Withdrawal by Subject|1
888960|NCT01237327|2931110|P2|Overall Study|Protocol Specific Withdrawal Criteria|0
888961|NCT01237327|2931111|P1|Overall Study|Protocol Specific Withdrawal Criteria|1
888962|NCT01237327|2931110|P2|Overall Study|Progression of Disease: Extension Study|13
888963|NCT01237327|2931111|P1|Overall Study|Progression of Disease: Extension Study|15
888964|NCT01237327|2931110|P2|Overall Study|Progression of Disease: Core Study|22
888965|NCT01237327|2931111|P1|Overall Study|Progression of Disease: Core Study|18
888966|NCT01237327|2931110|P2|Overall Study|Completed 26 weeks treatment:Core Study|2
888967|NCT01237327|2931111|P1|Overall Study|Completed 26 weeks treatment:Core Study|3
888968|NCT01237327|2931110|P2|Overall Study|Protocol Violation: Core Study|0
888969|NCT01237327|2931111|P1|Overall Study|Protocol Violation: Core Study|1
888970|NCT01237223|2931146|P6|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
888971|NCT01237223|2931147|P5|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
888972|NCT01237223|2931148|P4|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2
888973|NCT01237223|2931149|P3|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
888974|NCT01237223|2931150|P2|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
888975|NCT01237223|2931151|P1|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0
888976|NCT01237223|2931146|P6|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1
888977|NCT01237223|2931147|P5|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
888978|NCT01237223|2931148|P4|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
888979|NCT01237223|2931149|P3|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
888980|NCT01237223|2931150|P2|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
888981|NCT01237223|2931151|P1|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
888982|NCT01237223|2931146|P6|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
888983|NCT01237223|2931147|P5|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
888984|NCT01237223|2931148|P4|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0
888985|NCT01237223|2931149|P3|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
888986|NCT01237223|2931150|P2|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
888987|NCT01237223|2931151|P1|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
888988|NCT01237223|2931146|P6|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
888989|NCT01237223|2931147|P5|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0
888990|NCT01237223|2931148|P4|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
888991|NCT01237223|2931149|P3|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7
888992|NCT01237223|2931150|P2|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6
888993|NCT01237223|2931151|P1|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20
888994|NCT01237223|2931146|P6|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1
888995|NCT01237223|2931147|P5|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
888996|NCT01237223|2931148|P4|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
888997|NCT01237223|2931149|P3|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3
888998|NCT01237223|2931150|P2|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4
888999|NCT01237223|2931151|P1|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12
889000|NCT01237223|2931146|P6|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
889001|NCT01237223|2931147|P5|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
889002|NCT01237223|2931148|P4|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
889003|NCT01237223|2931149|P3|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
889004|NCT01237223|2931150|P2|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
889005|NCT01237223|2931151|P1|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8
889006|NCT01237223|2931146|P6|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
889007|NCT01237223|2931147|P5|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
889008|NCT01237223|2931148|P4|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
889009|NCT01237223|2931149|P3|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
889010|NCT01237223|2931150|P2|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
889011|NCT01237223|2931151|P1|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28
889012|NCT01237223|2931146|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
889013|NCT01237223|2931147|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
889014|NCT01237223|2931148|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
889015|NCT01237223|2931149|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
889016|NCT01237223|2931150|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
889017|NCT01237223|2931151|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308
889018|NCT01237223|2931146|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
889019|NCT01237223|2931147|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
889020|NCT01237223|2931148|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
889021|NCT01237223|2931149|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
889022|NCT01237223|2931150|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
889023|NCT01237223|2931151|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25
889024|NCT01237223|2931146|P6|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
889025|NCT01237223|2931147|P5|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
889026|NCT01237223|2931148|P4|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
889027|NCT01237223|2931149|P3|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
889028|NCT01237223|2931150|P2|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
889029|NCT01237223|2931151|P1|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29
889030|NCT01237054|2931210|P1|Overall Study|imaging 10C0096|1
889031|NCT01236573|2931275|P11|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1
889032|NCT01236573|2931276|P10|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
889033|NCT01236573|2931277|P9|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
889034|NCT01236573|2931278|P8|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
889035|NCT01236573|2931279|P7|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
889036|NCT01236573|2931280|P6|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
889037|NCT01236573|2931281|P5|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
889038|NCT01236573|2931282|P4|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
889039|NCT01236573|2931283|P3|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
889040|NCT01236573|2931284|P2|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
889041|NCT01236573|2931285|P1|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
889042|NCT01236573|2931275|P11|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
889043|NCT01236573|2931276|P10|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
889044|NCT01236573|2931277|P9|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1
889045|NCT01236573|2931278|P8|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
889046|NCT01236573|2931279|P7|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
889047|NCT01236573|2931280|P6|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
889048|NCT01236573|2931281|P5|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
889049|NCT01236573|2931282|P4|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
889050|NCT01236573|2931283|P3|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
889051|NCT01236573|2931284|P2|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
889052|NCT01236573|2931285|P1|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
889053|NCT01236573|2931275|P11|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
889054|NCT01236573|2931276|P10|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
889055|NCT01236573|2931277|P9|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
889056|NCT01236573|2931278|P8|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
889057|NCT01236573|2931279|P7|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
889058|NCT01236573|2931280|P6|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
889059|NCT01236573|2931281|P5|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
889060|NCT01236573|2931282|P4|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
889061|NCT01236573|2931283|P3|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
889062|NCT01236573|2931284|P2|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
889063|NCT01236573|2931285|P1|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
889064|NCT01236534|2931323|P2|Overall Study|Adverse Event|0
889065|NCT01236534|2931324|P1|Overall Study|Adverse Event|3
889066|NCT01236521|2931334|P2|Overall Study|Lost to Follow-up|7
889067|NCT01236521|2931335|P1|Overall Study|Lost to Follow-up|7
889068|NCT01236521|2931334|P2|Overall Study|Death|1
889069|NCT01236521|2931335|P1|Overall Study|Death|2
889070|NCT01236521|2931334|P2|Overall Study|Withdrawal by Subject|17
889071|NCT01236521|2931335|P1|Overall Study|Withdrawal by Subject|12
889072|NCT01236365|2931385|P2|Overall Study|Dropped at Randomization due to high LFT|0
889073|NCT01236365|2931386|P1|Overall Study|Dropped at Randomization due to high LFT|1
889074|NCT01236365|2931385|P2|Overall Study|Moved Out of State|0
889075|NCT01236365|2931386|P1|Overall Study|Moved Out of State|1
889076|NCT01236365|2931385|P2|Overall Study|Lost to Follow-up|2
889077|NCT01236365|2931386|P1|Overall Study|Lost to Follow-up|0
889078|NCT01236339|2931400|P2|Overall Study|Termination of study by sponsor|13
889079|NCT01236339|2931401|P1|Overall Study|Termination of study by sponsor|11
889080|NCT01236118|2931469|P3|Overall Study|Withdrawal by Subject|1
889081|NCT01236118|2931470|P2|Overall Study|Withdrawal by Subject|0
889082|NCT01236118|2931471|P1|Overall Study|Withdrawal by Subject|0
889083|NCT01236118|2931469|P3|Overall Study|Physician Decision|0
889084|NCT01236118|2931470|P2|Overall Study|Physician Decision|1
889085|NCT01236118|2931471|P1|Overall Study|Physician Decision|0
889086|NCT01236118|2931469|P3|Overall Study|Adverse Event|2
889087|NCT01236118|2931470|P2|Overall Study|Adverse Event|0
889088|NCT01236118|2931471|P1|Overall Study|Adverse Event|2
889089|NCT01236001|2931672|P2|Overall Study|Planned Visit After End of Study|1
889090|NCT01236001|2931673|P1|Overall Study|Planned Visit After End of Study|0
889091|NCT01236001|2931672|P2|Overall Study|Incompliance|0
889092|NCT01236001|2931673|P1|Overall Study|Incompliance|1
889093|NCT01236001|2931672|P2|Overall Study|Lost to Follow-up|1
889094|NCT01236001|2931673|P1|Overall Study|Lost to Follow-up|6
889095|NCT01236001|2931672|P2|Overall Study|Lack of Efficacy|6
889096|NCT01236001|2931673|P1|Overall Study|Lack of Efficacy|6
889097|NCT01236001|2931672|P2|Overall Study|Adverse Event|14
889098|NCT01236001|2931673|P1|Overall Study|Adverse Event|5
889099|NCT01235975|2931705|P2|Overall Study|Lost to Follow-up|3
889100|NCT01235975|2931706|P1|Overall Study|Lost to Follow-up|7
889101|NCT01235975|2931705|P2|Overall Study|Migrated/moved from study area|1
889102|NCT01235975|2931706|P1|Overall Study|Migrated/moved from study area|2
889103|NCT01235975|2931705|P2|Overall Study|Withdrawal by Subject|2
889104|NCT01235975|2931706|P1|Overall Study|Withdrawal by Subject|8
889105|NCT01235975|2931705|P2|Overall Study|Serious Adverse Event|1
889106|NCT01235975|2931706|P1|Overall Study|Serious Adverse Event|0
889107|NCT01235793|2931760|P1|Overall Study|Death|6
889108|NCT01235741|2931768|P3|Follow-Up Post Treatment up to Month 6|not specified|0
889109|NCT01235741|2931769|P2|Follow-Up Post Treatment up to Month 6|not specified|1
889110|NCT01235741|2931770|P1|Follow-Up Post Treatment up to Month 6|not specified|0
889111|NCT01235741|2931768|P3|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1
889112|NCT01235741|2931769|P2|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5
889193|NCT01235442|2932014|P1|Overall Study|Pregnancy|1
889113|NCT01235741|2931770|P1|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0
889114|NCT01235741|2931768|P3|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6
889115|NCT01235741|2931769|P2|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3
889116|NCT01235741|2931770|P1|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0
889117|NCT01235741|2931768|P3|Randomized to Treatment|Sponsor terminated study|34
889118|NCT01235741|2931769|P2|Randomized to Treatment|Sponsor terminated study|35
889119|NCT01235741|2931770|P1|Randomized to Treatment|Sponsor terminated study|0
889120|NCT01235741|2931768|P3|Randomized to Treatment|Adverse Event|1
889121|NCT01235741|2931769|P2|Randomized to Treatment|Adverse Event|1
889122|NCT01235741|2931770|P1|Randomized to Treatment|Adverse Event|0
889123|NCT01235741|2931768|P3|Randomized to Treatment|Withdrawal by Subject|1
889124|NCT01235741|2931769|P2|Randomized to Treatment|Withdrawal by Subject|0
889125|NCT01235741|2931770|P1|Randomized to Treatment|Withdrawal by Subject|0
889126|NCT01235741|2931768|P3|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
889127|NCT01235741|2931769|P2|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
889128|NCT01235741|2931770|P1|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4
889129|NCT01235741|2931768|P3|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
889130|NCT01235741|2931769|P2|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
889131|NCT01235741|2931770|P1|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5
889132|NCT01235741|2931768|P3|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
889133|NCT01235741|2931769|P2|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
889134|NCT01235741|2931770|P1|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1
889135|NCT01235741|2931768|P3|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
889136|NCT01235741|2931769|P2|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
889137|NCT01235741|2931770|P1|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1
889138|NCT01235741|2931768|P3|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
889139|NCT01235741|2931769|P2|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
889140|NCT01235741|2931770|P1|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121
889141|NCT01235741|2931768|P3|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
889142|NCT01235741|2931769|P2|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
889143|NCT01235741|2931770|P1|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9
889144|NCT01235728|2931797|P8|Overall Study|Protocol Violation|0
889145|NCT01235728|2931798|P7|Overall Study|Protocol Violation|0
889146|NCT01235728|2931799|P6|Overall Study|Protocol Violation|0
889147|NCT01235728|2931800|P5|Overall Study|Protocol Violation|0
889148|NCT01235728|2931801|P4|Overall Study|Protocol Violation|1
889149|NCT01235728|2931802|P3|Overall Study|Protocol Violation|0
889150|NCT01235728|2931803|P2|Overall Study|Protocol Violation|0
889151|NCT01235728|2931804|P1|Overall Study|Protocol Violation|0
889152|NCT01235715|2931814|P2|Overall Study|Physician Decision|2
889153|NCT01235715|2931815|P1|Overall Study|Physician Decision|0
889154|NCT01235689|2931855|P2|Overall Study|Miscellaneous|5
889155|NCT01235689|2931856|P1|Overall Study|Miscellaneous|1
889156|NCT01235689|2931855|P2|Overall Study|Lost to Follow-up|2
889157|NCT01235689|2931856|P1|Overall Study|Lost to Follow-up|1
889158|NCT01235689|2931855|P2|Overall Study|Withdrawal by Subject|4
889159|NCT01235689|2931856|P1|Overall Study|Withdrawal by Subject|3
889160|NCT01235689|2931855|P2|Overall Study|Lack of Efficacy|5
889161|NCT01235689|2931856|P1|Overall Study|Lack of Efficacy|12
889162|NCT01235689|2931855|P2|Overall Study|Adverse Event|16
889163|NCT01235689|2931856|P1|Overall Study|Adverse Event|12
889164|NCT01235598|2931928|P2|Overall Study|Withdrawal by Subject|0
889165|NCT01235598|2931929|P1|Overall Study|Withdrawal by Subject|1
889166|NCT01235598|2931928|P2|Overall Study|Lack of Efficacy|1
889167|NCT01235598|2931929|P1|Overall Study|Lack of Efficacy|0
889168|NCT01235598|2931928|P2|Overall Study|Adverse Event|3
889169|NCT01235598|2931929|P1|Overall Study|Adverse Event|0
889170|NCT01235546|2931974|P2|Overall Study|Protocol Violation|1
889171|NCT01235546|2931975|P1|Overall Study|Protocol Violation|1
889172|NCT01235546|2931974|P2|Overall Study|Staff error, medication not administered|0
889173|NCT01235546|2931975|P1|Overall Study|Staff error, medication not administered|1
889174|NCT01235507|2931999|P1|Overall Study|Withdrawal by Subject|1
889175|NCT01235507|2931999|P1|Overall Study|Adverse Event|1
889176|NCT01235442|2932013|P2|Overall Study|Other unspecified|2
889177|NCT01235442|2932014|P1|Overall Study|Other unspecified|1
889178|NCT01235442|2932013|P2|Overall Study|Administrative decision|2
889179|NCT01235442|2932014|P1|Overall Study|Administrative decision|1
889180|NCT01235442|2932013|P2|Overall Study|Noncompliance|2
889181|NCT01235442|2932014|P1|Overall Study|Noncompliance|1
889182|NCT01235442|2932013|P2|Overall Study|Lack of Efficacy|3
889183|NCT01235442|2932014|P1|Overall Study|Lack of Efficacy|1
889184|NCT01235442|2932013|P2|Overall Study|Withdrawal by Subject|9
889185|NCT01235442|2932014|P1|Overall Study|Withdrawal by Subject|15
889186|NCT01235442|2932013|P2|Overall Study|Adverse Event|6
889187|NCT01235442|2932014|P1|Overall Study|Adverse Event|4
889188|NCT01235442|2932013|P2|Overall Study|Protocol Violation|3
889189|NCT01235442|2932014|P1|Overall Study|Protocol Violation|3
889190|NCT01235442|2932013|P2|Overall Study|Ineligibility determined|4
889191|NCT01235442|2932014|P1|Overall Study|Ineligibility determined|5
889192|NCT01235442|2932013|P2|Overall Study|Pregnancy|1
889194|NCT01235442|2932013|P2|Overall Study|Death|2
889195|NCT01235442|2932014|P1|Overall Study|Death|0
889196|NCT01235442|2932013|P2|Overall Study|Lost to Follow-up|10
889197|NCT01235442|2932014|P1|Overall Study|Lost to Follow-up|12
889198|NCT01235403|2932032|P1|Overall Study|Other reasons for premature termination|4
889199|NCT01235403|2932032|P1|Overall Study|Lack of Efficacy|2
889200|NCT01235403|2932032|P1|Overall Study|Withdrawal by Subject|4
889201|NCT01235403|2932032|P1|Overall Study|Lost to Follow-up|2
889202|NCT01235403|2932032|P1|Overall Study|Adverse Event|14
889203|NCT01235338|2932049|P2|Overall Study|Prohibited meds|0
889204|NCT01235338|2932050|P1|Overall Study|Prohibited meds|1
889205|NCT01235338|2932049|P2|Overall Study|Positive drug screen|1
889206|NCT01235338|2932050|P1|Overall Study|Positive drug screen|0
889207|NCT01235338|2932049|P2|Overall Study|Exclusion criteria violations|1
889208|NCT01235338|2932050|P1|Overall Study|Exclusion criteria violations|1
889209|NCT01235338|2932049|P2|Overall Study|Withdrawal by Subject|0
889210|NCT01235338|2932050|P1|Overall Study|Withdrawal by Subject|5
889211|NCT01235338|2932049|P2|Overall Study|Protocol Violation|1
889212|NCT01235338|2932050|P1|Overall Study|Protocol Violation|1
889213|NCT01235338|2932049|P2|Overall Study|Adverse Event|2
889214|NCT01235338|2932050|P1|Overall Study|Adverse Event|3
889215|NCT01235234|2932095|P3|Overall Study|Adverse Event|1
889216|NCT01235234|2932096|P2|Overall Study|Adverse Event|2
889217|NCT01235234|2932097|P1|Overall Study|Adverse Event|2
889218|NCT01234883|2932145|P2|Overall Study|Inclusion/exclusion failure|0
889219|NCT01234883|2932146|P1|Overall Study|Inclusion/exclusion failure|1
889220|NCT01234883|2932145|P2|Overall Study|Technical difficulties with IV infusion|1
889221|NCT01234883|2932146|P1|Overall Study|Technical difficulties with IV infusion|0
889222|NCT01234883|2932145|P2|Overall Study|Parent/guardian withdrew consent|2
889223|NCT01234883|2932146|P1|Overall Study|Parent/guardian withdrew consent|1
889224|NCT01234883|2932145|P2|Overall Study|Early treatment release|10
889225|NCT01234883|2932146|P1|Overall Study|Early treatment release|8
889226|NCT01234675|2932193|P2|First Intervention (6 Weeks)|Withdrawal by Subject|0
889227|NCT01234675|2932194|P1|First Intervention (6 Weeks)|Withdrawal by Subject|1
889228|NCT01234675|2932193|P2|First Intervention (6 Weeks)|Adverse Event|1
889229|NCT01234675|2932194|P1|First Intervention (6 Weeks)|Adverse Event|0
889230|NCT01234467|2932208|P1|Overall Study|Other complicating disease (stroke)|1
889231|NCT01234467|2932208|P1|Overall Study|Physician Decision|1
889232|NCT01234467|2932208|P1|Overall Study|Clinical deterioration|1
889233|NCT01234467|2932208|P1|Overall Study|Disease Progression|2
889234|NCT01234467|2932208|P1|Overall Study|Withdrawal by Subject|2
889235|NCT01234467|2932208|P1|Overall Study|Death|2
889236|NCT01234467|2932208|P1|Overall Study|Adverse Event|3
889237|NCT01234337|2932219|P2|Overall Study|Switch to commercial drug|1
889238|NCT01234337|2932220|P1|Overall Study|Switch to commercial drug|0
889239|NCT01234337|2932219|P2|Overall Study|Death|1
889240|NCT01234337|2932220|P1|Overall Study|Death|0
889241|NCT01234337|2932219|P2|Overall Study|Withdrawal by Subject|9
889242|NCT01234337|2932220|P1|Overall Study|Withdrawal by Subject|11
889243|NCT01234337|2932219|P2|Overall Study|Protocol Violation|3
889244|NCT01234337|2932220|P1|Overall Study|Protocol Violation|2
889245|NCT01234337|2932219|P2|Overall Study|Lost to Follow-up|1
889246|NCT01234337|2932220|P1|Overall Study|Lost to Follow-up|0
889247|NCT01234337|2932219|P2|Overall Study|Randomized but not treated|4
889248|NCT01234337|2932220|P1|Overall Study|Randomized but not treated|6
889249|NCT01234337|2932219|P2|Overall Study|Non-compliant with study medication|2
889250|NCT01234337|2932220|P1|Overall Study|Non-compliant with study medication|3
889251|NCT01234337|2932219|P2|Overall Study|Investi. decision not protocol driven|6
889252|NCT01234337|2932220|P1|Overall Study|Investi. decision not protocol driven|5
889253|NCT01234337|2932219|P2|Overall Study|Disease progression/recurrence/relapse|223
889254|NCT01234337|2932220|P1|Overall Study|Disease progression/recurrence/relapse|181
889255|NCT01234337|2932219|P2|Overall Study|Adverse Event|21
889256|NCT01234337|2932220|P1|Overall Study|Adverse Event|58
889257|NCT01233999|2932280|P1|Overall Study|Lost to Follow-up|1
889258|NCT01233999|2932280|P1|Overall Study|Withdrawal by Subject|1
889259|NCT01233869|2932299|P4|Extended Treatment Period (46 Months)|Adverse Event|1
889260|NCT01233869|2932300|P3|Extended Treatment Period (46 Months)|Adverse Event|0
889261|NCT01233869|2932301|P2|Extended Treatment Period (46 Months)|Adverse Event|0
889262|NCT01233869|2932302|P1|Extended Treatment Period (46 Months)|Adverse Event|1
889263|NCT01233869|2932299|P4|Extended Treatment Period (46 Months)|Other|3
889264|NCT01233869|2932300|P3|Extended Treatment Period (46 Months)|Other|0
889265|NCT01233869|2932301|P2|Extended Treatment Period (46 Months)|Other|0
889266|NCT01233869|2932302|P1|Extended Treatment Period (46 Months)|Other|3
889267|NCT01233869|2932299|P4|Extended Treatment Period (46 Months)|Withdrawal by Subject|11
889268|NCT01233869|2932300|P3|Extended Treatment Period (46 Months)|Withdrawal by Subject|5
889269|NCT01233869|2932301|P2|Extended Treatment Period (46 Months)|Withdrawal by Subject|3
889270|NCT01233869|2932302|P1|Extended Treatment Period (46 Months)|Withdrawal by Subject|10
889271|NCT01233869|2932299|P4|Extended Treatment Period (46 Months)|Lost to Follow-up|1
889272|NCT01233869|2932300|P3|Extended Treatment Period (46 Months)|Lost to Follow-up|0
889273|NCT01233869|2932301|P2|Extended Treatment Period (46 Months)|Lost to Follow-up|0
889274|NCT01233869|2932302|P1|Extended Treatment Period (46 Months)|Lost to Follow-up|0
889275|NCT01233869|2932299|P4|Initial Treatment Period (24 Months)|Not Related to Study Drug|19
889442|NCT01232452|2932909|P2|Overall Study|Protocol Violation|1
889276|NCT01233869|2932300|P3|Initial Treatment Period (24 Months)|Not Related to Study Drug|2
889277|NCT01233869|2932301|P2|Initial Treatment Period (24 Months)|Not Related to Study Drug|11
889278|NCT01233869|2932302|P1|Initial Treatment Period (24 Months)|Not Related to Study Drug|14
889279|NCT01233869|2932299|P4|Initial Treatment Period (24 Months)|Adverse Event|3
889280|NCT01233869|2932300|P3|Initial Treatment Period (24 Months)|Adverse Event|0
889281|NCT01233869|2932301|P2|Initial Treatment Period (24 Months)|Adverse Event|17
889282|NCT01233869|2932302|P1|Initial Treatment Period (24 Months)|Adverse Event|9
889283|NCT01233869|2932299|P4|Initial Treatment Period (24 Months)|Death|0
889284|NCT01233869|2932300|P3|Initial Treatment Period (24 Months)|Death|0
889285|NCT01233869|2932301|P2|Initial Treatment Period (24 Months)|Death|0
889286|NCT01233869|2932302|P1|Initial Treatment Period (24 Months)|Death|1
889287|NCT01233817|2932388|P1|Overall Study|Withdrawal by Subject|2
889288|NCT01233817|2932388|P1|Overall Study|Lost to Follow-up|1
889289|NCT01233687|2932435|P1|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1
889290|NCT01233687|2932435|P1|Phase II AMG 102 + Erlotinib|Physician Decision|2
889291|NCT01233687|2932435|P1|Phase II AMG 102 + Erlotinib|Death|1
889292|NCT01233609|2932445|P2|Overall Study|Withdrawal by Subject|0
889293|NCT01233609|2932446|P1|Overall Study|Withdrawal by Subject|3
889294|NCT01233609|2932445|P2|Overall Study|Adverse Event|1
889295|NCT01233609|2932446|P1|Overall Study|Adverse Event|2
889296|NCT01233609|2932445|P2|Overall Study|Lost to Follow-up|1
889297|NCT01233609|2932446|P1|Overall Study|Lost to Follow-up|3
889298|NCT01233609|2932445|P2|Overall Study|Death|0
889299|NCT01233609|2932446|P1|Overall Study|Death|1
889300|NCT01233284|2932470|P5|Period 4 (4 Weeks)|Lost to Follow-up|0
889301|NCT01233284|2932471|P4|Period 4 (4 Weeks)|Lost to Follow-up|1
889302|NCT01233284|2932472|P3|Period 4 (4 Weeks)|Lost to Follow-up|0
889303|NCT01233284|2932473|P2|Period 4 (4 Weeks)|Lost to Follow-up|0
889304|NCT01233284|2932474|P1|Period 4 (4 Weeks)|Lost to Follow-up|0
889305|NCT01233284|2932470|P5|Period 4 (4 Weeks)|Adverse Event|0
889306|NCT01233284|2932471|P4|Period 4 (4 Weeks)|Adverse Event|0
889307|NCT01233284|2932472|P3|Period 4 (4 Weeks)|Adverse Event|0
889308|NCT01233284|2932473|P2|Period 4 (4 Weeks)|Adverse Event|1
889309|NCT01233284|2932474|P1|Period 4 (4 Weeks)|Adverse Event|0
889310|NCT01233284|2932470|P5|Period 3 (4 Weeks)|Other|0
889311|NCT01233284|2932471|P4|Period 3 (4 Weeks)|Other|1
889312|NCT01233284|2932472|P3|Period 3 (4 Weeks)|Other|0
889313|NCT01233284|2932473|P2|Period 3 (4 Weeks)|Other|0
889314|NCT01233284|2932474|P1|Period 3 (4 Weeks)|Other|0
889315|NCT01233284|2932470|P5|Period 3 (4 Weeks)|Withdrawal by Subject|0
889316|NCT01233284|2932471|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
889317|NCT01233284|2932472|P3|Period 3 (4 Weeks)|Withdrawal by Subject|1
889318|NCT01233284|2932473|P2|Period 3 (4 Weeks)|Withdrawal by Subject|0
889319|NCT01233284|2932474|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
889320|NCT01233284|2932470|P5|Period 2 (4 Weeks)|Withdrawal by Subject|0
889321|NCT01233284|2932471|P4|Period 2 (4 Weeks)|Withdrawal by Subject|0
889322|NCT01233284|2932472|P3|Period 2 (4 Weeks)|Withdrawal by Subject|1
889323|NCT01233284|2932473|P2|Period 2 (4 Weeks)|Withdrawal by Subject|0
889324|NCT01233284|2932474|P1|Period 2 (4 Weeks)|Withdrawal by Subject|0
889325|NCT01233284|2932470|P5|Period 1 (4 Weeks)|Other|0
889326|NCT01233284|2932471|P4|Period 1 (4 Weeks)|Other|0
889327|NCT01233284|2932472|P3|Period 1 (4 Weeks)|Other|1
889328|NCT01233284|2932473|P2|Period 1 (4 Weeks)|Other|0
889329|NCT01233284|2932474|P1|Period 1 (4 Weeks)|Other|0
889330|NCT01233284|2932470|P5|Period 1 (4 Weeks)|Withdrawal by Subject|0
889331|NCT01233284|2932471|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
889332|NCT01233284|2932472|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
889333|NCT01233284|2932473|P2|Period 1 (4 Weeks)|Withdrawal by Subject|1
889334|NCT01233284|2932474|P1|Period 1 (4 Weeks)|Withdrawal by Subject|0
889335|NCT01233284|2932470|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
889336|NCT01233284|2932471|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
889337|NCT01233284|2932472|P3|Period 1 (4 Weeks)|Lost to Follow-up|0
889338|NCT01233284|2932473|P2|Period 1 (4 Weeks)|Lost to Follow-up|0
889339|NCT01233284|2932474|P1|Period 1 (4 Weeks)|Lost to Follow-up|1
889340|NCT01233258|2932555|P6|First Intervention (6 Months)|Non-compliance with study medication|0
889341|NCT01233258|2932556|P5|First Intervention (6 Months)|Non-compliance with study medication|0
889342|NCT01233258|2932557|P4|First Intervention (6 Months)|Non-compliance with study medication|0
889343|NCT01233258|2932558|P3|First Intervention (6 Months)|Non-compliance with study medication|0
889344|NCT01233258|2932559|P2|First Intervention (6 Months)|Non-compliance with study medication|0
889345|NCT01233258|2932560|P1|First Intervention (6 Months)|Non-compliance with study medication|1
889346|NCT01233258|2932555|P6|First Intervention (6 Months)|Protocol Violation|0
889347|NCT01233258|2932556|P5|First Intervention (6 Months)|Protocol Violation|0
889348|NCT01233258|2932557|P4|First Intervention (6 Months)|Protocol Violation|0
889349|NCT01233258|2932558|P3|First Intervention (6 Months)|Protocol Violation|1
889350|NCT01233258|2932559|P2|First Intervention (6 Months)|Protocol Violation|0
889351|NCT01233258|2932560|P1|First Intervention (6 Months)|Protocol Violation|0
889352|NCT01233258|2932555|P6|First Intervention (6 Months)|Withdrawal by Subject|1
889353|NCT01233258|2932556|P5|First Intervention (6 Months)|Withdrawal by Subject|0
889354|NCT01233258|2932557|P4|First Intervention (6 Months)|Withdrawal by Subject|1
889355|NCT01233258|2932558|P3|First Intervention (6 Months)|Withdrawal by Subject|0
889356|NCT01233258|2932559|P2|First Intervention (6 Months)|Withdrawal by Subject|0
889357|NCT01233258|2932560|P1|First Intervention (6 Months)|Withdrawal by Subject|0
889358|NCT01233232|2932580|P3|Overall Study|Voluntary Discontinuation by Subject|0
889359|NCT01233232|2932581|P2|Overall Study|Voluntary Discontinuation by Subject|0
889360|NCT01233232|2932582|P1|Overall Study|Voluntary Discontinuation by Subject|1
889361|NCT01233076|2932635|P2|Period 2, One Week|Lost to Follow-up|0
889362|NCT01233076|2932636|P1|Period 2, One Week|Lost to Follow-up|1
889363|NCT01233050|2932644|P2|Overall Study|protocol deviation (inclusion/exclusion)|6
889364|NCT01233050|2932645|P1|Overall Study|protocol deviation (inclusion/exclusion)|8
889365|NCT01232894|2932678|P2|Overall Study|Physician Decision|1
889366|NCT01232894|2932679|P1|Overall Study|Physician Decision|2
889367|NCT01232894|2932678|P2|Overall Study|Withdrawal by Subject|5
889368|NCT01232894|2932679|P1|Overall Study|Withdrawal by Subject|8
889369|NCT01232894|2932678|P2|Overall Study|Protocol Violation|1
889370|NCT01232894|2932679|P1|Overall Study|Protocol Violation|1
889371|NCT01232894|2932678|P2|Overall Study|Death|0
889372|NCT01232894|2932679|P1|Overall Study|Death|1
889373|NCT01232894|2932678|P2|Overall Study|Lost to Follow-up|1
889374|NCT01232894|2932679|P1|Overall Study|Lost to Follow-up|0
889375|NCT01232868|2932687|P2|Overall Study|Lost to Follow-up|4
889376|NCT01232868|2932688|P1|Overall Study|Lost to Follow-up|2
889377|NCT01232790|2932702|P2|Second Crossover|Withdrawal by Subject|2
889378|NCT01232790|2932703|P1|Second Crossover|Withdrawal by Subject|1
889379|NCT01232790|2932702|P2|First Crossover|Withdrawal by Subject|0
889380|NCT01232790|2932703|P1|First Crossover|Withdrawal by Subject|1
889381|NCT01232790|2932702|P2|Initial Assessment|Withdrawal by Subject|1
889382|NCT01232790|2932703|P1|Initial Assessment|Withdrawal by Subject|0
889383|NCT01232790|2932702|P2|Randomization|Physician Decision|1
889384|NCT01232790|2932703|P1|Randomization|Physician Decision|0
889385|NCT01232790|2932702|P2|Randomization|Protocol Violation|1
889386|NCT01232790|2932703|P1|Randomization|Protocol Violation|0
889387|NCT01232790|2932702|P2|Randomization|Withdrawal by Subject|0
889388|NCT01232790|2932703|P1|Randomization|Withdrawal by Subject|2
889389|NCT01232738|2932757|P1|Overall Study|Adverse Event|5
889390|NCT01232738|2932757|P1|Overall Study|Withdrawal by Subject|2
889391|NCT01232738|2932757|P1|Overall Study|Lost to Follow-up|1
889392|NCT01232738|2932757|P1|Overall Study|Physician Decision|2
889393|NCT01232738|2932757|P1|Overall Study|Death|3
889394|NCT01232569|2932773|P4|Double-blind Treatment Period|Death|0
889395|NCT01232569|2932774|P3|Double-blind Treatment Period|Death|0
889396|NCT01232569|2932775|P2|Double-blind Treatment Period|Death|0
889397|NCT01232569|2932776|P1|Double-blind Treatment Period|Death|2
889398|NCT01232569|2932773|P4|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
889399|NCT01232569|2932774|P3|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
889400|NCT01232569|2932775|P2|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3
889401|NCT01232569|2932776|P1|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9
889402|NCT01232569|2932773|P4|Double-blind Treatment Period|Physician Decision|0
889403|NCT01232569|2932774|P3|Double-blind Treatment Period|Physician Decision|0
889404|NCT01232569|2932775|P2|Double-blind Treatment Period|Physician Decision|0
889405|NCT01232569|2932776|P1|Double-blind Treatment Period|Physician Decision|1
889406|NCT01232569|2932773|P4|Double-blind Treatment Period|Lack of Efficacy|0
889407|NCT01232569|2932774|P3|Double-blind Treatment Period|Lack of Efficacy|0
889408|NCT01232569|2932775|P2|Double-blind Treatment Period|Lack of Efficacy|2
889409|NCT01232569|2932776|P1|Double-blind Treatment Period|Lack of Efficacy|1
889410|NCT01232569|2932773|P4|Double-blind Treatment Period|Lost to Follow-up|0
889411|NCT01232569|2932774|P3|Double-blind Treatment Period|Lost to Follow-up|0
889412|NCT01232569|2932775|P2|Double-blind Treatment Period|Lost to Follow-up|0
889413|NCT01232569|2932776|P1|Double-blind Treatment Period|Lost to Follow-up|4
889414|NCT01232569|2932773|P4|Double-blind Treatment Period|Escape|0
889415|NCT01232569|2932774|P3|Double-blind Treatment Period|Escape|0
889416|NCT01232569|2932775|P2|Double-blind Treatment Period|Escape|2
889417|NCT01232569|2932776|P1|Double-blind Treatment Period|Escape|2
889418|NCT01232569|2932773|P4|Double-blind Treatment Period|Withdrawal by Subject|0
889419|NCT01232569|2932774|P3|Double-blind Treatment Period|Withdrawal by Subject|0
889420|NCT01232569|2932775|P2|Double-blind Treatment Period|Withdrawal by Subject|2
889421|NCT01232569|2932776|P1|Double-blind Treatment Period|Withdrawal by Subject|9
889422|NCT01232556|2932819|P2|Overall Study|Other|4
889423|NCT01232556|2932820|P1|Overall Study|Other|6
889424|NCT01232556|2932819|P2|Overall Study|Terminated by Sponsor|51
889425|NCT01232556|2932820|P1|Overall Study|Terminated by Sponsor|35
889426|NCT01232556|2932819|P2|Overall Study|Lost to Follow-up|2
889427|NCT01232556|2932820|P1|Overall Study|Lost to Follow-up|0
889428|NCT01232556|2932819|P2|Overall Study|Death|97
889429|NCT01232556|2932820|P1|Overall Study|Death|97
889430|NCT01232556|2932819|P2|Overall Study|Withdrawal by Subject|17
889431|NCT01232556|2932820|P1|Overall Study|Withdrawal by Subject|21
889432|NCT01232491|2932879|P2|Overall Study|Other|18
889433|NCT01232491|2932880|P1|Overall Study|Other|21
889434|NCT01232491|2932879|P2|Overall Study|Withdrawal Criteria|21
889435|NCT01232491|2932880|P1|Overall Study|Withdrawal Criteria|12
889436|NCT01232491|2932879|P2|Overall Study|Protocol Violation|11
889437|NCT01232491|2932880|P1|Overall Study|Protocol Violation|13
889438|NCT01232491|2932879|P2|Overall Study|Lack of Efficacy|5
889439|NCT01232491|2932880|P1|Overall Study|Lack of Efficacy|1
889440|NCT01232491|2932879|P2|Overall Study|Adverse Event|8
889441|NCT01232491|2932880|P1|Overall Study|Adverse Event|13
889443|NCT01232452|2932910|P1|Overall Study|Protocol Violation|0
889444|NCT01232452|2932909|P2|Overall Study|Sponsor Decision|1
889445|NCT01232452|2932910|P1|Overall Study|Sponsor Decision|3
889446|NCT01232452|2932909|P2|Overall Study|Protocol entry criterion not met|2
889447|NCT01232452|2932910|P1|Overall Study|Protocol entry criterion not met|0
889448|NCT01232452|2932909|P2|Overall Study|Physician Decision|12
889449|NCT01232452|2932910|P1|Overall Study|Physician Decision|8
889450|NCT01232452|2932909|P2|Overall Study|Withdrawal by Subject|8
889451|NCT01232452|2932910|P1|Overall Study|Withdrawal by Subject|11
889452|NCT01232452|2932909|P2|Overall Study|Adverse Event|15
889453|NCT01232452|2932910|P1|Overall Study|Adverse Event|17
889454|NCT01232296|2932936|P2|Overall Study|Death|6
889455|NCT01232296|2932937|P1|Overall Study|Death|1
889456|NCT01232296|2932936|P2|Overall Study|Subject/guardian decision|2
889457|NCT01232296|2932937|P1|Overall Study|Subject/guardian decision|10
889458|NCT01232296|2932936|P2|Overall Study|Technical problems|0
889459|NCT01232296|2932937|P1|Overall Study|Technical problems|3
889460|NCT01232296|2932936|P2|Overall Study|Study terminated by sponsor|1
889461|NCT01232296|2932937|P1|Overall Study|Study terminated by sponsor|0
889462|NCT01232296|2932936|P2|Overall Study|Progressive disease|61
889463|NCT01232296|2932937|P1|Overall Study|Progressive disease|43
889464|NCT01232296|2932936|P2|Overall Study|Physician Decision|1
889465|NCT01232296|2932937|P1|Overall Study|Physician Decision|1
889466|NCT01232296|2932936|P2|Overall Study|Adverse Event|12
889467|NCT01232296|2932937|P1|Overall Study|Adverse Event|24
889468|NCT01232283|2932954|P10|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3
889469|NCT01232283|2932955|P9|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7
889470|NCT01232283|2932956|P8|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
889471|NCT01232283|2932957|P7|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
889472|NCT01232283|2932958|P6|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
889473|NCT01232283|2932959|P5|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
889474|NCT01232283|2932960|P4|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
889475|NCT01232283|2932961|P3|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
889476|NCT01232283|2932962|P2|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
889477|NCT01232283|2932963|P1|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
889478|NCT01232283|2932954|P10|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
889479|NCT01232283|2932955|P9|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1
889480|NCT01232283|2932956|P8|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
889481|NCT01232283|2932957|P7|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
889482|NCT01232283|2932958|P6|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
889483|NCT01232283|2932959|P5|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
889484|NCT01232283|2932960|P4|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
889485|NCT01232283|2932961|P3|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
889486|NCT01232283|2932962|P2|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
889487|NCT01232283|2932963|P1|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
889488|NCT01232283|2932954|P10|Long-Term Extension Phase (Weeks 52-260)|Death|0
889489|NCT01232283|2932955|P9|Long-Term Extension Phase (Weeks 52-260)|Death|1
889490|NCT01232283|2932956|P8|Long-Term Extension Phase (Weeks 52-260)|Death|0
889491|NCT01232283|2932957|P7|Long-Term Extension Phase (Weeks 52-260)|Death|0
889492|NCT01232283|2932958|P6|Long-Term Extension Phase (Weeks 52-260)|Death|0
889493|NCT01232283|2932959|P5|Long-Term Extension Phase (Weeks 52-260)|Death|0
889494|NCT01232283|2932960|P4|Long-Term Extension Phase (Weeks 52-260)|Death|0
889495|NCT01232283|2932961|P3|Long-Term Extension Phase (Weeks 52-260)|Death|0
889496|NCT01232283|2932962|P2|Long-Term Extension Phase (Weeks 52-260)|Death|0
889497|NCT01232283|2932963|P1|Long-Term Extension Phase (Weeks 52-260)|Death|0
889498|NCT01232283|2932954|P10|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6
889499|NCT01232283|2932955|P9|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9
889500|NCT01232283|2932956|P8|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
889501|NCT01232283|2932957|P7|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
889502|NCT01232283|2932958|P6|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
889503|NCT01232283|2932959|P5|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
889504|NCT01232283|2932960|P4|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
889505|NCT01232283|2932961|P3|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
889506|NCT01232283|2932962|P2|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
889507|NCT01232283|2932963|P1|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
889508|NCT01232283|2932954|P10|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14
889509|NCT01232283|2932955|P9|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30
889510|NCT01232283|2932956|P8|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
889511|NCT01232283|2932957|P7|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
889512|NCT01232283|2932958|P6|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
889513|NCT01232283|2932959|P5|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
889514|NCT01232283|2932960|P4|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
889515|NCT01232283|2932961|P3|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
889516|NCT01232283|2932962|P2|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
889517|NCT01232283|2932963|P1|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
889518|NCT01232283|2932954|P10|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2
889519|NCT01232283|2932955|P9|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3
889520|NCT01232283|2932956|P8|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
889521|NCT01232283|2932957|P7|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
889522|NCT01232283|2932958|P6|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
889523|NCT01232283|2932959|P5|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
889524|NCT01232283|2932960|P4|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
889525|NCT01232283|2932961|P3|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
889526|NCT01232283|2932962|P2|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
889527|NCT01232283|2932963|P1|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
889528|NCT01232283|2932954|P10|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30
889529|NCT01232283|2932955|P9|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46
889530|NCT01232283|2932956|P8|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
889531|NCT01232283|2932957|P7|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
889532|NCT01232283|2932958|P6|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
889533|NCT01232283|2932959|P5|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
889534|NCT01232283|2932960|P4|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
889535|NCT01232283|2932961|P3|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
889536|NCT01232283|2932962|P2|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
889537|NCT01232283|2932963|P1|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
889538|NCT01232283|2932954|P10|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6
889539|NCT01232283|2932955|P9|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11
889540|NCT01232283|2932956|P8|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
889541|NCT01232283|2932957|P7|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
889542|NCT01232283|2932958|P6|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
889543|NCT01232283|2932959|P5|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
889544|NCT01232283|2932960|P4|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
889545|NCT01232283|2932961|P3|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
889546|NCT01232283|2932962|P2|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
889547|NCT01232283|2932963|P1|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
889548|NCT01232283|2932954|P10|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
889549|NCT01232283|2932955|P9|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
889550|NCT01232283|2932956|P8|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
889551|NCT01232283|2932957|P7|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
889552|NCT01232283|2932958|P6|Randomized Withdrawal Phase(Weeks 32-52)|Other|1
889553|NCT01232283|2932959|P5|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
889554|NCT01232283|2932960|P4|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
889555|NCT01232283|2932961|P3|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
889556|NCT01232283|2932962|P2|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
889557|NCT01232283|2932963|P1|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
889558|NCT01232283|2932954|P10|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
889559|NCT01232283|2932955|P9|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
889560|NCT01232283|2932956|P8|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1
889561|NCT01232283|2932957|P7|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
889562|NCT01232283|2932958|P6|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
889563|NCT01232283|2932959|P5|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
889564|NCT01232283|2932960|P4|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
889565|NCT01232283|2932961|P3|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
889566|NCT01232283|2932962|P2|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
889567|NCT01232283|2932963|P1|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
889568|NCT01232283|2932954|P10|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
889569|NCT01232283|2932955|P9|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
889570|NCT01232283|2932956|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
889571|NCT01232283|2932957|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
889572|NCT01232283|2932958|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
889573|NCT01232283|2932959|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2
889574|NCT01232283|2932960|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
889575|NCT01232283|2932961|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
889576|NCT01232283|2932962|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
889577|NCT01232283|2932963|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
889578|NCT01232283|2932954|P10|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
889579|NCT01232283|2932955|P9|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
889580|NCT01232283|2932956|P8|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
889581|NCT01232283|2932957|P7|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
889582|NCT01232283|2932958|P6|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
889583|NCT01232283|2932959|P5|Randomized Withdrawal Phase(Weeks 32-52)|Death|1
889584|NCT01232283|2932960|P4|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
889585|NCT01232283|2932961|P3|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
889586|NCT01232283|2932962|P2|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
889587|NCT01232283|2932963|P1|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
889588|NCT01232283|2932954|P10|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
889589|NCT01232283|2932955|P9|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
889590|NCT01232283|2932956|P8|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4
889591|NCT01232283|2932957|P7|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
889592|NCT01232283|2932958|P6|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
889593|NCT01232283|2932959|P5|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
889594|NCT01232283|2932960|P4|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
889595|NCT01232283|2932961|P3|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
889596|NCT01232283|2932962|P2|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
889597|NCT01232283|2932963|P1|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
889598|NCT01232283|2932954|P10|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
889599|NCT01232283|2932955|P9|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
889600|NCT01232283|2932956|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5
889601|NCT01232283|2932957|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13
889602|NCT01232283|2932958|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
889603|NCT01232283|2932959|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4
889604|NCT01232283|2932960|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
889605|NCT01232283|2932961|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
889606|NCT01232283|2932962|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
889607|NCT01232283|2932963|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
889608|NCT01232283|2932954|P10|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
889609|NCT01232283|2932955|P9|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
889610|NCT01232283|2932956|P8|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
889611|NCT01232283|2932957|P7|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
889612|NCT01232283|2932958|P6|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
889613|NCT01232283|2932959|P5|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2
889614|NCT01232283|2932960|P4|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
889615|NCT01232283|2932961|P3|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
889616|NCT01232283|2932962|P2|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
889617|NCT01232283|2932963|P1|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
889618|NCT01232283|2932954|P10|Maintenance Phase (Weeks16-32)|Other|0
889619|NCT01232283|2932955|P9|Maintenance Phase (Weeks16-32)|Other|0
889620|NCT01232283|2932956|P8|Maintenance Phase (Weeks16-32)|Other|0
889621|NCT01232283|2932957|P7|Maintenance Phase (Weeks16-32)|Other|0
889622|NCT01232283|2932958|P6|Maintenance Phase (Weeks16-32)|Other|0
889623|NCT01232283|2932959|P5|Maintenance Phase (Weeks16-32)|Other|0
889624|NCT01232283|2932960|P4|Maintenance Phase (Weeks16-32)|Other|0
889625|NCT01232283|2932961|P3|Maintenance Phase (Weeks16-32)|Other|2
889626|NCT01232283|2932962|P2|Maintenance Phase (Weeks16-32)|Other|0
889627|NCT01232283|2932963|P1|Maintenance Phase (Weeks16-32)|Other|0
889628|NCT01232283|2932954|P10|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
889629|NCT01232283|2932955|P9|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
889630|NCT01232283|2932956|P8|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
889631|NCT01232283|2932957|P7|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
889632|NCT01232283|2932958|P6|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
889633|NCT01232283|2932959|P5|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
889634|NCT01232283|2932960|P4|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2
889635|NCT01232283|2932961|P3|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3
889636|NCT01232283|2932962|P2|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
889637|NCT01232283|2932963|P1|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
889638|NCT01232283|2932954|P10|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
889639|NCT01232283|2932955|P9|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
889640|NCT01232283|2932956|P8|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
889641|NCT01232283|2932957|P7|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
889642|NCT01232283|2932958|P6|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
889643|NCT01232283|2932959|P5|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
889644|NCT01232283|2932960|P4|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1
889645|NCT01232283|2932961|P3|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7
889646|NCT01232283|2932962|P2|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
889647|NCT01232283|2932963|P1|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
889648|NCT01232283|2932954|P10|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
889649|NCT01232283|2932955|P9|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
889650|NCT01232283|2932956|P8|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
889651|NCT01232283|2932957|P7|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
889652|NCT01232283|2932958|P6|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
889653|NCT01232283|2932959|P5|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
889654|NCT01232283|2932960|P4|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
889655|NCT01232283|2932961|P3|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1
889656|NCT01232283|2932962|P2|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
889657|NCT01232283|2932963|P1|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
889658|NCT01232283|2932954|P10|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
889659|NCT01232283|2932955|P9|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
889660|NCT01232283|2932956|P8|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
889661|NCT01232283|2932957|P7|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
889662|NCT01232283|2932958|P6|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
889663|NCT01232283|2932959|P5|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
889664|NCT01232283|2932960|P4|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3
889665|NCT01232283|2932961|P3|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19
889666|NCT01232283|2932962|P2|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
889667|NCT01232283|2932963|P1|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
889668|NCT01232283|2932954|P10|Maintenance Phase (Weeks16-32)|Adverse Event|0
889669|NCT01232283|2932955|P9|Maintenance Phase (Weeks16-32)|Adverse Event|0
889670|NCT01232283|2932956|P8|Maintenance Phase (Weeks16-32)|Adverse Event|0
889671|NCT01232283|2932957|P7|Maintenance Phase (Weeks16-32)|Adverse Event|0
889672|NCT01232283|2932958|P6|Maintenance Phase (Weeks16-32)|Adverse Event|0
889673|NCT01232283|2932959|P5|Maintenance Phase (Weeks16-32)|Adverse Event|0
889674|NCT01232283|2932960|P4|Maintenance Phase (Weeks16-32)|Adverse Event|2
889675|NCT01232283|2932961|P3|Maintenance Phase (Weeks16-32)|Adverse Event|8
889676|NCT01232283|2932962|P2|Maintenance Phase (Weeks16-32)|Adverse Event|0
889677|NCT01232283|2932963|P1|Maintenance Phase (Weeks16-32)|Adverse Event|0
889678|NCT01232283|2932954|P10|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
889679|NCT01232283|2932955|P9|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
889680|NCT01232283|2932956|P8|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
889681|NCT01232283|2932957|P7|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
889682|NCT01232283|2932958|P6|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
889683|NCT01232283|2932959|P5|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
889684|NCT01232283|2932960|P4|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
889685|NCT01232283|2932961|P3|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
889686|NCT01232283|2932962|P2|Placebo Controlled Phase (Weeks 0-16)|Not specified|1
889687|NCT01232283|2932963|P1|Placebo Controlled Phase (Weeks 0-16)|Not specified|2
889688|NCT01232283|2932954|P10|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
889689|NCT01232283|2932955|P9|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
889690|NCT01232283|2932956|P8|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
889691|NCT01232283|2932957|P7|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
889692|NCT01232283|2932958|P6|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
889693|NCT01232283|2932959|P5|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
889694|NCT01232283|2932960|P4|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
889695|NCT01232283|2932961|P3|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
889696|NCT01232283|2932962|P2|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2
889697|NCT01232283|2932963|P1|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3
889698|NCT01232283|2932954|P10|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
889699|NCT01232283|2932955|P9|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
889700|NCT01232283|2932956|P8|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
889701|NCT01232283|2932957|P7|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
889702|NCT01232283|2932958|P6|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
889703|NCT01232283|2932959|P5|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
889704|NCT01232283|2932960|P4|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
889705|NCT01232283|2932961|P3|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
889706|NCT01232283|2932962|P2|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
889707|NCT01232283|2932963|P1|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
889708|NCT01232283|2932954|P10|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
889709|NCT01232283|2932955|P9|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
889710|NCT01232283|2932956|P8|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
889711|NCT01232283|2932957|P7|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
889712|NCT01232283|2932958|P6|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
889713|NCT01232283|2932959|P5|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
889714|NCT01232283|2932960|P4|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
889715|NCT01232283|2932961|P3|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
889716|NCT01232283|2932962|P2|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7
889717|NCT01232283|2932963|P1|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9
889718|NCT01232283|2932954|P10|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
889719|NCT01232283|2932955|P9|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
889720|NCT01232283|2932956|P8|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
889721|NCT01232283|2932957|P7|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
889722|NCT01232283|2932958|P6|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
889723|NCT01232283|2932959|P5|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
889724|NCT01232283|2932960|P4|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
889725|NCT01232283|2932961|P3|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
889726|NCT01232283|2932962|P2|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
889727|NCT01232283|2932963|P1|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1
889728|NCT01232283|2932954|P10|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
889729|NCT01232283|2932955|P9|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
889730|NCT01232283|2932956|P8|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
889731|NCT01232283|2932957|P7|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
889732|NCT01232283|2932958|P6|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
889733|NCT01232283|2932959|P5|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
889734|NCT01232283|2932960|P4|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
889735|NCT01232283|2932961|P3|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
889736|NCT01232283|2932962|P2|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2
889737|NCT01232283|2932963|P1|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3
889738|NCT01232283|2932954|P10|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
889739|NCT01232283|2932955|P9|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
889740|NCT01232283|2932956|P8|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
889741|NCT01232283|2932957|P7|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
889742|NCT01232283|2932958|P6|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
889743|NCT01232283|2932959|P5|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
889744|NCT01232283|2932960|P4|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
889745|NCT01232283|2932961|P3|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
889746|NCT01232283|2932962|P2|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8
889747|NCT01232283|2932963|P1|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12
889748|NCT01232127|2933004|P3|Period 1: Days 1-10|Discontinued due to dosing error|0
889749|NCT01232127|2933005|P2|Period 1: Days 1-10|Discontinued due to dosing error|0
889750|NCT01232127|2933006|P1|Period 1: Days 1-10|Discontinued due to dosing error|1
889751|NCT01231984|2933030|P4|Study Period 2|Did not continue to meet I/E Criteria|1
889752|NCT01231984|2933031|P3|Study Period 2|Did not continue to meet I/E Criteria|0
889753|NCT01231984|2933032|P2|Study Period 2|Did not continue to meet I/E Criteria|1
889754|NCT01231984|2933033|P1|Study Period 2|Did not continue to meet I/E Criteria|1
889755|NCT01231984|2933030|P4|Study Period 2|Lost to Follow-up|3
889756|NCT01231984|2933031|P3|Study Period 2|Lost to Follow-up|0
889757|NCT01231984|2933032|P2|Study Period 2|Lost to Follow-up|0
889758|NCT01231984|2933033|P1|Study Period 2|Lost to Follow-up|1
889759|NCT01231984|2933030|P4|Study Period 2|Withdrawal by Subject|0
889760|NCT01231984|2933031|P3|Study Period 2|Withdrawal by Subject|0
889761|NCT01231984|2933032|P2|Study Period 2|Withdrawal by Subject|1
889762|NCT01231984|2933033|P1|Study Period 2|Withdrawal by Subject|1
889763|NCT01231984|2933030|P4|Study Period 1|Not Specified|1
889764|NCT01231984|2933031|P3|Study Period 1|Not Specified|0
889765|NCT01231984|2933032|P2|Study Period 1|Not Specified|0
889766|NCT01231984|2933033|P1|Study Period 1|Not Specified|0
889767|NCT01231984|2933030|P4|Study Period 1|Adverse Event|0
889768|NCT01231984|2933031|P3|Study Period 1|Adverse Event|0
889769|NCT01231984|2933032|P2|Study Period 1|Adverse Event|0
889770|NCT01231984|2933033|P1|Study Period 1|Adverse Event|1
889771|NCT01231984|2933030|P4|Study Period 1|Protocol Violation|3
889772|NCT01231984|2933031|P3|Study Period 1|Protocol Violation|2
889773|NCT01231984|2933032|P2|Study Period 1|Protocol Violation|4
889774|NCT01231984|2933033|P1|Study Period 1|Protocol Violation|3
889775|NCT01231984|2933030|P4|Study Period 1|Non-compliance with study requirements|1
889776|NCT01231984|2933031|P3|Study Period 1|Non-compliance with study requirements|2
889777|NCT01231984|2933032|P2|Study Period 1|Non-compliance with study requirements|0
889778|NCT01231984|2933033|P1|Study Period 1|Non-compliance with study requirements|5
889779|NCT01231984|2933030|P4|Study Period 1|Screen Failure|1
889780|NCT01231984|2933031|P3|Study Period 1|Screen Failure|0
889781|NCT01231984|2933032|P2|Study Period 1|Screen Failure|0
889782|NCT01231984|2933033|P1|Study Period 1|Screen Failure|0
889783|NCT01231984|2933030|P4|Study Period 1|Did not continue to meet I/E Criteria|2
889784|NCT01231984|2933031|P3|Study Period 1|Did not continue to meet I/E Criteria|2
889785|NCT01231984|2933032|P2|Study Period 1|Did not continue to meet I/E Criteria|2
889786|NCT01231984|2933033|P1|Study Period 1|Did not continue to meet I/E Criteria|2
889787|NCT01231984|2933030|P4|Study Period 1|Lost to Follow-up|0
889788|NCT01231984|2933031|P3|Study Period 1|Lost to Follow-up|1
889789|NCT01231984|2933032|P2|Study Period 1|Lost to Follow-up|1
889790|NCT01231984|2933033|P1|Study Period 1|Lost to Follow-up|1
889791|NCT01231984|2933030|P4|Study Period 1|Withdrawal by Subject|1
889792|NCT01231984|2933031|P3|Study Period 1|Withdrawal by Subject|0
889793|NCT01231984|2933032|P2|Study Period 1|Withdrawal by Subject|0
889794|NCT01231984|2933033|P1|Study Period 1|Withdrawal by Subject|0
889795|NCT01231620|2933102|P3|Overall Study|Lost to Follow-up|9
889796|NCT01231620|2933103|P2|Overall Study|Lost to Follow-up|4
889797|NCT01231620|2933104|P1|Overall Study|Lost to Follow-up|3
889798|NCT01231620|2933102|P3|Overall Study|Withdrawal by Subject|8
889799|NCT01231620|2933103|P2|Overall Study|Withdrawal by Subject|6
889800|NCT01231620|2933104|P1|Overall Study|Withdrawal by Subject|6
889801|NCT01231620|2933102|P3|Overall Study|Adverse Event|1
889802|NCT01231620|2933103|P2|Overall Study|Adverse Event|2
889803|NCT01231620|2933104|P1|Overall Study|Adverse Event|2
889804|NCT01231620|2933102|P3|Overall Study|Death|11
889805|NCT01231620|2933103|P2|Overall Study|Death|14
889806|NCT01231620|2933104|P1|Overall Study|Death|12
889807|NCT01231620|2933102|P3|Overall Study|Physician Decision|10
889808|NCT01231620|2933103|P2|Overall Study|Physician Decision|5
889809|NCT01231620|2933104|P1|Overall Study|Physician Decision|3
889810|NCT01231607|2933210|P5|Overall Study|Withdrawal by Subject|9
889811|NCT01231607|2933211|P4|Overall Study|Withdrawal by Subject|17
889812|NCT01231607|2933212|P3|Overall Study|Withdrawal by Subject|14
889813|NCT01231607|2933213|P2|Overall Study|Withdrawal by Subject|9
889814|NCT01231607|2933214|P1|Overall Study|Withdrawal by Subject|9
889815|NCT01231607|2933210|P5|Overall Study|Protocol Violation|2
889816|NCT01231607|2933211|P4|Overall Study|Protocol Violation|2
889817|NCT01231607|2933212|P3|Overall Study|Protocol Violation|0
889818|NCT01231607|2933213|P2|Overall Study|Protocol Violation|2
889819|NCT01231607|2933214|P1|Overall Study|Protocol Violation|3
889820|NCT01231607|2933210|P5|Overall Study|Physician Decision|4
889821|NCT01231607|2933211|P4|Overall Study|Physician Decision|5
889822|NCT01231607|2933212|P3|Overall Study|Physician Decision|3
889823|NCT01231607|2933213|P2|Overall Study|Physician Decision|4
889824|NCT01231607|2933214|P1|Overall Study|Physician Decision|4
889825|NCT01231607|2933210|P5|Overall Study|Lost to Follow-up|4
889826|NCT01231607|2933211|P4|Overall Study|Lost to Follow-up|10
889827|NCT01231607|2933212|P3|Overall Study|Lost to Follow-up|10
889828|NCT01231607|2933213|P2|Overall Study|Lost to Follow-up|11
889829|NCT01231607|2933214|P1|Overall Study|Lost to Follow-up|13
889830|NCT01231607|2933210|P5|Overall Study|Adverse Event|5
889831|NCT01231607|2933211|P4|Overall Study|Adverse Event|4
889832|NCT01231607|2933212|P3|Overall Study|Adverse Event|4
889833|NCT01231607|2933213|P2|Overall Study|Adverse Event|8
889834|NCT01231607|2933214|P1|Overall Study|Adverse Event|0
889835|NCT01231581|2933306|P2|Overall Study|Ongoing|0
889836|NCT01231581|2933307|P1|Overall Study|Ongoing|1
889837|NCT01231581|2933306|P2|Overall Study|Death|64
889838|NCT01231581|2933307|P1|Overall Study|Death|65
889839|NCT01231581|2933306|P2|Overall Study|Study Closed/Terminated|5
889840|NCT01231581|2933307|P1|Overall Study|Study Closed/Terminated|6
889841|NCT01231581|2933306|P2|Overall Study|Withdrawal by Subject|9
889842|NCT01231581|2933307|P1|Overall Study|Withdrawal by Subject|6
889843|NCT01231581|2933306|P2|Overall Study|Lost to Follow-up|2
889844|NCT01231581|2933307|P1|Overall Study|Lost to Follow-up|2
889845|NCT01231555|2933328|P3|Overall Study|Withdrawal by Subject|0
889846|NCT01231555|2933329|P2|Overall Study|Withdrawal by Subject|2
889847|NCT01231555|2933330|P1|Overall Study|Withdrawal by Subject|0
889848|NCT01231555|2933328|P3|Overall Study|Study terminated|8
889849|NCT01231555|2933329|P2|Overall Study|Study terminated|5
889850|NCT01231555|2933330|P1|Overall Study|Study terminated|8
889851|NCT01231516|2933361|P2|Open-label Phase|Ongoing at the time of analysis|23
889852|NCT01231516|2933362|P1|Open-label Phase|Ongoing at the time of analysis|282
889853|NCT01231516|2933361|P2|Open-label Phase|Withdrawal by Subject|0
889854|NCT01231516|2933362|P1|Open-label Phase|Withdrawal by Subject|1
889855|NCT01231516|2933361|P2|Open-label Phase|Lost to Follow-up|0
889856|NCT01231516|2933362|P1|Open-label Phase|Lost to Follow-up|3
889857|NCT01231516|2933361|P2|Open-label Phase|Protocol Violation|0
889858|NCT01231516|2933362|P1|Open-label Phase|Protocol Violation|2
889859|NCT01231516|2933361|P2|Open-label Phase|Lack of Efficacy|3
889860|NCT01231516|2933362|P1|Open-label Phase|Lack of Efficacy|7
889861|NCT01231516|2933361|P2|48 Week Double-blind Phase|Site Closed|1
889862|NCT01231516|2933362|P1|48 Week Double-blind Phase|Site Closed|3
889863|NCT01231516|2933361|P2|48 Week Double-blind Phase|Withdrawal by Subject|5
889864|NCT01231516|2933362|P1|48 Week Double-blind Phase|Withdrawal by Subject|11
889865|NCT01231516|2933361|P2|48 Week Double-blind Phase|Physician Decision|1
889866|NCT01231516|2933362|P1|48 Week Double-blind Phase|Physician Decision|1
889867|NCT01231516|2933361|P2|48 Week Double-blind Phase|Lost to Follow-up|10
889868|NCT01231516|2933362|P1|48 Week Double-blind Phase|Lost to Follow-up|5
889869|NCT01231516|2933361|P2|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|3
889870|NCT01231516|2933362|P1|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|5
889871|NCT01231516|2933361|P2|48 Week Double-blind Phase|Protocol Violation|6
889872|NCT01231516|2933362|P1|48 Week Double-blind Phase|Protocol Violation|9
889873|NCT01231516|2933361|P2|48 Week Double-blind Phase|Lack of Efficacy|42
889874|NCT01231516|2933362|P1|48 Week Double-blind Phase|Lack of Efficacy|20
889875|NCT01231516|2933361|P2|48 Week Double-blind Phase|Adverse Event|11
889876|NCT01231516|2933362|P1|48 Week Double-blind Phase|Adverse Event|4
889877|NCT01231503|2933392|P8|Overall Study|Protocol Violation|0
889878|NCT01231503|2933393|P7|Overall Study|Protocol Violation|0
889879|NCT01231503|2933394|P6|Overall Study|Protocol Violation|0
889880|NCT01231503|2933395|P5|Overall Study|Protocol Violation|0
889881|NCT01231503|2933396|P4|Overall Study|Protocol Violation|1
889882|NCT01231503|2933397|P3|Overall Study|Protocol Violation|0
889883|NCT01231503|2933398|P2|Overall Study|Protocol Violation|0
889884|NCT01231503|2933399|P1|Overall Study|Protocol Violation|0
889885|NCT01231503|2933392|P8|Overall Study|Lost to Follow-up|6
889886|NCT01231503|2933393|P7|Overall Study|Lost to Follow-up|6
889887|NCT01231503|2933394|P6|Overall Study|Lost to Follow-up|9
889888|NCT01231503|2933395|P5|Overall Study|Lost to Follow-up|7
889889|NCT01231503|2933396|P4|Overall Study|Lost to Follow-up|5
889890|NCT01231503|2933397|P3|Overall Study|Lost to Follow-up|8
889891|NCT01231503|2933398|P2|Overall Study|Lost to Follow-up|10
889892|NCT01231503|2933399|P1|Overall Study|Lost to Follow-up|8
889893|NCT01231503|2933392|P8|Overall Study|Withdrawal by Subject|2
889894|NCT01231503|2933393|P7|Overall Study|Withdrawal by Subject|1
889895|NCT01231503|2933394|P6|Overall Study|Withdrawal by Subject|5
889896|NCT01231503|2933395|P5|Overall Study|Withdrawal by Subject|3
889897|NCT01231503|2933396|P4|Overall Study|Withdrawal by Subject|1
889898|NCT01231503|2933397|P3|Overall Study|Withdrawal by Subject|3
889899|NCT01231503|2933398|P2|Overall Study|Withdrawal by Subject|3
889900|NCT01231503|2933399|P1|Overall Study|Withdrawal by Subject|6
889901|NCT01231503|2933392|P8|Overall Study|Adverse event, serious fatal|0
889902|NCT01231503|2933393|P7|Overall Study|Adverse event, serious fatal|0
889903|NCT01231503|2933394|P6|Overall Study|Adverse event, serious fatal|1
889904|NCT01231503|2933395|P5|Overall Study|Adverse event, serious fatal|0
889905|NCT01231503|2933396|P4|Overall Study|Adverse event, serious fatal|1
889906|NCT01231503|2933397|P3|Overall Study|Adverse event, serious fatal|1
889907|NCT01231503|2933398|P2|Overall Study|Adverse event, serious fatal|0
889908|NCT01231503|2933399|P1|Overall Study|Adverse event, serious fatal|0
889909|NCT01231503|2933392|P8|Overall Study|Adverse Event|0
889910|NCT01231503|2933393|P7|Overall Study|Adverse Event|0
889911|NCT01231503|2933394|P6|Overall Study|Adverse Event|1
889912|NCT01231503|2933395|P5|Overall Study|Adverse Event|0
889913|NCT01231503|2933396|P4|Overall Study|Adverse Event|0
889914|NCT01231503|2933397|P3|Overall Study|Adverse Event|0
889915|NCT01231503|2933398|P2|Overall Study|Adverse Event|0
889916|NCT01231503|2933399|P1|Overall Study|Adverse Event|0
889917|NCT01231464|2933639|P2|Overall Study|Withdrawal by Subject|2
889918|NCT01231464|2933640|P1|Overall Study|Withdrawal by Subject|3
889919|NCT01231464|2933639|P2|Overall Study|Lost to Follow-up|2
889920|NCT01231464|2933640|P1|Overall Study|Lost to Follow-up|1
889921|NCT01231464|2933639|P2|Overall Study|Protocol Violation|2
889922|NCT01231464|2933640|P1|Overall Study|Protocol Violation|1
889923|NCT01231464|2933639|P2|Overall Study|Adverse Event|1
889924|NCT01231464|2933640|P1|Overall Study|Adverse Event|0
889925|NCT01231373|2933689|P4|Overall Study|Withdrew Consent|0
889926|NCT01231373|2933690|P3|Overall Study|Withdrew Consent|0
889927|NCT01231373|2933691|P2|Overall Study|Withdrew Consent|0
889928|NCT01231373|2933692|P1|Overall Study|Withdrew Consent|1
889929|NCT01231373|2933689|P4|Overall Study|Lost to Follow-up|1
889930|NCT01231373|2933690|P3|Overall Study|Lost to Follow-up|0
889931|NCT01231373|2933691|P2|Overall Study|Lost to Follow-up|0
889932|NCT01231373|2933692|P1|Overall Study|Lost to Follow-up|0
889933|NCT01231373|2933689|P4|Overall Study|Withdrew consent prior to randomization|0
889934|NCT01231373|2933690|P3|Overall Study|Withdrew consent prior to randomization|0
889935|NCT01231373|2933691|P2|Overall Study|Withdrew consent prior to randomization|1
889936|NCT01231373|2933692|P1|Overall Study|Withdrew consent prior to randomization|2
889937|NCT01231321|2933731|P1|Overall Study|Lack of Efficacy|2
889938|NCT01231321|2933731|P1|Overall Study|Adverse Event|3
889939|NCT01230892|2933779|P2|Overall Study|Lost to Follow-up|0
889940|NCT01230892|2933780|P1|Overall Study|Lost to Follow-up|2
889941|NCT01230892|2933779|P2|Overall Study|Withdrawal by Subject|1
889942|NCT01230892|2933780|P1|Overall Study|Withdrawal by Subject|1
889943|NCT01230827|2933790|P4|Overall Study|Study terminated by Sponsor|63
889944|NCT01230827|2933791|P3|Overall Study|Study terminated by Sponsor|56
889945|NCT01230827|2933792|P2|Overall Study|Study terminated by Sponsor|2
889946|NCT01230827|2933793|P1|Overall Study|Study terminated by Sponsor|0
889947|NCT01230827|2933790|P4|Overall Study|Recovery|0
889948|NCT01230827|2933791|P3|Overall Study|Recovery|0
889949|NCT01230827|2933792|P2|Overall Study|Recovery|6
889950|NCT01230827|2933793|P1|Overall Study|Recovery|0
889951|NCT01230827|2933790|P4|Overall Study|Adverse Event|7
889952|NCT01230827|2933791|P3|Overall Study|Adverse Event|3
889953|NCT01230827|2933792|P2|Overall Study|Adverse Event|2
889954|NCT01230827|2933793|P1|Overall Study|Adverse Event|4
889955|NCT01230827|2933790|P4|Overall Study|Lack of Efficacy|3
889956|NCT01230827|2933791|P3|Overall Study|Lack of Efficacy|2
889957|NCT01230827|2933792|P2|Overall Study|Lack of Efficacy|1
889958|NCT01230827|2933793|P1|Overall Study|Lack of Efficacy|14
889959|NCT01230827|2933790|P4|Overall Study|Withdrawal by Subject|2
889960|NCT01230827|2933791|P3|Overall Study|Withdrawal by Subject|3
889961|NCT01230827|2933792|P2|Overall Study|Withdrawal by Subject|0
889962|NCT01230827|2933793|P1|Overall Study|Withdrawal by Subject|1
889963|NCT01230827|2933790|P4|Overall Study|Lost to Follow-up|3
889964|NCT01230827|2933791|P3|Overall Study|Lost to Follow-up|1
889965|NCT01230827|2933792|P2|Overall Study|Lost to Follow-up|0
889966|NCT01230827|2933793|P1|Overall Study|Lost to Follow-up|0
889967|NCT01230814|2933809|P2|Overall Study|Discontinued (not due to adverse event)|1
889968|NCT01230814|2933810|P1|Overall Study|Discontinued (not due to adverse event)|2
889969|NCT01230814|2933809|P2|Overall Study|Lost to Follow-up|3
889970|NCT01230814|2933810|P1|Overall Study|Lost to Follow-up|11
889971|NCT01230788|2933860|P1|Overall Study|Prescribed exclusion drug|1
889972|NCT01230749|2933872|P4|Overall Study|Fasting glucose more than 270 mg/dL|1
889973|NCT01230749|2933873|P3|Overall Study|Fasting glucose more than 270 mg/dL|1
889974|NCT01230749|2933874|P2|Overall Study|Fasting glucose more than 270 mg/dL|1
889975|NCT01230749|2933875|P1|Overall Study|Fasting glucose more than 270 mg/dL|0
889976|NCT01230749|2933872|P4|Overall Study|Withdrawal by Subject|0
889977|NCT01230749|2933873|P3|Overall Study|Withdrawal by Subject|0
889978|NCT01230749|2933874|P2|Overall Study|Withdrawal by Subject|1
889979|NCT01230749|2933875|P1|Overall Study|Withdrawal by Subject|0
889980|NCT01230749|2933872|P4|Overall Study|Physician Decision|0
889981|NCT01230749|2933873|P3|Overall Study|Physician Decision|1
889982|NCT01230749|2933874|P2|Overall Study|Physician Decision|0
889983|NCT01230749|2933875|P1|Overall Study|Physician Decision|0
889984|NCT01230749|2933872|P4|Overall Study|Adverse Event|1
889985|NCT01230749|2933873|P3|Overall Study|Adverse Event|0
889986|NCT01230749|2933874|P2|Overall Study|Adverse Event|0
889987|NCT01230749|2933875|P1|Overall Study|Adverse Event|0
889988|NCT01230710|2933910|P1|Overall Study|Withdrawal of Consent|1
889989|NCT01230710|2933910|P1|Overall Study|Death|4
889990|NCT01230710|2933910|P1|Overall Study|Lost to Follow-up|3
889991|NCT01230710|2933910|P1|Overall Study|Disease Progression|41
889992|NCT01230489|2933950|P1|Overall Study|Treatment modality changed|1
889993|NCT01230489|2933950|P1|Overall Study|Adverse Event|2
889994|NCT01230489|2933950|P1|Overall Study|Death|2
889995|NCT01230307|2933985|P2|Overall Study|LVAD Placement|2
889996|NCT01230307|2933986|P1|Overall Study|LVAD Placement|0
889997|NCT01230060|2934006|P1|Overall Study|Withdrawal by Subject|1
889998|NCT01229735|2934079|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
889999|NCT01229735|2934080|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
890000|NCT01229735|2934079|P2|Overall Study|AE, non-serious non-fatal|17
890001|NCT01229735|2934080|P1|Overall Study|AE, non-serious non-fatal|13
890002|NCT01229735|2934079|P2|Overall Study|SAE, non-fatal|4
890003|NCT01229735|2934080|P1|Overall Study|SAE, non-fatal|0
890004|NCT01229735|2934079|P2|Overall Study|Other Reason|10
890005|NCT01229735|2934080|P1|Overall Study|Other Reason|13
890006|NCT01229735|2934079|P2|Overall Study|Withdrawal by Subject|17
890007|NCT01229735|2934080|P1|Overall Study|Withdrawal by Subject|18
890008|NCT01229735|2934079|P2|Overall Study|Lost to Follow-up|2
890009|NCT01229735|2934080|P1|Overall Study|Lost to Follow-up|0
890010|NCT01229735|2934079|P2|Overall Study|Protocol Violation|8
890011|NCT01229735|2934080|P1|Overall Study|Protocol Violation|13
890012|NCT01229735|2934079|P2|Overall Study|Lack of Efficacy|8
890013|NCT01229735|2934080|P1|Overall Study|Lack of Efficacy|8
890014|NCT01229449|2934133|P5|Overall Study|Physician Decision|0
890015|NCT01229449|2934134|P4|Overall Study|Physician Decision|0
890016|NCT01229449|2934135|P3|Overall Study|Physician Decision|1
890017|NCT01229449|2934136|P2|Overall Study|Physician Decision|0
890018|NCT01229449|2934137|P1|Overall Study|Physician Decision|0
890019|NCT01229449|2934133|P5|Overall Study|Lost to Follow-up|0
890020|NCT01229449|2934134|P4|Overall Study|Lost to Follow-up|0
890021|NCT01229449|2934135|P3|Overall Study|Lost to Follow-up|1
890022|NCT01229449|2934136|P2|Overall Study|Lost to Follow-up|1
890023|NCT01229449|2934137|P1|Overall Study|Lost to Follow-up|1
890024|NCT01229449|2934133|P5|Overall Study|Withdrawal by Subject|1
890025|NCT01229449|2934134|P4|Overall Study|Withdrawal by Subject|1
890026|NCT01229449|2934135|P3|Overall Study|Withdrawal by Subject|0
890027|NCT01229449|2934136|P2|Overall Study|Withdrawal by Subject|3
890028|NCT01229449|2934137|P1|Overall Study|Withdrawal by Subject|0
890029|NCT01229436|2934194|P1|Overall Study|Lost to Follow-up|3
890030|NCT01229436|2934194|P1|Overall Study|Withdrawal by Subject|2
890031|NCT01229397|2934256|P2|Overall Study|Migrated/moved from study area|0
890032|NCT01229397|2934257|P1|Overall Study|Migrated/moved from study area|1
890033|NCT01229397|2934256|P2|Overall Study|Lost to Follow-up|6
890034|NCT01229397|2934257|P1|Overall Study|Lost to Follow-up|7
890035|NCT01229397|2934256|P2|Overall Study|Withdrawal by Subject|3
890036|NCT01229397|2934257|P1|Overall Study|Withdrawal by Subject|3
890037|NCT01229371|2934275|P4|Overall Study|Withdrawal by Subject|0
890038|NCT01229371|2934276|P3|Overall Study|Withdrawal by Subject|0
890039|NCT01229371|2934277|P2|Overall Study|Withdrawal by Subject|1
890040|NCT01229371|2934278|P1|Overall Study|Withdrawal by Subject|0
890041|NCT01229267|2934305|P5|Overall Study|Lost to Follow-up|22
890042|NCT01229267|2934306|P4|Overall Study|Lost to Follow-up|3
890043|NCT01229267|2934307|P3|Overall Study|Lost to Follow-up|8
890044|NCT01229267|2934308|P2|Overall Study|Lost to Follow-up|5
890045|NCT01229267|2934309|P1|Overall Study|Lost to Follow-up|6
890046|NCT01229267|2934305|P5|Overall Study|Physician Decision|25
890047|NCT01229267|2934306|P4|Overall Study|Physician Decision|3
890048|NCT01229267|2934307|P3|Overall Study|Physician Decision|8
890049|NCT01229267|2934308|P2|Overall Study|Physician Decision|11
890050|NCT01229267|2934309|P1|Overall Study|Physician Decision|8
890051|NCT01229267|2934305|P5|Overall Study|Progressive disease|1
890052|NCT01229267|2934306|P4|Overall Study|Progressive disease|0
890053|NCT01229267|2934307|P3|Overall Study|Progressive disease|0
890054|NCT01229267|2934308|P2|Overall Study|Progressive disease|0
890055|NCT01229267|2934309|P1|Overall Study|Progressive disease|0
890056|NCT01229267|2934305|P5|Overall Study|Protocol Violation|0
890057|NCT01229267|2934306|P4|Overall Study|Protocol Violation|0
890058|NCT01229267|2934307|P3|Overall Study|Protocol Violation|0
890059|NCT01229267|2934308|P2|Overall Study|Protocol Violation|1
890060|NCT01229267|2934309|P1|Overall Study|Protocol Violation|0
890061|NCT01229267|2934305|P5|Overall Study|Withdrawal by Subject|59
890062|NCT01229267|2934306|P4|Overall Study|Withdrawal by Subject|14
890063|NCT01229267|2934307|P3|Overall Study|Withdrawal by Subject|32
890064|NCT01229267|2934308|P2|Overall Study|Withdrawal by Subject|22
890065|NCT01229267|2934309|P1|Overall Study|Withdrawal by Subject|23
890066|NCT01229267|2934305|P5|Overall Study|Death|103
890067|NCT01229267|2934306|P4|Overall Study|Death|13
890068|NCT01229267|2934307|P3|Overall Study|Death|35
890069|NCT01229267|2934308|P2|Overall Study|Death|37
890070|NCT01229267|2934309|P1|Overall Study|Death|40
890071|NCT01229267|2934305|P5|Overall Study|Adverse Event|10
890072|NCT01229267|2934306|P4|Overall Study|Adverse Event|2
890073|NCT01229267|2934307|P3|Overall Study|Adverse Event|3
890074|NCT01229267|2934308|P2|Overall Study|Adverse Event|6
890075|NCT01229267|2934309|P1|Overall Study|Adverse Event|4
890076|NCT01229254|2934328|P3|Overall Study|Non-compliance with Study Drug|1
890077|NCT01229254|2934329|P2|Overall Study|Non-compliance with Study Drug|1
890078|NCT01229254|2934330|P1|Overall Study|Non-compliance with Study Drug|0
890079|NCT01229254|2934328|P3|Overall Study|Withdrawal by Subject|1
890080|NCT01229254|2934329|P2|Overall Study|Withdrawal by Subject|0
890081|NCT01229254|2934330|P1|Overall Study|Withdrawal by Subject|1
890082|NCT01229254|2934328|P3|Overall Study|Protocol Violation|5
890083|NCT01229254|2934329|P2|Overall Study|Protocol Violation|6
890084|NCT01229254|2934330|P1|Overall Study|Protocol Violation|4
890085|NCT01229254|2934328|P3|Overall Study|Physician Decision|0
890086|NCT01229254|2934329|P2|Overall Study|Physician Decision|3
890087|NCT01229254|2934330|P1|Overall Study|Physician Decision|0
890088|NCT01229254|2934328|P3|Overall Study|Lost to Follow-up|1
890089|NCT01229254|2934329|P2|Overall Study|Lost to Follow-up|0
890090|NCT01229254|2934330|P1|Overall Study|Lost to Follow-up|3
890091|NCT01229254|2934328|P3|Overall Study|Adverse Event|3
890092|NCT01229254|2934329|P2|Overall Study|Adverse Event|5
890093|NCT01229254|2934330|P1|Overall Study|Adverse Event|4
890094|NCT01229254|2934328|P3|Overall Study|Not Continuing Into Safety Extension|1
890095|NCT01229254|2934329|P2|Overall Study|Not Continuing Into Safety Extension|1
890096|NCT01229254|2934330|P1|Overall Study|Not Continuing Into Safety Extension|3
890097|NCT01229176|2934368|P8|Overall Study|Lost to Follow-up|2
890098|NCT01229176|2934369|P7|Overall Study|Lost to Follow-up|0
890099|NCT01229176|2934370|P6|Overall Study|Lost to Follow-up|1
890100|NCT01229176|2934371|P5|Overall Study|Lost to Follow-up|1
890101|NCT01229176|2934372|P4|Overall Study|Lost to Follow-up|0
890102|NCT01229176|2934373|P3|Overall Study|Lost to Follow-up|0
890103|NCT01229176|2934374|P2|Overall Study|Lost to Follow-up|3
890104|NCT01229176|2934375|P1|Overall Study|Lost to Follow-up|0
890105|NCT01229176|2934368|P8|Overall Study|Withdrawal by Subject|1
890106|NCT01229176|2934369|P7|Overall Study|Withdrawal by Subject|0
890107|NCT01229176|2934370|P6|Overall Study|Withdrawal by Subject|1
890108|NCT01229176|2934371|P5|Overall Study|Withdrawal by Subject|1
890109|NCT01229176|2934372|P4|Overall Study|Withdrawal by Subject|1
890110|NCT01229176|2934373|P3|Overall Study|Withdrawal by Subject|0
890111|NCT01229176|2934374|P2|Overall Study|Withdrawal by Subject|0
890112|NCT01229176|2934375|P1|Overall Study|Withdrawal by Subject|0
890113|NCT01229150|2934429|P4|Overall Study|Toxicity|0
890114|NCT01229150|2934430|P3|Overall Study|Toxicity|0
890115|NCT01229150|2934431|P2|Overall Study|Toxicity|2
890116|NCT01229150|2934432|P1|Overall Study|Toxicity|2
890117|NCT01229111|2934489|P1|Overall Study|Death|1
890118|NCT01228747|2934538|P2|Overall Study|Other Reason|5
890119|NCT01228747|2934539|P1|Overall Study|Other Reason|2
890120|NCT01228747|2934538|P2|Overall Study|Withdrawal by Subject|1
890121|NCT01228747|2934539|P1|Overall Study|Withdrawal by Subject|5
890122|NCT01228747|2934538|P2|Overall Study|Lost to Follow-up|3
890123|NCT01228747|2934539|P1|Overall Study|Lost to Follow-up|4
890124|NCT01228747|2934538|P2|Overall Study|Protocol Violation|5
890125|NCT01228747|2934539|P1|Overall Study|Protocol Violation|6
890126|NCT01228747|2934538|P2|Overall Study|Lack of Efficacy|27
890127|NCT01228747|2934539|P1|Overall Study|Lack of Efficacy|40
890128|NCT01228747|2934538|P2|Overall Study|Adverse Event|4
890129|NCT01228747|2934539|P1|Overall Study|Adverse Event|8
890130|NCT01228734|2934555|P2|Overall Study|Randomized, but not treated|4
890131|NCT01228734|2934556|P1|Overall Study|Randomized, but not treated|0
890132|NCT01228734|2934555|P2|Overall Study|Ongoing at clinical cut-off date|4
890133|NCT01228734|2934556|P1|Overall Study|Ongoing at clinical cut-off date|16
890134|NCT01228591|2934570|P2|Baseline|Lack of Efficacy|2
890135|NCT01228591|2934571|P1|Baseline|Lack of Efficacy|1
890136|NCT01228318|2934600|P2|Overall Study|Incarcerated|0
890137|NCT01228318|2934601|P1|Overall Study|Incarcerated|1
890138|NCT01228318|2934600|P2|Overall Study|Moved|2
890139|NCT01228318|2934601|P1|Overall Study|Moved|0
890140|NCT01228318|2934600|P2|Overall Study|Unable to contact|5
890141|NCT01228318|2934601|P1|Overall Study|Unable to contact|2
890142|NCT01228318|2934600|P2|Overall Study|Clinic no show to receive intervention|0
890143|NCT01228318|2934601|P1|Overall Study|Clinic no show to receive intervention|1
890144|NCT01228175|2934617|P2|Overall Study|Physician Decision|1
890145|NCT01228175|2934618|P1|Overall Study|Physician Decision|1
890146|NCT01228175|2934617|P2|Overall Study|Withdrawal by Subject|2
890147|NCT01228175|2934618|P1|Overall Study|Withdrawal by Subject|1
890148|NCT01228175|2934617|P2|Overall Study|Lost to Follow-up|50
890149|NCT01228175|2934618|P1|Overall Study|Lost to Follow-up|64
890150|NCT01228071|2934660|P1|Overall Study|Withdrawal by Subject|1
890151|NCT01228071|2934660|P1|Overall Study|Protocol Violation|1
890152|NCT01228019|2934666|P1|Overall Study|Violation of Entry Criterion|9
890153|NCT01228019|2934666|P1|Overall Study|Triglyceride Entry Criteria Not Met|152
890154|NCT01228019|2934666|P1|Overall Study|Missing pre-treatment data|72
890155|NCT01228019|2934666|P1|Overall Study|Duplicate enrollment|1
890156|NCT01228019|2934666|P1|Overall Study|Dose Violation|70
890157|NCT01227967|2934732|P2|Overall Study|Taking Additional Antiviral Drug|0
890158|NCT01227967|2934733|P1|Overall Study|Taking Additional Antiviral Drug|1
890159|NCT01227967|2934732|P2|Overall Study|Never Started Treatment|4
890160|NCT01227967|2934733|P1|Overall Study|Never Started Treatment|0
890161|NCT01227967|2934732|P2|Overall Study|Physician Decision|1
890162|NCT01227967|2934733|P1|Overall Study|Physician Decision|0
890163|NCT01227967|2934732|P2|Overall Study|Withdrawal by Subject|3
890164|NCT01227967|2934733|P1|Overall Study|Withdrawal by Subject|4
890165|NCT01227967|2934732|P2|Overall Study|Lost to Follow-up|3
890166|NCT01227967|2934733|P1|Overall Study|Lost to Follow-up|8
890167|NCT01227967|2934732|P2|Overall Study|Death|1
890168|NCT01227967|2934733|P1|Overall Study|Death|0
890169|NCT01227967|2934732|P2|Overall Study|Protocol Violation|1
890170|NCT01227967|2934733|P1|Overall Study|Protocol Violation|3
890171|NCT01227954|2934767|P1|Overall Study|No protocol treatment|7
890172|NCT01227954|2934767|P1|Overall Study|Protocol Violation|6
890173|NCT01227928|2934781|P2|Overall Study|Death|12
890174|NCT01227928|2934782|P1|Overall Study|Death|14
890175|NCT01227928|2934781|P2|Overall Study|Withdrawal by Subject|3
890176|NCT01227928|2934782|P1|Overall Study|Withdrawal by Subject|4
890177|NCT01227928|2934781|P2|Overall Study|Lost to Follow-up|2
890178|NCT01227928|2934782|P1|Overall Study|Lost to Follow-up|4
890179|NCT01227902|2934820|P4|Overall Study|Withdrawal by Subject|3
890180|NCT01227902|2934821|P3|Overall Study|Withdrawal by Subject|4
890181|NCT01227902|2934822|P2|Overall Study|Withdrawal by Subject|2
890182|NCT01227902|2934823|P1|Overall Study|Withdrawal by Subject|4
890183|NCT01227902|2934820|P4|Overall Study|Physician Decision|0
890184|NCT01227902|2934821|P3|Overall Study|Physician Decision|1
890185|NCT01227902|2934822|P2|Overall Study|Physician Decision|1
890186|NCT01227902|2934823|P1|Overall Study|Physician Decision|0
890187|NCT01227902|2934820|P4|Overall Study|Lost to Follow-up|2
890188|NCT01227902|2934821|P3|Overall Study|Lost to Follow-up|1
890189|NCT01227902|2934822|P2|Overall Study|Lost to Follow-up|0
890190|NCT01227902|2934823|P1|Overall Study|Lost to Follow-up|0
890191|NCT01227902|2934820|P4|Overall Study|Protocol Violation|0
890192|NCT01227902|2934821|P3|Overall Study|Protocol Violation|0
890193|NCT01227902|2934822|P2|Overall Study|Protocol Violation|0
890194|NCT01227902|2934823|P1|Overall Study|Protocol Violation|1
890195|NCT01227902|2934820|P4|Overall Study|Lack of Efficacy|1
890196|NCT01227902|2934821|P3|Overall Study|Lack of Efficacy|2
890197|NCT01227902|2934822|P2|Overall Study|Lack of Efficacy|2
890198|NCT01227902|2934823|P1|Overall Study|Lack of Efficacy|1
890199|NCT01227902|2934820|P4|Overall Study|Adverse Event|4
890200|NCT01227902|2934821|P3|Overall Study|Adverse Event|11
890201|NCT01227902|2934822|P2|Overall Study|Adverse Event|8
890202|NCT01227902|2934823|P1|Overall Study|Adverse Event|12
890203|NCT01227889|2934916|P2|Crossover Phase|Withdrawal by Subject|1
890204|NCT01227889|2934917|P1|Crossover Phase|Withdrawal by Subject|0
890205|NCT01227889|2934916|P2|Crossover Phase|Study Terminated By Sponsor|1
890206|NCT01227889|2934917|P1|Crossover Phase|Study Terminated By Sponsor|0
890207|NCT01227889|2934916|P2|Crossover Phase|Progressive Disease|31
890208|NCT01227889|2934917|P1|Crossover Phase|Progressive Disease|0
890209|NCT01227889|2934916|P2|Crossover Phase|Physician Decision|3
890210|NCT01227889|2934917|P1|Crossover Phase|Physician Decision|0
890211|NCT01227889|2934916|P2|Crossover Phase|Adverse Event|1
890212|NCT01227889|2934917|P1|Crossover Phase|Adverse Event|0
890213|NCT01227889|2934916|P2|Randomized Phase (RP)|Withdrawal by Subject|3
890214|NCT01227889|2934917|P1|Randomized Phase (RP)|Withdrawal by Subject|15
890215|NCT01227889|2934916|P2|Randomized Phase (RP)|Missing|3
890216|NCT01227889|2934917|P1|Randomized Phase (RP)|Missing|1
890217|NCT01227889|2934916|P2|Randomized Phase (RP)|Study terminated by sponsor|0
890218|NCT01227889|2934917|P1|Randomized Phase (RP)|Study terminated by sponsor|10
890219|NCT01227889|2934916|P2|Randomized Phase (RP)|Progressive Disease|52
890220|NCT01227889|2934917|P1|Randomized Phase (RP)|Progressive Disease|135
890221|NCT01227889|2934916|P2|Randomized Phase (RP)|Physician Decision|5
890222|NCT01227889|2934917|P1|Randomized Phase (RP)|Physician Decision|13
890223|NCT01227889|2934916|P2|Randomized Phase (RP)|Adverse Event|0
890224|NCT01227889|2934917|P1|Randomized Phase (RP)|Adverse Event|13
890225|NCT01227824|2934944|P3|Open-label Phase: Median of 1267 Days|Physician Decision|3
890226|NCT01227824|2934945|P2|Open-label Phase: Median of 1267 Days|Physician Decision|0
890227|NCT01227824|2934946|P1|Open-label Phase: Median of 1267 Days|Physician Decision|0
890228|NCT01227824|2934944|P3|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8
890229|NCT01227824|2934945|P2|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
890230|NCT01227824|2934946|P1|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
890231|NCT01227824|2934944|P3|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15
890232|NCT01227824|2934945|P2|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
890233|NCT01227824|2934946|P1|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
890234|NCT01227824|2934944|P3|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4
890235|NCT01227824|2934945|P2|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
890236|NCT01227824|2934946|P1|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
890237|NCT01227824|2934944|P3|Open-label Phase: Median of 1267 Days|Protocol Violation|5
890238|NCT01227824|2934945|P2|Open-label Phase: Median of 1267 Days|Protocol Violation|0
890239|NCT01227824|2934946|P1|Open-label Phase: Median of 1267 Days|Protocol Violation|0
890240|NCT01227824|2934944|P3|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5
890241|NCT01227824|2934945|P2|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
890242|NCT01227824|2934946|P1|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
890243|NCT01227824|2934944|P3|Open-label Phase: Median of 1267 Days|Adverse Event|4
890244|NCT01227824|2934945|P2|Open-label Phase: Median of 1267 Days|Adverse Event|0
890245|NCT01227824|2934946|P1|Open-label Phase: Median of 1267 Days|Adverse Event|0
890246|NCT01227824|2934944|P3|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
890247|NCT01227824|2934945|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
890248|NCT01227824|2934946|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|3
890249|NCT01227824|2934944|P3|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0
890250|NCT01227824|2934945|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14
890251|NCT01227824|2934946|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18
890252|NCT01227824|2934944|P3|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0
890253|NCT01227824|2934945|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10
890254|NCT01227824|2934946|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22
890255|NCT01227824|2934944|P3|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0
890256|NCT01227824|2934945|P2|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4
890257|NCT01227824|2934946|P1|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6
890258|NCT01227824|2934944|P3|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0
890259|NCT01227824|2934945|P2|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3
890260|NCT01227824|2934946|P1|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6
890261|NCT01227824|2934944|P3|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0
890262|NCT01227824|2934945|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16
890263|NCT01227824|2934946|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18
890264|NCT01227824|2934944|P3|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0
890265|NCT01227824|2934945|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25
890266|NCT01227824|2934946|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22
890267|NCT01227824|2934944|P3|Double-blind Phase: 96 Weeks Duration|Adverse Event|0
890268|NCT01227824|2934945|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|7
890269|NCT01227824|2934946|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|12
890270|NCT01227707|2935041|P1|Overall Study|Death|1
890271|NCT01227707|2935041|P1|Overall Study|Medical decision|6
890272|NCT01227707|2935041|P1|Overall Study|Patient non-compliance|3
890273|NCT01227707|2935041|P1|Overall Study|Withdrawal by Subject|1
890274|NCT01227707|2935041|P1|Overall Study|Progression of disease|3
890275|NCT01227707|2935041|P1|Overall Study|Adverse Event|10
890276|NCT01227668|2935068|P2|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1
890277|NCT01227668|2935069|P1|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0
890278|NCT01227668|2935068|P2|Phase 2 (Randomization Phase)|Lack of Efficacy|23
890279|NCT01227668|2935069|P1|Phase 2 (Randomization Phase)|Lack of Efficacy|13
890280|NCT01227668|2935068|P2|Phase 2 (Randomization Phase)|Lost to Follow-up|0
890281|NCT01227668|2935069|P1|Phase 2 (Randomization Phase)|Lost to Follow-up|1
890282|NCT01227668|2935068|P2|Phase 2 (Randomization Phase)|Withdrawal by Subject|0
890283|NCT01227668|2935069|P1|Phase 2 (Randomization Phase)|Withdrawal by Subject|5
890284|NCT01227668|2935068|P2|Phase 2 (Randomization Phase)|Adverse Event|1
890285|NCT01227668|2935069|P1|Phase 2 (Randomization Phase)|Adverse Event|0
890286|NCT01227668|2935068|P2|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0
890287|NCT01227668|2935069|P1|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2
890288|NCT01227668|2935068|P2|Phase 1 (Stabilization Phase)|Lack of Efficacy|0
890289|NCT01227668|2935069|P1|Phase 1 (Stabilization Phase)|Lack of Efficacy|25
890290|NCT01227668|2935068|P2|Phase 1 (Stabilization Phase)|No longer meets study criteria|0
890291|NCT01227668|2935069|P1|Phase 1 (Stabilization Phase)|No longer meets study criteria|7
890292|NCT01227668|2935068|P2|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0
890293|NCT01227668|2935069|P1|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11
890294|NCT01227668|2935068|P2|Phase 1 (Stabilization Phase)|Lost to Follow-up|0
890295|NCT01227668|2935069|P1|Phase 1 (Stabilization Phase)|Lost to Follow-up|8
890296|NCT01227668|2935068|P2|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0
890297|NCT01227668|2935069|P1|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7
890298|NCT01227668|2935068|P2|Phase 1 (Stabilization Phase)|Adverse Event|0
890299|NCT01227668|2935069|P1|Phase 1 (Stabilization Phase)|Adverse Event|12
890300|NCT01227629|2935115|P10|Overall Study|Not Specified|1
890301|NCT01227629|2935116|P9|Overall Study|Not Specified|2
890302|NCT01227629|2935117|P8|Overall Study|Not Specified|0
890303|NCT01227629|2935118|P7|Overall Study|Not Specified|0
890304|NCT01227629|2935119|P6|Overall Study|Not Specified|0
890305|NCT01227629|2935120|P5|Overall Study|Not Specified|0
890306|NCT01227629|2935121|P4|Overall Study|Not Specified|1
890307|NCT01227629|2935122|P3|Overall Study|Not Specified|0
890308|NCT01227629|2935123|P2|Overall Study|Not Specified|0
890309|NCT01227629|2935124|P1|Overall Study|Not Specified|0
890310|NCT01227629|2935115|P10|Overall Study|Withdrawal by Subject|1
890311|NCT01227629|2935116|P9|Overall Study|Withdrawal by Subject|0
890312|NCT01227629|2935117|P8|Overall Study|Withdrawal by Subject|0
890313|NCT01227629|2935118|P7|Overall Study|Withdrawal by Subject|2
890314|NCT01227629|2935119|P6|Overall Study|Withdrawal by Subject|0
890315|NCT01227629|2935120|P5|Overall Study|Withdrawal by Subject|0
890316|NCT01227629|2935121|P4|Overall Study|Withdrawal by Subject|0
890317|NCT01227629|2935122|P3|Overall Study|Withdrawal by Subject|0
890318|NCT01227629|2935123|P2|Overall Study|Withdrawal by Subject|0
890319|NCT01227629|2935124|P1|Overall Study|Withdrawal by Subject|0
890320|NCT01227629|2935115|P10|Overall Study|Lost to Follow-up|0
890321|NCT01227629|2935116|P9|Overall Study|Lost to Follow-up|0
890322|NCT01227629|2935117|P8|Overall Study|Lost to Follow-up|0
890323|NCT01227629|2935118|P7|Overall Study|Lost to Follow-up|0
890324|NCT01227629|2935119|P6|Overall Study|Lost to Follow-up|0
890325|NCT01227629|2935120|P5|Overall Study|Lost to Follow-up|1
890326|NCT01227629|2935121|P4|Overall Study|Lost to Follow-up|0
890327|NCT01227629|2935122|P3|Overall Study|Lost to Follow-up|0
890328|NCT01227629|2935123|P2|Overall Study|Lost to Follow-up|0
890329|NCT01227629|2935124|P1|Overall Study|Lost to Follow-up|0
890330|NCT01227629|2935115|P10|Overall Study|Protocol Violation|0
890331|NCT01227629|2935116|P9|Overall Study|Protocol Violation|0
890332|NCT01227629|2935117|P8|Overall Study|Protocol Violation|0
890333|NCT01227629|2935118|P7|Overall Study|Protocol Violation|0
890334|NCT01227629|2935119|P6|Overall Study|Protocol Violation|0
890335|NCT01227629|2935120|P5|Overall Study|Protocol Violation|0
890336|NCT01227629|2935121|P4|Overall Study|Protocol Violation|1
890337|NCT01227629|2935122|P3|Overall Study|Protocol Violation|0
890338|NCT01227629|2935123|P2|Overall Study|Protocol Violation|0
890339|NCT01227629|2935124|P1|Overall Study|Protocol Violation|0
890340|NCT01227629|2935115|P10|Overall Study|Adverse Event|0
890341|NCT01227629|2935116|P9|Overall Study|Adverse Event|4
890342|NCT01227629|2935117|P8|Overall Study|Adverse Event|6
890343|NCT01227629|2935118|P7|Overall Study|Adverse Event|6
890344|NCT01227629|2935119|P6|Overall Study|Adverse Event|1
890345|NCT01227629|2935120|P5|Overall Study|Adverse Event|1
890346|NCT01227629|2935121|P4|Overall Study|Adverse Event|6
890347|NCT01227629|2935122|P3|Overall Study|Adverse Event|1
890348|NCT01227629|2935123|P2|Overall Study|Adverse Event|2
890349|NCT01227629|2935124|P1|Overall Study|Adverse Event|2
890350|NCT01227577|2935360|P1|Overall Study|Adverse Event|17
890351|NCT01227577|2935360|P1|Overall Study|Lack of Efficacy|5
890352|NCT01227577|2935360|P1|Overall Study|Withdrawal by Subject|4
890353|NCT01227577|2935360|P1|Overall Study|Lost to Follow-up|1
890354|NCT01227577|2935360|P1|Overall Study|Administrative problems|2
890355|NCT01227577|2935360|P1|Overall Study|Death|3
890356|NCT01227577|2935360|P1|Overall Study|Protocol deviation|3
890357|NCT01227564|2935375|P3|Overall Study|Participant moved to another town|1
890358|NCT01227564|2935376|P2|Overall Study|Participant moved to another town|0
890359|NCT01227564|2935377|P1|Overall Study|Participant moved to another town|0
890360|NCT01227564|2935375|P3|Overall Study|No Longer Willing to Participate|5
890361|NCT01227564|2935376|P2|Overall Study|No Longer Willing to Participate|2
890362|NCT01227564|2935377|P1|Overall Study|No Longer Willing to Participate|4
890363|NCT01227512|2935515|P2|Overall Study|Participant met withdrawal criteria|1
890364|NCT01227512|2935516|P1|Overall Study|Participant met withdrawal criteria|0
890365|NCT01227512|2935515|P2|Overall Study|Withdrawal by Subject|0
890366|NCT01227512|2935516|P1|Overall Study|Withdrawal by Subject|3
890367|NCT01227512|2935515|P2|Overall Study|Adverse Event|3
890368|NCT01227512|2935516|P1|Overall Study|Adverse Event|4
890369|NCT01227512|2935515|P2|Overall Study|Physician Decision|6
890370|NCT01227512|2935516|P1|Overall Study|Physician Decision|6
890371|NCT01227421|2935550|P3|Overall Study|Randomized in error|0
890372|NCT01227421|2935551|P2|Overall Study|Randomized in error|1
890373|NCT01227421|2935552|P1|Overall Study|Randomized in error|1
890374|NCT01227421|2935550|P3|Overall Study|Protocol Violation|2
890375|NCT01227421|2935551|P2|Overall Study|Protocol Violation|1
890376|NCT01227421|2935552|P1|Overall Study|Protocol Violation|1
890377|NCT01227421|2935550|P3|Overall Study|Withdrawal by Subject|1
890378|NCT01227421|2935551|P2|Overall Study|Withdrawal by Subject|2
890379|NCT01227421|2935552|P1|Overall Study|Withdrawal by Subject|1
890380|NCT01227421|2935550|P3|Overall Study|Adverse Event|2
890381|NCT01227421|2935551|P2|Overall Study|Adverse Event|7
890382|NCT01227421|2935552|P1|Overall Study|Adverse Event|2
890383|NCT01227421|2935550|P3|Overall Study|Lost to Follow-up|5
890384|NCT01227421|2935551|P2|Overall Study|Lost to Follow-up|7
890385|NCT01227421|2935552|P1|Overall Study|Lost to Follow-up|6
890386|NCT01227395|2935604|P2|Overall Study|Protocol Violation|1
890387|NCT01227395|2935605|P1|Overall Study|Protocol Violation|0
890388|NCT01227278|2935645|P2|Overall Study|Other|2
890389|NCT01227278|2935646|P1|Overall Study|Other|1
890390|NCT01227278|2935645|P2|Overall Study|Death|2
890391|NCT01227278|2935646|P1|Overall Study|Death|0
890392|NCT01227278|2935645|P2|Overall Study|Withdrawal by Subject|4
890393|NCT01227278|2935646|P1|Overall Study|Withdrawal by Subject|4
890394|NCT01227265|2935673|P3|Overall Study|Adverse Event|5
890395|NCT01227265|2935674|P2|Overall Study|Adverse Event|10
890396|NCT01227265|2935675|P1|Overall Study|Adverse Event|6
890397|NCT01227265|2935673|P3|Overall Study|Lost to Follow-up|3
890398|NCT01227265|2935674|P2|Overall Study|Lost to Follow-up|0
890399|NCT01227265|2935675|P1|Overall Study|Lost to Follow-up|2
890400|NCT01227265|2935673|P3|Overall Study|Withdrawal by Subject|3
890401|NCT01227265|2935674|P2|Overall Study|Withdrawal by Subject|7
890402|NCT01227265|2935675|P1|Overall Study|Withdrawal by Subject|7
890403|NCT01227265|2935673|P3|Overall Study|Protocol Violation|0
890404|NCT01227265|2935674|P2|Overall Study|Protocol Violation|1
890405|NCT01227265|2935675|P1|Overall Study|Protocol Violation|2
890406|NCT01227265|2935673|P3|Overall Study|Did Not Meet Protocol Eligibility|1
890407|NCT01227265|2935674|P2|Overall Study|Did Not Meet Protocol Eligibility|0
890408|NCT01227265|2935675|P1|Overall Study|Did Not Meet Protocol Eligibility|0
890409|NCT01227265|2935673|P3|Overall Study|Administrative|2
890410|NCT01227265|2935674|P2|Overall Study|Administrative|0
890411|NCT01227265|2935675|P1|Overall Study|Administrative|1
890412|NCT01227265|2935673|P3|Overall Study|Did Not Receive Treatment|0
890413|NCT01227265|2935674|P2|Overall Study|Did Not Receive Treatment|2
890414|NCT01227265|2935675|P1|Overall Study|Did Not Receive Treatment|1
890415|NCT01227018|2935714|P1|Overall Study|Withdrew after beginning treatment|4
890416|NCT01227018|2935714|P1|Overall Study|Toxicity|2
890417|NCT01227018|2935714|P1|Overall Study|Disease progression|9
890418|NCT01226745|2935741|P6|Overall Study|Other|1
890419|NCT01226745|2935742|P5|Overall Study|Other|3
890420|NCT01226745|2935743|P4|Overall Study|Other|4
890421|NCT01226745|2935744|P3|Overall Study|Other|8
890422|NCT01226745|2935745|P2|Overall Study|Other|7
890423|NCT01226745|2935746|P1|Overall Study|Other|6
890424|NCT01226745|2935741|P6|Overall Study|Death|1
890425|NCT01226745|2935742|P5|Overall Study|Death|0
890426|NCT01226745|2935743|P4|Overall Study|Death|0
890427|NCT01226745|2935744|P3|Overall Study|Death|0
890428|NCT01226745|2935745|P2|Overall Study|Death|0
890429|NCT01226745|2935746|P1|Overall Study|Death|1
890430|NCT01226745|2935741|P6|Overall Study|Lost to Follow-up|2
890431|NCT01226745|2935742|P5|Overall Study|Lost to Follow-up|1
890432|NCT01226745|2935743|P4|Overall Study|Lost to Follow-up|1
890433|NCT01226745|2935744|P3|Overall Study|Lost to Follow-up|6
890434|NCT01226745|2935745|P2|Overall Study|Lost to Follow-up|6
890435|NCT01226745|2935746|P1|Overall Study|Lost to Follow-up|2
890436|NCT01226745|2935741|P6|Overall Study|Did not complete schedule of assessments|1
890437|NCT01226745|2935742|P5|Overall Study|Did not complete schedule of assessments|0
890438|NCT01226745|2935743|P4|Overall Study|Did not complete schedule of assessments|0
890439|NCT01226745|2935744|P3|Overall Study|Did not complete schedule of assessments|6
890440|NCT01226745|2935745|P2|Overall Study|Did not complete schedule of assessments|3
890441|NCT01226745|2935746|P1|Overall Study|Did not complete schedule of assessments|8
890442|NCT01226511|2935942|P2|Taper Period|Parent/Caregiver Decision|1
890443|NCT01226511|2935943|P1|Taper Period|Parent/Caregiver Decision|1
890444|NCT01226511|2935942|P2|Taper Period|Protocol Violation|0
890445|NCT01226511|2935943|P1|Taper Period|Protocol Violation|1
890446|NCT01226511|2935942|P2|Taper Period|Lost to Follow-up|2
890447|NCT01226511|2935943|P1|Taper Period|Lost to Follow-up|2
890448|NCT01226511|2935942|P2|Taper Period|Adverse Event|0
890449|NCT01226511|2935943|P1|Taper Period|Adverse Event|1
890450|NCT01226511|2935942|P2|Extension Treatment Period|Sponsor Decision|1
890451|NCT01226511|2935943|P1|Extension Treatment Period|Sponsor Decision|1
890452|NCT01226511|2935942|P2|Extension Treatment Period|Parent/Caregiver Decision|8
890453|NCT01226511|2935943|P1|Extension Treatment Period|Parent/Caregiver Decision|8
890454|NCT01226511|2935942|P2|Extension Treatment Period|Withdrawal by Subject|3
890455|NCT01226511|2935943|P1|Extension Treatment Period|Withdrawal by Subject|1
890456|NCT01226511|2935942|P2|Extension Treatment Period|Protocol Violation|2
890457|NCT01226511|2935943|P1|Extension Treatment Period|Protocol Violation|2
890458|NCT01226511|2935942|P2|Extension Treatment Period|Lost to Follow-up|3
890459|NCT01226511|2935943|P1|Extension Treatment Period|Lost to Follow-up|4
890460|NCT01226511|2935942|P2|Extension Treatment Period|Lack of Efficacy|2
890461|NCT01226511|2935943|P1|Extension Treatment Period|Lack of Efficacy|3
890462|NCT01226511|2935942|P2|Extension Treatment Period|Adverse Event|8
890463|NCT01226511|2935943|P1|Extension Treatment Period|Adverse Event|8
890464|NCT01226511|2935942|P2|Acute Treatment Period|Withdrawal by Subject|6
890465|NCT01226511|2935943|P1|Acute Treatment Period|Withdrawal by Subject|10
890466|NCT01226511|2935942|P2|Acute Treatment Period|Protocol Violation|5
890467|NCT01226511|2935943|P1|Acute Treatment Period|Protocol Violation|5
890468|NCT01226511|2935942|P2|Acute Treatment Period|Parent/caregiver decision|7
890469|NCT01226511|2935943|P1|Acute Treatment Period|Parent/caregiver decision|5
890470|NCT01226511|2935942|P2|Acute Treatment Period|Lost to Follow-up|6
890471|NCT01226511|2935943|P1|Acute Treatment Period|Lost to Follow-up|3
890472|NCT01226511|2935942|P2|Acute Treatment Period|Lack of Efficacy|1
890473|NCT01226511|2935943|P1|Acute Treatment Period|Lack of Efficacy|2
890474|NCT01226511|2935942|P2|Acute Treatment Period|Adverse Event|6
890475|NCT01226511|2935943|P1|Acute Treatment Period|Adverse Event|7
890476|NCT01226459|2935981|P2|Overall Study|Pregnancy|0
890477|NCT01226459|2935982|P1|Overall Study|Pregnancy|1
890478|NCT01226459|2935981|P2|Overall Study|Lost to Follow-up|8
890479|NCT01226459|2935982|P1|Overall Study|Lost to Follow-up|4
890480|NCT01226459|2935981|P2|Overall Study|Withdrawal by Subject|13
890481|NCT01226459|2935982|P1|Overall Study|Withdrawal by Subject|10
890482|NCT01226459|2935981|P2|Overall Study|Protocol Violation|3
890483|NCT01226459|2935982|P1|Overall Study|Protocol Violation|4
890484|NCT01226459|2935981|P2|Overall Study|Adverse Event|8
890485|NCT01226459|2935982|P1|Overall Study|Adverse Event|2
890486|NCT01226121|2936000|P3|Overall Study|Lost to Follow-up|1
890487|NCT01226121|2936001|P2|Overall Study|Lost to Follow-up|0
890488|NCT01226121|2936002|P1|Overall Study|Lost to Follow-up|2
890489|NCT01226095|2936013|P1|Overall Study|Poor compliance|1
890490|NCT01226043|2936038|P4|30-week Observational Phase|Physician Decision|2
890491|NCT01226043|2936039|P3|30-week Observational Phase|Physician Decision|2
890492|NCT01226043|2936040|P2|30-week Observational Phase|Physician Decision|0
890493|NCT01226043|2936041|P1|30-week Observational Phase|Physician Decision|0
890494|NCT01226043|2936038|P4|30-week Observational Phase|Withdrawal by Subject|7
890495|NCT01226043|2936039|P3|30-week Observational Phase|Withdrawal by Subject|1
890496|NCT01226043|2936040|P2|30-week Observational Phase|Withdrawal by Subject|0
890497|NCT01226043|2936041|P1|30-week Observational Phase|Withdrawal by Subject|0
890498|NCT01226043|2936038|P4|30-week Observational Phase|Lost to Follow-up|2
890499|NCT01226043|2936039|P3|30-week Observational Phase|Lost to Follow-up|2
890500|NCT01226043|2936040|P2|30-week Observational Phase|Lost to Follow-up|0
890501|NCT01226043|2936041|P1|30-week Observational Phase|Lost to Follow-up|0
890502|NCT01226043|2936038|P4|30-week Observational Phase|Protocol Violation|1
890503|NCT01226043|2936039|P3|30-week Observational Phase|Protocol Violation|0
890504|NCT01226043|2936040|P2|30-week Observational Phase|Protocol Violation|0
890505|NCT01226043|2936041|P1|30-week Observational Phase|Protocol Violation|0
890506|NCT01226043|2936038|P4|30-week Observational Phase|Adverse Event|1
890507|NCT01226043|2936039|P3|30-week Observational Phase|Adverse Event|1
890508|NCT01226043|2936040|P2|30-week Observational Phase|Adverse Event|0
890509|NCT01226043|2936041|P1|30-week Observational Phase|Adverse Event|0
890510|NCT01226043|2936038|P4|6-week Re-randomization Phase|completed in error|1
890511|NCT01226043|2936039|P3|6-week Re-randomization Phase|completed in error|0
890512|NCT01226043|2936040|P2|6-week Re-randomization Phase|completed in error|0
890513|NCT01226043|2936041|P1|6-week Re-randomization Phase|completed in error|0
890514|NCT01226043|2936038|P4|6-week Re-randomization Phase|Physician Decision|2
890515|NCT01226043|2936039|P3|6-week Re-randomization Phase|Physician Decision|3
890516|NCT01226043|2936040|P2|6-week Re-randomization Phase|Physician Decision|0
890517|NCT01226043|2936041|P1|6-week Re-randomization Phase|Physician Decision|0
890518|NCT01226043|2936038|P4|6-week Re-randomization Phase|Withdrawal by Subject|3
890519|NCT01226043|2936039|P3|6-week Re-randomization Phase|Withdrawal by Subject|1
890520|NCT01226043|2936040|P2|6-week Re-randomization Phase|Withdrawal by Subject|0
890521|NCT01226043|2936041|P1|6-week Re-randomization Phase|Withdrawal by Subject|0
890522|NCT01226043|2936038|P4|6-week Re-randomization Phase|Lost to Follow-up|3
890523|NCT01226043|2936039|P3|6-week Re-randomization Phase|Lost to Follow-up|1
890524|NCT01226043|2936040|P2|6-week Re-randomization Phase|Lost to Follow-up|0
890525|NCT01226043|2936041|P1|6-week Re-randomization Phase|Lost to Follow-up|0
890526|NCT01226043|2936038|P4|6-week Re-randomization Phase|Protocol Violation|1
890527|NCT01226043|2936039|P3|6-week Re-randomization Phase|Protocol Violation|1
890528|NCT01226043|2936040|P2|6-week Re-randomization Phase|Protocol Violation|0
890529|NCT01226043|2936041|P1|6-week Re-randomization Phase|Protocol Violation|0
890530|NCT01226043|2936038|P4|6-week Re-randomization Phase|Adverse Event|1
890531|NCT01226043|2936039|P3|6-week Re-randomization Phase|Adverse Event|1
890532|NCT01226043|2936040|P2|6-week Re-randomization Phase|Adverse Event|0
890533|NCT01226043|2936041|P1|6-week Re-randomization Phase|Adverse Event|0
890534|NCT01226043|2936038|P4|4-week Crossover Phase - Period 2|Physician Decision|0
890535|NCT01226043|2936039|P3|4-week Crossover Phase - Period 2|Physician Decision|0
890536|NCT01226043|2936040|P2|4-week Crossover Phase - Period 2|Physician Decision|5
890537|NCT01226043|2936041|P1|4-week Crossover Phase - Period 2|Physician Decision|4
890538|NCT01226043|2936038|P4|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
890539|NCT01226043|2936039|P3|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
890540|NCT01226043|2936040|P2|4-week Crossover Phase - Period 2|Withdrawal by Subject|1
890541|NCT01226043|2936041|P1|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
890542|NCT01226043|2936038|P4|4-week Crossover Phase - Period 1|Physician Decision|0
890543|NCT01226043|2936039|P3|4-week Crossover Phase - Period 1|Physician Decision|0
890544|NCT01226043|2936040|P2|4-week Crossover Phase - Period 1|Physician Decision|6
890545|NCT01226043|2936041|P1|4-week Crossover Phase - Period 1|Physician Decision|0
890546|NCT01226043|2936038|P4|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
890547|NCT01226043|2936039|P3|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
890548|NCT01226043|2936040|P2|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
890549|NCT01226043|2936041|P1|4-week Crossover Phase - Period 1|Withdrawal by Subject|2
890550|NCT01226043|2936038|P4|4-week Crossover Phase - Period 1|Lost to Follow-up|0
890551|NCT01226043|2936039|P3|4-week Crossover Phase - Period 1|Lost to Follow-up|0
890552|NCT01226043|2936040|P2|4-week Crossover Phase - Period 1|Lost to Follow-up|1
890553|NCT01226043|2936041|P1|4-week Crossover Phase - Period 1|Lost to Follow-up|0
890554|NCT01226043|2936038|P4|4-week Crossover Phase - Period 1|Protocol Violation|0
890555|NCT01226043|2936039|P3|4-week Crossover Phase - Period 1|Protocol Violation|0
890556|NCT01226043|2936040|P2|4-week Crossover Phase - Period 1|Protocol Violation|2
890557|NCT01226043|2936041|P1|4-week Crossover Phase - Period 1|Protocol Violation|1
890558|NCT01225991|2936079|P1|Overall Study|Withdrawal by Subject|6
890559|NCT01225952|2936090|P3|Overall Study|Surgical complications|0
890560|NCT01225952|2936091|P2|Overall Study|Surgical complications|0
890561|NCT01225952|2936092|P1|Overall Study|Surgical complications|1
890562|NCT01225952|2936090|P3|Overall Study|Withdrawal by Subject|5
890563|NCT01225952|2936091|P2|Overall Study|Withdrawal by Subject|4
890564|NCT01225952|2936092|P1|Overall Study|Withdrawal by Subject|4
890565|NCT01225952|2936090|P3|Overall Study|Study Eye Explanted|1
890566|NCT01225952|2936091|P2|Overall Study|Study Eye Explanted|0
890567|NCT01225952|2936092|P1|Overall Study|Study Eye Explanted|0
890568|NCT01225952|2936090|P3|Overall Study|Lost to Follow-up|0
890569|NCT01225952|2936091|P2|Overall Study|Lost to Follow-up|0
890570|NCT01225952|2936092|P1|Overall Study|Lost to Follow-up|1
890571|NCT01225887|2936184|P1|Overall Study|Ineligible:inadequate pathology|2
890572|NCT01225887|2936184|P1|Overall Study|Ineligible;improper pre-protocol therapy|1
890573|NCT01225887|2936184|P1|Overall Study|Ineligible:required test not done|2
890574|NCT01225835|2936194|P2|Overall Study|not specified|1
890575|NCT01225835|2936195|P1|Overall Study|not specified|1
890576|NCT01225835|2936194|P2|Overall Study|Adverse Event|1
890577|NCT01225835|2936195|P1|Overall Study|Adverse Event|2
890578|NCT01225835|2936194|P2|Overall Study|Did not meet hCG criterion|0
890579|NCT01225835|2936195|P1|Overall Study|Did not meet hCG criterion|2
890580|NCT01225835|2936194|P2|Overall Study|Completed protocol|1
890581|NCT01225835|2936195|P1|Overall Study|Completed protocol|2
890582|NCT01225822|2936243|P5|Overall Study|Not Specified|7
890583|NCT01225822|2936244|P4|Overall Study|Not Specified|10
890584|NCT01225822|2936245|P3|Overall Study|Not Specified|7
890585|NCT01225822|2936246|P2|Overall Study|Not Specified|10
890586|NCT01225822|2936247|P1|Overall Study|Not Specified|13
890587|NCT01225822|2936243|P5|Overall Study|Withdrawal by Subject|6
890588|NCT01225822|2936244|P4|Overall Study|Withdrawal by Subject|11
890589|NCT01225822|2936245|P3|Overall Study|Withdrawal by Subject|7
890590|NCT01225822|2936246|P2|Overall Study|Withdrawal by Subject|7
890591|NCT01225822|2936247|P1|Overall Study|Withdrawal by Subject|6
890592|NCT01225822|2936243|P5|Overall Study|Lost to Follow-up|0
890593|NCT01225822|2936244|P4|Overall Study|Lost to Follow-up|1
890594|NCT01225822|2936245|P3|Overall Study|Lost to Follow-up|0
890595|NCT01225822|2936246|P2|Overall Study|Lost to Follow-up|0
890596|NCT01225822|2936247|P1|Overall Study|Lost to Follow-up|0
890597|NCT01225822|2936243|P5|Overall Study|Protocol Violation|4
890598|NCT01225822|2936244|P4|Overall Study|Protocol Violation|7
890599|NCT01225822|2936245|P3|Overall Study|Protocol Violation|6
890600|NCT01225822|2936246|P2|Overall Study|Protocol Violation|8
890601|NCT01225822|2936247|P1|Overall Study|Protocol Violation|6
890602|NCT01225822|2936243|P5|Overall Study|Adverse Event|14
890603|NCT01225822|2936244|P4|Overall Study|Adverse Event|23
890604|NCT01225822|2936245|P3|Overall Study|Adverse Event|18
890605|NCT01225822|2936246|P2|Overall Study|Adverse Event|31
890606|NCT01225822|2936247|P1|Overall Study|Adverse Event|13
890607|NCT01225731|2936314|P13|Part 3|Withdrawal by Subject|4
890608|NCT01225731|2936315|P12|Part 3|Withdrawal by Subject|6
890609|NCT01225731|2936316|P11|Part 3|Withdrawal by Subject|4
890610|NCT01225731|2936317|P10|Part 3|Withdrawal by Subject|0
890611|NCT01225731|2936318|P9|Part 3|Withdrawal by Subject|0
890612|NCT01225731|2936319|P8|Part 3|Withdrawal by Subject|0
890613|NCT01225731|2936320|P7|Part 3|Withdrawal by Subject|0
890614|NCT01225731|2936321|P6|Part 3|Withdrawal by Subject|0
890615|NCT01225731|2936322|P5|Part 3|Withdrawal by Subject|0
890616|NCT01225731|2936323|P4|Part 3|Withdrawal by Subject|0
890617|NCT01225731|2936324|P3|Part 3|Withdrawal by Subject|0
890618|NCT01225731|2936325|P2|Part 3|Withdrawal by Subject|0
890619|NCT01225731|2936326|P1|Part 3|Withdrawal by Subject|0
890620|NCT01225731|2936314|P13|Part 3|Physician Decision|2
890621|NCT01225731|2936315|P12|Part 3|Physician Decision|1
890622|NCT01225731|2936316|P11|Part 3|Physician Decision|0
890623|NCT01225731|2936317|P10|Part 3|Physician Decision|0
890624|NCT01225731|2936318|P9|Part 3|Physician Decision|0
890625|NCT01225731|2936319|P8|Part 3|Physician Decision|0
890626|NCT01225731|2936320|P7|Part 3|Physician Decision|0
890627|NCT01225731|2936321|P6|Part 3|Physician Decision|0
890628|NCT01225731|2936322|P5|Part 3|Physician Decision|0
890629|NCT01225731|2936323|P4|Part 3|Physician Decision|0
890630|NCT01225731|2936324|P3|Part 3|Physician Decision|0
890631|NCT01225731|2936325|P2|Part 3|Physician Decision|0
890632|NCT01225731|2936326|P1|Part 3|Physician Decision|0
890633|NCT01225731|2936314|P13|Part 3|Lost to Follow-up|1
890634|NCT01225731|2936315|P12|Part 3|Lost to Follow-up|2
890635|NCT01225731|2936316|P11|Part 3|Lost to Follow-up|1
890636|NCT01225731|2936317|P10|Part 3|Lost to Follow-up|0
890637|NCT01225731|2936318|P9|Part 3|Lost to Follow-up|0
890638|NCT01225731|2936319|P8|Part 3|Lost to Follow-up|0
890639|NCT01225731|2936320|P7|Part 3|Lost to Follow-up|0
890640|NCT01225731|2936321|P6|Part 3|Lost to Follow-up|0
890641|NCT01225731|2936322|P5|Part 3|Lost to Follow-up|0
890642|NCT01225731|2936323|P4|Part 3|Lost to Follow-up|0
890643|NCT01225731|2936324|P3|Part 3|Lost to Follow-up|0
890644|NCT01225731|2936325|P2|Part 3|Lost to Follow-up|0
890645|NCT01225731|2936326|P1|Part 3|Lost to Follow-up|0
890646|NCT01225731|2936314|P13|Part 3|Adverse Event|0
890647|NCT01225731|2936315|P12|Part 3|Adverse Event|1
890648|NCT01225731|2936316|P11|Part 3|Adverse Event|1
890649|NCT01225731|2936317|P10|Part 3|Adverse Event|0
890650|NCT01225731|2936318|P9|Part 3|Adverse Event|0
890651|NCT01225731|2936319|P8|Part 3|Adverse Event|0
890652|NCT01225731|2936320|P7|Part 3|Adverse Event|0
890653|NCT01225731|2936321|P6|Part 3|Adverse Event|0
890654|NCT01225731|2936322|P5|Part 3|Adverse Event|0
890655|NCT01225731|2936323|P4|Part 3|Adverse Event|0
890656|NCT01225731|2936324|P3|Part 3|Adverse Event|0
890657|NCT01225731|2936325|P2|Part 3|Adverse Event|0
890658|NCT01225731|2936326|P1|Part 3|Adverse Event|0
890659|NCT01225731|2936314|P13|Part 2|Withdrawal by Subject|0
890660|NCT01225731|2936315|P12|Part 2|Withdrawal by Subject|0
890661|NCT01225731|2936316|P11|Part 2|Withdrawal by Subject|0
890662|NCT01225731|2936317|P10|Part 2|Withdrawal by Subject|0
890663|NCT01225731|2936318|P9|Part 2|Withdrawal by Subject|1
890664|NCT01225731|2936319|P8|Part 2|Withdrawal by Subject|4
890665|NCT01225731|2936320|P7|Part 2|Withdrawal by Subject|3
890666|NCT01225731|2936321|P6|Part 2|Withdrawal by Subject|1
890667|NCT01225731|2936322|P5|Part 2|Withdrawal by Subject|0
890668|NCT01225731|2936323|P4|Part 2|Withdrawal by Subject|0
890669|NCT01225731|2936324|P3|Part 2|Withdrawal by Subject|0
890670|NCT01225731|2936325|P2|Part 2|Withdrawal by Subject|0
890671|NCT01225731|2936326|P1|Part 2|Withdrawal by Subject|0
890672|NCT01225731|2936314|P13|Part 2|Physician Decision|0
890673|NCT01225731|2936315|P12|Part 2|Physician Decision|0
890674|NCT01225731|2936316|P11|Part 2|Physician Decision|0
890675|NCT01225731|2936317|P10|Part 2|Physician Decision|0
890676|NCT01225731|2936318|P9|Part 2|Physician Decision|2
890677|NCT01225731|2936319|P8|Part 2|Physician Decision|2
890678|NCT01225731|2936320|P7|Part 2|Physician Decision|0
890679|NCT01225731|2936321|P6|Part 2|Physician Decision|0
890680|NCT01225731|2936322|P5|Part 2|Physician Decision|0
890681|NCT01225731|2936323|P4|Part 2|Physician Decision|0
890682|NCT01225731|2936324|P3|Part 2|Physician Decision|0
890683|NCT01225731|2936325|P2|Part 2|Physician Decision|0
890684|NCT01225731|2936326|P1|Part 2|Physician Decision|0
890685|NCT01225731|2936314|P13|Part 2|Lost to Follow-up|0
890686|NCT01225731|2936315|P12|Part 2|Lost to Follow-up|0
890687|NCT01225731|2936316|P11|Part 2|Lost to Follow-up|0
890688|NCT01225731|2936317|P10|Part 2|Lost to Follow-up|0
890689|NCT01225731|2936318|P9|Part 2|Lost to Follow-up|1
890690|NCT01225731|2936319|P8|Part 2|Lost to Follow-up|3
890691|NCT01225731|2936320|P7|Part 2|Lost to Follow-up|0
890692|NCT01225731|2936321|P6|Part 2|Lost to Follow-up|0
890693|NCT01225731|2936322|P5|Part 2|Lost to Follow-up|0
890694|NCT01225731|2936323|P4|Part 2|Lost to Follow-up|0
890695|NCT01225731|2936324|P3|Part 2|Lost to Follow-up|0
890696|NCT01225731|2936325|P2|Part 2|Lost to Follow-up|0
890697|NCT01225731|2936326|P1|Part 2|Lost to Follow-up|0
890698|NCT01225731|2936314|P13|Part 2|Pregnancy|0
890699|NCT01225731|2936315|P12|Part 2|Pregnancy|0
890700|NCT01225731|2936316|P11|Part 2|Pregnancy|0
890701|NCT01225731|2936317|P10|Part 2|Pregnancy|0
890702|NCT01225731|2936318|P9|Part 2|Pregnancy|1
890703|NCT01225731|2936319|P8|Part 2|Pregnancy|0
890704|NCT01225731|2936320|P7|Part 2|Pregnancy|1
890705|NCT01225731|2936321|P6|Part 2|Pregnancy|0
890706|NCT01225731|2936322|P5|Part 2|Pregnancy|0
890707|NCT01225731|2936323|P4|Part 2|Pregnancy|0
890708|NCT01225731|2936324|P3|Part 2|Pregnancy|0
890709|NCT01225731|2936325|P2|Part 2|Pregnancy|0
890710|NCT01225731|2936326|P1|Part 2|Pregnancy|0
890711|NCT01225731|2936314|P13|Part 2|Lack of Efficacy|0
890712|NCT01225731|2936315|P12|Part 2|Lack of Efficacy|0
890713|NCT01225731|2936316|P11|Part 2|Lack of Efficacy|0
890714|NCT01225731|2936317|P10|Part 2|Lack of Efficacy|0
890715|NCT01225731|2936318|P9|Part 2|Lack of Efficacy|3
890716|NCT01225731|2936319|P8|Part 2|Lack of Efficacy|12
890717|NCT01225731|2936320|P7|Part 2|Lack of Efficacy|0
890718|NCT01225731|2936321|P6|Part 2|Lack of Efficacy|1
890719|NCT01225731|2936322|P5|Part 2|Lack of Efficacy|0
890720|NCT01225731|2936323|P4|Part 2|Lack of Efficacy|0
890721|NCT01225731|2936324|P3|Part 2|Lack of Efficacy|0
890722|NCT01225731|2936325|P2|Part 2|Lack of Efficacy|0
890723|NCT01225731|2936326|P1|Part 2|Lack of Efficacy|0
890724|NCT01225731|2936314|P13|Part 2|Adverse Event|0
890725|NCT01225731|2936315|P12|Part 2|Adverse Event|0
890726|NCT01225731|2936316|P11|Part 2|Adverse Event|0
890727|NCT01225731|2936317|P10|Part 2|Adverse Event|0
890728|NCT01225731|2936318|P9|Part 2|Adverse Event|2
890729|NCT01225731|2936319|P8|Part 2|Adverse Event|4
890730|NCT01225731|2936320|P7|Part 2|Adverse Event|4
890731|NCT01225731|2936321|P6|Part 2|Adverse Event|0
890732|NCT01225731|2936322|P5|Part 2|Adverse Event|0
890733|NCT01225731|2936323|P4|Part 2|Adverse Event|0
890734|NCT01225731|2936324|P3|Part 2|Adverse Event|0
890735|NCT01225731|2936325|P2|Part 2|Adverse Event|0
890736|NCT01225731|2936326|P1|Part 2|Adverse Event|0
890737|NCT01225731|2936314|P13|Part 2|Protocol Violation|0
890738|NCT01225731|2936315|P12|Part 2|Protocol Violation|0
890739|NCT01225731|2936316|P11|Part 2|Protocol Violation|0
890740|NCT01225731|2936317|P10|Part 2|Protocol Violation|0
890741|NCT01225731|2936318|P9|Part 2|Protocol Violation|1
890742|NCT01225731|2936319|P8|Part 2|Protocol Violation|0
890743|NCT01225731|2936320|P7|Part 2|Protocol Violation|0
890744|NCT01225731|2936321|P6|Part 2|Protocol Violation|1
890745|NCT01225731|2936322|P5|Part 2|Protocol Violation|0
890746|NCT01225731|2936323|P4|Part 2|Protocol Violation|0
890747|NCT01225731|2936324|P3|Part 2|Protocol Violation|0
890748|NCT01225731|2936325|P2|Part 2|Protocol Violation|0
890749|NCT01225731|2936326|P1|Part 2|Protocol Violation|0
890750|NCT01225731|2936314|P13|Part 1|Protocol Violation|0
890751|NCT01225731|2936315|P12|Part 1|Protocol Violation|0
890752|NCT01225731|2936316|P11|Part 1|Protocol Violation|0
890753|NCT01225731|2936317|P10|Part 1|Protocol Violation|0
890754|NCT01225731|2936318|P9|Part 1|Protocol Violation|0
890755|NCT01225731|2936319|P8|Part 1|Protocol Violation|0
890756|NCT01225731|2936320|P7|Part 1|Protocol Violation|0
890757|NCT01225731|2936321|P6|Part 1|Protocol Violation|0
890758|NCT01225731|2936322|P5|Part 1|Protocol Violation|0
890759|NCT01225731|2936323|P4|Part 1|Protocol Violation|1
890760|NCT01225731|2936324|P3|Part 1|Protocol Violation|0
890761|NCT01225731|2936325|P2|Part 1|Protocol Violation|0
890762|NCT01225731|2936326|P1|Part 1|Protocol Violation|0
890763|NCT01225731|2936314|P13|Part 1|Withdrawal by Subject|0
890764|NCT01225731|2936315|P12|Part 1|Withdrawal by Subject|0
890765|NCT01225731|2936316|P11|Part 1|Withdrawal by Subject|0
890766|NCT01225731|2936317|P10|Part 1|Withdrawal by Subject|0
890767|NCT01225731|2936318|P9|Part 1|Withdrawal by Subject|0
890768|NCT01225731|2936319|P8|Part 1|Withdrawal by Subject|0
890769|NCT01225731|2936320|P7|Part 1|Withdrawal by Subject|0
890770|NCT01225731|2936321|P6|Part 1|Withdrawal by Subject|0
890771|NCT01225731|2936322|P5|Part 1|Withdrawal by Subject|4
890772|NCT01225731|2936323|P4|Part 1|Withdrawal by Subject|0
890773|NCT01225731|2936324|P3|Part 1|Withdrawal by Subject|0
890774|NCT01225731|2936325|P2|Part 1|Withdrawal by Subject|3
890775|NCT01225731|2936326|P1|Part 1|Withdrawal by Subject|0
890776|NCT01225731|2936314|P13|Part 1|Adverse Event|0
890777|NCT01225731|2936315|P12|Part 1|Adverse Event|0
890778|NCT01225731|2936316|P11|Part 1|Adverse Event|0
890779|NCT01225731|2936317|P10|Part 1|Adverse Event|0
890780|NCT01225731|2936318|P9|Part 1|Adverse Event|0
890781|NCT01225731|2936319|P8|Part 1|Adverse Event|0
890782|NCT01225731|2936320|P7|Part 1|Adverse Event|0
890783|NCT01225731|2936321|P6|Part 1|Adverse Event|0
890784|NCT01225731|2936322|P5|Part 1|Adverse Event|1
890785|NCT01225731|2936323|P4|Part 1|Adverse Event|1
890786|NCT01225731|2936324|P3|Part 1|Adverse Event|1
890787|NCT01225731|2936325|P2|Part 1|Adverse Event|2
890788|NCT01225731|2936326|P1|Part 1|Adverse Event|1
890789|NCT01225731|2936314|P13|Part 1|Did not meet eligibility criteria|0
890790|NCT01225731|2936315|P12|Part 1|Did not meet eligibility criteria|0
890791|NCT01225731|2936316|P11|Part 1|Did not meet eligibility criteria|0
890792|NCT01225731|2936317|P10|Part 1|Did not meet eligibility criteria|0
890793|NCT01225731|2936318|P9|Part 1|Did not meet eligibility criteria|0
890794|NCT01225731|2936319|P8|Part 1|Did not meet eligibility criteria|0
890795|NCT01225731|2936320|P7|Part 1|Did not meet eligibility criteria|0
890796|NCT01225731|2936321|P6|Part 1|Did not meet eligibility criteria|0
890797|NCT01225731|2936322|P5|Part 1|Did not meet eligibility criteria|1
890798|NCT01225731|2936323|P4|Part 1|Did not meet eligibility criteria|0
890799|NCT01225731|2936324|P3|Part 1|Did not meet eligibility criteria|0
890800|NCT01225731|2936325|P2|Part 1|Did not meet eligibility criteria|0
890801|NCT01225731|2936326|P1|Part 1|Did not meet eligibility criteria|1
890802|NCT01225562|2936421|P3|Overall Study|Lost to Follow-up|1
890803|NCT01225562|2936422|P2|Overall Study|Lost to Follow-up|6
890804|NCT01225562|2936423|P1|Overall Study|Lost to Follow-up|3
890805|NCT01225562|2936421|P3|Overall Study|Withdrawal by Subject|52
890806|NCT01225562|2936422|P2|Overall Study|Withdrawal by Subject|50
890807|NCT01225562|2936423|P1|Overall Study|Withdrawal by Subject|52
890808|NCT01225549|2936440|P10|Period 6 - Washout|Disallowed medication|0
890809|NCT01225549|2936441|P9|Period 6 - Washout|Disallowed medication|0
890810|NCT01225549|2936442|P8|Period 6 - Washout|Disallowed medication|0
890811|NCT01225549|2936443|P7|Period 6 - Washout|Disallowed medication|0
890812|NCT01225549|2936444|P6|Period 6 - Washout|Disallowed medication|0
890813|NCT01225549|2936445|P5|Period 6 - Washout|Disallowed medication|0
890814|NCT01225549|2936446|P4|Period 6 - Washout|Disallowed medication|1
890815|NCT01225549|2936447|P3|Period 6 - Washout|Disallowed medication|0
890816|NCT01225549|2936448|P2|Period 6 - Washout|Disallowed medication|0
890817|NCT01225549|2936449|P1|Period 6 - Washout|Disallowed medication|0
890818|NCT01225549|2936440|P10|Period 4 - Washout|Disallowed medication|0
890819|NCT01225549|2936441|P9|Period 4 - Washout|Disallowed medication|0
890820|NCT01225549|2936442|P8|Period 4 - Washout|Disallowed medication|0
890821|NCT01225549|2936443|P7|Period 4 - Washout|Disallowed medication|0
890822|NCT01225549|2936444|P6|Period 4 - Washout|Disallowed medication|0
890823|NCT01225549|2936445|P5|Period 4 - Washout|Disallowed medication|0
890824|NCT01225549|2936446|P4|Period 4 - Washout|Disallowed medication|0
890825|NCT01225549|2936447|P3|Period 4 - Washout|Disallowed medication|0
890826|NCT01225549|2936448|P2|Period 4 - Washout|Disallowed medication|1
890827|NCT01225549|2936449|P1|Period 4 - Washout|Disallowed medication|0
890828|NCT01225211|2936532|P10|Overall Study|Other|1
890829|NCT01225211|2936533|P9|Overall Study|Other|0
890830|NCT01225211|2936534|P8|Overall Study|Other|0
890831|NCT01225211|2936535|P7|Overall Study|Other|0
890832|NCT01225211|2936536|P6|Overall Study|Other|0
890833|NCT01225211|2936537|P5|Overall Study|Other|0
890834|NCT01225211|2936538|P4|Overall Study|Other|0
890835|NCT01225211|2936539|P3|Overall Study|Other|0
890836|NCT01225211|2936540|P2|Overall Study|Other|0
890837|NCT01225211|2936541|P1|Overall Study|Other|0
890838|NCT01225211|2936532|P10|Overall Study|Withdrawal by Subject|3
890839|NCT01225211|2936533|P9|Overall Study|Withdrawal by Subject|1
890840|NCT01225211|2936534|P8|Overall Study|Withdrawal by Subject|0
890841|NCT01225211|2936535|P7|Overall Study|Withdrawal by Subject|1
890842|NCT01225211|2936536|P6|Overall Study|Withdrawal by Subject|0
890843|NCT01225211|2936537|P5|Overall Study|Withdrawal by Subject|0
890844|NCT01225211|2936538|P4|Overall Study|Withdrawal by Subject|0
890845|NCT01225211|2936539|P3|Overall Study|Withdrawal by Subject|0
890846|NCT01225211|2936540|P2|Overall Study|Withdrawal by Subject|0
890847|NCT01225211|2936541|P1|Overall Study|Withdrawal by Subject|0
890848|NCT01225211|2936532|P10|Overall Study|Adverse Event|1
890849|NCT01225211|2936533|P9|Overall Study|Adverse Event|0
890850|NCT01225211|2936534|P8|Overall Study|Adverse Event|0
890851|NCT01225211|2936535|P7|Overall Study|Adverse Event|0
890852|NCT01225211|2936536|P6|Overall Study|Adverse Event|0
890853|NCT01225211|2936537|P5|Overall Study|Adverse Event|0
890854|NCT01225211|2936538|P4|Overall Study|Adverse Event|0
890855|NCT01225211|2936539|P3|Overall Study|Adverse Event|1
890856|NCT01225211|2936540|P2|Overall Study|Adverse Event|0
890857|NCT01225211|2936541|P1|Overall Study|Adverse Event|0
890858|NCT01225159|2936644|P2|Overall Study|Change operation|0
890859|NCT01225159|2936645|P1|Overall Study|Change operation|1
890860|NCT01225146|2936655|P2|Overall Study|Sponsor discontinued making 2mg drug|2
890861|NCT01225146|2936656|P1|Overall Study|Sponsor discontinued making 2mg drug|0
890862|NCT01224821|2936722|P1|Long-Term Follow-Up|Completion of 10 Year Follow-up|9
890863|NCT01224821|2936722|P1|Long-Term Follow-Up|Death|2
890864|NCT01224821|2936722|P1|Dosimetric and Therapeutic Treatment|Started Other Treatment|1
890865|NCT01224821|2936722|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1
890866|NCT01224821|2936722|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
890867|NCT01224821|2936722|P1|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3
890868|NCT01224821|2936722|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|38
890869|NCT01224821|2936722|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
890870|NCT01224782|2936741|P1|Overall Study|Transplantation|1
890871|NCT01224782|2936741|P1|Overall Study|Deterioration|1
890872|NCT01224782|2936741|P1|Overall Study|Financial Reasons|1
890873|NCT01224782|2936741|P1|Overall Study|Change of Treatment|1
890874|NCT01224782|2936741|P1|Overall Study|Start of Dialysis|3
890875|NCT01224782|2936741|P1|Overall Study|Not Specified|4
890876|NCT01224782|2936741|P1|Overall Study|Noncompliance|10
890877|NCT01224782|2936741|P1|Overall Study|Adverse Reaction|11
890878|NCT01224782|2936741|P1|Overall Study|Adverse Event|12
890879|NCT01224782|2936741|P1|Overall Study|Improvement|13
890880|NCT01224782|2936741|P1|Overall Study|Death|14
890881|NCT01224782|2936741|P1|Overall Study|Withdrawal by Subject|16
890882|NCT01224782|2936741|P1|Overall Study|Lost to Follow-up|177
890883|NCT01224639|2936767|P8|Overall Study|Adverse Event|1
890884|NCT01224639|2936768|P7|Overall Study|Adverse Event|0
890885|NCT01224639|2936769|P6|Overall Study|Adverse Event|0
890886|NCT01224639|2936770|P5|Overall Study|Adverse Event|0
890887|NCT01224639|2936771|P4|Overall Study|Adverse Event|0
890888|NCT01224639|2936772|P3|Overall Study|Adverse Event|0
890889|NCT01224639|2936773|P2|Overall Study|Adverse Event|0
890890|NCT01224639|2936774|P1|Overall Study|Adverse Event|0
890891|NCT01224639|2936767|P8|Overall Study|Withdrawal by Subject|1
890892|NCT01224639|2936768|P7|Overall Study|Withdrawal by Subject|1
890893|NCT01224639|2936769|P6|Overall Study|Withdrawal by Subject|0
890894|NCT01224639|2936770|P5|Overall Study|Withdrawal by Subject|2
890895|NCT01224639|2936771|P4|Overall Study|Withdrawal by Subject|0
890896|NCT01224639|2936772|P3|Overall Study|Withdrawal by Subject|0
890897|NCT01224639|2936773|P2|Overall Study|Withdrawal by Subject|0
890898|NCT01224639|2936774|P1|Overall Study|Withdrawal by Subject|0
890899|NCT01224431|2936892|P2|Overall Study|no video record|1
890900|NCT01224431|2936893|P1|Overall Study|no video record|0
890901|NCT01224431|2936892|P2|Overall Study|not randomized|4
890902|NCT01224431|2936893|P1|Overall Study|not randomized|0
890903|NCT01224171|2936914|P2|Overall Study|Lost to Follow-up|3
890904|NCT01224171|2936915|P1|Overall Study|Lost to Follow-up|0
890905|NCT01224171|2936914|P2|Overall Study|Withdrawal of Consent|4
890906|NCT01224171|2936915|P1|Overall Study|Withdrawal of Consent|2
890907|NCT01224171|2936914|P2|Overall Study|Lack of Efficacy|1
890908|NCT01224171|2936915|P1|Overall Study|Lack of Efficacy|5
890909|NCT01224171|2936914|P2|Overall Study|Protocol Violation|1
890910|NCT01224171|2936915|P1|Overall Study|Protocol Violation|0
890911|NCT01224171|2936914|P2|Overall Study|Adverse Event|4
890912|NCT01224171|2936915|P1|Overall Study|Adverse Event|8
890913|NCT01223937|2936955|P2|Overall Study|Not specified|1
890914|NCT01223937|2936956|P1|Overall Study|Not specified|4
890915|NCT01223937|2936955|P2|Overall Study|Protocol Violation|7
890916|NCT01223937|2936956|P1|Overall Study|Protocol Violation|8
890917|NCT01223937|2936955|P2|Overall Study|Adverse Event|4
890918|NCT01223937|2936956|P1|Overall Study|Adverse Event|1
890919|NCT01223937|2936955|P2|Overall Study|Lost to Follow-up|4
890920|NCT01223937|2936956|P1|Overall Study|Lost to Follow-up|1
890921|NCT01223937|2936955|P2|Overall Study|Withdrawal by Subject|2
890922|NCT01223937|2936956|P1|Overall Study|Withdrawal by Subject|3
890923|NCT01223404|2937002|P6|Third Intervention (1 Day)|Non-compliance (slept)|0
890924|NCT01223404|2937003|P5|Third Intervention (1 Day)|Non-compliance (slept)|0
890925|NCT01223404|2937004|P4|Third Intervention (1 Day)|Non-compliance (slept)|1
890926|NCT01223404|2937005|P3|Third Intervention (1 Day)|Non-compliance (slept)|0
890927|NCT01223404|2937006|P2|Third Intervention (1 Day)|Non-compliance (slept)|0
890928|NCT01223404|2937007|P1|Third Intervention (1 Day)|Non-compliance (slept)|0
890929|NCT01223404|2937002|P6|Second Intervention (1 Day)|Adverse Event|0
890930|NCT01223404|2937003|P5|Second Intervention (1 Day)|Adverse Event|0
890931|NCT01223404|2937004|P4|Second Intervention (1 Day)|Adverse Event|0
890932|NCT01223404|2937005|P3|Second Intervention (1 Day)|Adverse Event|0
890933|NCT01223404|2937006|P2|Second Intervention (1 Day)|Adverse Event|0
890934|NCT01223404|2937007|P1|Second Intervention (1 Day)|Adverse Event|1
890935|NCT01223404|2937002|P6|First Intervention (1 Day)|Adverse Event|0
890936|NCT01223404|2937003|P5|First Intervention (1 Day)|Adverse Event|0
890937|NCT01223404|2937004|P4|First Intervention (1 Day)|Adverse Event|1
890938|NCT01223404|2937005|P3|First Intervention (1 Day)|Adverse Event|0
890939|NCT01223404|2937006|P2|First Intervention (1 Day)|Adverse Event|0
890940|NCT01223404|2937007|P1|First Intervention (1 Day)|Adverse Event|0
890941|NCT01223365|2937071|P1|Open-label Treatment Period|Physician Decision|2
890942|NCT01223365|2937071|P1|Open-label Treatment Period|Starting physical therapy|1
890943|NCT01223365|2937071|P1|Open-label Treatment Period|"Out of window"|1
890944|NCT01223365|2937071|P1|Open-label Treatment Period|Negative urine drug screen when on treat|1
890945|NCT01223365|2937071|P1|Open-label Treatment Period|Moved out of area|2
890946|NCT01223365|2937071|P1|Open-label Treatment Period|Noncompliance with study procedures|6
890947|NCT01223365|2937071|P1|Open-label Treatment Period|Noncompliance with study drug admin|7
890948|NCT01223365|2937071|P1|Open-label Treatment Period|Lost to Follow-up|7
890949|NCT01223365|2937071|P1|Open-label Treatment Period|Protocol Violation|15
890950|NCT01223365|2937071|P1|Open-label Treatment Period|Withdrawal by Subject|19
890951|NCT01223365|2937071|P1|Open-label Treatment Period|Lack of Efficacy|2
890952|NCT01223365|2937071|P1|Open-label Treatment Period|Adverse Event|39
890953|NCT01223365|2937071|P1|Open-label Titration Period|Starting physical therapy|1
890954|NCT01223365|2937071|P1|Open-label Titration Period|Noncompliance with study procedures|2
890955|NCT01223365|2937071|P1|Open-label Titration Period|Noncompliance with study drug admin|1
890956|NCT01223365|2937071|P1|Open-label Titration Period|Lost to Follow-up|2
890957|NCT01223365|2937071|P1|Open-label Titration Period|Protocol Violation|1
890958|NCT01223365|2937071|P1|Open-label Titration Period|Withdrawal by Subject|5
890959|NCT01223365|2937071|P1|Open-label Titration Period|Lack of Efficacy|3
890960|NCT01223365|2937071|P1|Open-label Titration Period|Adverse Event|23
890961|NCT01223365|2937071|P1|Open-label Titration Period|Enrolled but not treated|1
890962|NCT01223235|2937135|P1|Overall Study|Withdrawal by Subject|1
890963|NCT01223196|2937143|P2|Overall Study|Withdrawal by Subject|0
890964|NCT01223196|2937144|P1|Overall Study|Withdrawal by Subject|1
890965|NCT01223196|2937143|P2|Overall Study|Physician Decision|0
890966|NCT01223196|2937144|P1|Overall Study|Physician Decision|1
890967|NCT01223196|2937143|P2|Overall Study|Lost to Follow-up|0
890968|NCT01223196|2937144|P1|Overall Study|Lost to Follow-up|2
890969|NCT01223183|2937156|P2|Washout Period (5-24 Days)|Physician Decision|0
890970|NCT01223183|2937157|P1|Washout Period (5-24 Days)|Physician Decision|1
890971|NCT01223183|2937156|P2|Washout Period (5-24 Days)|Lost to Follow-up|0
890972|NCT01223183|2937157|P1|Washout Period (5-24 Days)|Lost to Follow-up|1
890973|NCT01223183|2937156|P2|Imaging Day 1|Physician Decision|1
890974|NCT01223183|2937157|P1|Imaging Day 1|Physician Decision|0
890975|NCT01223027|2937167|P2|Overall Study|Study terminated by sponsor|8
890976|NCT01223027|2937168|P1|Overall Study|Study terminated by sponsor|2
890977|NCT01223027|2937167|P2|Overall Study|New therapy for study indication|8
890978|NCT01223027|2937168|P1|Overall Study|New therapy for study indication|17
890979|NCT01223027|2937167|P2|Overall Study|Subject/guardian decicion|16
890980|NCT01223027|2937168|P1|Overall Study|Subject/guardian decicion|18
890981|NCT01223027|2937167|P2|Overall Study|Protocol Violation|1
890982|NCT01223027|2937168|P1|Overall Study|Protocol Violation|2
890983|NCT01223027|2937167|P2|Overall Study|Progressive Disease|183
890984|NCT01223027|2937168|P1|Overall Study|Progressive Disease|167
890985|NCT01223027|2937167|P2|Overall Study|Physician Decision|8
890986|NCT01223027|2937168|P1|Overall Study|Physician Decision|4
890987|NCT01223027|2937167|P2|Overall Study|Lost to Follow-up|1
890988|NCT01223027|2937168|P1|Overall Study|Lost to Follow-up|2
890989|NCT01223027|2937167|P2|Overall Study|Death|42
890990|NCT01223027|2937168|P1|Overall Study|Death|42
890991|NCT01223027|2937167|P2|Overall Study|Adverse Event|10
890992|NCT01223027|2937168|P1|Overall Study|Adverse Event|20
890993|NCT01222715|2937230|P2|Overall Study|Surgery or radiation therapy in 1st 6 wk|0
890994|NCT01222715|2937231|P1|Overall Study|Surgery or radiation therapy in 1st 6 wk|1
890995|NCT01222715|2937230|P2|Overall Study|Ineligible|1
890996|NCT01222715|2937231|P1|Overall Study|Ineligible|0
890997|NCT01222715|2937230|P2|Overall Study|Pt cannot receive treatment for >9 wks|1
890998|NCT01222715|2937231|P1|Overall Study|Pt cannot receive treatment for >9 wks|1
890999|NCT01222715|2937230|P2|Overall Study|Refusal of further protocol therapy|4
891000|NCT01222715|2937231|P1|Overall Study|Refusal of further protocol therapy|0
891001|NCT01222715|2937230|P2|Overall Study|Physician Decision|2
891002|NCT01222715|2937231|P1|Overall Study|Physician Decision|12
891003|NCT01222715|2937230|P2|Overall Study|Lack of Efficacy|14
891004|NCT01222715|2937231|P1|Overall Study|Lack of Efficacy|22
891005|NCT01222715|2937230|P2|Overall Study|Death|1
891006|NCT01222715|2937231|P1|Overall Study|Death|0
891007|NCT01222715|2937230|P2|Overall Study|Adverse Event|4
891008|NCT01222715|2937231|P1|Overall Study|Adverse Event|0
891009|NCT01222533|2937270|P1|Overall Study|Other|4
891010|NCT01222533|2937270|P1|Overall Study|Withdrawal by Subject|5
891011|NCT01222533|2937270|P1|Overall Study|Adverse Event|5
891012|NCT01222520|2937409|P2|Double-blind Period|Study medication stolen|0
891013|NCT01222520|2937410|P1|Double-blind Period|Study medication stolen|1
891014|NCT01222520|2937409|P2|Double-blind Period|Lack of Efficacy|1
891015|NCT01222520|2937410|P1|Double-blind Period|Lack of Efficacy|0
891016|NCT01222520|2937409|P2|Double-blind Period|Adverse Event|1
891017|NCT01222520|2937410|P1|Double-blind Period|Adverse Event|0
891018|NCT01222520|2937409|P2|Open-label run-in Period|Number of patients fulfilled|3
891019|NCT01222520|2937410|P1|Open-label run-in Period|Number of patients fulfilled|0
891020|NCT01222520|2937409|P2|Open-label run-in Period|Blood pressure criteria not met|18
891021|NCT01222520|2937410|P1|Open-label run-in Period|Blood pressure criteria not met|0
891022|NCT01222520|2937409|P2|Open-label run-in Period|Withdrawal by Subject|2
891023|NCT01222520|2937410|P1|Open-label run-in Period|Withdrawal by Subject|0
891024|NCT01222507|2937428|P1|Overall Study|Withdrawal by Subject|1
891025|NCT01222507|2937428|P1|Overall Study|Physician Decision|1
891026|NCT01222416|2937456|P2|Overall Study|Death|0
891027|NCT01222416|2937457|P1|Overall Study|Death|1
891028|NCT01222416|2937456|P2|Overall Study|missed view/scan|0
891029|NCT01222416|2937457|P1|Overall Study|missed view/scan|1
891030|NCT01222416|2937456|P2|Overall Study|scheduling|0
891031|NCT01222416|2937457|P1|Overall Study|scheduling|6
891032|NCT01222416|2937456|P2|Overall Study|Withdrawal by Subject|0
891033|NCT01222416|2937457|P1|Overall Study|Withdrawal by Subject|5
891034|NCT01222416|2937456|P2|Overall Study|Adverse Event|0
891035|NCT01222416|2937457|P1|Overall Study|Adverse Event|4
891036|NCT01222416|2937456|P2|Overall Study|ineligible;metastasis|0
891037|NCT01222416|2937457|P1|Overall Study|ineligible;metastasis|3
891038|NCT01222403|2937467|P2|Overall Study|Inappropriate enrollment|2
891039|NCT01222403|2937468|P1|Overall Study|Inappropriate enrollment|0
891040|NCT01222104|2937577|P1|Overall Study|Death|10
891041|NCT01222104|2937577|P1|Overall Study|Lost to Follow-up|37
891042|NCT01222078|2937600|P1|Overall Study|Early termination of the study|1
891043|NCT01221948|2937634|P1|Overall Study|Protocol Violation|4
891044|NCT01221948|2937634|P1|Overall Study|Death|1
891045|NCT01221948|2937634|P1|Overall Study|not disclosed|2
891046|NCT01221948|2937634|P1|Overall Study|Withdrawal by Subject|2
891047|NCT01221948|2937634|P1|Overall Study|Physician Decision|5
891048|NCT01221753|2937645|P1|Overall Study|Adverse Event|1
891049|NCT01221727|2937652|P2|Overall Study|Withdrawal by Subject|1
891050|NCT01221727|2937653|P1|Overall Study|Withdrawal by Subject|1
891051|NCT01221727|2937652|P2|Overall Study|Physician Decision|0
891052|NCT01221727|2937653|P1|Overall Study|Physician Decision|2
891053|NCT01221623|2937674|P2|Overall Study|Other|2
891054|NCT01221623|2937675|P1|Overall Study|Other|5
891055|NCT01221623|2937674|P2|Overall Study|Death|0
891056|NCT01221623|2937675|P1|Overall Study|Death|1
891057|NCT01221623|2937674|P2|Overall Study|Adverse Event|3
891058|NCT01221623|2937675|P1|Overall Study|Adverse Event|6
891059|NCT01221623|2937674|P2|Overall Study|Lost to Follow-up|1
891060|NCT01221623|2937675|P1|Overall Study|Lost to Follow-up|7
891061|NCT01221623|2937674|P2|Overall Study|Withdrawal by Subject|8
891062|NCT01221623|2937675|P1|Overall Study|Withdrawal by Subject|19
891063|NCT01221597|2937699|P2|Overall Study|Death|0
891064|NCT01221597|2937700|P1|Overall Study|Death|2
891065|NCT01221597|2937699|P2|Overall Study|Other|4
891066|NCT01221597|2937700|P1|Overall Study|Other|3
891067|NCT01221597|2937699|P2|Overall Study|Protocol Violation|0
891068|NCT01221597|2937700|P1|Overall Study|Protocol Violation|1
891069|NCT01221597|2937699|P2|Overall Study|Lost to Follow-up|5
891070|NCT01221597|2937700|P1|Overall Study|Lost to Follow-up|6
891071|NCT01221597|2937699|P2|Overall Study|Withdrawal by Subject|6
891072|NCT01221597|2937700|P1|Overall Study|Withdrawal by Subject|20
891073|NCT01221597|2937699|P2|Overall Study|Adverse Event|1
891074|NCT01221597|2937700|P1|Overall Study|Adverse Event|4
891075|NCT01221363|2937757|P2|Overall Study|Withdrawal by Subject|5
891076|NCT01221363|2937758|P1|Overall Study|Withdrawal by Subject|11
891077|NCT01221363|2937757|P2|Overall Study|Pregnancy|0
891078|NCT01221363|2937758|P1|Overall Study|Pregnancy|1
891079|NCT01221350|2937768|P2|Overall Study|Withdrawal by Subject|2
891080|NCT01221350|2937769|P1|Overall Study|Withdrawal by Subject|4
891081|NCT01221350|2937768|P2|Overall Study|Exclusion criteria, asthma exacerbation|1
891082|NCT01221350|2937769|P1|Overall Study|Exclusion criteria, asthma exacerbation|0
891083|NCT01221350|2937768|P2|Overall Study|Discontinued intervention (GERD)|0
891084|NCT01221350|2937769|P1|Overall Study|Discontinued intervention (GERD)|1
891085|NCT01221285|2937828|P1|Overall Study|Withdrawal by Subject|1
891086|NCT01221272|2937837|P2|Period 2|Adverse Event|2
891087|NCT01221272|2937838|P1|Period 2|Adverse Event|0
891088|NCT01221272|2937837|P2|Period 1|Significant Dosing Noncompliance|1
891089|NCT01221272|2937838|P1|Period 1|Significant Dosing Noncompliance|0
891090|NCT01221272|2937837|P2|Period 1|Consent Withdrawal|1
891091|NCT01221272|2937838|P1|Period 1|Consent Withdrawal|0
891092|NCT01221272|2937837|P2|Period 1|Adverse Event|0
891093|NCT01221272|2937838|P1|Period 1|Adverse Event|2
891094|NCT01221090|2937857|P4|Overall Study|Withdrawal by Subject|2
891095|NCT01221090|2937858|P3|Overall Study|Withdrawal by Subject|27
891096|NCT01221090|2937859|P2|Overall Study|Withdrawal by Subject|22
891097|NCT01221090|2937860|P1|Overall Study|Withdrawal by Subject|0
891098|NCT01221090|2937857|P4|Overall Study|Non-Compliant or Unable to Contact|20
891099|NCT01221090|2937858|P3|Overall Study|Non-Compliant or Unable to Contact|15
891100|NCT01221090|2937859|P2|Overall Study|Non-Compliant or Unable to Contact|12
891101|NCT01221090|2937860|P1|Overall Study|Non-Compliant or Unable to Contact|15
891102|NCT01220609|2937909|P1|Overall Study|Ineligible-Never treated|1
891103|NCT01220609|2937909|P1|Overall Study|Ineligible- Wrong cell type|1
891104|NCT01220609|2937909|P1|Overall Study|Ineligible-Wrong primary cancer site|1
891105|NCT01220557|2937923|P2|Overall Study|attended less than 6 lessons|2
891106|NCT01220557|2937924|P1|Overall Study|attended less than 6 lessons|1
891107|NCT01220557|2937923|P2|Overall Study|Lost to Follow-up|3
891108|NCT01220557|2937924|P1|Overall Study|Lost to Follow-up|5
891109|NCT01220414|2937957|P4|Overall Study|Withdrawal by Subject|1
891110|NCT01220414|2937958|P3|Overall Study|Withdrawal by Subject|0
891111|NCT01220414|2937959|P2|Overall Study|Withdrawal by Subject|0
891112|NCT01220414|2937960|P1|Overall Study|Withdrawal by Subject|1
891113|NCT01220401|2937967|P1|Overall Study|Protocol Violation|1
891114|NCT01220401|2937967|P1|Overall Study|Withdrawal by Subject|2
891115|NCT01220297|2937976|P1|Overall Study|Lost to Follow-up|1
891116|NCT01220297|2937976|P1|Overall Study|Death|2
891117|NCT01220180|2937993|P1|Overall Study|Randomized but not treated|1
891118|NCT01220180|2937993|P1|Overall Study|Death|1
891119|NCT01220180|2937993|P1|Overall Study|Lack of Efficacy|22
891120|NCT01220180|2937993|P1|Overall Study|Adverse Event|35
891121|NCT01220180|2937993|P1|Overall Study|Other|72
891122|NCT01220180|2937993|P1|Overall Study|Lost to Follow-up|76
891123|NCT01220128|2938023|P7|Overall Study|Consent withdrawn by subject|0
891124|NCT01220128|2938024|P6|Overall Study|Consent withdrawn by subject|0
891125|NCT01220128|2938025|P5|Overall Study|Consent withdrawn by subject|0
891126|NCT01220128|2938026|P4|Overall Study|Consent withdrawn by subject|0
891127|NCT01220128|2938027|P3|Overall Study|Consent withdrawn by subject|0
891128|NCT01220128|2938028|P2|Overall Study|Consent withdrawn by subject|0
891129|NCT01220128|2938029|P1|Overall Study|Consent withdrawn by subject|1
891130|NCT01220128|2938023|P7|Overall Study|Other|0
891131|NCT01220128|2938024|P6|Overall Study|Other|0
891132|NCT01220128|2938025|P5|Overall Study|Other|0
891133|NCT01220128|2938026|P4|Overall Study|Other|0
891134|NCT01220128|2938027|P3|Overall Study|Other|1
891135|NCT01220128|2938028|P2|Overall Study|Other|0
891136|NCT01220128|2938029|P1|Overall Study|Other|0
891137|NCT01220128|2938023|P7|Overall Study|Adverse event, non-fatal|3
891138|NCT01220128|2938024|P6|Overall Study|Adverse event, non-fatal|0
891139|NCT01220128|2938025|P5|Overall Study|Adverse event, non-fatal|0
891140|NCT01220128|2938026|P4|Overall Study|Adverse event, non-fatal|0
891141|NCT01220128|2938027|P3|Overall Study|Adverse event, non-fatal|0
891142|NCT01220128|2938028|P2|Overall Study|Adverse event, non-fatal|0
891143|NCT01220128|2938029|P1|Overall Study|Adverse event, non-fatal|1
891144|NCT01220128|2938023|P7|Overall Study|Adverse event, serious fatal|1
891145|NCT01220128|2938024|P6|Overall Study|Adverse event, serious fatal|0
891146|NCT01220128|2938025|P5|Overall Study|Adverse event, serious fatal|0
891147|NCT01220128|2938026|P4|Overall Study|Adverse event, serious fatal|0
891148|NCT01220128|2938027|P3|Overall Study|Adverse event, serious fatal|0
891149|NCT01220128|2938028|P2|Overall Study|Adverse event, serious fatal|0
891150|NCT01220128|2938029|P1|Overall Study|Adverse event, serious fatal|2
891151|NCT01220128|2938023|P7|Overall Study|Sponsor study termination|1
891152|NCT01220128|2938024|P6|Overall Study|Sponsor study termination|0
891153|NCT01220128|2938025|P5|Overall Study|Sponsor study termination|0
891154|NCT01220128|2938026|P4|Overall Study|Sponsor study termination|0
891155|NCT01220128|2938027|P3|Overall Study|Sponsor study termination|0
891156|NCT01220128|2938028|P2|Overall Study|Sponsor study termination|1
891157|NCT01220128|2938029|P1|Overall Study|Sponsor study termination|0
891158|NCT01220128|2938023|P7|Overall Study|Progressive disease|0
891159|NCT01220128|2938024|P6|Overall Study|Progressive disease|0
891160|NCT01220128|2938025|P5|Overall Study|Progressive disease|0
891161|NCT01220128|2938026|P4|Overall Study|Progressive disease|0
891162|NCT01220128|2938027|P3|Overall Study|Progressive disease|2
891163|NCT01220128|2938028|P2|Overall Study|Progressive disease|0
891164|NCT01220128|2938029|P1|Overall Study|Progressive disease|0
891165|NCT01219985|2938234|P1|Overall Study|Physician Decision|20
891166|NCT01219933|2938240|P1|Overall Study|Lack of Efficacy|1
891167|NCT01219933|2938240|P1|Overall Study|Protocol Violation|8
891168|NCT01219933|2938240|P1|Overall Study|Withdrawal by Subject|5
891169|NCT01219933|2938240|P1|Overall Study|GC free|1
891170|NCT01219933|2938240|P1|Overall Study|Lost to Follow-up|3
891171|NCT01219933|2938240|P1|Overall Study|No LDA maintained|7
891172|NCT01219933|2938240|P1|Overall Study|No LDA reached|5
891173|NCT01219933|2938240|P1|Overall Study|Adverse Event|8
891174|NCT01218867|2938450|P11|Overall Study|Death during treatment|0
891175|NCT01218867|2938451|P10|Overall Study|Death during treatment|0
891176|NCT01218867|2938452|P9|Overall Study|Death during treatment|0
891177|NCT01218867|2938453|P8|Overall Study|Death during treatment|0
891178|NCT01218867|2938454|P7|Overall Study|Death during treatment|1
891179|NCT01218867|2938455|P6|Overall Study|Death during treatment|0
891180|NCT01218867|2938456|P5|Overall Study|Death during treatment|0
891181|NCT01218867|2938457|P4|Overall Study|Death during treatment|0
891182|NCT01218867|2938458|P3|Overall Study|Death during treatment|0
891183|NCT01218867|2938459|P2|Overall Study|Death during treatment|0
891184|NCT01218867|2938460|P1|Overall Study|Death during treatment|0
891185|NCT01218802|2938508|P2|Overall Study|Incarcerated|0
891186|NCT01218802|2938509|P1|Overall Study|Incarcerated|2
891187|NCT01218802|2938508|P2|Overall Study|Adverse Event|2
891188|NCT01218802|2938509|P1|Overall Study|Adverse Event|0
891189|NCT01218802|2938508|P2|Overall Study|Withdrawal by Subject|10
891190|NCT01218802|2938509|P1|Overall Study|Withdrawal by Subject|3
891191|NCT01218802|2938508|P2|Overall Study|Lost to Follow-up|6
891192|NCT01218802|2938509|P1|Overall Study|Lost to Follow-up|5
891193|NCT01218659|2938519|P3|12-Month OLE|Declined to participate in the OLE|4
891194|NCT01218659|2938520|P2|12-Month OLE|Declined to participate in the OLE|0
891195|NCT01218659|2938521|P1|12-Month OLE|Declined to participate in the OLE|0
891196|NCT01218659|2938519|P3|12-Month OLE|Lack of Efficacy|1
891197|NCT01218659|2938520|P2|12-Month OLE|Lack of Efficacy|0
891198|NCT01218659|2938521|P1|12-Month OLE|Lack of Efficacy|0
891199|NCT01218659|2938519|P3|12-Month OLE|Pregnancy|1
891200|NCT01218659|2938520|P2|12-Month OLE|Pregnancy|0
891201|NCT01218659|2938521|P1|12-Month OLE|Pregnancy|0
891202|NCT01218659|2938519|P3|12-Month OLE|Lost to Follow-up|1
891203|NCT01218659|2938520|P2|12-Month OLE|Lost to Follow-up|0
891204|NCT01218659|2938521|P1|12-Month OLE|Lost to Follow-up|0
891205|NCT01218659|2938519|P3|12-Month OLE|Physician Decision|1
891206|NCT01218659|2938520|P2|12-Month OLE|Physician Decision|0
891207|NCT01218659|2938521|P1|12-Month OLE|Physician Decision|0
891208|NCT01218659|2938519|P3|12-Month OLE|Withdrawal by Subject|2
891209|NCT01218659|2938520|P2|12-Month OLE|Withdrawal by Subject|0
891210|NCT01218659|2938521|P1|12-Month OLE|Withdrawal by Subject|0
891211|NCT01218659|2938519|P3|18-Month Randomized Period|Did not receive study drug|0
891212|NCT01218659|2938520|P2|18-Month Randomized Period|Did not receive study drug|3
891213|NCT01218659|2938521|P1|18-Month Randomized Period|Did not receive study drug|0
891214|NCT01218659|2938519|P3|18-Month Randomized Period|Withdrawal by Subject|0
891215|NCT01218659|2938520|P2|18-Month Randomized Period|Withdrawal by Subject|3
891216|NCT01218659|2938521|P1|18-Month Randomized Period|Withdrawal by Subject|2
891217|NCT01218646|2938536|P4|Overall Study|Protocol Violation|1
891218|NCT01218646|2938537|P3|Overall Study|Protocol Violation|1
891219|NCT01218646|2938538|P2|Overall Study|Protocol Violation|0
891220|NCT01218646|2938539|P1|Overall Study|Protocol Violation|0
891221|NCT01218646|2938536|P4|Overall Study|Lost to Follow-up|0
891222|NCT01218646|2938537|P3|Overall Study|Lost to Follow-up|0
891223|NCT01218646|2938538|P2|Overall Study|Lost to Follow-up|0
891224|NCT01218646|2938539|P1|Overall Study|Lost to Follow-up|1
891225|NCT01218646|2938536|P4|Overall Study|Adverse Event|0
891226|NCT01218646|2938537|P3|Overall Study|Adverse Event|1
891227|NCT01218646|2938538|P2|Overall Study|Adverse Event|0
891228|NCT01218646|2938539|P1|Overall Study|Adverse Event|0
891229|NCT01218594|2938577|P1|Overall Study|Physician Decision|6
891230|NCT01218594|2938577|P1|Overall Study|Adverse Event|2
891231|NCT01218594|2938577|P1|Overall Study|Withdrawal by Subject|3
891232|NCT01218594|2938577|P1|Overall Study|Death|1
891233|NCT01218477|2938585|P4|Overall Study|Maximum clinical benefit|0
891234|NCT01218477|2938586|P3|Overall Study|Maximum clinical benefit|0
891235|NCT01218477|2938587|P2|Overall Study|Maximum clinical benefit|2
891236|NCT01218477|2938588|P1|Overall Study|Maximum clinical benefit|0
891237|NCT01218477|2938585|P4|Overall Study|Administrative reason by sponsor|0
891238|NCT01218477|2938586|P3|Overall Study|Administrative reason by sponsor|1
891239|NCT01218477|2938587|P2|Overall Study|Administrative reason by sponsor|0
891240|NCT01218477|2938588|P1|Overall Study|Administrative reason by sponsor|0
891241|NCT01218477|2938585|P4|Overall Study|Prepared for cell transplantation|0
891242|NCT01218477|2938586|P3|Overall Study|Prepared for cell transplantation|1
891243|NCT01218477|2938587|P2|Overall Study|Prepared for cell transplantation|1
891244|NCT01218477|2938588|P1|Overall Study|Prepared for cell transplantation|0
891245|NCT01218477|2938585|P4|Overall Study|Withdrawal by Subject|0
891246|NCT01218477|2938586|P3|Overall Study|Withdrawal by Subject|1
891247|NCT01218477|2938587|P2|Overall Study|Withdrawal by Subject|0
891248|NCT01218477|2938588|P1|Overall Study|Withdrawal by Subject|0
891249|NCT01218477|2938585|P4|Overall Study|No longer meets study criteria|0
891250|NCT01218477|2938586|P3|Overall Study|No longer meets study criteria|0
891251|NCT01218477|2938587|P2|Overall Study|No longer meets study criteria|0
891252|NCT01218477|2938588|P1|Overall Study|No longer meets study criteria|1
891253|NCT01218477|2938585|P4|Overall Study|Study drug toxicity|0
891254|NCT01218477|2938586|P3|Overall Study|Study drug toxicity|5
891255|NCT01218477|2938587|P2|Overall Study|Study drug toxicity|2
891256|NCT01218477|2938588|P1|Overall Study|Study drug toxicity|0
891257|NCT01218477|2938585|P4|Overall Study|Disease progression|2
891258|NCT01218477|2938586|P3|Overall Study|Disease progression|6
891259|NCT01218477|2938587|P2|Overall Study|Disease progression|3
891260|NCT01218477|2938588|P1|Overall Study|Disease progression|2
891261|NCT01218438|2938605|P1|Epoch 4|Withdrawal by Subject|2
891262|NCT01218438|2938605|P1|Epoch 4|Physician Decision|1
891263|NCT01218438|2938605|P1|Epoch 3|Adverse Event|1
891264|NCT01218438|2938605|P1|Epoch 3|Withdrawal by Subject|3
891265|NCT01218438|2938605|P1|Epoch 1|Adverse Event|1
891266|NCT01218438|2938605|P1|Epoch 1|Physician Decision|2
891267|NCT01218308|2938771|P2|Overall Study|Other|21
891268|NCT01218308|2938772|P1|Overall Study|Other|14
891269|NCT01218308|2938771|P2|Overall Study|Lost to Follow-up|31
891270|NCT01218308|2938772|P1|Overall Study|Lost to Follow-up|27
891271|NCT01218308|2938771|P2|Overall Study|Withdrawal by Subject|64
891272|NCT01218308|2938772|P1|Overall Study|Withdrawal by Subject|61
891273|NCT01218308|2938771|P2|Overall Study|Protocol Violation|2
891274|NCT01218308|2938772|P1|Overall Study|Protocol Violation|0
891275|NCT01218308|2938771|P2|Overall Study|Adverse Event|2
891276|NCT01218308|2938772|P1|Overall Study|Adverse Event|1
891277|NCT01218243|2938816|P2|Overall Study|Protocol Violation|10
891278|NCT01218243|2938817|P1|Overall Study|Protocol Violation|5
891279|NCT01218243|2938816|P2|Overall Study|Lost to Follow-up|3
891280|NCT01218243|2938817|P1|Overall Study|Lost to Follow-up|3
891281|NCT01218243|2938816|P2|Overall Study|Lack of Efficacy|1
891282|NCT01218243|2938817|P1|Overall Study|Lack of Efficacy|1
891283|NCT01218204|2938833|P4|Part B Pooled Treatment Arm|Protocol Violation|1
891284|NCT01218204|2938834|P3|Part B Pooled Treatment Arm|Protocol Violation|0
891285|NCT01218204|2938835|P2|Part B Pooled Treatment Arm|Protocol Violation|0
891286|NCT01218204|2938836|P1|Part B Pooled Treatment Arm|Protocol Violation|0
891287|NCT01218204|2938833|P4|Part B Pooled Treatment Arm|Adverse Event|2
891288|NCT01218204|2938834|P3|Part B Pooled Treatment Arm|Adverse Event|0
891289|NCT01218204|2938835|P2|Part B Pooled Treatment Arm|Adverse Event|0
891290|NCT01218204|2938836|P1|Part B Pooled Treatment Arm|Adverse Event|0
891291|NCT01218204|2938833|P4|Part B Run-in|Withdrawal by Subject|0
891292|NCT01218204|2938834|P3|Part B Run-in|Withdrawal by Subject|3
891293|NCT01218204|2938835|P2|Part B Run-in|Withdrawal by Subject|0
891294|NCT01218204|2938836|P1|Part B Run-in|Withdrawal by Subject|0
891295|NCT01218204|2938833|P4|Part B Run-in|Protocol Violation|0
891296|NCT01218204|2938834|P3|Part B Run-in|Protocol Violation|2
891297|NCT01218204|2938835|P2|Part B Run-in|Protocol Violation|0
891298|NCT01218204|2938836|P1|Part B Run-in|Protocol Violation|0
891299|NCT01218204|2938833|P4|Part B Run-in|Adverse Event|0
891300|NCT01218204|2938834|P3|Part B Run-in|Adverse Event|1
891301|NCT01218204|2938835|P2|Part B Run-in|Adverse Event|0
891302|NCT01218204|2938836|P1|Part B Run-in|Adverse Event|0
891303|NCT01218204|2938833|P4|Part B Washout|Did not meet continuation criteria|0
891304|NCT01218204|2938834|P3|Part B Washout|Did not meet continuation criteria|0
891305|NCT01218204|2938835|P2|Part B Washout|Did not meet continuation criteria|112
891306|NCT01218204|2938836|P1|Part B Washout|Did not meet continuation criteria|0
891307|NCT01218204|2938833|P4|Part B Washout|Reached defined stopping criteria|0
891308|NCT01218204|2938834|P3|Part B Washout|Reached defined stopping criteria|0
891309|NCT01218204|2938835|P2|Part B Washout|Reached defined stopping criteria|2
891310|NCT01218204|2938836|P1|Part B Washout|Reached defined stopping criteria|0
891311|NCT01218204|2938833|P4|Part B Washout|Withdrawal by Subject|0
891312|NCT01218204|2938834|P3|Part B Washout|Withdrawal by Subject|0
891313|NCT01218204|2938835|P2|Part B Washout|Withdrawal by Subject|14
891314|NCT01218204|2938836|P1|Part B Washout|Withdrawal by Subject|0
891315|NCT01218204|2938833|P4|Part B Washout|Physician Decision|0
891316|NCT01218204|2938834|P3|Part B Washout|Physician Decision|0
891317|NCT01218204|2938835|P2|Part B Washout|Physician Decision|14
891318|NCT01218204|2938836|P1|Part B Washout|Physician Decision|0
891319|NCT01218204|2938833|P4|Part B Washout|Lost to Follow-up|0
891320|NCT01218204|2938834|P3|Part B Washout|Lost to Follow-up|0
891321|NCT01218204|2938835|P2|Part B Washout|Lost to Follow-up|2
891322|NCT01218204|2938836|P1|Part B Washout|Lost to Follow-up|0
891323|NCT01218204|2938833|P4|Part B Washout|Adverse Event|0
891324|NCT01218204|2938834|P3|Part B Washout|Adverse Event|0
891325|NCT01218204|2938835|P2|Part B Washout|Adverse Event|1
891326|NCT01218204|2938836|P1|Part B Washout|Adverse Event|0
891327|NCT01218126|2939100|P4|Overall Study|Withdrawal by Subject|6
891328|NCT01218126|2939101|P3|Overall Study|Withdrawal by Subject|4
891329|NCT01218126|2939102|P2|Overall Study|Withdrawal by Subject|5
891330|NCT01218126|2939103|P1|Overall Study|Withdrawal by Subject|2
891331|NCT01218126|2939100|P4|Overall Study|Physician Decision|2
891332|NCT01218126|2939101|P3|Overall Study|Physician Decision|4
891333|NCT01218126|2939102|P2|Overall Study|Physician Decision|2
891334|NCT01218126|2939103|P1|Overall Study|Physician Decision|1
891335|NCT01218126|2939100|P4|Overall Study|Lost to Follow-up|2
891336|NCT01218126|2939101|P3|Overall Study|Lost to Follow-up|0
891337|NCT01218126|2939102|P2|Overall Study|Lost to Follow-up|0
891338|NCT01218126|2939103|P1|Overall Study|Lost to Follow-up|0
891339|NCT01218126|2939100|P4|Overall Study|Protocol-defined stopping criteria|0
891340|NCT01218126|2939101|P3|Overall Study|Protocol-defined stopping criteria|0
891341|NCT01218126|2939102|P2|Overall Study|Protocol-defined stopping criteria|1
891342|NCT01218126|2939103|P1|Overall Study|Protocol-defined stopping criteria|1
891343|NCT01218126|2939100|P4|Overall Study|Protocol Violation|3
891344|NCT01218126|2939101|P3|Overall Study|Protocol Violation|2
891345|NCT01218126|2939102|P2|Overall Study|Protocol Violation|2
891346|NCT01218126|2939103|P1|Overall Study|Protocol Violation|5
891347|NCT01218126|2939100|P4|Overall Study|Lack of Efficacy|6
891348|NCT01218126|2939101|P3|Overall Study|Lack of Efficacy|2
891349|NCT01218126|2939102|P2|Overall Study|Lack of Efficacy|2
891350|NCT01218126|2939103|P1|Overall Study|Lack of Efficacy|7
891351|NCT01218126|2939100|P4|Overall Study|Adverse Event|16
891352|NCT01218126|2939101|P3|Overall Study|Adverse Event|12
891353|NCT01218126|2939102|P2|Overall Study|Adverse Event|10
891354|NCT01218126|2939103|P1|Overall Study|Adverse Event|8
891355|NCT01218113|2939144|P3|Overall Study|Protocol Deviation Eligibility Criteria|1
891356|NCT01218113|2939145|P2|Overall Study|Protocol Deviation Eligibility Criteria|0
891357|NCT01218113|2939146|P1|Overall Study|Protocol Deviation Eligibility Criteria|0
891358|NCT01218113|2939144|P3|Overall Study|Lost to Follow-up|4
891359|NCT01218113|2939145|P2|Overall Study|Lost to Follow-up|1
891360|NCT01218113|2939146|P1|Overall Study|Lost to Follow-up|4
891361|NCT01218113|2939144|P3|Overall Study|Withdrawal by Subject|1
891362|NCT01218113|2939145|P2|Overall Study|Withdrawal by Subject|0
891363|NCT01218113|2939146|P1|Overall Study|Withdrawal by Subject|1
891364|NCT01218100|2939327|P4|Overall Study|Other Reason|4
891365|NCT01218100|2939328|P3|Overall Study|Other Reason|6
891366|NCT01218100|2939329|P2|Overall Study|Other Reason|2
891367|NCT01218100|2939330|P1|Overall Study|Other Reason|2
891368|NCT01218100|2939327|P4|Overall Study|Lost to Follow-up|1
891369|NCT01218100|2939328|P3|Overall Study|Lost to Follow-up|2
891370|NCT01218100|2939329|P2|Overall Study|Lost to Follow-up|8
891371|NCT01218100|2939330|P1|Overall Study|Lost to Follow-up|3
891372|NCT01218100|2939327|P4|Overall Study|Withdrawal by Subject|7
891373|NCT01218100|2939328|P3|Overall Study|Withdrawal by Subject|6
891374|NCT01218100|2939329|P2|Overall Study|Withdrawal by Subject|2
891375|NCT01218100|2939330|P1|Overall Study|Withdrawal by Subject|5
891376|NCT01218100|2939327|P4|Overall Study|Protocol Violation|1
891377|NCT01218100|2939328|P3|Overall Study|Protocol Violation|1
891378|NCT01218100|2939329|P2|Overall Study|Protocol Violation|0
891379|NCT01218100|2939330|P1|Overall Study|Protocol Violation|0
891380|NCT01218100|2939327|P4|Overall Study|Lack of Efficacy|12
891381|NCT01218100|2939328|P3|Overall Study|Lack of Efficacy|5
891382|NCT01218100|2939329|P2|Overall Study|Lack of Efficacy|6
891383|NCT01218100|2939330|P1|Overall Study|Lack of Efficacy|9
891384|NCT01218100|2939327|P4|Overall Study|Adverse Event|7
891385|NCT01218100|2939328|P3|Overall Study|Adverse Event|6
891386|NCT01218100|2939329|P2|Overall Study|Adverse Event|6
891387|NCT01218100|2939330|P1|Overall Study|Adverse Event|4
891388|NCT01218100|2939327|P4|Overall Study|Did not meet InclusionExclusion criteria|2
891389|NCT01218100|2939328|P3|Overall Study|Did not meet InclusionExclusion criteria|1
891390|NCT01218100|2939329|P2|Overall Study|Did not meet InclusionExclusion criteria|1
891391|NCT01218100|2939330|P1|Overall Study|Did not meet InclusionExclusion criteria|1
891392|NCT01218087|2939346|P2|Overall Study|Transferred|5
891393|NCT01218087|2939347|P1|Overall Study|Transferred|8
891394|NCT01218087|2939346|P2|Overall Study|Withdrawal by Subject|0
891395|NCT01218087|2939347|P1|Overall Study|Withdrawal by Subject|5
891396|NCT01218087|2939346|P2|Overall Study|Death|1
891397|NCT01218087|2939347|P1|Overall Study|Death|2
891398|NCT01218009|2939369|P2|Overall Study|Sponsor terminated study|163
891399|NCT01218009|2939370|P1|Overall Study|Sponsor terminated study|161
891400|NCT01218009|2939369|P2|Overall Study|Withdrawal by Subject|1
891401|NCT01218009|2939370|P1|Overall Study|Withdrawal by Subject|3
891402|NCT01218009|2939369|P2|Overall Study|Protocol Violation|1
891403|NCT01218009|2939370|P1|Overall Study|Protocol Violation|2
891404|NCT01217957|2939393|P5|Phase 2|Withdrawal by Patient|1
891405|NCT01217957|2939394|P4|Phase 2|Withdrawal by Patient|0
891406|NCT01217957|2939395|P3|Phase 2|Withdrawal by Patient|0
891407|NCT01217957|2939396|P2|Phase 2|Withdrawal by Patient|0
891408|NCT01217957|2939397|P1|Phase 2|Withdrawal by Patient|0
891409|NCT01217957|2939393|P5|Phase 1|Withdrawal by Patient|0
891410|NCT01217957|2939394|P4|Phase 1|Withdrawal by Patient|1
891411|NCT01217957|2939395|P3|Phase 1|Withdrawal by Patient|1
891412|NCT01217957|2939396|P2|Phase 1|Withdrawal by Patient|0
891413|NCT01217957|2939397|P1|Phase 1|Withdrawal by Patient|1
891414|NCT01217944|2939456|P3|Overall Study|Lack of Efficacy|0
891415|NCT01217944|2939457|P2|Overall Study|Lack of Efficacy|0
891416|NCT01217944|2939458|P1|Overall Study|Lack of Efficacy|1
891417|NCT01217944|2939456|P3|Overall Study|Withdrawal by Subject|0
891418|NCT01217944|2939457|P2|Overall Study|Withdrawal by Subject|2
891419|NCT01217944|2939458|P1|Overall Study|Withdrawal by Subject|1
891420|NCT01217944|2939456|P3|Overall Study|Lost to Follow-up|0
891421|NCT01217944|2939457|P2|Overall Study|Lost to Follow-up|1
891422|NCT01217944|2939458|P1|Overall Study|Lost to Follow-up|3
891423|NCT01217944|2939456|P3|Overall Study|Protocol Violation|0
891424|NCT01217944|2939457|P2|Overall Study|Protocol Violation|1
891425|NCT01217944|2939458|P1|Overall Study|Protocol Violation|1
891426|NCT01217892|2939501|P4|Overall Study|Poor/Non-Compliance|0
891427|NCT01217892|2939502|P3|Overall Study|Poor/Non-Compliance|1
891428|NCT01217892|2939503|P2|Overall Study|Poor/Non-Compliance|0
891429|NCT01217892|2939504|P1|Overall Study|Poor/Non-Compliance|0
891430|NCT01217892|2939501|P4|Overall Study|Incorrect enrollment|0
891431|NCT01217892|2939502|P3|Overall Study|Incorrect enrollment|1
891432|NCT01217892|2939503|P2|Overall Study|Incorrect enrollment|1
891433|NCT01217892|2939504|P1|Overall Study|Incorrect enrollment|0
891434|NCT01217892|2939501|P4|Overall Study|Subject no longer meets study criteria|8
891435|NCT01217892|2939502|P3|Overall Study|Subject no longer meets study criteria|4
891436|NCT01217892|2939503|P2|Overall Study|Subject no longer meets study criteria|2
891437|NCT01217892|2939504|P1|Overall Study|Subject no longer meets study criteria|5
891438|NCT01217892|2939501|P4|Overall Study|Lab value|0
891439|NCT01217892|2939502|P3|Overall Study|Lab value|1
891440|NCT01217892|2939503|P2|Overall Study|Lab value|0
891441|NCT01217892|2939504|P1|Overall Study|Lab value|1
891442|NCT01217892|2939501|P4|Overall Study|Withdrawal by Subject|0
891443|NCT01217892|2939502|P3|Overall Study|Withdrawal by Subject|1
891444|NCT01217892|2939503|P2|Overall Study|Withdrawal by Subject|2
891445|NCT01217892|2939504|P1|Overall Study|Withdrawal by Subject|0
891446|NCT01217892|2939501|P4|Overall Study|Adverse Event|0
891447|NCT01217892|2939502|P3|Overall Study|Adverse Event|1
891448|NCT01217892|2939503|P2|Overall Study|Adverse Event|1
891449|NCT01217892|2939504|P1|Overall Study|Adverse Event|1
891450|NCT01217814|2939567|P3|Overall Study|Lack of Efficacy|1
891451|NCT01217814|2939568|P2|Overall Study|Lack of Efficacy|0
891452|NCT01217814|2939569|P1|Overall Study|Lack of Efficacy|0
891453|NCT01217814|2939567|P3|Overall Study|Adverse Event|0
891454|NCT01217814|2939568|P2|Overall Study|Adverse Event|1
891455|NCT01217814|2939569|P1|Overall Study|Adverse Event|1
891456|NCT01217801|2939595|P2|Period 1|Withdrawal by Subject|1
891457|NCT01217801|2939596|P1|Period 1|Withdrawal by Subject|0
891458|NCT01217801|2939595|P2|Period 1|Protocol Violation|1
891459|NCT01217801|2939596|P1|Period 1|Protocol Violation|1
891460|NCT01217606|2939625|P2|9-Month Masked Extension|Lack of Efficacy|0
891461|NCT01217606|2939626|P1|9-Month Masked Extension|Lack of Efficacy|2
891462|NCT01217606|2939625|P2|9-Month Masked Extension|Pregnancy|0
891463|NCT01217606|2939626|P1|9-Month Masked Extension|Pregnancy|1
891464|NCT01217606|2939625|P2|9-Month Masked Extension|Lost to Follow-up|0
891465|NCT01217606|2939626|P1|9-Month Masked Extension|Lost to Follow-up|1
891466|NCT01217606|2939625|P2|9-Month Masked Extension|Personal Reasons|1
891467|NCT01217606|2939626|P1|9-Month Masked Extension|Personal Reasons|2
891468|NCT01217606|2939625|P2|9-Month Masked Extension|Other Reasons|4
891469|NCT01217606|2939626|P1|9-Month Masked Extension|Other Reasons|4
891470|NCT01217606|2939625|P2|9-Month Masked Extension|Adverse Event|6
891471|NCT01217606|2939626|P1|9-Month Masked Extension|Adverse Event|3
891472|NCT01217606|2939625|P2|Initial Treatment Phase|Adverse Event|6
891473|NCT01217606|2939626|P1|Initial Treatment Phase|Adverse Event|10
891474|NCT01217606|2939625|P2|Initial Treatment Phase|Lack of Efficacy|0
891475|NCT01217606|2939626|P1|Initial Treatment Phase|Lack of Efficacy|1
891476|NCT01217606|2939625|P2|Initial Treatment Phase|Personal Reasons|2
891477|NCT01217606|2939626|P1|Initial Treatment Phase|Personal Reasons|0
891478|NCT01217606|2939625|P2|Initial Treatment Phase|Protocol Violation|2
891479|NCT01217606|2939626|P1|Initial Treatment Phase|Protocol Violation|3
891480|NCT01217606|2939625|P2|Initial Treatment Phase|Other Reasons|2
891481|NCT01217606|2939626|P1|Initial Treatment Phase|Other Reasons|0
891482|NCT01217476|2939657|P2|Overall Study|Other|0
891483|NCT01217476|2939658|P1|Overall Study|Other|2
891484|NCT01217476|2939657|P2|Overall Study|Protocol Deviation|0
891485|NCT01217476|2939658|P1|Overall Study|Protocol Deviation|1
891486|NCT01217476|2939657|P2|Overall Study|Surgery on the Target Limb|2
891487|NCT01217476|2939658|P1|Overall Study|Surgery on the Target Limb|0
891488|NCT01217476|2939657|P2|Overall Study|Withdrawal by Subject|3
891489|NCT01217476|2939658|P1|Overall Study|Withdrawal by Subject|3
891490|NCT01217476|2939657|P2|Overall Study|Physician Decision|1
891491|NCT01217476|2939658|P1|Overall Study|Physician Decision|0
891492|NCT01217476|2939657|P2|Overall Study|Adverse Event|1
891493|NCT01217476|2939658|P1|Overall Study|Adverse Event|6
891494|NCT01217463|2939668|P2|Overall Study|Other|1
891495|NCT01217463|2939669|P1|Overall Study|Other|1
891496|NCT01217463|2939668|P2|Overall Study|Patient Non-compliant|0
891497|NCT01217463|2939669|P1|Overall Study|Patient Non-compliant|1
891498|NCT01217463|2939668|P2|Overall Study|Surgery on the Target Limb|1
891499|NCT01217463|2939669|P1|Overall Study|Surgery on the Target Limb|0
891500|NCT01217463|2939668|P2|Overall Study|Withdrawal by Subject|0
891501|NCT01217463|2939669|P1|Overall Study|Withdrawal by Subject|3
891502|NCT01217463|2939668|P2|Overall Study|Physician Decision|1
891503|NCT01217463|2939669|P1|Overall Study|Physician Decision|0
891504|NCT01217463|2939668|P2|Overall Study|Adverse Event|5
891505|NCT01217463|2939669|P1|Overall Study|Adverse Event|8
891506|NCT01217307|2939689|P2|Overall Study|Withdrawal by Subject|1
891507|NCT01217307|2939690|P1|Overall Study|Withdrawal by Subject|0
891508|NCT01217112|2939705|P5|Overall Study|Physician Decision|1
891509|NCT01217112|2939706|P4|Overall Study|Physician Decision|0
891510|NCT01217112|2939707|P3|Overall Study|Physician Decision|0
891511|NCT01217112|2939708|P2|Overall Study|Physician Decision|0
891512|NCT01217112|2939709|P1|Overall Study|Physician Decision|0
891513|NCT01217112|2939705|P5|Overall Study|Withdrawal by Subject|0
891514|NCT01217112|2939706|P4|Overall Study|Withdrawal by Subject|0
891515|NCT01217112|2939707|P3|Overall Study|Withdrawal by Subject|1
891516|NCT01217112|2939708|P2|Overall Study|Withdrawal by Subject|0
891517|NCT01217112|2939709|P1|Overall Study|Withdrawal by Subject|0
891518|NCT01217112|2939705|P5|Overall Study|Adverse Event|0
891519|NCT01217112|2939706|P4|Overall Study|Adverse Event|2
891520|NCT01217112|2939707|P3|Overall Study|Adverse Event|0
891521|NCT01217112|2939708|P2|Overall Study|Adverse Event|2
891522|NCT01217112|2939709|P1|Overall Study|Adverse Event|0
891523|NCT01217073|2939942|P8|Extension Period|Withdrawal by Subject|8
891524|NCT01217073|2939943|P7|Extension Period|Withdrawal by Subject|30
891525|NCT01217073|2939944|P6|Extension Period|Withdrawal by Subject|0
891526|NCT01217073|2939945|P5|Extension Period|Withdrawal by Subject|0
891527|NCT01217073|2939946|P4|Extension Period|Withdrawal by Subject|0
891528|NCT01217073|2939947|P3|Extension Period|Withdrawal by Subject|0
891529|NCT01217073|2939948|P2|Extension Period|Withdrawal by Subject|0
891530|NCT01217073|2939949|P1|Extension Period|Withdrawal by Subject|0
891531|NCT01217073|2939942|P8|Extension Period|Site discontinued study participation|2
891532|NCT01217073|2939943|P7|Extension Period|Site discontinued study participation|7
891533|NCT01217073|2939944|P6|Extension Period|Site discontinued study participation|0
891534|NCT01217073|2939945|P5|Extension Period|Site discontinued study participation|0
891535|NCT01217073|2939946|P4|Extension Period|Site discontinued study participation|0
891536|NCT01217073|2939947|P3|Extension Period|Site discontinued study participation|0
891537|NCT01217073|2939948|P2|Extension Period|Site discontinued study participation|0
891538|NCT01217073|2939949|P1|Extension Period|Site discontinued study participation|0
891539|NCT01217073|2939942|P8|Extension Period|Protocol Violation|1
891540|NCT01217073|2939943|P7|Extension Period|Protocol Violation|2
891541|NCT01217073|2939944|P6|Extension Period|Protocol Violation|0
891542|NCT01217073|2939945|P5|Extension Period|Protocol Violation|0
891543|NCT01217073|2939946|P4|Extension Period|Protocol Violation|0
891544|NCT01217073|2939947|P3|Extension Period|Protocol Violation|0
891545|NCT01217073|2939948|P2|Extension Period|Protocol Violation|0
891546|NCT01217073|2939949|P1|Extension Period|Protocol Violation|0
891547|NCT01217073|2939942|P8|Extension Period|Physician Decision|1
891548|NCT01217073|2939943|P7|Extension Period|Physician Decision|4
891549|NCT01217073|2939944|P6|Extension Period|Physician Decision|0
891550|NCT01217073|2939945|P5|Extension Period|Physician Decision|0
891551|NCT01217073|2939946|P4|Extension Period|Physician Decision|0
891552|NCT01217073|2939947|P3|Extension Period|Physician Decision|0
891553|NCT01217073|2939948|P2|Extension Period|Physician Decision|0
891554|NCT01217073|2939949|P1|Extension Period|Physician Decision|0
891555|NCT01217073|2939942|P8|Extension Period|Non-compliance with study drug|1
891556|NCT01217073|2939943|P7|Extension Period|Non-compliance with study drug|0
891557|NCT01217073|2939944|P6|Extension Period|Non-compliance with study drug|0
891558|NCT01217073|2939945|P5|Extension Period|Non-compliance with study drug|0
891559|NCT01217073|2939946|P4|Extension Period|Non-compliance with study drug|0
891560|NCT01217073|2939947|P3|Extension Period|Non-compliance with study drug|0
891561|NCT01217073|2939948|P2|Extension Period|Non-compliance with study drug|0
891562|NCT01217073|2939949|P1|Extension Period|Non-compliance with study drug|0
891563|NCT01217073|2939942|P8|Extension Period|Lost to Follow-up|1
891564|NCT01217073|2939943|P7|Extension Period|Lost to Follow-up|9
891565|NCT01217073|2939944|P6|Extension Period|Lost to Follow-up|0
891566|NCT01217073|2939945|P5|Extension Period|Lost to Follow-up|0
891567|NCT01217073|2939946|P4|Extension Period|Lost to Follow-up|0
891568|NCT01217073|2939947|P3|Extension Period|Lost to Follow-up|0
891569|NCT01217073|2939948|P2|Extension Period|Lost to Follow-up|0
891570|NCT01217073|2939949|P1|Extension Period|Lost to Follow-up|0
891571|NCT01217073|2939942|P8|Extension Period|Lack of Efficacy|0
891572|NCT01217073|2939943|P7|Extension Period|Lack of Efficacy|3
891573|NCT01217073|2939944|P6|Extension Period|Lack of Efficacy|0
891574|NCT01217073|2939945|P5|Extension Period|Lack of Efficacy|0
891575|NCT01217073|2939946|P4|Extension Period|Lack of Efficacy|0
891576|NCT01217073|2939947|P3|Extension Period|Lack of Efficacy|0
891577|NCT01217073|2939948|P2|Extension Period|Lack of Efficacy|0
891578|NCT01217073|2939949|P1|Extension Period|Lack of Efficacy|0
891579|NCT01217073|2939942|P8|Extension Period|Excluded medication|0
891580|NCT01217073|2939943|P7|Extension Period|Excluded medication|2
891581|NCT01217073|2939944|P6|Extension Period|Excluded medication|0
891582|NCT01217073|2939945|P5|Extension Period|Excluded medication|0
891583|NCT01217073|2939946|P4|Extension Period|Excluded medication|0
891584|NCT01217073|2939947|P3|Extension Period|Excluded medication|0
891585|NCT01217073|2939948|P2|Extension Period|Excluded medication|0
891586|NCT01217073|2939949|P1|Extension Period|Excluded medication|0
891587|NCT01217073|2939942|P8|Extension Period|Death|0
891588|NCT01217073|2939943|P7|Extension Period|Death|1
891589|NCT01217073|2939944|P6|Extension Period|Death|0
891590|NCT01217073|2939945|P5|Extension Period|Death|0
891591|NCT01217073|2939946|P4|Extension Period|Death|0
891592|NCT01217073|2939947|P3|Extension Period|Death|0
891593|NCT01217073|2939948|P2|Extension Period|Death|0
891594|NCT01217073|2939949|P1|Extension Period|Death|0
891595|NCT01217073|2939942|P8|Extension Period|Creatinine/eGFR|1
891596|NCT01217073|2939943|P7|Extension Period|Creatinine/eGFR|11
891597|NCT01217073|2939944|P6|Extension Period|Creatinine/eGFR|0
891598|NCT01217073|2939945|P5|Extension Period|Creatinine/eGFR|0
891599|NCT01217073|2939946|P4|Extension Period|Creatinine/eGFR|0
891600|NCT01217073|2939947|P3|Extension Period|Creatinine/eGFR|0
891601|NCT01217073|2939948|P2|Extension Period|Creatinine/eGFR|0
891602|NCT01217073|2939949|P1|Extension Period|Creatinine/eGFR|0
891603|NCT01217073|2939942|P8|Extension Period|Contraindication to study medication|0
891604|NCT01217073|2939943|P7|Extension Period|Contraindication to study medication|1
891605|NCT01217073|2939944|P6|Extension Period|Contraindication to study medication|0
891606|NCT01217073|2939945|P5|Extension Period|Contraindication to study medication|0
891607|NCT01217073|2939946|P4|Extension Period|Contraindication to study medication|0
891608|NCT01217073|2939947|P3|Extension Period|Contraindication to study medication|0
891609|NCT01217073|2939948|P2|Extension Period|Contraindication to study medication|0
891610|NCT01217073|2939949|P1|Extension Period|Contraindication to study medication|0
891611|NCT01217073|2939942|P8|Extension Period|ALT/AST|0
891612|NCT01217073|2939943|P7|Extension Period|ALT/AST|2
891613|NCT01217073|2939944|P6|Extension Period|ALT/AST|0
891614|NCT01217073|2939945|P5|Extension Period|ALT/AST|0
891615|NCT01217073|2939946|P4|Extension Period|ALT/AST|0
891616|NCT01217073|2939947|P3|Extension Period|ALT/AST|0
891617|NCT01217073|2939948|P2|Extension Period|ALT/AST|0
891618|NCT01217073|2939949|P1|Extension Period|ALT/AST|0
891619|NCT01217073|2939942|P8|Extension Period|Adverse Event|5
891620|NCT01217073|2939943|P7|Extension Period|Adverse Event|19
891621|NCT01217073|2939944|P6|Extension Period|Adverse Event|0
891622|NCT01217073|2939945|P5|Extension Period|Adverse Event|0
891623|NCT01217073|2939946|P4|Extension Period|Adverse Event|0
891624|NCT01217073|2939947|P3|Extension Period|Adverse Event|0
891625|NCT01217073|2939948|P2|Extension Period|Adverse Event|0
891626|NCT01217073|2939949|P1|Extension Period|Adverse Event|0
891627|NCT01217073|2939942|P8|Base Period|Withdrawal by Subject|0
891628|NCT01217073|2939943|P7|Base Period|Withdrawal by Subject|0
891629|NCT01217073|2939944|P6|Base Period|Withdrawal by Subject|5
891630|NCT01217073|2939945|P5|Base Period|Withdrawal by Subject|5
891631|NCT01217073|2939946|P4|Base Period|Withdrawal by Subject|1
891632|NCT01217073|2939947|P3|Base Period|Withdrawal by Subject|5
891633|NCT01217073|2939948|P2|Base Period|Withdrawal by Subject|5
891634|NCT01217073|2939949|P1|Base Period|Withdrawal by Subject|4
891635|NCT01217073|2939942|P8|Base Period|Protocol Violation|0
891636|NCT01217073|2939943|P7|Base Period|Protocol Violation|0
891637|NCT01217073|2939944|P6|Base Period|Protocol Violation|2
891638|NCT01217073|2939945|P5|Base Period|Protocol Violation|1
891639|NCT01217073|2939946|P4|Base Period|Protocol Violation|0
891640|NCT01217073|2939947|P3|Base Period|Protocol Violation|0
891641|NCT01217073|2939948|P2|Base Period|Protocol Violation|0
891642|NCT01217073|2939949|P1|Base Period|Protocol Violation|1
891643|NCT01217073|2939942|P8|Base Period|Physician Decision|0
891644|NCT01217073|2939943|P7|Base Period|Physician Decision|0
891645|NCT01217073|2939944|P6|Base Period|Physician Decision|0
891646|NCT01217073|2939945|P5|Base Period|Physician Decision|1
891647|NCT01217073|2939946|P4|Base Period|Physician Decision|0
891648|NCT01217073|2939947|P3|Base Period|Physician Decision|0
891649|NCT01217073|2939948|P2|Base Period|Physician Decision|0
891650|NCT01217073|2939949|P1|Base Period|Physician Decision|0
891651|NCT01217073|2939942|P8|Base Period|Lost to Follow-up|0
891652|NCT01217073|2939943|P7|Base Period|Lost to Follow-up|0
891653|NCT01217073|2939944|P6|Base Period|Lost to Follow-up|0
891654|NCT01217073|2939945|P5|Base Period|Lost to Follow-up|3
891655|NCT01217073|2939946|P4|Base Period|Lost to Follow-up|1
891656|NCT01217073|2939947|P3|Base Period|Lost to Follow-up|1
891657|NCT01217073|2939948|P2|Base Period|Lost to Follow-up|0
891658|NCT01217073|2939949|P1|Base Period|Lost to Follow-up|0
891659|NCT01217073|2939942|P8|Base Period|Lack of Efficacy|0
891660|NCT01217073|2939943|P7|Base Period|Lack of Efficacy|0
891661|NCT01217073|2939944|P6|Base Period|Lack of Efficacy|1
891662|NCT01217073|2939945|P5|Base Period|Lack of Efficacy|0
891663|NCT01217073|2939946|P4|Base Period|Lack of Efficacy|0
891664|NCT01217073|2939947|P3|Base Period|Lack of Efficacy|0
891665|NCT01217073|2939948|P2|Base Period|Lack of Efficacy|0
891666|NCT01217073|2939949|P1|Base Period|Lack of Efficacy|0
891667|NCT01217073|2939942|P8|Base Period|Excluded medication|0
891668|NCT01217073|2939943|P7|Base Period|Excluded medication|0
891669|NCT01217073|2939944|P6|Base Period|Excluded medication|0
891670|NCT01217073|2939945|P5|Base Period|Excluded medication|1
891671|NCT01217073|2939946|P4|Base Period|Excluded medication|0
891672|NCT01217073|2939947|P3|Base Period|Excluded medication|0
891673|NCT01217073|2939948|P2|Base Period|Excluded medication|0
891674|NCT01217073|2939949|P1|Base Period|Excluded medication|0
891675|NCT01217073|2939942|P8|Base Period|Alanine aminotransferase (ALT)/AST|0
891676|NCT01217073|2939943|P7|Base Period|Alanine aminotransferase (ALT)/AST|0
891677|NCT01217073|2939944|P6|Base Period|Alanine aminotransferase (ALT)/AST|0
891678|NCT01217073|2939945|P5|Base Period|Alanine aminotransferase (ALT)/AST|0
891679|NCT01217073|2939946|P4|Base Period|Alanine aminotransferase (ALT)/AST|0
891680|NCT01217073|2939947|P3|Base Period|Alanine aminotransferase (ALT)/AST|0
891681|NCT01217073|2939948|P2|Base Period|Alanine aminotransferase (ALT)/AST|0
891682|NCT01217073|2939949|P1|Base Period|Alanine aminotransferase (ALT)/AST|1
891683|NCT01217073|2939942|P8|Base Period|Adverse Event|0
891684|NCT01217073|2939943|P7|Base Period|Adverse Event|0
891685|NCT01217073|2939944|P6|Base Period|Adverse Event|1
891686|NCT01217073|2939945|P5|Base Period|Adverse Event|4
891687|NCT01217073|2939946|P4|Base Period|Adverse Event|0
891688|NCT01217073|2939947|P3|Base Period|Adverse Event|1
891689|NCT01217073|2939948|P2|Base Period|Adverse Event|0
891690|NCT01217073|2939949|P1|Base Period|Adverse Event|1
891691|NCT01216319|2940138|P1|Overall Study|Unanticipated chemo for breast cancer|2
891692|NCT01216319|2940138|P1|Overall Study|Lost to Follow-up|2
891693|NCT01216163|2940155|P3|Overall Study|Withdrawal by Subject|0
891694|NCT01216163|2940156|P2|Overall Study|Withdrawal by Subject|1
891695|NCT01216163|2940157|P1|Overall Study|Withdrawal by Subject|1
891696|NCT01216072|2940209|P2|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3
891697|NCT01216072|2940210|P1|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0
891698|NCT01216072|2940209|P2|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1
891699|NCT01216072|2940210|P1|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0
891700|NCT01216072|2940209|P2|Open-Label Extension Period (3 Months)|Adverse Event|10
891701|NCT01216072|2940210|P1|Open-Label Extension Period (3 Months)|Adverse Event|0
891702|NCT01216072|2940209|P2|Open-Label Core Period ( 6 Months)|Protocol Deviation|4
891703|NCT01216072|2940210|P1|Open-Label Core Period ( 6 Months)|Protocol Deviation|11
891704|NCT01216072|2940209|P2|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0
891705|NCT01216072|2940210|P1|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5
891706|NCT01216072|2940209|P2|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22
891707|NCT01216072|2940210|P1|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12
891708|NCT01216072|2940209|P2|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4
891709|NCT01216072|2940210|P1|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3
891710|NCT01216072|2940209|P2|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0
891711|NCT01216072|2940210|P1|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3
891712|NCT01216072|2940209|P2|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0
891713|NCT01216072|2940210|P1|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2
891714|NCT01216072|2940209|P2|Open-Label Core Period ( 6 Months)|Adverse Event|4
891715|NCT01216072|2940210|P1|Open-Label Core Period ( 6 Months)|Adverse Event|40
891716|NCT01215981|2940238|P2|Overall Study|Withdrawal by Subject|0
891717|NCT01215981|2940239|P1|Overall Study|Withdrawal by Subject|1
891718|NCT01215981|2940238|P2|Overall Study|Protocol Violation|0
891719|NCT01215981|2940239|P1|Overall Study|Protocol Violation|1
891720|NCT01215981|2940238|P2|Overall Study|Physician Decision|1
891721|NCT01215981|2940239|P1|Overall Study|Physician Decision|0
891722|NCT01215968|2940249|P2|Overall Study|Not received study drug|1
891723|NCT01215968|2940250|P1|Overall Study|Not received study drug|0
891724|NCT01215968|2940249|P2|Overall Study|Protocol Violation|4
891725|NCT01215968|2940250|P1|Overall Study|Protocol Violation|2
891726|NCT01215968|2940249|P2|Overall Study|Adverse Event|2
891727|NCT01215968|2940250|P1|Overall Study|Adverse Event|0
891728|NCT01215955|2940270|P4|Overall Study|Quality Issues|2
891729|NCT01215955|2940271|P3|Overall Study|Quality Issues|3
891730|NCT01215955|2940272|P2|Overall Study|Quality Issues|0
891731|NCT01215955|2940273|P1|Overall Study|Quality Issues|0
891732|NCT01215955|2940270|P4|Overall Study|Withdrawal by Subject|9
891733|NCT01215955|2940271|P3|Overall Study|Withdrawal by Subject|13
891734|NCT01215955|2940272|P2|Overall Study|Withdrawal by Subject|15
891735|NCT01215955|2940273|P1|Overall Study|Withdrawal by Subject|14
891736|NCT01215955|2940270|P4|Overall Study|Sponsor Decision|1
891737|NCT01215955|2940271|P3|Overall Study|Sponsor Decision|0
891738|NCT01215955|2940272|P2|Overall Study|Sponsor Decision|2
891739|NCT01215955|2940273|P1|Overall Study|Sponsor Decision|1
891740|NCT01215955|2940270|P4|Overall Study|Protocol Violation|8
891741|NCT01215955|2940271|P3|Overall Study|Protocol Violation|8
891742|NCT01215955|2940272|P2|Overall Study|Protocol Violation|13
891743|NCT01215955|2940273|P1|Overall Study|Protocol Violation|17
891744|NCT01215955|2940270|P4|Overall Study|Physician Decision|11
891745|NCT01215955|2940271|P3|Overall Study|Physician Decision|8
891746|NCT01215955|2940272|P2|Overall Study|Physician Decision|10
891747|NCT01215955|2940273|P1|Overall Study|Physician Decision|4
891748|NCT01215955|2940270|P4|Overall Study|Lost to Follow-up|9
891749|NCT01215955|2940271|P3|Overall Study|Lost to Follow-up|8
891750|NCT01215955|2940272|P2|Overall Study|Lost to Follow-up|4
891751|NCT01215955|2940273|P1|Overall Study|Lost to Follow-up|4
891752|NCT01215955|2940270|P4|Overall Study|Lack of Efficacy|0
891753|NCT01215955|2940271|P3|Overall Study|Lack of Efficacy|1
891754|NCT01215955|2940272|P2|Overall Study|Lack of Efficacy|2
891755|NCT01215955|2940273|P1|Overall Study|Lack of Efficacy|1
891756|NCT01215955|2940270|P4|Overall Study|Entry Criteria Not Met|7
891757|NCT01215955|2940271|P3|Overall Study|Entry Criteria Not Met|4
891758|NCT01215955|2940272|P2|Overall Study|Entry Criteria Not Met|3
891759|NCT01215955|2940273|P1|Overall Study|Entry Criteria Not Met|1
891760|NCT01215955|2940270|P4|Overall Study|Death|3
891761|NCT01215955|2940271|P3|Overall Study|Death|1
891762|NCT01215955|2940272|P2|Overall Study|Death|0
891763|NCT01215955|2940273|P1|Overall Study|Death|2
891764|NCT01215955|2940270|P4|Overall Study|Adverse Event|3
891765|NCT01215955|2940271|P3|Overall Study|Adverse Event|2
891766|NCT01215955|2940272|P2|Overall Study|Adverse Event|4
891767|NCT01215955|2940273|P1|Overall Study|Adverse Event|1
891768|NCT01215942|2940341|P2|Post-Treatment Follow-Up Period|Sponsor Decision|61
891769|NCT01215942|2940342|P1|Post-Treatment Follow-Up Period|Sponsor Decision|28
891770|NCT01215942|2940341|P2|Post-Treatment Follow-Up Period|Physician Decision|2
891771|NCT01215942|2940342|P1|Post-Treatment Follow-Up Period|Physician Decision|1
891772|NCT01215942|2940341|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|69
891773|NCT01215942|2940342|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|43
891774|NCT01215942|2940341|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|13
891775|NCT01215942|2940342|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|13
891776|NCT01215942|2940341|P2|Post-Treatment Follow-Up Period|Death|1
891777|NCT01215942|2940342|P1|Post-Treatment Follow-Up Period|Death|0
891778|NCT01215942|2940341|P2|Treatment Period|Sponsor Decision|530
891779|NCT01215942|2940342|P1|Treatment Period|Sponsor Decision|349
891780|NCT01215942|2940341|P2|Treatment Period|Protocol Violation|1
891781|NCT01215942|2940342|P1|Treatment Period|Protocol Violation|0
891782|NCT01215942|2940341|P2|Treatment Period|Physician Decision|5
891783|NCT01215942|2940342|P1|Treatment Period|Physician Decision|5
891784|NCT01215942|2940341|P2|Treatment Period|Withdrawal by Subject|40
891785|NCT01215942|2940342|P1|Treatment Period|Withdrawal by Subject|17
891786|NCT01215942|2940341|P2|Treatment Period|Lost to Follow-up|4
891787|NCT01215942|2940342|P1|Treatment Period|Lost to Follow-up|3
891788|NCT01215942|2940341|P2|Treatment Period|Lack of Efficacy|62
891789|NCT01215942|2940342|P1|Treatment Period|Lack of Efficacy|23
891790|NCT01215942|2940341|P2|Treatment Period|Death|4
891791|NCT01215942|2940342|P1|Treatment Period|Death|2
891792|NCT01215942|2940341|P2|Treatment Period|Adverse Event|26
891793|NCT01215942|2940342|P1|Treatment Period|Adverse Event|15
891794|NCT01215851|2940472|P6|Follow up Period|Lost to Follow-up|1
891795|NCT01215851|2940473|P5|Follow up Period|Lost to Follow-up|0
891796|NCT01215851|2940474|P4|Follow up Period|Lost to Follow-up|0
891797|NCT01215851|2940475|P3|Follow up Period|Lost to Follow-up|0
891798|NCT01215851|2940476|P2|Follow up Period|Lost to Follow-up|0
891799|NCT01215851|2940477|P1|Follow up Period|Lost to Follow-up|0
891800|NCT01215851|2940472|P6|Treatment Period|Adverse Event|1
891801|NCT01215851|2940473|P5|Treatment Period|Adverse Event|0
891802|NCT01215851|2940474|P4|Treatment Period|Adverse Event|3
891803|NCT01215851|2940475|P3|Treatment Period|Adverse Event|1
891804|NCT01215851|2940476|P2|Treatment Period|Adverse Event|1
891805|NCT01215851|2940477|P1|Treatment Period|Adverse Event|1
891806|NCT01215734|2940536|P2|Overall Study|Death|1
891807|NCT01215734|2940537|P1|Overall Study|Death|0
891808|NCT01215721|2940545|P1|Overall Study|Adverse Event|2
891809|NCT01215513|2940677|P1|Overall Study|Miscellaneous reasons (CS42A)|2
891810|NCT01215513|2940677|P1|Overall Study|Withdrawal by subject (CS42A)|5
891811|NCT01215513|2940677|P1|Overall Study|Physician decision (CS42A)|6
891812|NCT01215513|2940677|P1|Overall Study|Adverse event (CS42A)|2
891813|NCT01215513|2940677|P1|Overall Study|Not enrolled from CS42 to CS42A|21
891814|NCT01215513|2940677|P1|Overall Study|Not completed CS42|9
891815|NCT01215435|2940686|P2|Overall Study|Unclassified|5
891816|NCT01215435|2940687|P1|Overall Study|Unclassified|5
891817|NCT01215435|2940686|P2|Overall Study|Lost to Follow-up|0
891818|NCT01215435|2940687|P1|Overall Study|Lost to Follow-up|3
891819|NCT01215435|2940686|P2|Overall Study|Withdrawal Criteria|11
891820|NCT01215435|2940687|P1|Overall Study|Withdrawal Criteria|8
891821|NCT01215435|2940686|P2|Overall Study|Protocol Violation|0
891822|NCT01215435|2940687|P1|Overall Study|Protocol Violation|2
891823|NCT01215435|2940686|P2|Overall Study|Adverse Event|0
891824|NCT01215435|2940687|P1|Overall Study|Adverse Event|1
891825|NCT01215422|2940701|P4|Overall Study|Did not complete all intubations|0
891826|NCT01215422|2940702|P3|Overall Study|Did not complete all intubations|0
891827|NCT01215422|2940703|P2|Overall Study|Did not complete all intubations|0
891828|NCT01215422|2940704|P1|Overall Study|Did not complete all intubations|7
891829|NCT01215422|2940701|P4|Overall Study|Failed intubations|8
891830|NCT01215422|2940702|P3|Overall Study|Failed intubations|3
891831|NCT01215422|2940703|P2|Overall Study|Failed intubations|0
891832|NCT01215422|2940704|P1|Overall Study|Failed intubations|0
891833|NCT01215422|2940701|P4|Overall Study|Relocation|0
891834|NCT01215422|2940702|P3|Overall Study|Relocation|0
891835|NCT01215422|2940703|P2|Overall Study|Relocation|0
891836|NCT01215422|2940704|P1|Overall Study|Relocation|1
891837|NCT01215357|2940726|P1|Overall Study|Protocol Violation|9
891838|NCT01215357|2940726|P1|Overall Study|Withdrawal by Subject|3
891839|NCT01215253|2940841|P2|Overall Study|Other|12
891840|NCT01215253|2940842|P1|Overall Study|Other|14
891841|NCT01215253|2940841|P2|Overall Study|Lost to Follow-up|4
891842|NCT01215253|2940842|P1|Overall Study|Lost to Follow-up|6
891843|NCT01215253|2940841|P2|Overall Study|Physician Decision|12
891844|NCT01215253|2940842|P1|Overall Study|Physician Decision|9
891845|NCT01215253|2940841|P2|Overall Study|Withdrawal by Subject|35
891846|NCT01215253|2940842|P1|Overall Study|Withdrawal by Subject|57
891847|NCT01215227|2940876|P6|Overall Study|Randomized but not treated|1
891848|NCT01215227|2940877|P5|Overall Study|Randomized but not treated|0
891849|NCT01215227|2940878|P4|Overall Study|Randomized but not treated|1
891850|NCT01215227|2940879|P3|Overall Study|Randomized but not treated|1
891851|NCT01215227|2940880|P2|Overall Study|Randomized but not treated|0
891852|NCT01215227|2940881|P1|Overall Study|Randomized but not treated|0
891853|NCT01215227|2940876|P6|Overall Study|Missing Status|0
891854|NCT01215227|2940877|P5|Overall Study|Missing Status|0
891855|NCT01215227|2940878|P4|Overall Study|Missing Status|0
891856|NCT01215227|2940879|P3|Overall Study|Missing Status|0
891857|NCT01215227|2940880|P2|Overall Study|Missing Status|1
891858|NCT01215227|2940881|P1|Overall Study|Missing Status|0
891859|NCT01215227|2940876|P6|Overall Study|Administrative|40
891860|NCT01215227|2940877|P5|Overall Study|Administrative|28
891861|NCT01215227|2940878|P4|Overall Study|Administrative|24
891862|NCT01215227|2940879|P3|Overall Study|Administrative|42
891863|NCT01215227|2940880|P2|Overall Study|Administrative|73
891864|NCT01215227|2940881|P1|Overall Study|Administrative|83
891865|NCT01215227|2940876|P6|Overall Study|Non-Compliance With Protocol|0
891866|NCT01215227|2940877|P5|Overall Study|Non-Compliance With Protocol|0
891867|NCT01215227|2940878|P4|Overall Study|Non-Compliance With Protocol|0
891868|NCT01215227|2940879|P3|Overall Study|Non-Compliance With Protocol|1
891869|NCT01215227|2940880|P2|Overall Study|Non-Compliance With Protocol|6
891870|NCT01215227|2940881|P1|Overall Study|Non-Compliance With Protocol|2
891871|NCT01215227|2940876|P6|Overall Study|Subject Withdrew Consent|8
891872|NCT01215227|2940877|P5|Overall Study|Subject Withdrew Consent|11
891873|NCT01215227|2940878|P4|Overall Study|Subject Withdrew Consent|10
891874|NCT01215227|2940879|P3|Overall Study|Subject Withdrew Consent|7
891875|NCT01215227|2940880|P2|Overall Study|Subject Withdrew Consent|20
891876|NCT01215227|2940881|P1|Overall Study|Subject Withdrew Consent|16
891877|NCT01215227|2940876|P6|Overall Study|Lost to Follow-up|2
891878|NCT01215227|2940877|P5|Overall Study|Lost to Follow-up|1
891879|NCT01215227|2940878|P4|Overall Study|Lost to Follow-up|1
891880|NCT01215227|2940879|P3|Overall Study|Lost to Follow-up|1
891881|NCT01215227|2940880|P2|Overall Study|Lost to Follow-up|4
891882|NCT01215227|2940881|P1|Overall Study|Lost to Follow-up|1
891883|NCT01215227|2940876|P6|Overall Study|Treatment Failure|1
891884|NCT01215227|2940877|P5|Overall Study|Treatment Failure|1
891885|NCT01215227|2940878|P4|Overall Study|Treatment Failure|5
891886|NCT01215227|2940879|P3|Overall Study|Treatment Failure|1
891887|NCT01215227|2940880|P2|Overall Study|Treatment Failure|4
891888|NCT01215227|2940881|P1|Overall Study|Treatment Failure|8
891889|NCT01215227|2940876|P6|Overall Study|Adverse Event|6
891890|NCT01215227|2940877|P5|Overall Study|Adverse Event|7
891891|NCT01215227|2940878|P4|Overall Study|Adverse Event|8
891892|NCT01215227|2940879|P3|Overall Study|Adverse Event|4
891893|NCT01215227|2940880|P2|Overall Study|Adverse Event|11
891894|NCT01215227|2940881|P1|Overall Study|Adverse Event|11
891895|NCT01215097|2941000|P2|Overall Study|patient's private reason|1
891896|NCT01215097|2941001|P1|Overall Study|patient's private reason|1
891897|NCT01215097|2941000|P2|Overall Study|patient's refusal to come|2
891898|NCT01215097|2941001|P1|Overall Study|patient's refusal to come|2
891899|NCT01215097|2941000|P2|Overall Study|Lack of Efficacy|3
891900|NCT01215097|2941001|P1|Overall Study|Lack of Efficacy|0
891901|NCT01215097|2941000|P2|Overall Study|Withdrawal by Subject|3
891902|NCT01215097|2941001|P1|Overall Study|Withdrawal by Subject|6
891903|NCT01215097|2941000|P2|Overall Study|Lost to Follow-up|0
891904|NCT01215097|2941001|P1|Overall Study|Lost to Follow-up|2
891905|NCT01215097|2941000|P2|Overall Study|Protocol Violation|2
891906|NCT01215097|2941001|P1|Overall Study|Protocol Violation|0
891907|NCT01215097|2941000|P2|Overall Study|Adverse Event|3
891908|NCT01215097|2941001|P1|Overall Study|Adverse Event|1
891909|NCT01215032|2941033|P1|Overall Study|Lack of Efficacy|17
891910|NCT01215032|2941033|P1|Overall Study|Adverse Event|3
891911|NCT01214915|2941058|P1|Overall Study|Lack of Efficacy|3
891912|NCT01214915|2941058|P1|Overall Study|Adverse Event|8
891913|NCT01214850|2941069|P3|Overall Study|Unable to classify|1
891914|NCT01214850|2941070|P2|Overall Study|Unable to classify|1
891915|NCT01214850|2941071|P1|Overall Study|Unable to classify|2
891916|NCT01214850|2941069|P3|Overall Study|Administrative reason|0
891917|NCT01214850|2941070|P2|Overall Study|Administrative reason|0
891918|NCT01214850|2941071|P1|Overall Study|Administrative reason|1
891919|NCT01214850|2941069|P3|Overall Study|Inappropriate enrollment|0
891920|NCT01214850|2941070|P2|Overall Study|Inappropriate enrollment|1
891921|NCT01214850|2941071|P1|Overall Study|Inappropriate enrollment|2
891922|NCT01214850|2941069|P3|Overall Study|Adverse event or death|3
891923|NCT01214850|2941070|P2|Overall Study|Adverse event or death|8
891924|NCT01214850|2941071|P1|Overall Study|Adverse event or death|11
891925|NCT01214850|2941069|P3|Overall Study|Protocol Violation|6
891926|NCT01214850|2941070|P2|Overall Study|Protocol Violation|5
891927|NCT01214850|2941071|P1|Overall Study|Protocol Violation|5
891928|NCT01214850|2941069|P3|Overall Study|Lost to Follow-up|123
891929|NCT01214850|2941070|P2|Overall Study|Lost to Follow-up|98
891930|NCT01214850|2941071|P1|Overall Study|Lost to Follow-up|124
891931|NCT01214850|2941069|P3|Overall Study|Withdrawal by Subject|28
891932|NCT01214850|2941070|P2|Overall Study|Withdrawal by Subject|31
891933|NCT01214850|2941071|P1|Overall Study|Withdrawal by Subject|38
891934|NCT01214837|2941155|P3|Overall Study|Unable to Classify|0
891935|NCT01214837|2941156|P2|Overall Study|Unable to Classify|3
891936|NCT01214837|2941157|P1|Overall Study|Unable to Classify|1
891937|NCT01214837|2941155|P3|Overall Study|Protocol Violation|5
891938|NCT01214837|2941156|P2|Overall Study|Protocol Violation|1
891939|NCT01214837|2941157|P1|Overall Study|Protocol Violation|3
891940|NCT01214837|2941155|P3|Overall Study|Administrative Reason|4
891941|NCT01214837|2941156|P2|Overall Study|Administrative Reason|6
891942|NCT01214837|2941157|P1|Overall Study|Administrative Reason|2
891943|NCT01214837|2941155|P3|Overall Study|Inappropriate Enrolment|2
891944|NCT01214837|2941156|P2|Overall Study|Inappropriate Enrolment|1
891945|NCT01214837|2941157|P1|Overall Study|Inappropriate Enrolment|0
891946|NCT01214837|2941155|P3|Overall Study|Lost to Follow-up|21
891947|NCT01214837|2941156|P2|Overall Study|Lost to Follow-up|15
891948|NCT01214837|2941157|P1|Overall Study|Lost to Follow-up|20
891949|NCT01214837|2941155|P3|Overall Study|Withdrawal by Subject|28
891950|NCT01214837|2941156|P2|Overall Study|Withdrawal by Subject|36
891951|NCT01214837|2941157|P1|Overall Study|Withdrawal by Subject|27
891952|NCT01214837|2941155|P3|Overall Study|Adverse Event|1
891953|NCT01214837|2941156|P2|Overall Study|Adverse Event|2
891954|NCT01214837|2941157|P1|Overall Study|Adverse Event|1
891955|NCT01214837|2941155|P3|Overall Study|Death|1
891956|NCT01214837|2941156|P2|Overall Study|Death|0
891957|NCT01214837|2941157|P1|Overall Study|Death|0
891958|NCT01214720|2941213|P2|Overall Study|Lost to Follow-up|2
891959|NCT01214720|2941214|P1|Overall Study|Lost to Follow-up|6
891960|NCT01214720|2941213|P2|Overall Study|Alive and in follow-up|48
891961|NCT01214720|2941214|P1|Overall Study|Alive and in follow-up|45
891962|NCT01214720|2941213|P2|Overall Study|Alive and still on treatment|18
891963|NCT01214720|2941214|P1|Overall Study|Alive and still on treatment|34
891964|NCT01214668|2941237|P6|Overall Study|Withdrawal by Subject|0
891965|NCT01214668|2941238|P5|Overall Study|Withdrawal by Subject|1
891966|NCT01214668|2941239|P4|Overall Study|Withdrawal by Subject|0
891967|NCT01214668|2941240|P3|Overall Study|Withdrawal by Subject|0
891968|NCT01214668|2941241|P2|Overall Study|Withdrawal by Subject|0
891969|NCT01214668|2941242|P1|Overall Study|Withdrawal by Subject|0
891970|NCT01214668|2941237|P6|Overall Study|Progressive Disease|5
891971|NCT01214668|2941238|P5|Overall Study|Progressive Disease|4
891972|NCT01214668|2941239|P4|Overall Study|Progressive Disease|4
891973|NCT01214668|2941240|P3|Overall Study|Progressive Disease|5
891974|NCT01214668|2941241|P2|Overall Study|Progressive Disease|2
891975|NCT01214668|2941242|P1|Overall Study|Progressive Disease|4
891976|NCT01214668|2941237|P6|Overall Study|Death|0
891977|NCT01214668|2941238|P5|Overall Study|Death|0
891978|NCT01214668|2941239|P4|Overall Study|Death|0
891979|NCT01214668|2941240|P3|Overall Study|Death|1
891980|NCT01214668|2941241|P2|Overall Study|Death|0
891981|NCT01214668|2941242|P1|Overall Study|Death|0
891982|NCT01214668|2941237|P6|Overall Study|Adverse Event|1
891983|NCT01214668|2941238|P5|Overall Study|Adverse Event|1
891984|NCT01214668|2941239|P4|Overall Study|Adverse Event|2
891985|NCT01214668|2941240|P3|Overall Study|Adverse Event|0
891986|NCT01214668|2941241|P2|Overall Study|Adverse Event|1
891987|NCT01214668|2941242|P1|Overall Study|Adverse Event|0
891988|NCT01214642|2941288|P12|Overall Study|Physician Decision|2
891989|NCT01214642|2941289|P11|Overall Study|Physician Decision|0
891990|NCT01214642|2941290|P10|Overall Study|Physician Decision|0
891991|NCT01214642|2941291|P9|Overall Study|Physician Decision|0
891992|NCT01214642|2941292|P8|Overall Study|Physician Decision|0
891993|NCT01214642|2941293|P7|Overall Study|Physician Decision|0
891994|NCT01214642|2941294|P6|Overall Study|Physician Decision|0
891995|NCT01214642|2941295|P5|Overall Study|Physician Decision|1
891996|NCT01214642|2941296|P4|Overall Study|Physician Decision|1
891997|NCT01214642|2941297|P3|Overall Study|Physician Decision|1
891998|NCT01214642|2941298|P2|Overall Study|Physician Decision|0
891999|NCT01214642|2941299|P1|Overall Study|Physician Decision|0
892000|NCT01214642|2941288|P12|Overall Study|Withdrawal by Subject|0
892001|NCT01214642|2941289|P11|Overall Study|Withdrawal by Subject|1
892002|NCT01214642|2941290|P10|Overall Study|Withdrawal by Subject|1
892003|NCT01214642|2941291|P9|Overall Study|Withdrawal by Subject|3
892004|NCT01214642|2941292|P8|Overall Study|Withdrawal by Subject|0
892005|NCT01214642|2941293|P7|Overall Study|Withdrawal by Subject|0
892006|NCT01214642|2941294|P6|Overall Study|Withdrawal by Subject|0
892007|NCT01214642|2941295|P5|Overall Study|Withdrawal by Subject|0
892008|NCT01214642|2941296|P4|Overall Study|Withdrawal by Subject|0
892009|NCT01214642|2941297|P3|Overall Study|Withdrawal by Subject|1
892010|NCT01214642|2941298|P2|Overall Study|Withdrawal by Subject|0
892011|NCT01214642|2941299|P1|Overall Study|Withdrawal by Subject|0
892012|NCT01214642|2941288|P12|Overall Study|Death|0
892013|NCT01214642|2941289|P11|Overall Study|Death|1
892014|NCT01214642|2941290|P10|Overall Study|Death|0
892015|NCT01214642|2941291|P9|Overall Study|Death|0
892016|NCT01214642|2941292|P8|Overall Study|Death|0
892017|NCT01214642|2941293|P7|Overall Study|Death|0
892018|NCT01214642|2941294|P6|Overall Study|Death|0
892019|NCT01214642|2941295|P5|Overall Study|Death|0
892020|NCT01214642|2941296|P4|Overall Study|Death|0
892021|NCT01214642|2941297|P3|Overall Study|Death|1
892022|NCT01214642|2941298|P2|Overall Study|Death|0
892023|NCT01214642|2941299|P1|Overall Study|Death|0
892024|NCT01214642|2941288|P12|Overall Study|Adverse Event|0
892025|NCT01214642|2941289|P11|Overall Study|Adverse Event|1
892026|NCT01214642|2941290|P10|Overall Study|Adverse Event|1
892027|NCT01214642|2941291|P9|Overall Study|Adverse Event|0
892028|NCT01214642|2941292|P8|Overall Study|Adverse Event|0
892029|NCT01214642|2941293|P7|Overall Study|Adverse Event|1
892030|NCT01214642|2941294|P6|Overall Study|Adverse Event|0
892031|NCT01214642|2941295|P5|Overall Study|Adverse Event|0
892032|NCT01214642|2941296|P4|Overall Study|Adverse Event|0
892033|NCT01214642|2941297|P3|Overall Study|Adverse Event|0
892034|NCT01214642|2941298|P2|Overall Study|Adverse Event|1
892035|NCT01214642|2941299|P1|Overall Study|Adverse Event|0
892036|NCT01214642|2941288|P12|Overall Study|Progressive Disease|4
892037|NCT01214642|2941289|P11|Overall Study|Progressive Disease|1
892038|NCT01214642|2941290|P10|Overall Study|Progressive Disease|2
892039|NCT01214642|2941291|P9|Overall Study|Progressive Disease|10
892040|NCT01214642|2941292|P8|Overall Study|Progressive Disease|3
892041|NCT01214642|2941293|P7|Overall Study|Progressive Disease|5
892042|NCT01214642|2941294|P6|Overall Study|Progressive Disease|3
892043|NCT01214642|2941295|P5|Overall Study|Progressive Disease|5
892044|NCT01214642|2941296|P4|Overall Study|Progressive Disease|5
892045|NCT01214642|2941297|P3|Overall Study|Progressive Disease|3
892046|NCT01214642|2941298|P2|Overall Study|Progressive Disease|2
892047|NCT01214642|2941299|P1|Overall Study|Progressive Disease|3
892048|NCT01214629|2941379|P11|Overall Study|Withdrawal by Subject|0
892049|NCT01214629|2941380|P10|Overall Study|Withdrawal by Subject|1
892050|NCT01214629|2941381|P9|Overall Study|Withdrawal by Subject|0
892051|NCT01214629|2941382|P8|Overall Study|Withdrawal by Subject|0
892052|NCT01214629|2941383|P7|Overall Study|Withdrawal by Subject|0
892053|NCT01214629|2941384|P6|Overall Study|Withdrawal by Subject|0
892054|NCT01214629|2941385|P5|Overall Study|Withdrawal by Subject|0
892055|NCT01214629|2941386|P4|Overall Study|Withdrawal by Subject|0
892056|NCT01214629|2941387|P3|Overall Study|Withdrawal by Subject|0
892057|NCT01214629|2941388|P2|Overall Study|Withdrawal by Subject|0
892058|NCT01214629|2941389|P1|Overall Study|Withdrawal by Subject|0
892059|NCT01214629|2941379|P11|Overall Study|Physician Decision|1
892060|NCT01214629|2941380|P10|Overall Study|Physician Decision|0
892061|NCT01214629|2941381|P9|Overall Study|Physician Decision|0
892062|NCT01214629|2941382|P8|Overall Study|Physician Decision|0
892063|NCT01214629|2941383|P7|Overall Study|Physician Decision|0
892064|NCT01214629|2941384|P6|Overall Study|Physician Decision|0
892065|NCT01214629|2941385|P5|Overall Study|Physician Decision|0
892066|NCT01214629|2941386|P4|Overall Study|Physician Decision|0
892067|NCT01214629|2941387|P3|Overall Study|Physician Decision|0
892068|NCT01214629|2941388|P2|Overall Study|Physician Decision|0
892069|NCT01214629|2941389|P1|Overall Study|Physician Decision|0
892070|NCT01214629|2941379|P11|Overall Study|Adverse Event|0
892071|NCT01214629|2941380|P10|Overall Study|Adverse Event|1
892072|NCT01214629|2941381|P9|Overall Study|Adverse Event|0
892073|NCT01214629|2941382|P8|Overall Study|Adverse Event|0
892074|NCT01214629|2941383|P7|Overall Study|Adverse Event|0
892075|NCT01214629|2941384|P6|Overall Study|Adverse Event|1
892076|NCT01214629|2941385|P5|Overall Study|Adverse Event|0
892077|NCT01214629|2941386|P4|Overall Study|Adverse Event|1
892078|NCT01214629|2941387|P3|Overall Study|Adverse Event|0
892079|NCT01214629|2941388|P2|Overall Study|Adverse Event|0
892080|NCT01214629|2941389|P1|Overall Study|Adverse Event|0
892081|NCT01214629|2941379|P11|Overall Study|Progressive Disease|1
892082|NCT01214629|2941380|P10|Overall Study|Progressive Disease|5
892083|NCT01214629|2941381|P9|Overall Study|Progressive Disease|1
892084|NCT01214629|2941382|P8|Overall Study|Progressive Disease|1
892085|NCT01214629|2941383|P7|Overall Study|Progressive Disease|1
892086|NCT01214629|2941384|P6|Overall Study|Progressive Disease|3
892087|NCT01214629|2941385|P5|Overall Study|Progressive Disease|2
892088|NCT01214629|2941386|P4|Overall Study|Progressive Disease|1
892089|NCT01214629|2941387|P3|Overall Study|Progressive Disease|0
892090|NCT01214629|2941388|P2|Overall Study|Progressive Disease|1
892091|NCT01214629|2941389|P1|Overall Study|Progressive Disease|1
892092|NCT01214616|2941454|P4|Overall Study|Withdrawal by Subject|1
892093|NCT01214616|2941455|P3|Overall Study|Withdrawal by Subject|0
892094|NCT01214616|2941456|P2|Overall Study|Withdrawal by Subject|0
892095|NCT01214616|2941457|P1|Overall Study|Withdrawal by Subject|1
892096|NCT01214616|2941454|P4|Overall Study|Other adverse events|1
892097|NCT01214616|2941455|P3|Overall Study|Other adverse events|1
892098|NCT01214616|2941456|P2|Overall Study|Other adverse events|1
892099|NCT01214616|2941457|P1|Overall Study|Other adverse events|0
892100|NCT01214616|2941454|P4|Overall Study|Dose limiting toxicity|0
892101|NCT01214616|2941455|P3|Overall Study|Dose limiting toxicity|0
892102|NCT01214616|2941456|P2|Overall Study|Dose limiting toxicity|2
892103|NCT01214616|2941457|P1|Overall Study|Dose limiting toxicity|0
892104|NCT01214616|2941454|P4|Overall Study|Progressive disease|4
892105|NCT01214616|2941455|P3|Overall Study|Progressive disease|2
892106|NCT01214616|2941456|P2|Overall Study|Progressive disease|2
892107|NCT01214616|2941457|P1|Overall Study|Progressive disease|2
892108|NCT01214603|2941494|P3|Overall Study|Progressive Disease|3
892109|NCT01214603|2941495|P2|Overall Study|Progressive Disease|1
892110|NCT01214603|2941496|P1|Overall Study|Progressive Disease|4
892111|NCT01214603|2941494|P3|Overall Study|Death|0
892112|NCT01214603|2941495|P2|Overall Study|Death|0
892113|NCT01214603|2941496|P1|Overall Study|Death|1
892114|NCT01214603|2941494|P3|Overall Study|Adverse Event|1
892115|NCT01214603|2941495|P2|Overall Study|Adverse Event|0
892116|NCT01214603|2941496|P1|Overall Study|Adverse Event|0
892117|NCT01214434|2941519|P2|Overall Study|Site error|0
892118|NCT01214434|2941520|P1|Overall Study|Site error|1
892119|NCT01214434|2941519|P2|Overall Study|Lost to Follow-up|2
892120|NCT01214434|2941520|P1|Overall Study|Lost to Follow-up|2
892121|NCT01214434|2941519|P2|Overall Study|Withdrawal by Subject|0
892122|NCT01214434|2941520|P1|Overall Study|Withdrawal by Subject|1
892123|NCT01214395|2941536|P1|Overall Study|All patients had infection|5
892124|NCT01214252|2941554|P1|Overall Study|Not eligible per protocol|82
892125|NCT01214239|2941562|P2|Overall Study|patient's private reason|1
892126|NCT01214239|2941563|P1|Overall Study|patient's private reason|1
892127|NCT01214239|2941562|P2|Overall Study|Lack of Efficacy|2
892128|NCT01214239|2941563|P1|Overall Study|Lack of Efficacy|1
892129|NCT01214239|2941562|P2|Overall Study|Withdrawal by Subject|9
892130|NCT01214239|2941563|P1|Overall Study|Withdrawal by Subject|4
892131|NCT01214239|2941562|P2|Overall Study|Lost to Follow-up|1
892132|NCT01214239|2941563|P1|Overall Study|Lost to Follow-up|1
892133|NCT01214239|2941562|P2|Overall Study|Protocol Violation|1
892134|NCT01214239|2941563|P1|Overall Study|Protocol Violation|2
892135|NCT01214239|2941562|P2|Overall Study|Adverse Event|4
892136|NCT01214239|2941563|P1|Overall Study|Adverse Event|3
892137|NCT01214187|2941597|P2|Overall Study|Withdrawal by Subject|3
892138|NCT01214187|2941598|P1|Overall Study|Withdrawal by Subject|0
892139|NCT01214187|2941597|P2|Overall Study|Death|1
892140|NCT01214187|2941598|P1|Overall Study|Death|1
892141|NCT01214187|2941597|P2|Overall Study|Adverse Event|2
892142|NCT01214187|2941598|P1|Overall Study|Adverse Event|6
892143|NCT01214174|2941615|P3|Overall Study|Withdrawal by Subject|1
892144|NCT01214174|2941616|P2|Overall Study|Withdrawal by Subject|0
892145|NCT01214174|2941617|P1|Overall Study|Withdrawal by Subject|0
892146|NCT01213966|2941771|P4|Overall Study|Protocol Violation|1
892147|NCT01213966|2941772|P3|Overall Study|Protocol Violation|3
892148|NCT01213966|2941773|P2|Overall Study|Protocol Violation|0
892149|NCT01213966|2941774|P1|Overall Study|Protocol Violation|1
892150|NCT01213836|2941786|P2|Period 1, First Intervention|Withdrawal by Subject|1
892151|NCT01213836|2941787|P1|Period 1, First Intervention|Withdrawal by Subject|1
892152|NCT01213836|2941786|P2|Period 1, First Intervention|Protocol Violation|1
892153|NCT01213836|2941787|P1|Period 1, First Intervention|Protocol Violation|0
892154|NCT01213836|2941786|P2|Period 1, First Intervention|Adverse Event|1
892155|NCT01213836|2941787|P1|Period 1, First Intervention|Adverse Event|2
892156|NCT01213264|2941900|P3|Overall Study|Lost to Follow-up|6
892157|NCT01213264|2941901|P2|Overall Study|Lost to Follow-up|2
892158|NCT01213264|2941902|P1|Overall Study|Lost to Follow-up|1
892159|NCT01213264|2941900|P3|Overall Study|Adverse Event|0
892160|NCT01213264|2941901|P2|Overall Study|Adverse Event|0
892161|NCT01213264|2941902|P1|Overall Study|Adverse Event|1
892162|NCT01213251|2941922|P3|Overall Study|Missed 18-Month Follow-up|1
892163|NCT01213251|2941923|P2|Overall Study|Missed 18-Month Follow-up|0
892164|NCT01213251|2941924|P1|Overall Study|Missed 18-Month Follow-up|0
892165|NCT01213251|2941922|P3|Overall Study|Protocol Violation|0
892166|NCT01213251|2941923|P2|Overall Study|Protocol Violation|1
892167|NCT01213251|2941924|P1|Overall Study|Protocol Violation|1
892168|NCT01213251|2941922|P3|Overall Study|Exit|8
892169|NCT01213251|2941923|P2|Overall Study|Exit|2
892170|NCT01213251|2941924|P1|Overall Study|Exit|3
892171|NCT01213251|2941922|P3|Overall Study|Death|2
892172|NCT01213251|2941923|P2|Overall Study|Death|1
892173|NCT01213251|2941924|P1|Overall Study|Death|2
892174|NCT01213173|2941951|P2|Overall Study|Incorrect Enrollment|3
892175|NCT01213173|2941952|P1|Overall Study|Incorrect Enrollment|1
892176|NCT01213173|2941951|P2|Overall Study|Withdrawal by Subject|5
892177|NCT01213173|2941952|P1|Overall Study|Withdrawal by Subject|5
892178|NCT01213173|2941951|P2|Overall Study|Adverse Event|8
892179|NCT01213173|2941952|P1|Overall Study|Adverse Event|4
892180|NCT01213173|2941951|P2|Overall Study|Protocol Violation|0
892181|NCT01213173|2941952|P1|Overall Study|Protocol Violation|2
892182|NCT01213082|2941985|P3|Overall Study|Physician Decision|1
892183|NCT01213082|2941986|P2|Overall Study|Physician Decision|0
892184|NCT01213082|2941987|P1|Overall Study|Physician Decision|0
892185|NCT01213082|2941985|P3|Overall Study|Lost to Follow-up|4
892186|NCT01213082|2941986|P2|Overall Study|Lost to Follow-up|7
892187|NCT01213082|2941987|P1|Overall Study|Lost to Follow-up|6
892188|NCT01212991|2942029|P2|Overall Study|Continuing Treatment|61
892189|NCT01212991|2942030|P1|Overall Study|Continuing Treatment|367
892190|NCT01212991|2942029|P2|Overall Study|Withdrawal by Subject|14
892191|NCT01212991|2942030|P1|Overall Study|Withdrawal by Subject|4
892192|NCT01212991|2942029|P2|Overall Study|Death|299
892193|NCT01212991|2942030|P1|Overall Study|Death|241
892194|NCT01212991|2942029|P2|Overall Study|Lost to Follow-up|0
892195|NCT01212991|2942030|P1|Overall Study|Lost to Follow-up|1
892196|NCT01212770|2942071|P9|Long-term Safety Phase (Year 5)|Death|0
892197|NCT01212770|2942072|P8|Long-term Safety Phase (Year 5)|Death|1
892198|NCT01212770|2942073|P7|Long-term Safety Phase (Year 5)|Death|0
892199|NCT01212770|2942074|P6|Long-term Safety Phase (Year 5)|Death|0
892200|NCT01212770|2942075|P5|Long-term Safety Phase (Year 5)|Death|0
892201|NCT01212770|2942076|P4|Long-term Safety Phase (Year 5)|Death|0
892202|NCT01212770|2942077|P3|Long-term Safety Phase (Year 5)|Death|0
892203|NCT01212770|2942078|P2|Long-term Safety Phase (Year 5)|Death|0
892204|NCT01212770|2942079|P1|Long-term Safety Phase (Year 5)|Death|0
892205|NCT01212770|2942071|P9|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
892206|NCT01212770|2942072|P8|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
892207|NCT01212770|2942073|P7|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
892208|NCT01212770|2942074|P6|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
892209|NCT01212770|2942075|P5|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
892210|NCT01212770|2942076|P4|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
892211|NCT01212770|2942077|P3|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
892212|NCT01212770|2942078|P2|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
892213|NCT01212770|2942079|P1|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
892214|NCT01212770|2942071|P9|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
892215|NCT01212770|2942072|P8|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
892216|NCT01212770|2942073|P7|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
892217|NCT01212770|2942074|P6|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
892218|NCT01212770|2942075|P5|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
892219|NCT01212770|2942076|P4|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
892220|NCT01212770|2942077|P3|Long-term Safety Phase (Year 5)|Lack of Efficacy|4
892221|NCT01212770|2942078|P2|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
892222|NCT01212770|2942079|P1|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
892223|NCT01212770|2942071|P9|Long-term Safety Phase (Year 5)|Adverse Event|1
892224|NCT01212770|2942072|P8|Long-term Safety Phase (Year 5)|Adverse Event|0
892225|NCT01212770|2942073|P7|Long-term Safety Phase (Year 5)|Adverse Event|0
892226|NCT01212770|2942074|P6|Long-term Safety Phase (Year 5)|Adverse Event|0
892227|NCT01212770|2942075|P5|Long-term Safety Phase (Year 5)|Adverse Event|0
892228|NCT01212770|2942076|P4|Long-term Safety Phase (Year 5)|Adverse Event|0
892229|NCT01212770|2942077|P3|Long-term Safety Phase (Year 5)|Adverse Event|2
892230|NCT01212770|2942078|P2|Long-term Safety Phase (Year 5)|Adverse Event|0
892231|NCT01212770|2942079|P1|Long-term Safety Phase (Year 5)|Adverse Event|0
892232|NCT01212770|2942071|P9|Long-term Safety Phase (Year 5)|Miscellaneous|0
892233|NCT01212770|2942072|P8|Long-term Safety Phase (Year 5)|Miscellaneous|0
892234|NCT01212770|2942073|P7|Long-term Safety Phase (Year 5)|Miscellaneous|0
892235|NCT01212770|2942074|P6|Long-term Safety Phase (Year 5)|Miscellaneous|0
892236|NCT01212770|2942075|P5|Long-term Safety Phase (Year 5)|Miscellaneous|0
892237|NCT01212770|2942076|P4|Long-term Safety Phase (Year 5)|Miscellaneous|0
892238|NCT01212770|2942077|P3|Long-term Safety Phase (Year 5)|Miscellaneous|3
892239|NCT01212770|2942078|P2|Long-term Safety Phase (Year 5)|Miscellaneous|0
892240|NCT01212770|2942079|P1|Long-term Safety Phase (Year 5)|Miscellaneous|0
892241|NCT01212770|2942071|P9|Long-term Safety Phase (Year 5)|Missing|0
892242|NCT01212770|2942072|P8|Long-term Safety Phase (Year 5)|Missing|0
892243|NCT01212770|2942073|P7|Long-term Safety Phase (Year 5)|Missing|0
892244|NCT01212770|2942074|P6|Long-term Safety Phase (Year 5)|Missing|0
892245|NCT01212770|2942075|P5|Long-term Safety Phase (Year 5)|Missing|0
892246|NCT01212770|2942076|P4|Long-term Safety Phase (Year 5)|Missing|0
892247|NCT01212770|2942077|P3|Long-term Safety Phase (Year 5)|Missing|1
892248|NCT01212770|2942078|P2|Long-term Safety Phase (Year 5)|Missing|0
892249|NCT01212770|2942079|P1|Long-term Safety Phase (Year 5)|Missing|0
892250|NCT01212770|2942071|P9|Long-term Safety Phase (Year 4)|Miscellaneous|1
892251|NCT01212770|2942072|P8|Long-term Safety Phase (Year 4)|Miscellaneous|0
892252|NCT01212770|2942073|P7|Long-term Safety Phase (Year 4)|Miscellaneous|0
892253|NCT01212770|2942074|P6|Long-term Safety Phase (Year 4)|Miscellaneous|0
892254|NCT01212770|2942075|P5|Long-term Safety Phase (Year 4)|Miscellaneous|0
892255|NCT01212770|2942076|P4|Long-term Safety Phase (Year 4)|Miscellaneous|0
892256|NCT01212770|2942077|P3|Long-term Safety Phase (Year 4)|Miscellaneous|0
892257|NCT01212770|2942078|P2|Long-term Safety Phase (Year 4)|Miscellaneous|1
892258|NCT01212770|2942079|P1|Long-term Safety Phase (Year 4)|Miscellaneous|0
892259|NCT01212770|2942071|P9|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
892260|NCT01212770|2942072|P8|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
892261|NCT01212770|2942073|P7|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
892262|NCT01212770|2942074|P6|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
892263|NCT01212770|2942075|P5|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
892264|NCT01212770|2942076|P4|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
892265|NCT01212770|2942077|P3|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
892266|NCT01212770|2942078|P2|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
892267|NCT01212770|2942079|P1|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
892268|NCT01212770|2942071|P9|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
892269|NCT01212770|2942072|P8|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
892270|NCT01212770|2942073|P7|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
892271|NCT01212770|2942074|P6|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
892272|NCT01212770|2942075|P5|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
892273|NCT01212770|2942076|P4|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
892274|NCT01212770|2942077|P3|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3
892275|NCT01212770|2942078|P2|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2
892276|NCT01212770|2942079|P1|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
892277|NCT01212770|2942071|P9|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
892278|NCT01212770|2942072|P8|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
892279|NCT01212770|2942073|P7|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
892280|NCT01212770|2942074|P6|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
892281|NCT01212770|2942075|P5|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
892282|NCT01212770|2942076|P4|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
892283|NCT01212770|2942077|P3|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
892284|NCT01212770|2942078|P2|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
892285|NCT01212770|2942079|P1|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
892286|NCT01212770|2942071|P9|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
892287|NCT01212770|2942072|P8|Long-term Safety Phase (Year 4)|Lack of Efficacy|2
892288|NCT01212770|2942073|P7|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
892289|NCT01212770|2942074|P6|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
892290|NCT01212770|2942075|P5|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
892291|NCT01212770|2942076|P4|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
892292|NCT01212770|2942077|P3|Long-term Safety Phase (Year 4)|Lack of Efficacy|5
892293|NCT01212770|2942078|P2|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
892294|NCT01212770|2942079|P1|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
892295|NCT01212770|2942071|P9|Long-term Safety Phase (Year 4)|Adverse Event|1
892296|NCT01212770|2942072|P8|Long-term Safety Phase (Year 4)|Adverse Event|0
892297|NCT01212770|2942073|P7|Long-term Safety Phase (Year 4)|Adverse Event|0
892298|NCT01212770|2942074|P6|Long-term Safety Phase (Year 4)|Adverse Event|0
892299|NCT01212770|2942075|P5|Long-term Safety Phase (Year 4)|Adverse Event|0
892300|NCT01212770|2942076|P4|Long-term Safety Phase (Year 4)|Adverse Event|0
892301|NCT01212770|2942077|P3|Long-term Safety Phase (Year 4)|Adverse Event|1
892302|NCT01212770|2942078|P2|Long-term Safety Phase (Year 4)|Adverse Event|1
892303|NCT01212770|2942079|P1|Long-term Safety Phase (Year 4)|Adverse Event|0
892304|NCT01212770|2942071|P9|Long-term Safety Phase (Year 3)|Miscellaneous|1
892305|NCT01212770|2942072|P8|Long-term Safety Phase (Year 3)|Miscellaneous|1
892306|NCT01212770|2942073|P7|Long-term Safety Phase (Year 3)|Miscellaneous|0
892307|NCT01212770|2942074|P6|Long-term Safety Phase (Year 3)|Miscellaneous|0
892308|NCT01212770|2942075|P5|Long-term Safety Phase (Year 3)|Miscellaneous|0
892309|NCT01212770|2942076|P4|Long-term Safety Phase (Year 3)|Miscellaneous|0
892310|NCT01212770|2942077|P3|Long-term Safety Phase (Year 3)|Miscellaneous|1
892311|NCT01212770|2942078|P2|Long-term Safety Phase (Year 3)|Miscellaneous|2
892312|NCT01212770|2942079|P1|Long-term Safety Phase (Year 3)|Miscellaneous|0
892313|NCT01212770|2942071|P9|Long-term Safety Phase (Year 3)|Protocol Violation|0
892314|NCT01212770|2942072|P8|Long-term Safety Phase (Year 3)|Protocol Violation|1
892315|NCT01212770|2942073|P7|Long-term Safety Phase (Year 3)|Protocol Violation|0
892316|NCT01212770|2942074|P6|Long-term Safety Phase (Year 3)|Protocol Violation|0
892317|NCT01212770|2942075|P5|Long-term Safety Phase (Year 3)|Protocol Violation|0
892318|NCT01212770|2942076|P4|Long-term Safety Phase (Year 3)|Protocol Violation|0
892319|NCT01212770|2942077|P3|Long-term Safety Phase (Year 3)|Protocol Violation|0
892320|NCT01212770|2942078|P2|Long-term Safety Phase (Year 3)|Protocol Violation|0
892321|NCT01212770|2942079|P1|Long-term Safety Phase (Year 3)|Protocol Violation|0
892322|NCT01212770|2942071|P9|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
892323|NCT01212770|2942072|P8|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
892324|NCT01212770|2942073|P7|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
892325|NCT01212770|2942074|P6|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
892326|NCT01212770|2942075|P5|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
892327|NCT01212770|2942076|P4|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
892328|NCT01212770|2942077|P3|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
892329|NCT01212770|2942078|P2|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
892330|NCT01212770|2942079|P1|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
892331|NCT01212770|2942071|P9|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
892332|NCT01212770|2942072|P8|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
892333|NCT01212770|2942073|P7|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
892334|NCT01212770|2942074|P6|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
892335|NCT01212770|2942075|P5|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
892336|NCT01212770|2942076|P4|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
892337|NCT01212770|2942077|P3|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
892338|NCT01212770|2942078|P2|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3
892339|NCT01212770|2942079|P1|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
892340|NCT01212770|2942071|P9|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
892341|NCT01212770|2942072|P8|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
892342|NCT01212770|2942073|P7|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
892343|NCT01212770|2942074|P6|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
892344|NCT01212770|2942075|P5|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
892345|NCT01212770|2942076|P4|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
892346|NCT01212770|2942077|P3|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
892347|NCT01212770|2942078|P2|Long-term Safety Phase (Year 3)|Lack of Efficacy|3
892348|NCT01212770|2942079|P1|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
892349|NCT01212770|2942071|P9|Long-term Safety Phase (Year 3)|Adverse Event|1
892350|NCT01212770|2942072|P8|Long-term Safety Phase (Year 3)|Adverse Event|2
892351|NCT01212770|2942073|P7|Long-term Safety Phase (Year 3)|Adverse Event|0
892352|NCT01212770|2942074|P6|Long-term Safety Phase (Year 3)|Adverse Event|0
892353|NCT01212770|2942075|P5|Long-term Safety Phase (Year 3)|Adverse Event|0
892354|NCT01212770|2942076|P4|Long-term Safety Phase (Year 3)|Adverse Event|0
892355|NCT01212770|2942077|P3|Long-term Safety Phase (Year 3)|Adverse Event|2
892356|NCT01212770|2942078|P2|Long-term Safety Phase (Year 3)|Adverse Event|2
892357|NCT01212770|2942079|P1|Long-term Safety Phase (Year 3)|Adverse Event|0
892358|NCT01212770|2942071|P9|Long-term Safety Phase (Year 2)|Miscellaneous|1
892359|NCT01212770|2942072|P8|Long-term Safety Phase (Year 2)|Miscellaneous|0
892360|NCT01212770|2942073|P7|Long-term Safety Phase (Year 2)|Miscellaneous|0
892361|NCT01212770|2942074|P6|Long-term Safety Phase (Year 2)|Miscellaneous|0
892362|NCT01212770|2942075|P5|Long-term Safety Phase (Year 2)|Miscellaneous|0
892363|NCT01212770|2942076|P4|Long-term Safety Phase (Year 2)|Miscellaneous|0
892364|NCT01212770|2942077|P3|Long-term Safety Phase (Year 2)|Miscellaneous|1
892365|NCT01212770|2942078|P2|Long-term Safety Phase (Year 2)|Miscellaneous|2
892366|NCT01212770|2942079|P1|Long-term Safety Phase (Year 2)|Miscellaneous|0
892367|NCT01212770|2942071|P9|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
892368|NCT01212770|2942072|P8|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
892369|NCT01212770|2942073|P7|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
892370|NCT01212770|2942074|P6|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
892371|NCT01212770|2942075|P5|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
892372|NCT01212770|2942076|P4|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
892373|NCT01212770|2942077|P3|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
892374|NCT01212770|2942078|P2|Long-term Safety Phase (Year 2)|Lost to Follow-up|2
892375|NCT01212770|2942079|P1|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
892376|NCT01212770|2942071|P9|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
892377|NCT01212770|2942072|P8|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
892378|NCT01212770|2942073|P7|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
892379|NCT01212770|2942074|P6|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
892380|NCT01212770|2942075|P5|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
892381|NCT01212770|2942076|P4|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
892382|NCT01212770|2942077|P3|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
892383|NCT01212770|2942078|P2|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9
892384|NCT01212770|2942079|P1|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
892385|NCT01212770|2942071|P9|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
892386|NCT01212770|2942072|P8|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
892387|NCT01212770|2942073|P7|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
892388|NCT01212770|2942074|P6|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
892389|NCT01212770|2942075|P5|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
892390|NCT01212770|2942076|P4|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
892391|NCT01212770|2942077|P3|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
892392|NCT01212770|2942078|P2|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1
892393|NCT01212770|2942079|P1|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
892394|NCT01212770|2942071|P9|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
892395|NCT01212770|2942072|P8|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
892396|NCT01212770|2942073|P7|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
892397|NCT01212770|2942074|P6|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
892398|NCT01212770|2942075|P5|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
892399|NCT01212770|2942076|P4|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
892400|NCT01212770|2942077|P3|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
892401|NCT01212770|2942078|P2|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
892402|NCT01212770|2942079|P1|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
892403|NCT01212770|2942071|P9|Long-term Safety Phase (Year 2)|Adverse Event|2
892404|NCT01212770|2942072|P8|Long-term Safety Phase (Year 2)|Adverse Event|0
892405|NCT01212770|2942073|P7|Long-term Safety Phase (Year 2)|Adverse Event|0
892406|NCT01212770|2942074|P6|Long-term Safety Phase (Year 2)|Adverse Event|0
892407|NCT01212770|2942075|P5|Long-term Safety Phase (Year 2)|Adverse Event|0
892408|NCT01212770|2942076|P4|Long-term Safety Phase (Year 2)|Adverse Event|0
892409|NCT01212770|2942077|P3|Long-term Safety Phase (Year 2)|Adverse Event|3
892410|NCT01212770|2942078|P2|Long-term Safety Phase (Year 2)|Adverse Event|3
892411|NCT01212770|2942079|P1|Long-term Safety Phase (Year 2)|Adverse Event|0
892412|NCT01212770|2942071|P9|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
892413|NCT01212770|2942072|P8|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
892414|NCT01212770|2942073|P7|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
892415|NCT01212770|2942074|P6|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
892416|NCT01212770|2942075|P5|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
892417|NCT01212770|2942076|P4|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
892418|NCT01212770|2942077|P3|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
892419|NCT01212770|2942078|P2|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
892420|NCT01212770|2942079|P1|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
892421|NCT01212770|2942071|P9|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
892422|NCT01212770|2942072|P8|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
892423|NCT01212770|2942073|P7|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
892424|NCT01212770|2942074|P6|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
892425|NCT01212770|2942075|P5|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
892426|NCT01212770|2942076|P4|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1
892427|NCT01212770|2942077|P3|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
892428|NCT01212770|2942078|P2|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
892429|NCT01212770|2942079|P1|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
892430|NCT01212770|2942071|P9|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
892431|NCT01212770|2942072|P8|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
892432|NCT01212770|2942073|P7|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
892433|NCT01212770|2942074|P6|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
892434|NCT01212770|2942075|P5|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
892435|NCT01212770|2942076|P4|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
892436|NCT01212770|2942077|P3|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
892437|NCT01212770|2942078|P2|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
892438|NCT01212770|2942079|P1|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
892439|NCT01212770|2942071|P9|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
892440|NCT01212770|2942072|P8|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
892441|NCT01212770|2942073|P7|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
892442|NCT01212770|2942074|P6|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
892443|NCT01212770|2942075|P5|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
892444|NCT01212770|2942076|P4|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
892445|NCT01212770|2942077|P3|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
892446|NCT01212770|2942078|P2|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6
892447|NCT01212770|2942079|P1|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
892448|NCT01212770|2942071|P9|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
892449|NCT01212770|2942072|P8|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
892450|NCT01212770|2942073|P7|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
892451|NCT01212770|2942074|P6|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2
892452|NCT01212770|2942075|P5|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1
892453|NCT01212770|2942076|P4|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
892454|NCT01212770|2942077|P3|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5
892455|NCT01212770|2942078|P2|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
892456|NCT01212770|2942079|P1|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
892457|NCT01212770|2942071|P9|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
892458|NCT01212770|2942072|P8|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
892459|NCT01212770|2942073|P7|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
892460|NCT01212770|2942074|P6|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
892461|NCT01212770|2942075|P5|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
892462|NCT01212770|2942076|P4|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
892463|NCT01212770|2942077|P3|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
892464|NCT01212770|2942078|P2|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6
892465|NCT01212770|2942079|P1|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
892466|NCT01212770|2942071|P9|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
892992|NCT01210118|2943151|P1|Overall Study|Spontaneous abortion|1
892467|NCT01212770|2942072|P8|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
892468|NCT01212770|2942073|P7|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
892469|NCT01212770|2942074|P6|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
892470|NCT01212770|2942075|P5|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
892471|NCT01212770|2942076|P4|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
892472|NCT01212770|2942077|P3|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2
892473|NCT01212770|2942078|P2|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1
892474|NCT01212770|2942079|P1|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3
892475|NCT01212770|2942071|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
892476|NCT01212770|2942072|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
892477|NCT01212770|2942073|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
892478|NCT01212770|2942074|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
892479|NCT01212770|2942075|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
892480|NCT01212770|2942076|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
892481|NCT01212770|2942077|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
892482|NCT01212770|2942078|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
892483|NCT01212770|2942079|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
892484|NCT01212770|2942071|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
892485|NCT01212770|2942072|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
892486|NCT01212770|2942073|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
892487|NCT01212770|2942074|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
892488|NCT01212770|2942075|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
892489|NCT01212770|2942076|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
892490|NCT01212770|2942077|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3
892491|NCT01212770|2942078|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
892492|NCT01212770|2942079|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
892493|NCT01212770|2942071|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
892494|NCT01212770|2942072|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
892495|NCT01212770|2942073|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
892496|NCT01212770|2942074|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
892497|NCT01212770|2942075|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
892498|NCT01212770|2942076|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
892499|NCT01212770|2942077|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
892500|NCT01212770|2942078|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
892501|NCT01212770|2942079|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
892502|NCT01212770|2942071|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
892503|NCT01212770|2942072|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
892504|NCT01212770|2942073|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
892505|NCT01212770|2942074|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
892506|NCT01212770|2942075|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
892507|NCT01212770|2942076|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
892508|NCT01212770|2942077|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7
892509|NCT01212770|2942078|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5
892510|NCT01212770|2942079|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
892511|NCT01212770|2942071|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
892512|NCT01212770|2942072|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
892513|NCT01212770|2942073|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
892514|NCT01212770|2942074|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
892515|NCT01212770|2942075|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
892516|NCT01212770|2942076|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
892517|NCT01212770|2942077|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8
892518|NCT01212770|2942078|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
892519|NCT01212770|2942079|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
892520|NCT01212757|2942276|P9|Long-Term Safety Phase (Year 5)|Miscellaneous|0
892521|NCT01212757|2942277|P8|Long-Term Safety Phase (Year 5)|Miscellaneous|0
892522|NCT01212757|2942278|P7|Long-Term Safety Phase (Year 5)|Miscellaneous|0
892523|NCT01212757|2942279|P6|Long-Term Safety Phase (Year 5)|Miscellaneous|0
892524|NCT01212757|2942280|P5|Long-Term Safety Phase (Year 5)|Miscellaneous|0
892525|NCT01212757|2942281|P4|Long-Term Safety Phase (Year 5)|Miscellaneous|0
892526|NCT01212757|2942282|P3|Long-Term Safety Phase (Year 5)|Miscellaneous|1
892527|NCT01212757|2942283|P2|Long-Term Safety Phase (Year 5)|Miscellaneous|1
892528|NCT01212757|2942284|P1|Long-Term Safety Phase (Year 5)|Miscellaneous|0
892529|NCT01212757|2942276|P9|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
892530|NCT01212757|2942277|P8|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
892531|NCT01212757|2942278|P7|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
892532|NCT01212757|2942279|P6|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
892533|NCT01212757|2942280|P5|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
892534|NCT01212757|2942281|P4|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
892535|NCT01212757|2942282|P3|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
892536|NCT01212757|2942283|P2|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1
892537|NCT01212757|2942284|P1|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
892538|NCT01212757|2942276|P9|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
892539|NCT01212757|2942277|P8|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
892540|NCT01212757|2942278|P7|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
892541|NCT01212757|2942279|P6|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
892542|NCT01212757|2942280|P5|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
892543|NCT01212757|2942281|P4|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
892544|NCT01212757|2942282|P3|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
892545|NCT01212757|2942283|P2|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
892546|NCT01212757|2942284|P1|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
892547|NCT01212757|2942276|P9|Long-Term Safety Phase (Year 5)|Adverse Event|0
892548|NCT01212757|2942277|P8|Long-Term Safety Phase (Year 5)|Adverse Event|2
892549|NCT01212757|2942278|P7|Long-Term Safety Phase (Year 5)|Adverse Event|0
892550|NCT01212757|2942279|P6|Long-Term Safety Phase (Year 5)|Adverse Event|0
892551|NCT01212757|2942280|P5|Long-Term Safety Phase (Year 5)|Adverse Event|0
892552|NCT01212757|2942281|P4|Long-Term Safety Phase (Year 5)|Adverse Event|0
892553|NCT01212757|2942282|P3|Long-Term Safety Phase (Year 5)|Adverse Event|2
892554|NCT01212757|2942283|P2|Long-Term Safety Phase (Year 5)|Adverse Event|2
892555|NCT01212757|2942284|P1|Long-Term Safety Phase (Year 5)|Adverse Event|0
892556|NCT01212757|2942276|P9|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
892557|NCT01212757|2942277|P8|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
892558|NCT01212757|2942278|P7|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
892559|NCT01212757|2942279|P6|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
892560|NCT01212757|2942280|P5|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
892561|NCT01212757|2942281|P4|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
892562|NCT01212757|2942282|P3|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
892563|NCT01212757|2942283|P2|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
892564|NCT01212757|2942284|P1|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
892565|NCT01212757|2942276|P9|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
892566|NCT01212757|2942277|P8|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1
892567|NCT01212757|2942278|P7|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
892568|NCT01212757|2942279|P6|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
892569|NCT01212757|2942280|P5|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
892570|NCT01212757|2942281|P4|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
892571|NCT01212757|2942282|P3|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
892572|NCT01212757|2942283|P2|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
892573|NCT01212757|2942284|P1|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
892574|NCT01212757|2942276|P9|Long-Term Safety Phase (Year 4)|Death|1
892575|NCT01212757|2942277|P8|Long-Term Safety Phase (Year 4)|Death|0
892576|NCT01212757|2942278|P7|Long-Term Safety Phase (Year 4)|Death|0
892577|NCT01212757|2942279|P6|Long-Term Safety Phase (Year 4)|Death|0
892578|NCT01212757|2942280|P5|Long-Term Safety Phase (Year 4)|Death|0
892579|NCT01212757|2942281|P4|Long-Term Safety Phase (Year 4)|Death|0
892580|NCT01212757|2942282|P3|Long-Term Safety Phase (Year 4)|Death|1
892581|NCT01212757|2942283|P2|Long-Term Safety Phase (Year 4)|Death|0
892582|NCT01212757|2942284|P1|Long-Term Safety Phase (Year 4)|Death|0
892583|NCT01212757|2942276|P9|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3
892584|NCT01212757|2942277|P8|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1
892585|NCT01212757|2942278|P7|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
892586|NCT01212757|2942279|P6|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
892587|NCT01212757|2942280|P5|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
892588|NCT01212757|2942281|P4|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
892589|NCT01212757|2942282|P3|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2
892590|NCT01212757|2942283|P2|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4
892591|NCT01212757|2942284|P1|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
892592|NCT01212757|2942276|P9|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
892593|NCT01212757|2942277|P8|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
892594|NCT01212757|2942278|P7|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
892595|NCT01212757|2942279|P6|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
892596|NCT01212757|2942280|P5|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
892597|NCT01212757|2942281|P4|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
892598|NCT01212757|2942282|P3|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
892599|NCT01212757|2942283|P2|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
892600|NCT01212757|2942284|P1|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
892601|NCT01212757|2942276|P9|Long-Term Safety Phase (Year 4)|Adverse Event|1
892602|NCT01212757|2942277|P8|Long-Term Safety Phase (Year 4)|Adverse Event|1
892603|NCT01212757|2942278|P7|Long-Term Safety Phase (Year 4)|Adverse Event|0
892604|NCT01212757|2942279|P6|Long-Term Safety Phase (Year 4)|Adverse Event|0
892605|NCT01212757|2942280|P5|Long-Term Safety Phase (Year 4)|Adverse Event|0
892606|NCT01212757|2942281|P4|Long-Term Safety Phase (Year 4)|Adverse Event|0
892607|NCT01212757|2942282|P3|Long-Term Safety Phase (Year 4)|Adverse Event|2
892608|NCT01212757|2942283|P2|Long-Term Safety Phase (Year 4)|Adverse Event|1
892609|NCT01212757|2942284|P1|Long-Term Safety Phase (Year 4)|Adverse Event|0
892610|NCT01212757|2942276|P9|Long-Term Safety Phase (Year 4)|Miscellaneous|1
892611|NCT01212757|2942277|P8|Long-Term Safety Phase (Year 4)|Miscellaneous|0
892993|NCT01210118|2943150|P2|Overall Study|Protocol Violation|1
892612|NCT01212757|2942278|P7|Long-Term Safety Phase (Year 4)|Miscellaneous|0
892613|NCT01212757|2942279|P6|Long-Term Safety Phase (Year 4)|Miscellaneous|0
892614|NCT01212757|2942280|P5|Long-Term Safety Phase (Year 4)|Miscellaneous|0
892615|NCT01212757|2942281|P4|Long-Term Safety Phase (Year 4)|Miscellaneous|0
892616|NCT01212757|2942282|P3|Long-Term Safety Phase (Year 4)|Miscellaneous|0
892617|NCT01212757|2942283|P2|Long-Term Safety Phase (Year 4)|Miscellaneous|2
892618|NCT01212757|2942284|P1|Long-Term Safety Phase (Year 4)|Miscellaneous|0
892619|NCT01212757|2942276|P9|Long-Term Safety Phase (Year 3)|Miscellaneous|2
892620|NCT01212757|2942277|P8|Long-Term Safety Phase (Year 3)|Miscellaneous|0
892621|NCT01212757|2942278|P7|Long-Term Safety Phase (Year 3)|Miscellaneous|0
892622|NCT01212757|2942279|P6|Long-Term Safety Phase (Year 3)|Miscellaneous|0
892623|NCT01212757|2942280|P5|Long-Term Safety Phase (Year 3)|Miscellaneous|0
892624|NCT01212757|2942281|P4|Long-Term Safety Phase (Year 3)|Miscellaneous|0
892625|NCT01212757|2942282|P3|Long-Term Safety Phase (Year 3)|Miscellaneous|3
892626|NCT01212757|2942283|P2|Long-Term Safety Phase (Year 3)|Miscellaneous|0
892627|NCT01212757|2942284|P1|Long-Term Safety Phase (Year 3)|Miscellaneous|0
892628|NCT01212757|2942276|P9|Long-Term Safety Phase (Year 3)|Protocol Violation|0
892629|NCT01212757|2942277|P8|Long-Term Safety Phase (Year 3)|Protocol Violation|0
892630|NCT01212757|2942278|P7|Long-Term Safety Phase (Year 3)|Protocol Violation|0
892631|NCT01212757|2942279|P6|Long-Term Safety Phase (Year 3)|Protocol Violation|0
892632|NCT01212757|2942280|P5|Long-Term Safety Phase (Year 3)|Protocol Violation|0
892633|NCT01212757|2942281|P4|Long-Term Safety Phase (Year 3)|Protocol Violation|0
892634|NCT01212757|2942282|P3|Long-Term Safety Phase (Year 3)|Protocol Violation|0
892635|NCT01212757|2942283|P2|Long-Term Safety Phase (Year 3)|Protocol Violation|1
892636|NCT01212757|2942284|P1|Long-Term Safety Phase (Year 3)|Protocol Violation|0
892637|NCT01212757|2942276|P9|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1
892638|NCT01212757|2942277|P8|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
892639|NCT01212757|2942278|P7|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
892640|NCT01212757|2942279|P6|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
892641|NCT01212757|2942280|P5|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
892642|NCT01212757|2942281|P4|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
892643|NCT01212757|2942282|P3|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
892644|NCT01212757|2942283|P2|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
892645|NCT01212757|2942284|P1|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
892646|NCT01212757|2942276|P9|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
892647|NCT01212757|2942277|P8|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
892648|NCT01212757|2942278|P7|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
892649|NCT01212757|2942279|P6|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
892650|NCT01212757|2942280|P5|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
892651|NCT01212757|2942281|P4|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
892652|NCT01212757|2942282|P3|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
892653|NCT01212757|2942283|P2|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5
892654|NCT01212757|2942284|P1|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
892655|NCT01212757|2942276|P9|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
892656|NCT01212757|2942277|P8|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
892657|NCT01212757|2942278|P7|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
892658|NCT01212757|2942279|P6|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
892659|NCT01212757|2942280|P5|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
892660|NCT01212757|2942281|P4|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
892661|NCT01212757|2942282|P3|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1
892662|NCT01212757|2942283|P2|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
892663|NCT01212757|2942284|P1|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
892664|NCT01212757|2942276|P9|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1
892665|NCT01212757|2942277|P8|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3
892666|NCT01212757|2942278|P7|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
892667|NCT01212757|2942279|P6|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
892668|NCT01212757|2942280|P5|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
892669|NCT01212757|2942281|P4|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
892670|NCT01212757|2942282|P3|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5
892671|NCT01212757|2942283|P2|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8
892672|NCT01212757|2942284|P1|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
892673|NCT01212757|2942276|P9|Long-Term Safety Phase (Year 3)|Adverse Event|0
892674|NCT01212757|2942277|P8|Long-Term Safety Phase (Year 3)|Adverse Event|2
892675|NCT01212757|2942278|P7|Long-Term Safety Phase (Year 3)|Adverse Event|0
892676|NCT01212757|2942279|P6|Long-Term Safety Phase (Year 3)|Adverse Event|0
892677|NCT01212757|2942280|P5|Long-Term Safety Phase (Year 3)|Adverse Event|0
892678|NCT01212757|2942281|P4|Long-Term Safety Phase (Year 3)|Adverse Event|0
892679|NCT01212757|2942282|P3|Long-Term Safety Phase (Year 3)|Adverse Event|1
892680|NCT01212757|2942283|P2|Long-Term Safety Phase (Year 3)|Adverse Event|4
892681|NCT01212757|2942284|P1|Long-Term Safety Phase (Year 3)|Adverse Event|0
892682|NCT01212757|2942276|P9|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
892683|NCT01212757|2942277|P8|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
892684|NCT01212757|2942278|P7|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
892685|NCT01212757|2942279|P6|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
892686|NCT01212757|2942280|P5|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
892687|NCT01212757|2942281|P4|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
892688|NCT01212757|2942282|P3|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2
892689|NCT01212757|2942283|P2|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
892690|NCT01212757|2942284|P1|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
892691|NCT01212757|2942276|P9|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6
892692|NCT01212757|2942277|P8|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4
892693|NCT01212757|2942278|P7|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
892694|NCT01212757|2942279|P6|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
892695|NCT01212757|2942280|P5|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
892696|NCT01212757|2942281|P4|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
892697|NCT01212757|2942282|P3|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9
892698|NCT01212757|2942283|P2|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7
892699|NCT01212757|2942284|P1|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
892700|NCT01212757|2942276|P9|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
892701|NCT01212757|2942277|P8|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
892702|NCT01212757|2942278|P7|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
892703|NCT01212757|2942279|P6|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
892704|NCT01212757|2942280|P5|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
892705|NCT01212757|2942281|P4|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
892706|NCT01212757|2942282|P3|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2
892707|NCT01212757|2942283|P2|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
892708|NCT01212757|2942284|P1|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
892709|NCT01212757|2942276|P9|Long-Term Safety Phase (Year 2)|Adverse Event|2
892710|NCT01212757|2942277|P8|Long-Term Safety Phase (Year 2)|Adverse Event|2
892711|NCT01212757|2942278|P7|Long-Term Safety Phase (Year 2)|Adverse Event|0
892712|NCT01212757|2942279|P6|Long-Term Safety Phase (Year 2)|Adverse Event|0
892713|NCT01212757|2942280|P5|Long-Term Safety Phase (Year 2)|Adverse Event|0
892714|NCT01212757|2942281|P4|Long-Term Safety Phase (Year 2)|Adverse Event|0
892715|NCT01212757|2942282|P3|Long-Term Safety Phase (Year 2)|Adverse Event|1
892716|NCT01212757|2942283|P2|Long-Term Safety Phase (Year 2)|Adverse Event|1
892717|NCT01212757|2942284|P1|Long-Term Safety Phase (Year 2)|Adverse Event|0
892718|NCT01212757|2942276|P9|Long-Term Safety Phase (Year 2)|Miscellaneous|1
892719|NCT01212757|2942277|P8|Long-Term Safety Phase (Year 2)|Miscellaneous|0
892720|NCT01212757|2942278|P7|Long-Term Safety Phase (Year 2)|Miscellaneous|0
892721|NCT01212757|2942279|P6|Long-Term Safety Phase (Year 2)|Miscellaneous|0
892722|NCT01212757|2942280|P5|Long-Term Safety Phase (Year 2)|Miscellaneous|0
892723|NCT01212757|2942281|P4|Long-Term Safety Phase (Year 2)|Miscellaneous|0
892724|NCT01212757|2942282|P3|Long-Term Safety Phase (Year 2)|Miscellaneous|0
892725|NCT01212757|2942283|P2|Long-Term Safety Phase (Year 2)|Miscellaneous|0
892726|NCT01212757|2942284|P1|Long-Term Safety Phase (Year 2)|Miscellaneous|0
892727|NCT01212757|2942276|P9|Active Treatment Phase (Weeks 24 - 52)|Other|0
892728|NCT01212757|2942277|P8|Active Treatment Phase (Weeks 24 - 52)|Other|0
892729|NCT01212757|2942278|P7|Active Treatment Phase (Weeks 24 - 52)|Other|0
892730|NCT01212757|2942279|P6|Active Treatment Phase (Weeks 24 - 52)|Other|0
892731|NCT01212757|2942280|P5|Active Treatment Phase (Weeks 24 - 52)|Other|0
892732|NCT01212757|2942281|P4|Active Treatment Phase (Weeks 24 - 52)|Other|0
892733|NCT01212757|2942282|P3|Active Treatment Phase (Weeks 24 - 52)|Other|1
892734|NCT01212757|2942283|P2|Active Treatment Phase (Weeks 24 - 52)|Other|1
892735|NCT01212757|2942284|P1|Active Treatment Phase (Weeks 24 - 52)|Other|0
892736|NCT01212757|2942276|P9|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
892737|NCT01212757|2942277|P8|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
892738|NCT01212757|2942278|P7|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
892739|NCT01212757|2942279|P6|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
892740|NCT01212757|2942280|P5|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
892741|NCT01212757|2942281|P4|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
892742|NCT01212757|2942282|P3|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
892743|NCT01212757|2942283|P2|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
892744|NCT01212757|2942284|P1|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
892745|NCT01212757|2942276|P9|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
892746|NCT01212757|2942277|P8|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
892747|NCT01212757|2942278|P7|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
892748|NCT01212757|2942279|P6|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
892749|NCT01212757|2942280|P5|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1
892750|NCT01212757|2942281|P4|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
892751|NCT01212757|2942282|P3|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7
892752|NCT01212757|2942283|P2|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
892753|NCT01212757|2942284|P1|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
892754|NCT01212757|2942276|P9|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
892755|NCT01212757|2942277|P8|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
892756|NCT01212757|2942278|P7|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
892757|NCT01212757|2942279|P6|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
892758|NCT01212757|2942280|P5|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
892759|NCT01212757|2942281|P4|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
892760|NCT01212757|2942282|P3|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2
892761|NCT01212757|2942283|P2|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
892762|NCT01212757|2942284|P1|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
892763|NCT01212757|2942276|P9|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
892764|NCT01212757|2942277|P8|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
892765|NCT01212757|2942278|P7|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
892766|NCT01212757|2942279|P6|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2
892767|NCT01212757|2942280|P5|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
892768|NCT01212757|2942281|P4|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4
892769|NCT01212757|2942282|P3|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7
892770|NCT01212757|2942283|P2|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5
892771|NCT01212757|2942284|P1|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
892772|NCT01212757|2942276|P9|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
892773|NCT01212757|2942277|P8|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
892774|NCT01212757|2942278|P7|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
892775|NCT01212757|2942279|P6|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
892776|NCT01212757|2942280|P5|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
892777|NCT01212757|2942281|P4|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1
892778|NCT01212757|2942282|P3|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3
892779|NCT01212757|2942283|P2|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
892780|NCT01212757|2942284|P1|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
892781|NCT01212757|2942276|P9|Placebo-controlled Phase (Week 0 - 24)|Other|0
892782|NCT01212757|2942277|P8|Placebo-controlled Phase (Week 0 - 24)|Other|0
892783|NCT01212757|2942278|P7|Placebo-controlled Phase (Week 0 - 24)|Other|0
892784|NCT01212757|2942279|P6|Placebo-controlled Phase (Week 0 - 24)|Other|0
892785|NCT01212757|2942280|P5|Placebo-controlled Phase (Week 0 - 24)|Other|0
892786|NCT01212757|2942281|P4|Placebo-controlled Phase (Week 0 - 24)|Other|0
892787|NCT01212757|2942282|P3|Placebo-controlled Phase (Week 0 - 24)|Other|0
892788|NCT01212757|2942283|P2|Placebo-controlled Phase (Week 0 - 24)|Other|2
892789|NCT01212757|2942284|P1|Placebo-controlled Phase (Week 0 - 24)|Other|1
892790|NCT01212757|2942276|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
892791|NCT01212757|2942277|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
892792|NCT01212757|2942278|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
892793|NCT01212757|2942279|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
892794|NCT01212757|2942280|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
892795|NCT01212757|2942281|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
892796|NCT01212757|2942282|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
892797|NCT01212757|2942283|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
892798|NCT01212757|2942284|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
892799|NCT01212757|2942276|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
892800|NCT01212757|2942277|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
892801|NCT01212757|2942278|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
892802|NCT01212757|2942279|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
892803|NCT01212757|2942280|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
892804|NCT01212757|2942281|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
892805|NCT01212757|2942282|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
892806|NCT01212757|2942283|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
892807|NCT01212757|2942284|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
892808|NCT01212757|2942276|P9|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
892809|NCT01212757|2942277|P8|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
892810|NCT01212757|2942278|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
892811|NCT01212757|2942279|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
892812|NCT01212757|2942280|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
892813|NCT01212757|2942281|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
892814|NCT01212757|2942282|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
892815|NCT01212757|2942283|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
892816|NCT01212757|2942284|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3
892817|NCT01212757|2942276|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
892818|NCT01212757|2942277|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
892819|NCT01212757|2942278|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
892820|NCT01212757|2942279|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
892821|NCT01212757|2942280|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
892822|NCT01212757|2942281|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
892823|NCT01212757|2942282|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
892824|NCT01212757|2942283|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9
892825|NCT01212757|2942284|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7
892826|NCT01212757|2942276|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
892827|NCT01212757|2942277|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
892828|NCT01212757|2942278|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
892829|NCT01212757|2942279|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
892830|NCT01212757|2942280|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
892831|NCT01212757|2942281|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
892832|NCT01212757|2942282|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
892833|NCT01212757|2942283|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
892834|NCT01212757|2942284|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
892835|NCT01212757|2942276|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
892836|NCT01212757|2942277|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
892837|NCT01212757|2942278|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
892838|NCT01212757|2942279|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
892839|NCT01212757|2942280|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
892840|NCT01212757|2942281|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
892841|NCT01212757|2942282|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
892842|NCT01212757|2942283|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
892843|NCT01212757|2942284|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
892844|NCT01212185|2942523|P2|Overall Study|Protocol Violation|1
892845|NCT01212185|2942524|P1|Overall Study|Protocol Violation|2
892846|NCT01212159|2942543|P2|Overall Study|Withdrawal by Subject|12
892847|NCT01212159|2942544|P1|Overall Study|Withdrawal by Subject|12
892848|NCT01212094|2942557|P3|Years 2 & 3: Treatment Randomization|Adverse Event|1
892849|NCT01212094|2942558|P2|Years 2 & 3: Treatment Randomization|Adverse Event|0
892850|NCT01212094|2942559|P1|Years 2 & 3: Treatment Randomization|Adverse Event|0
892851|NCT01212094|2942557|P3|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3
892852|NCT01212094|2942558|P2|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
892853|NCT01212094|2942559|P1|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
892854|NCT01212094|2942557|P3|Years 2 & 3: Treatment Randomization|Study terminated|7
892855|NCT01212094|2942558|P2|Years 2 & 3: Treatment Randomization|Study terminated|4
892856|NCT01212094|2942559|P1|Years 2 & 3: Treatment Randomization|Study terminated|0
892857|NCT01212094|2942557|P3|Year 1: Baseline Monitoring|Started on DMT|0
892858|NCT01212094|2942558|P2|Year 1: Baseline Monitoring|Started on DMT|0
892859|NCT01212094|2942559|P1|Year 1: Baseline Monitoring|Started on DMT|2
892860|NCT01212094|2942557|P3|Year 1: Baseline Monitoring|Withdrawal by Subject|0
892861|NCT01212094|2942558|P2|Year 1: Baseline Monitoring|Withdrawal by Subject|0
892862|NCT01212094|2942559|P1|Year 1: Baseline Monitoring|Withdrawal by Subject|7
892863|NCT01212094|2942557|P3|Year 1: Baseline Monitoring|Study terminated|0
892864|NCT01212094|2942558|P2|Year 1: Baseline Monitoring|Study terminated|0
892865|NCT01212094|2942559|P1|Year 1: Baseline Monitoring|Study terminated|7
892866|NCT01211769|2942606|P4|Overall Study|Adverse Event|1
892867|NCT01211769|2942607|P3|Overall Study|Adverse Event|1
892868|NCT01211769|2942608|P2|Overall Study|Adverse Event|1
892869|NCT01211769|2942609|P1|Overall Study|Adverse Event|0
892870|NCT01211769|2942606|P4|Overall Study|Physician Decision|1
892871|NCT01211769|2942607|P3|Overall Study|Physician Decision|2
892872|NCT01211769|2942608|P2|Overall Study|Physician Decision|0
892873|NCT01211769|2942609|P1|Overall Study|Physician Decision|2
892874|NCT01211769|2942606|P4|Overall Study|Lost to Follow-up|9
892875|NCT01211769|2942607|P3|Overall Study|Lost to Follow-up|5
892876|NCT01211769|2942608|P2|Overall Study|Lost to Follow-up|9
892877|NCT01211769|2942609|P1|Overall Study|Lost to Follow-up|7
892878|NCT01211665|2942648|P2|Overall Study|Death|0
892879|NCT01211665|2942649|P1|Overall Study|Death|1
892880|NCT01211665|2942648|P2|Overall Study|Withdrawal by Subject|0
892881|NCT01211665|2942649|P1|Overall Study|Withdrawal by Subject|1
892882|NCT01211613|2942676|P3|Overall Study|Withdrawal by Subject|0
892883|NCT01211613|2942677|P2|Overall Study|Withdrawal by Subject|0
892884|NCT01211613|2942678|P1|Overall Study|Withdrawal by Subject|1
892885|NCT01211613|2942676|P3|Overall Study|Lost to Follow-up|2
892886|NCT01211613|2942677|P2|Overall Study|Lost to Follow-up|2
892887|NCT01211613|2942678|P1|Overall Study|Lost to Follow-up|2
892888|NCT01211535|2942691|P2|Overall Study|Adverse Event|1
892889|NCT01211535|2942692|P1|Overall Study|Adverse Event|0
892890|NCT01211197|2942711|P6|Washout Period 2 (7 Days)|Adverse Event|0
892891|NCT01211197|2942712|P5|Washout Period 2 (7 Days)|Adverse Event|0
892892|NCT01211197|2942713|P4|Washout Period 2 (7 Days)|Adverse Event|0
892893|NCT01211197|2942714|P3|Washout Period 2 (7 Days)|Adverse Event|0
892894|NCT01211197|2942715|P2|Washout Period 2 (7 Days)|Adverse Event|0
892895|NCT01211197|2942716|P1|Washout Period 2 (7 Days)|Adverse Event|1
892896|NCT01211197|2942711|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
892897|NCT01211197|2942712|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
892898|NCT01211197|2942713|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
892899|NCT01211197|2942714|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|1
892900|NCT01211197|2942715|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
892901|NCT01211197|2942716|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
892902|NCT01211184|2942763|P3|Overall Study|Withdrawal by Subject|1
892903|NCT01211184|2942764|P2|Overall Study|Withdrawal by Subject|2
892904|NCT01211184|2942765|P1|Overall Study|Withdrawal by Subject|0
892905|NCT01211145|2942780|P4|Overall Study|Patient decision|2
892906|NCT01211145|2942781|P3|Overall Study|Patient decision|0
892907|NCT01211145|2942782|P2|Overall Study|Patient decision|1
892908|NCT01211145|2942783|P1|Overall Study|Patient decision|2
892909|NCT01211145|2942780|P4|Overall Study|Eligibility criteria not fulfilled|15
892910|NCT01211145|2942781|P3|Overall Study|Eligibility criteria not fulfilled|10
892911|NCT01211145|2942782|P2|Overall Study|Eligibility criteria not fulfilled|12
892912|NCT01211145|2942783|P1|Overall Study|Eligibility criteria not fulfilled|16
892913|NCT01211145|2942780|P4|Overall Study|Severe noncompliance to protocol|0
892914|NCT01211145|2942781|P3|Overall Study|Severe noncompliance to protocol|0
892915|NCT01211145|2942782|P2|Overall Study|Severe noncompliance to protocol|0
892916|NCT01211145|2942783|P1|Overall Study|Severe noncompliance to protocol|1
892917|NCT01211145|2942780|P4|Overall Study|Study-specific withdrawal criteria|0
892918|NCT01211145|2942781|P3|Overall Study|Study-specific withdrawal criteria|0
892919|NCT01211145|2942782|P2|Overall Study|Study-specific withdrawal criteria|0
892920|NCT01211145|2942783|P1|Overall Study|Study-specific withdrawal criteria|1
892921|NCT01211145|2942780|P4|Overall Study|Lost to Follow-up|2
892922|NCT01211145|2942781|P3|Overall Study|Lost to Follow-up|1
892923|NCT01211145|2942782|P2|Overall Study|Lost to Follow-up|2
892924|NCT01211145|2942783|P1|Overall Study|Lost to Follow-up|3
892925|NCT01211145|2942780|P4|Overall Study|Reason not specified|1
892926|NCT01211145|2942781|P3|Overall Study|Reason not specified|2
892927|NCT01211145|2942782|P2|Overall Study|Reason not specified|2
892928|NCT01211145|2942783|P1|Overall Study|Reason not specified|3
892929|NCT01210807|2942837|P2|Overall Study|Not implanted bilaterally|1
892930|NCT01210807|2942838|P1|Overall Study|Not implanted bilaterally|2
892931|NCT01210807|2942837|P2|Overall Study|Lost to Follow-up|2
892932|NCT01210807|2942838|P1|Overall Study|Lost to Follow-up|1
892933|NCT01210690|2942853|P1|Overall Study|Patient could not take glucose|1
892934|NCT01210690|2942853|P1|Overall Study|Patient refused to swallow|1
892935|NCT01210690|2942853|P1|Overall Study|Withdrawal by Subject|1
892936|NCT01210690|2942853|P1|Overall Study|Disease Remission|1
892937|NCT01210690|2942853|P1|Overall Study|Lost to Follow-up|3
892938|NCT01210690|2942853|P1|Overall Study|Lack of Efficacy|12
892939|NCT01210690|2942853|P1|Overall Study|Adverse Event|7
892940|NCT01210664|2942866|P4|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1
892941|NCT01210664|2942867|P3|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
892942|NCT01210664|2942868|P2|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
892943|NCT01210664|2942869|P1|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
892944|NCT01210664|2942866|P4|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
892945|NCT01210664|2942867|P3|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1
892946|NCT01210664|2942868|P2|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
892947|NCT01210664|2942869|P1|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
892948|NCT01210664|2942866|P4|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
892949|NCT01210664|2942867|P3|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1
892950|NCT01210664|2942868|P2|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
892951|NCT01210664|2942869|P1|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
892952|NCT01210651|2942897|P2|Overall Study|Injury outside study|0
892953|NCT01210651|2942898|P1|Overall Study|Injury outside study|2
892954|NCT01210651|2942897|P2|Overall Study|Withdrawal by Subject|1
892955|NCT01210651|2942898|P1|Overall Study|Withdrawal by Subject|1
892956|NCT01210651|2942897|P2|Overall Study|Withdrawn by PI for disruptive behavior|1
892957|NCT01210651|2942898|P1|Overall Study|Withdrawn by PI for disruptive behavior|0
892958|NCT01210651|2942897|P2|Overall Study|schedule conflicts|5
892959|NCT01210651|2942898|P1|Overall Study|schedule conflicts|1
892960|NCT01210651|2942897|P2|Overall Study|Lost to Follow-up|1
892961|NCT01210651|2942898|P1|Overall Study|Lost to Follow-up|1
892962|NCT01210495|2943018|P4|Overall Study|Other unspecified|0
892963|NCT01210495|2943019|P3|Overall Study|Other unspecified|6
892964|NCT01210495|2943020|P2|Overall Study|Other unspecified|0
892965|NCT01210495|2943021|P1|Overall Study|Other unspecified|0
892966|NCT01210495|2943018|P4|Overall Study|Lost to Follow-up|1
892967|NCT01210495|2943019|P3|Overall Study|Lost to Follow-up|1
892968|NCT01210495|2943020|P2|Overall Study|Lost to Follow-up|0
892969|NCT01210495|2943021|P1|Overall Study|Lost to Follow-up|0
892970|NCT01210495|2943018|P4|Overall Study|Study Terminated by Sponsor|11
892971|NCT01210495|2943019|P3|Overall Study|Study Terminated by Sponsor|4
892972|NCT01210495|2943020|P2|Overall Study|Study Terminated by Sponsor|0
892973|NCT01210495|2943021|P1|Overall Study|Study Terminated by Sponsor|0
892974|NCT01210495|2943018|P4|Overall Study|Death|54
892975|NCT01210495|2943019|P3|Overall Study|Death|112
892976|NCT01210495|2943020|P2|Overall Study|Death|7
892977|NCT01210495|2943021|P1|Overall Study|Death|14
892978|NCT01210495|2943018|P4|Overall Study|Participant Refused Further Follow-Up|2
892979|NCT01210495|2943019|P3|Overall Study|Participant Refused Further Follow-Up|11
892980|NCT01210495|2943020|P2|Overall Study|Participant Refused Further Follow-Up|0
892981|NCT01210495|2943021|P1|Overall Study|Participant Refused Further Follow-Up|1
892982|NCT01210443|2943083|P1|Overall Study|Study terminated by sponsor|2
892983|NCT01210222|2943091|P1|Overall Study|Never treated|1
892984|NCT01210222|2943091|P1|Overall Study|Ineligible|2
892985|NCT01210144|2943127|P2|Overall Study|No transfer|0
892986|NCT01210144|2943128|P1|Overall Study|No transfer|1
892987|NCT01210144|2943127|P2|Overall Study|No fertilization|0
892988|NCT01210144|2943128|P1|Overall Study|No fertilization|1
892989|NCT01210144|2943127|P2|Overall Study|Lack of ovarian response|0
892990|NCT01210144|2943128|P1|Overall Study|Lack of ovarian response|1
892991|NCT01210118|2943150|P2|Overall Study|Spontaneous abortion|3
892994|NCT01210118|2943151|P1|Overall Study|Protocol Violation|1
892995|NCT01210118|2943150|P2|Overall Study|Lost to Follow-up|1
892996|NCT01210118|2943151|P1|Overall Study|Lost to Follow-up|1
892997|NCT01210001|2943175|P3|Overall Study|Other reason not defined above|1
892998|NCT01210001|2943176|P2|Overall Study|Other reason not defined above|2
892999|NCT01210001|2943177|P1|Overall Study|Other reason not defined above|2
893000|NCT01210001|2943175|P3|Overall Study|Patient refusal to continue,not due toAE|1
893001|NCT01210001|2943176|P2|Overall Study|Patient refusal to continue,not due toAE|2
893002|NCT01210001|2943177|P1|Overall Study|Patient refusal to continue,not due toAE|6
893003|NCT01210001|2943175|P3|Overall Study|Lost to Follow-up|2
893004|NCT01210001|2943176|P2|Overall Study|Lost to Follow-up|3
893005|NCT01210001|2943177|P1|Overall Study|Lost to Follow-up|4
893006|NCT01210001|2943175|P3|Overall Study|Non compliant with protocol|3
893007|NCT01210001|2943176|P2|Overall Study|Non compliant with protocol|2
893008|NCT01210001|2943177|P1|Overall Study|Non compliant with protocol|2
893009|NCT01210001|2943175|P3|Overall Study|Adverse Event|5
893010|NCT01210001|2943176|P2|Overall Study|Adverse Event|2
893011|NCT01210001|2943177|P1|Overall Study|Adverse Event|4
893012|NCT01210001|2943175|P3|Overall Study|Not treated|0
893013|NCT01210001|2943176|P2|Overall Study|Not treated|0
893014|NCT01210001|2943177|P1|Overall Study|Not treated|1
893015|NCT01209949|2943197|P1|Overall Study|Lost to Follow-up|3
893016|NCT01209780|2943207|P5|Overall Study|Inappropriate enrollment|1
893017|NCT01209780|2943208|P4|Overall Study|Inappropriate enrollment|0
893018|NCT01209780|2943209|P3|Overall Study|Inappropriate enrollment|0
893019|NCT01209780|2943210|P2|Overall Study|Inappropriate enrollment|2
893020|NCT01209780|2943211|P1|Overall Study|Inappropriate enrollment|0
893021|NCT01209780|2943207|P5|Overall Study|Protocol Violation|0
893022|NCT01209780|2943208|P4|Overall Study|Protocol Violation|0
893023|NCT01209780|2943209|P3|Overall Study|Protocol Violation|0
893024|NCT01209780|2943210|P2|Overall Study|Protocol Violation|1
893025|NCT01209780|2943211|P1|Overall Study|Protocol Violation|0
893026|NCT01209780|2943207|P5|Overall Study|Lost to Follow-up|4
893027|NCT01209780|2943208|P4|Overall Study|Lost to Follow-up|9
893028|NCT01209780|2943209|P3|Overall Study|Lost to Follow-up|3
893029|NCT01209780|2943210|P2|Overall Study|Lost to Follow-up|12
893030|NCT01209780|2943211|P1|Overall Study|Lost to Follow-up|17
893031|NCT01209780|2943207|P5|Overall Study|Withdrawal by Subject|0
893032|NCT01209780|2943208|P4|Overall Study|Withdrawal by Subject|1
893033|NCT01209780|2943209|P3|Overall Study|Withdrawal by Subject|1
893034|NCT01209780|2943210|P2|Overall Study|Withdrawal by Subject|2
893035|NCT01209780|2943211|P1|Overall Study|Withdrawal by Subject|9
893036|NCT01209780|2943207|P5|Overall Study|Adverse Event|0
893037|NCT01209780|2943208|P4|Overall Study|Adverse Event|0
893038|NCT01209780|2943209|P3|Overall Study|Adverse Event|0
893039|NCT01209780|2943210|P2|Overall Study|Adverse Event|1
893040|NCT01209780|2943211|P1|Overall Study|Adverse Event|0
893041|NCT01209767|2943237|P1|Overall Study|Lost to Follow-up|3
893042|NCT01209767|2943237|P1|Overall Study|Withdrawal by Subject|1
893043|NCT01209689|2943306|P2|Overall Study|Sponsor's Decision to Stop the Study|17
893044|NCT01209689|2943307|P1|Overall Study|Sponsor's Decision to Stop the Study|68
893045|NCT01209689|2943306|P2|Overall Study|Failure to Return|0
893046|NCT01209689|2943307|P1|Overall Study|Failure to Return|3
893047|NCT01209689|2943306|P2|Overall Study|Violation of Selection Criteria at Entry|0
893048|NCT01209689|2943307|P1|Overall Study|Violation of Selection Criteria at Entry|1
893049|NCT01209689|2943306|P2|Overall Study|Adverse Event|0
893050|NCT01209689|2943307|P1|Overall Study|Adverse Event|4
893051|NCT01209689|2943306|P2|Overall Study|Refused Treatment|3
893052|NCT01209689|2943307|P1|Overall Study|Refused Treatment|8
893053|NCT01209689|2943306|P2|Overall Study|Insufficient Therapeutic Response|2
893054|NCT01209689|2943307|P1|Overall Study|Insufficient Therapeutic Response|7
893055|NCT01209624|2943313|P1|Overall Study|Other|4
893056|NCT01209624|2943313|P1|Overall Study|Lost to Follow-up|290
893057|NCT01209624|2943313|P1|Overall Study|Lack of Efficacy|17
893058|NCT01209624|2943313|P1|Overall Study|Adverse Event|13
893059|NCT01209624|2943313|P1|Overall Study|Death|2
893060|NCT01209598|2943346|P2|Overall Study|Withdrawal by Subject|0
893061|NCT01209598|2943347|P1|Overall Study|Withdrawal by Subject|1
893062|NCT01209520|2943355|P1|Overall Study|Withdrawal by Subject|3
893063|NCT01209286|2943363|P3|Overall Study|Other|0
893064|NCT01209286|2943364|P2|Overall Study|Other|1
893065|NCT01209286|2943365|P1|Overall Study|Other|0
893066|NCT01209286|2943363|P3|Overall Study|Physician Decision|0
893067|NCT01209286|2943364|P2|Overall Study|Physician Decision|2
893068|NCT01209286|2943365|P1|Overall Study|Physician Decision|0
893069|NCT01209286|2943363|P3|Overall Study|Remission Not Achieved in 2 Cycles|1
893070|NCT01209286|2943364|P2|Overall Study|Remission Not Achieved in 2 Cycles|3
893071|NCT01209286|2943365|P1|Overall Study|Remission Not Achieved in 2 Cycles|1
893072|NCT01209286|2943363|P3|Overall Study|Hematological Relapse After Remission|1
893073|NCT01209286|2943364|P2|Overall Study|Hematological Relapse After Remission|1
893074|NCT01209286|2943365|P1|Overall Study|Hematological Relapse After Remission|0
893075|NCT01209286|2943363|P3|Overall Study|Adverse Event|1
893076|NCT01209286|2943364|P2|Overall Study|Adverse Event|3
893077|NCT01209286|2943365|P1|Overall Study|Adverse Event|4
893078|NCT01209143|2943474|P2|Overall Study|Disease progression|16
893079|NCT01209143|2943475|P1|Overall Study|Disease progression|11
893080|NCT01209143|2943474|P2|Overall Study|Withdrawal by Subject|1
893081|NCT01209143|2943475|P1|Overall Study|Withdrawal by Subject|2
893082|NCT01209143|2943474|P2|Overall Study|Lost to Follow-up|0
893083|NCT01209143|2943475|P1|Overall Study|Lost to Follow-up|1
893084|NCT01209143|2943474|P2|Overall Study|Physician Decision|1
893085|NCT01209143|2943475|P1|Overall Study|Physician Decision|3
893086|NCT01209143|2943474|P2|Overall Study|Death|1
893087|NCT01209143|2943475|P1|Overall Study|Death|0
893088|NCT01209143|2943474|P2|Overall Study|Adverse Event|1
893089|NCT01209143|2943475|P1|Overall Study|Adverse Event|2
893090|NCT01209078|2943485|P2|Overall Study|Withdrawal by Subject|1
893091|NCT01209078|2943486|P1|Overall Study|Withdrawal by Subject|2
893092|NCT01209078|2943485|P2|Overall Study|Physician Decision|2
893093|NCT01209078|2943486|P1|Overall Study|Physician Decision|5
893094|NCT01209078|2943485|P2|Overall Study|Lost to Follow-up|0
893095|NCT01209078|2943486|P1|Overall Study|Lost to Follow-up|4
893096|NCT01209078|2943485|P2|Overall Study|Adverse Event|0
893097|NCT01209078|2943486|P1|Overall Study|Adverse Event|5
893098|NCT01208961|2943561|P2|High-Fat Period III|Protocol Violation|0
893099|NCT01208961|2943562|P1|High-Fat Period III|Protocol Violation|1
893100|NCT01208870|2943573|P2|Overall Study|Lost to Follow-up|8
893101|NCT01208870|2943574|P1|Overall Study|Lost to Follow-up|2
893102|NCT01208415|2943590|P1|Overall Study|Still be eligible for follow-up|33
893103|NCT01208415|2943590|P1|Overall Study|Device not placed|1
893104|NCT01208415|2943590|P1|Overall Study|Withdrawal by Subject|3
893105|NCT01208415|2943590|P1|Overall Study|Lost to Follow-up|2
893106|NCT01208415|2943590|P1|Overall Study|Death|1
893107|NCT01208402|2943596|P2|Overall Study|Withdrawal by Subject|0
893108|NCT01208402|2943597|P1|Overall Study|Withdrawal by Subject|1
893109|NCT01208337|2943613|P1|Overall Study|Death|3
893110|NCT01208233|2943627|P6|Overall Study|Withdrawal by Subject|2
893111|NCT01208233|2943628|P5|Overall Study|Withdrawal by Subject|4
893112|NCT01208233|2943629|P4|Overall Study|Withdrawal by Subject|1
893113|NCT01208233|2943630|P3|Overall Study|Withdrawal by Subject|1
893114|NCT01208233|2943631|P2|Overall Study|Withdrawal by Subject|0
893115|NCT01208233|2943632|P1|Overall Study|Withdrawal by Subject|1
893116|NCT01208233|2943627|P6|Overall Study|Other|1
893117|NCT01208233|2943628|P5|Overall Study|Other|0
893118|NCT01208233|2943629|P4|Overall Study|Other|0
893119|NCT01208233|2943630|P3|Overall Study|Other|0
893120|NCT01208233|2943631|P2|Overall Study|Other|1
893121|NCT01208233|2943632|P1|Overall Study|Other|2
893122|NCT01208233|2943627|P6|Overall Study|Protocol Violation|0
893123|NCT01208233|2943628|P5|Overall Study|Protocol Violation|3
893124|NCT01208233|2943629|P4|Overall Study|Protocol Violation|0
893125|NCT01208233|2943630|P3|Overall Study|Protocol Violation|0
893126|NCT01208233|2943631|P2|Overall Study|Protocol Violation|0
893127|NCT01208233|2943632|P1|Overall Study|Protocol Violation|0
893128|NCT01208233|2943627|P6|Overall Study|Study terminated by sponsor|7
893129|NCT01208233|2943628|P5|Overall Study|Study terminated by sponsor|10
893130|NCT01208233|2943629|P4|Overall Study|Study terminated by sponsor|0
893131|NCT01208233|2943630|P3|Overall Study|Study terminated by sponsor|0
893132|NCT01208233|2943631|P2|Overall Study|Study terminated by sponsor|0
893133|NCT01208233|2943632|P1|Overall Study|Study terminated by sponsor|0
893134|NCT01208233|2943627|P6|Overall Study|Medication error without adverse event|1
893135|NCT01208233|2943628|P5|Overall Study|Medication error without adverse event|0
893136|NCT01208233|2943629|P4|Overall Study|Medication error without adverse event|0
893137|NCT01208233|2943630|P3|Overall Study|Medication error without adverse event|0
893138|NCT01208233|2943631|P2|Overall Study|Medication error without adverse event|0
893139|NCT01208233|2943632|P1|Overall Study|Medication error without adverse event|0
893140|NCT01208233|2943627|P6|Overall Study|Did not meet entrance criteria|0
893141|NCT01208233|2943628|P5|Overall Study|Did not meet entrance criteria|1
893142|NCT01208233|2943629|P4|Overall Study|Did not meet entrance criteria|0
893143|NCT01208233|2943630|P3|Overall Study|Did not meet entrance criteria|1
893144|NCT01208233|2943631|P2|Overall Study|Did not meet entrance criteria|1
893145|NCT01208233|2943632|P1|Overall Study|Did not meet entrance criteria|2
893146|NCT01208233|2943627|P6|Overall Study|Death|5
893147|NCT01208233|2943628|P5|Overall Study|Death|3
893148|NCT01208233|2943629|P4|Overall Study|Death|0
893149|NCT01208233|2943630|P3|Overall Study|Death|0
893150|NCT01208233|2943631|P2|Overall Study|Death|0
893151|NCT01208233|2943632|P1|Overall Study|Death|0
893152|NCT01208233|2943627|P6|Overall Study|Adverse Event|5
893153|NCT01208233|2943628|P5|Overall Study|Adverse Event|3
893154|NCT01208233|2943629|P4|Overall Study|Adverse Event|0
893155|NCT01208233|2943630|P3|Overall Study|Adverse Event|2
893156|NCT01208233|2943631|P2|Overall Study|Adverse Event|1
893157|NCT01208233|2943632|P1|Overall Study|Adverse Event|0
893158|NCT01208207|2943757|P7|Part II|Technical Problems|0
893159|NCT01208207|2943758|P6|Part II|Technical Problems|1
893160|NCT01208207|2943759|P5|Part II|Technical Problems|0
893161|NCT01208207|2943760|P4|Part II|Technical Problems|1
893162|NCT01208207|2943761|P3|Part II|Technical Problems|0
893163|NCT01208207|2943762|P2|Part II|Technical Problems|0
893164|NCT01208207|2943763|P1|Part II|Technical Problems|0
893165|NCT01208207|2943757|P7|Part II|Protocol Violation|0
893166|NCT01208207|2943758|P6|Part II|Protocol Violation|0
893167|NCT01208207|2943759|P5|Part II|Protocol Violation|0
893168|NCT01208207|2943760|P4|Part II|Protocol Violation|1
893169|NCT01208207|2943761|P3|Part II|Protocol Violation|0
893170|NCT01208207|2943762|P2|Part II|Protocol Violation|0
893171|NCT01208207|2943763|P1|Part II|Protocol Violation|0
893172|NCT01208207|2943757|P7|Part II|Physician Decision|0
893173|NCT01208207|2943758|P6|Part II|Physician Decision|2
893174|NCT01208207|2943759|P5|Part II|Physician Decision|0
893175|NCT01208207|2943760|P4|Part II|Physician Decision|1
893176|NCT01208207|2943761|P3|Part II|Physician Decision|0
893177|NCT01208207|2943762|P2|Part II|Physician Decision|0
893178|NCT01208207|2943763|P1|Part II|Physician Decision|0
893179|NCT01208207|2943757|P7|Part II|Non-Compliance With Study Drug|0
893180|NCT01208207|2943758|P6|Part II|Non-Compliance With Study Drug|1
893181|NCT01208207|2943759|P5|Part II|Non-Compliance With Study Drug|1
893182|NCT01208207|2943760|P4|Part II|Non-Compliance With Study Drug|4
893183|NCT01208207|2943761|P3|Part II|Non-Compliance With Study Drug|0
893184|NCT01208207|2943762|P2|Part II|Non-Compliance With Study Drug|0
893185|NCT01208207|2943763|P1|Part II|Non-Compliance With Study Drug|0
893186|NCT01208207|2943757|P7|Part II|Lost to Follow-up|1
893187|NCT01208207|2943758|P6|Part II|Lost to Follow-up|2
893188|NCT01208207|2943759|P5|Part II|Lost to Follow-up|0
893189|NCT01208207|2943760|P4|Part II|Lost to Follow-up|4
893190|NCT01208207|2943761|P3|Part II|Lost to Follow-up|0
893191|NCT01208207|2943762|P2|Part II|Lost to Follow-up|0
893192|NCT01208207|2943763|P1|Part II|Lost to Follow-up|0
893193|NCT01208207|2943757|P7|Part II|Lack of Efficacy|3
893194|NCT01208207|2943758|P6|Part II|Lack of Efficacy|3
893195|NCT01208207|2943759|P5|Part II|Lack of Efficacy|4
893196|NCT01208207|2943760|P4|Part II|Lack of Efficacy|6
893197|NCT01208207|2943761|P3|Part II|Lack of Efficacy|0
893198|NCT01208207|2943762|P2|Part II|Lack of Efficacy|0
893199|NCT01208207|2943763|P1|Part II|Lack of Efficacy|0
893200|NCT01208207|2943757|P7|Part II|Adverse Event|2
893201|NCT01208207|2943758|P6|Part II|Adverse Event|4
893202|NCT01208207|2943759|P5|Part II|Adverse Event|9
893203|NCT01208207|2943760|P4|Part II|Adverse Event|5
893204|NCT01208207|2943761|P3|Part II|Adverse Event|0
893205|NCT01208207|2943762|P2|Part II|Adverse Event|0
893206|NCT01208207|2943763|P1|Part II|Adverse Event|0
893207|NCT01208207|2943757|P7|Part II|Withdrawal by Subject|5
893208|NCT01208207|2943758|P6|Part II|Withdrawal by Subject|3
893209|NCT01208207|2943759|P5|Part II|Withdrawal by Subject|9
893210|NCT01208207|2943760|P4|Part II|Withdrawal by Subject|10
893211|NCT01208207|2943761|P3|Part II|Withdrawal by Subject|0
893212|NCT01208207|2943762|P2|Part II|Withdrawal by Subject|0
893213|NCT01208207|2943763|P1|Part II|Withdrawal by Subject|0
893214|NCT01208207|2943757|P7|Part I|Withdrawal by Subject|0
893215|NCT01208207|2943758|P6|Part I|Withdrawal by Subject|0
893216|NCT01208207|2943759|P5|Part I|Withdrawal by Subject|0
893217|NCT01208207|2943760|P4|Part I|Withdrawal by Subject|0
893218|NCT01208207|2943761|P3|Part I|Withdrawal by Subject|4
893219|NCT01208207|2943762|P2|Part I|Withdrawal by Subject|4
893220|NCT01208207|2943763|P1|Part I|Withdrawal by Subject|14
893221|NCT01208207|2943757|P7|Part I|Protocol Violation|0
893222|NCT01208207|2943758|P6|Part I|Protocol Violation|0
893223|NCT01208207|2943759|P5|Part I|Protocol Violation|0
893224|NCT01208207|2943760|P4|Part I|Protocol Violation|0
893225|NCT01208207|2943761|P3|Part I|Protocol Violation|2
893226|NCT01208207|2943762|P2|Part I|Protocol Violation|0
893227|NCT01208207|2943763|P1|Part I|Protocol Violation|8
893228|NCT01208207|2943757|P7|Part I|Progressive Disease|0
893229|NCT01208207|2943758|P6|Part I|Progressive Disease|0
893230|NCT01208207|2943759|P5|Part I|Progressive Disease|0
893231|NCT01208207|2943760|P4|Part I|Progressive Disease|0
893232|NCT01208207|2943761|P3|Part I|Progressive Disease|0
893233|NCT01208207|2943762|P2|Part I|Progressive Disease|0
893234|NCT01208207|2943763|P1|Part I|Progressive Disease|1
893235|NCT01208207|2943757|P7|Part I|Physician Decision|0
893236|NCT01208207|2943758|P6|Part I|Physician Decision|0
893237|NCT01208207|2943759|P5|Part I|Physician Decision|0
893238|NCT01208207|2943760|P4|Part I|Physician Decision|0
893239|NCT01208207|2943761|P3|Part I|Physician Decision|0
893240|NCT01208207|2943762|P2|Part I|Physician Decision|1
893241|NCT01208207|2943763|P1|Part I|Physician Decision|0
893242|NCT01208207|2943757|P7|Part I|Non-Compliance With Study Drug|0
893243|NCT01208207|2943758|P6|Part I|Non-Compliance With Study Drug|0
893244|NCT01208207|2943759|P5|Part I|Non-Compliance With Study Drug|0
893245|NCT01208207|2943760|P4|Part I|Non-Compliance With Study Drug|0
893246|NCT01208207|2943761|P3|Part I|Non-Compliance With Study Drug|1
893247|NCT01208207|2943762|P2|Part I|Non-Compliance With Study Drug|0
893248|NCT01208207|2943763|P1|Part I|Non-Compliance With Study Drug|1
893249|NCT01208207|2943757|P7|Part I|Lost to Follow-up|0
893250|NCT01208207|2943758|P6|Part I|Lost to Follow-up|0
893251|NCT01208207|2943759|P5|Part I|Lost to Follow-up|0
893252|NCT01208207|2943760|P4|Part I|Lost to Follow-up|0
893253|NCT01208207|2943761|P3|Part I|Lost to Follow-up|0
893254|NCT01208207|2943762|P2|Part I|Lost to Follow-up|1
893255|NCT01208207|2943763|P1|Part I|Lost to Follow-up|6
893256|NCT01208207|2943757|P7|Part I|Lack of Efficacy|0
893257|NCT01208207|2943758|P6|Part I|Lack of Efficacy|0
893258|NCT01208207|2943759|P5|Part I|Lack of Efficacy|0
893259|NCT01208207|2943760|P4|Part I|Lack of Efficacy|0
893260|NCT01208207|2943761|P3|Part I|Lack of Efficacy|2
893261|NCT01208207|2943762|P2|Part I|Lack of Efficacy|3
893262|NCT01208207|2943763|P1|Part I|Lack of Efficacy|21
893263|NCT01208207|2943757|P7|Part I|Adverse Event|0
893264|NCT01208207|2943758|P6|Part I|Adverse Event|0
893265|NCT01208207|2943759|P5|Part I|Adverse Event|0
893266|NCT01208207|2943760|P4|Part I|Adverse Event|0
893267|NCT01208207|2943761|P3|Part I|Adverse Event|6
893268|NCT01208207|2943762|P2|Part I|Adverse Event|2
893269|NCT01208207|2943763|P1|Part I|Adverse Event|19
893270|NCT01208181|2943790|P5|Part 2|Lack of Efficacy|0
893271|NCT01208181|2943791|P4|Part 2|Lack of Efficacy|7
893272|NCT01208181|2943792|P3|Part 2|Lack of Efficacy|5
893273|NCT01208181|2943793|P2|Part 2|Lack of Efficacy|0
893274|NCT01208181|2943794|P1|Part 2|Lack of Efficacy|0
893275|NCT01208181|2943790|P5|Part 2|Lost to Follow-up|0
893276|NCT01208181|2943791|P4|Part 2|Lost to Follow-up|2
893277|NCT01208181|2943792|P3|Part 2|Lost to Follow-up|1
893278|NCT01208181|2943793|P2|Part 2|Lost to Follow-up|0
893279|NCT01208181|2943794|P1|Part 2|Lost to Follow-up|0
893280|NCT01208181|2943790|P5|Part 2|Non-compliance with study drug|0
893281|NCT01208181|2943791|P4|Part 2|Non-compliance with study drug|1
893282|NCT01208181|2943792|P3|Part 2|Non-compliance with study drug|1
893283|NCT01208181|2943793|P2|Part 2|Non-compliance with study drug|0
893284|NCT01208181|2943794|P1|Part 2|Non-compliance with study drug|0
893285|NCT01208181|2943790|P5|Part 2|Physician Decision|0
893286|NCT01208181|2943791|P4|Part 2|Physician Decision|2
893287|NCT01208181|2943792|P3|Part 2|Physician Decision|1
893288|NCT01208181|2943793|P2|Part 2|Physician Decision|0
893289|NCT01208181|2943794|P1|Part 2|Physician Decision|0
893290|NCT01208181|2943790|P5|Part 2|Protocol Violation|0
893291|NCT01208181|2943791|P4|Part 2|Protocol Violation|0
893292|NCT01208181|2943792|P3|Part 2|Protocol Violation|1
893293|NCT01208181|2943793|P2|Part 2|Protocol Violation|0
893294|NCT01208181|2943794|P1|Part 2|Protocol Violation|0
893295|NCT01208181|2943790|P5|Part 2|Withdrawal by Subject|0
893296|NCT01208181|2943791|P4|Part 2|Withdrawal by Subject|1
893297|NCT01208181|2943792|P3|Part 2|Withdrawal by Subject|1
893298|NCT01208181|2943793|P2|Part 2|Withdrawal by Subject|0
893299|NCT01208181|2943794|P1|Part 2|Withdrawal by Subject|0
893300|NCT01208181|2943790|P5|Part 2|Adverse Event|0
893301|NCT01208181|2943791|P4|Part 2|Adverse Event|7
893302|NCT01208181|2943792|P3|Part 2|Adverse Event|6
893303|NCT01208181|2943793|P2|Part 2|Adverse Event|0
893304|NCT01208181|2943794|P1|Part 2|Adverse Event|0
893305|NCT01208181|2943790|P5|Part 1|Adverse Event|4
893306|NCT01208181|2943791|P4|Part 1|Adverse Event|0
893307|NCT01208181|2943792|P3|Part 1|Adverse Event|0
893308|NCT01208181|2943793|P2|Part 1|Adverse Event|24
893309|NCT01208181|2943794|P1|Part 1|Adverse Event|26
893310|NCT01208181|2943790|P5|Part 1|Lack of Efficacy|17
893311|NCT01208181|2943791|P4|Part 1|Lack of Efficacy|0
893312|NCT01208181|2943792|P3|Part 1|Lack of Efficacy|0
893313|NCT01208181|2943793|P2|Part 1|Lack of Efficacy|12
893314|NCT01208181|2943794|P1|Part 1|Lack of Efficacy|37
893315|NCT01208181|2943790|P5|Part 1|Lost to Follow-up|1
893316|NCT01208181|2943791|P4|Part 1|Lost to Follow-up|0
893317|NCT01208181|2943792|P3|Part 1|Lost to Follow-up|0
893318|NCT01208181|2943793|P2|Part 1|Lost to Follow-up|3
893319|NCT01208181|2943794|P1|Part 1|Lost to Follow-up|5
893320|NCT01208181|2943790|P5|Part 1|Non-compliance with study drug|0
893321|NCT01208181|2943791|P4|Part 1|Non-compliance with study drug|0
893322|NCT01208181|2943792|P3|Part 1|Non-compliance with study drug|0
893323|NCT01208181|2943793|P2|Part 1|Non-compliance with study drug|1
893324|NCT01208181|2943794|P1|Part 1|Non-compliance with study drug|1
893325|NCT01208181|2943790|P5|Part 1|Physician Decision|0
893326|NCT01208181|2943791|P4|Part 1|Physician Decision|0
893327|NCT01208181|2943792|P3|Part 1|Physician Decision|0
893328|NCT01208181|2943793|P2|Part 1|Physician Decision|0
893329|NCT01208181|2943794|P1|Part 1|Physician Decision|4
893330|NCT01208181|2943790|P5|Part 1|Protocol Violation|0
893331|NCT01208181|2943791|P4|Part 1|Protocol Violation|0
893332|NCT01208181|2943792|P3|Part 1|Protocol Violation|0
893333|NCT01208181|2943793|P2|Part 1|Protocol Violation|5
893334|NCT01208181|2943794|P1|Part 1|Protocol Violation|10
893335|NCT01208181|2943790|P5|Part 1|Technical problem|0
893336|NCT01208181|2943791|P4|Part 1|Technical problem|0
893337|NCT01208181|2943792|P3|Part 1|Technical problem|0
893338|NCT01208181|2943793|P2|Part 1|Technical problem|0
893339|NCT01208181|2943794|P1|Part 1|Technical problem|5
893340|NCT01208181|2943790|P5|Part 1|Withdrawal by Subject|0
893341|NCT01208181|2943791|P4|Part 1|Withdrawal by Subject|0
893342|NCT01208181|2943792|P3|Part 1|Withdrawal by Subject|0
893343|NCT01208181|2943793|P2|Part 1|Withdrawal by Subject|10
893344|NCT01208181|2943794|P1|Part 1|Withdrawal by Subject|11
893345|NCT01207687|2943851|P1|Overall Study|Withdrawal by Subject|1
893346|NCT01207687|2943851|P1|Overall Study|Adverse Event|1
893347|NCT01207596|2943889|P1|Overall Study|Withdrawal by Subject|1
893348|NCT01207596|2943889|P1|Overall Study|Adverse Event|3
893349|NCT01207596|2943889|P1|Overall Study|Lack of Efficacy|1
893350|NCT01207596|2943889|P1|Overall Study|Physician Decision|4
893351|NCT01207583|2943902|P3|Overall Study|Lost to Follow-up|0
893352|NCT01207583|2943903|P2|Overall Study|Lost to Follow-up|2
893353|NCT01207583|2943904|P1|Overall Study|Lost to Follow-up|0
893354|NCT01207583|2943902|P3|Overall Study|Participant failed to return|0
893355|NCT01207583|2943903|P2|Overall Study|Participant failed to return|0
893356|NCT01207583|2943904|P1|Overall Study|Participant failed to return|1
893357|NCT01207583|2943902|P3|Overall Study|Withdrawal by Subject|1
893358|NCT01207583|2943903|P2|Overall Study|Withdrawal by Subject|3
893359|NCT01207583|2943904|P1|Overall Study|Withdrawal by Subject|0
893360|NCT01207492|2943957|P1|Overall Study|Toxicity|1
893361|NCT01207492|2943957|P1|Overall Study|Progressive disease|3
893362|NCT01207492|2943957|P1|Overall Study|Physician Decision|1
893363|NCT01207492|2943957|P1|Overall Study|Withdrawal by Subject|9
893364|NCT01207492|2943957|P1|Overall Study|Still on study|1
893365|NCT01207453|2943972|P2|2nd Intervention|Lost to Follow-up|0
893366|NCT01207453|2943973|P1|2nd Intervention|Lost to Follow-up|1
893367|NCT01207453|2943972|P2|2nd Intervention|Adverse Event|2
893368|NCT01207453|2943973|P1|2nd Intervention|Adverse Event|1
893369|NCT01207453|2943972|P2|Washout|Lost to Follow-up|0
893370|NCT01207453|2943973|P1|Washout|Lost to Follow-up|1
893371|NCT01207453|2943972|P2|Washout|Adverse Event|0
893372|NCT01207453|2943973|P1|Washout|Adverse Event|1
893373|NCT01207453|2943972|P2|First Intervention|Adverse Event|1
893374|NCT01207453|2943973|P1|First Intervention|Adverse Event|2
893375|NCT01207427|2943995|P3|Double-blind Treatment Period|Withdrawal by Subject|0
893376|NCT01207427|2943996|P2|Double-blind Treatment Period|Withdrawal by Subject|0
893377|NCT01207427|2943997|P1|Double-blind Treatment Period|Withdrawal by Subject|1
893378|NCT01207427|2943995|P3|Double-blind Treatment Period|Protocol Violation|1
893379|NCT01207427|2943996|P2|Double-blind Treatment Period|Protocol Violation|1
893380|NCT01207427|2943997|P1|Double-blind Treatment Period|Protocol Violation|2
893381|NCT01207427|2943995|P3|Double-blind Treatment Period|Lost to Follow-up|1
893382|NCT01207427|2943996|P2|Double-blind Treatment Period|Lost to Follow-up|0
893383|NCT01207427|2943997|P1|Double-blind Treatment Period|Lost to Follow-up|0
893384|NCT01207427|2943995|P3|Double-blind Treatment Period|Adverse Event|0
893385|NCT01207427|2943996|P2|Double-blind Treatment Period|Adverse Event|1
893386|NCT01207427|2943997|P1|Double-blind Treatment Period|Adverse Event|0
893387|NCT01207414|2944007|P2|Overall Study|Randomized in error|0
893388|NCT01207414|2944008|P1|Overall Study|Randomized in error|1
893389|NCT01207414|2944007|P2|Overall Study|Protocol deviation|9
893390|NCT01207414|2944008|P1|Overall Study|Protocol deviation|12
893391|NCT01207414|2944007|P2|Overall Study|Administrative problems|1
893392|NCT01207414|2944008|P1|Overall Study|Administrative problems|1
893393|NCT01207414|2944007|P2|Overall Study|Lost to Follow-up|17
893394|NCT01207414|2944008|P1|Overall Study|Lost to Follow-up|15
893395|NCT01207414|2944007|P2|Overall Study|Patient withdrew consent|11
893396|NCT01207414|2944008|P1|Overall Study|Patient withdrew consent|14
893397|NCT01207414|2944007|P2|Overall Study|Unsatisfactory therapeutic effect|4
893398|NCT01207414|2944008|P1|Overall Study|Unsatisfactory therapeutic effect|5
893399|NCT01207414|2944007|P2|Overall Study|Abnormal test procedure results|1
893400|NCT01207414|2944008|P1|Overall Study|Abnormal test procedure results|0
893401|NCT01207414|2944007|P2|Overall Study|Adverse Event|39
893402|NCT01207414|2944008|P1|Overall Study|Adverse Event|25
893403|NCT01207388|2944033|P1|Overall Study|Other|1
893404|NCT01207388|2944033|P1|Overall Study|Physician Decision|2
893405|NCT01207388|2944033|P1|Overall Study|Disease Relapse|10
893406|NCT01207388|2944033|P1|Overall Study|Adverse Event|20
893407|NCT01207219|2944056|P3|Overall Study|Lost to Follow-up|6
893408|NCT01207219|2944057|P2|Overall Study|Lost to Follow-up|8
893409|NCT01207219|2944058|P1|Overall Study|Lost to Follow-up|6
893410|NCT01207219|2944056|P3|Overall Study|changed diagnosis during study period|1
893411|NCT01207219|2944057|P2|Overall Study|changed diagnosis during study period|3
893412|NCT01207219|2944058|P1|Overall Study|changed diagnosis during study period|5
893413|NCT01207102|2944078|P1|Overall Study|Withdrawal by Treating Physician|1
893414|NCT01207102|2944078|P1|Overall Study|progression|2
893415|NCT01207102|2944078|P1|Overall Study|Adverse Event|2
893416|NCT01207102|2944078|P1|Overall Study|Withdrawal by Subject|5
893417|NCT01206777|2944083|P1|Overall Study|Adverse Event|1
893418|NCT01206777|2944083|P1|Overall Study|Death|1
893419|NCT01206582|2944139|P2|Overall Study|Discontinued intervention before week 8|2
893420|NCT01206582|2944140|P1|Overall Study|Discontinued intervention before week 8|1
893421|NCT01206582|2944139|P2|Overall Study|Withdrew prior to study|0
893422|NCT01206582|2944140|P1|Overall Study|Withdrew prior to study|1
893423|NCT01206517|2944172|P6|Overall Study|Withdrawal by Subject|0
893424|NCT01206517|2944173|P5|Overall Study|Withdrawal by Subject|1
893425|NCT01206517|2944174|P4|Overall Study|Withdrawal by Subject|0
893426|NCT01206517|2944175|P3|Overall Study|Withdrawal by Subject|2
893427|NCT01206517|2944176|P2|Overall Study|Withdrawal by Subject|0
893428|NCT01206517|2944177|P1|Overall Study|Withdrawal by Subject|0
893429|NCT01206439|2944257|P1|Overall Study|subject did not meet inclusion criteria|1
893430|NCT01206322|2944280|P4|Overall Study|Adverse Event|1
893431|NCT01206322|2944281|P3|Overall Study|Adverse Event|0
893432|NCT01206322|2944282|P2|Overall Study|Adverse Event|0
893433|NCT01206322|2944283|P1|Overall Study|Adverse Event|0
893434|NCT01206140|2944299|P2|Overall Study|Deemed ineligible due to incorrect diag.|0
893435|NCT01206140|2944300|P1|Overall Study|Deemed ineligible due to incorrect diag.|1
893436|NCT01206101|2944312|P2|Overall Study|Unclassified|0
893437|NCT01206101|2944313|P1|Overall Study|Unclassified|1
893438|NCT01206101|2944312|P2|Overall Study|Physician Decision|1
893439|NCT01206101|2944313|P1|Overall Study|Physician Decision|0
893440|NCT01206101|2944312|P2|Overall Study|Adverse Event|0
893441|NCT01206101|2944313|P1|Overall Study|Adverse Event|1
893442|NCT01205776|2944354|P2|3 Years Follow-up|Withdrawal by Subject|2
893443|NCT01205776|2944355|P1|3 Years Follow-up|Withdrawal by Subject|1
893444|NCT01205776|2944354|P2|3 Years Follow-up|Lost to Follow-up|22
893445|NCT01205776|2944355|P1|3 Years Follow-up|Lost to Follow-up|15
893446|NCT01205776|2944354|P2|2 Years Follow-up|Withdrawal by Subject|19
893447|NCT01205776|2944355|P1|2 Years Follow-up|Withdrawal by Subject|4
893448|NCT01205776|2944354|P2|2 Years Follow-up|Lost to Follow-up|13
893449|NCT01205776|2944355|P1|2 Years Follow-up|Lost to Follow-up|12
893450|NCT01205776|2944354|P2|1 Month Follow-up|Withdrawal by Subject|10
893451|NCT01205776|2944355|P1|1 Month Follow-up|Withdrawal by Subject|5
893452|NCT01205776|2944354|P2|1 Month Follow-up|Lost to Follow-up|2
893453|NCT01205776|2944355|P1|1 Month Follow-up|Lost to Follow-up|0
893454|NCT01205685|2944495|P1|Overall Study|Withdrawal by Subject|1
893455|NCT01205685|2944495|P1|Overall Study|Disease Progression|10
893456|NCT01205581|2944515|P6|Overall Study|Withdrawal by Subject|0
893457|NCT01205581|2944516|P5|Overall Study|Withdrawal by Subject|0
893458|NCT01205581|2944517|P4|Overall Study|Withdrawal by Subject|0
893459|NCT01205581|2944518|P3|Overall Study|Withdrawal by Subject|0
893460|NCT01205581|2944519|P2|Overall Study|Withdrawal by Subject|0
893461|NCT01205581|2944520|P1|Overall Study|Withdrawal by Subject|1
893462|NCT01205529|2944590|P1|Overall Study|No longer met criteria|30
893463|NCT01205529|2944590|P1|Overall Study|Unstable post op|15
893464|NCT01205529|2944590|P1|Overall Study|Physician Decision|4
893465|NCT01205529|2944590|P1|Overall Study|Withdrawal by Subject|2
893466|NCT01205529|2944590|P1|Overall Study|Procedure Cancelled|4
893467|NCT01205451|2944613|P2|Overall Study|Withdrawal by Subject|9
893468|NCT01205451|2944614|P1|Overall Study|Withdrawal by Subject|5
893469|NCT01205451|2944613|P2|Overall Study|Lost to Follow-up|1
893470|NCT01205451|2944614|P1|Overall Study|Lost to Follow-up|1
893471|NCT01205438|2944659|P3|Overall Study|Sponsor Decision|1
893472|NCT01205438|2944660|P2|Overall Study|Sponsor Decision|1
893473|NCT01205438|2944661|P1|Overall Study|Sponsor Decision|0
893474|NCT01205438|2944659|P3|Overall Study|Protocol Violation|4
893475|NCT01205438|2944660|P2|Overall Study|Protocol Violation|7
893476|NCT01205438|2944661|P1|Overall Study|Protocol Violation|2
893477|NCT01205438|2944659|P3|Overall Study|Physician Decision|2
893478|NCT01205438|2944660|P2|Overall Study|Physician Decision|3
893479|NCT01205438|2944661|P1|Overall Study|Physician Decision|0
893480|NCT01205438|2944659|P3|Overall Study|Withdrawal by Subject|19
893481|NCT01205438|2944660|P2|Overall Study|Withdrawal by Subject|25
893482|NCT01205438|2944661|P1|Overall Study|Withdrawal by Subject|19
893483|NCT01205438|2944659|P3|Overall Study|Lost to Follow-up|8
893484|NCT01205438|2944660|P2|Overall Study|Lost to Follow-up|7
893485|NCT01205438|2944661|P1|Overall Study|Lost to Follow-up|6
893486|NCT01205438|2944659|P3|Overall Study|Lack of Efficacy|14
893487|NCT01205438|2944660|P2|Overall Study|Lack of Efficacy|11
893488|NCT01205438|2944661|P1|Overall Study|Lack of Efficacy|14
893489|NCT01205438|2944659|P3|Overall Study|Entry Criteria Not Met|13
893490|NCT01205438|2944660|P2|Overall Study|Entry Criteria Not Met|15
893491|NCT01205438|2944661|P1|Overall Study|Entry Criteria Not Met|16
893492|NCT01205438|2944659|P3|Overall Study|Death|3
893493|NCT01205438|2944660|P2|Overall Study|Death|1
893494|NCT01205438|2944661|P1|Overall Study|Death|1
893495|NCT01205438|2944659|P3|Overall Study|Adverse Event|24
893496|NCT01205438|2944660|P2|Overall Study|Adverse Event|17
893497|NCT01205438|2944661|P1|Overall Study|Adverse Event|19
893498|NCT01205269|2944717|P6|Period 4 - Washout|Eligibility criteria not fulfilled|0
893499|NCT01205269|2944718|P5|Period 4 - Washout|Eligibility criteria not fulfilled|0
893500|NCT01205269|2944719|P4|Period 4 - Washout|Eligibility criteria not fulfilled|1
893501|NCT01205269|2944720|P3|Period 4 - Washout|Eligibility criteria not fulfilled|0
893502|NCT01205269|2944721|P2|Period 4 - Washout|Eligibility criteria not fulfilled|0
893503|NCT01205269|2944722|P1|Period 4 - Washout|Eligibility criteria not fulfilled|0
893504|NCT01205230|2944762|P2|Overall Study|Physician Decision|0
893505|NCT01205230|2944763|P1|Overall Study|Physician Decision|1
893506|NCT01205230|2944762|P2|Overall Study|Adverse Event|0
893507|NCT01205230|2944763|P1|Overall Study|Adverse Event|4
893508|NCT01205165|2944806|P1|Overall Study|Lost to Follow-up|2
893509|NCT01205152|2944819|P1|Overall Study|Death|1
893510|NCT01205126|2944832|P2|Maintenance Phase|Withdrawal by Subject|11
893511|NCT01205126|2944833|P1|Maintenance Phase|Withdrawal by Subject|8
893512|NCT01205126|2944832|P2|Maintenance Phase|Lost to Follow-up|5
893513|NCT01205126|2944833|P1|Maintenance Phase|Lost to Follow-up|5
893514|NCT01205126|2944832|P2|Maintenance Phase|Other|8
893515|NCT01205126|2944833|P1|Maintenance Phase|Other|11
893516|NCT01205126|2944832|P2|Maintenance Phase|Prohibited drugs used|0
893517|NCT01205126|2944833|P1|Maintenance Phase|Prohibited drugs used|1
893518|NCT01205126|2944832|P2|Maintenance Phase|More than the maximum dosage required|5
893519|NCT01205126|2944833|P1|Maintenance Phase|More than the maximum dosage required|5
893520|NCT01205126|2944832|P2|Maintenance Phase|Death|4
893521|NCT01205126|2944833|P1|Maintenance Phase|Death|4
893522|NCT01205126|2944832|P2|Maintenance Phase|Adverse Event|7
893523|NCT01205126|2944833|P1|Maintenance Phase|Adverse Event|3
893524|NCT01205126|2944832|P2|Between Titration & Maintenance Phase|Other|4
893525|NCT01205126|2944833|P1|Between Titration & Maintenance Phase|Other|0
893526|NCT01205126|2944832|P2|Titration Phase|Other|6
893527|NCT01205126|2944833|P1|Titration Phase|Other|8
893528|NCT01205126|2944832|P2|Titration Phase|More than maximum dosage required|3
893529|NCT01205126|2944833|P1|Titration Phase|More than maximum dosage required|2
893530|NCT01205126|2944832|P2|Titration Phase|No stable titration dose|0
893531|NCT01205126|2944833|P1|Titration Phase|No stable titration dose|1
893532|NCT01205126|2944832|P2|Titration Phase|Lost to Follow-up|2
893533|NCT01205126|2944833|P1|Titration Phase|Lost to Follow-up|2
893534|NCT01205126|2944832|P2|Titration Phase|Withdrawal by Subject|5
893535|NCT01205126|2944833|P1|Titration Phase|Withdrawal by Subject|5
893536|NCT01205126|2944832|P2|Titration Phase|Adverse Event|3
893537|NCT01205126|2944833|P1|Titration Phase|Adverse Event|5
893538|NCT01205035|2944851|P2|Overall Study|Physician Decision|0
893539|NCT01205035|2944852|P1|Overall Study|Physician Decision|1
893540|NCT01205035|2944851|P2|Overall Study|Withdrawal by Subject|0
893541|NCT01205035|2944852|P1|Overall Study|Withdrawal by Subject|1
893542|NCT01204918|2944869|P3|Overall Study|Withdrawal by Subject|5
893543|NCT01204918|2944870|P2|Overall Study|Withdrawal by Subject|10
893544|NCT01204918|2944871|P1|Overall Study|Withdrawal by Subject|4
893545|NCT01204775|2944914|P2|Overall Study|Withdrawal by Subject|0
893546|NCT01204775|2944915|P1|Overall Study|Withdrawal by Subject|1
893547|NCT01204775|2944914|P2|Overall Study|Poor/non-compliance|1
893548|NCT01204775|2944915|P1|Overall Study|Poor/non-compliance|0
893549|NCT01204710|2944940|P2|Optional Olaratumab Monotherapy|Withdrawal by Subject|1
893550|NCT01204710|2944941|P1|Optional Olaratumab Monotherapy|Withdrawal by Subject|0
893551|NCT01204710|2944940|P2|Optional Olaratumab Monotherapy|Physician Decision|1
893552|NCT01204710|2944941|P1|Optional Olaratumab Monotherapy|Physician Decision|0
893553|NCT01204710|2944940|P2|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1
893554|NCT01204710|2944941|P1|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0
893555|NCT01204710|2944940|P2|Randomization Treatment|Moved and Followed for Survival|1
893556|NCT01204710|2944941|P1|Randomization Treatment|Moved and Followed for Survival|0
893557|NCT01204710|2944940|P2|Randomization Treatment|Worsening of General condition|1
893558|NCT01204710|2944941|P1|Randomization Treatment|Worsening of General condition|0
893559|NCT01204710|2944940|P2|Randomization Treatment|Sponsor Decision|1
893560|NCT01204710|2944941|P1|Randomization Treatment|Sponsor Decision|0
893561|NCT01204710|2944940|P2|Randomization Treatment|Adverse Event|2
893562|NCT01204710|2944941|P1|Randomization Treatment|Adverse Event|4
893563|NCT01204710|2944940|P2|Randomization Treatment|Entry criteria not met|1
893564|NCT01204710|2944941|P1|Randomization Treatment|Entry criteria not met|0
893565|NCT01204710|2944940|P2|Randomization Treatment|Physician Decision|2
893566|NCT01204710|2944941|P1|Randomization Treatment|Physician Decision|3
893567|NCT01204710|2944940|P2|Randomization Treatment|Withdrawal by Subject|5
893568|NCT01204710|2944941|P1|Randomization Treatment|Withdrawal by Subject|6
893569|NCT01204710|2944940|P2|Randomization Treatment|Lost to Follow-up|0
893570|NCT01204710|2944941|P1|Randomization Treatment|Lost to Follow-up|1
893571|NCT01204697|2944977|P2|Overall Study|Randomized, but not treated|1
893572|NCT01204697|2944978|P1|Overall Study|Randomized, but not treated|0
893573|NCT01204697|2944977|P2|Overall Study|Withdrawal by Subject|4
893574|NCT01204697|2944978|P1|Overall Study|Withdrawal by Subject|2
893575|NCT01204697|2944977|P2|Overall Study|Lost to Follow-up|4
893576|NCT01204697|2944978|P1|Overall Study|Lost to Follow-up|3
893577|NCT01204697|2944977|P2|Overall Study|Death|27
893578|NCT01204697|2944978|P1|Overall Study|Death|26
893579|NCT01204671|2944999|P5|Overall Study|Physician Decision|0
893580|NCT01204671|2945000|P4|Overall Study|Physician Decision|1
893581|NCT01204671|2945001|P3|Overall Study|Physician Decision|0
893582|NCT01204671|2945002|P2|Overall Study|Physician Decision|0
893583|NCT01204671|2945003|P1|Overall Study|Physician Decision|0
893584|NCT01204671|2944999|P5|Overall Study|Unknown Completion Status|0
893585|NCT01204671|2945000|P4|Overall Study|Unknown Completion Status|0
893586|NCT01204671|2945001|P3|Overall Study|Unknown Completion Status|0
893587|NCT01204671|2945002|P2|Overall Study|Unknown Completion Status|1
893588|NCT01204671|2945003|P1|Overall Study|Unknown Completion Status|1
893589|NCT01204671|2944999|P5|Overall Study|Lost to Follow-up|0
893590|NCT01204671|2945000|P4|Overall Study|Lost to Follow-up|4
893591|NCT01204671|2945001|P3|Overall Study|Lost to Follow-up|6
893592|NCT01204671|2945002|P2|Overall Study|Lost to Follow-up|8
893593|NCT01204671|2945003|P1|Overall Study|Lost to Follow-up|7
893594|NCT01204671|2944999|P5|Overall Study|Withdrawal by Subject|3
893595|NCT01204671|2945000|P4|Overall Study|Withdrawal by Subject|5
893596|NCT01204671|2945001|P3|Overall Study|Withdrawal by Subject|4
893597|NCT01204671|2945002|P2|Overall Study|Withdrawal by Subject|3
893598|NCT01204671|2945003|P1|Overall Study|Withdrawal by Subject|2
893599|NCT01204671|2944999|P5|Overall Study|Adverse Event|1
893600|NCT01204671|2945000|P4|Overall Study|Adverse Event|3
893601|NCT01204671|2945001|P3|Overall Study|Adverse Event|3
893602|NCT01204671|2945002|P2|Overall Study|Adverse Event|3
893603|NCT01204671|2945003|P1|Overall Study|Adverse Event|4
893604|NCT01204658|2945065|P4|Primary Phase|Adverse Event|0
893605|NCT01204658|2945066|P3|Primary Phase|Adverse Event|1
893606|NCT01204658|2945067|P2|Primary Phase|Adverse Event|0
893607|NCT01204658|2945068|P1|Primary Phase|Adverse Event|0
893608|NCT01204398|2945186|P1|Overall Study|Adverse Event|1
893609|NCT01204294|2945203|P7|Overall Study|Other (house moving)|0
893610|NCT01204294|2945204|P6|Overall Study|Other (house moving)|0
893611|NCT01204294|2945205|P5|Overall Study|Other (house moving)|0
893612|NCT01204294|2945206|P4|Overall Study|Other (house moving)|0
893613|NCT01204294|2945207|P3|Overall Study|Other (house moving)|1
893614|NCT01204294|2945208|P2|Overall Study|Other (house moving)|0
893615|NCT01204294|2945209|P1|Overall Study|Other (house moving)|0
893616|NCT01204294|2945203|P7|Overall Study|Lack of Efficacy|0
893617|NCT01204294|2945204|P6|Overall Study|Lack of Efficacy|0
893618|NCT01204294|2945205|P5|Overall Study|Lack of Efficacy|0
893619|NCT01204294|2945206|P4|Overall Study|Lack of Efficacy|2
893620|NCT01204294|2945207|P3|Overall Study|Lack of Efficacy|0
893621|NCT01204294|2945208|P2|Overall Study|Lack of Efficacy|0
893622|NCT01204294|2945209|P1|Overall Study|Lack of Efficacy|0
893623|NCT01204294|2945203|P7|Overall Study|Withdrawal by Subject|2
893624|NCT01204294|2945204|P6|Overall Study|Withdrawal by Subject|1
893625|NCT01204294|2945205|P5|Overall Study|Withdrawal by Subject|1
893626|NCT01204294|2945206|P4|Overall Study|Withdrawal by Subject|1
893627|NCT01204294|2945207|P3|Overall Study|Withdrawal by Subject|2
893628|NCT01204294|2945208|P2|Overall Study|Withdrawal by Subject|2
893629|NCT01204294|2945209|P1|Overall Study|Withdrawal by Subject|0
893630|NCT01204294|2945203|P7|Overall Study|Protocol Violation|0
893631|NCT01204294|2945204|P6|Overall Study|Protocol Violation|0
893632|NCT01204294|2945205|P5|Overall Study|Protocol Violation|0
893633|NCT01204294|2945206|P4|Overall Study|Protocol Violation|1
893634|NCT01204294|2945207|P3|Overall Study|Protocol Violation|2
893635|NCT01204294|2945208|P2|Overall Study|Protocol Violation|0
893636|NCT01204294|2945209|P1|Overall Study|Protocol Violation|1
893637|NCT01204294|2945203|P7|Overall Study|Adverse Event|0
893638|NCT01204294|2945204|P6|Overall Study|Adverse Event|4
893639|NCT01204294|2945205|P5|Overall Study|Adverse Event|1
893640|NCT01204294|2945206|P4|Overall Study|Adverse Event|7
893641|NCT01204294|2945207|P3|Overall Study|Adverse Event|0
893642|NCT01204294|2945208|P2|Overall Study|Adverse Event|6
893643|NCT01204294|2945209|P1|Overall Study|Adverse Event|2
893644|NCT01203956|2945243|P2|Second Two-week Period|Non-compliant: no evaluable results|6
893645|NCT01203956|2945244|P1|Second Two-week Period|Non-compliant: no evaluable results|5
893646|NCT01203930|2945253|P2|Overall Study|Adverse Event|5
893647|NCT01203930|2945254|P1|Overall Study|Adverse Event|17
893648|NCT01203930|2945253|P2|Overall Study|Poor tolerance of study drug|1
893649|NCT01203930|2945254|P1|Overall Study|Poor tolerance of study drug|0
893650|NCT01203930|2945253|P2|Overall Study|Study Terminated by Sponsor|12
893651|NCT01203930|2945254|P1|Overall Study|Study Terminated by Sponsor|0
893652|NCT01203930|2945253|P2|Overall Study|Investigator Request|8
893653|NCT01203930|2945254|P1|Overall Study|Investigator Request|0
893654|NCT01203930|2945253|P2|Overall Study|Withdrew Consent|10
893655|NCT01203930|2945254|P1|Overall Study|Withdrew Consent|1
893656|NCT01203930|2945253|P2|Overall Study|Death|1
893657|NCT01203930|2945254|P1|Overall Study|Death|3
893658|NCT01203930|2945253|P2|Overall Study|Disease Progression|4
893659|NCT01203930|2945254|P1|Overall Study|Disease Progression|0
893660|NCT01203917|2945276|P1|Overall Study|Due to EGFR M+I patient|1
893661|NCT01203917|2945276|P1|Overall Study|Due to objective disease progression|1
893662|NCT01203917|2945276|P1|Overall Study|Withdrawal by Subject|3
893663|NCT01203917|2945276|P1|Overall Study|Lost to Follow-up|2
893664|NCT01203917|2945276|P1|Overall Study|Death|29
893665|NCT01203878|2945289|P3|Overall Study|Adverse Event|2
893666|NCT01203878|2945290|P2|Overall Study|Adverse Event|0
893667|NCT01203878|2945291|P1|Overall Study|Adverse Event|0
893668|NCT01203878|2945289|P3|Overall Study|Withdrawal by Subject|1
893669|NCT01203878|2945290|P2|Overall Study|Withdrawal by Subject|0
893670|NCT01203878|2945291|P1|Overall Study|Withdrawal by Subject|0
893671|NCT01203852|2945302|P1|Washout 2 Weeks|Physician Decision|46
893672|NCT01203852|2945302|P1|Metoprolol 8 Weeks|Physician Decision|470
893673|NCT01203787|2945320|P2|Overall Study|Adverse Event|15
893674|NCT01203787|2945321|P1|Overall Study|Adverse Event|11
893675|NCT01203787|2945320|P2|Overall Study|Lost to Follow-up|0
893676|NCT01203787|2945321|P1|Overall Study|Lost to Follow-up|2
893677|NCT01203787|2945320|P2|Overall Study|Withdrawal by Subject|2
893678|NCT01203787|2945321|P1|Overall Study|Withdrawal by Subject|6
893679|NCT01203787|2945320|P2|Overall Study|Death|10
893680|NCT01203787|2945321|P1|Overall Study|Death|12
893681|NCT01203098|2945392|P3|Overall Study|Withdrawal by Subject|3
893682|NCT01203098|2945393|P2|Overall Study|Withdrawal by Subject|1
893683|NCT01203098|2945394|P1|Overall Study|Withdrawal by Subject|1
893684|NCT01203098|2945392|P3|Overall Study|Physician Decision|0
893685|NCT01203098|2945393|P2|Overall Study|Physician Decision|2
893686|NCT01203098|2945394|P1|Overall Study|Physician Decision|2
893687|NCT01203098|2945392|P3|Overall Study|Lost to Follow-up|1
893688|NCT01203098|2945393|P2|Overall Study|Lost to Follow-up|0
893689|NCT01203098|2945394|P1|Overall Study|Lost to Follow-up|0
893690|NCT01203098|2945392|P3|Overall Study|Adverse Event|7
893691|NCT01203098|2945393|P2|Overall Study|Adverse Event|1
893692|NCT01203098|2945394|P1|Overall Study|Adverse Event|3
893693|NCT01203072|2945410|P5|Overall Study|Withdrawal by Subject|3
893694|NCT01203072|2945411|P4|Overall Study|Withdrawal by Subject|2
893695|NCT01203072|2945412|P3|Overall Study|Withdrawal by Subject|1
893696|NCT01203072|2945413|P2|Overall Study|Withdrawal by Subject|2
893697|NCT01203072|2945414|P1|Overall Study|Withdrawal by Subject|2
893698|NCT01203072|2945410|P5|Overall Study|Protocol Violation|1
893699|NCT01203072|2945411|P4|Overall Study|Protocol Violation|0
893700|NCT01203072|2945412|P3|Overall Study|Protocol Violation|0
893701|NCT01203072|2945413|P2|Overall Study|Protocol Violation|0
893702|NCT01203072|2945414|P1|Overall Study|Protocol Violation|2
893703|NCT01203072|2945410|P5|Overall Study|Lost to Follow-up|0
893704|NCT01203072|2945411|P4|Overall Study|Lost to Follow-up|0
893705|NCT01203072|2945412|P3|Overall Study|Lost to Follow-up|0
893706|NCT01203072|2945413|P2|Overall Study|Lost to Follow-up|1
893707|NCT01203072|2945414|P1|Overall Study|Lost to Follow-up|0
893708|NCT01203072|2945410|P5|Overall Study|Lack of Efficacy|0
893709|NCT01203072|2945411|P4|Overall Study|Lack of Efficacy|0
893710|NCT01203072|2945412|P3|Overall Study|Lack of Efficacy|0
893711|NCT01203072|2945413|P2|Overall Study|Lack of Efficacy|0
893712|NCT01203072|2945414|P1|Overall Study|Lack of Efficacy|1
893713|NCT01203072|2945410|P5|Overall Study|Adverse Event|2
893714|NCT01203072|2945411|P4|Overall Study|Adverse Event|4
893715|NCT01203072|2945412|P3|Overall Study|Adverse Event|2
893716|NCT01203072|2945413|P2|Overall Study|Adverse Event|3
893717|NCT01203072|2945414|P1|Overall Study|Adverse Event|5
893718|NCT01202955|2945449|P2|Period 1: 10 Days|Withdrawal by Subject|2
893719|NCT01202955|2945450|P1|Period 1: 10 Days|Withdrawal by Subject|0
893720|NCT01202903|2945462|P2|Overall Study|Withdrawal by Subject|4
893721|NCT01202903|2945463|P1|Overall Study|Withdrawal by Subject|4
893722|NCT01202903|2945462|P2|Overall Study|Adverse Event|3
893723|NCT01202903|2945463|P1|Overall Study|Adverse Event|3
893724|NCT01202903|2945462|P2|Overall Study|Lack of Efficacy|3
893725|NCT01202903|2945463|P1|Overall Study|Lack of Efficacy|1
893726|NCT01202903|2945462|P2|Overall Study|Lost to Follow-up|1
893727|NCT01202903|2945463|P1|Overall Study|Lost to Follow-up|1
893728|NCT01202903|2945462|P2|Overall Study|Death|0
893729|NCT01202903|2945463|P1|Overall Study|Death|1
893730|NCT01202903|2945462|P2|Overall Study|Protocol Violation|1
893731|NCT01202903|2945463|P1|Overall Study|Protocol Violation|0
893732|NCT01202903|2945462|P2|Overall Study|Administrative Probelms|4
893733|NCT01202903|2945463|P1|Overall Study|Administrative Probelms|1
893734|NCT01202877|2945490|P3|Overall Study|Death|1
893735|NCT01202877|2945491|P2|Overall Study|Death|0
893736|NCT01202877|2945492|P1|Overall Study|Death|0
893737|NCT01202877|2945490|P3|Overall Study|Withdrawal by Subject|1
893738|NCT01202877|2945491|P2|Overall Study|Withdrawal by Subject|0
893739|NCT01202877|2945492|P1|Overall Study|Withdrawal by Subject|0
893740|NCT01202877|2945490|P3|Overall Study|Adverse Event|2
893741|NCT01202877|2945491|P2|Overall Study|Adverse Event|0
893742|NCT01202877|2945492|P1|Overall Study|Adverse Event|0
893743|NCT01202877|2945490|P3|Overall Study|Disease Progression|2
893744|NCT01202877|2945491|P2|Overall Study|Disease Progression|1
893745|NCT01202877|2945492|P1|Overall Study|Disease Progression|0
893746|NCT01202773|2945506|P3|Overall Study|Sponsor Decision|23
893747|NCT01202773|2945507|P2|Overall Study|Sponsor Decision|20
893748|NCT01202773|2945508|P1|Overall Study|Sponsor Decision|19
893749|NCT01202773|2945506|P3|Overall Study|Protocol Violation|10
893750|NCT01202773|2945507|P2|Overall Study|Protocol Violation|6
893751|NCT01202773|2945508|P1|Overall Study|Protocol Violation|11
893752|NCT01202773|2945506|P3|Overall Study|Physician Decision|0
893753|NCT01202773|2945507|P2|Overall Study|Physician Decision|0
893754|NCT01202773|2945508|P1|Overall Study|Physician Decision|2
893755|NCT01202773|2945506|P3|Overall Study|Withdrawal by Subject|5
893756|NCT01202773|2945507|P2|Overall Study|Withdrawal by Subject|6
893757|NCT01202773|2945508|P1|Overall Study|Withdrawal by Subject|13
893758|NCT01202773|2945506|P3|Overall Study|Lost to Follow-up|2
893759|NCT01202773|2945507|P2|Overall Study|Lost to Follow-up|2
893760|NCT01202773|2945508|P1|Overall Study|Lost to Follow-up|1
893761|NCT01202773|2945506|P3|Overall Study|Entry Criteria Not Met|1
893762|NCT01202773|2945507|P2|Overall Study|Entry Criteria Not Met|0
893763|NCT01202773|2945508|P1|Overall Study|Entry Criteria Not Met|2
893764|NCT01202773|2945506|P3|Overall Study|Lack of Efficacy|9
893765|NCT01202773|2945507|P2|Overall Study|Lack of Efficacy|4
893766|NCT01202773|2945508|P1|Overall Study|Lack of Efficacy|5
893767|NCT01202773|2945506|P3|Overall Study|Adverse Event|5
893768|NCT01202773|2945507|P2|Overall Study|Adverse Event|5
893769|NCT01202773|2945508|P1|Overall Study|Adverse Event|4
893770|NCT01202760|2945585|P3|Overall Study|Sponsor Decision|0
893771|NCT01202760|2945586|P2|Overall Study|Sponsor Decision|4
893772|NCT01202760|2945587|P1|Overall Study|Sponsor Decision|4
893773|NCT01202760|2945585|P3|Overall Study|Protocol Violation|2
893774|NCT01202760|2945586|P2|Overall Study|Protocol Violation|5
893775|NCT01202760|2945587|P1|Overall Study|Protocol Violation|7
893776|NCT01202760|2945585|P3|Overall Study|Physician Decision|0
893777|NCT01202760|2945586|P2|Overall Study|Physician Decision|1
893778|NCT01202760|2945587|P1|Overall Study|Physician Decision|0
893779|NCT01202760|2945585|P3|Overall Study|Withdrawal by Subject|14
893780|NCT01202760|2945586|P2|Overall Study|Withdrawal by Subject|18
893781|NCT01202760|2945587|P1|Overall Study|Withdrawal by Subject|17
893782|NCT01202760|2945585|P3|Overall Study|Parent / Caregiver Decision|0
893783|NCT01202760|2945586|P2|Overall Study|Parent / Caregiver Decision|1
893784|NCT01202760|2945587|P1|Overall Study|Parent / Caregiver Decision|0
893785|NCT01202760|2945585|P3|Overall Study|Lost to Follow-up|1
893786|NCT01202760|2945586|P2|Overall Study|Lost to Follow-up|2
893787|NCT01202760|2945587|P1|Overall Study|Lost to Follow-up|0
893788|NCT01202760|2945585|P3|Overall Study|Lack of Efficacy|7
893789|NCT01202760|2945586|P2|Overall Study|Lack of Efficacy|8
893790|NCT01202760|2945587|P1|Overall Study|Lack of Efficacy|6
893791|NCT01202760|2945585|P3|Overall Study|Death|0
893792|NCT01202760|2945586|P2|Overall Study|Death|1
893793|NCT01202760|2945587|P1|Overall Study|Death|2
893794|NCT01202760|2945585|P3|Overall Study|Adverse Event|10
893795|NCT01202760|2945586|P2|Overall Study|Adverse Event|9
893796|NCT01202760|2945587|P1|Overall Study|Adverse Event|11
893797|NCT01202760|2945585|P3|Overall Study|Entry Criteria Not Met|1
893798|NCT01202760|2945586|P2|Overall Study|Entry Criteria Not Met|3
893799|NCT01202760|2945587|P1|Overall Study|Entry Criteria Not Met|0
893800|NCT01202747|2945655|P1|Overall Study|Withdrawal by Subject|1
893801|NCT01202591|2945687|P6|Overall Study|Objective Disease Progression|0
893802|NCT01202591|2945688|P5|Overall Study|Objective Disease Progression|2
893803|NCT01202591|2945689|P4|Overall Study|Objective Disease Progression|0
893804|NCT01202591|2945690|P3|Overall Study|Objective Disease Progression|0
893805|NCT01202591|2945691|P2|Overall Study|Objective Disease Progression|0
893806|NCT01202591|2945692|P1|Overall Study|Objective Disease Progression|0
893807|NCT01202591|2945687|P6|Overall Study|Withdrawal by Subject|1
893808|NCT01202591|2945688|P5|Overall Study|Withdrawal by Subject|2
893809|NCT01202591|2945689|P4|Overall Study|Withdrawal by Subject|0
893810|NCT01202591|2945690|P3|Overall Study|Withdrawal by Subject|0
893811|NCT01202591|2945691|P2|Overall Study|Withdrawal by Subject|0
893812|NCT01202591|2945692|P1|Overall Study|Withdrawal by Subject|0
893813|NCT01202591|2945687|P6|Overall Study|Other reason as per investigator|3
893814|NCT01202591|2945688|P5|Overall Study|Other reason as per investigator|1
893815|NCT01202591|2945689|P4|Overall Study|Other reason as per investigator|3
893816|NCT01202591|2945690|P3|Overall Study|Other reason as per investigator|7
893817|NCT01202591|2945691|P2|Overall Study|Other reason as per investigator|4
893818|NCT01202591|2945692|P1|Overall Study|Other reason as per investigator|3
893819|NCT01202591|2945687|P6|Overall Study|Adverse Event|0
893820|NCT01202591|2945688|P5|Overall Study|Adverse Event|0
893821|NCT01202591|2945689|P4|Overall Study|Adverse Event|4
893822|NCT01202591|2945690|P3|Overall Study|Adverse Event|4
893823|NCT01202591|2945691|P2|Overall Study|Adverse Event|1
893824|NCT01202591|2945692|P1|Overall Study|Adverse Event|2
893825|NCT01202279|2945738|P2|Overall Study|study compliance|2
893826|NCT01202279|2945739|P1|Overall Study|study compliance|5
893827|NCT01202279|2945738|P2|Overall Study|Protocol Violation|1
893828|NCT01202279|2945739|P1|Overall Study|Protocol Violation|1
893829|NCT01202279|2945738|P2|Overall Study|Lost to Follow-up|7
893830|NCT01202279|2945739|P1|Overall Study|Lost to Follow-up|10
893831|NCT01202279|2945738|P2|Overall Study|Physician Decision|1
893832|NCT01202279|2945739|P1|Overall Study|Physician Decision|0
893833|NCT01202279|2945738|P2|Overall Study|Withdrawal by Subject|10
893834|NCT01202279|2945739|P1|Overall Study|Withdrawal by Subject|13
893835|NCT01202279|2945738|P2|Overall Study|Adverse Event|6
893836|NCT01202279|2945739|P1|Overall Study|Adverse Event|8
893837|NCT01202227|2945791|P1|Overall Study|Lack of Efficacy|1
893838|NCT01202227|2945791|P1|Overall Study|Withdrawal by Subject|2
893839|NCT01202227|2945791|P1|Overall Study|Adverse Event|16
893840|NCT01202188|2945815|P5|Overall Study|Abnormal test procedure result (s)|0
893841|NCT01202188|2945816|P4|Overall Study|Abnormal test procedure result (s)|0
893842|NCT01202188|2945817|P3|Overall Study|Abnormal test procedure result (s)|2
893843|NCT01202188|2945818|P2|Overall Study|Abnormal test procedure result (s)|0
893844|NCT01202188|2945819|P1|Overall Study|Abnormal test procedure result (s)|0
893845|NCT01202188|2945815|P5|Overall Study|Death|0
893846|NCT01202188|2945816|P4|Overall Study|Death|1
893847|NCT01202188|2945817|P3|Overall Study|Death|1
893848|NCT01202188|2945818|P2|Overall Study|Death|1
893849|NCT01202188|2945819|P1|Overall Study|Death|1
893850|NCT01202188|2945815|P5|Overall Study|Lost to Follow-up|1
893851|NCT01202188|2945816|P4|Overall Study|Lost to Follow-up|4
893852|NCT01202188|2945817|P3|Overall Study|Lost to Follow-up|0
893853|NCT01202188|2945818|P2|Overall Study|Lost to Follow-up|1
893854|NCT01202188|2945819|P1|Overall Study|Lost to Follow-up|1
893855|NCT01202188|2945815|P5|Overall Study|Unsatisfactory therapeutic effect|8
893856|NCT01202188|2945816|P4|Overall Study|Unsatisfactory therapeutic effect|5
893857|NCT01202188|2945817|P3|Overall Study|Unsatisfactory therapeutic effect|2
893858|NCT01202188|2945818|P2|Overall Study|Unsatisfactory therapeutic effect|8
893859|NCT01202188|2945819|P1|Overall Study|Unsatisfactory therapeutic effect|2
893860|NCT01202188|2945815|P5|Overall Study|Administrative problems|2
893861|NCT01202188|2945816|P4|Overall Study|Administrative problems|1
893862|NCT01202188|2945817|P3|Overall Study|Administrative problems|1
893863|NCT01202188|2945818|P2|Overall Study|Administrative problems|2
893864|NCT01202188|2945819|P1|Overall Study|Administrative problems|3
893865|NCT01202188|2945815|P5|Overall Study|Adverse Event|10
893866|NCT01202188|2945816|P4|Overall Study|Adverse Event|10
893867|NCT01202188|2945817|P3|Overall Study|Adverse Event|13
893868|NCT01202188|2945818|P2|Overall Study|Adverse Event|23
893869|NCT01202188|2945819|P1|Overall Study|Adverse Event|5
893870|NCT01202188|2945815|P5|Overall Study|Subject withdrew consent|13
893871|NCT01202188|2945816|P4|Overall Study|Subject withdrew consent|11
893872|NCT01202188|2945817|P3|Overall Study|Subject withdrew consent|22
893873|NCT01202188|2945818|P2|Overall Study|Subject withdrew consent|13
893874|NCT01202188|2945819|P1|Overall Study|Subject withdrew consent|12
893875|NCT01202188|2945815|P5|Overall Study|Protocol deviation|11
893876|NCT01202188|2945816|P4|Overall Study|Protocol deviation|10
893877|NCT01202188|2945817|P3|Overall Study|Protocol deviation|12
893878|NCT01202188|2945818|P2|Overall Study|Protocol deviation|8
893879|NCT01202188|2945819|P1|Overall Study|Protocol deviation|14
893880|NCT01201967|2945966|P2|Overall Study|Lost to Follow-up|5
893881|NCT01201967|2945967|P1|Overall Study|Lost to Follow-up|6
893882|NCT01201915|2945992|P3|Overall Study|Target Lesion Progression|0
893883|NCT01201915|2945993|P2|Overall Study|Target Lesion Progression|3
893884|NCT01201915|2945994|P1|Overall Study|Target Lesion Progression|0
893885|NCT01201915|2945992|P3|Overall Study|Subject Decision|5
893886|NCT01201915|2945993|P2|Overall Study|Subject Decision|3
893887|NCT01201915|2945994|P1|Overall Study|Subject Decision|3
893888|NCT01201915|2945992|P3|Overall Study|Physician Decision|0
893889|NCT01201915|2945993|P2|Overall Study|Physician Decision|0
893890|NCT01201915|2945994|P1|Overall Study|Physician Decision|3
893891|NCT01201915|2945992|P3|Overall Study|Lost to Follow-up|0
893892|NCT01201915|2945993|P2|Overall Study|Lost to Follow-up|4
893893|NCT01201915|2945994|P1|Overall Study|Lost to Follow-up|0
893894|NCT01201915|2945992|P3|Overall Study|Adverse Event|1
893895|NCT01201915|2945993|P2|Overall Study|Adverse Event|1
893896|NCT01201915|2945994|P1|Overall Study|Adverse Event|2
893897|NCT01201811|2946005|P1|Overall Study|Physician Decision|1
893898|NCT01201811|2946005|P1|Overall Study|Treatment Failure|2
893899|NCT01201811|2946005|P1|Overall Study|Death|4
893900|NCT01201811|2946005|P1|Overall Study|Withdrawal by Subject|3
893901|NCT01201811|2946005|P1|Overall Study|Disease progression|3
893902|NCT01201811|2946005|P1|Overall Study|Adverse Event|6
893903|NCT01201798|2946027|P2|Overall Study|Treatment Failure|8
893904|NCT01201798|2946028|P1|Overall Study|Treatment Failure|1
893905|NCT01201798|2946027|P2|Overall Study|Protocol Violation|1
893906|NCT01201798|2946028|P1|Overall Study|Protocol Violation|1
893907|NCT01201798|2946027|P2|Overall Study|Noncompliance|0
893908|NCT01201798|2946028|P1|Overall Study|Noncompliance|1
893909|NCT01201798|2946027|P2|Overall Study|Decision Unrelated to an Adverse Event|1
893910|NCT01201798|2946028|P1|Overall Study|Decision Unrelated to an Adverse Event|1
893911|NCT01201798|2946027|P2|Overall Study|Lost to Follow-up|5
893912|NCT01201798|2946028|P1|Overall Study|Lost to Follow-up|3
893913|NCT01201798|2946027|P2|Overall Study|Adverse Event|0
893914|NCT01201798|2946028|P1|Overall Study|Adverse Event|2
893915|NCT01201785|2946052|P1|Overall Study|Lost to Follow-up|16
893916|NCT01201759|2946069|P2|Visit 4 Crossover|Lost to Follow-up|1
893917|NCT01201759|2946070|P1|Visit 4 Crossover|Lost to Follow-up|0
893918|NCT01201759|2946069|P2|Visit 3 - Washout|Lost to Follow-up|0
893919|NCT01201759|2946070|P1|Visit 3 - Washout|Lost to Follow-up|1
893920|NCT01201759|2946069|P2|Visit 3 - Washout|Adverse Event|3
893921|NCT01201759|2946070|P1|Visit 3 - Washout|Adverse Event|0
893922|NCT01201759|2946069|P2|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1
893923|NCT01201759|2946070|P1|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2
893924|NCT01201343|2946099|P1|Overall Study|Randomized, not treated|3
893925|NCT01201343|2946099|P1|Overall Study|Participant wrongly included in trial|1
893926|NCT01201343|2946099|P1|Overall Study|Lack of Efficacy|2
893927|NCT01201343|2946099|P1|Overall Study|Lost to Follow-up|2
893928|NCT01201343|2946099|P1|Overall Study|Withdrawal by Subject|5
893929|NCT01201343|2946099|P1|Overall Study|Adverse Event|6
893930|NCT01201317|2946113|P3|Overall Study|Safety, possible history of tuberculosis|1
893931|NCT01201317|2946114|P2|Overall Study|Safety, possible history of tuberculosis|0
893932|NCT01201317|2946115|P1|Overall Study|Safety, possible history of tuberculosis|0
893933|NCT01201317|2946113|P3|Overall Study|Lack of Efficacy|0
893934|NCT01201317|2946114|P2|Overall Study|Lack of Efficacy|0
893935|NCT01201317|2946115|P1|Overall Study|Lack of Efficacy|1
893936|NCT01201317|2946113|P3|Overall Study|Decrease in renal function|0
893937|NCT01201317|2946114|P2|Overall Study|Decrease in renal function|1
893938|NCT01201317|2946115|P1|Overall Study|Decrease in renal function|0
893939|NCT01201317|2946113|P3|Overall Study|Painful Diabetic Neuropathy worsening|0
893940|NCT01201317|2946114|P2|Overall Study|Painful Diabetic Neuropathy worsening|1
893941|NCT01201317|2946115|P1|Overall Study|Painful Diabetic Neuropathy worsening|0
893942|NCT01201317|2946113|P3|Overall Study|Study-specific withdrawal criteria|1
893943|NCT01201317|2946114|P2|Overall Study|Study-specific withdrawal criteria|0
893944|NCT01201317|2946115|P1|Overall Study|Study-specific withdrawal criteria|0
893945|NCT01201317|2946113|P3|Overall Study|Death|0
893946|NCT01201317|2946114|P2|Overall Study|Death|1
893947|NCT01201317|2946115|P1|Overall Study|Death|0
893948|NCT01201317|2946113|P3|Overall Study|Protocol Violation|1
893949|NCT01201317|2946114|P2|Overall Study|Protocol Violation|1
893950|NCT01201317|2946115|P1|Overall Study|Protocol Violation|0
893951|NCT01201317|2946113|P3|Overall Study|Screen failure|0
893952|NCT01201317|2946114|P2|Overall Study|Screen failure|1
893953|NCT01201317|2946115|P1|Overall Study|Screen failure|1
893954|NCT01201317|2946113|P3|Overall Study|Adverse Event|2
893955|NCT01201317|2946114|P2|Overall Study|Adverse Event|2
893956|NCT01201317|2946115|P1|Overall Study|Adverse Event|2
893957|NCT01201317|2946113|P3|Overall Study|Withdrawal by Subject|3
893958|NCT01201317|2946114|P2|Overall Study|Withdrawal by Subject|0
893959|NCT01201317|2946115|P1|Overall Study|Withdrawal by Subject|5
893960|NCT01201265|2946135|P1|Overall Study|Disease Progression|4
893961|NCT01201265|2946135|P1|Overall Study|Withdrawal by Subject|7
893962|NCT01201265|2946135|P1|Overall Study|Lost to Follow-up|10
893963|NCT01201265|2946135|P1|Overall Study|Insufficient Therapeutic Response|3
893964|NCT01201265|2946135|P1|Overall Study|Death|14
893965|NCT01200992|2946149|P2|Overall Study|Randomized but not treated|0
893966|NCT01200992|2946150|P1|Overall Study|Randomized but not treated|2
893967|NCT01200992|2946149|P2|Overall Study|Study terminated early|41
893968|NCT01200992|2946150|P1|Overall Study|Study terminated early|35
893969|NCT01200810|2946164|P2|Overall Study|Sponsor stopped making study drug|3
893970|NCT01200810|2946165|P1|Overall Study|Sponsor stopped making study drug|3
893971|NCT01200810|2946164|P2|Overall Study|Withdrawal by Subject|2
893972|NCT01200810|2946165|P1|Overall Study|Withdrawal by Subject|1
893973|NCT01200810|2946164|P2|Overall Study|Physician Decision|0
893974|NCT01200810|2946165|P1|Overall Study|Physician Decision|1
893975|NCT01200797|2946185|P1|Overall Study|Disease Progression|13
893976|NCT01200797|2946185|P1|Overall Study|Adverse Event|4
893977|NCT01200797|2946185|P1|Overall Study|symptomatic deterioration|2
893978|NCT01200758|2946195|P4|Stage 2|Death|5
893979|NCT01200758|2946196|P3|Stage 2|Death|3
893980|NCT01200758|2946197|P2|Stage 2|Death|0
893981|NCT01200758|2946198|P1|Stage 2|Death|0
893982|NCT01200758|2946195|P4|Stage 2|Protocol Violation|4
893983|NCT01200758|2946196|P3|Stage 2|Protocol Violation|1
893984|NCT01200758|2946197|P2|Stage 2|Protocol Violation|0
893985|NCT01200758|2946198|P1|Stage 2|Protocol Violation|0
893986|NCT01200758|2946195|P4|Stage 2|Lost to Follow-up|1
893987|NCT01200758|2946196|P3|Stage 2|Lost to Follow-up|3
893988|NCT01200758|2946197|P2|Stage 2|Lost to Follow-up|0
893989|NCT01200758|2946198|P1|Stage 2|Lost to Follow-up|0
893990|NCT01200758|2946195|P4|Stage 2|Withdrawal by Subject|1
893991|NCT01200758|2946196|P3|Stage 2|Withdrawal by Subject|4
893992|NCT01200758|2946197|P2|Stage 2|Withdrawal by Subject|0
893993|NCT01200758|2946198|P1|Stage 2|Withdrawal by Subject|0
893994|NCT01200758|2946195|P4|Stage 2|Adverse Event|9
893995|NCT01200758|2946196|P3|Stage 2|Adverse Event|5
893996|NCT01200758|2946197|P2|Stage 2|Adverse Event|0
893997|NCT01200758|2946198|P1|Stage 2|Adverse Event|0
893998|NCT01200758|2946195|P4|Stage 2|Physician Decision|7
893999|NCT01200758|2946196|P3|Stage 2|Physician Decision|5
894000|NCT01200758|2946197|P2|Stage 2|Physician Decision|0
894001|NCT01200758|2946198|P1|Stage 2|Physician Decision|0
894002|NCT01200758|2946195|P4|Stage 2|Lack of Efficacy|2
894003|NCT01200758|2946196|P3|Stage 2|Lack of Efficacy|4
894004|NCT01200758|2946197|P2|Stage 2|Lack of Efficacy|0
894005|NCT01200758|2946198|P1|Stage 2|Lack of Efficacy|0
894006|NCT01200758|2946195|P4|Stage 2|Disease Progression|21
894007|NCT01200758|2946196|P3|Stage 2|Disease Progression|16
894008|NCT01200758|2946197|P2|Stage 2|Disease Progression|0
894009|NCT01200758|2946198|P1|Stage 2|Disease Progression|0
894010|NCT01200758|2946195|P4|Stage I|Disease Progression|0
894011|NCT01200758|2946196|P3|Stage I|Disease Progression|0
894012|NCT01200758|2946197|P2|Stage I|Disease Progression|7
894013|NCT01200758|2946198|P1|Stage I|Disease Progression|9
894014|NCT01200758|2946195|P4|Stage I|Withdrawal by Subject|0
894015|NCT01200758|2946196|P3|Stage I|Withdrawal by Subject|0
894016|NCT01200758|2946197|P2|Stage I|Withdrawal by Subject|2
894017|NCT01200758|2946198|P1|Stage I|Withdrawal by Subject|1
894018|NCT01200758|2946195|P4|Stage I|Adverse Event|0
894019|NCT01200758|2946196|P3|Stage I|Adverse Event|0
894020|NCT01200758|2946197|P2|Stage I|Adverse Event|5
894021|NCT01200758|2946198|P1|Stage I|Adverse Event|5
894022|NCT01200758|2946195|P4|Stage I|Lack of Efficacy|0
894023|NCT01200758|2946196|P3|Stage I|Lack of Efficacy|0
894024|NCT01200758|2946197|P2|Stage I|Lack of Efficacy|1
894025|NCT01200758|2946198|P1|Stage I|Lack of Efficacy|2
894026|NCT01200758|2946195|P4|Stage I|Physician Decision|0
894027|NCT01200758|2946196|P3|Stage I|Physician Decision|0
894028|NCT01200758|2946197|P2|Stage I|Physician Decision|1
894029|NCT01200758|2946198|P1|Stage I|Physician Decision|1
894030|NCT01200758|2946195|P4|Stage I|Death|0
894031|NCT01200758|2946196|P3|Stage I|Death|0
894032|NCT01200758|2946197|P2|Stage I|Death|1
894033|NCT01200758|2946198|P1|Stage I|Death|0
894034|NCT01200589|2946271|P2|Overall Study|Study terminated|172
894035|NCT01200589|2946272|P1|Overall Study|Study terminated|170
894036|NCT01200589|2946271|P2|Overall Study|Lost to Follow-up|4
894037|NCT01200589|2946272|P1|Overall Study|Lost to Follow-up|5
894038|NCT01200589|2946271|P2|Overall Study|Physician Decision|2
894039|NCT01200589|2946272|P1|Overall Study|Physician Decision|2
894040|NCT01200589|2946271|P2|Overall Study|Withdrawal by Subject|11
894041|NCT01200589|2946272|P1|Overall Study|Withdrawal by Subject|13
894042|NCT01200524|2946299|P3|Overall Study|Non availability of study nurse|1
894043|NCT01200524|2946300|P2|Overall Study|Non availability of study nurse|0
894044|NCT01200524|2946301|P1|Overall Study|Non availability of study nurse|0
894045|NCT01200524|2946299|P3|Overall Study|Adverse Event|0
894046|NCT01200524|2946300|P2|Overall Study|Adverse Event|0
894047|NCT01200524|2946301|P1|Overall Study|Adverse Event|1
894048|NCT01200524|2946299|P3|Overall Study|Withdrawal by Subject|3
894049|NCT01200524|2946300|P2|Overall Study|Withdrawal by Subject|1
894050|NCT01200524|2946301|P1|Overall Study|Withdrawal by Subject|1
894051|NCT01200511|2946321|P1|Overall Study|Adverse Event|1
894052|NCT01200511|2946321|P1|Overall Study|Withdrawal by Subject|1
894053|NCT01200511|2946321|P1|Overall Study|Lost to Follow-up|3
894054|NCT01200368|2946359|P3|Toddler Dose|Adverse Event|1
894055|NCT01200368|2946360|P2|Toddler Dose|Adverse Event|3
894056|NCT01200368|2946361|P1|Toddler Dose|Adverse Event|0
894057|NCT01200368|2946359|P3|After Infant Series|Other|2
894058|NCT01200368|2946360|P2|After Infant Series|Other|2
894059|NCT01200368|2946361|P1|After Infant Series|Other|1
894060|NCT01200368|2946359|P3|After Infant Series|Lost to Follow-up|0
894061|NCT01200368|2946360|P2|After Infant Series|Lost to Follow-up|0
894062|NCT01200368|2946361|P1|After Infant Series|Lost to Follow-up|1
894063|NCT01200368|2946359|P3|After Infant Series|Withdrawal by Subject|4
894064|NCT01200368|2946360|P2|After Infant Series|Withdrawal by Subject|8
894065|NCT01200368|2946361|P1|After Infant Series|Withdrawal by Subject|10
894066|NCT01200368|2946359|P3|After Infant Series|Adverse Event|3
894067|NCT01200368|2946360|P2|After Infant Series|Adverse Event|6
894068|NCT01200368|2946361|P1|After Infant Series|Adverse Event|6
894069|NCT01200368|2946359|P3|Infant Series|Other|0
894070|NCT01200368|2946360|P2|Infant Series|Other|0
894071|NCT01200368|2946361|P1|Infant Series|Other|1
894072|NCT01200368|2946359|P3|Infant Series|Randomized, not vaccinated|1
894073|NCT01200368|2946360|P2|Infant Series|Randomized, not vaccinated|1
894074|NCT01200368|2946361|P1|Infant Series|Randomized, not vaccinated|0
894075|NCT01200368|2946359|P3|Infant Series|Did not meet entrance criteria|0
894076|NCT01200368|2946360|P2|Infant Series|Did not meet entrance criteria|1
894077|NCT01200368|2946361|P1|Infant Series|Did not meet entrance criteria|0
894078|NCT01200368|2946359|P3|Infant Series|Withdrawal by Subject|2
894079|NCT01200368|2946360|P2|Infant Series|Withdrawal by Subject|2
894080|NCT01200368|2946361|P1|Infant Series|Withdrawal by Subject|0
894081|NCT01200368|2946359|P3|Infant Series|Adverse Event|3
894082|NCT01200368|2946360|P2|Infant Series|Adverse Event|2
894083|NCT01200368|2946361|P1|Infant Series|Adverse Event|2
894084|NCT01200355|2946427|P2|Overall Study|Death|2
894085|NCT01200355|2946428|P1|Overall Study|Death|7
894086|NCT01200342|2946442|P1|Overall Study|Disease Progression|1
894087|NCT01200290|2946447|P1|Post-Treatment Follow-Up Period|Death|2
894088|NCT01200290|2946447|P1|Treatment Period|Adverse Event|1
894089|NCT01200238|2946460|P2|Overall Study|Withdrawal by Subject|1
894090|NCT01200238|2946461|P1|Overall Study|Withdrawal by Subject|0
894091|NCT01200238|2946460|P2|Overall Study|Progressive Disease|8
894092|NCT01200238|2946461|P1|Overall Study|Progressive Disease|5
894093|NCT01200238|2946460|P2|Overall Study|Adverse Event|1
894094|NCT01200238|2946461|P1|Overall Study|Adverse Event|2
894095|NCT01200069|2946485|P2|Overall Study|Withdrawal by Subject|1
894096|NCT01200069|2946486|P1|Overall Study|Withdrawal by Subject|0
894097|NCT01199939|2946555|P1|Overall Study|Reached a virologic endpoint|4
894098|NCT01199939|2946555|P1|Overall Study|Lost to Follow-up|2
894099|NCT01199939|2946555|P1|Overall Study|Protocol Violation|3
894100|NCT01199939|2946555|P1|Overall Study|Adverse Event|4
894101|NCT01199861|2946587|P2|Overall Study|Adverse Event|0
894102|NCT01199861|2946588|P1|Overall Study|Adverse Event|1
894103|NCT01199861|2946587|P2|Overall Study|Administrative problems|0
894104|NCT01199861|2946588|P1|Overall Study|Administrative problems|1
894105|NCT01199822|2946609|P3|Overall Study|Investigator discontinued therapy|0
894106|NCT01199822|2946610|P2|Overall Study|Investigator discontinued therapy|1
894107|NCT01199822|2946611|P1|Overall Study|Investigator discontinued therapy|0
894108|NCT01199731|2946660|P3|Overall Study|Withdrawal by Subject|0
894109|NCT01199731|2946661|P2|Overall Study|Withdrawal by Subject|0
894110|NCT01199731|2946662|P1|Overall Study|Withdrawal by Subject|2
894111|NCT01199731|2946660|P3|Overall Study|Physician Decision|1
894112|NCT01199731|2946661|P2|Overall Study|Physician Decision|1
894113|NCT01199731|2946662|P1|Overall Study|Physician Decision|0
894114|NCT01199731|2946660|P3|Overall Study|Lost to Follow-up|2
894115|NCT01199731|2946661|P2|Overall Study|Lost to Follow-up|0
894116|NCT01199731|2946662|P1|Overall Study|Lost to Follow-up|0
894117|NCT01199731|2946660|P3|Overall Study|Study closed/terminated|7
894118|NCT01199731|2946661|P2|Overall Study|Study closed/terminated|9
894119|NCT01199731|2946662|P1|Overall Study|Study closed/terminated|7
894120|NCT01199731|2946660|P3|Overall Study|Adverse Event|0
894121|NCT01199731|2946661|P2|Overall Study|Adverse Event|1
894122|NCT01199731|2946662|P1|Overall Study|Adverse Event|0
894123|NCT01199705|2946700|P1|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1
894124|NCT01199601|2946732|P2|Overall Study|Insecurity prevented staff interviewing.|9
894125|NCT01199601|2946733|P1|Overall Study|Insecurity prevented staff interviewing.|7
894126|NCT01199601|2946732|P2|Overall Study|Withdrawal by Subject|3
894127|NCT01199601|2946733|P1|Overall Study|Withdrawal by Subject|15
894128|NCT01199601|2946732|P2|Overall Study|Lost to Follow-up|66
894129|NCT01199601|2946733|P1|Overall Study|Lost to Follow-up|47
894130|NCT01199575|2946743|P1|Overall Study|Withdrawal by Subject|5
894131|NCT01199471|2946748|P1|Overall Study|Physician Decision|1
894132|NCT01199471|2946748|P1|Overall Study|Withdrawal by Subject|1
894133|NCT01199471|2946748|P1|Overall Study|Protocol Violation|4
894134|NCT01199042|2946780|P1|At Home (3 Months)|Lost to Follow-up|1
894135|NCT01199042|2946780|P1|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2
894136|NCT01199016|2946789|P1|Overall Study|Lost to Follow-up|25
894137|NCT01199016|2946789|P1|Overall Study|Withdrawal by Subject|21
894138|NCT01199016|2946789|P1|Overall Study|Other|13
894139|NCT01199016|2946789|P1|Overall Study|Protocol Violation|9
894140|NCT01199016|2946789|P1|Overall Study|Entrance criteria|5
894141|NCT01199016|2946789|P1|Overall Study|No longer meets eligibility criteria|4
894142|NCT01198977|2946798|P2|Overall Study|Lost to Follow-up|0
894143|NCT01198977|2946799|P1|Overall Study|Lost to Follow-up|1
894144|NCT01198873|2946811|P2|Overall Study|Other than above|2
894145|NCT01198873|2946812|P1|Overall Study|Other than above|4
894146|NCT01198873|2946811|P2|Overall Study|Study closure|23
894147|NCT01198873|2946812|P1|Overall Study|Study closure|29
894148|NCT01198873|2946811|P2|Overall Study|Adverse Event|7
894149|NCT01198873|2946812|P1|Overall Study|Adverse Event|4
894150|NCT01198795|2946826|P1|Overall Study|Other Reason|4
894151|NCT01198795|2946826|P1|Overall Study|Protocol Violation|2
894152|NCT01198795|2946826|P1|Overall Study|Lack of Efficacy|5
894153|NCT01198795|2946826|P1|Overall Study|Adverse Event|9
894154|NCT01198795|2946826|P1|Overall Study|Lost to Follow-up|15
894155|NCT01198795|2946826|P1|Overall Study|Withdrawal by Subject|17
894156|NCT01198795|2946826|P1|Overall Study|Did not meet InclusionExclusion criteria|30
894157|NCT01198756|2946843|P4|Overall Study|Lost to Follow-up|18
894158|NCT01198756|2946844|P3|Overall Study|Lost to Follow-up|23
894159|NCT01198756|2946845|P2|Overall Study|Lost to Follow-up|36
894160|NCT01198756|2946846|P1|Overall Study|Lost to Follow-up|29
894161|NCT01198756|2946843|P4|Overall Study|Withdrawal by Subject|5
894162|NCT01198756|2946844|P3|Overall Study|Withdrawal by Subject|7
894163|NCT01198756|2946845|P2|Overall Study|Withdrawal by Subject|4
894164|NCT01198756|2946846|P1|Overall Study|Withdrawal by Subject|9
894165|NCT01198756|2946843|P4|Overall Study|Protocol Violation|2
894166|NCT01198756|2946844|P3|Overall Study|Protocol Violation|0
894167|NCT01198756|2946845|P2|Overall Study|Protocol Violation|0
894168|NCT01198756|2946846|P1|Overall Study|Protocol Violation|0
894169|NCT01198756|2946843|P4|Overall Study|Adverse Event|1
894170|NCT01198756|2946844|P3|Overall Study|Adverse Event|0
894171|NCT01198756|2946845|P2|Overall Study|Adverse Event|0
894172|NCT01198756|2946846|P1|Overall Study|Adverse Event|0
894173|NCT01198600|2946957|P4|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
894174|NCT01198600|2946958|P3|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1
894175|NCT01198600|2946959|P2|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
894176|NCT01198600|2946960|P1|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
894177|NCT01198600|2946957|P4|Phase 2: 56 Days of Wear|Relocation|0
894178|NCT01198600|2946958|P3|Phase 2: 56 Days of Wear|Relocation|2
894179|NCT01198600|2946959|P2|Phase 2: 56 Days of Wear|Relocation|0
894180|NCT01198600|2946960|P1|Phase 2: 56 Days of Wear|Relocation|0
894181|NCT01198600|2946957|P4|Phase 2: 56 Days of Wear|Inconvenience|0
894182|NCT01198600|2946958|P3|Phase 2: 56 Days of Wear|Inconvenience|2
894183|NCT01198600|2946959|P2|Phase 2: 56 Days of Wear|Inconvenience|0
894184|NCT01198600|2946960|P1|Phase 2: 56 Days of Wear|Inconvenience|0
894185|NCT01198600|2946957|P4|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
894186|NCT01198600|2946958|P3|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
894187|NCT01198600|2946959|P2|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1
894188|NCT01198600|2946960|P1|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
894189|NCT01198600|2946957|P4|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
894190|NCT01198600|2946958|P3|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
894191|NCT01198600|2946959|P2|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1
894192|NCT01198600|2946960|P1|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
894193|NCT01198600|2946957|P4|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
894194|NCT01198600|2946958|P3|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
894195|NCT01198600|2946959|P2|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
894196|NCT01198600|2946960|P1|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1
894197|NCT01198600|2946957|P4|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
894198|NCT01198600|2946958|P3|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
894199|NCT01198600|2946959|P2|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
894200|NCT01198600|2946960|P1|Phase 1: Period One, 30 Days of Wear|Inconvenience|1
894201|NCT01198587|2946986|P4|Overall Study|Lost to Follow-up|0
894202|NCT01198587|2946987|P3|Overall Study|Lost to Follow-up|9
894203|NCT01198587|2946988|P2|Overall Study|Lost to Follow-up|0
894204|NCT01198587|2946989|P1|Overall Study|Lost to Follow-up|8
894205|NCT01198574|2947011|P4|Overall Study|Resigned from schools|4
894206|NCT01198574|2947012|P3|Overall Study|Resigned from schools|1
894207|NCT01198574|2947013|P2|Overall Study|Resigned from schools|1
894208|NCT01198574|2947014|P1|Overall Study|Resigned from schools|4
894209|NCT01198548|2947032|P1|Overall Study|Administrative Decision|1
894210|NCT01198548|2947032|P1|Overall Study|Disease Progression|9
894211|NCT01198509|2947047|P6|Overall Study|Withdrawal by Subject|0
894212|NCT01198509|2947048|P5|Overall Study|Withdrawal by Subject|0
894213|NCT01198509|2947049|P4|Overall Study|Withdrawal by Subject|0
894214|NCT01198509|2947050|P3|Overall Study|Withdrawal by Subject|0
894215|NCT01198509|2947051|P2|Overall Study|Withdrawal by Subject|0
894216|NCT01198509|2947052|P1|Overall Study|Withdrawal by Subject|1
894217|NCT01198470|2947069|P1|Overall Study|Adverse Event|2
894218|NCT01198275|2947135|P2|Overall Study|spontaneous return to sinus rhythm|2
894219|NCT01198275|2947136|P1|Overall Study|spontaneous return to sinus rhythm|4
894220|NCT01198275|2947135|P2|Overall Study|Adverse Event|3
894221|NCT01198275|2947136|P1|Overall Study|Adverse Event|2
894222|NCT01198145|2947144|P2|Overall Study|Withdrawal by Subject|1
894223|NCT01198145|2947145|P1|Overall Study|Withdrawal by Subject|1
894224|NCT01198132|2947167|P2|Overall Study|Protocol Violation|0
894225|NCT01198132|2947168|P1|Overall Study|Protocol Violation|1
894226|NCT01198132|2947167|P2|Overall Study|Adverse Event|1
894227|NCT01198132|2947168|P1|Overall Study|Adverse Event|0
894228|NCT01198132|2947167|P2|Overall Study|Abnormal/clinically significant biologic|1
894229|NCT01198132|2947168|P1|Overall Study|Abnormal/clinically significant biologic|1
894230|NCT01198132|2947167|P2|Overall Study|Sign/symptoms of underlying disease|1
894231|NCT01198132|2947168|P1|Overall Study|Sign/symptoms of underlying disease|2
894232|NCT01198132|2947167|P2|Overall Study|Lack of Efficacy|3
894233|NCT01198132|2947168|P1|Overall Study|Lack of Efficacy|2
894234|NCT01198132|2947167|P2|Overall Study|Other Unspecified|6
894235|NCT01198132|2947168|P1|Overall Study|Other Unspecified|3
894236|NCT01198132|2947167|P2|Overall Study|Physician Decision|4
894237|NCT01198132|2947168|P1|Overall Study|Physician Decision|5
894238|NCT01198132|2947167|P2|Overall Study|Withdrawal by Subject|5
894239|NCT01198132|2947168|P1|Overall Study|Withdrawal by Subject|4
894240|NCT01198002|2947195|P3|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75
894241|NCT01198002|2947196|P2|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70
894242|NCT01198002|2947197|P1|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62
894243|NCT01198002|2947195|P3|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
894244|NCT01198002|2947196|P2|Treatment Period 2 (Weeks 52-100)|Physician Decision|0
894245|NCT01198002|2947197|P1|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
894246|NCT01198002|2947195|P3|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
894247|NCT01198002|2947196|P2|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2
894248|NCT01198002|2947197|P1|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
894249|NCT01198002|2947195|P3|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
894250|NCT01198002|2947196|P2|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
894251|NCT01198002|2947197|P1|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1
894252|NCT01198002|2947195|P3|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
894253|NCT01198002|2947196|P2|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
894254|NCT01198002|2947197|P1|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3
894255|NCT01198002|2947195|P3|Treatment Period 2 (Weeks 52-100)|Adverse Event|1
894256|NCT01198002|2947196|P2|Treatment Period 2 (Weeks 52-100)|Adverse Event|0
894257|NCT01198002|2947197|P1|Treatment Period 2 (Weeks 52-100)|Adverse Event|2
894258|NCT01198002|2947195|P3|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224
894259|NCT01198002|2947196|P2|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216
894260|NCT01198002|2947197|P1|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213
894261|NCT01198002|2947195|P3|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
894262|NCT01198002|2947196|P2|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
894263|NCT01198002|2947197|P1|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14
894264|NCT01198002|2947195|P3|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
894265|NCT01198002|2947196|P2|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
894266|NCT01198002|2947197|P1|Treatment Period 1 (Weeks 0-52)|Physician Decision|1
894267|NCT01198002|2947195|P3|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12
894268|NCT01198002|2947196|P2|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21
894269|NCT01198002|2947197|P1|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16
894270|NCT01198002|2947195|P3|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
894271|NCT01198002|2947196|P2|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2
894272|NCT01198002|2947197|P1|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
894273|NCT01198002|2947195|P3|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
894274|NCT01198002|2947196|P2|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
894275|NCT01198002|2947197|P1|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1
894276|NCT01198002|2947195|P3|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6
894277|NCT01198002|2947196|P2|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9
894278|NCT01198002|2947197|P1|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10
894279|NCT01198002|2947195|P3|Treatment Period 1 (Weeks 0-52)|Death|1
894280|NCT01198002|2947196|P2|Treatment Period 1 (Weeks 0-52)|Death|0
894281|NCT01198002|2947197|P1|Treatment Period 1 (Weeks 0-52)|Death|2
894282|NCT01198002|2947195|P3|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
894283|NCT01198002|2947196|P2|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
894284|NCT01198002|2947197|P1|Treatment Period 1 (Weeks 0-52)|Adverse Event|18
894285|NCT01197911|2947312|P3|Overall Study|Adverse Event|1
894286|NCT01197911|2947313|P2|Overall Study|Adverse Event|0
894287|NCT01197911|2947314|P1|Overall Study|Adverse Event|0
894288|NCT01197794|2947429|P7|Overall Study|Other|4
894289|NCT01197794|2947430|P6|Overall Study|Other|2
894290|NCT01197794|2947431|P5|Overall Study|Other|2
894291|NCT01197794|2947432|P4|Overall Study|Other|0
894292|NCT01197794|2947433|P3|Overall Study|Other|3
894293|NCT01197794|2947434|P2|Overall Study|Other|1
894294|NCT01197794|2947435|P1|Overall Study|Other|1
894295|NCT01197794|2947429|P7|Overall Study|Lost to Follow-up|0
894296|NCT01197794|2947430|P6|Overall Study|Lost to Follow-up|1
894297|NCT01197794|2947431|P5|Overall Study|Lost to Follow-up|0
894298|NCT01197794|2947432|P4|Overall Study|Lost to Follow-up|1
894299|NCT01197794|2947433|P3|Overall Study|Lost to Follow-up|0
894300|NCT01197794|2947434|P2|Overall Study|Lost to Follow-up|1
894301|NCT01197794|2947435|P1|Overall Study|Lost to Follow-up|1
894302|NCT01197794|2947429|P7|Overall Study|Withdrawal by Subject|6
894303|NCT01197794|2947430|P6|Overall Study|Withdrawal by Subject|5
894304|NCT01197794|2947431|P5|Overall Study|Withdrawal by Subject|1
894305|NCT01197794|2947432|P4|Overall Study|Withdrawal by Subject|1
894306|NCT01197794|2947433|P3|Overall Study|Withdrawal by Subject|4
894307|NCT01197794|2947434|P2|Overall Study|Withdrawal by Subject|3
894308|NCT01197794|2947435|P1|Overall Study|Withdrawal by Subject|3
894309|NCT01197794|2947429|P7|Overall Study|Eligibility criteria not fulfilled|6
894310|NCT01197794|2947430|P6|Overall Study|Eligibility criteria not fulfilled|9
894311|NCT01197794|2947431|P5|Overall Study|Eligibility criteria not fulfilled|5
894312|NCT01197794|2947432|P4|Overall Study|Eligibility criteria not fulfilled|5
894313|NCT01197794|2947433|P3|Overall Study|Eligibility criteria not fulfilled|2
894314|NCT01197794|2947434|P2|Overall Study|Eligibility criteria not fulfilled|8
894315|NCT01197794|2947435|P1|Overall Study|Eligibility criteria not fulfilled|5
894316|NCT01197794|2947429|P7|Overall Study|Development of study withdrawal criteria|1
894317|NCT01197794|2947430|P6|Overall Study|Development of study withdrawal criteria|0
894318|NCT01197794|2947431|P5|Overall Study|Development of study withdrawal criteria|0
894319|NCT01197794|2947432|P4|Overall Study|Development of study withdrawal criteria|1
894320|NCT01197794|2947433|P3|Overall Study|Development of study withdrawal criteria|0
894321|NCT01197794|2947434|P2|Overall Study|Development of study withdrawal criteria|0
894322|NCT01197794|2947435|P1|Overall Study|Development of study withdrawal criteria|3
894323|NCT01197794|2947429|P7|Overall Study|Protocol Violation|1
894324|NCT01197794|2947430|P6|Overall Study|Protocol Violation|0
894325|NCT01197794|2947431|P5|Overall Study|Protocol Violation|2
894326|NCT01197794|2947432|P4|Overall Study|Protocol Violation|0
894327|NCT01197794|2947433|P3|Overall Study|Protocol Violation|0
894328|NCT01197794|2947434|P2|Overall Study|Protocol Violation|0
894329|NCT01197794|2947435|P1|Overall Study|Protocol Violation|0
894330|NCT01197794|2947429|P7|Overall Study|Adverse Event|3
894331|NCT01197794|2947430|P6|Overall Study|Adverse Event|2
894332|NCT01197794|2947431|P5|Overall Study|Adverse Event|4
894333|NCT01197794|2947432|P4|Overall Study|Adverse Event|4
894334|NCT01197794|2947433|P3|Overall Study|Adverse Event|4
894335|NCT01197794|2947434|P2|Overall Study|Adverse Event|2
894336|NCT01197794|2947435|P1|Overall Study|Adverse Event|3
894337|NCT01197755|2947517|P3|Overall Study|eg, change in circumstances|2
894338|NCT01197755|2947518|P2|Overall Study|eg, change in circumstances|3
894339|NCT01197755|2947519|P1|Overall Study|eg, change in circumstances|7
894340|NCT01197755|2947517|P3|Overall Study|Lost to Follow-up|1
894341|NCT01197755|2947518|P2|Overall Study|Lost to Follow-up|0
894342|NCT01197755|2947519|P1|Overall Study|Lost to Follow-up|0
894343|NCT01197755|2947517|P3|Overall Study|Withdrawal by Subject|0
894344|NCT01197755|2947518|P2|Overall Study|Withdrawal by Subject|0
894345|NCT01197755|2947519|P1|Overall Study|Withdrawal by Subject|1
894346|NCT01197755|2947517|P3|Overall Study|Severe non-compliance to the protocol|2
894347|NCT01197755|2947518|P2|Overall Study|Severe non-compliance to the protocol|1
894348|NCT01197755|2947519|P1|Overall Study|Severe non-compliance to the protocol|2
894349|NCT01197755|2947517|P3|Overall Study|Lack of therapeutic response|4
894350|NCT01197755|2947518|P2|Overall Study|Lack of therapeutic response|7
894351|NCT01197755|2947519|P1|Overall Study|Lack of therapeutic response|0
894352|NCT01197755|2947517|P3|Overall Study|Entered the long-term extension study|35
894353|NCT01197755|2947518|P2|Overall Study|Entered the long-term extension study|21
894354|NCT01197755|2947519|P1|Overall Study|Entered the long-term extension study|18
894355|NCT01197755|2947517|P3|Overall Study|Study-specific discontinuation criteria|0
894356|NCT01197755|2947518|P2|Overall Study|Study-specific discontinuation criteria|1
894357|NCT01197755|2947519|P1|Overall Study|Study-specific discontinuation criteria|2
894358|NCT01197755|2947517|P3|Overall Study|Adverse Event|10
894359|NCT01197755|2947518|P2|Overall Study|Adverse Event|10
894360|NCT01197755|2947519|P1|Overall Study|Adverse Event|8
894361|NCT01197560|2947591|P2|Overall Study|Missing|1
894362|NCT01197560|2947592|P1|Overall Study|Missing|0
894363|NCT01197560|2947591|P2|Overall Study|Elected to discontinue before cycle end|2
894364|NCT01197560|2947592|P1|Overall Study|Elected to discontinue before cycle end|0
894365|NCT01197560|2947591|P2|Overall Study|Proceeded to transplant|1
894366|NCT01197560|2947592|P1|Overall Study|Proceeded to transplant|1
894367|NCT01197560|2947591|P2|Overall Study|Disease progression|35
894368|NCT01197560|2947592|P1|Overall Study|Disease progression|39
894369|NCT01197560|2947591|P2|Overall Study|Withdrawal by Subject|1
894370|NCT01197560|2947592|P1|Overall Study|Withdrawal by Subject|1
894371|NCT01197560|2947591|P2|Overall Study|Death|5
894372|NCT01197560|2947592|P1|Overall Study|Death|1
894373|NCT01197560|2947591|P2|Overall Study|Adverse Event|8
894374|NCT01197560|2947592|P1|Overall Study|Adverse Event|4
894375|NCT01197534|2947625|P3|Overall Study|Adverse Event|24
894376|NCT01197534|2947626|P2|Overall Study|Adverse Event|36
894377|NCT01197534|2947627|P1|Overall Study|Adverse Event|35
894378|NCT01197534|2947625|P3|Overall Study|Lost to Follow-up|2
894379|NCT01197534|2947626|P2|Overall Study|Lost to Follow-up|4
894380|NCT01197534|2947627|P1|Overall Study|Lost to Follow-up|1
894381|NCT01197534|2947625|P3|Overall Study|Dev. of study specific discont. criteria|2
894382|NCT01197534|2947626|P2|Overall Study|Dev. of study specific discont. criteria|6
894383|NCT01197534|2947627|P1|Overall Study|Dev. of study specific discont. criteria|13
894384|NCT01197534|2947625|P3|Overall Study|Lack of therapeutic response|9
894385|NCT01197534|2947626|P2|Overall Study|Lack of therapeutic response|4
894386|NCT01197534|2947627|P1|Overall Study|Lack of therapeutic response|9
894387|NCT01197534|2947625|P3|Overall Study|Severe non-compliance to protocol|1
894388|NCT01197534|2947626|P2|Overall Study|Severe non-compliance to protocol|4
894389|NCT01197534|2947627|P1|Overall Study|Severe non-compliance to protocol|3
894390|NCT01197534|2947625|P3|Overall Study|Enrolment in long term extension|119
894391|NCT01197534|2947626|P2|Overall Study|Enrolment in long term extension|66
894392|NCT01197534|2947627|P1|Overall Study|Enrolment in long term extension|57
894393|NCT01197534|2947625|P3|Overall Study|Not reported|16
894394|NCT01197534|2947626|P2|Overall Study|Not reported|10
894395|NCT01197534|2947627|P1|Overall Study|Not reported|16
894396|NCT01197521|2947671|P3|Overall Study|Adverse Event|24
894397|NCT01197521|2947672|P2|Overall Study|Adverse Event|28
894398|NCT01197521|2947673|P1|Overall Study|Adverse Event|25
894399|NCT01197521|2947671|P3|Overall Study|Lost to Follow-up|2
894400|NCT01197521|2947672|P2|Overall Study|Lost to Follow-up|2
894401|NCT01197521|2947673|P1|Overall Study|Lost to Follow-up|3
894402|NCT01197521|2947671|P3|Overall Study|Dev. of study specific discont. criteria|2
894403|NCT01197521|2947672|P2|Overall Study|Dev. of study specific discont. criteria|16
894404|NCT01197521|2947673|P1|Overall Study|Dev. of study specific discont. criteria|6
894405|NCT01197521|2947671|P3|Overall Study|Lack of therapeutic response|4
894406|NCT01197521|2947672|P2|Overall Study|Lack of therapeutic response|3
894407|NCT01197521|2947673|P1|Overall Study|Lack of therapeutic response|2
894408|NCT01197521|2947671|P3|Overall Study|Severe non-compliance to protocol|3
894409|NCT01197521|2947672|P2|Overall Study|Severe non-compliance to protocol|3
894410|NCT01197521|2947673|P1|Overall Study|Severe non-compliance to protocol|1
894411|NCT01197521|2947671|P3|Overall Study|Enrolment in long term extension|87
894412|NCT01197521|2947672|P2|Overall Study|Enrolment in long term extension|36
894413|NCT01197521|2947673|P1|Overall Study|Enrolment in long term extension|42
894414|NCT01197521|2947671|P3|Overall Study|Not reported|21
894415|NCT01197521|2947672|P2|Overall Study|Not reported|25
894416|NCT01197521|2947673|P1|Overall Study|Not reported|24
894417|NCT01197508|2947718|P4|Overall Study|Not specified|2
894418|NCT01197508|2947719|P3|Overall Study|Not specified|2
894419|NCT01197508|2947720|P2|Overall Study|Not specified|3
894420|NCT01197508|2947721|P1|Overall Study|Not specified|2
894421|NCT01197508|2947718|P4|Overall Study|Lost to Follow-up|0
894422|NCT01197508|2947719|P3|Overall Study|Lost to Follow-up|2
894423|NCT01197508|2947720|P2|Overall Study|Lost to Follow-up|1
894424|NCT01197508|2947721|P1|Overall Study|Lost to Follow-up|1
894425|NCT01197508|2947718|P4|Overall Study|Study-specific withdrawal criteria|2
894426|NCT01197508|2947719|P3|Overall Study|Study-specific withdrawal criteria|1
894427|NCT01197508|2947720|P2|Overall Study|Study-specific withdrawal criteria|0
894428|NCT01197508|2947721|P1|Overall Study|Study-specific withdrawal criteria|0
894429|NCT01197508|2947718|P4|Overall Study|Lack of Efficacy|1
894430|NCT01197508|2947719|P3|Overall Study|Lack of Efficacy|2
894431|NCT01197508|2947720|P2|Overall Study|Lack of Efficacy|2
894432|NCT01197508|2947721|P1|Overall Study|Lack of Efficacy|1
894433|NCT01197508|2947718|P4|Overall Study|Condition under investigation worsened|1
894434|NCT01197508|2947719|P3|Overall Study|Condition under investigation worsened|1
894435|NCT01197508|2947720|P2|Overall Study|Condition under investigation worsened|1
894436|NCT01197508|2947721|P1|Overall Study|Condition under investigation worsened|1
894437|NCT01197508|2947718|P4|Overall Study|Severe non-compliance to protocol|3
894438|NCT01197508|2947719|P3|Overall Study|Severe non-compliance to protocol|1
894439|NCT01197508|2947720|P2|Overall Study|Severe non-compliance to protocol|3
894440|NCT01197508|2947721|P1|Overall Study|Severe non-compliance to protocol|0
894441|NCT01197508|2947718|P4|Overall Study|Adverse Event|3
894442|NCT01197508|2947719|P3|Overall Study|Adverse Event|23
894443|NCT01197508|2947720|P2|Overall Study|Adverse Event|13
894444|NCT01197508|2947721|P1|Overall Study|Adverse Event|10
894445|NCT01197508|2947718|P4|Overall Study|Eligiblity criteria not fulfilled|0
894446|NCT01197508|2947719|P3|Overall Study|Eligiblity criteria not fulfilled|2
894447|NCT01197508|2947720|P2|Overall Study|Eligiblity criteria not fulfilled|0
894448|NCT01197508|2947721|P1|Overall Study|Eligiblity criteria not fulfilled|0
894449|NCT01197508|2947718|P4|Overall Study|Withdrawal by Subject|4
894450|NCT01197508|2947719|P3|Overall Study|Withdrawal by Subject|15
894451|NCT01197508|2947720|P2|Overall Study|Withdrawal by Subject|7
894452|NCT01197508|2947721|P1|Overall Study|Withdrawal by Subject|8
894453|NCT01197417|2947831|P2|Overall Study|No 25-hour magnesium level|2
894454|NCT01197417|2947832|P1|Overall Study|No 25-hour magnesium level|0
894455|NCT01197417|2947831|P2|Overall Study|Found to be ineligible|5
894456|NCT01197417|2947832|P1|Overall Study|Found to be ineligible|2
894457|NCT01197417|2947831|P2|Overall Study|Hypotension|2
894458|NCT01197417|2947832|P1|Overall Study|Hypotension|1
894459|NCT01197417|2947831|P2|Overall Study|Not consented in time to receive drug|1
894460|NCT01197417|2947832|P1|Overall Study|Not consented in time to receive drug|0
894461|NCT01197417|2947831|P2|Overall Study|Subject transferred to intensive care|1
894462|NCT01197417|2947832|P1|Overall Study|Subject transferred to intensive care|0
894463|NCT01197417|2947831|P2|Overall Study|Site miscommunication|1
894464|NCT01197417|2947832|P1|Overall Study|Site miscommunication|0
894465|NCT01197417|2947831|P2|Overall Study|Withdrawal by Subject|4
894466|NCT01197417|2947832|P1|Overall Study|Withdrawal by Subject|2
894467|NCT01197417|2947831|P2|Overall Study|Physician Decision|2
894468|NCT01197417|2947832|P1|Overall Study|Physician Decision|3
894469|NCT01197378|2947850|P1|Overall Study|Other|2
894470|NCT01197378|2947850|P1|Overall Study|Physician Decision|1
894471|NCT01197378|2947850|P1|Overall Study|Withdrawal by Subject|1
894472|NCT01197378|2947850|P1|Overall Study|Adverse Event|3
894473|NCT01196988|2947871|P4|Overall Study|Other|0
894474|NCT01196988|2947872|P3|Overall Study|Other|0
894475|NCT01196988|2947873|P2|Overall Study|Other|0
894476|NCT01196988|2947874|P1|Overall Study|Other|2
894477|NCT01196988|2947871|P4|Overall Study|Lost to Follow-up|1
894478|NCT01196988|2947872|P3|Overall Study|Lost to Follow-up|21
894479|NCT01196988|2947873|P2|Overall Study|Lost to Follow-up|29
894480|NCT01196988|2947874|P1|Overall Study|Lost to Follow-up|16
894481|NCT01196988|2947871|P4|Overall Study|Withdrawal by Subject|0
894482|NCT01196988|2947872|P3|Overall Study|Withdrawal by Subject|4
894483|NCT01196988|2947873|P2|Overall Study|Withdrawal by Subject|1
894484|NCT01196988|2947874|P1|Overall Study|Withdrawal by Subject|5
894485|NCT01196988|2947871|P4|Overall Study|Adverse Event|0
894486|NCT01196988|2947872|P3|Overall Study|Adverse Event|0
894487|NCT01196988|2947873|P2|Overall Study|Adverse Event|2
894488|NCT01196988|2947874|P1|Overall Study|Adverse Event|1
894489|NCT01196975|2947968|P5|Overall Study|Lost to Follow-up|11
894490|NCT01196975|2947969|P4|Overall Study|Lost to Follow-up|5
894491|NCT01196975|2947970|P3|Overall Study|Lost to Follow-up|5
894492|NCT01196975|2947971|P2|Overall Study|Lost to Follow-up|6
894493|NCT01196975|2947972|P1|Overall Study|Lost to Follow-up|11
894494|NCT01196975|2947968|P5|Overall Study|Withdrawal by Subject|0
894495|NCT01196975|2947969|P4|Overall Study|Withdrawal by Subject|1
894496|NCT01196975|2947970|P3|Overall Study|Withdrawal by Subject|0
894497|NCT01196975|2947971|P2|Overall Study|Withdrawal by Subject|1
894498|NCT01196975|2947972|P1|Overall Study|Withdrawal by Subject|2
894499|NCT01196975|2947968|P5|Overall Study|Adverse Event|2
894500|NCT01196975|2947969|P4|Overall Study|Adverse Event|0
894501|NCT01196975|2947970|P3|Overall Study|Adverse Event|0
894502|NCT01196975|2947971|P2|Overall Study|Adverse Event|2
894503|NCT01196975|2947972|P1|Overall Study|Adverse Event|2
894504|NCT01196741|2948227|P2|Overall Study|Protocol Violation|1
894505|NCT01196741|2948228|P1|Overall Study|Protocol Violation|2
894506|NCT01196741|2948227|P2|Overall Study|Other|2
894507|NCT01196741|2948228|P1|Overall Study|Other|3
894508|NCT01196741|2948227|P2|Overall Study|Other reason|3
894509|NCT01196741|2948228|P1|Overall Study|Other reason|3
894510|NCT01196741|2948227|P2|Overall Study|Withdrawal by Subject|0
894511|NCT01196741|2948228|P1|Overall Study|Withdrawal by Subject|3
894512|NCT01196741|2948227|P2|Overall Study|Dose limiting Adverse Event|1
894513|NCT01196741|2948228|P1|Overall Study|Dose limiting Adverse Event|2
894514|NCT01196741|2948227|P2|Overall Study|Serious Adverse Event|1
894515|NCT01196741|2948228|P1|Overall Study|Serious Adverse Event|3
894516|NCT01196741|2948227|P2|Overall Study|Adverse Event|6
894517|NCT01196741|2948228|P1|Overall Study|Adverse Event|10
894518|NCT01196741|2948227|P2|Overall Study|Disease progression|14
894519|NCT01196741|2948228|P1|Overall Study|Disease progression|34
894520|NCT01196429|2948254|P2|Overall Study|Refused – Never Treated|0
894521|NCT01196429|2948255|P1|Overall Study|Refused – Never Treated|1
894522|NCT01196429|2948254|P2|Overall Study|Ineligible - wrong cell type|0
894523|NCT01196429|2948255|P1|Overall Study|Ineligible - wrong cell type|1
894524|NCT01196429|2948254|P2|Overall Study|Ineligible - inadequate pathology|0
894525|NCT01196429|2948255|P1|Overall Study|Ineligible - inadequate pathology|1
894526|NCT01196416|2948271|P1|Overall Study|Withdrawal by Subject|2
894527|NCT01196104|2948297|P2|Overall Study|Various|1
894528|NCT01196104|2948298|P1|Overall Study|Various|0
894529|NCT01196104|2948297|P2|Overall Study|Withdrawal by Subject|3
894530|NCT01196104|2948298|P1|Overall Study|Withdrawal by Subject|3
894531|NCT01196104|2948297|P2|Overall Study|Physician Decision|1
894532|NCT01196104|2948298|P1|Overall Study|Physician Decision|0
894533|NCT01196104|2948297|P2|Overall Study|Lost to Follow-up|0
894534|NCT01196104|2948298|P1|Overall Study|Lost to Follow-up|1
894535|NCT01196091|2948341|P3|Overall Study|Randomized, No Study Drug Received|1
894536|NCT01196091|2948342|P2|Overall Study|Randomized, No Study Drug Received|0
894537|NCT01196091|2948343|P1|Overall Study|Randomized, No Study Drug Received|1
894538|NCT01196091|2948341|P3|Overall Study|Excluded Site|8
894539|NCT01196091|2948342|P2|Overall Study|Excluded Site|11
894540|NCT01196091|2948343|P1|Overall Study|Excluded Site|5
894541|NCT01196091|2948341|P3|Overall Study|Sponsor Decision|4
894542|NCT01196091|2948342|P2|Overall Study|Sponsor Decision|5
894543|NCT01196091|2948343|P1|Overall Study|Sponsor Decision|6
894544|NCT01196091|2948341|P3|Overall Study|Protocol Violation|3
894545|NCT01196091|2948342|P2|Overall Study|Protocol Violation|3
894546|NCT01196091|2948343|P1|Overall Study|Protocol Violation|1
894547|NCT01196091|2948341|P3|Overall Study|Physician Decision|4
894548|NCT01196091|2948342|P2|Overall Study|Physician Decision|3
894549|NCT01196091|2948343|P1|Overall Study|Physician Decision|3
894550|NCT01196091|2948341|P3|Overall Study|Withdrawal by Subject|22
894551|NCT01196091|2948342|P2|Overall Study|Withdrawal by Subject|19
894552|NCT01196091|2948343|P1|Overall Study|Withdrawal by Subject|16
894553|NCT01196091|2948341|P3|Overall Study|Parent/Caregiver Decision|1
894554|NCT01196091|2948342|P2|Overall Study|Parent/Caregiver Decision|0
894555|NCT01196091|2948343|P1|Overall Study|Parent/Caregiver Decision|0
894556|NCT01196091|2948341|P3|Overall Study|Lost to Follow-up|6
894557|NCT01196091|2948342|P2|Overall Study|Lost to Follow-up|5
894558|NCT01196091|2948343|P1|Overall Study|Lost to Follow-up|5
894559|NCT01196091|2948341|P3|Overall Study|Lack of Efficacy|17
894560|NCT01196091|2948342|P2|Overall Study|Lack of Efficacy|12
894561|NCT01196091|2948343|P1|Overall Study|Lack of Efficacy|15
894562|NCT01196091|2948341|P3|Overall Study|Entry Criteria Not Met|10
894563|NCT01196091|2948342|P2|Overall Study|Entry Criteria Not Met|11
894564|NCT01196091|2948343|P1|Overall Study|Entry Criteria Not Met|11
894565|NCT01196091|2948341|P3|Overall Study|Death|2
894566|NCT01196091|2948342|P2|Overall Study|Death|2
894567|NCT01196091|2948343|P1|Overall Study|Death|3
894568|NCT01196091|2948341|P3|Overall Study|Adverse Event|26
894569|NCT01196091|2948342|P2|Overall Study|Adverse Event|27
894570|NCT01196091|2948343|P1|Overall Study|Adverse Event|22
894571|NCT01196078|2948395|P2|Overall Study|Death|4
894572|NCT01196078|2948396|P1|Overall Study|Death|6
894573|NCT01196078|2948395|P2|Overall Study|Lost to Follow-up|0
894574|NCT01196078|2948396|P1|Overall Study|Lost to Follow-up|1
894575|NCT01196078|2948395|P2|Overall Study|Lack of Efficacy|23
894576|NCT01196078|2948396|P1|Overall Study|Lack of Efficacy|17
894577|NCT01196078|2948395|P2|Overall Study|Protocol Violation|1
894578|NCT01196078|2948396|P1|Overall Study|Protocol Violation|2
894579|NCT01196078|2948395|P2|Overall Study|Adverse Event|4
894580|NCT01196078|2948396|P1|Overall Study|Adverse Event|4
894581|NCT01196078|2948395|P2|Overall Study|Withdrawal by Subject|5
894582|NCT01196078|2948396|P1|Overall Study|Withdrawal by Subject|3
894583|NCT01196052|2948424|P1|Overall Study|Withdrawal by Subject|6
894584|NCT01196052|2948424|P1|Overall Study|Reason not Specified|5
894585|NCT01196052|2948424|P1|Overall Study|Noncompliance to Protocol Requirements|2
894586|NCT01196052|2948424|P1|Overall Study|Lost to Follow-up|1
894587|NCT01196052|2948424|P1|Overall Study|Adverse Event|9
894588|NCT01196026|2948441|P6|Overall Study|Other|0
894589|NCT01196026|2948442|P5|Overall Study|Other|0
894590|NCT01196026|2948443|P4|Overall Study|Other|0
894591|NCT01196026|2948444|P3|Overall Study|Other|0
894592|NCT01196026|2948445|P2|Overall Study|Other|1
894593|NCT01196026|2948446|P1|Overall Study|Other|0
894594|NCT01196026|2948441|P6|Overall Study|Lost to Follow-up|0
894595|NCT01196026|2948442|P5|Overall Study|Lost to Follow-up|1
894596|NCT01196026|2948443|P4|Overall Study|Lost to Follow-up|0
894597|NCT01196026|2948444|P3|Overall Study|Lost to Follow-up|0
894598|NCT01196026|2948445|P2|Overall Study|Lost to Follow-up|3
894599|NCT01196026|2948446|P1|Overall Study|Lost to Follow-up|0
894600|NCT01196026|2948441|P6|Overall Study|Withdrawal by Subject|0
894601|NCT01196026|2948442|P5|Overall Study|Withdrawal by Subject|0
894602|NCT01196026|2948443|P4|Overall Study|Withdrawal by Subject|0
894603|NCT01196026|2948444|P3|Overall Study|Withdrawal by Subject|0
894604|NCT01196026|2948445|P2|Overall Study|Withdrawal by Subject|4
894605|NCT01196026|2948446|P1|Overall Study|Withdrawal by Subject|1
894606|NCT01195948|2948680|P3|Overall Study|Lost to Follow-up|2
894607|NCT01195948|2948681|P2|Overall Study|Lost to Follow-up|1
894608|NCT01195948|2948682|P1|Overall Study|Lost to Follow-up|0
894609|NCT01195844|2948735|P1|Overall Study|Fecal sample not collected|40
894610|NCT01195831|2948752|P2|Overall Study|Protocol Violation|2
894611|NCT01195831|2948753|P1|Overall Study|Protocol Violation|0
894612|NCT01195831|2948752|P2|Overall Study|Adverse Event|2
894613|NCT01195831|2948753|P1|Overall Study|Adverse Event|4
894614|NCT01195831|2948752|P2|Overall Study|Withdrawal by Subject|2
894615|NCT01195831|2948753|P1|Overall Study|Withdrawal by Subject|2
894616|NCT01195831|2948752|P2|Overall Study|Lost to Follow-up|4
894617|NCT01195831|2948753|P1|Overall Study|Lost to Follow-up|2
894618|NCT01195675|2948993|P1|Overall Study|Withdrawal by Subject|2
894619|NCT01195675|2948993|P1|Overall Study|Adverse Event|1
894620|NCT01195662|2949026|P3|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
894621|NCT01195662|2949027|P2|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
894622|NCT01195662|2949028|P1|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1
894623|NCT01195662|2949026|P3|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1
894624|NCT01195662|2949027|P2|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0
894625|NCT01195662|2949028|P1|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2
894626|NCT01195662|2949026|P3|Double Blind Treatment Period|Missing disposition information|1
894627|NCT01195662|2949027|P2|Double Blind Treatment Period|Missing disposition information|1
894628|NCT01195662|2949028|P1|Double Blind Treatment Period|Missing disposition information|0
894629|NCT01195662|2949026|P3|Double Blind Treatment Period|Non-specified|0
894630|NCT01195662|2949027|P2|Double Blind Treatment Period|Non-specified|0
894631|NCT01195662|2949028|P1|Double Blind Treatment Period|Non-specified|3
894632|NCT01195662|2949026|P3|Double Blind Treatment Period|Lack of Efficacy|0
894633|NCT01195662|2949027|P2|Double Blind Treatment Period|Lack of Efficacy|0
894634|NCT01195662|2949028|P1|Double Blind Treatment Period|Lack of Efficacy|2
894635|NCT01195662|2949026|P3|Double Blind Treatment Period|No Longer Meets Criteria|2
894636|NCT01195662|2949027|P2|Double Blind Treatment Period|No Longer Meets Criteria|5
894637|NCT01195662|2949028|P1|Double Blind Treatment Period|No Longer Meets Criteria|1
894638|NCT01195662|2949026|P3|Double Blind Treatment Period|Requested discontinue treatment|1
894639|NCT01195662|2949027|P2|Double Blind Treatment Period|Requested discontinue treatment|0
894640|NCT01195662|2949028|P1|Double Blind Treatment Period|Requested discontinue treatment|1
894641|NCT01195662|2949026|P3|Double Blind Treatment Period|Administrative reason|1
894642|NCT01195662|2949027|P2|Double Blind Treatment Period|Administrative reason|1
894643|NCT01195662|2949028|P1|Double Blind Treatment Period|Administrative reason|2
894644|NCT01195662|2949026|P3|Double Blind Treatment Period|Lost to Follow-up|3
894645|NCT01195662|2949027|P2|Double Blind Treatment Period|Lost to Follow-up|2
894646|NCT01195662|2949028|P1|Double Blind Treatment Period|Lost to Follow-up|3
894647|NCT01195662|2949026|P3|Double Blind Treatment Period|Withdrawal by Subject|4
894648|NCT01195662|2949027|P2|Double Blind Treatment Period|Withdrawal by Subject|4
894649|NCT01195662|2949028|P1|Double Blind Treatment Period|Withdrawal by Subject|6
894650|NCT01195662|2949026|P3|Double Blind Treatment Period|Adverse Event|2
894651|NCT01195662|2949027|P2|Double Blind Treatment Period|Adverse Event|1
894652|NCT01195662|2949028|P1|Double Blind Treatment Period|Adverse Event|4
894653|NCT01195636|2949058|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|1
894654|NCT01195636|2949059|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|0
894655|NCT01195636|2949058|P2|Second Intervention (3 Weeks)|Adverse Event|1
894656|NCT01195636|2949059|P1|Second Intervention (3 Weeks)|Adverse Event|1
894657|NCT01195636|2949058|P2|Washout Period (2 Weeks)|Withdrawal by Subject|2
894658|NCT01195636|2949059|P1|Washout Period (2 Weeks)|Withdrawal by Subject|1
894659|NCT01195636|2949058|P2|Washout Period (2 Weeks)|Adverse Event|1
894660|NCT01195636|2949059|P1|Washout Period (2 Weeks)|Adverse Event|1
894661|NCT01195636|2949058|P2|First Intervention (3 Weeks)|Lost to Follow-up|0
894662|NCT01195636|2949059|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
894663|NCT01195636|2949058|P2|First Intervention (3 Weeks)|Withdrawal by Subject|0
894664|NCT01195636|2949059|P1|First Intervention (3 Weeks)|Withdrawal by Subject|1
894665|NCT01195636|2949058|P2|First Intervention (3 Weeks)|Protocol Violation|0
894666|NCT01195636|2949059|P1|First Intervention (3 Weeks)|Protocol Violation|1
894667|NCT01195636|2949058|P2|First Intervention (3 Weeks)|Adverse Event|3
894668|NCT01195636|2949059|P1|First Intervention (3 Weeks)|Adverse Event|2
894669|NCT01195623|2949085|P2|Overall Study|Lost to Follow-up|37
894670|NCT01195623|2949086|P1|Overall Study|Lost to Follow-up|35
894671|NCT01195545|2949115|P1|Overall Study|Protocol Violation|4
894672|NCT01195415|2949127|P1|Overall Study|No repeat biopsy due to progression|2
894673|NCT01195363|2949136|P2|Overall Study|incarceration|0
894674|NCT01195363|2949137|P1|Overall Study|incarceration|1
894675|NCT01195363|2949136|P2|Overall Study|Lack of Efficacy|4
894676|NCT01195363|2949137|P1|Overall Study|Lack of Efficacy|0
894677|NCT01195363|2949136|P2|Overall Study|Adverse Event|1
894678|NCT01195363|2949137|P1|Overall Study|Adverse Event|3
894679|NCT01195363|2949136|P2|Overall Study|Lost to Follow-up|4
894680|NCT01195363|2949137|P1|Overall Study|Lost to Follow-up|7
894681|NCT01195272|2949143|P1|Overall Study|Lack of Efficacy|3
894682|NCT01195272|2949143|P1|Overall Study|Adverse Event|1
894683|NCT01195103|2949172|P3|Overall Study|Withdrawal by Subject|0
894684|NCT01195103|2949173|P2|Overall Study|Withdrawal by Subject|0
894685|NCT01195103|2949174|P1|Overall Study|Withdrawal by Subject|1
894686|NCT01195090|2949184|P2|Overall Study|Protocol Violation|4
894687|NCT01195090|2949185|P1|Overall Study|Protocol Violation|3
894688|NCT01195090|2949184|P2|Overall Study|Lost to Follow-up|2
894689|NCT01195090|2949185|P1|Overall Study|Lost to Follow-up|2
894690|NCT01195090|2949184|P2|Overall Study|Adverse Event|2
894691|NCT01195090|2949185|P1|Overall Study|Adverse Event|1
894692|NCT01194999|2949254|P1|Overall Study|Lost to Follow-up|17
894693|NCT01194973|2949258|P1|26 Week Treatment Period|Pregnancy|1
894694|NCT01194973|2949258|P1|26 Week Treatment Period|Lack of Efficacy|1
894695|NCT01194973|2949258|P1|26 Week Treatment Period|Adverse Event|1
894696|NCT01194973|2949258|P1|Screening Period|Screen Failure|3
894697|NCT01194869|2949278|P1|Overall Study|Toxicity|2
894698|NCT01194869|2949278|P1|Overall Study|Disease Progression|2
894699|NCT01194830|2949309|P2|Overall Study|Other Reason|8
894700|NCT01194830|2949310|P1|Overall Study|Other Reason|12
894701|NCT01194830|2949309|P2|Overall Study|Non-compliance issues|4
894702|NCT01194830|2949310|P1|Overall Study|Non-compliance issues|4
894703|NCT01194830|2949309|P2|Overall Study|Lack of Efficacy|1
894704|NCT01194830|2949310|P1|Overall Study|Lack of Efficacy|1
894705|NCT01194830|2949309|P2|Overall Study|Withdrawal by Subject|1
894706|NCT01194830|2949310|P1|Overall Study|Withdrawal by Subject|2
894707|NCT01194830|2949309|P2|Overall Study|Lost to Follow-up|7
894708|NCT01194830|2949310|P1|Overall Study|Lost to Follow-up|9
894709|NCT01194830|2949309|P2|Overall Study|Protocol Violation|4
894710|NCT01194830|2949310|P1|Overall Study|Protocol Violation|5
894711|NCT01194830|2949309|P2|Overall Study|Adverse Event|2
894712|NCT01194830|2949310|P1|Overall Study|Adverse Event|3
894713|NCT01194570|2949346|P2|Overall Study|Lost to Follow-up|4
894714|NCT01194570|2949347|P1|Overall Study|Lost to Follow-up|1
894715|NCT01194570|2949346|P2|Overall Study|Pregnancy|1
894716|NCT01194570|2949347|P1|Overall Study|Pregnancy|1
894717|NCT01194570|2949346|P2|Overall Study|Withdrawal by Subject|22
894718|NCT01194570|2949347|P1|Overall Study|Withdrawal by Subject|21
894719|NCT01194570|2949346|P2|Overall Study|Lack of Efficacy|21
894720|NCT01194570|2949347|P1|Overall Study|Lack of Efficacy|27
894721|NCT01194570|2949346|P2|Overall Study|Non-compliance|2
894722|NCT01194570|2949347|P1|Overall Study|Non-compliance|2
894723|NCT01194570|2949346|P2|Overall Study|Adverse Event|18
894724|NCT01194570|2949347|P1|Overall Study|Adverse Event|12
894725|NCT01194570|2949346|P2|Overall Study|Non-compliance with study drug|2
894726|NCT01194570|2949347|P1|Overall Study|Non-compliance with study drug|2
894727|NCT01194570|2949346|P2|Overall Study|Protocol Violation|2
894728|NCT01194570|2949347|P1|Overall Study|Protocol Violation|0
894729|NCT01194570|2949346|P2|Overall Study|Reason not specified|20
894730|NCT01194570|2949347|P1|Overall Study|Reason not specified|13
894731|NCT01194570|2949346|P2|Overall Study|Physician Decision|6
894732|NCT01194570|2949347|P1|Overall Study|Physician Decision|2
894733|NCT01194570|2949346|P2|Overall Study|Ongoing at CCOD|387
894734|NCT01194570|2949347|P1|Overall Study|Ongoing at CCOD|162
894735|NCT01194570|2949346|P2|Overall Study|Death|3
894736|NCT01194570|2949347|P1|Overall Study|Death|1
894737|NCT01194531|2949367|P2|Overall Study|Physician Decision|2
894738|NCT01194531|2949368|P1|Overall Study|Physician Decision|0
894739|NCT01194531|2949367|P2|Overall Study|Protocol Violation|1
894740|NCT01194531|2949368|P1|Overall Study|Protocol Violation|4
894741|NCT01194531|2949367|P2|Overall Study|Withdrawal by Subject|0
894742|NCT01194531|2949368|P1|Overall Study|Withdrawal by Subject|1
894743|NCT01194440|2949412|P1|6-months (2nd Dose)|Change in therapy|4
894744|NCT01194440|2949412|P1|Baseline (First Dose)|Adverse Event|1
894745|NCT01194440|2949412|P1|Baseline (First Dose)|Change in therapy|1
894746|NCT01194440|2949412|P1|Baseline (First Dose)|Lack of Efficacy|1
894747|NCT01194440|2949412|P1|Baseline (First Dose)|Reason not specified|4
894748|NCT01194414|2949425|P4|72 Weeks Open Label Extension|Death|2
894749|NCT01194414|2949426|P3|72 Weeks Open Label Extension|Death|0
894750|NCT01194414|2949427|P2|72 Weeks Open Label Extension|Death|2
894751|NCT01194414|2949428|P1|72 Weeks Open Label Extension|Death|1
894752|NCT01194414|2949425|P4|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
894753|NCT01194414|2949426|P3|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
894754|NCT01194414|2949427|P2|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
894755|NCT01194414|2949428|P1|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
894756|NCT01194414|2949425|P4|72 Weeks Open Label Extension|Adverse Event|12
894757|NCT01194414|2949426|P3|72 Weeks Open Label Extension|Adverse Event|2
894758|NCT01194414|2949427|P2|72 Weeks Open Label Extension|Adverse Event|21
894759|NCT01194414|2949428|P1|72 Weeks Open Label Extension|Adverse Event|35
894760|NCT01194414|2949425|P4|72 Weeks Open Label Extension|Protocol Violation|1
894761|NCT01194414|2949426|P3|72 Weeks Open Label Extension|Protocol Violation|0
894762|NCT01194414|2949427|P2|72 Weeks Open Label Extension|Protocol Violation|0
894763|NCT01194414|2949428|P1|72 Weeks Open Label Extension|Protocol Violation|0
894764|NCT01194414|2949425|P4|72 Weeks Open Label Extension|Other|0
894765|NCT01194414|2949426|P3|72 Weeks Open Label Extension|Other|0
894766|NCT01194414|2949427|P2|72 Weeks Open Label Extension|Other|1
894767|NCT01194414|2949428|P1|72 Weeks Open Label Extension|Other|2
894768|NCT01194414|2949425|P4|72 Weeks Open Label Extension|Pregnancy|1
894769|NCT01194414|2949426|P3|72 Weeks Open Label Extension|Pregnancy|1
894770|NCT01194414|2949427|P2|72 Weeks Open Label Extension|Pregnancy|3
894771|NCT01194414|2949428|P1|72 Weeks Open Label Extension|Pregnancy|1
894772|NCT01194414|2949425|P4|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
894773|NCT01194414|2949426|P3|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
894774|NCT01194414|2949427|P2|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5
894775|NCT01194414|2949428|P1|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3
894776|NCT01194414|2949425|P4|72 Weeks Open Label Extension|Lost to Follow-up|1
894777|NCT01194414|2949426|P3|72 Weeks Open Label Extension|Lost to Follow-up|2
894778|NCT01194414|2949427|P2|72 Weeks Open Label Extension|Lost to Follow-up|3
894779|NCT01194414|2949428|P1|72 Weeks Open Label Extension|Lost to Follow-up|4
894780|NCT01194414|2949425|P4|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3
894781|NCT01194414|2949426|P3|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2
894782|NCT01194414|2949427|P2|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11
894783|NCT01194414|2949428|P1|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9
894784|NCT01194414|2949425|P4|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6
894785|NCT01194414|2949426|P3|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1
894786|NCT01194414|2949427|P2|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14
894787|NCT01194414|2949428|P1|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20
894788|NCT01194414|2949425|P4|72 Weeks Open Label Extension|Randomized but not Treated|0
894789|NCT01194414|2949426|P3|72 Weeks Open Label Extension|Randomized but not Treated|0
894790|NCT01194414|2949427|P2|72 Weeks Open Label Extension|Randomized but not Treated|5
894791|NCT01194414|2949428|P1|72 Weeks Open Label Extension|Randomized but not Treated|3
894792|NCT01194414|2949425|P4|24 Weeks Double Blind Period|Death|0
894793|NCT01194414|2949426|P3|24 Weeks Double Blind Period|Death|0
894794|NCT01194414|2949427|P2|24 Weeks Double Blind Period|Death|1
894795|NCT01194414|2949428|P1|24 Weeks Double Blind Period|Death|0
894796|NCT01194414|2949425|P4|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
894797|NCT01194414|2949426|P3|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
894798|NCT01194414|2949427|P2|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1
894799|NCT01194414|2949428|P1|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2
894800|NCT01194414|2949425|P4|24 Weeks Double Blind Period|Adverse Event|0
894801|NCT01194414|2949426|P3|24 Weeks Double Blind Period|Adverse Event|0
894802|NCT01194414|2949427|P2|24 Weeks Double Blind Period|Adverse Event|40
894803|NCT01194414|2949428|P1|24 Weeks Double Blind Period|Adverse Event|28
894804|NCT01194414|2949425|P4|24 Weeks Double Blind Period|Other|0
894805|NCT01194414|2949426|P3|24 Weeks Double Blind Period|Other|0
894806|NCT01194414|2949427|P2|24 Weeks Double Blind Period|Other|1
894807|NCT01194414|2949428|P1|24 Weeks Double Blind Period|Other|0
894808|NCT01194414|2949425|P4|24 Weeks Double Blind Period|Lost to Follow-up|0
894809|NCT01194414|2949426|P3|24 Weeks Double Blind Period|Lost to Follow-up|0
894810|NCT01194414|2949427|P2|24 Weeks Double Blind Period|Lost to Follow-up|1
894811|NCT01194414|2949428|P1|24 Weeks Double Blind Period|Lost to Follow-up|2
894812|NCT01194414|2949425|P4|24 Weeks Double Blind Period|Pregnancy|0
894813|NCT01194414|2949426|P3|24 Weeks Double Blind Period|Pregnancy|0
894814|NCT01194414|2949427|P2|24 Weeks Double Blind Period|Pregnancy|2
894815|NCT01194414|2949428|P1|24 Weeks Double Blind Period|Pregnancy|2
894816|NCT01194414|2949425|P4|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
894817|NCT01194414|2949426|P3|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
894818|NCT01194414|2949427|P2|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5
894819|NCT01194414|2949428|P1|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
894820|NCT01194414|2949425|P4|24 Weeks Double Blind Period|Protocol Violation|0
894821|NCT01194414|2949426|P3|24 Weeks Double Blind Period|Protocol Violation|0
894822|NCT01194414|2949427|P2|24 Weeks Double Blind Period|Protocol Violation|3
894823|NCT01194414|2949428|P1|24 Weeks Double Blind Period|Protocol Violation|5
894824|NCT01194414|2949425|P4|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
894825|NCT01194414|2949426|P3|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
894826|NCT01194414|2949427|P2|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5
894827|NCT01194414|2949428|P1|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9
894828|NCT01194414|2949425|P4|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
894829|NCT01194414|2949426|P3|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
894830|NCT01194414|2949427|P2|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8
894831|NCT01194414|2949428|P1|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11
894832|NCT01194258|2949499|P5|Period 2 (12 Weeks)|Withdrawal by Subject|0
894833|NCT01194258|2949500|P4|Period 2 (12 Weeks)|Withdrawal by Subject|0
894834|NCT01194258|2949501|P3|Period 2 (12 Weeks)|Withdrawal by Subject|1
894835|NCT01194258|2949502|P2|Period 2 (12 Weeks)|Withdrawal by Subject|1
894836|NCT01194258|2949503|P1|Period 2 (12 Weeks)|Withdrawal by Subject|0
894837|NCT01194258|2949499|P5|Period 2 (12 Weeks)|Adverse Event|0
894838|NCT01194258|2949500|P4|Period 2 (12 Weeks)|Adverse Event|0
894839|NCT01194258|2949501|P3|Period 2 (12 Weeks)|Adverse Event|0
894840|NCT01194258|2949502|P2|Period 2 (12 Weeks)|Adverse Event|1
894841|NCT01194258|2949503|P1|Period 2 (12 Weeks)|Adverse Event|0
894842|NCT01194258|2949499|P5|Period 2 (12 Weeks)|Lost to Follow-up|2
894843|NCT01194258|2949500|P4|Period 2 (12 Weeks)|Lost to Follow-up|0
894844|NCT01194258|2949501|P3|Period 2 (12 Weeks)|Lost to Follow-up|0
894845|NCT01194258|2949502|P2|Period 2 (12 Weeks)|Lost to Follow-up|0
894846|NCT01194258|2949503|P1|Period 2 (12 Weeks)|Lost to Follow-up|0
894847|NCT01194258|2949499|P5|Period 1 (12 Weeks)|Death|1
894848|NCT01194258|2949500|P4|Period 1 (12 Weeks)|Death|0
894849|NCT01194258|2949501|P3|Period 1 (12 Weeks)|Death|0
894850|NCT01194258|2949502|P2|Period 1 (12 Weeks)|Death|0
894851|NCT01194258|2949503|P1|Period 1 (12 Weeks)|Death|0
894852|NCT01194258|2949499|P5|Titration Period|Titration failure|0
894853|NCT01194258|2949500|P4|Titration Period|Titration failure|0
894854|NCT01194258|2949501|P3|Titration Period|Titration failure|0
894855|NCT01194258|2949502|P2|Titration Period|Titration failure|0
894856|NCT01194258|2949503|P1|Titration Period|Titration failure|3
894857|NCT01194258|2949499|P5|Titration Period|Lost to Follow-up|0
894858|NCT01194258|2949500|P4|Titration Period|Lost to Follow-up|0
894859|NCT01194258|2949501|P3|Titration Period|Lost to Follow-up|0
894860|NCT01194258|2949502|P2|Titration Period|Lost to Follow-up|0
894861|NCT01194258|2949503|P1|Titration Period|Lost to Follow-up|2
894862|NCT01194258|2949499|P5|Titration Period|Withdrawal by Subject|0
894863|NCT01194258|2949500|P4|Titration Period|Withdrawal by Subject|0
894864|NCT01194258|2949501|P3|Titration Period|Withdrawal by Subject|0
894865|NCT01194258|2949502|P2|Titration Period|Withdrawal by Subject|0
894866|NCT01194258|2949503|P1|Titration Period|Withdrawal by Subject|6
894867|NCT01194245|2949527|P5|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
894868|NCT01194245|2949528|P4|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
894869|NCT01194245|2949529|P3|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
894870|NCT01194245|2949530|P2|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
894871|NCT01194245|2949531|P1|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
894872|NCT01194245|2949527|P5|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
894873|NCT01194245|2949528|P4|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
894874|NCT01194245|2949529|P3|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
894875|NCT01194245|2949530|P2|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
894876|NCT01194245|2949531|P1|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
894877|NCT01194245|2949527|P5|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
894878|NCT01194245|2949528|P4|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
894879|NCT01194245|2949529|P3|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
894880|NCT01194245|2949530|P2|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
894881|NCT01194245|2949531|P1|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7
894882|NCT01194245|2949527|P5|Titration Period (4 to 6 Weeks)|Titration Failure|0
894883|NCT01194245|2949528|P4|Titration Period (4 to 6 Weeks)|Titration Failure|0
894884|NCT01194245|2949529|P3|Titration Period (4 to 6 Weeks)|Titration Failure|0
894885|NCT01194245|2949530|P2|Titration Period (4 to 6 Weeks)|Titration Failure|0
894886|NCT01194245|2949531|P1|Titration Period (4 to 6 Weeks)|Titration Failure|3
894887|NCT01194245|2949527|P5|Titration Period (4 to 6 Weeks)|Physician Decision|0
894888|NCT01194245|2949528|P4|Titration Period (4 to 6 Weeks)|Physician Decision|0
894889|NCT01194245|2949529|P3|Titration Period (4 to 6 Weeks)|Physician Decision|0
894890|NCT01194245|2949530|P2|Titration Period (4 to 6 Weeks)|Physician Decision|0
894891|NCT01194245|2949531|P1|Titration Period (4 to 6 Weeks)|Physician Decision|3
894892|NCT01194245|2949527|P5|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
894893|NCT01194245|2949528|P4|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
894894|NCT01194245|2949529|P3|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
894895|NCT01194245|2949530|P2|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
894896|NCT01194245|2949531|P1|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5
894897|NCT01194219|2949552|P10|Long-Term Extension Weeks 52 to 260|Miscellaneous|2
894898|NCT01194219|2949553|P9|Long-Term Extension Weeks 52 to 260|Miscellaneous|11
894899|NCT01194219|2949554|P8|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
894900|NCT01194219|2949555|P7|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
894901|NCT01194219|2949556|P6|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
894902|NCT01194219|2949557|P5|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
894903|NCT01194219|2949558|P4|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
894904|NCT01194219|2949559|P3|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
894905|NCT01194219|2949560|P2|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
894906|NCT01194219|2949561|P1|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
894907|NCT01194219|2949552|P10|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
894908|NCT01194219|2949553|P9|Long-Term Extension Weeks 52 to 260|Protocol Violation|3
894909|NCT01194219|2949554|P8|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
894910|NCT01194219|2949555|P7|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
894911|NCT01194219|2949556|P6|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
894912|NCT01194219|2949557|P5|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
894913|NCT01194219|2949558|P4|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
894914|NCT01194219|2949559|P3|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
894915|NCT01194219|2949560|P2|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
894916|NCT01194219|2949561|P1|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
894917|NCT01194219|2949552|P10|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10
894918|NCT01194219|2949553|P9|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24
894919|NCT01194219|2949554|P8|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
894920|NCT01194219|2949555|P7|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
894921|NCT01194219|2949556|P6|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
894922|NCT01194219|2949557|P5|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
894923|NCT01194219|2949558|P4|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
894924|NCT01194219|2949559|P3|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
894925|NCT01194219|2949560|P2|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
894926|NCT01194219|2949561|P1|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
894927|NCT01194219|2949552|P10|Long-Term Extension Weeks 52 to 260|Death|1
894928|NCT01194219|2949553|P9|Long-Term Extension Weeks 52 to 260|Death|1
894929|NCT01194219|2949554|P8|Long-Term Extension Weeks 52 to 260|Death|0
894930|NCT01194219|2949555|P7|Long-Term Extension Weeks 52 to 260|Death|0
894931|NCT01194219|2949556|P6|Long-Term Extension Weeks 52 to 260|Death|0
894932|NCT01194219|2949557|P5|Long-Term Extension Weeks 52 to 260|Death|0
894933|NCT01194219|2949558|P4|Long-Term Extension Weeks 52 to 260|Death|0
894934|NCT01194219|2949559|P3|Long-Term Extension Weeks 52 to 260|Death|0
894935|NCT01194219|2949560|P2|Long-Term Extension Weeks 52 to 260|Death|0
894936|NCT01194219|2949561|P1|Long-Term Extension Weeks 52 to 260|Death|0
894937|NCT01194219|2949552|P10|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32
894938|NCT01194219|2949553|P9|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66
894939|NCT01194219|2949554|P8|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
894940|NCT01194219|2949555|P7|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
894941|NCT01194219|2949556|P6|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
894942|NCT01194219|2949557|P5|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
894943|NCT01194219|2949558|P4|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
894944|NCT01194219|2949559|P3|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
894945|NCT01194219|2949560|P2|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
894946|NCT01194219|2949561|P1|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
894947|NCT01194219|2949552|P10|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4
894948|NCT01194219|2949553|P9|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9
894949|NCT01194219|2949554|P8|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
894950|NCT01194219|2949555|P7|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
894951|NCT01194219|2949556|P6|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
894952|NCT01194219|2949557|P5|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
894953|NCT01194219|2949558|P4|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
894954|NCT01194219|2949559|P3|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
894955|NCT01194219|2949560|P2|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
894956|NCT01194219|2949561|P1|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
894957|NCT01194219|2949552|P10|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49
894958|NCT01194219|2949553|P9|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81
894959|NCT01194219|2949554|P8|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
894960|NCT01194219|2949555|P7|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
894961|NCT01194219|2949556|P6|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
894962|NCT01194219|2949557|P5|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
894963|NCT01194219|2949558|P4|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
895108|NCT01194219|2949553|P9|Maintenance Phase Weeks16-32|Adverse Event|0
894964|NCT01194219|2949559|P3|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
894965|NCT01194219|2949560|P2|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
894966|NCT01194219|2949561|P1|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
894967|NCT01194219|2949552|P10|Long-Term Extension Weeks 52 to 260|Adverse Event|14
894968|NCT01194219|2949553|P9|Long-Term Extension Weeks 52 to 260|Adverse Event|25
894969|NCT01194219|2949554|P8|Long-Term Extension Weeks 52 to 260|Adverse Event|0
894970|NCT01194219|2949555|P7|Long-Term Extension Weeks 52 to 260|Adverse Event|0
894971|NCT01194219|2949556|P6|Long-Term Extension Weeks 52 to 260|Adverse Event|0
894972|NCT01194219|2949557|P5|Long-Term Extension Weeks 52 to 260|Adverse Event|0
894973|NCT01194219|2949558|P4|Long-Term Extension Weeks 52 to 260|Adverse Event|0
894974|NCT01194219|2949559|P3|Long-Term Extension Weeks 52 to 260|Adverse Event|0
894975|NCT01194219|2949560|P2|Long-Term Extension Weeks 52 to 260|Adverse Event|0
894976|NCT01194219|2949561|P1|Long-Term Extension Weeks 52 to 260|Adverse Event|0
894977|NCT01194219|2949552|P10|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
894978|NCT01194219|2949553|P9|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
894979|NCT01194219|2949554|P8|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
894980|NCT01194219|2949555|P7|Randomized Withdrawal Phase-Weeks 32-52|Not specified|1
894981|NCT01194219|2949556|P6|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
894982|NCT01194219|2949557|P5|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
894983|NCT01194219|2949558|P4|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
894984|NCT01194219|2949559|P3|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
894985|NCT01194219|2949560|P2|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
894986|NCT01194219|2949561|P1|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
894987|NCT01194219|2949552|P10|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
894988|NCT01194219|2949553|P9|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
894989|NCT01194219|2949554|P8|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1
894990|NCT01194219|2949555|P7|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
894991|NCT01194219|2949556|P6|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
894992|NCT01194219|2949557|P5|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
894993|NCT01194219|2949558|P4|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
894994|NCT01194219|2949559|P3|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
894995|NCT01194219|2949560|P2|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
894996|NCT01194219|2949561|P1|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
894997|NCT01194219|2949552|P10|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
894998|NCT01194219|2949553|P9|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
894999|NCT01194219|2949554|P8|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
895000|NCT01194219|2949555|P7|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5
895001|NCT01194219|2949556|P6|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2
895002|NCT01194219|2949557|P5|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1
895003|NCT01194219|2949558|P4|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
895004|NCT01194219|2949559|P3|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
895005|NCT01194219|2949560|P2|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
895006|NCT01194219|2949561|P1|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
895007|NCT01194219|2949552|P10|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
895008|NCT01194219|2949553|P9|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
895009|NCT01194219|2949554|P8|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6
895010|NCT01194219|2949555|P7|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12
895011|NCT01194219|2949556|P6|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
895012|NCT01194219|2949557|P5|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1
895013|NCT01194219|2949558|P4|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
895014|NCT01194219|2949559|P3|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
895015|NCT01194219|2949560|P2|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
895016|NCT01194219|2949561|P1|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
895017|NCT01194219|2949552|P10|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
895018|NCT01194219|2949553|P9|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
895019|NCT01194219|2949554|P8|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
895020|NCT01194219|2949555|P7|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2
895021|NCT01194219|2949556|P6|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
895022|NCT01194219|2949557|P5|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1
895023|NCT01194219|2949558|P4|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
895024|NCT01194219|2949559|P3|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
895025|NCT01194219|2949560|P2|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
895026|NCT01194219|2949561|P1|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
895027|NCT01194219|2949552|P10|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
895028|NCT01194219|2949553|P9|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
895029|NCT01194219|2949554|P8|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33
895030|NCT01194219|2949555|P7|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35
895031|NCT01194219|2949556|P6|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
895032|NCT01194219|2949557|P5|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
895033|NCT01194219|2949558|P4|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
895034|NCT01194219|2949559|P3|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
895035|NCT01194219|2949560|P2|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
895036|NCT01194219|2949561|P1|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
895037|NCT01194219|2949552|P10|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
895038|NCT01194219|2949553|P9|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
895039|NCT01194219|2949554|P8|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5
895040|NCT01194219|2949555|P7|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6
895041|NCT01194219|2949556|P6|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1
895042|NCT01194219|2949557|P5|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
895043|NCT01194219|2949558|P4|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
895044|NCT01194219|2949559|P3|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
895045|NCT01194219|2949560|P2|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
895046|NCT01194219|2949561|P1|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
895047|NCT01194219|2949552|P10|Maintenance Phase Weeks16-32|Other|0
895048|NCT01194219|2949553|P9|Maintenance Phase Weeks16-32|Other|0
895049|NCT01194219|2949554|P8|Maintenance Phase Weeks16-32|Other|0
895050|NCT01194219|2949555|P7|Maintenance Phase Weeks16-32|Other|0
895051|NCT01194219|2949556|P6|Maintenance Phase Weeks16-32|Other|0
895052|NCT01194219|2949557|P5|Maintenance Phase Weeks16-32|Other|0
895053|NCT01194219|2949558|P4|Maintenance Phase Weeks16-32|Other|1
895054|NCT01194219|2949559|P3|Maintenance Phase Weeks16-32|Other|2
895055|NCT01194219|2949560|P2|Maintenance Phase Weeks16-32|Other|0
895056|NCT01194219|2949561|P1|Maintenance Phase Weeks16-32|Other|0
895057|NCT01194219|2949552|P10|Maintenance Phase Weeks16-32|Protocol Violation|0
895058|NCT01194219|2949553|P9|Maintenance Phase Weeks16-32|Protocol Violation|0
895059|NCT01194219|2949554|P8|Maintenance Phase Weeks16-32|Protocol Violation|0
895060|NCT01194219|2949555|P7|Maintenance Phase Weeks16-32|Protocol Violation|0
895061|NCT01194219|2949556|P6|Maintenance Phase Weeks16-32|Protocol Violation|0
895062|NCT01194219|2949557|P5|Maintenance Phase Weeks16-32|Protocol Violation|0
895063|NCT01194219|2949558|P4|Maintenance Phase Weeks16-32|Protocol Violation|1
895064|NCT01194219|2949559|P3|Maintenance Phase Weeks16-32|Protocol Violation|0
895065|NCT01194219|2949560|P2|Maintenance Phase Weeks16-32|Protocol Violation|0
895066|NCT01194219|2949561|P1|Maintenance Phase Weeks16-32|Protocol Violation|0
895067|NCT01194219|2949552|P10|Maintenance Phase Weeks16-32|Lost to Follow-up|0
895068|NCT01194219|2949553|P9|Maintenance Phase Weeks16-32|Lost to Follow-up|0
895069|NCT01194219|2949554|P8|Maintenance Phase Weeks16-32|Lost to Follow-up|0
895070|NCT01194219|2949555|P7|Maintenance Phase Weeks16-32|Lost to Follow-up|0
895071|NCT01194219|2949556|P6|Maintenance Phase Weeks16-32|Lost to Follow-up|0
895072|NCT01194219|2949557|P5|Maintenance Phase Weeks16-32|Lost to Follow-up|0
895073|NCT01194219|2949558|P4|Maintenance Phase Weeks16-32|Lost to Follow-up|0
895074|NCT01194219|2949559|P3|Maintenance Phase Weeks16-32|Lost to Follow-up|9
895075|NCT01194219|2949560|P2|Maintenance Phase Weeks16-32|Lost to Follow-up|0
895076|NCT01194219|2949561|P1|Maintenance Phase Weeks16-32|Lost to Follow-up|0
895077|NCT01194219|2949552|P10|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
895078|NCT01194219|2949553|P9|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
895079|NCT01194219|2949554|P8|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
895080|NCT01194219|2949555|P7|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
895081|NCT01194219|2949556|P6|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
895082|NCT01194219|2949557|P5|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
895083|NCT01194219|2949558|P4|Maintenance Phase Weeks16-32|Withdrawal by Subject|3
895084|NCT01194219|2949559|P3|Maintenance Phase Weeks16-32|Withdrawal by Subject|12
895085|NCT01194219|2949560|P2|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
895086|NCT01194219|2949561|P1|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
895087|NCT01194219|2949552|P10|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
895088|NCT01194219|2949553|P9|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
895089|NCT01194219|2949554|P8|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
895090|NCT01194219|2949555|P7|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
895091|NCT01194219|2949556|P6|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
895092|NCT01194219|2949557|P5|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
895093|NCT01194219|2949558|P4|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1
895094|NCT01194219|2949559|P3|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2
895095|NCT01194219|2949560|P2|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
895096|NCT01194219|2949561|P1|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
895097|NCT01194219|2949552|P10|Maintenance Phase Weeks16-32|Lack of Efficacy|0
895098|NCT01194219|2949553|P9|Maintenance Phase Weeks16-32|Lack of Efficacy|0
895099|NCT01194219|2949554|P8|Maintenance Phase Weeks16-32|Lack of Efficacy|0
895100|NCT01194219|2949555|P7|Maintenance Phase Weeks16-32|Lack of Efficacy|0
895101|NCT01194219|2949556|P6|Maintenance Phase Weeks16-32|Lack of Efficacy|0
895102|NCT01194219|2949557|P5|Maintenance Phase Weeks16-32|Lack of Efficacy|0
895103|NCT01194219|2949558|P4|Maintenance Phase Weeks16-32|Lack of Efficacy|15
895104|NCT01194219|2949559|P3|Maintenance Phase Weeks16-32|Lack of Efficacy|37
895105|NCT01194219|2949560|P2|Maintenance Phase Weeks16-32|Lack of Efficacy|0
895106|NCT01194219|2949561|P1|Maintenance Phase Weeks16-32|Lack of Efficacy|0
895107|NCT01194219|2949552|P10|Maintenance Phase Weeks16-32|Adverse Event|0
895109|NCT01194219|2949554|P8|Maintenance Phase Weeks16-32|Adverse Event|0
895110|NCT01194219|2949555|P7|Maintenance Phase Weeks16-32|Adverse Event|0
895111|NCT01194219|2949556|P6|Maintenance Phase Weeks16-32|Adverse Event|0
895112|NCT01194219|2949557|P5|Maintenance Phase Weeks16-32|Adverse Event|0
895113|NCT01194219|2949558|P4|Maintenance Phase Weeks16-32|Adverse Event|9
895114|NCT01194219|2949559|P3|Maintenance Phase Weeks16-32|Adverse Event|8
895115|NCT01194219|2949560|P2|Maintenance Phase Weeks16-32|Adverse Event|0
895116|NCT01194219|2949561|P1|Maintenance Phase Weeks16-32|Adverse Event|0
895117|NCT01194219|2949552|P10|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
895118|NCT01194219|2949553|P9|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
895119|NCT01194219|2949554|P8|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
895120|NCT01194219|2949555|P7|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
895121|NCT01194219|2949556|P6|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
895122|NCT01194219|2949557|P5|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
895123|NCT01194219|2949558|P4|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
895124|NCT01194219|2949559|P3|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
895125|NCT01194219|2949560|P2|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
895126|NCT01194219|2949561|P1|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
895127|NCT01194219|2949552|P10|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
895128|NCT01194219|2949553|P9|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
895129|NCT01194219|2949554|P8|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
895130|NCT01194219|2949555|P7|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
895131|NCT01194219|2949556|P6|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
895132|NCT01194219|2949557|P5|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
895133|NCT01194219|2949558|P4|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
895134|NCT01194219|2949559|P3|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
895135|NCT01194219|2949560|P2|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1
895136|NCT01194219|2949561|P1|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7
895137|NCT01194219|2949552|P10|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
895138|NCT01194219|2949553|P9|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
895139|NCT01194219|2949554|P8|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
895140|NCT01194219|2949555|P7|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
895141|NCT01194219|2949556|P6|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
895142|NCT01194219|2949557|P5|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
895143|NCT01194219|2949558|P4|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
895144|NCT01194219|2949559|P3|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
895145|NCT01194219|2949560|P2|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9
895146|NCT01194219|2949561|P1|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7
895147|NCT01194219|2949552|P10|Placebo-Controlled Phase Weeks 0-16|Death|0
895148|NCT01194219|2949553|P9|Placebo-Controlled Phase Weeks 0-16|Death|0
895149|NCT01194219|2949554|P8|Placebo-Controlled Phase Weeks 0-16|Death|0
895150|NCT01194219|2949555|P7|Placebo-Controlled Phase Weeks 0-16|Death|0
895151|NCT01194219|2949556|P6|Placebo-Controlled Phase Weeks 0-16|Death|0
895152|NCT01194219|2949557|P5|Placebo-Controlled Phase Weeks 0-16|Death|0
895153|NCT01194219|2949558|P4|Placebo-Controlled Phase Weeks 0-16|Death|0
895154|NCT01194219|2949559|P3|Placebo-Controlled Phase Weeks 0-16|Death|0
895155|NCT01194219|2949560|P2|Placebo-Controlled Phase Weeks 0-16|Death|1
895156|NCT01194219|2949561|P1|Placebo-Controlled Phase Weeks 0-16|Death|0
895157|NCT01194219|2949552|P10|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
895158|NCT01194219|2949553|P9|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
895159|NCT01194219|2949554|P8|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
895160|NCT01194219|2949555|P7|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
895161|NCT01194219|2949556|P6|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
895162|NCT01194219|2949557|P5|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
895163|NCT01194219|2949558|P4|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
895164|NCT01194219|2949559|P3|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
895165|NCT01194219|2949560|P2|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9
895166|NCT01194219|2949561|P1|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12
895167|NCT01194219|2949552|P10|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
895168|NCT01194219|2949553|P9|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
895169|NCT01194219|2949554|P8|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
895170|NCT01194219|2949555|P7|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
895171|NCT01194219|2949556|P6|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
895172|NCT01194219|2949557|P5|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
895173|NCT01194219|2949558|P4|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
895174|NCT01194219|2949559|P3|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
895175|NCT01194219|2949560|P2|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
895176|NCT01194219|2949561|P1|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7
895177|NCT01194219|2949552|P10|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
895178|NCT01194219|2949553|P9|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
895179|NCT01194219|2949554|P8|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
895180|NCT01194219|2949555|P7|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
895181|NCT01194219|2949556|P6|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
895182|NCT01194219|2949557|P5|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
895183|NCT01194219|2949558|P4|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
895184|NCT01194219|2949559|P3|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
895185|NCT01194219|2949560|P2|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7
895186|NCT01194219|2949561|P1|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2
895187|NCT01194219|2949552|P10|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
895188|NCT01194219|2949553|P9|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
895189|NCT01194219|2949554|P8|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
895190|NCT01194219|2949555|P7|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
895191|NCT01194219|2949556|P6|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
895192|NCT01194219|2949557|P5|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
895193|NCT01194219|2949558|P4|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
895194|NCT01194219|2949559|P3|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
895195|NCT01194219|2949560|P2|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5
895196|NCT01194219|2949561|P1|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23
895197|NCT01194154|2949595|P2|Overall Study|Did not receive study medication|4
895198|NCT01194154|2949596|P1|Overall Study|Did not receive study medication|2
895199|NCT01194154|2949595|P2|Overall Study|Other|0
895200|NCT01194154|2949596|P1|Overall Study|Other|4
895201|NCT01194154|2949595|P2|Overall Study|Treatment with prohibited medication|5
895202|NCT01194154|2949596|P1|Overall Study|Treatment with prohibited medication|4
895203|NCT01194154|2949595|P2|Overall Study|Skipping of CERA treatment at two visits|0
895204|NCT01194154|2949596|P1|Overall Study|Skipping of CERA treatment at two visits|3
895205|NCT01194154|2949595|P2|Overall Study|Hemoglobin increase|3
895206|NCT01194154|2949596|P1|Overall Study|Hemoglobin increase|12
895207|NCT01194154|2949595|P2|Overall Study|Hemoglobin decrease|1
895208|NCT01194154|2949596|P1|Overall Study|Hemoglobin decrease|0
895209|NCT01194154|2949595|P2|Overall Study|Blood pressure increase|3
895210|NCT01194154|2949596|P1|Overall Study|Blood pressure increase|5
895211|NCT01194154|2949595|P2|Overall Study|Withdrawal by Subject|6
895212|NCT01194154|2949596|P1|Overall Study|Withdrawal by Subject|5
895213|NCT01194154|2949595|P2|Overall Study|Protocol Violation|1
895214|NCT01194154|2949596|P1|Overall Study|Protocol Violation|0
895215|NCT01194154|2949595|P2|Overall Study|Lost to Follow-up|3
895216|NCT01194154|2949596|P1|Overall Study|Lost to Follow-up|2
895217|NCT01194154|2949595|P2|Overall Study|Adverse Event|7
895218|NCT01194154|2949596|P1|Overall Study|Adverse Event|12
895219|NCT01193920|2949637|P10|Overall Study|Unable to classify|0
895220|NCT01193920|2949638|P9|Overall Study|Unable to classify|0
895221|NCT01193920|2949639|P8|Overall Study|Unable to classify|1
895222|NCT01193920|2949640|P7|Overall Study|Unable to classify|0
895223|NCT01193920|2949641|P6|Overall Study|Unable to classify|0
895224|NCT01193920|2949642|P5|Overall Study|Unable to classify|0
895225|NCT01193920|2949643|P4|Overall Study|Unable to classify|1
895226|NCT01193920|2949644|P3|Overall Study|Unable to classify|0
895227|NCT01193920|2949645|P2|Overall Study|Unable to classify|0
895228|NCT01193920|2949646|P1|Overall Study|Unable to classify|0
895229|NCT01193920|2949637|P10|Overall Study|Death|4
895230|NCT01193920|2949638|P9|Overall Study|Death|2
895231|NCT01193920|2949639|P8|Overall Study|Death|3
895232|NCT01193920|2949640|P7|Overall Study|Death|2
895233|NCT01193920|2949641|P6|Overall Study|Death|0
895234|NCT01193920|2949642|P5|Overall Study|Death|0
895235|NCT01193920|2949643|P4|Overall Study|Death|1
895236|NCT01193920|2949644|P3|Overall Study|Death|0
895237|NCT01193920|2949645|P2|Overall Study|Death|0
895238|NCT01193920|2949646|P1|Overall Study|Death|0
895239|NCT01193920|2949637|P10|Overall Study|Protocol Violation|0
895240|NCT01193920|2949638|P9|Overall Study|Protocol Violation|0
895241|NCT01193920|2949639|P8|Overall Study|Protocol Violation|0
895242|NCT01193920|2949640|P7|Overall Study|Protocol Violation|0
895243|NCT01193920|2949641|P6|Overall Study|Protocol Violation|0
895244|NCT01193920|2949642|P5|Overall Study|Protocol Violation|0
895245|NCT01193920|2949643|P4|Overall Study|Protocol Violation|0
895246|NCT01193920|2949644|P3|Overall Study|Protocol Violation|0
895247|NCT01193920|2949645|P2|Overall Study|Protocol Violation|0
895248|NCT01193920|2949646|P1|Overall Study|Protocol Violation|1
895249|NCT01193920|2949637|P10|Overall Study|Lost to Follow-up|3
895250|NCT01193920|2949638|P9|Overall Study|Lost to Follow-up|2
895251|NCT01193920|2949639|P8|Overall Study|Lost to Follow-up|0
895252|NCT01193920|2949640|P7|Overall Study|Lost to Follow-up|1
895253|NCT01193920|2949641|P6|Overall Study|Lost to Follow-up|3
895254|NCT01193920|2949642|P5|Overall Study|Lost to Follow-up|3
895255|NCT01193920|2949643|P4|Overall Study|Lost to Follow-up|1
895256|NCT01193920|2949644|P3|Overall Study|Lost to Follow-up|1
895257|NCT01193920|2949645|P2|Overall Study|Lost to Follow-up|0
895258|NCT01193920|2949646|P1|Overall Study|Lost to Follow-up|1
895259|NCT01193920|2949637|P10|Overall Study|Withdrawal by Subject|0
895260|NCT01193920|2949638|P9|Overall Study|Withdrawal by Subject|1
895261|NCT01193920|2949639|P8|Overall Study|Withdrawal by Subject|0
895262|NCT01193920|2949640|P7|Overall Study|Withdrawal by Subject|3
895263|NCT01193920|2949641|P6|Overall Study|Withdrawal by Subject|1
895264|NCT01193920|2949642|P5|Overall Study|Withdrawal by Subject|3
895265|NCT01193920|2949643|P4|Overall Study|Withdrawal by Subject|1
895266|NCT01193920|2949644|P3|Overall Study|Withdrawal by Subject|5
895267|NCT01193920|2949645|P2|Overall Study|Withdrawal by Subject|0
895268|NCT01193920|2949646|P1|Overall Study|Withdrawal by Subject|1
895269|NCT01193842|2949742|P5|Phase II: Randomized Groups|Disease progression/relapse on treatment|3
895270|NCT01193842|2949743|P4|Phase II: Randomized Groups|Disease progression/relapse on treatment|5
895271|NCT01193842|2949744|P3|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
895272|NCT01193842|2949745|P2|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
895273|NCT01193842|2949746|P1|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
895274|NCT01193842|2949742|P5|Phase II: Randomized Groups|Ineligible|1
895275|NCT01193842|2949743|P4|Phase II: Randomized Groups|Ineligible|0
895276|NCT01193842|2949744|P3|Phase II: Randomized Groups|Ineligible|0
895277|NCT01193842|2949745|P2|Phase II: Randomized Groups|Ineligible|0
895278|NCT01193842|2949746|P1|Phase II: Randomized Groups|Ineligible|0
895279|NCT01193842|2949742|P5|Phase II: Randomized Groups|Withdrawal by Subject|2
895280|NCT01193842|2949743|P4|Phase II: Randomized Groups|Withdrawal by Subject|1
895281|NCT01193842|2949744|P3|Phase II: Randomized Groups|Withdrawal by Subject|0
895282|NCT01193842|2949745|P2|Phase II: Randomized Groups|Withdrawal by Subject|0
895283|NCT01193842|2949746|P1|Phase II: Randomized Groups|Withdrawal by Subject|0
895284|NCT01193842|2949742|P5|Phase II: Randomized Groups|Adverse Event|3
895285|NCT01193842|2949743|P4|Phase II: Randomized Groups|Adverse Event|5
895286|NCT01193842|2949744|P3|Phase II: Randomized Groups|Adverse Event|0
895287|NCT01193842|2949745|P2|Phase II: Randomized Groups|Adverse Event|0
895288|NCT01193842|2949746|P1|Phase II: Randomized Groups|Adverse Event|0
895289|NCT01193842|2949742|P5|Phase II: Randomized Groups|Death|1
895290|NCT01193842|2949743|P4|Phase II: Randomized Groups|Death|1
895291|NCT01193842|2949744|P3|Phase II: Randomized Groups|Death|0
895292|NCT01193842|2949745|P2|Phase II: Randomized Groups|Death|0
895293|NCT01193842|2949746|P1|Phase II: Randomized Groups|Death|0
895294|NCT01193842|2949742|P5|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
895295|NCT01193842|2949743|P4|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
895296|NCT01193842|2949744|P3|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1
895297|NCT01193842|2949745|P2|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
895298|NCT01193842|2949746|P1|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
895299|NCT01193842|2949742|P5|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
895300|NCT01193842|2949743|P4|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
895301|NCT01193842|2949744|P3|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
895302|NCT01193842|2949745|P2|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
895303|NCT01193842|2949746|P1|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1
895304|NCT01193842|2949742|P5|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
895305|NCT01193842|2949743|P4|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
895306|NCT01193842|2949744|P3|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
895307|NCT01193842|2949745|P2|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1
895308|NCT01193842|2949746|P1|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
895309|NCT01193686|2949781|P2|Overall Study|Removed by Investigators; unable to matc|0
895310|NCT01193686|2949782|P1|Overall Study|Removed by Investigators; unable to matc|3
895311|NCT01193686|2949781|P2|Overall Study|Withdrawal by Subject|1
895312|NCT01193686|2949782|P1|Overall Study|Withdrawal by Subject|4
895313|NCT01193660|2949799|P3|Overall Study|Physician Decision|1
895314|NCT01193660|2949800|P2|Overall Study|Physician Decision|0
895315|NCT01193660|2949801|P1|Overall Study|Physician Decision|1
895316|NCT01193660|2949799|P3|Overall Study|Death|0
895317|NCT01193660|2949800|P2|Overall Study|Death|0
895318|NCT01193660|2949801|P1|Overall Study|Death|1
895319|NCT01193660|2949799|P3|Overall Study|Withdrawal by Subject|1
895320|NCT01193660|2949800|P2|Overall Study|Withdrawal by Subject|3
895321|NCT01193660|2949801|P1|Overall Study|Withdrawal by Subject|2
895322|NCT01193608|2949845|P6|Overall Study|Adverse Event|0
895323|NCT01193608|2949846|P5|Overall Study|Adverse Event|1
895324|NCT01193608|2949847|P4|Overall Study|Adverse Event|0
895325|NCT01193608|2949848|P3|Overall Study|Adverse Event|0
895326|NCT01193608|2949849|P2|Overall Study|Adverse Event|0
895327|NCT01193608|2949850|P1|Overall Study|Adverse Event|0
895328|NCT01193608|2949845|P6|Overall Study|Lost to Follow-up|2
895329|NCT01193608|2949846|P5|Overall Study|Lost to Follow-up|1
895330|NCT01193608|2949847|P4|Overall Study|Lost to Follow-up|0
895331|NCT01193608|2949848|P3|Overall Study|Lost to Follow-up|0
895332|NCT01193608|2949849|P2|Overall Study|Lost to Follow-up|0
895333|NCT01193608|2949850|P1|Overall Study|Lost to Follow-up|0
895334|NCT01193608|2949845|P6|Overall Study|Withdrawal by Subject|0
895335|NCT01193608|2949846|P5|Overall Study|Withdrawal by Subject|3
895336|NCT01193608|2949847|P4|Overall Study|Withdrawal by Subject|3
895337|NCT01193608|2949848|P3|Overall Study|Withdrawal by Subject|2
895338|NCT01193608|2949849|P2|Overall Study|Withdrawal by Subject|1
895339|NCT01193608|2949850|P1|Overall Study|Withdrawal by Subject|0
895340|NCT01193608|2949845|P6|Overall Study|Other|0
895341|NCT01193608|2949846|P5|Overall Study|Other|0
895342|NCT01193608|2949847|P4|Overall Study|Other|0
895343|NCT01193608|2949848|P3|Overall Study|Other|0
895344|NCT01193608|2949849|P2|Overall Study|Other|1
895345|NCT01193608|2949850|P1|Overall Study|Other|0
895346|NCT01193582|2950087|P4|12 Month Follow-up|Withdrawal by Subject|11
895347|NCT01193582|2950088|P3|12 Month Follow-up|Withdrawal by Subject|3
895348|NCT01193582|2950089|P2|12 Month Follow-up|Withdrawal by Subject|0
895349|NCT01193582|2950090|P1|12 Month Follow-up|Withdrawal by Subject|6
895350|NCT01193582|2950087|P4|12 Month Follow-up|Death|0
895351|NCT01193582|2950088|P3|12 Month Follow-up|Death|1
895352|NCT01193582|2950089|P2|12 Month Follow-up|Death|0
895353|NCT01193582|2950090|P1|12 Month Follow-up|Death|0
895354|NCT01193582|2950087|P4|Vaccination Series|Withdrawal by Subject|3
895355|NCT01193582|2950088|P3|Vaccination Series|Withdrawal by Subject|8
895356|NCT01193582|2950089|P2|Vaccination Series|Withdrawal by Subject|13
895357|NCT01193582|2950090|P1|Vaccination Series|Withdrawal by Subject|11
895358|NCT01193556|2950120|P2|Overall Study|Study termination|25
895359|NCT01193556|2950121|P1|Overall Study|Study termination|26
895360|NCT01193348|2950129|P1|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2
895361|NCT01193348|2950129|P1|Extension Treatment Period|Physician Decision|1
895362|NCT01193348|2950129|P1|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1
895363|NCT01193348|2950129|P1|Treatment Period (26 Weeks)|Serious Adverse Event|1
895364|NCT01193348|2950129|P1|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1
895365|NCT01193348|2950129|P1|Screening Period|Screen Failure|5
895366|NCT01193335|2950149|P2|2-Year Follow-up|No Longer Met Eligibility Criteria|2
895367|NCT01193335|2950150|P1|2-Year Follow-up|No Longer Met Eligibility Criteria|2
895368|NCT01193335|2950149|P2|2-Year Follow-up|No Longer Willing to Participate|6
895369|NCT01193335|2950150|P1|2-Year Follow-up|No Longer Willing to Participate|5
895370|NCT01193335|2950149|P2|1-Year Follow-up|Lost to Follow-up|0
895371|NCT01193335|2950150|P1|1-Year Follow-up|Lost to Follow-up|4
895372|NCT01193335|2950149|P2|1-Year Follow-up|No Longer Willing to Participate|9
895373|NCT01193335|2950150|P1|1-Year Follow-up|No Longer Willing to Participate|7
895374|NCT01193335|2950149|P2|After Infant Series|No Longer Met Eligibility Criteria|1
895375|NCT01193335|2950150|P1|After Infant Series|No Longer Met Eligibility Criteria|0
895376|NCT01193335|2950149|P2|After Infant Series|Lost to Follow-up|2
895377|NCT01193335|2950150|P1|After Infant Series|Lost to Follow-up|1
895378|NCT01193283|2950245|P1|Overall Study|Death|1
895379|NCT01193244|2950251|P2|Overall Study|Lost to Follow-up|15
895380|NCT01193244|2950252|P1|Overall Study|Lost to Follow-up|6
895381|NCT01193244|2950251|P2|Overall Study|Other|278
895382|NCT01193244|2950252|P1|Overall Study|Other|303
895383|NCT01193244|2950251|P2|Overall Study|Withdrawal by Subject|97
895384|NCT01193244|2950252|P1|Overall Study|Withdrawal by Subject|79
895385|NCT01193218|2950307|P8|12-52 Weeks|Other reason than above|0
895386|NCT01193218|2950308|P7|12-52 Weeks|Other reason than above|0
895387|NCT01193218|2950309|P6|12-52 Weeks|Other reason than above|0
895388|NCT01193218|2950310|P5|12-52 Weeks|Other reason than above|1
895389|NCT01193218|2950311|P4|12-52 Weeks|Other reason than above|1
895390|NCT01193218|2950312|P3|12-52 Weeks|Other reason than above|0
895391|NCT01193218|2950313|P2|12-52 Weeks|Other reason than above|0
895392|NCT01193218|2950314|P1|12-52 Weeks|Other reason than above|1
895393|NCT01193218|2950307|P8|12-52 Weeks|Withdrawal by Subject|2
895394|NCT01193218|2950308|P7|12-52 Weeks|Withdrawal by Subject|1
895395|NCT01193218|2950309|P6|12-52 Weeks|Withdrawal by Subject|2
895396|NCT01193218|2950310|P5|12-52 Weeks|Withdrawal by Subject|0
895397|NCT01193218|2950311|P4|12-52 Weeks|Withdrawal by Subject|0
895398|NCT01193218|2950312|P3|12-52 Weeks|Withdrawal by Subject|3
895399|NCT01193218|2950313|P2|12-52 Weeks|Withdrawal by Subject|0
895400|NCT01193218|2950314|P1|12-52 Weeks|Withdrawal by Subject|3
895401|NCT01193218|2950307|P8|12-52 Weeks|Lack of Efficacy|0
895402|NCT01193218|2950308|P7|12-52 Weeks|Lack of Efficacy|1
895403|NCT01193218|2950309|P6|12-52 Weeks|Lack of Efficacy|0
895404|NCT01193218|2950310|P5|12-52 Weeks|Lack of Efficacy|0
895405|NCT01193218|2950311|P4|12-52 Weeks|Lack of Efficacy|0
895406|NCT01193218|2950312|P3|12-52 Weeks|Lack of Efficacy|0
895407|NCT01193218|2950313|P2|12-52 Weeks|Lack of Efficacy|0
895408|NCT01193218|2950314|P1|12-52 Weeks|Lack of Efficacy|0
895409|NCT01193218|2950307|P8|12-52 Weeks|Adverse Event|2
895410|NCT01193218|2950308|P7|12-52 Weeks|Adverse Event|1
895411|NCT01193218|2950309|P6|12-52 Weeks|Adverse Event|3
895412|NCT01193218|2950310|P5|12-52 Weeks|Adverse Event|3
895413|NCT01193218|2950311|P4|12-52 Weeks|Adverse Event|2
895414|NCT01193218|2950312|P3|12-52 Weeks|Adverse Event|1
895415|NCT01193218|2950313|P2|12-52 Weeks|Adverse Event|0
895416|NCT01193218|2950314|P1|12-52 Weeks|Adverse Event|1
895417|NCT01193218|2950307|P8|0-12 Weeks|Withdrawal by Subject|0
895418|NCT01193218|2950308|P7|0-12 Weeks|Withdrawal by Subject|1
895419|NCT01193218|2950309|P6|0-12 Weeks|Withdrawal by Subject|0
895420|NCT01193218|2950310|P5|0-12 Weeks|Withdrawal by Subject|0
895421|NCT01193218|2950311|P4|0-12 Weeks|Withdrawal by Subject|0
895422|NCT01193218|2950312|P3|0-12 Weeks|Withdrawal by Subject|2
895423|NCT01193218|2950313|P2|0-12 Weeks|Withdrawal by Subject|0
895424|NCT01193218|2950314|P1|0-12 Weeks|Withdrawal by Subject|3
895425|NCT01193218|2950307|P8|0-12 Weeks|Protocol Violation|0
895426|NCT01193218|2950308|P7|0-12 Weeks|Protocol Violation|0
895427|NCT01193218|2950309|P6|0-12 Weeks|Protocol Violation|1
895428|NCT01193218|2950310|P5|0-12 Weeks|Protocol Violation|1
895429|NCT01193218|2950311|P4|0-12 Weeks|Protocol Violation|0
895430|NCT01193218|2950312|P3|0-12 Weeks|Protocol Violation|0
895431|NCT01193218|2950313|P2|0-12 Weeks|Protocol Violation|0
895432|NCT01193218|2950314|P1|0-12 Weeks|Protocol Violation|0
895433|NCT01193218|2950307|P8|0-12 Weeks|Adverse Event|0
895434|NCT01193218|2950308|P7|0-12 Weeks|Adverse Event|2
895435|NCT01193218|2950309|P6|0-12 Weeks|Adverse Event|2
895436|NCT01193218|2950310|P5|0-12 Weeks|Adverse Event|0
895437|NCT01193218|2950311|P4|0-12 Weeks|Adverse Event|0
895438|NCT01193218|2950312|P3|0-12 Weeks|Adverse Event|1
895439|NCT01193218|2950313|P2|0-12 Weeks|Adverse Event|0
895440|NCT01193218|2950314|P1|0-12 Weeks|Adverse Event|6
895441|NCT01193153|2950345|P2|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3
895442|NCT01193153|2950346|P1|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1
895443|NCT01193153|2950345|P2|Double Blind Relapse Prevention Period|Experienced Relapse|57
895444|NCT01193153|2950346|P1|Double Blind Relapse Prevention Period|Experienced Relapse|25
895445|NCT01193153|2950345|P2|Double Blind Relapse Prevention Period|Withdrawal by Subject|30
895446|NCT01193153|2950346|P1|Double Blind Relapse Prevention Period|Withdrawal by Subject|19
895447|NCT01193153|2950345|P2|Double Blind Relapse Prevention Period|Pregnancy|0
895448|NCT01193153|2950346|P1|Double Blind Relapse Prevention Period|Pregnancy|1
895449|NCT01193153|2950345|P2|Double Blind Relapse Prevention Period|Lost to Follow-up|9
895450|NCT01193153|2950346|P1|Double Blind Relapse Prevention Period|Lost to Follow-up|2
895451|NCT01193153|2950345|P2|Double Blind Relapse Prevention Period|Death|0
895452|NCT01193153|2950346|P1|Double Blind Relapse Prevention Period|Death|2
895453|NCT01193153|2950345|P2|Double Blind Relapse Prevention Period|Adverse Event|3
895454|NCT01193153|2950346|P1|Double Blind Relapse Prevention Period|Adverse Event|12
895455|NCT01193153|2950345|P2|Double Blind Relapse Prevention Period|Other|3
895456|NCT01193153|2950346|P1|Double Blind Relapse Prevention Period|Other|2
895457|NCT01193153|2950345|P2|Open-label Stabilization Period|Other|0
895458|NCT01193153|2950346|P1|Open-label Stabilization Period|Other|8
895459|NCT01193153|2950345|P2|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0
895460|NCT01193153|2950346|P1|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35
895461|NCT01193153|2950345|P2|Open-label Stabilization Period|Withdrawal by Subject|0
895462|NCT01193153|2950346|P1|Open-label Stabilization Period|Withdrawal by Subject|29
895463|NCT01193153|2950345|P2|Open-label Stabilization Period|Lack of Efficacy|0
895464|NCT01193153|2950346|P1|Open-label Stabilization Period|Lack of Efficacy|5
895465|NCT01193153|2950345|P2|Open-label Stabilization Period|Lost to Follow-up|0
895466|NCT01193153|2950346|P1|Open-label Stabilization Period|Lost to Follow-up|10
895467|NCT01193153|2950345|P2|Open-label Stabilization Period|Death|0
895468|NCT01193153|2950346|P1|Open-label Stabilization Period|Death|2
895469|NCT01193153|2950345|P2|Open-label Stabilization Period|Adverse Event|0
895470|NCT01193153|2950346|P1|Open-label Stabilization Period|Adverse Event|9
895471|NCT01193153|2950345|P2|Open-label Lead in Period|Lack of Efficacy|0
895472|NCT01193153|2950346|P1|Open-label Lead in Period|Lack of Efficacy|26
895473|NCT01193153|2950345|P2|Open-label Lead in Period|Death|0
895474|NCT01193153|2950346|P1|Open-label Lead in Period|Death|1
895475|NCT01193153|2950345|P2|Open-label Lead in Period|Adverse Event|0
895476|NCT01193153|2950346|P1|Open-label Lead in Period|Adverse Event|41
895477|NCT01193153|2950345|P2|Open-label Lead in Period|Subject Failed Stabilization Criteria|0
895478|NCT01193153|2950346|P1|Open-label Lead in Period|Subject Failed Stabilization Criteria|47
895479|NCT01193153|2950345|P2|Open-label Lead in Period|Other|0
895480|NCT01193153|2950346|P1|Open-label Lead in Period|Other|14
895481|NCT01193153|2950345|P2|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0
895482|NCT01193153|2950346|P1|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4
895483|NCT01193153|2950345|P2|Open-label Lead in Period|Withdrawal by Subject|0
895484|NCT01193153|2950346|P1|Open-label Lead in Period|Withdrawal by Subject|69
895485|NCT01193153|2950345|P2|Open-label Lead in Period|Pregnancy|0
895486|NCT01193153|2950346|P1|Open-label Lead in Period|Pregnancy|1
895487|NCT01193153|2950345|P2|Open-label Lead in Period|Lost to Follow-up|0
895488|NCT01193153|2950346|P1|Open-label Lead in Period|Lost to Follow-up|32
895489|NCT01193127|2950381|P4|Treated|Withdrawal by Subject|1
895490|NCT01193127|2950382|P3|Treated|Withdrawal by Subject|0
895491|NCT01193127|2950383|P2|Treated|Withdrawal by Subject|0
895492|NCT01193127|2950384|P1|Treated|Withdrawal by Subject|0
895493|NCT01193127|2950381|P4|Randomized|Surgery Cancelled|1
895494|NCT01193127|2950382|P3|Randomized|Surgery Cancelled|0
895495|NCT01193127|2950383|P2|Randomized|Surgery Cancelled|0
895496|NCT01193127|2950384|P1|Randomized|Surgery Cancelled|0
895497|NCT01193101|2950709|P4|Overall Study|Abnormal test procedure results|0
895498|NCT01193101|2950710|P3|Overall Study|Abnormal test procedure results|0
895499|NCT01193101|2950711|P2|Overall Study|Abnormal test procedure results|1
895500|NCT01193101|2950712|P1|Overall Study|Abnormal test procedure results|0
895501|NCT01193101|2950709|P4|Overall Study|Administrative problems|0
895502|NCT01193101|2950710|P3|Overall Study|Administrative problems|1
895503|NCT01193101|2950711|P2|Overall Study|Administrative problems|0
895504|NCT01193101|2950712|P1|Overall Study|Administrative problems|0
895505|NCT01193101|2950709|P4|Overall Study|Withdrawal by Subject|1
895506|NCT01193101|2950710|P3|Overall Study|Withdrawal by Subject|1
895507|NCT01193101|2950711|P2|Overall Study|Withdrawal by Subject|4
895508|NCT01193101|2950712|P1|Overall Study|Withdrawal by Subject|2
895509|NCT01193101|2950709|P4|Overall Study|Lack of Efficacy|8
895510|NCT01193101|2950710|P3|Overall Study|Lack of Efficacy|0
895511|NCT01193101|2950711|P2|Overall Study|Lack of Efficacy|1
895512|NCT01193101|2950712|P1|Overall Study|Lack of Efficacy|3
895513|NCT01193101|2950709|P4|Overall Study|Adverse Event|3
895514|NCT01193101|2950710|P3|Overall Study|Adverse Event|1
895515|NCT01193101|2950711|P2|Overall Study|Adverse Event|1
895516|NCT01193101|2950712|P1|Overall Study|Adverse Event|0
895517|NCT01192776|2950818|P4|Overall Study|Lost to Follow-up|5
895518|NCT01192776|2950819|P3|Overall Study|Lost to Follow-up|3
895519|NCT01192776|2950820|P2|Overall Study|Lost to Follow-up|6
895520|NCT01192776|2950821|P1|Overall Study|Lost to Follow-up|3
895521|NCT01192776|2950818|P4|Overall Study|Death|15
895522|NCT01192776|2950819|P3|Overall Study|Death|18
895523|NCT01192776|2950820|P2|Overall Study|Death|15
895524|NCT01192776|2950821|P1|Overall Study|Death|8
895525|NCT01192516|2950895|P3|Overall Study|Unable to follow Actiwatch instructions|0
895526|NCT01192516|2950896|P2|Overall Study|Unable to follow Actiwatch instructions|2
895527|NCT01192516|2950897|P1|Overall Study|Unable to follow Actiwatch instructions|4
895528|NCT01192516|2950895|P3|Overall Study|started new treatment|0
895529|NCT01192516|2950896|P2|Overall Study|started new treatment|1
895530|NCT01192516|2950897|P1|Overall Study|started new treatment|5
895531|NCT01192516|2950895|P3|Overall Study|Withdrawal by Subject|1
895532|NCT01192516|2950896|P2|Overall Study|Withdrawal by Subject|4
895533|NCT01192516|2950897|P1|Overall Study|Withdrawal by Subject|4
895534|NCT01192516|2950895|P3|Overall Study|Lost to Follow-up|7
895535|NCT01192516|2950896|P2|Overall Study|Lost to Follow-up|10
895536|NCT01192516|2950897|P1|Overall Study|Lost to Follow-up|7
895537|NCT01192412|2950931|P2|Overall Study|Withdrawal by Subject|1
895538|NCT01192412|2950932|P1|Overall Study|Withdrawal by Subject|2
895539|NCT01192412|2950931|P2|Overall Study|Lost to Follow-up|1
895540|NCT01192412|2950932|P1|Overall Study|Lost to Follow-up|2
895541|NCT01192399|2950940|P1|Overall Study|Lack of Efficacy|2
895542|NCT01192347|2950950|P1|Overall Study|Patient did not show up for visits|1
895543|NCT01192347|2950950|P1|Overall Study|Patient not visiting hospital regularly|1
895544|NCT01192347|2950950|P1|Overall Study|Patient seen in different hospital|1
895545|NCT01192347|2950950|P1|Overall Study|Suspected serious adverse drug reaction|1
895546|NCT01192347|2950950|P1|Overall Study|Adverse Event|1
895547|NCT01192347|2950950|P1|Overall Study|Withdrawal by Subject|1
895548|NCT01192347|2950950|P1|Overall Study|Lost to Follow-up|3
895549|NCT01192347|2950950|P1|Overall Study|Death|3
895550|NCT01192295|2950973|P2|Overall Study|Administrative|6
895551|NCT01192295|2950974|P1|Overall Study|Administrative|4
895552|NCT01192295|2950973|P2|Overall Study|Lack of Efficacy|5
895553|NCT01192295|2950974|P1|Overall Study|Lack of Efficacy|0
895554|NCT01192295|2950973|P2|Overall Study|Lost to Follow-up|1
895555|NCT01192295|2950974|P1|Overall Study|Lost to Follow-up|0
895556|NCT01192295|2950973|P2|Overall Study|Withdrawal by Subject|4
895557|NCT01192295|2950974|P1|Overall Study|Withdrawal by Subject|3
895558|NCT01192295|2950973|P2|Overall Study|Adverse Event|7
895559|NCT01192295|2950974|P1|Overall Study|Adverse Event|3
895560|NCT01192204|2951008|P2|Overall Study|could not keep recall appointments|0
895561|NCT01192204|2951009|P1|Overall Study|could not keep recall appointments|1
895562|NCT01192191|2951021|P2|Overall Study|Withdrawal by Subject|6
895563|NCT01192191|2951022|P1|Overall Study|Withdrawal by Subject|1
895564|NCT01192191|2951021|P2|Overall Study|Lost to Follow-up|1
895565|NCT01192191|2951022|P1|Overall Study|Lost to Follow-up|0
895566|NCT01192191|2951021|P2|Overall Study|Participants Reached Stopping Criteria|2
895567|NCT01192191|2951022|P1|Overall Study|Participants Reached Stopping Criteria|3
895568|NCT01192191|2951021|P2|Overall Study|Adverse Event|12
895569|NCT01192191|2951022|P1|Overall Study|Adverse Event|7
895570|NCT01192178|2951048|P2|Overall Study|Lack of Efficacy|2
895571|NCT01192178|2951049|P1|Overall Study|Lack of Efficacy|1
895572|NCT01192178|2951048|P2|Overall Study|Adverse Event|1
895573|NCT01192178|2951049|P1|Overall Study|Adverse Event|2
895574|NCT01192178|2951048|P2|Overall Study|Lost to Follow-up|3
895575|NCT01192178|2951049|P1|Overall Study|Lost to Follow-up|3
895576|NCT01192178|2951048|P2|Overall Study|Physician Decision|4
895577|NCT01192178|2951049|P1|Overall Study|Physician Decision|2
895578|NCT01192178|2951048|P2|Overall Study|Protocol Violation|3
895579|NCT01192178|2951049|P1|Overall Study|Protocol Violation|10
895580|NCT01192178|2951048|P2|Overall Study|Withdrawal by Subject|10
895581|NCT01192178|2951049|P1|Overall Study|Withdrawal by Subject|6
895582|NCT01192152|2951069|P2|Period 3|family emergency|0
895583|NCT01192152|2951070|P1|Period 3|family emergency|1
895584|NCT01192152|2951069|P2|Period 1|left prematurely (while on treatment B)|1
895585|NCT01192152|2951070|P1|Period 1|left prematurely (while on treatment B)|0
895586|NCT01192126|2951241|P2|First Intervention (1 Week)|Lost to Follow-up|1
895587|NCT01192126|2951242|P1|First Intervention (1 Week)|Lost to Follow-up|1
895588|NCT01192126|2951241|P2|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0
895589|NCT01192126|2951242|P1|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1
895590|NCT01192022|2951254|P5|Overall Study|Parents did not allow all follow up|0
895591|NCT01192022|2951255|P4|Overall Study|Parents did not allow all follow up|1
895592|NCT01192022|2951256|P3|Overall Study|Parents did not allow all follow up|0
895593|NCT01192022|2951257|P2|Overall Study|Parents did not allow all follow up|0
895594|NCT01192022|2951258|P1|Overall Study|Parents did not allow all follow up|0
895595|NCT01192022|2951254|P5|Overall Study|Patient needed surgery|0
895596|NCT01192022|2951255|P4|Overall Study|Patient needed surgery|0
895597|NCT01192022|2951256|P3|Overall Study|Patient needed surgery|0
895598|NCT01192022|2951257|P2|Overall Study|Patient needed surgery|1
895599|NCT01192022|2951258|P1|Overall Study|Patient needed surgery|0
895600|NCT01192022|2951254|P5|Overall Study|Patient too sick from chemotherapy|0
895601|NCT01192022|2951255|P4|Overall Study|Patient too sick from chemotherapy|0
895602|NCT01192022|2951256|P3|Overall Study|Patient too sick from chemotherapy|0
895603|NCT01192022|2951257|P2|Overall Study|Patient too sick from chemotherapy|1
895604|NCT01192022|2951258|P1|Overall Study|Patient too sick from chemotherapy|0
895694|NCT01191268|2951546|P2|Overall Study|Withdrawal by Subject|25
895605|NCT01192022|2951254|P5|Overall Study|Physician withdrew-patient hardship|0
895606|NCT01192022|2951255|P4|Overall Study|Physician withdrew-patient hardship|0
895607|NCT01192022|2951256|P3|Overall Study|Physician withdrew-patient hardship|0
895608|NCT01192022|2951257|P2|Overall Study|Physician withdrew-patient hardship|0
895609|NCT01192022|2951258|P1|Overall Study|Physician withdrew-patient hardship|1
895610|NCT01192022|2951254|P5|Overall Study|Fatal Adverse Event|1
895611|NCT01192022|2951255|P4|Overall Study|Fatal Adverse Event|0
895612|NCT01192022|2951256|P3|Overall Study|Fatal Adverse Event|0
895613|NCT01192022|2951257|P2|Overall Study|Fatal Adverse Event|6
895614|NCT01192022|2951258|P1|Overall Study|Fatal Adverse Event|4
895615|NCT01192022|2951254|P5|Overall Study|Adverse Event|0
895616|NCT01192022|2951255|P4|Overall Study|Adverse Event|0
895617|NCT01192022|2951256|P3|Overall Study|Adverse Event|0
895618|NCT01192022|2951257|P2|Overall Study|Adverse Event|0
895619|NCT01192022|2951258|P1|Overall Study|Adverse Event|1
895620|NCT01192022|2951254|P5|Overall Study|Lost to Follow-up|0
895621|NCT01192022|2951255|P4|Overall Study|Lost to Follow-up|1
895622|NCT01192022|2951256|P3|Overall Study|Lost to Follow-up|1
895623|NCT01192022|2951257|P2|Overall Study|Lost to Follow-up|2
895624|NCT01192022|2951258|P1|Overall Study|Lost to Follow-up|4
895625|NCT01192022|2951254|P5|Overall Study|Withdrawal of Consent|0
895626|NCT01192022|2951255|P4|Overall Study|Withdrawal of Consent|0
895627|NCT01192022|2951256|P3|Overall Study|Withdrawal of Consent|0
895628|NCT01192022|2951257|P2|Overall Study|Withdrawal of Consent|1
895629|NCT01192022|2951258|P1|Overall Study|Withdrawal of Consent|3
895630|NCT01191944|2951281|P2|Overall Study|Other|3
895631|NCT01191944|2951282|P1|Overall Study|Other|1
895632|NCT01191944|2951281|P2|Overall Study|Withdrawal by Subject|2
895633|NCT01191944|2951282|P1|Overall Study|Withdrawal by Subject|4
895634|NCT01191944|2951281|P2|Overall Study|Protocol Violation|2
895635|NCT01191944|2951282|P1|Overall Study|Protocol Violation|1
895636|NCT01191944|2951281|P2|Overall Study|Adverse Event|12
895637|NCT01191944|2951282|P1|Overall Study|Adverse Event|11
895638|NCT01191840|2951328|P2|Overall Study|Withdrawal by Subject|0
895639|NCT01191840|2951329|P1|Overall Study|Withdrawal by Subject|2
895640|NCT01191840|2951328|P2|Overall Study|lab error speciation - non Staph infecti|1
895641|NCT01191840|2951329|P1|Overall Study|lab error speciation - non Staph infecti|0
895642|NCT01191840|2951328|P2|Overall Study|IRB approval lapse|2
895643|NCT01191840|2951329|P1|Overall Study|IRB approval lapse|0
895644|NCT01191840|2951328|P2|Overall Study|ineligible at enrollment|0
895645|NCT01191840|2951329|P1|Overall Study|ineligible at enrollment|1
895646|NCT01191840|2951328|P2|Overall Study|Non Staph Infection|3
895647|NCT01191840|2951329|P1|Overall Study|Non Staph Infection|4
895648|NCT01191840|2951328|P2|Overall Study|Lost to Follow-up|6
895649|NCT01191840|2951329|P1|Overall Study|Lost to Follow-up|4
895650|NCT01191840|2951328|P2|Overall Study|Subject discontinued treatment|2
895651|NCT01191840|2951329|P1|Overall Study|Subject discontinued treatment|1
895652|NCT01191840|2951328|P2|Overall Study|withdrew consent|1
895653|NCT01191840|2951329|P1|Overall Study|withdrew consent|2
895654|NCT01191801|2951354|P2|Overall Study|Not Provided|27
895655|NCT01191801|2951355|P1|Overall Study|Not Provided|45
895656|NCT01191801|2951354|P2|Overall Study|Withdrawal by Subject|4
895657|NCT01191801|2951355|P1|Overall Study|Withdrawal by Subject|1
895658|NCT01191801|2951354|P2|Overall Study|Physician Decision|24
895659|NCT01191801|2951355|P1|Overall Study|Physician Decision|47
895660|NCT01191801|2951354|P2|Overall Study|Protocol Violation|4
895661|NCT01191801|2951355|P1|Overall Study|Protocol Violation|2
895662|NCT01191801|2951354|P2|Overall Study|Adverse Event|8
895663|NCT01191801|2951355|P1|Overall Study|Adverse Event|9
895664|NCT01191801|2951354|P2|Overall Study|Lack of Efficacy|258
895665|NCT01191801|2951355|P1|Overall Study|Lack of Efficacy|176
895666|NCT01191801|2951354|P2|Overall Study|Death|12
895667|NCT01191801|2951355|P1|Overall Study|Death|36
895668|NCT01191788|2951375|P2|Overall Study|Lost to Follow-up|22
895669|NCT01191788|2951376|P1|Overall Study|Lost to Follow-up|21
895670|NCT01191762|2951386|P2|Overall Study|Adverse Event|0
895671|NCT01191762|2951387|P1|Overall Study|Adverse Event|1
895672|NCT01191268|2951545|P3|Overall Study|Sponsor Decision|0
895673|NCT01191268|2951546|P2|Overall Study|Sponsor Decision|2
895674|NCT01191268|2951547|P1|Overall Study|Sponsor Decision|0
895675|NCT01191268|2951545|P3|Overall Study|Protocol Violation|1
895676|NCT01191268|2951546|P2|Overall Study|Protocol Violation|0
895677|NCT01191268|2951547|P1|Overall Study|Protocol Violation|1
895678|NCT01191268|2951545|P3|Overall Study|Death|3
895679|NCT01191268|2951546|P2|Overall Study|Death|1
895680|NCT01191268|2951547|P1|Overall Study|Death|0
895681|NCT01191268|2951545|P3|Overall Study|Entry Criteria Not Met|1
895682|NCT01191268|2951546|P2|Overall Study|Entry Criteria Not Met|1
895683|NCT01191268|2951547|P1|Overall Study|Entry Criteria Not Met|3
895684|NCT01191268|2951545|P3|Overall Study|Lost to Follow-up|9
895685|NCT01191268|2951546|P2|Overall Study|Lost to Follow-up|5
895686|NCT01191268|2951547|P1|Overall Study|Lost to Follow-up|8
895687|NCT01191268|2951545|P3|Overall Study|Physician Decision|9
895688|NCT01191268|2951546|P2|Overall Study|Physician Decision|8
895689|NCT01191268|2951547|P1|Overall Study|Physician Decision|6
895690|NCT01191268|2951545|P3|Overall Study|Adverse Event|8
895691|NCT01191268|2951546|P2|Overall Study|Adverse Event|13
895692|NCT01191268|2951547|P1|Overall Study|Adverse Event|21
895693|NCT01191268|2951545|P3|Overall Study|Withdrawal by Subject|21
895695|NCT01191268|2951547|P1|Overall Study|Withdrawal by Subject|19
895696|NCT01191190|2951688|P1|Overall Study|Withdrawal by Subject|1
895697|NCT01191086|2951701|P1|Overall Study|Other|1
895698|NCT01191086|2951701|P1|Overall Study|Discontinuation criterion met|1
895699|NCT01191086|2951701|P1|Overall Study|Withdrawal by Subject|24
895700|NCT01191086|2951701|P1|Overall Study|Physician Decision|2
895701|NCT01191086|2951701|P1|Overall Study|Lost to Follow-up|4
895702|NCT01191086|2951701|P1|Overall Study|Lack of Efficacy|10
895703|NCT01191086|2951701|P1|Overall Study|Adverse Event|20
895704|NCT01191008|2951705|P1|Overall Study|Lost to Follow-up|8
895705|NCT01191008|2951705|P1|Overall Study|Protocol Violation|7
895706|NCT01190891|2951713|P2|Overall Study|Withdrawal by Subject|0
895707|NCT01190891|2951714|P1|Overall Study|Withdrawal by Subject|5
895708|NCT01190891|2951713|P2|Overall Study|Protocol Violation|0
895709|NCT01190891|2951714|P1|Overall Study|Protocol Violation|1
895710|NCT01190865|2951739|P1|Overall Study|Non-compliance|2
895711|NCT01190865|2951739|P1|Overall Study|Withdrawal by Subject|1
895712|NCT01190839|2951746|P2|Overall Study|Randomized but not treated|4
895713|NCT01190839|2951747|P1|Overall Study|Randomized but not treated|2
895714|NCT01190839|2951746|P2|Overall Study|Undefined|31
895715|NCT01190839|2951747|P1|Overall Study|Undefined|35
895716|NCT01190839|2951746|P2|Overall Study|Trial stopped by Sponsor|68
895717|NCT01190839|2951747|P1|Overall Study|Trial stopped by Sponsor|71
895718|NCT01190839|2951746|P2|Overall Study|Death|0
895719|NCT01190839|2951747|P1|Overall Study|Death|1
895720|NCT01190839|2951746|P2|Overall Study|Lost to Follow-up|1
895721|NCT01190839|2951747|P1|Overall Study|Lost to Follow-up|7
895722|NCT01190839|2951746|P2|Overall Study|Protocol Violation|2
895723|NCT01190839|2951747|P1|Overall Study|Protocol Violation|2
895724|NCT01190839|2951746|P2|Overall Study|Adverse Event|41
895725|NCT01190839|2951747|P1|Overall Study|Adverse Event|32
895726|NCT01190813|2951761|P2|Overall Study|Adverse Event|1
895727|NCT01190813|2951762|P1|Overall Study|Adverse Event|0
895728|NCT01190813|2951761|P2|Overall Study|Refused study treatment after randomized|0
895729|NCT01190813|2951762|P1|Overall Study|Refused study treatment after randomized|1
895730|NCT01190813|2951761|P2|Overall Study|Withdrawal by Subject|1
895731|NCT01190813|2951762|P1|Overall Study|Withdrawal by Subject|2
895732|NCT01190813|2951761|P2|Overall Study|Lost to Follow-up|2
895733|NCT01190813|2951762|P1|Overall Study|Lost to Follow-up|1
895734|NCT01190514|2951883|P4|Third Intervention (Period 3)|Adverse Event|0
895735|NCT01190514|2951884|P3|Third Intervention (Period 3)|Adverse Event|0
895736|NCT01190514|2951885|P2|Third Intervention (Period 3)|Adverse Event|0
895737|NCT01190514|2951886|P1|Third Intervention (Period 3)|Adverse Event|1
895738|NCT01190514|2951883|P4|First Intervention (Period 1)|Adverse Event|0
895739|NCT01190514|2951884|P3|First Intervention (Period 1)|Adverse Event|0
895740|NCT01190514|2951885|P2|First Intervention (Period 1)|Adverse Event|0
895741|NCT01190514|2951886|P1|First Intervention (Period 1)|Adverse Event|1
895742|NCT01190449|2951931|P2|Overall Study|Ineligible|4
895743|NCT01190449|2951932|P1|Overall Study|Ineligible|0
895744|NCT01190436|2951940|P1|Overall Study|Other|4
895745|NCT01190436|2951940|P1|Overall Study|Lost to Follow-up|35
895746|NCT01190267|2951965|P2|Overall Study|Protocol Violation|1
895747|NCT01190267|2951966|P1|Overall Study|Protocol Violation|8
895748|NCT01190267|2951965|P2|Overall Study|Withdrawal by Subject|1
895749|NCT01190267|2951966|P1|Overall Study|Withdrawal by Subject|13
895750|NCT01190267|2951965|P2|Overall Study|Lost to Follow-up|0
895751|NCT01190267|2951966|P1|Overall Study|Lost to Follow-up|2
895752|NCT01190267|2951965|P2|Overall Study|Treatment Failure|2
895753|NCT01190267|2951966|P1|Overall Study|Treatment Failure|8
895754|NCT01190267|2951965|P2|Overall Study|Adverse Event|0
895755|NCT01190267|2951966|P1|Overall Study|Adverse Event|10
895756|NCT01190254|2951977|P3|Overall Study|Did not meet protocol eligibility|0
895757|NCT01190254|2951978|P2|Overall Study|Did not meet protocol eligibility|0
895758|NCT01190254|2951979|P1|Overall Study|Did not meet protocol eligibility|1
895759|NCT01190254|2951977|P3|Overall Study|Protocol Violation|2
895760|NCT01190254|2951978|P2|Overall Study|Protocol Violation|0
895761|NCT01190254|2951979|P1|Overall Study|Protocol Violation|2
895762|NCT01190254|2951977|P3|Overall Study|Withdrawal by Subject|7
895763|NCT01190254|2951978|P2|Overall Study|Withdrawal by Subject|5
895764|NCT01190254|2951979|P1|Overall Study|Withdrawal by Subject|4
895765|NCT01190254|2951977|P3|Overall Study|Lost to Follow-up|0
895766|NCT01190254|2951978|P2|Overall Study|Lost to Follow-up|2
895767|NCT01190254|2951979|P1|Overall Study|Lost to Follow-up|4
895768|NCT01190254|2951977|P3|Overall Study|Lack of Efficacy|5
895769|NCT01190254|2951978|P2|Overall Study|Lack of Efficacy|4
895770|NCT01190254|2951979|P1|Overall Study|Lack of Efficacy|7
895771|NCT01190254|2951977|P3|Overall Study|Adverse Event|8
895772|NCT01190254|2951978|P2|Overall Study|Adverse Event|6
895773|NCT01190254|2951979|P1|Overall Study|Adverse Event|3
895774|NCT01190228|2952044|P3|Overall Study|Withdrawal by Subject|0
895775|NCT01190228|2952045|P2|Overall Study|Withdrawal by Subject|0
895776|NCT01190228|2952046|P1|Overall Study|Withdrawal by Subject|1
895777|NCT01190228|2952044|P3|Overall Study|Protocol Violation|0
895778|NCT01190228|2952045|P2|Overall Study|Protocol Violation|0
895779|NCT01190228|2952046|P1|Overall Study|Protocol Violation|4
895780|NCT01190215|2952069|P2|Up to Month 6|Lost to Follow-up|0
895781|NCT01190215|2952070|P1|Up to Month 6|Lost to Follow-up|2
895782|NCT01190176|2952138|P1|Overall Study|Lost to Follow-up|1
895783|NCT01190176|2952138|P1|Overall Study|Withdrawal by Subject|1
895784|NCT01190150|2952159|P2|Washout|Difficulty in adherence|1
895785|NCT01190150|2952160|P1|Washout|Difficulty in adherence|0
895786|NCT01190150|2952159|P2|Washout|Withdrawal by Subject|1
895787|NCT01190150|2952160|P1|Washout|Withdrawal by Subject|0
895788|NCT01190150|2952159|P2|First Treatment|Withdrawal by Subject|0
895789|NCT01190150|2952160|P1|First Treatment|Withdrawal by Subject|1
895790|NCT01190124|2952187|P3|Overall Study|Lost to Follow-up|0
895791|NCT01190124|2952188|P2|Overall Study|Lost to Follow-up|0
895792|NCT01190124|2952189|P1|Overall Study|Lost to Follow-up|2
895793|NCT01190124|2952187|P3|Overall Study|Therapeutic Failure|1
895794|NCT01190124|2952188|P2|Overall Study|Therapeutic Failure|0
895795|NCT01190124|2952189|P1|Overall Study|Therapeutic Failure|12
895796|NCT01190124|2952187|P3|Overall Study|Death|0
895797|NCT01190124|2952188|P2|Overall Study|Death|0
895798|NCT01190124|2952189|P1|Overall Study|Death|3
895799|NCT01190098|2952227|P2|Overall Study|Other|1
895800|NCT01190098|2952228|P1|Overall Study|Other|0
895801|NCT01190098|2952227|P2|Overall Study|Lack of transportation|0
895802|NCT01190098|2952228|P1|Overall Study|Lack of transportation|1
895803|NCT01190098|2952227|P2|Overall Study|Patient coomorbidity|1
895804|NCT01190098|2952228|P1|Overall Study|Patient coomorbidity|0
895805|NCT01190098|2952227|P2|Overall Study|Adverse Event|0
895806|NCT01190098|2952228|P1|Overall Study|Adverse Event|2
895807|NCT01190007|2952267|P1|Overall Study|Participant was arrested|1
895808|NCT01190007|2952267|P1|Overall Study|Difficulty of visit for complications|1
895809|NCT01190007|2952267|P1|Overall Study|Adverse Event|8
895810|NCT01190007|2952267|P1|Overall Study|Withdrawal by Subject|4
895811|NCT01189890|2952284|P2|Overall Study|Hyperglycemia Discontinuation Criteria|5
895812|NCT01189890|2952285|P1|Overall Study|Hyperglycemia Discontinuation Criteria|5
895813|NCT01189890|2952284|P2|Overall Study|Physician Decision|4
895814|NCT01189890|2952285|P1|Overall Study|Physician Decision|5
895815|NCT01189890|2952284|P2|Overall Study|Non Compliance|1
895816|NCT01189890|2952285|P1|Overall Study|Non Compliance|0
895817|NCT01189890|2952284|P2|Overall Study|Withdrawal by Subject|11
895818|NCT01189890|2952285|P1|Overall Study|Withdrawal by Subject|15
895819|NCT01189890|2952284|P2|Overall Study|Protocol Violation|5
895820|NCT01189890|2952285|P1|Overall Study|Protocol Violation|1
895821|NCT01189890|2952284|P2|Overall Study|Lost to Follow-up|7
895822|NCT01189890|2952285|P1|Overall Study|Lost to Follow-up|1
895823|NCT01189890|2952284|P2|Overall Study|Lack of Efficacy|2
895824|NCT01189890|2952285|P1|Overall Study|Lack of Efficacy|7
895825|NCT01189890|2952284|P2|Overall Study|Adverse Event|4
895826|NCT01189890|2952285|P1|Overall Study|Adverse Event|3
895827|NCT01189812|2952307|P2|Overall Study|Moved out of State|2
895828|NCT01189812|2952308|P1|Overall Study|Moved out of State|1
895829|NCT01189812|2952307|P2|Overall Study|Out of Window|3
895830|NCT01189812|2952308|P1|Overall Study|Out of Window|4
895831|NCT01189812|2952307|P2|Overall Study|Adverse Event|0
895832|NCT01189812|2952308|P1|Overall Study|Adverse Event|1
895833|NCT01189812|2952307|P2|Overall Study|Withdrawal by Subject|3
895834|NCT01189812|2952308|P1|Overall Study|Withdrawal by Subject|2
895835|NCT01189604|2952392|P7|Overall Study|Withdrawal by Subject|0
895836|NCT01189604|2952393|P6|Overall Study|Withdrawal by Subject|0
895837|NCT01189604|2952394|P5|Overall Study|Withdrawal by Subject|0
895838|NCT01189604|2952395|P4|Overall Study|Withdrawal by Subject|0
895839|NCT01189604|2952396|P3|Overall Study|Withdrawal by Subject|0
895840|NCT01189604|2952397|P2|Overall Study|Withdrawal by Subject|0
895841|NCT01189604|2952398|P1|Overall Study|Withdrawal by Subject|1
895842|NCT01189604|2952392|P7|Overall Study|Adverse Event|1
895843|NCT01189604|2952393|P6|Overall Study|Adverse Event|0
895844|NCT01189604|2952394|P5|Overall Study|Adverse Event|2
895845|NCT01189604|2952395|P4|Overall Study|Adverse Event|0
895846|NCT01189604|2952396|P3|Overall Study|Adverse Event|0
895847|NCT01189604|2952397|P2|Overall Study|Adverse Event|1
895848|NCT01189604|2952398|P1|Overall Study|Adverse Event|0
895849|NCT01189604|2952392|P7|Overall Study|Impossible to visit|0
895850|NCT01189604|2952393|P6|Overall Study|Impossible to visit|1
895851|NCT01189604|2952394|P5|Overall Study|Impossible to visit|0
895852|NCT01189604|2952395|P4|Overall Study|Impossible to visit|0
895853|NCT01189604|2952396|P3|Overall Study|Impossible to visit|0
895854|NCT01189604|2952397|P2|Overall Study|Impossible to visit|0
895855|NCT01189604|2952398|P1|Overall Study|Impossible to visit|0
895856|NCT01189500|2952442|P1|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1
895857|NCT01189500|2952442|P1|Period 1: TAMOX Alone|Adverse Event|1
895858|NCT01189487|2952503|P1|Overall Study|Adverse Event|1
895859|NCT01189487|2952503|P1|Overall Study|Lack of Efficacy|2
895860|NCT01189461|2952511|P1|Overall Study|Other|8
895861|NCT01189461|2952511|P1|Overall Study|Did not meet entrance criteria|3
895862|NCT01189461|2952511|P1|Overall Study|Adverse Event|2
895863|NCT01189461|2952511|P1|Overall Study|Protocol Violation|1
895864|NCT01189461|2952511|P1|Overall Study|Withdrawal by Subject|6
895865|NCT01189461|2952511|P1|Overall Study|Lost to Follow-up|1
895866|NCT01189461|2952511|P1|Overall Study|Lack of Efficacy|13
895867|NCT01189435|2952518|P1|Overall Study|Physician Decision|1
895868|NCT01189435|2952518|P1|Overall Study|Withdrawal by Subject|1
895869|NCT01189227|2952618|P2|Overall Study|Study terminated due to low accrual|3
895870|NCT01189227|2952619|P1|Overall Study|Study terminated due to low accrual|6
895871|NCT01189201|2952625|P1|Overall Study|Adverse Event|1
895872|NCT01189032|2952728|P3|Overall Study|Protocol Violation|1
895873|NCT01189032|2952729|P2|Overall Study|Protocol Violation|1
895874|NCT01189032|2952730|P1|Overall Study|Protocol Violation|1
895875|NCT01189032|2952728|P3|Overall Study|Withdrawal by Subject|1
895876|NCT01189032|2952729|P2|Overall Study|Withdrawal by Subject|0
895877|NCT01189032|2952730|P1|Overall Study|Withdrawal by Subject|1
895878|NCT01189032|2952728|P3|Overall Study|Lack of Efficacy|0
895879|NCT01189032|2952729|P2|Overall Study|Lack of Efficacy|3
895880|NCT01189032|2952730|P1|Overall Study|Lack of Efficacy|2
895881|NCT01189032|2952728|P3|Overall Study|Adverse Event|4
895882|NCT01189032|2952729|P2|Overall Study|Adverse Event|3
895883|NCT01189032|2952730|P1|Overall Study|Adverse Event|1
895884|NCT01188967|2952740|P2|Overall Study|Lost to Follow-up|2
895885|NCT01188967|2952741|P1|Overall Study|Lost to Follow-up|3
895886|NCT01188967|2952740|P2|Overall Study|Physician Decision|1
895887|NCT01188967|2952741|P1|Overall Study|Physician Decision|1
895888|NCT01188967|2952740|P2|Overall Study|Withdrawal by Subject|1
895889|NCT01188967|2952741|P1|Overall Study|Withdrawal by Subject|1
895890|NCT01188811|2952794|P2|Overall Study|Adverse Event|0
895891|NCT01188811|2952795|P1|Overall Study|Adverse Event|6
895892|NCT01188811|2952794|P2|Overall Study|Withdrawal by Subject|2
895893|NCT01188811|2952795|P1|Overall Study|Withdrawal by Subject|0
895894|NCT01188798|2952807|P2|Overall Study|Protocol closure|1
895895|NCT01188798|2952808|P1|Overall Study|Protocol closure|1
895896|NCT01188798|2952807|P2|Overall Study|Required additional transplant|1
895897|NCT01188798|2952808|P1|Overall Study|Required additional transplant|1
895898|NCT01188798|2952807|P2|Overall Study|Death|1
895899|NCT01188798|2952808|P1|Overall Study|Death|0
895900|NCT01188772|2952820|P4|Overall Study|Withdrawal by Subject|0
895901|NCT01188772|2952821|P3|Overall Study|Withdrawal by Subject|2
895902|NCT01188772|2952822|P2|Overall Study|Withdrawal by Subject|0
895903|NCT01188772|2952823|P1|Overall Study|Withdrawal by Subject|0
895904|NCT01188772|2952820|P4|Overall Study|Virologic Failure|0
895905|NCT01188772|2952821|P3|Overall Study|Virologic Failure|0
895906|NCT01188772|2952822|P2|Overall Study|Virologic Failure|0
895907|NCT01188772|2952823|P1|Overall Study|Virologic Failure|1
895908|NCT01188772|2952820|P4|Overall Study|Treatment Failure|0
895909|NCT01188772|2952821|P3|Overall Study|Treatment Failure|1
895910|NCT01188772|2952822|P2|Overall Study|Treatment Failure|0
895911|NCT01188772|2952823|P1|Overall Study|Treatment Failure|0
895912|NCT01188772|2952820|P4|Overall Study|Terminated by Sponsor|0
895913|NCT01188772|2952821|P3|Overall Study|Terminated by Sponsor|1
895914|NCT01188772|2952822|P2|Overall Study|Terminated by Sponsor|0
895915|NCT01188772|2952823|P1|Overall Study|Terminated by Sponsor|0
895916|NCT01188772|2952820|P4|Overall Study|Physician Decision|0
895917|NCT01188772|2952821|P3|Overall Study|Physician Decision|1
895918|NCT01188772|2952822|P2|Overall Study|Physician Decision|0
895919|NCT01188772|2952823|P1|Overall Study|Physician Decision|0
895920|NCT01188772|2952820|P4|Overall Study|Non-responder|0
895921|NCT01188772|2952821|P3|Overall Study|Non-responder|3
895922|NCT01188772|2952822|P2|Overall Study|Non-responder|0
895923|NCT01188772|2952823|P1|Overall Study|Non-responder|0
895924|NCT01188772|2952820|P4|Overall Study|Lost to Follow-up|1
895925|NCT01188772|2952821|P3|Overall Study|Lost to Follow-up|1
895926|NCT01188772|2952822|P2|Overall Study|Lost to Follow-up|1
895927|NCT01188772|2952823|P1|Overall Study|Lost to Follow-up|4
895928|NCT01188772|2952820|P4|Overall Study|Adverse Event|0
895929|NCT01188772|2952821|P3|Overall Study|Adverse Event|2
895930|NCT01188772|2952822|P2|Overall Study|Adverse Event|1
895931|NCT01188772|2952823|P1|Overall Study|Adverse Event|0
895932|NCT01188772|2952820|P4|Overall Study|Randomized but Not Treated|0
895933|NCT01188772|2952821|P3|Overall Study|Randomized but Not Treated|0
895934|NCT01188772|2952822|P2|Overall Study|Randomized but Not Treated|1
895935|NCT01188772|2952823|P1|Overall Study|Randomized but Not Treated|0
895936|NCT01188681|2952895|P4|Overall Study|Withdrawal by Subject|1
895937|NCT01188681|2952896|P3|Overall Study|Withdrawal by Subject|0
895938|NCT01188681|2952897|P2|Overall Study|Withdrawal by Subject|0
895939|NCT01188681|2952898|P1|Overall Study|Withdrawal by Subject|0
895940|NCT01188681|2952895|P4|Overall Study|bladder cancer|0
895941|NCT01188681|2952896|P3|Overall Study|bladder cancer|1
895942|NCT01188681|2952897|P2|Overall Study|bladder cancer|0
895943|NCT01188681|2952898|P1|Overall Study|bladder cancer|0
895944|NCT01188668|2952912|P1|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1
895945|NCT01188668|2952912|P1|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2
895946|NCT01188668|2952912|P1|Period 1: ARIP Alone|Protocol Violation|2
895947|NCT01188655|2952945|P1|Overall Study|Other|11
895948|NCT01188655|2952945|P1|Overall Study|Lost to Follow-up|1
895949|NCT01188655|2952945|P1|Overall Study|Lack of Efficacy|1
895950|NCT01188564|2952989|P2|Double-blind Phase|randomized not treated|0
895951|NCT01188564|2952990|P1|Double-blind Phase|randomized not treated|1
895952|NCT01188551|2953002|P4|Overall Study|Pharmacy issues|0
895953|NCT01188551|2953003|P3|Overall Study|Pharmacy issues|0
895954|NCT01188551|2953004|P2|Overall Study|Pharmacy issues|0
895955|NCT01188551|2953005|P1|Overall Study|Pharmacy issues|1
895956|NCT01188538|2953021|P2|Overall Study|Lost to Follow-up|1
895957|NCT01188538|2953022|P1|Overall Study|Lost to Follow-up|0
895958|NCT01188343|2953109|P3|Overall Study|Withdrawal by Subject|0
895959|NCT01188343|2953110|P2|Overall Study|Withdrawal by Subject|24
895960|NCT01188343|2953111|P1|Overall Study|Withdrawal by Subject|1
895961|NCT01188343|2953109|P3|Overall Study|Not vaccinated|1
895962|NCT01188343|2953110|P2|Overall Study|Not vaccinated|2
895963|NCT01188343|2953111|P1|Overall Study|Not vaccinated|0
895964|NCT01188226|2953137|P1|Overall Study|Withdrawal by Subject|4
895965|NCT01187953|2953183|P2|Overall Study|Withdrawal by Subject|3
895966|NCT01187953|2953184|P1|Overall Study|Withdrawal by Subject|3
895967|NCT01187953|2953183|P2|Overall Study|Lost to Follow-up|3
895968|NCT01187953|2953184|P1|Overall Study|Lost to Follow-up|0
895969|NCT01187953|2953183|P2|Overall Study|Adverse Event|2
895970|NCT01187953|2953184|P1|Overall Study|Adverse Event|1
895971|NCT01187953|2953183|P2|Overall Study|Death|13
895972|NCT01187953|2953184|P1|Overall Study|Death|11
895973|NCT01187901|2953198|P2|Overall Study|Pregnancy|2
895974|NCT01187901|2953199|P1|Overall Study|Pregnancy|0
895975|NCT01187901|2953198|P2|Overall Study|No Endpoint due to Early Study Halt|3
895976|NCT01187901|2953199|P1|Overall Study|No Endpoint due to Early Study Halt|2
895977|NCT01187901|2953198|P2|Overall Study|Adverse Event|0
895978|NCT01187901|2953199|P1|Overall Study|Adverse Event|3
895979|NCT01187901|2953198|P2|Overall Study|Suspected Allergic Reaction|1
895980|NCT01187901|2953199|P1|Overall Study|Suspected Allergic Reaction|1
895981|NCT01187901|2953198|P2|Overall Study|Unrelated Health Reasons|2
895982|NCT01187901|2953199|P1|Overall Study|Unrelated Health Reasons|1
895983|NCT01187901|2953198|P2|Overall Study|Lost to Follow-up|2
895984|NCT01187901|2953199|P1|Overall Study|Lost to Follow-up|1
895985|NCT01187901|2953198|P2|Overall Study|Protocol Violation|0
895986|NCT01187901|2953199|P1|Overall Study|Protocol Violation|1
895987|NCT01187550|2953240|P2|Overall Study|Randomized but not treated|0
895988|NCT01187550|2953241|P1|Overall Study|Randomized but not treated|8
895989|NCT01187550|2953240|P2|Overall Study|Other|0
895990|NCT01187550|2953241|P1|Overall Study|Other|3
895991|NCT01187550|2953240|P2|Overall Study|Protocol Violation|1
895992|NCT01187550|2953241|P1|Overall Study|Protocol Violation|3
895993|NCT01187446|2953397|P2|Overall Study|Patient started non-protocol therapy|1
895994|NCT01187446|2953398|P1|Overall Study|Patient started non-protocol therapy|0
895995|NCT01187433|2953414|P2|Overall Study|Withdrawal by Subject|2
895996|NCT01187433|2953415|P1|Overall Study|Withdrawal by Subject|5
895997|NCT01187433|2953414|P2|Overall Study|Protocol Violation|2
895998|NCT01187433|2953415|P1|Overall Study|Protocol Violation|6
895999|NCT01187407|2953445|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
896000|NCT01187407|2953446|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
896001|NCT01187407|2953447|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
896002|NCT01187407|2953448|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
896003|NCT01187407|2953449|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
896004|NCT01187407|2953445|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22
896005|NCT01187407|2953446|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11
896006|NCT01187407|2953447|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
896007|NCT01187407|2953448|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
896008|NCT01187407|2953449|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
896009|NCT01187407|2953445|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10
896010|NCT01187407|2953446|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3
896011|NCT01187407|2953447|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
896012|NCT01187407|2953448|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6
896013|NCT01187407|2953449|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
896014|NCT01187407|2953445|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
896015|NCT01187407|2953446|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
896016|NCT01187407|2953447|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
896017|NCT01187407|2953448|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
896018|NCT01187407|2953449|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
896019|NCT01187407|2953445|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
896020|NCT01187407|2953446|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
896021|NCT01187407|2953447|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
896022|NCT01187407|2953448|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
896023|NCT01187407|2953449|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
896024|NCT01187407|2953445|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13
896025|NCT01187407|2953446|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5
896026|NCT01187407|2953447|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
896027|NCT01187407|2953448|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3
896028|NCT01187407|2953449|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
896029|NCT01187407|2953445|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12
896030|NCT01187407|2953446|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5
896031|NCT01187407|2953447|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6
896032|NCT01187407|2953448|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
896033|NCT01187407|2953449|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
896034|NCT01187407|2953445|P5|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
896035|NCT01187407|2953446|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
896036|NCT01187407|2953447|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
896037|NCT01187407|2953448|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
896038|NCT01187407|2953449|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4
896039|NCT01187407|2953445|P5|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
896040|NCT01187407|2953446|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
896041|NCT01187407|2953447|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
896042|NCT01187407|2953448|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
896043|NCT01187407|2953449|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29
896044|NCT01187407|2953445|P5|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
896045|NCT01187407|2953446|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
896046|NCT01187407|2953447|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
896047|NCT01187407|2953448|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
896048|NCT01187407|2953449|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13
896049|NCT01187407|2953445|P5|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
896050|NCT01187407|2953446|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
896051|NCT01187407|2953447|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
896052|NCT01187407|2953448|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
896053|NCT01187407|2953449|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
896054|NCT01187407|2953445|P5|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
896055|NCT01187407|2953446|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
896056|NCT01187407|2953447|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
896057|NCT01187407|2953448|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
896058|NCT01187407|2953449|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9
896059|NCT01187407|2953445|P5|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
896060|NCT01187407|2953446|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
896061|NCT01187407|2953447|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
896062|NCT01187407|2953448|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
896063|NCT01187407|2953449|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4
896064|NCT01187407|2953445|P5|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
896065|NCT01187407|2953446|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
896066|NCT01187407|2953447|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
896067|NCT01187407|2953448|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
896068|NCT01187407|2953449|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29
896069|NCT01187043|2953562|P5|Overall Study|Unable to make scheduled visits|1
896070|NCT01187043|2953563|P4|Overall Study|Unable to make scheduled visits|0
896071|NCT01187043|2953564|P3|Overall Study|Unable to make scheduled visits|4
896072|NCT01187043|2953565|P2|Overall Study|Unable to make scheduled visits|0
896073|NCT01187043|2953566|P1|Overall Study|Unable to make scheduled visits|1
896074|NCT01187043|2953562|P5|Overall Study|Adverse Event|1
896075|NCT01187043|2953563|P4|Overall Study|Adverse Event|0
896076|NCT01187043|2953564|P3|Overall Study|Adverse Event|0
896077|NCT01187043|2953565|P2|Overall Study|Adverse Event|0
896078|NCT01187043|2953566|P1|Overall Study|Adverse Event|0
896079|NCT01186939|2953592|P1|Overall Study|Transformation to AML|1
896080|NCT01186939|2953592|P1|Overall Study|Bone marrow transplant|1
896081|NCT01186939|2953592|P1|Overall Study|Myocardial infarction|1
896082|NCT01186939|2953592|P1|Overall Study|NCI CTC Grade 3 or 4 toxicity|1
896083|NCT01186939|2953592|P1|Overall Study|Started additional treatment|1
896084|NCT01186939|2953592|P1|Overall Study|Sponsor decision|4
896085|NCT01186939|2953592|P1|Overall Study|Program closed|5
896086|NCT01186939|2953592|P1|Overall Study|No longer receiving clinical benefit|17
896087|NCT01186939|2953592|P1|Overall Study|Withdrawal by Subject|2
896088|NCT01186939|2953592|P1|Overall Study|Death|7
896089|NCT01186848|2953596|P1|Overall Study|Adverse Event|2
896090|NCT01186848|2953596|P1|Overall Study|Withdrawal by Subject|2
896091|NCT01186848|2953596|P1|Overall Study|Lost to Follow-up|4
896092|NCT01186796|2953604|P2|Overall Study|Protocol Violation|1
896093|NCT01186796|2953605|P1|Overall Study|Protocol Violation|0
896094|NCT01186796|2953604|P2|Overall Study|Withdrawal by Subject|1
896095|NCT01186796|2953605|P1|Overall Study|Withdrawal by Subject|1
896096|NCT01186796|2953604|P2|Overall Study|Adverse Event|0
896097|NCT01186796|2953605|P1|Overall Study|Adverse Event|3
896098|NCT01186744|2953625|P6|Overall Study|Death|0
896099|NCT01186744|2953626|P5|Overall Study|Death|0
896100|NCT01186744|2953627|P4|Overall Study|Death|0
896101|NCT01186744|2953628|P3|Overall Study|Death|0
896102|NCT01186744|2953629|P2|Overall Study|Death|0
896103|NCT01186744|2953630|P1|Overall Study|Death|1
896104|NCT01186744|2953625|P6|Overall Study|Adverse Event|4
896105|NCT01186744|2953626|P5|Overall Study|Adverse Event|1
896106|NCT01186744|2953627|P4|Overall Study|Adverse Event|0
896107|NCT01186744|2953628|P3|Overall Study|Adverse Event|1
896108|NCT01186744|2953629|P2|Overall Study|Adverse Event|14
896109|NCT01186744|2953630|P1|Overall Study|Adverse Event|10
896110|NCT01186744|2953625|P6|Overall Study|Not specified|5
896111|NCT01186744|2953626|P5|Overall Study|Not specified|1
896112|NCT01186744|2953627|P4|Overall Study|Not specified|2
896113|NCT01186744|2953628|P3|Overall Study|Not specified|1
896114|NCT01186744|2953629|P2|Overall Study|Not specified|10
896115|NCT01186744|2953630|P1|Overall Study|Not specified|9
896116|NCT01186744|2953625|P6|Overall Study|Study terminated by Sponsor|0
896117|NCT01186744|2953626|P5|Overall Study|Study terminated by Sponsor|0
896118|NCT01186744|2953627|P4|Overall Study|Study terminated by Sponsor|0
896119|NCT01186744|2953628|P3|Overall Study|Study terminated by Sponsor|0
896120|NCT01186744|2953629|P2|Overall Study|Study terminated by Sponsor|0
896121|NCT01186744|2953630|P1|Overall Study|Study terminated by Sponsor|1
896122|NCT01186744|2953625|P6|Overall Study|Withdrawal by Subject|6
896123|NCT01186744|2953626|P5|Overall Study|Withdrawal by Subject|0
896124|NCT01186744|2953627|P4|Overall Study|Withdrawal by Subject|5
896125|NCT01186744|2953628|P3|Overall Study|Withdrawal by Subject|2
896126|NCT01186744|2953629|P2|Overall Study|Withdrawal by Subject|10
896127|NCT01186744|2953630|P1|Overall Study|Withdrawal by Subject|14
896128|NCT01186744|2953625|P6|Overall Study|Screen failure|0
896129|NCT01186744|2953626|P5|Overall Study|Screen failure|0
896130|NCT01186744|2953627|P4|Overall Study|Screen failure|1
896131|NCT01186744|2953628|P3|Overall Study|Screen failure|0
896132|NCT01186744|2953629|P2|Overall Study|Screen failure|1
896133|NCT01186744|2953630|P1|Overall Study|Screen failure|1
896134|NCT01186744|2953625|P6|Overall Study|Lost to Follow-up|4
896135|NCT01186744|2953626|P5|Overall Study|Lost to Follow-up|1
896136|NCT01186744|2953627|P4|Overall Study|Lost to Follow-up|1
896137|NCT01186744|2953628|P3|Overall Study|Lost to Follow-up|2
896138|NCT01186744|2953629|P2|Overall Study|Lost to Follow-up|16
896139|NCT01186744|2953630|P1|Overall Study|Lost to Follow-up|15
896140|NCT01186744|2953625|P6|Overall Study|Protocol Violation|2
896141|NCT01186744|2953626|P5|Overall Study|Protocol Violation|1
896142|NCT01186744|2953627|P4|Overall Study|Protocol Violation|1
896143|NCT01186744|2953628|P3|Overall Study|Protocol Violation|0
896144|NCT01186744|2953629|P2|Overall Study|Protocol Violation|2
896145|NCT01186744|2953630|P1|Overall Study|Protocol Violation|1
896146|NCT01186744|2953625|P6|Overall Study|Lack of Efficacy|5
896147|NCT01186744|2953626|P5|Overall Study|Lack of Efficacy|2
896148|NCT01186744|2953627|P4|Overall Study|Lack of Efficacy|2
896149|NCT01186744|2953628|P3|Overall Study|Lack of Efficacy|0
896150|NCT01186744|2953629|P2|Overall Study|Lack of Efficacy|99
896151|NCT01186744|2953630|P1|Overall Study|Lack of Efficacy|156
896152|NCT01186692|2954050|P1|Overall Study|Adverse Event|2
896153|NCT01186692|2954050|P1|Overall Study|Futher testing contraindicated implant|19
896154|NCT01186692|2954050|P1|Overall Study|Not Catheterized|11
896155|NCT01186458|2954077|P1|Overall Study|Adverse Event|1
896156|NCT01186419|2954086|P2|Overall Study|Not specified|1
896157|NCT01186419|2954087|P1|Overall Study|Not specified|1
896158|NCT01186419|2954086|P2|Overall Study|Physician Decision|3
896159|NCT01186419|2954087|P1|Overall Study|Physician Decision|0
896160|NCT01186419|2954086|P2|Overall Study|Adverse Event|2
896161|NCT01186419|2954087|P1|Overall Study|Adverse Event|1
896162|NCT01186419|2954086|P2|Overall Study|Withdrawal by Subject|3
896163|NCT01186419|2954087|P1|Overall Study|Withdrawal by Subject|5
896164|NCT01185964|2954125|P4|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2
896165|NCT01185964|2954126|P3|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
896166|NCT01185964|2954127|P2|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
896167|NCT01185964|2954128|P1|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
896168|NCT01185964|2954125|P4|Optional Olaratumab Monotherapy on Dox|Adverse Event|1
896169|NCT01185964|2954126|P3|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
896170|NCT01185964|2954127|P2|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
896171|NCT01185964|2954128|P1|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
896172|NCT01185964|2954125|P4|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2
896173|NCT01185964|2954126|P3|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
896174|NCT01185964|2954127|P2|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
896175|NCT01185964|2954128|P1|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
896176|NCT01185964|2954125|P4|Phase 1b and Phase 2|Off Treatment but alive and on study|0
896177|NCT01185964|2954126|P3|Phase 1b and Phase 2|Off Treatment but alive and on study|1
896178|NCT01185964|2954127|P2|Phase 1b and Phase 2|Off Treatment but alive and on study|1
896179|NCT01185964|2954128|P1|Phase 1b and Phase 2|Off Treatment but alive and on study|0
896180|NCT01185964|2954125|P4|Phase 1b and Phase 2|Adverse Event|0
896181|NCT01185964|2954126|P3|Phase 1b and Phase 2|Adverse Event|2
896182|NCT01185964|2954127|P2|Phase 1b and Phase 2|Adverse Event|0
896183|NCT01185964|2954128|P1|Phase 1b and Phase 2|Adverse Event|1
896184|NCT01185964|2954125|P4|Phase 1b and Phase 2|Participant was beyond maximum weight|0
896185|NCT01185964|2954126|P3|Phase 1b and Phase 2|Participant was beyond maximum weight|1
896186|NCT01185964|2954127|P2|Phase 1b and Phase 2|Participant was beyond maximum weight|0
896187|NCT01185964|2954128|P1|Phase 1b and Phase 2|Participant was beyond maximum weight|0
896188|NCT01185964|2954125|P4|Phase 1b and Phase 2|Other Therapy Started|0
896189|NCT01185964|2954126|P3|Phase 1b and Phase 2|Other Therapy Started|3
896190|NCT01185964|2954127|P2|Phase 1b and Phase 2|Other Therapy Started|3
896191|NCT01185964|2954128|P1|Phase 1b and Phase 2|Other Therapy Started|0
896192|NCT01185964|2954125|P4|Phase 1b and Phase 2|Withdrawal by Subject|0
896193|NCT01185964|2954126|P3|Phase 1b and Phase 2|Withdrawal by Subject|2
896194|NCT01185964|2954127|P2|Phase 1b and Phase 2|Withdrawal by Subject|6
896195|NCT01185964|2954128|P1|Phase 1b and Phase 2|Withdrawal by Subject|1
896196|NCT01185834|2954154|P1|Overall Study|Early exit - Site error|2
896197|NCT01185834|2954154|P1|Overall Study|Time/Job Conflict|2
896198|NCT01185834|2954154|P1|Overall Study|Biomicroscopy|4
896199|NCT01185834|2954154|P1|Overall Study|Discomfort|4
896200|NCT01185834|2954154|P1|Overall Study|Lost to Follow-up|2
896201|NCT01185821|2954164|P5|Overall Study|Administrative problems|2
896202|NCT01185821|2954165|P4|Overall Study|Administrative problems|1
896203|NCT01185821|2954166|P3|Overall Study|Administrative problems|1
896204|NCT01185821|2954167|P2|Overall Study|Administrative problems|0
896205|NCT01185821|2954168|P1|Overall Study|Administrative problems|0
896206|NCT01185821|2954164|P5|Overall Study|Lost to Follow-up|2
896207|NCT01185821|2954165|P4|Overall Study|Lost to Follow-up|1
896208|NCT01185821|2954166|P3|Overall Study|Lost to Follow-up|2
896209|NCT01185821|2954167|P2|Overall Study|Lost to Follow-up|1
896210|NCT01185821|2954168|P1|Overall Study|Lost to Follow-up|1
896211|NCT01185821|2954164|P5|Overall Study|Withdrawal by Subject|3
896212|NCT01185821|2954165|P4|Overall Study|Withdrawal by Subject|1
896213|NCT01185821|2954166|P3|Overall Study|Withdrawal by Subject|2
896214|NCT01185821|2954167|P2|Overall Study|Withdrawal by Subject|2
896215|NCT01185821|2954168|P1|Overall Study|Withdrawal by Subject|3
896216|NCT01185821|2954164|P5|Overall Study|Lack of Efficacy|9
896217|NCT01185821|2954165|P4|Overall Study|Lack of Efficacy|0
896218|NCT01185821|2954166|P3|Overall Study|Lack of Efficacy|3
896219|NCT01185821|2954167|P2|Overall Study|Lack of Efficacy|0
896220|NCT01185821|2954168|P1|Overall Study|Lack of Efficacy|0
896221|NCT01185821|2954164|P5|Overall Study|Adverse Event|5
896222|NCT01185821|2954165|P4|Overall Study|Adverse Event|2
896223|NCT01185821|2954166|P3|Overall Study|Adverse Event|1
896224|NCT01185821|2954167|P2|Overall Study|Adverse Event|3
896225|NCT01185821|2954168|P1|Overall Study|Adverse Event|2
896226|NCT01185821|2954164|P5|Overall Study|Condition no longer required study drug|1
896227|NCT01185821|2954165|P4|Overall Study|Condition no longer required study drug|0
896228|NCT01185821|2954166|P3|Overall Study|Condition no longer required study drug|0
896229|NCT01185821|2954167|P2|Overall Study|Condition no longer required study drug|0
896230|NCT01185821|2954168|P1|Overall Study|Condition no longer required study drug|0
896231|NCT01185821|2954164|P5|Overall Study|Death|0
896232|NCT01185821|2954165|P4|Overall Study|Death|0
896233|NCT01185821|2954166|P3|Overall Study|Death|0
896234|NCT01185821|2954167|P2|Overall Study|Death|1
896235|NCT01185821|2954168|P1|Overall Study|Death|0
896236|NCT01185821|2954164|P5|Overall Study|Abnormal test procedure result|1
896237|NCT01185821|2954165|P4|Overall Study|Abnormal test procedure result|0
896238|NCT01185821|2954166|P3|Overall Study|Abnormal test procedure result|0
896239|NCT01185821|2954167|P2|Overall Study|Abnormal test procedure result|0
896240|NCT01185821|2954168|P1|Overall Study|Abnormal test procedure result|0
896241|NCT01185821|2954164|P5|Overall Study|Protocol Violation|1
896242|NCT01185821|2954165|P4|Overall Study|Protocol Violation|1
896243|NCT01185821|2954166|P3|Overall Study|Protocol Violation|0
896244|NCT01185821|2954167|P2|Overall Study|Protocol Violation|0
896245|NCT01185821|2954168|P1|Overall Study|Protocol Violation|0
896246|NCT01185821|2954164|P5|Overall Study|Abnormal laboratory value(s)|0
896247|NCT01185821|2954165|P4|Overall Study|Abnormal laboratory value(s)|0
896248|NCT01185821|2954166|P3|Overall Study|Abnormal laboratory value(s)|1
896249|NCT01185821|2954167|P2|Overall Study|Abnormal laboratory value(s)|2
896250|NCT01185821|2954168|P1|Overall Study|Abnormal laboratory value(s)|1
896251|NCT01185782|2954219|P2|Overall Study|Randomized but not treated|4
896252|NCT01185782|2954220|P1|Overall Study|Randomized but not treated|0
896253|NCT01185782|2954219|P2|Overall Study|Other|5
896254|NCT01185782|2954220|P1|Overall Study|Other|2
896255|NCT01185782|2954219|P2|Overall Study|Poor Response to Treatment|1
896256|NCT01185782|2954220|P1|Overall Study|Poor Response to Treatment|3
896257|NCT01185782|2954219|P2|Overall Study|Protocol Violation|0
896258|NCT01185782|2954220|P1|Overall Study|Protocol Violation|1
896259|NCT01185782|2954219|P2|Overall Study|Adverse Event|1
896260|NCT01185782|2954220|P1|Overall Study|Adverse Event|0
896261|NCT01185704|2954248|P2|Overall Study|Ectopic pregnancy|1
896262|NCT01185704|2954249|P1|Overall Study|Ectopic pregnancy|0
896263|NCT01185704|2954248|P2|Overall Study|Ovarian hyperstimulation syndrome risk|3
896264|NCT01185704|2954249|P1|Overall Study|Ovarian hyperstimulation syndrome risk|5
896265|NCT01185704|2954248|P2|Overall Study|Lack of ovarian response|1
896266|NCT01185704|2954249|P1|Overall Study|Lack of ovarian response|5
896267|NCT01185704|2954248|P2|Overall Study|Randomized but not treated|3
896268|NCT01185704|2954249|P1|Overall Study|Randomized but not treated|3
896269|NCT01185600|2954285|P2|Overall Study|Hold by DSMB|2
896270|NCT01185600|2954286|P1|Overall Study|Hold by DSMB|1
896271|NCT01185600|2954285|P2|Overall Study|Withdrawal by Subject|1
896272|NCT01185600|2954286|P1|Overall Study|Withdrawal by Subject|1
896273|NCT01185600|2954285|P2|Overall Study|Physician Decision|35
896274|NCT01185600|2954286|P1|Overall Study|Physician Decision|29
896275|NCT01185600|2954285|P2|Overall Study|Lost to Follow-up|5
896276|NCT01185600|2954286|P1|Overall Study|Lost to Follow-up|0
896277|NCT01185600|2954285|P2|Overall Study|Death|1
896278|NCT01185600|2954286|P1|Overall Study|Death|0
896279|NCT01185600|2954285|P2|Overall Study|Adverse Event|1
896280|NCT01185600|2954286|P1|Overall Study|Adverse Event|1
896281|NCT01185561|2954308|P2|Overall Study|Withdrawal by Subject|8
896282|NCT01185561|2954309|P1|Overall Study|Withdrawal by Subject|2
896283|NCT01185561|2954308|P2|Overall Study|Lost to Follow-up|4
896284|NCT01185561|2954309|P1|Overall Study|Lost to Follow-up|0
896285|NCT01185548|2954321|P1|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2
896286|NCT01185522|2954334|P1|Overall Study|Other reasons|12
896287|NCT01185522|2954334|P1|Overall Study|Poor tolerance|39
896288|NCT01185522|2954334|P1|Overall Study|Withdrawal by Subject|10
896289|NCT01185522|2954334|P1|Overall Study|Lost to Follow-up|19
896290|NCT01185522|2954334|P1|Overall Study|Lack of Efficacy|28
896291|NCT01185509|2954360|P2|Overall Study|Intercurrent Illness|1
896292|NCT01185509|2954361|P1|Overall Study|Intercurrent Illness|0
896293|NCT01185509|2954360|P2|Overall Study|Death|1
896294|NCT01185509|2954361|P1|Overall Study|Death|0
896295|NCT01185509|2954360|P2|Overall Study|Withdrawal by Subject|1
896296|NCT01185509|2954361|P1|Overall Study|Withdrawal by Subject|0
896297|NCT01185509|2954360|P2|Overall Study|Physician Decision|2
896298|NCT01185509|2954361|P1|Overall Study|Physician Decision|2
896299|NCT01185509|2954360|P2|Overall Study|Progression/Relapse|15
896300|NCT01185509|2954361|P1|Overall Study|Progression/Relapse|9
896301|NCT01185353|2954376|P10|Part D (Weeks 76 Through 128)|Adverse Event|0
896302|NCT01185353|2954377|P9|Part D (Weeks 76 Through 128)|Adverse Event|2
896303|NCT01185353|2954378|P8|Part D (Weeks 76 Through 128)|Adverse Event|1
896304|NCT01185353|2954379|P7|Part D (Weeks 76 Through 128)|Adverse Event|0
896305|NCT01185353|2954380|P6|Part D (Weeks 76 Through 128)|Adverse Event|0
896306|NCT01185353|2954381|P5|Part D (Weeks 76 Through 128)|Adverse Event|0
896307|NCT01185353|2954382|P4|Part D (Weeks 76 Through 128)|Adverse Event|0
896308|NCT01185353|2954383|P3|Part D (Weeks 76 Through 128)|Adverse Event|0
896309|NCT01185353|2954384|P2|Part D (Weeks 76 Through 128)|Adverse Event|0
896310|NCT01185353|2954385|P1|Part D (Weeks 76 Through 128)|Adverse Event|0
896311|NCT01185353|2954376|P10|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
896312|NCT01185353|2954377|P9|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2
896313|NCT01185353|2954378|P8|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
896314|NCT01185353|2954379|P7|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
896315|NCT01185353|2954380|P6|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
896316|NCT01185353|2954381|P5|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
896317|NCT01185353|2954382|P4|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
896318|NCT01185353|2954383|P3|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
896319|NCT01185353|2954384|P2|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
896320|NCT01185353|2954385|P1|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
896321|NCT01185353|2954376|P10|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
896322|NCT01185353|2954377|P9|Part D (Weeks 76 Through 128)|Lost to Follow-up|3
896323|NCT01185353|2954378|P8|Part D (Weeks 76 Through 128)|Lost to Follow-up|1
896324|NCT01185353|2954379|P7|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
896325|NCT01185353|2954380|P6|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
896326|NCT01185353|2954381|P5|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
896327|NCT01185353|2954382|P4|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
896328|NCT01185353|2954383|P3|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
896329|NCT01185353|2954384|P2|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
896330|NCT01185353|2954385|P1|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
896331|NCT01185353|2954376|P10|Part C (Weeks 24 Through 76)|Reason missing|0
896332|NCT01185353|2954377|P9|Part C (Weeks 24 Through 76)|Reason missing|1
896333|NCT01185353|2954378|P8|Part C (Weeks 24 Through 76)|Reason missing|0
896334|NCT01185353|2954379|P7|Part C (Weeks 24 Through 76)|Reason missing|0
896335|NCT01185353|2954380|P6|Part C (Weeks 24 Through 76)|Reason missing|0
896336|NCT01185353|2954381|P5|Part C (Weeks 24 Through 76)|Reason missing|0
896337|NCT01185353|2954382|P4|Part C (Weeks 24 Through 76)|Reason missing|0
896338|NCT01185353|2954383|P3|Part C (Weeks 24 Through 76)|Reason missing|0
896339|NCT01185353|2954384|P2|Part C (Weeks 24 Through 76)|Reason missing|0
896340|NCT01185353|2954385|P1|Part C (Weeks 24 Through 76)|Reason missing|0
896341|NCT01185353|2954376|P10|Part C (Weeks 24 Through 76)|Physician Decision|1
896342|NCT01185353|2954377|P9|Part C (Weeks 24 Through 76)|Physician Decision|0
896343|NCT01185353|2954378|P8|Part C (Weeks 24 Through 76)|Physician Decision|0
896344|NCT01185353|2954379|P7|Part C (Weeks 24 Through 76)|Physician Decision|0
896345|NCT01185353|2954380|P6|Part C (Weeks 24 Through 76)|Physician Decision|0
896346|NCT01185353|2954381|P5|Part C (Weeks 24 Through 76)|Physician Decision|0
896347|NCT01185353|2954382|P4|Part C (Weeks 24 Through 76)|Physician Decision|0
896348|NCT01185353|2954383|P3|Part C (Weeks 24 Through 76)|Physician Decision|0
896349|NCT01185353|2954384|P2|Part C (Weeks 24 Through 76)|Physician Decision|0
896350|NCT01185353|2954385|P1|Part C (Weeks 24 Through 76)|Physician Decision|0
896351|NCT01185353|2954376|P10|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1
896352|NCT01185353|2954377|P9|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
896353|NCT01185353|2954378|P8|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
896354|NCT01185353|2954379|P7|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
896355|NCT01185353|2954380|P6|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
896356|NCT01185353|2954381|P5|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
896357|NCT01185353|2954382|P4|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
896358|NCT01185353|2954383|P3|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
896359|NCT01185353|2954384|P2|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
896360|NCT01185353|2954385|P1|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
896361|NCT01185353|2954376|P10|Part C (Weeks 24 Through 76)|Death|1
896362|NCT01185353|2954377|P9|Part C (Weeks 24 Through 76)|Death|0
896363|NCT01185353|2954378|P8|Part C (Weeks 24 Through 76)|Death|0
896364|NCT01185353|2954379|P7|Part C (Weeks 24 Through 76)|Death|0
896365|NCT01185353|2954380|P6|Part C (Weeks 24 Through 76)|Death|0
896366|NCT01185353|2954381|P5|Part C (Weeks 24 Through 76)|Death|0
896367|NCT01185353|2954382|P4|Part C (Weeks 24 Through 76)|Death|0
896368|NCT01185353|2954383|P3|Part C (Weeks 24 Through 76)|Death|0
896369|NCT01185353|2954384|P2|Part C (Weeks 24 Through 76)|Death|0
896370|NCT01185353|2954385|P1|Part C (Weeks 24 Through 76)|Death|0
896371|NCT01185353|2954376|P10|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
896372|NCT01185353|2954377|P9|Part C (Weeks 24 Through 76)|Lack of Efficacy|2
896373|NCT01185353|2954378|P8|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
896374|NCT01185353|2954379|P7|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
896375|NCT01185353|2954380|P6|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
896376|NCT01185353|2954381|P5|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
896377|NCT01185353|2954382|P4|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
896378|NCT01185353|2954383|P3|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
896379|NCT01185353|2954384|P2|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
896380|NCT01185353|2954385|P1|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
896381|NCT01185353|2954376|P10|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
896382|NCT01185353|2954377|P9|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
896383|NCT01185353|2954378|P8|Part C (Weeks 24 Through 76)|Lost to Follow-up|2
896384|NCT01185353|2954379|P7|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
896385|NCT01185353|2954380|P6|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
896386|NCT01185353|2954381|P5|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
896387|NCT01185353|2954382|P4|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
896388|NCT01185353|2954383|P3|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
896389|NCT01185353|2954384|P2|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
896390|NCT01185353|2954385|P1|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
896391|NCT01185353|2954376|P10|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
896392|NCT01185353|2954377|P9|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
896393|NCT01185353|2954378|P8|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6
896394|NCT01185353|2954379|P7|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
896395|NCT01185353|2954380|P6|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
896396|NCT01185353|2954381|P5|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
896397|NCT01185353|2954382|P4|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
896398|NCT01185353|2954383|P3|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
896399|NCT01185353|2954384|P2|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
896400|NCT01185353|2954385|P1|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
896401|NCT01185353|2954376|P10|Part C (Weeks 24 Through 76)|Adverse Event|2
896402|NCT01185353|2954377|P9|Part C (Weeks 24 Through 76)|Adverse Event|2
896403|NCT01185353|2954378|P8|Part C (Weeks 24 Through 76)|Adverse Event|8
896404|NCT01185353|2954379|P7|Part C (Weeks 24 Through 76)|Adverse Event|0
896405|NCT01185353|2954380|P6|Part C (Weeks 24 Through 76)|Adverse Event|0
896406|NCT01185353|2954381|P5|Part C (Weeks 24 Through 76)|Adverse Event|0
896407|NCT01185353|2954382|P4|Part C (Weeks 24 Through 76)|Adverse Event|0
896408|NCT01185353|2954383|P3|Part C (Weeks 24 Through 76)|Adverse Event|0
896409|NCT01185353|2954384|P2|Part C (Weeks 24 Through 76)|Adverse Event|0
896410|NCT01185353|2954385|P1|Part C (Weeks 24 Through 76)|Adverse Event|0
896411|NCT01185353|2954376|P10|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
896412|NCT01185353|2954377|P9|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
896413|NCT01185353|2954378|P8|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
896414|NCT01185353|2954379|P7|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1
896415|NCT01185353|2954380|P6|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
896416|NCT01185353|2954381|P5|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
896417|NCT01185353|2954382|P4|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
896418|NCT01185353|2954383|P3|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
896419|NCT01185353|2954384|P2|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
896420|NCT01185353|2954385|P1|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
896421|NCT01185353|2954376|P10|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
896422|NCT01185353|2954377|P9|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
896423|NCT01185353|2954378|P8|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
896424|NCT01185353|2954379|P7|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4
896425|NCT01185353|2954380|P6|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3
896426|NCT01185353|2954381|P5|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
896427|NCT01185353|2954382|P4|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2
896428|NCT01185353|2954383|P3|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1
896429|NCT01185353|2954384|P2|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
896430|NCT01185353|2954385|P1|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
896431|NCT01185353|2954376|P10|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
896432|NCT01185353|2954377|P9|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
896433|NCT01185353|2954378|P8|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
896434|NCT01185353|2954379|P7|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
896435|NCT01185353|2954380|P6|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
896436|NCT01185353|2954381|P5|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
896437|NCT01185353|2954382|P4|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
896438|NCT01185353|2954383|P3|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
896439|NCT01185353|2954384|P2|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
896440|NCT01185353|2954385|P1|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
896441|NCT01185353|2954376|P10|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
896442|NCT01185353|2954377|P9|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
896443|NCT01185353|2954378|P8|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
896444|NCT01185353|2954379|P7|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
896445|NCT01185353|2954380|P6|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
896446|NCT01185353|2954381|P5|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
896447|NCT01185353|2954382|P4|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
896448|NCT01185353|2954383|P3|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
896449|NCT01185353|2954384|P2|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
896450|NCT01185353|2954385|P1|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
896451|NCT01185353|2954376|P10|Part B (Weeks 12 Through 24)|Adverse Event|0
896452|NCT01185353|2954377|P9|Part B (Weeks 12 Through 24)|Adverse Event|0
896453|NCT01185353|2954378|P8|Part B (Weeks 12 Through 24)|Adverse Event|0
896454|NCT01185353|2954379|P7|Part B (Weeks 12 Through 24)|Adverse Event|0
896455|NCT01185353|2954380|P6|Part B (Weeks 12 Through 24)|Adverse Event|1
896456|NCT01185353|2954381|P5|Part B (Weeks 12 Through 24)|Adverse Event|0
896457|NCT01185353|2954382|P4|Part B (Weeks 12 Through 24)|Adverse Event|0
896458|NCT01185353|2954383|P3|Part B (Weeks 12 Through 24)|Adverse Event|1
896459|NCT01185353|2954384|P2|Part B (Weeks 12 Through 24)|Adverse Event|0
896460|NCT01185353|2954385|P1|Part B (Weeks 12 Through 24)|Adverse Event|0
896461|NCT01185353|2954376|P10|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
896462|NCT01185353|2954377|P9|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
896463|NCT01185353|2954378|P8|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
896464|NCT01185353|2954379|P7|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
896465|NCT01185353|2954380|P6|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
896466|NCT01185353|2954381|P5|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3
896467|NCT01185353|2954382|P4|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
896468|NCT01185353|2954383|P3|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
896469|NCT01185353|2954384|P2|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
896470|NCT01185353|2954385|P1|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2
896471|NCT01185353|2954376|P10|Part A (Weeks 0 Through 12)|Protocol Violation|0
896472|NCT01185353|2954377|P9|Part A (Weeks 0 Through 12)|Protocol Violation|0
896473|NCT01185353|2954378|P8|Part A (Weeks 0 Through 12)|Protocol Violation|0
896474|NCT01185353|2954379|P7|Part A (Weeks 0 Through 12)|Protocol Violation|0
896475|NCT01185353|2954380|P6|Part A (Weeks 0 Through 12)|Protocol Violation|0
896476|NCT01185353|2954381|P5|Part A (Weeks 0 Through 12)|Protocol Violation|1
896477|NCT01185353|2954382|P4|Part A (Weeks 0 Through 12)|Protocol Violation|0
896478|NCT01185353|2954383|P3|Part A (Weeks 0 Through 12)|Protocol Violation|0
896479|NCT01185353|2954384|P2|Part A (Weeks 0 Through 12)|Protocol Violation|0
896480|NCT01185353|2954385|P1|Part A (Weeks 0 Through 12)|Protocol Violation|0
896481|NCT01185353|2954376|P10|Part A (Weeks 0 Through 12)|Physician Decision|0
896482|NCT01185353|2954377|P9|Part A (Weeks 0 Through 12)|Physician Decision|0
896483|NCT01185353|2954378|P8|Part A (Weeks 0 Through 12)|Physician Decision|0
896484|NCT01185353|2954379|P7|Part A (Weeks 0 Through 12)|Physician Decision|0
896485|NCT01185353|2954380|P6|Part A (Weeks 0 Through 12)|Physician Decision|0
896486|NCT01185353|2954381|P5|Part A (Weeks 0 Through 12)|Physician Decision|2
896487|NCT01185353|2954382|P4|Part A (Weeks 0 Through 12)|Physician Decision|0
896488|NCT01185353|2954383|P3|Part A (Weeks 0 Through 12)|Physician Decision|1
896489|NCT01185353|2954384|P2|Part A (Weeks 0 Through 12)|Physician Decision|0
896490|NCT01185353|2954385|P1|Part A (Weeks 0 Through 12)|Physician Decision|0
896491|NCT01185353|2954376|P10|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
896492|NCT01185353|2954377|P9|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
896493|NCT01185353|2954378|P8|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
896494|NCT01185353|2954379|P7|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
896495|NCT01185353|2954380|P6|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
896496|NCT01185353|2954381|P5|Part A (Weeks 0 Through 12)|Lack of Efficacy|1
896497|NCT01185353|2954382|P4|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
896498|NCT01185353|2954383|P3|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
896499|NCT01185353|2954384|P2|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
896500|NCT01185353|2954385|P1|Part A (Weeks 0 Through 12)|Lack of Efficacy|2
896501|NCT01185353|2954376|P10|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
896502|NCT01185353|2954377|P9|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
896503|NCT01185353|2954378|P8|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
896504|NCT01185353|2954379|P7|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
896505|NCT01185353|2954380|P6|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
896506|NCT01185353|2954381|P5|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4
896507|NCT01185353|2954382|P4|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
896508|NCT01185353|2954383|P3|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
896509|NCT01185353|2954384|P2|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
896510|NCT01185353|2954385|P1|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
896511|NCT01185353|2954376|P10|Part A (Weeks 0 Through 12)|Adverse Event|0
896512|NCT01185353|2954377|P9|Part A (Weeks 0 Through 12)|Adverse Event|0
896513|NCT01185353|2954378|P8|Part A (Weeks 0 Through 12)|Adverse Event|0
896514|NCT01185353|2954379|P7|Part A (Weeks 0 Through 12)|Adverse Event|0
896515|NCT01185353|2954380|P6|Part A (Weeks 0 Through 12)|Adverse Event|0
896516|NCT01185353|2954381|P5|Part A (Weeks 0 Through 12)|Adverse Event|5
896517|NCT01185353|2954382|P4|Part A (Weeks 0 Through 12)|Adverse Event|1
896518|NCT01185353|2954383|P3|Part A (Weeks 0 Through 12)|Adverse Event|1
896519|NCT01185353|2954384|P2|Part A (Weeks 0 Through 12)|Adverse Event|1
896520|NCT01185353|2954385|P1|Part A (Weeks 0 Through 12)|Adverse Event|1
896521|NCT01185340|2954546|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
896522|NCT01185340|2954547|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3
896523|NCT01185340|2954548|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
896524|NCT01185340|2954549|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
896525|NCT01185340|2954546|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
896526|NCT01185340|2954547|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
896527|NCT01185340|2954548|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
896528|NCT01185340|2954549|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
896529|NCT01185340|2954546|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
896530|NCT01185340|2954547|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2
896531|NCT01185340|2954548|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
896532|NCT01185340|2954549|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
896533|NCT01185340|2954546|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
896534|NCT01185340|2954547|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
896535|NCT01185340|2954548|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
896536|NCT01185340|2954549|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
896537|NCT01185340|2954546|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7
896538|NCT01185340|2954547|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
896539|NCT01185340|2954548|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4
896540|NCT01185340|2954549|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
896541|NCT01185340|2954546|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
896542|NCT01185340|2954547|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7
896543|NCT01185340|2954548|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
896544|NCT01185340|2954549|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
896545|NCT01185340|2954546|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
896546|NCT01185340|2954547|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8
896547|NCT01185340|2954548|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
896548|NCT01185340|2954549|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
896549|NCT01185340|2954546|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
896550|NCT01185340|2954547|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
896551|NCT01185340|2954548|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
896552|NCT01185340|2954549|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3
896553|NCT01185340|2954546|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
896554|NCT01185340|2954547|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
896555|NCT01185340|2954548|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
896556|NCT01185340|2954549|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32
896557|NCT01185340|2954546|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
896558|NCT01185340|2954547|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
896559|NCT01185340|2954548|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
896560|NCT01185340|2954549|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16
896561|NCT01185340|2954546|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
896562|NCT01185340|2954547|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
896563|NCT01185340|2954548|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
896564|NCT01185340|2954549|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
896565|NCT01185340|2954546|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
896566|NCT01185340|2954547|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
896567|NCT01185340|2954548|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
896568|NCT01185340|2954549|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5
896569|NCT01185340|2954546|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
896570|NCT01185340|2954547|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
896571|NCT01185340|2954548|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
896572|NCT01185340|2954549|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6
896573|NCT01185340|2954546|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
896574|NCT01185340|2954547|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
896575|NCT01185340|2954548|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
896576|NCT01185340|2954549|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24
896577|NCT01185301|2954601|P4|Overall Study|Other Reason|2
896578|NCT01185301|2954602|P3|Overall Study|Other Reason|2
896579|NCT01185301|2954603|P2|Overall Study|Other Reason|2
896580|NCT01185301|2954604|P1|Overall Study|Other Reason|3
896581|NCT01185301|2954601|P4|Overall Study|Lost to Follow-up|1
896582|NCT01185301|2954602|P3|Overall Study|Lost to Follow-up|0
896583|NCT01185301|2954603|P2|Overall Study|Lost to Follow-up|0
896584|NCT01185301|2954604|P1|Overall Study|Lost to Follow-up|2
896585|NCT01185301|2954601|P4|Overall Study|Withdrawal by Subject|3
896586|NCT01185301|2954602|P3|Overall Study|Withdrawal by Subject|2
896587|NCT01185301|2954603|P2|Overall Study|Withdrawal by Subject|5
896588|NCT01185301|2954604|P1|Overall Study|Withdrawal by Subject|7
896589|NCT01185301|2954601|P4|Overall Study|Adverse Event|3
896590|NCT01185301|2954602|P3|Overall Study|Adverse Event|2
896591|NCT01185301|2954603|P2|Overall Study|Adverse Event|0
896592|NCT01185301|2954604|P1|Overall Study|Adverse Event|3
896593|NCT01185288|2954664|P2|Overall Study|Noncompliance|1
896594|NCT01185288|2954665|P1|Overall Study|Noncompliance|0
896595|NCT01185288|2954664|P2|Overall Study|Did not meet inclusion criteria|0
896596|NCT01185288|2954665|P1|Overall Study|Did not meet inclusion criteria|1
896597|NCT01185288|2954664|P2|Overall Study|Investigator discretion|0
896598|NCT01185288|2954665|P1|Overall Study|Investigator discretion|1
896599|NCT01185288|2954664|P2|Overall Study|Lack of Efficacy|0
896600|NCT01185288|2954665|P1|Overall Study|Lack of Efficacy|2
896601|NCT01185288|2954664|P2|Overall Study|Lost to Follow-up|5
896602|NCT01185288|2954665|P1|Overall Study|Lost to Follow-up|2
896603|NCT01185288|2954664|P2|Overall Study|Withdrawal by Subject|4
896604|NCT01185288|2954665|P1|Overall Study|Withdrawal by Subject|6
896605|NCT01185288|2954664|P2|Overall Study|Adverse Event|6
896606|NCT01185288|2954665|P1|Overall Study|Adverse Event|7
896607|NCT01185249|2954683|P1|Overall Study|Patients discharged or change in status|42
896608|NCT01185080|2954691|P3|Overall Study|Personal reasons|1
896609|NCT01185080|2954692|P2|Overall Study|Personal reasons|0
896610|NCT01185080|2954693|P1|Overall Study|Personal reasons|0
896611|NCT01185080|2954691|P3|Overall Study|Adverse Event|0
896612|NCT01185080|2954692|P2|Overall Study|Adverse Event|1
896613|NCT01185080|2954693|P1|Overall Study|Adverse Event|1
896614|NCT01184989|2954745|P1|Overall Study|Withdrawal by Subject|1
896615|NCT01184989|2954745|P1|Overall Study|Adverse Event|11
896616|NCT01184872|2954765|P2|Overall Study|Protocol deviation|0
896617|NCT01184872|2954766|P1|Overall Study|Protocol deviation|1
896618|NCT01184872|2954765|P2|Overall Study|Administrative problems|1
896619|NCT01184872|2954766|P1|Overall Study|Administrative problems|1
896620|NCT01184872|2954765|P2|Overall Study|Lost to Follow-up|1
896621|NCT01184872|2954766|P1|Overall Study|Lost to Follow-up|0
896622|NCT01184872|2954765|P2|Overall Study|Withdrawal by Subject|0
896623|NCT01184872|2954766|P1|Overall Study|Withdrawal by Subject|2
896624|NCT01184872|2954765|P2|Overall Study|Unsatisfactory therapeutic effect|2
896625|NCT01184872|2954766|P1|Overall Study|Unsatisfactory therapeutic effect|3
896626|NCT01184872|2954765|P2|Overall Study|Adverse Event|4
896627|NCT01184872|2954766|P1|Overall Study|Adverse Event|3
896628|NCT01184859|2954785|P5|Period 2: Daily Dose for 28 Days|Adverse Event|0
896629|NCT01184859|2954786|P4|Period 2: Daily Dose for 28 Days|Adverse Event|0
896630|NCT01184859|2954787|P3|Period 2: Daily Dose for 28 Days|Adverse Event|0
896631|NCT01184859|2954788|P2|Period 2: Daily Dose for 28 Days|Adverse Event|0
896632|NCT01184859|2954789|P1|Period 2: Daily Dose for 28 Days|Adverse Event|1
896633|NCT01184859|2954785|P5|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1
896634|NCT01184859|2954786|P4|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
896635|NCT01184859|2954787|P3|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
896636|NCT01184859|2954788|P2|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
896637|NCT01184859|2954789|P1|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
896638|NCT01184859|2954785|P5|Period 1: Single Dose|Adverse Event|1
896639|NCT01184859|2954786|P4|Period 1: Single Dose|Adverse Event|0
896640|NCT01184859|2954787|P3|Period 1: Single Dose|Adverse Event|0
896641|NCT01184859|2954788|P2|Period 1: Single Dose|Adverse Event|0
896642|NCT01184859|2954789|P1|Period 1: Single Dose|Adverse Event|0
896643|NCT01184859|2954785|P5|Period 1: Single Dose|Protocol Violation|0
896644|NCT01184859|2954786|P4|Period 1: Single Dose|Protocol Violation|0
896645|NCT01184859|2954787|P3|Period 1: Single Dose|Protocol Violation|0
896646|NCT01184859|2954788|P2|Period 1: Single Dose|Protocol Violation|1
896647|NCT01184859|2954789|P1|Period 1: Single Dose|Protocol Violation|0
896648|NCT01184859|2954785|P5|Period 1: Single Dose|Insufficient urine production|0
896649|NCT01184859|2954786|P4|Period 1: Single Dose|Insufficient urine production|0
896650|NCT01184859|2954787|P3|Period 1: Single Dose|Insufficient urine production|0
896651|NCT01184859|2954788|P2|Period 1: Single Dose|Insufficient urine production|1
896652|NCT01184859|2954789|P1|Period 1: Single Dose|Insufficient urine production|0
896653|NCT01184846|2954881|P1|Overall Study|Insufficient response|1
896654|NCT01184846|2954881|P1|Overall Study|Adverse Event|2
896655|NCT01184508|2954914|P2|Overall Study|Randomized, Not Treated|1
896656|NCT01184508|2954915|P1|Overall Study|Randomized, Not Treated|0
896657|NCT01184508|2954914|P2|Overall Study|Withdrawal by Subject|3
896658|NCT01184508|2954915|P1|Overall Study|Withdrawal by Subject|1
896659|NCT01184508|2954914|P2|Overall Study|Sponsor Decision|2
896660|NCT01184508|2954915|P1|Overall Study|Sponsor Decision|5
896661|NCT01184508|2954914|P2|Overall Study|Protocol Violation|1
896662|NCT01184508|2954915|P1|Overall Study|Protocol Violation|3
896663|NCT01184508|2954914|P2|Overall Study|Physician Decision|0
896664|NCT01184508|2954915|P1|Overall Study|Physician Decision|1
896665|NCT01184508|2954914|P2|Overall Study|Lost to Follow-up|1
896666|NCT01184508|2954915|P1|Overall Study|Lost to Follow-up|1
896667|NCT01184508|2954914|P2|Overall Study|Lack of Efficacy|1
896668|NCT01184508|2954915|P1|Overall Study|Lack of Efficacy|1
896669|NCT01184508|2954914|P2|Overall Study|Adverse Event|6
896670|NCT01184508|2954915|P1|Overall Study|Adverse Event|4
896671|NCT01184326|2954963|P1|Overall Study|Withdrawal by Subject|1
896672|NCT01184326|2954963|P1|Overall Study|Death|1
896673|NCT01184326|2954963|P1|Overall Study|Adverse Event|3
896674|NCT01184118|2954971|P1|Overall Study|Withdrawal by Subject|5
896675|NCT01184118|2954971|P1|Overall Study|Exclusionary medical condition|2
896676|NCT01184118|2954971|P1|Overall Study|FEV1 <60% predicted|2
896677|NCT01184118|2954971|P1|Overall Study|No physiologic confirmation of asthma|8
896678|NCT01184118|2954971|P1|Overall Study|Only asthma step 1 - screen fail|1
896679|NCT01184079|2954979|P2|Overall Study|Lost to Follow-up|2
896680|NCT01184079|2954980|P1|Overall Study|Lost to Follow-up|14
896681|NCT01184053|2954990|P1|Overall Study|progression while on treatment|3
896682|NCT01183975|2955006|P1|Overall Study|Lost to Follow-up|73
896683|NCT01183858|2955013|P2|Overall Study|Lost to Follow-up|1
896684|NCT01183858|2955014|P1|Overall Study|Lost to Follow-up|1
896685|NCT01183858|2955013|P2|Overall Study|Death related to Progressive Disease|5
896686|NCT01183858|2955014|P1|Overall Study|Death related to Progressive Disease|4
896687|NCT01183858|2955013|P2|Overall Study|Progressive Disease|115
896688|NCT01183858|2955014|P1|Overall Study|Progressive Disease|112
896689|NCT01183858|2955013|P2|Overall Study|Administrative/Other|6
896690|NCT01183858|2955014|P1|Overall Study|Administrative/Other|6
896691|NCT01183858|2955013|P2|Overall Study|Protocol Violation|0
896692|NCT01183858|2955014|P1|Overall Study|Protocol Violation|1
896693|NCT01183858|2955013|P2|Overall Study|Discontinued Smoking|1
896694|NCT01183858|2955014|P1|Overall Study|Discontinued Smoking|3
896695|NCT01183858|2955013|P2|Overall Study|Withdrew Consent|4
896696|NCT01183858|2955014|P1|Overall Study|Withdrew Consent|4
896697|NCT01183858|2955013|P2|Overall Study|Refused Treatment|4
896698|NCT01183858|2955014|P1|Overall Study|Refused Treatment|1
896699|NCT01183858|2955013|P2|Overall Study|Insufficient Therapeutic Response|0
896700|NCT01183858|2955014|P1|Overall Study|Insufficient Therapeutic Response|2
896701|NCT01183858|2955013|P2|Overall Study|Investigator's Decision|3
896702|NCT01183858|2955014|P1|Overall Study|Investigator's Decision|0
896703|NCT01183858|2955013|P2|Overall Study|Adverse Event|11
896704|NCT01183858|2955014|P1|Overall Study|Adverse Event|14
896705|NCT01183858|2955013|P2|Overall Study|Death not related to Progressive Disease|6
896706|NCT01183858|2955014|P1|Overall Study|Death not related to Progressive Disease|5
896707|NCT01183780|2955036|P2|Overall Study|Lost to Follow-up|11
896708|NCT01183780|2955037|P1|Overall Study|Lost to Follow-up|6
896709|NCT01183780|2955036|P2|Overall Study|Withdrawal by Subject|14
896710|NCT01183780|2955037|P1|Overall Study|Withdrawal by Subject|25
896711|NCT01183468|2955170|P4|Overall Study|Withdrawal by Subject|0
896712|NCT01183468|2955171|P3|Overall Study|Withdrawal by Subject|0
896713|NCT01183468|2955172|P2|Overall Study|Withdrawal by Subject|1
896714|NCT01183468|2955173|P1|Overall Study|Withdrawal by Subject|0
896715|NCT01183468|2955170|P4|Overall Study|Physician Decision|0
896716|NCT01183468|2955171|P3|Overall Study|Physician Decision|0
896717|NCT01183468|2955172|P2|Overall Study|Physician Decision|0
896718|NCT01183468|2955173|P1|Overall Study|Physician Decision|1
896719|NCT01183468|2955170|P4|Overall Study|Lost to Follow-up|0
896720|NCT01183468|2955171|P3|Overall Study|Lost to Follow-up|0
896721|NCT01183468|2955172|P2|Overall Study|Lost to Follow-up|1
896722|NCT01183468|2955173|P1|Overall Study|Lost to Follow-up|2
896723|NCT01183390|2955183|P2|First Intervention|Adverse Event|1
896724|NCT01183390|2955184|P1|First Intervention|Adverse Event|0
896725|NCT01183260|2955217|P2|Overall Study|Death|0
896726|NCT01183260|2955218|P1|Overall Study|Death|1
896727|NCT01183260|2955217|P2|Overall Study|Revised within 30 days|1
896728|NCT01183260|2955218|P1|Overall Study|Revised within 30 days|0
896729|NCT01183260|2955217|P2|Overall Study|Withdrawal by Subject|1
896730|NCT01183260|2955218|P1|Overall Study|Withdrawal by Subject|1
896731|NCT01183260|2955217|P2|Overall Study|Intraop screen failure|0
896732|NCT01183260|2955218|P1|Overall Study|Intraop screen failure|2
896733|NCT01183234|2955228|P2|First Intervention|Adverse Event|0
896734|NCT01183234|2955229|P1|First Intervention|Adverse Event|1
896735|NCT01183143|2955321|P1|Overall Study|Subjects enrolled, but not treated|11
896736|NCT01183143|2955321|P1|Overall Study|Subject Questionnaires not returned|5
896737|NCT01183143|2955321|P1|Overall Study|Withdrawal by Subject|19
896738|NCT01183143|2955321|P1|Overall Study|Protocol Violation|115
896739|NCT01183104|2955337|P2|Overall Study|Did not receive study drug|9
896740|NCT01183104|2955338|P1|Overall Study|Did not receive study drug|5
896741|NCT01183104|2955337|P2|Overall Study|Nonparticipation in Extension Study|50
896742|NCT01183104|2955338|P1|Overall Study|Nonparticipation in Extension Study|39
896743|NCT01183104|2955337|P2|Overall Study|Withdrawal by Subject|11
896744|NCT01183104|2955338|P1|Overall Study|Withdrawal by Subject|6
896745|NCT01183104|2955337|P2|Overall Study|Physician Decision|8
896746|NCT01183104|2955338|P1|Overall Study|Physician Decision|5
896747|NCT01183104|2955337|P2|Overall Study|Lost to Follow-up|7
896748|NCT01183104|2955338|P1|Overall Study|Lost to Follow-up|14
896749|NCT01183104|2955337|P2|Overall Study|Death|1
896750|NCT01183104|2955338|P1|Overall Study|Death|0
896751|NCT01183104|2955337|P2|Overall Study|Adverse Event|6
896752|NCT01183104|2955338|P1|Overall Study|Adverse Event|8
896753|NCT01183065|2955354|P1|Overall Study|Patient no longer fits eligibility crite|1
896754|NCT01183013|2955365|P7|Overall Study|Reasons other than stated above|13
896755|NCT01183013|2955366|P6|Overall Study|Reasons other than stated above|15
896756|NCT01183013|2955367|P5|Overall Study|Reasons other than stated above|12
896757|NCT01183013|2955368|P4|Overall Study|Reasons other than stated above|12
896758|NCT01183013|2955369|P3|Overall Study|Reasons other than stated above|17
896759|NCT01183013|2955370|P2|Overall Study|Reasons other than stated above|11
896760|NCT01183013|2955371|P1|Overall Study|Reasons other than stated above|15
896761|NCT01183013|2955365|P7|Overall Study|Withdrawal by Subject|10
896762|NCT01183013|2955366|P6|Overall Study|Withdrawal by Subject|9
896763|NCT01183013|2955367|P5|Overall Study|Withdrawal by Subject|7
896764|NCT01183013|2955368|P4|Overall Study|Withdrawal by Subject|8
896765|NCT01183013|2955369|P3|Overall Study|Withdrawal by Subject|10
896766|NCT01183013|2955370|P2|Overall Study|Withdrawal by Subject|13
896767|NCT01183013|2955371|P1|Overall Study|Withdrawal by Subject|9
896768|NCT01183013|2955365|P7|Overall Study|Lost to Follow-up|5
896769|NCT01183013|2955366|P6|Overall Study|Lost to Follow-up|6
896770|NCT01183013|2955367|P5|Overall Study|Lost to Follow-up|2
896771|NCT01183013|2955368|P4|Overall Study|Lost to Follow-up|3
896772|NCT01183013|2955369|P3|Overall Study|Lost to Follow-up|4
896773|NCT01183013|2955370|P2|Overall Study|Lost to Follow-up|3
896774|NCT01183013|2955371|P1|Overall Study|Lost to Follow-up|7
896775|NCT01183013|2955365|P7|Overall Study|Protocol Violation|3
896776|NCT01183013|2955366|P6|Overall Study|Protocol Violation|3
896777|NCT01183013|2955367|P5|Overall Study|Protocol Violation|4
896778|NCT01183013|2955368|P4|Overall Study|Protocol Violation|0
896779|NCT01183013|2955369|P3|Overall Study|Protocol Violation|4
896780|NCT01183013|2955370|P2|Overall Study|Protocol Violation|2
896781|NCT01183013|2955371|P1|Overall Study|Protocol Violation|5
896782|NCT01183013|2955365|P7|Overall Study|Lack of Efficacy|0
896783|NCT01183013|2955366|P6|Overall Study|Lack of Efficacy|2
896784|NCT01183013|2955367|P5|Overall Study|Lack of Efficacy|1
896785|NCT01183013|2955368|P4|Overall Study|Lack of Efficacy|2
896786|NCT01183013|2955369|P3|Overall Study|Lack of Efficacy|1
896787|NCT01183013|2955370|P2|Overall Study|Lack of Efficacy|2
896788|NCT01183013|2955371|P1|Overall Study|Lack of Efficacy|3
896789|NCT01183013|2955365|P7|Overall Study|Adverse Event|6
896790|NCT01183013|2955366|P6|Overall Study|Adverse Event|10
896791|NCT01183013|2955367|P5|Overall Study|Adverse Event|10
896792|NCT01183013|2955368|P4|Overall Study|Adverse Event|5
896793|NCT01183013|2955369|P3|Overall Study|Adverse Event|5
896794|NCT01183013|2955370|P2|Overall Study|Adverse Event|8
896795|NCT01183013|2955371|P1|Overall Study|Adverse Event|6
896796|NCT01182441|2955517|P2|Overall Study|Physician Decision|1
896797|NCT01182441|2955518|P1|Overall Study|Physician Decision|1
896798|NCT01182441|2955517|P2|Overall Study|Adverse Event|0
896799|NCT01182441|2955518|P1|Overall Study|Adverse Event|2
896800|NCT01182441|2955517|P2|Overall Study|Implant Not Attempted|0
896801|NCT01182441|2955518|P1|Overall Study|Implant Not Attempted|4
896802|NCT01182441|2955517|P2|Overall Study|Withdrawal by Subject|13
896803|NCT01182441|2955518|P1|Overall Study|Withdrawal by Subject|6
896804|NCT01182441|2955517|P2|Overall Study|Lost to Follow-up|8
896805|NCT01182441|2955518|P1|Overall Study|Lost to Follow-up|5
896806|NCT01182441|2955517|P2|Overall Study|Implant Attempt Unsuccessful|0
896807|NCT01182441|2955518|P1|Overall Study|Implant Attempt Unsuccessful|13
896808|NCT01182441|2955517|P2|Overall Study|Death|25
896809|NCT01182441|2955518|P1|Overall Study|Death|37
896810|NCT01182441|2955517|P2|Overall Study|Patient Still in Follow-up|72
896811|NCT01182441|2955518|P1|Overall Study|Patient Still in Follow-up|152
896812|NCT01182428|2955529|P2|Overall Study|Withdrawal by Subject|0
896813|NCT01182428|2955530|P1|Overall Study|Withdrawal by Subject|1
896814|NCT01182428|2955529|P2|Overall Study|Lost to Follow-up|1
896815|NCT01182428|2955530|P1|Overall Study|Lost to Follow-up|9
896816|NCT01182428|2955529|P2|Overall Study|Physician Decision|0
896817|NCT01182428|2955530|P1|Overall Study|Physician Decision|1
896818|NCT01182415|2955594|P1|Overall Study|Lost to Follow-up|1
896819|NCT01182337|2955612|P2|Overall Study|Lost to Follow-up|1
896820|NCT01182337|2955613|P1|Overall Study|Lost to Follow-up|0
896821|NCT01182337|2955612|P2|Overall Study|Withdrawal by Subject|1
896822|NCT01182337|2955613|P1|Overall Study|Withdrawal by Subject|3
896823|NCT01182298|2955631|P1|Overall Study|Withdrawal by Subject|2
896824|NCT01182298|2955631|P1|Overall Study|Lack of Efficacy|4
896825|NCT01182285|2955635|P3|Third Intervention Week 11-52|Other|2
896826|NCT01182285|2955636|P2|Third Intervention Week 11-52|Other|0
896827|NCT01182285|2955637|P1|Third Intervention Week 11-52|Other|0
896828|NCT01182285|2955635|P3|Third Intervention Week 11-52|Disease Progression|6
896829|NCT01182285|2955636|P2|Third Intervention Week 11-52|Disease Progression|0
896830|NCT01182285|2955637|P1|Third Intervention Week 11-52|Disease Progression|0
896831|NCT01182285|2955635|P3|First Intervention Week 1-10|Non-compliance|0
896832|NCT01182285|2955636|P2|First Intervention Week 1-10|Non-compliance|0
896833|NCT01182285|2955637|P1|First Intervention Week 1-10|Non-compliance|1
896834|NCT01182285|2955635|P3|First Intervention Week 1-10|Adverse Event|0
896835|NCT01182285|2955636|P2|First Intervention Week 1-10|Adverse Event|0
896836|NCT01182285|2955637|P1|First Intervention Week 1-10|Adverse Event|1
896837|NCT01182285|2955635|P3|First Intervention Week 1-10|Disease progression|0
896838|NCT01182285|2955636|P2|First Intervention Week 1-10|Disease progression|0
896839|NCT01182285|2955637|P1|First Intervention Week 1-10|Disease progression|1
896840|NCT01182207|2955647|P2|Second Intervention|Emeses within 1 hour of dosing|0
896841|NCT01182207|2955648|P1|Second Intervention|Emeses within 1 hour of dosing|1
896842|NCT01182207|2955647|P2|First Intervention|Positive Hepatitis Results|1
896843|NCT01182207|2955648|P1|First Intervention|Positive Hepatitis Results|0
896844|NCT01182194|2955666|P2|Washout of 28 Days|Withdrawal by Subject|0
896845|NCT01182194|2955667|P1|Washout of 28 Days|Withdrawal by Subject|1
896846|NCT01182181|2955685|P2|Washout of 21 Days|Withdrawal by Subject|1
896847|NCT01182181|2955686|P1|Washout of 21 Days|Withdrawal by Subject|0
896848|NCT01182181|2955685|P2|First Intervention|Adverse Event|0
896849|NCT01182181|2955686|P1|First Intervention|Adverse Event|1
896850|NCT01181986|2955711|P3|Phase 2|Medical condition|0
896851|NCT01181986|2955712|P2|Phase 2|Medical condition|1
896852|NCT01181986|2955713|P1|Phase 2|Medical condition|0
896853|NCT01181986|2955711|P3|Phase 2|Adverse Event|0
896854|NCT01181986|2955712|P2|Phase 2|Adverse Event|3
896855|NCT01181986|2955713|P1|Phase 2|Adverse Event|0
896856|NCT01181986|2955711|P3|Phase 1|Protocol Violation|0
896857|NCT01181986|2955712|P2|Phase 1|Protocol Violation|0
896858|NCT01181986|2955713|P1|Phase 1|Protocol Violation|1
896859|NCT01181986|2955711|P3|Phase 1|Adverse Event|1
896860|NCT01181986|2955712|P2|Phase 1|Adverse Event|0
896861|NCT01181986|2955713|P1|Phase 1|Adverse Event|0
896862|NCT01181986|2955711|P3|Phase 1|Lost to Follow-up|1
896863|NCT01181986|2955712|P2|Phase 1|Lost to Follow-up|1
896864|NCT01181986|2955713|P1|Phase 1|Lost to Follow-up|0
896865|NCT01181921|2955734|P1|Overall Study|Lost to Follow-up|1
896866|NCT01181895|2955741|P3|Overall Study|Withdrawal by Subject|5
896867|NCT01181895|2955742|P2|Overall Study|Withdrawal by Subject|0
896868|NCT01181895|2955743|P1|Overall Study|Withdrawal by Subject|3
896869|NCT01181895|2955741|P3|Overall Study|Investigator Discretion|1
896870|NCT01181895|2955742|P2|Overall Study|Investigator Discretion|2
896871|NCT01181895|2955743|P1|Overall Study|Investigator Discretion|1
896872|NCT01181895|2955741|P3|Overall Study|Lost to Follow-up|2
896873|NCT01181895|2955742|P2|Overall Study|Lost to Follow-up|1
896874|NCT01181895|2955743|P1|Overall Study|Lost to Follow-up|0
896875|NCT01181895|2955741|P3|Overall Study|Protocol Violation|0
896876|NCT01181895|2955742|P2|Overall Study|Protocol Violation|1
896877|NCT01181895|2955743|P1|Overall Study|Protocol Violation|2
896878|NCT01181895|2955741|P3|Overall Study|Lack of Efficacy|9
896879|NCT01181895|2955742|P2|Overall Study|Lack of Efficacy|9
896880|NCT01181895|2955743|P1|Overall Study|Lack of Efficacy|8
896881|NCT01181895|2955741|P3|Overall Study|Adverse Event|1
896882|NCT01181895|2955742|P2|Overall Study|Adverse Event|1
896883|NCT01181895|2955743|P1|Overall Study|Adverse Event|3
896884|NCT01181778|2955801|P1|Overall Study|Physician Decision|48
896885|NCT01181726|2955809|P2|First Intervention|Adverse Event|0
896886|NCT01181726|2955810|P1|First Intervention|Adverse Event|1
896887|NCT01181609|2955856|P1|Overall Study|Death|50
896888|NCT01181609|2955856|P1|Overall Study|Lost to Follow-up|1
896889|NCT01181609|2955856|P1|Overall Study|Withdrawal by Subject|1
896890|NCT01181609|2955856|P1|Overall Study|Adverse Event|1
896891|NCT01181531|2955869|P2|Overall Study|Adverse Event|1
896892|NCT01181531|2955870|P1|Overall Study|Adverse Event|0
896893|NCT01181531|2955869|P2|Overall Study|Death|12
896894|NCT01181531|2955870|P1|Overall Study|Death|9
896895|NCT01181531|2955869|P2|Overall Study|Protocol Violation|6
896896|NCT01181531|2955870|P1|Overall Study|Protocol Violation|6
896897|NCT01181531|2955869|P2|Overall Study|Withdrawal by Subject|7
896898|NCT01181531|2955870|P1|Overall Study|Withdrawal by Subject|8
896899|NCT01181531|2955869|P2|Overall Study|Pregnancy|1
896900|NCT01181531|2955870|P1|Overall Study|Pregnancy|0
896901|NCT01181531|2955869|P2|Overall Study|Protocol Specified Criteria|8
896902|NCT01181531|2955870|P1|Overall Study|Protocol Specified Criteria|15
896903|NCT01181531|2955869|P2|Overall Study|Ineligibility determined|2
896904|NCT01181531|2955870|P1|Overall Study|Ineligibility determined|1
896905|NCT01181531|2955869|P2|Overall Study|Noncompliance|2
896906|NCT01181531|2955870|P1|Overall Study|Noncompliance|2
896907|NCT01181531|2955869|P2|Overall Study|Physician Decision|1
896908|NCT01181531|2955870|P1|Overall Study|Physician Decision|3
896909|NCT01181531|2955869|P2|Overall Study|Partial consent by subject withdrawn|1
896910|NCT01181531|2955870|P1|Overall Study|Partial consent by subject withdrawn|0
896911|NCT01181531|2955869|P2|Overall Study|Other|12
896912|NCT01181531|2955870|P1|Overall Study|Other|17
896913|NCT01181271|2956012|P1|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1
896914|NCT01181271|2956012|P1|Evaluation for Allogeneic Transplant|No suitable donor|2
896915|NCT01181271|2956012|P1|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4
896916|NCT01181271|2956012|P1|Evaluation for Allogeneic Transplant|Lack of Efficacy|6
896917|NCT01181167|2956036|P2|Overall Study|Withdrawal by Subject|8
896918|NCT01181167|2956037|P1|Overall Study|Withdrawal by Subject|6
896919|NCT01181167|2956036|P2|Overall Study|Protocol Violation|0
896920|NCT01181167|2956037|P1|Overall Study|Protocol Violation|3
896921|NCT01181167|2956036|P2|Overall Study|Physician Decision|3
896922|NCT01181167|2956037|P1|Overall Study|Physician Decision|2
896923|NCT01181167|2956036|P2|Overall Study|Lost to Follow-up|0
896924|NCT01181167|2956037|P1|Overall Study|Lost to Follow-up|1
896925|NCT01181167|2956036|P2|Overall Study|Adverse Event|21
896926|NCT01181167|2956037|P1|Overall Study|Adverse Event|11
896927|NCT01181141|2956047|P2|Overall Study|Withdrawal by Subject|1
896928|NCT01181141|2956048|P1|Overall Study|Withdrawal by Subject|3
896929|NCT01181141|2956047|P2|Overall Study|Protocol Violation|1
896930|NCT01181141|2956048|P1|Overall Study|Protocol Violation|3
896931|NCT01181141|2956047|P2|Overall Study|Physician Decision|0
896932|NCT01181141|2956048|P1|Overall Study|Physician Decision|2
896933|NCT01181141|2956047|P2|Overall Study|Lost to Follow-up|1
896934|NCT01181141|2956048|P1|Overall Study|Lost to Follow-up|1
896935|NCT01181141|2956047|P2|Overall Study|Lack of Efficacy|0
896936|NCT01181141|2956048|P1|Overall Study|Lack of Efficacy|1
896937|NCT01181141|2956047|P2|Overall Study|Adverse Event|1
896938|NCT01181141|2956048|P1|Overall Study|Adverse Event|2
896939|NCT01181128|2956057|P3|Overall Study|Not Specified|1
896940|NCT01181128|2956058|P2|Overall Study|Not Specified|1
896941|NCT01181128|2956059|P1|Overall Study|Not Specified|1
896942|NCT01181128|2956057|P3|Overall Study|Adverse Event|0
896943|NCT01181128|2956058|P2|Overall Study|Adverse Event|2
896944|NCT01181128|2956059|P1|Overall Study|Adverse Event|0
896945|NCT01181128|2956057|P3|Overall Study|Physician Decision|0
896946|NCT01181128|2956058|P2|Overall Study|Physician Decision|0
896947|NCT01181128|2956059|P1|Overall Study|Physician Decision|2
896948|NCT01181128|2956057|P3|Overall Study|Death|0
896949|NCT01181128|2956058|P2|Overall Study|Death|0
896950|NCT01181128|2956059|P1|Overall Study|Death|1
896951|NCT01181128|2956057|P3|Overall Study|Withdrawal by Subject|0
896952|NCT01181128|2956058|P2|Overall Study|Withdrawal by Subject|2
896953|NCT01181128|2956059|P1|Overall Study|Withdrawal by Subject|2
896954|NCT01181102|2956147|P2|Overall Study|Withdrawal by Subject|12
896955|NCT01181102|2956148|P1|Overall Study|Withdrawal by Subject|10
896956|NCT01181102|2956147|P2|Overall Study|Protocol Violation|6
896957|NCT01181102|2956148|P1|Overall Study|Protocol Violation|5
896958|NCT01181102|2956147|P2|Overall Study|Physician Decision|1
896959|NCT01181102|2956148|P1|Overall Study|Physician Decision|3
896960|NCT01181102|2956147|P2|Overall Study|Lost to Follow-up|0
896961|NCT01181102|2956148|P1|Overall Study|Lost to Follow-up|2
896962|NCT01181102|2956147|P2|Overall Study|Lack of Efficacy|1
896963|NCT01181102|2956148|P1|Overall Study|Lack of Efficacy|3
896964|NCT01181102|2956147|P2|Overall Study|Adverse Event|26
896965|NCT01181102|2956148|P1|Overall Study|Adverse Event|28
896966|NCT01181011|2956169|P1|Overall Study|Lost to Follow-up|1
896967|NCT01181011|2956169|P1|Overall Study|Adverse Event|2
896968|NCT01180998|2956219|P3|Overall Study|Poor lens handling|2
896969|NCT01180998|2956220|P2|Overall Study|Poor lens handling|0
896970|NCT01180998|2956221|P1|Overall Study|Poor lens handling|0
896971|NCT01180998|2956219|P3|Overall Study|Poor comfort|4
896972|NCT01180998|2956220|P2|Overall Study|Poor comfort|0
896973|NCT01180998|2956221|P1|Overall Study|Poor comfort|3
896974|NCT01180998|2956219|P3|Overall Study|Withdrawal by Subject|1
896975|NCT01180998|2956220|P2|Overall Study|Withdrawal by Subject|0
896976|NCT01180998|2956221|P1|Overall Study|Withdrawal by Subject|0
896977|NCT01180998|2956219|P3|Overall Study|Protocol Violation|0
896978|NCT01180998|2956220|P2|Overall Study|Protocol Violation|2
896979|NCT01180998|2956221|P1|Overall Study|Protocol Violation|1
896980|NCT01180998|2956219|P3|Overall Study|Lost to Follow-up|1
896981|NCT01180998|2956220|P2|Overall Study|Lost to Follow-up|0
896982|NCT01180998|2956221|P1|Overall Study|Lost to Follow-up|0
896983|NCT01180998|2956219|P3|Overall Study|Poor Vision|2
896984|NCT01180998|2956220|P2|Overall Study|Poor Vision|2
896985|NCT01180998|2956221|P1|Overall Study|Poor Vision|0
896986|NCT01180985|2956235|P2|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0
896987|NCT01180985|2956236|P1|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1
896988|NCT01180790|2956275|P7|Overall Study|Severe coronary atherosclerosis (death)|0
896989|NCT01180790|2956276|P6|Overall Study|Severe coronary atherosclerosis (death)|0
896990|NCT01180790|2956277|P5|Overall Study|Severe coronary atherosclerosis (death)|0
896991|NCT01180790|2956278|P4|Overall Study|Severe coronary atherosclerosis (death)|0
896992|NCT01180790|2956279|P3|Overall Study|Severe coronary atherosclerosis (death)|1
896993|NCT01180790|2956280|P2|Overall Study|Severe coronary atherosclerosis (death)|0
896994|NCT01180790|2956281|P1|Overall Study|Severe coronary atherosclerosis (death)|0
896995|NCT01180790|2956275|P7|Overall Study|compliance|0
896996|NCT01180790|2956276|P6|Overall Study|compliance|0
896997|NCT01180790|2956277|P5|Overall Study|compliance|0
896998|NCT01180790|2956278|P4|Overall Study|compliance|0
896999|NCT01180790|2956279|P3|Overall Study|compliance|0
897000|NCT01180790|2956280|P2|Overall Study|compliance|1
897001|NCT01180790|2956281|P1|Overall Study|compliance|0
897002|NCT01180790|2956275|P7|Overall Study|Lack of Efficacy|0
897003|NCT01180790|2956276|P6|Overall Study|Lack of Efficacy|3
897004|NCT01180790|2956277|P5|Overall Study|Lack of Efficacy|1
897005|NCT01180790|2956278|P4|Overall Study|Lack of Efficacy|6
897006|NCT01180790|2956279|P3|Overall Study|Lack of Efficacy|5
897007|NCT01180790|2956280|P2|Overall Study|Lack of Efficacy|2
897008|NCT01180790|2956281|P1|Overall Study|Lack of Efficacy|1
897009|NCT01180790|2956275|P7|Overall Study|Physician Decision|0
897010|NCT01180790|2956276|P6|Overall Study|Physician Decision|0
897011|NCT01180790|2956277|P5|Overall Study|Physician Decision|0
897012|NCT01180790|2956278|P4|Overall Study|Physician Decision|1
897013|NCT01180790|2956279|P3|Overall Study|Physician Decision|0
897014|NCT01180790|2956280|P2|Overall Study|Physician Decision|0
897015|NCT01180790|2956281|P1|Overall Study|Physician Decision|1
897016|NCT01180790|2956275|P7|Overall Study|Lost to Follow-up|1
897017|NCT01180790|2956276|P6|Overall Study|Lost to Follow-up|0
897018|NCT01180790|2956277|P5|Overall Study|Lost to Follow-up|1
897019|NCT01180790|2956278|P4|Overall Study|Lost to Follow-up|2
897020|NCT01180790|2956279|P3|Overall Study|Lost to Follow-up|0
897021|NCT01180790|2956280|P2|Overall Study|Lost to Follow-up|1
897022|NCT01180790|2956281|P1|Overall Study|Lost to Follow-up|3
897023|NCT01180790|2956275|P7|Overall Study|Withdrawal by Subject|0
897024|NCT01180790|2956276|P6|Overall Study|Withdrawal by Subject|1
897025|NCT01180790|2956277|P5|Overall Study|Withdrawal by Subject|2
897026|NCT01180790|2956278|P4|Overall Study|Withdrawal by Subject|0
897027|NCT01180790|2956279|P3|Overall Study|Withdrawal by Subject|5
897028|NCT01180790|2956280|P2|Overall Study|Withdrawal by Subject|0
897029|NCT01180790|2956281|P1|Overall Study|Withdrawal by Subject|3
897030|NCT01180790|2956275|P7|Overall Study|Adverse Event|0
897031|NCT01180790|2956276|P6|Overall Study|Adverse Event|3
897032|NCT01180790|2956277|P5|Overall Study|Adverse Event|1
897033|NCT01180790|2956278|P4|Overall Study|Adverse Event|0
897034|NCT01180790|2956279|P3|Overall Study|Adverse Event|2
897035|NCT01180790|2956280|P2|Overall Study|Adverse Event|1
897036|NCT01180790|2956281|P1|Overall Study|Adverse Event|1
897037|NCT01180777|2956346|P1|Overall Study|Adverse Event|1
897038|NCT01180777|2956346|P1|Overall Study|Lost to Follow-up|1
897039|NCT01180777|2956346|P1|Overall Study|Poor lens fit|4
897040|NCT01180777|2956346|P1|Overall Study|Protocol Violation|6
897041|NCT01180660|2956360|P2|Overall Study|Changed to open surgery|0
897042|NCT01180660|2956361|P1|Overall Study|Changed to open surgery|1
897043|NCT01180647|2956371|P2|Overall Study|Lost to Follow-up|6
897044|NCT01180647|2956372|P1|Overall Study|Lost to Follow-up|5
897045|NCT01180400|2956407|P2|Overall Study|Not specified|1
897046|NCT01180400|2956408|P1|Overall Study|Not specified|0
897047|NCT01180400|2956407|P2|Overall Study|Lost to Follow-up|3
897048|NCT01180400|2956408|P1|Overall Study|Lost to Follow-up|2
897049|NCT01180400|2956407|P2|Overall Study|Study-specific withdrawal criteria|2
897050|NCT01180400|2956408|P1|Overall Study|Study-specific withdrawal criteria|1
897051|NCT01180400|2956407|P2|Overall Study|Lack of Efficacy|0
897052|NCT01180400|2956408|P1|Overall Study|Lack of Efficacy|2
897053|NCT01180400|2956407|P2|Overall Study|Condition under investigation worsened|1
897054|NCT01180400|2956408|P1|Overall Study|Condition under investigation worsened|2
897055|NCT01180400|2956407|P2|Overall Study|Severe non-compliance to protocol|2
897056|NCT01180400|2956408|P1|Overall Study|Severe non-compliance to protocol|1
897057|NCT01180400|2956407|P2|Overall Study|Adverse Event|10
897058|NCT01180400|2956408|P1|Overall Study|Adverse Event|12
897059|NCT01180400|2956407|P2|Overall Study|Eligibility criteria not fulfilled|2
897060|NCT01180400|2956408|P1|Overall Study|Eligibility criteria not fulfilled|0
897061|NCT01180400|2956407|P2|Overall Study|Withdrawal by Subject|6
897062|NCT01180400|2956408|P1|Overall Study|Withdrawal by Subject|5
897063|NCT01180296|2956456|P2|Overall Study|Protocol Violation|2
897064|NCT01180296|2956457|P1|Overall Study|Protocol Violation|1
897065|NCT01180244|2956465|P2|Overall Study|Lost to Follow-up|0
897066|NCT01180244|2956466|P1|Overall Study|Lost to Follow-up|1
897067|NCT01180244|2956465|P2|Overall Study|Protocol Violation|0
897068|NCT01180244|2956466|P1|Overall Study|Protocol Violation|1
897069|NCT01180244|2956465|P2|Overall Study|Withdrawal by Subject|1
897070|NCT01180244|2956466|P1|Overall Study|Withdrawal by Subject|0
897071|NCT01180244|2956465|P2|Overall Study|Adverse Event|0
897072|NCT01180244|2956466|P1|Overall Study|Adverse Event|1
897073|NCT01180244|2956465|P2|Overall Study|Physician Decision|0
897074|NCT01180244|2956466|P1|Overall Study|Physician Decision|3
897075|NCT01180244|2956465|P2|Overall Study|Lack of Efficacy|7
897076|NCT01180244|2956466|P1|Overall Study|Lack of Efficacy|0
897077|NCT01180049|2956511|P2|Overall Study|Ongoing on treatment|10
897078|NCT01180049|2956512|P1|Overall Study|Ongoing on treatment|18
897079|NCT01180049|2956511|P2|Overall Study|Death|28
897080|NCT01180049|2956512|P1|Overall Study|Death|23
897081|NCT01180049|2956511|P2|Overall Study|Lost to Follow-up|1
897082|NCT01180049|2956512|P1|Overall Study|Lost to Follow-up|0
897083|NCT01180049|2956511|P2|Overall Study|Participant Refused Follow Up|3
897084|NCT01180049|2956512|P1|Overall Study|Participant Refused Follow Up|5
897085|NCT01180049|2956511|P2|Overall Study|Enrolled to Another Clinical Trial|1
897086|NCT01180049|2956512|P1|Overall Study|Enrolled to Another Clinical Trial|1
897087|NCT01179919|2956538|P1|Overall Study|Adverse Event|1
897088|NCT01179919|2956538|P1|Overall Study|Protocol Violation|1
897089|NCT01179737|2956547|P4|Extension|The study was terminated|0
897090|NCT01179737|2956548|P3|Extension|The study was terminated|0
897091|NCT01179737|2956549|P2|Extension|The study was terminated|0
897092|NCT01179737|2956550|P1|Extension|The study was terminated|3
897093|NCT01179737|2956547|P4|Cohort 1 & Cohort 2 Expansion|Death|0
897094|NCT01179737|2956548|P3|Cohort 1 & Cohort 2 Expansion|Death|0
897095|NCT01179737|2956549|P2|Cohort 1 & Cohort 2 Expansion|Death|0
897096|NCT01179737|2956550|P1|Cohort 1 & Cohort 2 Expansion|Death|1
897097|NCT01179737|2956547|P4|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
897098|NCT01179737|2956548|P3|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
897099|NCT01179737|2956549|P2|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1
897100|NCT01179737|2956550|P1|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
897101|NCT01179737|2956547|P4|Cohort 1 & Cohort 2|Death|0
897102|NCT01179737|2956548|P3|Cohort 1 & Cohort 2|Death|1
897103|NCT01179737|2956549|P2|Cohort 1 & Cohort 2|Death|0
897104|NCT01179737|2956550|P1|Cohort 1 & Cohort 2|Death|0
897105|NCT01179737|2956547|P4|Cohort 1 & Cohort 2|Administrative problems|4
897106|NCT01179737|2956548|P3|Cohort 1 & Cohort 2|Administrative problems|2
897107|NCT01179737|2956549|P2|Cohort 1 & Cohort 2|Administrative problems|0
897108|NCT01179737|2956550|P1|Cohort 1 & Cohort 2|Administrative problems|0
897109|NCT01179737|2956547|P4|Cohort 1 & Cohort 2|Withdrew consent|0
897110|NCT01179737|2956548|P3|Cohort 1 & Cohort 2|Withdrew consent|0
897111|NCT01179737|2956549|P2|Cohort 1 & Cohort 2|Withdrew consent|0
897112|NCT01179737|2956550|P1|Cohort 1 & Cohort 2|Withdrew consent|2
897113|NCT01179737|2956547|P4|Cohort 1 & Cohort 2|Adverse Event|0
897114|NCT01179737|2956548|P3|Cohort 1 & Cohort 2|Adverse Event|1
897115|NCT01179737|2956549|P2|Cohort 1 & Cohort 2|Adverse Event|1
897116|NCT01179737|2956550|P1|Cohort 1 & Cohort 2|Adverse Event|3
897117|NCT01179672|2956561|P2|Overall Study|Physician Decision|1
897118|NCT01179672|2956562|P1|Overall Study|Physician Decision|1
897119|NCT01179672|2956561|P2|Overall Study|Protocol Violation|2
897120|NCT01179672|2956562|P1|Overall Study|Protocol Violation|2
897121|NCT01179672|2956561|P2|Overall Study|Lost to Follow-up|1
897122|NCT01179672|2956562|P1|Overall Study|Lost to Follow-up|0
897123|NCT01179672|2956561|P2|Overall Study|Entry Criteria Not Met|2
897124|NCT01179672|2956562|P1|Overall Study|Entry Criteria Not Met|0
897125|NCT01179672|2956561|P2|Overall Study|Withdrawal by Subject|12
897126|NCT01179672|2956562|P1|Overall Study|Withdrawal by Subject|10
897127|NCT01179672|2956561|P2|Overall Study|Adverse Event|8
897128|NCT01179672|2956562|P1|Overall Study|Adverse Event|17
897129|NCT01179516|2956618|P3|Overall Study|Other|2
897130|NCT01179516|2956619|P2|Overall Study|Other|0
897131|NCT01179516|2956620|P1|Overall Study|Other|2
897132|NCT01179516|2956618|P3|Overall Study|Lost to Follow-up|3
897133|NCT01179516|2956619|P2|Overall Study|Lost to Follow-up|7
897134|NCT01179516|2956620|P1|Overall Study|Lost to Follow-up|7
897135|NCT01179516|2956618|P3|Overall Study|Withdrawal of Consent|10
897136|NCT01179516|2956619|P2|Overall Study|Withdrawal of Consent|6
897137|NCT01179516|2956620|P1|Overall Study|Withdrawal of Consent|2
897138|NCT01179516|2956618|P3|Overall Study|Protocol Deviations|3
897139|NCT01179516|2956619|P2|Overall Study|Protocol Deviations|3
897140|NCT01179516|2956620|P1|Overall Study|Protocol Deviations|4
897141|NCT01179516|2956618|P3|Overall Study|Noncompliance with Study Drug|1
897142|NCT01179516|2956619|P2|Overall Study|Noncompliance with Study Drug|0
897143|NCT01179516|2956620|P1|Overall Study|Noncompliance with Study Drug|2
897144|NCT01179516|2956618|P3|Overall Study|Lack of Efficacy|0
897145|NCT01179516|2956619|P2|Overall Study|Lack of Efficacy|2
897146|NCT01179516|2956620|P1|Overall Study|Lack of Efficacy|4
897147|NCT01179516|2956618|P3|Overall Study|Pretreatment Event or Adverse Event|12
897148|NCT01179516|2956619|P2|Overall Study|Pretreatment Event or Adverse Event|8
897149|NCT01179516|2956620|P1|Overall Study|Pretreatment Event or Adverse Event|6
897150|NCT01179399|2956664|P1|Overall Study|Withdrawal by Subject|1
897151|NCT01179399|2956664|P1|Overall Study|Lack of Efficacy|30
897152|NCT01179399|2956664|P1|Overall Study|Adverse Event|1
897153|NCT01179347|2956670|P2|Open-label Period (12 Weeks)|Other|4
897154|NCT01179347|2956671|P1|Open-label Period (12 Weeks)|Other|7
897155|NCT01179347|2956670|P2|Open-label Period (12 Weeks)|Protocol Violation|0
897156|NCT01179347|2956671|P1|Open-label Period (12 Weeks)|Protocol Violation|1
897157|NCT01179347|2956670|P2|Open-label Period (12 Weeks)|Withdrawal by Subject|1
897158|NCT01179347|2956671|P1|Open-label Period (12 Weeks)|Withdrawal by Subject|1
897159|NCT01179347|2956670|P2|Open-label Period (12 Weeks)|Lost to Follow-up|0
897160|NCT01179347|2956671|P1|Open-label Period (12 Weeks)|Lost to Follow-up|1
897161|NCT01179347|2956670|P2|Open-label Period (12 Weeks)|Lack of Efficacy|2
897162|NCT01179347|2956671|P1|Open-label Period (12 Weeks)|Lack of Efficacy|0
897163|NCT01179347|2956670|P2|Open-label Period (12 Weeks)|Adverse Event|9
897164|NCT01179347|2956671|P1|Open-label Period (12 Weeks)|Adverse Event|5
897165|NCT01179347|2956670|P2|Double-blind Period (12 Weeks)|Other|4
897166|NCT01179347|2956671|P1|Double-blind Period (12 Weeks)|Other|2
897167|NCT01179347|2956670|P2|Double-blind Period (12 Weeks)|Withdrawal by Subject|2
897168|NCT01179347|2956671|P1|Double-blind Period (12 Weeks)|Withdrawal by Subject|1
897169|NCT01179347|2956670|P2|Double-blind Period (12 Weeks)|Lost to Follow-up|2
897170|NCT01179347|2956671|P1|Double-blind Period (12 Weeks)|Lost to Follow-up|1
897171|NCT01179347|2956670|P2|Double-blind Period (12 Weeks)|Protocol Violation|0
897172|NCT01179347|2956671|P1|Double-blind Period (12 Weeks)|Protocol Violation|2
897173|NCT01179347|2956670|P2|Double-blind Period (12 Weeks)|Adverse Event|6
897174|NCT01179347|2956671|P1|Double-blind Period (12 Weeks)|Adverse Event|2
897175|NCT01179334|2956693|P2|Long-term Extension (LTE) Period|Adverse Event|4
897176|NCT01179334|2956694|P1|Long-term Extension (LTE) Period|Adverse Event|2
897177|NCT01179334|2956693|P2|Long-term Extension (LTE) Period|Death|0
897178|NCT01179334|2956694|P1|Long-term Extension (LTE) Period|Death|3
897179|NCT01179334|2956693|P2|Long-term Extension (LTE) Period|Study terminated by sponsor|2
897180|NCT01179334|2956694|P1|Long-term Extension (LTE) Period|Study terminated by sponsor|6
897181|NCT01179334|2956693|P2|Treatment Period|Adverse Event|0
897182|NCT01179334|2956694|P1|Treatment Period|Adverse Event|1
897183|NCT01179191|2956749|P1|Maintenance Phase (8 Weeks)|Other|66
897184|NCT01179191|2956749|P1|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29
897185|NCT01179191|2956749|P1|Maintenance Phase (8 Weeks)|Physician Decision|3
897186|NCT01179191|2956749|P1|Maintenance Phase (8 Weeks)|Lost to Follow-up|9
897187|NCT01179191|2956749|P1|Maintenance Phase (8 Weeks)|Adverse Event|10
897188|NCT01179191|2956749|P1|Titration Phase (up to 6 Weeks)|Other|62
897189|NCT01179191|2956749|P1|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13
897190|NCT01179191|2956749|P1|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162
897191|NCT01179191|2956749|P1|Titration Phase (up to 6 Weeks)|Physician Decision|30
897192|NCT01179191|2956749|P1|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19
897193|NCT01179191|2956749|P1|Titration Phase (up to 6 Weeks)|Adverse Event|47
897194|NCT01179048|2956781|P2|Overall Study|Alive|142
897195|NCT01179048|2956782|P1|Overall Study|Alive|127
897196|NCT01179048|2956781|P2|Overall Study|Lost to Follow-up|9
897197|NCT01179048|2956782|P1|Overall Study|Lost to Follow-up|8
897198|NCT01179048|2956781|P2|Overall Study|Withdrawn - does not allow contact|8
897199|NCT01179048|2956782|P1|Overall Study|Withdrawn - does not allow contact|4
897200|NCT01178853|2956809|P2|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1
897201|NCT01178853|2956810|P1|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0
897202|NCT01178853|2956809|P2|Period 4 (Warfarin + Study Drug)|Adverse Event|2
897203|NCT01178853|2956810|P1|Period 4 (Warfarin + Study Drug)|Adverse Event|0
897204|NCT01178853|2956809|P2|Period 3 (Warfarin Titration)|Adverse Event|0
897205|NCT01178853|2956810|P1|Period 3 (Warfarin Titration)|Adverse Event|1
897206|NCT01178853|2956809|P2|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0
897207|NCT01178853|2956810|P1|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1
897208|NCT01178853|2956809|P2|Period 1 (Warfarin Titration)|INR Out of Range|2
897209|NCT01178853|2956810|P1|Period 1 (Warfarin Titration)|INR Out of Range|1
897210|NCT01178762|2956850|P1|Overall Study|Lost to Follow-up|15
897211|NCT01178671|2956856|P2|Overall Study|Physician Decision|6
897212|NCT01178671|2956857|P1|Overall Study|Physician Decision|4
897213|NCT01178671|2956856|P2|Overall Study|Lost to Follow-up|1
897214|NCT01178671|2956857|P1|Overall Study|Lost to Follow-up|3
897215|NCT01178671|2956856|P2|Overall Study|Lack of Efficacy|1
897216|NCT01178671|2956857|P1|Overall Study|Lack of Efficacy|0
897217|NCT01178671|2956856|P2|Overall Study|Protocol Violation|1
897218|NCT01178671|2956857|P1|Overall Study|Protocol Violation|1
897219|NCT01178671|2956856|P2|Overall Study|Adverse Event|6
897220|NCT01178671|2956857|P1|Overall Study|Adverse Event|4
897221|NCT01178385|2956905|P2|Overall Study|Withdrawal by Subject|0
897222|NCT01178385|2956906|P1|Overall Study|Withdrawal by Subject|2
897223|NCT01178294|2956975|P1|Overall Study|Completion status could not be verified|1
897224|NCT01178294|2956975|P1|Overall Study|Subject status is terminal|1
897225|NCT01178294|2956975|P1|Overall Study|Development of inhibitors to OBI-1|1
897226|NCT01178294|2956975|P1|Overall Study|Death|1
897227|NCT01178294|2956975|P1|Overall Study|Lack of Efficacy|1
897228|NCT01178294|2956975|P1|Overall Study|Lost to Follow-up|2
897229|NCT01178294|2956975|P1|Overall Study|Adverse Event|4
897230|NCT01178281|2956998|P2|Overall Study|Prohibited Medications|2
897231|NCT01178281|2956999|P1|Overall Study|Prohibited Medications|0
897232|NCT01178281|2956998|P2|Overall Study|Adverse Event|9
897233|NCT01178281|2956999|P1|Overall Study|Adverse Event|39
897234|NCT01178281|2956998|P2|Overall Study|Withdrawal by Subject|7
897235|NCT01178281|2956999|P1|Overall Study|Withdrawal by Subject|18
897236|NCT01178281|2956998|P2|Overall Study|Death|5
897237|NCT01178281|2956999|P1|Overall Study|Death|4
897238|NCT01178281|2956998|P2|Overall Study|Disease Progression|6
897239|NCT01178281|2956999|P1|Overall Study|Disease Progression|18
897240|NCT01178281|2956998|P2|Overall Study|Non-compliance to study drug|0
897241|NCT01178281|2956999|P1|Overall Study|Non-compliance to study drug|1
897242|NCT01178281|2956998|P2|Overall Study|Lack of Efficacy|38
897243|NCT01178281|2956999|P1|Overall Study|Lack of Efficacy|60
897244|NCT01178281|2956998|P2|Overall Study|Loss of Clinical Benefit|7
897245|NCT01178281|2956999|P1|Overall Study|Loss of Clinical Benefit|5
897246|NCT01178281|2956998|P2|Overall Study|Physician Decision|3
897247|NCT01178281|2956999|P1|Overall Study|Physician Decision|4
897248|NCT01178138|2957234|P1|Overall Study|Physician Decision|8
897249|NCT01178138|2957234|P1|Overall Study|Withdrawal by Subject|7
897250|NCT01178138|2957234|P1|Overall Study|Lost to Follow-up|8
897251|NCT01178125|2957255|P1|Overall Study|Investigator Decision|5
897252|NCT01178125|2957255|P1|Overall Study|Protocol Violation|17
897253|NCT01178125|2957255|P1|Overall Study|Sponsor Decision|28
897254|NCT01178125|2957255|P1|Overall Study|Other Reason|39
897255|NCT01178125|2957255|P1|Overall Study|Pregnancy|55
897256|NCT01178125|2957255|P1|Overall Study|Noncompliance|184
897257|NCT01178125|2957255|P1|Overall Study|Withdrawal by Subject|209
897258|NCT01178125|2957255|P1|Overall Study|Adverse Event|244
897259|NCT01178125|2957255|P1|Overall Study|Lost to Follow-up|397
897260|NCT01178099|2957286|P2|Overall Study|Physician Decision|1
897261|NCT01178099|2957287|P1|Overall Study|Physician Decision|0
897262|NCT01178086|2957327|P1|Overall Study|Excluded from EAS|20
897263|NCT01178086|2957327|P1|Overall Study|Other unspecified|89
897264|NCT01178086|2957327|P1|Overall Study|Death|59
897265|NCT01178086|2957327|P1|Overall Study|Switch to other CLL therapy|113
897266|NCT01178086|2957327|P1|Overall Study|Physician Decision|44
897267|NCT01178086|2957327|P1|Overall Study|Participant refusal|7
897268|NCT01178073|2957354|P3|Overall Study|Missing Completion Status|0
897269|NCT01178073|2957355|P2|Overall Study|Missing Completion Status|0
897270|NCT01178073|2957356|P1|Overall Study|Missing Completion Status|1
897271|NCT01178073|2957354|P3|Overall Study|Withdrawal by Subject|8
897272|NCT01178073|2957355|P2|Overall Study|Withdrawal by Subject|6
897273|NCT01178073|2957356|P1|Overall Study|Withdrawal by Subject|10
897274|NCT01178073|2957354|P3|Overall Study|Physician Decision|10
897275|NCT01178073|2957355|P2|Overall Study|Physician Decision|10
897276|NCT01178073|2957356|P1|Overall Study|Physician Decision|14
897277|NCT01178073|2957354|P3|Overall Study|Lost to Follow-up|3
897278|NCT01178073|2957355|P2|Overall Study|Lost to Follow-up|0
897279|NCT01178073|2957356|P1|Overall Study|Lost to Follow-up|2
897280|NCT01178073|2957354|P3|Overall Study|Protocol Violation|1
897281|NCT01178073|2957355|P2|Overall Study|Protocol Violation|1
897282|NCT01178073|2957356|P1|Overall Study|Protocol Violation|1
897283|NCT01178073|2957354|P3|Overall Study|Adverse Event|24
897284|NCT01178073|2957355|P2|Overall Study|Adverse Event|27
897285|NCT01178073|2957356|P1|Overall Study|Adverse Event|34
897286|NCT01177969|2957387|P2|Overall Study|Withdrawal by Subject|2
897287|NCT01177969|2957388|P1|Overall Study|Withdrawal by Subject|1
897288|NCT01177969|2957387|P2|Overall Study|Protocol Violation|1
897289|NCT01177969|2957388|P1|Overall Study|Protocol Violation|2
897290|NCT01177943|2957411|P2|First Intervention|Withdrawal by Subject|0
897291|NCT01177943|2957412|P1|First Intervention|Withdrawal by Subject|2
897292|NCT01177813|2957425|P5|Overall Study|Other reason not defined above|2
897293|NCT01177813|2957426|P4|Overall Study|Other reason not defined above|3
897294|NCT01177813|2957427|P3|Overall Study|Other reason not defined above|2
897295|NCT01177813|2957428|P2|Overall Study|Other reason not defined above|2
897296|NCT01177813|2957429|P1|Overall Study|Other reason not defined above|5
897297|NCT01177813|2957425|P5|Overall Study|Withdrawal by Subject|3
897298|NCT01177813|2957426|P4|Overall Study|Withdrawal by Subject|5
897299|NCT01177813|2957427|P3|Overall Study|Withdrawal by Subject|6
897300|NCT01177813|2957428|P2|Overall Study|Withdrawal by Subject|7
897301|NCT01177813|2957429|P1|Overall Study|Withdrawal by Subject|12
897302|NCT01177813|2957425|P5|Overall Study|Lost to Follow-up|0
897303|NCT01177813|2957426|P4|Overall Study|Lost to Follow-up|3
897304|NCT01177813|2957427|P3|Overall Study|Lost to Follow-up|6
897305|NCT01177813|2957428|P2|Overall Study|Lost to Follow-up|5
897306|NCT01177813|2957429|P1|Overall Study|Lost to Follow-up|12
897307|NCT01177813|2957425|P5|Overall Study|Protocol Violation|1
897308|NCT01177813|2957426|P4|Overall Study|Protocol Violation|0
897309|NCT01177813|2957427|P3|Overall Study|Protocol Violation|2
897310|NCT01177813|2957428|P2|Overall Study|Protocol Violation|2
897311|NCT01177813|2957429|P1|Overall Study|Protocol Violation|3
897312|NCT01177813|2957425|P5|Overall Study|Lack of Efficacy|0
897313|NCT01177813|2957426|P4|Overall Study|Lack of Efficacy|0
897314|NCT01177813|2957427|P3|Overall Study|Lack of Efficacy|0
897315|NCT01177813|2957428|P2|Overall Study|Lack of Efficacy|0
897316|NCT01177813|2957429|P1|Overall Study|Lack of Efficacy|1
897317|NCT01177813|2957425|P5|Overall Study|Adverse Event|3
897318|NCT01177813|2957426|P4|Overall Study|Adverse Event|6
897319|NCT01177813|2957427|P3|Overall Study|Adverse Event|4
897320|NCT01177813|2957428|P2|Overall Study|Adverse Event|2
897321|NCT01177813|2957429|P1|Overall Study|Adverse Event|8
897322|NCT01177800|2957458|P2|Overall Study|Withdrawal of informed consent|1
897323|NCT01177800|2957459|P1|Overall Study|Withdrawal of informed consent|0
897324|NCT01177800|2957458|P2|Overall Study|Physician Decision|0
897325|NCT01177800|2957459|P1|Overall Study|Physician Decision|1
897326|NCT01177800|2957458|P2|Overall Study|Protocol Violation|1
897327|NCT01177800|2957459|P1|Overall Study|Protocol Violation|0
897328|NCT01177800|2957458|P2|Overall Study|Adverse Event|3
897329|NCT01177800|2957459|P1|Overall Study|Adverse Event|9
897330|NCT01177722|2957481|P4|Overall Study|Withdrawal by Subject|6
897331|NCT01177722|2957482|P3|Overall Study|Withdrawal by Subject|4
897332|NCT01177722|2957483|P2|Overall Study|Withdrawal by Subject|6
897333|NCT01177722|2957484|P1|Overall Study|Withdrawal by Subject|10
897334|NCT01177722|2957481|P4|Overall Study|Lost to Follow-up|1
897335|NCT01177722|2957482|P3|Overall Study|Lost to Follow-up|3
897336|NCT01177722|2957483|P2|Overall Study|Lost to Follow-up|4
897337|NCT01177722|2957484|P1|Overall Study|Lost to Follow-up|3
897338|NCT01177722|2957481|P4|Overall Study|Protocol Violation|0
897339|NCT01177722|2957482|P3|Overall Study|Protocol Violation|1
897340|NCT01177722|2957483|P2|Overall Study|Protocol Violation|0
897341|NCT01177722|2957484|P1|Overall Study|Protocol Violation|0
897342|NCT01177722|2957481|P4|Overall Study|Serious Adverse Event|0
897343|NCT01177722|2957482|P3|Overall Study|Serious Adverse Event|1
897344|NCT01177722|2957483|P2|Overall Study|Serious Adverse Event|0
897345|NCT01177722|2957484|P1|Overall Study|Serious Adverse Event|0
897346|NCT01177670|2957516|P1|Overall Study|Withdrawal by Subject|4
897347|NCT01177670|2957516|P1|Overall Study|Physician Decision|50
897348|NCT01177670|2957516|P1|Overall Study|Study Terminated|115
897349|NCT01177553|2957523|P2|Overall Study|babies not yet 6 months of age|0
897350|NCT01177553|2957524|P1|Overall Study|babies not yet 6 months of age|1
897351|NCT01177410|2957533|P3|Overall Study|Lost to Follow-up|0
897352|NCT01177410|2957534|P2|Overall Study|Lost to Follow-up|1
897353|NCT01177410|2957535|P1|Overall Study|Lost to Follow-up|0
897354|NCT01177410|2957533|P3|Overall Study|Withdrawal by Subject|3
897355|NCT01177410|2957534|P2|Overall Study|Withdrawal by Subject|4
897356|NCT01177410|2957535|P1|Overall Study|Withdrawal by Subject|1
897357|NCT01177410|2957533|P3|Overall Study|Adverse Event|2
897358|NCT01177410|2957534|P2|Overall Study|Adverse Event|2
897359|NCT01177410|2957535|P1|Overall Study|Adverse Event|0
897360|NCT01177384|2957548|P2|Overall Study|Withdrawal by Subject|12
897361|NCT01177384|2957549|P1|Overall Study|Withdrawal by Subject|5
897362|NCT01177384|2957548|P2|Overall Study|Protocol Violation|2
897363|NCT01177384|2957549|P1|Overall Study|Protocol Violation|0
897364|NCT01177384|2957548|P2|Overall Study|Physician Decision|3
897365|NCT01177384|2957549|P1|Overall Study|Physician Decision|0
897366|NCT01177384|2957548|P2|Overall Study|Lost to Follow-up|4
897367|NCT01177384|2957549|P1|Overall Study|Lost to Follow-up|3
897368|NCT01177384|2957548|P2|Overall Study|Lack of Efficacy|1
897369|NCT01177384|2957549|P1|Overall Study|Lack of Efficacy|0
897370|NCT01177384|2957548|P2|Overall Study|Adverse Event|4
897371|NCT01177384|2957549|P1|Overall Study|Adverse Event|6
897372|NCT01177293|2957561|P2|Washout Period (of 14 Days)|Lost to Follow-up|1
897373|NCT01177293|2957562|P1|Washout Period (of 14 Days)|Lost to Follow-up|0
897374|NCT01177228|2957580|P4|Overall Study|Withdrawal by Subject|0
897375|NCT01177228|2957581|P3|Overall Study|Withdrawal by Subject|0
897376|NCT01177228|2957582|P2|Overall Study|Withdrawal by Subject|1
897377|NCT01177228|2957583|P1|Overall Study|Withdrawal by Subject|0
897378|NCT01177228|2957580|P4|Overall Study|Worsening disease activity|0
897379|NCT01177228|2957581|P3|Overall Study|Worsening disease activity|0
897380|NCT01177228|2957582|P2|Overall Study|Worsening disease activity|0
897381|NCT01177228|2957583|P1|Overall Study|Worsening disease activity|1
897382|NCT01177228|2957580|P4|Overall Study|Positive tuberculosis test|0
897383|NCT01177228|2957581|P3|Overall Study|Positive tuberculosis test|0
897384|NCT01177228|2957582|P2|Overall Study|Positive tuberculosis test|1
897385|NCT01177228|2957583|P1|Overall Study|Positive tuberculosis test|0
897386|NCT01177137|2957624|P3|Overall Study|Withdrawal by Subject|2
897387|NCT01177137|2957625|P2|Overall Study|Withdrawal by Subject|10
897388|NCT01177137|2957626|P1|Overall Study|Withdrawal by Subject|10
897389|NCT01177007|2957710|P1|Overall Study|Change in treatment modality|21
897390|NCT01177007|2957710|P1|Overall Study|Required additional Y90 treatment|6
897391|NCT01177007|2957710|P1|Overall Study|Entered hospice care|5
897392|NCT01177007|2957710|P1|Overall Study|Death|4
897393|NCT01177007|2957710|P1|Overall Study|Lost to Follow-up|2
897394|NCT01176968|2957724|P2|Overall Study|Reason not defined|3
897395|NCT01176968|2957725|P1|Overall Study|Reason not defined|5
897396|NCT01176968|2957724|P2|Overall Study|Study terminated by sponsor|1
897397|NCT01176968|2957725|P1|Overall Study|Study terminated by sponsor|0
897398|NCT01176968|2957724|P2|Overall Study|Did Not Meet Entrance Criteria|0
897399|NCT01176968|2957725|P1|Overall Study|Did Not Meet Entrance Criteria|1
897400|NCT01176968|2957724|P2|Overall Study|Protocol Violation|1
897401|NCT01176968|2957725|P1|Overall Study|Protocol Violation|2
897402|NCT01176968|2957724|P2|Overall Study|Withdrawal by Subject|48
897403|NCT01176968|2957725|P1|Overall Study|Withdrawal by Subject|48
897404|NCT01176968|2957724|P2|Overall Study|Lost to Follow-up|14
897405|NCT01176968|2957725|P1|Overall Study|Lost to Follow-up|16
897406|NCT01176968|2957724|P2|Overall Study|Lack of Efficacy|1
897407|NCT01176968|2957725|P1|Overall Study|Lack of Efficacy|0
897408|NCT01176968|2957724|P2|Overall Study|Death|3
897409|NCT01176968|2957725|P1|Overall Study|Death|2
897410|NCT01176968|2957724|P2|Overall Study|Adverse Event|11
897411|NCT01176968|2957725|P1|Overall Study|Adverse Event|10
897412|NCT01176773|2957776|P1|Overall Study|Withdrew consent|1
897413|NCT01176773|2957776|P1|Overall Study|Screen Failure|2
897414|NCT01176565|2957800|P2|Overall Study|Not Analyzed (any other reason)|2
897415|NCT01176565|2957801|P1|Overall Study|Not Analyzed (any other reason)|1
897416|NCT01176565|2957800|P2|Overall Study|Withdrawal by Subject|1
897417|NCT01176565|2957801|P1|Overall Study|Withdrawal by Subject|7
897418|NCT01176565|2957800|P2|Overall Study|Lost to Follow-up|16
897419|NCT01176565|2957801|P1|Overall Study|Lost to Follow-up|12
897420|NCT01176513|2957819|P1|Overall Study|Withdrew subjects prior to dosing|3
897421|NCT01176292|2957847|P2|Overall Study|Has not scheduled one-year visit yet|2
897422|NCT01176292|2957848|P1|Overall Study|Has not scheduled one-year visit yet|2
897423|NCT01176292|2957847|P2|Overall Study|Physician Decision|2
897424|NCT01176292|2957848|P1|Overall Study|Physician Decision|0
897425|NCT01176292|2957847|P2|Overall Study|Adverse Event|1
897426|NCT01176292|2957848|P1|Overall Study|Adverse Event|1
897427|NCT01176292|2957847|P2|Overall Study|Lost to Follow-up|4
897428|NCT01176292|2957848|P1|Overall Study|Lost to Follow-up|2
897429|NCT01176266|2957866|P1|Overall Study|Withdrawal by Subject|3
897430|NCT01176266|2957866|P1|Overall Study|Death|6
897431|NCT01176240|2957890|P2|Study 306B|withdrew prior to dosing|1
897432|NCT01176240|2957891|P1|Study 306B|withdrew prior to dosing|2
897433|NCT01176240|2957890|P2|Study 306B|Lost to Follow-up|1
897434|NCT01176240|2957891|P1|Study 306B|Lost to Follow-up|0
897435|NCT01176240|2957890|P2|Study 306B|Supine Hypertension|2
897436|NCT01176240|2957891|P1|Study 306B|Supine Hypertension|1
897437|NCT01176240|2957890|P2|Study 306B|Physician Decision|1
897438|NCT01176240|2957891|P1|Study 306B|Physician Decision|2
897439|NCT01176240|2957890|P2|Study 306B|Withdrawal by Subject|1
897440|NCT01176240|2957891|P1|Study 306B|Withdrawal by Subject|4
897441|NCT01176240|2957890|P2|Study 306B|Protocol Violation|3
897442|NCT01176240|2957891|P1|Study 306B|Protocol Violation|2
897443|NCT01176240|2957890|P2|Study 306B|Adverse Event|5
897444|NCT01176240|2957891|P1|Study 306B|Adverse Event|10
897445|NCT01176240|2957890|P2|Study 306B|Lack of Efficacy|3
897446|NCT01176240|2957891|P1|Study 306B|Lack of Efficacy|5
897447|NCT01176240|2957890|P2|Study 306A|Stop due to diverse problems|0
897448|NCT01176240|2957891|P1|Study 306A|Stop due to diverse problems|1
897449|NCT01176240|2957890|P2|Study 306A|Withdrawal by Subject|1
897450|NCT01176240|2957891|P1|Study 306A|Withdrawal by Subject|0
897451|NCT01176240|2957890|P2|Study 306A|Protocol Violation|1
897452|NCT01176240|2957891|P1|Study 306A|Protocol Violation|0
897453|NCT01176240|2957890|P2|Study 306A|Lack of Efficacy|1
897454|NCT01176240|2957891|P1|Study 306A|Lack of Efficacy|2
897455|NCT01176058|2957917|P2|Overall Study|Withdrawal by Subject|0
897456|NCT01176058|2957918|P1|Overall Study|Withdrawal by Subject|1
897457|NCT01176058|2957917|P2|Overall Study|Insufficient mycological response|1
897458|NCT01176058|2957918|P1|Overall Study|Insufficient mycological response|0
897459|NCT01176058|2957917|P2|Overall Study|Insufficient clinical response|2
897460|NCT01176058|2957918|P1|Overall Study|Insufficient clinical response|2
897461|NCT01176058|2957917|P2|Overall Study|Adverse Event|0
897462|NCT01176058|2957918|P1|Overall Study|Adverse Event|1
897463|NCT01176032|2957942|P2|Overall Study|Not available|0
897464|NCT01176032|2957943|P1|Overall Study|Not available|1
897465|NCT01176032|2957942|P2|Overall Study|Informed consent withdrawn|0
897466|NCT01176032|2957943|P1|Overall Study|Informed consent withdrawn|3
897467|NCT01176032|2957942|P2|Overall Study|Protocol Violation|0
897468|NCT01176032|2957943|P1|Overall Study|Protocol Violation|1
897469|NCT01176032|2957942|P2|Overall Study|Unsatisfactory therapeutic effect|1
897470|NCT01176032|2957943|P1|Overall Study|Unsatisfactory therapeutic effect|0
897471|NCT01176032|2957942|P2|Overall Study|Adverse Event|0
897472|NCT01176032|2957943|P1|Overall Study|Adverse Event|1
897473|NCT01175824|2958067|P2|Overall Study|Entry Criteria Not Met|4
897474|NCT01175824|2958068|P1|Overall Study|Entry Criteria Not Met|6
897475|NCT01175824|2958067|P2|Overall Study|Sponsor Decision|0
897476|NCT01175824|2958068|P1|Overall Study|Sponsor Decision|1
897477|NCT01175824|2958067|P2|Overall Study|Withdrawal by Subject|7
897478|NCT01175824|2958068|P1|Overall Study|Withdrawal by Subject|3
897479|NCT01175824|2958067|P2|Overall Study|Protocol Violation|5
897480|NCT01175824|2958068|P1|Overall Study|Protocol Violation|2
897481|NCT01175824|2958067|P2|Overall Study|Physician Decision|4
897482|NCT01175824|2958068|P1|Overall Study|Physician Decision|0
897483|NCT01175824|2958067|P2|Overall Study|Lost to Follow-up|1
897484|NCT01175824|2958068|P1|Overall Study|Lost to Follow-up|0
897485|NCT01175824|2958067|P2|Overall Study|Lack of Efficacy|0
897486|NCT01175824|2958068|P1|Overall Study|Lack of Efficacy|2
897487|NCT01175824|2958067|P2|Overall Study|Adverse Event|1
897488|NCT01175824|2958068|P1|Overall Study|Adverse Event|2
897489|NCT01175811|2958102|P2|Overall Study|Withdrawal by Subject|7
897490|NCT01175811|2958103|P1|Overall Study|Withdrawal by Subject|6
897491|NCT01175811|2958102|P2|Overall Study|Protocol Violation|2
897492|NCT01175811|2958103|P1|Overall Study|Protocol Violation|1
897493|NCT01175811|2958102|P2|Overall Study|Physician Decision|1
897494|NCT01175811|2958103|P1|Overall Study|Physician Decision|1
897495|NCT01175811|2958102|P2|Overall Study|Lost to Follow-up|2
897496|NCT01175811|2958103|P1|Overall Study|Lost to Follow-up|3
897497|NCT01175811|2958102|P2|Overall Study|Lack of Efficacy|0
897498|NCT01175811|2958103|P1|Overall Study|Lack of Efficacy|1
897499|NCT01175811|2958102|P2|Overall Study|Entry criteria not met|1
897500|NCT01175811|2958103|P1|Overall Study|Entry criteria not met|3
897501|NCT01175811|2958102|P2|Overall Study|Adverse Event|1
897502|NCT01175811|2958103|P1|Overall Study|Adverse Event|1
897503|NCT01175707|2958138|P2|Overall Study|Adverse Event|6
897504|NCT01175707|2958139|P1|Overall Study|Adverse Event|4
897505|NCT01175668|2958175|P2|Overall Study|Withdrawal by Subject|0
897506|NCT01175668|2958176|P1|Overall Study|Withdrawal by Subject|2
897507|NCT01175590|2958186|P2|Overall Study|Protocol Violation|1
897508|NCT01175590|2958187|P1|Overall Study|Protocol Violation|0
897509|NCT01175590|2958186|P2|Overall Study|Herpes Simplex Dermatitis|0
897510|NCT01175590|2958187|P1|Overall Study|Herpes Simplex Dermatitis|1
897511|NCT01175590|2958186|P2|Overall Study|Treated not as randomized|2
897512|NCT01175590|2958187|P1|Overall Study|Treated not as randomized|3
897513|NCT01175590|2958186|P2|Overall Study|Residual Bacterial Conjunctivitis|0
897514|NCT01175590|2958187|P1|Overall Study|Residual Bacterial Conjunctivitis|1
897515|NCT01175590|2958186|P2|Overall Study|Lack of Efficacy|1
897516|NCT01175590|2958187|P1|Overall Study|Lack of Efficacy|1
897517|NCT01175590|2958186|P2|Overall Study|Physician Decision|4
897518|NCT01175590|2958187|P1|Overall Study|Physician Decision|1
897519|NCT01175590|2958186|P2|Overall Study|Adverse Event|0
897520|NCT01175590|2958187|P1|Overall Study|Adverse Event|4
897521|NCT01175590|2958186|P2|Overall Study|Withdrawal by Subject|2
897522|NCT01175590|2958187|P1|Overall Study|Withdrawal by Subject|0
897523|NCT01175590|2958186|P2|Overall Study|Lost to Follow-up|0
897524|NCT01175590|2958187|P1|Overall Study|Lost to Follow-up|1
897525|NCT01175473|2958221|P2|Overall Study|Adverse Event|2
897526|NCT01175473|2958222|P1|Overall Study|Adverse Event|2
897527|NCT01175382|2958263|P3|Overall Study|Unable to tolerate study meds|1
897528|NCT01175382|2958264|P2|Overall Study|Unable to tolerate study meds|1
897529|NCT01175382|2958265|P1|Overall Study|Unable to tolerate study meds|0
897530|NCT01175382|2958263|P3|Overall Study|Unwilling to follow protocol|0
897531|NCT01175382|2958264|P2|Overall Study|Unwilling to follow protocol|1
897532|NCT01175382|2958265|P1|Overall Study|Unwilling to follow protocol|0
897533|NCT01175382|2958263|P3|Overall Study|Unable/unwilling to attend visits|2
897534|NCT01175382|2958264|P2|Overall Study|Unable/unwilling to attend visits|1
897535|NCT01175382|2958265|P1|Overall Study|Unable/unwilling to attend visits|3
897536|NCT01175382|2958263|P3|Overall Study|No longer having problem|1
897537|NCT01175382|2958264|P2|Overall Study|No longer having problem|0
897538|NCT01175382|2958265|P1|Overall Study|No longer having problem|1
897539|NCT01175382|2958263|P3|Overall Study|Withdrawal by Subject|1
897540|NCT01175382|2958264|P2|Overall Study|Withdrawal by Subject|0
897541|NCT01175382|2958265|P1|Overall Study|Withdrawal by Subject|0
897542|NCT01175382|2958263|P3|Overall Study|Physician Decision|0
897543|NCT01175382|2958264|P2|Overall Study|Physician Decision|1
897544|NCT01175382|2958265|P1|Overall Study|Physician Decision|0
897545|NCT01175382|2958263|P3|Overall Study|Lost to Follow-up|1
897546|NCT01175382|2958264|P2|Overall Study|Lost to Follow-up|3
897547|NCT01175382|2958265|P1|Overall Study|Lost to Follow-up|4
897548|NCT01175356|2958351|P1|Overall Study|Initiation other tx prior to completion|9
897549|NCT01175356|2958351|P1|Overall Study|Inadequate stem cell for transplant|1
897550|NCT01175356|2958351|P1|Overall Study|On other COG study w/tumor tx intent|7
897551|NCT01175356|2958351|P1|Overall Study|Pts MIBG non-avid after enrollment|2
897552|NCT01175356|2958351|P1|Overall Study|Refusal by patient/parent/guardian|6
897553|NCT01175356|2958351|P1|Overall Study|Treatment Slot Not Available|18
897554|NCT01175356|2958351|P1|Overall Study|Ineligible|1
897555|NCT01175356|2958351|P1|Overall Study|Physician Decision|23
897556|NCT01175356|2958351|P1|Overall Study|Lost to Follow-up|1
897557|NCT01175356|2958351|P1|Overall Study|Lack of Efficacy|12
897558|NCT01175356|2958351|P1|Overall Study|Death|1
897559|NCT01175213|2958391|P2|Safety Follow-up|Adverse Event|0
897560|NCT01175213|2958392|P1|Safety Follow-up|Adverse Event|1
897561|NCT01175213|2958391|P2|IGSC, 10%/rHuPH20|site elected to exit study|0
897562|NCT01175213|2958392|P1|IGSC, 10%/rHuPH20|site elected to exit study|3
897563|NCT01175213|2958391|P2|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0
897564|NCT01175213|2958392|P1|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6
897565|NCT01175213|2958391|P2|IGSC, 10%/rHuPH20|bone marrow transplant|0
897566|NCT01175213|2958392|P1|IGSC, 10%/rHuPH20|bone marrow transplant|1
897567|NCT01175213|2958391|P2|IGSC, 10%/rHuPH20|Death|0
897568|NCT01175213|2958392|P1|IGSC, 10%/rHuPH20|Death|1
897569|NCT01175213|2958391|P2|IGSC, 10%/rHuPH20|Withdrawal by Subject|0
897570|NCT01175213|2958392|P1|IGSC, 10%/rHuPH20|Withdrawal by Subject|4
897571|NCT01175135|2958449|P4|Overall Study|Randomized But Not Treated|0
897572|NCT01175135|2958450|P3|Overall Study|Randomized But Not Treated|1
897573|NCT01175135|2958451|P2|Overall Study|Randomized But Not Treated|0
897574|NCT01175135|2958452|P1|Overall Study|Randomized But Not Treated|0
897575|NCT01175135|2958449|P4|Overall Study|Other|0
897576|NCT01175135|2958450|P3|Overall Study|Other|3
897577|NCT01175135|2958451|P2|Overall Study|Other|1
897578|NCT01175135|2958452|P1|Overall Study|Other|3
897579|NCT01175135|2958449|P4|Overall Study|Withdrawal by Subject|5
897580|NCT01175135|2958450|P3|Overall Study|Withdrawal by Subject|5
897581|NCT01175135|2958451|P2|Overall Study|Withdrawal by Subject|8
897582|NCT01175135|2958452|P1|Overall Study|Withdrawal by Subject|4
897583|NCT01175135|2958449|P4|Overall Study|Protocol Violation|0
897584|NCT01175135|2958450|P3|Overall Study|Protocol Violation|0
897585|NCT01175135|2958451|P2|Overall Study|Protocol Violation|1
897586|NCT01175135|2958452|P1|Overall Study|Protocol Violation|1
897587|NCT01175135|2958449|P4|Overall Study|Lost to Follow-up|0
897588|NCT01175135|2958450|P3|Overall Study|Lost to Follow-up|0
897589|NCT01175135|2958451|P2|Overall Study|Lost to Follow-up|2
897590|NCT01175135|2958452|P1|Overall Study|Lost to Follow-up|1
897591|NCT01175135|2958449|P4|Overall Study|Lack of Efficacy|5
897592|NCT01175135|2958450|P3|Overall Study|Lack of Efficacy|0
897593|NCT01175135|2958451|P2|Overall Study|Lack of Efficacy|5
897594|NCT01175135|2958452|P1|Overall Study|Lack of Efficacy|4
897595|NCT01175135|2958449|P4|Overall Study|Death|0
897596|NCT01175135|2958450|P3|Overall Study|Death|0
897597|NCT01175135|2958451|P2|Overall Study|Death|0
897598|NCT01175135|2958452|P1|Overall Study|Death|1
897599|NCT01175135|2958449|P4|Overall Study|Adverse Event|4
897600|NCT01175135|2958450|P3|Overall Study|Adverse Event|3
897601|NCT01175135|2958451|P2|Overall Study|Adverse Event|5
897602|NCT01175135|2958452|P1|Overall Study|Adverse Event|2
897603|NCT01175018|2958544|P2|Overall Study|Adverse Event|1
897604|NCT01175018|2958545|P1|Overall Study|Adverse Event|3
897605|NCT01174563|2958632|P1|Overall Study|Sponsor's decision|1
897606|NCT01174563|2958632|P1|Overall Study|Rash Adverse Event|1
897607|NCT01174563|2958632|P1|Overall Study|Participant Withdrew Consent|3
897608|NCT01174563|2958632|P1|Overall Study|Investigator's Discretion|5
897609|NCT01174563|2958632|P1|Overall Study|Death|5
897610|NCT01174563|2958632|P1|Overall Study|Progressive Disease|45
897611|NCT01174550|2958640|P2|Overall Study|Withdrawal by Subject|289
897612|NCT01174550|2958641|P1|Overall Study|Withdrawal by Subject|543
897613|NCT01174550|2958640|P2|Overall Study|Lost to Follow-up|510
897614|NCT01174550|2958641|P1|Overall Study|Lost to Follow-up|652
897615|NCT01174550|2958640|P2|Overall Study|Death|74
897616|NCT01174550|2958641|P1|Overall Study|Death|75
897617|NCT01174459|2958669|P1|Overall Study|case report form (CRF) not collected|5
897618|NCT01174446|2958674|P4|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
897619|NCT01174446|2958675|P3|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
897620|NCT01174446|2958676|P2|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1
897621|NCT01174446|2958677|P1|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
897622|NCT01174446|2958674|P4|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
897623|NCT01174446|2958675|P3|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
897624|NCT01174446|2958676|P2|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
897625|NCT01174446|2958677|P1|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1
897626|NCT01174446|2958674|P4|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
897627|NCT01174446|2958675|P3|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1
897628|NCT01174446|2958676|P2|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
897629|NCT01174446|2958677|P1|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
897630|NCT01174446|2958674|P4|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
897631|NCT01174446|2958675|P3|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1
897632|NCT01174446|2958676|P2|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
897633|NCT01174446|2958677|P1|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
897634|NCT01174368|2958864|P1|Overall Study|Withdrawal by Subject|1
897635|NCT01174342|2958870|P1|Overall Study|Conversion to cesarean section|4
897636|NCT01174264|2958877|P3|Steady-state Pharmacokinetics|Not evaluable|2
897637|NCT01174264|2958878|P2|Steady-state Pharmacokinetics|Not evaluable|0
897638|NCT01174264|2958879|P1|Steady-state Pharmacokinetics|Not evaluable|6
897639|NCT01174264|2958877|P3|Single Dose Pharmacokinetics|Patient entered hospice care|1
897640|NCT01174264|2958878|P2|Single Dose Pharmacokinetics|Patient entered hospice care|0
897641|NCT01174264|2958879|P1|Single Dose Pharmacokinetics|Patient entered hospice care|0
897642|NCT01174264|2958877|P3|Single Dose Pharmacokinetics|Early progressive disease|1
897643|NCT01174264|2958878|P2|Single Dose Pharmacokinetics|Early progressive disease|0
897644|NCT01174264|2958879|P1|Single Dose Pharmacokinetics|Early progressive disease|1
897645|NCT01174238|2958911|P1|Overall Study|Lost to Follow-up|2
897646|NCT01174186|2958922|P2|Overall Study|Withdrawal by Subject|2
897647|NCT01174186|2958923|P1|Overall Study|Withdrawal by Subject|0
897648|NCT01174186|2958922|P2|Overall Study|Lost to Follow-up|1
897649|NCT01174186|2958923|P1|Overall Study|Lost to Follow-up|0
897650|NCT01174173|2958930|P1|Overall Study|drug-drug interaction|1
897651|NCT01174160|2958941|P2|Overall Study|Withdrawal by Subject|0
897652|NCT01174160|2958942|P1|Overall Study|Withdrawal by Subject|1
897653|NCT01174160|2958941|P2|Overall Study|Protocol Violation|6
897654|NCT01174160|2958942|P1|Overall Study|Protocol Violation|4
897655|NCT01174160|2958941|P2|Overall Study|Physician Decision|0
897656|NCT01174160|2958942|P1|Overall Study|Physician Decision|1
897657|NCT01174160|2958941|P2|Overall Study|Lost to Follow-up|0
897658|NCT01174160|2958942|P1|Overall Study|Lost to Follow-up|1
897659|NCT01174160|2958941|P2|Overall Study|Adverse Event|0
897660|NCT01174160|2958942|P1|Overall Study|Adverse Event|1
897661|NCT01174043|2958957|P1|Overall Study|Withdrawal by Subject|2
897662|NCT01174043|2958957|P1|Overall Study|Death|1
897663|NCT01174043|2958957|P1|Overall Study|Adverse Event|3
897664|NCT01174043|2958957|P1|Overall Study|Disease progression|5
897665|NCT01174004|2958996|P2|Overall Study|Physician Decision|0
897666|NCT01174004|2958997|P1|Overall Study|Physician Decision|1
897667|NCT01174004|2958996|P2|Overall Study|Protocol Violation|1
897668|NCT01174004|2958997|P1|Overall Study|Protocol Violation|0
897669|NCT01174004|2958996|P2|Overall Study|At Discretion of Sponsor|2
897670|NCT01174004|2958997|P1|Overall Study|At Discretion of Sponsor|2
897671|NCT01174004|2958996|P2|Overall Study|Withdrawal by Subject|3
897672|NCT01174004|2958997|P1|Overall Study|Withdrawal by Subject|2
897673|NCT01174004|2958996|P2|Overall Study|Adverse Event|10
897674|NCT01174004|2958997|P1|Overall Study|Adverse Event|2
897675|NCT01173718|2959028|P1|Overall Study|Abandonment of study graft|27
897676|NCT01173718|2959028|P1|Overall Study|Death|17
897677|NCT01173679|2959037|P1|Overall Study|Death|1
897678|NCT01173653|2959045|P2|Overall Study|Pts unwilling to provide follow-up|41
897679|NCT01173653|2959046|P1|Overall Study|Pts unwilling to provide follow-up|53
897680|NCT01173601|2959056|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6
897681|NCT01173601|2959057|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
897682|NCT01173601|2959058|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
897683|NCT01173601|2959059|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
897684|NCT01173601|2959060|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
897685|NCT01173601|2959056|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
897686|NCT01173601|2959057|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5
897687|NCT01173601|2959058|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7
897688|NCT01173601|2959059|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
897689|NCT01173601|2959060|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
897690|NCT01173601|2959056|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
897691|NCT01173601|2959057|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4
897692|NCT01173601|2959058|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
897693|NCT01173601|2959059|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1
897694|NCT01173601|2959060|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
897695|NCT01173601|2959056|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
897696|NCT01173601|2959057|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
897697|NCT01173601|2959058|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
897698|NCT01173601|2959059|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
897699|NCT01173601|2959060|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
897700|NCT01173601|2959056|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
897701|NCT01173601|2959057|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
897702|NCT01173601|2959058|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
897703|NCT01173601|2959059|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
897704|NCT01173601|2959060|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
897705|NCT01173601|2959056|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9
897706|NCT01173601|2959057|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
897707|NCT01173601|2959058|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6
897708|NCT01173601|2959059|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10
897709|NCT01173601|2959060|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
897710|NCT01173601|2959056|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14
897711|NCT01173601|2959057|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7
897712|NCT01173601|2959058|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15
897713|NCT01173601|2959059|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10
897714|NCT01173601|2959060|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
897715|NCT01173601|2959056|P5|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
897716|NCT01173601|2959057|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
897717|NCT01173601|2959058|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
897718|NCT01173601|2959059|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
898162|NCT01172808|2959674|P2|Overall Study|Withdrawal by Subject|1
897719|NCT01173601|2959060|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6
897720|NCT01173601|2959056|P5|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
897721|NCT01173601|2959057|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
897722|NCT01173601|2959058|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
897723|NCT01173601|2959059|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
897724|NCT01173601|2959060|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25
897725|NCT01173601|2959056|P5|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
897726|NCT01173601|2959057|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
897727|NCT01173601|2959058|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
897728|NCT01173601|2959059|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
897729|NCT01173601|2959060|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15
897730|NCT01173601|2959056|P5|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
897731|NCT01173601|2959057|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
897732|NCT01173601|2959058|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
897733|NCT01173601|2959059|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
897734|NCT01173601|2959060|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3
897735|NCT01173601|2959056|P5|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
897736|NCT01173601|2959057|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
897737|NCT01173601|2959058|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
897738|NCT01173601|2959059|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
897739|NCT01173601|2959060|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7
897740|NCT01173601|2959056|P5|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
897741|NCT01173601|2959057|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
897742|NCT01173601|2959058|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
897743|NCT01173601|2959059|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
897744|NCT01173601|2959060|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9
897745|NCT01173601|2959056|P5|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
897746|NCT01173601|2959057|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
897747|NCT01173601|2959058|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
897748|NCT01173601|2959059|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
897749|NCT01173601|2959060|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23
897750|NCT01173523|2959137|P2|Overall Study|Other|3
897751|NCT01173523|2959138|P1|Overall Study|Other|2
897752|NCT01173523|2959137|P2|Overall Study|Progressive Disease|8
897753|NCT01173523|2959138|P1|Overall Study|Progressive Disease|10
897754|NCT01173523|2959137|P2|Overall Study|Clinical Progression|1
897755|NCT01173523|2959138|P1|Overall Study|Clinical Progression|1
897756|NCT01173471|2959154|P4|Overall Study|Reason given as Other|0
897757|NCT01173471|2959155|P3|Overall Study|Reason given as Other|1
897758|NCT01173471|2959156|P2|Overall Study|Reason given as Other|0
897759|NCT01173471|2959157|P1|Overall Study|Reason given as Other|0
897760|NCT01173471|2959154|P4|Overall Study|Lost to Follow-up|0
897761|NCT01173471|2959155|P3|Overall Study|Lost to Follow-up|1
897762|NCT01173471|2959156|P2|Overall Study|Lost to Follow-up|0
897763|NCT01173471|2959157|P1|Overall Study|Lost to Follow-up|0
897764|NCT01173471|2959154|P4|Overall Study|Condition under investigation worsened|0
897765|NCT01173471|2959155|P3|Overall Study|Condition under investigation worsened|0
897766|NCT01173471|2959156|P2|Overall Study|Condition under investigation worsened|0
897767|NCT01173471|2959157|P1|Overall Study|Condition under investigation worsened|2
897768|NCT01173471|2959154|P4|Overall Study|Eligibility criteria not fulfilled|1
897769|NCT01173471|2959155|P3|Overall Study|Eligibility criteria not fulfilled|1
897770|NCT01173471|2959156|P2|Overall Study|Eligibility criteria not fulfilled|0
897771|NCT01173471|2959157|P1|Overall Study|Eligibility criteria not fulfilled|0
897772|NCT01173120|2959287|P1|Overall Study|Switch-Difficulty With Device|12
897773|NCT01173120|2959287|P1|Overall Study|Switch-Participant Decision|12
897774|NCT01173120|2959287|P1|Overall Study|Switch-Administrative Reason By Sponsor|33
897775|NCT01173120|2959287|P1|Overall Study|Participant Decision|2
897776|NCT01173120|2959287|P1|Overall Study|Lost to Follow-up|1
897777|NCT01173120|2959287|P1|Overall Study|Lack of Efficacy|2
897778|NCT01173055|2959305|P2|Period 2 - Day 64 to 112|Adverse Event|1
897779|NCT01173055|2959306|P1|Period 2 - Day 64 to 112|Adverse Event|0
897780|NCT01173055|2959305|P2|Period 1 - Day 1 to 49|Withdrawal by Subject|2
897781|NCT01173055|2959306|P1|Period 1 - Day 1 to 49|Withdrawal by Subject|2
897782|NCT01172938|2959345|P9|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1
897783|NCT01172938|2959346|P8|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
897784|NCT01172938|2959347|P7|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
897785|NCT01172938|2959348|P6|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
897786|NCT01172938|2959349|P5|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
897787|NCT01172938|2959350|P4|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
897788|NCT01172938|2959351|P3|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
897789|NCT01172938|2959352|P2|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
897790|NCT01172938|2959353|P1|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
897791|NCT01172938|2959345|P9|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
897792|NCT01172938|2959346|P8|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
897793|NCT01172938|2959347|P7|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
897794|NCT01172938|2959348|P6|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
897795|NCT01172938|2959349|P5|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
897796|NCT01172938|2959350|P4|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
897797|NCT01172938|2959351|P3|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1
897798|NCT01172938|2959352|P2|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
897799|NCT01172938|2959353|P1|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
897800|NCT01172938|2959345|P9|Active-Treatment Phase (Weeks 208-260)|Death|0
897801|NCT01172938|2959346|P8|Active-Treatment Phase (Weeks 208-260)|Death|0
897802|NCT01172938|2959347|P7|Active-Treatment Phase (Weeks 208-260)|Death|0
897803|NCT01172938|2959348|P6|Active-Treatment Phase (Weeks 208-260)|Death|0
897804|NCT01172938|2959349|P5|Active-Treatment Phase (Weeks 208-260)|Death|0
897805|NCT01172938|2959350|P4|Active-Treatment Phase (Weeks 208-260)|Death|0
897806|NCT01172938|2959351|P3|Active-Treatment Phase (Weeks 208-260)|Death|1
897807|NCT01172938|2959352|P2|Active-Treatment Phase (Weeks 208-260)|Death|0
897808|NCT01172938|2959353|P1|Active-Treatment Phase (Weeks 208-260)|Death|0
897809|NCT01172938|2959345|P9|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
897810|NCT01172938|2959346|P8|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1
897811|NCT01172938|2959347|P7|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
897812|NCT01172938|2959348|P6|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
897813|NCT01172938|2959349|P5|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
897814|NCT01172938|2959350|P4|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
897815|NCT01172938|2959351|P3|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3
897816|NCT01172938|2959352|P2|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2
897817|NCT01172938|2959353|P1|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
897818|NCT01172938|2959345|P9|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
897819|NCT01172938|2959346|P8|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
897820|NCT01172938|2959347|P7|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
897821|NCT01172938|2959348|P6|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
897822|NCT01172938|2959349|P5|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
897823|NCT01172938|2959350|P4|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
897824|NCT01172938|2959351|P3|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
897825|NCT01172938|2959352|P2|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
897826|NCT01172938|2959353|P1|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
897827|NCT01172938|2959345|P9|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
897828|NCT01172938|2959346|P8|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
897829|NCT01172938|2959347|P7|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
897830|NCT01172938|2959348|P6|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
897831|NCT01172938|2959349|P5|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
897832|NCT01172938|2959350|P4|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
897833|NCT01172938|2959351|P3|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2
897834|NCT01172938|2959352|P2|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
897835|NCT01172938|2959353|P1|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
897836|NCT01172938|2959345|P9|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
897837|NCT01172938|2959346|P8|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
897838|NCT01172938|2959347|P7|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
897839|NCT01172938|2959348|P6|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
897840|NCT01172938|2959349|P5|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
897841|NCT01172938|2959350|P4|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
897842|NCT01172938|2959351|P3|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
897843|NCT01172938|2959352|P2|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
897844|NCT01172938|2959353|P1|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
897845|NCT01172938|2959345|P9|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
897846|NCT01172938|2959346|P8|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1
897847|NCT01172938|2959347|P7|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
897848|NCT01172938|2959348|P6|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
897849|NCT01172938|2959349|P5|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
897850|NCT01172938|2959350|P4|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
897851|NCT01172938|2959351|P3|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
897852|NCT01172938|2959352|P2|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
897853|NCT01172938|2959353|P1|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
897854|NCT01172938|2959345|P9|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
897855|NCT01172938|2959346|P8|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
897856|NCT01172938|2959347|P7|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
897857|NCT01172938|2959348|P6|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
897858|NCT01172938|2959349|P5|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
897859|NCT01172938|2959350|P4|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
897860|NCT01172938|2959351|P3|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
897861|NCT01172938|2959352|P2|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
897862|NCT01172938|2959353|P1|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
897863|NCT01172938|2959345|P9|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
897864|NCT01172938|2959346|P8|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
897865|NCT01172938|2959347|P7|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
897866|NCT01172938|2959348|P6|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
897867|NCT01172938|2959349|P5|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
897868|NCT01172938|2959350|P4|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
897869|NCT01172938|2959351|P3|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
897870|NCT01172938|2959352|P2|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
897871|NCT01172938|2959353|P1|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
897872|NCT01172938|2959345|P9|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2
897873|NCT01172938|2959346|P8|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3
897874|NCT01172938|2959347|P7|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
897875|NCT01172938|2959348|P6|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
897876|NCT01172938|2959349|P5|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
897877|NCT01172938|2959350|P4|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
897878|NCT01172938|2959351|P3|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
897879|NCT01172938|2959352|P2|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
897880|NCT01172938|2959353|P1|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
897881|NCT01172938|2959345|P9|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
897882|NCT01172938|2959346|P8|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3
897883|NCT01172938|2959347|P7|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
897884|NCT01172938|2959348|P6|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
897885|NCT01172938|2959349|P5|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
897886|NCT01172938|2959350|P4|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
897887|NCT01172938|2959351|P3|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1
897888|NCT01172938|2959352|P2|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4
897889|NCT01172938|2959353|P1|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
897890|NCT01172938|2959345|P9|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
897891|NCT01172938|2959346|P8|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
897892|NCT01172938|2959347|P7|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
897893|NCT01172938|2959348|P6|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
897894|NCT01172938|2959349|P5|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
897895|NCT01172938|2959350|P4|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
897896|NCT01172938|2959351|P3|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2
897897|NCT01172938|2959352|P2|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
897898|NCT01172938|2959353|P1|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
897899|NCT01172938|2959345|P9|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
897900|NCT01172938|2959346|P8|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
897901|NCT01172938|2959347|P7|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
897902|NCT01172938|2959348|P6|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
897903|NCT01172938|2959349|P5|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
897904|NCT01172938|2959350|P4|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
897905|NCT01172938|2959351|P3|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
897906|NCT01172938|2959352|P2|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1
897907|NCT01172938|2959353|P1|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
897908|NCT01172938|2959345|P9|Active-Treatment Phase Weeks (104-156)|Death|0
897909|NCT01172938|2959346|P8|Active-Treatment Phase Weeks (104-156)|Death|1
897910|NCT01172938|2959347|P7|Active-Treatment Phase Weeks (104-156)|Death|0
897911|NCT01172938|2959348|P6|Active-Treatment Phase Weeks (104-156)|Death|0
897912|NCT01172938|2959349|P5|Active-Treatment Phase Weeks (104-156)|Death|0
897913|NCT01172938|2959350|P4|Active-Treatment Phase Weeks (104-156)|Death|0
897914|NCT01172938|2959351|P3|Active-Treatment Phase Weeks (104-156)|Death|0
897915|NCT01172938|2959352|P2|Active-Treatment Phase Weeks (104-156)|Death|0
897916|NCT01172938|2959353|P1|Active-Treatment Phase Weeks (104-156)|Death|0
897917|NCT01172938|2959345|P9|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1
897918|NCT01172938|2959346|P8|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2
897919|NCT01172938|2959347|P7|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
897920|NCT01172938|2959348|P6|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
897921|NCT01172938|2959349|P5|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
897922|NCT01172938|2959350|P4|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
897923|NCT01172938|2959351|P3|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3
897924|NCT01172938|2959352|P2|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6
897925|NCT01172938|2959353|P1|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
897926|NCT01172938|2959345|P9|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
897927|NCT01172938|2959346|P8|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
897928|NCT01172938|2959347|P7|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
897929|NCT01172938|2959348|P6|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
897930|NCT01172938|2959349|P5|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
897931|NCT01172938|2959350|P4|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
897932|NCT01172938|2959351|P3|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
897933|NCT01172938|2959352|P2|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4
897934|NCT01172938|2959353|P1|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
897935|NCT01172938|2959345|P9|Active-Treatment Phase Weeks (104-156)|Adverse Event|1
897936|NCT01172938|2959346|P8|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
897937|NCT01172938|2959347|P7|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
897938|NCT01172938|2959348|P6|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
897939|NCT01172938|2959349|P5|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
897940|NCT01172938|2959350|P4|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
897941|NCT01172938|2959351|P3|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
897942|NCT01172938|2959352|P2|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
897943|NCT01172938|2959353|P1|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
897944|NCT01172938|2959345|P9|Active-Treatment Phase (Weeks 52-104)|Missing|0
897945|NCT01172938|2959346|P8|Active-Treatment Phase (Weeks 52-104)|Missing|0
897946|NCT01172938|2959347|P7|Active-Treatment Phase (Weeks 52-104)|Missing|0
897947|NCT01172938|2959348|P6|Active-Treatment Phase (Weeks 52-104)|Missing|0
897948|NCT01172938|2959349|P5|Active-Treatment Phase (Weeks 52-104)|Missing|0
897949|NCT01172938|2959350|P4|Active-Treatment Phase (Weeks 52-104)|Missing|0
897950|NCT01172938|2959351|P3|Active-Treatment Phase (Weeks 52-104)|Missing|0
897951|NCT01172938|2959352|P2|Active-Treatment Phase (Weeks 52-104)|Missing|1
897952|NCT01172938|2959353|P1|Active-Treatment Phase (Weeks 52-104)|Missing|0
897953|NCT01172938|2959345|P9|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1
897954|NCT01172938|2959346|P8|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
897955|NCT01172938|2959347|P7|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
897956|NCT01172938|2959348|P6|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
897957|NCT01172938|2959349|P5|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
897958|NCT01172938|2959350|P4|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
897959|NCT01172938|2959351|P3|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
897960|NCT01172938|2959352|P2|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2
897961|NCT01172938|2959353|P1|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
897962|NCT01172938|2959345|P9|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
897963|NCT01172938|2959346|P8|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3
897964|NCT01172938|2959347|P7|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
897965|NCT01172938|2959348|P6|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
897966|NCT01172938|2959349|P5|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
897967|NCT01172938|2959350|P4|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
897968|NCT01172938|2959351|P3|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
897969|NCT01172938|2959352|P2|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
897970|NCT01172938|2959353|P1|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
897971|NCT01172938|2959345|P9|Active-Treatment Phase (Weeks 52-104)|Death|0
897972|NCT01172938|2959346|P8|Active-Treatment Phase (Weeks 52-104)|Death|0
897973|NCT01172938|2959347|P7|Active-Treatment Phase (Weeks 52-104)|Death|0
897974|NCT01172938|2959348|P6|Active-Treatment Phase (Weeks 52-104)|Death|0
897975|NCT01172938|2959349|P5|Active-Treatment Phase (Weeks 52-104)|Death|0
897976|NCT01172938|2959350|P4|Active-Treatment Phase (Weeks 52-104)|Death|0
897977|NCT01172938|2959351|P3|Active-Treatment Phase (Weeks 52-104)|Death|1
897978|NCT01172938|2959352|P2|Active-Treatment Phase (Weeks 52-104)|Death|0
897979|NCT01172938|2959353|P1|Active-Treatment Phase (Weeks 52-104)|Death|0
897980|NCT01172938|2959345|P9|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2
897981|NCT01172938|2959346|P8|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5
897982|NCT01172938|2959347|P7|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
897983|NCT01172938|2959348|P6|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
897984|NCT01172938|2959349|P5|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
897985|NCT01172938|2959350|P4|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
897986|NCT01172938|2959351|P3|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8
897987|NCT01172938|2959352|P2|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10
897988|NCT01172938|2959353|P1|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
897989|NCT01172938|2959345|P9|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
897990|NCT01172938|2959346|P8|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
897991|NCT01172938|2959347|P7|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
897992|NCT01172938|2959348|P6|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
897993|NCT01172938|2959349|P5|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
897994|NCT01172938|2959350|P4|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
897995|NCT01172938|2959351|P3|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2
897996|NCT01172938|2959352|P2|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
897997|NCT01172938|2959353|P1|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
897998|NCT01172938|2959345|P9|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
897999|NCT01172938|2959346|P8|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4
898000|NCT01172938|2959347|P7|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
898001|NCT01172938|2959348|P6|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
898002|NCT01172938|2959349|P5|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
898003|NCT01172938|2959350|P4|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
898004|NCT01172938|2959351|P3|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8
898005|NCT01172938|2959352|P2|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7
898006|NCT01172938|2959353|P1|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
898007|NCT01172938|2959345|P9|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
898008|NCT01172938|2959346|P8|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3
898009|NCT01172938|2959347|P7|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
898010|NCT01172938|2959348|P6|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
898163|NCT01172808|2959675|P1|Overall Study|Withdrawal by Subject|4
898011|NCT01172938|2959349|P5|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
898012|NCT01172938|2959350|P4|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
898013|NCT01172938|2959351|P3|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
898014|NCT01172938|2959352|P2|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2
898015|NCT01172938|2959353|P1|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
898016|NCT01172938|2959345|P9|Active Treatment Phase (Weeks 25-52)|Not specified|0
898017|NCT01172938|2959346|P8|Active Treatment Phase (Weeks 25-52)|Not specified|0
898018|NCT01172938|2959347|P7|Active Treatment Phase (Weeks 25-52)|Not specified|1
898019|NCT01172938|2959348|P6|Active Treatment Phase (Weeks 25-52)|Not specified|1
898020|NCT01172938|2959349|P5|Active Treatment Phase (Weeks 25-52)|Not specified|0
898021|NCT01172938|2959350|P4|Active Treatment Phase (Weeks 25-52)|Not specified|0
898022|NCT01172938|2959351|P3|Active Treatment Phase (Weeks 25-52)|Not specified|0
898023|NCT01172938|2959352|P2|Active Treatment Phase (Weeks 25-52)|Not specified|0
898024|NCT01172938|2959353|P1|Active Treatment Phase (Weeks 25-52)|Not specified|0
898025|NCT01172938|2959345|P9|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
898026|NCT01172938|2959346|P8|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
898027|NCT01172938|2959347|P7|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
898028|NCT01172938|2959348|P6|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
898029|NCT01172938|2959349|P5|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
898030|NCT01172938|2959350|P4|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
898031|NCT01172938|2959351|P3|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
898032|NCT01172938|2959352|P2|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
898033|NCT01172938|2959353|P1|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
898034|NCT01172938|2959345|P9|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
898035|NCT01172938|2959346|P8|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
898036|NCT01172938|2959347|P7|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
898037|NCT01172938|2959348|P6|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9
898038|NCT01172938|2959349|P5|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
898039|NCT01172938|2959350|P4|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
898040|NCT01172938|2959351|P3|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
898041|NCT01172938|2959352|P2|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5
898042|NCT01172938|2959353|P1|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
898043|NCT01172938|2959345|P9|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
898044|NCT01172938|2959346|P8|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
898045|NCT01172938|2959347|P7|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
898046|NCT01172938|2959348|P6|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
898047|NCT01172938|2959349|P5|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
898048|NCT01172938|2959350|P4|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
898049|NCT01172938|2959351|P3|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1
898050|NCT01172938|2959352|P2|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
898051|NCT01172938|2959353|P1|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
898052|NCT01172938|2959345|P9|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
898053|NCT01172938|2959346|P8|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
898054|NCT01172938|2959347|P7|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
898055|NCT01172938|2959348|P6|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
898056|NCT01172938|2959349|P5|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1
898057|NCT01172938|2959350|P4|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
898058|NCT01172938|2959351|P3|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7
898059|NCT01172938|2959352|P2|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4
898060|NCT01172938|2959353|P1|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
898061|NCT01172938|2959345|P9|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
898062|NCT01172938|2959346|P8|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
898063|NCT01172938|2959347|P7|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
898064|NCT01172938|2959348|P6|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
898065|NCT01172938|2959349|P5|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
898066|NCT01172938|2959350|P4|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
898067|NCT01172938|2959351|P3|Active Treatment Phase (Weeks 25-52)|Adverse Event|5
898068|NCT01172938|2959352|P2|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
898069|NCT01172938|2959353|P1|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
898070|NCT01172938|2959345|P9|Placebo-controlled Phase (Week 0-24)|Not specified|0
898071|NCT01172938|2959346|P8|Placebo-controlled Phase (Week 0-24)|Not specified|0
898072|NCT01172938|2959347|P7|Placebo-controlled Phase (Week 0-24)|Not specified|0
898073|NCT01172938|2959348|P6|Placebo-controlled Phase (Week 0-24)|Not specified|0
898074|NCT01172938|2959349|P5|Placebo-controlled Phase (Week 0-24)|Not specified|0
898075|NCT01172938|2959350|P4|Placebo-controlled Phase (Week 0-24)|Not specified|0
898076|NCT01172938|2959351|P3|Placebo-controlled Phase (Week 0-24)|Not specified|1
898077|NCT01172938|2959352|P2|Placebo-controlled Phase (Week 0-24)|Not specified|2
898078|NCT01172938|2959353|P1|Placebo-controlled Phase (Week 0-24)|Not specified|0
898079|NCT01172938|2959345|P9|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
898080|NCT01172938|2959346|P8|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
898081|NCT01172938|2959347|P7|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
898082|NCT01172938|2959348|P6|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
898083|NCT01172938|2959349|P5|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
898084|NCT01172938|2959350|P4|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
898085|NCT01172938|2959351|P3|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
898086|NCT01172938|2959352|P2|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
898087|NCT01172938|2959353|P1|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1
898088|NCT01172938|2959345|P9|Placebo-controlled Phase (Week 0-24)|Death|0
898089|NCT01172938|2959346|P8|Placebo-controlled Phase (Week 0-24)|Death|0
898090|NCT01172938|2959347|P7|Placebo-controlled Phase (Week 0-24)|Death|0
898091|NCT01172938|2959348|P6|Placebo-controlled Phase (Week 0-24)|Death|0
898092|NCT01172938|2959349|P5|Placebo-controlled Phase (Week 0-24)|Death|0
898093|NCT01172938|2959350|P4|Placebo-controlled Phase (Week 0-24)|Death|0
898094|NCT01172938|2959351|P3|Placebo-controlled Phase (Week 0-24)|Death|0
898095|NCT01172938|2959352|P2|Placebo-controlled Phase (Week 0-24)|Death|1
898096|NCT01172938|2959353|P1|Placebo-controlled Phase (Week 0-24)|Death|0
898097|NCT01172938|2959345|P9|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
898098|NCT01172938|2959346|P8|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
898099|NCT01172938|2959347|P7|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
898100|NCT01172938|2959348|P6|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
898101|NCT01172938|2959349|P5|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
898102|NCT01172938|2959350|P4|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
898103|NCT01172938|2959351|P3|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
898104|NCT01172938|2959352|P2|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
898105|NCT01172938|2959353|P1|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2
898106|NCT01172938|2959345|P9|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
898107|NCT01172938|2959346|P8|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
898108|NCT01172938|2959347|P7|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
898109|NCT01172938|2959348|P6|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
898110|NCT01172938|2959349|P5|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
898111|NCT01172938|2959350|P4|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
898112|NCT01172938|2959351|P3|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2
898113|NCT01172938|2959352|P2|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
898114|NCT01172938|2959353|P1|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
898115|NCT01172938|2959345|P9|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
898116|NCT01172938|2959346|P8|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
898117|NCT01172938|2959347|P7|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
898118|NCT01172938|2959348|P6|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
898119|NCT01172938|2959349|P5|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
898120|NCT01172938|2959350|P4|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
898121|NCT01172938|2959351|P3|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
898122|NCT01172938|2959352|P2|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
898123|NCT01172938|2959353|P1|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
898124|NCT01172938|2959345|P9|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
898125|NCT01172938|2959346|P8|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
898126|NCT01172938|2959347|P7|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
898127|NCT01172938|2959348|P6|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
898128|NCT01172938|2959349|P5|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
898129|NCT01172938|2959350|P4|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
898130|NCT01172938|2959351|P3|Placebo-controlled Phase (Week 0-24)|Adverse Event|10
898131|NCT01172938|2959352|P2|Placebo-controlled Phase (Week 0-24)|Adverse Event|8
898132|NCT01172938|2959353|P1|Placebo-controlled Phase (Week 0-24)|Adverse Event|11
898133|NCT01172873|2959539|P2|Overall Study|Withdrawal by Subject|2
898134|NCT01172873|2959540|P1|Overall Study|Withdrawal by Subject|3
898135|NCT01172847|2959550|P1|Overall Study|Withdrawal by Subject|3
898136|NCT01172821|2959579|P4|Overall Study|Other|3
898137|NCT01172821|2959580|P3|Overall Study|Other|5
898138|NCT01172821|2959581|P2|Overall Study|Other|4
898139|NCT01172821|2959582|P1|Overall Study|Other|3
898140|NCT01172821|2959579|P4|Overall Study|Withdrawal by Subject|3
898141|NCT01172821|2959580|P3|Overall Study|Withdrawal by Subject|3
898142|NCT01172821|2959581|P2|Overall Study|Withdrawal by Subject|3
898143|NCT01172821|2959582|P1|Overall Study|Withdrawal by Subject|2
898144|NCT01172821|2959579|P4|Overall Study|Lost to Follow-up|2
898145|NCT01172821|2959580|P3|Overall Study|Lost to Follow-up|2
898146|NCT01172821|2959581|P2|Overall Study|Lost to Follow-up|1
898147|NCT01172821|2959582|P1|Overall Study|Lost to Follow-up|4
898148|NCT01172821|2959579|P4|Overall Study|Protocol Violation|2
898149|NCT01172821|2959580|P3|Overall Study|Protocol Violation|1
898150|NCT01172821|2959581|P2|Overall Study|Protocol Violation|2
898151|NCT01172821|2959582|P1|Overall Study|Protocol Violation|0
898152|NCT01172821|2959579|P4|Overall Study|Adverse Event|7
898153|NCT01172821|2959580|P3|Overall Study|Adverse Event|2
898154|NCT01172821|2959581|P2|Overall Study|Adverse Event|2
898155|NCT01172821|2959582|P1|Overall Study|Adverse Event|5
898156|NCT01172808|2959672|P4|Overall Study|Other|7
898157|NCT01172808|2959673|P3|Overall Study|Other|9
898158|NCT01172808|2959674|P2|Overall Study|Other|5
898159|NCT01172808|2959675|P1|Overall Study|Other|6
898160|NCT01172808|2959672|P4|Overall Study|Withdrawal by Subject|2
898161|NCT01172808|2959673|P3|Overall Study|Withdrawal by Subject|3
898164|NCT01172808|2959672|P4|Overall Study|Lost to Follow-up|3
898165|NCT01172808|2959673|P3|Overall Study|Lost to Follow-up|1
898166|NCT01172808|2959674|P2|Overall Study|Lost to Follow-up|1
898167|NCT01172808|2959675|P1|Overall Study|Lost to Follow-up|0
898168|NCT01172808|2959672|P4|Overall Study|Protocol Violation|0
898169|NCT01172808|2959673|P3|Overall Study|Protocol Violation|2
898170|NCT01172808|2959674|P2|Overall Study|Protocol Violation|2
898171|NCT01172808|2959675|P1|Overall Study|Protocol Violation|2
898172|NCT01172808|2959672|P4|Overall Study|Lack of Efficacy|0
898173|NCT01172808|2959673|P3|Overall Study|Lack of Efficacy|0
898174|NCT01172808|2959674|P2|Overall Study|Lack of Efficacy|0
898175|NCT01172808|2959675|P1|Overall Study|Lack of Efficacy|1
898176|NCT01172808|2959672|P4|Overall Study|Adverse Event|3
898177|NCT01172808|2959673|P3|Overall Study|Adverse Event|8
898178|NCT01172808|2959674|P2|Overall Study|Adverse Event|4
898179|NCT01172808|2959675|P1|Overall Study|Adverse Event|8
898180|NCT01172535|2959794|P1|Overall Study|Unwilling to adhere to study requirement|1
898181|NCT01172535|2959794|P1|Overall Study|Ineligible at study entry|1
898182|NCT01172535|2959794|P1|Overall Study|Lost to Follow-up|1
898183|NCT01172535|2959794|P1|Overall Study|Withdrawal by Subject|2
898184|NCT01172535|2959794|P1|Overall Study|Death|3
898185|NCT01172288|2959847|P2|Overall Study|Protocol Violation|1
898186|NCT01172288|2959848|P1|Overall Study|Protocol Violation|0
898187|NCT01172288|2959847|P2|Overall Study|Adverse Event|0
898188|NCT01172288|2959848|P1|Overall Study|Adverse Event|1
898189|NCT01171989|2959903|P3|Overall Study|Lost to Follow-up|1
898190|NCT01171989|2959904|P2|Overall Study|Lost to Follow-up|0
898191|NCT01171989|2959905|P1|Overall Study|Lost to Follow-up|0
898192|NCT01171976|2959979|P3|Overall Study|Adverse Event|5
898193|NCT01171976|2959980|P2|Overall Study|Adverse Event|2
898194|NCT01171976|2959981|P1|Overall Study|Adverse Event|6
898195|NCT01171976|2959979|P3|Overall Study|Abnormal test result|0
898196|NCT01171976|2959980|P2|Overall Study|Abnormal test result|0
898197|NCT01171976|2959981|P1|Overall Study|Abnormal test result|1
898198|NCT01171976|2959979|P3|Overall Study|Withdrawal by Subject|6
898199|NCT01171976|2959980|P2|Overall Study|Withdrawal by Subject|5
898200|NCT01171976|2959981|P1|Overall Study|Withdrawal by Subject|1
898201|NCT01171976|2959979|P3|Overall Study|Lost to Follow-up|2
898202|NCT01171976|2959980|P2|Overall Study|Lost to Follow-up|0
898203|NCT01171976|2959981|P1|Overall Study|Lost to Follow-up|4
898204|NCT01171976|2959979|P3|Overall Study|Death|1
898205|NCT01171976|2959980|P2|Overall Study|Death|4
898206|NCT01171976|2959981|P1|Overall Study|Death|2
898207|NCT01171976|2959979|P3|Overall Study|Protocol Violation|1
898208|NCT01171976|2959980|P2|Overall Study|Protocol Violation|0
898209|NCT01171976|2959981|P1|Overall Study|Protocol Violation|0
898210|NCT01171963|2960018|P2|Overall Study|Withdrawal by Subject|129
898211|NCT01171963|2960019|P1|Overall Study|Withdrawal by Subject|114
898212|NCT01171963|2960018|P2|Overall Study|Other - diarrhoea|0
898213|NCT01171963|2960019|P1|Overall Study|Other - diarrhoea|1
898214|NCT01171963|2960018|P2|Overall Study|Lost to Follow-up|24
898215|NCT01171963|2960019|P1|Overall Study|Lost to Follow-up|23
898216|NCT01171963|2960018|P2|Overall Study|Adverse Event|15
898217|NCT01171963|2960019|P1|Overall Study|Adverse Event|10
898218|NCT01171898|2960088|P4|Overall Study|Other|2
898219|NCT01171898|2960089|P3|Overall Study|Other|0
898220|NCT01171898|2960090|P2|Overall Study|Other|5
898221|NCT01171898|2960091|P1|Overall Study|Other|1
898222|NCT01171898|2960088|P4|Overall Study|Ongoing|0
898223|NCT01171898|2960089|P3|Overall Study|Ongoing|3
898224|NCT01171898|2960090|P2|Overall Study|Ongoing|9
898225|NCT01171898|2960091|P1|Overall Study|Ongoing|1
898226|NCT01171898|2960088|P4|Overall Study|Terminated by Sponsor|0
898227|NCT01171898|2960089|P3|Overall Study|Terminated by Sponsor|0
898228|NCT01171898|2960090|P2|Overall Study|Terminated by Sponsor|0
898229|NCT01171898|2960091|P1|Overall Study|Terminated by Sponsor|1
898230|NCT01171898|2960088|P4|Overall Study|Withdrawal by Subject|3
898231|NCT01171898|2960089|P3|Overall Study|Withdrawal by Subject|6
898232|NCT01171898|2960090|P2|Overall Study|Withdrawal by Subject|4
898233|NCT01171898|2960091|P1|Overall Study|Withdrawal by Subject|1
898234|NCT01171898|2960088|P4|Overall Study|Lost to Follow-up|1
898235|NCT01171898|2960089|P3|Overall Study|Lost to Follow-up|1
898236|NCT01171898|2960090|P2|Overall Study|Lost to Follow-up|1
898237|NCT01171898|2960091|P1|Overall Study|Lost to Follow-up|0
898238|NCT01171898|2960088|P4|Overall Study|Death|0
898239|NCT01171898|2960089|P3|Overall Study|Death|2
898240|NCT01171898|2960090|P2|Overall Study|Death|0
898241|NCT01171898|2960091|P1|Overall Study|Death|0
898242|NCT01171820|2960115|P2|Overall Study|1-Year Missed Visit|1
898243|NCT01171820|2960116|P1|Overall Study|1-Year Missed Visit|1
898244|NCT01171820|2960115|P2|Overall Study|Physician Decision|1
898245|NCT01171820|2960116|P1|Overall Study|Physician Decision|0
898246|NCT01171820|2960115|P2|Overall Study|Withdrawal by Subject|0
898247|NCT01171820|2960116|P1|Overall Study|Withdrawal by Subject|2
898248|NCT01171820|2960115|P2|Overall Study|Lost to Follow-up|1
898249|NCT01171820|2960116|P1|Overall Study|Lost to Follow-up|0
898250|NCT01171820|2960115|P2|Overall Study|Death|3
898251|NCT01171820|2960116|P1|Overall Study|Death|3
898252|NCT01171677|2960194|P2|Overall Study|completed <70% IntenSati classes|0
898253|NCT01171677|2960195|P1|Overall Study|completed <70% IntenSati classes|5
898254|NCT01171677|2960194|P2|Overall Study|Adverse Event|0
898255|NCT01171677|2960195|P1|Overall Study|Adverse Event|1
898256|NCT01171677|2960194|P2|Overall Study|Withdrawal by Subject|3
898257|NCT01171677|2960195|P1|Overall Study|Withdrawal by Subject|0
898258|NCT01171612|2960227|P1|Overall Study|Lost to Follow-up|51
898259|NCT01171534|2960237|P2|Overall Study|screen failure|1
898260|NCT01171534|2960238|P1|Overall Study|screen failure|0
898261|NCT01171534|2960237|P2|Overall Study|Lost to Follow-up|2
898262|NCT01171534|2960238|P1|Overall Study|Lost to Follow-up|0
898263|NCT01171521|2960250|P1|Overall Study|screen failure|1
898264|NCT01171521|2960250|P1|Overall Study|Lost to Follow-up|5
898265|NCT01171183|2960257|P2|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0
898266|NCT01171183|2960258|P1|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1
898267|NCT01171183|2960257|P2|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3
898268|NCT01171183|2960258|P1|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7
898269|NCT01171183|2960257|P2|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
898270|NCT01171183|2960258|P1|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
898271|NCT01171183|2960257|P2|Residential Facility (Weeks 1-2)|BP outside of study parameters|3
898272|NCT01171183|2960258|P1|Residential Facility (Weeks 1-2)|BP outside of study parameters|0
898273|NCT01171183|2960257|P2|Residential Facility (Weeks 1-2)|Protocol Violation|1
898274|NCT01171183|2960258|P1|Residential Facility (Weeks 1-2)|Protocol Violation|0
898275|NCT01171183|2960257|P2|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
898276|NCT01171183|2960258|P1|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
898277|NCT01170962|2960279|P3|Follow up Period|Others|3
898278|NCT01170962|2960280|P2|Follow up Period|Others|7
898279|NCT01170962|2960281|P1|Follow up Period|Others|10
898280|NCT01170962|2960279|P3|Follow up Period|Death|0
898281|NCT01170962|2960280|P2|Follow up Period|Death|2
898282|NCT01170962|2960281|P1|Follow up Period|Death|2
898283|NCT01170962|2960279|P3|Follow up Period|Lost to Follow-up|1
898284|NCT01170962|2960280|P2|Follow up Period|Lost to Follow-up|8
898285|NCT01170962|2960281|P1|Follow up Period|Lost to Follow-up|13
898286|NCT01170962|2960279|P3|Follow up Period|Withdrawal by Subject|2
898287|NCT01170962|2960280|P2|Follow up Period|Withdrawal by Subject|10
898288|NCT01170962|2960281|P1|Follow up Period|Withdrawal by Subject|14
898289|NCT01170962|2960279|P3|Treatment Period|Completed 24 Week treatment period only|0
898290|NCT01170962|2960280|P2|Treatment Period|Completed 24 Week treatment period only|2
898291|NCT01170962|2960281|P1|Treatment Period|Completed 24 Week treatment period only|10
898292|NCT01170962|2960279|P3|Treatment Period|Request to discontinue treatment|1
898293|NCT01170962|2960280|P2|Treatment Period|Request to discontinue treatment|3
898294|NCT01170962|2960281|P1|Treatment Period|Request to discontinue treatment|7
898295|NCT01170962|2960279|P3|Treatment Period|Participant no longer meets criteria|0
898296|NCT01170962|2960280|P2|Treatment Period|Participant no longer meets criteria|1
898297|NCT01170962|2960281|P1|Treatment Period|Participant no longer meets criteria|0
898298|NCT01170962|2960279|P3|Treatment Period|Lost to Follow-up|1
898299|NCT01170962|2960280|P2|Treatment Period|Lost to Follow-up|1
898300|NCT01170962|2960281|P1|Treatment Period|Lost to Follow-up|1
898301|NCT01170962|2960279|P3|Treatment Period|Withdrawal by Subject|0
898302|NCT01170962|2960280|P2|Treatment Period|Withdrawal by Subject|1
898303|NCT01170962|2960281|P1|Treatment Period|Withdrawal by Subject|2
898304|NCT01170962|2960279|P3|Treatment Period|Adverse Event|3
898305|NCT01170962|2960280|P2|Treatment Period|Adverse Event|12
898306|NCT01170962|2960281|P1|Treatment Period|Adverse Event|11
898307|NCT01170962|2960279|P3|Treatment Period|Lack of Efficacy|7
898308|NCT01170962|2960280|P2|Treatment Period|Lack of Efficacy|91
898309|NCT01170962|2960281|P1|Treatment Period|Lack of Efficacy|96
898310|NCT01170663|2960376|P2|Overall Study|Withdrawal of consent without follow-up|11
898311|NCT01170663|2960377|P1|Overall Study|Withdrawal of consent without follow-up|11
898312|NCT01170663|2960376|P2|Overall Study|Lost to Follow-up|9
898313|NCT01170663|2960377|P1|Overall Study|Lost to Follow-up|3
898314|NCT01170598|2960405|P1|Overall Study|Refused|1
898315|NCT01170598|2960405|P1|Overall Study|Lost to Follow-up|1
898316|NCT01170598|2960405|P1|Overall Study|Death|3
898317|NCT01170598|2960405|P1|Overall Study|Withdrawal by Subject|1
898318|NCT01170364|2960468|P2|Overall Study|Protocol Violation|1
898319|NCT01170364|2960469|P1|Overall Study|Protocol Violation|4
898320|NCT01170273|2960477|P2|Overall Study|Adverse Event|1
898321|NCT01170273|2960478|P1|Overall Study|Adverse Event|0
898322|NCT01170273|2960477|P2|Overall Study|Death|0
898323|NCT01170273|2960478|P1|Overall Study|Death|1
898324|NCT01170273|2960477|P2|Overall Study|Protocol Violation|0
898325|NCT01170273|2960478|P1|Overall Study|Protocol Violation|1
898326|NCT01170273|2960477|P2|Overall Study|Lost to Follow-up|8
898327|NCT01170273|2960478|P1|Overall Study|Lost to Follow-up|6
898328|NCT01170221|2960495|P2|Overall Study|Randomized but not treated|0
898329|NCT01170221|2960496|P1|Overall Study|Randomized but not treated|1
898330|NCT01170221|2960495|P2|Overall Study|Subject completed only screening and LFU|0
898331|NCT01170221|2960496|P1|Overall Study|Subject completed only screening and LFU|1
898332|NCT01170221|2960495|P2|Overall Study|Withdrawal by Subject|7
898333|NCT01170221|2960496|P1|Overall Study|Withdrawal by Subject|9
898334|NCT01170221|2960495|P2|Overall Study|Lost to Follow-up|21
898335|NCT01170221|2960496|P1|Overall Study|Lost to Follow-up|22
898336|NCT01170208|2960519|P3|Overall Study|Protocol Violation|1
898337|NCT01170208|2960520|P2|Overall Study|Protocol Violation|0
898338|NCT01170208|2960521|P1|Overall Study|Protocol Violation|1
898339|NCT01170208|2960519|P3|Overall Study|Withdrawal by Subject|1
898340|NCT01170208|2960520|P2|Overall Study|Withdrawal by Subject|0
898341|NCT01170208|2960521|P1|Overall Study|Withdrawal by Subject|5
898342|NCT01170091|2960540|P1|Overall Study|Treatment duration is less than 4 weeks|21
898343|NCT01170091|2960540|P1|Overall Study|Missing efficacy evaluation|3
898344|NCT01170039|2960549|P2|Overall Study|Lack of funding, drug not available|3
898345|NCT01170039|2960550|P1|Overall Study|Lack of funding, drug not available|3
898346|NCT01170039|2960549|P2|Overall Study|Withdrawal by Subject|3
898347|NCT01170039|2960550|P1|Overall Study|Withdrawal by Subject|5
898348|NCT01169987|2960562|P1|Overall Study|Not Specified|4
898349|NCT01169987|2960562|P1|Overall Study|Lost to Follow-up|24
898350|NCT01169987|2960562|P1|Overall Study|Withdrawal by Subject|3
898351|NCT01169779|2960628|P2|Overall Study|Familial and personal reasons|3
898352|NCT01169779|2960629|P1|Overall Study|Familial and personal reasons|3
898353|NCT01169779|2960628|P2|Overall Study|Withdrawal by Subject|2
898354|NCT01169779|2960629|P1|Overall Study|Withdrawal by Subject|3
898355|NCT01169779|2960628|P2|Overall Study|Protocol Violation|1
898356|NCT01169779|2960629|P1|Overall Study|Protocol Violation|1
898357|NCT01169779|2960628|P2|Overall Study|Lack of Efficacy|0
898358|NCT01169779|2960629|P1|Overall Study|Lack of Efficacy|1
898359|NCT01169779|2960628|P2|Overall Study|Adverse Event|11
898360|NCT01169779|2960629|P1|Overall Study|Adverse Event|3
898361|NCT01169701|2960664|P2|Overall Study|Sponsor decision|1
898362|NCT01169701|2960665|P1|Overall Study|Sponsor decision|0
898363|NCT01169701|2960664|P2|Overall Study|Serious adverse event|1
898364|NCT01169701|2960665|P1|Overall Study|Serious adverse event|0
898365|NCT01169701|2960664|P2|Overall Study|Administrative problems|1
898366|NCT01169701|2960665|P1|Overall Study|Administrative problems|0
898367|NCT01169701|2960664|P2|Overall Study|Death|1
898368|NCT01169701|2960665|P1|Overall Study|Death|0
898369|NCT01169701|2960664|P2|Overall Study|Exclusion criteria|0
898370|NCT01169701|2960665|P1|Overall Study|Exclusion criteria|2
898371|NCT01169701|2960664|P2|Overall Study|Adverse Event|2
898372|NCT01169701|2960665|P1|Overall Study|Adverse Event|1
898373|NCT01169701|2960664|P2|Overall Study|Withdrawal by Subject|3
898374|NCT01169701|2960665|P1|Overall Study|Withdrawal by Subject|1
898375|NCT01169701|2960664|P2|Overall Study|Lost to Follow-up|1
898376|NCT01169701|2960665|P1|Overall Study|Lost to Follow-up|1
898377|NCT01169675|2960702|P5|Overall Study|Other Reason Not Defined Above|1
898378|NCT01169675|2960703|P4|Overall Study|Other Reason Not Defined Above|1
898379|NCT01169675|2960704|P3|Overall Study|Other Reason Not Defined Above|0
898380|NCT01169675|2960705|P2|Overall Study|Other Reason Not Defined Above|0
898381|NCT01169675|2960706|P1|Overall Study|Other Reason Not Defined Above|0
898382|NCT01169675|2960702|P5|Overall Study|Withdrawal by Subject|2
898383|NCT01169675|2960703|P4|Overall Study|Withdrawal by Subject|1
898384|NCT01169675|2960704|P3|Overall Study|Withdrawal by Subject|0
898385|NCT01169675|2960705|P2|Overall Study|Withdrawal by Subject|0
898386|NCT01169675|2960706|P1|Overall Study|Withdrawal by Subject|1
898387|NCT01169675|2960702|P5|Overall Study|Adverse Event|0
898388|NCT01169675|2960703|P4|Overall Study|Adverse Event|0
898389|NCT01169675|2960704|P3|Overall Study|Adverse Event|2
898390|NCT01169675|2960705|P2|Overall Study|Adverse Event|1
898391|NCT01169675|2960706|P1|Overall Study|Adverse Event|5
898392|NCT01169675|2960702|P5|Overall Study|Dose Limiting Toxicity (DLT)|2
898393|NCT01169675|2960703|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
898394|NCT01169675|2960704|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
898395|NCT01169675|2960705|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
898396|NCT01169675|2960706|P1|Overall Study|Dose Limiting Toxicity (DLT)|1
898397|NCT01169675|2960702|P5|Overall Study|Progressive disease|1
898398|NCT01169675|2960703|P4|Overall Study|Progressive disease|15
898399|NCT01169675|2960704|P3|Overall Study|Progressive disease|5
898400|NCT01169675|2960705|P2|Overall Study|Progressive disease|2
898401|NCT01169675|2960706|P1|Overall Study|Progressive disease|13
898402|NCT01169649|2960743|P1|Overall Study|Patient Not Treated|3
898403|NCT01169558|2960755|P1|Overall Study|Partial response|2
898404|NCT01169558|2960755|P1|Overall Study|Protocol Violation|2
898405|NCT01169558|2960755|P1|Overall Study|Non-compliance|2
898406|NCT01169558|2960755|P1|Overall Study|Need for Surgery|4
898407|NCT01169558|2960755|P1|Overall Study|Lost to Follow-up|4
898408|NCT01169558|2960755|P1|Overall Study|Stable Disease|4
898409|NCT01169558|2960755|P1|Overall Study|Medical Decision|7
898410|NCT01169558|2960755|P1|Overall Study|Withdrawal of Consent|8
898411|NCT01169558|2960755|P1|Overall Study|Adverse Event|25
898412|NCT01169558|2960755|P1|Overall Study|Disease progression|98
898413|NCT01169493|2960780|P6|Period 3 (6 Months)|Physician Decision|0
898414|NCT01169493|2960781|P5|Period 3 (6 Months)|Physician Decision|0
898415|NCT01169493|2960782|P4|Period 3 (6 Months)|Physician Decision|0
898416|NCT01169493|2960783|P3|Period 3 (6 Months)|Physician Decision|1
898417|NCT01169493|2960784|P2|Period 3 (6 Months)|Physician Decision|1
898418|NCT01169493|2960785|P1|Period 3 (6 Months)|Physician Decision|0
898419|NCT01169493|2960780|P6|Period 3 (6 Months)|Adverse Event|0
898420|NCT01169493|2960781|P5|Period 3 (6 Months)|Adverse Event|0
898421|NCT01169493|2960782|P4|Period 3 (6 Months)|Adverse Event|0
898422|NCT01169493|2960783|P3|Period 3 (6 Months)|Adverse Event|0
898423|NCT01169493|2960784|P2|Period 3 (6 Months)|Adverse Event|1
898424|NCT01169493|2960785|P1|Period 3 (6 Months)|Adverse Event|0
898425|NCT01169493|2960780|P6|Period 1 (6 Months)|Withdrawal by Subject|3
898426|NCT01169493|2960781|P5|Period 1 (6 Months)|Withdrawal by Subject|0
898427|NCT01169493|2960782|P4|Period 1 (6 Months)|Withdrawal by Subject|0
898428|NCT01169493|2960783|P3|Period 1 (6 Months)|Withdrawal by Subject|2
898429|NCT01169493|2960784|P2|Period 1 (6 Months)|Withdrawal by Subject|1
898430|NCT01169493|2960785|P1|Period 1 (6 Months)|Withdrawal by Subject|0
898431|NCT01169350|2960831|P1|Overall Study|Lost to Follow-up|2
898432|NCT01169350|2960831|P1|Overall Study|Physician Decision|3
898433|NCT01169103|2960852|P2|Overall Study|Withdrawal by Subject|1
898434|NCT01169103|2960853|P1|Overall Study|Withdrawal by Subject|3
898435|NCT01169103|2960852|P2|Overall Study|Lost to Follow-up|3
898436|NCT01169103|2960853|P1|Overall Study|Lost to Follow-up|3
898437|NCT01169038|2960880|P1|Overall Study|Required antibiotic administration|1
898438|NCT01169038|2960880|P1|Overall Study|Adverse Event|5
898439|NCT01169038|2960880|P1|Overall Study|Death|1
898440|NCT01168999|2960888|P4|Overall Study|Lost to Follow-up|0
898441|NCT01168999|2960889|P3|Overall Study|Lost to Follow-up|0
898442|NCT01168999|2960890|P2|Overall Study|Lost to Follow-up|1
898443|NCT01168999|2960891|P1|Overall Study|Lost to Follow-up|2
898444|NCT01168973|2960957|P2|Overall Study|Protocol Criterion Not Met and Deviation|9
898445|NCT01168973|2960958|P1|Overall Study|Protocol Criterion Not Met and Deviation|7
898446|NCT01168973|2960957|P2|Overall Study|Sponsor Decision|1
898447|NCT01168973|2960958|P1|Overall Study|Sponsor Decision|2
898448|NCT01168973|2960957|P2|Overall Study|Physician Decision|19
898449|NCT01168973|2960958|P1|Overall Study|Physician Decision|37
898450|NCT01168973|2960957|P2|Overall Study|Death|45
898451|NCT01168973|2960958|P1|Overall Study|Death|42
898452|NCT01168973|2960957|P2|Overall Study|Withdrawal by Subject|53
898453|NCT01168973|2960958|P1|Overall Study|Withdrawal by Subject|90
898454|NCT01168973|2960957|P2|Overall Study|Adverse Event|55
898455|NCT01168973|2960958|P1|Overall Study|Adverse Event|94
898456|NCT01168973|2960957|P2|Overall Study|Progressive Disease|429
898457|NCT01168973|2960958|P1|Overall Study|Progressive Disease|341
898458|NCT01168856|2961031|P2|Overall Study|Protocol Violation|6
898459|NCT01168856|2961032|P1|Overall Study|Protocol Violation|4
898460|NCT01168856|2961031|P2|Overall Study|Other|291
898461|NCT01168856|2961032|P1|Overall Study|Other|1
898462|NCT01168856|2961031|P2|Overall Study|Death|2
898463|NCT01168856|2961032|P1|Overall Study|Death|0
898464|NCT01168856|2961031|P2|Overall Study|Participant received anti-HCV treatment|0
898465|NCT01168856|2961032|P1|Overall Study|Participant received anti-HCV treatment|1
898466|NCT01168856|2961031|P2|Overall Study|Confirmed Quantifiable HCV RNA|1
898467|NCT01168856|2961032|P1|Overall Study|Confirmed Quantifiable HCV RNA|0
898468|NCT01168856|2961031|P2|Overall Study|Physician Decision|1
898469|NCT01168856|2961032|P1|Overall Study|Physician Decision|2
898470|NCT01168856|2961031|P2|Overall Study|Withdrawal by Subject|8
898471|NCT01168856|2961032|P1|Overall Study|Withdrawal by Subject|6
898472|NCT01168856|2961031|P2|Overall Study|Lost to Follow-up|34
898473|NCT01168856|2961032|P1|Overall Study|Lost to Follow-up|4
898474|NCT01168596|2961130|P2|Overall Study|Withdrawal by Subject|1
898475|NCT01168596|2961131|P1|Overall Study|Withdrawal by Subject|3
898476|NCT01168427|2961175|P1|Overall Study|Patient exited prior to implant|1
898477|NCT01168401|2961191|P11|Overall Study|Withdrawal by Subject|0
898478|NCT01168401|2961192|P10|Overall Study|Withdrawal by Subject|0
898479|NCT01168401|2961193|P9|Overall Study|Withdrawal by Subject|0
898480|NCT01168401|2961194|P8|Overall Study|Withdrawal by Subject|0
898481|NCT01168401|2961195|P7|Overall Study|Withdrawal by Subject|0
898482|NCT01168401|2961196|P6|Overall Study|Withdrawal by Subject|0
898483|NCT01168401|2961197|P5|Overall Study|Withdrawal by Subject|0
898484|NCT01168401|2961198|P4|Overall Study|Withdrawal by Subject|1
898485|NCT01168401|2961199|P3|Overall Study|Withdrawal by Subject|0
898486|NCT01168401|2961200|P2|Overall Study|Withdrawal by Subject|0
898487|NCT01168401|2961201|P1|Overall Study|Withdrawal by Subject|0
898488|NCT01168401|2961191|P11|Overall Study|Lost to Follow-up|0
898489|NCT01168401|2961192|P10|Overall Study|Lost to Follow-up|0
898490|NCT01168401|2961193|P9|Overall Study|Lost to Follow-up|0
898491|NCT01168401|2961194|P8|Overall Study|Lost to Follow-up|0
898492|NCT01168401|2961195|P7|Overall Study|Lost to Follow-up|0
898493|NCT01168401|2961196|P6|Overall Study|Lost to Follow-up|0
898494|NCT01168401|2961197|P5|Overall Study|Lost to Follow-up|0
898495|NCT01168401|2961198|P4|Overall Study|Lost to Follow-up|1
898496|NCT01168401|2961199|P3|Overall Study|Lost to Follow-up|2
898497|NCT01168401|2961200|P2|Overall Study|Lost to Follow-up|1
898498|NCT01168401|2961201|P1|Overall Study|Lost to Follow-up|1
898499|NCT01168349|2961434|P1|Overall Study|Protocol Violation|76
898500|NCT01168349|2961434|P1|Overall Study|Other|22
898501|NCT01168349|2961434|P1|Overall Study|Kidney transplantation|3
898502|NCT01168349|2961434|P1|Overall Study|Withdrawal by Subject|9
898503|NCT01168349|2961434|P1|Overall Study|Lost to Follow-up|34
898504|NCT01168349|2961434|P1|Overall Study|Death|157
898505|NCT01168232|2961540|P1|Overall Study|Ineligible-Inadequate pathology|1
898506|NCT01168232|2961540|P1|Overall Study|Ineligible- Wrong cell type|6
898507|NCT01168232|2961540|P1|Overall Study|Ineligible-Second primary cancer site|1
898508|NCT01167907|2961568|P2|Overall Study|saphenous catheter dislodged before comp|1
898509|NCT01167907|2961569|P1|Overall Study|saphenous catheter dislodged before comp|1
898510|NCT01167907|2961568|P2|Overall Study|Protocol Violation|0
898511|NCT01167907|2961569|P1|Overall Study|Protocol Violation|1
898512|NCT01167881|2961587|P2|Overall Study|Other not defined above|55
898513|NCT01167881|2961588|P1|Overall Study|Other not defined above|31
898514|NCT01167881|2961587|P2|Overall Study|Not treated|0
898515|NCT01167881|2961588|P1|Overall Study|Not treated|4
898516|NCT01167881|2961587|P2|Overall Study|Patient refusal to cont., not due to AE|40
898517|NCT01167881|2961588|P1|Overall Study|Patient refusal to cont., not due to AE|45
898518|NCT01167881|2961587|P2|Overall Study|Lost to Follow-up|20
898519|NCT01167881|2961588|P1|Overall Study|Lost to Follow-up|19
898520|NCT01167881|2961587|P2|Overall Study|Non compliant with protocol|18
898521|NCT01167881|2961588|P1|Overall Study|Non compliant with protocol|9
898522|NCT01167881|2961587|P2|Overall Study|Lack of Efficacy|7
898523|NCT01167881|2961588|P1|Overall Study|Lack of Efficacy|4
898524|NCT01167881|2961587|P2|Overall Study|Adverse Event|51
898525|NCT01167881|2961588|P1|Overall Study|Adverse Event|47
898526|NCT01167634|2961642|P4|Overall Study|Withdrawal by Subject|0
898527|NCT01167634|2961643|P3|Overall Study|Withdrawal by Subject|0
898528|NCT01167634|2961644|P2|Overall Study|Withdrawal by Subject|1
898529|NCT01167634|2961645|P1|Overall Study|Withdrawal by Subject|1
898530|NCT01167634|2961642|P4|Overall Study|Lost to Follow-up|4
898531|NCT01167634|2961643|P3|Overall Study|Lost to Follow-up|3
898532|NCT01167634|2961644|P2|Overall Study|Lost to Follow-up|3
898533|NCT01167634|2961645|P1|Overall Study|Lost to Follow-up|1
898534|NCT01167582|2961666|P2|Overall Study|Lost to Follow-up|1
898535|NCT01167582|2961667|P1|Overall Study|Lost to Follow-up|0
898536|NCT01167426|2961707|P1|Overall Study|Sponsor Decision|1
898537|NCT01167426|2961707|P1|Overall Study|Withdrawal by Subject|2
898538|NCT01167426|2961707|P1|Overall Study|Protocol Violation|1
898539|NCT01167426|2961707|P1|Overall Study|Lost to Follow-up|6
898540|NCT01167257|2961715|P2|Overall Study|Withdrew consent|1
898541|NCT01167257|2961716|P1|Overall Study|Withdrew consent|1
898542|NCT01167257|2961715|P2|Overall Study|Lost to Follow-up|2
898543|NCT01167257|2961716|P1|Overall Study|Lost to Follow-up|2
898544|NCT01167192|2961738|P1|Overall Study|Insurance denial|1
898545|NCT01167192|2961738|P1|Overall Study|Withdrawal by Subject|1
898546|NCT01167192|2961738|P1|Overall Study|Death|1
898547|NCT01167192|2961738|P1|Overall Study|Adverse Event|1
898548|NCT01167179|2961755|P2|Overall Study|diverse|5
898549|NCT01167179|2961756|P1|Overall Study|diverse|6
898550|NCT01167179|2961755|P2|Overall Study|Withdrawal by Subject|2
898551|NCT01167179|2961756|P1|Overall Study|Withdrawal by Subject|1
898552|NCT01167179|2961755|P2|Overall Study|Death|10
898553|NCT01167179|2961756|P1|Overall Study|Death|4
898554|NCT01167179|2961755|P2|Overall Study|disease recurrence|4
898555|NCT01167179|2961756|P1|Overall Study|disease recurrence|4
898556|NCT01167153|2961766|P2|Overall Study|Subject initiation withdrawal, Other|8
898557|NCT01167153|2961767|P1|Overall Study|Subject initiation withdrawal, Other|5
898558|NCT01167153|2961766|P2|Overall Study|Withdrawal consent|1
898559|NCT01167153|2961767|P1|Overall Study|Withdrawal consent|1
898560|NCT01167153|2961766|P2|Overall Study|Investigator initiation withdrawal,Other|1
898561|NCT01167153|2961767|P1|Overall Study|Investigator initiation withdrawal,Other|1
898562|NCT01167153|2961766|P2|Overall Study|Non-compliance to concomitant medication|2
898563|NCT01167153|2961767|P1|Overall Study|Non-compliance to concomitant medication|0
898564|NCT01167153|2961766|P2|Overall Study|Lost to Follow-up|9
898565|NCT01167153|2961767|P1|Overall Study|Lost to Follow-up|7
898566|NCT01167153|2961766|P2|Overall Study|Hypotension|0
898567|NCT01167153|2961767|P1|Overall Study|Hypotension|1
898568|NCT01167153|2961766|P2|Overall Study|AE including clinical laboratory AE|8
898569|NCT01167153|2961767|P1|Overall Study|AE including clinical laboratory AE|2
898570|NCT01167153|2961766|P2|Overall Study|Non-effective therapy|4
898571|NCT01167153|2961767|P1|Overall Study|Non-effective therapy|1
898572|NCT01167140|2961785|P1|Overall Study|Withdrawal by Subject|1
898573|NCT01167023|2961793|P3|Overall Study|Withdrawal by Subject|1
898574|NCT01167023|2961794|P2|Overall Study|Withdrawal by Subject|0
898575|NCT01167023|2961795|P1|Overall Study|Withdrawal by Subject|0
898576|NCT01167023|2961793|P3|Overall Study|Sponsor Decision|0
898577|NCT01167023|2961794|P2|Overall Study|Sponsor Decision|1
898578|NCT01167023|2961795|P1|Overall Study|Sponsor Decision|0
898579|NCT01167023|2961793|P3|Overall Study|Screen Failure|0
898580|NCT01167023|2961794|P2|Overall Study|Screen Failure|1
898581|NCT01167023|2961795|P1|Overall Study|Screen Failure|0
898582|NCT01167023|2961793|P3|Overall Study|Lost to Follow-up|1
898583|NCT01167023|2961794|P2|Overall Study|Lost to Follow-up|1
898584|NCT01167023|2961795|P1|Overall Study|Lost to Follow-up|0
898585|NCT01166958|2961835|P2|Overall Study|Withdrawal by Subject|0
898586|NCT01166958|2961836|P1|Overall Study|Withdrawal by Subject|1
898587|NCT01166763|2961850|P1|Overall Study|Withdrawal by Subject|3
898588|NCT01166750|2961858|P2|Overall Study|Lost to Follow-up|0
898589|NCT01166750|2961859|P1|Overall Study|Lost to Follow-up|1
898590|NCT01166659|2961876|P1|Overall Study|Study Closed at Site|1
898591|NCT01166659|2961876|P1|Overall Study|Lost to Follow-up|1
898592|NCT01166659|2961876|P1|Overall Study|Death|1
898593|NCT01166659|2961876|P1|Overall Study|Investigator Decision|2
898594|NCT01166659|2961876|P1|Overall Study|Subject Decision|8
898595|NCT01166646|2961885|P2|Overall Study|Adverse Event|0
898596|NCT01166646|2961886|P1|Overall Study|Adverse Event|1
898597|NCT01166646|2961885|P2|Overall Study|Protocol Violation|1
898598|NCT01166646|2961886|P1|Overall Study|Protocol Violation|0
898599|NCT01166568|2961905|P3|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1
898600|NCT01166568|2961906|P2|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
898601|NCT01166568|2961907|P1|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7
898602|NCT01166568|2961905|P3|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0
898603|NCT01166568|2961906|P2|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1
898604|NCT01166568|2961907|P1|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7
898605|NCT01166568|2961905|P3|Deferred Implantation- Randomized|Withdrawal by Subject|1
898606|NCT01166568|2961906|P2|Deferred Implantation- Randomized|Withdrawal by Subject|0
898607|NCT01166568|2961907|P1|Deferred Implantation- Randomized|Withdrawal by Subject|0
898608|NCT01166438|2961920|P2|Off Treatment Follow-up Phase|Lack of Efficacy|52
898609|NCT01166438|2961921|P1|Off Treatment Follow-up Phase|Lack of Efficacy|29
898610|NCT01166438|2961920|P2|Off Treatment Follow-up Phase|Lost to Follow-up|2
898611|NCT01166438|2961921|P1|Off Treatment Follow-up Phase|Lost to Follow-up|4
898612|NCT01166438|2961920|P2|Off Treatment Follow-up Phase|Withdrawal by Subject|2
898613|NCT01166438|2961921|P1|Off Treatment Follow-up Phase|Withdrawal by Subject|1
898614|NCT01166438|2961920|P2|Double-blind Phase: 1st 6 Months|Not treated|1
898615|NCT01166438|2961921|P1|Double-blind Phase: 1st 6 Months|Not treated|1
898616|NCT01166438|2961920|P2|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4
898617|NCT01166438|2961921|P1|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0
898618|NCT01166438|2961920|P2|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4
898619|NCT01166438|2961921|P1|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8
898620|NCT01166282|2961970|P3|Open-label Period|Irregular Compliance|1
898621|NCT01166282|2961971|P2|Open-label Period|Irregular Compliance|0
898622|NCT01166282|2961972|P1|Open-label Period|Irregular Compliance|0
898623|NCT01166282|2961970|P3|Open-label Period|Remission|4
898624|NCT01166282|2961971|P2|Open-label Period|Remission|0
898625|NCT01166282|2961972|P1|Open-label Period|Remission|0
898626|NCT01166282|2961970|P3|Open-label Period|Lack of Efficacy|2
898627|NCT01166282|2961971|P2|Open-label Period|Lack of Efficacy|0
898628|NCT01166282|2961972|P1|Open-label Period|Lack of Efficacy|0
898629|NCT01166282|2961970|P3|Open-label Period|Withdrawal by Subject|4
898630|NCT01166282|2961971|P2|Open-label Period|Withdrawal by Subject|0
898631|NCT01166282|2961972|P1|Open-label Period|Withdrawal by Subject|0
898632|NCT01166282|2961970|P3|Open-label Period|Adverse Event|6
898633|NCT01166282|2961971|P2|Open-label Period|Adverse Event|0
898634|NCT01166282|2961972|P1|Open-label Period|Adverse Event|0
898635|NCT01166178|2962011|P2|Overall Study|Study was terminated|8
898636|NCT01166178|2962012|P1|Overall Study|Study was terminated|20
898637|NCT01166178|2962011|P2|Overall Study|Withdrawal by Subject|0
898638|NCT01166178|2962012|P1|Overall Study|Withdrawal by Subject|1
898639|NCT01165996|2962051|P1|Overall Study|Physician Decision|1
898640|NCT01165996|2962051|P1|Overall Study|Death|1
898641|NCT01165684|2962118|P2|Overall Study|Unclassified|22
898642|NCT01165684|2962119|P1|Overall Study|Unclassified|16
898643|NCT01165684|2962118|P2|Overall Study|Withdrawal Criteria|13
898644|NCT01165684|2962119|P1|Overall Study|Withdrawal Criteria|2
898645|NCT01165684|2962118|P2|Overall Study|Protocol Violation|15
898646|NCT01165684|2962119|P1|Overall Study|Protocol Violation|7
898647|NCT01165684|2962118|P2|Overall Study|Lack of Efficacy|1
898648|NCT01165684|2962119|P1|Overall Study|Lack of Efficacy|2
898649|NCT01165684|2962118|P2|Overall Study|Adverse Event|1
898650|NCT01165684|2962119|P1|Overall Study|Adverse Event|1
898651|NCT01165554|2962153|P1|Overall Study|Withdrawal by Subject|23
898652|NCT01165424|2962176|P1|Overall Study|Participant moved (relocated)|1
898653|NCT01165424|2962176|P1|Overall Study|Did not meet entry criteria|1
898654|NCT01165424|2962176|P1|Overall Study|Laboratory adverse experiences|1
898655|NCT01165424|2962176|P1|Overall Study|Clinical adverse experiences|1
898656|NCT01165320|2962183|P3|Overall Study|Reason unknown|0
898657|NCT01165320|2962184|P2|Overall Study|Reason unknown|1
898658|NCT01165320|2962185|P1|Overall Study|Reason unknown|0
898659|NCT01165320|2962183|P3|Overall Study|Lack of Efficacy|0
898660|NCT01165320|2962184|P2|Overall Study|Lack of Efficacy|2
898661|NCT01165320|2962185|P1|Overall Study|Lack of Efficacy|0
898662|NCT01165320|2962183|P3|Overall Study|Laboratory adverse experience|0
898663|NCT01165320|2962184|P2|Overall Study|Laboratory adverse experience|0
898664|NCT01165320|2962185|P1|Overall Study|Laboratory adverse experience|1
898665|NCT01165320|2962183|P3|Overall Study|Clinical adverse experience|0
898666|NCT01165320|2962184|P2|Overall Study|Clinical adverse experience|1
898667|NCT01165320|2962185|P1|Overall Study|Clinical adverse experience|2
898668|NCT01165307|2962195|P2|Overall Study|Subject not available for contact|0
898669|NCT01165307|2962196|P1|Overall Study|Subject not available for contact|1
898670|NCT01165307|2962195|P2|Overall Study|Withdrawal by Subject|0
898671|NCT01165307|2962196|P1|Overall Study|Withdrawal by Subject|2
898672|NCT01165307|2962195|P2|Overall Study|Lost to Follow-up|3
898673|NCT01165307|2962196|P1|Overall Study|Lost to Follow-up|11
898674|NCT01165281|2962226|P2|Overall Study|Other|0
898675|NCT01165281|2962227|P1|Overall Study|Other|6
898676|NCT01165281|2962226|P2|Overall Study|Progressive Disease|14
898677|NCT01165281|2962227|P1|Overall Study|Progressive Disease|10
898678|NCT01165281|2962226|P2|Overall Study|Noncompliance with Study Drug|4
898679|NCT01165281|2962227|P1|Overall Study|Noncompliance with Study Drug|1
898680|NCT01165281|2962226|P2|Overall Study|Withdrawal by Subject|7
898681|NCT01165281|2962227|P1|Overall Study|Withdrawal by Subject|8
898682|NCT01165281|2962226|P2|Overall Study|Protocol Violation|5
898683|NCT01165281|2962227|P1|Overall Study|Protocol Violation|6
898684|NCT01165281|2962226|P2|Overall Study|Physician Decision|1
898685|NCT01165281|2962227|P1|Overall Study|Physician Decision|8
898686|NCT01165281|2962226|P2|Overall Study|Lost to Follow-up|1
898687|NCT01165281|2962227|P1|Overall Study|Lost to Follow-up|0
898688|NCT01165281|2962226|P2|Overall Study|Lack of Efficacy|1
898689|NCT01165281|2962227|P1|Overall Study|Lack of Efficacy|4
898690|NCT01165281|2962226|P2|Overall Study|Death|4
898691|NCT01165281|2962227|P1|Overall Study|Death|3
898692|NCT01165281|2962226|P2|Overall Study|Adverse Event|14
898693|NCT01165281|2962227|P1|Overall Study|Adverse Event|12
898694|NCT01165242|2962248|P3|Overall Study|Lost to Follow-up|10
898695|NCT01165242|2962249|P2|Overall Study|Lost to Follow-up|7
898696|NCT01165242|2962250|P1|Overall Study|Lost to Follow-up|9
898697|NCT01165242|2962248|P3|Overall Study|Extended Holiday|1
898698|NCT01165242|2962249|P2|Overall Study|Extended Holiday|0
898699|NCT01165242|2962250|P1|Overall Study|Extended Holiday|0
898700|NCT01165242|2962248|P3|Overall Study|Withdrawal by Subject|2
898701|NCT01165242|2962249|P2|Overall Study|Withdrawal by Subject|2
898702|NCT01165242|2962250|P1|Overall Study|Withdrawal by Subject|0
898703|NCT01165242|2962248|P3|Overall Study|Visit 2 Declined by Subject|1
898704|NCT01165242|2962249|P2|Overall Study|Visit 2 Declined by Subject|0
898705|NCT01165242|2962250|P1|Overall Study|Visit 2 Declined by Subject|0
898706|NCT01165242|2962248|P3|Overall Study|Incarcerated Subjects|0
898707|NCT01165242|2962249|P2|Overall Study|Incarcerated Subjects|1
898708|NCT01165242|2962250|P1|Overall Study|Incarcerated Subjects|0
898709|NCT01165242|2962248|P3|Overall Study|Unreachable Subjects|0
898710|NCT01165242|2962249|P2|Overall Study|Unreachable Subjects|0
898711|NCT01165242|2962250|P1|Overall Study|Unreachable Subjects|1
898712|NCT01165229|2962284|P2|Overall Study|Screening criteria unmet|0
898713|NCT01165229|2962285|P1|Overall Study|Screening criteria unmet|1
898714|NCT01165229|2962284|P2|Overall Study|Lack of time|0
898715|NCT01165229|2962285|P1|Overall Study|Lack of time|1
898716|NCT01165229|2962284|P2|Overall Study|Missed visit|0
898717|NCT01165229|2962285|P1|Overall Study|Missed visit|1
898718|NCT01165229|2962284|P2|Overall Study|Sponsor study termination|0
898719|NCT01165229|2962285|P1|Overall Study|Sponsor study termination|1
898720|NCT01165229|2962284|P2|Overall Study|Investigator decision|2
898721|NCT01165229|2962285|P1|Overall Study|Investigator decision|0
898722|NCT01165229|2962284|P2|Overall Study|Personal reason|4
898723|NCT01165229|2962285|P1|Overall Study|Personal reason|10
898724|NCT01165229|2962284|P2|Overall Study|Site closure|20
898725|NCT01165229|2962285|P1|Overall Study|Site closure|18
898726|NCT01165229|2962284|P2|Overall Study|Health issues|56
898727|NCT01165229|2962285|P1|Overall Study|Health issues|61
898728|NCT01165229|2962284|P2|Overall Study|Patient not eligible|1
898729|NCT01165229|2962285|P1|Overall Study|Patient not eligible|0
898730|NCT01165229|2962284|P2|Overall Study|Page entered in error|1
898731|NCT01165229|2962285|P1|Overall Study|Page entered in error|0
898732|NCT01165229|2962284|P2|Overall Study|No reason from the subject|1
898733|NCT01165229|2962285|P1|Overall Study|No reason from the subject|0
898734|NCT01165229|2962284|P2|Overall Study|Suspected HZ Episode|2
898735|NCT01165229|2962285|P1|Overall Study|Suspected HZ Episode|0
898736|NCT01165229|2962284|P2|Overall Study|Lost to Follow-up|138
898737|NCT01165229|2962285|P1|Overall Study|Lost to Follow-up|124
898738|NCT01165229|2962284|P2|Overall Study|Migrated/moved from study area|46
898739|NCT01165229|2962285|P1|Overall Study|Migrated/moved from study area|51
898740|NCT01165229|2962284|P2|Overall Study|Withdrawal by Subject|403
898741|NCT01165229|2962285|P1|Overall Study|Withdrawal by Subject|396
898742|NCT01165229|2962284|P2|Overall Study|Protocol Violation|12
898743|NCT01165229|2962285|P1|Overall Study|Protocol Violation|10
898744|NCT01165229|2962284|P2|Overall Study|Non-Serious Adverse Event|15
898745|NCT01165229|2962285|P1|Overall Study|Non-Serious Adverse Event|47
898746|NCT01165229|2962284|P2|Overall Study|Serious Adverse Event|487
898747|NCT01165229|2962285|P1|Overall Study|Serious Adverse Event|459
898748|NCT01165229|2962284|P2|Overall Study|Unknown completion status|1
898749|NCT01165229|2962285|P1|Overall Study|Unknown completion status|0
898750|NCT01165216|2962413|P2|Overall Study|Disease progression|3
898751|NCT01165216|2962414|P1|Overall Study|Disease progression|1
898752|NCT01165216|2962413|P2|Overall Study|Withdrawal by Subject|1
898753|NCT01165216|2962414|P1|Overall Study|Withdrawal by Subject|1
898754|NCT01165216|2962413|P2|Overall Study|Adverse Event|3
898755|NCT01165216|2962414|P1|Overall Study|Adverse Event|6
898756|NCT01165203|2962436|P2|Extended Safety Follow-up Phase|Other-subjects business reasons|1
898757|NCT01165203|2962437|P1|Extended Safety Follow-up Phase|Other-subjects business reasons|0
898758|NCT01165203|2962436|P2|Extended Safety Follow-up Phase|Lost to Follow-up|0
898759|NCT01165203|2962437|P1|Extended Safety Follow-up Phase|Lost to Follow-up|2
898760|NCT01165203|2962436|P2|Extended Safety Follow-up Phase|Migrated/moved from study area|1
898761|NCT01165203|2962437|P1|Extended Safety Follow-up Phase|Migrated/moved from study area|2
898762|NCT01165203|2962436|P2|Extended Safety Follow-up Phase|Withdrawal by Subject|2
898763|NCT01165203|2962437|P1|Extended Safety Follow-up Phase|Withdrawal by Subject|2
898764|NCT01165203|2962436|P2|Extended Safety Follow-up Phase|Serious Adverse Event|0
898765|NCT01165203|2962437|P1|Extended Safety Follow-up Phase|Serious Adverse Event|1
898766|NCT01165203|2962436|P2|Active Phase|Lost to Follow-up|0
898767|NCT01165203|2962437|P1|Active Phase|Lost to Follow-up|2
898768|NCT01165203|2962436|P2|Active Phase|Migrated/moved from study area|1
898769|NCT01165203|2962437|P1|Active Phase|Migrated/moved from study area|0
898770|NCT01165203|2962436|P2|Active Phase|Withdrawal by Subject|1
898771|NCT01165203|2962437|P1|Active Phase|Withdrawal by Subject|2
898772|NCT01165203|2962436|P2|Active Phase|Serious Adverse Event|0
898773|NCT01165203|2962437|P1|Active Phase|Serious Adverse Event|1
898774|NCT01165177|2962527|P2|Overall Study|Death|1
898775|NCT01165177|2962528|P1|Overall Study|Death|0
898776|NCT01165177|2962527|P2|Overall Study|Personal Reasons|4
898777|NCT01165177|2962528|P1|Overall Study|Personal Reasons|1
898778|NCT01165177|2962527|P2|Overall Study|Physician Decision|1
898779|NCT01165177|2962528|P1|Overall Study|Physician Decision|0
898780|NCT01165177|2962527|P2|Overall Study|Non-serious Adverse Event|20
898781|NCT01165177|2962528|P1|Overall Study|Non-serious Adverse Event|32
898782|NCT01165177|2962527|P2|Overall Study|Migrated/moved from study area|43
898783|NCT01165177|2962528|P1|Overall Study|Migrated/moved from study area|48
898784|NCT01165177|2962527|P2|Overall Study|Subject missed visit|2
898785|NCT01165177|2962528|P1|Overall Study|Subject missed visit|5
898786|NCT01165177|2962527|P2|Overall Study|Previous health issues worsening|11
898787|NCT01165177|2962528|P1|Overall Study|Previous health issues worsening|9
898788|NCT01165177|2962527|P2|Overall Study|Subject non-compliant with procedures|2
898789|NCT01165177|2962528|P1|Overall Study|Subject non-compliant with procedures|12
898790|NCT01165177|2962527|P2|Overall Study|Site closure|5
898791|NCT01165177|2962528|P1|Overall Study|Site closure|7
898792|NCT01165177|2962527|P2|Overall Study|Protocol Violation|22
898793|NCT01165177|2962528|P1|Overall Study|Protocol Violation|19
898794|NCT01165177|2962527|P2|Overall Study|Lost to Follow-up|195
898795|NCT01165177|2962528|P1|Overall Study|Lost to Follow-up|188
898796|NCT01165177|2962527|P2|Overall Study|Serious Adverse Event|240
898797|NCT01165177|2962528|P1|Overall Study|Serious Adverse Event|229
898798|NCT01165177|2962527|P2|Overall Study|Withdrawal by Subject|356
898799|NCT01165177|2962528|P1|Overall Study|Withdrawal by Subject|372
898800|NCT01165138|2962653|P4|Overall Study|Withdrawal by Subject|3
898801|NCT01165138|2962654|P3|Overall Study|Withdrawal by Subject|6
898802|NCT01165138|2962655|P2|Overall Study|Withdrawal by Subject|6
898803|NCT01165138|2962656|P1|Overall Study|Withdrawal by Subject|0
898804|NCT01165138|2962653|P4|Overall Study|Physician Decision|6
898805|NCT01165138|2962654|P3|Overall Study|Physician Decision|7
898806|NCT01165138|2962655|P2|Overall Study|Physician Decision|6
898807|NCT01165138|2962656|P1|Overall Study|Physician Decision|0
898808|NCT01165138|2962653|P4|Overall Study|Lost to Follow-up|2
898809|NCT01165138|2962654|P3|Overall Study|Lost to Follow-up|1
898810|NCT01165138|2962655|P2|Overall Study|Lost to Follow-up|0
898811|NCT01165138|2962656|P1|Overall Study|Lost to Follow-up|0
898812|NCT01165138|2962653|P4|Overall Study|Protocol Violation|2
898813|NCT01165138|2962654|P3|Overall Study|Protocol Violation|0
898814|NCT01165138|2962655|P2|Overall Study|Protocol Violation|7
898815|NCT01165138|2962656|P1|Overall Study|Protocol Violation|0
898816|NCT01165138|2962653|P4|Overall Study|Lack of Efficacy|7
898817|NCT01165138|2962654|P3|Overall Study|Lack of Efficacy|6
898818|NCT01165138|2962655|P2|Overall Study|Lack of Efficacy|32
898819|NCT01165138|2962656|P1|Overall Study|Lack of Efficacy|0
898820|NCT01165138|2962653|P4|Overall Study|Adverse Event|2
898821|NCT01165138|2962654|P3|Overall Study|Adverse Event|0
898822|NCT01165138|2962655|P2|Overall Study|Adverse Event|1
898823|NCT01165138|2962656|P1|Overall Study|Adverse Event|0
898824|NCT01165021|2962726|P1|Overall Study|Death|1
898825|NCT01164891|2962734|P1|Overall Study|Adverse Event|1
898826|NCT01164891|2962734|P1|Overall Study|Disease Progression|5
898827|NCT01164865|2962754|P2|Overall Study|Lost to Follow-up|1
898828|NCT01164865|2962755|P1|Overall Study|Lost to Follow-up|2
898829|NCT01164722|2962765|P2|Overall Study|enrolled on other study, concomitant med|3
898830|NCT01164722|2962766|P1|Overall Study|enrolled on other study, concomitant med|1
898831|NCT01164722|2962765|P2|Overall Study|met protocol criteria for non-treatment|1
898832|NCT01164722|2962766|P1|Overall Study|met protocol criteria for non-treatment|11
898833|NCT01164722|2962765|P2|Overall Study|Lost to Follow-up|6
898834|NCT01164722|2962766|P1|Overall Study|Lost to Follow-up|3
898835|NCT01164722|2962765|P2|Overall Study|Withdrawal by Subject|4
898836|NCT01164722|2962766|P1|Overall Study|Withdrawal by Subject|3
898837|NCT01164722|2962765|P2|Overall Study|Adverse Event|1
898838|NCT01164722|2962766|P1|Overall Study|Adverse Event|0
898839|NCT01164579|2962796|P3|Overall Study|Reason not specified|0
898840|NCT01164579|2962797|P2|Overall Study|Reason not specified|0
898841|NCT01164579|2962798|P1|Overall Study|Reason not specified|1
898842|NCT01164579|2962796|P3|Overall Study|Adverse Event|5
898843|NCT01164579|2962797|P2|Overall Study|Adverse Event|2
898844|NCT01164579|2962798|P1|Overall Study|Adverse Event|4
898845|NCT01164579|2962796|P3|Overall Study|Protocol Violation|2
898846|NCT01164579|2962797|P2|Overall Study|Protocol Violation|1
898847|NCT01164579|2962798|P1|Overall Study|Protocol Violation|0
898848|NCT01164579|2962796|P3|Overall Study|Withdrawal by Subject|3
898849|NCT01164579|2962797|P2|Overall Study|Withdrawal by Subject|5
898850|NCT01164579|2962798|P1|Overall Study|Withdrawal by Subject|2
898851|NCT01164579|2962796|P3|Overall Study|Lost to Follow-up|0
898852|NCT01164579|2962797|P2|Overall Study|Lost to Follow-up|1
898853|NCT01164579|2962798|P1|Overall Study|Lost to Follow-up|1
898854|NCT01164579|2962796|P3|Overall Study|Lack of Efficacy|6
898855|NCT01164579|2962797|P2|Overall Study|Lack of Efficacy|0
898856|NCT01164579|2962798|P1|Overall Study|Lack of Efficacy|0
898857|NCT01164501|2962878|P3|Overall Study|Other reason not defined above|4
898858|NCT01164501|2962879|P2|Overall Study|Other reason not defined above|1
898859|NCT01164501|2962880|P1|Overall Study|Other reason not defined above|9
898860|NCT01164501|2962878|P3|Overall Study|Patient refusal to continue,not due toAE|8
898861|NCT01164501|2962879|P2|Overall Study|Patient refusal to continue,not due toAE|4
898862|NCT01164501|2962880|P1|Overall Study|Patient refusal to continue,not due toAE|10
898863|NCT01164501|2962878|P3|Overall Study|Lost to Follow-up|3
898864|NCT01164501|2962879|P2|Overall Study|Lost to Follow-up|0
898865|NCT01164501|2962880|P1|Overall Study|Lost to Follow-up|3
898866|NCT01164501|2962878|P3|Overall Study|Non compliant with protocol|4
898867|NCT01164501|2962879|P2|Overall Study|Non compliant with protocol|1
898868|NCT01164501|2962880|P1|Overall Study|Non compliant with protocol|1
898869|NCT01164501|2962878|P3|Overall Study|Lack of Efficacy|1
898870|NCT01164501|2962879|P2|Overall Study|Lack of Efficacy|0
898871|NCT01164501|2962880|P1|Overall Study|Lack of Efficacy|0
898872|NCT01164501|2962878|P3|Overall Study|Adverse Event|21
898873|NCT01164501|2962879|P2|Overall Study|Adverse Event|4
898874|NCT01164501|2962880|P1|Overall Study|Adverse Event|18
898875|NCT01164501|2962878|P3|Overall Study|Not treated|1
898876|NCT01164501|2962879|P2|Overall Study|Not treated|0
898877|NCT01164501|2962880|P1|Overall Study|Not treated|2
898878|NCT01164475|2962897|P2|Overall Study|Protocol Violation|0
898879|NCT01164475|2962898|P1|Overall Study|Protocol Violation|1
898880|NCT01164475|2962897|P2|Overall Study|Progressive disease|1
898881|NCT01164475|2962898|P1|Overall Study|Progressive disease|0
898882|NCT01164475|2962897|P2|Overall Study|Other|1
898883|NCT01164475|2962898|P1|Overall Study|Other|0
898884|NCT01164475|2962897|P2|Overall Study|Lack of Efficacy|0
898885|NCT01164475|2962898|P1|Overall Study|Lack of Efficacy|1
898886|NCT01164007|2962952|P1|Overall Study|Medical Decision|3
898887|NCT01164007|2962952|P1|Overall Study|Withdrawal by Subject|1
898888|NCT01164007|2962952|P1|Overall Study|Protocol Violation|1
898889|NCT01164007|2962952|P1|Overall Study|Progression of Disease|30
898890|NCT01164007|2962952|P1|Overall Study|Adverse Event|5
898891|NCT01163916|2962978|P3|Overall Study|Other|16
898892|NCT01163916|2962979|P2|Overall Study|Other|4
898893|NCT01163916|2962980|P1|Overall Study|Other|24
898894|NCT01163916|2962978|P3|Overall Study|Lack of Efficacy|1
898895|NCT01163916|2962979|P2|Overall Study|Lack of Efficacy|0
898896|NCT01163916|2962980|P1|Overall Study|Lack of Efficacy|2
898897|NCT01163916|2962978|P3|Overall Study|Adverse Event|1
898898|NCT01163916|2962979|P2|Overall Study|Adverse Event|0
898899|NCT01163916|2962980|P1|Overall Study|Adverse Event|2
898900|NCT01163916|2962978|P3|Overall Study|Withdrawal by Subject|2
898901|NCT01163916|2962979|P2|Overall Study|Withdrawal by Subject|0
898902|NCT01163916|2962980|P1|Overall Study|Withdrawal by Subject|2
898903|NCT01163851|2963018|P2|Overall Study|Enrolled but not treated|0
898904|NCT01163851|2963019|P1|Overall Study|Enrolled but not treated|1
898905|NCT01163851|2963018|P2|Overall Study|Site Closure|1
898906|NCT01163851|2963019|P1|Overall Study|Site Closure|0
898907|NCT01163747|2963114|P2|Overall Study|Refused Treatment|4
898908|NCT01163747|2963115|P1|Overall Study|Refused Treatment|6
898909|NCT01163747|2963114|P2|Overall Study|Protocol Violation|1
898910|NCT01163747|2963115|P1|Overall Study|Protocol Violation|0
898911|NCT01163747|2963114|P2|Overall Study|Insufficient Therapeutic Response|1
898912|NCT01163747|2963115|P1|Overall Study|Insufficient Therapeutic Response|0
898913|NCT01163747|2963114|P2|Overall Study|Adverse Event|5
898914|NCT01163747|2963115|P1|Overall Study|Adverse Event|0
898915|NCT01163721|2963135|P2|Overall Study|Physician Decision|1
898916|NCT01163721|2963136|P1|Overall Study|Physician Decision|0
898917|NCT01163721|2963135|P2|Overall Study|Lost to Follow-up|1
898918|NCT01163721|2963136|P1|Overall Study|Lost to Follow-up|0
898919|NCT01163721|2963135|P2|Overall Study|Withdrawal by Subject|4
898920|NCT01163721|2963136|P1|Overall Study|Withdrawal by Subject|3
898921|NCT01163721|2963135|P2|Overall Study|Adverse Event|6
898922|NCT01163721|2963136|P1|Overall Study|Adverse Event|5
898923|NCT01163617|2963155|P8|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
898924|NCT01163617|2963156|P7|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
898925|NCT01163617|2963157|P6|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
898926|NCT01163617|2963158|P5|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
898927|NCT01163617|2963159|P4|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
898928|NCT01163617|2963160|P3|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1
898929|NCT01163617|2963161|P2|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
898930|NCT01163617|2963162|P1|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
898931|NCT01163617|2963155|P8|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
898932|NCT01163617|2963156|P7|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
898933|NCT01163617|2963157|P6|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
898934|NCT01163617|2963158|P5|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
898935|NCT01163617|2963159|P4|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
898936|NCT01163617|2963160|P3|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
898937|NCT01163617|2963161|P2|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1
898938|NCT01163617|2963162|P1|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
898939|NCT01163617|2963155|P8|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
898940|NCT01163617|2963156|P7|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
898941|NCT01163617|2963157|P6|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
898942|NCT01163617|2963158|P5|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
898943|NCT01163617|2963159|P4|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
898944|NCT01163617|2963160|P3|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
898945|NCT01163617|2963161|P2|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1
898946|NCT01163617|2963162|P1|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
898947|NCT01163474|2963191|P1|Overall Study|Lost to Follow-up|3
898948|NCT01163474|2963191|P1|Overall Study|Tech barriers to videoteleconference vis|12
898949|NCT01163474|2963191|P1|Overall Study|Withdrawal by Subject|1
898950|NCT01163318|2963202|P1|Overall Study|Multiple Reasons Per Participant|224
898951|NCT01163318|2963202|P1|Overall Study|Participants Without Case Report Form|7
898952|NCT01163318|2963202|P1|Overall Study|History/comorbidity of malignant tumor|3
898953|NCT01163318|2963202|P1|Overall Study|Did Not Continue Use of Adalimumab|26
898954|NCT01163318|2963202|P1|Overall Study|Off-Label Use of Adalimumab|8
898955|NCT01163292|2963211|P2|Overall Study|No further visits|7
898956|NCT01163292|2963212|P1|Overall Study|No further visits|5
898957|NCT01163292|2963211|P2|Overall Study|Economic reasons|0
898958|NCT01163292|2963212|P1|Overall Study|Economic reasons|6
898959|NCT01163292|2963211|P2|Overall Study|Refusal to receive adalimumab|0
898960|NCT01163292|2963212|P1|Overall Study|Refusal to receive adalimumab|7
898961|NCT01163292|2963211|P2|Overall Study|Sufficient response to adalimumab|0
898962|NCT01163292|2963212|P1|Overall Study|Sufficient response to adalimumab|8
898963|NCT01163292|2963211|P2|Overall Study|Initiation of biological therapy|15
898964|NCT01163292|2963212|P1|Overall Study|Initiation of biological therapy|0
898965|NCT01163292|2963211|P2|Overall Study|Adverse Event|0
898966|NCT01163292|2963212|P1|Overall Study|Adverse Event|6
898967|NCT01163292|2963211|P2|Overall Study|Lack of Efficacy|0
898968|NCT01163292|2963212|P1|Overall Study|Lack of Efficacy|9
898969|NCT01163279|2963228|P2|Overall Study|Withdrawal by Subject|0
898970|NCT01163279|2963229|P1|Overall Study|Withdrawal by Subject|2
898971|NCT01163266|2963258|P3|Overall Study|Other|2
898972|NCT01163266|2963259|P2|Overall Study|Other|1
898973|NCT01163266|2963260|P1|Overall Study|Other|1
898974|NCT01163266|2963258|P3|Overall Study|Lost to Follow-up|10
898975|NCT01163266|2963259|P2|Overall Study|Lost to Follow-up|7
898976|NCT01163266|2963260|P1|Overall Study|Lost to Follow-up|7
898977|NCT01163266|2963258|P3|Overall Study|Withdrawal of Consent|3
898978|NCT01163266|2963259|P2|Overall Study|Withdrawal of Consent|7
898979|NCT01163266|2963260|P1|Overall Study|Withdrawal of Consent|5
898980|NCT01163266|2963258|P3|Overall Study|Protocol Deviations|5
898981|NCT01163266|2963259|P2|Overall Study|Protocol Deviations|2
898982|NCT01163266|2963260|P1|Overall Study|Protocol Deviations|2
898983|NCT01163266|2963258|P3|Overall Study|Noncompliance with Study Drug|0
898984|NCT01163266|2963259|P2|Overall Study|Noncompliance with Study Drug|2
898985|NCT01163266|2963260|P1|Overall Study|Noncompliance with Study Drug|0
898986|NCT01163266|2963258|P3|Overall Study|Lack of Efficacy|1
898987|NCT01163266|2963259|P2|Overall Study|Lack of Efficacy|3
898988|NCT01163266|2963260|P1|Overall Study|Lack of Efficacy|1
898989|NCT01163266|2963258|P3|Overall Study|Pretreatment Event or Adverse Event|7
898990|NCT01163266|2963259|P2|Overall Study|Pretreatment Event or Adverse Event|9
898991|NCT01163266|2963260|P1|Overall Study|Pretreatment Event or Adverse Event|2
898992|NCT01163253|2963285|P2|Overall Study|Other Unspecified|34
898993|NCT01163253|2963286|P1|Overall Study|Other Unspecified|170
898994|NCT01163253|2963285|P2|Overall Study|Ongoing|4
898995|NCT01163253|2963286|P1|Overall Study|Ongoing|13
898996|NCT01163253|2963285|P2|Overall Study|Death|5
898997|NCT01163253|2963286|P1|Overall Study|Death|17
898998|NCT01163253|2963285|P2|Overall Study|Adverse Event|78
898999|NCT01163253|2963286|P1|Overall Study|Adverse Event|300
899000|NCT01163253|2963285|P2|Overall Study|Insufficient Clinical Response|29
899001|NCT01163253|2963286|P1|Overall Study|Insufficient Clinical Response|423
899002|NCT01163253|2963285|P2|Overall Study|Lost to Follow-up|23
899003|NCT01163253|2963286|P1|Overall Study|Lost to Follow-up|125
899004|NCT01163253|2963285|P2|Overall Study|Medication Error|0
899005|NCT01163253|2963286|P1|Overall Study|Medication Error|1
899006|NCT01163253|2963285|P2|Overall Study|Withdrawal by Subject|50
899007|NCT01163253|2963286|P1|Overall Study|Withdrawal by Subject|199
899008|NCT01163253|2963285|P2|Overall Study|Protocol Violation|12
899009|NCT01163253|2963286|P1|Overall Study|Protocol Violation|43
899010|NCT01163253|2963285|P2|Overall Study|Study Terminated by Sponsor|349
899011|NCT01163253|2963286|P1|Overall Study|Study Terminated by Sponsor|978
899012|NCT01163253|2963285|P2|Overall Study|Withdrawn Due to Pregnancy|2
899013|NCT01163253|2963286|P1|Overall Study|Withdrawn Due to Pregnancy|12
899014|NCT01163149|2963474|P3|Extension Treatment Period|Noncompliance|1
899015|NCT01163149|2963475|P2|Extension Treatment Period|Noncompliance|0
899016|NCT01163149|2963476|P1|Extension Treatment Period|Noncompliance|0
899017|NCT01163149|2963474|P3|Extension Treatment Period|Adverse Event|0
899018|NCT01163149|2963475|P2|Extension Treatment Period|Adverse Event|1
899019|NCT01163149|2963476|P1|Extension Treatment Period|Adverse Event|0
899020|NCT01163149|2963474|P3|Extension Treatment Period|Withdrawal by Subject|1
899021|NCT01163149|2963475|P2|Extension Treatment Period|Withdrawal by Subject|0
899022|NCT01163149|2963476|P1|Extension Treatment Period|Withdrawal by Subject|2
899023|NCT01163032|2963576|P3|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2
899024|NCT01163032|2963577|P2|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
899025|NCT01163032|2963578|P1|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
899026|NCT01163032|2963576|P3|Open Label Extension Phase|Study Termination|7
899027|NCT01163032|2963577|P2|Open Label Extension Phase|Study Termination|0
899028|NCT01163032|2963578|P1|Open Label Extension Phase|Study Termination|0
899029|NCT01163032|2963576|P3|Open Label Extension Phase|Protocol Violation|1
899030|NCT01163032|2963577|P2|Open Label Extension Phase|Protocol Violation|0
899031|NCT01163032|2963578|P1|Open Label Extension Phase|Protocol Violation|0
899032|NCT01163032|2963576|P3|Open Label Extension Phase|Withdrawal by Subject|3
899033|NCT01163032|2963577|P2|Open Label Extension Phase|Withdrawal by Subject|0
899034|NCT01163032|2963578|P1|Open Label Extension Phase|Withdrawal by Subject|0
899035|NCT01163032|2963576|P3|Open Label Extension Phase|Adverse Event|3
899036|NCT01163032|2963577|P2|Open Label Extension Phase|Adverse Event|0
899037|NCT01163032|2963578|P1|Open Label Extension Phase|Adverse Event|0
899038|NCT01163032|2963576|P3|Randomization Phase|Unsatisfactory Therapeutic Effect|0
899039|NCT01163032|2963577|P2|Randomization Phase|Unsatisfactory Therapeutic Effect|1
899040|NCT01163032|2963578|P1|Randomization Phase|Unsatisfactory Therapeutic Effect|0
899041|NCT01163032|2963576|P3|Randomization Phase|Various*|0
899042|NCT01163032|2963577|P2|Randomization Phase|Various*|4
899043|NCT01163032|2963578|P1|Randomization Phase|Various*|5
899044|NCT01163032|2963576|P3|Randomization Phase|Protocol Violation|0
899045|NCT01163032|2963577|P2|Randomization Phase|Protocol Violation|1
899046|NCT01163032|2963578|P1|Randomization Phase|Protocol Violation|0
899047|NCT01163032|2963576|P3|Randomization Phase|Adverse Event|0
899048|NCT01163032|2963577|P2|Randomization Phase|Adverse Event|3
899049|NCT01163032|2963578|P1|Randomization Phase|Adverse Event|3
899050|NCT01163032|2963576|P3|Randomization Phase|Withdrawal by Subject|0
899051|NCT01163032|2963577|P2|Randomization Phase|Withdrawal by Subject|3
899052|NCT01163032|2963578|P1|Randomization Phase|Withdrawal by Subject|2
899053|NCT01162863|2963611|P3|Overall Study|Adverse Event|0
899054|NCT01162863|2963612|P2|Overall Study|Adverse Event|1
899055|NCT01162863|2963613|P1|Overall Study|Adverse Event|0
899056|NCT01162863|2963611|P3|Overall Study|Lack of Efficacy|0
899057|NCT01162863|2963612|P2|Overall Study|Lack of Efficacy|0
899058|NCT01162863|2963613|P1|Overall Study|Lack of Efficacy|1
899059|NCT01162499|2963638|P2|Intervention 1 (4 Hours)|Unable to establish IV access|1
899060|NCT01162499|2963639|P1|Intervention 1 (4 Hours)|Unable to establish IV access|0
899061|NCT01162473|2963661|P2|Overall Study|Withdrawal by Subject|4
899062|NCT01162473|2963662|P1|Overall Study|Withdrawal by Subject|0
899063|NCT01162473|2963661|P2|Overall Study|Adverse Event|1
899064|NCT01162473|2963662|P1|Overall Study|Adverse Event|2
899065|NCT01162421|2963670|P2|Overall Study|Not specified|3
899066|NCT01162421|2963671|P1|Overall Study|Not specified|2
899067|NCT01162421|2963670|P2|Overall Study|Lack of Efficacy|2
899068|NCT01162421|2963671|P1|Overall Study|Lack of Efficacy|2
899069|NCT01162421|2963670|P2|Overall Study|Lost to Follow-up|2
899070|NCT01162421|2963671|P1|Overall Study|Lost to Follow-up|0
899071|NCT01162421|2963670|P2|Overall Study|Adverse Event|5
899072|NCT01162421|2963671|P1|Overall Study|Adverse Event|2
899073|NCT01162421|2963670|P2|Overall Study|Did not receive study drug|1
899074|NCT01162421|2963671|P1|Overall Study|Did not receive study drug|2
899075|NCT01162343|2963749|P1|Overall Study|Refused psychiatrist assessment|12
899076|NCT01162343|2963749|P1|Overall Study|Left ED prior to psychiatrist assessment|80
899077|NCT01162304|2963764|P1|Overall Study|Beck scale to high|11
899078|NCT01162135|2963778|P1|Overall Study|Ineligible|1
899079|NCT01162135|2963778|P1|Overall Study|Severe back pain|1
899080|NCT01162135|2963778|P1|Overall Study|Withdrawal by Subject|1
899081|NCT01162122|2963784|P2|Overall Study|Missing primary reason|0
899082|NCT01162122|2963785|P1|Overall Study|Missing primary reason|1
899083|NCT01162122|2963784|P2|Overall Study|Unable to classify|7
899084|NCT01162122|2963785|P1|Overall Study|Unable to classify|3
899085|NCT01162122|2963784|P2|Overall Study|Administrative reason|1
899086|NCT01162122|2963785|P1|Overall Study|Administrative reason|1
899087|NCT01162122|2963784|P2|Overall Study|Inappropriate enrollment|4
899088|NCT01162122|2963785|P1|Overall Study|Inappropriate enrollment|5
899089|NCT01162122|2963784|P2|Overall Study|Protocol Violation|2
899090|NCT01162122|2963785|P1|Overall Study|Protocol Violation|2
899091|NCT01162122|2963784|P2|Overall Study|Death|46
899092|NCT01162122|2963785|P1|Overall Study|Death|51
899093|NCT01162122|2963784|P2|Overall Study|Adverse Event|2
899094|NCT01162122|2963785|P1|Overall Study|Adverse Event|3
899095|NCT01162122|2963784|P2|Overall Study|Lost to Follow-up|91
899096|NCT01162122|2963785|P1|Overall Study|Lost to Follow-up|73
899097|NCT01162122|2963784|P2|Overall Study|Withdrawal by Subject|43
899098|NCT01162122|2963785|P1|Overall Study|Withdrawal by Subject|52
899099|NCT01161628|2963880|P1|Overall Study|Lack of Efficacy|2
899100|NCT01161628|2963880|P1|Overall Study|Death|6
899101|NCT01161537|2963903|P1|Part B|Withdrawal by Subject|2
899102|NCT01161498|2963921|P2|Overall Study|Disease Progression|1
899103|NCT01161498|2963922|P1|Overall Study|Disease Progression|0
899104|NCT01161472|2963946|P4|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
899191|NCT01160640|2964362|P2|Overall Study|Incarceration|0
899105|NCT01161472|2963947|P3|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
899106|NCT01161472|2963948|P2|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
899107|NCT01161472|2963949|P1|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1
899108|NCT01161446|2964005|P2|Overall Study|Withdrawal by Subject|1
899109|NCT01161446|2964006|P1|Overall Study|Withdrawal by Subject|0
899110|NCT01161446|2964005|P2|Overall Study|Lost to Follow-up|14
899111|NCT01161446|2964006|P1|Overall Study|Lost to Follow-up|18
899112|NCT01161407|2964032|P2|Overall Study|Protocol Violation|1
899113|NCT01161407|2964033|P1|Overall Study|Protocol Violation|3
899114|NCT01161173|2964088|P1|Overall Study|Reasons Not Specified|23
899115|NCT01161173|2964088|P1|Overall Study|End of Study|2
899116|NCT01161173|2964088|P1|Overall Study|Death|194
899117|NCT01161173|2964088|P1|Overall Study|Unacceptable Toxicity|21
899118|NCT01161173|2964088|P1|Overall Study|Withdrawal of Consent|5
899119|NCT01161173|2964088|P1|Overall Study|Progressive Disease|82
899120|NCT01161173|2964088|P1|Overall Study|Lost to Follow-up|7
899121|NCT01161173|2964088|P1|Overall Study|Protocol Violation|13
899122|NCT01160822|2964215|P7|Overall Study|Protocol deviation|0
899123|NCT01160822|2964216|P6|Overall Study|Protocol deviation|0
899124|NCT01160822|2964217|P5|Overall Study|Protocol deviation|2
899125|NCT01160822|2964218|P4|Overall Study|Protocol deviation|0
899126|NCT01160822|2964219|P3|Overall Study|Protocol deviation|0
899127|NCT01160822|2964220|P2|Overall Study|Protocol deviation|0
899128|NCT01160822|2964221|P1|Overall Study|Protocol deviation|0
899129|NCT01160822|2964215|P7|Overall Study|Administrative problems|0
899130|NCT01160822|2964216|P6|Overall Study|Administrative problems|0
899131|NCT01160822|2964217|P5|Overall Study|Administrative problems|1
899132|NCT01160822|2964218|P4|Overall Study|Administrative problems|0
899133|NCT01160822|2964219|P3|Overall Study|Administrative problems|0
899134|NCT01160822|2964220|P2|Overall Study|Administrative problems|0
899135|NCT01160822|2964221|P1|Overall Study|Administrative problems|0
899136|NCT01160822|2964215|P7|Overall Study|Lost to Follow-up|0
899137|NCT01160822|2964216|P6|Overall Study|Lost to Follow-up|0
899138|NCT01160822|2964217|P5|Overall Study|Lost to Follow-up|1
899139|NCT01160822|2964218|P4|Overall Study|Lost to Follow-up|0
899140|NCT01160822|2964219|P3|Overall Study|Lost to Follow-up|0
899141|NCT01160822|2964220|P2|Overall Study|Lost to Follow-up|0
899142|NCT01160822|2964221|P1|Overall Study|Lost to Follow-up|0
899143|NCT01160822|2964215|P7|Overall Study|Withdrawal by Subject|1
899144|NCT01160822|2964216|P6|Overall Study|Withdrawal by Subject|0
899145|NCT01160822|2964217|P5|Overall Study|Withdrawal by Subject|0
899146|NCT01160822|2964218|P4|Overall Study|Withdrawal by Subject|0
899147|NCT01160822|2964219|P3|Overall Study|Withdrawal by Subject|0
899148|NCT01160822|2964220|P2|Overall Study|Withdrawal by Subject|0
899149|NCT01160822|2964221|P1|Overall Study|Withdrawal by Subject|0
899150|NCT01160822|2964215|P7|Overall Study|Unsatisfactory therapeutic effect|3
899151|NCT01160822|2964216|P6|Overall Study|Unsatisfactory therapeutic effect|5
899152|NCT01160822|2964217|P5|Overall Study|Unsatisfactory therapeutic effect|4
899153|NCT01160822|2964218|P4|Overall Study|Unsatisfactory therapeutic effect|0
899154|NCT01160822|2964219|P3|Overall Study|Unsatisfactory therapeutic effect|0
899155|NCT01160822|2964220|P2|Overall Study|Unsatisfactory therapeutic effect|0
899156|NCT01160822|2964221|P1|Overall Study|Unsatisfactory therapeutic effect|0
899157|NCT01160822|2964215|P7|Overall Study|Adverse Event|5
899158|NCT01160822|2964216|P6|Overall Study|Adverse Event|2
899159|NCT01160822|2964217|P5|Overall Study|Adverse Event|1
899160|NCT01160822|2964218|P4|Overall Study|Adverse Event|0
899161|NCT01160822|2964219|P3|Overall Study|Adverse Event|0
899162|NCT01160822|2964220|P2|Overall Study|Adverse Event|0
899163|NCT01160822|2964221|P1|Overall Study|Adverse Event|0
899164|NCT01160770|2964310|P1|Overall Study|Other Reasons|1
899165|NCT01160770|2964310|P1|Overall Study|Lack of Efficacy|15
899166|NCT01160770|2964310|P1|Overall Study|Death|9
899167|NCT01160770|2964310|P1|Overall Study|Study termination or sponsor request|1
899168|NCT01160770|2964310|P1|Overall Study|Lost to Follow-up|7
899169|NCT01160770|2964310|P1|Overall Study|Physician Decision|1
899170|NCT01160770|2964310|P1|Overall Study|Subject/parent/caregiver request|33
899171|NCT01160770|2964310|P1|Overall Study|Protocol Violation|2
899172|NCT01160770|2964310|P1|Overall Study|Adverse Event|10
899173|NCT01160744|2964323|P4|Overall Study|Alive and Still on Treatment|14
899174|NCT01160744|2964324|P3|Overall Study|Alive and Still on Treatment|8
899175|NCT01160744|2964325|P2|Overall Study|Alive and Still on Treatment|11
899176|NCT01160744|2964326|P1|Overall Study|Alive and Still on Treatment|9
899177|NCT01160744|2964323|P4|Overall Study|Not Specified|4
899178|NCT01160744|2964324|P3|Overall Study|Not Specified|5
899179|NCT01160744|2964325|P2|Overall Study|Not Specified|9
899180|NCT01160744|2964326|P1|Overall Study|Not Specified|5
899181|NCT01160744|2964323|P4|Overall Study|Not meet inclusion/exclusion criteria|0
899182|NCT01160744|2964324|P3|Overall Study|Not meet inclusion/exclusion criteria|1
899183|NCT01160744|2964325|P2|Overall Study|Not meet inclusion/exclusion criteria|0
899184|NCT01160744|2964326|P1|Overall Study|Not meet inclusion/exclusion criteria|0
899185|NCT01160744|2964323|P4|Overall Study|Withdrawal by Subject|4
899186|NCT01160744|2964324|P3|Overall Study|Withdrawal by Subject|6
899187|NCT01160744|2964325|P2|Overall Study|Withdrawal by Subject|5
899188|NCT01160744|2964326|P1|Overall Study|Withdrawal by Subject|6
899189|NCT01160640|2964362|P2|Overall Study|Withdrawal by Subject|3
899190|NCT01160640|2964363|P1|Overall Study|Withdrawal by Subject|0
899192|NCT01160640|2964363|P1|Overall Study|Incarceration|1
899193|NCT01160640|2964362|P2|Overall Study|Physician Decision|3
899194|NCT01160640|2964363|P1|Overall Study|Physician Decision|3
899195|NCT01160614|2964379|P2|Overall Study|Withdrawal by Subject|2
899196|NCT01160614|2964380|P1|Overall Study|Withdrawal by Subject|0
899197|NCT01160484|2964428|P1|Overall Study|inclusion/exclusion criteria failure|1
899198|NCT01160484|2964428|P1|Overall Study|Withdrawal by Subject|2
899199|NCT01160484|2964428|P1|Overall Study|Adverse Event|6
899200|NCT01160484|2964428|P1|Overall Study|Lack of Efficacy|9
899201|NCT01160198|2964509|P3|Overall Study|Participant lost drug; withdrew consent|1
899202|NCT01160198|2964510|P2|Overall Study|Participant lost drug; withdrew consent|0
899203|NCT01160198|2964511|P1|Overall Study|Participant lost drug; withdrew consent|0
899204|NCT01160198|2964509|P3|Overall Study|Lost to Follow-up|0
899205|NCT01160198|2964510|P2|Overall Study|Lost to Follow-up|1
899206|NCT01160198|2964511|P1|Overall Study|Lost to Follow-up|0
899207|NCT01160198|2964509|P3|Overall Study|Adverse Event|0
899208|NCT01160198|2964510|P2|Overall Study|Adverse Event|1
899209|NCT01160198|2964511|P1|Overall Study|Adverse Event|0
899210|NCT01160198|2964509|P3|Overall Study|Withdrawal by Subject|0
899211|NCT01160198|2964510|P2|Overall Study|Withdrawal by Subject|1
899212|NCT01160198|2964511|P1|Overall Study|Withdrawal by Subject|2
899213|NCT01159938|2964533|P5|First Study Period|Protocol Violation (Microalbuminuria)|0
899214|NCT01159938|2964534|P4|First Study Period|Protocol Violation (Microalbuminuria)|0
899215|NCT01159938|2964535|P3|First Study Period|Protocol Violation (Microalbuminuria)|1
899216|NCT01159938|2964536|P2|First Study Period|Protocol Violation (Microalbuminuria)|0
899217|NCT01159938|2964537|P1|First Study Period|Protocol Violation (Microalbuminuria)|0
899218|NCT01159912|2964600|P3|Overall Study|Withdrawal by Subject|3
899219|NCT01159912|2964601|P2|Overall Study|Withdrawal by Subject|3
899220|NCT01159912|2964602|P1|Overall Study|Withdrawal by Subject|10
899221|NCT01159912|2964600|P3|Overall Study|Physician Decision|3
899222|NCT01159912|2964601|P2|Overall Study|Physician Decision|0
899223|NCT01159912|2964602|P1|Overall Study|Physician Decision|0
899224|NCT01159912|2964600|P3|Overall Study|Lost to Follow-up|0
899225|NCT01159912|2964601|P2|Overall Study|Lost to Follow-up|0
899226|NCT01159912|2964602|P1|Overall Study|Lost to Follow-up|4
899227|NCT01159912|2964600|P3|Overall Study|Protocol Violation|3
899228|NCT01159912|2964601|P2|Overall Study|Protocol Violation|2
899229|NCT01159912|2964602|P1|Overall Study|Protocol Violation|1
899230|NCT01159912|2964600|P3|Overall Study|Lack of Efficacy|14
899231|NCT01159912|2964601|P2|Overall Study|Lack of Efficacy|15
899232|NCT01159912|2964602|P1|Overall Study|Lack of Efficacy|23
899233|NCT01159912|2964600|P3|Overall Study|Adverse Event|3
899234|NCT01159912|2964601|P2|Overall Study|Adverse Event|2
899235|NCT01159912|2964602|P1|Overall Study|Adverse Event|2
899236|NCT01159769|2964625|P1|Overall Study|Adverse Event|1
899237|NCT01159691|2964645|P1|Overall Study|Disc. Neupro lack of efficacy & unknown|1
899238|NCT01159691|2964645|P1|Overall Study|Disc. Neupro due to AE & unknown reasons|2
899239|NCT01159691|2964645|P1|Overall Study|Disc. Neupro other & unknown reasons|7
899240|NCT01159691|2964645|P1|Overall Study|Disc. Neupro other & lost to follow-up|2
899241|NCT01159691|2964645|P1|Overall Study|Discontinued Neupro due to other reasons|1
899242|NCT01159691|2964645|P1|Overall Study|Discontinued Neupro due to Adverse Event|6
899243|NCT01159691|2964645|P1|Overall Study|Unknown reasons|1
899244|NCT01159691|2964645|P1|Overall Study|Lost to Follow-up|2
899245|NCT01159665|2964658|P6|Overall Study|Withdrawal by Subject|0
899246|NCT01159665|2964659|P5|Overall Study|Withdrawal by Subject|0
899247|NCT01159665|2964660|P4|Overall Study|Withdrawal by Subject|0
899248|NCT01159665|2964661|P3|Overall Study|Withdrawal by Subject|0
899249|NCT01159665|2964662|P2|Overall Study|Withdrawal by Subject|1
899250|NCT01159665|2964663|P1|Overall Study|Withdrawal by Subject|0
899251|NCT01159600|2964691|P8|Overall Study|Other reason not defined above|3
899252|NCT01159600|2964692|P7|Overall Study|Other reason not defined above|3
899253|NCT01159600|2964693|P6|Overall Study|Other reason not defined above|7
899254|NCT01159600|2964694|P5|Overall Study|Other reason not defined above|5
899255|NCT01159600|2964695|P4|Overall Study|Other reason not defined above|2
899256|NCT01159600|2964696|P3|Overall Study|Other reason not defined above|4
899257|NCT01159600|2964697|P2|Overall Study|Other reason not defined above|0
899258|NCT01159600|2964698|P1|Overall Study|Other reason not defined above|3
899259|NCT01159600|2964691|P8|Overall Study|Patient refusal to continue,not due toAE|5
899260|NCT01159600|2964692|P7|Overall Study|Patient refusal to continue,not due toAE|2
899261|NCT01159600|2964693|P6|Overall Study|Patient refusal to continue,not due toAE|4
899262|NCT01159600|2964694|P5|Overall Study|Patient refusal to continue,not due toAE|4
899263|NCT01159600|2964695|P4|Overall Study|Patient refusal to continue,not due toAE|5
899264|NCT01159600|2964696|P3|Overall Study|Patient refusal to continue,not due toAE|4
899265|NCT01159600|2964697|P2|Overall Study|Patient refusal to continue,not due toAE|2
899266|NCT01159600|2964698|P1|Overall Study|Patient refusal to continue,not due toAE|7
899267|NCT01159600|2964691|P8|Overall Study|Lost to Follow-up|2
899268|NCT01159600|2964692|P7|Overall Study|Lost to Follow-up|3
899269|NCT01159600|2964693|P6|Overall Study|Lost to Follow-up|0
899270|NCT01159600|2964694|P5|Overall Study|Lost to Follow-up|3
899271|NCT01159600|2964695|P4|Overall Study|Lost to Follow-up|3
899272|NCT01159600|2964696|P3|Overall Study|Lost to Follow-up|4
899273|NCT01159600|2964697|P2|Overall Study|Lost to Follow-up|3
899274|NCT01159600|2964698|P1|Overall Study|Lost to Follow-up|2
899275|NCT01159600|2964691|P8|Overall Study|Non compliant with protocol|0
899276|NCT01159600|2964692|P7|Overall Study|Non compliant with protocol|2
899277|NCT01159600|2964693|P6|Overall Study|Non compliant with protocol|0
899278|NCT01159600|2964694|P5|Overall Study|Non compliant with protocol|2
899279|NCT01159600|2964695|P4|Overall Study|Non compliant with protocol|0
899280|NCT01159600|2964696|P3|Overall Study|Non compliant with protocol|0
899281|NCT01159600|2964697|P2|Overall Study|Non compliant with protocol|1
899282|NCT01159600|2964698|P1|Overall Study|Non compliant with protocol|2
899283|NCT01159600|2964691|P8|Overall Study|Lack of Efficacy|1
899284|NCT01159600|2964692|P7|Overall Study|Lack of Efficacy|0
899285|NCT01159600|2964693|P6|Overall Study|Lack of Efficacy|0
899286|NCT01159600|2964694|P5|Overall Study|Lack of Efficacy|2
899287|NCT01159600|2964695|P4|Overall Study|Lack of Efficacy|0
899288|NCT01159600|2964696|P3|Overall Study|Lack of Efficacy|0
899289|NCT01159600|2964697|P2|Overall Study|Lack of Efficacy|0
899290|NCT01159600|2964698|P1|Overall Study|Lack of Efficacy|0
899291|NCT01159600|2964691|P8|Overall Study|Adverse Event|5
899292|NCT01159600|2964692|P7|Overall Study|Adverse Event|7
899293|NCT01159600|2964693|P6|Overall Study|Adverse Event|6
899294|NCT01159600|2964694|P5|Overall Study|Adverse Event|8
899295|NCT01159600|2964695|P4|Overall Study|Adverse Event|1
899296|NCT01159600|2964696|P3|Overall Study|Adverse Event|5
899297|NCT01159600|2964697|P2|Overall Study|Adverse Event|2
899298|NCT01159600|2964698|P1|Overall Study|Adverse Event|7
899299|NCT01159600|2964691|P8|Overall Study|Not treated|2
899300|NCT01159600|2964692|P7|Overall Study|Not treated|2
899301|NCT01159600|2964693|P6|Overall Study|Not treated|1
899302|NCT01159600|2964694|P5|Overall Study|Not treated|0
899303|NCT01159600|2964695|P4|Overall Study|Not treated|0
899304|NCT01159600|2964696|P3|Overall Study|Not treated|1
899305|NCT01159600|2964697|P2|Overall Study|Not treated|0
899306|NCT01159600|2964698|P1|Overall Study|Not treated|0
899307|NCT01159574|2964740|P1|Follow Up Phase|still being followed for overall surviva|18
899308|NCT01159574|2964740|P1|Follow Up Phase|Lost to Follow-up|2
899309|NCT01159574|2964740|P1|Treatment Phase|still on treatment|2
899310|NCT01159574|2964740|P1|Treatment Phase|Withdrawal by Subject|7
899311|NCT01159574|2964740|P1|Treatment Phase|Physician Decision|2
899312|NCT01159574|2964740|P1|Treatment Phase|Death|6
899313|NCT01159574|2964740|P1|Treatment Phase|Adverse Event|3
899314|NCT01159574|2964740|P1|Treatment Phase|non-evaluable/not included in analysis|1
899315|NCT01159431|2964761|P2|Overall Study|Lack of Efficacy|3
899316|NCT01159431|2964762|P1|Overall Study|Lack of Efficacy|0
899317|NCT01159431|2964761|P2|Overall Study|non-compliance|1
899318|NCT01159431|2964762|P1|Overall Study|non-compliance|1
899319|NCT01159431|2964761|P2|Overall Study|Adverse Event|2
899320|NCT01159431|2964762|P1|Overall Study|Adverse Event|1
899321|NCT01159171|2964815|P1|Overall Study|Death|1
899322|NCT01159171|2964815|P1|Overall Study|Medical Decision|4
899323|NCT01159171|2964815|P1|Overall Study|Need for Surgery|5
899324|NCT01159171|2964815|P1|Overall Study|Protocol Violation|1
899325|NCT01159171|2964815|P1|Overall Study|Progression of Disease|28
899326|NCT01159171|2964815|P1|Overall Study|Adverse Event|11
899327|NCT01158924|2964889|P2|Overall Study|Lost to Follow-up|1
899328|NCT01158924|2964890|P1|Overall Study|Lost to Follow-up|0
899329|NCT01158924|2964889|P2|Overall Study|Withdrawal by Subject|2
899330|NCT01158924|2964890|P1|Overall Study|Withdrawal by Subject|1
899331|NCT01158534|2964984|P1|Overall Study|Other|1
899332|NCT01158534|2964984|P1|Overall Study|Death|1
899333|NCT01158534|2964984|P1|Overall Study|Withdrawal by Subject|1
899334|NCT01158378|2965003|P2|Overall Study|Withdrawal by Subject|0
899335|NCT01158378|2965004|P1|Overall Study|Withdrawal by Subject|4
899336|NCT01158378|2965003|P2|Overall Study|Lost to Follow-up|4
899337|NCT01158378|2965004|P1|Overall Study|Lost to Follow-up|2
899338|NCT01158378|2965003|P2|Overall Study|Death|5
899339|NCT01158378|2965004|P1|Overall Study|Death|4
899340|NCT01158261|2965016|P1|Overall Study|Withdrawal by Subject|1
899341|NCT01158261|2965016|P1|Overall Study|Death|7
899342|NCT01158261|2965016|P1|Overall Study|Lost to Follow-up|9
899343|NCT01158222|2965020|P1|Overall Study|Not eligible for intermediate phase|17
899344|NCT01158118|2965028|P2|Overall Study|Death|1
899345|NCT01158118|2965029|P1|Overall Study|Death|0
899346|NCT01158118|2965028|P2|Overall Study|Suffered stroke prior to transplant|1
899347|NCT01158118|2965029|P1|Overall Study|Suffered stroke prior to transplant|0
899348|NCT01158118|2965028|P2|Overall Study|Donor match was a screen failure|1
899349|NCT01158118|2965029|P1|Overall Study|Donor match was a screen failure|0
899350|NCT01158118|2965028|P2|Overall Study|Screen failure|0
899351|NCT01158118|2965029|P1|Overall Study|Screen failure|1
899352|NCT01157845|2965045|P1|Overall Study|Device malfunction|1
899353|NCT01157845|2965045|P1|Overall Study|Study was ended|1
899354|NCT01157845|2965045|P1|Overall Study|Protocol Violation|13
899355|NCT01157845|2965045|P1|Overall Study|Physician Decision|3
899356|NCT01157845|2965045|P1|Overall Study|Withdrawal by Subject|12
899357|NCT01157845|2965045|P1|Overall Study|Lost to Follow-up|5
899358|NCT01157377|2965079|P7|Overall Study|Other Miscellaneous Reasons|1
899359|NCT01157377|2965080|P6|Overall Study|Other Miscellaneous Reasons|1
899360|NCT01157377|2965081|P5|Overall Study|Other Miscellaneous Reasons|1
899361|NCT01157377|2965082|P4|Overall Study|Other Miscellaneous Reasons|0
899362|NCT01157377|2965083|P3|Overall Study|Other Miscellaneous Reasons|0
899363|NCT01157377|2965084|P2|Overall Study|Other Miscellaneous Reasons|2
899364|NCT01157377|2965085|P1|Overall Study|Other Miscellaneous Reasons|0
899365|NCT01157377|2965079|P7|Overall Study|Lack of Efficacy|1
899366|NCT01157377|2965080|P6|Overall Study|Lack of Efficacy|0
899367|NCT01157377|2965081|P5|Overall Study|Lack of Efficacy|0
899368|NCT01157377|2965082|P4|Overall Study|Lack of Efficacy|0
899369|NCT01157377|2965083|P3|Overall Study|Lack of Efficacy|0
899370|NCT01157377|2965084|P2|Overall Study|Lack of Efficacy|0
899371|NCT01157377|2965085|P1|Overall Study|Lack of Efficacy|0
899372|NCT01157377|2965079|P7|Overall Study|Protocol Violation|0
899373|NCT01157377|2965080|P6|Overall Study|Protocol Violation|1
899374|NCT01157377|2965081|P5|Overall Study|Protocol Violation|0
899375|NCT01157377|2965082|P4|Overall Study|Protocol Violation|0
899376|NCT01157377|2965083|P3|Overall Study|Protocol Violation|0
899377|NCT01157377|2965084|P2|Overall Study|Protocol Violation|0
899378|NCT01157377|2965085|P1|Overall Study|Protocol Violation|0
899379|NCT01157377|2965079|P7|Overall Study|Personal Reasons|0
899380|NCT01157377|2965080|P6|Overall Study|Personal Reasons|0
899381|NCT01157377|2965081|P5|Overall Study|Personal Reasons|0
899382|NCT01157377|2965082|P4|Overall Study|Personal Reasons|1
899383|NCT01157377|2965083|P3|Overall Study|Personal Reasons|0
899384|NCT01157377|2965084|P2|Overall Study|Personal Reasons|1
899385|NCT01157377|2965085|P1|Overall Study|Personal Reasons|2
899386|NCT01157377|2965079|P7|Overall Study|Lost to Follow-up|0
899387|NCT01157377|2965080|P6|Overall Study|Lost to Follow-up|1
899388|NCT01157377|2965081|P5|Overall Study|Lost to Follow-up|1
899389|NCT01157377|2965082|P4|Overall Study|Lost to Follow-up|0
899390|NCT01157377|2965083|P3|Overall Study|Lost to Follow-up|1
899391|NCT01157377|2965084|P2|Overall Study|Lost to Follow-up|0
899392|NCT01157377|2965085|P1|Overall Study|Lost to Follow-up|0
899393|NCT01157351|2965103|P2|Overall Study|Randomized but not Treated|2
899394|NCT01157351|2965104|P1|Overall Study|Randomized but not Treated|4
899395|NCT01157351|2965103|P2|Overall Study|Noncompliance with Study Drug|3
899396|NCT01157351|2965104|P1|Overall Study|Noncompliance with Study Drug|0
899397|NCT01157351|2965103|P2|Overall Study|Other|36
899398|NCT01157351|2965104|P1|Overall Study|Other|32
899399|NCT01157351|2965103|P2|Overall Study|Protocol Violation|1
899400|NCT01157351|2965104|P1|Overall Study|Protocol Violation|0
899401|NCT01157351|2965103|P2|Overall Study|Physician Decision|4
899402|NCT01157351|2965104|P1|Overall Study|Physician Decision|5
899403|NCT01157351|2965103|P2|Overall Study|Withdrawal by Subject|27
899404|NCT01157351|2965104|P1|Overall Study|Withdrawal by Subject|37
899405|NCT01157351|2965103|P2|Overall Study|Lost to Follow-up|55
899406|NCT01157351|2965104|P1|Overall Study|Lost to Follow-up|53
899407|NCT01157351|2965103|P2|Overall Study|Death|0
899408|NCT01157351|2965104|P1|Overall Study|Death|1
899409|NCT01157351|2965103|P2|Overall Study|Adverse Event|4
899410|NCT01157351|2965104|P1|Overall Study|Adverse Event|5
899411|NCT01157234|2965122|P2|Overall Study|Withdrawal by Subject|0
899412|NCT01157234|2965123|P1|Overall Study|Withdrawal by Subject|1
899413|NCT01157182|2965155|P2|Washout of 28 Days|Adverse Event|0
899414|NCT01157182|2965156|P1|Washout of 28 Days|Adverse Event|2
899415|NCT01157169|2965204|P2|Second Intervention|Emesis Within 4 hrs of Administration|1
899416|NCT01157169|2965205|P1|Second Intervention|Emesis Within 4 hrs of Administration|0
899417|NCT01157169|2965204|P2|First Intervention|Emesis Within 4 hrs of Administration|2
899418|NCT01157169|2965205|P1|First Intervention|Emesis Within 4 hrs of Administration|4
899419|NCT01157169|2965204|P2|First Intervention|Protocol Violation|0
899420|NCT01157169|2965205|P1|First Intervention|Protocol Violation|0
899421|NCT01157117|2965224|P3|Overall Study|Unknown (Pending Final Form Submission)|13
899422|NCT01157117|2965225|P2|Overall Study|Unknown (Pending Final Form Submission)|5
899423|NCT01157117|2965226|P1|Overall Study|Unknown (Pending Final Form Submission)|4
899424|NCT01157117|2965224|P3|Overall Study|Lost to Follow-up|1
899425|NCT01157117|2965225|P2|Overall Study|Lost to Follow-up|0
899426|NCT01157117|2965226|P1|Overall Study|Lost to Follow-up|0
899427|NCT01157117|2965224|P3|Overall Study|Lack of Efficacy|0
899428|NCT01157117|2965225|P2|Overall Study|Lack of Efficacy|1
899429|NCT01157117|2965226|P1|Overall Study|Lack of Efficacy|1
899430|NCT01157117|2965224|P3|Overall Study|Withdrawal by Subject|1
899431|NCT01157117|2965225|P2|Overall Study|Withdrawal by Subject|1
899432|NCT01157117|2965226|P1|Overall Study|Withdrawal by Subject|4
899433|NCT01157117|2965224|P3|Overall Study|Dosing Symptoms|0
899434|NCT01157117|2965225|P2|Overall Study|Dosing Symptoms|4
899435|NCT01157117|2965226|P1|Overall Study|Dosing Symptoms|0
899436|NCT01157078|2965267|P2|Overall Study|Not specified|4
899437|NCT01157078|2965268|P1|Overall Study|Not specified|2
899438|NCT01157078|2965267|P2|Overall Study|Lost to Follow-up|5
899439|NCT01157078|2965268|P1|Overall Study|Lost to Follow-up|7
899440|NCT01157078|2965267|P2|Overall Study|Study-specific withdrawal criteria|2
899441|NCT01157078|2965268|P1|Overall Study|Study-specific withdrawal criteria|2
899442|NCT01157078|2965267|P2|Overall Study|Lack of Efficacy|0
899443|NCT01157078|2965268|P1|Overall Study|Lack of Efficacy|2
899444|NCT01157078|2965267|P2|Overall Study|Condition under investigation worsened|1
899445|NCT01157078|2965268|P1|Overall Study|Condition under investigation worsened|0
899446|NCT01157078|2965267|P2|Overall Study|Severe non-compliance to protocol|4
899447|NCT01157078|2965268|P1|Overall Study|Severe non-compliance to protocol|2
899448|NCT01157078|2965267|P2|Overall Study|Adverse Event|6
899449|NCT01157078|2965268|P1|Overall Study|Adverse Event|6
899450|NCT01157078|2965267|P2|Overall Study|Eligibility criteria not fulfilled|0
899451|NCT01157078|2965268|P1|Overall Study|Eligibility criteria not fulfilled|2
899452|NCT01157078|2965267|P2|Overall Study|Withdrawal by Subject|14
899453|NCT01157078|2965268|P1|Overall Study|Withdrawal by Subject|12
899454|NCT01157065|2965318|P2|Overall Study|Death|1
899455|NCT01157065|2965319|P1|Overall Study|Death|0
899456|NCT01156844|2965340|P4|Overall Study|Protocol deviation|0
899457|NCT01156844|2965341|P3|Overall Study|Protocol deviation|0
899458|NCT01156844|2965342|P2|Overall Study|Protocol deviation|0
899459|NCT01156844|2965343|P1|Overall Study|Protocol deviation|2
899460|NCT01156844|2965340|P4|Overall Study|Administrative problems|1
899461|NCT01156844|2965341|P3|Overall Study|Administrative problems|0
899462|NCT01156844|2965342|P2|Overall Study|Administrative problems|1
899463|NCT01156844|2965343|P1|Overall Study|Administrative problems|0
899464|NCT01156844|2965340|P4|Overall Study|Lost to Follow-up|0
899465|NCT01156844|2965341|P3|Overall Study|Lost to Follow-up|1
899466|NCT01156844|2965342|P2|Overall Study|Lost to Follow-up|0
899467|NCT01156844|2965343|P1|Overall Study|Lost to Follow-up|0
899468|NCT01156844|2965340|P4|Overall Study|Withdrawal by Subject|2
899469|NCT01156844|2965341|P3|Overall Study|Withdrawal by Subject|2
899470|NCT01156844|2965342|P2|Overall Study|Withdrawal by Subject|0
899471|NCT01156844|2965343|P1|Overall Study|Withdrawal by Subject|0
899472|NCT01156844|2965340|P4|Overall Study|Abnormal test procedure result(s)|2
899473|NCT01156844|2965341|P3|Overall Study|Abnormal test procedure result(s)|2
899474|NCT01156844|2965342|P2|Overall Study|Abnormal test procedure result(s)|1
899475|NCT01156844|2965343|P1|Overall Study|Abnormal test procedure result(s)|0
899476|NCT01156844|2965340|P4|Overall Study|Adverse Event|1
899477|NCT01156844|2965341|P3|Overall Study|Adverse Event|1
899478|NCT01156844|2965342|P2|Overall Study|Adverse Event|0
899479|NCT01156844|2965343|P1|Overall Study|Adverse Event|0
899480|NCT01156792|2965362|P1|Overall Study|other Sponsor Decision (Protocol Amendme|11
899481|NCT01156792|2965362|P1|Overall Study|Withdrawal by Subject|9
899482|NCT01156792|2965362|P1|Overall Study|Physician Decision|3
899483|NCT01156792|2965362|P1|Overall Study|Lost to Follow-up|3
899484|NCT01156792|2965362|P1|Overall Study|Protocol Violation|6
899485|NCT01156792|2965362|P1|Overall Study|Lack of Efficacy|36
899486|NCT01156792|2965362|P1|Overall Study|Adverse Event|1
899487|NCT01156675|2965467|P3|Overall Study|No data|2
899488|NCT01156675|2965468|P2|Overall Study|No data|22
899489|NCT01156675|2965469|P1|Overall Study|No data|29
899490|NCT01156675|2965467|P3|Overall Study|Death|0
899491|NCT01156675|2965468|P2|Overall Study|Death|3
899492|NCT01156675|2965469|P1|Overall Study|Death|5
899493|NCT01156532|2965527|P1|Overall Study|Lost to Follow-up|1
899494|NCT01156532|2965527|P1|Overall Study|Family Reasons|1
899495|NCT01156480|2965539|P2|Overall Study|change in diagnosis|1
899496|NCT01156480|2965540|P1|Overall Study|change in diagnosis|0
899497|NCT01156376|2965551|P3|Overall Study|Withdrawal by Subject|3
899498|NCT01156376|2965552|P2|Overall Study|Withdrawal by Subject|0
899499|NCT01156376|2965553|P1|Overall Study|Withdrawal by Subject|0
899500|NCT01156376|2965551|P3|Overall Study|Adverse Event|1
899501|NCT01156376|2965552|P2|Overall Study|Adverse Event|0
899502|NCT01156376|2965553|P1|Overall Study|Adverse Event|1
899503|NCT01156363|2965774|P1|Overall Study|Other|6
899504|NCT01156363|2965774|P1|Overall Study|Refused Treatment|4
899505|NCT01156363|2965774|P1|Overall Study|Failure to Return|1
899506|NCT01156363|2965774|P1|Overall Study|Insufficient Therapeutic Response|5
899507|NCT01156363|2965774|P1|Overall Study|Adverse Event|6
899508|NCT01156311|2965796|P4|6-month Add-on Therapy Period|Not Specified|2
899509|NCT01156311|2965797|P3|6-month Add-on Therapy Period|Not Specified|1
899510|NCT01156311|2965798|P2|6-month Add-on Therapy Period|Not Specified|0
899511|NCT01156311|2965799|P1|6-month Add-on Therapy Period|Not Specified|0
899512|NCT01156311|2965796|P4|6-month Add-on Therapy Period|Physician Decision|0
899513|NCT01156311|2965797|P3|6-month Add-on Therapy Period|Physician Decision|1
899514|NCT01156311|2965798|P2|6-month Add-on Therapy Period|Physician Decision|0
899515|NCT01156311|2965799|P1|6-month Add-on Therapy Period|Physician Decision|0
899516|NCT01156311|2965796|P4|6-month Add-on Therapy Period|Disease Activity|2
899517|NCT01156311|2965797|P3|6-month Add-on Therapy Period|Disease Activity|1
899518|NCT01156311|2965798|P2|6-month Add-on Therapy Period|Disease Activity|0
899519|NCT01156311|2965799|P1|6-month Add-on Therapy Period|Disease Activity|0
899520|NCT01156311|2965796|P4|6-month Add-on Therapy Period|Lost to Follow-up|0
899521|NCT01156311|2965797|P3|6-month Add-on Therapy Period|Lost to Follow-up|2
899522|NCT01156311|2965798|P2|6-month Add-on Therapy Period|Lost to Follow-up|0
899523|NCT01156311|2965799|P1|6-month Add-on Therapy Period|Lost to Follow-up|0
899524|NCT01156311|2965796|P4|6-month Add-on Therapy Period|Adverse Event|6
899525|NCT01156311|2965797|P3|6-month Add-on Therapy Period|Adverse Event|7
899526|NCT01156311|2965798|P2|6-month Add-on Therapy Period|Adverse Event|0
899527|NCT01156311|2965799|P1|6-month Add-on Therapy Period|Adverse Event|0
899528|NCT01156311|2965796|P4|2-Month Monotherapy Period|Not specified|0
899529|NCT01156311|2965797|P3|2-Month Monotherapy Period|Not specified|0
899530|NCT01156311|2965798|P2|2-Month Monotherapy Period|Not specified|0
899531|NCT01156311|2965799|P1|2-Month Monotherapy Period|Not specified|1
899532|NCT01156311|2965796|P4|2-Month Monotherapy Period|Physician Decision|0
899533|NCT01156311|2965797|P3|2-Month Monotherapy Period|Physician Decision|0
899534|NCT01156311|2965798|P2|2-Month Monotherapy Period|Physician Decision|1
899535|NCT01156311|2965799|P1|2-Month Monotherapy Period|Physician Decision|0
899536|NCT01156311|2965796|P4|2-Month Monotherapy Period|Withdrawal by Subject|0
899537|NCT01156311|2965797|P3|2-Month Monotherapy Period|Withdrawal by Subject|0
899538|NCT01156311|2965798|P2|2-Month Monotherapy Period|Withdrawal by Subject|1
899539|NCT01156311|2965799|P1|2-Month Monotherapy Period|Withdrawal by Subject|1
899540|NCT01156142|2965823|P2|Overall Study|Ineligible|1
899541|NCT01156142|2965824|P1|Overall Study|Ineligible|0
899542|NCT01156142|2965823|P2|Overall Study|Withdrawal by Subject|6
899543|NCT01156142|2965824|P1|Overall Study|Withdrawal by Subject|8
899544|NCT01156116|2965842|P2|Overall Study|CPAP intolerance|0
899545|NCT01156116|2965843|P1|Overall Study|CPAP intolerance|2
899546|NCT01156116|2965842|P2|Overall Study|Withdrawal by Subject|1
899547|NCT01156116|2965843|P1|Overall Study|Withdrawal by Subject|3
899548|NCT01156051|2965857|P2|Overall Study|patient not compliant with protocol|1
899549|NCT01156051|2965858|P1|Overall Study|patient not compliant with protocol|0
899550|NCT01156051|2965857|P2|Overall Study|Lost to Follow-up|0
899551|NCT01156051|2965858|P1|Overall Study|Lost to Follow-up|1
899552|NCT01156012|2965872|P2|Overall Study|Non respect of one of inclusion criteria|1
899553|NCT01156012|2965873|P1|Overall Study|Non respect of one of inclusion criteria|2
899554|NCT01156012|2965872|P2|Overall Study|use of commercial drug instead of study|1
899555|NCT01156012|2965873|P1|Overall Study|use of commercial drug instead of study|0
899556|NCT01156012|2965872|P2|Overall Study|Withdrawal by Subject|0
899557|NCT01156012|2965873|P1|Overall Study|Withdrawal by Subject|1
899558|NCT01156012|2965872|P2|Overall Study|Lost to Follow-up|0
899559|NCT01156012|2965873|P1|Overall Study|Lost to Follow-up|1
899560|NCT01156012|2965872|P2|Overall Study|Adverse Event|1
899561|NCT01156012|2965873|P1|Overall Study|Adverse Event|3
899562|NCT01155869|2965890|P2|Overall Study|Lost to Follow-up|1
899563|NCT01155869|2965891|P1|Overall Study|Lost to Follow-up|3
899564|NCT01155726|2965915|P4|Period 1, 3 Days (Masked)|Inconvenience|0
899565|NCT01155726|2965916|P3|Period 1, 3 Days (Masked)|Inconvenience|2
899566|NCT01155726|2965917|P2|Period 1, 3 Days (Masked)|Inconvenience|0
899567|NCT01155726|2965918|P1|Period 1, 3 Days (Masked)|Inconvenience|1
899568|NCT01155661|2965940|P1|Overall Study|Sponsor Decision|13
899569|NCT01155661|2965940|P1|Overall Study|Withdrawal by Subject|73
899570|NCT01155661|2965940|P1|Overall Study|Protocol Violation|35
899571|NCT01155661|2965940|P1|Overall Study|Physician Decision|3
899572|NCT01155661|2965940|P1|Overall Study|Lost to Follow-up|22
899573|NCT01155661|2965940|P1|Overall Study|Lack of Efficacy|32
899574|NCT01155661|2965940|P1|Overall Study|Death|1
899575|NCT01155661|2965940|P1|Overall Study|Adverse Event|101
899576|NCT01155570|2965966|P1|Overall Study|Other Reasons|23
899577|NCT01155570|2965966|P1|Overall Study|Participant's Economic Reasons + Other|1
899578|NCT01155570|2965966|P1|Overall Study|Adverse Event + Other Reasons|7
899579|NCT01155570|2965966|P1|Overall Study|Adverse Event + Lack of Efficacy|2
899580|NCT01155570|2965966|P1|Overall Study|No Hospital Visits|7
899581|NCT01155570|2965966|P1|Overall Study|Participant's Economic Reasons|17
899582|NCT01155570|2965966|P1|Overall Study|Lack of Efficacy|46
899583|NCT01155570|2965966|P1|Overall Study|Adverse Event|39
899584|NCT01155531|2966000|P4|Overall Study|Withdrawal by Subject|0
899585|NCT01155531|2966001|P3|Overall Study|Withdrawal by Subject|1
899586|NCT01155531|2966002|P2|Overall Study|Withdrawal by Subject|0
899587|NCT01155531|2966003|P1|Overall Study|Withdrawal by Subject|1
899588|NCT01155531|2966000|P4|Overall Study|Lost to Follow-up|1
899589|NCT01155531|2966001|P3|Overall Study|Lost to Follow-up|0
899590|NCT01155531|2966002|P2|Overall Study|Lost to Follow-up|0
899591|NCT01155531|2966003|P1|Overall Study|Lost to Follow-up|0
899592|NCT01155531|2966000|P4|Overall Study|Adverse Event|0
899593|NCT01155531|2966001|P3|Overall Study|Adverse Event|1
899594|NCT01155531|2966002|P2|Overall Study|Adverse Event|0
899595|NCT01155531|2966003|P1|Overall Study|Adverse Event|0
899596|NCT01155479|2966026|P5|Part II|Non-Compliance with Protocol|0
899597|NCT01155479|2966027|P4|Part II|Non-Compliance with Protocol|2
899598|NCT01155479|2966028|P3|Part II|Non-Compliance with Protocol|0
899599|NCT01155479|2966029|P2|Part II|Non-Compliance with Protocol|1
899600|NCT01155479|2966030|P1|Part II|Non-Compliance with Protocol|0
899601|NCT01155479|2966026|P5|Part II|Treatment Failure|1
899602|NCT01155479|2966027|P4|Part II|Treatment Failure|0
899603|NCT01155479|2966028|P3|Part II|Treatment Failure|2
899604|NCT01155479|2966029|P2|Part II|Treatment Failure|1
899605|NCT01155479|2966030|P1|Part II|Treatment Failure|0
899606|NCT01155479|2966026|P5|Part II|Lost to Follow-up|1
899607|NCT01155479|2966027|P4|Part II|Lost to Follow-up|0
899608|NCT01155479|2966028|P3|Part II|Lost to Follow-up|0
899609|NCT01155479|2966029|P2|Part II|Lost to Follow-up|0
899610|NCT01155479|2966030|P1|Part II|Lost to Follow-up|1
899611|NCT01155479|2966026|P5|Part II|Withdrawal by Subject|3
899612|NCT01155479|2966027|P4|Part II|Withdrawal by Subject|7
899613|NCT01155479|2966028|P3|Part II|Withdrawal by Subject|12
899614|NCT01155479|2966029|P2|Part II|Withdrawal by Subject|4
899615|NCT01155479|2966030|P1|Part II|Withdrawal by Subject|8
899616|NCT01155479|2966026|P5|Part II|Administrative|46
899617|NCT01155479|2966027|P4|Part II|Administrative|38
899618|NCT01155479|2966028|P3|Part II|Administrative|36
899619|NCT01155479|2966029|P2|Part II|Administrative|49
899620|NCT01155479|2966030|P1|Part II|Administrative|43
899621|NCT01155479|2966026|P5|Part II|Adverse Event|4
899622|NCT01155479|2966027|P4|Part II|Adverse Event|3
899623|NCT01155479|2966028|P3|Part II|Adverse Event|8
899624|NCT01155479|2966029|P2|Part II|Adverse Event|6
899625|NCT01155479|2966030|P1|Part II|Adverse Event|7
899626|NCT01155479|2966026|P5|Part I|Non-Compliance with Protocol|2
899627|NCT01155479|2966027|P4|Part I|Non-Compliance with Protocol|3
899628|NCT01155479|2966028|P3|Part I|Non-Compliance with Protocol|3
899629|NCT01155479|2966029|P2|Part I|Non-Compliance with Protocol|1
899630|NCT01155479|2966030|P1|Part I|Non-Compliance with Protocol|2
899631|NCT01155479|2966026|P5|Part I|Did Not Receive Treatment|1
899632|NCT01155479|2966027|P4|Part I|Did Not Receive Treatment|6
899633|NCT01155479|2966028|P3|Part I|Did Not Receive Treatment|2
899634|NCT01155479|2966029|P2|Part I|Did Not Receive Treatment|2
899635|NCT01155479|2966030|P1|Part I|Did Not Receive Treatment|4
899636|NCT01155479|2966026|P5|Part I|Treatment Failure|2
899637|NCT01155479|2966027|P4|Part I|Treatment Failure|1
899638|NCT01155479|2966028|P3|Part I|Treatment Failure|3
899639|NCT01155479|2966029|P2|Part I|Treatment Failure|0
899640|NCT01155479|2966030|P1|Part I|Treatment Failure|3
899641|NCT01155479|2966026|P5|Part I|Lost to Follow-up|0
899642|NCT01155479|2966027|P4|Part I|Lost to Follow-up|1
899643|NCT01155479|2966028|P3|Part I|Lost to Follow-up|1
899644|NCT01155479|2966029|P2|Part I|Lost to Follow-up|0
899645|NCT01155479|2966030|P1|Part I|Lost to Follow-up|0
899646|NCT01155479|2966026|P5|Part I|Withdrawal by Subject|9
899647|NCT01155479|2966027|P4|Part I|Withdrawal by Subject|8
899648|NCT01155479|2966028|P3|Part I|Withdrawal by Subject|8
899649|NCT01155479|2966029|P2|Part I|Withdrawal by Subject|13
899650|NCT01155479|2966030|P1|Part I|Withdrawal by Subject|11
899651|NCT01155479|2966026|P5|Part I|Did Not Meet Protocol Eligibility|3
899652|NCT01155479|2966027|P4|Part I|Did Not Meet Protocol Eligibility|1
899653|NCT01155479|2966028|P3|Part I|Did Not Meet Protocol Eligibility|2
899654|NCT01155479|2966029|P2|Part I|Did Not Meet Protocol Eligibility|1
899655|NCT01155479|2966030|P1|Part I|Did Not Meet Protocol Eligibility|3
899656|NCT01155479|2966026|P5|Part I|Administrative|0
899657|NCT01155479|2966027|P4|Part I|Administrative|0
899658|NCT01155479|2966028|P3|Part I|Administrative|2
899659|NCT01155479|2966029|P2|Part I|Administrative|2
899660|NCT01155479|2966030|P1|Part I|Administrative|2
899661|NCT01155479|2966026|P5|Part I|Adverse Event|6
899662|NCT01155479|2966027|P4|Part I|Adverse Event|7
899663|NCT01155479|2966028|P3|Part I|Adverse Event|18
899664|NCT01155479|2966029|P2|Part I|Adverse Event|8
899665|NCT01155479|2966030|P1|Part I|Adverse Event|13
899666|NCT01155466|2966082|P5|Overall Study|Randomized not treated|2
899667|NCT01155466|2966083|P4|Overall Study|Randomized not treated|0
899668|NCT01155466|2966084|P3|Overall Study|Randomized not treated|3
899669|NCT01155466|2966085|P2|Overall Study|Randomized not treated|2
899670|NCT01155466|2966086|P1|Overall Study|Randomized not treated|2
899671|NCT01155466|2966082|P5|Overall Study|Administrative|0
899672|NCT01155466|2966083|P4|Overall Study|Administrative|0
899673|NCT01155466|2966084|P3|Overall Study|Administrative|0
899674|NCT01155466|2966085|P2|Overall Study|Administrative|3
899675|NCT01155466|2966086|P1|Overall Study|Administrative|0
899676|NCT01155466|2966082|P5|Overall Study|Protocol Violation|1
899677|NCT01155466|2966083|P4|Overall Study|Protocol Violation|0
899678|NCT01155466|2966084|P3|Overall Study|Protocol Violation|2
899679|NCT01155466|2966085|P2|Overall Study|Protocol Violation|0
899680|NCT01155466|2966086|P1|Overall Study|Protocol Violation|0
899681|NCT01155466|2966082|P5|Overall Study|Withdrawal by Subject|4
899682|NCT01155466|2966083|P4|Overall Study|Withdrawal by Subject|4
899683|NCT01155466|2966084|P3|Overall Study|Withdrawal by Subject|9
899684|NCT01155466|2966085|P2|Overall Study|Withdrawal by Subject|5
899685|NCT01155466|2966086|P1|Overall Study|Withdrawal by Subject|7
899686|NCT01155466|2966082|P5|Overall Study|Lost to Follow-up|2
899687|NCT01155466|2966083|P4|Overall Study|Lost to Follow-up|0
899688|NCT01155466|2966084|P3|Overall Study|Lost to Follow-up|0
899689|NCT01155466|2966085|P2|Overall Study|Lost to Follow-up|0
899690|NCT01155466|2966086|P1|Overall Study|Lost to Follow-up|0
899691|NCT01155466|2966082|P5|Overall Study|Adverse Event|18
899692|NCT01155466|2966083|P4|Overall Study|Adverse Event|17
899693|NCT01155466|2966084|P3|Overall Study|Adverse Event|6
899694|NCT01155466|2966085|P2|Overall Study|Adverse Event|15
899695|NCT01155466|2966086|P1|Overall Study|Adverse Event|13
899696|NCT01155388|2966140|P2|Overall Study|Adverse Event|0
899697|NCT01155388|2966141|P1|Overall Study|Adverse Event|1
899698|NCT01155375|2966151|P2|Overall Study|Adverse Event|0
899699|NCT01155375|2966152|P1|Overall Study|Adverse Event|1
899700|NCT01155323|2966171|P2|Second Intervention|Lost to Follow-up|1
899701|NCT01155323|2966172|P1|Second Intervention|Lost to Follow-up|1
899702|NCT01155323|2966171|P2|First Intervention|exclusion criteria|1
899703|NCT01155323|2966172|P1|First Intervention|exclusion criteria|1
899704|NCT01155284|2966190|P2|Overall Study|Adverse Event|0
899705|NCT01155284|2966191|P1|Overall Study|Adverse Event|1
899706|NCT01155284|2966190|P2|Overall Study|Physician Decision|0
899707|NCT01155284|2966191|P1|Overall Study|Physician Decision|1
899708|NCT01155284|2966190|P2|Overall Study|Lost to Follow-up|2
899709|NCT01155284|2966191|P1|Overall Study|Lost to Follow-up|1
899710|NCT01155284|2966190|P2|Overall Study|Withdrawal by Subject|3
899711|NCT01155284|2966191|P1|Overall Study|Withdrawal by Subject|4
899712|NCT01155219|2966201|P2|Overall Study|non-medical reason|2
899713|NCT01155219|2966202|P1|Overall Study|non-medical reason|1
899714|NCT01155219|2966201|P2|Overall Study|Adverse Event|1
899715|NCT01155219|2966202|P1|Overall Study|Adverse Event|3
899716|NCT01155167|2966251|P2|Overall Study|Access site changed to femoral artery|0
899717|NCT01155167|2966252|P1|Overall Study|Access site changed to femoral artery|1
899718|NCT01155167|2966251|P2|Overall Study|Insufficient ultrasound data|0
899719|NCT01155167|2966252|P1|Overall Study|Insufficient ultrasound data|2
899720|NCT01155141|2966275|P1|Overall Study|Screen Failure|1
899721|NCT01155141|2966275|P1|Overall Study|Withdrawal by Subject|1
899722|NCT01155063|2966287|P1|Overall Study|Study terminated by sponsor|87
899723|NCT01155063|2966287|P1|Overall Study|Withdrawal by Subject|1
899724|NCT01155063|2966287|P1|Overall Study|Adverse Event|1
899725|NCT01155024|2966297|P2|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2
899726|NCT01155024|2966298|P1|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0
899727|NCT01155024|2966297|P2|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2
899728|NCT01155024|2966298|P1|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0
899729|NCT01155024|2966297|P2|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2
899730|NCT01155024|2966298|P1|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0
899731|NCT01155011|2966308|P2|6 to 12 Months|Death|5
899732|NCT01155011|2966309|P1|6 to 12 Months|Death|1
899733|NCT01155011|2966308|P2|6 to 12 Months|Withdrawal by Subject|5
899734|NCT01155011|2966309|P1|6 to 12 Months|Withdrawal by Subject|8
899735|NCT01155011|2966308|P2|Baseline to 6 Months|Death|1
899736|NCT01155011|2966309|P1|Baseline to 6 Months|Death|0
899737|NCT01155011|2966308|P2|Baseline to 6 Months|investigator decision, moved|5
899738|NCT01155011|2966309|P1|Baseline to 6 Months|investigator decision, moved|4
899739|NCT01155011|2966308|P2|Baseline to 6 Months|Withdrawal by Subject|19
899740|NCT01155011|2966309|P1|Baseline to 6 Months|Withdrawal by Subject|18
899741|NCT01154816|2966350|P12|Overall Study|Adverse Event|0
899742|NCT01154816|2966351|P11|Overall Study|Adverse Event|0
899743|NCT01154816|2966352|P10|Overall Study|Adverse Event|0
899744|NCT01154816|2966353|P9|Overall Study|Adverse Event|0
899745|NCT01154816|2966354|P8|Overall Study|Adverse Event|1
899746|NCT01154816|2966355|P7|Overall Study|Adverse Event|1
899747|NCT01154816|2966356|P6|Overall Study|Adverse Event|0
899748|NCT01154816|2966357|P5|Overall Study|Adverse Event|0
899749|NCT01154816|2966358|P4|Overall Study|Adverse Event|0
899750|NCT01154816|2966359|P3|Overall Study|Adverse Event|0
899751|NCT01154816|2966360|P2|Overall Study|Adverse Event|2
899752|NCT01154816|2966361|P1|Overall Study|Adverse Event|5
899753|NCT01154816|2966350|P12|Overall Study|Physician Decision|1
899754|NCT01154816|2966351|P11|Overall Study|Physician Decision|1
899755|NCT01154816|2966352|P10|Overall Study|Physician Decision|1
899756|NCT01154816|2966353|P9|Overall Study|Physician Decision|0
899757|NCT01154816|2966354|P8|Overall Study|Physician Decision|0
899758|NCT01154816|2966355|P7|Overall Study|Physician Decision|0
899759|NCT01154816|2966356|P6|Overall Study|Physician Decision|0
899760|NCT01154816|2966357|P5|Overall Study|Physician Decision|2
899761|NCT01154816|2966358|P4|Overall Study|Physician Decision|0
899762|NCT01154816|2966359|P3|Overall Study|Physician Decision|1
899763|NCT01154816|2966360|P2|Overall Study|Physician Decision|0
899764|NCT01154816|2966361|P1|Overall Study|Physician Decision|1
899765|NCT01154816|2966350|P12|Overall Study|Progressive Disease|3
899766|NCT01154816|2966351|P11|Overall Study|Progressive Disease|10
899767|NCT01154816|2966352|P10|Overall Study|Progressive Disease|6
899768|NCT01154816|2966353|P9|Overall Study|Progressive Disease|8
899769|NCT01154816|2966354|P8|Overall Study|Progressive Disease|6
899770|NCT01154816|2966355|P7|Overall Study|Progressive Disease|5
899771|NCT01154816|2966356|P6|Overall Study|Progressive Disease|8
899772|NCT01154816|2966357|P5|Overall Study|Progressive Disease|8
899773|NCT01154816|2966358|P4|Overall Study|Progressive Disease|9
899774|NCT01154816|2966359|P3|Overall Study|Progressive Disease|9
899775|NCT01154816|2966360|P2|Overall Study|Progressive Disease|8
899776|NCT01154816|2966361|P1|Overall Study|Progressive Disease|13
899777|NCT01154816|2966350|P12|Overall Study|Withdrawal by Subject|0
899778|NCT01154816|2966351|P11|Overall Study|Withdrawal by Subject|0
899779|NCT01154816|2966352|P10|Overall Study|Withdrawal by Subject|3
899780|NCT01154816|2966353|P9|Overall Study|Withdrawal by Subject|1
899781|NCT01154816|2966354|P8|Overall Study|Withdrawal by Subject|0
899782|NCT01154816|2966355|P7|Overall Study|Withdrawal by Subject|0
899783|NCT01154816|2966356|P6|Overall Study|Withdrawal by Subject|0
899784|NCT01154816|2966357|P5|Overall Study|Withdrawal by Subject|0
899785|NCT01154816|2966358|P4|Overall Study|Withdrawal by Subject|1
899786|NCT01154816|2966359|P3|Overall Study|Withdrawal by Subject|0
899787|NCT01154816|2966360|P2|Overall Study|Withdrawal by Subject|0
899788|NCT01154816|2966361|P1|Overall Study|Withdrawal by Subject|1
899789|NCT01154673|2966438|P2|Overall Study|moved out of province|0
899790|NCT01154673|2966439|P1|Overall Study|moved out of province|1
899791|NCT01154673|2966438|P2|Overall Study|Lost to Follow-up|0
899792|NCT01154673|2966439|P1|Overall Study|Lost to Follow-up|1
899793|NCT01154452|2966494|P4|Phase II|Adverse Event|4
899794|NCT01154452|2966495|P3|Phase II|Adverse Event|4
899795|NCT01154452|2966496|P2|Phase II|Adverse Event|0
899796|NCT01154452|2966497|P1|Phase II|Adverse Event|0
899797|NCT01154452|2966494|P4|Phase II|Withdrawal by Subject|2
899798|NCT01154452|2966495|P3|Phase II|Withdrawal by Subject|1
899799|NCT01154452|2966496|P2|Phase II|Withdrawal by Subject|0
899800|NCT01154452|2966497|P1|Phase II|Withdrawal by Subject|0
899801|NCT01154452|2966494|P4|Phase Ib|Adverse Event|0
899802|NCT01154452|2966495|P3|Phase Ib|Adverse Event|0
899803|NCT01154452|2966496|P2|Phase Ib|Adverse Event|1
899804|NCT01154452|2966497|P1|Phase Ib|Adverse Event|2
899805|NCT01154452|2966494|P4|Phase Ib|Not Treated|0
899806|NCT01154452|2966495|P3|Phase Ib|Not Treated|0
899807|NCT01154452|2966496|P2|Phase Ib|Not Treated|0
899808|NCT01154452|2966497|P1|Phase Ib|Not Treated|1
899809|NCT01154296|2966529|P2|6-month Follow-up|Declined by Study Coordinator|4
899810|NCT01154296|2966530|P1|6-month Follow-up|Declined by Study Coordinator|5
899811|NCT01154296|2966529|P2|6-month Follow-up|Death|2
899812|NCT01154296|2966530|P1|6-month Follow-up|Death|3
899813|NCT01154296|2966529|P2|6-month Follow-up|Withdrew consent|15
899814|NCT01154296|2966530|P1|6-month Follow-up|Withdrew consent|14
899815|NCT01154296|2966529|P2|6-month Follow-up|Incarcerated|32
899816|NCT01154296|2966530|P1|6-month Follow-up|Incarcerated|37
899817|NCT01154296|2966529|P2|6-month Follow-up|Lost contact|275
899818|NCT01154296|2966530|P1|6-month Follow-up|Lost contact|269
899819|NCT01154296|2966529|P2|Randomization and Intervention|Left clinic early|0
899820|NCT01154296|2966530|P1|Randomization and Intervention|Left clinic early|2
899821|NCT01154296|2966529|P2|Randomization and Intervention|Left before test|1
899822|NCT01154296|2966530|P1|Randomization and Intervention|Left before test|0
899823|NCT01154296|2966529|P2|Randomization and Intervention|Did not return|0
899824|NCT01154296|2966530|P1|Randomization and Intervention|Did not return|1
899825|NCT01154296|2966529|P2|Randomization and Intervention|Declined by staff|0
899826|NCT01154296|2966530|P1|Randomization and Intervention|Declined by staff|1
899827|NCT01154296|2966529|P2|Randomization and Intervention|Decided to decline|1
899828|NCT01154296|2966530|P1|Randomization and Intervention|Decided to decline|1
899829|NCT01154283|2966548|P2|7-12 Weeks|Withdrawal by Subject|1
899830|NCT01154283|2966549|P1|7-12 Weeks|Withdrawal by Subject|0
899831|NCT01154283|2966548|P2|7-12 Weeks|Death|0
899832|NCT01154283|2966549|P1|7-12 Weeks|Death|1
899833|NCT01154283|2966548|P2|0-6 Weeks|Death|1
899834|NCT01154283|2966549|P1|0-6 Weeks|Death|0
899835|NCT01154283|2966548|P2|0-6 Weeks|Withdrawal by Subject|2
899836|NCT01154283|2966549|P1|0-6 Weeks|Withdrawal by Subject|7
899837|NCT01154231|2966561|P1|Overall Study|No Info. After 1st Day, No Drug Admin.|1
899838|NCT01154231|2966561|P1|Overall Study|Safety Unassessable, No Drug Admin.|1
899839|NCT01154218|2966567|P4|Fourth Intervention Period|Withdrawal by Subject|0
899840|NCT01154218|2966568|P3|Fourth Intervention Period|Withdrawal by Subject|0
899841|NCT01154218|2966569|P2|Fourth Intervention Period|Withdrawal by Subject|0
899842|NCT01154218|2966570|P1|Fourth Intervention Period|Withdrawal by Subject|1
899843|NCT01154218|2966567|P4|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
899844|NCT01154218|2966568|P3|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
899845|NCT01154218|2966569|P2|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
899846|NCT01154218|2966570|P1|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
899847|NCT01154218|2966567|P4|Third Intervention Period|Adverse Event|0
899848|NCT01154218|2966568|P3|Third Intervention Period|Adverse Event|0
899849|NCT01154218|2966569|P2|Third Intervention Period|Adverse Event|1
899850|NCT01154218|2966570|P1|Third Intervention Period|Adverse Event|0
899851|NCT01154166|2966622|P2|Overall Study|Poor Compliance|0
899852|NCT01154166|2966623|P1|Overall Study|Poor Compliance|1
899853|NCT01154166|2966622|P2|Overall Study|Disease Progression|0
899854|NCT01154166|2966623|P1|Overall Study|Disease Progression|1
899855|NCT01154166|2966622|P2|Overall Study|Lack of Efficacy|0
899856|NCT01154166|2966623|P1|Overall Study|Lack of Efficacy|3
899857|NCT01154166|2966622|P2|Overall Study|Withdrawal by Subject|1
899858|NCT01154166|2966623|P1|Overall Study|Withdrawal by Subject|10
899859|NCT01154166|2966622|P2|Overall Study|Protocol Violation|1
899860|NCT01154166|2966623|P1|Overall Study|Protocol Violation|4
899861|NCT01154166|2966622|P2|Overall Study|Lost to Follow-up|1
899862|NCT01154166|2966623|P1|Overall Study|Lost to Follow-up|1
899863|NCT01154166|2966622|P2|Overall Study|Adverse Event|9
899864|NCT01154166|2966623|P1|Overall Study|Adverse Event|14
899865|NCT01154153|2966655|P2|Overall Study|Withdrew consent|0
899866|NCT01154153|2966656|P1|Overall Study|Withdrew consent|1
899867|NCT01154153|2966655|P2|Overall Study|Unable to use labs|3
899868|NCT01154153|2966656|P1|Overall Study|Unable to use labs|2
899869|NCT01154153|2966655|P2|Overall Study|Poor compliance to protocol|0
899870|NCT01154153|2966656|P1|Overall Study|Poor compliance to protocol|2
899871|NCT01154140|2966674|P2|Overall Study|Randomized but not treated|2
899872|NCT01154140|2966675|P1|Overall Study|Randomized but not treated|1
899873|NCT01154140|2966674|P2|Overall Study|Other|1
899874|NCT01154140|2966675|P1|Overall Study|Other|3
899875|NCT01154140|2966674|P2|Overall Study|Withdrawal by Subject|13
899876|NCT01154140|2966675|P1|Overall Study|Withdrawal by Subject|12
899877|NCT01154140|2966674|P2|Overall Study|Lost to Follow-up|5
899878|NCT01154140|2966675|P1|Overall Study|Lost to Follow-up|4
899879|NCT01154140|2966674|P2|Overall Study|Death|81
899880|NCT01154140|2966675|P1|Overall Study|Death|71
899881|NCT01154127|2966728|P2|Period 2 (21 Days)|Protocol Deviation|1
899882|NCT01154127|2966729|P1|Period 2 (21 Days)|Protocol Deviation|0
899883|NCT01154127|2966728|P2|Washout (14 - 28 Days)|Abnormal Test Procedure|0
899884|NCT01154127|2966729|P1|Washout (14 - 28 Days)|Abnormal Test Procedure|1
899885|NCT01154127|2966728|P2|Washout (14 - 28 Days)|Adverse Event|0
899886|NCT01154127|2966729|P1|Washout (14 - 28 Days)|Adverse Event|2
899887|NCT01154127|2966728|P2|Period 1 (21 Days)|Withdrawal by Subject|2
899888|NCT01154127|2966729|P1|Period 1 (21 Days)|Withdrawal by Subject|0
899889|NCT01154127|2966728|P2|Period 1 (21 Days)|Adverse Event|4
899890|NCT01154127|2966729|P1|Period 1 (21 Days)|Adverse Event|3
899891|NCT01154101|2966756|P5|Overall Study|Withdrawal by Subject|1
899892|NCT01154101|2966757|P4|Overall Study|Withdrawal by Subject|0
899893|NCT01154101|2966758|P3|Overall Study|Withdrawal by Subject|2
899894|NCT01154101|2966759|P2|Overall Study|Withdrawal by Subject|1
899895|NCT01154101|2966760|P1|Overall Study|Withdrawal by Subject|0
899896|NCT01154101|2966756|P5|Overall Study|Lost to Follow-up|0
899897|NCT01154101|2966757|P4|Overall Study|Lost to Follow-up|1
899898|NCT01154101|2966758|P3|Overall Study|Lost to Follow-up|0
899899|NCT01154101|2966759|P2|Overall Study|Lost to Follow-up|1
899900|NCT01154101|2966760|P1|Overall Study|Lost to Follow-up|0
899901|NCT01154101|2966756|P5|Overall Study|Adverse Event|0
899902|NCT01154101|2966757|P4|Overall Study|Adverse Event|1
899903|NCT01154101|2966758|P3|Overall Study|Adverse Event|1
899904|NCT01154101|2966759|P2|Overall Study|Adverse Event|2
899905|NCT01154101|2966760|P1|Overall Study|Adverse Event|0
899906|NCT01154088|2966815|P3|Overall Study|Lost to Follow-up|7
899907|NCT01154088|2966816|P2|Overall Study|Lost to Follow-up|6
899908|NCT01154088|2966817|P1|Overall Study|Lost to Follow-up|4
899909|NCT01154036|2966857|P8|Phase II|Withdrawal by Subject|4
899910|NCT01154036|2966858|P7|Phase II|Withdrawal by Subject|5
899911|NCT01154036|2966859|P6|Phase II|Withdrawal by Subject|2
899912|NCT01154036|2966860|P5|Phase II|Withdrawal by Subject|4
899913|NCT01154036|2966861|P4|Phase II|Withdrawal by Subject|0
899914|NCT01154036|2966862|P3|Phase II|Withdrawal by Subject|0
899915|NCT01154036|2966863|P2|Phase II|Withdrawal by Subject|0
899916|NCT01154036|2966864|P1|Phase II|Withdrawal by Subject|0
899917|NCT01154036|2966857|P8|Phase II|Protocol Violation|0
899918|NCT01154036|2966858|P7|Phase II|Protocol Violation|0
899919|NCT01154036|2966859|P6|Phase II|Protocol Violation|2
899920|NCT01154036|2966860|P5|Phase II|Protocol Violation|1
899921|NCT01154036|2966861|P4|Phase II|Protocol Violation|0
899922|NCT01154036|2966862|P3|Phase II|Protocol Violation|0
899923|NCT01154036|2966863|P2|Phase II|Protocol Violation|0
899924|NCT01154036|2966864|P1|Phase II|Protocol Violation|0
899925|NCT01154036|2966857|P8|Phase II|Lost to Follow-up|1
899926|NCT01154036|2966858|P7|Phase II|Lost to Follow-up|2
899927|NCT01154036|2966859|P6|Phase II|Lost to Follow-up|0
899928|NCT01154036|2966860|P5|Phase II|Lost to Follow-up|2
899929|NCT01154036|2966861|P4|Phase II|Lost to Follow-up|1
899930|NCT01154036|2966862|P3|Phase II|Lost to Follow-up|0
899931|NCT01154036|2966863|P2|Phase II|Lost to Follow-up|0
899932|NCT01154036|2966864|P1|Phase II|Lost to Follow-up|0
899933|NCT01154036|2966857|P8|Phase II|Physician Decision|0
899934|NCT01154036|2966858|P7|Phase II|Physician Decision|1
899935|NCT01154036|2966859|P6|Phase II|Physician Decision|0
899936|NCT01154036|2966860|P5|Phase II|Physician Decision|0
899937|NCT01154036|2966861|P4|Phase II|Physician Decision|0
899938|NCT01154036|2966862|P3|Phase II|Physician Decision|0
899939|NCT01154036|2966863|P2|Phase II|Physician Decision|0
899940|NCT01154036|2966864|P1|Phase II|Physician Decision|0
899941|NCT01154036|2966857|P8|Phase II|Adverse Event|1
899942|NCT01154036|2966858|P7|Phase II|Adverse Event|1
899943|NCT01154036|2966859|P6|Phase II|Adverse Event|1
899944|NCT01154036|2966860|P5|Phase II|Adverse Event|1
899945|NCT01154036|2966861|P4|Phase II|Adverse Event|0
899946|NCT01154036|2966862|P3|Phase II|Adverse Event|0
899947|NCT01154036|2966863|P2|Phase II|Adverse Event|0
899948|NCT01154036|2966864|P1|Phase II|Adverse Event|0
899949|NCT01154036|2966857|P8|Phase I|Adverse Event|0
899950|NCT01154036|2966858|P7|Phase I|Adverse Event|0
899951|NCT01154036|2966859|P6|Phase I|Adverse Event|0
899952|NCT01154036|2966860|P5|Phase I|Adverse Event|0
899953|NCT01154036|2966861|P4|Phase I|Adverse Event|0
899954|NCT01154036|2966862|P3|Phase I|Adverse Event|12
899955|NCT01154036|2966863|P2|Phase I|Adverse Event|11
899956|NCT01154036|2966864|P1|Phase I|Adverse Event|1
899957|NCT01154036|2966857|P8|Phase I|Withdrawal by Subject|0
899958|NCT01154036|2966858|P7|Phase I|Withdrawal by Subject|0
899959|NCT01154036|2966859|P6|Phase I|Withdrawal by Subject|0
899960|NCT01154036|2966860|P5|Phase I|Withdrawal by Subject|0
899961|NCT01154036|2966861|P4|Phase I|Withdrawal by Subject|0
899962|NCT01154036|2966862|P3|Phase I|Withdrawal by Subject|29
899963|NCT01154036|2966863|P2|Phase I|Withdrawal by Subject|10
899964|NCT01154036|2966864|P1|Phase I|Withdrawal by Subject|2
899965|NCT01154036|2966857|P8|Phase I|Protocol Violation|0
899966|NCT01154036|2966858|P7|Phase I|Protocol Violation|0
899967|NCT01154036|2966859|P6|Phase I|Protocol Violation|0
899968|NCT01154036|2966860|P5|Phase I|Protocol Violation|0
899969|NCT01154036|2966861|P4|Phase I|Protocol Violation|0
899970|NCT01154036|2966862|P3|Phase I|Protocol Violation|9
899971|NCT01154036|2966863|P2|Phase I|Protocol Violation|3
899972|NCT01154036|2966864|P1|Phase I|Protocol Violation|0
899973|NCT01154036|2966857|P8|Phase I|Lost to Follow-up|0
899974|NCT01154036|2966858|P7|Phase I|Lost to Follow-up|0
899975|NCT01154036|2966859|P6|Phase I|Lost to Follow-up|0
899976|NCT01154036|2966860|P5|Phase I|Lost to Follow-up|0
899977|NCT01154036|2966861|P4|Phase I|Lost to Follow-up|0
899978|NCT01154036|2966862|P3|Phase I|Lost to Follow-up|6
899979|NCT01154036|2966863|P2|Phase I|Lost to Follow-up|3
899980|NCT01154036|2966864|P1|Phase I|Lost to Follow-up|0
899981|NCT01154036|2966857|P8|Phase I|Physician Decision|0
899982|NCT01154036|2966858|P7|Phase I|Physician Decision|0
899983|NCT01154036|2966859|P6|Phase I|Physician Decision|0
899984|NCT01154036|2966860|P5|Phase I|Physician Decision|0
899985|NCT01154036|2966861|P4|Phase I|Physician Decision|0
899986|NCT01154036|2966862|P3|Phase I|Physician Decision|0
899987|NCT01154036|2966863|P2|Phase I|Physician Decision|1
899988|NCT01154036|2966864|P1|Phase I|Physician Decision|0
899989|NCT01154010|2966988|P2|Overall Study|Lost to Follow-up|1
899990|NCT01154010|2966989|P1|Overall Study|Lost to Follow-up|0
899991|NCT01153984|2966995|P1|Overall Study|Adverse Event|1
899992|NCT01153984|2966995|P1|Overall Study|Withdrawal by Subject|1
899993|NCT01153971|2967006|P1|Follow-up (Months 17-40 of Study)|Disease progression|2
899994|NCT01153971|2967006|P1|Follow-up (Months 17-40 of Study)|Protocol Violation|1
899995|NCT01153971|2967006|P1|Follow-up (Months 17-40 of Study)|Adverse Event|1
899996|NCT01153971|2967006|P1|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1
899997|NCT01153971|2967006|P1|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2
899998|NCT01153971|2967006|P1|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1
899999|NCT01153971|2967006|P1|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2
900000|NCT01153958|2967029|P2|Overall Study|Study Terminated|32
900001|NCT01153958|2967030|P1|Overall Study|Study Terminated|36
900002|NCT01153893|2967048|P2|Overall Study|Adverse Event|0
900003|NCT01153893|2967049|P1|Overall Study|Adverse Event|1
900004|NCT01153841|2967075|P2|Overall Study|Lost to Follow-up|0
900005|NCT01153841|2967076|P1|Overall Study|Lost to Follow-up|2
900006|NCT01153841|2967075|P2|Overall Study|Protocol Violation|0
900007|NCT01153841|2967076|P1|Overall Study|Protocol Violation|2
900008|NCT01153841|2967075|P2|Overall Study|Withdrawal by Subject|0
900009|NCT01153841|2967076|P1|Overall Study|Withdrawal by Subject|1
900010|NCT01153841|2967075|P2|Overall Study|Adverse Event|0
900011|NCT01153841|2967076|P1|Overall Study|Adverse Event|1
900012|NCT01153815|2967092|P2|Overall Study|Withdrawal by Subject|4
900013|NCT01153815|2967093|P1|Overall Study|Withdrawal by Subject|6
900014|NCT01153815|2967092|P2|Overall Study|Adverse Event|1
900015|NCT01153815|2967093|P1|Overall Study|Adverse Event|3
900016|NCT01153763|2967115|P1|Overall Study|Withdrawal by Subject|2
900017|NCT01153763|2967115|P1|Overall Study|Physician Decision|2
900018|NCT01153763|2967115|P1|Overall Study|Lost to Follow-up|1
900019|NCT01153763|2967115|P1|Overall Study|Study Closed|16
900020|NCT01153724|2967131|P1|Treatment Period 2|Other reason not defined above|1
900021|NCT01153724|2967131|P1|Treatment Period 2|Adverse Event|1
900022|NCT01153724|2967131|P1|Treatment Period 1|Withdrawal by Subject|1
900023|NCT01153698|2967171|P1|Overall Study|Not treated with Pradaxa|5
900024|NCT01153698|2967171|P1|Overall Study|Other|2
900025|NCT01153698|2967171|P1|Overall Study|Switch to other anticoagulants|4
900026|NCT01153698|2967171|P1|Overall Study|Withdrawal by Subject|2
900027|NCT01153698|2967171|P1|Overall Study|Lost to Follow-up|4
900028|NCT01153698|2967171|P1|Overall Study|Adverse Event|12
900029|NCT01153633|2967222|P2|Overall Study|Therapeutic failure|3
900030|NCT01153633|2967223|P1|Overall Study|Therapeutic failure|3
900031|NCT01153633|2967222|P2|Overall Study|Protocol Violation|1
900032|NCT01153633|2967223|P1|Overall Study|Protocol Violation|1
900033|NCT01153425|2967273|P2|Overall Study|Withdrawal by Subject|3
900034|NCT01153425|2967274|P1|Overall Study|Withdrawal by Subject|3
900035|NCT01153347|2967286|P4|Overall Study|Death|0
900036|NCT01153347|2967287|P3|Overall Study|Death|0
900037|NCT01153347|2967288|P2|Overall Study|Death|0
900038|NCT01153347|2967289|P1|Overall Study|Death|1
900039|NCT01153347|2967286|P4|Overall Study|Not specified|0
900040|NCT01153347|2967287|P3|Overall Study|Not specified|4
900041|NCT01153347|2967288|P2|Overall Study|Not specified|5
900042|NCT01153347|2967289|P1|Overall Study|Not specified|5
900043|NCT01153347|2967286|P4|Overall Study|Lost to Follow-up|8
900044|NCT01153347|2967287|P3|Overall Study|Lost to Follow-up|11
900045|NCT01153347|2967288|P2|Overall Study|Lost to Follow-up|9
900046|NCT01153347|2967289|P1|Overall Study|Lost to Follow-up|4
900047|NCT01153347|2967286|P4|Overall Study|Study-specific withdrawal criteria|2
900048|NCT01153347|2967287|P3|Overall Study|Study-specific withdrawal criteria|1
900049|NCT01153347|2967288|P2|Overall Study|Study-specific withdrawal criteria|3
900050|NCT01153347|2967289|P1|Overall Study|Study-specific withdrawal criteria|4
900051|NCT01153347|2967286|P4|Overall Study|Lack of Efficacy|4
900052|NCT01153347|2967287|P3|Overall Study|Lack of Efficacy|0
900053|NCT01153347|2967288|P2|Overall Study|Lack of Efficacy|2
900054|NCT01153347|2967289|P1|Overall Study|Lack of Efficacy|2
900055|NCT01153347|2967286|P4|Overall Study|Condition under investigation worsened|0
900056|NCT01153347|2967287|P3|Overall Study|Condition under investigation worsened|0
900057|NCT01153347|2967288|P2|Overall Study|Condition under investigation worsened|1
900058|NCT01153347|2967289|P1|Overall Study|Condition under investigation worsened|1
900059|NCT01153347|2967286|P4|Overall Study|Severe non-compliance to protocol|3
900060|NCT01153347|2967287|P3|Overall Study|Severe non-compliance to protocol|4
900061|NCT01153347|2967288|P2|Overall Study|Severe non-compliance to protocol|7
900062|NCT01153347|2967289|P1|Overall Study|Severe non-compliance to protocol|6
900063|NCT01153347|2967286|P4|Overall Study|Adverse Event|7
900064|NCT01153347|2967287|P3|Overall Study|Adverse Event|21
900065|NCT01153347|2967288|P2|Overall Study|Adverse Event|9
900066|NCT01153347|2967289|P1|Overall Study|Adverse Event|3
900067|NCT01153347|2967286|P4|Overall Study|Eligibility criteria not fulfilled|1
900068|NCT01153347|2967287|P3|Overall Study|Eligibility criteria not fulfilled|2
900069|NCT01153347|2967288|P2|Overall Study|Eligibility criteria not fulfilled|1
900070|NCT01153347|2967289|P1|Overall Study|Eligibility criteria not fulfilled|0
900071|NCT01153347|2967286|P4|Overall Study|Withdrawal by Subject|7
900072|NCT01153347|2967287|P3|Overall Study|Withdrawal by Subject|7
900073|NCT01153347|2967288|P2|Overall Study|Withdrawal by Subject|7
900074|NCT01153347|2967289|P1|Overall Study|Withdrawal by Subject|7
900075|NCT01153321|2967389|P2|Overall Study|Adverse Event|1
900076|NCT01153321|2967390|P1|Overall Study|Adverse Event|1
900077|NCT01153321|2967389|P2|Overall Study|Withdrawal by Subject|1
900078|NCT01153321|2967390|P1|Overall Study|Withdrawal by Subject|0
900079|NCT01153321|2967389|P2|Overall Study|Development of study withdrawal criteria|1
900080|NCT01153321|2967390|P1|Overall Study|Development of study withdrawal criteria|0
900081|NCT01153269|2967502|P1|Overall Study|Antiretroviral therapy break|1
900082|NCT01153269|2967502|P1|Overall Study|Withdrawal by Subject|1
900083|NCT01153009|2967565|P4|Overall Study|Other|2
900084|NCT01153009|2967566|P3|Overall Study|Other|3
900085|NCT01153009|2967567|P2|Overall Study|Other|1
900086|NCT01153009|2967568|P1|Overall Study|Other|1
900087|NCT01153009|2967565|P4|Overall Study|Lost to Follow-up|15
900088|NCT01153009|2967566|P3|Overall Study|Lost to Follow-up|11
900089|NCT01153009|2967567|P2|Overall Study|Lost to Follow-up|8
900090|NCT01153009|2967568|P1|Overall Study|Lost to Follow-up|8
900091|NCT01153009|2967565|P4|Overall Study|Withdrawal of Consent|6
900092|NCT01153009|2967566|P3|Overall Study|Withdrawal of Consent|4
900093|NCT01153009|2967567|P2|Overall Study|Withdrawal of Consent|5
900094|NCT01153009|2967568|P1|Overall Study|Withdrawal of Consent|5
900095|NCT01153009|2967565|P4|Overall Study|Protocol Deviations|2
900096|NCT01153009|2967566|P3|Overall Study|Protocol Deviations|3
900097|NCT01153009|2967567|P2|Overall Study|Protocol Deviations|3
900098|NCT01153009|2967568|P1|Overall Study|Protocol Deviations|4
900099|NCT01153009|2967565|P4|Overall Study|Noncompliance with Study Medication|1
900100|NCT01153009|2967566|P3|Overall Study|Noncompliance with Study Medication|4
900101|NCT01153009|2967567|P2|Overall Study|Noncompliance with Study Medication|3
900102|NCT01153009|2967568|P1|Overall Study|Noncompliance with Study Medication|1
900103|NCT01153009|2967565|P4|Overall Study|Lack of Efficacy|1
900104|NCT01153009|2967566|P3|Overall Study|Lack of Efficacy|2
900105|NCT01153009|2967567|P2|Overall Study|Lack of Efficacy|0
900106|NCT01153009|2967568|P1|Overall Study|Lack of Efficacy|9
900107|NCT01153009|2967565|P4|Overall Study|Adverse Event|10
900108|NCT01153009|2967566|P3|Overall Study|Adverse Event|14
900109|NCT01153009|2967567|P2|Overall Study|Adverse Event|14
900110|NCT01153009|2967568|P1|Overall Study|Adverse Event|4
900111|NCT01152996|2967598|P1|Overall Study|Elevated liver enzymes|1
900112|NCT01152996|2967598|P1|Overall Study|Protocol Violation|22
900113|NCT01152996|2967598|P1|Overall Study|Other|36
900114|NCT01152996|2967598|P1|Overall Study|Noncompliance|41
900115|NCT01152996|2967598|P1|Overall Study|Lack of Efficacy|68
900116|NCT01152996|2967598|P1|Overall Study|Lost to Follow-up|112
900117|NCT01152996|2967598|P1|Overall Study|Adverse Event|115
900118|NCT01152996|2967598|P1|Overall Study|Withdrawal by Subject|142
900119|NCT01152814|2967611|P1|Overall Study|Lost to Follow-up|2
900120|NCT01152788|2967620|P2|Overall Study|No treatment|1
900121|NCT01152788|2967621|P1|Overall Study|No treatment|0
900122|NCT01152788|2967620|P2|Overall Study|Withdrawal by Subject|3
900123|NCT01152788|2967621|P1|Overall Study|Withdrawal by Subject|0
900124|NCT01152580|2967658|P2|Overall Study|Withdrawal by Subject|1
900125|NCT01152580|2967659|P1|Overall Study|Withdrawal by Subject|0
900126|NCT01152554|2967681|P2|Overall Study|Death|1
900127|NCT01152554|2967682|P1|Overall Study|Death|1
900128|NCT01152554|2967681|P2|Overall Study|Not specified|8
900129|NCT01152554|2967682|P1|Overall Study|Not specified|28
900130|NCT01152554|2967681|P2|Overall Study|Lost to Follow-up|32
900131|NCT01152554|2967682|P1|Overall Study|Lost to Follow-up|87
900132|NCT01152554|2967681|P2|Overall Study|Study-specific withdrawal criteria|8
900133|NCT01152554|2967682|P1|Overall Study|Study-specific withdrawal criteria|17
900134|NCT01152554|2967681|P2|Overall Study|Lack of Efficacy|3
900135|NCT01152554|2967682|P1|Overall Study|Lack of Efficacy|20
900136|NCT01152554|2967681|P2|Overall Study|Condition under investigation worsened|2
900137|NCT01152554|2967682|P1|Overall Study|Condition under investigation worsened|5
900138|NCT01152554|2967681|P2|Overall Study|Severe non-compliance to protocol|14
900139|NCT01152554|2967682|P1|Overall Study|Severe non-compliance to protocol|36
900140|NCT01152554|2967681|P2|Overall Study|Adverse Event|14
900141|NCT01152554|2967682|P1|Overall Study|Adverse Event|67
900142|NCT01152554|2967681|P2|Overall Study|Eligiblity criteria not fulfilled|1
900143|NCT01152554|2967682|P1|Overall Study|Eligiblity criteria not fulfilled|0
900144|NCT01152554|2967681|P2|Overall Study|Withdrawal by Subject|28
900145|NCT01152554|2967682|P1|Overall Study|Withdrawal by Subject|73
900146|NCT01152450|2967704|P6|Period 1 (4 Weeks)|Lost to Follow-up|0
900147|NCT01152450|2967705|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
900148|NCT01152450|2967706|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
900149|NCT01152450|2967707|P3|Period 1 (4 Weeks)|Lost to Follow-up|1
900150|NCT01152450|2967708|P2|Period 1 (4 Weeks)|Lost to Follow-up|1
900151|NCT01152450|2967709|P1|Period 1 (4 Weeks)|Lost to Follow-up|0
900152|NCT01152450|2967704|P6|Period 1 (4 Weeks)|Protocol Violation|0
900153|NCT01152450|2967705|P5|Period 1 (4 Weeks)|Protocol Violation|1
900154|NCT01152450|2967706|P4|Period 1 (4 Weeks)|Protocol Violation|0
900155|NCT01152450|2967707|P3|Period 1 (4 Weeks)|Protocol Violation|0
900156|NCT01152450|2967708|P2|Period 1 (4 Weeks)|Protocol Violation|0
900157|NCT01152450|2967709|P1|Period 1 (4 Weeks)|Protocol Violation|0
900158|NCT01152450|2967704|P6|Period 1 (4 Weeks)|Adverse Event|1
900159|NCT01152450|2967705|P5|Period 1 (4 Weeks)|Adverse Event|1
900160|NCT01152450|2967706|P4|Period 1 (4 Weeks)|Adverse Event|0
900161|NCT01152450|2967707|P3|Period 1 (4 Weeks)|Adverse Event|0
900162|NCT01152450|2967708|P2|Period 1 (4 Weeks)|Adverse Event|0
900163|NCT01152450|2967709|P1|Period 1 (4 Weeks)|Adverse Event|0
900164|NCT01152437|2967780|P3|Overall Study|Refusal to continue taking trial medicat|2
900165|NCT01152437|2967781|P2|Overall Study|Refusal to continue taking trial medicat|0
900166|NCT01152437|2967782|P1|Overall Study|Refusal to continue taking trial medicat|1
900167|NCT01152437|2967780|P3|Overall Study|Progressive disease|32
900168|NCT01152437|2967781|P2|Overall Study|Progressive disease|13
900169|NCT01152437|2967782|P1|Overall Study|Progressive disease|27
900170|NCT01152437|2967780|P3|Overall Study|Not treated|2
900171|NCT01152437|2967781|P2|Overall Study|Not treated|1
900172|NCT01152437|2967782|P1|Overall Study|Not treated|0
900173|NCT01152437|2967780|P3|Overall Study|Other Adverse Event|7
900174|NCT01152437|2967781|P2|Overall Study|Other Adverse Event|1
900175|NCT01152437|2967782|P1|Overall Study|Other Adverse Event|8
900176|NCT01152385|2967802|P4|Overall Study|Other|3
900177|NCT01152385|2967803|P3|Overall Study|Other|2
900178|NCT01152385|2967804|P2|Overall Study|Other|3
900179|NCT01152385|2967805|P1|Overall Study|Other|4
900180|NCT01152385|2967802|P4|Overall Study|Study-specific withdrawal criteria|0
900181|NCT01152385|2967803|P3|Overall Study|Study-specific withdrawal criteria|2
900182|NCT01152385|2967804|P2|Overall Study|Study-specific withdrawal criteria|1
900183|NCT01152385|2967805|P1|Overall Study|Study-specific withdrawal criteria|1
900184|NCT01152385|2967802|P4|Overall Study|Adverse Event|0
900185|NCT01152385|2967803|P3|Overall Study|Adverse Event|0
900186|NCT01152385|2967804|P2|Overall Study|Adverse Event|1
900187|NCT01152385|2967805|P1|Overall Study|Adverse Event|1
900188|NCT01152385|2967802|P4|Overall Study|Protocol Violation|1
900189|NCT01152385|2967803|P3|Overall Study|Protocol Violation|0
900190|NCT01152385|2967804|P2|Overall Study|Protocol Violation|0
900191|NCT01152385|2967805|P1|Overall Study|Protocol Violation|0
900192|NCT01152385|2967802|P4|Overall Study|Withdrawal by Subject|1
900193|NCT01152385|2967803|P3|Overall Study|Withdrawal by Subject|1
900194|NCT01152385|2967804|P2|Overall Study|Withdrawal by Subject|1
900195|NCT01152385|2967805|P1|Overall Study|Withdrawal by Subject|3
900196|NCT01152190|2967872|P2|Overall Study|Withdrawal by Subject|3
900197|NCT01152190|2967873|P1|Overall Study|Withdrawal by Subject|1
900198|NCT01152190|2967872|P2|Overall Study|Protocol Violation|1
900199|NCT01152190|2967873|P1|Overall Study|Protocol Violation|1
900200|NCT01152190|2967872|P2|Overall Study|Death|0
900201|NCT01152190|2967873|P1|Overall Study|Death|1
900202|NCT01152190|2967872|P2|Overall Study|Adverse Event|4
900203|NCT01152190|2967873|P1|Overall Study|Adverse Event|2
900204|NCT01151579|2967932|P2|Overall Study|Not meet inclusion criteria|4
900205|NCT01151579|2967933|P1|Overall Study|Not meet inclusion criteria|6
900206|NCT01151579|2967932|P2|Overall Study|Withdrawal by Subject|2
900207|NCT01151579|2967933|P1|Overall Study|Withdrawal by Subject|3
900208|NCT01151579|2967932|P2|Overall Study|Physician Decision|1
900209|NCT01151579|2967933|P1|Overall Study|Physician Decision|3
900210|NCT01151410|2967987|P2|Overall Study|Abnormal laboratory value(s)|1
900211|NCT01151410|2967988|P1|Overall Study|Abnormal laboratory value(s)|0
900212|NCT01151410|2967987|P2|Overall Study|Unsatisfactory therapeutic effect|1
900213|NCT01151410|2967988|P1|Overall Study|Unsatisfactory therapeutic effect|1
900214|NCT01151410|2967987|P2|Overall Study|Administrative problems|1
900215|NCT01151410|2967988|P1|Overall Study|Administrative problems|1
900216|NCT01151410|2967987|P2|Overall Study|Protocol deviation|1
900217|NCT01151410|2967988|P1|Overall Study|Protocol deviation|2
900218|NCT01151410|2967987|P2|Overall Study|Adverse Event|2
900219|NCT01151410|2967988|P1|Overall Study|Adverse Event|1
900220|NCT01151410|2967987|P2|Overall Study|Lost to Follow-up|4
900221|NCT01151410|2967988|P1|Overall Study|Lost to Follow-up|3
900222|NCT01151410|2967987|P2|Overall Study|Withdrawal by Subject|5
900223|NCT01151410|2967988|P1|Overall Study|Withdrawal by Subject|3
900224|NCT01151345|2968032|P2|First Intervention Period|Protocol Violation|1
900225|NCT01151345|2968033|P1|First Intervention Period|Protocol Violation|0
900226|NCT01151280|2968047|P1|Overall Study|Lack of Efficacy|3
900227|NCT01151280|2968047|P1|Overall Study|Adverse Event|1
900228|NCT01151215|2968060|P3|Overall Study|Safety as judged by the investigator|1
900229|NCT01151215|2968061|P2|Overall Study|Safety as judged by the investigator|0
900230|NCT01151215|2968062|P1|Overall Study|Safety as judged by the investigator|0
900231|NCT01151215|2968060|P3|Overall Study|Disease progression|1
900232|NCT01151215|2968061|P2|Overall Study|Disease progression|1
900233|NCT01151215|2968062|P1|Overall Study|Disease progression|0
900234|NCT01151215|2968060|P3|Overall Study|Withdrawal by Subject|2
900235|NCT01151215|2968061|P2|Overall Study|Withdrawal by Subject|1
900236|NCT01151215|2968062|P1|Overall Study|Withdrawal by Subject|3
900237|NCT01151215|2968060|P3|Overall Study|Lost to Follow-up|3
900238|NCT01151215|2968061|P2|Overall Study|Lost to Follow-up|0
900239|NCT01151215|2968062|P1|Overall Study|Lost to Follow-up|0
900240|NCT01151215|2968060|P3|Overall Study|Death|11
900241|NCT01151215|2968061|P2|Overall Study|Death|20
900242|NCT01151215|2968062|P1|Overall Study|Death|16
900243|NCT01151215|2968060|P3|Overall Study|Worsening of condition under study|1
900244|NCT01151215|2968061|P2|Overall Study|Worsening of condition under study|1
900245|NCT01151215|2968062|P1|Overall Study|Worsening of condition under study|1
900246|NCT01151137|2968100|P2|Overall Study|Lost to Follow-up|1
900247|NCT01151137|2968101|P1|Overall Study|Lost to Follow-up|1
900248|NCT01151137|2968100|P2|Overall Study|Death|27
900249|NCT01151137|2968101|P1|Overall Study|Death|15
900250|NCT01151098|2968119|P1|Overall Study|Miscellaneous|13
900251|NCT01151098|2968119|P1|Overall Study|Protocol Violation|1
900252|NCT01151098|2968119|P1|Overall Study|Lack of Efficacy|15
900253|NCT01151098|2968119|P1|Overall Study|Lost to Follow-up|6
900254|NCT01151098|2968119|P1|Overall Study|Adverse Event|82
900255|NCT01151085|2968123|P1|Overall Study|Protocol Violation|25
900256|NCT01151085|2968123|P1|Overall Study|Lost to Follow-up|31
900257|NCT01151020|2968154|P1|Overall Study|Still be eligible for follow-up|79
900258|NCT01151020|2968154|P1|Overall Study|Patients did not receive the device|2
900259|NCT01151020|2968154|P1|Overall Study|Withdrawal by Subject|12
900260|NCT01151020|2968154|P1|Overall Study|Lost to Follow-up|1
900261|NCT01151020|2968154|P1|Overall Study|Conversion to open repair|1
900262|NCT01151020|2968154|P1|Overall Study|Death|15
900263|NCT01150474|2968233|P2|Overall Study|Surgery Changed|0
900264|NCT01150474|2968234|P1|Overall Study|Surgery Changed|1
900265|NCT01150474|2968233|P2|Overall Study|Drug not administered|0
900266|NCT01150474|2968234|P1|Overall Study|Drug not administered|1
900267|NCT01150474|2968233|P2|Overall Study|Drug did not arrive in time|0
900268|NCT01150474|2968234|P1|Overall Study|Drug did not arrive in time|1
900269|NCT01150474|2968233|P2|Overall Study|Rectotomy|0
900270|NCT01150474|2968234|P1|Overall Study|Rectotomy|1
900271|NCT01150474|2968233|P2|Overall Study|Multiple Studies|1
900272|NCT01150474|2968234|P1|Overall Study|Multiple Studies|0
900273|NCT01150474|2968233|P2|Overall Study|Cancer found|0
900274|NCT01150474|2968234|P1|Overall Study|Cancer found|1
900275|NCT01150474|2968233|P2|Overall Study|Withdrawal by Subject|2
900276|NCT01150474|2968234|P1|Overall Study|Withdrawal by Subject|5
900277|NCT01150357|2968279|P3|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
900278|NCT01150357|2968280|P2|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
900279|NCT01150357|2968281|P1|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1
900280|NCT01150357|2968279|P3|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
900281|NCT01150357|2968280|P2|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
900282|NCT01150357|2968281|P1|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2
900283|NCT01150357|2968279|P3|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2
900284|NCT01150357|2968280|P2|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
900285|NCT01150357|2968281|P1|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
900286|NCT01150357|2968279|P3|Dose Response Phase (Phase 1)|Withdrawal by Participants|1
900287|NCT01150357|2968280|P2|Dose Response Phase (Phase 1)|Withdrawal by Participants|2
900288|NCT01150357|2968281|P1|Dose Response Phase (Phase 1)|Withdrawal by Participants|0
900289|NCT01150357|2968279|P3|Dose Response Phase (Phase 1)|Adverse Event|1
900290|NCT01150357|2968280|P2|Dose Response Phase (Phase 1)|Adverse Event|0
900291|NCT01150357|2968281|P1|Dose Response Phase (Phase 1)|Adverse Event|0
900292|NCT01150357|2968279|P3|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
900293|NCT01150357|2968280|P2|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
900294|NCT01150357|2968281|P1|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1
900295|NCT01150357|2968279|P3|Dose Response Phase (Phase 1)|Protocol Violation|1
900296|NCT01150357|2968280|P2|Dose Response Phase (Phase 1)|Protocol Violation|1
900297|NCT01150357|2968281|P1|Dose Response Phase (Phase 1)|Protocol Violation|0
900298|NCT01150123|2968361|P18|Overall Study|Lost to Follow-up|0
900299|NCT01150123|2968362|P17|Overall Study|Lost to Follow-up|0
900300|NCT01150123|2968363|P16|Overall Study|Lost to Follow-up|0
900301|NCT01150123|2968364|P15|Overall Study|Lost to Follow-up|0
900302|NCT01150123|2968365|P14|Overall Study|Lost to Follow-up|0
900303|NCT01150123|2968366|P13|Overall Study|Lost to Follow-up|2
900304|NCT01150123|2968367|P12|Overall Study|Lost to Follow-up|1
900305|NCT01150123|2968368|P11|Overall Study|Lost to Follow-up|1
900306|NCT01150123|2968369|P10|Overall Study|Lost to Follow-up|1
900307|NCT01150123|2968370|P9|Overall Study|Lost to Follow-up|3
900308|NCT01150123|2968371|P8|Overall Study|Lost to Follow-up|0
900309|NCT01150123|2968372|P7|Overall Study|Lost to Follow-up|0
900310|NCT01150123|2968373|P6|Overall Study|Lost to Follow-up|5
900311|NCT01150123|2968374|P5|Overall Study|Lost to Follow-up|2
900312|NCT01150123|2968375|P4|Overall Study|Lost to Follow-up|2
900313|NCT01150123|2968376|P3|Overall Study|Lost to Follow-up|2
900314|NCT01150123|2968377|P2|Overall Study|Lost to Follow-up|1
900315|NCT01150123|2968378|P1|Overall Study|Lost to Follow-up|2
900316|NCT01150123|2968361|P18|Overall Study|Withdrawal by Subject|1
900317|NCT01150123|2968362|P17|Overall Study|Withdrawal by Subject|0
900318|NCT01150123|2968363|P16|Overall Study|Withdrawal by Subject|1
900319|NCT01150123|2968364|P15|Overall Study|Withdrawal by Subject|0
900320|NCT01150123|2968365|P14|Overall Study|Withdrawal by Subject|0
900321|NCT01150123|2968366|P13|Overall Study|Withdrawal by Subject|1
900322|NCT01150123|2968367|P12|Overall Study|Withdrawal by Subject|0
900323|NCT01150123|2968368|P11|Overall Study|Withdrawal by Subject|1
900324|NCT01150123|2968369|P10|Overall Study|Withdrawal by Subject|0
900325|NCT01150123|2968370|P9|Overall Study|Withdrawal by Subject|2
900326|NCT01150123|2968371|P8|Overall Study|Withdrawal by Subject|3
900327|NCT01150123|2968372|P7|Overall Study|Withdrawal by Subject|0
900328|NCT01150123|2968373|P6|Overall Study|Withdrawal by Subject|1
900329|NCT01150123|2968374|P5|Overall Study|Withdrawal by Subject|1
900330|NCT01150123|2968375|P4|Overall Study|Withdrawal by Subject|1
900331|NCT01150123|2968376|P3|Overall Study|Withdrawal by Subject|2
900332|NCT01150123|2968377|P2|Overall Study|Withdrawal by Subject|1
900333|NCT01150123|2968378|P1|Overall Study|Withdrawal by Subject|1
900334|NCT01150097|2968554|P3|Months 24 to 48 Post-transplantation|Death|0
900335|NCT01150097|2968555|P2|Months 24 to 48 Post-transplantation|Death|0
900336|NCT01150097|2968556|P1|Months 24 to 48 Post-transplantation|Death|2
900337|NCT01150097|2968554|P3|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
900338|NCT01150097|2968555|P2|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
900339|NCT01150097|2968556|P1|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4
900340|NCT01150097|2968554|P3|Months 24 to 48 Post-transplantation|Administrative problems|0
900341|NCT01150097|2968555|P2|Months 24 to 48 Post-transplantation|Administrative problems|4
900342|NCT01150097|2968556|P1|Months 24 to 48 Post-transplantation|Administrative problems|5
900343|NCT01150097|2968554|P3|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
900344|NCT01150097|2968555|P2|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0
900345|NCT01150097|2968556|P1|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
900346|NCT01150097|2968554|P3|Months 24 to 36 Post-transplantation|Lost to Follow-up|3
900347|NCT01150097|2968555|P2|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
900348|NCT01150097|2968556|P1|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
900349|NCT01150097|2968554|P3|Months 24 to 36 Post-transplantation|Administrative problems|2
900350|NCT01150097|2968555|P2|Months 24 to 36 Post-transplantation|Administrative problems|2
900351|NCT01150097|2968556|P1|Months 24 to 36 Post-transplantation|Administrative problems|5
900352|NCT01150097|2968554|P3|Months 24 to 36 Post-transplantation|Death|0
900353|NCT01150097|2968555|P2|Months 24 to 36 Post-transplantation|Death|0
900354|NCT01150097|2968556|P1|Months 24 to 36 Post-transplantation|Death|2
900355|NCT01149863|2968600|P1|Overall Study|Missing data or Not receiveing studydrug|3
900356|NCT01149655|2968677|P4|Period 3-DB Maintenance Phase|Relapse With AE|18
900357|NCT01149655|2968678|P3|Period 3-DB Maintenance Phase|Relapse With AE|19
900358|NCT01149655|2968679|P2|Period 3-DB Maintenance Phase|Relapse With AE|0
900359|NCT01149655|2968680|P1|Period 3-DB Maintenance Phase|Relapse With AE|0
900360|NCT01149655|2968677|P4|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
900361|NCT01149655|2968678|P3|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
900362|NCT01149655|2968679|P2|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
900363|NCT01149655|2968680|P1|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
900364|NCT01149655|2968677|P4|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
900365|NCT01149655|2968678|P3|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
900366|NCT01149655|2968679|P2|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
900367|NCT01149655|2968680|P1|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
900368|NCT01149655|2968677|P4|Period 3-DB Maintenance Phase|Physician Decision|0
900369|NCT01149655|2968678|P3|Period 3-DB Maintenance Phase|Physician Decision|1
900370|NCT01149655|2968679|P2|Period 3-DB Maintenance Phase|Physician Decision|0
900371|NCT01149655|2968680|P1|Period 3-DB Maintenance Phase|Physician Decision|0
900372|NCT01149655|2968677|P4|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19
900373|NCT01149655|2968678|P3|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58
900374|NCT01149655|2968679|P2|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
900375|NCT01149655|2968680|P1|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
900376|NCT01149655|2968677|P4|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
900377|NCT01149655|2968678|P3|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
900378|NCT01149655|2968679|P2|Period 2-Stabilization Phase|Adverse Event Without Relapse|6
900379|NCT01149655|2968680|P1|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
900380|NCT01149655|2968677|P4|Period 2-Stabilization Phase|Withdrawal by Subject|0
900381|NCT01149655|2968678|P3|Period 2-Stabilization Phase|Withdrawal by Subject|0
900382|NCT01149655|2968679|P2|Period 2-Stabilization Phase|Withdrawal by Subject|5
900383|NCT01149655|2968680|P1|Period 2-Stabilization Phase|Withdrawal by Subject|0
900384|NCT01149655|2968677|P4|Period 2-Stabilization Phase|Physician Decision|0
900385|NCT01149655|2968678|P3|Period 2-Stabilization Phase|Physician Decision|0
900386|NCT01149655|2968679|P2|Period 2-Stabilization Phase|Physician Decision|3
900387|NCT01149655|2968680|P1|Period 2-Stabilization Phase|Physician Decision|0
900388|NCT01149655|2968677|P4|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
900389|NCT01149655|2968678|P3|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
900390|NCT01149655|2968679|P2|Period 2-Stabilization Phase|Met Withdrawal Criteria|7
900391|NCT01149655|2968680|P1|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
900392|NCT01149655|2968677|P4|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
900393|NCT01149655|2968678|P3|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
900394|NCT01149655|2968679|P2|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16
900395|NCT01149655|2968680|P1|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
900396|NCT01149655|2968677|P4|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
900397|NCT01149655|2968678|P3|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
900398|NCT01149655|2968679|P2|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
900399|NCT01149655|2968680|P1|Period 1 - Conversion Phase|Adverse Event Without Relapse|3
900400|NCT01149655|2968677|P4|Period 1 - Conversion Phase|Withdrawal by Subject|0
900401|NCT01149655|2968678|P3|Period 1 - Conversion Phase|Withdrawal by Subject|0
900402|NCT01149655|2968679|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
900403|NCT01149655|2968680|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
900404|NCT01149655|2968677|P4|Period 1 - Conversion Phase|Physician Decision|0
900405|NCT01149655|2968678|P3|Period 1 - Conversion Phase|Physician Decision|0
900406|NCT01149655|2968679|P2|Period 1 - Conversion Phase|Physician Decision|0
900407|NCT01149655|2968680|P1|Period 1 - Conversion Phase|Physician Decision|2
900408|NCT01149655|2968677|P4|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
900409|NCT01149655|2968678|P3|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
900410|NCT01149655|2968679|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
900411|NCT01149655|2968680|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
900412|NCT01149655|2968677|P4|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
900413|NCT01149655|2968678|P3|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
900414|NCT01149655|2968679|P2|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
900415|NCT01149655|2968680|P1|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4
900416|NCT01149655|2968677|P4|Period 1 - Conversion Phase|Lost to Follow-up|0
900417|NCT01149655|2968678|P3|Period 1 - Conversion Phase|Lost to Follow-up|0
900418|NCT01149655|2968679|P2|Period 1 - Conversion Phase|Lost to Follow-up|0
900419|NCT01149655|2968680|P1|Period 1 - Conversion Phase|Lost to Follow-up|1
900420|NCT01149538|2968723|P2|Overall Study|Withdrawal by Subject|3
900421|NCT01149538|2968724|P1|Overall Study|Withdrawal by Subject|5
900422|NCT01149538|2968723|P2|Overall Study|Lost to Follow-up|1
900423|NCT01149538|2968724|P1|Overall Study|Lost to Follow-up|0
900424|NCT01149486|2968745|P2|First Intervention|Adverse Event|1
900425|NCT01149486|2968746|P1|First Intervention|Adverse Event|0
900426|NCT01149473|2968770|P2|Washout of 7 Days|Withdrawal by Subject|1
900427|NCT01149473|2968771|P1|Washout of 7 Days|Withdrawal by Subject|1
900428|NCT01149473|2968770|P2|First Intervention|Adverse Event|1
900429|NCT01149473|2968771|P1|First Intervention|Adverse Event|1
900430|NCT01149460|2968789|P2|Overall Study|Withdrawal by Subject|2
900431|NCT01149460|2968790|P1|Overall Study|Withdrawal by Subject|0
900432|NCT01149421|2968823|P3|Overall Study|Protocol Violation|6
900433|NCT01149421|2968824|P2|Overall Study|Protocol Violation|2
900434|NCT01149421|2968825|P1|Overall Study|Protocol Violation|2
900435|NCT01149421|2968823|P3|Overall Study|Entry Criteria Not Met|2
900436|NCT01149421|2968824|P2|Overall Study|Entry Criteria Not Met|1
900437|NCT01149421|2968825|P1|Overall Study|Entry Criteria Not Met|1
900438|NCT01149421|2968823|P3|Overall Study|Physician Decision|6
900439|NCT01149421|2968824|P2|Overall Study|Physician Decision|3
900440|NCT01149421|2968825|P1|Overall Study|Physician Decision|5
900441|NCT01149421|2968823|P3|Overall Study|Lost to Follow-up|5
900442|NCT01149421|2968824|P2|Overall Study|Lost to Follow-up|4
900443|NCT01149421|2968825|P1|Overall Study|Lost to Follow-up|2
900444|NCT01149421|2968823|P3|Overall Study|Sponsor Decision|1
900445|NCT01149421|2968824|P2|Overall Study|Sponsor Decision|1
900446|NCT01149421|2968825|P1|Overall Study|Sponsor Decision|0
900447|NCT01149421|2968823|P3|Overall Study|Withdrawal by Subject|13
900448|NCT01149421|2968824|P2|Overall Study|Withdrawal by Subject|12
900449|NCT01149421|2968825|P1|Overall Study|Withdrawal by Subject|20
900450|NCT01149421|2968823|P3|Overall Study|Adverse Event|11
900451|NCT01149421|2968824|P2|Overall Study|Adverse Event|6
900452|NCT01149421|2968825|P1|Overall Study|Adverse Event|22
900453|NCT01149343|2968908|P4|Overall Study|Recurrence / Progressive disease|0
900454|NCT01149343|2968909|P3|Overall Study|Recurrence / Progressive disease|1
900455|NCT01149343|2968910|P2|Overall Study|Recurrence / Progressive disease|0
900456|NCT01149343|2968911|P1|Overall Study|Recurrence / Progressive disease|0
900457|NCT01149343|2968908|P4|Overall Study|Sponsor study termination|2
900458|NCT01149343|2968909|P3|Overall Study|Sponsor study termination|0
900459|NCT01149343|2968910|P2|Overall Study|Sponsor study termination|0
900460|NCT01149343|2968911|P1|Overall Study|Sponsor study termination|0
900461|NCT01149343|2968908|P4|Overall Study|Other|14
900462|NCT01149343|2968909|P3|Overall Study|Other|2
900463|NCT01149343|2968910|P2|Overall Study|Other|10
900464|NCT01149343|2968911|P1|Overall Study|Other|8
900465|NCT01149343|2968908|P4|Overall Study|Lost to Follow-up|1
900466|NCT01149343|2968909|P3|Overall Study|Lost to Follow-up|0
900467|NCT01149343|2968910|P2|Overall Study|Lost to Follow-up|0
900468|NCT01149343|2968911|P1|Overall Study|Lost to Follow-up|1
900469|NCT01149343|2968908|P4|Overall Study|Death|18
900470|NCT01149343|2968909|P3|Overall Study|Death|18
900471|NCT01149343|2968910|P2|Overall Study|Death|13
900472|NCT01149343|2968911|P1|Overall Study|Death|10
900473|NCT01149343|2968908|P4|Overall Study|Withdrawal by Subject|5
900474|NCT01149343|2968909|P3|Overall Study|Withdrawal by Subject|1
900475|NCT01149343|2968910|P2|Overall Study|Withdrawal by Subject|1
900476|NCT01149343|2968911|P1|Overall Study|Withdrawal by Subject|1
900477|NCT01149148|2968996|P2|Overall Study|Death|0
900478|NCT01149148|2968997|P1|Overall Study|Death|1
900479|NCT01149148|2968996|P2|Overall Study|Lost to Follow-up|2
900480|NCT01149148|2968997|P1|Overall Study|Lost to Follow-up|1
900481|NCT01149057|2969005|P1|Overall Study|Other|6
900482|NCT01149057|2969005|P1|Overall Study|High Parathyroid Hormone Value|1
900483|NCT01149057|2969005|P1|Overall Study|Lost to Follow-up|1
900484|NCT01149057|2969005|P1|Overall Study|Participant Non-Compliance|2
900485|NCT01149057|2969005|P1|Overall Study|B Cell Depletion|4
900486|NCT01149057|2969005|P1|Overall Study|Positive Hepatitis B Core Antibody|5
900487|NCT01149057|2969005|P1|Overall Study|Withdrawal by Subject|9
900488|NCT01149057|2969005|P1|Overall Study|Adverse Event|13
900489|NCT01149057|2969005|P1|Overall Study|Lack of Efficacy|16
900490|NCT01148979|2969032|P2|Overall Study|Lost to Follow-up|1
900491|NCT01148979|2969033|P1|Overall Study|Lost to Follow-up|0
900492|NCT01148862|2969039|P2|Second Intervention|Withdrawal by Subject|2
900493|NCT01148862|2969040|P1|Second Intervention|Withdrawal by Subject|0
900494|NCT01148771|2969072|P2|Washout Period|Withdrawal by Subject|1
900495|NCT01148771|2969073|P1|Washout Period|Withdrawal by Subject|0
900496|NCT01148693|2969093|P2|Overall Study|Attempts for cannulation were failed|10
900497|NCT01148693|2969094|P1|Overall Study|Attempts for cannulation were failed|13
900498|NCT01148537|2969114|P3|Overall Study|Adverse Event|1
900499|NCT01148537|2969115|P2|Overall Study|Adverse Event|0
900500|NCT01148537|2969116|P1|Overall Study|Adverse Event|2
900501|NCT01148537|2969114|P3|Overall Study|Withdrawal by Subject|2
900502|NCT01148537|2969115|P2|Overall Study|Withdrawal by Subject|0
900503|NCT01148537|2969116|P1|Overall Study|Withdrawal by Subject|1
900504|NCT01148511|2969202|P3|Randomized|Not Specified|1
900505|NCT01148511|2969203|P2|Randomized|Not Specified|1
900506|NCT01148511|2969204|P1|Randomized|Not Specified|0
900507|NCT01148511|2969202|P3|Randomized|Consent withdrawal|3
900508|NCT01148511|2969203|P2|Randomized|Consent withdrawal|5
900509|NCT01148511|2969204|P1|Randomized|Consent withdrawal|0
900510|NCT01148511|2969202|P3|Randomized|Lost to Follow-up|1
900511|NCT01148511|2969203|P2|Randomized|Lost to Follow-up|1
900512|NCT01148511|2969204|P1|Randomized|Lost to Follow-up|0
900513|NCT01148511|2969202|P3|Randomized|Protocol Violation|1
900514|NCT01148511|2969203|P2|Randomized|Protocol Violation|2
900515|NCT01148511|2969204|P1|Randomized|Protocol Violation|0
900516|NCT01148511|2969202|P3|Randomized|Adverse Event|0
900517|NCT01148511|2969203|P2|Randomized|Adverse Event|1
900518|NCT01148511|2969204|P1|Randomized|Adverse Event|0
900519|NCT01148511|2969202|P3|Exposed to Study Drug|Lost to Follow-up|0
900520|NCT01148511|2969203|P2|Exposed to Study Drug|Lost to Follow-up|0
900521|NCT01148511|2969204|P1|Exposed to Study Drug|Lost to Follow-up|4
900522|NCT01148511|2969202|P3|Exposed to Study Drug|Protocol Violation|0
900523|NCT01148511|2969203|P2|Exposed to Study Drug|Protocol Violation|0
900524|NCT01148511|2969204|P1|Exposed to Study Drug|Protocol Violation|2
900525|NCT01148017|2969242|P4|Overall Study|Unable to classify|0
900526|NCT01148017|2969243|P3|Overall Study|Unable to classify|0
900527|NCT01148017|2969244|P2|Overall Study|Unable to classify|1
900528|NCT01148017|2969245|P1|Overall Study|Unable to classify|3
900529|NCT01148017|2969242|P4|Overall Study|Administrative reason|0
900530|NCT01148017|2969243|P3|Overall Study|Administrative reason|0
900531|NCT01148017|2969244|P2|Overall Study|Administrative reason|9
900532|NCT01148017|2969245|P1|Overall Study|Administrative reason|22
900533|NCT01148017|2969242|P4|Overall Study|Inappropriate enrollment|0
900534|NCT01148017|2969243|P3|Overall Study|Inappropriate enrollment|0
900535|NCT01148017|2969244|P2|Overall Study|Inappropriate enrollment|0
900536|NCT01148017|2969245|P1|Overall Study|Inappropriate enrollment|1
900537|NCT01148017|2969242|P4|Overall Study|Lost to Follow-up|0
900538|NCT01148017|2969243|P3|Overall Study|Lost to Follow-up|0
900539|NCT01148017|2969244|P2|Overall Study|Lost to Follow-up|10
900540|NCT01148017|2969245|P1|Overall Study|Lost to Follow-up|23
900541|NCT01148017|2969242|P4|Overall Study|Withdrawal by Subject|0
900542|NCT01148017|2969243|P3|Overall Study|Withdrawal by Subject|0
900543|NCT01148017|2969244|P2|Overall Study|Withdrawal by Subject|14
900544|NCT01148017|2969245|P1|Overall Study|Withdrawal by Subject|31
900545|NCT01147926|2969284|P2|Overall Study|Colonoscopy result|1
900546|NCT01147926|2969285|P1|Overall Study|Colonoscopy result|0
900547|NCT01147926|2969284|P2|Overall Study|Went on holiday|1
900548|NCT01147926|2969285|P1|Overall Study|Went on holiday|0
900549|NCT01147926|2969284|P2|Overall Study|Too busy, no time for study|0
900550|NCT01147926|2969285|P1|Overall Study|Too busy, no time for study|1
900551|NCT01147926|2969284|P2|Overall Study|Lack of Efficacy|0
900552|NCT01147926|2969285|P1|Overall Study|Lack of Efficacy|1
900553|NCT01147926|2969284|P2|Overall Study|Sponsor's Decision|1
900554|NCT01147926|2969285|P1|Overall Study|Sponsor's Decision|0
900555|NCT01147926|2969284|P2|Overall Study|Lost to Follow-up|2
900556|NCT01147926|2969285|P1|Overall Study|Lost to Follow-up|0
900557|NCT01147926|2969284|P2|Overall Study|Selection criteria not met|1
900558|NCT01147926|2969285|P1|Overall Study|Selection criteria not met|3
900559|NCT01147926|2969284|P2|Overall Study|Principal investigator left hospital|3
900560|NCT01147926|2969285|P1|Overall Study|Principal investigator left hospital|1
900561|NCT01147926|2969284|P2|Overall Study|Subject Non-Compliant|4
900562|NCT01147926|2969285|P1|Overall Study|Subject Non-Compliant|5
900563|NCT01147926|2969284|P2|Overall Study|Adverse Event|6
900564|NCT01147926|2969285|P1|Overall Study|Adverse Event|7
900565|NCT01147926|2969284|P2|Overall Study|Subject Withdrew Consent|10
900566|NCT01147926|2969285|P1|Overall Study|Subject Withdrew Consent|9
900567|NCT01147900|2969320|P3|At Year 10|Lost to Follow-up|0
900568|NCT01147900|2969321|P2|At Year 10|Lost to Follow-up|1
900569|NCT01147900|2969322|P1|At Year 10|Lost to Follow-up|0
900570|NCT01147874|2969381|P1|Overall Study|Withdrawal by Subject|24
900571|NCT01147874|2969381|P1|Overall Study|Sponsor's Decision|2
900572|NCT01147874|2969381|P1|Overall Study|Protocol Violation|5
900573|NCT01147874|2969381|P1|Overall Study|Other|5
900574|NCT01147874|2969381|P1|Overall Study|Lost to Follow-up|25
900575|NCT01147874|2969381|P1|Overall Study|Investigator’s Request|1
900576|NCT01147874|2969381|P1|Overall Study|Adverse Event|5
900577|NCT01147848|2969389|P3|Randomized Phase|Withdrawal by Subject|9
900578|NCT01147848|2969390|P2|Randomized Phase|Withdrawal by Subject|7
900579|NCT01147848|2969391|P1|Randomized Phase|Withdrawal by Subject|0
900580|NCT01147848|2969389|P3|Randomized Phase|Physician Decision|1
900581|NCT01147848|2969390|P2|Randomized Phase|Physician Decision|0
900582|NCT01147848|2969391|P1|Randomized Phase|Physician Decision|0
900583|NCT01147848|2969389|P3|Randomized Phase|Lost to Follow-up|7
900584|NCT01147848|2969390|P2|Randomized Phase|Lost to Follow-up|5
900585|NCT01147848|2969391|P1|Randomized Phase|Lost to Follow-up|0
900586|NCT01147848|2969389|P3|Randomized Phase|Protocol Violation|10
900587|NCT01147848|2969390|P2|Randomized Phase|Protocol Violation|7
900588|NCT01147848|2969391|P1|Randomized Phase|Protocol Violation|0
900589|NCT01147848|2969389|P3|Randomized Phase|Lack of Efficacy|11
900590|NCT01147848|2969390|P2|Randomized Phase|Lack of Efficacy|20
900591|NCT01147848|2969391|P1|Randomized Phase|Lack of Efficacy|0
900592|NCT01147848|2969389|P3|Randomized Phase|Adverse Event|8
900593|NCT01147848|2969390|P2|Randomized Phase|Adverse Event|6
900594|NCT01147848|2969391|P1|Randomized Phase|Adverse Event|0
900595|NCT01147848|2969389|P3|Run-in Period|Run-in Failure|0
900596|NCT01147848|2969390|P2|Run-in Period|Run-in Failure|0
900597|NCT01147848|2969391|P1|Run-in Period|Run-in Failure|135
900598|NCT01147848|2969389|P3|Run-in Period|Screen Failure|0
900599|NCT01147848|2969390|P2|Run-in Period|Screen Failure|0
900600|NCT01147848|2969391|P1|Run-in Period|Screen Failure|623
900601|NCT01147822|2969423|P2|Overall Study|Not Completed/Ongoing|102
900602|NCT01147822|2969424|P1|Overall Study|Not Completed/Ongoing|111
900603|NCT01147822|2969423|P2|Overall Study|Withdrawal by Subject|13
900604|NCT01147822|2969424|P1|Overall Study|Withdrawal by Subject|8
900605|NCT01147822|2969423|P2|Overall Study|Physician Decision|2
900606|NCT01147822|2969424|P1|Overall Study|Physician Decision|0
900607|NCT01147822|2969423|P2|Overall Study|Lost to Follow-up|2
900608|NCT01147822|2969424|P1|Overall Study|Lost to Follow-up|3
900609|NCT01147822|2969423|P2|Overall Study|Protocol Violation|1
900610|NCT01147822|2969424|P1|Overall Study|Protocol Violation|0
900611|NCT01147822|2969423|P2|Overall Study|Death|59
900612|NCT01147822|2969424|P1|Overall Study|Death|66
900613|NCT01147809|2969444|P6|Phase II (168 Days)|Ongoing|0
900614|NCT01147809|2969445|P5|Phase II (168 Days)|Ongoing|1
900615|NCT01147809|2969446|P4|Phase II (168 Days)|Ongoing|0
900616|NCT01147809|2969447|P3|Phase II (168 Days)|Ongoing|0
900617|NCT01147809|2969448|P2|Phase II (168 Days)|Ongoing|0
900618|NCT01147809|2969449|P1|Phase II (168 Days)|Ongoing|0
900619|NCT01147809|2969444|P6|Phase II (168 Days)|Withdrawal by Subject|15
900620|NCT01147809|2969445|P5|Phase II (168 Days)|Withdrawal by Subject|7
900621|NCT01147809|2969446|P4|Phase II (168 Days)|Withdrawal by Subject|0
900622|NCT01147809|2969447|P3|Phase II (168 Days)|Withdrawal by Subject|0
900623|NCT01147809|2969448|P2|Phase II (168 Days)|Withdrawal by Subject|0
900624|NCT01147809|2969449|P1|Phase II (168 Days)|Withdrawal by Subject|0
900625|NCT01147809|2969444|P6|Phase II (168 Days)|Physician Decision|11
900626|NCT01147809|2969445|P5|Phase II (168 Days)|Physician Decision|5
900627|NCT01147809|2969446|P4|Phase II (168 Days)|Physician Decision|0
900628|NCT01147809|2969447|P3|Phase II (168 Days)|Physician Decision|0
900629|NCT01147809|2969448|P2|Phase II (168 Days)|Physician Decision|0
900630|NCT01147809|2969449|P1|Phase II (168 Days)|Physician Decision|0
900631|NCT01147809|2969444|P6|Phase II (168 Days)|Protocol Violation|1
900632|NCT01147809|2969445|P5|Phase II (168 Days)|Protocol Violation|0
900633|NCT01147809|2969446|P4|Phase II (168 Days)|Protocol Violation|0
900634|NCT01147809|2969447|P3|Phase II (168 Days)|Protocol Violation|0
900635|NCT01147809|2969448|P2|Phase II (168 Days)|Protocol Violation|0
900636|NCT01147809|2969449|P1|Phase II (168 Days)|Protocol Violation|0
900637|NCT01147809|2969444|P6|Phase II (168 Days)|Adverse Event|6
900638|NCT01147809|2969445|P5|Phase II (168 Days)|Adverse Event|3
900639|NCT01147809|2969446|P4|Phase II (168 Days)|Adverse Event|0
900640|NCT01147809|2969447|P3|Phase II (168 Days)|Adverse Event|0
900641|NCT01147809|2969448|P2|Phase II (168 Days)|Adverse Event|0
900642|NCT01147809|2969449|P1|Phase II (168 Days)|Adverse Event|0
900643|NCT01147809|2969444|P6|Phase I (168 Days)|Withdrawal by Subject|0
900644|NCT01147809|2969445|P5|Phase I (168 Days)|Withdrawal by Subject|0
900645|NCT01147809|2969446|P4|Phase I (168 Days)|Withdrawal by Subject|3
900646|NCT01147809|2969447|P3|Phase I (168 Days)|Withdrawal by Subject|0
900647|NCT01147809|2969448|P2|Phase I (168 Days)|Withdrawal by Subject|0
900648|NCT01147809|2969449|P1|Phase I (168 Days)|Withdrawal by Subject|0
900649|NCT01147809|2969444|P6|Phase I (168 Days)|Physician Decision|0
900650|NCT01147809|2969445|P5|Phase I (168 Days)|Physician Decision|0
900651|NCT01147809|2969446|P4|Phase I (168 Days)|Physician Decision|0
900652|NCT01147809|2969447|P3|Phase I (168 Days)|Physician Decision|2
900653|NCT01147809|2969448|P2|Phase I (168 Days)|Physician Decision|1
900654|NCT01147809|2969449|P1|Phase I (168 Days)|Physician Decision|0
900655|NCT01147809|2969444|P6|Phase I (168 Days)|Lost to Follow-up|0
900656|NCT01147809|2969445|P5|Phase I (168 Days)|Lost to Follow-up|0
900657|NCT01147809|2969446|P4|Phase I (168 Days)|Lost to Follow-up|1
900658|NCT01147809|2969447|P3|Phase I (168 Days)|Lost to Follow-up|0
900659|NCT01147809|2969448|P2|Phase I (168 Days)|Lost to Follow-up|0
900660|NCT01147809|2969449|P1|Phase I (168 Days)|Lost to Follow-up|1
900661|NCT01147809|2969444|P6|Phase I (168 Days)|Adverse Event|0
900662|NCT01147809|2969445|P5|Phase I (168 Days)|Adverse Event|0
900663|NCT01147809|2969446|P4|Phase I (168 Days)|Adverse Event|1
900664|NCT01147809|2969447|P3|Phase I (168 Days)|Adverse Event|0
900665|NCT01147809|2969448|P2|Phase I (168 Days)|Adverse Event|0
900666|NCT01147809|2969449|P1|Phase I (168 Days)|Adverse Event|0
900667|NCT01147744|2969570|P7|Overall Study|Met Protocol-defined Stopping Criteria|0
900668|NCT01147744|2969571|P6|Overall Study|Met Protocol-defined Stopping Criteria|1
900669|NCT01147744|2969572|P5|Overall Study|Met Protocol-defined Stopping Criteria|0
900670|NCT01147744|2969573|P4|Overall Study|Met Protocol-defined Stopping Criteria|0
900671|NCT01147744|2969574|P3|Overall Study|Met Protocol-defined Stopping Criteria|0
900672|NCT01147744|2969575|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
900673|NCT01147744|2969576|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
900674|NCT01147744|2969570|P7|Overall Study|Sponsor decision to amend protocol|6
900675|NCT01147744|2969571|P6|Overall Study|Sponsor decision to amend protocol|2
900676|NCT01147744|2969572|P5|Overall Study|Sponsor decision to amend protocol|7
900677|NCT01147744|2969573|P4|Overall Study|Sponsor decision to amend protocol|5
900678|NCT01147744|2969574|P3|Overall Study|Sponsor decision to amend protocol|2
900679|NCT01147744|2969575|P2|Overall Study|Sponsor decision to amend protocol|4
900680|NCT01147744|2969576|P1|Overall Study|Sponsor decision to amend protocol|7
900681|NCT01147744|2969570|P7|Overall Study|Lost to Follow-up|0
900682|NCT01147744|2969571|P6|Overall Study|Lost to Follow-up|0
900683|NCT01147744|2969572|P5|Overall Study|Lost to Follow-up|0
900684|NCT01147744|2969573|P4|Overall Study|Lost to Follow-up|0
900685|NCT01147744|2969574|P3|Overall Study|Lost to Follow-up|0
900686|NCT01147744|2969575|P2|Overall Study|Lost to Follow-up|1
900687|NCT01147744|2969576|P1|Overall Study|Lost to Follow-up|0
900688|NCT01147744|2969570|P7|Overall Study|Withdrawal by Subject|2
900689|NCT01147744|2969571|P6|Overall Study|Withdrawal by Subject|5
900690|NCT01147744|2969572|P5|Overall Study|Withdrawal by Subject|2
900691|NCT01147744|2969573|P4|Overall Study|Withdrawal by Subject|2
900692|NCT01147744|2969574|P3|Overall Study|Withdrawal by Subject|2
900693|NCT01147744|2969575|P2|Overall Study|Withdrawal by Subject|4
900694|NCT01147744|2969576|P1|Overall Study|Withdrawal by Subject|8
900695|NCT01147744|2969570|P7|Overall Study|Adverse Event|2
900696|NCT01147744|2969571|P6|Overall Study|Adverse Event|1
900697|NCT01147744|2969572|P5|Overall Study|Adverse Event|2
900698|NCT01147744|2969573|P4|Overall Study|Adverse Event|0
900699|NCT01147744|2969574|P3|Overall Study|Adverse Event|3
900700|NCT01147744|2969575|P2|Overall Study|Adverse Event|2
900701|NCT01147744|2969576|P1|Overall Study|Adverse Event|1
900702|NCT01147744|2969570|P7|Overall Study|Lack of Efficacy|7
900703|NCT01147744|2969571|P6|Overall Study|Lack of Efficacy|8
900704|NCT01147744|2969572|P5|Overall Study|Lack of Efficacy|13
900705|NCT01147744|2969573|P4|Overall Study|Lack of Efficacy|11
900706|NCT01147744|2969574|P3|Overall Study|Lack of Efficacy|9
900707|NCT01147744|2969575|P2|Overall Study|Lack of Efficacy|11
900708|NCT01147744|2969576|P1|Overall Study|Lack of Efficacy|11
900709|NCT01147744|2969570|P7|Overall Study|Physician Decision|1
900710|NCT01147744|2969571|P6|Overall Study|Physician Decision|0
900711|NCT01147744|2969572|P5|Overall Study|Physician Decision|0
900712|NCT01147744|2969573|P4|Overall Study|Physician Decision|0
900713|NCT01147744|2969574|P3|Overall Study|Physician Decision|1
900714|NCT01147744|2969575|P2|Overall Study|Physician Decision|1
900715|NCT01147744|2969576|P1|Overall Study|Physician Decision|0
900716|NCT01147744|2969570|P7|Overall Study|Protocol Violation|1
900717|NCT01147744|2969571|P6|Overall Study|Protocol Violation|3
900718|NCT01147744|2969572|P5|Overall Study|Protocol Violation|1
900719|NCT01147744|2969573|P4|Overall Study|Protocol Violation|0
900720|NCT01147744|2969574|P3|Overall Study|Protocol Violation|1
900721|NCT01147744|2969575|P2|Overall Study|Protocol Violation|0
900722|NCT01147744|2969576|P1|Overall Study|Protocol Violation|1
900723|NCT01147653|2969671|P2|Year 2|Withdrawal by Subject|3
900724|NCT01147653|2969672|P1|Year 2|Withdrawal by Subject|2
900725|NCT01147640|2969733|P2|Overall Study|Didn't meet eligibility criteria|0
900726|NCT01147640|2969734|P1|Overall Study|Didn't meet eligibility criteria|1
900727|NCT01147640|2969733|P2|Overall Study|Lost to Follow-up|1
900728|NCT01147640|2969734|P1|Overall Study|Lost to Follow-up|0
900729|NCT01147640|2969733|P2|Overall Study|Withdrawal by Subject|0
900730|NCT01147640|2969734|P1|Overall Study|Withdrawal by Subject|1
900731|NCT01147640|2969733|P2|Overall Study|Physician Decision|0
900732|NCT01147640|2969734|P1|Overall Study|Physician Decision|1
900733|NCT01147640|2969733|P2|Overall Study|Adverse Event|0
900734|NCT01147640|2969734|P1|Overall Study|Adverse Event|2
900735|NCT01147497|2969766|P2|Overall Study|failed insertion|0
900736|NCT01147497|2969767|P1|Overall Study|failed insertion|2
900737|NCT01147471|2969787|P2|6 Month Follow Up|Lost to Follow-up|2
900738|NCT01147471|2969788|P1|6 Month Follow Up|Lost to Follow-up|4
900739|NCT01147471|2969787|P2|3 Month Follow Up|Physician Decision|1
900740|NCT01147471|2969788|P1|3 Month Follow Up|Physician Decision|0
900741|NCT01147471|2969787|P2|3 Month Follow Up|Lost to Follow-up|1
900742|NCT01147471|2969788|P1|3 Month Follow Up|Lost to Follow-up|1
900743|NCT01147471|2969787|P2|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1
900744|NCT01147471|2969788|P1|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0
900745|NCT01147471|2969787|P2|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1
900907|NCT01146613|2970211|P1|Overall Study|Withdrawal by Subject|0
900746|NCT01147471|2969788|P1|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0
900747|NCT01147471|2969787|P2|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1
900748|NCT01147471|2969788|P1|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0
900749|NCT01147458|2969802|P4|Second Intervention|Other|0
900750|NCT01147458|2969803|P3|Second Intervention|Other|1
900751|NCT01147458|2969804|P2|Second Intervention|Other|0
900752|NCT01147458|2969805|P1|Second Intervention|Other|0
900753|NCT01147458|2969802|P4|Second Intervention|Adverse Event|1
900754|NCT01147458|2969803|P3|Second Intervention|Adverse Event|1
900755|NCT01147458|2969804|P2|Second Intervention|Adverse Event|0
900756|NCT01147458|2969805|P1|Second Intervention|Adverse Event|2
900757|NCT01147458|2969802|P4|Second Intervention|Withdrawal by Subject|0
900758|NCT01147458|2969803|P3|Second Intervention|Withdrawal by Subject|0
900759|NCT01147458|2969804|P2|Second Intervention|Withdrawal by Subject|1
900760|NCT01147458|2969805|P1|Second Intervention|Withdrawal by Subject|0
900761|NCT01147458|2969802|P4|Second Intervention|Protocol Violation|0
900762|NCT01147458|2969803|P3|Second Intervention|Protocol Violation|1
900763|NCT01147458|2969804|P2|Second Intervention|Protocol Violation|1
900764|NCT01147458|2969805|P1|Second Intervention|Protocol Violation|0
900765|NCT01147458|2969802|P4|Second Intervention|Study terminated by sponsor|3
900766|NCT01147458|2969803|P3|Second Intervention|Study terminated by sponsor|5
900767|NCT01147458|2969804|P2|Second Intervention|Study terminated by sponsor|5
900768|NCT01147458|2969805|P1|Second Intervention|Study terminated by sponsor|7
900769|NCT01147458|2969802|P4|First Intervention|Other|0
900770|NCT01147458|2969803|P3|First Intervention|Other|0
900771|NCT01147458|2969804|P2|First Intervention|Other|2
900772|NCT01147458|2969805|P1|First Intervention|Other|1
900773|NCT01147458|2969802|P4|First Intervention|Adverse Event|3
900774|NCT01147458|2969803|P3|First Intervention|Adverse Event|2
900775|NCT01147458|2969804|P2|First Intervention|Adverse Event|3
900776|NCT01147458|2969805|P1|First Intervention|Adverse Event|0
900777|NCT01147458|2969802|P4|First Intervention|Withdrawal by Subject|0
900778|NCT01147458|2969803|P3|First Intervention|Withdrawal by Subject|1
900779|NCT01147458|2969804|P2|First Intervention|Withdrawal by Subject|0
900780|NCT01147458|2969805|P1|First Intervention|Withdrawal by Subject|3
900781|NCT01147458|2969802|P4|First Intervention|Protocol Violation|3
900782|NCT01147458|2969803|P3|First Intervention|Protocol Violation|2
900783|NCT01147458|2969804|P2|First Intervention|Protocol Violation|3
900784|NCT01147458|2969805|P1|First Intervention|Protocol Violation|2
900785|NCT01147458|2969802|P4|First Intervention|Study terminated by sponsor|8
900786|NCT01147458|2969803|P3|First Intervention|Study terminated by sponsor|7
900787|NCT01147458|2969804|P2|First Intervention|Study terminated by sponsor|8
900788|NCT01147458|2969805|P1|First Intervention|Study terminated by sponsor|8
900789|NCT01147393|2969884|P1|Dose Level -1|Dose Limited Toxicity|1
900790|NCT01147393|2969884|P1|Dose Level 1|Dose limiting Toxicity|2
900791|NCT01147341|2969905|P2|Open Label Period|Subject moved|0
900792|NCT01147341|2969906|P1|Open Label Period|Subject moved|1
900793|NCT01147341|2969905|P2|Open Label Period|Lack of Efficacy|0
900794|NCT01147341|2969906|P1|Open Label Period|Lack of Efficacy|3
900795|NCT01147341|2969905|P2|Double Blind Period|Withdrawal by Subject|1
900796|NCT01147341|2969906|P1|Double Blind Period|Withdrawal by Subject|0
900797|NCT01147341|2969905|P2|Double Blind Period|Lack of Efficacy|1
900798|NCT01147341|2969906|P1|Double Blind Period|Lack of Efficacy|1
900799|NCT01147250|2969969|P2|Overall Study|Other than specified|1
900800|NCT01147250|2969970|P1|Overall Study|Other than specified|0
900801|NCT01147250|2969969|P2|Overall Study|Site termination by sponsor|5
900802|NCT01147250|2969970|P1|Overall Study|Site termination by sponsor|13
900803|NCT01147250|2969969|P2|Overall Study|Withdrawal by Subject|88
900804|NCT01147250|2969970|P1|Overall Study|Withdrawal by Subject|83
900805|NCT01147250|2969969|P2|Overall Study|Lost to Follow-up|11
900806|NCT01147250|2969970|P1|Overall Study|Lost to Follow-up|14
900807|NCT01147172|2969982|P1|Overall Study|Lost to Follow-up|2
900808|NCT01147172|2969982|P1|Overall Study|Withdrawal by Subject|2
900809|NCT01147068|2970000|P7|Subjects That Completed Safety Follow-up|Ineligible|0
900810|NCT01147068|2970001|P6|Subjects That Completed Safety Follow-up|Ineligible|0
900811|NCT01147068|2970002|P5|Subjects That Completed Safety Follow-up|Ineligible|0
900812|NCT01147068|2970003|P4|Subjects That Completed Safety Follow-up|Ineligible|0
900813|NCT01147068|2970004|P3|Subjects That Completed Safety Follow-up|Ineligible|0
900814|NCT01147068|2970005|P2|Subjects That Completed Safety Follow-up|Ineligible|1
900815|NCT01147068|2970006|P1|Subjects That Completed Safety Follow-up|Ineligible|0
900816|NCT01147068|2970000|P7|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
900817|NCT01147068|2970001|P6|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
900818|NCT01147068|2970002|P5|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
900819|NCT01147068|2970003|P4|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2
900820|NCT01147068|2970004|P3|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
900821|NCT01147068|2970005|P2|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
900822|NCT01147068|2970006|P1|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
900823|NCT01147068|2970000|P7|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
900824|NCT01147068|2970001|P6|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
900825|NCT01147068|2970002|P5|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
900826|NCT01147068|2970003|P4|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
900827|NCT01147068|2970004|P3|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
900828|NCT01147068|2970005|P2|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
900829|NCT01147068|2970006|P1|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
900830|NCT01147068|2970000|P7|Subjects That Received 2nd Dose|Other|0
900831|NCT01147068|2970001|P6|Subjects That Received 2nd Dose|Other|0
900832|NCT01147068|2970002|P5|Subjects That Received 2nd Dose|Other|1
900833|NCT01147068|2970003|P4|Subjects That Received 2nd Dose|Other|0
900834|NCT01147068|2970004|P3|Subjects That Received 2nd Dose|Other|3
900835|NCT01147068|2970005|P2|Subjects That Received 2nd Dose|Other|3
900836|NCT01147068|2970006|P1|Subjects That Received 2nd Dose|Other|0
900837|NCT01147068|2970000|P7|Subjects That Received 2nd Dose|Did not complete the study|0
900838|NCT01147068|2970001|P6|Subjects That Received 2nd Dose|Did not complete the study|1
900839|NCT01147068|2970002|P5|Subjects That Received 2nd Dose|Did not complete the study|0
900840|NCT01147068|2970003|P4|Subjects That Received 2nd Dose|Did not complete the study|0
900841|NCT01147068|2970004|P3|Subjects That Received 2nd Dose|Did not complete the study|0
900842|NCT01147068|2970005|P2|Subjects That Received 2nd Dose|Did not complete the study|1
900843|NCT01147068|2970006|P1|Subjects That Received 2nd Dose|Did not complete the study|0
900844|NCT01147068|2970000|P7|Subjects That Received 2nd Dose|Ineligible|0
900845|NCT01147068|2970001|P6|Subjects That Received 2nd Dose|Ineligible|0
900846|NCT01147068|2970002|P5|Subjects That Received 2nd Dose|Ineligible|0
900847|NCT01147068|2970003|P4|Subjects That Received 2nd Dose|Ineligible|0
900848|NCT01147068|2970004|P3|Subjects That Received 2nd Dose|Ineligible|0
900849|NCT01147068|2970005|P2|Subjects That Received 2nd Dose|Ineligible|1
900850|NCT01147068|2970006|P1|Subjects That Received 2nd Dose|Ineligible|0
900851|NCT01147068|2970000|P7|Subjects That Received 2nd Dose|Lost to Follow-up|0
900852|NCT01147068|2970001|P6|Subjects That Received 2nd Dose|Lost to Follow-up|1
900853|NCT01147068|2970002|P5|Subjects That Received 2nd Dose|Lost to Follow-up|0
900854|NCT01147068|2970003|P4|Subjects That Received 2nd Dose|Lost to Follow-up|0
900855|NCT01147068|2970004|P3|Subjects That Received 2nd Dose|Lost to Follow-up|0
900856|NCT01147068|2970005|P2|Subjects That Received 2nd Dose|Lost to Follow-up|0
900857|NCT01147068|2970006|P1|Subjects That Received 2nd Dose|Lost to Follow-up|1
900858|NCT01147055|2970036|P2|First Intervention Period|Lost to Follow-up|0
900859|NCT01147055|2970037|P1|First Intervention Period|Lost to Follow-up|1
900860|NCT01146951|2970079|P2|Overall Study|Adverse Event|1
900861|NCT01146951|2970080|P1|Overall Study|Adverse Event|4
900862|NCT01146912|2970101|P8|Overall Study|Duplicate patient|0
900863|NCT01146912|2970102|P7|Overall Study|Duplicate patient|0
900864|NCT01146912|2970103|P6|Overall Study|Duplicate patient|0
900865|NCT01146912|2970104|P5|Overall Study|Duplicate patient|0
900866|NCT01146912|2970105|P4|Overall Study|Duplicate patient|0
900867|NCT01146912|2970106|P3|Overall Study|Duplicate patient|1
900868|NCT01146912|2970107|P2|Overall Study|Duplicate patient|0
900869|NCT01146912|2970108|P1|Overall Study|Duplicate patient|0
900870|NCT01146912|2970101|P8|Overall Study|< 14 weeks gestational age|0
900871|NCT01146912|2970102|P7|Overall Study|< 14 weeks gestational age|0
900872|NCT01146912|2970103|P6|Overall Study|< 14 weeks gestational age|0
900873|NCT01146912|2970104|P5|Overall Study|< 14 weeks gestational age|0
900874|NCT01146912|2970105|P4|Overall Study|< 14 weeks gestational age|2
900875|NCT01146912|2970106|P3|Overall Study|< 14 weeks gestational age|3
900876|NCT01146912|2970107|P2|Overall Study|< 14 weeks gestational age|0
900877|NCT01146912|2970108|P1|Overall Study|< 14 weeks gestational age|0
900878|NCT01146912|2970101|P8|Overall Study|Already received influenza vaccination|0
900879|NCT01146912|2970102|P7|Overall Study|Already received influenza vaccination|56
900880|NCT01146912|2970103|P6|Overall Study|Already received influenza vaccination|61
900881|NCT01146912|2970104|P5|Overall Study|Already received influenza vaccination|41
900882|NCT01146912|2970105|P4|Overall Study|Already received influenza vaccination|15
900883|NCT01146912|2970106|P3|Overall Study|Already received influenza vaccination|13
900884|NCT01146912|2970107|P2|Overall Study|Already received influenza vaccination|822
900885|NCT01146912|2970108|P1|Overall Study|Already received influenza vaccination|817
900886|NCT01146873|2970130|P2|Overall Study|Transfer out|6
900887|NCT01146873|2970131|P1|Overall Study|Transfer out|0
900888|NCT01146860|2970147|P2|Overall Study|Withdrawal by Subject|1
900889|NCT01146860|2970148|P1|Overall Study|Withdrawal by Subject|0
900890|NCT01146782|2970168|P1|Primary Endpoint Cohort|Physician Decision|1
900891|NCT01146782|2970168|P1|Primary Endpoint Cohort|Withdrawal by Subject|5
900892|NCT01146782|2970168|P1|Safety Cohort|TST <4 hrs|14
900893|NCT01146782|2970168|P1|Safety Cohort|Control AHI <5|4
900894|NCT01146782|2970168|P1|Safety Cohort|Withdrawal by Subject|4
900895|NCT01146782|2970168|P1|Safety Cohort|Screen Failure|61
900896|NCT01146782|2970168|P1|Screening Cohort|Withdrawal by Subject|29
900897|NCT01146782|2970168|P1|Screening Cohort|Physician Decision|1
900898|NCT01146782|2970168|P1|Screening Cohort|Lost to Follow-up|4
900899|NCT01146782|2970168|P1|Screening Cohort|Screen Failure|187
900900|NCT01146665|2970177|P2|Overall Study|Withdrawal by Subject|16
900901|NCT01146665|2970178|P1|Overall Study|Withdrawal by Subject|10
900902|NCT01146613|2970210|P2|Overall Study|Outpatient detox|0
900903|NCT01146613|2970211|P1|Overall Study|Outpatient detox|1
900904|NCT01146613|2970210|P2|Overall Study|schedule conflict|0
900905|NCT01146613|2970211|P1|Overall Study|schedule conflict|1
900906|NCT01146613|2970210|P2|Overall Study|Withdrawal by Subject|3
900908|NCT01146613|2970210|P2|Overall Study|Physician Decision|0
900909|NCT01146613|2970211|P1|Overall Study|Physician Decision|1
900910|NCT01146613|2970210|P2|Overall Study|Death|0
900911|NCT01146613|2970211|P1|Overall Study|Death|1
900912|NCT01146613|2970210|P2|Overall Study|Lack of Efficacy|1
900913|NCT01146613|2970211|P1|Overall Study|Lack of Efficacy|0
900914|NCT01146613|2970210|P2|Overall Study|Lost to Follow-up|8
900915|NCT01146613|2970211|P1|Overall Study|Lost to Follow-up|3
900916|NCT01146288|2970302|P2|First Intervention(1 Day)|Adverse Event|1
900917|NCT01146288|2970303|P1|First Intervention(1 Day)|Adverse Event|0
900918|NCT01146054|2970317|P1|Overall Study|Lost to Follow-up|1
900919|NCT01146054|2970317|P1|Overall Study|Other illness precluded treatment|2
900920|NCT01146054|2970317|P1|Overall Study|Rapid tumor progression|2
900921|NCT01146054|2970317|P1|Overall Study|Did not meet dose constraints for SBRT|5
900922|NCT01145898|2970327|P2|3-year Treatment|medication change by treating physician|16
900923|NCT01145898|2970328|P1|3-year Treatment|medication change by treating physician|3
900924|NCT01145755|2970362|P3|Overall Study|Positive urine ethanol|0
900925|NCT01145755|2970363|P2|Overall Study|Positive urine ethanol|1
900926|NCT01145755|2970364|P1|Overall Study|Positive urine ethanol|0
900927|NCT01145755|2970362|P3|Overall Study|Withdrawal by Subject|1
900928|NCT01145755|2970363|P2|Overall Study|Withdrawal by Subject|0
900929|NCT01145755|2970364|P1|Overall Study|Withdrawal by Subject|0
900930|NCT01145755|2970362|P3|Overall Study|Patient could not swollow medication|1
900931|NCT01145755|2970363|P2|Overall Study|Patient could not swollow medication|0
900932|NCT01145755|2970364|P1|Overall Study|Patient could not swollow medication|0
900933|NCT01145755|2970362|P3|Overall Study|Lack of Efficacy|0
900934|NCT01145755|2970363|P2|Overall Study|Lack of Efficacy|1
900935|NCT01145755|2970364|P1|Overall Study|Lack of Efficacy|0
900936|NCT01145755|2970362|P3|Overall Study|Study Closure|17
900937|NCT01145755|2970363|P2|Overall Study|Study Closure|14
900938|NCT01145755|2970364|P1|Overall Study|Study Closure|14
900939|NCT01145755|2970362|P3|Overall Study|Protocol Violation|1
900940|NCT01145755|2970363|P2|Overall Study|Protocol Violation|3
900941|NCT01145755|2970364|P1|Overall Study|Protocol Violation|0
900942|NCT01145755|2970362|P3|Overall Study|Lost to Follow-up|1
900943|NCT01145755|2970363|P2|Overall Study|Lost to Follow-up|3
900944|NCT01145755|2970364|P1|Overall Study|Lost to Follow-up|2
900945|NCT01145755|2970362|P3|Overall Study|Withdrawal by Subject|2
900946|NCT01145755|2970363|P2|Overall Study|Withdrawal by Subject|2
900947|NCT01145755|2970364|P1|Overall Study|Withdrawal by Subject|2
900948|NCT01145755|2970362|P3|Overall Study|Adverse Event|2
900949|NCT01145755|2970363|P2|Overall Study|Adverse Event|4
900950|NCT01145755|2970364|P1|Overall Study|Adverse Event|2
900951|NCT01145625|2970391|P2|Overall Study|Pregnancy|1
900952|NCT01145625|2970392|P1|Overall Study|Pregnancy|0
900953|NCT01145625|2970391|P2|Overall Study|Withdrawal by Subject|16
900954|NCT01145625|2970392|P1|Overall Study|Withdrawal by Subject|7
900955|NCT01145625|2970391|P2|Overall Study|Protocol Violation|1
900956|NCT01145625|2970392|P1|Overall Study|Protocol Violation|3
900957|NCT01145625|2970391|P2|Overall Study|Adverse Event|4
900958|NCT01145625|2970392|P1|Overall Study|Adverse Event|6
900959|NCT01145625|2970391|P2|Overall Study|Lost to Follow-up|9
900960|NCT01145625|2970392|P1|Overall Study|Lost to Follow-up|8
900961|NCT01145560|2970405|P3|Overall Study|Withdrawal of therapy|1
900962|NCT01145560|2970406|P2|Overall Study|Withdrawal of therapy|0
900963|NCT01145560|2970407|P1|Overall Study|Withdrawal of therapy|0
900964|NCT01145560|2970405|P3|Overall Study|False insurance information|0
900965|NCT01145560|2970406|P2|Overall Study|False insurance information|1
900966|NCT01145560|2970407|P1|Overall Study|False insurance information|0
900967|NCT01145560|2970405|P3|Overall Study|Accidental unblinding of study treatment|0
900968|NCT01145560|2970406|P2|Overall Study|Accidental unblinding of study treatment|1
900969|NCT01145560|2970407|P1|Overall Study|Accidental unblinding of study treatment|0
900970|NCT01145560|2970405|P3|Overall Study|No study drug by 24h after organ failure|0
900971|NCT01145560|2970406|P2|Overall Study|No study drug by 24h after organ failure|0
900972|NCT01145560|2970407|P1|Overall Study|No study drug by 24h after organ failure|1
900973|NCT01145560|2970405|P3|Overall Study|Lost to Follow-up|1
900974|NCT01145560|2970406|P2|Overall Study|Lost to Follow-up|1
900975|NCT01145560|2970407|P1|Overall Study|Lost to Follow-up|1
900976|NCT01145560|2970405|P3|Overall Study|Withdrawal by Subject|0
900977|NCT01145560|2970406|P2|Overall Study|Withdrawal by Subject|1
900978|NCT01145560|2970407|P1|Overall Study|Withdrawal by Subject|2
900979|NCT01145508|2970433|P2|Overall Study|Never started treatment|1
900980|NCT01145508|2970434|P1|Overall Study|Never started treatment|1
900981|NCT01145508|2970433|P2|Overall Study|Physician Decision|1
900982|NCT01145508|2970434|P1|Overall Study|Physician Decision|2
900983|NCT01145508|2970433|P2|Overall Study|Death|0
900984|NCT01145508|2970434|P1|Overall Study|Death|1
900985|NCT01145508|2970433|P2|Overall Study|Adverse Event|0
900986|NCT01145508|2970434|P1|Overall Study|Adverse Event|1
900987|NCT01145495|2970440|P1|Overall Study|Disease progression after respone|1
900988|NCT01145495|2970440|P1|Overall Study|Withdrawal by Subject|5
900989|NCT01145495|2970440|P1|Overall Study|Adverse Event|6
900990|NCT01145482|2970446|P2|First Intervention (1 Day)|Withdrawal by Subject|1
900991|NCT01145482|2970447|P1|First Intervention (1 Day)|Withdrawal by Subject|0
900992|NCT01145417|2970457|P2|Overall Study|Other|0
900993|NCT01145417|2970458|P1|Overall Study|Other|1
900994|NCT01145417|2970457|P2|Overall Study|Study terminated by sponsor|43
900995|NCT01145417|2970458|P1|Overall Study|Study terminated by sponsor|35
900996|NCT01145417|2970457|P2|Overall Study|Adverse Event|1
900997|NCT01145417|2970458|P1|Overall Study|Adverse Event|0
900998|NCT01145417|2970457|P2|Overall Study|Pregnancy|0
900999|NCT01145417|2970458|P1|Overall Study|Pregnancy|1
901000|NCT01145417|2970457|P2|Overall Study|Withdrawal by Subject|2
901001|NCT01145417|2970458|P1|Overall Study|Withdrawal by Subject|1
901002|NCT01145417|2970457|P2|Overall Study|Lost to Follow-up|1
901003|NCT01145417|2970458|P1|Overall Study|Lost to Follow-up|2
901004|NCT01145417|2970457|P2|Overall Study|Death|0
901005|NCT01145417|2970458|P1|Overall Study|Death|1
901006|NCT01145352|2970491|P1|Overall Study|Syringe formulation was used|1
901007|NCT01145352|2970491|P1|Overall Study|Treated before marketing approval|4
901008|NCT01145352|2970491|P1|Overall Study|Found to have been registered twice|6
901009|NCT01145053|2970499|P1|Overall Study|Other|18
901010|NCT01145053|2970499|P1|Overall Study|Withdrawal by Subject|25
901011|NCT01145053|2970499|P1|Overall Study|Lost to Follow-up|28
901012|NCT01145053|2970499|P1|Overall Study|Adverse Event|22
901013|NCT01144715|2970551|P2|Overall Study|Adverse Event|1
901014|NCT01144715|2970552|P1|Overall Study|Adverse Event|0
901015|NCT01144715|2970551|P2|Overall Study|Withdrawal by Subject|1
901016|NCT01144715|2970552|P1|Overall Study|Withdrawal by Subject|2
901017|NCT01144715|2970551|P2|Overall Study|Lost to Follow-up|1
901018|NCT01144715|2970552|P1|Overall Study|Lost to Follow-up|2
901019|NCT01144416|2970621|P2|Intervention Period|Other|5
901020|NCT01144416|2970622|P1|Intervention Period|Other|7
901021|NCT01144416|2970621|P2|Intervention Period|No/too few/bad quality embryos|3
901022|NCT01144416|2970622|P1|Intervention Period|No/too few/bad quality embryos|3
901023|NCT01144416|2970621|P2|Intervention Period|No or abnormal fertilization|10
901024|NCT01144416|2970622|P1|Intervention Period|No or abnormal fertilization|25
901025|NCT01144416|2970621|P2|Intervention Period|No/too few/bad oocytes|5
901026|NCT01144416|2970622|P1|Intervention Period|No/too few/bad oocytes|7
901027|NCT01144416|2970621|P2|Intervention Period|Too high ovarian response|2
901028|NCT01144416|2970622|P1|Intervention Period|Too high ovarian response|4
901029|NCT01144416|2970621|P2|Intervention Period|Risk of OHSS|1
901030|NCT01144416|2970622|P1|Intervention Period|Risk of OHSS|0
901031|NCT01144416|2970621|P2|Intervention Period|Insufficient ovarian response|17
901032|NCT01144416|2970622|P1|Intervention Period|Insufficient ovarian response|11
901033|NCT01144416|2970621|P2|Intervention Period|Adverse Event|6
901034|NCT01144416|2970622|P1|Intervention Period|Adverse Event|5
901035|NCT01144403|2970638|P1|Overall Study|Adverse Event|1
901036|NCT01144403|2970638|P1|Overall Study|Death|1
901037|NCT01144403|2970638|P1|Overall Study|Lost to Follow-up|3
901038|NCT01144377|2970650|P5|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
901039|NCT01144377|2970651|P4|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
901040|NCT01144377|2970652|P3|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
901041|NCT01144377|2970653|P2|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
901042|NCT01144377|2970654|P1|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1
901043|NCT01144377|2970650|P5|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1
901044|NCT01144377|2970651|P4|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
901045|NCT01144377|2970652|P3|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
901046|NCT01144377|2970653|P2|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
901047|NCT01144377|2970654|P1|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
901048|NCT01144377|2970650|P5|Optional 40 Week Safety Follow-up Period|Adverse Event|1
901049|NCT01144377|2970651|P4|Optional 40 Week Safety Follow-up Period|Adverse Event|0
901050|NCT01144377|2970652|P3|Optional 40 Week Safety Follow-up Period|Adverse Event|0
901051|NCT01144377|2970653|P2|Optional 40 Week Safety Follow-up Period|Adverse Event|1
901052|NCT01144377|2970654|P1|Optional 40 Week Safety Follow-up Period|Adverse Event|0
901053|NCT01144377|2970650|P5|52 Week Treatment Period|Sponsor Decision|1
901054|NCT01144377|2970651|P4|52 Week Treatment Period|Sponsor Decision|0
901055|NCT01144377|2970652|P3|52 Week Treatment Period|Sponsor Decision|0
901056|NCT01144377|2970653|P2|52 Week Treatment Period|Sponsor Decision|0
901057|NCT01144377|2970654|P1|52 Week Treatment Period|Sponsor Decision|0
901058|NCT01144377|2970650|P5|52 Week Treatment Period|Withdrawal by Subject|0
901059|NCT01144377|2970651|P4|52 Week Treatment Period|Withdrawal by Subject|1
901060|NCT01144377|2970652|P3|52 Week Treatment Period|Withdrawal by Subject|1
901061|NCT01144377|2970653|P2|52 Week Treatment Period|Withdrawal by Subject|1
901062|NCT01144377|2970654|P1|52 Week Treatment Period|Withdrawal by Subject|4
901063|NCT01144377|2970650|P5|52 Week Treatment Period|Lost to Follow-up|0
901064|NCT01144377|2970651|P4|52 Week Treatment Period|Lost to Follow-up|0
901065|NCT01144377|2970652|P3|52 Week Treatment Period|Lost to Follow-up|0
901066|NCT01144377|2970653|P2|52 Week Treatment Period|Lost to Follow-up|0
901067|NCT01144377|2970654|P1|52 Week Treatment Period|Lost to Follow-up|1
901068|NCT01144377|2970650|P5|52 Week Treatment Period|Protocol Violation|1
901069|NCT01144377|2970651|P4|52 Week Treatment Period|Protocol Violation|0
901070|NCT01144377|2970652|P3|52 Week Treatment Period|Protocol Violation|0
901071|NCT01144377|2970653|P2|52 Week Treatment Period|Protocol Violation|0
901072|NCT01144377|2970654|P1|52 Week Treatment Period|Protocol Violation|0
901073|NCT01144377|2970650|P5|52 Week Treatment Period|Entry Criteria Not Met|0
901074|NCT01144377|2970651|P4|52 Week Treatment Period|Entry Criteria Not Met|1
901075|NCT01144377|2970652|P3|52 Week Treatment Period|Entry Criteria Not Met|1
901076|NCT01144377|2970653|P2|52 Week Treatment Period|Entry Criteria Not Met|0
901077|NCT01144377|2970654|P1|52 Week Treatment Period|Entry Criteria Not Met|0
901078|NCT01144377|2970650|P5|52 Week Treatment Period|Adverse Event|1
901079|NCT01144377|2970651|P4|52 Week Treatment Period|Adverse Event|2
901080|NCT01144377|2970652|P3|52 Week Treatment Period|Adverse Event|3
901081|NCT01144377|2970653|P2|52 Week Treatment Period|Adverse Event|0
901082|NCT01144377|2970654|P1|52 Week Treatment Period|Adverse Event|0
901083|NCT01144364|2970703|P3|Follow-Up/Maintenance Phase|Physician Decision|1
901084|NCT01144364|2970704|P2|Follow-Up/Maintenance Phase|Physician Decision|0
901085|NCT01144364|2970705|P1|Follow-Up/Maintenance Phase|Physician Decision|0
901086|NCT01144364|2970703|P3|Follow-Up/Maintenance Phase|Relapse|5
901087|NCT01144364|2970704|P2|Follow-Up/Maintenance Phase|Relapse|5
901088|NCT01144364|2970705|P1|Follow-Up/Maintenance Phase|Relapse|0
901089|NCT01144364|2970703|P3|Follow-Up/Maintenance Phase|Lost to Follow-up|4
901090|NCT01144364|2970704|P2|Follow-Up/Maintenance Phase|Lost to Follow-up|1
901091|NCT01144364|2970705|P1|Follow-Up/Maintenance Phase|Lost to Follow-up|0
901092|NCT01144364|2970703|P3|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
901093|NCT01144364|2970704|P2|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
901094|NCT01144364|2970705|P1|Follow-Up/Maintenance Phase|Withdrawal by Subject|0
901095|NCT01144364|2970703|P3|Follow-Up/Maintenance Phase|Death|0
901096|NCT01144364|2970704|P2|Follow-Up/Maintenance Phase|Death|2
901097|NCT01144364|2970705|P1|Follow-Up/Maintenance Phase|Death|0
901098|NCT01144364|2970703|P3|Follow-Up/Maintenance Phase|Adverse Event|1
901099|NCT01144364|2970704|P2|Follow-Up/Maintenance Phase|Adverse Event|3
901100|NCT01144364|2970705|P1|Follow-Up/Maintenance Phase|Adverse Event|0
901101|NCT01144364|2970703|P3|Follow-Up/Maintenance Phase|Disease progression|29
901102|NCT01144364|2970704|P2|Follow-Up/Maintenance Phase|Disease progression|23
901103|NCT01144364|2970705|P1|Follow-Up/Maintenance Phase|Disease progression|0
901104|NCT01144364|2970703|P3|Induction Phase|Protocol Violation|0
901105|NCT01144364|2970704|P2|Induction Phase|Protocol Violation|0
901106|NCT01144364|2970705|P1|Induction Phase|Protocol Violation|1
901107|NCT01144364|2970703|P3|Induction Phase|Secondary neoplasia|0
901108|NCT01144364|2970704|P2|Induction Phase|Secondary neoplasia|0
901109|NCT01144364|2970705|P1|Induction Phase|Secondary neoplasia|1
901110|NCT01144364|2970703|P3|Induction Phase|Stable disease|0
901111|NCT01144364|2970704|P2|Induction Phase|Stable disease|0
901112|NCT01144364|2970705|P1|Induction Phase|Stable disease|2
901113|NCT01144364|2970703|P3|Induction Phase|Physician Decision|0
901114|NCT01144364|2970704|P2|Induction Phase|Physician Decision|0
901115|NCT01144364|2970705|P1|Induction Phase|Physician Decision|1
901116|NCT01144364|2970703|P3|Induction Phase|Lost to Follow-up|0
901117|NCT01144364|2970704|P2|Induction Phase|Lost to Follow-up|0
901118|NCT01144364|2970705|P1|Induction Phase|Lost to Follow-up|2
901119|NCT01144364|2970703|P3|Induction Phase|Withdrawal by Subject|0
901120|NCT01144364|2970704|P2|Induction Phase|Withdrawal by Subject|0
901121|NCT01144364|2970705|P1|Induction Phase|Withdrawal by Subject|1
901122|NCT01144364|2970703|P3|Induction Phase|Death|0
901123|NCT01144364|2970704|P2|Induction Phase|Death|0
901124|NCT01144364|2970705|P1|Induction Phase|Death|1
901125|NCT01144364|2970703|P3|Induction Phase|Adverse Event|0
901126|NCT01144364|2970704|P2|Induction Phase|Adverse Event|0
901127|NCT01144364|2970705|P1|Induction Phase|Adverse Event|9
901128|NCT01144364|2970703|P3|Induction Phase|Disease progression|0
901129|NCT01144364|2970704|P2|Induction Phase|Disease progression|0
901130|NCT01144364|2970705|P1|Induction Phase|Disease progression|14
901131|NCT01144299|2970754|P2|Overall Study|Withdrawal by Subject|0
901132|NCT01144299|2970755|P1|Overall Study|Withdrawal by Subject|1
901133|NCT01144299|2970754|P2|Overall Study|Lost to Follow-up|0
901134|NCT01144299|2970755|P1|Overall Study|Lost to Follow-up|1
901135|NCT01144182|2970800|P2|Overall Study|Lost to Follow-up|9
901136|NCT01144182|2970801|P1|Overall Study|Lost to Follow-up|9
901137|NCT01144182|2970800|P2|Overall Study|Withdrawal by Subject|6
901138|NCT01144182|2970801|P1|Overall Study|Withdrawal by Subject|3
901139|NCT01144182|2970800|P2|Overall Study|Death|6
901140|NCT01144182|2970801|P1|Overall Study|Death|5
901141|NCT01144052|2970861|P2|Overall Study|Withdrawal by Subject|1
901142|NCT01144052|2970862|P1|Overall Study|Withdrawal by Subject|1
901143|NCT01143896|2970893|P2|Overall Study|Death|3
901144|NCT01143896|2970894|P1|Overall Study|Death|6
901145|NCT01143896|2970893|P2|Overall Study|Withdrawal by Subject|5
901146|NCT01143896|2970894|P1|Overall Study|Withdrawal by Subject|13
901147|NCT01143896|2970893|P2|Overall Study|Lost to Follow-up|13
901148|NCT01143896|2970894|P1|Overall Study|Lost to Follow-up|18
901149|NCT01143896|2970893|P2|Overall Study|Did not complete Baseline Interview|4
901150|NCT01143896|2970894|P1|Overall Study|Did not complete Baseline Interview|5
901151|NCT01143714|2971006|P2|Overall Study|wound size increased|0
901152|NCT01143714|2971007|P1|Overall Study|wound size increased|1
901153|NCT01143714|2971006|P2|Overall Study|wound closed = deemed healed|0
901154|NCT01143714|2971007|P1|Overall Study|wound closed = deemed healed|1
901155|NCT01143714|2971006|P2|Overall Study|Subject non-compliance|1
901156|NCT01143714|2971007|P1|Overall Study|Subject non-compliance|0
901157|NCT01143714|2971006|P2|Overall Study|Withdrawal by Subject|0
901158|NCT01143714|2971007|P1|Overall Study|Withdrawal by Subject|1
901159|NCT01143714|2971006|P2|Overall Study|Adverse Event|2
901160|NCT01143714|2971007|P1|Overall Study|Adverse Event|4
901161|NCT01143402|2971112|P3|Overall Study|Not Treated|1
901162|NCT01143402|2971113|P2|Overall Study|Not Treated|0
901163|NCT01143402|2971114|P1|Overall Study|Not Treated|0
901164|NCT01143402|2971112|P3|Overall Study|Rapid clinical decline|0
901165|NCT01143402|2971113|P2|Overall Study|Rapid clinical decline|1
901166|NCT01143402|2971114|P1|Overall Study|Rapid clinical decline|1
901167|NCT01143389|2971125|P2|Overall Study|Lost to Follow-up|25
901168|NCT01143389|2971126|P1|Overall Study|Lost to Follow-up|26
901169|NCT01143337|2971140|P3|Overall Study|Other reason|5
901170|NCT01143337|2971141|P2|Overall Study|Other reason|0
901171|NCT01143337|2971142|P1|Overall Study|Other reason|0
901172|NCT01143337|2971140|P3|Overall Study|Withdrawal by Subject|1
901173|NCT01143337|2971141|P2|Overall Study|Withdrawal by Subject|0
901174|NCT01143337|2971142|P1|Overall Study|Withdrawal by Subject|0
901175|NCT01143337|2971140|P3|Overall Study|Protocol Violation|0
901176|NCT01143337|2971141|P2|Overall Study|Protocol Violation|0
901177|NCT01143337|2971142|P1|Overall Study|Protocol Violation|1
901178|NCT01143337|2971140|P3|Overall Study|Lack of Efficacy|1
901179|NCT01143337|2971141|P2|Overall Study|Lack of Efficacy|2
901180|NCT01143337|2971142|P1|Overall Study|Lack of Efficacy|6
901181|NCT01143337|2971140|P3|Overall Study|Adverse Event|5
901182|NCT01143337|2971141|P2|Overall Study|Adverse Event|9
901183|NCT01143337|2971142|P1|Overall Study|Adverse Event|3
901184|NCT01143324|2971156|P1|Overall Study|Explant of the device|4
901185|NCT01143324|2971156|P1|Overall Study|Withdrawal by Subject|4
901186|NCT01143324|2971156|P1|Overall Study|Lost to Follow-up|11
901187|NCT01143259|2971195|P2|Overall Study|Screen Failure|9
901188|NCT01143259|2971196|P1|Overall Study|Screen Failure|7
901189|NCT01143259|2971195|P2|Overall Study|Protocol Violation|9
901190|NCT01143259|2971196|P1|Overall Study|Protocol Violation|13
901191|NCT01143259|2971195|P2|Overall Study|Withdrawal by Subject|2
901192|NCT01143259|2971196|P1|Overall Study|Withdrawal by Subject|3
901193|NCT01143207|2971204|P1|Overall Study|Lost to Follow-up|2
901194|NCT01143090|2971224|P1|Overall Study|Administrative|1
901195|NCT01143090|2971224|P1|Overall Study|Failure to meet eligibility criteria|1
901196|NCT01143090|2971224|P1|Overall Study|Non-compliance with study drug|1
901197|NCT01143090|2971224|P1|Overall Study|Withdrawal by Subject|18
901198|NCT01143090|2971224|P1|Overall Study|Protocol Violation|2
901199|NCT01143090|2971224|P1|Overall Study|Lost to Follow-up|9
901200|NCT01143090|2971224|P1|Overall Study|Adverse Event|17
901201|NCT01143090|2971224|P1|Overall Study|Lack of Efficacy|2
901202|NCT01143077|2971231|P3|Overall Study|Principal Investigator Decision|1
901203|NCT01143077|2971232|P2|Overall Study|Principal Investigator Decision|0
901204|NCT01143077|2971233|P1|Overall Study|Principal Investigator Decision|2
901205|NCT01143077|2971231|P3|Overall Study|Administrative|0
901206|NCT01143077|2971232|P2|Overall Study|Administrative|0
901207|NCT01143077|2971233|P1|Overall Study|Administrative|1
901208|NCT01143077|2971231|P3|Overall Study|Non-compliance with study drug|1
901209|NCT01143077|2971232|P2|Overall Study|Non-compliance with study drug|1
901210|NCT01143077|2971233|P1|Overall Study|Non-compliance with study drug|0
901211|NCT01143077|2971231|P3|Overall Study|Withdrawal by Subject|3
901212|NCT01143077|2971232|P2|Overall Study|Withdrawal by Subject|3
901213|NCT01143077|2971233|P1|Overall Study|Withdrawal by Subject|4
901214|NCT01143077|2971231|P3|Overall Study|Protocol Violation|0
901215|NCT01143077|2971232|P2|Overall Study|Protocol Violation|0
901216|NCT01143077|2971233|P1|Overall Study|Protocol Violation|2
901217|NCT01143077|2971231|P3|Overall Study|Lost to Follow-up|4
901218|NCT01143077|2971232|P2|Overall Study|Lost to Follow-up|3
901219|NCT01143077|2971233|P1|Overall Study|Lost to Follow-up|2
901220|NCT01143077|2971231|P3|Overall Study|Adverse Event|5
901221|NCT01143077|2971232|P2|Overall Study|Adverse Event|6
901222|NCT01143077|2971233|P1|Overall Study|Adverse Event|5
901223|NCT01143077|2971231|P3|Overall Study|Lack of Efficacy|1
901224|NCT01143077|2971232|P2|Overall Study|Lack of Efficacy|2
901225|NCT01143077|2971233|P1|Overall Study|Lack of Efficacy|0
901226|NCT01143051|2971250|P6|3-14 Day Washout|Withdrawal by Subject|1
901227|NCT01143051|2971251|P5|3-14 Day Washout|Withdrawal by Subject|0
901228|NCT01143051|2971252|P4|3-14 Day Washout|Withdrawal by Subject|0
901229|NCT01143051|2971253|P3|3-14 Day Washout|Withdrawal by Subject|0
901230|NCT01143051|2971254|P2|3-14 Day Washout|Withdrawal by Subject|0
901231|NCT01143051|2971255|P1|3-14 Day Washout|Withdrawal by Subject|0
901232|NCT01143051|2971250|P6|3-14 Day Washout|Withdrawal by Subject|0
901233|NCT01143051|2971251|P5|3-14 Day Washout|Withdrawal by Subject|0
901234|NCT01143051|2971252|P4|3-14 Day Washout|Withdrawal by Subject|0
901235|NCT01143051|2971253|P3|3-14 Day Washout|Withdrawal by Subject|1
901236|NCT01143051|2971254|P2|3-14 Day Washout|Withdrawal by Subject|0
901237|NCT01143051|2971255|P1|3-14 Day Washout|Withdrawal by Subject|0
901238|NCT01143038|2971304|P1|Overall Study|Death|1
901239|NCT01143038|2971304|P1|Overall Study|Protocol Deviation|1
901240|NCT01143038|2971304|P1|Overall Study|Lost to Follow-up|2
901241|NCT01143038|2971304|P1|Overall Study|Adverse Event|3
901242|NCT01143038|2971304|P1|Overall Study|Requirement for alternative therapy|5
901243|NCT01143038|2971304|P1|Overall Study|Withdrawal by Subject|4
901244|NCT01142908|2971314|P2|Overall Study|Withdrawal by Subject|0
901245|NCT01142908|2971315|P1|Overall Study|Withdrawal by Subject|3
901246|NCT01142908|2971314|P2|Overall Study|Excluded - did not meet criteria|5
901247|NCT01142908|2971315|P1|Overall Study|Excluded - did not meet criteria|9
901248|NCT01142908|2971314|P2|Overall Study|Death|4
901249|NCT01142908|2971315|P1|Overall Study|Death|1
901250|NCT01142908|2971314|P2|Overall Study|Lost to Follow-up|13
901251|NCT01142908|2971315|P1|Overall Study|Lost to Follow-up|19
901252|NCT01142726|2971364|P3|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
901253|NCT01142726|2971365|P2|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1
901254|NCT01142726|2971366|P1|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
901255|NCT01142726|2971364|P3|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1
901256|NCT01142726|2971365|P2|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
901257|NCT01142726|2971366|P1|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
901258|NCT01142726|2971364|P3|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
901259|NCT01142726|2971365|P2|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
901260|NCT01142726|2971366|P1|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
901261|NCT01142726|2971364|P3|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1
901262|NCT01142726|2971365|P2|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
901263|NCT01142726|2971366|P1|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
901264|NCT01142726|2971364|P3|Withdrawal Phase: Months 12 up to 24|non-specified|1
901265|NCT01142726|2971365|P2|Withdrawal Phase: Months 12 up to 24|non-specified|1
901266|NCT01142726|2971366|P1|Withdrawal Phase: Months 12 up to 24|non-specified|0
901267|NCT01142726|2971364|P3|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53
901268|NCT01142726|2971365|P2|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54
901269|NCT01142726|2971366|P1|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65
901270|NCT01142726|2971364|P3|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
901271|NCT01142726|2971365|P2|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
901272|NCT01142726|2971366|P1|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1
901273|NCT01142726|2971364|P3|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
901274|NCT01142726|2971365|P2|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
901275|NCT01142726|2971366|P1|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2
901276|NCT01142726|2971364|P3|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
901277|NCT01142726|2971365|P2|Withdrawal Phase: Months 12 up to 24|Pregnancy|0
901278|NCT01142726|2971366|P1|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
901279|NCT01142726|2971364|P3|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2
901280|NCT01142726|2971365|P2|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
901281|NCT01142726|2971366|P1|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
901282|NCT01142726|2971364|P3|Withdrawal Phase: Months 12 up to 24|Adverse Event|1
901283|NCT01142726|2971365|P2|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
901284|NCT01142726|2971366|P1|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
901285|NCT01142726|2971364|P3|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11
901286|NCT01142726|2971365|P2|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6
901287|NCT01142726|2971366|P1|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5
901288|NCT01142726|2971364|P3|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
901289|NCT01142726|2971365|P2|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
901290|NCT01142726|2971366|P1|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1
901291|NCT01142726|2971364|P3|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
901292|NCT01142726|2971365|P2|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2
901293|NCT01142726|2971366|P1|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
901294|NCT01142726|2971364|P3|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3
901295|NCT01142726|2971365|P2|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9
901296|NCT01142726|2971366|P1|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4
901297|NCT01142726|2971364|P3|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
901298|NCT01142726|2971365|P2|Treatment Phase: Day 1 Through Month 12|Adverse Event|8
901299|NCT01142726|2971366|P1|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
901300|NCT01142661|2971429|P1|Overall Study|Physician Decision|1
901301|NCT01142661|2971429|P1|Overall Study|Withdrawal by Subject|1
901302|NCT01142661|2971429|P1|Overall Study|Adverse Event|2
901303|NCT01142596|2971436|P2|Overall Study|Other reason (not specified)|4
901304|NCT01142596|2971437|P1|Overall Study|Other reason (not specified)|5
901305|NCT01142596|2971436|P2|Overall Study|Lost to Follow-up|3
901306|NCT01142596|2971437|P1|Overall Study|Lost to Follow-up|2
901307|NCT01142596|2971436|P2|Overall Study|Lack of Efficacy|9
901308|NCT01142596|2971437|P1|Overall Study|Lack of Efficacy|5
901309|NCT01142596|2971436|P2|Overall Study|Adverse Event|35
901310|NCT01142596|2971437|P1|Overall Study|Adverse Event|8
901311|NCT01142596|2971436|P2|Overall Study|Withdrawal by Subject|35
901312|NCT01142596|2971437|P1|Overall Study|Withdrawal by Subject|9
901313|NCT01142466|2971489|P2|Overall Study|Withdrawal by Subject|1
901314|NCT01142466|2971490|P1|Overall Study|Withdrawal by Subject|1
901315|NCT01142466|2971489|P2|Overall Study|Adverse Event|1
901316|NCT01142466|2971490|P1|Overall Study|Adverse Event|2
901317|NCT01142388|2971510|P2|Overall Study|Never started therapy|3
901318|NCT01142388|2971511|P1|Overall Study|Never started therapy|7
901319|NCT01142388|2971510|P2|Overall Study|Other|1
901320|NCT01142388|2971511|P1|Overall Study|Other|1
901321|NCT01142388|2971510|P2|Overall Study|Other complications|2
901322|NCT01142388|2971511|P1|Overall Study|Other complications|0
901323|NCT01142388|2971510|P2|Overall Study|Alternative therapy|0
901324|NCT01142388|2971511|P1|Overall Study|Alternative therapy|1
901325|NCT01142388|2971510|P2|Overall Study|Withdrawal by Subject|3
901326|NCT01142388|2971511|P1|Overall Study|Withdrawal by Subject|5
901327|NCT01142388|2971510|P2|Overall Study|Death|2
901328|NCT01142388|2971511|P1|Overall Study|Death|3
901329|NCT01142388|2971510|P2|Overall Study|Adverse Event|5
901330|NCT01142388|2971511|P1|Overall Study|Adverse Event|9
901331|NCT01142388|2971510|P2|Overall Study|Lack of Efficacy|31
901332|NCT01142388|2971511|P1|Overall Study|Lack of Efficacy|21
901333|NCT01142336|2971523|P2|Overall Study|Lost to Follow-up|1
901334|NCT01142336|2971524|P1|Overall Study|Lost to Follow-up|0
901335|NCT01142336|2971523|P2|Overall Study|Adverse Event|1
901336|NCT01142336|2971524|P1|Overall Study|Adverse Event|1
901337|NCT01142193|2971558|P2|Overall Study|Other|2
901338|NCT01142193|2971559|P1|Overall Study|Other|1
901339|NCT01142193|2971558|P2|Overall Study|Protocol Discontinuation Criterion Met|0
901340|NCT01142193|2971559|P1|Overall Study|Protocol Discontinuation Criterion Met|1
901341|NCT01142193|2971558|P2|Overall Study|Withdrawal by Subject|3
901342|NCT01142193|2971559|P1|Overall Study|Withdrawal by Subject|4
901343|NCT01142193|2971558|P2|Overall Study|Physician Decision|1
901344|NCT01142193|2971559|P1|Overall Study|Physician Decision|1
901345|NCT01142193|2971558|P2|Overall Study|Lack of Efficacy|1
901346|NCT01142193|2971559|P1|Overall Study|Lack of Efficacy|2
901347|NCT01142193|2971558|P2|Overall Study|Adverse Event|4
901348|NCT01142193|2971559|P1|Overall Study|Adverse Event|12
901349|NCT01142128|2971587|P1|Overall Study|Withdrawal by Subject|2
901350|NCT01142128|2971587|P1|Overall Study|Lost to Follow-up|1
901351|NCT01142128|2971587|P1|Overall Study|Physician Decision|1
901352|NCT01142115|2971597|P2|First Intervention|Adverse Event|0
901353|NCT01142115|2971598|P1|First Intervention|Adverse Event|1
901354|NCT01142115|2971597|P2|First Intervention|Lack of Efficacy|1
901355|NCT01142115|2971598|P1|First Intervention|Lack of Efficacy|1
901356|NCT01142089|2971615|P2|Overall Study|Patient required rescue medication|17
901357|NCT01142089|2971616|P1|Overall Study|Patient required rescue medication|8
901358|NCT01142089|2971615|P2|Overall Study|Noncompliance with study procedures|1
901359|NCT01142089|2971616|P1|Overall Study|Noncompliance with study procedures|2
901360|NCT01142089|2971615|P2|Overall Study|Use of prohibited medications|1
901361|NCT01142089|2971616|P1|Overall Study|Use of prohibited medications|0
901362|NCT01142089|2971615|P2|Overall Study|Withdrawal by Subject|2
901363|NCT01142089|2971616|P1|Overall Study|Withdrawal by Subject|1
901364|NCT01142089|2971615|P2|Overall Study|Physician Decision|0
901365|NCT01142089|2971616|P1|Overall Study|Physician Decision|1
901366|NCT01141712|2971638|P1|Overall Study|Disease progression|3
901367|NCT01141660|2971659|P2|Overall Study|Physician Decision|12
901368|NCT01141660|2971660|P1|Overall Study|Physician Decision|0
901369|NCT01141283|2971728|P1|Overall Study|Lack of Efficacy|10
901370|NCT01141283|2971728|P1|Overall Study|Administrative|4
901371|NCT01141283|2971728|P1|Overall Study|Withdrawal by Subject|14
901372|NCT01141283|2971728|P1|Overall Study|Lost to Follow-up|4
901373|NCT01141283|2971728|P1|Overall Study|Adverse Event|56
901374|NCT01141205|2971734|P2|Overall Study|Withdrawal by Subject|1
901375|NCT01141205|2971735|P1|Overall Study|Withdrawal by Subject|1
901376|NCT01141205|2971734|P2|Overall Study|Lost to Follow-up|0
901377|NCT01141205|2971735|P1|Overall Study|Lost to Follow-up|1
901378|NCT01141205|2971734|P2|Overall Study|Physician Decision|1
901379|NCT01141205|2971735|P1|Overall Study|Physician Decision|1
901380|NCT01140906|2971762|P4|Overall Study|Administrative or other reason|2
901381|NCT01140906|2971763|P3|Overall Study|Administrative or other reason|3
901382|NCT01140906|2971764|P2|Overall Study|Administrative or other reason|5
901383|NCT01140906|2971765|P1|Overall Study|Administrative or other reason|0
901384|NCT01140906|2971762|P4|Overall Study|Lost to Follow-up|2
901385|NCT01140906|2971763|P3|Overall Study|Lost to Follow-up|0
901386|NCT01140906|2971764|P2|Overall Study|Lost to Follow-up|1
901387|NCT01140906|2971765|P1|Overall Study|Lost to Follow-up|1
901388|NCT01140906|2971762|P4|Overall Study|Withdrawal of consent|2
901389|NCT01140906|2971763|P3|Overall Study|Withdrawal of consent|2
901390|NCT01140906|2971764|P2|Overall Study|Withdrawal of consent|6
901391|NCT01140906|2971765|P1|Overall Study|Withdrawal of consent|6
901392|NCT01140906|2971762|P4|Overall Study|Protocol Violation|1
901393|NCT01140906|2971763|P3|Overall Study|Protocol Violation|2
901394|NCT01140906|2971764|P2|Overall Study|Protocol Violation|3
901395|NCT01140906|2971765|P1|Overall Study|Protocol Violation|5
901396|NCT01140906|2971762|P4|Overall Study|Non-compliance|1
901397|NCT01140906|2971763|P3|Overall Study|Non-compliance|0
901398|NCT01140906|2971764|P2|Overall Study|Non-compliance|1
901399|NCT01140906|2971765|P1|Overall Study|Non-compliance|0
901400|NCT01140906|2971762|P4|Overall Study|Lack of Efficacy|1
901401|NCT01140906|2971763|P3|Overall Study|Lack of Efficacy|2
901402|NCT01140906|2971764|P2|Overall Study|Lack of Efficacy|8
901403|NCT01140906|2971765|P1|Overall Study|Lack of Efficacy|6
901404|NCT01140906|2971762|P4|Overall Study|Adverse Event|7
901405|NCT01140906|2971763|P3|Overall Study|Adverse Event|17
901406|NCT01140906|2971764|P2|Overall Study|Adverse Event|10
901407|NCT01140906|2971765|P1|Overall Study|Adverse Event|7
901408|NCT01140880|2971805|P2|Overall Study|Protocol Violation|30
901409|NCT01140880|2971806|P1|Overall Study|Protocol Violation|0
901410|NCT01140880|2971805|P2|Overall Study|Lost to Follow-up|10
901411|NCT01140880|2971806|P1|Overall Study|Lost to Follow-up|8
901412|NCT01140880|2971805|P2|Overall Study|Withdrawal by Subject|3
901413|NCT01140880|2971806|P1|Overall Study|Withdrawal by Subject|6
901414|NCT01140880|2971805|P2|Overall Study|Death|1
901415|NCT01140880|2971806|P1|Overall Study|Death|0
901416|NCT01140867|2971818|P1|Overall Study|Medication Noncompliance|2
901417|NCT01140867|2971818|P1|Overall Study|Uncooperative patient|2
901418|NCT01140867|2971818|P1|Overall Study|Protocol Violation|1
901419|NCT01140867|2971818|P1|Overall Study|Withdrawal by Subject|1
901420|NCT01140867|2971818|P1|Overall Study|Lost to Follow-up|2
901421|NCT01140867|2971818|P1|Overall Study|Lack of Efficacy|3
901422|NCT01140867|2971818|P1|Overall Study|Adverse Event|22
901423|NCT01140646|2971858|P1|Overall Study|Refused Further Treatment|5
901424|NCT01140646|2971858|P1|Overall Study|Adverse Event|4
901425|NCT01140503|2971862|P1|Overall Study|Withdrawal by Subject|1
901426|NCT01140477|2971870|P2|Overall Study|Subject explanted|1
901427|NCT01140477|2971871|P1|Overall Study|Subject explanted|0
901428|NCT01140477|2971870|P2|Overall Study|Death|1
901429|NCT01140477|2971871|P1|Overall Study|Death|1
901430|NCT01140477|2971870|P2|Overall Study|Surgical complication preventing implant|0
901431|NCT01140477|2971871|P1|Overall Study|Surgical complication preventing implant|2
901432|NCT01140477|2971870|P2|Overall Study|Withdrawal by Subject|4
901433|NCT01140477|2971871|P1|Overall Study|Withdrawal by Subject|1
901434|NCT01140477|2971870|P2|Overall Study|Lost to Follow-up|0
901435|NCT01140477|2971871|P1|Overall Study|Lost to Follow-up|4
901436|NCT01140347|2971886|P2|Overall Study|Withdrawal by Subject|8
901437|NCT01140347|2971887|P1|Overall Study|Withdrawal by Subject|13
901438|NCT01140347|2971886|P2|Overall Study|Lost to Follow-up|6
901439|NCT01140347|2971887|P1|Overall Study|Lost to Follow-up|5
901440|NCT01140061|2971940|P10|Extension|Laboratory Adverse Event|1
901441|NCT01140061|2971941|P9|Extension|Laboratory Adverse Event|0
901442|NCT01140061|2971942|P8|Extension|Laboratory Adverse Event|0
901443|NCT01140061|2971943|P7|Extension|Laboratory Adverse Event|0
901444|NCT01140061|2971944|P6|Extension|Laboratory Adverse Event|0
901445|NCT01140061|2971945|P5|Extension|Laboratory Adverse Event|0
901446|NCT01140061|2971946|P4|Extension|Laboratory Adverse Event|0
901447|NCT01140061|2971947|P3|Extension|Laboratory Adverse Event|0
901448|NCT01140061|2971948|P2|Extension|Laboratory Adverse Event|0
901449|NCT01140061|2971949|P1|Extension|Laboratory Adverse Event|0
901450|NCT01140061|2971940|P10|Part I|Adverse Event|0
901451|NCT01140061|2971941|P9|Part I|Adverse Event|0
901452|NCT01140061|2971942|P8|Part I|Adverse Event|0
901453|NCT01140061|2971943|P7|Part I|Adverse Event|0
901454|NCT01140061|2971944|P6|Part I|Adverse Event|0
901455|NCT01140061|2971945|P5|Part I|Adverse Event|0
901456|NCT01140061|2971946|P4|Part I|Adverse Event|0
901457|NCT01140061|2971947|P3|Part I|Adverse Event|0
901458|NCT01140061|2971948|P2|Part I|Adverse Event|0
901459|NCT01140061|2971949|P1|Part I|Adverse Event|1
901460|NCT01140048|2971976|P1|Overall Study|Lost to Follow-up|31
901461|NCT01140048|2971976|P1|Overall Study|Withdrawal by Subject|13
901462|NCT01140048|2971976|P1|Overall Study|Physician Decision|1
901463|NCT01139775|2972016|P3|Overall Study|Physician Decision|2
901464|NCT01139775|2972017|P2|Overall Study|Physician Decision|2
901465|NCT01139775|2972018|P1|Overall Study|Physician Decision|0
901466|NCT01139775|2972016|P3|Overall Study|Withdrawal by Subject|2
901467|NCT01139775|2972017|P2|Overall Study|Withdrawal by Subject|0
901468|NCT01139775|2972018|P1|Overall Study|Withdrawal by Subject|1
901469|NCT01139775|2972016|P3|Overall Study|Protocol Violation|0
901470|NCT01139775|2972017|P2|Overall Study|Protocol Violation|5
901471|NCT01139775|2972018|P1|Overall Study|Protocol Violation|0
901472|NCT01139775|2972016|P3|Overall Study|Adverse Event|2
901473|NCT01139775|2972017|P2|Overall Study|Adverse Event|6
901474|NCT01139775|2972018|P1|Overall Study|Adverse Event|0
901475|NCT01139762|2972050|P3|Double-Blind Randomized Active Treatment|Lost to Follow-up|4
901476|NCT01139762|2972051|P2|Double-Blind Randomized Active Treatment|Lost to Follow-up|3
901477|NCT01139762|2972052|P1|Double-Blind Randomized Active Treatment|Lost to Follow-up|0
901478|NCT01139762|2972050|P3|Double-Blind Randomized Active Treatment|Lack of Efficacy|5
901479|NCT01139762|2972051|P2|Double-Blind Randomized Active Treatment|Lack of Efficacy|3
901480|NCT01139762|2972052|P1|Double-Blind Randomized Active Treatment|Lack of Efficacy|0
901481|NCT01139762|2972050|P3|Double-Blind Randomized Active Treatment|Sponsor Decision|6
901482|NCT01139762|2972051|P2|Double-Blind Randomized Active Treatment|Sponsor Decision|5
901483|NCT01139762|2972052|P1|Double-Blind Randomized Active Treatment|Sponsor Decision|0
901484|NCT01139762|2972050|P3|Double-Blind Randomized Active Treatment|Physician Decision|0
901485|NCT01139762|2972051|P2|Double-Blind Randomized Active Treatment|Physician Decision|2
901486|NCT01139762|2972052|P1|Double-Blind Randomized Active Treatment|Physician Decision|0
901487|NCT01139762|2972050|P3|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13
901488|NCT01139762|2972051|P2|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6
901489|NCT01139762|2972052|P1|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0
901490|NCT01139762|2972050|P3|Double-Blind Randomized Active Treatment|Protocol Violation|8
901491|NCT01139762|2972051|P2|Double-Blind Randomized Active Treatment|Protocol Violation|2
901492|NCT01139762|2972052|P1|Double-Blind Randomized Active Treatment|Protocol Violation|0
901493|NCT01139762|2972050|P3|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17
901494|NCT01139762|2972051|P2|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14
901495|NCT01139762|2972052|P1|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0
901496|NCT01139762|2972050|P3|Double-Blind Randomized Active Treatment|Death|1
901497|NCT01139762|2972051|P2|Double-Blind Randomized Active Treatment|Death|1
901498|NCT01139762|2972052|P1|Double-Blind Randomized Active Treatment|Death|0
901499|NCT01139762|2972050|P3|Double-Blind Randomized Active Treatment|Adverse Event|10
901500|NCT01139762|2972051|P2|Double-Blind Randomized Active Treatment|Adverse Event|4
901501|NCT01139762|2972052|P1|Double-Blind Randomized Active Treatment|Adverse Event|0
901502|NCT01139762|2972050|P3|Washout and Placebo Lead-In Period|Lost to Follow-up|0
901503|NCT01139762|2972051|P2|Washout and Placebo Lead-In Period|Lost to Follow-up|0
901504|NCT01139762|2972052|P1|Washout and Placebo Lead-In Period|Lost to Follow-up|10
901505|NCT01139762|2972050|P3|Washout and Placebo Lead-In Period|Sponsor Decision|0
901506|NCT01139762|2972051|P2|Washout and Placebo Lead-In Period|Sponsor Decision|0
901507|NCT01139762|2972052|P1|Washout and Placebo Lead-In Period|Sponsor Decision|10
901508|NCT01139762|2972050|P3|Washout and Placebo Lead-In Period|Physician Decision|0
901509|NCT01139762|2972051|P2|Washout and Placebo Lead-In Period|Physician Decision|0
901510|NCT01139762|2972052|P1|Washout and Placebo Lead-In Period|Physician Decision|12
901511|NCT01139762|2972050|P3|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
901512|NCT01139762|2972051|P2|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
901513|NCT01139762|2972052|P1|Washout and Placebo Lead-In Period|Withdrawal by Subject|83
901514|NCT01139762|2972050|P3|Washout and Placebo Lead-In Period|Adverse Event|0
901515|NCT01139762|2972051|P2|Washout and Placebo Lead-In Period|Adverse Event|0
901516|NCT01139762|2972052|P1|Washout and Placebo Lead-In Period|Adverse Event|1
901517|NCT01139762|2972050|P3|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
901518|NCT01139762|2972051|P2|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
901519|NCT01139762|2972052|P1|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258
901520|NCT01139658|2972087|P2|Overall Study|Not specified|75
901521|NCT01139658|2972088|P1|Overall Study|Not specified|28
901522|NCT01139658|2972087|P2|Overall Study|No documentation of treatment|0
901523|NCT01139658|2972088|P1|Overall Study|No documentation of treatment|1
901524|NCT01139658|2972087|P2|Overall Study|Withdrawal by Subject|4
901525|NCT01139658|2972088|P1|Overall Study|Withdrawal by Subject|2
901526|NCT01139658|2972087|P2|Overall Study|Lack of Efficacy|7
901527|NCT01139658|2972088|P1|Overall Study|Lack of Efficacy|15
901528|NCT01139658|2972087|P2|Overall Study|Adverse Event|27
901529|NCT01139658|2972088|P1|Overall Study|Adverse Event|10
901530|NCT01139580|2972126|P2|Overall Study|Participant Randomization in Error|1
901531|NCT01139580|2972127|P1|Overall Study|Participant Randomization in Error|0
901532|NCT01139580|2972126|P2|Overall Study|Beginning Study Exclusion Treatment|1
901533|NCT01139580|2972127|P1|Overall Study|Beginning Study Exclusion Treatment|0
901534|NCT01139580|2972126|P2|Overall Study|Misrandomized|0
901535|NCT01139580|2972127|P1|Overall Study|Misrandomized|1
901536|NCT01139580|2972126|P2|Overall Study|Did Not Meet Exclusion Criteria|0
901537|NCT01139580|2972127|P1|Overall Study|Did Not Meet Exclusion Criteria|1
901538|NCT01139580|2972126|P2|Overall Study|Used Excluded Medicine After Enrollment|0
901539|NCT01139580|2972127|P1|Overall Study|Used Excluded Medicine After Enrollment|1
901540|NCT01139580|2972126|P2|Overall Study|Withdrawal by Subject|9
901541|NCT01139580|2972127|P1|Overall Study|Withdrawal by Subject|6
901542|NCT01139580|2972126|P2|Overall Study|Lack of Efficacy|2
901543|NCT01139580|2972127|P1|Overall Study|Lack of Efficacy|0
901544|NCT01139580|2972126|P2|Overall Study|Lost to Follow-up|1
901545|NCT01139580|2972127|P1|Overall Study|Lost to Follow-up|9
901546|NCT01139580|2972126|P2|Overall Study|Adverse Event|4
901547|NCT01139580|2972127|P1|Overall Study|Adverse Event|5
901548|NCT01139450|2972175|P3|Overall Study|Adverse Event|3
901549|NCT01139450|2972176|P2|Overall Study|Adverse Event|2
901550|NCT01139450|2972177|P1|Overall Study|Adverse Event|2
901551|NCT01139450|2972175|P3|Overall Study|Administrative|1
901552|NCT01139450|2972176|P2|Overall Study|Administrative|0
901553|NCT01139450|2972177|P1|Overall Study|Administrative|0
901554|NCT01139450|2972175|P3|Overall Study|Lost to Follow-up|11
901555|NCT01139450|2972176|P2|Overall Study|Lost to Follow-up|7
901556|NCT01139450|2972177|P1|Overall Study|Lost to Follow-up|9
901557|NCT01139450|2972175|P3|Overall Study|Protocol Violation|2
901558|NCT01139450|2972176|P2|Overall Study|Protocol Violation|5
901559|NCT01139450|2972177|P1|Overall Study|Protocol Violation|6
901560|NCT01139450|2972175|P3|Overall Study|Lack of Efficacy|8
901561|NCT01139450|2972176|P2|Overall Study|Lack of Efficacy|1
901562|NCT01139450|2972177|P1|Overall Study|Lack of Efficacy|3
901563|NCT01139450|2972175|P3|Overall Study|Withdrawal by Subject|13
901564|NCT01139450|2972176|P2|Overall Study|Withdrawal by Subject|10
901565|NCT01139450|2972177|P1|Overall Study|Withdrawal by Subject|7
901566|NCT01139164|2972229|P3|Overall Study|Withdrawn prior to study start|0
901567|NCT01139164|2972230|P2|Overall Study|Withdrawn prior to study start|2
901568|NCT01139164|2972231|P1|Overall Study|Withdrawn prior to study start|0
901569|NCT01139125|2972245|P1|Overall Study|Withdrawal by Subject|1
901570|NCT01139047|2972249|P1|Overall Study|Withdrawal by Subject|1
901571|NCT01139021|2972264|P6|Overall Study|Withdrawal by Subject|0
901572|NCT01139021|2972265|P5|Overall Study|Withdrawal by Subject|4
901573|NCT01139021|2972266|P4|Overall Study|Withdrawal by Subject|1
901574|NCT01139021|2972267|P3|Overall Study|Withdrawal by Subject|0
901575|NCT01139021|2972268|P2|Overall Study|Withdrawal by Subject|0
901576|NCT01139021|2972269|P1|Overall Study|Withdrawal by Subject|0
901577|NCT01139021|2972264|P6|Overall Study|Protocol Violation|0
901578|NCT01139021|2972265|P5|Overall Study|Protocol Violation|2
901579|NCT01139021|2972266|P4|Overall Study|Protocol Violation|0
901580|NCT01139021|2972267|P3|Overall Study|Protocol Violation|0
901581|NCT01139021|2972268|P2|Overall Study|Protocol Violation|0
901582|NCT01139021|2972269|P1|Overall Study|Protocol Violation|1
901583|NCT01139021|2972264|P6|Overall Study|Lost to Follow-up|0
901584|NCT01139021|2972265|P5|Overall Study|Lost to Follow-up|2
901585|NCT01139021|2972266|P4|Overall Study|Lost to Follow-up|0
901586|NCT01139021|2972267|P3|Overall Study|Lost to Follow-up|0
901587|NCT01139021|2972268|P2|Overall Study|Lost to Follow-up|0
901588|NCT01139021|2972269|P1|Overall Study|Lost to Follow-up|0
901589|NCT01139021|2972264|P6|Overall Study|Adverse Event|0
901590|NCT01139021|2972265|P5|Overall Study|Adverse Event|1
901591|NCT01139021|2972266|P4|Overall Study|Adverse Event|0
901592|NCT01139021|2972267|P3|Overall Study|Adverse Event|0
901593|NCT01139021|2972268|P2|Overall Study|Adverse Event|0
901594|NCT01139021|2972269|P1|Overall Study|Adverse Event|0
901595|NCT01139008|2972305|P1|Overall Study|Non-compliant, lost product|1
901596|NCT01139008|2972305|P1|Overall Study|Withdrawal by Subject|5
901597|NCT01138826|2972338|P6|Washout Period I (of 16 Days)|Lost to Follow-up|0
901598|NCT01138826|2972339|P5|Washout Period I (of 16 Days)|Lost to Follow-up|1
901599|NCT01138826|2972340|P4|Washout Period I (of 16 Days)|Lost to Follow-up|0
901600|NCT01138826|2972341|P3|Washout Period I (of 16 Days)|Lost to Follow-up|0
901601|NCT01138826|2972342|P2|Washout Period I (of 16 Days)|Lost to Follow-up|1
901602|NCT01138826|2972343|P1|Washout Period I (of 16 Days)|Lost to Follow-up|1
901603|NCT01138657|2972380|P2|Overall Study|Miscellaneous Reasons|4
901604|NCT01138657|2972381|P1|Overall Study|Miscellaneous Reasons|3
901605|NCT01138657|2972380|P2|Overall Study|Lost to Follow-up|3
901606|NCT01138657|2972381|P1|Overall Study|Lost to Follow-up|0
901607|NCT01138657|2972380|P2|Overall Study|Lack of Efficacy|1
901608|NCT01138657|2972381|P1|Overall Study|Lack of Efficacy|2
901609|NCT01138657|2972380|P2|Overall Study|Adverse Event|10
901610|NCT01138657|2972381|P1|Overall Study|Adverse Event|3
901611|NCT01138501|2972444|P1|Overall Study|Withdrawal by Subject|3
901612|NCT01138501|2972444|P1|Overall Study|Protocol Violation|2
901613|NCT01138150|2972488|P2|Overall Study|Physician Decision|0
901614|NCT01138150|2972489|P1|Overall Study|Physician Decision|1
901615|NCT01138150|2972488|P2|Overall Study|blood unable to be processed|1
901616|NCT01138150|2972489|P1|Overall Study|blood unable to be processed|0
901617|NCT01138111|2972570|P1|Overall Study|Lost to Follow-up|2
901618|NCT01138111|2972570|P1|Overall Study|Death|1
901619|NCT01138111|2972570|P1|Overall Study|Adverse Event|1
901620|NCT01138111|2972570|P1|Overall Study|Withdrawal by Subject|5
901621|NCT01138046|2972624|P1|Overall Study|Withdrawal due to death|6
901622|NCT01138007|2972644|P3|Overall Study|Withdrawal by Subject|15
901623|NCT01138007|2972645|P2|Overall Study|Withdrawal by Subject|6
901624|NCT01138007|2972646|P1|Overall Study|Withdrawal by Subject|5
901625|NCT01138007|2972644|P3|Overall Study|Physician Decision|3
901626|NCT01138007|2972645|P2|Overall Study|Physician Decision|5
901627|NCT01138007|2972646|P1|Overall Study|Physician Decision|0
901628|NCT01138007|2972644|P3|Overall Study|Lost to Follow-up|5
901629|NCT01138007|2972645|P2|Overall Study|Lost to Follow-up|3
901630|NCT01138007|2972646|P1|Overall Study|Lost to Follow-up|3
901631|NCT01138007|2972644|P3|Overall Study|Protocol-Defined Stopping Criteria|8
901632|NCT01138007|2972645|P2|Overall Study|Protocol-Defined Stopping Criteria|1
901633|NCT01138007|2972646|P1|Overall Study|Protocol-Defined Stopping Criteria|6
901634|NCT01138007|2972644|P3|Overall Study|Protocol Violation|2
901635|NCT01138007|2972645|P2|Overall Study|Protocol Violation|3
901636|NCT01138007|2972646|P1|Overall Study|Protocol Violation|2
901637|NCT01138007|2972644|P3|Overall Study|Lack of Efficacy|6
901638|NCT01138007|2972645|P2|Overall Study|Lack of Efficacy|0
901639|NCT01138007|2972646|P1|Overall Study|Lack of Efficacy|2
901640|NCT01138007|2972644|P3|Overall Study|Adverse Event|9
901641|NCT01138007|2972645|P2|Overall Study|Adverse Event|12
901642|NCT01138007|2972646|P1|Overall Study|Adverse Event|4
901643|NCT01137812|2972753|P2|Overall Study|Not specified|27
901644|NCT01137812|2972754|P1|Overall Study|Not specified|19
901645|NCT01137812|2972753|P2|Overall Study|Patient met glycemic withdrawal criteria|85
901646|NCT01137812|2972754|P1|Overall Study|Patient met glycemic withdrawal criteria|40
901647|NCT01137812|2972753|P2|Overall Study|Death|0
901648|NCT01137812|2972754|P1|Overall Study|Death|2
901649|NCT01137812|2972753|P2|Overall Study|Withdrawal by Subject|13
901650|NCT01137812|2972754|P1|Overall Study|Withdrawal by Subject|5
901651|NCT01137812|2972753|P2|Overall Study|Protocol Violation|4
901652|NCT01137812|2972754|P1|Overall Study|Protocol Violation|5
901653|NCT01137812|2972753|P2|Overall Study|Physician Decision|17
901654|NCT01137812|2972754|P1|Overall Study|Physician Decision|25
901655|NCT01137812|2972753|P2|Overall Study|Lost to Follow-up|8
901656|NCT01137812|2972754|P1|Overall Study|Lost to Follow-up|6
901657|NCT01137812|2972753|P2|Overall Study|Adverse Event|14
901658|NCT01137812|2972754|P1|Overall Study|Adverse Event|21
901659|NCT01137786|2972774|P2|Overall Study|Withdrawal by Subject|1
901660|NCT01137786|2972775|P1|Overall Study|Withdrawal by Subject|1
901661|NCT01137786|2972774|P2|Overall Study|Lost to Follow-up|2
901662|NCT01137786|2972775|P1|Overall Study|Lost to Follow-up|0
901663|NCT01137773|2972785|P2|Overall Study|Lost to Follow-up|0
901664|NCT01137773|2972786|P1|Overall Study|Lost to Follow-up|6
901665|NCT01137773|2972785|P2|Overall Study|Death|3
901666|NCT01137773|2972786|P1|Overall Study|Death|3
901667|NCT01137682|2972797|P3|Overall Study|Did not receive treatment in extension|1
901668|NCT01137682|2972798|P2|Overall Study|Did not receive treatment in extension|0
901669|NCT01137682|2972799|P1|Overall Study|Did not receive treatment in extension|0
901670|NCT01137682|2972797|P3|Overall Study|Did not enter extension|2
901671|NCT01137682|2972798|P2|Overall Study|Did not enter extension|3
901672|NCT01137682|2972799|P1|Overall Study|Did not enter extension|2
901673|NCT01137682|2972797|P3|Overall Study|Protocol Violation-Extension|0
901674|NCT01137682|2972798|P2|Overall Study|Protocol Violation-Extension|1
901675|NCT01137682|2972799|P1|Overall Study|Protocol Violation-Extension|2
901676|NCT01137682|2972797|P3|Overall Study|Death-Extension|0
901677|NCT01137682|2972798|P2|Overall Study|Death-Extension|0
901678|NCT01137682|2972799|P1|Overall Study|Death-Extension|2
901679|NCT01137682|2972797|P3|Overall Study|Administrative problems-Extension|0
901680|NCT01137682|2972798|P2|Overall Study|Administrative problems-Extension|2
901681|NCT01137682|2972799|P1|Overall Study|Administrative problems-Extension|0
901682|NCT01137682|2972797|P3|Overall Study|Lost to Follow Up-Extension|0
901683|NCT01137682|2972798|P2|Overall Study|Lost to Follow Up-Extension|1
901684|NCT01137682|2972799|P1|Overall Study|Lost to Follow Up-Extension|0
901685|NCT01137682|2972797|P3|Overall Study|Withdrawal by Subject-Extension|8
901686|NCT01137682|2972798|P2|Overall Study|Withdrawal by Subject-Extension|8
901687|NCT01137682|2972799|P1|Overall Study|Withdrawal by Subject-Extension|6
901688|NCT01137682|2972797|P3|Overall Study|Lack of Efficacy-Extension|13
901689|NCT01137682|2972798|P2|Overall Study|Lack of Efficacy-Extension|9
901690|NCT01137682|2972799|P1|Overall Study|Lack of Efficacy-Extension|15
901691|NCT01137682|2972797|P3|Overall Study|Adverse Event-Extension|7
901692|NCT01137682|2972798|P2|Overall Study|Adverse Event-Extension|8
901693|NCT01137682|2972799|P1|Overall Study|Adverse Event-Extension|4
901694|NCT01137682|2972797|P3|Overall Study|Protocol Violation-CORE|1
901695|NCT01137682|2972798|P2|Overall Study|Protocol Violation-CORE|1
901696|NCT01137682|2972799|P1|Overall Study|Protocol Violation-CORE|0
901697|NCT01137682|2972797|P3|Overall Study|Administrative problems-CORE|0
901698|NCT01137682|2972798|P2|Overall Study|Administrative problems-CORE|1
901699|NCT01137682|2972799|P1|Overall Study|Administrative problems-CORE|2
901700|NCT01137682|2972797|P3|Overall Study|Withdrawal by Subject-CORE|2
901701|NCT01137682|2972798|P2|Overall Study|Withdrawal by Subject-CORE|2
901702|NCT01137682|2972799|P1|Overall Study|Withdrawal by Subject-CORE|2
901703|NCT01137682|2972797|P3|Overall Study|Adverse Event-CORE|0
901704|NCT01137682|2972798|P2|Overall Study|Adverse Event-CORE|4
901705|NCT01137682|2972799|P1|Overall Study|Adverse Event-CORE|2
901706|NCT01137604|2972849|P4|Overall Study|Clinical Decline|1
901707|NCT01137604|2972850|P3|Overall Study|Clinical Decline|1
901708|NCT01137604|2972851|P2|Overall Study|Clinical Decline|0
901709|NCT01137604|2972852|P1|Overall Study|Clinical Decline|0
901710|NCT01137604|2972849|P4|Overall Study|Participant's Decision|0
901711|NCT01137604|2972850|P3|Overall Study|Participant's Decision|0
901712|NCT01137604|2972851|P2|Overall Study|Participant's Decision|0
901713|NCT01137604|2972852|P1|Overall Study|Participant's Decision|1
901714|NCT01137604|2972849|P4|Overall Study|Clinical Progression|0
901715|NCT01137604|2972850|P3|Overall Study|Clinical Progression|1
901716|NCT01137604|2972851|P2|Overall Study|Clinical Progression|2
901717|NCT01137604|2972852|P1|Overall Study|Clinical Progression|0
901718|NCT01137604|2972849|P4|Overall Study|Withdrawal by Subject|1
901719|NCT01137604|2972850|P3|Overall Study|Withdrawal by Subject|2
901720|NCT01137604|2972851|P2|Overall Study|Withdrawal by Subject|2
901721|NCT01137604|2972852|P1|Overall Study|Withdrawal by Subject|0
901722|NCT01137604|2972849|P4|Overall Study|Adverse Event|9
901723|NCT01137604|2972850|P3|Overall Study|Adverse Event|9
901724|NCT01137604|2972851|P2|Overall Study|Adverse Event|6
901725|NCT01137604|2972852|P1|Overall Study|Adverse Event|1
901726|NCT01137578|2972886|P3|Overall Study|Not Specified|6
901727|NCT01137578|2972887|P2|Overall Study|Not Specified|2
901728|NCT01137578|2972888|P1|Overall Study|Not Specified|12
901729|NCT01137578|2972886|P3|Overall Study|Withdrawal by Subject|0
901730|NCT01137578|2972887|P2|Overall Study|Withdrawal by Subject|0
901731|NCT01137578|2972888|P1|Overall Study|Withdrawal by Subject|1
901732|NCT01137578|2972886|P3|Overall Study|Participant requested to Discontinue|0
901733|NCT01137578|2972887|P2|Overall Study|Participant requested to Discontinue|0
901734|NCT01137578|2972888|P1|Overall Study|Participant requested to Discontinue|3
901735|NCT01137474|2972937|P4|Overall Study|Administrative reason by sponsor|0
901736|NCT01137474|2972938|P3|Overall Study|Administrative reason by sponsor|0
901737|NCT01137474|2972939|P2|Overall Study|Administrative reason by sponsor|1
901738|NCT01137474|2972940|P1|Overall Study|Administrative reason by sponsor|0
901739|NCT01137474|2972937|P4|Overall Study|Pregnancy|0
901740|NCT01137474|2972938|P3|Overall Study|Pregnancy|0
901741|NCT01137474|2972939|P2|Overall Study|Pregnancy|1
901742|NCT01137474|2972940|P1|Overall Study|Pregnancy|0
901743|NCT01137474|2972937|P4|Overall Study|Not specified|0
901744|NCT01137474|2972938|P3|Overall Study|Not specified|0
901745|NCT01137474|2972939|P2|Overall Study|Not specified|1
901746|NCT01137474|2972940|P1|Overall Study|Not specified|3
901747|NCT01137474|2972937|P4|Overall Study|Lack of Efficacy|2
901748|NCT01137474|2972938|P3|Overall Study|Lack of Efficacy|0
901749|NCT01137474|2972939|P2|Overall Study|Lack of Efficacy|0
901750|NCT01137474|2972940|P1|Overall Study|Lack of Efficacy|0
901751|NCT01137474|2972937|P4|Overall Study|Lost to Follow-up|2
901752|NCT01137474|2972938|P3|Overall Study|Lost to Follow-up|0
901753|NCT01137474|2972939|P2|Overall Study|Lost to Follow-up|1
901754|NCT01137474|2972940|P1|Overall Study|Lost to Follow-up|5
901755|NCT01137474|2972937|P4|Overall Study|No longer met study criteria|5
901756|NCT01137474|2972938|P3|Overall Study|No longer met study criteria|0
901757|NCT01137474|2972939|P2|Overall Study|No longer met study criteria|1
901758|NCT01137474|2972940|P1|Overall Study|No longer met study criteria|6
901759|NCT01137474|2972937|P4|Overall Study|Withdrawal by Subject|9
901760|NCT01137474|2972938|P3|Overall Study|Withdrawal by Subject|6
901761|NCT01137474|2972939|P2|Overall Study|Withdrawal by Subject|2
901762|NCT01137474|2972940|P1|Overall Study|Withdrawal by Subject|7
901763|NCT01137474|2972937|P4|Overall Study|Adverse Event|3
901764|NCT01137474|2972938|P3|Overall Study|Adverse Event|1
901765|NCT01137474|2972939|P2|Overall Study|Adverse Event|5
901766|NCT01137474|2972940|P1|Overall Study|Adverse Event|3
901767|NCT01137435|2972958|P1|Overall Study|Off label usage|4
901768|NCT01137435|2972958|P1|Overall Study|Lost to Follow-up|24
901769|NCT01137292|2972985|P1|Overall Study|Other|7
901770|NCT01137292|2972985|P1|Overall Study|Lost to Follow-up|1
901771|NCT01137292|2972985|P1|Overall Study|Lack of Efficacy|13
901772|NCT01137292|2972985|P1|Overall Study|Adverse Event|3
901773|NCT01137292|2972985|P1|Overall Study|Death|30
901774|NCT01137071|2972992|P1|Overall Study|Wrongly Included|1
901775|NCT01137071|2972992|P1|Overall Study|Withdrawal by Subject|2
901776|NCT01137071|2972992|P1|Overall Study|Disease Progression|11
901777|NCT01136967|2973061|P2|Overall Study|Diagnosis of Second Primary Cancer|1
901778|NCT01136967|2973062|P1|Overall Study|Diagnosis of Second Primary Cancer|0
901779|NCT01136967|2973061|P2|Overall Study|Increase in Lesion Size|2
901780|NCT01136967|2973062|P1|Overall Study|Increase in Lesion Size|0
901781|NCT01136967|2973061|P2|Overall Study|Investigator's Choice|1
901782|NCT01136967|2973062|P1|Overall Study|Investigator's Choice|1
901783|NCT01136967|2973061|P2|Overall Study|Non Compliance|0
901784|NCT01136967|2973062|P1|Overall Study|Non Compliance|1
901785|NCT01136967|2973061|P2|Overall Study|Radiation|0
901786|NCT01136967|2973062|P1|Overall Study|Radiation|1
901787|NCT01136967|2973061|P2|Overall Study|Clinical Progression|5
901788|NCT01136967|2973062|P1|Overall Study|Clinical Progression|3
901789|NCT01136967|2973061|P2|Overall Study|Withdrawal by Subject|2
901790|NCT01136967|2973062|P1|Overall Study|Withdrawal by Subject|1
901791|NCT01136967|2973061|P2|Overall Study|Lost to Follow-up|1
901792|NCT01136967|2973062|P1|Overall Study|Lost to Follow-up|0
901793|NCT01136967|2973061|P2|Overall Study|Participant Choice|3
901794|NCT01136967|2973062|P1|Overall Study|Participant Choice|8
901795|NCT01136967|2973061|P2|Overall Study|Adverse Event|12
901796|NCT01136967|2973062|P1|Overall Study|Adverse Event|9
901797|NCT01136954|2973080|P2|Overall Study|Not Specified|3
901798|NCT01136954|2973081|P1|Overall Study|Not Specified|1
901799|NCT01136954|2973080|P2|Overall Study|Physician Decision|1
901800|NCT01136954|2973081|P1|Overall Study|Physician Decision|0
901801|NCT01136954|2973080|P2|Overall Study|Lack of Efficacy|13
901802|NCT01136954|2973081|P1|Overall Study|Lack of Efficacy|14
901803|NCT01136954|2973080|P2|Overall Study|Withdrawal by Subject|2
901804|NCT01136954|2973081|P1|Overall Study|Withdrawal by Subject|6
901805|NCT01136954|2973080|P2|Overall Study|Adverse Event|2
901806|NCT01136954|2973081|P1|Overall Study|Adverse Event|3
901807|NCT01136915|2973095|P2|Overall Study|Exclusion criterion met|1
901808|NCT01136915|2973096|P1|Overall Study|Exclusion criterion met|0
901809|NCT01136915|2973095|P2|Overall Study|Lost to Follow-up|0
901810|NCT01136915|2973096|P1|Overall Study|Lost to Follow-up|2
901811|NCT01136876|2973106|P2|Overall Study|Physician Decision|5
901812|NCT01136876|2973107|P1|Overall Study|Physician Decision|3
901813|NCT01136876|2973106|P2|Overall Study|Lost to Follow-up|1
901814|NCT01136876|2973107|P1|Overall Study|Lost to Follow-up|0
901815|NCT01136785|2973136|P2|Overall Study|Protocol Violation|1
901816|NCT01136785|2973137|P1|Overall Study|Protocol Violation|2
901817|NCT01136772|2973152|P2|Overall Study|Did not follow up after first injection|2
901818|NCT01136772|2973153|P1|Overall Study|Did not follow up after first injection|2
901819|NCT01136772|2973152|P2|Overall Study|Did not receive injection|7
901820|NCT01136772|2973153|P1|Overall Study|Did not receive injection|10
901821|NCT01136772|2973152|P2|Overall Study|Withdrawal by Subject|36
901822|NCT01136772|2973153|P1|Overall Study|Withdrawal by Subject|33
901823|NCT01136772|2973152|P2|Overall Study|Administrative|12
901824|NCT01136772|2973153|P1|Overall Study|Administrative|14
901825|NCT01136772|2973152|P2|Overall Study|Lack of Efficacy|39
901826|NCT01136772|2973153|P1|Overall Study|Lack of Efficacy|42
901827|NCT01136772|2973152|P2|Overall Study|Adverse Event|14
901828|NCT01136772|2973153|P1|Overall Study|Adverse Event|15
901829|NCT01136746|2973163|P2|Overall Study|Death|0
901830|NCT01136746|2973164|P1|Overall Study|Death|1
901831|NCT01136746|2973163|P2|Overall Study|Protocol Violation|1
901832|NCT01136746|2973164|P1|Overall Study|Protocol Violation|2
901833|NCT01136746|2973163|P2|Overall Study|Lost to Follow-up|2
901834|NCT01136746|2973164|P1|Overall Study|Lost to Follow-up|0
901835|NCT01136655|2973224|P1|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1
901836|NCT01136655|2973224|P1|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1
901837|NCT01136655|2973224|P1|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1
901838|NCT01136655|2973224|P1|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1
901839|NCT01136408|2973257|P3|Overall Study|Protocol Violation|1
901840|NCT01136408|2973258|P2|Overall Study|Protocol Violation|1
901841|NCT01136408|2973259|P1|Overall Study|Protocol Violation|1
901842|NCT01136408|2973257|P3|Overall Study|Adverse Event|4
901843|NCT01136408|2973258|P2|Overall Study|Adverse Event|8
901844|NCT01136408|2973259|P1|Overall Study|Adverse Event|4
901845|NCT01136382|2973316|P2|Overall Study|Withdrawal by Subject|1
901846|NCT01136382|2973317|P1|Overall Study|Withdrawal by Subject|4
901847|NCT01136382|2973316|P2|Overall Study|Severe Non-Compliance to Protocol|2
901848|NCT01136382|2973317|P1|Overall Study|Severe Non-Compliance to Protocol|0
901849|NCT01136382|2973316|P2|Overall Study|Study-Specific Withdrawal Criteria|25
901850|NCT01136382|2973317|P1|Overall Study|Study-Specific Withdrawal Criteria|48
901851|NCT01136382|2973316|P2|Overall Study|Not Specified|3
901852|NCT01136382|2973317|P1|Overall Study|Not Specified|8
901853|NCT01136356|2973343|P2|Second 18-day Withdrawal|Withdrawal by Subject|1
901854|NCT01136356|2973344|P1|Second 18-day Withdrawal|Withdrawal by Subject|0
901855|NCT01136356|2973343|P2|First 18-day Withdrawal|Physician Decision|0
901856|NCT01136356|2973344|P1|First 18-day Withdrawal|Physician Decision|1
901857|NCT01136356|2973343|P2|First 18-day Withdrawal|Withdrawal by Subject|0
901858|NCT01136356|2973344|P1|First 18-day Withdrawal|Withdrawal by Subject|3
901859|NCT01136291|2973355|P2|Overall Study|Lost to Follow-up|1
901860|NCT01136291|2973356|P1|Overall Study|Lost to Follow-up|1
901861|NCT01136174|2973375|P4|Overall Study|Adverse Event|4
901862|NCT01136174|2973376|P3|Overall Study|Adverse Event|0
901863|NCT01136174|2973377|P2|Overall Study|Adverse Event|0
901864|NCT01136174|2973378|P1|Overall Study|Adverse Event|0
901865|NCT01135992|2973458|P1|Overall Study|Unclassified|7
901866|NCT01135992|2973458|P1|Overall Study|Withdrawal criteria|10
901867|NCT01135992|2973458|P1|Overall Study|Protocol Violation|2
901868|NCT01135992|2973458|P1|Overall Study|Lack of Efficacy|1
901869|NCT01135992|2973458|P1|Overall Study|Adverse Event|1
901870|NCT01135914|2973470|P3|Overall Study|Adverse Event|2
901871|NCT01135914|2973471|P2|Overall Study|Adverse Event|1
901872|NCT01135914|2973472|P1|Overall Study|Adverse Event|0
901873|NCT01135914|2973470|P3|Overall Study|Lack of Efficacy|10
901874|NCT01135914|2973471|P2|Overall Study|Lack of Efficacy|1
901875|NCT01135914|2973472|P1|Overall Study|Lack of Efficacy|2
901876|NCT01135914|2973470|P3|Overall Study|Protocol Violation|3
901877|NCT01135914|2973471|P2|Overall Study|Protocol Violation|0
901878|NCT01135914|2973472|P1|Overall Study|Protocol Violation|0
901879|NCT01135914|2973470|P3|Overall Study|Lost to Follow-up|1
901880|NCT01135914|2973471|P2|Overall Study|Lost to Follow-up|0
901881|NCT01135914|2973472|P1|Overall Study|Lost to Follow-up|1
901882|NCT01135914|2973470|P3|Overall Study|Withdrawal by Subject|6
901883|NCT01135914|2973471|P2|Overall Study|Withdrawal by Subject|3
901884|NCT01135914|2973472|P1|Overall Study|Withdrawal by Subject|1
901885|NCT01135524|2973501|P1|Overall Study|Lack of Efficacy|8
901886|NCT01135524|2973501|P1|Overall Study|Administrative|151
901887|NCT01135524|2973501|P1|Overall Study|Lost to Follow-up|3
901888|NCT01135524|2973501|P1|Overall Study|Adverse Event|20
901889|NCT01135524|2973501|P1|Overall Study|Withdrawal by Subject|14
901890|NCT01135511|2973514|P9|Overall Study|Withdrawal by Subject|1
901891|NCT01135511|2973515|P8|Overall Study|Withdrawal by Subject|0
901892|NCT01135511|2973516|P7|Overall Study|Withdrawal by Subject|1
901893|NCT01135511|2973517|P6|Overall Study|Withdrawal by Subject|0
901894|NCT01135511|2973518|P5|Overall Study|Withdrawal by Subject|0
901895|NCT01135511|2973519|P4|Overall Study|Withdrawal by Subject|0
901896|NCT01135511|2973520|P3|Overall Study|Withdrawal by Subject|0
901897|NCT01135511|2973521|P2|Overall Study|Withdrawal by Subject|0
901898|NCT01135511|2973522|P1|Overall Study|Withdrawal by Subject|0
901899|NCT01135511|2973514|P9|Overall Study|noncompliance with study drug taken|0
901900|NCT01135511|2973515|P8|Overall Study|noncompliance with study drug taken|0
901901|NCT01135511|2973516|P7|Overall Study|noncompliance with study drug taken|0
901902|NCT01135511|2973517|P6|Overall Study|noncompliance with study drug taken|0
901903|NCT01135511|2973518|P5|Overall Study|noncompliance with study drug taken|1
901904|NCT01135511|2973519|P4|Overall Study|noncompliance with study drug taken|0
901905|NCT01135511|2973520|P3|Overall Study|noncompliance with study drug taken|0
901906|NCT01135511|2973521|P2|Overall Study|noncompliance with study drug taken|0
901907|NCT01135511|2973522|P1|Overall Study|noncompliance with study drug taken|0
901908|NCT01135511|2973514|P9|Overall Study|could not visit the clinic|0
901909|NCT01135511|2973515|P8|Overall Study|could not visit the clinic|0
901910|NCT01135511|2973516|P7|Overall Study|could not visit the clinic|0
901911|NCT01135511|2973517|P6|Overall Study|could not visit the clinic|0
901912|NCT01135511|2973518|P5|Overall Study|could not visit the clinic|0
901913|NCT01135511|2973519|P4|Overall Study|could not visit the clinic|0
901914|NCT01135511|2973520|P3|Overall Study|could not visit the clinic|2
901915|NCT01135511|2973521|P2|Overall Study|could not visit the clinic|1
901916|NCT01135511|2973522|P1|Overall Study|could not visit the clinic|0
901917|NCT01135511|2973514|P9|Overall Study|Pregnancy|0
901918|NCT01135511|2973515|P8|Overall Study|Pregnancy|0
901919|NCT01135511|2973516|P7|Overall Study|Pregnancy|0
901920|NCT01135511|2973517|P6|Overall Study|Pregnancy|0
901921|NCT01135511|2973518|P5|Overall Study|Pregnancy|0
901922|NCT01135511|2973519|P4|Overall Study|Pregnancy|1
901923|NCT01135511|2973520|P3|Overall Study|Pregnancy|0
901924|NCT01135511|2973521|P2|Overall Study|Pregnancy|0
901925|NCT01135511|2973522|P1|Overall Study|Pregnancy|0
901926|NCT01135511|2973514|P9|Overall Study|Protocol Violation|0
901927|NCT01135511|2973515|P8|Overall Study|Protocol Violation|0
901928|NCT01135511|2973516|P7|Overall Study|Protocol Violation|0
901929|NCT01135511|2973517|P6|Overall Study|Protocol Violation|0
901930|NCT01135511|2973518|P5|Overall Study|Protocol Violation|0
901931|NCT01135511|2973519|P4|Overall Study|Protocol Violation|0
901932|NCT01135511|2973520|P3|Overall Study|Protocol Violation|3
901933|NCT01135511|2973521|P2|Overall Study|Protocol Violation|0
901934|NCT01135511|2973522|P1|Overall Study|Protocol Violation|0
901935|NCT01135511|2973514|P9|Overall Study|Lack of Efficacy|0
901936|NCT01135511|2973515|P8|Overall Study|Lack of Efficacy|0
901937|NCT01135511|2973516|P7|Overall Study|Lack of Efficacy|0
901938|NCT01135511|2973517|P6|Overall Study|Lack of Efficacy|0
901939|NCT01135511|2973518|P5|Overall Study|Lack of Efficacy|0
901940|NCT01135511|2973519|P4|Overall Study|Lack of Efficacy|2
901941|NCT01135511|2973520|P3|Overall Study|Lack of Efficacy|1
901942|NCT01135511|2973521|P2|Overall Study|Lack of Efficacy|1
901943|NCT01135511|2973522|P1|Overall Study|Lack of Efficacy|0
901944|NCT01135511|2973514|P9|Overall Study|Adverse Event|0
901945|NCT01135511|2973515|P8|Overall Study|Adverse Event|1
901946|NCT01135511|2973516|P7|Overall Study|Adverse Event|0
901947|NCT01135511|2973517|P6|Overall Study|Adverse Event|1
901948|NCT01135511|2973518|P5|Overall Study|Adverse Event|0
901949|NCT01135511|2973519|P4|Overall Study|Adverse Event|0
901950|NCT01135511|2973520|P3|Overall Study|Adverse Event|2
901951|NCT01135511|2973521|P2|Overall Study|Adverse Event|1
901952|NCT01135511|2973522|P1|Overall Study|Adverse Event|0
901953|NCT01135498|2973804|P1|Overall Study|Ongoing at time of analysis|2
901954|NCT01135498|2973804|P1|Overall Study|Death|1
901955|NCT01135498|2973804|P1|Overall Study|Withdrawal by Subject|4
901956|NCT01135498|2973804|P1|Overall Study|Investigator judgement|25
901957|NCT01135498|2973804|P1|Overall Study|Progressive disease|38
901958|NCT01135498|2973804|P1|Overall Study|Adverse Event|20
901959|NCT01135134|2973983|P2|Overall Study|Did not meet protocol eligibility|0
901960|NCT01135134|2973984|P1|Overall Study|Did not meet protocol eligibility|1
901961|NCT01135134|2973983|P2|Overall Study|Adverse Event|1
901962|NCT01135134|2973984|P1|Overall Study|Adverse Event|1
901963|NCT01135017|2974007|P2|Overall Study|Other than above|4
901964|NCT01135017|2974008|P1|Overall Study|Other than above|3
901965|NCT01135017|2974007|P2|Overall Study|Adverse Event|8
901966|NCT01135017|2974008|P1|Overall Study|Adverse Event|3
901967|NCT01134939|2974046|P8|Overall Study|Termination page not available|0
901968|NCT01134939|2974047|P7|Overall Study|Termination page not available|7
901969|NCT01134939|2974048|P6|Overall Study|Termination page not available|3
901970|NCT01134939|2974049|P5|Overall Study|Termination page not available|0
901971|NCT01134939|2974050|P4|Overall Study|Termination page not available|8
901972|NCT01134939|2974051|P3|Overall Study|Termination page not available|5
901973|NCT01134939|2974052|P2|Overall Study|Termination page not available|6
901974|NCT01134939|2974053|P1|Overall Study|Termination page not available|4
901975|NCT01134939|2974046|P8|Overall Study|Death|0
901976|NCT01134939|2974047|P7|Overall Study|Death|0
901977|NCT01134939|2974048|P6|Overall Study|Death|0
901978|NCT01134939|2974049|P5|Overall Study|Death|0
901979|NCT01134939|2974050|P4|Overall Study|Death|0
901980|NCT01134939|2974051|P3|Overall Study|Death|0
901981|NCT01134939|2974052|P2|Overall Study|Death|1
901982|NCT01134939|2974053|P1|Overall Study|Death|0
901983|NCT01134939|2974046|P8|Overall Study|Lost to Follow-up|0
901984|NCT01134939|2974047|P7|Overall Study|Lost to Follow-up|0
901985|NCT01134939|2974048|P6|Overall Study|Lost to Follow-up|1
901986|NCT01134939|2974049|P5|Overall Study|Lost to Follow-up|2
901987|NCT01134939|2974050|P4|Overall Study|Lost to Follow-up|1
901988|NCT01134939|2974051|P3|Overall Study|Lost to Follow-up|0
901989|NCT01134939|2974052|P2|Overall Study|Lost to Follow-up|3
901990|NCT01134939|2974053|P1|Overall Study|Lost to Follow-up|2
901991|NCT01134939|2974046|P8|Overall Study|Lack of Efficacy|0
901992|NCT01134939|2974047|P7|Overall Study|Lack of Efficacy|1
901993|NCT01134939|2974048|P6|Overall Study|Lack of Efficacy|0
901994|NCT01134939|2974049|P5|Overall Study|Lack of Efficacy|3
901995|NCT01134939|2974050|P4|Overall Study|Lack of Efficacy|0
901996|NCT01134939|2974051|P3|Overall Study|Lack of Efficacy|1
901997|NCT01134939|2974052|P2|Overall Study|Lack of Efficacy|5
901998|NCT01134939|2974053|P1|Overall Study|Lack of Efficacy|2
901999|NCT01134939|2974046|P8|Overall Study|Adverse Event|0
902000|NCT01134939|2974047|P7|Overall Study|Adverse Event|1
902001|NCT01134939|2974048|P6|Overall Study|Adverse Event|5
902002|NCT01134939|2974049|P5|Overall Study|Adverse Event|5
902003|NCT01134939|2974050|P4|Overall Study|Adverse Event|5
902004|NCT01134939|2974051|P3|Overall Study|Adverse Event|4
902005|NCT01134939|2974052|P2|Overall Study|Adverse Event|3
902006|NCT01134939|2974053|P1|Overall Study|Adverse Event|9
902007|NCT01134783|2974191|P2|Overall Study|Lost to Follow-up|20
902008|NCT01134783|2974192|P1|Overall Study|Lost to Follow-up|5
902009|NCT01134783|2974191|P2|Overall Study|Withdrawal by Subject|9
902010|NCT01134783|2974192|P1|Overall Study|Withdrawal by Subject|15
902011|NCT01134783|2974191|P2|Overall Study|Pregnancy|8
902012|NCT01134783|2974192|P1|Overall Study|Pregnancy|16
902013|NCT01134731|2974211|P3|Overall Study|Lost to Follow-up|3
902014|NCT01134731|2974212|P2|Overall Study|Lost to Follow-up|4
902015|NCT01134731|2974213|P1|Overall Study|Lost to Follow-up|5
902016|NCT01134731|2974211|P3|Overall Study|Withdrawal by Subject|1
902017|NCT01134731|2974212|P2|Overall Study|Withdrawal by Subject|3
902018|NCT01134731|2974213|P1|Overall Study|Withdrawal by Subject|3
902019|NCT01134731|2974211|P3|Overall Study|Lack of Efficacy|1
902020|NCT01134731|2974212|P2|Overall Study|Lack of Efficacy|0
902021|NCT01134731|2974213|P1|Overall Study|Lack of Efficacy|0
902022|NCT01134731|2974211|P3|Overall Study|Physician Decision|2
902023|NCT01134731|2974212|P2|Overall Study|Physician Decision|2
902024|NCT01134731|2974213|P1|Overall Study|Physician Decision|2
902025|NCT01134731|2974211|P3|Overall Study|Adverse Event|1
902026|NCT01134731|2974212|P2|Overall Study|Adverse Event|2
902027|NCT01134731|2974213|P1|Overall Study|Adverse Event|3
902028|NCT01134705|2974226|P2|Overall Study|Other|6
902029|NCT01134705|2974227|P1|Overall Study|Other|1
902030|NCT01134705|2974226|P2|Overall Study|Protocol Violation|1
902031|NCT01134705|2974227|P1|Overall Study|Protocol Violation|1
902032|NCT01134705|2974226|P2|Overall Study|Lost to Follow-up|2
902033|NCT01134705|2974227|P1|Overall Study|Lost to Follow-up|5
902034|NCT01134705|2974226|P2|Overall Study|Pregnancy|0
902035|NCT01134705|2974227|P1|Overall Study|Pregnancy|1
902036|NCT01134705|2974226|P2|Overall Study|Withdrawal by Subject|6
902037|NCT01134705|2974227|P1|Overall Study|Withdrawal by Subject|6
902038|NCT01134705|2974226|P2|Overall Study|Adverse Event|7
902039|NCT01134705|2974227|P1|Overall Study|Adverse Event|1
902040|NCT01134627|2974239|P2|Overall Study|Other|14
902041|NCT01134627|2974240|P1|Overall Study|Other|11
902042|NCT01134627|2974239|P2|Overall Study|Planning to become pregnant/pregnancy|0
902043|NCT01134627|2974240|P1|Overall Study|Planning to become pregnant/pregnancy|1
902044|NCT01134627|2974239|P2|Overall Study|Withdrawal by Subject|3
902045|NCT01134627|2974240|P1|Overall Study|Withdrawal by Subject|4
902046|NCT01134627|2974239|P2|Overall Study|Lack of Efficacy|12
902047|NCT01134627|2974240|P1|Overall Study|Lack of Efficacy|2
902048|NCT01134627|2974239|P2|Overall Study|Protocol Violation|5
902049|NCT01134627|2974240|P1|Overall Study|Protocol Violation|3
902050|NCT01134627|2974239|P2|Overall Study|Lost to Follow-up|2
902051|NCT01134627|2974240|P1|Overall Study|Lost to Follow-up|1
902052|NCT01134627|2974239|P2|Overall Study|Adverse Event|31
902053|NCT01134627|2974240|P1|Overall Study|Adverse Event|47
902054|NCT01134614|2974270|P2|Overall Study|Patient in hospice care|1
902055|NCT01134614|2974271|P1|Overall Study|Patient in hospice care|0
902056|NCT01134614|2974270|P2|Overall Study|Symptomatic deterioration|1
902057|NCT01134614|2974271|P1|Overall Study|Symptomatic deterioration|0
902058|NCT01134614|2974270|P2|Overall Study|Pt received tx not allowed on study|1
902059|NCT01134614|2974271|P1|Overall Study|Pt received tx not allowed on study|0
902060|NCT01134614|2974270|P2|Overall Study|Never started treatment|1
902061|NCT01134614|2974271|P1|Overall Study|Never started treatment|4
902062|NCT01134614|2974270|P2|Overall Study|Physician's decision|1
902063|NCT01134614|2974271|P1|Overall Study|Physician's decision|0
902064|NCT01134614|2974270|P2|Overall Study|Complicating disease|1
902065|NCT01134614|2974271|P1|Overall Study|Complicating disease|2
902066|NCT01134614|2974270|P2|Overall Study|Alternative therapy|0
902067|NCT01134614|2974271|P1|Overall Study|Alternative therapy|2
902068|NCT01134614|2974270|P2|Overall Study|Withdrawal by Subject|2
902069|NCT01134614|2974271|P1|Overall Study|Withdrawal by Subject|3
902070|NCT01134614|2974270|P2|Overall Study|Death|8
902071|NCT01134614|2974271|P1|Overall Study|Death|5
902072|NCT01134614|2974270|P2|Overall Study|Adverse Event|39
902073|NCT01134614|2974271|P1|Overall Study|Adverse Event|26
902074|NCT01134614|2974270|P2|Overall Study|Progressive disease|54
902075|NCT01134614|2974271|P1|Overall Study|Progressive disease|60
902076|NCT01134614|2974270|P2|Overall Study|Still on treatment as of March 2013|13
902077|NCT01134614|2974271|P1|Overall Study|Still on treatment as of March 2013|21
902078|NCT01134562|2974286|P5|Overall Study|Adverse Event|0
902079|NCT01134562|2974287|P4|Overall Study|Adverse Event|0
902080|NCT01134562|2974288|P3|Overall Study|Adverse Event|0
902081|NCT01134562|2974289|P2|Overall Study|Adverse Event|1
902082|NCT01134562|2974290|P1|Overall Study|Adverse Event|0
902083|NCT01134393|2974462|P1|Overall Study|Other|6
902084|NCT01134393|2974462|P1|Overall Study|Withdrawal by Subject|11
902085|NCT01134393|2974462|P1|Overall Study|Lost to Follow-up|3
902086|NCT01134393|2974462|P1|Overall Study|Protocol Violation|12
902087|NCT01134393|2974462|P1|Overall Study|Lack of Efficacy|2
902088|NCT01134393|2974462|P1|Overall Study|Adverse Event|18
902089|NCT01134315|2974583|P2|Overall Study|Other Reason|17
902090|NCT01134315|2974584|P1|Overall Study|Other Reason|8
902091|NCT01134315|2974583|P2|Overall Study|Adverse Event|2
902092|NCT01134315|2974584|P1|Overall Study|Adverse Event|1
902093|NCT01134107|2974628|P2|Period 2-Second Treatment Intervention|Sponsor Decision|0
902094|NCT01134107|2974629|P1|Period 2-Second Treatment Intervention|Sponsor Decision|1
902095|NCT01134107|2974628|P2|Period 2-Second Treatment Intervention|Physician Decision|0
902096|NCT01134107|2974629|P1|Period 2-Second Treatment Intervention|Physician Decision|1
902097|NCT01134107|2974628|P2|Period 2-Second Treatment Intervention|Withdrawal by Subject|0
902098|NCT01134107|2974629|P1|Period 2-Second Treatment Intervention|Withdrawal by Subject|2
902099|NCT01134107|2974628|P2|Period 1-First Treatment Intervention|Physician Decision|0
902100|NCT01134107|2974629|P1|Period 1-First Treatment Intervention|Physician Decision|1
902101|NCT01134107|2974628|P2|Period 1-First Treatment Intervention|Withdrawal by Subject|4
902102|NCT01134107|2974629|P1|Period 1-First Treatment Intervention|Withdrawal by Subject|3
902103|NCT01134107|2974628|P2|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
902104|NCT01134107|2974629|P1|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
902105|NCT01134107|2974628|P2|Period 1-First Treatment Intervention|Adverse Event|0
902106|NCT01134107|2974629|P1|Period 1-First Treatment Intervention|Adverse Event|1
902107|NCT01134055|2974676|P7|Overall Study|Physician Decision|1
902108|NCT01134055|2974677|P6|Overall Study|Physician Decision|0
902109|NCT01134055|2974678|P5|Overall Study|Physician Decision|0
902110|NCT01134055|2974679|P4|Overall Study|Physician Decision|0
902111|NCT01134055|2974680|P3|Overall Study|Physician Decision|0
902112|NCT01134055|2974681|P2|Overall Study|Physician Decision|0
902113|NCT01134055|2974682|P1|Overall Study|Physician Decision|0
902114|NCT01134055|2974676|P7|Overall Study|Protocol Violation|0
902115|NCT01134055|2974677|P6|Overall Study|Protocol Violation|0
902116|NCT01134055|2974678|P5|Overall Study|Protocol Violation|1
902117|NCT01134055|2974679|P4|Overall Study|Protocol Violation|1
902118|NCT01134055|2974680|P3|Overall Study|Protocol Violation|0
902119|NCT01134055|2974681|P2|Overall Study|Protocol Violation|0
902120|NCT01134055|2974682|P1|Overall Study|Protocol Violation|0
902121|NCT01134055|2974676|P7|Overall Study|Withdrawal by Subject|8
902122|NCT01134055|2974677|P6|Overall Study|Withdrawal by Subject|0
902123|NCT01134055|2974678|P5|Overall Study|Withdrawal by Subject|0
902124|NCT01134055|2974679|P4|Overall Study|Withdrawal by Subject|2
902125|NCT01134055|2974680|P3|Overall Study|Withdrawal by Subject|1
902126|NCT01134055|2974681|P2|Overall Study|Withdrawal by Subject|3
902127|NCT01134055|2974682|P1|Overall Study|Withdrawal by Subject|3
902128|NCT01134055|2974676|P7|Overall Study|Lost to Follow-up|0
902129|NCT01134055|2974677|P6|Overall Study|Lost to Follow-up|0
902130|NCT01134055|2974678|P5|Overall Study|Lost to Follow-up|0
902131|NCT01134055|2974679|P4|Overall Study|Lost to Follow-up|1
902132|NCT01134055|2974680|P3|Overall Study|Lost to Follow-up|0
902133|NCT01134055|2974681|P2|Overall Study|Lost to Follow-up|1
902134|NCT01134055|2974682|P1|Overall Study|Lost to Follow-up|0
902135|NCT01134055|2974676|P7|Overall Study|Adverse Event|2
902136|NCT01134055|2974677|P6|Overall Study|Adverse Event|7
902137|NCT01134055|2974678|P5|Overall Study|Adverse Event|5
902138|NCT01134055|2974679|P4|Overall Study|Adverse Event|2
902139|NCT01134055|2974680|P3|Overall Study|Adverse Event|2
902140|NCT01134055|2974681|P2|Overall Study|Adverse Event|2
902141|NCT01134055|2974682|P1|Overall Study|Adverse Event|5
902142|NCT01134042|2974816|P3|Overall Study|Withdrawal by Subject|7
902143|NCT01134042|2974817|P2|Overall Study|Withdrawal by Subject|4
902144|NCT01134042|2974818|P1|Overall Study|Withdrawal by Subject|13
902145|NCT01134042|2974816|P3|Overall Study|Physician Decision|1
902146|NCT01134042|2974817|P2|Overall Study|Physician Decision|8
902147|NCT01134042|2974818|P1|Overall Study|Physician Decision|4
902148|NCT01134042|2974816|P3|Overall Study|Lost to Follow-up|1
902149|NCT01134042|2974817|P2|Overall Study|Lost to Follow-up|0
902150|NCT01134042|2974818|P1|Overall Study|Lost to Follow-up|2
902151|NCT01134042|2974816|P3|Overall Study|Protocol Violation|5
902152|NCT01134042|2974817|P2|Overall Study|Protocol Violation|3
902153|NCT01134042|2974818|P1|Overall Study|Protocol Violation|5
902154|NCT01134042|2974816|P3|Overall Study|Lack of Efficacy|18
902155|NCT01134042|2974817|P2|Overall Study|Lack of Efficacy|6
902156|NCT01134042|2974818|P1|Overall Study|Lack of Efficacy|21
902157|NCT01134042|2974816|P3|Overall Study|Adverse Event|2
902158|NCT01134042|2974817|P2|Overall Study|Adverse Event|7
902159|NCT01134042|2974818|P1|Overall Study|Adverse Event|3
902160|NCT01133977|2974894|P5|Overall Study|Withdrawal by Subject|1
902161|NCT01133977|2974895|P4|Overall Study|Withdrawal by Subject|5
902162|NCT01133977|2974896|P3|Overall Study|Withdrawal by Subject|0
902163|NCT01133977|2974897|P2|Overall Study|Withdrawal by Subject|0
902164|NCT01133977|2974898|P1|Overall Study|Withdrawal by Subject|0
902165|NCT01133977|2974894|P5|Overall Study|Lost to Follow-up|1
902166|NCT01133977|2974895|P4|Overall Study|Lost to Follow-up|2
902167|NCT01133977|2974896|P3|Overall Study|Lost to Follow-up|0
902168|NCT01133977|2974897|P2|Overall Study|Lost to Follow-up|0
902169|NCT01133977|2974898|P1|Overall Study|Lost to Follow-up|0
902170|NCT01133977|2974894|P5|Overall Study|Started a New Line of Therapy|33
902171|NCT01133977|2974895|P4|Overall Study|Started a New Line of Therapy|25
902172|NCT01133977|2974896|P3|Overall Study|Started a New Line of Therapy|4
902173|NCT01133977|2974897|P2|Overall Study|Started a New Line of Therapy|6
902174|NCT01133977|2974898|P1|Overall Study|Started a New Line of Therapy|2
902175|NCT01133977|2974894|P5|Overall Study|Death|3
902176|NCT01133977|2974895|P4|Overall Study|Death|7
902177|NCT01133977|2974896|P3|Overall Study|Death|1
902178|NCT01133977|2974897|P2|Overall Study|Death|1
902179|NCT01133977|2974898|P1|Overall Study|Death|1
902180|NCT01133977|2974894|P5|Overall Study|Adverse Event|0
902181|NCT01133977|2974895|P4|Overall Study|Adverse Event|0
902182|NCT01133977|2974896|P3|Overall Study|Adverse Event|1
902183|NCT01133977|2974897|P2|Overall Study|Adverse Event|0
902184|NCT01133977|2974898|P1|Overall Study|Adverse Event|0
902185|NCT01133847|2974925|P3|Follow-Up Phase|Lost to Follow-up|7
902186|NCT01133847|2974926|P2|Follow-Up Phase|Lost to Follow-up|3
902187|NCT01133847|2974927|P1|Follow-Up Phase|Lost to Follow-up|1
902188|NCT01133847|2974925|P3|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3
902189|NCT01133847|2974926|P2|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1
902190|NCT01133847|2974927|P1|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5
902191|NCT01133821|2974967|P2|Overall Study|Refused participation|3
902192|NCT01133821|2974968|P1|Overall Study|Refused participation|1
902193|NCT01133821|2974967|P2|Overall Study|Protocol Violation|1
902194|NCT01133821|2974968|P1|Overall Study|Protocol Violation|0
902195|NCT01133821|2974967|P2|Overall Study|preferred other treatment|1
902196|NCT01133821|2974968|P1|Overall Study|preferred other treatment|1
902197|NCT01133821|2974967|P2|Overall Study|Withdrawal by Subject|3
902198|NCT01133821|2974968|P1|Overall Study|Withdrawal by Subject|8
902199|NCT01133821|2974967|P2|Overall Study|Lost to Follow-up|11
902200|NCT01133821|2974968|P1|Overall Study|Lost to Follow-up|8
902201|NCT01133756|2974979|P3|Overall Study|Progression of Disease|1
902202|NCT01133756|2974980|P2|Overall Study|Progression of Disease|0
902203|NCT01133756|2974981|P1|Overall Study|Progression of Disease|0
902204|NCT01133756|2974979|P3|Overall Study|Withdrawal by Subject|0
902205|NCT01133756|2974980|P2|Overall Study|Withdrawal by Subject|1
902206|NCT01133756|2974981|P1|Overall Study|Withdrawal by Subject|0
902207|NCT01133756|2974979|P3|Overall Study|Investigator Decision|0
902208|NCT01133756|2974980|P2|Overall Study|Investigator Decision|0
902209|NCT01133756|2974981|P1|Overall Study|Investigator Decision|1
902210|NCT01133756|2974979|P3|Overall Study|Adverse Event|1
902211|NCT01133756|2974980|P2|Overall Study|Adverse Event|2
902212|NCT01133756|2974981|P1|Overall Study|Adverse Event|1
902213|NCT01133704|2974997|P2|Overall Study|Study Closure|0
902214|NCT01133704|2974998|P1|Overall Study|Study Closure|1
902215|NCT01133704|2974997|P2|Overall Study|Patient refused to continue|0
902216|NCT01133704|2974998|P1|Overall Study|Patient refused to continue|4
902217|NCT01133704|2974997|P2|Overall Study|Death|26
902218|NCT01133704|2974998|P1|Overall Study|Death|44
902219|NCT01133665|2975006|P1|Overall Study|Physician Decision|2
902220|NCT01133626|2975067|P3|Overall Study|Not specified|0
902221|NCT01133626|2975068|P2|Overall Study|Not specified|2
902222|NCT01133626|2975069|P1|Overall Study|Not specified|0
902223|NCT01133626|2975067|P3|Overall Study|Withdrawal by Subject|2
902224|NCT01133626|2975068|P2|Overall Study|Withdrawal by Subject|2
902225|NCT01133626|2975069|P1|Overall Study|Withdrawal by Subject|1
902226|NCT01133626|2975067|P3|Overall Study|Adverse Event|0
902227|NCT01133626|2975068|P2|Overall Study|Adverse Event|1
902228|NCT01133626|2975069|P1|Overall Study|Adverse Event|0
902229|NCT01133522|2975087|P10|Overall Study|Physician Decision|0
902230|NCT01133522|2975088|P9|Overall Study|Physician Decision|0
902231|NCT01133522|2975089|P8|Overall Study|Physician Decision|0
902232|NCT01133522|2975090|P7|Overall Study|Physician Decision|0
902233|NCT01133522|2975091|P6|Overall Study|Physician Decision|0
902234|NCT01133522|2975092|P5|Overall Study|Physician Decision|1
902235|NCT01133522|2975093|P4|Overall Study|Physician Decision|0
902236|NCT01133522|2975094|P3|Overall Study|Physician Decision|0
902237|NCT01133522|2975095|P2|Overall Study|Physician Decision|0
902238|NCT01133522|2975096|P1|Overall Study|Physician Decision|0
902239|NCT01133522|2975087|P10|Overall Study|Withdrawal by Subject|0
902240|NCT01133522|2975088|P9|Overall Study|Withdrawal by Subject|0
902241|NCT01133522|2975089|P8|Overall Study|Withdrawal by Subject|0
902242|NCT01133522|2975090|P7|Overall Study|Withdrawal by Subject|0
902243|NCT01133522|2975091|P6|Overall Study|Withdrawal by Subject|0
902244|NCT01133522|2975092|P5|Overall Study|Withdrawal by Subject|0
902245|NCT01133522|2975093|P4|Overall Study|Withdrawal by Subject|1
902246|NCT01133522|2975094|P3|Overall Study|Withdrawal by Subject|0
902247|NCT01133522|2975095|P2|Overall Study|Withdrawal by Subject|1
902248|NCT01133522|2975096|P1|Overall Study|Withdrawal by Subject|0
902249|NCT01133418|2975164|P2|Overall Study|Lost to Follow-up|6
902250|NCT01133418|2975165|P1|Overall Study|Lost to Follow-up|5
902251|NCT01133392|2975179|P2|Interval Between Dosing (4-7 Days)|Protocol Violation|1
902252|NCT01133392|2975180|P1|Interval Between Dosing (4-7 Days)|Protocol Violation|0
902253|NCT01133392|2975179|P2|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1
902254|NCT01133392|2975180|P1|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0
902255|NCT01133379|2975197|P3|Overall Study|Lost to Follow-up|1
902256|NCT01133379|2975198|P2|Overall Study|Lost to Follow-up|1
902257|NCT01133379|2975199|P1|Overall Study|Lost to Follow-up|1
902258|NCT01133379|2975197|P3|Overall Study|Withdrawal by Subject|1
902259|NCT01133379|2975198|P2|Overall Study|Withdrawal by Subject|1
902260|NCT01133379|2975199|P1|Overall Study|Withdrawal by Subject|0
902261|NCT01133288|2975252|P1|Intervention Allocation|study terminated|2
902262|NCT01133288|2975252|P1|Eligibility Assessment|met exclusion criteria|5
902263|NCT01133275|2975257|P1|Overall Study|Cerebrovascular accident (CVA)|1
902264|NCT01133275|2975257|P1|Overall Study|Withdrawal by Subject|1
902265|NCT01133171|2975265|P3|Overall Study|Withdrawal by Subject|0
902266|NCT01133171|2975266|P2|Overall Study|Withdrawal by Subject|2
902267|NCT01133171|2975267|P1|Overall Study|Withdrawal by Subject|1
902268|NCT01133067|2975283|P1|Overall Study|Lost to Follow-up|3
902269|NCT01133067|2975283|P1|Overall Study|Death|136
902270|NCT01132820|2975343|P1|Overall Study|Inadequate data|1
902271|NCT01132820|2975343|P1|Overall Study|Never treated|1
902272|NCT01132820|2975343|P1|Overall Study|Ineligible:Inadequate pathology|1
902273|NCT01132820|2975343|P1|Overall Study|Ineligible:Improper pre-protocol therapy|1
902274|NCT01132820|2975343|P1|Overall Study|Ineligible: wrong cell type|1
902275|NCT01132664|2975376|P5|BM Cohort|Withdrawal by Subject|1
902276|NCT01132664|2975377|P4|BM Cohort|Withdrawal by Subject|0
902277|NCT01132664|2975378|P3|BM Cohort|Withdrawal by Subject|0
902278|NCT01132664|2975379|P2|BM Cohort|Withdrawal by Subject|0
902279|NCT01132664|2975380|P1|BM Cohort|Withdrawal by Subject|0
902280|NCT01132664|2975376|P5|BM Cohort|Adverse Event|1
902281|NCT01132664|2975377|P4|BM Cohort|Adverse Event|0
902282|NCT01132664|2975378|P3|BM Cohort|Adverse Event|0
902283|NCT01132664|2975379|P2|BM Cohort|Adverse Event|0
902284|NCT01132664|2975380|P1|BM Cohort|Adverse Event|0
902285|NCT01132664|2975376|P5|BM Cohort|Disease progression|4
902286|NCT01132664|2975377|P4|BM Cohort|Disease progression|3
902287|NCT01132664|2975378|P3|BM Cohort|Disease progression|0
902288|NCT01132664|2975379|P2|BM Cohort|Disease progression|0
902289|NCT01132664|2975380|P1|BM Cohort|Disease progression|0
902290|NCT01132664|2975376|P5|Phase ll|Disease progression|0
902291|NCT01132664|2975377|P4|Phase ll|Disease progression|0
902292|NCT01132664|2975378|P3|Phase ll|Disease progression|35
902293|NCT01132664|2975379|P2|Phase ll|Disease progression|0
902294|NCT01132664|2975380|P1|Phase ll|Disease progression|0
902295|NCT01132664|2975376|P5|Phase ll|Withdrawal by Subject|0
902296|NCT01132664|2975377|P4|Phase ll|Withdrawal by Subject|0
902297|NCT01132664|2975378|P3|Phase ll|Withdrawal by Subject|3
902298|NCT01132664|2975379|P2|Phase ll|Withdrawal by Subject|0
902299|NCT01132664|2975380|P1|Phase ll|Withdrawal by Subject|0
902300|NCT01132664|2975376|P5|Phase ll|Adverse Event|0
902301|NCT01132664|2975377|P4|Phase ll|Adverse Event|0
902302|NCT01132664|2975378|P3|Phase ll|Adverse Event|10
902303|NCT01132664|2975379|P2|Phase ll|Adverse Event|0
902304|NCT01132664|2975380|P1|Phase ll|Adverse Event|0
902305|NCT01132664|2975376|P5|Phase ll|Death|0
902306|NCT01132664|2975377|P4|Phase ll|Death|0
902307|NCT01132664|2975378|P3|Phase ll|Death|2
902308|NCT01132664|2975379|P2|Phase ll|Death|0
902309|NCT01132664|2975380|P1|Phase ll|Death|0
902310|NCT01132664|2975376|P5|Phase lb|Disease Progression|0
902311|NCT01132664|2975377|P4|Phase lb|Disease Progression|0
902312|NCT01132664|2975378|P3|Phase lb|Disease Progression|0
902313|NCT01132664|2975379|P2|Phase lb|Disease Progression|9
902314|NCT01132664|2975380|P1|Phase lb|Disease Progression|4
902315|NCT01132664|2975376|P5|Phase lb|Withdrawal by Subject|0
902316|NCT01132664|2975377|P4|Phase lb|Withdrawal by Subject|0
902317|NCT01132664|2975378|P3|Phase lb|Withdrawal by Subject|0
902318|NCT01132664|2975379|P2|Phase lb|Withdrawal by Subject|2
902319|NCT01132664|2975380|P1|Phase lb|Withdrawal by Subject|1
902320|NCT01132664|2975376|P5|Phase lb|Adverse Event|0
902321|NCT01132664|2975377|P4|Phase lb|Adverse Event|0
902322|NCT01132664|2975378|P3|Phase lb|Adverse Event|0
902323|NCT01132664|2975379|P2|Phase lb|Adverse Event|1
902324|NCT01132664|2975380|P1|Phase lb|Adverse Event|0
902325|NCT01132651|2975414|P2|Overall Study|Lost to Follow-up|1
902326|NCT01132651|2975415|P1|Overall Study|Lost to Follow-up|1
902327|NCT01132612|2975426|P3|Overall Study|Lack of Efficacy|73
902328|NCT01132612|2975427|P2|Overall Study|Lack of Efficacy|22
902329|NCT01132612|2975428|P1|Overall Study|Lack of Efficacy|23
902330|NCT01132612|2975426|P3|Overall Study|Administrative problems|52
902331|NCT01132612|2975427|P2|Overall Study|Administrative problems|1
902332|NCT01132612|2975428|P1|Overall Study|Administrative problems|5
902333|NCT01132612|2975426|P3|Overall Study|Withdrawal by Subject|19
902334|NCT01132612|2975427|P2|Overall Study|Withdrawal by Subject|8
902335|NCT01132612|2975428|P1|Overall Study|Withdrawal by Subject|5
902336|NCT01132612|2975426|P3|Overall Study|Adverse Event|15
902337|NCT01132612|2975427|P2|Overall Study|Adverse Event|2
902338|NCT01132612|2975428|P1|Overall Study|Adverse Event|5
902339|NCT01132612|2975426|P3|Overall Study|Lost to Follow-up|7
902340|NCT01132612|2975427|P2|Overall Study|Lost to Follow-up|2
902341|NCT01132612|2975428|P1|Overall Study|Lost to Follow-up|2
902342|NCT01132612|2975426|P3|Overall Study|Protocol deviation|3
902343|NCT01132612|2975427|P2|Overall Study|Protocol deviation|0
902344|NCT01132612|2975428|P1|Overall Study|Protocol deviation|0
902345|NCT01132612|2975426|P3|Overall Study|Death|1
902346|NCT01132612|2975427|P2|Overall Study|Death|0
902347|NCT01132612|2975428|P1|Overall Study|Death|0
902348|NCT01132547|2975444|P2|Overall Study|Death|0
902349|NCT01132547|2975445|P1|Overall Study|Death|1
902350|NCT01132547|2975444|P2|Overall Study|Withdrawal by Subject|1
902351|NCT01132547|2975445|P1|Overall Study|Withdrawal by Subject|3
902352|NCT01132495|2975515|P4|Overall Study|Various reasons|12
902353|NCT01132495|2975516|P3|Overall Study|Various reasons|20
902354|NCT01132495|2975517|P2|Overall Study|Various reasons|38
902355|NCT01132495|2975518|P1|Overall Study|Various reasons|40
902356|NCT01132326|2975531|P1|Overall Study|Subject Unable to Come To Visits|1
902357|NCT01132326|2975531|P1|Overall Study|Death|5
902358|NCT01132326|2975531|P1|Overall Study|Caregiver Withdrew Consent|1
902359|NCT01132326|2975531|P1|Overall Study|Pregnancy|1
902360|NCT01132326|2975531|P1|Overall Study|Declining Health|1
902361|NCT01132326|2975531|P1|Overall Study|Study Termination|80
902362|NCT01132326|2975531|P1|Overall Study|Physician Decision|10
902363|NCT01132326|2975531|P1|Overall Study|Withdrawal by Subject|40
902364|NCT01132326|2975531|P1|Overall Study|Lost to Follow-up|16
902365|NCT01132326|2975531|P1|Overall Study|Protocol Violation|1
902366|NCT01132326|2975531|P1|Overall Study|Adverse Event|37
902367|NCT01132326|2975531|P1|Overall Study|Lack of Efficacy|25
902368|NCT01132313|2975547|P12|Overall Study|Other reason not defined above|0
902369|NCT01132313|2975548|P11|Overall Study|Other reason not defined above|0
902370|NCT01132313|2975549|P10|Overall Study|Other reason not defined above|0
902371|NCT01132313|2975550|P9|Overall Study|Other reason not defined above|0
902372|NCT01132313|2975551|P8|Overall Study|Other reason not defined above|1
902373|NCT01132313|2975552|P7|Overall Study|Other reason not defined above|0
902374|NCT01132313|2975553|P6|Overall Study|Other reason not defined above|0
902375|NCT01132313|2975554|P5|Overall Study|Other reason not defined above|0
902376|NCT01132313|2975555|P4|Overall Study|Other reason not defined above|0
902377|NCT01132313|2975556|P3|Overall Study|Other reason not defined above|0
902378|NCT01132313|2975557|P2|Overall Study|Other reason not defined above|0
902379|NCT01132313|2975558|P1|Overall Study|Other reason not defined above|0
902380|NCT01132313|2975547|P12|Overall Study|Lack of antiviral response|0
902381|NCT01132313|2975548|P11|Overall Study|Lack of antiviral response|1
902382|NCT01132313|2975549|P10|Overall Study|Lack of antiviral response|0
902383|NCT01132313|2975550|P9|Overall Study|Lack of antiviral response|0
902384|NCT01132313|2975551|P8|Overall Study|Lack of antiviral response|0
902385|NCT01132313|2975552|P7|Overall Study|Lack of antiviral response|21
902386|NCT01132313|2975553|P6|Overall Study|Lack of antiviral response|18
902387|NCT01132313|2975554|P5|Overall Study|Lack of antiviral response|18
902388|NCT01132313|2975555|P4|Overall Study|Lack of antiviral response|18
902389|NCT01132313|2975556|P3|Overall Study|Lack of antiviral response|12
902390|NCT01132313|2975557|P2|Overall Study|Lack of antiviral response|0
902391|NCT01132313|2975558|P1|Overall Study|Lack of antiviral response|0
902392|NCT01132313|2975547|P12|Overall Study|Withdrawal by Subject|0
902393|NCT01132313|2975548|P11|Overall Study|Withdrawal by Subject|0
902394|NCT01132313|2975549|P10|Overall Study|Withdrawal by Subject|2
902395|NCT01132313|2975550|P9|Overall Study|Withdrawal by Subject|0
902396|NCT01132313|2975551|P8|Overall Study|Withdrawal by Subject|0
902397|NCT01132313|2975552|P7|Overall Study|Withdrawal by Subject|1
902398|NCT01132313|2975553|P6|Overall Study|Withdrawal by Subject|0
902399|NCT01132313|2975554|P5|Overall Study|Withdrawal by Subject|6
902400|NCT01132313|2975555|P4|Overall Study|Withdrawal by Subject|3
902401|NCT01132313|2975556|P3|Overall Study|Withdrawal by Subject|3
902402|NCT01132313|2975557|P2|Overall Study|Withdrawal by Subject|0
902403|NCT01132313|2975558|P1|Overall Study|Withdrawal by Subject|0
902404|NCT01132313|2975547|P12|Overall Study|Lost to Follow-up|0
902405|NCT01132313|2975548|P11|Overall Study|Lost to Follow-up|0
902406|NCT01132313|2975549|P10|Overall Study|Lost to Follow-up|0
902407|NCT01132313|2975550|P9|Overall Study|Lost to Follow-up|0
902408|NCT01132313|2975551|P8|Overall Study|Lost to Follow-up|1
902409|NCT01132313|2975552|P7|Overall Study|Lost to Follow-up|0
902410|NCT01132313|2975553|P6|Overall Study|Lost to Follow-up|0
902411|NCT01132313|2975554|P5|Overall Study|Lost to Follow-up|0
902412|NCT01132313|2975555|P4|Overall Study|Lost to Follow-up|0
902413|NCT01132313|2975556|P3|Overall Study|Lost to Follow-up|1
902414|NCT01132313|2975557|P2|Overall Study|Lost to Follow-up|0
902415|NCT01132313|2975558|P1|Overall Study|Lost to Follow-up|0
902416|NCT01132313|2975547|P12|Overall Study|Protocol Violation|0
902417|NCT01132313|2975548|P11|Overall Study|Protocol Violation|0
902418|NCT01132313|2975549|P10|Overall Study|Protocol Violation|0
902419|NCT01132313|2975550|P9|Overall Study|Protocol Violation|0
902420|NCT01132313|2975551|P8|Overall Study|Protocol Violation|0
902421|NCT01132313|2975552|P7|Overall Study|Protocol Violation|0
902422|NCT01132313|2975553|P6|Overall Study|Protocol Violation|0
902423|NCT01132313|2975554|P5|Overall Study|Protocol Violation|0
902424|NCT01132313|2975555|P4|Overall Study|Protocol Violation|1
902425|NCT01132313|2975556|P3|Overall Study|Protocol Violation|0
902426|NCT01132313|2975557|P2|Overall Study|Protocol Violation|0
902427|NCT01132313|2975558|P1|Overall Study|Protocol Violation|0
902428|NCT01132313|2975547|P12|Overall Study|Adverse Event|0
902429|NCT01132313|2975548|P11|Overall Study|Adverse Event|0
902430|NCT01132313|2975549|P10|Overall Study|Adverse Event|2
902431|NCT01132313|2975550|P9|Overall Study|Adverse Event|7
902432|NCT01132313|2975551|P8|Overall Study|Adverse Event|3
902433|NCT01132313|2975552|P7|Overall Study|Adverse Event|5
902434|NCT01132313|2975553|P6|Overall Study|Adverse Event|6
902435|NCT01132313|2975554|P5|Overall Study|Adverse Event|19
902436|NCT01132313|2975555|P4|Overall Study|Adverse Event|10
902437|NCT01132313|2975556|P3|Overall Study|Adverse Event|4
902438|NCT01132313|2975557|P2|Overall Study|Adverse Event|0
902439|NCT01132313|2975558|P1|Overall Study|Adverse Event|0
902440|NCT01132313|2975547|P12|Overall Study|Not treated|0
902441|NCT01132313|2975548|P11|Overall Study|Not treated|0
902442|NCT01132313|2975549|P10|Overall Study|Not treated|0
902443|NCT01132313|2975550|P9|Overall Study|Not treated|0
902444|NCT01132313|2975551|P8|Overall Study|Not treated|0
902445|NCT01132313|2975552|P7|Overall Study|Not treated|3
902446|NCT01132313|2975553|P6|Overall Study|Not treated|1
902447|NCT01132313|2975554|P5|Overall Study|Not treated|2
902448|NCT01132313|2975555|P4|Overall Study|Not treated|0
902449|NCT01132313|2975556|P3|Overall Study|Not treated|0
902450|NCT01132313|2975557|P2|Overall Study|Not treated|0
902451|NCT01132313|2975558|P1|Overall Study|Not treated|2
902452|NCT01132313|2975547|P12|Overall Study|Lack of Efficacy|0
902453|NCT01132313|2975548|P11|Overall Study|Lack of Efficacy|0
902454|NCT01132313|2975549|P10|Overall Study|Lack of Efficacy|16
902455|NCT01132313|2975550|P9|Overall Study|Lack of Efficacy|14
902456|NCT01132313|2975551|P8|Overall Study|Lack of Efficacy|3
902457|NCT01132313|2975552|P7|Overall Study|Lack of Efficacy|0
902458|NCT01132313|2975553|P6|Overall Study|Lack of Efficacy|0
902459|NCT01132313|2975554|P5|Overall Study|Lack of Efficacy|0
902460|NCT01132313|2975555|P4|Overall Study|Lack of Efficacy|0
902461|NCT01132313|2975556|P3|Overall Study|Lack of Efficacy|0
902462|NCT01132313|2975557|P2|Overall Study|Lack of Efficacy|0
902463|NCT01132313|2975558|P1|Overall Study|Lack of Efficacy|1
902464|NCT01132118|2975638|P2|Second Intervention (8 Weeks)|Adverse Event|1
902465|NCT01132118|2975639|P1|Second Intervention (8 Weeks)|Adverse Event|0
902466|NCT01132118|2975638|P2|First Intervention (8 Weeks)|Withdrawal by Subject|3
902467|NCT01132118|2975639|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
902468|NCT01132118|2975638|P2|First Intervention (8 Weeks)|Adverse Event|0
902469|NCT01132118|2975639|P1|First Intervention (8 Weeks)|Adverse Event|1
902470|NCT01131676|2975669|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2
902471|NCT01131676|2975670|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
902472|NCT01131676|2975671|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
902473|NCT01131676|2975669|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5
902474|NCT01131676|2975670|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6
902475|NCT01131676|2975671|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7
902476|NCT01131676|2975669|P3|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7
902477|NCT01131676|2975670|P2|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9
902478|NCT01131676|2975671|P1|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5
902479|NCT01131676|2975669|P3|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19
902480|NCT01131676|2975670|P2|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21
902481|NCT01131676|2975671|P1|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20
902482|NCT01131676|2975669|P3|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5
902483|NCT01131676|2975670|P2|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6
902484|NCT01131676|2975671|P1|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8
902485|NCT01131676|2975669|P3|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25
902486|NCT01131676|2975670|P2|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35
902487|NCT01131676|2975671|P1|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23
902488|NCT01131676|2975669|P3|Discontinuation From Treatment|Adverse Event|273
902489|NCT01131676|2975670|P2|Discontinuation From Treatment|Adverse Event|267
902490|NCT01131676|2975671|P1|Discontinuation From Treatment|Adverse Event|303
902491|NCT01131676|2975669|P3|Discontinuation From Treatment|Other than those specified|125
902492|NCT01131676|2975670|P2|Discontinuation From Treatment|Other than those specified|142
902493|NCT01131676|2975671|P1|Discontinuation From Treatment|Other than those specified|162
902494|NCT01131676|2975669|P3|Discontinuation From Treatment|Refusal to continue, not due to AE|122
902495|NCT01131676|2975670|P2|Discontinuation From Treatment|Refusal to continue, not due to AE|118
902496|NCT01131676|2975671|P1|Discontinuation From Treatment|Refusal to continue, not due to AE|172
902497|NCT01131676|2975669|P3|Discontinuation From Treatment|Lost to Follow-up|6
902498|NCT01131676|2975670|P2|Discontinuation From Treatment|Lost to Follow-up|9
902499|NCT01131676|2975671|P1|Discontinuation From Treatment|Lost to Follow-up|15
902500|NCT01131676|2975669|P3|Discontinuation From Treatment|Non compliant with protocol|12
902501|NCT01131676|2975670|P2|Discontinuation From Treatment|Non compliant with protocol|15
902502|NCT01131676|2975671|P1|Discontinuation From Treatment|Non compliant with protocol|15
902503|NCT01131676|2975669|P3|Discontinuation From Treatment|Lack of Efficacy|0
902504|NCT01131676|2975670|P2|Discontinuation From Treatment|Lack of Efficacy|1
902505|NCT01131676|2975671|P1|Discontinuation From Treatment|Lack of Efficacy|11
902506|NCT01131676|2975669|P3|Discontinuation From Treatment|Not treated|2
902507|NCT01131676|2975670|P2|Discontinuation From Treatment|Not treated|2
902508|NCT01131676|2975671|P1|Discontinuation From Treatment|Not treated|4
902509|NCT01131676|2975669|P3|Discontinuation From Treatment|Study drug stopped, reason missing|4
902510|NCT01131676|2975670|P2|Discontinuation From Treatment|Study drug stopped, reason missing|3
902511|NCT01131676|2975671|P1|Discontinuation From Treatment|Study drug stopped, reason missing|5
902512|NCT01131585|2975706|P2|Overall Study|Study termination|32
902513|NCT01131585|2975707|P1|Overall Study|Study termination|78
902514|NCT01131585|2975706|P2|Overall Study|Administrative problems|1
902515|NCT01131585|2975707|P1|Overall Study|Administrative problems|1
902516|NCT01131585|2975706|P2|Overall Study|Lost to Follow-up|1
902517|NCT01131585|2975707|P1|Overall Study|Lost to Follow-up|0
902518|NCT01131585|2975706|P2|Overall Study|Withdrawal by Subject|3
902519|NCT01131585|2975707|P1|Overall Study|Withdrawal by Subject|3
902520|NCT01131585|2975706|P2|Overall Study|Protocol Violation|1
902521|NCT01131585|2975707|P1|Overall Study|Protocol Violation|2
902522|NCT01131585|2975706|P2|Overall Study|Unsatisfactory therapeutic effect|3
902523|NCT01131585|2975707|P1|Overall Study|Unsatisfactory therapeutic effect|0
902524|NCT01131585|2975706|P2|Overall Study|Abnormal laboratory value|0
902525|NCT01131585|2975707|P1|Overall Study|Abnormal laboratory value|1
902526|NCT01131585|2975706|P2|Overall Study|Adverse Event|2
902527|NCT01131585|2975707|P1|Overall Study|Adverse Event|0
902528|NCT01131520|2975715|P2|Overall Study|Subject changed history after enrollment|1
902529|NCT01131520|2975716|P1|Overall Study|Subject changed history after enrollment|0
902530|NCT01131520|2975715|P2|Overall Study|Counselor not available|3
902531|NCT01131520|2975716|P1|Overall Study|Counselor not available|0
902532|NCT01131520|2975715|P2|Overall Study|Computer problem|0
902533|NCT01131520|2975716|P1|Overall Study|Computer problem|1
902534|NCT01131507|2975738|P1|Overall Study|Withdrawal by Subject|1
902535|NCT01131507|2975738|P1|Overall Study|Lost to Follow-up|1
902536|NCT01131507|2975738|P1|Overall Study|Adverse Event|1
902537|NCT01131494|2975743|P1|Overall Study|Withdrawal by Subject|2
902538|NCT01131455|2975753|P3|Overall Study|Death of PI|0
902539|NCT01131455|2975754|P2|Overall Study|Death of PI|4
902540|NCT01131455|2975755|P1|Overall Study|Death of PI|6
902541|NCT01131312|2975766|P3|Overall Study|Lost to Follow-up|351
902542|NCT01131312|2975767|P2|Overall Study|Lost to Follow-up|229
902543|NCT01131312|2975768|P1|Overall Study|Lost to Follow-up|425
902544|NCT01131299|2975779|P2|Overall Study|Withdrawal by Subject|7
902545|NCT01131299|2975780|P1|Overall Study|Withdrawal by Subject|4
902546|NCT01131182|2975793|P2|Overall Study|Other Reason|0
902547|NCT01131182|2975794|P1|Overall Study|Other Reason|1
902548|NCT01131182|2975793|P2|Overall Study|Lost to Follow-up|15
902549|NCT01131182|2975794|P1|Overall Study|Lost to Follow-up|14
902550|NCT01131182|2975793|P2|Overall Study|Withdrawal by Subject|1
902551|NCT01131182|2975794|P1|Overall Study|Withdrawal by Subject|1
902552|NCT01131130|2975802|P1|Period 3- Crossover|+ Slit lamp finding|1
902553|NCT01131130|2975802|P1|Period 1 - Baseline|Pregnancy|1
902554|NCT01131104|2975815|P1|Overall Study|No Information on Index Date of Onset|1
902555|NCT01131104|2975815|P1|Overall Study|Information Not Available|5
902556|NCT01131104|2975815|P1|Overall Study|Physician Decision|4
902557|NCT01131104|2975815|P1|Overall Study|Withdrawal by Subject|3
902558|NCT01131078|2975822|P3|Overall Study|Other|0
902559|NCT01131078|2975823|P2|Overall Study|Other|1
902560|NCT01131078|2975824|P1|Overall Study|Other|0
902561|NCT01131078|2975822|P3|Overall Study|Death|2
902562|NCT01131078|2975823|P2|Overall Study|Death|0
902563|NCT01131078|2975824|P1|Overall Study|Death|4
902564|NCT01131078|2975822|P3|Overall Study|Physician Decision|8
902565|NCT01131078|2975823|P2|Overall Study|Physician Decision|6
902566|NCT01131078|2975824|P1|Overall Study|Physician Decision|10
902567|NCT01131078|2975822|P3|Overall Study|Non-compliance|0
902568|NCT01131078|2975823|P2|Overall Study|Non-compliance|0
902569|NCT01131078|2975824|P1|Overall Study|Non-compliance|3
902570|NCT01131078|2975822|P3|Overall Study|Withdrawal by Subject|3
902571|NCT01131078|2975823|P2|Overall Study|Withdrawal by Subject|4
902572|NCT01131078|2975824|P1|Overall Study|Withdrawal by Subject|2
902573|NCT01131078|2975822|P3|Overall Study|Lost to Follow-up|1
902574|NCT01131078|2975823|P2|Overall Study|Lost to Follow-up|1
902575|NCT01131078|2975824|P1|Overall Study|Lost to Follow-up|1
902576|NCT01131078|2975822|P3|Overall Study|Protocol Violation|0
902577|NCT01131078|2975823|P2|Overall Study|Protocol Violation|0
902578|NCT01131078|2975824|P1|Overall Study|Protocol Violation|1
902579|NCT01131078|2975822|P3|Overall Study|Progressive Disease|71
902580|NCT01131078|2975823|P2|Overall Study|Progressive Disease|77
902581|NCT01131078|2975824|P1|Overall Study|Progressive Disease|58
902582|NCT01131078|2975822|P3|Overall Study|Adverse Event|17
902583|NCT01131078|2975823|P2|Overall Study|Adverse Event|12
902584|NCT01131078|2975824|P1|Overall Study|Adverse Event|22
902585|NCT01130974|2975911|P2|Overall Study|Ineligibility criteria|2
902586|NCT01130974|2975912|P1|Overall Study|Ineligibility criteria|5
902587|NCT01130974|2975911|P2|Overall Study|Withdrawal by Subject|1
902588|NCT01130974|2975912|P1|Overall Study|Withdrawal by Subject|0
902589|NCT01130974|2975911|P2|Overall Study|Protocol Violation|10
902590|NCT01130974|2975912|P1|Overall Study|Protocol Violation|10
902591|NCT01130883|2975932|P1|Overall Study|Adverse Event|3
902592|NCT01130883|2975932|P1|Overall Study|Reason Unknown|1
902593|NCT01130883|2975932|P1|Overall Study|Patient Noncompliance|6
902594|NCT01130831|2975989|P1|Overall Study|Information was missing|3
902595|NCT01130831|2975989|P1|Overall Study|Death|4
902596|NCT01130831|2975989|P1|Overall Study|Withdrawal by Subject|7
902597|NCT01130597|2976028|P1|Overall Study|Protocol Violation|1
902598|NCT01130597|2976028|P1|Overall Study|Death|1
902599|NCT01130597|2976028|P1|Overall Study|Adverse Event|4
902600|NCT01130597|2976028|P1|Overall Study|Protocol-specified (High K+)|1
902601|NCT01130532|2976053|P4|Period IV (Weeks 13-16)|Withdrawal by Subject|3
902602|NCT01130532|2976054|P3|Period IV (Weeks 13-16)|Withdrawal by Subject|0
902603|NCT01130532|2976055|P2|Period IV (Weeks 13-16)|Withdrawal by Subject|0
902604|NCT01130532|2976056|P1|Period IV (Weeks 13-16)|Withdrawal by Subject|0
902605|NCT01130532|2976053|P4|Period IV (Weeks 13-16)|Lost to Follow-up|5
902606|NCT01130532|2976054|P3|Period IV (Weeks 13-16)|Lost to Follow-up|0
902607|NCT01130532|2976055|P2|Period IV (Weeks 13-16)|Lost to Follow-up|0
902608|NCT01130532|2976056|P1|Period IV (Weeks 13-16)|Lost to Follow-up|0
902609|NCT01130532|2976053|P4|Period IV (Weeks 13-16)|Entry Criteria Not Met|1
902610|NCT01130532|2976054|P3|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
902611|NCT01130532|2976055|P2|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
902612|NCT01130532|2976056|P1|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
902613|NCT01130532|2976053|P4|Period IV (Weeks 13-16)|Adverse Event|1
902614|NCT01130532|2976054|P3|Period IV (Weeks 13-16)|Adverse Event|0
902615|NCT01130532|2976055|P2|Period IV (Weeks 13-16)|Adverse Event|0
902616|NCT01130532|2976056|P1|Period IV (Weeks 13-16)|Adverse Event|0
902617|NCT01130532|2976053|P4|Period III (Weeks 0-12)|Withdrawal by Subject|0
902618|NCT01130532|2976054|P3|Period III (Weeks 0-12)|Withdrawal by Subject|6
902619|NCT01130532|2976055|P2|Period III (Weeks 0-12)|Withdrawal by Subject|7
902620|NCT01130532|2976056|P1|Period III (Weeks 0-12)|Withdrawal by Subject|7
902621|NCT01130532|2976053|P4|Period III (Weeks 0-12)|Sponsor Decision|0
902622|NCT01130532|2976054|P3|Period III (Weeks 0-12)|Sponsor Decision|2
902623|NCT01130532|2976055|P2|Period III (Weeks 0-12)|Sponsor Decision|4
902624|NCT01130532|2976056|P1|Period III (Weeks 0-12)|Sponsor Decision|3
902625|NCT01130532|2976053|P4|Period III (Weeks 0-12)|Protocol Violation|0
902626|NCT01130532|2976054|P3|Period III (Weeks 0-12)|Protocol Violation|1
902627|NCT01130532|2976055|P2|Period III (Weeks 0-12)|Protocol Violation|0
902628|NCT01130532|2976056|P1|Period III (Weeks 0-12)|Protocol Violation|0
902629|NCT01130532|2976053|P4|Period III (Weeks 0-12)|Lost to Follow-up|0
902630|NCT01130532|2976054|P3|Period III (Weeks 0-12)|Lost to Follow-up|3
902631|NCT01130532|2976055|P2|Period III (Weeks 0-12)|Lost to Follow-up|2
902632|NCT01130532|2976056|P1|Period III (Weeks 0-12)|Lost to Follow-up|2
902633|NCT01130532|2976053|P4|Period III (Weeks 0-12)|Lack of Efficacy|0
902634|NCT01130532|2976054|P3|Period III (Weeks 0-12)|Lack of Efficacy|1
902635|NCT01130532|2976055|P2|Period III (Weeks 0-12)|Lack of Efficacy|0
902636|NCT01130532|2976056|P1|Period III (Weeks 0-12)|Lack of Efficacy|2
902637|NCT01130532|2976053|P4|Period III (Weeks 0-12)|Entry Criteria Not Met|0
902638|NCT01130532|2976054|P3|Period III (Weeks 0-12)|Entry Criteria Not Met|4
902639|NCT01130532|2976055|P2|Period III (Weeks 0-12)|Entry Criteria Not Met|2
902640|NCT01130532|2976056|P1|Period III (Weeks 0-12)|Entry Criteria Not Met|4
902641|NCT01130532|2976053|P4|Period III (Weeks 0-12)|Adverse Event|0
902642|NCT01130532|2976054|P3|Period III (Weeks 0-12)|Adverse Event|2
902643|NCT01130532|2976055|P2|Period III (Weeks 0-12)|Adverse Event|3
902644|NCT01130532|2976056|P1|Period III (Weeks 0-12)|Adverse Event|3
902645|NCT01130493|2976101|P3|Part 2: OLE|Withdrawal by Subject|4
902646|NCT01130493|2976102|P2|Part 2: OLE|Withdrawal by Subject|1
902647|NCT01130493|2976103|P1|Part 2: OLE|Withdrawal by Subject|0
902648|NCT01130493|2976101|P3|Part 2: OLE|Adverse Event|1
902649|NCT01130493|2976102|P2|Part 2: OLE|Adverse Event|2
902650|NCT01130493|2976103|P1|Part 2: OLE|Adverse Event|0
902651|NCT01130493|2976101|P3|Part 1: Double-blind Treatment Period 2|Noncompliance|1
902652|NCT01130493|2976102|P2|Part 1: Double-blind Treatment Period 2|Noncompliance|0
902653|NCT01130493|2976103|P1|Part 1: Double-blind Treatment Period 2|Noncompliance|0
902654|NCT01130493|2976101|P3|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1
902655|NCT01130493|2976102|P2|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
902656|NCT01130493|2976103|P1|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
902657|NCT01130493|2976101|P3|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1
902658|NCT01130493|2976102|P2|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
902659|NCT01130493|2976103|P1|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
902660|NCT01130493|2976101|P3|Part 1: Open-Label IPX066 Washout|Adverse Event|1
902661|NCT01130493|2976102|P2|Part 1: Open-Label IPX066 Washout|Adverse Event|0
902662|NCT01130493|2976103|P1|Part 1: Open-Label IPX066 Washout|Adverse Event|0
902663|NCT01130493|2976101|P3|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
902664|NCT01130493|2976102|P2|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1
902665|NCT01130493|2976103|P1|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
902666|NCT01130493|2976101|P3|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
902667|NCT01130493|2976102|P2|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1
902668|NCT01130493|2976103|P1|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
902669|NCT01130493|2976101|P3|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
902670|NCT01130493|2976102|P2|Part 1: Double-blind Treatment Period 1|Protocol Violation|1
902671|NCT01130493|2976103|P1|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
902672|NCT01130493|2976101|P3|Open-label Dose Conversion to IPX066|Diary imcomplete|0
902673|NCT01130493|2976102|P2|Open-label Dose Conversion to IPX066|Diary imcomplete|0
902674|NCT01130493|2976103|P1|Open-label Dose Conversion to IPX066|Diary imcomplete|1
902675|NCT01130493|2976101|P3|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
902676|NCT01130493|2976102|P2|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
902677|NCT01130493|2976103|P1|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7
902678|NCT01130493|2976101|P3|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
902679|NCT01130493|2976102|P2|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
902680|NCT01130493|2976103|P1|Open-label Dose Conversion to IPX066|Lack of Efficacy|7
902681|NCT01130493|2976101|P3|Open-label Dose Conversion to IPX066|Protocol Violation|0
902682|NCT01130493|2976102|P2|Open-label Dose Conversion to IPX066|Protocol Violation|0
902683|NCT01130493|2976103|P1|Open-label Dose Conversion to IPX066|Protocol Violation|3
902684|NCT01130493|2976101|P3|Open-label Dose Conversion to IPX066|Adverse Event|0
902685|NCT01130493|2976102|P2|Open-label Dose Conversion to IPX066|Adverse Event|0
902686|NCT01130493|2976103|P1|Open-label Dose Conversion to IPX066|Adverse Event|1
902687|NCT01130337|2976120|P1|Overall Study|Surgical resection (R2)|1
902688|NCT01130337|2976120|P1|Overall Study|Toxicity, AE/intercurrent disease|7
902689|NCT01130337|2976120|P1|Overall Study|Disease progression|1
902690|NCT01130337|2976120|P1|Overall Study|Death|1
902691|NCT01130337|2976120|P1|Overall Study|Principal investigator decision|1
902692|NCT01130337|2976120|P1|Overall Study|Withdrawal by Subject|3
902693|NCT01130168|2976127|P6|Period 1|Adverse Event|0
902694|NCT01130168|2976128|P5|Period 1|Adverse Event|0
902695|NCT01130168|2976129|P4|Period 1|Adverse Event|1
902696|NCT01130168|2976130|P3|Period 1|Adverse Event|0
902697|NCT01130168|2976131|P2|Period 1|Adverse Event|0
902698|NCT01130168|2976132|P1|Period 1|Adverse Event|0
902699|NCT01130168|2976127|P6|Period 1|Discontinued For Other Reason|0
902700|NCT01130168|2976128|P5|Period 1|Discontinued For Other Reason|0
902701|NCT01130168|2976129|P4|Period 1|Discontinued For Other Reason|1
902702|NCT01130168|2976130|P3|Period 1|Discontinued For Other Reason|1
902703|NCT01130168|2976131|P2|Period 1|Discontinued For Other Reason|0
902704|NCT01130168|2976132|P1|Period 1|Discontinued For Other Reason|0
902705|NCT01130168|2976127|P6|Period 1|Withdrawal by Subject|0
902706|NCT01130168|2976128|P5|Period 1|Withdrawal by Subject|0
902707|NCT01130168|2976129|P4|Period 1|Withdrawal by Subject|1
902708|NCT01130168|2976130|P3|Period 1|Withdrawal by Subject|0
902709|NCT01130168|2976131|P2|Period 1|Withdrawal by Subject|1
902710|NCT01130168|2976132|P1|Period 1|Withdrawal by Subject|0
902711|NCT01130103|2976169|P2|Maintenance Treatment|Withdrawal by Subject|0
902712|NCT01130103|2976170|P1|Maintenance Treatment|Withdrawal by Subject|1
902713|NCT01130103|2976169|P2|Maintenance Treatment|Lost to Follow-up|1
902714|NCT01130103|2976170|P1|Maintenance Treatment|Lost to Follow-up|1
902715|NCT01130103|2976169|P2|Maintenance Treatment|Lack of Efficacy|1
902716|NCT01130103|2976170|P1|Maintenance Treatment|Lack of Efficacy|0
902717|NCT01130103|2976169|P2|Randomized Treatment|Withdrawal by Subject|2
902718|NCT01130103|2976170|P1|Randomized Treatment|Withdrawal by Subject|1
902719|NCT01130103|2976169|P2|Randomized Treatment|Protocol Violation|2
902720|NCT01130103|2976170|P1|Randomized Treatment|Protocol Violation|3
902721|NCT01130103|2976169|P2|Randomized Treatment|Lost to Follow-up|0
902722|NCT01130103|2976170|P1|Randomized Treatment|Lost to Follow-up|1
902723|NCT01130103|2976169|P2|Randomized Treatment|Adverse Event|1
902724|NCT01130103|2976170|P1|Randomized Treatment|Adverse Event|1
902725|NCT01130051|2976184|P2|Washout Period of 14 Days|Protocol Violation|1
902726|NCT01130051|2976185|P1|Washout Period of 14 Days|Protocol Violation|1
902727|NCT01130051|2976184|P2|Washout Period of 14 Days|Withdrawal by Subject|1
902728|NCT01130051|2976185|P1|Washout Period of 14 Days|Withdrawal by Subject|0
902729|NCT01129960|2976199|P4|Overall Study|Pregnancy|0
902730|NCT01129960|2976200|P3|Overall Study|Pregnancy|0
902731|NCT01129960|2976201|P2|Overall Study|Pregnancy|0
902732|NCT01129960|2976202|P1|Overall Study|Pregnancy|1
902733|NCT01129960|2976199|P4|Overall Study|Physician Decision|0
902734|NCT01129960|2976200|P3|Overall Study|Physician Decision|0
902735|NCT01129960|2976201|P2|Overall Study|Physician Decision|0
902736|NCT01129960|2976202|P1|Overall Study|Physician Decision|1
902737|NCT01129960|2976199|P4|Overall Study|Discontinuation of the study by Sponsor|0
902738|NCT01129960|2976200|P3|Overall Study|Discontinuation of the study by Sponsor|0
902739|NCT01129960|2976201|P2|Overall Study|Discontinuation of the study by Sponsor|1
902740|NCT01129960|2976202|P1|Overall Study|Discontinuation of the study by Sponsor|0
902741|NCT01129960|2976199|P4|Overall Study|Lost to Follow-up|3
902742|NCT01129960|2976200|P3|Overall Study|Lost to Follow-up|3
902743|NCT01129960|2976201|P2|Overall Study|Lost to Follow-up|2
902744|NCT01129960|2976202|P1|Overall Study|Lost to Follow-up|0
902745|NCT01129960|2976199|P4|Overall Study|Protocol Violation|0
902746|NCT01129960|2976200|P3|Overall Study|Protocol Violation|3
902747|NCT01129960|2976201|P2|Overall Study|Protocol Violation|2
902748|NCT01129960|2976202|P1|Overall Study|Protocol Violation|1
902749|NCT01129960|2976199|P4|Overall Study|Adverse Event|7
902750|NCT01129960|2976200|P3|Overall Study|Adverse Event|16
902751|NCT01129960|2976201|P2|Overall Study|Adverse Event|16
902752|NCT01129960|2976202|P1|Overall Study|Adverse Event|23
902753|NCT01129960|2976199|P4|Overall Study|Lack of Efficacy|1
902754|NCT01129960|2976200|P3|Overall Study|Lack of Efficacy|1
902755|NCT01129960|2976201|P2|Overall Study|Lack of Efficacy|1
902756|NCT01129960|2976202|P1|Overall Study|Lack of Efficacy|1
902757|NCT01129960|2976199|P4|Overall Study|Withdrawal by Subject|2
902758|NCT01129960|2976200|P3|Overall Study|Withdrawal by Subject|3
902759|NCT01129960|2976201|P2|Overall Study|Withdrawal by Subject|0
902760|NCT01129960|2976202|P1|Overall Study|Withdrawal by Subject|3
902761|NCT01129921|2976214|P2|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1
902762|NCT01129921|2976215|P1|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0
902763|NCT01129921|2976214|P2|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4
902764|NCT01129921|2976215|P1|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0
902765|NCT01129921|2976214|P2|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1
902766|NCT01129921|2976215|P1|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0
902767|NCT01129921|2976214|P2|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1
902768|NCT01129921|2976215|P1|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2
902769|NCT01129622|2976239|P1|Overall Study|Withdrawal by Subject|2
902770|NCT01129583|2976246|P2|Overall Study|Ipsilateral Upper Extremity Injury|1
902771|NCT01129583|2976247|P1|Overall Study|Ipsilateral Upper Extremity Injury|1
902772|NCT01129583|2976246|P2|Overall Study|Lost to Follow-up|1
902773|NCT01129583|2976247|P1|Overall Study|Lost to Follow-up|1
902774|NCT01129583|2976246|P2|Overall Study|Death|0
902775|NCT01129583|2976247|P1|Overall Study|Death|1
902776|NCT01129557|2976260|P3|Overall Study|Novartis terminated study early|2
902777|NCT01129557|2976261|P2|Overall Study|Novartis terminated study early|3
902778|NCT01129557|2976262|P1|Overall Study|Novartis terminated study early|3
902779|NCT01129557|2976260|P3|Overall Study|Adverse Event|2
902780|NCT01129557|2976261|P2|Overall Study|Adverse Event|2
902781|NCT01129557|2976262|P1|Overall Study|Adverse Event|1
902782|NCT01129336|2976357|P2|Overall Study|Death|4
902783|NCT01129336|2976358|P1|Overall Study|Death|0
902784|NCT01129336|2976357|P2|Overall Study|Missing Study Completion Status|3
902785|NCT01129336|2976358|P1|Overall Study|Missing Study Completion Status|2
902786|NCT01129336|2976357|P2|Overall Study|Adverse Event|1
902787|NCT01129336|2976358|P1|Overall Study|Adverse Event|0
902788|NCT01129336|2976357|P2|Overall Study|Withdrawal by Subject|4
902789|NCT01129336|2976358|P1|Overall Study|Withdrawal by Subject|7
902790|NCT01129336|2976357|P2|Overall Study|Lost to Follow-up|0
902791|NCT01129336|2976358|P1|Overall Study|Lost to Follow-up|1
902792|NCT01129336|2976357|P2|Overall Study|Disease Progression|4
902793|NCT01129336|2976358|P1|Overall Study|Disease Progression|1
902794|NCT01129336|2976357|P2|Overall Study|Protocol Violation|0
902795|NCT01129336|2976358|P1|Overall Study|Protocol Violation|1
902796|NCT01129284|2976373|P3|Overall Study|Adverse Event|1
902797|NCT01129284|2976374|P2|Overall Study|Adverse Event|0
902798|NCT01129284|2976375|P1|Overall Study|Adverse Event|2
902799|NCT01129128|2976415|P3|Overall Study|Physician Decision|0
902800|NCT01129128|2976416|P2|Overall Study|Physician Decision|0
902801|NCT01129128|2976417|P1|Overall Study|Physician Decision|1
902802|NCT01129128|2976415|P3|Overall Study|Withdrawal by Subject|3
902803|NCT01129128|2976416|P2|Overall Study|Withdrawal by Subject|1
902804|NCT01129128|2976417|P1|Overall Study|Withdrawal by Subject|0
902805|NCT01129128|2976415|P3|Overall Study|Protocol Violation|0
902806|NCT01129128|2976416|P2|Overall Study|Protocol Violation|1
902807|NCT01129128|2976417|P1|Overall Study|Protocol Violation|0
902808|NCT01129128|2976415|P3|Overall Study|Lost to Follow-up|1
902809|NCT01129128|2976416|P2|Overall Study|Lost to Follow-up|2
902810|NCT01129128|2976417|P1|Overall Study|Lost to Follow-up|2
902811|NCT01129115|2976441|P4|Overall Study|Protocol Violation|2
902812|NCT01129115|2976442|P3|Overall Study|Protocol Violation|2
902813|NCT01129115|2976443|P2|Overall Study|Protocol Violation|2
902814|NCT01129115|2976444|P1|Overall Study|Protocol Violation|0
902815|NCT01129115|2976441|P4|Overall Study|Withdrawal by Subject|4
902816|NCT01129115|2976442|P3|Overall Study|Withdrawal by Subject|1
902817|NCT01129115|2976443|P2|Overall Study|Withdrawal by Subject|3
902818|NCT01129115|2976444|P1|Overall Study|Withdrawal by Subject|1
902819|NCT01129115|2976441|P4|Overall Study|Adverse Event|3
902820|NCT01129115|2976442|P3|Overall Study|Adverse Event|3
902821|NCT01129115|2976443|P2|Overall Study|Adverse Event|2
902822|NCT01129115|2976444|P1|Overall Study|Adverse Event|1
902823|NCT01129102|2976481|P3|Overall Study|Lost to Follow-up|0
902824|NCT01129102|2976482|P2|Overall Study|Lost to Follow-up|0
902825|NCT01129102|2976483|P1|Overall Study|Lost to Follow-up|2
902826|NCT01129102|2976481|P3|Overall Study|Adverse Event|1
902827|NCT01129102|2976482|P2|Overall Study|Adverse Event|2
902828|NCT01129102|2976483|P1|Overall Study|Adverse Event|2
902829|NCT01129102|2976481|P3|Overall Study|Pregnancy|1
902830|NCT01129102|2976482|P2|Overall Study|Pregnancy|0
902831|NCT01129102|2976483|P1|Overall Study|Pregnancy|0
902832|NCT01129102|2976481|P3|Overall Study|Protocol Violation|1
902833|NCT01129102|2976482|P2|Overall Study|Protocol Violation|1
902834|NCT01129102|2976483|P1|Overall Study|Protocol Violation|0
902835|NCT01129102|2976481|P3|Overall Study|Withdrawal by Subject|3
902836|NCT01129102|2976482|P2|Overall Study|Withdrawal by Subject|0
902837|NCT01129102|2976483|P1|Overall Study|Withdrawal by Subject|2
902838|NCT01129102|2976481|P3|Overall Study|No study drug treatment|1
902839|NCT01129102|2976482|P2|Overall Study|No study drug treatment|3
902840|NCT01129102|2976483|P1|Overall Study|No study drug treatment|2
902841|NCT01129011|2976494|P2|Overall Study|misc|4
902842|NCT01129011|2976495|P1|Overall Study|misc|7
902843|NCT01129011|2976494|P2|Overall Study|Duodenal Ulcer|8
902844|NCT01129011|2976495|P1|Overall Study|Duodenal Ulcer|2
902845|NCT01129011|2976494|P2|Overall Study|Lost to Follow-up|7
902846|NCT01129011|2976495|P1|Overall Study|Lost to Follow-up|6
902847|NCT01129011|2976494|P2|Overall Study|Withdrawal by Subject|8
902848|NCT01129011|2976495|P1|Overall Study|Withdrawal by Subject|24
902849|NCT01129011|2976494|P2|Overall Study|Adverse Event|30
902850|NCT01129011|2976495|P1|Overall Study|Adverse Event|20
902851|NCT01128959|2976550|P1|Treatment Period|Withdrawal by Subject|1
902852|NCT01128959|2976550|P1|Treatment Period|Adverse Event|3
902853|NCT01128959|2976550|P1|Lead in Period|Adverse Event|3
902854|NCT01128946|2976556|P4|Period III|Protocol Violation|0
902855|NCT01128946|2976557|P3|Period III|Protocol Violation|0
902856|NCT01128946|2976558|P2|Period III|Protocol Violation|0
902857|NCT01128946|2976559|P1|Period III|Protocol Violation|1
902858|NCT01128946|2976556|P4|Period II|Withdrawal by Subject|1
902859|NCT01128946|2976557|P3|Period II|Withdrawal by Subject|0
902860|NCT01128946|2976558|P2|Period II|Withdrawal by Subject|0
902861|NCT01128946|2976559|P1|Period II|Withdrawal by Subject|0
902862|NCT01128946|2976556|P4|Period II|Protocol Violation|0
902863|NCT01128946|2976557|P3|Period II|Protocol Violation|0
902864|NCT01128946|2976558|P2|Period II|Protocol Violation|1
902865|NCT01128946|2976559|P1|Period II|Protocol Violation|0
902866|NCT01128946|2976556|P4|Period I|Withdrawal by Subject|1
902867|NCT01128946|2976557|P3|Period I|Withdrawal by Subject|1
902868|NCT01128946|2976558|P2|Period I|Withdrawal by Subject|0
902869|NCT01128946|2976559|P1|Period I|Withdrawal by Subject|0
902870|NCT01128946|2976556|P4|Period I|Protocol Violation|0
902871|NCT01128946|2976557|P3|Period I|Protocol Violation|0
902872|NCT01128946|2976558|P2|Period I|Protocol Violation|1
902873|NCT01128946|2976559|P1|Period I|Protocol Violation|0
902874|NCT01128894|2976577|P2|Overall Study|Conflicting HbA1c Results at Screening|0
902875|NCT01128894|2976578|P1|Overall Study|Conflicting HbA1c Results at Screening|1
902876|NCT01128894|2976577|P2|Overall Study|Physician Decision|1
902877|NCT01128894|2976578|P1|Overall Study|Physician Decision|2
902878|NCT01128894|2976577|P2|Overall Study|Withdrawal by Subject|12
902879|NCT01128894|2976578|P1|Overall Study|Withdrawal by Subject|10
902880|NCT01128894|2976577|P2|Overall Study|Lost to Follow-up|8
902881|NCT01128894|2976578|P1|Overall Study|Lost to Follow-up|8
902882|NCT01128894|2976577|P2|Overall Study|Noncompliance|5
902883|NCT01128894|2976578|P1|Overall Study|Noncompliance|4
902884|NCT01128894|2976577|P2|Overall Study|Protocol Violation|1
902885|NCT01128894|2976578|P1|Overall Study|Protocol Violation|2
902886|NCT01128894|2976577|P2|Overall Study|Adverse Event|41
902887|NCT01128894|2976578|P1|Overall Study|Adverse Event|31
902888|NCT01128738|2976603|P2|Second TP|Withdrawal by Subject|2
902889|NCT01128738|2976604|P1|Second TP|Withdrawal by Subject|0
902890|NCT01128738|2976603|P2|Second TP|Lost to Follow-up|1
902891|NCT01128738|2976604|P1|Second TP|Lost to Follow-up|0
902892|NCT01128738|2976603|P2|First Treatment Phase (TP)|Withdrawal by Subject|1
902893|NCT01128738|2976604|P1|First Treatment Phase (TP)|Withdrawal by Subject|3
902894|NCT01128738|2976603|P2|First Treatment Phase (TP)|Lost to Follow-up|0
902895|NCT01128738|2976604|P1|First Treatment Phase (TP)|Lost to Follow-up|1
902896|NCT01128621|2976729|P2|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2
902897|NCT01128621|2976730|P1|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0
902898|NCT01128595|2976851|P4|Treatment Period 3|Withdrawal by Subject|0
902899|NCT01128595|2976852|P3|Treatment Period 3|Withdrawal by Subject|0
902900|NCT01128595|2976853|P2|Treatment Period 3|Withdrawal by Subject|1
902901|NCT01128595|2976854|P1|Treatment Period 3|Withdrawal by Subject|0
902902|NCT01128569|2976884|P6|Treatment Period 2|Withdrawal by Subject|0
902903|NCT01128569|2976885|P5|Treatment Period 2|Withdrawal by Subject|0
902904|NCT01128569|2976886|P4|Treatment Period 2|Withdrawal by Subject|0
902905|NCT01128569|2976887|P3|Treatment Period 2|Withdrawal by Subject|0
902906|NCT01128569|2976888|P2|Treatment Period 2|Withdrawal by Subject|1
902907|NCT01128569|2976889|P1|Treatment Period 2|Withdrawal by Subject|0
902908|NCT01128569|2976884|P6|Washout Period 1|Adverse Event|0
902909|NCT01128569|2976885|P5|Washout Period 1|Adverse Event|0
902910|NCT01128569|2976886|P4|Washout Period 1|Adverse Event|0
902911|NCT01128569|2976887|P3|Washout Period 1|Adverse Event|1
902912|NCT01128569|2976888|P2|Washout Period 1|Adverse Event|0
902913|NCT01128569|2976889|P1|Washout Period 1|Adverse Event|0
902914|NCT01128543|2976906|P1|Overall Study|Protocol Violation|1
902915|NCT01128543|2976906|P1|Overall Study|Withdrawal by Subject|3
902916|NCT01128413|2976932|P2|Overall Study|Pt made DNR|0
902917|NCT01128413|2976933|P1|Overall Study|Pt made DNR|1
902918|NCT01128413|2976932|P2|Overall Study|NICOM Monitor Problems|1
902919|NCT01128413|2976933|P1|Overall Study|NICOM Monitor Problems|2
902920|NCT01128413|2976932|P2|Overall Study|Withdrawal by Subject|0
902921|NCT01128413|2976933|P1|Overall Study|Withdrawal by Subject|1
902922|NCT01128400|2976942|P3|Overall Study|Excluded due to sinus problems|0
902923|NCT01128400|2976943|P2|Overall Study|Excluded due to sinus problems|1
902924|NCT01128400|2976944|P1|Overall Study|Excluded due to sinus problems|0
902925|NCT01128400|2976942|P3|Overall Study|were not invited to participate on taste|15
902926|NCT01128400|2976943|P2|Overall Study|were not invited to participate on taste|0
902927|NCT01128400|2976944|P1|Overall Study|were not invited to participate on taste|0
902928|NCT01128400|2976942|P3|Overall Study|Screening failure|0
902929|NCT01128400|2976943|P2|Overall Study|Screening failure|0
902930|NCT01128400|2976944|P1|Overall Study|Screening failure|1
902931|NCT01128400|2976942|P3|Overall Study|Lost to Follow-up|1
902932|NCT01128400|2976943|P2|Overall Study|Lost to Follow-up|0
902933|NCT01128400|2976944|P1|Overall Study|Lost to Follow-up|1
902934|NCT01128387|2976957|P2|Overall Study|Physician Decision|1
902935|NCT01128387|2976958|P1|Overall Study|Physician Decision|0
902936|NCT01128361|2976968|P2|Overall Study|Withdrawal by Subject|2
902937|NCT01128361|2976969|P1|Overall Study|Withdrawal by Subject|5
902938|NCT01128361|2976968|P2|Overall Study|Lost to Follow-up|1
902939|NCT01128361|2976969|P1|Overall Study|Lost to Follow-up|0
902940|NCT01128296|2976981|P6|Overall Study|Withdrawal by Subject|2
902941|NCT01128296|2976982|P5|Overall Study|Withdrawal by Subject|0
902942|NCT01128296|2976983|P4|Overall Study|Withdrawal by Subject|0
902943|NCT01128296|2976984|P3|Overall Study|Withdrawal by Subject|0
902944|NCT01128296|2976985|P2|Overall Study|Withdrawal by Subject|0
902945|NCT01128296|2976986|P1|Overall Study|Withdrawal by Subject|0
902946|NCT01128296|2976981|P6|Overall Study|Physician Decision|3
902947|NCT01128296|2976982|P5|Overall Study|Physician Decision|0
902948|NCT01128296|2976983|P4|Overall Study|Physician Decision|0
902949|NCT01128296|2976984|P3|Overall Study|Physician Decision|0
902950|NCT01128296|2976985|P2|Overall Study|Physician Decision|0
902951|NCT01128296|2976986|P1|Overall Study|Physician Decision|0
902952|NCT01128244|2977017|P1|Overall Study|Scheduling conflict|2
902953|NCT01128244|2977017|P1|Overall Study|Adverse Event|1
902954|NCT01128179|2977058|P2|Overall Study|Protocol Violation|0
902955|NCT01128179|2977059|P1|Overall Study|Protocol Violation|1
902956|NCT01128179|2977058|P2|Overall Study|Death|0
902957|NCT01128179|2977059|P1|Overall Study|Death|1
902958|NCT01128153|2977079|P2|Overall Study|Developed discontinuation criteria|1
902959|NCT01128153|2977080|P1|Overall Study|Developed discontinuation criteria|1
902960|NCT01128153|2977079|P2|Overall Study|Protocol Violation|0
902961|NCT01128153|2977080|P1|Overall Study|Protocol Violation|2
902962|NCT01128153|2977079|P2|Overall Study|Incorrect enrolment to study|1
902963|NCT01128153|2977080|P1|Overall Study|Incorrect enrolment to study|2
902964|NCT01128153|2977079|P2|Overall Study|Withdrawal by Subject|3
902965|NCT01128153|2977080|P1|Overall Study|Withdrawal by Subject|2
902966|NCT01128153|2977079|P2|Overall Study|Condition under investigation worsened|7
902967|NCT01128153|2977080|P1|Overall Study|Condition under investigation worsened|8
902968|NCT01128153|2977079|P2|Overall Study|Adverse Event|3
902969|NCT01128153|2977080|P1|Overall Study|Adverse Event|1
902970|NCT01128114|2977096|P1|Overall Study|Screening Failed|2
902971|NCT01128114|2977096|P1|Overall Study|Treatment Withdrawn|6
902972|NCT01127763|2977113|P1|Overall Study|Physician Decision|2
902973|NCT01127763|2977113|P1|Overall Study|Withdrawal by Subject|1
902974|NCT01127763|2977113|P1|Overall Study|Adverse Event|2
902975|NCT01127646|2977158|P2|Overall Study|Protocol Violation|1
902976|NCT01127646|2977159|P1|Overall Study|Protocol Violation|0
902977|NCT01127646|2977158|P2|Overall Study|Entry Criteria Not Met|0
902978|NCT01127646|2977159|P1|Overall Study|Entry Criteria Not Met|1
902979|NCT01127633|2977193|P2|Overall Study|Not treated|0
902980|NCT01127633|2977194|P1|Overall Study|Not treated|1
902981|NCT01127633|2977193|P2|Overall Study|Abnormal Lab/ECG Result|1
902982|NCT01127633|2977194|P1|Overall Study|Abnormal Lab/ECG Result|0
902983|NCT01127633|2977193|P2|Overall Study|Protocol Violation|16
902984|NCT01127633|2977194|P1|Overall Study|Protocol Violation|8
902985|NCT01127633|2977193|P2|Overall Study|Sponsor Decision|195
902986|NCT01127633|2977194|P1|Overall Study|Sponsor Decision|163
902987|NCT01127633|2977193|P2|Overall Study|Withdrawal by Subject|72
902988|NCT01127633|2977194|P1|Overall Study|Withdrawal by Subject|57
902989|NCT01127633|2977193|P2|Overall Study|Physician Decision|45
902990|NCT01127633|2977194|P1|Overall Study|Physician Decision|60
902991|NCT01127633|2977193|P2|Overall Study|Parent/Caregiver Decision|228
902992|NCT01127633|2977194|P1|Overall Study|Parent/Caregiver Decision|246
902993|NCT01127633|2977193|P2|Overall Study|Lost to Follow-up|0
902994|NCT01127633|2977194|P1|Overall Study|Lost to Follow-up|4
902995|NCT01127633|2977193|P2|Overall Study|Death|43
902996|NCT01127633|2977194|P1|Overall Study|Death|40
902997|NCT01127633|2977193|P2|Overall Study|Adverse Event|73
902998|NCT01127633|2977194|P1|Overall Study|Adverse Event|74
902999|NCT01127607|2977226|P2|Phase II (Between Subjects)|Withdrawal by Subject|0
903000|NCT01127607|2977227|P1|Phase II (Between Subjects)|Withdrawal by Subject|1
903001|NCT01127607|2977226|P2|Phase II (Between Subjects)|Lost to Follow-up|2
903002|NCT01127607|2977227|P1|Phase II (Between Subjects)|Lost to Follow-up|0
903003|NCT01127256|2977402|P2|Overall Study|Protocol Violation|0
903004|NCT01127256|2977403|P1|Overall Study|Protocol Violation|1
903005|NCT01127256|2977402|P2|Overall Study|Withdrawal by Subject|9
903006|NCT01127256|2977403|P1|Overall Study|Withdrawal by Subject|5
903007|NCT01127256|2977402|P2|Overall Study|Lost to Follow-up|17
903008|NCT01127256|2977403|P1|Overall Study|Lost to Follow-up|16
903009|NCT01127256|2977402|P2|Overall Study|Lack of Efficacy|0
903010|NCT01127256|2977403|P1|Overall Study|Lack of Efficacy|4
903011|NCT01127256|2977402|P2|Overall Study|Adverse Event|13
903012|NCT01127256|2977403|P1|Overall Study|Adverse Event|13
903013|NCT01127165|2977415|P2|Overall Study|Protocol Violation|1
903014|NCT01127165|2977416|P1|Overall Study|Protocol Violation|0
903015|NCT01127165|2977415|P2|Overall Study|Withdrawal by Subject|3
903016|NCT01127165|2977416|P1|Overall Study|Withdrawal by Subject|1
903017|NCT01127165|2977415|P2|Overall Study|Lost to Follow-up|5
903018|NCT01127165|2977416|P1|Overall Study|Lost to Follow-up|3
903019|NCT01127165|2977415|P2|Overall Study|Lack of Efficacy|8
903020|NCT01127165|2977416|P1|Overall Study|Lack of Efficacy|10
903021|NCT01127165|2977415|P2|Overall Study|Adverse Event|2
903022|NCT01127165|2977416|P1|Overall Study|Adverse Event|2
903023|NCT01127139|2977428|P1|Overall Study|Reason not specified|1
903024|NCT01127139|2977428|P1|Overall Study|Lack of Efficacy|4
903025|NCT01127139|2977428|P1|Overall Study|Incompliance|12
903026|NCT01127139|2977428|P1|Overall Study|Adverse Event|40
903027|NCT01126619|2977494|P1|Overall Study|Non-compliance|1
903028|NCT01126619|2977494|P1|Overall Study|Withdrawal by Subject|9
903029|NCT01126619|2977494|P1|Overall Study|Serious adverse event|1
903030|NCT01126619|2977494|P1|Overall Study|Investigator decision|4
903031|NCT01126619|2977494|P1|Overall Study|Not eligible for the study|2
903032|NCT01126580|2977522|P3|Overall Study|Treatment Non-compliance|3
903033|NCT01126580|2977523|P2|Overall Study|Treatment Non-compliance|2
903034|NCT01126580|2977524|P1|Overall Study|Treatment Non-compliance|0
903035|NCT01126580|2977522|P3|Overall Study|Lost to Follow-up|9
903036|NCT01126580|2977523|P2|Overall Study|Lost to Follow-up|13
903037|NCT01126580|2977524|P1|Overall Study|Lost to Follow-up|15
903038|NCT01126580|2977522|P3|Overall Study|Protocol Violation|2
903039|NCT01126580|2977523|P2|Overall Study|Protocol Violation|1
903040|NCT01126580|2977524|P1|Overall Study|Protocol Violation|0
903041|NCT01126580|2977522|P3|Overall Study|Lack of Efficacy|4
903042|NCT01126580|2977523|P2|Overall Study|Lack of Efficacy|3
903043|NCT01126580|2977524|P1|Overall Study|Lack of Efficacy|2
903044|NCT01126580|2977522|P3|Overall Study|Entry Criteria Not Met|2
903045|NCT01126580|2977523|P2|Overall Study|Entry Criteria Not Met|1
903046|NCT01126580|2977524|P1|Overall Study|Entry Criteria Not Met|1
903047|NCT01126580|2977522|P3|Overall Study|Physician Decision|2
903048|NCT01126580|2977523|P2|Overall Study|Physician Decision|1
903049|NCT01126580|2977524|P1|Overall Study|Physician Decision|1
903050|NCT01126580|2977522|P3|Overall Study|Sponsor Decision|7
903051|NCT01126580|2977523|P2|Overall Study|Sponsor Decision|4
903052|NCT01126580|2977524|P1|Overall Study|Sponsor Decision|5
903053|NCT01126580|2977522|P3|Overall Study|Withdrawal by Subject|14
903054|NCT01126580|2977523|P2|Overall Study|Withdrawal by Subject|19
903055|NCT01126580|2977524|P1|Overall Study|Withdrawal by Subject|11
903056|NCT01126580|2977522|P3|Overall Study|Adverse Event|12
903057|NCT01126580|2977523|P2|Overall Study|Adverse Event|8
903058|NCT01126580|2977524|P1|Overall Study|Adverse Event|14
903059|NCT01126541|2977619|P3|Overall Study|Administrative reason or other|2
903060|NCT01126541|2977620|P2|Overall Study|Administrative reason or other|1
903061|NCT01126541|2977621|P1|Overall Study|Administrative reason or other|1
903062|NCT01126541|2977619|P3|Overall Study|Protocol Violation|1
903063|NCT01126541|2977620|P2|Overall Study|Protocol Violation|0
903064|NCT01126541|2977621|P1|Overall Study|Protocol Violation|0
903065|NCT01126541|2977619|P3|Overall Study|Withdrawal by Subject|6
903066|NCT01126541|2977620|P2|Overall Study|Withdrawal by Subject|5
903067|NCT01126541|2977621|P1|Overall Study|Withdrawal by Subject|2
903068|NCT01126541|2977619|P3|Overall Study|Lost to Follow-up|2
903069|NCT01126541|2977620|P2|Overall Study|Lost to Follow-up|2
903070|NCT01126541|2977621|P1|Overall Study|Lost to Follow-up|1
903071|NCT01126541|2977619|P3|Overall Study|Lack of Efficacy|11
903072|NCT01126541|2977620|P2|Overall Study|Lack of Efficacy|1
903073|NCT01126541|2977621|P1|Overall Study|Lack of Efficacy|6
903074|NCT01126541|2977619|P3|Overall Study|Death|0
903075|NCT01126541|2977620|P2|Overall Study|Death|1
903076|NCT01126541|2977621|P1|Overall Study|Death|0
903077|NCT01126541|2977619|P3|Overall Study|Adverse Event|4
903078|NCT01126541|2977620|P2|Overall Study|Adverse Event|2
903079|NCT01126541|2977621|P1|Overall Study|Adverse Event|0
903080|NCT01126437|2977705|P3|Overall Study|Other reason not specified|178
903081|NCT01126437|2977706|P2|Overall Study|Other reason not specified|176
903082|NCT01126437|2977707|P1|Overall Study|Other reason not specified|210
903083|NCT01126437|2977705|P3|Overall Study|Withdrawal by Subject|319
903084|NCT01126437|2977706|P2|Overall Study|Withdrawal by Subject|335
903085|NCT01126437|2977707|P1|Overall Study|Withdrawal by Subject|331
903086|NCT01126437|2977705|P3|Overall Study|Lost to Follow-up|55
903087|NCT01126437|2977706|P2|Overall Study|Lost to Follow-up|63
903088|NCT01126437|2977707|P1|Overall Study|Lost to Follow-up|52
903089|NCT01126437|2977705|P3|Overall Study|Protocol Violation|41
903090|NCT01126437|2977706|P2|Overall Study|Protocol Violation|66
903091|NCT01126437|2977707|P1|Overall Study|Protocol Violation|64
903092|NCT01126437|2977705|P3|Overall Study|Lack of Efficacy|59
903093|NCT01126437|2977706|P2|Overall Study|Lack of Efficacy|60
903094|NCT01126437|2977707|P1|Overall Study|Lack of Efficacy|65
903095|NCT01126437|2977705|P3|Overall Study|Adverse Event|635
903096|NCT01126437|2977706|P2|Overall Study|Adverse Event|606
903097|NCT01126437|2977707|P1|Overall Study|Adverse Event|602
903098|NCT01126437|2977705|P3|Overall Study|Sites with data irregularities/fraud|7
903099|NCT01126437|2977706|P2|Overall Study|Sites with data irregularities/fraud|6
903100|NCT01126437|2977707|P1|Overall Study|Sites with data irregularities/fraud|6
903101|NCT01126437|2977705|P3|Overall Study|Not treated|19
903102|NCT01126437|2977706|P2|Overall Study|Not treated|18
903103|NCT01126437|2977707|P1|Overall Study|Not treated|11
903104|NCT01126424|2977745|P6|Overall Study|Withdrawal by Subject|0
903105|NCT01126424|2977746|P5|Overall Study|Withdrawal by Subject|1
903106|NCT01126424|2977747|P4|Overall Study|Withdrawal by Subject|3
903107|NCT01126424|2977748|P3|Overall Study|Withdrawal by Subject|1
903108|NCT01126424|2977749|P2|Overall Study|Withdrawal by Subject|0
903109|NCT01126424|2977750|P1|Overall Study|Withdrawal by Subject|0
903110|NCT01126424|2977745|P6|Overall Study|Adverse Event|0
903111|NCT01126424|2977746|P5|Overall Study|Adverse Event|1
903112|NCT01126424|2977747|P4|Overall Study|Adverse Event|0
903113|NCT01126424|2977748|P3|Overall Study|Adverse Event|0
903114|NCT01126424|2977749|P2|Overall Study|Adverse Event|0
903115|NCT01126424|2977750|P1|Overall Study|Adverse Event|0
903116|NCT01126359|2977773|P2|First Intervention (20-minutes)|Physician Decision|1
903117|NCT01126359|2977774|P1|First Intervention (20-minutes)|Physician Decision|0
903118|NCT01126268|2977786|P1|Overall Study|Adverse Event|1
903119|NCT01126060|2977825|P2|Overall Study|Protocol Violation|2
903120|NCT01126060|2977826|P1|Overall Study|Protocol Violation|0
903121|NCT01125930|2977834|P2|Overall Study|Lost to Follow-up|2
903122|NCT01125930|2977835|P1|Overall Study|Lost to Follow-up|0
903123|NCT01125930|2977834|P2|Overall Study|Protocol Violation|1
903124|NCT01125930|2977835|P1|Overall Study|Protocol Violation|0
903125|NCT01125930|2977834|P2|Overall Study|Withdrawal by Subject|6
903126|NCT01125930|2977835|P1|Overall Study|Withdrawal by Subject|1
903127|NCT01125930|2977834|P2|Overall Study|Adverse Event|1
903128|NCT01125930|2977835|P1|Overall Study|Adverse Event|0
903129|NCT01125917|2977989|P1|Overall Study|Lack of Efficacy|19
903130|NCT01125917|2977989|P1|Overall Study|Administrative|223
903131|NCT01125917|2977989|P1|Overall Study|Withdrawal by Subject|31
903132|NCT01125917|2977989|P1|Overall Study|Lost to Follow-up|23
903133|NCT01125917|2977989|P1|Overall Study|Adverse Event|43
903134|NCT01125813|2977993|P1|Overall Study|Screen Failures|4
903135|NCT01125813|2977993|P1|Overall Study|Withdrawal by Subject|1
903136|NCT01125813|2977993|P1|Overall Study|Death|1
903137|NCT01125800|2978003|P5|Phase II|Disease progression|8
903138|NCT01125800|2978004|P4|Phase II|Disease progression|1
903139|NCT01125800|2978005|P3|Phase II|Disease progression|0
903140|NCT01125800|2978006|P2|Phase II|Disease progression|0
903141|NCT01125800|2978007|P1|Phase II|Disease progression|0
903142|NCT01125800|2978003|P5|Phase II|Adverse Event|2
903143|NCT01125800|2978004|P4|Phase II|Adverse Event|0
903144|NCT01125800|2978005|P3|Phase II|Adverse Event|0
903145|NCT01125800|2978006|P2|Phase II|Adverse Event|0
903146|NCT01125800|2978007|P1|Phase II|Adverse Event|0
903147|NCT01125800|2978003|P5|Phase II|Protocol Violation|1
903148|NCT01125800|2978004|P4|Phase II|Protocol Violation|0
903149|NCT01125800|2978005|P3|Phase II|Protocol Violation|0
903150|NCT01125800|2978006|P2|Phase II|Protocol Violation|0
903151|NCT01125800|2978007|P1|Phase II|Protocol Violation|0
903152|NCT01125800|2978003|P5|Phase I|Disease progression|0
903153|NCT01125800|2978004|P4|Phase I|Disease progression|3
903154|NCT01125800|2978005|P3|Phase I|Disease progression|1
903155|NCT01125800|2978006|P2|Phase I|Disease progression|4
903156|NCT01125800|2978007|P1|Phase I|Disease progression|5
903157|NCT01125800|2978003|P5|Phase I|Withdrawal by Subject|0
903158|NCT01125800|2978004|P4|Phase I|Withdrawal by Subject|0
903159|NCT01125800|2978005|P3|Phase I|Withdrawal by Subject|1
903160|NCT01125800|2978006|P2|Phase I|Withdrawal by Subject|0
903161|NCT01125800|2978007|P1|Phase I|Withdrawal by Subject|0
903162|NCT01125800|2978003|P5|Phase I|Administrative problems|0
903163|NCT01125800|2978004|P4|Phase I|Administrative problems|0
903164|NCT01125800|2978005|P3|Phase I|Administrative problems|0
903165|NCT01125800|2978006|P2|Phase I|Administrative problems|0
903166|NCT01125800|2978007|P1|Phase I|Administrative problems|1
903167|NCT01125800|2978003|P5|Phase I|Adverse Event|0
903168|NCT01125800|2978004|P4|Phase I|Adverse Event|7
903169|NCT01125800|2978005|P3|Phase I|Adverse Event|1
903170|NCT01125800|2978006|P2|Phase I|Adverse Event|2
903171|NCT01125800|2978007|P1|Phase I|Adverse Event|2
903172|NCT01125800|2978003|P5|Phase I|Protocol Violation|0
903173|NCT01125800|2978004|P4|Phase I|Protocol Violation|1
903174|NCT01125800|2978005|P3|Phase I|Protocol Violation|1
903175|NCT01125800|2978006|P2|Phase I|Protocol Violation|3
903176|NCT01125800|2978007|P1|Phase I|Protocol Violation|0
903177|NCT01125748|2978073|P2|Overall Study|Patient Decision to Withdraw|4
903178|NCT01125748|2978074|P1|Overall Study|Patient Decision to Withdraw|2
903179|NCT01125748|2978073|P2|Overall Study|Physician Decision|7
903180|NCT01125748|2978074|P1|Overall Study|Physician Decision|8
903181|NCT01125748|2978073|P2|Overall Study|Lost to Follow-up|1
903182|NCT01125748|2978074|P1|Overall Study|Lost to Follow-up|0
903183|NCT01125748|2978073|P2|Overall Study|Adverse Event|2
903184|NCT01125748|2978074|P1|Overall Study|Adverse Event|0
903185|NCT01125722|2978084|P2|Overall Study|Lost to Follow-up|0
903186|NCT01125722|2978085|P1|Overall Study|Lost to Follow-up|1
903187|NCT01125722|2978084|P2|Overall Study|Withdrawal by Subject|1
903188|NCT01125722|2978085|P1|Overall Study|Withdrawal by Subject|2
903189|NCT01125566|2978132|P3|Patients Who Switched From AV to TV|Refused to continue taking medication|4
903190|NCT01125566|2978133|P2|Patients Who Switched From AV to TV|Refused to continue taking medication|0
903191|NCT01125566|2978134|P1|Patients Who Switched From AV to TV|Refused to continue taking medication|0
903192|NCT01125566|2978132|P3|Patients Who Switched From AV to TV|Progressive disease according to RECIST|20
903193|NCT01125566|2978133|P2|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
903194|NCT01125566|2978134|P1|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
903195|NCT01125566|2978132|P3|Patients Before the Switch (26Apr2013)|Other than those stated above|0
903196|NCT01125566|2978133|P2|Patients Before the Switch (26Apr2013)|Other than those stated above|5
903197|NCT01125566|2978134|P1|Patients Before the Switch (26Apr2013)|Other than those stated above|23
903198|NCT01125566|2978132|P3|Patients Before the Switch (26Apr2013)|Not treated|0
903199|NCT01125566|2978133|P2|Patients Before the Switch (26Apr2013)|Not treated|0
903200|NCT01125566|2978134|P1|Patients Before the Switch (26Apr2013)|Not treated|2
903201|NCT01125566|2978132|P3|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0
903202|NCT01125566|2978133|P2|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|21
903203|NCT01125566|2978134|P1|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|25
903204|NCT01125566|2978132|P3|Patients Before the Switch (26Apr2013)|Protocol Violation|0
903205|NCT01125566|2978133|P2|Patients Before the Switch (26Apr2013)|Protocol Violation|1
903206|NCT01125566|2978134|P1|Patients Before the Switch (26Apr2013)|Protocol Violation|0
903207|NCT01125566|2978132|P3|Patients Before the Switch (26Apr2013)|Adverse Event|0
903208|NCT01125566|2978133|P2|Patients Before the Switch (26Apr2013)|Adverse Event|5
903209|NCT01125566|2978134|P1|Patients Before the Switch (26Apr2013)|Adverse Event|24
903210|NCT01125566|2978132|P3|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0
903211|NCT01125566|2978133|P2|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|4
903212|NCT01125566|2978134|P1|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|5
903213|NCT01125566|2978132|P3|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0
903214|NCT01125566|2978133|P2|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|100
903215|NCT01125566|2978134|P1|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|181
903216|NCT01125514|2978147|P1|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1
903217|NCT01125514|2978147|P1|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1
903218|NCT01125514|2978147|P1|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2
903219|NCT01125514|2978147|P1|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3
903220|NCT01125514|2978147|P1|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1
903221|NCT01125514|2978147|P1|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1
903222|NCT01125189|2978247|P3|Follow up Period|Other reasons|5
903223|NCT01125189|2978248|P2|Follow up Period|Other reasons|4
903224|NCT01125189|2978249|P1|Follow up Period|Other reasons|4
903225|NCT01125189|2978247|P3|Follow up Period|Lost to Follow-up|6
903226|NCT01125189|2978248|P2|Follow up Period|Lost to Follow-up|9
903227|NCT01125189|2978249|P1|Follow up Period|Lost to Follow-up|12
903228|NCT01125189|2978247|P3|Follow up Period|Death|0
903229|NCT01125189|2978248|P2|Follow up Period|Death|0
903230|NCT01125189|2978249|P1|Follow up Period|Death|1
903231|NCT01125189|2978247|P3|Follow up Period|Withdrawal by Subject|5
903232|NCT01125189|2978248|P2|Follow up Period|Withdrawal by Subject|2
903233|NCT01125189|2978249|P1|Follow up Period|Withdrawal by Subject|3
903234|NCT01125189|2978247|P3|Treatment Period|Completed 24 week treatment period only|2
903235|NCT01125189|2978248|P2|Treatment Period|Completed 24 week treatment period only|1
903236|NCT01125189|2978249|P1|Treatment Period|Completed 24 week treatment period only|2
903237|NCT01125189|2978247|P3|Treatment Period|Other reasons|0
903238|NCT01125189|2978248|P2|Treatment Period|Other reasons|1
903239|NCT01125189|2978249|P1|Treatment Period|Other reasons|1
903240|NCT01125189|2978247|P3|Treatment Period|Participants requested to discontinue|4
903241|NCT01125189|2978248|P2|Treatment Period|Participants requested to discontinue|3
903242|NCT01125189|2978249|P1|Treatment Period|Participants requested to discontinue|1
903243|NCT01125189|2978247|P3|Treatment Period|Poor compliance/noncompliance|0
903244|NCT01125189|2978248|P2|Treatment Period|Poor compliance/noncompliance|1
903245|NCT01125189|2978249|P1|Treatment Period|Poor compliance/noncompliance|0
903246|NCT01125189|2978247|P3|Treatment Period|Lost to Follow-up|1
903247|NCT01125189|2978248|P2|Treatment Period|Lost to Follow-up|2
903248|NCT01125189|2978249|P1|Treatment Period|Lost to Follow-up|1
903249|NCT01125189|2978247|P3|Treatment Period|Death|0
903250|NCT01125189|2978248|P2|Treatment Period|Death|0
903251|NCT01125189|2978249|P1|Treatment Period|Death|1
903252|NCT01125189|2978247|P3|Treatment Period|Withdrawal by Subject|1
903253|NCT01125189|2978248|P2|Treatment Period|Withdrawal by Subject|1
903254|NCT01125189|2978249|P1|Treatment Period|Withdrawal by Subject|3
903255|NCT01125189|2978247|P3|Treatment Period|Adverse Event|8
903256|NCT01125189|2978248|P2|Treatment Period|Adverse Event|8
903257|NCT01125189|2978249|P1|Treatment Period|Adverse Event|7
903258|NCT01125189|2978247|P3|Treatment Period|Lack of Efficacy|25
903259|NCT01125189|2978248|P2|Treatment Period|Lack of Efficacy|18
903260|NCT01125189|2978249|P1|Treatment Period|Lack of Efficacy|15
903261|NCT01124916|2978303|P2|Overall Study|Lost to Follow-up|2
903262|NCT01124916|2978304|P1|Overall Study|Lost to Follow-up|3
903263|NCT01124864|2978318|P6|Overall Study|Protocol Violation|0
903264|NCT01124864|2978319|P5|Overall Study|Protocol Violation|1
903265|NCT01124864|2978320|P4|Overall Study|Protocol Violation|0
903266|NCT01124864|2978321|P3|Overall Study|Protocol Violation|0
903267|NCT01124864|2978322|P2|Overall Study|Protocol Violation|0
903268|NCT01124864|2978323|P1|Overall Study|Protocol Violation|1
903269|NCT01124864|2978318|P6|Overall Study|Lost to Follow-up|0
903270|NCT01124864|2978319|P5|Overall Study|Lost to Follow-up|0
903271|NCT01124864|2978320|P4|Overall Study|Lost to Follow-up|1
903272|NCT01124864|2978321|P3|Overall Study|Lost to Follow-up|0
903273|NCT01124864|2978322|P2|Overall Study|Lost to Follow-up|1
903274|NCT01124864|2978323|P1|Overall Study|Lost to Follow-up|1
903275|NCT01124864|2978318|P6|Overall Study|Withdrawal by Subject|1
903276|NCT01124864|2978319|P5|Overall Study|Withdrawal by Subject|2
903277|NCT01124864|2978320|P4|Overall Study|Withdrawal by Subject|0
903278|NCT01124864|2978321|P3|Overall Study|Withdrawal by Subject|4
903279|NCT01124864|2978322|P2|Overall Study|Withdrawal by Subject|3
903280|NCT01124864|2978323|P1|Overall Study|Withdrawal by Subject|2
903281|NCT01124864|2978318|P6|Overall Study|Death|0
903282|NCT01124864|2978319|P5|Overall Study|Death|1
903283|NCT01124864|2978320|P4|Overall Study|Death|2
903284|NCT01124864|2978321|P3|Overall Study|Death|6
903285|NCT01124864|2978322|P2|Overall Study|Death|9
903286|NCT01124864|2978323|P1|Overall Study|Death|6
903287|NCT01124864|2978318|P6|Overall Study|Follow up phase competed as per protocol|2
903288|NCT01124864|2978319|P5|Overall Study|Follow up phase competed as per protocol|26
903289|NCT01124864|2978320|P4|Overall Study|Follow up phase competed as per protocol|18
903290|NCT01124864|2978321|P3|Overall Study|Follow up phase competed as per protocol|24
903291|NCT01124864|2978322|P2|Overall Study|Follow up phase competed as per protocol|22
903292|NCT01124864|2978323|P1|Overall Study|Follow up phase competed as per protocol|18
903293|NCT01124838|2978357|P2|Overall Study|Lost to Follow-up|0
903294|NCT01124838|2978358|P1|Overall Study|Lost to Follow-up|2
903295|NCT01124838|2978357|P2|Overall Study|Withdrawal by Subject|2
903296|NCT01124838|2978358|P1|Overall Study|Withdrawal by Subject|3
903297|NCT01124838|2978357|P2|Overall Study|Lack of Efficacy|0
903298|NCT01124838|2978358|P1|Overall Study|Lack of Efficacy|2
903299|NCT01124838|2978357|P2|Overall Study|Adverse Event|11
903300|NCT01124838|2978358|P1|Overall Study|Adverse Event|7
903301|NCT01124838|2978357|P2|Overall Study|Miscellaneous|2
903302|NCT01124838|2978358|P1|Overall Study|Miscellaneous|4
903303|NCT01124643|2978425|P1|Overall Study|Death|1
903304|NCT01124617|2978439|P2|Overall Study|Other|1
903305|NCT01124617|2978440|P1|Overall Study|Other|2
903306|NCT01124617|2978439|P2|Overall Study|Withdrawal by Subject|1
903307|NCT01124617|2978440|P1|Overall Study|Withdrawal by Subject|9
903308|NCT01124617|2978439|P2|Overall Study|Protocol Violation|1
903309|NCT01124617|2978440|P1|Overall Study|Protocol Violation|1
903310|NCT01124617|2978439|P2|Overall Study|Lack of Efficacy|1
903311|NCT01124617|2978440|P1|Overall Study|Lack of Efficacy|2
903312|NCT01124617|2978439|P2|Overall Study|Adverse Event|2
903313|NCT01124617|2978440|P1|Overall Study|Adverse Event|5
903314|NCT01124604|2978472|P2|Overall Study|Disease Progression|1
903315|NCT01124604|2978473|P1|Overall Study|Disease Progression|0
903316|NCT01124604|2978472|P2|Overall Study|Withdrawal by Subject|0
903317|NCT01124604|2978473|P1|Overall Study|Withdrawal by Subject|4
903318|NCT01124604|2978472|P2|Overall Study|Lack of Efficacy|0
903319|NCT01124604|2978473|P1|Overall Study|Lack of Efficacy|1
903320|NCT01124604|2978472|P2|Overall Study|Adverse Event|1
903321|NCT01124604|2978473|P1|Overall Study|Adverse Event|10
903322|NCT01124448|2978512|P2|Overall Study|Protocol Violation|0
903323|NCT01124448|2978513|P1|Overall Study|Protocol Violation|2
903324|NCT01124448|2978512|P2|Overall Study|Lost to Follow-up|3
903325|NCT01124448|2978513|P1|Overall Study|Lost to Follow-up|0
903326|NCT01124422|2978521|P3|4-Week Double-blind Treatment Phase|Lost to Follow-up|1
903327|NCT01124422|2978522|P2|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
903328|NCT01124422|2978523|P1|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
903329|NCT01124422|2978521|P3|4-Week Double-blind Treatment Phase|Physician Decision|2
903330|NCT01124422|2978522|P2|4-Week Double-blind Treatment Phase|Physician Decision|5
903331|NCT01124422|2978523|P1|4-Week Double-blind Treatment Phase|Physician Decision|0
903332|NCT01124422|2978521|P3|4-Week Double-blind Treatment Phase|Adverse Event|3
903333|NCT01124422|2978522|P2|4-Week Double-blind Treatment Phase|Adverse Event|6
903334|NCT01124422|2978523|P1|4-Week Double-blind Treatment Phase|Adverse Event|0
903335|NCT01124422|2978521|P3|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3
903336|NCT01124422|2978522|P2|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
903337|NCT01124422|2978523|P1|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
903338|NCT01124422|2978521|P3|4-Week Open-label Run-in Phase|Protocol Violation|0
903339|NCT01124422|2978522|P2|4-Week Open-label Run-in Phase|Protocol Violation|0
903340|NCT01124422|2978523|P1|4-Week Open-label Run-in Phase|Protocol Violation|5
903341|NCT01124422|2978521|P3|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
903342|NCT01124422|2978522|P2|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
903343|NCT01124422|2978523|P1|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61
903344|NCT01124422|2978521|P3|4-Week Open-label Run-in Phase|Lost to Follow-up|0
903345|NCT01124422|2978522|P2|4-Week Open-label Run-in Phase|Lost to Follow-up|0
903346|NCT01124422|2978523|P1|4-Week Open-label Run-in Phase|Lost to Follow-up|1
903347|NCT01124422|2978521|P3|4-Week Open-label Run-in Phase|Physician Decision|0
903348|NCT01124422|2978522|P2|4-Week Open-label Run-in Phase|Physician Decision|0
903349|NCT01124422|2978523|P1|4-Week Open-label Run-in Phase|Physician Decision|4
903350|NCT01124422|2978521|P3|4-Week Open-label Run-in Phase|Adverse Event|0
903351|NCT01124422|2978522|P2|4-Week Open-label Run-in Phase|Adverse Event|0
903352|NCT01124422|2978523|P1|4-Week Open-label Run-in Phase|Adverse Event|7
903353|NCT01124422|2978521|P3|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
903354|NCT01124422|2978522|P2|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
903355|NCT01124422|2978523|P1|4-Week Open-label Run-in Phase|Withdrawal by Subject|5
903356|NCT01124292|2978593|P3|Overall Study|piercing track closed|1
903357|NCT01124292|2978594|P2|Overall Study|piercing track closed|2
903358|NCT01124292|2978595|P1|Overall Study|piercing track closed|0
903359|NCT01124292|2978593|P3|Overall Study|medical issue unrelated to the study|2
903360|NCT01124292|2978594|P2|Overall Study|medical issue unrelated to the study|0
903361|NCT01124292|2978595|P1|Overall Study|medical issue unrelated to the study|0
903362|NCT01124292|2978593|P3|Overall Study|Withdrawal by Subject|2
903363|NCT01124292|2978594|P2|Overall Study|Withdrawal by Subject|6
903364|NCT01124292|2978595|P1|Overall Study|Withdrawal by Subject|0
903365|NCT01124292|2978593|P3|Overall Study|Physician Decision|2
903366|NCT01124292|2978594|P2|Overall Study|Physician Decision|3
903367|NCT01124292|2978595|P1|Overall Study|Physician Decision|0
903368|NCT01124292|2978593|P3|Overall Study|Lost to Follow-up|3
903369|NCT01124292|2978594|P2|Overall Study|Lost to Follow-up|4
903370|NCT01124292|2978595|P1|Overall Study|Lost to Follow-up|2
903371|NCT01124175|2978666|P2|Washout of 7 Days|Withdrawal by Subject|2
903372|NCT01124175|2978667|P1|Washout of 7 Days|Withdrawal by Subject|0
903373|NCT01124162|2978685|P2|Washout of 7 Days|Withdrawal by Subject|0
903374|NCT01124162|2978686|P1|Washout of 7 Days|Withdrawal by Subject|1
903375|NCT01124162|2978685|P2|First Intervention|Adverse Event|0
903376|NCT01124162|2978686|P1|First Intervention|Adverse Event|2
903377|NCT01124149|2978702|P1|Maintenance Phase|Non-compliance|1
903378|NCT01124149|2978702|P1|Maintenance Phase|Coordinator error|1
903379|NCT01124149|2978702|P1|Maintenance Phase|Protocol Violation|5
903380|NCT01124149|2978702|P1|Maintenance Phase|Withdrawal by Subject|10
903381|NCT01124149|2978702|P1|Maintenance Phase|Lost to Follow-up|15
903382|NCT01124149|2978702|P1|Maintenance Phase|Adverse Event|24
903383|NCT01124149|2978702|P1|Maintenance Phase|Lack of Efficacy|40
903384|NCT01124149|2978702|P1|Acute Phase|Sponsor decision|1
903385|NCT01124149|2978702|P1|Acute Phase|Travelling to another country|1
903386|NCT01124149|2978702|P1|Acute Phase|Low hemoglobin|1
903387|NCT01124149|2978702|P1|Acute Phase|Non-compliance|1
903388|NCT01124149|2978702|P1|Acute Phase|UC symptoms not ameliorated|1
903389|NCT01124149|2978702|P1|Acute Phase|Sponsor request|1
903390|NCT01124149|2978702|P1|Acute Phase|Prolonged antibiotic therapy|1
903391|NCT01124149|2978702|P1|Acute Phase|Lost to Follow-up|2
903392|NCT01124149|2978702|P1|Acute Phase|Protocol Violation|14
903393|NCT01124149|2978702|P1|Acute Phase|Lack of Efficacy|17
903394|NCT01124149|2978702|P1|Acute Phase|Adverse Event|21
903395|NCT01124149|2978702|P1|Acute Phase|Withdrawal by Subject|22
903396|NCT01124097|2978722|P4|Overall Study|Physician Decision|0
903397|NCT01124097|2978723|P3|Overall Study|Physician Decision|0
903398|NCT01124097|2978724|P2|Overall Study|Physician Decision|1
903399|NCT01124097|2978725|P1|Overall Study|Physician Decision|2
903400|NCT01124097|2978722|P4|Overall Study|Protocol Violation|1
903401|NCT01124097|2978723|P3|Overall Study|Protocol Violation|2
903402|NCT01124097|2978724|P2|Overall Study|Protocol Violation|0
903403|NCT01124097|2978725|P1|Overall Study|Protocol Violation|2
903404|NCT01124097|2978722|P4|Overall Study|Adverse Event|7
903405|NCT01124097|2978723|P3|Overall Study|Adverse Event|15
903406|NCT01124097|2978724|P2|Overall Study|Adverse Event|15
903407|NCT01124097|2978725|P1|Overall Study|Adverse Event|24
903408|NCT01124097|2978722|P4|Overall Study|Lack of Efficacy|3
903409|NCT01124097|2978723|P3|Overall Study|Lack of Efficacy|1
903410|NCT01124097|2978724|P2|Overall Study|Lack of Efficacy|3
903411|NCT01124097|2978725|P1|Overall Study|Lack of Efficacy|2
903412|NCT01124097|2978722|P4|Overall Study|Withdrawal by Subject|3
903413|NCT01124097|2978723|P3|Overall Study|Withdrawal by Subject|2
903414|NCT01124097|2978724|P2|Overall Study|Withdrawal by Subject|3
903415|NCT01124097|2978725|P1|Overall Study|Withdrawal by Subject|4
903416|NCT01124045|2978737|P2|Overall Study|Physician Decision|2
903417|NCT01124045|2978738|P1|Overall Study|Physician Decision|0
903418|NCT01124045|2978737|P2|Overall Study|Lost to Follow-up|1
903419|NCT01124045|2978738|P1|Overall Study|Lost to Follow-up|0
903420|NCT01124006|2978771|P3|Overall Study|Other|1
903421|NCT01124006|2978772|P2|Overall Study|Other|0
903422|NCT01124006|2978773|P1|Overall Study|Other|0
903423|NCT01124006|2978771|P3|Overall Study|Lost to Follow-up|1
903424|NCT01124006|2978772|P2|Overall Study|Lost to Follow-up|0
903425|NCT01124006|2978773|P1|Overall Study|Lost to Follow-up|1
903426|NCT01124006|2978771|P3|Overall Study|Withdrawal by Subject|0
903427|NCT01124006|2978772|P2|Overall Study|Withdrawal by Subject|2
903428|NCT01124006|2978773|P1|Overall Study|Withdrawal by Subject|2
903429|NCT01123980|2978801|P2|Overall Study|Unclassified|7
903430|NCT01123980|2978802|P1|Overall Study|Unclassified|6
903431|NCT01123980|2978801|P2|Overall Study|Withdrawal by Subject|3
903432|NCT01123980|2978802|P1|Overall Study|Withdrawal by Subject|5
903433|NCT01123980|2978801|P2|Overall Study|Protocol Violation|6
903434|NCT01123980|2978802|P1|Overall Study|Protocol Violation|6
903435|NCT01123980|2978801|P2|Overall Study|Lost to Follow-up|6
903436|NCT01123980|2978802|P1|Overall Study|Lost to Follow-up|0
903437|NCT01123980|2978801|P2|Overall Study|Physician Decision|1
903438|NCT01123980|2978802|P1|Overall Study|Physician Decision|0
903439|NCT01123980|2978801|P2|Overall Study|Lack of Efficacy|0
903440|NCT01123980|2978802|P1|Overall Study|Lack of Efficacy|1
903441|NCT01123980|2978801|P2|Overall Study|Adverse Event|1
903442|NCT01123980|2978802|P1|Overall Study|Adverse Event|1
903443|NCT01123941|2978822|P2|Overall Study|Lost to Follow-up|1
903444|NCT01123941|2978823|P1|Overall Study|Lost to Follow-up|2
903445|NCT01123889|2978858|P2|Overall Study|Lost to Follow-up|1
903446|NCT01123889|2978859|P1|Overall Study|Lost to Follow-up|3
903447|NCT01123850|2978869|P1|Overall Study|Slow enrollment|45
903448|NCT01123642|2978874|P1|Overall Study|ineligible at baseline assessment|36
903449|NCT01123642|2978874|P1|Overall Study|Withdrawal by Subject|9
903450|NCT01123642|2978874|P1|Overall Study|Lost to Follow-up|23
903451|NCT01123395|2978890|P2|Washout Period of 14 Days|Withdrawal by Subject|1
903452|NCT01123395|2978891|P1|Washout Period of 14 Days|Withdrawal by Subject|0
903453|NCT01123382|2978903|P2|Overall Study|Lost to Follow-up|2
903454|NCT01123382|2978904|P1|Overall Study|Lost to Follow-up|1
903455|NCT01123382|2978903|P2|Overall Study|Withdrawal by Subject|4
903456|NCT01123382|2978904|P1|Overall Study|Withdrawal by Subject|1
903457|NCT01123356|2978926|P1|Overall Study|Withdrawal by Subject|1
903458|NCT01123356|2978926|P1|Overall Study|Lack of Efficacy|4
903459|NCT01123356|2978926|P1|Overall Study|Adverse Event|2
903460|NCT01123200|2978934|P1|Overall Study|Withdrawal by Subject|1
903461|NCT01123161|2978941|P2|Overall Study|Withdrawal by Subject|0
903462|NCT01123161|2978942|P1|Overall Study|Withdrawal by Subject|1
903463|NCT01123161|2978941|P2|Overall Study|Lost to Follow-up|0
903464|NCT01123161|2978942|P1|Overall Study|Lost to Follow-up|1
903465|NCT01123148|2978960|P1|Overall Study|Didn't meet milestone criteria|1
903466|NCT01123148|2978960|P1|Overall Study|Coughing caused unacceptable EEG quality|1
903467|NCT01123083|2978966|P2|Overall Study|Participant/legal representative request|3
903468|NCT01123083|2978967|P1|Overall Study|Participant/legal representative request|7
903469|NCT01123083|2978966|P2|Overall Study|Withdrew for another reason not covered|1
903470|NCT01123083|2978967|P1|Overall Study|Withdrew for another reason not covered|0
903471|NCT01123083|2978966|P2|Overall Study|Adverse Event|0
903472|NCT01123083|2978967|P1|Overall Study|Adverse Event|1
903473|NCT01123083|2978966|P2|Overall Study|Lost to Follow-up|6
903474|NCT01123083|2978967|P1|Overall Study|Lost to Follow-up|2
903475|NCT01123083|2978966|P2|Overall Study|Administrative reasons|4
903476|NCT01123083|2978967|P1|Overall Study|Administrative reasons|0
903477|NCT01123083|2978966|P2|Overall Study|Investigator recommendation|1
903478|NCT01123083|2978967|P1|Overall Study|Investigator recommendation|1
903479|NCT01122927|2978991|P2|Period 2- Open-label Treatment Phase|Lack of Efficacy|7
903480|NCT01122927|2978992|P1|Period 2- Open-label Treatment Phase|Lack of Efficacy|0
903481|NCT01122927|2978991|P2|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65
903482|NCT01122927|2978992|P1|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0
903483|NCT01122927|2978991|P2|Period 2- Open-label Treatment Phase|Physician Decision|12
903484|NCT01122927|2978992|P1|Period 2- Open-label Treatment Phase|Physician Decision|0
903485|NCT01122927|2978991|P2|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9
903486|NCT01122927|2978992|P1|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0
903487|NCT01122927|2978991|P2|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165
903488|NCT01122927|2978992|P1|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0
903489|NCT01122927|2978991|P2|Period 2- Open-label Treatment Phase|Adverse Event|33
903490|NCT01122927|2978992|P1|Period 2- Open-label Treatment Phase|Adverse Event|0
903491|NCT01122927|2978991|P2|Period 2- Open-label Treatment Phase|Lost to Follow-up|21
903492|NCT01122927|2978992|P1|Period 2- Open-label Treatment Phase|Lost to Follow-up|0
903493|NCT01122927|2978991|P2|Period 1 - Conversion Phase|Protocol Deviation|0
903494|NCT01122927|2978992|P1|Period 1 - Conversion Phase|Protocol Deviation|1
903495|NCT01122927|2978991|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
903496|NCT01122927|2978992|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
903497|NCT01122927|2978991|P2|Period 1 - Conversion Phase|Physician Decision|0
903498|NCT01122927|2978992|P1|Period 1 - Conversion Phase|Physician Decision|2
903499|NCT01122927|2978991|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
903500|NCT01122927|2978992|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
903501|NCT01122927|2978991|P2|Period 1 - Conversion Phase|Adverse Event|0
903502|NCT01122927|2978992|P1|Period 1 - Conversion Phase|Adverse Event|3
903503|NCT01122862|2979044|P3|Period 2|Adverse Event|1
903504|NCT01122862|2979045|P2|Period 2|Adverse Event|0
903505|NCT01122862|2979046|P1|Period 2|Adverse Event|0
903506|NCT01122862|2979044|P3|Period 1|Protocol Violation|0
903507|NCT01122862|2979045|P2|Period 1|Protocol Violation|1
903508|NCT01122862|2979046|P1|Period 1|Protocol Violation|0
903509|NCT01122680|2979152|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
903510|NCT01122680|2979153|P3|Period 3 (4 Weeks)|Withdrawal by Subject|0
903511|NCT01122680|2979154|P2|Period 3 (4 Weeks)|Withdrawal by Subject|1
903512|NCT01122680|2979155|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
903513|NCT01122680|2979152|P4|Period 3 (4 Weeks)|Adverse Event|0
903514|NCT01122680|2979153|P3|Period 3 (4 Weeks)|Adverse Event|0
903515|NCT01122680|2979154|P2|Period 3 (4 Weeks)|Adverse Event|0
903516|NCT01122680|2979155|P1|Period 3 (4 Weeks)|Adverse Event|1
903517|NCT01122680|2979152|P4|Period 2 (4 Weeks)|Other|0
903518|NCT01122680|2979153|P3|Period 2 (4 Weeks)|Other|0
903519|NCT01122680|2979154|P2|Period 2 (4 Weeks)|Other|0
903520|NCT01122680|2979155|P1|Period 2 (4 Weeks)|Other|1
903521|NCT01122680|2979152|P4|Period 2 (4 Weeks)|Protocol Violation|1
903522|NCT01122680|2979153|P3|Period 2 (4 Weeks)|Protocol Violation|0
903523|NCT01122680|2979154|P2|Period 2 (4 Weeks)|Protocol Violation|0
903524|NCT01122680|2979155|P1|Period 2 (4 Weeks)|Protocol Violation|0
903525|NCT01122680|2979152|P4|Period 1 (4 Weeks)|Other|0
903526|NCT01122680|2979153|P3|Period 1 (4 Weeks)|Other|0
903527|NCT01122680|2979154|P2|Period 1 (4 Weeks)|Other|1
903528|NCT01122680|2979155|P1|Period 1 (4 Weeks)|Other|1
903529|NCT01122680|2979152|P4|Period 1 (4 Weeks)|Protocol Violation|0
903530|NCT01122680|2979153|P3|Period 1 (4 Weeks)|Protocol Violation|0
903531|NCT01122680|2979154|P2|Period 1 (4 Weeks)|Protocol Violation|0
903532|NCT01122680|2979155|P1|Period 1 (4 Weeks)|Protocol Violation|1
903533|NCT01122680|2979152|P4|Period 1 (4 Weeks)|Adverse Event|0
903534|NCT01122680|2979153|P3|Period 1 (4 Weeks)|Adverse Event|0
903535|NCT01122680|2979154|P2|Period 1 (4 Weeks)|Adverse Event|0
903536|NCT01122680|2979155|P1|Period 1 (4 Weeks)|Adverse Event|1
903537|NCT01122576|2979220|P3|Post-Cataract Surgery|Fellow Eye Explanted|1
903538|NCT01122576|2979221|P2|Post-Cataract Surgery|Fellow Eye Explanted|0
903539|NCT01122576|2979222|P1|Post-Cataract Surgery|Fellow Eye Explanted|0
903540|NCT01122576|2979220|P3|Post-Cataract Surgery|Central Macular Edema|1
903541|NCT01122576|2979221|P2|Post-Cataract Surgery|Central Macular Edema|0
903542|NCT01122576|2979222|P1|Post-Cataract Surgery|Central Macular Edema|0
903543|NCT01122576|2979220|P3|Pre-Cataract Surgery|Withdrawal by Subject|2
903544|NCT01122576|2979221|P2|Pre-Cataract Surgery|Withdrawal by Subject|1
903545|NCT01122576|2979222|P1|Pre-Cataract Surgery|Withdrawal by Subject|0
903546|NCT01122394|2979376|P2|Overall Study|Adverse Event|1
903547|NCT01122394|2979377|P1|Overall Study|Adverse Event|0
903548|NCT01122394|2979376|P2|Overall Study|Lost to Follow-up|2
903549|NCT01122394|2979377|P1|Overall Study|Lost to Follow-up|2
903550|NCT01122394|2979376|P2|Overall Study|Withdrawal by Subject|1
903551|NCT01122394|2979377|P1|Overall Study|Withdrawal by Subject|1
903552|NCT01122381|2979393|P2|Overall Study|study terminated early|1
903553|NCT01122381|2979394|P1|Overall Study|study terminated early|0
903554|NCT01122264|2979403|P3|Overall Study|Lack of Efficacy|1
903555|NCT01122264|2979404|P2|Overall Study|Lack of Efficacy|1
903556|NCT01122264|2979405|P1|Overall Study|Lack of Efficacy|3
903557|NCT01122264|2979403|P3|Overall Study|Physician Decision|1
903558|NCT01122264|2979404|P2|Overall Study|Physician Decision|1
903559|NCT01122264|2979405|P1|Overall Study|Physician Decision|3
903560|NCT01122264|2979403|P3|Overall Study|Withdrawal by Subject|16
903561|NCT01122264|2979404|P2|Overall Study|Withdrawal by Subject|6
903562|NCT01122264|2979405|P1|Overall Study|Withdrawal by Subject|6
903563|NCT01122264|2979403|P3|Overall Study|Protocol Violation|9
903564|NCT01122264|2979404|P2|Overall Study|Protocol Violation|7
903565|NCT01122264|2979405|P1|Overall Study|Protocol Violation|7
903566|NCT01122264|2979403|P3|Overall Study|Entry Criteria Not Met|0
903567|NCT01122264|2979404|P2|Overall Study|Entry Criteria Not Met|0
903568|NCT01122264|2979405|P1|Overall Study|Entry Criteria Not Met|1
903569|NCT01122264|2979403|P3|Overall Study|Lost to Follow-up|13
903570|NCT01122264|2979404|P2|Overall Study|Lost to Follow-up|9
903571|NCT01122264|2979405|P1|Overall Study|Lost to Follow-up|5
903572|NCT01122264|2979403|P3|Overall Study|Death|0
903573|NCT01122264|2979404|P2|Overall Study|Death|0
903574|NCT01122264|2979405|P1|Overall Study|Death|1
903575|NCT01122264|2979403|P3|Overall Study|Adverse Event|7
903576|NCT01122264|2979404|P2|Overall Study|Adverse Event|5
903577|NCT01122264|2979405|P1|Overall Study|Adverse Event|6
903578|NCT01122173|2979515|P1|Overall Study|Left study for other reasons|3
903579|NCT01122173|2979515|P1|Overall Study|Withdrawal by Subject|3
903580|NCT01122173|2979515|P1|Overall Study|Lost to Follow-up|3
903581|NCT01121991|2979738|P1|Overall Study|No Fertilization|1
903582|NCT01121991|2979738|P1|Overall Study|No Oocytes Retrieved|3
903583|NCT01121991|2979738|P1|Overall Study|Lack of Ovarian Response|2
903584|NCT01121926|2979763|P2|Washout Period|Positive pregnancy test|1
903585|NCT01121926|2979764|P1|Washout Period|Positive pregnancy test|0
903586|NCT01121926|2979763|P2|Washout Period|Adverse Event|1
903587|NCT01121926|2979764|P1|Washout Period|Adverse Event|0
903588|NCT01121926|2979763|P2|First Intervention Period|Adverse Event|0
903589|NCT01121926|2979764|P1|First Intervention Period|Adverse Event|1
903590|NCT01121913|2979782|P4|Third Washout Period|Adverse Event|0
903591|NCT01121913|2979783|P3|Third Washout Period|Adverse Event|0
903592|NCT01121913|2979784|P2|Third Washout Period|Adverse Event|0
903593|NCT01121913|2979785|P1|Third Washout Period|Adverse Event|1
903594|NCT01121913|2979782|P4|Second Washout Period|Withdrawal by Subject|0
903595|NCT01121913|2979783|P3|Second Washout Period|Withdrawal by Subject|1
903596|NCT01121913|2979784|P2|Second Washout Period|Withdrawal by Subject|0
903597|NCT01121913|2979785|P1|Second Washout Period|Withdrawal by Subject|0
903598|NCT01121913|2979782|P4|Second Intervention Period|Adverse Event|0
903599|NCT01121913|2979783|P3|Second Intervention Period|Adverse Event|1
903600|NCT01121913|2979784|P2|Second Intervention Period|Adverse Event|0
903601|NCT01121913|2979785|P1|Second Intervention Period|Adverse Event|0
903602|NCT01121913|2979782|P4|First Washout Period|Withdrawal by Subject|0
903603|NCT01121913|2979783|P3|First Washout Period|Withdrawal by Subject|0
903604|NCT01121913|2979784|P2|First Washout Period|Withdrawal by Subject|0
903605|NCT01121913|2979785|P1|First Washout Period|Withdrawal by Subject|1
903606|NCT01121913|2979782|P4|First Intervention Period|Adverse Event|0
903607|NCT01121913|2979783|P3|First Intervention Period|Adverse Event|1
903608|NCT01121913|2979784|P2|First Intervention Period|Adverse Event|0
903609|NCT01121913|2979785|P1|First Intervention Period|Adverse Event|0
903610|NCT01121900|2979815|P2|Washout Period of 7 Days|Withdrawal by Subject|1
903611|NCT01121900|2979816|P1|Washout Period of 7 Days|Withdrawal by Subject|0
903612|NCT01121900|2979815|P2|First Intervention Period|Adverse Event|1
903613|NCT01121900|2979816|P1|First Intervention Period|Adverse Event|1
903614|NCT01121757|2979836|P2|Combination|Disease Progression|0
903615|NCT01121757|2979837|P1|Combination|Disease Progression|2
903616|NCT01121757|2979836|P2|Combination|Physician Decision|1
903617|NCT01121757|2979837|P1|Combination|Physician Decision|0
903618|NCT01121757|2979836|P2|First Drug|Disease Progression|2
903619|NCT01121757|2979837|P1|First Drug|Disease Progression|0
903620|NCT01121757|2979836|P2|First Drug|Death|0
903621|NCT01121757|2979837|P1|First Drug|Death|1
903622|NCT01121666|2979853|P2|Overall Study|Protocol Violation|10
903623|NCT01121666|2979854|P1|Overall Study|Protocol Violation|29
903624|NCT01121575|2979910|P6|Overall Study|Death|1
903625|NCT01121575|2979911|P5|Overall Study|Death|7
903626|NCT01121575|2979912|P4|Overall Study|Death|1
903627|NCT01121575|2979913|P3|Overall Study|Death|0
903628|NCT01121575|2979914|P2|Overall Study|Death|0
903629|NCT01121575|2979915|P1|Overall Study|Death|6
903630|NCT01121575|2979910|P6|Overall Study|Unspecified Reasons|10
903631|NCT01121575|2979911|P5|Overall Study|Unspecified Reasons|13
903632|NCT01121575|2979912|P4|Overall Study|Unspecified Reasons|5
903633|NCT01121575|2979913|P3|Overall Study|Unspecified Reasons|7
903634|NCT01121575|2979914|P2|Overall Study|Unspecified Reasons|6
903635|NCT01121575|2979915|P1|Overall Study|Unspecified Reasons|8
903636|NCT01121575|2979910|P6|Overall Study|Participant Refused Further Follow-Up|1
903637|NCT01121575|2979911|P5|Overall Study|Participant Refused Further Follow-Up|5
903638|NCT01121575|2979912|P4|Overall Study|Participant Refused Further Follow-Up|0
903639|NCT01121575|2979913|P3|Overall Study|Participant Refused Further Follow-Up|0
903640|NCT01121575|2979914|P2|Overall Study|Participant Refused Further Follow-Up|0
903641|NCT01121575|2979915|P1|Overall Study|Participant Refused Further Follow-Up|0
903642|NCT01121562|2980039|P1|Overall Study|Met study discontinuation criteria|1
903643|NCT01121562|2980039|P1|Overall Study|Sponsor Decision|1
903644|NCT01121562|2980039|P1|Overall Study|Adverse Event|1
903645|NCT01121562|2980039|P1|Overall Study|Withdrawal by Subject|1
903646|NCT01121562|2980039|P1|Overall Study|Objective progression or relapse|8
903647|NCT01121549|2980048|P1|Overall Study|Other|58
903648|NCT01121549|2980048|P1|Overall Study|Withdrawal by Subject|16
903649|NCT01121549|2980048|P1|Overall Study|Protocol Violation|33
903650|NCT01121549|2980048|P1|Overall Study|Pregnancy|1
903651|NCT01121549|2980048|P1|Overall Study|Study terminated by sponsor|197
903652|NCT01121549|2980048|P1|Overall Study|Did not meet entrance criteria|9
903653|NCT01121549|2980048|P1|Overall Study|Lost to Follow-up|12
903654|NCT01121549|2980048|P1|Overall Study|Lack of Efficacy|11
903655|NCT01121549|2980048|P1|Overall Study|Adverse Event|10
903656|NCT01121536|2980059|P1|Overall Study|Not specified|118
903657|NCT01121536|2980059|P1|Overall Study|Lost to Follow-up|39
903658|NCT01121536|2980059|P1|Overall Study|Noncompliance with study procedures|9
903659|NCT01121536|2980059|P1|Overall Study|Noncompliance with study medication|12
903660|NCT01121536|2980059|P1|Overall Study|Protocol Violation|20
903661|NCT01121536|2980059|P1|Overall Study|Withdrawal by Subject|65
903662|NCT01121536|2980059|P1|Overall Study|Lack of Efficacy|35
903663|NCT01121536|2980059|P1|Overall Study|Adverse Event|63
903664|NCT01121484|2980080|P2|Overall Study|Randomized, not treated|4
903665|NCT01121484|2980081|P1|Overall Study|Randomized, not treated|1
903666|NCT01121484|2980080|P2|Overall Study|Other|3
903667|NCT01121484|2980081|P1|Overall Study|Other|3
903668|NCT01121484|2980080|P2|Overall Study|Discontinuation of study by sponsor|1
903669|NCT01121484|2980081|P1|Overall Study|Discontinuation of study by sponsor|0
903670|NCT01121484|2980080|P2|Overall Study|Withdrawal by Subject|7
903671|NCT01121484|2980081|P1|Overall Study|Withdrawal by Subject|8
903672|NCT01121484|2980080|P2|Overall Study|Protocol Violation|0
903673|NCT01121484|2980081|P1|Overall Study|Protocol Violation|1
903674|NCT01121484|2980080|P2|Overall Study|Physician Decision|3
903675|NCT01121484|2980081|P1|Overall Study|Physician Decision|0
903676|NCT01121484|2980080|P2|Overall Study|Lost to Follow-up|9
903677|NCT01121484|2980081|P1|Overall Study|Lost to Follow-up|5
903678|NCT01121484|2980080|P2|Overall Study|Lack of Efficacy|11
903679|NCT01121484|2980081|P1|Overall Study|Lack of Efficacy|3
903680|NCT01121484|2980080|P2|Overall Study|Adverse Event|5
903681|NCT01121484|2980081|P1|Overall Study|Adverse Event|12
903682|NCT01121406|2980099|P2|Overall Study|Not treated|0
903683|NCT01121406|2980100|P1|Overall Study|Not treated|1
903684|NCT01121406|2980099|P2|Overall Study|Reason other than specified above|6
903685|NCT01121406|2980100|P1|Overall Study|Reason other than specified above|2
903686|NCT01121406|2980099|P2|Overall Study|Refused continuation of study med.|2
903687|NCT01121406|2980100|P1|Overall Study|Refused continuation of study med.|1
903688|NCT01121406|2980099|P2|Overall Study|Lost to Follow-up|1
903689|NCT01121406|2980100|P1|Overall Study|Lost to Follow-up|0
903690|NCT01121406|2980099|P2|Overall Study|Non−compliant with protocol|2
903691|NCT01121406|2980100|P1|Overall Study|Non−compliant with protocol|0
903692|NCT01121406|2980099|P2|Overall Study|Other AE|10
903693|NCT01121406|2980100|P1|Overall Study|Other AE|3
903694|NCT01121406|2980099|P2|Overall Study|Wors. or AE of underlying cancer disease|6
903695|NCT01121406|2980100|P1|Overall Study|Wors. or AE of underlying cancer disease|4
903696|NCT01121406|2980099|P2|Overall Study|Progressive disease RECIST|28
903697|NCT01121406|2980100|P1|Overall Study|Progressive disease RECIST|44
903698|NCT01121393|2980150|P2|Overall Study|Not treated|9
903699|NCT01121393|2980151|P1|Overall Study|Not treated|3
903700|NCT01121393|2980150|P2|Overall Study|Refused cont. medication|7
903701|NCT01121393|2980151|P1|Overall Study|Refused cont. medication|7
903702|NCT01121393|2980150|P2|Overall Study|Lost to Follow-up|0
903703|NCT01121393|2980151|P1|Overall Study|Lost to Follow-up|1
903704|NCT01121393|2980150|P2|Overall Study|Non-compliant with protocol|3
903705|NCT01121393|2980151|P1|Overall Study|Non-compliant with protocol|0
903706|NCT01121393|2980150|P2|Overall Study|Other Adverse events|45
903707|NCT01121393|2980151|P1|Overall Study|Other Adverse events|22
903708|NCT01121393|2980150|P2|Overall Study|Progressive disease|20
903709|NCT01121393|2980151|P1|Overall Study|Progressive disease|186
903710|NCT01121263|2980196|P2|Overall Study|Withdrawal by Subject|1
903711|NCT01121263|2980197|P1|Overall Study|Withdrawal by Subject|0
903712|NCT01121263|2980196|P2|Overall Study|Lost to Follow-up|12
903713|NCT01121263|2980197|P1|Overall Study|Lost to Follow-up|22
903714|NCT01121263|2980196|P2|Overall Study|Death|2
903715|NCT01121263|2980197|P1|Overall Study|Death|3
903716|NCT01121185|2980262|P2|Overall Study|Not transplanted|0
903717|NCT01121185|2980263|P1|Overall Study|Not transplanted|1
903718|NCT01121185|2980262|P2|Overall Study|Not infused|1
903719|NCT01121185|2980263|P1|Overall Study|Not infused|0
903720|NCT01121146|2980297|P2|Overall Study|Lost to Follow-up|16
903721|NCT01121146|2980298|P1|Overall Study|Lost to Follow-up|7
903722|NCT01121146|2980297|P2|Overall Study|Adverse Event|11
903723|NCT01121146|2980298|P1|Overall Study|Adverse Event|2
903724|NCT01121146|2980297|P2|Overall Study|Death|15
903725|NCT01121146|2980298|P1|Overall Study|Death|17
903726|NCT01120899|2980319|P1|Overall Study|Withdrawal by Subject|3
903727|NCT01120782|2980347|P1|Overall Study|Test article shipping error|11
903728|NCT01120717|2980353|P2|Overall Study|Abnormal Test Procedure Result(s)|0
903729|NCT01120717|2980354|P1|Overall Study|Abnormal Test Procedure Result(s)|1
903730|NCT01120717|2980353|P2|Overall Study|Death|1
903731|NCT01120717|2980354|P1|Overall Study|Death|3
903732|NCT01120717|2980353|P2|Overall Study|Lost to Follow-up|3
903733|NCT01120717|2980354|P1|Overall Study|Lost to Follow-up|2
903734|NCT01120717|2980353|P2|Overall Study|Unsatisfactory Therapeutic Effect|3
903735|NCT01120717|2980354|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
903736|NCT01120717|2980353|P2|Overall Study|Protocol Deviation|5
903737|NCT01120717|2980354|P1|Overall Study|Protocol Deviation|2
903738|NCT01120717|2980353|P2|Overall Study|Adverse Event|6
903739|NCT01120717|2980354|P1|Overall Study|Adverse Event|10
903740|NCT01120717|2980353|P2|Overall Study|Withdrawal by Subject|6
903741|NCT01120717|2980354|P1|Overall Study|Withdrawal by Subject|11
903742|NCT01120691|2980460|P3|Overall Study|Abnormal laboratory value(s)|4
903743|NCT01120691|2980461|P2|Overall Study|Abnormal laboratory value(s)|3
903744|NCT01120691|2980462|P1|Overall Study|Abnormal laboratory value(s)|1
903745|NCT01120691|2980460|P3|Overall Study|Patient's inability to use the device|0
903746|NCT01120691|2980461|P2|Overall Study|Patient's inability to use the device|1
903747|NCT01120691|2980462|P1|Overall Study|Patient's inability to use the device|3
903748|NCT01120691|2980460|P3|Overall Study|Abnormal test procedure result(s)|1
903749|NCT01120691|2980461|P2|Overall Study|Abnormal test procedure result(s)|2
903750|NCT01120691|2980462|P1|Overall Study|Abnormal test procedure result(s)|3
903751|NCT01120691|2980460|P3|Overall Study|Lost to Follow-up|4
903752|NCT01120691|2980461|P2|Overall Study|Lost to Follow-up|6
903753|NCT01120691|2980462|P1|Overall Study|Lost to Follow-up|5
903754|NCT01120691|2980460|P3|Overall Study|Protocol deviation|12
903755|NCT01120691|2980461|P2|Overall Study|Protocol deviation|12
903756|NCT01120691|2980462|P1|Overall Study|Protocol deviation|13
903757|NCT01120691|2980460|P3|Overall Study|Administrative problems|9
903758|NCT01120691|2980461|P2|Overall Study|Administrative problems|8
903759|NCT01120691|2980462|P1|Overall Study|Administrative problems|15
903760|NCT01120691|2980460|P3|Overall Study|Unsatisfactory therapeutic effect|38
903761|NCT01120691|2980461|P2|Overall Study|Unsatisfactory therapeutic effect|32
903762|NCT01120691|2980462|P1|Overall Study|Unsatisfactory therapeutic effect|18
903763|NCT01120691|2980460|P3|Overall Study|Death|24
903764|NCT01120691|2980461|P2|Overall Study|Death|22
903765|NCT01120691|2980462|P1|Overall Study|Death|21
903766|NCT01120691|2980460|P3|Overall Study|Subject withdrew consent|44
903767|NCT01120691|2980461|P2|Overall Study|Subject withdrew consent|50
903768|NCT01120691|2980462|P1|Overall Study|Subject withdrew consent|33
903769|NCT01120691|2980460|P3|Overall Study|Adverse Event|47
903770|NCT01120691|2980461|P2|Overall Study|Adverse Event|67
903771|NCT01120691|2980462|P1|Overall Study|Adverse Event|59
903772|NCT01120626|2980506|P2|Overall Study|Withdrawal by Subject|0
903773|NCT01120626|2980507|P1|Overall Study|Withdrawal by Subject|1
903774|NCT01120600|2980517|P2|Overall Study|Withdrawal by Subject|11
903775|NCT01120600|2980518|P1|Overall Study|Withdrawal by Subject|10
903776|NCT01120600|2980517|P2|Overall Study|Protocol Violation|4
903777|NCT01120600|2980518|P1|Overall Study|Protocol Violation|0
903778|NCT01120600|2980517|P2|Overall Study|Physician Decision|3
903779|NCT01120600|2980518|P1|Overall Study|Physician Decision|1
903780|NCT01120600|2980517|P2|Overall Study|Lost to Follow-up|3
903781|NCT01120600|2980518|P1|Overall Study|Lost to Follow-up|1
903782|NCT01120600|2980517|P2|Overall Study|Excessive Bone Loss|4
903783|NCT01120600|2980518|P1|Overall Study|Excessive Bone Loss|0
903784|NCT01120600|2980517|P2|Overall Study|Adverse Event|7
903785|NCT01120600|2980518|P1|Overall Study|Adverse Event|7
903786|NCT01120379|2980573|P1|Four Year Timepoint|Any other reason for early termination|217
903787|NCT01120379|2980573|P1|Four Year Timepoint|Physician Decision|5
903788|NCT01120379|2980573|P1|Four Year Timepoint|Death|131
903789|NCT01120379|2980573|P1|Four Year Timepoint|Lost to Follow-up|10
903790|NCT01120379|2980573|P1|Four Year Timepoint|Withdrawal by Subject|5
903791|NCT01120379|2980573|P1|Three Year Timepoint|Any other reason for early termination|17
903792|NCT01120379|2980573|P1|Three Year Timepoint|Physician Decision|9
903793|NCT01120379|2980573|P1|Three Year Timepoint|Death|120
903794|NCT01120379|2980573|P1|Three Year Timepoint|Lost to Follow-up|43
903795|NCT01120379|2980573|P1|Three Year Timepoint|Withdrawal by Subject|25
903796|NCT01120379|2980573|P1|Two Year Timepoint|Any other reason for early termination|4
903797|NCT01120379|2980573|P1|Two Year Timepoint|Physician Decision|12
903798|NCT01120379|2980573|P1|Two Year Timepoint|Death|123
903799|NCT01120379|2980573|P1|Two Year Timepoint|Lost to Follow-up|87
903800|NCT01120379|2980573|P1|Two Year Timepoint|Withdrawal by Subject|11
903801|NCT01120379|2980573|P1|One Year Timepoint|Any other reason for early termination|5
903802|NCT01120379|2980573|P1|One Year Timepoint|Physician Decision|9
903803|NCT01120379|2980573|P1|One Year Timepoint|Death|108
903804|NCT01120379|2980573|P1|One Year Timepoint|Lost to Follow-up|115
903805|NCT01120379|2980573|P1|One Year Timepoint|Withdrawal by Subject|41
903806|NCT01120275|2980609|P1|Overall Study|Not specific|1
903807|NCT01120275|2980609|P1|Overall Study|Refusal|1
903808|NCT01120275|2980609|P1|Overall Study|Withdrawal by Subject|1
903809|NCT01120275|2980609|P1|Overall Study|Ineligible|3
903810|NCT01120275|2980609|P1|Overall Study|Progression|27
903811|NCT01120275|2980609|P1|Overall Study|Adverse Event|3
903812|NCT01120210|2980676|P2|MAIN INFUSION|Withdrawal by Subject|1
903813|NCT01120210|2980677|P1|MAIN INFUSION|Withdrawal by Subject|0
903814|NCT01120210|2980676|P2|MAIN INFUSION|Adverse Event|0
903815|NCT01120210|2980677|P1|MAIN INFUSION|Adverse Event|1
903816|NCT01120184|2980727|P3|Overall Study|Death|169
903817|NCT01120184|2980728|P2|Overall Study|Death|176
903818|NCT01120184|2980729|P1|Overall Study|Death|170
903819|NCT01120184|2980727|P3|Overall Study|Subject/ Guardian Decision to Withdraw|25
903820|NCT01120184|2980728|P2|Overall Study|Subject/ Guardian Decision to Withdraw|29
903821|NCT01120184|2980729|P1|Overall Study|Subject/ Guardian Decision to Withdraw|32
903822|NCT01120184|2980727|P3|Overall Study|Sponsor Decision to Terminate Study|143
903823|NCT01120184|2980728|P2|Overall Study|Sponsor Decision to Terminate Study|144
903824|NCT01120184|2980729|P1|Overall Study|Sponsor Decision to Terminate Study|133
903825|NCT01120184|2980727|P3|Overall Study|Reason not Specified|12
903826|NCT01120184|2980728|P2|Overall Study|Reason not Specified|3
903827|NCT01120184|2980729|P1|Overall Study|Reason not Specified|8
903828|NCT01120184|2980727|P3|Overall Study|Physician Decision|3
903829|NCT01120184|2980728|P2|Overall Study|Physician Decision|1
903830|NCT01120184|2980729|P1|Overall Study|Physician Decision|9
903831|NCT01120184|2980727|P3|Overall Study|Lost to Follow-up|11
903832|NCT01120184|2980728|P2|Overall Study|Lost to Follow-up|13
903833|NCT01120184|2980729|P1|Overall Study|Lost to Follow-up|13
903834|NCT01120184|2980727|P3|Overall Study|Adverse Event|0
903835|NCT01120184|2980728|P2|Overall Study|Adverse Event|1
903836|NCT01120184|2980729|P1|Overall Study|Adverse Event|0
903837|NCT01120093|2980851|P5|Treatment Period 5|Adverse Event|0
903838|NCT01120093|2980852|P4|Treatment Period 5|Adverse Event|1
903839|NCT01120093|2980853|P3|Treatment Period 5|Adverse Event|0
903840|NCT01120093|2980854|P2|Treatment Period 5|Adverse Event|1
903841|NCT01120093|2980855|P1|Treatment Period 5|Adverse Event|0
903842|NCT01120093|2980851|P5|Treatment Period 4|Adverse Event|0
903843|NCT01120093|2980852|P4|Treatment Period 4|Adverse Event|0
903844|NCT01120093|2980853|P3|Treatment Period 4|Adverse Event|0
903845|NCT01120093|2980854|P2|Treatment Period 4|Adverse Event|0
903846|NCT01120093|2980855|P1|Treatment Period 4|Adverse Event|1
903847|NCT01120093|2980851|P5|Treatment Period 3|Withdrawal by Subject|0
903848|NCT01120093|2980852|P4|Treatment Period 3|Withdrawal by Subject|0
903849|NCT01120093|2980853|P3|Treatment Period 3|Withdrawal by Subject|1
903850|NCT01120093|2980854|P2|Treatment Period 3|Withdrawal by Subject|0
903851|NCT01120093|2980855|P1|Treatment Period 3|Withdrawal by Subject|0
903852|NCT01120093|2980851|P5|Treatment Period 3|Adverse Event|1
903853|NCT01120093|2980852|P4|Treatment Period 3|Adverse Event|0
903854|NCT01120093|2980853|P3|Treatment Period 3|Adverse Event|0
903855|NCT01120093|2980854|P2|Treatment Period 3|Adverse Event|0
903856|NCT01120093|2980855|P1|Treatment Period 3|Adverse Event|0
903857|NCT01120093|2980851|P5|Treatment Period 3|Lack of Efficacy|0
903858|NCT01120093|2980852|P4|Treatment Period 3|Lack of Efficacy|1
903859|NCT01120093|2980853|P3|Treatment Period 3|Lack of Efficacy|0
903860|NCT01120093|2980854|P2|Treatment Period 3|Lack of Efficacy|0
903861|NCT01120093|2980855|P1|Treatment Period 3|Lack of Efficacy|0
903862|NCT01120093|2980851|P5|Treatment Period 2|Withdrawal by Subject|1
903863|NCT01120093|2980852|P4|Treatment Period 2|Withdrawal by Subject|0
903864|NCT01120093|2980853|P3|Treatment Period 2|Withdrawal by Subject|0
903865|NCT01120093|2980854|P2|Treatment Period 2|Withdrawal by Subject|0
903866|NCT01120093|2980855|P1|Treatment Period 2|Withdrawal by Subject|0
903867|NCT01120093|2980851|P5|Treatment Period 2|Adverse Event|0
903868|NCT01120093|2980852|P4|Treatment Period 2|Adverse Event|1
903869|NCT01120093|2980853|P3|Treatment Period 2|Adverse Event|0
903870|NCT01120093|2980854|P2|Treatment Period 2|Adverse Event|0
903871|NCT01120093|2980855|P1|Treatment Period 2|Adverse Event|0
903872|NCT01120093|2980851|P5|Treatment Period 1|Withdrawal by Subject|0
903873|NCT01120093|2980852|P4|Treatment Period 1|Withdrawal by Subject|0
903874|NCT01120093|2980853|P3|Treatment Period 1|Withdrawal by Subject|0
903875|NCT01120093|2980854|P2|Treatment Period 1|Withdrawal by Subject|1
903876|NCT01120093|2980855|P1|Treatment Period 1|Withdrawal by Subject|0
903877|NCT01120093|2980851|P5|Treatment Period 1|Adverse Event|1
903878|NCT01120093|2980852|P4|Treatment Period 1|Adverse Event|0
903879|NCT01120093|2980853|P3|Treatment Period 1|Adverse Event|1
903880|NCT01120093|2980854|P2|Treatment Period 1|Adverse Event|0
903881|NCT01120093|2980855|P1|Treatment Period 1|Adverse Event|0
903882|NCT01120067|2980884|P2|Overall Study|fail to engage >3 sessions|0
903883|NCT01120067|2980885|P1|Overall Study|fail to engage >3 sessions|2
903884|NCT01120067|2980884|P2|Overall Study|Lost to Follow-up|1
903885|NCT01120067|2980885|P1|Overall Study|Lost to Follow-up|3
903886|NCT01119963|2980893|P2|Overall Study|Lost to Follow-up|1
903887|NCT01119963|2980894|P1|Overall Study|Lost to Follow-up|1
903888|NCT01119950|2980904|P1|Overall Study|Death|1
903889|NCT01119950|2980904|P1|Overall Study|Abnormal lab value|1
903890|NCT01119950|2980904|P1|Overall Study|Administrative|2
903891|NCT01119950|2980904|P1|Overall Study|Lost to Follow-up|4
903892|NCT01119950|2980904|P1|Overall Study|Protocol Violation|5
903893|NCT01119950|2980904|P1|Overall Study|Withdrawal by Subject|9
903894|NCT01119950|2980904|P1|Overall Study|Adverse Event|25
903895|NCT01119937|2981151|P2|Overall Study|Withdrawal by Subject|1
903896|NCT01119937|2981152|P1|Overall Study|Withdrawal by Subject|2
903897|NCT01119937|2981151|P2|Overall Study|Unsatisfactory therapeutic effect|0
903898|NCT01119937|2981152|P1|Overall Study|Unsatisfactory therapeutic effect|3
903899|NCT01119937|2981151|P2|Overall Study|Protocol deviation|1
903900|NCT01119937|2981152|P1|Overall Study|Protocol deviation|3
903901|NCT01119937|2981151|P2|Overall Study|Adverse Event|5
903902|NCT01119937|2981152|P1|Overall Study|Adverse Event|11
903903|NCT01119859|2981180|P2|Overall Study|Failure to return|0
903904|NCT01119859|2981181|P1|Overall Study|Failure to return|3
903905|NCT01119859|2981180|P2|Overall Study|Refused treatment|6
903906|NCT01119859|2981181|P1|Overall Study|Refused treatment|3
903907|NCT01119859|2981180|P2|Overall Study|Insufficient therapeutic response|14
903908|NCT01119859|2981181|P1|Overall Study|Insufficient therapeutic response|7
903909|NCT01119859|2981180|P2|Overall Study|Death|0
903910|NCT01119859|2981181|P1|Overall Study|Death|2
903911|NCT01119859|2981180|P2|Overall Study|Adverse Event|10
903912|NCT01119859|2981181|P1|Overall Study|Adverse Event|9
903913|NCT01119846|2981200|P3|Overall Study|Withdrawal by Subject|4
903914|NCT01119846|2981201|P2|Overall Study|Withdrawal by Subject|0
903915|NCT01119846|2981202|P1|Overall Study|Withdrawal by Subject|0
903916|NCT01119846|2981200|P3|Overall Study|Protocol Violation|1
903917|NCT01119846|2981201|P2|Overall Study|Protocol Violation|0
903918|NCT01119846|2981202|P1|Overall Study|Protocol Violation|0
903919|NCT01119846|2981200|P3|Overall Study|Physician Decision|0
903920|NCT01119846|2981201|P2|Overall Study|Physician Decision|0
903921|NCT01119846|2981202|P1|Overall Study|Physician Decision|1
903922|NCT01119846|2981200|P3|Overall Study|Adverse Event|6
903923|NCT01119846|2981201|P2|Overall Study|Adverse Event|0
903924|NCT01119846|2981202|P1|Overall Study|Adverse Event|1
903925|NCT01119768|2981416|P2|Treatment Period|Lack of Efficacy|25
903926|NCT01119768|2981417|P1|Treatment Period|Lack of Efficacy|18
903927|NCT01119703|2981473|P2|Overall Study|Adverse Event|1
903928|NCT01119703|2981474|P1|Overall Study|Adverse Event|0
903929|NCT01119625|2981488|P2|Overall Study|Other|1
903930|NCT01119625|2981489|P1|Overall Study|Other|0
903931|NCT01119625|2981488|P2|Overall Study|Withdrawal by Subject|1
903932|NCT01119625|2981489|P1|Overall Study|Withdrawal by Subject|2
903933|NCT01119625|2981488|P2|Overall Study|Lost to Follow-up|2
903934|NCT01119625|2981489|P1|Overall Study|Lost to Follow-up|1
903935|NCT01119443|2981531|P2|Crossover Period 1 (5 Days)|Adverse Event|1
903936|NCT01119443|2981532|P1|Crossover Period 1 (5 Days)|Adverse Event|0
903937|NCT01119287|2981575|P6|Overall Study|Patient Decision, not related to AE|0
903938|NCT01119287|2981576|P5|Overall Study|Patient Decision, not related to AE|1
903939|NCT01119287|2981577|P4|Overall Study|Patient Decision, not related to AE|2
903940|NCT01119287|2981578|P3|Overall Study|Patient Decision, not related to AE|2
903941|NCT01119287|2981579|P2|Overall Study|Patient Decision, not related to AE|0
903942|NCT01119287|2981580|P1|Overall Study|Patient Decision, not related to AE|0
903943|NCT01119248|2981593|P1|Overall Study|Physician Decision|5
903944|NCT01119131|2981643|P3|Overall Study|Physician Decision|1
903945|NCT01119131|2981644|P2|Overall Study|Physician Decision|0
903946|NCT01119131|2981645|P1|Overall Study|Physician Decision|0
903947|NCT01119131|2981643|P3|Overall Study|Non-Compliance|4
903948|NCT01119131|2981644|P2|Overall Study|Non-Compliance|0
903949|NCT01119131|2981645|P1|Overall Study|Non-Compliance|1
903950|NCT01119131|2981643|P3|Overall Study|Adverse Event|1
903951|NCT01119131|2981644|P2|Overall Study|Adverse Event|1
903952|NCT01119131|2981645|P1|Overall Study|Adverse Event|1
903953|NCT01119118|2981674|P1|Overall Study|Adverse Event|1
903954|NCT01119001|2981686|P1|Overall Study|Withdrawal by Subject|2
903955|NCT01118975|2981730|P2|Overall Study|Adverse Event|1
903956|NCT01118975|2981731|P1|Overall Study|Adverse Event|0
903957|NCT01118962|2981737|P1|Overall Study|Non-compliance with Medicinal Product|1
903958|NCT01118962|2981737|P1|Overall Study|Pregnancy|1
903959|NCT01118962|2981737|P1|Overall Study|Withdrawal by Subject|4
903960|NCT01118962|2981737|P1|Overall Study|Protocol Violation|1
903961|NCT01118962|2981737|P1|Overall Study|Lack of Efficacy|1
903962|NCT01118962|2981737|P1|Overall Study|Adverse Event|2
903963|NCT01118949|2981742|P1|Overall Study|Withdrawal by Subject|4
903964|NCT01118949|2981742|P1|Overall Study|Adverse Event|5
903965|NCT01118780|2981772|P2|Overall Study|Withdrawal by Subject|8
903966|NCT01118780|2981773|P1|Overall Study|Withdrawal by Subject|13
903967|NCT01118780|2981772|P2|Overall Study|Protocol Violation|6
903968|NCT01118780|2981773|P1|Overall Study|Protocol Violation|3
903969|NCT01118780|2981772|P2|Overall Study|Physician Decision|0
903970|NCT01118780|2981773|P1|Overall Study|Physician Decision|2
903971|NCT01118780|2981772|P2|Overall Study|Lack of Efficacy|6
903972|NCT01118780|2981773|P1|Overall Study|Lack of Efficacy|2
903973|NCT01118780|2981772|P2|Overall Study|Death|0
903974|NCT01118780|2981773|P1|Overall Study|Death|1
903975|NCT01118780|2981772|P2|Overall Study|Adverse Event|15
903976|NCT01118780|2981773|P1|Overall Study|Adverse Event|15
903977|NCT01118728|2981831|P1|Overall Study|Lost to Follow-up|4
903978|NCT01118728|2981831|P1|Overall Study|Withdrawal by Subject|3
903979|NCT01118728|2981831|P1|Overall Study|Sponsor's decision to discontinue study|172
903980|NCT01118728|2981831|P1|Overall Study|Lack of Efficacy|27
903981|NCT01118728|2981831|P1|Overall Study|Adverse Event|17
903982|NCT01118663|2981838|P2|Overall Study|Withdrawal by Subject|1
903983|NCT01118663|2981839|P1|Overall Study|Withdrawal by Subject|0
903984|NCT01118663|2981838|P2|Overall Study|Adverse Event|1
903985|NCT01118663|2981839|P1|Overall Study|Adverse Event|2
903986|NCT01118455|2981862|P2|Baseline [Visits 1 & 2]|Adverse Event|0
903987|NCT01118455|2981863|P1|Baseline [Visits 1 & 2]|Adverse Event|1
903988|NCT01118377|2981891|P1|Overall Study|Failure to Return|3
903989|NCT01118377|2981891|P1|Overall Study|Death|38
903990|NCT01118377|2981891|P1|Overall Study|Did Not Receive Study Medication|1
903991|NCT01118325|2981900|P3|Overall Study|Adverse Event|1
903992|NCT01118325|2981901|P2|Overall Study|Adverse Event|0
903993|NCT01118325|2981902|P1|Overall Study|Adverse Event|1
903994|NCT01118312|2981948|P2|Overall Study|Withdrawal by Subject|3
903995|NCT01118312|2981949|P1|Overall Study|Withdrawal by Subject|1
903996|NCT01118312|2981948|P2|Overall Study|Lost to Follow-up|32
903997|NCT01118312|2981949|P1|Overall Study|Lost to Follow-up|33
903998|NCT01118143|2982147|P2|Overall Study|Withdrawal by Subject|5
903999|NCT01118143|2982148|P1|Overall Study|Withdrawal by Subject|2
904000|NCT01118117|2982158|P2|Overall Study|Missed 12 Month Visit|0
904001|NCT01118117|2982159|P1|Overall Study|Missed 12 Month Visit|7
904002|NCT01118117|2982158|P2|Overall Study|Lost to Follow-up|0
904003|NCT01118117|2982159|P1|Overall Study|Lost to Follow-up|6
904004|NCT01118117|2982158|P2|Overall Study|Death|0
904005|NCT01118117|2982159|P1|Overall Study|Death|8
904006|NCT01118052|2982191|P1|Overall Study|Never treated|2
904007|NCT01117987|2982214|P2|Overall Study|Administrative problems|22
904008|NCT01117987|2982215|P1|Overall Study|Administrative problems|25
904009|NCT01117987|2982214|P2|Overall Study|Adverse Event|26
904010|NCT01117987|2982215|P1|Overall Study|Adverse Event|19
904011|NCT01117987|2982214|P2|Overall Study|Withdrawal by Subject|10
904012|NCT01117987|2982215|P1|Overall Study|Withdrawal by Subject|5
904013|NCT01117987|2982214|P2|Overall Study|Death|10
904014|NCT01117987|2982215|P1|Overall Study|Death|5
904015|NCT01117987|2982214|P2|Overall Study|Lack of Efficacy|4
904016|NCT01117987|2982215|P1|Overall Study|Lack of Efficacy|3
904017|NCT01117987|2982214|P2|Overall Study|Abnormal test procedure result|0
904018|NCT01117987|2982215|P1|Overall Study|Abnormal test procedure result|2
904019|NCT01117987|2982214|P2|Overall Study|Lost to Follow-up|1
904020|NCT01117987|2982215|P1|Overall Study|Lost to Follow-up|1
904021|NCT01117987|2982214|P2|Overall Study|Subject no longer requires study drug|0
904022|NCT01117987|2982215|P1|Overall Study|Subject no longer requires study drug|1
904023|NCT01117987|2982214|P2|Overall Study|Protocol deviation|1
904024|NCT01117987|2982215|P1|Overall Study|Protocol deviation|0
904025|NCT01117870|2982236|P2|Overall Study|Inability to place needle|0
904026|NCT01117870|2982237|P1|Overall Study|Inability to place needle|1
904027|NCT01117857|2982251|P1|Overall Study|Physician Decision|1
904028|NCT01117857|2982251|P1|Overall Study|Withdrawal by Subject|4
904029|NCT01117857|2982251|P1|Overall Study|Lost to Follow-up|4
904030|NCT01117766|2982259|P2|Second Intervention|Withdrawal by Subject|1
904031|NCT01117766|2982260|P1|Second Intervention|Withdrawal by Subject|0
904032|NCT01117766|2982259|P2|Second Intervention|Adverse Event|2
904033|NCT01117766|2982260|P1|Second Intervention|Adverse Event|0
904034|NCT01117766|2982259|P2|Second Intervention|Other|2
904035|NCT01117766|2982260|P1|Second Intervention|Other|1
904036|NCT01117766|2982259|P2|Second Intervention|Lost to Follow-up|0
904037|NCT01117766|2982260|P1|Second Intervention|Lost to Follow-up|1
904038|NCT01117766|2982259|P2|Washout Period|Protocol Violation|2
904039|NCT01117766|2982260|P1|Washout Period|Protocol Violation|0
904040|NCT01117766|2982259|P2|First Intervention|Protocol Violation|0
904041|NCT01117766|2982260|P1|First Intervention|Protocol Violation|1
904042|NCT01117766|2982259|P2|First Intervention|Other|0
904043|NCT01117766|2982260|P1|First Intervention|Other|0
904044|NCT01117766|2982259|P2|First Intervention|Adverse Event|1
904045|NCT01117766|2982260|P1|First Intervention|Adverse Event|0
904046|NCT01117623|2982297|P8|Overall Study|Invest. text: completed all planned txs|0
904047|NCT01117623|2982298|P7|Overall Study|Invest. text: completed all planned txs|0
904048|NCT01117623|2982299|P6|Overall Study|Invest. text: completed all planned txs|1
904049|NCT01117623|2982300|P5|Overall Study|Invest. text: completed all planned txs|0
904050|NCT01117623|2982301|P4|Overall Study|Invest. text: completed all planned txs|0
904051|NCT01117623|2982302|P3|Overall Study|Invest. text: completed all planned txs|0
904052|NCT01117623|2982303|P2|Overall Study|Invest. text: completed all planned txs|0
904053|NCT01117623|2982304|P1|Overall Study|Invest. text: completed all planned txs|0
904054|NCT01117623|2982297|P8|Overall Study|Non-compliance with study medication|1
904055|NCT01117623|2982298|P7|Overall Study|Non-compliance with study medication|0
904056|NCT01117623|2982299|P6|Overall Study|Non-compliance with study medication|0
904057|NCT01117623|2982300|P5|Overall Study|Non-compliance with study medication|0
904058|NCT01117623|2982301|P4|Overall Study|Non-compliance with study medication|0
904059|NCT01117623|2982302|P3|Overall Study|Non-compliance with study medication|0
904060|NCT01117623|2982303|P2|Overall Study|Non-compliance with study medication|0
904061|NCT01117623|2982304|P1|Overall Study|Non-compliance with study medication|0
904062|NCT01117623|2982297|P8|Overall Study|Withdrawal by Subject|1
904063|NCT01117623|2982298|P7|Overall Study|Withdrawal by Subject|1
904064|NCT01117623|2982299|P6|Overall Study|Withdrawal by Subject|1
904065|NCT01117623|2982300|P5|Overall Study|Withdrawal by Subject|0
904066|NCT01117623|2982301|P4|Overall Study|Withdrawal by Subject|0
904067|NCT01117623|2982302|P3|Overall Study|Withdrawal by Subject|2
904068|NCT01117623|2982303|P2|Overall Study|Withdrawal by Subject|0
904069|NCT01117623|2982304|P1|Overall Study|Withdrawal by Subject|0
904070|NCT01117623|2982297|P8|Overall Study|Disease progression, recurrence, relapse|22
904071|NCT01117623|2982298|P7|Overall Study|Disease progression, recurrence, relapse|5
904072|NCT01117623|2982299|P6|Overall Study|Disease progression, recurrence, relapse|14
904073|NCT01117623|2982300|P5|Overall Study|Disease progression, recurrence, relapse|8
904074|NCT01117623|2982301|P4|Overall Study|Disease progression, recurrence, relapse|6
904075|NCT01117623|2982302|P3|Overall Study|Disease progression, recurrence, relapse|5
904076|NCT01117623|2982303|P2|Overall Study|Disease progression, recurrence, relapse|6
904077|NCT01117623|2982304|P1|Overall Study|Disease progression, recurrence, relapse|3
904078|NCT01117623|2982297|P8|Overall Study|Adverse Event|2
904079|NCT01117623|2982298|P7|Overall Study|Adverse Event|0
904080|NCT01117623|2982299|P6|Overall Study|Adverse Event|0
904081|NCT01117623|2982300|P5|Overall Study|Adverse Event|2
904082|NCT01117623|2982301|P4|Overall Study|Adverse Event|0
904083|NCT01117623|2982302|P3|Overall Study|Adverse Event|4
904084|NCT01117623|2982303|P2|Overall Study|Adverse Event|2
904085|NCT01117623|2982304|P1|Overall Study|Adverse Event|0
904086|NCT01117480|2982456|P1|Overall Study|Did Not Start Adalimumab Therapy|20
904087|NCT01117480|2982456|P1|Overall Study|Protocol Violation|8
904088|NCT01117454|2982464|P2|Overall Study|Pregnancy|1
904089|NCT01117454|2982465|P1|Overall Study|Pregnancy|0
904090|NCT01117428|2982477|P6|Overall Study|Progressive disease|17
904091|NCT01117428|2982478|P5|Overall Study|Progressive disease|16
904092|NCT01117428|2982479|P4|Overall Study|Progressive disease|12
904093|NCT01117428|2982480|P3|Overall Study|Progressive disease|10
904094|NCT01117428|2982481|P2|Overall Study|Progressive disease|27
904095|NCT01117428|2982482|P1|Overall Study|Progressive disease|15
904096|NCT01117428|2982477|P6|Overall Study|Withdrawal by Subject|0
904097|NCT01117428|2982478|P5|Overall Study|Withdrawal by Subject|0
904098|NCT01117428|2982479|P4|Overall Study|Withdrawal by Subject|0
904099|NCT01117428|2982480|P3|Overall Study|Withdrawal by Subject|1
904100|NCT01117428|2982481|P2|Overall Study|Withdrawal by Subject|0
904101|NCT01117428|2982482|P1|Overall Study|Withdrawal by Subject|0
904102|NCT01117428|2982477|P6|Overall Study|Physician Decision|0
904103|NCT01117428|2982478|P5|Overall Study|Physician Decision|0
904104|NCT01117428|2982479|P4|Overall Study|Physician Decision|0
904105|NCT01117428|2982480|P3|Overall Study|Physician Decision|0
904106|NCT01117428|2982481|P2|Overall Study|Physician Decision|1
904107|NCT01117428|2982482|P1|Overall Study|Physician Decision|0
904108|NCT01117428|2982477|P6|Overall Study|Death|1
904109|NCT01117428|2982478|P5|Overall Study|Death|0
904110|NCT01117428|2982479|P4|Overall Study|Death|0
904111|NCT01117428|2982480|P3|Overall Study|Death|2
904112|NCT01117428|2982481|P2|Overall Study|Death|1
904113|NCT01117428|2982482|P1|Overall Study|Death|0
904114|NCT01117428|2982477|P6|Overall Study|Adverse Event|2
904115|NCT01117428|2982478|P5|Overall Study|Adverse Event|1
904116|NCT01117428|2982479|P4|Overall Study|Adverse Event|0
904117|NCT01117428|2982480|P3|Overall Study|Adverse Event|0
904118|NCT01117428|2982481|P2|Overall Study|Adverse Event|0
904119|NCT01117428|2982482|P1|Overall Study|Adverse Event|4
904120|NCT01117428|2982477|P6|Overall Study|Lack of Efficacy|0
904121|NCT01117428|2982478|P5|Overall Study|Lack of Efficacy|0
904122|NCT01117428|2982479|P4|Overall Study|Lack of Efficacy|0
904123|NCT01117428|2982480|P3|Overall Study|Lack of Efficacy|0
904124|NCT01117428|2982481|P2|Overall Study|Lack of Efficacy|0
904125|NCT01117428|2982482|P1|Overall Study|Lack of Efficacy|1
904126|NCT01117350|2982516|P2|Extension Period|Prohibited medication|1
904127|NCT01117350|2982517|P1|Extension Period|Prohibited medication|0
904128|NCT01117350|2982516|P2|Extension Period|Inclusion criteria not respected|1
904129|NCT01117350|2982517|P1|Extension Period|Inclusion criteria not respected|0
904130|NCT01117350|2982516|P2|Extension Period|Lack of Efficacy|2
904131|NCT01117350|2982517|P1|Extension Period|Lack of Efficacy|0
904132|NCT01117350|2982516|P2|Extension Period|Withdrawal by Subject|3
904133|NCT01117350|2982517|P1|Extension Period|Withdrawal by Subject|0
904134|NCT01117350|2982516|P2|Extension Period|Lost to Follow-up|2
904135|NCT01117350|2982517|P1|Extension Period|Lost to Follow-up|0
904136|NCT01117350|2982516|P2|Extension Period|Protocol Violation|2
904137|NCT01117350|2982517|P1|Extension Period|Protocol Violation|0
904138|NCT01117350|2982516|P2|Extension Period|Adverse Event|2
904139|NCT01117350|2982517|P1|Extension Period|Adverse Event|0
904140|NCT01117350|2982516|P2|Extension Period|Not included in extension, not treated|50
904141|NCT01117350|2982517|P1|Extension Period|Not included in extension, not treated|0
904142|NCT01117350|2982516|P2|Comparative Period|Move to another city/country|1
904143|NCT01117350|2982517|P1|Comparative Period|Move to another city/country|2
904144|NCT01117350|2982516|P2|Comparative Period|Physician Decision|1
904145|NCT01117350|2982517|P1|Comparative Period|Physician Decision|0
904146|NCT01117350|2982516|P2|Comparative Period|Lack of Efficacy|0
904147|NCT01117350|2982517|P1|Comparative Period|Lack of Efficacy|1
904148|NCT01117350|2982516|P2|Comparative Period|Protocol Violation|12
904149|NCT01117350|2982517|P1|Comparative Period|Protocol Violation|8
904150|NCT01117350|2982516|P2|Comparative Period|Withdrawal by Subject|13
904151|NCT01117350|2982517|P1|Comparative Period|Withdrawal by Subject|9
904152|NCT01117350|2982516|P2|Comparative Period|Lost to Follow-up|7
904153|NCT01117350|2982517|P1|Comparative Period|Lost to Follow-up|11
904154|NCT01117350|2982516|P2|Comparative Period|Adverse Event|33
904155|NCT01117350|2982517|P1|Comparative Period|Adverse Event|6
904156|NCT01117350|2982516|P2|Comparative Period|Not Treated|8
904157|NCT01117350|2982517|P1|Comparative Period|Not Treated|5
904158|NCT01117337|2982549|P2|Overall Study|Lost to Follow-up|0
904159|NCT01117337|2982550|P1|Overall Study|Lost to Follow-up|4
904160|NCT01117181|2982571|P2|Overall Study|Withdrawal by Subject|2
904161|NCT01117181|2982572|P1|Overall Study|Withdrawal by Subject|0
904162|NCT01117181|2982571|P2|Overall Study|Lost to Follow-up|0
904163|NCT01117181|2982572|P1|Overall Study|Lost to Follow-up|1
904164|NCT01117051|2982605|P2|Overall Study|Convenience issue|0
904165|NCT01117051|2982606|P1|Overall Study|Convenience issue|1
904166|NCT01117051|2982605|P2|Overall Study|Randomized by mistake|1
904167|NCT01117051|2982606|P1|Overall Study|Randomized by mistake|0
904168|NCT01117051|2982605|P2|Overall Study|Surgical procedure|1
904169|NCT01117051|2982606|P1|Overall Study|Surgical procedure|0
904170|NCT01117051|2982605|P2|Overall Study|Sponsor's decision|1
904171|NCT01117051|2982606|P1|Overall Study|Sponsor's decision|3
904172|NCT01117051|2982605|P2|Overall Study|Did not meet in-/exclusion criteria|1
904173|NCT01117051|2982606|P1|Overall Study|Did not meet in-/exclusion criteria|0
904174|NCT01117051|2982605|P2|Overall Study|Lost to Follow-up|1
904175|NCT01117051|2982606|P1|Overall Study|Lost to Follow-up|0
904176|NCT01117051|2982605|P2|Overall Study|Adverse Event|3
904177|NCT01117051|2982606|P1|Overall Study|Adverse Event|4
904178|NCT01117051|2982605|P2|Overall Study|Withdrawal by Subject|3
904179|NCT01117051|2982606|P1|Overall Study|Withdrawal by Subject|5
904180|NCT01117012|2982616|P2|Overall Study|Undefined|3
904181|NCT01117012|2982617|P1|Overall Study|Undefined|4
904182|NCT01117012|2982616|P2|Overall Study|Withdrawal by Subject|0
904183|NCT01117012|2982617|P1|Overall Study|Withdrawal by Subject|3
904184|NCT01117012|2982616|P2|Overall Study|Death|1
904185|NCT01117012|2982617|P1|Overall Study|Death|1
904186|NCT01117012|2982616|P2|Overall Study|Adverse Event|1
904187|NCT01117012|2982617|P1|Overall Study|Adverse Event|0
904188|NCT01116882|2982791|P2|12-month|Withdrawal by Subject|8
904189|NCT01116882|2982792|P1|12-month|Withdrawal by Subject|5
904190|NCT01116882|2982791|P2|12-month|Other Reasons|49
904191|NCT01116882|2982792|P1|12-month|Other Reasons|151
904192|NCT01116882|2982791|P2|12-month|Lost to Follow-up|42
904193|NCT01116882|2982792|P1|12-month|Lost to Follow-up|111
904194|NCT01116882|2982791|P2|30-day|Other Reasons|6
904195|NCT01116882|2982792|P1|30-day|Other Reasons|16
904196|NCT01116882|2982791|P2|30-day|Withdrawal by Subject|4
904197|NCT01116882|2982792|P1|30-day|Withdrawal by Subject|2
904198|NCT01116882|2982791|P2|30-day|Lost to Follow-up|21
904199|NCT01116882|2982792|P1|30-day|Lost to Follow-up|50
904200|NCT01116687|2982830|P1|Overall Study|Withdrawal by Subject|4
904201|NCT01116427|2982847|P2|Extension Phase|Not using appropriate birth control|0
904202|NCT01116427|2982848|P1|Extension Phase|Not using appropriate birth control|1
904203|NCT01116427|2982847|P2|Extension Phase|Withdrawal by Subject|1
904204|NCT01116427|2982848|P1|Extension Phase|Withdrawal by Subject|5
904205|NCT01116427|2982847|P2|Extension Phase|Lost to Follow-up|0
904206|NCT01116427|2982848|P1|Extension Phase|Lost to Follow-up|2
904207|NCT01116427|2982847|P2|Extension Phase|Adverse Event|1
904208|NCT01116427|2982848|P1|Extension Phase|Adverse Event|1
904209|NCT01116427|2982847|P2|Core Phase|Worsening Multiple Sclerosis|0
904210|NCT01116427|2982848|P1|Core Phase|Worsening Multiple Sclerosis|1
904211|NCT01116427|2982847|P2|Core Phase|Withdrawal by Subject|0
904212|NCT01116427|2982848|P1|Core Phase|Withdrawal by Subject|3
904213|NCT01116427|2982847|P2|Core Phase|Lost to Follow-up|0
904214|NCT01116427|2982848|P1|Core Phase|Lost to Follow-up|1
904215|NCT01116427|2982847|P2|Core Phase|Adverse Event|1
904216|NCT01116427|2982848|P1|Core Phase|Adverse Event|0
904217|NCT01116232|2982889|P1|Overall Study|Progressive diease|4
904218|NCT01115998|2982997|P2|Overall Study|Lost to Follow-up|6
904219|NCT01115998|2982998|P1|Overall Study|Lost to Follow-up|6
904220|NCT01115933|2983008|P1|Overall Study|Did not receive XIENCE PRIME SV|1
904221|NCT01115855|2983105|P2|Overall Study|Other|6
904222|NCT01115855|2983106|P1|Overall Study|Other|8
904223|NCT01115855|2983105|P2|Overall Study|Withdrawal by Subject|5
904224|NCT01115855|2983106|P1|Overall Study|Withdrawal by Subject|5
904225|NCT01115855|2983105|P2|Overall Study|Protocol Violation|1
904226|NCT01115855|2983106|P1|Overall Study|Protocol Violation|0
904227|NCT01115855|2983105|P2|Overall Study|Lab Abnormality|1
904228|NCT01115855|2983106|P1|Overall Study|Lab Abnormality|1
904229|NCT01115855|2983105|P2|Overall Study|Death|5
904230|NCT01115855|2983106|P1|Overall Study|Death|6
904231|NCT01115855|2983105|P2|Overall Study|Adverse Event|18
904232|NCT01115855|2983106|P1|Overall Study|Adverse Event|16
904233|NCT01115738|2983157|P3|Overall Study|Withdrawal by Subject|9
904234|NCT01115738|2983158|P2|Overall Study|Withdrawal by Subject|6
904235|NCT01115738|2983159|P1|Overall Study|Withdrawal by Subject|6
904236|NCT01115738|2983157|P3|Overall Study|Physician Decision|17
904237|NCT01115738|2983158|P2|Overall Study|Physician Decision|15
904238|NCT01115738|2983159|P1|Overall Study|Physician Decision|18
904239|NCT01115738|2983157|P3|Overall Study|Lost to Follow-up|1
904240|NCT01115738|2983158|P2|Overall Study|Lost to Follow-up|0
904241|NCT01115738|2983159|P1|Overall Study|Lost to Follow-up|0
904242|NCT01115738|2983157|P3|Overall Study|Death|0
904243|NCT01115738|2983158|P2|Overall Study|Death|0
904244|NCT01115738|2983159|P1|Overall Study|Death|1
904245|NCT01115569|2983357|P2|Maintenance Phase|Administrative|1
904246|NCT01115569|2983358|P1|Maintenance Phase|Administrative|0
904247|NCT01115569|2983357|P2|Maintenance Phase|Non-Compliance with Study Drug|48
904248|NCT01115569|2983358|P1|Maintenance Phase|Non-Compliance with Study Drug|0
904249|NCT01115569|2983357|P2|Maintenance Phase|Withdrawal by Subject|27
904250|NCT01115569|2983358|P1|Maintenance Phase|Withdrawal by Subject|0
904251|NCT01115569|2983357|P2|Maintenance Phase|Protocol Violation|9
904252|NCT01115569|2983358|P1|Maintenance Phase|Protocol Violation|0
904253|NCT01115569|2983357|P2|Maintenance Phase|Physician Decision|3
904254|NCT01115569|2983358|P1|Maintenance Phase|Physician Decision|0
904255|NCT01115569|2983357|P2|Maintenance Phase|Lost to Follow-up|8
904256|NCT01115569|2983358|P1|Maintenance Phase|Lost to Follow-up|0
904257|NCT01115569|2983357|P2|Maintenance Phase|Adverse Event|43
904258|NCT01115569|2983358|P1|Maintenance Phase|Adverse Event|0
904259|NCT01115569|2983357|P2|Conversion/Titration Phase|Non-Compliance with Study Drug|0
904260|NCT01115569|2983358|P1|Conversion/Titration Phase|Non-Compliance with Study Drug|53
904261|NCT01115569|2983357|P2|Conversion/Titration Phase|Withdrawal by Subject|0
904262|NCT01115569|2983358|P1|Conversion/Titration Phase|Withdrawal by Subject|26
904263|NCT01115569|2983357|P2|Conversion/Titration Phase|Protocol Violation|0
904264|NCT01115569|2983358|P1|Conversion/Titration Phase|Protocol Violation|68
904265|NCT01115569|2983357|P2|Conversion/Titration Phase|Physician Decision|0
904266|NCT01115569|2983358|P1|Conversion/Titration Phase|Physician Decision|5
904267|NCT01115569|2983357|P2|Conversion/Titration Phase|Lost to Follow-up|0
904268|NCT01115569|2983358|P1|Conversion/Titration Phase|Lost to Follow-up|3
904269|NCT01115569|2983357|P2|Conversion/Titration Phase|Adverse Event|0
904270|NCT01115569|2983358|P1|Conversion/Titration Phase|Adverse Event|59
904271|NCT01115491|2983387|P1|Overall Study|Physician Decision|1
904272|NCT01115491|2983387|P1|Overall Study|Withdrawal by Subject|1
904273|NCT01115491|2983387|P1|Overall Study|Lost to Follow-up|3
904274|NCT01115491|2983387|P1|Overall Study|Adverse Event|3
904275|NCT01115491|2983387|P1|Overall Study|Death|22
904276|NCT01114880|2983562|P2|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2
904277|NCT01114880|2983563|P1|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0
904278|NCT01114880|2983562|P2|Period 2 (Week 12 to Week 24)|Adverse Event|0
904279|NCT01114880|2983563|P1|Period 2 (Week 12 to Week 24)|Adverse Event|3
904280|NCT01114880|2983562|P2|Period 1 (Week 0 to Week 12)|Poor subject compliance|1
904281|NCT01114880|2983563|P1|Period 1 (Week 0 to Week 12)|Poor subject compliance|0
904282|NCT01114880|2983562|P2|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1
904283|NCT01114880|2983563|P1|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0
904284|NCT01114880|2983562|P2|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0
904285|NCT01114880|2983563|P1|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1
904286|NCT01114880|2983562|P2|Period 1 (Week 0 to Week 12)|Adverse Event|0
904287|NCT01114880|2983563|P1|Period 1 (Week 0 to Week 12)|Adverse Event|4
904288|NCT01114828|2983615|P2|Overall Study|Withdrawal by Subject|1
904289|NCT01114828|2983616|P1|Overall Study|Withdrawal by Subject|0
904290|NCT01114828|2983615|P2|Overall Study|Protocol Violation|0
904291|NCT01114828|2983616|P1|Overall Study|Protocol Violation|2
904292|NCT01114828|2983615|P2|Overall Study|Lack of Efficacy|2
904293|NCT01114828|2983616|P1|Overall Study|Lack of Efficacy|0
904294|NCT01114828|2983615|P2|Overall Study|Adverse Event|1
904295|NCT01114828|2983616|P1|Overall Study|Adverse Event|1
904296|NCT01114737|2983626|P2|Open-Label Treatment Period|Difficult Personal Events|0
904297|NCT01114737|2983627|P1|Open-Label Treatment Period|Difficult Personal Events|1
904298|NCT01114737|2983626|P2|Open-Label Treatment Period|Lost to Follow-up|1
904299|NCT01114737|2983627|P1|Open-Label Treatment Period|Lost to Follow-up|3
904300|NCT01114737|2983626|P2|Open-Label Treatment Period|Withdrawal by Subject|1
904301|NCT01114737|2983627|P1|Open-Label Treatment Period|Withdrawal by Subject|1
904302|NCT01114737|2983626|P2|Randomized Treatment Period|Pregnancy|0
904303|NCT01114737|2983627|P1|Randomized Treatment Period|Pregnancy|1
904304|NCT01114737|2983626|P2|Randomized Treatment Period|Lost to Follow-up|1
904305|NCT01114737|2983627|P1|Randomized Treatment Period|Lost to Follow-up|1
904306|NCT01114737|2983626|P2|Randomized Treatment Period|Withdrawal by Subject|0
904307|NCT01114737|2983627|P1|Randomized Treatment Period|Withdrawal by Subject|1
904308|NCT01114724|2983675|P1|Overall Study|Withdrawal by Subject|1
904309|NCT01114724|2983675|P1|Overall Study|Lost to Follow-up|1
904310|NCT01114724|2983675|P1|Overall Study|Death|8
904311|NCT01114672|2983695|P2|Overall Study|transplanted|0
904312|NCT01114672|2983696|P1|Overall Study|transplanted|1
904313|NCT01114672|2983695|P2|Overall Study|Lost to Follow-up|0
904314|NCT01114672|2983696|P1|Overall Study|Lost to Follow-up|1
904315|NCT01114672|2983695|P2|Overall Study|Withdrawal by Subject|1
904316|NCT01114672|2983696|P1|Overall Study|Withdrawal by Subject|2
904317|NCT01114672|2983695|P2|Overall Study|Death|1
904318|NCT01114672|2983696|P1|Overall Study|Death|0
904319|NCT01114646|2983704|P2|Overall Study|Withdrawal by Subject|2
904320|NCT01114646|2983705|P1|Overall Study|Withdrawal by Subject|3
904321|NCT01114529|2983758|P3|Completed Study Phase at Month 24|Missing|0
904322|NCT01114529|2983759|P2|Completed Study Phase at Month 24|Missing|0
904323|NCT01114529|2983760|P1|Completed Study Phase at Month 24|Missing|2
904324|NCT01114529|2983758|P3|Completed Study Phase at Month 24|Other|0
904325|NCT01114529|2983759|P2|Completed Study Phase at Month 24|Other|0
904326|NCT01114529|2983760|P1|Completed Study Phase at Month 24|Other|2
904327|NCT01114529|2983758|P3|Completed Study Phase at Month 24|Death|4
904328|NCT01114529|2983759|P2|Completed Study Phase at Month 24|Death|5
904329|NCT01114529|2983760|P1|Completed Study Phase at Month 24|Death|8
904330|NCT01114529|2983758|P3|Completed Study Phase at Month 24|Lost to Follow-up|7
904331|NCT01114529|2983759|P2|Completed Study Phase at Month 24|Lost to Follow-up|5
904332|NCT01114529|2983760|P1|Completed Study Phase at Month 24|Lost to Follow-up|10
904333|NCT01114529|2983758|P3|Completed Study Phase at Month 24|Withdrawal by Subject|3
904334|NCT01114529|2983759|P2|Completed Study Phase at Month 24|Withdrawal by Subject|6
904335|NCT01114529|2983760|P1|Completed Study Phase at Month 24|Withdrawal by Subject|18
904412|NCT01114217|2983910|P2|Overall Study|Other-Early termination|10
904336|NCT01114529|2983758|P3|Completed Study Medication at Month 24|Missing|0
904337|NCT01114529|2983759|P2|Completed Study Medication at Month 24|Missing|0
904338|NCT01114529|2983760|P1|Completed Study Medication at Month 24|Missing|2
904339|NCT01114529|2983758|P3|Completed Study Medication at Month 24|Protocol Violation|2
904340|NCT01114529|2983759|P2|Completed Study Medication at Month 24|Protocol Violation|5
904341|NCT01114529|2983760|P1|Completed Study Medication at Month 24|Protocol Violation|0
904342|NCT01114529|2983758|P3|Completed Study Medication at Month 24|Graft loss|0
904343|NCT01114529|2983759|P2|Completed Study Medication at Month 24|Graft loss|2
904344|NCT01114529|2983760|P1|Completed Study Medication at Month 24|Graft loss|0
904345|NCT01114529|2983758|P3|Completed Study Medication at Month 24|Death|2
904346|NCT01114529|2983759|P2|Completed Study Medication at Month 24|Death|1
904347|NCT01114529|2983760|P1|Completed Study Medication at Month 24|Death|2
904348|NCT01114529|2983758|P3|Completed Study Medication at Month 24|Administrative problems|2
904349|NCT01114529|2983759|P2|Completed Study Medication at Month 24|Administrative problems|1
904350|NCT01114529|2983760|P1|Completed Study Medication at Month 24|Administrative problems|2
904351|NCT01114529|2983758|P3|Completed Study Medication at Month 24|Lost to Follow-up|2
904352|NCT01114529|2983759|P2|Completed Study Medication at Month 24|Lost to Follow-up|4
904353|NCT01114529|2983760|P1|Completed Study Medication at Month 24|Lost to Follow-up|1
904354|NCT01114529|2983758|P3|Completed Study Medication at Month 24|Withdrawal by Subject|2
904355|NCT01114529|2983759|P2|Completed Study Medication at Month 24|Withdrawal by Subject|8
904356|NCT01114529|2983760|P1|Completed Study Medication at Month 24|Withdrawal by Subject|18
904357|NCT01114529|2983758|P3|Completed Study Medication at Month 24|Subject's no longer required drug|1
904358|NCT01114529|2983759|P2|Completed Study Medication at Month 24|Subject's no longer required drug|1
904359|NCT01114529|2983760|P1|Completed Study Medication at Month 24|Subject's no longer required drug|1
904360|NCT01114529|2983758|P3|Completed Study Medication at Month 24|Lack of Efficacy|2
904361|NCT01114529|2983759|P2|Completed Study Medication at Month 24|Lack of Efficacy|1
904362|NCT01114529|2983760|P1|Completed Study Medication at Month 24|Lack of Efficacy|2
904363|NCT01114529|2983758|P3|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1
904364|NCT01114529|2983759|P2|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0
904365|NCT01114529|2983760|P1|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3
904366|NCT01114529|2983758|P3|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1
904367|NCT01114529|2983759|P2|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0
904368|NCT01114529|2983760|P1|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6
904369|NCT01114529|2983758|P3|Completed Study Medication at Month 24|Adverse Event|17
904370|NCT01114529|2983759|P2|Completed Study Medication at Month 24|Adverse Event|18
904371|NCT01114529|2983760|P1|Completed Study Medication at Month 24|Adverse Event|87
904372|NCT01114516|2983779|P2|Overall Study|Lost to Follow-up|1
904373|NCT01114516|2983780|P1|Overall Study|Lost to Follow-up|2
904374|NCT01114438|2983815|P1|Overall Study|Withdrawal by Subject|2
904375|NCT01114438|2983815|P1|Overall Study|Physician Decision|1
904376|NCT01114438|2983815|P1|Overall Study|concomitant medication|1
904377|NCT01114438|2983815|P1|Overall Study|Adverse Event|10
904378|NCT01114373|2983825|P2|Intervention 2 (4 Weeks)|Lost to Follow-up|1
904379|NCT01114373|2983826|P1|Intervention 2 (4 Weeks)|Lost to Follow-up|0
904380|NCT01114373|2983825|P2|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0
904381|NCT01114373|2983826|P1|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1
904382|NCT01114373|2983825|P2|Intervention 1 (4 Weeks)|Incarceration|0
904383|NCT01114373|2983826|P1|Intervention 1 (4 Weeks)|Incarceration|1
904384|NCT01114373|2983825|P2|Intervention 1 (4 Weeks)|Lost to Follow-up|0
904385|NCT01114373|2983826|P1|Intervention 1 (4 Weeks)|Lost to Follow-up|1
904386|NCT01114360|2983858|P2|Intervention 1 (4 Weeks)|Physician Decision|1
904387|NCT01114360|2983859|P1|Intervention 1 (4 Weeks)|Physician Decision|0
904388|NCT01114217|2983910|P2|Overall Study|Other-Withdrawal by Subject|1
904389|NCT01114217|2983911|P1|Overall Study|Other-Withdrawal by Subject|1
904390|NCT01114217|2983910|P2|Overall Study|Other-Lost to Follow-up|0
904391|NCT01114217|2983911|P1|Overall Study|Other-Lost to Follow-up|1
904392|NCT01114217|2983910|P2|Overall Study|Other-Site Stopped Communicating|0
904393|NCT01114217|2983911|P1|Overall Study|Other-Site Stopped Communicating|2
904394|NCT01114217|2983910|P2|Overall Study|Other-Study Withdrawn|1
904395|NCT01114217|2983911|P1|Overall Study|Other-Study Withdrawn|1
904396|NCT01114217|2983910|P2|Overall Study|Other-Study Termination|1
904397|NCT01114217|2983911|P1|Overall Study|Other-Study Termination|0
904398|NCT01114217|2983910|P2|Overall Study|Other-Sponsor Decision|12
904399|NCT01114217|2983911|P1|Overall Study|Other-Sponsor Decision|10
904400|NCT01114217|2983910|P2|Overall Study|Other-Physician Decision|1
904401|NCT01114217|2983911|P1|Overall Study|Other-Physician Decision|1
904402|NCT01114217|2983910|P2|Overall Study|Other-Non Compliance|0
904403|NCT01114217|2983911|P1|Overall Study|Other-Non Compliance|2
904404|NCT01114217|2983910|P2|Overall Study|Other-Lack of Efficacy|0
904405|NCT01114217|2983911|P1|Overall Study|Other-Lack of Efficacy|1
904406|NCT01114217|2983910|P2|Overall Study|Other-Protocol Violation|3
904407|NCT01114217|2983911|P1|Overall Study|Other-Protocol Violation|1
904408|NCT01114217|2983910|P2|Overall Study|Other-Pregnancy|4
904409|NCT01114217|2983911|P1|Overall Study|Other-Pregnancy|2
904410|NCT01114217|2983910|P2|Overall Study|Other-Procedure|1
904411|NCT01114217|2983911|P1|Overall Study|Other-Procedure|1
904413|NCT01114217|2983911|P1|Overall Study|Other-Early termination|6
904414|NCT01114217|2983910|P2|Overall Study|Other-Clerical Error|0
904415|NCT01114217|2983911|P1|Overall Study|Other-Clerical Error|3
904416|NCT01114217|2983910|P2|Overall Study|Withdrawal by Subject|28
904417|NCT01114217|2983911|P1|Overall Study|Withdrawal by Subject|21
904418|NCT01114217|2983910|P2|Overall Study|Lost to Follow-up|33
904419|NCT01114217|2983911|P1|Overall Study|Lost to Follow-up|17
904420|NCT01114217|2983910|P2|Overall Study|Adverse Event|3
904421|NCT01114217|2983911|P1|Overall Study|Adverse Event|5
904422|NCT01114204|2983923|P2|Overall Study|Other-Protocol Violation|0
904423|NCT01114204|2983924|P1|Overall Study|Other-Protocol Violation|1
904424|NCT01114204|2983923|P2|Overall Study|Other-Participant request|0
904425|NCT01114204|2983924|P1|Overall Study|Other-Participant request|2
904426|NCT01114204|2983923|P2|Overall Study|Other-Medical monitor request|0
904427|NCT01114204|2983924|P1|Overall Study|Other-Medical monitor request|1
904428|NCT01114204|2983923|P2|Overall Study|Other-Personal reasons|0
904429|NCT01114204|2983924|P1|Overall Study|Other-Personal reasons|2
904430|NCT01114204|2983923|P2|Overall Study|Death|0
904431|NCT01114204|2983924|P1|Overall Study|Death|1
904432|NCT01114204|2983923|P2|Overall Study|Withdrawal by Subject|6
904433|NCT01114204|2983924|P1|Overall Study|Withdrawal by Subject|10
904434|NCT01114204|2983923|P2|Overall Study|Lost to Follow-up|0
904435|NCT01114204|2983924|P1|Overall Study|Lost to Follow-up|1
904436|NCT01114204|2983923|P2|Overall Study|Adverse Event|2
904437|NCT01114204|2983924|P1|Overall Study|Adverse Event|3
904438|NCT01114139|2983942|P2|Overall Study|Other-Withdrew prior to receiving dose|3
904439|NCT01114139|2983943|P1|Overall Study|Other-Withdrew prior to receiving dose|1
904440|NCT01114139|2983942|P2|Overall Study|Other-Physician changed treatment|0
904441|NCT01114139|2983943|P1|Overall Study|Other-Physician changed treatment|1
904442|NCT01114139|2983942|P2|Overall Study|Other-Participant went on hospice|1
904443|NCT01114139|2983943|P1|Overall Study|Other-Participant went on hospice|0
904444|NCT01114139|2983942|P2|Overall Study|Other-Participant falsified records|1
904445|NCT01114139|2983943|P1|Overall Study|Other-Participant falsified records|0
904446|NCT01114139|2983942|P2|Overall Study|Other-Out of window for study drug dose|0
904447|NCT01114139|2983943|P1|Overall Study|Other-Out of window for study drug dose|1
904448|NCT01114139|2983942|P2|Overall Study|Other-Protocol Violation|0
904449|NCT01114139|2983943|P1|Overall Study|Other-Protocol Violation|1
904450|NCT01114139|2983942|P2|Overall Study|Other-Missed 1 visit|0
904451|NCT01114139|2983943|P1|Overall Study|Other-Missed 1 visit|1
904452|NCT01114139|2983942|P2|Overall Study|Withdrawal by Subject|6
904453|NCT01114139|2983943|P1|Overall Study|Withdrawal by Subject|17
904454|NCT01114139|2983942|P2|Overall Study|Lost to Follow-up|3
904455|NCT01114139|2983943|P1|Overall Study|Lost to Follow-up|15
904456|NCT01114139|2983942|P2|Overall Study|Adverse Event|2
904457|NCT01114139|2983943|P1|Overall Study|Adverse Event|3
904458|NCT01113931|2983961|P2|Overall Study|Withdrawal by Subject|0
904459|NCT01113931|2983962|P1|Overall Study|Withdrawal by Subject|3
904460|NCT01113931|2983961|P2|Overall Study|Various|4
904461|NCT01113931|2983962|P1|Overall Study|Various|2
904462|NCT01113931|2983961|P2|Overall Study|Lost to Follow-up|9
904463|NCT01113931|2983962|P1|Overall Study|Lost to Follow-up|12
904464|NCT01113931|2983961|P2|Overall Study|Physician Decision|2
904465|NCT01113931|2983962|P1|Overall Study|Physician Decision|0
904466|NCT01113931|2983961|P2|Overall Study|Adverse Event|2
904467|NCT01113931|2983962|P1|Overall Study|Adverse Event|2
904468|NCT01113801|2983978|P4|Overall Study|Clinical Endpoint (ESRD)|5
904469|NCT01113801|2983979|P3|Overall Study|Clinical Endpoint (ESRD)|2
904470|NCT01113801|2983980|P2|Overall Study|Clinical Endpoint (ESRD)|4
904471|NCT01113801|2983981|P1|Overall Study|Clinical Endpoint (ESRD)|7
904472|NCT01113801|2983978|P4|Overall Study|Sponsor Decision|15
904473|NCT01113801|2983979|P3|Overall Study|Sponsor Decision|20
904474|NCT01113801|2983980|P2|Overall Study|Sponsor Decision|21
904475|NCT01113801|2983981|P1|Overall Study|Sponsor Decision|15
904476|NCT01113801|2983978|P4|Overall Study|Physician Decision|3
904477|NCT01113801|2983979|P3|Overall Study|Physician Decision|3
904478|NCT01113801|2983980|P2|Overall Study|Physician Decision|2
904479|NCT01113801|2983981|P1|Overall Study|Physician Decision|2
904480|NCT01113801|2983978|P4|Overall Study|Withdrawal by Subject|8
904481|NCT01113801|2983979|P3|Overall Study|Withdrawal by Subject|7
904482|NCT01113801|2983980|P2|Overall Study|Withdrawal by Subject|7
904483|NCT01113801|2983981|P1|Overall Study|Withdrawal by Subject|9
904484|NCT01113801|2983978|P4|Overall Study|Protocol Violation|0
904485|NCT01113801|2983979|P3|Overall Study|Protocol Violation|0
904486|NCT01113801|2983980|P2|Overall Study|Protocol Violation|1
904487|NCT01113801|2983981|P1|Overall Study|Protocol Violation|0
904488|NCT01113801|2983978|P4|Overall Study|Death|4
904489|NCT01113801|2983979|P3|Overall Study|Death|3
904490|NCT01113801|2983980|P2|Overall Study|Death|5
904491|NCT01113801|2983981|P1|Overall Study|Death|4
904492|NCT01113801|2983978|P4|Overall Study|Adverse Event|6
904493|NCT01113801|2983979|P3|Overall Study|Adverse Event|2
904494|NCT01113801|2983980|P2|Overall Study|Adverse Event|0
904495|NCT01113801|2983981|P1|Overall Study|Adverse Event|4
904496|NCT01113749|2984009|P2|Overall Study|Lost to Follow-up|2
904497|NCT01113749|2984010|P1|Overall Study|Lost to Follow-up|1
904498|NCT01113710|2984033|P1|Overall Study|Subject Did Not Receive Neupro|3
904499|NCT01113710|2984033|P1|Overall Study|Compliance/Subject Withdrawal/AE|1
904500|NCT01113710|2984033|P1|Overall Study|Lack of Patient's Compliance/Other|1
904501|NCT01113710|2984033|P1|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1
904502|NCT01113710|2984033|P1|Overall Study|Compliance/Efficacy/Subject Withdrawal|1
904503|NCT01113710|2984033|P1|Overall Study|Compliance/Efficacy/AE/Other|1
904504|NCT01113710|2984033|P1|Overall Study|Compliance/Efficacy/Adverse Event|1
904505|NCT01113710|2984033|P1|Overall Study|Efficacy/Withdrawal by Subject/Other|1
904506|NCT01113710|2984033|P1|Overall Study|Lost to Follow up/Withdrawal by Subject|2
904507|NCT01113710|2984033|P1|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2
904508|NCT01113710|2984033|P1|Overall Study|Efficacy/Subject Withdrawal/AE|2
904509|NCT01113710|2984033|P1|Overall Study|Lack of Efficacy/Adverse Event|3
904510|NCT01113710|2984033|P1|Overall Study|Patient Compliance/Withdrawal by Subject|4
904511|NCT01113710|2984033|P1|Overall Study|Lack of Efficacy/Other|4
904512|NCT01113710|2984033|P1|Overall Study|Patient's Compliance/Lost to Follow up|5
904513|NCT01113710|2984033|P1|Overall Study|Adverse Event/Other|5
904514|NCT01113710|2984033|P1|Overall Study|Other|7
904515|NCT01113710|2984033|P1|Overall Study|Lack of Patient's Compliance|8
904516|NCT01113710|2984033|P1|Overall Study|Withdrawal by Subject/Adverse Event|11
904517|NCT01113710|2984033|P1|Overall Study|Lack of Efficacy/Withdrawal by Subject|13
904518|NCT01113710|2984033|P1|Overall Study|Lost to Follow-up|20
904519|NCT01113710|2984033|P1|Overall Study|Withdrawal by Subject|28
904520|NCT01113710|2984033|P1|Overall Study|No Information Available|40
904521|NCT01113710|2984033|P1|Overall Study|Lack of Efficacy|41
904522|NCT01113710|2984033|P1|Overall Study|Adverse Event|64
904523|NCT01113580|2984061|P2|Overall Study|Protocol Violation|0
904524|NCT01113580|2984062|P1|Overall Study|Protocol Violation|1
904525|NCT01113541|2984076|P1|Overall Study|Adverse Event|4
904526|NCT01113541|2984076|P1|Overall Study|Study Terminated by Sponsor|7
904527|NCT01113541|2984076|P1|Overall Study|Protocol Violation|1
904528|NCT01113541|2984076|P1|Overall Study|Withdrawal by Subject|1
904529|NCT01113463|2984109|P1|Overall Study|Physician Decision|5
904530|NCT01112917|2984139|P2|Overall Study|Unable to Convert Filter|0
904531|NCT01112917|2984140|P1|Overall Study|Unable to Convert Filter|3
904532|NCT01112917|2984139|P2|Overall Study|Withdrawal by Subject|3
904533|NCT01112917|2984140|P1|Overall Study|Withdrawal by Subject|1
904534|NCT01112917|2984139|P2|Overall Study|Lost to Follow-up|1
904535|NCT01112917|2984140|P1|Overall Study|Lost to Follow-up|1
904536|NCT01112917|2984139|P2|Overall Study|Death|11
904537|NCT01112917|2984140|P1|Overall Study|Death|2
904538|NCT01112579|2984244|P2|Overall Study|Death|2
904539|NCT01112579|2984245|P1|Overall Study|Death|0
904540|NCT01112579|2984244|P2|Overall Study|Missed Visit|1
904541|NCT01112579|2984245|P1|Overall Study|Missed Visit|1
904542|NCT01112514|2984255|P1|Overall Study|Lost to Follow-up|1
904543|NCT01112267|2984300|P2|Overall Study|Participants not receive any study drug|2
904544|NCT01112267|2984301|P1|Overall Study|Participants not receive any study drug|1
904545|NCT01112267|2984300|P2|Overall Study|Participants not compliant|2
904546|NCT01112267|2984301|P1|Overall Study|Participants not compliant|1
904547|NCT01112267|2984300|P2|Overall Study|Protocol Violation|3
904548|NCT01112267|2984301|P1|Overall Study|Protocol Violation|5
904549|NCT01112267|2984300|P2|Overall Study|Withdrawal by Subject|5
904550|NCT01112267|2984301|P1|Overall Study|Withdrawal by Subject|3
904551|NCT01112267|2984300|P2|Overall Study|Adverse Event|6
904552|NCT01112267|2984301|P1|Overall Study|Adverse Event|24
904553|NCT01112059|2984334|P2|Overall Study|Withdrawal by Subject|0
904554|NCT01112059|2984335|P1|Overall Study|Withdrawal by Subject|1
904555|NCT01111851|2984349|P2|Overall Study|All planned PET scans were not obtained.|0
904556|NCT01111851|2984350|P1|Overall Study|All planned PET scans were not obtained.|2
904557|NCT01111838|2984362|P1|Overall Study|Other Complicating Disease|1
904558|NCT01111838|2984362|P1|Overall Study|Clinical deterioration|1
904559|NCT01111838|2984362|P1|Overall Study|Not Treated|3
904560|NCT01111838|2984362|P1|Overall Study|Patient Ineligible|2
904561|NCT01111825|2984370|P4|Overall Study|Discontinuation by Sponsor|20
904562|NCT01111825|2984371|P3|Overall Study|Discontinuation by Sponsor|0
904563|NCT01111825|2984372|P2|Overall Study|Discontinuation by Sponsor|0
904564|NCT01111825|2984373|P1|Overall Study|Discontinuation by Sponsor|0
904565|NCT01111825|2984370|P4|Overall Study|Disease Progression|0
904566|NCT01111825|2984371|P3|Overall Study|Disease Progression|0
904567|NCT01111825|2984372|P2|Overall Study|Disease Progression|0
904568|NCT01111825|2984373|P1|Overall Study|Disease Progression|1
904569|NCT01111825|2984370|P4|Overall Study|Adverse Event|0
904570|NCT01111825|2984371|P3|Overall Study|Adverse Event|4
904571|NCT01111825|2984372|P2|Overall Study|Adverse Event|1
904572|NCT01111825|2984373|P1|Overall Study|Adverse Event|2
904573|NCT01111825|2984370|P4|Overall Study|Lost to Follow-up|1
904574|NCT01111825|2984371|P3|Overall Study|Lost to Follow-up|3
904575|NCT01111825|2984372|P2|Overall Study|Lost to Follow-up|0
904576|NCT01111825|2984373|P1|Overall Study|Lost to Follow-up|0
904577|NCT01111825|2984370|P4|Overall Study|Withdrawal by Subject|0
904578|NCT01111825|2984371|P3|Overall Study|Withdrawal by Subject|1
904579|NCT01111825|2984372|P2|Overall Study|Withdrawal by Subject|0
904580|NCT01111825|2984373|P1|Overall Study|Withdrawal by Subject|0
904581|NCT01111526|2984392|P3|Overall Study|GVHD Disease Progression|2
904582|NCT01111526|2984393|P2|Overall Study|GVHD Disease Progression|1
904583|NCT01111526|2984394|P1|Overall Study|GVHD Disease Progression|0
904584|NCT01111461|2984406|P1|Overall Study|Not specified|6
904585|NCT01111461|2984406|P1|Overall Study|Withdrawal by Subject|1
904586|NCT01111461|2984406|P1|Overall Study|Lost to Follow-up|1
904587|NCT01111461|2984406|P1|Overall Study|Participant choice|11
904588|NCT01111461|2984406|P1|Overall Study|Adverse Event|32
904589|NCT01111292|2984586|P2|Treatment|Physician Decision|1
904590|NCT01111292|2984587|P1|Treatment|Physician Decision|1
904591|NCT01111240|2984593|P1|Overall Study|Not Specified|312
904592|NCT01111240|2984593|P1|Overall Study|Lack of Efficacy and Adverse Event|19
904593|NCT01111240|2984593|P1|Overall Study|Lack of Efficacy|545
904594|NCT01111240|2984593|P1|Overall Study|Adverse Event|190
904595|NCT01111149|2984623|P3|Overall Study|Withdrawal by Subject|2
904596|NCT01111149|2984624|P2|Overall Study|Withdrawal by Subject|0
904597|NCT01111149|2984625|P1|Overall Study|Withdrawal by Subject|1
904598|NCT01111149|2984623|P3|Overall Study|Protocol Violation|2
904599|NCT01111149|2984624|P2|Overall Study|Protocol Violation|1
904600|NCT01111149|2984625|P1|Overall Study|Protocol Violation|1
904601|NCT01111123|2984701|P2|Maintenance Phase|Lost to Follow-up|2
904602|NCT01111123|2984702|P1|Maintenance Phase|Lost to Follow-up|0
904603|NCT01111123|2984701|P2|Open- Label Phase|Failed to be clear or almost cleared|0
904604|NCT01111123|2984702|P1|Open- Label Phase|Failed to be clear or almost cleared|14
904605|NCT01110915|2984736|P2|Overall Study|Withdrawal by Subject|1
904606|NCT01110915|2984737|P1|Overall Study|Withdrawal by Subject|7
904607|NCT01110915|2984736|P2|Overall Study|Lost to Follow-up|0
904608|NCT01110915|2984737|P1|Overall Study|Lost to Follow-up|1
904609|NCT01110915|2984736|P2|Overall Study|Death|1
904610|NCT01110915|2984737|P1|Overall Study|Death|2
904611|NCT01110707|2984754|P2|Overall Study|Protocol Violation|3
904612|NCT01110707|2984755|P1|Overall Study|Protocol Violation|0
904613|NCT01110408|2984835|P2|Overall Study|Protocol Violation|0
904614|NCT01110408|2984836|P1|Overall Study|Protocol Violation|1
904615|NCT01110382|2984856|P2|Overall Study|Protocol Violation|1
904616|NCT01110382|2984857|P1|Overall Study|Protocol Violation|0
904617|NCT01110382|2984856|P2|Overall Study|Withdrawal by Subject|1
904618|NCT01110382|2984857|P1|Overall Study|Withdrawal by Subject|0
904619|NCT01110330|2984878|P3|Overall Study|Not specified|1
904620|NCT01110330|2984879|P2|Overall Study|Not specified|1
904621|NCT01110330|2984880|P1|Overall Study|Not specified|1
904622|NCT01110330|2984878|P3|Overall Study|Withdrawal by Subject|2
904623|NCT01110330|2984879|P2|Overall Study|Withdrawal by Subject|6
904624|NCT01110330|2984880|P1|Overall Study|Withdrawal by Subject|0
904625|NCT01110330|2984878|P3|Overall Study|Protocol Violation|4
904626|NCT01110330|2984879|P2|Overall Study|Protocol Violation|0
904627|NCT01110330|2984880|P1|Overall Study|Protocol Violation|2
904628|NCT01110330|2984878|P3|Overall Study|Physician Decision|0
904629|NCT01110330|2984879|P2|Overall Study|Physician Decision|1
904630|NCT01110330|2984880|P1|Overall Study|Physician Decision|0
904631|NCT01110330|2984878|P3|Overall Study|Lost to Follow-up|15
904632|NCT01110330|2984879|P2|Overall Study|Lost to Follow-up|10
904633|NCT01110330|2984880|P1|Overall Study|Lost to Follow-up|9
904634|NCT01110330|2984878|P3|Overall Study|Lack of Efficacy|1
904635|NCT01110330|2984879|P2|Overall Study|Lack of Efficacy|1
904636|NCT01110330|2984880|P1|Overall Study|Lack of Efficacy|3
904637|NCT01110330|2984878|P3|Overall Study|Adverse Event|3
904638|NCT01110330|2984879|P2|Overall Study|Adverse Event|4
904639|NCT01110330|2984880|P1|Overall Study|Adverse Event|0
904640|NCT01110239|2984908|P4|7.5 Min Ischemia|Withdrawal by Subject|0
904641|NCT01110239|2984909|P3|7.5 Min Ischemia|Withdrawal by Subject|1
904642|NCT01110239|2984910|P2|7.5 Min Ischemia|Withdrawal by Subject|0
904643|NCT01110239|2984911|P1|7.5 Min Ischemia|Withdrawal by Subject|0
904644|NCT01110239|2984908|P4|Sham Preconditioning|Withdrawal by Subject|0
904645|NCT01110239|2984909|P3|Sham Preconditioning|Withdrawal by Subject|1
904646|NCT01110239|2984910|P2|Sham Preconditioning|Withdrawal by Subject|0
904647|NCT01110239|2984911|P1|Sham Preconditioning|Withdrawal by Subject|0
904648|NCT01110200|2984927|P2|Overall Study|Lost to Follow-up|7
904649|NCT01110200|2984928|P1|Overall Study|Lost to Follow-up|10
904650|NCT01110200|2984927|P2|Overall Study|Physician Decision|17
904651|NCT01110200|2984928|P1|Overall Study|Physician Decision|13
904652|NCT01110200|2984927|P2|Overall Study|Protocol Violation|12
904653|NCT01110200|2984928|P1|Overall Study|Protocol Violation|14
904654|NCT01110200|2984927|P2|Overall Study|Lack of Efficacy|25
904655|NCT01110200|2984928|P1|Overall Study|Lack of Efficacy|16
904656|NCT01110200|2984927|P2|Overall Study|Withdrawal by Subject|32
904657|NCT01110200|2984928|P1|Overall Study|Withdrawal by Subject|25
904658|NCT01110200|2984927|P2|Overall Study|Adverse Event|28
904659|NCT01110200|2984928|P1|Overall Study|Adverse Event|28
904660|NCT01110005|2984959|P2|Overall Study|Withdrawal by Subject|1
904661|NCT01110005|2984960|P1|Overall Study|Withdrawal by Subject|0
904662|NCT01110005|2984959|P2|Overall Study|missing consent|2
904663|NCT01110005|2984960|P1|Overall Study|missing consent|3
904664|NCT01110005|2984959|P2|Overall Study|ineligible|2
904665|NCT01110005|2984960|P1|Overall Study|ineligible|1
904666|NCT01109992|2984972|P2|Overall Study|Movement during rest scan.|1
904667|NCT01109992|2984973|P1|Overall Study|Movement during rest scan.|0
904668|NCT01109992|2984972|P2|Overall Study|Withdrawal by Subject|1
904669|NCT01109992|2984973|P1|Overall Study|Withdrawal by Subject|0
904670|NCT01109979|2984987|P2|Overall Study|Withdrawal by Subject|1
904671|NCT01109979|2984988|P1|Overall Study|Withdrawal by Subject|0
904672|NCT01109979|2984987|P2|Overall Study|Physician Decision|0
904673|NCT01109979|2984988|P1|Overall Study|Physician Decision|2
904674|NCT01109849|2984996|P5|Adaptive Randomization: Weight Recovery|moved away|0
904675|NCT01109849|2984997|P4|Adaptive Randomization: Weight Recovery|moved away|2
904676|NCT01109849|2984998|P3|Adaptive Randomization: Weight Recovery|moved away|0
904677|NCT01109849|2984999|P2|Adaptive Randomization: Weight Recovery|moved away|0
904678|NCT01109849|2985000|P1|Adaptive Randomization: Weight Recovery|moved away|0
904679|NCT01109849|2984996|P5|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
904680|NCT01109849|2984997|P4|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
904681|NCT01109849|2984998|P3|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
904682|NCT01109849|2984999|P2|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
904683|NCT01109849|2985000|P1|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
904684|NCT01109849|2984996|P5|Initial Randomization: ADHD Treatment|move away|0
904685|NCT01109849|2984997|P4|Initial Randomization: ADHD Treatment|move away|0
904686|NCT01109849|2984998|P3|Initial Randomization: ADHD Treatment|move away|0
904687|NCT01109849|2984999|P2|Initial Randomization: ADHD Treatment|move away|7
904688|NCT01109849|2985000|P1|Initial Randomization: ADHD Treatment|move away|2
904689|NCT01109849|2984996|P5|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
904690|NCT01109849|2984997|P4|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
904691|NCT01109849|2984998|P3|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
904692|NCT01109849|2984999|P2|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7
904693|NCT01109849|2985000|P1|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6
904694|NCT01109849|2984996|P5|Initial Randomization: ADHD Treatment|Protocol Violation|0
904695|NCT01109849|2984997|P4|Initial Randomization: ADHD Treatment|Protocol Violation|0
904696|NCT01109849|2984998|P3|Initial Randomization: ADHD Treatment|Protocol Violation|0
904697|NCT01109849|2984999|P2|Initial Randomization: ADHD Treatment|Protocol Violation|0
904698|NCT01109849|2985000|P1|Initial Randomization: ADHD Treatment|Protocol Violation|1
904699|NCT01109849|2984996|P5|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
904700|NCT01109849|2984997|P4|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
904701|NCT01109849|2984998|P3|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
904702|NCT01109849|2984999|P2|Initial Randomization: ADHD Treatment|Lost to Follow-up|35
904703|NCT01109849|2985000|P1|Initial Randomization: ADHD Treatment|Lost to Follow-up|9
904704|NCT01109524|2985069|P1|Overall Study|Not specified|5
904705|NCT01109524|2985069|P1|Overall Study|Participant requested to end treatment|4
904706|NCT01109524|2985069|P1|Overall Study|No longer meets criteria|2
904707|NCT01109524|2985069|P1|Overall Study|Death|2
904708|NCT01109524|2985069|P1|Overall Study|Maximum clinical benefit|3
904709|NCT01109524|2985069|P1|Overall Study|Withdrawal by Subject|2
904710|NCT01109524|2985069|P1|Overall Study|Adverse Event|4
904711|NCT01109524|2985069|P1|Overall Study|Study Drug toxicity|6
904712|NCT01109524|2985069|P1|Overall Study|Disease Progression|29
904713|NCT01109316|2985091|P3|Study Period 3|Withdrawal by Subject|1
904714|NCT01109316|2985092|P2|Study Period 3|Withdrawal by Subject|1
904715|NCT01109316|2985093|P1|Study Period 3|Withdrawal by Subject|0
904716|NCT01109316|2985091|P3|Study Period 3|Lost to Follow-up|0
904717|NCT01109316|2985092|P2|Study Period 3|Lost to Follow-up|1
904718|NCT01109316|2985093|P1|Study Period 3|Lost to Follow-up|0
904719|NCT01109316|2985091|P3|Study Period 2|Withdrawal by Subject|0
904720|NCT01109316|2985092|P2|Study Period 2|Withdrawal by Subject|1
904721|NCT01109316|2985093|P1|Study Period 2|Withdrawal by Subject|1
904722|NCT01109316|2985091|P3|Study Period 2|Protocol Violation|0
904723|NCT01109316|2985092|P2|Study Period 2|Protocol Violation|1
904724|NCT01109316|2985093|P1|Study Period 2|Protocol Violation|0
904725|NCT01109316|2985091|P3|Study Period 2|Physician Decision|1
904726|NCT01109316|2985092|P2|Study Period 2|Physician Decision|0
904727|NCT01109316|2985093|P1|Study Period 2|Physician Decision|0
904728|NCT01109316|2985091|P3|Study Period 2|Entry Criteria Not Met|1
904729|NCT01109316|2985092|P2|Study Period 2|Entry Criteria Not Met|0
904730|NCT01109316|2985093|P1|Study Period 2|Entry Criteria Not Met|0
904731|NCT01109316|2985091|P3|Study Period 1|Sponsor Decision|2
904732|NCT01109316|2985092|P2|Study Period 1|Sponsor Decision|0
904733|NCT01109316|2985093|P1|Study Period 1|Sponsor Decision|0
904734|NCT01109316|2985091|P3|Study Period 1|Withdrawal by Subject|2
904735|NCT01109316|2985092|P2|Study Period 1|Withdrawal by Subject|1
904736|NCT01109316|2985093|P1|Study Period 1|Withdrawal by Subject|0
904737|NCT01109316|2985091|P3|Study Period 1|Lost to Follow-up|0
904738|NCT01109316|2985092|P2|Study Period 1|Lost to Follow-up|2
904739|NCT01109316|2985093|P1|Study Period 1|Lost to Follow-up|0
904740|NCT01109316|2985091|P3|Study Period 1|Adverse Event|0
904741|NCT01109316|2985092|P2|Study Period 1|Adverse Event|1
904742|NCT01109316|2985093|P1|Study Period 1|Adverse Event|0
904743|NCT01109173|2985141|P4|Overall Study|Not Specifiied|14
904744|NCT01109173|2985142|P3|Overall Study|Not Specifiied|9
904745|NCT01109173|2985143|P2|Overall Study|Not Specifiied|4
904746|NCT01109173|2985144|P1|Overall Study|Not Specifiied|5
904747|NCT01109173|2985141|P4|Overall Study|Patient Did Not Use Study Medication|7
904748|NCT01109173|2985142|P3|Overall Study|Patient Did Not Use Study Medication|11
904749|NCT01109173|2985143|P2|Overall Study|Patient Did Not Use Study Medication|26
904750|NCT01109173|2985144|P1|Overall Study|Patient Did Not Use Study Medication|34
904751|NCT01109173|2985141|P4|Overall Study|Protocol Violation|2
904752|NCT01109173|2985142|P3|Overall Study|Protocol Violation|1
904753|NCT01109173|2985143|P2|Overall Study|Protocol Violation|5
904754|NCT01109173|2985144|P1|Overall Study|Protocol Violation|4
904755|NCT01109173|2985141|P4|Overall Study|Treatment Failure|64
904756|NCT01109173|2985142|P3|Overall Study|Treatment Failure|69
904757|NCT01109173|2985143|P2|Overall Study|Treatment Failure|32
904758|NCT01109173|2985144|P1|Overall Study|Treatment Failure|25
904759|NCT01109173|2985141|P4|Overall Study|Noncompliance|0
904760|NCT01109173|2985142|P3|Overall Study|Noncompliance|0
904761|NCT01109173|2985143|P2|Overall Study|Noncompliance|1
904762|NCT01109173|2985144|P1|Overall Study|Noncompliance|0
904763|NCT01109173|2985141|P4|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
904764|NCT01109173|2985142|P3|Overall Study|Patient Decision Unrelated to Advrs Evnt|2
904765|NCT01109173|2985143|P2|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
904766|NCT01109173|2985144|P1|Overall Study|Patient Decision Unrelated to Advrs Evnt|5
904767|NCT01109173|2985141|P4|Overall Study|Lost to Follow-up|0
904768|NCT01109173|2985142|P3|Overall Study|Lost to Follow-up|0
904769|NCT01109173|2985143|P2|Overall Study|Lost to Follow-up|1
904770|NCT01109173|2985144|P1|Overall Study|Lost to Follow-up|0
904771|NCT01109173|2985141|P4|Overall Study|Adverse Event|6
904772|NCT01109173|2985142|P3|Overall Study|Adverse Event|9
904773|NCT01109173|2985143|P2|Overall Study|Adverse Event|17
904774|NCT01109173|2985144|P1|Overall Study|Adverse Event|15
904775|NCT01108809|2985250|P1|Overall Study|Lost to Follow-up|1
904776|NCT01108809|2985250|P1|Overall Study|Adverse Event|3
904777|NCT01108796|2985267|P2|Overall Study|Lost to Follow-up|6
904778|NCT01108796|2985268|P1|Overall Study|Lost to Follow-up|7
904779|NCT01108796|2985267|P2|Overall Study|Adverse Event|1
904780|NCT01108796|2985268|P1|Overall Study|Adverse Event|0
904781|NCT01108731|2985311|P2|Overall Study|Adverse Event|3
904782|NCT01108731|2985312|P1|Overall Study|Adverse Event|3
904783|NCT01108731|2985311|P2|Overall Study|Withdrawal by Subject|1
904784|NCT01108731|2985312|P1|Overall Study|Withdrawal by Subject|1
904785|NCT01108718|2985324|P2|Received Second Intervention (2 Months)|Withdrawal by Subject|0
904786|NCT01108718|2985325|P1|Received Second Intervention (2 Months)|Withdrawal by Subject|1
904787|NCT01108523|2985330|P1|Overall Study|Protocol Violation|4
904788|NCT01108510|2985337|P2|Overall Study|Death|1
904789|NCT01108510|2985338|P1|Overall Study|Death|1
904790|NCT01108510|2985337|P2|Overall Study|Pregnancy|3
904791|NCT01108510|2985338|P1|Overall Study|Pregnancy|0
904792|NCT01108510|2985337|P2|Overall Study|Lack of Efficacy|0
904793|NCT01108510|2985338|P1|Overall Study|Lack of Efficacy|3
904794|NCT01108510|2985337|P2|Overall Study|Participant Noncompliance|7
904795|NCT01108510|2985338|P1|Overall Study|Participant Noncompliance|5
904796|NCT01108510|2985337|P2|Overall Study|Investigator’s Discretion|10
904797|NCT01108510|2985338|P1|Overall Study|Investigator’s Discretion|12
904798|NCT01108510|2985337|P2|Overall Study|Withdrew Consent|15
904799|NCT01108510|2985338|P1|Overall Study|Withdrew Consent|21
904800|NCT01108510|2985337|P2|Overall Study|Lost to Follow-up|17
904801|NCT01108510|2985338|P1|Overall Study|Lost to Follow-up|20
904802|NCT01108510|2985337|P2|Overall Study|Adverse Event|19
904803|NCT01108510|2985338|P1|Overall Study|Adverse Event|26
904804|NCT01108510|2985337|P2|Overall Study|Joined Another Gilead-sponsored Study|195
904805|NCT01108510|2985338|P1|Overall Study|Joined Another Gilead-sponsored Study|186
904806|NCT01108510|2985337|P2|Overall Study|Randomized but Not Treated|1
904807|NCT01108510|2985338|P1|Overall Study|Randomized but Not Treated|5
904808|NCT01108458|2985358|P1|Overall Study|Withdrawal by Subject|1
904809|NCT01108341|2985410|P1|Overall Study|not specified|1
904810|NCT01108341|2985410|P1|Overall Study|Lost to Follow-up|1
904811|NCT01108341|2985410|P1|Overall Study|Withdrawal by Subject|1
904812|NCT01108341|2985410|P1|Overall Study|Death|2
904813|NCT01108263|2985417|P2|Overall Study|Adverse Event|1
904814|NCT01108263|2985418|P1|Overall Study|Adverse Event|0
904815|NCT01108237|2985428|P2|Overall Study|Did not meet criteria for analysis|0
904816|NCT01108237|2985429|P1|Overall Study|Did not meet criteria for analysis|7
904817|NCT01108237|2985428|P2|Overall Study|No alignment data|17
904818|NCT01108237|2985429|P1|Overall Study|No alignment data|2
904819|NCT01108185|2985435|P1|Overall Study|Lost to Follow-up|12
904820|NCT01108185|2985435|P1|Overall Study|Non-compliance|15
904821|NCT01108094|2985452|P4|Overall Study|Withdrawal by Subject|0
904822|NCT01108094|2985453|P3|Overall Study|Withdrawal by Subject|0
904823|NCT01108094|2985454|P2|Overall Study|Withdrawal by Subject|0
904824|NCT01108094|2985455|P1|Overall Study|Withdrawal by Subject|1
904825|NCT01108094|2985452|P4|Overall Study|Adverse Event|0
904826|NCT01108094|2985453|P3|Overall Study|Adverse Event|0
904827|NCT01108094|2985454|P2|Overall Study|Adverse Event|0
904828|NCT01108094|2985455|P1|Overall Study|Adverse Event|2
904829|NCT01108068|2985499|P2|Overall Study|5 not started, 1 stop due to side effect|0
904830|NCT01108068|2985500|P1|Overall Study|5 not started, 1 stop due to side effect|6
904831|NCT01108055|2985507|P1|Overall Study|Not evaluable- didn't complete treatment|4
904832|NCT01108055|2985507|P1|Overall Study|Ineligible|11
904833|NCT01107925|2985545|P6|Period 2|Withdrawal by Subject|1
904834|NCT01107925|2985546|P5|Period 2|Withdrawal by Subject|0
904835|NCT01107925|2985547|P4|Period 2|Withdrawal by Subject|0
904836|NCT01107925|2985548|P3|Period 2|Withdrawal by Subject|0
904837|NCT01107925|2985549|P2|Period 2|Withdrawal by Subject|1
904838|NCT01107925|2985550|P1|Period 2|Withdrawal by Subject|0
904839|NCT01107925|2985545|P6|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
904840|NCT01107925|2985546|P5|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
904841|NCT01107925|2985547|P4|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
904842|NCT01107925|2985548|P3|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
904843|NCT01107925|2985549|P2|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
904844|NCT01107925|2985550|P1|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
904845|NCT01107912|2985588|P6|Period 3|Withdrawal by Subject|0
904846|NCT01107912|2985589|P5|Period 3|Withdrawal by Subject|0
904847|NCT01107912|2985590|P4|Period 3|Withdrawal by Subject|1
904848|NCT01107912|2985591|P3|Period 3|Withdrawal by Subject|0
904849|NCT01107912|2985592|P2|Period 3|Withdrawal by Subject|0
904850|NCT01107912|2985593|P1|Period 3|Withdrawal by Subject|0
904851|NCT01107912|2985588|P6|Period 3|Adverse Event|0
904852|NCT01107912|2985589|P5|Period 3|Adverse Event|0
904853|NCT01107912|2985590|P4|Period 3|Adverse Event|0
904854|NCT01107912|2985591|P3|Period 3|Adverse Event|1
904855|NCT01107912|2985592|P2|Period 3|Adverse Event|1
904856|NCT01107912|2985593|P1|Period 3|Adverse Event|0
904857|NCT01107912|2985588|P6|Period 2|Physician Decision|0
904858|NCT01107912|2985589|P5|Period 2|Physician Decision|0
904859|NCT01107912|2985590|P4|Period 2|Physician Decision|0
904860|NCT01107912|2985591|P3|Period 2|Physician Decision|1
904861|NCT01107912|2985592|P2|Period 2|Physician Decision|0
904862|NCT01107912|2985593|P1|Period 2|Physician Decision|0
904863|NCT01107912|2985588|P6|Period 1|Withdrawal by Subject|0
904864|NCT01107912|2985589|P5|Period 1|Withdrawal by Subject|0
904865|NCT01107912|2985590|P4|Period 1|Withdrawal by Subject|0
904866|NCT01107912|2985591|P3|Period 1|Withdrawal by Subject|0
904867|NCT01107912|2985592|P2|Period 1|Withdrawal by Subject|0
904868|NCT01107912|2985593|P1|Period 1|Withdrawal by Subject|1
904869|NCT01107912|2985588|P6|Period 1|Physician Decision|0
904870|NCT01107912|2985589|P5|Period 1|Physician Decision|1
904871|NCT01107912|2985590|P4|Period 1|Physician Decision|0
904872|NCT01107912|2985591|P3|Period 1|Physician Decision|0
904873|NCT01107912|2985592|P2|Period 1|Physician Decision|0
904874|NCT01107912|2985593|P1|Period 1|Physician Decision|0
904875|NCT01107912|2985588|P6|Period 1|Adverse Event|0
904876|NCT01107912|2985589|P5|Period 1|Adverse Event|2
904877|NCT01107912|2985590|P4|Period 1|Adverse Event|0
904878|NCT01107912|2985591|P3|Period 1|Adverse Event|0
904879|NCT01107912|2985592|P2|Period 1|Adverse Event|0
904880|NCT01107912|2985593|P1|Period 1|Adverse Event|0
904881|NCT01107899|2985630|P3|Overall Study|Withdrawal by Subject|1
904882|NCT01107899|2985631|P2|Overall Study|Withdrawal by Subject|0
904883|NCT01107899|2985632|P1|Overall Study|Withdrawal by Subject|0
904884|NCT01107899|2985630|P3|Overall Study|Physician Decision|3
904885|NCT01107899|2985631|P2|Overall Study|Physician Decision|0
904886|NCT01107899|2985632|P1|Overall Study|Physician Decision|5
904887|NCT01107886|2985678|P2|Overall Study|Administrative withdrawal of consent|5
904888|NCT01107886|2985679|P1|Overall Study|Administrative withdrawal of consent|7
904889|NCT01107886|2985678|P2|Overall Study|Withdrawal by Subject|196
904890|NCT01107886|2985679|P1|Overall Study|Withdrawal by Subject|180
904891|NCT01107886|2985678|P2|Overall Study|Lost to Follow-up|13
904892|NCT01107886|2985679|P1|Overall Study|Lost to Follow-up|15
904893|NCT01107743|2985708|P1|Overall Study|Protocol Violation|46
904894|NCT01107535|2985807|P1|Overall Study|Death|5
904895|NCT01107457|2985820|P6|Part B and C|Clinical Relapse|4
904896|NCT01107457|2985821|P5|Part B and C|Clinical Relapse|0
904897|NCT01107457|2985822|P4|Part B and C|Clinical Relapse|0
904898|NCT01107457|2985823|P3|Part B and C|Clinical Relapse|0
904899|NCT01107457|2985824|P2|Part B and C|Clinical Relapse|0
904900|NCT01107457|2985825|P1|Part B and C|Clinical Relapse|0
904901|NCT01107457|2985820|P6|Part B and C|Withdrawal by Subject|16
904902|NCT01107457|2985821|P5|Part B and C|Withdrawal by Subject|0
904903|NCT01107457|2985822|P4|Part B and C|Withdrawal by Subject|0
904904|NCT01107457|2985823|P3|Part B and C|Withdrawal by Subject|0
904905|NCT01107457|2985824|P2|Part B and C|Withdrawal by Subject|0
904906|NCT01107457|2985825|P1|Part B and C|Withdrawal by Subject|0
904907|NCT01107457|2985820|P6|Part B and C|Sponsor Decision|66
904908|NCT01107457|2985821|P5|Part B and C|Sponsor Decision|0
904909|NCT01107457|2985822|P4|Part B and C|Sponsor Decision|0
904910|NCT01107457|2985823|P3|Part B and C|Sponsor Decision|0
904911|NCT01107457|2985824|P2|Part B and C|Sponsor Decision|0
904912|NCT01107457|2985825|P1|Part B and C|Sponsor Decision|0
904913|NCT01107457|2985820|P6|Part B and C|Protocol Violation|1
904914|NCT01107457|2985821|P5|Part B and C|Protocol Violation|0
904915|NCT01107457|2985822|P4|Part B and C|Protocol Violation|0
904916|NCT01107457|2985823|P3|Part B and C|Protocol Violation|0
904917|NCT01107457|2985824|P2|Part B and C|Protocol Violation|0
904918|NCT01107457|2985825|P1|Part B and C|Protocol Violation|0
904919|NCT01107457|2985820|P6|Part B and C|Lost to Follow-up|10
904920|NCT01107457|2985821|P5|Part B and C|Lost to Follow-up|0
904921|NCT01107457|2985822|P4|Part B and C|Lost to Follow-up|0
904922|NCT01107457|2985823|P3|Part B and C|Lost to Follow-up|0
904923|NCT01107457|2985824|P2|Part B and C|Lost to Follow-up|0
904924|NCT01107457|2985825|P1|Part B and C|Lost to Follow-up|0
904925|NCT01107457|2985820|P6|Part B and C|Lack of Efficacy|7
904926|NCT01107457|2985821|P5|Part B and C|Lack of Efficacy|0
904927|NCT01107457|2985822|P4|Part B and C|Lack of Efficacy|0
904928|NCT01107457|2985823|P3|Part B and C|Lack of Efficacy|0
904929|NCT01107457|2985824|P2|Part B and C|Lack of Efficacy|0
904930|NCT01107457|2985825|P1|Part B and C|Lack of Efficacy|0
904931|NCT01107457|2985820|P6|Part B and C|Physician Decision|3
904932|NCT01107457|2985821|P5|Part B and C|Physician Decision|0
904933|NCT01107457|2985822|P4|Part B and C|Physician Decision|0
904934|NCT01107457|2985823|P3|Part B and C|Physician Decision|0
904935|NCT01107457|2985824|P2|Part B and C|Physician Decision|0
904936|NCT01107457|2985825|P1|Part B and C|Physician Decision|0
904937|NCT01107457|2985820|P6|Part B and C|Inclusion/Exclusion Criteria Not Met|1
904938|NCT01107457|2985821|P5|Part B and C|Inclusion/Exclusion Criteria Not Met|0
904939|NCT01107457|2985822|P4|Part B and C|Inclusion/Exclusion Criteria Not Met|0
904940|NCT01107457|2985823|P3|Part B and C|Inclusion/Exclusion Criteria Not Met|0
904941|NCT01107457|2985824|P2|Part B and C|Inclusion/Exclusion Criteria Not Met|0
904942|NCT01107457|2985825|P1|Part B and C|Inclusion/Exclusion Criteria Not Met|0
904943|NCT01107457|2985820|P6|Part B and C|Adverse Event|12
904944|NCT01107457|2985821|P5|Part B and C|Adverse Event|0
904945|NCT01107457|2985822|P4|Part B and C|Adverse Event|0
904946|NCT01107457|2985823|P3|Part B and C|Adverse Event|0
904947|NCT01107457|2985824|P2|Part B and C|Adverse Event|0
904948|NCT01107457|2985825|P1|Part B and C|Adverse Event|0
904949|NCT01107457|2985820|P6|Part A|Protocol Violation|0
904950|NCT01107457|2985821|P5|Part A|Protocol Violation|0
904951|NCT01107457|2985822|P4|Part A|Protocol Violation|0
904952|NCT01107457|2985823|P3|Part A|Protocol Violation|0
904953|NCT01107457|2985824|P2|Part A|Protocol Violation|1
904954|NCT01107457|2985825|P1|Part A|Protocol Violation|0
904955|NCT01107457|2985820|P6|Part A|Lack of Efficacy|0
904956|NCT01107457|2985821|P5|Part A|Lack of Efficacy|0
904957|NCT01107457|2985822|P4|Part A|Lack of Efficacy|0
904958|NCT01107457|2985823|P3|Part A|Lack of Efficacy|0
904959|NCT01107457|2985824|P2|Part A|Lack of Efficacy|0
904960|NCT01107457|2985825|P1|Part A|Lack of Efficacy|1
904961|NCT01107457|2985820|P6|Part A|Lost to Follow-up|0
904962|NCT01107457|2985821|P5|Part A|Lost to Follow-up|0
904963|NCT01107457|2985822|P4|Part A|Lost to Follow-up|0
904964|NCT01107457|2985823|P3|Part A|Lost to Follow-up|0
904965|NCT01107457|2985824|P2|Part A|Lost to Follow-up|1
904966|NCT01107457|2985825|P1|Part A|Lost to Follow-up|0
904967|NCT01107457|2985820|P6|Part A|Withdrawal by Subject|0
904968|NCT01107457|2985821|P5|Part A|Withdrawal by Subject|1
904969|NCT01107457|2985822|P4|Part A|Withdrawal by Subject|3
904970|NCT01107457|2985823|P3|Part A|Withdrawal by Subject|0
904971|NCT01107457|2985824|P2|Part A|Withdrawal by Subject|3
904972|NCT01107457|2985825|P1|Part A|Withdrawal by Subject|3
904973|NCT01107457|2985820|P6|Part A|Adverse Event|0
904974|NCT01107457|2985821|P5|Part A|Adverse Event|0
904975|NCT01107457|2985822|P4|Part A|Adverse Event|0
904976|NCT01107457|2985823|P3|Part A|Adverse Event|1
904977|NCT01107457|2985824|P2|Part A|Adverse Event|2
904978|NCT01107457|2985825|P1|Part A|Adverse Event|1
904979|NCT01107418|2985955|P1|Overall Study|Entered Extension Study|1
904980|NCT01107418|2985955|P1|Overall Study|Started Other Therapy|1
904981|NCT01107418|2985955|P1|Overall Study|Study Closing|1
904982|NCT01107418|2985955|P1|Overall Study|Withdrawal by Subject|1
904983|NCT01107418|2985955|P1|Overall Study|Adverse Event|3
904984|NCT01107418|2985955|P1|Overall Study|Disease Progression|45
904985|NCT01107405|2986028|P5|Overall Study|Protocol Violation|0
904986|NCT01107405|2986029|P4|Overall Study|Protocol Violation|1
904987|NCT01107405|2986030|P3|Overall Study|Protocol Violation|1
904988|NCT01107405|2986031|P2|Overall Study|Protocol Violation|0
904989|NCT01107405|2986032|P1|Overall Study|Protocol Violation|0
904990|NCT01107405|2986028|P5|Overall Study|Withdrawal by Subject|1
904991|NCT01107405|2986029|P4|Overall Study|Withdrawal by Subject|2
904992|NCT01107405|2986030|P3|Overall Study|Withdrawal by Subject|1
904993|NCT01107405|2986031|P2|Overall Study|Withdrawal by Subject|0
904994|NCT01107405|2986032|P1|Overall Study|Withdrawal by Subject|1
904995|NCT01107405|2986028|P5|Overall Study|Adverse Event|2
904996|NCT01107405|2986029|P4|Overall Study|Adverse Event|0
904997|NCT01107405|2986030|P3|Overall Study|Adverse Event|0
904998|NCT01107405|2986031|P2|Overall Study|Adverse Event|1
904999|NCT01107405|2986032|P1|Overall Study|Adverse Event|1
905000|NCT01107392|2986071|P2|Overall Study|Administrative decision|0
905001|NCT01107392|2986072|P1|Overall Study|Administrative decision|1
905002|NCT01107392|2986071|P2|Overall Study|Personal Reasons|3
905003|NCT01107392|2986072|P1|Overall Study|Personal Reasons|2
905004|NCT01107392|2986071|P2|Overall Study|Adverse Event|0
905005|NCT01107392|2986072|P1|Overall Study|Adverse Event|2
905006|NCT01107379|2986084|P1|Overall Study|Lost to Follow-up|3
905007|NCT01107379|2986084|P1|Overall Study|Withdrawal by Subject|18
905008|NCT01107353|2986095|P2|Overall Study|Positive Drug Screen|0
905009|NCT01107353|2986096|P1|Overall Study|Positive Drug Screen|1
905010|NCT01107197|2986104|P2|Overall Study|Withdrawal by Subject|5
905011|NCT01107197|2986105|P1|Overall Study|Withdrawal by Subject|3
905012|NCT01107197|2986104|P2|Overall Study|Lost to Follow-up|8
905013|NCT01107197|2986105|P1|Overall Study|Lost to Follow-up|5
905014|NCT01107197|2986104|P2|Overall Study|Death|10
905015|NCT01107197|2986105|P1|Overall Study|Death|12
905016|NCT01106976|2986140|P1|Overall Study|Lost to Follow-up|8
905017|NCT01106911|2986154|P1|Overall Study|deemed ineligible after screening|3
905018|NCT01106911|2986154|P1|Overall Study|Physician Decision|2
905019|NCT01106898|2986158|P1|Overall Study|Adverse Event|6
905020|NCT01106846|2986203|P2|Overall Study|Change in surgical procedure|1
905021|NCT01106846|2986204|P1|Overall Study|Change in surgical procedure|0
905022|NCT01106690|2986254|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
905023|NCT01106690|2986255|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
905024|NCT01106690|2986256|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
905025|NCT01106690|2986254|P3|Extension Period: Week 26 to Week 52|Not specified|4
905026|NCT01106690|2986255|P2|Extension Period: Week 26 to Week 52|Not specified|3
905027|NCT01106690|2986256|P1|Extension Period: Week 26 to Week 52|Not specified|8
905028|NCT01106690|2986254|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
905029|NCT01106690|2986255|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
905030|NCT01106690|2986256|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
905031|NCT01106690|2986254|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
905032|NCT01106690|2986255|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
905033|NCT01106690|2986256|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
905034|NCT01106690|2986254|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
905035|NCT01106690|2986255|P2|Extension Period: Week 26 to Week 52|Physician Decision|2
905036|NCT01106690|2986256|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
905037|NCT01106690|2986254|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
905038|NCT01106690|2986255|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
905039|NCT01106690|2986256|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
905040|NCT01106690|2986254|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
905041|NCT01106690|2986255|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
905042|NCT01106690|2986256|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
905043|NCT01106690|2986254|P3|Core Period: Baseline to Week 26|Not specified|6
905044|NCT01106690|2986255|P2|Core Period: Baseline to Week 26|Not specified|2
905045|NCT01106690|2986256|P1|Core Period: Baseline to Week 26|Not specified|10
905046|NCT01106690|2986254|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
905047|NCT01106690|2986255|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
905048|NCT01106690|2986256|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
905049|NCT01106690|2986254|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
905050|NCT01106690|2986255|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
905051|NCT01106690|2986256|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
905052|NCT01106690|2986254|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
905053|NCT01106690|2986255|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
905054|NCT01106690|2986256|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
905055|NCT01106690|2986254|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
905056|NCT01106690|2986255|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
905057|NCT01106690|2986256|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0
905058|NCT01106690|2986254|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|0
905059|NCT01106690|2986255|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|1
905060|NCT01106690|2986256|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
905061|NCT01106690|2986254|P3|Core Period: Baseline to Week 26|Protocol Violation|0
905062|NCT01106690|2986255|P2|Core Period: Baseline to Week 26|Protocol Violation|0
905063|NCT01106690|2986256|P1|Core Period: Baseline to Week 26|Protocol Violation|1
905064|NCT01106690|2986254|P3|Core Period: Baseline to Week 26|Lost to Follow-up|2
905065|NCT01106690|2986255|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
905066|NCT01106690|2986256|P1|Core Period: Baseline to Week 26|Lost to Follow-up|1
905067|NCT01106690|2986254|P3|Core Period: Baseline to Week 26|Adverse Event|4
905068|NCT01106690|2986255|P2|Core Period: Baseline to Week 26|Adverse Event|1
905069|NCT01106690|2986256|P1|Core Period: Baseline to Week 26|Adverse Event|6
905070|NCT01106677|2986292|P4|Extension Period: Week 26 to Week 52|Not specified|5
905071|NCT01106677|2986293|P3|Extension Period: Week 26 to Week 52|Not specified|8
905072|NCT01106677|2986294|P2|Extension Period: Week 26 to Week 52|Not specified|5
905073|NCT01106677|2986295|P1|Extension Period: Week 26 to Week 52|Not specified|6
905074|NCT01106677|2986292|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
905075|NCT01106677|2986293|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
905076|NCT01106677|2986294|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
905077|NCT01106677|2986295|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
905078|NCT01106677|2986292|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
905079|NCT01106677|2986293|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3
905080|NCT01106677|2986294|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
905081|NCT01106677|2986295|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
905082|NCT01106677|2986292|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
905083|NCT01106677|2986293|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
905084|NCT01106677|2986294|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3
905085|NCT01106677|2986295|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
905086|NCT01106677|2986292|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
905087|NCT01106677|2986293|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
905088|NCT01106677|2986294|P2|Extension Period: Week 26 to Week 52|Protocol Violation|0
905089|NCT01106677|2986295|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
905090|NCT01106677|2986292|P4|Extension Period: Week 26 to Week 52|Physician Decision|3
905091|NCT01106677|2986293|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
905092|NCT01106677|2986294|P2|Extension Period: Week 26 to Week 52|Physician Decision|3
905093|NCT01106677|2986295|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
905094|NCT01106677|2986292|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
905095|NCT01106677|2986293|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
905096|NCT01106677|2986294|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
905097|NCT01106677|2986295|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
905098|NCT01106677|2986292|P4|Extension Period: Week 26 to Week 52|Lack of Efficacy|4
905099|NCT01106677|2986293|P3|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
905100|NCT01106677|2986294|P2|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
905101|NCT01106677|2986295|P1|Extension Period: Week 26 to Week 52|Lack of Efficacy|2
905102|NCT01106677|2986292|P4|Extension Period: Week 26 to Week 52|Death|1
905103|NCT01106677|2986293|P3|Extension Period: Week 26 to Week 52|Death|0
905104|NCT01106677|2986294|P2|Extension Period: Week 26 to Week 52|Death|0
905105|NCT01106677|2986295|P1|Extension Period: Week 26 to Week 52|Death|0
905106|NCT01106677|2986292|P4|Extension Period: Week 26 to Week 52|Adverse Event|9
905107|NCT01106677|2986293|P3|Extension Period: Week 26 to Week 52|Adverse Event|5
905108|NCT01106677|2986294|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
905109|NCT01106677|2986295|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
905110|NCT01106677|2986292|P4|Core Period: Baseline to Week 26|Pregnancy|0
905111|NCT01106677|2986293|P3|Core Period: Baseline to Week 26|Pregnancy|0
905112|NCT01106677|2986294|P2|Core Period: Baseline to Week 26|Pregnancy|1
905113|NCT01106677|2986295|P1|Core Period: Baseline to Week 26|Pregnancy|0
905114|NCT01106677|2986292|P4|Core Period: Baseline to Week 26|Not specified|23
905115|NCT01106677|2986293|P3|Core Period: Baseline to Week 26|Not specified|8
905116|NCT01106677|2986294|P2|Core Period: Baseline to Week 26|Not specified|14
905117|NCT01106677|2986295|P1|Core Period: Baseline to Week 26|Not specified|8
905118|NCT01106677|2986292|P4|Core Period: Baseline to Week 26|Product quality complaint|0
905119|NCT01106677|2986293|P3|Core Period: Baseline to Week 26|Product quality complaint|1
905120|NCT01106677|2986294|P2|Core Period: Baseline to Week 26|Product quality complaint|1
905121|NCT01106677|2986295|P1|Core Period: Baseline to Week 26|Product quality complaint|0
905122|NCT01106677|2986292|P4|Core Period: Baseline to Week 26|Study terminated by sponsor|0
905123|NCT01106677|2986293|P3|Core Period: Baseline to Week 26|Study terminated by sponsor|2
905124|NCT01106677|2986294|P2|Core Period: Baseline to Week 26|Study terminated by sponsor|1
905125|NCT01106677|2986295|P1|Core Period: Baseline to Week 26|Study terminated by sponsor|0
905126|NCT01106677|2986292|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|0
905127|NCT01106677|2986293|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
905128|NCT01106677|2986294|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|3
905129|NCT01106677|2986295|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
905130|NCT01106677|2986292|P4|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
905131|NCT01106677|2986293|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
905132|NCT01106677|2986294|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
905133|NCT01106677|2986295|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
905134|NCT01106677|2986292|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|6
905135|NCT01106677|2986293|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|15
905136|NCT01106677|2986294|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
905137|NCT01106677|2986295|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|5
905138|NCT01106677|2986292|P4|Core Period: Baseline to Week 26|Protocol Violation|3
905139|NCT01106677|2986293|P3|Core Period: Baseline to Week 26|Protocol Violation|0
905140|NCT01106677|2986294|P2|Core Period: Baseline to Week 26|Protocol Violation|1
905141|NCT01106677|2986295|P1|Core Period: Baseline to Week 26|Protocol Violation|0
905142|NCT01106677|2986292|P4|Core Period: Baseline to Week 26|Physician Decision|1
905143|NCT01106677|2986293|P3|Core Period: Baseline to Week 26|Physician Decision|3
905144|NCT01106677|2986294|P2|Core Period: Baseline to Week 26|Physician Decision|1
905145|NCT01106677|2986295|P1|Core Period: Baseline to Week 26|Physician Decision|2
905146|NCT01106677|2986292|P4|Core Period: Baseline to Week 26|Lost to Follow-up|3
905147|NCT01106677|2986293|P3|Core Period: Baseline to Week 26|Lost to Follow-up|6
905148|NCT01106677|2986294|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
905149|NCT01106677|2986295|P1|Core Period: Baseline to Week 26|Lost to Follow-up|3
905150|NCT01106677|2986292|P4|Core Period: Baseline to Week 26|Lack of Efficacy|0
905151|NCT01106677|2986293|P3|Core Period: Baseline to Week 26|Lack of Efficacy|0
905152|NCT01106677|2986294|P2|Core Period: Baseline to Week 26|Lack of Efficacy|0
905153|NCT01106677|2986295|P1|Core Period: Baseline to Week 26|Lack of Efficacy|1
905154|NCT01106677|2986292|P4|Core Period: Baseline to Week 26|Death|0
905155|NCT01106677|2986293|P3|Core Period: Baseline to Week 26|Death|1
905156|NCT01106677|2986294|P2|Core Period: Baseline to Week 26|Death|0
905157|NCT01106677|2986295|P1|Core Period: Baseline to Week 26|Death|0
905158|NCT01106677|2986292|P4|Core Period: Baseline to Week 26|Adverse Event|8
905159|NCT01106677|2986293|P3|Core Period: Baseline to Week 26|Adverse Event|6
905160|NCT01106677|2986294|P2|Core Period: Baseline to Week 26|Adverse Event|18
905161|NCT01106677|2986295|P1|Core Period: Baseline to Week 26|Adverse Event|7
905162|NCT01106651|2986358|P3|Overall Study|Death|0
905163|NCT01106651|2986359|P2|Overall Study|Death|3
905164|NCT01106651|2986360|P1|Overall Study|Death|0
905165|NCT01106651|2986358|P3|Overall Study|Not specified|21
905166|NCT01106651|2986359|P2|Overall Study|Not specified|31
905167|NCT01106651|2986360|P1|Overall Study|Not specified|34
905168|NCT01106651|2986358|P3|Overall Study|Noncompliance with study drug|2
905169|NCT01106651|2986359|P2|Overall Study|Noncompliance with study drug|0
905170|NCT01106651|2986360|P1|Overall Study|Noncompliance with study drug|1
905171|NCT01106651|2986358|P3|Overall Study|Withdrawal by Subject|4
905172|NCT01106651|2986359|P2|Overall Study|Withdrawal by Subject|7
905173|NCT01106651|2986360|P1|Overall Study|Withdrawal by Subject|14
905174|NCT01106651|2986358|P3|Overall Study|Protocol Violation|1
905175|NCT01106651|2986359|P2|Overall Study|Protocol Violation|2
905176|NCT01106651|2986360|P1|Overall Study|Protocol Violation|1
905177|NCT01106651|2986358|P3|Overall Study|Physician Decision|1
905178|NCT01106651|2986359|P2|Overall Study|Physician Decision|3
905179|NCT01106651|2986360|P1|Overall Study|Physician Decision|4
905180|NCT01106651|2986358|P3|Overall Study|Lost to Follow-up|6
905181|NCT01106651|2986359|P2|Overall Study|Lost to Follow-up|2
905182|NCT01106651|2986360|P1|Overall Study|Lost to Follow-up|8
905183|NCT01106651|2986358|P3|Overall Study|Adverse Event|23
905184|NCT01106651|2986359|P2|Overall Study|Adverse Event|9
905185|NCT01106651|2986360|P1|Overall Study|Adverse Event|17
905186|NCT01106625|2986413|P3|Extension Period: Week 26 to Week 52|Not specified|4
905187|NCT01106625|2986414|P2|Extension Period: Week 26 to Week 52|Not specified|5
905188|NCT01106625|2986415|P1|Extension Period: Week 26 to Week 52|Not specified|5
905189|NCT01106625|2986413|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
905190|NCT01106625|2986414|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
905191|NCT01106625|2986415|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
905192|NCT01106625|2986413|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4
905193|NCT01106625|2986414|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5
905194|NCT01106625|2986415|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14
905195|NCT01106625|2986413|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
905196|NCT01106625|2986414|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
905197|NCT01106625|2986415|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4
905198|NCT01106625|2986413|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
905199|NCT01106625|2986414|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
905200|NCT01106625|2986415|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
905201|NCT01106625|2986413|P3|Extension Period: Week 26 to Week 52|Physician Decision|1
905202|NCT01106625|2986414|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
905203|NCT01106625|2986415|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
905204|NCT01106625|2986413|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
905205|NCT01106625|2986414|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|3
905206|NCT01106625|2986415|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
905207|NCT01106625|2986413|P3|Extension Period: Week 26 to Week 52|Adverse Event|3
905208|NCT01106625|2986414|P2|Extension Period: Week 26 to Week 52|Adverse Event|2
905209|NCT01106625|2986415|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
905210|NCT01106625|2986413|P3|Core Period: Baseline to Week 26|Not specified|4
905211|NCT01106625|2986414|P2|Core Period: Baseline to Week 26|Not specified|7
905212|NCT01106625|2986415|P1|Core Period: Baseline to Week 26|Not specified|8
905213|NCT01106625|2986413|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
905214|NCT01106625|2986414|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
905215|NCT01106625|2986415|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
905216|NCT01106625|2986413|P3|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
905217|NCT01106625|2986414|P2|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
905218|NCT01106625|2986415|P1|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0
905219|NCT01106625|2986413|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
905220|NCT01106625|2986414|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
905221|NCT01106625|2986415|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|4
905222|NCT01106625|2986413|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|7
905223|NCT01106625|2986414|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|9
905224|NCT01106625|2986415|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|6
905225|NCT01106625|2986413|P3|Core Period: Baseline to Week 26|Protocol Violation|3
905226|NCT01106625|2986414|P2|Core Period: Baseline to Week 26|Protocol Violation|1
905227|NCT01106625|2986415|P1|Core Period: Baseline to Week 26|Protocol Violation|2
905228|NCT01106625|2986413|P3|Core Period: Baseline to Week 26|Physician Decision|0
905229|NCT01106625|2986414|P2|Core Period: Baseline to Week 26|Physician Decision|0
905230|NCT01106625|2986415|P1|Core Period: Baseline to Week 26|Physician Decision|1
905231|NCT01106625|2986413|P3|Core Period: Baseline to Week 26|Lost to Follow-up|4
905232|NCT01106625|2986414|P2|Core Period: Baseline to Week 26|Lost to Follow-up|0
905233|NCT01106625|2986415|P1|Core Period: Baseline to Week 26|Lost to Follow-up|5
905234|NCT01106625|2986413|P3|Core Period: Baseline to Week 26|Adverse Event|8
905235|NCT01106625|2986414|P2|Core Period: Baseline to Week 26|Adverse Event|8
905236|NCT01106625|2986415|P1|Core Period: Baseline to Week 26|Adverse Event|6
905237|NCT01106586|2986446|P2|Overall Study|Participant Transferred to Another Study|197
905238|NCT01106586|2986447|P1|Overall Study|Participant Transferred to Another Study|212
905239|NCT01106586|2986446|P2|Overall Study|Protocol Violation|0
905240|NCT01106586|2986447|P1|Overall Study|Protocol Violation|1
905241|NCT01106586|2986446|P2|Overall Study|Participant Noncompliance|10
905242|NCT01106586|2986447|P1|Overall Study|Participant Noncompliance|12
905243|NCT01106586|2986446|P2|Overall Study|Lost to Follow-up|20
905244|NCT01106586|2986447|P1|Overall Study|Lost to Follow-up|24
905245|NCT01106586|2986446|P2|Overall Study|Withdrew Consent|30
905246|NCT01106586|2986447|P1|Overall Study|Withdrew Consent|18
905247|NCT01106586|2986446|P2|Overall Study|Investigator's Discretion|8
905248|NCT01106586|2986447|P1|Overall Study|Investigator's Discretion|5
905249|NCT01106586|2986446|P2|Overall Study|Lack of Efficacy|0
905250|NCT01106586|2986447|P1|Overall Study|Lack of Efficacy|1
905251|NCT01106586|2986446|P2|Overall Study|Pregnancy|2
905252|NCT01106586|2986447|P1|Overall Study|Pregnancy|2
905253|NCT01106586|2986446|P2|Overall Study|Death|3
905254|NCT01106586|2986447|P1|Overall Study|Death|1
905255|NCT01106586|2986446|P2|Overall Study|Adverse Event|15
905256|NCT01106586|2986447|P1|Overall Study|Adverse Event|9
905257|NCT01106534|2986465|P1|Overall Study|Physician Decision|1
905258|NCT01106534|2986465|P1|Overall Study|Death|16
905259|NCT01106534|2986465|P1|Overall Study|Lost to Follow-up|2
905260|NCT01106534|2986465|P1|Overall Study|Withdrawal by Subject|18
905261|NCT01106430|2986497|P2|Overall Study|Withdrawal by Subject|4
905262|NCT01106430|2986498|P1|Overall Study|Withdrawal by Subject|8
905263|NCT01106430|2986497|P2|Overall Study|Protocol Violation|2
905264|NCT01106430|2986498|P1|Overall Study|Protocol Violation|7
905265|NCT01106430|2986497|P2|Overall Study|Previous Use Of Marijuana|0
905266|NCT01106430|2986498|P1|Overall Study|Previous Use Of Marijuana|1
905267|NCT01106430|2986497|P2|Overall Study|Hard Time Swallowing The Pills|0
905268|NCT01106430|2986498|P1|Overall Study|Hard Time Swallowing The Pills|1
905269|NCT01106430|2986497|P2|Overall Study|Noncompliance|1
905270|NCT01106430|2986498|P1|Overall Study|Noncompliance|0
905271|NCT01106430|2986497|P2|Overall Study|Refused To Take Medication|1
905272|NCT01106430|2986498|P1|Overall Study|Refused To Take Medication|0
905273|NCT01106430|2986497|P2|Overall Study|Moved Out Of State|1
905274|NCT01106430|2986498|P1|Overall Study|Moved Out Of State|0
905275|NCT01106430|2986497|P2|Overall Study|Early Termination Requested By Sponsor|0
905276|NCT01106430|2986498|P1|Overall Study|Early Termination Requested By Sponsor|1
905277|NCT01106430|2986497|P2|Overall Study|Lost to Follow-up|1
905278|NCT01106430|2986498|P1|Overall Study|Lost to Follow-up|5
905279|NCT01106430|2986497|P2|Overall Study|Lack of Efficacy|13
905280|NCT01106430|2986498|P1|Overall Study|Lack of Efficacy|2
905281|NCT01106430|2986497|P2|Overall Study|Adverse Event|10
905282|NCT01106430|2986498|P1|Overall Study|Adverse Event|8
905283|NCT01106404|2986520|P2|Period I (First 6 Weeks)|Lack of Efficacy|1
905284|NCT01106404|2986521|P1|Period I (First 6 Weeks)|Lack of Efficacy|0
905285|NCT01106404|2986520|P2|Period I (First 6 Weeks)|Lost to Follow-up|1
905286|NCT01106404|2986521|P1|Period I (First 6 Weeks)|Lost to Follow-up|0
905287|NCT01106404|2986520|P2|Period I (First 6 Weeks)|Physician Decision|0
905288|NCT01106404|2986521|P1|Period I (First 6 Weeks)|Physician Decision|1
905289|NCT01106404|2986520|P2|Period I (First 6 Weeks)|Adverse Event|0
905290|NCT01106404|2986521|P1|Period I (First 6 Weeks)|Adverse Event|2
905291|NCT01106352|2986544|P5|Overall Study|Home hospice since July 2013|0
905292|NCT01106352|2986545|P4|Overall Study|Home hospice since July 2013|1
905293|NCT01106352|2986546|P3|Overall Study|Home hospice since July 2013|0
905294|NCT01106352|2986547|P2|Overall Study|Home hospice since July 2013|0
905295|NCT01106352|2986548|P1|Overall Study|Home hospice since July 2013|0
905296|NCT01106352|2986544|P5|Overall Study|Subject entered hospice|0
905297|NCT01106352|2986545|P4|Overall Study|Subject entered hospice|1
905298|NCT01106352|2986546|P3|Overall Study|Subject entered hospice|0
905299|NCT01106352|2986547|P2|Overall Study|Subject entered hospice|0
905300|NCT01106352|2986548|P1|Overall Study|Subject entered hospice|0
905301|NCT01106352|2986544|P5|Overall Study|Went on hospice|0
905302|NCT01106352|2986545|P4|Overall Study|Went on hospice|1
905303|NCT01106352|2986546|P3|Overall Study|Went on hospice|0
905304|NCT01106352|2986547|P2|Overall Study|Went on hospice|0
905305|NCT01106352|2986548|P1|Overall Study|Went on hospice|0
905306|NCT01106352|2986544|P5|Overall Study|Withdrawal by Subject|2
905307|NCT01106352|2986545|P4|Overall Study|Withdrawal by Subject|3
905308|NCT01106352|2986546|P3|Overall Study|Withdrawal by Subject|0
905309|NCT01106352|2986547|P2|Overall Study|Withdrawal by Subject|0
905310|NCT01106352|2986548|P1|Overall Study|Withdrawal by Subject|0
905311|NCT01106352|2986544|P5|Overall Study|Disease progression|0
905312|NCT01106352|2986545|P4|Overall Study|Disease progression|1
905313|NCT01106352|2986546|P3|Overall Study|Disease progression|0
905314|NCT01106352|2986547|P2|Overall Study|Disease progression|0
905315|NCT01106352|2986548|P1|Overall Study|Disease progression|0
905316|NCT01106352|2986544|P5|Overall Study|Death|1
905317|NCT01106352|2986545|P4|Overall Study|Death|3
905318|NCT01106352|2986546|P3|Overall Study|Death|1
905319|NCT01106352|2986547|P2|Overall Study|Death|0
905320|NCT01106352|2986548|P1|Overall Study|Death|0
905321|NCT01106352|2986544|P5|Overall Study|Lost to Follow-up|1
905322|NCT01106352|2986545|P4|Overall Study|Lost to Follow-up|0
905323|NCT01106352|2986546|P3|Overall Study|Lost to Follow-up|0
905324|NCT01106352|2986547|P2|Overall Study|Lost to Follow-up|0
905325|NCT01106352|2986548|P1|Overall Study|Lost to Follow-up|0
905326|NCT01106352|2986544|P5|Overall Study|Too ill to come in for the visit|0
905327|NCT01106352|2986545|P4|Overall Study|Too ill to come in for the visit|0
905328|NCT01106352|2986546|P3|Overall Study|Too ill to come in for the visit|1
905329|NCT01106352|2986547|P2|Overall Study|Too ill to come in for the visit|0
905330|NCT01106352|2986548|P1|Overall Study|Too ill to come in for the visit|0
905331|NCT01106352|2986544|P5|Overall Study|Sponsor Decision|0
905332|NCT01106352|2986545|P4|Overall Study|Sponsor Decision|0
905333|NCT01106352|2986546|P3|Overall Study|Sponsor Decision|0
905334|NCT01106352|2986547|P2|Overall Study|Sponsor Decision|0
905335|NCT01106352|2986548|P1|Overall Study|Sponsor Decision|1
905336|NCT01106352|2986544|P5|Overall Study|Subjects untreated|4
905337|NCT01106352|2986545|P4|Overall Study|Subjects untreated|3
905338|NCT01106352|2986546|P3|Overall Study|Subjects untreated|0
905339|NCT01106352|2986547|P2|Overall Study|Subjects untreated|0
905340|NCT01106352|2986548|P1|Overall Study|Subjects untreated|0
905341|NCT01106287|2986644|P4|Overall Study|Adverse Event|0
905342|NCT01106287|2986645|P3|Overall Study|Adverse Event|0
905343|NCT01106287|2986646|P2|Overall Study|Adverse Event|0
905344|NCT01106287|2986647|P1|Overall Study|Adverse Event|1
905345|NCT01106248|2986667|P1|Overall Study|Administrative|2
905346|NCT01106248|2986667|P1|Overall Study|Adverse Event|1
905347|NCT01106157|2986675|P2|Overall Study|Withdrawal by Subject|0
905348|NCT01106157|2986676|P1|Overall Study|Withdrawal by Subject|1
905349|NCT01106092|2986704|P4|Overall Study|Withdrawal by Subject|1
905350|NCT01106092|2986705|P3|Overall Study|Withdrawal by Subject|0
905351|NCT01106092|2986706|P2|Overall Study|Withdrawal by Subject|0
905352|NCT01106092|2986707|P1|Overall Study|Withdrawal by Subject|0
905353|NCT01106027|2986790|P1|Overall Study|Lost graft early, discontinued|1
905354|NCT01106014|2986796|P2|Overall Study|Lost to Follow-up|3
905355|NCT01106014|2986797|P1|Overall Study|Lost to Follow-up|2
905356|NCT01106014|2986796|P2|Overall Study|Administrative reason|6
905357|NCT01106014|2986797|P1|Overall Study|Administrative reason|7
905358|NCT01106014|2986796|P2|Overall Study|Withdrawal by Subject|37
905359|NCT01106014|2986797|P1|Overall Study|Withdrawal by Subject|43
905360|NCT01106014|2986796|P2|Overall Study|Adverse Event|42
905361|NCT01106014|2986797|P1|Overall Study|Adverse Event|78
905362|NCT01106014|2986796|P2|Overall Study|Morbidity or Mortality primary endpoint|242
905363|NCT01106014|2986797|P1|Overall Study|Morbidity or Mortality primary endpoint|155
905364|NCT01105975|2986817|P10|Overall Study|Abnormal Lab/Electrocardiogram Result|0
905365|NCT01105975|2986818|P9|Overall Study|Abnormal Lab/Electrocardiogram Result|2
905366|NCT01105975|2986819|P8|Overall Study|Abnormal Lab/Electrocardiogram Result|1
905367|NCT01105975|2986820|P7|Overall Study|Abnormal Lab/Electrocardiogram Result|1
905368|NCT01105975|2986821|P6|Overall Study|Abnormal Lab/Electrocardiogram Result|2
905369|NCT01105975|2986822|P5|Overall Study|Abnormal Lab/Electrocardiogram Result|0
905370|NCT01105975|2986823|P4|Overall Study|Abnormal Lab/Electrocardiogram Result|0
905371|NCT01105975|2986824|P3|Overall Study|Abnormal Lab/Electrocardiogram Result|1
905372|NCT01105975|2986825|P2|Overall Study|Abnormal Lab/Electrocardiogram Result|0
905373|NCT01105975|2986826|P1|Overall Study|Abnormal Lab/Electrocardiogram Result|0
905374|NCT01105975|2986817|P10|Overall Study|Protocol Violation|2
905375|NCT01105975|2986818|P9|Overall Study|Protocol Violation|2
905376|NCT01105975|2986819|P8|Overall Study|Protocol Violation|1
905377|NCT01105975|2986820|P7|Overall Study|Protocol Violation|1
905378|NCT01105975|2986821|P6|Overall Study|Protocol Violation|1
905379|NCT01105975|2986822|P5|Overall Study|Protocol Violation|1
905380|NCT01105975|2986823|P4|Overall Study|Protocol Violation|0
905381|NCT01105975|2986824|P3|Overall Study|Protocol Violation|2
905382|NCT01105975|2986825|P2|Overall Study|Protocol Violation|2
905383|NCT01105975|2986826|P1|Overall Study|Protocol Violation|0
905384|NCT01105975|2986817|P10|Overall Study|Physician Decision|0
905385|NCT01105975|2986818|P9|Overall Study|Physician Decision|0
905386|NCT01105975|2986819|P8|Overall Study|Physician Decision|0
905387|NCT01105975|2986820|P7|Overall Study|Physician Decision|2
905388|NCT01105975|2986821|P6|Overall Study|Physician Decision|0
905389|NCT01105975|2986822|P5|Overall Study|Physician Decision|0
905390|NCT01105975|2986823|P4|Overall Study|Physician Decision|0
905391|NCT01105975|2986824|P3|Overall Study|Physician Decision|0
905392|NCT01105975|2986825|P2|Overall Study|Physician Decision|0
905393|NCT01105975|2986826|P1|Overall Study|Physician Decision|0
905394|NCT01105975|2986817|P10|Overall Study|Lost to Follow-up|0
905395|NCT01105975|2986818|P9|Overall Study|Lost to Follow-up|1
905396|NCT01105975|2986819|P8|Overall Study|Lost to Follow-up|0
905397|NCT01105975|2986820|P7|Overall Study|Lost to Follow-up|0
905398|NCT01105975|2986821|P6|Overall Study|Lost to Follow-up|0
905399|NCT01105975|2986822|P5|Overall Study|Lost to Follow-up|1
905400|NCT01105975|2986823|P4|Overall Study|Lost to Follow-up|1
905401|NCT01105975|2986824|P3|Overall Study|Lost to Follow-up|0
905402|NCT01105975|2986825|P2|Overall Study|Lost to Follow-up|0
905403|NCT01105975|2986826|P1|Overall Study|Lost to Follow-up|1
905404|NCT01105975|2986817|P10|Overall Study|Withdrawal by Subject|3
905405|NCT01105975|2986818|P9|Overall Study|Withdrawal by Subject|0
905406|NCT01105975|2986819|P8|Overall Study|Withdrawal by Subject|1
905407|NCT01105975|2986820|P7|Overall Study|Withdrawal by Subject|2
905408|NCT01105975|2986821|P6|Overall Study|Withdrawal by Subject|1
905409|NCT01105975|2986822|P5|Overall Study|Withdrawal by Subject|4
905410|NCT01105975|2986823|P4|Overall Study|Withdrawal by Subject|0
905411|NCT01105975|2986824|P3|Overall Study|Withdrawal by Subject|2
905412|NCT01105975|2986825|P2|Overall Study|Withdrawal by Subject|2
905413|NCT01105975|2986826|P1|Overall Study|Withdrawal by Subject|2
905414|NCT01105975|2986817|P10|Overall Study|Adverse Event|4
905415|NCT01105975|2986818|P9|Overall Study|Adverse Event|1
905416|NCT01105975|2986819|P8|Overall Study|Adverse Event|4
905417|NCT01105975|2986820|P7|Overall Study|Adverse Event|2
905418|NCT01105975|2986821|P6|Overall Study|Adverse Event|1
905419|NCT01105975|2986822|P5|Overall Study|Adverse Event|0
905420|NCT01105975|2986823|P4|Overall Study|Adverse Event|1
905421|NCT01105975|2986824|P3|Overall Study|Adverse Event|5
905422|NCT01105975|2986825|P2|Overall Study|Adverse Event|1
905423|NCT01105975|2986826|P1|Overall Study|Adverse Event|2
905424|NCT01105936|2986974|P4|Period 3|Protocol Violation|0
905425|NCT01105936|2986975|P3|Period 3|Protocol Violation|0
905426|NCT01105936|2986976|P2|Period 3|Protocol Violation|2
905427|NCT01105936|2986977|P1|Period 3|Protocol Violation|0
905428|NCT01105936|2986974|P4|Period 2|Adverse Event|0
905429|NCT01105936|2986975|P3|Period 2|Adverse Event|0
905430|NCT01105936|2986976|P2|Period 2|Adverse Event|0
905431|NCT01105936|2986977|P1|Period 2|Adverse Event|1
905432|NCT01105936|2986974|P4|Period 1|Adverse Event|1
905433|NCT01105936|2986975|P3|Period 1|Adverse Event|0
905434|NCT01105936|2986976|P2|Period 1|Adverse Event|0
905435|NCT01105936|2986977|P1|Period 1|Adverse Event|0
905436|NCT01105767|2987006|P3|Overall Study|Lost to Follow-up|1184
905437|NCT01105767|2987007|P2|Overall Study|Lost to Follow-up|1614
905438|NCT01105767|2987008|P1|Overall Study|Lost to Follow-up|1160
905439|NCT01105533|2987060|P9|Overall Study|Physician Decision|0
905440|NCT01105533|2987061|P8|Overall Study|Physician Decision|1
905441|NCT01105533|2987062|P7|Overall Study|Physician Decision|0
905442|NCT01105533|2987063|P6|Overall Study|Physician Decision|0
905443|NCT01105533|2987064|P5|Overall Study|Physician Decision|0
905444|NCT01105533|2987065|P4|Overall Study|Physician Decision|0
905445|NCT01105533|2987066|P3|Overall Study|Physician Decision|0
905446|NCT01105533|2987067|P2|Overall Study|Physician Decision|0
905447|NCT01105533|2987068|P1|Overall Study|Physician Decision|0
905448|NCT01105533|2987060|P9|Overall Study|Other|2
905449|NCT01105533|2987061|P8|Overall Study|Other|1
905450|NCT01105533|2987062|P7|Overall Study|Other|3
905451|NCT01105533|2987063|P6|Overall Study|Other|0
905452|NCT01105533|2987064|P5|Overall Study|Other|1
905453|NCT01105533|2987065|P4|Overall Study|Other|0
905454|NCT01105533|2987066|P3|Overall Study|Other|0
905455|NCT01105533|2987067|P2|Overall Study|Other|0
905456|NCT01105533|2987068|P1|Overall Study|Other|0
905457|NCT01105533|2987060|P9|Overall Study|Adverse Event|1
905458|NCT01105533|2987061|P8|Overall Study|Adverse Event|0
905459|NCT01105533|2987062|P7|Overall Study|Adverse Event|2
905460|NCT01105533|2987063|P6|Overall Study|Adverse Event|2
905461|NCT01105533|2987064|P5|Overall Study|Adverse Event|1
905462|NCT01105533|2987065|P4|Overall Study|Adverse Event|0
905463|NCT01105533|2987066|P3|Overall Study|Adverse Event|0
905464|NCT01105533|2987067|P2|Overall Study|Adverse Event|0
905465|NCT01105533|2987068|P1|Overall Study|Adverse Event|0
905466|NCT01105533|2987060|P9|Overall Study|Lack of Efficacy|9
905467|NCT01105533|2987061|P8|Overall Study|Lack of Efficacy|2
905468|NCT01105533|2987062|P7|Overall Study|Lack of Efficacy|3
905469|NCT01105533|2987063|P6|Overall Study|Lack of Efficacy|5
905470|NCT01105533|2987064|P5|Overall Study|Lack of Efficacy|4
905471|NCT01105533|2987065|P4|Overall Study|Lack of Efficacy|3
905472|NCT01105533|2987066|P3|Overall Study|Lack of Efficacy|3
905473|NCT01105533|2987067|P2|Overall Study|Lack of Efficacy|1
905474|NCT01105533|2987068|P1|Overall Study|Lack of Efficacy|1
905475|NCT01105533|2987060|P9|Overall Study|Death|0
905476|NCT01105533|2987061|P8|Overall Study|Death|0
905477|NCT01105533|2987062|P7|Overall Study|Death|0
905478|NCT01105533|2987063|P6|Overall Study|Death|0
905479|NCT01105533|2987064|P5|Overall Study|Death|1
905480|NCT01105533|2987065|P4|Overall Study|Death|0
905481|NCT01105533|2987066|P3|Overall Study|Death|0
905482|NCT01105533|2987067|P2|Overall Study|Death|0
905483|NCT01105533|2987068|P1|Overall Study|Death|0
905484|NCT01105377|2987158|P2|Overall Study|Withdrawal by Subject|1
905485|NCT01105377|2987159|P1|Overall Study|Withdrawal by Subject|0
905486|NCT01105130|2987207|P3|Overall Study|Multiple Reasons|2
905487|NCT01105130|2987208|P2|Overall Study|Multiple Reasons|0
905488|NCT01105130|2987209|P1|Overall Study|Multiple Reasons|3
905489|NCT01105130|2987207|P3|Overall Study|Toxicity|2
905490|NCT01105130|2987208|P2|Overall Study|Toxicity|3
905491|NCT01105130|2987209|P1|Overall Study|Toxicity|1
905492|NCT01105130|2987207|P3|Overall Study|Never Started|4
905493|NCT01105130|2987208|P2|Overall Study|Never Started|2
905494|NCT01105130|2987209|P1|Overall Study|Never Started|2
905495|NCT01105130|2987207|P3|Overall Study|Withdrawal by Subject|2
905496|NCT01105130|2987208|P2|Overall Study|Withdrawal by Subject|6
905497|NCT01105130|2987209|P1|Overall Study|Withdrawal by Subject|4
905498|NCT01105091|2987239|P2|Overall Study|Death|0
905499|NCT01105091|2987240|P1|Overall Study|Death|2
905500|NCT01105065|2987264|P1|Overall Study|Technical Problems|1
905501|NCT01105065|2987264|P1|Overall Study|Adverse Event|5
905502|NCT01104870|2987273|P3|Overall Study|Withdrawal by Subject|1
905503|NCT01104870|2987274|P2|Overall Study|Withdrawal by Subject|0
905504|NCT01104870|2987275|P1|Overall Study|Withdrawal by Subject|0
905505|NCT01104870|2987273|P3|Overall Study|Death|1
905506|NCT01104870|2987274|P2|Overall Study|Death|0
905507|NCT01104870|2987275|P1|Overall Study|Death|0
905508|NCT01104870|2987273|P3|Overall Study|Adverse Event|0
905509|NCT01104870|2987274|P2|Overall Study|Adverse Event|1
905510|NCT01104870|2987275|P1|Overall Study|Adverse Event|1
905511|NCT01104779|2987307|P3|Overall Study|Withdrawal by Subject|32
905512|NCT01104779|2987308|P2|Overall Study|Withdrawal by Subject|25
905513|NCT01104779|2987309|P1|Overall Study|Withdrawal by Subject|16
905514|NCT01104779|2987307|P3|Overall Study|Lost to Follow-up|1
905515|NCT01104779|2987308|P2|Overall Study|Lost to Follow-up|0
905516|NCT01104779|2987309|P1|Overall Study|Lost to Follow-up|2
905517|NCT01104779|2987307|P3|Overall Study|Other reasons|0
905518|NCT01104779|2987308|P2|Overall Study|Other reasons|1
905519|NCT01104779|2987309|P1|Overall Study|Other reasons|0
905520|NCT01104779|2987307|P3|Overall Study|Did not meet inc/exc criteria|1
905521|NCT01104779|2987308|P2|Overall Study|Did not meet inc/exc criteria|1
905522|NCT01104779|2987309|P1|Overall Study|Did not meet inc/exc criteria|1
905523|NCT01104779|2987307|P3|Overall Study|Adverse Event|13
905524|NCT01104779|2987308|P2|Overall Study|Adverse Event|14
905525|NCT01104779|2987309|P1|Overall Study|Adverse Event|13
905526|NCT01104779|2987307|P3|Overall Study|Lack of Efficacy|13
905527|NCT01104779|2987308|P2|Overall Study|Lack of Efficacy|12
905528|NCT01104779|2987309|P1|Overall Study|Lack of Efficacy|26
905529|NCT01104779|2987307|P3|Overall Study|Protocol Violation|2
905530|NCT01104779|2987308|P2|Overall Study|Protocol Violation|2
905531|NCT01104779|2987309|P1|Overall Study|Protocol Violation|1
905532|NCT01104766|2987324|P4|Overall Study|Lost to Follow-up|1
905533|NCT01104766|2987325|P3|Overall Study|Lost to Follow-up|1
905534|NCT01104766|2987326|P2|Overall Study|Lost to Follow-up|2
905535|NCT01104766|2987327|P1|Overall Study|Lost to Follow-up|1
905536|NCT01104766|2987324|P4|Overall Study|Withdrawal by Subject|15
905537|NCT01104766|2987325|P3|Overall Study|Withdrawal by Subject|25
905538|NCT01104766|2987326|P2|Overall Study|Withdrawal by Subject|19
905539|NCT01104766|2987327|P1|Overall Study|Withdrawal by Subject|17
905540|NCT01104766|2987324|P4|Overall Study|Protocol Violation|0
905541|NCT01104766|2987325|P3|Overall Study|Protocol Violation|0
905542|NCT01104766|2987326|P2|Overall Study|Protocol Violation|0
905543|NCT01104766|2987327|P1|Overall Study|Protocol Violation|2
905544|NCT01104766|2987324|P4|Overall Study|Lack of Efficacy|8
905545|NCT01104766|2987325|P3|Overall Study|Lack of Efficacy|14
905546|NCT01104766|2987326|P2|Overall Study|Lack of Efficacy|15
905547|NCT01104766|2987327|P1|Overall Study|Lack of Efficacy|20
905548|NCT01104766|2987324|P4|Overall Study|Adverse Event|14
905549|NCT01104766|2987325|P3|Overall Study|Adverse Event|20
905550|NCT01104766|2987326|P2|Overall Study|Adverse Event|15
905551|NCT01104766|2987327|P1|Overall Study|Adverse Event|17
905552|NCT01104766|2987324|P4|Overall Study|Did not meet inc/exc criteria|0
905553|NCT01104766|2987325|P3|Overall Study|Did not meet inc/exc criteria|0
905554|NCT01104766|2987326|P2|Overall Study|Did not meet inc/exc criteria|0
905555|NCT01104766|2987327|P1|Overall Study|Did not meet inc/exc criteria|1
905556|NCT01104701|2987345|P4|Overall Study|Physician Decision|0
905557|NCT01104701|2987346|P3|Overall Study|Physician Decision|0
905558|NCT01104701|2987347|P2|Overall Study|Physician Decision|2
905559|NCT01104701|2987348|P1|Overall Study|Physician Decision|0
905560|NCT01104701|2987345|P4|Overall Study|Adverse Event|1
905561|NCT01104701|2987346|P3|Overall Study|Adverse Event|0
905562|NCT01104701|2987347|P2|Overall Study|Adverse Event|0
905563|NCT01104701|2987348|P1|Overall Study|Adverse Event|0
905564|NCT01104701|2987345|P4|Overall Study|Withdrawal by Subject|1
905565|NCT01104701|2987346|P3|Overall Study|Withdrawal by Subject|2
905566|NCT01104701|2987347|P2|Overall Study|Withdrawal by Subject|1
905567|NCT01104701|2987348|P1|Overall Study|Withdrawal by Subject|0
905568|NCT01104662|2987410|P8|Overall Study|Randomized but not treated|0
905569|NCT01104662|2987411|P7|Overall Study|Randomized but not treated|0
905570|NCT01104662|2987412|P6|Overall Study|Randomized but not treated|1
905571|NCT01104662|2987413|P5|Overall Study|Randomized but not treated|0
905572|NCT01104662|2987414|P4|Overall Study|Randomized but not treated|0
905573|NCT01104662|2987415|P3|Overall Study|Randomized but not treated|1
905574|NCT01104662|2987416|P2|Overall Study|Randomized but not treated|4
905575|NCT01104662|2987417|P1|Overall Study|Randomized but not treated|3
905576|NCT01104662|2987410|P8|Overall Study|Reason not specified|0
905577|NCT01104662|2987411|P7|Overall Study|Reason not specified|0
905578|NCT01104662|2987412|P6|Overall Study|Reason not specified|1
905579|NCT01104662|2987413|P5|Overall Study|Reason not specified|0
905580|NCT01104662|2987414|P4|Overall Study|Reason not specified|0
905581|NCT01104662|2987415|P3|Overall Study|Reason not specified|0
905582|NCT01104662|2987416|P2|Overall Study|Reason not specified|3
905583|NCT01104662|2987417|P1|Overall Study|Reason not specified|3
905584|NCT01104662|2987410|P8|Overall Study|Participant left investigator’s care|0
905585|NCT01104662|2987411|P7|Overall Study|Participant left investigator’s care|0
905586|NCT01104662|2987412|P6|Overall Study|Participant left investigator’s care|0
905587|NCT01104662|2987413|P5|Overall Study|Participant left investigator’s care|0
905588|NCT01104662|2987414|P4|Overall Study|Participant left investigator’s care|0
905589|NCT01104662|2987415|P3|Overall Study|Participant left investigator’s care|0
905590|NCT01104662|2987416|P2|Overall Study|Participant left investigator’s care|1
905591|NCT01104662|2987417|P1|Overall Study|Participant left investigator’s care|1
905592|NCT01104662|2987410|P8|Overall Study|Clinical Failure|0
905593|NCT01104662|2987411|P7|Overall Study|Clinical Failure|0
905594|NCT01104662|2987412|P6|Overall Study|Clinical Failure|1
905595|NCT01104662|2987413|P5|Overall Study|Clinical Failure|0
905596|NCT01104662|2987414|P4|Overall Study|Clinical Failure|0
905597|NCT01104662|2987415|P3|Overall Study|Clinical Failure|0
905598|NCT01104662|2987416|P2|Overall Study|Clinical Failure|0
905599|NCT01104662|2987417|P1|Overall Study|Clinical Failure|1
905600|NCT01104662|2987410|P8|Overall Study|Adverse Event|0
905601|NCT01104662|2987411|P7|Overall Study|Adverse Event|0
905602|NCT01104662|2987412|P6|Overall Study|Adverse Event|1
905603|NCT01104662|2987413|P5|Overall Study|Adverse Event|1
905604|NCT01104662|2987414|P4|Overall Study|Adverse Event|1
905605|NCT01104662|2987415|P3|Overall Study|Adverse Event|0
905606|NCT01104662|2987416|P2|Overall Study|Adverse Event|2
905607|NCT01104662|2987417|P1|Overall Study|Adverse Event|2
905608|NCT01104636|2987443|P1|Overall Study|Ongoing|21
905609|NCT01104636|2987443|P1|Overall Study|Adverse Event|40
905610|NCT01104636|2987443|P1|Overall Study|Pregnancy|2
905611|NCT01104636|2987443|P1|Overall Study|Study terminated by sponsor|1
905612|NCT01104636|2987443|P1|Overall Study|Other|43
905613|NCT01104636|2987443|P1|Overall Study|Withdrawal by Subject|4
905614|NCT01104636|2987443|P1|Overall Study|Lost to Follow-up|24
905615|NCT01104636|2987443|P1|Overall Study|Lack of Efficacy|43
905616|NCT01104584|2987448|P1|Overall Study|Study prematurely discontinued|2
905617|NCT01104584|2987448|P1|Overall Study|Study drug never administered|21
905618|NCT01104558|2987518|P1|Overall Study|Missing of genetic analysis results|1
905619|NCT01104558|2987518|P1|Overall Study|Missing of primary efficacy assessment|10
905620|NCT01104558|2987518|P1|Overall Study|Protocol Violation|6
905621|NCT01104493|2987561|P2|Overall Study|Lost to Follow-up|2
905622|NCT01104493|2987562|P1|Overall Study|Lost to Follow-up|0
905623|NCT01104415|2987580|P1|Overall Study|Withdrawal by Subject|1
905624|NCT01104376|2987623|P1|Overall Study|Consented but excluded after labs|13
905625|NCT01104376|2987623|P1|Overall Study|Withdrawal by Subject|15
905626|NCT01104311|2987629|P2|Overall Study|Adverse Event|2
905627|NCT01104311|2987630|P1|Overall Study|Adverse Event|1
905628|NCT01104311|2987629|P2|Overall Study|low compliance|1
905629|NCT01104311|2987630|P1|Overall Study|low compliance|1
905630|NCT01104311|2987629|P2|Overall Study|Physician Decision|2
905631|NCT01104311|2987630|P1|Overall Study|Physician Decision|2
905632|NCT01104311|2987629|P2|Overall Study|Protocol Violation|1
905633|NCT01104311|2987630|P1|Overall Study|Protocol Violation|0
905634|NCT01104311|2987629|P2|Overall Study|Withdrawal by Subject|6
905635|NCT01104311|2987630|P1|Overall Study|Withdrawal by Subject|6
905636|NCT01104246|2987657|P1|Overall Study|did not meet inclusion criteria|4
905637|NCT01104246|2987657|P1|Overall Study|Withdrawal by Subject|1
905638|NCT01104155|2987672|P2|Overall Study|Not specified|4
905639|NCT01104155|2987673|P1|Overall Study|Not specified|3
905640|NCT01104155|2987672|P2|Overall Study|Withdrawal of consent|1
905641|NCT01104155|2987673|P1|Overall Study|Withdrawal of consent|1
905642|NCT01104155|2987672|P2|Overall Study|Participant choice|5
905643|NCT01104155|2987673|P1|Overall Study|Participant choice|6
905644|NCT01104155|2987672|P2|Overall Study|Adverse Event|8
905645|NCT01104155|2987673|P1|Overall Study|Adverse Event|15
905646|NCT01103960|2987716|P2|Overall Study|Other|0
905647|NCT01103960|2987717|P1|Overall Study|Other|1
905648|NCT01103960|2987716|P2|Overall Study|Withdrawal by Subject|1
905649|NCT01103960|2987717|P1|Overall Study|Withdrawal by Subject|2
905650|NCT01103960|2987716|P2|Overall Study|Adverse Event|1
905651|NCT01103960|2987717|P1|Overall Study|Adverse Event|2
905652|NCT01103778|2987752|P1|Overall Study|Screen failure|1
905653|NCT01103778|2987752|P1|Overall Study|Proteinuria improved prior to enrollment|1
905654|NCT01103778|2987752|P1|Overall Study|Lost to Follow-up|1
905655|NCT01103713|2987759|P1|Overall Study|Not specified|1
905656|NCT01103713|2987759|P1|Overall Study|Study terminated by sponsor|2
905657|NCT01103713|2987759|P1|Overall Study|Withdrawal by Subject|8
905658|NCT01103713|2987759|P1|Overall Study|Lost to Follow-up|2
905659|NCT01103479|2987792|P3|Overall Study|Saw non-study physician|0
905660|NCT01103479|2987793|P2|Overall Study|Saw non-study physician|0
905661|NCT01103479|2987794|P1|Overall Study|Saw non-study physician|2
905662|NCT01103479|2987792|P3|Overall Study|Active cancer|0
905663|NCT01103479|2987793|P2|Overall Study|Active cancer|0
905664|NCT01103479|2987794|P1|Overall Study|Active cancer|1
905665|NCT01103479|2987792|P3|Overall Study|Family history of CRC|2
905666|NCT01103479|2987793|P2|Overall Study|Family history of CRC|0
905667|NCT01103479|2987794|P1|Overall Study|Family history of CRC|1
905668|NCT01103479|2987792|P3|Overall Study|Up to date with CRC screening|12
905669|NCT01103479|2987793|P2|Overall Study|Up to date with CRC screening|9
905670|NCT01103479|2987794|P1|Overall Study|Up to date with CRC screening|1
905671|NCT01103466|2987807|P3|Third Period (14 +/- 3 Days)|not satisfied with product|1
905672|NCT01103466|2987808|P2|Third Period (14 +/- 3 Days)|not satisfied with product|0
905673|NCT01103466|2987809|P1|Third Period (14 +/- 3 Days)|not satisfied with product|0
905674|NCT01103466|2987807|P3|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
905675|NCT01103466|2987808|P2|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
905676|NCT01103466|2987809|P1|Third Period (14 +/- 3 Days)|Lack of Efficacy|1
905677|NCT01103466|2987807|P3|Third Period (14 +/- 3 Days)|Adverse Event|0
905678|NCT01103466|2987808|P2|Third Period (14 +/- 3 Days)|Adverse Event|0
905679|NCT01103466|2987809|P1|Third Period (14 +/- 3 Days)|Adverse Event|1
905680|NCT01103466|2987807|P3|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
905681|NCT01103466|2987808|P2|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
905682|NCT01103466|2987809|P1|Second Period (14 +/- 3 Days)|Lack of Efficacy|0
905683|NCT01103466|2987807|P3|Second Period (14 +/- 3 Days)|Adverse Event|0
905684|NCT01103466|2987808|P2|Second Period (14 +/- 3 Days)|Adverse Event|1
905685|NCT01103466|2987809|P1|Second Period (14 +/- 3 Days)|Adverse Event|2
905686|NCT01103466|2987807|P3|First Period (14 +/- 3 Days)|Protocol Violation|0
905687|NCT01103466|2987808|P2|First Period (14 +/- 3 Days)|Protocol Violation|0
905688|NCT01103466|2987809|P1|First Period (14 +/- 3 Days)|Protocol Violation|2
905689|NCT01103362|2987899|P1|Overall Study|study terminated|596
905690|NCT01103323|2987905|P2|Switched From Placebo to Regorafenib|Adverse Event|1
905691|NCT01103323|2987906|P1|Switched From Placebo to Regorafenib|Adverse Event|0
905692|NCT01103323|2987905|P2|Without/Before Drug Switch|Switch to Regorafenib|4
905693|NCT01103323|2987906|P1|Without/Before Drug Switch|Switch to Regorafenib|0
905694|NCT01103323|2987905|P2|Without/Before Drug Switch|did not receive study treatment|2
905695|NCT01103323|2987906|P1|Without/Before Drug Switch|did not receive study treatment|5
905696|NCT01103323|2987905|P2|Without/Before Drug Switch|Physician Decision|0
905697|NCT01103323|2987906|P1|Without/Before Drug Switch|Physician Decision|2
905698|NCT01103323|2987905|P2|Without/Before Drug Switch|Protocol Violation|0
905699|NCT01103323|2987906|P1|Without/Before Drug Switch|Protocol Violation|2
905700|NCT01103323|2987905|P2|Without/Before Drug Switch|Withdrawal by Subject|5
905701|NCT01103323|2987906|P1|Without/Before Drug Switch|Withdrawal by Subject|17
905702|NCT01103323|2987905|P2|Without/Before Drug Switch|Adverse Event|7
905703|NCT01103323|2987906|P1|Without/Before Drug Switch|Adverse Event|50
905704|NCT01103284|2987923|P2|Overall Study|Missing CRF entries for study completion|2
905705|NCT01103284|2987924|P1|Overall Study|Missing CRF entries for study completion|0
905706|NCT01103284|2987923|P2|Overall Study|Not described|1
905707|NCT01103284|2987924|P1|Overall Study|Not described|2
905708|NCT01103284|2987923|P2|Overall Study|Termination by the Sponsor|1
905709|NCT01103284|2987924|P1|Overall Study|Termination by the Sponsor|0
905710|NCT01103284|2987923|P2|Overall Study|Dermal Hypersensitivity|1
905711|NCT01103284|2987924|P1|Overall Study|Dermal Hypersensitivity|0
905712|NCT01103284|2987923|P2|Overall Study|Withdrawal by Subject|18
905713|NCT01103284|2987924|P1|Overall Study|Withdrawal by Subject|14
905714|NCT01103284|2987923|P2|Overall Study|Adverse Event|5
905715|NCT01103284|2987924|P1|Overall Study|Adverse Event|0
905716|NCT01103284|2987923|P2|Overall Study|Protocol Violation|5
905717|NCT01103284|2987924|P1|Overall Study|Protocol Violation|12
905718|NCT01103284|2987923|P2|Overall Study|Pregnancy|1
905719|NCT01103284|2987924|P1|Overall Study|Pregnancy|3
905720|NCT01103284|2987923|P2|Overall Study|Lost to Follow-up|10
905721|NCT01103284|2987924|P1|Overall Study|Lost to Follow-up|9
905722|NCT01103284|2987923|P2|Overall Study|Death|0
905723|NCT01103284|2987924|P1|Overall Study|Death|2
905724|NCT01103245|2987952|P4|Overall Study|Physician Decision|0
905725|NCT01103245|2987953|P3|Overall Study|Physician Decision|0
905726|NCT01103245|2987954|P2|Overall Study|Physician Decision|0
905727|NCT01103245|2987955|P1|Overall Study|Physician Decision|1
905728|NCT01103245|2987952|P4|Overall Study|Adverse Event|0
905729|NCT01103245|2987953|P3|Overall Study|Adverse Event|1
905730|NCT01103245|2987954|P2|Overall Study|Adverse Event|2
905731|NCT01103245|2987955|P1|Overall Study|Adverse Event|0
905732|NCT01103245|2987952|P4|Overall Study|Inadequate IV access|0
905733|NCT01103245|2987953|P3|Overall Study|Inadequate IV access|0
905734|NCT01103245|2987954|P2|Overall Study|Inadequate IV access|0
905735|NCT01103245|2987955|P1|Overall Study|Inadequate IV access|1
905736|NCT01103245|2987952|P4|Overall Study|Withdrawal by Subject|0
905737|NCT01103245|2987953|P3|Overall Study|Withdrawal by Subject|3
905738|NCT01103245|2987954|P2|Overall Study|Withdrawal by Subject|0
905739|NCT01103245|2987955|P1|Overall Study|Withdrawal by Subject|1
905740|NCT01103232|2987971|P2|Overall Study|Protocol Violation|1
905741|NCT01103232|2987972|P1|Overall Study|Protocol Violation|0
905742|NCT01103232|2987971|P2|Overall Study|Withdrawal by Subject|1
905743|NCT01103232|2987972|P1|Overall Study|Withdrawal by Subject|1
905744|NCT01103141|2987980|P2|Overall Study|Lost to Follow-up|1
905745|NCT01103141|2987981|P1|Overall Study|Lost to Follow-up|2
905746|NCT01103141|2987980|P2|Overall Study|Death|1
905747|NCT01103141|2987981|P1|Overall Study|Death|0
905748|NCT01103063|2987989|P2|Overall Study|Death|1
905749|NCT01103063|2987990|P1|Overall Study|Death|3
905750|NCT01103063|2987989|P2|Overall Study|Study terminated by Sponsor|342
905751|NCT01103063|2987990|P1|Overall Study|Study terminated by Sponsor|326
905752|NCT01103063|2987989|P2|Overall Study|Protocol Violation|0
905753|NCT01103063|2987990|P1|Overall Study|Protocol Violation|1
905754|NCT01103063|2987989|P2|Overall Study|Not specified|11
905755|NCT01103063|2987990|P1|Overall Study|Not specified|16
905756|NCT01103063|2987989|P2|Overall Study|Withdrawal by Subject|15
905757|NCT01103063|2987990|P1|Overall Study|Withdrawal by Subject|60
905758|NCT01103063|2987989|P2|Overall Study|Lost to Follow-up|51
905759|NCT01103063|2987990|P1|Overall Study|Lost to Follow-up|68
905760|NCT01103063|2987989|P2|Overall Study|Adverse Event|1
905761|NCT01103063|2987990|P1|Overall Study|Adverse Event|3
905762|NCT01102972|2988058|P2|Overall Study|Withdrawal by Subject|6
905763|NCT01102972|2988059|P1|Overall Study|Withdrawal by Subject|6
905764|NCT01102972|2988058|P2|Overall Study|Investigator Discretion|0
905765|NCT01102972|2988059|P1|Overall Study|Investigator Discretion|2
905766|NCT01102972|2988058|P2|Overall Study|Lost to Follow-up|5
905767|NCT01102972|2988059|P1|Overall Study|Lost to Follow-up|10
905768|NCT01102972|2988058|P2|Overall Study|Protocol Violation|0
905769|NCT01102972|2988059|P1|Overall Study|Protocol Violation|1
905770|NCT01102972|2988058|P2|Overall Study|Lack of Efficacy|1
905771|NCT01102972|2988059|P1|Overall Study|Lack of Efficacy|2
905772|NCT01102972|2988058|P2|Overall Study|Adverse Event|2
905773|NCT01102972|2988059|P1|Overall Study|Adverse Event|8
905774|NCT01102803|2988123|P2|Post to Follow-Up|Lost to Follow-up|3
905775|NCT01102803|2988124|P1|Post to Follow-Up|Lost to Follow-up|1
905776|NCT01102803|2988123|P2|Baseline to Post-Treatment|Lost to Follow-up|0
905777|NCT01102803|2988124|P1|Baseline to Post-Treatment|Lost to Follow-up|3
905778|NCT01102777|2988138|P2|Overall Study|Lost to Follow-up|10
905779|NCT01102777|2988139|P1|Overall Study|Lost to Follow-up|7
905780|NCT01102777|2988138|P2|Overall Study|Death|6
905781|NCT01102777|2988139|P1|Overall Study|Death|2
905782|NCT01102491|2988178|P2|Overall Study|Protocol Violation|12
905783|NCT01102491|2988179|P1|Overall Study|Protocol Violation|11
905784|NCT01102374|2988198|P2|Overall Study|Lost to Follow-up|6
905785|NCT01102374|2988199|P1|Overall Study|Lost to Follow-up|7
905786|NCT01102374|2988198|P2|Overall Study|Death|13
905787|NCT01102374|2988199|P1|Overall Study|Death|9
905788|NCT01102257|2988248|P2|Overall Study|Adverse Event|0
905789|NCT01102257|2988249|P1|Overall Study|Adverse Event|1
905790|NCT01102257|2988248|P2|Overall Study|Adverse Event|0
905791|NCT01102257|2988249|P1|Overall Study|Adverse Event|1
905792|NCT01102140|2988266|P2|Overall Study|Investigator terminated study|2
905793|NCT01102140|2988267|P1|Overall Study|Investigator terminated study|2
905794|NCT01102140|2988266|P2|Overall Study|Lost to Follow-up|0
905795|NCT01102140|2988267|P1|Overall Study|Lost to Follow-up|1
905796|NCT01101841|2988322|P2|Overall Study|Eligibility Criteria|2
905797|NCT01101841|2988323|P1|Overall Study|Eligibility Criteria|1
905798|NCT01101841|2988322|P2|Overall Study|Suicidality Tracking Scale|1
905799|NCT01101841|2988323|P1|Overall Study|Suicidality Tracking Scale|3
905800|NCT01101841|2988322|P2|Overall Study|Not Specified|1
905801|NCT01101841|2988323|P1|Overall Study|Not Specified|0
905802|NCT01101841|2988322|P2|Overall Study|Lack of Efficacy|2
905803|NCT01101841|2988323|P1|Overall Study|Lack of Efficacy|0
905804|NCT01101841|2988322|P2|Overall Study|Physician Decision|2
905805|NCT01101841|2988323|P1|Overall Study|Physician Decision|0
905806|NCT01101841|2988322|P2|Overall Study|Protocol Violation|1
905807|NCT01101841|2988323|P1|Overall Study|Protocol Violation|1
905808|NCT01101841|2988322|P2|Overall Study|Withdrawal by Subject|40
905809|NCT01101841|2988323|P1|Overall Study|Withdrawal by Subject|21
905810|NCT01101841|2988322|P2|Overall Study|Lost to Follow-up|3
905811|NCT01101841|2988323|P1|Overall Study|Lost to Follow-up|9
905812|NCT01101841|2988322|P2|Overall Study|Adverse Event|15
905813|NCT01101841|2988323|P1|Overall Study|Adverse Event|15
905814|NCT01101542|2988361|P1|Year 6 Surveillance Period|Withdrawal by Subject|4
905815|NCT01101542|2988361|P1|Year 6 Surveillance Period|Pregnancy|1
905816|NCT01101542|2988361|P1|Year 6 Surveillance Period|Lost to Follow-up|986
905817|NCT01101542|2988361|P1|Year 5 Surveillance Period|Pregnancy|1
905818|NCT01101542|2988361|P1|Year 5 Surveillance Period|Lost to Follow-up|140
905819|NCT01101542|2988361|P1|Year 4 Surveillance Period|Other|287
905820|NCT01101542|2988361|P1|Year 3 Surveillance Period|Withdrawal by Subject|4
905821|NCT01101542|2988361|P1|Year 3 Surveillance Period|Lost to Follow-up|7
905822|NCT01101477|2988377|P3|Overall Study|Protocol Violation|1
905823|NCT01101477|2988378|P2|Overall Study|Protocol Violation|3
905824|NCT01101477|2988379|P1|Overall Study|Protocol Violation|5
905825|NCT01101321|2988400|P2|Period 1|Adverse Event|3
905826|NCT01101321|2988401|P1|Period 1|Adverse Event|3
905827|NCT01101321|2988400|P2|Period 1|Withdrawal by Subject|1
905828|NCT01101321|2988401|P1|Period 1|Withdrawal by Subject|1
905829|NCT01101308|2988411|P2|Period 1|Positive for cotinine|0
905830|NCT01101308|2988412|P1|Period 1|Positive for cotinine|1
905831|NCT01101308|2988411|P2|Period 1|Adverse Event|1
905832|NCT01101308|2988412|P1|Period 1|Adverse Event|2
905833|NCT01101191|2988423|P2|Period 1|Adverse Event|2
905834|NCT01101191|2988424|P1|Period 1|Adverse Event|1
905835|NCT01101191|2988423|P2|Period 1|Withdrawal by Subject|0
905836|NCT01101191|2988424|P1|Period 1|Withdrawal by Subject|1
905837|NCT01101178|2988435|P2|Period 2|Withdrawal by Subject|1
905838|NCT01101178|2988436|P1|Period 2|Withdrawal by Subject|0
905839|NCT01101178|2988435|P2|Period 1|Adverse Event|1
905840|NCT01101178|2988436|P1|Period 1|Adverse Event|2
905841|NCT01101178|2988435|P2|Period 1|Positive drug screen|1
905842|NCT01101178|2988436|P1|Period 1|Positive drug screen|1
905843|NCT01101178|2988435|P2|Period 1|Withdrawal by Subject|2
905844|NCT01101178|2988436|P1|Period 1|Withdrawal by Subject|1
905845|NCT01101165|2988447|P2|Period 2|Adverse Event|0
905846|NCT01101165|2988448|P1|Period 2|Adverse Event|1
905847|NCT01101165|2988447|P2|Period 2|Withdrawal by Subject|1
905848|NCT01101165|2988448|P1|Period 2|Withdrawal by Subject|3
905849|NCT01101165|2988447|P2|Period 1|Lost to Follow-up|0
905850|NCT01101165|2988448|P1|Period 1|Lost to Follow-up|1
905851|NCT01101165|2988447|P2|Period 1|Positive Drug Screen|1
905852|NCT01101165|2988448|P1|Period 1|Positive Drug Screen|0
905853|NCT01101165|2988447|P2|Period 1|Withdrawal by Subject|2
905854|NCT01101165|2988448|P1|Period 1|Withdrawal by Subject|0
905855|NCT01101165|2988447|P2|Period 1|Adverse Event|2
905856|NCT01101165|2988448|P1|Period 1|Adverse Event|1
905857|NCT01101035|2988460|P2|Overall Study|Reason not Specified|363
905858|NCT01101035|2988461|P1|Overall Study|Reason not Specified|333
905859|NCT01101035|2988460|P2|Overall Study|Voluntary Withdrawal|587
905860|NCT01101035|2988461|P1|Overall Study|Voluntary Withdrawal|595
905861|NCT01101035|2988460|P2|Overall Study|Lost to Follow-up|223
905862|NCT01101035|2988461|P1|Overall Study|Lost to Follow-up|226
905863|NCT01101035|2988460|P2|Overall Study|Major Protocol Deviation|46
905864|NCT01101035|2988461|P1|Overall Study|Major Protocol Deviation|52
905865|NCT01101035|2988460|P2|Overall Study|Adverse Event|172
905866|NCT01101035|2988461|P1|Overall Study|Adverse Event|191
905867|NCT01101022|2988481|P2|Overall Study|Vacation|1
905868|NCT01101022|2988482|P1|Overall Study|Vacation|0
905869|NCT01101022|2988481|P2|Overall Study|Work schedule|1
905870|NCT01101022|2988482|P1|Overall Study|Work schedule|1
905871|NCT01101022|2988481|P2|Overall Study|Non-compliance|0
905872|NCT01101022|2988482|P1|Overall Study|Non-compliance|1
905873|NCT01101022|2988481|P2|Overall Study|Sponsor decision|1
905874|NCT01101022|2988482|P1|Overall Study|Sponsor decision|1
905875|NCT01101022|2988481|P2|Overall Study|Lack of Efficacy|7
905876|NCT01101022|2988482|P1|Overall Study|Lack of Efficacy|0
905877|NCT01101022|2988481|P2|Overall Study|Lost to Follow-up|4
905878|NCT01101022|2988482|P1|Overall Study|Lost to Follow-up|1
905879|NCT01101022|2988481|P2|Overall Study|Withdrawal by Subject|8
905880|NCT01101022|2988482|P1|Overall Study|Withdrawal by Subject|3
905881|NCT01101022|2988481|P2|Overall Study|Protocol Violation|3
905882|NCT01101022|2988482|P1|Overall Study|Protocol Violation|4
905883|NCT01101022|2988481|P2|Overall Study|Adverse Event|2
905884|NCT01101022|2988482|P1|Overall Study|Adverse Event|6
905885|NCT01100944|2988516|P3|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
905886|NCT01100944|2988517|P2|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2
905887|NCT01100944|2988518|P1|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
905888|NCT01100944|2988516|P3|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
905889|NCT01100944|2988517|P2|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
905890|NCT01100944|2988518|P1|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1
905891|NCT01100944|2988516|P3|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
905892|NCT01100944|2988517|P2|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
905893|NCT01100944|2988518|P1|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1
905894|NCT01100944|2988516|P3|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
905895|NCT01100944|2988517|P2|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
905896|NCT01100944|2988518|P1|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2
905897|NCT01100853|2988576|P2|Overall Study|Withdrawal by Subject|4
905898|NCT01100853|2988577|P1|Overall Study|Withdrawal by Subject|6
905899|NCT01100853|2988576|P2|Overall Study|Received <4 study injections|13
905900|NCT01100853|2988577|P1|Overall Study|Received <4 study injections|10
905901|NCT01100853|2988576|P2|Overall Study|Lost to Follow-up|6
905902|NCT01100853|2988577|P1|Overall Study|Lost to Follow-up|11
905903|NCT01100658|2988623|P1|Overall Study|Withdrawal by Subject|1
905904|NCT01100567|2988655|P2|Overall Study|Deemed ineligible after consent|1
905905|NCT01100567|2988656|P1|Overall Study|Deemed ineligible after consent|0
905906|NCT01100567|2988655|P2|Overall Study|Physician Decision|1
905907|NCT01100567|2988656|P1|Overall Study|Physician Decision|0
905908|NCT01100567|2988655|P2|Overall Study|Lost to Follow-up|2
905909|NCT01100567|2988656|P1|Overall Study|Lost to Follow-up|1
905910|NCT01100567|2988655|P2|Overall Study|Early Hospital Discharge|4
905911|NCT01100567|2988656|P1|Overall Study|Early Hospital Discharge|6
905912|NCT01100567|2988655|P2|Overall Study|Withdrawal by Subject|8
905913|NCT01100567|2988656|P1|Overall Study|Withdrawal by Subject|5
905914|NCT01100528|2988664|P1|Overall Study|Withdrawal by Subject|2
905915|NCT01100528|2988664|P1|Overall Study|Death|1
905916|NCT01100502|2988672|P2|Long-Term Follow-up|Continuing in long-term follow-up|129
905917|NCT01100502|2988673|P1|Long-Term Follow-up|Continuing in long-term follow-up|122
905918|NCT01100502|2988672|P2|Long-Term Follow-up|Lost to Follow-up|2
905919|NCT01100502|2988673|P1|Long-Term Follow-up|Lost to Follow-up|5
905920|NCT01100502|2988672|P2|Long-Term Follow-up|Withdrawal by Subject|8
905921|NCT01100502|2988673|P1|Long-Term Follow-up|Withdrawal by Subject|10
905922|NCT01100502|2988672|P2|Treatment Period|Progressive Disease|69
905923|NCT01100502|2988673|P1|Treatment Period|Progressive Disease|24
905924|NCT01100502|2988672|P2|Treatment Period|Withdrawal by Subject|4
905925|NCT01100502|2988673|P1|Treatment Period|Withdrawal by Subject|9
905926|NCT01100502|2988672|P2|Treatment Period|Adverse Event|10
905927|NCT01100502|2988673|P1|Treatment Period|Adverse Event|54
905928|NCT01100437|2988683|P3|Maintenance|Sponsor termination of study|1
905929|NCT01100437|2988684|P2|Maintenance|Sponsor termination of study|0
905930|NCT01100437|2988685|P1|Maintenance|Sponsor termination of study|0
905931|NCT01100437|2988683|P3|Maintenance|Withdrawal by Subject|1
905932|NCT01100437|2988684|P2|Maintenance|Withdrawal by Subject|0
905933|NCT01100437|2988685|P1|Maintenance|Withdrawal by Subject|0
905934|NCT01100437|2988683|P3|Titration/Stabilization|Sponsor canceled study|1
905935|NCT01100437|2988684|P2|Titration/Stabilization|Sponsor canceled study|0
905936|NCT01100437|2988685|P1|Titration/Stabilization|Sponsor canceled study|0
905937|NCT01100437|2988683|P3|Titration/Stabilization|Non-compliance|1
905938|NCT01100437|2988684|P2|Titration/Stabilization|Non-compliance|0
905939|NCT01100437|2988685|P1|Titration/Stabilization|Non-compliance|0
905940|NCT01100437|2988683|P3|Titration/Stabilization|Adverse Event|4
905941|NCT01100437|2988684|P2|Titration/Stabilization|Adverse Event|0
905942|NCT01100437|2988685|P1|Titration/Stabilization|Adverse Event|0
905943|NCT01100320|2988722|P2|Period 2|Withdrawal by Subject|1
905944|NCT01100320|2988723|P1|Period 2|Withdrawal by Subject|1
905945|NCT01100320|2988722|P2|Period 1|Adverse Event|2
905946|NCT01100320|2988723|P1|Period 1|Adverse Event|2
905947|NCT01100320|2988722|P2|Period 1|Positive Drug Screen|1
905948|NCT01100320|2988723|P1|Period 1|Positive Drug Screen|1
905949|NCT01100320|2988722|P2|Period 1|Withdrawal by Subject|4
905950|NCT01100320|2988723|P1|Period 1|Withdrawal by Subject|2
905951|NCT01100307|2988735|P2|Open Phase (Week 24 up to Week 54)|Adverse Event|8
905952|NCT01100307|2988736|P1|Open Phase (Week 24 up to Week 54)|Adverse Event|3
905953|NCT01100307|2988735|P2|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3
905954|NCT01100307|2988736|P1|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2
905955|NCT01100307|2988735|P2|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2
905956|NCT01100307|2988736|P1|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1
905957|NCT01100307|2988735|P2|Double Masked Phase (Up to Week 24)|Adverse Event|2
905958|NCT01100307|2988736|P1|Double Masked Phase (Up to Week 24)|Adverse Event|5
905959|NCT01100307|2988735|P2|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1
905960|NCT01100307|2988736|P1|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0
905961|NCT01100307|2988735|P2|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
905962|NCT01100307|2988736|P1|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
905963|NCT01100086|2988805|P2|Period 1|Withdrawal by Subject|0
905964|NCT01100086|2988806|P1|Period 1|Withdrawal by Subject|1
905965|NCT01100073|2988816|P1|Overall Study|Missing|5
905966|NCT01100073|2988816|P1|Overall Study|Other|8
905967|NCT01100073|2988816|P1|Overall Study|Insufficient tolerability +patients wish|8
905968|NCT01100073|2988816|P1|Overall Study|Lack of effect + patient's wish|2
905969|NCT01100073|2988816|P1|Overall Study|Lost to Follow-up|39
905970|NCT01100073|2988816|P1|Overall Study|Withdrawal by Subject|13
905971|NCT01100073|2988816|P1|Overall Study|Insufficient Tolerability|21
905972|NCT01100073|2988816|P1|Overall Study|Lack of Efficacy|4
905973|NCT01099917|2988860|P1|Overall Study|Not Treated|24
905974|NCT01099917|2988860|P1|Overall Study|Adverse Event|3
905975|NCT01099709|2988922|P2|Period 1|Adverse Event|0
905976|NCT01099709|2988923|P1|Period 1|Adverse Event|1
905977|NCT01099709|2988922|P2|Period 1|Positive cotinine test|1
905978|NCT01099709|2988923|P1|Period 1|Positive cotinine test|0
905979|NCT01099709|2988922|P2|Period 1|Withdrawal by Subject|1
905980|NCT01099709|2988923|P1|Period 1|Withdrawal by Subject|0
905981|NCT01099579|2988949|P3|Stage 2 (ATV Capsule)|Adverse Event|0
905982|NCT01099579|2988950|P2|Stage 2 (ATV Capsule)|Adverse Event|1
905983|NCT01099579|2988951|P1|Stage 2 (ATV Capsule)|Adverse Event|0
905984|NCT01099579|2988949|P3|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1
905985|NCT01099579|2988950|P2|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0
905986|NCT01099579|2988951|P1|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2
905987|NCT01099579|2988949|P3|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
905988|NCT01099579|2988950|P2|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
905989|NCT01099579|2988951|P1|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
905990|NCT01099579|2988949|P3|Stage 2 (ATV Capsule)|Lack of Efficacy|2
905991|NCT01099579|2988950|P2|Stage 2 (ATV Capsule)|Lack of Efficacy|0
905992|NCT01099579|2988951|P1|Stage 2 (ATV Capsule)|Lack of Efficacy|0
905993|NCT01099579|2988949|P3|Stage 2 (ATV Capsule)|Lost to Follow-up|1
905994|NCT01099579|2988950|P2|Stage 2 (ATV Capsule)|Lost to Follow-up|1
905995|NCT01099579|2988951|P1|Stage 2 (ATV Capsule)|Lost to Follow-up|1
905996|NCT01099579|2988949|P3|Stage 2 (ATV Capsule)|No longer met study criteria|1
905997|NCT01099579|2988950|P2|Stage 2 (ATV Capsule)|No longer met study criteria|2
905998|NCT01099579|2988951|P1|Stage 2 (ATV Capsule)|No longer met study criteria|2
905999|NCT01099579|2988949|P3|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
906000|NCT01099579|2988950|P2|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2
906001|NCT01099579|2988951|P1|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
906002|NCT01099579|2988949|P3|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
906003|NCT01099579|2988950|P2|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2
906004|NCT01099579|2988951|P1|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
906005|NCT01099579|2988949|P3|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1
906006|NCT01099579|2988950|P2|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
906007|NCT01099579|2988951|P1|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
906008|NCT01099579|2988949|P3|Stage 1 (ATV Powder Formulation)|Adverse Event|0
906009|NCT01099579|2988950|P2|Stage 1 (ATV Powder Formulation)|Adverse Event|1
906010|NCT01099579|2988951|P1|Stage 1 (ATV Powder Formulation)|Adverse Event|4
906011|NCT01099397|2989020|P1|Overall Study|Withdrawal by Subject|5
906012|NCT01099397|2989020|P1|Overall Study|Protocol Violation|4
906013|NCT01099397|2989020|P1|Overall Study|Lost to Follow-up|4
906014|NCT01099267|2989047|P1|MDS-003 Study|Secondary Malign Disease|1
906015|NCT01099267|2989047|P1|MDS-003 Study|Loss of Response|1
906016|NCT01099267|2989047|P1|MDS-003 Study|Non-Compliance|2
906017|NCT01099267|2989047|P1|MDS-003 Study|Investigator Decision|2
906018|NCT01099267|2989047|P1|MDS-003 Study|Disease Progression|7
906019|NCT01099267|2989047|P1|MDS-003 Study|Study Closed by Sponsor|2
906020|NCT01099267|2989047|P1|MDS-003 Study|Death|11
906021|NCT01099267|2989047|P1|MDS-003 Study|Lost to Follow-up|1
906022|NCT01099267|2989047|P1|MDS-003 Study|Withdrawal by Subject|8
906023|NCT01099267|2989047|P1|MDS-003 Study|Lack of Efficacy|52
906024|NCT01099267|2989047|P1|MDS-003 Study|Adverse Event|37
906025|NCT01099215|2989057|P2|Overall Study|Adverse Event|1
906026|NCT01099215|2989058|P1|Overall Study|Adverse Event|0
906027|NCT01099215|2989057|P2|Overall Study|Withdrawal by Subject|0
906028|NCT01099215|2989058|P1|Overall Study|Withdrawal by Subject|1
906029|NCT01098851|2989128|P2|Overall Study|Equipment failure|0
906030|NCT01098851|2989129|P1|Overall Study|Equipment failure|1
906031|NCT01098812|2989140|P3|Overall Study|Lost to Follow-up|0
906032|NCT01098812|2989141|P2|Overall Study|Lost to Follow-up|1
906033|NCT01098812|2989142|P1|Overall Study|Lost to Follow-up|0
906034|NCT01098812|2989140|P3|Overall Study|Death|1
906035|NCT01098812|2989141|P2|Overall Study|Death|0
906036|NCT01098812|2989142|P1|Overall Study|Death|2
906037|NCT01098539|2989218|P2|Overall Study|Physician Decision|3
906038|NCT01098539|2989219|P1|Overall Study|Physician Decision|5
906039|NCT01098539|2989218|P2|Overall Study|Withdrawal by Subject|26
906040|NCT01098539|2989219|P1|Overall Study|Withdrawal by Subject|12
906041|NCT01098539|2989218|P2|Overall Study|Lost to Follow-up|4
906042|NCT01098539|2989219|P1|Overall Study|Lost to Follow-up|4
906043|NCT01098539|2989218|P2|Overall Study|Noncompliance|5
906044|NCT01098539|2989219|P1|Overall Study|Noncompliance|3
906045|NCT01098539|2989218|P2|Overall Study|Protocol Violation|4
906046|NCT01098539|2989219|P1|Overall Study|Protocol Violation|1
906047|NCT01098539|2989218|P2|Overall Study|Adverse Event|26
906048|NCT01098539|2989219|P1|Overall Study|Adverse Event|26
906049|NCT01098487|2989270|P1|Overall Study|Physician Decision|1
906050|NCT01098487|2989270|P1|Overall Study|Lost to Follow-up|3
906051|NCT01098487|2989270|P1|Overall Study|Withdrawal by Subject|7
906052|NCT01098487|2989270|P1|Overall Study|Lack of Efficacy|11
906053|NCT01098487|2989270|P1|Overall Study|Adverse Event|22
906054|NCT01098474|2989288|P6|Follow Up Phase|Lost to Follow-up|0
906055|NCT01098474|2989289|P5|Follow Up Phase|Lost to Follow-up|1
906056|NCT01098474|2989290|P4|Follow Up Phase|Lost to Follow-up|0
906057|NCT01098474|2989291|P3|Follow Up Phase|Lost to Follow-up|0
906058|NCT01098474|2989292|P2|Follow Up Phase|Lost to Follow-up|0
906059|NCT01098474|2989293|P1|Follow Up Phase|Lost to Follow-up|0
906060|NCT01098474|2989288|P6|Follow Up Phase|Withdrawal by Subject|1
906061|NCT01098474|2989289|P5|Follow Up Phase|Withdrawal by Subject|0
906062|NCT01098474|2989290|P4|Follow Up Phase|Withdrawal by Subject|2
906063|NCT01098474|2989291|P3|Follow Up Phase|Withdrawal by Subject|0
906064|NCT01098474|2989292|P2|Follow Up Phase|Withdrawal by Subject|0
906065|NCT01098474|2989293|P1|Follow Up Phase|Withdrawal by Subject|0
906066|NCT01098474|2989288|P6|Follow Up Phase|Other|4
906067|NCT01098474|2989289|P5|Follow Up Phase|Other|0
906068|NCT01098474|2989290|P4|Follow Up Phase|Other|0
906069|NCT01098474|2989291|P3|Follow Up Phase|Other|0
906070|NCT01098474|2989292|P2|Follow Up Phase|Other|0
906071|NCT01098474|2989293|P1|Follow Up Phase|Other|0
906072|NCT01098474|2989288|P6|Follow Up Phase|Travelled out of study area|0
906073|NCT01098474|2989289|P5|Follow Up Phase|Travelled out of study area|1
906074|NCT01098474|2989290|P4|Follow Up Phase|Travelled out of study area|0
906075|NCT01098474|2989291|P3|Follow Up Phase|Travelled out of study area|0
906076|NCT01098474|2989292|P2|Follow Up Phase|Travelled out of study area|0
906077|NCT01098474|2989293|P1|Follow Up Phase|Travelled out of study area|0
906078|NCT01098474|2989288|P6|Active Phase|Lost to Follow-up|0
906079|NCT01098474|2989289|P5|Active Phase|Lost to Follow-up|0
906080|NCT01098474|2989290|P4|Active Phase|Lost to Follow-up|0
906081|NCT01098474|2989291|P3|Active Phase|Lost to Follow-up|0
906082|NCT01098474|2989292|P2|Active Phase|Lost to Follow-up|0
906083|NCT01098474|2989293|P1|Active Phase|Lost to Follow-up|1
906084|NCT01098474|2989288|P6|Active Phase|Withdrawal by Subject|0
906085|NCT01098474|2989289|P5|Active Phase|Withdrawal by Subject|0
906086|NCT01098474|2989290|P4|Active Phase|Withdrawal by Subject|0
906087|NCT01098474|2989291|P3|Active Phase|Withdrawal by Subject|2
906088|NCT01098474|2989292|P2|Active Phase|Withdrawal by Subject|1
906089|NCT01098474|2989293|P1|Active Phase|Withdrawal by Subject|1
906090|NCT01098474|2989288|P6|Active Phase|Other|0
906091|NCT01098474|2989289|P5|Active Phase|Other|0
906092|NCT01098474|2989290|P4|Active Phase|Other|0
906093|NCT01098474|2989291|P3|Active Phase|Other|3
906094|NCT01098474|2989292|P2|Active Phase|Other|0
906095|NCT01098474|2989293|P1|Active Phase|Other|0
906096|NCT01098461|2989527|P4|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
906097|NCT01098461|2989528|P3|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
906098|NCT01098461|2989529|P2|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
906099|NCT01098461|2989530|P1|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
906100|NCT01098461|2989527|P4|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
906101|NCT01098461|2989528|P3|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
906102|NCT01098461|2989529|P2|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1
906103|NCT01098461|2989530|P1|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
906104|NCT01098461|2989527|P4|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
906105|NCT01098461|2989528|P3|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
906106|NCT01098461|2989529|P2|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1
906107|NCT01098461|2989530|P1|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
906108|NCT01098461|2989527|P4|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
906109|NCT01098461|2989528|P3|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
906110|NCT01098461|2989529|P2|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1
906111|NCT01098461|2989530|P1|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
906112|NCT01098461|2989527|P4|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
906113|NCT01098461|2989528|P3|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
906114|NCT01098461|2989529|P2|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2
906115|NCT01098461|2989530|P1|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1
906116|NCT01098461|2989527|P4|Treatment Period (TP) (16 Weeks)|Adverse Event|3
906117|NCT01098461|2989528|P3|Treatment Period (TP) (16 Weeks)|Adverse Event|1
906118|NCT01098461|2989529|P2|Treatment Period (TP) (16 Weeks)|Adverse Event|2
906119|NCT01098461|2989530|P1|Treatment Period (TP) (16 Weeks)|Adverse Event|1
906120|NCT01098461|2989527|P4|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
906121|NCT01098461|2989528|P3|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
906122|NCT01098461|2989529|P2|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2
906123|NCT01098461|2989530|P1|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10
906124|NCT01098305|2989590|P2|Overall Study|Lost to Follow-up|33
906125|NCT01098305|2989591|P1|Overall Study|Lost to Follow-up|31
906126|NCT01098240|2989610|P3|Double-Blind Phase|Adverse Event|3
906127|NCT01098240|2989611|P2|Double-Blind Phase|Adverse Event|3
906128|NCT01098240|2989612|P1|Double-Blind Phase|Adverse Event|0
906129|NCT01098240|2989610|P3|Double-Blind Phase|Withdrawal by Subject|3
906130|NCT01098240|2989611|P2|Double-Blind Phase|Withdrawal by Subject|1
906131|NCT01098240|2989612|P1|Double-Blind Phase|Withdrawal by Subject|0
906132|NCT01098240|2989610|P3|Double-Blind Phase|Insufficient Clinical Response|2
906133|NCT01098240|2989611|P2|Double-Blind Phase|Insufficient Clinical Response|1
906134|NCT01098240|2989612|P1|Double-Blind Phase|Insufficient Clinical Response|0
906135|NCT01098240|2989610|P3|Double-Blind Phase|Did Not Meet Entrance Criteria|0
906136|NCT01098240|2989611|P2|Double-Blind Phase|Did Not Meet Entrance Criteria|1
906137|NCT01098240|2989612|P1|Double-Blind Phase|Did Not Meet Entrance Criteria|0
906138|NCT01098240|2989610|P3|Double-Blind Phase|Other|2
906139|NCT01098240|2989611|P2|Double-Blind Phase|Other|2
906140|NCT01098240|2989612|P1|Double-Blind Phase|Other|0
906141|NCT01098240|2989610|P3|Double-Blind Phase|Lost to Follow-up|0
906142|NCT01098240|2989611|P2|Double-Blind Phase|Lost to Follow-up|2
906143|NCT01098240|2989612|P1|Double-Blind Phase|Lost to Follow-up|0
906144|NCT01098240|2989610|P3|Double-Blind Phase|Protocol Violation|4
906145|NCT01098240|2989611|P2|Double-Blind Phase|Protocol Violation|2
906146|NCT01098240|2989612|P1|Double-Blind Phase|Protocol Violation|0
906147|NCT01098240|2989610|P3|Double-Blind Phase|Study Terminated by Sponsor|8
906148|NCT01098240|2989611|P2|Double-Blind Phase|Study Terminated by Sponsor|5
906149|NCT01098240|2989612|P1|Double-Blind Phase|Study Terminated by Sponsor|0
906150|NCT01098240|2989610|P3|Open-Label Phase|Adverse Event|0
906151|NCT01098240|2989611|P2|Open-Label Phase|Adverse Event|0
906152|NCT01098240|2989612|P1|Open-Label Phase|Adverse Event|12
906153|NCT01098240|2989610|P3|Open-Label Phase|Withdrawal by Subject|0
906154|NCT01098240|2989611|P2|Open-Label Phase|Withdrawal by Subject|0
906155|NCT01098240|2989612|P1|Open-Label Phase|Withdrawal by Subject|9
906156|NCT01098240|2989610|P3|Open-Label Phase|Pregnancy|0
906157|NCT01098240|2989611|P2|Open-Label Phase|Pregnancy|0
906158|NCT01098240|2989612|P1|Open-Label Phase|Pregnancy|1
906159|NCT01098240|2989610|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
906160|NCT01098240|2989611|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
906161|NCT01098240|2989612|P1|Open-Label Phase|Did Not Meet Entrance Criteria|50
906162|NCT01098240|2989610|P3|Open-Label Phase|Other|0
906163|NCT01098240|2989611|P2|Open-Label Phase|Other|0
906164|NCT01098240|2989612|P1|Open-Label Phase|Other|19
906165|NCT01098240|2989610|P3|Open-Label Phase|Lost to Follow-up|0
906166|NCT01098240|2989611|P2|Open-Label Phase|Lost to Follow-up|0
906167|NCT01098240|2989612|P1|Open-Label Phase|Lost to Follow-up|13
906168|NCT01098240|2989610|P3|Open-Label Phase|Protocol Violation|0
906169|NCT01098240|2989611|P2|Open-Label Phase|Protocol Violation|0
906170|NCT01098240|2989612|P1|Open-Label Phase|Protocol Violation|4
906171|NCT01098240|2989610|P3|Open-Label Phase|Study Terminated by Sponsor|0
906172|NCT01098240|2989611|P2|Open-Label Phase|Study Terminated by Sponsor|0
906173|NCT01098240|2989612|P1|Open-Label Phase|Study Terminated by Sponsor|27
906174|NCT01098162|2989642|P1|Overall Study|Reason Unknown|26
906175|NCT01098162|2989642|P1|Overall Study|Other Reason|1
906176|NCT01098162|2989642|P1|Overall Study|Wish of Patient & Lost to Follow-up|1
906177|NCT01098162|2989642|P1|Overall Study|AE & Lack of Efficacy & Wish of Patient|1
906178|NCT01098162|2989642|P1|Overall Study|Adverse Event & Lost to Follow-up|2
906179|NCT01098162|2989642|P1|Overall Study|Adverse Event & Wish of Patient|13
906180|NCT01098162|2989642|P1|Overall Study|Adverse Event & Lack of Efficacy|6
906181|NCT01098162|2989642|P1|Overall Study|Lack of Efficacy & Wish of Patient|5
906182|NCT01098162|2989642|P1|Overall Study|Lost to Follow-up|9
906183|NCT01098162|2989642|P1|Overall Study|Wish of Patient|7
906184|NCT01098162|2989642|P1|Overall Study|Lack of Efficacy|4
906185|NCT01098162|2989642|P1|Overall Study|Adverse Event|37
906186|NCT01098110|2989654|P3|Overall Study|Untreated|0
906187|NCT01098110|2989655|P2|Overall Study|Untreated|1
906188|NCT01098110|2989656|P1|Overall Study|Untreated|1
906189|NCT01098110|2989654|P3|Overall Study|Not Specified|5
906190|NCT01098110|2989655|P2|Overall Study|Not Specified|7
906191|NCT01098110|2989656|P1|Overall Study|Not Specified|4
906192|NCT01098110|2989654|P3|Overall Study|Lack of Efficacy|27
906193|NCT01098110|2989655|P2|Overall Study|Lack of Efficacy|9
906194|NCT01098110|2989656|P1|Overall Study|Lack of Efficacy|13
906195|NCT01098110|2989654|P3|Overall Study|Adverse Event|43
906196|NCT01098110|2989655|P2|Overall Study|Adverse Event|32
906197|NCT01098110|2989656|P1|Overall Study|Adverse Event|30
906198|NCT01098110|2989654|P3|Overall Study|Withdrawal by Subject|19
906199|NCT01098110|2989655|P2|Overall Study|Withdrawal by Subject|24
906200|NCT01098110|2989656|P1|Overall Study|Withdrawal by Subject|14
906201|NCT01098097|2989697|P1|Overall Study|No reason reported|31
906202|NCT01098097|2989697|P1|Overall Study|Status unknown|16
906203|NCT01098097|2989697|P1|Overall Study|Lost to Follow-up|18
906204|NCT01098097|2989697|P1|Overall Study|Adverse Event|17
906205|NCT01098071|2989706|P1|Overall Study|Lost to Follow-up|13
906206|NCT01098071|2989706|P1|Overall Study|Surgery (adenoidectomy)|2
906207|NCT01098032|2989719|P2|Overall Study|Withdrawal by Subject|1
906208|NCT01098032|2989720|P1|Overall Study|Withdrawal by Subject|1
906209|NCT01097863|2989829|P3|Overall Study|Did not return for final visit|1
906210|NCT01097863|2989830|P2|Overall Study|Did not return for final visit|0
906211|NCT01097863|2989831|P1|Overall Study|Did not return for final visit|0
906212|NCT01097863|2989829|P3|Overall Study|Discomfort|1
906213|NCT01097863|2989830|P2|Overall Study|Discomfort|0
906214|NCT01097863|2989831|P1|Overall Study|Discomfort|1
906215|NCT01097694|2989852|P2|Overall Study|Withdrawal by Subject|1
906216|NCT01097694|2989853|P1|Overall Study|Withdrawal by Subject|3
906217|NCT01097694|2989852|P2|Overall Study|Lost to Follow-up|3
906218|NCT01097694|2989853|P1|Overall Study|Lost to Follow-up|0
906219|NCT01097694|2989852|P2|Overall Study|Adverse Event|0
906220|NCT01097694|2989853|P1|Overall Study|Adverse Event|5
906221|NCT01097668|2989915|P2|Overall Study|Lost to Follow-up|0
906222|NCT01097668|2989916|P1|Overall Study|Lost to Follow-up|1
906223|NCT01097668|2989915|P2|Overall Study|Withdrawal by Subject|2
906224|NCT01097668|2989916|P1|Overall Study|Withdrawal by Subject|1
906225|NCT01097655|2989926|P1|Overall Study|Did Not Meet Inclusion Criteria|8
906226|NCT01097655|2989926|P1|Overall Study|Subject Documented Twice|1
906227|NCT01097655|2989926|P1|Overall Study|Withdrawal by Subject|1
906228|NCT01097629|2989936|P8|DB RO Phase|Lost to Follow-up|0
906229|NCT01097629|2989937|P7|DB RO Phase|Lost to Follow-up|2
906230|NCT01097629|2989938|P6|DB RO Phase|Lost to Follow-up|0
906231|NCT01097629|2989939|P5|DB RO Phase|Lost to Follow-up|0
906232|NCT01097629|2989940|P4|DB RO Phase|Lost to Follow-up|0
906233|NCT01097629|2989941|P3|DB RO Phase|Lost to Follow-up|0
906234|NCT01097629|2989942|P2|DB RO Phase|Lost to Follow-up|0
906235|NCT01097629|2989943|P1|DB RO Phase|Lost to Follow-up|0
906236|NCT01097629|2989936|P8|DB RO Phase|Protocol Violation|0
906237|NCT01097629|2989937|P7|DB RO Phase|Protocol Violation|1
906238|NCT01097629|2989938|P6|DB RO Phase|Protocol Violation|1
906239|NCT01097629|2989939|P5|DB RO Phase|Protocol Violation|0
906240|NCT01097629|2989940|P4|DB RO Phase|Protocol Violation|1
906241|NCT01097629|2989941|P3|DB RO Phase|Protocol Violation|0
906242|NCT01097629|2989942|P2|DB RO Phase|Protocol Violation|0
906243|NCT01097629|2989943|P1|DB RO Phase|Protocol Violation|0
906244|NCT01097629|2989936|P8|DB RO Phase|Withdrawal by Subject|1
906245|NCT01097629|2989937|P7|DB RO Phase|Withdrawal by Subject|0
906246|NCT01097629|2989938|P6|DB RO Phase|Withdrawal by Subject|0
906247|NCT01097629|2989939|P5|DB RO Phase|Withdrawal by Subject|0
906248|NCT01097629|2989940|P4|DB RO Phase|Withdrawal by Subject|0
906249|NCT01097629|2989941|P3|DB RO Phase|Withdrawal by Subject|0
906250|NCT01097629|2989942|P2|DB RO Phase|Withdrawal by Subject|0
906251|NCT01097629|2989943|P1|DB RO Phase|Withdrawal by Subject|0
906252|NCT01097629|2989936|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
906253|NCT01097629|2989937|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
906254|NCT01097629|2989938|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
906255|NCT01097629|2989939|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
906256|NCT01097629|2989940|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
906257|NCT01097629|2989941|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4
906258|NCT01097629|2989942|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5
906259|NCT01097629|2989943|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
906260|NCT01097629|2989936|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
906261|NCT01097629|2989937|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
906262|NCT01097629|2989938|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
906263|NCT01097629|2989939|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
906264|NCT01097629|2989940|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
906265|NCT01097629|2989941|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
906266|NCT01097629|2989942|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1
906267|NCT01097629|2989943|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2
906268|NCT01097629|2989936|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
906269|NCT01097629|2989937|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
906270|NCT01097629|2989938|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
906271|NCT01097629|2989939|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
906272|NCT01097629|2989940|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
906273|NCT01097629|2989941|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8
906274|NCT01097629|2989942|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4
906275|NCT01097629|2989943|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
906276|NCT01097629|2989936|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
906277|NCT01097629|2989937|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
906278|NCT01097629|2989938|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
906279|NCT01097629|2989939|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
906280|NCT01097629|2989940|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
906281|NCT01097629|2989941|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
906282|NCT01097629|2989942|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4
906283|NCT01097629|2989943|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2
906284|NCT01097629|2989936|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
906285|NCT01097629|2989937|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
906286|NCT01097629|2989938|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
906287|NCT01097629|2989939|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
906288|NCT01097629|2989940|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
906289|NCT01097629|2989941|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8
906290|NCT01097629|2989942|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4
906291|NCT01097629|2989943|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
906292|NCT01097629|2989936|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
906293|NCT01097629|2989937|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
906294|NCT01097629|2989938|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
906295|NCT01097629|2989939|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
906296|NCT01097629|2989940|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
906297|NCT01097629|2989941|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19
906298|NCT01097629|2989942|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9
906299|NCT01097629|2989943|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
906300|NCT01097629|2989936|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
906301|NCT01097629|2989937|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
906302|NCT01097629|2989938|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
906303|NCT01097629|2989939|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
906304|NCT01097629|2989940|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
906305|NCT01097629|2989941|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17
906306|NCT01097629|2989942|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19
906307|NCT01097629|2989943|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10
906308|NCT01097616|2989994|P8|DB RO Phase|Not Treated in RO|0
906309|NCT01097616|2989995|P7|DB RO Phase|Not Treated in RO|0
906310|NCT01097616|2989996|P6|DB RO Phase|Not Treated in RO|1
906311|NCT01097616|2989997|P5|DB RO Phase|Not Treated in RO|0
906312|NCT01097616|2989998|P4|DB RO Phase|Not Treated in RO|0
906313|NCT01097616|2989999|P3|DB RO Phase|Not Treated in RO|0
906314|NCT01097616|2990000|P2|DB RO Phase|Not Treated in RO|0
906315|NCT01097616|2990001|P1|DB RO Phase|Not Treated in RO|0
906316|NCT01097616|2989994|P8|DB RO Phase|Lost to Follow-up|1
906317|NCT01097616|2989995|P7|DB RO Phase|Lost to Follow-up|0
906318|NCT01097616|2989996|P6|DB RO Phase|Lost to Follow-up|0
906319|NCT01097616|2989997|P5|DB RO Phase|Lost to Follow-up|1
906320|NCT01097616|2989998|P4|DB RO Phase|Lost to Follow-up|1
906321|NCT01097616|2989999|P3|DB RO Phase|Lost to Follow-up|0
906322|NCT01097616|2990000|P2|DB RO Phase|Lost to Follow-up|0
906323|NCT01097616|2990001|P1|DB RO Phase|Lost to Follow-up|0
906324|NCT01097616|2989994|P8|DB RO Phase|Withdrawal by Subject|0
906325|NCT01097616|2989995|P7|DB RO Phase|Withdrawal by Subject|0
906326|NCT01097616|2989996|P6|DB RO Phase|Withdrawal by Subject|1
906327|NCT01097616|2989997|P5|DB RO Phase|Withdrawal by Subject|0
906328|NCT01097616|2989998|P4|DB RO Phase|Withdrawal by Subject|0
906329|NCT01097616|2989999|P3|DB RO Phase|Withdrawal by Subject|0
906330|NCT01097616|2990000|P2|DB RO Phase|Withdrawal by Subject|0
906331|NCT01097616|2990001|P1|DB RO Phase|Withdrawal by Subject|0
906332|NCT01097616|2989994|P8|DB RO Phase|Adverse Event|0
906333|NCT01097616|2989995|P7|DB RO Phase|Adverse Event|1
906334|NCT01097616|2989996|P6|DB RO Phase|Adverse Event|0
906335|NCT01097616|2989997|P5|DB RO Phase|Adverse Event|0
906336|NCT01097616|2989998|P4|DB RO Phase|Adverse Event|0
906337|NCT01097616|2989999|P3|DB RO Phase|Adverse Event|0
906338|NCT01097616|2990000|P2|DB RO Phase|Adverse Event|0
906339|NCT01097616|2990001|P1|DB RO Phase|Adverse Event|0
906340|NCT01097616|2989994|P8|Optional DB EXT Phase|Physician Decision|0
906341|NCT01097616|2989995|P7|Optional DB EXT Phase|Physician Decision|0
906342|NCT01097616|2989996|P6|Optional DB EXT Phase|Physician Decision|0
906343|NCT01097616|2989997|P5|Optional DB EXT Phase|Physician Decision|0
906344|NCT01097616|2989998|P4|Optional DB EXT Phase|Physician Decision|0
906345|NCT01097616|2989999|P3|Optional DB EXT Phase|Physician Decision|0
906346|NCT01097616|2990000|P2|Optional DB EXT Phase|Physician Decision|0
906347|NCT01097616|2990001|P1|Optional DB EXT Phase|Physician Decision|1
906348|NCT01097616|2989994|P8|Optional DB EXT Phase|Lack of Efficacy|0
906349|NCT01097616|2989995|P7|Optional DB EXT Phase|Lack of Efficacy|0
906350|NCT01097616|2989996|P6|Optional DB EXT Phase|Lack of Efficacy|0
906351|NCT01097616|2989997|P5|Optional DB EXT Phase|Lack of Efficacy|0
906352|NCT01097616|2989998|P4|Optional DB EXT Phase|Lack of Efficacy|0
906353|NCT01097616|2989999|P3|Optional DB EXT Phase|Lack of Efficacy|1
906354|NCT01097616|2990000|P2|Optional DB EXT Phase|Lack of Efficacy|1
906355|NCT01097616|2990001|P1|Optional DB EXT Phase|Lack of Efficacy|1
906356|NCT01097616|2989994|P8|Optional DB EXT Phase|Lost to Follow-up|0
906357|NCT01097616|2989995|P7|Optional DB EXT Phase|Lost to Follow-up|0
906358|NCT01097616|2989996|P6|Optional DB EXT Phase|Lost to Follow-up|0
906359|NCT01097616|2989997|P5|Optional DB EXT Phase|Lost to Follow-up|0
906360|NCT01097616|2989998|P4|Optional DB EXT Phase|Lost to Follow-up|0
906361|NCT01097616|2989999|P3|Optional DB EXT Phase|Lost to Follow-up|1
906362|NCT01097616|2990000|P2|Optional DB EXT Phase|Lost to Follow-up|5
906363|NCT01097616|2990001|P1|Optional DB EXT Phase|Lost to Follow-up|1
906364|NCT01097616|2989994|P8|Optional DB EXT Phase|Protocol Violation|0
906365|NCT01097616|2989995|P7|Optional DB EXT Phase|Protocol Violation|0
906366|NCT01097616|2989996|P6|Optional DB EXT Phase|Protocol Violation|0
906367|NCT01097616|2989997|P5|Optional DB EXT Phase|Protocol Violation|0
906368|NCT01097616|2989998|P4|Optional DB EXT Phase|Protocol Violation|0
906369|NCT01097616|2989999|P3|Optional DB EXT Phase|Protocol Violation|3
906370|NCT01097616|2990000|P2|Optional DB EXT Phase|Protocol Violation|2
906371|NCT01097616|2990001|P1|Optional DB EXT Phase|Protocol Violation|0
906372|NCT01097616|2989994|P8|Optional DB EXT Phase|Withdrawal by Subject|0
906373|NCT01097616|2989995|P7|Optional DB EXT Phase|Withdrawal by Subject|0
906374|NCT01097616|2989996|P6|Optional DB EXT Phase|Withdrawal by Subject|0
906375|NCT01097616|2989997|P5|Optional DB EXT Phase|Withdrawal by Subject|0
906376|NCT01097616|2989998|P4|Optional DB EXT Phase|Withdrawal by Subject|0
906377|NCT01097616|2989999|P3|Optional DB EXT Phase|Withdrawal by Subject|3
906378|NCT01097616|2990000|P2|Optional DB EXT Phase|Withdrawal by Subject|6
906379|NCT01097616|2990001|P1|Optional DB EXT Phase|Withdrawal by Subject|12
906380|NCT01097616|2989994|P8|Optional DB EXT Phase|Adverse Event|0
906381|NCT01097616|2989995|P7|Optional DB EXT Phase|Adverse Event|0
906382|NCT01097616|2989996|P6|Optional DB EXT Phase|Adverse Event|0
906383|NCT01097616|2989997|P5|Optional DB EXT Phase|Adverse Event|0
906384|NCT01097616|2989998|P4|Optional DB EXT Phase|Adverse Event|0
906385|NCT01097616|2989999|P3|Optional DB EXT Phase|Adverse Event|2
906386|NCT01097616|2990000|P2|Optional DB EXT Phase|Adverse Event|7
906387|NCT01097616|2990001|P1|Optional DB EXT Phase|Adverse Event|0
906388|NCT01097616|2989994|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
906389|NCT01097616|2989995|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
906390|NCT01097616|2989996|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
906391|NCT01097616|2989997|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
906392|NCT01097616|2989998|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
906393|NCT01097616|2989999|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
906394|NCT01097616|2990000|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
906395|NCT01097616|2990001|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
906396|NCT01097616|2989994|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
906397|NCT01097616|2989995|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
906398|NCT01097616|2989996|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
906399|NCT01097616|2989997|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
906400|NCT01097616|2989998|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
906401|NCT01097616|2989999|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
906402|NCT01097616|2990000|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3
906403|NCT01097616|2990001|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4
906404|NCT01097616|2989994|P8|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
906405|NCT01097616|2989995|P7|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
906406|NCT01097616|2989996|P6|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
906407|NCT01097616|2989997|P5|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
906408|NCT01097616|2989998|P4|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
906409|NCT01097616|2989999|P3|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
906410|NCT01097616|2990000|P2|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
906411|NCT01097616|2990001|P1|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
906412|NCT01097616|2989994|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
906413|NCT01097616|2989995|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
906414|NCT01097616|2989996|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
906415|NCT01097616|2989997|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
906416|NCT01097616|2989998|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
906417|NCT01097616|2989999|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9
906418|NCT01097616|2990000|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
906419|NCT01097616|2990001|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1
906420|NCT01097616|2989994|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
906421|NCT01097616|2989995|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
906422|NCT01097616|2989996|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
906423|NCT01097616|2989997|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
906424|NCT01097616|2989998|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
906425|NCT01097616|2989999|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
906426|NCT01097616|2990000|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
906427|NCT01097616|2990001|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
906428|NCT01097616|2989994|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
906509|NCT01096667|2990317|P3|Overall Study|Withdrawal by Subject|0
906429|NCT01097616|2989995|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
906430|NCT01097616|2989996|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
906431|NCT01097616|2989997|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
906432|NCT01097616|2989998|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
906433|NCT01097616|2989999|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1
906434|NCT01097616|2990000|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3
906435|NCT01097616|2990001|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
906436|NCT01097616|2989994|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
906437|NCT01097616|2989995|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
906438|NCT01097616|2989996|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
906439|NCT01097616|2989997|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
906440|NCT01097616|2989998|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
906441|NCT01097616|2989999|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12
906442|NCT01097616|2990000|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
906443|NCT01097616|2990001|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6
906444|NCT01097616|2989994|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
906445|NCT01097616|2989995|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
906446|NCT01097616|2989996|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
906447|NCT01097616|2989997|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
906448|NCT01097616|2989998|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
906449|NCT01097616|2989999|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21
906450|NCT01097616|2990000|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15
906451|NCT01097616|2990001|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6
906452|NCT01097421|2990076|P1|Overall Study|Withdrawal by Subject|3
906453|NCT01097421|2990076|P1|Overall Study|Lost to Follow-up|1
906454|NCT01097421|2990076|P1|Overall Study|Protocol Violation|2
906455|NCT01097421|2990076|P1|Overall Study|Adverse Event|8
906456|NCT01097057|2990100|P1|Overall Study|Physician Decision|3
906457|NCT01097005|2990107|P1|Overall Study|Discontinuance by complication|50
906458|NCT01097005|2990107|P1|Overall Study|Adverse Event|14
906459|NCT01097005|2990107|P1|Overall Study|Deviation from exclusion criteria|37
906460|NCT01097005|2990107|P1|Overall Study|No examination data available|244
906461|NCT01097005|2990107|P1|Overall Study|Poor medication compliance|1
906462|NCT01097005|2990107|P1|Overall Study|Subjects cannot visit the hospital|1
906463|NCT01097005|2990107|P1|Overall Study|Case Report Form not collected|18
906464|NCT01096849|2990131|P3|Overall Study|Lost to Follow-up|1
906465|NCT01096849|2990132|P2|Overall Study|Lost to Follow-up|3
906466|NCT01096849|2990133|P1|Overall Study|Lost to Follow-up|1
906467|NCT01096849|2990131|P3|Overall Study|Administrative Reasons|2
906468|NCT01096849|2990132|P2|Overall Study|Administrative Reasons|1
906469|NCT01096849|2990133|P1|Overall Study|Administrative Reasons|0
906470|NCT01096849|2990131|P3|Overall Study|Investigator or Medical Monitor Decision|0
906471|NCT01096849|2990132|P2|Overall Study|Investigator or Medical Monitor Decision|1
906472|NCT01096849|2990133|P1|Overall Study|Investigator or Medical Monitor Decision|0
906473|NCT01096849|2990131|P3|Overall Study|Unacceptable/ Intolerable AE(s)|1
906474|NCT01096849|2990132|P2|Overall Study|Unacceptable/ Intolerable AE(s)|1
906475|NCT01096849|2990133|P1|Overall Study|Unacceptable/ Intolerable AE(s)|0
906476|NCT01096849|2990131|P3|Overall Study|Lack of Efficacy|0
906477|NCT01096849|2990132|P2|Overall Study|Lack of Efficacy|2
906478|NCT01096849|2990133|P1|Overall Study|Lack of Efficacy|0
906479|NCT01096849|2990131|P3|Overall Study|Consent Withdrawn|2
906480|NCT01096849|2990132|P2|Overall Study|Consent Withdrawn|4
906481|NCT01096849|2990133|P1|Overall Study|Consent Withdrawn|1
906482|NCT01096784|2990209|P2|Overall Study|Other Unspecified|1
906483|NCT01096784|2990210|P1|Overall Study|Other Unspecified|0
906484|NCT01096784|2990209|P2|Overall Study|Administrative Decision|1
906485|NCT01096784|2990210|P1|Overall Study|Administrative Decision|0
906486|NCT01096784|2990209|P2|Overall Study|Protocol Deviation|2
906487|NCT01096784|2990210|P1|Overall Study|Protocol Deviation|2
906488|NCT01096784|2990209|P2|Overall Study|Adverse Event|9
906489|NCT01096784|2990210|P1|Overall Study|Adverse Event|11
906490|NCT01096784|2990209|P2|Overall Study|Withdrawal by Subject|1
906491|NCT01096784|2990210|P1|Overall Study|Withdrawal by Subject|2
906492|NCT01096667|2990315|P5|Overall Study|Not treated|0
906493|NCT01096667|2990316|P4|Overall Study|Not treated|0
906494|NCT01096667|2990317|P3|Overall Study|Not treated|0
906495|NCT01096667|2990318|P2|Overall Study|Not treated|0
906496|NCT01096667|2990319|P1|Overall Study|Not treated|1
906497|NCT01096667|2990315|P5|Overall Study|Protocol Violation|0
906498|NCT01096667|2990316|P4|Overall Study|Protocol Violation|1
906499|NCT01096667|2990317|P3|Overall Study|Protocol Violation|0
906500|NCT01096667|2990318|P2|Overall Study|Protocol Violation|0
906501|NCT01096667|2990319|P1|Overall Study|Protocol Violation|0
906502|NCT01096667|2990315|P5|Overall Study|Reason not available|0
906503|NCT01096667|2990316|P4|Overall Study|Reason not available|1
906504|NCT01096667|2990317|P3|Overall Study|Reason not available|1
906505|NCT01096667|2990318|P2|Overall Study|Reason not available|1
906506|NCT01096667|2990319|P1|Overall Study|Reason not available|0
906507|NCT01096667|2990315|P5|Overall Study|Withdrawal by Subject|0
906508|NCT01096667|2990316|P4|Overall Study|Withdrawal by Subject|1
906510|NCT01096667|2990318|P2|Overall Study|Withdrawal by Subject|0
906511|NCT01096667|2990319|P1|Overall Study|Withdrawal by Subject|1
906512|NCT01096667|2990315|P5|Overall Study|Lost to Follow-up|0
906513|NCT01096667|2990316|P4|Overall Study|Lost to Follow-up|0
906514|NCT01096667|2990317|P3|Overall Study|Lost to Follow-up|1
906515|NCT01096667|2990318|P2|Overall Study|Lost to Follow-up|1
906516|NCT01096667|2990319|P1|Overall Study|Lost to Follow-up|1
906517|NCT01096589|2990461|P4|Overall Study|found treatment exhausting|1
906518|NCT01096589|2990462|P3|Overall Study|found treatment exhausting|0
906519|NCT01096589|2990463|P2|Overall Study|found treatment exhausting|0
906520|NCT01096589|2990464|P1|Overall Study|found treatment exhausting|0
906521|NCT01096589|2990461|P4|Overall Study|Compliance with protocol|0
906522|NCT01096589|2990462|P3|Overall Study|Compliance with protocol|1
906523|NCT01096589|2990463|P2|Overall Study|Compliance with protocol|0
906524|NCT01096589|2990464|P1|Overall Study|Compliance with protocol|0
906525|NCT01096589|2990461|P4|Overall Study|Withdrawal by Subject|1
906526|NCT01096589|2990462|P3|Overall Study|Withdrawal by Subject|1
906527|NCT01096589|2990463|P2|Overall Study|Withdrawal by Subject|1
906528|NCT01096589|2990464|P1|Overall Study|Withdrawal by Subject|2
906529|NCT01096589|2990461|P4|Overall Study|Adverse Event|1
906530|NCT01096589|2990462|P3|Overall Study|Adverse Event|2
906531|NCT01096589|2990463|P2|Overall Study|Adverse Event|1
906532|NCT01096589|2990464|P1|Overall Study|Adverse Event|2
906533|NCT01096550|2990480|P2|Overall Study|Lost to Follow-up|9
906534|NCT01096550|2990481|P1|Overall Study|Lost to Follow-up|12
906535|NCT01096550|2990480|P2|Overall Study|non-African American participant|6
906536|NCT01096550|2990481|P1|Overall Study|non-African American participant|13
906537|NCT01096550|2990480|P2|Overall Study|Withdrawal by Subject|1
906538|NCT01096550|2990481|P1|Overall Study|Withdrawal by Subject|0
906539|NCT01096550|2990480|P2|Overall Study|clinic readmission|1
906540|NCT01096550|2990481|P1|Overall Study|clinic readmission|1
906541|NCT01096550|2990480|P2|Overall Study|non-regular treatment track at clinic|1
906542|NCT01096550|2990481|P1|Overall Study|non-regular treatment track at clinic|1
906543|NCT01096550|2990480|P2|Overall Study|discontinued site|11
906544|NCT01096550|2990481|P1|Overall Study|discontinued site|10
906545|NCT01096446|2990489|P2|Overall Study|Protocol Violation|0
906546|NCT01096446|2990490|P1|Overall Study|Protocol Violation|2
906547|NCT01096446|2990489|P2|Overall Study|Death|0
906548|NCT01096446|2990490|P1|Overall Study|Death|1
906549|NCT01096342|2990495|P1|Overall Study|Protocol Violation|1
906550|NCT01096316|2990503|P2|Overall Study|Lost to Follow-up|9
906551|NCT01096316|2990504|P1|Overall Study|Lost to Follow-up|15
906552|NCT01096186|2990514|P1|Overall Study|Noncompliance with study drug|1
906553|NCT01096186|2990514|P1|Overall Study|Physician Decision|1
906554|NCT01096186|2990514|P1|Overall Study|Withdrawal by Subject|22
906555|NCT01096186|2990514|P1|Overall Study|Lost to Follow-up|2
906556|NCT01096186|2990514|P1|Overall Study|Lack of Efficacy|4
906557|NCT01096186|2990514|P1|Overall Study|Death|4
906558|NCT01096186|2990514|P1|Overall Study|Adverse Event|16
906559|NCT01096056|2990522|P2|Overall Study|Lost to Follow-up|1
906560|NCT01096056|2990523|P1|Overall Study|Lost to Follow-up|0
906561|NCT01096017|2990555|P2|Treatment Period 2|Eligibility criteria not fulfilled|1
906562|NCT01096017|2990556|P1|Treatment Period 2|Eligibility criteria not fulfilled|1
906563|NCT01095978|2990584|P1|Overall Study|Adverse Event|1
906564|NCT01095978|2990584|P1|Overall Study|Did not take Klacid SR|2
906565|NCT01095835|2990618|P3|Overall Study|Protocol Violation|0
906566|NCT01095835|2990619|P2|Overall Study|Protocol Violation|2
906567|NCT01095835|2990620|P1|Overall Study|Protocol Violation|1
906568|NCT01095835|2990618|P3|Overall Study|Non study compliance|1
906569|NCT01095835|2990619|P2|Overall Study|Non study compliance|0
906570|NCT01095835|2990620|P1|Overall Study|Non study compliance|0
906571|NCT01095835|2990618|P3|Overall Study|Withdrawal by Subject|0
906572|NCT01095835|2990619|P2|Overall Study|Withdrawal by Subject|3
906573|NCT01095835|2990620|P1|Overall Study|Withdrawal by Subject|1
906574|NCT01095835|2990618|P3|Overall Study|Physician Decision|1
906575|NCT01095835|2990619|P2|Overall Study|Physician Decision|0
906576|NCT01095835|2990620|P1|Overall Study|Physician Decision|0
906577|NCT01095835|2990618|P3|Overall Study|Lack of Efficacy|0
906578|NCT01095835|2990619|P2|Overall Study|Lack of Efficacy|1
906579|NCT01095835|2990620|P1|Overall Study|Lack of Efficacy|0
906580|NCT01095835|2990618|P3|Overall Study|Adverse Event|6
906581|NCT01095835|2990619|P2|Overall Study|Adverse Event|6
906582|NCT01095835|2990620|P1|Overall Study|Adverse Event|8
906583|NCT01095796|2990658|P2|Overall Study|Participant Transferred to Another Study|200
906584|NCT01095796|2990659|P1|Overall Study|Participant Transferred to Another Study|215
906585|NCT01095796|2990658|P2|Overall Study|Protocol Violation|0
906586|NCT01095796|2990659|P1|Overall Study|Protocol Violation|1
906587|NCT01095796|2990658|P2|Overall Study|Participant Noncompliance|10
906588|NCT01095796|2990659|P1|Overall Study|Participant Noncompliance|5
906589|NCT01095796|2990658|P2|Overall Study|Lost to Follow-up|29
906590|NCT01095796|2990659|P1|Overall Study|Lost to Follow-up|27
906591|NCT01095796|2990658|P2|Overall Study|Withdrew Consent|22
906592|NCT01095796|2990659|P1|Overall Study|Withdrew Consent|16
906593|NCT01095796|2990658|P2|Overall Study|Investigator's Discretion|2
906594|NCT01095796|2990659|P1|Overall Study|Investigator's Discretion|7
906595|NCT01095796|2990658|P2|Overall Study|Lack of Efficacy|3
906596|NCT01095796|2990659|P1|Overall Study|Lack of Efficacy|5
906597|NCT01095796|2990658|P2|Overall Study|Pregnancy|0
906598|NCT01095796|2990659|P1|Overall Study|Pregnancy|2
906599|NCT01095796|2990658|P2|Overall Study|Death|2
906600|NCT01095796|2990659|P1|Overall Study|Death|3
906601|NCT01095796|2990658|P2|Overall Study|Adverse Event|19
906602|NCT01095796|2990659|P1|Overall Study|Adverse Event|9
906603|NCT01095796|2990658|P2|Overall Study|Randomized but Not Treated|2
906604|NCT01095796|2990659|P1|Overall Study|Randomized but Not Treated|5
906605|NCT01095666|2990689|P3|Overall Study|Non-compliance, not met criteria etc.|2
906606|NCT01095666|2990690|P2|Overall Study|Non-compliance, not met criteria etc.|2
906607|NCT01095666|2990691|P1|Overall Study|Non-compliance, not met criteria etc.|7
906608|NCT01095666|2990689|P3|Overall Study|Withdrawal by Subject|1
906609|NCT01095666|2990690|P2|Overall Study|Withdrawal by Subject|6
906610|NCT01095666|2990691|P1|Overall Study|Withdrawal by Subject|6
906611|NCT01095666|2990689|P3|Overall Study|Lost to Follow-up|0
906612|NCT01095666|2990690|P2|Overall Study|Lost to Follow-up|2
906613|NCT01095666|2990691|P1|Overall Study|Lost to Follow-up|2
906614|NCT01095666|2990689|P3|Overall Study|Adverse Event|3
906615|NCT01095666|2990690|P2|Overall Study|Adverse Event|1
906616|NCT01095666|2990691|P1|Overall Study|Adverse Event|2
906617|NCT01095666|2990689|P3|Overall Study|Lack of Efficacy|1
906618|NCT01095666|2990690|P2|Overall Study|Lack of Efficacy|0
906619|NCT01095666|2990691|P1|Overall Study|Lack of Efficacy|0
906620|NCT01095653|2990714|P3|Overall Study|non-compliance, not met criteria, etc.|5
906621|NCT01095653|2990715|P2|Overall Study|non-compliance, not met criteria, etc.|6
906622|NCT01095653|2990716|P1|Overall Study|non-compliance, not met criteria, etc.|10
906623|NCT01095653|2990714|P3|Overall Study|Withdrawal by Subject|3
906624|NCT01095653|2990715|P2|Overall Study|Withdrawal by Subject|5
906625|NCT01095653|2990716|P1|Overall Study|Withdrawal by Subject|4
906626|NCT01095653|2990714|P3|Overall Study|Lost to Follow-up|4
906627|NCT01095653|2990715|P2|Overall Study|Lost to Follow-up|0
906628|NCT01095653|2990716|P1|Overall Study|Lost to Follow-up|1
906629|NCT01095653|2990714|P3|Overall Study|Adverse Event|4
906630|NCT01095653|2990715|P2|Overall Study|Adverse Event|4
906631|NCT01095653|2990716|P1|Overall Study|Adverse Event|1
906632|NCT01095653|2990714|P3|Overall Study|Lack of Efficacy|0
906633|NCT01095653|2990715|P2|Overall Study|Lack of Efficacy|0
906634|NCT01095653|2990716|P1|Overall Study|Lack of Efficacy|3
906635|NCT01095250|2990774|P4|Overall Study|Withdrawal by Subject|0
906636|NCT01095250|2990775|P3|Overall Study|Withdrawal by Subject|1
906637|NCT01095250|2990776|P2|Overall Study|Withdrawal by Subject|0
906638|NCT01095250|2990777|P1|Overall Study|Withdrawal by Subject|0
906639|NCT01095250|2990774|P4|Overall Study|administrative reasons|5
906640|NCT01095250|2990775|P3|Overall Study|administrative reasons|7
906641|NCT01095250|2990776|P2|Overall Study|administrative reasons|10
906642|NCT01095250|2990777|P1|Overall Study|administrative reasons|8
906643|NCT01095094|2990807|P1|Overall Study|Physician Decision|1
906644|NCT01095094|2990807|P1|Overall Study|Death|1
906645|NCT01095094|2990807|P1|Overall Study|Withdrawal by Subject|1
906646|NCT01094886|2990812|P1|Overall Study|Withdrawal by Subject|5
906647|NCT01094886|2990812|P1|Overall Study|Adverse Event|2
906648|NCT01094808|2990822|P3|Overall Study|Withdrawal by Subject|0
906649|NCT01094808|2990823|P2|Overall Study|Withdrawal by Subject|1
906650|NCT01094808|2990824|P1|Overall Study|Withdrawal by Subject|1
906651|NCT01094782|2990865|P6|Overall Study|Noncompliance With Study Schedule|0
906652|NCT01094782|2990866|P5|Overall Study|Noncompliance With Study Schedule|0
906653|NCT01094782|2990867|P4|Overall Study|Noncompliance With Study Schedule|1
906654|NCT01094782|2990868|P3|Overall Study|Noncompliance With Study Schedule|0
906655|NCT01094782|2990869|P2|Overall Study|Noncompliance With Study Schedule|0
906656|NCT01094782|2990870|P1|Overall Study|Noncompliance With Study Schedule|0
906657|NCT01094782|2990865|P6|Overall Study|Low Visual Analog Scale (VAS) Score|0
906658|NCT01094782|2990866|P5|Overall Study|Low Visual Analog Scale (VAS) Score|1
906659|NCT01094782|2990867|P4|Overall Study|Low Visual Analog Scale (VAS) Score|0
906660|NCT01094782|2990868|P3|Overall Study|Low Visual Analog Scale (VAS) Score|0
906661|NCT01094782|2990869|P2|Overall Study|Low Visual Analog Scale (VAS) Score|0
906662|NCT01094782|2990870|P1|Overall Study|Low Visual Analog Scale (VAS) Score|0
906663|NCT01094782|2990865|P6|Overall Study|Recent Interventional Injection|1
906664|NCT01094782|2990866|P5|Overall Study|Recent Interventional Injection|0
906665|NCT01094782|2990867|P4|Overall Study|Recent Interventional Injection|0
906666|NCT01094782|2990868|P3|Overall Study|Recent Interventional Injection|0
906667|NCT01094782|2990869|P2|Overall Study|Recent Interventional Injection|0
906668|NCT01094782|2990870|P1|Overall Study|Recent Interventional Injection|0
906669|NCT01094782|2990865|P6|Overall Study|Wrong Pain Condition|1
906670|NCT01094782|2990866|P5|Overall Study|Wrong Pain Condition|1
906671|NCT01094782|2990867|P4|Overall Study|Wrong Pain Condition|2
906672|NCT01094782|2990868|P3|Overall Study|Wrong Pain Condition|0
906673|NCT01094782|2990869|P2|Overall Study|Wrong Pain Condition|0
906674|NCT01094782|2990870|P1|Overall Study|Wrong Pain Condition|0
906675|NCT01094782|2990865|P6|Overall Study|Hypertension|0
906676|NCT01094782|2990866|P5|Overall Study|Hypertension|0
906677|NCT01094782|2990867|P4|Overall Study|Hypertension|0
906678|NCT01094782|2990868|P3|Overall Study|Hypertension|1
906679|NCT01094782|2990869|P2|Overall Study|Hypertension|0
906680|NCT01094782|2990870|P1|Overall Study|Hypertension|0
906681|NCT01094782|2990865|P6|Overall Study|Healthy Subject Had Pain|0
906682|NCT01094782|2990866|P5|Overall Study|Healthy Subject Had Pain|0
906683|NCT01094782|2990867|P4|Overall Study|Healthy Subject Had Pain|0
906684|NCT01094782|2990868|P3|Overall Study|Healthy Subject Had Pain|0
906685|NCT01094782|2990869|P2|Overall Study|Healthy Subject Had Pain|1
906686|NCT01094782|2990870|P1|Overall Study|Healthy Subject Had Pain|0
906687|NCT01094782|2990865|P6|Overall Study|Unable to Complete Questionnaires|0
906688|NCT01094782|2990866|P5|Overall Study|Unable to Complete Questionnaires|0
906689|NCT01094782|2990867|P4|Overall Study|Unable to Complete Questionnaires|0
906690|NCT01094782|2990868|P3|Overall Study|Unable to Complete Questionnaires|0
906691|NCT01094782|2990869|P2|Overall Study|Unable to Complete Questionnaires|1
906692|NCT01094782|2990870|P1|Overall Study|Unable to Complete Questionnaires|0
906693|NCT01094782|2990865|P6|Overall Study|Sensory Deficit at Site of QST|0
906694|NCT01094782|2990866|P5|Overall Study|Sensory Deficit at Site of QST|0
906695|NCT01094782|2990867|P4|Overall Study|Sensory Deficit at Site of QST|0
906696|NCT01094782|2990868|P3|Overall Study|Sensory Deficit at Site of QST|0
906697|NCT01094782|2990869|P2|Overall Study|Sensory Deficit at Site of QST|1
906698|NCT01094782|2990870|P1|Overall Study|Sensory Deficit at Site of QST|0
906699|NCT01094782|2990865|P6|Overall Study|Positive Drug Screen|2
906700|NCT01094782|2990866|P5|Overall Study|Positive Drug Screen|3
906701|NCT01094782|2990867|P4|Overall Study|Positive Drug Screen|1
906702|NCT01094782|2990868|P3|Overall Study|Positive Drug Screen|1
906703|NCT01094782|2990869|P2|Overall Study|Positive Drug Screen|2
906704|NCT01094782|2990870|P1|Overall Study|Positive Drug Screen|2
906705|NCT01094782|2990865|P6|Overall Study|Lost to Follow-up|4
906706|NCT01094782|2990866|P5|Overall Study|Lost to Follow-up|1
906707|NCT01094782|2990867|P4|Overall Study|Lost to Follow-up|2
906708|NCT01094782|2990868|P3|Overall Study|Lost to Follow-up|0
906709|NCT01094782|2990869|P2|Overall Study|Lost to Follow-up|0
906710|NCT01094782|2990870|P1|Overall Study|Lost to Follow-up|1
906711|NCT01094782|2990865|P6|Overall Study|Withdrawal by Subject|0
906712|NCT01094782|2990866|P5|Overall Study|Withdrawal by Subject|5
906713|NCT01094782|2990867|P4|Overall Study|Withdrawal by Subject|5
906714|NCT01094782|2990868|P3|Overall Study|Withdrawal by Subject|1
906715|NCT01094782|2990869|P2|Overall Study|Withdrawal by Subject|5
906716|NCT01094782|2990870|P1|Overall Study|Withdrawal by Subject|5
906717|NCT01094743|2990914|P1|Period 1|Unsatisfactory comfort at lens fitting|2
906718|NCT01094730|2990931|P2|Period 2 (14 Days)|Unsatisfactory lens fitting|1
906719|NCT01094730|2990932|P1|Period 2 (14 Days)|Unsatisfactory lens fitting|0
906720|NCT01094730|2990931|P2|Period 2 (14 Days)|Adverse Event|1
906721|NCT01094730|2990932|P1|Period 2 (14 Days)|Adverse Event|0
906722|NCT01094730|2990931|P2|Period 2 (14 Days)|No time for the follow-up visit|0
906723|NCT01094730|2990932|P1|Period 2 (14 Days)|No time for the follow-up visit|1
906724|NCT01094730|2990931|P2|Period 2 (14 Days)|Protocol Violation|0
906725|NCT01094730|2990932|P1|Period 2 (14 Days)|Protocol Violation|2
906726|NCT01094730|2990931|P2|Period 1 (14 Days)|Unsatisfactory visual response|0
906727|NCT01094730|2990932|P1|Period 1 (14 Days)|Unsatisfactory visual response|1
906728|NCT01094730|2990931|P2|Period 1 (14 Days)|No time for the follow-up visit|0
906729|NCT01094730|2990932|P1|Period 1 (14 Days)|No time for the follow-up visit|1
906730|NCT01094730|2990931|P2|Period 1 (14 Days)|Withdrawal by Subject|1
906731|NCT01094730|2990932|P1|Period 1 (14 Days)|Withdrawal by Subject|0
906732|NCT01094730|2990931|P2|Period 1 (14 Days)|Lost to Follow-up|1
906733|NCT01094730|2990932|P1|Period 1 (14 Days)|Lost to Follow-up|0
906734|NCT01094301|2991049|P1|Implant Stage|No return of pain|4
906735|NCT01094301|2991049|P1|Implant Stage|Withdrawal by Subject|2
906736|NCT01094301|2991049|P1|Implant Stage|Protocol Violation|1
906737|NCT01094301|2991049|P1|Implant Stage|Adverse Event|1
906738|NCT01094301|2991049|P1|Trial Stage|Withdrawal by Subject|1
906739|NCT01094184|2991073|P2|Overall Study|Death|11
906740|NCT01094184|2991074|P1|Overall Study|Death|35
906741|NCT01094171|2991308|P1|Overall Study|Other|1
906742|NCT01094171|2991308|P1|Overall Study|Migration from the study area|3
906743|NCT01094171|2991308|P1|Overall Study|Informed consent withdrawal|4
906744|NCT01094171|2991308|P1|Overall Study|Lost to Follow-up|2
906745|NCT01094119|2991317|P2|Overall Study|Lack of Efficacy|4
906746|NCT01094119|2991318|P1|Overall Study|Lack of Efficacy|2
906747|NCT01093885|2991330|P1|Overall Study|Lost to Follow-up|1
906748|NCT01093885|2991330|P1|Overall Study|Adverse Event|4
906749|NCT01093846|2991338|P3|Overall Study|Administrative Problems|15
906750|NCT01093846|2991339|P2|Overall Study|Administrative Problems|17
906751|NCT01093846|2991340|P1|Overall Study|Administrative Problems|18
906752|NCT01093846|2991338|P3|Overall Study|Condition no longer required study drug|1
906753|NCT01093846|2991339|P2|Overall Study|Condition no longer required study drug|1
906754|NCT01093846|2991340|P1|Overall Study|Condition no longer required study drug|1
906755|NCT01093846|2991338|P3|Overall Study|Lack of Efficacy|4
906756|NCT01093846|2991339|P2|Overall Study|Lack of Efficacy|0
906757|NCT01093846|2991340|P1|Overall Study|Lack of Efficacy|0
906758|NCT01093846|2991338|P3|Overall Study|Adverse Event|1
906759|NCT01093846|2991339|P2|Overall Study|Adverse Event|0
906760|NCT01093846|2991340|P1|Overall Study|Adverse Event|0
906761|NCT01093755|2991365|P2|Overall Study|Withdrawal by Subject|4
906762|NCT01093755|2991366|P1|Overall Study|Withdrawal by Subject|3
906763|NCT01093625|2991406|P2|1-Year Visit|Lost to Follow-up|3
906764|NCT01093625|2991407|P1|1-Year Visit|Lost to Follow-up|5
906765|NCT01093625|2991406|P2|6-Month Visit|Lost to Follow-up|2
906766|NCT01093625|2991407|P1|6-Month Visit|Lost to Follow-up|2
906767|NCT01093625|2991406|P2|6-Month Visit|Withdrawal by Subject|7
906768|NCT01093625|2991407|P1|6-Month Visit|Withdrawal by Subject|6
906769|NCT01093625|2991406|P2|3-Month Visit|Lost to Follow-up|0
906770|NCT01093625|2991407|P1|3-Month Visit|Lost to Follow-up|2
906771|NCT01093625|2991406|P2|1-Month Visit|Lost to Follow-up|0
906772|NCT01093625|2991407|P1|1-Month Visit|Lost to Follow-up|2
906773|NCT01093625|2991406|P2|2-Week Visit|Withdrawal by Subject|0
906774|NCT01093625|2991407|P1|2-Week Visit|Withdrawal by Subject|1
906775|NCT01093625|2991406|P2|Baseline and Dispensed|Withdrawal by Subject|0
906776|NCT01093625|2991407|P1|Baseline and Dispensed|Withdrawal by Subject|2
906777|NCT01093599|2991427|P2|Overall Study|Lost to Follow-up|46
906778|NCT01093599|2991428|P1|Overall Study|Lost to Follow-up|32
906779|NCT01093534|2991437|P3|Overall Study|Other|4
906780|NCT01093534|2991438|P2|Overall Study|Other|3
906781|NCT01093534|2991439|P1|Overall Study|Other|1
906782|NCT01093534|2991437|P3|Overall Study|Withdrawal by Subject|2
906783|NCT01093534|2991438|P2|Overall Study|Withdrawal by Subject|7
906784|NCT01093534|2991439|P1|Overall Study|Withdrawal by Subject|5
906785|NCT01093534|2991437|P3|Overall Study|Lack of Efficacy|1
906786|NCT01093534|2991438|P2|Overall Study|Lack of Efficacy|1
906787|NCT01093534|2991439|P1|Overall Study|Lack of Efficacy|2
906788|NCT01093534|2991437|P3|Overall Study|Adverse Event|2
906789|NCT01093534|2991438|P2|Overall Study|Adverse Event|5
906790|NCT01093534|2991439|P1|Overall Study|Adverse Event|2
906791|NCT01093222|2991587|P1|Overall Study|Not protocol specified|1
906792|NCT01093222|2991587|P1|Overall Study|Death|2
906793|NCT01093222|2991587|P1|Overall Study|Progression/relapse|24
906794|NCT01093222|2991587|P1|Overall Study|Adverse Event|7
906795|NCT01093222|2991587|P1|Overall Study|Ineligible|6
906796|NCT01092832|2991660|P2|Overall Study|Not specified|0
906797|NCT01092832|2991661|P1|Overall Study|Not specified|1
906798|NCT01092780|2991673|P4|Washout Period 2|Adverse Event|0
906799|NCT01092780|2991674|P3|Washout Period 2|Adverse Event|1
906800|NCT01092780|2991675|P2|Washout Period 2|Adverse Event|1
906801|NCT01092780|2991676|P1|Washout Period 2|Adverse Event|0
906802|NCT01092780|2991673|P4|Washout Period 1|Noncompliance with nCPAP|0
906803|NCT01092780|2991674|P3|Washout Period 1|Noncompliance with nCPAP|0
906804|NCT01092780|2991675|P2|Washout Period 1|Noncompliance with nCPAP|0
906805|NCT01092780|2991676|P1|Washout Period 1|Noncompliance with nCPAP|1
906806|NCT01092780|2991673|P4|Washout Period 1|Adverse Event|0
906807|NCT01092780|2991674|P3|Washout Period 1|Adverse Event|0
906808|NCT01092780|2991675|P2|Washout Period 1|Adverse Event|1
906809|NCT01092780|2991676|P1|Washout Period 1|Adverse Event|0
906810|NCT01092728|2991712|P2|Overall Study|Prohibited Concomitant Medications|0
906811|NCT01092728|2991713|P1|Overall Study|Prohibited Concomitant Medications|1
906812|NCT01092728|2991712|P2|Overall Study|Disease Progression|13
906813|NCT01092728|2991713|P1|Overall Study|Disease Progression|1
906814|NCT01092728|2991712|P2|Overall Study|Adverse Event|1
906815|NCT01092728|2991713|P1|Overall Study|Adverse Event|0
906816|NCT01092728|2991712|P2|Overall Study|Withdrawal by Subject|0
906817|NCT01092728|2991713|P1|Overall Study|Withdrawal by Subject|2
906818|NCT01092702|2991721|P1|Overall Study|Lost to Follow-up|2
906819|NCT01092702|2991721|P1|Overall Study|Withdrawal by Subject|7
906820|NCT01092663|2991727|P2|Overall Study|Protocol Violation|1
906821|NCT01092663|2991728|P1|Overall Study|Protocol Violation|0
906822|NCT01092663|2991727|P2|Overall Study|Adverse Event|1
906823|NCT01092663|2991728|P1|Overall Study|Adverse Event|1
906824|NCT01092663|2991727|P2|Overall Study|High fasting triglyceride|0
906825|NCT01092663|2991728|P1|Overall Study|High fasting triglyceride|2
906826|NCT01092663|2991727|P2|Overall Study|Glucose >300mg/dL|0
906827|NCT01092663|2991728|P1|Overall Study|Glucose >300mg/dL|1
906828|NCT01092663|2991727|P2|Overall Study|Withdrawal by Subject|2
906829|NCT01092663|2991728|P1|Overall Study|Withdrawal by Subject|3
906830|NCT01092637|2991776|P2|Overall Study|Death|49
906831|NCT01092637|2991777|P1|Overall Study|Death|47
906832|NCT01092546|2991792|P1|Overall Study|Subjects withdrawn prior to dosing|4
906833|NCT01092507|2991799|P2|Overall Study|Withdrawal by Subject|0
906834|NCT01092507|2991800|P1|Overall Study|Withdrawal by Subject|2
906835|NCT01092416|2991835|P1|12-Month Follow-up|Data collected after close of 1Y window|2
906836|NCT01092416|2991835|P1|12-Month Follow-up|Missed 1-year follow-up|1
906837|NCT01092416|2991835|P1|12-Month Follow-up|Withdrawal by Subject|2
906838|NCT01092416|2991835|P1|12-Month Follow-up|Lost to Follow-up|4
906839|NCT01092416|2991835|P1|12-Month Follow-up|Death|16
906840|NCT01092416|2991835|P1|30-Day Follow-up|Data collected after close of 30D window|5
906841|NCT01092416|2991835|P1|30-Day Follow-up|Missed 30-day follow-up|3
906842|NCT01092416|2991835|P1|30-Day Follow-up|Death|2
906843|NCT01092416|2991835|P1|Enrollment|Atherectomy device not inserted|3
906844|NCT01091974|2991872|P4|Overall Study|side-effects|2
906845|NCT01091974|2991873|P3|Overall Study|side-effects|0
906846|NCT01091974|2991874|P2|Overall Study|side-effects|1
906847|NCT01091974|2991875|P1|Overall Study|side-effects|1
906848|NCT01091974|2991872|P4|Overall Study|Withdrawal by Subject|2
906849|NCT01091974|2991873|P3|Overall Study|Withdrawal by Subject|2
906850|NCT01091974|2991874|P2|Overall Study|Withdrawal by Subject|3
906851|NCT01091974|2991875|P1|Overall Study|Withdrawal by Subject|1
906852|NCT01091974|2991872|P4|Overall Study|resumed sleep medication|2
906853|NCT01091974|2991873|P3|Overall Study|resumed sleep medication|1
906854|NCT01091974|2991874|P2|Overall Study|resumed sleep medication|0
906855|NCT01091974|2991875|P1|Overall Study|resumed sleep medication|0
906856|NCT01091974|2991872|P4|Overall Study|Did not start intervention|1
906857|NCT01091974|2991873|P3|Overall Study|Did not start intervention|3
906858|NCT01091974|2991874|P2|Overall Study|Did not start intervention|1
906859|NCT01091974|2991875|P1|Overall Study|Did not start intervention|3
906860|NCT01091675|2991910|P1|Overall Study|Lack of Efficacy|27
906861|NCT01091675|2991910|P1|Overall Study|Adverse Event|7
906862|NCT01091662|2991916|P2|Overall Study|unable to swallow capsule|1
906863|NCT01091662|2991917|P1|Overall Study|unable to swallow capsule|0
906864|NCT01091662|2991916|P2|Overall Study|Protocol Violation|2
906865|NCT01091662|2991917|P1|Overall Study|Protocol Violation|0
906866|NCT01091662|2991916|P2|Overall Study|Pregnancy|1
906867|NCT01091662|2991917|P1|Overall Study|Pregnancy|0
906868|NCT01091662|2991916|P2|Overall Study|Lost to Follow-up|1
906869|NCT01091662|2991917|P1|Overall Study|Lost to Follow-up|0
906870|NCT01091662|2991916|P2|Overall Study|met exclusion criteria|0
906871|NCT01091662|2991917|P1|Overall Study|met exclusion criteria|1
906872|NCT01091662|2991916|P2|Overall Study|met exit criteria|13
906873|NCT01091662|2991917|P1|Overall Study|met exit criteria|7
906874|NCT01091662|2991916|P2|Overall Study|Withdrawal by Subject|6
906875|NCT01091662|2991917|P1|Overall Study|Withdrawal by Subject|7
906876|NCT01091662|2991916|P2|Overall Study|Physician Decision|1
906877|NCT01091662|2991917|P1|Overall Study|Physician Decision|1
906878|NCT01091662|2991916|P2|Overall Study|Adverse Event|9
906879|NCT01091662|2991917|P1|Overall Study|Adverse Event|1
906880|NCT01091519|2991955|P2|Overall Study|Randomized not treated|4
906881|NCT01091519|2991956|P1|Overall Study|Randomized not treated|4
906882|NCT01091519|2991955|P2|Overall Study|Other|8
906883|NCT01091519|2991956|P1|Overall Study|Other|6
906884|NCT01091519|2991955|P2|Overall Study|Withdrawal by Subject|2
906885|NCT01091519|2991956|P1|Overall Study|Withdrawal by Subject|2
906886|NCT01091519|2991955|P2|Overall Study|Lost to Follow-up|24
906887|NCT01091519|2991956|P1|Overall Study|Lost to Follow-up|14
906888|NCT01091519|2991955|P2|Overall Study|Lack of Efficacy|19
906889|NCT01091519|2991956|P1|Overall Study|Lack of Efficacy|16
906890|NCT01091519|2991955|P2|Overall Study|Death|0
906891|NCT01091519|2991956|P1|Overall Study|Death|1
906892|NCT01091519|2991955|P2|Overall Study|Adverse Event|16
906893|NCT01091519|2991956|P1|Overall Study|Adverse Event|12
906894|NCT01091454|2991968|P1|Overall Study|Ineligible|1
906895|NCT01091428|2991981|P4|Phase 2|Physician Decision|0
906896|NCT01091428|2991982|P3|Phase 2|Physician Decision|2
906897|NCT01091428|2991983|P2|Phase 2|Physician Decision|0
906898|NCT01091428|2991984|P1|Phase 2|Physician Decision|0
906899|NCT01091428|2991981|P4|Phase 2|Reason not specified|3
906900|NCT01091428|2991982|P3|Phase 2|Reason not specified|4
906901|NCT01091428|2991983|P2|Phase 2|Reason not specified|0
906902|NCT01091428|2991984|P1|Phase 2|Reason not specified|0
906903|NCT01091428|2991981|P4|Phase 2|Unsatisfactory Therapeutic Response|1
906904|NCT01091428|2991982|P3|Phase 2|Unsatisfactory Therapeutic Response|1
906905|NCT01091428|2991983|P2|Phase 2|Unsatisfactory Therapeutic Response|0
906906|NCT01091428|2991984|P1|Phase 2|Unsatisfactory Therapeutic Response|0
906907|NCT01091428|2991981|P4|Phase 2|Withdrawal by Subject|8
906908|NCT01091428|2991982|P3|Phase 2|Withdrawal by Subject|9
906909|NCT01091428|2991983|P2|Phase 2|Withdrawal by Subject|0
906910|NCT01091428|2991984|P1|Phase 2|Withdrawal by Subject|0
906911|NCT01091428|2991981|P4|Phase 2|Adverse Event|5
906912|NCT01091428|2991982|P3|Phase 2|Adverse Event|12
906913|NCT01091428|2991983|P2|Phase 2|Adverse Event|0
906914|NCT01091428|2991984|P1|Phase 2|Adverse Event|0
906915|NCT01091428|2991981|P4|Phase 2|Symptomatic Deterioration|6
906916|NCT01091428|2991982|P3|Phase 2|Symptomatic Deterioration|1
906917|NCT01091428|2991983|P2|Phase 2|Symptomatic Deterioration|0
906918|NCT01091428|2991984|P1|Phase 2|Symptomatic Deterioration|0
906919|NCT01091428|2991981|P4|Phase 2|Progressive Disease|46
906920|NCT01091428|2991982|P3|Phase 2|Progressive Disease|44
906921|NCT01091428|2991983|P2|Phase 2|Progressive Disease|0
906922|NCT01091428|2991984|P1|Phase 2|Progressive Disease|0
906923|NCT01091428|2991981|P4|Phase 1|Single-Patient IND|0
906924|NCT01091428|2991982|P3|Phase 1|Single-Patient IND|0
906925|NCT01091428|2991983|P2|Phase 1|Single-Patient IND|0
906926|NCT01091428|2991984|P1|Phase 1|Single-Patient IND|2
906927|NCT01091428|2991981|P4|Phase 1|Reason not specified|0
906928|NCT01091428|2991982|P3|Phase 1|Reason not specified|0
906929|NCT01091428|2991983|P2|Phase 1|Reason not specified|1
906930|NCT01091428|2991984|P1|Phase 1|Reason not specified|0
906931|NCT01091428|2991981|P4|Phase 1|Withdrawal by Subject|0
906932|NCT01091428|2991982|P3|Phase 1|Withdrawal by Subject|0
906933|NCT01091428|2991983|P2|Phase 1|Withdrawal by Subject|0
906934|NCT01091428|2991984|P1|Phase 1|Withdrawal by Subject|7
906935|NCT01091428|2991981|P4|Phase 1|Adverse Event|0
906936|NCT01091428|2991982|P3|Phase 1|Adverse Event|0
906937|NCT01091428|2991983|P2|Phase 1|Adverse Event|0
906938|NCT01091428|2991984|P1|Phase 1|Adverse Event|2
906939|NCT01091428|2991981|P4|Phase 1|Symptomatic Deterioration|0
906940|NCT01091428|2991982|P3|Phase 1|Symptomatic Deterioration|0
906941|NCT01091428|2991983|P2|Phase 1|Symptomatic Deterioration|2
906942|NCT01091428|2991984|P1|Phase 1|Symptomatic Deterioration|3
906943|NCT01091428|2991981|P4|Phase 1|Progressive Disease|0
906944|NCT01091428|2991982|P3|Phase 1|Progressive Disease|0
906945|NCT01091428|2991983|P2|Phase 1|Progressive Disease|8
906946|NCT01091428|2991984|P1|Phase 1|Progressive Disease|24
906947|NCT01091259|2992085|P1|Overall Study|Lack of Efficacy|2
906948|NCT01091259|2992085|P1|Overall Study|Adverse Event|3
906949|NCT01091246|2992096|P3|Overall Study|Subject not dosed|1
906950|NCT01091246|2992097|P2|Overall Study|Subject not dosed|0
906951|NCT01091246|2992098|P1|Overall Study|Subject not dosed|2
906952|NCT01091246|2992096|P3|Overall Study|Withdrawal by Subject|4
906953|NCT01091246|2992097|P2|Overall Study|Withdrawal by Subject|5
906954|NCT01091246|2992098|P1|Overall Study|Withdrawal by Subject|9
906955|NCT01091246|2992096|P3|Overall Study|Adverse Event|1
906956|NCT01091246|2992097|P2|Overall Study|Adverse Event|0
906957|NCT01091246|2992098|P1|Overall Study|Adverse Event|1
906958|NCT01091246|2992096|P3|Overall Study|Lost to Follow-up|7
906959|NCT01091246|2992097|P2|Overall Study|Lost to Follow-up|11
906960|NCT01091246|2992098|P1|Overall Study|Lost to Follow-up|23
906961|NCT01091103|2992237|P1|Overall Study|Progressive Disease|3
906962|NCT01091103|2992237|P1|Overall Study|Adverse Event|1
906963|NCT01090973|2992257|P1|Overall Study|Disease progression|1
906964|NCT01090765|2992273|P6|Overall Study|Vasovagal reaction with first infusion|0
906965|NCT01090765|2992274|P5|Overall Study|Vasovagal reaction with first infusion|1
906966|NCT01090765|2992275|P4|Overall Study|Vasovagal reaction with first infusion|0
906967|NCT01090765|2992276|P3|Overall Study|Vasovagal reaction with first infusion|0
906968|NCT01090765|2992277|P2|Overall Study|Vasovagal reaction with first infusion|0
906969|NCT01090765|2992278|P1|Overall Study|Vasovagal reaction with first infusion|0
906970|NCT01090765|2992273|P6|Overall Study|Developed a DVT, needed anticoagulation|0
906971|NCT01090765|2992274|P5|Overall Study|Developed a DVT, needed anticoagulation|0
906972|NCT01090765|2992275|P4|Overall Study|Developed a DVT, needed anticoagulation|1
906973|NCT01090765|2992276|P3|Overall Study|Developed a DVT, needed anticoagulation|0
906974|NCT01090765|2992277|P2|Overall Study|Developed a DVT, needed anticoagulation|0
906975|NCT01090765|2992278|P1|Overall Study|Developed a DVT, needed anticoagulation|0
906976|NCT01090765|2992273|P6|Overall Study|Patient withdrew consent|1
906977|NCT01090765|2992274|P5|Overall Study|Patient withdrew consent|1
906978|NCT01090765|2992275|P4|Overall Study|Patient withdrew consent|0
906979|NCT01090765|2992276|P3|Overall Study|Patient withdrew consent|0
906980|NCT01090765|2992277|P2|Overall Study|Patient withdrew consent|0
906981|NCT01090765|2992278|P1|Overall Study|Patient withdrew consent|0
906982|NCT01090739|2992324|P1|36 Month Follow-up|Visit still pending|17
906983|NCT01090739|2992324|P1|36 Month Follow-up|Withdrawal by Subject|6
906984|NCT01090739|2992324|P1|24 Month Follow-up|Death|1
906985|NCT01090739|2992324|P1|24 Month Follow-up|Lost to Follow-up|1
906986|NCT01090739|2992324|P1|24 Month Follow-up|Withdrawal by Subject|7
906987|NCT01090739|2992324|P1|12 Month Follow-up|Death|1
906988|NCT01090739|2992324|P1|12 Month Follow-up|Physician Decision|1
906989|NCT01090739|2992324|P1|12 Month Follow-up|Lost to Follow-up|1
906990|NCT01090739|2992324|P1|12 Month Follow-up|Withdrawal by Subject|2
906991|NCT01090739|2992324|P1|Enrollment|Adverse Event|1
906992|NCT01090739|2992324|P1|Enrollment|Study implant limit reached|2
906993|NCT01090739|2992324|P1|Enrollment|Sponsor termination of site|4
906994|NCT01090739|2992324|P1|Enrollment|Physician Decision|5
906995|NCT01090739|2992324|P1|Enrollment|Lost to Follow-up|5
906996|NCT01090739|2992324|P1|Enrollment|Protocol Violation|14
906997|NCT01090739|2992324|P1|Enrollment|Withdrawal by Subject|24
906998|NCT01090492|2992349|P8|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
906999|NCT01090492|2992350|P7|Second Intervention Period (4 Weeks)|Lost to Follow-up|1
907000|NCT01090492|2992351|P6|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
907001|NCT01090492|2992352|P5|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
907002|NCT01090492|2992353|P4|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
907003|NCT01090492|2992354|P3|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
907004|NCT01090492|2992355|P2|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
907005|NCT01090492|2992356|P1|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
907006|NCT01090492|2992349|P8|Second Intervention Period (4 Weeks)|Adverse Event|1
907007|NCT01090492|2992350|P7|Second Intervention Period (4 Weeks)|Adverse Event|7
907008|NCT01090492|2992351|P6|Second Intervention Period (4 Weeks)|Adverse Event|1
907009|NCT01090492|2992352|P5|Second Intervention Period (4 Weeks)|Adverse Event|1
907010|NCT01090492|2992353|P4|Second Intervention Period (4 Weeks)|Adverse Event|0
907011|NCT01090492|2992354|P3|Second Intervention Period (4 Weeks)|Adverse Event|1
907012|NCT01090492|2992355|P2|Second Intervention Period (4 Weeks)|Adverse Event|0
907013|NCT01090492|2992356|P1|Second Intervention Period (4 Weeks)|Adverse Event|0
907014|NCT01090492|2992349|P8|Second Intervention Period (4 Weeks)|Other|0
907015|NCT01090492|2992350|P7|Second Intervention Period (4 Weeks)|Other|0
907016|NCT01090492|2992351|P6|Second Intervention Period (4 Weeks)|Other|0
907017|NCT01090492|2992352|P5|Second Intervention Period (4 Weeks)|Other|0
907018|NCT01090492|2992353|P4|Second Intervention Period (4 Weeks)|Other|0
907019|NCT01090492|2992354|P3|Second Intervention Period (4 Weeks)|Other|1
907020|NCT01090492|2992355|P2|Second Intervention Period (4 Weeks)|Other|1
907021|NCT01090492|2992356|P1|Second Intervention Period (4 Weeks)|Other|0
907022|NCT01090492|2992349|P8|Second Intervention Period (4 Weeks)|Non-compliance|0
907023|NCT01090492|2992350|P7|Second Intervention Period (4 Weeks)|Non-compliance|0
907024|NCT01090492|2992351|P6|Second Intervention Period (4 Weeks)|Non-compliance|0
907025|NCT01090492|2992352|P5|Second Intervention Period (4 Weeks)|Non-compliance|0
907026|NCT01090492|2992353|P4|Second Intervention Period (4 Weeks)|Non-compliance|0
907027|NCT01090492|2992354|P3|Second Intervention Period (4 Weeks)|Non-compliance|0
907028|NCT01090492|2992355|P2|Second Intervention Period (4 Weeks)|Non-compliance|1
907029|NCT01090492|2992356|P1|Second Intervention Period (4 Weeks)|Non-compliance|0
907030|NCT01090492|2992349|P8|Second Intervention Period (4 Weeks)|Protocol Violation|1
907031|NCT01090492|2992350|P7|Second Intervention Period (4 Weeks)|Protocol Violation|1
907032|NCT01090492|2992351|P6|Second Intervention Period (4 Weeks)|Protocol Violation|0
907033|NCT01090492|2992352|P5|Second Intervention Period (4 Weeks)|Protocol Violation|1
907034|NCT01090492|2992353|P4|Second Intervention Period (4 Weeks)|Protocol Violation|0
907035|NCT01090492|2992354|P3|Second Intervention Period (4 Weeks)|Protocol Violation|0
907036|NCT01090492|2992355|P2|Second Intervention Period (4 Weeks)|Protocol Violation|0
907037|NCT01090492|2992356|P1|Second Intervention Period (4 Weeks)|Protocol Violation|1
907038|NCT01090492|2992349|P8|First Intervention Period (4 Weeks)|Adverse Event|5
907039|NCT01090492|2992350|P7|First Intervention Period (4 Weeks)|Adverse Event|0
907040|NCT01090492|2992351|P6|First Intervention Period (4 Weeks)|Adverse Event|2
907041|NCT01090492|2992352|P5|First Intervention Period (4 Weeks)|Adverse Event|1
907042|NCT01090492|2992353|P4|First Intervention Period (4 Weeks)|Adverse Event|3
907043|NCT01090492|2992354|P3|First Intervention Period (4 Weeks)|Adverse Event|0
907044|NCT01090492|2992355|P2|First Intervention Period (4 Weeks)|Adverse Event|2
907045|NCT01090492|2992356|P1|First Intervention Period (4 Weeks)|Adverse Event|0
907046|NCT01090492|2992349|P8|First Intervention Period (4 Weeks)|Pregnancy|0
907047|NCT01090492|2992350|P7|First Intervention Period (4 Weeks)|Pregnancy|0
907048|NCT01090492|2992351|P6|First Intervention Period (4 Weeks)|Pregnancy|0
907049|NCT01090492|2992352|P5|First Intervention Period (4 Weeks)|Pregnancy|1
907050|NCT01090492|2992353|P4|First Intervention Period (4 Weeks)|Pregnancy|0
907051|NCT01090492|2992354|P3|First Intervention Period (4 Weeks)|Pregnancy|0
907052|NCT01090492|2992355|P2|First Intervention Period (4 Weeks)|Pregnancy|0
907053|NCT01090492|2992356|P1|First Intervention Period (4 Weeks)|Pregnancy|0
907054|NCT01090492|2992349|P8|First Intervention Period (4 Weeks)|Other|0
907055|NCT01090492|2992350|P7|First Intervention Period (4 Weeks)|Other|0
907056|NCT01090492|2992351|P6|First Intervention Period (4 Weeks)|Other|0
907057|NCT01090492|2992352|P5|First Intervention Period (4 Weeks)|Other|2
907058|NCT01090492|2992353|P4|First Intervention Period (4 Weeks)|Other|1
907059|NCT01090492|2992354|P3|First Intervention Period (4 Weeks)|Other|1
907060|NCT01090492|2992355|P2|First Intervention Period (4 Weeks)|Other|0
907061|NCT01090492|2992356|P1|First Intervention Period (4 Weeks)|Other|0
907062|NCT01090492|2992349|P8|First Intervention Period (4 Weeks)|Lost to Follow-up|0
907063|NCT01090492|2992350|P7|First Intervention Period (4 Weeks)|Lost to Follow-up|0
907064|NCT01090492|2992351|P6|First Intervention Period (4 Weeks)|Lost to Follow-up|0
907065|NCT01090492|2992352|P5|First Intervention Period (4 Weeks)|Lost to Follow-up|0
907066|NCT01090492|2992353|P4|First Intervention Period (4 Weeks)|Lost to Follow-up|0
907067|NCT01090492|2992354|P3|First Intervention Period (4 Weeks)|Lost to Follow-up|1
907068|NCT01090492|2992355|P2|First Intervention Period (4 Weeks)|Lost to Follow-up|0
907069|NCT01090492|2992356|P1|First Intervention Period (4 Weeks)|Lost to Follow-up|0
907070|NCT01090492|2992349|P8|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1
907071|NCT01090492|2992350|P7|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
907072|NCT01090492|2992351|P6|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
907073|NCT01090492|2992352|P5|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
907074|NCT01090492|2992353|P4|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
907075|NCT01090492|2992354|P3|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
907076|NCT01090492|2992355|P2|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2
907077|NCT01090492|2992356|P1|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
907078|NCT01090492|2992349|P8|First Intervention Period (4 Weeks)|Protocol Violation|0
907079|NCT01090492|2992350|P7|First Intervention Period (4 Weeks)|Protocol Violation|1
907080|NCT01090492|2992351|P6|First Intervention Period (4 Weeks)|Protocol Violation|0
907081|NCT01090492|2992352|P5|First Intervention Period (4 Weeks)|Protocol Violation|0
907082|NCT01090492|2992353|P4|First Intervention Period (4 Weeks)|Protocol Violation|2
907083|NCT01090492|2992354|P3|First Intervention Period (4 Weeks)|Protocol Violation|1
907084|NCT01090492|2992355|P2|First Intervention Period (4 Weeks)|Protocol Violation|1
907085|NCT01090492|2992356|P1|First Intervention Period (4 Weeks)|Protocol Violation|1
907086|NCT01090453|2992424|P2|Overall Study|Eligibility Criteria|1
907087|NCT01090453|2992425|P1|Overall Study|Eligibility Criteria|0
907088|NCT01090453|2992424|P2|Overall Study|Other|4
907089|NCT01090453|2992425|P1|Overall Study|Other|2
907090|NCT01090453|2992424|P2|Overall Study|Protocol Violation|0
907091|NCT01090453|2992425|P1|Overall Study|Protocol Violation|2
907092|NCT01090453|2992424|P2|Overall Study|Non serious AEs|0
907093|NCT01090453|2992425|P1|Overall Study|Non serious AEs|1
907094|NCT01090453|2992424|P2|Overall Study|Lost to Follow-up|7
907095|NCT01090453|2992425|P1|Overall Study|Lost to Follow-up|7
907096|NCT01090453|2992424|P2|Overall Study|Withdrawal by Subject|2
907097|NCT01090453|2992425|P1|Overall Study|Withdrawal by Subject|1
907098|NCT01090427|2992476|P7|After Controlled Period|Adverse Event|0
907099|NCT01090427|2992477|P6|After Controlled Period|Adverse Event|1
907100|NCT01090427|2992478|P5|After Controlled Period|Adverse Event|0
907101|NCT01090427|2992479|P4|After Controlled Period|Adverse Event|2
907102|NCT01090427|2992480|P3|After Controlled Period|Adverse Event|0
907103|NCT01090427|2992481|P2|After Controlled Period|Adverse Event|0
907104|NCT01090427|2992482|P1|After Controlled Period|Adverse Event|0
907105|NCT01090427|2992476|P7|After Controlled Period|Lack of Efficacy|2
907106|NCT01090427|2992477|P6|After Controlled Period|Lack of Efficacy|3
907107|NCT01090427|2992478|P5|After Controlled Period|Lack of Efficacy|0
907108|NCT01090427|2992479|P4|After Controlled Period|Lack of Efficacy|0
907109|NCT01090427|2992480|P3|After Controlled Period|Lack of Efficacy|0
907110|NCT01090427|2992481|P2|After Controlled Period|Lack of Efficacy|0
907111|NCT01090427|2992482|P1|After Controlled Period|Lack of Efficacy|0
907112|NCT01090427|2992476|P7|After Controlled Period|Death|0
907113|NCT01090427|2992477|P6|After Controlled Period|Death|1
907114|NCT01090427|2992478|P5|After Controlled Period|Death|0
907115|NCT01090427|2992479|P4|After Controlled Period|Death|0
907116|NCT01090427|2992480|P3|After Controlled Period|Death|0
907117|NCT01090427|2992481|P2|After Controlled Period|Death|0
907118|NCT01090427|2992482|P1|After Controlled Period|Death|0
907119|NCT01090323|2992517|P2|Overall Study|Stopped end of extension 1#|1
907120|NCT01090323|2992518|P1|Overall Study|Stopped end of extension 1#|3
907121|NCT01090323|2992517|P2|Overall Study|Stopped end of core|0
907122|NCT01090323|2992518|P1|Overall Study|Stopped end of core|7
907123|NCT01090323|2992517|P2|Overall Study|Death|2
907124|NCT01090323|2992518|P1|Overall Study|Death|1
907125|NCT01090323|2992517|P2|Overall Study|Administrative problems|4
907126|NCT01090323|2992518|P1|Overall Study|Administrative problems|6
907127|NCT01090323|2992517|P2|Overall Study|Lost to Follow-up|6
907128|NCT01090323|2992518|P1|Overall Study|Lost to Follow-up|11
907129|NCT01090323|2992517|P2|Overall Study|Withdrew consent|11
907130|NCT01090323|2992518|P1|Overall Study|Withdrew consent|33
907131|NCT01090323|2992517|P2|Overall Study|Protocol Violation|1
907132|NCT01090323|2992518|P1|Overall Study|Protocol Violation|2
907133|NCT01090323|2992517|P2|Overall Study|Condition no longer requires drug|4
907134|NCT01090323|2992518|P1|Overall Study|Condition no longer requires drug|5
907135|NCT01090323|2992517|P2|Overall Study|Unsatisfactory therapeutic effect|2
907136|NCT01090323|2992518|P1|Overall Study|Unsatisfactory therapeutic effect|4
907137|NCT01090323|2992517|P2|Overall Study|Abnormal Test Procedure Results|0
907138|NCT01090323|2992518|P1|Overall Study|Abnormal Test Procedure Results|2
907139|NCT01090323|2992517|P2|Overall Study|Abnormal Lab Values|1
907140|NCT01090323|2992518|P1|Overall Study|Abnormal Lab Values|3
907141|NCT01090323|2992517|P2|Overall Study|Adverse Event|2
907142|NCT01090323|2992518|P1|Overall Study|Adverse Event|12
907143|NCT01090310|2992530|P4|Extension Study|Subject withdrew consent|0
907144|NCT01090310|2992531|P3|Extension Study|Subject withdrew consent|0
907145|NCT01090310|2992532|P2|Extension Study|Subject withdrew consent|1
907146|NCT01090310|2992533|P1|Extension Study|Subject withdrew consent|0
907147|NCT01090310|2992530|P4|Extension Study|Unsatisfactory therapeutic effect|1
907148|NCT01090310|2992531|P3|Extension Study|Unsatisfactory therapeutic effect|1
907149|NCT01090310|2992532|P2|Extension Study|Unsatisfactory therapeutic effect|0
907150|NCT01090310|2992533|P1|Extension Study|Unsatisfactory therapeutic effect|1
907151|NCT01090310|2992530|P4|Extension Study|Adverse Event|1
907152|NCT01090310|2992531|P3|Extension Study|Adverse Event|0
907153|NCT01090310|2992532|P2|Extension Study|Adverse Event|0
907154|NCT01090310|2992533|P1|Extension Study|Adverse Event|0
907155|NCT01090310|2992530|P4|Extension Study|Aministrative problems|18
907156|NCT01090310|2992531|P3|Extension Study|Aministrative problems|14
907157|NCT01090310|2992532|P2|Extension Study|Aministrative problems|15
907158|NCT01090310|2992533|P1|Extension Study|Aministrative problems|13
907159|NCT01090310|2992530|P4|Core Study|Protocol deviation|1
907160|NCT01090310|2992531|P3|Core Study|Protocol deviation|0
907161|NCT01090310|2992532|P2|Core Study|Protocol deviation|0
907162|NCT01090310|2992533|P1|Core Study|Protocol deviation|1
907163|NCT01090310|2992530|P4|Core Study|Administrative reasons|4
907164|NCT01090310|2992531|P3|Core Study|Administrative reasons|4
907165|NCT01090310|2992532|P2|Core Study|Administrative reasons|6
907166|NCT01090310|2992533|P1|Core Study|Administrative reasons|5
907167|NCT01090310|2992530|P4|Core Study|Abnormal test procedure result|0
907168|NCT01090310|2992531|P3|Core Study|Abnormal test procedure result|1
907169|NCT01090310|2992532|P2|Core Study|Abnormal test procedure result|0
907170|NCT01090310|2992533|P1|Core Study|Abnormal test procedure result|0
907171|NCT01090310|2992530|P4|Core Study|Subject withdrew consent|1
907172|NCT01090310|2992531|P3|Core Study|Subject withdrew consent|1
907173|NCT01090310|2992532|P2|Core Study|Subject withdrew consent|3
907174|NCT01090310|2992533|P1|Core Study|Subject withdrew consent|0
907175|NCT01090310|2992530|P4|Core Study|Adverse Event|1
907176|NCT01090310|2992531|P3|Core Study|Adverse Event|1
907177|NCT01090310|2992532|P2|Core Study|Adverse Event|2
907178|NCT01090310|2992533|P1|Core Study|Adverse Event|2
907179|NCT01090102|2992572|P2|Second 12 Weeks|Withdrawal by Subject|1
907180|NCT01090102|2992573|P1|Second 12 Weeks|Withdrawal by Subject|0
907181|NCT01090102|2992572|P2|First 12 Weeks|Death|1
907182|NCT01090102|2992573|P1|First 12 Weeks|Death|1
907183|NCT01090102|2992572|P2|First 12 Weeks|Adverse Event|0
907184|NCT01090102|2992573|P1|First 12 Weeks|Adverse Event|2
907185|NCT01090102|2992572|P2|First 12 Weeks|Withdrawal by Subject|1
907186|NCT01090102|2992573|P1|First 12 Weeks|Withdrawal by Subject|1
907187|NCT01090076|2992583|P2|Overall Study|Withdrawal by Subject|1
907188|NCT01090076|2992584|P1|Overall Study|Withdrawal by Subject|0
907189|NCT01090076|2992583|P2|Overall Study|Death|1
907190|NCT01090076|2992584|P1|Overall Study|Death|1
907191|NCT01090063|2992594|P1|Treatment|Withdrawal by Subject|4
907192|NCT01090063|2992594|P1|Screen|Screen Failed|4
907193|NCT01090050|2992610|P2|Overall Study|Physician Decision|1
907194|NCT01090050|2992611|P1|Overall Study|Physician Decision|0
907195|NCT01090050|2992610|P2|Overall Study|Lack of Efficacy|5
907196|NCT01090050|2992611|P1|Overall Study|Lack of Efficacy|1
907197|NCT01090050|2992610|P2|Overall Study|Lost to Follow-up|1
907198|NCT01090050|2992611|P1|Overall Study|Lost to Follow-up|0
907199|NCT01090011|2992631|P1|Overall Study|Other reason not defined above|5
907200|NCT01090011|2992631|P1|Overall Study|Refusal to start/continue medication|5
907201|NCT01090011|2992631|P1|Overall Study|Protocol Violation|1
907202|NCT01090011|2992631|P1|Overall Study|Adverse Event|32
907203|NCT01090011|2992631|P1|Overall Study|Progressive disease|128
907204|NCT01089608|2992724|P2|Overall Study|Lost to Follow-up|2
907205|NCT01089608|2992725|P1|Overall Study|Lost to Follow-up|0
907206|NCT01089608|2992724|P2|Overall Study|Adverse Event|4
907207|NCT01089608|2992725|P1|Overall Study|Adverse Event|0
907208|NCT01089582|2992742|P1|Overall Study|Withdrawal by Subject|1
907209|NCT01089582|2992742|P1|Overall Study|Other|4
907210|NCT01089582|2992742|P1|Overall Study|Lost to Follow-up|8
907211|NCT01089582|2992742|P1|Overall Study|Adverse Event|15
907212|NCT01089582|2992742|P1|Overall Study|Death|2
907213|NCT01089556|2992785|P6|Study Period III (Weeks 9-16)|Withdrawal by Subject|2
907214|NCT01089556|2992786|P5|Study Period III (Weeks 9-16)|Withdrawal by Subject|1
907215|NCT01089556|2992787|P4|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
907216|NCT01089556|2992788|P3|Study Period III (Weeks 9-16)|Withdrawal by Subject|3
907217|NCT01089556|2992789|P2|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
907218|NCT01089556|2992790|P1|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
907219|NCT01089556|2992785|P6|Study Period III (Weeks 9-16)|Satisfactory Response|1
907220|NCT01089556|2992786|P5|Study Period III (Weeks 9-16)|Satisfactory Response|4
907221|NCT01089556|2992787|P4|Study Period III (Weeks 9-16)|Satisfactory Response|3
907222|NCT01089556|2992788|P3|Study Period III (Weeks 9-16)|Satisfactory Response|4
907223|NCT01089556|2992789|P2|Study Period III (Weeks 9-16)|Satisfactory Response|0
907224|NCT01089556|2992790|P1|Study Period III (Weeks 9-16)|Satisfactory Response|0
907225|NCT01089556|2992785|P6|Study Period III (Weeks 9-16)|Protocol Violation|0
907226|NCT01089556|2992786|P5|Study Period III (Weeks 9-16)|Protocol Violation|1
907227|NCT01089556|2992787|P4|Study Period III (Weeks 9-16)|Protocol Violation|1
907228|NCT01089556|2992788|P3|Study Period III (Weeks 9-16)|Protocol Violation|1
907229|NCT01089556|2992789|P2|Study Period III (Weeks 9-16)|Protocol Violation|0
907230|NCT01089556|2992790|P1|Study Period III (Weeks 9-16)|Protocol Violation|0
907231|NCT01089556|2992785|P6|Study Period III (Weeks 9-16)|Lost to Follow-up|0
907232|NCT01089556|2992786|P5|Study Period III (Weeks 9-16)|Lost to Follow-up|0
907233|NCT01089556|2992787|P4|Study Period III (Weeks 9-16)|Lost to Follow-up|0
907234|NCT01089556|2992788|P3|Study Period III (Weeks 9-16)|Lost to Follow-up|1
907235|NCT01089556|2992789|P2|Study Period III (Weeks 9-16)|Lost to Follow-up|0
907236|NCT01089556|2992790|P1|Study Period III (Weeks 9-16)|Lost to Follow-up|0
907237|NCT01089556|2992785|P6|Study Period III (Weeks 9-16)|Lack of Efficacy|0
907238|NCT01089556|2992786|P5|Study Period III (Weeks 9-16)|Lack of Efficacy|1
907239|NCT01089556|2992787|P4|Study Period III (Weeks 9-16)|Lack of Efficacy|2
907240|NCT01089556|2992788|P3|Study Period III (Weeks 9-16)|Lack of Efficacy|0
907241|NCT01089556|2992789|P2|Study Period III (Weeks 9-16)|Lack of Efficacy|0
907242|NCT01089556|2992790|P1|Study Period III (Weeks 9-16)|Lack of Efficacy|0
907243|NCT01089556|2992785|P6|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
907244|NCT01089556|2992786|P5|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
907245|NCT01089556|2992787|P4|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
907246|NCT01089556|2992788|P3|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
907247|NCT01089556|2992789|P2|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
907248|NCT01089556|2992790|P1|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
907249|NCT01089556|2992785|P6|Study Period III (Weeks 9-16)|Adverse Event|3
907250|NCT01089556|2992786|P5|Study Period III (Weeks 9-16)|Adverse Event|4
907251|NCT01089556|2992787|P4|Study Period III (Weeks 9-16)|Adverse Event|2
907252|NCT01089556|2992788|P3|Study Period III (Weeks 9-16)|Adverse Event|4
907253|NCT01089556|2992789|P2|Study Period III (Weeks 9-16)|Adverse Event|0
907254|NCT01089556|2992790|P1|Study Period III (Weeks 9-16)|Adverse Event|0
907255|NCT01089556|2992785|P6|Study Period II (Weeks 1-8)|Not received any study drug|0
907256|NCT01089556|2992786|P5|Study Period II (Weeks 1-8)|Not received any study drug|0
907257|NCT01089556|2992787|P4|Study Period II (Weeks 1-8)|Not received any study drug|0
907258|NCT01089556|2992788|P3|Study Period II (Weeks 1-8)|Not received any study drug|0
907259|NCT01089556|2992789|P2|Study Period II (Weeks 1-8)|Not received any study drug|4
907260|NCT01089556|2992790|P1|Study Period II (Weeks 1-8)|Not received any study drug|3
907261|NCT01089556|2992785|P6|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
907262|NCT01089556|2992786|P5|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
907263|NCT01089556|2992787|P4|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
907264|NCT01089556|2992788|P3|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
907265|NCT01089556|2992789|P2|Study Period II (Weeks 1-8)|Withdrawal by Subject|14
907266|NCT01089556|2992790|P1|Study Period II (Weeks 1-8)|Withdrawal by Subject|12
907267|NCT01089556|2992785|P6|Study Period II (Weeks 1-8)|Protocol Violation|0
907268|NCT01089556|2992786|P5|Study Period II (Weeks 1-8)|Protocol Violation|0
907269|NCT01089556|2992787|P4|Study Period II (Weeks 1-8)|Protocol Violation|0
907270|NCT01089556|2992788|P3|Study Period II (Weeks 1-8)|Protocol Violation|0
907271|NCT01089556|2992789|P2|Study Period II (Weeks 1-8)|Protocol Violation|4
907272|NCT01089556|2992790|P1|Study Period II (Weeks 1-8)|Protocol Violation|4
907273|NCT01089556|2992785|P6|Study Period II (Weeks 1-8)|Physician Decision|0
907274|NCT01089556|2992786|P5|Study Period II (Weeks 1-8)|Physician Decision|0
907275|NCT01089556|2992787|P4|Study Period II (Weeks 1-8)|Physician Decision|0
907276|NCT01089556|2992788|P3|Study Period II (Weeks 1-8)|Physician Decision|0
907277|NCT01089556|2992789|P2|Study Period II (Weeks 1-8)|Physician Decision|0
907278|NCT01089556|2992790|P1|Study Period II (Weeks 1-8)|Physician Decision|4
907279|NCT01089556|2992785|P6|Study Period II (Weeks 1-8)|Lost to Follow-up|0
907280|NCT01089556|2992786|P5|Study Period II (Weeks 1-8)|Lost to Follow-up|0
907281|NCT01089556|2992787|P4|Study Period II (Weeks 1-8)|Lost to Follow-up|0
907282|NCT01089556|2992788|P3|Study Period II (Weeks 1-8)|Lost to Follow-up|0
907283|NCT01089556|2992789|P2|Study Period II (Weeks 1-8)|Lost to Follow-up|3
907284|NCT01089556|2992790|P1|Study Period II (Weeks 1-8)|Lost to Follow-up|0
907285|NCT01089556|2992785|P6|Study Period II (Weeks 1-8)|Lack of Efficacy|0
907286|NCT01089556|2992786|P5|Study Period II (Weeks 1-8)|Lack of Efficacy|0
907287|NCT01089556|2992787|P4|Study Period II (Weeks 1-8)|Lack of Efficacy|0
907288|NCT01089556|2992788|P3|Study Period II (Weeks 1-8)|Lack of Efficacy|0
907289|NCT01089556|2992789|P2|Study Period II (Weeks 1-8)|Lack of Efficacy|2
907290|NCT01089556|2992790|P1|Study Period II (Weeks 1-8)|Lack of Efficacy|1
907291|NCT01089556|2992785|P6|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
907292|NCT01089556|2992786|P5|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
907293|NCT01089556|2992787|P4|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
907294|NCT01089556|2992788|P3|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
907295|NCT01089556|2992789|P2|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8
907296|NCT01089556|2992790|P1|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12
907297|NCT01089556|2992785|P6|Study Period II (Weeks 1-8)|Adverse Event|0
907298|NCT01089556|2992786|P5|Study Period II (Weeks 1-8)|Adverse Event|0
907299|NCT01089556|2992787|P4|Study Period II (Weeks 1-8)|Adverse Event|0
907300|NCT01089556|2992788|P3|Study Period II (Weeks 1-8)|Adverse Event|0
907301|NCT01089556|2992789|P2|Study Period II (Weeks 1-8)|Adverse Event|39
907302|NCT01089556|2992790|P1|Study Period II (Weeks 1-8)|Adverse Event|35
907303|NCT01089543|2992864|P4|Overall Study|Adverse Event|0
907304|NCT01089543|2992865|P3|Overall Study|Adverse Event|0
907305|NCT01089543|2992866|P2|Overall Study|Adverse Event|1
907306|NCT01089543|2992867|P1|Overall Study|Adverse Event|0
907307|NCT01089543|2992864|P4|Overall Study|Physician Decision|1
907308|NCT01089543|2992865|P3|Overall Study|Physician Decision|0
907309|NCT01089543|2992866|P2|Overall Study|Physician Decision|0
907310|NCT01089543|2992867|P1|Overall Study|Physician Decision|1
907311|NCT01089543|2992864|P4|Overall Study|Withdrawal by Subject|1
907312|NCT01089543|2992865|P3|Overall Study|Withdrawal by Subject|3
907313|NCT01089543|2992866|P2|Overall Study|Withdrawal by Subject|3
907314|NCT01089543|2992867|P1|Overall Study|Withdrawal by Subject|2
907315|NCT01089504|2992902|P2|Overall Study|Withdrawal by Subject|0
907316|NCT01089504|2992903|P1|Overall Study|Withdrawal by Subject|2
907317|NCT01089504|2992902|P2|Overall Study|Lost to Follow-up|1
907318|NCT01089504|2992903|P1|Overall Study|Lost to Follow-up|1
907319|NCT01089413|2992916|P1|Overall Study|Other|71
907320|NCT01089413|2992916|P1|Overall Study|Metastasectomy|13
907321|NCT01089413|2992916|P1|Overall Study|Death|10
907322|NCT01089413|2992916|P1|Overall Study|Unacceptable Toxicity|12
907323|NCT01089413|2992916|P1|Overall Study|Participant Withdrew Consent|1
907324|NCT01089413|2992916|P1|Overall Study|Progressive Disease|93
907325|NCT01089413|2992916|P1|Overall Study|Lost to Follow-up|1
907326|NCT01089361|2992935|P2|Overall Study|Death|0
907327|NCT01089361|2992936|P1|Overall Study|Death|1
907328|NCT01089127|2992985|P6|Overall Study|Protocol deviation|0
907329|NCT01089127|2992986|P5|Overall Study|Protocol deviation|1
907330|NCT01089127|2992987|P4|Overall Study|Protocol deviation|0
907331|NCT01089127|2992988|P3|Overall Study|Protocol deviation|0
907332|NCT01089127|2992989|P2|Overall Study|Protocol deviation|1
907333|NCT01089127|2992990|P1|Overall Study|Protocol deviation|0
907334|NCT01089127|2992985|P6|Overall Study|Lost to Follow-up|0
907335|NCT01089127|2992986|P5|Overall Study|Lost to Follow-up|1
907336|NCT01089127|2992987|P4|Overall Study|Lost to Follow-up|0
907337|NCT01089127|2992988|P3|Overall Study|Lost to Follow-up|0
907338|NCT01089127|2992989|P2|Overall Study|Lost to Follow-up|1
907339|NCT01089127|2992990|P1|Overall Study|Lost to Follow-up|1
907340|NCT01089127|2992985|P6|Overall Study|Abnormal test procedure result(s)|0
907341|NCT01089127|2992986|P5|Overall Study|Abnormal test procedure result(s)|0
907342|NCT01089127|2992987|P4|Overall Study|Abnormal test procedure result(s)|0
907343|NCT01089127|2992988|P3|Overall Study|Abnormal test procedure result(s)|0
907344|NCT01089127|2992989|P2|Overall Study|Abnormal test procedure result(s)|1
907345|NCT01089127|2992990|P1|Overall Study|Abnormal test procedure result(s)|2
907346|NCT01089127|2992985|P6|Overall Study|Subject withdrew consent|2
907347|NCT01089127|2992986|P5|Overall Study|Subject withdrew consent|0
907348|NCT01089127|2992987|P4|Overall Study|Subject withdrew consent|1
907349|NCT01089127|2992988|P3|Overall Study|Subject withdrew consent|1
907350|NCT01089127|2992989|P2|Overall Study|Subject withdrew consent|1
907351|NCT01089127|2992990|P1|Overall Study|Subject withdrew consent|0
907352|NCT01089127|2992985|P6|Overall Study|Adverse Event|1
907353|NCT01089127|2992986|P5|Overall Study|Adverse Event|0
907354|NCT01089127|2992987|P4|Overall Study|Adverse Event|0
907355|NCT01089127|2992988|P3|Overall Study|Adverse Event|1
907356|NCT01089127|2992989|P2|Overall Study|Adverse Event|1
907357|NCT01089127|2992990|P1|Overall Study|Adverse Event|5
907358|NCT01089023|2993044|P1|Overall Study|Lack of Efficacy|1
907359|NCT01089023|2993044|P1|Overall Study|Protocol Violation|1
907360|NCT01089023|2993044|P1|Overall Study|Withdrawal by Subject|1
907361|NCT01089023|2993044|P1|Overall Study|Adverse Event|1
907362|NCT01089023|2993044|P1|Overall Study|Lost to Follow-up|3
907363|NCT01088997|2993058|P2|Overall Study|Excluded prior to receiving drug|1
907364|NCT01088997|2993059|P1|Overall Study|Excluded prior to receiving drug|1
907365|NCT01088997|2993058|P2|Overall Study|Req. Extracorporeal membrane oxygenation|1
907366|NCT01088997|2993059|P1|Overall Study|Req. Extracorporeal membrane oxygenation|1
907367|NCT01088997|2993058|P2|Overall Study|Physician Decision|1
907368|NCT01088997|2993059|P1|Overall Study|Physician Decision|1
907369|NCT01088984|2993070|P2|Phase 2|Not Specified|1
907370|NCT01088984|2993071|P1|Phase 2|Not Specified|0
907371|NCT01088984|2993070|P2|Phase 2|DIsease Progression|25
907372|NCT01088984|2993071|P1|Phase 2|DIsease Progression|0
907373|NCT01088984|2993070|P2|Phase 2|Withdrawal by Subject|1
907374|NCT01088984|2993071|P1|Phase 2|Withdrawal by Subject|0
907375|NCT01088984|2993070|P2|Phase 2|Death|5
907376|NCT01088984|2993071|P1|Phase 2|Death|0
907377|NCT01088984|2993070|P2|Phase 1|Not Specified|1
907378|NCT01088984|2993071|P1|Phase 1|Not Specified|1
907379|NCT01088984|2993070|P2|Phase 1|Disease Progression|4
907380|NCT01088984|2993071|P1|Phase 1|Disease Progression|2
907381|NCT01088984|2993070|P2|Phase 1|Death|1
907382|NCT01088984|2993071|P1|Phase 1|Death|2
907383|NCT01088529|2993132|P2|Overall Study|Did not receive study treatment|1
907384|NCT01088529|2993133|P1|Overall Study|Did not receive study treatment|0
907385|NCT01088503|2993146|P3|Overall Study|Death|7
907386|NCT01088503|2993147|P2|Overall Study|Death|358
907387|NCT01088503|2993148|P1|Overall Study|Death|64
907388|NCT01088503|2993146|P3|Overall Study|Withdrawal by Subject|10
907389|NCT01088503|2993147|P2|Overall Study|Withdrawal by Subject|327
907390|NCT01088503|2993148|P1|Overall Study|Withdrawal by Subject|118
907391|NCT01088438|2993226|P2|Overall Study|Lost to Follow-up|30
907392|NCT01088438|2993227|P1|Overall Study|Lost to Follow-up|18
907393|NCT01088438|2993226|P2|Overall Study|Withdrawal by Subject|6
907394|NCT01088438|2993227|P1|Overall Study|Withdrawal by Subject|11
907395|NCT01088399|2993240|P3|Overall Study|Study summary visit not completed|80
907396|NCT01088399|2993241|P2|Overall Study|Study summary visit not completed|283
907397|NCT01088399|2993242|P1|Overall Study|Study summary visit not completed|2398
907398|NCT01088399|2993240|P3|Overall Study|Enrollment criteria not met|70
907399|NCT01088399|2993241|P2|Overall Study|Enrollment criteria not met|119
907400|NCT01088399|2993242|P1|Overall Study|Enrollment criteria not met|48
907401|NCT01088399|2993240|P3|Overall Study|Protocol Violation|0
907402|NCT01088399|2993241|P2|Overall Study|Protocol Violation|1
907403|NCT01088399|2993242|P1|Overall Study|Protocol Violation|10
907404|NCT01088399|2993240|P3|Overall Study|Sponsor decision|7
907405|NCT01088399|2993241|P2|Overall Study|Sponsor decision|298
907406|NCT01088399|2993242|P1|Overall Study|Sponsor decision|1573
907407|NCT01088399|2993240|P3|Overall Study|Change to or start of somatropin therapy|12
907408|NCT01088399|2993241|P2|Overall Study|Change to or start of somatropin therapy|17
907409|NCT01088399|2993242|P1|Overall Study|Change to or start of somatropin therapy|234
907410|NCT01088399|2993240|P3|Overall Study|Withdrawal by Subject|33
907411|NCT01088399|2993241|P2|Overall Study|Withdrawal by Subject|195
907412|NCT01088399|2993242|P1|Overall Study|Withdrawal by Subject|544
907413|NCT01088399|2993240|P3|Overall Study|Physician Decision|16
907414|NCT01088399|2993241|P2|Overall Study|Physician Decision|88
907415|NCT01088399|2993242|P1|Overall Study|Physician Decision|531
907416|NCT01088399|2993240|P3|Overall Study|Lost to Follow-up|58
907417|NCT01088399|2993241|P2|Overall Study|Lost to Follow-up|278
907418|NCT01088399|2993242|P1|Overall Study|Lost to Follow-up|1070
907419|NCT01088399|2993240|P3|Overall Study|Lack of Efficacy|5
907420|NCT01088399|2993241|P2|Overall Study|Lack of Efficacy|7
907421|NCT01088399|2993242|P1|Overall Study|Lack of Efficacy|298
907422|NCT01088399|2993240|P3|Overall Study|Death|0
907423|NCT01088399|2993241|P2|Overall Study|Death|45
907424|NCT01088399|2993242|P1|Overall Study|Death|204
907425|NCT01088399|2993240|P3|Overall Study|Adverse Event|0
907426|NCT01088399|2993241|P2|Overall Study|Adverse Event|16
907427|NCT01088399|2993242|P1|Overall Study|Adverse Event|211
907428|NCT01088243|2993271|P2|Overall Study|Adverse Event|0
907429|NCT01088243|2993272|P1|Overall Study|Adverse Event|1
907430|NCT01087970|2993313|P1|Overall Study|Protocol Violation|2
907431|NCT01087957|2993325|P2|Overall Study|Physician Decision|9
907432|NCT01087957|2993326|P1|Overall Study|Physician Decision|5
907433|NCT01087957|2993325|P2|Overall Study|Withdrawal by Subject|15
907434|NCT01087957|2993326|P1|Overall Study|Withdrawal by Subject|18
907435|NCT01087957|2993325|P2|Overall Study|Protocol Violation|25
907436|NCT01087957|2993326|P1|Overall Study|Protocol Violation|13
907437|NCT01087957|2993325|P2|Overall Study|Lost to Follow-up|4
907438|NCT01087957|2993326|P1|Overall Study|Lost to Follow-up|3
907439|NCT01087957|2993325|P2|Overall Study|Death|2
907440|NCT01087957|2993326|P1|Overall Study|Death|2
907441|NCT01087944|2993352|P2|Period 2 (Week 4-6)|Adverse Event|2
907442|NCT01087944|2993353|P1|Period 2 (Week 4-6)|Adverse Event|0
907443|NCT01087944|2993352|P2|Period 1 (Week 1-3)|Adverse Event|0
907444|NCT01087944|2993353|P1|Period 1 (Week 1-3)|Adverse Event|1
907445|NCT01087905|2993433|P8|Overall Study|Withdrawal by Subject|5
907446|NCT01087905|2993434|P7|Overall Study|Withdrawal by Subject|3
907447|NCT01087905|2993435|P6|Overall Study|Withdrawal by Subject|3
907448|NCT01087905|2993436|P5|Overall Study|Withdrawal by Subject|4
907449|NCT01087905|2993437|P4|Overall Study|Withdrawal by Subject|5
907450|NCT01087905|2993438|P3|Overall Study|Withdrawal by Subject|4
907451|NCT01087905|2993439|P2|Overall Study|Withdrawal by Subject|4
907452|NCT01087905|2993440|P1|Overall Study|Withdrawal by Subject|5
907453|NCT01087905|2993433|P8|Overall Study|Lost to Follow-up|24
907454|NCT01087905|2993434|P7|Overall Study|Lost to Follow-up|20
907455|NCT01087905|2993435|P6|Overall Study|Lost to Follow-up|25
907456|NCT01087905|2993436|P5|Overall Study|Lost to Follow-up|27
907457|NCT01087905|2993437|P4|Overall Study|Lost to Follow-up|31
907458|NCT01087905|2993438|P3|Overall Study|Lost to Follow-up|18
907459|NCT01087905|2993439|P2|Overall Study|Lost to Follow-up|28
907460|NCT01087905|2993440|P1|Overall Study|Lost to Follow-up|24
907461|NCT01087814|2993462|P2|Second Intervention (5 Days)|Physician Decision|0
907462|NCT01087814|2993463|P1|Second Intervention (5 Days)|Physician Decision|1
907463|NCT01087814|2993462|P2|First Intervention (5 Days)|Withdrawal by Subject|1
907464|NCT01087814|2993463|P1|First Intervention (5 Days)|Withdrawal by Subject|3
907465|NCT01087788|2993481|P3|Open-Label Period (OL-P)|Personal reasons|1
907466|NCT01087788|2993482|P2|Open-Label Period (OL-P)|Personal reasons|0
907467|NCT01087788|2993483|P1|Open-Label Period (OL-P)|Personal reasons|0
907468|NCT01087788|2993481|P3|Open-Label Period (OL-P)|No participation in study extension|1
907469|NCT01087788|2993482|P2|Open-Label Period (OL-P)|No participation in study extension|0
907470|NCT01087788|2993483|P1|Open-Label Period (OL-P)|No participation in study extension|0
907471|NCT01087788|2993481|P3|Open-Label Period (OL-P)|Principal investigator decision|2
907472|NCT01087788|2993482|P2|Open-Label Period (OL-P)|Principal investigator decision|1
907473|NCT01087788|2993483|P1|Open-Label Period (OL-P)|Principal investigator decision|0
907474|NCT01087788|2993481|P3|Open-Label Period (OL-P)|Sponsor request|0
907475|NCT01087788|2993482|P2|Open-Label Period (OL-P)|Sponsor request|0
907476|NCT01087788|2993483|P1|Open-Label Period (OL-P)|Sponsor request|1
907477|NCT01087788|2993481|P3|Open-Label Period (OL-P)|AE, non-serious unknown|0
907478|NCT01087788|2993482|P2|Open-Label Period (OL-P)|AE, non-serious unknown|0
907479|NCT01087788|2993483|P1|Open-Label Period (OL-P)|AE, non-serious unknown|1
907480|NCT01087788|2993481|P3|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
907481|NCT01087788|2993482|P2|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1
907482|NCT01087788|2993483|P1|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
907483|NCT01087788|2993481|P3|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
907484|NCT01087788|2993482|P2|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
907485|NCT01087788|2993483|P1|Open-Label Period (OL-P)|AE, non-serious non-fatal|6
907486|NCT01087788|2993481|P3|Open-Label Period (OL-P)|AE, serious non-fatal|4
907487|NCT01087788|2993482|P2|Open-Label Period (OL-P)|AE, serious non-fatal|3
907488|NCT01087788|2993483|P1|Open-Label Period (OL-P)|AE, serious non-fatal|1
907489|NCT01087788|2993481|P3|Open-Label Period (OL-P)|AE, serious fatal|1
907490|NCT01087788|2993482|P2|Open-Label Period (OL-P)|AE, serious fatal|0
907491|NCT01087788|2993483|P1|Open-Label Period (OL-P)|AE, serious fatal|2
907492|NCT01087788|2993481|P3|Open-Label Period (OL-P)|Withdrawal by Subject|10
907493|NCT01087788|2993482|P2|Open-Label Period (OL-P)|Withdrawal by Subject|8
907494|NCT01087788|2993483|P1|Open-Label Period (OL-P)|Withdrawal by Subject|13
907495|NCT01087788|2993481|P3|Open-Label Period (OL-P)|Lost to Follow-up|2
907496|NCT01087788|2993482|P2|Open-Label Period (OL-P)|Lost to Follow-up|4
907497|NCT01087788|2993483|P1|Open-Label Period (OL-P)|Lost to Follow-up|0
907498|NCT01087788|2993481|P3|Open-Label Period (OL-P)|Protocol Violation|0
907499|NCT01087788|2993482|P2|Open-Label Period (OL-P)|Protocol Violation|1
907500|NCT01087788|2993483|P1|Open-Label Period (OL-P)|Protocol Violation|2
907501|NCT01087788|2993481|P3|Open-Label Period (OL-P)|Lack of Efficacy|3
907502|NCT01087788|2993482|P2|Open-Label Period (OL-P)|Lack of Efficacy|2
907503|NCT01087788|2993483|P1|Open-Label Period (OL-P)|Lack of Efficacy|4
907504|NCT01087788|2993481|P3|24-weeks Dose-blind Period|Patient moved|1
907505|NCT01087788|2993482|P2|24-weeks Dose-blind Period|Patient moved|0
907506|NCT01087788|2993483|P1|24-weeks Dose-blind Period|Patient moved|0
907507|NCT01087788|2993481|P3|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
907508|NCT01087788|2993482|P2|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
907509|NCT01087788|2993483|P1|24-weeks Dose-blind Period|Sponsor decision following missed visits|1
907510|NCT01087788|2993481|P3|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
907511|NCT01087788|2993482|P2|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
907512|NCT01087788|2993483|P1|24-weeks Dose-blind Period|AE, non-serious non-fatal|2
907513|NCT01087788|2993481|P3|24-weeks Dose-blind Period|AE, serious non-fatal|2
907514|NCT01087788|2993482|P2|24-weeks Dose-blind Period|AE, serious non-fatal|1
907515|NCT01087788|2993483|P1|24-weeks Dose-blind Period|AE, serious non-fatal|2
907516|NCT01087788|2993481|P3|24-weeks Dose-blind Period|AE, serious fatal|0
907517|NCT01087788|2993482|P2|24-weeks Dose-blind Period|AE, serious fatal|1
907518|NCT01087788|2993483|P1|24-weeks Dose-blind Period|AE, serious fatal|0
907519|NCT01087788|2993481|P3|24-weeks Dose-blind Period|Withdrawal by Subject|0
907520|NCT01087788|2993482|P2|24-weeks Dose-blind Period|Withdrawal by Subject|0
907521|NCT01087788|2993483|P1|24-weeks Dose-blind Period|Withdrawal by Subject|1
907522|NCT01087788|2993481|P3|24-weeks Dose-blind Period|Lost to Follow-up|1
907523|NCT01087788|2993482|P2|24-weeks Dose-blind Period|Lost to Follow-up|0
907524|NCT01087788|2993483|P1|24-weeks Dose-blind Period|Lost to Follow-up|1
907525|NCT01087788|2993481|P3|24-weeks Dose-blind Period|Lack of Efficacy|1
907526|NCT01087788|2993482|P2|24-weeks Dose-blind Period|Lack of Efficacy|2
907527|NCT01087788|2993483|P1|24-weeks Dose-blind Period|Lack of Efficacy|0
907528|NCT01087788|2993481|P3|24-weeks Double-blind Period|P cannot comply with scheduled visits|1
907529|NCT01087788|2993482|P2|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
907530|NCT01087788|2993483|P1|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
907531|NCT01087788|2993481|P3|24-weeks Double-blind Period|Exclusion criteria were not met|0
907532|NCT01087788|2993482|P2|24-weeks Double-blind Period|Exclusion criteria were not met|1
907533|NCT01087788|2993483|P1|24-weeks Double-blind Period|Exclusion criteria were not met|0
907534|NCT01087788|2993481|P3|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
907535|NCT01087788|2993482|P2|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1
907536|NCT01087788|2993483|P1|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
907537|NCT01087788|2993481|P3|24-weeks Double-blind Period|Patient (P) does not want to attend|0
907538|NCT01087788|2993482|P2|24-weeks Double-blind Period|Patient (P) does not want to attend|0
907539|NCT01087788|2993483|P1|24-weeks Double-blind Period|Patient (P) does not want to attend|1
907540|NCT01087788|2993481|P3|24-weeks Double-blind Period|AE, unknown type|1
907541|NCT01087788|2993482|P2|24-weeks Double-blind Period|AE, unknown type|0
907542|NCT01087788|2993483|P1|24-weeks Double-blind Period|AE, unknown type|0
907543|NCT01087788|2993481|P3|24-weeks Double-blind Period|AE, non-serious non-fatal|2
907544|NCT01087788|2993482|P2|24-weeks Double-blind Period|AE, non-serious non-fatal|1
907545|NCT01087788|2993483|P1|24-weeks Double-blind Period|AE, non-serious non-fatal|2
907546|NCT01087788|2993481|P3|24-weeks Double-blind Period|AE, serious non-fatal|3
907547|NCT01087788|2993482|P2|24-weeks Double-blind Period|AE, serious non-fatal|2
907548|NCT01087788|2993483|P1|24-weeks Double-blind Period|AE, serious non-fatal|0
907549|NCT01087788|2993481|P3|24-weeks Double-blind Period|AE, serious fatal|1
907550|NCT01087788|2993482|P2|24-weeks Double-blind Period|AE, serious fatal|1
907551|NCT01087788|2993483|P1|24-weeks Double-blind Period|AE, serious fatal|0
907552|NCT01087788|2993481|P3|24-weeks Double-blind Period|Withdrawal by Subject|5
907553|NCT01087788|2993482|P2|24-weeks Double-blind Period|Withdrawal by Subject|2
907554|NCT01087788|2993483|P1|24-weeks Double-blind Period|Withdrawal by Subject|7
907555|NCT01087788|2993481|P3|24-weeks Double-blind Period|Lost to Follow-up|1
907556|NCT01087788|2993482|P2|24-weeks Double-blind Period|Lost to Follow-up|1
907557|NCT01087788|2993483|P1|24-weeks Double-blind Period|Lost to Follow-up|4
907558|NCT01087788|2993481|P3|24-weeks Double-blind Period|Protocol Violation|0
907559|NCT01087788|2993482|P2|24-weeks Double-blind Period|Protocol Violation|1
907560|NCT01087788|2993483|P1|24-weeks Double-blind Period|Protocol Violation|0
907561|NCT01087788|2993481|P3|24-weeks Double-blind Period|Lack of Efficacy|1
907562|NCT01087788|2993482|P2|24-weeks Double-blind Period|Lack of Efficacy|0
907563|NCT01087788|2993483|P1|24-weeks Double-blind Period|Lack of Efficacy|2
907564|NCT01087762|2993513|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4
907565|NCT01087762|2993514|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2
907566|NCT01087762|2993515|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
907567|NCT01087762|2993516|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
907568|NCT01087762|2993517|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
907569|NCT01087762|2993513|P5|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13
907570|NCT01087762|2993514|P4|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16
907571|NCT01087762|2993515|P3|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
907572|NCT01087762|2993516|P2|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
907573|NCT01087762|2993517|P1|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
907574|NCT01087762|2993513|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4
907575|NCT01087762|2993514|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7
907576|NCT01087762|2993515|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
907577|NCT01087762|2993516|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
907578|NCT01087762|2993517|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
907579|NCT01087762|2993513|P5|Open-Label Period (Weeks 48-204)|Other|4
907580|NCT01087762|2993514|P4|Open-Label Period (Weeks 48-204)|Other|2
907581|NCT01087762|2993515|P3|Open-Label Period (Weeks 48-204)|Other|0
907582|NCT01087762|2993516|P2|Open-Label Period (Weeks 48-204)|Other|0
907583|NCT01087762|2993517|P1|Open-Label Period (Weeks 48-204)|Other|0
907584|NCT01087762|2993513|P5|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15
907585|NCT01087762|2993514|P4|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22
907586|NCT01087762|2993515|P3|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
907587|NCT01087762|2993516|P2|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
907588|NCT01087762|2993517|P1|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
907589|NCT01087762|2993513|P5|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2
907590|NCT01087762|2993514|P4|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5
907591|NCT01087762|2993515|P3|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
907592|NCT01087762|2993516|P2|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
907593|NCT01087762|2993517|P1|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
907594|NCT01087762|2993513|P5|Open-Label Period (Weeks 48-204)|Protocol Violation|1
907595|NCT01087762|2993514|P4|Open-Label Period (Weeks 48-204)|Protocol Violation|1
907596|NCT01087762|2993515|P3|Open-Label Period (Weeks 48-204)|Protocol Violation|0
907597|NCT01087762|2993516|P2|Open-Label Period (Weeks 48-204)|Protocol Violation|0
907598|NCT01087762|2993517|P1|Open-Label Period (Weeks 48-204)|Protocol Violation|0
907599|NCT01087762|2993513|P5|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14
907600|NCT01087762|2993514|P4|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4
907601|NCT01087762|2993515|P3|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
907602|NCT01087762|2993516|P2|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
907603|NCT01087762|2993517|P1|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
907604|NCT01087762|2993513|P5|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
907605|NCT01087762|2993514|P4|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
907606|NCT01087762|2993515|P3|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3
907607|NCT01087762|2993516|P2|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
907608|NCT01087762|2993517|P1|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
907609|NCT01087762|2993513|P5|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
907610|NCT01087762|2993514|P4|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
907611|NCT01087762|2993515|P3|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
907612|NCT01087762|2993516|P2|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2
907613|NCT01087762|2993517|P1|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
907614|NCT01087762|2993513|P5|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
907615|NCT01087762|2993514|P4|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
907616|NCT01087762|2993515|P3|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
907617|NCT01087762|2993516|P2|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2
907618|NCT01087762|2993517|P1|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
907619|NCT01087762|2993513|P5|Double Blind Period (Weeks 0-24)|Protocol Violation|0
907620|NCT01087762|2993514|P4|Double Blind Period (Weeks 0-24)|Protocol Violation|0
907621|NCT01087762|2993515|P3|Double Blind Period (Weeks 0-24)|Protocol Violation|1
907622|NCT01087762|2993516|P2|Double Blind Period (Weeks 0-24)|Protocol Violation|0
907623|NCT01087762|2993517|P1|Double Blind Period (Weeks 0-24)|Protocol Violation|6
907624|NCT01087762|2993513|P5|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
907625|NCT01087762|2993514|P4|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
907626|NCT01087762|2993515|P3|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3
907627|NCT01087762|2993516|P2|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
907628|NCT01087762|2993517|P1|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2
907629|NCT01087736|2993565|P2|Overall Study|Withdrawal by Subject|1
907630|NCT01087736|2993566|P1|Overall Study|Withdrawal by Subject|0
907631|NCT01087736|2993565|P2|Overall Study|Death|1
907632|NCT01087736|2993566|P1|Overall Study|Death|0
907633|NCT01087736|2993565|P2|Overall Study|Lost to Follow-up|0
907634|NCT01087736|2993566|P1|Overall Study|Lost to Follow-up|1
907635|NCT01087723|2993576|P2|Overall Study|Reason Not Specified|2
907636|NCT01087723|2993577|P1|Overall Study|Reason Not Specified|1
907637|NCT01087723|2993576|P2|Overall Study|Lost to Follow-up|4
907638|NCT01087723|2993577|P1|Overall Study|Lost to Follow-up|1
907639|NCT01087723|2993576|P2|Overall Study|Physician Decision|0
907640|NCT01087723|2993577|P1|Overall Study|Physician Decision|2
907641|NCT01087723|2993576|P2|Overall Study|Withdrawal by Subject|13
907642|NCT01087723|2993577|P1|Overall Study|Withdrawal by Subject|10
907643|NCT01087723|2993576|P2|Overall Study|1 Year Visit Too Early (<335 days)|1
907644|NCT01087723|2993577|P1|Overall Study|1 Year Visit Too Early (<335 days)|0
907645|NCT01087528|2993618|P1|Overall Study|Incomplete CE procedure|6
907646|NCT01087528|2993618|P1|Overall Study|Withdrawal by Subject|1
907647|NCT01087502|2993624|P2|Up to Final Analysis (Week 52)|Other reason not described above|4
907648|NCT01087502|2993625|P1|Up to Final Analysis (Week 52)|Other reason not described above|5
907649|NCT01087502|2993624|P2|Up to Final Analysis (Week 52)|Study site excluded from analysis|5
907650|NCT01087502|2993625|P1|Up to Final Analysis (Week 52)|Study site excluded from analysis|1
907651|NCT01087502|2993624|P2|Up to Final Analysis (Week 52)|Withdrawal by Subject|2
907652|NCT01087502|2993625|P1|Up to Final Analysis (Week 52)|Withdrawal by Subject|3
907653|NCT01087502|2993624|P2|Up to Final Analysis (Week 52)|Lost to Follow-up|0
907654|NCT01087502|2993625|P1|Up to Final Analysis (Week 52)|Lost to Follow-up|2
907655|NCT01087502|2993624|P2|Up to Final Analysis (Week 52)|Protocol Violation|0
907656|NCT01087502|2993625|P1|Up to Final Analysis (Week 52)|Protocol Violation|4
907657|NCT01087502|2993624|P2|Up to Final Analysis (Week 52)|Lack of Efficacy|2
907658|NCT01087502|2993625|P1|Up to Final Analysis (Week 52)|Lack of Efficacy|1
907659|NCT01087502|2993624|P2|Up to Final Analysis (Week 52)|Adverse Event|10
907660|NCT01087502|2993625|P1|Up to Final Analysis (Week 52)|Adverse Event|17
907661|NCT01087502|2993624|P2|Up to Interim Analysis (Week 12)|Other reason not described above|2
907662|NCT01087502|2993625|P1|Up to Interim Analysis (Week 12)|Other reason not described above|1
907663|NCT01087502|2993624|P2|Up to Interim Analysis (Week 12)|Lack of Efficacy|0
907664|NCT01087502|2993625|P1|Up to Interim Analysis (Week 12)|Lack of Efficacy|1
907665|NCT01087502|2993624|P2|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
907666|NCT01087502|2993625|P1|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
907752|NCT01086384|2993918|P1|2-week Run-in Period|Withdrawal by Subject|19
907667|NCT01087502|2993624|P2|Up to Interim Analysis (Week 12)|Protocol Violation|1
907668|NCT01087502|2993625|P1|Up to Interim Analysis (Week 12)|Protocol Violation|1
907669|NCT01087502|2993624|P2|Up to Interim Analysis (Week 12)|Adverse Event|4
907670|NCT01087502|2993625|P1|Up to Interim Analysis (Week 12)|Adverse Event|5
907671|NCT01087489|2993644|P2|Overall Study|unable to survey by telephone|1
907672|NCT01087489|2993645|P1|Overall Study|unable to survey by telephone|0
907673|NCT01087489|2993644|P2|Overall Study|Death|1
907674|NCT01087489|2993645|P1|Overall Study|Death|0
907675|NCT01087489|2993644|P2|Overall Study|enrolled in another VA study|1
907676|NCT01087489|2993645|P1|Overall Study|enrolled in another VA study|0
907677|NCT01086969|2993658|P3|Overall Study|Withdrawal by Subject|0
907678|NCT01086969|2993659|P2|Overall Study|Withdrawal by Subject|2
907679|NCT01086969|2993660|P1|Overall Study|Withdrawal by Subject|1
907680|NCT01086423|2993770|P3|Overall Study|Lost to Follow-up|1
907681|NCT01086423|2993771|P2|Overall Study|Lost to Follow-up|0
907682|NCT01086423|2993772|P1|Overall Study|Lost to Follow-up|0
907683|NCT01086423|2993770|P3|Overall Study|Withdrawal by Subject|3
907684|NCT01086423|2993771|P2|Overall Study|Withdrawal by Subject|1
907685|NCT01086423|2993772|P1|Overall Study|Withdrawal by Subject|5
907686|NCT01086423|2993770|P3|Overall Study|Adverse event, non-fatal|0
907687|NCT01086423|2993771|P2|Overall Study|Adverse event, non-fatal|1
907688|NCT01086423|2993772|P1|Overall Study|Adverse event, non-fatal|2
907689|NCT01086423|2993770|P3|Overall Study|Adverse event, fatal|0
907690|NCT01086423|2993771|P2|Overall Study|Adverse event, fatal|1
907691|NCT01086423|2993772|P1|Overall Study|Adverse event, fatal|1
907692|NCT01086423|2993770|P3|Overall Study|Migrated/moved from study area|4
907693|NCT01086423|2993771|P2|Overall Study|Migrated/moved from study area|0
907694|NCT01086423|2993772|P1|Overall Study|Migrated/moved from study area|2
907695|NCT01086423|2993770|P3|Overall Study|Protocol Violation|1
907696|NCT01086423|2993771|P2|Overall Study|Protocol Violation|0
907697|NCT01086423|2993772|P1|Overall Study|Protocol Violation|0
907698|NCT01086410|2993817|P4|Overall Study|Lost to Follow-up|0
907699|NCT01086410|2993818|P3|Overall Study|Lost to Follow-up|1
907700|NCT01086410|2993819|P2|Overall Study|Lost to Follow-up|0
907701|NCT01086410|2993820|P1|Overall Study|Lost to Follow-up|0
907702|NCT01086410|2993817|P4|Overall Study|Protocol Violation|0
907703|NCT01086410|2993818|P3|Overall Study|Protocol Violation|0
907704|NCT01086410|2993819|P2|Overall Study|Protocol Violation|1
907705|NCT01086410|2993820|P1|Overall Study|Protocol Violation|1
907706|NCT01086410|2993817|P4|Overall Study|Lack of Efficacy|0
907707|NCT01086410|2993818|P3|Overall Study|Lack of Efficacy|0
907708|NCT01086410|2993819|P2|Overall Study|Lack of Efficacy|1
907709|NCT01086410|2993820|P1|Overall Study|Lack of Efficacy|1
907710|NCT01086410|2993817|P4|Overall Study|Adverse Event|2
907711|NCT01086410|2993818|P3|Overall Study|Adverse Event|0
907712|NCT01086410|2993819|P2|Overall Study|Adverse Event|0
907713|NCT01086410|2993820|P1|Overall Study|Adverse Event|1
907714|NCT01086384|2993916|P3|Treatment Period|Received Treatment in Error|0
907715|NCT01086384|2993917|P2|Treatment Period|Received Treatment in Error|1
907716|NCT01086384|2993918|P1|Treatment Period|Received Treatment in Error|0
907717|NCT01086384|2993916|P3|Treatment Period|Protocol-Defined Stopping Criteria|1
907718|NCT01086384|2993917|P2|Treatment Period|Protocol-Defined Stopping Criteria|0
907719|NCT01086384|2993918|P1|Treatment Period|Protocol-Defined Stopping Criteria|0
907720|NCT01086384|2993916|P3|Treatment Period|Study Closed/Terminated|8
907721|NCT01086384|2993917|P2|Treatment Period|Study Closed/Terminated|7
907722|NCT01086384|2993918|P1|Treatment Period|Study Closed/Terminated|0
907723|NCT01086384|2993916|P3|Treatment Period|Physician Decision|6
907724|NCT01086384|2993917|P2|Treatment Period|Physician Decision|9
907725|NCT01086384|2993918|P1|Treatment Period|Physician Decision|0
907726|NCT01086384|2993916|P3|Treatment Period|Lost to Follow-up|9
907727|NCT01086384|2993917|P2|Treatment Period|Lost to Follow-up|11
907728|NCT01086384|2993918|P1|Treatment Period|Lost to Follow-up|0
907729|NCT01086384|2993916|P3|Treatment Period|Adverse Event|15
907730|NCT01086384|2993917|P2|Treatment Period|Adverse Event|19
907731|NCT01086384|2993918|P1|Treatment Period|Adverse Event|0
907732|NCT01086384|2993916|P3|Treatment Period|Lack of Efficacy|13
907733|NCT01086384|2993917|P2|Treatment Period|Lack of Efficacy|22
907734|NCT01086384|2993918|P1|Treatment Period|Lack of Efficacy|0
907735|NCT01086384|2993916|P3|Treatment Period|Protocol Violation|17
907736|NCT01086384|2993917|P2|Treatment Period|Protocol Violation|26
907737|NCT01086384|2993918|P1|Treatment Period|Protocol Violation|0
907738|NCT01086384|2993916|P3|Treatment Period|Withdrawal by Subject|55
907739|NCT01086384|2993917|P2|Treatment Period|Withdrawal by Subject|53
907740|NCT01086384|2993918|P1|Treatment Period|Withdrawal by Subject|0
907741|NCT01086384|2993916|P3|2-week Run-in Period|Randomized in Error|0
907742|NCT01086384|2993917|P2|2-week Run-in Period|Randomized in Error|0
907743|NCT01086384|2993918|P1|2-week Run-in Period|Randomized in Error|1
907744|NCT01086384|2993916|P3|2-week Run-in Period|Continuation Criteria Not Met|0
907745|NCT01086384|2993917|P2|2-week Run-in Period|Continuation Criteria Not Met|0
907746|NCT01086384|2993918|P1|2-week Run-in Period|Continuation Criteria Not Met|92
907747|NCT01086384|2993916|P3|2-week Run-in Period|Study Closed/Terminated|0
907748|NCT01086384|2993917|P2|2-week Run-in Period|Study Closed/Terminated|0
907749|NCT01086384|2993918|P1|2-week Run-in Period|Study Closed/Terminated|42
907750|NCT01086384|2993916|P3|2-week Run-in Period|Withdrawal by Subject|0
907751|NCT01086384|2993917|P2|2-week Run-in Period|Withdrawal by Subject|0
907753|NCT01086384|2993916|P3|2-week Run-in Period|Physician Decision|0
907754|NCT01086384|2993917|P2|2-week Run-in Period|Physician Decision|0
907755|NCT01086384|2993918|P1|2-week Run-in Period|Physician Decision|6
907756|NCT01086384|2993916|P3|2-week Run-in Period|Lost to Follow-up|0
907757|NCT01086384|2993917|P2|2-week Run-in Period|Lost to Follow-up|0
907758|NCT01086384|2993918|P1|2-week Run-in Period|Lost to Follow-up|1
907759|NCT01086384|2993916|P3|2-week Run-in Period|Protocol Violation|0
907760|NCT01086384|2993917|P2|2-week Run-in Period|Protocol Violation|0
907761|NCT01086384|2993918|P1|2-week Run-in Period|Protocol Violation|1
907762|NCT01086384|2993916|P3|2-week Run-in Period|Adverse Event|0
907763|NCT01086384|2993917|P2|2-week Run-in Period|Adverse Event|0
907764|NCT01086384|2993918|P1|2-week Run-in Period|Adverse Event|1
907765|NCT01086358|2993928|P2|Second Intervention|Lost to Follow-up|4
907766|NCT01086358|2993929|P1|Second Intervention|Lost to Follow-up|4
907767|NCT01086358|2993928|P2|First Intervention|Withdrawal by Subject|1
907768|NCT01086358|2993929|P1|First Intervention|Withdrawal by Subject|0
907769|NCT01086358|2993928|P2|First Intervention|Lost to Follow-up|4
907770|NCT01086358|2993929|P1|First Intervention|Lost to Follow-up|9
907771|NCT01086215|2993999|P4|Overall Study|Lost to Follow-up|2
907772|NCT01086215|2994000|P3|Overall Study|Lost to Follow-up|18
907773|NCT01086215|2994001|P2|Overall Study|Lost to Follow-up|39
907774|NCT01086215|2994002|P1|Overall Study|Lost to Follow-up|22
907775|NCT01086215|2993999|P4|Overall Study|Death|1
907776|NCT01086215|2994000|P3|Overall Study|Death|8
907777|NCT01086215|2994001|P2|Overall Study|Death|8
907778|NCT01086215|2994002|P1|Overall Study|Death|14
907779|NCT01086033|2994020|P1|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1
907780|NCT01086033|2994020|P1|Overall Study|AE and Other Reason|1
907781|NCT01086033|2994020|P1|Overall Study|AE and Lost to Follow-up|1
907782|NCT01086033|2994020|P1|Overall Study|Death|1
907783|NCT01086033|2994020|P1|Overall Study|AE and Lack of Efficacy|4
907784|NCT01086033|2994020|P1|Overall Study|Withdrew consent and Other Reason|4
907785|NCT01086033|2994020|P1|Overall Study|Withdrew Consent and Lack of Efficacy|5
907786|NCT01086033|2994020|P1|Overall Study|AE and Withdrew Consent|5
907787|NCT01086033|2994020|P1|Overall Study|Other|13
907788|NCT01086033|2994020|P1|Overall Study|Other|14
907789|NCT01086033|2994020|P1|Overall Study|Withdrawal by Subject|41
907790|NCT01086033|2994020|P1|Overall Study|Adverse Event|42
907791|NCT01086033|2994020|P1|Overall Study|Lost to Follow-up|86
907792|NCT01086033|2994020|P1|Overall Study|Lack of efficacy/Exacerbation of RA|86
907793|NCT01085734|2994126|P2|Overall Study|Withdrawal by Subject|1
907794|NCT01085734|2994127|P1|Overall Study|Withdrawal by Subject|0
907795|NCT01085734|2994126|P2|Overall Study|Lost to Follow-up|1
907796|NCT01085734|2994127|P1|Overall Study|Lost to Follow-up|0
907797|NCT01085734|2994126|P2|Overall Study|Death|0
907798|NCT01085734|2994127|P1|Overall Study|Death|1
907799|NCT01085734|2994126|P2|Overall Study|Adverse Event|2
907800|NCT01085734|2994127|P1|Overall Study|Adverse Event|0
907801|NCT01085682|2994139|P2|Overall Study|Withdrawal by Subject|25
907802|NCT01085682|2994140|P1|Overall Study|Withdrawal by Subject|25
907803|NCT01085591|2994158|P3|Overall Study|Not Properly Consented|0
907804|NCT01085591|2994159|P2|Overall Study|Not Properly Consented|0
907805|NCT01085591|2994160|P1|Overall Study|Not Properly Consented|1
907806|NCT01085591|2994158|P3|Overall Study|Other|0
907807|NCT01085591|2994159|P2|Overall Study|Other|1
907808|NCT01085591|2994160|P1|Overall Study|Other|0
907809|NCT01085591|2994158|P3|Overall Study|Protocol Violation|1
907810|NCT01085591|2994159|P2|Overall Study|Protocol Violation|1
907811|NCT01085591|2994160|P1|Overall Study|Protocol Violation|1
907812|NCT01085591|2994158|P3|Overall Study|Lost to Follow-up|1
907813|NCT01085591|2994159|P2|Overall Study|Lost to Follow-up|1
907814|NCT01085591|2994160|P1|Overall Study|Lost to Follow-up|0
907815|NCT01085591|2994158|P3|Overall Study|Withdrawal by Subject|1
907816|NCT01085591|2994159|P2|Overall Study|Withdrawal by Subject|2
907817|NCT01085591|2994160|P1|Overall Study|Withdrawal by Subject|0
907818|NCT01085591|2994158|P3|Overall Study|Physician Decision|1
907819|NCT01085591|2994159|P2|Overall Study|Physician Decision|0
907820|NCT01085591|2994160|P1|Overall Study|Physician Decision|1
907821|NCT01085591|2994158|P3|Overall Study|Adverse Event|3
907822|NCT01085591|2994159|P2|Overall Study|Adverse Event|1
907823|NCT01085591|2994160|P1|Overall Study|Adverse Event|0
907824|NCT01085357|2994211|P2|Overall Study|Lost to Follow-up|0
907825|NCT01085357|2994212|P1|Overall Study|Lost to Follow-up|2
907826|NCT01085357|2994211|P2|Overall Study|Death|1
907827|NCT01085357|2994212|P1|Overall Study|Death|11
907828|NCT01085357|2994211|P2|Overall Study|Investigator Decision|1
907829|NCT01085357|2994212|P1|Overall Study|Investigator Decision|1
907830|NCT01085357|2994211|P2|Overall Study|Subject Decision|3
907831|NCT01085357|2994212|P1|Overall Study|Subject Decision|4
907832|NCT01085357|2994211|P2|Overall Study|Adverse Event|1
907833|NCT01085357|2994212|P1|Overall Study|Adverse Event|1
907834|NCT01085214|2994275|P1|Overall Study|Alternate treatment required|1
907835|NCT01085201|2994287|P5|Overall Study|Fond ineligible after consent|0
907836|NCT01085201|2994288|P4|Overall Study|Fond ineligible after consent|0
907837|NCT01085201|2994289|P3|Overall Study|Fond ineligible after consent|1
907838|NCT01085201|2994290|P2|Overall Study|Fond ineligible after consent|1
907839|NCT01085201|2994291|P1|Overall Study|Fond ineligible after consent|0
907840|NCT01085201|2994287|P5|Overall Study|Unknown- no study drug|0
907841|NCT01085201|2994288|P4|Overall Study|Unknown- no study drug|0
907842|NCT01085201|2994289|P3|Overall Study|Unknown- no study drug|0
907843|NCT01085201|2994290|P2|Overall Study|Unknown- no study drug|0
907844|NCT01085201|2994291|P1|Overall Study|Unknown- no study drug|2
907845|NCT01085201|2994287|P5|Overall Study|Scheduling conflict|0
907846|NCT01085201|2994288|P4|Overall Study|Scheduling conflict|0
907847|NCT01085201|2994289|P3|Overall Study|Scheduling conflict|1
907848|NCT01085201|2994290|P2|Overall Study|Scheduling conflict|0
907849|NCT01085201|2994291|P1|Overall Study|Scheduling conflict|1
907850|NCT01085136|2994313|P3|Part B|Other reason not defined above|3
907851|NCT01085136|2994314|P2|Part B|Other reason not defined above|6
907852|NCT01085136|2994315|P1|Part B|Other reason not defined above|0
907853|NCT01085136|2994313|P3|Part B|Not treated|8
907854|NCT01085136|2994314|P2|Part B|Not treated|4
907855|NCT01085136|2994315|P1|Part B|Not treated|0
907856|NCT01085136|2994313|P3|Part B|Refusal to continue trial medication|7
907857|NCT01085136|2994314|P2|Part B|Refusal to continue trial medication|12
907858|NCT01085136|2994315|P1|Part B|Refusal to continue trial medication|0
907859|NCT01085136|2994313|P3|Part B|Other AE|8
907860|NCT01085136|2994314|P2|Part B|Other AE|29
907861|NCT01085136|2994315|P1|Part B|Other AE|0
907862|NCT01085136|2994313|P3|Part A|Other reason not defined above|0
907863|NCT01085136|2994314|P2|Part A|Other reason not defined above|0
907864|NCT01085136|2994315|P1|Part A|Other reason not defined above|30
907865|NCT01085136|2994313|P3|Part A|Refusal to continue trial medication|0
907866|NCT01085136|2994314|P2|Part A|Refusal to continue trial medication|0
907867|NCT01085136|2994315|P1|Part A|Refusal to continue trial medication|64
907868|NCT01085136|2994313|P3|Part A|Lost to Follow-up|0
907869|NCT01085136|2994314|P2|Part A|Lost to Follow-up|0
907870|NCT01085136|2994315|P1|Part A|Lost to Follow-up|3
907871|NCT01085136|2994313|P3|Part A|Protocol Violation|0
907872|NCT01085136|2994314|P2|Part A|Protocol Violation|0
907873|NCT01085136|2994315|P1|Part A|Protocol Violation|3
907874|NCT01085136|2994313|P3|Part A|Other Adverse event|0
907875|NCT01085136|2994314|P2|Part A|Other Adverse event|0
907876|NCT01085136|2994315|P1|Part A|Other Adverse event|223
907877|NCT01085045|2994331|P1|Part B|Adverse Event|6
907878|NCT01085045|2994331|P1|Part B|Lost to Follow-up|1
907879|NCT01085045|2994331|P1|Part B|Protocol Specified Criteria|6
907880|NCT01085045|2994331|P1|Part B|Withdrawal by Subject|2
907881|NCT01085045|2994331|P1|Part A|Protocol Specified Criteria|7
907882|NCT01085045|2994331|P1|Part A|Protocol Violation|1
907883|NCT01085045|2994331|P1|Part A|Adverse Event|6
907884|NCT01085045|2994331|P1|Part A|Withdrawal by Subject|4
907885|NCT01084707|2994446|P1|Overall Study|Withdrawal by Subject|6
907886|NCT01084668|2994480|P1|Overall Study|Non-compliance|1
907887|NCT01084668|2994480|P1|Overall Study|Pregnancy|1
907888|NCT01084668|2994480|P1|Overall Study|Withdrawal by Subject|2
907889|NCT01084668|2994480|P1|Overall Study|Lack of Efficacy|5
907890|NCT01084603|2994489|P1|Washout Period 4|Adverse Event|1
907891|NCT01084603|2994489|P1|Oral Nicotine 1|Withdrawal by Subject|1
907892|NCT01084603|2994489|P1|Nicorette® Gum|Withdrawal by Subject|1
907893|NCT01084603|2994489|P1|NiQuitinTM Lozenge|Withdrawal by Subject|1
907894|NCT01084603|2994489|P1|Baseline|Withdrawal by Subject|2
907895|NCT01084551|2994525|P3|Overall Study|Physician Decision|0
907896|NCT01084551|2994526|P2|Overall Study|Physician Decision|0
907897|NCT01084551|2994527|P1|Overall Study|Physician Decision|1
907898|NCT01084551|2994525|P3|Overall Study|Lost to Follow-up|3
907899|NCT01084551|2994526|P2|Overall Study|Lost to Follow-up|0
907900|NCT01084551|2994527|P1|Overall Study|Lost to Follow-up|0
907901|NCT01084551|2994525|P3|Overall Study|Protocol Violation|0
907902|NCT01084551|2994526|P2|Overall Study|Protocol Violation|4
907903|NCT01084551|2994527|P1|Overall Study|Protocol Violation|2
907904|NCT01084551|2994525|P3|Overall Study|Withdrawal by Subject|0
907905|NCT01084551|2994526|P2|Overall Study|Withdrawal by Subject|1
907906|NCT01084551|2994527|P1|Overall Study|Withdrawal by Subject|2
907907|NCT01084551|2994525|P3|Overall Study|Lack of Efficacy|1
907908|NCT01084551|2994526|P2|Overall Study|Lack of Efficacy|0
907909|NCT01084551|2994527|P1|Overall Study|Lack of Efficacy|2
907910|NCT01084551|2994525|P3|Overall Study|Adverse Event|4
907911|NCT01084551|2994526|P2|Overall Study|Adverse Event|9
907912|NCT01084551|2994527|P1|Overall Study|Adverse Event|2
907913|NCT01084538|2994565|P1|Overall Study|Reason unknown|8
907914|NCT01084538|2994565|P1|Overall Study|Over-suppression of parathyroid gland|2
907915|NCT01084538|2994565|P1|Overall Study|Change of residence|2
907916|NCT01084538|2994565|P1|Overall Study|Nodular hyperplasia of parathyroid gland|2
907917|NCT01084538|2994565|P1|Overall Study|Hyperphosphatemia|2
907918|NCT01084538|2994565|P1|Overall Study|Patient noncompliance|2
907919|NCT01084538|2994565|P1|Overall Study|Lack of effectiveness|2
907920|NCT01084538|2994565|P1|Overall Study|Serious Adverse Event|3
907921|NCT01084538|2994565|P1|Overall Study|Kidney transplant|6
907922|NCT01084538|2994565|P1|Overall Study|Adverse Event|9
907923|NCT01084538|2994565|P1|Overall Study|Drug not available|30
907924|NCT01084239|2994676|P2|28-Day Follow-up|Lost to Follow-up|9
907925|NCT01084239|2994677|P1|28-Day Follow-up|Lost to Follow-up|4
907926|NCT01084174|2994695|P2|Overall Study|Participant noncompliance|1
907927|NCT01084174|2994696|P1|Overall Study|Participant noncompliance|0
907928|NCT01084174|2994695|P2|Overall Study|Anaphylaxis|1
907929|NCT01084174|2994696|P1|Overall Study|Anaphylaxis|0
907930|NCT01084174|2994695|P2|Overall Study|Eosinophilic esophagitis|1
907931|NCT01084174|2994696|P1|Overall Study|Eosinophilic esophagitis|0
907932|NCT01084174|2994695|P2|Overall Study|gastrointestinal symptoms|1
907933|NCT01084174|2994696|P1|Overall Study|gastrointestinal symptoms|1
907934|NCT01084135|2994729|P2|20 Week|Physician Decision|1
907935|NCT01084135|2994730|P1|20 Week|Physician Decision|0
907936|NCT01084083|2994740|P1|Overall Study|Never started assigned therapy|1
907937|NCT01084083|2994740|P1|Overall Study|Other|2
907938|NCT01084083|2994740|P1|Overall Study|Complicating disease|1
907939|NCT01084083|2994740|P1|Overall Study|Withdrawal by Subject|2
907940|NCT01084083|2994740|P1|Overall Study|Death|1
907941|NCT01084083|2994740|P1|Overall Study|Adverse Event|5
907942|NCT01084005|2994748|P2|Overall Study|Withdrawal by Subject|1
907943|NCT01084005|2994749|P1|Overall Study|Withdrawal by Subject|1
907944|NCT01084005|2994748|P2|Overall Study|Protocol Violation|7
907945|NCT01084005|2994749|P1|Overall Study|Protocol Violation|3
907946|NCT01084005|2994748|P2|Overall Study|Adverse Event|8
907947|NCT01084005|2994749|P1|Overall Study|Adverse Event|1
907948|NCT01083810|2994830|P3|Overall Study|Virologic failure|0
907949|NCT01083810|2994831|P2|Overall Study|Virologic failure|8
907950|NCT01083810|2994832|P1|Overall Study|Virologic failure|1
907951|NCT01083810|2994830|P3|Overall Study|Therapy break|2
907952|NCT01083810|2994831|P2|Overall Study|Therapy break|2
907953|NCT01083810|2994832|P1|Overall Study|Therapy break|1
907954|NCT01083810|2994830|P3|Overall Study|Participation in study|0
907955|NCT01083810|2994831|P2|Overall Study|Participation in study|0
907956|NCT01083810|2994832|P1|Overall Study|Participation in study|1
907957|NCT01083810|2994830|P3|Overall Study|Co-morbidities|0
907958|NCT01083810|2994831|P2|Overall Study|Co-morbidities|0
907959|NCT01083810|2994832|P1|Overall Study|Co-morbidities|1
907960|NCT01083810|2994830|P3|Overall Study|Death|3
907961|NCT01083810|2994831|P2|Overall Study|Death|2
907962|NCT01083810|2994832|P1|Overall Study|Death|2
907963|NCT01083810|2994830|P3|Overall Study|Simplification|0
907964|NCT01083810|2994831|P2|Overall Study|Simplification|1
907965|NCT01083810|2994832|P1|Overall Study|Simplification|4
907966|NCT01083810|2994830|P3|Overall Study|Non-compliance|2
907967|NCT01083810|2994831|P2|Overall Study|Non-compliance|7
907968|NCT01083810|2994832|P1|Overall Study|Non-compliance|4
907969|NCT01083810|2994830|P3|Overall Study|Reason not reported|1
907970|NCT01083810|2994831|P2|Overall Study|Reason not reported|1
907971|NCT01083810|2994832|P1|Overall Study|Reason not reported|6
907972|NCT01083810|2994830|P3|Overall Study|Withdrawal by Subject|4
907973|NCT01083810|2994831|P2|Overall Study|Withdrawal by Subject|2
907974|NCT01083810|2994832|P1|Overall Study|Withdrawal by Subject|7
907975|NCT01083810|2994830|P3|Overall Study|Adverse Event|4
907976|NCT01083810|2994831|P2|Overall Study|Adverse Event|11
907977|NCT01083810|2994832|P1|Overall Study|Adverse Event|15
907978|NCT01083810|2994830|P3|Overall Study|Lost to Follow-up|4
907979|NCT01083810|2994831|P2|Overall Study|Lost to Follow-up|11
907980|NCT01083810|2994832|P1|Overall Study|Lost to Follow-up|23
907981|NCT01083771|2994853|P1|Overall Study|Withdrawal by Subject|3
907982|NCT01083771|2994853|P1|Overall Study|non-compliant|2
907983|NCT01083693|2994954|P3|Overall Study|Reason unknown|1
907984|NCT01083693|2994955|P2|Overall Study|Reason unknown|0
907985|NCT01083693|2994956|P1|Overall Study|Reason unknown|0
907986|NCT01083693|2994954|P3|Overall Study|Withdrawal by Subject|2
907987|NCT01083693|2994955|P2|Overall Study|Withdrawal by Subject|0
907988|NCT01083693|2994956|P1|Overall Study|Withdrawal by Subject|3
907989|NCT01083693|2994954|P3|Overall Study|Other medical condition/surgery|0
907990|NCT01083693|2994955|P2|Overall Study|Other medical condition/surgery|1
907991|NCT01083693|2994956|P1|Overall Study|Other medical condition/surgery|1
907992|NCT01083693|2994954|P3|Overall Study|Complete remission|0
907993|NCT01083693|2994955|P2|Overall Study|Complete remission|1
907994|NCT01083693|2994956|P1|Overall Study|Complete remission|0
907995|NCT01083693|2994954|P3|Overall Study|Patient Moved|0
907996|NCT01083693|2994955|P2|Overall Study|Patient Moved|1
907997|NCT01083693|2994956|P1|Overall Study|Patient Moved|0
907998|NCT01083693|2994954|P3|Overall Study|Lack of effectiveness|2
907999|NCT01083693|2994955|P2|Overall Study|Lack of effectiveness|2
908000|NCT01083693|2994956|P1|Overall Study|Lack of effectiveness|13
908001|NCT01083693|2994954|P3|Overall Study|Lost to Follow-up|2
908002|NCT01083693|2994955|P2|Overall Study|Lost to Follow-up|0
908003|NCT01083693|2994956|P1|Overall Study|Lost to Follow-up|2
908004|NCT01083693|2994954|P3|Overall Study|Adverse Event|0
908005|NCT01083693|2994955|P2|Overall Study|Adverse Event|1
908006|NCT01083693|2994956|P1|Overall Study|Adverse Event|1
908007|NCT01083680|2994991|P1|Overall Study|Withdrawal by Subject|1086
908008|NCT01083680|2994991|P1|Overall Study|Lost to Follow-up|2758
908009|NCT01083641|2995014|P1|Overall Study|Withdrawal by Subject|2
908010|NCT01083602|2995021|P1|Overall Study|Lack of Efficacy|36
908011|NCT01083602|2995021|P1|Overall Study|Withdrawal by Subject|5
908012|NCT01083602|2995021|P1|Overall Study|Death|1
908013|NCT01083602|2995021|P1|Overall Study|New Cancer Therapy|2
908014|NCT01083602|2995021|P1|Overall Study|Adverse Event|11
908015|NCT01083576|2995032|P2|Overall Study|Treatment Failure|1
908016|NCT01083576|2995033|P1|Overall Study|Treatment Failure|6
908017|NCT01083485|2995063|P2|Overall Study|Other|0
908018|NCT01083485|2995064|P1|Overall Study|Other|1
908019|NCT01083485|2995063|P2|Overall Study|Withdrawal by Subject|2
908020|NCT01083485|2995064|P1|Overall Study|Withdrawal by Subject|5
908021|NCT01083485|2995063|P2|Overall Study|Protocol Violation|0
908022|NCT01083485|2995064|P1|Overall Study|Protocol Violation|1
908023|NCT01083485|2995063|P2|Overall Study|Adverse Event|1
908024|NCT01083485|2995064|P1|Overall Study|Adverse Event|0
908025|NCT01083316|2995081|P1|Overall Study|Withdrawal by Subject|1
908026|NCT01083316|2995081|P1|Overall Study|Adverse Event|2
908027|NCT01083186|2995092|P1|Overall Study|Non-compliance to Study Treatment|1
908028|NCT01083186|2995092|P1|Overall Study|Administrative Reasons|2
908029|NCT01083186|2995092|P1|Overall Study|Hemodialysis Initiation|28
908030|NCT01083186|2995092|P1|Overall Study|Lack of Efficacy|2
908031|NCT01083186|2995092|P1|Overall Study|Adverse Event|3
908032|NCT01083186|2995092|P1|Overall Study|Death|3
908033|NCT01083186|2995092|P1|Overall Study|Consent Withdrawal|7
908034|NCT01083186|2995092|P1|Overall Study|Lost to Follow-up|48
908035|NCT01083173|2995133|P2|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46
908036|NCT01083173|2995134|P1|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0
908037|NCT01083173|2995133|P2|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136
908038|NCT01083173|2995134|P1|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0
908039|NCT01083173|2995133|P2|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195
908040|NCT01083173|2995134|P1|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0
908041|NCT01083173|2995133|P2|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101
908042|NCT01083173|2995134|P1|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0
908043|NCT01083173|2995133|P2|Long-term Surveillance: Safety Group|Violation of the dosage|1
908044|NCT01083173|2995134|P1|Long-term Surveillance: Safety Group|Violation of the dosage|0
908045|NCT01083173|2995133|P2|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
908046|NCT01083173|2995134|P1|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
908047|NCT01083173|2995133|P2|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0
908048|NCT01083173|2995134|P1|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13
908049|NCT01083173|2995133|P2|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0
908050|NCT01083173|2995134|P1|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168
908051|NCT01083173|2995133|P2|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0
908052|NCT01083173|2995134|P1|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201
908053|NCT01083173|2995133|P2|Main Surveillance: Safety Group|Violation of the use/dosage|0
908054|NCT01083173|2995134|P1|Main Surveillance: Safety Group|Violation of the use/dosage|1
908055|NCT01083173|2995133|P2|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
908056|NCT01083173|2995134|P1|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
908057|NCT01083160|2995152|P1|Overall Study|Adverse Event|1
908058|NCT01083121|2995159|P1|Overall Study|Use of Humira outside the approved label|81
908059|NCT01082965|2995169|P2|Overall Study|Other|1
908060|NCT01082965|2995170|P1|Overall Study|Other|1
908061|NCT01082965|2995169|P2|Overall Study|Protocol Violation|1
908062|NCT01082965|2995170|P1|Overall Study|Protocol Violation|0
908063|NCT01082874|2995207|P4|Overall Study|Withdrawal by Subject|3
908064|NCT01082874|2995208|P3|Overall Study|Withdrawal by Subject|5
908065|NCT01082874|2995209|P2|Overall Study|Withdrawal by Subject|2
908066|NCT01082874|2995210|P1|Overall Study|Withdrawal by Subject|1
908067|NCT01082874|2995207|P4|Overall Study|Lost to Follow-up|10
908068|NCT01082874|2995208|P3|Overall Study|Lost to Follow-up|6
908069|NCT01082874|2995209|P2|Overall Study|Lost to Follow-up|10
908070|NCT01082874|2995210|P1|Overall Study|Lost to Follow-up|10
908071|NCT01082640|2995223|P3|Overall Study|Other|3
908072|NCT01082640|2995224|P2|Overall Study|Other|1
908073|NCT01082640|2995225|P1|Overall Study|Other|2
908074|NCT01082640|2995223|P3|Overall Study|Lost to Follow-up|0
908075|NCT01082640|2995224|P2|Overall Study|Lost to Follow-up|3
908076|NCT01082640|2995225|P1|Overall Study|Lost to Follow-up|0
908077|NCT01082640|2995223|P3|Overall Study|Major protocol deviation|0
908078|NCT01082640|2995224|P2|Overall Study|Major protocol deviation|3
908079|NCT01082640|2995225|P1|Overall Study|Major protocol deviation|3
908080|NCT01082640|2995223|P3|Overall Study|Withdrawal by Subject|2
908081|NCT01082640|2995224|P2|Overall Study|Withdrawal by Subject|3
908082|NCT01082640|2995225|P1|Overall Study|Withdrawal by Subject|3
908083|NCT01082640|2995223|P3|Overall Study|Adverse Event|3
908084|NCT01082640|2995224|P2|Overall Study|Adverse Event|5
908085|NCT01082640|2995225|P1|Overall Study|Adverse Event|9
908086|NCT01082614|2995247|P2|Overall Study|Physician Decision|0
908087|NCT01082614|2995248|P1|Overall Study|Physician Decision|2
908088|NCT01082614|2995247|P2|Overall Study|Equipment Malfunction|1
908089|NCT01082614|2995248|P1|Overall Study|Equipment Malfunction|0
908090|NCT01082614|2995247|P2|Overall Study|Adverse Event|4
908091|NCT01082614|2995248|P1|Overall Study|Adverse Event|1
908092|NCT01082367|2995319|P2|Follow-up (F-U) Period|Adverse Event|1
908093|NCT01082367|2995320|P1|Follow-up (F-U) Period|Adverse Event|0
908094|NCT01082367|2995319|P2|Follow-up (F-U) Period|Abnormal lab values|0
908095|NCT01082367|2995320|P1|Follow-up (F-U) Period|Abnormal lab values|1
908096|NCT01082367|2995319|P2|Follow-up (F-U) Period|Administrative problems|0
908097|NCT01082367|2995320|P1|Follow-up (F-U) Period|Administrative problems|1
908098|NCT01082367|2995319|P2|Double-blind Period|Adverse Event|1
908099|NCT01082367|2995320|P1|Double-blind Period|Adverse Event|0
908100|NCT01082367|2995319|P2|Double-blind Period|Lack of Efficacy|11
908101|NCT01082367|2995320|P1|Double-blind Period|Lack of Efficacy|5
908102|NCT01082367|2995319|P2|Double-blind Period|Administrative problems|1
908103|NCT01082367|2995320|P1|Double-blind Period|Administrative problems|0
908104|NCT01082328|2995334|P1|Overall Study|Adverse Event|1
908105|NCT01082211|2995343|P1|Overall Study|No protocol treatment received|3
908106|NCT01082211|2995343|P1|Overall Study|Protocol Violation|4
908107|NCT01082081|2995364|P3|Overall Study|Other Reason|0
908108|NCT01082081|2995365|P2|Overall Study|Other Reason|1
908109|NCT01082081|2995366|P1|Overall Study|Other Reason|0
908110|NCT01082081|2995364|P3|Overall Study|Withdrawal by Subject|1
908111|NCT01082081|2995365|P2|Overall Study|Withdrawal by Subject|0
908112|NCT01082081|2995366|P1|Overall Study|Withdrawal by Subject|0
908113|NCT01082081|2995364|P3|Overall Study|Lost to Follow-up|1
908114|NCT01082081|2995365|P2|Overall Study|Lost to Follow-up|0
908115|NCT01082081|2995366|P1|Overall Study|Lost to Follow-up|0
908116|NCT01081951|2995418|P2|Overall Study|Lost to Follow-up|1
908117|NCT01081951|2995419|P1|Overall Study|Lost to Follow-up|0
908118|NCT01081951|2995418|P2|Overall Study|Allocated treatment but did not take it|1
908119|NCT01081951|2995419|P1|Overall Study|Allocated treatment but did not take it|0
908120|NCT01081951|2995418|P2|Overall Study|Withdrawal by Subject|6
908121|NCT01081951|2995419|P1|Overall Study|Withdrawal by Subject|2
908122|NCT01081951|2995418|P2|Overall Study|Death|47
908123|NCT01081951|2995419|P1|Overall Study|Death|54
908124|NCT01081912|2995429|P3|Maintenance Treatment|Withdrawal by Medical Monitor|1
908125|NCT01081912|2995430|P2|Maintenance Treatment|Withdrawal by Medical Monitor|0
908126|NCT01081912|2995431|P1|Maintenance Treatment|Withdrawal by Medical Monitor|0
908127|NCT01081912|2995429|P3|Maintenance Treatment|Non-Compliance|7
908128|NCT01081912|2995430|P2|Maintenance Treatment|Non-Compliance|4
908129|NCT01081912|2995431|P1|Maintenance Treatment|Non-Compliance|0
908130|NCT01081912|2995429|P3|Maintenance Treatment|Withdrawal by Subject|5
908131|NCT01081912|2995430|P2|Maintenance Treatment|Withdrawal by Subject|5
908132|NCT01081912|2995431|P1|Maintenance Treatment|Withdrawal by Subject|0
908133|NCT01081912|2995429|P3|Maintenance Treatment|Protocol Violation|2
908134|NCT01081912|2995430|P2|Maintenance Treatment|Protocol Violation|1
908135|NCT01081912|2995431|P1|Maintenance Treatment|Protocol Violation|0
908136|NCT01081912|2995429|P3|Maintenance Treatment|Physician Decision|1
908137|NCT01081912|2995430|P2|Maintenance Treatment|Physician Decision|0
908138|NCT01081912|2995431|P1|Maintenance Treatment|Physician Decision|0
908139|NCT01081912|2995429|P3|Maintenance Treatment|Lost to Follow-up|0
908140|NCT01081912|2995430|P2|Maintenance Treatment|Lost to Follow-up|1
908141|NCT01081912|2995431|P1|Maintenance Treatment|Lost to Follow-up|0
908142|NCT01081912|2995429|P3|Maintenance Treatment|Lack of Efficacy|64
908143|NCT01081912|2995430|P2|Maintenance Treatment|Lack of Efficacy|14
908144|NCT01081912|2995431|P1|Maintenance Treatment|Lack of Efficacy|0
908145|NCT01081912|2995429|P3|Maintenance Treatment|Adverse Event|12
908146|NCT01081912|2995430|P2|Maintenance Treatment|Adverse Event|2
908147|NCT01081912|2995431|P1|Maintenance Treatment|Adverse Event|0
908148|NCT01081912|2995429|P3|Conversion/Titration|Non-Compliance|0
908149|NCT01081912|2995430|P2|Conversion/Titration|Non-Compliance|0
908150|NCT01081912|2995431|P1|Conversion/Titration|Non-Compliance|47
908151|NCT01081912|2995429|P3|Conversion/Titration|Withdrawal by Subject|0
908152|NCT01081912|2995430|P2|Conversion/Titration|Withdrawal by Subject|0
908153|NCT01081912|2995431|P1|Conversion/Titration|Withdrawal by Subject|23
908154|NCT01081912|2995429|P3|Conversion/Titration|Protocol Violation|0
908155|NCT01081912|2995430|P2|Conversion/Titration|Protocol Violation|0
908156|NCT01081912|2995431|P1|Conversion/Titration|Protocol Violation|67
908157|NCT01081912|2995429|P3|Conversion/Titration|Physician Decision|0
908158|NCT01081912|2995430|P2|Conversion/Titration|Physician Decision|0
908159|NCT01081912|2995431|P1|Conversion/Titration|Physician Decision|2
908160|NCT01081912|2995429|P3|Conversion/Titration|Lost to Follow-up|0
908161|NCT01081912|2995430|P2|Conversion/Titration|Lost to Follow-up|0
908162|NCT01081912|2995431|P1|Conversion/Titration|Lost to Follow-up|5
908163|NCT01081912|2995429|P3|Conversion/Titration|Lack of Efficacy|0
908164|NCT01081912|2995430|P2|Conversion/Titration|Lack of Efficacy|0
908165|NCT01081912|2995431|P1|Conversion/Titration|Lack of Efficacy|17
908166|NCT01081912|2995429|P3|Conversion/Titration|Adverse Event|0
908167|NCT01081912|2995430|P2|Conversion/Titration|Adverse Event|0
908168|NCT01081912|2995431|P1|Conversion/Titration|Adverse Event|47
908169|NCT01081886|2995440|P2|Overall Study|Study termination|13
908170|NCT01081886|2995441|P1|Overall Study|Study termination|11
908171|NCT01081873|2995449|P1|Overall Study|Other|47
908172|NCT01081873|2995449|P1|Overall Study|Progression of prostate cancer|13
908173|NCT01081873|2995449|P1|Overall Study|Lost to Follow-up|142
908174|NCT01081873|2995449|P1|Overall Study|Withdrawal by Subject|10
908175|NCT01081873|2995449|P1|Overall Study|Death|86
908176|NCT01081834|2995521|P5|Extension Period: Week 26 to Week 52|Physician Decision|0
908177|NCT01081834|2995522|P4|Extension Period: Week 26 to Week 52|Physician Decision|0
908178|NCT01081834|2995523|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
908179|NCT01081834|2995524|P2|Extension Period: Week 26 to Week 52|Physician Decision|1
908180|NCT01081834|2995525|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
908181|NCT01081834|2995521|P5|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
908182|NCT01081834|2995522|P4|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
908183|NCT01081834|2995523|P3|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
908184|NCT01081834|2995524|P2|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1
908185|NCT01081834|2995525|P1|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7
908186|NCT01081834|2995521|P5|Extension Period: Week 26 to Week 52|Not specified|0
908187|NCT01081834|2995522|P4|Extension Period: Week 26 to Week 52|Not specified|0
908188|NCT01081834|2995523|P3|Extension Period: Week 26 to Week 52|Not specified|4
908189|NCT01081834|2995524|P2|Extension Period: Week 26 to Week 52|Not specified|5
908190|NCT01081834|2995525|P1|Extension Period: Week 26 to Week 52|Not specified|4
908191|NCT01081834|2995521|P5|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
908192|NCT01081834|2995522|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
908193|NCT01081834|2995523|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
908194|NCT01081834|2995524|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
908195|NCT01081834|2995525|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
908196|NCT01081834|2995521|P5|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
908197|NCT01081834|2995522|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
908198|NCT01081834|2995523|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
908199|NCT01081834|2995524|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
908200|NCT01081834|2995525|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
908201|NCT01081834|2995521|P5|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
908202|NCT01081834|2995522|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
908203|NCT01081834|2995523|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
908204|NCT01081834|2995524|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
908205|NCT01081834|2995525|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
908206|NCT01081834|2995521|P5|Extension Period: Week 26 to Week 52|Protocol Violation|0
908207|NCT01081834|2995522|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
908208|NCT01081834|2995523|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
908209|NCT01081834|2995524|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
908210|NCT01081834|2995525|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
908211|NCT01081834|2995521|P5|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
908212|NCT01081834|2995522|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
908213|NCT01081834|2995523|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
908214|NCT01081834|2995524|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
908215|NCT01081834|2995525|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
908216|NCT01081834|2995521|P5|Extension Period: Week 26 to Week 52|Death|0
908217|NCT01081834|2995522|P4|Extension Period: Week 26 to Week 52|Death|0
908218|NCT01081834|2995523|P3|Extension Period: Week 26 to Week 52|Death|0
908219|NCT01081834|2995524|P2|Extension Period: Week 26 to Week 52|Death|0
908220|NCT01081834|2995525|P1|Extension Period: Week 26 to Week 52|Death|1
908221|NCT01081834|2995521|P5|Extension Period: Week 26 to Week 52|Adverse Event|0
908222|NCT01081834|2995522|P4|Extension Period: Week 26 to Week 52|Adverse Event|0
908223|NCT01081834|2995523|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
908224|NCT01081834|2995524|P2|Extension Period: Week 26 to Week 52|Adverse Event|0
908225|NCT01081834|2995525|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
908226|NCT01081834|2995521|P5|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
908227|NCT01081834|2995522|P4|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
908228|NCT01081834|2995523|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
908229|NCT01081834|2995524|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
908230|NCT01081834|2995525|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3
908231|NCT01081834|2995521|P5|Core Period: Baseline to Week 26|Not specified|0
908232|NCT01081834|2995522|P4|Core Period: Baseline to Week 26|Not specified|1
908233|NCT01081834|2995523|P3|Core Period: Baseline to Week 26|Not specified|3
908234|NCT01081834|2995524|P2|Core Period: Baseline to Week 26|Not specified|4
908235|NCT01081834|2995525|P1|Core Period: Baseline to Week 26|Not specified|4
908236|NCT01081834|2995521|P5|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
908237|NCT01081834|2995522|P4|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
908238|NCT01081834|2995523|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
908239|NCT01081834|2995524|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
908240|NCT01081834|2995525|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
908241|NCT01081834|2995521|P5|Core Period: Baseline to Week 26|Noncompliance with study drug|0
908242|NCT01081834|2995522|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|2
908243|NCT01081834|2995523|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|2
908244|NCT01081834|2995524|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|4
908245|NCT01081834|2995525|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|3
908246|NCT01081834|2995521|P5|Core Period: Baseline to Week 26|Withdrawal by Subject|1
908247|NCT01081834|2995522|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|3
908248|NCT01081834|2995523|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|9
908249|NCT01081834|2995524|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
908250|NCT01081834|2995525|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|15
908251|NCT01081834|2995521|P5|Core Period: Baseline to Week 26|Protocol Violation|2
908252|NCT01081834|2995522|P4|Core Period: Baseline to Week 26|Protocol Violation|0
908253|NCT01081834|2995523|P3|Core Period: Baseline to Week 26|Protocol Violation|0
908254|NCT01081834|2995524|P2|Core Period: Baseline to Week 26|Protocol Violation|4
908255|NCT01081834|2995525|P1|Core Period: Baseline to Week 26|Protocol Violation|0
908256|NCT01081834|2995521|P5|Core Period: Baseline to Week 26|Lost to Follow-up|0
908257|NCT01081834|2995522|P4|Core Period: Baseline to Week 26|Lost to Follow-up|0
908258|NCT01081834|2995523|P3|Core Period: Baseline to Week 26|Lost to Follow-up|5
908259|NCT01081834|2995524|P2|Core Period: Baseline to Week 26|Lost to Follow-up|2
908260|NCT01081834|2995525|P1|Core Period: Baseline to Week 26|Lost to Follow-up|2
908261|NCT01081834|2995521|P5|Core Period: Baseline to Week 26|Death|0
908262|NCT01081834|2995522|P4|Core Period: Baseline to Week 26|Death|0
908263|NCT01081834|2995523|P3|Core Period: Baseline to Week 26|Death|0
908264|NCT01081834|2995524|P2|Core Period: Baseline to Week 26|Death|0
908265|NCT01081834|2995525|P1|Core Period: Baseline to Week 26|Death|1
908266|NCT01081834|2995521|P5|Core Period: Baseline to Week 26|Adverse Event|1
908267|NCT01081834|2995522|P4|Core Period: Baseline to Week 26|Adverse Event|1
908268|NCT01081834|2995523|P3|Core Period: Baseline to Week 26|Adverse Event|3
908269|NCT01081834|2995524|P2|Core Period: Baseline to Week 26|Adverse Event|5
908270|NCT01081834|2995525|P1|Core Period: Baseline to Week 26|Adverse Event|2
908271|NCT01081834|2995521|P5|Core Period: Baseline to Week 26|Pregnancy|0
908272|NCT01081834|2995522|P4|Core Period: Baseline to Week 26|Pregnancy|0
908273|NCT01081834|2995523|P3|Core Period: Baseline to Week 26|Pregnancy|0
908274|NCT01081834|2995524|P2|Core Period: Baseline to Week 26|Pregnancy|0
908275|NCT01081834|2995525|P1|Core Period: Baseline to Week 26|Pregnancy|1
908276|NCT01081795|2995586|P3|Overall Study|Other|0
908277|NCT01081795|2995587|P2|Overall Study|Other|2
908278|NCT01081795|2995588|P1|Overall Study|Other|1
908279|NCT01081795|2995586|P3|Overall Study|Using drug with restricted days of use|2
908280|NCT01081795|2995587|P2|Overall Study|Using drug with restricted days of use|3
908281|NCT01081795|2995588|P1|Overall Study|Using drug with restricted days of use|2
908282|NCT01081795|2995586|P3|Overall Study|Use of a prohibited concomitant drug|1
908283|NCT01081795|2995587|P2|Overall Study|Use of a prohibited concomitant drug|1
908284|NCT01081795|2995588|P1|Overall Study|Use of a prohibited concomitant drug|1
908285|NCT01081795|2995586|P3|Overall Study|Ineligible for participation|0
908286|NCT01081795|2995587|P2|Overall Study|Ineligible for participation|0
908287|NCT01081795|2995588|P1|Overall Study|Ineligible for participation|1
908288|NCT01081795|2995586|P3|Overall Study|Revocation of informed consent|0
908289|NCT01081795|2995587|P2|Overall Study|Revocation of informed consent|0
908290|NCT01081795|2995588|P1|Overall Study|Revocation of informed consent|2
908291|NCT01081795|2995586|P3|Overall Study|Subject’s schedule|2
908292|NCT01081795|2995587|P2|Overall Study|Subject’s schedule|1
908293|NCT01081795|2995588|P1|Overall Study|Subject’s schedule|1
908294|NCT01081795|2995586|P3|Overall Study|Lack of Efficacy|19
908295|NCT01081795|2995587|P2|Overall Study|Lack of Efficacy|5
908296|NCT01081795|2995588|P1|Overall Study|Lack of Efficacy|7
908297|NCT01081795|2995586|P3|Overall Study|Adverse Event|6
908298|NCT01081795|2995587|P2|Overall Study|Adverse Event|23
908299|NCT01081795|2995588|P1|Overall Study|Adverse Event|18
908300|NCT01081769|2995625|P2|CORE Intent-To-Treat|Patient Moved|2
908301|NCT01081769|2995626|P1|CORE Intent-To-Treat|Patient Moved|2
908302|NCT01081769|2995625|P2|CORE Intent-To-Treat|Visit Schedule Issues|2
908303|NCT01081769|2995626|P1|CORE Intent-To-Treat|Visit Schedule Issues|1
908304|NCT01081769|2995625|P2|CORE Intent-To-Treat|Ineligibility|4
908305|NCT01081769|2995626|P1|CORE Intent-To-Treat|Ineligibility|3
908306|NCT01081769|2995625|P2|CORE Intent-To-Treat|Other|1
908307|NCT01081769|2995626|P1|CORE Intent-To-Treat|Other|0
908308|NCT01081769|2995625|P2|CORE Intent-To-Treat|Noncompliance With Study Drug|5
908309|NCT01081769|2995626|P1|CORE Intent-To-Treat|Noncompliance With Study Drug|0
908310|NCT01081769|2995625|P2|CORE Intent-To-Treat|Withdrawal by Subject|60
908311|NCT01081769|2995626|P1|CORE Intent-To-Treat|Withdrawal by Subject|52
908312|NCT01081769|2995625|P2|CORE Intent-To-Treat|Pregnancy|0
908313|NCT01081769|2995626|P1|CORE Intent-To-Treat|Pregnancy|1
908314|NCT01081769|2995625|P2|CORE Intent-To-Treat|Lost to Follow-up|5
908315|NCT01081769|2995626|P1|CORE Intent-To-Treat|Lost to Follow-up|4
908316|NCT01081769|2995625|P2|CORE Intent-To-Treat|Lack of Efficacy|6
908317|NCT01081769|2995626|P1|CORE Intent-To-Treat|Lack of Efficacy|2
908318|NCT01081769|2995625|P2|CORE Intent-To-Treat|Death|1
908319|NCT01081769|2995626|P1|CORE Intent-To-Treat|Death|1
908320|NCT01081769|2995625|P2|CORE Intent-To-Treat|Adverse Event|11
908321|NCT01081769|2995626|P1|CORE Intent-To-Treat|Adverse Event|14
908322|NCT01081769|2995625|P2|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0
908323|NCT01081769|2995626|P1|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2
908324|NCT01081769|2995625|P2|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7
908325|NCT01081769|2995626|P1|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6
908326|NCT01081769|2995625|P2|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
908327|NCT01081769|2995626|P1|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
908328|NCT01081769|2995625|P2|Whole Intent-to-Treat|Missing Responder Assessment|12
908329|NCT01081769|2995626|P1|Whole Intent-to-Treat|Missing Responder Assessment|10
908330|NCT01081665|2995660|P1|Overall Study|Lack of Efficacy|1
908331|NCT01081665|2995660|P1|Overall Study|Adverse Event|1
908332|NCT01081665|2995660|P1|Overall Study|Change in renal replacement therapy|2
908333|NCT01081665|2995660|P1|Overall Study|Regulation of iPTH|5
908334|NCT01081665|2995660|P1|Overall Study|Change of dialysis unit|10
908335|NCT01081665|2995660|P1|Overall Study|Withdrawal by Subject|17
908336|NCT01081665|2995660|P1|Overall Study|Lost to Follow-up|18
908337|NCT01081665|2995660|P1|Overall Study|Death|41
908338|NCT01081626|2995672|P2|Overall Study|Other|30
908339|NCT01081626|2995673|P1|Overall Study|Other|33
908340|NCT01081626|2995672|P2|Overall Study|Lost to Follow-up|1
908341|NCT01081626|2995673|P1|Overall Study|Lost to Follow-up|0
908342|NCT01081626|2995672|P2|Overall Study|Overstimulation|1
908343|NCT01081626|2995673|P1|Overall Study|Overstimulation|0
908344|NCT01081626|2995672|P2|Overall Study|Low antral follicle count|0
908345|NCT01081626|2995673|P1|Overall Study|Low antral follicle count|1
908346|NCT01081626|2995672|P2|Overall Study|Missing Estradiol|28
908347|NCT01081626|2995673|P1|Overall Study|Missing Estradiol|25
908348|NCT01081626|2995672|P2|Overall Study|Dosing error|1
908349|NCT01081626|2995673|P1|Overall Study|Dosing error|1
908350|NCT01081301|2995699|P1|Overall Study|Lost to Follow-up|4
908351|NCT01081301|2995699|P1|Overall Study|Patient too ill|2
908352|NCT01081301|2995699|P1|Overall Study|Too busy|5
908353|NCT01081301|2995699|P1|Overall Study|Bereaved|3
908354|NCT01081249|2995737|P2|Overall Study|Diagnosed with Bipolar Disorder|1
908355|NCT01081249|2995738|P1|Overall Study|Diagnosed with Bipolar Disorder|0
908356|NCT01081145|2995744|P2|Double-Blind Randomized-Withdrawal Phase|Not specified|3
908357|NCT01081145|2995745|P1|Double-Blind Randomized-Withdrawal Phase|Not specified|4
908358|NCT01081145|2995744|P2|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71
908359|NCT01081145|2995745|P1|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47
908360|NCT01081145|2995744|P2|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20
908361|NCT01081145|2995745|P1|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13
908362|NCT01081145|2995744|P2|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2
908363|NCT01081145|2995745|P1|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3
908364|NCT01081145|2995744|P2|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8
908365|NCT01081145|2995745|P1|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10
908366|NCT01081145|2995744|P2|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0
908367|NCT01081145|2995745|P1|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1
908368|NCT01081145|2995744|P2|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2
908369|NCT01081145|2995745|P1|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3
908370|NCT01081145|2995744|P2|Open-Label Phase|Protocol Violation|0
908371|NCT01081145|2995745|P1|Open-Label Phase|Protocol Violation|4
908372|NCT01081145|2995744|P2|Open-Label Phase|Lost to Follow-up|0
908373|NCT01081145|2995745|P1|Open-Label Phase|Lost to Follow-up|11
908374|NCT01081145|2995744|P2|Open-Label Phase|Not specified|0
908375|NCT01081145|2995745|P1|Open-Label Phase|Not specified|12
908376|NCT01081145|2995744|P2|Open-Label Phase|Withdrawal by Subject|0
908377|NCT01081145|2995745|P1|Open-Label Phase|Withdrawal by Subject|41
908378|NCT01081145|2995744|P2|Open-Label Phase|Adverse Event|0
908379|NCT01081145|2995745|P1|Open-Label Phase|Adverse Event|42
908380|NCT01081145|2995744|P2|Open-Label Phase|Response criteria not met|0
908381|NCT01081145|2995745|P1|Open-Label Phase|Response criteria not met|46
908382|NCT01081145|2995744|P2|Open-Label Phase|Lack of Efficacy|0
908383|NCT01081145|2995745|P1|Open-Label Phase|Lack of Efficacy|56
908384|NCT01081132|2995773|P2|Overall Study|Protocol Violation|1
908385|NCT01081132|2995774|P1|Overall Study|Protocol Violation|3
908386|NCT01081132|2995773|P2|Overall Study|Declined Taper Phase|1
908387|NCT01081132|2995774|P1|Overall Study|Declined Taper Phase|0
908388|NCT01081132|2995773|P2|Overall Study|Patient Did Not Complete Wk14 and 15|1
908389|NCT01081132|2995774|P1|Overall Study|Patient Did Not Complete Wk14 and 15|0
908390|NCT01081132|2995773|P2|Overall Study|Stopped Taking Meds|0
908391|NCT01081132|2995774|P1|Overall Study|Stopped Taking Meds|2
908392|NCT01081132|2995773|P2|Overall Study|Missed Visits|1
908393|NCT01081132|2995774|P1|Overall Study|Missed Visits|1
908394|NCT01081132|2995773|P2|Overall Study|Lack Of Compliance|1
908395|NCT01081132|2995774|P1|Overall Study|Lack Of Compliance|0
908396|NCT01081132|2995773|P2|Overall Study|Non Compliance|2
908397|NCT01081132|2995774|P1|Overall Study|Non Compliance|4
908398|NCT01081132|2995773|P2|Overall Study|Adverse Event|9
908399|NCT01081132|2995774|P1|Overall Study|Adverse Event|3
908400|NCT01081132|2995773|P2|Overall Study|Lost to Follow-up|11
908401|NCT01081132|2995774|P1|Overall Study|Lost to Follow-up|4
908402|NCT01081132|2995773|P2|Overall Study|Withdrawal by Subject|16
908403|NCT01081132|2995774|P1|Overall Study|Withdrawal by Subject|13
908404|NCT01081132|2995773|P2|Overall Study|Lack of Efficacy|9
908405|NCT01081132|2995774|P1|Overall Study|Lack of Efficacy|25
908406|NCT01080807|2995858|P2|Overall Study|Moved away without notifying center|0
908407|NCT01080807|2995859|P1|Overall Study|Moved away without notifying center|1
908408|NCT01080807|2995858|P2|Overall Study|Switched to first shift|0
908409|NCT01080807|2995859|P1|Overall Study|Switched to first shift|1
908410|NCT01080807|2995858|P2|Overall Study|Work schedule and travel|1
908411|NCT01080807|2995859|P1|Overall Study|Work schedule and travel|0
908412|NCT01080807|2995858|P2|Overall Study|Work schedule changing|1
908413|NCT01080807|2995859|P1|Overall Study|Work schedule changing|1
908414|NCT01080807|2995858|P2|Overall Study|Stopped working consistent night shifts|1
908415|NCT01080807|2995859|P1|Overall Study|Stopped working consistent night shifts|0
908416|NCT01080807|2995858|P2|Overall Study|Laid off or terminated from job|2
908417|NCT01080807|2995859|P1|Overall Study|Laid off or terminated from job|1
908418|NCT01080807|2995858|P2|Overall Study|Began working day shift|2
908419|NCT01080807|2995859|P1|Overall Study|Began working day shift|0
908420|NCT01080807|2995858|P2|Overall Study|Noncompliance to study procedures|1
908421|NCT01080807|2995859|P1|Overall Study|Noncompliance to study procedures|1
908422|NCT01080807|2995858|P2|Overall Study|Noncompliance with drug administration|1
908423|NCT01080807|2995859|P1|Overall Study|Noncompliance with drug administration|1
908424|NCT01080807|2995858|P2|Overall Study|Lost to Follow-up|4
908425|NCT01080807|2995859|P1|Overall Study|Lost to Follow-up|6
908426|NCT01080807|2995858|P2|Overall Study|Protocol Violation|6
908427|NCT01080807|2995859|P1|Overall Study|Protocol Violation|7
908428|NCT01080807|2995858|P2|Overall Study|Withdrawal by Subject|2
908429|NCT01080807|2995859|P1|Overall Study|Withdrawal by Subject|7
908430|NCT01080807|2995858|P2|Overall Study|Lack of Efficacy|1
908431|NCT01080807|2995859|P1|Overall Study|Lack of Efficacy|0
908432|NCT01080807|2995858|P2|Overall Study|Adverse Event|1
908433|NCT01080807|2995859|P1|Overall Study|Adverse Event|9
908434|NCT01080768|2995968|P2|Overall Study|Protocol Deviation|1
908435|NCT01080768|2995969|P1|Overall Study|Protocol Deviation|2
908436|NCT01080716|2995979|P4|Part 1|Physician Decision|0
908437|NCT01080716|2995980|P3|Part 1|Physician Decision|0
908438|NCT01080716|2995981|P2|Part 1|Physician Decision|0
908439|NCT01080716|2995982|P1|Part 1|Physician Decision|1
908440|NCT01080625|2996021|P3|Overall Study|Physician Decision|1
908441|NCT01080625|2996022|P2|Overall Study|Physician Decision|2
908442|NCT01080625|2996023|P1|Overall Study|Physician Decision|0
908443|NCT01080391|2996033|P2|Overall Study|Randomized but not treated|4
908444|NCT01080391|2996034|P1|Overall Study|Randomized but not treated|7
908445|NCT01080326|2996052|P1|Overall Study|Surgeon decision|1
908446|NCT01080326|2996052|P1|Overall Study|Patient deterioration prior to procedure|3
908447|NCT01080300|2996058|P2|Overall Study|Reasons not specified|6
908448|NCT01080300|2996059|P1|Overall Study|Reasons not specified|4
908449|NCT01080300|2996058|P2|Overall Study|Withdrawal by Subject|28
908450|NCT01080300|2996059|P1|Overall Study|Withdrawal by Subject|12
908451|NCT01080300|2996058|P2|Overall Study|Death|1
908452|NCT01080300|2996059|P1|Overall Study|Death|0
908453|NCT01080300|2996058|P2|Overall Study|Lost to Follow-up|6
908454|NCT01080300|2996059|P1|Overall Study|Lost to Follow-up|10
908455|NCT01080300|2996058|P2|Overall Study|Protocol Violation|13
908456|NCT01080300|2996059|P1|Overall Study|Protocol Violation|7
908457|NCT01080300|2996058|P2|Overall Study|Lack of Efficacy|15
908458|NCT01080300|2996059|P1|Overall Study|Lack of Efficacy|12
908459|NCT01080300|2996058|P2|Overall Study|Adverse Event|35
908460|NCT01080300|2996059|P1|Overall Study|Adverse Event|49
908461|NCT01080131|2996144|P2|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5
908462|NCT01080131|2996145|P1|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4
908463|NCT01080131|2996144|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4
908464|NCT01080131|2996145|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3
908465|NCT01080131|2996144|P2|Extension Study 2 (25-72 Weeks)|Adverse Event|2
908466|NCT01080131|2996145|P1|Extension Study 2 (25-72 Weeks)|Adverse Event|1
908467|NCT01080131|2996144|P2|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0
908468|NCT01080131|2996145|P1|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1
908469|NCT01080131|2996144|P2|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3
908470|NCT01080131|2996145|P1|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4
908471|NCT01080131|2996144|P2|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1
908472|NCT01080131|2996145|P1|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0
908473|NCT01080131|2996144|P2|Extension Study 1 (12 -24 Weeks)|Adverse Event|0
908474|NCT01080131|2996145|P1|Extension Study 1 (12 -24 Weeks)|Adverse Event|1
908475|NCT01080131|2996144|P2|Core Study (0- 12 Weeks)|Protocol deviation|2
908476|NCT01080131|2996145|P1|Core Study (0- 12 Weeks)|Protocol deviation|0
908477|NCT01080131|2996144|P2|Core Study (0- 12 Weeks)|Death|0
908478|NCT01080131|2996145|P1|Core Study (0- 12 Weeks)|Death|1
908479|NCT01080131|2996144|P2|Core Study (0- 12 Weeks)|Administrative problems|1
908480|NCT01080131|2996145|P1|Core Study (0- 12 Weeks)|Administrative problems|0
908481|NCT01080131|2996144|P2|Core Study (0- 12 Weeks)|Lost to Follow-up|3
908482|NCT01080131|2996145|P1|Core Study (0- 12 Weeks)|Lost to Follow-up|5
908483|NCT01080131|2996144|P2|Core Study (0- 12 Weeks)|Patient withdrew consent|4
908484|NCT01080131|2996145|P1|Core Study (0- 12 Weeks)|Patient withdrew consent|6
908485|NCT01080131|2996144|P2|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
908486|NCT01080131|2996145|P1|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
908487|NCT01079988|2996240|P5|Overall Study|Other|1
908488|NCT01079988|2996241|P4|Overall Study|Other|2
908489|NCT01079988|2996242|P3|Overall Study|Other|0
908490|NCT01079988|2996243|P2|Overall Study|Other|0
908491|NCT01079988|2996244|P1|Overall Study|Other|0
908492|NCT01079988|2996240|P5|Overall Study|Lack of Efficacy|0
908493|NCT01079988|2996241|P4|Overall Study|Lack of Efficacy|0
908494|NCT01079988|2996242|P3|Overall Study|Lack of Efficacy|0
908495|NCT01079988|2996243|P2|Overall Study|Lack of Efficacy|0
908496|NCT01079988|2996244|P1|Overall Study|Lack of Efficacy|1
908497|NCT01079988|2996240|P5|Overall Study|Lost to Follow-up|0
908498|NCT01079988|2996241|P4|Overall Study|Lost to Follow-up|1
908499|NCT01079988|2996242|P3|Overall Study|Lost to Follow-up|0
908500|NCT01079988|2996243|P2|Overall Study|Lost to Follow-up|0
908501|NCT01079988|2996244|P1|Overall Study|Lost to Follow-up|0
908502|NCT01079962|2996263|P2|Overall Study|Due to arrhythmia/bradycardia|1
908503|NCT01079962|2996264|P1|Overall Study|Due to arrhythmia/bradycardia|1
908504|NCT01079962|2996263|P2|Overall Study|Participant not returning for next visit|0
908505|NCT01079962|2996264|P1|Overall Study|Participant not returning for next visit|1
908506|NCT01079962|2996263|P2|Overall Study|Inclusion/exclusion criteria|3
908507|NCT01079962|2996264|P1|Overall Study|Inclusion/exclusion criteria|1
908508|NCT01079962|2996263|P2|Overall Study|No blood pressure (BP) control|0
908509|NCT01079962|2996264|P1|Overall Study|No blood pressure (BP) control|3
908510|NCT01079962|2996263|P2|Overall Study|Protocol Violation|2
908511|NCT01079962|2996264|P1|Overall Study|Protocol Violation|2
908512|NCT01079962|2996263|P2|Overall Study|Withdrawal by Subject|7
908513|NCT01079962|2996264|P1|Overall Study|Withdrawal by Subject|5
908514|NCT01079962|2996263|P2|Overall Study|Adverse Event|2
908515|NCT01079962|2996264|P1|Overall Study|Adverse Event|2
908516|NCT01079949|2996292|P2|Overall Study|Randomized but not treated|0
908517|NCT01079949|2996293|P1|Overall Study|Randomized but not treated|1
908518|NCT01079949|2996292|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
908519|NCT01079949|2996293|P1|Overall Study|Withdrawal between OPU - embryo transfer|8
908520|NCT01079949|2996292|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8
908521|NCT01079949|2996293|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4
908522|NCT01079949|2996292|P2|Overall Study|Withdrawal before r-hCG administration|3
908523|NCT01079949|2996293|P1|Overall Study|Withdrawal before r-hCG administration|2
908524|NCT01079936|2996339|P5|Phase II|Insurance Issue|1
908525|NCT01079936|2996340|P4|Phase II|Insurance Issue|0
908526|NCT01079936|2996341|P3|Phase II|Insurance Issue|0
908527|NCT01079936|2996342|P2|Phase II|Insurance Issue|0
908528|NCT01079936|2996343|P1|Phase II|Insurance Issue|0
908529|NCT01079936|2996339|P5|Phase II|Adverse Event|0
908530|NCT01079936|2996340|P4|Phase II|Adverse Event|0
908531|NCT01079936|2996341|P3|Phase II|Adverse Event|1
908532|NCT01079936|2996342|P2|Phase II|Adverse Event|0
908533|NCT01079936|2996343|P1|Phase II|Adverse Event|0
908534|NCT01079936|2996339|P5|Phase I: MTD|No Stem Cell Transplantation|0
908535|NCT01079936|2996340|P4|Phase I: MTD|No Stem Cell Transplantation|0
908536|NCT01079936|2996341|P3|Phase I: MTD|No Stem Cell Transplantation|0
908537|NCT01079936|2996342|P2|Phase I: MTD|No Stem Cell Transplantation|0
908538|NCT01079936|2996343|P1|Phase I: MTD|No Stem Cell Transplantation|2
908539|NCT01079936|2996339|P5|Phase I: MTD|First Remission Status|0
908540|NCT01079936|2996340|P4|Phase I: MTD|First Remission Status|0
908541|NCT01079936|2996341|P3|Phase I: MTD|First Remission Status|0
908542|NCT01079936|2996342|P2|Phase I: MTD|First Remission Status|0
908543|NCT01079936|2996343|P1|Phase I: MTD|First Remission Status|2
908544|NCT01079832|2996362|P1|Overall Study|Withdrawal by Subject|1
908545|NCT01079806|2996372|P2|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|2
908546|NCT01079806|2996373|P1|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|0
908547|NCT01079806|2996372|P2|Day 1 to Week 96|Poor compliance or noncompliance|0
908548|NCT01079806|2996373|P1|Day 1 to Week 96|Poor compliance or noncompliance|1
908549|NCT01079806|2996372|P2|Day 1 to Week 96|Pregnancy|1
908550|NCT01079806|2996373|P1|Day 1 to Week 96|Pregnancy|0
908551|NCT01079806|2996372|P2|Day 1 to Week 96|Withdrawal by Subject|1
908552|NCT01079806|2996373|P1|Day 1 to Week 96|Withdrawal by Subject|3
908553|NCT01079806|2996372|P2|Day 1 to Week 96|Adverse Event|2
908554|NCT01079806|2996373|P1|Day 1 to Week 96|Adverse Event|0
908555|NCT01079741|2996398|P5|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3
908556|NCT01079741|2996399|P4|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
908557|NCT01079741|2996400|P3|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
908558|NCT01079741|2996401|P2|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
908559|NCT01079741|2996402|P1|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
908560|NCT01079741|2996398|P5|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
908561|NCT01079741|2996399|P4|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
908562|NCT01079741|2996400|P3|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
908563|NCT01079741|2996401|P2|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1
908564|NCT01079741|2996402|P1|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
908565|NCT01079234|2996450|P4|Extension: Week 27 to 52|Unclassified|7
908566|NCT01079234|2996451|P3|Extension: Week 27 to 52|Unclassified|4
908567|NCT01079234|2996452|P2|Extension: Week 27 to 52|Unclassified|0
908568|NCT01079234|2996453|P1|Extension: Week 27 to 52|Unclassified|0
908569|NCT01079234|2996450|P4|Extension: Week 27 to 52|Withdrawal criteria|2
908570|NCT01079234|2996451|P3|Extension: Week 27 to 52|Withdrawal criteria|4
908571|NCT01079234|2996452|P2|Extension: Week 27 to 52|Withdrawal criteria|0
908572|NCT01079234|2996453|P1|Extension: Week 27 to 52|Withdrawal criteria|0
908573|NCT01079234|2996450|P4|Extension: Week 27 to 52|Protocol Violation|5
908574|NCT01079234|2996451|P3|Extension: Week 27 to 52|Protocol Violation|2
908575|NCT01079234|2996452|P2|Extension: Week 27 to 52|Protocol Violation|0
908576|NCT01079234|2996453|P1|Extension: Week 27 to 52|Protocol Violation|0
908577|NCT01079234|2996450|P4|Extension: Week 27 to 52|Lack of Efficacy|2
908578|NCT01079234|2996451|P3|Extension: Week 27 to 52|Lack of Efficacy|0
908579|NCT01079234|2996452|P2|Extension: Week 27 to 52|Lack of Efficacy|0
908580|NCT01079234|2996453|P1|Extension: Week 27 to 52|Lack of Efficacy|0
908581|NCT01079234|2996450|P4|Extension: Week 27 to 52|Adverse Event|0
908582|NCT01079234|2996451|P3|Extension: Week 27 to 52|Adverse Event|1
908583|NCT01079234|2996452|P2|Extension: Week 27 to 52|Adverse Event|0
908584|NCT01079234|2996453|P1|Extension: Week 27 to 52|Adverse Event|0
908585|NCT01079234|2996450|P4|Main: Week 0 to 26|Unclassified|0
908586|NCT01079234|2996451|P3|Main: Week 0 to 26|Unclassified|4
908587|NCT01079234|2996452|P2|Main: Week 0 to 26|Unclassified|13
908588|NCT01079234|2996453|P1|Main: Week 0 to 26|Unclassified|7
908589|NCT01079234|2996450|P4|Main: Week 0 to 26|Withdrawal criteria|0
908590|NCT01079234|2996451|P3|Main: Week 0 to 26|Withdrawal criteria|2
908591|NCT01079234|2996452|P2|Main: Week 0 to 26|Withdrawal criteria|6
908592|NCT01079234|2996453|P1|Main: Week 0 to 26|Withdrawal criteria|6
908593|NCT01079234|2996450|P4|Main: Week 0 to 26|Protocol Violation|0
908594|NCT01079234|2996451|P3|Main: Week 0 to 26|Protocol Violation|4
908595|NCT01079234|2996452|P2|Main: Week 0 to 26|Protocol Violation|2
908596|NCT01079234|2996453|P1|Main: Week 0 to 26|Protocol Violation|6
908597|NCT01079234|2996450|P4|Main: Week 0 to 26|Lack of Efficacy|0
908598|NCT01079234|2996451|P3|Main: Week 0 to 26|Lack of Efficacy|1
908599|NCT01079234|2996452|P2|Main: Week 0 to 26|Lack of Efficacy|1
908600|NCT01079234|2996453|P1|Main: Week 0 to 26|Lack of Efficacy|2
908601|NCT01079234|2996450|P4|Main: Week 0 to 26|Adverse Event|0
908602|NCT01079234|2996451|P3|Main: Week 0 to 26|Adverse Event|1
908603|NCT01079234|2996452|P2|Main: Week 0 to 26|Adverse Event|4
908604|NCT01079234|2996453|P1|Main: Week 0 to 26|Adverse Event|5
908605|NCT01079195|2996471|P1|Overall Study|Non-compliance|2
908606|NCT01079195|2996471|P1|Overall Study|No Follow-up Documentation Available|4
908607|NCT01079195|2996471|P1|Overall Study|Improved Status of Participant|4
908608|NCT01079195|2996471|P1|Overall Study|Physician Decision|4
908609|NCT01079195|2996471|P1|Overall Study|Lack of Effectiveness|12
908610|NCT01079195|2996471|P1|Overall Study|Financial Reasons|15
908611|NCT01079195|2996471|P1|Overall Study|Withdrawal by Subject|18
908612|NCT01079195|2996471|P1|Overall Study|Reason Unknown|39
908613|NCT01079195|2996471|P1|Overall Study|Adverse Event|157
908614|NCT01079195|2996471|P1|Overall Study|No Documentation Available|437
908615|NCT01079195|2996471|P1|Overall Study|No Documentation of Tarka Therapy|739
908616|NCT01079182|2996477|P1|Overall Study|Reasons not Evaluated|271
908617|NCT01079182|2996477|P1|Overall Study|ADR and Lack of Effectiveness|39
908618|NCT01079182|2996477|P1|Overall Study|Lack of Efficacy|514
908619|NCT01079182|2996477|P1|Overall Study|Adverse Drug Reaction (ADR)|261
908620|NCT01079182|2996477|P1|Overall Study|Lost to Follow-up|1634
908621|NCT01079130|2996585|P6|Overall Study|Lost to Follow-up|0
908622|NCT01079130|2996586|P5|Overall Study|Lost to Follow-up|1
908623|NCT01079130|2996587|P4|Overall Study|Lost to Follow-up|0
908624|NCT01079130|2996588|P3|Overall Study|Lost to Follow-up|0
908625|NCT01079130|2996589|P2|Overall Study|Lost to Follow-up|0
908626|NCT01079130|2996590|P1|Overall Study|Lost to Follow-up|0
908627|NCT01079130|2996585|P6|Overall Study|Unsatisfactory therapeutic effect|0
908628|NCT01079130|2996586|P5|Overall Study|Unsatisfactory therapeutic effect|0
908629|NCT01079130|2996587|P4|Overall Study|Unsatisfactory therapeutic effect|2
908630|NCT01079130|2996588|P3|Overall Study|Unsatisfactory therapeutic effect|0
908631|NCT01079130|2996589|P2|Overall Study|Unsatisfactory therapeutic effect|0
908632|NCT01079130|2996590|P1|Overall Study|Unsatisfactory therapeutic effect|0
908633|NCT01079130|2996585|P6|Overall Study|Abnormal test procedure result(s)|0
908634|NCT01079130|2996586|P5|Overall Study|Abnormal test procedure result(s)|1
908635|NCT01079130|2996587|P4|Overall Study|Abnormal test procedure result(s)|0
908636|NCT01079130|2996588|P3|Overall Study|Abnormal test procedure result(s)|0
908637|NCT01079130|2996589|P2|Overall Study|Abnormal test procedure result(s)|0
908638|NCT01079130|2996590|P1|Overall Study|Abnormal test procedure result(s)|0
908639|NCT01079130|2996585|P6|Overall Study|Protocol deviation|0
908640|NCT01079130|2996586|P5|Overall Study|Protocol deviation|0
908641|NCT01079130|2996587|P4|Overall Study|Protocol deviation|2
908642|NCT01079130|2996588|P3|Overall Study|Protocol deviation|1
908643|NCT01079130|2996589|P2|Overall Study|Protocol deviation|2
908644|NCT01079130|2996590|P1|Overall Study|Protocol deviation|0
908645|NCT01079130|2996585|P6|Overall Study|Withdrawal by Subject|3
908646|NCT01079130|2996586|P5|Overall Study|Withdrawal by Subject|1
908647|NCT01079130|2996587|P4|Overall Study|Withdrawal by Subject|0
908648|NCT01079130|2996588|P3|Overall Study|Withdrawal by Subject|0
908649|NCT01079130|2996589|P2|Overall Study|Withdrawal by Subject|1
908650|NCT01079130|2996590|P1|Overall Study|Withdrawal by Subject|0
908651|NCT01079130|2996585|P6|Overall Study|Administrative problems|1
908652|NCT01079130|2996586|P5|Overall Study|Administrative problems|0
908653|NCT01079130|2996587|P4|Overall Study|Administrative problems|0
908654|NCT01079130|2996588|P3|Overall Study|Administrative problems|0
908655|NCT01079130|2996589|P2|Overall Study|Administrative problems|3
908656|NCT01079130|2996590|P1|Overall Study|Administrative problems|1
908657|NCT01079130|2996585|P6|Overall Study|Adverse Event|1
908658|NCT01079130|2996586|P5|Overall Study|Adverse Event|5
908659|NCT01079130|2996587|P4|Overall Study|Adverse Event|1
908660|NCT01079130|2996588|P3|Overall Study|Adverse Event|0
908661|NCT01079130|2996589|P2|Overall Study|Adverse Event|1
908662|NCT01079130|2996590|P1|Overall Study|Adverse Event|1
908663|NCT01078974|2996610|P1|Overall Study|Adverse Event|3
908664|NCT01078922|2996615|P1|Overall Study|Adverse Event|1
908665|NCT01078805|2996656|P1|Overall Study|Didn't take study drug|82
908666|NCT01078805|2996656|P1|Overall Study|Other|173
908667|NCT01078805|2996656|P1|Overall Study|Withdrawal by Subject|739
908668|NCT01078805|2996656|P1|Overall Study|Sponsor decision|46
908669|NCT01078805|2996656|P1|Overall Study|Serious adverse event|26
908670|NCT01078805|2996656|P1|Overall Study|Physician Decision|169
908671|NCT01078805|2996656|P1|Overall Study|Lost to Follow-up|676
908672|NCT01078805|2996656|P1|Overall Study|Death|134
908673|NCT01078805|2996656|P1|Overall Study|Clinically significant abnormal lab|5
908674|NCT01078675|2996683|P2|Overall Study|Adverse Event|0
908675|NCT01078675|2996684|P1|Overall Study|Adverse Event|3
908676|NCT01078675|2996683|P2|Overall Study|Provided in CRF for specific reasons|3
908677|NCT01078675|2996684|P1|Overall Study|Provided in CRF for specific reasons|2
908678|NCT01078675|2996683|P2|Overall Study|Protocol Violation|0
908679|NCT01078675|2996684|P1|Overall Study|Protocol Violation|56
908680|NCT01078675|2996683|P2|Overall Study|Withdrawal by Subject|3
908681|NCT01078675|2996684|P1|Overall Study|Withdrawal by Subject|7
908682|NCT01078662|2996706|P5|Overall Study|Lost to Follow-up|0
908683|NCT01078662|2996707|P4|Overall Study|Lost to Follow-up|0
908684|NCT01078662|2996708|P3|Overall Study|Lost to Follow-up|0
908685|NCT01078662|2996709|P2|Overall Study|Lost to Follow-up|0
908686|NCT01078662|2996710|P1|Overall Study|Lost to Follow-up|1
908687|NCT01078662|2996706|P5|Overall Study|Protocol Violation|0
908688|NCT01078662|2996707|P4|Overall Study|Protocol Violation|0
908689|NCT01078662|2996708|P3|Overall Study|Protocol Violation|0
908690|NCT01078662|2996709|P2|Overall Study|Protocol Violation|1
908691|NCT01078662|2996710|P1|Overall Study|Protocol Violation|0
908692|NCT01078662|2996706|P5|Overall Study|Withdrawal by Subject|0
908693|NCT01078662|2996707|P4|Overall Study|Withdrawal by Subject|0
908694|NCT01078662|2996708|P3|Overall Study|Withdrawal by Subject|1
908695|NCT01078662|2996709|P2|Overall Study|Withdrawal by Subject|11
908696|NCT01078662|2996710|P1|Overall Study|Withdrawal by Subject|4
908697|NCT01078662|2996706|P5|Overall Study|Patients reached data cut-off|3
908698|NCT01078662|2996707|P4|Overall Study|Patients reached data cut-off|2
908699|NCT01078662|2996708|P3|Overall Study|Patients reached data cut-off|2
908700|NCT01078662|2996709|P2|Overall Study|Patients reached data cut-off|53
908701|NCT01078662|2996710|P1|Overall Study|Patients reached data cut-off|12
908702|NCT01078662|2996706|P5|Overall Study|Death|8
908703|NCT01078662|2996707|P4|Overall Study|Death|5
908704|NCT01078662|2996708|P3|Overall Study|Death|18
908705|NCT01078662|2996709|P2|Overall Study|Death|103
908706|NCT01078662|2996710|P1|Overall Study|Death|41
908707|NCT01078623|2996749|P20|Treatment Period 4|Withdrawal by Subject|0
908708|NCT01078623|2996750|P19|Treatment Period 4|Withdrawal by Subject|0
908709|NCT01078623|2996751|P18|Treatment Period 4|Withdrawal by Subject|0
908710|NCT01078623|2996752|P17|Treatment Period 4|Withdrawal by Subject|0
908711|NCT01078623|2996753|P16|Treatment Period 4|Withdrawal by Subject|1
908712|NCT01078623|2996754|P15|Treatment Period 4|Withdrawal by Subject|0
908713|NCT01078623|2996755|P14|Treatment Period 4|Withdrawal by Subject|0
908714|NCT01078623|2996756|P13|Treatment Period 4|Withdrawal by Subject|0
908715|NCT01078623|2996757|P12|Treatment Period 4|Withdrawal by Subject|0
908716|NCT01078623|2996758|P11|Treatment Period 4|Withdrawal by Subject|0
908717|NCT01078623|2996759|P10|Treatment Period 4|Withdrawal by Subject|0
908718|NCT01078623|2996760|P9|Treatment Period 4|Withdrawal by Subject|0
908719|NCT01078623|2996761|P8|Treatment Period 4|Withdrawal by Subject|0
908720|NCT01078623|2996762|P7|Treatment Period 4|Withdrawal by Subject|0
908721|NCT01078623|2996763|P6|Treatment Period 4|Withdrawal by Subject|0
908722|NCT01078623|2996764|P5|Treatment Period 4|Withdrawal by Subject|0
908723|NCT01078623|2996765|P4|Treatment Period 4|Withdrawal by Subject|0
908724|NCT01078623|2996766|P3|Treatment Period 4|Withdrawal by Subject|0
908725|NCT01078623|2996767|P2|Treatment Period 4|Withdrawal by Subject|0
908726|NCT01078623|2996768|P1|Treatment Period 4|Withdrawal by Subject|0
908727|NCT01078623|2996749|P20|Treatment Period 4|Adverse Event|0
908728|NCT01078623|2996750|P19|Treatment Period 4|Adverse Event|0
908729|NCT01078623|2996751|P18|Treatment Period 4|Adverse Event|0
908730|NCT01078623|2996752|P17|Treatment Period 4|Adverse Event|0
908731|NCT01078623|2996753|P16|Treatment Period 4|Adverse Event|0
908732|NCT01078623|2996754|P15|Treatment Period 4|Adverse Event|0
908733|NCT01078623|2996755|P14|Treatment Period 4|Adverse Event|0
908734|NCT01078623|2996756|P13|Treatment Period 4|Adverse Event|0
908735|NCT01078623|2996757|P12|Treatment Period 4|Adverse Event|0
908736|NCT01078623|2996758|P11|Treatment Period 4|Adverse Event|0
908737|NCT01078623|2996759|P10|Treatment Period 4|Adverse Event|0
908738|NCT01078623|2996760|P9|Treatment Period 4|Adverse Event|0
908739|NCT01078623|2996761|P8|Treatment Period 4|Adverse Event|0
908740|NCT01078623|2996762|P7|Treatment Period 4|Adverse Event|0
908741|NCT01078623|2996763|P6|Treatment Period 4|Adverse Event|0
908742|NCT01078623|2996764|P5|Treatment Period 4|Adverse Event|0
908743|NCT01078623|2996765|P4|Treatment Period 4|Adverse Event|0
908744|NCT01078623|2996766|P3|Treatment Period 4|Adverse Event|1
908745|NCT01078623|2996767|P2|Treatment Period 4|Adverse Event|0
908746|NCT01078623|2996768|P1|Treatment Period 4|Adverse Event|0
908747|NCT01078623|2996749|P20|Treatment Period 3|Adverse Event|0
908748|NCT01078623|2996750|P19|Treatment Period 3|Adverse Event|0
908749|NCT01078623|2996751|P18|Treatment Period 3|Adverse Event|0
908750|NCT01078623|2996752|P17|Treatment Period 3|Adverse Event|0
908751|NCT01078623|2996753|P16|Treatment Period 3|Adverse Event|0
908752|NCT01078623|2996754|P15|Treatment Period 3|Adverse Event|0
908753|NCT01078623|2996755|P14|Treatment Period 3|Adverse Event|1
908754|NCT01078623|2996756|P13|Treatment Period 3|Adverse Event|0
908755|NCT01078623|2996757|P12|Treatment Period 3|Adverse Event|0
908756|NCT01078623|2996758|P11|Treatment Period 3|Adverse Event|0
908757|NCT01078623|2996759|P10|Treatment Period 3|Adverse Event|0
908758|NCT01078623|2996760|P9|Treatment Period 3|Adverse Event|0
908759|NCT01078623|2996761|P8|Treatment Period 3|Adverse Event|0
908760|NCT01078623|2996762|P7|Treatment Period 3|Adverse Event|0
908761|NCT01078623|2996763|P6|Treatment Period 3|Adverse Event|0
908762|NCT01078623|2996764|P5|Treatment Period 3|Adverse Event|1
908763|NCT01078623|2996765|P4|Treatment Period 3|Adverse Event|0
908764|NCT01078623|2996766|P3|Treatment Period 3|Adverse Event|0
908765|NCT01078623|2996767|P2|Treatment Period 3|Adverse Event|0
908766|NCT01078623|2996768|P1|Treatment Period 3|Adverse Event|0
908767|NCT01078623|2996749|P20|Treatment Period 2|Withdrawal by Subject|0
908768|NCT01078623|2996750|P19|Treatment Period 2|Withdrawal by Subject|0
908769|NCT01078623|2996751|P18|Treatment Period 2|Withdrawal by Subject|0
908770|NCT01078623|2996752|P17|Treatment Period 2|Withdrawal by Subject|0
908771|NCT01078623|2996753|P16|Treatment Period 2|Withdrawal by Subject|0
908772|NCT01078623|2996754|P15|Treatment Period 2|Withdrawal by Subject|0
908773|NCT01078623|2996755|P14|Treatment Period 2|Withdrawal by Subject|0
908774|NCT01078623|2996756|P13|Treatment Period 2|Withdrawal by Subject|0
908775|NCT01078623|2996757|P12|Treatment Period 2|Withdrawal by Subject|0
908776|NCT01078623|2996758|P11|Treatment Period 2|Withdrawal by Subject|0
908777|NCT01078623|2996759|P10|Treatment Period 2|Withdrawal by Subject|0
908778|NCT01078623|2996760|P9|Treatment Period 2|Withdrawal by Subject|0
908779|NCT01078623|2996761|P8|Treatment Period 2|Withdrawal by Subject|0
908780|NCT01078623|2996762|P7|Treatment Period 2|Withdrawal by Subject|0
908781|NCT01078623|2996763|P6|Treatment Period 2|Withdrawal by Subject|1
908782|NCT01078623|2996764|P5|Treatment Period 2|Withdrawal by Subject|0
908783|NCT01078623|2996765|P4|Treatment Period 2|Withdrawal by Subject|0
908784|NCT01078623|2996766|P3|Treatment Period 2|Withdrawal by Subject|0
908785|NCT01078623|2996767|P2|Treatment Period 2|Withdrawal by Subject|0
908786|NCT01078623|2996768|P1|Treatment Period 2|Withdrawal by Subject|0
908787|NCT01078623|2996749|P20|Treatment Period 2|Adverse Event|0
908788|NCT01078623|2996750|P19|Treatment Period 2|Adverse Event|1
908789|NCT01078623|2996751|P18|Treatment Period 2|Adverse Event|0
908790|NCT01078623|2996752|P17|Treatment Period 2|Adverse Event|0
908791|NCT01078623|2996753|P16|Treatment Period 2|Adverse Event|0
908792|NCT01078623|2996754|P15|Treatment Period 2|Adverse Event|0
908793|NCT01078623|2996755|P14|Treatment Period 2|Adverse Event|0
908794|NCT01078623|2996756|P13|Treatment Period 2|Adverse Event|0
908795|NCT01078623|2996757|P12|Treatment Period 2|Adverse Event|0
908796|NCT01078623|2996758|P11|Treatment Period 2|Adverse Event|0
908797|NCT01078623|2996759|P10|Treatment Period 2|Adverse Event|0
908798|NCT01078623|2996760|P9|Treatment Period 2|Adverse Event|0
908799|NCT01078623|2996761|P8|Treatment Period 2|Adverse Event|0
908800|NCT01078623|2996762|P7|Treatment Period 2|Adverse Event|1
908801|NCT01078623|2996763|P6|Treatment Period 2|Adverse Event|0
908802|NCT01078623|2996764|P5|Treatment Period 2|Adverse Event|0
908803|NCT01078623|2996765|P4|Treatment Period 2|Adverse Event|0
908804|NCT01078623|2996766|P3|Treatment Period 2|Adverse Event|0
908805|NCT01078623|2996767|P2|Treatment Period 2|Adverse Event|0
908806|NCT01078623|2996768|P1|Treatment Period 2|Adverse Event|0
908807|NCT01078623|2996749|P20|Treatment Period 1|Protocol Violation|0
908808|NCT01078623|2996750|P19|Treatment Period 1|Protocol Violation|0
908809|NCT01078623|2996751|P18|Treatment Period 1|Protocol Violation|0
908810|NCT01078623|2996752|P17|Treatment Period 1|Protocol Violation|0
908811|NCT01078623|2996753|P16|Treatment Period 1|Protocol Violation|0
908812|NCT01078623|2996754|P15|Treatment Period 1|Protocol Violation|0
908813|NCT01078623|2996755|P14|Treatment Period 1|Protocol Violation|0
908814|NCT01078623|2996756|P13|Treatment Period 1|Protocol Violation|0
908815|NCT01078623|2996757|P12|Treatment Period 1|Protocol Violation|0
908816|NCT01078623|2996758|P11|Treatment Period 1|Protocol Violation|0
908817|NCT01078623|2996759|P10|Treatment Period 1|Protocol Violation|0
908818|NCT01078623|2996760|P9|Treatment Period 1|Protocol Violation|0
908819|NCT01078623|2996761|P8|Treatment Period 1|Protocol Violation|0
908820|NCT01078623|2996762|P7|Treatment Period 1|Protocol Violation|0
908821|NCT01078623|2996763|P6|Treatment Period 1|Protocol Violation|1
908822|NCT01078623|2996764|P5|Treatment Period 1|Protocol Violation|0
908823|NCT01078623|2996765|P4|Treatment Period 1|Protocol Violation|0
908824|NCT01078623|2996766|P3|Treatment Period 1|Protocol Violation|0
908825|NCT01078623|2996767|P2|Treatment Period 1|Protocol Violation|0
908826|NCT01078623|2996768|P1|Treatment Period 1|Protocol Violation|0
908827|NCT01078623|2996749|P20|Treatment Period 1|Withdrawal by Subject|0
908828|NCT01078623|2996750|P19|Treatment Period 1|Withdrawal by Subject|0
908829|NCT01078623|2996751|P18|Treatment Period 1|Withdrawal by Subject|0
908830|NCT01078623|2996752|P17|Treatment Period 1|Withdrawal by Subject|0
908831|NCT01078623|2996753|P16|Treatment Period 1|Withdrawal by Subject|0
908832|NCT01078623|2996754|P15|Treatment Period 1|Withdrawal by Subject|0
908833|NCT01078623|2996755|P14|Treatment Period 1|Withdrawal by Subject|0
908834|NCT01078623|2996756|P13|Treatment Period 1|Withdrawal by Subject|0
908835|NCT01078623|2996757|P12|Treatment Period 1|Withdrawal by Subject|0
908836|NCT01078623|2996758|P11|Treatment Period 1|Withdrawal by Subject|1
908837|NCT01078623|2996759|P10|Treatment Period 1|Withdrawal by Subject|0
908838|NCT01078623|2996760|P9|Treatment Period 1|Withdrawal by Subject|0
908839|NCT01078623|2996761|P8|Treatment Period 1|Withdrawal by Subject|1
908840|NCT01078623|2996762|P7|Treatment Period 1|Withdrawal by Subject|0
908841|NCT01078623|2996763|P6|Treatment Period 1|Withdrawal by Subject|0
908842|NCT01078623|2996764|P5|Treatment Period 1|Withdrawal by Subject|0
908843|NCT01078623|2996765|P4|Treatment Period 1|Withdrawal by Subject|0
908844|NCT01078623|2996766|P3|Treatment Period 1|Withdrawal by Subject|0
908845|NCT01078623|2996767|P2|Treatment Period 1|Withdrawal by Subject|0
908846|NCT01078623|2996768|P1|Treatment Period 1|Withdrawal by Subject|0
908847|NCT01078623|2996749|P20|Treatment Period 1|Adverse Event|0
908848|NCT01078623|2996750|P19|Treatment Period 1|Adverse Event|0
908849|NCT01078623|2996751|P18|Treatment Period 1|Adverse Event|0
908850|NCT01078623|2996752|P17|Treatment Period 1|Adverse Event|0
908851|NCT01078623|2996753|P16|Treatment Period 1|Adverse Event|0
908852|NCT01078623|2996754|P15|Treatment Period 1|Adverse Event|0
908853|NCT01078623|2996755|P14|Treatment Period 1|Adverse Event|0
908854|NCT01078623|2996756|P13|Treatment Period 1|Adverse Event|0
908855|NCT01078623|2996757|P12|Treatment Period 1|Adverse Event|0
908856|NCT01078623|2996758|P11|Treatment Period 1|Adverse Event|0
908857|NCT01078623|2996759|P10|Treatment Period 1|Adverse Event|1
908858|NCT01078623|2996760|P9|Treatment Period 1|Adverse Event|1
908859|NCT01078623|2996761|P8|Treatment Period 1|Adverse Event|0
908860|NCT01078623|2996762|P7|Treatment Period 1|Adverse Event|1
908861|NCT01078623|2996763|P6|Treatment Period 1|Adverse Event|0
908862|NCT01078623|2996764|P5|Treatment Period 1|Adverse Event|0
908863|NCT01078623|2996765|P4|Treatment Period 1|Adverse Event|0
908864|NCT01078623|2996766|P3|Treatment Period 1|Adverse Event|1
908865|NCT01078623|2996767|P2|Treatment Period 1|Adverse Event|1
908866|NCT01078623|2996768|P1|Treatment Period 1|Adverse Event|1
908867|NCT01078584|2996790|P1|Overall Study|Multiple Reasons|2
908868|NCT01078584|2996790|P1|Overall Study|Serious Adverse Event|27
908869|NCT01078584|2996790|P1|Overall Study|Protocol Violation|75
908870|NCT01078584|2996790|P1|Overall Study|Lack of Efficacy|98
908871|NCT01078584|2996790|P1|Overall Study|Physician Discontinued Patient|12
908872|NCT01078584|2996790|P1|Overall Study|Physician Switched Medication|26
908873|NCT01078584|2996790|P1|Overall Study|Blood Pressure Controlled|49
908874|NCT01078584|2996790|P1|Overall Study|Non-compliance|67
908875|NCT01078584|2996790|P1|Overall Study|Physician Withdrew from Study|90
908876|NCT01078584|2996790|P1|Overall Study|Withdrawal of Consent|244
908877|NCT01078584|2996790|P1|Overall Study|Non-serious Adverse Event|577
908878|NCT01078584|2996790|P1|Overall Study|Lost to Follow-up|670
908879|NCT01078584|2996790|P1|Overall Study|Final Status Unknown|1073
908880|NCT01078571|2996871|P1|Overall Study|Protocol Violation|2
908881|NCT01078571|2996871|P1|Overall Study|Lost to Follow-up|8
908882|NCT01078571|2996871|P1|Overall Study|Withdrawal by Subject|12
908883|NCT01078571|2996871|P1|Overall Study|Reason not reported|21
908884|NCT01078571|2996871|P1|Overall Study|Lack of effectiveness|36
908885|NCT01078571|2996871|P1|Overall Study|Adverse Event|36
908886|NCT01078545|2996887|P1|Overall Study|Participant moved to another physician|1
908887|NCT01078545|2996887|P1|Overall Study|Death|3
908888|NCT01078545|2996887|P1|Overall Study|Withdrawal by Subject|3
908889|NCT01078545|2996887|P1|Overall Study|Physician Decision|6
908890|NCT01078545|2996887|P1|Overall Study|Lost to Follow-up|13
908891|NCT01078454|2996897|P2|Overall Study|Death|1
908892|NCT01078454|2996898|P1|Overall Study|Death|0
908893|NCT01078454|2996897|P2|Overall Study|Adverse Event|1
908894|NCT01078454|2996898|P1|Overall Study|Adverse Event|1
908895|NCT01078441|2996904|P1|Overall Study|Withdrawal by Subject|1
908896|NCT01078389|2996944|P2|Overall Study|Other|2
908897|NCT01078389|2996945|P1|Overall Study|Other|9
908898|NCT01078389|2996944|P2|Overall Study|Voluntary Withdrawal|36
908899|NCT01078389|2996945|P1|Overall Study|Voluntary Withdrawal|20
908900|NCT01078389|2996944|P2|Overall Study|Lost to Follow-up|23
908901|NCT01078389|2996945|P1|Overall Study|Lost to Follow-up|23
908902|NCT01078389|2996944|P2|Overall Study|Major Protocol Deviation|0
908903|NCT01078389|2996945|P1|Overall Study|Major Protocol Deviation|2
908904|NCT01078389|2996944|P2|Overall Study|Adverse Event|6
908905|NCT01078389|2996945|P1|Overall Study|Adverse Event|10
908906|NCT01078298|2997106|P2|Overall Study|Other|32
908907|NCT01078298|2997107|P1|Overall Study|Other|24
908908|NCT01078298|2997106|P2|Overall Study|Did not meet entrance criteria|1
908909|NCT01078298|2997107|P1|Overall Study|Did not meet entrance criteria|0
908910|NCT01078298|2997106|P2|Overall Study|Death|0
908911|NCT01078298|2997107|P1|Overall Study|Death|2
908912|NCT01078298|2997106|P2|Overall Study|Adverse Event|5
908913|NCT01078298|2997107|P1|Overall Study|Adverse Event|6
908914|NCT01078298|2997106|P2|Overall Study|Protocol Violation|6
908915|NCT01078298|2997107|P1|Overall Study|Protocol Violation|6
908916|NCT01078298|2997106|P2|Overall Study|Withdrawal by Subject|33
908917|NCT01078298|2997107|P1|Overall Study|Withdrawal by Subject|31
908918|NCT01078298|2997106|P2|Overall Study|Lost to Follow-up|13
908919|NCT01078298|2997107|P1|Overall Study|Lost to Follow-up|12
908920|NCT01078168|2997217|P2|Overall Study|Physician Decision|1
908921|NCT01078168|2997218|P1|Overall Study|Physician Decision|0
908922|NCT01078155|2997224|P1|Overall Study|Lost to Follow-up|15
908923|NCT01078155|2997224|P1|Overall Study|Participant's Decision|6
908924|NCT01078155|2997224|P1|Overall Study|Lack of Efficacy|16
908925|NCT01078155|2997224|P1|Overall Study|Adverse Event|7
908926|NCT01078116|2997240|P1|Overall Study|Case report form not completed|3
908927|NCT01078116|2997240|P1|Overall Study|Lack of effectiveness|15
908928|NCT01078116|2997240|P1|Overall Study|Withdrawal by Subject|8
908929|NCT01078116|2997240|P1|Overall Study|Adverse Event|5
908930|NCT01078116|2997240|P1|Overall Study|Lost to Follow-up|17
908931|NCT01078090|2997248|P1|Overall Study|Other|523
908932|NCT01078090|2997248|P1|Overall Study|ADR and lack of efficacy|61
908933|NCT01078090|2997248|P1|Overall Study|Lack of Efficacy|1193
908934|NCT01078090|2997248|P1|Overall Study|Adverse drug reaction (ADR)|453
908935|NCT01078090|2997248|P1|Overall Study|Lost to Follow-up|2363
908936|NCT01077960|2997342|P1|Overall Study|Reason unspecified|1
908937|NCT01077960|2997342|P1|Overall Study|Subject decision|1
908938|NCT01077960|2997342|P1|Overall Study|Lost to Follow-up|5
908939|NCT01077960|2997342|P1|Overall Study|Protocol Violation|3
908940|NCT01077960|2997342|P1|Overall Study|Adverse Event|6
908941|NCT01077804|2997592|P1|Overall Study|Other|18
908942|NCT01077804|2997592|P1|Overall Study|Refused to continue|79
908943|NCT01077804|2997592|P1|Overall Study|Unreachable|102
908944|NCT01077739|2997601|P2|Overall Study|Not specified|2
908945|NCT01077739|2997602|P1|Overall Study|Not specified|2
908946|NCT01077739|2997601|P2|Overall Study|Unacceptable toxicity|2
908947|NCT01077739|2997602|P1|Overall Study|Unacceptable toxicity|1
908948|NCT01077739|2997601|P2|Overall Study|Death|3
908949|NCT01077739|2997602|P1|Overall Study|Death|0
908950|NCT01077739|2997601|P2|Overall Study|Withdrawal by Subject|0
908951|NCT01077739|2997602|P1|Overall Study|Withdrawal by Subject|1
908952|NCT01077739|2997601|P2|Overall Study|Premature withdrawal|3
908953|NCT01077739|2997602|P1|Overall Study|Premature withdrawal|1
908954|NCT01077713|2997616|P2|Overall Study|Other|2
908955|NCT01077713|2997617|P1|Overall Study|Other|4
908956|NCT01077713|2997616|P2|Overall Study|Adverse Event|1
908957|NCT01077713|2997617|P1|Overall Study|Adverse Event|2
908958|NCT01077713|2997616|P2|Overall Study|Lost to Follow-up|1
908959|NCT01077713|2997617|P1|Overall Study|Lost to Follow-up|1
908960|NCT01077713|2997616|P2|Overall Study|Death|29
908961|NCT01077713|2997617|P1|Overall Study|Death|28
908962|NCT01077713|2997616|P2|Overall Study|Progressive Disease (PD)|1
908963|NCT01077713|2997617|P1|Overall Study|Progressive Disease (PD)|0
908964|NCT01077713|2997616|P2|Overall Study|Withdrawal by Subject|2
908965|NCT01077713|2997617|P1|Overall Study|Withdrawal by Subject|1
908966|NCT01077622|2997641|P1|Overall Study|Withdrawal by Subject|1
908967|NCT01077622|2997641|P1|Overall Study|Physician Decision|2
908968|NCT01077544|2997761|P2|Overall Study|Disease Progression|1
908969|NCT01077544|2997762|P1|Overall Study|Disease Progression|0
908970|NCT01077544|2997761|P2|Overall Study|Adverse Event|1
908971|NCT01077544|2997762|P1|Overall Study|Adverse Event|0
908972|NCT01077544|2997761|P2|Overall Study|New Cancer Therapy|3
908973|NCT01077544|2997762|P1|Overall Study|New Cancer Therapy|3
908974|NCT01077375|2997803|P2|Overall Study|Other Reason|1
908975|NCT01077375|2997804|P1|Overall Study|Other Reason|0
908976|NCT01077375|2997803|P2|Overall Study|Lost to Follow-up|5
908977|NCT01077375|2997804|P1|Overall Study|Lost to Follow-up|2
908978|NCT01077375|2997803|P2|Overall Study|Withdrawal by Subject|6
908979|NCT01077375|2997804|P1|Overall Study|Withdrawal by Subject|0
908980|NCT01077375|2997803|P2|Overall Study|Lack of Efficacy|8
908981|NCT01077375|2997804|P1|Overall Study|Lack of Efficacy|6
908982|NCT01077375|2997803|P2|Overall Study|Adverse Event|15
908983|NCT01077375|2997804|P1|Overall Study|Adverse Event|2
908984|NCT01077362|2997815|P3|Overall Study|Not Specified|2
908985|NCT01077362|2997816|P2|Overall Study|Not Specified|1
908986|NCT01077362|2997817|P1|Overall Study|Not Specified|0
908987|NCT01077362|2997815|P3|Overall Study|Withdrawal by Subject|5
908988|NCT01077362|2997816|P2|Overall Study|Withdrawal by Subject|3
908989|NCT01077362|2997817|P1|Overall Study|Withdrawal by Subject|5
908990|NCT01077362|2997815|P3|Overall Study|Adverse Event|4
908991|NCT01077362|2997816|P2|Overall Study|Adverse Event|7
908992|NCT01077362|2997817|P1|Overall Study|Adverse Event|12
908993|NCT01077362|2997815|P3|Overall Study|Lost to Follow-up|3
908994|NCT01077362|2997816|P2|Overall Study|Lost to Follow-up|0
908995|NCT01077362|2997817|P1|Overall Study|Lost to Follow-up|1
908996|NCT01077362|2997815|P3|Overall Study|Lack of Efficacy|10
908997|NCT01077362|2997816|P2|Overall Study|Lack of Efficacy|8
908998|NCT01077362|2997817|P1|Overall Study|Lack of Efficacy|13
908999|NCT01077323|2997853|P3|Overall Study|Baseline diagnosis of pancreatic disease|120
909000|NCT01077323|2997854|P2|Overall Study|Baseline diagnosis of pancreatic disease|2080
909001|NCT01077323|2997855|P1|Overall Study|Baseline diagnosis of pancreatic disease|152
909002|NCT01077323|2997853|P3|Overall Study|Dispensing of drug in baseline period|256446
909003|NCT01077323|2997854|P2|Overall Study|Dispensing of drug in baseline period|120229
909004|NCT01077323|2997855|P1|Overall Study|Dispensing of drug in baseline period|0
909005|NCT01077323|2997853|P3|Overall Study|<9 months enroll before drug dispensed|11655523
909006|NCT01077323|2997854|P2|Overall Study|<9 months enroll before drug dispensed|263954
909007|NCT01077323|2997855|P1|Overall Study|<9 months enroll before drug dispensed|11226
909008|NCT01077284|2997898|P3|Overall Study|Other|1
909009|NCT01077284|2997899|P2|Overall Study|Other|0
909010|NCT01077284|2997900|P1|Overall Study|Other|0
909011|NCT01077284|2997898|P3|Overall Study|Withdrawal by Subject|1
909012|NCT01077284|2997899|P2|Overall Study|Withdrawal by Subject|3
909013|NCT01077284|2997900|P1|Overall Study|Withdrawal by Subject|2
909014|NCT01077284|2997898|P3|Overall Study|Lost to Follow-up|0
909015|NCT01077284|2997899|P2|Overall Study|Lost to Follow-up|2
909016|NCT01077284|2997900|P1|Overall Study|Lost to Follow-up|1
909017|NCT01077284|2997898|P3|Overall Study|Adverse Event|1
909018|NCT01077284|2997899|P2|Overall Study|Adverse Event|0
909019|NCT01077284|2997900|P1|Overall Study|Adverse Event|2
909020|NCT01077271|2997921|P1|Overall Study|Mother unconvinced of the necessity|1
909021|NCT01077271|2997921|P1|Overall Study|End of RSV season nearly reached|1
909022|NCT01077271|2997921|P1|Overall Study|Parents thought too many injections|2
909023|NCT01077271|2997921|P1|Overall Study|Changed doctors|2
909024|NCT01077271|2997921|P1|Overall Study|Quota used up (insurance reimb issue)|2
909025|NCT01077271|2997921|P1|Overall Study|Noncompliance|2
909026|NCT01077271|2997921|P1|Overall Study|Screen failure, did not take palivizumab|4
909027|NCT01077271|2997921|P1|Overall Study|Parental desire|8
909028|NCT01077258|2997959|P1|Overall Study|Other reasons|260
909029|NCT01077258|2997959|P1|Overall Study|Clinical remission|37
909030|NCT01077258|2997959|P1|Overall Study|Lack of Efficacy|663
909031|NCT01077258|2997959|P1|Overall Study|Adverse drug reaction|218
909032|NCT01077258|2997959|P1|Overall Study|Lost to Follow-up|1390
909033|NCT01077193|2997995|P1|Overall Study|Study Terminated by Sponsor|40
909034|NCT01077193|2997995|P1|Overall Study|Lack of Efficacy|1
909035|NCT01077193|2997995|P1|Overall Study|Withdrawal by Subject|2
909036|NCT01077193|2997995|P1|Overall Study|Lost to Follow-up|1
909037|NCT01077154|2998001|P2|Overall Study|Protocol Deviation|0
909038|NCT01077154|2998002|P1|Overall Study|Protocol Deviation|1
909039|NCT01077154|2998001|P2|Overall Study|Administrative Decision|6
909040|NCT01077154|2998002|P1|Overall Study|Administrative Decision|1
909041|NCT01077154|2998001|P2|Overall Study|Adverse Event|8
909042|NCT01077154|2998002|P1|Overall Study|Adverse Event|8
909043|NCT01077154|2998001|P2|Overall Study|Other|11
909044|NCT01077154|2998002|P1|Overall Study|Other|13
909045|NCT01077154|2998001|P2|Overall Study|Ineligibility Determined|14
909046|NCT01077154|2998002|P1|Overall Study|Ineligibility Determined|10
909047|NCT01077154|2998001|P2|Overall Study|Disease Progression|20
909048|NCT01077154|2998002|P1|Overall Study|Disease Progression|17
909049|NCT01077154|2998001|P2|Overall Study|Noncompliance|20
909050|NCT01077154|2998002|P1|Overall Study|Noncompliance|22
909051|NCT01077154|2998001|P2|Overall Study|Lost to Follow-up|32
909052|NCT01077154|2998002|P1|Overall Study|Lost to Follow-up|39
909053|NCT01077154|2998001|P2|Overall Study|Death|207
909054|NCT01077154|2998002|P1|Overall Study|Death|204
909055|NCT01077154|2998001|P2|Overall Study|Withdrawal by Subject|368
909056|NCT01077154|2998002|P1|Overall Study|Withdrawal by Subject|355
909057|NCT01077154|2998001|P2|Overall Study|On-study as of Analysis Cutoff Date|1555
909058|NCT01077154|2998002|P1|Overall Study|On-study as of Analysis Cutoff Date|1571
909059|NCT01077128|2998016|P1|Overall Study|Not available|54
909060|NCT01077128|2998016|P1|Overall Study|Lack of efficacy/disease exacerbation|1
909061|NCT01077128|2998016|P1|Overall Study|Adverse event and disease exacerbation|1
909062|NCT01077128|2998016|P1|Overall Study|Adverse event and consent withdrawal|1
909063|NCT01077128|2998016|P1|Overall Study|Disease exacerbation|1
909064|NCT01077128|2998016|P1|Overall Study|Lack of Efficacy|1
909065|NCT01077128|2998016|P1|Overall Study|Adverse Event|8
909066|NCT01077076|2998074|P6|Third Intervention|Death in the participant's family|1
909067|NCT01077076|2998075|P5|Third Intervention|Death in the participant's family|0
909068|NCT01077076|2998076|P4|Third Intervention|Death in the participant's family|0
909069|NCT01077076|2998077|P3|Third Intervention|Death in the participant's family|0
909070|NCT01077076|2998078|P2|Third Intervention|Death in the participant's family|0
909071|NCT01077076|2998079|P1|Third Intervention|Death in the participant's family|0
909072|NCT01077076|2998074|P6|First Intervention|Withdrawal by Subject|0
909073|NCT01077076|2998075|P5|First Intervention|Withdrawal by Subject|0
909074|NCT01077076|2998076|P4|First Intervention|Withdrawal by Subject|0
909075|NCT01077076|2998077|P3|First Intervention|Withdrawal by Subject|0
909076|NCT01077076|2998078|P2|First Intervention|Withdrawal by Subject|0
909077|NCT01077076|2998079|P1|First Intervention|Withdrawal by Subject|1
909078|NCT01077063|2998089|P2|Overall Study|Withdrawal by Subject|2
909079|NCT01077063|2998090|P1|Overall Study|Withdrawal by Subject|0
909080|NCT01077063|2998089|P2|Overall Study|Death|1
909081|NCT01077063|2998090|P1|Overall Study|Death|1
909082|NCT01077063|2998089|P2|Overall Study|Adverse Event|0
909083|NCT01077063|2998090|P1|Overall Study|Adverse Event|3
909084|NCT01077050|2998096|P1|Overall Study|Screen failure|8
909085|NCT01077050|2998096|P1|Overall Study|Subjects signed ICF could not be located|1
909086|NCT01077024|2998102|P2|Overall Study|Other|4
909087|NCT01077024|2998103|P1|Overall Study|Other|4
909088|NCT01077024|2998102|P2|Overall Study|Incarcerated|8
909089|NCT01077024|2998103|P1|Overall Study|Incarcerated|7
909090|NCT01077024|2998102|P2|Overall Study|Withdrawal by Subject|2
909091|NCT01077024|2998103|P1|Overall Study|Withdrawal by Subject|0
909092|NCT01077024|2998102|P2|Overall Study|Lost to Follow-up|14
909093|NCT01077024|2998103|P1|Overall Study|Lost to Follow-up|20
909094|NCT01076959|2998142|P1|Overall Study|Other|119
909095|NCT01076959|2998142|P1|Overall Study|Lost to Follow-up|241
909096|NCT01076959|2998142|P1|Overall Study|Non-compliance|274
909097|NCT01076959|2998142|P1|Overall Study|Lack of Efficacy|849
909098|NCT01076959|2998142|P1|Overall Study|Adverse Event|767
909099|NCT01076647|2998178|P2|Overall Study|Unclassified|12
909100|NCT01076647|2998179|P1|Overall Study|Unclassified|12
909101|NCT01076647|2998178|P2|Overall Study|Withdrawal criteria|2
909102|NCT01076647|2998179|P1|Overall Study|Withdrawal criteria|2
909103|NCT01076647|2998178|P2|Overall Study|Protocol Violation|9
909104|NCT01076647|2998179|P1|Overall Study|Protocol Violation|7
909105|NCT01076647|2998178|P2|Overall Study|Lack of Efficacy|1
909106|NCT01076647|2998179|P1|Overall Study|Lack of Efficacy|0
909107|NCT01076647|2998178|P2|Overall Study|Adverse Event|1
909108|NCT01076647|2998179|P1|Overall Study|Adverse Event|4
909109|NCT01076400|2998210|P3|Overall Study|Progressive Disease|0
909110|NCT01076400|2998211|P2|Overall Study|Progressive Disease|0
909111|NCT01076400|2998212|P1|Overall Study|Progressive Disease|5
909112|NCT01076400|2998210|P3|Overall Study|Adverse Event|0
909113|NCT01076400|2998211|P2|Overall Study|Adverse Event|0
909114|NCT01076400|2998212|P1|Overall Study|Adverse Event|2
909115|NCT01076361|2998218|P1|Overall Study|22 leads were excluded from analysis|21
909116|NCT01076335|2998226|P1|Overall Study|Withdrawal without treatment|1
909117|NCT01076335|2998226|P1|Overall Study|Withdrawal by Subject|3
909118|NCT01076192|2998278|P1|Overall Study|Not specified|197
909119|NCT01076179|2998293|P1|Overall Study|Withdrawal by Subject|1
909120|NCT01076166|2998316|P1|Overall Study|Symptoms improved/resolved|6
909121|NCT01076166|2998316|P1|Overall Study|Adverse Event|3
909122|NCT01076153|2998323|P1|Overall Study|Adverse Event|1
909123|NCT01076153|2998323|P1|Overall Study|Symptoms improved/resolved|10
909124|NCT01076088|2998337|P6|Overall Study|Other protocol specified criteria|1
909125|NCT01076088|2998338|P5|Overall Study|Other protocol specified criteria|0
909126|NCT01076088|2998339|P4|Overall Study|Other protocol specified criteria|0
909127|NCT01076088|2998340|P3|Overall Study|Other protocol specified criteria|0
909128|NCT01076088|2998341|P2|Overall Study|Other protocol specified criteria|0
909129|NCT01076088|2998342|P1|Overall Study|Other protocol specified criteria|0
909130|NCT01076088|2998337|P6|Overall Study|Withdrawal by Subject|17
909131|NCT01076088|2998338|P5|Overall Study|Withdrawal by Subject|11
909132|NCT01076088|2998339|P4|Overall Study|Withdrawal by Subject|10
909133|NCT01076088|2998340|P3|Overall Study|Withdrawal by Subject|14
909134|NCT01076088|2998341|P2|Overall Study|Withdrawal by Subject|8
909135|NCT01076088|2998342|P1|Overall Study|Withdrawal by Subject|8
909136|NCT01076088|2998337|P6|Overall Study|Physician Decision|0
909137|NCT01076088|2998338|P5|Overall Study|Physician Decision|1
909138|NCT01076088|2998339|P4|Overall Study|Physician Decision|1
909139|NCT01076088|2998340|P3|Overall Study|Physician Decision|0
909140|NCT01076088|2998341|P2|Overall Study|Physician Decision|3
909141|NCT01076088|2998342|P1|Overall Study|Physician Decision|1
909142|NCT01076088|2998337|P6|Overall Study|Non-compliance with study drug|0
909143|NCT01076088|2998338|P5|Overall Study|Non-compliance with study drug|0
909144|NCT01076088|2998339|P4|Overall Study|Non-compliance with study drug|1
909145|NCT01076088|2998340|P3|Overall Study|Non-compliance with study drug|0
909146|NCT01076088|2998341|P2|Overall Study|Non-compliance with study drug|0
909147|NCT01076088|2998342|P1|Overall Study|Non-compliance with study drug|0
909148|NCT01076088|2998337|P6|Overall Study|Lost to Follow-up|2
909149|NCT01076088|2998338|P5|Overall Study|Lost to Follow-up|1
909150|NCT01076088|2998339|P4|Overall Study|Lost to Follow-up|1
909151|NCT01076088|2998340|P3|Overall Study|Lost to Follow-up|0
909152|NCT01076088|2998341|P2|Overall Study|Lost to Follow-up|1
909153|NCT01076088|2998342|P1|Overall Study|Lost to Follow-up|1
909154|NCT01076088|2998337|P6|Overall Study|Adverse Event|3
909155|NCT01076088|2998338|P5|Overall Study|Adverse Event|3
909156|NCT01076088|2998339|P4|Overall Study|Adverse Event|2
909157|NCT01076088|2998340|P3|Overall Study|Adverse Event|3
909158|NCT01076088|2998341|P2|Overall Study|Adverse Event|6
909159|NCT01076088|2998342|P1|Overall Study|Adverse Event|1
909160|NCT01076075|2998370|P2|Overall Study|Withdrawal by Subject|19
909161|NCT01076075|2998371|P1|Overall Study|Withdrawal by Subject|8
909162|NCT01076075|2998370|P2|Overall Study|Protocol Violation|1
909163|NCT01076075|2998371|P1|Overall Study|Protocol Violation|0
909164|NCT01076075|2998370|P2|Overall Study|other|9
909165|NCT01076075|2998371|P1|Overall Study|other|19
909166|NCT01076075|2998370|P2|Overall Study|Lost to Follow-up|5
909167|NCT01076075|2998371|P1|Overall Study|Lost to Follow-up|6
909168|NCT01076075|2998370|P2|Overall Study|Lack of Efficacy|4
909169|NCT01076075|2998371|P1|Overall Study|Lack of Efficacy|5
909170|NCT01076075|2998370|P2|Overall Study|Adverse Event|9
909171|NCT01076075|2998371|P1|Overall Study|Adverse Event|3
909172|NCT01076036|2998385|P1|Overall Study|Didn't meet inclusion/exclusion criteria|2
909173|NCT01075984|2998395|P5|Follow-up Phase|Treatment failure|4
909174|NCT01075984|2998396|P4|Follow-up Phase|Treatment failure|0
909175|NCT01075984|2998397|P3|Follow-up Phase|Treatment failure|0
909176|NCT01075984|2998398|P2|Follow-up Phase|Treatment failure|0
909177|NCT01075984|2998399|P1|Follow-up Phase|Treatment failure|0
909178|NCT01075984|2998395|P5|Follow-up Phase|Progression of disease|2
909179|NCT01075984|2998396|P4|Follow-up Phase|Progression of disease|0
909180|NCT01075984|2998397|P3|Follow-up Phase|Progression of disease|0
909181|NCT01075984|2998398|P2|Follow-up Phase|Progression of disease|0
909182|NCT01075984|2998399|P1|Follow-up Phase|Progression of disease|0
909183|NCT01075984|2998395|P5|Follow-up Phase|Withdrawal by Subject|10
909184|NCT01075984|2998396|P4|Follow-up Phase|Withdrawal by Subject|0
909185|NCT01075984|2998397|P3|Follow-up Phase|Withdrawal by Subject|0
909186|NCT01075984|2998398|P2|Follow-up Phase|Withdrawal by Subject|0
909187|NCT01075984|2998399|P1|Follow-up Phase|Withdrawal by Subject|0
909188|NCT01075984|2998395|P5|Follow-up Phase|Administrative|1
909189|NCT01075984|2998396|P4|Follow-up Phase|Administrative|0
909190|NCT01075984|2998397|P3|Follow-up Phase|Administrative|0
909191|NCT01075984|2998398|P2|Follow-up Phase|Administrative|0
909192|NCT01075984|2998399|P1|Follow-up Phase|Administrative|0
909193|NCT01075984|2998395|P5|Follow-up Phase|Adverse Event|27
909194|NCT01075984|2998396|P4|Follow-up Phase|Adverse Event|2
909195|NCT01075984|2998397|P3|Follow-up Phase|Adverse Event|0
909196|NCT01075984|2998398|P2|Follow-up Phase|Adverse Event|0
909197|NCT01075984|2998399|P1|Follow-up Phase|Adverse Event|0
909198|NCT01075984|2998395|P5|Follow-up Phase|Protocol Violation|3
909199|NCT01075984|2998396|P4|Follow-up Phase|Protocol Violation|0
909200|NCT01075984|2998397|P3|Follow-up Phase|Protocol Violation|1
909201|NCT01075984|2998398|P2|Follow-up Phase|Protocol Violation|0
909202|NCT01075984|2998399|P1|Follow-up Phase|Protocol Violation|0
909203|NCT01075984|2998395|P5|Treatment Phase|Progression of disease|2
909204|NCT01075984|2998396|P4|Treatment Phase|Progression of disease|0
909205|NCT01075984|2998397|P3|Treatment Phase|Progression of disease|0
909206|NCT01075984|2998398|P2|Treatment Phase|Progression of disease|0
909207|NCT01075984|2998399|P1|Treatment Phase|Progression of disease|0
909208|NCT01075984|2998395|P5|Treatment Phase|Treatment Failure|5
909209|NCT01075984|2998396|P4|Treatment Phase|Treatment Failure|0
909210|NCT01075984|2998397|P3|Treatment Phase|Treatment Failure|1
909211|NCT01075984|2998398|P2|Treatment Phase|Treatment Failure|0
909212|NCT01075984|2998399|P1|Treatment Phase|Treatment Failure|0
909213|NCT01075984|2998395|P5|Treatment Phase|Withdrawal by Subject|15
909214|NCT01075984|2998396|P4|Treatment Phase|Withdrawal by Subject|0
909215|NCT01075984|2998397|P3|Treatment Phase|Withdrawal by Subject|2
909216|NCT01075984|2998398|P2|Treatment Phase|Withdrawal by Subject|0
909217|NCT01075984|2998399|P1|Treatment Phase|Withdrawal by Subject|0
909218|NCT01075984|2998395|P5|Treatment Phase|Protocol Violation|3
909219|NCT01075984|2998396|P4|Treatment Phase|Protocol Violation|0
909220|NCT01075984|2998397|P3|Treatment Phase|Protocol Violation|1
909221|NCT01075984|2998398|P2|Treatment Phase|Protocol Violation|0
909222|NCT01075984|2998399|P1|Treatment Phase|Protocol Violation|0
909223|NCT01075984|2998395|P5|Treatment Phase|Adverse Event|35
909224|NCT01075984|2998396|P4|Treatment Phase|Adverse Event|7
909225|NCT01075984|2998397|P3|Treatment Phase|Adverse Event|3
909226|NCT01075984|2998398|P2|Treatment Phase|Adverse Event|1
909227|NCT01075984|2998399|P1|Treatment Phase|Adverse Event|0
909228|NCT01075958|2998457|P1|Overall Study|Blood sample could not be obtained|44
909229|NCT01075815|2998473|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
909230|NCT01075815|2998474|P1|Overall Study|Withdrawal between OPU - embryo transfer|3
909231|NCT01075815|2998473|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
909232|NCT01075815|2998474|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
909233|NCT01075815|2998473|P2|Overall Study|Withdrawal before r-hCG administration|1
909234|NCT01075815|2998474|P1|Overall Study|Withdrawal before r-hCG administration|6
909235|NCT01075763|2998512|P2|Overall Study|Withdrawal by Subject|2
909236|NCT01075763|2998513|P1|Overall Study|Withdrawal by Subject|2
909237|NCT01075763|2998512|P2|Overall Study|Lack of Efficacy|1
909238|NCT01075763|2998513|P1|Overall Study|Lack of Efficacy|0
909239|NCT01075763|2998512|P2|Overall Study|Lost to Follow-up|1
909240|NCT01075763|2998513|P1|Overall Study|Lost to Follow-up|2
909241|NCT01075685|2998537|P2|Overall Study|Lost to Follow-up|220
909242|NCT01075685|2998538|P1|Overall Study|Lost to Follow-up|563
909243|NCT01075685|2998537|P2|Overall Study|Withdrawal by Subject|5
909244|NCT01075685|2998538|P1|Overall Study|Withdrawal by Subject|20
909245|NCT01075685|2998537|P2|Overall Study|Protocol Violation|1
909246|NCT01075685|2998538|P1|Overall Study|Protocol Violation|9
909247|NCT01075646|2998554|P4|Overall Study|Lost to Follow-up|2
909248|NCT01075646|2998555|P3|Overall Study|Lost to Follow-up|1
909249|NCT01075646|2998556|P2|Overall Study|Lost to Follow-up|3
909250|NCT01075646|2998557|P1|Overall Study|Lost to Follow-up|4
909251|NCT01075412|2998589|P2|Overall Study|Withdrawal by Subject|1
909252|NCT01075412|2998590|P1|Overall Study|Withdrawal by Subject|0
909253|NCT01075282|2998618|P3|Overall Study|Death|2
909254|NCT01075282|2998619|P2|Overall Study|Death|1
909255|NCT01075282|2998620|P1|Overall Study|Death|0
909256|NCT01075282|2998618|P3|Overall Study|Protocol Violation|1
909257|NCT01075282|2998619|P2|Overall Study|Protocol Violation|2
909258|NCT01075282|2998620|P1|Overall Study|Protocol Violation|0
909259|NCT01075282|2998618|P3|Overall Study|Treatment Non-compliance|2
909260|NCT01075282|2998619|P2|Overall Study|Treatment Non-compliance|2
909261|NCT01075282|2998620|P1|Overall Study|Treatment Non-compliance|1
909262|NCT01075282|2998618|P3|Overall Study|Lack of Efficacy|0
909263|NCT01075282|2998619|P2|Overall Study|Lack of Efficacy|1
909264|NCT01075282|2998620|P1|Overall Study|Lack of Efficacy|1
909265|NCT01075282|2998618|P3|Overall Study|Physician Decision|3
909266|NCT01075282|2998619|P2|Overall Study|Physician Decision|3
909267|NCT01075282|2998620|P1|Overall Study|Physician Decision|3
909268|NCT01075282|2998618|P3|Overall Study|Lost to Follow-up|3
909269|NCT01075282|2998619|P2|Overall Study|Lost to Follow-up|3
909270|NCT01075282|2998620|P1|Overall Study|Lost to Follow-up|3
909271|NCT01075282|2998618|P3|Overall Study|Entry Criteria Not Met|0
909272|NCT01075282|2998619|P2|Overall Study|Entry Criteria Not Met|2
909273|NCT01075282|2998620|P1|Overall Study|Entry Criteria Not Met|3
909274|NCT01075282|2998618|P3|Overall Study|Adverse Event|5
909275|NCT01075282|2998619|P2|Overall Study|Adverse Event|8
909276|NCT01075282|2998620|P1|Overall Study|Adverse Event|9
909277|NCT01075282|2998618|P3|Overall Study|Withdrawal by Subject|11
909278|NCT01075282|2998619|P2|Overall Study|Withdrawal by Subject|7
909279|NCT01075282|2998620|P1|Overall Study|Withdrawal by Subject|11
909280|NCT01075256|2998703|P3|Overall Study|Withdrawal by Subject|0
909281|NCT01075256|2998704|P2|Overall Study|Withdrawal by Subject|0
909282|NCT01075256|2998705|P1|Overall Study|Withdrawal by Subject|1
909283|NCT01075243|2998737|P3|Overall Study|Withdrawal by Subject|0
909284|NCT01075243|2998738|P2|Overall Study|Withdrawal by Subject|1
909285|NCT01075243|2998739|P1|Overall Study|Withdrawal by Subject|1
909286|NCT01075243|2998737|P3|Overall Study|Lost to Follow-up|0
909287|NCT01075243|2998738|P2|Overall Study|Lost to Follow-up|2
909288|NCT01075243|2998739|P1|Overall Study|Lost to Follow-up|5
909289|NCT01075217|2998791|P2|Overall Study|Physician Decision|0
909290|NCT01075217|2998792|P1|Overall Study|Physician Decision|1
909291|NCT01075217|2998791|P2|Overall Study|Adverse Event|1
909292|NCT01075217|2998792|P1|Overall Study|Adverse Event|1
909293|NCT01075191|2998825|P1|Overall Study|Unknown Reasons|1
909294|NCT01075191|2998825|P1|Overall Study|Patient's Wish|2
909295|NCT01075191|2998825|P1|Overall Study|Therapy Break|3
909296|NCT01075191|2998825|P1|Overall Study|Noncompliance|3
909297|NCT01075191|2998825|P1|Overall Study|Adverse Event|4
909298|NCT01075191|2998825|P1|Overall Study|Co-morbidities|1
909299|NCT01075191|2998825|P1|Overall Study|Intensification|3
909300|NCT01075191|2998825|P1|Overall Study|Death|1
909301|NCT01075178|2998836|P2|Subject Chart Review|matched partner excluded (reasons above)|3
909302|NCT01075178|2998837|P1|Subject Chart Review|matched partner excluded (reasons above)|6
909303|NCT01075178|2998836|P2|Subject Chart Review|no data collected due to site closure|4
909304|NCT01075178|2998837|P1|Subject Chart Review|no data collected due to site closure|3
909305|NCT01075178|2998836|P2|Subject Chart Review|died before chart review period|2
909306|NCT01075178|2998837|P1|Subject Chart Review|died before chart review period|0
909307|NCT01075178|2998836|P2|Subject Matching|eligible but not matched|403
909308|NCT01075178|2998837|P1|Subject Matching|eligible but not matched|130
909309|NCT01075152|2998851|P2|Overall Study|Withdrawal by Subject|0
909310|NCT01075152|2998852|P1|Overall Study|Withdrawal by Subject|1
909311|NCT01075100|2998878|P2|Overall Study|Other|1
909312|NCT01075100|2998879|P1|Overall Study|Other|3
909313|NCT01075100|2998878|P2|Overall Study|Disease Progression|29
909314|NCT01075100|2998879|P1|Overall Study|Disease Progression|25
909315|NCT01075100|2998878|P2|Overall Study|Investigator Request|1
909316|NCT01075100|2998879|P1|Overall Study|Investigator Request|2
909317|NCT01075100|2998878|P2|Overall Study|Patient Request|4
909318|NCT01075100|2998879|P1|Overall Study|Patient Request|4
909319|NCT01075100|2998878|P2|Overall Study|Adverse Event|18
909320|NCT01075100|2998879|P1|Overall Study|Adverse Event|15
909321|NCT01075074|2998909|P3|Overall Study|Surgeon changed to open incisional case|2
909322|NCT01075074|2998910|P2|Overall Study|Surgeon changed to open incisional case|2
909323|NCT01075074|2998911|P1|Overall Study|Surgeon changed to open incisional case|1
909324|NCT01074944|2998928|P5|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3
909325|NCT01074944|2998929|P4|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
909326|NCT01074944|2998930|P3|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
909327|NCT01074944|2998931|P2|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
909328|NCT01074944|2998932|P1|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
909329|NCT01074944|2998928|P5|Extended Treatment (up to 42 Months)|Pregnancy|2
909330|NCT01074944|2998929|P4|Extended Treatment (up to 42 Months)|Pregnancy|0
909331|NCT01074944|2998930|P3|Extended Treatment (up to 42 Months)|Pregnancy|0
909332|NCT01074944|2998931|P2|Extended Treatment (up to 42 Months)|Pregnancy|0
909333|NCT01074944|2998932|P1|Extended Treatment (up to 42 Months)|Pregnancy|0
909334|NCT01074944|2998928|P5|Long Term Treatment|Withdrawal by Subject|0
909335|NCT01074944|2998929|P4|Long Term Treatment|Withdrawal by Subject|2
909336|NCT01074944|2998930|P3|Long Term Treatment|Withdrawal by Subject|0
909337|NCT01074944|2998931|P2|Long Term Treatment|Withdrawal by Subject|0
909338|NCT01074944|2998932|P1|Long Term Treatment|Withdrawal by Subject|0
909339|NCT01074944|2998928|P5|Long Term Treatment|Entered in Period, But Not Treated|0
909340|NCT01074944|2998929|P4|Long Term Treatment|Entered in Period, But Not Treated|1
909341|NCT01074944|2998930|P3|Long Term Treatment|Entered in Period, But Not Treated|0
909342|NCT01074944|2998931|P2|Long Term Treatment|Entered in Period, But Not Treated|0
909343|NCT01074944|2998932|P1|Long Term Treatment|Entered in Period, But Not Treated|0
909344|NCT01074944|2998928|P5|Long Term Treatment|Transitioned to Commercial Eliglustat|0
909345|NCT01074944|2998929|P4|Long Term Treatment|Transitioned to Commercial Eliglustat|18
909346|NCT01074944|2998930|P3|Long Term Treatment|Transitioned to Commercial Eliglustat|0
909347|NCT01074944|2998931|P2|Long Term Treatment|Transitioned to Commercial Eliglustat|0
909348|NCT01074944|2998932|P1|Long Term Treatment|Transitioned to Commercial Eliglustat|0
909349|NCT01074944|2998928|P5|Long Term Treatment|Lost to Follow-up|0
909350|NCT01074944|2998929|P4|Long Term Treatment|Lost to Follow-up|2
909351|NCT01074944|2998930|P3|Long Term Treatment|Lost to Follow-up|0
909352|NCT01074944|2998931|P2|Long Term Treatment|Lost to Follow-up|0
909353|NCT01074944|2998932|P1|Long Term Treatment|Lost to Follow-up|0
909354|NCT01074944|2998928|P5|Long Term Treatment|Adverse Event|0
909355|NCT01074944|2998929|P4|Long Term Treatment|Adverse Event|3
909356|NCT01074944|2998930|P3|Long Term Treatment|Adverse Event|0
909357|NCT01074944|2998931|P2|Long Term Treatment|Adverse Event|0
909358|NCT01074944|2998932|P1|Long Term Treatment|Adverse Event|0
909359|NCT01074944|2998928|P5|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
909360|NCT01074944|2998929|P4|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
909361|NCT01074944|2998930|P3|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
909362|NCT01074944|2998931|P2|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
909363|NCT01074944|2998932|P1|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
909364|NCT01074944|2998928|P5|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
909365|NCT01074944|2998929|P4|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
909366|NCT01074944|2998930|P3|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
909367|NCT01074944|2998931|P2|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1
909368|NCT01074944|2998932|P1|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
909369|NCT01074944|2998928|P5|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
909370|NCT01074944|2998929|P4|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
909371|NCT01074944|2998930|P3|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
909372|NCT01074944|2998931|P2|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
909373|NCT01074944|2998932|P1|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
909374|NCT01074944|2998928|P5|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
909375|NCT01074944|2998929|P4|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
909376|NCT01074944|2998930|P3|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1
909377|NCT01074944|2998931|P2|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6
909378|NCT01074944|2998932|P1|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
909379|NCT01074944|2998928|P5|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
909380|NCT01074944|2998929|P4|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
909381|NCT01074944|2998930|P3|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3
909382|NCT01074944|2998931|P2|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2
909383|NCT01074944|2998932|P1|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
909384|NCT01074944|2998928|P5|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
909385|NCT01074944|2998929|P4|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
909386|NCT01074944|2998930|P3|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
909387|NCT01074944|2998931|P2|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
909388|NCT01074944|2998932|P1|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6
909389|NCT01074944|2998928|P5|Lead-in Period (up to 78 Weeks)|Pregnancy|0
909390|NCT01074944|2998929|P4|Lead-in Period (up to 78 Weeks)|Pregnancy|0
909391|NCT01074944|2998930|P3|Lead-in Period (up to 78 Weeks)|Pregnancy|0
909392|NCT01074944|2998931|P2|Lead-in Period (up to 78 Weeks)|Pregnancy|0
909393|NCT01074944|2998932|P1|Lead-in Period (up to 78 Weeks)|Pregnancy|4
909394|NCT01074944|2998928|P5|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
909395|NCT01074944|2998929|P4|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
909396|NCT01074944|2998930|P3|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
909397|NCT01074944|2998931|P2|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
909398|NCT01074944|2998932|P1|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1
909399|NCT01074944|2998928|P5|Lead-in Period (up to 78 Weeks)|Adverse Event|0
909400|NCT01074944|2998929|P4|Lead-in Period (up to 78 Weeks)|Adverse Event|0
909401|NCT01074944|2998930|P3|Lead-in Period (up to 78 Weeks)|Adverse Event|0
909402|NCT01074944|2998931|P2|Lead-in Period (up to 78 Weeks)|Adverse Event|0
909403|NCT01074944|2998932|P1|Lead-in Period (up to 78 Weeks)|Adverse Event|2
909404|NCT01074931|2998986|P1|Overall Study|Death|5
909405|NCT01074931|2998986|P1|Overall Study|Economic reasons|1
909406|NCT01074658|2998998|P1|Overall Study|No implant attempted|19
909407|NCT01074554|2999006|P2|Overall Study|Lost to Follow-up|1
909408|NCT01074554|2999007|P1|Overall Study|Lost to Follow-up|0
909409|NCT01074554|2999006|P2|Overall Study|Adverse Event|3
909410|NCT01074554|2999007|P1|Overall Study|Adverse Event|3
909411|NCT01074502|2999017|P1|Overall Study|Withdrawal by Subject|1
909412|NCT01074450|2999041|P2|Second Intervention|Physician Decision|1
909413|NCT01074450|2999042|P1|Second Intervention|Physician Decision|0
909414|NCT01074450|2999041|P2|Second Intervention|Protocol Violation|0
909415|NCT01074450|2999042|P1|Second Intervention|Protocol Violation|1
909416|NCT01074450|2999041|P2|First Intervention|Emesis in Dosing Interval|2
909417|NCT01074450|2999042|P1|First Intervention|Emesis in Dosing Interval|0
909418|NCT01074307|2999071|P2|Overall Study|Protocol Violation|5
909419|NCT01074307|2999072|P1|Overall Study|Protocol Violation|8
909420|NCT01074307|2999071|P2|Overall Study|Exclusion criterion|1
909421|NCT01074307|2999072|P1|Overall Study|Exclusion criterion|0
909422|NCT01074307|2999071|P2|Overall Study|No primary endpoint evaluation|6
909423|NCT01074307|2999072|P1|Overall Study|No primary endpoint evaluation|14
909424|NCT01074268|2999094|P2|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2
909425|NCT01074268|2999095|P1|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3
909426|NCT01074268|2999094|P2|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
909427|NCT01074268|2999095|P1|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
909428|NCT01074268|2999094|P2|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2
909429|NCT01074268|2999095|P1|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0
909430|NCT01074268|2999094|P2|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
909431|NCT01074268|2999095|P1|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
909432|NCT01074268|2999094|P2|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5
909433|NCT01074268|2999095|P1|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8
909434|NCT01074268|2999094|P2|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3
909435|NCT01074268|2999095|P1|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6
909436|NCT01074268|2999094|P2|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4
909437|NCT01074268|2999095|P1|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3
909438|NCT01074268|2999094|P2|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2
909439|NCT01074268|2999095|P1|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0
909440|NCT01074268|2999094|P2|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1
909441|NCT01074268|2999095|P1|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3
909442|NCT01074255|2999121|P1|Overall Study|Did not receive EMEND|2
909443|NCT01074242|2999125|P1|Overall Study|Duplicate Case Report Form|5
909444|NCT01074242|2999125|P1|Overall Study|Violation of vaccine dose or dosage|351
909445|NCT01074242|2999125|P1|Overall Study|Case report unclear|6
909446|NCT01074242|2999125|P1|Overall Study|Lost to Follow-up|1
909447|NCT01074242|2999125|P1|Overall Study|Case report before date of contract|40
909448|NCT01074229|2999133|P3|Overall Study|Change to open surgical procedure|4
909449|NCT01074229|2999134|P2|Overall Study|Change to open surgical procedure|3
909450|NCT01074229|2999135|P1|Overall Study|Change to open surgical procedure|1
909451|NCT01074229|2999133|P3|Overall Study|Lost to Follow-up|0
909452|NCT01074229|2999134|P2|Overall Study|Lost to Follow-up|0
909453|NCT01074229|2999135|P1|Overall Study|Lost to Follow-up|1
909454|NCT01074216|2999146|P1|Overall Study|Not Treated|12
909455|NCT01074216|2999146|P1|Overall Study|Physician Decision|1
909456|NCT01074047|2999210|P2|Extension Phase|Death|0
909457|NCT01074047|2999211|P1|Extension Phase|Death|5
909458|NCT01074047|2999210|P2|Extension Phase|Withdrawal by Subject|0
909459|NCT01074047|2999211|P1|Extension Phase|Withdrawal by Subject|2
909460|NCT01074047|2999210|P2|Extension Phase|Disease Progression|0
909461|NCT01074047|2999211|P1|Extension Phase|Disease Progression|9
909462|NCT01074047|2999210|P2|Extension Phase|Adverse Event|0
909463|NCT01074047|2999211|P1|Extension Phase|Adverse Event|5
909464|NCT01074047|2999210|P2|Extension Phase|Physician Decision|0
909465|NCT01074047|2999211|P1|Extension Phase|Physician Decision|1
909466|NCT01074047|2999210|P2|Survival Follow-Up Phase|Alive at study closure|3
909467|NCT01074047|2999211|P1|Survival Follow-Up Phase|Alive at study closure|1
909468|NCT01074047|2999210|P2|Survival Follow-Up Phase|Death|124
909469|NCT01074047|2999211|P1|Survival Follow-Up Phase|Death|116
909470|NCT01074047|2999210|P2|Survival Follow-Up Phase|Lost to Follow-up|1
909471|NCT01074047|2999211|P1|Survival Follow-Up Phase|Lost to Follow-up|2
909472|NCT01074047|2999210|P2|Survival Follow-Up Phase|Withdrawal by Subject|8
909473|NCT01074047|2999211|P1|Survival Follow-Up Phase|Withdrawal by Subject|5
909474|NCT01074047|2999210|P2|Treatment Phase|Miscellaneous|39
909475|NCT01074047|2999211|P1|Treatment Phase|Miscellaneous|32
909476|NCT01074047|2999210|P2|Treatment Phase|Protocol Violation|1
909477|NCT01074047|2999211|P1|Treatment Phase|Protocol Violation|0
909478|NCT01074047|2999210|P2|Treatment Phase|Lost to Follow-up|1
909479|NCT01074047|2999211|P1|Treatment Phase|Lost to Follow-up|0
909480|NCT01074047|2999210|P2|Treatment Phase|Death|58
909481|NCT01074047|2999211|P1|Treatment Phase|Death|53
909482|NCT01074047|2999210|P2|Treatment Phase|Withdrawal by Subject|48
909483|NCT01074047|2999211|P1|Treatment Phase|Withdrawal by Subject|27
909484|NCT01074047|2999210|P2|Treatment Phase|Disease Progression|21
909485|NCT01074047|2999211|P1|Treatment Phase|Disease Progression|16
909486|NCT01074047|2999210|P2|Treatment Phase|Adverse Event|66
909487|NCT01074047|2999211|P1|Treatment Phase|Adverse Event|89
909488|NCT01074008|2999299|P9|Overall Study|Lost to Follow-up|4
909489|NCT01074008|2999300|P8|Overall Study|Lost to Follow-up|0
909490|NCT01074008|2999301|P7|Overall Study|Lost to Follow-up|1
909491|NCT01074008|2999302|P6|Overall Study|Lost to Follow-up|0
909492|NCT01074008|2999303|P5|Overall Study|Lost to Follow-up|1
909493|NCT01074008|2999304|P4|Overall Study|Lost to Follow-up|1
909494|NCT01074008|2999305|P3|Overall Study|Lost to Follow-up|1
909495|NCT01074008|2999306|P2|Overall Study|Lost to Follow-up|1
909496|NCT01074008|2999307|P1|Overall Study|Lost to Follow-up|0
909497|NCT01074008|2999299|P9|Overall Study|Withdrawal by Subject|0
909498|NCT01074008|2999300|P8|Overall Study|Withdrawal by Subject|0
909499|NCT01074008|2999301|P7|Overall Study|Withdrawal by Subject|0
909500|NCT01074008|2999302|P6|Overall Study|Withdrawal by Subject|0
909501|NCT01074008|2999303|P5|Overall Study|Withdrawal by Subject|1
909502|NCT01074008|2999304|P4|Overall Study|Withdrawal by Subject|0
909503|NCT01074008|2999305|P3|Overall Study|Withdrawal by Subject|1
909504|NCT01074008|2999306|P2|Overall Study|Withdrawal by Subject|1
909505|NCT01074008|2999307|P1|Overall Study|Withdrawal by Subject|1
909506|NCT01074008|2999299|P9|Overall Study|Adverse Event|0
909507|NCT01074008|2999300|P8|Overall Study|Adverse Event|0
909508|NCT01074008|2999301|P7|Overall Study|Adverse Event|0
909509|NCT01074008|2999302|P6|Overall Study|Adverse Event|0
909510|NCT01074008|2999303|P5|Overall Study|Adverse Event|0
909511|NCT01074008|2999304|P4|Overall Study|Adverse Event|0
909512|NCT01074008|2999305|P3|Overall Study|Adverse Event|0
909513|NCT01074008|2999306|P2|Overall Study|Adverse Event|1
909514|NCT01074008|2999307|P1|Overall Study|Adverse Event|0
909515|NCT01073943|2999417|P2|Overall Study|Could not tolerate prep|0
909516|NCT01073943|2999418|P1|Overall Study|Could not tolerate prep|1
909517|NCT01073943|2999417|P2|Overall Study|Unable to return for follow-up|1
909518|NCT01073943|2999418|P1|Overall Study|Unable to return for follow-up|0
909519|NCT01073943|2999417|P2|Overall Study|Subject forgot|1
909520|NCT01073943|2999418|P1|Overall Study|Subject forgot|0
909521|NCT01073943|2999417|P2|Overall Study|Power outage; colonoscopy not done|0
909522|NCT01073943|2999418|P1|Overall Study|Power outage; colonoscopy not done|1
909523|NCT01073943|2999417|P2|Overall Study|Lost to Follow-up|2
909524|NCT01073943|2999418|P1|Overall Study|Lost to Follow-up|0
909525|NCT01073943|2999417|P2|Overall Study|Adverse Event|1
909526|NCT01073943|2999418|P1|Overall Study|Adverse Event|1
909527|NCT01073943|2999417|P2|Overall Study|Protocol Violation|1
909528|NCT01073943|2999418|P1|Overall Study|Protocol Violation|2
909529|NCT01073943|2999417|P2|Overall Study|Withdrawal by Subject|2
909530|NCT01073943|2999418|P1|Overall Study|Withdrawal by Subject|8
909531|NCT01073930|2999444|P2|Overall Study|Inadequate prep; unable to do procedure|1
909532|NCT01073930|2999445|P1|Overall Study|Inadequate prep; unable to do procedure|0
909533|NCT01073930|2999444|P2|Overall Study|Noncompliance with study drug|1
909534|NCT01073930|2999445|P1|Overall Study|Noncompliance with study drug|0
909535|NCT01073930|2999444|P2|Overall Study|Adverse Event|1
909536|NCT01073930|2999445|P1|Overall Study|Adverse Event|0
909537|NCT01073930|2999444|P2|Overall Study|Lost to Follow-up|1
909538|NCT01073930|2999445|P1|Overall Study|Lost to Follow-up|0
909539|NCT01073930|2999444|P2|Overall Study|Withdrawal by Subject|2
909540|NCT01073930|2999445|P1|Overall Study|Withdrawal by Subject|3
909541|NCT01073865|2999469|P2|Overall Study|Withdrawal by Subject|5
909542|NCT01073865|2999470|P1|Overall Study|Withdrawal by Subject|5
909543|NCT01073865|2999469|P2|Overall Study|Death|2
909544|NCT01073865|2999470|P1|Overall Study|Death|3
909545|NCT01073865|2999469|P2|Overall Study|Lost to Follow-up|1
909546|NCT01073865|2999470|P1|Overall Study|Lost to Follow-up|1
909547|NCT01073865|2999469|P2|Overall Study|Reasons other than below|31
909548|NCT01073865|2999470|P1|Overall Study|Reasons other than below|19
909549|NCT01073631|2999489|P1|Overall Study|Other|63
909550|NCT01073631|2999489|P1|Overall Study|Adverse Event|24
909551|NCT01073631|2999489|P1|Overall Study|Death|82
909552|NCT01073618|2999494|P1|Overall Study|Other|80
909553|NCT01073618|2999494|P1|Overall Study|Adverse Event|19
909554|NCT01073618|2999494|P1|Overall Study|Death|208
909555|NCT01073605|2999502|P3|Overall Study|Randomized But Not Treated|1
909556|NCT01073605|2999503|P2|Overall Study|Randomized But Not Treated|1
909557|NCT01073605|2999504|P1|Overall Study|Randomized But Not Treated|0
909558|NCT01073605|2999502|P3|Overall Study|Withdrawal by Subject|22
909559|NCT01073605|2999503|P2|Overall Study|Withdrawal by Subject|39
909560|NCT01073605|2999504|P1|Overall Study|Withdrawal by Subject|31
909561|NCT01073605|2999502|P3|Overall Study|Other|29
909562|NCT01073605|2999503|P2|Overall Study|Other|21
909563|NCT01073605|2999504|P1|Overall Study|Other|25
909564|NCT01073605|2999502|P3|Overall Study|Lost to Follow-up|9
909565|NCT01073605|2999503|P2|Overall Study|Lost to Follow-up|4
909566|NCT01073605|2999504|P1|Overall Study|Lost to Follow-up|3
909567|NCT01073605|2999502|P3|Overall Study|Adverse Event|0
909568|NCT01073605|2999503|P2|Overall Study|Adverse Event|1
909569|NCT01073605|2999504|P1|Overall Study|Adverse Event|2
909570|NCT01073605|2999502|P3|Overall Study|Ongoing at Cutoff Date|0
909571|NCT01073605|2999503|P2|Overall Study|Ongoing at Cutoff Date|1
909572|NCT01073605|2999504|P1|Overall Study|Ongoing at Cutoff Date|1
909573|NCT01073566|2999550|P2|Period 2 (6 Weeks)|Adverse Event|0
909574|NCT01073566|2999551|P1|Period 2 (6 Weeks)|Adverse Event|1
909575|NCT01073462|2999563|P1|Overall Study|Lost to Follow-up|7
909576|NCT01073462|2999563|P1|Overall Study|Serious adverse event|2
909577|NCT01073462|2999563|P1|Overall Study|Low parathyroid hormone levels|8
909578|NCT01073462|2999563|P1|Overall Study|Kidney transplant|10
909579|NCT01073462|2999563|P1|Overall Study|Death|14
909580|NCT01073293|2999582|P2|Overall Study|Withdrawal by Subject|10
909581|NCT01073293|2999583|P1|Overall Study|Withdrawal by Subject|5
909582|NCT01073293|2999582|P2|Overall Study|Lost to Follow-up|1
909583|NCT01073293|2999583|P1|Overall Study|Lost to Follow-up|0
909584|NCT01073267|2999605|P1|Overall Study|Disease Progression|3
909585|NCT01073163|2999609|P1|Overall Study|Early termination|1
909586|NCT01073163|2999609|P1|Overall Study|Disease Progression|1
909587|NCT01073163|2999609|P1|Overall Study|Adverse Event|1
909588|NCT01072929|2999632|P3|Overall Study|Not specified|0
909589|NCT01072929|2999633|P2|Overall Study|Not specified|3
909590|NCT01072929|2999634|P1|Overall Study|Not specified|0
909591|NCT01072929|2999632|P3|Overall Study|Noncompliance with study procedures|1
909592|NCT01072929|2999633|P2|Overall Study|Noncompliance with study procedures|0
909593|NCT01072929|2999634|P1|Overall Study|Noncompliance with study procedures|1
909594|NCT01072929|2999632|P3|Overall Study|Noncompliance with study medication|0
909595|NCT01072929|2999633|P2|Overall Study|Noncompliance with study medication|3
909596|NCT01072929|2999634|P1|Overall Study|Noncompliance with study medication|0
909597|NCT01072929|2999632|P3|Overall Study|Lost to Follow-up|1
909598|NCT01072929|2999633|P2|Overall Study|Lost to Follow-up|4
909599|NCT01072929|2999634|P1|Overall Study|Lost to Follow-up|8
909600|NCT01072929|2999632|P3|Overall Study|Protocol Violation|2
909601|NCT01072929|2999633|P2|Overall Study|Protocol Violation|11
909602|NCT01072929|2999634|P1|Overall Study|Protocol Violation|13
909603|NCT01072929|2999632|P3|Overall Study|Withdrawal by Subject|3
909604|NCT01072929|2999633|P2|Overall Study|Withdrawal by Subject|15
909605|NCT01072929|2999634|P1|Overall Study|Withdrawal by Subject|7
909606|NCT01072929|2999632|P3|Overall Study|Lack of Efficacy|0
909607|NCT01072929|2999633|P2|Overall Study|Lack of Efficacy|4
909608|NCT01072929|2999634|P1|Overall Study|Lack of Efficacy|7
909609|NCT01072929|2999632|P3|Overall Study|Adverse Event|2
909610|NCT01072929|2999633|P2|Overall Study|Adverse Event|11
909611|NCT01072929|2999634|P1|Overall Study|Adverse Event|8
909612|NCT01072877|2999713|P5|Overall Study|Lost to Follow-up|0
909613|NCT01072877|2999714|P4|Overall Study|Lost to Follow-up|2
909614|NCT01072877|2999715|P3|Overall Study|Lost to Follow-up|0
909615|NCT01072877|2999716|P2|Overall Study|Lost to Follow-up|1
909616|NCT01072877|2999717|P1|Overall Study|Lost to Follow-up|1
909617|NCT01072630|2999780|P3|Overall Study|Not specified|1
909618|NCT01072630|2999781|P2|Overall Study|Not specified|2
909619|NCT01072630|2999782|P1|Overall Study|Not specified|3
909620|NCT01072630|2999780|P3|Overall Study|Noncompliance with study procedures|1
909621|NCT01072630|2999781|P2|Overall Study|Noncompliance with study procedures|2
909622|NCT01072630|2999782|P1|Overall Study|Noncompliance with study procedures|1
909623|NCT01072630|2999780|P3|Overall Study|Noncompliance with study medication|1
909624|NCT01072630|2999781|P2|Overall Study|Noncompliance with study medication|1
909625|NCT01072630|2999782|P1|Overall Study|Noncompliance with study medication|1
909626|NCT01072630|2999780|P3|Overall Study|Lost to Follow-up|1
909627|NCT01072630|2999781|P2|Overall Study|Lost to Follow-up|11
909628|NCT01072630|2999782|P1|Overall Study|Lost to Follow-up|11
909629|NCT01072630|2999780|P3|Overall Study|Protocol Violation|4
909630|NCT01072630|2999781|P2|Overall Study|Protocol Violation|8
909631|NCT01072630|2999782|P1|Overall Study|Protocol Violation|10
909632|NCT01072630|2999780|P3|Overall Study|Withdrawal by Subject|2
909633|NCT01072630|2999781|P2|Overall Study|Withdrawal by Subject|7
909634|NCT01072630|2999782|P1|Overall Study|Withdrawal by Subject|8
909635|NCT01072630|2999780|P3|Overall Study|Lack of Efficacy|1
909636|NCT01072630|2999781|P2|Overall Study|Lack of Efficacy|10
909637|NCT01072630|2999782|P1|Overall Study|Lack of Efficacy|10
909638|NCT01072630|2999780|P3|Overall Study|Adverse Event|2
909639|NCT01072630|2999781|P2|Overall Study|Adverse Event|19
909640|NCT01072630|2999782|P1|Overall Study|Adverse Event|11
909641|NCT01072539|2999863|P1|Overall Study|Protocol Violation|2
909642|NCT01072539|2999863|P1|Overall Study|Treated prior to the Site Initiation|1
909643|NCT01072500|2999887|P2|Overall Study|Withdrawal by Subject|10
909644|NCT01072500|2999888|P1|Overall Study|Withdrawal by Subject|17
909645|NCT01072500|2999887|P2|Overall Study|Lost to Follow-up|2
909646|NCT01072500|2999888|P1|Overall Study|Lost to Follow-up|5
909647|NCT01072500|2999887|P2|Overall Study|Death|2
909648|NCT01072500|2999888|P1|Overall Study|Death|2
909649|NCT01072448|2999898|P2|Overall Study|Death|2
909650|NCT01072448|2999899|P1|Overall Study|Death|0
909651|NCT01072448|2999898|P2|Overall Study|Abnormal laboratory value(s)|1
909652|NCT01072448|2999899|P1|Overall Study|Abnormal laboratory value(s)|0
909653|NCT01072448|2999898|P2|Overall Study|Lost to Follow-up|1
909654|NCT01072448|2999899|P1|Overall Study|Lost to Follow-up|1
909655|NCT01072448|2999898|P2|Overall Study|Unsatisfactory therapeutic effect|3
909656|NCT01072448|2999899|P1|Overall Study|Unsatisfactory therapeutic effect|1
909657|NCT01072448|2999898|P2|Overall Study|Abnormal test procedure result(s)|0
909658|NCT01072448|2999899|P1|Overall Study|Abnormal test procedure result(s)|1
909659|NCT01072448|2999898|P2|Overall Study|Protocol deviation|4
909660|NCT01072448|2999899|P1|Overall Study|Protocol deviation|3
909661|NCT01072448|2999898|P2|Overall Study|Subject withdrew consent|9
909662|NCT01072448|2999899|P1|Overall Study|Subject withdrew consent|4
909663|NCT01072448|2999898|P2|Overall Study|Adverse Event|10
909664|NCT01072448|2999899|P1|Overall Study|Adverse Event|9
909665|NCT01072396|2999913|P2|Period Two|Lost to Follow-up|0
909666|NCT01072396|2999914|P1|Period Two|Lost to Follow-up|1
909667|NCT01072396|2999913|P2|Period Two|Adverse Event|3
909668|NCT01072396|2999914|P1|Period Two|Adverse Event|0
909669|NCT01072396|2999913|P2|Washout Period|Missing termination information|1
909670|NCT01072396|2999914|P1|Washout Period|Missing termination information|0
909671|NCT01072396|2999913|P2|Period One|Withdrawal by Subject|0
909672|NCT01072396|2999914|P1|Period One|Withdrawal by Subject|2
909673|NCT01072396|2999913|P2|Period One|Protocol Violation|1
909674|NCT01072396|2999914|P1|Period One|Protocol Violation|2
909675|NCT01072396|2999913|P2|Period One|Adverse Event|1
909676|NCT01072396|2999914|P1|Period One|Adverse Event|1
909677|NCT01072357|2999926|P2|Overall Study|Lost to Follow-up|1
909678|NCT01072357|2999927|P1|Overall Study|Lost to Follow-up|0
909679|NCT01072344|2999937|P2|Overall Study|Lost to Follow-up|4
909680|NCT01072344|2999938|P1|Overall Study|Lost to Follow-up|3
909681|NCT01072344|2999937|P2|Overall Study|Protocol Violation|2
909682|NCT01072344|2999938|P1|Overall Study|Protocol Violation|1
909683|NCT01072344|2999937|P2|Overall Study|Relasped-reached end point|12
909684|NCT01072344|2999938|P1|Overall Study|Relasped-reached end point|7
909685|NCT01072201|2999976|P2|Overall Study|Lost to Follow-up|1
909686|NCT01072201|2999977|P1|Overall Study|Lost to Follow-up|0
909687|NCT01072175|3000010|P13|Part D (HPMC Capsules)|Ongoing|34
909688|NCT01072175|3000011|P12|Part D (HPMC Capsules)|Ongoing|34
909689|NCT01072175|3000012|P11|Part D (HPMC Capsules)|Ongoing|12
909690|NCT01072175|3000013|P10|Part D (HPMC Capsules)|Ongoing|10
909691|NCT01072175|3000014|P9|Part D (HPMC Capsules)|Ongoing|0
909692|NCT01072175|3000015|P8|Part D (HPMC Capsules)|Ongoing|0
909693|NCT01072175|3000016|P7|Part D (HPMC Capsules)|Ongoing|0
909694|NCT01072175|3000017|P6|Part D (HPMC Capsules)|Ongoing|0
909695|NCT01072175|3000018|P5|Part D (HPMC Capsules)|Ongoing|0
909696|NCT01072175|3000019|P4|Part D (HPMC Capsules)|Ongoing|0
909697|NCT01072175|3000020|P3|Part D (HPMC Capsules)|Ongoing|0
909698|NCT01072175|3000021|P2|Part D (HPMC Capsules)|Ongoing|0
909699|NCT01072175|3000022|P1|Part D (HPMC Capsules)|Ongoing|0
909700|NCT01072175|3000010|P13|Part D (HPMC Capsules)|Death|5
909701|NCT01072175|3000011|P12|Part D (HPMC Capsules)|Death|6
909702|NCT01072175|3000012|P11|Part D (HPMC Capsules)|Death|4
909703|NCT01072175|3000013|P10|Part D (HPMC Capsules)|Death|2
909704|NCT01072175|3000014|P9|Part D (HPMC Capsules)|Death|0
909705|NCT01072175|3000015|P8|Part D (HPMC Capsules)|Death|0
909706|NCT01072175|3000016|P7|Part D (HPMC Capsules)|Death|0
909707|NCT01072175|3000017|P6|Part D (HPMC Capsules)|Death|0
909708|NCT01072175|3000018|P5|Part D (HPMC Capsules)|Death|0
909709|NCT01072175|3000019|P4|Part D (HPMC Capsules)|Death|0
909710|NCT01072175|3000020|P3|Part D (HPMC Capsules)|Death|0
909711|NCT01072175|3000021|P2|Part D (HPMC Capsules)|Death|0
909712|NCT01072175|3000022|P1|Part D (HPMC Capsules)|Death|0
909713|NCT01072175|3000010|P13|Part D (HPMC Capsules)|Withdrawal by Subject|0
909714|NCT01072175|3000011|P12|Part D (HPMC Capsules)|Withdrawal by Subject|1
909715|NCT01072175|3000012|P11|Part D (HPMC Capsules)|Withdrawal by Subject|0
909716|NCT01072175|3000013|P10|Part D (HPMC Capsules)|Withdrawal by Subject|0
909717|NCT01072175|3000014|P9|Part D (HPMC Capsules)|Withdrawal by Subject|0
909718|NCT01072175|3000015|P8|Part D (HPMC Capsules)|Withdrawal by Subject|0
909719|NCT01072175|3000016|P7|Part D (HPMC Capsules)|Withdrawal by Subject|0
909720|NCT01072175|3000017|P6|Part D (HPMC Capsules)|Withdrawal by Subject|0
909721|NCT01072175|3000018|P5|Part D (HPMC Capsules)|Withdrawal by Subject|0
909722|NCT01072175|3000019|P4|Part D (HPMC Capsules)|Withdrawal by Subject|0
909723|NCT01072175|3000020|P3|Part D (HPMC Capsules)|Withdrawal by Subject|0
909724|NCT01072175|3000021|P2|Part D (HPMC Capsules)|Withdrawal by Subject|0
909725|NCT01072175|3000022|P1|Part D (HPMC Capsules)|Withdrawal by Subject|0
909726|NCT01072175|3000010|P13|Part D (HPMC Capsules)|Lost to Follow-up|0
909727|NCT01072175|3000011|P12|Part D (HPMC Capsules)|Lost to Follow-up|2
909728|NCT01072175|3000012|P11|Part D (HPMC Capsules)|Lost to Follow-up|0
909729|NCT01072175|3000013|P10|Part D (HPMC Capsules)|Lost to Follow-up|0
909730|NCT01072175|3000014|P9|Part D (HPMC Capsules)|Lost to Follow-up|0
909731|NCT01072175|3000015|P8|Part D (HPMC Capsules)|Lost to Follow-up|0
909732|NCT01072175|3000016|P7|Part D (HPMC Capsules)|Lost to Follow-up|0
909733|NCT01072175|3000017|P6|Part D (HPMC Capsules)|Lost to Follow-up|0
909734|NCT01072175|3000018|P5|Part D (HPMC Capsules)|Lost to Follow-up|0
909735|NCT01072175|3000019|P4|Part D (HPMC Capsules)|Lost to Follow-up|0
909736|NCT01072175|3000020|P3|Part D (HPMC Capsules)|Lost to Follow-up|0
909737|NCT01072175|3000021|P2|Part D (HPMC Capsules)|Lost to Follow-up|0
909738|NCT01072175|3000022|P1|Part D (HPMC Capsules)|Lost to Follow-up|0
909739|NCT01072175|3000010|P13|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
909740|NCT01072175|3000011|P12|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
909741|NCT01072175|3000012|P11|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
909742|NCT01072175|3000013|P10|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
909743|NCT01072175|3000014|P9|Part C (Phase II: Crossover Phase [CP])|Ongoing|28
909744|NCT01072175|3000015|P8|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
909745|NCT01072175|3000016|P7|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
909746|NCT01072175|3000017|P6|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
909747|NCT01072175|3000018|P5|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
909748|NCT01072175|3000019|P4|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
909749|NCT01072175|3000020|P3|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
909750|NCT01072175|3000021|P2|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
909751|NCT01072175|3000022|P1|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
909752|NCT01072175|3000010|P13|Part C (Phase II: Crossover Phase [CP])|Death|0
909753|NCT01072175|3000011|P12|Part C (Phase II: Crossover Phase [CP])|Death|0
909754|NCT01072175|3000012|P11|Part C (Phase II: Crossover Phase [CP])|Death|0
909755|NCT01072175|3000013|P10|Part C (Phase II: Crossover Phase [CP])|Death|0
909756|NCT01072175|3000014|P9|Part C (Phase II: Crossover Phase [CP])|Death|15
909757|NCT01072175|3000015|P8|Part C (Phase II: Crossover Phase [CP])|Death|0
909758|NCT01072175|3000016|P7|Part C (Phase II: Crossover Phase [CP])|Death|0
909759|NCT01072175|3000017|P6|Part C (Phase II: Crossover Phase [CP])|Death|0
909760|NCT01072175|3000018|P5|Part C (Phase II: Crossover Phase [CP])|Death|0
909761|NCT01072175|3000019|P4|Part C (Phase II: Crossover Phase [CP])|Death|0
909762|NCT01072175|3000020|P3|Part C (Phase II: Crossover Phase [CP])|Death|0
909763|NCT01072175|3000021|P2|Part C (Phase II: Crossover Phase [CP])|Death|0
909764|NCT01072175|3000022|P1|Part C (Phase II: Crossover Phase [CP])|Death|0
909765|NCT01072175|3000010|P13|Part C (Phase II: Randomized Phase)|Ongoing|0
909766|NCT01072175|3000011|P12|Part C (Phase II: Randomized Phase)|Ongoing|0
909767|NCT01072175|3000012|P11|Part C (Phase II: Randomized Phase)|Ongoing|0
909768|NCT01072175|3000013|P10|Part C (Phase II: Randomized Phase)|Ongoing|0
909769|NCT01072175|3000014|P9|Part C (Phase II: Randomized Phase)|Ongoing|0
909770|NCT01072175|3000015|P8|Part C (Phase II: Randomized Phase)|Ongoing|40
909771|NCT01072175|3000016|P7|Part C (Phase II: Randomized Phase)|Ongoing|32
909772|NCT01072175|3000017|P6|Part C (Phase II: Randomized Phase)|Ongoing|35
909773|NCT01072175|3000018|P5|Part C (Phase II: Randomized Phase)|Ongoing|0
909774|NCT01072175|3000019|P4|Part C (Phase II: Randomized Phase)|Ongoing|0
909775|NCT01072175|3000020|P3|Part C (Phase II: Randomized Phase)|Ongoing|0
909776|NCT01072175|3000021|P2|Part C (Phase II: Randomized Phase)|Ongoing|0
909777|NCT01072175|3000022|P1|Part C (Phase II: Randomized Phase)|Ongoing|0
909778|NCT01072175|3000010|P13|Part C (Phase II: Randomized Phase)|Death|0
909779|NCT01072175|3000011|P12|Part C (Phase II: Randomized Phase)|Death|0
909780|NCT01072175|3000012|P11|Part C (Phase II: Randomized Phase)|Death|0
909781|NCT01072175|3000013|P10|Part C (Phase II: Randomized Phase)|Death|0
909782|NCT01072175|3000014|P9|Part C (Phase II: Randomized Phase)|Death|0
909783|NCT01072175|3000015|P8|Part C (Phase II: Randomized Phase)|Death|14
909784|NCT01072175|3000016|P7|Part C (Phase II: Randomized Phase)|Death|18
909785|NCT01072175|3000017|P6|Part C (Phase II: Randomized Phase)|Death|19
909786|NCT01072175|3000018|P5|Part C (Phase II: Randomized Phase)|Death|0
909787|NCT01072175|3000019|P4|Part C (Phase II: Randomized Phase)|Death|0
909788|NCT01072175|3000020|P3|Part C (Phase II: Randomized Phase)|Death|0
909789|NCT01072175|3000021|P2|Part C (Phase II: Randomized Phase)|Death|0
909790|NCT01072175|3000022|P1|Part C (Phase II: Randomized Phase)|Death|0
909791|NCT01072175|3000010|P13|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
909792|NCT01072175|3000011|P12|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
909793|NCT01072175|3000012|P11|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
909794|NCT01072175|3000013|P10|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
909795|NCT01072175|3000014|P9|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
909796|NCT01072175|3000015|P8|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
909797|NCT01072175|3000016|P7|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|4
909798|NCT01072175|3000017|P6|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
909799|NCT01072175|3000018|P5|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
909800|NCT01072175|3000019|P4|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
909801|NCT01072175|3000020|P3|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
909802|NCT01072175|3000021|P2|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
909803|NCT01072175|3000022|P1|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
909804|NCT01072175|3000010|P13|Part B (Dose Escalation and Expansion)|Ongoing|0
909805|NCT01072175|3000011|P12|Part B (Dose Escalation and Expansion)|Ongoing|0
909806|NCT01072175|3000012|P11|Part B (Dose Escalation and Expansion)|Ongoing|0
909807|NCT01072175|3000013|P10|Part B (Dose Escalation and Expansion)|Ongoing|0
909808|NCT01072175|3000014|P9|Part B (Dose Escalation and Expansion)|Ongoing|0
909809|NCT01072175|3000015|P8|Part B (Dose Escalation and Expansion)|Ongoing|0
909810|NCT01072175|3000016|P7|Part B (Dose Escalation and Expansion)|Ongoing|0
909811|NCT01072175|3000017|P6|Part B (Dose Escalation and Expansion)|Ongoing|0
909812|NCT01072175|3000018|P5|Part B (Dose Escalation and Expansion)|Ongoing|28
909813|NCT01072175|3000019|P4|Part B (Dose Escalation and Expansion)|Ongoing|9
909814|NCT01072175|3000020|P3|Part B (Dose Escalation and Expansion)|Ongoing|10
909815|NCT01072175|3000021|P2|Part B (Dose Escalation and Expansion)|Ongoing|2
909816|NCT01072175|3000022|P1|Part B (Dose Escalation and Expansion)|Ongoing|0
909817|NCT01072175|3000010|P13|Part B (Dose Escalation and Expansion)|Death|0
909818|NCT01072175|3000011|P12|Part B (Dose Escalation and Expansion)|Death|0
909819|NCT01072175|3000012|P11|Part B (Dose Escalation and Expansion)|Death|0
909820|NCT01072175|3000013|P10|Part B (Dose Escalation and Expansion)|Death|0
909821|NCT01072175|3000014|P9|Part B (Dose Escalation and Expansion)|Death|0
909822|NCT01072175|3000015|P8|Part B (Dose Escalation and Expansion)|Death|0
909823|NCT01072175|3000016|P7|Part B (Dose Escalation and Expansion)|Death|0
909824|NCT01072175|3000017|P6|Part B (Dose Escalation and Expansion)|Death|0
909825|NCT01072175|3000018|P5|Part B (Dose Escalation and Expansion)|Death|36
909826|NCT01072175|3000019|P4|Part B (Dose Escalation and Expansion)|Death|12
909827|NCT01072175|3000020|P3|Part B (Dose Escalation and Expansion)|Death|10
909828|NCT01072175|3000021|P2|Part B (Dose Escalation and Expansion)|Death|3
909829|NCT01072175|3000022|P1|Part B (Dose Escalation and Expansion)|Death|0
909830|NCT01072175|3000010|P13|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
909831|NCT01072175|3000011|P12|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
909832|NCT01072175|3000012|P11|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
909833|NCT01072175|3000013|P10|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
909834|NCT01072175|3000014|P9|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
909835|NCT01072175|3000015|P8|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
909836|NCT01072175|3000016|P7|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
909837|NCT01072175|3000017|P6|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
909838|NCT01072175|3000018|P5|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|2
909839|NCT01072175|3000019|P4|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|2
909840|NCT01072175|3000020|P3|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
909841|NCT01072175|3000021|P2|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
909842|NCT01072175|3000022|P1|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
909843|NCT01072175|3000010|P13|Part B (Dose Escalation and Expansion)|Physician Decision|0
909844|NCT01072175|3000011|P12|Part B (Dose Escalation and Expansion)|Physician Decision|0
909845|NCT01072175|3000012|P11|Part B (Dose Escalation and Expansion)|Physician Decision|0
909846|NCT01072175|3000013|P10|Part B (Dose Escalation and Expansion)|Physician Decision|0
909847|NCT01072175|3000014|P9|Part B (Dose Escalation and Expansion)|Physician Decision|0
909848|NCT01072175|3000015|P8|Part B (Dose Escalation and Expansion)|Physician Decision|0
909849|NCT01072175|3000016|P7|Part B (Dose Escalation and Expansion)|Physician Decision|0
909850|NCT01072175|3000017|P6|Part B (Dose Escalation and Expansion)|Physician Decision|0
909851|NCT01072175|3000018|P5|Part B (Dose Escalation and Expansion)|Physician Decision|13
909852|NCT01072175|3000019|P4|Part B (Dose Escalation and Expansion)|Physician Decision|4
909853|NCT01072175|3000020|P3|Part B (Dose Escalation and Expansion)|Physician Decision|3
909854|NCT01072175|3000021|P2|Part B (Dose Escalation and Expansion)|Physician Decision|1
909855|NCT01072175|3000022|P1|Part B (Dose Escalation and Expansion)|Physician Decision|0
909856|NCT01072175|3000010|P13|Part A (Drug-Drug Interaction)|Death|0
909857|NCT01072175|3000011|P12|Part A (Drug-Drug Interaction)|Death|0
909858|NCT01072175|3000012|P11|Part A (Drug-Drug Interaction)|Death|0
909859|NCT01072175|3000013|P10|Part A (Drug-Drug Interaction)|Death|0
909860|NCT01072175|3000014|P9|Part A (Drug-Drug Interaction)|Death|0
909861|NCT01072175|3000015|P8|Part A (Drug-Drug Interaction)|Death|0
909862|NCT01072175|3000016|P7|Part A (Drug-Drug Interaction)|Death|0
909863|NCT01072175|3000017|P6|Part A (Drug-Drug Interaction)|Death|0
909864|NCT01072175|3000018|P5|Part A (Drug-Drug Interaction)|Death|0
909865|NCT01072175|3000019|P4|Part A (Drug-Drug Interaction)|Death|0
909866|NCT01072175|3000020|P3|Part A (Drug-Drug Interaction)|Death|0
909867|NCT01072175|3000021|P2|Part A (Drug-Drug Interaction)|Death|0
909868|NCT01072175|3000022|P1|Part A (Drug-Drug Interaction)|Death|1
909869|NCT01072175|3000010|P13|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
909870|NCT01072175|3000011|P12|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
909871|NCT01072175|3000012|P11|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
909872|NCT01072175|3000013|P10|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
909873|NCT01072175|3000014|P9|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
909874|NCT01072175|3000015|P8|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
909875|NCT01072175|3000016|P7|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
909876|NCT01072175|3000017|P6|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
909877|NCT01072175|3000018|P5|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
909878|NCT01072175|3000019|P4|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
909879|NCT01072175|3000020|P3|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
909880|NCT01072175|3000021|P2|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
909881|NCT01072175|3000022|P1|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1
909882|NCT01072175|3000010|P13|Part A (Drug-Drug Interaction)|Physician Decision|0
909883|NCT01072175|3000011|P12|Part A (Drug-Drug Interaction)|Physician Decision|0
909884|NCT01072175|3000012|P11|Part A (Drug-Drug Interaction)|Physician Decision|0
909885|NCT01072175|3000013|P10|Part A (Drug-Drug Interaction)|Physician Decision|0
909886|NCT01072175|3000014|P9|Part A (Drug-Drug Interaction)|Physician Decision|0
909887|NCT01072175|3000015|P8|Part A (Drug-Drug Interaction)|Physician Decision|0
909888|NCT01072175|3000016|P7|Part A (Drug-Drug Interaction)|Physician Decision|0
909889|NCT01072175|3000017|P6|Part A (Drug-Drug Interaction)|Physician Decision|0
909890|NCT01072175|3000018|P5|Part A (Drug-Drug Interaction)|Physician Decision|0
909891|NCT01072175|3000019|P4|Part A (Drug-Drug Interaction)|Physician Decision|0
909892|NCT01072175|3000020|P3|Part A (Drug-Drug Interaction)|Physician Decision|0
909893|NCT01072175|3000021|P2|Part A (Drug-Drug Interaction)|Physician Decision|0
909894|NCT01072175|3000022|P1|Part A (Drug-Drug Interaction)|Physician Decision|6
909895|NCT01072149|3000205|P18|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
909896|NCT01072149|3000206|P17|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
909897|NCT01072149|3000207|P16|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
909898|NCT01072149|3000208|P15|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
909899|NCT01072149|3000209|P14|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
909900|NCT01072149|3000210|P13|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
909901|NCT01072149|3000211|P12|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
909902|NCT01072149|3000212|P11|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
909903|NCT01072149|3000213|P10|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
909904|NCT01072149|3000214|P9|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
909905|NCT01072149|3000215|P8|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
909906|NCT01072149|3000216|P7|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
909907|NCT01072149|3000217|P6|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
909908|NCT01072149|3000218|P5|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
909909|NCT01072149|3000219|P4|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
909910|NCT01072149|3000220|P3|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
909911|NCT01072149|3000221|P2|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
909912|NCT01072149|3000222|P1|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
909913|NCT01072149|3000205|P18|Washout Period 2 (14 Days)|Lack of Efficacy|0
909914|NCT01072149|3000206|P17|Washout Period 2 (14 Days)|Lack of Efficacy|0
909915|NCT01072149|3000207|P16|Washout Period 2 (14 Days)|Lack of Efficacy|0
909916|NCT01072149|3000208|P15|Washout Period 2 (14 Days)|Lack of Efficacy|0
909917|NCT01072149|3000209|P14|Washout Period 2 (14 Days)|Lack of Efficacy|0
909918|NCT01072149|3000210|P13|Washout Period 2 (14 Days)|Lack of Efficacy|1
909919|NCT01072149|3000211|P12|Washout Period 2 (14 Days)|Lack of Efficacy|0
909920|NCT01072149|3000212|P11|Washout Period 2 (14 Days)|Lack of Efficacy|0
909921|NCT01072149|3000213|P10|Washout Period 2 (14 Days)|Lack of Efficacy|0
909922|NCT01072149|3000214|P9|Washout Period 2 (14 Days)|Lack of Efficacy|0
909923|NCT01072149|3000215|P8|Washout Period 2 (14 Days)|Lack of Efficacy|0
909924|NCT01072149|3000216|P7|Washout Period 2 (14 Days)|Lack of Efficacy|0
909925|NCT01072149|3000217|P6|Washout Period 2 (14 Days)|Lack of Efficacy|0
909926|NCT01072149|3000218|P5|Washout Period 2 (14 Days)|Lack of Efficacy|0
909927|NCT01072149|3000219|P4|Washout Period 2 (14 Days)|Lack of Efficacy|0
909928|NCT01072149|3000220|P3|Washout Period 2 (14 Days)|Lack of Efficacy|0
909929|NCT01072149|3000221|P2|Washout Period 2 (14 Days)|Lack of Efficacy|0
909930|NCT01072149|3000222|P1|Washout Period 2 (14 Days)|Lack of Efficacy|0
909931|NCT01072149|3000205|P18|Washout Period 2 (14 Days)|Adverse Event|0
909932|NCT01072149|3000206|P17|Washout Period 2 (14 Days)|Adverse Event|0
909933|NCT01072149|3000207|P16|Washout Period 2 (14 Days)|Adverse Event|1
909934|NCT01072149|3000208|P15|Washout Period 2 (14 Days)|Adverse Event|0
909935|NCT01072149|3000209|P14|Washout Period 2 (14 Days)|Adverse Event|0
909936|NCT01072149|3000210|P13|Washout Period 2 (14 Days)|Adverse Event|0
909937|NCT01072149|3000211|P12|Washout Period 2 (14 Days)|Adverse Event|0
909938|NCT01072149|3000212|P11|Washout Period 2 (14 Days)|Adverse Event|0
909939|NCT01072149|3000213|P10|Washout Period 2 (14 Days)|Adverse Event|0
909940|NCT01072149|3000214|P9|Washout Period 2 (14 Days)|Adverse Event|0
909941|NCT01072149|3000215|P8|Washout Period 2 (14 Days)|Adverse Event|0
909942|NCT01072149|3000216|P7|Washout Period 2 (14 Days)|Adverse Event|0
909943|NCT01072149|3000217|P6|Washout Period 2 (14 Days)|Adverse Event|0
909944|NCT01072149|3000218|P5|Washout Period 2 (14 Days)|Adverse Event|0
909945|NCT01072149|3000219|P4|Washout Period 2 (14 Days)|Adverse Event|0
909946|NCT01072149|3000220|P3|Washout Period 2 (14 Days)|Adverse Event|0
909947|NCT01072149|3000221|P2|Washout Period 2 (14 Days)|Adverse Event|0
909948|NCT01072149|3000222|P1|Washout Period 2 (14 Days)|Adverse Event|0
909949|NCT01072149|3000205|P18|Washout Period 2 (14 Days)|Withdrawal by Subject|0
909950|NCT01072149|3000206|P17|Washout Period 2 (14 Days)|Withdrawal by Subject|0
909951|NCT01072149|3000207|P16|Washout Period 2 (14 Days)|Withdrawal by Subject|1
909952|NCT01072149|3000208|P15|Washout Period 2 (14 Days)|Withdrawal by Subject|0
909953|NCT01072149|3000209|P14|Washout Period 2 (14 Days)|Withdrawal by Subject|0
909954|NCT01072149|3000210|P13|Washout Period 2 (14 Days)|Withdrawal by Subject|0
909955|NCT01072149|3000211|P12|Washout Period 2 (14 Days)|Withdrawal by Subject|0
909956|NCT01072149|3000212|P11|Washout Period 2 (14 Days)|Withdrawal by Subject|0
909957|NCT01072149|3000213|P10|Washout Period 2 (14 Days)|Withdrawal by Subject|0
909958|NCT01072149|3000214|P9|Washout Period 2 (14 Days)|Withdrawal by Subject|0
909959|NCT01072149|3000215|P8|Washout Period 2 (14 Days)|Withdrawal by Subject|0
909960|NCT01072149|3000216|P7|Washout Period 2 (14 Days)|Withdrawal by Subject|0
909961|NCT01072149|3000217|P6|Washout Period 2 (14 Days)|Withdrawal by Subject|0
909962|NCT01072149|3000218|P5|Washout Period 2 (14 Days)|Withdrawal by Subject|0
909963|NCT01072149|3000219|P4|Washout Period 2 (14 Days)|Withdrawal by Subject|0
909964|NCT01072149|3000220|P3|Washout Period 2 (14 Days)|Withdrawal by Subject|0
909965|NCT01072149|3000221|P2|Washout Period 2 (14 Days)|Withdrawal by Subject|0
909966|NCT01072149|3000222|P1|Washout Period 2 (14 Days)|Withdrawal by Subject|0
909967|NCT01072149|3000205|P18|Washout Period 2 (14 Days)|Physician Decision|0
909968|NCT01072149|3000206|P17|Washout Period 2 (14 Days)|Physician Decision|0
909969|NCT01072149|3000207|P16|Washout Period 2 (14 Days)|Physician Decision|0
909970|NCT01072149|3000208|P15|Washout Period 2 (14 Days)|Physician Decision|0
909971|NCT01072149|3000209|P14|Washout Period 2 (14 Days)|Physician Decision|0
909972|NCT01072149|3000210|P13|Washout Period 2 (14 Days)|Physician Decision|0
909973|NCT01072149|3000211|P12|Washout Period 2 (14 Days)|Physician Decision|0
909974|NCT01072149|3000212|P11|Washout Period 2 (14 Days)|Physician Decision|0
909975|NCT01072149|3000213|P10|Washout Period 2 (14 Days)|Physician Decision|0
909976|NCT01072149|3000214|P9|Washout Period 2 (14 Days)|Physician Decision|0
909977|NCT01072149|3000215|P8|Washout Period 2 (14 Days)|Physician Decision|0
909978|NCT01072149|3000216|P7|Washout Period 2 (14 Days)|Physician Decision|0
909979|NCT01072149|3000217|P6|Washout Period 2 (14 Days)|Physician Decision|0
909980|NCT01072149|3000218|P5|Washout Period 2 (14 Days)|Physician Decision|0
909981|NCT01072149|3000219|P4|Washout Period 2 (14 Days)|Physician Decision|0
909982|NCT01072149|3000220|P3|Washout Period 2 (14 Days)|Physician Decision|0
909983|NCT01072149|3000221|P2|Washout Period 2 (14 Days)|Physician Decision|0
909984|NCT01072149|3000222|P1|Washout Period 2 (14 Days)|Physician Decision|1
909985|NCT01072149|3000205|P18|Treatment Period 2 (28 Days)|Physician Decision|0
909986|NCT01072149|3000206|P17|Treatment Period 2 (28 Days)|Physician Decision|0
909987|NCT01072149|3000207|P16|Treatment Period 2 (28 Days)|Physician Decision|0
909988|NCT01072149|3000208|P15|Treatment Period 2 (28 Days)|Physician Decision|0
909989|NCT01072149|3000209|P14|Treatment Period 2 (28 Days)|Physician Decision|0
909990|NCT01072149|3000210|P13|Treatment Period 2 (28 Days)|Physician Decision|0
909991|NCT01072149|3000211|P12|Treatment Period 2 (28 Days)|Physician Decision|0
909992|NCT01072149|3000212|P11|Treatment Period 2 (28 Days)|Physician Decision|0
909993|NCT01072149|3000213|P10|Treatment Period 2 (28 Days)|Physician Decision|0
909994|NCT01072149|3000214|P9|Treatment Period 2 (28 Days)|Physician Decision|0
909995|NCT01072149|3000215|P8|Treatment Period 2 (28 Days)|Physician Decision|1
909996|NCT01072149|3000216|P7|Treatment Period 2 (28 Days)|Physician Decision|0
909997|NCT01072149|3000217|P6|Treatment Period 2 (28 Days)|Physician Decision|0
909998|NCT01072149|3000218|P5|Treatment Period 2 (28 Days)|Physician Decision|0
909999|NCT01072149|3000219|P4|Treatment Period 2 (28 Days)|Physician Decision|0
910000|NCT01072149|3000220|P3|Treatment Period 2 (28 Days)|Physician Decision|0
910001|NCT01072149|3000221|P2|Treatment Period 2 (28 Days)|Physician Decision|0
910002|NCT01072149|3000222|P1|Treatment Period 2 (28 Days)|Physician Decision|0
910003|NCT01072149|3000205|P18|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
910004|NCT01072149|3000206|P17|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
910005|NCT01072149|3000207|P16|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
910006|NCT01072149|3000208|P15|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
910007|NCT01072149|3000209|P14|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
910008|NCT01072149|3000210|P13|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
910009|NCT01072149|3000211|P12|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
910010|NCT01072149|3000212|P11|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
910011|NCT01072149|3000213|P10|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
910012|NCT01072149|3000214|P9|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
910013|NCT01072149|3000215|P8|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
910014|NCT01072149|3000216|P7|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
910015|NCT01072149|3000217|P6|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
910016|NCT01072149|3000218|P5|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
910017|NCT01072149|3000219|P4|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
910018|NCT01072149|3000220|P3|Treatment Period 2 (28 Days)|Withdrawal by Subject|1
910019|NCT01072149|3000221|P2|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
910020|NCT01072149|3000222|P1|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
910021|NCT01072149|3000205|P18|Treatment Period 2 (28 Days)|Lost to Follow-up|0
910022|NCT01072149|3000206|P17|Treatment Period 2 (28 Days)|Lost to Follow-up|0
910023|NCT01072149|3000207|P16|Treatment Period 2 (28 Days)|Lost to Follow-up|0
910024|NCT01072149|3000208|P15|Treatment Period 2 (28 Days)|Lost to Follow-up|0
910025|NCT01072149|3000209|P14|Treatment Period 2 (28 Days)|Lost to Follow-up|0
910026|NCT01072149|3000210|P13|Treatment Period 2 (28 Days)|Lost to Follow-up|0
910027|NCT01072149|3000211|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
910028|NCT01072149|3000212|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
910029|NCT01072149|3000213|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
910030|NCT01072149|3000214|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
910031|NCT01072149|3000215|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
910032|NCT01072149|3000216|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
910033|NCT01072149|3000217|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
910034|NCT01072149|3000218|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|0
910035|NCT01072149|3000219|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
910036|NCT01072149|3000220|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
910037|NCT01072149|3000221|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|1
910038|NCT01072149|3000222|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
910039|NCT01072149|3000205|P18|Treatment Period 1 (28 Days)|Lost to Follow-up|0
910040|NCT01072149|3000206|P17|Treatment Period 1 (28 Days)|Lost to Follow-up|0
910041|NCT01072149|3000207|P16|Treatment Period 1 (28 Days)|Lost to Follow-up|0
910042|NCT01072149|3000208|P15|Treatment Period 1 (28 Days)|Lost to Follow-up|0
910043|NCT01072149|3000209|P14|Treatment Period 1 (28 Days)|Lost to Follow-up|0
910044|NCT01072149|3000210|P13|Treatment Period 1 (28 Days)|Lost to Follow-up|0
910045|NCT01072149|3000211|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
910046|NCT01072149|3000212|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|1
910047|NCT01072149|3000213|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
910048|NCT01072149|3000214|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|0
910049|NCT01072149|3000215|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
910050|NCT01072149|3000216|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
910051|NCT01072149|3000217|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
910052|NCT01072149|3000218|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
910053|NCT01072149|3000219|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
910054|NCT01072149|3000220|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
910055|NCT01072149|3000221|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
910056|NCT01072149|3000222|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
910057|NCT01072149|3000205|P18|Treatment Period 1 (28 Days)|Protocol Violation|1
910058|NCT01072149|3000206|P17|Treatment Period 1 (28 Days)|Protocol Violation|0
910059|NCT01072149|3000207|P16|Treatment Period 1 (28 Days)|Protocol Violation|0
910060|NCT01072149|3000208|P15|Treatment Period 1 (28 Days)|Protocol Violation|0
910061|NCT01072149|3000209|P14|Treatment Period 1 (28 Days)|Protocol Violation|0
910062|NCT01072149|3000210|P13|Treatment Period 1 (28 Days)|Protocol Violation|0
910063|NCT01072149|3000211|P12|Treatment Period 1 (28 Days)|Protocol Violation|0
910064|NCT01072149|3000212|P11|Treatment Period 1 (28 Days)|Protocol Violation|0
910065|NCT01072149|3000213|P10|Treatment Period 1 (28 Days)|Protocol Violation|0
910066|NCT01072149|3000214|P9|Treatment Period 1 (28 Days)|Protocol Violation|0
910067|NCT01072149|3000215|P8|Treatment Period 1 (28 Days)|Protocol Violation|0
910068|NCT01072149|3000216|P7|Treatment Period 1 (28 Days)|Protocol Violation|0
910069|NCT01072149|3000217|P6|Treatment Period 1 (28 Days)|Protocol Violation|0
910070|NCT01072149|3000218|P5|Treatment Period 1 (28 Days)|Protocol Violation|0
910071|NCT01072149|3000219|P4|Treatment Period 1 (28 Days)|Protocol Violation|0
910072|NCT01072149|3000220|P3|Treatment Period 1 (28 Days)|Protocol Violation|0
910073|NCT01072149|3000221|P2|Treatment Period 1 (28 Days)|Protocol Violation|0
910074|NCT01072149|3000222|P1|Treatment Period 1 (28 Days)|Protocol Violation|0
910075|NCT01072149|3000205|P18|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
910076|NCT01072149|3000206|P17|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
910077|NCT01072149|3000207|P16|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
910078|NCT01072149|3000208|P15|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
910079|NCT01072149|3000209|P14|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
910080|NCT01072149|3000210|P13|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
910081|NCT01072149|3000211|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
910082|NCT01072149|3000212|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
910083|NCT01072149|3000213|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
910084|NCT01072149|3000214|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
910085|NCT01072149|3000215|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
910086|NCT01072149|3000216|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
910087|NCT01072149|3000217|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
910088|NCT01072149|3000218|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
910089|NCT01072149|3000219|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
910090|NCT01072149|3000220|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
910091|NCT01072149|3000221|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
910092|NCT01072149|3000222|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
910093|NCT01071915|3000311|P1|Overall Study|Miscellaneous Reasons|2
910094|NCT01071915|3000311|P1|Overall Study|Withdrawal by Subject|2
910095|NCT01071915|3000311|P1|Overall Study|Physician Decision|2
910096|NCT01071915|3000311|P1|Overall Study|Adverse Event|3
910097|NCT01071798|3000321|P1|Subpopulation Who Received Two Cycles|Patient Requirement|7
910098|NCT01071798|3000321|P1|Subpopulation Who Received Two Cycles|Lack of Tolerability|4
910099|NCT01071798|3000321|P1|Subpopulation Who Received Two Cycles|Lack of Efficacy|3
910100|NCT01071798|3000321|P1|Subpopulation Who Received Two Cycles|Remission|1
910101|NCT01071798|3000321|P1|Participants Who Received One Cycle|Severe concomitant disease|2
910102|NCT01071798|3000321|P1|Participants Who Received One Cycle|Change of therapy|6
910103|NCT01071798|3000321|P1|Participants Who Received One Cycle|Death|5
910104|NCT01071798|3000321|P1|Participants Who Received One Cycle|Patient requirement|20
910105|NCT01071798|3000321|P1|Participants Who Received One Cycle|Lack of tolerability|14
910106|NCT01071798|3000321|P1|Participants Who Received One Cycle|Lack of Efficacy|18
910107|NCT01071512|3000351|P1|Overall Study|positive anti-JC virus antibody test|2
910108|NCT01071512|3000351|P1|Overall Study|Development of antibodies to drug|2
910109|NCT01071512|3000351|P1|Overall Study|Adverse Event|1
910110|NCT01071395|3000361|P2|Overall Study|Adverse Event|1
910111|NCT01071395|3000362|P1|Overall Study|Adverse Event|3
910112|NCT01071395|3000361|P2|Overall Study|Withdrawal by Subject|1
910113|NCT01071395|3000362|P1|Overall Study|Withdrawal by Subject|2
910114|NCT01071317|3000381|P2|Overall Study|Lost to Follow-up|2
910115|NCT01071317|3000382|P1|Overall Study|Lost to Follow-up|2
910116|NCT01071278|3000394|P1|Overall Study|Completion Status Unknown|459
910117|NCT01071278|3000394|P1|Overall Study|Premature Discontinuation|254
910118|NCT01071252|3000405|P5|Overall Study|Death|1
910119|NCT01071252|3000406|P4|Overall Study|Death|0
910120|NCT01071252|3000407|P3|Overall Study|Death|0
910121|NCT01071252|3000408|P2|Overall Study|Death|0
910122|NCT01071252|3000409|P1|Overall Study|Death|0
910123|NCT01071252|3000405|P5|Overall Study|Adverse Event|0
910124|NCT01071252|3000406|P4|Overall Study|Adverse Event|1
910125|NCT01071252|3000407|P3|Overall Study|Adverse Event|0
910126|NCT01071252|3000408|P2|Overall Study|Adverse Event|1
910127|NCT01071252|3000409|P1|Overall Study|Adverse Event|1
910128|NCT01071252|3000405|P5|Overall Study|Lost to Follow-up|0
910129|NCT01071252|3000406|P4|Overall Study|Lost to Follow-up|2
910130|NCT01071252|3000407|P3|Overall Study|Lost to Follow-up|1
910131|NCT01071252|3000408|P2|Overall Study|Lost to Follow-up|0
910132|NCT01071252|3000409|P1|Overall Study|Lost to Follow-up|1
910133|NCT01071252|3000405|P5|Overall Study|administrative problems|1
910134|NCT01071252|3000406|P4|Overall Study|administrative problems|2
910135|NCT01071252|3000407|P3|Overall Study|administrative problems|0
910136|NCT01071252|3000408|P2|Overall Study|administrative problems|1
910137|NCT01071252|3000409|P1|Overall Study|administrative problems|1
910138|NCT01071252|3000405|P5|Overall Study|Withdrawal by Subject|3
910139|NCT01071252|3000406|P4|Overall Study|Withdrawal by Subject|2
910140|NCT01071252|3000407|P3|Overall Study|Withdrawal by Subject|1
910141|NCT01071252|3000408|P2|Overall Study|Withdrawal by Subject|2
910142|NCT01071252|3000409|P1|Overall Study|Withdrawal by Subject|8
910143|NCT01071252|3000405|P5|Overall Study|unsatisfactory therapeutic effect|6
910144|NCT01071252|3000406|P4|Overall Study|unsatisfactory therapeutic effect|0
910145|NCT01071252|3000407|P3|Overall Study|unsatisfactory therapeutic effect|2
910146|NCT01071252|3000408|P2|Overall Study|unsatisfactory therapeutic effect|6
910147|NCT01071252|3000409|P1|Overall Study|unsatisfactory therapeutic effect|4
910148|NCT01071200|3000437|P2|Overall Study|No viable embryos|1
910149|NCT01071200|3000438|P1|Overall Study|No viable embryos|0
910150|NCT01071200|3000437|P2|Overall Study|Ovarian Hyper Stimulation Syndrome|0
910151|NCT01071200|3000438|P1|Overall Study|Ovarian Hyper Stimulation Syndrome|1
910152|NCT01071200|3000437|P2|Overall Study|No oocytes retrieved|1
910153|NCT01071200|3000438|P1|Overall Study|No oocytes retrieved|1
910154|NCT01071200|3000437|P2|Overall Study|No fertilization|0
910155|NCT01071200|3000438|P1|Overall Study|No fertilization|4
910156|NCT01071200|3000437|P2|Overall Study|Lack of ovarian response|1
910157|NCT01071200|3000438|P1|Overall Study|Lack of ovarian response|1
910158|NCT01071096|3000470|P2|First Intervention (90 Days)|Lost to Follow-up|0
910159|NCT01071096|3000471|P1|First Intervention (90 Days)|Lost to Follow-up|1
910160|NCT01071083|3000495|P5|Overall Study|Subject Refused to Continue|0
910161|NCT01071083|3000496|P4|Overall Study|Subject Refused to Continue|0
910162|NCT01071083|3000497|P3|Overall Study|Subject Refused to Continue|0
910163|NCT01071083|3000498|P2|Overall Study|Subject Refused to Continue|0
910164|NCT01071083|3000499|P1|Overall Study|Subject Refused to Continue|1
910165|NCT01071083|3000495|P5|Overall Study|Did Not Want Per Protocol Treatment|1
910166|NCT01071083|3000496|P4|Overall Study|Did Not Want Per Protocol Treatment|0
910167|NCT01071083|3000497|P3|Overall Study|Did Not Want Per Protocol Treatment|1
910168|NCT01071083|3000498|P2|Overall Study|Did Not Want Per Protocol Treatment|0
910169|NCT01071083|3000499|P1|Overall Study|Did Not Want Per Protocol Treatment|0
910170|NCT01071083|3000495|P5|Overall Study|Did Not Meet Eligibility Criteria|1
910171|NCT01071083|3000496|P4|Overall Study|Did Not Meet Eligibility Criteria|1
910172|NCT01071083|3000497|P3|Overall Study|Did Not Meet Eligibility Criteria|1
910173|NCT01071083|3000498|P2|Overall Study|Did Not Meet Eligibility Criteria|0
910174|NCT01071083|3000499|P1|Overall Study|Did Not Meet Eligibility Criteria|0
910175|NCT01071083|3000495|P5|Overall Study|Images Not Usable (Motion)|0
910176|NCT01071083|3000496|P4|Overall Study|Images Not Usable (Motion)|0
910177|NCT01071083|3000497|P3|Overall Study|Images Not Usable (Motion)|0
910178|NCT01071083|3000498|P2|Overall Study|Images Not Usable (Motion)|1
910179|NCT01071083|3000499|P1|Overall Study|Images Not Usable (Motion)|0
910180|NCT01071083|3000495|P5|Overall Study|Subject Moved|0
910181|NCT01071083|3000496|P4|Overall Study|Subject Moved|0
910182|NCT01071083|3000497|P3|Overall Study|Subject Moved|0
910183|NCT01071083|3000498|P2|Overall Study|Subject Moved|1
910184|NCT01071083|3000499|P1|Overall Study|Subject Moved|0
910185|NCT01071083|3000495|P5|Overall Study|Early Rescue|1
910186|NCT01071083|3000496|P4|Overall Study|Early Rescue|0
910187|NCT01071083|3000497|P3|Overall Study|Early Rescue|0
910188|NCT01071083|3000498|P2|Overall Study|Early Rescue|0
910189|NCT01071083|3000499|P1|Overall Study|Early Rescue|1
910190|NCT01071083|3000495|P5|Overall Study|Physician Decision|1
910191|NCT01071083|3000496|P4|Overall Study|Physician Decision|1
910192|NCT01071083|3000497|P3|Overall Study|Physician Decision|0
910193|NCT01071083|3000498|P2|Overall Study|Physician Decision|0
910194|NCT01071083|3000499|P1|Overall Study|Physician Decision|1
910195|NCT01071083|3000495|P5|Overall Study|Withdrawal by Subject|3
910196|NCT01071083|3000496|P4|Overall Study|Withdrawal by Subject|0
910197|NCT01071083|3000497|P3|Overall Study|Withdrawal by Subject|2
910198|NCT01071083|3000498|P2|Overall Study|Withdrawal by Subject|0
910199|NCT01071083|3000499|P1|Overall Study|Withdrawal by Subject|3
910200|NCT01071083|3000495|P5|Overall Study|Adverse Event|1
910201|NCT01071083|3000496|P4|Overall Study|Adverse Event|0
910202|NCT01071083|3000497|P3|Overall Study|Adverse Event|1
910203|NCT01071083|3000498|P2|Overall Study|Adverse Event|0
910204|NCT01071083|3000499|P1|Overall Study|Adverse Event|1
910205|NCT01071070|3000518|P2|Overall Study|Hypercalcemia|0
910206|NCT01071070|3000519|P1|Overall Study|Hypercalcemia|1
910207|NCT01071070|3000518|P2|Overall Study|Missed 3 consecutive doses of study drug|0
910208|NCT01071070|3000519|P1|Overall Study|Missed 3 consecutive doses of study drug|2
910209|NCT01071070|3000518|P2|Overall Study|Withdrawal by Subject|0
910210|NCT01071070|3000519|P1|Overall Study|Withdrawal by Subject|1
910211|NCT01071070|3000518|P2|Overall Study|Adverse Event|3
910212|NCT01071070|3000519|P1|Overall Study|Adverse Event|0
910213|NCT01070979|3000565|P3|Overall Study|No study drug taken|0
910214|NCT01070979|3000566|P2|Overall Study|No study drug taken|1
910215|NCT01070979|3000567|P1|Overall Study|No study drug taken|0
910216|NCT01070979|3000565|P3|Overall Study|Withdrawal by Subject|1
910217|NCT01070979|3000566|P2|Overall Study|Withdrawal by Subject|1
910218|NCT01070979|3000567|P1|Overall Study|Withdrawal by Subject|3
910219|NCT01070979|3000565|P3|Overall Study|Surgery, moving, personal, abn. labs|2
910220|NCT01070979|3000566|P2|Overall Study|Surgery, moving, personal, abn. labs|4
910221|NCT01070979|3000567|P1|Overall Study|Surgery, moving, personal, abn. labs|4
910222|NCT01070979|3000565|P3|Overall Study|Protocol Violation|6
910223|NCT01070979|3000566|P2|Overall Study|Protocol Violation|2
910224|NCT01070979|3000567|P1|Overall Study|Protocol Violation|0
910225|NCT01070979|3000565|P3|Overall Study|Lost to Follow-up|1
910226|NCT01070979|3000566|P2|Overall Study|Lost to Follow-up|1
910227|NCT01070979|3000567|P1|Overall Study|Lost to Follow-up|2
910228|NCT01070979|3000565|P3|Overall Study|Adverse Event|3
910229|NCT01070979|3000566|P2|Overall Study|Adverse Event|3
910230|NCT01070979|3000567|P1|Overall Study|Adverse Event|2
910231|NCT01070966|3000593|P1|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2
910232|NCT01070966|3000593|P1|Participants for Efficacy Evaluation|No efficacy evaluation|19
910233|NCT01070966|3000593|P1|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61
910234|NCT01070966|3000593|P1|Participants for Safety Evaluation|TMT given before date of contract|3
910235|NCT01070966|3000593|P1|Participants for Safety Evaluation|Violation inclusion criteria/off label|3
910236|NCT01070966|3000593|P1|Participants for Safety Evaluation|Duplicate Participants|4
910237|NCT01070966|3000593|P1|Participants for Safety Evaluation|Off-label use|9
910238|NCT01070966|3000593|P1|Participants for Safety Evaluation|Violation of inclusion criteria|59
910239|NCT01070953|3000604|P1|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2
910240|NCT01070953|3000604|P1|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106
910241|NCT01070953|3000604|P1|Participants for Efficacy Evaluation|No efficacy evaluation|119
910242|NCT01070953|3000604|P1|Participants for Safety Evaluation|Duplicated participants & off-label use|1
910243|NCT01070953|3000604|P1|Participants for Safety Evaluation|Violation of inclusions & off label use|1
910244|NCT01070953|3000604|P1|Participants for Safety Evaluation|Uncontracted participants|4
910245|NCT01070953|3000604|P1|Participants for Safety Evaluation|Treatment prior to date of contract|8
910246|NCT01070953|3000604|P1|Participants for Safety Evaluation|Duplicated participants|22
910335|NCT01070550|3000754|P4|Overall Study|Relapse|4
910247|NCT01070953|3000604|P1|Participants for Safety Evaluation|Off-label use|283
910248|NCT01070953|3000604|P1|Participants for Safety Evaluation|Violation of inclusion criteria|612
910249|NCT01070888|3000617|P2|Washout (14 Days)|Physician Decision|0
910250|NCT01070888|3000618|P1|Washout (14 Days)|Physician Decision|1
910251|NCT01070888|3000617|P2|First Intervention (14 Days)|Lost to Follow-up|1
910252|NCT01070888|3000618|P1|First Intervention (14 Days)|Lost to Follow-up|0
910253|NCT01070888|3000617|P2|First Intervention (14 Days)|Adverse Event|1
910254|NCT01070888|3000618|P1|First Intervention (14 Days)|Adverse Event|0
910255|NCT01070784|3000643|P2|Overall Study|Adverse Event|9
910256|NCT01070784|3000644|P1|Overall Study|Adverse Event|14
910257|NCT01070784|3000643|P2|Overall Study|Withdrawal by Subject|9
910258|NCT01070784|3000644|P1|Overall Study|Withdrawal by Subject|6
910259|NCT01070771|3000732|P1|Overall Study|Protocol Violation|1
910260|NCT01070771|3000732|P1|Overall Study|Adverse Event|2
910261|NCT01070550|3000752|P6|Overall Study|Withdrawal by Subject|0
910262|NCT01070550|3000753|P5|Overall Study|Withdrawal by Subject|0
910263|NCT01070550|3000754|P4|Overall Study|Withdrawal by Subject|0
910264|NCT01070550|3000755|P3|Overall Study|Withdrawal by Subject|3
910265|NCT01070550|3000756|P2|Overall Study|Withdrawal by Subject|0
910266|NCT01070550|3000757|P1|Overall Study|Withdrawal by Subject|35
910267|NCT01070550|3000752|P6|Overall Study|Other|0
910268|NCT01070550|3000753|P5|Overall Study|Other|0
910269|NCT01070550|3000754|P4|Overall Study|Other|1
910270|NCT01070550|3000755|P3|Overall Study|Other|0
910271|NCT01070550|3000756|P2|Overall Study|Other|0
910272|NCT01070550|3000757|P1|Overall Study|Other|5
910273|NCT01070550|3000752|P6|Overall Study|Treatment was stopped early|0
910274|NCT01070550|3000753|P5|Overall Study|Treatment was stopped early|0
910275|NCT01070550|3000754|P4|Overall Study|Treatment was stopped early|0
910276|NCT01070550|3000755|P3|Overall Study|Treatment was stopped early|0
910277|NCT01070550|3000756|P2|Overall Study|Treatment was stopped early|0
910278|NCT01070550|3000757|P1|Overall Study|Treatment was stopped early|7
910279|NCT01070550|3000752|P6|Overall Study|Treatment unavailable|0
910280|NCT01070550|3000753|P5|Overall Study|Treatment unavailable|0
910281|NCT01070550|3000754|P4|Overall Study|Treatment unavailable|0
910282|NCT01070550|3000755|P3|Overall Study|Treatment unavailable|0
910283|NCT01070550|3000756|P2|Overall Study|Treatment unavailable|0
910284|NCT01070550|3000757|P1|Overall Study|Treatment unavailable|1
910285|NCT01070550|3000752|P6|Overall Study|Treatment stopped|0
910286|NCT01070550|3000753|P5|Overall Study|Treatment stopped|0
910287|NCT01070550|3000754|P4|Overall Study|Treatment stopped|0
910288|NCT01070550|3000755|P3|Overall Study|Treatment stopped|0
910289|NCT01070550|3000756|P2|Overall Study|Treatment stopped|0
910290|NCT01070550|3000757|P1|Overall Study|Treatment stopped|3
910291|NCT01070550|3000752|P6|Overall Study|Treatment restarted|0
910292|NCT01070550|3000753|P5|Overall Study|Treatment restarted|0
910293|NCT01070550|3000754|P4|Overall Study|Treatment restarted|0
910294|NCT01070550|3000755|P3|Overall Study|Treatment restarted|0
910295|NCT01070550|3000756|P2|Overall Study|Treatment restarted|1
910296|NCT01070550|3000757|P1|Overall Study|Treatment restarted|0
910297|NCT01070550|3000752|P6|Overall Study|Treatment not started|0
910298|NCT01070550|3000753|P5|Overall Study|Treatment not started|0
910299|NCT01070550|3000754|P4|Overall Study|Treatment not started|0
910300|NCT01070550|3000755|P3|Overall Study|Treatment not started|4
910301|NCT01070550|3000756|P2|Overall Study|Treatment not started|2
910302|NCT01070550|3000757|P1|Overall Study|Treatment not started|14
910303|NCT01070550|3000752|P6|Overall Study|Treatment interrupted|0
910304|NCT01070550|3000753|P5|Overall Study|Treatment interrupted|0
910305|NCT01070550|3000754|P4|Overall Study|Treatment interrupted|1
910306|NCT01070550|3000755|P3|Overall Study|Treatment interrupted|1
910307|NCT01070550|3000756|P2|Overall Study|Treatment interrupted|0
910308|NCT01070550|3000757|P1|Overall Study|Treatment interrupted|7
910309|NCT01070550|3000752|P6|Overall Study|Treatment duration shortened|0
910310|NCT01070550|3000753|P5|Overall Study|Treatment duration shortened|0
910311|NCT01070550|3000754|P4|Overall Study|Treatment duration shortened|0
910312|NCT01070550|3000755|P3|Overall Study|Treatment duration shortened|0
910313|NCT01070550|3000756|P2|Overall Study|Treatment duration shortened|0
910314|NCT01070550|3000757|P1|Overall Study|Treatment duration shortened|1
910315|NCT01070550|3000752|P6|Overall Study|Sponsor decision|0
910316|NCT01070550|3000753|P5|Overall Study|Sponsor decision|0
910317|NCT01070550|3000754|P4|Overall Study|Sponsor decision|0
910318|NCT01070550|3000755|P3|Overall Study|Sponsor decision|0
910319|NCT01070550|3000756|P2|Overall Study|Sponsor decision|0
910320|NCT01070550|3000757|P1|Overall Study|Sponsor decision|1
910321|NCT01070550|3000752|P6|Overall Study|Screen failure|0
910322|NCT01070550|3000753|P5|Overall Study|Screen failure|0
910323|NCT01070550|3000754|P4|Overall Study|Screen failure|0
910324|NCT01070550|3000755|P3|Overall Study|Screen failure|0
910325|NCT01070550|3000756|P2|Overall Study|Screen failure|0
910326|NCT01070550|3000757|P1|Overall Study|Screen failure|1
910327|NCT01070550|3000752|P6|Overall Study|Result not available|0
910328|NCT01070550|3000753|P5|Overall Study|Result not available|0
910329|NCT01070550|3000754|P4|Overall Study|Result not available|0
910330|NCT01070550|3000755|P3|Overall Study|Result not available|3
910331|NCT01070550|3000756|P2|Overall Study|Result not available|1
910332|NCT01070550|3000757|P1|Overall Study|Result not available|3
910333|NCT01070550|3000752|P6|Overall Study|Relapse|0
910334|NCT01070550|3000753|P5|Overall Study|Relapse|0
910336|NCT01070550|3000755|P3|Overall Study|Relapse|14
910337|NCT01070550|3000756|P2|Overall Study|Relapse|5
910338|NCT01070550|3000757|P1|Overall Study|Relapse|44
910339|NCT01070550|3000752|P6|Overall Study|Protocol Violation|0
910340|NCT01070550|3000753|P5|Overall Study|Protocol Violation|0
910341|NCT01070550|3000754|P4|Overall Study|Protocol Violation|1
910342|NCT01070550|3000755|P3|Overall Study|Protocol Violation|1
910343|NCT01070550|3000756|P2|Overall Study|Protocol Violation|1
910344|NCT01070550|3000757|P1|Overall Study|Protocol Violation|15
910345|NCT01070550|3000752|P6|Overall Study|Not categorized|1
910346|NCT01070550|3000753|P5|Overall Study|Not categorized|0
910347|NCT01070550|3000754|P4|Overall Study|Not categorized|1
910348|NCT01070550|3000755|P3|Overall Study|Not categorized|6
910349|NCT01070550|3000756|P2|Overall Study|Not categorized|2
910350|NCT01070550|3000757|P1|Overall Study|Not categorized|33
910351|NCT01070550|3000752|P6|Overall Study|Non-responders|2
910352|NCT01070550|3000753|P5|Overall Study|Non-responders|0
910353|NCT01070550|3000754|P4|Overall Study|Non-responders|20
910354|NCT01070550|3000755|P3|Overall Study|Non-responders|21
910355|NCT01070550|3000756|P2|Overall Study|Non-responders|4
910356|NCT01070550|3000757|P1|Overall Study|Non-responders|493
910357|NCT01070550|3000752|P6|Overall Study|New treatment started|0
910358|NCT01070550|3000753|P5|Overall Study|New treatment started|0
910359|NCT01070550|3000754|P4|Overall Study|New treatment started|2
910360|NCT01070550|3000755|P3|Overall Study|New treatment started|0
910361|NCT01070550|3000756|P2|Overall Study|New treatment started|1
910362|NCT01070550|3000757|P1|Overall Study|New treatment started|3
910363|NCT01070550|3000752|P6|Overall Study|Miscellaneous|0
910364|NCT01070550|3000753|P5|Overall Study|Miscellaneous|0
910365|NCT01070550|3000754|P4|Overall Study|Miscellaneous|1
910366|NCT01070550|3000755|P3|Overall Study|Miscellaneous|3
910367|NCT01070550|3000756|P2|Overall Study|Miscellaneous|2
910368|NCT01070550|3000757|P1|Overall Study|Miscellaneous|12
910369|NCT01070550|3000752|P6|Overall Study|Lack of Efficacy|1
910370|NCT01070550|3000753|P5|Overall Study|Lack of Efficacy|0
910371|NCT01070550|3000754|P4|Overall Study|Lack of Efficacy|5
910372|NCT01070550|3000755|P3|Overall Study|Lack of Efficacy|5
910373|NCT01070550|3000756|P2|Overall Study|Lack of Efficacy|1
910374|NCT01070550|3000757|P1|Overall Study|Lack of Efficacy|65
910375|NCT01070550|3000752|P6|Overall Study|Lab test not done|1
910376|NCT01070550|3000753|P5|Overall Study|Lab test not done|0
910377|NCT01070550|3000754|P4|Overall Study|Lab test not done|1
910378|NCT01070550|3000755|P3|Overall Study|Lab test not done|4
910379|NCT01070550|3000756|P2|Overall Study|Lab test not done|3
910380|NCT01070550|3000757|P1|Overall Study|Lab test not done|22
910381|NCT01070550|3000752|P6|Overall Study|Incomplete treatment|0
910382|NCT01070550|3000753|P5|Overall Study|Incomplete treatment|0
910383|NCT01070550|3000754|P4|Overall Study|Incomplete treatment|0
910384|NCT01070550|3000755|P3|Overall Study|Incomplete treatment|0
910385|NCT01070550|3000756|P2|Overall Study|Incomplete treatment|0
910386|NCT01070550|3000757|P1|Overall Study|Incomplete treatment|2
910387|NCT01070550|3000752|P6|Overall Study|Failed to return|2
910388|NCT01070550|3000753|P5|Overall Study|Failed to return|1
910389|NCT01070550|3000754|P4|Overall Study|Failed to return|40
910390|NCT01070550|3000755|P3|Overall Study|Failed to return|144
910391|NCT01070550|3000756|P2|Overall Study|Failed to return|33
910392|NCT01070550|3000757|P1|Overall Study|Failed to return|450
910393|NCT01070550|3000752|P6|Overall Study|Early termination|0
910394|NCT01070550|3000753|P5|Overall Study|Early termination|0
910395|NCT01070550|3000754|P4|Overall Study|Early termination|0
910396|NCT01070550|3000755|P3|Overall Study|Early termination|0
910397|NCT01070550|3000756|P2|Overall Study|Early termination|0
910398|NCT01070550|3000757|P1|Overall Study|Early termination|3
910399|NCT01070550|3000752|P6|Overall Study|Not meeting inclusion/exclusion criteria|0
910400|NCT01070550|3000753|P5|Overall Study|Not meeting inclusion/exclusion criteria|0
910401|NCT01070550|3000754|P4|Overall Study|Not meeting inclusion/exclusion criteria|0
910402|NCT01070550|3000755|P3|Overall Study|Not meeting inclusion/exclusion criteria|1
910403|NCT01070550|3000756|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
910404|NCT01070550|3000757|P1|Overall Study|Not meeting inclusion/exclusion criteria|2
910405|NCT01070550|3000752|P6|Overall Study|Death|0
910406|NCT01070550|3000753|P5|Overall Study|Death|0
910407|NCT01070550|3000754|P4|Overall Study|Death|0
910408|NCT01070550|3000755|P3|Overall Study|Death|3
910409|NCT01070550|3000756|P2|Overall Study|Death|4
910410|NCT01070550|3000757|P1|Overall Study|Death|20
910411|NCT01070550|3000752|P6|Overall Study|Adverse Event|0
910412|NCT01070550|3000753|P5|Overall Study|Adverse Event|0
910413|NCT01070550|3000754|P4|Overall Study|Adverse Event|0
910414|NCT01070550|3000755|P3|Overall Study|Adverse Event|3
910415|NCT01070550|3000756|P2|Overall Study|Adverse Event|1
910416|NCT01070550|3000757|P1|Overall Study|Adverse Event|43
910417|NCT01070394|3000897|P1|Overall Study|Withdrawal by Subject|1
910418|NCT01070394|3000897|P1|Overall Study|Adverse Event|6
910419|NCT01070381|3000908|P2|Period 2, 1 Week of Wear|Unacceptable Vision|0
910420|NCT01070381|3000909|P1|Period 2, 1 Week of Wear|Unacceptable Vision|1
910421|NCT01070381|3000908|P2|Period 2, 1 Week of Wear|Handling|1
910422|NCT01070381|3000909|P1|Period 2, 1 Week of Wear|Handling|0
910423|NCT01070329|3000917|P2|Overall Study|Sponsor Decision|1
910424|NCT01070329|3000918|P1|Overall Study|Sponsor Decision|0
910425|NCT01070329|3000917|P2|Overall Study|Entry Criteria Not Met|0
910426|NCT01070329|3000918|P1|Overall Study|Entry Criteria Not Met|1
910427|NCT01070329|3000917|P2|Overall Study|Physician Decision|1
910428|NCT01070329|3000918|P1|Overall Study|Physician Decision|2
910429|NCT01070329|3000917|P2|Overall Study|Lack of Efficacy|6
910430|NCT01070329|3000918|P1|Overall Study|Lack of Efficacy|2
910431|NCT01070329|3000917|P2|Overall Study|Protocol Violation|8
910432|NCT01070329|3000918|P1|Overall Study|Protocol Violation|3
910433|NCT01070329|3000917|P2|Overall Study|Withdrawal by Subject|11
910434|NCT01070329|3000918|P1|Overall Study|Withdrawal by Subject|9
910435|NCT01070329|3000917|P2|Overall Study|Lost to Follow-up|12
910436|NCT01070329|3000918|P1|Overall Study|Lost to Follow-up|22
910437|NCT01070329|3000917|P2|Overall Study|Adverse Event|10
910438|NCT01070329|3000918|P1|Overall Study|Adverse Event|13
910439|NCT01070316|3000950|P1|Extension Phase|Withdrawal by Subject|1
910440|NCT01070316|3000950|P1|Extension Phase|Lack of Efficacy|3
910441|NCT01070303|3000957|P1|Overall Study|Other|18
910442|NCT01070303|3000957|P1|Overall Study|Administrative Reason|1
910443|NCT01070303|3000957|P1|Overall Study|Lack of Efficacy|2
910444|NCT01070303|3000957|P1|Overall Study|Protocol Violation|0
910445|NCT01070303|3000957|P1|Overall Study|Lost to Follow-up|9
910446|NCT01070303|3000957|P1|Overall Study|Withdrawal by Subject|20
910447|NCT01070303|3000957|P1|Overall Study|Adverse Event|39
910448|NCT01070043|3001031|P3|Double-Blind Treatment|Adverse Event|2
910449|NCT01070043|3001032|P2|Double-Blind Treatment|Adverse Event|0
910450|NCT01070043|3001033|P1|Double-Blind Treatment|Adverse Event|0
910451|NCT01070043|3001031|P3|Run-In Phase|Did not Meet Inclusion Criteria|0
910452|NCT01070043|3001032|P2|Run-In Phase|Did not Meet Inclusion Criteria|0
910453|NCT01070043|3001033|P1|Run-In Phase|Did not Meet Inclusion Criteria|18
910454|NCT01069939|3001049|P2|Randomised and Included in the Analyses|Removal|0
910455|NCT01069939|3001050|P1|Randomised and Included in the Analyses|Removal|1
910456|NCT01069939|3001049|P2|Randomised and Included in the Analyses|Physician Decision|2
910457|NCT01069939|3001050|P1|Randomised and Included in the Analyses|Physician Decision|0
910458|NCT01069939|3001049|P2|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2
910459|NCT01069939|3001050|P1|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4
910460|NCT01069939|3001049|P2|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3
910461|NCT01069939|3001050|P1|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4
910462|NCT01069939|3001049|P2|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33
910463|NCT01069939|3001050|P1|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7
910464|NCT01069939|3001049|P2|Randomised and Included in the Analyses|Lack of Efficacy|1
910465|NCT01069939|3001050|P1|Randomised and Included in the Analyses|Lack of Efficacy|0
910466|NCT01069939|3001049|P2|Randomised and Included in the Analyses|Protocol Violation|1
910467|NCT01069939|3001050|P1|Randomised and Included in the Analyses|Protocol Violation|0
910468|NCT01069939|3001049|P2|Randomised and Included in the Analyses|Lost to Follow-up|1
910469|NCT01069939|3001050|P1|Randomised and Included in the Analyses|Lost to Follow-up|1
910470|NCT01069939|3001049|P2|Randomised and Included in the Analyses|Withdrawal by Subject|12
910471|NCT01069939|3001050|P1|Randomised and Included in the Analyses|Withdrawal by Subject|15
910472|NCT01069939|3001049|P2|Randomised and Included in the Analyses|Adverse Event|22
910473|NCT01069939|3001050|P1|Randomised and Included in the Analyses|Adverse Event|17
910474|NCT01069900|3001076|P2|Overall Study|Insufficient Therapeutic effect|0
910475|NCT01069900|3001077|P1|Overall Study|Insufficient Therapeutic effect|1
910476|NCT01069900|3001076|P2|Overall Study|Protocol Violation|1
910477|NCT01069900|3001077|P1|Overall Study|Protocol Violation|4
910478|NCT01069900|3001076|P2|Overall Study|Withdrawal by Subject|1
910479|NCT01069900|3001077|P1|Overall Study|Withdrawal by Subject|6
910480|NCT01069900|3001076|P2|Overall Study|Lost to Follow-up|1
910481|NCT01069900|3001077|P1|Overall Study|Lost to Follow-up|7
910482|NCT01069900|3001076|P2|Overall Study|Technical problems|1
910483|NCT01069900|3001077|P1|Overall Study|Technical problems|0
910484|NCT01069861|3001121|P1|Overall Study|Did not meet entrance criteria|1
910485|NCT01069861|3001121|P1|Overall Study|Adverse Event|1
910486|NCT01069861|3001121|P1|Overall Study|Death|1
910487|NCT01069627|3001134|P1|Overall Study|Protocol Violation|1
910488|NCT01069627|3001134|P1|Overall Study|Adverse Event|12
910489|NCT01069627|3001134|P1|Overall Study|Disease progression|7
910490|NCT01069523|3001184|P2|Overall Study|Withdrawal by Subject|7
910491|NCT01069523|3001185|P1|Overall Study|Withdrawal by Subject|4
910492|NCT01069484|3001195|P2|Overall Study|Illness mother or child|1
910493|NCT01069484|3001196|P1|Overall Study|Illness mother or child|3
910494|NCT01069484|3001195|P2|Overall Study|No specific reason|2
910495|NCT01069484|3001196|P1|Overall Study|No specific reason|8
910496|NCT01069484|3001195|P2|Overall Study|Death-in-near-family|0
910497|NCT01069484|3001196|P1|Overall Study|Death-in-near-family|1
910498|NCT01069419|3001204|P1|Overall Study|Missing termination information|13
910499|NCT01069419|3001204|P1|Overall Study|Other Reason|43
910500|NCT01069419|3001204|P1|Overall Study|Withdrawal by Subject|34
910501|NCT01069419|3001204|P1|Overall Study|Remission of disease|11
910502|NCT01069419|3001204|P1|Overall Study|Lost to Follow-up|49
910503|NCT01069419|3001204|P1|Overall Study|Lack of Efficacy|332
910504|NCT01069419|3001204|P1|Overall Study|Adverse Event|233
910505|NCT01069341|3001233|P1|Overall Study|Lost to Follow-up|1
910506|NCT01069289|3001246|P2|Overall Study|Due to deteriorating health condition|0
910507|NCT01069289|3001247|P1|Overall Study|Due to deteriorating health condition|1
910508|NCT01069289|3001246|P2|Overall Study|Severe non-compliance to protocol|2
910509|NCT01069289|3001247|P1|Overall Study|Severe non-compliance to protocol|3
910510|NCT01069289|3001246|P2|Overall Study|Eligibility criteria not fulfilled|0
910511|NCT01069289|3001247|P1|Overall Study|Eligibility criteria not fulfilled|2
910512|NCT01069289|3001246|P2|Overall Study|Adverse Event|28
910513|NCT01069289|3001247|P1|Overall Study|Adverse Event|21
910514|NCT01069289|3001246|P2|Overall Study|Withdrawal by Subject|26
910515|NCT01069289|3001247|P1|Overall Study|Withdrawal by Subject|15
910516|NCT01069172|3001296|P2|Overall Study|Withdrawal by Subject|0
910517|NCT01069172|3001297|P1|Overall Study|Withdrawal by Subject|1
910518|NCT01069120|3001307|P1|Overall Study|Study prematurely terminated|27
910519|NCT01068912|3001344|P3|Overall Study|other underlying illness|3
910520|NCT01068912|3001345|P2|Overall Study|other underlying illness|3
910521|NCT01068912|3001346|P1|Overall Study|other underlying illness|0
910522|NCT01068912|3001344|P3|Overall Study|aggravation influenza|1
910523|NCT01068912|3001345|P2|Overall Study|aggravation influenza|1
910524|NCT01068912|3001346|P1|Overall Study|aggravation influenza|1
910525|NCT01068912|3001344|P3|Overall Study|Protocol Violation|0
910526|NCT01068912|3001345|P2|Overall Study|Protocol Violation|2
910527|NCT01068912|3001346|P1|Overall Study|Protocol Violation|0
910528|NCT01068912|3001344|P3|Overall Study|Lost to Follow-up|3
910529|NCT01068912|3001345|P2|Overall Study|Lost to Follow-up|7
910530|NCT01068912|3001346|P1|Overall Study|Lost to Follow-up|3
910531|NCT01068912|3001344|P3|Overall Study|Withdrawal by Subject|6
910532|NCT01068912|3001345|P2|Overall Study|Withdrawal by Subject|6
910533|NCT01068912|3001346|P1|Overall Study|Withdrawal by Subject|5
910534|NCT01068912|3001344|P3|Overall Study|Adverse Event|2
910535|NCT01068912|3001345|P2|Overall Study|Adverse Event|3
910536|NCT01068912|3001346|P1|Overall Study|Adverse Event|2
910537|NCT01068860|3001364|P10|Overall Study|Lost to Follow-up|0
910538|NCT01068860|3001365|P9|Overall Study|Lost to Follow-up|0
910539|NCT01068860|3001366|P8|Overall Study|Lost to Follow-up|0
910540|NCT01068860|3001367|P7|Overall Study|Lost to Follow-up|0
910541|NCT01068860|3001368|P6|Overall Study|Lost to Follow-up|0
910542|NCT01068860|3001369|P5|Overall Study|Lost to Follow-up|0
910543|NCT01068860|3001370|P4|Overall Study|Lost to Follow-up|0
910544|NCT01068860|3001371|P3|Overall Study|Lost to Follow-up|0
910545|NCT01068860|3001372|P2|Overall Study|Lost to Follow-up|1
910546|NCT01068860|3001373|P1|Overall Study|Lost to Follow-up|0
910547|NCT01068860|3001364|P10|Overall Study|Administrative problems; misrandomized|1
910548|NCT01068860|3001365|P9|Overall Study|Administrative problems; misrandomized|0
910549|NCT01068860|3001366|P8|Overall Study|Administrative problems; misrandomized|0
910550|NCT01068860|3001367|P7|Overall Study|Administrative problems; misrandomized|0
910551|NCT01068860|3001368|P6|Overall Study|Administrative problems; misrandomized|0
910552|NCT01068860|3001369|P5|Overall Study|Administrative problems; misrandomized|0
910553|NCT01068860|3001370|P4|Overall Study|Administrative problems; misrandomized|1
910554|NCT01068860|3001371|P3|Overall Study|Administrative problems; misrandomized|0
910555|NCT01068860|3001372|P2|Overall Study|Administrative problems; misrandomized|0
910556|NCT01068860|3001373|P1|Overall Study|Administrative problems; misrandomized|0
910557|NCT01068860|3001364|P10|Overall Study|Withdrawal by Subject|3
910558|NCT01068860|3001365|P9|Overall Study|Withdrawal by Subject|0
910559|NCT01068860|3001366|P8|Overall Study|Withdrawal by Subject|0
910560|NCT01068860|3001367|P7|Overall Study|Withdrawal by Subject|0
910561|NCT01068860|3001368|P6|Overall Study|Withdrawal by Subject|2
910562|NCT01068860|3001369|P5|Overall Study|Withdrawal by Subject|0
910563|NCT01068860|3001370|P4|Overall Study|Withdrawal by Subject|0
910564|NCT01068860|3001371|P3|Overall Study|Withdrawal by Subject|0
910565|NCT01068860|3001372|P2|Overall Study|Withdrawal by Subject|0
910566|NCT01068860|3001373|P1|Overall Study|Withdrawal by Subject|0
910567|NCT01068769|3001556|P1|Overall Study|Ineligible|1
910568|NCT01068743|3001561|P4|Period 3|Adverse Event|0
910569|NCT01068743|3001562|P3|Period 3|Adverse Event|0
910570|NCT01068743|3001563|P2|Period 3|Adverse Event|1
910571|NCT01068743|3001564|P1|Period 3|Adverse Event|0
910572|NCT01068730|3001638|P4|Period 4|Family emergency|0
910573|NCT01068730|3001639|P3|Period 4|Family emergency|0
910574|NCT01068730|3001640|P2|Period 4|Family emergency|1
910575|NCT01068730|3001641|P1|Period 4|Family emergency|0
910576|NCT01068730|3001638|P4|Period 3|Personal reason|0
910577|NCT01068730|3001639|P3|Period 3|Personal reason|0
910578|NCT01068730|3001640|P2|Period 3|Personal reason|0
910579|NCT01068730|3001641|P1|Period 3|Personal reason|1
910580|NCT01068717|3001695|P4|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
910581|NCT01068717|3001696|P3|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
910582|NCT01068717|3001697|P2|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
910583|NCT01068717|3001698|P1|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1
910584|NCT01068678|3001754|P2|Overall Study|Unclassified|15
910585|NCT01068678|3001755|P1|Overall Study|Unclassified|18
910586|NCT01068678|3001754|P2|Overall Study|Withdrawal criteria|6
910587|NCT01068678|3001755|P1|Overall Study|Withdrawal criteria|12
910588|NCT01068678|3001754|P2|Overall Study|Protocol Violation|1
910589|NCT01068678|3001755|P1|Overall Study|Protocol Violation|5
910590|NCT01068678|3001754|P2|Overall Study|Lack of Efficacy|2
910591|NCT01068678|3001755|P1|Overall Study|Lack of Efficacy|3
910592|NCT01068665|3001765|P2|Overall Study|Other|12
910593|NCT01068665|3001766|P1|Overall Study|Other|17
910594|NCT01068665|3001765|P2|Overall Study|Withdrawal Criteria|9
910595|NCT01068665|3001766|P1|Overall Study|Withdrawal Criteria|3
910596|NCT01068665|3001765|P2|Overall Study|Protocol Violation|2
910597|NCT01068665|3001766|P1|Overall Study|Protocol Violation|5
910598|NCT01068665|3001765|P2|Overall Study|Lack of Efficacy|2
910599|NCT01068665|3001766|P1|Overall Study|Lack of Efficacy|0
910600|NCT01068665|3001765|P2|Overall Study|Adverse Event|4
910601|NCT01068665|3001766|P1|Overall Study|Adverse Event|5
910602|NCT01068652|3001776|P2|Overall Study|Unclassified|4
910603|NCT01068652|3001777|P1|Overall Study|Unclassified|7
910604|NCT01068652|3001776|P2|Overall Study|Patient was not eligible|0
910605|NCT01068652|3001777|P1|Overall Study|Patient was not eligible|1
910606|NCT01068652|3001776|P2|Overall Study|Withdrawal criteria|2
910607|NCT01068652|3001777|P1|Overall Study|Withdrawal criteria|1
910608|NCT01068652|3001776|P2|Overall Study|Protocol Violation|6
910609|NCT01068652|3001777|P1|Overall Study|Protocol Violation|3
910610|NCT01068652|3001776|P2|Overall Study|Lost to Follow-up|1
910611|NCT01068652|3001777|P1|Overall Study|Lost to Follow-up|2
910612|NCT01068652|3001776|P2|Overall Study|Lack of Efficacy|2
910613|NCT01068652|3001777|P1|Overall Study|Lack of Efficacy|0
910614|NCT01068652|3001776|P2|Overall Study|Adverse Event|0
910615|NCT01068652|3001777|P1|Overall Study|Adverse Event|4
910616|NCT01068626|3001817|P2|Overall Study|Withdrawal by Subject|2
910617|NCT01068626|3001818|P1|Overall Study|Withdrawal by Subject|0
910618|NCT01068626|3001817|P2|Overall Study|Adverse Event|0
910619|NCT01068626|3001818|P1|Overall Study|Adverse Event|3
910620|NCT01068600|3001836|P2|Overall Study|Administrative problems|1
910621|NCT01068600|3001837|P1|Overall Study|Administrative problems|0
910622|NCT01068600|3001836|P2|Overall Study|Unsatisfactory therapeutic effect|4
910623|NCT01068600|3001837|P1|Overall Study|Unsatisfactory therapeutic effect|0
910624|NCT01068600|3001836|P2|Overall Study|Protocol deviation|1
910625|NCT01068600|3001837|P1|Overall Study|Protocol deviation|1
910626|NCT01068600|3001836|P2|Overall Study|Lost to Follow-up|2
910627|NCT01068600|3001837|P1|Overall Study|Lost to Follow-up|1
910628|NCT01068600|3001836|P2|Overall Study|Abnormal laboratory value(s)|0
910629|NCT01068600|3001837|P1|Overall Study|Abnormal laboratory value(s)|1
910630|NCT01068600|3001836|P2|Overall Study|Adverse Event|3
910631|NCT01068600|3001837|P1|Overall Study|Adverse Event|3
910632|NCT01068600|3001836|P2|Overall Study|Withdrawal by Subject|6
910633|NCT01068600|3001837|P1|Overall Study|Withdrawal by Subject|5
910634|NCT01068509|3001857|P3|Overall Study|Reason Not Specified|0
910635|NCT01068509|3001858|P2|Overall Study|Reason Not Specified|1
910636|NCT01068509|3001859|P1|Overall Study|Reason Not Specified|0
910637|NCT01068509|3001857|P3|Overall Study|Withdrew Consent|2
910638|NCT01068509|3001858|P2|Overall Study|Withdrew Consent|1
910639|NCT01068509|3001859|P1|Overall Study|Withdrew Consent|0
910640|NCT01068509|3001857|P3|Overall Study|Lost to Follow-up|0
910641|NCT01068509|3001858|P2|Overall Study|Lost to Follow-up|0
910642|NCT01068509|3001859|P1|Overall Study|Lost to Follow-up|1
910643|NCT01068509|3001857|P3|Overall Study|Disease Progression|18
910644|NCT01068509|3001858|P2|Overall Study|Disease Progression|20
910645|NCT01068509|3001859|P1|Overall Study|Disease Progression|5
910646|NCT01068509|3001857|P3|Overall Study|Death|1
910647|NCT01068509|3001858|P2|Overall Study|Death|0
910648|NCT01068509|3001859|P1|Overall Study|Death|0
910649|NCT01068418|3001872|P1|Overall Study|Physician Decision|12
910650|NCT01068262|3001881|P4|Overall Study|Withdrawal by Subject|0
910651|NCT01068262|3001882|P3|Overall Study|Withdrawal by Subject|0
910652|NCT01068262|3001883|P2|Overall Study|Withdrawal by Subject|1
910653|NCT01068262|3001884|P1|Overall Study|Withdrawal by Subject|0
910654|NCT01068262|3001881|P4|Overall Study|Protocol Violation|0
910655|NCT01068262|3001882|P3|Overall Study|Protocol Violation|0
910656|NCT01068262|3001883|P2|Overall Study|Protocol Violation|0
910657|NCT01068262|3001884|P1|Overall Study|Protocol Violation|1
910658|NCT01068262|3001881|P4|Overall Study|Adverse Event|0
910659|NCT01068262|3001882|P3|Overall Study|Adverse Event|1
910660|NCT01068262|3001883|P2|Overall Study|Adverse Event|0
910661|NCT01068262|3001884|P1|Overall Study|Adverse Event|2
910662|NCT01068158|3001914|P2|Overall Study|Protocol Violation|2
910663|NCT01068158|3001915|P1|Overall Study|Protocol Violation|0
910664|NCT01068158|3001914|P2|Overall Study|Lost to Follow-up|0
910665|NCT01068158|3001915|P1|Overall Study|Lost to Follow-up|7
910666|NCT01068158|3001914|P2|Overall Study|Withdrawal by Subject|2
910667|NCT01068158|3001915|P1|Overall Study|Withdrawal by Subject|1
910668|NCT01067976|3001927|P1|Overall Study|Study prematurely discontinued|2
910669|NCT01067976|3001927|P1|Overall Study|Study drug never administered|20
910670|NCT01067846|3001988|P2|Overall Study|participation in other tx study|0
910671|NCT01067846|3001989|P1|Overall Study|participation in other tx study|1
910672|NCT01067846|3001988|P2|Overall Study|Withdrawal by Subject|0
910673|NCT01067846|3001989|P1|Overall Study|Withdrawal by Subject|1
910674|NCT01067846|3001988|P2|Overall Study|Lost to Follow-up|19
910675|NCT01067846|3001989|P1|Overall Study|Lost to Follow-up|17
910676|NCT01067521|3002047|P2|Open-Label Period|Lost to Follow-up|20
910677|NCT01067521|3002048|P1|Open-Label Period|Lost to Follow-up|21
910678|NCT01067521|3002047|P2|Open-Label Period|Teva requested subject to be withdrawn|2
910679|NCT01067521|3002048|P1|Open-Label Period|Teva requested subject to be withdrawn|5
910680|NCT01067521|3002047|P2|Open-Label Period|Pregnancy|8
910681|NCT01067521|3002048|P1|Open-Label Period|Pregnancy|14
910682|NCT01067521|3002047|P2|Open-Label Period|Protocol Violation|0
910683|NCT01067521|3002048|P1|Open-Label Period|Protocol Violation|3
910684|NCT01067521|3002047|P2|Open-Label Period|Non-compliance with study drug|0
910685|NCT01067521|3002048|P1|Open-Label Period|Non-compliance with study drug|5
910686|NCT01067521|3002047|P2|Open-Label Period|Physician Decision|11
910687|NCT01067521|3002048|P1|Open-Label Period|Physician Decision|13
910688|NCT01067521|3002047|P2|Open-Label Period|Withdrawal by Subject|88
910689|NCT01067521|3002048|P1|Open-Label Period|Withdrawal by Subject|160
910690|NCT01067521|3002047|P2|Open-Label Period|Adverse Event|28
910691|NCT01067521|3002048|P1|Open-Label Period|Adverse Event|30
910692|NCT01067521|3002047|P2|Open-Label Period|Death|1
910693|NCT01067521|3002048|P1|Open-Label Period|Death|3
910694|NCT01067521|3002047|P2|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1
910695|NCT01067521|3002048|P1|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5
910696|NCT01067521|3002047|P2|Double-Blind Placebo-Controlled Period|Pregnancy|4
910697|NCT01067521|3002048|P1|Double-Blind Placebo-Controlled Period|Pregnancy|7
910698|NCT01067521|3002047|P2|Double-Blind Placebo-Controlled Period|Protocol Violation|0
910699|NCT01067521|3002048|P1|Double-Blind Placebo-Controlled Period|Protocol Violation|2
910700|NCT01067521|3002047|P2|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0
910701|NCT01067521|3002048|P1|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2
910702|NCT01067521|3002047|P2|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1
910703|NCT01067521|3002048|P1|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4
910704|NCT01067521|3002047|P2|Double-Blind Placebo-Controlled Period|Physician Decision|1
910705|NCT01067521|3002048|P1|Double-Blind Placebo-Controlled Period|Physician Decision|1
910706|NCT01067521|3002047|P2|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17
910707|NCT01067521|3002048|P1|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34
910708|NCT01067521|3002047|P2|Double-Blind Placebo-Controlled Period|Adverse Event|6
910709|NCT01067521|3002048|P1|Double-Blind Placebo-Controlled Period|Adverse Event|29
910710|NCT01067521|3002047|P2|Double-Blind Placebo-Controlled Period|Death|1
910711|NCT01067521|3002048|P1|Double-Blind Placebo-Controlled Period|Death|0
910712|NCT01067352|3002088|P3|Overall Study|Physician Decision|0
910713|NCT01067352|3002089|P2|Overall Study|Physician Decision|1
910714|NCT01067352|3002090|P1|Overall Study|Physician Decision|0
910715|NCT01067352|3002088|P3|Overall Study|Withdrawal by Subject|1
910716|NCT01067352|3002089|P2|Overall Study|Withdrawal by Subject|2
910717|NCT01067352|3002090|P1|Overall Study|Withdrawal by Subject|1
910718|NCT01067339|3002106|P2|Overall Study|Withdrawal by Subject|5
910719|NCT01067339|3002107|P1|Overall Study|Withdrawal by Subject|6
910720|NCT01067326|3002117|P2|Overall Study|Early Study Termination|1
910721|NCT01067326|3002118|P1|Overall Study|Early Study Termination|1
910722|NCT01067326|3002117|P2|Overall Study|Withdrawal by Subject|0
910723|NCT01067326|3002118|P1|Overall Study|Withdrawal by Subject|1
910724|NCT01067326|3002117|P2|Overall Study|Adverse Event|2
910725|NCT01067326|3002118|P1|Overall Study|Adverse Event|0
910726|NCT01067144|3002132|P2|Follow-up|Death|1
910727|NCT01067144|3002133|P1|Follow-up|Death|0
910728|NCT01067144|3002132|P2|Follow-up|Surgery cancelled|1
910729|NCT01067144|3002133|P1|Follow-up|Surgery cancelled|0
910730|NCT01067144|3002132|P2|Follow-up|Withdrawal by Subject|14
910731|NCT01067144|3002133|P1|Follow-up|Withdrawal by Subject|18
910732|NCT01067144|3002132|P2|Follow-up|Censored owing to second surgery|28
910733|NCT01067144|3002133|P1|Follow-up|Censored owing to second surgery|19
910734|NCT01067144|3002132|P2|Follow-up|Lost to Follow-up|12
910735|NCT01067144|3002133|P1|Follow-up|Lost to Follow-up|22
910736|NCT01067144|3002132|P2|Treatment|Did not receive allocated intervention|7
910737|NCT01067144|3002133|P1|Treatment|Did not receive allocated intervention|4
910738|NCT01067105|3002149|P1|Overall Study|Other|31
910739|NCT01067105|3002149|P1|Overall Study|Physician Decision|6
910740|NCT01067105|3002149|P1|Overall Study|Lost to Follow-up|6
910741|NCT01067105|3002149|P1|Overall Study|Withdrawal by Subject|36
910742|NCT01067105|3002149|P1|Overall Study|Protocol Violation|48
910743|NCT01067105|3002149|P1|Overall Study|Adverse Event|14
910744|NCT01066923|3002170|P4|Overall Study|Withdrawal by Subject|8
910745|NCT01066923|3002171|P3|Overall Study|Withdrawal by Subject|8
910746|NCT01066923|3002172|P2|Overall Study|Withdrawal by Subject|3
910747|NCT01066923|3002173|P1|Overall Study|Withdrawal by Subject|3
910748|NCT01066897|3002197|P2|Overall Study|stopped study after developing the flu.|0
910749|NCT01066897|3002198|P1|Overall Study|stopped study after developing the flu.|1
910750|NCT01066897|3002197|P2|Overall Study|Withdrawal by Subject|0
910751|NCT01066897|3002198|P1|Overall Study|Withdrawal by Subject|1
910752|NCT01066871|3002212|P4|Overall Study|Other|2
910753|NCT01066871|3002213|P3|Overall Study|Other|1
910754|NCT01066871|3002214|P2|Overall Study|Other|2
910755|NCT01066871|3002215|P1|Overall Study|Other|0
910756|NCT01066871|3002212|P4|Overall Study|Withdrawal by Subject|0
910757|NCT01066871|3002213|P3|Overall Study|Withdrawal by Subject|0
910758|NCT01066871|3002214|P2|Overall Study|Withdrawal by Subject|1
910759|NCT01066871|3002215|P1|Overall Study|Withdrawal by Subject|3
910760|NCT01066871|3002212|P4|Overall Study|Lack of Efficacy|1
910761|NCT01066871|3002213|P3|Overall Study|Lack of Efficacy|0
910762|NCT01066871|3002214|P2|Overall Study|Lack of Efficacy|0
910763|NCT01066871|3002215|P1|Overall Study|Lack of Efficacy|0
910764|NCT01066871|3002212|P4|Overall Study|Protocol Violation|2
910765|NCT01066871|3002213|P3|Overall Study|Protocol Violation|3
910766|NCT01066871|3002214|P2|Overall Study|Protocol Violation|0
910767|NCT01066871|3002215|P1|Overall Study|Protocol Violation|1
910768|NCT01066871|3002212|P4|Overall Study|Lost to Follow-up|0
910769|NCT01066871|3002213|P3|Overall Study|Lost to Follow-up|2
910770|NCT01066871|3002214|P2|Overall Study|Lost to Follow-up|2
910771|NCT01066871|3002215|P1|Overall Study|Lost to Follow-up|0
910772|NCT01066819|3002279|P6|Overall Study|Other|0
910773|NCT01066819|3002280|P5|Overall Study|Other|0
910774|NCT01066819|3002281|P4|Overall Study|Other|0
910775|NCT01066819|3002282|P3|Overall Study|Other|1
910776|NCT01066819|3002283|P2|Overall Study|Other|1
910777|NCT01066819|3002284|P1|Overall Study|Other|5
910778|NCT01066819|3002279|P6|Overall Study|Treatment stopped|0
910779|NCT01066819|3002280|P5|Overall Study|Treatment stopped|0
910780|NCT01066819|3002281|P4|Overall Study|Treatment stopped|1
910781|NCT01066819|3002282|P3|Overall Study|Treatment stopped|2
910782|NCT01066819|3002283|P2|Overall Study|Treatment stopped|1
910783|NCT01066819|3002284|P1|Overall Study|Treatment stopped|12
910784|NCT01066819|3002279|P6|Overall Study|Treatment never started|2
910785|NCT01066819|3002280|P5|Overall Study|Treatment never started|2
910786|NCT01066819|3002281|P4|Overall Study|Treatment never started|3
910787|NCT01066819|3002282|P3|Overall Study|Treatment never started|19
910788|NCT01066819|3002283|P2|Overall Study|Treatment never started|19
910789|NCT01066819|3002284|P1|Overall Study|Treatment never started|85
910790|NCT01066819|3002279|P6|Overall Study|Spontaneous cure|0
910791|NCT01066819|3002280|P5|Overall Study|Spontaneous cure|0
910792|NCT01066819|3002281|P4|Overall Study|Spontaneous cure|0
910793|NCT01066819|3002282|P3|Overall Study|Spontaneous cure|0
910794|NCT01066819|3002283|P2|Overall Study|Spontaneous cure|0
910795|NCT01066819|3002284|P1|Overall Study|Spontaneous cure|1
910796|NCT01066819|3002279|P6|Overall Study|Screen failure|0
910797|NCT01066819|3002280|P5|Overall Study|Screen failure|0
910798|NCT01066819|3002281|P4|Overall Study|Screen failure|0
910799|NCT01066819|3002282|P3|Overall Study|Screen failure|0
910800|NCT01066819|3002283|P2|Overall Study|Screen failure|0
910801|NCT01066819|3002284|P1|Overall Study|Screen failure|1
910802|NCT01066819|3002279|P6|Overall Study|Results not available|0
910803|NCT01066819|3002280|P5|Overall Study|Results not available|0
910804|NCT01066819|3002281|P4|Overall Study|Results not available|0
910805|NCT01066819|3002282|P3|Overall Study|Results not available|0
910806|NCT01066819|3002283|P2|Overall Study|Results not available|0
910807|NCT01066819|3002284|P1|Overall Study|Results not available|1
910808|NCT01066819|3002279|P6|Overall Study|Relapse|0
910809|NCT01066819|3002280|P5|Overall Study|Relapse|0
910810|NCT01066819|3002281|P4|Overall Study|Relapse|0
910811|NCT01066819|3002282|P3|Overall Study|Relapse|3
910812|NCT01066819|3002283|P2|Overall Study|Relapse|4
910813|NCT01066819|3002284|P1|Overall Study|Relapse|16
910814|NCT01066819|3002279|P6|Overall Study|Not categorised|0
910815|NCT01066819|3002280|P5|Overall Study|Not categorised|0
910816|NCT01066819|3002281|P4|Overall Study|Not categorised|1
910817|NCT01066819|3002282|P3|Overall Study|Not categorised|6
910818|NCT01066819|3002283|P2|Overall Study|Not categorised|2
910819|NCT01066819|3002284|P1|Overall Study|Not categorised|9
910820|NCT01066819|3002279|P6|Overall Study|Non responders|1
910821|NCT01066819|3002280|P5|Overall Study|Non responders|0
910822|NCT01066819|3002281|P4|Overall Study|Non responders|2
910823|NCT01066819|3002282|P3|Overall Study|Non responders|7
910824|NCT01066819|3002283|P2|Overall Study|Non responders|2
910825|NCT01066819|3002284|P1|Overall Study|Non responders|123
910826|NCT01066819|3002279|P6|Overall Study|Miscellaneous|0
910827|NCT01066819|3002280|P5|Overall Study|Miscellaneous|0
910828|NCT01066819|3002281|P4|Overall Study|Miscellaneous|1
910829|NCT01066819|3002282|P3|Overall Study|Miscellaneous|18
910830|NCT01066819|3002283|P2|Overall Study|Miscellaneous|10
910831|NCT01066819|3002284|P1|Overall Study|Miscellaneous|28
910832|NCT01066819|3002279|P6|Overall Study|Lab test not done|0
910833|NCT01066819|3002280|P5|Overall Study|Lab test not done|0
910834|NCT01066819|3002281|P4|Overall Study|Lab test not done|1
910835|NCT01066819|3002282|P3|Overall Study|Lab test not done|2
910836|NCT01066819|3002283|P2|Overall Study|Lab test not done|0
910837|NCT01066819|3002284|P1|Overall Study|Lab test not done|9
910838|NCT01066819|3002279|P6|Overall Study|Failed to return|3
910839|NCT01066819|3002280|P5|Overall Study|Failed to return|2
910840|NCT01066819|3002281|P4|Overall Study|Failed to return|7
910841|NCT01066819|3002282|P3|Overall Study|Failed to return|68
910842|NCT01066819|3002283|P2|Overall Study|Failed to return|107
910843|NCT01066819|3002284|P1|Overall Study|Failed to return|298
910844|NCT01066819|3002279|P6|Overall Study|Early termination|0
910845|NCT01066819|3002280|P5|Overall Study|Early termination|0
910846|NCT01066819|3002281|P4|Overall Study|Early termination|0
910847|NCT01066819|3002282|P3|Overall Study|Early termination|0
910848|NCT01066819|3002283|P2|Overall Study|Early termination|0
910849|NCT01066819|3002284|P1|Overall Study|Early termination|2
910850|NCT01066819|3002279|P6|Overall Study|Not met inclusion/exclusion criteria|0
910851|NCT01066819|3002280|P5|Overall Study|Not met inclusion/exclusion criteria|0
910852|NCT01066819|3002281|P4|Overall Study|Not met inclusion/exclusion criteria|0
910853|NCT01066819|3002282|P3|Overall Study|Not met inclusion/exclusion criteria|0
910854|NCT01066819|3002283|P2|Overall Study|Not met inclusion/exclusion criteria|0
910855|NCT01066819|3002284|P1|Overall Study|Not met inclusion/exclusion criteria|1
910856|NCT01066819|3002279|P6|Overall Study|Administrative|0
910857|NCT01066819|3002280|P5|Overall Study|Administrative|0
910858|NCT01066819|3002281|P4|Overall Study|Administrative|0
910859|NCT01066819|3002282|P3|Overall Study|Administrative|2
910860|NCT01066819|3002283|P2|Overall Study|Administrative|4
910861|NCT01066819|3002284|P1|Overall Study|Administrative|6
910862|NCT01066819|3002279|P6|Overall Study|Withdrawal by Subject|0
910863|NCT01066819|3002280|P5|Overall Study|Withdrawal by Subject|0
910864|NCT01066819|3002281|P4|Overall Study|Withdrawal by Subject|0
910865|NCT01066819|3002282|P3|Overall Study|Withdrawal by Subject|6
910866|NCT01066819|3002283|P2|Overall Study|Withdrawal by Subject|11
910867|NCT01066819|3002284|P1|Overall Study|Withdrawal by Subject|29
910868|NCT01066819|3002279|P6|Overall Study|Protocol Violation|0
910869|NCT01066819|3002280|P5|Overall Study|Protocol Violation|0
910870|NCT01066819|3002281|P4|Overall Study|Protocol Violation|0
910871|NCT01066819|3002282|P3|Overall Study|Protocol Violation|0
910872|NCT01066819|3002283|P2|Overall Study|Protocol Violation|6
910873|NCT01066819|3002284|P1|Overall Study|Protocol Violation|12
910874|NCT01066819|3002279|P6|Overall Study|Physician Decision|0
910875|NCT01066819|3002280|P5|Overall Study|Physician Decision|0
910876|NCT01066819|3002281|P4|Overall Study|Physician Decision|0
910877|NCT01066819|3002282|P3|Overall Study|Physician Decision|3
910878|NCT01066819|3002283|P2|Overall Study|Physician Decision|2
910879|NCT01066819|3002284|P1|Overall Study|Physician Decision|6
910880|NCT01066819|3002279|P6|Overall Study|Lack of Efficacy|0
910881|NCT01066819|3002280|P5|Overall Study|Lack of Efficacy|0
910882|NCT01066819|3002281|P4|Overall Study|Lack of Efficacy|1
910883|NCT01066819|3002282|P3|Overall Study|Lack of Efficacy|2
910884|NCT01066819|3002283|P2|Overall Study|Lack of Efficacy|1
910885|NCT01066819|3002284|P1|Overall Study|Lack of Efficacy|22
910886|NCT01066819|3002279|P6|Overall Study|Death|0
910887|NCT01066819|3002280|P5|Overall Study|Death|0
910888|NCT01066819|3002281|P4|Overall Study|Death|0
910889|NCT01066819|3002282|P3|Overall Study|Death|1
910890|NCT01066819|3002283|P2|Overall Study|Death|0
910891|NCT01066819|3002284|P1|Overall Study|Death|5
910892|NCT01066819|3002279|P6|Overall Study|Adverse Event|0
910893|NCT01066819|3002280|P5|Overall Study|Adverse Event|0
910894|NCT01066819|3002281|P4|Overall Study|Adverse Event|0
910895|NCT01066819|3002282|P3|Overall Study|Adverse Event|6
910896|NCT01066819|3002283|P2|Overall Study|Adverse Event|1
910897|NCT01066819|3002284|P1|Overall Study|Adverse Event|18
910898|NCT01066793|3002425|P6|Overall Study|Treatment Stopped|0
910899|NCT01066793|3002426|P5|Overall Study|Treatment Stopped|0
910900|NCT01066793|3002427|P4|Overall Study|Treatment Stopped|1
910901|NCT01066793|3002428|P3|Overall Study|Treatment Stopped|0
910902|NCT01066793|3002429|P2|Overall Study|Treatment Stopped|1
910903|NCT01066793|3002430|P1|Overall Study|Treatment Stopped|2
910904|NCT01066793|3002425|P6|Overall Study|Treatment Never Started|0
910905|NCT01066793|3002426|P5|Overall Study|Treatment Never Started|0
910906|NCT01066793|3002427|P4|Overall Study|Treatment Never Started|1
910907|NCT01066793|3002428|P3|Overall Study|Treatment Never Started|4
910908|NCT01066793|3002429|P2|Overall Study|Treatment Never Started|5
910909|NCT01066793|3002430|P1|Overall Study|Treatment Never Started|18
910910|NCT01066793|3002425|P6|Overall Study|Treatment Interrupted|0
910911|NCT01066793|3002426|P5|Overall Study|Treatment Interrupted|0
910912|NCT01066793|3002427|P4|Overall Study|Treatment Interrupted|0
910913|NCT01066793|3002428|P3|Overall Study|Treatment Interrupted|0
910914|NCT01066793|3002429|P2|Overall Study|Treatment Interrupted|1
910915|NCT01066793|3002430|P1|Overall Study|Treatment Interrupted|1
910916|NCT01066793|3002425|P6|Overall Study|Result Not Available|0
910917|NCT01066793|3002426|P5|Overall Study|Result Not Available|0
910918|NCT01066793|3002427|P4|Overall Study|Result Not Available|0
910919|NCT01066793|3002428|P3|Overall Study|Result Not Available|0
910920|NCT01066793|3002429|P2|Overall Study|Result Not Available|0
910921|NCT01066793|3002430|P1|Overall Study|Result Not Available|1
910922|NCT01066793|3002425|P6|Overall Study|Relapse|0
910923|NCT01066793|3002426|P5|Overall Study|Relapse|0
910924|NCT01066793|3002427|P4|Overall Study|Relapse|3
910925|NCT01066793|3002428|P3|Overall Study|Relapse|2
910926|NCT01066793|3002429|P2|Overall Study|Relapse|8
910927|NCT01066793|3002430|P1|Overall Study|Relapse|20
910928|NCT01066793|3002425|P6|Overall Study|Other|0
910929|NCT01066793|3002426|P5|Overall Study|Other|0
910930|NCT01066793|3002427|P4|Overall Study|Other|2
910931|NCT01066793|3002428|P3|Overall Study|Other|6
910932|NCT01066793|3002429|P2|Overall Study|Other|5
910933|NCT01066793|3002430|P1|Overall Study|Other|15
910934|NCT01066793|3002425|P6|Overall Study|Non-responders|0
910935|NCT01066793|3002426|P5|Overall Study|Non-responders|0
910936|NCT01066793|3002427|P4|Overall Study|Non-responders|25
910937|NCT01066793|3002428|P3|Overall Study|Non-responders|11
910938|NCT01066793|3002429|P2|Overall Study|Non-responders|5
910939|NCT01066793|3002430|P1|Overall Study|Non-responders|104
910940|NCT01066793|3002425|P6|Overall Study|Miscellaneous|0
910941|NCT01066793|3002426|P5|Overall Study|Miscellaneous|0
910942|NCT01066793|3002427|P4|Overall Study|Miscellaneous|0
910943|NCT01066793|3002428|P3|Overall Study|Miscellaneous|6
910944|NCT01066793|3002429|P2|Overall Study|Miscellaneous|5
910945|NCT01066793|3002430|P1|Overall Study|Miscellaneous|4
910946|NCT01066793|3002425|P6|Overall Study|Lab test not done|0
910947|NCT01066793|3002426|P5|Overall Study|Lab test not done|0
910948|NCT01066793|3002427|P4|Overall Study|Lab test not done|1
910949|NCT01066793|3002428|P3|Overall Study|Lab test not done|0
910950|NCT01066793|3002429|P2|Overall Study|Lab test not done|0
910951|NCT01066793|3002430|P1|Overall Study|Lab test not done|7
910952|NCT01066793|3002425|P6|Overall Study|Early Termination|0
910953|NCT01066793|3002426|P5|Overall Study|Early Termination|0
910954|NCT01066793|3002427|P4|Overall Study|Early Termination|0
910955|NCT01066793|3002428|P3|Overall Study|Early Termination|0
910956|NCT01066793|3002429|P2|Overall Study|Early Termination|0
910957|NCT01066793|3002430|P1|Overall Study|Early Termination|3
910958|NCT01066793|3002425|P6|Overall Study|Withdrawal by Subject|0
910959|NCT01066793|3002426|P5|Overall Study|Withdrawal by Subject|0
910960|NCT01066793|3002427|P4|Overall Study|Withdrawal by Subject|0
910961|NCT01066793|3002428|P3|Overall Study|Withdrawal by Subject|1
910962|NCT01066793|3002429|P2|Overall Study|Withdrawal by Subject|4
910963|NCT01066793|3002430|P1|Overall Study|Withdrawal by Subject|7
910964|NCT01066793|3002425|P6|Overall Study|Protocol Violation|0
910965|NCT01066793|3002426|P5|Overall Study|Protocol Violation|0
910966|NCT01066793|3002427|P4|Overall Study|Protocol Violation|0
910967|NCT01066793|3002428|P3|Overall Study|Protocol Violation|2
910968|NCT01066793|3002429|P2|Overall Study|Protocol Violation|2
910969|NCT01066793|3002430|P1|Overall Study|Protocol Violation|3
910970|NCT01066793|3002425|P6|Overall Study|Physician Decision|0
910971|NCT01066793|3002426|P5|Overall Study|Physician Decision|0
910972|NCT01066793|3002427|P4|Overall Study|Physician Decision|0
910973|NCT01066793|3002428|P3|Overall Study|Physician Decision|0
910974|NCT01066793|3002429|P2|Overall Study|Physician Decision|0
910975|NCT01066793|3002430|P1|Overall Study|Physician Decision|3
910976|NCT01066793|3002425|P6|Overall Study|Lost to Follow-up|1
910977|NCT01066793|3002426|P5|Overall Study|Lost to Follow-up|0
910978|NCT01066793|3002427|P4|Overall Study|Lost to Follow-up|16
910979|NCT01066793|3002428|P3|Overall Study|Lost to Follow-up|82
910980|NCT01066793|3002429|P2|Overall Study|Lost to Follow-up|39
910981|NCT01066793|3002430|P1|Overall Study|Lost to Follow-up|180
910982|NCT01066793|3002425|P6|Overall Study|Lack of Efficacy|0
910983|NCT01066793|3002426|P5|Overall Study|Lack of Efficacy|0
910984|NCT01066793|3002427|P4|Overall Study|Lack of Efficacy|0
910985|NCT01066793|3002428|P3|Overall Study|Lack of Efficacy|0
910986|NCT01066793|3002429|P2|Overall Study|Lack of Efficacy|1
910987|NCT01066793|3002430|P1|Overall Study|Lack of Efficacy|2
910988|NCT01066793|3002425|P6|Overall Study|Death|0
910989|NCT01066793|3002426|P5|Overall Study|Death|0
910990|NCT01066793|3002427|P4|Overall Study|Death|0
910991|NCT01066793|3002428|P3|Overall Study|Death|1
910992|NCT01066793|3002429|P2|Overall Study|Death|1
910993|NCT01066793|3002430|P1|Overall Study|Death|4
910994|NCT01066780|3002570|P2|Overall Study|Withdrawn prior to ClearVoice exposure.|1
910995|NCT01066780|3002571|P1|Overall Study|Withdrawn prior to ClearVoice exposure.|1
910996|NCT01066585|3002590|P2|Overall Study|Withdrawal by Subject|3
910997|NCT01066585|3002591|P1|Overall Study|Withdrawal by Subject|0
910998|NCT01066585|3002590|P2|Overall Study|Protocol Violation|0
910999|NCT01066585|3002591|P1|Overall Study|Protocol Violation|1
911000|NCT01066546|3002603|P1|Overall Study|Study terminated by sponsor|5
911001|NCT01066156|3002633|P1|Overall Study|Withdrawal by Subject|1
911002|NCT01066156|3002633|P1|Overall Study|Lost to Follow-up|7
911003|NCT01066156|3002633|P1|Overall Study|ineligible|2
911004|NCT01066143|3002637|P1|Overall Study|ineligible for the study|8
911005|NCT01066104|3002643|P2|Overall Study|Protocol Violation|0
911006|NCT01066104|3002644|P1|Overall Study|Protocol Violation|1
911007|NCT01066104|3002643|P2|Overall Study|Adverse Event|1
911008|NCT01066104|3002644|P1|Overall Study|Adverse Event|1
911009|NCT01066039|3002652|P1|Overall Study|Drug/Dose Adjustment Required|1
911010|NCT01066039|3002652|P1|Overall Study|Failure to Control Blood Pressure|1
911011|NCT01066039|3002652|P1|Overall Study|Volunteer Failed to Make the Next Visit|2
911012|NCT01066039|3002652|P1|Overall Study|Additional Antihypertensive Required|4
911013|NCT01066039|3002652|P1|Overall Study|Dropout due to Insulin Administration|1
911014|NCT01066039|3002652|P1|Overall Study|Investigator’s Request|1
911015|NCT01066039|3002652|P1|Overall Study|Inclusion/Exclusion Criteria Violation|9
911016|NCT01066039|3002652|P1|Overall Study|Protocol Violation|2
911017|NCT01066039|3002652|P1|Overall Study|Withdrawal by Subject|17
911018|NCT01066039|3002652|P1|Overall Study|Adverse Event|6
911019|NCT01066000|3002665|P1|Overall Study|Adverse Event|1
911020|NCT01066000|3002665|P1|Overall Study|Withdrawal by Subject|1
911021|NCT01066000|3002665|P1|Overall Study|Death|3
911022|NCT01066000|3002665|P1|Overall Study|Protocol Violation|4
911023|NCT01065844|3002676|P1|Overall Study|Adverse Event|5
911024|NCT01065818|3002680|P1|Overall Study|Not a candidate for surgery|1
911025|NCT01065818|3002680|P1|Overall Study|Withdrawal by Subject|1
911026|NCT01065779|3002684|P1|Overall Study|Inclusion Criteria Violation|7
911027|NCT01065779|3002684|P1|Overall Study|Failed to Follow-up|10
911028|NCT01065779|3002684|P1|Overall Study|Not Administered With Study Drug|17
911029|NCT01065779|3002684|P1|Overall Study|Non-enrollment Period Administration|10
911030|NCT01065779|3002684|P1|Overall Study|Investigation Before Contract Date|37
911031|NCT01065779|3002684|P1|Overall Study|Duplicate Investigation|1
911032|NCT01065766|3002695|P1|Overall Study|Violated dosage/administration|25
911033|NCT01065766|3002695|P1|Overall Study|Contraindication to administration|6
911034|NCT01065766|3002695|P1|Overall Study|Assessed before the contracted date|1
911035|NCT01065597|3002714|P1|Overall Study|Adverse Event|1
911036|NCT01065454|3002748|P4|Follow up|study ongoing|41
911037|NCT01065454|3002749|P3|Follow up|study ongoing|15
911038|NCT01065454|3002750|P2|Follow up|study ongoing|22
911039|NCT01065454|3002751|P1|Follow up|study ongoing|37
911040|NCT01065454|3002748|P4|Follow up|Withdrawal by Subject|0
911041|NCT01065454|3002749|P3|Follow up|Withdrawal by Subject|1
911042|NCT01065454|3002750|P2|Follow up|Withdrawal by Subject|1
911043|NCT01065454|3002751|P1|Follow up|Withdrawal by Subject|1
911044|NCT01065454|3002748|P4|Follow up|Progressive disease|1
911045|NCT01065454|3002749|P3|Follow up|Progressive disease|0
911046|NCT01065454|3002750|P2|Follow up|Progressive disease|0
911047|NCT01065454|3002751|P1|Follow up|Progressive disease|0
911048|NCT01065454|3002748|P4|Follow up|Lost to Follow-up|1
911049|NCT01065454|3002749|P3|Follow up|Lost to Follow-up|0
911050|NCT01065454|3002750|P2|Follow up|Lost to Follow-up|0
911051|NCT01065454|3002751|P1|Follow up|Lost to Follow-up|0
911052|NCT01065454|3002748|P4|Follow up|Death|0
911053|NCT01065454|3002749|P3|Follow up|Death|1
911054|NCT01065454|3002750|P2|Follow up|Death|1
911055|NCT01065454|3002751|P1|Follow up|Death|0
911056|NCT01065454|3002748|P4|Follow up|Adverse Event|1
911057|NCT01065454|3002749|P3|Follow up|Adverse Event|0
911058|NCT01065454|3002750|P2|Follow up|Adverse Event|0
911059|NCT01065454|3002751|P1|Follow up|Adverse Event|1
911060|NCT01065454|3002748|P4|Treatment|Withdrawal by Subject|3
911061|NCT01065454|3002749|P3|Treatment|Withdrawal by Subject|2
911062|NCT01065454|3002750|P2|Treatment|Withdrawal by Subject|1
911063|NCT01065454|3002751|P1|Treatment|Withdrawal by Subject|3
911064|NCT01065454|3002748|P4|Treatment|Protocol Violation|0
911065|NCT01065454|3002749|P3|Treatment|Protocol Violation|1
911066|NCT01065454|3002750|P2|Treatment|Protocol Violation|0
911067|NCT01065454|3002751|P1|Treatment|Protocol Violation|1
911068|NCT01065454|3002748|P4|Treatment|Protocol Decision|2
911069|NCT01065454|3002749|P3|Treatment|Protocol Decision|3
911070|NCT01065454|3002750|P2|Treatment|Protocol Decision|0
911071|NCT01065454|3002751|P1|Treatment|Protocol Decision|0
911072|NCT01065454|3002748|P4|Treatment|Non-compliance|1
911073|NCT01065454|3002749|P3|Treatment|Non-compliance|0
911074|NCT01065454|3002750|P2|Treatment|Non-compliance|0
911075|NCT01065454|3002751|P1|Treatment|Non-compliance|1
911076|NCT01065454|3002748|P4|Treatment|Death|0
911077|NCT01065454|3002749|P3|Treatment|Death|0
911078|NCT01065454|3002750|P2|Treatment|Death|0
911079|NCT01065454|3002751|P1|Treatment|Death|1
911080|NCT01065454|3002748|P4|Treatment|Adverse Event|6
911081|NCT01065454|3002749|P3|Treatment|Adverse Event|3
911082|NCT01065454|3002750|P2|Treatment|Adverse Event|4
911083|NCT01065454|3002751|P1|Treatment|Adverse Event|7
911084|NCT01065350|3002874|P2|Overall Study|Received incorrect drug allocation|1
911085|NCT01065350|3002875|P1|Overall Study|Received incorrect drug allocation|0
911086|NCT01064947|3002936|P1|Overall Study|negative culture|41
911087|NCT01064856|3002977|P4|Open-label (OL) Period|Not specified|7
911088|NCT01064856|3002978|P3|Open-label (OL) Period|Not specified|7
911089|NCT01064856|3002979|P2|Open-label (OL) Period|Not specified|0
911090|NCT01064856|3002980|P1|Open-label (OL) Period|Not specified|0
911091|NCT01064856|3002977|P4|Open-label (OL) Period|Lost to Follow-up|1
911092|NCT01064856|3002978|P3|Open-label (OL) Period|Lost to Follow-up|2
911093|NCT01064856|3002979|P2|Open-label (OL) Period|Lost to Follow-up|0
911094|NCT01064856|3002980|P1|Open-label (OL) Period|Lost to Follow-up|0
911095|NCT01064856|3002977|P4|Open-label (OL) Period|Consent withdrawn by participant|6
911096|NCT01064856|3002978|P3|Open-label (OL) Period|Consent withdrawn by participant|5
911097|NCT01064856|3002979|P2|Open-label (OL) Period|Consent withdrawn by participant|0
911098|NCT01064856|3002980|P1|Open-label (OL) Period|Consent withdrawn by participant|0
911099|NCT01064856|3002977|P4|Open-label (OL) Period|Adverse Event|6
911100|NCT01064856|3002978|P3|Open-label (OL) Period|Adverse Event|12
911101|NCT01064856|3002979|P2|Open-label (OL) Period|Adverse Event|0
911102|NCT01064856|3002980|P1|Open-label (OL) Period|Adverse Event|0
911103|NCT01064856|3002977|P4|Double-blind (DB) Period|Consent withdrawn by participant|0
911104|NCT01064856|3002978|P3|Double-blind (DB) Period|Consent withdrawn by participant|0
911105|NCT01064856|3002979|P2|Double-blind (DB) Period|Consent withdrawn by participant|0
911106|NCT01064856|3002980|P1|Double-blind (DB) Period|Consent withdrawn by participant|1
911107|NCT01064856|3002977|P4|Double-blind (DB) Period|Adverse Event|0
911108|NCT01064856|3002978|P3|Double-blind (DB) Period|Adverse Event|0
911109|NCT01064856|3002979|P2|Double-blind (DB) Period|Adverse Event|0
911110|NCT01064856|3002980|P1|Double-blind (DB) Period|Adverse Event|1
911111|NCT01064817|3003024|P2|Study Completion|Withdrawal by Subject|0
911112|NCT01064817|3003025|P1|Study Completion|Withdrawal by Subject|1
911113|NCT01064817|3003024|P2|Study Completion|Physician Decision|0
911114|NCT01064817|3003025|P1|Study Completion|Physician Decision|1
911115|NCT01064739|3003037|P1|Fixed Sodium Diet + Fava Beans|Adverse Event|1
911116|NCT01064687|3003108|P4|Overall Study|Treatment Noncompliance|0
911117|NCT01064687|3003109|P3|Overall Study|Treatment Noncompliance|1
911118|NCT01064687|3003110|P2|Overall Study|Treatment Noncompliance|1
911119|NCT01064687|3003111|P1|Overall Study|Treatment Noncompliance|1
911120|NCT01064687|3003108|P4|Overall Study|Withdrawal by Subject|5
911121|NCT01064687|3003109|P3|Overall Study|Withdrawal by Subject|12
911122|NCT01064687|3003110|P2|Overall Study|Withdrawal by Subject|7
911123|NCT01064687|3003111|P1|Overall Study|Withdrawal by Subject|9
911124|NCT01064687|3003108|P4|Overall Study|Sponsor Decision|0
911125|NCT01064687|3003109|P3|Overall Study|Sponsor Decision|3
911126|NCT01064687|3003110|P2|Overall Study|Sponsor Decision|0
911127|NCT01064687|3003111|P1|Overall Study|Sponsor Decision|0
911128|NCT01064687|3003108|P4|Overall Study|Protocol Violation|1
911129|NCT01064687|3003109|P3|Overall Study|Protocol Violation|0
911130|NCT01064687|3003110|P2|Overall Study|Protocol Violation|1
911131|NCT01064687|3003111|P1|Overall Study|Protocol Violation|1
911132|NCT01064687|3003108|P4|Overall Study|Physician Decision|0
911133|NCT01064687|3003109|P3|Overall Study|Physician Decision|0
911134|NCT01064687|3003110|P2|Overall Study|Physician Decision|2
911135|NCT01064687|3003111|P1|Overall Study|Physician Decision|2
911136|NCT01064687|3003108|P4|Overall Study|Lost to Follow-up|5
911137|NCT01064687|3003109|P3|Overall Study|Lost to Follow-up|13
911138|NCT01064687|3003110|P2|Overall Study|Lost to Follow-up|10
911139|NCT01064687|3003111|P1|Overall Study|Lost to Follow-up|7
911140|NCT01064687|3003108|P4|Overall Study|Lack of Efficacy|3
911141|NCT01064687|3003109|P3|Overall Study|Lack of Efficacy|2
911142|NCT01064687|3003110|P2|Overall Study|Lack of Efficacy|0
911143|NCT01064687|3003111|P1|Overall Study|Lack of Efficacy|1
911144|NCT01064687|3003108|P4|Overall Study|Entry Criteria Not Met|0
911145|NCT01064687|3003109|P3|Overall Study|Entry Criteria Not Met|0
911146|NCT01064687|3003110|P2|Overall Study|Entry Criteria Not Met|0
911147|NCT01064687|3003111|P1|Overall Study|Entry Criteria Not Met|3
911148|NCT01064687|3003108|P4|Overall Study|Death|0
911149|NCT01064687|3003109|P3|Overall Study|Death|0
911150|NCT01064687|3003110|P2|Overall Study|Death|1
911151|NCT01064687|3003111|P1|Overall Study|Death|1
911152|NCT01064687|3003108|P4|Overall Study|Adverse Event|3
911153|NCT01064687|3003109|P3|Overall Study|Adverse Event|10
911154|NCT01064687|3003110|P2|Overall Study|Adverse Event|4
911155|NCT01064687|3003111|P1|Overall Study|Adverse Event|9
911156|NCT01064622|3003291|P2|Randomized Phase II|Protocol Violation|1
911157|NCT01064622|3003292|P1|Randomized Phase II|Protocol Violation|0
911158|NCT01064622|3003291|P2|Randomized Phase II|Withdrawal by Subject|2
911159|NCT01064622|3003292|P1|Randomized Phase II|Withdrawal by Subject|2
911160|NCT01064414|3003316|P3|Extension Period: Week 26 to Week 52|Not specified|1
911161|NCT01064414|3003317|P2|Extension Period: Week 26 to Week 52|Not specified|2
911162|NCT01064414|3003318|P1|Extension Period: Week 26 to Week 52|Not specified|5
911163|NCT01064414|3003316|P3|Extension Period: Week 26 to Week 52|Protocol Violation|1
911164|NCT01064414|3003317|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
911165|NCT01064414|3003318|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
911166|NCT01064414|3003316|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
911167|NCT01064414|3003317|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
911168|NCT01064414|3003318|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
911169|NCT01064414|3003316|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
911170|NCT01064414|3003317|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
911171|NCT01064414|3003318|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
911172|NCT01064414|3003316|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
911173|NCT01064414|3003317|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
911174|NCT01064414|3003318|P1|Extension Period: Week 26 to Week 52|Physician Decision|1
911175|NCT01064414|3003316|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
911176|NCT01064414|3003317|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
911177|NCT01064414|3003318|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
911178|NCT01064414|3003316|P3|Extension Period: Week 26 to Week 52|Death|0
911179|NCT01064414|3003317|P2|Extension Period: Week 26 to Week 52|Death|1
911180|NCT01064414|3003318|P1|Extension Period: Week 26 to Week 52|Death|0
911181|NCT01064414|3003316|P3|Extension Period: Week 26 to Week 52|Adverse Event|2
911182|NCT01064414|3003317|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
911183|NCT01064414|3003318|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
911184|NCT01064414|3003316|P3|Core Period: Baseline to Week 26|Not specified|2
911185|NCT01064414|3003317|P2|Core Period: Baseline to Week 26|Not specified|7
911186|NCT01064414|3003318|P1|Core Period: Baseline to Week 26|Not specified|4
911187|NCT01064414|3003316|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
911188|NCT01064414|3003317|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
911189|NCT01064414|3003318|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
911190|NCT01064414|3003316|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|2
911191|NCT01064414|3003317|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|2
911192|NCT01064414|3003318|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
911193|NCT01064414|3003316|P3|Core Period: Baseline to Week 26|Protocol Violation|1
911194|NCT01064414|3003317|P2|Core Period: Baseline to Week 26|Protocol Violation|0
911195|NCT01064414|3003318|P1|Core Period: Baseline to Week 26|Protocol Violation|1
911196|NCT01064414|3003316|P3|Core Period: Baseline to Week 26|Death|0
911197|NCT01064414|3003317|P2|Core Period: Baseline to Week 26|Death|1
911198|NCT01064414|3003318|P1|Core Period: Baseline to Week 26|Death|0
911199|NCT01064414|3003316|P3|Core Period: Baseline to Week 26|Adverse Event|2
911200|NCT01064414|3003317|P2|Core Period: Baseline to Week 26|Adverse Event|4
911201|NCT01064414|3003318|P1|Core Period: Baseline to Week 26|Adverse Event|4
911202|NCT01064401|3003337|P2|Overall Study|Not Specified|1
911203|NCT01064401|3003338|P1|Overall Study|Not Specified|2
911204|NCT01064401|3003337|P2|Overall Study|Site Closure|5
911205|NCT01064401|3003338|P1|Overall Study|Site Closure|4
911206|NCT01064401|3003337|P2|Overall Study|Noncompliance|8
911207|NCT01064401|3003338|P1|Overall Study|Noncompliance|7
911208|NCT01064401|3003337|P2|Overall Study|Pregnancy|7
911209|NCT01064401|3003338|P1|Overall Study|Pregnancy|4
911210|NCT01064401|3003337|P2|Overall Study|Death|0
911211|NCT01064401|3003338|P1|Overall Study|Death|4
911212|NCT01064401|3003337|P2|Overall Study|Investigator Decision|6
911213|NCT01064401|3003338|P1|Overall Study|Investigator Decision|4
911214|NCT01064401|3003337|P2|Overall Study|Consent Withdrawn|80
911215|NCT01064401|3003338|P1|Overall Study|Consent Withdrawn|98
911216|NCT01064401|3003337|P2|Overall Study|Lost to Follow-up|9
911217|NCT01064401|3003338|P1|Overall Study|Lost to Follow-up|12
911218|NCT01064401|3003337|P2|Overall Study|Lack of Efficacy|23
911219|NCT01064401|3003338|P1|Overall Study|Lack of Efficacy|46
911220|NCT01064401|3003337|P2|Overall Study|Adverse Event|56
911221|NCT01064401|3003338|P1|Overall Study|Adverse Event|47
911222|NCT01064310|3003387|P3|Open Label Pazopinib|Physician Decision|20
911223|NCT01064310|3003388|P2|Open Label Pazopinib|Physician Decision|0
911224|NCT01064310|3003389|P1|Open Label Pazopinib|Physician Decision|0
911225|NCT01064310|3003387|P3|Open Label Pazopinib|Lack of Efficacy|51
911226|NCT01064310|3003388|P2|Open Label Pazopinib|Lack of Efficacy|0
911227|NCT01064310|3003389|P1|Open Label Pazopinib|Lack of Efficacy|0
911228|NCT01064310|3003387|P3|Open Label Pazopinib|Adverse Event|12
911229|NCT01064310|3003388|P2|Open Label Pazopinib|Adverse Event|0
911230|NCT01064310|3003389|P1|Open Label Pazopinib|Adverse Event|0
911231|NCT01064310|3003387|P3|Open Label Pazopinib|Withdrawal by Subject|1
911232|NCT01064310|3003388|P2|Open Label Pazopinib|Withdrawal by Subject|0
911233|NCT01064310|3003389|P1|Open Label Pazopinib|Withdrawal by Subject|0
911234|NCT01064310|3003387|P3|Period 2|Lack of Efficacy|0
911235|NCT01064310|3003388|P2|Period 2|Lack of Efficacy|4
911236|NCT01064310|3003389|P1|Period 2|Lack of Efficacy|1
911237|NCT01064310|3003387|P3|Period 2|Entered Open-label Period|0
911238|NCT01064310|3003388|P2|Period 2|Entered Open-label Period|0
911239|NCT01064310|3003389|P1|Period 2|Entered Open-label Period|1
911240|NCT01064310|3003387|P3|Period 2|Physician Decision|0
911241|NCT01064310|3003388|P2|Period 2|Physician Decision|1
911242|NCT01064310|3003389|P1|Period 2|Physician Decision|0
911243|NCT01064310|3003387|P3|Period 2|Adverse Event|0
911244|NCT01064310|3003388|P2|Period 2|Adverse Event|1
911245|NCT01064310|3003389|P1|Period 2|Adverse Event|2
911246|NCT01064310|3003387|P3|Period 1|Entered Open-label Period|0
911247|NCT01064310|3003388|P2|Period 1|Entered Open-label Period|1
911248|NCT01064310|3003389|P1|Period 1|Entered Open-label Period|1
911249|NCT01064310|3003387|P3|Period 1|Lack of Efficacy|0
911250|NCT01064310|3003388|P2|Period 1|Lack of Efficacy|5
911251|NCT01064310|3003389|P1|Period 1|Lack of Efficacy|3
911252|NCT01064310|3003387|P3|Period 1|Withdrawal by Subject|0
911253|NCT01064310|3003388|P2|Period 1|Withdrawal by Subject|2
911254|NCT01064310|3003389|P1|Period 1|Withdrawal by Subject|2
911255|NCT01064310|3003387|P3|Period 1|Physician Decision|0
911256|NCT01064310|3003388|P2|Period 1|Physician Decision|0
911257|NCT01064310|3003389|P1|Period 1|Physician Decision|1
911258|NCT01064310|3003387|P3|Period 1|Adverse Event|0
911259|NCT01064310|3003388|P2|Period 1|Adverse Event|10
911260|NCT01064310|3003389|P1|Period 1|Adverse Event|7
911261|NCT01064297|3003419|P3|Overall Study|Lost to Follow-up|133
911262|NCT01064297|3003420|P2|Overall Study|Lost to Follow-up|48
911263|NCT01064297|3003421|P1|Overall Study|Lost to Follow-up|791
911264|NCT01064167|3003490|P2|Overall Study|Protocol Violation|15
911265|NCT01064167|3003491|P1|Overall Study|Protocol Violation|14
911266|NCT01063881|3003538|P3|Overall Study|Reason for not completed not specified|0
911267|NCT01063881|3003539|P2|Overall Study|Reason for not completed not specified|1
911268|NCT01063881|3003540|P1|Overall Study|Reason for not completed not specified|5
911269|NCT01063881|3003538|P3|Overall Study|Withdrawal by Subject|0
911270|NCT01063881|3003539|P2|Overall Study|Withdrawal by Subject|1
911271|NCT01063881|3003540|P1|Overall Study|Withdrawal by Subject|25
911272|NCT01063881|3003538|P3|Overall Study|Lost to Follow-up|1
911273|NCT01063881|3003539|P2|Overall Study|Lost to Follow-up|7
911274|NCT01063881|3003540|P1|Overall Study|Lost to Follow-up|13
911275|NCT01063881|3003538|P3|Overall Study|Adverse Event|0
911276|NCT01063881|3003539|P2|Overall Study|Adverse Event|2
911277|NCT01063881|3003540|P1|Overall Study|Adverse Event|12
911278|NCT01063868|3003564|P2|Overall Study|Study Terminated By Sponsor|4
911279|NCT01063868|3003565|P1|Overall Study|Study Terminated By Sponsor|23
911280|NCT01063868|3003564|P2|Overall Study|Withdrawal by Subject|1
911281|NCT01063868|3003565|P1|Overall Study|Withdrawal by Subject|3
911282|NCT01063868|3003564|P2|Overall Study|Adverse Event|7
911283|NCT01063868|3003565|P1|Overall Study|Adverse Event|9
911284|NCT01063855|3003573|P2|Overall Study|Reason not specified|11
911285|NCT01063855|3003574|P1|Overall Study|Reason not specified|13
911286|NCT01063855|3003573|P2|Overall Study|Withdrawal by Subject|8
911287|NCT01063855|3003574|P1|Overall Study|Withdrawal by Subject|11
911288|NCT01063855|3003573|P2|Overall Study|Lack of Efficacy|1
911289|NCT01063855|3003574|P1|Overall Study|Lack of Efficacy|0
911290|NCT01063855|3003573|P2|Overall Study|Pregnancy|0
911291|NCT01063855|3003574|P1|Overall Study|Pregnancy|1
911292|NCT01063855|3003573|P2|Overall Study|Lost to Follow-up|4
911293|NCT01063855|3003574|P1|Overall Study|Lost to Follow-up|8
911294|NCT01063855|3003573|P2|Overall Study|Death|1
911295|NCT01063855|3003574|P1|Overall Study|Death|0
911296|NCT01063855|3003573|P2|Overall Study|Adverse Event|4
911297|NCT01063855|3003574|P1|Overall Study|Adverse Event|4
911298|NCT01063764|3003621|P1|2nd Period (Week 22 to the End of Study)|Protocol Violation|1
911299|NCT01063764|3003621|P1|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7
911300|NCT01063764|3003621|P1|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9
911301|NCT01063764|3003621|P1|2nd Period (Week 22 to the End of Study)|Adverse Event|3
911302|NCT01063764|3003621|P1|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1
911303|NCT01063764|3003621|P1|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6
911304|NCT01063764|3003621|P1|1st Period (From Week 8 to Week 22)|Adverse Event|4
911305|NCT01063595|3003640|P2|First Intervention|Reason not Specified|1
911306|NCT01063595|3003641|P1|First Intervention|Reason not Specified|0
911307|NCT01063595|3003640|P2|First Intervention|Withdrawal by Subject|0
911308|NCT01063595|3003641|P1|First Intervention|Withdrawal by Subject|1
911309|NCT01063595|3003640|P2|First Intervention|Adverse Event|4
911310|NCT01063595|3003641|P1|First Intervention|Adverse Event|1
911311|NCT01063595|3003640|P2|Enrolled in Study and Randomized|Withdrawn by the Investigator|1
911312|NCT01063595|3003641|P1|Enrolled in Study and Randomized|Withdrawn by the Investigator|0
911313|NCT01063595|3003640|P2|Enrolled in Study and Randomized|Adverse Event|1
911314|NCT01063595|3003641|P1|Enrolled in Study and Randomized|Adverse Event|0
911315|NCT01063595|3003640|P2|Enrolled in Study and Randomized|Reason not Specified|0
911316|NCT01063595|3003641|P1|Enrolled in Study and Randomized|Reason not Specified|1
911317|NCT01063517|3003653|P2|Overall Study|Death|48
911318|NCT01063517|3003654|P1|Overall Study|Death|33
911319|NCT01063517|3003653|P2|Overall Study|Withdrawal by Subject|2
911320|NCT01063517|3003654|P1|Overall Study|Withdrawal by Subject|1
911321|NCT01063517|3003653|P2|Overall Study|Lost to Follow-up|3
911322|NCT01063517|3003654|P1|Overall Study|Lost to Follow-up|4
911323|NCT01063517|3003653|P2|Overall Study|Study reached data cut-off|7
911324|NCT01063517|3003654|P1|Overall Study|Study reached data cut-off|19
911325|NCT01063517|3003653|P2|Overall Study|Consent withdrawal|0
911326|NCT01063517|3003654|P1|Overall Study|Consent withdrawal|1
911327|NCT01063348|3003694|P2|Overall Study|Lost to Follow-up|10
911328|NCT01063348|3003695|P1|Overall Study|Lost to Follow-up|3
911329|NCT01063153|3003705|P2|Overall Study|Physician Decision|4
911330|NCT01063153|3003706|P1|Overall Study|Physician Decision|0
911331|NCT01063153|3003705|P2|Overall Study|Withdrawal by Subject|1
911332|NCT01063153|3003706|P1|Overall Study|Withdrawal by Subject|0
911333|NCT01063153|3003705|P2|Overall Study|Lost to Follow-up|7
911334|NCT01063153|3003706|P1|Overall Study|Lost to Follow-up|0
911335|NCT01063153|3003705|P2|Overall Study|Found Ineligible During Screening|0
911336|NCT01063153|3003706|P1|Overall Study|Found Ineligible During Screening|2
911337|NCT01063062|3003737|P2|Overall Study|Miscellaneous reason|1
911338|NCT01063062|3003738|P1|Overall Study|Miscellaneous reason|0
911339|NCT01063062|3003737|P2|Overall Study|Lost to Follow-up|2
911340|NCT01063062|3003738|P1|Overall Study|Lost to Follow-up|0
911341|NCT01063062|3003737|P2|Overall Study|Investigator's request|0
911342|NCT01063062|3003738|P1|Overall Study|Investigator's request|1
911343|NCT01063062|3003737|P2|Overall Study|Protocol Violation|4
911344|NCT01063062|3003738|P1|Overall Study|Protocol Violation|5
911345|NCT01063062|3003737|P2|Overall Study|Adverse Event|4
911346|NCT01063062|3003738|P1|Overall Study|Adverse Event|2
911347|NCT01063062|3003737|P2|Overall Study|Patient withdrew consent|1
911348|NCT01063062|3003738|P1|Overall Study|Patient withdrew consent|0
911349|NCT01063036|3003792|P1|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32
911350|NCT01063036|3003792|P1|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6
911351|NCT01063036|3003792|P1|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1
911352|NCT01063036|3003792|P1|Participants Treated With Study Drug|Pregnancy|1
911353|NCT01063036|3003792|P1|Participants Treated With Study Drug|Lost to Follow-up|1
911354|NCT01063036|3003792|P1|Participants Treated With Study Drug|Withdrawal by Subject|2
911355|NCT01063036|3003792|P1|Participants Treated With Study Drug|Protocol Violation|1
911356|NCT01063036|3003792|P1|Participants Treated With Study Drug|Adverse Event|1
911357|NCT01062841|3003837|P2|Overall Study|Withdrawal by Study|0
911358|NCT01062841|3003838|P1|Overall Study|Withdrawal by Study|3
911359|NCT01062841|3003837|P2|Overall Study|Withdrawal by Subject|0
911360|NCT01062841|3003838|P1|Overall Study|Withdrawal by Subject|2
911361|NCT01062841|3003837|P2|Overall Study|Death|5
911362|NCT01062841|3003838|P1|Overall Study|Death|3
911363|NCT01062841|3003837|P2|Overall Study|Indwelling Device Removed|48
911364|NCT01062841|3003838|P1|Overall Study|Indwelling Device Removed|41
911365|NCT01062763|3003868|P2|Overall Study|Adverse Event|4
911366|NCT01062763|3003869|P1|Overall Study|Adverse Event|3
911367|NCT01062425|3003881|P2|Overall Study|Protocol Violation|6
911368|NCT01062425|3003882|P1|Overall Study|Protocol Violation|3
911369|NCT01062399|3003899|P5|Overall Study|Protocol Violation|4
911370|NCT01062399|3003900|P4|Overall Study|Protocol Violation|6
911371|NCT01062399|3003901|P3|Overall Study|Protocol Violation|0
911372|NCT01062399|3003902|P2|Overall Study|Protocol Violation|1
911373|NCT01062399|3003903|P1|Overall Study|Protocol Violation|0
911374|NCT01062256|3003947|P3|Overall Study|Administrative|0
911375|NCT01062256|3003948|P2|Overall Study|Administrative|2
911376|NCT01062256|3003949|P1|Overall Study|Administrative|0
911377|NCT01062256|3003947|P3|Overall Study|Ineligible|3
911378|NCT01062256|3003948|P2|Overall Study|Ineligible|4
911379|NCT01062256|3003949|P1|Overall Study|Ineligible|1
911380|NCT01062256|3003947|P3|Overall Study|Withdrawal by Subject|1
911381|NCT01062256|3003948|P2|Overall Study|Withdrawal by Subject|1
911382|NCT01062256|3003949|P1|Overall Study|Withdrawal by Subject|1
911383|NCT01062256|3003947|P3|Overall Study|Adverse Event|0
911384|NCT01062256|3003948|P2|Overall Study|Adverse Event|0
911385|NCT01062256|3003949|P1|Overall Study|Adverse Event|1
911386|NCT01062113|3003983|P3|Overall Study|Withdrawal by Subject|0
911387|NCT01062113|3003984|P2|Overall Study|Withdrawal by Subject|0
911388|NCT01062113|3003985|P1|Overall Study|Withdrawal by Subject|1
911389|NCT01062113|3003983|P3|Overall Study|Lack of Efficacy|31
911390|NCT01062113|3003984|P2|Overall Study|Lack of Efficacy|22
911391|NCT01062113|3003985|P1|Overall Study|Lack of Efficacy|38
911392|NCT01062113|3003983|P3|Overall Study|Adverse Event|0
911393|NCT01062113|3003984|P2|Overall Study|Adverse Event|0
911394|NCT01062113|3003985|P1|Overall Study|Adverse Event|1
911395|NCT01062061|3004003|P1|Overall Study|Failed to meet inclusion criteria|2
911396|NCT01062061|3004003|P1|Overall Study|Outside chief indications|10
911397|NCT01062061|3004003|P1|Overall Study|Investigated before study start|13
911398|NCT01062061|3004003|P1|Overall Study|Enrolled more than once|2
911399|NCT01061866|3004017|P1|Overall Study|Adverse Event|2
911400|NCT01061775|3004021|P1|Overall Study|Lost to Follow-up|1
911401|NCT01061775|3004021|P1|Overall Study|Physician Decision|2
911402|NCT01061736|3004038|P10|Overall Study|Other than specified above|21
911403|NCT01061736|3004039|P9|Overall Study|Other than specified above|15
911404|NCT01061736|3004040|P8|Overall Study|Other than specified above|18
911405|NCT01061736|3004041|P7|Overall Study|Other than specified above|0
911406|NCT01061736|3004042|P6|Overall Study|Other than specified above|0
911407|NCT01061736|3004043|P5|Overall Study|Other than specified above|1
911408|NCT01061736|3004044|P4|Overall Study|Other than specified above|0
911409|NCT01061736|3004045|P3|Overall Study|Other than specified above|2
911410|NCT01061736|3004046|P2|Overall Study|Other than specified above|1
911411|NCT01061736|3004047|P1|Overall Study|Other than specified above|0
911412|NCT01061736|3004038|P10|Overall Study|Not treated|0
911413|NCT01061736|3004039|P9|Overall Study|Not treated|1
911414|NCT01061736|3004040|P8|Overall Study|Not treated|2
911415|NCT01061736|3004041|P7|Overall Study|Not treated|0
911416|NCT01061736|3004042|P6|Overall Study|Not treated|0
911417|NCT01061736|3004043|P5|Overall Study|Not treated|1
911418|NCT01061736|3004044|P4|Overall Study|Not treated|0
911419|NCT01061736|3004045|P3|Overall Study|Not treated|0
911420|NCT01061736|3004046|P2|Overall Study|Not treated|0
911421|NCT01061736|3004047|P1|Overall Study|Not treated|0
911422|NCT01061736|3004038|P10|Overall Study|Poor compliance to protocol|9
911423|NCT01061736|3004039|P9|Overall Study|Poor compliance to protocol|5
911424|NCT01061736|3004040|P8|Overall Study|Poor compliance to protocol|2
911425|NCT01061736|3004041|P7|Overall Study|Poor compliance to protocol|0
911426|NCT01061736|3004042|P6|Overall Study|Poor compliance to protocol|0
911427|NCT01061736|3004043|P5|Overall Study|Poor compliance to protocol|0
911428|NCT01061736|3004044|P4|Overall Study|Poor compliance to protocol|0
911429|NCT01061736|3004045|P3|Overall Study|Poor compliance to protocol|0
911430|NCT01061736|3004046|P2|Overall Study|Poor compliance to protocol|0
911431|NCT01061736|3004047|P1|Overall Study|Poor compliance to protocol|0
911432|NCT01061736|3004038|P10|Overall Study|Lack of Efficacy|10
911433|NCT01061736|3004039|P9|Overall Study|Lack of Efficacy|9
911434|NCT01061736|3004040|P8|Overall Study|Lack of Efficacy|9
911435|NCT01061736|3004041|P7|Overall Study|Lack of Efficacy|1
911436|NCT01061736|3004042|P6|Overall Study|Lack of Efficacy|2
911437|NCT01061736|3004043|P5|Overall Study|Lack of Efficacy|1
911438|NCT01061736|3004044|P4|Overall Study|Lack of Efficacy|1
911439|NCT01061736|3004045|P3|Overall Study|Lack of Efficacy|1
911440|NCT01061736|3004046|P2|Overall Study|Lack of Efficacy|2
911441|NCT01061736|3004047|P1|Overall Study|Lack of Efficacy|0
911442|NCT01061736|3004038|P10|Overall Study|Adverse Event|34
911443|NCT01061736|3004039|P9|Overall Study|Adverse Event|67
911444|NCT01061736|3004040|P8|Overall Study|Adverse Event|63
911445|NCT01061736|3004041|P7|Overall Study|Adverse Event|4
911446|NCT01061736|3004042|P6|Overall Study|Adverse Event|1
911447|NCT01061736|3004043|P5|Overall Study|Adverse Event|4
911448|NCT01061736|3004044|P4|Overall Study|Adverse Event|2
911449|NCT01061736|3004045|P3|Overall Study|Adverse Event|3
911450|NCT01061736|3004046|P2|Overall Study|Adverse Event|1
911451|NCT01061736|3004047|P1|Overall Study|Adverse Event|13
911452|NCT01061736|3004038|P10|Overall Study|Dose regimen not selected|0
911453|NCT01061736|3004039|P9|Overall Study|Dose regimen not selected|0
911454|NCT01061736|3004040|P8|Overall Study|Dose regimen not selected|0
911455|NCT01061736|3004041|P7|Overall Study|Dose regimen not selected|79
911456|NCT01061736|3004042|P6|Overall Study|Dose regimen not selected|0
911457|NCT01061736|3004043|P5|Overall Study|Dose regimen not selected|0
911458|NCT01061736|3004044|P4|Overall Study|Dose regimen not selected|0
911459|NCT01061736|3004045|P3|Overall Study|Dose regimen not selected|0
911460|NCT01061736|3004046|P2|Overall Study|Dose regimen not selected|0
911461|NCT01061736|3004047|P1|Overall Study|Dose regimen not selected|0
911462|NCT01061723|3004086|P6|Overall Study|Other than specified above|1
911463|NCT01061723|3004087|P5|Overall Study|Other than specified above|0
911464|NCT01061723|3004088|P4|Overall Study|Other than specified above|1
911465|NCT01061723|3004089|P3|Overall Study|Other than specified above|1
911466|NCT01061723|3004090|P2|Overall Study|Other than specified above|1
911467|NCT01061723|3004091|P1|Overall Study|Other than specified above|2
911468|NCT01061723|3004086|P6|Overall Study|Randomized but not treated|1
911469|NCT01061723|3004087|P5|Overall Study|Randomized but not treated|0
911470|NCT01061723|3004088|P4|Overall Study|Randomized but not treated|0
911471|NCT01061723|3004089|P3|Overall Study|Randomized but not treated|0
911472|NCT01061723|3004090|P2|Overall Study|Randomized but not treated|0
911473|NCT01061723|3004091|P1|Overall Study|Randomized but not treated|0
911474|NCT01061723|3004086|P6|Overall Study|Lack of Efficacy|1
911475|NCT01061723|3004087|P5|Overall Study|Lack of Efficacy|1
911476|NCT01061723|3004088|P4|Overall Study|Lack of Efficacy|2
911477|NCT01061723|3004089|P3|Overall Study|Lack of Efficacy|4
911478|NCT01061723|3004090|P2|Overall Study|Lack of Efficacy|3
911479|NCT01061723|3004091|P1|Overall Study|Lack of Efficacy|2
911480|NCT01061723|3004086|P6|Overall Study|Adverse Event|6
911481|NCT01061723|3004087|P5|Overall Study|Adverse Event|2
911482|NCT01061723|3004088|P4|Overall Study|Adverse Event|5
911483|NCT01061723|3004089|P3|Overall Study|Adverse Event|5
911484|NCT01061723|3004090|P2|Overall Study|Adverse Event|2
911485|NCT01061723|3004091|P1|Overall Study|Adverse Event|0
911486|NCT01061710|3004171|P1|Overall Study|Protocol Violation|14
911487|NCT01061671|3004181|P2|Overall Study|Death|30
911488|NCT01061671|3004182|P1|Overall Study|Death|28
911489|NCT01061671|3004181|P2|Overall Study|Lost to Follow-up|5
911490|NCT01061671|3004182|P1|Overall Study|Lost to Follow-up|3
911491|NCT01061671|3004181|P2|Overall Study|Withdrawal by Subject|20
911492|NCT01061671|3004182|P1|Overall Study|Withdrawal by Subject|16
911493|NCT01061606|3004194|P1|Overall Study|alternative therapy|2
911494|NCT01061606|3004194|P1|Overall Study|Disease Progression|4
911495|NCT01061606|3004194|P1|Overall Study|Death|1
911496|NCT01061606|3004194|P1|Overall Study|Adverse Event|1
911497|NCT01061567|3004203|P1|Overall Study|Other reason than stated above|3
911498|NCT01061567|3004203|P1|Overall Study|Withdrawal by Subject|11
911499|NCT01061567|3004203|P1|Overall Study|Protocol Violation|1
911500|NCT01061567|3004203|P1|Overall Study|Lost to Follow-up|24
911501|NCT01061567|3004203|P1|Overall Study|Lack of Efficacy|3
911502|NCT01061567|3004203|P1|Overall Study|Death|2
911503|NCT01061567|3004203|P1|Overall Study|Adverse Event|32
911504|NCT01061385|3004227|P2|Overall Study|subject decision not related to AE|1
911505|NCT01061385|3004228|P1|Overall Study|subject decision not related to AE|0
911506|NCT01061385|3004227|P2|Overall Study|Lost to Follow-up|0
911507|NCT01061385|3004228|P1|Overall Study|Lost to Follow-up|1
911508|NCT01061359|3004236|P1|Overall Study|Secondary neoplasm|11
911509|NCT01061359|3004236|P1|Overall Study|Relapse|187
911510|NCT01061359|3004236|P1|Overall Study|Lost to Follow-up|1072
911511|NCT01061359|3004236|P1|Overall Study|Death|32
911512|NCT01061333|3004242|P2|Period 4: 20-day Washout|Discontinued by Study Team|1
911513|NCT01061333|3004243|P1|Period 4: 20-day Washout|Discontinued by Study Team|0
911514|NCT01061177|3004281|P1|Overall Study|Death|4
911515|NCT01061177|3004281|P1|Overall Study|Administratie problems|4
911516|NCT01061177|3004281|P1|Overall Study|Abnormal test procedure results|4
911517|NCT01061177|3004281|P1|Overall Study|Abnormal laboratory values|6
911518|NCT01061177|3004281|P1|Overall Study|New cancer therapy|9
911519|NCT01061177|3004281|P1|Overall Study|Lost to Follow-up|9
911520|NCT01061177|3004281|P1|Overall Study|Protocol Violation|11
911521|NCT01061177|3004281|P1|Overall Study|Disease progression|17
911522|NCT01061177|3004281|P1|Overall Study|Withdrawal by Subject|27
911523|NCT01061177|3004281|P1|Overall Study|Adverse Event|117
911524|NCT01061151|3004304|P4|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3
911525|NCT01061151|3004305|P3|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1
911526|NCT01061151|3004306|P2|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8
911527|NCT01061151|3004307|P1|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5
911528|NCT01061151|3004304|P4|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5
911529|NCT01061151|3004305|P3|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15
911530|NCT01061151|3004306|P2|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26
911531|NCT01061151|3004307|P1|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28
911532|NCT01061151|3004304|P4|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0
911533|NCT01061151|3004305|P3|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2
911534|NCT01061151|3004306|P2|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11
911535|NCT01061151|3004307|P1|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12
911536|NCT01061151|3004304|P4|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4
911537|NCT01061151|3004305|P3|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25
911538|NCT01061151|3004306|P2|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36
911539|NCT01061151|3004307|P1|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49
911540|NCT01061151|3004304|P4|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3
911541|NCT01061151|3004305|P3|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31
911542|NCT01061151|3004306|P2|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52
911543|NCT01061151|3004307|P1|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54
911544|NCT01061151|3004304|P4|Protocol Version 3.0: 10/2012-10/2014|Death|1
911545|NCT01061151|3004305|P3|Protocol Version 3.0: 10/2012-10/2014|Death|1
911546|NCT01061151|3004306|P2|Protocol Version 3.0: 10/2012-10/2014|Death|5
911547|NCT01061151|3004307|P1|Protocol Version 3.0: 10/2012-10/2014|Death|3
911548|NCT01061151|3004304|P4|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
911549|NCT01061151|3004305|P3|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
911550|NCT01061151|3004306|P2|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
911551|NCT01061151|3004307|P1|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1
911552|NCT01061151|3004304|P4|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4
911553|NCT01061151|3004305|P3|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2
911554|NCT01061151|3004306|P2|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
911555|NCT01061151|3004307|P1|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
911556|NCT01061151|3004304|P4|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0
911557|NCT01061151|3004305|P3|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1
911558|NCT01061151|3004306|P2|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5
911559|NCT01061151|3004307|P1|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3
911560|NCT01061151|3004304|P4|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5
911561|NCT01061151|3004305|P3|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2
911562|NCT01061151|3004306|P2|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61
911563|NCT01061151|3004307|P1|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44
911564|NCT01061151|3004304|P4|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0
911565|NCT01061151|3004305|P3|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1
911566|NCT01061151|3004306|P2|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19
911567|NCT01061151|3004307|P1|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15
911568|NCT01061151|3004304|P4|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10
911569|NCT01061151|3004305|P3|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2
911570|NCT01061151|3004306|P2|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65
911571|NCT01061151|3004307|P1|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73
911572|NCT01061151|3004304|P4|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10
911573|NCT01061151|3004305|P3|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2
911574|NCT01061151|3004306|P2|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82
911575|NCT01061151|3004307|P1|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89
911576|NCT01061151|3004304|P4|Protocol Version 2.0: 04/2011-09/2012|Death|2
911577|NCT01061151|3004305|P3|Protocol Version 2.0: 04/2011-09/2012|Death|1
911578|NCT01061151|3004306|P2|Protocol Version 2.0: 04/2011-09/2012|Death|9
911579|NCT01061151|3004307|P1|Protocol Version 2.0: 04/2011-09/2012|Death|6
911580|NCT01061151|3004304|P4|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1
911581|NCT01061151|3004305|P3|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
911582|NCT01061151|3004306|P2|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
911583|NCT01061151|3004307|P1|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2
911584|NCT01061008|3004366|P2|Overall Study|Adverse Event|1
911585|NCT01061008|3004367|P1|Overall Study|Adverse Event|0
911586|NCT01061008|3004366|P2|Overall Study|Unable to exercise following surgery|0
911587|NCT01061008|3004367|P1|Overall Study|Unable to exercise following surgery|1
911588|NCT01061008|3004366|P2|Overall Study|Withdrawal by Subject|3
911589|NCT01061008|3004367|P1|Overall Study|Withdrawal by Subject|1
911590|NCT01061008|3004366|P2|Overall Study|Death|0
911591|NCT01061008|3004367|P1|Overall Study|Death|1
911592|NCT01061008|3004366|P2|Overall Study|Badiocephalic fistula failed|2
911593|NCT01061008|3004367|P1|Overall Study|Badiocephalic fistula failed|3
911594|NCT01060670|3004375|P2|Run In|screen failure|238
911595|NCT01060670|3004376|P1|Run In|screen failure|0
911596|NCT01060553|3004411|P2|Overall Study|Lack of Efficacy|0
911597|NCT01060553|3004412|P1|Overall Study|Lack of Efficacy|1
911598|NCT01060553|3004411|P2|Overall Study|Withdrawal by Subject|5
911599|NCT01060553|3004412|P1|Overall Study|Withdrawal by Subject|5
911600|NCT01060553|3004411|P2|Overall Study|Lost to Follow-up|5
911601|NCT01060553|3004412|P1|Overall Study|Lost to Follow-up|3
911602|NCT01060540|3004419|P2|Overall Study|Physician Decision|1
911603|NCT01060540|3004420|P1|Overall Study|Physician Decision|0
911604|NCT01060540|3004419|P2|Overall Study|Death|1
911605|NCT01060540|3004420|P1|Overall Study|Death|2
911606|NCT01060540|3004419|P2|Overall Study|Lost to Follow-up|43
911607|NCT01060540|3004420|P1|Overall Study|Lost to Follow-up|52
911608|NCT01060540|3004419|P2|Overall Study|Withdrawal by Subject|20
911609|NCT01060540|3004420|P1|Overall Study|Withdrawal by Subject|10
911610|NCT01060384|3004434|P5|Overall Study|Intercurrent illness|1
911611|NCT01060384|3004435|P4|Overall Study|Intercurrent illness|0
911612|NCT01060384|3004436|P3|Overall Study|Intercurrent illness|0
911613|NCT01060384|3004437|P2|Overall Study|Intercurrent illness|0
911614|NCT01060384|3004438|P1|Overall Study|Intercurrent illness|0
911615|NCT01060384|3004434|P5|Overall Study|Death|1
911616|NCT01060384|3004435|P4|Overall Study|Death|0
911617|NCT01060384|3004436|P3|Overall Study|Death|0
911618|NCT01060384|3004437|P2|Overall Study|Death|0
911619|NCT01060384|3004438|P1|Overall Study|Death|0
911620|NCT01060384|3004434|P5|Overall Study|Withdrawal by Subject|0
911621|NCT01060384|3004435|P4|Overall Study|Withdrawal by Subject|0
911622|NCT01060384|3004436|P3|Overall Study|Withdrawal by Subject|0
911623|NCT01060384|3004437|P2|Overall Study|Withdrawal by Subject|1
911624|NCT01060384|3004438|P1|Overall Study|Withdrawal by Subject|0
911625|NCT01060150|3004447|P1|Overall Study|Enrolled, but not treated|2
911626|NCT01060150|3004447|P1|Overall Study|Withdrawal by Subject|8
911627|NCT01060150|3004447|P1|Overall Study|Protocol Violation|6
911628|NCT01060150|3004447|P1|Overall Study|Lost to Follow-up|1
911629|NCT01060150|3004447|P1|Overall Study|Adverse Event|6
911630|NCT01060124|3004462|P1|Overall Study|Withdrawal by Subject|7
911631|NCT01060124|3004462|P1|Overall Study|Adverse Event|14
911632|NCT01060124|3004462|P1|Overall Study|Other|16
911633|NCT01060111|3004473|P3|Overall Study|Other|4
911634|NCT01060111|3004474|P2|Overall Study|Other|3
911635|NCT01060111|3004475|P1|Overall Study|Other|2
911636|NCT01060111|3004473|P3|Overall Study|Participants' non-cooperation|0
911637|NCT01060111|3004474|P2|Overall Study|Participants' non-cooperation|0
911638|NCT01060111|3004475|P1|Overall Study|Participants' non-cooperation|1
911639|NCT01060111|3004473|P3|Overall Study|Adverse event and insufficient effect|0
911640|NCT01060111|3004474|P2|Overall Study|Adverse event and insufficient effect|1
911641|NCT01060111|3004475|P1|Overall Study|Adverse event and insufficient effect|0
911642|NCT01060111|3004473|P3|Overall Study|Participants' non-cooperation|6
911643|NCT01060111|3004474|P2|Overall Study|Participants' non-cooperation|6
911644|NCT01060111|3004475|P1|Overall Study|Participants' non-cooperation|8
911645|NCT01060111|3004473|P3|Overall Study|Participants' evasion for hospital visit|2
911646|NCT01060111|3004474|P2|Overall Study|Participants' evasion for hospital visit|3
911647|NCT01060111|3004475|P1|Overall Study|Participants' evasion for hospital visit|0
911648|NCT01060111|3004473|P3|Overall Study|Inappropriate participant|5
911649|NCT01060111|3004474|P2|Overall Study|Inappropriate participant|4
911650|NCT01060111|3004475|P1|Overall Study|Inappropriate participant|5
911651|NCT01060111|3004473|P3|Overall Study|Lack of Efficacy|0
911652|NCT01060111|3004474|P2|Overall Study|Lack of Efficacy|1
911653|NCT01060111|3004475|P1|Overall Study|Lack of Efficacy|2
911654|NCT01060111|3004473|P3|Overall Study|Adverse Event|18
911655|NCT01060111|3004474|P2|Overall Study|Adverse Event|5
911656|NCT01060111|3004475|P1|Overall Study|Adverse Event|9
911657|NCT01060072|3004494|P2|Overall Study|Excluded Medications|1
911658|NCT01060072|3004495|P1|Overall Study|Excluded Medications|0
911659|NCT01060072|3004494|P2|Overall Study|Acute cholecystitis|0
911660|NCT01060072|3004495|P1|Overall Study|Acute cholecystitis|1
911661|NCT01060072|3004494|P2|Overall Study|Protocol Violation|1
911662|NCT01060072|3004495|P1|Overall Study|Protocol Violation|0
911663|NCT01060072|3004494|P2|Overall Study|Physician Decision|2
911664|NCT01060072|3004495|P1|Overall Study|Physician Decision|0
911665|NCT01060072|3004494|P2|Overall Study|Adverse Event|1
911666|NCT01060072|3004495|P1|Overall Study|Adverse Event|1
911667|NCT01060059|3004511|P2|Overall Study|lack of compliance|2
911668|NCT01060059|3004512|P1|Overall Study|lack of compliance|5
911669|NCT01060059|3004511|P2|Overall Study|lack of glycemic control|1
911670|NCT01060059|3004512|P1|Overall Study|lack of glycemic control|2
911671|NCT01060059|3004511|P2|Overall Study|Withdrawal by Subject|23
911672|NCT01060059|3004512|P1|Overall Study|Withdrawal by Subject|35
911673|NCT01060059|3004511|P2|Overall Study|entry criteria not met|3
911674|NCT01060059|3004512|P1|Overall Study|entry criteria not met|4
911675|NCT01060059|3004511|P2|Overall Study|Lost to Follow-up|34
911676|NCT01060059|3004512|P1|Overall Study|Lost to Follow-up|18
911677|NCT01060059|3004511|P2|Overall Study|Death|3
911678|NCT01060059|3004512|P1|Overall Study|Death|2
911679|NCT01060059|3004511|P2|Overall Study|Adverse Event|1
911680|NCT01060059|3004512|P1|Overall Study|Adverse Event|1
911681|NCT01060007|3004570|P1|Overall Study|Inevaluable for response at surgery|3
911682|NCT01060007|3004570|P1|Overall Study|Withdrawal by Subject|1
911683|NCT01059903|3004638|P2|Period 1: First Intervention- 24 Hours|Adverse Event|1
911684|NCT01059903|3004639|P1|Period 1: First Intervention- 24 Hours|Adverse Event|1
911685|NCT01059864|3004682|P3|Double-Blind Treatment Phase|Adverse Event|3
911686|NCT01059864|3004683|P2|Double-Blind Treatment Phase|Adverse Event|3
911687|NCT01059864|3004684|P1|Double-Blind Treatment Phase|Adverse Event|0
911688|NCT01059864|3004682|P3|Open-Label Run-In Phase|Protocol Violation|0
911689|NCT01059864|3004683|P2|Open-Label Run-In Phase|Protocol Violation|0
911690|NCT01059864|3004684|P1|Open-Label Run-In Phase|Protocol Violation|2
911691|NCT01059864|3004682|P3|Open-Label Run-In Phase|Withdrawal by Subject|0
911692|NCT01059864|3004683|P2|Open-Label Run-In Phase|Withdrawal by Subject|0
911693|NCT01059864|3004684|P1|Open-Label Run-In Phase|Withdrawal by Subject|1
911694|NCT01059864|3004682|P3|Open-Label Run-In Phase|Lost to Follow-up|0
911695|NCT01059864|3004683|P2|Open-Label Run-In Phase|Lost to Follow-up|0
911696|NCT01059864|3004684|P1|Open-Label Run-In Phase|Lost to Follow-up|2
911697|NCT01059864|3004682|P3|Open-Label Run-In Phase|Lack of Efficacy|0
911698|NCT01059864|3004683|P2|Open-Label Run-In Phase|Lack of Efficacy|0
911699|NCT01059864|3004684|P1|Open-Label Run-In Phase|Lack of Efficacy|1
911700|NCT01059864|3004682|P3|Open-Label Run-In Phase|Adverse Event|0
911701|NCT01059864|3004683|P2|Open-Label Run-In Phase|Adverse Event|0
911702|NCT01059864|3004684|P1|Open-Label Run-In Phase|Adverse Event|7
911703|NCT01059825|3004758|P7|Treatment Period|Adverse event not related to study drug|0
911704|NCT01059825|3004759|P6|Treatment Period|Adverse event not related to study drug|1
911705|NCT01059825|3004760|P5|Treatment Period|Adverse event not related to study drug|1
911706|NCT01059825|3004761|P4|Treatment Period|Adverse event not related to study drug|1
911707|NCT01059825|3004762|P3|Treatment Period|Adverse event not related to study drug|2
911708|NCT01059825|3004763|P2|Treatment Period|Adverse event not related to study drug|1
911709|NCT01059825|3004764|P1|Treatment Period|Adverse event not related to study drug|0
911710|NCT01059825|3004758|P7|Treatment Period|Insufficient clinical response|0
911711|NCT01059825|3004759|P6|Treatment Period|Insufficient clinical response|0
911712|NCT01059825|3004760|P5|Treatment Period|Insufficient clinical response|0
911713|NCT01059825|3004761|P4|Treatment Period|Insufficient clinical response|0
911714|NCT01059825|3004762|P3|Treatment Period|Insufficient clinical response|0
911715|NCT01059825|3004763|P2|Treatment Period|Insufficient clinical response|0
911716|NCT01059825|3004764|P1|Treatment Period|Insufficient clinical response|3
911717|NCT01059825|3004758|P7|Treatment Period|Adverse event related to study drug|0
911718|NCT01059825|3004759|P6|Treatment Period|Adverse event related to study drug|0
911719|NCT01059825|3004760|P5|Treatment Period|Adverse event related to study drug|0
911720|NCT01059825|3004761|P4|Treatment Period|Adverse event related to study drug|1
911721|NCT01059825|3004762|P3|Treatment Period|Adverse event related to study drug|1
911722|NCT01059825|3004763|P2|Treatment Period|Adverse event related to study drug|0
911723|NCT01059825|3004764|P1|Treatment Period|Adverse event related to study drug|1
911724|NCT01059825|3004758|P7|Treatment Period|Protocol Violation|0
911725|NCT01059825|3004759|P6|Treatment Period|Protocol Violation|1
911726|NCT01059825|3004760|P5|Treatment Period|Protocol Violation|1
911727|NCT01059825|3004761|P4|Treatment Period|Protocol Violation|1
911728|NCT01059825|3004762|P3|Treatment Period|Protocol Violation|1
911729|NCT01059825|3004763|P2|Treatment Period|Protocol Violation|0
911730|NCT01059825|3004764|P1|Treatment Period|Protocol Violation|0
911731|NCT01059825|3004758|P7|Treatment Period|Other reason not specified|0
911732|NCT01059825|3004759|P6|Treatment Period|Other reason not specified|0
911733|NCT01059825|3004760|P5|Treatment Period|Other reason not specified|0
911734|NCT01059825|3004761|P4|Treatment Period|Other reason not specified|2
911735|NCT01059825|3004762|P3|Treatment Period|Other reason not specified|1
911736|NCT01059825|3004763|P2|Treatment Period|Other reason not specified|2
911737|NCT01059825|3004764|P1|Treatment Period|Other reason not specified|1
911738|NCT01059825|3004758|P7|Treatment Period|Withdrawal by Subject|0
911739|NCT01059825|3004759|P6|Treatment Period|Withdrawal by Subject|1
911740|NCT01059825|3004760|P5|Treatment Period|Withdrawal by Subject|4
911741|NCT01059825|3004761|P4|Treatment Period|Withdrawal by Subject|5
911742|NCT01059825|3004762|P3|Treatment Period|Withdrawal by Subject|1
911743|NCT01059825|3004763|P2|Treatment Period|Withdrawal by Subject|0
911744|NCT01059825|3004764|P1|Treatment Period|Withdrawal by Subject|3
911745|NCT01059825|3004758|P7|Treatment Period|Lost to Follow-up|0
911746|NCT01059825|3004759|P6|Treatment Period|Lost to Follow-up|0
911747|NCT01059825|3004760|P5|Treatment Period|Lost to Follow-up|2
911748|NCT01059825|3004761|P4|Treatment Period|Lost to Follow-up|1
911749|NCT01059825|3004762|P3|Treatment Period|Lost to Follow-up|0
911750|NCT01059825|3004763|P2|Treatment Period|Lost to Follow-up|1
911751|NCT01059825|3004764|P1|Treatment Period|Lost to Follow-up|2
911752|NCT01059825|3004758|P7|Enrolled, Run-in Period|Protocol Violation|5
911753|NCT01059825|3004759|P6|Enrolled, Run-in Period|Protocol Violation|0
911754|NCT01059825|3004760|P5|Enrolled, Run-in Period|Protocol Violation|0
911755|NCT01059825|3004761|P4|Enrolled, Run-in Period|Protocol Violation|0
911756|NCT01059825|3004762|P3|Enrolled, Run-in Period|Protocol Violation|0
911757|NCT01059825|3004763|P2|Enrolled, Run-in Period|Protocol Violation|0
911758|NCT01059825|3004764|P1|Enrolled, Run-in Period|Protocol Violation|0
911759|NCT01059825|3004758|P7|Enrolled, Run-in Period|Other reason not specified|7
911760|NCT01059825|3004759|P6|Enrolled, Run-in Period|Other reason not specified|0
911761|NCT01059825|3004760|P5|Enrolled, Run-in Period|Other reason not specified|0
911762|NCT01059825|3004761|P4|Enrolled, Run-in Period|Other reason not specified|0
911763|NCT01059825|3004762|P3|Enrolled, Run-in Period|Other reason not specified|0
911764|NCT01059825|3004763|P2|Enrolled, Run-in Period|Other reason not specified|0
911765|NCT01059825|3004764|P1|Enrolled, Run-in Period|Other reason not specified|0
911766|NCT01059825|3004758|P7|Enrolled, Run-in Period|Withdrawal by Subject|13
911767|NCT01059825|3004759|P6|Enrolled, Run-in Period|Withdrawal by Subject|0
911768|NCT01059825|3004760|P5|Enrolled, Run-in Period|Withdrawal by Subject|0
911769|NCT01059825|3004761|P4|Enrolled, Run-in Period|Withdrawal by Subject|0
911770|NCT01059825|3004762|P3|Enrolled, Run-in Period|Withdrawal by Subject|0
911771|NCT01059825|3004763|P2|Enrolled, Run-in Period|Withdrawal by Subject|0
911772|NCT01059825|3004764|P1|Enrolled, Run-in Period|Withdrawal by Subject|0
911773|NCT01059825|3004758|P7|Enrolled, Run-in Period|Lost to Follow-up|5
911774|NCT01059825|3004759|P6|Enrolled, Run-in Period|Lost to Follow-up|0
911775|NCT01059825|3004760|P5|Enrolled, Run-in Period|Lost to Follow-up|0
911776|NCT01059825|3004761|P4|Enrolled, Run-in Period|Lost to Follow-up|0
911777|NCT01059825|3004762|P3|Enrolled, Run-in Period|Lost to Follow-up|0
911778|NCT01059825|3004763|P2|Enrolled, Run-in Period|Lost to Follow-up|0
911779|NCT01059825|3004764|P1|Enrolled, Run-in Period|Lost to Follow-up|0
911780|NCT01059825|3004758|P7|Enrolled, Run-in Period|Did not meet entrance criteria|14
911781|NCT01059825|3004759|P6|Enrolled, Run-in Period|Did not meet entrance criteria|0
911782|NCT01059825|3004760|P5|Enrolled, Run-in Period|Did not meet entrance criteria|0
911783|NCT01059825|3004761|P4|Enrolled, Run-in Period|Did not meet entrance criteria|0
911784|NCT01059825|3004762|P3|Enrolled, Run-in Period|Did not meet entrance criteria|0
911785|NCT01059825|3004763|P2|Enrolled, Run-in Period|Did not meet entrance criteria|0
911786|NCT01059825|3004764|P1|Enrolled, Run-in Period|Did not meet entrance criteria|0
911787|NCT01059825|3004758|P7|Enrolled, Run-in Period|Adverse event not related to study drug|3
911788|NCT01059825|3004759|P6|Enrolled, Run-in Period|Adverse event not related to study drug|0
911789|NCT01059825|3004760|P5|Enrolled, Run-in Period|Adverse event not related to study drug|0
911790|NCT01059825|3004761|P4|Enrolled, Run-in Period|Adverse event not related to study drug|0
911791|NCT01059825|3004762|P3|Enrolled, Run-in Period|Adverse event not related to study drug|0
911792|NCT01059825|3004763|P2|Enrolled, Run-in Period|Adverse event not related to study drug|0
911793|NCT01059825|3004764|P1|Enrolled, Run-in Period|Adverse event not related to study drug|0
911794|NCT01059812|3004951|P2|Overall Study|Unclassified|4
911795|NCT01059812|3004952|P1|Overall Study|Unclassified|14
911796|NCT01059812|3004951|P2|Overall Study|Withdrawal Criteria|4
911797|NCT01059812|3004952|P1|Overall Study|Withdrawal Criteria|9
911798|NCT01059812|3004951|P2|Overall Study|Protocol Violation|1
911799|NCT01059812|3004952|P1|Overall Study|Protocol Violation|3
911800|NCT01059812|3004951|P2|Overall Study|Lack of Efficacy|2
911801|NCT01059812|3004952|P1|Overall Study|Lack of Efficacy|2
911802|NCT01059812|3004951|P2|Overall Study|Adverse Event|5
911803|NCT01059812|3004952|P1|Overall Study|Adverse Event|9
911804|NCT01059799|3004968|P2|Overall Study|Other|3
911805|NCT01059799|3004969|P1|Overall Study|Other|12
911806|NCT01059799|3004968|P2|Overall Study|Withdrawal criteria|2
911807|NCT01059799|3004969|P1|Overall Study|Withdrawal criteria|13
911808|NCT01059799|3004968|P2|Overall Study|Protocol Violation|2
911809|NCT01059799|3004969|P1|Overall Study|Protocol Violation|3
911810|NCT01059799|3004968|P2|Overall Study|Lack of Efficacy|0
911811|NCT01059799|3004969|P1|Overall Study|Lack of Efficacy|1
911812|NCT01059799|3004968|P2|Overall Study|Adverse Event|3
911813|NCT01059799|3004969|P1|Overall Study|Adverse Event|2
911814|NCT01059773|3004983|P2|Overall Study|Other|3
911815|NCT01059773|3004984|P1|Overall Study|Other|1
911816|NCT01059773|3004983|P2|Overall Study|Ineligible follow TB screening criteria|1
911817|NCT01059773|3004984|P1|Overall Study|Ineligible follow TB screening criteria|0
911818|NCT01059773|3004983|P2|Overall Study|Malignancy including squamous cell skin|1
911819|NCT01059773|3004984|P1|Overall Study|Malignancy including squamous cell skin|0
911820|NCT01059773|3004983|P2|Overall Study|Death|1
911821|NCT01059773|3004984|P1|Overall Study|Death|0
911822|NCT01059773|3004983|P2|Overall Study|Lack of Efficacy|3
911823|NCT01059773|3004984|P1|Overall Study|Lack of Efficacy|3
911824|NCT01059773|3004983|P2|Overall Study|Physician Decision|4
911825|NCT01059773|3004984|P1|Overall Study|Physician Decision|5
911826|NCT01059773|3004983|P2|Overall Study|Protocol Violation|2
911827|NCT01059773|3004984|P1|Overall Study|Protocol Violation|6
911828|NCT01059773|3004983|P2|Overall Study|Pregnancy|1
911829|NCT01059773|3004984|P1|Overall Study|Pregnancy|1
911830|NCT01059773|3004983|P2|Overall Study|Lost to Follow-up|1
911831|NCT01059773|3004984|P1|Overall Study|Lost to Follow-up|1
911832|NCT01059773|3004983|P2|Overall Study|Withdrawal by Subject|5
911833|NCT01059773|3004984|P1|Overall Study|Withdrawal by Subject|1
911834|NCT01059773|3004983|P2|Overall Study|Adverse Event|2
911835|NCT01059773|3004984|P1|Overall Study|Adverse Event|2
911836|NCT01059643|3005123|P1|Overall Study|Physician Decision|1
911837|NCT01059643|3005123|P1|Overall Study|Withdrawal by Subject|2
911838|NCT01059643|3005123|P1|Overall Study|Adverse Event|3
911839|NCT01059630|3005138|P2|Maintenance Period (up to 2 Years)|Other|3
911840|NCT01059630|3005139|P1|Maintenance Period (up to 2 Years)|Other|0
911841|NCT01059630|3005138|P2|Maintenance Period (up to 2 Years)|Physician Decision|2
911842|NCT01059630|3005139|P1|Maintenance Period (up to 2 Years)|Physician Decision|0
911843|NCT01059630|3005138|P2|Maintenance Period (up to 2 Years)|Death|2
911844|NCT01059630|3005139|P1|Maintenance Period (up to 2 Years)|Death|0
911845|NCT01059630|3005138|P2|Maintenance Period (up to 2 Years)|Withdrawal by Subject|3
911846|NCT01059630|3005139|P1|Maintenance Period (up to 2 Years)|Withdrawal by Subject|0
911847|NCT01059630|3005138|P2|Maintenance Period (up to 2 Years)|Progressive Disease|44
911848|NCT01059630|3005139|P1|Maintenance Period (up to 2 Years)|Progressive Disease|0
911849|NCT01059630|3005138|P2|Maintenance Period (up to 2 Years)|Adverse Event|8
911850|NCT01059630|3005139|P1|Maintenance Period (up to 2 Years)|Adverse Event|0
911851|NCT01059630|3005138|P2|Maintenance Period (up to 2 Years)|Maintenance ongoing|46
911852|NCT01059630|3005139|P1|Maintenance Period (up to 2 Years)|Maintenance ongoing|0
911853|NCT01059630|3005138|P2|Induction Period (6 Months)|Randomized but not Treated|0
911854|NCT01059630|3005139|P1|Induction Period (6 Months)|Randomized but not Treated|4
911855|NCT01059630|3005138|P2|Induction Period (6 Months)|Other|0
911856|NCT01059630|3005139|P1|Induction Period (6 Months)|Other|1
911857|NCT01059630|3005138|P2|Induction Period (6 Months)|Physician Decision|4
911858|NCT01059630|3005139|P1|Induction Period (6 Months)|Physician Decision|2
911859|NCT01059630|3005138|P2|Induction Period (6 Months)|Death|2
911860|NCT01059630|3005139|P1|Induction Period (6 Months)|Death|2
911861|NCT01059630|3005138|P2|Induction Period (6 Months)|Withdrawal by Subject|2
911862|NCT01059630|3005139|P1|Induction Period (6 Months)|Withdrawal by Subject|7
911863|NCT01059630|3005138|P2|Induction Period (6 Months)|Progressive Disease|9
911864|NCT01059630|3005139|P1|Induction Period (6 Months)|Progressive Disease|14
911865|NCT01059630|3005138|P2|Induction Period (6 Months)|Adverse Event|15
911866|NCT01059630|3005139|P1|Induction Period (6 Months)|Adverse Event|30
911867|NCT01059630|3005138|P2|Induction Period (6 Months)|Induction ongoing|6
911868|NCT01059630|3005139|P1|Induction Period (6 Months)|Induction ongoing|13
911869|NCT01059617|3005199|P4|Overall Study|Other|6
911870|NCT01059617|3005200|P3|Overall Study|Other|8
911871|NCT01059617|3005201|P2|Overall Study|Other|1
911872|NCT01059617|3005202|P1|Overall Study|Other|7
911954|NCT01058668|3005530|P1|Double-blind Treatment Phase|Adverse Event|8
911873|NCT01059565|3005372|P2|24-Week Open-Label Phase|Pulmonologist/participant decision|1
911874|NCT01059565|3005373|P1|24-Week Open-Label Phase|Pulmonologist/participant decision|0
911875|NCT01059565|3005372|P2|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1
911876|NCT01059565|3005373|P1|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0
911877|NCT01059565|3005372|P2|24-Week Open-Label Phase|Subject noncompliance|0
911878|NCT01059565|3005373|P1|24-Week Open-Label Phase|Subject noncompliance|1
911879|NCT01059565|3005372|P2|24-Week Open-Label Phase|Withdrawal by Subject|0
911880|NCT01059565|3005373|P1|24-Week Open-Label Phase|Withdrawal by Subject|1
911881|NCT01059565|3005372|P2|24-Week Open-Label Phase|Worsening health (physician decision)|1
911882|NCT01059565|3005373|P1|24-Week Open-Label Phase|Worsening health (physician decision)|1
911883|NCT01059565|3005372|P2|24-Week Open-Label Phase|Adverse Event|0
911884|NCT01059565|3005373|P1|24-Week Open-Label Phase|Adverse Event|2
911885|NCT01059565|3005372|P2|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5
911886|NCT01059565|3005373|P1|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1
911887|NCT01059565|3005372|P2|24-Week Randomized Phase|Lost to Follow-up|1
911888|NCT01059565|3005373|P1|24-Week Randomized Phase|Lost to Follow-up|0
911889|NCT01059565|3005372|P2|24-Week Randomized Phase|Withdrawal by Subject|1
911890|NCT01059565|3005373|P1|24-Week Randomized Phase|Withdrawal by Subject|3
911891|NCT01059565|3005372|P2|24-Week Randomized Phase|Adverse Event|0
911892|NCT01059565|3005373|P1|24-Week Randomized Phase|Adverse Event|5
911893|NCT01059565|3005372|P2|24-Week Randomized Phase|Randomized but not treated|0
911894|NCT01059565|3005373|P1|24-Week Randomized Phase|Randomized but not treated|1
911895|NCT01059526|3005409|P2|Overall Study|Patient found to be dermatographic|0
911896|NCT01059526|3005410|P1|Overall Study|Patient found to be dermatographic|1
911897|NCT01059526|3005409|P2|Overall Study|Lost to Follow-up|1
911898|NCT01059526|3005410|P1|Overall Study|Lost to Follow-up|4
911899|NCT01059526|3005409|P2|Overall Study|Withdrawal by Subject|1
911900|NCT01059526|3005410|P1|Overall Study|Withdrawal by Subject|3
911901|NCT01059526|3005409|P2|Overall Study|Protocol Violation|1
911902|NCT01059526|3005410|P1|Overall Study|Protocol Violation|0
911903|NCT01059526|3005409|P2|Overall Study|Adverse Event|2
911904|NCT01059526|3005410|P1|Overall Study|Adverse Event|2
911905|NCT01059526|3005409|P2|Overall Study|Patient enrolled but not treated|17
911906|NCT01059526|3005410|P1|Overall Study|Patient enrolled but not treated|20
911907|NCT01059344|3005429|P2|Overall Study|Other|6
911908|NCT01059344|3005430|P1|Overall Study|Other|3
911909|NCT01059344|3005429|P2|Overall Study|Lost to Follow-up|1
911910|NCT01059344|3005430|P1|Overall Study|Lost to Follow-up|1
911911|NCT01059344|3005429|P2|Overall Study|Withdrawal by Subject|9
911912|NCT01059344|3005430|P1|Overall Study|Withdrawal by Subject|6
911913|NCT01059344|3005429|P2|Overall Study|Adverse Event|30
911914|NCT01059344|3005430|P1|Overall Study|Adverse Event|12
911915|NCT01059175|3005454|P2|Overall Study|Lost to Follow-up|1
911916|NCT01059175|3005455|P1|Overall Study|Lost to Follow-up|0
911917|NCT01059175|3005454|P2|Overall Study|Adverse Event|2
911918|NCT01059175|3005455|P1|Overall Study|Adverse Event|4
911919|NCT01059175|3005454|P2|Overall Study|Death|17
911920|NCT01059175|3005455|P1|Overall Study|Death|17
911921|NCT01059071|3005477|P4|Overall Study|Physician Decision|1
911922|NCT01059071|3005478|P3|Overall Study|Physician Decision|0
911923|NCT01059071|3005479|P2|Overall Study|Physician Decision|0
911924|NCT01059071|3005480|P1|Overall Study|Physician Decision|0
911925|NCT01059071|3005477|P4|Overall Study|Withdrawal by Subject|2
911926|NCT01059071|3005478|P3|Overall Study|Withdrawal by Subject|0
911927|NCT01059071|3005479|P2|Overall Study|Withdrawal by Subject|0
911928|NCT01059071|3005480|P1|Overall Study|Withdrawal by Subject|1
911929|NCT01059071|3005477|P4|Overall Study|Lack of Efficacy|3
911930|NCT01059071|3005478|P3|Overall Study|Lack of Efficacy|2
911931|NCT01059071|3005479|P2|Overall Study|Lack of Efficacy|4
911932|NCT01059071|3005480|P1|Overall Study|Lack of Efficacy|1
911933|NCT01058863|3005507|P1|Overall Study|Randomized in error|1
911934|NCT01058863|3005507|P1|Overall Study|Sponsor requested withdrawal|1
911935|NCT01058863|3005507|P1|Overall Study|Withdrawal by Subject|1
911936|NCT01058863|3005507|P1|Overall Study|Lost to Follow-up|1
911937|NCT01058668|3005528|P3|Double-blind Treatment Phase|Other Unspecified|0
911938|NCT01058668|3005529|P2|Double-blind Treatment Phase|Other Unspecified|1
911939|NCT01058668|3005530|P1|Double-blind Treatment Phase|Other Unspecified|1
911940|NCT01058668|3005528|P3|Double-blind Treatment Phase|Lost to Follow-up|1
911941|NCT01058668|3005529|P2|Double-blind Treatment Phase|Lost to Follow-up|1
911942|NCT01058668|3005530|P1|Double-blind Treatment Phase|Lost to Follow-up|0
911943|NCT01058668|3005528|P3|Double-blind Treatment Phase|Withdrawal of Consent|17
911944|NCT01058668|3005529|P2|Double-blind Treatment Phase|Withdrawal of Consent|18
911945|NCT01058668|3005530|P1|Double-blind Treatment Phase|Withdrawal of Consent|14
911946|NCT01058668|3005528|P3|Double-blind Treatment Phase|Protocol Violation|2
911947|NCT01058668|3005529|P2|Double-blind Treatment Phase|Protocol Violation|1
911948|NCT01058668|3005530|P1|Double-blind Treatment Phase|Protocol Violation|1
911949|NCT01058668|3005528|P3|Double-blind Treatment Phase|Insufficient Therapeutic Response|5
911950|NCT01058668|3005529|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|2
911951|NCT01058668|3005530|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|15
911952|NCT01058668|3005528|P3|Double-blind Treatment Phase|Adverse Event|25
911953|NCT01058668|3005529|P2|Double-blind Treatment Phase|Adverse Event|15
911955|NCT01058655|3005545|P4|Overall Study|Other|4
911956|NCT01058655|3005546|P3|Overall Study|Other|0
911957|NCT01058655|3005547|P2|Overall Study|Other|0
911958|NCT01058655|3005548|P1|Overall Study|Other|0
911959|NCT01058655|3005545|P4|Overall Study|Disease Progression|24
911960|NCT01058655|3005546|P3|Overall Study|Disease Progression|4
911961|NCT01058655|3005547|P2|Overall Study|Disease Progression|2
911962|NCT01058655|3005548|P1|Overall Study|Disease Progression|1
911963|NCT01058655|3005545|P4|Overall Study|Death|0
911964|NCT01058655|3005546|P3|Overall Study|Death|1
911965|NCT01058655|3005547|P2|Overall Study|Death|1
911966|NCT01058655|3005548|P1|Overall Study|Death|0
911967|NCT01058655|3005545|P4|Overall Study|Clinical Progression (non-RECIST)|7
911968|NCT01058655|3005546|P3|Overall Study|Clinical Progression (non-RECIST)|0
911969|NCT01058655|3005547|P2|Overall Study|Clinical Progression (non-RECIST)|0
911970|NCT01058655|3005548|P1|Overall Study|Clinical Progression (non-RECIST)|1
911971|NCT01058655|3005545|P4|Overall Study|Symptomatic Deterioration|1
911972|NCT01058655|3005546|P3|Overall Study|Symptomatic Deterioration|0
911973|NCT01058655|3005547|P2|Overall Study|Symptomatic Deterioration|0
911974|NCT01058655|3005548|P1|Overall Study|Symptomatic Deterioration|0
911975|NCT01058655|3005545|P4|Overall Study|Prolonged Treatment Delay|2
911976|NCT01058655|3005546|P3|Overall Study|Prolonged Treatment Delay|0
911977|NCT01058655|3005547|P2|Overall Study|Prolonged Treatment Delay|0
911978|NCT01058655|3005548|P1|Overall Study|Prolonged Treatment Delay|0
911979|NCT01058655|3005545|P4|Overall Study|Withdrawal by Subject|4
911980|NCT01058655|3005546|P3|Overall Study|Withdrawal by Subject|3
911981|NCT01058655|3005547|P2|Overall Study|Withdrawal by Subject|0
911982|NCT01058655|3005548|P1|Overall Study|Withdrawal by Subject|1
911983|NCT01058642|3005566|P4|Treatment Period 1|Lack of Compliance with Study Drug|0
911984|NCT01058642|3005567|P3|Treatment Period 1|Lack of Compliance with Study Drug|0
911985|NCT01058642|3005568|P2|Treatment Period 1|Lack of Compliance with Study Drug|0
911986|NCT01058642|3005569|P1|Treatment Period 1|Lack of Compliance with Study Drug|1
911987|NCT01058642|3005566|P4|Treatment Period 1|Protocol Violation|1
911988|NCT01058642|3005567|P3|Treatment Period 1|Protocol Violation|0
911989|NCT01058642|3005568|P2|Treatment Period 1|Protocol Violation|0
911990|NCT01058642|3005569|P1|Treatment Period 1|Protocol Violation|0
911991|NCT01058642|3005566|P4|Treatment Period 1|Lack of Efficacy|1
911992|NCT01058642|3005567|P3|Treatment Period 1|Lack of Efficacy|0
911993|NCT01058642|3005568|P2|Treatment Period 1|Lack of Efficacy|0
911994|NCT01058642|3005569|P1|Treatment Period 1|Lack of Efficacy|0
911995|NCT01058642|3005566|P4|Treatment Period 1|Withdrawal by Subject|0
911996|NCT01058642|3005567|P3|Treatment Period 1|Withdrawal by Subject|0
911997|NCT01058642|3005568|P2|Treatment Period 1|Withdrawal by Subject|0
911998|NCT01058642|3005569|P1|Treatment Period 1|Withdrawal by Subject|1
911999|NCT01058642|3005566|P4|Treatment Period 1|Physician Decision|0
912000|NCT01058642|3005567|P3|Treatment Period 1|Physician Decision|1
912001|NCT01058642|3005568|P2|Treatment Period 1|Physician Decision|0
912002|NCT01058642|3005569|P1|Treatment Period 1|Physician Decision|0
912003|NCT01058642|3005566|P4|Treatment Period 1|Adverse Event|0
912004|NCT01058642|3005567|P3|Treatment Period 1|Adverse Event|1
912005|NCT01058642|3005568|P2|Treatment Period 1|Adverse Event|1
912006|NCT01058642|3005569|P1|Treatment Period 1|Adverse Event|0
912007|NCT01058421|3005579|P2|6 Month Outcomes|Remained in Other Facility|3
912008|NCT01058421|3005580|P1|6 Month Outcomes|Remained in Other Facility|1
912009|NCT01058421|3005579|P2|6 Month Outcomes|Lost to Follow-up|21
912010|NCT01058421|3005580|P1|6 Month Outcomes|Lost to Follow-up|16
912011|NCT01058421|3005579|P2|6 Month Outcomes|Death|2
912012|NCT01058421|3005580|P1|6 Month Outcomes|Death|2
912013|NCT01058421|3005579|P2|3 Month Outcomes|Remained in Other Facility|8
912014|NCT01058421|3005580|P1|3 Month Outcomes|Remained in Other Facility|5
912015|NCT01058421|3005579|P2|3 Month Outcomes|Remained in Hospital|2
912016|NCT01058421|3005580|P1|3 Month Outcomes|Remained in Hospital|0
912017|NCT01058421|3005579|P2|3 Month Outcomes|Lost to Follow-up|11
912018|NCT01058421|3005580|P1|3 Month Outcomes|Lost to Follow-up|12
912019|NCT01058421|3005579|P2|3 Month Outcomes|Death|5
912020|NCT01058421|3005580|P1|3 Month Outcomes|Death|3
912021|NCT01058421|3005579|P2|1 Month Outcomes|Remained in Other Facility|17
912022|NCT01058421|3005580|P1|1 Month Outcomes|Remained in Other Facility|16
912023|NCT01058421|3005579|P2|1 Month Outcomes|Remained in Hospital|12
912024|NCT01058421|3005580|P1|1 Month Outcomes|Remained in Hospital|5
912025|NCT01058421|3005579|P2|1 Month Outcomes|Lost to Follow-up|7
912026|NCT01058421|3005580|P1|1 Month Outcomes|Lost to Follow-up|8
912027|NCT01058421|3005579|P2|1 Month Outcomes|Death|6
912028|NCT01058421|3005580|P1|1 Month Outcomes|Death|10
912029|NCT01058395|3005604|P2|Overall Study|Lost to Follow-up|0
912030|NCT01058395|3005605|P1|Overall Study|Lost to Follow-up|1
912031|NCT01058395|3005604|P2|Overall Study|Death|1
912032|NCT01058395|3005605|P1|Overall Study|Death|2
912033|NCT01058356|3005614|P1|Overall Study|Lost to Follow-up|4
912034|NCT01058356|3005614|P1|Overall Study|Withdrawal by Subject|21
912035|NCT01058356|3005614|P1|Overall Study|Administration of contraindicated drugs|12
912036|NCT01058356|3005614|P1|Overall Study|Adverse Event|5
912037|NCT01058304|3005621|P2|Overall Study|Developed exclusion criterion|12
912038|NCT01058304|3005622|P1|Overall Study|Developed exclusion criterion|6
912039|NCT01058304|3005621|P2|Overall Study|Lost to Follow-up|16
912040|NCT01058304|3005622|P1|Overall Study|Lost to Follow-up|13
912041|NCT01058304|3005621|P2|Overall Study|Withdrawal by Subject|5
912042|NCT01058304|3005622|P1|Overall Study|Withdrawal by Subject|8
912043|NCT01058265|3005632|P2|Overall Study|Lost to Follow-up|12
912044|NCT01058265|3005633|P1|Overall Study|Lost to Follow-up|11
912045|NCT01058096|3005652|P2|Double-blind Treatment Phase|Other Unspecified|0
912046|NCT01058096|3005653|P1|Double-blind Treatment Phase|Other Unspecified|2
912047|NCT01058096|3005652|P2|Double-blind Treatment Phase|Lost to Follow-up|1
912048|NCT01058096|3005653|P1|Double-blind Treatment Phase|Lost to Follow-up|0
912049|NCT01058096|3005652|P2|Double-blind Treatment Phase|Withdrawal of Consent|26
912050|NCT01058096|3005653|P1|Double-blind Treatment Phase|Withdrawal of Consent|17
912051|NCT01058096|3005652|P2|Double-blind Treatment Phase|Protocol Violation|1
912052|NCT01058096|3005653|P1|Double-blind Treatment Phase|Protocol Violation|2
912053|NCT01058096|3005652|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|7
912054|NCT01058096|3005653|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|16
912055|NCT01058096|3005652|P2|Double-blind Treatment Phase|Adverse Event|15
912056|NCT01058096|3005653|P1|Double-blind Treatment Phase|Adverse Event|11
912057|NCT01058005|3005669|P3|Overall Study|Reason Missing|1
912058|NCT01058005|3005670|P2|Overall Study|Reason Missing|3
912059|NCT01058005|3005671|P1|Overall Study|Reason Missing|5
912060|NCT01058005|3005669|P3|Overall Study|Withdrawn Due to Study Termination|7
912061|NCT01058005|3005670|P2|Overall Study|Withdrawn Due to Study Termination|13
912062|NCT01058005|3005671|P1|Overall Study|Withdrawn Due to Study Termination|27
912063|NCT01058005|3005669|P3|Overall Study|Withdrawal by Subject|11
912064|NCT01058005|3005670|P2|Overall Study|Withdrawal by Subject|5
912065|NCT01058005|3005671|P1|Overall Study|Withdrawal by Subject|4
912066|NCT01058005|3005669|P3|Overall Study|Physician Decision|0
912067|NCT01058005|3005670|P2|Overall Study|Physician Decision|2
912068|NCT01058005|3005671|P1|Overall Study|Physician Decision|2
912069|NCT01058005|3005669|P3|Overall Study|Adverse Event|1
912070|NCT01058005|3005670|P2|Overall Study|Adverse Event|2
912071|NCT01058005|3005671|P1|Overall Study|Adverse Event|0
912072|NCT01057862|3005706|P2|Overall Study|Withdrawal by Subject|2
912073|NCT01057862|3005707|P1|Overall Study|Withdrawal by Subject|1
912074|NCT01057810|3005717|P2|Overall Study|Other|14
912075|NCT01057810|3005718|P1|Overall Study|Other|7
912076|NCT01057810|3005717|P2|Overall Study|No longer met study criteria|1
912077|NCT01057810|3005718|P1|Overall Study|No longer met study criteria|0
912078|NCT01057810|3005717|P2|Overall Study|Poor/non-compliance|1
912079|NCT01057810|3005718|P1|Overall Study|Poor/non-compliance|0
912080|NCT01057810|3005717|P2|Overall Study|Maximum clinical benefit|5
912081|NCT01057810|3005718|P1|Overall Study|Maximum clinical benefit|5
912082|NCT01057810|3005717|P2|Overall Study|Death|12
912083|NCT01057810|3005718|P1|Overall Study|Death|2
912084|NCT01057810|3005717|P2|Overall Study|Withdrawal by Subject|25
912085|NCT01057810|3005718|P1|Overall Study|Withdrawal by Subject|10
912086|NCT01057810|3005717|P2|Overall Study|Adverse event unrelated to study drug|29
912087|NCT01057810|3005718|P1|Overall Study|Adverse event unrelated to study drug|13
912088|NCT01057810|3005717|P2|Overall Study|Study drug toxicity|114
912089|NCT01057810|3005718|P1|Overall Study|Study drug toxicity|5
912090|NCT01057810|3005717|P2|Overall Study|Disease progression|197
912091|NCT01057810|3005718|P1|Overall Study|Disease progression|156
912092|NCT01057693|3005734|P3|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2
912093|NCT01057693|3005735|P2|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
912094|NCT01057693|3005736|P1|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
912095|NCT01057693|3005734|P3|Double-Blind Phase (Week 7 to Week 19)|Other|0
912096|NCT01057693|3005735|P2|Double-Blind Phase (Week 7 to Week 19)|Other|1
912097|NCT01057693|3005736|P1|Double-Blind Phase (Week 7 to Week 19)|Other|0
912098|NCT01057693|3005734|P3|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6
912099|NCT01057693|3005735|P2|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8
912100|NCT01057693|3005736|P1|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0
912101|NCT01057693|3005734|P3|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4
912102|NCT01057693|3005735|P2|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
912103|NCT01057693|3005736|P1|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
912104|NCT01057693|3005734|P3|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5
912105|NCT01057693|3005735|P2|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2
912106|NCT01057693|3005736|P1|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0
912107|NCT01057693|3005734|P3|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8
912108|NCT01057693|3005735|P2|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3
912109|NCT01057693|3005736|P1|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0
912110|NCT01057693|3005734|P3|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11
912111|NCT01057693|3005735|P2|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8
912112|NCT01057693|3005736|P1|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0
912113|NCT01057693|3005734|P3|Between Single-Blind and Double-Blind|Other|0
912114|NCT01057693|3005735|P2|Between Single-Blind and Double-Blind|Other|0
912115|NCT01057693|3005736|P1|Between Single-Blind and Double-Blind|Other|6
912116|NCT01057693|3005734|P3|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
912117|NCT01057693|3005735|P2|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
912118|NCT01057693|3005736|P1|Between Single-Blind and Double-Blind|Withdrawal by Subject|4
912119|NCT01057693|3005734|P3|Between Single-Blind and Double-Blind|Protocol Violation|0
912120|NCT01057693|3005735|P2|Between Single-Blind and Double-Blind|Protocol Violation|0
912121|NCT01057693|3005736|P1|Between Single-Blind and Double-Blind|Protocol Violation|7
912122|NCT01057693|3005734|P3|Between Single-Blind and Double-Blind|Lost to Follow-up|0
912123|NCT01057693|3005735|P2|Between Single-Blind and Double-Blind|Lost to Follow-up|0
912124|NCT01057693|3005736|P1|Between Single-Blind and Double-Blind|Lost to Follow-up|1
912125|NCT01057693|3005734|P3|Between Single-Blind and Double-Blind|Lack of Efficacy|0
912126|NCT01057693|3005735|P2|Between Single-Blind and Double-Blind|Lack of Efficacy|0
912127|NCT01057693|3005736|P1|Between Single-Blind and Double-Blind|Lack of Efficacy|247
912128|NCT01057693|3005734|P3|Between Single-Blind and Double-Blind|Adverse Event|0
912129|NCT01057693|3005735|P2|Between Single-Blind and Double-Blind|Adverse Event|0
912130|NCT01057693|3005736|P1|Between Single-Blind and Double-Blind|Adverse Event|5
912131|NCT01057693|3005734|P3|Single-Blind Phase (Up to Week 6)|Other|0
912132|NCT01057693|3005735|P2|Single-Blind Phase (Up to Week 6)|Other|0
912133|NCT01057693|3005736|P1|Single-Blind Phase (Up to Week 6)|Other|2
912134|NCT01057693|3005734|P3|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
912135|NCT01057693|3005735|P2|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
912136|NCT01057693|3005736|P1|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22
912137|NCT01057693|3005734|P3|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
912138|NCT01057693|3005735|P2|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
912139|NCT01057693|3005736|P1|Single-Blind Phase (Up to Week 6)|Protocol Violation|9
912140|NCT01057693|3005734|P3|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
912141|NCT01057693|3005735|P2|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
912142|NCT01057693|3005736|P1|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14
912143|NCT01057693|3005734|P3|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
912144|NCT01057693|3005735|P2|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
912145|NCT01057693|3005736|P1|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7
912146|NCT01057693|3005734|P3|Single-Blind Phase (Up to Week 6)|Adverse Event|0
912147|NCT01057693|3005735|P2|Single-Blind Phase (Up to Week 6)|Adverse Event|0
912148|NCT01057693|3005736|P1|Single-Blind Phase (Up to Week 6)|Adverse Event|45
912149|NCT01057589|3005782|P1|Overall Study|Lost to Follow-up|1
912150|NCT01057589|3005782|P1|Overall Study|Death|8
912151|NCT01057589|3005782|P1|Overall Study|Sponsor Decision|1
912152|NCT01057589|3005782|P1|Overall Study|Withdrawal by Subject|3
912153|NCT01057589|3005782|P1|Overall Study|Physician Decision|8
912154|NCT01057589|3005782|P1|Overall Study|Adverse Event|10
912155|NCT01057589|3005782|P1|Overall Study|Disease Progression|35
912156|NCT01057433|3005791|P1|Overall Study|Adverse Event|1
912157|NCT01057394|3005795|P2|Overall Study|Not eligible|2
912158|NCT01057394|3005796|P1|Overall Study|Not eligible|0
912159|NCT01057251|3005806|P2|Overall Study|Other Reason|1
912160|NCT01057251|3005807|P1|Overall Study|Other Reason|1
912161|NCT01057251|3005806|P2|Overall Study|Lost to Follow-up|6
912162|NCT01057251|3005807|P1|Overall Study|Lost to Follow-up|7
912163|NCT01057251|3005806|P2|Overall Study|Withdrawal by Subject|5
912164|NCT01057251|3005807|P1|Overall Study|Withdrawal by Subject|4
912165|NCT01057251|3005806|P2|Overall Study|Protocol Violation|2
912166|NCT01057251|3005807|P1|Overall Study|Protocol Violation|6
912167|NCT01057251|3005806|P2|Overall Study|Lack of Efficacy|11
912168|NCT01057251|3005807|P1|Overall Study|Lack of Efficacy|2
912169|NCT01057251|3005806|P2|Overall Study|Adverse Event|2
912170|NCT01057251|3005807|P1|Overall Study|Adverse Event|4
912171|NCT01057251|3005806|P2|Overall Study|Did not meet InclusionExclusion criteria|2
912172|NCT01057251|3005807|P1|Overall Study|Did not meet InclusionExclusion criteria|4
912173|NCT01056822|3005885|P2|Overall Study|Lost to Follow-up|0
912174|NCT01056822|3005886|P1|Overall Study|Lost to Follow-up|1
912175|NCT01056822|3005885|P2|Overall Study|Withdrawal by Subject|1
912176|NCT01056822|3005886|P1|Overall Study|Withdrawal by Subject|1
912177|NCT01056822|3005885|P2|Overall Study|Protocol Violation|5
912178|NCT01056822|3005886|P1|Overall Study|Protocol Violation|6
912179|NCT01056822|3005885|P2|Overall Study|Adverse Event|1
912180|NCT01056822|3005886|P1|Overall Study|Adverse Event|0
912181|NCT01056718|3005935|P1|Overall Study|Ischemia on baseline stress test|1
912182|NCT01056718|3005935|P1|Overall Study|Withdrawal by Subject|2
912183|NCT01056653|3005968|P3|Overall Study|Lost to Follow-up|2
912184|NCT01056653|3005969|P2|Overall Study|Lost to Follow-up|0
912185|NCT01056653|3005970|P1|Overall Study|Lost to Follow-up|0
912186|NCT01056640|3005986|P2|Overall Study|Death|4
912187|NCT01056640|3005987|P1|Overall Study|Death|15
912188|NCT01056640|3005986|P2|Overall Study|Withdrawal by Subject|8
912189|NCT01056640|3005987|P1|Overall Study|Withdrawal by Subject|11
912190|NCT01056523|3005999|P7|Overall Study|Death|1
912191|NCT01056523|3006000|P6|Overall Study|Death|0
912192|NCT01056523|3006001|P5|Overall Study|Death|0
912193|NCT01056523|3006002|P4|Overall Study|Death|3
912194|NCT01056523|3006003|P3|Overall Study|Death|2
912195|NCT01056523|3006004|P2|Overall Study|Death|0
912196|NCT01056523|3006005|P1|Overall Study|Death|1
912197|NCT01056510|3006015|P2|Overall Study|Missing|1
912198|NCT01056510|3006016|P1|Overall Study|Missing|0
912199|NCT01056510|3006015|P2|Overall Study|Not Specified|12
912200|NCT01056510|3006016|P1|Overall Study|Not Specified|10
912201|NCT01056510|3006015|P2|Overall Study|Lost to Follow-up|6
912202|NCT01056510|3006016|P1|Overall Study|Lost to Follow-up|5
912203|NCT01056510|3006015|P2|Overall Study|Physician Decision|5
912204|NCT01056510|3006016|P1|Overall Study|Physician Decision|4
912205|NCT01056510|3006015|P2|Overall Study|Noncompliance|3
912206|NCT01056510|3006016|P1|Overall Study|Noncompliance|1
912207|NCT01056510|3006015|P2|Overall Study|Death|34
912208|NCT01056510|3006016|P1|Overall Study|Death|29
912209|NCT01056510|3006015|P2|Overall Study|Withdrawal by Subject|2
912210|NCT01056510|3006016|P1|Overall Study|Withdrawal by Subject|4
912211|NCT01056510|3006015|P2|Overall Study|Dropout Before Start of Treatment|1
912212|NCT01056510|3006016|P1|Overall Study|Dropout Before Start of Treatment|1
912213|NCT01056484|3006062|P2|Follow up - Non-randomized|Withdrawal by Subject|2
912214|NCT01056484|3006063|P1|Follow up - Non-randomized|Withdrawal by Subject|0
912215|NCT01056484|3006062|P2|Randomized Controlled Trial|Physician Decision|0
912216|NCT01056484|3006063|P1|Randomized Controlled Trial|Physician Decision|1
912217|NCT01056484|3006062|P2|Randomized Controlled Trial|Withdrawal by Subject|1
912218|NCT01056484|3006063|P1|Randomized Controlled Trial|Withdrawal by Subject|6
912219|NCT01056380|3006079|P2|Overall Study|Lost to Follow-up|3
912220|NCT01056380|3006080|P1|Overall Study|Lost to Follow-up|2
912221|NCT01056341|3006107|P5|Overall Study|Other reasons|5
912222|NCT01056341|3006108|P4|Overall Study|Other reasons|9
912223|NCT01056341|3006109|P3|Overall Study|Other reasons|8
912224|NCT01056341|3006110|P2|Overall Study|Other reasons|4
912225|NCT01056341|3006111|P1|Overall Study|Other reasons|4
912226|NCT01056341|3006107|P5|Overall Study|Lack of Efficacy|9
912227|NCT01056341|3006108|P4|Overall Study|Lack of Efficacy|25
912228|NCT01056341|3006109|P3|Overall Study|Lack of Efficacy|7
912229|NCT01056341|3006110|P2|Overall Study|Lack of Efficacy|30
912230|NCT01056341|3006111|P1|Overall Study|Lack of Efficacy|32
912231|NCT01056341|3006107|P5|Overall Study|Treatment Intolerance|0
912232|NCT01056341|3006108|P4|Overall Study|Treatment Intolerance|2
912233|NCT01056341|3006109|P3|Overall Study|Treatment Intolerance|0
912234|NCT01056341|3006110|P2|Overall Study|Treatment Intolerance|2
912235|NCT01056341|3006111|P1|Overall Study|Treatment Intolerance|0
912236|NCT01056289|3006184|P4|Double-blind Phase|Physician Decision|0
912237|NCT01056289|3006185|P3|Double-blind Phase|Physician Decision|1
912238|NCT01056289|3006186|P2|Double-blind Phase|Physician Decision|0
912239|NCT01056289|3006187|P1|Double-blind Phase|Physician Decision|0
912240|NCT01056289|3006184|P4|Double-blind Phase|Discontinuation symptom|2
912241|NCT01056289|3006185|P3|Double-blind Phase|Discontinuation symptom|2
912242|NCT01056289|3006186|P2|Double-blind Phase|Discontinuation symptom|1
912243|NCT01056289|3006187|P1|Double-blind Phase|Discontinuation symptom|0
912244|NCT01056289|3006184|P4|Double-blind Phase|Withdrawal by Subject|2
912245|NCT01056289|3006185|P3|Double-blind Phase|Withdrawal by Subject|4
912246|NCT01056289|3006186|P2|Double-blind Phase|Withdrawal by Subject|0
912247|NCT01056289|3006187|P1|Double-blind Phase|Withdrawal by Subject|0
912248|NCT01056289|3006184|P4|Double-blind Phase|Protocol Violation|1
912249|NCT01056289|3006185|P3|Double-blind Phase|Protocol Violation|1
912250|NCT01056289|3006186|P2|Double-blind Phase|Protocol Violation|0
912251|NCT01056289|3006187|P1|Double-blind Phase|Protocol Violation|0
912252|NCT01056289|3006184|P4|Double-blind Phase|Other|2
912253|NCT01056289|3006185|P3|Double-blind Phase|Other|1
912254|NCT01056289|3006186|P2|Double-blind Phase|Other|0
912255|NCT01056289|3006187|P1|Double-blind Phase|Other|0
912256|NCT01056289|3006184|P4|Double-blind Phase|Lost to Follow-up|2
912257|NCT01056289|3006185|P3|Double-blind Phase|Lost to Follow-up|2
912258|NCT01056289|3006186|P2|Double-blind Phase|Lost to Follow-up|2
912259|NCT01056289|3006187|P1|Double-blind Phase|Lost to Follow-up|0
912260|NCT01056289|3006184|P4|Double-blind Phase|Adverse Event|1
912261|NCT01056289|3006185|P3|Double-blind Phase|Adverse Event|2
912262|NCT01056289|3006186|P2|Double-blind Phase|Adverse Event|1
912263|NCT01056289|3006187|P1|Double-blind Phase|Adverse Event|0
912264|NCT01056289|3006184|P4|Open-label Phase|Not randomized to Double-blind phase|0
912265|NCT01056289|3006185|P3|Open-label Phase|Not randomized to Double-blind phase|0
912266|NCT01056289|3006186|P2|Open-label Phase|Not randomized to Double-blind phase|0
912267|NCT01056289|3006187|P1|Open-label Phase|Not randomized to Double-blind phase|1
912268|NCT01056289|3006184|P4|Open-label Phase|Lack of Efficacy|0
912269|NCT01056289|3006185|P3|Open-label Phase|Lack of Efficacy|0
912270|NCT01056289|3006186|P2|Open-label Phase|Lack of Efficacy|0
912271|NCT01056289|3006187|P1|Open-label Phase|Lack of Efficacy|18
912272|NCT01056289|3006184|P4|Open-label Phase|Withdrawal by Subject|0
912273|NCT01056289|3006185|P3|Open-label Phase|Withdrawal by Subject|0
912274|NCT01056289|3006186|P2|Open-label Phase|Withdrawal by Subject|0
912275|NCT01056289|3006187|P1|Open-label Phase|Withdrawal by Subject|26
912276|NCT01056289|3006184|P4|Open-label Phase|Protocol Violation|0
912277|NCT01056289|3006185|P3|Open-label Phase|Protocol Violation|0
912278|NCT01056289|3006186|P2|Open-label Phase|Protocol Violation|0
912279|NCT01056289|3006187|P1|Open-label Phase|Protocol Violation|6
912280|NCT01056289|3006184|P4|Open-label Phase|Other|0
912281|NCT01056289|3006185|P3|Open-label Phase|Other|0
912282|NCT01056289|3006186|P2|Open-label Phase|Other|0
912283|NCT01056289|3006187|P1|Open-label Phase|Other|9
912284|NCT01056289|3006184|P4|Open-label Phase|Lost to Follow-up|0
912285|NCT01056289|3006185|P3|Open-label Phase|Lost to Follow-up|0
912286|NCT01056289|3006186|P2|Open-label Phase|Lost to Follow-up|0
912287|NCT01056289|3006187|P1|Open-label Phase|Lost to Follow-up|30
912288|NCT01056289|3006184|P4|Open-label Phase|Adverse Event|0
912289|NCT01056289|3006185|P3|Open-label Phase|Adverse Event|0
912290|NCT01056289|3006186|P2|Open-label Phase|Adverse Event|0
912291|NCT01056289|3006187|P1|Open-label Phase|Adverse Event|29
912292|NCT01056276|3006204|P2|Maintenance Therapy|Continuing maintenance therapy|14
912293|NCT01056276|3006205|P1|Maintenance Therapy|Continuing maintenance therapy|0
912294|NCT01056276|3006204|P2|Maintenance Therapy|Intercurrent Illness|1
912295|NCT01056276|3006205|P1|Maintenance Therapy|Intercurrent Illness|0
912296|NCT01056276|3006204|P2|Maintenance Therapy|Withdrawal by Subject|1
912297|NCT01056276|3006205|P1|Maintenance Therapy|Withdrawal by Subject|0
912298|NCT01056276|3006204|P2|Maintenance Therapy|Physician Decision|1
912299|NCT01056276|3006205|P1|Maintenance Therapy|Physician Decision|0
912300|NCT01056276|3006204|P2|Maintenance Therapy|Progressive Disease|9
912301|NCT01056276|3006205|P1|Maintenance Therapy|Progressive Disease|0
912302|NCT01056276|3006204|P2|Maintenance Therapy|Toxicity|2
912303|NCT01056276|3006205|P1|Maintenance Therapy|Toxicity|0
912304|NCT01056276|3006204|P2|Treatment Period-Cycles 1-8|Lost to Follow-up|0
912305|NCT01056276|3006205|P1|Treatment Period-Cycles 1-8|Lost to Follow-up|1
912306|NCT01056276|3006204|P2|Treatment Period-Cycles 1-8|Death|1
912307|NCT01056276|3006205|P1|Treatment Period-Cycles 1-8|Death|3
912308|NCT01056276|3006204|P2|Treatment Period-Cycles 1-8|Physician Decision|0
912309|NCT01056276|3006205|P1|Treatment Period-Cycles 1-8|Physician Decision|3
912310|NCT01056276|3006204|P2|Treatment Period-Cycles 1-8|Intercurrent Illness|2
912311|NCT01056276|3006205|P1|Treatment Period-Cycles 1-8|Intercurrent Illness|1
912312|NCT01056276|3006204|P2|Treatment Period-Cycles 1-8|Disease Progression|2
912313|NCT01056276|3006205|P1|Treatment Period-Cycles 1-8|Disease Progression|2
912314|NCT01056276|3006204|P2|Treatment Period-Cycles 1-8|Withdrawal by Subject|2
912315|NCT01056276|3006205|P1|Treatment Period-Cycles 1-8|Withdrawal by Subject|1
912316|NCT01056276|3006204|P2|Treatment Period-Cycles 1-8|Toxicity|1
912317|NCT01056276|3006205|P1|Treatment Period-Cycles 1-8|Toxicity|2
912318|NCT01056263|3006219|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|5
912319|NCT01056263|3006219|P1|Overall Study|Objective progression or relapse|1
912320|NCT01056263|3006219|P1|Overall Study|Neoplasm progression|1
912321|NCT01056263|3006219|P1|Overall Study|Progressive disease|2
912322|NCT01056263|3006219|P1|Overall Study|Lack of Efficacy|29
912323|NCT01056263|3006219|P1|Overall Study|Withdrawal by Subject|1
912324|NCT01056263|3006219|P1|Overall Study|Death|1
912325|NCT01056263|3006219|P1|Overall Study|Adverse Event|12
912326|NCT01056107|3006242|P4|Overall Study|Withdrawal by Subject|0
912327|NCT01056107|3006243|P3|Overall Study|Withdrawal by Subject|3
912328|NCT01056107|3006244|P2|Overall Study|Withdrawal by Subject|1
912329|NCT01056107|3006245|P1|Overall Study|Withdrawal by Subject|0
912330|NCT01055886|3006302|P2|Overall Study|Withdrawal by PI|1
912331|NCT01055886|3006303|P1|Overall Study|Withdrawal by PI|0
912332|NCT01055886|3006302|P2|Overall Study|Lost to Follow-up|1
912333|NCT01055886|3006303|P1|Overall Study|Lost to Follow-up|1
912334|NCT01055886|3006302|P2|Overall Study|Withdrawal by Subject|9
912335|NCT01055886|3006303|P1|Overall Study|Withdrawal by Subject|4
912336|NCT01055834|3006315|P2|Treatment Period I|Adverse Event|0
912337|NCT01055834|3006316|P1|Treatment Period I|Adverse Event|1
912338|NCT01055639|3006401|P2|Overall Study|Withdrawal by Subject|11
912339|NCT01055639|3006402|P1|Overall Study|Withdrawal by Subject|8
912340|NCT01055639|3006401|P2|Overall Study|Protocol Violation|5
912341|NCT01055639|3006402|P1|Overall Study|Protocol Violation|5
912342|NCT01055639|3006401|P2|Overall Study|Lost to Follow-up|11
912343|NCT01055639|3006402|P1|Overall Study|Lost to Follow-up|8
912344|NCT01055639|3006401|P2|Overall Study|Lack of Efficacy|1
912345|NCT01055639|3006402|P1|Overall Study|Lack of Efficacy|0
912346|NCT01055639|3006401|P2|Overall Study|Adverse Event|1
912347|NCT01055639|3006402|P1|Overall Study|Adverse Event|0
912348|NCT01055613|3006426|P2|Overall Study|Subject Disinterest|1
912349|NCT01055613|3006427|P1|Overall Study|Subject Disinterest|1
912350|NCT01055613|3006426|P2|Overall Study|Protocol Violation|1
912351|NCT01055613|3006427|P1|Overall Study|Protocol Violation|1
912352|NCT01055613|3006426|P2|Overall Study|Lost to Follow-up|1
912353|NCT01055613|3006427|P1|Overall Study|Lost to Follow-up|1
912354|NCT01055613|3006426|P2|Overall Study|Discomfort|1
912355|NCT01055613|3006427|P1|Overall Study|Discomfort|2
912356|NCT01055613|3006426|P2|Overall Study|Unacceptable lens fit|0
912357|NCT01055613|3006427|P1|Overall Study|Unacceptable lens fit|1
912358|NCT01055613|3006426|P2|Overall Study|No Longer Meets Eligibility Criteria|0
912359|NCT01055613|3006427|P1|Overall Study|No Longer Meets Eligibility Criteria|3
912360|NCT01055457|3006445|P10|Overall Study|Adverse Event|0
912361|NCT01055457|3006446|P9|Overall Study|Adverse Event|0
912362|NCT01055457|3006447|P8|Overall Study|Adverse Event|0
912363|NCT01055457|3006448|P7|Overall Study|Adverse Event|0
912364|NCT01055457|3006449|P6|Overall Study|Adverse Event|0
912365|NCT01055457|3006450|P5|Overall Study|Adverse Event|0
912366|NCT01055457|3006451|P4|Overall Study|Adverse Event|1
912367|NCT01055457|3006452|P3|Overall Study|Adverse Event|0
912368|NCT01055457|3006453|P2|Overall Study|Adverse Event|0
912369|NCT01055457|3006454|P1|Overall Study|Adverse Event|0
912370|NCT01055457|3006445|P10|Overall Study|Pregnancy|0
912371|NCT01055457|3006446|P9|Overall Study|Pregnancy|0
912372|NCT01055457|3006447|P8|Overall Study|Pregnancy|0
912373|NCT01055457|3006448|P7|Overall Study|Pregnancy|0
912374|NCT01055457|3006449|P6|Overall Study|Pregnancy|0
912375|NCT01055457|3006450|P5|Overall Study|Pregnancy|0
912376|NCT01055457|3006451|P4|Overall Study|Pregnancy|1
912377|NCT01055457|3006452|P3|Overall Study|Pregnancy|0
912378|NCT01055457|3006453|P2|Overall Study|Pregnancy|0
912379|NCT01055457|3006454|P1|Overall Study|Pregnancy|0
912380|NCT01055457|3006445|P10|Overall Study|Discomfort|0
912381|NCT01055457|3006446|P9|Overall Study|Discomfort|0
912382|NCT01055457|3006447|P8|Overall Study|Discomfort|0
912383|NCT01055457|3006448|P7|Overall Study|Discomfort|0
912384|NCT01055457|3006449|P6|Overall Study|Discomfort|0
912385|NCT01055457|3006450|P5|Overall Study|Discomfort|1
912386|NCT01055457|3006451|P4|Overall Study|Discomfort|0
912387|NCT01055457|3006452|P3|Overall Study|Discomfort|0
912388|NCT01055457|3006453|P2|Overall Study|Discomfort|0
912389|NCT01055457|3006454|P1|Overall Study|Discomfort|0
912390|NCT01055457|3006445|P10|Overall Study|Subject Ineligible|0
912391|NCT01055457|3006446|P9|Overall Study|Subject Ineligible|0
912392|NCT01055457|3006447|P8|Overall Study|Subject Ineligible|0
912393|NCT01055457|3006448|P7|Overall Study|Subject Ineligible|0
912394|NCT01055457|3006449|P6|Overall Study|Subject Ineligible|0
912395|NCT01055457|3006450|P5|Overall Study|Subject Ineligible|1
912396|NCT01055457|3006451|P4|Overall Study|Subject Ineligible|0
912397|NCT01055457|3006452|P3|Overall Study|Subject Ineligible|1
912398|NCT01055457|3006453|P2|Overall Study|Subject Ineligible|0
912399|NCT01055457|3006454|P1|Overall Study|Subject Ineligible|1
912400|NCT01055457|3006445|P10|Overall Study|Subject Disinterest|0
912401|NCT01055457|3006446|P9|Overall Study|Subject Disinterest|0
912402|NCT01055457|3006447|P8|Overall Study|Subject Disinterest|1
912403|NCT01055457|3006448|P7|Overall Study|Subject Disinterest|0
912404|NCT01055457|3006449|P6|Overall Study|Subject Disinterest|0
912405|NCT01055457|3006450|P5|Overall Study|Subject Disinterest|0
912406|NCT01055457|3006451|P4|Overall Study|Subject Disinterest|0
912407|NCT01055457|3006452|P3|Overall Study|Subject Disinterest|0
912408|NCT01055457|3006453|P2|Overall Study|Subject Disinterest|0
912409|NCT01055457|3006454|P1|Overall Study|Subject Disinterest|0
912410|NCT01055457|3006445|P10|Overall Study|Protocol Violation|1
912411|NCT01055457|3006446|P9|Overall Study|Protocol Violation|0
912412|NCT01055457|3006447|P8|Overall Study|Protocol Violation|0
912413|NCT01055457|3006448|P7|Overall Study|Protocol Violation|1
912414|NCT01055457|3006449|P6|Overall Study|Protocol Violation|2
912415|NCT01055457|3006450|P5|Overall Study|Protocol Violation|1
912416|NCT01055457|3006451|P4|Overall Study|Protocol Violation|1
912417|NCT01055457|3006452|P3|Overall Study|Protocol Violation|1
912418|NCT01055457|3006453|P2|Overall Study|Protocol Violation|0
912419|NCT01055457|3006454|P1|Overall Study|Protocol Violation|0
912420|NCT01055457|3006445|P10|Overall Study|Lost to Follow-up|0
912421|NCT01055457|3006446|P9|Overall Study|Lost to Follow-up|0
912422|NCT01055457|3006447|P8|Overall Study|Lost to Follow-up|0
912423|NCT01055457|3006448|P7|Overall Study|Lost to Follow-up|0
912424|NCT01055457|3006449|P6|Overall Study|Lost to Follow-up|1
912425|NCT01055457|3006450|P5|Overall Study|Lost to Follow-up|0
912426|NCT01055457|3006451|P4|Overall Study|Lost to Follow-up|0
912427|NCT01055457|3006452|P3|Overall Study|Lost to Follow-up|0
912428|NCT01055457|3006453|P2|Overall Study|Lost to Follow-up|1
912429|NCT01055457|3006454|P1|Overall Study|Lost to Follow-up|0
912430|NCT01055314|3006488|P2|Overall Study|No treatment|0
912431|NCT01055314|3006489|P1|Overall Study|No treatment|1
912432|NCT01055314|3006488|P2|Overall Study|Refusal of further protocol therapy|4
912433|NCT01055314|3006489|P1|Overall Study|Refusal of further protocol therapy|10
912434|NCT01055314|3006488|P2|Overall Study|Ineligible|5
912435|NCT01055314|3006489|P1|Overall Study|Ineligible|3
912436|NCT01055314|3006488|P2|Overall Study|Withdrawal by Subject|0
912437|NCT01055314|3006489|P1|Overall Study|Withdrawal by Subject|1
912438|NCT01055314|3006488|P2|Overall Study|Physician Decision|5
912439|NCT01055314|3006489|P1|Overall Study|Physician Decision|10
912440|NCT01055314|3006488|P2|Overall Study|Lack of Efficacy|19
912441|NCT01055314|3006489|P1|Overall Study|Lack of Efficacy|11
912442|NCT01055314|3006488|P2|Overall Study|Death|1
912443|NCT01055314|3006489|P1|Overall Study|Death|2
912444|NCT01055314|3006488|P2|Overall Study|Adverse Event|4
912445|NCT01055314|3006489|P1|Overall Study|Adverse Event|7
912446|NCT01055262|3006501|P1|Overall Study|Uncooperativeness|1
912447|NCT01055262|3006501|P1|Overall Study|Protocol Violation|3
912448|NCT01055262|3006501|P1|Overall Study|Adverse Event|5
912449|NCT01055197|3006542|P2|Overall Study|Withdrawal by Subject|0
912450|NCT01055197|3006543|P1|Overall Study|Withdrawal by Subject|2
912451|NCT01055197|3006542|P2|Overall Study|Protocol Violation|2
912452|NCT01055197|3006543|P1|Overall Study|Protocol Violation|7
912453|NCT01055132|3006578|P2|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1
912454|NCT01055132|3006579|P1|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0
912455|NCT01055132|3006578|P2|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0
912456|NCT01055132|3006579|P1|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1
912457|NCT01055028|3006592|P2|Inter-treatment Period|Did not start Cycle 4|3
912458|NCT01055028|3006593|P1|Inter-treatment Period|Did not start Cycle 4|0
912459|NCT01055028|3006592|P2|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
912460|NCT01055028|3006593|P1|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
912461|NCT01055028|3006592|P2|Treatment Cycles 1 to 3|Adverse Event|1
912462|NCT01055028|3006593|P1|Treatment Cycles 1 to 3|Adverse Event|0
912463|NCT01055028|3006592|P2|Screening|Screen Failure|1
912464|NCT01055028|3006593|P1|Screening|Screen Failure|1
912465|NCT01054976|3006607|P1|Overall Study|Not specified|8
912466|NCT01054976|3006607|P1|Overall Study|Withdrawal by Subject|4
912467|NCT01054976|3006607|P1|Overall Study|Uncooperative participations to study|7
912468|NCT01054976|3006607|P1|Overall Study|Adverse Event|16
912469|NCT01054885|3006628|P7|24-week, Double-blind Treatment Period|Withdrawal by Subject|2
912470|NCT01054885|3006629|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
912471|NCT01054885|3006630|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
912472|NCT01054885|3006631|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
912473|NCT01054885|3006632|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
912474|NCT01054885|3006633|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|8
912475|NCT01054885|3006634|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
912476|NCT01054885|3006628|P7|24-week, Double-blind Treatment Period|Physician Decision|1
912477|NCT01054885|3006629|P6|24-week, Double-blind Treatment Period|Physician Decision|1
912478|NCT01054885|3006630|P5|24-week, Double-blind Treatment Period|Physician Decision|3
912479|NCT01054885|3006631|P4|24-week, Double-blind Treatment Period|Physician Decision|6
912480|NCT01054885|3006632|P3|24-week, Double-blind Treatment Period|Physician Decision|1
912481|NCT01054885|3006633|P2|24-week, Double-blind Treatment Period|Physician Decision|4
912482|NCT01054885|3006634|P1|24-week, Double-blind Treatment Period|Physician Decision|0
912483|NCT01054885|3006628|P7|24-week, Double-blind Treatment Period|Lost to Follow-up|1
912484|NCT01054885|3006629|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|2
912485|NCT01054885|3006630|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|0
912486|NCT01054885|3006631|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
912487|NCT01054885|3006632|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|2
912488|NCT01054885|3006633|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
912489|NCT01054885|3006634|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
912490|NCT01054885|3006628|P7|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
912491|NCT01054885|3006629|P6|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
912492|NCT01054885|3006630|P5|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
912493|NCT01054885|3006631|P4|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
912494|NCT01054885|3006632|P3|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
912495|NCT01054885|3006633|P2|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
912496|NCT01054885|3006634|P1|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
912497|NCT01054885|3006628|P7|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
912498|NCT01054885|3006629|P6|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15
912499|NCT01054885|3006630|P5|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
912500|NCT01054885|3006631|P4|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
912501|NCT01054885|3006632|P3|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
912502|NCT01054885|3006633|P2|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
912503|NCT01054885|3006634|P1|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0
912504|NCT01054885|3006628|P7|24-week, Double-blind Treatment Period|Protocol Violation|4
912505|NCT01054885|3006629|P6|24-week, Double-blind Treatment Period|Protocol Violation|8
912506|NCT01054885|3006630|P5|24-week, Double-blind Treatment Period|Protocol Violation|3
912507|NCT01054885|3006631|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
912508|NCT01054885|3006632|P3|24-week, Double-blind Treatment Period|Protocol Violation|7
912509|NCT01054885|3006633|P2|24-week, Double-blind Treatment Period|Protocol Violation|7
912510|NCT01054885|3006634|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
912511|NCT01054885|3006628|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
912512|NCT01054885|3006629|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
912513|NCT01054885|3006630|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11
912514|NCT01054885|3006631|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5
912515|NCT01054885|3006632|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2
912516|NCT01054885|3006633|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
912517|NCT01054885|3006634|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
912518|NCT01054885|3006628|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
912519|NCT01054885|3006629|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
912520|NCT01054885|3006630|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
912521|NCT01054885|3006631|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
912522|NCT01054885|3006632|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
912523|NCT01054885|3006633|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
912524|NCT01054885|3006634|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
912525|NCT01054885|3006628|P7|24-week, Double-blind Treatment Period|Adverse Event|19
912526|NCT01054885|3006629|P6|24-week, Double-blind Treatment Period|Adverse Event|17
912527|NCT01054885|3006630|P5|24-week, Double-blind Treatment Period|Adverse Event|15
912528|NCT01054885|3006631|P4|24-week, Double-blind Treatment Period|Adverse Event|15
912529|NCT01054885|3006632|P3|24-week, Double-blind Treatment Period|Adverse Event|12
912530|NCT01054885|3006633|P2|24-week, Double-blind Treatment Period|Adverse Event|18
912531|NCT01054885|3006634|P1|24-week, Double-blind Treatment Period|Adverse Event|0
912532|NCT01054885|3006628|P7|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
912533|NCT01054885|3006629|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
912534|NCT01054885|3006630|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
912535|NCT01054885|3006631|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
912536|NCT01054885|3006632|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
912537|NCT01054885|3006633|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
912538|NCT01054885|3006634|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|68
912539|NCT01054885|3006628|P7|2-week, Single-blind Run-In Period|Adverse Event|0
912540|NCT01054885|3006629|P6|2-week, Single-blind Run-In Period|Adverse Event|0
912541|NCT01054885|3006630|P5|2-week, Single-blind Run-In Period|Adverse Event|0
912542|NCT01054885|3006631|P4|2-week, Single-blind Run-In Period|Adverse Event|0
912543|NCT01054885|3006632|P3|2-week, Single-blind Run-In Period|Adverse Event|0
912544|NCT01054885|3006633|P2|2-week, Single-blind Run-In Period|Adverse Event|0
912545|NCT01054885|3006634|P1|2-week, Single-blind Run-In Period|Adverse Event|7
912546|NCT01054885|3006628|P7|2-week, Single-blind Run-In Period|Lost to Follow-up|0
912547|NCT01054885|3006629|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
912548|NCT01054885|3006630|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
912549|NCT01054885|3006631|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
912550|NCT01054885|3006632|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
912551|NCT01054885|3006633|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
912552|NCT01054885|3006634|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
912553|NCT01054885|3006628|P7|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
912554|NCT01054885|3006629|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
912555|NCT01054885|3006630|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
912556|NCT01054885|3006631|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
912557|NCT01054885|3006632|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
912558|NCT01054885|3006633|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
912559|NCT01054885|3006634|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|23
912560|NCT01054885|3006628|P7|2-week, Single-blind Run-In Period|Physician Decision|0
912561|NCT01054885|3006629|P6|2-week, Single-blind Run-In Period|Physician Decision|0
912562|NCT01054885|3006630|P5|2-week, Single-blind Run-In Period|Physician Decision|0
912563|NCT01054885|3006631|P4|2-week, Single-blind Run-In Period|Physician Decision|0
912564|NCT01054885|3006632|P3|2-week, Single-blind Run-In Period|Physician Decision|0
912565|NCT01054885|3006633|P2|2-week, Single-blind Run-In Period|Physician Decision|0
912566|NCT01054885|3006634|P1|2-week, Single-blind Run-In Period|Physician Decision|6
912567|NCT01054885|3006628|P7|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
912568|NCT01054885|3006629|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
912569|NCT01054885|3006630|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
912570|NCT01054885|3006631|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
912571|NCT01054885|3006632|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
912572|NCT01054885|3006633|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
912573|NCT01054885|3006634|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246
912574|NCT01054846|3006674|P2|Overall Study|Lost to Follow-up|17
912575|NCT01054846|3006675|P1|Overall Study|Lost to Follow-up|76
912576|NCT01054820|3006682|P1|Overall Study|Withdrawal by Subject|2
912577|NCT01054729|3006704|P4|Overall Study|Lack of Efficacy|1
912578|NCT01054729|3006705|P3|Overall Study|Lack of Efficacy|0
912579|NCT01054729|3006706|P2|Overall Study|Lack of Efficacy|0
912580|NCT01054729|3006707|P1|Overall Study|Lack of Efficacy|0
912581|NCT01054729|3006704|P4|Overall Study|Subject moved|0
912582|NCT01054729|3006705|P3|Overall Study|Subject moved|1
912583|NCT01054729|3006706|P2|Overall Study|Subject moved|0
912584|NCT01054729|3006707|P1|Overall Study|Subject moved|0
912585|NCT01054729|3006704|P4|Overall Study|Personal/Obligations|0
912586|NCT01054729|3006705|P3|Overall Study|Personal/Obligations|0
912587|NCT01054729|3006706|P2|Overall Study|Personal/Obligations|1
912588|NCT01054729|3006707|P1|Overall Study|Personal/Obligations|0
912589|NCT01054729|3006704|P4|Overall Study|PEG/RBV Non-responder|0
912590|NCT01054729|3006705|P3|Overall Study|PEG/RBV Non-responder|1
912591|NCT01054729|3006706|P2|Overall Study|PEG/RBV Non-responder|0
912592|NCT01054729|3006707|P1|Overall Study|PEG/RBV Non-responder|1
912593|NCT01054729|3006704|P4|Overall Study|Non-responder|1
912594|NCT01054729|3006705|P3|Overall Study|Non-responder|1
912595|NCT01054729|3006706|P2|Overall Study|Non-responder|0
912596|NCT01054729|3006707|P1|Overall Study|Non-responder|1
912597|NCT01054729|3006704|P4|Overall Study|Lost to Follow-up, Later Contacted Site|0
912598|NCT01054729|3006705|P3|Overall Study|Lost to Follow-up, Later Contacted Site|0
912599|NCT01054729|3006706|P2|Overall Study|Lost to Follow-up, Later Contacted Site|1
912600|NCT01054729|3006707|P1|Overall Study|Lost to Follow-up, Later Contacted Site|0
912601|NCT01054729|3006704|P4|Overall Study|Lost to Follow-up|0
912602|NCT01054729|3006705|P3|Overall Study|Lost to Follow-up|0
912603|NCT01054729|3006706|P2|Overall Study|Lost to Follow-up|1
912604|NCT01054729|3006707|P1|Overall Study|Lost to Follow-up|0
912605|NCT01054729|3006704|P4|Overall Study|Withdrawal by Subject|0
912606|NCT01054729|3006705|P3|Overall Study|Withdrawal by Subject|1
912607|NCT01054729|3006706|P2|Overall Study|Withdrawal by Subject|0
912608|NCT01054729|3006707|P1|Overall Study|Withdrawal by Subject|1
912609|NCT01054729|3006704|P4|Overall Study|Adverse Event|1
912610|NCT01054729|3006705|P3|Overall Study|Adverse Event|2
912611|NCT01054729|3006706|P2|Overall Study|Adverse Event|1
912612|NCT01054729|3006707|P1|Overall Study|Adverse Event|1
912613|NCT01054729|3006704|P4|Overall Study|Randomized but Not Treated|0
912614|NCT01054729|3006705|P3|Overall Study|Randomized but Not Treated|0
912615|NCT01054729|3006706|P2|Overall Study|Randomized but Not Treated|1
912616|NCT01054729|3006707|P1|Overall Study|Randomized but Not Treated|0
912617|NCT01054599|3006805|P2|Overall Study|Withdrawal by Subject|1
912618|NCT01054599|3006806|P1|Overall Study|Withdrawal by Subject|0
912619|NCT01054599|3006805|P2|Overall Study|Adverse Event|1
912620|NCT01054599|3006806|P1|Overall Study|Adverse Event|0
912621|NCT01054599|3006805|P2|Overall Study|Lost to Follow-up|2
912622|NCT01054599|3006806|P1|Overall Study|Lost to Follow-up|0
912623|NCT01054599|3006805|P2|Overall Study|Visual impairment, WTAR <80|1
912624|NCT01054599|3006806|P1|Overall Study|Visual impairment, WTAR <80|0
912625|NCT01054599|3006805|P2|Overall Study|Timing/scheduling difficulties|1
912626|NCT01054599|3006806|P1|Overall Study|Timing/scheduling difficulties|1
912627|NCT01054599|3006805|P2|Overall Study|Spells/seizure-like episodes|1
912628|NCT01054599|3006806|P1|Overall Study|Spells/seizure-like episodes|1
912629|NCT01054599|3006805|P2|Overall Study|Protocol Violation|0
912630|NCT01054599|3006806|P1|Overall Study|Protocol Violation|1
912631|NCT01054599|3006805|P2|Overall Study|Dizziness due to phenytoin toxicity|0
912632|NCT01054599|3006806|P1|Overall Study|Dizziness due to phenytoin toxicity|1
912633|NCT01054573|3006913|P4|Overall Study|Withdrawal by Subject|1
912634|NCT01054573|3006914|P3|Overall Study|Withdrawal by Subject|2
912635|NCT01054573|3006915|P2|Overall Study|Withdrawal by Subject|2
912636|NCT01054573|3006916|P1|Overall Study|Withdrawal by Subject|0
912637|NCT01054573|3006913|P4|Overall Study|Lost to Follow-up|0
912638|NCT01054573|3006914|P3|Overall Study|Lost to Follow-up|0
912639|NCT01054573|3006915|P2|Overall Study|Lost to Follow-up|2
912640|NCT01054573|3006916|P1|Overall Study|Lost to Follow-up|0
912641|NCT01054573|3006913|P4|Overall Study|Adverse Event|1
912642|NCT01054573|3006914|P3|Overall Study|Adverse Event|1
912643|NCT01054573|3006915|P2|Overall Study|Adverse Event|0
912644|NCT01054573|3006916|P1|Overall Study|Adverse Event|1
912645|NCT01054560|3006962|P2|Overall Study|Physician Decision|0
912646|NCT01054560|3006963|P1|Overall Study|Physician Decision|1
912647|NCT01054560|3006962|P2|Overall Study|Withdrawal by Subject|2
912648|NCT01054560|3006963|P1|Overall Study|Withdrawal by Subject|0
912649|NCT01054560|3006962|P2|Overall Study|Lost to Follow-up|5
912650|NCT01054560|3006963|P1|Overall Study|Lost to Follow-up|2
912651|NCT01054560|3006962|P2|Overall Study|Death|21
912652|NCT01054560|3006963|P1|Overall Study|Death|10
912653|NCT01054300|3007015|P4|Period 2|Withdrawal by Subject|0
912654|NCT01054300|3007016|P3|Period 2|Withdrawal by Subject|1
912655|NCT01054300|3007017|P2|Period 2|Withdrawal by Subject|0
912656|NCT01054300|3007018|P1|Period 2|Withdrawal by Subject|0
912657|NCT01054300|3007015|P4|Period 1|Adverse Event|0
912658|NCT01054300|3007016|P3|Period 1|Adverse Event|0
912659|NCT01054300|3007017|P2|Period 1|Adverse Event|0
912660|NCT01054300|3007018|P1|Period 1|Adverse Event|1
912661|NCT01054222|3007068|P1|Overall Study|Withdrawal by Subject|6
912662|NCT01054222|3007068|P1|Overall Study|Lost to Follow-up|4
912663|NCT01054222|3007068|P1|Overall Study|Lack of Efficacy|1
912664|NCT01054170|3007109|P2|Overall Study|Adverse Event|4
912665|NCT01054170|3007110|P1|Overall Study|Adverse Event|0
912666|NCT01054170|3007109|P2|Overall Study|Withdrawal by Subject|2
912667|NCT01054170|3007110|P1|Overall Study|Withdrawal by Subject|3
912668|NCT01054170|3007109|P2|Overall Study|Protocol Violation|0
912669|NCT01054170|3007110|P1|Overall Study|Protocol Violation|1
912670|NCT01053988|3007175|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
912671|NCT01053988|3007176|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|10
912672|NCT01053988|3007177|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
912673|NCT01053988|3007178|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
912674|NCT01053988|3007179|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|11
912675|NCT01053988|3007180|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
912676|NCT01053988|3007175|P6|24-week, Double-blind Treatment Period|Physician Decision|4
912677|NCT01053988|3007176|P5|24-week, Double-blind Treatment Period|Physician Decision|5
912678|NCT01053988|3007177|P4|24-week, Double-blind Treatment Period|Physician Decision|5
912679|NCT01053988|3007178|P3|24-week, Double-blind Treatment Period|Physician Decision|2
912680|NCT01053988|3007179|P2|24-week, Double-blind Treatment Period|Physician Decision|5
912681|NCT01053988|3007180|P1|24-week, Double-blind Treatment Period|Physician Decision|0
912682|NCT01053988|3007175|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|3
912683|NCT01053988|3007176|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
912684|NCT01053988|3007177|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|2
912685|NCT01053988|3007178|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
912686|NCT01053988|3007179|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|4
912687|NCT01053988|3007180|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
912688|NCT01053988|3007175|P6|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
912689|NCT01053988|3007176|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
912690|NCT01053988|3007177|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8
912691|NCT01053988|3007178|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5
912692|NCT01053988|3007179|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
912693|NCT01053988|3007180|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
912694|NCT01053988|3007175|P6|24-week, Double-blind Treatment Period|Protocol Violation|4
912695|NCT01053988|3007176|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
912696|NCT01053988|3007177|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
912697|NCT01053988|3007178|P3|24-week, Double-blind Treatment Period|Protocol Violation|4
912698|NCT01053988|3007179|P2|24-week, Double-blind Treatment Period|Protocol Violation|3
912699|NCT01053988|3007180|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
912700|NCT01053988|3007175|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
912701|NCT01053988|3007176|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9
912702|NCT01053988|3007177|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
912703|NCT01053988|3007178|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16
912704|NCT01053988|3007179|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17
912705|NCT01053988|3007180|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
912706|NCT01053988|3007175|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
912707|NCT01053988|3007176|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
912708|NCT01053988|3007177|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
912709|NCT01053988|3007178|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
912710|NCT01053988|3007179|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
912711|NCT01053988|3007180|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
912712|NCT01053988|3007175|P6|24-week, Double-blind Treatment Period|Adverse Event|14
912713|NCT01053988|3007176|P5|24-week, Double-blind Treatment Period|Adverse Event|17
912714|NCT01053988|3007177|P4|24-week, Double-blind Treatment Period|Adverse Event|24
912715|NCT01053988|3007178|P3|24-week, Double-blind Treatment Period|Adverse Event|23
912716|NCT01053988|3007179|P2|24-week, Double-blind Treatment Period|Adverse Event|15
912717|NCT01053988|3007180|P1|24-week, Double-blind Treatment Period|Adverse Event|0
912718|NCT01053988|3007175|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
912719|NCT01053988|3007176|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
912720|NCT01053988|3007177|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
912721|NCT01053988|3007178|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
912722|NCT01053988|3007179|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
912723|NCT01053988|3007180|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
912724|NCT01053988|3007175|P6|2-week, Single-blind Run-In Period|Physician Decision|0
912725|NCT01053988|3007176|P5|2-week, Single-blind Run-In Period|Physician Decision|0
912726|NCT01053988|3007177|P4|2-week, Single-blind Run-In Period|Physician Decision|0
912727|NCT01053988|3007178|P3|2-week, Single-blind Run-In Period|Physician Decision|0
912728|NCT01053988|3007179|P2|2-week, Single-blind Run-In Period|Physician Decision|0
912729|NCT01053988|3007180|P1|2-week, Single-blind Run-In Period|Physician Decision|5
912730|NCT01053988|3007175|P6|2-week, Single-blind Run-In Period|Adverse Event|0
912731|NCT01053988|3007176|P5|2-week, Single-blind Run-In Period|Adverse Event|0
912732|NCT01053988|3007177|P4|2-week, Single-blind Run-In Period|Adverse Event|0
912733|NCT01053988|3007178|P3|2-week, Single-blind Run-In Period|Adverse Event|0
912734|NCT01053988|3007179|P2|2-week, Single-blind Run-In Period|Adverse Event|0
912735|NCT01053988|3007180|P1|2-week, Single-blind Run-In Period|Adverse Event|6
912736|NCT01053988|3007175|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
912737|NCT01053988|3007176|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
912738|NCT01053988|3007177|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
912739|NCT01053988|3007178|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
912740|NCT01053988|3007179|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
912741|NCT01053988|3007180|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|30
912742|NCT01053988|3007175|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
912743|NCT01053988|3007176|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
912744|NCT01053988|3007177|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
912745|NCT01053988|3007178|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
912746|NCT01053988|3007179|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
912747|NCT01053988|3007180|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|98
912748|NCT01053988|3007175|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
912749|NCT01053988|3007176|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
912750|NCT01053988|3007177|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
912751|NCT01053988|3007178|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
912752|NCT01053988|3007179|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
912753|NCT01053988|3007180|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220
912754|NCT01053741|3007231|P2|2nd Study Intervention|Physician Decision|1
912755|NCT01053741|3007232|P1|2nd Study Intervention|Physician Decision|0
912756|NCT01053663|3007241|P1|Overall Study|Negative Influenza Diagnosis|1
912757|NCT01053663|3007241|P1|Overall Study|Transferred to Another Hospital|1
912758|NCT01053663|3007241|P1|Overall Study|Poor IV Access|1
912759|NCT01053663|3007241|P1|Overall Study|Lost to Follow-up|1
912760|NCT01053663|3007241|P1|Overall Study|Death|2
912761|NCT01053429|3007299|P1|Overall Study|Other|309
912762|NCT01053429|3007299|P1|Overall Study|Adverse Event|64
912763|NCT01053247|3007329|P3|Overall Study|Adverse Event|3
912764|NCT01053247|3007330|P2|Overall Study|Adverse Event|9
912765|NCT01053247|3007331|P1|Overall Study|Adverse Event|0
912766|NCT01053247|3007329|P3|Overall Study|Lost to Follow-up|7
912767|NCT01053247|3007330|P2|Overall Study|Lost to Follow-up|5
912768|NCT01053247|3007331|P1|Overall Study|Lost to Follow-up|8
912769|NCT01053247|3007329|P3|Overall Study|Protocol Violation|2
912770|NCT01053247|3007330|P2|Overall Study|Protocol Violation|1
912771|NCT01053247|3007331|P1|Overall Study|Protocol Violation|2
912772|NCT01053247|3007329|P3|Overall Study|Lack of Efficacy|1
912773|NCT01053247|3007330|P2|Overall Study|Lack of Efficacy|0
912774|NCT01053247|3007331|P1|Overall Study|Lack of Efficacy|1
912775|NCT01053247|3007329|P3|Overall Study|Withdrawal by Subject|15
912776|NCT01053247|3007330|P2|Overall Study|Withdrawal by Subject|4
912777|NCT01053247|3007331|P1|Overall Study|Withdrawal by Subject|9
912778|NCT01052844|3007425|P2|Overall Study|Adverse Event|1
912779|NCT01052844|3007426|P1|Overall Study|Adverse Event|0
912780|NCT01052779|3007447|P2|Overall Study|Other-Missed Week 5 Visit|0
912781|NCT01052779|3007448|P1|Overall Study|Other-Missed Week 5 Visit|2
912782|NCT01052779|3007447|P2|Overall Study|Other-Surgery|2
912783|NCT01052779|3007448|P1|Overall Study|Other-Surgery|0
912784|NCT01052779|3007447|P2|Overall Study|Other-Protocol Violation|1
912785|NCT01052779|3007448|P1|Overall Study|Other-Protocol Violation|1
912786|NCT01052779|3007447|P2|Overall Study|Withdrawal by Subject|2
912787|NCT01052779|3007448|P1|Overall Study|Withdrawal by Subject|1
912788|NCT01052779|3007447|P2|Overall Study|Adverse Event|4
912789|NCT01052779|3007448|P1|Overall Study|Adverse Event|1
912790|NCT01052714|3007458|P3|Overall Study|Withdrawal by Subject|1
912791|NCT01052714|3007459|P2|Overall Study|Withdrawal by Subject|12
912792|NCT01052714|3007460|P1|Overall Study|Withdrawal by Subject|7
912793|NCT01052714|3007458|P3|Overall Study|Physician Decision|1
912794|NCT01052714|3007459|P2|Overall Study|Physician Decision|9
912795|NCT01052714|3007460|P1|Overall Study|Physician Decision|9
912796|NCT01052714|3007458|P3|Overall Study|Lost to Follow-up|0
912797|NCT01052714|3007459|P2|Overall Study|Lost to Follow-up|3
912798|NCT01052714|3007460|P1|Overall Study|Lost to Follow-up|2
912799|NCT01052714|3007458|P3|Overall Study|Death|0
912800|NCT01052714|3007459|P2|Overall Study|Death|2
912801|NCT01052714|3007460|P1|Overall Study|Death|1
912802|NCT01052714|3007458|P3|Overall Study|Adverse Event|0
912803|NCT01052714|3007459|P2|Overall Study|Adverse Event|3
912804|NCT01052714|3007460|P1|Overall Study|Adverse Event|6
912805|NCT01052662|3007514|P3|Overall Study|Administrative|0
912806|NCT01052662|3007515|P2|Overall Study|Administrative|3
912807|NCT01052662|3007516|P1|Overall Study|Administrative|0
912808|NCT01052662|3007514|P3|Overall Study|Legal Problem|0
912809|NCT01052662|3007515|P2|Overall Study|Legal Problem|0
912810|NCT01052662|3007516|P1|Overall Study|Legal Problem|2
912811|NCT01052662|3007514|P3|Overall Study|Adverse Event|0
912812|NCT01052662|3007515|P2|Overall Study|Adverse Event|1
912813|NCT01052662|3007516|P1|Overall Study|Adverse Event|1
912814|NCT01052662|3007514|P3|Overall Study|Pharmacy issue|3
912815|NCT01052662|3007515|P2|Overall Study|Pharmacy issue|3
912816|NCT01052662|3007516|P1|Overall Study|Pharmacy issue|1
912817|NCT01052662|3007514|P3|Overall Study|Withdrawal by Subject|1
912818|NCT01052662|3007515|P2|Overall Study|Withdrawal by Subject|2
912819|NCT01052662|3007516|P1|Overall Study|Withdrawal by Subject|3
912820|NCT01052662|3007514|P3|Overall Study|Lost to Follow-up|18
912821|NCT01052662|3007515|P2|Overall Study|Lost to Follow-up|13
912822|NCT01052662|3007516|P1|Overall Study|Lost to Follow-up|15
912823|NCT01052480|3007547|P2|Overall Study|Death|5
912824|NCT01052480|3007548|P1|Overall Study|Death|1
912825|NCT01052480|3007547|P2|Overall Study|Physician Decision|2
912826|NCT01052480|3007548|P1|Overall Study|Physician Decision|0
912827|NCT01052480|3007547|P2|Overall Study|Withdrawal by Subject|7
912828|NCT01052480|3007548|P1|Overall Study|Withdrawal by Subject|3
912829|NCT01052480|3007547|P2|Overall Study|Protocol Violation|0
912830|NCT01052480|3007548|P1|Overall Study|Protocol Violation|1
912831|NCT01052480|3007547|P2|Overall Study|Lost to Follow-up|3
912832|NCT01052480|3007548|P1|Overall Study|Lost to Follow-up|3
912833|NCT01052428|3007598|P2|Overall Study|Withdrawal by Subject|1
912834|NCT01052428|3007599|P1|Overall Study|Withdrawal by Subject|0
912835|NCT01052428|3007598|P2|Overall Study|Death|0
912836|NCT01052428|3007599|P1|Overall Study|Death|1
912837|NCT01052272|3007621|P4|Overall Study|decline in health|0
912838|NCT01052272|3007622|P3|Overall Study|decline in health|1
912839|NCT01052272|3007623|P2|Overall Study|decline in health|0
912840|NCT01052272|3007624|P1|Overall Study|decline in health|0
912841|NCT01052272|3007621|P4|Overall Study|placed in long-term care|0
912842|NCT01052272|3007622|P3|Overall Study|placed in long-term care|1
912843|NCT01052272|3007623|P2|Overall Study|placed in long-term care|0
912844|NCT01052272|3007624|P1|Overall Study|placed in long-term care|0
912845|NCT01052272|3007621|P4|Overall Study|Withdrawal by Subject|2
912846|NCT01052272|3007622|P3|Overall Study|Withdrawal by Subject|3
912847|NCT01052272|3007623|P2|Overall Study|Withdrawal by Subject|2
912848|NCT01052272|3007624|P1|Overall Study|Withdrawal by Subject|0
912849|NCT01052272|3007621|P4|Overall Study|patient refuses follow-up|4
912850|NCT01052272|3007622|P3|Overall Study|patient refuses follow-up|2
912851|NCT01052272|3007623|P2|Overall Study|patient refuses follow-up|4
912852|NCT01052272|3007624|P1|Overall Study|patient refuses follow-up|5
912853|NCT01052272|3007621|P4|Overall Study|Physician Decision|0
912854|NCT01052272|3007622|P3|Overall Study|Physician Decision|0
912855|NCT01052272|3007623|P2|Overall Study|Physician Decision|1
912856|NCT01052272|3007624|P1|Overall Study|Physician Decision|0
912857|NCT01052272|3007621|P4|Overall Study|Death|1
912858|NCT01052272|3007622|P3|Overall Study|Death|1
912859|NCT01052272|3007623|P2|Overall Study|Death|0
912860|NCT01052272|3007624|P1|Overall Study|Death|0
912861|NCT01052116|3007669|P2|Overall Study|Spirometry not performed|4
912862|NCT01052116|3007670|P1|Overall Study|Spirometry not performed|0
912863|NCT01052116|3007669|P2|Overall Study|Withdrawal by Subject|6
912864|NCT01052116|3007670|P1|Overall Study|Withdrawal by Subject|3
912865|NCT01052116|3007669|P2|Overall Study|Lost to Follow-up|17
912866|NCT01052116|3007670|P1|Overall Study|Lost to Follow-up|11
912867|NCT01052077|3007678|P4|Phase A+|Withdrawal by Subject|7
912868|NCT01052077|3007679|P3|Phase A+|Withdrawal by Subject|0
912869|NCT01052077|3007680|P2|Phase A+|Withdrawal by Subject|0
912870|NCT01052077|3007681|P1|Phase A+|Withdrawal by Subject|0
912871|NCT01052077|3007678|P4|Phase A+|Met Withdrawal Criteria|2
912872|NCT01052077|3007679|P3|Phase A+|Met Withdrawal Criteria|0
912873|NCT01052077|3007680|P2|Phase A+|Met Withdrawal Criteria|0
912874|NCT01052077|3007681|P1|Phase A+|Met Withdrawal Criteria|0
912875|NCT01052077|3007678|P4|Phase A+|Adverse Event|4
912876|NCT01052077|3007679|P3|Phase A+|Adverse Event|0
912877|NCT01052077|3007680|P2|Phase A+|Adverse Event|0
912878|NCT01052077|3007681|P1|Phase A+|Adverse Event|0
912879|NCT01052077|3007678|P4|Phase A+|Lost to Follow-up|8
912880|NCT01052077|3007679|P3|Phase A+|Lost to Follow-up|0
912881|NCT01052077|3007680|P2|Phase A+|Lost to Follow-up|0
912882|NCT01052077|3007681|P1|Phase A+|Lost to Follow-up|0
912883|NCT01052077|3007678|P4|Phase B|Lack of Efficacy|0
912884|NCT01052077|3007679|P3|Phase B|Lack of Efficacy|0
912885|NCT01052077|3007680|P2|Phase B|Lack of Efficacy|1
912886|NCT01052077|3007681|P1|Phase B|Lack of Efficacy|0
912887|NCT01052077|3007678|P4|Phase B|Protocol Deviation|0
912888|NCT01052077|3007679|P3|Phase B|Protocol Deviation|4
912889|NCT01052077|3007680|P2|Phase B|Protocol Deviation|3
912890|NCT01052077|3007681|P1|Phase B|Protocol Deviation|0
912891|NCT01052077|3007678|P4|Phase B|Withdrawal by Subject|0
912892|NCT01052077|3007679|P3|Phase B|Withdrawal by Subject|5
912893|NCT01052077|3007680|P2|Phase B|Withdrawal by Subject|0
912894|NCT01052077|3007681|P1|Phase B|Withdrawal by Subject|0
912895|NCT01052077|3007678|P4|Phase B|Physician Decision|0
912896|NCT01052077|3007679|P3|Phase B|Physician Decision|1
912897|NCT01052077|3007680|P2|Phase B|Physician Decision|1
912898|NCT01052077|3007681|P1|Phase B|Physician Decision|0
912899|NCT01052077|3007678|P4|Phase B|Met Withdrawal Criteria|0
912900|NCT01052077|3007679|P3|Phase B|Met Withdrawal Criteria|1
912901|NCT01052077|3007680|P2|Phase B|Met Withdrawal Criteria|2
912902|NCT01052077|3007681|P1|Phase B|Met Withdrawal Criteria|0
912903|NCT01052077|3007678|P4|Phase B|Adverse Event|0
912904|NCT01052077|3007679|P3|Phase B|Adverse Event|2
912905|NCT01052077|3007680|P2|Phase B|Adverse Event|9
912906|NCT01052077|3007681|P1|Phase B|Adverse Event|0
912907|NCT01052077|3007678|P4|Phase B|Lost to Follow-up|0
912908|NCT01052077|3007679|P3|Phase B|Lost to Follow-up|3
912909|NCT01052077|3007680|P2|Phase B|Lost to Follow-up|2
912910|NCT01052077|3007681|P1|Phase B|Lost to Follow-up|0
912911|NCT01052077|3007678|P4|Phase A|Protocol Deviation|0
912912|NCT01052077|3007679|P3|Phase A|Protocol Deviation|0
912913|NCT01052077|3007680|P2|Phase A|Protocol Deviation|0
912914|NCT01052077|3007681|P1|Phase A|Protocol Deviation|27
912915|NCT01052077|3007678|P4|Phase A|Withdrawal by Subject|0
912916|NCT01052077|3007679|P3|Phase A|Withdrawal by Subject|0
912917|NCT01052077|3007680|P2|Phase A|Withdrawal by Subject|0
912918|NCT01052077|3007681|P1|Phase A|Withdrawal by Subject|29
912919|NCT01052077|3007678|P4|Phase A|Physician Decision|0
912920|NCT01052077|3007679|P3|Phase A|Physician Decision|0
912921|NCT01052077|3007680|P2|Phase A|Physician Decision|0
912922|NCT01052077|3007681|P1|Phase A|Physician Decision|10
912923|NCT01052077|3007678|P4|Phase A|Met Withdrawal Criteria|0
912924|NCT01052077|3007679|P3|Phase A|Met Withdrawal Criteria|0
912925|NCT01052077|3007680|P2|Phase A|Met Withdrawal Criteria|0
912926|NCT01052077|3007681|P1|Phase A|Met Withdrawal Criteria|26
912927|NCT01052077|3007678|P4|Phase A|Adverse Event|0
912928|NCT01052077|3007679|P3|Phase A|Adverse Event|0
912929|NCT01052077|3007680|P2|Phase A|Adverse Event|0
912930|NCT01052077|3007681|P1|Phase A|Adverse Event|32
912931|NCT01052077|3007678|P4|Phase A|Lost to Follow-up|0
912932|NCT01052077|3007679|P3|Phase A|Lost to Follow-up|0
912933|NCT01052077|3007680|P2|Phase A|Lost to Follow-up|0
912934|NCT01052077|3007681|P1|Phase A|Lost to Follow-up|22
912935|NCT01052038|3007708|P3|Overall Study|Protocol Violation|3
912936|NCT01052038|3007709|P2|Overall Study|Protocol Violation|3
912937|NCT01052038|3007710|P1|Overall Study|Protocol Violation|2
912938|NCT01052038|3007708|P3|Overall Study|Lost to Follow-up|1
912939|NCT01052038|3007709|P2|Overall Study|Lost to Follow-up|3
912940|NCT01052038|3007710|P1|Overall Study|Lost to Follow-up|2
912941|NCT01051986|3007732|P2|Overall Study|Protocol Violation|3
912942|NCT01051986|3007733|P1|Overall Study|Protocol Violation|2
912943|NCT01051986|3007732|P2|Overall Study|Withdrawal by Subject|1
912944|NCT01051986|3007733|P1|Overall Study|Withdrawal by Subject|2
912945|NCT01051986|3007732|P2|Overall Study|Death|0
912946|NCT01051986|3007733|P1|Overall Study|Death|1
912947|NCT01051921|3007747|P1|Overall Study|patient moved|1
912948|NCT01051921|3007747|P1|Overall Study|virological failure|1
912949|NCT01051921|3007747|P1|Overall Study|Lost to Follow-up|4
912950|NCT01051921|3007747|P1|Overall Study|Withdrawal by Subject|7
912951|NCT01051921|3007747|P1|Overall Study|Adverse Event|8
912952|NCT01051921|3007747|P1|Overall Study|Physician Decision|9
912953|NCT01051856|3007754|P2|Overall Study|Withdrawal by Subject|0
912954|NCT01051856|3007755|P1|Overall Study|Withdrawal by Subject|1
912955|NCT01051817|3007765|P2|Overall Study|Protocol Violation|1
912956|NCT01051817|3007766|P1|Overall Study|Protocol Violation|0
912957|NCT01051817|3007765|P2|Overall Study|Withdrawal by Subject|5
912958|NCT01051817|3007766|P1|Overall Study|Withdrawal by Subject|3
912959|NCT01051817|3007765|P2|Overall Study|Abnormal Test Proceedure reults|1
912960|NCT01051817|3007766|P1|Overall Study|Abnormal Test Proceedure reults|0
912961|NCT01051817|3007765|P2|Overall Study|Adverse Event|2
912962|NCT01051817|3007766|P1|Overall Study|Adverse Event|0
912963|NCT01051791|3007776|P1|Overall Study|Withdrawal by Subject|1
912964|NCT01051791|3007776|P1|Overall Study|Failed screening|3
912965|NCT01051739|3007794|P2|Overall Study|Withdrawal by Subject|10
912966|NCT01051739|3007795|P1|Overall Study|Withdrawal by Subject|25
912967|NCT01051739|3007794|P2|Overall Study|Death|3
912968|NCT01051739|3007795|P1|Overall Study|Death|3
912969|NCT01051557|3007812|P7|Overall Study|Adverse Event|4
912970|NCT01051557|3007813|P6|Overall Study|Adverse Event|3
912971|NCT01051557|3007814|P5|Overall Study|Adverse Event|1
912972|NCT01051557|3007815|P4|Overall Study|Adverse Event|1
912973|NCT01051557|3007816|P3|Overall Study|Adverse Event|0
912974|NCT01051557|3007817|P2|Overall Study|Adverse Event|0
912975|NCT01051557|3007818|P1|Overall Study|Adverse Event|0
912976|NCT01051557|3007812|P7|Overall Study|Withdrawal by Subject|1
912977|NCT01051557|3007813|P6|Overall Study|Withdrawal by Subject|0
912978|NCT01051557|3007814|P5|Overall Study|Withdrawal by Subject|2
912979|NCT01051557|3007815|P4|Overall Study|Withdrawal by Subject|0
912980|NCT01051557|3007816|P3|Overall Study|Withdrawal by Subject|1
912981|NCT01051557|3007817|P2|Overall Study|Withdrawal by Subject|0
912982|NCT01051557|3007818|P1|Overall Study|Withdrawal by Subject|0
912983|NCT01051557|3007812|P7|Overall Study|disease progression|1
912984|NCT01051557|3007813|P6|Overall Study|disease progression|3
912985|NCT01051557|3007814|P5|Overall Study|disease progression|4
912986|NCT01051557|3007815|P4|Overall Study|disease progression|2
912987|NCT01051557|3007816|P3|Overall Study|disease progression|5
912988|NCT01051557|3007817|P2|Overall Study|disease progression|3
912989|NCT01051557|3007818|P1|Overall Study|disease progression|3
912990|NCT01051557|3007812|P7|Overall Study|Physician Decision|0
912991|NCT01051557|3007813|P6|Overall Study|Physician Decision|0
912992|NCT01051557|3007814|P5|Overall Study|Physician Decision|0
912993|NCT01051557|3007815|P4|Overall Study|Physician Decision|0
912994|NCT01051557|3007816|P3|Overall Study|Physician Decision|0
912995|NCT01051557|3007817|P2|Overall Study|Physician Decision|0
912996|NCT01051557|3007818|P1|Overall Study|Physician Decision|1
912997|NCT01051466|3007837|P2|Overall Study|Physician Decision|0
912998|NCT01051466|3007838|P1|Overall Study|Physician Decision|1
912999|NCT01051466|3007837|P2|Overall Study|Entry Criteria Not Met|3
913000|NCT01051466|3007838|P1|Overall Study|Entry Criteria Not Met|0
913001|NCT01051466|3007837|P2|Overall Study|Withdrawal by Subject|1
913002|NCT01051466|3007838|P1|Overall Study|Withdrawal by Subject|5
913003|NCT01051466|3007837|P2|Overall Study|Lost to Follow-up|1
913004|NCT01051466|3007838|P1|Overall Study|Lost to Follow-up|1
913005|NCT01051466|3007837|P2|Overall Study|Adverse Event|0
913006|NCT01051466|3007838|P1|Overall Study|Adverse Event|1
913007|NCT01051349|3007883|P1|Overall Study|Reason not Specified|12
913008|NCT01051349|3007883|P1|Overall Study|Subject non-compliance|7
913009|NCT01051349|3007883|P1|Overall Study|Lost to Follow-up|6
913010|NCT01051349|3007883|P1|Overall Study|Investigator Decision|6
913011|NCT01051349|3007883|P1|Overall Study|Consent Withdrawn|54
913012|NCT01051349|3007883|P1|Overall Study|Adverse Event|88
913013|NCT01051323|3007912|P1|Overall Study|Missing|37
913014|NCT01051323|3007912|P1|Overall Study|Other|148
913015|NCT01051323|3007912|P1|Overall Study|Hospitalization|28
913016|NCT01051323|3007912|P1|Overall Study|Death|129
913017|NCT01051323|3007912|P1|Overall Study|Lost to Follow-up|31
913018|NCT01051323|3007912|P1|Overall Study|Withdrawal by Subject|13
913019|NCT01051323|3007912|P1|Overall Study|Dialysis dependency|22
913020|NCT01051323|3007912|P1|Overall Study|Transplantation|28
913021|NCT01051323|3007912|P1|Overall Study|Discontinuation of treatment|103
913022|NCT01051063|3007936|P2|Overall Study|Lost to Follow-up|1
913023|NCT01051063|3007937|P1|Overall Study|Lost to Follow-up|0
913024|NCT01051063|3007936|P2|Overall Study|Not specified|0
913025|NCT01051063|3007937|P1|Overall Study|Not specified|1
913026|NCT01051063|3007936|P2|Overall Study|Moved from the study site area|0
913027|NCT01051063|3007937|P1|Overall Study|Moved from the study site area|1
913028|NCT01051063|3007936|P2|Overall Study|Termination of the study|0
913029|NCT01051063|3007937|P1|Overall Study|Termination of the study|5
913030|NCT01051063|3007936|P2|Overall Study|Withdrawal by Subject|1
913031|NCT01051063|3007937|P1|Overall Study|Withdrawal by Subject|1
913032|NCT01051063|3007936|P2|Overall Study|Death|2
913033|NCT01051063|3007937|P1|Overall Study|Death|2
913034|NCT01050998|3007957|P5|Overall Study|Data integrity issues|4
913035|NCT01050998|3007958|P4|Overall Study|Data integrity issues|1
913036|NCT01050998|3007959|P3|Overall Study|Data integrity issues|1
913037|NCT01050998|3007960|P2|Overall Study|Data integrity issues|0
913038|NCT01050998|3007961|P1|Overall Study|Data integrity issues|0
913039|NCT01050998|3007957|P5|Overall Study|Other|5
913040|NCT01050998|3007958|P4|Overall Study|Other|1
913041|NCT01050998|3007959|P3|Overall Study|Other|1
913042|NCT01050998|3007960|P2|Overall Study|Other|2
913043|NCT01050998|3007961|P1|Overall Study|Other|3
913044|NCT01050998|3007957|P5|Overall Study|Withdrawal by Subject|3
913045|NCT01050998|3007958|P4|Overall Study|Withdrawal by Subject|1
913046|NCT01050998|3007959|P3|Overall Study|Withdrawal by Subject|0
913047|NCT01050998|3007960|P2|Overall Study|Withdrawal by Subject|0
913048|NCT01050998|3007961|P1|Overall Study|Withdrawal by Subject|0
913049|NCT01050998|3007957|P5|Overall Study|Adverse Event|2
913050|NCT01050998|3007958|P4|Overall Study|Adverse Event|0
913051|NCT01050998|3007959|P3|Overall Study|Adverse Event|1
913052|NCT01050998|3007960|P2|Overall Study|Adverse Event|0
913053|NCT01050998|3007961|P1|Overall Study|Adverse Event|1
913054|NCT01050816|3008295|P1|Overall Study|patient's refusal|2
913055|NCT01050816|3008295|P1|Overall Study|Lost to Follow-up|2
913056|NCT01050790|3008301|P1|Overall Study|Adverse Event|1
913057|NCT01050764|3008311|P1|Overall Study|Death after HSCT, before T-cell infusion|1
913058|NCT01050764|3008311|P1|Overall Study|Donor mobilization failure, death|1
913059|NCT01050764|3008311|P1|Overall Study|Death, before HSCT|1
913060|NCT01050673|3008322|P2|Overall Study|Physician Decision|5
913061|NCT01050673|3008323|P1|Overall Study|Physician Decision|4
913062|NCT01050634|3008391|P1|Overall Study|Ongoing at Date of Cut-Off|5
913063|NCT01050634|3008391|P1|Overall Study|Other|21
913064|NCT01050634|3008391|P1|Overall Study|Lost to Follow-up|2
913065|NCT01050634|3008391|P1|Overall Study|Adverse Event|42
913066|NCT01050634|3008391|P1|Overall Study|Death|2
913067|NCT01050634|3008391|P1|Overall Study|Enrolled, but Not Treated|56
913068|NCT01050569|3008415|P3|Overall Study|Physician Decision|3
913069|NCT01050569|3008416|P2|Overall Study|Physician Decision|3
913070|NCT01050569|3008417|P1|Overall Study|Physician Decision|3
913071|NCT01050569|3008415|P3|Overall Study|Adverse Event|0
913072|NCT01050569|3008416|P2|Overall Study|Adverse Event|0
913073|NCT01050569|3008417|P1|Overall Study|Adverse Event|1
913074|NCT01050569|3008415|P3|Overall Study|Lack of Efficacy|3
913075|NCT01050569|3008416|P2|Overall Study|Lack of Efficacy|4
913076|NCT01050569|3008417|P1|Overall Study|Lack of Efficacy|5
913077|NCT01050569|3008415|P3|Overall Study|Withdrawal by Subject|11
913078|NCT01050569|3008416|P2|Overall Study|Withdrawal by Subject|3
913079|NCT01050569|3008417|P1|Overall Study|Withdrawal by Subject|9
913080|NCT01050569|3008415|P3|Overall Study|Lost to Follow-up|16
913081|NCT01050569|3008416|P2|Overall Study|Lost to Follow-up|14
913082|NCT01050569|3008417|P1|Overall Study|Lost to Follow-up|20
913083|NCT01050543|3008436|P2|Overall Study|Administrative|1
913084|NCT01050543|3008437|P1|Overall Study|Administrative|4
913085|NCT01050543|3008436|P2|Overall Study|Protocol Violation|1
913086|NCT01050543|3008437|P1|Overall Study|Protocol Violation|0
913087|NCT01050543|3008436|P2|Overall Study|Withdrawal by Subject|2
913088|NCT01050543|3008437|P1|Overall Study|Withdrawal by Subject|0
913089|NCT01050530|3008445|P2|Overall Study|Protocol Violation|0
913090|NCT01050530|3008446|P1|Overall Study|Protocol Violation|1
913091|NCT01050530|3008445|P2|Overall Study|Withdrawal by Subject|3
913092|NCT01050530|3008446|P1|Overall Study|Withdrawal by Subject|0
913093|NCT01050530|3008445|P2|Overall Study|Lack of Efficacy|4
913094|NCT01050530|3008446|P1|Overall Study|Lack of Efficacy|1
913095|NCT01050530|3008445|P2|Overall Study|Adverse Event|3
913096|NCT01050530|3008446|P1|Overall Study|Adverse Event|6
913097|NCT01050257|3008457|P3|Overall Study|Death|1
913098|NCT01050257|3008458|P2|Overall Study|Death|0
913099|NCT01050257|3008459|P1|Overall Study|Death|0
913100|NCT01050257|3008457|P3|Overall Study|Failure to return|0
913101|NCT01050257|3008458|P2|Overall Study|Failure to return|2
913102|NCT01050257|3008459|P1|Overall Study|Failure to return|0
913103|NCT01050257|3008457|P3|Overall Study|Violation criteria|0
913104|NCT01050257|3008458|P2|Overall Study|Violation criteria|1
913105|NCT01050257|3008459|P1|Overall Study|Violation criteria|0
913106|NCT01050257|3008457|P3|Overall Study|Refused treatment/ Did not Cooperate|0
913107|NCT01050257|3008458|P2|Overall Study|Refused treatment/ Did not Cooperate|1
913108|NCT01050257|3008459|P1|Overall Study|Refused treatment/ Did not Cooperate|1
913109|NCT01050257|3008457|P3|Overall Study|No reason specified|2
913110|NCT01050257|3008458|P2|Overall Study|No reason specified|0
913111|NCT01050257|3008459|P1|Overall Study|No reason specified|0
913112|NCT01050257|3008457|P3|Overall Study|Withdrawal by Subject|0
913113|NCT01050257|3008458|P2|Overall Study|Withdrawal by Subject|3
913114|NCT01050257|3008459|P1|Overall Study|Withdrawal by Subject|0
913115|NCT01050257|3008457|P3|Overall Study|Admin/Other (did not switch to oral)|2
913116|NCT01050257|3008458|P2|Overall Study|Admin/Other (did not switch to oral)|2
913117|NCT01050257|3008459|P1|Overall Study|Admin/Other (did not switch to oral)|6
913118|NCT01050257|3008457|P3|Overall Study|Adverse Event|2
913119|NCT01050257|3008458|P2|Overall Study|Adverse Event|4
913120|NCT01050257|3008459|P1|Overall Study|Adverse Event|4
913121|NCT01050218|3008494|P1|Overall Study|Family emergency|1
913122|NCT01050218|3008494|P1|Overall Study|Serious Adverse Event|1
913123|NCT01050218|3008494|P1|Overall Study|Failed to return|7
913124|NCT01050218|3008494|P1|Overall Study|Compliance|2
913125|NCT01050218|3008494|P1|Overall Study|Discontinued by sponsor|18
913126|NCT01050218|3008494|P1|Overall Study|Withdrawal by Subject|18
913127|NCT01050218|3008494|P1|Overall Study|Protocol Violation|3
913128|NCT01050218|3008494|P1|Overall Study|Lack of Efficacy|8
913129|NCT01050218|3008494|P1|Overall Study|Adverse Event|37
913130|NCT01050205|3008500|P2|Overall Study|Discontinued Intervention|0
913131|NCT01050205|3008501|P1|Overall Study|Discontinued Intervention|2
913132|NCT01050205|3008500|P2|Overall Study|Relocated from area|2
913133|NCT01050205|3008501|P1|Overall Study|Relocated from area|1
913134|NCT01050205|3008500|P2|Overall Study|Withdrawal by Subject|1
913135|NCT01050205|3008501|P1|Overall Study|Withdrawal by Subject|1
913136|NCT01050205|3008500|P2|Overall Study|Lost to Follow-up|1
913137|NCT01050205|3008501|P1|Overall Study|Lost to Follow-up|7
913138|NCT01050062|3008558|P2|Overall Study|Others|11
913139|NCT01050062|3008559|P1|Overall Study|Others|17
913140|NCT01050062|3008558|P2|Overall Study|Physician Decision|9
913141|NCT01050062|3008559|P1|Overall Study|Physician Decision|74
913142|NCT01050062|3008558|P2|Overall Study|Lack of Efficacy|35
913143|NCT01050062|3008559|P1|Overall Study|Lack of Efficacy|22
913144|NCT01050062|3008558|P2|Overall Study|Lost to Follow-up|35
913145|NCT01050062|3008559|P1|Overall Study|Lost to Follow-up|83
913146|NCT01050062|3008558|P2|Overall Study|Adverse Event|22
913147|NCT01050062|3008559|P1|Overall Study|Adverse Event|75
913148|NCT01049984|3008581|P2|Overall Study|Treatment failure|2
913149|NCT01049984|3008582|P1|Overall Study|Treatment failure|0
913150|NCT01049984|3008581|P2|Overall Study|Adverse Event|7
913151|NCT01049984|3008582|P1|Overall Study|Adverse Event|13
913152|NCT01049984|3008581|P2|Overall Study|Lost to Follow-up|1
913153|NCT01049984|3008582|P1|Overall Study|Lost to Follow-up|2
913154|NCT01049984|3008581|P2|Overall Study|Protocol Violation|4
913155|NCT01049984|3008582|P1|Overall Study|Protocol Violation|3
913156|NCT01049984|3008581|P2|Overall Study|Withdrawal by Subject|5
913157|NCT01049984|3008582|P1|Overall Study|Withdrawal by Subject|1
913158|NCT01049581|3008642|P2|Overall Study|Lost to Follow-up|1
913159|NCT01049581|3008643|P1|Overall Study|Lost to Follow-up|2
913160|NCT01049503|3008658|P6|Overall Study|Lost to Follow-up|8
913161|NCT01049503|3008659|P5|Overall Study|Lost to Follow-up|27
913162|NCT01049503|3008660|P4|Overall Study|Lost to Follow-up|26
913163|NCT01049503|3008661|P3|Overall Study|Lost to Follow-up|24
913164|NCT01049503|3008662|P2|Overall Study|Lost to Follow-up|12
913165|NCT01049503|3008663|P1|Overall Study|Lost to Follow-up|11
913166|NCT01049412|3008694|P2|Period II|Lost to Follow-up|0
913167|NCT01049412|3008695|P1|Period II|Lost to Follow-up|1
913168|NCT01049412|3008694|P2|Period II|Adverse Event|0
913169|NCT01049412|3008695|P1|Period II|Adverse Event|1
913170|NCT01049412|3008694|P2|Period II|Withdrawal by Subject|3
913171|NCT01049412|3008695|P1|Period II|Withdrawal by Subject|2
913172|NCT01049412|3008694|P2|Period I|Adverse Event|0
913173|NCT01049412|3008695|P1|Period I|Adverse Event|1
913174|NCT01049412|3008694|P2|Period I|Protocol Violation|2
913175|NCT01049412|3008695|P1|Period I|Protocol Violation|1
913176|NCT01049412|3008694|P2|Period I|Physician Decision|3
913177|NCT01049412|3008695|P1|Period I|Physician Decision|0
913178|NCT01049412|3008694|P2|Period I|Lost to Follow-up|2
913179|NCT01049412|3008695|P1|Period I|Lost to Follow-up|2
913180|NCT01049412|3008694|P2|Period I|Withdrawal by Subject|6
913181|NCT01049412|3008695|P1|Period I|Withdrawal by Subject|4
913182|NCT01049373|3008724|P2|Overall Study|Non-cooperation|1
913183|NCT01049373|3008725|P1|Overall Study|Non-cooperation|0
913184|NCT01049373|3008724|P2|Overall Study|Not specified|1
913185|NCT01049373|3008725|P1|Overall Study|Not specified|1
913186|NCT01049373|3008724|P2|Overall Study|no evaluable study values|21
913187|NCT01049373|3008725|P1|Overall Study|no evaluable study values|9
913188|NCT01049373|3008724|P2|Overall Study|Lost to Follow-up|4
913189|NCT01049373|3008725|P1|Overall Study|Lost to Follow-up|9
913190|NCT01049373|3008724|P2|Overall Study|Adverse Event|3
913191|NCT01049373|3008725|P1|Overall Study|Adverse Event|3
913192|NCT01049373|3008724|P2|Overall Study|Withdrawal by Subject|5
913193|NCT01049373|3008725|P1|Overall Study|Withdrawal by Subject|8
913194|NCT01049373|3008724|P2|Overall Study|Protocol Violation|9
913195|NCT01049373|3008725|P1|Overall Study|Protocol Violation|9
913196|NCT01049360|3008739|P20|Period 4|Withdrawal by Subject|0
913197|NCT01049360|3008740|P19|Period 4|Withdrawal by Subject|0
913198|NCT01049360|3008741|P18|Period 4|Withdrawal by Subject|0
913199|NCT01049360|3008742|P17|Period 4|Withdrawal by Subject|0
913200|NCT01049360|3008743|P16|Period 4|Withdrawal by Subject|0
913201|NCT01049360|3008744|P15|Period 4|Withdrawal by Subject|0
913202|NCT01049360|3008745|P14|Period 4|Withdrawal by Subject|0
913203|NCT01049360|3008746|P13|Period 4|Withdrawal by Subject|0
913204|NCT01049360|3008747|P12|Period 4|Withdrawal by Subject|0
913205|NCT01049360|3008748|P11|Period 4|Withdrawal by Subject|0
913206|NCT01049360|3008749|P10|Period 4|Withdrawal by Subject|0
913207|NCT01049360|3008750|P9|Period 4|Withdrawal by Subject|0
913208|NCT01049360|3008751|P8|Period 4|Withdrawal by Subject|0
913209|NCT01049360|3008752|P7|Period 4|Withdrawal by Subject|0
913210|NCT01049360|3008753|P6|Period 4|Withdrawal by Subject|0
913211|NCT01049360|3008754|P5|Period 4|Withdrawal by Subject|0
913212|NCT01049360|3008755|P4|Period 4|Withdrawal by Subject|1
913213|NCT01049360|3008756|P3|Period 4|Withdrawal by Subject|0
913214|NCT01049360|3008757|P2|Period 4|Withdrawal by Subject|0
913215|NCT01049360|3008758|P1|Period 4|Withdrawal by Subject|0
913216|NCT01049360|3008739|P20|Period 4|Protocol Violation|0
913217|NCT01049360|3008740|P19|Period 4|Protocol Violation|0
913218|NCT01049360|3008741|P18|Period 4|Protocol Violation|1
913219|NCT01049360|3008742|P17|Period 4|Protocol Violation|0
913220|NCT01049360|3008743|P16|Period 4|Protocol Violation|0
913221|NCT01049360|3008744|P15|Period 4|Protocol Violation|0
913222|NCT01049360|3008745|P14|Period 4|Protocol Violation|0
913223|NCT01049360|3008746|P13|Period 4|Protocol Violation|0
913224|NCT01049360|3008747|P12|Period 4|Protocol Violation|0
913225|NCT01049360|3008748|P11|Period 4|Protocol Violation|0
913226|NCT01049360|3008749|P10|Period 4|Protocol Violation|0
913227|NCT01049360|3008750|P9|Period 4|Protocol Violation|0
913228|NCT01049360|3008751|P8|Period 4|Protocol Violation|0
913229|NCT01049360|3008752|P7|Period 4|Protocol Violation|0
913230|NCT01049360|3008753|P6|Period 4|Protocol Violation|0
913231|NCT01049360|3008754|P5|Period 4|Protocol Violation|0
913232|NCT01049360|3008755|P4|Period 4|Protocol Violation|0
913233|NCT01049360|3008756|P3|Period 4|Protocol Violation|0
913234|NCT01049360|3008757|P2|Period 4|Protocol Violation|0
913235|NCT01049360|3008758|P1|Period 4|Protocol Violation|0
913236|NCT01049360|3008739|P20|Period 2|Lack of Efficacy|0
913237|NCT01049360|3008740|P19|Period 2|Lack of Efficacy|0
913238|NCT01049360|3008741|P18|Period 2|Lack of Efficacy|0
913239|NCT01049360|3008742|P17|Period 2|Lack of Efficacy|0
913240|NCT01049360|3008743|P16|Period 2|Lack of Efficacy|0
913241|NCT01049360|3008744|P15|Period 2|Lack of Efficacy|0
913242|NCT01049360|3008745|P14|Period 2|Lack of Efficacy|0
913243|NCT01049360|3008746|P13|Period 2|Lack of Efficacy|0
913244|NCT01049360|3008747|P12|Period 2|Lack of Efficacy|0
913245|NCT01049360|3008748|P11|Period 2|Lack of Efficacy|0
913246|NCT01049360|3008749|P10|Period 2|Lack of Efficacy|0
913247|NCT01049360|3008750|P9|Period 2|Lack of Efficacy|0
913248|NCT01049360|3008751|P8|Period 2|Lack of Efficacy|0
913249|NCT01049360|3008752|P7|Period 2|Lack of Efficacy|0
913250|NCT01049360|3008753|P6|Period 2|Lack of Efficacy|1
913251|NCT01049360|3008754|P5|Period 2|Lack of Efficacy|0
913252|NCT01049360|3008755|P4|Period 2|Lack of Efficacy|0
913253|NCT01049360|3008756|P3|Period 2|Lack of Efficacy|0
913254|NCT01049360|3008757|P2|Period 2|Lack of Efficacy|0
913255|NCT01049360|3008758|P1|Period 2|Lack of Efficacy|0
913256|NCT01049360|3008739|P20|Period 2|Withdrawal by Subject|1
913257|NCT01049360|3008740|P19|Period 2|Withdrawal by Subject|0
913258|NCT01049360|3008741|P18|Period 2|Withdrawal by Subject|0
913259|NCT01049360|3008742|P17|Period 2|Withdrawal by Subject|0
913260|NCT01049360|3008743|P16|Period 2|Withdrawal by Subject|0
913261|NCT01049360|3008744|P15|Period 2|Withdrawal by Subject|1
913262|NCT01049360|3008745|P14|Period 2|Withdrawal by Subject|0
913263|NCT01049360|3008746|P13|Period 2|Withdrawal by Subject|0
913264|NCT01049360|3008747|P12|Period 2|Withdrawal by Subject|0
913265|NCT01049360|3008748|P11|Period 2|Withdrawal by Subject|0
913266|NCT01049360|3008749|P10|Period 2|Withdrawal by Subject|0
913267|NCT01049360|3008750|P9|Period 2|Withdrawal by Subject|0
913268|NCT01049360|3008751|P8|Period 2|Withdrawal by Subject|0
913269|NCT01049360|3008752|P7|Period 2|Withdrawal by Subject|0
913270|NCT01049360|3008753|P6|Period 2|Withdrawal by Subject|0
913271|NCT01049360|3008754|P5|Period 2|Withdrawal by Subject|0
913272|NCT01049360|3008755|P4|Period 2|Withdrawal by Subject|1
913273|NCT01049360|3008756|P3|Period 2|Withdrawal by Subject|0
913274|NCT01049360|3008757|P2|Period 2|Withdrawal by Subject|0
913275|NCT01049360|3008758|P1|Period 2|Withdrawal by Subject|0
913276|NCT01049360|3008739|P20|Period 2|Adverse Event|1
913277|NCT01049360|3008740|P19|Period 2|Adverse Event|0
913278|NCT01049360|3008741|P18|Period 2|Adverse Event|0
913279|NCT01049360|3008742|P17|Period 2|Adverse Event|0
913280|NCT01049360|3008743|P16|Period 2|Adverse Event|0
913281|NCT01049360|3008744|P15|Period 2|Adverse Event|0
913282|NCT01049360|3008745|P14|Period 2|Adverse Event|0
913283|NCT01049360|3008746|P13|Period 2|Adverse Event|0
913284|NCT01049360|3008747|P12|Period 2|Adverse Event|0
913285|NCT01049360|3008748|P11|Period 2|Adverse Event|0
913286|NCT01049360|3008749|P10|Period 2|Adverse Event|0
913287|NCT01049360|3008750|P9|Period 2|Adverse Event|1
913288|NCT01049360|3008751|P8|Period 2|Adverse Event|0
913289|NCT01049360|3008752|P7|Period 2|Adverse Event|0
913290|NCT01049360|3008753|P6|Period 2|Adverse Event|0
913291|NCT01049360|3008754|P5|Period 2|Adverse Event|0
913292|NCT01049360|3008755|P4|Period 2|Adverse Event|0
913293|NCT01049360|3008756|P3|Period 2|Adverse Event|0
913294|NCT01049360|3008757|P2|Period 2|Adverse Event|1
913295|NCT01049360|3008758|P1|Period 2|Adverse Event|0
913296|NCT01049360|3008739|P20|Period 2|Protocol Violation|0
913297|NCT01049360|3008740|P19|Period 2|Protocol Violation|0
913298|NCT01049360|3008741|P18|Period 2|Protocol Violation|0
913299|NCT01049360|3008742|P17|Period 2|Protocol Violation|0
913300|NCT01049360|3008743|P16|Period 2|Protocol Violation|1
913301|NCT01049360|3008744|P15|Period 2|Protocol Violation|1
913302|NCT01049360|3008745|P14|Period 2|Protocol Violation|0
913303|NCT01049360|3008746|P13|Period 2|Protocol Violation|0
913304|NCT01049360|3008747|P12|Period 2|Protocol Violation|0
913305|NCT01049360|3008748|P11|Period 2|Protocol Violation|0
913306|NCT01049360|3008749|P10|Period 2|Protocol Violation|0
913307|NCT01049360|3008750|P9|Period 2|Protocol Violation|0
913308|NCT01049360|3008751|P8|Period 2|Protocol Violation|0
913309|NCT01049360|3008752|P7|Period 2|Protocol Violation|0
913310|NCT01049360|3008753|P6|Period 2|Protocol Violation|0
913311|NCT01049360|3008754|P5|Period 2|Protocol Violation|0
913312|NCT01049360|3008755|P4|Period 2|Protocol Violation|1
913313|NCT01049360|3008756|P3|Period 2|Protocol Violation|0
913314|NCT01049360|3008757|P2|Period 2|Protocol Violation|0
913315|NCT01049360|3008758|P1|Period 2|Protocol Violation|0
913316|NCT01049360|3008739|P20|Period 1|Withdrawal by Subject|0
913317|NCT01049360|3008740|P19|Period 1|Withdrawal by Subject|0
913318|NCT01049360|3008741|P18|Period 1|Withdrawal by Subject|0
913319|NCT01049360|3008742|P17|Period 1|Withdrawal by Subject|0
913320|NCT01049360|3008743|P16|Period 1|Withdrawal by Subject|0
913321|NCT01049360|3008744|P15|Period 1|Withdrawal by Subject|0
913322|NCT01049360|3008745|P14|Period 1|Withdrawal by Subject|0
913323|NCT01049360|3008746|P13|Period 1|Withdrawal by Subject|1
913324|NCT01049360|3008747|P12|Period 1|Withdrawal by Subject|0
913325|NCT01049360|3008748|P11|Period 1|Withdrawal by Subject|1
913326|NCT01049360|3008749|P10|Period 1|Withdrawal by Subject|0
913327|NCT01049360|3008750|P9|Period 1|Withdrawal by Subject|1
913328|NCT01049360|3008751|P8|Period 1|Withdrawal by Subject|0
913329|NCT01049360|3008752|P7|Period 1|Withdrawal by Subject|0
913330|NCT01049360|3008753|P6|Period 1|Withdrawal by Subject|0
913331|NCT01049360|3008754|P5|Period 1|Withdrawal by Subject|0
913332|NCT01049360|3008755|P4|Period 1|Withdrawal by Subject|0
913333|NCT01049360|3008756|P3|Period 1|Withdrawal by Subject|0
913334|NCT01049360|3008757|P2|Period 1|Withdrawal by Subject|0
913335|NCT01049360|3008758|P1|Period 1|Withdrawal by Subject|0
913336|NCT01049360|3008739|P20|Period 1|Did not meet inc/exc criteria|0
913337|NCT01049360|3008740|P19|Period 1|Did not meet inc/exc criteria|0
913338|NCT01049360|3008741|P18|Period 1|Did not meet inc/exc criteria|0
913339|NCT01049360|3008742|P17|Period 1|Did not meet inc/exc criteria|0
913340|NCT01049360|3008743|P16|Period 1|Did not meet inc/exc criteria|0
913341|NCT01049360|3008744|P15|Period 1|Did not meet inc/exc criteria|0
913342|NCT01049360|3008745|P14|Period 1|Did not meet inc/exc criteria|0
913343|NCT01049360|3008746|P13|Period 1|Did not meet inc/exc criteria|0
913344|NCT01049360|3008747|P12|Period 1|Did not meet inc/exc criteria|0
913345|NCT01049360|3008748|P11|Period 1|Did not meet inc/exc criteria|0
913346|NCT01049360|3008749|P10|Period 1|Did not meet inc/exc criteria|0
913347|NCT01049360|3008750|P9|Period 1|Did not meet inc/exc criteria|1
913348|NCT01049360|3008751|P8|Period 1|Did not meet inc/exc criteria|1
913349|NCT01049360|3008752|P7|Period 1|Did not meet inc/exc criteria|0
913350|NCT01049360|3008753|P6|Period 1|Did not meet inc/exc criteria|0
913351|NCT01049360|3008754|P5|Period 1|Did not meet inc/exc criteria|0
913352|NCT01049360|3008755|P4|Period 1|Did not meet inc/exc criteria|0
913353|NCT01049360|3008756|P3|Period 1|Did not meet inc/exc criteria|0
913354|NCT01049360|3008757|P2|Period 1|Did not meet inc/exc criteria|0
913355|NCT01049360|3008758|P1|Period 1|Did not meet inc/exc criteria|0
913356|NCT01049360|3008739|P20|Period 1|Adverse Event|0
913357|NCT01049360|3008740|P19|Period 1|Adverse Event|1
913358|NCT01049360|3008741|P18|Period 1|Adverse Event|0
913359|NCT01049360|3008742|P17|Period 1|Adverse Event|1
913360|NCT01049360|3008743|P16|Period 1|Adverse Event|0
913361|NCT01049360|3008744|P15|Period 1|Adverse Event|0
913362|NCT01049360|3008745|P14|Period 1|Adverse Event|1
913363|NCT01049360|3008746|P13|Period 1|Adverse Event|1
913364|NCT01049360|3008747|P12|Period 1|Adverse Event|0
913365|NCT01049360|3008748|P11|Period 1|Adverse Event|0
913366|NCT01049360|3008749|P10|Period 1|Adverse Event|0
913367|NCT01049360|3008750|P9|Period 1|Adverse Event|0
913368|NCT01049360|3008751|P8|Period 1|Adverse Event|1
913369|NCT01049360|3008752|P7|Period 1|Adverse Event|0
913370|NCT01049360|3008753|P6|Period 1|Adverse Event|0
913371|NCT01049360|3008754|P5|Period 1|Adverse Event|0
913372|NCT01049360|3008755|P4|Period 1|Adverse Event|1
913373|NCT01049360|3008756|P3|Period 1|Adverse Event|0
913374|NCT01049360|3008757|P2|Period 1|Adverse Event|1
913375|NCT01049360|3008758|P1|Period 1|Adverse Event|0
913376|NCT01049334|3008782|P2|Overall Study|Protocol Violation|1
913377|NCT01049334|3008783|P1|Overall Study|Protocol Violation|0
913378|NCT01049334|3008782|P2|Overall Study|Physician Decision|0
913379|NCT01049334|3008783|P1|Overall Study|Physician Decision|2
913380|NCT01049334|3008782|P2|Overall Study|Adverse Event|3
913381|NCT01049334|3008783|P1|Overall Study|Adverse Event|2
913382|NCT01049334|3008782|P2|Overall Study|Withdrawal by Subject|3
913383|NCT01049334|3008783|P1|Overall Study|Withdrawal by Subject|5
913384|NCT01049308|3008819|P1|Pill Counts|Withdrawal by Subject|83
913385|NCT01049217|3008833|P2|Overall Study|Randomized but not Treated|2
913386|NCT01049217|3008834|P1|Overall Study|Randomized but not Treated|0
913387|NCT01049217|3008833|P2|Overall Study|Other|2
913388|NCT01049217|3008834|P1|Overall Study|Other|1
913389|NCT01049217|3008833|P2|Overall Study|Study Terminated by Sponsor|43
913390|NCT01049217|3008834|P1|Overall Study|Study Terminated by Sponsor|43
913391|NCT01049217|3008833|P2|Overall Study|Pregnancy|0
913392|NCT01049217|3008834|P1|Overall Study|Pregnancy|1
913393|NCT01049217|3008833|P2|Overall Study|Protocol Violation|3
913394|NCT01049217|3008834|P1|Overall Study|Protocol Violation|1
913395|NCT01049217|3008833|P2|Overall Study|Withdrawal by Subject|3
913396|NCT01049217|3008834|P1|Overall Study|Withdrawal by Subject|4
913397|NCT01049217|3008833|P2|Overall Study|Lost to Follow-up|8
913398|NCT01049217|3008834|P1|Overall Study|Lost to Follow-up|3
913399|NCT01049217|3008833|P2|Overall Study|Lack of Efficacy|1
913400|NCT01049217|3008834|P1|Overall Study|Lack of Efficacy|1
913401|NCT01049217|3008833|P2|Overall Study|Adverse Event|1
913402|NCT01049217|3008834|P1|Overall Study|Adverse Event|2
913403|NCT01049009|3008906|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|7
913404|NCT01049009|3008907|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|8
913405|NCT01049009|3008906|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3
913406|NCT01049009|3008907|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
913407|NCT01049009|3008906|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
913408|NCT01049009|3008907|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
913409|NCT01049009|3008906|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|2
913410|NCT01049009|3008907|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
913411|NCT01048944|3008919|P4|Overall Study|Protocol Violation|2
913412|NCT01048944|3008920|P3|Overall Study|Protocol Violation|10
913413|NCT01048944|3008921|P2|Overall Study|Protocol Violation|10
913414|NCT01048944|3008922|P1|Overall Study|Protocol Violation|8
913415|NCT01048866|3008954|P2|Overall Study|not specified|1
913416|NCT01048866|3008955|P1|Overall Study|not specified|1
913417|NCT01048866|3008954|P2|Overall Study|Lost to Follow-up|2
913418|NCT01048866|3008955|P1|Overall Study|Lost to Follow-up|0
913419|NCT01048866|3008954|P2|Overall Study|Withdrawal by Subject|2
913420|NCT01048866|3008955|P1|Overall Study|Withdrawal by Subject|0
913421|NCT01048866|3008954|P2|Overall Study|Physician Decision|0
913422|NCT01048866|3008955|P1|Overall Study|Physician Decision|1
913423|NCT01048866|3008954|P2|Overall Study|Protocol Violation|0
913424|NCT01048866|3008955|P1|Overall Study|Protocol Violation|1
913425|NCT01048866|3008954|P2|Overall Study|Adverse Event|0
913426|NCT01048866|3008955|P1|Overall Study|Adverse Event|1
913427|NCT01048788|3009000|P3|Overall Study|Withdrawal by Subject|0
913428|NCT01048788|3009001|P2|Overall Study|Withdrawal by Subject|1
913429|NCT01048788|3009002|P1|Overall Study|Withdrawal by Subject|0
913430|NCT01048788|3009000|P3|Overall Study|Lack of Efficacy|1
913431|NCT01048788|3009001|P2|Overall Study|Lack of Efficacy|0
913432|NCT01048788|3009002|P1|Overall Study|Lack of Efficacy|0
913433|NCT01048788|3009000|P3|Overall Study|Adverse Event|1
913434|NCT01048788|3009001|P2|Overall Study|Adverse Event|1
913435|NCT01048788|3009002|P1|Overall Study|Adverse Event|5
913436|NCT01048671|3009024|P3|Overall Study|Protocol Violation|1
913437|NCT01048671|3009025|P2|Overall Study|Protocol Violation|1
913438|NCT01048671|3009026|P1|Overall Study|Protocol Violation|0
913439|NCT01048541|3009103|P2|Overall Study|Withdrawal by Subject|0
913440|NCT01048541|3009104|P1|Overall Study|Withdrawal by Subject|1
913441|NCT01048502|3009114|P4|Overall Study|Physician Decision|1
913442|NCT01048502|3009115|P3|Overall Study|Physician Decision|0
913443|NCT01048502|3009116|P2|Overall Study|Physician Decision|3
913444|NCT01048502|3009117|P1|Overall Study|Physician Decision|0
913445|NCT01048502|3009114|P4|Overall Study|Withdrawal by Subject|3
913446|NCT01048502|3009115|P3|Overall Study|Withdrawal by Subject|5
913447|NCT01048502|3009116|P2|Overall Study|Withdrawal by Subject|4
913448|NCT01048502|3009117|P1|Overall Study|Withdrawal by Subject|1
913449|NCT01048502|3009114|P4|Overall Study|Adverse Event|0
913450|NCT01048502|3009115|P3|Overall Study|Adverse Event|0
913451|NCT01048502|3009116|P2|Overall Study|Adverse Event|0
913452|NCT01048502|3009117|P1|Overall Study|Adverse Event|1
913453|NCT01048502|3009114|P4|Overall Study|Lost to Follow-up|0
913454|NCT01048502|3009115|P3|Overall Study|Lost to Follow-up|0
913455|NCT01048502|3009116|P2|Overall Study|Lost to Follow-up|0
913456|NCT01048502|3009117|P1|Overall Study|Lost to Follow-up|2
913457|NCT01048333|3009153|P6|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
913458|NCT01048333|3009154|P5|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
913459|NCT01048333|3009155|P4|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
913460|NCT01048333|3009156|P3|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
913461|NCT01048333|3009157|P2|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1
913462|NCT01048333|3009158|P1|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
913463|NCT01048242|3009180|P2|Overall Study|See study flow chart|2
913464|NCT01048242|3009181|P1|Overall Study|See study flow chart|4
913465|NCT01048099|3009196|P1|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202
913466|NCT01048099|3009196|P1|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57
913467|NCT01047553|3009226|P2|Overall Study|PI's decision|1
913468|NCT01047553|3009227|P1|Overall Study|PI's decision|0
913469|NCT01047553|3009226|P2|Overall Study|Sever Non-Compliance to Protocol|0
913470|NCT01047553|3009227|P1|Overall Study|Sever Non-Compliance to Protocol|1
913471|NCT01047553|3009226|P2|Overall Study|Lost to Follow-up|0
913472|NCT01047553|3009227|P1|Overall Study|Lost to Follow-up|1
913473|NCT01047553|3009226|P2|Overall Study|Development of Study-Specific Withdrawal|1
913474|NCT01047553|3009227|P1|Overall Study|Development of Study-Specific Withdrawal|1
913475|NCT01047553|3009226|P2|Overall Study|Withdrawal by Subject|2
913476|NCT01047553|3009227|P1|Overall Study|Withdrawal by Subject|4
913477|NCT01047553|3009226|P2|Overall Study|Adverse Event|5
913478|NCT01047553|3009227|P1|Overall Study|Adverse Event|10
913479|NCT01047436|3009334|P2|Overall Study|Protocol Violation|0
913480|NCT01047436|3009335|P1|Overall Study|Protocol Violation|1
913481|NCT01047345|3009360|P3|Extension|Lost to Follow-up|5
913482|NCT01047345|3009361|P2|Extension|Lost to Follow-up|0
913483|NCT01047345|3009362|P1|Extension|Lost to Follow-up|0
913484|NCT01047345|3009360|P3|Extension|Withdrawal by Subject|1
913485|NCT01047345|3009361|P2|Extension|Withdrawal by Subject|0
913486|NCT01047345|3009362|P1|Extension|Withdrawal by Subject|0
913487|NCT01047345|3009360|P3|Base Study|Withdrawal by Subject|0
913488|NCT01047345|3009361|P2|Base Study|Withdrawal by Subject|4
913489|NCT01047345|3009362|P1|Base Study|Withdrawal by Subject|12
913490|NCT01047345|3009360|P3|Base Study|Protocol Violation|0
913491|NCT01047345|3009361|P2|Base Study|Protocol Violation|1
913492|NCT01047345|3009362|P1|Base Study|Protocol Violation|3
913493|NCT01047345|3009360|P3|Base Study|Lost to Follow-up|0
913494|NCT01047345|3009361|P2|Base Study|Lost to Follow-up|1
913495|NCT01047345|3009362|P1|Base Study|Lost to Follow-up|4
913496|NCT01047345|3009360|P3|Base Study|Adverse Event|0
913497|NCT01047345|3009361|P2|Base Study|Adverse Event|0
913498|NCT01047345|3009362|P1|Base Study|Adverse Event|3
913499|NCT01047332|3009384|P2|Overall Study|Lost to Follow-up|3
913500|NCT01047332|3009385|P1|Overall Study|Lost to Follow-up|8
913501|NCT01047332|3009384|P2|Overall Study|Died Unobstructed|41
913502|NCT01047332|3009385|P1|Overall Study|Died Unobstructed|38
913503|NCT01047332|3009384|P2|Overall Study|SEMS Obstruction|20
913504|NCT01047332|3009385|P1|Overall Study|SEMS Obstruction|11
913505|NCT01047306|3009399|P2|Overall Study|Lost to Follow-up|0
913506|NCT01047306|3009400|P1|Overall Study|Lost to Follow-up|1
913507|NCT01047306|3009399|P2|Overall Study|Withdrawal by Subject|0
913508|NCT01047306|3009400|P1|Overall Study|Withdrawal by Subject|2
913509|NCT01047293|3009474|P4|Overall Study|DLT criteria not fulfilled|0
913510|NCT01047293|3009475|P3|Overall Study|DLT criteria not fulfilled|0
913511|NCT01047293|3009476|P2|Overall Study|DLT criteria not fulfilled|1
913512|NCT01047293|3009477|P1|Overall Study|DLT criteria not fulfilled|1
913513|NCT01047007|3009508|P4|Overall Study|Progressive Disease|0
913514|NCT01047007|3009509|P3|Overall Study|Progressive Disease|1
913515|NCT01047007|3009510|P2|Overall Study|Progressive Disease|4
913516|NCT01047007|3009511|P1|Overall Study|Progressive Disease|2
913517|NCT01047007|3009508|P4|Overall Study|Adverse Event|0
913518|NCT01047007|3009509|P3|Overall Study|Adverse Event|1
913519|NCT01047007|3009510|P2|Overall Study|Adverse Event|2
913520|NCT01047007|3009511|P1|Overall Study|Adverse Event|0
913521|NCT01046903|3009522|P1|Overall Study|Other|5
913522|NCT01046903|3009522|P1|Overall Study|Withdrawal by Subject|3
913523|NCT01046903|3009522|P1|Overall Study|Adverse Event|4
913524|NCT01046903|3009522|P1|Overall Study|Lost to Follow-up|16
913525|NCT01046877|3009535|P1|Overall Study|Exited voluntarily after tube extrusion|11
913526|NCT01046877|3009535|P1|Overall Study|Exited voluntarily before tube extrusion|7
913527|NCT01046695|3009551|P2|Overall Study|TENS interfered with the cardiac monitor|1
913528|NCT01046695|3009552|P1|Overall Study|TENS interfered with the cardiac monitor|0
913529|NCT01046695|3009551|P2|Overall Study|Subject had a pacemaker|1
913530|NCT01046695|3009552|P1|Overall Study|Subject had a pacemaker|0
913531|NCT01046682|3009564|P2|Overall Study|Adverse Event|0
913532|NCT01046682|3009565|P1|Overall Study|Adverse Event|2
913533|NCT01046643|3009573|P4|First Period Treatment or Placebo|Withdrawal by Subject|0
913534|NCT01046643|3009574|P3|First Period Treatment or Placebo|Withdrawal by Subject|0
913535|NCT01046643|3009575|P2|First Period Treatment or Placebo|Withdrawal by Subject|1
913536|NCT01046643|3009576|P1|First Period Treatment or Placebo|Withdrawal by Subject|0
913537|NCT01046565|3009598|P1|Overall Study|Withdrawal by Subject|7
913538|NCT01046565|3009598|P1|Overall Study|Adverse Event|2
913539|NCT01046396|3009607|P1|Overall Study|Withdrawal by Subject|5
913540|NCT01046253|3009618|P2|Second Intervention|Protocol Violation|1
913541|NCT01046253|3009619|P1|Second Intervention|Protocol Violation|0
913542|NCT01046253|3009618|P2|Second Intervention|Adverse Event|1
913543|NCT01046253|3009619|P1|Second Intervention|Adverse Event|0
913544|NCT01046136|3009631|P2|Overall Study|Lost to Follow-up|3
913545|NCT01046136|3009632|P1|Overall Study|Lost to Follow-up|3
913546|NCT01046136|3009631|P2|Overall Study|Physician Decision|1
913547|NCT01046136|3009632|P1|Overall Study|Physician Decision|1
913548|NCT01046136|3009631|P2|Overall Study|Withdrawal by Subject|4
913549|NCT01046136|3009632|P1|Overall Study|Withdrawal by Subject|0
913550|NCT01046110|3009644|P2|Overall Study|Unclassified|35
913551|NCT01046110|3009645|P1|Overall Study|Unclassified|36
913552|NCT01046110|3009644|P2|Overall Study|Withdrawal Criteria|5
913553|NCT01046110|3009645|P1|Overall Study|Withdrawal Criteria|3
913554|NCT01046110|3009644|P2|Overall Study|Protocol Violation|12
913555|NCT01046110|3009645|P1|Overall Study|Protocol Violation|7
913556|NCT01046110|3009644|P2|Overall Study|Lack of Efficacy|1
913557|NCT01046110|3009645|P1|Overall Study|Lack of Efficacy|0
913558|NCT01046110|3009644|P2|Overall Study|Adverse Event|2
913559|NCT01046110|3009645|P1|Overall Study|Adverse Event|9
913560|NCT01046084|3009655|P2|Third Washout of 7 Days|Withdrawal by Subject|0
913561|NCT01046084|3009656|P1|Third Washout of 7 Days|Withdrawal by Subject|2
913562|NCT01045993|3009670|P4|Overall Study|Treated-later found eligibility not met|0
913563|NCT01045993|3009671|P3|Overall Study|Treated-later found eligibility not met|0
913564|NCT01045993|3009672|P2|Overall Study|Treated-later found eligibility not met|1
913565|NCT01045993|3009673|P1|Overall Study|Treated-later found eligibility not met|0
913566|NCT01045967|3009749|P2|Second Intervention|Protocol Violation|1
913567|NCT01045967|3009750|P1|Second Intervention|Protocol Violation|0
913568|NCT01045798|3009762|P2|Overall Study|Received Systemic Antifungal Prestudy|1
913569|NCT01045798|3009763|P1|Overall Study|Received Systemic Antifungal Prestudy|0
913570|NCT01045798|3009762|P2|Overall Study|Changed to Other Antifungal Therapy|2
913571|NCT01045798|3009763|P1|Overall Study|Changed to Other Antifungal Therapy|1
913572|NCT01045798|3009762|P2|Overall Study|Invasive Fungal Infection at Baseline|1
913573|NCT01045798|3009763|P1|Overall Study|Invasive Fungal Infection at Baseline|0
913574|NCT01045798|3009762|P2|Overall Study|Changed to Open-Label Caspofungin|0
913575|NCT01045798|3009763|P1|Overall Study|Changed to Open-Label Caspofungin|1
913576|NCT01045707|3009771|P2|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5
913577|NCT01045707|3009772|P1|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6
913578|NCT01045707|3009771|P2|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1
913579|NCT01045707|3009772|P1|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2
913580|NCT01045707|3009771|P2|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3
913581|NCT01045707|3009772|P1|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2
913582|NCT01045707|3009771|P2|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
913583|NCT01045707|3009772|P1|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
913584|NCT01045707|3009771|P2|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11
913585|NCT01045707|3009772|P1|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10
913586|NCT01045707|3009771|P2|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11
913587|NCT01045707|3009772|P1|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22
913588|NCT01045707|3009771|P2|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5
913589|NCT01045707|3009772|P1|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6
913590|NCT01045707|3009771|P2|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2
913591|NCT01045707|3009772|P1|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4
913592|NCT01045707|3009771|P2|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3
913593|NCT01045707|3009772|P1|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5
913594|NCT01045694|3009788|P1|Overall Study|Withdrawal by Subject|2
913595|NCT01045447|3009804|P2|Overall Study|Unclassified|13
913596|NCT01045447|3009805|P1|Overall Study|Unclassified|17
913597|NCT01045447|3009804|P2|Overall Study|Withdrawal Criteria|10
913598|NCT01045447|3009805|P1|Overall Study|Withdrawal Criteria|10
913599|NCT01045447|3009804|P2|Overall Study|Protocol Violation|3
913600|NCT01045447|3009805|P1|Overall Study|Protocol Violation|6
913601|NCT01045447|3009804|P2|Overall Study|Lack of Efficacy|1
913602|NCT01045447|3009805|P1|Overall Study|Lack of Efficacy|3
913603|NCT01045447|3009804|P2|Overall Study|Adverse Event|1
913604|NCT01045447|3009805|P1|Overall Study|Adverse Event|0
913605|NCT01045421|3009819|P11|Phase 2|Other|1
913606|NCT01045421|3009820|P10|Phase 2|Other|0
913607|NCT01045421|3009821|P9|Phase 2|Other|0
913608|NCT01045421|3009822|P8|Phase 2|Other|3
913609|NCT01045421|3009823|P7|Phase 2|Other|0
913610|NCT01045421|3009824|P6|Phase 2|Other|0
913611|NCT01045421|3009825|P5|Phase 2|Other|0
913612|NCT01045421|3009826|P4|Phase 2|Other|0
913613|NCT01045421|3009827|P3|Phase 2|Other|0
913614|NCT01045421|3009828|P2|Phase 2|Other|0
913615|NCT01045421|3009829|P1|Phase 2|Other|0
913616|NCT01045421|3009819|P11|Phase 2|Death|0
913617|NCT01045421|3009820|P10|Phase 2|Death|2
913618|NCT01045421|3009821|P9|Phase 2|Death|1
913619|NCT01045421|3009822|P8|Phase 2|Death|1
913620|NCT01045421|3009823|P7|Phase 2|Death|0
913621|NCT01045421|3009824|P6|Phase 2|Death|0
913622|NCT01045421|3009825|P5|Phase 2|Death|0
913623|NCT01045421|3009826|P4|Phase 2|Death|0
913624|NCT01045421|3009827|P3|Phase 2|Death|0
913625|NCT01045421|3009828|P2|Phase 2|Death|0
913626|NCT01045421|3009829|P1|Phase 2|Death|0
913627|NCT01045421|3009819|P11|Phase 2|Progressive Disease|1
913628|NCT01045421|3009820|P10|Phase 2|Progressive Disease|1
913629|NCT01045421|3009821|P9|Phase 2|Progressive Disease|1
913630|NCT01045421|3009822|P8|Phase 2|Progressive Disease|1
913631|NCT01045421|3009823|P7|Phase 2|Progressive Disease|0
913632|NCT01045421|3009824|P6|Phase 2|Progressive Disease|0
913633|NCT01045421|3009825|P5|Phase 2|Progressive Disease|0
913634|NCT01045421|3009826|P4|Phase 2|Progressive Disease|0
913635|NCT01045421|3009827|P3|Phase 2|Progressive Disease|0
913636|NCT01045421|3009828|P2|Phase 2|Progressive Disease|0
913637|NCT01045421|3009829|P1|Phase 2|Progressive Disease|0
913638|NCT01045421|3009819|P11|Phase 1|Withdrawal by Subject|0
913639|NCT01045421|3009820|P10|Phase 1|Withdrawal by Subject|0
913640|NCT01045421|3009821|P9|Phase 1|Withdrawal by Subject|0
913641|NCT01045421|3009822|P8|Phase 1|Withdrawal by Subject|0
913642|NCT01045421|3009823|P7|Phase 1|Withdrawal by Subject|0
913643|NCT01045421|3009824|P6|Phase 1|Withdrawal by Subject|0
913644|NCT01045421|3009825|P5|Phase 1|Withdrawal by Subject|0
913645|NCT01045421|3009826|P4|Phase 1|Withdrawal by Subject|1
913646|NCT01045421|3009827|P3|Phase 1|Withdrawal by Subject|0
913647|NCT01045421|3009828|P2|Phase 1|Withdrawal by Subject|0
913648|NCT01045421|3009829|P1|Phase 1|Withdrawal by Subject|0
913649|NCT01045421|3009819|P11|Phase 1|Progressive Disease|0
913650|NCT01045421|3009820|P10|Phase 1|Progressive Disease|0
913651|NCT01045421|3009821|P9|Phase 1|Progressive Disease|0
913652|NCT01045421|3009822|P8|Phase 1|Progressive Disease|0
913653|NCT01045421|3009823|P7|Phase 1|Progressive Disease|0
913654|NCT01045421|3009824|P6|Phase 1|Progressive Disease|0
913655|NCT01045421|3009825|P5|Phase 1|Progressive Disease|1
913656|NCT01045421|3009826|P4|Phase 1|Progressive Disease|0
913657|NCT01045421|3009827|P3|Phase 1|Progressive Disease|0
913658|NCT01045421|3009828|P2|Phase 1|Progressive Disease|0
913659|NCT01045421|3009829|P1|Phase 1|Progressive Disease|0
913660|NCT01045161|3009923|P3|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6
913661|NCT01045161|3009924|P2|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1
913662|NCT01045161|3009925|P1|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5
913663|NCT01045161|3009923|P3|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
913664|NCT01045161|3009924|P2|Part B - 40 Additional Weeks Open Label|Protocol Violation|6
913665|NCT01045161|3009925|P1|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
913666|NCT01045161|3009923|P3|Part B - 40 Additional Weeks Open Label|Other Reason|1
913667|NCT01045161|3009924|P2|Part B - 40 Additional Weeks Open Label|Other Reason|2
913668|NCT01045161|3009925|P1|Part B - 40 Additional Weeks Open Label|Other Reason|4
913669|NCT01045161|3009923|P3|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
913670|NCT01045161|3009924|P2|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5
913671|NCT01045161|3009925|P1|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
913672|NCT01045161|3009923|P3|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
913673|NCT01045161|3009924|P2|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
913674|NCT01045161|3009925|P1|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3
913675|NCT01045161|3009923|P3|Part B - 40 Additional Weeks Open Label|Adverse Event|7
913676|NCT01045161|3009924|P2|Part B - 40 Additional Weeks Open Label|Adverse Event|10
913677|NCT01045161|3009925|P1|Part B - 40 Additional Weeks Open Label|Adverse Event|10
913678|NCT01045161|3009923|P3|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9
913679|NCT01045161|3009924|P2|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7
913680|NCT01045161|3009925|P1|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10
913681|NCT01045161|3009923|P3|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2
913682|NCT01045161|3009924|P2|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
913683|NCT01045161|3009925|P1|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
913684|NCT01045161|3009923|P3|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
913685|NCT01045161|3009924|P2|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4
913686|NCT01045161|3009925|P1|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
913687|NCT01045161|3009923|P3|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
913688|NCT01045161|3009924|P2|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
913689|NCT01045161|3009925|P1|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
913690|NCT01045161|3009923|P3|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6
913691|NCT01045161|3009924|P2|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1
913692|NCT01045161|3009925|P1|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4
913693|NCT01045161|3009923|P3|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2
913694|NCT01045161|3009924|P2|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3
913695|NCT01045161|3009925|P1|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6
913696|NCT01045161|3009923|P3|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8
913697|NCT01045161|3009924|P2|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3
913698|NCT01045161|3009925|P1|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4
913699|NCT01045161|3009923|P3|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6
913700|NCT01045161|3009924|P2|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12
913701|NCT01045161|3009925|P1|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8
913702|NCT01045096|3009955|P3|Overall Study|Other|0
913703|NCT01045096|3009956|P2|Overall Study|Other|0
913704|NCT01045096|3009957|P1|Overall Study|Other|1
913705|NCT01045096|3009955|P3|Overall Study|Withdrawal by Subject|0
913706|NCT01045096|3009956|P2|Overall Study|Withdrawal by Subject|0
913707|NCT01045096|3009957|P1|Overall Study|Withdrawal by Subject|2
913708|NCT01044732|3010068|P2|Overall Study|Technical error or malfunction|14
913709|NCT01044732|3010069|P1|Overall Study|Technical error or malfunction|15
913710|NCT01044732|3010068|P2|Overall Study|Inability to reach cecum|2
913711|NCT01044732|3010069|P1|Overall Study|Inability to reach cecum|5
913712|NCT01044732|3010068|P2|Overall Study|Inadequate bowel preparation|17
913713|NCT01044732|3010069|P1|Overall Study|Inadequate bowel preparation|11
913714|NCT01044732|3010068|P2|Overall Study|Withdrawal by Subject|1
913715|NCT01044732|3010069|P1|Overall Study|Withdrawal by Subject|0
913716|NCT01044732|3010068|P2|Overall Study|Protocol Violation|12
913717|NCT01044732|3010069|P1|Overall Study|Protocol Violation|11
913718|NCT01044732|3010068|P2|Overall Study|Physician Decision|3
913719|NCT01044732|3010069|P1|Overall Study|Physician Decision|5
913720|NCT01044732|3010068|P2|Overall Study|Lost to Follow-up|1
913721|NCT01044732|3010069|P1|Overall Study|Lost to Follow-up|2
913722|NCT01044498|3010258|P2|Overall Study|Not specified|0
913723|NCT01044498|3010259|P1|Overall Study|Not specified|1
913724|NCT01044498|3010258|P2|Overall Study|Adverse Event|1
913725|NCT01044498|3010259|P1|Overall Study|Adverse Event|1
913726|NCT01044498|3010258|P2|Overall Study|Withdrew consent|1
913727|NCT01044498|3010259|P1|Overall Study|Withdrew consent|1
913728|NCT01044459|3010285|P2|Overall Study|Lost to Follow-up|12
913729|NCT01044459|3010286|P1|Overall Study|Lost to Follow-up|18
913730|NCT01044459|3010285|P2|Overall Study|COPD exacerbation|8
913731|NCT01044459|3010286|P1|Overall Study|COPD exacerbation|9
913732|NCT01044459|3010285|P2|Overall Study|Other Reason|14
913733|NCT01044459|3010286|P1|Overall Study|Other Reason|7
913734|NCT01044459|3010285|P2|Overall Study|Protocol Violation|16
913735|NCT01044459|3010286|P1|Overall Study|Protocol Violation|11
913736|NCT01044459|3010285|P2|Overall Study|Lack of Efficacy|12
913737|NCT01044459|3010286|P1|Overall Study|Lack of Efficacy|23
913738|NCT01044459|3010285|P2|Overall Study|Adverse Event|20
913739|NCT01044459|3010286|P1|Overall Study|Adverse Event|22
913740|NCT01044459|3010285|P2|Overall Study|Terminated by Sponsor|21
913741|NCT01044459|3010286|P1|Overall Study|Terminated by Sponsor|22
913742|NCT01044459|3010285|P2|Overall Study|Withdrawal by Subject|28
913743|NCT01044459|3010286|P1|Overall Study|Withdrawal by Subject|21
913744|NCT01044303|3010294|P1|Overall Study|Lost to Follow-up|2
913745|NCT01044290|3010304|P3|Follow-Up 2|Withdrawal by Subject|1
913746|NCT01044290|3010305|P2|Follow-Up 2|Withdrawal by Subject|1
913747|NCT01044290|3010306|P1|Follow-Up 2|Withdrawal by Subject|0
913748|NCT01044290|3010304|P3|Follow-Up 2|Death|1
913749|NCT01044290|3010305|P2|Follow-Up 2|Death|1
913750|NCT01044290|3010306|P1|Follow-Up 2|Death|0
913751|NCT01044290|3010304|P3|Follow-up 1|Withdrawal by Subject|0
913752|NCT01044290|3010305|P2|Follow-up 1|Withdrawal by Subject|2
913753|NCT01044290|3010306|P1|Follow-up 1|Withdrawal by Subject|2
913754|NCT01044290|3010304|P3|Follow-up 1|Death|1
913755|NCT01044290|3010305|P2|Follow-up 1|Death|3
913756|NCT01044290|3010306|P1|Follow-up 1|Death|3
913757|NCT01043874|3010426|P1|Overall Study|Administrative Problems|1
913758|NCT01043874|3010426|P1|Overall Study|Lack of Efficacy|1
913759|NCT01043874|3010426|P1|Overall Study|Withdrawal by Subject|1
913760|NCT01043874|3010426|P1|Overall Study|Adverse Event|3
913761|NCT01043705|3010436|P3|Overall Study|Other|25
913762|NCT01043705|3010437|P2|Overall Study|Other|19
913763|NCT01043705|3010438|P1|Overall Study|Other|0
913764|NCT01043705|3010436|P3|Overall Study|Screen Fail|0
913765|NCT01043705|3010437|P2|Overall Study|Screen Fail|0
913766|NCT01043705|3010438|P1|Overall Study|Screen Fail|21
913767|NCT01043705|3010436|P3|Overall Study|Adverse Event|0
913768|NCT01043705|3010437|P2|Overall Study|Adverse Event|2
913769|NCT01043705|3010438|P1|Overall Study|Adverse Event|0
913770|NCT01043705|3010436|P3|Overall Study|Subsequent Procedure|29
913771|NCT01043705|3010437|P2|Overall Study|Subsequent Procedure|24
913772|NCT01043705|3010438|P1|Overall Study|Subsequent Procedure|9
913773|NCT01043705|3010436|P3|Overall Study|Site Closure|0
913774|NCT01043705|3010437|P2|Overall Study|Site Closure|0
913775|NCT01043705|3010438|P1|Overall Study|Site Closure|8
913776|NCT01043705|3010436|P3|Overall Study|Withdrawal by Subject|0
913777|NCT01043705|3010437|P2|Overall Study|Withdrawal by Subject|6
913778|NCT01043705|3010438|P1|Overall Study|Withdrawal by Subject|8
913779|NCT01043705|3010436|P3|Overall Study|Protocol Violation|0
913780|NCT01043705|3010437|P2|Overall Study|Protocol Violation|1
913781|NCT01043705|3010438|P1|Overall Study|Protocol Violation|2
913782|NCT01043705|3010436|P3|Overall Study|Multiple Reasons|0
913783|NCT01043705|3010437|P2|Overall Study|Multiple Reasons|7
913784|NCT01043705|3010438|P1|Overall Study|Multiple Reasons|4
913785|NCT01043705|3010436|P3|Overall Study|Lost to Follow-up|0
913786|NCT01043705|3010437|P2|Overall Study|Lost to Follow-up|12
913787|NCT01043705|3010438|P1|Overall Study|Lost to Follow-up|27
913788|NCT01043705|3010436|P3|Overall Study|Death|26
913789|NCT01043705|3010437|P2|Overall Study|Death|60
913790|NCT01043705|3010438|P1|Overall Study|Death|28
913791|NCT01043185|3010527|P10|Period 6 - Third Washout Period|Protocol Violation|0
913792|NCT01043185|3010528|P9|Period 6 - Third Washout Period|Protocol Violation|1
913793|NCT01043185|3010529|P8|Period 6 - Third Washout Period|Protocol Violation|0
913794|NCT01043185|3010530|P7|Period 6 - Third Washout Period|Protocol Violation|0
913795|NCT01043185|3010531|P6|Period 6 - Third Washout Period|Protocol Violation|0
913796|NCT01043185|3010532|P5|Period 6 - Third Washout Period|Protocol Violation|0
913797|NCT01043185|3010533|P4|Period 6 - Third Washout Period|Protocol Violation|0
913798|NCT01043185|3010534|P3|Period 6 - Third Washout Period|Protocol Violation|0
913799|NCT01043185|3010535|P2|Period 6 - Third Washout Period|Protocol Violation|0
913800|NCT01043185|3010536|P1|Period 6 - Third Washout Period|Protocol Violation|0
913801|NCT01042977|3010612|P2|Overall Study|Various|0
913802|NCT01042977|3010613|P1|Overall Study|Various|3
913803|NCT01042977|3010612|P2|Overall Study|Administrative reason by sponsor|1
913804|NCT01042977|3010613|P1|Overall Study|Administrative reason by sponsor|0
913805|NCT01042977|3010612|P2|Overall Study|Safety|2
913806|NCT01042977|3010613|P1|Overall Study|Safety|0
913807|NCT01042977|3010612|P2|Overall Study|Incorrect enrollment|4
913808|NCT01042977|3010613|P1|Overall Study|Incorrect enrollment|6
913809|NCT01042977|3010612|P2|Overall Study|Subject no longer meets study criteria|13
913810|NCT01042977|3010613|P1|Overall Study|Subject no longer meets study criteria|15
913811|NCT01042977|3010612|P2|Overall Study|Poor/non-compliance|4
913812|NCT01042977|3010613|P1|Overall Study|Poor/non-compliance|3
913813|NCT01042977|3010612|P2|Overall Study|Lost to Follow-up|2
913814|NCT01042977|3010613|P1|Overall Study|Lost to Follow-up|0
913815|NCT01042977|3010612|P2|Overall Study|Withdrawal by Subject|16
913816|NCT01042977|3010613|P1|Overall Study|Withdrawal by Subject|8
913817|NCT01042977|3010612|P2|Overall Study|Death|1
913818|NCT01042977|3010613|P1|Overall Study|Death|2
913819|NCT01042977|3010612|P2|Overall Study|Adverse Event|12
913820|NCT01042977|3010613|P1|Overall Study|Adverse Event|4
913821|NCT01042938|3010633|P2|Overall Study|Ineligible: RTOG study conflict|0
913822|NCT01042938|3010634|P1|Overall Study|Ineligible: RTOG study conflict|1
913823|NCT01042938|3010633|P2|Overall Study|Protocol Violation|1
913824|NCT01042938|3010634|P1|Overall Study|Protocol Violation|1
913825|NCT01042938|3010633|P2|Overall Study|Withdrawal by Subject|1
913826|NCT01042938|3010634|P1|Overall Study|Withdrawal by Subject|1
913827|NCT01042678|3010653|P6|Overall Study|Physician Decision|0
913828|NCT01042678|3010654|P5|Overall Study|Physician Decision|0
913829|NCT01042678|3010655|P4|Overall Study|Physician Decision|0
913830|NCT01042678|3010656|P3|Overall Study|Physician Decision|0
913831|NCT01042678|3010657|P2|Overall Study|Physician Decision|0
913832|NCT01042678|3010658|P1|Overall Study|Physician Decision|1
913833|NCT01042600|3010696|P2|Overall Study|Ineligible|0
913834|NCT01042600|3010697|P1|Overall Study|Ineligible|1
913835|NCT01042535|3010705|P1|Overall Study|complications from other disease|2
913836|NCT01042535|3010705|P1|Overall Study|disease progression during treatment|3
913837|NCT01042535|3010705|P1|Overall Study|disease progression prior to treatment|3
913838|NCT01042392|3010739|P4|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
913839|NCT01042392|3010740|P3|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
913840|NCT01042392|3010741|P2|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
913841|NCT01042392|3010742|P1|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0
913842|NCT01042392|3010739|P4|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
913843|NCT01042392|3010740|P3|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2
913844|NCT01042392|3010741|P2|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
913845|NCT01042392|3010742|P1|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
913846|NCT01042392|3010739|P4|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
913847|NCT01042392|3010740|P3|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
913848|NCT01042392|3010741|P2|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
913849|NCT01042392|3010742|P1|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2
913850|NCT01042392|3010739|P4|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
913851|NCT01042392|3010740|P3|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1
913852|NCT01042392|3010741|P2|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
913853|NCT01042392|3010742|P1|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
913854|NCT01042392|3010739|P4|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
913855|NCT01042392|3010740|P3|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
913856|NCT01042392|3010741|P2|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
913857|NCT01042392|3010742|P1|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2
913858|NCT01042392|3010739|P4|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
913859|NCT01042392|3010740|P3|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1
913860|NCT01042392|3010741|P2|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
913861|NCT01042392|3010742|P1|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
913862|NCT01042392|3010739|P4|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
913863|NCT01042392|3010740|P3|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2
913864|NCT01042392|3010741|P2|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
913865|NCT01042392|3010742|P1|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1
913866|NCT01042392|3010739|P4|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
913867|NCT01042392|3010740|P3|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
913868|NCT01042392|3010741|P2|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
913869|NCT01042392|3010742|P1|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1
913870|NCT01042392|3010739|P4|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
913871|NCT01042392|3010740|P3|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5
913872|NCT01042392|3010741|P2|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
913873|NCT01042392|3010742|P1|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6
913874|NCT01042236|3010790|P6|Treatment Period 3|Protocol Violation|0
913875|NCT01042236|3010791|P5|Treatment Period 3|Protocol Violation|0
913876|NCT01042236|3010792|P4|Treatment Period 3|Protocol Violation|1
913877|NCT01042236|3010793|P3|Treatment Period 3|Protocol Violation|0
913878|NCT01042236|3010794|P2|Treatment Period 3|Protocol Violation|0
913879|NCT01042236|3010795|P1|Treatment Period 3|Protocol Violation|0
913880|NCT01042236|3010790|P6|Treatment Period 3|Adverse Event|0
913881|NCT01042236|3010791|P5|Treatment Period 3|Adverse Event|0
913882|NCT01042236|3010792|P4|Treatment Period 3|Adverse Event|1
913883|NCT01042236|3010793|P3|Treatment Period 3|Adverse Event|0
913884|NCT01042236|3010794|P2|Treatment Period 3|Adverse Event|0
913885|NCT01042236|3010795|P1|Treatment Period 3|Adverse Event|0
913886|NCT01042236|3010790|P6|Treatment Period 1|Adverse Event|0
913887|NCT01042236|3010791|P5|Treatment Period 1|Adverse Event|1
913888|NCT01042236|3010792|P4|Treatment Period 1|Adverse Event|0
913889|NCT01042236|3010793|P3|Treatment Period 1|Adverse Event|0
913890|NCT01042236|3010794|P2|Treatment Period 1|Adverse Event|1
913891|NCT01042236|3010795|P1|Treatment Period 1|Adverse Event|0
913892|NCT01042158|3010832|P1|Overall Study|Physician Decision|1
913893|NCT01042093|3010862|P4|Overall Study|Withdrawal by Subject|1
913894|NCT01042093|3010863|P3|Overall Study|Withdrawal by Subject|0
913895|NCT01042093|3010864|P2|Overall Study|Withdrawal by Subject|0
913896|NCT01042093|3010865|P1|Overall Study|Withdrawal by Subject|0
913897|NCT01042093|3010862|P4|Overall Study|Protocol Violation|3
913898|NCT01042093|3010863|P3|Overall Study|Protocol Violation|2
913899|NCT01042093|3010864|P2|Overall Study|Protocol Violation|2
913900|NCT01042093|3010865|P1|Overall Study|Protocol Violation|2
913901|NCT01041976|3010885|P2|Overall Study|Death|4
913902|NCT01041976|3010886|P1|Overall Study|Death|0
913903|NCT01041976|3010885|P2|Overall Study|Incarceration|0
913904|NCT01041976|3010886|P1|Overall Study|Incarceration|2
913905|NCT01041976|3010885|P2|Overall Study|Withdrawal by Subject|0
913906|NCT01041976|3010886|P1|Overall Study|Withdrawal by Subject|3
913907|NCT01041859|3010896|P3|Double-Blind Maintenance|Withdrawal by Subject|9
913908|NCT01041859|3010897|P2|Double-Blind Maintenance|Withdrawal by Subject|8
913909|NCT01041859|3010898|P1|Double-Blind Maintenance|Withdrawal by Subject|0
913910|NCT01041859|3010896|P3|Double-Blind Maintenance|Noncompliance With Study Drug|6
913911|NCT01041859|3010897|P2|Double-Blind Maintenance|Noncompliance With Study Drug|2
913912|NCT01041859|3010898|P1|Double-Blind Maintenance|Noncompliance With Study Drug|0
913913|NCT01041859|3010896|P3|Double-Blind Maintenance|Other|2
913914|NCT01041859|3010897|P2|Double-Blind Maintenance|Other|6
913915|NCT01041859|3010898|P1|Double-Blind Maintenance|Other|0
913916|NCT01041859|3010896|P3|Double-Blind Maintenance|Protocol Violation|3
913917|NCT01041859|3010897|P2|Double-Blind Maintenance|Protocol Violation|1
913918|NCT01041859|3010898|P1|Double-Blind Maintenance|Protocol Violation|0
913919|NCT01041859|3010896|P3|Double-Blind Maintenance|Physician Decision|1
913920|NCT01041859|3010897|P2|Double-Blind Maintenance|Physician Decision|2
913921|NCT01041859|3010898|P1|Double-Blind Maintenance|Physician Decision|0
913922|NCT01041859|3010896|P3|Double-Blind Maintenance|Lost to Follow-up|0
913923|NCT01041859|3010897|P2|Double-Blind Maintenance|Lost to Follow-up|1
913924|NCT01041859|3010898|P1|Double-Blind Maintenance|Lost to Follow-up|0
913925|NCT01041859|3010896|P3|Double-Blind Maintenance|Lack of Efficacy|11
913926|NCT01041859|3010897|P2|Double-Blind Maintenance|Lack of Efficacy|3
913927|NCT01041859|3010898|P1|Double-Blind Maintenance|Lack of Efficacy|0
913928|NCT01041859|3010896|P3|Double-Blind Maintenance|Adverse Event|13
913929|NCT01041859|3010897|P2|Double-Blind Maintenance|Adverse Event|23
913930|NCT01041859|3010898|P1|Double-Blind Maintenance|Adverse Event|0
913931|NCT01041859|3010896|P3|Open-Label Titration|Withdrawal by Subject|0
913932|NCT01041859|3010897|P2|Open-Label Titration|Withdrawal by Subject|0
913933|NCT01041859|3010898|P1|Open-Label Titration|Withdrawal by Subject|11
913934|NCT01041859|3010896|P3|Open-Label Titration|Noncompliance With Study Drug|0
913935|NCT01041859|3010897|P2|Open-Label Titration|Noncompliance With Study Drug|0
913936|NCT01041859|3010898|P1|Open-Label Titration|Noncompliance With Study Drug|8
913937|NCT01041859|3010896|P3|Open-Label Titration|Other|0
913938|NCT01041859|3010897|P2|Open-Label Titration|Other|0
913939|NCT01041859|3010898|P1|Open-Label Titration|Other|7
913940|NCT01041859|3010896|P3|Open-Label Titration|Protocol Violation|0
913941|NCT01041859|3010897|P2|Open-Label Titration|Protocol Violation|0
913942|NCT01041859|3010898|P1|Open-Label Titration|Protocol Violation|1
913943|NCT01041859|3010896|P3|Open-Label Titration|Physician Decision|0
913944|NCT01041859|3010897|P2|Open-Label Titration|Physician Decision|0
913945|NCT01041859|3010898|P1|Open-Label Titration|Physician Decision|1
913946|NCT01041859|3010896|P3|Open-Label Titration|Lost to Follow-up|0
913947|NCT01041859|3010897|P2|Open-Label Titration|Lost to Follow-up|0
913948|NCT01041859|3010898|P1|Open-Label Titration|Lost to Follow-up|1
913949|NCT01041859|3010896|P3|Open-Label Titration|Lack of Efficacy|0
913950|NCT01041859|3010897|P2|Open-Label Titration|Lack of Efficacy|0
913951|NCT01041859|3010898|P1|Open-Label Titration|Lack of Efficacy|3
913952|NCT01041859|3010896|P3|Open-Label Titration|Adverse Event|0
913953|NCT01041859|3010897|P2|Open-Label Titration|Adverse Event|0
913954|NCT01041859|3010898|P1|Open-Label Titration|Adverse Event|69
913955|NCT01041638|3010934|P1|Overall Study|Withdrawal by Subject|11
913956|NCT01041638|3010934|P1|Overall Study|Physician Decision|4
913957|NCT01041638|3010934|P1|Overall Study|Lack of Efficacy|7
913958|NCT01041638|3010934|P1|Overall Study|Death|1
913959|NCT01041638|3010934|P1|Overall Study|Adverse Event|4
913960|NCT01041573|3010942|P4|Overall Study|positive to anti-HCV|0
913961|NCT01041573|3010943|P3|Overall Study|positive to anti-HCV|0
913962|NCT01041573|3010944|P2|Overall Study|positive to anti-HCV|0
913963|NCT01041573|3010945|P1|Overall Study|positive to anti-HCV|1
913964|NCT01041573|3010942|P4|Overall Study|further blood extraction|0
913965|NCT01041573|3010943|P3|Overall Study|further blood extraction|0
913966|NCT01041573|3010944|P2|Overall Study|further blood extraction|1
913967|NCT01041573|3010945|P1|Overall Study|further blood extraction|0
913968|NCT01041573|3010942|P4|Overall Study|relocation|1
913969|NCT01041573|3010943|P3|Overall Study|relocation|3
913970|NCT01041573|3010944|P2|Overall Study|relocation|4
913971|NCT01041573|3010945|P1|Overall Study|relocation|1
913972|NCT01041573|3010942|P4|Overall Study|Adverse Event|0
913973|NCT01041573|3010943|P3|Overall Study|Adverse Event|0
913974|NCT01041573|3010944|P2|Overall Study|Adverse Event|2
913975|NCT01041573|3010945|P1|Overall Study|Adverse Event|0
913976|NCT01041573|3010942|P4|Overall Study|Lost to Follow-up|1
913977|NCT01041573|3010943|P3|Overall Study|Lost to Follow-up|2
913978|NCT01041573|3010944|P2|Overall Study|Lost to Follow-up|1
913979|NCT01041573|3010945|P1|Overall Study|Lost to Follow-up|0
913980|NCT01041573|3010942|P4|Overall Study|Death|0
913981|NCT01041573|3010943|P3|Overall Study|Death|0
913982|NCT01041573|3010944|P2|Overall Study|Death|0
913983|NCT01041573|3010945|P1|Overall Study|Death|1
913984|NCT01041573|3010942|P4|Overall Study|Withdrawal by Subject|0
913985|NCT01041573|3010943|P3|Overall Study|Withdrawal by Subject|2
913986|NCT01041573|3010944|P2|Overall Study|Withdrawal by Subject|5
913987|NCT01041573|3010945|P1|Overall Study|Withdrawal by Subject|2
913988|NCT01041417|3010957|P2|Overall Study|Death|0
913989|NCT01041417|3010958|P1|Overall Study|Death|1
913990|NCT01041417|3010957|P2|Overall Study|Lost to Follow-up|1
913991|NCT01041417|3010958|P1|Overall Study|Lost to Follow-up|1
913992|NCT01041417|3010957|P2|Overall Study|Adverse Event|2
913993|NCT01041417|3010958|P1|Overall Study|Adverse Event|5
913994|NCT01041404|3010996|P2|Overall Study|Not Specified|23
913995|NCT01041404|3010997|P1|Overall Study|Not Specified|11
913996|NCT01041404|3010996|P2|Overall Study|Failure to Return|2
913997|NCT01041404|3010997|P1|Overall Study|Failure to Return|1
913998|NCT01041404|3010996|P2|Overall Study|Withdrawal by Subject|23
913999|NCT01041404|3010997|P1|Overall Study|Withdrawal by Subject|29
914000|NCT01041404|3010996|P2|Overall Study|Protocol Violation|0
914001|NCT01041404|3010997|P1|Overall Study|Protocol Violation|4
914002|NCT01041404|3010996|P2|Overall Study|Violation of Selection Criteria|1
914003|NCT01041404|3010997|P1|Overall Study|Violation of Selection Criteria|0
914004|NCT01041404|3010996|P2|Overall Study|Lack of Efficacy|210
914005|NCT01041404|3010997|P1|Overall Study|Lack of Efficacy|200
914006|NCT01041404|3010996|P2|Overall Study|Adverse Event|35
914007|NCT01041404|3010997|P1|Overall Study|Adverse Event|45
914008|NCT01041287|3011038|P2|Treatment Period 2 (3 Months)|Adverse Event|2
914009|NCT01041287|3011039|P1|Treatment Period 2 (3 Months)|Adverse Event|0
914010|NCT01041287|3011038|P2|Treatment Period 2 (3 Months)|Lost to Follow-up|3
914011|NCT01041287|3011039|P1|Treatment Period 2 (3 Months)|Lost to Follow-up|3
914012|NCT01040871|3011077|P2|Overall Study|Randomized and Not Treated|1
914013|NCT01040871|3011078|P1|Overall Study|Randomized and Not Treated|2
914014|NCT01040871|3011077|P2|Overall Study|drug supply issue|0
914015|NCT01040871|3011078|P1|Overall Study|drug supply issue|1
914016|NCT01040871|3011077|P2|Overall Study|Lack of Efficacy|1
914017|NCT01040871|3011078|P1|Overall Study|Lack of Efficacy|1
914018|NCT01040871|3011077|P2|Overall Study|Death|3
914019|NCT01040871|3011078|P1|Overall Study|Death|1
914020|NCT01040871|3011077|P2|Overall Study|Withdrawal by Subject|0
914021|NCT01040871|3011078|P1|Overall Study|Withdrawal by Subject|2
914022|NCT01040871|3011077|P2|Overall Study|Adverse Event|2
914023|NCT01040871|3011078|P1|Overall Study|Adverse Event|6
914024|NCT01040845|3011129|P2|Overall Study|Physician Decision|0
914025|NCT01040845|3011130|P1|Overall Study|Physician Decision|1
914026|NCT01040845|3011129|P2|Overall Study|Withdrawal by Subject|1
914027|NCT01040845|3011130|P1|Overall Study|Withdrawal by Subject|1
914028|NCT01040832|3011145|P2|Overall Study|Other|1
914029|NCT01040832|3011146|P1|Overall Study|Other|2
914030|NCT01040832|3011145|P2|Overall Study|Symptomatic deterioration|5
914031|NCT01040832|3011146|P1|Overall Study|Symptomatic deterioration|2
914032|NCT01040832|3011145|P2|Overall Study|Progressive disease|17
914033|NCT01040832|3011146|P1|Overall Study|Progressive disease|32
914034|NCT01040832|3011145|P2|Overall Study|Withdrawal by Subject|3
914035|NCT01040832|3011146|P1|Overall Study|Withdrawal by Subject|2
914036|NCT01040832|3011145|P2|Overall Study|Death|6
914037|NCT01040832|3011146|P1|Overall Study|Death|4
914038|NCT01040832|3011145|P2|Overall Study|Adverse Event|5
914039|NCT01040832|3011146|P1|Overall Study|Adverse Event|4
914040|NCT01040793|3011169|P6|Overall Study|Other reasons not listed above|0
914041|NCT01040793|3011170|P5|Overall Study|Other reasons not listed above|1
914042|NCT01040793|3011171|P4|Overall Study|Other reasons not listed above|0
914043|NCT01040793|3011172|P3|Overall Study|Other reasons not listed above|1
914044|NCT01040793|3011173|P2|Overall Study|Other reasons not listed above|0
914045|NCT01040793|3011174|P1|Overall Study|Other reasons not listed above|0
914046|NCT01040793|3011169|P6|Overall Study|Withdrawal by Subject|0
914047|NCT01040793|3011170|P5|Overall Study|Withdrawal by Subject|0
914048|NCT01040793|3011171|P4|Overall Study|Withdrawal by Subject|2
914049|NCT01040793|3011172|P3|Overall Study|Withdrawal by Subject|0
914050|NCT01040793|3011173|P2|Overall Study|Withdrawal by Subject|0
914051|NCT01040793|3011174|P1|Overall Study|Withdrawal by Subject|0
914052|NCT01040793|3011169|P6|Overall Study|Lost to Follow-up|0
914053|NCT01040793|3011170|P5|Overall Study|Lost to Follow-up|0
914054|NCT01040793|3011171|P4|Overall Study|Lost to Follow-up|0
914055|NCT01040793|3011172|P3|Overall Study|Lost to Follow-up|1
914056|NCT01040793|3011173|P2|Overall Study|Lost to Follow-up|1
914057|NCT01040793|3011174|P1|Overall Study|Lost to Follow-up|0
914058|NCT01040793|3011169|P6|Overall Study|Protocol Violation|0
914059|NCT01040793|3011170|P5|Overall Study|Protocol Violation|1
914060|NCT01040793|3011171|P4|Overall Study|Protocol Violation|0
914061|NCT01040793|3011172|P3|Overall Study|Protocol Violation|1
914062|NCT01040793|3011173|P2|Overall Study|Protocol Violation|1
914063|NCT01040793|3011174|P1|Overall Study|Protocol Violation|1
914064|NCT01040793|3011169|P6|Overall Study|Adverse Event|1
914065|NCT01040793|3011170|P5|Overall Study|Adverse Event|2
914066|NCT01040793|3011171|P4|Overall Study|Adverse Event|2
914067|NCT01040793|3011172|P3|Overall Study|Adverse Event|0
914068|NCT01040793|3011173|P2|Overall Study|Adverse Event|3
914069|NCT01040793|3011174|P1|Overall Study|Adverse Event|5
914070|NCT01040780|3011253|P2|Overall Study|Protocol Violation|3
914071|NCT01040780|3011254|P1|Overall Study|Protocol Violation|1
914072|NCT01040728|3011268|P4|Overall Study|Other reasons not listed above|0
914073|NCT01040728|3011269|P3|Overall Study|Other reasons not listed above|0
914074|NCT01040728|3011270|P2|Overall Study|Other reasons not listed above|1
914075|NCT01040728|3011271|P1|Overall Study|Other reasons not listed above|0
914076|NCT01040728|3011268|P4|Overall Study|Lack of Efficacy|1
914077|NCT01040728|3011269|P3|Overall Study|Lack of Efficacy|0
914078|NCT01040728|3011270|P2|Overall Study|Lack of Efficacy|1
914079|NCT01040728|3011271|P1|Overall Study|Lack of Efficacy|0
914080|NCT01040728|3011268|P4|Overall Study|Protocol Violation|1
914081|NCT01040728|3011269|P3|Overall Study|Protocol Violation|0
914082|NCT01040728|3011270|P2|Overall Study|Protocol Violation|0
914083|NCT01040728|3011271|P1|Overall Study|Protocol Violation|0
914084|NCT01040728|3011268|P4|Overall Study|Withdrawal by Subject|0
914085|NCT01040728|3011269|P3|Overall Study|Withdrawal by Subject|1
914086|NCT01040728|3011270|P2|Overall Study|Withdrawal by Subject|1
914087|NCT01040728|3011271|P1|Overall Study|Withdrawal by Subject|0
914088|NCT01040728|3011268|P4|Overall Study|Adverse Event|4
914089|NCT01040728|3011269|P3|Overall Study|Adverse Event|0
914090|NCT01040728|3011270|P2|Overall Study|Adverse Event|8
914091|NCT01040728|3011271|P1|Overall Study|Adverse Event|4
914092|NCT01040689|3011341|P4|Overall Study|Other reasons not listed above|0
914093|NCT01040689|3011342|P3|Overall Study|Other reasons not listed above|0
914094|NCT01040689|3011343|P2|Overall Study|Other reasons not listed above|1
914095|NCT01040689|3011344|P1|Overall Study|Other reasons not listed above|0
914096|NCT01040689|3011341|P4|Overall Study|Withdrawal by Subject|0
914097|NCT01040689|3011342|P3|Overall Study|Withdrawal by Subject|1
914098|NCT01040689|3011343|P2|Overall Study|Withdrawal by Subject|1
914099|NCT01040689|3011344|P1|Overall Study|Withdrawal by Subject|2
914100|NCT01040689|3011341|P4|Overall Study|Lost to Follow-up|0
914101|NCT01040689|3011342|P3|Overall Study|Lost to Follow-up|0
914102|NCT01040689|3011343|P2|Overall Study|Lost to Follow-up|0
914103|NCT01040689|3011344|P1|Overall Study|Lost to Follow-up|1
914104|NCT01040689|3011341|P4|Overall Study|Lack of Efficacy|0
914105|NCT01040689|3011342|P3|Overall Study|Lack of Efficacy|1
914106|NCT01040689|3011343|P2|Overall Study|Lack of Efficacy|0
914107|NCT01040689|3011344|P1|Overall Study|Lack of Efficacy|0
914108|NCT01040689|3011341|P4|Overall Study|Adverse Event|4
914109|NCT01040689|3011342|P3|Overall Study|Adverse Event|2
914110|NCT01040689|3011343|P2|Overall Study|Adverse Event|0
914111|NCT01040689|3011344|P1|Overall Study|Adverse Event|0
914112|NCT01040403|3011423|P1|Overall Study|Other reason not defined above|6
914113|NCT01040403|3011423|P1|Overall Study|Not treated|1
914114|NCT01040403|3011423|P1|Overall Study|Lost to Follow-up|1
914115|NCT01040403|3011423|P1|Overall Study|Protocol Violation|2
914116|NCT01040403|3011423|P1|Overall Study|Adverse Event|10
914117|NCT01040351|3011611|P2|Overall Study|poor ovarian response|2
914118|NCT01040351|3011612|P1|Overall Study|poor ovarian response|1
914119|NCT01040260|3011622|P2|Overall Study|Lost to Follow-up|5
914120|NCT01040260|3011623|P1|Overall Study|Lost to Follow-up|3
914121|NCT01040260|3011622|P2|Overall Study|Withdrawal by Subject|6
914122|NCT01040260|3011623|P1|Overall Study|Withdrawal by Subject|12
914123|NCT01040169|3011650|P2|Overall Study|Lost to Follow-up|8
914124|NCT01040169|3011651|P1|Overall Study|Lost to Follow-up|3
914125|NCT01040130|3011659|P6|Overall Study|Other reasons not listed above|0
914126|NCT01040130|3011660|P5|Overall Study|Other reasons not listed above|0
914127|NCT01040130|3011661|P4|Overall Study|Other reasons not listed above|0
914128|NCT01040130|3011662|P3|Overall Study|Other reasons not listed above|0
914129|NCT01040130|3011663|P2|Overall Study|Other reasons not listed above|0
914130|NCT01040130|3011664|P1|Overall Study|Other reasons not listed above|2
914131|NCT01040130|3011659|P6|Overall Study|Withdrawal by Subject|1
914132|NCT01040130|3011660|P5|Overall Study|Withdrawal by Subject|0
914133|NCT01040130|3011661|P4|Overall Study|Withdrawal by Subject|0
914134|NCT01040130|3011662|P3|Overall Study|Withdrawal by Subject|0
914135|NCT01040130|3011663|P2|Overall Study|Withdrawal by Subject|2
914136|NCT01040130|3011664|P1|Overall Study|Withdrawal by Subject|0
914137|NCT01040130|3011659|P6|Overall Study|Protocol Violation|0
914138|NCT01040130|3011660|P5|Overall Study|Protocol Violation|0
914139|NCT01040130|3011661|P4|Overall Study|Protocol Violation|0
914140|NCT01040130|3011662|P3|Overall Study|Protocol Violation|2
914141|NCT01040130|3011663|P2|Overall Study|Protocol Violation|0
914142|NCT01040130|3011664|P1|Overall Study|Protocol Violation|0
914143|NCT01040130|3011659|P6|Overall Study|Adverse Event|3
914144|NCT01040130|3011660|P5|Overall Study|Adverse Event|0
914145|NCT01040130|3011661|P4|Overall Study|Adverse Event|5
914146|NCT01040130|3011662|P3|Overall Study|Adverse Event|0
914147|NCT01040130|3011663|P2|Overall Study|Adverse Event|1
914148|NCT01040130|3011664|P1|Overall Study|Adverse Event|1
914149|NCT01039688|3011757|P3|Overall Study|Death|0
914150|NCT01039688|3011758|P2|Overall Study|Death|0
914151|NCT01039688|3011759|P1|Overall Study|Death|2
914152|NCT01039688|3011757|P3|Overall Study|Withdrawal by Subject|13
914153|NCT01039688|3011758|P2|Overall Study|Withdrawal by Subject|27
914154|NCT01039688|3011759|P1|Overall Study|Withdrawal by Subject|23
914155|NCT01039688|3011757|P3|Overall Study|Not specified|12
914156|NCT01039688|3011758|P2|Overall Study|Not specified|25
914157|NCT01039688|3011759|P1|Overall Study|Not specified|13
914158|NCT01039688|3011757|P3|Overall Study|Lost to Follow-up|5
914159|NCT01039688|3011758|P2|Overall Study|Lost to Follow-up|9
914160|NCT01039688|3011759|P1|Overall Study|Lost to Follow-up|11
914161|NCT01039688|3011757|P3|Overall Study|Lack of Efficacy|26
914162|NCT01039688|3011758|P2|Overall Study|Lack of Efficacy|11
914163|NCT01039688|3011759|P1|Overall Study|Lack of Efficacy|20
914164|NCT01039688|3011757|P3|Overall Study|Adverse Event|24
914165|NCT01039688|3011758|P2|Overall Study|Adverse Event|39
914166|NCT01039688|3011759|P1|Overall Study|Adverse Event|38
914167|NCT01039675|3012030|P2|Overall Study|Physician Decision|1
914168|NCT01039675|3012031|P1|Overall Study|Physician Decision|0
914169|NCT01039675|3012030|P2|Overall Study|Lost to Follow-up|1
914170|NCT01039675|3012031|P1|Overall Study|Lost to Follow-up|0
914171|NCT01039675|3012030|P2|Overall Study|Withdrawal by Subject|1
914172|NCT01039675|3012031|P1|Overall Study|Withdrawal by Subject|0
914173|NCT01039675|3012030|P2|Overall Study|Lack of Efficacy|2
914174|NCT01039675|3012031|P1|Overall Study|Lack of Efficacy|0
914175|NCT01039675|3012030|P2|Overall Study|Adverse Event|2
914176|NCT01039675|3012031|P1|Overall Study|Adverse Event|0
914177|NCT01039584|3012044|P3|Overall Study|Positive for Chlamydia or gonorrhea|8
914178|NCT01039584|3012045|P2|Overall Study|Positive for Chlamydia or gonorrhea|10
914179|NCT01039584|3012046|P1|Overall Study|Positive for Chlamydia or gonorrhea|7
914180|NCT01039584|3012044|P3|Overall Study|Pap smear with significant pathology|3
914181|NCT01039584|3012045|P2|Overall Study|Pap smear with significant pathology|10
914182|NCT01039584|3012046|P1|Overall Study|Pap smear with significant pathology|10
914183|NCT01039584|3012044|P3|Overall Study|other|1
914184|NCT01039584|3012045|P2|Overall Study|other|3
914185|NCT01039584|3012046|P1|Overall Study|other|1
914186|NCT01039584|3012044|P3|Overall Study|Lack of Efficacy|10
914187|NCT01039584|3012045|P2|Overall Study|Lack of Efficacy|6
914188|NCT01039584|3012046|P1|Overall Study|Lack of Efficacy|7
914189|NCT01039584|3012044|P3|Overall Study|Negative Baseline culture for Candida|24
914190|NCT01039584|3012045|P2|Overall Study|Negative Baseline culture for Candida|59
914191|NCT01039584|3012046|P1|Overall Study|Negative Baseline culture for Candida|59
914192|NCT01039584|3012044|P3|Overall Study|Lost to Follow-up|4
914193|NCT01039584|3012045|P2|Overall Study|Lost to Follow-up|3
914194|NCT01039584|3012046|P1|Overall Study|Lost to Follow-up|5
914195|NCT01039584|3012044|P3|Overall Study|Protocol Violation|6
914196|NCT01039584|3012045|P2|Overall Study|Protocol Violation|4
914197|NCT01039584|3012046|P1|Overall Study|Protocol Violation|10
914198|NCT01039584|3012044|P3|Overall Study|Withdrawal by Subject|1
914199|NCT01039584|3012045|P2|Overall Study|Withdrawal by Subject|2
914200|NCT01039584|3012046|P1|Overall Study|Withdrawal by Subject|4
914201|NCT01039519|3012060|P1|Survival Follow-up|Sponsor decision|4
914202|NCT01039519|3012060|P1|Survival Follow-up|Death|23
914203|NCT01039519|3012060|P1|Treatment|Physician Decision|2
914204|NCT01039519|3012060|P1|Treatment|Adverse Event|3
914205|NCT01039519|3012060|P1|Treatment|Treatment failure|2
914206|NCT01039519|3012060|P1|Treatment|Progressive disease|20
914207|NCT01039428|3012071|P2|Overall Study|Withdrawal by Subject|0
914208|NCT01039428|3012072|P1|Overall Study|Withdrawal by Subject|1
914209|NCT01039428|3012071|P2|Overall Study|Protocol Violation|0
914210|NCT01039428|3012072|P1|Overall Study|Protocol Violation|1
914211|NCT01039376|3012096|P2|Overall Study|Ongoing|182
914212|NCT01039376|3012097|P1|Overall Study|Ongoing|189
914213|NCT01039376|3012096|P2|Overall Study|Withdrawal by Subject|17
914214|NCT01039376|3012097|P1|Overall Study|Withdrawal by Subject|11
914215|NCT01039376|3012096|P2|Overall Study|Physician Decision|2
914216|NCT01039376|3012097|P1|Overall Study|Physician Decision|4
914217|NCT01039376|3012096|P2|Overall Study|Lost to Follow-up|1
914218|NCT01039376|3012097|P1|Overall Study|Lost to Follow-up|2
914219|NCT01038921|3012165|P2|Overall Study|Physician Decision|0
914220|NCT01038921|3012166|P1|Overall Study|Physician Decision|1
914221|NCT01038921|3012165|P2|Overall Study|Withdrawal by Subject|0
914222|NCT01038921|3012166|P1|Overall Study|Withdrawal by Subject|1
914223|NCT01038869|3012172|P1|Overall Study|Lost to Follow-up|6
914224|NCT01038869|3012172|P1|Overall Study|Withdrawal by Subject|1
914225|NCT01038856|3012180|P1|Overall Study|Adverse Event|2
914226|NCT01038752|3012189|P2|Overall Study|Lost to Follow-up|3
914227|NCT01038752|3012190|P1|Overall Study|Lost to Follow-up|3
914228|NCT01038752|3012189|P2|Overall Study|Tumor Progression|2
914229|NCT01038752|3012190|P1|Overall Study|Tumor Progression|2
914230|NCT01038713|3012213|P3|Overall Study|Autoimmune Pancreatitis|0
914231|NCT01038713|3012214|P2|Overall Study|Autoimmune Pancreatitis|0
914232|NCT01038713|3012215|P1|Overall Study|Autoimmune Pancreatitis|1
914233|NCT01038713|3012213|P3|Overall Study|died from PEP|0
914234|NCT01038713|3012214|P2|Overall Study|died from PEP|1
914235|NCT01038713|3012215|P1|Overall Study|died from PEP|0
914236|NCT01038713|3012213|P3|Overall Study|Neuroendocrine Tumor|0
914237|NCT01038713|3012214|P2|Overall Study|Neuroendocrine Tumor|1
914238|NCT01038713|3012215|P1|Overall Study|Neuroendocrine Tumor|0
914239|NCT01038713|3012213|P3|Overall Study|Lost to Follow-up|0
914240|NCT01038713|3012214|P2|Overall Study|Lost to Follow-up|0
914241|NCT01038713|3012215|P1|Overall Study|Lost to Follow-up|3
914242|NCT01038713|3012213|P3|Overall Study|Patient to hospice|1
914243|NCT01038713|3012214|P2|Overall Study|Patient to hospice|1
914244|NCT01038713|3012215|P1|Overall Study|Patient to hospice|1
914245|NCT01038635|3012244|P9|Overall Study|Death|2
914246|NCT01038635|3012245|P8|Overall Study|Death|1
914247|NCT01038635|3012246|P7|Overall Study|Death|1
914248|NCT01038635|3012247|P6|Overall Study|Death|0
914249|NCT01038635|3012248|P5|Overall Study|Death|1
914250|NCT01038635|3012249|P4|Overall Study|Death|0
914251|NCT01038635|3012250|P3|Overall Study|Death|0
914252|NCT01038635|3012251|P2|Overall Study|Death|0
914253|NCT01038635|3012252|P1|Overall Study|Death|0
914254|NCT01038635|3012244|P9|Overall Study|Disease Progression|0
914255|NCT01038635|3012245|P8|Overall Study|Disease Progression|4
914256|NCT01038635|3012246|P7|Overall Study|Disease Progression|1
914257|NCT01038635|3012247|P6|Overall Study|Disease Progression|0
914258|NCT01038635|3012248|P5|Overall Study|Disease Progression|0
914259|NCT01038635|3012249|P4|Overall Study|Disease Progression|0
914260|NCT01038635|3012250|P3|Overall Study|Disease Progression|0
914261|NCT01038635|3012251|P2|Overall Study|Disease Progression|0
914262|NCT01038635|3012252|P1|Overall Study|Disease Progression|2
914263|NCT01038609|3012278|P5|Overall Study|Refusal of Blood Draws|0
914264|NCT01038609|3012279|P4|Overall Study|Refusal of Blood Draws|0
914265|NCT01038609|3012280|P3|Overall Study|Refusal of Blood Draws|0
914266|NCT01038609|3012281|P2|Overall Study|Refusal of Blood Draws|1
914267|NCT01038609|3012282|P1|Overall Study|Refusal of Blood Draws|0
914268|NCT01038609|3012278|P5|Overall Study|Death in the Family|0
914269|NCT01038609|3012279|P4|Overall Study|Death in the Family|0
914270|NCT01038609|3012280|P3|Overall Study|Death in the Family|0
914271|NCT01038609|3012281|P2|Overall Study|Death in the Family|0
914272|NCT01038609|3012282|P1|Overall Study|Death in the Family|1
914273|NCT01038609|3012278|P5|Overall Study|Dosing Error|1
914274|NCT01038609|3012279|P4|Overall Study|Dosing Error|1
914275|NCT01038609|3012280|P3|Overall Study|Dosing Error|0
914276|NCT01038609|3012281|P2|Overall Study|Dosing Error|0
914277|NCT01038609|3012282|P1|Overall Study|Dosing Error|0
914278|NCT01038609|3012278|P5|Overall Study|Adverse Event|0
914279|NCT01038609|3012279|P4|Overall Study|Adverse Event|0
914280|NCT01038609|3012280|P3|Overall Study|Adverse Event|1
914281|NCT01038609|3012281|P2|Overall Study|Adverse Event|0
914282|NCT01038609|3012282|P1|Overall Study|Adverse Event|0
914283|NCT01038323|3012361|P3|Overall Study|Withdrawal by Subject|4
914284|NCT01038323|3012362|P2|Overall Study|Withdrawal by Subject|2
914285|NCT01038323|3012363|P1|Overall Study|Withdrawal by Subject|3
914286|NCT01038128|3012377|P1|Overall Study|Withdrawal by Subject|2
914287|NCT01038128|3012377|P1|Overall Study|Lost to Follow-up|1
914288|NCT01038128|3012377|P1|Overall Study|Lack of Efficacy|1
914289|NCT01037244|3012470|P4|Overall Study|Various|1
914290|NCT01037244|3012471|P3|Overall Study|Various|1
914291|NCT01037244|3012472|P2|Overall Study|Various|2
914292|NCT01037244|3012473|P1|Overall Study|Various|3
914293|NCT01037244|3012470|P4|Overall Study|Partner Withdrew Consent|0
914294|NCT01037244|3012471|P3|Overall Study|Partner Withdrew Consent|0
914295|NCT01037244|3012472|P2|Overall Study|Partner Withdrew Consent|1
914296|NCT01037244|3012473|P1|Overall Study|Partner Withdrew Consent|2
914297|NCT01037244|3012470|P4|Overall Study|Withdrawal by Subject|5
914298|NCT01037244|3012471|P3|Overall Study|Withdrawal by Subject|3
914299|NCT01037244|3012472|P2|Overall Study|Withdrawal by Subject|5
914300|NCT01037244|3012473|P1|Overall Study|Withdrawal by Subject|1
914301|NCT01037244|3012470|P4|Overall Study|Lost to Follow-up|4
914302|NCT01037244|3012471|P3|Overall Study|Lost to Follow-up|4
914303|NCT01037244|3012472|P2|Overall Study|Lost to Follow-up|3
914304|NCT01037244|3012473|P1|Overall Study|Lost to Follow-up|3
914305|NCT01037244|3012470|P4|Overall Study|Lack of Efficacy|1
914306|NCT01037244|3012471|P3|Overall Study|Lack of Efficacy|0
914307|NCT01037244|3012472|P2|Overall Study|Lack of Efficacy|1
914308|NCT01037244|3012473|P1|Overall Study|Lack of Efficacy|1
914309|NCT01037244|3012470|P4|Overall Study|Adverse Event|3
914310|NCT01037244|3012471|P3|Overall Study|Adverse Event|6
914311|NCT01037244|3012472|P2|Overall Study|Adverse Event|2
914312|NCT01037244|3012473|P1|Overall Study|Adverse Event|3
914313|NCT01037218|3012535|P4|Overall Study|Various|1
914314|NCT01037218|3012536|P3|Overall Study|Various|3
914315|NCT01037218|3012537|P2|Overall Study|Various|2
914316|NCT01037218|3012538|P1|Overall Study|Various|3
914317|NCT01037218|3012535|P4|Overall Study|Protocol Violation|2
914318|NCT01037218|3012536|P3|Overall Study|Protocol Violation|2
914319|NCT01037218|3012537|P2|Overall Study|Protocol Violation|0
914320|NCT01037218|3012538|P1|Overall Study|Protocol Violation|0
914321|NCT01037218|3012535|P4|Overall Study|Partner Withdrew Consent|1
914322|NCT01037218|3012536|P3|Overall Study|Partner Withdrew Consent|2
914323|NCT01037218|3012537|P2|Overall Study|Partner Withdrew Consent|3
914324|NCT01037218|3012538|P1|Overall Study|Partner Withdrew Consent|0
914325|NCT01037218|3012535|P4|Overall Study|Withdrawal by Subject|4
914326|NCT01037218|3012536|P3|Overall Study|Withdrawal by Subject|7
914327|NCT01037218|3012537|P2|Overall Study|Withdrawal by Subject|7
914328|NCT01037218|3012538|P1|Overall Study|Withdrawal by Subject|6
914329|NCT01037218|3012535|P4|Overall Study|Lost to Follow-up|2
914330|NCT01037218|3012536|P3|Overall Study|Lost to Follow-up|4
914331|NCT01037218|3012537|P2|Overall Study|Lost to Follow-up|5
914332|NCT01037218|3012538|P1|Overall Study|Lost to Follow-up|3
914333|NCT01037218|3012535|P4|Overall Study|Lack of Efficacy|5
914334|NCT01037218|3012536|P3|Overall Study|Lack of Efficacy|1
914335|NCT01037218|3012537|P2|Overall Study|Lack of Efficacy|2
914336|NCT01037218|3012538|P1|Overall Study|Lack of Efficacy|0
914337|NCT01037218|3012535|P4|Overall Study|Adverse Event|1
914338|NCT01037218|3012536|P3|Overall Study|Adverse Event|2
914339|NCT01037218|3012537|P2|Overall Study|Adverse Event|2
914340|NCT01037218|3012538|P1|Overall Study|Adverse Event|4
914341|NCT01037127|3012609|P2|Overall Study|Study Closed Terminated|17
914342|NCT01037127|3012610|P1|Overall Study|Study Closed Terminated|2
914343|NCT01037127|3012609|P2|Overall Study|Physician Decision|0
914344|NCT01037127|3012610|P1|Overall Study|Physician Decision|1
914345|NCT01037127|3012609|P2|Overall Study|Lost to Follow-up|4
914346|NCT01037127|3012610|P1|Overall Study|Lost to Follow-up|2
914347|NCT01037114|3012642|P1|Year 20|Others|1
914348|NCT01037088|3012655|P1|Overall Study|Withdrawal by Subject|3
914349|NCT01036763|3012687|P1|Overall Study|Other reason (not specified)|40
914350|NCT01036763|3012687|P1|Overall Study|Lost to Follow-up|28
914351|NCT01036763|3012687|P1|Overall Study|Adverse Event|25
914352|NCT01036724|3012699|P2|Overall Study|Protocol Violation|5
914353|NCT01036724|3012700|P1|Overall Study|Protocol Violation|4
914354|NCT01036724|3012699|P2|Overall Study|Lack of Efficacy|1
914355|NCT01036724|3012700|P1|Overall Study|Lack of Efficacy|1
914356|NCT01036724|3012699|P2|Overall Study|Adverse Event|2
914357|NCT01036724|3012700|P1|Overall Study|Adverse Event|1
914358|NCT01036529|3012710|P2|Overall Study|Sponsor study termination|12
914359|NCT01036529|3012711|P1|Overall Study|Sponsor study termination|11
914360|NCT01036529|3012710|P2|Overall Study|Withdrawal by Subject|1
914361|NCT01036529|3012711|P1|Overall Study|Withdrawal by Subject|1
914362|NCT01036529|3012710|P2|Overall Study|Physician Decision|0
914363|NCT01036529|3012711|P1|Overall Study|Physician Decision|1
914364|NCT01036529|3012710|P2|Overall Study|Lost to Follow-up|1
914365|NCT01036529|3012711|P1|Overall Study|Lost to Follow-up|0
914366|NCT01036529|3012710|P2|Overall Study|Adverse Event|1
914367|NCT01036529|3012711|P1|Overall Study|Adverse Event|0
914368|NCT01036438|3012738|P2|Overall Study|No effect of study treatment|1
914369|NCT01036438|3012739|P1|Overall Study|No effect of study treatment|3
914370|NCT01036438|3012738|P2|Overall Study|Death|1
914371|NCT01036438|3012739|P1|Overall Study|Death|0
914372|NCT01036438|3012738|P2|Overall Study|Adverse Event|8
914373|NCT01036438|3012739|P1|Overall Study|Adverse Event|7
914374|NCT01036321|3012747|P2|Overall Study|Adverse Event|1
914375|NCT01036321|3012748|P1|Overall Study|Adverse Event|2
914376|NCT01036321|3012747|P2|Overall Study|Withdrawal by Subject|2
914377|NCT01036321|3012748|P1|Overall Study|Withdrawal by Subject|3
914378|NCT01036321|3012747|P2|Overall Study|Ineligible after randomization|1
914379|NCT01036321|3012748|P1|Overall Study|Ineligible after randomization|0
914380|NCT01036165|3012772|P1|Overall Study|Problems finding proper area to inject|1
914381|NCT01036165|3012772|P1|Overall Study|Device Related Issues|3
914382|NCT01036165|3012772|P1|Overall Study|Withdrawal by Subject|3
914383|NCT01036165|3012772|P1|Overall Study|Lost to Follow-up|2
914384|NCT01036165|3012772|P1|Overall Study|Adverse Event|6
914385|NCT01036022|3012783|P6|Overall Study|Withdrawal by Subject|0
914386|NCT01036022|3012784|P5|Overall Study|Withdrawal by Subject|2
914387|NCT01036022|3012785|P4|Overall Study|Withdrawal by Subject|1
914388|NCT01036022|3012786|P3|Overall Study|Withdrawal by Subject|0
914389|NCT01036022|3012787|P2|Overall Study|Withdrawal by Subject|0
914390|NCT01036022|3012788|P1|Overall Study|Withdrawal by Subject|0
914391|NCT01036022|3012783|P6|Overall Study|Physician Decision|0
914392|NCT01036022|3012784|P5|Overall Study|Physician Decision|0
914393|NCT01036022|3012785|P4|Overall Study|Physician Decision|0
914394|NCT01036022|3012786|P3|Overall Study|Physician Decision|1
914395|NCT01036022|3012787|P2|Overall Study|Physician Decision|0
914396|NCT01036022|3012788|P1|Overall Study|Physician Decision|0
914397|NCT01036022|3012783|P6|Overall Study|Lack of Efficacy|1
914398|NCT01036022|3012784|P5|Overall Study|Lack of Efficacy|1
914399|NCT01036022|3012785|P4|Overall Study|Lack of Efficacy|0
914400|NCT01036022|3012786|P3|Overall Study|Lack of Efficacy|1
914401|NCT01036022|3012787|P2|Overall Study|Lack of Efficacy|1
914402|NCT01036022|3012788|P1|Overall Study|Lack of Efficacy|1
914403|NCT01036022|3012783|P6|Overall Study|Adverse Event|2
914404|NCT01036022|3012784|P5|Overall Study|Adverse Event|0
914405|NCT01036022|3012785|P4|Overall Study|Adverse Event|1
914406|NCT01036022|3012786|P3|Overall Study|Adverse Event|2
914407|NCT01036022|3012787|P2|Overall Study|Adverse Event|3
914408|NCT01036022|3012788|P1|Overall Study|Adverse Event|1
914409|NCT01035905|3012924|P2|Overall Study|Lack of Efficacy|1
914410|NCT01035905|3012925|P1|Overall Study|Lack of Efficacy|1
914411|NCT01035606|3013098|P3|Overall Study|change in health, job demands,family|4
914412|NCT01035606|3013099|P2|Overall Study|change in health, job demands,family|3
914413|NCT01035606|3013100|P1|Overall Study|change in health, job demands,family|3
914414|NCT01035255|3013142|P2|Overall Study|patient's request|13
914415|NCT01035255|3013143|P1|Overall Study|patient's request|15
914416|NCT01035255|3013142|P2|Overall Study|Lost to Follow-up|5
914417|NCT01035255|3013143|P1|Overall Study|Lost to Follow-up|2
914418|NCT01035255|3013142|P2|Overall Study|Death|844
914419|NCT01035255|3013143|P1|Overall Study|Death|724
914420|NCT01035229|3013161|P2|Overall Study|Disease Progression|152
914421|NCT01035229|3013162|P1|Overall Study|Disease Progression|261
914422|NCT01035229|3013161|P2|Overall Study|Sponsor's decision to end study|3
914423|NCT01035229|3013162|P1|Overall Study|Sponsor's decision to end study|3
914424|NCT01035229|3013161|P2|Overall Study|Protocol Violation|2
914425|NCT01035229|3013162|P1|Overall Study|Protocol Violation|0
914426|NCT01035229|3013161|P2|Overall Study|New cancer therapy|0
914427|NCT01035229|3013162|P1|Overall Study|New cancer therapy|2
914428|NCT01035229|3013161|P2|Overall Study|Death|5
914429|NCT01035229|3013162|P1|Overall Study|Death|13
914430|NCT01035229|3013161|P2|Overall Study|Administrative problems|1
914431|NCT01035229|3013162|P1|Overall Study|Administrative problems|1
914432|NCT01035229|3013161|P2|Overall Study|Lost to Follow-up|0
914433|NCT01035229|3013162|P1|Overall Study|Lost to Follow-up|1
914434|NCT01035229|3013161|P2|Overall Study|Withdrawal by Subject|7
914435|NCT01035229|3013162|P1|Overall Study|Withdrawal by Subject|20
914436|NCT01035229|3013161|P2|Overall Study|Adverse Event|14
914437|NCT01035229|3013162|P1|Overall Study|Adverse Event|61
914438|NCT01035138|3013183|P3|Overall Study|Lost to Follow-up|1
914439|NCT01035138|3013184|P2|Overall Study|Lost to Follow-up|0
914440|NCT01035138|3013185|P1|Overall Study|Lost to Follow-up|0
914441|NCT01035138|3013183|P3|Overall Study|Sponsor Decision|42
914442|NCT01035138|3013184|P2|Overall Study|Sponsor Decision|60
914443|NCT01035138|3013185|P1|Overall Study|Sponsor Decision|66
914444|NCT01035138|3013183|P3|Overall Study|Physician Decision|1
914445|NCT01035138|3013184|P2|Overall Study|Physician Decision|0
914446|NCT01035138|3013185|P1|Overall Study|Physician Decision|0
914447|NCT01035138|3013183|P3|Overall Study|Withdrawal by Subject|0
914448|NCT01035138|3013184|P2|Overall Study|Withdrawal by Subject|0
914449|NCT01035138|3013185|P1|Overall Study|Withdrawal by Subject|1
914450|NCT01035138|3013183|P3|Overall Study|Caregiver Decision|1
914451|NCT01035138|3013184|P2|Overall Study|Caregiver Decision|0
914452|NCT01035138|3013185|P1|Overall Study|Caregiver Decision|2
914453|NCT01035138|3013183|P3|Overall Study|Adverse Event|2
914454|NCT01035138|3013184|P2|Overall Study|Adverse Event|0
914455|NCT01035138|3013185|P1|Overall Study|Adverse Event|4
914456|NCT01035060|3013241|P2|Overall Study|Physician Decision|0
914457|NCT01035060|3013242|P1|Overall Study|Physician Decision|2
914458|NCT01035060|3013241|P2|Overall Study|Withdrawal by Subject|6
914459|NCT01035060|3013242|P1|Overall Study|Withdrawal by Subject|8
914460|NCT01035060|3013241|P2|Overall Study|Did not quality after 2nd screening|1
914461|NCT01035060|3013242|P1|Overall Study|Did not quality after 2nd screening|14
914462|NCT01035060|3013241|P2|Overall Study|Lost to Follow-up|7
914463|NCT01035060|3013242|P1|Overall Study|Lost to Follow-up|0
914464|NCT01034709|3013267|P2|Overall Study|Protocol Violation|16
914465|NCT01034709|3013268|P1|Overall Study|Protocol Violation|9
914466|NCT01034657|3013274|P3|Randomized Phase|Adverse Event|1
914467|NCT01034657|3013275|P2|Randomized Phase|Adverse Event|2
914468|NCT01034657|3013276|P1|Randomized Phase|Adverse Event|0
914469|NCT01034657|3013274|P3|Randomized Phase|Abnormal laboratory value|0
914470|NCT01034657|3013275|P2|Randomized Phase|Abnormal laboratory value|1
914471|NCT01034657|3013276|P1|Randomized Phase|Abnormal laboratory value|0
914472|NCT01034657|3013274|P3|Randomized Phase|Lack of Efficacy|0
914473|NCT01034657|3013275|P2|Randomized Phase|Lack of Efficacy|1
914474|NCT01034657|3013276|P1|Randomized Phase|Lack of Efficacy|5
914475|NCT01034657|3013274|P3|Randomized Phase|Withdrawal by Subject|0
914476|NCT01034657|3013275|P2|Randomized Phase|Withdrawal by Subject|2
914477|NCT01034657|3013276|P1|Randomized Phase|Withdrawal by Subject|0
914478|NCT01034657|3013274|P3|Core Phase|Protocol Violation|0
914479|NCT01034657|3013275|P2|Core Phase|Protocol Violation|0
914480|NCT01034657|3013276|P1|Core Phase|Protocol Violation|2
914481|NCT01034657|3013274|P3|Core Phase|Adverse Event|0
914482|NCT01034657|3013275|P2|Core Phase|Adverse Event|0
914483|NCT01034657|3013276|P1|Core Phase|Adverse Event|8
914484|NCT01034657|3013274|P3|Core Phase|Abnormal laboratory value|0
914485|NCT01034657|3013275|P2|Core Phase|Abnormal laboratory value|0
914486|NCT01034657|3013276|P1|Core Phase|Abnormal laboratory value|1
914487|NCT01034657|3013274|P3|Core Phase|Lack of Efficacy|0
914488|NCT01034657|3013275|P2|Core Phase|Lack of Efficacy|0
914489|NCT01034657|3013276|P1|Core Phase|Lack of Efficacy|2
914490|NCT01034657|3013274|P3|Core Phase|Withdrawal by Subject|0
914491|NCT01034657|3013275|P2|Core Phase|Withdrawal by Subject|0
914492|NCT01034657|3013276|P1|Core Phase|Withdrawal by Subject|1
914493|NCT01034631|3013317|P3|Phase II|Determined Ineligible per protocol|0
914494|NCT01034631|3013318|P2|Phase II|Determined Ineligible per protocol|1
914495|NCT01034631|3013319|P1|Phase II|Determined Ineligible per protocol|0
914496|NCT01034631|3013317|P3|Phase II|Not Evaluable per protocol|2
914497|NCT01034631|3013318|P2|Phase II|Not Evaluable per protocol|0
914498|NCT01034631|3013319|P1|Phase II|Not Evaluable per protocol|0
914499|NCT01034631|3013317|P3|Phase I|Symptomatic Deterioration before Treatme|0
914500|NCT01034631|3013318|P2|Phase I|Symptomatic Deterioration before Treatme|0
914501|NCT01034631|3013319|P1|Phase I|Symptomatic Deterioration before Treatme|3
914502|NCT01034540|3013386|P2|Overall Study|Adverse Event|1
914503|NCT01034540|3013387|P1|Overall Study|Adverse Event|0
914504|NCT01034462|3013397|P2|Overall Study|Other reasons|2
914505|NCT01034462|3013398|P1|Overall Study|Other reasons|1
914506|NCT01034462|3013397|P2|Overall Study|Lost to Follow-up|16
914507|NCT01034462|3013398|P1|Overall Study|Lost to Follow-up|14
914508|NCT01034462|3013397|P2|Overall Study|Withdrawal by Subject|8
914509|NCT01034462|3013398|P1|Overall Study|Withdrawal by Subject|9
914510|NCT01034462|3013397|P2|Overall Study|Protocol Violation|7
914511|NCT01034462|3013398|P1|Overall Study|Protocol Violation|10
914512|NCT01034462|3013397|P2|Overall Study|Lack of Efficacy|4
914513|NCT01034462|3013398|P1|Overall Study|Lack of Efficacy|4
914514|NCT01034462|3013397|P2|Overall Study|Adverse Event|17
914515|NCT01034462|3013398|P1|Overall Study|Adverse Event|7
914516|NCT01034397|3013408|P2|Overall Study|Not specified|1
914517|NCT01034397|3013409|P1|Overall Study|Not specified|0
914518|NCT01034397|3013408|P2|Overall Study|Adverse Event|0
914519|NCT01034397|3013409|P1|Overall Study|Adverse Event|4
914520|NCT01034397|3013408|P2|Overall Study|Lack of Efficacy|0
914521|NCT01034397|3013409|P1|Overall Study|Lack of Efficacy|3
914522|NCT01034397|3013408|P2|Overall Study|Lack of compliance|1
914523|NCT01034397|3013409|P1|Overall Study|Lack of compliance|0
914524|NCT01034358|3013558|P1|Overall Study|Protocol Violation|1
914525|NCT01034358|3013558|P1|Overall Study|Withdrawal by Subject|1
914526|NCT01034306|3013564|P2|Overall Study|Noncomplience|0
914527|NCT01034306|3013565|P1|Overall Study|Noncomplience|1
914528|NCT01034306|3013564|P2|Overall Study|hospitalized and decided to stop|0
914529|NCT01034306|3013565|P1|Overall Study|hospitalized and decided to stop|1
914530|NCT01034306|3013564|P2|Overall Study|Withdrawal by Subject|2
914531|NCT01034306|3013565|P1|Overall Study|Withdrawal by Subject|2
914532|NCT01034306|3013564|P2|Overall Study|Lost to Follow-up|1
914533|NCT01034306|3013565|P1|Overall Study|Lost to Follow-up|0
914534|NCT01034306|3013564|P2|Overall Study|Adverse Event|0
914535|NCT01034306|3013565|P1|Overall Study|Adverse Event|1
914536|NCT01034176|3013573|P2|Overall Study|Lost to Follow-up|1
914537|NCT01034176|3013574|P1|Overall Study|Lost to Follow-up|0
914538|NCT01034176|3013573|P2|Overall Study|Withdrawal by Subject|1
914539|NCT01034176|3013574|P1|Overall Study|Withdrawal by Subject|0
914540|NCT01034176|3013573|P2|Overall Study|Physician Decision|0
914541|NCT01034176|3013574|P1|Overall Study|Physician Decision|2
914542|NCT01034163|3013584|P2|Overall Study|Abnormal laboratory value|0
914543|NCT01034163|3013585|P1|Overall Study|Abnormal laboratory value|1
914544|NCT01034163|3013584|P2|Overall Study|Administrative problems|1
914545|NCT01034163|3013585|P1|Overall Study|Administrative problems|0
914546|NCT01034163|3013584|P2|Overall Study|Adverse Event|0
914547|NCT01034163|3013585|P1|Overall Study|Adverse Event|6
914548|NCT01034163|3013584|P2|Overall Study|Disease progression|4
914549|NCT01034163|3013585|P1|Overall Study|Disease progression|3
914550|NCT01034163|3013584|P2|Overall Study|Protocol deviation|0
914551|NCT01034163|3013585|P1|Overall Study|Protocol deviation|1
914552|NCT01034163|3013584|P2|Overall Study|Withdrawal by Subject|2
914553|NCT01034163|3013585|P1|Overall Study|Withdrawal by Subject|8
914554|NCT01034163|3013584|P2|Overall Study|Treatment completed as per protocol|7
914555|NCT01034163|3013585|P1|Overall Study|Treatment completed as per protocol|8
914556|NCT01034137|3013594|P3|Overall Study|Administrative or other|4
914557|NCT01034137|3013595|P2|Overall Study|Administrative or other|3
914558|NCT01034137|3013596|P1|Overall Study|Administrative or other|2
914559|NCT01034137|3013594|P3|Overall Study|Refused treatment or did not cooperate|1
914560|NCT01034137|3013595|P2|Overall Study|Refused treatment or did not cooperate|0
914561|NCT01034137|3013596|P1|Overall Study|Refused treatment or did not cooperate|2
914562|NCT01034137|3013594|P3|Overall Study|Protocol Violation|1
914563|NCT01034137|3013595|P2|Overall Study|Protocol Violation|2
914564|NCT01034137|3013596|P1|Overall Study|Protocol Violation|2
914565|NCT01034137|3013594|P3|Overall Study|Lack of Efficacy|13
914566|NCT01034137|3013595|P2|Overall Study|Lack of Efficacy|4
914567|NCT01034137|3013596|P1|Overall Study|Lack of Efficacy|9
914568|NCT01034137|3013594|P3|Overall Study|Withdrawal by Subject|3
914569|NCT01034137|3013595|P2|Overall Study|Withdrawal by Subject|3
914570|NCT01034137|3013596|P1|Overall Study|Withdrawal by Subject|4
914571|NCT01034137|3013594|P3|Overall Study|Adverse Event|8
914572|NCT01034137|3013595|P2|Overall Study|Adverse Event|10
914573|NCT01034137|3013596|P1|Overall Study|Adverse Event|9
914574|NCT01033942|3013735|P3|Overall Study|Enrolled in Extension Study|0
914575|NCT01033942|3013736|P2|Overall Study|Enrolled in Extension Study|3
914576|NCT01033942|3013737|P1|Overall Study|Enrolled in Extension Study|0
914577|NCT01033942|3013735|P3|Overall Study|Lost to Follow-up|0
914578|NCT01033942|3013736|P2|Overall Study|Lost to Follow-up|0
914579|NCT01033942|3013737|P1|Overall Study|Lost to Follow-up|1
914580|NCT01033942|3013735|P3|Overall Study|Withdrawal by Subject|1
914581|NCT01033942|3013736|P2|Overall Study|Withdrawal by Subject|1
914582|NCT01033942|3013737|P1|Overall Study|Withdrawal by Subject|1
914583|NCT01033851|3014035|P2|Overall Study|Withdrawal by Subject|7
914584|NCT01033851|3014036|P1|Overall Study|Withdrawal by Subject|3
914585|NCT01033825|3014051|P7|Overall Study|Other|0
914586|NCT01033825|3014052|P6|Overall Study|Other|0
914587|NCT01033825|3014053|P5|Overall Study|Other|1
914588|NCT01033825|3014054|P4|Overall Study|Other|0
914589|NCT01033825|3014055|P3|Overall Study|Other|0
914590|NCT01033825|3014056|P2|Overall Study|Other|0
914591|NCT01033825|3014057|P1|Overall Study|Other|0
914592|NCT01033825|3014051|P7|Overall Study|Protocol Violation|0
914593|NCT01033825|3014052|P6|Overall Study|Protocol Violation|0
914594|NCT01033825|3014053|P5|Overall Study|Protocol Violation|0
914595|NCT01033825|3014054|P4|Overall Study|Protocol Violation|0
914596|NCT01033825|3014055|P3|Overall Study|Protocol Violation|0
914597|NCT01033825|3014056|P2|Overall Study|Protocol Violation|0
914598|NCT01033825|3014057|P1|Overall Study|Protocol Violation|1
914599|NCT01033825|3014051|P7|Overall Study|Adverse Event|0
914600|NCT01033825|3014052|P6|Overall Study|Adverse Event|0
914601|NCT01033825|3014053|P5|Overall Study|Adverse Event|0
914602|NCT01033825|3014054|P4|Overall Study|Adverse Event|1
914603|NCT01033825|3014055|P3|Overall Study|Adverse Event|0
914604|NCT01033825|3014056|P2|Overall Study|Adverse Event|0
914605|NCT01033825|3014057|P1|Overall Study|Adverse Event|0
914606|NCT01033825|3014051|P7|Overall Study|Withdrawal by Subject|0
914607|NCT01033825|3014052|P6|Overall Study|Withdrawal by Subject|0
914608|NCT01033825|3014053|P5|Overall Study|Withdrawal by Subject|1
914609|NCT01033825|3014054|P4|Overall Study|Withdrawal by Subject|1
914610|NCT01033825|3014055|P3|Overall Study|Withdrawal by Subject|2
914611|NCT01033825|3014056|P2|Overall Study|Withdrawal by Subject|3
914612|NCT01033825|3014057|P1|Overall Study|Withdrawal by Subject|2
914613|NCT01033747|3014278|P2|Overall Study|Stopped at end of Extension 1|0
914614|NCT01033747|3014279|P1|Overall Study|Stopped at end of Extension 1|2
914615|NCT01033747|3014278|P2|Overall Study|Stopped at end of prolongation visit 1|0
914616|NCT01033747|3014279|P1|Overall Study|Stopped at end of prolongation visit 1|1
914617|NCT01033747|3014278|P2|Overall Study|Withdrawal by Subject|6
914618|NCT01033747|3014279|P1|Overall Study|Withdrawal by Subject|9
914619|NCT01033747|3014278|P2|Overall Study|Protocol Violation|0
914620|NCT01033747|3014279|P1|Overall Study|Protocol Violation|1
914621|NCT01033747|3014278|P2|Overall Study|Unsatisfactory therapeutic effect|4
914622|NCT01033747|3014279|P1|Overall Study|Unsatisfactory therapeutic effect|14
914623|NCT01033747|3014278|P2|Overall Study|Abnormal test procedure|1
914624|NCT01033747|3014279|P1|Overall Study|Abnormal test procedure|0
914625|NCT01033747|3014278|P2|Overall Study|Abnormal Laboratory Value|0
914626|NCT01033747|3014279|P1|Overall Study|Abnormal Laboratory Value|1
914627|NCT01033747|3014278|P2|Overall Study|Adverse Event|4
914628|NCT01033747|3014279|P1|Overall Study|Adverse Event|9
914629|NCT01033734|3014287|P1|Overall Study|Withdrawal by Subject|1
914630|NCT01033487|3014343|P10|Fourth Intervention Period|Adverse Event|0
914631|NCT01033487|3014344|P9|Fourth Intervention Period|Adverse Event|1
914632|NCT01033487|3014345|P8|Fourth Intervention Period|Adverse Event|0
914633|NCT01033487|3014346|P7|Fourth Intervention Period|Adverse Event|0
914634|NCT01033487|3014347|P6|Fourth Intervention Period|Adverse Event|0
914635|NCT01033487|3014348|P5|Fourth Intervention Period|Adverse Event|0
914636|NCT01033487|3014349|P4|Fourth Intervention Period|Adverse Event|0
914637|NCT01033487|3014350|P3|Fourth Intervention Period|Adverse Event|0
914638|NCT01033487|3014351|P2|Fourth Intervention Period|Adverse Event|0
914639|NCT01033487|3014352|P1|Fourth Intervention Period|Adverse Event|0
914640|NCT01033448|3014406|P1|Overall Study|Unknown disposition|1
914641|NCT01033448|3014406|P1|Overall Study|Withdrew due to other reasons|3
914642|NCT01033448|3014406|P1|Overall Study|Lost to Follow-up|3
914643|NCT01033448|3014406|P1|Overall Study|Positive HCV-RNA at week 48|1
914644|NCT01033448|3014406|P1|Overall Study|Withdrawal by Subject|4
914645|NCT01033136|3014452|P2|Follow-Up (3 Month)|Lost to Follow-up|2
914646|NCT01033136|3014453|P1|Follow-Up (3 Month)|Lost to Follow-up|2
914647|NCT01033071|3014464|P3|Overall Study|Other|3
914648|NCT01033071|3014465|P2|Overall Study|Other|4
914649|NCT01033071|3014466|P1|Overall Study|Other|6
914650|NCT01033071|3014464|P3|Overall Study|Lack of Efficacy|1
914651|NCT01033071|3014465|P2|Overall Study|Lack of Efficacy|1
914652|NCT01033071|3014466|P1|Overall Study|Lack of Efficacy|0
914653|NCT01033071|3014464|P3|Overall Study|Withdrawal by Subject|11
914654|NCT01033071|3014465|P2|Overall Study|Withdrawal by Subject|14
914655|NCT01033071|3014466|P1|Overall Study|Withdrawal by Subject|17
914656|NCT01033071|3014464|P3|Overall Study|Lost to Follow-up|5
914657|NCT01033071|3014465|P2|Overall Study|Lost to Follow-up|5
914658|NCT01033071|3014466|P1|Overall Study|Lost to Follow-up|4
914659|NCT01033071|3014464|P3|Overall Study|Protocol Violation|1
914660|NCT01033071|3014465|P2|Overall Study|Protocol Violation|2
914661|NCT01033071|3014466|P1|Overall Study|Protocol Violation|0
914662|NCT01033071|3014464|P3|Overall Study|Adverse Event|26
914663|NCT01033071|3014465|P2|Overall Study|Adverse Event|51
914664|NCT01033071|3014466|P1|Overall Study|Adverse Event|28
914665|NCT01033019|3014537|P2|Overall Study|Withdrawal by Subject|0
914666|NCT01033019|3014538|P1|Overall Study|Withdrawal by Subject|1
914667|NCT01032915|3014576|P4|Overall Study|Protocol Violation|1
914668|NCT01032915|3014577|P3|Overall Study|Protocol Violation|0
914669|NCT01032915|3014578|P2|Overall Study|Protocol Violation|0
914670|NCT01032915|3014579|P1|Overall Study|Protocol Violation|1
914671|NCT01032915|3014576|P4|Overall Study|Administrative reasons|4
914672|NCT01032915|3014577|P3|Overall Study|Administrative reasons|4
914673|NCT01032915|3014578|P2|Overall Study|Administrative reasons|6
914674|NCT01032915|3014579|P1|Overall Study|Administrative reasons|5
914675|NCT01032915|3014576|P4|Overall Study|Withdrawal by Subject|1
914676|NCT01032915|3014577|P3|Overall Study|Withdrawal by Subject|1
914677|NCT01032915|3014578|P2|Overall Study|Withdrawal by Subject|3
914678|NCT01032915|3014579|P1|Overall Study|Withdrawal by Subject|0
914679|NCT01032915|3014576|P4|Overall Study|Abnormal test procedure result|0
914680|NCT01032915|3014577|P3|Overall Study|Abnormal test procedure result|1
914681|NCT01032915|3014578|P2|Overall Study|Abnormal test procedure result|0
914682|NCT01032915|3014579|P1|Overall Study|Abnormal test procedure result|0
914683|NCT01032915|3014576|P4|Overall Study|Adverse Event|1
914684|NCT01032915|3014577|P3|Overall Study|Adverse Event|1
914685|NCT01032915|3014578|P2|Overall Study|Adverse Event|2
914686|NCT01032915|3014579|P1|Overall Study|Adverse Event|2
914687|NCT01032889|3014604|P3|Overall Study|Miscellaneous Reasons|1
914688|NCT01032889|3014605|P2|Overall Study|Miscellaneous Reasons|1
914689|NCT01032889|3014606|P1|Overall Study|Miscellaneous Reasons|2
914690|NCT01032889|3014604|P3|Overall Study|Lack of Submental Fat|1
914691|NCT01032889|3014605|P2|Overall Study|Lack of Submental Fat|8
914692|NCT01032889|3014606|P1|Overall Study|Lack of Submental Fat|2
914693|NCT01032889|3014604|P3|Overall Study|Lost to Follow-up|0
914694|NCT01032889|3014605|P2|Overall Study|Lost to Follow-up|1
914695|NCT01032889|3014606|P1|Overall Study|Lost to Follow-up|1
914696|NCT01032889|3014604|P3|Overall Study|Patient Request|0
914697|NCT01032889|3014605|P2|Overall Study|Patient Request|1
914698|NCT01032889|3014606|P1|Overall Study|Patient Request|0
914699|NCT01032889|3014604|P3|Overall Study|Withdrawal of Consent|1
914700|NCT01032889|3014605|P2|Overall Study|Withdrawal of Consent|2
914701|NCT01032889|3014606|P1|Overall Study|Withdrawal of Consent|1
914702|NCT01032889|3014604|P3|Overall Study|Adverse Event|0
914703|NCT01032889|3014605|P2|Overall Study|Adverse Event|2
914704|NCT01032889|3014606|P1|Overall Study|Adverse Event|2
914705|NCT01032837|3014637|P4|Overall Study|Refused treatment|1
914706|NCT01032837|3014638|P3|Overall Study|Refused treatment|0
914707|NCT01032837|3014639|P2|Overall Study|Refused treatment|0
914708|NCT01032837|3014640|P1|Overall Study|Refused treatment|0
914709|NCT01032837|3014637|P4|Overall Study|Failed to return|0
914710|NCT01032837|3014638|P3|Overall Study|Failed to return|1
914711|NCT01032837|3014639|P2|Overall Study|Failed to return|0
914712|NCT01032837|3014640|P1|Overall Study|Failed to return|0
914713|NCT01032837|3014637|P4|Overall Study|Withdrew consent|1
914714|NCT01032837|3014638|P3|Overall Study|Withdrew consent|0
914715|NCT01032837|3014639|P2|Overall Study|Withdrew consent|2
914716|NCT01032837|3014640|P1|Overall Study|Withdrew consent|0
914717|NCT01032837|3014637|P4|Overall Study|Adverse event/internal illness|1
914718|NCT01032837|3014638|P3|Overall Study|Adverse event/internal illness|0
914719|NCT01032837|3014639|P2|Overall Study|Adverse event/internal illness|1
914720|NCT01032837|3014640|P1|Overall Study|Adverse event/internal illness|0
914721|NCT01032382|3014745|P2|Overall Study|Index lesion relapse|3
914722|NCT01032382|3014746|P1|Overall Study|Index lesion relapse|1
914723|NCT01032382|3014745|P2|Overall Study|Treatment failure|1
914724|NCT01032382|3014746|P1|Overall Study|Treatment failure|3
914725|NCT01032382|3014745|P2|Overall Study|Disease dissemination|1
914726|NCT01032382|3014746|P1|Overall Study|Disease dissemination|1
914727|NCT01032291|3014775|P3|Proof of Concept|Never Received Study Drug|0
914728|NCT01032291|3014776|P2|Proof of Concept|Never Received Study Drug|1
914729|NCT01032291|3014777|P1|Proof of Concept|Never Received Study Drug|0
914730|NCT01032291|3014775|P3|Proof of Concept|Lack of Efficacy|0
914731|NCT01032291|3014776|P2|Proof of Concept|Lack of Efficacy|1
914732|NCT01032291|3014777|P1|Proof of Concept|Lack of Efficacy|0
914733|NCT01032291|3014775|P3|Proof of Concept|Death|2
914734|NCT01032291|3014776|P2|Proof of Concept|Death|1
914735|NCT01032291|3014777|P1|Proof of Concept|Death|0
914736|NCT01032291|3014775|P3|Proof of Concept|Adverse Event|1
914737|NCT01032291|3014776|P2|Proof of Concept|Adverse Event|5
914738|NCT01032291|3014777|P1|Proof of Concept|Adverse Event|0
914739|NCT01032291|3014775|P3|Safety Lead-in|Death|0
914740|NCT01032291|3014776|P2|Safety Lead-in|Death|0
914741|NCT01032291|3014777|P1|Safety Lead-in|Death|1
914742|NCT01032291|3014775|P3|Safety Lead-in|Adverse Event|0
914743|NCT01032291|3014776|P2|Safety Lead-in|Adverse Event|0
914744|NCT01032291|3014777|P1|Safety Lead-in|Adverse Event|1
914745|NCT01032239|3014824|P2|Overall Study|Protocol Violation|0
914746|NCT01032239|3014825|P1|Overall Study|Protocol Violation|1
914747|NCT01032239|3014824|P2|Overall Study|Death|0
914748|NCT01032239|3014825|P1|Overall Study|Death|1
914749|NCT01032239|3014824|P2|Overall Study|Withdrawal by Subject|3
914750|NCT01032239|3014825|P1|Overall Study|Withdrawal by Subject|2
914751|NCT01032239|3014824|P2|Overall Study|Lost to Follow-up|2
914752|NCT01032239|3014825|P1|Overall Study|Lost to Follow-up|3
914753|NCT01032200|3014855|P2|Overall Study|Multiple|1
914754|NCT01032200|3014856|P1|Overall Study|Multiple|1
914755|NCT01032200|3014855|P2|Overall Study|Progression|0
914756|NCT01032200|3014856|P1|Overall Study|Progression|1
914757|NCT01032200|3014855|P2|Overall Study|Toxicity|2
914758|NCT01032200|3014856|P1|Overall Study|Toxicity|0
914759|NCT01032200|3014855|P2|Overall Study|Withdrawal by Subject|3
914760|NCT01032200|3014856|P1|Overall Study|Withdrawal by Subject|1
914761|NCT01032200|3014855|P2|Overall Study|Death|1
914762|NCT01032200|3014856|P1|Overall Study|Death|1
914763|NCT01032174|3014872|P2|Overall Study|Adverse Event|1
914764|NCT01032174|3014873|P1|Overall Study|Adverse Event|0
914765|NCT01032070|3015113|P2|Overall Study|Withdrawal by Subject|2
914766|NCT01032070|3015114|P1|Overall Study|Withdrawal by Subject|0
914767|NCT01032070|3015113|P2|Overall Study|Medical or ethical reasons|2
914768|NCT01032070|3015114|P1|Overall Study|Medical or ethical reasons|0
914769|NCT01032070|3015113|P2|Overall Study|Disease progression|8
914770|NCT01032070|3015114|P1|Overall Study|Disease progression|13
914771|NCT01032044|3015143|P2|Overall Study|Lost to Follow-up|11
914772|NCT01032044|3015144|P1|Overall Study|Lost to Follow-up|11
914773|NCT01032044|3015143|P2|Overall Study|Adverse Event|1
914774|NCT01032044|3015144|P1|Overall Study|Adverse Event|0
914775|NCT01032044|3015143|P2|Overall Study|Protocol Violation|8
914776|NCT01032044|3015144|P1|Overall Study|Protocol Violation|14
914777|NCT01032018|3015152|P2|Overall Study|Death|1
914778|NCT01032018|3015153|P1|Overall Study|Death|0
914779|NCT01032018|3015152|P2|Overall Study|Lost to Follow-up|5
914780|NCT01032018|3015153|P1|Overall Study|Lost to Follow-up|6
914781|NCT01031979|3015163|P2|Overall Study|Lost to Follow-up|4
914782|NCT01031979|3015164|P1|Overall Study|Lost to Follow-up|5
914783|NCT01031836|3015197|P6|Stage II|Other|0
914784|NCT01031836|3015198|P5|Stage II|Other|1
914785|NCT01031836|3015199|P4|Stage II|Other|1
914786|NCT01031836|3015200|P3|Stage II|Other|0
914787|NCT01031836|3015201|P2|Stage II|Other|0
914788|NCT01031836|3015202|P1|Stage II|Other|2
914789|NCT01031836|3015197|P6|Stage II|Adverse Event|1
914790|NCT01031836|3015198|P5|Stage II|Adverse Event|1
914791|NCT01031836|3015199|P4|Stage II|Adverse Event|2
914792|NCT01031836|3015200|P3|Stage II|Adverse Event|2
914793|NCT01031836|3015201|P2|Stage II|Adverse Event|0
914794|NCT01031836|3015202|P1|Stage II|Adverse Event|0
914795|NCT01031836|3015197|P6|Stage I|Other|1
914796|NCT01031836|3015198|P5|Stage I|Other|0
914797|NCT01031836|3015199|P4|Stage I|Other|0
914798|NCT01031836|3015200|P3|Stage I|Other|0
914799|NCT01031836|3015201|P2|Stage I|Other|1
914800|NCT01031836|3015202|P1|Stage I|Other|0
914801|NCT01031836|3015197|P6|Stage I|Adverse Event|0
914802|NCT01031836|3015198|P5|Stage I|Adverse Event|0
914803|NCT01031836|3015199|P4|Stage I|Adverse Event|0
914804|NCT01031836|3015200|P3|Stage I|Adverse Event|0
914805|NCT01031836|3015201|P2|Stage I|Adverse Event|1
914806|NCT01031836|3015202|P1|Stage I|Adverse Event|1
914807|NCT01031706|3015263|P2|Overall Study|Withdrawal by Subject|1
914808|NCT01031706|3015264|P1|Overall Study|Withdrawal by Subject|1
914809|NCT01031706|3015263|P2|Overall Study|Adverse Event|0
914810|NCT01031706|3015264|P1|Overall Study|Adverse Event|1
914811|NCT01031680|3015274|P2|Overall Study|Various|2
914812|NCT01031680|3015275|P1|Overall Study|Various|0
914813|NCT01031680|3015274|P2|Overall Study|Administrative Reason by Sponsor|1
914814|NCT01031680|3015275|P1|Overall Study|Administrative Reason by Sponsor|0
914815|NCT01031680|3015274|P2|Overall Study|Incorrect Enrolment|2
914816|NCT01031680|3015275|P1|Overall Study|Incorrect Enrolment|1
914817|NCT01031680|3015274|P2|Overall Study|Safety|0
914818|NCT01031680|3015275|P1|Overall Study|Safety|1
914819|NCT01031680|3015274|P2|Overall Study|Poor/Non-compliance|6
914820|NCT01031680|3015275|P1|Overall Study|Poor/Non-compliance|5
914821|NCT01031680|3015274|P2|Overall Study|Subject No Longer Meets Study Criteria|17
914822|NCT01031680|3015275|P1|Overall Study|Subject No Longer Meets Study Criteria|26
914823|NCT01031680|3015274|P2|Overall Study|Death|1
914824|NCT01031680|3015275|P1|Overall Study|Death|2
914825|NCT01031680|3015274|P2|Overall Study|Withdrawal by Subject|16
914826|NCT01031680|3015275|P1|Overall Study|Withdrawal by Subject|12
914827|NCT01031680|3015274|P2|Overall Study|Lost to Follow-up|10
914828|NCT01031680|3015275|P1|Overall Study|Lost to Follow-up|2
914829|NCT01031680|3015274|P2|Overall Study|Adverse Event|3
914830|NCT01031680|3015275|P1|Overall Study|Adverse Event|8
914831|NCT01031628|3015295|P4|Overall Study|Study terminated early|0
914832|NCT01031628|3015296|P3|Overall Study|Study terminated early|3
914833|NCT01031628|3015297|P2|Overall Study|Study terminated early|1
914834|NCT01031628|3015298|P1|Overall Study|Study terminated early|0
914835|NCT01031537|3015323|P1|Overall Study|PI removal, no longer met eligibility|12
914836|NCT01031537|3015323|P1|Overall Study|Withdrawal by Subject|5
914837|NCT01031537|3015323|P1|Overall Study|moved, met exclusion criteria|10
914838|NCT01031537|3015323|P1|Overall Study|retired from NIH, met exclusion criteria|1
914839|NCT01031537|3015323|P1|Overall Study|Lack of Efficacy|1
914840|NCT01031537|3015323|P1|Overall Study|medical reasons not related to study|3
914841|NCT01031446|3015341|P1|Overall Study|Still on treatment|1
914842|NCT01031446|3015341|P1|Overall Study|Withdrawal by Subject|3
914843|NCT01031446|3015341|P1|Overall Study|Physician Decision|4
914844|NCT01031446|3015341|P1|Overall Study|Adverse Event|9
914845|NCT01031446|3015341|P1|Overall Study|Disease Progression|38
914846|NCT01031381|3015350|P1|Overall Study|Withdrawal by Subject|6
914847|NCT01031381|3015350|P1|Overall Study|Physician Decision|3
914848|NCT01031004|3015381|P2|Overall Study|Lost to Follow-up|0
914849|NCT01031004|3015382|P1|Overall Study|Lost to Follow-up|1
914850|NCT01031004|3015381|P2|Overall Study|Protocol Violation|1
914851|NCT01031004|3015382|P1|Overall Study|Protocol Violation|0
914852|NCT01030965|3015426|P4|Overall Study|Withdrawal by Subject|2
914853|NCT01030965|3015427|P3|Overall Study|Withdrawal by Subject|0
914854|NCT01030965|3015428|P2|Overall Study|Withdrawal by Subject|1
914855|NCT01030965|3015429|P1|Overall Study|Withdrawal by Subject|0
914856|NCT01030965|3015426|P4|Overall Study|Protocol-defined Stopping Criteria|0
914857|NCT01030965|3015427|P3|Overall Study|Protocol-defined Stopping Criteria|1
914858|NCT01030965|3015428|P2|Overall Study|Protocol-defined Stopping Criteria|1
914859|NCT01030965|3015429|P1|Overall Study|Protocol-defined Stopping Criteria|0
914860|NCT01030965|3015426|P4|Overall Study|Adverse Event|1
914861|NCT01030965|3015427|P3|Overall Study|Adverse Event|2
914862|NCT01030965|3015428|P2|Overall Study|Adverse Event|1
914863|NCT01030965|3015429|P1|Overall Study|Adverse Event|0
914864|NCT01030965|3015426|P4|Overall Study|Protocol Violation|1
914865|NCT01030965|3015427|P3|Overall Study|Protocol Violation|1
914866|NCT01030965|3015428|P2|Overall Study|Protocol Violation|1
914867|NCT01030965|3015429|P1|Overall Study|Protocol Violation|1
914868|NCT01030965|3015426|P4|Overall Study|Lack of Efficacy|3
914869|NCT01030965|3015427|P3|Overall Study|Lack of Efficacy|0
914870|NCT01030965|3015428|P2|Overall Study|Lack of Efficacy|2
914871|NCT01030965|3015429|P1|Overall Study|Lack of Efficacy|3
914872|NCT01030952|3015449|P2|Overall Study|Unexplained|1
914873|NCT01030952|3015450|P1|Overall Study|Unexplained|1
914874|NCT01030952|3015449|P2|Overall Study|Lost to Follow-up|1
914875|NCT01030952|3015450|P1|Overall Study|Lost to Follow-up|0
914876|NCT01030952|3015449|P2|Overall Study|Informed consent withdrawal|0
914877|NCT01030952|3015450|P1|Overall Study|Informed consent withdrawal|1
914878|NCT01030952|3015449|P2|Overall Study|Protocol Violation|1
914879|NCT01030952|3015450|P1|Overall Study|Protocol Violation|0
914880|NCT01030822|3015487|P3|Overall Study|Lost to Follow-up|7
914881|NCT01030822|3015488|P2|Overall Study|Lost to Follow-up|4
914882|NCT01030822|3015489|P1|Overall Study|Lost to Follow-up|9
914883|NCT01030822|3015487|P3|Overall Study|Withdrawal by Subject|16
914884|NCT01030822|3015488|P2|Overall Study|Withdrawal by Subject|13
914885|NCT01030822|3015489|P1|Overall Study|Withdrawal by Subject|16
914886|NCT01030822|3015487|P3|Overall Study|Moved/migrated from study area|3
914887|NCT01030822|3015488|P2|Overall Study|Moved/migrated from study area|7
914888|NCT01030822|3015489|P1|Overall Study|Moved/migrated from study area|6
914889|NCT01030718|3015544|P3|Study CA180-036 Only|Other Reasons|0
914890|NCT01030718|3015545|P2|Study CA180-036 Only|Other Reasons|2
914891|NCT01030718|3015546|P1|Study CA180-036 Only|Other Reasons|0
914892|NCT01030718|3015544|P3|Study CA180-036 Only|Death|0
914893|NCT01030718|3015545|P2|Study CA180-036 Only|Death|1
914894|NCT01030718|3015546|P1|Study CA180-036 Only|Death|0
914895|NCT01030718|3015544|P3|Study CA180-036 Only|Adverse Event|0
914896|NCT01030718|3015545|P2|Study CA180-036 Only|Adverse Event|3
914897|NCT01030718|3015546|P1|Study CA180-036 Only|Adverse Event|2
914898|NCT01030718|3015544|P3|Study CA180-036 Only|insufficient effect|5
914899|NCT01030718|3015545|P2|Study CA180-036 Only|insufficient effect|1
914900|NCT01030718|3015546|P1|Study CA180-036 Only|insufficient effect|1
914901|NCT01030718|3015544|P3|Studies CA180-031 and -036 Combined|other reasons|0
914902|NCT01030718|3015545|P2|Studies CA180-031 and -036 Combined|other reasons|2
914903|NCT01030718|3015546|P1|Studies CA180-031 and -036 Combined|other reasons|0
914904|NCT01030718|3015544|P3|Studies CA180-031 and -036 Combined|Death|0
914905|NCT01030718|3015545|P2|Studies CA180-031 and -036 Combined|Death|1
914906|NCT01030718|3015546|P1|Studies CA180-031 and -036 Combined|Death|0
914907|NCT01030718|3015544|P3|Studies CA180-031 and -036 Combined|Adverse Event|1
914908|NCT01030718|3015545|P2|Studies CA180-031 and -036 Combined|Adverse Event|5
914909|NCT01030718|3015546|P1|Studies CA180-031 and -036 Combined|Adverse Event|3
914910|NCT01030718|3015544|P3|Studies CA180-031 and -036 Combined|Insufficient effect|11
914911|NCT01030718|3015545|P2|Studies CA180-031 and -036 Combined|Insufficient effect|1
914912|NCT01030718|3015546|P1|Studies CA180-031 and -036 Combined|Insufficient effect|1
914913|NCT01030666|3015607|P2|Overall Study|Lost to Follow-up|2
914914|NCT01030666|3015608|P1|Overall Study|Lost to Follow-up|3
914915|NCT01030536|3015633|P5|Overall Study|Death|0
914916|NCT01030536|3015634|P4|Overall Study|Death|0
914917|NCT01030536|3015635|P3|Overall Study|Death|0
914918|NCT01030536|3015636|P2|Overall Study|Death|1
914919|NCT01030536|3015637|P1|Overall Study|Death|0
914920|NCT01030536|3015633|P5|Overall Study|Progressive disease|0
914921|NCT01030536|3015634|P4|Overall Study|Progressive disease|2
914922|NCT01030536|3015635|P3|Overall Study|Progressive disease|3
914923|NCT01030536|3015636|P2|Overall Study|Progressive disease|2
914924|NCT01030536|3015637|P1|Overall Study|Progressive disease|6
914925|NCT01030536|3015633|P5|Overall Study|Adverse Event|1
914926|NCT01030536|3015634|P4|Overall Study|Adverse Event|0
914927|NCT01030536|3015635|P3|Overall Study|Adverse Event|1
914928|NCT01030536|3015636|P2|Overall Study|Adverse Event|3
914929|NCT01030536|3015637|P1|Overall Study|Adverse Event|0
914930|NCT01030536|3015633|P5|Overall Study|undefined|0
914931|NCT01030536|3015634|P4|Overall Study|undefined|1
914932|NCT01030536|3015635|P3|Overall Study|undefined|1
914933|NCT01030536|3015636|P2|Overall Study|undefined|0
914934|NCT01030536|3015637|P1|Overall Study|undefined|1
914935|NCT01030536|3015633|P5|Overall Study|Withdrawal by Subject|0
914936|NCT01030536|3015634|P4|Overall Study|Withdrawal by Subject|0
914937|NCT01030536|3015635|P3|Overall Study|Withdrawal by Subject|1
914938|NCT01030536|3015636|P2|Overall Study|Withdrawal by Subject|0
914939|NCT01030536|3015637|P1|Overall Study|Withdrawal by Subject|0
914940|NCT01030458|3015742|P2|Overall Study|Side effect of medication|1
914941|NCT01030458|3015743|P1|Overall Study|Side effect of medication|1
914942|NCT01030458|3015742|P2|Overall Study|Moved or changed job|13
914943|NCT01030458|3015743|P1|Overall Study|Moved or changed job|6
914944|NCT01030458|3015742|P2|Overall Study|Logistical reasons|5
914945|NCT01030458|3015743|P1|Overall Study|Logistical reasons|9
914946|NCT01030458|3015742|P2|Overall Study|Withdrawal by Subject|3
914947|NCT01030458|3015743|P1|Overall Study|Withdrawal by Subject|2
914948|NCT01030458|3015742|P2|Overall Study|Lost to Follow-up|10
914949|NCT01030458|3015743|P1|Overall Study|Lost to Follow-up|9
914950|NCT01030341|3015776|P1|Overall Study|Lost to Follow-up|2
914951|NCT01030341|3015776|P1|Overall Study|Withdrawal by Subject|1
914952|NCT01030133|3015799|P2|Overall Study|failed to experience pain at level 7/10|2
914953|NCT01030133|3015800|P1|Overall Study|failed to experience pain at level 7/10|2
914954|NCT01029925|3015812|P1|Completion of Cycle 2 (56 Days)|off study due to disease progression|1
914955|NCT01029925|3015812|P1|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2
914956|NCT01029925|3015812|P1|Completion of Cycle 1 (28 Days)|Death|2
914957|NCT01029886|3015831|P2|Overall Study|Loss Glucose Control|1
914958|NCT01029886|3015832|P1|Overall Study|Loss Glucose Control|7
914959|NCT01029886|3015831|P2|Overall Study|Sponsor Decision|0
914960|NCT01029886|3015832|P1|Overall Study|Sponsor Decision|1
914961|NCT01029886|3015831|P2|Overall Study|Entry Criteria Not Met|5
914962|NCT01029886|3015832|P1|Overall Study|Entry Criteria Not Met|13
914963|NCT01029886|3015831|P2|Overall Study|Withdrawal by Subject|18
914964|NCT01029886|3015832|P1|Overall Study|Withdrawal by Subject|8
914965|NCT01029886|3015831|P2|Overall Study|Protocol Violation|5
914966|NCT01029886|3015832|P1|Overall Study|Protocol Violation|17
914967|NCT01029886|3015831|P2|Overall Study|Physician Decision|6
914968|NCT01029886|3015832|P1|Overall Study|Physician Decision|2
914969|NCT01029886|3015831|P2|Overall Study|Lost to Follow-up|0
914970|NCT01029886|3015832|P1|Overall Study|Lost to Follow-up|1
914971|NCT01029886|3015831|P2|Overall Study|Adverse Event|25
914972|NCT01029886|3015832|P1|Overall Study|Adverse Event|12
914973|NCT01029795|3015860|P2|Overall Study|Withdrawal by Subject|3
914974|NCT01029795|3015861|P1|Overall Study|Withdrawal by Subject|1
914975|NCT01029795|3015860|P2|Overall Study|Sponsor Decision|17
914976|NCT01029795|3015861|P1|Overall Study|Sponsor Decision|11
914977|NCT01029795|3015860|P2|Overall Study|Physician Decision|1
914978|NCT01029795|3015861|P1|Overall Study|Physician Decision|2
914979|NCT01029795|3015860|P2|Overall Study|Entry Criteria Not Met|1
914980|NCT01029795|3015861|P1|Overall Study|Entry Criteria Not Met|2
914981|NCT01029782|3015915|P2|Overall Study|Withdrawal by Subject|1
914982|NCT01029782|3015916|P1|Overall Study|Withdrawal by Subject|0
914983|NCT01029782|3015915|P2|Overall Study|Protocol Violation|2
914984|NCT01029782|3015916|P1|Overall Study|Protocol Violation|0
914985|NCT01029782|3015915|P2|Overall Study|Physician Decision|1
914986|NCT01029782|3015916|P1|Overall Study|Physician Decision|0
914987|NCT01029782|3015915|P2|Overall Study|Adverse Event|1
914988|NCT01029782|3015916|P1|Overall Study|Adverse Event|0
914989|NCT01029782|3015915|P2|Overall Study|Diagnosis changed|1
914990|NCT01029782|3015916|P1|Overall Study|Diagnosis changed|1
914991|NCT01029782|3015915|P2|Overall Study|Lost to Follow-up|2
914992|NCT01029782|3015916|P1|Overall Study|Lost to Follow-up|2
914993|NCT01029691|3015968|P3|Continued APAP to Delivery|Death|1
914994|NCT01029691|3015969|P2|Continued APAP to Delivery|Death|0
914995|NCT01029691|3015970|P1|Continued APAP to Delivery|Death|0
914996|NCT01029652|3015995|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1
914997|NCT01029652|3015996|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0
914998|NCT01029652|3015995|P2|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1
914999|NCT01029652|3015996|P1|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0
915000|NCT01029652|3015995|P2|Extension Study 2 (25-72 Weeks)|Death|1
915001|NCT01029652|3015996|P1|Extension Study 2 (25-72 Weeks)|Death|1
915002|NCT01029652|3015995|P2|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1
915003|NCT01029652|3015996|P1|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0
915004|NCT01029652|3015995|P2|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0
915005|NCT01029652|3015996|P1|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1
915006|NCT01029652|3015995|P2|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3
915007|NCT01029652|3015996|P1|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2
915008|NCT01029652|3015995|P2|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1
915009|NCT01029652|3015996|P1|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0
915010|NCT01029652|3015995|P2|Core Study (0-12 Weeks)|Death|1
915011|NCT01029652|3015996|P1|Core Study (0-12 Weeks)|Death|0
915012|NCT01029652|3015995|P2|Core Study (0-12 Weeks)|Administrative problems|1
915013|NCT01029652|3015996|P1|Core Study (0-12 Weeks)|Administrative problems|2
915014|NCT01029652|3015995|P2|Core Study (0-12 Weeks)|Lost to Follow-up|1
915015|NCT01029652|3015996|P1|Core Study (0-12 Weeks)|Lost to Follow-up|3
915016|NCT01029652|3015995|P2|Core Study (0-12 Weeks)|Patient Withdrew Consent|3
915017|NCT01029652|3015996|P1|Core Study (0-12 Weeks)|Patient Withdrew Consent|1
915018|NCT01029652|3015995|P2|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4
915019|NCT01029652|3015996|P1|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0
915020|NCT01029535|3016074|P1|Overall Study|Death|1
915021|NCT01029535|3016074|P1|Overall Study|Use of Another Treatment|1
915022|NCT01029535|3016074|P1|Overall Study|Adverse Event|1
915023|NCT01029535|3016074|P1|Overall Study|Participant Withdrew Consent|2
915024|NCT01029535|3016074|P1|Overall Study|Protocol Violation|2
915025|NCT01029535|3016074|P1|Overall Study|Lost to Follow-up|24
915026|NCT01029405|3016103|P4|Overall Study|Other|1
915027|NCT01029405|3016104|P3|Overall Study|Other|0
915028|NCT01029405|3016105|P2|Overall Study|Other|1
915029|NCT01029405|3016106|P1|Overall Study|Other|0
915030|NCT01029405|3016103|P4|Overall Study|Lost to Follow-up|2
915031|NCT01029405|3016104|P3|Overall Study|Lost to Follow-up|1
915032|NCT01029405|3016105|P2|Overall Study|Lost to Follow-up|1
915033|NCT01029405|3016106|P1|Overall Study|Lost to Follow-up|2
915034|NCT01029405|3016103|P4|Overall Study|Adverse Event|1
915035|NCT01029405|3016104|P3|Overall Study|Adverse Event|1
915036|NCT01029405|3016105|P2|Overall Study|Adverse Event|0
915037|NCT01029405|3016106|P1|Overall Study|Adverse Event|0
915038|NCT01029405|3016103|P4|Overall Study|Protocol Violation|1
915039|NCT01029405|3016104|P3|Overall Study|Protocol Violation|0
915040|NCT01029405|3016105|P2|Overall Study|Protocol Violation|0
915041|NCT01029405|3016106|P1|Overall Study|Protocol Violation|0
915042|NCT01029405|3016103|P4|Overall Study|Withdrawal by Subject|0
915043|NCT01029405|3016104|P3|Overall Study|Withdrawal by Subject|2
915044|NCT01029405|3016105|P2|Overall Study|Withdrawal by Subject|1
915045|NCT01029405|3016106|P1|Overall Study|Withdrawal by Subject|0
915046|NCT01029392|3016118|P2|Overall Study|Physician Decision|0
915047|NCT01029392|3016119|P1|Overall Study|Physician Decision|2
915048|NCT01029392|3016118|P2|Overall Study|Withdrawal by Subject|11
915049|NCT01029392|3016119|P1|Overall Study|Withdrawal by Subject|18
915050|NCT01029366|3016129|P2|Overall Study|manufacturing failure|1
915051|NCT01029366|3016130|P1|Overall Study|manufacturing failure|0
915052|NCT01029366|3016129|P2|Overall Study|disease progression|0
915053|NCT01029366|3016130|P1|Overall Study|disease progression|2
915054|NCT01029366|3016129|P2|Overall Study|Death|1
915055|NCT01029366|3016130|P1|Overall Study|Death|1
915056|NCT01029366|3016129|P2|Overall Study|Withdrawal by Subject|0
915057|NCT01029366|3016130|P1|Overall Study|Withdrawal by Subject|1
915058|NCT01029340|3016142|P6|Extension Period|Physician Decision|1
915059|NCT01029340|3016143|P5|Extension Period|Physician Decision|0
915060|NCT01029340|3016144|P4|Extension Period|Physician Decision|0
915061|NCT01029340|3016145|P3|Extension Period|Physician Decision|0
915062|NCT01029340|3016146|P2|Extension Period|Physician Decision|0
915063|NCT01029340|3016147|P1|Extension Period|Physician Decision|0
915064|NCT01029340|3016142|P6|Extension Period|Withdrawal by Subject|1
915065|NCT01029340|3016143|P5|Extension Period|Withdrawal by Subject|0
915066|NCT01029340|3016144|P4|Extension Period|Withdrawal by Subject|0
915067|NCT01029340|3016145|P3|Extension Period|Withdrawal by Subject|0
915068|NCT01029340|3016146|P2|Extension Period|Withdrawal by Subject|0
915069|NCT01029340|3016147|P1|Extension Period|Withdrawal by Subject|0
915070|NCT01029340|3016142|P6|Extension Period|non-compliance|1
915071|NCT01029340|3016143|P5|Extension Period|non-compliance|0
915072|NCT01029340|3016144|P4|Extension Period|non-compliance|0
915073|NCT01029340|3016145|P3|Extension Period|non-compliance|0
915074|NCT01029340|3016146|P2|Extension Period|non-compliance|0
915075|NCT01029340|3016147|P1|Extension Period|non-compliance|0
915076|NCT01029340|3016142|P6|Extension Period|starting another study|8
915077|NCT01029340|3016143|P5|Extension Period|starting another study|0
915078|NCT01029340|3016144|P4|Extension Period|starting another study|0
915079|NCT01029340|3016145|P3|Extension Period|starting another study|0
915080|NCT01029340|3016146|P2|Extension Period|starting another study|0
915081|NCT01029340|3016147|P1|Extension Period|starting another study|0
915082|NCT01029340|3016142|P6|Extension Period|Adverse Event|1
915083|NCT01029340|3016143|P5|Extension Period|Adverse Event|0
915084|NCT01029340|3016144|P4|Extension Period|Adverse Event|0
915085|NCT01029340|3016145|P3|Extension Period|Adverse Event|0
915086|NCT01029340|3016146|P2|Extension Period|Adverse Event|0
915087|NCT01029340|3016147|P1|Extension Period|Adverse Event|0
915088|NCT01029340|3016142|P6|Part B Treatment Period|Protocol Violation|0
915089|NCT01029340|3016143|P5|Part B Treatment Period|Protocol Violation|0
915090|NCT01029340|3016144|P4|Part B Treatment Period|Protocol Violation|0
915091|NCT01029340|3016145|P3|Part B Treatment Period|Protocol Violation|1
915092|NCT01029340|3016146|P2|Part B Treatment Period|Protocol Violation|0
915093|NCT01029340|3016147|P1|Part B Treatment Period|Protocol Violation|0
915094|NCT01029340|3016142|P6|Part B Treatment Period|Withdrawal by Subject|0
915095|NCT01029340|3016143|P5|Part B Treatment Period|Withdrawal by Subject|0
915096|NCT01029340|3016144|P4|Part B Treatment Period|Withdrawal by Subject|0
915097|NCT01029340|3016145|P3|Part B Treatment Period|Withdrawal by Subject|1
915098|NCT01029340|3016146|P2|Part B Treatment Period|Withdrawal by Subject|0
915099|NCT01029340|3016147|P1|Part B Treatment Period|Withdrawal by Subject|0
915100|NCT01029262|3016178|P2|Overall Study|Other|5
915101|NCT01029262|3016179|P1|Overall Study|Other|1
915102|NCT01029262|3016178|P2|Overall Study|Protocol Violation|3
915103|NCT01029262|3016179|P1|Overall Study|Protocol Violation|2
915104|NCT01029262|3016178|P2|Overall Study|Withdrawal by Subject|16
915105|NCT01029262|3016179|P1|Overall Study|Withdrawal by Subject|10
915106|NCT01029262|3016178|P2|Overall Study|Lack of therapeutic effect|69
915107|NCT01029262|3016179|P1|Overall Study|Lack of therapeutic effect|56
915108|NCT01029262|3016178|P2|Overall Study|Adverse Event|52
915109|NCT01029262|3016179|P1|Overall Study|Adverse Event|9
915110|NCT01028651|3016337|P1|Overall Study|Adverse Event|1
915111|NCT01028651|3016337|P1|Overall Study|Death|2
915112|NCT01028391|3016360|P2|Overall Study|Needed excluded medication|1
915113|NCT01028391|3016361|P1|Overall Study|Needed excluded medication|1
915114|NCT01028391|3016360|P2|Overall Study|Withdrawal by Subject|3
915115|NCT01028391|3016361|P1|Overall Study|Withdrawal by Subject|6
915116|NCT01028391|3016360|P2|Overall Study|Physician Decision|1
915117|NCT01028391|3016361|P1|Overall Study|Physician Decision|0
915118|NCT01028391|3016360|P2|Overall Study|Lost to Follow-up|4
915119|NCT01028391|3016361|P1|Overall Study|Lost to Follow-up|3
915120|NCT01028391|3016360|P2|Overall Study|Lack of Efficacy|2
915121|NCT01028391|3016361|P1|Overall Study|Lack of Efficacy|0
915122|NCT01028391|3016360|P2|Overall Study|Adverse Event|0
915123|NCT01028391|3016361|P1|Overall Study|Adverse Event|4
915124|NCT01028378|3016369|P1|Overall Study|Adminstrative Reasons|4
915125|NCT01028378|3016369|P1|Overall Study|Withdrawal by Subject|1
915126|NCT01028378|3016369|P1|Overall Study|Lost to Follow-up|12
915127|NCT01028352|3016381|P1|Overall Study|Withdrawal by Subject|1
915128|NCT01028352|3016381|P1|Overall Study|Ineligible due to baseline average pain|5
915129|NCT01028300|3016386|P1|Overall Study|Study Terminated|4
915130|NCT01028222|3016395|P2|Overall Study|Adverse Event|0
915131|NCT01028222|3016396|P1|Overall Study|Adverse Event|2
915132|NCT01028222|3016395|P2|Overall Study|Crossover to nilotinib w/out progression|2
915133|NCT01028222|3016396|P1|Overall Study|Crossover to nilotinib w/out progression|0
915134|NCT01028222|3016395|P2|Overall Study|Withdrawal by Subject|0
915135|NCT01028222|3016396|P1|Overall Study|Withdrawal by Subject|1
915136|NCT01028222|3016395|P2|Overall Study|Lost to Follow-up|1
915137|NCT01028222|3016396|P1|Overall Study|Lost to Follow-up|0
915138|NCT01028222|3016395|P2|Overall Study|Administrative problems|1
915139|NCT01028222|3016396|P1|Overall Study|Administrative problems|1
915140|NCT01028222|3016395|P2|Overall Study|Disease progression|9
915141|NCT01028222|3016396|P1|Overall Study|Disease progression|33
915142|NCT01028222|3016395|P2|Overall Study|Protocol deviation|0
915143|NCT01028222|3016396|P1|Overall Study|Protocol deviation|1
915144|NCT01028053|3016438|P1|Overall Study|Various reasons|4
915145|NCT01028053|3016438|P1|Overall Study|Terminated by Sponsor|1
915146|NCT01028053|3016438|P1|Overall Study|Technical Problem|1
915147|NCT01028053|3016438|P1|Overall Study|Physician Decision|2
915148|NCT01028053|3016438|P1|Overall Study|Protocol Violation|1
915149|NCT01028053|3016438|P1|Overall Study|Patient Request|11
915150|NCT01028053|3016438|P1|Overall Study|Screen Failure|113
915151|NCT01028027|3016446|P2|Overall Study|Lack of Efficacy|1
915152|NCT01028027|3016447|P1|Overall Study|Lack of Efficacy|0
915153|NCT01028027|3016446|P2|Overall Study|Protocol Violation|1
915154|NCT01028027|3016447|P1|Overall Study|Protocol Violation|3
915155|NCT01028027|3016446|P2|Overall Study|Adverse Event|7
915156|NCT01028027|3016447|P1|Overall Study|Adverse Event|4
915157|NCT01028027|3016446|P2|Overall Study|Withdrawal by Subject|3
915158|NCT01028027|3016447|P1|Overall Study|Withdrawal by Subject|5
915159|NCT01028027|3016446|P2|Overall Study|Lost to Follow-up|1
915160|NCT01028027|3016447|P1|Overall Study|Lost to Follow-up|4
915161|NCT01028014|3016469|P6|Overall Study|Lost to Follow-up|2
915162|NCT01028014|3016470|P5|Overall Study|Lost to Follow-up|1
915163|NCT01028014|3016471|P4|Overall Study|Lost to Follow-up|1
915164|NCT01028014|3016472|P3|Overall Study|Lost to Follow-up|0
915165|NCT01028014|3016473|P2|Overall Study|Lost to Follow-up|2
915166|NCT01028014|3016474|P1|Overall Study|Lost to Follow-up|1
915167|NCT01027897|3016515|P1|Overall Study|Withdrawal by Subject|1
915168|NCT01027897|3016515|P1|Overall Study|Protocol Violation|1
915169|NCT01027884|3016523|P2|Overall Study|Spinal fixation surgery|3
915170|NCT01027884|3016524|P1|Overall Study|Spinal fixation surgery|0
915171|NCT01027884|3016523|P2|Overall Study|Lost to Follow-up|1
915172|NCT01027884|3016524|P1|Overall Study|Lost to Follow-up|0
915173|NCT01027884|3016523|P2|Overall Study|Withdrawal by Subject|1
915174|NCT01027884|3016524|P1|Overall Study|Withdrawal by Subject|0
915175|NCT01027884|3016523|P2|Overall Study|Non-compliance|1
915176|NCT01027884|3016524|P1|Overall Study|Non-compliance|1
915177|NCT01027884|3016523|P2|Overall Study|Protocol Violation|0
915178|NCT01027884|3016524|P1|Overall Study|Protocol Violation|1
915179|NCT01027884|3016523|P2|Overall Study|Adverse Event|1
915180|NCT01027884|3016524|P1|Overall Study|Adverse Event|2
915181|NCT01027871|3016541|P3|Overall Study|Discontinued Prior to Treatment|1
915182|NCT01027871|3016542|P2|Overall Study|Discontinued Prior to Treatment|0
915183|NCT01027871|3016543|P1|Overall Study|Discontinued Prior to Treatment|0
915184|NCT01027871|3016541|P3|Overall Study|Sponsor Decision|0
915185|NCT01027871|3016542|P2|Overall Study|Sponsor Decision|2
915186|NCT01027871|3016543|P1|Overall Study|Sponsor Decision|0
915187|NCT01027871|3016541|P3|Overall Study|Adverse Event|2
915188|NCT01027871|3016542|P2|Overall Study|Adverse Event|2
915189|NCT01027871|3016543|P1|Overall Study|Adverse Event|0
915190|NCT01027871|3016541|P3|Overall Study|Withdrawal by Subject|2
915191|NCT01027871|3016542|P2|Overall Study|Withdrawal by Subject|2
915192|NCT01027871|3016543|P1|Overall Study|Withdrawal by Subject|1
915193|NCT01027871|3016541|P3|Overall Study|Protocol Violation|2
915194|NCT01027871|3016542|P2|Overall Study|Protocol Violation|2
915195|NCT01027871|3016543|P1|Overall Study|Protocol Violation|0
915196|NCT01027871|3016541|P3|Overall Study|Physician Decision|0
915197|NCT01027871|3016542|P2|Overall Study|Physician Decision|5
915198|NCT01027871|3016543|P1|Overall Study|Physician Decision|1
915199|NCT01027702|3016622|P7|Overall Study|Death|0
915200|NCT01027702|3016623|P6|Overall Study|Death|0
915201|NCT01027702|3016624|P5|Overall Study|Death|0
915202|NCT01027702|3016625|P4|Overall Study|Death|0
915203|NCT01027702|3016626|P3|Overall Study|Death|1
915204|NCT01027702|3016627|P2|Overall Study|Death|0
915205|NCT01027702|3016628|P1|Overall Study|Death|0
915206|NCT01027702|3016622|P7|Overall Study|Received subsequent therapy|1
915207|NCT01027702|3016623|P6|Overall Study|Received subsequent therapy|0
915208|NCT01027702|3016624|P5|Overall Study|Received subsequent therapy|1
915209|NCT01027702|3016625|P4|Overall Study|Received subsequent therapy|4
915210|NCT01027702|3016626|P3|Overall Study|Received subsequent therapy|0
915211|NCT01027702|3016627|P2|Overall Study|Received subsequent therapy|2
915212|NCT01027702|3016628|P1|Overall Study|Received subsequent therapy|1
915213|NCT01027650|3016654|P8|Overall Study|Lack of Efficacy|0
915214|NCT01027650|3016655|P7|Overall Study|Lack of Efficacy|0
915215|NCT01027650|3016656|P6|Overall Study|Lack of Efficacy|1
915216|NCT01027650|3016657|P5|Overall Study|Lack of Efficacy|0
915217|NCT01027650|3016658|P4|Overall Study|Lack of Efficacy|0
915218|NCT01027650|3016659|P3|Overall Study|Lack of Efficacy|0
915219|NCT01027650|3016660|P2|Overall Study|Lack of Efficacy|0
915220|NCT01027650|3016661|P1|Overall Study|Lack of Efficacy|0
915221|NCT01027650|3016654|P8|Overall Study|Lost to Follow-up|0
915222|NCT01027650|3016655|P7|Overall Study|Lost to Follow-up|1
915223|NCT01027650|3016656|P6|Overall Study|Lost to Follow-up|0
915224|NCT01027650|3016657|P5|Overall Study|Lost to Follow-up|0
915225|NCT01027650|3016658|P4|Overall Study|Lost to Follow-up|0
915226|NCT01027650|3016659|P3|Overall Study|Lost to Follow-up|0
915227|NCT01027650|3016660|P2|Overall Study|Lost to Follow-up|0
915228|NCT01027650|3016661|P1|Overall Study|Lost to Follow-up|0
915229|NCT01027650|3016654|P8|Overall Study|Personal Reasons|0
915230|NCT01027650|3016655|P7|Overall Study|Personal Reasons|0
915231|NCT01027650|3016656|P6|Overall Study|Personal Reasons|1
915232|NCT01027650|3016657|P5|Overall Study|Personal Reasons|2
915233|NCT01027650|3016658|P4|Overall Study|Personal Reasons|0
915234|NCT01027650|3016659|P3|Overall Study|Personal Reasons|0
915235|NCT01027650|3016660|P2|Overall Study|Personal Reasons|0
915236|NCT01027650|3016661|P1|Overall Study|Personal Reasons|0
915237|NCT01027416|3016737|P2|Overall Study|Physician Decision|4
915238|NCT01027416|3016738|P1|Overall Study|Physician Decision|1
915239|NCT01027416|3016737|P2|Overall Study|Withdrawal by Subject|1
915240|NCT01027416|3016738|P1|Overall Study|Withdrawal by Subject|0
915241|NCT01027364|3016750|P4|Overall Study|Withdrawal by Subject|0
915242|NCT01027364|3016751|P3|Overall Study|Withdrawal by Subject|0
915243|NCT01027364|3016752|P2|Overall Study|Withdrawal by Subject|2
915244|NCT01027364|3016753|P1|Overall Study|Withdrawal by Subject|1
915245|NCT01027364|3016750|P4|Overall Study|Protocol Violation|1
915246|NCT01027364|3016751|P3|Overall Study|Protocol Violation|0
915247|NCT01027364|3016752|P2|Overall Study|Protocol Violation|0
915248|NCT01027364|3016753|P1|Overall Study|Protocol Violation|1
915249|NCT01027364|3016750|P4|Overall Study|Lost to Follow-up|0
915250|NCT01027364|3016751|P3|Overall Study|Lost to Follow-up|0
915251|NCT01027364|3016752|P2|Overall Study|Lost to Follow-up|0
915252|NCT01027364|3016753|P1|Overall Study|Lost to Follow-up|1
915253|NCT01027364|3016750|P4|Overall Study|Adverse Event|0
915254|NCT01027364|3016751|P3|Overall Study|Adverse Event|1
915255|NCT01027364|3016752|P2|Overall Study|Adverse Event|0
915256|NCT01027364|3016753|P1|Overall Study|Adverse Event|1
915257|NCT01027351|3016848|P6|Overall Study|Protocol Violation|0
915258|NCT01027351|3016849|P5|Overall Study|Protocol Violation|1
915259|NCT01027351|3016850|P4|Overall Study|Protocol Violation|1
915260|NCT01027351|3016851|P3|Overall Study|Protocol Violation|0
915261|NCT01027351|3016852|P2|Overall Study|Protocol Violation|0
915262|NCT01027351|3016853|P1|Overall Study|Protocol Violation|1
915263|NCT01027351|3016848|P6|Overall Study|Inappropriate enrollment|0
915264|NCT01027351|3016849|P5|Overall Study|Inappropriate enrollment|1
915265|NCT01027351|3016850|P4|Overall Study|Inappropriate enrollment|0
915266|NCT01027351|3016851|P3|Overall Study|Inappropriate enrollment|0
915267|NCT01027351|3016852|P2|Overall Study|Inappropriate enrollment|0
915268|NCT01027351|3016853|P1|Overall Study|Inappropriate enrollment|0
915269|NCT01027351|3016848|P6|Overall Study|Lost to Follow-up|0
915270|NCT01027351|3016849|P5|Overall Study|Lost to Follow-up|6
915271|NCT01027351|3016850|P4|Overall Study|Lost to Follow-up|1
915272|NCT01027351|3016851|P3|Overall Study|Lost to Follow-up|0
915273|NCT01027351|3016852|P2|Overall Study|Lost to Follow-up|1
915274|NCT01027351|3016853|P1|Overall Study|Lost to Follow-up|1
915275|NCT01027351|3016848|P6|Overall Study|Withdrawal by Subject|5
915276|NCT01027351|3016849|P5|Overall Study|Withdrawal by Subject|3
915277|NCT01027351|3016850|P4|Overall Study|Withdrawal by Subject|0
915278|NCT01027351|3016851|P3|Overall Study|Withdrawal by Subject|1
915279|NCT01027351|3016852|P2|Overall Study|Withdrawal by Subject|0
915280|NCT01027351|3016853|P1|Overall Study|Withdrawal by Subject|1
915281|NCT01027286|3016937|P2|Overall Study|Lost to Follow-up|1
915282|NCT01027286|3016938|P1|Overall Study|Lost to Follow-up|0
915283|NCT01027286|3016937|P2|Overall Study|Unable to Obtain Required Blood Volume|0
915284|NCT01027286|3016938|P1|Overall Study|Unable to Obtain Required Blood Volume|1
915285|NCT01027273|3016958|P2|Overall Study|Death|2
915286|NCT01027273|3016959|P1|Overall Study|Death|2
915287|NCT01027273|3016958|P2|Overall Study|Lost to Follow-up|31
915288|NCT01027273|3016959|P1|Overall Study|Lost to Follow-up|57
915289|NCT01026974|3017006|P4|Overall Study|Inappropriate enrollment|0
915290|NCT01026974|3017007|P3|Overall Study|Inappropriate enrollment|1
915291|NCT01026974|3017008|P2|Overall Study|Inappropriate enrollment|0
915292|NCT01026974|3017009|P1|Overall Study|Inappropriate enrollment|0
915293|NCT01026974|3017006|P4|Overall Study|Adverse Event|1
915294|NCT01026974|3017007|P3|Overall Study|Adverse Event|0
915295|NCT01026974|3017008|P2|Overall Study|Adverse Event|0
915296|NCT01026974|3017009|P1|Overall Study|Adverse Event|0
915297|NCT01026974|3017006|P4|Overall Study|Lost to Follow-up|0
915298|NCT01026974|3017007|P3|Overall Study|Lost to Follow-up|4
915299|NCT01026974|3017008|P2|Overall Study|Lost to Follow-up|1
915300|NCT01026974|3017009|P1|Overall Study|Lost to Follow-up|1
915301|NCT01026974|3017006|P4|Overall Study|Withdrawal by Subject|2
915302|NCT01026974|3017007|P3|Overall Study|Withdrawal by Subject|7
915303|NCT01026974|3017008|P2|Overall Study|Withdrawal by Subject|1
915304|NCT01026974|3017009|P1|Overall Study|Withdrawal by Subject|0
915305|NCT01026948|3017066|P1|Overall Study|Physician Decision|8
915306|NCT01026831|3017099|P2|Overall Study|Withdrawal by Subject|5
915307|NCT01026831|3017100|P1|Overall Study|Withdrawal by Subject|7
915308|NCT01026831|3017099|P2|Overall Study|Protocol Violation|2
915309|NCT01026831|3017100|P1|Overall Study|Protocol Violation|0
915310|NCT01026831|3017099|P2|Overall Study|Physician Decision|1
915311|NCT01026831|3017100|P1|Overall Study|Physician Decision|1
915312|NCT01026831|3017099|P2|Overall Study|Lost to Follow-up|0
915313|NCT01026831|3017100|P1|Overall Study|Lost to Follow-up|2
915314|NCT01026831|3017099|P2|Overall Study|Adverse Event|3
915315|NCT01026831|3017100|P1|Overall Study|Adverse Event|4
915316|NCT01026818|3017111|P4|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1
915317|NCT01026818|3017112|P3|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
915318|NCT01026818|3017113|P2|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2
915319|NCT01026818|3017114|P1|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
915320|NCT01026818|3017111|P4|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
915321|NCT01026818|3017112|P3|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3
915322|NCT01026818|3017113|P2|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
915323|NCT01026818|3017114|P1|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0
915324|NCT01026818|3017111|P4|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
915325|NCT01026818|3017112|P3|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2
915326|NCT01026818|3017113|P2|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
915327|NCT01026818|3017114|P1|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0
915328|NCT01026818|3017111|P4|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
915329|NCT01026818|3017112|P3|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
915330|NCT01026818|3017113|P2|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1
915331|NCT01026818|3017114|P1|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
915332|NCT01026818|3017111|P4|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
915333|NCT01026818|3017112|P3|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
915334|NCT01026818|3017113|P2|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2
915335|NCT01026818|3017114|P1|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
915336|NCT01026818|3017111|P4|Drug-Free Washout Period (Month 9-10.5)|Death|1
915337|NCT01026818|3017112|P3|Drug-Free Washout Period (Month 9-10.5)|Death|0
915338|NCT01026818|3017113|P2|Drug-Free Washout Period (Month 9-10.5)|Death|0
915339|NCT01026818|3017114|P1|Drug-Free Washout Period (Month 9-10.5)|Death|0
915340|NCT01026818|3017111|P4|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
915341|NCT01026818|3017112|P3|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2
915342|NCT01026818|3017113|P2|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1
915343|NCT01026818|3017114|P1|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
915344|NCT01026818|3017111|P4|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
915345|NCT01026818|3017112|P3|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
915346|NCT01026818|3017113|P2|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1
915347|NCT01026818|3017114|P1|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
915348|NCT01026818|3017111|P4|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
915349|NCT01026818|3017112|P3|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
915350|NCT01026818|3017113|P2|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
915351|NCT01026818|3017114|P1|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
915352|NCT01026818|3017111|P4|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2
915353|NCT01026818|3017112|P3|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
915354|NCT01026818|3017113|P2|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1
915355|NCT01026818|3017114|P1|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
915356|NCT01026818|3017111|P4|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
915357|NCT01026818|3017112|P3|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
915358|NCT01026818|3017113|P2|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1
915359|NCT01026818|3017114|P1|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
915360|NCT01026818|3017111|P4|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
915361|NCT01026818|3017112|P3|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1
915362|NCT01026818|3017113|P2|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
915363|NCT01026818|3017114|P1|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0
915364|NCT01026818|3017111|P4|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
915365|NCT01026818|3017112|P3|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1
915366|NCT01026818|3017113|P2|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
915367|NCT01026818|3017114|P1|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0
915368|NCT01026818|3017111|P4|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2
915369|NCT01026818|3017112|P3|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1
915370|NCT01026818|3017113|P2|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
915371|NCT01026818|3017114|P1|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
915372|NCT01026818|3017111|P4|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7
915373|NCT01026818|3017112|P3|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9
915374|NCT01026818|3017113|P2|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2
915375|NCT01026818|3017114|P1|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0
915376|NCT01026818|3017111|P4|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4
915377|NCT01026818|3017112|P3|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
915378|NCT01026818|3017113|P2|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3
915379|NCT01026818|3017114|P1|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
915380|NCT01026818|3017111|P4|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6
915381|NCT01026818|3017112|P3|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2
915382|NCT01026818|3017113|P2|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3
915383|NCT01026818|3017114|P1|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0
915384|NCT01026818|3017111|P4|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
915385|NCT01026818|3017112|P3|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
915386|NCT01026818|3017113|P2|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7
915387|NCT01026818|3017114|P1|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0
915388|NCT01026818|3017111|P4|DB Treatment Period (Month 0 - 9)|Adverse Event|4
915389|NCT01026818|3017112|P3|DB Treatment Period (Month 0 - 9)|Adverse Event|6
915390|NCT01026818|3017113|P2|DB Treatment Period (Month 0 - 9)|Adverse Event|10
915391|NCT01026818|3017114|P1|DB Treatment Period (Month 0 - 9)|Adverse Event|0
915392|NCT01026818|3017111|P4|Screening Period|Physician Decision|0
915393|NCT01026818|3017112|P3|Screening Period|Physician Decision|0
915394|NCT01026818|3017113|P2|Screening Period|Physician Decision|0
915395|NCT01026818|3017114|P1|Screening Period|Physician Decision|1
915396|NCT01026818|3017111|P4|Screening Period|Adverse Event|0
915397|NCT01026818|3017112|P3|Screening Period|Adverse Event|0
915398|NCT01026818|3017113|P2|Screening Period|Adverse Event|0
915399|NCT01026818|3017114|P1|Screening Period|Adverse Event|2
915400|NCT01026818|3017111|P4|Screening Period|Protocol Deviation|0
915401|NCT01026818|3017112|P3|Screening Period|Protocol Deviation|0
915402|NCT01026818|3017113|P2|Screening Period|Protocol Deviation|0
915403|NCT01026818|3017114|P1|Screening Period|Protocol Deviation|3
915404|NCT01026818|3017111|P4|Screening Period|Withdrawal by Subject|0
915405|NCT01026818|3017112|P3|Screening Period|Withdrawal by Subject|0
915406|NCT01026818|3017113|P2|Screening Period|Withdrawal by Subject|0
915407|NCT01026818|3017114|P1|Screening Period|Withdrawal by Subject|49
915408|NCT01026818|3017111|P4|Screening Period|Entry Criteria Not Met|0
915409|NCT01026818|3017112|P3|Screening Period|Entry Criteria Not Met|0
915410|NCT01026818|3017113|P2|Screening Period|Entry Criteria Not Met|0
915411|NCT01026818|3017114|P1|Screening Period|Entry Criteria Not Met|105
915412|NCT01026792|3017202|P1|Overall Study|Protocol Violation|1
915413|NCT01026493|3017214|P8|Overall Study|Protocol Violation|1
915414|NCT01026493|3017215|P7|Overall Study|Protocol Violation|4
915415|NCT01026493|3017216|P6|Overall Study|Protocol Violation|3
915416|NCT01026493|3017217|P5|Overall Study|Protocol Violation|2
915417|NCT01026493|3017218|P4|Overall Study|Protocol Violation|0
915418|NCT01026493|3017219|P3|Overall Study|Protocol Violation|0
915419|NCT01026493|3017220|P2|Overall Study|Protocol Violation|1
915420|NCT01026493|3017221|P1|Overall Study|Protocol Violation|0
915421|NCT01026454|3017249|P2|Second Intervention|Pregnancy|1
915422|NCT01026454|3017250|P1|Second Intervention|Pregnancy|1
915423|NCT01026389|3017599|P2|Overall Study|change of treatment, patient moved|2
915424|NCT01026389|3017600|P1|Overall Study|change of treatment, patient moved|4
915425|NCT01026389|3017599|P2|Overall Study|Withdrawal by Subject|3
915426|NCT01026389|3017600|P1|Overall Study|Withdrawal by Subject|1
915427|NCT01026324|3017615|P3|Follow up/Survival|Withdrawal by Subject|0
915428|NCT01026324|3017616|P2|Follow up/Survival|Withdrawal by Subject|0
915429|NCT01026324|3017617|P1|Follow up/Survival|Withdrawal by Subject|1
915430|NCT01026220|3017627|P3|Consolidation Maintenance|Withdrawal by Subject|6
915431|NCT01026220|3017628|P2|Consolidation Maintenance|Withdrawal by Subject|2
915432|NCT01026220|3017629|P1|Consolidation Maintenance|Withdrawal by Subject|0
915433|NCT01026220|3017627|P3|Consolidation Maintenance|Physician Decision|7
915434|NCT01026220|3017628|P2|Consolidation Maintenance|Physician Decision|2
915435|NCT01026220|3017629|P1|Consolidation Maintenance|Physician Decision|0
915436|NCT01026220|3017627|P3|Consolidation Maintenance|Lack of Efficacy|1
915437|NCT01026220|3017628|P2|Consolidation Maintenance|Lack of Efficacy|1
915438|NCT01026220|3017629|P1|Consolidation Maintenance|Lack of Efficacy|0
915439|NCT01026220|3017627|P3|Consolidation Maintenance|Death|0
915440|NCT01026220|3017628|P2|Consolidation Maintenance|Death|1
915441|NCT01026220|3017629|P1|Consolidation Maintenance|Death|0
915442|NCT01026220|3017627|P3|Induction|Ineligible|0
915443|NCT01026220|3017628|P2|Induction|Ineligible|0
915444|NCT01026220|3017629|P1|Induction|Ineligible|1
915445|NCT01026220|3017627|P3|Induction|Withdrawal by Subject|0
915446|NCT01026220|3017628|P2|Induction|Withdrawal by Subject|0
915447|NCT01026220|3017629|P1|Induction|Withdrawal by Subject|9
915448|NCT01026220|3017627|P3|Induction|Physician Decision|0
915449|NCT01026220|3017628|P2|Induction|Physician Decision|0
915450|NCT01026220|3017629|P1|Induction|Physician Decision|12
915451|NCT01026220|3017627|P3|Induction|Lack of Efficacy|0
915452|NCT01026220|3017628|P2|Induction|Lack of Efficacy|0
915453|NCT01026220|3017629|P1|Induction|Lack of Efficacy|2
915454|NCT01026220|3017627|P3|Induction|Death|0
915455|NCT01026220|3017628|P2|Induction|Death|0
915456|NCT01026220|3017629|P1|Induction|Death|1
915457|NCT01026194|3017653|P2|Period 2：Open-label Period|Withdrawal by Subject|4
915458|NCT01026194|3017654|P1|Period 2：Open-label Period|Withdrawal by Subject|0
915459|NCT01026194|3017653|P2|Period 2：Open-label Period|Physician Decision|1
915460|NCT01026194|3017654|P1|Period 2：Open-label Period|Physician Decision|3
915461|NCT01026194|3017653|P2|Period 2：Open-label Period|Adverse Event|5
915462|NCT01026194|3017654|P1|Period 2：Open-label Period|Adverse Event|4
915463|NCT01026194|3017653|P2|Period 1：Double Blind Period|Physician Decision|4
915464|NCT01026194|3017654|P1|Period 1：Double Blind Period|Physician Decision|0
915465|NCT01026194|3017653|P2|Period 1：Double Blind Period|Lack of Efficacy|0
915466|NCT01026194|3017654|P1|Period 1：Double Blind Period|Lack of Efficacy|1
915467|NCT01026194|3017653|P2|Period 1：Double Blind Period|Adverse Event|1
915468|NCT01026194|3017654|P1|Period 1：Double Blind Period|Adverse Event|2
915469|NCT01026142|3017686|P2|Overall Study|Withdrew consent or lost to follow-up|29
915470|NCT01026142|3017687|P1|Overall Study|Withdrew consent or lost to follow-up|36
915471|NCT01026142|3017686|P2|Overall Study|Death|134
915472|NCT01026142|3017687|P1|Overall Study|Death|136
915473|NCT01026103|3017709|P1|Overall Study|did not receive study device bc of error|1
915474|NCT01026103|3017709|P1|Overall Study|Physician Decision|1
915475|NCT01026038|3017719|P3|Overall Study|Lost to Follow-up|0
915476|NCT01026038|3017720|P2|Overall Study|Lost to Follow-up|1
915477|NCT01026038|3017721|P1|Overall Study|Lost to Follow-up|1
915478|NCT01025843|3017770|P10|Washout 4|Withdrawal by Subject|0
915479|NCT01025843|3017771|P9|Washout 4|Withdrawal by Subject|0
915480|NCT01025843|3017772|P8|Washout 4|Withdrawal by Subject|0
915481|NCT01025843|3017773|P7|Washout 4|Withdrawal by Subject|0
915482|NCT01025843|3017774|P6|Washout 4|Withdrawal by Subject|0
915483|NCT01025843|3017775|P5|Washout 4|Withdrawal by Subject|0
915484|NCT01025843|3017776|P4|Washout 4|Withdrawal by Subject|1
915485|NCT01025843|3017777|P3|Washout 4|Withdrawal by Subject|1
915486|NCT01025843|3017778|P2|Washout 4|Withdrawal by Subject|0
915487|NCT01025843|3017779|P1|Washout 4|Withdrawal by Subject|0
915488|NCT01025817|3017873|P2|Completed Study|Lost to Follow-up|1
915489|NCT01025817|3017874|P1|Completed Study|Lost to Follow-up|0
915490|NCT01025817|3017873|P2|Completed Study|Missing|0
915491|NCT01025817|3017874|P1|Completed Study|Missing|2
915492|NCT01025817|3017873|P2|Completed Study|Death|5
915493|NCT01025817|3017874|P1|Completed Study|Death|6
915494|NCT01025817|3017873|P2|Completed Study|Withdrawal by Subject|16
915495|NCT01025817|3017874|P1|Completed Study|Withdrawal by Subject|8
915496|NCT01025817|3017873|P2|Completed Study Medication|Lost to Follow-up|1
915497|NCT01025817|3017874|P1|Completed Study Medication|Lost to Follow-up|0
915498|NCT01025817|3017873|P2|Completed Study Medication|Subject no longer required study drug|1
915499|NCT01025817|3017874|P1|Completed Study Medication|Subject no longer required study drug|0
915500|NCT01025817|3017873|P2|Completed Study Medication|Abnormal lab values|2
915501|NCT01025817|3017874|P1|Completed Study Medication|Abnormal lab values|0
915502|NCT01025817|3017873|P2|Completed Study Medication|Death|2
915503|NCT01025817|3017874|P1|Completed Study Medication|Death|2
915504|NCT01025817|3017873|P2|Completed Study Medication|Graft loss|5
915505|NCT01025817|3017874|P1|Completed Study Medication|Graft loss|2
915506|NCT01025817|3017873|P2|Completed Study Medication|Abnormal test procedure|0
915507|NCT01025817|3017874|P1|Completed Study Medication|Abnormal test procedure|4
915508|NCT01025817|3017873|P2|Completed Study Medication|Unsatisfactory therapeutic effect|0
915509|NCT01025817|3017874|P1|Completed Study Medication|Unsatisfactory therapeutic effect|7
915510|NCT01025817|3017873|P2|Completed Study Medication|Administrative problems|5
915511|NCT01025817|3017874|P1|Completed Study Medication|Administrative problems|7
915512|NCT01025817|3017873|P2|Completed Study Medication|Withdrawal by Subject|9
915513|NCT01025817|3017874|P1|Completed Study Medication|Withdrawal by Subject|8
915514|NCT01025817|3017873|P2|Completed Study Medication|Protocol Deviation|8
915515|NCT01025817|3017874|P1|Completed Study Medication|Protocol Deviation|9
915516|NCT01025817|3017873|P2|Completed Study Medication|Adverse Event|39
915517|NCT01025817|3017874|P1|Completed Study Medication|Adverse Event|66
915518|NCT01025752|3017894|P2|Overall Study|Physician Decision|3
915519|NCT01025752|3017895|P1|Overall Study|Physician Decision|1
915520|NCT01025752|3017894|P2|Overall Study|Lost to Follow-up|10
915521|NCT01025752|3017895|P1|Overall Study|Lost to Follow-up|7
915522|NCT01025635|3017915|P2|Overall Study|Reason not known|2
915523|NCT01025635|3017916|P1|Overall Study|Reason not known|4
915524|NCT01025635|3017915|P2|Overall Study|Lost to Follow-up|13
915525|NCT01025635|3017916|P1|Overall Study|Lost to Follow-up|9
915526|NCT01025635|3017915|P2|Overall Study|Lack of Efficacy|1
915527|NCT01025635|3017916|P1|Overall Study|Lack of Efficacy|0
915528|NCT01025635|3017915|P2|Overall Study|Protocol Violation|2
915529|NCT01025635|3017916|P1|Overall Study|Protocol Violation|4
915530|NCT01025635|3017915|P2|Overall Study|Withdrawal by Subject|7
915531|NCT01025635|3017916|P1|Overall Study|Withdrawal by Subject|6
915532|NCT01025336|3017944|P5|Overall Study|Protocol Violation|0
915533|NCT01025336|3017945|P4|Overall Study|Protocol Violation|2
915534|NCT01025336|3017946|P3|Overall Study|Protocol Violation|0
915535|NCT01025336|3017947|P2|Overall Study|Protocol Violation|0
915536|NCT01025336|3017948|P1|Overall Study|Protocol Violation|0
915537|NCT01025284|3018003|P3|Overall Study|Withdrawal by Subject|0
915538|NCT01025284|3018004|P2|Overall Study|Withdrawal by Subject|1
915539|NCT01025284|3018005|P1|Overall Study|Withdrawal by Subject|0
915540|NCT01025284|3018003|P3|Overall Study|Investigator Decision|0
915541|NCT01025284|3018004|P2|Overall Study|Investigator Decision|1
915542|NCT01025284|3018005|P1|Overall Study|Investigator Decision|0
915543|NCT01025232|3018030|P2|Overall Study|Study drug no longer available|6
915544|NCT01025232|3018031|P1|Overall Study|Study drug no longer available|3
915545|NCT01025193|3018049|P1|Overall Study|Adverse Event|3
915546|NCT01025193|3018049|P1|Overall Study|Protocol Violation|1
915547|NCT01025154|3018059|P1|Overall Study|Withdrawal by Subject|1
915548|NCT01025154|3018059|P1|Overall Study|Lost to Follow-up|1
915549|NCT01025037|3018068|P1|Overall Study|Withdrawal by Subject|1
915550|NCT01025037|3018068|P1|Overall Study|Lost to Follow-up|7
915551|NCT01025037|3018068|P1|Overall Study|Adverse Event|3
915552|NCT01024959|3018090|P1|Overall Study|missing results required for analysis|17
915553|NCT01024959|3018090|P1|Overall Study|results not evaluable|12
915554|NCT01024959|3018090|P1|Overall Study|ineligible|12
915555|NCT01024946|3018099|P1|Overall Study|Adverse Event|1
915556|NCT01024946|3018099|P1|Overall Study|Withdrawal by Subject|1
915557|NCT01024946|3018099|P1|Overall Study|Screen Failure|3
915558|NCT01024855|3018103|P1|Overall Study|Inclusion/exclusion criteria|1
915559|NCT01024751|3018110|P2|Eligible Participants|Ineligible|1
915560|NCT01024751|3018111|P1|Eligible Participants|Ineligible|0
915561|NCT01024751|3018110|P2|Eligible Participants|Lost to Follow-up|1
915562|NCT01024751|3018111|P1|Eligible Participants|Lost to Follow-up|0
915563|NCT01024751|3018110|P2|Eligible Participants|Withdrawal by Subject|1
915564|NCT01024751|3018111|P1|Eligible Participants|Withdrawal by Subject|0
915565|NCT01024751|3018110|P2|Enrolled Participants|Ineligible at baseline|4
915566|NCT01024751|3018111|P1|Enrolled Participants|Ineligible at baseline|3
915567|NCT01024608|3018134|P2|Overall Study|Never received study treatment|0
915568|NCT01024608|3018135|P1|Overall Study|Never received study treatment|2
915569|NCT01024608|3018134|P2|Overall Study|Protocol Violation|3
915570|NCT01024608|3018135|P1|Overall Study|Protocol Violation|0
915571|NCT01024608|3018134|P2|Overall Study|Lost to Follow-up|1
915572|NCT01024608|3018135|P1|Overall Study|Lost to Follow-up|0
915573|NCT01024608|3018134|P2|Overall Study|Withdrawal by Subject|0
915574|NCT01024608|3018135|P1|Overall Study|Withdrawal by Subject|1
915575|NCT01024608|3018134|P2|Overall Study|Adverse Event|0
915576|NCT01024608|3018135|P1|Overall Study|Adverse Event|1
915577|NCT01024465|3018147|P1|Overall Study|Physician Decision|1
915578|NCT01024465|3018147|P1|Overall Study|Adverse Event|2
915579|NCT01024387|3018151|P1|Overall Study|Other|5
915580|NCT01024387|3018151|P1|Overall Study|Adverse Event|3
915581|NCT01024387|3018151|P1|Overall Study|Prolonged Treatment Delay|1
915582|NCT01024387|3018151|P1|Overall Study|Death|2
915583|NCT01024387|3018151|P1|Overall Study|Withdrawal by Subject|5
915584|NCT01024387|3018151|P1|Overall Study|Physician Decision|5
915585|NCT01024387|3018151|P1|Overall Study|Symptomatic Progression|10
915586|NCT01024387|3018151|P1|Overall Study|Radiographic Progression|29
915587|NCT01024309|3018172|P2|Overall Study|Withdrawal by Subject|4
915588|NCT01024309|3018173|P1|Overall Study|Withdrawal by Subject|4
915589|NCT01024309|3018172|P2|Overall Study|Physician Decision|0
915590|NCT01024309|3018173|P1|Overall Study|Physician Decision|4
915591|NCT01024244|3018205|P5|Overall Study|Withdrawal by Subject|0
915592|NCT01024244|3018206|P4|Overall Study|Withdrawal by Subject|0
915593|NCT01024244|3018207|P3|Overall Study|Withdrawal by Subject|0
915594|NCT01024244|3018208|P2|Overall Study|Withdrawal by Subject|1
915595|NCT01024244|3018209|P1|Overall Study|Withdrawal by Subject|0
915596|NCT01024244|3018205|P5|Overall Study|Sponsor Decision|10
915597|NCT01024244|3018206|P4|Overall Study|Sponsor Decision|12
915598|NCT01024244|3018207|P3|Overall Study|Sponsor Decision|14
915599|NCT01024244|3018208|P2|Overall Study|Sponsor Decision|7
915600|NCT01024244|3018209|P1|Overall Study|Sponsor Decision|14
915601|NCT01024244|3018205|P5|Overall Study|Protocol Violation|2
915602|NCT01024244|3018206|P4|Overall Study|Protocol Violation|0
915603|NCT01024244|3018207|P3|Overall Study|Protocol Violation|0
915604|NCT01024244|3018208|P2|Overall Study|Protocol Violation|0
915605|NCT01024244|3018209|P1|Overall Study|Protocol Violation|1
915606|NCT01024244|3018205|P5|Overall Study|Lack of Efficacy|0
915607|NCT01024244|3018206|P4|Overall Study|Lack of Efficacy|0
915608|NCT01024244|3018207|P3|Overall Study|Lack of Efficacy|0
915609|NCT01024244|3018208|P2|Overall Study|Lack of Efficacy|0
915610|NCT01024244|3018209|P1|Overall Study|Lack of Efficacy|1
915611|NCT01024244|3018205|P5|Overall Study|Entry Criteria Not Met|0
915612|NCT01024244|3018206|P4|Overall Study|Entry Criteria Not Met|0
915613|NCT01024244|3018207|P3|Overall Study|Entry Criteria Not Met|0
915614|NCT01024244|3018208|P2|Overall Study|Entry Criteria Not Met|1
915615|NCT01024244|3018209|P1|Overall Study|Entry Criteria Not Met|0
915616|NCT01024244|3018205|P5|Overall Study|Adverse Event|2
915617|NCT01024244|3018206|P4|Overall Study|Adverse Event|1
915618|NCT01024244|3018207|P3|Overall Study|Adverse Event|0
915619|NCT01024244|3018208|P2|Overall Study|Adverse Event|2
915620|NCT01024244|3018209|P1|Overall Study|Adverse Event|1
915621|NCT01024036|3018323|P2|Follow-Up Period|Adverse Event|1
915622|NCT01024036|3018324|P1|Follow-Up Period|Adverse Event|4
915623|NCT01024036|3018323|P2|Follow-Up Period|Withdrawal by Subject|1
915624|NCT01024036|3018324|P1|Follow-Up Period|Withdrawal by Subject|0
915625|NCT01024036|3018323|P2|Follow-Up Period|Lost to Follow-up|1
915626|NCT01024036|3018324|P1|Follow-Up Period|Lost to Follow-up|1
915627|NCT01024036|3018323|P2|Unblinded Treatment|Lack of Efficacy|2
915628|NCT01024036|3018324|P1|Unblinded Treatment|Lack of Efficacy|0
915629|NCT01024036|3018323|P2|Unblinded Treatment|Adverse Event|1
915630|NCT01024036|3018324|P1|Unblinded Treatment|Adverse Event|0
915631|NCT01024036|3018323|P2|Blinded Treatment|Withdrawal by Subject|3
915632|NCT01024036|3018324|P1|Blinded Treatment|Withdrawal by Subject|4
915633|NCT01024036|3018323|P2|Blinded Treatment|Death|2
915634|NCT01024036|3018324|P1|Blinded Treatment|Death|0
915635|NCT01024036|3018323|P2|Blinded Treatment|Physician Decision|0
915636|NCT01024036|3018324|P1|Blinded Treatment|Physician Decision|1
915637|NCT01024036|3018323|P2|Blinded Treatment|Lack of Efficacy|14
915638|NCT01024036|3018324|P1|Blinded Treatment|Lack of Efficacy|16
915639|NCT01024036|3018323|P2|Blinded Treatment|Adverse Event|1
915640|NCT01024036|3018324|P1|Blinded Treatment|Adverse Event|1
915641|NCT01023958|3018371|P1|Overall Study|Refused to continue medication|1
915642|NCT01023958|3018371|P1|Overall Study|Other adverse event|1
915643|NCT01023958|3018371|P1|Overall Study|Progressive disease|48
915644|NCT01023815|3018419|P4|Randomized Period (Day 90 to Month 12)|Graft Loss|0
915645|NCT01023815|3018420|P3|Randomized Period (Day 90 to Month 12)|Graft Loss|0
915646|NCT01023815|3018421|P2|Randomized Period (Day 90 to Month 12)|Graft Loss|1
915647|NCT01023815|3018422|P1|Randomized Period (Day 90 to Month 12)|Graft Loss|0
915648|NCT01023815|3018419|P4|Randomized Period (Day 90 to Month 12)|Administrative Problems|2
915649|NCT01023815|3018420|P3|Randomized Period (Day 90 to Month 12)|Administrative Problems|6
915650|NCT01023815|3018421|P2|Randomized Period (Day 90 to Month 12)|Administrative Problems|1
915651|NCT01023815|3018422|P1|Randomized Period (Day 90 to Month 12)|Administrative Problems|0
915652|NCT01023815|3018419|P4|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
915653|NCT01023815|3018420|P3|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
915654|NCT01023815|3018421|P2|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
915655|NCT01023815|3018422|P1|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
915656|NCT01023815|3018419|P4|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
915657|NCT01023815|3018420|P3|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
915658|NCT01023815|3018421|P2|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
915659|NCT01023815|3018422|P1|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
915660|NCT01023815|3018419|P4|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
915661|NCT01023815|3018420|P3|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
915662|NCT01023815|3018421|P2|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
915663|NCT01023815|3018422|P1|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144
915664|NCT01023789|3018441|P1|3 - Year Visit|Lost to Follow-up|13
915665|NCT01023789|3018441|P1|3 - Year Visit|Withdrawal of consent|1
915666|NCT01023789|3018441|P1|3 - Year Visit|Death|29
915667|NCT01023672|3018527|P1|Overall Study|Death|1
915668|NCT01023672|3018527|P1|Overall Study|Worsening disease|2
915669|NCT01023659|3018534|P3|Overall Study|Lost to Follow-up|99
915670|NCT01023659|3018535|P2|Overall Study|Lost to Follow-up|228
915671|NCT01023659|3018536|P1|Overall Study|Lost to Follow-up|73
915672|NCT01023581|3018552|P7|Overall Study|Other|0
915673|NCT01023581|3018553|P6|Overall Study|Other|0
915674|NCT01023581|3018554|P5|Overall Study|Other|1
915675|NCT01023581|3018555|P4|Overall Study|Other|0
915676|NCT01023581|3018556|P3|Overall Study|Other|1
915677|NCT01023581|3018557|P2|Overall Study|Other|0
915678|NCT01023581|3018558|P1|Overall Study|Other|1
915679|NCT01023581|3018552|P7|Overall Study|Physician Decision|1
915680|NCT01023581|3018553|P6|Overall Study|Physician Decision|1
915681|NCT01023581|3018554|P5|Overall Study|Physician Decision|1
915682|NCT01023581|3018555|P4|Overall Study|Physician Decision|1
915683|NCT01023581|3018556|P3|Overall Study|Physician Decision|2
915684|NCT01023581|3018557|P2|Overall Study|Physician Decision|0
915685|NCT01023581|3018558|P1|Overall Study|Physician Decision|2
915686|NCT01023581|3018552|P7|Overall Study|Lack of Efficacy|1
915687|NCT01023581|3018553|P6|Overall Study|Lack of Efficacy|2
915688|NCT01023581|3018554|P5|Overall Study|Lack of Efficacy|1
915689|NCT01023581|3018555|P4|Overall Study|Lack of Efficacy|2
915690|NCT01023581|3018556|P3|Overall Study|Lack of Efficacy|6
915691|NCT01023581|3018557|P2|Overall Study|Lack of Efficacy|3
915692|NCT01023581|3018558|P1|Overall Study|Lack of Efficacy|9
915693|NCT01023581|3018552|P7|Overall Study|Pregnancy|0
915694|NCT01023581|3018553|P6|Overall Study|Pregnancy|1
915695|NCT01023581|3018554|P5|Overall Study|Pregnancy|0
915696|NCT01023581|3018555|P4|Overall Study|Pregnancy|2
915697|NCT01023581|3018556|P3|Overall Study|Pregnancy|0
915698|NCT01023581|3018557|P2|Overall Study|Pregnancy|0
915699|NCT01023581|3018558|P1|Overall Study|Pregnancy|0
915700|NCT01023581|3018552|P7|Overall Study|Withdrawal by Subject|5
915701|NCT01023581|3018553|P6|Overall Study|Withdrawal by Subject|8
915702|NCT01023581|3018554|P5|Overall Study|Withdrawal by Subject|6
915703|NCT01023581|3018555|P4|Overall Study|Withdrawal by Subject|10
915704|NCT01023581|3018556|P3|Overall Study|Withdrawal by Subject|16
915705|NCT01023581|3018557|P2|Overall Study|Withdrawal by Subject|8
915706|NCT01023581|3018558|P1|Overall Study|Withdrawal by Subject|13
915707|NCT01023581|3018552|P7|Overall Study|Lost to Follow-up|2
915708|NCT01023581|3018553|P6|Overall Study|Lost to Follow-up|2
915709|NCT01023581|3018554|P5|Overall Study|Lost to Follow-up|5
915710|NCT01023581|3018555|P4|Overall Study|Lost to Follow-up|2
915711|NCT01023581|3018556|P3|Overall Study|Lost to Follow-up|7
915712|NCT01023581|3018557|P2|Overall Study|Lost to Follow-up|8
915713|NCT01023581|3018558|P1|Overall Study|Lost to Follow-up|4
915714|NCT01023581|3018552|P7|Overall Study|Major protocol deviation|0
915715|NCT01023581|3018553|P6|Overall Study|Major protocol deviation|0
915716|NCT01023581|3018554|P5|Overall Study|Major protocol deviation|0
915717|NCT01023581|3018555|P4|Overall Study|Major protocol deviation|0
915718|NCT01023581|3018556|P3|Overall Study|Major protocol deviation|3
915719|NCT01023581|3018557|P2|Overall Study|Major protocol deviation|0
915720|NCT01023581|3018558|P1|Overall Study|Major protocol deviation|2
915721|NCT01023581|3018552|P7|Overall Study|Adverse Event|11
915722|NCT01023581|3018553|P6|Overall Study|Adverse Event|5
915723|NCT01023581|3018554|P5|Overall Study|Adverse Event|2
915724|NCT01023581|3018555|P4|Overall Study|Adverse Event|3
915725|NCT01023581|3018556|P3|Overall Study|Adverse Event|7
915726|NCT01023581|3018557|P2|Overall Study|Adverse Event|4
915727|NCT01023581|3018558|P1|Overall Study|Adverse Event|4
915728|NCT01023516|3018615|P2|Overall Study|Incorrect enrolment|2
915729|NCT01023516|3018616|P1|Overall Study|Incorrect enrolment|4
915730|NCT01023516|3018615|P2|Overall Study|Study-specific criteria|2
915731|NCT01023516|3018616|P1|Overall Study|Study-specific criteria|4
915732|NCT01023516|3018615|P2|Overall Study|Safety reason|3
915733|NCT01023516|3018616|P1|Overall Study|Safety reason|0
915734|NCT01023516|3018615|P2|Overall Study|Adverse Event|6
915735|NCT01023516|3018616|P1|Overall Study|Adverse Event|9
915736|NCT01023516|3018615|P2|Overall Study|Voluntary discontinuation|5
915737|NCT01023516|3018616|P1|Overall Study|Voluntary discontinuation|7
915738|NCT01023308|3018698|P2|Overall Study|Withdrawal by Subject|18
915739|NCT01023308|3018699|P1|Overall Study|Withdrawal by Subject|34
915740|NCT01023308|3018698|P2|Overall Study|Lost to Follow-up|0
915741|NCT01023308|3018699|P1|Overall Study|Lost to Follow-up|1
915742|NCT01023308|3018698|P2|Overall Study|Untreated|5
915743|NCT01023308|3018699|P1|Overall Study|Untreated|5
915744|NCT01023308|3018698|P2|Overall Study|Protocol Violation|4
915745|NCT01023308|3018699|P1|Overall Study|Protocol Violation|3
915746|NCT01023308|3018698|P2|Overall Study|New Cancer therapy|7
915747|NCT01023308|3018699|P1|Overall Study|New Cancer therapy|4
915748|NCT01023308|3018698|P2|Overall Study|Disease progression|153
915749|NCT01023308|3018699|P1|Overall Study|Disease progression|82
915750|NCT01023308|3018698|P2|Overall Study|Death|17
915751|NCT01023308|3018699|P1|Overall Study|Death|21
915752|NCT01023308|3018698|P2|Overall Study|Adverse Event|66
915753|NCT01023308|3018699|P1|Overall Study|Adverse Event|130
915754|NCT01023308|3018698|P2|Overall Study|Administrative problems|1
915755|NCT01023308|3018699|P1|Overall Study|Administrative problems|2
915756|NCT01023308|3018698|P2|Overall Study|Abnormal test proceedure results|8
915757|NCT01023308|3018699|P1|Overall Study|Abnormal test proceedure results|3
915758|NCT01023256|3018729|P4|Overall Study|Withdrawal by Subject|2
915759|NCT01023256|3018730|P3|Overall Study|Withdrawal by Subject|0
915760|NCT01023256|3018731|P2|Overall Study|Withdrawal by Subject|0
915761|NCT01023256|3018732|P1|Overall Study|Withdrawal by Subject|0
915762|NCT01023256|3018729|P4|Overall Study|Adverse Event|1
915763|NCT01023256|3018730|P3|Overall Study|Adverse Event|0
915764|NCT01023256|3018731|P2|Overall Study|Adverse Event|0
915765|NCT01023256|3018732|P1|Overall Study|Adverse Event|0
915766|NCT01023256|3018729|P4|Overall Study|Not specified|2
915767|NCT01023256|3018730|P3|Overall Study|Not specified|0
915768|NCT01023256|3018731|P2|Overall Study|Not specified|0
915769|NCT01023256|3018732|P1|Overall Study|Not specified|1
915770|NCT01023256|3018729|P4|Overall Study|Randomized but not treated|0
915771|NCT01023256|3018730|P3|Overall Study|Randomized but not treated|1
915772|NCT01023256|3018731|P2|Overall Study|Randomized but not treated|0
915773|NCT01023256|3018732|P1|Overall Study|Randomized but not treated|1
915774|NCT01023256|3018729|P4|Overall Study|Protocol Violation|0
915775|NCT01023256|3018730|P3|Overall Study|Protocol Violation|0
915776|NCT01023256|3018731|P2|Overall Study|Protocol Violation|3
915777|NCT01023256|3018732|P1|Overall Study|Protocol Violation|2
915778|NCT01023217|3018774|P2|Overall Study|Withdrawal by Subject|0
915779|NCT01023217|3018775|P1|Overall Study|Withdrawal by Subject|1
915780|NCT01023061|3018813|P1|Overall Study|Withdrawal prior to treatment|2
915781|NCT01023035|3018822|P3|Follow-up Period (up to Week 72)|Non-medical Reason|38
915782|NCT01023035|3018823|P2|Follow-up Period (up to Week 72)|Non-medical Reason|28
915783|NCT01023035|3018824|P1|Follow-up Period (up to Week 72)|Non-medical Reason|26
915784|NCT01023035|3018822|P3|Follow-up Period (up to Week 72)|Adverse Event|1
915785|NCT01023035|3018823|P2|Follow-up Period (up to Week 72)|Adverse Event|0
915786|NCT01023035|3018824|P1|Follow-up Period (up to Week 72)|Adverse Event|2
915787|NCT01023035|3018822|P3|Treatment Period|Treatment Failure|24
915788|NCT01023035|3018823|P2|Treatment Period|Treatment Failure|31
915789|NCT01023035|3018824|P1|Treatment Period|Treatment Failure|26
915790|NCT01023035|3018822|P3|Treatment Period|Non-Medical Reasons|44
915791|NCT01023035|3018823|P2|Treatment Period|Non-Medical Reasons|22
915792|NCT01023035|3018824|P1|Treatment Period|Non-Medical Reasons|19
915793|NCT01023035|3018822|P3|Treatment Period|Adverse Event|50
915794|NCT01023035|3018823|P2|Treatment Period|Adverse Event|32
915795|NCT01023035|3018824|P1|Treatment Period|Adverse Event|27
915796|NCT01023022|3018834|P1|Overall Study|due to technical issues|2
915797|NCT01023022|3018834|P1|Overall Study|Lost to Follow-up|7
915798|NCT01023022|3018834|P1|Overall Study|Death|5
915799|NCT01022996|3018840|P1|Overall Study|Protocol Violation|1
915800|NCT01022996|3018840|P1|Overall Study|Disease Progression|32
915801|NCT01022996|3018840|P1|Overall Study|Administrative problems|6
915802|NCT01022996|3018840|P1|Overall Study|Lost to Follow-up|1
915803|NCT01022996|3018840|P1|Overall Study|Withdrawal by Subject|3
915804|NCT01022996|3018840|P1|Overall Study|Adverse Event|14
915805|NCT01022853|3018854|P5|Overall Study|Other not stated above|0
915806|NCT01022853|3018855|P4|Overall Study|Other not stated above|0
915807|NCT01022853|3018856|P3|Overall Study|Other not stated above|1
915808|NCT01022853|3018857|P2|Overall Study|Other not stated above|0
915809|NCT01022853|3018858|P1|Overall Study|Other not stated above|1
915810|NCT01022853|3018854|P5|Overall Study|Withdrawal by Subject|0
915811|NCT01022853|3018855|P4|Overall Study|Withdrawal by Subject|1
915812|NCT01022853|3018856|P3|Overall Study|Withdrawal by Subject|1
915813|NCT01022853|3018857|P2|Overall Study|Withdrawal by Subject|1
915814|NCT01022853|3018858|P1|Overall Study|Withdrawal by Subject|0
915815|NCT01022853|3018854|P5|Overall Study|Dose-limiting toxicity|1
915816|NCT01022853|3018855|P4|Overall Study|Dose-limiting toxicity|0
915817|NCT01022853|3018856|P3|Overall Study|Dose-limiting toxicity|0
915818|NCT01022853|3018857|P2|Overall Study|Dose-limiting toxicity|0
915819|NCT01022853|3018858|P1|Overall Study|Dose-limiting toxicity|0
915820|NCT01022853|3018854|P5|Overall Study|Progressive disease|1
915821|NCT01022853|3018855|P4|Overall Study|Progressive disease|7
915822|NCT01022853|3018856|P3|Overall Study|Progressive disease|11
915823|NCT01022853|3018857|P2|Overall Study|Progressive disease|3
915824|NCT01022853|3018858|P1|Overall Study|Progressive disease|2
915825|NCT01022762|3018937|P2|Overall Study|Unclassified|20
915826|NCT01022762|3018938|P1|Overall Study|Unclassified|12
915827|NCT01022762|3018937|P2|Overall Study|Protocol Violation|6
915828|NCT01022762|3018938|P1|Overall Study|Protocol Violation|7
915829|NCT01022762|3018937|P2|Overall Study|Lack of Efficacy|1
915830|NCT01022762|3018938|P1|Overall Study|Lack of Efficacy|0
915831|NCT01022762|3018937|P2|Overall Study|Adverse Event|1
915832|NCT01022762|3018938|P1|Overall Study|Adverse Event|3
915833|NCT01022502|3018973|P1|Overall Study|Withdrawal by Subject|1
915834|NCT01022502|3018973|P1|Overall Study|employment related reasons|1
915835|NCT01022502|3018973|P1|Overall Study|Adverse Event|1
915836|NCT01022424|3018987|P1|Overall Study|eGFR under the withdrawal criteria|2
915837|NCT01022424|3018987|P1|Overall Study|Physician Decision|1
915838|NCT01022424|3018987|P1|Overall Study|Adverse Event|1
915839|NCT01022398|3019002|P2|Overall Study|Study terminated|2
915840|NCT01022398|3019003|P1|Overall Study|Study terminated|2
915841|NCT01022203|3019028|P2|Follow-Up Assessment|Lost to Follow-up|2
915842|NCT01022203|3019029|P1|Follow-Up Assessment|Lost to Follow-up|2
915843|NCT01022203|3019028|P2|Post Treatment Assessment|Adverse Event|2
915844|NCT01022203|3019029|P1|Post Treatment Assessment|Adverse Event|0
915845|NCT01022203|3019028|P2|Post Treatment Assessment|Physician Decision|0
915846|NCT01022203|3019029|P1|Post Treatment Assessment|Physician Decision|2
915847|NCT01022203|3019028|P2|Post Treatment Assessment|Withdrawal by Subject|12
915848|NCT01022203|3019029|P1|Post Treatment Assessment|Withdrawal by Subject|12
915849|NCT01022112|3019048|P5|Overall Study|Fasting plasma glucose level increased|7
915850|NCT01022112|3019049|P4|Overall Study|Fasting plasma glucose level increased|0
915851|NCT01022112|3019050|P3|Overall Study|Fasting plasma glucose level increased|0
915852|NCT01022112|3019051|P2|Overall Study|Fasting plasma glucose level increased|0
915853|NCT01022112|3019052|P1|Overall Study|Fasting plasma glucose level increased|1
915854|NCT01022112|3019048|P5|Overall Study|Withdrawal by Subject|1
915855|NCT01022112|3019049|P4|Overall Study|Withdrawal by Subject|2
915856|NCT01022112|3019050|P3|Overall Study|Withdrawal by Subject|2
915857|NCT01022112|3019051|P2|Overall Study|Withdrawal by Subject|1
915858|NCT01022112|3019052|P1|Overall Study|Withdrawal by Subject|0
915859|NCT01022112|3019048|P5|Overall Study|Physician Decision|1
915860|NCT01022112|3019049|P4|Overall Study|Physician Decision|0
915861|NCT01022112|3019050|P3|Overall Study|Physician Decision|1
915862|NCT01022112|3019051|P2|Overall Study|Physician Decision|0
915863|NCT01022112|3019052|P1|Overall Study|Physician Decision|0
915864|NCT01022112|3019048|P5|Overall Study|Lack of Efficacy|1
915865|NCT01022112|3019049|P4|Overall Study|Lack of Efficacy|0
915866|NCT01022112|3019050|P3|Overall Study|Lack of Efficacy|0
915867|NCT01022112|3019051|P2|Overall Study|Lack of Efficacy|0
915868|NCT01022112|3019052|P1|Overall Study|Lack of Efficacy|1
915869|NCT01022112|3019048|P5|Overall Study|Adverse Event|0
915870|NCT01022112|3019049|P4|Overall Study|Adverse Event|1
915871|NCT01022112|3019050|P3|Overall Study|Adverse Event|0
915872|NCT01022112|3019051|P2|Overall Study|Adverse Event|2
915873|NCT01022112|3019052|P1|Overall Study|Adverse Event|1
915874|NCT01021878|3019101|P2|Overall Study|Transplantation|1
915875|NCT01021878|3019102|P1|Overall Study|Transplantation|6
915876|NCT01021878|3019101|P2|Overall Study|Adverse Event|5
915877|NCT01021878|3019102|P1|Overall Study|Adverse Event|6
915878|NCT01021878|3019101|P2|Overall Study|Death|1
915879|NCT01021878|3019102|P1|Overall Study|Death|0
915880|NCT01021878|3019101|P2|Overall Study|Lost to Follow-up|3
915881|NCT01021878|3019102|P1|Overall Study|Lost to Follow-up|4
915882|NCT01021852|3019124|P8|Treatment Period 2|Withdrawal by Subject|2
915883|NCT01021852|3019125|P7|Treatment Period 2|Withdrawal by Subject|1
915884|NCT01021852|3019126|P6|Treatment Period 2|Withdrawal by Subject|0
915885|NCT01021852|3019127|P5|Treatment Period 2|Withdrawal by Subject|0
915886|NCT01021852|3019128|P4|Treatment Period 2|Withdrawal by Subject|0
915887|NCT01021852|3019129|P3|Treatment Period 2|Withdrawal by Subject|0
915888|NCT01021852|3019130|P2|Treatment Period 2|Withdrawal by Subject|0
915889|NCT01021852|3019131|P1|Treatment Period 2|Withdrawal by Subject|0
915890|NCT01021852|3019124|P8|Treatment Period 2|Protocol Violation|0
915891|NCT01021852|3019125|P7|Treatment Period 2|Protocol Violation|1
915892|NCT01021852|3019126|P6|Treatment Period 2|Protocol Violation|0
915893|NCT01021852|3019127|P5|Treatment Period 2|Protocol Violation|1
915894|NCT01021852|3019128|P4|Treatment Period 2|Protocol Violation|0
915895|NCT01021852|3019129|P3|Treatment Period 2|Protocol Violation|0
915896|NCT01021852|3019130|P2|Treatment Period 2|Protocol Violation|0
915897|NCT01021852|3019131|P1|Treatment Period 2|Protocol Violation|0
915898|NCT01021852|3019124|P8|Treatment Period 2|Physician Decision|0
915899|NCT01021852|3019125|P7|Treatment Period 2|Physician Decision|0
915900|NCT01021852|3019126|P6|Treatment Period 2|Physician Decision|0
915901|NCT01021852|3019127|P5|Treatment Period 2|Physician Decision|0
915902|NCT01021852|3019128|P4|Treatment Period 2|Physician Decision|0
915903|NCT01021852|3019129|P3|Treatment Period 2|Physician Decision|1
915904|NCT01021852|3019130|P2|Treatment Period 2|Physician Decision|0
915905|NCT01021852|3019131|P1|Treatment Period 2|Physician Decision|0
915906|NCT01021852|3019124|P8|Treatment Period 2|Lack of Efficacy|0
915907|NCT01021852|3019125|P7|Treatment Period 2|Lack of Efficacy|0
915908|NCT01021852|3019126|P6|Treatment Period 2|Lack of Efficacy|1
915909|NCT01021852|3019127|P5|Treatment Period 2|Lack of Efficacy|0
915910|NCT01021852|3019128|P4|Treatment Period 2|Lack of Efficacy|0
915911|NCT01021852|3019129|P3|Treatment Period 2|Lack of Efficacy|0
915912|NCT01021852|3019130|P2|Treatment Period 2|Lack of Efficacy|0
915913|NCT01021852|3019131|P1|Treatment Period 2|Lack of Efficacy|0
915914|NCT01021852|3019124|P8|Treatment Period 2|Adverse Event|0
915915|NCT01021852|3019125|P7|Treatment Period 2|Adverse Event|1
915916|NCT01021852|3019126|P6|Treatment Period 2|Adverse Event|0
915917|NCT01021852|3019127|P5|Treatment Period 2|Adverse Event|1
915918|NCT01021852|3019128|P4|Treatment Period 2|Adverse Event|0
915919|NCT01021852|3019129|P3|Treatment Period 2|Adverse Event|0
915920|NCT01021852|3019130|P2|Treatment Period 2|Adverse Event|1
915921|NCT01021852|3019131|P1|Treatment Period 2|Adverse Event|0
915922|NCT01021852|3019124|P8|Washout Period-No Drug|Adverse Event|0
915923|NCT01021852|3019125|P7|Washout Period-No Drug|Adverse Event|0
915924|NCT01021852|3019126|P6|Washout Period-No Drug|Adverse Event|1
915925|NCT01021852|3019127|P5|Washout Period-No Drug|Adverse Event|0
915926|NCT01021852|3019128|P4|Washout Period-No Drug|Adverse Event|0
915927|NCT01021852|3019129|P3|Washout Period-No Drug|Adverse Event|0
915928|NCT01021852|3019130|P2|Washout Period-No Drug|Adverse Event|0
915929|NCT01021852|3019131|P1|Washout Period-No Drug|Adverse Event|1
915930|NCT01021852|3019124|P8|Washout Period-Placebo|Protocol Violation|0
915931|NCT01021852|3019125|P7|Washout Period-Placebo|Protocol Violation|1
915932|NCT01021852|3019126|P6|Washout Period-Placebo|Protocol Violation|0
915933|NCT01021852|3019127|P5|Washout Period-Placebo|Protocol Violation|0
915934|NCT01021852|3019128|P4|Washout Period-Placebo|Protocol Violation|0
915935|NCT01021852|3019129|P3|Washout Period-Placebo|Protocol Violation|0
915936|NCT01021852|3019130|P2|Washout Period-Placebo|Protocol Violation|0
915937|NCT01021852|3019131|P1|Washout Period-Placebo|Protocol Violation|0
915938|NCT01021852|3019124|P8|Washout Period-Placebo|Lost to Follow-up|0
915939|NCT01021852|3019125|P7|Washout Period-Placebo|Lost to Follow-up|0
915940|NCT01021852|3019126|P6|Washout Period-Placebo|Lost to Follow-up|0
915941|NCT01021852|3019127|P5|Washout Period-Placebo|Lost to Follow-up|1
915942|NCT01021852|3019128|P4|Washout Period-Placebo|Lost to Follow-up|0
915943|NCT01021852|3019129|P3|Washout Period-Placebo|Lost to Follow-up|0
915944|NCT01021852|3019130|P2|Washout Period-Placebo|Lost to Follow-up|0
915945|NCT01021852|3019131|P1|Washout Period-Placebo|Lost to Follow-up|0
915946|NCT01021852|3019124|P8|Washout Period-Placebo|Adverse Event|0
915947|NCT01021852|3019125|P7|Washout Period-Placebo|Adverse Event|0
915948|NCT01021852|3019126|P6|Washout Period-Placebo|Adverse Event|1
915949|NCT01021852|3019127|P5|Washout Period-Placebo|Adverse Event|0
915950|NCT01021852|3019128|P4|Washout Period-Placebo|Adverse Event|1
915951|NCT01021852|3019129|P3|Washout Period-Placebo|Adverse Event|0
915952|NCT01021852|3019130|P2|Washout Period-Placebo|Adverse Event|0
915953|NCT01021852|3019131|P1|Washout Period-Placebo|Adverse Event|0
915954|NCT01021852|3019124|P8|Treatment Period 1|Not Treated|0
915955|NCT01021852|3019125|P7|Treatment Period 1|Not Treated|0
915956|NCT01021852|3019126|P6|Treatment Period 1|Not Treated|0
915957|NCT01021852|3019127|P5|Treatment Period 1|Not Treated|0
915958|NCT01021852|3019128|P4|Treatment Period 1|Not Treated|2
915959|NCT01021852|3019129|P3|Treatment Period 1|Not Treated|0
915960|NCT01021852|3019130|P2|Treatment Period 1|Not Treated|0
915961|NCT01021852|3019131|P1|Treatment Period 1|Not Treated|0
915962|NCT01021852|3019124|P8|Treatment Period 1|Withdrawal by Subject|1
915963|NCT01021852|3019125|P7|Treatment Period 1|Withdrawal by Subject|0
915964|NCT01021852|3019126|P6|Treatment Period 1|Withdrawal by Subject|0
915965|NCT01021852|3019127|P5|Treatment Period 1|Withdrawal by Subject|1
915966|NCT01021852|3019128|P4|Treatment Period 1|Withdrawal by Subject|0
915967|NCT01021852|3019129|P3|Treatment Period 1|Withdrawal by Subject|0
915968|NCT01021852|3019130|P2|Treatment Period 1|Withdrawal by Subject|0
915969|NCT01021852|3019131|P1|Treatment Period 1|Withdrawal by Subject|0
915970|NCT01021852|3019124|P8|Treatment Period 1|Pregnancy|0
915971|NCT01021852|3019125|P7|Treatment Period 1|Pregnancy|0
915972|NCT01021852|3019126|P6|Treatment Period 1|Pregnancy|0
915973|NCT01021852|3019127|P5|Treatment Period 1|Pregnancy|0
915974|NCT01021852|3019128|P4|Treatment Period 1|Pregnancy|0
915975|NCT01021852|3019129|P3|Treatment Period 1|Pregnancy|1
915976|NCT01021852|3019130|P2|Treatment Period 1|Pregnancy|0
915977|NCT01021852|3019131|P1|Treatment Period 1|Pregnancy|0
915978|NCT01021852|3019124|P8|Treatment Period 1|Adverse Event|0
915979|NCT01021852|3019125|P7|Treatment Period 1|Adverse Event|0
915980|NCT01021852|3019126|P6|Treatment Period 1|Adverse Event|2
915981|NCT01021852|3019127|P5|Treatment Period 1|Adverse Event|2
915982|NCT01021852|3019128|P4|Treatment Period 1|Adverse Event|0
915983|NCT01021852|3019129|P3|Treatment Period 1|Adverse Event|1
915984|NCT01021852|3019130|P2|Treatment Period 1|Adverse Event|1
915985|NCT01021852|3019131|P1|Treatment Period 1|Adverse Event|3
915986|NCT01021813|3019167|P5|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
915987|NCT01021813|3019168|P4|DB Randomized Discontinuation Phase|Withdrawal by Subject|1
915988|NCT01021813|3019169|P3|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
915989|NCT01021813|3019170|P2|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
915990|NCT01021813|3019171|P1|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
915991|NCT01021813|3019167|P5|DB Randomized Discontinuation Phase|Protocol Violation|0
915992|NCT01021813|3019168|P4|DB Randomized Discontinuation Phase|Protocol Violation|0
915993|NCT01021813|3019169|P3|DB Randomized Discontinuation Phase|Protocol Violation|1
915994|NCT01021813|3019170|P2|DB Randomized Discontinuation Phase|Protocol Violation|0
915995|NCT01021813|3019171|P1|DB Randomized Discontinuation Phase|Protocol Violation|0
915996|NCT01021813|3019167|P5|DB Randomized Discontinuation Phase|Lost to Follow-up|1
915997|NCT01021813|3019168|P4|DB Randomized Discontinuation Phase|Lost to Follow-up|0
915998|NCT01021813|3019169|P3|DB Randomized Discontinuation Phase|Lost to Follow-up|0
915999|NCT01021813|3019170|P2|DB Randomized Discontinuation Phase|Lost to Follow-up|0
916000|NCT01021813|3019171|P1|DB Randomized Discontinuation Phase|Lost to Follow-up|0
916001|NCT01021813|3019167|P5|DB Randomized Discontinuation Phase|Lack of Efficacy|0
916002|NCT01021813|3019168|P4|DB Randomized Discontinuation Phase|Lack of Efficacy|1
916003|NCT01021813|3019169|P3|DB Randomized Discontinuation Phase|Lack of Efficacy|0
916004|NCT01021813|3019170|P2|DB Randomized Discontinuation Phase|Lack of Efficacy|0
916005|NCT01021813|3019171|P1|DB Randomized Discontinuation Phase|Lack of Efficacy|0
916006|NCT01021813|3019167|P5|DB Randomized Discontinuation Phase|Adverse Event|1
916007|NCT01021813|3019168|P4|DB Randomized Discontinuation Phase|Adverse Event|3
916008|NCT01021813|3019169|P3|DB Randomized Discontinuation Phase|Adverse Event|0
916009|NCT01021813|3019170|P2|DB Randomized Discontinuation Phase|Adverse Event|0
916010|NCT01021813|3019171|P1|DB Randomized Discontinuation Phase|Adverse Event|0
916011|NCT01021813|3019167|P5|DB Treatment Phase|Withdrawal by Subject|0
916012|NCT01021813|3019168|P4|DB Treatment Phase|Withdrawal by Subject|0
916013|NCT01021813|3019169|P3|DB Treatment Phase|Withdrawal by Subject|0
916014|NCT01021813|3019170|P2|DB Treatment Phase|Withdrawal by Subject|24
916015|NCT01021813|3019171|P1|DB Treatment Phase|Withdrawal by Subject|60
916016|NCT01021813|3019167|P5|DB Treatment Phase|Protocol Violation|0
916017|NCT01021813|3019168|P4|DB Treatment Phase|Protocol Violation|0
916018|NCT01021813|3019169|P3|DB Treatment Phase|Protocol Violation|0
916019|NCT01021813|3019170|P2|DB Treatment Phase|Protocol Violation|3
916020|NCT01021813|3019171|P1|DB Treatment Phase|Protocol Violation|4
916021|NCT01021813|3019167|P5|DB Treatment Phase|Pregnancy|0
916022|NCT01021813|3019168|P4|DB Treatment Phase|Pregnancy|0
916023|NCT01021813|3019169|P3|DB Treatment Phase|Pregnancy|0
916024|NCT01021813|3019170|P2|DB Treatment Phase|Pregnancy|0
916025|NCT01021813|3019171|P1|DB Treatment Phase|Pregnancy|1
916026|NCT01021813|3019167|P5|DB Treatment Phase|Physician Decision|0
916027|NCT01021813|3019168|P4|DB Treatment Phase|Physician Decision|0
916028|NCT01021813|3019169|P3|DB Treatment Phase|Physician Decision|0
916029|NCT01021813|3019170|P2|DB Treatment Phase|Physician Decision|8
916030|NCT01021813|3019171|P1|DB Treatment Phase|Physician Decision|17
916031|NCT01021813|3019167|P5|DB Treatment Phase|Lost to Follow-up|0
916032|NCT01021813|3019168|P4|DB Treatment Phase|Lost to Follow-up|0
916033|NCT01021813|3019169|P3|DB Treatment Phase|Lost to Follow-up|0
916034|NCT01021813|3019170|P2|DB Treatment Phase|Lost to Follow-up|12
916035|NCT01021813|3019171|P1|DB Treatment Phase|Lost to Follow-up|14
916036|NCT01021813|3019167|P5|DB Treatment Phase|Lack of Efficacy|0
916037|NCT01021813|3019168|P4|DB Treatment Phase|Lack of Efficacy|0
916038|NCT01021813|3019169|P3|DB Treatment Phase|Lack of Efficacy|0
916039|NCT01021813|3019170|P2|DB Treatment Phase|Lack of Efficacy|28
916040|NCT01021813|3019171|P1|DB Treatment Phase|Lack of Efficacy|44
916041|NCT01021813|3019167|P5|DB Treatment Phase|Adverse Event|0
916042|NCT01021813|3019168|P4|DB Treatment Phase|Adverse Event|0
916043|NCT01021813|3019169|P3|DB Treatment Phase|Adverse Event|0
916044|NCT01021813|3019170|P2|DB Treatment Phase|Adverse Event|22
916045|NCT01021813|3019171|P1|DB Treatment Phase|Adverse Event|60
916046|NCT01021748|3019232|P9|Overall Study|Not Treated|0
916047|NCT01021748|3019233|P8|Overall Study|Not Treated|0
916048|NCT01021748|3019234|P7|Overall Study|Not Treated|0
916049|NCT01021748|3019235|P6|Overall Study|Not Treated|0
916050|NCT01021748|3019236|P5|Overall Study|Not Treated|0
916051|NCT01021748|3019237|P4|Overall Study|Not Treated|0
916052|NCT01021748|3019238|P3|Overall Study|Not Treated|0
916053|NCT01021748|3019239|P2|Overall Study|Not Treated|1
916054|NCT01021748|3019240|P1|Overall Study|Not Treated|0
916055|NCT01021748|3019232|P9|Overall Study|Withdrawal by Subject|1
916056|NCT01021748|3019233|P8|Overall Study|Withdrawal by Subject|0
916057|NCT01021748|3019234|P7|Overall Study|Withdrawal by Subject|1
916058|NCT01021748|3019235|P6|Overall Study|Withdrawal by Subject|0
916059|NCT01021748|3019236|P5|Overall Study|Withdrawal by Subject|0
916060|NCT01021748|3019237|P4|Overall Study|Withdrawal by Subject|0
916061|NCT01021748|3019238|P3|Overall Study|Withdrawal by Subject|0
916062|NCT01021748|3019239|P2|Overall Study|Withdrawal by Subject|0
916063|NCT01021748|3019240|P1|Overall Study|Withdrawal by Subject|0
916064|NCT01021748|3019232|P9|Overall Study|Progressive Disease|6
916065|NCT01021748|3019233|P8|Overall Study|Progressive Disease|5
916066|NCT01021748|3019234|P7|Overall Study|Progressive Disease|0
916067|NCT01021748|3019235|P6|Overall Study|Progressive Disease|3
916068|NCT01021748|3019236|P5|Overall Study|Progressive Disease|7
916069|NCT01021748|3019237|P4|Overall Study|Progressive Disease|6
916070|NCT01021748|3019238|P3|Overall Study|Progressive Disease|4
916071|NCT01021748|3019239|P2|Overall Study|Progressive Disease|3
916072|NCT01021748|3019240|P1|Overall Study|Progressive Disease|3
916073|NCT01021748|3019232|P9|Overall Study|Physician Decision|2
916074|NCT01021748|3019233|P8|Overall Study|Physician Decision|1
916075|NCT01021748|3019234|P7|Overall Study|Physician Decision|1
916076|NCT01021748|3019235|P6|Overall Study|Physician Decision|0
916077|NCT01021748|3019236|P5|Overall Study|Physician Decision|0
916078|NCT01021748|3019237|P4|Overall Study|Physician Decision|1
916079|NCT01021748|3019238|P3|Overall Study|Physician Decision|1
916080|NCT01021748|3019239|P2|Overall Study|Physician Decision|0
916081|NCT01021748|3019240|P1|Overall Study|Physician Decision|1
916082|NCT01021748|3019232|P9|Overall Study|Adverse Event|7
916083|NCT01021748|3019233|P8|Overall Study|Adverse Event|0
916084|NCT01021748|3019234|P7|Overall Study|Adverse Event|1
916085|NCT01021748|3019235|P6|Overall Study|Adverse Event|0
916086|NCT01021748|3019236|P5|Overall Study|Adverse Event|2
916087|NCT01021748|3019237|P4|Overall Study|Adverse Event|0
916088|NCT01021748|3019238|P3|Overall Study|Adverse Event|2
916089|NCT01021748|3019239|P2|Overall Study|Adverse Event|1
916090|NCT01021748|3019240|P1|Overall Study|Adverse Event|2
916091|NCT01021683|3019287|P1|Overall Study|Other|8
916092|NCT01021683|3019287|P1|Overall Study|Recovery of neutrophil count|51
916093|NCT01021683|3019287|P1|Overall Study|Lack of Efficacy|12
916094|NCT01021553|3019313|P3|Overall Study|Withdrawal by Subject|0
916095|NCT01021553|3019314|P2|Overall Study|Withdrawal by Subject|1
916096|NCT01021553|3019315|P1|Overall Study|Withdrawal by Subject|1
916097|NCT01021553|3019313|P3|Overall Study|Lost to Follow-up|1
916098|NCT01021553|3019314|P2|Overall Study|Lost to Follow-up|0
916099|NCT01021553|3019315|P1|Overall Study|Lost to Follow-up|0
916100|NCT01021553|3019313|P3|Overall Study|Protocol Violation|2
916101|NCT01021553|3019314|P2|Overall Study|Protocol Violation|2
916102|NCT01021553|3019315|P1|Overall Study|Protocol Violation|0
916103|NCT01021553|3019313|P3|Overall Study|Lack of Efficacy|0
916104|NCT01021553|3019314|P2|Overall Study|Lack of Efficacy|2
916105|NCT01021553|3019315|P1|Overall Study|Lack of Efficacy|2
916106|NCT01021553|3019313|P3|Overall Study|Adverse Event|0
916107|NCT01021553|3019314|P2|Overall Study|Adverse Event|0
916108|NCT01021553|3019315|P1|Overall Study|Adverse Event|1
916109|NCT01021423|3019369|P2|Overall Study|Study terminated|5
916110|NCT01021423|3019370|P1|Overall Study|Study terminated|4
916111|NCT01021332|3019386|P1|Overall Study|Miscellaneous|3
916112|NCT01021332|3019386|P1|Overall Study|Protocol Violation|9
916113|NCT01021332|3019386|P1|Overall Study|Lost to Follow-up|4
916114|NCT01021332|3019386|P1|Overall Study|Withdrawal of Consent|23
916115|NCT01021332|3019386|P1|Overall Study|Lack of Efficacy|19
916116|NCT01021332|3019386|P1|Overall Study|Adverse Event|43
916117|NCT01021332|3019386|P1|Overall Study|Not fulfilling incl./excl.criteria|5
916118|NCT01021293|3019447|P2|Overall Study|Lost to Follow-up|1
916119|NCT01021293|3019448|P1|Overall Study|Lost to Follow-up|1
916120|NCT01021293|3019447|P2|Overall Study|Migrated/moved from study area|18
916121|NCT01021293|3019448|P1|Overall Study|Migrated/moved from study area|6
916122|NCT01021293|3019447|P2|Overall Study|Withdrawal by Subject|3
916123|NCT01021293|3019448|P1|Overall Study|Withdrawal by Subject|1
916124|NCT01021293|3019447|P2|Overall Study|Adverse Event|1
916125|NCT01021293|3019448|P1|Overall Study|Adverse Event|2
916126|NCT01021293|3019447|P2|Overall Study|Serious Adverse Event|1
916127|NCT01021293|3019448|P1|Overall Study|Serious Adverse Event|2
916128|NCT01021215|3019467|P2|Overall Study|Lost to Follow-up|0
916129|NCT01021215|3019468|P1|Overall Study|Lost to Follow-up|3
916130|NCT01021020|3019483|P1|14 Day Washout Period A|Physician Decision|1
916131|NCT01021020|3019483|P1|Period I|Withdrawal by Subject|1
916132|NCT01021020|3019483|P1|Period I|Protocol Violation|1
916133|NCT01021007|3019499|P2|Overall Study|Adverse Event|3
916134|NCT01021007|3019500|P1|Overall Study|Adverse Event|1
916135|NCT01021007|3019499|P2|Overall Study|Lost to Follow-up|1
916136|NCT01021007|3019500|P1|Overall Study|Lost to Follow-up|1
916137|NCT01020981|3019512|P2|Overall Study|Participant declined to complete survey|0
916138|NCT01020981|3019513|P1|Overall Study|Participant declined to complete survey|2
916139|NCT01020981|3019512|P2|Overall Study|Survey returned undeliverable|32
916140|NCT01020981|3019513|P1|Overall Study|Survey returned undeliverable|8
916141|NCT01020981|3019512|P2|Overall Study|Did not return mailed survey|58
916142|NCT01020981|3019513|P1|Overall Study|Did not return mailed survey|74
916143|NCT01020877|3019534|P2|Second Intervention|Withdrawal by Subject|0
916144|NCT01020877|3019535|P1|Second Intervention|Withdrawal by Subject|1
916145|NCT01020838|3019545|P1|Overall Study|Most common: Study ended by sponsor|77
916146|NCT01020838|3019545|P1|Overall Study|Lost to Follow-up|6
916147|NCT01020838|3019545|P1|Overall Study|Withdrawal by Subject|9
916148|NCT01020838|3019545|P1|Overall Study|Adverse Event|1
916149|NCT01020838|3019545|P1|Overall Study|Death|90
916150|NCT01020812|3019560|P1|Overall Study|Protocol Violation|1
916151|NCT01020812|3019560|P1|Overall Study|Withdrawal by Subject|1
916152|NCT01020812|3019560|P1|Overall Study|Physician Decision|1
916153|NCT01020799|3019570|P3|Overall Study|Lost to Follow-up|2
916154|NCT01020799|3019571|P2|Overall Study|Lost to Follow-up|4
916155|NCT01020799|3019572|P1|Overall Study|Lost to Follow-up|6
916156|NCT01020799|3019570|P3|Overall Study|Withdrawal by Subject|3
916157|NCT01020799|3019571|P2|Overall Study|Withdrawal by Subject|2
916158|NCT01020799|3019572|P1|Overall Study|Withdrawal by Subject|2
916159|NCT01020799|3019570|P3|Overall Study|Protocol Violation|0
916160|NCT01020799|3019571|P2|Overall Study|Protocol Violation|2
916161|NCT01020799|3019572|P1|Overall Study|Protocol Violation|3
916162|NCT01020799|3019570|P3|Overall Study|non-compliance; lack of efficacy; etc.|0
916163|NCT01020799|3019571|P2|Overall Study|non-compliance; lack of efficacy; etc.|3
916164|NCT01020799|3019572|P1|Overall Study|non-compliance; lack of efficacy; etc.|4
916165|NCT01020799|3019570|P3|Overall Study|Adverse Event|2
916166|NCT01020799|3019571|P2|Overall Study|Adverse Event|3
916167|NCT01020799|3019572|P1|Overall Study|Adverse Event|4
916168|NCT01020786|3019595|P1|Maintenance Period|Sponsor Decision|1
916169|NCT01020786|3019595|P1|Maintenance Period|Withdrawal by Subject|8
916170|NCT01020786|3019595|P1|Maintenance Period|Progressive Disease|43
916171|NCT01020786|3019595|P1|Maintenance Period|Adverse Event|8
916172|NCT01020786|3019595|P1|Induction Period|Withdrawal by Subject|3
916173|NCT01020786|3019595|P1|Induction Period|Investigator Decision|3
916174|NCT01020786|3019595|P1|Induction Period|Progressive Disease|31
916175|NCT01020786|3019595|P1|Induction Period|Adverse Event|10
916176|NCT01020786|3019595|P1|Induction Period|Entry Criteria Not Met|2
916177|NCT01020773|3019609|P2|Overall Study|Withdrawal by Subject|3
916178|NCT01020773|3019610|P1|Overall Study|Withdrawal by Subject|4
916179|NCT01020747|3019616|P1|Overall Study|Withdrawal by Subject|1
916180|NCT01020526|3019632|P1|Overall Study|Adverse Event|2
916181|NCT01020526|3019632|P1|Overall Study|Lost to Follow-up|1
916182|NCT01020526|3019632|P1|Overall Study|Insufficient clinical response|3
916183|NCT01020526|3019632|P1|Overall Study|Other reasons|3
916184|NCT01020526|3019632|P1|Overall Study|Withdrawal by Subject|5
916185|NCT01020474|3019638|P2|Overall Study|Insufficient Clinical Response|3
916186|NCT01020474|3019639|P1|Overall Study|Insufficient Clinical Response|0
916187|NCT01020474|3019638|P2|Overall Study|Other Reasons|1
916188|NCT01020474|3019639|P1|Overall Study|Other Reasons|1
916189|NCT01020474|3019638|P2|Overall Study|Withdrawal by Subject|7
916190|NCT01020474|3019639|P1|Overall Study|Withdrawal by Subject|5
916191|NCT01020474|3019638|P2|Overall Study|Protocol Violation|2
916192|NCT01020474|3019639|P1|Overall Study|Protocol Violation|0
916193|NCT01020474|3019638|P2|Overall Study|Adverse Event|4
916194|NCT01020474|3019639|P1|Overall Study|Adverse Event|4
916195|NCT01020448|3019659|P1|Treatment|Lost to Follow-up|2
916196|NCT01020448|3019659|P1|Treatment|Lack of Efficacy|8
916197|NCT01020448|3019659|P1|Treatment|Disease Progression|2
916198|NCT01020448|3019659|P1|Treatment|Consent Withdrawn|3
916199|NCT01020448|3019659|P1|Treatment|Adverse Event|11
916200|NCT01020448|3019659|P1|Pre-assignment|Does Not Meet Entry Criteria|2
916201|NCT01020448|3019659|P1|Pre-assignment|Withdrawal by Subject|5
916202|NCT01020448|3019659|P1|Pre-assignment|Adverse Event|6
916203|NCT01020435|3019670|P2|Overall Study|Lost to Follow-up|1
916204|NCT01020435|3019671|P1|Overall Study|Lost to Follow-up|0
916205|NCT01020305|3019679|P1|Overall Study|Adverse Event|2
916206|NCT01020123|3019690|P7|Extention Period|Lost to Follow-up|0
916207|NCT01020123|3019691|P6|Extention Period|Lost to Follow-up|2
916208|NCT01020123|3019692|P5|Extention Period|Lost to Follow-up|0
916209|NCT01020123|3019693|P4|Extention Period|Lost to Follow-up|0
916210|NCT01020123|3019694|P3|Extention Period|Lost to Follow-up|0
916211|NCT01020123|3019695|P2|Extention Period|Lost to Follow-up|0
916212|NCT01020123|3019696|P1|Extention Period|Lost to Follow-up|0
916213|NCT01020123|3019690|P7|Extention Period|Protocol Violation|1
916214|NCT01020123|3019691|P6|Extention Period|Protocol Violation|0
916215|NCT01020123|3019692|P5|Extention Period|Protocol Violation|0
916216|NCT01020123|3019693|P4|Extention Period|Protocol Violation|0
916217|NCT01020123|3019694|P3|Extention Period|Protocol Violation|1
916218|NCT01020123|3019695|P2|Extention Period|Protocol Violation|1
916219|NCT01020123|3019696|P1|Extention Period|Protocol Violation|1
916220|NCT01020123|3019690|P7|Extention Period|Adverse Event|0
916221|NCT01020123|3019691|P6|Extention Period|Adverse Event|0
916222|NCT01020123|3019692|P5|Extention Period|Adverse Event|0
916223|NCT01020123|3019693|P4|Extention Period|Adverse Event|1
916224|NCT01020123|3019694|P3|Extention Period|Adverse Event|0
916225|NCT01020123|3019695|P2|Extention Period|Adverse Event|0
916226|NCT01020123|3019696|P1|Extention Period|Adverse Event|0
916227|NCT01020123|3019690|P7|Extention Period|Withdrawal by Subject|0
916228|NCT01020123|3019691|P6|Extention Period|Withdrawal by Subject|0
916229|NCT01020123|3019692|P5|Extention Period|Withdrawal by Subject|0
916230|NCT01020123|3019693|P4|Extention Period|Withdrawal by Subject|0
916231|NCT01020123|3019694|P3|Extention Period|Withdrawal by Subject|1
916232|NCT01020123|3019695|P2|Extention Period|Withdrawal by Subject|1
916233|NCT01020123|3019696|P1|Extention Period|Withdrawal by Subject|2
916234|NCT01020123|3019690|P7|Main Period|Unclasified|6
916235|NCT01020123|3019691|P6|Main Period|Unclasified|3
916236|NCT01020123|3019692|P5|Main Period|Unclasified|1
916237|NCT01020123|3019693|P4|Main Period|Unclasified|0
916238|NCT01020123|3019694|P3|Main Period|Unclasified|1
916239|NCT01020123|3019695|P2|Main Period|Unclasified|0
916240|NCT01020123|3019696|P1|Main Period|Unclasified|2
916241|NCT01020123|3019690|P7|Main Period|Lost to Follow-up|0
916242|NCT01020123|3019691|P6|Main Period|Lost to Follow-up|0
916243|NCT01020123|3019692|P5|Main Period|Lost to Follow-up|0
916244|NCT01020123|3019693|P4|Main Period|Lost to Follow-up|0
916245|NCT01020123|3019694|P3|Main Period|Lost to Follow-up|0
916246|NCT01020123|3019695|P2|Main Period|Lost to Follow-up|2
916247|NCT01020123|3019696|P1|Main Period|Lost to Follow-up|0
916248|NCT01020123|3019690|P7|Main Period|Protocol Violation|2
916249|NCT01020123|3019691|P6|Main Period|Protocol Violation|3
916250|NCT01020123|3019692|P5|Main Period|Protocol Violation|2
916251|NCT01020123|3019693|P4|Main Period|Protocol Violation|5
916252|NCT01020123|3019694|P3|Main Period|Protocol Violation|2
916253|NCT01020123|3019695|P2|Main Period|Protocol Violation|4
916254|NCT01020123|3019696|P1|Main Period|Protocol Violation|4
916255|NCT01020123|3019690|P7|Main Period|Adverse Event|1
916256|NCT01020123|3019691|P6|Main Period|Adverse Event|2
916257|NCT01020123|3019692|P5|Main Period|Adverse Event|1
916258|NCT01020123|3019693|P4|Main Period|Adverse Event|1
916259|NCT01020123|3019694|P3|Main Period|Adverse Event|2
916260|NCT01020123|3019695|P2|Main Period|Adverse Event|2
916261|NCT01020123|3019696|P1|Main Period|Adverse Event|5
916262|NCT01020123|3019690|P7|Main Period|Eligibility Criteria not fullfilled|0
916263|NCT01020123|3019691|P6|Main Period|Eligibility Criteria not fullfilled|0
916264|NCT01020123|3019692|P5|Main Period|Eligibility Criteria not fullfilled|1
916265|NCT01020123|3019693|P4|Main Period|Eligibility Criteria not fullfilled|0
916266|NCT01020123|3019694|P3|Main Period|Eligibility Criteria not fullfilled|0
916267|NCT01020123|3019695|P2|Main Period|Eligibility Criteria not fullfilled|1
916268|NCT01020123|3019696|P1|Main Period|Eligibility Criteria not fullfilled|0
916269|NCT01020123|3019690|P7|Main Period|Withdrawal by Subject|2
916270|NCT01020123|3019691|P6|Main Period|Withdrawal by Subject|3
916271|NCT01020123|3019692|P5|Main Period|Withdrawal by Subject|6
916272|NCT01020123|3019693|P4|Main Period|Withdrawal by Subject|1
916273|NCT01020123|3019694|P3|Main Period|Withdrawal by Subject|3
916274|NCT01020123|3019695|P2|Main Period|Withdrawal by Subject|5
916275|NCT01020123|3019696|P1|Main Period|Withdrawal by Subject|6
916276|NCT01020019|3019891|P2|Overall Study|moving|2
916277|NCT01020019|3019892|P1|Overall Study|moving|0
916278|NCT01020019|3019891|P2|Overall Study|not interested in treatment|4
916279|NCT01020019|3019892|P1|Overall Study|not interested in treatment|4
916280|NCT01020019|3019891|P2|Overall Study|Adverse Event|5
916281|NCT01020019|3019892|P1|Overall Study|Adverse Event|1
916282|NCT01020019|3019891|P2|Overall Study|Lost to Follow-up|18
916283|NCT01020019|3019892|P1|Overall Study|Lost to Follow-up|21
916284|NCT01019980|3019913|P2|Overall Study|Drug not available.|0
916285|NCT01019980|3019914|P1|Overall Study|Drug not available.|2
916286|NCT01019694|3019977|P3|Overall Study|Other reason (not specified)|6
916287|NCT01019694|3019978|P2|Overall Study|Other reason (not specified)|5
916288|NCT01019694|3019979|P1|Overall Study|Other reason (not specified)|1
916289|NCT01019694|3019977|P3|Overall Study|Not treated|3
916290|NCT01019694|3019978|P2|Overall Study|Not treated|2
916291|NCT01019694|3019979|P1|Overall Study|Not treated|0
916292|NCT01019694|3019977|P3|Overall Study|Withdrawal by Subject|12
916293|NCT01019694|3019978|P2|Overall Study|Withdrawal by Subject|6
916294|NCT01019694|3019979|P1|Overall Study|Withdrawal by Subject|4
916295|NCT01019694|3019977|P3|Overall Study|Lost to Follow-up|3
916296|NCT01019694|3019978|P2|Overall Study|Lost to Follow-up|3
916297|NCT01019694|3019979|P1|Overall Study|Lost to Follow-up|5
916298|NCT01019694|3019977|P3|Overall Study|Protocol Violation|4
916299|NCT01019694|3019978|P2|Overall Study|Protocol Violation|6
916300|NCT01019694|3019979|P1|Overall Study|Protocol Violation|2
916301|NCT01019694|3019977|P3|Overall Study|Adverse Event|19
916302|NCT01019694|3019978|P2|Overall Study|Adverse Event|16
916303|NCT01019694|3019979|P1|Overall Study|Adverse Event|12
916304|NCT01019486|3020104|P3|Overall Study|Withdrawal by Subject|1
916305|NCT01019486|3020105|P2|Overall Study|Withdrawal by Subject|1
916306|NCT01019486|3020106|P1|Overall Study|Withdrawal by Subject|1
916307|NCT01019369|3020120|P2|Overall Study|Withdrawal by Subject|1
916308|NCT01019369|3020121|P1|Overall Study|Withdrawal by Subject|0
916309|NCT01019369|3020120|P2|Overall Study|Lost to Follow-up|6
916310|NCT01019369|3020121|P1|Overall Study|Lost to Follow-up|10
916311|NCT01019317|3020129|P1|Overall Study|Not Eligible|4
916312|NCT01019252|3020135|P2|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5
916313|NCT01019252|3020136|P1|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0
916314|NCT01019252|3020135|P2|Wait List Cross-over to CBT for ADHD|Time constraints|2
916315|NCT01019252|3020136|P1|Wait List Cross-over to CBT for ADHD|Time constraints|0
916316|NCT01019252|3020135|P2|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0
916317|NCT01019252|3020136|P1|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1
916318|NCT01019252|3020135|P2|Initial CBT for ADHD vs. Wait List|Time constraints|0
916319|NCT01019252|3020136|P1|Initial CBT for ADHD vs. Wait List|Time constraints|2
916320|NCT01019135|3020149|P3|Overall Study|Did not attend CR|6
916321|NCT01019135|3020150|P2|Overall Study|Did not attend CR|13
916322|NCT01019135|3020151|P1|Overall Study|Did not attend CR|8
916323|NCT01019135|3020149|P3|Overall Study|Did not receive allocated intervention|25
916324|NCT01019135|3020150|P2|Overall Study|Did not receive allocated intervention|6
916325|NCT01019135|3020151|P1|Overall Study|Did not receive allocated intervention|12
916326|NCT01018992|3020179|P2|Overall Study|Lost to Follow-up|1
916327|NCT01018992|3020180|P1|Overall Study|Lost to Follow-up|5
916328|NCT01018992|3020179|P2|Overall Study|Protocol Violation|4
916329|NCT01018992|3020180|P1|Overall Study|Protocol Violation|0
916330|NCT01018992|3020179|P2|Overall Study|Withdrawal by Subject|8
916331|NCT01018992|3020180|P1|Overall Study|Withdrawal by Subject|3
916332|NCT01018992|3020179|P2|Overall Study|Adverse Event|3
916333|NCT01018992|3020180|P1|Overall Study|Adverse Event|8
916334|NCT01018979|3020194|P2|Overall Study|Not received at least one dose|1
916335|NCT01018979|3020195|P1|Overall Study|Not received at least one dose|0
916336|NCT01018979|3020194|P2|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9
916337|NCT01018979|3020195|P1|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3
916338|NCT01018953|3020225|P1|Overall Study|Study termination by sponsor|5
916339|NCT01018953|3020225|P1|Overall Study|Withdrawal by Subject|1
916340|NCT01018953|3020225|P1|Overall Study|Adverse Event|2
916341|NCT01018862|3020238|P3|Overall Study|administrative problems|4
916342|NCT01018862|3020239|P2|Overall Study|administrative problems|4
916343|NCT01018862|3020240|P1|Overall Study|administrative problems|5
916344|NCT01018862|3020238|P3|Overall Study|Withdrawal by Subject|1
916345|NCT01018862|3020239|P2|Overall Study|Withdrawal by Subject|2
916346|NCT01018862|3020240|P1|Overall Study|Withdrawal by Subject|1
916347|NCT01018862|3020238|P3|Overall Study|Protocol Violation|3
916348|NCT01018862|3020239|P2|Overall Study|Protocol Violation|3
916349|NCT01018862|3020240|P1|Overall Study|Protocol Violation|1
916350|NCT01018862|3020238|P3|Overall Study|Lost to Follow-up|0
916351|NCT01018862|3020239|P2|Overall Study|Lost to Follow-up|1
916352|NCT01018862|3020240|P1|Overall Study|Lost to Follow-up|3
916353|NCT01018862|3020238|P3|Overall Study|Lack of Efficacy|2
916354|NCT01018862|3020239|P2|Overall Study|Lack of Efficacy|0
916355|NCT01018862|3020240|P1|Overall Study|Lack of Efficacy|1
916356|NCT01018862|3020238|P3|Overall Study|Adverse Event|6
916357|NCT01018862|3020239|P2|Overall Study|Adverse Event|0
916358|NCT01018862|3020240|P1|Overall Study|Adverse Event|2
916359|NCT01018810|3020262|P5|Overall Study|Sponsor Decision|1
916360|NCT01018810|3020263|P4|Overall Study|Sponsor Decision|1
916361|NCT01018810|3020264|P3|Overall Study|Sponsor Decision|1
916362|NCT01018810|3020265|P2|Overall Study|Sponsor Decision|0
916363|NCT01018810|3020266|P1|Overall Study|Sponsor Decision|2
916364|NCT01018810|3020262|P5|Overall Study|Withdrawal by Subject|0
916365|NCT01018810|3020263|P4|Overall Study|Withdrawal by Subject|0
916366|NCT01018810|3020264|P3|Overall Study|Withdrawal by Subject|0
916367|NCT01018810|3020265|P2|Overall Study|Withdrawal by Subject|1
916368|NCT01018810|3020266|P1|Overall Study|Withdrawal by Subject|0
916369|NCT01018732|3020326|P3|Overall Study|Unable to Classify|1
916370|NCT01018732|3020327|P2|Overall Study|Unable to Classify|0
916371|NCT01018732|3020328|P1|Overall Study|Unable to Classify|0
916372|NCT01018732|3020326|P3|Overall Study|Inappropriate Enrollment|0
916373|NCT01018732|3020327|P2|Overall Study|Inappropriate Enrollment|1
916374|NCT01018732|3020328|P1|Overall Study|Inappropriate Enrollment|0
916375|NCT01018732|3020326|P3|Overall Study|Protocol Violation|0
916376|NCT01018732|3020327|P2|Overall Study|Protocol Violation|1
916377|NCT01018732|3020328|P1|Overall Study|Protocol Violation|1
916378|NCT01018732|3020326|P3|Overall Study|Lost to Follow-up|3
916379|NCT01018732|3020327|P2|Overall Study|Lost to Follow-up|0
916380|NCT01018732|3020328|P1|Overall Study|Lost to Follow-up|0
916381|NCT01018680|3020362|P2|Overall Study|Physician Decision|1
916382|NCT01018680|3020363|P1|Overall Study|Physician Decision|3
916383|NCT01018680|3020362|P2|Overall Study|Entry Criteria Not Met|4
916384|NCT01018680|3020363|P1|Overall Study|Entry Criteria Not Met|1
916385|NCT01018680|3020362|P2|Overall Study|Lost to Follow-up|3
916386|NCT01018680|3020363|P1|Overall Study|Lost to Follow-up|5
916387|NCT01018680|3020362|P2|Overall Study|Lack of Efficacy|2
916388|NCT01018680|3020363|P1|Overall Study|Lack of Efficacy|8
916389|NCT01018680|3020362|P2|Overall Study|Sponsor Decision|7
916390|NCT01018680|3020363|P1|Overall Study|Sponsor Decision|6
916391|NCT01018680|3020362|P2|Overall Study|Protocol Violation|8
916392|NCT01018680|3020363|P1|Overall Study|Protocol Violation|5
916393|NCT01018680|3020362|P2|Overall Study|Withdrawal by Subject|10
916394|NCT01018680|3020363|P1|Overall Study|Withdrawal by Subject|10
916395|NCT01018680|3020362|P2|Overall Study|Adverse Event|40
916396|NCT01018680|3020363|P1|Overall Study|Adverse Event|23
916397|NCT01020487|3020406|P3|Part 2 Open-label Period|Adverse Event|1
916398|NCT01020487|3020407|P2|Part 2 Open-label Period|Adverse Event|4
916399|NCT01020487|3020408|P1|Part 2 Open-label Period|Adverse Event|0
916400|NCT01020487|3020406|P3|Part 2 Double-blind Treatment Period|Randomized in Error|1
916401|NCT01020487|3020407|P2|Part 2 Double-blind Treatment Period|Randomized in Error|0
916402|NCT01020487|3020408|P1|Part 2 Double-blind Treatment Period|Randomized in Error|0
916403|NCT01020487|3020406|P3|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3
916404|NCT01020487|3020407|P2|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
916405|NCT01020487|3020408|P1|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
916406|NCT01020487|3020406|P3|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1
916407|NCT01020487|3020407|P2|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
916408|NCT01020487|3020408|P1|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
916409|NCT01020487|3020406|P3|Part 2 Double-blind Treatment Period|Adverse Event|1
916410|NCT01020487|3020407|P2|Part 2 Double-blind Treatment Period|Adverse Event|2
916411|NCT01020487|3020408|P1|Part 2 Double-blind Treatment Period|Adverse Event|0
916412|NCT01018511|3020433|P4|Overall Study|Miscellaneous|0
916413|NCT01018511|3020434|P3|Overall Study|Miscellaneous|0
916414|NCT01018511|3020435|P2|Overall Study|Miscellaneous|2
916415|NCT01018511|3020436|P1|Overall Study|Miscellaneous|0
916416|NCT01018511|3020433|P4|Overall Study|Protocol Violation|9
916417|NCT01018511|3020434|P3|Overall Study|Protocol Violation|7
916418|NCT01018511|3020435|P2|Overall Study|Protocol Violation|8
916419|NCT01018511|3020436|P1|Overall Study|Protocol Violation|5
916420|NCT01018511|3020433|P4|Overall Study|Lost to Follow-up|0
916421|NCT01018511|3020434|P3|Overall Study|Lost to Follow-up|1
916422|NCT01018511|3020435|P2|Overall Study|Lost to Follow-up|0
916423|NCT01018511|3020436|P1|Overall Study|Lost to Follow-up|0
916424|NCT01018511|3020433|P4|Overall Study|Withdrawal by Subject|9
916425|NCT01018511|3020434|P3|Overall Study|Withdrawal by Subject|11
916426|NCT01018511|3020435|P2|Overall Study|Withdrawal by Subject|5
916427|NCT01018511|3020436|P1|Overall Study|Withdrawal by Subject|6
916428|NCT01018511|3020433|P4|Overall Study|Lack of Efficacy|2
916429|NCT01018511|3020434|P3|Overall Study|Lack of Efficacy|1
916430|NCT01018511|3020435|P2|Overall Study|Lack of Efficacy|1
916431|NCT01018511|3020436|P1|Overall Study|Lack of Efficacy|4
916432|NCT01018511|3020433|P4|Overall Study|Adverse Event|10
916433|NCT01018511|3020434|P3|Overall Study|Adverse Event|13
916434|NCT01018511|3020435|P2|Overall Study|Adverse Event|9
916435|NCT01018511|3020436|P1|Overall Study|Adverse Event|5
916436|NCT01018511|3020433|P4|Overall Study|Not fulfilling eligibility criteria|3
916437|NCT01018511|3020434|P3|Overall Study|Not fulfilling eligibility criteria|7
916438|NCT01018511|3020435|P2|Overall Study|Not fulfilling eligibility criteria|7
916439|NCT01018511|3020436|P1|Overall Study|Not fulfilling eligibility criteria|6
916440|NCT01018394|3020633|P2|Overall Study|Lost to Follow-up|3
916441|NCT01018394|3020634|P1|Overall Study|Lost to Follow-up|4
916442|NCT01018394|3020633|P2|Overall Study|Withdrawal by Subject|5
916443|NCT01018394|3020634|P1|Overall Study|Withdrawal by Subject|5
916444|NCT01018264|3020644|P2|Overall Study|Lost to Follow-up|1
916445|NCT01018264|3020645|P1|Overall Study|Lost to Follow-up|0
916446|NCT01018264|3020644|P2|Overall Study|Withdrawal by Subject|0
916447|NCT01018264|3020645|P1|Overall Study|Withdrawal by Subject|1
916448|NCT01018186|3020662|P4|52-week Double-blind Treatment Period|Withdrawal by Subject|9
916449|NCT01018186|3020663|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|7
916450|NCT01018186|3020664|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|10
916451|NCT01018186|3020665|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
916452|NCT01018186|3020662|P4|52-week Double-blind Treatment Period|Physician Decision|3
916453|NCT01018186|3020663|P3|52-week Double-blind Treatment Period|Physician Decision|0
916454|NCT01018186|3020664|P2|52-week Double-blind Treatment Period|Physician Decision|1
916455|NCT01018186|3020665|P1|52-week Double-blind Treatment Period|Physician Decision|0
916456|NCT01018186|3020662|P4|52-week Double-blind Treatment Period|Lost to Follow-up|4
916457|NCT01018186|3020663|P3|52-week Double-blind Treatment Period|Lost to Follow-up|3
916458|NCT01018186|3020664|P2|52-week Double-blind Treatment Period|Lost to Follow-up|1
916459|NCT01018186|3020665|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
916460|NCT01018186|3020662|P4|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
916461|NCT01018186|3020663|P3|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16
916462|NCT01018186|3020664|P2|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14
916463|NCT01018186|3020665|P1|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
916464|NCT01018186|3020662|P4|52-week Double-blind Treatment Period|Protocol Violation|2
916465|NCT01018186|3020663|P3|52-week Double-blind Treatment Period|Protocol Violation|8
916466|NCT01018186|3020664|P2|52-week Double-blind Treatment Period|Protocol Violation|8
916467|NCT01018186|3020665|P1|52-week Double-blind Treatment Period|Protocol Violation|0
916468|NCT01018186|3020662|P4|52-week Double-blind Treatment Period|Lack of Efficacy|1
916469|NCT01018186|3020663|P3|52-week Double-blind Treatment Period|Lack of Efficacy|4
916470|NCT01018186|3020664|P2|52-week Double-blind Treatment Period|Lack of Efficacy|1
916471|NCT01018186|3020665|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
916472|NCT01018186|3020662|P4|52-week Double-blind Treatment Period|Adverse Event|6
916473|NCT01018186|3020663|P3|52-week Double-blind Treatment Period|Adverse Event|3
916474|NCT01018186|3020664|P2|52-week Double-blind Treatment Period|Adverse Event|5
916475|NCT01018186|3020665|P1|52-week Double-blind Treatment Period|Adverse Event|0
916476|NCT01018186|3020662|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
916477|NCT01018186|3020663|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
916478|NCT01018186|3020664|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
916479|NCT01018186|3020665|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|97
916480|NCT01018186|3020662|P4|2-week Run-in Period|Withdrawal by Subject|0
916481|NCT01018186|3020663|P3|2-week Run-in Period|Withdrawal by Subject|0
916482|NCT01018186|3020664|P2|2-week Run-in Period|Withdrawal by Subject|0
916483|NCT01018186|3020665|P1|2-week Run-in Period|Withdrawal by Subject|11
916484|NCT01018186|3020662|P4|2-week Run-in Period|Physician Decision|0
916485|NCT01018186|3020663|P3|2-week Run-in Period|Physician Decision|0
916486|NCT01018186|3020664|P2|2-week Run-in Period|Physician Decision|0
916487|NCT01018186|3020665|P1|2-week Run-in Period|Physician Decision|3
916488|NCT01018186|3020662|P4|2-week Run-in Period|Lost to Follow-up|0
916489|NCT01018186|3020663|P3|2-week Run-in Period|Lost to Follow-up|0
916490|NCT01018186|3020664|P2|2-week Run-in Period|Lost to Follow-up|0
916491|NCT01018186|3020665|P1|2-week Run-in Period|Lost to Follow-up|2
916492|NCT01018186|3020662|P4|2-week Run-in Period|Protocol Violation|0
916493|NCT01018186|3020663|P3|2-week Run-in Period|Protocol Violation|0
916494|NCT01018186|3020664|P2|2-week Run-in Period|Protocol Violation|0
916495|NCT01018186|3020665|P1|2-week Run-in Period|Protocol Violation|1
916496|NCT01018030|3020866|P3|Overall Study|Did Not Receive Study Drug|0
916497|NCT01018030|3020867|P2|Overall Study|Did Not Receive Study Drug|3
916498|NCT01018030|3020868|P1|Overall Study|Did Not Receive Study Drug|1
916499|NCT01018030|3020866|P3|Overall Study|Lack of Efficacy|0
916500|NCT01018030|3020867|P2|Overall Study|Lack of Efficacy|0
916501|NCT01018030|3020868|P1|Overall Study|Lack of Efficacy|1
916502|NCT01018030|3020866|P3|Overall Study|Physician Decision|1
916503|NCT01018030|3020867|P2|Overall Study|Physician Decision|0
916504|NCT01018030|3020868|P1|Overall Study|Physician Decision|1
916505|NCT01018030|3020866|P3|Overall Study|Protocol Violation|0
916506|NCT01018030|3020867|P2|Overall Study|Protocol Violation|1
916507|NCT01018030|3020868|P1|Overall Study|Protocol Violation|2
916508|NCT01018030|3020866|P3|Overall Study|Lost to Follow-up|3
916509|NCT01018030|3020867|P2|Overall Study|Lost to Follow-up|0
916510|NCT01018030|3020868|P1|Overall Study|Lost to Follow-up|2
916511|NCT01018030|3020866|P3|Overall Study|Withdrawal by Subject|4
916512|NCT01018030|3020867|P2|Overall Study|Withdrawal by Subject|2
916513|NCT01018030|3020868|P1|Overall Study|Withdrawal by Subject|2
916514|NCT01018030|3020866|P3|Overall Study|Adverse Event|5
916515|NCT01018030|3020867|P2|Overall Study|Adverse Event|5
916516|NCT01018030|3020868|P1|Overall Study|Adverse Event|10
916517|NCT01017952|3020919|P5|52-week, Double-blind Treatment Period|Physician Decision|7
916518|NCT01017952|3020920|P4|52-week, Double-blind Treatment Period|Physician Decision|9
916519|NCT01017952|3020921|P3|52-week, Double-blind Treatment Period|Physician Decision|8
916520|NCT01017952|3020922|P2|52-week, Double-blind Treatment Period|Physician Decision|10
916521|NCT01017952|3020923|P1|52-week, Double-blind Treatment Period|Physician Decision|0
916522|NCT01017952|3020919|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|10
916523|NCT01017952|3020920|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
916524|NCT01017952|3020921|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|8
916525|NCT01017952|3020922|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|6
916526|NCT01017952|3020923|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
916527|NCT01017952|3020919|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
916528|NCT01017952|3020920|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
916529|NCT01017952|3020921|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
916530|NCT01017952|3020922|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
916531|NCT01017952|3020923|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
916532|NCT01017952|3020919|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
916533|NCT01017952|3020920|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12
916534|NCT01017952|3020921|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
916535|NCT01017952|3020922|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
916536|NCT01017952|3020923|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
916537|NCT01017952|3020919|P5|52-week, Double-blind Treatment Period|Protocol Violation|8
916538|NCT01017952|3020920|P4|52-week, Double-blind Treatment Period|Protocol Violation|9
916539|NCT01017952|3020921|P3|52-week, Double-blind Treatment Period|Protocol Violation|11
916540|NCT01017952|3020922|P2|52-week, Double-blind Treatment Period|Protocol Violation|7
916541|NCT01017952|3020923|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
916542|NCT01017952|3020919|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|14
916543|NCT01017952|3020920|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|16
916544|NCT01017952|3020921|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|14
916545|NCT01017952|3020922|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|35
916546|NCT01017952|3020923|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
916547|NCT01017952|3020919|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
916548|NCT01017952|3020920|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
916549|NCT01017952|3020921|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
916550|NCT01017952|3020922|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|30
916551|NCT01017952|3020923|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
916552|NCT01017952|3020919|P5|52-week, Double-blind Treatment Period|Adverse Event|30
916553|NCT01017952|3020920|P4|52-week, Double-blind Treatment Period|Adverse Event|35
916554|NCT01017952|3020921|P3|52-week, Double-blind Treatment Period|Adverse Event|32
916555|NCT01017952|3020922|P2|52-week, Double-blind Treatment Period|Adverse Event|25
916556|NCT01017952|3020923|P1|52-week, Double-blind Treatment Period|Adverse Event|0
916557|NCT01017952|3020919|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
916558|NCT01017952|3020920|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
916559|NCT01017952|3020921|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
916560|NCT01017952|3020922|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
916561|NCT01017952|3020923|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|63
916562|NCT01017952|3020919|P5|4-week, Open-label Run-In Period|Physician Decision|0
916563|NCT01017952|3020920|P4|4-week, Open-label Run-In Period|Physician Decision|0
916564|NCT01017952|3020921|P3|4-week, Open-label Run-In Period|Physician Decision|0
916565|NCT01017952|3020922|P2|4-week, Open-label Run-In Period|Physician Decision|0
916566|NCT01017952|3020923|P1|4-week, Open-label Run-In Period|Physician Decision|10
916567|NCT01017952|3020919|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
916568|NCT01017952|3020920|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
916569|NCT01017952|3020921|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
916570|NCT01017952|3020922|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
916571|NCT01017952|3020923|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
916572|NCT01017952|3020919|P5|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
916573|NCT01017952|3020920|P4|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
916574|NCT01017952|3020921|P3|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
916575|NCT01017952|3020922|P2|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
916576|NCT01017952|3020923|P1|4-week, Open-label Run-In Period|Study Closed/Tterminated|1
916577|NCT01017952|3020919|P5|4-week, Open-label Run-In Period|Adverse Event|0
916578|NCT01017952|3020920|P4|4-week, Open-label Run-In Period|Adverse Event|0
916579|NCT01017952|3020921|P3|4-week, Open-label Run-In Period|Adverse Event|0
916580|NCT01017952|3020922|P2|4-week, Open-label Run-In Period|Adverse Event|0
916581|NCT01017952|3020923|P1|4-week, Open-label Run-In Period|Adverse Event|23
916582|NCT01017952|3020919|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
916583|NCT01017952|3020920|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
916584|NCT01017952|3020921|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
916585|NCT01017952|3020922|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
916586|NCT01017952|3020923|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356
916587|NCT01017874|3020947|P2|Overall Study|Physician Decision|3
916588|NCT01017874|3020948|P1|Overall Study|Physician Decision|1
916589|NCT01017874|3020947|P2|Overall Study|Lost to Follow-up|2
916590|NCT01017874|3020948|P1|Overall Study|Lost to Follow-up|3
916591|NCT01017874|3020947|P2|Overall Study|Sponsor decision|1
916592|NCT01017874|3020948|P1|Overall Study|Sponsor decision|3
916593|NCT01017874|3020947|P2|Overall Study|Withdrawal by Subject|20
916594|NCT01017874|3020948|P1|Overall Study|Withdrawal by Subject|23
916595|NCT01017731|3020966|P1|Overall Study|Adverse Event|1
916596|NCT01017731|3020966|P1|Overall Study|Physician Decision|2
916597|NCT01017731|3020966|P1|Overall Study|Withdrawal by Subject|3
916598|NCT01017731|3020966|P1|Overall Study|Lost to Follow-up|2
916599|NCT01017601|3020995|P2|Overall Study|Withdrawal by Subject|1
916600|NCT01017601|3020996|P1|Overall Study|Withdrawal by Subject|0
916601|NCT01017601|3020995|P2|Overall Study|Disease Progression|12
916602|NCT01017601|3020996|P1|Overall Study|Disease Progression|12
916603|NCT01017575|3021023|P5|Overall Study|Withdrawal by Subject|0
916604|NCT01017575|3021024|P4|Overall Study|Withdrawal by Subject|0
916605|NCT01017575|3021025|P3|Overall Study|Withdrawal by Subject|0
916606|NCT01017575|3021026|P2|Overall Study|Withdrawal by Subject|0
916607|NCT01017575|3021027|P1|Overall Study|Withdrawal by Subject|1
916608|NCT01017575|3021023|P5|Overall Study|Adverse Event|2
916609|NCT01017575|3021024|P4|Overall Study|Adverse Event|0
916610|NCT01017575|3021025|P3|Overall Study|Adverse Event|0
916611|NCT01017575|3021026|P2|Overall Study|Adverse Event|1
916612|NCT01017575|3021027|P1|Overall Study|Adverse Event|0
916613|NCT01017575|3021023|P5|Overall Study|Lack of Efficacy|1
916614|NCT01017575|3021024|P4|Overall Study|Lack of Efficacy|1
916615|NCT01017575|3021025|P3|Overall Study|Lack of Efficacy|0
916616|NCT01017575|3021026|P2|Overall Study|Lack of Efficacy|1
916617|NCT01017575|3021027|P1|Overall Study|Lack of Efficacy|0
916618|NCT01017549|3021064|P1|One-year Follow-up|Withdrawal by Subject|5
916619|NCT01017549|3021064|P1|One-year Follow-up|Lost to Follow-up|2
916620|NCT01017549|3021064|P1|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1
916621|NCT01017263|3021095|P1|Overall Study|not eligible|12
916622|NCT01017146|3021176|P2|Overall Study|Change in Work Situation|0
916623|NCT01017146|3021177|P1|Overall Study|Change in Work Situation|1
916624|NCT01017146|3021176|P2|Overall Study|Did Not Meet Eligibility Criteria|2
916625|NCT01017146|3021177|P1|Overall Study|Did Not Meet Eligibility Criteria|1
916626|NCT01017146|3021176|P2|Overall Study|Took Excluded Medication|0
916627|NCT01017146|3021177|P1|Overall Study|Took Excluded Medication|2
916628|NCT01017146|3021176|P2|Overall Study|Protocol Violation|0
916629|NCT01017146|3021177|P1|Overall Study|Protocol Violation|2
916630|NCT01017146|3021176|P2|Overall Study|Pregnancy|1
916631|NCT01017146|3021177|P1|Overall Study|Pregnancy|2
916632|NCT01017146|3021176|P2|Overall Study|Relocation|4
916633|NCT01017146|3021177|P1|Overall Study|Relocation|0
916634|NCT01017146|3021176|P2|Overall Study|Withdrawal by Subject|16
916635|NCT01017146|3021177|P1|Overall Study|Withdrawal by Subject|32
916636|NCT01017146|3021176|P2|Overall Study|Noncompliance with Study Product|1
916637|NCT01017146|3021177|P1|Overall Study|Noncompliance with Study Product|1
916638|NCT01017146|3021176|P2|Overall Study|Lost to Follow-up|14
916639|NCT01017146|3021177|P1|Overall Study|Lost to Follow-up|14
916640|NCT01017146|3021176|P2|Overall Study|Adverse Event|1
916641|NCT01017146|3021177|P1|Overall Study|Adverse Event|11
916642|NCT01017120|3021215|P2|Overall Study|Parent Unable to Provide Transportation|0
916643|NCT01017120|3021216|P1|Overall Study|Parent Unable to Provide Transportation|1
916644|NCT01017120|3021215|P2|Overall Study|Protocol Violation|0
916645|NCT01017120|3021216|P1|Overall Study|Protocol Violation|1
916646|NCT01017120|3021215|P2|Overall Study|Relocated Out of Town|2
916647|NCT01017120|3021216|P1|Overall Study|Relocated Out of Town|0
916648|NCT01017120|3021215|P2|Overall Study|Did Not Meet Eligibility Criteria|0
916649|NCT01017120|3021216|P1|Overall Study|Did Not Meet Eligibility Criteria|1
916650|NCT01017120|3021215|P2|Overall Study|Pregnancy|1
916651|NCT01017120|3021216|P1|Overall Study|Pregnancy|1
916652|NCT01017120|3021215|P2|Overall Study|Withdrawal by Subject|21
916653|NCT01017120|3021216|P1|Overall Study|Withdrawal by Subject|39
916654|NCT01017120|3021215|P2|Overall Study|Lack of Efficacy|0
916655|NCT01017120|3021216|P1|Overall Study|Lack of Efficacy|1
916656|NCT01017120|3021215|P2|Overall Study|Lost to Follow-up|11
916657|NCT01017120|3021216|P1|Overall Study|Lost to Follow-up|13
916658|NCT01017120|3021215|P2|Overall Study|Adverse Event|0
916659|NCT01017120|3021216|P1|Overall Study|Adverse Event|9
916660|NCT01017029|3021277|P2|Overall Study|Death|1
916661|NCT01017029|3021278|P1|Overall Study|Death|3
916662|NCT01017029|3021277|P2|Overall Study|Administrative problem|1
916663|NCT01017029|3021278|P1|Overall Study|Administrative problem|0
916664|NCT01017029|3021277|P2|Overall Study|Lost to Follow-up|0
916665|NCT01017029|3021278|P1|Overall Study|Lost to Follow-up|1
916666|NCT01016977|3021306|P2|Overall Study|Withdrawal by Subject|2
916667|NCT01016977|3021307|P1|Overall Study|Withdrawal by Subject|2
916668|NCT01016977|3021306|P2|Overall Study|Lost to Follow-up|0
916669|NCT01016977|3021307|P1|Overall Study|Lost to Follow-up|1
916670|NCT01016964|3021343|P2|Overall Study|Lost to Follow-up|3
916671|NCT01016964|3021344|P1|Overall Study|Lost to Follow-up|3
916672|NCT01016912|3021360|P5|Follow-up Period|Other reason|0
916673|NCT01016912|3021361|P4|Follow-up Period|Other reason|1
916674|NCT01016912|3021362|P3|Follow-up Period|Other reason|1
916675|NCT01016912|3021363|P2|Follow-up Period|Other reason|0
916676|NCT01016912|3021364|P1|Follow-up Period|Other reason|0
916677|NCT01016912|3021360|P5|End of Treatment Period|Completed double-blind period only|0
916678|NCT01016912|3021361|P4|End of Treatment Period|Completed double-blind period only|0
916679|NCT01016912|3021362|P3|End of Treatment Period|Completed double-blind period only|0
916680|NCT01016912|3021363|P2|End of Treatment Period|Completed double-blind period only|1
916681|NCT01016912|3021364|P1|End of Treatment Period|Completed double-blind period only|0
916682|NCT01016912|3021360|P5|End of Treatment Period|Adverse Event|0
916683|NCT01016912|3021361|P4|End of Treatment Period|Adverse Event|0
916684|NCT01016912|3021362|P3|End of Treatment Period|Adverse Event|1
916685|NCT01016912|3021363|P2|End of Treatment Period|Adverse Event|1
916686|NCT01016912|3021364|P1|End of Treatment Period|Adverse Event|0
916687|NCT01016912|3021360|P5|End of Treatment Period|Lack of Efficacy|4
916688|NCT01016912|3021361|P4|End of Treatment Period|Lack of Efficacy|4
916689|NCT01016912|3021362|P3|End of Treatment Period|Lack of Efficacy|0
916690|NCT01016912|3021363|P2|End of Treatment Period|Lack of Efficacy|1
916691|NCT01016912|3021364|P1|End of Treatment Period|Lack of Efficacy|0
916692|NCT01016600|3021525|P4|Overall Study|Did not start treatment|0
916693|NCT01016600|3021526|P3|Overall Study|Did not start treatment|0
916694|NCT01016600|3021527|P2|Overall Study|Did not start treatment|0
916695|NCT01016600|3021528|P1|Overall Study|Did not start treatment|1
916696|NCT01016132|3021713|P1|Overall Study|Discomfort|1
916697|NCT01016067|3021728|P2|Overall Study|Withdrew due to Relocation|1
916698|NCT01016067|3021729|P1|Overall Study|Withdrew due to Relocation|0
916699|NCT01016067|3021728|P2|Overall Study|Physician Decision|1
916700|NCT01016067|3021729|P1|Overall Study|Physician Decision|1
916701|NCT01016067|3021728|P2|Overall Study|Lost to Follow-up|2
916702|NCT01016067|3021729|P1|Overall Study|Lost to Follow-up|1
916703|NCT01016015|3021747|P1|Overall Study|Adverse Event|15
916704|NCT01016015|3021747|P1|Overall Study|Withdrawal by Subject|1
916705|NCT01016015|3021747|P1|Overall Study|Not Treated|3
916706|NCT01015833|3021758|P2|Overall Study|Did not start treatment|0
916707|NCT01015833|3021759|P1|Overall Study|Did not start treatment|1
916708|NCT01015833|3021758|P2|Overall Study|Motor Vehicle Accidents|0
916709|NCT01015833|3021759|P1|Overall Study|Motor Vehicle Accidents|1
916710|NCT01015833|3021758|P2|Overall Study|Other|1
916711|NCT01015833|3021759|P1|Overall Study|Other|5
916712|NCT01015833|3021758|P2|Overall Study|Symptomatic deterioration|1
916713|NCT01015833|3021759|P1|Overall Study|Symptomatic deterioration|0
916714|NCT01015833|3021758|P2|Overall Study|Physician Decision|0
916715|NCT01015833|3021759|P1|Overall Study|Physician Decision|2
916716|NCT01015833|3021758|P2|Overall Study|Adverse Event|1
916717|NCT01015833|3021759|P1|Overall Study|Adverse Event|0
916718|NCT01015833|3021758|P2|Overall Study|Withdrawal by Subject|2
916719|NCT01015833|3021759|P1|Overall Study|Withdrawal by Subject|3
916720|NCT01015833|3021758|P2|Overall Study|Death|0
916721|NCT01015833|3021759|P1|Overall Study|Death|1
916722|NCT01015820|3021775|P2|Overall Study|Suboptimal measurements|0
916723|NCT01015820|3021776|P1|Overall Study|Suboptimal measurements|1
916724|NCT01015703|3021811|P5|Overall Study|Protocol Violation|0
916725|NCT01015703|3021812|P4|Overall Study|Protocol Violation|0
916726|NCT01015703|3021813|P3|Overall Study|Protocol Violation|0
916727|NCT01015703|3021814|P2|Overall Study|Protocol Violation|0
916728|NCT01015703|3021815|P1|Overall Study|Protocol Violation|1
916729|NCT01015703|3021811|P5|Overall Study|Adverse Event|0
916730|NCT01015703|3021812|P4|Overall Study|Adverse Event|0
916731|NCT01015703|3021813|P3|Overall Study|Adverse Event|0
916732|NCT01015703|3021814|P2|Overall Study|Adverse Event|0
916733|NCT01015703|3021815|P1|Overall Study|Adverse Event|1
916734|NCT01015703|3021811|P5|Overall Study|Withdrawal by Subject|0
916735|NCT01015703|3021812|P4|Overall Study|Withdrawal by Subject|0
916736|NCT01015703|3021813|P3|Overall Study|Withdrawal by Subject|0
916737|NCT01015703|3021814|P2|Overall Study|Withdrawal by Subject|1
916738|NCT01015703|3021815|P1|Overall Study|Withdrawal by Subject|0
916739|NCT01015677|3021830|P3|Overall Study|Withdrawal by Subject|0
916740|NCT01015677|3021831|P2|Overall Study|Withdrawal by Subject|1
916741|NCT01015677|3021832|P1|Overall Study|Withdrawal by Subject|1
916742|NCT01015677|3021830|P3|Overall Study|Protocol Violation|0
916743|NCT01015677|3021831|P2|Overall Study|Protocol Violation|1
916744|NCT01015677|3021832|P1|Overall Study|Protocol Violation|0
916745|NCT01015677|3021830|P3|Overall Study|Lack of Efficacy|0
916746|NCT01015677|3021831|P2|Overall Study|Lack of Efficacy|1
916747|NCT01015677|3021832|P1|Overall Study|Lack of Efficacy|0
916748|NCT01015677|3021830|P3|Overall Study|Adverse Event|0
916749|NCT01015677|3021831|P2|Overall Study|Adverse Event|1
916750|NCT01015677|3021832|P1|Overall Study|Adverse Event|0
916751|NCT01015638|3021854|P2|Overall Study|Withdrawal by Subject|0
916752|NCT01015638|3021855|P1|Overall Study|Withdrawal by Subject|1
916753|NCT01015612|3021883|P1|Overall Study|Withdrawal by Subject|40
916754|NCT01015612|3021883|P1|Overall Study|Death|113
916755|NCT01015560|3021893|P1|Overall Study|Withdrawal by Subject|1
916756|NCT01015560|3021893|P1|Overall Study|Not protocol specified|1
916757|NCT01015560|3021893|P1|Overall Study|Adverse Event|1
916758|NCT01015287|3021942|P2|Overall Study|Protocol Violation|1
916759|NCT01015287|3021943|P1|Overall Study|Protocol Violation|1
916760|NCT01015287|3021942|P2|Overall Study|Lost to Follow-up|1
916761|NCT01015287|3021943|P1|Overall Study|Lost to Follow-up|2
916762|NCT01015287|3021942|P2|Overall Study|Entry Criteria not Met|14
916763|NCT01015287|3021943|P1|Overall Study|Entry Criteria not Met|11
916764|NCT01015287|3021942|P2|Overall Study|Withdrawal by Subject|19
916765|NCT01015287|3021943|P1|Overall Study|Withdrawal by Subject|14
916766|NCT01015287|3021942|P2|Overall Study|Physician Decision|21
916767|NCT01015287|3021943|P1|Overall Study|Physician Decision|19
916768|NCT01015287|3021942|P2|Overall Study|Sponsor Decision|7
916769|NCT01015287|3021943|P1|Overall Study|Sponsor Decision|3
916770|NCT01015287|3021942|P2|Overall Study|Adverse Event|0
916771|NCT01015287|3021943|P1|Overall Study|Adverse Event|1
916772|NCT01015287|3021942|P2|Overall Study|Death|16
916773|NCT01015287|3021943|P1|Overall Study|Death|21
916774|NCT01015131|3021975|P1|Overall Study|Other Protocol Specified Criteria|4
916775|NCT01015131|3021975|P1|Overall Study|Withdrawal by Subject|2
916776|NCT01015131|3021975|P1|Overall Study|Protocol Violation|1
916777|NCT01015131|3021975|P1|Overall Study|Physician Decision|1
916778|NCT01015118|3021991|P2|Overall Study|Other than stated above|23
916779|NCT01015118|3021992|P1|Overall Study|Other than stated above|42
916780|NCT01015118|3021991|P2|Overall Study|Not treated|5
916781|NCT01015118|3021992|P1|Overall Study|Not treated|9
916782|NCT01015118|3021991|P2|Overall Study|Progressive disease|229
916783|NCT01015118|3021992|P1|Overall Study|Progressive disease|364
916784|NCT01015118|3021991|P2|Overall Study|Worsening or AE of underlying disease|4
916785|NCT01015118|3021992|P1|Overall Study|Worsening or AE of underlying disease|5
916786|NCT01015118|3021991|P2|Overall Study|Other Adverse Event (AE)|33
916787|NCT01015118|3021992|P1|Overall Study|Other Adverse Event (AE)|141
916788|NCT01015118|3021991|P2|Overall Study|Withdrawal by Subject|27
916789|NCT01015118|3021992|P1|Overall Study|Withdrawal by Subject|103
916790|NCT01015118|3021991|P2|Overall Study|Protocol Violation|6
916791|NCT01015118|3021992|P1|Overall Study|Protocol Violation|5
916792|NCT01014988|3022020|P6|Overall Study|Withdrawal by Subject|0
916793|NCT01014988|3022021|P5|Overall Study|Withdrawal by Subject|0
916794|NCT01014988|3022022|P4|Overall Study|Withdrawal by Subject|0
916795|NCT01014988|3022023|P3|Overall Study|Withdrawal by Subject|0
916796|NCT01014988|3022024|P2|Overall Study|Withdrawal by Subject|0
916797|NCT01014988|3022025|P1|Overall Study|Withdrawal by Subject|1
916798|NCT01014988|3022020|P6|Overall Study|Physician Decision|0
916799|NCT01014988|3022021|P5|Overall Study|Physician Decision|0
916800|NCT01014988|3022022|P4|Overall Study|Physician Decision|0
916801|NCT01014988|3022023|P3|Overall Study|Physician Decision|0
916802|NCT01014988|3022024|P2|Overall Study|Physician Decision|0
916803|NCT01014988|3022025|P1|Overall Study|Physician Decision|1
916804|NCT01014988|3022020|P6|Overall Study|Lost to Follow-up|0
916805|NCT01014988|3022021|P5|Overall Study|Lost to Follow-up|0
916806|NCT01014988|3022022|P4|Overall Study|Lost to Follow-up|0
916807|NCT01014988|3022023|P3|Overall Study|Lost to Follow-up|1
916808|NCT01014988|3022024|P2|Overall Study|Lost to Follow-up|0
916809|NCT01014988|3022025|P1|Overall Study|Lost to Follow-up|1
916810|NCT01014988|3022020|P6|Overall Study|Adverse Event|3
916811|NCT01014988|3022021|P5|Overall Study|Adverse Event|1
916812|NCT01014988|3022022|P4|Overall Study|Adverse Event|0
916813|NCT01014988|3022023|P3|Overall Study|Adverse Event|1
916814|NCT01014988|3022024|P2|Overall Study|Adverse Event|0
916815|NCT01014988|3022025|P1|Overall Study|Adverse Event|20
916816|NCT01014975|3022197|P3|Overall Study|Lost to Follow-up|1
916817|NCT01014975|3022198|P2|Overall Study|Lost to Follow-up|0
916818|NCT01014975|3022199|P1|Overall Study|Lost to Follow-up|0
916819|NCT01014975|3022197|P3|Overall Study|Death|4
916820|NCT01014975|3022198|P2|Overall Study|Death|3
916821|NCT01014975|3022199|P1|Overall Study|Death|3
916822|NCT01014975|3022197|P3|Overall Study|Withdrawal by Subject|1
916823|NCT01014975|3022198|P2|Overall Study|Withdrawal by Subject|0
916824|NCT01014975|3022199|P1|Overall Study|Withdrawal by Subject|1
916825|NCT01014910|3022704|P2|Overall Study|Withdrawal by Subject|2
916826|NCT01014910|3022705|P1|Overall Study|Withdrawal by Subject|0
916827|NCT01014689|3022749|P2|Overall Study|Pregnancy|0
916828|NCT01014689|3022750|P1|Overall Study|Pregnancy|1
916829|NCT01014689|3022749|P2|Overall Study|Lost to Follow-up|7
916830|NCT01014689|3022750|P1|Overall Study|Lost to Follow-up|3
916831|NCT01014689|3022749|P2|Overall Study|Protocol Violation|1
916832|NCT01014689|3022750|P1|Overall Study|Protocol Violation|1
916833|NCT01014689|3022749|P2|Overall Study|Withdrawal by Subject|4
916834|NCT01014689|3022750|P1|Overall Study|Withdrawal by Subject|5
916835|NCT01014689|3022749|P2|Overall Study|Adverse Event|0
916836|NCT01014689|3022750|P1|Overall Study|Adverse Event|3
916837|NCT01014689|3022749|P2|Overall Study|Lack of Efficacy|1
916838|NCT01014689|3022750|P1|Overall Study|Lack of Efficacy|0
916839|NCT01014585|3022785|P4|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
916840|NCT01014585|3022786|P3|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
916841|NCT01014585|3022787|P2|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23
916842|NCT01014585|3022788|P1|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18
916843|NCT01014585|3022785|P4|Overall Study|Lost to Follow-up|2
916844|NCT01014585|3022786|P3|Overall Study|Lost to Follow-up|0
916845|NCT01014585|3022787|P2|Overall Study|Lost to Follow-up|0
916846|NCT01014585|3022788|P1|Overall Study|Lost to Follow-up|0
916847|NCT01014585|3022785|P4|Overall Study|Withdrawal by Subject|3
916848|NCT01014585|3022786|P3|Overall Study|Withdrawal by Subject|1
916849|NCT01014585|3022787|P2|Overall Study|Withdrawal by Subject|0
916850|NCT01014585|3022788|P1|Overall Study|Withdrawal by Subject|2
916851|NCT01014585|3022785|P4|Overall Study|Adverse Event|3
916852|NCT01014585|3022786|P3|Overall Study|Adverse Event|0
916853|NCT01014585|3022787|P2|Overall Study|Adverse Event|2
916854|NCT01014585|3022788|P1|Overall Study|Adverse Event|0
916855|NCT01014533|3022808|P2|Overall Study|unable to come to appointment|3
916856|NCT01014533|3022809|P1|Overall Study|unable to come to appointment|0
916857|NCT01014533|3022808|P2|Overall Study|Withdrawal by Subject|0
916858|NCT01014533|3022809|P1|Overall Study|Withdrawal by Subject|2
916859|NCT01014533|3022808|P2|Overall Study|Protocol Violation|2
916860|NCT01014533|3022809|P1|Overall Study|Protocol Violation|3
916861|NCT01014442|3022830|P2|Overall Study|Unspecified Reason|1
916862|NCT01014442|3022831|P1|Overall Study|Unspecified Reason|1
916863|NCT01014442|3022830|P2|Overall Study|Lack of Compliance|1
916864|NCT01014442|3022831|P1|Overall Study|Lack of Compliance|0
916865|NCT01014442|3022830|P2|Overall Study|Protocol Violation|5
916866|NCT01014442|3022831|P1|Overall Study|Protocol Violation|2
916867|NCT01014442|3022830|P2|Overall Study|Withdrawal by Subject|4
916868|NCT01014442|3022831|P1|Overall Study|Withdrawal by Subject|4
916869|NCT01014442|3022830|P2|Overall Study|Adverse Event|8
916870|NCT01014442|3022831|P1|Overall Study|Adverse Event|0
916871|NCT01014208|3022951|P2|Overall Study|Study Closed/terminated|83
916872|NCT01014208|3022952|P1|Overall Study|Study Closed/terminated|78
916873|NCT01014208|3022951|P2|Overall Study|Did Not Receive Study Drug|0
916874|NCT01014208|3022952|P1|Overall Study|Did Not Receive Study Drug|2
916875|NCT01014208|3022951|P2|Overall Study|Participant Withdrew Consent|12
916876|NCT01014208|3022952|P1|Overall Study|Participant Withdrew Consent|12
916877|NCT01014208|3022951|P2|Overall Study|Lost to Follow-up|5
916878|NCT01014208|3022952|P1|Overall Study|Lost to Follow-up|2
916879|NCT01014143|3022994|P3|Second Intervention|Lost to Follow-up|0
916880|NCT01014143|3022995|P2|Second Intervention|Lost to Follow-up|0
916881|NCT01014143|3022996|P1|Second Intervention|Lost to Follow-up|2
916882|NCT01014013|3023091|P2|Overall Study|Inappropriate therapy duration, < 7 Days|1
916883|NCT01014013|3023092|P1|Overall Study|Inappropriate therapy duration, < 7 Days|0
916884|NCT01014013|3023091|P2|Overall Study|Appendectomy|0
916885|NCT01014013|3023092|P1|Overall Study|Appendectomy|1
916886|NCT01014013|3023091|P2|Overall Study|Another antibiotic therapy required|1
916887|NCT01014013|3023092|P1|Overall Study|Another antibiotic therapy required|0
916888|NCT01014013|3023091|P2|Overall Study|Physician Decision|1
916889|NCT01014013|3023092|P1|Overall Study|Physician Decision|0
916890|NCT01014013|3023091|P2|Overall Study|Pathogen resistant|4
916891|NCT01014013|3023092|P1|Overall Study|Pathogen resistant|7
916892|NCT01014013|3023091|P2|Overall Study|Negative urine culture|0
916893|NCT01014013|3023092|P1|Overall Study|Negative urine culture|2
916894|NCT01014013|3023091|P2|Overall Study|Pathogen culture = no growth|34
916895|NCT01014013|3023092|P1|Overall Study|Pathogen culture = no growth|26
916896|NCT01014013|3023091|P2|Overall Study|Clinical/microbiologic failure|2
916897|NCT01014013|3023092|P1|Overall Study|Clinical/microbiologic failure|1
916898|NCT01014013|3023091|P2|Overall Study|Withdrawal by Subject|4
916899|NCT01014013|3023092|P1|Overall Study|Withdrawal by Subject|7
916900|NCT01014013|3023091|P2|Overall Study|Protocol Violation|3
916901|NCT01014013|3023092|P1|Overall Study|Protocol Violation|1
916902|NCT01014013|3023091|P2|Overall Study|Laboratory adverse experience|1
916903|NCT01014013|3023092|P1|Overall Study|Laboratory adverse experience|1
916904|NCT01014013|3023091|P2|Overall Study|Clinical adverse experience|2
916905|NCT01014013|3023092|P1|Overall Study|Clinical adverse experience|4
916906|NCT01014013|3023091|P2|Overall Study|Inclusion/Exclusion criteria not met|3
916907|NCT01014013|3023092|P1|Overall Study|Inclusion/Exclusion criteria not met|1
916908|NCT01013961|3023104|P2|Overall Study|Physician Decision|1
916909|NCT01013961|3023105|P1|Overall Study|Physician Decision|0
916910|NCT01013961|3023104|P2|Overall Study|Withdrawal by Subject|0
916911|NCT01013961|3023105|P1|Overall Study|Withdrawal by Subject|1
916912|NCT01013961|3023104|P2|Overall Study|Adverse Event|2
916913|NCT01013961|3023105|P1|Overall Study|Adverse Event|2
916914|NCT01013883|3023123|P2|Overall Study|Lost to Follow-up|2
916915|NCT01013883|3023124|P1|Overall Study|Lost to Follow-up|2
916916|NCT01013870|3023136|P2|Overall Study|Lost to Follow-up|3
916917|NCT01013870|3023137|P1|Overall Study|Lost to Follow-up|1
916918|NCT01013792|3023186|P2|Overall Study|Lost to Follow-up|1
916919|NCT01013792|3023187|P1|Overall Study|Lost to Follow-up|0
916920|NCT01013792|3023186|P2|Overall Study|Adverse Event|3
916921|NCT01013792|3023187|P1|Overall Study|Adverse Event|0
916922|NCT01013792|3023186|P2|Overall Study|Study suspended|1
916923|NCT01013792|3023187|P1|Overall Study|Study suspended|2
916924|NCT01013753|3023193|P1|Overall Study|Other|2
916925|NCT01013753|3023193|P1|Overall Study|Withdrawal by Subject|2
916926|NCT01013753|3023193|P1|Overall Study|Lost to Follow-up|1
916927|NCT01013753|3023193|P1|Overall Study|Protocol Violation|3
916928|NCT01013753|3023193|P1|Overall Study|Adverse Event|8
916929|NCT01013740|3023389|P2|Overall Study|Ongoing: Study records not completed|2
916930|NCT01013740|3023390|P1|Overall Study|Ongoing: Study records not completed|0
916931|NCT01013740|3023389|P2|Overall Study|Missing|1
916932|NCT01013740|3023390|P1|Overall Study|Missing|2
916933|NCT01013740|3023389|P2|Overall Study|study close / terminated : done in error|1
916934|NCT01013740|3023390|P1|Overall Study|study close / terminated : done in error|2
916935|NCT01013740|3023389|P2|Overall Study|Withdrawal by Subject|10
916936|NCT01013740|3023390|P1|Overall Study|Withdrawal by Subject|2
916937|NCT01013740|3023389|P2|Overall Study|Physician Decision|0
916938|NCT01013740|3023390|P1|Overall Study|Physician Decision|2
916939|NCT01013740|3023389|P2|Overall Study|Lost to Follow-up|5
916940|NCT01013740|3023390|P1|Overall Study|Lost to Follow-up|3
916941|NCT01013701|3023414|P1|Overall Study|study prematurely terminated|7
916942|NCT01013597|3023421|P1|Overall Study|Withdrawal by Subject|1
916943|NCT01013207|3023431|P1|CPAP Post Nexus (S9)|Lost to Follow-up|6
916944|NCT01012999|3023449|P1|Overall Study|Protocol Violation|1
916945|NCT01012973|3023455|P2|Overall Study|Withdrawal by Subject|6
916946|NCT01012973|3023456|P1|Overall Study|Withdrawal by Subject|4
916947|NCT01012973|3023455|P2|Overall Study|Protocol Violation|2
916948|NCT01012973|3023456|P1|Overall Study|Protocol Violation|5
916949|NCT01012973|3023455|P2|Overall Study|Increase in vis. acuity, never injected|1
916950|NCT01012973|3023456|P1|Overall Study|Increase in vis. acuity, never injected|0
916951|NCT01012973|3023455|P2|Overall Study|(Overseas travel - indefinite period)|0
916952|NCT01012973|3023456|P1|Overall Study|(Overseas travel - indefinite period)|1
916953|NCT01012973|3023455|P2|Overall Study|Lost to Follow-up|0
916954|NCT01012973|3023456|P1|Overall Study|Lost to Follow-up|1
916955|NCT01012973|3023455|P2|Overall Study|Lack of Efficacy|5
916956|NCT01012973|3023456|P1|Overall Study|Lack of Efficacy|0
916957|NCT01012973|3023455|P2|Overall Study|Adverse Event|5
916958|NCT01012973|3023456|P1|Overall Study|Adverse Event|5
916959|NCT01012947|3023481|P5|Overall Study|Lost to Follow-up|142
916960|NCT01012947|3023482|P4|Overall Study|Lost to Follow-up|118
916961|NCT01012947|3023483|P3|Overall Study|Lost to Follow-up|130
916962|NCT01012947|3023484|P2|Overall Study|Lost to Follow-up|135
916963|NCT01012947|3023485|P1|Overall Study|Lost to Follow-up|131
916964|NCT01012765|3023506|P6|Treatment Period 2|Unsatisfactory therapeutic effect|0
916965|NCT01012765|3023507|P5|Treatment Period 2|Unsatisfactory therapeutic effect|0
916966|NCT01012765|3023508|P4|Treatment Period 2|Unsatisfactory therapeutic effect|0
916967|NCT01012765|3023509|P3|Treatment Period 2|Unsatisfactory therapeutic effect|1
916968|NCT01012765|3023510|P2|Treatment Period 2|Unsatisfactory therapeutic effect|1
916969|NCT01012765|3023511|P1|Treatment Period 2|Unsatisfactory therapeutic effect|0
916970|NCT01012765|3023506|P6|Treatment Period 2|Adverse Event|0
916971|NCT01012765|3023507|P5|Treatment Period 2|Adverse Event|0
916972|NCT01012765|3023508|P4|Treatment Period 2|Adverse Event|0
916973|NCT01012765|3023509|P3|Treatment Period 2|Adverse Event|1
916974|NCT01012765|3023510|P2|Treatment Period 2|Adverse Event|1
916975|NCT01012765|3023511|P1|Treatment Period 2|Adverse Event|0
916976|NCT01012765|3023506|P6|Treatment Period 2|Abnormal laboratory value(s)|1
916977|NCT01012765|3023507|P5|Treatment Period 2|Abnormal laboratory value(s)|0
916978|NCT01012765|3023508|P4|Treatment Period 2|Abnormal laboratory value(s)|0
916979|NCT01012765|3023509|P3|Treatment Period 2|Abnormal laboratory value(s)|0
916980|NCT01012765|3023510|P2|Treatment Period 2|Abnormal laboratory value(s)|0
916981|NCT01012765|3023511|P1|Treatment Period 2|Abnormal laboratory value(s)|0
916982|NCT01012765|3023506|P6|Treatment Period 2|Withdrawal by Subject|0
916983|NCT01012765|3023507|P5|Treatment Period 2|Withdrawal by Subject|1
916984|NCT01012765|3023508|P4|Treatment Period 2|Withdrawal by Subject|0
916985|NCT01012765|3023509|P3|Treatment Period 2|Withdrawal by Subject|1
916986|NCT01012765|3023510|P2|Treatment Period 2|Withdrawal by Subject|0
916987|NCT01012765|3023511|P1|Treatment Period 2|Withdrawal by Subject|1
916988|NCT01012765|3023506|P6|Treatment Period 1|Unsatisfactory therapeutic effect|0
916989|NCT01012765|3023507|P5|Treatment Period 1|Unsatisfactory therapeutic effect|1
916990|NCT01012765|3023508|P4|Treatment Period 1|Unsatisfactory therapeutic effect|0
916991|NCT01012765|3023509|P3|Treatment Period 1|Unsatisfactory therapeutic effect|0
916992|NCT01012765|3023510|P2|Treatment Period 1|Unsatisfactory therapeutic effect|0
916993|NCT01012765|3023511|P1|Treatment Period 1|Unsatisfactory therapeutic effect|0
916994|NCT01012765|3023506|P6|Treatment Period 1|Protocol Violation|0
916995|NCT01012765|3023507|P5|Treatment Period 1|Protocol Violation|1
916996|NCT01012765|3023508|P4|Treatment Period 1|Protocol Violation|2
916997|NCT01012765|3023509|P3|Treatment Period 1|Protocol Violation|0
916998|NCT01012765|3023510|P2|Treatment Period 1|Protocol Violation|0
916999|NCT01012765|3023511|P1|Treatment Period 1|Protocol Violation|0
917000|NCT01012765|3023506|P6|Treatment Period 1|Administrative problems|0
917001|NCT01012765|3023507|P5|Treatment Period 1|Administrative problems|1
917002|NCT01012765|3023508|P4|Treatment Period 1|Administrative problems|1
917003|NCT01012765|3023509|P3|Treatment Period 1|Administrative problems|1
917004|NCT01012765|3023510|P2|Treatment Period 1|Administrative problems|0
917005|NCT01012765|3023511|P1|Treatment Period 1|Administrative problems|0
917006|NCT01012765|3023506|P6|Treatment Period 1|Withdrawal by Subject|0
917007|NCT01012765|3023507|P5|Treatment Period 1|Withdrawal by Subject|0
917008|NCT01012765|3023508|P4|Treatment Period 1|Withdrawal by Subject|0
917009|NCT01012765|3023509|P3|Treatment Period 1|Withdrawal by Subject|0
917010|NCT01012765|3023510|P2|Treatment Period 1|Withdrawal by Subject|0
917011|NCT01012765|3023511|P1|Treatment Period 1|Withdrawal by Subject|2
917012|NCT01012765|3023506|P6|Treatment Period 1|Adverse Event|0
917013|NCT01012765|3023507|P5|Treatment Period 1|Adverse Event|0
917014|NCT01012765|3023508|P4|Treatment Period 1|Adverse Event|0
917015|NCT01012765|3023509|P3|Treatment Period 1|Adverse Event|1
917016|NCT01012765|3023510|P2|Treatment Period 1|Adverse Event|0
917017|NCT01012765|3023511|P1|Treatment Period 1|Adverse Event|1
917018|NCT01012739|3023540|P4|Treatment Period 2|Abnormal test procedure results|1
917019|NCT01012739|3023541|P3|Treatment Period 2|Abnormal test procedure results|0
917020|NCT01012739|3023542|P2|Treatment Period 2|Abnormal test procedure results|0
917021|NCT01012739|3023543|P1|Treatment Period 2|Abnormal test procedure results|0
917022|NCT01012739|3023540|P4|Treatment Period 1|Adverse Event|1
917023|NCT01012739|3023541|P3|Treatment Period 1|Adverse Event|0
917024|NCT01012739|3023542|P2|Treatment Period 1|Adverse Event|0
917025|NCT01012739|3023543|P1|Treatment Period 1|Adverse Event|0
917026|NCT01012713|3023571|P1|Overall Study|Lack of Efficacy|3
917027|NCT01012622|3023597|P1|Overall Study|withdrawal of consent by a parent|2
917028|NCT01012622|3023597|P1|Overall Study|screening failure|1
917029|NCT01012622|3023597|P1|Overall Study|Other|1
917030|NCT01012622|3023597|P1|Overall Study|non-compliance with the drug|9
917031|NCT01012622|3023597|P1|Overall Study|Adverse Event|7
917032|NCT01012622|3023597|P1|Overall Study|Lost to Follow-up|5
917033|NCT01012622|3023597|P1|Overall Study|Withdrawal by Subject|6
917034|NCT01012440|3023621|P1|Overall Study|Withdrawal by Subject|2
917035|NCT01012414|3023625|P1|Overall Study|Trial was stopped before completed|7
917036|NCT01012414|3023625|P1|Overall Study|Lost to Follow-up|1
917037|NCT01012414|3023625|P1|Overall Study|Withdrawal by Subject|2
917038|NCT01012323|3023666|P1|Overall Study|Investigator Judgment|1
917039|NCT01012258|3023703|P1|Overall Study|Ongoing|29
917040|NCT01012258|3023703|P1|Overall Study|Another Tumor Discovered|1
917041|NCT01012258|3023703|P1|Overall Study|Another Anti-cancer Drug Received|1
917042|NCT01012258|3023703|P1|Overall Study|Symptomatic Deterioration|1
917043|NCT01012258|3023703|P1|Overall Study|Progressive Disease (PD)|18
917044|NCT01012258|3023703|P1|Overall Study|Adverse Event|1
917045|NCT01012258|3023703|P1|Overall Study|Lost to Follow-up|1
917046|NCT01012258|3023703|P1|Overall Study|Death|14
917047|NCT01012219|3023750|P1|Period 2|Withdrawal by Subject|1
917048|NCT01012219|3023750|P1|Period 1|Withdrawal by Subject|1
917049|NCT01012037|3024041|P3|Overall Study|Other reason (not specified)|1
917050|NCT01012037|3024042|P2|Overall Study|Other reason (not specified)|1
917051|NCT01012037|3024043|P1|Overall Study|Other reason (not specified)|1
917052|NCT01012037|3024041|P3|Overall Study|Withdrawal by Subject|1
917053|NCT01012037|3024042|P2|Overall Study|Withdrawal by Subject|4
917054|NCT01012037|3024043|P1|Overall Study|Withdrawal by Subject|0
917055|NCT01012037|3024041|P3|Overall Study|Protocol Violation|5
917056|NCT01012037|3024042|P2|Overall Study|Protocol Violation|3
917057|NCT01012037|3024043|P1|Overall Study|Protocol Violation|0
917058|NCT01012037|3024041|P3|Overall Study|Adverse Event|3
917059|NCT01012037|3024042|P2|Overall Study|Adverse Event|8
917060|NCT01012037|3024043|P1|Overall Study|Adverse Event|0
917061|NCT01011946|3024078|P1|Overall Study|No pathological lab value|1
917062|NCT01011946|3024078|P1|Overall Study|Transferred to another hospital|2
917063|NCT01011933|3024082|P1|Overall Study|Never treated|1
917064|NCT01011933|3024082|P1|Overall Study|Inadequate pathology|1
917065|NCT01011933|3024082|P1|Overall Study|Improper pre-protocol Rx|1
917066|NCT01011933|3024082|P1|Overall Study|Wrong cell type|1
917067|NCT01011907|3024099|P2|Overall Study|Adverse Event|4
917068|NCT01011907|3024100|P1|Overall Study|Adverse Event|1
917069|NCT01011907|3024099|P2|Overall Study|Withdrawal by Subject|11
917070|NCT01011907|3024100|P1|Overall Study|Withdrawal by Subject|13
917071|NCT01011868|3024117|P3|After Week 78 Follow-up|Other reason not defined above|16
917072|NCT01011868|3024118|P2|After Week 78 Follow-up|Other reason not defined above|5
917073|NCT01011868|3024119|P1|After Week 78 Follow-up|Other reason not defined above|5
917074|NCT01011868|3024117|P3|After Week 78 Follow-up|Withdrawal by Subject|1
917075|NCT01011868|3024118|P2|After Week 78 Follow-up|Withdrawal by Subject|8
917076|NCT01011868|3024119|P1|After Week 78 Follow-up|Withdrawal by Subject|9
917077|NCT01011868|3024117|P3|After Week 78 Follow-up|Lost to Follow-up|4
917078|NCT01011868|3024118|P2|After Week 78 Follow-up|Lost to Follow-up|6
917079|NCT01011868|3024119|P1|After Week 78 Follow-up|Lost to Follow-up|11
917080|NCT01011868|3024117|P3|After Week 78 Follow-up|Protocol Violation|2
917081|NCT01011868|3024118|P2|After Week 78 Follow-up|Protocol Violation|1
917082|NCT01011868|3024119|P1|After Week 78 Follow-up|Protocol Violation|9
917083|NCT01011868|3024117|P3|After Week 78 Follow-up|Lack of Efficacy|0
917084|NCT01011868|3024118|P2|After Week 78 Follow-up|Lack of Efficacy|0
917085|NCT01011868|3024119|P1|After Week 78 Follow-up|Lack of Efficacy|4
917086|NCT01011868|3024117|P3|After Week 78 Follow-up|Adverse Event|21
917087|NCT01011868|3024118|P2|After Week 78 Follow-up|Adverse Event|18
917088|NCT01011868|3024119|P1|After Week 78 Follow-up|Adverse Event|14
917089|NCT01011868|3024117|P3|After Week 18 Follow-up|Other reason not defined above|12
917090|NCT01011868|3024118|P2|After Week 18 Follow-up|Other reason not defined above|3
917091|NCT01011868|3024119|P1|After Week 18 Follow-up|Other reason not defined above|2
917092|NCT01011868|3024117|P3|After Week 18 Follow-up|Withdrawal by Subject|0
917093|NCT01011868|3024118|P2|After Week 18 Follow-up|Withdrawal by Subject|3
917094|NCT01011868|3024119|P1|After Week 18 Follow-up|Withdrawal by Subject|6
917095|NCT01011868|3024117|P3|After Week 18 Follow-up|Lost to Follow-up|0
917096|NCT01011868|3024118|P2|After Week 18 Follow-up|Lost to Follow-up|3
917097|NCT01011868|3024119|P1|After Week 18 Follow-up|Lost to Follow-up|5
917098|NCT01011868|3024117|P3|After Week 18 Follow-up|Protocol Violation|1
917099|NCT01011868|3024118|P2|After Week 18 Follow-up|Protocol Violation|1
917100|NCT01011868|3024119|P1|After Week 18 Follow-up|Protocol Violation|1
917101|NCT01011868|3024117|P3|After Week 18 Follow-up|Lack of Efficacy|0
917102|NCT01011868|3024118|P2|After Week 18 Follow-up|Lack of Efficacy|0
917103|NCT01011868|3024119|P1|After Week 18 Follow-up|Lack of Efficacy|1
917104|NCT01011868|3024117|P3|After Week 18 Follow-up|Adverse Event|13
917105|NCT01011868|3024118|P2|After Week 18 Follow-up|Adverse Event|6
917106|NCT01011868|3024119|P1|After Week 18 Follow-up|Adverse Event|8
917107|NCT01011738|3024181|P3|Overall Study|Unknown reasons|17
917108|NCT01011738|3024182|P2|Overall Study|Unknown reasons|291
917109|NCT01011738|3024183|P1|Overall Study|Unknown reasons|312
917110|NCT01011738|3024181|P3|Overall Study|Death|0
917111|NCT01011738|3024182|P2|Overall Study|Death|3
917112|NCT01011738|3024183|P1|Overall Study|Death|12
917113|NCT01011673|3024223|P2|24 Hour Follow-up|Lost to Follow-up|3
917114|NCT01011673|3024224|P1|24 Hour Follow-up|Lost to Follow-up|3
917115|NCT01011673|3024223|P2|Randomized|Secondary headache|1
917116|NCT01011673|3024224|P1|Randomized|Secondary headache|2
917117|NCT01011556|3024247|P4|Overall Study|Inclusion/exclusion criteria not met|5
917118|NCT01011556|3024248|P3|Overall Study|Inclusion/exclusion criteria not met|3
917119|NCT01011556|3024249|P2|Overall Study|Inclusion/exclusion criteria not met|1
917120|NCT01011556|3024250|P1|Overall Study|Inclusion/exclusion criteria not met|2
917121|NCT01011556|3024247|P4|Overall Study|Sponsor decision|2
917122|NCT01011556|3024248|P3|Overall Study|Sponsor decision|1
917123|NCT01011556|3024249|P2|Overall Study|Sponsor decision|1
917124|NCT01011556|3024250|P1|Overall Study|Sponsor decision|0
917125|NCT01011556|3024247|P4|Overall Study|Withdrawal by Subject|4
917126|NCT01011556|3024248|P3|Overall Study|Withdrawal by Subject|4
917127|NCT01011556|3024249|P2|Overall Study|Withdrawal by Subject|2
917128|NCT01011556|3024250|P1|Overall Study|Withdrawal by Subject|1
917129|NCT01011556|3024247|P4|Overall Study|Protocol Violation|0
917130|NCT01011556|3024248|P3|Overall Study|Protocol Violation|0
917131|NCT01011556|3024249|P2|Overall Study|Protocol Violation|1
917132|NCT01011556|3024250|P1|Overall Study|Protocol Violation|0
917133|NCT01011556|3024247|P4|Overall Study|Physician Decision|1
917134|NCT01011556|3024248|P3|Overall Study|Physician Decision|0
917135|NCT01011556|3024249|P2|Overall Study|Physician Decision|0
917136|NCT01011556|3024250|P1|Overall Study|Physician Decision|1
917137|NCT01011556|3024247|P4|Overall Study|Lost to Follow-up|0
917138|NCT01011556|3024248|P3|Overall Study|Lost to Follow-up|0
917139|NCT01011556|3024249|P2|Overall Study|Lost to Follow-up|0
917140|NCT01011556|3024250|P1|Overall Study|Lost to Follow-up|1
917141|NCT01011556|3024247|P4|Overall Study|Adverse Event|1
917142|NCT01011556|3024248|P3|Overall Study|Adverse Event|2
917143|NCT01011556|3024249|P2|Overall Study|Adverse Event|3
917144|NCT01011556|3024250|P1|Overall Study|Adverse Event|1
917145|NCT01011465|3024328|P8|Overall Study|Withdrawal by Subject|0
917146|NCT01011465|3024329|P7|Overall Study|Withdrawal by Subject|1
917147|NCT01011465|3024330|P6|Overall Study|Withdrawal by Subject|0
917148|NCT01011465|3024331|P5|Overall Study|Withdrawal by Subject|1
917149|NCT01011465|3024332|P4|Overall Study|Withdrawal by Subject|0
917150|NCT01011465|3024333|P3|Overall Study|Withdrawal by Subject|0
917151|NCT01011465|3024334|P2|Overall Study|Withdrawal by Subject|1
917152|NCT01011465|3024335|P1|Overall Study|Withdrawal by Subject|2
917153|NCT01011439|3024363|P1|Overall Study|Sponsor's decision|15
917154|NCT01011439|3024363|P1|Overall Study|Withdrawal by Subject|1
917155|NCT01011439|3024363|P1|Overall Study|Lost to Follow-up|4
917156|NCT01011439|3024363|P1|Overall Study|Death|37
917157|NCT01011387|3024373|P1|Overall Study|Protocol Violation|1
917158|NCT01011387|3024373|P1|Overall Study|Adverse Event|2
917159|NCT01011387|3024373|P1|Overall Study|Withdrawal by Subject|3
917160|NCT01011335|3024381|P13|Overall Study|Adverse Event|1
917161|NCT01011335|3024382|P12|Overall Study|Adverse Event|0
917162|NCT01011335|3024383|P11|Overall Study|Adverse Event|4
917163|NCT01011335|3024384|P10|Overall Study|Adverse Event|0
917164|NCT01011335|3024385|P9|Overall Study|Adverse Event|0
917165|NCT01011335|3024386|P8|Overall Study|Adverse Event|0
917166|NCT01011335|3024387|P7|Overall Study|Adverse Event|0
917167|NCT01011335|3024388|P6|Overall Study|Adverse Event|0
917168|NCT01011335|3024389|P5|Overall Study|Adverse Event|0
917169|NCT01011335|3024390|P4|Overall Study|Adverse Event|0
917170|NCT01011335|3024391|P3|Overall Study|Adverse Event|0
917171|NCT01011335|3024392|P2|Overall Study|Adverse Event|0
917172|NCT01011335|3024393|P1|Overall Study|Adverse Event|0
917173|NCT01011335|3024381|P13|Overall Study|Moved/deployed or no booster|0
917174|NCT01011335|3024382|P12|Overall Study|Moved/deployed or no booster|0
917175|NCT01011335|3024383|P11|Overall Study|Moved/deployed or no booster|2
917176|NCT01011335|3024384|P10|Overall Study|Moved/deployed or no booster|0
917177|NCT01011335|3024385|P9|Overall Study|Moved/deployed or no booster|1
917178|NCT01011335|3024386|P8|Overall Study|Moved/deployed or no booster|0
917179|NCT01011335|3024387|P7|Overall Study|Moved/deployed or no booster|1
917180|NCT01011335|3024388|P6|Overall Study|Moved/deployed or no booster|0
917181|NCT01011335|3024389|P5|Overall Study|Moved/deployed or no booster|0
917182|NCT01011335|3024390|P4|Overall Study|Moved/deployed or no booster|1
917183|NCT01011335|3024391|P3|Overall Study|Moved/deployed or no booster|0
917184|NCT01011335|3024392|P2|Overall Study|Moved/deployed or no booster|0
917185|NCT01011335|3024393|P1|Overall Study|Moved/deployed or no booster|1
917186|NCT01011335|3024381|P13|Overall Study|Protocol Violation|0
917187|NCT01011335|3024382|P12|Overall Study|Protocol Violation|0
917188|NCT01011335|3024383|P11|Overall Study|Protocol Violation|0
917189|NCT01011335|3024384|P10|Overall Study|Protocol Violation|0
917190|NCT01011335|3024385|P9|Overall Study|Protocol Violation|0
917191|NCT01011335|3024386|P8|Overall Study|Protocol Violation|0
917192|NCT01011335|3024387|P7|Overall Study|Protocol Violation|0
917193|NCT01011335|3024388|P6|Overall Study|Protocol Violation|0
917194|NCT01011335|3024389|P5|Overall Study|Protocol Violation|0
917195|NCT01011335|3024390|P4|Overall Study|Protocol Violation|0
917196|NCT01011335|3024391|P3|Overall Study|Protocol Violation|0
917197|NCT01011335|3024392|P2|Overall Study|Protocol Violation|1
917198|NCT01011335|3024393|P1|Overall Study|Protocol Violation|0
917199|NCT01011335|3024381|P13|Overall Study|Lost to Follow-up|2
917200|NCT01011335|3024382|P12|Overall Study|Lost to Follow-up|1
917201|NCT01011335|3024383|P11|Overall Study|Lost to Follow-up|0
917202|NCT01011335|3024384|P10|Overall Study|Lost to Follow-up|0
917203|NCT01011335|3024385|P9|Overall Study|Lost to Follow-up|1
917204|NCT01011335|3024386|P8|Overall Study|Lost to Follow-up|2
917205|NCT01011335|3024387|P7|Overall Study|Lost to Follow-up|2
917206|NCT01011335|3024388|P6|Overall Study|Lost to Follow-up|1
917207|NCT01011335|3024389|P5|Overall Study|Lost to Follow-up|1
917208|NCT01011335|3024390|P4|Overall Study|Lost to Follow-up|1
917209|NCT01011335|3024391|P3|Overall Study|Lost to Follow-up|1
917210|NCT01011335|3024392|P2|Overall Study|Lost to Follow-up|0
917211|NCT01011335|3024393|P1|Overall Study|Lost to Follow-up|0
917212|NCT01011309|3024433|P3|Overall Study|Protocol Violation|3
917213|NCT01011309|3024434|P2|Overall Study|Protocol Violation|1
917214|NCT01011309|3024435|P1|Overall Study|Protocol Violation|0
917215|NCT01011309|3024433|P3|Overall Study|Lack of Efficacy|0
917216|NCT01011309|3024434|P2|Overall Study|Lack of Efficacy|1
917217|NCT01011309|3024435|P1|Overall Study|Lack of Efficacy|0
917218|NCT01011309|3024433|P3|Overall Study|Adverse Event|2
917219|NCT01011309|3024434|P2|Overall Study|Adverse Event|1
917220|NCT01011309|3024435|P1|Overall Study|Adverse Event|2
917221|NCT01011283|3024451|P2|Overall Study|Not Specified|2
917222|NCT01011283|3024452|P1|Overall Study|Not Specified|2
917223|NCT01011283|3024451|P2|Overall Study|Terminated by Sponsor|5
917224|NCT01011283|3024452|P1|Overall Study|Terminated by Sponsor|5
917225|NCT01011283|3024451|P2|Overall Study|Progressive Disease|2
917226|NCT01011283|3024452|P1|Overall Study|Progressive Disease|0
917227|NCT01011283|3024451|P2|Overall Study|Adverse Event|2
917228|NCT01011283|3024452|P1|Overall Study|Adverse Event|4
917229|NCT01011153|3024501|P3|Overall Study|Less than 78 cases completed|9
917230|NCT01011153|3024502|P2|Overall Study|Less than 78 cases completed|11
917231|NCT01011153|3024503|P1|Overall Study|Less than 78 cases completed|8
917232|NCT01011049|3024532|P4|Overall Study|Withdrawal by Subject|0
917233|NCT01011049|3024533|P3|Overall Study|Withdrawal by Subject|1
917234|NCT01011049|3024534|P2|Overall Study|Withdrawal by Subject|0
917235|NCT01011049|3024535|P1|Overall Study|Withdrawal by Subject|0
917236|NCT01011049|3024532|P4|Overall Study|Lost to Follow-up|0
917237|NCT01011049|3024533|P3|Overall Study|Lost to Follow-up|1
917238|NCT01011049|3024534|P2|Overall Study|Lost to Follow-up|2
917239|NCT01011049|3024535|P1|Overall Study|Lost to Follow-up|1
917240|NCT01011049|3024532|P4|Overall Study|Protocol Violation|0
917241|NCT01011049|3024533|P3|Overall Study|Protocol Violation|2
917242|NCT01011049|3024534|P2|Overall Study|Protocol Violation|0
917243|NCT01011049|3024535|P1|Overall Study|Protocol Violation|0
917244|NCT01010971|3024565|P3|Overall Study|Other|2
917245|NCT01010971|3024566|P2|Overall Study|Other|0
917246|NCT01010971|3024567|P1|Overall Study|Other|1
917247|NCT01010971|3024565|P3|Overall Study|Lost to Follow-up|3
917248|NCT01010971|3024566|P2|Overall Study|Lost to Follow-up|2
917249|NCT01010971|3024567|P1|Overall Study|Lost to Follow-up|0
917250|NCT01010971|3024565|P3|Overall Study|Withdrawal by Subject|5
917251|NCT01010971|3024566|P2|Overall Study|Withdrawal by Subject|2
917252|NCT01010971|3024567|P1|Overall Study|Withdrawal by Subject|0
917253|NCT01010971|3024565|P3|Overall Study|Adverse Event|3
917254|NCT01010971|3024566|P2|Overall Study|Adverse Event|4
917255|NCT01010971|3024567|P1|Overall Study|Adverse Event|2
917256|NCT01010867|3024695|P1|Overall Study|< 50% adherence to probiotic|1
917257|NCT01010776|3024707|P1|Extension Phase|Not specified|3
917258|NCT01010776|3024707|P1|In-Between Main Phase & Extension Phase|Extension phase was optional|15
917259|NCT01010776|3024707|P1|Main Phase|Did not received study medication|5
917260|NCT01010776|3024707|P1|Main Phase|Not specified|1
917261|NCT01010776|3024707|P1|Main Phase|Inform consent withdrawal|1
917262|NCT01010776|3024707|P1|Main Phase|Selection failure|2
917263|NCT01010776|3024707|P1|Main Phase|Non-compliance to study medication|5
917264|NCT01010776|3024707|P1|Main Phase|Lost to Follow-up|6
917265|NCT01010776|3024707|P1|Main Phase|Adverse Event|7
917266|NCT01010776|3024707|P1|Main Phase|Lack of Efficacy|8
917267|NCT01010776|3024707|P1|Main Phase|Withdrawal by Subject|14
917268|NCT01010750|3024735|P6|Second Intervention|Adverse Event|0
917269|NCT01010750|3024736|P5|Second Intervention|Adverse Event|0
917270|NCT01010750|3024737|P4|Second Intervention|Adverse Event|0
917271|NCT01010750|3024738|P3|Second Intervention|Adverse Event|0
917272|NCT01010750|3024739|P2|Second Intervention|Adverse Event|1
917273|NCT01010750|3024740|P1|Second Intervention|Adverse Event|0
917274|NCT01010633|3024765|P2|Overall Study|Investigator decision|1
917275|NCT01010633|3024766|P1|Overall Study|Investigator decision|0
917276|NCT01010633|3024765|P2|Overall Study|Withdrawal by Subject|1
917277|NCT01010633|3024766|P1|Overall Study|Withdrawal by Subject|2
917278|NCT01010633|3024765|P2|Overall Study|Protocol Violation|2
917279|NCT01010633|3024766|P1|Overall Study|Protocol Violation|1
917280|NCT01010633|3024765|P2|Overall Study|Adverse Event|1
917281|NCT01010633|3024766|P1|Overall Study|Adverse Event|1
917282|NCT01010503|3024793|P1|Overall Study|Death|1
917283|NCT01010503|3024793|P1|Overall Study|Adverse Event|1
917284|NCT01010230|3024852|P2|Overall Study|Lost to Follow-up|2
917285|NCT01010230|3024853|P1|Overall Study|Lost to Follow-up|4
917286|NCT01010230|3024852|P2|Overall Study|Withdrawal by Subject|5
917287|NCT01010230|3024853|P1|Overall Study|Withdrawal by Subject|6
917288|NCT01010204|3024885|P2|Overall Study|psychiatric hospitalization|1
917289|NCT01010204|3024886|P1|Overall Study|psychiatric hospitalization|2
917290|NCT01010204|3024885|P2|Overall Study|Withdrawal by Subject|3
917291|NCT01010204|3024886|P1|Overall Study|Withdrawal by Subject|2
917292|NCT01010204|3024885|P2|Overall Study|Adverse Event|3
917293|NCT01010204|3024886|P1|Overall Study|Adverse Event|1
917294|NCT01010204|3024885|P2|Overall Study|Lost to Follow-up|2
917295|NCT01010204|3024886|P1|Overall Study|Lost to Follow-up|2
917296|NCT01010061|3024898|P2|Overall Study|Did Not Receive Treatment|2
917297|NCT01010061|3024899|P1|Overall Study|Did Not Receive Treatment|2
917298|NCT01010061|3024898|P2|Overall Study|Violation of Selection Criteria|1
917299|NCT01010061|3024899|P1|Overall Study|Violation of Selection Criteria|0
917300|NCT01010061|3024898|P2|Overall Study|Insufficient Therapeutic Response|5
917301|NCT01010061|3024899|P1|Overall Study|Insufficient Therapeutic Response|1
917302|NCT01010061|3024898|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
917303|NCT01010061|3024899|P1|Overall Study|Refused Treatment/Did Not Cooperate|2
917304|NCT01010061|3024898|P2|Overall Study|Administrative/Other|1
917305|NCT01010061|3024899|P1|Overall Study|Administrative/Other|0
917306|NCT01010061|3024898|P2|Overall Study|Death|6
917307|NCT01010061|3024899|P1|Overall Study|Death|3
917308|NCT01010061|3024898|P2|Overall Study|Withdrew Consent|1
917309|NCT01010061|3024899|P1|Overall Study|Withdrew Consent|5
917310|NCT01010061|3024898|P2|Overall Study|Disease Progression|8
917311|NCT01010061|3024899|P1|Overall Study|Disease Progression|2
917312|NCT01010061|3024898|P2|Overall Study|Adverse Events or Intercurrent Illness|16
917313|NCT01010061|3024899|P1|Overall Study|Adverse Events or Intercurrent Illness|33
917314|NCT01009983|3024950|P1|Overall Study|necessary scans not completed|1
917315|NCT01009840|3024963|P1|Overall Study|Subject Withdrew Consent to Participate|1
917316|NCT01009840|3024963|P1|Overall Study|Subject was Withdrawn by Investigator|1
917317|NCT01009840|3024963|P1|Overall Study|Subject Met Withdrawal Criteria|7
917318|NCT01009840|3024963|P1|Overall Study|Adverse Event|4
917319|NCT01009840|3024963|P1|Overall Study|Lost to Follow-up|1
917320|NCT01009645|3024993|P4|Overall Study|Lost to Follow-up|5
917321|NCT01009645|3024994|P3|Overall Study|Lost to Follow-up|4
917322|NCT01009645|3024995|P2|Overall Study|Lost to Follow-up|8
917323|NCT01009645|3024996|P1|Overall Study|Lost to Follow-up|2
917324|NCT01009580|3025033|P2|Overall Study|Unclassified|21
917325|NCT01009580|3025034|P1|Overall Study|Unclassified|17
917326|NCT01009580|3025033|P2|Overall Study|Withdrawal Criteria|6
917327|NCT01009580|3025034|P1|Overall Study|Withdrawal Criteria|4
917328|NCT01009580|3025033|P2|Overall Study|Protocol Violation|3
917329|NCT01009580|3025034|P1|Overall Study|Protocol Violation|2
917330|NCT01009580|3025033|P2|Overall Study|Lack of Efficacy|1
917331|NCT01009580|3025034|P1|Overall Study|Lack of Efficacy|0
917332|NCT01009580|3025033|P2|Overall Study|Adverse Event|4
917333|NCT01009580|3025034|P1|Overall Study|Adverse Event|4
917334|NCT01009554|3025048|P2|Overall Study|Noncompliant with Study Product|3
917335|NCT01009554|3025049|P1|Overall Study|Noncompliant with Study Product|0
917336|NCT01009554|3025048|P2|Overall Study|Withdrawal by Subject|3
917337|NCT01009554|3025049|P1|Overall Study|Withdrawal by Subject|1
917338|NCT01009554|3025048|P2|Overall Study|Adverse Event|1
917339|NCT01009554|3025049|P1|Overall Study|Adverse Event|1
917340|NCT01009515|3025181|P1|Overall Study|Withdrawal by Subject|3
917341|NCT01009463|3025192|P5|52-week, Double-blind Treatment Period|Physician Decision|8
917342|NCT01009463|3025193|P4|52-week, Double-blind Treatment Period|Physician Decision|6
917343|NCT01009463|3025194|P3|52-week, Double-blind Treatment Period|Physician Decision|6
917344|NCT01009463|3025195|P2|52-week, Double-blind Treatment Period|Physician Decision|4
917345|NCT01009463|3025196|P1|52-week, Double-blind Treatment Period|Physician Decision|0
917346|NCT01009463|3025192|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|5
917347|NCT01009463|3025193|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
917348|NCT01009463|3025194|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|7
917349|NCT01009463|3025195|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|11
917350|NCT01009463|3025196|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
917351|NCT01009463|3025192|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
917352|NCT01009463|3025193|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
917353|NCT01009463|3025194|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
917354|NCT01009463|3025195|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|2
917355|NCT01009463|3025196|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
917356|NCT01009463|3025192|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
917357|NCT01009463|3025193|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
917358|NCT01009463|3025194|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14
917359|NCT01009463|3025195|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
917360|NCT01009463|3025196|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
917361|NCT01009463|3025192|P5|52-week, Double-blind Treatment Period|Protocol Violation|7
917362|NCT01009463|3025193|P4|52-week, Double-blind Treatment Period|Protocol Violation|8
917363|NCT01009463|3025194|P3|52-week, Double-blind Treatment Period|Protocol Violation|7
917364|NCT01009463|3025195|P2|52-week, Double-blind Treatment Period|Protocol Violation|8
917365|NCT01009463|3025196|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
917366|NCT01009463|3025192|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|18
917367|NCT01009463|3025193|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|11
917368|NCT01009463|3025194|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|16
917369|NCT01009463|3025195|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|24
917370|NCT01009463|3025196|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
917371|NCT01009463|3025192|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
917372|NCT01009463|3025193|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|17
917373|NCT01009463|3025194|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|18
917374|NCT01009463|3025195|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|34
917375|NCT01009463|3025196|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
917376|NCT01009463|3025192|P5|52-week, Double-blind Treatment Period|Adverse Event|31
917377|NCT01009463|3025193|P4|52-week, Double-blind Treatment Period|Adverse Event|29
917378|NCT01009463|3025194|P3|52-week, Double-blind Treatment Period|Adverse Event|25
917379|NCT01009463|3025195|P2|52-week, Double-blind Treatment Period|Adverse Event|22
917380|NCT01009463|3025196|P1|52-week, Double-blind Treatment Period|Adverse Event|0
917381|NCT01009463|3025192|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
917382|NCT01009463|3025193|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
917383|NCT01009463|3025194|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
917384|NCT01009463|3025195|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
917385|NCT01009463|3025196|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|50
917386|NCT01009463|3025192|P5|4-week, Open-label Run-In Period|Physician Decision|0
917387|NCT01009463|3025193|P4|4-week, Open-label Run-In Period|Physician Decision|0
917388|NCT01009463|3025194|P3|4-week, Open-label Run-In Period|Physician Decision|0
917389|NCT01009463|3025195|P2|4-week, Open-label Run-In Period|Physician Decision|0
917390|NCT01009463|3025196|P1|4-week, Open-label Run-In Period|Physician Decision|10
917391|NCT01009463|3025192|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
917392|NCT01009463|3025193|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
917393|NCT01009463|3025194|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
917394|NCT01009463|3025195|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
917395|NCT01009463|3025196|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
917396|NCT01009463|3025192|P5|4-week, Open-label Run-In Period|Adverse Event|0
917397|NCT01009463|3025193|P4|4-week, Open-label Run-In Period|Adverse Event|0
917398|NCT01009463|3025194|P3|4-week, Open-label Run-In Period|Adverse Event|0
917399|NCT01009463|3025195|P2|4-week, Open-label Run-In Period|Adverse Event|0
917400|NCT01009463|3025196|P1|4-week, Open-label Run-In Period|Adverse Event|10
917401|NCT01009463|3025192|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
917402|NCT01009463|3025193|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
917403|NCT01009463|3025194|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
917404|NCT01009463|3025195|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
917405|NCT01009463|3025196|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373
917406|NCT01009346|3025218|P1|Overall Study|Adverse Event|4
917407|NCT01009203|3025242|P1|Overall Study|Treatment-unrelated death|1
917408|NCT01009203|3025242|P1|Overall Study|Adverse Event|5
917409|NCT01009203|3025242|P1|Overall Study|Withdrawal by Subject|1
917410|NCT01009099|3025282|P2|Overall Study|Death|1
917411|NCT01009099|3025283|P1|Overall Study|Death|0
917412|NCT01009099|3025282|P2|Overall Study|Withdrawal by Subject|1
917413|NCT01009099|3025283|P1|Overall Study|Withdrawal by Subject|1
917414|NCT01009099|3025282|P2|Overall Study|Physician Decision|2
917415|NCT01009099|3025283|P1|Overall Study|Physician Decision|3
917416|NCT01009099|3025282|P2|Overall Study|Lost to Follow-up|0
917417|NCT01009099|3025283|P1|Overall Study|Lost to Follow-up|1
917418|NCT01009086|3025292|P3|Overall Study|Other|1
917419|NCT01009086|3025293|P2|Overall Study|Other|5
917420|NCT01009086|3025294|P1|Overall Study|Other|3
917421|NCT01009086|3025292|P3|Overall Study|Withdrawal by Subject|13
917422|NCT01009086|3025293|P2|Overall Study|Withdrawal by Subject|11
917423|NCT01009086|3025294|P1|Overall Study|Withdrawal by Subject|9
917424|NCT01009086|3025292|P3|Overall Study|Adverse Event|8
917425|NCT01009086|3025293|P2|Overall Study|Adverse Event|11
917426|NCT01009086|3025294|P1|Overall Study|Adverse Event|12
917427|NCT01009086|3025292|P3|Overall Study|Lost to Follow-up|3
917428|NCT01009086|3025293|P2|Overall Study|Lost to Follow-up|5
917429|NCT01009086|3025294|P1|Overall Study|Lost to Follow-up|4
917430|NCT01009086|3025292|P3|Overall Study|Lack of Efficacy|9
917431|NCT01009086|3025293|P2|Overall Study|Lack of Efficacy|15
917432|NCT01009086|3025294|P1|Overall Study|Lack of Efficacy|16
917433|NCT01009060|3025329|P2|Overall Study|Withdrawal by Subject|1
917434|NCT01009060|3025330|P1|Overall Study|Withdrawal by Subject|1
917435|NCT01009060|3025329|P2|Overall Study|Physician Decision|1
917436|NCT01009060|3025330|P1|Overall Study|Physician Decision|1
917437|NCT01009060|3025329|P2|Overall Study|Lost to Follow-up|0
917438|NCT01009060|3025330|P1|Overall Study|Lost to Follow-up|1
917439|NCT01009060|3025329|P2|Overall Study|Protocol Violation|1
917440|NCT01009060|3025330|P1|Overall Study|Protocol Violation|0
917441|NCT01009060|3025329|P2|Overall Study|Adverse Event|2
917442|NCT01009060|3025330|P1|Overall Study|Adverse Event|1
917443|NCT01009047|3025368|P2|Overall Study|Other|2
917444|NCT01009047|3025369|P1|Overall Study|Other|3
917445|NCT01009047|3025368|P2|Overall Study|Withdrawal by consent|11
917446|NCT01009047|3025369|P1|Overall Study|Withdrawal by consent|16
917447|NCT01009047|3025368|P2|Overall Study|Lack of Efficacy|11
917448|NCT01009047|3025369|P1|Overall Study|Lack of Efficacy|4
917449|NCT01009047|3025368|P2|Overall Study|Lost to Follow-up|2
917450|NCT01009047|3025369|P1|Overall Study|Lost to Follow-up|0
917451|NCT01009047|3025368|P2|Overall Study|Adverse Event|0
917452|NCT01009047|3025369|P1|Overall Study|Adverse Event|5
917453|NCT01009034|3025391|P1|Overall Study|Withdrawal by Subject|2
917454|NCT01009034|3025391|P1|Overall Study|Lost to Follow-up|2
917455|NCT01008995|3025399|P4|After Controlled Period|Not specified|0
917456|NCT01008995|3025400|P3|After Controlled Period|Not specified|1
917457|NCT01008995|3025401|P2|After Controlled Period|Not specified|0
917458|NCT01008995|3025402|P1|After Controlled Period|Not specified|0
917459|NCT01008995|3025399|P4|After Controlled Period|Adverse Event|1
917460|NCT01008995|3025400|P3|After Controlled Period|Adverse Event|1
917461|NCT01008995|3025401|P2|After Controlled Period|Adverse Event|0
917462|NCT01008995|3025402|P1|After Controlled Period|Adverse Event|0
917463|NCT01008995|3025399|P4|Controlled Period|Not specified|0
917464|NCT01008995|3025400|P3|Controlled Period|Not specified|0
917465|NCT01008995|3025401|P2|Controlled Period|Not specified|1
917466|NCT01008995|3025402|P1|Controlled Period|Not specified|2
917467|NCT01008995|3025399|P4|Controlled Period|Adverse Event|0
917468|NCT01008995|3025400|P3|Controlled Period|Adverse Event|0
917469|NCT01008995|3025401|P2|Controlled Period|Adverse Event|2
917470|NCT01008995|3025402|P1|Controlled Period|Adverse Event|1
917471|NCT01008943|3025419|P1|Overall Study|Withdrawal by Subject|1
917472|NCT01008904|3025426|P1|Overall Study|unexpected unrelated surgery|1
917473|NCT01008904|3025426|P1|Overall Study|Adverse Event|2
917474|NCT01008904|3025426|P1|Overall Study|Lost to Follow-up|1
917475|NCT01008696|3025444|P2|Overall Study|Other|2
917476|NCT01008696|3025445|P1|Overall Study|Other|0
917477|NCT01008696|3025444|P2|Overall Study|Other|3
917478|NCT01008696|3025445|P1|Overall Study|Other|2
917479|NCT01008696|3025444|P2|Overall Study|Participants' non-cooperation|3
917480|NCT01008696|3025445|P1|Overall Study|Participants' non-cooperation|2
917481|NCT01008696|3025444|P2|Overall Study|Adverse Event|0
917482|NCT01008696|3025445|P1|Overall Study|Adverse Event|1
917483|NCT01008696|3025444|P2|Overall Study|Physician Decision|1
917484|NCT01008696|3025445|P1|Overall Study|Physician Decision|5
917485|NCT01008696|3025444|P2|Overall Study|Withdrawal by Subject|4
917486|NCT01008696|3025445|P1|Overall Study|Withdrawal by Subject|2
917487|NCT01008696|3025444|P2|Overall Study|Participant's evasion of hospital visit|4
917488|NCT01008696|3025445|P1|Overall Study|Participant's evasion of hospital visit|5
917489|NCT01008618|3025455|P3|Period 2 (Double-Blind Period)|Not appropriate for this study|1
917490|NCT01008618|3025456|P2|Period 2 (Double-Blind Period)|Not appropriate for this study|0
917491|NCT01008618|3025457|P1|Period 2 (Double-Blind Period)|Not appropriate for this study|0
917492|NCT01008618|3025455|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29
917493|NCT01008618|3025456|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21
917494|NCT01008618|3025457|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
917495|NCT01008618|3025455|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
917496|NCT01008618|3025456|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
917497|NCT01008618|3025457|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
917498|NCT01008618|3025455|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3
917499|NCT01008618|3025456|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
917500|NCT01008618|3025457|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
917501|NCT01008618|3025455|P3|Period 2 (Double-Blind Period)|Physician Decision|0
917502|NCT01008618|3025456|P2|Period 2 (Double-Blind Period)|Physician Decision|1
917503|NCT01008618|3025457|P1|Period 2 (Double-Blind Period)|Physician Decision|0
917504|NCT01008618|3025455|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
917664|NCT01007123|3025832|P4|Overall Study|Protocol Violation|1
917505|NCT01008618|3025456|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|3
917506|NCT01008618|3025457|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
917507|NCT01008618|3025455|P3|Period 2 (Double-Blind Period)|Adverse Event|2
917508|NCT01008618|3025456|P2|Period 2 (Double-Blind Period)|Adverse Event|11
917509|NCT01008618|3025457|P1|Period 2 (Double-Blind Period)|Adverse Event|0
917510|NCT01008618|3025455|P3|Period 1 (Titration Period)|Aggravated symptom|0
917511|NCT01008618|3025456|P2|Period 1 (Titration Period)|Aggravated symptom|0
917512|NCT01008618|3025457|P1|Period 1 (Titration Period)|Aggravated symptom|2
917513|NCT01008618|3025455|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
917514|NCT01008618|3025456|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
917515|NCT01008618|3025457|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20
917516|NCT01008618|3025455|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
917517|NCT01008618|3025456|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
917518|NCT01008618|3025457|P1|Period 1 (Titration Period)|Withdrawal by Subject|11
917519|NCT01008618|3025455|P3|Period 1 (Titration Period)|Adverse Event|0
917520|NCT01008618|3025456|P2|Period 1 (Titration Period)|Adverse Event|0
917521|NCT01008618|3025457|P1|Period 1 (Titration Period)|Adverse Event|33
917522|NCT01008618|3025455|P3|Period 1 (Titration Period)|Physician Decision|0
917523|NCT01008618|3025456|P2|Period 1 (Titration Period)|Physician Decision|0
917524|NCT01008618|3025457|P1|Period 1 (Titration Period)|Physician Decision|2
917525|NCT01008553|3025506|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35
917526|NCT01008553|3025507|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18
917527|NCT01008553|3025508|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
917528|NCT01008553|3025506|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
917529|NCT01008553|3025507|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
917530|NCT01008553|3025508|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
917531|NCT01008553|3025506|P3|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3
917532|NCT01008553|3025507|P2|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
917533|NCT01008553|3025508|P1|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
917534|NCT01008553|3025506|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4
917535|NCT01008553|3025507|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1
917536|NCT01008553|3025508|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
917537|NCT01008553|3025506|P3|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
917538|NCT01008553|3025507|P2|Period 2 (Double-Blind Period)|Impossible to perform required tests|1
917539|NCT01008553|3025508|P1|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
917540|NCT01008553|3025506|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
917541|NCT01008553|3025507|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
917542|NCT01008553|3025508|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
917543|NCT01008553|3025506|P3|Period 2 (Double-Blind Period)|Adverse Event|4
917544|NCT01008553|3025507|P2|Period 2 (Double-Blind Period)|Adverse Event|14
917545|NCT01008553|3025508|P1|Period 2 (Double-Blind Period)|Adverse Event|0
917546|NCT01008553|3025506|P3|Period 2 (Double-Blind Period)|Physician Decision|2
917547|NCT01008553|3025507|P2|Period 2 (Double-Blind Period)|Physician Decision|1
917548|NCT01008553|3025508|P1|Period 2 (Double-Blind Period)|Physician Decision|0
917549|NCT01008553|3025506|P3|Period 1 (Titration Period)|Not appropriate for this study|0
917550|NCT01008553|3025507|P2|Period 1 (Titration Period)|Not appropriate for this study|0
917551|NCT01008553|3025508|P1|Period 1 (Titration Period)|Not appropriate for this study|1
917552|NCT01008553|3025506|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
917553|NCT01008553|3025507|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
917554|NCT01008553|3025508|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50
917555|NCT01008553|3025506|P3|Period 1 (Titration Period)|Determined to increase dosage|0
917556|NCT01008553|3025507|P2|Period 1 (Titration Period)|Determined to increase dosage|0
917557|NCT01008553|3025508|P1|Period 1 (Titration Period)|Determined to increase dosage|3
917558|NCT01008553|3025506|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
917559|NCT01008553|3025507|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
917560|NCT01008553|3025508|P1|Period 1 (Titration Period)|Withdrawal by Subject|6
917561|NCT01008553|3025506|P3|Period 1 (Titration Period)|Adverse Event|0
917562|NCT01008553|3025507|P2|Period 1 (Titration Period)|Adverse Event|0
917563|NCT01008553|3025508|P1|Period 1 (Titration Period)|Adverse Event|33
917564|NCT01008553|3025506|P3|Period 1 (Titration Period)|Physician Decision|0
917565|NCT01008553|3025507|P2|Period 1 (Titration Period)|Physician Decision|0
917566|NCT01008553|3025508|P1|Period 1 (Titration Period)|Physician Decision|2
917567|NCT01008475|3025540|P7|Overall Study|Ongoing treatment at data cut-off date|4
917568|NCT01008475|3025541|P6|Overall Study|Ongoing treatment at data cut-off date|6
917569|NCT01008475|3025542|P5|Overall Study|Ongoing treatment at data cut-off date|5
917570|NCT01008475|3025543|P4|Overall Study|Ongoing treatment at data cut-off date|0
917571|NCT01008475|3025544|P3|Overall Study|Ongoing treatment at data cut-off date|0
917572|NCT01008475|3025545|P2|Overall Study|Ongoing treatment at data cut-off date|0
917573|NCT01008475|3025546|P1|Overall Study|Ongoing treatment at data cut-off date|0
917574|NCT01008449|3025576|P2|Overall Study|Lost to Follow-up|19
917575|NCT01008449|3025577|P1|Overall Study|Lost to Follow-up|29
917576|NCT01007916|3025623|P2|Period 2, 4 Weeks of Wear|Relocation|0
917577|NCT01007916|3025624|P1|Period 2, 4 Weeks of Wear|Relocation|1
917578|NCT01007916|3025623|P2|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0
917579|NCT01007916|3025624|P1|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1
917580|NCT01007942|3025632|P2|Overall Study|Patients untreated|3
917581|NCT01007942|3025633|P1|Overall Study|Patients untreated|4
917582|NCT01007942|3025632|P2|Overall Study|Death|2
917583|NCT01007942|3025633|P1|Overall Study|Death|3
917584|NCT01007942|3025632|P2|Overall Study|Administrative problems|0
917585|NCT01007942|3025633|P1|Overall Study|Administrative problems|2
917586|NCT01007942|3025632|P2|Overall Study|Lost to Follow-up|0
917587|NCT01007942|3025633|P1|Overall Study|Lost to Follow-up|1
917588|NCT01007942|3025632|P2|Overall Study|Withdrawal by Subject|14
917589|NCT01007942|3025633|P1|Overall Study|Withdrawal by Subject|19
917590|NCT01007942|3025632|P2|Overall Study|Protocol Violation|1
917591|NCT01007942|3025633|P1|Overall Study|Protocol Violation|1
917592|NCT01007942|3025632|P2|Overall Study|New cancer therapy|1
917593|NCT01007942|3025633|P1|Overall Study|New cancer therapy|5
917594|NCT01007942|3025632|P2|Overall Study|Disease progression|242
917595|NCT01007942|3025633|P1|Overall Study|Disease progression|217
917596|NCT01007942|3025632|P2|Overall Study|Abnormal test procedure|1
917597|NCT01007942|3025633|P1|Overall Study|Abnormal test procedure|0
917598|NCT01007942|3025632|P2|Overall Study|Adverse Event|14
917599|NCT01007942|3025633|P1|Overall Study|Adverse Event|29
917600|NCT01007838|3025659|P4|Overall Study|Started home haemodialysis|0
917601|NCT01007838|3025660|P3|Overall Study|Started home haemodialysis|0
917602|NCT01007838|3025661|P2|Overall Study|Started home haemodialysis|0
917603|NCT01007838|3025662|P1|Overall Study|Started home haemodialysis|1
917604|NCT01007838|3025659|P4|Overall Study|Physician Decision|0
917605|NCT01007838|3025660|P3|Overall Study|Physician Decision|0
917606|NCT01007838|3025661|P2|Overall Study|Physician Decision|0
917607|NCT01007838|3025662|P1|Overall Study|Physician Decision|1
917608|NCT01007838|3025659|P4|Overall Study|Withdrawal by Subject|0
917609|NCT01007838|3025660|P3|Overall Study|Withdrawal by Subject|0
917610|NCT01007838|3025661|P2|Overall Study|Withdrawal by Subject|0
917611|NCT01007838|3025662|P1|Overall Study|Withdrawal by Subject|1
917612|NCT01007812|3025672|P2|Period 1, One Week|Discomfort|0
917613|NCT01007812|3025673|P1|Period 1, One Week|Discomfort|1
917614|NCT01007812|3025672|P2|Period 1, One Week|Lost to Follow-up|1
917615|NCT01007812|3025673|P1|Period 1, One Week|Lost to Follow-up|0
917616|NCT01007552|3025706|P1|Overall Study|Withdrawal by Subject|1
917617|NCT01007435|3025720|P4|Overall Study|Reason not Specified|1
917618|NCT01007435|3025721|P3|Overall Study|Reason not Specified|2
917619|NCT01007435|3025722|P2|Overall Study|Reason not Specified|1
917620|NCT01007435|3025723|P1|Overall Study|Reason not Specified|1
917621|NCT01007435|3025720|P4|Overall Study|Failure to Return|6
917622|NCT01007435|3025721|P3|Overall Study|Failure to Return|3
917623|NCT01007435|3025722|P2|Overall Study|Failure to Return|4
917624|NCT01007435|3025723|P1|Overall Study|Failure to Return|5
917625|NCT01007435|3025720|P4|Overall Study|Refused Treatment|8
917626|NCT01007435|3025721|P3|Overall Study|Refused Treatment|5
917627|NCT01007435|3025722|P2|Overall Study|Refused Treatment|13
917628|NCT01007435|3025723|P1|Overall Study|Refused Treatment|13
917629|NCT01007435|3025720|P4|Overall Study|Other Protocol Violation|0
917630|NCT01007435|3025721|P3|Overall Study|Other Protocol Violation|1
917631|NCT01007435|3025722|P2|Overall Study|Other Protocol Violation|0
917632|NCT01007435|3025723|P1|Overall Study|Other Protocol Violation|2
917633|NCT01007435|3025720|P4|Overall Study|Violation of Selection Criteria at Entry|0
917634|NCT01007435|3025721|P3|Overall Study|Violation of Selection Criteria at Entry|2
917635|NCT01007435|3025722|P2|Overall Study|Violation of Selection Criteria at Entry|5
917636|NCT01007435|3025723|P1|Overall Study|Violation of Selection Criteria at Entry|3
917637|NCT01007435|3025720|P4|Overall Study|Insufficient Therapeutic Response|9
917638|NCT01007435|3025721|P3|Overall Study|Insufficient Therapeutic Response|2
917639|NCT01007435|3025722|P2|Overall Study|Insufficient Therapeutic Response|7
917640|NCT01007435|3025723|P1|Overall Study|Insufficient Therapeutic Response|21
917641|NCT01007435|3025720|P4|Overall Study|Death|1
917642|NCT01007435|3025721|P3|Overall Study|Death|2
917643|NCT01007435|3025722|P2|Overall Study|Death|4
917644|NCT01007435|3025723|P1|Overall Study|Death|2
917645|NCT01007435|3025720|P4|Overall Study|Adverse Event|31
917646|NCT01007435|3025721|P3|Overall Study|Adverse Event|47
917647|NCT01007435|3025722|P2|Overall Study|Adverse Event|25
917648|NCT01007435|3025723|P1|Overall Study|Adverse Event|16
917649|NCT01007396|3025765|P1|Overall Study|Lost to Follow-up|47
917650|NCT01007253|3025770|P4|Washout Period (2 Weeks) # 3|Physician Decision|0
917651|NCT01007253|3025771|P3|Washout Period (2 Weeks) # 3|Physician Decision|0
917652|NCT01007253|3025772|P2|Washout Period (2 Weeks) # 3|Physician Decision|0
917653|NCT01007253|3025773|P1|Washout Period (2 Weeks) # 3|Physician Decision|1
917654|NCT01007149|3025805|P2|Overall Study|Administrative problems|1
917655|NCT01007149|3025806|P1|Overall Study|Administrative problems|0
917656|NCT01007123|3025832|P4|Overall Study|Lost to Follow-up|0
917657|NCT01007123|3025833|P3|Overall Study|Lost to Follow-up|0
917658|NCT01007123|3025834|P2|Overall Study|Lost to Follow-up|1
917659|NCT01007123|3025835|P1|Overall Study|Lost to Follow-up|0
917660|NCT01007123|3025832|P4|Overall Study|Withdrawal by Subject|0
917661|NCT01007123|3025833|P3|Overall Study|Withdrawal by Subject|1
917662|NCT01007123|3025834|P2|Overall Study|Withdrawal by Subject|0
917663|NCT01007123|3025835|P1|Overall Study|Withdrawal by Subject|1
917665|NCT01007123|3025833|P3|Overall Study|Protocol Violation|2
917666|NCT01007123|3025834|P2|Overall Study|Protocol Violation|1
917667|NCT01007123|3025835|P1|Overall Study|Protocol Violation|1
917668|NCT01007123|3025832|P4|Overall Study|Lack of Efficacy|4
917669|NCT01007123|3025833|P3|Overall Study|Lack of Efficacy|1
917670|NCT01007123|3025834|P2|Overall Study|Lack of Efficacy|0
917671|NCT01007123|3025835|P1|Overall Study|Lack of Efficacy|1
917672|NCT01007123|3025832|P4|Overall Study|Adverse Event|1
917673|NCT01007123|3025833|P3|Overall Study|Adverse Event|7
917674|NCT01007123|3025834|P2|Overall Study|Adverse Event|4
917675|NCT01007123|3025835|P1|Overall Study|Adverse Event|3
917676|NCT01006980|3025894|P2|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10
917677|NCT01006980|3025895|P1|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0
917678|NCT01006980|3025894|P2|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1
917679|NCT01006980|3025895|P1|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0
917680|NCT01006980|3025894|P2|Crossover: Dacarbazine to Vemurafenib|Progression|65
917681|NCT01006980|3025895|P1|Crossover: Dacarbazine to Vemurafenib|Progression|0
917682|NCT01006980|3025894|P2|Crossover: Dacarbazine to Vemurafenib|Death|4
917683|NCT01006980|3025895|P1|Crossover: Dacarbazine to Vemurafenib|Death|0
917684|NCT01006980|3025894|P2|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4
917685|NCT01006980|3025895|P1|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0
917686|NCT01006980|3025894|P2|Vemurafenib and Dacarbazine|Reason Not Specified|43
917687|NCT01006980|3025895|P1|Vemurafenib and Dacarbazine|Reason Not Specified|26
917688|NCT01006980|3025894|P2|Vemurafenib and Dacarbazine|Protocol Violation|3
917689|NCT01006980|3025895|P1|Vemurafenib and Dacarbazine|Protocol Violation|2
917690|NCT01006980|3025894|P2|Vemurafenib and Dacarbazine|Refuse Treatment|6
917691|NCT01006980|3025895|P1|Vemurafenib and Dacarbazine|Refuse Treatment|9
917692|NCT01006980|3025894|P2|Vemurafenib and Dacarbazine|Withdrawal of Consent|6
917693|NCT01006980|3025895|P1|Vemurafenib and Dacarbazine|Withdrawal of Consent|4
917694|NCT01006980|3025894|P2|Vemurafenib and Dacarbazine|Progression|218
917695|NCT01006980|3025895|P1|Vemurafenib and Dacarbazine|Progression|257
917696|NCT01006980|3025894|P2|Vemurafenib and Dacarbazine|Death|12
917697|NCT01006980|3025895|P1|Vemurafenib and Dacarbazine|Death|13
917698|NCT01006980|3025894|P2|Vemurafenib and Dacarbazine|Adverse Event|5
917699|NCT01006980|3025895|P1|Vemurafenib and Dacarbazine|Adverse Event|25
917700|NCT01006980|3025894|P2|Vemurafenib and Dacarbazine|Randomized but Not Treated|45
917701|NCT01006980|3025895|P1|Vemurafenib and Dacarbazine|Randomized but Not Treated|1
917702|NCT01006889|3025934|P1|Overall Study|Withdrawal by Subject|3
917703|NCT01006707|3025945|P3|Study Session 1|Could not tolerate withdrawal in scanner|0
917704|NCT01006707|3025946|P2|Study Session 1|Could not tolerate withdrawal in scanner|0
917705|NCT01006707|3025947|P1|Study Session 1|Could not tolerate withdrawal in scanner|3
917706|NCT01006707|3025945|P3|Study Session 1|Lost to Follow-up|0
917707|NCT01006707|3025946|P2|Study Session 1|Lost to Follow-up|0
917708|NCT01006707|3025947|P1|Study Session 1|Lost to Follow-up|2
917709|NCT01006629|3025967|P1|Overall Study|Parent unable to perform site visit|4
917710|NCT01006629|3025967|P1|Overall Study|Parent refused to continue participation|1
917711|NCT01006629|3025967|P1|Overall Study|Adverse Event|1
917712|NCT01006616|3025982|P4|Period 2 (18 Months)|Study Terminated|70
917713|NCT01006616|3025983|P3|Period 2 (18 Months)|Study Terminated|44
917714|NCT01006616|3025984|P2|Period 2 (18 Months)|Study Terminated|46
917715|NCT01006616|3025985|P1|Period 2 (18 Months)|Study Terminated|63
917716|NCT01006616|3025982|P4|Period 2 (18 Months)|Noncompliance With Protocol|1
917717|NCT01006616|3025983|P3|Period 2 (18 Months)|Noncompliance With Protocol|0
917718|NCT01006616|3025984|P2|Period 2 (18 Months)|Noncompliance With Protocol|1
917719|NCT01006616|3025985|P1|Period 2 (18 Months)|Noncompliance With Protocol|0
917720|NCT01006616|3025982|P4|Period 2 (18 Months)|Withdrawal by Subject|1
917721|NCT01006616|3025983|P3|Period 2 (18 Months)|Withdrawal by Subject|0
917722|NCT01006616|3025984|P2|Period 2 (18 Months)|Withdrawal by Subject|4
917723|NCT01006616|3025985|P1|Period 2 (18 Months)|Withdrawal by Subject|1
917724|NCT01006616|3025982|P4|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2
917725|NCT01006616|3025983|P3|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1
917726|NCT01006616|3025984|P2|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6
917727|NCT01006616|3025985|P1|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0
917728|NCT01006616|3025982|P4|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2
917729|NCT01006616|3025983|P3|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
917730|NCT01006616|3025984|P2|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0
917731|NCT01006616|3025985|P1|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
917732|NCT01006616|3025982|P4|Period 2 (18 Months)|Lost to Follow-up|0
917733|NCT01006616|3025983|P3|Period 2 (18 Months)|Lost to Follow-up|0
917734|NCT01006616|3025984|P2|Period 2 (18 Months)|Lost to Follow-up|0
917735|NCT01006616|3025985|P1|Period 2 (18 Months)|Lost to Follow-up|2
917736|NCT01006616|3025982|P4|Period 2 (18 Months)|Lack of Efficacy|2
917737|NCT01006616|3025983|P3|Period 2 (18 Months)|Lack of Efficacy|1
917738|NCT01006616|3025984|P2|Period 2 (18 Months)|Lack of Efficacy|0
917739|NCT01006616|3025985|P1|Period 2 (18 Months)|Lack of Efficacy|0
917740|NCT01006616|3025982|P4|Period 2 (18 Months)|Adverse Event|4
917741|NCT01006616|3025983|P3|Period 2 (18 Months)|Adverse Event|6
917742|NCT01006616|3025984|P2|Period 2 (18 Months)|Adverse Event|6
917743|NCT01006616|3025985|P1|Period 2 (18 Months)|Adverse Event|6
917744|NCT01006616|3025982|P4|Period 1 (6 Months)|Not Treated|1
917745|NCT01006616|3025983|P3|Period 1 (6 Months)|Not Treated|1
917746|NCT01006616|3025984|P2|Period 1 (6 Months)|Not Treated|0
917747|NCT01006616|3025985|P1|Period 1 (6 Months)|Not Treated|0
917748|NCT01006616|3025982|P4|Period 1 (6 Months)|Noncompliance With Protocol|3
917749|NCT01006616|3025983|P3|Period 1 (6 Months)|Noncompliance With Protocol|2
917750|NCT01006616|3025984|P2|Period 1 (6 Months)|Noncompliance With Protocol|2
917751|NCT01006616|3025985|P1|Period 1 (6 Months)|Noncompliance With Protocol|0
917752|NCT01006616|3025982|P4|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
917753|NCT01006616|3025983|P3|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
917754|NCT01006616|3025984|P2|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7
917755|NCT01006616|3025985|P1|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
917756|NCT01006616|3025982|P4|Period 1 (6 Months)|Withdrawal by Subject|0
917757|NCT01006616|3025983|P3|Period 1 (6 Months)|Withdrawal by Subject|2
917758|NCT01006616|3025984|P2|Period 1 (6 Months)|Withdrawal by Subject|2
917759|NCT01006616|3025985|P1|Period 1 (6 Months)|Withdrawal by Subject|2
917760|NCT01006616|3025982|P4|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2
917761|NCT01006616|3025983|P3|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1
917762|NCT01006616|3025984|P2|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3
917763|NCT01006616|3025985|P1|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0
917764|NCT01006616|3025982|P4|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3
917765|NCT01006616|3025983|P3|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2
917766|NCT01006616|3025984|P2|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5
917767|NCT01006616|3025985|P1|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6
917768|NCT01006616|3025982|P4|Period 1 (6 Months)|Lost to Follow-up|0
917769|NCT01006616|3025983|P3|Period 1 (6 Months)|Lost to Follow-up|1
917770|NCT01006616|3025984|P2|Period 1 (6 Months)|Lost to Follow-up|0
917771|NCT01006616|3025985|P1|Period 1 (6 Months)|Lost to Follow-up|0
917772|NCT01006616|3025982|P4|Period 1 (6 Months)|Lack of Efficacy|4
917773|NCT01006616|3025983|P3|Period 1 (6 Months)|Lack of Efficacy|0
917774|NCT01006616|3025984|P2|Period 1 (6 Months)|Lack of Efficacy|4
917775|NCT01006616|3025985|P1|Period 1 (6 Months)|Lack of Efficacy|3
917776|NCT01006616|3025982|P4|Period 1 (6 Months)|Adverse Event|9
917777|NCT01006616|3025983|P3|Period 1 (6 Months)|Adverse Event|37
917778|NCT01006616|3025984|P2|Period 1 (6 Months)|Adverse Event|31
917779|NCT01006616|3025985|P1|Period 1 (6 Months)|Adverse Event|10
917780|NCT01006603|3026121|P2|Overall Study|Other|7
917781|NCT01006603|3026122|P1|Overall Study|Other|3
917782|NCT01006603|3026121|P2|Overall Study|Study specific discontinuation criteria|34
917783|NCT01006603|3026122|P1|Overall Study|Study specific discontinuation criteria|33
917784|NCT01006603|3026121|P2|Overall Study|Death|1
917785|NCT01006603|3026122|P1|Overall Study|Death|1
917786|NCT01006603|3026121|P2|Overall Study|Adverse Event|7
917787|NCT01006603|3026122|P1|Overall Study|Adverse Event|15
917788|NCT01006603|3026121|P2|Overall Study|Incorrect enrolment|2
917789|NCT01006603|3026122|P1|Overall Study|Incorrect enrolment|0
917790|NCT01006603|3026121|P2|Overall Study|Protocol Violation|3
917791|NCT01006603|3026122|P1|Overall Study|Protocol Violation|1
917792|NCT01006603|3026121|P2|Overall Study|Safety reason|1
917793|NCT01006603|3026122|P1|Overall Study|Safety reason|1
917794|NCT01006603|3026121|P2|Overall Study|Lost to Follow-up|1
917795|NCT01006603|3026122|P1|Overall Study|Lost to Follow-up|0
917796|NCT01006603|3026121|P2|Overall Study|Withdrawal by Subject|19
917797|NCT01006603|3026122|P1|Overall Study|Withdrawal by Subject|17
917798|NCT01006590|3026142|P2|Overall Study|Not specified|2
917799|NCT01006590|3026143|P1|Overall Study|Not specified|3
917800|NCT01006590|3026142|P2|Overall Study|Study specific discontinuation criteria|23
917801|NCT01006590|3026143|P1|Overall Study|Study specific discontinuation criteria|16
917802|NCT01006590|3026142|P2|Overall Study|Withdrawal by Subject|2
917803|NCT01006590|3026143|P1|Overall Study|Withdrawal by Subject|4
917804|NCT01006590|3026142|P2|Overall Study|Protocol Violation|0
917805|NCT01006590|3026143|P1|Overall Study|Protocol Violation|1
917806|NCT01006590|3026142|P2|Overall Study|Lost to Follow-up|1
917807|NCT01006590|3026143|P1|Overall Study|Lost to Follow-up|1
917808|NCT01006590|3026142|P2|Overall Study|Death|1
917809|NCT01006590|3026143|P1|Overall Study|Death|1
917810|NCT01006590|3026142|P2|Overall Study|Adverse Event|3
917811|NCT01006590|3026143|P1|Overall Study|Adverse Event|2
917812|NCT01006356|3026159|P1|Overall Study|Other|23
917813|NCT01006356|3026159|P1|Overall Study|Protocol Violation|3
917814|NCT01006356|3026159|P1|Overall Study|Choice by participants|2
917815|NCT01006356|3026159|P1|Overall Study|Withdrawal by Subject|1
917816|NCT01006356|3026159|P1|Overall Study|Paticipants did not cooperate|6
917817|NCT01006356|3026159|P1|Overall Study|Physician Decision|1
917818|NCT01006356|3026159|P1|Overall Study|Adverse Event|6
917819|NCT01006291|3026174|P3|Overall Study|Other|17
917820|NCT01006291|3026175|P2|Overall Study|Other|14
917821|NCT01006291|3026176|P1|Overall Study|Other|14
917822|NCT01006291|3026174|P3|Overall Study|Withdrawal criteria|4
917823|NCT01006291|3026175|P2|Overall Study|Withdrawal criteria|4
917824|NCT01006291|3026176|P1|Overall Study|Withdrawal criteria|5
917825|NCT01006291|3026174|P3|Overall Study|Protocol Violation|3
917826|NCT01006291|3026175|P2|Overall Study|Protocol Violation|3
917827|NCT01006291|3026176|P1|Overall Study|Protocol Violation|3
917828|NCT01006291|3026174|P3|Overall Study|Lack of Efficacy|1
917829|NCT01006291|3026175|P2|Overall Study|Lack of Efficacy|2
917830|NCT01006291|3026176|P1|Overall Study|Lack of Efficacy|2
917831|NCT01006291|3026174|P3|Overall Study|Adverse Event|2
917832|NCT01006291|3026175|P2|Overall Study|Adverse Event|1
917833|NCT01006291|3026176|P1|Overall Study|Adverse Event|2
917834|NCT01006135|3026226|P1|Overall Study|Other|72
917835|NCT01006135|3026226|P1|Overall Study|Lost to Follow-up|32
917836|NCT01006135|3026226|P1|Overall Study|Protocol Violation|14
917837|NCT01006135|3026226|P1|Overall Study|Adverse Event|22
917838|NCT01006122|3026233|P2|Second Double-blind Intervention Period|Death|1
917839|NCT01006122|3026234|P1|Second Double-blind Intervention Period|Death|0
917840|NCT01006122|3026233|P2|Second Double-blind Intervention Period|Withdrawal by Subject|2
917841|NCT01006122|3026234|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
917842|NCT01006122|3026233|P2|Second Double-blind Intervention Period|Lost to Follow-up|3
917843|NCT01006122|3026234|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
917844|NCT01006122|3026233|P2|Second Double-blind Intervention Period|Protocol Violation|0
917845|NCT01006122|3026234|P1|Second Double-blind Intervention Period|Protocol Violation|1
917846|NCT01006122|3026233|P2|Second Double-blind Intervention Period|Adverse Event|1
917847|NCT01006122|3026234|P1|Second Double-blind Intervention Period|Adverse Event|1
917848|NCT01006122|3026233|P2|First Double-blind Intervention Period|Adverse Event|4
917849|NCT01006122|3026234|P1|First Double-blind Intervention Period|Adverse Event|0
917850|NCT01006122|3026233|P2|First Double-blind Intervention Period|Other|0
917851|NCT01006122|3026234|P1|First Double-blind Intervention Period|Other|3
917852|NCT01006122|3026233|P2|First Double-blind Intervention Period|Lack of Efficacy|1
917853|NCT01006122|3026234|P1|First Double-blind Intervention Period|Lack of Efficacy|2
917854|NCT01006122|3026233|P2|First Double-blind Intervention Period|Does not meet entrance criteria|0
917855|NCT01006122|3026234|P1|First Double-blind Intervention Period|Does not meet entrance criteria|1
917856|NCT01006122|3026233|P2|First Double-blind Intervention Period|Withdrawal by Subject|8
917857|NCT01006122|3026234|P1|First Double-blind Intervention Period|Withdrawal by Subject|9
917858|NCT01006122|3026233|P2|First Double-blind Intervention Period|Pregnancy|1
917859|NCT01006122|3026234|P1|First Double-blind Intervention Period|Pregnancy|0
917860|NCT01006122|3026233|P2|First Double-blind Intervention Period|Protocol Violation|1
917861|NCT01006122|3026234|P1|First Double-blind Intervention Period|Protocol Violation|1
917862|NCT01006122|3026233|P2|First Double-blind Intervention Period|Lost to Follow-up|2
917863|NCT01006122|3026234|P1|First Double-blind Intervention Period|Lost to Follow-up|0
917864|NCT01005966|3026285|P5|Treatment Period 4 (14 Days)|Other Reason|1
917865|NCT01005966|3026286|P4|Treatment Period 4 (14 Days)|Other Reason|0
917866|NCT01005966|3026287|P3|Treatment Period 4 (14 Days)|Other Reason|0
917867|NCT01005966|3026288|P2|Treatment Period 4 (14 Days)|Other Reason|0
917868|NCT01005966|3026289|P1|Treatment Period 4 (14 Days)|Other Reason|0
917869|NCT01005966|3026285|P5|Treatment Period 4 (14 Days)|Protocol Violation|0
917870|NCT01005966|3026286|P4|Treatment Period 4 (14 Days)|Protocol Violation|0
917871|NCT01005966|3026287|P3|Treatment Period 4 (14 Days)|Protocol Violation|0
917872|NCT01005966|3026288|P2|Treatment Period 4 (14 Days)|Protocol Violation|1
917873|NCT01005966|3026289|P1|Treatment Period 4 (14 Days)|Protocol Violation|0
917874|NCT01005966|3026285|P5|Treatment Period 3 (14 Days)|Protocol Violation|1
917875|NCT01005966|3026286|P4|Treatment Period 3 (14 Days)|Protocol Violation|0
917876|NCT01005966|3026287|P3|Treatment Period 3 (14 Days)|Protocol Violation|0
917877|NCT01005966|3026288|P2|Treatment Period 3 (14 Days)|Protocol Violation|1
917878|NCT01005966|3026289|P1|Treatment Period 3 (14 Days)|Protocol Violation|0
917879|NCT01005966|3026285|P5|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
917880|NCT01005966|3026286|P4|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
917881|NCT01005966|3026287|P3|Treatment Period 2 (14 Days)|Withdrawal by Subject|1
917882|NCT01005966|3026288|P2|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
917883|NCT01005966|3026289|P1|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
917884|NCT01005966|3026285|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
917885|NCT01005966|3026286|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
917886|NCT01005966|3026287|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
917887|NCT01005966|3026288|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
917888|NCT01005966|3026289|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
917889|NCT01005966|3026285|P5|Treatment Period 2 (14 Days)|Adverse Event|0
917890|NCT01005966|3026286|P4|Treatment Period 2 (14 Days)|Adverse Event|0
917891|NCT01005966|3026287|P3|Treatment Period 2 (14 Days)|Adverse Event|1
917892|NCT01005966|3026288|P2|Treatment Period 2 (14 Days)|Adverse Event|1
917893|NCT01005966|3026289|P1|Treatment Period 2 (14 Days)|Adverse Event|0
917894|NCT01005966|3026285|P5|Washout Period 1 (4 Days)|Withdrawal by Subject|0
917895|NCT01005966|3026286|P4|Washout Period 1 (4 Days)|Withdrawal by Subject|1
917896|NCT01005966|3026287|P3|Washout Period 1 (4 Days)|Withdrawal by Subject|0
917897|NCT01005966|3026288|P2|Washout Period 1 (4 Days)|Withdrawal by Subject|0
917898|NCT01005966|3026289|P1|Washout Period 1 (4 Days)|Withdrawal by Subject|0
917899|NCT01005966|3026285|P5|Treatment Period 1 (14 Days)|Protocol Violation|0
917900|NCT01005966|3026286|P4|Treatment Period 1 (14 Days)|Protocol Violation|0
917901|NCT01005966|3026287|P3|Treatment Period 1 (14 Days)|Protocol Violation|1
917902|NCT01005966|3026288|P2|Treatment Period 1 (14 Days)|Protocol Violation|0
917903|NCT01005966|3026289|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
917904|NCT01005966|3026285|P5|Treatment Period 1 (14 Days)|Adverse Event|0
917905|NCT01005966|3026286|P4|Treatment Period 1 (14 Days)|Adverse Event|0
917906|NCT01005966|3026287|P3|Treatment Period 1 (14 Days)|Adverse Event|0
917907|NCT01005966|3026288|P2|Treatment Period 1 (14 Days)|Adverse Event|0
917908|NCT01005966|3026289|P1|Treatment Period 1 (14 Days)|Adverse Event|1
917909|NCT01005914|3026309|P1|Overall Study|Withdrawal by Subject|1
917910|NCT01005914|3026309|P1|Overall Study|Lack of Efficacy|1
917911|NCT01005914|3026309|P1|Overall Study|Death|4
917912|NCT01005914|3026309|P1|Overall Study|Adverse Event|4
917913|NCT01005901|3026315|P2|Overall Study|No longer requires study drug|1
917914|NCT01005901|3026316|P1|Overall Study|No longer requires study drug|0
917915|NCT01005901|3026315|P2|Overall Study|Patient's inability to use the device|1
917916|NCT01005901|3026316|P1|Overall Study|Patient's inability to use the device|1
917917|NCT01005901|3026315|P2|Overall Study|Lost to Follow-up|2
917918|NCT01005901|3026316|P1|Overall Study|Lost to Follow-up|1
917919|NCT01005901|3026315|P2|Overall Study|Death|3
917920|NCT01005901|3026316|P1|Overall Study|Death|2
917921|NCT01005901|3026315|P2|Overall Study|Protocol Violation|3
917922|NCT01005901|3026316|P1|Overall Study|Protocol Violation|4
917923|NCT01005901|3026315|P2|Overall Study|Unsatisfactory therapeutic effect|5
917924|NCT01005901|3026316|P1|Overall Study|Unsatisfactory therapeutic effect|5
917925|NCT01005901|3026315|P2|Overall Study|Administrative problems|13
917926|NCT01005901|3026316|P1|Overall Study|Administrative problems|21
917927|NCT01005901|3026315|P2|Overall Study|Adverse Event|16
917928|NCT01005901|3026316|P1|Overall Study|Adverse Event|30
917929|NCT01005901|3026315|P2|Overall Study|Withdrawal by Subject|14
917930|NCT01005901|3026316|P1|Overall Study|Withdrawal by Subject|38
917931|NCT01005875|3026379|P1|Overall Study|Death|3
917932|NCT01005745|3026396|P1|Overall Study|Inappropriate antidiuretic hormone|1
917933|NCT01005745|3026396|P1|Overall Study|Death prior to treatment|1
917934|NCT01005745|3026396|P1|Overall Study|Disease progressed during TIL growth|3
917935|NCT01005745|3026396|P1|Overall Study|No TIL growth|1
917936|NCT01005732|3026401|P1|Overall Study|Death|1
917937|NCT01005732|3026401|P1|Overall Study|Lost to Follow-up|10
917938|NCT01005719|3026417|P6|Period 2|Adverse Event|1
917939|NCT01005719|3026418|P5|Period 2|Adverse Event|1
917940|NCT01005719|3026419|P4|Period 2|Adverse Event|0
917941|NCT01005719|3026420|P3|Period 2|Adverse Event|0
917942|NCT01005719|3026421|P2|Period 2|Adverse Event|0
917943|NCT01005719|3026422|P1|Period 2|Adverse Event|0
917944|NCT01005719|3026417|P6|Period 1|Delay in completing study procedures|1
917945|NCT01005719|3026418|P5|Period 1|Delay in completing study procedures|0
917946|NCT01005719|3026419|P4|Period 1|Delay in completing study procedures|0
917947|NCT01005719|3026420|P3|Period 1|Delay in completing study procedures|0
917948|NCT01005719|3026421|P2|Period 1|Delay in completing study procedures|0
917949|NCT01005719|3026422|P1|Period 1|Delay in completing study procedures|0
917950|NCT01005719|3026417|P6|Period 1|Adverse Event|0
917951|NCT01005719|3026418|P5|Period 1|Adverse Event|0
917952|NCT01005719|3026419|P4|Period 1|Adverse Event|1
917953|NCT01005719|3026420|P3|Period 1|Adverse Event|0
917954|NCT01005719|3026421|P2|Period 1|Adverse Event|0
917955|NCT01005719|3026422|P1|Period 1|Adverse Event|0
917956|NCT01005680|3026489|P2|Overall Study|Physician Decision|1
917957|NCT01005680|3026490|P1|Overall Study|Physician Decision|1
917958|NCT01005680|3026489|P2|Overall Study|Withdrawal by Subject|4
917959|NCT01005680|3026490|P1|Overall Study|Withdrawal by Subject|1
917960|NCT01005680|3026489|P2|Overall Study|Lost to Follow-up|6
917961|NCT01005680|3026490|P1|Overall Study|Lost to Follow-up|4
917962|NCT01005602|3026514|P2|Overall Study|Excluded due to unreliable clinical data|0
917963|NCT01005602|3026515|P1|Overall Study|Excluded due to unreliable clinical data|1
917964|NCT01005329|3026603|P1|Overall Study|Ineligible or received no protocol trt.|4
917965|NCT01005316|3026616|P4|Overall Study|Retransplanted|0
917966|NCT01005316|3026617|P3|Overall Study|Retransplanted|0
917967|NCT01005316|3026618|P2|Overall Study|Retransplanted|1
917968|NCT01005316|3026619|P1|Overall Study|Retransplanted|0
917969|NCT01005316|3026616|P4|Overall Study|Transferred Care|3
917970|NCT01005316|3026617|P3|Overall Study|Transferred Care|1
917971|NCT01005316|3026618|P2|Overall Study|Transferred Care|0
917972|NCT01005316|3026619|P1|Overall Study|Transferred Care|1
917973|NCT01005316|3026616|P4|Overall Study|Delisted|0
917974|NCT01005316|3026617|P3|Overall Study|Delisted|0
917975|NCT01005316|3026618|P2|Overall Study|Delisted|0
917976|NCT01005316|3026619|P1|Overall Study|Delisted|8
917977|NCT01005316|3026616|P4|Overall Study|Consented to Another Study|0
917978|NCT01005316|3026617|P3|Overall Study|Consented to Another Study|0
917979|NCT01005316|3026618|P2|Overall Study|Consented to Another Study|0
917980|NCT01005316|3026619|P1|Overall Study|Consented to Another Study|2
917981|NCT01005316|3026616|P4|Overall Study|Withdrawal by Subject|2
917982|NCT01005316|3026617|P3|Overall Study|Withdrawal by Subject|0
917983|NCT01005316|3026618|P2|Overall Study|Withdrawal by Subject|1
917984|NCT01005316|3026619|P1|Overall Study|Withdrawal by Subject|1
917985|NCT01005316|3026616|P4|Overall Study|Sponsor Decision|0
917986|NCT01005316|3026617|P3|Overall Study|Sponsor Decision|0
917987|NCT01005316|3026618|P2|Overall Study|Sponsor Decision|3
917988|NCT01005316|3026619|P1|Overall Study|Sponsor Decision|6
917989|NCT01005316|3026616|P4|Overall Study|Physician Decision|0
917990|NCT01005316|3026617|P3|Overall Study|Physician Decision|0
917991|NCT01005316|3026618|P2|Overall Study|Physician Decision|0
917992|NCT01005316|3026619|P1|Overall Study|Physician Decision|6
917993|NCT01005316|3026616|P4|Overall Study|Lost to Follow-up|2
917994|NCT01005316|3026617|P3|Overall Study|Lost to Follow-up|0
917995|NCT01005316|3026618|P2|Overall Study|Lost to Follow-up|3
917996|NCT01005316|3026619|P1|Overall Study|Lost to Follow-up|1
917997|NCT01005316|3026616|P4|Overall Study|Study Termination|85
917998|NCT01005316|3026617|P3|Overall Study|Study Termination|9
917999|NCT01005316|3026618|P2|Overall Study|Study Termination|63
918000|NCT01005316|3026619|P1|Overall Study|Study Termination|5
918001|NCT01005316|3026616|P4|Overall Study|Death|15
918002|NCT01005316|3026617|P3|Overall Study|Death|1
918003|NCT01005316|3026618|P2|Overall Study|Death|5
918004|NCT01005316|3026619|P1|Overall Study|Death|20
918005|NCT01005316|3026616|P4|Overall Study|Adverse Event|1
918006|NCT01005316|3026617|P3|Overall Study|Adverse Event|0
918007|NCT01005316|3026618|P2|Overall Study|Adverse Event|0
918008|NCT01005316|3026619|P1|Overall Study|Adverse Event|0
918009|NCT01005251|3026686|P5|Overall Study|Lack of Efficacy|0
918010|NCT01005251|3026687|P4|Overall Study|Lack of Efficacy|1
918011|NCT01005251|3026688|P3|Overall Study|Lack of Efficacy|1
918012|NCT01005251|3026689|P2|Overall Study|Lack of Efficacy|0
918013|NCT01005251|3026690|P1|Overall Study|Lack of Efficacy|0
918014|NCT01005251|3026686|P5|Overall Study|Randomized in error|0
918015|NCT01005251|3026687|P4|Overall Study|Randomized in error|1
918016|NCT01005251|3026688|P3|Overall Study|Randomized in error|1
918017|NCT01005251|3026689|P2|Overall Study|Randomized in error|0
918018|NCT01005251|3026690|P1|Overall Study|Randomized in error|0
918019|NCT01005251|3026686|P5|Overall Study|Wrong drug dispensed|0
918020|NCT01005251|3026687|P4|Overall Study|Wrong drug dispensed|0
918021|NCT01005251|3026688|P3|Overall Study|Wrong drug dispensed|0
918022|NCT01005251|3026689|P2|Overall Study|Wrong drug dispensed|1
918023|NCT01005251|3026690|P1|Overall Study|Wrong drug dispensed|0
918024|NCT01005251|3026686|P5|Overall Study|Patient moved|0
918025|NCT01005251|3026687|P4|Overall Study|Patient moved|0
918026|NCT01005251|3026688|P3|Overall Study|Patient moved|0
918027|NCT01005251|3026689|P2|Overall Study|Patient moved|0
918028|NCT01005251|3026690|P1|Overall Study|Patient moved|1
918029|NCT01005251|3026686|P5|Overall Study|Physician Decision|2
918030|NCT01005251|3026687|P4|Overall Study|Physician Decision|0
918031|NCT01005251|3026688|P3|Overall Study|Physician Decision|0
918032|NCT01005251|3026689|P2|Overall Study|Physician Decision|0
918033|NCT01005251|3026690|P1|Overall Study|Physician Decision|0
918034|NCT01005251|3026686|P5|Overall Study|Lost to Follow-up|0
918035|NCT01005251|3026687|P4|Overall Study|Lost to Follow-up|0
918036|NCT01005251|3026688|P3|Overall Study|Lost to Follow-up|2
918037|NCT01005251|3026689|P2|Overall Study|Lost to Follow-up|4
918038|NCT01005251|3026690|P1|Overall Study|Lost to Follow-up|1
918039|NCT01005251|3026686|P5|Overall Study|Developed study-specific withdrawal crit|1
918040|NCT01005251|3026687|P4|Overall Study|Developed study-specific withdrawal crit|0
918041|NCT01005251|3026688|P3|Overall Study|Developed study-specific withdrawal crit|3
918042|NCT01005251|3026689|P2|Overall Study|Developed study-specific withdrawal crit|0
918043|NCT01005251|3026690|P1|Overall Study|Developed study-specific withdrawal crit|2
918044|NCT01005251|3026686|P5|Overall Study|Protocol Violation|2
918045|NCT01005251|3026687|P4|Overall Study|Protocol Violation|0
918046|NCT01005251|3026688|P3|Overall Study|Protocol Violation|0
918047|NCT01005251|3026689|P2|Overall Study|Protocol Violation|0
918048|NCT01005251|3026690|P1|Overall Study|Protocol Violation|1
918049|NCT01005251|3026686|P5|Overall Study|Adverse Event|4
918050|NCT01005251|3026687|P4|Overall Study|Adverse Event|5
918051|NCT01005251|3026688|P3|Overall Study|Adverse Event|8
918052|NCT01005251|3026689|P2|Overall Study|Adverse Event|6
918053|NCT01005251|3026690|P1|Overall Study|Adverse Event|2
918054|NCT01005251|3026686|P5|Overall Study|Eligibility criteria not fulfilled|0
918055|NCT01005251|3026687|P4|Overall Study|Eligibility criteria not fulfilled|1
918056|NCT01005251|3026688|P3|Overall Study|Eligibility criteria not fulfilled|4
918057|NCT01005251|3026689|P2|Overall Study|Eligibility criteria not fulfilled|0
918058|NCT01005251|3026690|P1|Overall Study|Eligibility criteria not fulfilled|4
918059|NCT01005251|3026686|P5|Overall Study|Withdrawal by Subject|9
918060|NCT01005251|3026687|P4|Overall Study|Withdrawal by Subject|4
918061|NCT01005251|3026688|P3|Overall Study|Withdrawal by Subject|3
918062|NCT01005251|3026689|P2|Overall Study|Withdrawal by Subject|5
918063|NCT01005251|3026690|P1|Overall Study|Withdrawal by Subject|2
918064|NCT01004848|3026763|P2|Overall Study|Lost to Follow-up|45
918065|NCT01004848|3026764|P1|Overall Study|Lost to Follow-up|55
918066|NCT01004822|3026802|P8|Overall Study|Other|0
918067|NCT01004822|3026803|P7|Overall Study|Other|0
918068|NCT01004822|3026804|P6|Overall Study|Other|1
918069|NCT01004822|3026805|P5|Overall Study|Other|0
918070|NCT01004822|3026806|P4|Overall Study|Other|1
918071|NCT01004822|3026807|P3|Overall Study|Other|4
918072|NCT01004822|3026808|P2|Overall Study|Other|0
918073|NCT01004822|3026809|P1|Overall Study|Other|0
918074|NCT01004822|3026802|P8|Overall Study|Adverse Event|1
918075|NCT01004822|3026803|P7|Overall Study|Adverse Event|1
918076|NCT01004822|3026804|P6|Overall Study|Adverse Event|0
918077|NCT01004822|3026805|P5|Overall Study|Adverse Event|0
918078|NCT01004822|3026806|P4|Overall Study|Adverse Event|0
918079|NCT01004822|3026807|P3|Overall Study|Adverse Event|0
918080|NCT01004822|3026808|P2|Overall Study|Adverse Event|0
918081|NCT01004822|3026809|P1|Overall Study|Adverse Event|0
918082|NCT01004822|3026802|P8|Overall Study|No longer willing to continue|0
918083|NCT01004822|3026803|P7|Overall Study|No longer willing to continue|1
918084|NCT01004822|3026804|P6|Overall Study|No longer willing to continue|1
918085|NCT01004822|3026805|P5|Overall Study|No longer willing to continue|2
918086|NCT01004822|3026806|P4|Overall Study|No longer willing to continue|1
918087|NCT01004822|3026807|P3|Overall Study|No longer willing to continue|0
918088|NCT01004822|3026808|P2|Overall Study|No longer willing to continue|0
918089|NCT01004822|3026809|P1|Overall Study|No longer willing to continue|0
918090|NCT01004822|3026802|P8|Overall Study|Global deterioration of health status|0
918091|NCT01004822|3026803|P7|Overall Study|Global deterioration of health status|1
918092|NCT01004822|3026804|P6|Overall Study|Global deterioration of health status|0
918093|NCT01004822|3026805|P5|Overall Study|Global deterioration of health status|0
918094|NCT01004822|3026806|P4|Overall Study|Global deterioration of health status|1
918095|NCT01004822|3026807|P3|Overall Study|Global deterioration of health status|0
918096|NCT01004822|3026808|P2|Overall Study|Global deterioration of health status|0
918097|NCT01004822|3026809|P1|Overall Study|Global deterioration of health status|0
918098|NCT01004822|3026802|P8|Overall Study|Objective progression or relapse|4
918099|NCT01004822|3026803|P7|Overall Study|Objective progression or relapse|1
918100|NCT01004822|3026804|P6|Overall Study|Objective progression or relapse|2
918101|NCT01004822|3026805|P5|Overall Study|Objective progression or relapse|2
918102|NCT01004822|3026806|P4|Overall Study|Objective progression or relapse|1
918103|NCT01004822|3026807|P3|Overall Study|Objective progression or relapse|0
918104|NCT01004822|3026808|P2|Overall Study|Objective progression or relapse|3
918105|NCT01004822|3026809|P1|Overall Study|Objective progression or relapse|3
918106|NCT01004614|3026974|P4|Washout|Withdrawal by Subject|0
918107|NCT01004614|3026975|P3|Washout|Withdrawal by Subject|0
918108|NCT01004614|3026976|P2|Washout|Withdrawal by Subject|1
918109|NCT01004614|3026977|P1|Washout|Withdrawal by Subject|0
918110|NCT01004510|3027011|P1|Overall Study|Adverse Event|1
918111|NCT01004432|3027015|P5|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10
918112|NCT01004432|3027016|P4|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
918113|NCT01004432|3027017|P3|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
918114|NCT01004432|3027018|P2|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
918115|NCT01004432|3027019|P1|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
918116|NCT01004432|3027015|P5|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2
918117|NCT01004432|3027016|P4|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
918118|NCT01004432|3027017|P3|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
918119|NCT01004432|3027018|P2|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
918120|NCT01004432|3027019|P1|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
918121|NCT01004432|3027015|P5|OL Study Extension (Week 52 - 76)|Protocol Violation|4
918122|NCT01004432|3027016|P4|OL Study Extension (Week 52 - 76)|Protocol Violation|0
918123|NCT01004432|3027017|P3|OL Study Extension (Week 52 - 76)|Protocol Violation|0
918124|NCT01004432|3027018|P2|OL Study Extension (Week 52 - 76)|Protocol Violation|0
918125|NCT01004432|3027019|P1|OL Study Extension (Week 52 - 76)|Protocol Violation|0
918126|NCT01004432|3027015|P5|OL Study Extension (Week 52 - 76)|Adverse Event|2
918127|NCT01004432|3027016|P4|OL Study Extension (Week 52 - 76)|Adverse Event|0
918128|NCT01004432|3027017|P3|OL Study Extension (Week 52 - 76)|Adverse Event|0
918129|NCT01004432|3027018|P2|OL Study Extension (Week 52 - 76)|Adverse Event|0
918130|NCT01004432|3027019|P1|OL Study Extension (Week 52 - 76)|Adverse Event|0
918131|NCT01004432|3027015|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
918132|NCT01004432|3027016|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
918133|NCT01004432|3027017|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1
918134|NCT01004432|3027018|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
918135|NCT01004432|3027019|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
918136|NCT01004432|3027015|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
918137|NCT01004432|3027016|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37
918138|NCT01004432|3027017|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24
918139|NCT01004432|3027018|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2
918140|NCT01004432|3027019|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
918141|NCT01004432|3027015|P5|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
918142|NCT01004432|3027016|P4|OL/Double-Blind (DB) Period (Week 16-52)|Death|1
918143|NCT01004432|3027017|P3|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
918144|NCT01004432|3027018|P2|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
918145|NCT01004432|3027019|P1|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
918146|NCT01004432|3027015|P5|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
918147|NCT01004432|3027016|P4|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7
918148|NCT01004432|3027017|P3|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4
918149|NCT01004432|3027018|P2|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1
918150|NCT01004432|3027019|P1|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
918151|NCT01004432|3027015|P5|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
918152|NCT01004432|3027016|P4|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4
918153|NCT01004432|3027017|P3|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
918154|NCT01004432|3027018|P2|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
918155|NCT01004432|3027019|P1|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
918156|NCT01004432|3027015|P5|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
918157|NCT01004432|3027016|P4|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6
918158|NCT01004432|3027017|P3|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5
918159|NCT01004432|3027018|P2|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1
918160|NCT01004432|3027019|P1|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
918161|NCT01004432|3027015|P5|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
918162|NCT01004432|3027016|P4|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
918163|NCT01004432|3027017|P3|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
918164|NCT01004432|3027018|P2|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
918165|NCT01004432|3027019|P1|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|2
918166|NCT01004432|3027015|P5|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
918167|NCT01004432|3027016|P4|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
918168|NCT01004432|3027017|P3|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
918169|NCT01004432|3027018|P2|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
918170|NCT01004432|3027019|P1|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|15
918171|NCT01004432|3027015|P5|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
918172|NCT01004432|3027016|P4|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
918173|NCT01004432|3027017|P3|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
918174|NCT01004432|3027018|P2|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
918175|NCT01004432|3027019|P1|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|17
918176|NCT01004432|3027015|P5|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
918177|NCT01004432|3027016|P4|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
918178|NCT01004432|3027017|P3|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
918179|NCT01004432|3027018|P2|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
918180|NCT01004432|3027019|P1|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|29
918181|NCT01004432|3027015|P5|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
918182|NCT01004432|3027016|P4|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
918183|NCT01004432|3027017|P3|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
918184|NCT01004432|3027018|P2|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
918185|NCT01004432|3027019|P1|Open-label (OL) Period (Week 0 – 16)|Adverse Event|20
918186|NCT01004263|3027062|P1|Overall Study|Lack of Qualifying Event|2
918187|NCT01004263|3027062|P1|Overall Study|Physician Decision|15
918188|NCT01004263|3027062|P1|Overall Study|Pregnancy|2
918189|NCT01004263|3027062|P1|Overall Study|Lack of Efficacy|13
918190|NCT01004263|3027062|P1|Overall Study|Lost to Follow-up|64
918191|NCT01004263|3027062|P1|Overall Study|Protocol Violation|10
918192|NCT01004263|3027062|P1|Overall Study|Withdrawal by Subject|58
918193|NCT01004263|3027062|P1|Overall Study|Adverse Event|15
918194|NCT01004250|3027070|P1|Follow-Up (FU) Period|Lost to Follow-up|1
918195|NCT01004250|3027070|P1|Maintenance Therapy Period|Physician Decision|4
918196|NCT01004250|3027070|P1|Maintenance Therapy Period|Withdrawal by Subject|5
918197|NCT01004250|3027070|P1|Maintenance Therapy Period|Protocol Violation|1
918198|NCT01004250|3027070|P1|Maintenance Therapy Period|Lost to Follow-up|1
918199|NCT01004250|3027070|P1|Maintenance Therapy Period|Adverse Event|15
918200|NCT01004250|3027070|P1|Induction Therapy Period|Physician Decision|2
918201|NCT01004250|3027070|P1|Induction Therapy Period|Withdrawal by Subject|2
918202|NCT01004250|3027070|P1|Induction Therapy Period|Entry Criteria Not Met|1
918203|NCT01004250|3027070|P1|Induction Therapy Period|Adverse Event|10
918204|NCT01004185|3027082|P2|Overall Study|Withdrawal by Subject|1
918205|NCT01004185|3027083|P1|Overall Study|Withdrawal by Subject|2
918206|NCT01004185|3027082|P2|Overall Study|Sponsor Terminated Study|5
918207|NCT01004185|3027083|P1|Overall Study|Sponsor Terminated Study|4
918208|NCT01004185|3027082|P2|Overall Study|Lack of Efficacy|1
918209|NCT01004185|3027083|P1|Overall Study|Lack of Efficacy|2
918210|NCT01004185|3027082|P2|Overall Study|Lost to Follow-up|1
918211|NCT01004185|3027083|P1|Overall Study|Lost to Follow-up|0
918212|NCT01004185|3027082|P2|Overall Study|Adverse Event|1
918213|NCT01004185|3027083|P1|Overall Study|Adverse Event|1
918214|NCT01004172|3027091|P1|Overall Study|Symptomatic Deterioration|2
918215|NCT01004172|3027091|P1|Overall Study|Physician Decision|1
918216|NCT01004172|3027091|P1|Overall Study|Adverse Event|1
918217|NCT01004172|3027091|P1|Overall Study|Progressive Disease in CNS and Non-CNS|2
918218|NCT01004172|3027091|P1|Overall Study|Progressive Disease in Non-CNS Only|16
918219|NCT01004172|3027091|P1|Overall Study|Progressive Disease in CNS Only|16
918220|NCT01004159|3027097|P1|Overall Study|Disease Progression|18
918221|NCT01004159|3027097|P1|Overall Study|Adverse Event|2
918222|NCT01004146|3027104|P2|Overall Study|Withdrawal by Subject|5
918223|NCT01004146|3027105|P1|Overall Study|Withdrawal by Subject|4
918224|NCT01004003|3027199|P9|Overall Study|Other|0
918225|NCT01004003|3027200|P8|Overall Study|Other|0
918226|NCT01004003|3027201|P7|Overall Study|Other|0
918227|NCT01004003|3027202|P6|Overall Study|Other|1
918228|NCT01004003|3027203|P5|Overall Study|Other|0
918229|NCT01004003|3027204|P4|Overall Study|Other|0
918230|NCT01004003|3027205|P3|Overall Study|Other|0
918231|NCT01004003|3027206|P2|Overall Study|Other|0
918232|NCT01004003|3027207|P1|Overall Study|Other|0
918233|NCT01004003|3027199|P9|Overall Study|Refused to continue taking trial med.|2
918234|NCT01004003|3027200|P8|Overall Study|Refused to continue taking trial med.|0
918235|NCT01004003|3027201|P7|Overall Study|Refused to continue taking trial med.|0
918236|NCT01004003|3027202|P6|Overall Study|Refused to continue taking trial med.|0
918237|NCT01004003|3027203|P5|Overall Study|Refused to continue taking trial med.|0
918238|NCT01004003|3027204|P4|Overall Study|Refused to continue taking trial med.|0
918239|NCT01004003|3027205|P3|Overall Study|Refused to continue taking trial med.|0
918240|NCT01004003|3027206|P2|Overall Study|Refused to continue taking trial med.|0
918241|NCT01004003|3027207|P1|Overall Study|Refused to continue taking trial med.|0
918242|NCT01004003|3027199|P9|Overall Study|Adverse Event|6
918243|NCT01004003|3027200|P8|Overall Study|Adverse Event|21
918244|NCT01004003|3027201|P7|Overall Study|Adverse Event|7
918245|NCT01004003|3027202|P6|Overall Study|Adverse Event|2
918246|NCT01004003|3027203|P5|Overall Study|Adverse Event|2
918247|NCT01004003|3027204|P4|Overall Study|Adverse Event|3
918248|NCT01004003|3027205|P3|Overall Study|Adverse Event|3
918249|NCT01004003|3027206|P2|Overall Study|Adverse Event|2
918250|NCT01004003|3027207|P1|Overall Study|Adverse Event|4
918251|NCT01004003|3027199|P9|Overall Study|Progressive disease|22
918252|NCT01004003|3027200|P8|Overall Study|Progressive disease|39
918253|NCT01004003|3027201|P7|Overall Study|Progressive disease|1
918254|NCT01004003|3027202|P6|Overall Study|Progressive disease|1
918255|NCT01004003|3027203|P5|Overall Study|Progressive disease|2
918256|NCT01004003|3027204|P4|Overall Study|Progressive disease|0
918257|NCT01004003|3027205|P3|Overall Study|Progressive disease|1
918258|NCT01004003|3027206|P2|Overall Study|Progressive disease|1
918259|NCT01004003|3027207|P1|Overall Study|Progressive disease|2
918260|NCT01003990|3027238|P3|Overall Study|Subject Withdrew Consent|7
918261|NCT01003990|3027239|P2|Overall Study|Subject Withdrew Consent|5
918262|NCT01003990|3027240|P1|Overall Study|Subject Withdrew Consent|12
918263|NCT01003990|3027238|P3|Overall Study|No Longer Met Study Criteria|0
918264|NCT01003990|3027239|P2|Overall Study|No Longer Met Study Criteria|1
918265|NCT01003990|3027240|P1|Overall Study|No Longer Met Study Criteria|4
918266|NCT01003990|3027238|P3|Overall Study|Pregnancy|4
918267|NCT01003990|3027239|P2|Overall Study|Pregnancy|2
918268|NCT01003990|3027240|P1|Overall Study|Pregnancy|10
918269|NCT01003990|3027238|P3|Overall Study|Poor/Non-compliance|2
918270|NCT01003990|3027239|P2|Overall Study|Poor/Non-compliance|3
918271|NCT01003990|3027240|P1|Overall Study|Poor/Non-compliance|4
918272|NCT01003990|3027238|P3|Overall Study|Reasons Not Identified|8
918273|NCT01003990|3027239|P2|Overall Study|Reasons Not Identified|13
918274|NCT01003990|3027240|P1|Overall Study|Reasons Not Identified|14
918275|NCT01003990|3027238|P3|Overall Study|Lost to Follow-up|7
918276|NCT01003990|3027239|P2|Overall Study|Lost to Follow-up|12
918277|NCT01003990|3027240|P1|Overall Study|Lost to Follow-up|30
918278|NCT01003990|3027238|P3|Overall Study|Lack of Efficacy|3
918279|NCT01003990|3027239|P2|Overall Study|Lack of Efficacy|2
918280|NCT01003990|3027240|P1|Overall Study|Lack of Efficacy|10
918281|NCT01003990|3027238|P3|Overall Study|Death|1
918282|NCT01003990|3027239|P2|Overall Study|Death|8
918283|NCT01003990|3027240|P1|Overall Study|Death|0
918284|NCT01003990|3027238|P3|Overall Study|Adverse Event|11
918285|NCT01003990|3027239|P2|Overall Study|Adverse Event|5
918286|NCT01003990|3027240|P1|Overall Study|Adverse Event|8
918287|NCT01003899|3027257|P1|Overall Study|Progressive disease|34
918288|NCT01003899|3027257|P1|Overall Study|Not treated|1
918289|NCT01003899|3027257|P1|Overall Study|Not entered|4
918290|NCT01003899|3027257|P1|Overall Study|Other Adverse Event|8
918291|NCT01003886|3027266|P1|Overall Study|Adverse Event|3
918292|NCT01003886|3027266|P1|Overall Study|Other|14
918293|NCT01003886|3027266|P1|Overall Study|Withdrawal by Subject|39
918294|NCT01003886|3027266|P1|Overall Study|Lost to Follow-up|169
918295|NCT01003886|3027266|P1|Overall Study|Lack of Efficacy|5
918296|NCT01003249|3027300|P2|Second Intervention (4 Weeks)|Adverse Event|0
918297|NCT01003249|3027301|P1|Second Intervention (4 Weeks)|Adverse Event|1
918298|NCT01003249|3027300|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
918299|NCT01003249|3027301|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|0
918300|NCT01003249|3027300|P2|First Intervention (4 Weeks)|Non-Serious Event|1
918301|NCT01003249|3027301|P1|First Intervention (4 Weeks)|Non-Serious Event|1
918302|NCT01003249|3027300|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
918303|NCT01003249|3027301|P1|First Intervention (4 Weeks)|Withdrawal by Subject|1
918304|NCT01003210|3027319|P2|Overall Study|Lost to Follow-up|3
918305|NCT01003210|3027320|P1|Overall Study|Lost to Follow-up|1
918306|NCT01003184|3027332|P2|Overall Study|Physician Decision|0
918307|NCT01003184|3027333|P1|Overall Study|Physician Decision|1
918308|NCT01003184|3027332|P2|Overall Study|Withdrawal by Subject|6
918309|NCT01003184|3027333|P1|Overall Study|Withdrawal by Subject|1
918310|NCT01003184|3027332|P2|Overall Study|Protocol Violation|0
918311|NCT01003184|3027333|P1|Overall Study|Protocol Violation|3
918312|NCT01003184|3027332|P2|Overall Study|Loss of glucose control|1
918313|NCT01003184|3027333|P1|Overall Study|Loss of glucose control|1
918314|NCT01003184|3027332|P2|Overall Study|Lost to Follow-up|0
918315|NCT01003184|3027333|P1|Overall Study|Lost to Follow-up|1
918316|NCT01003184|3027332|P2|Overall Study|Adverse Event|5
918317|NCT01003184|3027333|P1|Overall Study|Adverse Event|12
918318|NCT01002989|3027416|P1|Overall Study|exclusion criteria, no consent|5
918319|NCT01002742|3027425|P2|Overall Study|Determined to be ineligible|1
918320|NCT01002742|3027426|P1|Overall Study|Determined to be ineligible|0
918321|NCT01002573|3027462|P2|Overall Study|Subject did not receive at least 1 dose|7
918322|NCT01002573|3027463|P1|Overall Study|Subject did not receive at least 1 dose|11
918323|NCT01002547|3027484|P3|Overall Study|Adverse Event|0
918324|NCT01002547|3027485|P2|Overall Study|Adverse Event|0
918325|NCT01002547|3027486|P1|Overall Study|Adverse Event|1
918326|NCT01002547|3027484|P3|Overall Study|Death|2
918327|NCT01002547|3027485|P2|Overall Study|Death|2
918328|NCT01002547|3027486|P1|Overall Study|Death|0
918329|NCT01002547|3027484|P3|Overall Study|Physician Decision|0
918330|NCT01002547|3027485|P2|Overall Study|Physician Decision|0
918331|NCT01002547|3027486|P1|Overall Study|Physician Decision|1
918332|NCT01002547|3027484|P3|Overall Study|Lost to Follow-up|1
918333|NCT01002547|3027485|P2|Overall Study|Lost to Follow-up|1
918334|NCT01002547|3027486|P1|Overall Study|Lost to Follow-up|2
918335|NCT01002547|3027484|P3|Overall Study|Withdrawal by Subject|5
918336|NCT01002547|3027485|P2|Overall Study|Withdrawal by Subject|0
918337|NCT01002547|3027486|P1|Overall Study|Withdrawal by Subject|4
918338|NCT01002482|3027544|P2|Overall Study|Included twice|0
918339|NCT01002482|3027545|P1|Overall Study|Included twice|1
918340|NCT01002482|3027544|P2|Overall Study|Withdrawal by Subject|21
918341|NCT01002482|3027545|P1|Overall Study|Withdrawal by Subject|14
918342|NCT01002339|3027579|P3|Overall Study|Randomized. Not transplanted|1
918343|NCT01002339|3027580|P2|Overall Study|Randomized. Not transplanted|0
918344|NCT01002339|3027581|P1|Overall Study|Randomized. Not transplanted|0
918345|NCT01002339|3027579|P3|Overall Study|Lung cancer detected before transplant|1
918346|NCT01002339|3027580|P2|Overall Study|Lung cancer detected before transplant|0
918347|NCT01002339|3027581|P1|Overall Study|Lung cancer detected before transplant|0
918348|NCT01002339|3027579|P3|Overall Study|Protocol Violation|2
918349|NCT01002339|3027580|P2|Overall Study|Protocol Violation|0
918350|NCT01002339|3027581|P1|Overall Study|Protocol Violation|0
918351|NCT01002339|3027579|P3|Overall Study|Incorrect treatment assignment|1
918352|NCT01002339|3027580|P2|Overall Study|Incorrect treatment assignment|0
918353|NCT01002339|3027581|P1|Overall Study|Incorrect treatment assignment|0
918354|NCT01002339|3027579|P3|Overall Study|Withdrawal by Subject|0
918355|NCT01002339|3027580|P2|Overall Study|Withdrawal by Subject|1
918356|NCT01002339|3027581|P1|Overall Study|Withdrawal by Subject|0
918357|NCT01002105|3027657|P2|Overall Study|condition worsened|2
918358|NCT01002105|3027658|P1|Overall Study|condition worsened|4
918359|NCT01002105|3027657|P2|Overall Study|non compliance|3
918360|NCT01002105|3027658|P1|Overall Study|non compliance|5
918361|NCT01002105|3027657|P2|Overall Study|Lost to Follow-up|16
918362|NCT01002105|3027658|P1|Overall Study|Lost to Follow-up|10
918363|NCT01001988|3027674|P1|Overall Study|Lost to Follow-up|15
918364|NCT01001988|3027674|P1|Overall Study|Withdrawal by Subject|18
918365|NCT01001988|3027674|P1|Overall Study|Protocol Violation|84
918366|NCT01001832|3027692|P2|Follow-up Period|Not specified|1
918367|NCT01001832|3027693|P1|Follow-up Period|Not specified|2
918368|NCT01001832|3027692|P2|Follow-up Period|Follow-up no longer required /protocol|20
918369|NCT01001832|3027693|P1|Follow-up Period|Follow-up no longer required /protocol|15
918370|NCT01001832|3027692|P2|Follow-up Period|Withdrawal by Subject|0
918371|NCT01001832|3027693|P1|Follow-up Period|Withdrawal by Subject|1
918372|NCT01001832|3027692|P2|Long-term Period|Not specified|2
918373|NCT01001832|3027693|P1|Long-term Period|Not specified|1
918374|NCT01001832|3027692|P2|Long-term Period|Lack of Efficacy|2
918375|NCT01001832|3027693|P1|Long-term Period|Lack of Efficacy|0
918376|NCT01001832|3027692|P2|Long-term Period|Withdrawal by Subject|0
918377|NCT01001832|3027693|P1|Long-term Period|Withdrawal by Subject|1
918378|NCT01001832|3027692|P2|Long-term Period|Adverse Event|1
918379|NCT01001832|3027693|P1|Long-term Period|Adverse Event|2
918380|NCT01001832|3027692|P2|Short-term Period|Adverse Event|3
918381|NCT01001832|3027693|P1|Short-term Period|Adverse Event|2
918382|NCT01001767|3027751|P2|Overall Study|Physician Decision|0
918383|NCT01001767|3027752|P1|Overall Study|Physician Decision|1
918384|NCT01001767|3027751|P2|Overall Study|Lost to Follow-up|0
918385|NCT01001767|3027752|P1|Overall Study|Lost to Follow-up|1
918386|NCT01001767|3027751|P2|Overall Study|Protocol Violation|0
918387|NCT01001767|3027752|P1|Overall Study|Protocol Violation|1
918388|NCT01001767|3027751|P2|Overall Study|no baseline study performed|0
918389|NCT01001767|3027752|P1|Overall Study|no baseline study performed|1
918390|NCT01001702|3027758|P1|Overall Study|Lack of Efficacy per Investigator|3
918391|NCT01001702|3027758|P1|Overall Study|Withdrawal by Subject|19
918392|NCT01001702|3027758|P1|Overall Study|Investigator withdrew Subject|10
918393|NCT01001702|3027758|P1|Overall Study|Subject met Withdrawal Criteria|22
918394|NCT01001702|3027758|P1|Overall Study|Sponsor Discontinued Study|4
918395|NCT01001702|3027758|P1|Overall Study|Adverse Event|7
918396|NCT01001702|3027758|P1|Overall Study|Lost to Follow-up|7
918397|NCT01001572|3027771|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
918398|NCT01001572|3027772|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
918399|NCT01001572|3027773|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
918400|NCT01001572|3027771|P3|Double-Blind Treatment Phase|Protocol deviation|1
918401|NCT01001572|3027772|P2|Double-Blind Treatment Phase|Protocol deviation|0
918402|NCT01001572|3027773|P1|Double-Blind Treatment Phase|Protocol deviation|0
918403|NCT01001572|3027771|P3|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1
918404|NCT01001572|3027772|P2|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
918405|NCT01001572|3027773|P1|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
918406|NCT01001572|3027771|P3|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1
918407|NCT01001572|3027772|P2|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
918408|NCT01001572|3027773|P1|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
918409|NCT01001572|3027771|P3|Double-Blind Treatment Phase|Withdrawal by Subject|13
918410|NCT01001572|3027772|P2|Double-Blind Treatment Phase|Withdrawal by Subject|8
918411|NCT01001572|3027773|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
918412|NCT01001572|3027771|P3|Double-Blind Treatment Phase|Adverse Event|2
918413|NCT01001572|3027772|P2|Double-Blind Treatment Phase|Adverse Event|2
918414|NCT01001572|3027773|P1|Double-Blind Treatment Phase|Adverse Event|0
918415|NCT01001572|3027771|P3|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
918416|NCT01001572|3027772|P2|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
918417|NCT01001572|3027773|P1|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45
918418|NCT01001572|3027771|P3|Single-Blind Valsartan 160 mg|Administrative problems|0
918419|NCT01001572|3027772|P2|Single-Blind Valsartan 160 mg|Administrative problems|0
918420|NCT01001572|3027773|P1|Single-Blind Valsartan 160 mg|Administrative problems|82
918421|NCT01001572|3027771|P3|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
918422|NCT01001572|3027772|P2|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
918423|NCT01001572|3027773|P1|Single-Blind Valsartan 160 mg|Lost to Follow-up|4
918424|NCT01001572|3027771|P3|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
918425|NCT01001572|3027772|P2|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
918426|NCT01001572|3027773|P1|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1
918427|NCT01001572|3027771|P3|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
918428|NCT01001572|3027772|P2|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
918429|NCT01001572|3027773|P1|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7
918430|NCT01001572|3027771|P3|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
918431|NCT01001572|3027772|P2|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
918432|NCT01001572|3027773|P1|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96
918433|NCT01001572|3027771|P3|Single-Blind Valsartan 160 mg|Adverse Event|0
918434|NCT01001572|3027772|P2|Single-Blind Valsartan 160 mg|Adverse Event|0
918435|NCT01001572|3027773|P1|Single-Blind Valsartan 160 mg|Adverse Event|11
918436|NCT01001572|3027771|P3|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
918437|NCT01001572|3027772|P2|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
918438|NCT01001572|3027773|P1|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32
918439|NCT01001520|3027811|P2|Medication Period 2|Withdrawal by Subject|3
918440|NCT01001520|3027812|P1|Medication Period 2|Withdrawal by Subject|0
918441|NCT01001520|3027811|P2|Washout Period|Withdrawal by Subject|1
918442|NCT01001520|3027812|P1|Washout Period|Withdrawal by Subject|2
918443|NCT01001520|3027811|P2|Medication Period 1|Ineligible: Claustrophobia in fMRI|0
918444|NCT01001520|3027812|P1|Medication Period 1|Ineligible: Claustrophobia in fMRI|2
918445|NCT01001520|3027811|P2|Medication Period 1|Ineligible: fMRI contraindicated metal|2
918446|NCT01001520|3027812|P1|Medication Period 1|Ineligible: fMRI contraindicated metal|0
918447|NCT01001520|3027811|P2|Medication Period 1|Ineligible: Positive Urine Drug Screen|3
918448|NCT01001520|3027812|P1|Medication Period 1|Ineligible: Positive Urine Drug Screen|0
918449|NCT01001520|3027811|P2|Medication Period 1|Withdrawal by Subject|2
918450|NCT01001520|3027812|P1|Medication Period 1|Withdrawal by Subject|2
918451|NCT01001494|3027839|P3|Overall Study|Other|3
918452|NCT01001494|3027840|P2|Overall Study|Other|1
918453|NCT01001494|3027841|P1|Overall Study|Other|0
918454|NCT01001494|3027839|P3|Overall Study|Lack of Efficacy|8
918455|NCT01001494|3027840|P2|Overall Study|Lack of Efficacy|0
918456|NCT01001494|3027841|P1|Overall Study|Lack of Efficacy|2
918457|NCT01001494|3027839|P3|Overall Study|COPD exacerbation|5
918458|NCT01001494|3027840|P2|Overall Study|COPD exacerbation|4
918459|NCT01001494|3027841|P1|Overall Study|COPD exacerbation|3
918460|NCT01001494|3027839|P3|Overall Study|Withdrawal by Subject|17
918461|NCT01001494|3027840|P2|Overall Study|Withdrawal by Subject|7
918462|NCT01001494|3027841|P1|Overall Study|Withdrawal by Subject|9
918463|NCT01001494|3027839|P3|Overall Study|Lost to Follow-up|1
918464|NCT01001494|3027840|P2|Overall Study|Lost to Follow-up|0
918465|NCT01001494|3027841|P1|Overall Study|Lost to Follow-up|2
918466|NCT01001494|3027839|P3|Overall Study|Protocol Violation|1
918467|NCT01001494|3027840|P2|Overall Study|Protocol Violation|1
918468|NCT01001494|3027841|P1|Overall Study|Protocol Violation|0
918469|NCT01001494|3027839|P3|Overall Study|Adverse Event|6
918470|NCT01001494|3027840|P2|Overall Study|Adverse Event|4
918471|NCT01001494|3027841|P1|Overall Study|Adverse Event|8
918472|NCT01001429|3027926|P2|Overall Study|surgery cancelled|1
918473|NCT01001429|3027927|P1|Overall Study|surgery cancelled|0
918474|NCT01001390|3027966|P2|Overall Study|Failure to wear AFO device|0
918475|NCT01001390|3027967|P1|Overall Study|Failure to wear AFO device|2
918476|NCT01001377|3027975|P2|Overall Study|Death|384
918477|NCT01001377|3027976|P1|Overall Study|Death|391
918478|NCT01001377|3027975|P2|Overall Study|Lost to Follow-up|17
918479|NCT01001377|3027976|P1|Overall Study|Lost to Follow-up|14
918480|NCT01001377|3027975|P2|Overall Study|Withdrawal by Subject|20
918481|NCT01001377|3027976|P1|Overall Study|Withdrawal by Subject|19
918482|NCT01001377|3027975|P2|Overall Study|Ineligibility determined|0
918483|NCT01001377|3027976|P1|Overall Study|Ineligibility determined|2
918484|NCT01001325|3028006|P2|Overall Study|Protocol Violation|0
918485|NCT01001325|3028007|P1|Overall Study|Protocol Violation|2
918486|NCT01001325|3028006|P2|Overall Study|Lost to Follow-up|10
918487|NCT01001325|3028007|P1|Overall Study|Lost to Follow-up|16
918488|NCT01001299|3028013|P1|Overall Study|Withdrew Consent|1
918489|NCT01001299|3028013|P1|Overall Study|Began Taking Commercially Available Drug|2
918490|NCT01001299|3028013|P1|Overall Study|Death|1
918491|NCT01001299|3028013|P1|Overall Study|Adverse event or Intercurrent Illness|1
918492|NCT01001299|3028013|P1|Overall Study|Insufficient Therapeutic Response|20
918493|NCT01001234|3028042|P5|Overall Study|Not Treated: Lack of Qualifying Event|0
918494|NCT01001234|3028043|P4|Overall Study|Not Treated: Lack of Qualifying Event|0
918495|NCT01001234|3028044|P3|Overall Study|Not Treated: Lack of Qualifying Event|0
918496|NCT01001234|3028045|P2|Overall Study|Not Treated: Lack of Qualifying Event|13
918497|NCT01001234|3028046|P1|Overall Study|Not Treated: Lack of Qualifying Event|248
918498|NCT01001234|3028042|P5|Overall Study|Not Treated: Physician Decision|0
918499|NCT01001234|3028043|P4|Overall Study|Not Treated: Physician Decision|0
918500|NCT01001234|3028044|P3|Overall Study|Not Treated: Physician Decision|0
918501|NCT01001234|3028045|P2|Overall Study|Not Treated: Physician Decision|4
918502|NCT01001234|3028046|P1|Overall Study|Not Treated: Physician Decision|37
918503|NCT01001234|3028042|P5|Overall Study|Not Treated: Pregnancy|0
918504|NCT01001234|3028043|P4|Overall Study|Not Treated: Pregnancy|0
918505|NCT01001234|3028044|P3|Overall Study|Not Treated: Pregnancy|0
918506|NCT01001234|3028045|P2|Overall Study|Not Treated: Pregnancy|0
918507|NCT01001234|3028046|P1|Overall Study|Not Treated: Pregnancy|3
918508|NCT01001234|3028042|P5|Overall Study|Not Treated: Lost to Follow-up|0
918509|NCT01001234|3028043|P4|Overall Study|Not Treated: Lost to Follow-up|5
918510|NCT01001234|3028044|P3|Overall Study|Not Treated: Lost to Follow-up|7
918511|NCT01001234|3028045|P2|Overall Study|Not Treated: Lost to Follow-up|4
918512|NCT01001234|3028046|P1|Overall Study|Not Treated: Lost to Follow-up|53
918513|NCT01001234|3028042|P5|Overall Study|Not Treated: Protocol Violation|0
918514|NCT01001234|3028043|P4|Overall Study|Not Treated: Protocol Violation|0
918515|NCT01001234|3028044|P3|Overall Study|Not Treated: Protocol Violation|0
918516|NCT01001234|3028045|P2|Overall Study|Not Treated: Protocol Violation|0
918517|NCT01001234|3028046|P1|Overall Study|Not Treated: Protocol Violation|3
918518|NCT01001234|3028042|P5|Overall Study|Not Treated: Withdrawal by Subject|0
918519|NCT01001234|3028043|P4|Overall Study|Not Treated: Withdrawal by Subject|0
918520|NCT01001234|3028044|P3|Overall Study|Not Treated: Withdrawal by Subject|2
918521|NCT01001234|3028045|P2|Overall Study|Not Treated: Withdrawal by Subject|2
918522|NCT01001234|3028046|P1|Overall Study|Not Treated: Withdrawal by Subject|23
918523|NCT01001234|3028042|P5|Overall Study|Not Treated: Adverse Event|0
918524|NCT01001234|3028043|P4|Overall Study|Not Treated: Adverse Event|0
918525|NCT01001234|3028044|P3|Overall Study|Not Treated: Adverse Event|0
918526|NCT01001234|3028045|P2|Overall Study|Not Treated: Adverse Event|0
918527|NCT01001234|3028046|P1|Overall Study|Not Treated: Adverse Event|1
918528|NCT01001234|3028042|P5|Overall Study|Physician Decision|0
918529|NCT01001234|3028043|P4|Overall Study|Physician Decision|0
918530|NCT01001234|3028044|P3|Overall Study|Physician Decision|0
918531|NCT01001234|3028045|P2|Overall Study|Physician Decision|0
918532|NCT01001234|3028046|P1|Overall Study|Physician Decision|1
918533|NCT01001234|3028042|P5|Overall Study|Lost to Follow-up|0
918534|NCT01001234|3028043|P4|Overall Study|Lost to Follow-up|2
918535|NCT01001234|3028044|P3|Overall Study|Lost to Follow-up|1
918536|NCT01001234|3028045|P2|Overall Study|Lost to Follow-up|0
918537|NCT01001234|3028046|P1|Overall Study|Lost to Follow-up|0
918538|NCT01001234|3028042|P5|Overall Study|Protocol Violation|0
918539|NCT01001234|3028043|P4|Overall Study|Protocol Violation|18
918540|NCT01001234|3028044|P3|Overall Study|Protocol Violation|19
918541|NCT01001234|3028045|P2|Overall Study|Protocol Violation|3
918542|NCT01001234|3028046|P1|Overall Study|Protocol Violation|34
918543|NCT01001234|3028042|P5|Overall Study|Withdrawal by Subject|0
918544|NCT01001234|3028043|P4|Overall Study|Withdrawal by Subject|0
918545|NCT01001234|3028044|P3|Overall Study|Withdrawal by Subject|3
918546|NCT01001234|3028045|P2|Overall Study|Withdrawal by Subject|0
918547|NCT01001234|3028046|P1|Overall Study|Withdrawal by Subject|2
918548|NCT01001221|3028062|P5|Overall Study|Not treated; protocol exclusion|0
918549|NCT01001221|3028063|P4|Overall Study|Not treated; protocol exclusion|0
918550|NCT01001221|3028064|P3|Overall Study|Not treated; protocol exclusion|1
918551|NCT01001221|3028065|P2|Overall Study|Not treated; protocol exclusion|0
918552|NCT01001221|3028066|P1|Overall Study|Not treated; protocol exclusion|0
918553|NCT01001221|3028062|P5|Overall Study|Not specified|0
918554|NCT01001221|3028063|P4|Overall Study|Not specified|0
918555|NCT01001221|3028064|P3|Overall Study|Not specified|0
918556|NCT01001221|3028065|P2|Overall Study|Not specified|1
918557|NCT01001221|3028066|P1|Overall Study|Not specified|1
918558|NCT01001221|3028062|P5|Overall Study|Disease progression|0
918559|NCT01001221|3028063|P4|Overall Study|Disease progression|4
918560|NCT01001221|3028064|P3|Overall Study|Disease progression|2
918561|NCT01001221|3028065|P2|Overall Study|Disease progression|2
918562|NCT01001221|3028066|P1|Overall Study|Disease progression|3
918563|NCT01001221|3028062|P5|Overall Study|Adverse Event|0
918564|NCT01001221|3028063|P4|Overall Study|Adverse Event|2
918565|NCT01001221|3028064|P3|Overall Study|Adverse Event|0
918566|NCT01001221|3028065|P2|Overall Study|Adverse Event|2
918567|NCT01001221|3028066|P1|Overall Study|Adverse Event|1
918568|NCT01001208|3028241|P2|Overall Study|Other|2
918569|NCT01001208|3028242|P1|Overall Study|Other|0
918570|NCT01001208|3028241|P2|Overall Study|Disease Progression|3
918571|NCT01001208|3028242|P1|Overall Study|Disease Progression|0
918572|NCT01001208|3028241|P2|Overall Study|Noncompliance|7
918573|NCT01001208|3028242|P1|Overall Study|Noncompliance|4
918574|NCT01001208|3028241|P2|Overall Study|Ineligibility Determined|2
918575|NCT01001208|3028242|P1|Overall Study|Ineligibility Determined|4
918576|NCT01001208|3028241|P2|Overall Study|Withdrawal by Subject|5
918577|NCT01001208|3028242|P1|Overall Study|Withdrawal by Subject|4
918578|NCT01001208|3028241|P2|Overall Study|Physician Decision|0
918579|NCT01001208|3028242|P1|Overall Study|Physician Decision|1
918580|NCT01001208|3028241|P2|Overall Study|Lost to Follow-up|9
918581|NCT01001208|3028242|P1|Overall Study|Lost to Follow-up|5
918582|NCT01001208|3028241|P2|Overall Study|Adverse Event|5
918583|NCT01001208|3028242|P1|Overall Study|Adverse Event|10
918584|NCT01001169|3028285|P2|Overall Study|Withdrawal by Subject|1
918585|NCT01001169|3028286|P1|Overall Study|Withdrawal by Subject|2
918586|NCT01001104|3028394|P4|Overall Study|Withdrawal by Subject|2
918587|NCT01001104|3028395|P3|Overall Study|Withdrawal by Subject|0
918588|NCT01001104|3028396|P2|Overall Study|Withdrawal by Subject|0
918589|NCT01001104|3028397|P1|Overall Study|Withdrawal by Subject|0
918590|NCT01001104|3028394|P4|Overall Study|Entry Criteria Not Met|1
918591|NCT01001104|3028395|P3|Overall Study|Entry Criteria Not Met|0
918592|NCT01001104|3028396|P2|Overall Study|Entry Criteria Not Met|0
918593|NCT01001104|3028397|P1|Overall Study|Entry Criteria Not Met|0
918594|NCT01001104|3028394|P4|Overall Study|Lost to Follow-up|0
918595|NCT01001104|3028395|P3|Overall Study|Lost to Follow-up|1
918596|NCT01001104|3028396|P2|Overall Study|Lost to Follow-up|0
918597|NCT01001104|3028397|P1|Overall Study|Lost to Follow-up|0
918598|NCT01001104|3028394|P4|Overall Study|Adverse Event|0
918599|NCT01001104|3028395|P3|Overall Study|Adverse Event|0
918600|NCT01001104|3028396|P2|Overall Study|Adverse Event|1
918601|NCT01001104|3028397|P1|Overall Study|Adverse Event|2
918602|NCT01000974|3028488|P3|Booster Vaccination Phase|Other|4
918603|NCT01000974|3028489|P2|Booster Vaccination Phase|Other|6
918604|NCT01000974|3028490|P1|Booster Vaccination Phase|Other|24
918605|NCT01000974|3028488|P3|Booster Vaccination Phase|Lost to Follow-up|7
918606|NCT01000974|3028489|P2|Booster Vaccination Phase|Lost to Follow-up|5
918607|NCT01000974|3028490|P1|Booster Vaccination Phase|Lost to Follow-up|40
918608|NCT01000974|3028488|P3|Booster Vaccination Phase|Withdrawal by Subject|1
918609|NCT01000974|3028489|P2|Booster Vaccination Phase|Withdrawal by Subject|1
918610|NCT01000974|3028490|P1|Booster Vaccination Phase|Withdrawal by Subject|3
918611|NCT01000974|3028488|P3|Booster Vaccination Phase|Protocol Violation|2
918612|NCT01000974|3028489|P2|Booster Vaccination Phase|Protocol Violation|0
918613|NCT01000974|3028490|P1|Booster Vaccination Phase|Protocol Violation|0
918614|NCT01000974|3028488|P3|Primary Vaccination Phase|Other|12
918615|NCT01000974|3028489|P2|Primary Vaccination Phase|Other|9
918616|NCT01000974|3028490|P1|Primary Vaccination Phase|Other|4
918617|NCT01000974|3028488|P3|Primary Vaccination Phase|Adverse Event|2
918618|NCT01000974|3028489|P2|Primary Vaccination Phase|Adverse Event|2
918619|NCT01000974|3028490|P1|Primary Vaccination Phase|Adverse Event|14
918620|NCT01000974|3028488|P3|Primary Vaccination Phase|Protocol Violation|2
918621|NCT01000974|3028489|P2|Primary Vaccination Phase|Protocol Violation|3
918622|NCT01000974|3028490|P1|Primary Vaccination Phase|Protocol Violation|40
918623|NCT01000974|3028488|P3|Primary Vaccination Phase|Lost to Follow-up|26
918624|NCT01000974|3028489|P2|Primary Vaccination Phase|Lost to Follow-up|19
918625|NCT01000974|3028490|P1|Primary Vaccination Phase|Lost to Follow-up|171
918626|NCT01000974|3028488|P3|Primary Vaccination Phase|Withdrawal by Subject|21
918627|NCT01000974|3028489|P2|Primary Vaccination Phase|Withdrawal by Subject|17
918628|NCT01000974|3028490|P1|Primary Vaccination Phase|Withdrawal by Subject|109
918629|NCT01000961|3028597|P2|First Intervention (3 Weeks)|Infection after pre-planned surgery|1
918630|NCT01000961|3028598|P1|First Intervention (3 Weeks)|Infection after pre-planned surgery|0
918631|NCT01000961|3028597|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
918632|NCT01000961|3028598|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
918633|NCT01000805|3028621|P2|Overall Study|Sponsor Decision|1
918634|NCT01000805|3028622|P1|Overall Study|Sponsor Decision|0
918635|NCT01000805|3028621|P2|Overall Study|Withdrawal by Subject|6
918636|NCT01000805|3028622|P1|Overall Study|Withdrawal by Subject|16
918637|NCT01000805|3028621|P2|Overall Study|Protocol Violation|8
918638|NCT01000805|3028622|P1|Overall Study|Protocol Violation|12
918639|NCT01000805|3028621|P2|Overall Study|Physician Decision|1
918640|NCT01000805|3028622|P1|Overall Study|Physician Decision|0
918641|NCT01000805|3028621|P2|Overall Study|Lost to Follow-up|21
918642|NCT01000805|3028622|P1|Overall Study|Lost to Follow-up|16
918643|NCT01000805|3028621|P2|Overall Study|Lack of Efficacy|16
918644|NCT01000805|3028622|P1|Overall Study|Lack of Efficacy|5
918645|NCT01000805|3028621|P2|Overall Study|Adverse Event|9
918646|NCT01000805|3028622|P1|Overall Study|Adverse Event|21
918647|NCT01000727|3028656|P2|Overall Study|Study closed/terminated|24
918648|NCT01000727|3028657|P1|Overall Study|Study closed/terminated|23
918649|NCT01000727|3028656|P2|Overall Study|Withdrawal by Subject|109
918650|NCT01000727|3028657|P1|Overall Study|Withdrawal by Subject|111
918651|NCT01000727|3028656|P2|Overall Study|Lost to Follow-up|43
918652|NCT01000727|3028657|P1|Overall Study|Lost to Follow-up|41
918653|NCT01000649|3028698|P4|Overall Study|Lost to Follow-up|2
918654|NCT01000649|3028699|P3|Overall Study|Lost to Follow-up|0
918655|NCT01000649|3028700|P2|Overall Study|Lost to Follow-up|2
918656|NCT01000649|3028701|P1|Overall Study|Lost to Follow-up|0
918657|NCT01000649|3028698|P4|Overall Study|Adverse Event|4
918658|NCT01000649|3028699|P3|Overall Study|Adverse Event|2
918659|NCT01000649|3028700|P2|Overall Study|Adverse Event|1
918660|NCT01000649|3028701|P1|Overall Study|Adverse Event|5
918661|NCT01000610|3028782|P1|Overall Study|Treatment failure|1
918662|NCT01000610|3028782|P1|Overall Study|Lost to Follow-up|4
918663|NCT01000610|3028782|P1|Overall Study|Adverse Event|1
918664|NCT01000506|3028793|P4|Overall Study|Withdrawal by Subject|7
918665|NCT01000506|3028794|P3|Overall Study|Withdrawal by Subject|2
918666|NCT01000506|3028795|P2|Overall Study|Withdrawal by Subject|8
918667|NCT01000506|3028796|P1|Overall Study|Withdrawal by Subject|11
918668|NCT01000506|3028793|P4|Overall Study|Physician Decision|3
918669|NCT01000506|3028794|P3|Overall Study|Physician Decision|3
918670|NCT01000506|3028795|P2|Overall Study|Physician Decision|3
918671|NCT01000506|3028796|P1|Overall Study|Physician Decision|1
918672|NCT01000506|3028793|P4|Overall Study|Lost to Follow-up|0
918673|NCT01000506|3028794|P3|Overall Study|Lost to Follow-up|4
918674|NCT01000506|3028795|P2|Overall Study|Lost to Follow-up|1
918675|NCT01000506|3028796|P1|Overall Study|Lost to Follow-up|1
918676|NCT01000506|3028793|P4|Overall Study|Protocol Violation|0
918677|NCT01000506|3028794|P3|Overall Study|Protocol Violation|0
918678|NCT01000506|3028795|P2|Overall Study|Protocol Violation|1
918679|NCT01000506|3028796|P1|Overall Study|Protocol Violation|1
918680|NCT01000506|3028793|P4|Overall Study|Lack of Efficacy|4
918681|NCT01000506|3028794|P3|Overall Study|Lack of Efficacy|4
918682|NCT01000506|3028795|P2|Overall Study|Lack of Efficacy|6
918683|NCT01000506|3028796|P1|Overall Study|Lack of Efficacy|8
918684|NCT01000506|3028793|P4|Overall Study|Adverse Event|9
918685|NCT01000506|3028794|P3|Overall Study|Adverse Event|8
918686|NCT01000506|3028795|P2|Overall Study|Adverse Event|5
918687|NCT01000506|3028796|P1|Overall Study|Adverse Event|6
918688|NCT01000493|3028840|P2|Overall Study|Withdrawal by Subject|7
918689|NCT01000493|3028841|P1|Overall Study|Withdrawal by Subject|3
918690|NCT01000493|3028840|P2|Overall Study|Physician Decision|1
918691|NCT01000493|3028841|P1|Overall Study|Physician Decision|1
918692|NCT01000493|3028840|P2|Overall Study|Lost to Follow-up|9
918693|NCT01000493|3028841|P1|Overall Study|Lost to Follow-up|5
918694|NCT01000493|3028840|P2|Overall Study|Study closed/terminated|23
918695|NCT01000493|3028841|P1|Overall Study|Study closed/terminated|25
918696|NCT01000493|3028840|P2|Overall Study|Protocol Violation|8
918697|NCT01000493|3028841|P1|Overall Study|Protocol Violation|1
918698|NCT01000493|3028840|P2|Overall Study|Lack of Efficacy|1
918699|NCT01000493|3028841|P1|Overall Study|Lack of Efficacy|1
918700|NCT01000493|3028840|P2|Overall Study|Adverse Event|6
918701|NCT01000493|3028841|P1|Overall Study|Adverse Event|3
918702|NCT01000480|3028891|P1|Concurrent Therapy Phase|Physician Decision|1
918703|NCT01000480|3028891|P1|Concurrent Therapy Phase|Withdrawal by Subject|3
918704|NCT01000480|3028891|P1|Concurrent Therapy Phase|Protocol Violation|2
918705|NCT01000480|3028891|P1|Concurrent Therapy Phase|Adverse Event|4
918706|NCT01000480|3028891|P1|Induction Phase|Entry Criteria Not Met|3
918707|NCT01000480|3028891|P1|Induction Phase|Physician Decision|1
918708|NCT01000480|3028891|P1|Induction Phase|Lost to Follow-up|1
918709|NCT01000480|3028891|P1|Induction Phase|Adverse Event|2
918710|NCT01000376|3028899|P2|Cycle 1 Day 1|Progressive Disease|0
918711|NCT01000376|3028900|P1|Cycle 1 Day 1|Progressive Disease|1
918712|NCT01000376|3028899|P2|Cycle 1 Day 1|Adverse Event|0
918713|NCT01000376|3028900|P1|Cycle 1 Day 1|Adverse Event|1
918714|NCT01000337|3028910|P2|Overall Study|Lost to Follow-up|3
918715|NCT01000337|3028911|P1|Overall Study|Lost to Follow-up|4
918716|NCT01000311|3028929|P2|Overall Study|Administrative reason|15
918717|NCT01000311|3028930|P1|Overall Study|Administrative reason|9
918718|NCT01000311|3028929|P2|Overall Study|Inappropriate enrollment|0
918719|NCT01000311|3028930|P1|Overall Study|Inappropriate enrollment|2
918720|NCT01000311|3028929|P2|Overall Study|Protocol Violation|2
918721|NCT01000311|3028930|P1|Overall Study|Protocol Violation|1
918722|NCT01000311|3028929|P2|Overall Study|Lost to Follow-up|24
918723|NCT01000311|3028930|P1|Overall Study|Lost to Follow-up|15
918724|NCT01000311|3028929|P2|Overall Study|Withdrawal by Subject|24
918725|NCT01000311|3028930|P1|Overall Study|Withdrawal by Subject|16
918726|NCT01000311|3028929|P2|Overall Study|Adverse Event|5
918727|NCT01000311|3028930|P1|Overall Study|Adverse Event|2
918728|NCT01000155|3028980|P1|Overall Study|Adverse Event|1
918729|NCT01000155|3028980|P1|Overall Study|Withdrawal by Subject|1
918730|NCT01000064|3028986|P2|Overall Study|Withdrawal by Subject|1
918731|NCT01000064|3028987|P1|Overall Study|Withdrawal by Subject|1
918732|NCT01000025|3029010|P2|Overall Study|Intercurrent Illness|7
918733|NCT01000025|3029011|P1|Overall Study|Intercurrent Illness|26
918734|NCT01000025|3029010|P2|Overall Study|Lack of Efficacy|208
918735|NCT01000025|3029011|P1|Overall Study|Lack of Efficacy|363
918736|NCT01000025|3029010|P2|Overall Study|Death|13
918737|NCT01000025|3029011|P1|Overall Study|Death|23
918738|NCT01000025|3029010|P2|Overall Study|Withdrawal by Subject|8
918739|NCT01000025|3029011|P1|Overall Study|Withdrawal by Subject|13
918740|NCT01000025|3029010|P2|Overall Study|Adverse Event|2
918741|NCT01000025|3029011|P1|Overall Study|Adverse Event|43
918742|NCT00999921|3029029|P2|Overall Study|Lost to Follow-up|19
918743|NCT00999921|3029030|P1|Overall Study|Lost to Follow-up|10
918744|NCT00999908|3029040|P3|Treatment Period 2|Protocol Violation|0
918745|NCT00999908|3029041|P2|Treatment Period 2|Protocol Violation|0
918746|NCT00999908|3029042|P1|Treatment Period 2|Protocol Violation|1
918747|NCT00999908|3029040|P3|Treatment Period 1|Subject withdrew consent|0
918748|NCT00999908|3029041|P2|Treatment Period 1|Subject withdrew consent|0
918749|NCT00999908|3029042|P1|Treatment Period 1|Subject withdrew consent|2
918750|NCT00999804|3029071|P2|Overall Study|Ineligible|0
918751|NCT00999804|3029072|P1|Overall Study|Ineligible|3
918752|NCT00999804|3029071|P2|Overall Study|Death|0
918753|NCT00999804|3029072|P1|Overall Study|Death|1
918754|NCT00999804|3029071|P2|Overall Study|Withdrawal by Subject|0
918755|NCT00999804|3029072|P1|Overall Study|Withdrawal by Subject|4
918756|NCT00999804|3029071|P2|Overall Study|Adverse Event|3
918757|NCT00999804|3029072|P1|Overall Study|Adverse Event|4
918758|NCT00999804|3029071|P2|Overall Study|Lack of Efficacy|2
918759|NCT00999804|3029072|P1|Overall Study|Lack of Efficacy|9
918760|NCT00999713|3029086|P2|Overall Study|Physician Decision|0
918761|NCT00999713|3029087|P1|Overall Study|Physician Decision|2
918762|NCT00999687|3029101|P1|Second Intervention|Lack of Efficacy|1
918763|NCT00999687|3029101|P1|Second Intervention|Withdrawal by Subject|2
918764|NCT00999687|3029101|P1|First Intervention|Withdrawal by Subject|1
918765|NCT00999661|3029108|P1|Overall Study|Not meeting eligibility criteria|9
918766|NCT00999661|3029108|P1|Overall Study|Withdrawal by Subject|1
918767|NCT00999661|3029108|P1|Overall Study|Adverse Event|1
918768|NCT00999661|3029108|P1|Overall Study|Lost to Follow-up|59
918769|NCT00999596|3029129|P1|Overall Study|Statistical population not required|101
918770|NCT00999544|3029134|P1|Overall Study|Withdrawal by Subject|1
918771|NCT00999466|3029170|P3|Main Part|Adverse Event|2
918772|NCT00999466|3029171|P2|Main Part|Adverse Event|4
918773|NCT00999466|3029172|P1|Main Part|Adverse Event|0
918774|NCT00999466|3029170|P3|Main Part|Withdrawal by Subject|2
918775|NCT00999466|3029171|P2|Main Part|Withdrawal by Subject|0
918776|NCT00999466|3029172|P1|Main Part|Withdrawal by Subject|0
918777|NCT00999167|3029449|P3|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
918778|NCT00999167|3029450|P2|Part B: Randomized, Placebo Controlled|Physician stopped drug|1
918779|NCT00999167|3029451|P1|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
918780|NCT00999167|3029449|P3|Part B: Randomized, Placebo Controlled|Physician Decision|0
918781|NCT00999167|3029450|P2|Part B: Randomized, Placebo Controlled|Physician Decision|1
918782|NCT00999167|3029451|P1|Part B: Randomized, Placebo Controlled|Physician Decision|0
918783|NCT00999167|3029449|P3|Part B: Randomized, Placebo Controlled|Noncompliance|0
918784|NCT00999167|3029450|P2|Part B: Randomized, Placebo Controlled|Noncompliance|1
918785|NCT00999167|3029451|P1|Part B: Randomized, Placebo Controlled|Noncompliance|0
918786|NCT00999167|3029449|P3|Part B: Randomized, Placebo Controlled|Adverse Event|1
918787|NCT00999167|3029450|P2|Part B: Randomized, Placebo Controlled|Adverse Event|6
918788|NCT00999167|3029451|P1|Part B: Randomized, Placebo Controlled|Adverse Event|0
918789|NCT00999167|3029449|P3|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4
918790|NCT00999167|3029450|P2|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7
918791|NCT00999167|3029451|P1|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0
918792|NCT00999167|3029449|P3|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16
918793|NCT00999167|3029450|P2|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19
918794|NCT00999167|3029451|P1|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0
918795|NCT00999167|3029449|P3|Part A: Open Label Safety run-in|Adverse Event|0
918796|NCT00999167|3029450|P2|Part A: Open Label Safety run-in|Adverse Event|0
918797|NCT00999167|3029451|P1|Part A: Open Label Safety run-in|Adverse Event|3
918798|NCT00999167|3029449|P3|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
918799|NCT00999167|3029450|P2|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
918800|NCT00999167|3029451|P1|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4
918801|NCT00998985|3029589|P14|Overall Study|Protocol Violation|0
918802|NCT00998985|3029590|P13|Overall Study|Protocol Violation|0
918803|NCT00998985|3029591|P12|Overall Study|Protocol Violation|0
918804|NCT00998985|3029592|P11|Overall Study|Protocol Violation|0
918805|NCT00998985|3029593|P10|Overall Study|Protocol Violation|0
918806|NCT00998985|3029594|P9|Overall Study|Protocol Violation|0
918807|NCT00998985|3029595|P8|Overall Study|Protocol Violation|0
918808|NCT00998985|3029596|P7|Overall Study|Protocol Violation|0
918809|NCT00998985|3029597|P6|Overall Study|Protocol Violation|1
918810|NCT00998985|3029598|P5|Overall Study|Protocol Violation|0
918811|NCT00998985|3029599|P4|Overall Study|Protocol Violation|0
918812|NCT00998985|3029600|P3|Overall Study|Protocol Violation|0
918813|NCT00998985|3029601|P2|Overall Study|Protocol Violation|0
918814|NCT00998985|3029602|P1|Overall Study|Protocol Violation|0
918815|NCT00998985|3029589|P14|Overall Study|Withdrawal by Subject|0
918816|NCT00998985|3029590|P13|Overall Study|Withdrawal by Subject|0
918817|NCT00998985|3029591|P12|Overall Study|Withdrawal by Subject|0
918818|NCT00998985|3029592|P11|Overall Study|Withdrawal by Subject|0
918819|NCT00998985|3029593|P10|Overall Study|Withdrawal by Subject|0
918820|NCT00998985|3029594|P9|Overall Study|Withdrawal by Subject|1
918821|NCT00998985|3029595|P8|Overall Study|Withdrawal by Subject|0
918822|NCT00998985|3029596|P7|Overall Study|Withdrawal by Subject|0
918823|NCT00998985|3029597|P6|Overall Study|Withdrawal by Subject|0
918824|NCT00998985|3029598|P5|Overall Study|Withdrawal by Subject|0
918825|NCT00998985|3029599|P4|Overall Study|Withdrawal by Subject|0
918826|NCT00998985|3029600|P3|Overall Study|Withdrawal by Subject|0
918827|NCT00998985|3029601|P2|Overall Study|Withdrawal by Subject|0
918828|NCT00998985|3029602|P1|Overall Study|Withdrawal by Subject|0
918829|NCT00998881|3029670|P2|Overall Study|Personal matter|0
918830|NCT00998881|3029671|P1|Overall Study|Personal matter|1
918831|NCT00998881|3029670|P2|Overall Study|Withdrawal by Subject|0
918832|NCT00998881|3029671|P1|Overall Study|Withdrawal by Subject|1
918833|NCT00998881|3029670|P2|Overall Study|Physician Decision|0
918834|NCT00998881|3029671|P1|Overall Study|Physician Decision|3
918835|NCT00998881|3029670|P2|Overall Study|Lack of Efficacy|0
918836|NCT00998881|3029671|P1|Overall Study|Lack of Efficacy|1
918837|NCT00998881|3029670|P2|Overall Study|Adverse Event|2
918838|NCT00998881|3029671|P1|Overall Study|Adverse Event|2
918839|NCT00998790|3029690|P1|Overall Study|Withdrawal by Subject|21
918840|NCT00998764|3029700|P2|Overall Study|Recurrent Episode of vasogenic edema|0
918841|NCT00998764|3029701|P1|Overall Study|Recurrent Episode of vasogenic edema|1
918842|NCT00998764|3029700|P2|Overall Study|Not specified|4
918843|NCT00998764|3029701|P1|Overall Study|Not specified|4
918844|NCT00998764|3029700|P2|Overall Study|Loss of Caregiver|3
918845|NCT00998764|3029701|P1|Overall Study|Loss of Caregiver|0
918846|NCT00998764|3029700|P2|Overall Study|Lost to Follow-up|1
918847|NCT00998764|3029701|P1|Overall Study|Lost to Follow-up|1
918848|NCT00998764|3029700|P2|Overall Study|Failed to Return|1
918849|NCT00998764|3029701|P1|Overall Study|Failed to Return|1
918850|NCT00998764|3029700|P2|Overall Study|Protocol Violation|1
918851|NCT00998764|3029701|P1|Overall Study|Protocol Violation|0
918852|NCT00998764|3029700|P2|Overall Study|Discontinuation of Study by Sponsor|217
918853|NCT00998764|3029701|P1|Overall Study|Discontinuation of Study by Sponsor|164
918854|NCT00998764|3029700|P2|Overall Study|Death|1
918855|NCT00998764|3029701|P1|Overall Study|Death|3
918856|NCT00998764|3029700|P2|Overall Study|Physician Decision|3
918857|NCT00998764|3029701|P1|Overall Study|Physician Decision|3
918858|NCT00998764|3029700|P2|Overall Study|Withdrawal by Subject|25
918859|NCT00998764|3029701|P1|Overall Study|Withdrawal by Subject|19
918860|NCT00998764|3029700|P2|Overall Study|Adverse Event|12
918861|NCT00998764|3029701|P1|Overall Study|Adverse Event|17
918862|NCT00998764|3029700|P2|Overall Study|Lack of Efficacy|6
918863|NCT00998764|3029701|P1|Overall Study|Lack of Efficacy|3
918864|NCT00998738|3029723|P1|Overall Study|Uknown|1
918865|NCT00998335|3029806|P2|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2
918866|NCT00998335|3029807|P1|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0
918867|NCT00998309|3029835|P1|Overall Study|Protocol Violation|4
918868|NCT00998296|3029902|P11|Overall Study|Reason other than those specified above|0
918869|NCT00998296|3029903|P10|Overall Study|Reason other than those specified above|1
918870|NCT00998296|3029904|P9|Overall Study|Reason other than those specified above|0
918871|NCT00998296|3029905|P8|Overall Study|Reason other than those specified above|0
918872|NCT00998296|3029906|P7|Overall Study|Reason other than those specified above|0
918873|NCT00998296|3029907|P6|Overall Study|Reason other than those specified above|0
918874|NCT00998296|3029908|P5|Overall Study|Reason other than those specified above|0
918875|NCT00998296|3029909|P4|Overall Study|Reason other than those specified above|0
918876|NCT00998296|3029910|P3|Overall Study|Reason other than those specified above|0
918877|NCT00998296|3029911|P2|Overall Study|Reason other than those specified above|0
918878|NCT00998296|3029912|P1|Overall Study|Reason other than those specified above|0
918879|NCT00998296|3029902|P11|Overall Study|Refused to continue taking trial med.|0
918880|NCT00998296|3029903|P10|Overall Study|Refused to continue taking trial med.|2
918881|NCT00998296|3029904|P9|Overall Study|Refused to continue taking trial med.|0
918882|NCT00998296|3029905|P8|Overall Study|Refused to continue taking trial med.|0
918883|NCT00998296|3029906|P7|Overall Study|Refused to continue taking trial med.|0
918884|NCT00998296|3029907|P6|Overall Study|Refused to continue taking trial med.|0
918885|NCT00998296|3029908|P5|Overall Study|Refused to continue taking trial med.|0
918886|NCT00998296|3029909|P4|Overall Study|Refused to continue taking trial med.|0
918887|NCT00998296|3029910|P3|Overall Study|Refused to continue taking trial med.|0
918888|NCT00998296|3029911|P2|Overall Study|Refused to continue taking trial med.|0
918889|NCT00998296|3029912|P1|Overall Study|Refused to continue taking trial med.|0
918890|NCT00998296|3029902|P11|Overall Study|Other adverse event|2
918891|NCT00998296|3029903|P10|Overall Study|Other adverse event|1
918892|NCT00998296|3029904|P9|Overall Study|Other adverse event|0
918893|NCT00998296|3029905|P8|Overall Study|Other adverse event|0
918894|NCT00998296|3029906|P7|Overall Study|Other adverse event|0
918895|NCT00998296|3029907|P6|Overall Study|Other adverse event|0
918896|NCT00998296|3029908|P5|Overall Study|Other adverse event|1
918897|NCT00998296|3029909|P4|Overall Study|Other adverse event|0
918898|NCT00998296|3029910|P3|Overall Study|Other adverse event|0
918899|NCT00998296|3029911|P2|Overall Study|Other adverse event|0
918900|NCT00998296|3029912|P1|Overall Study|Other adverse event|0
918901|NCT00998296|3029902|P11|Overall Study|Dose limiting or dose reducing toxicity|0
918902|NCT00998296|3029903|P10|Overall Study|Dose limiting or dose reducing toxicity|0
918903|NCT00998296|3029904|P9|Overall Study|Dose limiting or dose reducing toxicity|2
918904|NCT00998296|3029905|P8|Overall Study|Dose limiting or dose reducing toxicity|2
918905|NCT00998296|3029906|P7|Overall Study|Dose limiting or dose reducing toxicity|0
918906|NCT00998296|3029907|P6|Overall Study|Dose limiting or dose reducing toxicity|0
918907|NCT00998296|3029908|P5|Overall Study|Dose limiting or dose reducing toxicity|1
918908|NCT00998296|3029909|P4|Overall Study|Dose limiting or dose reducing toxicity|0
918909|NCT00998296|3029910|P3|Overall Study|Dose limiting or dose reducing toxicity|0
918910|NCT00998296|3029911|P2|Overall Study|Dose limiting or dose reducing toxicity|0
918911|NCT00998296|3029912|P1|Overall Study|Dose limiting or dose reducing toxicity|0
918912|NCT00998296|3029902|P11|Overall Study|Progressive disease|5
918913|NCT00998296|3029903|P10|Overall Study|Progressive disease|14
918914|NCT00998296|3029904|P9|Overall Study|Progressive disease|0
918915|NCT00998296|3029905|P8|Overall Study|Progressive disease|0
918916|NCT00998296|3029906|P7|Overall Study|Progressive disease|1
918917|NCT00998296|3029907|P6|Overall Study|Progressive disease|0
918918|NCT00998296|3029908|P5|Overall Study|Progressive disease|0
918919|NCT00998296|3029909|P4|Overall Study|Progressive disease|0
918920|NCT00998296|3029910|P3|Overall Study|Progressive disease|0
918921|NCT00998296|3029911|P2|Overall Study|Progressive disease|1
918922|NCT00998296|3029912|P1|Overall Study|Progressive disease|0
918923|NCT00997984|3030007|P3|Overall Study|Work schedule|2
918924|NCT00997984|3030008|P2|Overall Study|Work schedule|0
918925|NCT00997984|3030009|P1|Overall Study|Work schedule|0
918926|NCT00997984|3030007|P3|Overall Study|Suicidal ideation|1
918927|NCT00997984|3030008|P2|Overall Study|Suicidal ideation|0
918928|NCT00997984|3030009|P1|Overall Study|Suicidal ideation|0
918929|NCT00997984|3030007|P3|Overall Study|Wrong medication dispensed|0
918930|NCT00997984|3030008|P2|Overall Study|Wrong medication dispensed|1
918931|NCT00997984|3030009|P1|Overall Study|Wrong medication dispensed|0
918932|NCT00997984|3030007|P3|Overall Study|non-compliance|3
918933|NCT00997984|3030008|P2|Overall Study|non-compliance|2
918934|NCT00997984|3030009|P1|Overall Study|non-compliance|0
918935|NCT00997984|3030007|P3|Overall Study|Met exclusion criteria|0
918936|NCT00997984|3030008|P2|Overall Study|Met exclusion criteria|0
918937|NCT00997984|3030009|P1|Overall Study|Met exclusion criteria|1
918938|NCT00997984|3030007|P3|Overall Study|Lack of Efficacy|3
918939|NCT00997984|3030008|P2|Overall Study|Lack of Efficacy|6
918940|NCT00997984|3030009|P1|Overall Study|Lack of Efficacy|20
918941|NCT00997984|3030007|P3|Overall Study|Lost to Follow-up|4
918942|NCT00997984|3030008|P2|Overall Study|Lost to Follow-up|5
918943|NCT00997984|3030009|P1|Overall Study|Lost to Follow-up|8
918944|NCT00997984|3030007|P3|Overall Study|Withdrawal by Subject|5
918945|NCT00997984|3030008|P2|Overall Study|Withdrawal by Subject|9
918946|NCT00997984|3030009|P1|Overall Study|Withdrawal by Subject|6
918947|NCT00997984|3030007|P3|Overall Study|Protocol Violation|0
918948|NCT00997984|3030008|P2|Overall Study|Protocol Violation|3
918949|NCT00997984|3030009|P1|Overall Study|Protocol Violation|1
918950|NCT00997984|3030007|P3|Overall Study|Adverse Event|8
918951|NCT00997984|3030008|P2|Overall Study|Adverse Event|8
918952|NCT00997984|3030009|P1|Overall Study|Adverse Event|1
918953|NCT00997503|3030167|P1|Overall Study|Other reason|13
918954|NCT00997503|3030167|P1|Overall Study|Missed 12-month follow-up|85
918955|NCT00997503|3030167|P1|Overall Study|Physician Decision|10
918956|NCT00997503|3030167|P1|Overall Study|Adverse Event|3
918957|NCT00997503|3030167|P1|Overall Study|Lost to Follow-up|33
918958|NCT00997503|3030167|P1|Overall Study|Withdrawal by Subject|76
918959|NCT00997503|3030167|P1|Overall Study|Death|53
918960|NCT00997438|3030210|P3|Overall Study|Exclusion criteria at visit 1|3
918961|NCT00997438|3030211|P2|Overall Study|Exclusion criteria at visit 1|2
918962|NCT00997438|3030212|P1|Overall Study|Exclusion criteria at visit 1|2
918963|NCT00997438|3030210|P3|Overall Study|Withdrawal by Subject|0
918964|NCT00997438|3030211|P2|Overall Study|Withdrawal by Subject|1
918965|NCT00997438|3030212|P1|Overall Study|Withdrawal by Subject|1
918966|NCT00997438|3030210|P3|Overall Study|Blood draw difficulty|1
918967|NCT00997438|3030211|P2|Overall Study|Blood draw difficulty|0
918968|NCT00997438|3030212|P1|Overall Study|Blood draw difficulty|2
918969|NCT00997373|3030254|P2|Overall Study|could not have hysterectomy|0
918970|NCT00997373|3030255|P1|Overall Study|could not have hysterectomy|6
918971|NCT00997373|3030254|P2|Overall Study|wrong tumor type|0
918972|NCT00997373|3030255|P1|Overall Study|wrong tumor type|4
918973|NCT00997373|3030254|P2|Overall Study|Withdrawal by Subject|0
918974|NCT00997373|3030255|P1|Overall Study|Withdrawal by Subject|5
918975|NCT00997334|3030261|P1|Overall Study|Ineligible|1
918976|NCT00997334|3030261|P1|Overall Study|No lesion amenable|1
918977|NCT00997334|3030261|P1|Overall Study|Urgent Palliative Care|2
918978|NCT00997334|3030261|P1|Overall Study|Death|2
918979|NCT00997334|3030261|P1|Overall Study|Withdrawal by Subject|3
918980|NCT00997334|3030261|P1|Overall Study|Patient non-compliance|1
918981|NCT00997334|3030261|P1|Overall Study|Adverse Event|3
918982|NCT00997334|3030261|P1|Overall Study|still on therapy|12
918983|NCT00997321|3030270|P2|Overall Study|did not undergo sedation after enrollmen|3
918984|NCT00997321|3030271|P1|Overall Study|did not undergo sedation after enrollmen|0
918985|NCT00997243|3030283|P1|Overall Study|Early termination of study by sponsor|7
918986|NCT00997126|3030315|P2|Overall Study|Physician Decision|11
918987|NCT00997126|3030316|P1|Overall Study|Physician Decision|7
918988|NCT00997035|3030345|P2|3-month Follow-up Visit|Lost to Follow-up|6
918989|NCT00997035|3030346|P1|3-month Follow-up Visit|Lost to Follow-up|12
918990|NCT00997035|3030345|P2|3-week Followup Visit|Lost to Follow-up|6
918991|NCT00997035|3030346|P1|3-week Followup Visit|Lost to Follow-up|9
918992|NCT00996996|3030366|P1|Overall Study|Did Not Receive Study Medications|1
918993|NCT00996996|3030366|P1|Overall Study|Death|5
918994|NCT00996996|3030366|P1|Overall Study|Lost to Follow-up|9
918995|NCT00996996|3030366|P1|Overall Study|Non-compliance|8
918996|NCT00996996|3030366|P1|Overall Study|Progressive Disease|10
918997|NCT00996944|3030400|P2|Long-term Treatment Period|Study Closed/Terminated|5
918998|NCT00996944|3030401|P1|Long-term Treatment Period|Study Closed/Terminated|12
918999|NCT00996944|3030400|P2|Double-blind Treatment Period|Withdrawal by Subject|1
919000|NCT00996944|3030401|P1|Double-blind Treatment Period|Withdrawal by Subject|1
919001|NCT00996944|3030400|P2|Double-blind Treatment Period|Study Closed/Terminated|5
919002|NCT00996944|3030401|P1|Double-blind Treatment Period|Study Closed/Terminated|6
919003|NCT00996944|3030400|P2|Double-blind Treatment Period|Protocol Violation|0
919004|NCT00996944|3030401|P1|Double-blind Treatment Period|Protocol Violation|1
919005|NCT00996944|3030400|P2|Double-blind Treatment Period|Adverse Event|1
919006|NCT00996944|3030401|P1|Double-blind Treatment Period|Adverse Event|2
919007|NCT00996918|3030453|P5|Overall Study|Not Specified|0
919008|NCT00996918|3030454|P4|Overall Study|Not Specified|0
919009|NCT00996918|3030455|P3|Overall Study|Not Specified|0
919010|NCT00996918|3030456|P2|Overall Study|Not Specified|1
919011|NCT00996918|3030457|P1|Overall Study|Not Specified|3
919012|NCT00996918|3030453|P5|Overall Study|Loss of Caregiver|0
919013|NCT00996918|3030454|P4|Overall Study|Loss of Caregiver|0
919014|NCT00996918|3030455|P3|Overall Study|Loss of Caregiver|0
919015|NCT00996918|3030456|P2|Overall Study|Loss of Caregiver|1
919016|NCT00996918|3030457|P1|Overall Study|Loss of Caregiver|0
919017|NCT00996918|3030453|P5|Overall Study|Discontinuation of Study by Sponsor|2
919018|NCT00996918|3030454|P4|Overall Study|Discontinuation of Study by Sponsor|45
919019|NCT00996918|3030455|P3|Overall Study|Discontinuation of Study by Sponsor|30
919020|NCT00996918|3030456|P2|Overall Study|Discontinuation of Study by Sponsor|54
919021|NCT00996918|3030457|P1|Overall Study|Discontinuation of Study by Sponsor|31
919022|NCT00996918|3030453|P5|Overall Study|Physician Decision|0
919023|NCT00996918|3030454|P4|Overall Study|Physician Decision|0
919024|NCT00996918|3030455|P3|Overall Study|Physician Decision|0
919025|NCT00996918|3030456|P2|Overall Study|Physician Decision|0
919026|NCT00996918|3030457|P1|Overall Study|Physician Decision|1
919027|NCT00996918|3030453|P5|Overall Study|Withdrawal by Subject|2
919028|NCT00996918|3030454|P4|Overall Study|Withdrawal by Subject|3
919029|NCT00996918|3030455|P3|Overall Study|Withdrawal by Subject|3
919030|NCT00996918|3030456|P2|Overall Study|Withdrawal by Subject|4
919031|NCT00996918|3030457|P1|Overall Study|Withdrawal by Subject|1
919032|NCT00996918|3030453|P5|Overall Study|Adverse Event|0
919033|NCT00996918|3030454|P4|Overall Study|Adverse Event|6
919034|NCT00996918|3030455|P3|Overall Study|Adverse Event|2
919035|NCT00996918|3030456|P2|Overall Study|Adverse Event|5
919036|NCT00996918|3030457|P1|Overall Study|Adverse Event|2
919037|NCT00996918|3030453|P5|Overall Study|Lack of Efficacy|0
919038|NCT00996918|3030454|P4|Overall Study|Lack of Efficacy|2
919039|NCT00996918|3030455|P3|Overall Study|Lack of Efficacy|2
919040|NCT00996918|3030456|P2|Overall Study|Lack of Efficacy|1
919041|NCT00996918|3030457|P1|Overall Study|Lack of Efficacy|1
919042|NCT00996892|3030501|P20|Expansion Stage 2A|Disease Progression|31
919043|NCT00996892|3030502|P19|Expansion Stage 2A|Disease Progression|0
919044|NCT00996892|3030503|P18|Expansion Stage 2A|Disease Progression|0
919045|NCT00996892|3030504|P17|Expansion Stage 2A|Disease Progression|0
919046|NCT00996892|3030505|P16|Expansion Stage 2A|Disease Progression|0
919047|NCT00996892|3030506|P15|Expansion Stage 2A|Disease Progression|0
919048|NCT00996892|3030507|P14|Expansion Stage 2A|Disease Progression|0
919049|NCT00996892|3030508|P13|Expansion Stage 2A|Disease Progression|0
919050|NCT00996892|3030509|P12|Expansion Stage 2A|Disease Progression|0
919051|NCT00996892|3030510|P11|Expansion Stage 2A|Disease Progression|0
919052|NCT00996892|3030511|P10|Expansion Stage 2A|Disease Progression|0
919053|NCT00996892|3030512|P9|Expansion Stage 2A|Disease Progression|0
919054|NCT00996892|3030513|P8|Expansion Stage 2A|Disease Progression|0
919055|NCT00996892|3030514|P7|Expansion Stage 2A|Disease Progression|0
919056|NCT00996892|3030515|P6|Expansion Stage 2A|Disease Progression|0
919057|NCT00996892|3030516|P5|Expansion Stage 2A|Disease Progression|0
919058|NCT00996892|3030517|P4|Expansion Stage 2A|Disease Progression|0
919059|NCT00996892|3030518|P3|Expansion Stage 2A|Disease Progression|0
919060|NCT00996892|3030519|P2|Expansion Stage 2A|Disease Progression|0
919061|NCT00996892|3030520|P1|Expansion Stage 2A|Disease Progression|0
919062|NCT00996892|3030501|P20|Expansion Stage 2A|Withdrawal by Subject|4
919063|NCT00996892|3030502|P19|Expansion Stage 2A|Withdrawal by Subject|0
919064|NCT00996892|3030503|P18|Expansion Stage 2A|Withdrawal by Subject|0
919065|NCT00996892|3030504|P17|Expansion Stage 2A|Withdrawal by Subject|0
919066|NCT00996892|3030505|P16|Expansion Stage 2A|Withdrawal by Subject|0
919067|NCT00996892|3030506|P15|Expansion Stage 2A|Withdrawal by Subject|0
919068|NCT00996892|3030507|P14|Expansion Stage 2A|Withdrawal by Subject|0
919069|NCT00996892|3030508|P13|Expansion Stage 2A|Withdrawal by Subject|0
919070|NCT00996892|3030509|P12|Expansion Stage 2A|Withdrawal by Subject|0
919071|NCT00996892|3030510|P11|Expansion Stage 2A|Withdrawal by Subject|0
919072|NCT00996892|3030511|P10|Expansion Stage 2A|Withdrawal by Subject|0
919073|NCT00996892|3030512|P9|Expansion Stage 2A|Withdrawal by Subject|0
919074|NCT00996892|3030513|P8|Expansion Stage 2A|Withdrawal by Subject|0
919075|NCT00996892|3030514|P7|Expansion Stage 2A|Withdrawal by Subject|0
919076|NCT00996892|3030515|P6|Expansion Stage 2A|Withdrawal by Subject|0
919077|NCT00996892|3030516|P5|Expansion Stage 2A|Withdrawal by Subject|0
919078|NCT00996892|3030517|P4|Expansion Stage 2A|Withdrawal by Subject|0
919079|NCT00996892|3030518|P3|Expansion Stage 2A|Withdrawal by Subject|0
919080|NCT00996892|3030519|P2|Expansion Stage 2A|Withdrawal by Subject|0
919081|NCT00996892|3030520|P1|Expansion Stage 2A|Withdrawal by Subject|0
919082|NCT00996892|3030501|P20|Expansion Stage 2A|Physician Decision|2
919083|NCT00996892|3030502|P19|Expansion Stage 2A|Physician Decision|0
919084|NCT00996892|3030503|P18|Expansion Stage 2A|Physician Decision|0
919085|NCT00996892|3030504|P17|Expansion Stage 2A|Physician Decision|0
919086|NCT00996892|3030505|P16|Expansion Stage 2A|Physician Decision|0
919087|NCT00996892|3030506|P15|Expansion Stage 2A|Physician Decision|0
919088|NCT00996892|3030507|P14|Expansion Stage 2A|Physician Decision|0
919089|NCT00996892|3030508|P13|Expansion Stage 2A|Physician Decision|0
919090|NCT00996892|3030509|P12|Expansion Stage 2A|Physician Decision|0
919091|NCT00996892|3030510|P11|Expansion Stage 2A|Physician Decision|0
919092|NCT00996892|3030511|P10|Expansion Stage 2A|Physician Decision|0
919093|NCT00996892|3030512|P9|Expansion Stage 2A|Physician Decision|0
919094|NCT00996892|3030513|P8|Expansion Stage 2A|Physician Decision|0
919095|NCT00996892|3030514|P7|Expansion Stage 2A|Physician Decision|0
919096|NCT00996892|3030515|P6|Expansion Stage 2A|Physician Decision|0
919097|NCT00996892|3030516|P5|Expansion Stage 2A|Physician Decision|0
919098|NCT00996892|3030517|P4|Expansion Stage 2A|Physician Decision|0
919099|NCT00996892|3030518|P3|Expansion Stage 2A|Physician Decision|0
919100|NCT00996892|3030519|P2|Expansion Stage 2A|Physician Decision|0
919101|NCT00996892|3030520|P1|Expansion Stage 2A|Physician Decision|0
919102|NCT00996892|3030501|P20|Expansion Stage 2A|Adverse Event|8
919103|NCT00996892|3030502|P19|Expansion Stage 2A|Adverse Event|0
919104|NCT00996892|3030503|P18|Expansion Stage 2A|Adverse Event|0
919105|NCT00996892|3030504|P17|Expansion Stage 2A|Adverse Event|0
919106|NCT00996892|3030505|P16|Expansion Stage 2A|Adverse Event|0
919107|NCT00996892|3030506|P15|Expansion Stage 2A|Adverse Event|0
919108|NCT00996892|3030507|P14|Expansion Stage 2A|Adverse Event|0
919109|NCT00996892|3030508|P13|Expansion Stage 2A|Adverse Event|0
919110|NCT00996892|3030509|P12|Expansion Stage 2A|Adverse Event|0
919111|NCT00996892|3030510|P11|Expansion Stage 2A|Adverse Event|0
919112|NCT00996892|3030511|P10|Expansion Stage 2A|Adverse Event|0
919113|NCT00996892|3030512|P9|Expansion Stage 2A|Adverse Event|0
919114|NCT00996892|3030513|P8|Expansion Stage 2A|Adverse Event|0
919115|NCT00996892|3030514|P7|Expansion Stage 2A|Adverse Event|0
919116|NCT00996892|3030515|P6|Expansion Stage 2A|Adverse Event|0
919117|NCT00996892|3030516|P5|Expansion Stage 2A|Adverse Event|0
919118|NCT00996892|3030517|P4|Expansion Stage 2A|Adverse Event|0
919119|NCT00996892|3030518|P3|Expansion Stage 2A|Adverse Event|0
919120|NCT00996892|3030519|P2|Expansion Stage 2A|Adverse Event|0
919121|NCT00996892|3030520|P1|Expansion Stage 2A|Adverse Event|0
919122|NCT00996892|3030501|P20|Expansion Stage 2|Disease Progression|0
919123|NCT00996892|3030502|P19|Expansion Stage 2|Disease Progression|28
919124|NCT00996892|3030503|P18|Expansion Stage 2|Disease Progression|0
919125|NCT00996892|3030504|P17|Expansion Stage 2|Disease Progression|0
919126|NCT00996892|3030505|P16|Expansion Stage 2|Disease Progression|0
919127|NCT00996892|3030506|P15|Expansion Stage 2|Disease Progression|0
919128|NCT00996892|3030507|P14|Expansion Stage 2|Disease Progression|0
919129|NCT00996892|3030508|P13|Expansion Stage 2|Disease Progression|0
919130|NCT00996892|3030509|P12|Expansion Stage 2|Disease Progression|0
919131|NCT00996892|3030510|P11|Expansion Stage 2|Disease Progression|0
919132|NCT00996892|3030511|P10|Expansion Stage 2|Disease Progression|0
919133|NCT00996892|3030512|P9|Expansion Stage 2|Disease Progression|0
919134|NCT00996892|3030513|P8|Expansion Stage 2|Disease Progression|0
919135|NCT00996892|3030514|P7|Expansion Stage 2|Disease Progression|0
919136|NCT00996892|3030515|P6|Expansion Stage 2|Disease Progression|0
919137|NCT00996892|3030516|P5|Expansion Stage 2|Disease Progression|0
919138|NCT00996892|3030517|P4|Expansion Stage 2|Disease Progression|0
919139|NCT00996892|3030518|P3|Expansion Stage 2|Disease Progression|0
919140|NCT00996892|3030519|P2|Expansion Stage 2|Disease Progression|0
919141|NCT00996892|3030520|P1|Expansion Stage 2|Disease Progression|0
919142|NCT00996892|3030501|P20|Expansion Stage 2|Withdrawal by Subject|0
919143|NCT00996892|3030502|P19|Expansion Stage 2|Withdrawal by Subject|1
919144|NCT00996892|3030503|P18|Expansion Stage 2|Withdrawal by Subject|0
919145|NCT00996892|3030504|P17|Expansion Stage 2|Withdrawal by Subject|0
919146|NCT00996892|3030505|P16|Expansion Stage 2|Withdrawal by Subject|0
919147|NCT00996892|3030506|P15|Expansion Stage 2|Withdrawal by Subject|0
919148|NCT00996892|3030507|P14|Expansion Stage 2|Withdrawal by Subject|0
919149|NCT00996892|3030508|P13|Expansion Stage 2|Withdrawal by Subject|0
919150|NCT00996892|3030509|P12|Expansion Stage 2|Withdrawal by Subject|0
919151|NCT00996892|3030510|P11|Expansion Stage 2|Withdrawal by Subject|0
919152|NCT00996892|3030511|P10|Expansion Stage 2|Withdrawal by Subject|0
919153|NCT00996892|3030512|P9|Expansion Stage 2|Withdrawal by Subject|0
919154|NCT00996892|3030513|P8|Expansion Stage 2|Withdrawal by Subject|0
919155|NCT00996892|3030514|P7|Expansion Stage 2|Withdrawal by Subject|0
919156|NCT00996892|3030515|P6|Expansion Stage 2|Withdrawal by Subject|0
919157|NCT00996892|3030516|P5|Expansion Stage 2|Withdrawal by Subject|0
919158|NCT00996892|3030517|P4|Expansion Stage 2|Withdrawal by Subject|0
919159|NCT00996892|3030518|P3|Expansion Stage 2|Withdrawal by Subject|0
919160|NCT00996892|3030519|P2|Expansion Stage 2|Withdrawal by Subject|0
919161|NCT00996892|3030520|P1|Expansion Stage 2|Withdrawal by Subject|0
919162|NCT00996892|3030501|P20|Expansion Stage 2|Physician Decision|0
919163|NCT00996892|3030502|P19|Expansion Stage 2|Physician Decision|1
919164|NCT00996892|3030503|P18|Expansion Stage 2|Physician Decision|0
919165|NCT00996892|3030504|P17|Expansion Stage 2|Physician Decision|0
919166|NCT00996892|3030505|P16|Expansion Stage 2|Physician Decision|0
919167|NCT00996892|3030506|P15|Expansion Stage 2|Physician Decision|0
919168|NCT00996892|3030507|P14|Expansion Stage 2|Physician Decision|0
919169|NCT00996892|3030508|P13|Expansion Stage 2|Physician Decision|0
919170|NCT00996892|3030509|P12|Expansion Stage 2|Physician Decision|0
919171|NCT00996892|3030510|P11|Expansion Stage 2|Physician Decision|0
919172|NCT00996892|3030511|P10|Expansion Stage 2|Physician Decision|0
919173|NCT00996892|3030512|P9|Expansion Stage 2|Physician Decision|0
919174|NCT00996892|3030513|P8|Expansion Stage 2|Physician Decision|0
919175|NCT00996892|3030514|P7|Expansion Stage 2|Physician Decision|0
919176|NCT00996892|3030515|P6|Expansion Stage 2|Physician Decision|0
919177|NCT00996892|3030516|P5|Expansion Stage 2|Physician Decision|0
919178|NCT00996892|3030517|P4|Expansion Stage 2|Physician Decision|0
919179|NCT00996892|3030518|P3|Expansion Stage 2|Physician Decision|0
919180|NCT00996892|3030519|P2|Expansion Stage 2|Physician Decision|0
919181|NCT00996892|3030520|P1|Expansion Stage 2|Physician Decision|0
919182|NCT00996892|3030501|P20|Expansion Stage 2|Death|0
919183|NCT00996892|3030502|P19|Expansion Stage 2|Death|2
919184|NCT00996892|3030503|P18|Expansion Stage 2|Death|0
919185|NCT00996892|3030504|P17|Expansion Stage 2|Death|0
919186|NCT00996892|3030505|P16|Expansion Stage 2|Death|0
919187|NCT00996892|3030506|P15|Expansion Stage 2|Death|0
919188|NCT00996892|3030507|P14|Expansion Stage 2|Death|0
919189|NCT00996892|3030508|P13|Expansion Stage 2|Death|0
919190|NCT00996892|3030509|P12|Expansion Stage 2|Death|0
919191|NCT00996892|3030510|P11|Expansion Stage 2|Death|0
919192|NCT00996892|3030511|P10|Expansion Stage 2|Death|0
919193|NCT00996892|3030512|P9|Expansion Stage 2|Death|0
919194|NCT00996892|3030513|P8|Expansion Stage 2|Death|0
919195|NCT00996892|3030514|P7|Expansion Stage 2|Death|0
919196|NCT00996892|3030515|P6|Expansion Stage 2|Death|0
919197|NCT00996892|3030516|P5|Expansion Stage 2|Death|0
919198|NCT00996892|3030517|P4|Expansion Stage 2|Death|0
919199|NCT00996892|3030518|P3|Expansion Stage 2|Death|0
919200|NCT00996892|3030519|P2|Expansion Stage 2|Death|0
919201|NCT00996892|3030520|P1|Expansion Stage 2|Death|0
919202|NCT00996892|3030501|P20|Expansion Stage 2|Adverse Event|0
919203|NCT00996892|3030502|P19|Expansion Stage 2|Adverse Event|3
919204|NCT00996892|3030503|P18|Expansion Stage 2|Adverse Event|0
919205|NCT00996892|3030504|P17|Expansion Stage 2|Adverse Event|0
919206|NCT00996892|3030505|P16|Expansion Stage 2|Adverse Event|0
919207|NCT00996892|3030506|P15|Expansion Stage 2|Adverse Event|0
919208|NCT00996892|3030507|P14|Expansion Stage 2|Adverse Event|0
919209|NCT00996892|3030508|P13|Expansion Stage 2|Adverse Event|0
919210|NCT00996892|3030509|P12|Expansion Stage 2|Adverse Event|0
919211|NCT00996892|3030510|P11|Expansion Stage 2|Adverse Event|0
919212|NCT00996892|3030511|P10|Expansion Stage 2|Adverse Event|0
919213|NCT00996892|3030512|P9|Expansion Stage 2|Adverse Event|0
919214|NCT00996892|3030513|P8|Expansion Stage 2|Adverse Event|0
919215|NCT00996892|3030514|P7|Expansion Stage 2|Adverse Event|0
919216|NCT00996892|3030515|P6|Expansion Stage 2|Adverse Event|0
919217|NCT00996892|3030516|P5|Expansion Stage 2|Adverse Event|0
919218|NCT00996892|3030517|P4|Expansion Stage 2|Adverse Event|0
919219|NCT00996892|3030518|P3|Expansion Stage 2|Adverse Event|0
919220|NCT00996892|3030519|P2|Expansion Stage 2|Adverse Event|0
919221|NCT00996892|3030520|P1|Expansion Stage 2|Adverse Event|0
919222|NCT00996892|3030501|P20|Dose-Escalation Stage 1B|Disease Progression|0
919223|NCT00996892|3030502|P19|Dose-Escalation Stage 1B|Disease Progression|0
919224|NCT00996892|3030503|P18|Dose-Escalation Stage 1B|Disease Progression|3
919225|NCT00996892|3030504|P17|Dose-Escalation Stage 1B|Disease Progression|3
919226|NCT00996892|3030505|P16|Dose-Escalation Stage 1B|Disease Progression|3
919227|NCT00996892|3030506|P15|Dose-Escalation Stage 1B|Disease Progression|4
919228|NCT00996892|3030507|P14|Dose-Escalation Stage 1B|Disease Progression|0
919229|NCT00996892|3030508|P13|Dose-Escalation Stage 1B|Disease Progression|0
919230|NCT00996892|3030509|P12|Dose-Escalation Stage 1B|Disease Progression|0
919231|NCT00996892|3030510|P11|Dose-Escalation Stage 1B|Disease Progression|0
919232|NCT00996892|3030511|P10|Dose-Escalation Stage 1B|Disease Progression|0
919233|NCT00996892|3030512|P9|Dose-Escalation Stage 1B|Disease Progression|0
919234|NCT00996892|3030513|P8|Dose-Escalation Stage 1B|Disease Progression|0
919235|NCT00996892|3030514|P7|Dose-Escalation Stage 1B|Disease Progression|0
919236|NCT00996892|3030515|P6|Dose-Escalation Stage 1B|Disease Progression|0
919237|NCT00996892|3030516|P5|Dose-Escalation Stage 1B|Disease Progression|0
919238|NCT00996892|3030517|P4|Dose-Escalation Stage 1B|Disease Progression|0
919239|NCT00996892|3030518|P3|Dose-Escalation Stage 1B|Disease Progression|0
919240|NCT00996892|3030519|P2|Dose-Escalation Stage 1B|Disease Progression|0
919241|NCT00996892|3030520|P1|Dose-Escalation Stage 1B|Disease Progression|0
919242|NCT00996892|3030501|P20|Dose-Escalation Stage 1B|Physician Decision|0
919243|NCT00996892|3030502|P19|Dose-Escalation Stage 1B|Physician Decision|0
919244|NCT00996892|3030503|P18|Dose-Escalation Stage 1B|Physician Decision|2
919245|NCT00996892|3030504|P17|Dose-Escalation Stage 1B|Physician Decision|0
919246|NCT00996892|3030505|P16|Dose-Escalation Stage 1B|Physician Decision|0
919247|NCT00996892|3030506|P15|Dose-Escalation Stage 1B|Physician Decision|0
919248|NCT00996892|3030507|P14|Dose-Escalation Stage 1B|Physician Decision|0
919249|NCT00996892|3030508|P13|Dose-Escalation Stage 1B|Physician Decision|0
919250|NCT00996892|3030509|P12|Dose-Escalation Stage 1B|Physician Decision|0
919251|NCT00996892|3030510|P11|Dose-Escalation Stage 1B|Physician Decision|0
919252|NCT00996892|3030511|P10|Dose-Escalation Stage 1B|Physician Decision|0
919253|NCT00996892|3030512|P9|Dose-Escalation Stage 1B|Physician Decision|0
919254|NCT00996892|3030513|P8|Dose-Escalation Stage 1B|Physician Decision|0
919255|NCT00996892|3030514|P7|Dose-Escalation Stage 1B|Physician Decision|0
919256|NCT00996892|3030515|P6|Dose-Escalation Stage 1B|Physician Decision|0
919257|NCT00996892|3030516|P5|Dose-Escalation Stage 1B|Physician Decision|0
919258|NCT00996892|3030517|P4|Dose-Escalation Stage 1B|Physician Decision|0
919259|NCT00996892|3030518|P3|Dose-Escalation Stage 1B|Physician Decision|0
919260|NCT00996892|3030519|P2|Dose-Escalation Stage 1B|Physician Decision|0
919261|NCT00996892|3030520|P1|Dose-Escalation Stage 1B|Physician Decision|0
919262|NCT00996892|3030501|P20|Dose-Escalation Stage 1A|Disease Progression|0
919263|NCT00996892|3030502|P19|Dose-Escalation Stage 1A|Disease Progression|0
919264|NCT00996892|3030503|P18|Dose-Escalation Stage 1A|Disease Progression|0
919265|NCT00996892|3030504|P17|Dose-Escalation Stage 1A|Disease Progression|0
919266|NCT00996892|3030505|P16|Dose-Escalation Stage 1A|Disease Progression|0
919267|NCT00996892|3030506|P15|Dose-Escalation Stage 1A|Disease Progression|0
919268|NCT00996892|3030507|P14|Dose-Escalation Stage 1A|Disease Progression|4
919269|NCT00996892|3030508|P13|Dose-Escalation Stage 1A|Disease Progression|6
919270|NCT00996892|3030509|P12|Dose-Escalation Stage 1A|Disease Progression|7
919271|NCT00996892|3030510|P11|Dose-Escalation Stage 1A|Disease Progression|5
919272|NCT00996892|3030511|P10|Dose-Escalation Stage 1A|Disease Progression|1
919273|NCT00996892|3030512|P9|Dose-Escalation Stage 1A|Disease Progression|3
919274|NCT00996892|3030513|P8|Dose-Escalation Stage 1A|Disease Progression|2
919275|NCT00996892|3030514|P7|Dose-Escalation Stage 1A|Disease Progression|0
919276|NCT00996892|3030515|P6|Dose-Escalation Stage 1A|Disease Progression|0
919277|NCT00996892|3030516|P5|Dose-Escalation Stage 1A|Disease Progression|0
919278|NCT00996892|3030517|P4|Dose-Escalation Stage 1A|Disease Progression|0
919279|NCT00996892|3030518|P3|Dose-Escalation Stage 1A|Disease Progression|0
919280|NCT00996892|3030519|P2|Dose-Escalation Stage 1A|Disease Progression|0
919281|NCT00996892|3030520|P1|Dose-Escalation Stage 1A|Disease Progression|0
919282|NCT00996892|3030501|P20|Dose-Escalation Stage 1A|Withdrawal by Subject|0
919283|NCT00996892|3030502|P19|Dose-Escalation Stage 1A|Withdrawal by Subject|0
919284|NCT00996892|3030503|P18|Dose-Escalation Stage 1A|Withdrawal by Subject|0
919285|NCT00996892|3030504|P17|Dose-Escalation Stage 1A|Withdrawal by Subject|0
919286|NCT00996892|3030505|P16|Dose-Escalation Stage 1A|Withdrawal by Subject|0
919287|NCT00996892|3030506|P15|Dose-Escalation Stage 1A|Withdrawal by Subject|0
919288|NCT00996892|3030507|P14|Dose-Escalation Stage 1A|Withdrawal by Subject|0
919289|NCT00996892|3030508|P13|Dose-Escalation Stage 1A|Withdrawal by Subject|1
919290|NCT00996892|3030509|P12|Dose-Escalation Stage 1A|Withdrawal by Subject|1
919291|NCT00996892|3030510|P11|Dose-Escalation Stage 1A|Withdrawal by Subject|1
919292|NCT00996892|3030511|P10|Dose-Escalation Stage 1A|Withdrawal by Subject|1
919293|NCT00996892|3030512|P9|Dose-Escalation Stage 1A|Withdrawal by Subject|0
919294|NCT00996892|3030513|P8|Dose-Escalation Stage 1A|Withdrawal by Subject|0
919295|NCT00996892|3030514|P7|Dose-Escalation Stage 1A|Withdrawal by Subject|0
919296|NCT00996892|3030515|P6|Dose-Escalation Stage 1A|Withdrawal by Subject|0
919297|NCT00996892|3030516|P5|Dose-Escalation Stage 1A|Withdrawal by Subject|0
919298|NCT00996892|3030517|P4|Dose-Escalation Stage 1A|Withdrawal by Subject|0
919299|NCT00996892|3030518|P3|Dose-Escalation Stage 1A|Withdrawal by Subject|0
919300|NCT00996892|3030519|P2|Dose-Escalation Stage 1A|Withdrawal by Subject|0
919301|NCT00996892|3030520|P1|Dose-Escalation Stage 1A|Withdrawal by Subject|0
919302|NCT00996892|3030501|P20|Dose-Escalation Stage 1A|Physician Decision|0
919303|NCT00996892|3030502|P19|Dose-Escalation Stage 1A|Physician Decision|0
919304|NCT00996892|3030503|P18|Dose-Escalation Stage 1A|Physician Decision|0
919305|NCT00996892|3030504|P17|Dose-Escalation Stage 1A|Physician Decision|0
919306|NCT00996892|3030505|P16|Dose-Escalation Stage 1A|Physician Decision|0
919307|NCT00996892|3030506|P15|Dose-Escalation Stage 1A|Physician Decision|0
919308|NCT00996892|3030507|P14|Dose-Escalation Stage 1A|Physician Decision|0
919309|NCT00996892|3030508|P13|Dose-Escalation Stage 1A|Physician Decision|0
919310|NCT00996892|3030509|P12|Dose-Escalation Stage 1A|Physician Decision|0
919311|NCT00996892|3030510|P11|Dose-Escalation Stage 1A|Physician Decision|0
919312|NCT00996892|3030511|P10|Dose-Escalation Stage 1A|Physician Decision|0
919313|NCT00996892|3030512|P9|Dose-Escalation Stage 1A|Physician Decision|0
919314|NCT00996892|3030513|P8|Dose-Escalation Stage 1A|Physician Decision|1
919315|NCT00996892|3030514|P7|Dose-Escalation Stage 1A|Physician Decision|0
919316|NCT00996892|3030515|P6|Dose-Escalation Stage 1A|Physician Decision|0
919317|NCT00996892|3030516|P5|Dose-Escalation Stage 1A|Physician Decision|0
919318|NCT00996892|3030517|P4|Dose-Escalation Stage 1A|Physician Decision|0
919319|NCT00996892|3030518|P3|Dose-Escalation Stage 1A|Physician Decision|0
919320|NCT00996892|3030519|P2|Dose-Escalation Stage 1A|Physician Decision|0
919321|NCT00996892|3030520|P1|Dose-Escalation Stage 1A|Physician Decision|0
919322|NCT00996892|3030501|P20|Dose-Escalation Stage 1A|Death|0
919323|NCT00996892|3030502|P19|Dose-Escalation Stage 1A|Death|0
919324|NCT00996892|3030503|P18|Dose-Escalation Stage 1A|Death|0
919325|NCT00996892|3030504|P17|Dose-Escalation Stage 1A|Death|0
919326|NCT00996892|3030505|P16|Dose-Escalation Stage 1A|Death|0
919327|NCT00996892|3030506|P15|Dose-Escalation Stage 1A|Death|0
919328|NCT00996892|3030507|P14|Dose-Escalation Stage 1A|Death|0
919329|NCT00996892|3030508|P13|Dose-Escalation Stage 1A|Death|1
919330|NCT00996892|3030509|P12|Dose-Escalation Stage 1A|Death|1
919331|NCT00996892|3030510|P11|Dose-Escalation Stage 1A|Death|0
919332|NCT00996892|3030511|P10|Dose-Escalation Stage 1A|Death|2
919333|NCT00996892|3030512|P9|Dose-Escalation Stage 1A|Death|0
919334|NCT00996892|3030513|P8|Dose-Escalation Stage 1A|Death|0
919335|NCT00996892|3030514|P7|Dose-Escalation Stage 1A|Death|0
919336|NCT00996892|3030515|P6|Dose-Escalation Stage 1A|Death|0
919337|NCT00996892|3030516|P5|Dose-Escalation Stage 1A|Death|0
919338|NCT00996892|3030517|P4|Dose-Escalation Stage 1A|Death|0
919339|NCT00996892|3030518|P3|Dose-Escalation Stage 1A|Death|0
919340|NCT00996892|3030519|P2|Dose-Escalation Stage 1A|Death|0
919341|NCT00996892|3030520|P1|Dose-Escalation Stage 1A|Death|0
919342|NCT00996892|3030501|P20|Dose-Escalation Stage 1A|Adverse Event|0
919343|NCT00996892|3030502|P19|Dose-Escalation Stage 1A|Adverse Event|0
919344|NCT00996892|3030503|P18|Dose-Escalation Stage 1A|Adverse Event|0
919345|NCT00996892|3030504|P17|Dose-Escalation Stage 1A|Adverse Event|0
919346|NCT00996892|3030505|P16|Dose-Escalation Stage 1A|Adverse Event|0
919347|NCT00996892|3030506|P15|Dose-Escalation Stage 1A|Adverse Event|0
919348|NCT00996892|3030507|P14|Dose-Escalation Stage 1A|Adverse Event|1
919349|NCT00996892|3030508|P13|Dose-Escalation Stage 1A|Adverse Event|0
919350|NCT00996892|3030509|P12|Dose-Escalation Stage 1A|Adverse Event|0
919351|NCT00996892|3030510|P11|Dose-Escalation Stage 1A|Adverse Event|1
919352|NCT00996892|3030511|P10|Dose-Escalation Stage 1A|Adverse Event|0
919353|NCT00996892|3030512|P9|Dose-Escalation Stage 1A|Adverse Event|0
919354|NCT00996892|3030513|P8|Dose-Escalation Stage 1A|Adverse Event|0
919355|NCT00996892|3030514|P7|Dose-Escalation Stage 1A|Adverse Event|0
919356|NCT00996892|3030515|P6|Dose-Escalation Stage 1A|Adverse Event|0
919357|NCT00996892|3030516|P5|Dose-Escalation Stage 1A|Adverse Event|0
919358|NCT00996892|3030517|P4|Dose-Escalation Stage 1A|Adverse Event|0
919359|NCT00996892|3030518|P3|Dose-Escalation Stage 1A|Adverse Event|0
919360|NCT00996892|3030519|P2|Dose-Escalation Stage 1A|Adverse Event|0
919361|NCT00996892|3030520|P1|Dose-Escalation Stage 1A|Adverse Event|0
919362|NCT00996892|3030501|P20|Dose-Escalation Stage 1|Disease Progression|0
919363|NCT00996892|3030502|P19|Dose-Escalation Stage 1|Disease Progression|0
919364|NCT00996892|3030503|P18|Dose-Escalation Stage 1|Disease Progression|0
919365|NCT00996892|3030504|P17|Dose-Escalation Stage 1|Disease Progression|0
919366|NCT00996892|3030505|P16|Dose-Escalation Stage 1|Disease Progression|0
919367|NCT00996892|3030506|P15|Dose-Escalation Stage 1|Disease Progression|0
919368|NCT00996892|3030507|P14|Dose-Escalation Stage 1|Disease Progression|0
919369|NCT00996892|3030508|P13|Dose-Escalation Stage 1|Disease Progression|0
919370|NCT00996892|3030509|P12|Dose-Escalation Stage 1|Disease Progression|0
919371|NCT00996892|3030510|P11|Dose-Escalation Stage 1|Disease Progression|0
919372|NCT00996892|3030511|P10|Dose-Escalation Stage 1|Disease Progression|0
919373|NCT00996892|3030512|P9|Dose-Escalation Stage 1|Disease Progression|0
919374|NCT00996892|3030513|P8|Dose-Escalation Stage 1|Disease Progression|0
919375|NCT00996892|3030514|P7|Dose-Escalation Stage 1|Disease Progression|0
919376|NCT00996892|3030515|P6|Dose-Escalation Stage 1|Disease Progression|7
919377|NCT00996892|3030516|P5|Dose-Escalation Stage 1|Disease Progression|10
919378|NCT00996892|3030517|P4|Dose-Escalation Stage 1|Disease Progression|4
919379|NCT00996892|3030518|P3|Dose-Escalation Stage 1|Disease Progression|3
919380|NCT00996892|3030519|P2|Dose-Escalation Stage 1|Disease Progression|2
919381|NCT00996892|3030520|P1|Dose-Escalation Stage 1|Disease Progression|2
919382|NCT00996892|3030501|P20|Dose-Escalation Stage 1|Withdrawal by Subject|0
919383|NCT00996892|3030502|P19|Dose-Escalation Stage 1|Withdrawal by Subject|0
919384|NCT00996892|3030503|P18|Dose-Escalation Stage 1|Withdrawal by Subject|0
919385|NCT00996892|3030504|P17|Dose-Escalation Stage 1|Withdrawal by Subject|0
919386|NCT00996892|3030505|P16|Dose-Escalation Stage 1|Withdrawal by Subject|0
919387|NCT00996892|3030506|P15|Dose-Escalation Stage 1|Withdrawal by Subject|0
919388|NCT00996892|3030507|P14|Dose-Escalation Stage 1|Withdrawal by Subject|0
919389|NCT00996892|3030508|P13|Dose-Escalation Stage 1|Withdrawal by Subject|0
919390|NCT00996892|3030509|P12|Dose-Escalation Stage 1|Withdrawal by Subject|0
919391|NCT00996892|3030510|P11|Dose-Escalation Stage 1|Withdrawal by Subject|0
919392|NCT00996892|3030511|P10|Dose-Escalation Stage 1|Withdrawal by Subject|0
919393|NCT00996892|3030512|P9|Dose-Escalation Stage 1|Withdrawal by Subject|0
919394|NCT00996892|3030513|P8|Dose-Escalation Stage 1|Withdrawal by Subject|0
919395|NCT00996892|3030514|P7|Dose-Escalation Stage 1|Withdrawal by Subject|1
919396|NCT00996892|3030515|P6|Dose-Escalation Stage 1|Withdrawal by Subject|1
919397|NCT00996892|3030516|P5|Dose-Escalation Stage 1|Withdrawal by Subject|1
919398|NCT00996892|3030517|P4|Dose-Escalation Stage 1|Withdrawal by Subject|2
919399|NCT00996892|3030518|P3|Dose-Escalation Stage 1|Withdrawal by Subject|0
919400|NCT00996892|3030519|P2|Dose-Escalation Stage 1|Withdrawal by Subject|1
919401|NCT00996892|3030520|P1|Dose-Escalation Stage 1|Withdrawal by Subject|0
919402|NCT00996892|3030501|P20|Dose-Escalation Stage 1|Physician Decision|0
919403|NCT00996892|3030502|P19|Dose-Escalation Stage 1|Physician Decision|0
919404|NCT00996892|3030503|P18|Dose-Escalation Stage 1|Physician Decision|0
919405|NCT00996892|3030504|P17|Dose-Escalation Stage 1|Physician Decision|0
919406|NCT00996892|3030505|P16|Dose-Escalation Stage 1|Physician Decision|0
919407|NCT00996892|3030506|P15|Dose-Escalation Stage 1|Physician Decision|0
919408|NCT00996892|3030507|P14|Dose-Escalation Stage 1|Physician Decision|0
919409|NCT00996892|3030508|P13|Dose-Escalation Stage 1|Physician Decision|0
919410|NCT00996892|3030509|P12|Dose-Escalation Stage 1|Physician Decision|0
919411|NCT00996892|3030510|P11|Dose-Escalation Stage 1|Physician Decision|0
919412|NCT00996892|3030511|P10|Dose-Escalation Stage 1|Physician Decision|0
919413|NCT00996892|3030512|P9|Dose-Escalation Stage 1|Physician Decision|0
919414|NCT00996892|3030513|P8|Dose-Escalation Stage 1|Physician Decision|0
919415|NCT00996892|3030514|P7|Dose-Escalation Stage 1|Physician Decision|2
919416|NCT00996892|3030515|P6|Dose-Escalation Stage 1|Physician Decision|1
919417|NCT00996892|3030516|P5|Dose-Escalation Stage 1|Physician Decision|0
919418|NCT00996892|3030517|P4|Dose-Escalation Stage 1|Physician Decision|1
919419|NCT00996892|3030518|P3|Dose-Escalation Stage 1|Physician Decision|0
919420|NCT00996892|3030519|P2|Dose-Escalation Stage 1|Physician Decision|0
919421|NCT00996892|3030520|P1|Dose-Escalation Stage 1|Physician Decision|1
919422|NCT00996892|3030501|P20|Dose-Escalation Stage 1|Death|0
919423|NCT00996892|3030502|P19|Dose-Escalation Stage 1|Death|0
919424|NCT00996892|3030503|P18|Dose-Escalation Stage 1|Death|0
919425|NCT00996892|3030504|P17|Dose-Escalation Stage 1|Death|0
919426|NCT00996892|3030505|P16|Dose-Escalation Stage 1|Death|0
919427|NCT00996892|3030506|P15|Dose-Escalation Stage 1|Death|0
919428|NCT00996892|3030507|P14|Dose-Escalation Stage 1|Death|0
919429|NCT00996892|3030508|P13|Dose-Escalation Stage 1|Death|0
919430|NCT00996892|3030509|P12|Dose-Escalation Stage 1|Death|0
919431|NCT00996892|3030510|P11|Dose-Escalation Stage 1|Death|0
919432|NCT00996892|3030511|P10|Dose-Escalation Stage 1|Death|0
919433|NCT00996892|3030512|P9|Dose-Escalation Stage 1|Death|0
919434|NCT00996892|3030513|P8|Dose-Escalation Stage 1|Death|0
919435|NCT00996892|3030514|P7|Dose-Escalation Stage 1|Death|0
919436|NCT00996892|3030515|P6|Dose-Escalation Stage 1|Death|1
919437|NCT00996892|3030516|P5|Dose-Escalation Stage 1|Death|0
919438|NCT00996892|3030517|P4|Dose-Escalation Stage 1|Death|0
919439|NCT00996892|3030518|P3|Dose-Escalation Stage 1|Death|0
919440|NCT00996892|3030519|P2|Dose-Escalation Stage 1|Death|0
919441|NCT00996892|3030520|P1|Dose-Escalation Stage 1|Death|1
919442|NCT00996892|3030501|P20|Dose-Escalation Stage 1|Adverse Event|0
919443|NCT00996892|3030502|P19|Dose-Escalation Stage 1|Adverse Event|0
919444|NCT00996892|3030503|P18|Dose-Escalation Stage 1|Adverse Event|0
919445|NCT00996892|3030504|P17|Dose-Escalation Stage 1|Adverse Event|0
919446|NCT00996892|3030505|P16|Dose-Escalation Stage 1|Adverse Event|0
919447|NCT00996892|3030506|P15|Dose-Escalation Stage 1|Adverse Event|0
919448|NCT00996892|3030507|P14|Dose-Escalation Stage 1|Adverse Event|0
919449|NCT00996892|3030508|P13|Dose-Escalation Stage 1|Adverse Event|0
919450|NCT00996892|3030509|P12|Dose-Escalation Stage 1|Adverse Event|0
919451|NCT00996892|3030510|P11|Dose-Escalation Stage 1|Adverse Event|0
919452|NCT00996892|3030511|P10|Dose-Escalation Stage 1|Adverse Event|0
919453|NCT00996892|3030512|P9|Dose-Escalation Stage 1|Adverse Event|0
919454|NCT00996892|3030513|P8|Dose-Escalation Stage 1|Adverse Event|0
919455|NCT00996892|3030514|P7|Dose-Escalation Stage 1|Adverse Event|1
919456|NCT00996892|3030515|P6|Dose-Escalation Stage 1|Adverse Event|0
919457|NCT00996892|3030516|P5|Dose-Escalation Stage 1|Adverse Event|0
919458|NCT00996892|3030517|P4|Dose-Escalation Stage 1|Adverse Event|2
919459|NCT00996892|3030518|P3|Dose-Escalation Stage 1|Adverse Event|0
919460|NCT00996892|3030519|P2|Dose-Escalation Stage 1|Adverse Event|0
919461|NCT00996892|3030520|P1|Dose-Escalation Stage 1|Adverse Event|0
919462|NCT00996840|3031114|P5|Overall Study|Withdrawal by Subject|0
919463|NCT00996840|3031115|P4|Overall Study|Withdrawal by Subject|0
919464|NCT00996840|3031116|P3|Overall Study|Withdrawal by Subject|0
919465|NCT00996840|3031117|P2|Overall Study|Withdrawal by Subject|1
919466|NCT00996840|3031118|P1|Overall Study|Withdrawal by Subject|1
919467|NCT00996840|3031114|P5|Overall Study|Physician Decision|2
919468|NCT00996840|3031115|P4|Overall Study|Physician Decision|1
919469|NCT00996840|3031116|P3|Overall Study|Physician Decision|1
919470|NCT00996840|3031117|P2|Overall Study|Physician Decision|0
919471|NCT00996840|3031118|P1|Overall Study|Physician Decision|0
919472|NCT00996840|3031114|P5|Overall Study|Adverse Event|0
919473|NCT00996840|3031115|P4|Overall Study|Adverse Event|0
919474|NCT00996840|3031116|P3|Overall Study|Adverse Event|0
919475|NCT00996840|3031117|P2|Overall Study|Adverse Event|1
919476|NCT00996840|3031118|P1|Overall Study|Adverse Event|0
919477|NCT00996801|3031268|P6|Overall Study|Withdrawal by Subject|9
919478|NCT00996801|3031269|P5|Overall Study|Withdrawal by Subject|5
919479|NCT00996801|3031270|P4|Overall Study|Withdrawal by Subject|5
919480|NCT00996801|3031271|P3|Overall Study|Withdrawal by Subject|9
919481|NCT00996801|3031272|P2|Overall Study|Withdrawal by Subject|6
919482|NCT00996801|3031273|P1|Overall Study|Withdrawal by Subject|8
919483|NCT00996801|3031268|P6|Overall Study|Study Terminated by Sponsor|0
919484|NCT00996801|3031269|P5|Overall Study|Study Terminated by Sponsor|46
919485|NCT00996801|3031270|P4|Overall Study|Study Terminated by Sponsor|0
919486|NCT00996801|3031271|P3|Overall Study|Study Terminated by Sponsor|0
919487|NCT00996801|3031272|P2|Overall Study|Study Terminated by Sponsor|1
919488|NCT00996801|3031273|P1|Overall Study|Study Terminated by Sponsor|0
919489|NCT00996801|3031268|P6|Overall Study|Protocol Violation|4
919490|NCT00996801|3031269|P5|Overall Study|Protocol Violation|3
919491|NCT00996801|3031270|P4|Overall Study|Protocol Violation|2
919492|NCT00996801|3031271|P3|Overall Study|Protocol Violation|1
919493|NCT00996801|3031272|P2|Overall Study|Protocol Violation|4
919494|NCT00996801|3031273|P1|Overall Study|Protocol Violation|3
919495|NCT00996801|3031268|P6|Overall Study|Progressive Disease|0
919496|NCT00996801|3031269|P5|Overall Study|Progressive Disease|0
919497|NCT00996801|3031270|P4|Overall Study|Progressive Disease|0
919498|NCT00996801|3031271|P3|Overall Study|Progressive Disease|0
919499|NCT00996801|3031272|P2|Overall Study|Progressive Disease|1
919500|NCT00996801|3031273|P1|Overall Study|Progressive Disease|0
919501|NCT00996801|3031268|P6|Overall Study|Physician Decision|0
919502|NCT00996801|3031269|P5|Overall Study|Physician Decision|0
919503|NCT00996801|3031270|P4|Overall Study|Physician Decision|1
919504|NCT00996801|3031271|P3|Overall Study|Physician Decision|0
919505|NCT00996801|3031272|P2|Overall Study|Physician Decision|0
919506|NCT00996801|3031273|P1|Overall Study|Physician Decision|0
919507|NCT00996801|3031268|P6|Overall Study|Lost to Follow-up|2
919508|NCT00996801|3031269|P5|Overall Study|Lost to Follow-up|3
919509|NCT00996801|3031270|P4|Overall Study|Lost to Follow-up|3
919510|NCT00996801|3031271|P3|Overall Study|Lost to Follow-up|0
919511|NCT00996801|3031272|P2|Overall Study|Lost to Follow-up|0
919512|NCT00996801|3031273|P1|Overall Study|Lost to Follow-up|0
919513|NCT00996801|3031268|P6|Overall Study|Lack of Efficacy|1
919514|NCT00996801|3031269|P5|Overall Study|Lack of Efficacy|0
919515|NCT00996801|3031270|P4|Overall Study|Lack of Efficacy|3
919516|NCT00996801|3031271|P3|Overall Study|Lack of Efficacy|1
919517|NCT00996801|3031272|P2|Overall Study|Lack of Efficacy|0
919518|NCT00996801|3031273|P1|Overall Study|Lack of Efficacy|3
919519|NCT00996801|3031268|P6|Overall Study|Adverse Event|3
919520|NCT00996801|3031269|P5|Overall Study|Adverse Event|31
919521|NCT00996801|3031270|P4|Overall Study|Adverse Event|17
919522|NCT00996801|3031271|P3|Overall Study|Adverse Event|12
919523|NCT00996801|3031272|P2|Overall Study|Adverse Event|4
919524|NCT00996801|3031273|P1|Overall Study|Adverse Event|6
919525|NCT00996736|3031385|P2|Overall Study|Visit not within 3-month window|3
919526|NCT00996736|3031386|P1|Overall Study|Visit not within 3-month window|5
919527|NCT00996736|3031385|P2|Overall Study|Lost to Follow-up|14
919528|NCT00996736|3031386|P1|Overall Study|Lost to Follow-up|15
919529|NCT00996736|3031385|P2|Overall Study|Death|1
919530|NCT00996736|3031386|P1|Overall Study|Death|1
919531|NCT00996658|3031406|P2|Overall Study|Other|7
919532|NCT00996658|3031407|P1|Overall Study|Other|9
919533|NCT00996658|3031406|P2|Overall Study|Non-compliance issues|3
919534|NCT00996658|3031407|P1|Overall Study|Non-compliance issues|3
919535|NCT00996658|3031406|P2|Overall Study|Lost to Follow-up|5
919536|NCT00996658|3031407|P1|Overall Study|Lost to Follow-up|2
919537|NCT00996658|3031406|P2|Overall Study|Protocol Violation|1
919538|NCT00996658|3031407|P1|Overall Study|Protocol Violation|0
919539|NCT00996658|3031406|P2|Overall Study|Adverse Event|5
919540|NCT00996658|3031407|P1|Overall Study|Adverse Event|2
919541|NCT00996632|3031435|P2|Overall Study|Physician Decision|0
919542|NCT00996632|3031436|P1|Overall Study|Physician Decision|0
919543|NCT00996606|3031444|P1|Overall Study|Withdrawal by Subject|3
919544|NCT00996606|3031444|P1|Overall Study|Protocol Violation|1
919545|NCT00996606|3031444|P1|Overall Study|Insufficient Therapeutic Response|2
919546|NCT00996606|3031444|P1|Overall Study|Adverse Event or Intercurrent Illness|2
919547|NCT00996593|3031538|P1|Long-Term Follow-Up|Site Closed|1
919548|NCT00996593|3031538|P1|Long-Term Follow-Up|Withdrawal by Subject|2
919549|NCT00996593|3031538|P1|Dosimetric and Therapeutic Treatment|Non-compliance|1
919550|NCT00996593|3031538|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3
919551|NCT00996593|3031538|P1|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6
919552|NCT00996593|3031538|P1|Dosimetric and Therapeutic Treatment|Death|1
919553|NCT00996593|3031538|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|22
919554|NCT00996593|3031538|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3
919555|NCT00996593|3031538|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7
919556|NCT00996580|3031566|P1|Overall Study|Not specified|29
919557|NCT00996580|3031566|P1|Overall Study|Withdrawal by Subject|217
919558|NCT00996580|3031566|P1|Overall Study|Sponsor requested participant withdrawal|35
919559|NCT00996580|3031566|P1|Overall Study|Protocol Violation|16
919560|NCT00996580|3031566|P1|Overall Study|Pregnancy|68
919561|NCT00996580|3031566|P1|Overall Study|Physician Decision|5
919562|NCT00996580|3031566|P1|Overall Study|Noncompliance with the protocol|137
919563|NCT00996580|3031566|P1|Overall Study|Lost to Follow-up|480
919564|NCT00996580|3031566|P1|Overall Study|Adverse Event|466
919565|NCT00996476|3031603|P5|Overall Study|Adverse Event|1
919566|NCT00996476|3031604|P4|Overall Study|Adverse Event|0
919567|NCT00996476|3031605|P3|Overall Study|Adverse Event|0
919568|NCT00996476|3031606|P2|Overall Study|Adverse Event|1
919569|NCT00996476|3031607|P1|Overall Study|Adverse Event|0
919570|NCT00996476|3031603|P5|Overall Study|Withdrawal by Subject|1
919571|NCT00996476|3031604|P4|Overall Study|Withdrawal by Subject|0
919572|NCT00996476|3031605|P3|Overall Study|Withdrawal by Subject|1
919573|NCT00996476|3031606|P2|Overall Study|Withdrawal by Subject|2
919574|NCT00996476|3031607|P1|Overall Study|Withdrawal by Subject|1
919575|NCT00996437|3031675|P2|Overall Study|Missed|5
919576|NCT00996437|3031676|P1|Overall Study|Missed|2
919577|NCT00996437|3031675|P2|Overall Study|Dropped|2
919578|NCT00996437|3031676|P1|Overall Study|Dropped|2
919579|NCT00996437|3031675|P2|Overall Study|Death|0
919580|NCT00996437|3031676|P1|Overall Study|Death|1
919581|NCT00996333|3031721|P1|Overall Study|Other|5
919582|NCT00996333|3031721|P1|Overall Study|Physician Decision|1
919583|NCT00996333|3031721|P1|Overall Study|Adverse Event|1
919584|NCT00996333|3031721|P1|Overall Study|Death|4
919585|NCT00996333|3031721|P1|Overall Study|Withdrawal by Subject|1
919586|NCT00996333|3031721|P1|Overall Study|Screen failure|1
919587|NCT00996307|3031731|P4|Overall Study|Unable to classify|1
919588|NCT00996307|3031732|P3|Overall Study|Unable to classify|2
919589|NCT00996307|3031733|P2|Overall Study|Unable to classify|0
919590|NCT00996307|3031734|P1|Overall Study|Unable to classify|4
919591|NCT00996307|3031731|P4|Overall Study|Administrative reason|0
919592|NCT00996307|3031732|P3|Overall Study|Administrative reason|0
919593|NCT00996307|3031733|P2|Overall Study|Administrative reason|1
919594|NCT00996307|3031734|P1|Overall Study|Administrative reason|0
919595|NCT00996307|3031731|P4|Overall Study|Lost to Follow-up|15
919596|NCT00996307|3031732|P3|Overall Study|Lost to Follow-up|7
919597|NCT00996307|3031733|P2|Overall Study|Lost to Follow-up|13
919598|NCT00996307|3031734|P1|Overall Study|Lost to Follow-up|13
919599|NCT00996307|3031731|P4|Overall Study|Withdrawal by Subject|5
919600|NCT00996307|3031732|P3|Overall Study|Withdrawal by Subject|5
919601|NCT00996307|3031733|P2|Overall Study|Withdrawal by Subject|2
919602|NCT00996307|3031734|P1|Overall Study|Withdrawal by Subject|3
919603|NCT00996307|3031731|P4|Overall Study|Adverse Event|0
919604|NCT00996307|3031732|P3|Overall Study|Adverse Event|0
919605|NCT00996307|3031733|P2|Overall Study|Adverse Event|1
919606|NCT00996307|3031734|P1|Overall Study|Adverse Event|0
919607|NCT00996281|3031794|P2|Overall Study|Other|7
919608|NCT00996281|3031795|P1|Overall Study|Other|5
919609|NCT00996281|3031794|P2|Overall Study|Lack of Efficacy|2
919610|NCT00996281|3031795|P1|Overall Study|Lack of Efficacy|0
919611|NCT00996281|3031794|P2|Overall Study|Withdrawal by Subject|20
919612|NCT00996281|3031795|P1|Overall Study|Withdrawal by Subject|31
919613|NCT00996281|3031794|P2|Overall Study|Lost to Follow-up|16
919614|NCT00996281|3031795|P1|Overall Study|Lost to Follow-up|14
919615|NCT00996281|3031794|P2|Overall Study|Major Protocol Deviation|7
919616|NCT00996281|3031795|P1|Overall Study|Major Protocol Deviation|6
919617|NCT00996281|3031794|P2|Overall Study|Adverse Event|37
919618|NCT00996281|3031795|P1|Overall Study|Adverse Event|75
919619|NCT00996216|3031803|P1|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1
919620|NCT00996216|3031803|P1|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3
919621|NCT00996216|3031803|P1|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1
919622|NCT00996203|3031819|P1|Overall Study|Protocol Violation|2
919623|NCT00996203|3031819|P1|Overall Study|Lack of Efficacy|1
919624|NCT00996203|3031819|P1|Overall Study|Lost to Follow-up|1
919625|NCT00996203|3031819|P1|Overall Study|Adverse Event|3
919626|NCT00996125|3031851|P2|Overall Study|Withdrawal by Subject|3
919627|NCT00996125|3031852|P1|Overall Study|Withdrawal by Subject|4
919628|NCT00996125|3031851|P2|Overall Study|Lost to Follow-up|6
919629|NCT00996125|3031852|P1|Overall Study|Lost to Follow-up|1
919630|NCT00996125|3031851|P2|Overall Study|Adverse Event|2
919631|NCT00996125|3031852|P1|Overall Study|Adverse Event|0
919632|NCT00996034|3031872|P1|Overall Study|withdrawn by PI|1
919633|NCT00996034|3031872|P1|Overall Study|Lost to Follow-up|2
919634|NCT00995930|3031878|P2|Overall Study|Adverse Event|14
919635|NCT00995930|3031879|P1|Overall Study|Adverse Event|11
919636|NCT00995930|3031878|P2|Overall Study|Withdrawal by Subject|4
919637|NCT00995930|3031879|P1|Overall Study|Withdrawal by Subject|3
919638|NCT00995930|3031878|P2|Overall Study|Lost to Follow-up|2
919639|NCT00995930|3031879|P1|Overall Study|Lost to Follow-up|1
919640|NCT00995930|3031878|P2|Overall Study|Administrative problems|2
919641|NCT00995930|3031879|P1|Overall Study|Administrative problems|4
919642|NCT00995930|3031878|P2|Overall Study|Death|1
919643|NCT00995930|3031879|P1|Overall Study|Death|0
919644|NCT00995930|3031878|P2|Overall Study|Protocol deviation|5
919645|NCT00995930|3031879|P1|Overall Study|Protocol deviation|2
919646|NCT00995865|3031930|P3|Overall Study|Lost to Follow-up|1
919647|NCT00995865|3031931|P2|Overall Study|Lost to Follow-up|0
919648|NCT00995865|3031932|P1|Overall Study|Lost to Follow-up|0
919649|NCT00995865|3031930|P3|Overall Study|Protocol Violation|0
919650|NCT00995865|3031931|P2|Overall Study|Protocol Violation|0
919651|NCT00995865|3031932|P1|Overall Study|Protocol Violation|2
919652|NCT00995774|3031954|P2|Training Period 2|Withdrawal by Subject|0
919653|NCT00995774|3031955|P1|Training Period 2|Withdrawal by Subject|2
919654|NCT00995709|3031989|P3|Overall Study|Protocol Violation|0
919655|NCT00995709|3031990|P2|Overall Study|Protocol Violation|1
919656|NCT00995709|3031991|P1|Overall Study|Protocol Violation|2
919657|NCT00995709|3031989|P3|Overall Study|Death|0
919658|NCT00995709|3031990|P2|Overall Study|Death|1
919659|NCT00995709|3031991|P1|Overall Study|Death|0
919660|NCT00995709|3031989|P3|Overall Study|Lost to Follow-up|0
919661|NCT00995709|3031990|P2|Overall Study|Lost to Follow-up|0
919662|NCT00995709|3031991|P1|Overall Study|Lost to Follow-up|1
919663|NCT00995709|3031989|P3|Overall Study|Withdrawal by Subject|1
919664|NCT00995709|3031990|P2|Overall Study|Withdrawal by Subject|4
919665|NCT00995709|3031991|P1|Overall Study|Withdrawal by Subject|0
919666|NCT00995709|3031989|P3|Overall Study|Lack of Efficacy|4
919667|NCT00995709|3031990|P2|Overall Study|Lack of Efficacy|1
919668|NCT00995709|3031991|P1|Overall Study|Lack of Efficacy|0
919669|NCT00995709|3031989|P3|Overall Study|Adverse Event|0
919670|NCT00995709|3031990|P2|Overall Study|Adverse Event|2
919671|NCT00995709|3031991|P1|Overall Study|Adverse Event|4
919672|NCT00995670|3032017|P3|Overall Study|Failed arterial cannulation|3
919673|NCT00995670|3032018|P2|Overall Study|Failed arterial cannulation|0
919674|NCT00995670|3032019|P1|Overall Study|Failed arterial cannulation|1
919675|NCT00995566|3032027|P1|Overall Study|Early study termination|52
919676|NCT00995566|3032027|P1|Overall Study|Adverse Event|2
919677|NCT00995553|3032041|P2|Overall Study|Withdrawal by Subject|6
919678|NCT00995553|3032042|P1|Overall Study|Withdrawal by Subject|2
919679|NCT00995488|3032091|P1|Overall Study|Withdrawal by Subject|1
919680|NCT00995436|3032114|P3|Overall Study|Withdrawal by Subject|0
919681|NCT00995436|3032115|P2|Overall Study|Withdrawal by Subject|5
919682|NCT00995436|3032116|P1|Overall Study|Withdrawal by Subject|2
919683|NCT00995410|3032124|P1|Overall Study|Misc|28
919684|NCT00995410|3032124|P1|Overall Study|Lost to Follow-up|2
919685|NCT00995410|3032124|P1|Overall Study|Withdrawal by Subject|7
919686|NCT00995410|3032124|P1|Overall Study|Adverse Event|51
919687|NCT00995371|3032131|P2|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
919688|NCT00995371|3032132|P1|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
919689|NCT00995345|3032150|P5|Overall Study|all other reasons combined|3
919690|NCT00995345|3032151|P4|Overall Study|all other reasons combined|1
919691|NCT00995345|3032152|P3|Overall Study|all other reasons combined|2
919692|NCT00995345|3032153|P2|Overall Study|all other reasons combined|2
919693|NCT00995345|3032154|P1|Overall Study|all other reasons combined|2
919694|NCT00995345|3032150|P5|Overall Study|Lost to Follow-up|0
919695|NCT00995345|3032151|P4|Overall Study|Lost to Follow-up|1
919696|NCT00995345|3032152|P3|Overall Study|Lost to Follow-up|2
919697|NCT00995345|3032153|P2|Overall Study|Lost to Follow-up|2
919698|NCT00995345|3032154|P1|Overall Study|Lost to Follow-up|2
919699|NCT00995345|3032150|P5|Overall Study|Adverse Event|1
919700|NCT00995345|3032151|P4|Overall Study|Adverse Event|0
919701|NCT00995345|3032152|P3|Overall Study|Adverse Event|2
919702|NCT00995345|3032153|P2|Overall Study|Adverse Event|1
919703|NCT00995345|3032154|P1|Overall Study|Adverse Event|3
919704|NCT00995345|3032150|P5|Overall Study|Withdrawal by Subject|1
919705|NCT00995345|3032151|P4|Overall Study|Withdrawal by Subject|3
919706|NCT00995345|3032152|P3|Overall Study|Withdrawal by Subject|1
919707|NCT00995345|3032153|P2|Overall Study|Withdrawal by Subject|2
919708|NCT00995345|3032154|P1|Overall Study|Withdrawal by Subject|4
919709|NCT00995085|3032181|P1|Overall Study|Withdrawal by Subject|5
919710|NCT00995020|3032187|P2|Overall Study|specimen fragmentation, thermal damage|2
919711|NCT00995020|3032188|P1|Overall Study|specimen fragmentation, thermal damage|1
919712|NCT00995020|3032187|P2|Overall Study|margin analysis not performed|5
919713|NCT00995020|3032188|P1|Overall Study|margin analysis not performed|2
919714|NCT00995007|3032198|P2|Overall Study|Toxicity|0
919715|NCT00995007|3032199|P1|Overall Study|Toxicity|8
919716|NCT00995007|3032198|P2|Overall Study|Refused further treatment|2
919717|NCT00995007|3032199|P1|Overall Study|Refused further treatment|8
919718|NCT00995007|3032198|P2|Overall Study|Withdrew consent|0
919719|NCT00995007|3032199|P1|Overall Study|Withdrew consent|1
919720|NCT00994682|3032262|P2|Pioglitazone Open Label|Physician Decision|1
919721|NCT00994682|3032263|P1|Pioglitazone Open Label|Physician Decision|6
919722|NCT00994682|3032262|P2|Pioglitazone Open Label|Lost to Follow-up|2
919723|NCT00994682|3032263|P1|Pioglitazone Open Label|Lost to Follow-up|3
919724|NCT00994682|3032262|P2|Pioglitazone Open Label|Withdrawal by Subject|4
919725|NCT00994682|3032263|P1|Pioglitazone Open Label|Withdrawal by Subject|4
919726|NCT00994682|3032262|P2|Double Bilnd|Adverse Event|0
919727|NCT00994682|3032263|P1|Double Bilnd|Adverse Event|1
919728|NCT00994682|3032262|P2|Double Bilnd|Lost to Follow-up|3
919729|NCT00994682|3032263|P1|Double Bilnd|Lost to Follow-up|3
919730|NCT00994682|3032262|P2|Double Bilnd|Withdrawal by Subject|6
919731|NCT00994682|3032263|P1|Double Bilnd|Withdrawal by Subject|5
919732|NCT00994643|3032307|P1|Overall Study|Withdrawal by Subject|1
919733|NCT00994461|3032321|P3|Overall Study|Adverse Event|0
919734|NCT00994461|3032322|P2|Overall Study|Adverse Event|1
919735|NCT00994461|3032323|P1|Overall Study|Adverse Event|2
919736|NCT00994448|3032351|P2|Overall Study|Physician Decision|0
919737|NCT00994448|3032352|P1|Overall Study|Physician Decision|1
919738|NCT00994448|3032351|P2|Overall Study|Withdrawal by Subject|1
919739|NCT00994448|3032352|P1|Overall Study|Withdrawal by Subject|1
919740|NCT00994448|3032351|P2|Overall Study|Lost to Follow-up|1
919741|NCT00994448|3032352|P1|Overall Study|Lost to Follow-up|5
919742|NCT00994448|3032351|P2|Overall Study|Adverse Event|0
919743|NCT00994448|3032352|P1|Overall Study|Adverse Event|1
919744|NCT00994422|3032360|P2|Overall Study|Lost to Follow-up|1
919745|NCT00994422|3032361|P1|Overall Study|Lost to Follow-up|7
919746|NCT00994279|3032386|P2|Overall Study|Multiple reasons|3
919747|NCT00994279|3032387|P1|Overall Study|Multiple reasons|1
919748|NCT00994279|3032386|P2|Overall Study|Toxicity|0
919749|NCT00994279|3032387|P1|Overall Study|Toxicity|1
919750|NCT00994279|3032386|P2|Overall Study|Withdrawal by Subject|2
919751|NCT00994279|3032387|P1|Overall Study|Withdrawal by Subject|2
919752|NCT00994240|3032397|P2|Overall Study|study termination|3
919753|NCT00994240|3032398|P1|Overall Study|study termination|2
919754|NCT00994240|3032397|P2|Overall Study|Withdrawal by Subject|0
919755|NCT00994240|3032398|P1|Overall Study|Withdrawal by Subject|1
919756|NCT00994240|3032397|P2|Overall Study|Lost to Follow-up|2
919757|NCT00994240|3032398|P1|Overall Study|Lost to Follow-up|3
919758|NCT00994214|3032408|P4|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
919759|NCT00994214|3032409|P3|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
919760|NCT00994214|3032410|P2|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3
919761|NCT00994214|3032411|P1|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4
919762|NCT00994214|3032408|P4|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1
919763|NCT00994214|3032409|P3|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
919764|NCT00994214|3032410|P2|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
919765|NCT00994214|3032411|P1|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
919766|NCT00994214|3032408|P4|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14
919767|NCT00994214|3032409|P3|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
919768|NCT00994214|3032410|P2|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12
919769|NCT00994214|3032411|P1|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
919770|NCT00994214|3032408|P4|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
919771|NCT00994214|3032409|P3|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
919772|NCT00994214|3032410|P2|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
919773|NCT00994214|3032411|P1|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1
919774|NCT00994214|3032408|P4|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1
919775|NCT00994214|3032409|P3|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
919776|NCT00994214|3032410|P2|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
919777|NCT00994214|3032411|P1|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
919778|NCT00994214|3032408|P4|ITT (Intention-to-Treat) - Part A|Adverse Event|0
919779|NCT00994214|3032409|P3|ITT (Intention-to-Treat) - Part A|Adverse Event|0
919780|NCT00994214|3032410|P2|ITT (Intention-to-Treat) - Part A|Adverse Event|1
919781|NCT00994214|3032411|P1|ITT (Intention-to-Treat) - Part A|Adverse Event|0
919782|NCT00994110|3032490|P2|Overall Study|Pt not eligible|5
919783|NCT00994110|3032491|P1|Overall Study|Pt not eligible|10
919784|NCT00994110|3032490|P2|Overall Study|Patient not resected|52
919785|NCT00994110|3032491|P1|Overall Study|Patient not resected|41
919786|NCT00994110|3032490|P2|Overall Study|Adverse Event|0
919787|NCT00994110|3032491|P1|Overall Study|Adverse Event|1
919788|NCT00994110|3032490|P2|Overall Study|Not Treated|8
919789|NCT00994110|3032491|P1|Overall Study|Not Treated|4
919790|NCT00994110|3032490|P2|Overall Study|Withdrawal by Subject|9
919791|NCT00994110|3032491|P1|Overall Study|Withdrawal by Subject|9
919792|NCT00993967|3032497|P1|Overall Study|Protocol Violation|2
919793|NCT00993967|3032497|P1|Overall Study|Withdrawal by Subject|36
919794|NCT00993967|3032497|P1|Overall Study|Lost to Follow-up|14
919795|NCT00993967|3032497|P1|Overall Study|Death|1
919796|NCT00993967|3032497|P1|Overall Study|Adverse Event|8
919797|NCT00993954|3032504|P2|Overall Study|Protocol Violation|2
919798|NCT00993954|3032505|P1|Overall Study|Protocol Violation|21
919799|NCT00993928|3032518|P2|Overall Study|ineligible|0
919800|NCT00993928|3032519|P1|Overall Study|ineligible|1
919801|NCT00993928|3032518|P2|Overall Study|Withdrawal by Subject|7
919802|NCT00993928|3032519|P1|Overall Study|Withdrawal by Subject|4
919803|NCT00993915|3032533|P1|Overall Study|Ongoing|3
919804|NCT00993915|3032533|P1|Overall Study|Not specified|1
919805|NCT00993915|3032533|P1|Overall Study|Withdrawal by Subject|2
919806|NCT00993915|3032533|P1|Overall Study|Insufficient clinical response|3
919807|NCT00993668|3032559|P2|Open-Label Period|Lost to Follow-up|1
919808|NCT00993668|3032560|P1|Open-Label Period|Lost to Follow-up|6
919809|NCT00993668|3032559|P2|Open-Label Period|Withdrawal by Subject|3
919810|NCT00993668|3032560|P1|Open-Label Period|Withdrawal by Subject|4
919811|NCT00993668|3032559|P2|Open-Label Period|Lack of Efficacy|3
919812|NCT00993668|3032560|P1|Open-Label Period|Lack of Efficacy|4
919813|NCT00993668|3032559|P2|Open-Label Period|Adverse Event|8
919814|NCT00993668|3032560|P1|Open-Label Period|Adverse Event|9
919815|NCT00993668|3032559|P2|Single-Blind Period|Lost to Follow-up|1
919816|NCT00993668|3032560|P1|Single-Blind Period|Lost to Follow-up|3
919817|NCT00993668|3032559|P2|Single-Blind Period|Lack of Efficacy|1
919818|NCT00993668|3032560|P1|Single-Blind Period|Lack of Efficacy|0
919819|NCT00993668|3032559|P2|Single-Blind Period|Adverse Event|1
919820|NCT00993668|3032560|P1|Single-Blind Period|Adverse Event|1
919821|NCT00993616|3032604|P1|Overall Study|Never treated|1
919822|NCT00993616|3032604|P1|Overall Study|No tumor at entry|1
919823|NCT00993499|3032622|P6|Discontinued After Starting Course 3|Other adverse event|0
919824|NCT00993499|3032623|P5|Discontinued After Starting Course 3|Other adverse event|0
919825|NCT00993499|3032624|P4|Discontinued After Starting Course 3|Other adverse event|0
919826|NCT00993499|3032625|P3|Discontinued After Starting Course 3|Other adverse event|1
919827|NCT00993499|3032626|P2|Discontinued After Starting Course 3|Other adverse event|0
919828|NCT00993499|3032627|P1|Discontinued After Starting Course 3|Other adverse event|1
919829|NCT00993499|3032622|P6|Discontinued After Starting Course 3|DLT|0
919830|NCT00993499|3032623|P5|Discontinued After Starting Course 3|DLT|0
919831|NCT00993499|3032624|P4|Discontinued After Starting Course 3|DLT|1
919832|NCT00993499|3032625|P3|Discontinued After Starting Course 3|DLT|2
919833|NCT00993499|3032626|P2|Discontinued After Starting Course 3|DLT|0
919834|NCT00993499|3032627|P1|Discontinued After Starting Course 3|DLT|1
919835|NCT00993499|3032622|P6|Discontinued After Starting Course 3|Progressive Disease|3
919836|NCT00993499|3032623|P5|Discontinued After Starting Course 3|Progressive Disease|3
919837|NCT00993499|3032624|P4|Discontinued After Starting Course 3|Progressive Disease|1
919838|NCT00993499|3032625|P3|Discontinued After Starting Course 3|Progressive Disease|3
919839|NCT00993499|3032626|P2|Discontinued After Starting Course 3|Progressive Disease|4
919840|NCT00993499|3032627|P1|Discontinued After Starting Course 3|Progressive Disease|6
919841|NCT00993499|3032622|P6|Discontinued After Starting Course 3|Withdrawal by Subject|0
919842|NCT00993499|3032623|P5|Discontinued After Starting Course 3|Withdrawal by Subject|0
919843|NCT00993499|3032624|P4|Discontinued After Starting Course 3|Withdrawal by Subject|0
919844|NCT00993499|3032625|P3|Discontinued After Starting Course 3|Withdrawal by Subject|0
919845|NCT00993499|3032626|P2|Discontinued After Starting Course 3|Withdrawal by Subject|1
919846|NCT00993499|3032627|P1|Discontinued After Starting Course 3|Withdrawal by Subject|0
919847|NCT00993499|3032622|P6|Discontinued Before Starting Course 3|Non compliance with the protocol|0
919848|NCT00993499|3032623|P5|Discontinued Before Starting Course 3|Non compliance with the protocol|0
919849|NCT00993499|3032624|P4|Discontinued Before Starting Course 3|Non compliance with the protocol|0
919850|NCT00993499|3032625|P3|Discontinued Before Starting Course 3|Non compliance with the protocol|2
919851|NCT00993499|3032626|P2|Discontinued Before Starting Course 3|Non compliance with the protocol|0
919852|NCT00993499|3032627|P1|Discontinued Before Starting Course 3|Non compliance with the protocol|0
919853|NCT00993499|3032622|P6|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
919854|NCT00993499|3032623|P5|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
919855|NCT00993499|3032624|P4|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
919856|NCT00993499|3032625|P3|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
919857|NCT00993499|3032626|P2|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
919858|NCT00993499|3032627|P1|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
919859|NCT00993499|3032622|P6|Discontinued Before Starting Course 3|Withdrawal by Subject|0
919860|NCT00993499|3032623|P5|Discontinued Before Starting Course 3|Withdrawal by Subject|0
919861|NCT00993499|3032624|P4|Discontinued Before Starting Course 3|Withdrawal by Subject|0
919862|NCT00993499|3032625|P3|Discontinued Before Starting Course 3|Withdrawal by Subject|0
919863|NCT00993499|3032626|P2|Discontinued Before Starting Course 3|Withdrawal by Subject|2
919864|NCT00993499|3032627|P1|Discontinued Before Starting Course 3|Withdrawal by Subject|2
919865|NCT00993499|3032622|P6|Discontinued Before Starting Course 3|Progressive Disease|0
919866|NCT00993499|3032623|P5|Discontinued Before Starting Course 3|Progressive Disease|0
919867|NCT00993499|3032624|P4|Discontinued Before Starting Course 3|Progressive Disease|0
919868|NCT00993499|3032625|P3|Discontinued Before Starting Course 3|Progressive Disease|0
919869|NCT00993499|3032626|P2|Discontinued Before Starting Course 3|Progressive Disease|2
919870|NCT00993499|3032627|P1|Discontinued Before Starting Course 3|Progressive Disease|2
919871|NCT00993499|3032622|P6|Run-in Period (8 Days)|Progressive disease|0
919872|NCT00993499|3032623|P5|Run-in Period (8 Days)|Progressive disease|0
919873|NCT00993499|3032624|P4|Run-in Period (8 Days)|Progressive disease|0
919874|NCT00993499|3032625|P3|Run-in Period (8 Days)|Progressive disease|1
919875|NCT00993499|3032626|P2|Run-in Period (8 Days)|Progressive disease|1
919876|NCT00993499|3032627|P1|Run-in Period (8 Days)|Progressive disease|0
919877|NCT00993499|3032622|P6|Run-in Period (8 Days)|Consent withdrawn|0
919878|NCT00993499|3032623|P5|Run-in Period (8 Days)|Consent withdrawn|0
919879|NCT00993499|3032624|P4|Run-in Period (8 Days)|Consent withdrawn|0
919880|NCT00993499|3032625|P3|Run-in Period (8 Days)|Consent withdrawn|0
919881|NCT00993499|3032626|P2|Run-in Period (8 Days)|Consent withdrawn|1
919882|NCT00993499|3032627|P1|Run-in Period (8 Days)|Consent withdrawn|0
919883|NCT00993499|3032622|P6|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
919884|NCT00993499|3032623|P5|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
919885|NCT00993499|3032624|P4|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
919886|NCT00993499|3032625|P3|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
919887|NCT00993499|3032626|P2|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
919888|NCT00993499|3032627|P1|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1
919889|NCT00993499|3032622|P6|Run-in Period (8 Days)|Adverse Event|0
919890|NCT00993499|3032623|P5|Run-in Period (8 Days)|Adverse Event|0
919891|NCT00993499|3032624|P4|Run-in Period (8 Days)|Adverse Event|0
919892|NCT00993499|3032625|P3|Run-in Period (8 Days)|Adverse Event|0
919893|NCT00993499|3032626|P2|Run-in Period (8 Days)|Adverse Event|1
919894|NCT00993499|3032627|P1|Run-in Period (8 Days)|Adverse Event|0
919895|NCT00993473|3032709|P2|Overall Study|Family event|0
919896|NCT00993473|3032710|P1|Overall Study|Family event|1
919897|NCT00993473|3032709|P2|Overall Study|Technical problem with CGM device|1
919898|NCT00993473|3032710|P1|Overall Study|Technical problem with CGM device|0
919899|NCT00993473|3032709|P2|Overall Study|Withdrawal by Subject|5
919900|NCT00993473|3032710|P1|Overall Study|Withdrawal by Subject|1
919901|NCT00993473|3032709|P2|Overall Study|Lost to Follow-up|0
919902|NCT00993473|3032710|P1|Overall Study|Lost to Follow-up|1
919903|NCT00993473|3032709|P2|Overall Study|Protocol Violation|2
919904|NCT00993473|3032710|P1|Overall Study|Protocol Violation|1
919905|NCT00993473|3032709|P2|Overall Study|Adverse Event|2
919906|NCT00993473|3032710|P1|Overall Study|Adverse Event|0
919907|NCT00993447|3032748|P2|Overall Study|Adverse Event|0
919908|NCT00993447|3032749|P1|Overall Study|Adverse Event|1
919909|NCT00993447|3032748|P2|Overall Study|Lost to Follow-up|3
919910|NCT00993447|3032749|P1|Overall Study|Lost to Follow-up|1
919911|NCT00993447|3032748|P2|Overall Study|Protocol Violation|8
919912|NCT00993447|3032749|P1|Overall Study|Protocol Violation|12
919913|NCT00993447|3032748|P2|Overall Study|Withdrawal by Subject|8
919914|NCT00993447|3032749|P1|Overall Study|Withdrawal by Subject|23
919915|NCT00993421|3032786|P7|Overall Study|Protocol Violation|1
919916|NCT00993421|3032787|P6|Overall Study|Protocol Violation|2
919917|NCT00993421|3032788|P5|Overall Study|Protocol Violation|0
919918|NCT00993421|3032789|P4|Overall Study|Protocol Violation|0
919919|NCT00993421|3032790|P3|Overall Study|Protocol Violation|0
919920|NCT00993421|3032791|P2|Overall Study|Protocol Violation|0
919921|NCT00993421|3032792|P1|Overall Study|Protocol Violation|0
919922|NCT00993421|3032786|P7|Overall Study|Physician Decision|1
919923|NCT00993421|3032787|P6|Overall Study|Physician Decision|1
919924|NCT00993421|3032788|P5|Overall Study|Physician Decision|0
919925|NCT00993421|3032789|P4|Overall Study|Physician Decision|0
919926|NCT00993421|3032790|P3|Overall Study|Physician Decision|0
919927|NCT00993421|3032791|P2|Overall Study|Physician Decision|0
919928|NCT00993421|3032792|P1|Overall Study|Physician Decision|0
919929|NCT00993421|3032786|P7|Overall Study|Entry Criteria Exclusion|0
919930|NCT00993421|3032787|P6|Overall Study|Entry Criteria Exclusion|1
919931|NCT00993421|3032788|P5|Overall Study|Entry Criteria Exclusion|0
919932|NCT00993421|3032789|P4|Overall Study|Entry Criteria Exclusion|3
919933|NCT00993421|3032790|P3|Overall Study|Entry Criteria Exclusion|1
919934|NCT00993421|3032791|P2|Overall Study|Entry Criteria Exclusion|0
919935|NCT00993421|3032792|P1|Overall Study|Entry Criteria Exclusion|0
919936|NCT00993421|3032786|P7|Overall Study|Death|1
919937|NCT00993421|3032787|P6|Overall Study|Death|0
919938|NCT00993421|3032788|P5|Overall Study|Death|0
919939|NCT00993421|3032789|P4|Overall Study|Death|0
919940|NCT00993421|3032790|P3|Overall Study|Death|0
919941|NCT00993421|3032791|P2|Overall Study|Death|0
919942|NCT00993421|3032792|P1|Overall Study|Death|0
919943|NCT00993421|3032786|P7|Overall Study|Withdrawal by Subject|3
919944|NCT00993421|3032787|P6|Overall Study|Withdrawal by Subject|5
919945|NCT00993421|3032788|P5|Overall Study|Withdrawal by Subject|3
919946|NCT00993421|3032789|P4|Overall Study|Withdrawal by Subject|3
919947|NCT00993421|3032790|P3|Overall Study|Withdrawal by Subject|3
919948|NCT00993421|3032791|P2|Overall Study|Withdrawal by Subject|2
919949|NCT00993421|3032792|P1|Overall Study|Withdrawal by Subject|3
919950|NCT00993421|3032786|P7|Overall Study|Lost to Follow-up|6
919951|NCT00993421|3032787|P6|Overall Study|Lost to Follow-up|0
919952|NCT00993421|3032788|P5|Overall Study|Lost to Follow-up|0
919953|NCT00993421|3032789|P4|Overall Study|Lost to Follow-up|0
919954|NCT00993421|3032790|P3|Overall Study|Lost to Follow-up|5
919955|NCT00993421|3032791|P2|Overall Study|Lost to Follow-up|5
919956|NCT00993421|3032792|P1|Overall Study|Lost to Follow-up|3
919957|NCT00993421|3032786|P7|Overall Study|Sponsor Decision|29
919958|NCT00993421|3032787|P6|Overall Study|Sponsor Decision|30
919959|NCT00993421|3032788|P5|Overall Study|Sponsor Decision|38
919960|NCT00993421|3032789|P4|Overall Study|Sponsor Decision|30
919961|NCT00993421|3032790|P3|Overall Study|Sponsor Decision|28
919962|NCT00993421|3032791|P2|Overall Study|Sponsor Decision|31
919963|NCT00993421|3032792|P1|Overall Study|Sponsor Decision|36
919964|NCT00993421|3032786|P7|Overall Study|Adverse Event|1
919965|NCT00993421|3032787|P6|Overall Study|Adverse Event|7
919966|NCT00993421|3032788|P5|Overall Study|Adverse Event|5
919967|NCT00993421|3032789|P4|Overall Study|Adverse Event|9
919968|NCT00993421|3032790|P3|Overall Study|Adverse Event|6
919969|NCT00993421|3032791|P2|Overall Study|Adverse Event|7
919970|NCT00993421|3032792|P1|Overall Study|Adverse Event|2
919971|NCT00993317|3032943|P2|Overall Study|Early study termination at the site|0
919972|NCT00993317|3032944|P1|Overall Study|Early study termination at the site|1
919973|NCT00993317|3032943|P2|Overall Study|Investigator's opinion|1
919974|NCT00993317|3032944|P1|Overall Study|Investigator's opinion|0
919975|NCT00993317|3032943|P2|Overall Study|Withdrawal by Subject|2
919976|NCT00993317|3032944|P1|Overall Study|Withdrawal by Subject|0
919977|NCT00993317|3032943|P2|Overall Study|Lack of Efficacy|18
919978|NCT00993317|3032944|P1|Overall Study|Lack of Efficacy|18
919979|NCT00993317|3032943|P2|Overall Study|Adverse Event|4
919980|NCT00993317|3032944|P1|Overall Study|Adverse Event|2
919981|NCT00993291|3032962|P1|Overall Study|Withdrawal by Subject|1
919982|NCT00993265|3032968|P2|Overall Study|Non-compliant with study medication|0
919983|NCT00993265|3032969|P1|Overall Study|Non-compliant with study medication|1
919984|NCT00993265|3032968|P2|Overall Study|Changed dose of concomitant drug|0
919985|NCT00993265|3032969|P1|Overall Study|Changed dose of concomitant drug|2
919986|NCT00993265|3032968|P2|Overall Study|Adverse Event|0
919987|NCT00993265|3032969|P1|Overall Study|Adverse Event|1
919988|NCT00993148|3033021|P1|Overall Study|never initiated treatment|1
919989|NCT00993148|3033021|P1|Overall Study|Lost to Follow-up|2
919990|NCT00993044|3033033|P1|Irinotecan 50 mg|Physician Decision|1
919991|NCT00993031|3033040|P2|Overall Study|Lost to Follow-up|13
919992|NCT00993031|3033041|P1|Overall Study|Lost to Follow-up|19
919993|NCT00993031|3033040|P2|Overall Study|Withdrawal by Subject|3
919994|NCT00993031|3033041|P1|Overall Study|Withdrawal by Subject|3
919995|NCT00993031|3033040|P2|Overall Study|Physician Decision|2
919996|NCT00993031|3033041|P1|Overall Study|Physician Decision|0
919997|NCT00993031|3033040|P2|Overall Study|Death|1
919998|NCT00993031|3033041|P1|Overall Study|Death|0
919999|NCT00992992|3033059|P1|Overall Study|Sponsor Closed the Study|4
920000|NCT00992992|3033059|P1|Overall Study|GlaxoSmithKline Closed the Study|2
920001|NCT00992992|3033059|P1|Overall Study|Death|16
920002|NCT00992992|3033059|P1|Overall Study|Lost to Follow-up|3
920003|NCT00992836|3033090|P1|Overall Study|Protocol Violation|2
920004|NCT00992836|3033090|P1|Overall Study|Withdrawal by Subject|2
920005|NCT00992836|3033090|P1|Overall Study|Lost to Follow-up|1
920006|NCT00992784|3033105|P3|Overall Study|Withdrawal by Subject|1
920007|NCT00992784|3033106|P2|Overall Study|Withdrawal by Subject|1
920008|NCT00992784|3033107|P1|Overall Study|Withdrawal by Subject|1
920009|NCT00992784|3033105|P3|Overall Study|Adverse Event|0
920010|NCT00992784|3033106|P2|Overall Study|Adverse Event|1
920011|NCT00992784|3033107|P1|Overall Study|Adverse Event|2
920012|NCT00992589|3033219|P4|Double-Blind Phase|Not specified|3
920013|NCT00992589|3033220|P3|Double-Blind Phase|Not specified|6
920014|NCT00992589|3033221|P2|Double-Blind Phase|Not specified|1
920015|NCT00992589|3033222|P1|Double-Blind Phase|Not specified|0
920016|NCT00992589|3033219|P4|Double-Blind Phase|Lost to Follow-up|2
920017|NCT00992589|3033220|P3|Double-Blind Phase|Lost to Follow-up|0
920018|NCT00992589|3033221|P2|Double-Blind Phase|Lost to Follow-up|0
920019|NCT00992589|3033222|P1|Double-Blind Phase|Lost to Follow-up|0
920020|NCT00992589|3033219|P4|Double-Blind Phase|Withdrawal by Subject|2
920021|NCT00992589|3033220|P3|Double-Blind Phase|Withdrawal by Subject|5
920022|NCT00992589|3033221|P2|Double-Blind Phase|Withdrawal by Subject|6
920023|NCT00992589|3033222|P1|Double-Blind Phase|Withdrawal by Subject|0
920024|NCT00992589|3033219|P4|Double-Blind Phase|Adverse Event|3
920025|NCT00992589|3033220|P3|Double-Blind Phase|Adverse Event|2
920026|NCT00992589|3033221|P2|Double-Blind Phase|Adverse Event|6
920027|NCT00992589|3033222|P1|Double-Blind Phase|Adverse Event|0
920028|NCT00992589|3033219|P4|Open-Label Phase|Not specified|0
920029|NCT00992589|3033220|P3|Open-Label Phase|Not specified|0
920030|NCT00992589|3033221|P2|Open-Label Phase|Not specified|0
920031|NCT00992589|3033222|P1|Open-Label Phase|Not specified|45
920032|NCT00992589|3033219|P4|Open-Label Phase|Physician Decision|0
920033|NCT00992589|3033220|P3|Open-Label Phase|Physician Decision|0
920034|NCT00992589|3033221|P2|Open-Label Phase|Physician Decision|0
920035|NCT00992589|3033222|P1|Open-Label Phase|Physician Decision|4
920036|NCT00992589|3033219|P4|Open-Label Phase|Protocol Violation|0
920037|NCT00992589|3033220|P3|Open-Label Phase|Protocol Violation|0
920038|NCT00992589|3033221|P2|Open-Label Phase|Protocol Violation|0
920039|NCT00992589|3033222|P1|Open-Label Phase|Protocol Violation|3
920040|NCT00992589|3033219|P4|Open-Label Phase|Lost to Follow-up|0
920041|NCT00992589|3033220|P3|Open-Label Phase|Lost to Follow-up|0
920042|NCT00992589|3033221|P2|Open-Label Phase|Lost to Follow-up|0
920043|NCT00992589|3033222|P1|Open-Label Phase|Lost to Follow-up|1
920044|NCT00992589|3033219|P4|Open-Label Phase|Withdrawal by Subject|0
920045|NCT00992589|3033220|P3|Open-Label Phase|Withdrawal by Subject|0
920046|NCT00992589|3033221|P2|Open-Label Phase|Withdrawal by Subject|0
920047|NCT00992589|3033222|P1|Open-Label Phase|Withdrawal by Subject|20
920048|NCT00992589|3033219|P4|Open-Label Phase|Adverse Event|0
920049|NCT00992589|3033220|P3|Open-Label Phase|Adverse Event|0
920050|NCT00992589|3033221|P2|Open-Label Phase|Adverse Event|0
920051|NCT00992589|3033222|P1|Open-Label Phase|Adverse Event|4
920052|NCT00992459|3033266|P2|Overall Study|Adverse Event|0
920053|NCT00992459|3033267|P1|Overall Study|Adverse Event|1
920054|NCT00992459|3033266|P2|Overall Study|Withdrawal by Subject|1
920055|NCT00992459|3033267|P1|Overall Study|Withdrawal by Subject|0
920056|NCT00992446|3033291|P1|Overall Study|Maintenance Therapy Screen Fail|5
920057|NCT00992446|3033291|P1|Overall Study|Withdrawal by Subject|2
920058|NCT00992446|3033291|P1|Overall Study|Disease Progression|1
920059|NCT00992407|3033363|P2|Overall Study|Study medication not administered|13
920060|NCT00992407|3033364|P1|Overall Study|Study medication not administered|17
920061|NCT00992407|3033363|P2|Overall Study|Loss of follow-up & Adverse events|1
920062|NCT00992407|3033364|P1|Overall Study|Loss of follow-up & Adverse events|2
920063|NCT00992407|3033363|P2|Overall Study|Other|0
920064|NCT00992407|3033364|P1|Overall Study|Other|2
920065|NCT00992407|3033363|P2|Overall Study|protocol Violation & Adverse events|4
920066|NCT00992407|3033364|P1|Overall Study|protocol Violation & Adverse events|2
920067|NCT00992407|3033363|P2|Overall Study|Adverse Event|2
920068|NCT00992407|3033364|P1|Overall Study|Adverse Event|3
920069|NCT00992407|3033363|P2|Overall Study|Lost to Follow-up|3
920070|NCT00992407|3033364|P1|Overall Study|Lost to Follow-up|3
920071|NCT00992407|3033363|P2|Overall Study|Protocol Violation|1
920072|NCT00992407|3033364|P1|Overall Study|Protocol Violation|2
920073|NCT00992394|3033414|P2|Overall Study|Other event|0
920074|NCT00992394|3033415|P1|Overall Study|Other event|1
920075|NCT00992394|3033414|P2|Overall Study|Lost to Follow-up|0
920076|NCT00992394|3033415|P1|Overall Study|Lost to Follow-up|2
920077|NCT00992394|3033414|P2|Overall Study|Protocol Violation|4
920078|NCT00992394|3033415|P1|Overall Study|Protocol Violation|2
920079|NCT00992394|3033414|P2|Overall Study|Physician Decision|0
920080|NCT00992394|3033415|P1|Overall Study|Physician Decision|1
920081|NCT00992394|3033414|P2|Overall Study|Withdrawal by Subject|2
920082|NCT00992394|3033415|P1|Overall Study|Withdrawal by Subject|8
920083|NCT00992394|3033414|P2|Overall Study|Adverse Event|5
920084|NCT00992394|3033415|P1|Overall Study|Adverse Event|4
920085|NCT00992394|3033414|P2|Overall Study|Lack of Efficacy|3
920086|NCT00992394|3033415|P1|Overall Study|Lack of Efficacy|6
920087|NCT00992225|3033502|P1|Overall Study|Adverse Event|2
920088|NCT00992225|3033502|P1|Overall Study|Entry Criteria Not Met|8
920089|NCT00992186|3033512|P1|Overall Study|Refusal To Receive Study Agent|3
920090|NCT00992186|3033512|P1|Overall Study|Progressive Disease|30
920091|NCT00992186|3033512|P1|Overall Study|Adverse Event|9
920092|NCT00992186|3033512|P1|Overall Study|Physician Decision|1
920093|NCT00992186|3033512|P1|Overall Study|Protocol Violation|1
920094|NCT00992186|3033512|P1|Overall Study|Withdrawal by Subject|2
920095|NCT00992108|3033531|P2|Overall Study|Lost to Follow-up|1
920096|NCT00992108|3033532|P1|Overall Study|Lost to Follow-up|0
920097|NCT00992056|3033546|P2|Washout Period (2 Weeks)|Physician Decision|0
920098|NCT00992056|3033547|P1|Washout Period (2 Weeks)|Physician Decision|1
920099|NCT00992056|3033546|P2|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2
920100|NCT00992056|3033547|P1|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1
920101|NCT00992017|3033553|P1|Overall Study|Not adhere to study requirements|1
920102|NCT00992017|3033553|P1|Overall Study|Unable to get to clinic|5
920103|NCT00992017|3033553|P1|Overall Study|Withdrawal by Subject|2
920104|NCT00992017|3033553|P1|Overall Study|Lost to Follow-up|2
920105|NCT00991952|3033568|P2|Overall Study|Adverse Event|1
920106|NCT00991952|3033569|P1|Overall Study|Adverse Event|0
920107|NCT00991939|3033577|P2|Overall Study|Entire study terminated|1
920108|NCT00991939|3033578|P1|Overall Study|Entire study terminated|4
920109|NCT00991939|3033577|P2|Overall Study|Withdrawal by Subject|0
920110|NCT00991939|3033578|P1|Overall Study|Withdrawal by Subject|1
920111|NCT00991939|3033577|P2|Overall Study|Lost to Follow-up|1
920112|NCT00991939|3033578|P1|Overall Study|Lost to Follow-up|0
920113|NCT00991887|3033612|P2|Overall Study|Lost to Follow-up|1
920114|NCT00991887|3033613|P1|Overall Study|Lost to Follow-up|2
920115|NCT00991510|3033632|P2|Period III (Days 29-112)|Adverse Event|1
920116|NCT00991510|3033633|P1|Period III (Days 29-112)|Adverse Event|1
920117|NCT00991510|3033632|P2|Period I (Days 1-14)|Adverse Event|0
920118|NCT00991510|3033633|P1|Period I (Days 1-14)|Adverse Event|1
920119|NCT00991341|3033679|P2|Overall Study|Withdrawal by Subject|4
920120|NCT00991341|3033680|P1|Overall Study|Withdrawal by Subject|3
920121|NCT00991341|3033679|P2|Overall Study|Physician Decision|2
920122|NCT00991341|3033680|P1|Overall Study|Physician Decision|1
920123|NCT00991341|3033679|P2|Overall Study|no RBCs received 96hrs after randomized|155
920124|NCT00991341|3033680|P1|Overall Study|no RBCs received 96hrs after randomized|186
920125|NCT00991341|3033679|P2|Overall Study|Death|0
920126|NCT00991341|3033680|P1|Overall Study|Death|3
920127|NCT00991341|3033679|P2|Overall Study|no surgery w/in 30 days of randomization|18
920128|NCT00991341|3033680|P1|Overall Study|no surgery w/in 30 days of randomization|11
920129|NCT00991302|3033718|P2|Overall Study|Lost to Follow-up|12
920130|NCT00991302|3033719|P1|Overall Study|Lost to Follow-up|14
920131|NCT00991302|3033718|P2|Overall Study|Death|1
920132|NCT00991302|3033719|P1|Overall Study|Death|0
920133|NCT00991289|3033735|P1|Overall Study|Protocol Violation|2
920134|NCT00991289|3033735|P1|Overall Study|Lost to Follow-up|4
920135|NCT00991289|3033735|P1|Overall Study|Withdrawal by Subject|3
920136|NCT00991289|3033735|P1|Overall Study|Physician Decision|2
920137|NCT00991289|3033735|P1|Overall Study|Adverse Event|1
920138|NCT00991276|3033755|P6|Third Intervention Period|Withdrawal by Subject|0
920139|NCT00991276|3033756|P5|Third Intervention Period|Withdrawal by Subject|0
920140|NCT00991276|3033757|P4|Third Intervention Period|Withdrawal by Subject|1
920141|NCT00991276|3033758|P3|Third Intervention Period|Withdrawal by Subject|0
920142|NCT00991276|3033759|P2|Third Intervention Period|Withdrawal by Subject|0
920143|NCT00991276|3033760|P1|Third Intervention Period|Withdrawal by Subject|0
920144|NCT00991276|3033755|P6|Third Intervention Period|Adverse Event|0
920145|NCT00991276|3033756|P5|Third Intervention Period|Adverse Event|0
920146|NCT00991276|3033757|P4|Third Intervention Period|Adverse Event|0
920147|NCT00991276|3033758|P3|Third Intervention Period|Adverse Event|1
920148|NCT00991276|3033759|P2|Third Intervention Period|Adverse Event|0
920149|NCT00991276|3033760|P1|Third Intervention Period|Adverse Event|0
920150|NCT00991276|3033755|P6|Third Intervention Period|Other|1
920151|NCT00991276|3033756|P5|Third Intervention Period|Other|0
920152|NCT00991276|3033757|P4|Third Intervention Period|Other|0
920153|NCT00991276|3033758|P3|Third Intervention Period|Other|0
920154|NCT00991276|3033759|P2|Third Intervention Period|Other|0
920155|NCT00991276|3033760|P1|Third Intervention Period|Other|0
920156|NCT00991276|3033755|P6|Third Intervention Period|Protocol Violation|0
920157|NCT00991276|3033756|P5|Third Intervention Period|Protocol Violation|0
920158|NCT00991276|3033757|P4|Third Intervention Period|Protocol Violation|0
920159|NCT00991276|3033758|P3|Third Intervention Period|Protocol Violation|0
920160|NCT00991276|3033759|P2|Third Intervention Period|Protocol Violation|0
920161|NCT00991276|3033760|P1|Third Intervention Period|Protocol Violation|1
920162|NCT00991276|3033755|P6|Second Intervention Period|Other|1
920163|NCT00991276|3033756|P5|Second Intervention Period|Other|0
920164|NCT00991276|3033757|P4|Second Intervention Period|Other|1
920165|NCT00991276|3033758|P3|Second Intervention Period|Other|0
920166|NCT00991276|3033759|P2|Second Intervention Period|Other|0
920167|NCT00991276|3033760|P1|Second Intervention Period|Other|0
920168|NCT00991276|3033755|P6|Second Intervention Period|Protocol Violation|0
920169|NCT00991276|3033756|P5|Second Intervention Period|Protocol Violation|0
920170|NCT00991276|3033757|P4|Second Intervention Period|Protocol Violation|0
920171|NCT00991276|3033758|P3|Second Intervention Period|Protocol Violation|0
920172|NCT00991276|3033759|P2|Second Intervention Period|Protocol Violation|0
920173|NCT00991276|3033760|P1|Second Intervention Period|Protocol Violation|1
920174|NCT00991276|3033755|P6|Second Intervention Period|Adverse Event|0
920175|NCT00991276|3033756|P5|Second Intervention Period|Adverse Event|1
920176|NCT00991276|3033757|P4|Second Intervention Period|Adverse Event|1
920177|NCT00991276|3033758|P3|Second Intervention Period|Adverse Event|0
920178|NCT00991276|3033759|P2|Second Intervention Period|Adverse Event|2
920179|NCT00991276|3033760|P1|Second Intervention Period|Adverse Event|0
920180|NCT00991276|3033755|P6|First Intervention Period|Lost to Follow-up|0
920181|NCT00991276|3033756|P5|First Intervention Period|Lost to Follow-up|0
920182|NCT00991276|3033757|P4|First Intervention Period|Lost to Follow-up|1
920183|NCT00991276|3033758|P3|First Intervention Period|Lost to Follow-up|0
920184|NCT00991276|3033759|P2|First Intervention Period|Lost to Follow-up|1
920185|NCT00991276|3033760|P1|First Intervention Period|Lost to Follow-up|0
920186|NCT00991276|3033755|P6|First Intervention Period|Withdrawal by Subject|1
920187|NCT00991276|3033756|P5|First Intervention Period|Withdrawal by Subject|0
920188|NCT00991276|3033757|P4|First Intervention Period|Withdrawal by Subject|1
920189|NCT00991276|3033758|P3|First Intervention Period|Withdrawal by Subject|0
920190|NCT00991276|3033759|P2|First Intervention Period|Withdrawal by Subject|1
920191|NCT00991276|3033760|P1|First Intervention Period|Withdrawal by Subject|0
920192|NCT00991276|3033755|P6|First Intervention Period|Other|0
920193|NCT00991276|3033756|P5|First Intervention Period|Other|1
920194|NCT00991276|3033757|P4|First Intervention Period|Other|1
920195|NCT00991276|3033758|P3|First Intervention Period|Other|0
920196|NCT00991276|3033759|P2|First Intervention Period|Other|0
920197|NCT00991276|3033760|P1|First Intervention Period|Other|0
920198|NCT00991276|3033755|P6|First Intervention Period|Insufficient clinical response|0
920199|NCT00991276|3033756|P5|First Intervention Period|Insufficient clinical response|1
920200|NCT00991276|3033757|P4|First Intervention Period|Insufficient clinical response|0
920201|NCT00991276|3033758|P3|First Intervention Period|Insufficient clinical response|0
920202|NCT00991276|3033759|P2|First Intervention Period|Insufficient clinical response|0
920203|NCT00991276|3033760|P1|First Intervention Period|Insufficient clinical response|0
920204|NCT00991276|3033755|P6|First Intervention Period|Protocol Violation|0
920205|NCT00991276|3033756|P5|First Intervention Period|Protocol Violation|2
920206|NCT00991276|3033757|P4|First Intervention Period|Protocol Violation|0
920207|NCT00991276|3033758|P3|First Intervention Period|Protocol Violation|0
920208|NCT00991276|3033759|P2|First Intervention Period|Protocol Violation|0
920209|NCT00991276|3033760|P1|First Intervention Period|Protocol Violation|0
920210|NCT00991276|3033755|P6|First Intervention Period|Adverse Event|0
920211|NCT00991276|3033756|P5|First Intervention Period|Adverse Event|0
920212|NCT00991276|3033757|P4|First Intervention Period|Adverse Event|1
920213|NCT00991276|3033758|P3|First Intervention Period|Adverse Event|0
920214|NCT00991276|3033759|P2|First Intervention Period|Adverse Event|1
920215|NCT00991276|3033760|P1|First Intervention Period|Adverse Event|0
920216|NCT00990821|3033917|P14|Overall Study|Withdrawal by Subject|1
920217|NCT00990821|3033918|P13|Overall Study|Withdrawal by Subject|2
920218|NCT00990821|3033919|P12|Overall Study|Withdrawal by Subject|5
920219|NCT00990821|3033920|P11|Overall Study|Withdrawal by Subject|3
920220|NCT00990821|3033921|P10|Overall Study|Withdrawal by Subject|1
920221|NCT00990821|3033922|P9|Overall Study|Withdrawal by Subject|0
920222|NCT00990821|3033923|P8|Overall Study|Withdrawal by Subject|0
920223|NCT00990821|3033924|P7|Overall Study|Withdrawal by Subject|1
920224|NCT00990821|3033925|P6|Overall Study|Withdrawal by Subject|3
920225|NCT00990821|3033926|P5|Overall Study|Withdrawal by Subject|3
920226|NCT00990821|3033927|P4|Overall Study|Withdrawal by Subject|0
920227|NCT00990821|3033928|P3|Overall Study|Withdrawal by Subject|0
920228|NCT00990821|3033929|P2|Overall Study|Withdrawal by Subject|2
920229|NCT00990821|3033930|P1|Overall Study|Withdrawal by Subject|0
920230|NCT00990704|3033967|P2|Overall Study|Physician Decision|1
920231|NCT00990704|3033968|P1|Overall Study|Physician Decision|0
920232|NCT00990704|3033967|P2|Overall Study|Adverse Event|1
920233|NCT00990704|3033968|P1|Overall Study|Adverse Event|1
920234|NCT00990652|3033988|P1|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1
920235|NCT00990652|3033988|P1|Pre-surgical Bortezomib|Adverse Event|1
920236|NCT00990340|3034022|P2|First 14-day Treatment|Protocol Violation|2
920237|NCT00990340|3034023|P1|First 14-day Treatment|Protocol Violation|2
920238|NCT00990340|3034022|P2|First 14-day Treatment|Lost to Follow-up|1
920239|NCT00990340|3034023|P1|First 14-day Treatment|Lost to Follow-up|2
920240|NCT00990340|3034022|P2|First 14-day Treatment|Not Compliant|1
920241|NCT00990340|3034023|P1|First 14-day Treatment|Not Compliant|2
920242|NCT00990249|3034070|P1|Overall Study|Not treated|2
920243|NCT00990249|3034070|P1|Overall Study|Death|2
920244|NCT00990249|3034070|P1|Overall Study|Non-Compliance|1
920245|NCT00990249|3034070|P1|Overall Study|Disease Progression|8
920246|NCT00990184|3034074|P1|Overall Study|Physician Decision|1
920247|NCT00990106|3034082|P2|Overall Study|scheduling conflicts|2
920248|NCT00990106|3034083|P1|Overall Study|scheduling conflicts|0
920249|NCT00990106|3034082|P2|Overall Study|planned major surgery|1
920250|NCT00990106|3034083|P1|Overall Study|planned major surgery|0
920251|NCT00990106|3034082|P2|Overall Study|started exclusionary medication|1
920252|NCT00990106|3034083|P1|Overall Study|started exclusionary medication|0
920253|NCT00990106|3034082|P2|Overall Study|relocation/deployment|1
920254|NCT00990106|3034083|P1|Overall Study|relocation/deployment|4
920255|NCT00990106|3034082|P2|Overall Study|opted for open label prazosin|1
920256|NCT00990106|3034083|P1|Overall Study|opted for open label prazosin|1
920257|NCT00990106|3034082|P2|Overall Study|Withdrawal by Subject|1
920258|NCT00990106|3034083|P1|Overall Study|Withdrawal by Subject|2
920259|NCT00990106|3034082|P2|Overall Study|Lost to Follow-up|3
920260|NCT00990106|3034083|P1|Overall Study|Lost to Follow-up|1
920261|NCT00990106|3034082|P2|Overall Study|"too busy to continue"|2
920262|NCT00990106|3034083|P1|Overall Study|"too busy to continue"|1
920263|NCT00990093|3034093|P2|Test Period 2 (15-28 Days)|Not specified|1
920264|NCT00990093|3034094|P1|Test Period 2 (15-28 Days)|Not specified|0
920265|NCT00990093|3034093|P2|Test Period 2 (15-28 Days)|Lack of Efficacy|0
920266|NCT00990093|3034094|P1|Test Period 2 (15-28 Days)|Lack of Efficacy|1
920267|NCT00990093|3034093|P2|Test Period 2 (15-28 Days)|Adverse Event|0
920268|NCT00990093|3034094|P1|Test Period 2 (15-28 Days)|Adverse Event|1
920269|NCT00990093|3034093|P2|Test Period 1 (1-14 Days)|Lack of Efficacy|2
920270|NCT00990093|3034094|P1|Test Period 1 (1-14 Days)|Lack of Efficacy|0
920271|NCT00990093|3034093|P2|Test Period 1 (1-14 Days)|Not Specified|0
920272|NCT00990093|3034094|P1|Test Period 1 (1-14 Days)|Not Specified|1
920273|NCT00990093|3034093|P2|Test Period 1 (1-14 Days)|Withdrawal by Subject|0
920274|NCT00990093|3034094|P1|Test Period 1 (1-14 Days)|Withdrawal by Subject|2
920275|NCT00990093|3034093|P2|Test Period 1 (1-14 Days)|Adverse Event|0
920276|NCT00990093|3034094|P1|Test Period 1 (1-14 Days)|Adverse Event|1
920277|NCT00989950|3034147|P4|Randomized Phase|Adverse Event|0
920278|NCT00989950|3034148|P3|Randomized Phase|Adverse Event|0
920279|NCT00989950|3034149|P2|Randomized Phase|Adverse Event|1
920280|NCT00989950|3034150|P1|Randomized Phase|Adverse Event|0
920281|NCT00989950|3034147|P4|Randomized Phase|Protocol Violation|0
920282|NCT00989950|3034148|P3|Randomized Phase|Protocol Violation|0
920283|NCT00989950|3034149|P2|Randomized Phase|Protocol Violation|0
920284|NCT00989950|3034150|P1|Randomized Phase|Protocol Violation|1
920285|NCT00989833|3034167|P3|Overall Study|Incorrectly randomized|0
920286|NCT00989833|3034168|P2|Overall Study|Incorrectly randomized|0
920287|NCT00989833|3034169|P1|Overall Study|Incorrectly randomized|1
920288|NCT00989833|3034167|P3|Overall Study|Withdrawal by Subject|1
920289|NCT00989833|3034168|P2|Overall Study|Withdrawal by Subject|0
920290|NCT00989833|3034169|P1|Overall Study|Withdrawal by Subject|0
920291|NCT00989833|3034167|P3|Overall Study|Protocol Violation|1
920292|NCT00989833|3034168|P2|Overall Study|Protocol Violation|2
920293|NCT00989833|3034169|P1|Overall Study|Protocol Violation|1
920294|NCT00989833|3034167|P3|Overall Study|Lost to Follow-up|0
920295|NCT00989833|3034168|P2|Overall Study|Lost to Follow-up|1
920296|NCT00989833|3034169|P1|Overall Study|Lost to Follow-up|0
920297|NCT00989781|3034200|P2|Ovarian Response to hCG|Lost to Follow-up|2
920298|NCT00989781|3034201|P1|Ovarian Response to hCG|Lost to Follow-up|3
920299|NCT00989664|3034231|P1|Long-Term Follow-Up|Death|3
920300|NCT00989664|3034231|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1
920301|NCT00989664|3034231|P1|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7
920302|NCT00989664|3034231|P1|Dosimetric and Therapeutic Treatment|Death|1
920303|NCT00989664|3034231|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|49
920304|NCT00989664|3034231|P1|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2
920305|NCT00989664|3034231|P1|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1
920306|NCT00989287|3034277|P2|Overall Study|Lost to Follow-up|1
920307|NCT00989287|3034278|P1|Overall Study|Lost to Follow-up|0
920308|NCT00989287|3034277|P2|Overall Study|Adverse Event|0
920309|NCT00989287|3034278|P1|Overall Study|Adverse Event|1
920310|NCT00989235|3034380|P2|Overall Study|Lost to Follow-up|1
920311|NCT00989235|3034381|P1|Overall Study|Lost to Follow-up|0
920312|NCT00989235|3034380|P2|Overall Study|Randomized by Mistake|2
920313|NCT00989235|3034381|P1|Overall Study|Randomized by Mistake|0
920314|NCT00989235|3034380|P2|Overall Study|Desire to Become Pregnant|0
920315|NCT00989235|3034381|P1|Overall Study|Desire to Become Pregnant|1
920316|NCT00989235|3034380|P2|Overall Study|Withdrawal of Consent|1
920317|NCT00989235|3034381|P1|Overall Study|Withdrawal of Consent|1
920318|NCT00989235|3034380|P2|Overall Study|Lack of Efficacy|0
920319|NCT00989235|3034381|P1|Overall Study|Lack of Efficacy|1
920320|NCT00989235|3034380|P2|Overall Study|Adverse Event|1
920321|NCT00989235|3034381|P1|Overall Study|Adverse Event|0
920322|NCT00989235|3034380|P2|Overall Study|Death|1
920323|NCT00989235|3034381|P1|Overall Study|Death|0
920324|NCT00989196|3034426|P2|Treatment Period|Lost to Follow-up|0
920325|NCT00989196|3034427|P1|Treatment Period|Lost to Follow-up|1
920326|NCT00989092|3034465|P2|Overall Study|Did not receive study drug|0
920327|NCT00989092|3034466|P1|Overall Study|Did not receive study drug|2
920328|NCT00989092|3034465|P2|Overall Study|Erythropoietin therapy initiated|0
920329|NCT00989092|3034466|P1|Overall Study|Erythropoietin therapy initiated|2
920330|NCT00989092|3034465|P2|Overall Study|Protocol deviation|0
920331|NCT00989092|3034466|P1|Overall Study|Protocol deviation|2
920332|NCT00989092|3034465|P2|Overall Study|Other|1
920333|NCT00989092|3034466|P1|Overall Study|Other|3
920334|NCT00989092|3034465|P2|Overall Study|Lost to Follow-up|2
920335|NCT00989092|3034466|P1|Overall Study|Lost to Follow-up|6
920336|NCT00989092|3034465|P2|Overall Study|Ineligibility determined|3
920337|NCT00989092|3034466|P1|Overall Study|Ineligibility determined|3
920338|NCT00989092|3034465|P2|Overall Study|Death|2
920339|NCT00989092|3034466|P1|Overall Study|Death|14
920340|NCT00989092|3034465|P2|Overall Study|Withdrawal by Subject|9
920341|NCT00989092|3034466|P1|Overall Study|Withdrawal by Subject|17
920342|NCT00989092|3034465|P2|Overall Study|Chemotherapy initiated|4
920343|NCT00989092|3034466|P1|Overall Study|Chemotherapy initiated|12
920344|NCT00989092|3034465|P2|Overall Study|Adverse Event|1
920345|NCT00989092|3034466|P1|Overall Study|Adverse Event|20
920346|NCT00989092|3034465|P2|Overall Study|Physician Decision|6
920347|NCT00989092|3034466|P1|Overall Study|Physician Decision|9
920348|NCT00988884|3034518|P2|Overall Study|Withdrawal by Subject|18
920349|NCT00988884|3034519|P1|Overall Study|Withdrawal by Subject|15
920350|NCT00988884|3034518|P2|Overall Study|Protocol Violation|1
920351|NCT00988884|3034519|P1|Overall Study|Protocol Violation|0
920352|NCT00988884|3034518|P2|Overall Study|Lost to Follow-up|16
920353|NCT00988884|3034519|P1|Overall Study|Lost to Follow-up|20
920354|NCT00988884|3034518|P2|Overall Study|Adverse Event|1
920355|NCT00988884|3034519|P1|Overall Study|Adverse Event|0
920356|NCT00988858|3034541|P1|Overall Study|Sponsor Decision|1
920357|NCT00988858|3034541|P1|Overall Study|Physician Decision|1
920358|NCT00988858|3034541|P1|Overall Study|Death|1
920359|NCT00988858|3034541|P1|Overall Study|Adverse Event|7
920360|NCT00988637|3034590|P2|Overall Study|non-compliance with study drug|1
920361|NCT00988637|3034591|P1|Overall Study|non-compliance with study drug|0
920362|NCT00988637|3034590|P2|Overall Study|Withdrawal by Subject|1
920363|NCT00988637|3034591|P1|Overall Study|Withdrawal by Subject|1
920364|NCT00988637|3034590|P2|Overall Study|Lost to Follow-up|1
920365|NCT00988637|3034591|P1|Overall Study|Lost to Follow-up|2
920366|NCT00988559|3034625|P4|Overall Study|Lost to Follow-up|0
920367|NCT00988559|3034626|P3|Overall Study|Lost to Follow-up|1
920368|NCT00988559|3034627|P2|Overall Study|Lost to Follow-up|0
920369|NCT00988559|3034628|P1|Overall Study|Lost to Follow-up|0
920370|NCT00988559|3034625|P4|Overall Study|Pregnancy|0
920371|NCT00988559|3034626|P3|Overall Study|Pregnancy|1
920372|NCT00988559|3034627|P2|Overall Study|Pregnancy|1
920373|NCT00988559|3034628|P1|Overall Study|Pregnancy|0
920374|NCT00988559|3034625|P4|Overall Study|Withdrawal by Subject|1
920375|NCT00988559|3034626|P3|Overall Study|Withdrawal by Subject|0
920376|NCT00988559|3034627|P2|Overall Study|Withdrawal by Subject|1
920377|NCT00988559|3034628|P1|Overall Study|Withdrawal by Subject|1
920378|NCT00988533|3034642|P1|Overall Study|Lost to Follow-up|3
920379|NCT00988442|3034656|P2|Overall Study|Early Study Closure|25
920380|NCT00988442|3034657|P1|Overall Study|Early Study Closure|29
920381|NCT00988442|3034656|P2|Overall Study|Lost to Follow-up|1
920382|NCT00988442|3034657|P1|Overall Study|Lost to Follow-up|0
920383|NCT00988442|3034656|P2|Overall Study|Death|2
920384|NCT00988442|3034657|P1|Overall Study|Death|1
920385|NCT00988429|3034720|P3|Overall Study|other reasons|1
920386|NCT00988429|3034721|P2|Overall Study|other reasons|8
920387|NCT00988429|3034722|P1|Overall Study|other reasons|8
920388|NCT00988429|3034720|P3|Overall Study|Administrative Reasons|1
920389|NCT00988429|3034721|P2|Overall Study|Administrative Reasons|2
920390|NCT00988429|3034722|P1|Overall Study|Administrative Reasons|1
920391|NCT00988429|3034720|P3|Overall Study|Withdrawal by Subject|12
920392|NCT00988429|3034721|P2|Overall Study|Withdrawal by Subject|7
920393|NCT00988429|3034722|P1|Overall Study|Withdrawal by Subject|7
920394|NCT00988429|3034720|P3|Overall Study|Protocol Violation|3
920395|NCT00988429|3034721|P2|Overall Study|Protocol Violation|3
920396|NCT00988429|3034722|P1|Overall Study|Protocol Violation|4
920397|NCT00988429|3034720|P3|Overall Study|Pregnancy|0
920398|NCT00988429|3034721|P2|Overall Study|Pregnancy|1
920399|NCT00988429|3034722|P1|Overall Study|Pregnancy|2
920400|NCT00988429|3034720|P3|Overall Study|Physician Decision|3
920401|NCT00988429|3034721|P2|Overall Study|Physician Decision|0
920402|NCT00988429|3034722|P1|Overall Study|Physician Decision|1
920403|NCT00988429|3034720|P3|Overall Study|Non-Compliance with Study Drug|3
920404|NCT00988429|3034721|P2|Overall Study|Non-Compliance with Study Drug|1
920405|NCT00988429|3034722|P1|Overall Study|Non-Compliance with Study Drug|5
920406|NCT00988429|3034720|P3|Overall Study|Lack of Efficacy|1
920407|NCT00988429|3034721|P2|Overall Study|Lack of Efficacy|0
920408|NCT00988429|3034722|P1|Overall Study|Lack of Efficacy|0
920409|NCT00988429|3034720|P3|Overall Study|Adverse Event|45
920410|NCT00988429|3034721|P2|Overall Study|Adverse Event|21
920411|NCT00988429|3034722|P1|Overall Study|Adverse Event|9
920412|NCT00988351|3034735|P2|Overall Study|not using CPAP|3
920413|NCT00988351|3034736|P1|Overall Study|not using CPAP|5
920414|NCT00988351|3034735|P2|Overall Study|Lost to Follow-up|9
920415|NCT00988351|3034736|P1|Overall Study|Lost to Follow-up|6
920416|NCT00988351|3034735|P2|Overall Study|Withdrawal by Subject|0
920417|NCT00988351|3034736|P1|Overall Study|Withdrawal by Subject|8
920418|NCT00988247|3034813|P2|Overall Study|Not specified|0
920419|NCT00988247|3034814|P1|Overall Study|Not specified|3
920420|NCT00988247|3034813|P2|Overall Study|Sponsor requested withdrawal|1
920421|NCT00988247|3034814|P1|Overall Study|Sponsor requested withdrawal|3
920422|NCT00988247|3034813|P2|Overall Study|Protocol Violation|5
920423|NCT00988247|3034814|P1|Overall Study|Protocol Violation|4
920424|NCT00988247|3034813|P2|Overall Study|Lost to Follow-up|2
920425|NCT00988247|3034814|P1|Overall Study|Lost to Follow-up|11
920426|NCT00988247|3034813|P2|Overall Study|Pregnancy|2
920427|NCT00988247|3034814|P1|Overall Study|Pregnancy|1
920428|NCT00988247|3034813|P2|Overall Study|Withdrawal by Subject|13
920429|NCT00988247|3034814|P1|Overall Study|Withdrawal by Subject|44
920430|NCT00988247|3034813|P2|Overall Study|Adverse Event|3
920431|NCT00988247|3034814|P1|Overall Study|Adverse Event|17
920432|NCT00988221|3034833|P4|Part III|Refused Treatment|0
920433|NCT00988221|3034834|P3|Part III|Refused Treatment|1
920434|NCT00988221|3034835|P2|Part III|Refused Treatment|0
920435|NCT00988221|3034836|P1|Part III|Refused Treatment|0
920436|NCT00988221|3034833|P4|Part III|Insufficient Therapeutic Response|0
920437|NCT00988221|3034834|P3|Part III|Insufficient Therapeutic Response|1
920438|NCT00988221|3034835|P2|Part III|Insufficient Therapeutic Response|1
920439|NCT00988221|3034836|P1|Part III|Insufficient Therapeutic Response|0
920440|NCT00988221|3034833|P4|Part III|Adverse Event|0
920441|NCT00988221|3034834|P3|Part III|Adverse Event|1
920442|NCT00988221|3034835|P2|Part III|Adverse Event|0
920443|NCT00988221|3034836|P1|Part III|Adverse Event|1
920444|NCT00988221|3034833|P4|Part II|Reason not Specified|0
920445|NCT00988221|3034834|P3|Part II|Reason not Specified|1
920446|NCT00988221|3034835|P2|Part II|Reason not Specified|0
920447|NCT00988221|3034836|P1|Part II|Reason not Specified|0
920448|NCT00988221|3034833|P4|Part II|Withdrawal by Subject|2
920449|NCT00988221|3034834|P3|Part II|Withdrawal by Subject|2
920450|NCT00988221|3034835|P2|Part II|Withdrawal by Subject|0
920451|NCT00988221|3034836|P1|Part II|Withdrawal by Subject|0
920452|NCT00988221|3034833|P4|Part II|Adverse Event|1
920453|NCT00988221|3034834|P3|Part II|Adverse Event|0
920454|NCT00988221|3034835|P2|Part II|Adverse Event|0
920455|NCT00988221|3034836|P1|Part II|Adverse Event|1
920456|NCT00988221|3034833|P4|Part I|Lost to Follow-up|0
920457|NCT00988221|3034834|P3|Part I|Lost to Follow-up|0
920458|NCT00988221|3034835|P2|Part I|Lost to Follow-up|1
920459|NCT00988221|3034836|P1|Part I|Lost to Follow-up|0
920460|NCT00988221|3034833|P4|Part I|Refused Treatment|0
920461|NCT00988221|3034834|P3|Part I|Refused Treatment|1
920462|NCT00988221|3034835|P2|Part I|Refused Treatment|2
920463|NCT00988221|3034836|P1|Part I|Refused Treatment|0
920464|NCT00988221|3034833|P4|Part I|Insufficient Therapeutic Response|0
920465|NCT00988221|3034834|P3|Part I|Insufficient Therapeutic Response|5
920466|NCT00988221|3034835|P2|Part I|Insufficient Therapeutic Response|6
920467|NCT00988221|3034836|P1|Part I|Insufficient Therapeutic Response|4
920468|NCT00988221|3034833|P4|Part I|Adverse Event|0
920469|NCT00988221|3034834|P3|Part I|Adverse Event|2
920470|NCT00988221|3034835|P2|Part I|Adverse Event|1
920471|NCT00988221|3034836|P1|Part I|Adverse Event|0
920472|NCT00988208|3035009|P2|Overall Study|Other|3
920473|NCT00988208|3035010|P1|Overall Study|Other|8
920474|NCT00988208|3035009|P2|Overall Study|Subject Decision/Investigator Discretion|32
920475|NCT00988208|3035010|P1|Overall Study|Subject Decision/Investigator Discretion|32
920476|NCT00988208|3035009|P2|Overall Study|Clinical Deterioration|14
920477|NCT00988208|3035010|P1|Overall Study|Clinical Deterioration|7
920478|NCT00988208|3035009|P2|Overall Study|Biochemical Progression|7
920479|NCT00988208|3035010|P1|Overall Study|Biochemical Progression|21
920480|NCT00988208|3035009|P2|Overall Study|Clinical Progression|16
920481|NCT00988208|3035010|P1|Overall Study|Clinical Progression|17
920482|NCT00988208|3035009|P2|Overall Study|Sponsor Decision|78
920483|NCT00988208|3035010|P1|Overall Study|Sponsor Decision|102
920484|NCT00988208|3035009|P2|Overall Study|Protocol Violation|2
920485|NCT00988208|3035010|P1|Overall Study|Protocol Violation|9
920486|NCT00988208|3035009|P2|Overall Study|Lost to Follow-up|3
920487|NCT00988208|3035010|P1|Overall Study|Lost to Follow-up|2
920488|NCT00988208|3035009|P2|Overall Study|Death|15
920489|NCT00988208|3035010|P1|Overall Study|Death|9
920490|NCT00988208|3035009|P2|Overall Study|Withdrawal by Subject|57
920491|NCT00988208|3035010|P1|Overall Study|Withdrawal by Subject|50
920492|NCT00988208|3035009|P2|Overall Study|Disease Progression|89
920493|NCT00988208|3035010|P1|Overall Study|Disease Progression|103
920494|NCT00988208|3035009|P2|Overall Study|Adverse Event|122
920495|NCT00988208|3035010|P1|Overall Study|Adverse Event|71
920496|NCT00988169|3035028|P1|Overall Study|Withdrawal by Subject|1
920497|NCT00988117|3035080|P1|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2
920498|NCT00988117|3035080|P1|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1
920499|NCT00988091|3035089|P2|Open-label Period|Not specified|3
920500|NCT00988091|3035090|P1|Open-label Period|Not specified|2
920501|NCT00988091|3035089|P2|Open-label Period|Lost to Follow-up|5
920502|NCT00988091|3035090|P1|Open-label Period|Lost to Follow-up|3
920503|NCT00988091|3035089|P2|Open-label Period|Withdrawal by Subject|16
920504|NCT00988091|3035090|P1|Open-label Period|Withdrawal by Subject|10
920505|NCT00988091|3035089|P2|Open-label Period|Protocol Violation|1
920506|NCT00988091|3035090|P1|Open-label Period|Protocol Violation|1
920507|NCT00988091|3035089|P2|Open-label Period|Use of exclusionary medication|1
920508|NCT00988091|3035090|P1|Open-label Period|Use of exclusionary medication|1
920509|NCT00988091|3035089|P2|Open-label Period|Adverse Event|7
920510|NCT00988091|3035090|P1|Open-label Period|Adverse Event|4
920511|NCT00988091|3035089|P2|Double-blind Period|Use of exclusionary medication|3
920512|NCT00988091|3035090|P1|Double-blind Period|Use of exclusionary medication|2
920513|NCT00988091|3035089|P2|Double-blind Period|Adverse Event|9
920514|NCT00988091|3035090|P1|Double-blind Period|Adverse Event|6
920515|NCT00988091|3035089|P2|Double-blind Period|Not specified|8
920516|NCT00988091|3035090|P1|Double-blind Period|Not specified|8
920517|NCT00988091|3035089|P2|Double-blind Period|Lost to Follow-up|14
920518|NCT00988091|3035090|P1|Double-blind Period|Lost to Follow-up|12
920519|NCT00988091|3035089|P2|Double-blind Period|Withdrawal by Subject|13
920520|NCT00988091|3035090|P1|Double-blind Period|Withdrawal by Subject|15
920521|NCT00988065|3035112|P3|Overall Study|Noncompliance with protocol|9
920522|NCT00988065|3035113|P2|Overall Study|Noncompliance with protocol|6
920523|NCT00988065|3035114|P1|Overall Study|Noncompliance with protocol|5
920524|NCT00988065|3035112|P3|Overall Study|Subject withdrew consent|2
920525|NCT00988065|3035113|P2|Overall Study|Subject withdrew consent|5
920526|NCT00988065|3035114|P1|Overall Study|Subject withdrew consent|3
920527|NCT00988065|3035112|P3|Overall Study|Lost to Follow-up|2
920528|NCT00988065|3035113|P2|Overall Study|Lost to Follow-up|2
920529|NCT00988065|3035114|P1|Overall Study|Lost to Follow-up|1
920530|NCT00988065|3035112|P3|Overall Study|Adverse Event|2
920531|NCT00988065|3035113|P2|Overall Study|Adverse Event|10
920532|NCT00988065|3035114|P1|Overall Study|Adverse Event|4
920533|NCT00987935|3035148|P9|Overall Study|Reason other than those specified above|1
920534|NCT00987935|3035149|P8|Overall Study|Reason other than those specified above|0
920535|NCT00987935|3035150|P7|Overall Study|Reason other than those specified above|0
920536|NCT00987935|3035151|P6|Overall Study|Reason other than those specified above|0
920537|NCT00987935|3035152|P5|Overall Study|Reason other than those specified above|0
920538|NCT00987935|3035153|P4|Overall Study|Reason other than those specified above|0
920539|NCT00987935|3035154|P3|Overall Study|Reason other than those specified above|0
920540|NCT00987935|3035155|P2|Overall Study|Reason other than those specified above|0
920541|NCT00987935|3035156|P1|Overall Study|Reason other than those specified above|0
920542|NCT00987935|3035148|P9|Overall Study|Refused to continue taking trial med.|2
920543|NCT00987935|3035149|P8|Overall Study|Refused to continue taking trial med.|4
920544|NCT00987935|3035150|P7|Overall Study|Refused to continue taking trial med.|4
920545|NCT00987935|3035151|P6|Overall Study|Refused to continue taking trial med.|0
920546|NCT00987935|3035152|P5|Overall Study|Refused to continue taking trial med.|1
920547|NCT00987935|3035153|P4|Overall Study|Refused to continue taking trial med.|0
920548|NCT00987935|3035154|P3|Overall Study|Refused to continue taking trial med.|0
920549|NCT00987935|3035155|P2|Overall Study|Refused to continue taking trial med.|0
920550|NCT00987935|3035156|P1|Overall Study|Refused to continue taking trial med.|1
920551|NCT00987935|3035148|P9|Overall Study|Adverse Event|6
920552|NCT00987935|3035149|P8|Overall Study|Adverse Event|10
920553|NCT00987935|3035150|P7|Overall Study|Adverse Event|2
920554|NCT00987935|3035151|P6|Overall Study|Adverse Event|0
920555|NCT00987935|3035152|P5|Overall Study|Adverse Event|1
920556|NCT00987935|3035153|P4|Overall Study|Adverse Event|1
920557|NCT00987935|3035154|P3|Overall Study|Adverse Event|0
920558|NCT00987935|3035155|P2|Overall Study|Adverse Event|1
920559|NCT00987935|3035156|P1|Overall Study|Adverse Event|0
920560|NCT00987935|3035148|P9|Overall Study|Progressive disease|23
920561|NCT00987935|3035149|P8|Overall Study|Progressive disease|48
920562|NCT00987935|3035150|P7|Overall Study|Progressive disease|9
920563|NCT00987935|3035151|P6|Overall Study|Progressive disease|3
920564|NCT00987935|3035152|P5|Overall Study|Progressive disease|5
920565|NCT00987935|3035153|P4|Overall Study|Progressive disease|2
920566|NCT00987935|3035154|P3|Overall Study|Progressive disease|3
920567|NCT00987935|3035155|P2|Overall Study|Progressive disease|2
920568|NCT00987935|3035156|P1|Overall Study|Progressive disease|3
920569|NCT00987831|3035212|P3|Overall Study|Lost to Follow-up|0
920570|NCT00987831|3035213|P2|Overall Study|Lost to Follow-up|3
920571|NCT00987831|3035214|P1|Overall Study|Lost to Follow-up|0
920572|NCT00987831|3035212|P3|Overall Study|Never flared in 12 months|0
920573|NCT00987831|3035213|P2|Overall Study|Never flared in 12 months|0
920574|NCT00987831|3035214|P1|Overall Study|Never flared in 12 months|1
920575|NCT00987623|3035236|P2|Overall Study|Influenza|1
920576|NCT00987623|3035237|P1|Overall Study|Influenza|0
920577|NCT00987623|3035236|P2|Overall Study|Biomicroscopy|1
920578|NCT00987623|3035237|P1|Overall Study|Biomicroscopy|0
920579|NCT00987623|3035236|P2|Overall Study|Discomfort|0
920580|NCT00987623|3035237|P1|Overall Study|Discomfort|1
920581|NCT00987623|3035236|P2|Overall Study|Time/job conflict|0
920582|NCT00987623|3035237|P1|Overall Study|Time/job conflict|2
920583|NCT00987623|3035236|P2|Overall Study|Lost to Follow-up|1
920584|NCT00987623|3035237|P1|Overall Study|Lost to Follow-up|2
920585|NCT00987467|3035266|P1|Overall Study|Lost to Follow-up|2
920586|NCT00987402|3035290|P2|Overall Study|Insufficient data entry|98
920587|NCT00987402|3035291|P1|Overall Study|Insufficient data entry|86
920588|NCT00987337|3035300|P3|Overall Study|Participant Relapsed|5
920589|NCT00987337|3035301|P2|Overall Study|Participant Relapsed|20
920590|NCT00987337|3035302|P1|Overall Study|Participant Relapsed|18
920591|NCT00987337|3035300|P3|Overall Study|Protocol Violation|2
920592|NCT00987337|3035301|P2|Overall Study|Protocol Violation|0
920593|NCT00987337|3035302|P1|Overall Study|Protocol Violation|1
920594|NCT00987337|3035300|P3|Overall Study|Other|5
920595|NCT00987337|3035301|P2|Overall Study|Other|2
920596|NCT00987337|3035302|P1|Overall Study|Other|0
920597|NCT00987337|3035300|P3|Overall Study|Withdrawal by Subject|9
920598|NCT00987337|3035301|P2|Overall Study|Withdrawal by Subject|9
920599|NCT00987337|3035302|P1|Overall Study|Withdrawal by Subject|6
920600|NCT00987337|3035300|P3|Overall Study|Lost to Follow-up|2
920601|NCT00987337|3035301|P2|Overall Study|Lost to Follow-up|6
920602|NCT00987337|3035302|P1|Overall Study|Lost to Follow-up|10
920603|NCT00987337|3035300|P3|Overall Study|Virologic Breakthrough|8
920604|NCT00987337|3035301|P2|Overall Study|Virologic Breakthrough|2
920605|NCT00987337|3035302|P1|Overall Study|Virologic Breakthrough|2
920606|NCT00987337|3035300|P3|Overall Study|Insufficient Virologic Response|12
920607|NCT00987337|3035301|P2|Overall Study|Insufficient Virologic Response|7
920608|NCT00987337|3035302|P1|Overall Study|Insufficient Virologic Response|10
920609|NCT00987337|3035300|P3|Overall Study|Adverse Event|8
920610|NCT00987337|3035301|P2|Overall Study|Adverse Event|9
920611|NCT00987337|3035302|P1|Overall Study|Adverse Event|10
920612|NCT00986986|3035357|P2|Overall Study|Lost to Follow-up|1
920613|NCT00986986|3035358|P1|Overall Study|Lost to Follow-up|0
920614|NCT00986973|3035368|P1|Overall Study|Withdrawn by study team|1
920615|NCT00986921|3035394|P2|Overall Study|Physician Decision|0
920616|NCT00986921|3035395|P1|Overall Study|Physician Decision|1
920617|NCT00986674|3035431|P3|Overall Study|unknown/not specify|9
920618|NCT00986674|3035432|P2|Overall Study|unknown/not specify|7
920619|NCT00986674|3035433|P1|Overall Study|unknown/not specify|0
920620|NCT00986674|3035431|P3|Overall Study|not start protocol therapy|1
920621|NCT00986674|3035432|P2|Overall Study|not start protocol therapy|3
920622|NCT00986674|3035433|P1|Overall Study|not start protocol therapy|4
920623|NCT00986674|3035431|P3|Overall Study|alternative therapy|1
920624|NCT00986674|3035432|P2|Overall Study|alternative therapy|0
920625|NCT00986674|3035433|P1|Overall Study|alternative therapy|0
920626|NCT00986674|3035431|P3|Overall Study|Withdrawal by Subject|1
920627|NCT00986674|3035432|P2|Overall Study|Withdrawal by Subject|2
920628|NCT00986674|3035433|P1|Overall Study|Withdrawal by Subject|6
920629|NCT00986674|3035431|P3|Overall Study|Death|4
920630|NCT00986674|3035432|P2|Overall Study|Death|0
920631|NCT00986674|3035433|P1|Overall Study|Death|5
920632|NCT00986674|3035431|P3|Overall Study|Adverse Event|9
920633|NCT00986674|3035432|P2|Overall Study|Adverse Event|8
920634|NCT00986674|3035433|P1|Overall Study|Adverse Event|4
920635|NCT00986674|3035431|P3|Overall Study|Lack of Efficacy|23
920636|NCT00986674|3035432|P2|Overall Study|Lack of Efficacy|25
920637|NCT00986674|3035433|P1|Overall Study|Lack of Efficacy|28
920638|NCT00986570|3035466|P1|Overall Study|Potential bias for objective assessment|1
920639|NCT00986570|3035466|P1|Overall Study|Lost to Follow-up|6
920640|NCT00986479|3035483|P2|Period 1|Administrative reasons|0
920641|NCT00986479|3035484|P1|Period 1|Administrative reasons|1
920642|NCT00986479|3035483|P2|Period 1|Improved mood|0
920643|NCT00986479|3035484|P1|Period 1|Improved mood|1
920644|NCT00986427|3035530|P2|Overall Study|Withdrawal by Subject|0
920645|NCT00986427|3035531|P1|Overall Study|Withdrawal by Subject|1
920646|NCT00986427|3035530|P2|Overall Study|Lack of Efficacy|0
920647|NCT00986427|3035531|P1|Overall Study|Lack of Efficacy|1
920648|NCT00986427|3035530|P2|Overall Study|Lost to Follow-up|0
920649|NCT00986427|3035531|P1|Overall Study|Lost to Follow-up|2
920650|NCT00986362|3035559|P2|Overall Study|Lost to Follow-up|1
920651|NCT00986362|3035560|P1|Overall Study|Lost to Follow-up|0
920652|NCT00986362|3035559|P2|Overall Study|Death|0
920653|NCT00986362|3035560|P1|Overall Study|Death|2
920654|NCT00986349|3035566|P1|Overall Study|device migration|1
920655|NCT00986349|3035566|P1|Overall Study|Physician Decision|1
920656|NCT00986349|3035566|P1|Overall Study|Adverse Event|2
920657|NCT00986349|3035566|P1|Overall Study|Unsuccessful implant procedure|3
920658|NCT00986258|3035579|P1|Maintenance Period|Withdrawal by Subject|2
920659|NCT00986258|3035579|P1|Maintenance Period|Lack of Efficacy|2
920660|NCT00986258|3035579|P1|Maintenance Period|Adverse Event|5
920661|NCT00986258|3035579|P1|Titration and Optimal Dose Period|Other|1
920662|NCT00986258|3035579|P1|Titration and Optimal Dose Period|Non-Compliance|1
920663|NCT00986258|3035579|P1|Titration and Optimal Dose Period|Withdrawal by Subject|3
920664|NCT00986258|3035579|P1|Titration and Optimal Dose Period|Lack of Efficacy|3
920665|NCT00986258|3035579|P1|Titration and Optimal Dose Period|Adverse Event|15
920666|NCT00986258|3035579|P1|Observation Period|Not eligible to be dosed|11
920667|NCT00986245|3035607|P2|Second Intervention|Protocol Violation|1
920668|NCT00986245|3035608|P1|Second Intervention|Protocol Violation|0
920669|NCT00986245|3035607|P2|Second Intervention|Lost to Follow-up|0
920670|NCT00986245|3035608|P1|Second Intervention|Lost to Follow-up|1
920671|NCT00986245|3035607|P2|Second Intervention|Poor compliance|0
920672|NCT00986245|3035608|P1|Second Intervention|Poor compliance|1
920673|NCT00986245|3035607|P2|First Intervention|Out of indication|0
920674|NCT00986245|3035608|P1|First Intervention|Out of indication|1
920675|NCT00986245|3035607|P2|First Intervention|Protocol Violation|1
920676|NCT00986245|3035608|P1|First Intervention|Protocol Violation|0
920677|NCT00986245|3035607|P2|First Intervention|Withdrawal by Subject|1
920678|NCT00986245|3035608|P1|First Intervention|Withdrawal by Subject|0
920679|NCT00986245|3035607|P2|First Intervention|Lack of Efficacy|2
920680|NCT00986245|3035608|P1|First Intervention|Lack of Efficacy|1
920681|NCT00986245|3035607|P2|First Intervention|Poor compliance|4
920682|NCT00986245|3035608|P1|First Intervention|Poor compliance|8
920683|NCT00986232|3035645|P4|Overall Study|Incomplete safety follow-up|2
920684|NCT00986232|3035646|P3|Overall Study|Incomplete safety follow-up|2
920685|NCT00986232|3035647|P2|Overall Study|Incomplete safety follow-up|7
920686|NCT00986232|3035648|P1|Overall Study|Incomplete safety follow-up|3
920687|NCT00986232|3035645|P4|Overall Study|Missed one or more bleeds|7
920688|NCT00986232|3035646|P3|Overall Study|Missed one or more bleeds|6
920689|NCT00986232|3035647|P2|Overall Study|Missed one or more bleeds|10
920690|NCT00986232|3035648|P1|Overall Study|Missed one or more bleeds|13
920691|NCT00986232|3035645|P4|Overall Study|Withdrawal by Subject|3
920692|NCT00986232|3035646|P3|Overall Study|Withdrawal by Subject|12
920693|NCT00986232|3035647|P2|Overall Study|Withdrawal by Subject|16
920694|NCT00986232|3035648|P1|Overall Study|Withdrawal by Subject|13
920695|NCT00986232|3035645|P4|Overall Study|Protocol Violation|1
920696|NCT00986232|3035646|P3|Overall Study|Protocol Violation|0
920697|NCT00986232|3035647|P2|Overall Study|Protocol Violation|3
920698|NCT00986232|3035648|P1|Overall Study|Protocol Violation|2
920699|NCT00986232|3035645|P4|Overall Study|Lost to Follow-up|7
920700|NCT00986232|3035646|P3|Overall Study|Lost to Follow-up|12
920701|NCT00986232|3035647|P2|Overall Study|Lost to Follow-up|12
920702|NCT00986232|3035648|P1|Overall Study|Lost to Follow-up|19
920703|NCT00986232|3035645|P4|Overall Study|Adverse Event|0
920704|NCT00986232|3035646|P3|Overall Study|Adverse Event|3
920705|NCT00986232|3035647|P2|Overall Study|Adverse Event|2
920706|NCT00986232|3035648|P1|Overall Study|Adverse Event|1
920707|NCT00986180|3035722|P2|Overall Study|Miscellanies|11
920708|NCT00986180|3035723|P1|Overall Study|Miscellanies|10
920709|NCT00986180|3035722|P2|Overall Study|Withdrawal by Subject|9
920710|NCT00986180|3035723|P1|Overall Study|Withdrawal by Subject|1
920711|NCT00986180|3035722|P2|Overall Study|Protocol Violation|0
920712|NCT00986180|3035723|P1|Overall Study|Protocol Violation|2
920713|NCT00986180|3035722|P2|Overall Study|Physician Decision|3
920714|NCT00986180|3035723|P1|Overall Study|Physician Decision|1
920715|NCT00986180|3035722|P2|Overall Study|Lost to Follow-up|7
920716|NCT00986180|3035723|P1|Overall Study|Lost to Follow-up|5
920717|NCT00986180|3035722|P2|Overall Study|Lack of Efficacy|3
920718|NCT00986180|3035723|P1|Overall Study|Lack of Efficacy|4
920719|NCT00986180|3035722|P2|Overall Study|Adverse Event|23
920720|NCT00986180|3035723|P1|Overall Study|Adverse Event|21
920721|NCT00986154|3035801|P2|Overall Study|never received study drug|27
920722|NCT00986154|3035802|P1|Overall Study|never received study drug|25
920723|NCT00986154|3035801|P2|Overall Study|investigator/subject decide not continue|3
920724|NCT00986154|3035802|P1|Overall Study|investigator/subject decide not continue|6
920725|NCT00986154|3035801|P2|Overall Study|Withdrawal by Subject|33
920726|NCT00986154|3035802|P1|Overall Study|Withdrawal by Subject|32
920727|NCT00986154|3035801|P2|Overall Study|Lost to Follow-up|4
920728|NCT00986154|3035802|P1|Overall Study|Lost to Follow-up|7
920729|NCT00986154|3035801|P2|Overall Study|Death|127
920730|NCT00986154|3035802|P1|Overall Study|Death|136
920731|NCT00986102|3035816|P4|Overall Study|Withdrawal by Subject|0
920732|NCT00986102|3035817|P3|Overall Study|Withdrawal by Subject|0
920733|NCT00986102|3035818|P2|Overall Study|Withdrawal by Subject|1
920734|NCT00986102|3035819|P1|Overall Study|Withdrawal by Subject|1
920735|NCT00986102|3035816|P4|Overall Study|Lost to Follow-up|1
920736|NCT00986102|3035817|P3|Overall Study|Lost to Follow-up|0
920737|NCT00986102|3035818|P2|Overall Study|Lost to Follow-up|1
920738|NCT00986102|3035819|P1|Overall Study|Lost to Follow-up|0
920739|NCT00985985|3035869|P4|Overall Study|Other Reason|2
920740|NCT00985985|3035870|P3|Overall Study|Other Reason|4
920741|NCT00985985|3035871|P2|Overall Study|Other Reason|1
920742|NCT00985985|3035872|P1|Overall Study|Other Reason|6
920743|NCT00985985|3035869|P4|Overall Study|Withdrawal by Subject|2
920744|NCT00985985|3035870|P3|Overall Study|Withdrawal by Subject|2
920745|NCT00985985|3035871|P2|Overall Study|Withdrawal by Subject|2
920746|NCT00985985|3035872|P1|Overall Study|Withdrawal by Subject|4
920747|NCT00985985|3035869|P4|Overall Study|Lack of Efficacy|3
920748|NCT00985985|3035870|P3|Overall Study|Lack of Efficacy|1
920749|NCT00985985|3035871|P2|Overall Study|Lack of Efficacy|6
920750|NCT00985985|3035872|P1|Overall Study|Lack of Efficacy|5
920751|NCT00985985|3035869|P4|Overall Study|Protocol Violation|1
920752|NCT00985985|3035870|P3|Overall Study|Protocol Violation|0
920753|NCT00985985|3035871|P2|Overall Study|Protocol Violation|2
920754|NCT00985985|3035872|P1|Overall Study|Protocol Violation|1
920755|NCT00985985|3035869|P4|Overall Study|Lost to Follow-up|3
920756|NCT00985985|3035870|P3|Overall Study|Lost to Follow-up|2
920757|NCT00985985|3035871|P2|Overall Study|Lost to Follow-up|11
920758|NCT00985985|3035872|P1|Overall Study|Lost to Follow-up|4
920759|NCT00985985|3035869|P4|Overall Study|Adverse Event|2
920760|NCT00985985|3035870|P3|Overall Study|Adverse Event|2
920761|NCT00985985|3035871|P2|Overall Study|Adverse Event|2
920762|NCT00985985|3035872|P1|Overall Study|Adverse Event|4
920763|NCT00985959|3035913|P3|Overall Study|Other|11
920764|NCT00985959|3035914|P2|Overall Study|Other|0
920765|NCT00985959|3035915|P1|Overall Study|Other|0
920766|NCT00985959|3035913|P3|Overall Study|Complete response observed over 2 cycles|4
920767|NCT00985959|3035914|P2|Overall Study|Complete response observed over 2 cycles|1
920768|NCT00985959|3035915|P1|Overall Study|Complete response observed over 2 cycles|0
920769|NCT00985959|3035913|P3|Overall Study|Pneumonitis or pulmonary fibrosis|2
920770|NCT00985959|3035914|P2|Overall Study|Pneumonitis or pulmonary fibrosis|0
920771|NCT00985959|3035915|P1|Overall Study|Pneumonitis or pulmonary fibrosis|2
920772|NCT00985959|3035913|P3|Overall Study|Unrecovered toxicity|7
920773|NCT00985959|3035914|P2|Overall Study|Unrecovered toxicity|0
920774|NCT00985959|3035915|P1|Overall Study|Unrecovered toxicity|0
920775|NCT00985959|3035913|P3|Overall Study|Progressive disease|8
920776|NCT00985959|3035914|P2|Overall Study|Progressive disease|2
920777|NCT00985959|3035915|P1|Overall Study|Progressive disease|1
920778|NCT00985959|3035913|P3|Overall Study|Withdrawal by Subject|8
920779|NCT00985959|3035914|P2|Overall Study|Withdrawal by Subject|0
920780|NCT00985959|3035915|P1|Overall Study|Withdrawal by Subject|0
920781|NCT00985959|3035913|P3|Overall Study|Adverse Event|19
920782|NCT00985959|3035914|P2|Overall Study|Adverse Event|0
920783|NCT00985959|3035915|P1|Overall Study|Adverse Event|0
920784|NCT00985946|3035938|P1|Overall Study|Withdrawal by Subject|1
920785|NCT00985946|3035938|P1|Overall Study|Lost to Follow-up|6
920786|NCT00985790|3035957|P2|Overall Study|Lost to Follow-up|7
920787|NCT00985790|3035958|P1|Overall Study|Lost to Follow-up|6
920788|NCT00985790|3035957|P2|Overall Study|Withdrawal by Subject|1
920789|NCT00985790|3035958|P1|Overall Study|Withdrawal by Subject|1
920790|NCT00985751|3035999|P5|Overall Study|Adverse Event|1
920791|NCT00985751|3036000|P4|Overall Study|Adverse Event|0
920792|NCT00985751|3036001|P3|Overall Study|Adverse Event|0
920793|NCT00985751|3036002|P2|Overall Study|Adverse Event|0
920794|NCT00985751|3036003|P1|Overall Study|Adverse Event|0
920795|NCT00985738|3036066|P2|Overall Study|Study closed prematurely|8
920796|NCT00985738|3036067|P1|Overall Study|Study closed prematurely|8
920797|NCT00985725|3036075|P2|Overall Study|Out-of-window visits|1
920798|NCT00985725|3036076|P1|Overall Study|Out-of-window visits|0
920799|NCT00985725|3036075|P2|Overall Study|Non-compliance|2
920800|NCT00985725|3036076|P1|Overall Study|Non-compliance|1
920801|NCT00985725|3036075|P2|Overall Study|Lack of Efficacy|1
920802|NCT00985725|3036076|P1|Overall Study|Lack of Efficacy|0
920803|NCT00985725|3036075|P2|Overall Study|Lost to Follow-up|1
920804|NCT00985725|3036076|P1|Overall Study|Lost to Follow-up|1
920805|NCT00985725|3036075|P2|Overall Study|Withdrawal by Subject|4
920806|NCT00985725|3036076|P1|Overall Study|Withdrawal by Subject|4
920807|NCT00985725|3036075|P2|Overall Study|Protocol Violation|3
920808|NCT00985725|3036076|P1|Overall Study|Protocol Violation|1
920809|NCT00985725|3036075|P2|Overall Study|Adverse Event|1
920810|NCT00985725|3036076|P1|Overall Study|Adverse Event|4
920811|NCT00985712|3036112|P2|Overall Study|Sponsor decision|2
920812|NCT00985712|3036113|P1|Overall Study|Sponsor decision|0
920813|NCT00985712|3036112|P2|Overall Study|Withdrawal by Subject|1
920814|NCT00985712|3036113|P1|Overall Study|Withdrawal by Subject|4
920815|NCT00985712|3036112|P2|Overall Study|Protocol Violation|1
920816|NCT00985712|3036113|P1|Overall Study|Protocol Violation|0
920817|NCT00985712|3036112|P2|Overall Study|Lost to Follow-up|2
920818|NCT00985712|3036113|P1|Overall Study|Lost to Follow-up|2
920819|NCT00985712|3036112|P2|Overall Study|Adverse Event|1
920820|NCT00985712|3036113|P1|Overall Study|Adverse Event|0
920821|NCT00985686|3036131|P4|Overall Study|Lost to Follow-up|2
920822|NCT00985686|3036132|P3|Overall Study|Lost to Follow-up|0
920823|NCT00985686|3036133|P2|Overall Study|Lost to Follow-up|1
920824|NCT00985686|3036134|P1|Overall Study|Lost to Follow-up|1
920825|NCT00985673|3036148|P6|Overall Study|Other|0
920826|NCT00985673|3036149|P5|Overall Study|Other|1
920827|NCT00985673|3036150|P4|Overall Study|Other|0
920828|NCT00985673|3036151|P3|Overall Study|Other|1
920829|NCT00985673|3036152|P2|Overall Study|Other|0
920830|NCT00985673|3036153|P1|Overall Study|Other|1
920831|NCT00985673|3036148|P6|Overall Study|Withdrawal by Subject|3
920832|NCT00985673|3036149|P5|Overall Study|Withdrawal by Subject|2
920833|NCT00985673|3036150|P4|Overall Study|Withdrawal by Subject|2
920834|NCT00985673|3036151|P3|Overall Study|Withdrawal by Subject|5
920835|NCT00985673|3036152|P2|Overall Study|Withdrawal by Subject|4
920836|NCT00985673|3036153|P1|Overall Study|Withdrawal by Subject|0
920837|NCT00985673|3036148|P6|Overall Study|Lost to Follow-up|3
920838|NCT00985673|3036149|P5|Overall Study|Lost to Follow-up|5
920839|NCT00985673|3036150|P4|Overall Study|Lost to Follow-up|10
920840|NCT00985673|3036151|P3|Overall Study|Lost to Follow-up|6
920841|NCT00985673|3036152|P2|Overall Study|Lost to Follow-up|7
920842|NCT00985673|3036153|P1|Overall Study|Lost to Follow-up|6
920843|NCT00985504|3036415|P2|Optimization Period|Withdrawal by Subject|8
920844|NCT00985504|3036416|P1|Optimization Period|Withdrawal by Subject|10
920845|NCT00985504|3036415|P2|Optimization Period|Protocol Violation|1
920846|NCT00985504|3036416|P1|Optimization Period|Protocol Violation|3
920847|NCT00985504|3036415|P2|Optimization Period|Physician Decision|0
920848|NCT00985504|3036416|P1|Optimization Period|Physician Decision|1
920849|NCT00985504|3036415|P2|Optimization Period|Lost to Follow-up|1
920850|NCT00985504|3036416|P1|Optimization Period|Lost to Follow-up|0
920851|NCT00985504|3036415|P2|Optimization Period|Lack of Efficacy|3
920852|NCT00985504|3036416|P1|Optimization Period|Lack of Efficacy|5
920853|NCT00985504|3036415|P2|Optimization Period|Death|1
920854|NCT00985504|3036416|P1|Optimization Period|Death|0
920855|NCT00985504|3036415|P2|Optimization Period|Adverse Event|9
920856|NCT00985504|3036416|P1|Optimization Period|Adverse Event|7
920857|NCT00985504|3036415|P2|Acute Treatment Period|Withdrawal by Subject|5
920858|NCT00985504|3036416|P1|Acute Treatment Period|Withdrawal by Subject|9
920859|NCT00985504|3036415|P2|Acute Treatment Period|Sponsor Decision|1
920860|NCT00985504|3036416|P1|Acute Treatment Period|Sponsor Decision|0
920861|NCT00985504|3036415|P2|Acute Treatment Period|Protocol Violation|0
920862|NCT00985504|3036416|P1|Acute Treatment Period|Protocol Violation|2
920863|NCT00985504|3036415|P2|Acute Treatment Period|Entry Criteria Not Met|2
920864|NCT00985504|3036416|P1|Acute Treatment Period|Entry Criteria Not Met|1
920865|NCT00985504|3036415|P2|Acute Treatment Period|Adverse Event|4
920866|NCT00985504|3036416|P1|Acute Treatment Period|Adverse Event|3
920867|NCT00985491|3036442|P1|Overall Study|implant failure|3
920868|NCT00985491|3036442|P1|Overall Study|Withdrawal by Subject|1
920869|NCT00985491|3036442|P1|Overall Study|device migration|7
920870|NCT00985491|3036442|P1|Overall Study|Adverse Event|8
920871|NCT00985439|3036451|P4|Overall Study|Adverse Event|0
920872|NCT00985439|3036452|P3|Overall Study|Adverse Event|1
920873|NCT00985439|3036453|P2|Overall Study|Adverse Event|0
920874|NCT00985439|3036454|P1|Overall Study|Adverse Event|0
920875|NCT00985231|3036470|P2|Overall Study|Study related symptoms & complaints|2
920876|NCT00985231|3036471|P1|Overall Study|Study related symptoms & complaints|0
920877|NCT00985231|3036470|P2|Overall Study|Lost to Follow-up|1
920878|NCT00985231|3036471|P1|Overall Study|Lost to Follow-up|0
920879|NCT00985231|3036470|P2|Overall Study|Withdrawal by Subject|0
920880|NCT00985231|3036471|P1|Overall Study|Withdrawal by Subject|1
920881|NCT00985231|3036470|P2|Overall Study|Protocol Violation|0
920882|NCT00985231|3036471|P1|Overall Study|Protocol Violation|1
920883|NCT00985231|3036470|P2|Overall Study|ineligible|0
920884|NCT00985231|3036471|P1|Overall Study|ineligible|1
920885|NCT00985192|3036479|P1|Overall Study|Determined to be Ineligible During Trial|2
920886|NCT00985192|3036479|P1|Overall Study|Disease Progression|1
920887|NCT00985192|3036479|P1|Overall Study|Withdrawal by Subject|1
920888|NCT00985166|3036491|P3|Overall Study|Other|1
920889|NCT00985166|3036492|P2|Overall Study|Other|0
920890|NCT00985166|3036493|P1|Overall Study|Other|1
920891|NCT00985166|3036491|P3|Overall Study|Test not done|4
920892|NCT00985166|3036492|P2|Overall Study|Test not done|0
920893|NCT00985166|3036493|P1|Overall Study|Test not done|2
920894|NCT00985166|3036491|P3|Overall Study|Withdrawal by Subject|0
920895|NCT00985166|3036492|P2|Overall Study|Withdrawal by Subject|2
920896|NCT00985166|3036493|P1|Overall Study|Withdrawal by Subject|3
920897|NCT00985166|3036491|P3|Overall Study|Lost to Follow-up|2
920898|NCT00985166|3036492|P2|Overall Study|Lost to Follow-up|2
920899|NCT00985166|3036493|P1|Overall Study|Lost to Follow-up|3
920900|NCT00985153|3036513|P4|Overall Study|Incomplete Safety Follow-up|4
920901|NCT00985153|3036514|P3|Overall Study|Incomplete Safety Follow-up|4
920902|NCT00985153|3036515|P2|Overall Study|Incomplete Safety Follow-up|5
920903|NCT00985153|3036516|P1|Overall Study|Incomplete Safety Follow-up|3
920904|NCT00985153|3036513|P4|Overall Study|Missed One or More Bleeds|10
920905|NCT00985153|3036514|P3|Overall Study|Missed One or More Bleeds|8
920906|NCT00985153|3036515|P2|Overall Study|Missed One or More Bleeds|7
920907|NCT00985153|3036516|P1|Overall Study|Missed One or More Bleeds|7
920908|NCT00985153|3036513|P4|Overall Study|Withdrawal by Subject|10
920909|NCT00985153|3036514|P3|Overall Study|Withdrawal by Subject|11
920910|NCT00985153|3036515|P2|Overall Study|Withdrawal by Subject|11
920911|NCT00985153|3036516|P1|Overall Study|Withdrawal by Subject|6
920912|NCT00985153|3036513|P4|Overall Study|Protocol Violation|3
920913|NCT00985153|3036514|P3|Overall Study|Protocol Violation|4
920914|NCT00985153|3036515|P2|Overall Study|Protocol Violation|2
920915|NCT00985153|3036516|P1|Overall Study|Protocol Violation|3
920916|NCT00985153|3036513|P4|Overall Study|Lost to Follow-up|20
920917|NCT00985153|3036514|P3|Overall Study|Lost to Follow-up|17
920918|NCT00985153|3036515|P2|Overall Study|Lost to Follow-up|19
920919|NCT00985153|3036516|P1|Overall Study|Lost to Follow-up|16
920920|NCT00985114|3036564|P2|Overall Study|Withdrawal by Subject|2
920921|NCT00985114|3036565|P1|Overall Study|Withdrawal by Subject|0
920922|NCT00985114|3036564|P2|Overall Study|Adverse Event|0
920923|NCT00985114|3036565|P1|Overall Study|Adverse Event|1
920924|NCT00985088|3036579|P8|Overall Study|Lost to Follow-up|2
920925|NCT00985088|3036580|P7|Overall Study|Lost to Follow-up|3
920926|NCT00985088|3036581|P6|Overall Study|Lost to Follow-up|5
920927|NCT00985088|3036582|P5|Overall Study|Lost to Follow-up|6
920928|NCT00985088|3036583|P4|Overall Study|Lost to Follow-up|6
920929|NCT00985088|3036584|P3|Overall Study|Lost to Follow-up|2
920930|NCT00985088|3036585|P2|Overall Study|Lost to Follow-up|1
920931|NCT00985088|3036586|P1|Overall Study|Lost to Follow-up|6
920932|NCT00985088|3036579|P8|Overall Study|Migrated/moved from study area|1
920933|NCT00985088|3036580|P7|Overall Study|Migrated/moved from study area|0
920934|NCT00985088|3036581|P6|Overall Study|Migrated/moved from study area|0
920935|NCT00985088|3036582|P5|Overall Study|Migrated/moved from study area|0
920936|NCT00985088|3036583|P4|Overall Study|Migrated/moved from study area|0
920937|NCT00985088|3036584|P3|Overall Study|Migrated/moved from study area|1
920938|NCT00985088|3036585|P2|Overall Study|Migrated/moved from study area|0
920939|NCT00985088|3036586|P1|Overall Study|Migrated/moved from study area|0
920940|NCT00985088|3036579|P8|Overall Study|Withdrawal by Subject|2
920941|NCT00985088|3036580|P7|Overall Study|Withdrawal by Subject|1
920942|NCT00985088|3036581|P6|Overall Study|Withdrawal by Subject|2
920943|NCT00985088|3036582|P5|Overall Study|Withdrawal by Subject|3
920944|NCT00985088|3036583|P4|Overall Study|Withdrawal by Subject|1
920945|NCT00985088|3036584|P3|Overall Study|Withdrawal by Subject|0
920946|NCT00985088|3036585|P2|Overall Study|Withdrawal by Subject|0
920947|NCT00985088|3036586|P1|Overall Study|Withdrawal by Subject|4
920948|NCT00985088|3036579|P8|Overall Study|Adverse Event|0
920949|NCT00985088|3036580|P7|Overall Study|Adverse Event|0
920950|NCT00985088|3036581|P6|Overall Study|Adverse Event|0
920951|NCT00985088|3036582|P5|Overall Study|Adverse Event|0
920952|NCT00985088|3036583|P4|Overall Study|Adverse Event|0
920953|NCT00985088|3036584|P3|Overall Study|Adverse Event|1
920954|NCT00985088|3036585|P2|Overall Study|Adverse Event|0
920955|NCT00985088|3036586|P1|Overall Study|Adverse Event|0
920956|NCT00985088|3036579|P8|Overall Study|Serious Adverse Event|1
920957|NCT00985088|3036580|P7|Overall Study|Serious Adverse Event|0
920958|NCT00985088|3036581|P6|Overall Study|Serious Adverse Event|0
920959|NCT00985088|3036582|P5|Overall Study|Serious Adverse Event|0
920960|NCT00985088|3036583|P4|Overall Study|Serious Adverse Event|0
920961|NCT00985088|3036584|P3|Overall Study|Serious Adverse Event|0
920962|NCT00985088|3036585|P2|Overall Study|Serious Adverse Event|1
920963|NCT00985088|3036586|P1|Overall Study|Serious Adverse Event|1
920964|NCT00984867|3036855|P2|Overall Study|lack of efficacy and subject compliance|0
920965|NCT00984867|3036856|P1|Overall Study|lack of efficacy and subject compliance|1
920966|NCT00984867|3036855|P2|Overall Study|site closing|0
920967|NCT00984867|3036856|P1|Overall Study|site closing|1
920968|NCT00984867|3036855|P2|Overall Study|Subject no longer meets study criteria|1
920969|NCT00984867|3036856|P1|Overall Study|Subject no longer meets study criteria|1
920970|NCT00984867|3036855|P2|Overall Study|Poor/non-compliance|1
920971|NCT00984867|3036856|P1|Overall Study|Poor/non-compliance|0
920972|NCT00984867|3036855|P2|Overall Study|Lost to Follow-up|4
920973|NCT00984867|3036856|P1|Overall Study|Lost to Follow-up|3
920974|NCT00984867|3036855|P2|Overall Study|Withdrawal by Subject|4
920975|NCT00984867|3036856|P1|Overall Study|Withdrawal by Subject|13
920976|NCT00984867|3036855|P2|Overall Study|Death|0
920977|NCT00984867|3036856|P1|Overall Study|Death|1
920978|NCT00984867|3036855|P2|Overall Study|Adverse Event|7
920979|NCT00984867|3036856|P1|Overall Study|Adverse Event|3
920980|NCT00984659|3036896|P4|6-week Double-blind Treatment Period|Withdrawal by Subject|1
920981|NCT00984659|3036897|P3|6-week Double-blind Treatment Period|Withdrawal by Subject|7
920982|NCT00984659|3036898|P2|6-week Double-blind Treatment Period|Withdrawal by Subject|1
920983|NCT00984659|3036899|P1|6-week Double-blind Treatment Period|Withdrawal by Subject|0
920984|NCT00984659|3036896|P4|6-week Double-blind Treatment Period|Study Closed/Terminated|0
920985|NCT00984659|3036897|P3|6-week Double-blind Treatment Period|Study Closed/Terminated|1
920986|NCT00984659|3036898|P2|6-week Double-blind Treatment Period|Study Closed/Terminated|0
920987|NCT00984659|3036899|P1|6-week Double-blind Treatment Period|Study Closed/Terminated|0
920988|NCT00984659|3036896|P4|6-week Double-blind Treatment Period|Protocol Violation|4
920989|NCT00984659|3036897|P3|6-week Double-blind Treatment Period|Protocol Violation|0
920990|NCT00984659|3036898|P2|6-week Double-blind Treatment Period|Protocol Violation|0
920991|NCT00984659|3036899|P1|6-week Double-blind Treatment Period|Protocol Violation|0
920992|NCT00984659|3036896|P4|6-week Double-blind Treatment Period|Lack of Efficacy|1
920993|NCT00984659|3036897|P3|6-week Double-blind Treatment Period|Lack of Efficacy|0
920994|NCT00984659|3036898|P2|6-week Double-blind Treatment Period|Lack of Efficacy|2
920995|NCT00984659|3036899|P1|6-week Double-blind Treatment Period|Lack of Efficacy|0
920996|NCT00984659|3036896|P4|6-week Double-blind Treatment Period|Adverse Event|7
920997|NCT00984659|3036897|P3|6-week Double-blind Treatment Period|Adverse Event|3
920998|NCT00984659|3036898|P2|6-week Double-blind Treatment Period|Adverse Event|3
920999|NCT00984659|3036899|P1|6-week Double-blind Treatment Period|Adverse Event|0
921000|NCT00984659|3036896|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
921001|NCT00984659|3036897|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
921002|NCT00984659|3036898|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
921003|NCT00984659|3036899|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|14
921004|NCT00984659|3036896|P4|2-week Run-in Period|Withdrawal by Subject|0
921005|NCT00984659|3036897|P3|2-week Run-in Period|Withdrawal by Subject|0
921006|NCT00984659|3036898|P2|2-week Run-in Period|Withdrawal by Subject|0
921007|NCT00984659|3036899|P1|2-week Run-in Period|Withdrawal by Subject|10
921008|NCT00984659|3036896|P4|2-week Run-in Period|Physician Decision|0
921009|NCT00984659|3036897|P3|2-week Run-in Period|Physician Decision|0
921010|NCT00984659|3036898|P2|2-week Run-in Period|Physician Decision|0
921011|NCT00984659|3036899|P1|2-week Run-in Period|Physician Decision|10
921012|NCT00984659|3036896|P4|2-week Run-in Period|Lost to Follow-up|0
921013|NCT00984659|3036897|P3|2-week Run-in Period|Lost to Follow-up|0
921014|NCT00984659|3036898|P2|2-week Run-in Period|Lost to Follow-up|0
921015|NCT00984659|3036899|P1|2-week Run-in Period|Lost to Follow-up|3
921016|NCT00984659|3036896|P4|2-week Run-in Period|Study Closed/Terminated|0
921017|NCT00984659|3036897|P3|2-week Run-in Period|Study Closed/Terminated|0
921018|NCT00984659|3036898|P2|2-week Run-in Period|Study Closed/Terminated|0
921019|NCT00984659|3036899|P1|2-week Run-in Period|Study Closed/Terminated|2
921020|NCT00984659|3036896|P4|2-week Run-in Period|Protocol Violation|0
921021|NCT00984659|3036897|P3|2-week Run-in Period|Protocol Violation|0
921022|NCT00984659|3036898|P2|2-week Run-in Period|Protocol Violation|0
921023|NCT00984659|3036899|P1|2-week Run-in Period|Protocol Violation|5
921024|NCT00984659|3036896|P4|2-week Run-in Period|Adverse Event|0
921025|NCT00984659|3036897|P3|2-week Run-in Period|Adverse Event|0
921026|NCT00984659|3036898|P2|2-week Run-in Period|Adverse Event|0
921027|NCT00984659|3036899|P1|2-week Run-in Period|Adverse Event|8
921028|NCT00984620|3036926|P2|Overall Study|reason other than listed above|4
921029|NCT00984620|3036927|P1|Overall Study|reason other than listed above|0
921030|NCT00984620|3036926|P2|Overall Study|Withdrawal by Subject|2
921031|NCT00984620|3036927|P1|Overall Study|Withdrawal by Subject|0
921032|NCT00984620|3036926|P2|Overall Study|Lost to Follow-up|1
921033|NCT00984620|3036927|P1|Overall Study|Lost to Follow-up|1
921034|NCT00984620|3036926|P2|Overall Study|Adverse Event|5
921035|NCT00984620|3036927|P1|Overall Study|Adverse Event|5
921036|NCT00984594|3036965|P2|Overall Study|Withdrawal by Subject|1
921037|NCT00984594|3036966|P1|Overall Study|Withdrawal by Subject|0
921038|NCT00984594|3036965|P2|Overall Study|Lost to Follow-up|0
921039|NCT00984594|3036966|P1|Overall Study|Lost to Follow-up|1
921040|NCT00984568|3036982|P2|Overall Study|Unknown Reason|3
921041|NCT00984568|3036983|P1|Overall Study|Unknown Reason|1
921042|NCT00984568|3036982|P2|Overall Study|Opportunistic Infection|0
921043|NCT00984568|3036983|P1|Overall Study|Opportunistic Infection|1
921044|NCT00984568|3036982|P2|Overall Study|Lost to Follow-up|1
921045|NCT00984568|3036983|P1|Overall Study|Lost to Follow-up|0
921046|NCT00984568|3036982|P2|Overall Study|Did Not Meet Randomization Criteria|0
921047|NCT00984568|3036983|P1|Overall Study|Did Not Meet Randomization Criteria|1
921048|NCT00984568|3036982|P2|Overall Study|Adverse Event|0
921049|NCT00984568|3036983|P1|Overall Study|Adverse Event|2
921050|NCT00984568|3036982|P2|Overall Study|Lack of Efficacy|0
921051|NCT00984568|3036983|P1|Overall Study|Lack of Efficacy|2
921052|NCT00984568|3036982|P2|Overall Study|Withdrawal by Subject|2
921053|NCT00984568|3036983|P1|Overall Study|Withdrawal by Subject|1
921054|NCT00984542|3036991|P1|Overall Study|clinical deterioration|2
921055|NCT00984542|3036991|P1|Overall Study|Withdrawal by Subject|3
921056|NCT00984542|3036991|P1|Overall Study|complicating disease|3
921057|NCT00984542|3036991|P1|Overall Study|Death|7
921058|NCT00984542|3036991|P1|Overall Study|toxicity|7
921059|NCT00984542|3036991|P1|Overall Study|disease progression|19
921060|NCT00984295|3037041|P3|Overall Study|Incomplete safety follow-up|3
921061|NCT00984295|3037042|P2|Overall Study|Incomplete safety follow-up|2
921062|NCT00984295|3037043|P1|Overall Study|Incomplete safety follow-up|11
921063|NCT00984295|3037041|P3|Overall Study|Missed one or more blood samplings|2
921064|NCT00984295|3037042|P2|Overall Study|Missed one or more blood samplings|7
921065|NCT00984295|3037043|P1|Overall Study|Missed one or more blood samplings|3
921066|NCT00984295|3037041|P3|Overall Study|CAE – discontinued test vaccine|3
921067|NCT00984295|3037042|P2|Overall Study|CAE – discontinued test vaccine|1
921068|NCT00984295|3037043|P1|Overall Study|CAE – discontinued test vaccine|0
921069|NCT00984295|3037041|P3|Overall Study|Withdrawal by Subject|12
921070|NCT00984295|3037042|P2|Overall Study|Withdrawal by Subject|9
921071|NCT00984295|3037043|P1|Overall Study|Withdrawal by Subject|18
921072|NCT00984295|3037041|P3|Overall Study|Protocol Violation|4
921073|NCT00984295|3037042|P2|Overall Study|Protocol Violation|1
921074|NCT00984295|3037043|P1|Overall Study|Protocol Violation|2
921075|NCT00984295|3037041|P3|Overall Study|Lost to Follow-up|13
921076|NCT00984295|3037042|P2|Overall Study|Lost to Follow-up|12
921077|NCT00984295|3037043|P1|Overall Study|Lost to Follow-up|31
921078|NCT00984282|3037110|P2|Long Term Follow-up|Disease prog., recurrence or relapse|1
921079|NCT00984282|3037111|P1|Long Term Follow-up|Disease prog., recurrence or relapse|0
921080|NCT00984282|3037110|P2|Long Term Follow-up|Switched to commercial drug|2
921081|NCT00984282|3037111|P1|Long Term Follow-up|Switched to commercial drug|4
921082|NCT00984282|3037110|P2|Long Term Follow-up|Transferred to treat. continuation study|3
921083|NCT00984282|3037111|P1|Long Term Follow-up|Transferred to treat. continuation study|2
921084|NCT00984282|3037110|P2|Long Term Follow-up|Protocol driven decision point|26
921085|NCT00984282|3037111|P1|Long Term Follow-up|Protocol driven decision point|25
921086|NCT00984282|3037110|P2|Long Term Follow-up|Lost to Follow-up|6
921087|NCT00984282|3037111|P1|Long Term Follow-up|Lost to Follow-up|3
921088|NCT00984282|3037110|P2|Long Term Follow-up|Death|68
921089|NCT00984282|3037111|P1|Long Term Follow-up|Death|27
921090|NCT00984282|3037110|P2|Long Term Follow-up|Withdrawal by Subject|14
921091|NCT00984282|3037111|P1|Long Term Follow-up|Withdrawal by Subject|8
921092|NCT00984282|3037110|P2|Open-label Treatment|Physician Decision|0
921093|NCT00984282|3037111|P1|Open-label Treatment|Physician Decision|1
921094|NCT00984282|3037110|P2|Open-label Treatment|Switched to commercial drug|7
921095|NCT00984282|3037111|P1|Open-label Treatment|Switched to commercial drug|6
921096|NCT00984282|3037110|P2|Open-label Treatment|Transferred to treat. continuation study|3
921097|NCT00984282|3037111|P1|Open-label Treatment|Transferred to treat. continuation study|2
921098|NCT00984282|3037110|P2|Open-label Treatment|Protocol driven decision point|1
921099|NCT00984282|3037111|P1|Open-label Treatment|Protocol driven decision point|1
921100|NCT00984282|3037110|P2|Open-label Treatment|Target lesion removed|1
921101|NCT00984282|3037111|P1|Open-label Treatment|Target lesion removed|0
921102|NCT00984282|3037110|P2|Open-label Treatment|Non-compliant with study medication|0
921103|NCT00984282|3037111|P1|Open-label Treatment|Non-compliant with study medication|1
921104|NCT00984282|3037110|P2|Open-label Treatment|Patient convenience|0
921105|NCT00984282|3037111|P1|Open-label Treatment|Patient convenience|1
921106|NCT00984282|3037110|P2|Open-label Treatment|Lost to Follow-up|1
921107|NCT00984282|3037111|P1|Open-label Treatment|Lost to Follow-up|1
921108|NCT00984282|3037110|P2|Open-label Treatment|Progression, recurrence or relapse|82
921109|NCT00984282|3037111|P1|Open-label Treatment|Progression, recurrence or relapse|40
921110|NCT00984282|3037110|P2|Open-label Treatment|Death|15
921111|NCT00984282|3037111|P1|Open-label Treatment|Death|7
921112|NCT00984282|3037110|P2|Open-label Treatment|Withdrawal by Subject|21
921113|NCT00984282|3037111|P1|Open-label Treatment|Withdrawal by Subject|6
921114|NCT00984282|3037110|P2|Open-label Treatment|Adverse Event|30
921115|NCT00984282|3037111|P1|Open-label Treatment|Adverse Event|20
921116|NCT00984282|3037110|P2|Double Blind Treatment|Transferred to treat. continuation study|1
921117|NCT00984282|3037111|P1|Double Blind Treatment|Transferred to treat. continuation study|2
921118|NCT00984282|3037110|P2|Double Blind Treatment|Radiological and clinical progression|1
921119|NCT00984282|3037111|P1|Double Blind Treatment|Radiological and clinical progression|0
921120|NCT00984282|3037110|P2|Double Blind Treatment|protocol driven decision point|1
921121|NCT00984282|3037111|P1|Double Blind Treatment|protocol driven decision point|1
921122|NCT00984282|3037110|P2|Double Blind Treatment|Switched to commercial drug|1
921123|NCT00984282|3037111|P1|Double Blind Treatment|Switched to commercial drug|6
921124|NCT00984282|3037110|P2|Double Blind Treatment|Not treated|1
921125|NCT00984282|3037111|P1|Double Blind Treatment|Not treated|0
921126|NCT00984282|3037110|P2|Double Blind Treatment|Death|4
921127|NCT00984282|3037111|P1|Double Blind Treatment|Death|8
921128|NCT00984282|3037110|P2|Double Blind Treatment|Lost to Follow-up|0
921129|NCT00984282|3037111|P1|Double Blind Treatment|Lost to Follow-up|3
921130|NCT00984282|3037110|P2|Double Blind Treatment|Withdrawal by Subject|18
921131|NCT00984282|3037111|P1|Double Blind Treatment|Withdrawal by Subject|13
921132|NCT00984282|3037110|P2|Double Blind Treatment|Progression by clinical judgment|0
921133|NCT00984282|3037111|P1|Double Blind Treatment|Progression by clinical judgment|2
921134|NCT00984282|3037110|P2|Double Blind Treatment|Noncompliance with study medication|0
921135|NCT00984282|3037111|P1|Double Blind Treatment|Noncompliance with study medication|3
921136|NCT00984282|3037110|P2|Double Blind Treatment|Physician Decision|2
921137|NCT00984282|3037111|P1|Double Blind Treatment|Physician Decision|1
921138|NCT00984282|3037110|P2|Double Blind Treatment|Progression, recurrence or relapse|3
921139|NCT00984282|3037111|P1|Double Blind Treatment|Progression, recurrence or relapse|25
921140|NCT00984282|3037110|P2|Double Blind Treatment|Adverse Event|6
921141|NCT00984282|3037111|P1|Double Blind Treatment|Adverse Event|40
921142|NCT00984256|3037134|P2|Overall Study|Withdrawal by Subject|1
921143|NCT00984256|3037135|P1|Overall Study|Withdrawal by Subject|0
921144|NCT00984204|3037155|P1|Overall Study|Lack of Efficacy|10
921145|NCT00984204|3037155|P1|Overall Study|Lost to Follow-up|4
921146|NCT00984204|3037155|P1|Overall Study|Death|1
921147|NCT00984165|3037165|P4|Overall Study|removed with a pair recipient|1
921148|NCT00984165|3037166|P3|Overall Study|removed with a pair recipient|0
921149|NCT00984165|3037167|P2|Overall Study|removed with a pair recipient|0
921150|NCT00984165|3037168|P1|Overall Study|removed with a pair recipient|0
921151|NCT00984165|3037165|P4|Overall Study|P+/donor pair removed from protocol|1
921152|NCT00984165|3037166|P3|Overall Study|P+/donor pair removed from protocol|0
921153|NCT00984165|3037167|P2|Overall Study|P+/donor pair removed from protocol|0
921154|NCT00984165|3037168|P1|Overall Study|P+/donor pair removed from protocol|0
921155|NCT00984165|3037165|P4|Overall Study|New protocol|1
921156|NCT00984165|3037166|P3|Overall Study|New protocol|0
921157|NCT00984165|3037167|P2|Overall Study|New protocol|0
921158|NCT00984165|3037168|P1|Overall Study|New protocol|0
921159|NCT00984165|3037165|P4|Overall Study|Death of recipient|1
921160|NCT00984165|3037166|P3|Overall Study|Death of recipient|0
921161|NCT00984165|3037167|P2|Overall Study|Death of recipient|0
921162|NCT00984165|3037168|P1|Overall Study|Death of recipient|0
921163|NCT00984165|3037165|P4|Overall Study|Disease progression on study|0
921164|NCT00984165|3037166|P3|Overall Study|Disease progression on study|0
921165|NCT00984165|3037167|P2|Overall Study|Disease progression on study|1
921166|NCT00984165|3037168|P1|Overall Study|Disease progression on study|5
921167|NCT00984165|3037165|P4|Overall Study|Death on study|0
921168|NCT00984165|3037166|P3|Overall Study|Death on study|0
921169|NCT00984165|3037167|P2|Overall Study|Death on study|0
921170|NCT00984165|3037168|P1|Overall Study|Death on study|2
921171|NCT00984126|3037197|P4|Overall Study|Withdrawal criteria|9
921172|NCT00984126|3037198|P3|Overall Study|Withdrawal criteria|3
921173|NCT00984126|3037199|P2|Overall Study|Withdrawal criteria|1
921174|NCT00984126|3037200|P1|Overall Study|Withdrawal criteria|0
921175|NCT00984126|3037197|P4|Overall Study|Choose to join Pathfinder trial™ + other|46
921176|NCT00984126|3037198|P3|Overall Study|Choose to join Pathfinder trial™ + other|3
921177|NCT00984126|3037199|P2|Overall Study|Choose to join Pathfinder trial™ + other|7
921178|NCT00984126|3037200|P1|Overall Study|Choose to join Pathfinder trial™ + other|7
921179|NCT00984126|3037197|P4|Overall Study|Adverse Event|2
921180|NCT00984126|3037198|P3|Overall Study|Adverse Event|0
921181|NCT00984126|3037199|P2|Overall Study|Adverse Event|0
921182|NCT00984126|3037200|P1|Overall Study|Adverse Event|0
921183|NCT00984126|3037197|P4|Overall Study|Protocol Violation|2
921184|NCT00984126|3037198|P3|Overall Study|Protocol Violation|1
921185|NCT00984126|3037199|P2|Overall Study|Protocol Violation|0
921186|NCT00984126|3037200|P1|Overall Study|Protocol Violation|0
921187|NCT00984061|3037225|P1|Clarithromycin Alone|Protocol Violation|1
921188|NCT00984022|3037238|P2|Overall Study|Lost to Follow-up|14
921189|NCT00984022|3037239|P1|Overall Study|Lost to Follow-up|10
921190|NCT00984009|3037249|P1|Grapefruit Juice Alone|missed serving of grapefruit juice|1
921191|NCT00983957|3037282|P1|Overall Study|Personal Reasons|1
921192|NCT00983957|3037282|P1|Overall Study|Adverse Event|1
921193|NCT00983931|3037316|P1|14 Day Washout Period|Physician Decision|1
921194|NCT00983918|3037330|P4|Overall Study|conversion to open cholecystectomy|2
921195|NCT00983918|3037331|P3|Overall Study|conversion to open cholecystectomy|2
921196|NCT00983918|3037332|P2|Overall Study|conversion to open cholecystectomy|2
921197|NCT00983918|3037333|P1|Overall Study|conversion to open cholecystectomy|0
921198|NCT00983905|3037343|P1|Colchicine Alone|Adverse Event|2
921199|NCT00983905|3037343|P1|Theophylline Alone|Adverse Event|1
921200|NCT00983892|3037356|P2|Overall Study|Withdrawal by Subject|12
921201|NCT00983892|3037357|P1|Overall Study|Withdrawal by Subject|10
921202|NCT00983853|3037369|P6|Overall Study|Unable to come to study follow-up visits|0
921203|NCT00983853|3037370|P5|Overall Study|Unable to come to study follow-up visits|0
921204|NCT00983853|3037371|P4|Overall Study|Unable to come to study follow-up visits|0
921205|NCT00983853|3037372|P3|Overall Study|Unable to come to study follow-up visits|0
921206|NCT00983853|3037373|P2|Overall Study|Unable to come to study follow-up visits|1
921207|NCT00983853|3037374|P1|Overall Study|Unable to come to study follow-up visits|0
921208|NCT00983853|3037369|P6|Overall Study|Withdrawal by Subject|0
921209|NCT00983853|3037370|P5|Overall Study|Withdrawal by Subject|1
921210|NCT00983853|3037371|P4|Overall Study|Withdrawal by Subject|0
921211|NCT00983853|3037372|P3|Overall Study|Withdrawal by Subject|1
921212|NCT00983853|3037373|P2|Overall Study|Withdrawal by Subject|0
921213|NCT00983853|3037374|P1|Overall Study|Withdrawal by Subject|0
921214|NCT00983853|3037369|P6|Overall Study|Lost to Follow-up|1
921215|NCT00983853|3037370|P5|Overall Study|Lost to Follow-up|2
921216|NCT00983853|3037371|P4|Overall Study|Lost to Follow-up|2
921217|NCT00983853|3037372|P3|Overall Study|Lost to Follow-up|2
921218|NCT00983853|3037373|P2|Overall Study|Lost to Follow-up|1
921219|NCT00983853|3037374|P1|Overall Study|Lost to Follow-up|1
921220|NCT00983827|3037402|P1|Overall Study|Withdrawal by Subject|1
921221|NCT00983749|3037420|P2|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3
921222|NCT00983749|3037421|P1|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1
921223|NCT00983580|3037446|P2|Overall Study|Ineligible|0
921224|NCT00983580|3037447|P1|Overall Study|Ineligible|3
921225|NCT00983580|3037446|P2|Overall Study|Protocol Violation|1
921226|NCT00983580|3037447|P1|Overall Study|Protocol Violation|1
921227|NCT00983580|3037446|P2|Overall Study|Cancel Prior to treatment|3
921228|NCT00983580|3037447|P1|Overall Study|Cancel Prior to treatment|1
921229|NCT00983515|3037473|P1|Colchicine With Ritonavir|Lost to Follow-up|1
921230|NCT00983515|3037473|P1|Ritonavir Alone|liver panel out of range|6
921231|NCT00983476|3037500|P3|Overall Study|Did not receive intervention|0
921232|NCT00983476|3037501|P2|Overall Study|Did not receive intervention|22
921233|NCT00983476|3037502|P1|Overall Study|Did not receive intervention|17
921234|NCT00983437|3037534|P1|Overall Study|Other Reason|26
921235|NCT00983437|3037534|P1|Overall Study|Lost to Follow-up|2
921236|NCT00983437|3037534|P1|Overall Study|Noncompliance to Study Procedures|1
921237|NCT00983437|3037534|P1|Overall Study|Withdrawal by Subject|8
921238|NCT00983437|3037534|P1|Overall Study|Lack of Efficacy|1
921239|NCT00983437|3037534|P1|Overall Study|Adverse Event|9
921240|NCT00983385|3037553|P1|Observation Period|Not Evaluable due to Non Compliance|12
921241|NCT00983385|3037553|P1|Observation Period|Not eligible to be dosed|20
921242|NCT00983372|3037598|P1|Diltiazem ER Alone|Adverse Event|1
921243|NCT00983372|3037598|P1|Diltiazem ER Alone|missed diltiazem dose|2
921244|NCT00983372|3037598|P1|14 Day Washout Period|Withdrawal by Subject|1
921245|NCT00983294|3037625|P1|Colchicine With Azithromycin|Adverse Event|1
921246|NCT00983294|3037625|P1|14 Day Washout Period|Withdrawal by Subject|2
921247|NCT00983073|3037667|P1|Maintenance Period|Other Reason|7
921248|NCT00983073|3037667|P1|Maintenance Period|Lack of Efficacy|2
921249|NCT00983073|3037667|P1|Maintenance Period|Withdrawal by Subject|2
921250|NCT00983073|3037667|P1|Maintenance Period|Adverse Event|5
921251|NCT00983073|3037667|P1|Titration and Optimal Dose Period|Other reason|4
921252|NCT00983073|3037667|P1|Titration and Optimal Dose Period|Non-Compliance|1
921253|NCT00983073|3037667|P1|Titration and Optimal Dose Period|Lack of Efficacy|5
921254|NCT00983073|3037667|P1|Titration and Optimal Dose Period|Withdrawal by Subject|11
921255|NCT00983073|3037667|P1|Titration and Optimal Dose Period|Adverse Event|19
921256|NCT00982735|3037986|P1|Overall Study|Patient ineligible for trial|224
921257|NCT00982735|3037986|P1|Overall Study|Lost to Follow-up|6
921258|NCT00982657|3037996|P4|Overall Study|On going at date of cut-off|1
921259|NCT00982657|3037997|P3|Overall Study|On going at date of cut-off|0
921260|NCT00982657|3037998|P2|Overall Study|On going at date of cut-off|0
921261|NCT00982657|3037999|P1|Overall Study|On going at date of cut-off|0
921262|NCT00982657|3037996|P4|Overall Study|Other|4
921263|NCT00982657|3037997|P3|Overall Study|Other|0
921264|NCT00982657|3037998|P2|Overall Study|Other|0
921265|NCT00982657|3037999|P1|Overall Study|Other|0
921266|NCT00982657|3037996|P4|Overall Study|Withdrawal by Subject|3
921267|NCT00982657|3037997|P3|Overall Study|Withdrawal by Subject|1
921268|NCT00982657|3037998|P2|Overall Study|Withdrawal by Subject|0
921269|NCT00982657|3037999|P1|Overall Study|Withdrawal by Subject|0
921270|NCT00982657|3037996|P4|Overall Study|Death|1
921271|NCT00982657|3037997|P3|Overall Study|Death|1
921272|NCT00982657|3037998|P2|Overall Study|Death|0
921273|NCT00982657|3037999|P1|Overall Study|Death|1
921274|NCT00982644|3038040|P2|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7
921275|NCT00982644|3038041|P1|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23
921276|NCT00982644|3038040|P2|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3
921277|NCT00982644|3038041|P1|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6
921278|NCT00982644|3038040|P2|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4
921279|NCT00982644|3038041|P1|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2
921280|NCT00982644|3038040|P2|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1
921281|NCT00982644|3038041|P1|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3
921282|NCT00982644|3038040|P2|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5
921283|NCT00982644|3038041|P1|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12
921284|NCT00982644|3038040|P2|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30
921285|NCT00982644|3038041|P1|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84
921286|NCT00982644|3038040|P2|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5
921287|NCT00982644|3038041|P1|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9
921288|NCT00982644|3038040|P2|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18
921289|NCT00982644|3038041|P1|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46
921290|NCT00982644|3038040|P2|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2
921291|NCT00982644|3038041|P1|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7
921292|NCT00982644|3038040|P2|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5
921293|NCT00982644|3038041|P1|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20
921294|NCT00982488|3038092|P5|Overall Study|Withdrawal by Subject|0
921295|NCT00982488|3038093|P4|Overall Study|Withdrawal by Subject|0
921296|NCT00982488|3038094|P3|Overall Study|Withdrawal by Subject|1
921297|NCT00982488|3038095|P2|Overall Study|Withdrawal by Subject|1
921298|NCT00982488|3038096|P1|Overall Study|Withdrawal by Subject|5
921299|NCT00982488|3038092|P5|Overall Study|Study drug toxicity|0
921300|NCT00982488|3038093|P4|Overall Study|Study drug toxicity|0
921301|NCT00982488|3038094|P3|Overall Study|Study drug toxicity|6
921302|NCT00982488|3038095|P2|Overall Study|Study drug toxicity|1
921303|NCT00982488|3038096|P1|Overall Study|Study drug toxicity|34
921304|NCT00982488|3038092|P5|Overall Study|Stem cell transplant|0
921305|NCT00982488|3038093|P4|Overall Study|Stem cell transplant|1
921306|NCT00982488|3038094|P3|Overall Study|Stem cell transplant|0
921307|NCT00982488|3038095|P2|Overall Study|Stem cell transplant|0
921308|NCT00982488|3038096|P1|Overall Study|Stem cell transplant|2
921309|NCT00982488|3038092|P5|Overall Study|Poor compliance/noncompliance|0
921310|NCT00982488|3038093|P4|Overall Study|Poor compliance/noncompliance|0
921311|NCT00982488|3038094|P3|Overall Study|Poor compliance/noncompliance|0
921312|NCT00982488|3038095|P2|Overall Study|Poor compliance/noncompliance|1
921313|NCT00982488|3038096|P1|Overall Study|Poor compliance/noncompliance|0
921314|NCT00982488|3038092|P5|Overall Study|Not specified|0
921315|NCT00982488|3038093|P4|Overall Study|Not specified|1
921316|NCT00982488|3038094|P3|Overall Study|Not specified|3
921317|NCT00982488|3038095|P2|Overall Study|Not specified|1
921318|NCT00982488|3038096|P1|Overall Study|Not specified|15
921319|NCT00982488|3038092|P5|Overall Study|Maximum clinical benefit|0
921320|NCT00982488|3038093|P4|Overall Study|Maximum clinical benefit|0
921321|NCT00982488|3038094|P3|Overall Study|Maximum clinical benefit|1
921322|NCT00982488|3038095|P2|Overall Study|Maximum clinical benefit|1
921323|NCT00982488|3038096|P1|Overall Study|Maximum clinical benefit|1
921324|NCT00982488|3038092|P5|Overall Study|Lost to Follow-up|0
921325|NCT00982488|3038093|P4|Overall Study|Lost to Follow-up|0
921326|NCT00982488|3038094|P3|Overall Study|Lost to Follow-up|0
921327|NCT00982488|3038095|P2|Overall Study|Lost to Follow-up|0
921328|NCT00982488|3038096|P1|Overall Study|Lost to Follow-up|1
921329|NCT00982488|3038092|P5|Overall Study|Disease progression|1
921330|NCT00982488|3038093|P4|Overall Study|Disease progression|1
921331|NCT00982488|3038094|P3|Overall Study|Disease progression|10
921332|NCT00982488|3038095|P2|Overall Study|Disease progression|5
921333|NCT00982488|3038096|P1|Overall Study|Disease progression|30
921334|NCT00982488|3038092|P5|Overall Study|Death|0
921335|NCT00982488|3038093|P4|Overall Study|Death|0
921336|NCT00982488|3038094|P3|Overall Study|Death|2
921337|NCT00982488|3038095|P2|Overall Study|Death|0
921338|NCT00982488|3038096|P1|Overall Study|Death|11
921339|NCT00982488|3038092|P5|Overall Study|Adverse event unrelated to study drug|0
921340|NCT00982488|3038093|P4|Overall Study|Adverse event unrelated to study drug|0
921341|NCT00982488|3038094|P3|Overall Study|Adverse event unrelated to study drug|0
921342|NCT00982488|3038095|P2|Overall Study|Adverse event unrelated to study drug|1
921343|NCT00982488|3038096|P1|Overall Study|Adverse event unrelated to study drug|5
921344|NCT00982488|3038092|P5|Overall Study|Administrative reason by sponsor|0
921345|NCT00982488|3038093|P4|Overall Study|Administrative reason by sponsor|0
921346|NCT00982488|3038094|P3|Overall Study|Administrative reason by sponsor|11
921347|NCT00982488|3038095|P2|Overall Study|Administrative reason by sponsor|3
921348|NCT00982488|3038096|P1|Overall Study|Administrative reason by sponsor|81
921349|NCT00982410|3038129|P2|12-month Follow-up Assessment|scheduled, no-show|0
921350|NCT00982410|3038130|P1|12-month Follow-up Assessment|scheduled, no-show|1
921351|NCT00982410|3038129|P2|12-month Follow-up Assessment|incarceration|1
921352|NCT00982410|3038130|P1|12-month Follow-up Assessment|incarceration|2
921353|NCT00982410|3038129|P2|12-month Follow-up Assessment|Withdrawal by Subject|1
921354|NCT00982410|3038130|P1|12-month Follow-up Assessment|Withdrawal by Subject|0
921355|NCT00982410|3038129|P2|12-month Follow-up Assessment|could not reach to schedule|5
921356|NCT00982410|3038130|P1|12-month Follow-up Assessment|could not reach to schedule|6
921357|NCT00982410|3038129|P2|12-month Follow-up Assessment|Death|2
921358|NCT00982410|3038130|P1|12-month Follow-up Assessment|Death|0
921359|NCT00982410|3038129|P2|6-month Follow-up Assessment|scheduled, no-show|1
921360|NCT00982410|3038130|P1|6-month Follow-up Assessment|scheduled, no-show|0
921361|NCT00982410|3038129|P2|6-month Follow-up Assessment|patent surgery|1
921362|NCT00982410|3038130|P1|6-month Follow-up Assessment|patent surgery|0
921363|NCT00982410|3038129|P2|6-month Follow-up Assessment|incarceration|2
921364|NCT00982410|3038130|P1|6-month Follow-up Assessment|incarceration|0
921365|NCT00982410|3038129|P2|6-month Follow-up Assessment|participant no transportation|0
921366|NCT00982410|3038130|P1|6-month Follow-up Assessment|participant no transportation|1
921367|NCT00982410|3038129|P2|6-month Follow-up Assessment|Could not reach to schedule|7
921368|NCT00982410|3038130|P1|6-month Follow-up Assessment|Could not reach to schedule|5
921369|NCT00982410|3038129|P2|3-month Follow-up Assessment|Withdrawal by Subject|2
921370|NCT00982410|3038130|P1|3-month Follow-up Assessment|Withdrawal by Subject|0
921371|NCT00982410|3038129|P2|3-month Follow-up Assessment|Scheduled, no-show|2
921372|NCT00982410|3038130|P1|3-month Follow-up Assessment|Scheduled, no-show|1
921373|NCT00982410|3038129|P2|3-month Follow-up Assessment|Could not reach to schedule|9
921374|NCT00982410|3038130|P1|3-month Follow-up Assessment|Could not reach to schedule|8
921375|NCT00982319|3038171|P2|Overall Study|Pregnancy|1
921376|NCT00982319|3038172|P1|Overall Study|Pregnancy|0
921377|NCT00982319|3038171|P2|Overall Study|Preop values out of acceptable range|1
921378|NCT00982319|3038172|P1|Overall Study|Preop values out of acceptable range|1
921379|NCT00982319|3038171|P2|Overall Study|Surgery date change|0
921380|NCT00982319|3038172|P1|Overall Study|Surgery date change|1
921381|NCT00982280|3038180|P1|Maintenance Period|Adverse Event|1
921382|NCT00982280|3038180|P1|Titration and Optimal Dose Period|Withdrawal by Subject|1
921383|NCT00982280|3038180|P1|Titration and Optimal Dose Period|Lack of Efficacy|2
921384|NCT00982280|3038180|P1|Titration and Optimal Dose Period|Adverse Event|5
921385|NCT00982280|3038180|P1|Observation Period|Not eligible to be dosed|19
921386|NCT00982228|3038205|P2|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1
921387|NCT00982228|3038206|P1|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11
921388|NCT00982228|3038205|P2|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0
921389|NCT00982228|3038206|P1|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5
921390|NCT00982228|3038205|P2|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2
921391|NCT00982228|3038206|P1|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1
921392|NCT00982228|3038205|P2|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0
921393|NCT00982228|3038206|P1|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1
921394|NCT00982228|3038205|P2|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2
921395|NCT00982228|3038206|P1|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3
921396|NCT00982228|3038205|P2|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13
921397|NCT00982228|3038206|P1|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28
921398|NCT00982228|3038205|P2|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3
921399|NCT00982228|3038206|P1|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15
921400|NCT00982228|3038205|P2|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2
921401|NCT00982228|3038206|P1|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11
921402|NCT00982228|3038205|P2|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0
921403|NCT00982228|3038206|P1|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2
921404|NCT00982228|3038205|P2|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2
921405|NCT00982228|3038206|P1|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12
921406|NCT00982137|3038265|P4|Overall Study|Withdrawal by Subject|0
921407|NCT00982137|3038266|P3|Overall Study|Withdrawal by Subject|0
921408|NCT00982137|3038267|P2|Overall Study|Withdrawal by Subject|1
921409|NCT00982137|3038268|P1|Overall Study|Withdrawal by Subject|0
921410|NCT00982137|3038265|P4|Overall Study|Lost to Follow-up|1
921411|NCT00982137|3038266|P3|Overall Study|Lost to Follow-up|0
921412|NCT00982137|3038267|P2|Overall Study|Lost to Follow-up|0
921413|NCT00982137|3038268|P1|Overall Study|Lost to Follow-up|0
921414|NCT00982111|3038300|P2|Overall Study|Withdrawal by Subject|17
921415|NCT00982111|3038301|P1|Overall Study|Withdrawal by Subject|16
921416|NCT00982111|3038300|P2|Overall Study|On Study Treatment at Conclusion|0
921417|NCT00982111|3038301|P1|Overall Study|On Study Treatment at Conclusion|7
921418|NCT00982111|3038300|P2|Overall Study|New Anti-Cancer Therapy|5
921419|NCT00982111|3038301|P1|Overall Study|New Anti-Cancer Therapy|5
921420|NCT00982111|3038300|P2|Overall Study|Lost to Follow-up|6
921421|NCT00982111|3038301|P1|Overall Study|Lost to Follow-up|9
921422|NCT00982111|3038300|P2|Overall Study|Progressive Disease|37
921423|NCT00982111|3038301|P1|Overall Study|Progressive Disease|37
921424|NCT00982111|3038300|P2|Overall Study|Adverse Event|1
921425|NCT00982111|3038301|P1|Overall Study|Adverse Event|1
921426|NCT00982020|3038334|P2|Overall Study|Clinical Relapse|1
921427|NCT00982020|3038335|P1|Overall Study|Clinical Relapse|0
921428|NCT00982020|3038334|P2|Overall Study|Protocol Violation|2
921429|NCT00982020|3038335|P1|Overall Study|Protocol Violation|0
921430|NCT00982020|3038334|P2|Overall Study|Entry Criteria Not Met|1
921431|NCT00982020|3038335|P1|Overall Study|Entry Criteria Not Met|2
921432|NCT00982020|3038334|P2|Overall Study|Physician Decision|5
921433|NCT00982020|3038335|P1|Overall Study|Physician Decision|2
921434|NCT00982020|3038334|P2|Overall Study|Treatment Non-compliance|6
921435|NCT00982020|3038335|P1|Overall Study|Treatment Non-compliance|3
921436|NCT00982020|3038334|P2|Overall Study|Parent/Caregiver Decision|5
921437|NCT00982020|3038335|P1|Overall Study|Parent/Caregiver Decision|5
921438|NCT00982020|3038334|P2|Overall Study|Lack of Efficacy|4
921439|NCT00982020|3038335|P1|Overall Study|Lack of Efficacy|10
921440|NCT00982020|3038334|P2|Overall Study|Lost to Follow-up|11
921441|NCT00982020|3038335|P1|Overall Study|Lost to Follow-up|5
921442|NCT00982020|3038334|P2|Overall Study|Withdrawal by Subject|14
921443|NCT00982020|3038335|P1|Overall Study|Withdrawal by Subject|11
921444|NCT00982020|3038334|P2|Overall Study|Adverse Event|15
921445|NCT00982020|3038335|P1|Overall Study|Adverse Event|19
921446|NCT00981747|3038385|P1|Placebo Oral Tablet|Withdrawal by Subject|1
921447|NCT00981747|3038385|P1|Losartan|Death|1
921448|NCT00981747|3038385|P1|Losartan|Withdrawal by Subject|1
921449|NCT00981526|3038453|P2|Overall Study|Physician Decision|4
921450|NCT00981526|3038454|P1|Overall Study|Physician Decision|4
921451|NCT00981526|3038453|P2|Overall Study|Withdrawal by Subject|2
921452|NCT00981526|3038454|P1|Overall Study|Withdrawal by Subject|0
921453|NCT00981461|3038472|P2|Overall Study|Lost to Follow-up|2
921454|NCT00981461|3038473|P1|Overall Study|Lost to Follow-up|5
921455|NCT00981409|3038497|P2|Overall Study|Prostate Cancer Treatment before Trial|0
921456|NCT00981409|3038498|P1|Overall Study|Prostate Cancer Treatment before Trial|2
921457|NCT00981409|3038497|P2|Overall Study|Protocol Violation|1
921458|NCT00981409|3038498|P1|Overall Study|Protocol Violation|0
921459|NCT00981409|3038497|P2|Overall Study|Adverse Event|0
921460|NCT00981409|3038498|P1|Overall Study|Adverse Event|4
921461|NCT00981292|3038537|P6|Day 3|Protocol Violation|1
921462|NCT00981292|3038538|P5|Day 3|Protocol Violation|0
921463|NCT00981292|3038539|P4|Day 3|Protocol Violation|0
921464|NCT00981292|3038540|P3|Day 3|Protocol Violation|0
921465|NCT00981292|3038541|P2|Day 3|Protocol Violation|0
921466|NCT00981292|3038542|P1|Day 3|Protocol Violation|0
921467|NCT00981292|3038537|P6|Day 2|Protocol Violation|0
921468|NCT00981292|3038538|P5|Day 2|Protocol Violation|0
921469|NCT00981292|3038539|P4|Day 2|Protocol Violation|0
921470|NCT00981292|3038540|P3|Day 2|Protocol Violation|0
921471|NCT00981292|3038541|P2|Day 2|Protocol Violation|0
921472|NCT00981292|3038542|P1|Day 2|Protocol Violation|2
921473|NCT00981292|3038537|P6|Day 1|Protocol Violation|2
921474|NCT00981292|3038538|P5|Day 1|Protocol Violation|0
921475|NCT00981292|3038539|P4|Day 1|Protocol Violation|0
921476|NCT00981292|3038540|P3|Day 1|Protocol Violation|0
921477|NCT00981292|3038541|P2|Day 1|Protocol Violation|0
921478|NCT00981292|3038542|P1|Day 1|Protocol Violation|1
921479|NCT00981175|3038626|P2|Booster Dose Vaccination|Lost to Follow-up|3
921480|NCT00981175|3038627|P1|Booster Dose Vaccination|Lost to Follow-up|2
921481|NCT00981175|3038626|P2|Primary Dose Vaccination|Lost to Follow-up|1
921482|NCT00981175|3038627|P1|Primary Dose Vaccination|Lost to Follow-up|2
921483|NCT00981175|3038626|P2|Primary Dose Vaccination|Protocol Violation|1
921484|NCT00981175|3038627|P1|Primary Dose Vaccination|Protocol Violation|0
921485|NCT00981175|3038626|P2|Primary Dose Vaccination|Adverse Event|0
921486|NCT00981175|3038627|P1|Primary Dose Vaccination|Adverse Event|1
921487|NCT00981149|3038652|P2|Overall Study|Withdrawal by Subject|1
921488|NCT00981149|3038653|P1|Overall Study|Withdrawal by Subject|1
921489|NCT00981149|3038652|P2|Overall Study|Lost to Follow-up|2
921490|NCT00981149|3038653|P1|Overall Study|Lost to Follow-up|1
921491|NCT00981084|3038663|P2|Post Intervention (Data Analysis)|imbalance in disease subtype|0
921492|NCT00981084|3038664|P1|Post Intervention (Data Analysis)|imbalance in disease subtype|1
921493|NCT00981084|3038663|P2|Post Intervention (Data Analysis)|poor effort|1
921494|NCT00981084|3038664|P1|Post Intervention (Data Analysis)|poor effort|1
921495|NCT00981058|3038680|P2|Overall Study|On study treatment at conclusion|0
921496|NCT00981058|3038681|P1|Overall Study|On study treatment at conclusion|9
921497|NCT00981058|3038680|P2|Overall Study|Withdrawal by Subject|23
921498|NCT00981058|3038681|P1|Overall Study|Withdrawal by Subject|25
921499|NCT00981058|3038680|P2|Overall Study|Randomization Error|2
921500|NCT00981058|3038681|P1|Overall Study|Randomization Error|1
921501|NCT00981058|3038680|P2|Overall Study|Radiologist Error|1
921502|NCT00981058|3038681|P1|Overall Study|Radiologist Error|0
921503|NCT00981058|3038680|P2|Overall Study|Noncompliance|0
921504|NCT00981058|3038681|P1|Overall Study|Noncompliance|1
921505|NCT00981058|3038680|P2|Overall Study|New Anticancer Therapy|6
921506|NCT00981058|3038681|P1|Overall Study|New Anticancer Therapy|6
921507|NCT00981058|3038680|P2|Overall Study|Lost to Follow-up|15
921508|NCT00981058|3038681|P1|Overall Study|Lost to Follow-up|16
921509|NCT00981058|3038680|P2|Overall Study|Progressive Disease|49
921510|NCT00981058|3038681|P1|Overall Study|Progressive Disease|61
921511|NCT00981058|3038680|P2|Overall Study|Adverse Event|1
921512|NCT00981058|3038681|P1|Overall Study|Adverse Event|1
921513|NCT00981019|3038712|P1|Overall Study|Hit the survey after closure|79
921514|NCT00981019|3038712|P1|Overall Study|Inadvertent exclusion|239
921515|NCT00981019|3038712|P1|Overall Study|Did not match target population|94
921516|NCT00981019|3038712|P1|Overall Study|Did not respond|65
921517|NCT00980980|3038719|P3|Overall Study|Withdrawal by Hospital|0
921518|NCT00980980|3038720|P2|Overall Study|Withdrawal by Hospital|1
921519|NCT00980980|3038721|P1|Overall Study|Withdrawal by Hospital|0
921520|NCT00980798|3038752|P2|Overall Study|Other|1
921521|NCT00980798|3038753|P1|Overall Study|Other|0
921522|NCT00980798|3038752|P2|Overall Study|Withdrawal by Subject|11
921523|NCT00980798|3038753|P1|Overall Study|Withdrawal by Subject|8
921524|NCT00980798|3038752|P2|Overall Study|Physician Decision|1
921525|NCT00980798|3038753|P1|Overall Study|Physician Decision|2
921526|NCT00980798|3038752|P2|Overall Study|Lost to Follow-up|1
921527|NCT00980798|3038753|P1|Overall Study|Lost to Follow-up|0
921528|NCT00980798|3038752|P2|Overall Study|Lack of Efficacy|5
921529|NCT00980798|3038753|P1|Overall Study|Lack of Efficacy|16
921530|NCT00980798|3038752|P2|Overall Study|Adverse Event|36
921531|NCT00980798|3038753|P1|Overall Study|Adverse Event|7
921532|NCT00980655|3038794|P2|Overall Study|Other|1
921533|NCT00980655|3038795|P1|Overall Study|Other|0
921534|NCT00980655|3038794|P2|Overall Study|Parent/legal guardian request|0
921535|NCT00980655|3038795|P1|Overall Study|Parent/legal guardian request|1
921536|NCT00980655|3038794|P2|Overall Study|Lost to Follow-up|1
921537|NCT00980655|3038795|P1|Overall Study|Lost to Follow-up|0
921538|NCT00980655|3038794|P2|Overall Study|Withdrawal by Subject|4
921539|NCT00980655|3038795|P1|Overall Study|Withdrawal by Subject|0
921540|NCT00980655|3038794|P2|Overall Study|Protocol Violation|7
921541|NCT00980655|3038795|P1|Overall Study|Protocol Violation|2
921542|NCT00980655|3038794|P2|Overall Study|Death|7
921543|NCT00980655|3038795|P1|Overall Study|Death|0
921544|NCT00980655|3038794|P2|Overall Study|Adverse Event|31
921545|NCT00980655|3038795|P1|Overall Study|Adverse Event|13
921546|NCT00980343|3038871|P2|Overall Study|no tumor at surgery - treatment effect|3
921547|NCT00980343|3038872|P1|Overall Study|no tumor at surgery - treatment effect|1
921548|NCT00980330|3038896|P7|Overall Study|(not specified)|0
921549|NCT00980330|3038897|P6|Overall Study|(not specified)|1
921550|NCT00980330|3038898|P5|Overall Study|(not specified)|1
921551|NCT00980330|3038899|P4|Overall Study|(not specified)|1
921552|NCT00980330|3038900|P3|Overall Study|(not specified)|0
921553|NCT00980330|3038901|P2|Overall Study|(not specified)|0
921554|NCT00980330|3038902|P1|Overall Study|(not specified)|2
921555|NCT00980330|3038896|P7|Overall Study|Withdrawal by Subject|5
921556|NCT00980330|3038897|P6|Overall Study|Withdrawal by Subject|2
921557|NCT00980330|3038898|P5|Overall Study|Withdrawal by Subject|3
921558|NCT00980330|3038899|P4|Overall Study|Withdrawal by Subject|1
921559|NCT00980330|3038900|P3|Overall Study|Withdrawal by Subject|4
921560|NCT00980330|3038901|P2|Overall Study|Withdrawal by Subject|4
921561|NCT00980330|3038902|P1|Overall Study|Withdrawal by Subject|2
921562|NCT00980330|3038896|P7|Overall Study|Lost to Follow-up|2
921563|NCT00980330|3038897|P6|Overall Study|Lost to Follow-up|1
921564|NCT00980330|3038898|P5|Overall Study|Lost to Follow-up|1
921565|NCT00980330|3038899|P4|Overall Study|Lost to Follow-up|2
921566|NCT00980330|3038900|P3|Overall Study|Lost to Follow-up|4
921567|NCT00980330|3038901|P2|Overall Study|Lost to Follow-up|1
921568|NCT00980330|3038902|P1|Overall Study|Lost to Follow-up|1
921569|NCT00980330|3038896|P7|Overall Study|Adverse Event|0
921570|NCT00980330|3038897|P6|Overall Study|Adverse Event|0
921571|NCT00980330|3038898|P5|Overall Study|Adverse Event|0
921572|NCT00980330|3038899|P4|Overall Study|Adverse Event|1
921573|NCT00980330|3038900|P3|Overall Study|Adverse Event|0
921574|NCT00980330|3038901|P2|Overall Study|Adverse Event|0
921575|NCT00980330|3038902|P1|Overall Study|Adverse Event|0
921576|NCT00980200|3039017|P5|7-day Treatment Period 3|Lack of Efficacy|1
921577|NCT00980200|3039018|P4|7-day Treatment Period 3|Lack of Efficacy|0
921578|NCT00980200|3039019|P3|7-day Treatment Period 3|Lack of Efficacy|0
921579|NCT00980200|3039020|P2|7-day Treatment Period 3|Lack of Efficacy|1
921580|NCT00980200|3039021|P1|7-day Treatment Period 3|Lack of Efficacy|0
921581|NCT00980200|3039017|P5|7-day Treatment Period 1|Withdrawal by Subject|0
921582|NCT00980200|3039018|P4|7-day Treatment Period 1|Withdrawal by Subject|0
921583|NCT00980200|3039019|P3|7-day Treatment Period 1|Withdrawal by Subject|0
921584|NCT00980200|3039020|P2|7-day Treatment Period 1|Withdrawal by Subject|1
921585|NCT00980200|3039021|P1|7-day Treatment Period 1|Withdrawal by Subject|0
921586|NCT00980174|3039040|P2|Overall Study|Other|1
921587|NCT00980174|3039041|P1|Overall Study|Other|0
921588|NCT00980174|3039040|P2|Overall Study|Death|1
921589|NCT00980174|3039041|P1|Overall Study|Death|1
921590|NCT00980174|3039040|P2|Overall Study|Ineligibility determined|1
921591|NCT00980174|3039041|P1|Overall Study|Ineligibility determined|2
921592|NCT00980174|3039040|P2|Overall Study|Adverse Event|3
921593|NCT00980174|3039041|P1|Overall Study|Adverse Event|0
921594|NCT00980174|3039040|P2|Overall Study|Withdrawal by Subject|4
921595|NCT00980174|3039041|P1|Overall Study|Withdrawal by Subject|1
921596|NCT00980148|3039059|P2|Overall Study|Various other reasons|9
921597|NCT00980148|3039060|P1|Overall Study|Various other reasons|8
921598|NCT00980148|3039059|P2|Overall Study|Negative for chlamydia at enrollment|9
921599|NCT00980148|3039060|P1|Overall Study|Negative for chlamydia at enrollment|12
921600|NCT00980148|3039059|P2|Overall Study|Received other antichlamydia treatment|14
921601|NCT00980148|3039060|P1|Overall Study|Received other antichlamydia treatment|20
921602|NCT00980148|3039059|P2|Overall Study|Discharged from facility|96
921603|NCT00980148|3039060|P1|Overall Study|Discharged from facility|89
921604|NCT00980057|3039068|P2|Overall Study|Withdrawal by Subject|1
921605|NCT00980057|3039069|P1|Overall Study|Withdrawal by Subject|1
921606|NCT00980057|3039068|P2|Overall Study|Lost to Follow-up|0
921607|NCT00980057|3039069|P1|Overall Study|Lost to Follow-up|1
921608|NCT00980057|3039068|P2|Overall Study|Physician Decision|0
921609|NCT00980057|3039069|P1|Overall Study|Physician Decision|4
921610|NCT00980057|3039068|P2|Overall Study|Adverse Event|1
921611|NCT00980057|3039069|P1|Overall Study|Adverse Event|0
921612|NCT00980057|3039068|P2|Overall Study|Death|3
921613|NCT00980057|3039069|P1|Overall Study|Death|13
921614|NCT00980044|3039092|P3|Overall Study|Protocol Violation|2
921615|NCT00980044|3039093|P2|Overall Study|Protocol Violation|0
921616|NCT00980044|3039094|P1|Overall Study|Protocol Violation|0
921617|NCT00980044|3039092|P3|Overall Study|Withdrawal by Subject|3
921618|NCT00980044|3039093|P2|Overall Study|Withdrawal by Subject|7
921619|NCT00980044|3039094|P1|Overall Study|Withdrawal by Subject|5
921620|NCT00980005|3039113|P2|Overall Study|Other|3
921621|NCT00980005|3039114|P1|Overall Study|Other|4
921622|NCT00980005|3039113|P2|Overall Study|Lost to Follow-up|43
921623|NCT00980005|3039114|P1|Overall Study|Lost to Follow-up|37
921624|NCT00980005|3039113|P2|Overall Study|Withdrawal by Subject|17
921625|NCT00980005|3039114|P1|Overall Study|Withdrawal by Subject|6
921626|NCT00979992|3039154|P1|Overall Study|Refused – Never Treated|2
921627|NCT00979992|3039154|P1|Overall Study|Ineligible - wrong cell type|2
921628|NCT00979992|3039154|P1|Overall Study|Ineligible - inadequate pathology|1
921629|NCT00979953|3039166|P4|Overall Study|Protocol Violation|2
921630|NCT00979953|3039167|P3|Overall Study|Protocol Violation|2
921631|NCT00979953|3039168|P2|Overall Study|Protocol Violation|0
921632|NCT00979953|3039169|P1|Overall Study|Protocol Violation|1
921633|NCT00979953|3039166|P4|Overall Study|Withdrawal by Subject|1
921634|NCT00979953|3039167|P3|Overall Study|Withdrawal by Subject|2
921635|NCT00979953|3039168|P2|Overall Study|Withdrawal by Subject|0
921636|NCT00979953|3039169|P1|Overall Study|Withdrawal by Subject|0
921637|NCT00979953|3039166|P4|Overall Study|Lost to Follow-up|0
921638|NCT00979953|3039167|P3|Overall Study|Lost to Follow-up|1
921639|NCT00979953|3039168|P2|Overall Study|Lost to Follow-up|1
921640|NCT00979953|3039169|P1|Overall Study|Lost to Follow-up|1
921641|NCT00979953|3039166|P4|Overall Study|Lack of Efficacy|0
921642|NCT00979953|3039167|P3|Overall Study|Lack of Efficacy|0
921643|NCT00979953|3039168|P2|Overall Study|Lack of Efficacy|2
921644|NCT00979953|3039169|P1|Overall Study|Lack of Efficacy|1
921645|NCT00979953|3039166|P4|Overall Study|Adverse Event|4
921646|NCT00979953|3039167|P3|Overall Study|Adverse Event|17
921647|NCT00979953|3039168|P2|Overall Study|Adverse Event|2
921648|NCT00979953|3039169|P1|Overall Study|Adverse Event|5
921649|NCT00979901|3039192|P4|Overall Study|Treatment Group Terminated by Sponsor|112
921650|NCT00979901|3039193|P3|Overall Study|Treatment Group Terminated by Sponsor|0
921651|NCT00979901|3039194|P2|Overall Study|Treatment Group Terminated by Sponsor|0
921652|NCT00979901|3039195|P1|Overall Study|Treatment Group Terminated by Sponsor|0
921653|NCT00979901|3039192|P4|Overall Study|Left Country|0
921654|NCT00979901|3039193|P3|Overall Study|Left Country|1
921655|NCT00979901|3039194|P2|Overall Study|Left Country|0
921656|NCT00979901|3039195|P1|Overall Study|Left Country|0
921657|NCT00979901|3039192|P4|Overall Study|Discontinued in Error|0
921658|NCT00979901|3039193|P3|Overall Study|Discontinued in Error|0
921659|NCT00979901|3039194|P2|Overall Study|Discontinued in Error|1
921660|NCT00979901|3039195|P1|Overall Study|Discontinued in Error|0
921661|NCT00979901|3039192|P4|Overall Study|elevated lab values pre-randomization|0
921662|NCT00979901|3039193|P3|Overall Study|elevated lab values pre-randomization|0
921663|NCT00979901|3039194|P2|Overall Study|elevated lab values pre-randomization|0
921664|NCT00979901|3039195|P1|Overall Study|elevated lab values pre-randomization|1
921665|NCT00979901|3039192|P4|Overall Study|vacation|0
921666|NCT00979901|3039193|P3|Overall Study|vacation|0
921667|NCT00979901|3039194|P2|Overall Study|vacation|0
921668|NCT00979901|3039195|P1|Overall Study|vacation|1
921669|NCT00979901|3039192|P4|Overall Study|out-of-state|0
921670|NCT00979901|3039193|P3|Overall Study|out-of-state|0
921671|NCT00979901|3039194|P2|Overall Study|out-of-state|0
921672|NCT00979901|3039195|P1|Overall Study|out-of-state|1
921673|NCT00979901|3039192|P4|Overall Study|Noncompliance|0
921674|NCT00979901|3039193|P3|Overall Study|Noncompliance|0
921675|NCT00979901|3039194|P2|Overall Study|Noncompliance|0
921676|NCT00979901|3039195|P1|Overall Study|Noncompliance|1
921677|NCT00979901|3039192|P4|Overall Study|Withdrawal by Subject|1
921678|NCT00979901|3039193|P3|Overall Study|Withdrawal by Subject|1
921679|NCT00979901|3039194|P2|Overall Study|Withdrawal by Subject|1
921680|NCT00979901|3039195|P1|Overall Study|Withdrawal by Subject|2
921681|NCT00979901|3039192|P4|Overall Study|Protocol Violation|1
921682|NCT00979901|3039193|P3|Overall Study|Protocol Violation|7
921683|NCT00979901|3039194|P2|Overall Study|Protocol Violation|2
921684|NCT00979901|3039195|P1|Overall Study|Protocol Violation|2
921685|NCT00979901|3039192|P4|Overall Study|Lost to Follow-up|0
921686|NCT00979901|3039193|P3|Overall Study|Lost to Follow-up|2
921687|NCT00979901|3039194|P2|Overall Study|Lost to Follow-up|1
921688|NCT00979901|3039195|P1|Overall Study|Lost to Follow-up|1
921689|NCT00979901|3039192|P4|Overall Study|Lack of Efficacy|0
921690|NCT00979901|3039193|P3|Overall Study|Lack of Efficacy|9
921691|NCT00979901|3039194|P2|Overall Study|Lack of Efficacy|4
921692|NCT00979901|3039195|P1|Overall Study|Lack of Efficacy|8
921693|NCT00979901|3039192|P4|Overall Study|Adverse Event|2
921694|NCT00979901|3039193|P3|Overall Study|Adverse Event|9
921695|NCT00979901|3039194|P2|Overall Study|Adverse Event|3
921696|NCT00979901|3039195|P1|Overall Study|Adverse Event|1
921697|NCT00979654|3039268|P1|Overall Study|Unfavorable Risk-Benefit Analysis|1
921698|NCT00979654|3039268|P1|Overall Study|Serious Adverse Event|1
921699|NCT00979654|3039268|P1|Overall Study|Patient Wanted to Pursue Other Treatment|1
921700|NCT00979654|3039268|P1|Overall Study|Per Principal Investigator’s Discretion|1
921701|NCT00979654|3039268|P1|Overall Study|Adverse Event of Diverticulitis|1
921702|NCT00979654|3039268|P1|Overall Study|Adverse Event|1
921703|NCT00979654|3039268|P1|Overall Study|Lack of Efficacy|6
921704|NCT00979654|3039268|P1|Overall Study|Death|1
921705|NCT00979654|3039268|P1|Overall Study|Withdrawal by Subject|22
921706|NCT00979654|3039268|P1|Overall Study|Lost to Follow-up|1
921707|NCT00979628|3039283|P3|Overall Study|transferred to ICU|1
921708|NCT00979628|3039284|P2|Overall Study|transferred to ICU|2
921709|NCT00979628|3039285|P1|Overall Study|transferred to ICU|1
921710|NCT00979628|3039283|P3|Overall Study|received steroids|0
921711|NCT00979628|3039284|P2|Overall Study|received steroids|1
921712|NCT00979628|3039285|P1|Overall Study|received steroids|1
921713|NCT00979628|3039283|P3|Overall Study|received regimen < 24 hours|5
921714|NCT00979628|3039284|P2|Overall Study|received regimen < 24 hours|6
921715|NCT00979628|3039285|P1|Overall Study|received regimen < 24 hours|7
921716|NCT00979602|3039315|P2|Overall Study|Others|3
921717|NCT00979602|3039316|P1|Overall Study|Others|3
921718|NCT00979602|3039315|P2|Overall Study|Migrated/moved from study area|6
921719|NCT00979602|3039316|P1|Overall Study|Migrated/moved from study area|3
921720|NCT00979602|3039315|P2|Overall Study|Lost to Follow-up|96
921721|NCT00979602|3039316|P1|Overall Study|Lost to Follow-up|100
921722|NCT00979602|3039315|P2|Overall Study|Withdrawal by Subject|25
921723|NCT00979602|3039316|P1|Overall Study|Withdrawal by Subject|31
921724|NCT00979602|3039315|P2|Overall Study|Protocol Violation|0
921725|NCT00979602|3039316|P1|Overall Study|Protocol Violation|3
921726|NCT00979602|3039315|P2|Overall Study|Serious Adverse Event|3
921727|NCT00979602|3039316|P1|Overall Study|Serious Adverse Event|5
921728|NCT00979576|3039487|P3|Combination Followed by Monotherapy|Progressive Disease|1
921729|NCT00979576|3039488|P2|Combination Followed by Monotherapy|Progressive Disease|2
921730|NCT00979576|3039489|P1|Combination Followed by Monotherapy|Progressive Disease|0
921731|NCT00979576|3039487|P3|Combination Treatment Phase|Adverse Event|2
921732|NCT00979576|3039488|P2|Combination Treatment Phase|Adverse Event|2
921733|NCT00979576|3039489|P1|Combination Treatment Phase|Adverse Event|0
921734|NCT00979576|3039487|P3|Combination Treatment Phase|Dose limiting toxicity|2
921735|NCT00979576|3039488|P2|Combination Treatment Phase|Dose limiting toxicity|3
921736|NCT00979576|3039489|P1|Combination Treatment Phase|Dose limiting toxicity|0
921737|NCT00979576|3039487|P3|Combination Treatment Phase|Progressive disease|5
921738|NCT00979576|3039488|P2|Combination Treatment Phase|Progressive disease|1
921739|NCT00979576|3039489|P1|Combination Treatment Phase|Progressive disease|3
921740|NCT00979420|3039546|P4|Overall Study|Other reasons not related to Viramune|1
921741|NCT00979420|3039547|P3|Overall Study|Other reasons not related to Viramune|0
921742|NCT00979420|3039548|P2|Overall Study|Other reasons not related to Viramune|0
921743|NCT00979420|3039549|P1|Overall Study|Other reasons not related to Viramune|3
921744|NCT00979420|3039546|P4|Overall Study|Lack of Efficacy|1
921745|NCT00979420|3039547|P3|Overall Study|Lack of Efficacy|1
921746|NCT00979420|3039548|P2|Overall Study|Lack of Efficacy|0
921747|NCT00979420|3039549|P1|Overall Study|Lack of Efficacy|3
921748|NCT00979420|3039546|P4|Overall Study|Adverse Event|0
921749|NCT00979420|3039547|P3|Overall Study|Adverse Event|0
921750|NCT00979420|3039548|P2|Overall Study|Adverse Event|0
921751|NCT00979420|3039549|P1|Overall Study|Adverse Event|1
921752|NCT00979407|3039619|P2|Overall Study|Lost to Follow-up|3
921753|NCT00979407|3039620|P1|Overall Study|Lost to Follow-up|3
921754|NCT00979407|3039619|P2|Overall Study|Withdrawal by Subject|4
921755|NCT00979407|3039620|P1|Overall Study|Withdrawal by Subject|3
921756|NCT00979212|3039673|P2|Overall Study|No protocol therapy received|0
921757|NCT00979212|3039674|P1|Overall Study|No protocol therapy received|1
921758|NCT00979212|3039673|P2|Overall Study|Protocol Violation|8
921759|NCT00979212|3039674|P1|Overall Study|Protocol Violation|1
921760|NCT00978757|3039734|P2|Overall Study|Physician Decision|3
921761|NCT00978757|3039735|P1|Overall Study|Physician Decision|1
921762|NCT00978731|3039745|P4|Overall Study|No response|0
921763|NCT00978731|3039746|P3|Overall Study|No response|0
921764|NCT00978731|3039747|P2|Overall Study|No response|0
921765|NCT00978731|3039748|P1|Overall Study|No response|1
921766|NCT00978731|3039745|P4|Overall Study|Study closure|1
921767|NCT00978731|3039746|P3|Overall Study|Study closure|1
921768|NCT00978731|3039747|P2|Overall Study|Study closure|4
921769|NCT00978731|3039748|P1|Overall Study|Study closure|3
921770|NCT00978731|3039745|P4|Overall Study|Disease progression/relapse|2
921771|NCT00978731|3039746|P3|Overall Study|Disease progression/relapse|2
921772|NCT00978731|3039747|P2|Overall Study|Disease progression/relapse|4
921773|NCT00978731|3039748|P1|Overall Study|Disease progression/relapse|5
921774|NCT00978731|3039745|P4|Overall Study|Deterioration without progression|0
921775|NCT00978731|3039746|P3|Overall Study|Deterioration without progression|0
921776|NCT00978731|3039747|P2|Overall Study|Deterioration without progression|1
921777|NCT00978731|3039748|P1|Overall Study|Deterioration without progression|0
921778|NCT00978731|3039745|P4|Overall Study|Administrative reason|0
921779|NCT00978731|3039746|P3|Overall Study|Administrative reason|1
921780|NCT00978731|3039747|P2|Overall Study|Administrative reason|3
921781|NCT00978731|3039748|P1|Overall Study|Administrative reason|3
921782|NCT00978731|3039745|P4|Overall Study|Participant's request|0
921783|NCT00978731|3039746|P3|Overall Study|Participant's request|0
921784|NCT00978731|3039747|P2|Overall Study|Participant's request|0
921785|NCT00978731|3039748|P1|Overall Study|Participant's request|1
921786|NCT00978731|3039745|P4|Overall Study|Adverse Event|0
921787|NCT00978731|3039746|P3|Overall Study|Adverse Event|0
921788|NCT00978731|3039747|P2|Overall Study|Adverse Event|2
921789|NCT00978731|3039748|P1|Overall Study|Adverse Event|5
921790|NCT00978731|3039745|P4|Overall Study|Lost to Follow-up|1
921791|NCT00978731|3039746|P3|Overall Study|Lost to Follow-up|0
921792|NCT00978731|3039747|P2|Overall Study|Lost to Follow-up|0
921793|NCT00978731|3039748|P1|Overall Study|Lost to Follow-up|0
921794|NCT00978731|3039745|P4|Overall Study|Death|0
921795|NCT00978731|3039746|P3|Overall Study|Death|1
921796|NCT00978731|3039747|P2|Overall Study|Death|1
921797|NCT00978731|3039748|P1|Overall Study|Death|4
921798|NCT00978627|3039788|P2|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7
921799|NCT00978627|3039789|P1|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12
921800|NCT00978627|3039788|P2|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1
921801|NCT00978627|3039789|P1|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2
921802|NCT00978627|3039788|P2|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1
921803|NCT00978627|3039789|P1|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4
921804|NCT00978627|3039788|P2|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0
921805|NCT00978627|3039789|P1|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3
921806|NCT00978627|3039788|P2|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12
921807|NCT00978627|3039789|P1|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25
921808|NCT00978627|3039788|P2|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5
921809|NCT00978627|3039789|P1|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7
921810|NCT00978627|3039788|P2|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6
921811|NCT00978627|3039789|P1|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8
921812|NCT00978627|3039788|P2|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0
921813|NCT00978627|3039789|P1|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2
921814|NCT00978627|3039788|P2|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3
921815|NCT00978627|3039789|P1|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4
921816|NCT00978432|3039827|P3|Overall Study|Adverse Event|1
921817|NCT00978432|3039828|P2|Overall Study|Adverse Event|0
921818|NCT00978432|3039829|P1|Overall Study|Adverse Event|2
921819|NCT00978432|3039827|P3|Overall Study|Lack of Efficacy|3
921820|NCT00978432|3039828|P2|Overall Study|Lack of Efficacy|1
921821|NCT00978432|3039829|P1|Overall Study|Lack of Efficacy|1
921822|NCT00978432|3039827|P3|Overall Study|Withdrawal by Subject|1
921823|NCT00978432|3039828|P2|Overall Study|Withdrawal by Subject|0
921824|NCT00978432|3039829|P1|Overall Study|Withdrawal by Subject|0
921825|NCT00978380|3039880|P1|Overall Study|Unclassified|8
921826|NCT00978380|3039880|P1|Overall Study|Withdrawal criteria|9
921827|NCT00978380|3039880|P1|Overall Study|Protocol Violation|2
921828|NCT00978341|3039886|P2|Washout Period of 2 Weeks|Adverse Event|0
921829|NCT00978341|3039887|P1|Washout Period of 2 Weeks|Adverse Event|1
921830|NCT00978120|3039909|P4|Overall Study|Moved out of state|1
921831|NCT00978120|3039910|P3|Overall Study|Moved out of state|0
921832|NCT00978120|3039911|P2|Overall Study|Moved out of state|0
921833|NCT00978120|3039912|P1|Overall Study|Moved out of state|0
921834|NCT00978120|3039909|P4|Overall Study|Withdrawal by Subject|0
921835|NCT00978120|3039910|P3|Overall Study|Withdrawal by Subject|0
921836|NCT00978120|3039911|P2|Overall Study|Withdrawal by Subject|0
921837|NCT00978120|3039912|P1|Overall Study|Withdrawal by Subject|2
921838|NCT00978120|3039909|P4|Overall Study|Lost to Follow-up|0
921839|NCT00978120|3039910|P3|Overall Study|Lost to Follow-up|3
921840|NCT00978120|3039911|P2|Overall Study|Lost to Follow-up|0
921841|NCT00978120|3039912|P1|Overall Study|Lost to Follow-up|0
921842|NCT00978120|3039909|P4|Overall Study|Death|1
921843|NCT00978120|3039910|P3|Overall Study|Death|0
921844|NCT00978120|3039911|P2|Overall Study|Death|0
921845|NCT00978120|3039912|P1|Overall Study|Death|0
921846|NCT00978042|3039964|P2|Initial Treatment Period|Other Miscellaneous Reasons|0
921847|NCT00978042|3039965|P1|Initial Treatment Period|Other Miscellaneous Reasons|13
921848|NCT00978042|3039964|P2|Initial Treatment Period|Consent withdrawn|9
921849|NCT00978042|3039965|P1|Initial Treatment Period|Consent withdrawn|22
921850|NCT00978042|3039964|P2|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0
921851|NCT00978042|3039965|P1|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2
921852|NCT00978042|3039964|P2|Initial Treatment Period|Adverse Event|0
921853|NCT00978042|3039965|P1|Initial Treatment Period|Adverse Event|2
921854|NCT00978042|3039964|P2|Initial Treatment Period|Lost to Follow-up|3
921855|NCT00978042|3039965|P1|Initial Treatment Period|Lost to Follow-up|21
921856|NCT00978042|3039964|P2|Initial Treatment Period|Ineligibility|0
921857|NCT00978042|3039965|P1|Initial Treatment Period|Ineligibility|1
921858|NCT00978042|3039964|P2|Initial Treatment Period|Treated in Error|3
921859|NCT00978042|3039965|P1|Initial Treatment Period|Treated in Error|0
921860|NCT00978029|3039978|P3|Overall Study|Protocol Violation|0
921861|NCT00978029|3039979|P2|Overall Study|Protocol Violation|1
921862|NCT00978029|3039980|P1|Overall Study|Protocol Violation|0
921863|NCT00978029|3039978|P3|Overall Study|Withdrawal by Subject|1
921864|NCT00978029|3039979|P2|Overall Study|Withdrawal by Subject|0
921865|NCT00978029|3039980|P1|Overall Study|Withdrawal by Subject|0
921866|NCT00978029|3039978|P3|Overall Study|Adverse Event|5
921867|NCT00978029|3039979|P2|Overall Study|Adverse Event|2
921868|NCT00978029|3039980|P1|Overall Study|Adverse Event|1
921869|NCT00977938|3040007|P4|Observation (30-33 mo. Post Procedure)|Other|0
921870|NCT00977938|3040008|P3|Observation (30-33 mo. Post Procedure)|Other|0
921871|NCT00977938|3040009|P2|Observation (30-33 mo. Post Procedure)|Other|4
921872|NCT00977938|3040010|P1|Observation (30-33 mo. Post Procedure)|Other|8
921873|NCT00977938|3040007|P4|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3
921874|NCT00977938|3040008|P3|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10
921875|NCT00977938|3040009|P2|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42
921876|NCT00977938|3040010|P1|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34
921877|NCT00977938|3040007|P4|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0
921878|NCT00977938|3040008|P3|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2
921879|NCT00977938|3040009|P2|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12
921880|NCT00977938|3040010|P1|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9
921881|NCT00977938|3040007|P4|Treatment (12-30 mo. Post Procedure)|Other|4
921882|NCT00977938|3040008|P3|Treatment (12-30 mo. Post Procedure)|Other|3
921883|NCT00977938|3040009|P2|Treatment (12-30 mo. Post Procedure)|Other|18
921884|NCT00977938|3040010|P1|Treatment (12-30 mo. Post Procedure)|Other|17
921885|NCT00977938|3040007|P4|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37
921886|NCT00977938|3040008|P3|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30
921887|NCT00977938|3040009|P2|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91
921888|NCT00977938|3040010|P1|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88
921889|NCT00977938|3040007|P4|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20
921890|NCT00977938|3040008|P3|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13
921891|NCT00977938|3040009|P2|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116
921892|NCT00977938|3040010|P1|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132
921893|NCT00977665|3040074|P2|Overall Study|Treatment failure|1
921894|NCT00977665|3040075|P1|Overall Study|Treatment failure|0
921895|NCT00977665|3040074|P2|Overall Study|Adverse Event|7
921896|NCT00977665|3040075|P1|Overall Study|Adverse Event|14
921897|NCT00977665|3040074|P2|Overall Study|Death|2
921898|NCT00977665|3040075|P1|Overall Study|Death|3
921899|NCT00977665|3040074|P2|Overall Study|Lost to Follow-up|0
921900|NCT00977665|3040075|P1|Overall Study|Lost to Follow-up|1
921901|NCT00977665|3040074|P2|Overall Study|Sponsor requested withdrawal|1
921902|NCT00977665|3040075|P1|Overall Study|Sponsor requested withdrawal|0
921903|NCT00977665|3040074|P2|Overall Study|Physician Decision|1
921904|NCT00977665|3040075|P1|Overall Study|Physician Decision|2
921905|NCT00977665|3040074|P2|Overall Study|Withdrawal by Subject|3
921906|NCT00977665|3040075|P1|Overall Study|Withdrawal by Subject|1
921907|NCT00977613|3040107|P1|Overall Study|Lost to Follow-up|16
921908|NCT00977574|3040114|P3|Overall Study|Never Treated|4
921909|NCT00977574|3040115|P2|Overall Study|Never Treated|2
921910|NCT00977574|3040116|P1|Overall Study|Never Treated|4
921911|NCT00977561|3040135|P2|Overall Study|Other|0
921912|NCT00977561|3040136|P1|Overall Study|Other|2
921913|NCT00977561|3040135|P2|Overall Study|Study terminated|2
921914|NCT00977561|3040136|P1|Overall Study|Study terminated|0
921915|NCT00977561|3040135|P2|Overall Study|Death|2
921916|NCT00977561|3040136|P1|Overall Study|Death|3
921917|NCT00977548|3040163|P1|Overall Study|Withdrawal by Subject|1
921918|NCT00977548|3040163|P1|Overall Study|Adverse Event|8
921919|NCT00977548|3040163|P1|Overall Study|Ineligible|4
921920|NCT00977470|3040172|P2|Overall Study|Still on-study|0
921921|NCT00977470|3040173|P1|Overall Study|Still on-study|2
921922|NCT00977470|3040172|P2|Overall Study|prolonged recovery post-surgery|1
921923|NCT00977470|3040173|P1|Overall Study|prolonged recovery post-surgery|0
921924|NCT00977470|3040172|P2|Overall Study|clinical decline|1
921925|NCT00977470|3040173|P1|Overall Study|clinical decline|0
921926|NCT00977470|3040172|P2|Overall Study|Death|2
921927|NCT00977470|3040173|P1|Overall Study|Death|0
921928|NCT00977470|3040172|P2|Overall Study|Withdrawal by Subject|2
921929|NCT00977470|3040173|P1|Overall Study|Withdrawal by Subject|0
921930|NCT00977470|3040172|P2|Overall Study|Protocol Violation|0
921931|NCT00977470|3040173|P1|Overall Study|Protocol Violation|1
921932|NCT00977470|3040172|P2|Overall Study|Adverse Event|2
921933|NCT00977470|3040173|P1|Overall Study|Adverse Event|1
921934|NCT00977470|3040172|P2|Overall Study|Physician Decision|0
921935|NCT00977470|3040173|P1|Overall Study|Physician Decision|2
921936|NCT00977470|3040172|P2|Overall Study|Lack of Efficacy|30
921937|NCT00977470|3040173|P1|Overall Study|Lack of Efficacy|32
921938|NCT00977379|3040193|P2|Overall Study|Randomization Error|1
921939|NCT00977379|3040194|P1|Overall Study|Randomization Error|0
921940|NCT00977379|3040193|P2|Overall Study|Participant Moving House|1
921941|NCT00977379|3040194|P1|Overall Study|Participant Moving House|0
921942|NCT00977379|3040193|P2|Overall Study|Premature Study Termination|0
921943|NCT00977379|3040194|P1|Overall Study|Premature Study Termination|4
921944|NCT00977379|3040193|P2|Overall Study|Death|9
921945|NCT00977379|3040194|P1|Overall Study|Death|7
921946|NCT00977379|3040193|P2|Overall Study|Withdrawal by Subject|1
921947|NCT00977379|3040194|P1|Overall Study|Withdrawal by Subject|1
921948|NCT00977314|3040230|P2|Overall Study|Physician Decision|0
921949|NCT00977314|3040231|P1|Overall Study|Physician Decision|1
921950|NCT00977314|3040230|P2|Overall Study|Withdrawal by Subject|0
921951|NCT00977314|3040231|P1|Overall Study|Withdrawal by Subject|1
921952|NCT00977197|3040239|P2|Overall Study|Nonadherence|1
921953|NCT00977197|3040240|P1|Overall Study|Nonadherence|1
921954|NCT00977197|3040239|P2|Overall Study|Lost to Follow-up|3
921955|NCT00977197|3040240|P1|Overall Study|Lost to Follow-up|1
921956|NCT00977197|3040239|P2|Overall Study|Lack of Efficacy|0
921957|NCT00977197|3040240|P1|Overall Study|Lack of Efficacy|1
921958|NCT00977197|3040239|P2|Overall Study|Adverse Event|1
921959|NCT00977197|3040240|P1|Overall Study|Adverse Event|3
921960|NCT00977197|3040239|P2|Overall Study|Withdrawal by Subject|4
921961|NCT00977197|3040240|P1|Overall Study|Withdrawal by Subject|3
921962|NCT00977106|3040303|P2|Overall Study|Not specified|0
921963|NCT00977106|3040304|P1|Overall Study|Not specified|1
921964|NCT00977106|3040303|P2|Overall Study|Protocol Violation|1
921965|NCT00977106|3040304|P1|Overall Study|Protocol Violation|0
921966|NCT00977106|3040303|P2|Overall Study|Lack of Efficacy|2
921967|NCT00977106|3040304|P1|Overall Study|Lack of Efficacy|2
921968|NCT00977106|3040303|P2|Overall Study|Withdrawal by Subject|2
921969|NCT00977106|3040304|P1|Overall Study|Withdrawal by Subject|2
921970|NCT00977106|3040303|P2|Overall Study|Adverse Event|6
921971|NCT00977106|3040304|P1|Overall Study|Adverse Event|5
921972|NCT00977080|3040396|P4|Overall Study|Travel for family reasons|0
921973|NCT00977080|3040397|P3|Overall Study|Travel for family reasons|0
921974|NCT00977080|3040398|P2|Overall Study|Travel for family reasons|0
921975|NCT00977080|3040399|P1|Overall Study|Travel for family reasons|1
921976|NCT00977080|3040396|P4|Overall Study|Required kidney transplantation|1
921977|NCT00977080|3040397|P3|Overall Study|Required kidney transplantation|3
921978|NCT00977080|3040398|P2|Overall Study|Required kidney transplantation|3
921979|NCT00977080|3040399|P1|Overall Study|Required kidney transplantation|1
921980|NCT00977080|3040396|P4|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1
921981|NCT00977080|3040397|P3|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
921982|NCT00977080|3040398|P2|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
921983|NCT00977080|3040399|P1|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
921984|NCT00977080|3040396|P4|Overall Study|Noncompliance|0
921985|NCT00977080|3040397|P3|Overall Study|Noncompliance|1
921986|NCT00977080|3040398|P2|Overall Study|Noncompliance|2
921987|NCT00977080|3040399|P1|Overall Study|Noncompliance|0
921988|NCT00977080|3040396|P4|Overall Study|Protocol Violation|3
921989|NCT00977080|3040397|P3|Overall Study|Protocol Violation|4
921990|NCT00977080|3040398|P2|Overall Study|Protocol Violation|3
921991|NCT00977080|3040399|P1|Overall Study|Protocol Violation|7
921992|NCT00977080|3040396|P4|Overall Study|Withdrawal by Subject|5
921993|NCT00977080|3040397|P3|Overall Study|Withdrawal by Subject|1
921994|NCT00977080|3040398|P2|Overall Study|Withdrawal by Subject|5
921995|NCT00977080|3040399|P1|Overall Study|Withdrawal by Subject|1
921996|NCT00977080|3040396|P4|Overall Study|Adverse Event|7
921997|NCT00977080|3040397|P3|Overall Study|Adverse Event|7
921998|NCT00977080|3040398|P2|Overall Study|Adverse Event|7
921999|NCT00977080|3040399|P1|Overall Study|Adverse Event|2
922000|NCT00976989|3040432|P3|Overall Study|Other|1
922001|NCT00976989|3040433|P2|Overall Study|Other|0
922002|NCT00976989|3040434|P1|Overall Study|Other|1
922003|NCT00976989|3040432|P3|Overall Study|Recurrence of Disease|0
922004|NCT00976989|3040433|P2|Overall Study|Recurrence of Disease|1
922005|NCT00976989|3040434|P1|Overall Study|Recurrence of Disease|0
922006|NCT00976989|3040432|P3|Overall Study|Failure to Return|0
922007|NCT00976989|3040433|P2|Overall Study|Failure to Return|1
922008|NCT00976989|3040434|P1|Overall Study|Failure to Return|2
922009|NCT00976989|3040432|P3|Overall Study|Refused Treatment|5
922010|NCT00976989|3040433|P2|Overall Study|Refused Treatment|3
922011|NCT00976989|3040434|P1|Overall Study|Refused Treatment|4
922012|NCT00976989|3040432|P3|Overall Study|Death|10
922013|NCT00976989|3040433|P2|Overall Study|Death|7
922014|NCT00976989|3040434|P1|Overall Study|Death|5
922015|NCT00976989|3040432|P3|Overall Study|Violation of Selection Criteria at Entry|1
922016|NCT00976989|3040433|P2|Overall Study|Violation of Selection Criteria at Entry|0
922017|NCT00976989|3040434|P1|Overall Study|Violation of Selection Criteria at Entry|1
922018|NCT00976950|3040475|P1|Overall Study|Events with no relationship to Aptivus|3
922019|NCT00976950|3040475|P1|Overall Study|Adverse Event|3
922020|NCT00976937|3040483|P2|Overall Study|Personal and Familial Reason|2
922021|NCT00976937|3040484|P1|Overall Study|Personal and Familial Reason|2
922022|NCT00976937|3040483|P2|Overall Study|Poor compliance to protocol|0
922023|NCT00976937|3040484|P1|Overall Study|Poor compliance to protocol|3
922024|NCT00976937|3040483|P2|Overall Study|Withdrawal by Subject|3
922025|NCT00976937|3040484|P1|Overall Study|Withdrawal by Subject|5
922026|NCT00976937|3040483|P2|Overall Study|Lost to Follow-up|1
922027|NCT00976937|3040484|P1|Overall Study|Lost to Follow-up|2
922028|NCT00976937|3040483|P2|Overall Study|Adverse Event|5
922029|NCT00976937|3040484|P1|Overall Study|Adverse Event|4
922030|NCT00976911|3040526|P2|Overall Study|In Follow-Up as of 25 Jan 2013|37
922031|NCT00976911|3040527|P1|Overall Study|In Follow-Up as of 25 Jan 2013|30
922032|NCT00976911|3040526|P2|Overall Study|Not Specified|9
922033|NCT00976911|3040527|P1|Overall Study|Not Specified|8
922034|NCT00976911|3040526|P2|Overall Study|Protocol Violation|0
922035|NCT00976911|3040527|P1|Overall Study|Protocol Violation|2
922036|NCT00976911|3040526|P2|Overall Study|Adverse Event|1
922037|NCT00976911|3040527|P1|Overall Study|Adverse Event|0
922038|NCT00976911|3040526|P2|Overall Study|Death|126
922039|NCT00976911|3040527|P1|Overall Study|Death|138
922040|NCT00976911|3040526|P2|Overall Study|Withdrawal by Subject|6
922041|NCT00976911|3040527|P1|Overall Study|Withdrawal by Subject|4
922042|NCT00976898|3040545|P1|Overall Study|Progressive Disease|1
922043|NCT00976898|3040545|P1|Overall Study|Liver Transplant|1
922044|NCT00976898|3040545|P1|Overall Study|Physician Decision|1
922045|NCT00976898|3040545|P1|Overall Study|Adverse Event|1
922046|NCT00976898|3040545|P1|Overall Study|Protocol Violation|1
922047|NCT00976820|3040556|P4|Overall Study|Withdrawal by Subject|4
922048|NCT00976820|3040557|P3|Overall Study|Withdrawal by Subject|1
922049|NCT00976820|3040558|P2|Overall Study|Withdrawal by Subject|4
922050|NCT00976820|3040559|P1|Overall Study|Withdrawal by Subject|2
922051|NCT00976820|3040556|P4|Overall Study|Poor Compliance. Numerous Visits Booked|0
922052|NCT00976820|3040557|P3|Overall Study|Poor Compliance. Numerous Visits Booked|1
922053|NCT00976820|3040558|P2|Overall Study|Poor Compliance. Numerous Visits Booked|0
922054|NCT00976820|3040559|P1|Overall Study|Poor Compliance. Numerous Visits Booked|1
922055|NCT00976820|3040556|P4|Overall Study|Lost to Follow-up|3
922056|NCT00976820|3040557|P3|Overall Study|Lost to Follow-up|2
922057|NCT00976820|3040558|P2|Overall Study|Lost to Follow-up|16
922058|NCT00976820|3040559|P1|Overall Study|Lost to Follow-up|5
922059|NCT00976716|3040895|P1|Overall Study|Adverse Event|1
922060|NCT00976703|3040913|P2|Overall Study|ineligible for study|2
922061|NCT00976703|3040914|P1|Overall Study|ineligible for study|2
922062|NCT00976703|3040913|P2|Overall Study|Physician Decision|1
922063|NCT00976703|3040914|P1|Overall Study|Physician Decision|1
922064|NCT00976677|3040928|P2|Overall Study|Unknown/Missing|0
922065|NCT00976677|3040929|P1|Overall Study|Unknown/Missing|1
922066|NCT00976677|3040928|P2|Overall Study|Trial unblinded|2
922067|NCT00976677|3040929|P1|Overall Study|Trial unblinded|2
922068|NCT00976677|3040928|P2|Overall Study|Disease progression|1
922069|NCT00976677|3040929|P1|Overall Study|Disease progression|1
922070|NCT00976677|3040928|P2|Overall Study|Withdrawal by Subject|2
922071|NCT00976677|3040929|P1|Overall Study|Withdrawal by Subject|0
922072|NCT00976677|3040928|P2|Overall Study|Adverse Event|0
922073|NCT00976677|3040929|P1|Overall Study|Adverse Event|1
922074|NCT00976573|3041137|P2|Overall Study|Cancel prior to receiving treatment|2
922075|NCT00976573|3041138|P1|Overall Study|Cancel prior to receiving treatment|4
922076|NCT00976573|3041137|P2|Overall Study|Ineligible|1
922077|NCT00976573|3041138|P1|Overall Study|Ineligible|0
922078|NCT00976560|3041152|P2|Overall Study|Withdrawal by Subject|3
922079|NCT00976560|3041153|P1|Overall Study|Withdrawal by Subject|2
922080|NCT00976560|3041152|P2|Overall Study|Physician Decision|0
922081|NCT00976560|3041153|P1|Overall Study|Physician Decision|2
922082|NCT00976560|3041152|P2|Overall Study|Lost to Follow-up|0
922083|NCT00976560|3041153|P1|Overall Study|Lost to Follow-up|1
922084|NCT00976560|3041152|P2|Overall Study|Protocol Violation|0
922085|NCT00976560|3041153|P1|Overall Study|Protocol Violation|1
922086|NCT00976560|3041152|P2|Overall Study|Lack of Efficacy|5
922087|NCT00976560|3041153|P1|Overall Study|Lack of Efficacy|3
922088|NCT00976560|3041152|P2|Overall Study|Adverse Event|5
922089|NCT00976560|3041153|P1|Overall Study|Adverse Event|5
922090|NCT00976508|3041222|P2|Overall Study|Terminated by the Sponsor|1
922091|NCT00976508|3041223|P1|Overall Study|Terminated by the Sponsor|0
922092|NCT00976508|3041222|P2|Overall Study|Subject Enrolled in Hospice|0
922093|NCT00976508|3041223|P1|Overall Study|Subject Enrolled in Hospice|1
922094|NCT00976508|3041222|P2|Overall Study|Disease Progression|4
922095|NCT00976508|3041223|P1|Overall Study|Disease Progression|4
922096|NCT00976508|3041222|P2|Overall Study|Withdrawal by Subject|0
922097|NCT00976508|3041223|P1|Overall Study|Withdrawal by Subject|1
922098|NCT00976508|3041222|P2|Overall Study|Lost to Follow-up|0
922099|NCT00976508|3041223|P1|Overall Study|Lost to Follow-up|1
922100|NCT00976508|3041222|P2|Overall Study|Death|1
922101|NCT00976508|3041223|P1|Overall Study|Death|7
922102|NCT00976495|3041256|P3|Overall Study|Withdrawal by Subject|0
922103|NCT00976495|3041257|P2|Overall Study|Withdrawal by Subject|1
922104|NCT00976495|3041258|P1|Overall Study|Withdrawal by Subject|0
922105|NCT00976482|3041275|P1|Overall Study|Protocol Violation|5
922106|NCT00976482|3041275|P1|Overall Study|Center terminated|1
922107|NCT00976482|3041275|P1|Overall Study|Withdrawal by Subject|45
922108|NCT00976482|3041275|P1|Overall Study|Death|208
922109|NCT00976456|3041281|P2|Overall Study|screening failure, unknown|4
922110|NCT00976456|3041282|P1|Overall Study|screening failure, unknown|11
922111|NCT00976456|3041281|P2|Overall Study|Withdrawal by Subject|1
922112|NCT00976456|3041282|P1|Overall Study|Withdrawal by Subject|3
922113|NCT00976456|3041281|P2|Overall Study|Lack of Efficacy|2
922114|NCT00976456|3041282|P1|Overall Study|Lack of Efficacy|5
922115|NCT00976456|3041281|P2|Overall Study|Death|9
922116|NCT00976456|3041282|P1|Overall Study|Death|7
922117|NCT00976456|3041281|P2|Overall Study|Adverse Event|22
922118|NCT00976456|3041282|P1|Overall Study|Adverse Event|17
922119|NCT00976391|3041309|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
922120|NCT00976391|3041310|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
922121|NCT00976391|3041309|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|7
922122|NCT00976391|3041310|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
922123|NCT00976391|3041309|P2|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8
922124|NCT00976391|3041310|P1|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6
922125|NCT00976391|3041309|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
922126|NCT00976391|3041310|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|14
922127|NCT00976391|3041309|P2|Follow-up Period (8 Weeks)|Noncompliance|2
922128|NCT00976391|3041310|P1|Follow-up Period (8 Weeks)|Noncompliance|2
922129|NCT00976391|3041309|P2|Follow-up Period (8 Weeks)|Adverse Event|1
922130|NCT00976391|3041310|P1|Follow-up Period (8 Weeks)|Adverse Event|3
922131|NCT00976391|3041309|P2|Treatment Period (52 Weeks)|Pregnancy|0
922132|NCT00976391|3041310|P1|Treatment Period (52 Weeks)|Pregnancy|1
922133|NCT00976391|3041309|P2|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4
922134|NCT00976391|3041310|P1|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0
922135|NCT00976391|3041309|P2|Treatment Period (52 Weeks)|Physician Decision|1
922136|NCT00976391|3041310|P1|Treatment Period (52 Weeks)|Physician Decision|1
922137|NCT00976391|3041309|P2|Treatment Period (52 Weeks)|Withdrawal by Subject|19
922138|NCT00976391|3041310|P1|Treatment Period (52 Weeks)|Withdrawal by Subject|9
922139|NCT00976391|3041309|P2|Treatment Period (52 Weeks)|Lost to Follow-up|8
922140|NCT00976391|3041310|P1|Treatment Period (52 Weeks)|Lost to Follow-up|10
922141|NCT00976391|3041309|P2|Treatment Period (52 Weeks)|Noncompliance|4
922142|NCT00976391|3041310|P1|Treatment Period (52 Weeks)|Noncompliance|4
922143|NCT00976391|3041309|P2|Treatment Period (52 Weeks)|Protocol Violation|1
922144|NCT00976391|3041310|P1|Treatment Period (52 Weeks)|Protocol Violation|1
922145|NCT00976391|3041309|P2|Treatment Period (52 Weeks)|Adverse Event|2
922146|NCT00976391|3041310|P1|Treatment Period (52 Weeks)|Adverse Event|16
922147|NCT00976274|3041358|P2|Overall Study|Physician Decision|2
922148|NCT00976274|3041359|P1|Overall Study|Physician Decision|1
922149|NCT00976274|3041358|P2|Overall Study|Withdrawal by Subject|1
922150|NCT00976274|3041359|P1|Overall Study|Withdrawal by Subject|1
922151|NCT00976274|3041358|P2|Overall Study|Lost to Follow-up|5
922152|NCT00976274|3041359|P1|Overall Study|Lost to Follow-up|5
922153|NCT00976209|3041375|P2|Treatment Period 2|Lost to Follow-up|1
922154|NCT00976209|3041376|P1|Treatment Period 2|Lost to Follow-up|0
922155|NCT00976209|3041375|P2|Treatment Period 2|Withdrawal by Subject|1
922156|NCT00976209|3041376|P1|Treatment Period 2|Withdrawal by Subject|0
922157|NCT00976209|3041375|P2|Wash-out Period|Other|0
922158|NCT00976209|3041376|P1|Wash-out Period|Other|1
922159|NCT00976209|3041375|P2|Wash-out Period|Protocol Violation|0
922160|NCT00976209|3041376|P1|Wash-out Period|Protocol Violation|1
922161|NCT00976209|3041375|P2|Wash-out Period|Lost to Follow-up|0
922162|NCT00976209|3041376|P1|Wash-out Period|Lost to Follow-up|1
922163|NCT00976209|3041375|P2|Wash-out Period|Adverse Event|2
922164|NCT00976209|3041376|P1|Wash-out Period|Adverse Event|1
922165|NCT00976209|3041375|P2|Treatment Period 1|Other|1
922166|NCT00976209|3041376|P1|Treatment Period 1|Other|0
922167|NCT00976209|3041375|P2|Treatment Period 1|Lost to Follow-up|0
922168|NCT00976209|3041376|P1|Treatment Period 1|Lost to Follow-up|2
922169|NCT00976209|3041375|P2|Treatment Period 1|Protocol Violation|0
922170|NCT00976209|3041376|P1|Treatment Period 1|Protocol Violation|1
922171|NCT00976027|3041389|P2|Overall Study|Withdrawal by Subject|66
922172|NCT00976027|3041390|P1|Overall Study|Withdrawal by Subject|107
922173|NCT00976027|3041389|P2|Overall Study|Lost to Follow-up|103
922174|NCT00976027|3041390|P1|Overall Study|Lost to Follow-up|208
922175|NCT00976027|3041389|P2|Overall Study|Protocol Violation|27
922176|NCT00976027|3041390|P1|Overall Study|Protocol Violation|60
922177|NCT00976027|3041389|P2|Overall Study|Adverse Event|2
922178|NCT00976027|3041390|P1|Overall Study|Adverse Event|0
922179|NCT00976027|3041389|P2|Overall Study|Serious Adverse Event|17
922180|NCT00976027|3041390|P1|Overall Study|Serious Adverse Event|36
922181|NCT00975975|3041402|P1|Overall Study|Death|6
922182|NCT00975923|3041410|P2|Overall Study|Withdrawal by Subject|1
922183|NCT00975923|3041411|P1|Overall Study|Withdrawal by Subject|0
922184|NCT00975806|3041422|P3|Overall Study|Physician decision and disease related|1
922185|NCT00975806|3041423|P2|Overall Study|Physician decision and disease related|0
922186|NCT00975806|3041424|P1|Overall Study|Physician decision and disease related|1
922187|NCT00975806|3041422|P3|Overall Study|Death|0
922188|NCT00975806|3041423|P2|Overall Study|Death|1
922189|NCT00975806|3041424|P1|Overall Study|Death|0
922190|NCT00975806|3041422|P3|Overall Study|Withdrawal by Subject|0
922191|NCT00975806|3041423|P2|Overall Study|Withdrawal by Subject|0
922192|NCT00975806|3041424|P1|Overall Study|Withdrawal by Subject|1
922193|NCT00975806|3041422|P3|Overall Study|Disease Progression|1
922194|NCT00975806|3041423|P2|Overall Study|Disease Progression|5
922195|NCT00975806|3041424|P1|Overall Study|Disease Progression|1
922196|NCT00975806|3041422|P3|Overall Study|Adverse Event|2
922197|NCT00975806|3041423|P2|Overall Study|Adverse Event|1
922198|NCT00975806|3041424|P1|Overall Study|Adverse Event|2
922199|NCT00975780|3041448|P2|Follow Up|Discharged from Facility|12
922200|NCT00975780|3041449|P1|Follow Up|Discharged from Facility|7
922201|NCT00975780|3041448|P2|Follow Up|Facility Withdrawal|23
922202|NCT00975780|3041449|P1|Follow Up|Facility Withdrawal|7
922203|NCT00975780|3041448|P2|Follow Up|Death|122
922204|NCT00975780|3041449|P1|Follow Up|Death|88
922205|NCT00975715|3041459|P2|Maintenance Period|Adverse Event|1
922206|NCT00975715|3041460|P1|Maintenance Period|Adverse Event|2
922207|NCT00975715|3041459|P2|Titration Period|Protocol Violation|0
922208|NCT00975715|3041460|P1|Titration Period|Protocol Violation|1
922209|NCT00975715|3041459|P2|Titration Period|Adverse Event|0
922210|NCT00975715|3041460|P1|Titration Period|Adverse Event|6
922211|NCT00975689|3041476|P2|Overall Study|Physician Decision|0
922212|NCT00975689|3041477|P1|Overall Study|Physician Decision|1
922213|NCT00975689|3041476|P2|Overall Study|Withdrawal by Subject|0
922214|NCT00975689|3041477|P1|Overall Study|Withdrawal by Subject|1
922215|NCT00975689|3041476|P2|Overall Study|Adverse Event|3
922216|NCT00975689|3041477|P1|Overall Study|Adverse Event|0
922217|NCT00975611|3041546|P1|Overall Study|Physician Decision|1
922218|NCT00975611|3041546|P1|Overall Study|Screen Fail|16
922219|NCT00975585|3041552|P2|Overall Study|Lens issue|2
922220|NCT00975585|3041553|P1|Overall Study|Lens issue|2
922221|NCT00975585|3041552|P2|Overall Study|Withdrawal by Subject|1
922222|NCT00975585|3041553|P1|Overall Study|Withdrawal by Subject|2
922223|NCT00975585|3041552|P2|Overall Study|Lost to Follow-up|5
922224|NCT00975585|3041553|P1|Overall Study|Lost to Follow-up|3
922225|NCT00975585|3041552|P2|Overall Study|Adverse Event|4
922226|NCT00975585|3041553|P1|Overall Study|Adverse Event|0
922227|NCT00975507|3041573|P2|Overall Study|Withdrawal by Subject|3
922228|NCT00975507|3041574|P1|Overall Study|Withdrawal by Subject|10
922229|NCT00975507|3041573|P2|Overall Study|Protocol Violation|0
922230|NCT00975507|3041574|P1|Overall Study|Protocol Violation|2
922231|NCT00975507|3041573|P2|Overall Study|Lost to Follow-up|1
922232|NCT00975507|3041574|P1|Overall Study|Lost to Follow-up|7
922233|NCT00975507|3041573|P2|Overall Study|Adverse Event|0
922234|NCT00975507|3041574|P1|Overall Study|Adverse Event|1
922235|NCT00975481|3041594|P6|Fifth Intervention Period|Withdrawal by Subject|0
922236|NCT00975481|3041595|P5|Fifth Intervention Period|Withdrawal by Subject|1
922237|NCT00975481|3041596|P4|Fifth Intervention Period|Withdrawal by Subject|0
922238|NCT00975481|3041597|P3|Fifth Intervention Period|Withdrawal by Subject|0
922239|NCT00975481|3041598|P2|Fifth Intervention Period|Withdrawal by Subject|0
922240|NCT00975481|3041599|P1|Fifth Intervention Period|Withdrawal by Subject|0
922241|NCT00975481|3041594|P6|Fourth Intervention Period|Withdrawal by Subject|0
922242|NCT00975481|3041595|P5|Fourth Intervention Period|Withdrawal by Subject|0
922243|NCT00975481|3041596|P4|Fourth Intervention Period|Withdrawal by Subject|1
922244|NCT00975481|3041597|P3|Fourth Intervention Period|Withdrawal by Subject|1
922245|NCT00975481|3041598|P2|Fourth Intervention Period|Withdrawal by Subject|0
922246|NCT00975481|3041599|P1|Fourth Intervention Period|Withdrawal by Subject|0
922247|NCT00975481|3041594|P6|Second Intervention Period|Withdrawal by Subject|0
922248|NCT00975481|3041595|P5|Second Intervention Period|Withdrawal by Subject|0
922249|NCT00975481|3041596|P4|Second Intervention Period|Withdrawal by Subject|0
922250|NCT00975481|3041597|P3|Second Intervention Period|Withdrawal by Subject|1
922251|NCT00975481|3041598|P2|Second Intervention Period|Withdrawal by Subject|0
922252|NCT00975481|3041599|P1|Second Intervention Period|Withdrawal by Subject|0
922253|NCT00975481|3041594|P6|Second Intervention Period|Adverse Event|0
922254|NCT00975481|3041595|P5|Second Intervention Period|Adverse Event|0
922255|NCT00975481|3041596|P4|Second Intervention Period|Adverse Event|0
922256|NCT00975481|3041597|P3|Second Intervention Period|Adverse Event|0
922257|NCT00975481|3041598|P2|Second Intervention Period|Adverse Event|1
922258|NCT00975481|3041599|P1|Second Intervention Period|Adverse Event|2
922259|NCT00975416|3041699|P2|Overall Study|early discharge from tx|5
922260|NCT00975416|3041700|P1|Overall Study|early discharge from tx|3
922261|NCT00975286|3041709|P2|Overall Study|Sponsor Decision|2
922262|NCT00975286|3041710|P1|Overall Study|Sponsor Decision|0
922263|NCT00975286|3041709|P2|Overall Study|Poor Compliance to Protocol|2
922264|NCT00975286|3041710|P1|Overall Study|Poor Compliance to Protocol|0
922265|NCT00975286|3041709|P2|Overall Study|Familial and Personal Reasons|2
922266|NCT00975286|3041710|P1|Overall Study|Familial and Personal Reasons|2
922267|NCT00975286|3041709|P2|Overall Study|Withdrawal by Subject|2
922268|NCT00975286|3041710|P1|Overall Study|Withdrawal by Subject|0
922269|NCT00975286|3041709|P2|Overall Study|Protocol Violation|2
922270|NCT00975286|3041710|P1|Overall Study|Protocol Violation|1
922271|NCT00975286|3041709|P2|Overall Study|Adverse Event|19
922272|NCT00975286|3041710|P1|Overall Study|Adverse Event|9
922273|NCT00975221|3041742|P2|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0
922274|NCT00975221|3041743|P1|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1
922275|NCT00975221|3041742|P2|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
922276|NCT00975221|3041743|P1|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
922277|NCT00975221|3041742|P2|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1
922278|NCT00975221|3041743|P1|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0
922279|NCT00975221|3041742|P2|Titration Phase (Weeks 1-12)|Other|1
922280|NCT00975221|3041743|P1|Titration Phase (Weeks 1-12)|Other|0
922281|NCT00975221|3041742|P2|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0
922282|NCT00975221|3041743|P1|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1
922283|NCT00975221|3041742|P2|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3
922284|NCT00975221|3041743|P1|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2
922285|NCT00975195|3041759|P2|Overall Study|Not treated|2
922286|NCT00975195|3041760|P1|Overall Study|Not treated|1
922287|NCT00975195|3041759|P2|Overall Study|Other reason not defined above|33
922288|NCT00975195|3041760|P1|Overall Study|Other reason not defined above|29
922289|NCT00975195|3041759|P2|Overall Study|Withdrawal by Subject|61
922290|NCT00975195|3041760|P1|Overall Study|Withdrawal by Subject|48
922291|NCT00975195|3041759|P2|Overall Study|Lost to Follow-up|7
922292|NCT00975195|3041760|P1|Overall Study|Lost to Follow-up|9
922293|NCT00975195|3041759|P2|Overall Study|Protocol Violation|23
922294|NCT00975195|3041760|P1|Overall Study|Protocol Violation|27
922295|NCT00975195|3041759|P2|Overall Study|Lack of Efficacy|6
922296|NCT00975195|3041760|P1|Overall Study|Lack of Efficacy|6
922297|NCT00975195|3041759|P2|Overall Study|Adverse Event|101
922298|NCT00975195|3041760|P1|Overall Study|Adverse Event|108
922299|NCT00975156|3041820|P2|Overall Study|Protocol Violation|1
922300|NCT00975156|3041821|P1|Overall Study|Protocol Violation|0
922301|NCT00975143|3041833|P2|Overall Study|Details not available|4
922302|NCT00975143|3041834|P1|Overall Study|Details not available|10
922303|NCT00975143|3041833|P2|Overall Study|Physician Decision|2
922304|NCT00975143|3041834|P1|Overall Study|Physician Decision|1
922305|NCT00975143|3041833|P2|Overall Study|Non-compliance|8
922306|NCT00975143|3041834|P1|Overall Study|Non-compliance|5
922307|NCT00975143|3041833|P2|Overall Study|Lost to Follow-up|16
922308|NCT00975143|3041834|P1|Overall Study|Lost to Follow-up|20
922309|NCT00975143|3041833|P2|Overall Study|Withdrawal by Subject|15
922310|NCT00975143|3041834|P1|Overall Study|Withdrawal by Subject|15
922311|NCT00975143|3041833|P2|Overall Study|Adverse Event|15
922312|NCT00975143|3041834|P1|Overall Study|Adverse Event|19
922313|NCT00975130|3041844|P3|Study Part 2|Protocol Violation|1
922314|NCT00975130|3041845|P2|Study Part 2|Protocol Violation|0
922315|NCT00975130|3041846|P1|Study Part 2|Protocol Violation|0
922316|NCT00975130|3041844|P3|Study Part 2|Administrative|0
922317|NCT00975130|3041845|P2|Study Part 2|Administrative|1
922318|NCT00975130|3041846|P1|Study Part 2|Administrative|0
922319|NCT00975130|3041844|P3|Study Part 2|Did Not Meet Protocol Eligibility|1
922320|NCT00975130|3041845|P2|Study Part 2|Did Not Meet Protocol Eligibility|4
922321|NCT00975130|3041846|P1|Study Part 2|Did Not Meet Protocol Eligibility|0
922322|NCT00975130|3041844|P3|Study Part 2|Withdrew Consent|2
922323|NCT00975130|3041845|P2|Study Part 2|Withdrew Consent|6
922324|NCT00975130|3041846|P1|Study Part 2|Withdrew Consent|0
922325|NCT00975130|3041844|P3|Study Part 2|Withdrawal by Subject|5
922326|NCT00975130|3041845|P2|Study Part 2|Withdrawal by Subject|13
922327|NCT00975130|3041846|P1|Study Part 2|Withdrawal by Subject|0
922328|NCT00975130|3041844|P3|Study Part 2|Lost to Follow-up|1
922329|NCT00975130|3041845|P2|Study Part 2|Lost to Follow-up|0
922330|NCT00975130|3041846|P1|Study Part 2|Lost to Follow-up|0
922331|NCT00975130|3041844|P3|Study Part 2|Adverse Event|7
922332|NCT00975130|3041845|P2|Study Part 2|Adverse Event|14
922333|NCT00975130|3041846|P1|Study Part 2|Adverse Event|0
922334|NCT00975130|3041844|P3|Study Part 1|Withdrew Consent|0
922335|NCT00975130|3041845|P2|Study Part 1|Withdrew Consent|0
922336|NCT00975130|3041846|P1|Study Part 1|Withdrew Consent|24
922337|NCT00975130|3041844|P3|Study Part 1|Administrative|0
922338|NCT00975130|3041845|P2|Study Part 1|Administrative|0
922339|NCT00975130|3041846|P1|Study Part 1|Administrative|4
922340|NCT00975130|3041844|P3|Study Part 1|Did Not Meet Protocol Eligibility|0
922341|NCT00975130|3041845|P2|Study Part 1|Did Not Meet Protocol Eligibility|0
922342|NCT00975130|3041846|P1|Study Part 1|Did Not Meet Protocol Eligibility|9
922343|NCT00975130|3041844|P3|Study Part 1|Protocol Violation|0
922344|NCT00975130|3041845|P2|Study Part 1|Protocol Violation|0
922345|NCT00975130|3041846|P1|Study Part 1|Protocol Violation|13
922346|NCT00975130|3041844|P3|Study Part 1|Withdrawal by Subject|0
922347|NCT00975130|3041845|P2|Study Part 1|Withdrawal by Subject|0
922348|NCT00975130|3041846|P1|Study Part 1|Withdrawal by Subject|61
922349|NCT00975130|3041844|P3|Study Part 1|Lost to Follow-up|0
922350|NCT00975130|3041845|P2|Study Part 1|Lost to Follow-up|0
922351|NCT00975130|3041846|P1|Study Part 1|Lost to Follow-up|19
922352|NCT00975130|3041844|P3|Study Part 1|Adverse Event|0
922353|NCT00975130|3041845|P2|Study Part 1|Adverse Event|0
922354|NCT00975130|3041846|P1|Study Part 1|Adverse Event|150
922355|NCT00975000|3042030|P2|Overall Study|Non-compliance|1
922356|NCT00975000|3042031|P1|Overall Study|Non-compliance|0
922357|NCT00975000|3042030|P2|Overall Study|Protocol-specified Criteria|0
922358|NCT00975000|3042031|P1|Overall Study|Protocol-specified Criteria|1
922359|NCT00975000|3042030|P2|Overall Study|Lost to Follow-up|1
922360|NCT00975000|3042031|P1|Overall Study|Lost to Follow-up|0
922361|NCT00975000|3042030|P2|Overall Study|Withdrawal by Subject|2
922362|NCT00975000|3042031|P1|Overall Study|Withdrawal by Subject|2
922363|NCT00975000|3042030|P2|Overall Study|Adverse Event|1
922364|NCT00975000|3042031|P1|Overall Study|Adverse Event|1
922365|NCT00975000|3042030|P2|Overall Study|Other|0
922366|NCT00975000|3042031|P1|Overall Study|Other|1
922367|NCT00974974|3042055|P2|Maintenance - Double Blind Treatment|Various|0
922368|NCT00974974|3042056|P1|Maintenance - Double Blind Treatment|Various|4
922369|NCT00974974|3042055|P2|Maintenance - Double Blind Treatment|Withdrawal by Subject|2
922370|NCT00974974|3042056|P1|Maintenance - Double Blind Treatment|Withdrawal by Subject|5
922371|NCT00974974|3042055|P2|Maintenance - Double Blind Treatment|Lost to Follow-up|1
922372|NCT00974974|3042056|P1|Maintenance - Double Blind Treatment|Lost to Follow-up|0
922373|NCT00974974|3042055|P2|Maintenance - Double Blind Treatment|Lack of Efficacy|2
922374|NCT00974974|3042056|P1|Maintenance - Double Blind Treatment|Lack of Efficacy|2
922375|NCT00974974|3042055|P2|Maintenance - Double Blind Treatment|Noncompliance with study drug|1
922376|NCT00974974|3042056|P1|Maintenance - Double Blind Treatment|Noncompliance with study drug|0
922377|NCT00974974|3042055|P2|Maintenance - Double Blind Treatment|Protocol Violation|1
922378|NCT00974974|3042056|P1|Maintenance - Double Blind Treatment|Protocol Violation|1
922379|NCT00974974|3042055|P2|Maintenance - Double Blind Treatment|Adverse Event|3
922380|NCT00974974|3042056|P1|Maintenance - Double Blind Treatment|Adverse Event|3
922381|NCT00974974|3042055|P2|IPX066 Dose Conversion|Protocol Violation|0
922382|NCT00974974|3042056|P1|IPX066 Dose Conversion|Protocol Violation|4
922383|NCT00974974|3042055|P2|IPX066 Dose Conversion|Various|0
922384|NCT00974974|3042056|P1|IPX066 Dose Conversion|Various|3
922385|NCT00974974|3042055|P2|IPX066 Dose Conversion|Withdrawal by Subject|0
922386|NCT00974974|3042056|P1|IPX066 Dose Conversion|Withdrawal by Subject|12
922387|NCT00974974|3042055|P2|IPX066 Dose Conversion|Lack of Efficacy|0
922388|NCT00974974|3042056|P1|IPX066 Dose Conversion|Lack of Efficacy|13
922389|NCT00974974|3042055|P2|IPX066 Dose Conversion|Death|0
922390|NCT00974974|3042056|P1|IPX066 Dose Conversion|Death|2
922391|NCT00974974|3042055|P2|IPX066 Dose Conversion|Adverse Event|0
922392|NCT00974974|3042056|P1|IPX066 Dose Conversion|Adverse Event|23
922393|NCT00974974|3042055|P2|IR CD-LD Dose Adjustment|Various|9
922394|NCT00974974|3042056|P1|IR CD-LD Dose Adjustment|Various|0
922395|NCT00974974|3042055|P2|IR CD-LD Dose Adjustment|Withdrawal by Subject|7
922396|NCT00974974|3042056|P1|IR CD-LD Dose Adjustment|Withdrawal by Subject|0
922397|NCT00974974|3042055|P2|IR CD-LD Dose Adjustment|Noncompliance with study drug|1
922398|NCT00974974|3042056|P1|IR CD-LD Dose Adjustment|Noncompliance with study drug|0
922399|NCT00974974|3042055|P2|IR CD-LD Dose Adjustment|Protocol Violation|1
922400|NCT00974974|3042056|P1|IR CD-LD Dose Adjustment|Protocol Violation|0
922401|NCT00974974|3042055|P2|IR CD-LD Dose Adjustment|Adverse Event|3
922402|NCT00974974|3042056|P1|IR CD-LD Dose Adjustment|Adverse Event|0
922403|NCT00974922|3042066|P1|Overall Study|study terminated|24
922404|NCT00974675|3042084|P4|Overall Study|Participant on holiday; unable to attend|1
922405|NCT00974675|3042085|P3|Overall Study|Participant on holiday; unable to attend|0
922406|NCT00974675|3042086|P2|Overall Study|Participant on holiday; unable to attend|0
922407|NCT00974675|3042087|P1|Overall Study|Participant on holiday; unable to attend|0
922408|NCT00974675|3042084|P4|Overall Study|Physician Decision|0
922409|NCT00974675|3042085|P3|Overall Study|Physician Decision|1
922410|NCT00974675|3042086|P2|Overall Study|Physician Decision|0
922411|NCT00974675|3042087|P1|Overall Study|Physician Decision|0
922412|NCT00974675|3042084|P4|Overall Study|Adverse Event|1
922413|NCT00974675|3042085|P3|Overall Study|Adverse Event|1
922414|NCT00974675|3042086|P2|Overall Study|Adverse Event|1
922415|NCT00974675|3042087|P1|Overall Study|Adverse Event|2
922416|NCT00974571|3042136|P3|Overall Study|Other|10
922417|NCT00974571|3042137|P2|Overall Study|Other|0
922418|NCT00974571|3042138|P1|Overall Study|Other|4
922419|NCT00974571|3042136|P3|Overall Study|Patient Moved|1
922420|NCT00974571|3042137|P2|Overall Study|Patient Moved|0
922421|NCT00974571|3042138|P1|Overall Study|Patient Moved|1
922422|NCT00974571|3042136|P3|Overall Study|Withdrawal by Subject|16
922423|NCT00974571|3042137|P2|Overall Study|Withdrawal by Subject|5
922424|NCT00974571|3042138|P1|Overall Study|Withdrawal by Subject|14
922425|NCT00974571|3042136|P3|Overall Study|Protocol Violation|18
922426|NCT00974571|3042137|P2|Overall Study|Protocol Violation|4
922427|NCT00974571|3042138|P1|Overall Study|Protocol Violation|13
922428|NCT00974571|3042136|P3|Overall Study|Lost to Follow-up|2
922429|NCT00974571|3042137|P2|Overall Study|Lost to Follow-up|1
922430|NCT00974571|3042138|P1|Overall Study|Lost to Follow-up|2
922431|NCT00974571|3042136|P3|Overall Study|Lack of Efficacy|9
922432|NCT00974571|3042137|P2|Overall Study|Lack of Efficacy|2
922433|NCT00974571|3042138|P1|Overall Study|Lack of Efficacy|3
922434|NCT00974571|3042136|P3|Overall Study|Adverse Event|27
922435|NCT00974571|3042137|P2|Overall Study|Adverse Event|4
922436|NCT00974571|3042138|P1|Overall Study|Adverse Event|31
922437|NCT00974311|3042235|P2|Overall Study|Continuing Treatment|19
922438|NCT00974311|3042236|P1|Overall Study|Continuing Treatment|231
922439|NCT00974311|3042235|P2|Overall Study|Withdrawal of consent|5
922440|NCT00974311|3042236|P1|Overall Study|Withdrawal of consent|9
922441|NCT00974311|3042235|P2|Overall Study|Death|211
922442|NCT00974311|3042236|P1|Overall Study|Death|305
922443|NCT00974311|3042235|P2|Overall Study|Lost to Follow-up|1
922444|NCT00974311|3042236|P1|Overall Study|Lost to Follow-up|1
922445|NCT00974233|3042266|P1|Maintenance Lenalidomide|Adverse Event|8
922446|NCT00974233|3042266|P1|Maintenance Lenalidomide|Lack of Efficacy|5
922447|NCT00974233|3042266|P1|Induction Chemoimmunotherapy|Withdrawal by Subject|1
922448|NCT00974233|3042266|P1|Induction Chemoimmunotherapy|Adverse Event|7
922449|NCT00974233|3042266|P1|Induction Chemoimmunotherapy|Lack of Efficacy|5
922450|NCT00974233|3042266|P1|Induction Chemoimmunotherapy|Death|2
922451|NCT00974220|3042281|P2|Treatment Period 1|noncompliant subjects|1
922452|NCT00974220|3042282|P1|Treatment Period 1|noncompliant subjects|0
922453|NCT00974220|3042281|P2|Treatment Period 1|Adverse Event|1
922454|NCT00974220|3042282|P1|Treatment Period 1|Adverse Event|2
922455|NCT00974090|3042327|P2|Period 2: Open-label Period|Withdrawal by Subject|0
922456|NCT00974090|3042328|P1|Period 2: Open-label Period|Withdrawal by Subject|1
922457|NCT00974090|3042327|P2|Period 2: Open-label Period|Physician Decision|3
922458|NCT00974090|3042328|P1|Period 2: Open-label Period|Physician Decision|0
922459|NCT00974090|3042327|P2|Period 2: Open-label Period|Lack of Efficacy|1
922460|NCT00974090|3042328|P1|Period 2: Open-label Period|Lack of Efficacy|3
922461|NCT00974090|3042327|P2|Period 2: Open-label Period|Adverse Event|6
922462|NCT00974090|3042328|P1|Period 2: Open-label Period|Adverse Event|4
922463|NCT00974090|3042327|P2|Period 1: Double Blind Period|Physician Decision|0
922464|NCT00974090|3042328|P1|Period 1: Double Blind Period|Physician Decision|1
922465|NCT00974090|3042327|P2|Period 1: Double Blind Period|Adverse Event|1
922466|NCT00974090|3042328|P1|Period 1: Double Blind Period|Adverse Event|2
922467|NCT00973973|3042364|P2|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0
922468|NCT00973973|3042365|P1|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1
922469|NCT00973973|3042364|P2|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0
922470|NCT00973973|3042365|P1|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1
922471|NCT00973973|3042364|P2|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3
922472|NCT00973973|3042365|P1|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1
922473|NCT00973973|3042364|P2|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0
922474|NCT00973973|3042365|P1|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1
922475|NCT00973973|3042364|P2|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0
922476|NCT00973973|3042365|P1|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1
922477|NCT00973973|3042364|P2|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2
922478|NCT00973973|3042365|P1|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1
922479|NCT00973973|3042364|P2|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
922480|NCT00973973|3042365|P1|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
922481|NCT00973973|3042364|P2|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
922482|NCT00973973|3042365|P1|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
922483|NCT00973973|3042364|P2|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0
922484|NCT00973973|3042365|P1|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1
922485|NCT00973973|3042364|P2|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3
922486|NCT00973973|3042365|P1|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1
922487|NCT00973973|3042364|P2|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0
922488|NCT00973973|3042365|P1|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1
922489|NCT00973973|3042364|P2|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3
922490|NCT00973973|3042365|P1|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1
922491|NCT00973921|3042425|P1|Overall Study|IVUS results were not available|9
922492|NCT00973765|3042434|P2|Overall Study|Lost to Follow-up|14
922493|NCT00973765|3042435|P1|Overall Study|Lost to Follow-up|8
922494|NCT00973700|3042457|P5|Overall Study|Unable to Classify|1
922495|NCT00973700|3042458|P4|Overall Study|Unable to Classify|2
922496|NCT00973700|3042459|P3|Overall Study|Unable to Classify|1
922497|NCT00973700|3042460|P2|Overall Study|Unable to Classify|0
922498|NCT00973700|3042461|P1|Overall Study|Unable to Classify|0
922499|NCT00973700|3042457|P5|Overall Study|Inappropriate enrolment|0
922500|NCT00973700|3042458|P4|Overall Study|Inappropriate enrolment|4
922501|NCT00973700|3042459|P3|Overall Study|Inappropriate enrolment|0
922502|NCT00973700|3042460|P2|Overall Study|Inappropriate enrolment|0
922503|NCT00973700|3042461|P1|Overall Study|Inappropriate enrolment|0
922504|NCT00973700|3042457|P5|Overall Study|Lost to Follow-up|5
922505|NCT00973700|3042458|P4|Overall Study|Lost to Follow-up|8
922506|NCT00973700|3042459|P3|Overall Study|Lost to Follow-up|1
922507|NCT00973700|3042460|P2|Overall Study|Lost to Follow-up|0
922508|NCT00973700|3042461|P1|Overall Study|Lost to Follow-up|5
922509|NCT00973700|3042457|P5|Overall Study|Withdrawal by Subject|4
922510|NCT00973700|3042458|P4|Overall Study|Withdrawal by Subject|4
922511|NCT00973700|3042459|P3|Overall Study|Withdrawal by Subject|8
922512|NCT00973700|3042460|P2|Overall Study|Withdrawal by Subject|2
922513|NCT00973700|3042461|P1|Overall Study|Withdrawal by Subject|2
922514|NCT00973622|3042510|P2|Overall Study|did not complete rTMS sessions|2
922515|NCT00973622|3042511|P1|Overall Study|did not complete rTMS sessions|11
922516|NCT00973622|3042510|P2|Overall Study|did not pass MRI screen|0
922517|NCT00973622|3042511|P1|Overall Study|did not pass MRI screen|6
922518|NCT00973622|3042510|P2|Overall Study|did not attend MRI|3
922519|NCT00973622|3042511|P1|Overall Study|did not attend MRI|14
922520|NCT00973479|3042519|P2|Overall Study|Not Specified|7
922521|NCT00973479|3042520|P1|Overall Study|Not Specified|1
922522|NCT00973479|3042519|P2|Overall Study|Protocol Violation|2
922523|NCT00973479|3042520|P1|Overall Study|Protocol Violation|2
922524|NCT00973479|3042519|P2|Overall Study|Adverse Event|32
922525|NCT00973479|3042520|P1|Overall Study|Adverse Event|12
922526|NCT00973479|3042519|P2|Overall Study|Lack of Efficacy|7
922527|NCT00973479|3042520|P1|Overall Study|Lack of Efficacy|5
922528|NCT00973479|3042519|P2|Overall Study|Withdrawal by Subject|16
922529|NCT00973479|3042520|P1|Overall Study|Withdrawal by Subject|15
922530|NCT00973479|3042519|P2|Overall Study|Death|2
922531|NCT00973479|3042520|P1|Overall Study|Death|2
922532|NCT00973479|3042519|P2|Overall Study|Lost to Follow-up|3
922533|NCT00973479|3042520|P1|Overall Study|Lost to Follow-up|0
922534|NCT00973362|3042538|P2|3-Year Follow-up|Lost to Follow-up|0
922535|NCT00973362|3042539|P1|3-Year Follow-up|Lost to Follow-up|17
922536|NCT00973362|3042538|P2|Baseline Evaluation|Inevaluable|223
922537|NCT00973362|3042539|P1|Baseline Evaluation|Inevaluable|686
922538|NCT00973362|3042538|P2|Baseline Evaluation|No colposcopy visit|0
922539|NCT00973362|3042539|P1|Baseline Evaluation|No colposcopy visit|62
922540|NCT00973362|3042538|P2|Baseline Evaluation|W/D, later determined to be ineligible|0
922541|NCT00973362|3042539|P1|Baseline Evaluation|W/D, later determined to be ineligible|25
922542|NCT00973349|3042564|P16|Overall Study|Unable to classify|0
922543|NCT00973349|3042565|P15|Overall Study|Unable to classify|0
922544|NCT00973349|3042566|P14|Overall Study|Unable to classify|0
922545|NCT00973349|3042567|P13|Overall Study|Unable to classify|0
922546|NCT00973349|3042568|P12|Overall Study|Unable to classify|0
922547|NCT00973349|3042569|P11|Overall Study|Unable to classify|0
922548|NCT00973349|3042570|P10|Overall Study|Unable to classify|1
922549|NCT00973349|3042571|P9|Overall Study|Unable to classify|0
922550|NCT00973349|3042572|P8|Overall Study|Unable to classify|0
922551|NCT00973349|3042573|P7|Overall Study|Unable to classify|0
922552|NCT00973349|3042574|P6|Overall Study|Unable to classify|1
922553|NCT00973349|3042575|P5|Overall Study|Unable to classify|1
922554|NCT00973349|3042576|P4|Overall Study|Unable to classify|0
922555|NCT00973349|3042577|P3|Overall Study|Unable to classify|0
922556|NCT00973349|3042578|P2|Overall Study|Unable to classify|0
922557|NCT00973349|3042579|P1|Overall Study|Unable to classify|0
922558|NCT00973349|3042564|P16|Overall Study|Protocol Violation|0
922559|NCT00973349|3042565|P15|Overall Study|Protocol Violation|0
922560|NCT00973349|3042566|P14|Overall Study|Protocol Violation|0
922561|NCT00973349|3042567|P13|Overall Study|Protocol Violation|0
922562|NCT00973349|3042568|P12|Overall Study|Protocol Violation|0
922563|NCT00973349|3042569|P11|Overall Study|Protocol Violation|0
922564|NCT00973349|3042570|P10|Overall Study|Protocol Violation|0
922565|NCT00973349|3042571|P9|Overall Study|Protocol Violation|1
922566|NCT00973349|3042572|P8|Overall Study|Protocol Violation|0
922567|NCT00973349|3042573|P7|Overall Study|Protocol Violation|0
922568|NCT00973349|3042574|P6|Overall Study|Protocol Violation|0
922569|NCT00973349|3042575|P5|Overall Study|Protocol Violation|0
922570|NCT00973349|3042576|P4|Overall Study|Protocol Violation|0
922571|NCT00973349|3042577|P3|Overall Study|Protocol Violation|0
922572|NCT00973349|3042578|P2|Overall Study|Protocol Violation|0
922573|NCT00973349|3042579|P1|Overall Study|Protocol Violation|0
922574|NCT00973349|3042564|P16|Overall Study|Inappropriate enrolment|1
922575|NCT00973349|3042565|P15|Overall Study|Inappropriate enrolment|1
922576|NCT00973349|3042566|P14|Overall Study|Inappropriate enrolment|0
922577|NCT00973349|3042567|P13|Overall Study|Inappropriate enrolment|1
922578|NCT00973349|3042568|P12|Overall Study|Inappropriate enrolment|0
922579|NCT00973349|3042569|P11|Overall Study|Inappropriate enrolment|0
922580|NCT00973349|3042570|P10|Overall Study|Inappropriate enrolment|2
922581|NCT00973349|3042571|P9|Overall Study|Inappropriate enrolment|0
922582|NCT00973349|3042572|P8|Overall Study|Inappropriate enrolment|0
922583|NCT00973349|3042573|P7|Overall Study|Inappropriate enrolment|0
922584|NCT00973349|3042574|P6|Overall Study|Inappropriate enrolment|0
922585|NCT00973349|3042575|P5|Overall Study|Inappropriate enrolment|0
922586|NCT00973349|3042576|P4|Overall Study|Inappropriate enrolment|0
922587|NCT00973349|3042577|P3|Overall Study|Inappropriate enrolment|1
922588|NCT00973349|3042578|P2|Overall Study|Inappropriate enrolment|0
922589|NCT00973349|3042579|P1|Overall Study|Inappropriate enrolment|0
922590|NCT00973349|3042564|P16|Overall Study|Lost to Follow-up|1
922591|NCT00973349|3042565|P15|Overall Study|Lost to Follow-up|0
922592|NCT00973349|3042566|P14|Overall Study|Lost to Follow-up|0
922593|NCT00973349|3042567|P13|Overall Study|Lost to Follow-up|0
922594|NCT00973349|3042568|P12|Overall Study|Lost to Follow-up|1
922595|NCT00973349|3042569|P11|Overall Study|Lost to Follow-up|0
922596|NCT00973349|3042570|P10|Overall Study|Lost to Follow-up|1
922597|NCT00973349|3042571|P9|Overall Study|Lost to Follow-up|2
922598|NCT00973349|3042572|P8|Overall Study|Lost to Follow-up|1
922599|NCT00973349|3042573|P7|Overall Study|Lost to Follow-up|0
922600|NCT00973349|3042574|P6|Overall Study|Lost to Follow-up|3
922601|NCT00973349|3042575|P5|Overall Study|Lost to Follow-up|1
922602|NCT00973349|3042576|P4|Overall Study|Lost to Follow-up|2
922603|NCT00973349|3042577|P3|Overall Study|Lost to Follow-up|2
922604|NCT00973349|3042578|P2|Overall Study|Lost to Follow-up|1
922605|NCT00973349|3042579|P1|Overall Study|Lost to Follow-up|3
922606|NCT00973349|3042564|P16|Overall Study|Withdrawal by Subject|0
922607|NCT00973349|3042565|P15|Overall Study|Withdrawal by Subject|0
922608|NCT00973349|3042566|P14|Overall Study|Withdrawal by Subject|0
922609|NCT00973349|3042567|P13|Overall Study|Withdrawal by Subject|0
922610|NCT00973349|3042568|P12|Overall Study|Withdrawal by Subject|1
922611|NCT00973349|3042569|P11|Overall Study|Withdrawal by Subject|0
922612|NCT00973349|3042570|P10|Overall Study|Withdrawal by Subject|2
922613|NCT00973349|3042571|P9|Overall Study|Withdrawal by Subject|0
922614|NCT00973349|3042572|P8|Overall Study|Withdrawal by Subject|2
922615|NCT00973349|3042573|P7|Overall Study|Withdrawal by Subject|2
922616|NCT00973349|3042574|P6|Overall Study|Withdrawal by Subject|0
922617|NCT00973349|3042575|P5|Overall Study|Withdrawal by Subject|2
922618|NCT00973349|3042576|P4|Overall Study|Withdrawal by Subject|3
922619|NCT00973349|3042577|P3|Overall Study|Withdrawal by Subject|2
922620|NCT00973349|3042578|P2|Overall Study|Withdrawal by Subject|2
922621|NCT00973349|3042579|P1|Overall Study|Withdrawal by Subject|1
922622|NCT00973349|3042564|P16|Overall Study|Adverse Event|0
922623|NCT00973349|3042565|P15|Overall Study|Adverse Event|1
922624|NCT00973349|3042566|P14|Overall Study|Adverse Event|0
922625|NCT00973349|3042567|P13|Overall Study|Adverse Event|0
922626|NCT00973349|3042568|P12|Overall Study|Adverse Event|0
922627|NCT00973349|3042569|P11|Overall Study|Adverse Event|0
922628|NCT00973349|3042570|P10|Overall Study|Adverse Event|0
922629|NCT00973349|3042571|P9|Overall Study|Adverse Event|1
922630|NCT00973349|3042572|P8|Overall Study|Adverse Event|0
922631|NCT00973349|3042573|P7|Overall Study|Adverse Event|0
922632|NCT00973349|3042574|P6|Overall Study|Adverse Event|0
922633|NCT00973349|3042575|P5|Overall Study|Adverse Event|1
922634|NCT00973349|3042576|P4|Overall Study|Adverse Event|0
922635|NCT00973349|3042577|P3|Overall Study|Adverse Event|0
922636|NCT00973349|3042578|P2|Overall Study|Adverse Event|0
922637|NCT00973349|3042579|P1|Overall Study|Adverse Event|0
922638|NCT00972816|3042700|P8|Overall Study|Unable to classify|0
922639|NCT00972816|3042701|P7|Overall Study|Unable to classify|0
922640|NCT00972816|3042702|P6|Overall Study|Unable to classify|0
922641|NCT00972816|3042703|P5|Overall Study|Unable to classify|1
922642|NCT00972816|3042704|P4|Overall Study|Unable to classify|0
922643|NCT00972816|3042705|P3|Overall Study|Unable to classify|0
922644|NCT00972816|3042706|P2|Overall Study|Unable to classify|0
922645|NCT00972816|3042707|P1|Overall Study|Unable to classify|2
922646|NCT00972816|3042700|P8|Overall Study|Inappropriate enrolment|0
922647|NCT00972816|3042701|P7|Overall Study|Inappropriate enrolment|2
922648|NCT00972816|3042702|P6|Overall Study|Inappropriate enrolment|0
922649|NCT00972816|3042703|P5|Overall Study|Inappropriate enrolment|0
922650|NCT00972816|3042704|P4|Overall Study|Inappropriate enrolment|0
922651|NCT00972816|3042705|P3|Overall Study|Inappropriate enrolment|0
922652|NCT00972816|3042706|P2|Overall Study|Inappropriate enrolment|0
922653|NCT00972816|3042707|P1|Overall Study|Inappropriate enrolment|0
922654|NCT00972816|3042700|P8|Overall Study|Lost to Follow-up|7
922655|NCT00972816|3042701|P7|Overall Study|Lost to Follow-up|7
922656|NCT00972816|3042702|P6|Overall Study|Lost to Follow-up|10
922657|NCT00972816|3042703|P5|Overall Study|Lost to Follow-up|11
922658|NCT00972816|3042704|P4|Overall Study|Lost to Follow-up|5
922659|NCT00972816|3042705|P3|Overall Study|Lost to Follow-up|7
922660|NCT00972816|3042706|P2|Overall Study|Lost to Follow-up|9
922661|NCT00972816|3042707|P1|Overall Study|Lost to Follow-up|11
922662|NCT00972816|3042700|P8|Overall Study|Withdrawal by Subject|2
922663|NCT00972816|3042701|P7|Overall Study|Withdrawal by Subject|1
922664|NCT00972816|3042702|P6|Overall Study|Withdrawal by Subject|1
922665|NCT00972816|3042703|P5|Overall Study|Withdrawal by Subject|0
922666|NCT00972816|3042704|P4|Overall Study|Withdrawal by Subject|3
922667|NCT00972816|3042705|P3|Overall Study|Withdrawal by Subject|1
922668|NCT00972816|3042706|P2|Overall Study|Withdrawal by Subject|2
922669|NCT00972816|3042707|P1|Overall Study|Withdrawal by Subject|4
922670|NCT00972816|3042700|P8|Overall Study|Adverse Event|0
922671|NCT00972816|3042701|P7|Overall Study|Adverse Event|0
922672|NCT00972816|3042702|P6|Overall Study|Adverse Event|0
922673|NCT00972816|3042703|P5|Overall Study|Adverse Event|0
922674|NCT00972816|3042704|P4|Overall Study|Adverse Event|0
922675|NCT00972816|3042705|P3|Overall Study|Adverse Event|1
922676|NCT00972816|3042706|P2|Overall Study|Adverse Event|0
922677|NCT00972816|3042707|P1|Overall Study|Adverse Event|0
922678|NCT00972777|3042791|P2|Overall Study|Missed visit|0
922679|NCT00972777|3042792|P1|Overall Study|Missed visit|1
922680|NCT00972777|3042791|P2|Overall Study|Screening Failure|1
922681|NCT00972777|3042792|P1|Overall Study|Screening Failure|2
922682|NCT00972777|3042791|P2|Overall Study|Protocol Violation|2
922683|NCT00972777|3042792|P1|Overall Study|Protocol Violation|0
922684|NCT00972777|3042791|P2|Overall Study|Physician Decision|0
922685|NCT00972777|3042792|P1|Overall Study|Physician Decision|4
922686|NCT00972777|3042791|P2|Overall Study|Withdrawal by Subject|5
922687|NCT00972777|3042792|P1|Overall Study|Withdrawal by Subject|4
922688|NCT00972777|3042791|P2|Overall Study|Lost to Follow-up|4
922689|NCT00972777|3042792|P1|Overall Study|Lost to Follow-up|0
922690|NCT00972777|3042791|P2|Overall Study|Adverse Event|2
922691|NCT00972777|3042792|P1|Overall Study|Adverse Event|3
922692|NCT00972738|3042807|P3|Overall Study|Other|1
922693|NCT00972738|3042808|P2|Overall Study|Other|2
922694|NCT00972738|3042809|P1|Overall Study|Other|1
922695|NCT00972738|3042807|P3|Overall Study|Moved|1
922696|NCT00972738|3042808|P2|Overall Study|Moved|0
922697|NCT00972738|3042809|P1|Overall Study|Moved|0
922698|NCT00972738|3042807|P3|Overall Study|Withdrawal by Subject|4
922699|NCT00972738|3042808|P2|Overall Study|Withdrawal by Subject|1
922700|NCT00972738|3042809|P1|Overall Study|Withdrawal by Subject|5
922701|NCT00972738|3042807|P3|Overall Study|Lack of Efficacy|11
922702|NCT00972738|3042808|P2|Overall Study|Lack of Efficacy|1
922703|NCT00972738|3042809|P1|Overall Study|Lack of Efficacy|5
922704|NCT00972738|3042807|P3|Overall Study|Lost to Follow-up|1
922705|NCT00972738|3042808|P2|Overall Study|Lost to Follow-up|0
922706|NCT00972738|3042809|P1|Overall Study|Lost to Follow-up|1
922707|NCT00972738|3042807|P3|Overall Study|Protocol Violation|3
922708|NCT00972738|3042808|P2|Overall Study|Protocol Violation|1
922709|NCT00972738|3042809|P1|Overall Study|Protocol Violation|2
922710|NCT00972738|3042807|P3|Overall Study|Adverse Event|8
922711|NCT00972738|3042808|P2|Overall Study|Adverse Event|1
922712|NCT00972738|3042809|P1|Overall Study|Adverse Event|7
922713|NCT00972595|3042926|P2|Period 1|Adverse Event|0
922714|NCT00972595|3042927|P1|Period 1|Adverse Event|1
922715|NCT00972543|3042937|P2|Overall Study|Early study termination by sponsor|1
922716|NCT00972543|3042938|P1|Overall Study|Early study termination by sponsor|4
922717|NCT00972543|3042937|P2|Overall Study|Adverse Event|0
922718|NCT00972543|3042938|P1|Overall Study|Adverse Event|1
922719|NCT00972517|3043021|P6|Overall Study|Withdrawal by Subject|0
922720|NCT00972517|3043022|P5|Overall Study|Withdrawal by Subject|1
922721|NCT00972517|3043023|P4|Overall Study|Withdrawal by Subject|2
922722|NCT00972517|3043024|P3|Overall Study|Withdrawal by Subject|0
922723|NCT00972517|3043025|P2|Overall Study|Withdrawal by Subject|1
922724|NCT00972517|3043026|P1|Overall Study|Withdrawal by Subject|0
922725|NCT00972517|3043021|P6|Overall Study|Adverse Event|0
922726|NCT00972517|3043022|P5|Overall Study|Adverse Event|0
922727|NCT00972517|3043023|P4|Overall Study|Adverse Event|1
922728|NCT00972517|3043024|P3|Overall Study|Adverse Event|0
922729|NCT00972517|3043025|P2|Overall Study|Adverse Event|0
922730|NCT00972517|3043026|P1|Overall Study|Adverse Event|0
922731|NCT00972504|3043121|P1|Overall Study|Investigator discretion|1
922732|NCT00972504|3043121|P1|Overall Study|Adverse Event|2
922733|NCT00972478|3043153|P2|Overall Study|Not start protocol treatment|2
922734|NCT00972478|3043154|P1|Overall Study|Not start protocol treatment|1
922735|NCT00972478|3043153|P2|Overall Study|Ineligible|7
922736|NCT00972478|3043154|P1|Overall Study|Ineligible|1
922737|NCT00972478|3043153|P2|Overall Study|Not protocol specified|1
922738|NCT00972478|3043154|P1|Overall Study|Not protocol specified|1
922739|NCT00972478|3043153|P2|Overall Study|Death|2
922740|NCT00972478|3043154|P1|Overall Study|Death|0
922741|NCT00972478|3043153|P2|Overall Study|Progression/Relapse|2
922742|NCT00972478|3043154|P1|Overall Study|Progression/Relapse|0
922743|NCT00972478|3043153|P2|Overall Study|Withdrawal by Subject|8
922744|NCT00972478|3043154|P1|Overall Study|Withdrawal by Subject|1
922745|NCT00972478|3043153|P2|Overall Study|Adverse Event|16
922746|NCT00972478|3043154|P1|Overall Study|Adverse Event|3
922747|NCT00972322|3043199|P2|Overall Study|Consistently high glucose values|0
922748|NCT00972322|3043200|P1|Overall Study|Consistently high glucose values|1
922749|NCT00972322|3043199|P2|Overall Study|Lost to Follow-up|1
922750|NCT00972322|3043200|P1|Overall Study|Lost to Follow-up|0
922751|NCT00972322|3043199|P2|Overall Study|Positive drug screen|1
922752|NCT00972322|3043200|P1|Overall Study|Positive drug screen|0
922753|NCT00972322|3043199|P2|Overall Study|Adverse Event|1
922754|NCT00972322|3043200|P1|Overall Study|Adverse Event|2
922755|NCT00972283|3043212|P2|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5
922756|NCT00972283|3043213|P1|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11
922757|NCT00972283|3043212|P2|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2
922758|NCT00972283|3043213|P1|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6
922759|NCT00972283|3043212|P2|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0
922760|NCT00972283|3043213|P1|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5
922761|NCT00972283|3043212|P2|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
922762|NCT00972283|3043213|P1|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
922763|NCT00972283|3043212|P2|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0
922764|NCT00972283|3043213|P1|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4
922765|NCT00972283|3043212|P2|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17
922766|NCT00972283|3043213|P1|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72
922767|NCT00972283|3043212|P2|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2
922768|NCT00972283|3043213|P1|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8
922769|NCT00972283|3043212|P2|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12
922770|NCT00972283|3043213|P1|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23
922771|NCT00972283|3043212|P2|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0
922772|NCT00972283|3043213|P1|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3
922773|NCT00972283|3043212|P2|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9
922774|NCT00972283|3043213|P1|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31
922775|NCT00972244|3043240|P5|Overall Study|Various|2
922776|NCT00972244|3043241|P4|Overall Study|Various|0
922777|NCT00972244|3043242|P3|Overall Study|Various|0
922778|NCT00972244|3043243|P2|Overall Study|Various|0
922779|NCT00972244|3043244|P1|Overall Study|Various|0
922780|NCT00972244|3043240|P5|Overall Study|Death|0
922781|NCT00972244|3043241|P4|Overall Study|Death|0
922782|NCT00972244|3043242|P3|Overall Study|Death|0
922783|NCT00972244|3043243|P2|Overall Study|Death|0
922784|NCT00972244|3043244|P1|Overall Study|Death|1
922785|NCT00972244|3043240|P5|Overall Study|Safety|1
922786|NCT00972244|3043241|P4|Overall Study|Safety|0
922787|NCT00972244|3043242|P3|Overall Study|Safety|0
922788|NCT00972244|3043243|P2|Overall Study|Safety|0
922789|NCT00972244|3043244|P1|Overall Study|Safety|0
922790|NCT00972244|3043240|P5|Overall Study|Withdrawal by Subject|1
922791|NCT00972244|3043241|P4|Overall Study|Withdrawal by Subject|0
922792|NCT00972244|3043242|P3|Overall Study|Withdrawal by Subject|1
922793|NCT00972244|3043243|P2|Overall Study|Withdrawal by Subject|2
922794|NCT00972244|3043244|P1|Overall Study|Withdrawal by Subject|1
922795|NCT00972244|3043240|P5|Overall Study|Subject No Longer Meets Study Criteria|5
922796|NCT00972244|3043241|P4|Overall Study|Subject No Longer Meets Study Criteria|0
922797|NCT00972244|3043242|P3|Overall Study|Subject No Longer Meets Study Criteria|0
922798|NCT00972244|3043243|P2|Overall Study|Subject No Longer Meets Study Criteria|2
922799|NCT00972244|3043244|P1|Overall Study|Subject No Longer Meets Study Criteria|2
922800|NCT00972244|3043240|P5|Overall Study|Adverse Event|0
922801|NCT00972244|3043241|P4|Overall Study|Adverse Event|0
922802|NCT00972244|3043242|P3|Overall Study|Adverse Event|1
922803|NCT00972244|3043243|P2|Overall Study|Adverse Event|1
922804|NCT00972244|3043244|P1|Overall Study|Adverse Event|0
922805|NCT00972244|3043240|P5|Overall Study|Incorrect Enrolment|0
922806|NCT00972244|3043241|P4|Overall Study|Incorrect Enrolment|0
922807|NCT00972244|3043242|P3|Overall Study|Incorrect Enrolment|0
922808|NCT00972244|3043243|P2|Overall Study|Incorrect Enrolment|0
922809|NCT00972244|3043244|P1|Overall Study|Incorrect Enrolment|1
922810|NCT00972153|3043276|P3|Overall Study|Equipment malfunction during case|0
922811|NCT00972153|3043277|P2|Overall Study|Equipment malfunction during case|1
922812|NCT00972153|3043278|P1|Overall Study|Equipment malfunction during case|0
922813|NCT00972023|3043293|P1|Overall Study|Withdrawal by Subject|1
922814|NCT00971997|3043300|P1|Overall Study|Physician Decision|7
922815|NCT00971997|3043300|P1|Overall Study|Withdrawal by Subject|5
922816|NCT00971997|3043300|P1|Overall Study|Protocol Violation|4
922817|NCT00971997|3043300|P1|Overall Study|Death|1
922818|NCT00971997|3043300|P1|Overall Study|Adverse Event|2
922819|NCT00971932|3043318|P1|Overall Study|Ongoing|4
922820|NCT00971932|3043318|P1|Overall Study|Investigator's decision|2
922821|NCT00971932|3043318|P1|Overall Study|Withdrawal by Subject|1
922822|NCT00971425|3043398|P2|Overall Study|Withdrawal by Subject|1
922823|NCT00971425|3043399|P1|Overall Study|Withdrawal by Subject|0
922824|NCT00971425|3043398|P2|Overall Study|Adverse Event|1
922825|NCT00971425|3043399|P1|Overall Study|Adverse Event|1
922826|NCT00971243|3043463|P5|Open-label Period|Other reason|2
922827|NCT00971243|3043464|P4|Open-label Period|Other reason|0
922828|NCT00971243|3043465|P3|Open-label Period|Other reason|0
922829|NCT00971243|3043466|P2|Open-label Period|Other reason|0
922830|NCT00971243|3043467|P1|Open-label Period|Other reason|0
922831|NCT00971243|3043463|P5|Open-label Period|Withdrawal by Subject|1
922832|NCT00971243|3043464|P4|Open-label Period|Withdrawal by Subject|2
922833|NCT00971243|3043465|P3|Open-label Period|Withdrawal by Subject|0
922834|NCT00971243|3043466|P2|Open-label Period|Withdrawal by Subject|0
922835|NCT00971243|3043467|P1|Open-label Period|Withdrawal by Subject|1
922836|NCT00971243|3043463|P5|Open-label Period|Protocol Violation|1
922837|NCT00971243|3043464|P4|Open-label Period|Protocol Violation|0
922838|NCT00971243|3043465|P3|Open-label Period|Protocol Violation|1
922839|NCT00971243|3043466|P2|Open-label Period|Protocol Violation|1
922840|NCT00971243|3043467|P1|Open-label Period|Protocol Violation|1
922841|NCT00971243|3043463|P5|Open-label Period|Physician Decision|2
922842|NCT00971243|3043464|P4|Open-label Period|Physician Decision|7
922843|NCT00971243|3043465|P3|Open-label Period|Physician Decision|3
922844|NCT00971243|3043466|P2|Open-label Period|Physician Decision|9
922845|NCT00971243|3043467|P1|Open-label Period|Physician Decision|5
922846|NCT00971243|3043463|P5|Open-label Period|Adverse Event|0
922847|NCT00971243|3043464|P4|Open-label Period|Adverse Event|1
922848|NCT00971243|3043465|P3|Open-label Period|Adverse Event|1
922849|NCT00971243|3043466|P2|Open-label Period|Adverse Event|0
922850|NCT00971243|3043467|P1|Open-label Period|Adverse Event|1
922851|NCT00971243|3043463|P5|Double Blind Period|Other reasons|1
922852|NCT00971243|3043464|P4|Double Blind Period|Other reasons|0
922853|NCT00971243|3043465|P3|Double Blind Period|Other reasons|2
922854|NCT00971243|3043466|P2|Double Blind Period|Other reasons|0
922855|NCT00971243|3043467|P1|Double Blind Period|Other reasons|1
922856|NCT00971243|3043463|P5|Double Blind Period|Withdrawal by Subject|4
922857|NCT00971243|3043464|P4|Double Blind Period|Withdrawal by Subject|4
922858|NCT00971243|3043465|P3|Double Blind Period|Withdrawal by Subject|4
922859|NCT00971243|3043466|P2|Double Blind Period|Withdrawal by Subject|1
922860|NCT00971243|3043467|P1|Double Blind Period|Withdrawal by Subject|4
922861|NCT00971243|3043463|P5|Double Blind Period|Protocol Violation|2
922862|NCT00971243|3043464|P4|Double Blind Period|Protocol Violation|2
922863|NCT00971243|3043465|P3|Double Blind Period|Protocol Violation|3
922864|NCT00971243|3043466|P2|Double Blind Period|Protocol Violation|0
922865|NCT00971243|3043467|P1|Double Blind Period|Protocol Violation|2
922866|NCT00971243|3043463|P5|Double Blind Period|Physician Decision|7
922867|NCT00971243|3043464|P4|Double Blind Period|Physician Decision|6
922868|NCT00971243|3043465|P3|Double Blind Period|Physician Decision|7
922869|NCT00971243|3043466|P2|Double Blind Period|Physician Decision|6
922870|NCT00971243|3043467|P1|Double Blind Period|Physician Decision|10
922871|NCT00971243|3043463|P5|Double Blind Period|Lost to Follow-up|1
922872|NCT00971243|3043464|P4|Double Blind Period|Lost to Follow-up|0
922873|NCT00971243|3043465|P3|Double Blind Period|Lost to Follow-up|1
922874|NCT00971243|3043466|P2|Double Blind Period|Lost to Follow-up|1
922875|NCT00971243|3043467|P1|Double Blind Period|Lost to Follow-up|0
922876|NCT00971243|3043463|P5|Double Blind Period|Adverse Event|3
922877|NCT00971243|3043464|P4|Double Blind Period|Adverse Event|2
922878|NCT00971243|3043465|P3|Double Blind Period|Adverse Event|2
922879|NCT00971243|3043466|P2|Double Blind Period|Adverse Event|3
922880|NCT00971243|3043467|P1|Double Blind Period|Adverse Event|2
922881|NCT00971204|3043484|P1|Overall Study|Lost to Follow-up|10
922882|NCT00971204|3043484|P1|Overall Study|Did not meet all criteria-not treated|14
922883|NCT00971048|3043492|P4|Overall Study|Physician Decision|1
922884|NCT00971048|3043493|P3|Overall Study|Physician Decision|0
922885|NCT00971048|3043494|P2|Overall Study|Physician Decision|0
922886|NCT00971048|3043495|P1|Overall Study|Physician Decision|0
922887|NCT00971048|3043492|P4|Overall Study|Adverse Event|0
922888|NCT00971048|3043493|P3|Overall Study|Adverse Event|1
922889|NCT00971048|3043494|P2|Overall Study|Adverse Event|0
922890|NCT00971048|3043495|P1|Overall Study|Adverse Event|0
922891|NCT00971048|3043492|P4|Overall Study|Protocol Violation|1
922892|NCT00971048|3043493|P3|Overall Study|Protocol Violation|0
922893|NCT00971048|3043494|P2|Overall Study|Protocol Violation|2
922894|NCT00971048|3043495|P1|Overall Study|Protocol Violation|1
922895|NCT00970944|3043519|P2|Overall Study|Physician Decision|2
922896|NCT00970944|3043520|P1|Overall Study|Physician Decision|0
922897|NCT00970944|3043519|P2|Overall Study|Death|0
922898|NCT00970944|3043520|P1|Overall Study|Death|1
922899|NCT00970684|3043572|P1|Overall Study|Withdrawal by Subject|1
922900|NCT00970684|3043572|P1|Overall Study|Adverse Event|4
922901|NCT00970684|3043572|P1|Overall Study|Lack of Efficacy|5
922902|NCT00970632|3043581|P3|Overall Study|Sponsor decision|1
922903|NCT00970632|3043582|P2|Overall Study|Sponsor decision|0
922904|NCT00970632|3043583|P1|Overall Study|Sponsor decision|1
922905|NCT00970632|3043581|P3|Overall Study|Entry criteria not met|2
922906|NCT00970632|3043582|P2|Overall Study|Entry criteria not met|2
922907|NCT00970632|3043583|P1|Overall Study|Entry criteria not met|0
922908|NCT00970632|3043581|P3|Overall Study|Withdrawal by Subject|4
922909|NCT00970632|3043582|P2|Overall Study|Withdrawal by Subject|6
922910|NCT00970632|3043583|P1|Overall Study|Withdrawal by Subject|7
922911|NCT00970632|3043581|P3|Overall Study|Protocol Violation|8
922912|NCT00970632|3043582|P2|Overall Study|Protocol Violation|5
922913|NCT00970632|3043583|P1|Overall Study|Protocol Violation|8
922914|NCT00970632|3043581|P3|Overall Study|Lost to Follow-up|2
922915|NCT00970632|3043582|P2|Overall Study|Lost to Follow-up|0
922916|NCT00970632|3043583|P1|Overall Study|Lost to Follow-up|3
922917|NCT00970632|3043581|P3|Overall Study|Lack of Efficacy|0
922918|NCT00970632|3043582|P2|Overall Study|Lack of Efficacy|0
922919|NCT00970632|3043583|P1|Overall Study|Lack of Efficacy|3
922920|NCT00970632|3043581|P3|Overall Study|Adverse Event|1
922921|NCT00970632|3043582|P2|Overall Study|Adverse Event|2
922922|NCT00970632|3043583|P1|Overall Study|Adverse Event|2
922923|NCT00970502|3043648|P1|Overall Study|Withdrawal by Subject|1
922924|NCT00970489|3043659|P2|Overall Study|Death/Withdrew/Criteria Violation|41
922925|NCT00970489|3043660|P1|Overall Study|Death/Withdrew/Criteria Violation|54
922926|NCT00970359|3043672|P1|Overall Study|Not Treated|4
922927|NCT00970307|3043702|P3|Overall Study|Withdrawal by Subject|2
922928|NCT00970307|3043703|P2|Overall Study|Withdrawal by Subject|3
922929|NCT00970307|3043704|P1|Overall Study|Withdrawal by Subject|2
922930|NCT00970307|3043702|P3|Overall Study|Serious Adverse Event|0
922931|NCT00970307|3043703|P2|Overall Study|Serious Adverse Event|0
922932|NCT00970307|3043704|P1|Overall Study|Serious Adverse Event|1
922933|NCT00970294|3043778|P1|Overall Study|Withdrawal by Subject|1
922934|NCT00970294|3043778|P1|Overall Study|Physician Decision|4
922935|NCT00970281|3043786|P2|Overall Study|Physician Decision|1
922936|NCT00970281|3043787|P1|Overall Study|Physician Decision|1
922937|NCT00970281|3043786|P2|Overall Study|Withdrawal by Subject|1
922938|NCT00970281|3043787|P1|Overall Study|Withdrawal by Subject|0
922939|NCT00970281|3043786|P2|Overall Study|Lack of Efficacy|14
922940|NCT00970281|3043787|P1|Overall Study|Lack of Efficacy|1
922941|NCT00970268|3043805|P2|Overall Study|Inclusion/Exclusion Criteria|0
922942|NCT00970268|3043806|P1|Overall Study|Inclusion/Exclusion Criteria|1
922943|NCT00970268|3043805|P2|Overall Study|Lost to Follow-up|2
922944|NCT00970268|3043806|P1|Overall Study|Lost to Follow-up|1
922945|NCT00970268|3043805|P2|Overall Study|COPD Exacerbation|2
922946|NCT00970268|3043806|P1|Overall Study|COPD Exacerbation|4
922947|NCT00970268|3043805|P2|Overall Study|Other Reason|1
922948|NCT00970268|3043806|P1|Overall Study|Other Reason|3
922949|NCT00970268|3043805|P2|Overall Study|Protocol Violation|7
922950|NCT00970268|3043806|P1|Overall Study|Protocol Violation|4
922951|NCT00970268|3043805|P2|Overall Study|Lack of Efficacy|6
922952|NCT00970268|3043806|P1|Overall Study|Lack of Efficacy|3
922953|NCT00970268|3043805|P2|Overall Study|Adverse Event|12
922954|NCT00970268|3043806|P1|Overall Study|Adverse Event|15
922955|NCT00970268|3043805|P2|Overall Study|Withdrawal by Subject|19
922956|NCT00970268|3043806|P1|Overall Study|Withdrawal by Subject|12
922957|NCT00969709|3043861|P4|Overall Study|Other reasons|0
922958|NCT00969709|3043862|P3|Overall Study|Other reasons|3
922959|NCT00969709|3043863|P2|Overall Study|Other reasons|0
922960|NCT00969709|3043864|P1|Overall Study|Other reasons|0
922961|NCT00969709|3043861|P4|Overall Study|Lost to Follow-up|15
922962|NCT00969709|3043862|P3|Overall Study|Lost to Follow-up|8
922963|NCT00969709|3043863|P2|Overall Study|Lost to Follow-up|14
922964|NCT00969709|3043864|P1|Overall Study|Lost to Follow-up|10
922965|NCT00969709|3043861|P4|Overall Study|Withdrawal by Subject|23
922966|NCT00969709|3043862|P3|Overall Study|Withdrawal by Subject|11
922967|NCT00969709|3043863|P2|Overall Study|Withdrawal by Subject|12
922968|NCT00969709|3043864|P1|Overall Study|Withdrawal by Subject|9
922969|NCT00969709|3043861|P4|Overall Study|Protocol Violation|10
922970|NCT00969709|3043862|P3|Overall Study|Protocol Violation|9
922971|NCT00969709|3043863|P2|Overall Study|Protocol Violation|5
922972|NCT00969709|3043864|P1|Overall Study|Protocol Violation|9
922973|NCT00969709|3043861|P4|Overall Study|Lack of Efficacy|3
922974|NCT00969709|3043862|P3|Overall Study|Lack of Efficacy|1
922975|NCT00969709|3043863|P2|Overall Study|Lack of Efficacy|4
922976|NCT00969709|3043864|P1|Overall Study|Lack of Efficacy|7
922977|NCT00969709|3043861|P4|Overall Study|Adverse Event|12
922978|NCT00969709|3043862|P3|Overall Study|Adverse Event|26
922979|NCT00969709|3043863|P2|Overall Study|Adverse Event|13
922980|NCT00969709|3043864|P1|Overall Study|Adverse Event|3
922981|NCT00969618|3043878|P1|Overall Study|Withdrawal by Subject|27
922982|NCT00969618|3043878|P1|Overall Study|Protocol Violation|9
922983|NCT00969618|3043878|P1|Overall Study|Physician Decision|1
922984|NCT00969618|3043878|P1|Overall Study|Lost to Follow-up|7
922985|NCT00969618|3043878|P1|Overall Study|Lack of Efficacy|2
922986|NCT00969618|3043878|P1|Overall Study|Entry Criteria Not Met|3
922987|NCT00969618|3043878|P1|Overall Study|Adverse Event|29
922988|NCT00969540|3043891|P2|Overall Study|Lost to Follow-up|1
922989|NCT00969540|3043892|P1|Overall Study|Lost to Follow-up|1
922990|NCT00969436|3043917|P3|Overall Study|Lost to Follow-up|5
922991|NCT00969436|3043918|P2|Overall Study|Lost to Follow-up|8
922992|NCT00969436|3043919|P1|Overall Study|Lost to Follow-up|8
922993|NCT00969436|3043917|P3|Overall Study|Withdrawal by Subject|2
922994|NCT00969436|3043918|P2|Overall Study|Withdrawal by Subject|0
922995|NCT00969436|3043919|P1|Overall Study|Withdrawal by Subject|3
922996|NCT00969436|3043917|P3|Overall Study|Subject eliminated (other vaccine)|0
922997|NCT00969436|3043918|P2|Overall Study|Subject eliminated (other vaccine)|0
922998|NCT00969436|3043919|P1|Overall Study|Subject eliminated (other vaccine)|1
922999|NCT00969436|3043917|P3|Overall Study|Parents personal problem|1
923000|NCT00969436|3043918|P2|Overall Study|Parents personal problem|0
923001|NCT00969436|3043919|P1|Overall Study|Parents personal problem|0
923002|NCT00969436|3043917|P3|Overall Study|Father - serious health problem|1
923003|NCT00969436|3043918|P2|Overall Study|Father - serious health problem|0
923004|NCT00969436|3043919|P1|Overall Study|Father - serious health problem|0
923005|NCT00969436|3043917|P3|Overall Study|Migrated/moved from study area|2
923006|NCT00969436|3043918|P2|Overall Study|Migrated/moved from study area|10
923007|NCT00969436|3043919|P1|Overall Study|Migrated/moved from study area|12
923008|NCT00969436|3043917|P3|Overall Study|Protocol Violation|0
923009|NCT00969436|3043918|P2|Overall Study|Protocol Violation|3
923010|NCT00969436|3043919|P1|Overall Study|Protocol Violation|1
923011|NCT00969280|3043953|P2|Overall Study|infection of influenza A(H1N1)|1
923012|NCT00969280|3043954|P1|Overall Study|infection of influenza A(H1N1)|0
923013|NCT00969280|3043953|P2|Overall Study|Withdrawal by Subject|1
923014|NCT00969280|3043954|P1|Overall Study|Withdrawal by Subject|0
923015|NCT00969280|3043953|P2|Overall Study|Protocol Violation|1
923016|NCT00969280|3043954|P1|Overall Study|Protocol Violation|2
923017|NCT00969228|3043962|P2|Overall Study|Porcine circovirus detection in vaccine|14
923018|NCT00969228|3043963|P1|Overall Study|Porcine circovirus detection in vaccine|38
923019|NCT00969228|3043962|P2|Overall Study|Withdrawal by Subject|0
923020|NCT00969228|3043963|P1|Overall Study|Withdrawal by Subject|4
923021|NCT00969228|3043962|P2|Overall Study|Adverse Event|0
923022|NCT00969228|3043963|P1|Overall Study|Adverse Event|1
923023|NCT00969150|3043981|P2|Overall Study|Other reasons|0
923024|NCT00969150|3043982|P1|Overall Study|Other reasons|1
923025|NCT00969150|3043981|P2|Overall Study|Lost to Follow-up|4
923026|NCT00969150|3043982|P1|Overall Study|Lost to Follow-up|5
923027|NCT00969150|3043981|P2|Overall Study|Withdrawal by Subject|9
923028|NCT00969150|3043982|P1|Overall Study|Withdrawal by Subject|13
923029|NCT00969150|3043981|P2|Overall Study|Protocol Violation|12
923030|NCT00969150|3043982|P1|Overall Study|Protocol Violation|9
923031|NCT00969150|3043981|P2|Overall Study|Lack of Efficacy|1
923032|NCT00969150|3043982|P1|Overall Study|Lack of Efficacy|1
923033|NCT00969150|3043981|P2|Overall Study|Adverse Event|14
923034|NCT00969150|3043982|P1|Overall Study|Adverse Event|4
923035|NCT00969124|3043990|P1|Overall Study|Technical error|1
923036|NCT00969124|3043990|P1|Overall Study|Previously unrecognized disease|3
923037|NCT00969124|3043990|P1|Overall Study|Inability to reach cecum|9
923038|NCT00969124|3043990|P1|Overall Study|Inadequate bowel preparation|15
923039|NCT00969124|3043990|P1|Overall Study|Protocol Violation|2
923040|NCT00968981|3043999|P3|Overall Study|Withdrawal by Subject|3
923041|NCT00968981|3044000|P2|Overall Study|Withdrawal by Subject|3
923042|NCT00968981|3044001|P1|Overall Study|Withdrawal by Subject|1
923043|NCT00968981|3043999|P3|Overall Study|Physician Decision|5
923044|NCT00968981|3044000|P2|Overall Study|Physician Decision|3
923045|NCT00968981|3044001|P1|Overall Study|Physician Decision|5
923046|NCT00968981|3043999|P3|Overall Study|Lost to Follow-up|1
923047|NCT00968981|3044000|P2|Overall Study|Lost to Follow-up|0
923048|NCT00968981|3044001|P1|Overall Study|Lost to Follow-up|0
923049|NCT00968981|3043999|P3|Overall Study|Disease Progression|13
923050|NCT00968981|3044000|P2|Overall Study|Disease Progression|16
923051|NCT00968981|3044001|P1|Overall Study|Disease Progression|14
923052|NCT00968981|3043999|P3|Overall Study|Adverse Event|0
923053|NCT00968981|3044000|P2|Overall Study|Adverse Event|0
923054|NCT00968981|3044001|P1|Overall Study|Adverse Event|2
923055|NCT00968864|3044068|P1|Overall Study|Protocol exception/ not evaluable|1
923056|NCT00968812|3044096|P3|Overall Study|Not specified|40
923057|NCT00968812|3044097|P2|Overall Study|Not specified|37
923058|NCT00968812|3044098|P1|Overall Study|Not specified|25
923059|NCT00968812|3044096|P3|Overall Study|Unable to take rescue therapy|17
923060|NCT00968812|3044097|P2|Overall Study|Unable to take rescue therapy|12
923061|NCT00968812|3044098|P1|Overall Study|Unable to take rescue therapy|12
923062|NCT00968812|3044096|P3|Overall Study|Noncompliance with study drug|6
923063|NCT00968812|3044097|P2|Overall Study|Noncompliance with study drug|1
923064|NCT00968812|3044098|P1|Overall Study|Noncompliance with study drug|4
923065|NCT00968812|3044096|P3|Overall Study|Creatinine or eGFR withdrawal criteria|7
923066|NCT00968812|3044097|P2|Overall Study|Creatinine or eGFR withdrawal criteria|13
923067|NCT00968812|3044098|P1|Overall Study|Creatinine or eGFR withdrawal criteria|9
923068|NCT00968812|3044096|P3|Overall Study|Withdrawal by Subject|25
923069|NCT00968812|3044097|P2|Overall Study|Withdrawal by Subject|23
923070|NCT00968812|3044098|P1|Overall Study|Withdrawal by Subject|17
923071|NCT00968812|3044096|P3|Overall Study|Protocol Violation|3
923072|NCT00968812|3044097|P2|Overall Study|Protocol Violation|4
923073|NCT00968812|3044098|P1|Overall Study|Protocol Violation|7
923074|NCT00968812|3044096|P3|Overall Study|Physician Decision|9
923075|NCT00968812|3044097|P2|Overall Study|Physician Decision|5
923076|NCT00968812|3044098|P1|Overall Study|Physician Decision|8
923077|NCT00968812|3044096|P3|Overall Study|Lost to Follow-up|11
923078|NCT00968812|3044097|P2|Overall Study|Lost to Follow-up|12
923079|NCT00968812|3044098|P1|Overall Study|Lost to Follow-up|17
923080|NCT00968812|3044096|P3|Overall Study|Lack of Efficacy|16
923081|NCT00968812|3044097|P2|Overall Study|Lack of Efficacy|7
923082|NCT00968812|3044098|P1|Overall Study|Lack of Efficacy|9
923083|NCT00968812|3044096|P3|Overall Study|Death|1
923084|NCT00968812|3044097|P2|Overall Study|Death|2
923085|NCT00968812|3044098|P1|Overall Study|Death|2
923086|NCT00968812|3044096|P3|Overall Study|Adverse Event|33
923087|NCT00968812|3044097|P2|Overall Study|Adverse Event|46
923088|NCT00968812|3044098|P1|Overall Study|Adverse Event|30
923089|NCT00968799|3044118|P1|Overall Study|Advanced disease, HIPEC not applicable|2
923090|NCT00968708|3044128|P2|Overall Study|Other|34
923091|NCT00968708|3044129|P1|Overall Study|Other|26
923092|NCT00968708|3044128|P2|Overall Study|Investigator Discretion|1
923093|NCT00968708|3044129|P1|Overall Study|Investigator Discretion|0
923094|NCT00968708|3044128|P2|Overall Study|Voluntary Withdrawal|101
923095|NCT00968708|3044129|P1|Overall Study|Voluntary Withdrawal|104
923096|NCT00968708|3044128|P2|Overall Study|Lost to Follow-up|11
923097|NCT00968708|3044129|P1|Overall Study|Lost to Follow-up|19
923098|NCT00968708|3044128|P2|Overall Study|Major Protocol Deviation|1
923099|NCT00968708|3044129|P1|Overall Study|Major Protocol Deviation|0
923100|NCT00968708|3044128|P2|Overall Study|Adverse Event|150
923101|NCT00968708|3044129|P1|Overall Study|Adverse Event|169
923102|NCT00968669|3044141|P4|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1
923103|NCT00968669|3044142|P3|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
923104|NCT00968669|3044143|P2|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
923105|NCT00968669|3044144|P1|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
923106|NCT00968669|3044141|P4|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
923107|NCT00968669|3044142|P3|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
923108|NCT00968669|3044143|P2|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1
923109|NCT00968669|3044144|P1|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
923110|NCT00968669|3044141|P4|Overall Study|SUBJECT INCARCERATED|0
923111|NCT00968669|3044142|P3|Overall Study|SUBJECT INCARCERATED|0
923112|NCT00968669|3044143|P2|Overall Study|SUBJECT INCARCERATED|1
923113|NCT00968669|3044144|P1|Overall Study|SUBJECT INCARCERATED|0
923114|NCT00968669|3044141|P4|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
923115|NCT00968669|3044142|P3|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
923116|NCT00968669|3044143|P2|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1
923117|NCT00968669|3044144|P1|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
923118|NCT00968669|3044141|P4|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
923119|NCT00968669|3044142|P3|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1
923120|NCT00968669|3044143|P2|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
923121|NCT00968669|3044144|P1|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
923122|NCT00968669|3044141|P4|Overall Study|SPONSOR DECISION|0
923123|NCT00968669|3044142|P3|Overall Study|SPONSOR DECISION|0
923124|NCT00968669|3044143|P2|Overall Study|SPONSOR DECISION|1
923125|NCT00968669|3044144|P1|Overall Study|SPONSOR DECISION|0
923126|NCT00968669|3044141|P4|Overall Study|PATIENT WILL BE WORKING ABROAD|0
923127|NCT00968669|3044142|P3|Overall Study|PATIENT WILL BE WORKING ABROAD|0
923128|NCT00968669|3044143|P2|Overall Study|PATIENT WILL BE WORKING ABROAD|1
923129|NCT00968669|3044144|P1|Overall Study|PATIENT WILL BE WORKING ABROAD|0
923130|NCT00968669|3044141|P4|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
923131|NCT00968669|3044142|P3|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
923132|NCT00968669|3044143|P2|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1
923133|NCT00968669|3044144|P1|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
923134|NCT00968669|3044141|P4|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
923135|NCT00968669|3044142|P3|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
923136|NCT00968669|3044143|P2|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1
923137|NCT00968669|3044144|P1|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
923138|NCT00968669|3044141|P4|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
923139|NCT00968669|3044142|P3|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
923140|NCT00968669|3044143|P2|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1
923141|NCT00968669|3044144|P1|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
923142|NCT00968669|3044141|P4|Overall Study|INEGIBILITY TO PERFORM VISIT|0
923143|NCT00968669|3044142|P3|Overall Study|INEGIBILITY TO PERFORM VISIT|0
923144|NCT00968669|3044143|P2|Overall Study|INEGIBILITY TO PERFORM VISIT|0
923145|NCT00968669|3044144|P1|Overall Study|INEGIBILITY TO PERFORM VISIT|1
923146|NCT00968669|3044141|P4|Overall Study|ERROR IN HADS ADMINISTRATION|0
923147|NCT00968669|3044142|P3|Overall Study|ERROR IN HADS ADMINISTRATION|1
923148|NCT00968669|3044143|P2|Overall Study|ERROR IN HADS ADMINISTRATION|0
923149|NCT00968669|3044144|P1|Overall Study|ERROR IN HADS ADMINISTRATION|0
923150|NCT00968669|3044141|P4|Overall Study|EARLY WITHDRAWAL|0
923151|NCT00968669|3044142|P3|Overall Study|EARLY WITHDRAWAL|0
923152|NCT00968669|3044143|P2|Overall Study|EARLY WITHDRAWAL|1
923153|NCT00968669|3044144|P1|Overall Study|EARLY WITHDRAWAL|0
923154|NCT00968669|3044141|P4|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
923155|NCT00968669|3044142|P3|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1
923156|NCT00968669|3044143|P2|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
923157|NCT00968669|3044144|P1|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
923158|NCT00968669|3044141|P4|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
923159|NCT00968669|3044142|P3|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
923160|NCT00968669|3044143|P2|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
923161|NCT00968669|3044144|P1|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1
923162|NCT00968669|3044141|P4|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
923163|NCT00968669|3044142|P3|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
923164|NCT00968669|3044143|P2|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
923165|NCT00968669|3044144|P1|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1
923166|NCT00968669|3044141|P4|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1
923167|NCT00968669|3044142|P3|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
923168|NCT00968669|3044143|P2|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
923169|NCT00968669|3044144|P1|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
923170|NCT00968669|3044141|P4|Overall Study|AE|0
923171|NCT00968669|3044142|P3|Overall Study|AE|0
923172|NCT00968669|3044143|P2|Overall Study|AE|0
923173|NCT00968669|3044144|P1|Overall Study|AE|1
923174|NCT00968669|3044141|P4|Overall Study|Pregnancy|0
923175|NCT00968669|3044142|P3|Overall Study|Pregnancy|2
923176|NCT00968669|3044143|P2|Overall Study|Pregnancy|0
923177|NCT00968669|3044144|P1|Overall Study|Pregnancy|0
923178|NCT00968669|3044141|P4|Overall Study|Withdrawal by Subject|3
923179|NCT00968669|3044142|P3|Overall Study|Withdrawal by Subject|5
923180|NCT00968669|3044143|P2|Overall Study|Withdrawal by Subject|7
923181|NCT00968669|3044144|P1|Overall Study|Withdrawal by Subject|9
923182|NCT00968669|3044141|P4|Overall Study|Lost to Follow-up|4
923183|NCT00968669|3044142|P3|Overall Study|Lost to Follow-up|1
923184|NCT00968669|3044143|P2|Overall Study|Lost to Follow-up|2
923185|NCT00968669|3044144|P1|Overall Study|Lost to Follow-up|5
923186|NCT00968617|3044234|P1|Overall Study|Study terminated by sponsor|6
923187|NCT00968539|3044248|P2|Overall Study|Lost to follow-up (incompl. vaccination)|0
923188|NCT00968539|3044249|P1|Overall Study|Lost to follow-up (incompl. vaccination)|1
923189|NCT00968526|3044309|P2|Overall Study|Migrated/moved from study area|0
923190|NCT00968526|3044310|P1|Overall Study|Migrated/moved from study area|1
923191|NCT00968526|3044309|P2|Overall Study|Adverse Event|0
923192|NCT00968526|3044310|P1|Overall Study|Adverse Event|2
923193|NCT00968253|3044403|P3|Overall Study|Adverse Event|1
923194|NCT00968253|3044404|P2|Overall Study|Adverse Event|0
923195|NCT00968253|3044405|P1|Overall Study|Adverse Event|0
923196|NCT00968253|3044403|P3|Overall Study|Disease Progression|3
923197|NCT00968253|3044404|P2|Overall Study|Disease Progression|3
923198|NCT00968253|3044405|P1|Overall Study|Disease Progression|0
923199|NCT00968253|3044403|P3|Overall Study|Withdrawal by Subject|1
923200|NCT00968253|3044404|P2|Overall Study|Withdrawal by Subject|0
923201|NCT00968253|3044405|P1|Overall Study|Withdrawal by Subject|0
923202|NCT00968253|3044403|P3|Overall Study|Death|2
923203|NCT00968253|3044404|P2|Overall Study|Death|0
923204|NCT00968253|3044405|P1|Overall Study|Death|0
923205|NCT00968201|3044426|P3|Extension Study - (Period III)|Study Terminated for Admin Reasons|185
923206|NCT00968201|3044427|P2|Extension Study - (Period III)|Study Terminated for Admin Reasons|74
923207|NCT00968201|3044428|P1|Extension Study - (Period III)|Study Terminated for Admin Reasons|0
923208|NCT00968201|3044426|P3|Extension Study - (Period III)|Not Specified|2
923209|NCT00968201|3044427|P2|Extension Study - (Period III)|Not Specified|0
923210|NCT00968201|3044428|P1|Extension Study - (Period III)|Not Specified|0
923211|NCT00968201|3044426|P3|Extension Study - (Period III)|Noncompliance|3
923212|NCT00968201|3044427|P2|Extension Study - (Period III)|Noncompliance|0
923213|NCT00968201|3044428|P1|Extension Study - (Period III)|Noncompliance|0
923214|NCT00968201|3044426|P3|Extension Study - (Period III)|Patient Relocated|1
923215|NCT00968201|3044427|P2|Extension Study - (Period III)|Patient Relocated|1
923216|NCT00968201|3044428|P1|Extension Study - (Period III)|Patient Relocated|0
923217|NCT00968201|3044426|P3|Extension Study - (Period III)|Withdrawal by Subject|40
923218|NCT00968201|3044427|P2|Extension Study - (Period III)|Withdrawal by Subject|20
923219|NCT00968201|3044428|P1|Extension Study - (Period III)|Withdrawal by Subject|0
923220|NCT00968201|3044426|P3|Extension Study - (Period III)|Protocol Violation|14
923221|NCT00968201|3044427|P2|Extension Study - (Period III)|Protocol Violation|17
923222|NCT00968201|3044428|P1|Extension Study - (Period III)|Protocol Violation|0
923223|NCT00968201|3044426|P3|Extension Study - (Period III)|Lost to Follow-up|13
923224|NCT00968201|3044427|P2|Extension Study - (Period III)|Lost to Follow-up|7
923225|NCT00968201|3044428|P1|Extension Study - (Period III)|Lost to Follow-up|0
923226|NCT00968201|3044426|P3|Extension Study - (Period III)|Adverse Event|22
923227|NCT00968201|3044427|P2|Extension Study - (Period III)|Adverse Event|5
923228|NCT00968201|3044428|P1|Extension Study - (Period III)|Adverse Event|0
923229|NCT00968201|3044426|P3|Base Study - (Period II)|Site Error|1
923230|NCT00968201|3044427|P2|Base Study - (Period II)|Site Error|0
923231|NCT00968201|3044428|P1|Base Study - (Period II)|Site Error|0
923232|NCT00968201|3044426|P3|Base Study - (Period II)|Withdrawal by Subject|8
923233|NCT00968201|3044427|P2|Base Study - (Period II)|Withdrawal by Subject|0
923234|NCT00968201|3044428|P1|Base Study - (Period II)|Withdrawal by Subject|4
923235|NCT00968201|3044426|P3|Base Study - (Period II)|Protocol Violation|12
923236|NCT00968201|3044427|P2|Base Study - (Period II)|Protocol Violation|0
923237|NCT00968201|3044428|P1|Base Study - (Period II)|Protocol Violation|12
923238|NCT00968201|3044426|P3|Base Study - (Period II)|Lost to Follow-up|7
923239|NCT00968201|3044427|P2|Base Study - (Period II)|Lost to Follow-up|0
923240|NCT00968201|3044428|P1|Base Study - (Period II)|Lost to Follow-up|2
923241|NCT00968201|3044426|P3|Base Study - (Period II)|Lack of Efficacy|1
923242|NCT00968201|3044427|P2|Base Study - (Period II)|Lack of Efficacy|0
923243|NCT00968201|3044428|P1|Base Study - (Period II)|Lack of Efficacy|0
923244|NCT00968201|3044426|P3|Base Study - (Period II)|Adverse Event|16
923245|NCT00968201|3044427|P2|Base Study - (Period II)|Adverse Event|0
923246|NCT00968201|3044428|P1|Base Study - (Period II)|Adverse Event|8
923247|NCT00968149|3044489|P2|Overall Study|Withdrawal by Subject|0
923248|NCT00968149|3044490|P1|Overall Study|Withdrawal by Subject|2
923249|NCT00968149|3044489|P2|Overall Study|Protocol Violation|0
923250|NCT00968149|3044490|P1|Overall Study|Protocol Violation|4
923251|NCT00968149|3044489|P2|Overall Study|Lost to Follow-up|1
923252|NCT00968149|3044490|P1|Overall Study|Lost to Follow-up|0
923253|NCT00968149|3044489|P2|Overall Study|Lack of Efficacy|4
923254|NCT00968149|3044490|P1|Overall Study|Lack of Efficacy|0
923255|NCT00968149|3044489|P2|Overall Study|Adverse Event|1
923256|NCT00968149|3044490|P1|Overall Study|Adverse Event|5
923257|NCT00967798|3044545|P2|Overall Study|Lost to Follow-up|1
923258|NCT00967798|3044546|P1|Overall Study|Lost to Follow-up|4
923259|NCT00967798|3044545|P2|Overall Study|Withdrawal by Subject|2
923260|NCT00967798|3044546|P1|Overall Study|Withdrawal by Subject|5
923261|NCT00967694|3044560|P1|Overall Study|Withdrawal by Subject|6
923262|NCT00967668|3044567|P3|Overall Study|Pregnancy|0
923263|NCT00967668|3044568|P2|Overall Study|Pregnancy|0
923264|NCT00967668|3044569|P1|Overall Study|Pregnancy|1
923265|NCT00967668|3044567|P3|Overall Study|Refused 12-mo assessment|9
923266|NCT00967668|3044568|P2|Overall Study|Refused 12-mo assessment|1
923267|NCT00967668|3044569|P1|Overall Study|Refused 12-mo assessment|3
923268|NCT00967668|3044567|P3|Overall Study|Lost to Follow-up|16
923269|NCT00967668|3044568|P2|Overall Study|Lost to Follow-up|9
923270|NCT00967668|3044569|P1|Overall Study|Lost to Follow-up|15
923271|NCT00967668|3044567|P3|Overall Study|Lost to follow-up at 12-mo|26
923272|NCT00967668|3044568|P2|Overall Study|Lost to follow-up at 12-mo|29
923273|NCT00967668|3044569|P1|Overall Study|Lost to follow-up at 12-mo|27
923274|NCT00967668|3044567|P3|Overall Study|Refused Year 2|4
923275|NCT00967668|3044568|P2|Overall Study|Refused Year 2|6
923276|NCT00967668|3044569|P1|Overall Study|Refused Year 2|11
923277|NCT00967668|3044567|P3|Overall Study|Removed due to behavior|2
923278|NCT00967668|3044568|P2|Overall Study|Removed due to behavior|1
923279|NCT00967668|3044569|P1|Overall Study|Removed due to behavior|1
923280|NCT00967668|3044567|P3|Overall Study|Death|4
923281|NCT00967668|3044568|P2|Overall Study|Death|2
923282|NCT00967668|3044569|P1|Overall Study|Death|0
923283|NCT00967668|3044567|P3|Overall Study|Withdrawal by Subject|8
923284|NCT00967668|3044568|P2|Overall Study|Withdrawal by Subject|8
923285|NCT00967668|3044569|P1|Overall Study|Withdrawal by Subject|13
923286|NCT00967330|3044615|P2|Overall Study|Severe protocol deviation|1
923287|NCT00967330|3044616|P1|Overall Study|Severe protocol deviation|0
923288|NCT00967330|3044615|P2|Overall Study|Death|51
923289|NCT00967330|3044616|P1|Overall Study|Death|102
923290|NCT00967330|3044615|P2|Overall Study|Lost to Follow-up|1
923291|NCT00967330|3044616|P1|Overall Study|Lost to Follow-up|1
923292|NCT00967330|3044615|P2|Overall Study|Withdrawal by Subject|0
923293|NCT00967330|3044616|P1|Overall Study|Withdrawal by Subject|6
923294|NCT00967330|3044615|P2|Overall Study|Regular|3
923295|NCT00967330|3044616|P1|Overall Study|Regular|10
923296|NCT00967330|3044615|P2|Overall Study|Protocol Violation|4
923297|NCT00967330|3044616|P1|Overall Study|Protocol Violation|3
923298|NCT00967226|3044646|P2|Overall Study|Physician Decision|1
923299|NCT00967226|3044647|P1|Overall Study|Physician Decision|0
923300|NCT00967226|3044646|P2|Overall Study|Protocol Violation|0
923301|NCT00967226|3044647|P1|Overall Study|Protocol Violation|2
923302|NCT00967226|3044646|P2|Overall Study|Adverse Event|5
923303|NCT00967226|3044647|P1|Overall Study|Adverse Event|0
923304|NCT00967018|3044681|P1|Overall Study|Miscellaneous Reasons|9
923305|NCT00967018|3044681|P1|Overall Study|Withdrawal by Subject|1
923306|NCT00967018|3044681|P1|Overall Study|Lost to Follow-up|2
923307|NCT00967018|3044681|P1|Overall Study|Physician Decision|7
923308|NCT00967018|3044681|P1|Overall Study|Adverse Event|2
923309|NCT00967005|3044690|P2|Overall Study|Lost to Follow-up|10
923310|NCT00967005|3044691|P1|Overall Study|Lost to Follow-up|7
923311|NCT00966940|3044777|P2|Period 1, First 6 Weeks|Protocol Violation|0
923312|NCT00966940|3044778|P1|Period 1, First 6 Weeks|Protocol Violation|1
923313|NCT00966940|3044777|P2|Period 1, First 6 Weeks|Withdrawal by Subject|0
923314|NCT00966940|3044778|P1|Period 1, First 6 Weeks|Withdrawal by Subject|2
923315|NCT00966875|3044805|P9|Part B|Entry Criteria|1
923316|NCT00966875|3044806|P8|Part B|Entry Criteria|0
923317|NCT00966875|3044807|P7|Part B|Entry Criteria|1
923318|NCT00966875|3044808|P6|Part B|Entry Criteria|0
923319|NCT00966875|3044809|P5|Part B|Entry Criteria|0
923320|NCT00966875|3044810|P4|Part B|Entry Criteria|0
923321|NCT00966875|3044811|P3|Part B|Entry Criteria|0
923322|NCT00966875|3044812|P2|Part B|Entry Criteria|0
923323|NCT00966875|3044813|P1|Part B|Entry Criteria|0
923324|NCT00966875|3044805|P9|Part B|Withdrawal by Subject|5
923325|NCT00966875|3044806|P8|Part B|Withdrawal by Subject|5
923326|NCT00966875|3044807|P7|Part B|Withdrawal by Subject|4
923327|NCT00966875|3044808|P6|Part B|Withdrawal by Subject|1
923328|NCT00966875|3044809|P5|Part B|Withdrawal by Subject|2
923329|NCT00966875|3044810|P4|Part B|Withdrawal by Subject|1
923330|NCT00966875|3044811|P3|Part B|Withdrawal by Subject|2
923331|NCT00966875|3044812|P2|Part B|Withdrawal by Subject|1
923332|NCT00966875|3044813|P1|Part B|Withdrawal by Subject|2
923333|NCT00966875|3044805|P9|Part B|Sponsor Decision|1
923334|NCT00966875|3044806|P8|Part B|Sponsor Decision|2
923335|NCT00966875|3044807|P7|Part B|Sponsor Decision|0
923336|NCT00966875|3044808|P6|Part B|Sponsor Decision|1
923337|NCT00966875|3044809|P5|Part B|Sponsor Decision|0
923338|NCT00966875|3044810|P4|Part B|Sponsor Decision|0
923339|NCT00966875|3044811|P3|Part B|Sponsor Decision|0
923340|NCT00966875|3044812|P2|Part B|Sponsor Decision|0
923341|NCT00966875|3044813|P1|Part B|Sponsor Decision|1
923342|NCT00966875|3044805|P9|Part B|Physician Decision|2
923343|NCT00966875|3044806|P8|Part B|Physician Decision|0
923344|NCT00966875|3044807|P7|Part B|Physician Decision|0
923345|NCT00966875|3044808|P6|Part B|Physician Decision|1
923346|NCT00966875|3044809|P5|Part B|Physician Decision|2
923347|NCT00966875|3044810|P4|Part B|Physician Decision|0
923348|NCT00966875|3044811|P3|Part B|Physician Decision|1
923349|NCT00966875|3044812|P2|Part B|Physician Decision|0
923350|NCT00966875|3044813|P1|Part B|Physician Decision|0
923351|NCT00966875|3044805|P9|Part B|Lost to Follow-up|1
923352|NCT00966875|3044806|P8|Part B|Lost to Follow-up|0
923353|NCT00966875|3044807|P7|Part B|Lost to Follow-up|0
923354|NCT00966875|3044808|P6|Part B|Lost to Follow-up|0
923355|NCT00966875|3044809|P5|Part B|Lost to Follow-up|0
923356|NCT00966875|3044810|P4|Part B|Lost to Follow-up|1
923357|NCT00966875|3044811|P3|Part B|Lost to Follow-up|0
923358|NCT00966875|3044812|P2|Part B|Lost to Follow-up|0
923359|NCT00966875|3044813|P1|Part B|Lost to Follow-up|0
923360|NCT00966875|3044805|P9|Part B|Lack of Efficacy|6
923361|NCT00966875|3044806|P8|Part B|Lack of Efficacy|9
923362|NCT00966875|3044807|P7|Part B|Lack of Efficacy|12
923363|NCT00966875|3044808|P6|Part B|Lack of Efficacy|3
923364|NCT00966875|3044809|P5|Part B|Lack of Efficacy|2
923365|NCT00966875|3044810|P4|Part B|Lack of Efficacy|1
923366|NCT00966875|3044811|P3|Part B|Lack of Efficacy|1
923367|NCT00966875|3044812|P2|Part B|Lack of Efficacy|1
923368|NCT00966875|3044813|P1|Part B|Lack of Efficacy|2
923369|NCT00966875|3044805|P9|Part B|Death|0
923370|NCT00966875|3044806|P8|Part B|Death|1
923371|NCT00966875|3044807|P7|Part B|Death|0
923372|NCT00966875|3044808|P6|Part B|Death|0
923373|NCT00966875|3044809|P5|Part B|Death|0
923374|NCT00966875|3044810|P4|Part B|Death|0
923375|NCT00966875|3044811|P3|Part B|Death|1
923376|NCT00966875|3044812|P2|Part B|Death|0
923377|NCT00966875|3044813|P1|Part B|Death|0
923378|NCT00966875|3044805|P9|Part B|Adverse Event|2
923379|NCT00966875|3044806|P8|Part B|Adverse Event|2
923380|NCT00966875|3044807|P7|Part B|Adverse Event|5
923381|NCT00966875|3044808|P6|Part B|Adverse Event|0
923382|NCT00966875|3044809|P5|Part B|Adverse Event|1
923383|NCT00966875|3044810|P4|Part B|Adverse Event|0
923384|NCT00966875|3044811|P3|Part B|Adverse Event|1
923385|NCT00966875|3044812|P2|Part B|Adverse Event|1
923386|NCT00966875|3044813|P1|Part B|Adverse Event|0
923387|NCT00966875|3044805|P9|Part A|Protocol Violation|1
923388|NCT00966875|3044806|P8|Part A|Protocol Violation|1
923389|NCT00966875|3044807|P7|Part A|Protocol Violation|2
923390|NCT00966875|3044808|P6|Part A|Protocol Violation|0
923391|NCT00966875|3044809|P5|Part A|Protocol Violation|0
923392|NCT00966875|3044810|P4|Part A|Protocol Violation|0
923393|NCT00966875|3044811|P3|Part A|Protocol Violation|0
923394|NCT00966875|3044812|P2|Part A|Protocol Violation|0
923395|NCT00966875|3044813|P1|Part A|Protocol Violation|0
923396|NCT00966875|3044805|P9|Part A|Withdrawal by Subject|1
923397|NCT00966875|3044806|P8|Part A|Withdrawal by Subject|1
923398|NCT00966875|3044807|P7|Part A|Withdrawal by Subject|5
923399|NCT00966875|3044808|P6|Part A|Withdrawal by Subject|0
923400|NCT00966875|3044809|P5|Part A|Withdrawal by Subject|3
923401|NCT00966875|3044810|P4|Part A|Withdrawal by Subject|1
923402|NCT00966875|3044811|P3|Part A|Withdrawal by Subject|1
923403|NCT00966875|3044812|P2|Part A|Withdrawal by Subject|2
923404|NCT00966875|3044813|P1|Part A|Withdrawal by Subject|2
923405|NCT00966875|3044805|P9|Part A|Sponsor Decision|1
923406|NCT00966875|3044806|P8|Part A|Sponsor Decision|2
923407|NCT00966875|3044807|P7|Part A|Sponsor Decision|0
923408|NCT00966875|3044808|P6|Part A|Sponsor Decision|0
923409|NCT00966875|3044809|P5|Part A|Sponsor Decision|1
923410|NCT00966875|3044810|P4|Part A|Sponsor Decision|0
923411|NCT00966875|3044811|P3|Part A|Sponsor Decision|1
923412|NCT00966875|3044812|P2|Part A|Sponsor Decision|0
923413|NCT00966875|3044813|P1|Part A|Sponsor Decision|0
923414|NCT00966875|3044805|P9|Part A|Physician Decision|2
923415|NCT00966875|3044806|P8|Part A|Physician Decision|0
923416|NCT00966875|3044807|P7|Part A|Physician Decision|1
923417|NCT00966875|3044808|P6|Part A|Physician Decision|0
923418|NCT00966875|3044809|P5|Part A|Physician Decision|1
923419|NCT00966875|3044810|P4|Part A|Physician Decision|0
923420|NCT00966875|3044811|P3|Part A|Physician Decision|0
923421|NCT00966875|3044812|P2|Part A|Physician Decision|0
923422|NCT00966875|3044813|P1|Part A|Physician Decision|0
923423|NCT00966875|3044805|P9|Part A|Parent/Caregiver Decision|0
923424|NCT00966875|3044806|P8|Part A|Parent/Caregiver Decision|0
923425|NCT00966875|3044807|P7|Part A|Parent/Caregiver Decision|0
923426|NCT00966875|3044808|P6|Part A|Parent/Caregiver Decision|0
923427|NCT00966875|3044809|P5|Part A|Parent/Caregiver Decision|0
923428|NCT00966875|3044810|P4|Part A|Parent/Caregiver Decision|1
923429|NCT00966875|3044811|P3|Part A|Parent/Caregiver Decision|0
923430|NCT00966875|3044812|P2|Part A|Parent/Caregiver Decision|0
923431|NCT00966875|3044813|P1|Part A|Parent/Caregiver Decision|0
923432|NCT00966875|3044805|P9|Part A|Lost to Follow-up|0
923433|NCT00966875|3044806|P8|Part A|Lost to Follow-up|0
923434|NCT00966875|3044807|P7|Part A|Lost to Follow-up|0
923435|NCT00966875|3044808|P6|Part A|Lost to Follow-up|1
923436|NCT00966875|3044809|P5|Part A|Lost to Follow-up|0
923437|NCT00966875|3044810|P4|Part A|Lost to Follow-up|0
923438|NCT00966875|3044811|P3|Part A|Lost to Follow-up|0
923439|NCT00966875|3044812|P2|Part A|Lost to Follow-up|0
923440|NCT00966875|3044813|P1|Part A|Lost to Follow-up|2
923441|NCT00966875|3044805|P9|Part A|Lack of Efficacy|0
923442|NCT00966875|3044806|P8|Part A|Lack of Efficacy|0
923443|NCT00966875|3044807|P7|Part A|Lack of Efficacy|4
923444|NCT00966875|3044808|P6|Part A|Lack of Efficacy|0
923445|NCT00966875|3044809|P5|Part A|Lack of Efficacy|0
923446|NCT00966875|3044810|P4|Part A|Lack of Efficacy|0
923447|NCT00966875|3044811|P3|Part A|Lack of Efficacy|0
923448|NCT00966875|3044812|P2|Part A|Lack of Efficacy|1
923449|NCT00966875|3044813|P1|Part A|Lack of Efficacy|0
923450|NCT00966875|3044805|P9|Part A|Entry Criteria|0
923451|NCT00966875|3044806|P8|Part A|Entry Criteria|0
923452|NCT00966875|3044807|P7|Part A|Entry Criteria|0
923453|NCT00966875|3044808|P6|Part A|Entry Criteria|2
923454|NCT00966875|3044809|P5|Part A|Entry Criteria|0
923455|NCT00966875|3044810|P4|Part A|Entry Criteria|0
923456|NCT00966875|3044811|P3|Part A|Entry Criteria|0
923457|NCT00966875|3044812|P2|Part A|Entry Criteria|0
923458|NCT00966875|3044813|P1|Part A|Entry Criteria|0
923459|NCT00966875|3044805|P9|Part A|Adverse Event|3
923460|NCT00966875|3044806|P8|Part A|Adverse Event|3
923461|NCT00966875|3044807|P7|Part A|Adverse Event|0
923462|NCT00966875|3044808|P6|Part A|Adverse Event|1
923463|NCT00966875|3044809|P5|Part A|Adverse Event|0
923464|NCT00966875|3044810|P4|Part A|Adverse Event|1
923465|NCT00966875|3044811|P3|Part A|Adverse Event|0
923466|NCT00966875|3044812|P2|Part A|Adverse Event|1
923467|NCT00966875|3044813|P1|Part A|Adverse Event|2
923468|NCT00966654|3045140|P1|Overall Study|Study was terminated,PI left institution|12
923469|NCT00966355|3045214|P3|Overall Study|Lost to Follow-up|3
923470|NCT00966355|3045215|P2|Overall Study|Lost to Follow-up|4
923471|NCT00966355|3045216|P1|Overall Study|Lost to Follow-up|5
923472|NCT00966355|3045214|P3|Overall Study|newly diagnosed advanced HCC|10
923473|NCT00966355|3045215|P2|Overall Study|newly diagnosed advanced HCC|12
923474|NCT00966355|3045216|P1|Overall Study|newly diagnosed advanced HCC|11
923475|NCT00966355|3045214|P3|Overall Study|non-variceal bleeding on endoscopy|71
923476|NCT00966355|3045215|P2|Overall Study|non-variceal bleeding on endoscopy|70
923477|NCT00966355|3045216|P1|Overall Study|non-variceal bleeding on endoscopy|68
923478|NCT00966277|3045229|P2|Overall Study|Treatment Plan Changed|1
923479|NCT00966277|3045230|P1|Overall Study|Treatment Plan Changed|0
923480|NCT00966277|3045229|P2|Overall Study|Ineligible|3
923481|NCT00966277|3045230|P1|Overall Study|Ineligible|1
923482|NCT00966277|3045229|P2|Overall Study|Withdrawal by Subject|0
923483|NCT00966277|3045230|P1|Overall Study|Withdrawal by Subject|3
923484|NCT00966264|3045238|P2|Overall Study|Lost to Follow-up|3
923485|NCT00966264|3045239|P1|Overall Study|Lost to Follow-up|4
923486|NCT00965848|3045285|P3|Overall Study|Other|1
923487|NCT00965848|3045286|P2|Overall Study|Other|0
923488|NCT00965848|3045287|P1|Overall Study|Other|5
923489|NCT00965848|3045285|P3|Overall Study|Not Clinically Evaluable|1
923490|NCT00965848|3045286|P2|Overall Study|Not Clinically Evaluable|1
923491|NCT00965848|3045287|P1|Overall Study|Not Clinically Evaluable|7
923492|NCT00965848|3045285|P3|Overall Study|Indeterminate Clinical Outcome|1
923493|NCT00965848|3045286|P2|Overall Study|Indeterminate Clinical Outcome|0
923494|NCT00965848|3045287|P1|Overall Study|Indeterminate Clinical Outcome|2
923495|NCT00965848|3045285|P3|Overall Study|Withdrawal by Subject|0
923496|NCT00965848|3045286|P2|Overall Study|Withdrawal by Subject|0
923497|NCT00965848|3045287|P1|Overall Study|Withdrawal by Subject|1
923498|NCT00965848|3045285|P3|Overall Study|Lost to Follow-up|1
923499|NCT00965848|3045286|P2|Overall Study|Lost to Follow-up|0
923500|NCT00965848|3045287|P1|Overall Study|Lost to Follow-up|0
923501|NCT00965848|3045285|P3|Overall Study|Death|5
923502|NCT00965848|3045286|P2|Overall Study|Death|1
923503|NCT00965848|3045287|P1|Overall Study|Death|11
923504|NCT00965848|3045285|P3|Overall Study|Protocol Violation|1
923505|NCT00965848|3045286|P2|Overall Study|Protocol Violation|0
923506|NCT00965848|3045287|P1|Overall Study|Protocol Violation|3
923507|NCT00965757|3045306|P4|Extension Phase|Not Specified|1
923508|NCT00965757|3045307|P3|Extension Phase|Not Specified|2
923509|NCT00965757|3045308|P2|Extension Phase|Not Specified|0
923510|NCT00965757|3045309|P1|Extension Phase|Not Specified|0
923511|NCT00965757|3045306|P4|Extension Phase|Protocol Violation|1
923512|NCT00965757|3045307|P3|Extension Phase|Protocol Violation|0
923513|NCT00965757|3045308|P2|Extension Phase|Protocol Violation|0
923514|NCT00965757|3045309|P1|Extension Phase|Protocol Violation|0
923515|NCT00965757|3045306|P4|Extension Phase|Ineligible after Taking Study Drug|3
923516|NCT00965757|3045307|P3|Extension Phase|Ineligible after Taking Study Drug|3
923517|NCT00965757|3045308|P2|Extension Phase|Ineligible after Taking Study Drug|0
923518|NCT00965757|3045309|P1|Extension Phase|Ineligible after Taking Study Drug|0
923519|NCT00965757|3045306|P4|Extension Phase|Lost to Follow-up|1
923520|NCT00965757|3045307|P3|Extension Phase|Lost to Follow-up|0
923521|NCT00965757|3045308|P2|Extension Phase|Lost to Follow-up|0
923522|NCT00965757|3045309|P1|Extension Phase|Lost to Follow-up|0
923523|NCT00965757|3045306|P4|Extension Phase|Drug Refusal Due to Adverse Event|0
923524|NCT00965757|3045307|P3|Extension Phase|Drug Refusal Due to Adverse Event|4
923525|NCT00965757|3045308|P2|Extension Phase|Drug Refusal Due to Adverse Event|0
923526|NCT00965757|3045309|P1|Extension Phase|Drug Refusal Due to Adverse Event|0
923527|NCT00965757|3045306|P4|Extension Phase|Lack of Efficacy|12
923528|NCT00965757|3045307|P3|Extension Phase|Lack of Efficacy|8
923529|NCT00965757|3045308|P2|Extension Phase|Lack of Efficacy|0
923530|NCT00965757|3045309|P1|Extension Phase|Lack of Efficacy|0
923531|NCT00965757|3045306|P4|Extension Phase|Abnormal Laboratory Value|1
923532|NCT00965757|3045307|P3|Extension Phase|Abnormal Laboratory Value|6
923533|NCT00965757|3045308|P2|Extension Phase|Abnormal Laboratory Value|0
923534|NCT00965757|3045309|P1|Extension Phase|Abnormal Laboratory Value|0
923535|NCT00965757|3045306|P4|Extension Phase|Adverse drug reaction|3
923536|NCT00965757|3045307|P3|Extension Phase|Adverse drug reaction|6
923537|NCT00965757|3045308|P2|Extension Phase|Adverse drug reaction|0
923538|NCT00965757|3045309|P1|Extension Phase|Adverse drug reaction|0
923539|NCT00965757|3045306|P4|Extension Phase|Progression of concomitant disease|2
923540|NCT00965757|3045307|P3|Extension Phase|Progression of concomitant disease|4
923541|NCT00965757|3045308|P2|Extension Phase|Progression of concomitant disease|0
923542|NCT00965757|3045309|P1|Extension Phase|Progression of concomitant disease|0
923543|NCT00965757|3045306|P4|Double-blind Phase|Not specified|0
923544|NCT00965757|3045307|P3|Double-blind Phase|Not specified|0
923545|NCT00965757|3045308|P2|Double-blind Phase|Not specified|0
923546|NCT00965757|3045309|P1|Double-blind Phase|Not specified|1
923547|NCT00965757|3045306|P4|Double-blind Phase|Ineligible after Taking Study Drug|0
923548|NCT00965757|3045307|P3|Double-blind Phase|Ineligible after Taking Study Drug|0
923549|NCT00965757|3045308|P2|Double-blind Phase|Ineligible after Taking Study Drug|3
923550|NCT00965757|3045309|P1|Double-blind Phase|Ineligible after Taking Study Drug|2
923551|NCT00965757|3045306|P4|Double-blind Phase|Lost to Follow-up|0
923552|NCT00965757|3045307|P3|Double-blind Phase|Lost to Follow-up|0
923553|NCT00965757|3045308|P2|Double-blind Phase|Lost to Follow-up|1
923554|NCT00965757|3045309|P1|Double-blind Phase|Lost to Follow-up|0
923555|NCT00965757|3045306|P4|Double-blind Phase|Drug Refusal Due to Adverse Event|0
923556|NCT00965757|3045307|P3|Double-blind Phase|Drug Refusal Due to Adverse Event|0
923557|NCT00965757|3045308|P2|Double-blind Phase|Drug Refusal Due to Adverse Event|0
923558|NCT00965757|3045309|P1|Double-blind Phase|Drug Refusal Due to Adverse Event|2
923559|NCT00965757|3045306|P4|Double-blind Phase|Lack of Efficacy|0
923560|NCT00965757|3045307|P3|Double-blind Phase|Lack of Efficacy|0
923561|NCT00965757|3045308|P2|Double-blind Phase|Lack of Efficacy|11
923562|NCT00965757|3045309|P1|Double-blind Phase|Lack of Efficacy|7
923563|NCT00965757|3045306|P4|Double-blind Phase|Abnormal Laboratory Value|0
923564|NCT00965757|3045307|P3|Double-blind Phase|Abnormal Laboratory Value|0
923565|NCT00965757|3045308|P2|Double-blind Phase|Abnormal Laboratory Value|0
923566|NCT00965757|3045309|P1|Double-blind Phase|Abnormal Laboratory Value|2
923567|NCT00965757|3045306|P4|Double-blind Phase|Adverse drug reaction|0
923568|NCT00965757|3045307|P3|Double-blind Phase|Adverse drug reaction|0
923569|NCT00965757|3045308|P2|Double-blind Phase|Adverse drug reaction|1
923570|NCT00965757|3045309|P1|Double-blind Phase|Adverse drug reaction|2
923571|NCT00965757|3045306|P4|Double-blind Phase|Progression of concomitant disease|0
923572|NCT00965757|3045307|P3|Double-blind Phase|Progression of concomitant disease|0
923573|NCT00965757|3045308|P2|Double-blind Phase|Progression of concomitant disease|2
923574|NCT00965757|3045309|P1|Double-blind Phase|Progression of concomitant disease|1
923575|NCT00965731|3045343|P2|Overall Study|Not specified|15
923576|NCT00965731|3045344|P1|Overall Study|Not specified|7
923577|NCT00965731|3045343|P2|Overall Study|Withdrawal by Subject|1
923578|NCT00965731|3045344|P1|Overall Study|Withdrawal by Subject|0
923579|NCT00965731|3045343|P2|Overall Study|Death|4
923580|NCT00965731|3045344|P1|Overall Study|Death|0
923581|NCT00965718|3045408|P1|Overall Study|Withdrawal by Subject|4
923582|NCT00965562|3045421|P3|Overall Study|Withdrawal by Subject|0
923583|NCT00965562|3045422|P2|Overall Study|Withdrawal by Subject|2
923584|NCT00965562|3045423|P1|Overall Study|Withdrawal by Subject|2
923585|NCT00965562|3045421|P3|Overall Study|Lost to Follow-up|3
923586|NCT00965562|3045422|P2|Overall Study|Lost to Follow-up|2
923587|NCT00965562|3045423|P1|Overall Study|Lost to Follow-up|1
923588|NCT00965523|3045461|P1|Study 224|Physician Decision|1
923589|NCT00965523|3045461|P1|Study 224|Progressive Disease|5
923590|NCT00965523|3045461|P1|Study 221|Physician Decision|3
923591|NCT00965523|3045461|P1|Study 221|Progressive Disease|4
923592|NCT00965497|3045466|P1|Overall Study|Physician Decision|1
923593|NCT00965484|3045471|P1|Overall Study|Withdrawal by Subject|1
923594|NCT00965484|3045471|P1|Overall Study|Protocol Violation|1
923595|NCT00965458|3045480|P2|Overall Study|Withdrawal by Subject|1
923596|NCT00965458|3045481|P1|Overall Study|Withdrawal by Subject|0
923597|NCT00965458|3045480|P2|Overall Study|Lost to Follow-up|3
923598|NCT00965458|3045481|P1|Overall Study|Lost to Follow-up|1
923599|NCT00965458|3045480|P2|Overall Study|Adverse Event|0
923600|NCT00965458|3045481|P1|Overall Study|Adverse Event|1
923601|NCT00965419|3045497|P1|Follow-up Phase|Lack of Efficacy|28
923602|NCT00965419|3045497|P1|Follow-up Phase|Parent/Caregiver Decision|9
923603|NCT00965419|3045497|P1|Follow-up Phase|Physician Decision|4
923604|NCT00965419|3045497|P1|Follow-up Phase|Withdrawal by Subject|8
923605|NCT00965419|3045497|P1|Follow-up Phase|Protocol Violation|4
923606|NCT00965419|3045497|P1|Follow-up Phase|Adverse Event|9
923607|NCT00965419|3045497|P1|Open Label Treatment for Responders|Lost to Follow-up|46
923608|NCT00965419|3045497|P1|Open Label Treatment for Responders|Lack of Efficacy|67
923609|NCT00965419|3045497|P1|Open Label Treatment for Responders|Parent/Caregiver Decision|41
923610|NCT00965419|3045497|P1|Open Label Treatment for Responders|Sponsor Decision|5
923611|NCT00965419|3045497|P1|Open Label Treatment for Responders|Physician Decision|6
923612|NCT00965419|3045497|P1|Open Label Treatment for Responders|Withdrawal by Subject|27
923613|NCT00965419|3045497|P1|Open Label Treatment for Responders|Protocol Violation|21
923614|NCT00965419|3045497|P1|Open Label Treatment for Responders|Entry Criteria Not Met|1
923615|NCT00965419|3045497|P1|Open Label Treatment for Responders|Adverse Event|33
923616|NCT00965341|3045543|P2|Overall Study|Transportation issues|3
923617|NCT00965341|3045544|P1|Overall Study|Transportation issues|4
923618|NCT00965341|3045543|P2|Overall Study|Lost to Follow-up|0
923619|NCT00965341|3045544|P1|Overall Study|Lost to Follow-up|1
923620|NCT00965341|3045543|P2|Overall Study|Withdrew consent|5
923621|NCT00965341|3045544|P1|Overall Study|Withdrew consent|1
923622|NCT00965263|3045554|P2|Overall Study|Protocol Violation|2
923623|NCT00965263|3045555|P1|Overall Study|Protocol Violation|0
923624|NCT00965263|3045554|P2|Overall Study|Family emergency|1
923625|NCT00965263|3045555|P1|Overall Study|Family emergency|0
923626|NCT00965263|3045554|P2|Overall Study|Physician Decision|0
923627|NCT00965263|3045555|P1|Overall Study|Physician Decision|2
923628|NCT00965185|3045615|P2|Overall Study|Withdrawal by Subject|1
923629|NCT00965185|3045616|P1|Overall Study|Withdrawal by Subject|0
923630|NCT00965185|3045615|P2|Overall Study|Lost to Follow-up|0
923631|NCT00965185|3045616|P1|Overall Study|Lost to Follow-up|2
923632|NCT00965146|3045636|P1|Overall Study|Overall Study Termination|145
923633|NCT00965146|3045636|P1|Overall Study|Revision / Removal of Study Implant|6
923634|NCT00965146|3045636|P1|Overall Study|Intercurrent illness|1
923635|NCT00965146|3045636|P1|Overall Study|Unwilling to return|11
923636|NCT00965146|3045636|P1|Overall Study|Unable to return|1
923637|NCT00965146|3045636|P1|Overall Study|Withdrawal by Subject|17
923638|NCT00965146|3045636|P1|Overall Study|Lost to Follow-up|22
923639|NCT00965146|3045636|P1|Overall Study|Death|7
923640|NCT00965094|3045643|P2|Overall Study|Lost to Follow-up|1
923641|NCT00965094|3045644|P1|Overall Study|Lost to Follow-up|0
923642|NCT00965094|3045643|P2|Overall Study|Adverse Event|0
923643|NCT00965094|3045644|P1|Overall Study|Adverse Event|5
923644|NCT00965081|3045660|P2|Overall Study|Switched to Rescue Arm|12
923645|NCT00965081|3045661|P1|Overall Study|Switched to Rescue Arm|5
923646|NCT00965081|3045660|P2|Overall Study|Withdrawal by Subject|7
923647|NCT00965081|3045661|P1|Overall Study|Withdrawal by Subject|4
923648|NCT00965081|3045660|P2|Overall Study|Sponsor Decision|0
923649|NCT00965081|3045661|P1|Overall Study|Sponsor Decision|1
923650|NCT00965081|3045660|P2|Overall Study|Protocol Violation|5
923651|NCT00965081|3045661|P1|Overall Study|Protocol Violation|2
923652|NCT00965081|3045660|P2|Overall Study|Physician Decision|0
923653|NCT00965081|3045661|P1|Overall Study|Physician Decision|2
923654|NCT00965081|3045660|P2|Overall Study|Lost to Follow-up|5
923655|NCT00965081|3045661|P1|Overall Study|Lost to Follow-up|4
923656|NCT00965081|3045660|P2|Overall Study|Lack of Efficacy|5
923657|NCT00965081|3045661|P1|Overall Study|Lack of Efficacy|2
923658|NCT00965081|3045660|P2|Overall Study|Adverse Event|9
923659|NCT00965081|3045661|P1|Overall Study|Adverse Event|14
923660|NCT00964886|3045688|P4|Overall Study|Protocol Violation|0
923661|NCT00964886|3045689|P3|Overall Study|Protocol Violation|0
923662|NCT00964886|3045690|P2|Overall Study|Protocol Violation|2
923663|NCT00964886|3045691|P1|Overall Study|Protocol Violation|0
923664|NCT00964886|3045688|P4|Overall Study|Adverse Event|2
923665|NCT00964886|3045689|P3|Overall Study|Adverse Event|5
923666|NCT00964886|3045690|P2|Overall Study|Adverse Event|1
923667|NCT00964886|3045691|P1|Overall Study|Adverse Event|3
923668|NCT00964886|3045688|P4|Overall Study|Withdrawal by Subject|3
923669|NCT00964886|3045689|P3|Overall Study|Withdrawal by Subject|5
923670|NCT00964886|3045690|P2|Overall Study|Withdrawal by Subject|2
923671|NCT00964886|3045691|P1|Overall Study|Withdrawal by Subject|6
923672|NCT00964886|3045688|P4|Overall Study|Lost to Follow-up|4
923673|NCT00964886|3045689|P3|Overall Study|Lost to Follow-up|6
923674|NCT00964886|3045690|P2|Overall Study|Lost to Follow-up|2
923675|NCT00964886|3045691|P1|Overall Study|Lost to Follow-up|2
923676|NCT00964860|3045707|P2|Overall Study|Withdrawal by Subject|1
923677|NCT00964860|3045708|P1|Overall Study|Withdrawal by Subject|0
923678|NCT00964795|3045716|P1|Overall Study|Other|23
923679|NCT00964795|3045716|P1|Overall Study|Unwilling to sign ICF for amendment 4|3
923680|NCT00964795|3045716|P1|Overall Study|Termination of Study by Sponsor|169
923681|NCT00964795|3045716|P1|Overall Study|Lost to Follow-up|7
923682|NCT00964795|3045716|P1|Overall Study|Death|14
923683|NCT00964795|3045716|P1|Overall Study|Adverse Event|12
923684|NCT00964795|3045716|P1|Overall Study|Withdrawal by Subject|79
923685|NCT00964743|3045723|P1|Overall Study|Neither patient completed 8 weeks of tre|2
923686|NCT00964678|3045731|P1|Overall Study|Physician Decision|4
923687|NCT00964392|3045795|P2|Overall Study|Not completed|168
923688|NCT00964392|3045796|P1|Overall Study|Not completed|44
923689|NCT00964392|3045795|P2|Overall Study|Early Termination, non-study arrhythmia|6
923690|NCT00964392|3045796|P1|Overall Study|Early Termination, non-study arrhythmia|1
923691|NCT00964392|3045795|P2|Overall Study|Lost to Follow-up|10
923692|NCT00964392|3045796|P1|Overall Study|Lost to Follow-up|4
923693|NCT00964392|3045795|P2|Overall Study|Withdrawal by Subject|6
923694|NCT00964392|3045796|P1|Overall Study|Withdrawal by Subject|4
923695|NCT00964366|3045806|P2|Overall Study|Withdrawal by Subject|1
923696|NCT00964366|3045807|P1|Overall Study|Withdrawal by Subject|0
923697|NCT00964366|3045806|P2|Overall Study|Did not qualify at Day 1|0
923698|NCT00964366|3045807|P1|Overall Study|Did not qualify at Day 1|1
923699|NCT00964223|3045821|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
923700|NCT00964158|3045889|P3|Overall Study|Withdrawal by Subject|6
923701|NCT00964158|3045890|P2|Overall Study|Withdrawal by Subject|0
923702|NCT00964158|3045891|P1|Overall Study|Withdrawal by Subject|0
923703|NCT00964158|3045889|P3|Overall Study|Lost to Follow-up|2
923704|NCT00964158|3045890|P2|Overall Study|Lost to Follow-up|1
923705|NCT00964158|3045891|P1|Overall Study|Lost to Follow-up|0
923706|NCT00964028|3045966|P2|Overall Study|Withdrawal by Subject|1
923707|NCT00964028|3045967|P1|Overall Study|Withdrawal by Subject|0
923708|NCT00963937|3045982|P3|Overall Study|Physician Decision|4
923709|NCT00963937|3045983|P2|Overall Study|Physician Decision|10
923710|NCT00963937|3045984|P1|Overall Study|Physician Decision|18
923711|NCT00963937|3045982|P3|Overall Study|Protocol Violation|0
923712|NCT00963937|3045983|P2|Overall Study|Protocol Violation|1
923713|NCT00963937|3045984|P1|Overall Study|Protocol Violation|1
923714|NCT00963924|3046022|P2|Overall Study|Lost to Follow-up|1
923715|NCT00963924|3046023|P1|Overall Study|Lost to Follow-up|0
923716|NCT00963924|3046022|P2|Overall Study|Changed antipsychotic|1
923717|NCT00963924|3046023|P1|Overall Study|Changed antipsychotic|0
923718|NCT00963924|3046022|P2|Overall Study|Withdrawal by Subject|1
923719|NCT00963924|3046023|P1|Overall Study|Withdrawal by Subject|0
923720|NCT00963924|3046022|P2|Overall Study|Adverse Event|0
923721|NCT00963924|3046023|P1|Overall Study|Adverse Event|1
923722|NCT00963820|3046097|P12|Expansion Phase|Unsatisfactory Therapeutic Response|1
923723|NCT00963820|3046098|P11|Expansion Phase|Unsatisfactory Therapeutic Response|0
923724|NCT00963820|3046099|P10|Expansion Phase|Unsatisfactory Therapeutic Response|0
923725|NCT00963820|3046100|P9|Expansion Phase|Unsatisfactory Therapeutic Response|0
923726|NCT00963820|3046101|P8|Expansion Phase|Unsatisfactory Therapeutic Response|0
923727|NCT00963820|3046102|P7|Expansion Phase|Unsatisfactory Therapeutic Response|0
923728|NCT00963820|3046103|P6|Expansion Phase|Unsatisfactory Therapeutic Response|0
923729|NCT00963820|3046104|P5|Expansion Phase|Unsatisfactory Therapeutic Response|0
923730|NCT00963820|3046105|P4|Expansion Phase|Unsatisfactory Therapeutic Response|0
923731|NCT00963820|3046106|P3|Expansion Phase|Unsatisfactory Therapeutic Response|0
923732|NCT00963820|3046107|P2|Expansion Phase|Unsatisfactory Therapeutic Response|0
923733|NCT00963820|3046108|P1|Expansion Phase|Unsatisfactory Therapeutic Response|0
923734|NCT00963820|3046097|P12|Expansion Phase|Withdrawal by Subject|1
923735|NCT00963820|3046098|P11|Expansion Phase|Withdrawal by Subject|1
923736|NCT00963820|3046099|P10|Expansion Phase|Withdrawal by Subject|0
923737|NCT00963820|3046100|P9|Expansion Phase|Withdrawal by Subject|1
923738|NCT00963820|3046101|P8|Expansion Phase|Withdrawal by Subject|0
923739|NCT00963820|3046102|P7|Expansion Phase|Withdrawal by Subject|0
923740|NCT00963820|3046103|P6|Expansion Phase|Withdrawal by Subject|0
923741|NCT00963820|3046104|P5|Expansion Phase|Withdrawal by Subject|0
923742|NCT00963820|3046105|P4|Expansion Phase|Withdrawal by Subject|0
923743|NCT00963820|3046106|P3|Expansion Phase|Withdrawal by Subject|0
923744|NCT00963820|3046107|P2|Expansion Phase|Withdrawal by Subject|0
923745|NCT00963820|3046108|P1|Expansion Phase|Withdrawal by Subject|0
923746|NCT00963820|3046097|P12|Expansion Phase|Adverse Event|0
923747|NCT00963820|3046098|P11|Expansion Phase|Adverse Event|0
923748|NCT00963820|3046099|P10|Expansion Phase|Adverse Event|3
923749|NCT00963820|3046100|P9|Expansion Phase|Adverse Event|1
923750|NCT00963820|3046101|P8|Expansion Phase|Adverse Event|0
923751|NCT00963820|3046102|P7|Expansion Phase|Adverse Event|0
923752|NCT00963820|3046103|P6|Expansion Phase|Adverse Event|0
923753|NCT00963820|3046104|P5|Expansion Phase|Adverse Event|0
923754|NCT00963820|3046105|P4|Expansion Phase|Adverse Event|0
923755|NCT00963820|3046106|P3|Expansion Phase|Adverse Event|0
923756|NCT00963820|3046107|P2|Expansion Phase|Adverse Event|0
923757|NCT00963820|3046108|P1|Expansion Phase|Adverse Event|0
923758|NCT00963820|3046097|P12|Expansion Phase|Progressive Disease|2
923759|NCT00963820|3046098|P11|Expansion Phase|Progressive Disease|4
923760|NCT00963820|3046099|P10|Expansion Phase|Progressive Disease|6
923761|NCT00963820|3046100|P9|Expansion Phase|Progressive Disease|8
923762|NCT00963820|3046101|P8|Expansion Phase|Progressive Disease|0
923763|NCT00963820|3046102|P7|Expansion Phase|Progressive Disease|0
923764|NCT00963820|3046103|P6|Expansion Phase|Progressive Disease|0
923765|NCT00963820|3046104|P5|Expansion Phase|Progressive Disease|0
923766|NCT00963820|3046105|P4|Expansion Phase|Progressive Disease|0
923767|NCT00963820|3046106|P3|Expansion Phase|Progressive Disease|0
923768|NCT00963820|3046107|P2|Expansion Phase|Progressive Disease|0
923769|NCT00963820|3046108|P1|Expansion Phase|Progressive Disease|0
923770|NCT00963820|3046097|P12|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
923771|NCT00963820|3046098|P11|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
923772|NCT00963820|3046099|P10|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
923773|NCT00963820|3046100|P9|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
923774|NCT00963820|3046101|P8|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
923775|NCT00963820|3046102|P7|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
923776|NCT00963820|3046103|P6|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
923777|NCT00963820|3046104|P5|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
923778|NCT00963820|3046105|P4|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
923779|NCT00963820|3046106|P3|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
923780|NCT00963820|3046107|P2|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
923781|NCT00963820|3046108|P1|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
923782|NCT00963820|3046097|P12|Dose Escalation Phase|Withdrawal by Subject|0
923783|NCT00963820|3046098|P11|Dose Escalation Phase|Withdrawal by Subject|0
923784|NCT00963820|3046099|P10|Dose Escalation Phase|Withdrawal by Subject|0
923785|NCT00963820|3046100|P9|Dose Escalation Phase|Withdrawal by Subject|0
923786|NCT00963820|3046101|P8|Dose Escalation Phase|Withdrawal by Subject|2
923787|NCT00963820|3046102|P7|Dose Escalation Phase|Withdrawal by Subject|1
923788|NCT00963820|3046103|P6|Dose Escalation Phase|Withdrawal by Subject|0
923789|NCT00963820|3046104|P5|Dose Escalation Phase|Withdrawal by Subject|0
923790|NCT00963820|3046105|P4|Dose Escalation Phase|Withdrawal by Subject|0
923791|NCT00963820|3046106|P3|Dose Escalation Phase|Withdrawal by Subject|0
923792|NCT00963820|3046107|P2|Dose Escalation Phase|Withdrawal by Subject|0
923793|NCT00963820|3046108|P1|Dose Escalation Phase|Withdrawal by Subject|0
923794|NCT00963820|3046097|P12|Dose Escalation Phase|Adverse Event|0
923795|NCT00963820|3046098|P11|Dose Escalation Phase|Adverse Event|0
923796|NCT00963820|3046099|P10|Dose Escalation Phase|Adverse Event|0
923797|NCT00963820|3046100|P9|Dose Escalation Phase|Adverse Event|0
923798|NCT00963820|3046101|P8|Dose Escalation Phase|Adverse Event|1
923799|NCT00963820|3046102|P7|Dose Escalation Phase|Adverse Event|3
923800|NCT00963820|3046103|P6|Dose Escalation Phase|Adverse Event|0
923801|NCT00963820|3046104|P5|Dose Escalation Phase|Adverse Event|0
923802|NCT00963820|3046105|P4|Dose Escalation Phase|Adverse Event|0
923803|NCT00963820|3046106|P3|Dose Escalation Phase|Adverse Event|0
923804|NCT00963820|3046107|P2|Dose Escalation Phase|Adverse Event|0
923805|NCT00963820|3046108|P1|Dose Escalation Phase|Adverse Event|0
923806|NCT00963820|3046097|P12|Dose Escalation Phase|Progressive Disease|0
923807|NCT00963820|3046098|P11|Dose Escalation Phase|Progressive Disease|0
923808|NCT00963820|3046099|P10|Dose Escalation Phase|Progressive Disease|0
923809|NCT00963820|3046100|P9|Dose Escalation Phase|Progressive Disease|0
923810|NCT00963820|3046101|P8|Dose Escalation Phase|Progressive Disease|2
923811|NCT00963820|3046102|P7|Dose Escalation Phase|Progressive Disease|3
923812|NCT00963820|3046103|P6|Dose Escalation Phase|Progressive Disease|3
923813|NCT00963820|3046104|P5|Dose Escalation Phase|Progressive Disease|4
923814|NCT00963820|3046105|P4|Dose Escalation Phase|Progressive Disease|3
923815|NCT00963820|3046106|P3|Dose Escalation Phase|Progressive Disease|3
923816|NCT00963820|3046107|P2|Dose Escalation Phase|Progressive Disease|3
923817|NCT00963820|3046108|P1|Dose Escalation Phase|Progressive Disease|3
923818|NCT00963807|3046244|P1|Overall Study|Disease progression|15
923819|NCT00963807|3046244|P1|Overall Study|Reaction to study chemotherapy regimen|1
923820|NCT00963807|3046244|P1|Overall Study|Physician Decision|2
923821|NCT00963599|3046277|P4|Overall Study|Withdrawal by Subject|3
923822|NCT00963599|3046278|P3|Overall Study|Withdrawal by Subject|3
923823|NCT00963599|3046279|P2|Overall Study|Withdrawal by Subject|1
923824|NCT00963599|3046280|P1|Overall Study|Withdrawal by Subject|2
923825|NCT00963599|3046277|P4|Overall Study|Protocol Violation|4
923826|NCT00963599|3046278|P3|Overall Study|Protocol Violation|3
923827|NCT00963599|3046279|P2|Overall Study|Protocol Violation|2
923828|NCT00963599|3046280|P1|Overall Study|Protocol Violation|2
923829|NCT00963599|3046277|P4|Overall Study|Lost to Follow-up|1
923830|NCT00963599|3046278|P3|Overall Study|Lost to Follow-up|1
923831|NCT00963599|3046279|P2|Overall Study|Lost to Follow-up|1
923832|NCT00963599|3046280|P1|Overall Study|Lost to Follow-up|0
923833|NCT00963599|3046277|P4|Overall Study|Lack of Efficacy|4
923834|NCT00963599|3046278|P3|Overall Study|Lack of Efficacy|1
923835|NCT00963599|3046279|P2|Overall Study|Lack of Efficacy|2
923836|NCT00963599|3046280|P1|Overall Study|Lack of Efficacy|0
923837|NCT00963599|3046277|P4|Overall Study|Adverse Event|2
923838|NCT00963599|3046278|P3|Overall Study|Adverse Event|1
923839|NCT00963599|3046279|P2|Overall Study|Adverse Event|0
923840|NCT00963599|3046280|P1|Overall Study|Adverse Event|2
923841|NCT00963547|3046351|P7|Overall Study|Reason Unknown|0
923842|NCT00963547|3046352|P6|Overall Study|Reason Unknown|0
923843|NCT00963547|3046353|P5|Overall Study|Reason Unknown|0
923844|NCT00963547|3046354|P4|Overall Study|Reason Unknown|0
923845|NCT00963547|3046355|P3|Overall Study|Reason Unknown|0
923846|NCT00963547|3046356|P2|Overall Study|Reason Unknown|1
923847|NCT00963547|3046357|P1|Overall Study|Reason Unknown|0
923848|NCT00963547|3046351|P7|Overall Study|Withdrawal by Subject|0
923849|NCT00963547|3046352|P6|Overall Study|Withdrawal by Subject|0
923850|NCT00963547|3046353|P5|Overall Study|Withdrawal by Subject|0
923851|NCT00963547|3046354|P4|Overall Study|Withdrawal by Subject|0
923852|NCT00963547|3046355|P3|Overall Study|Withdrawal by Subject|3
923853|NCT00963547|3046356|P2|Overall Study|Withdrawal by Subject|0
923854|NCT00963547|3046357|P1|Overall Study|Withdrawal by Subject|0
923855|NCT00963547|3046351|P7|Overall Study|Progressive Disease|0
923856|NCT00963547|3046352|P6|Overall Study|Progressive Disease|0
923857|NCT00963547|3046353|P5|Overall Study|Progressive Disease|0
923858|NCT00963547|3046354|P4|Overall Study|Progressive Disease|5
923859|NCT00963547|3046355|P3|Overall Study|Progressive Disease|9
923860|NCT00963547|3046356|P2|Overall Study|Progressive Disease|8
923861|NCT00963547|3046357|P1|Overall Study|Progressive Disease|3
923862|NCT00963547|3046351|P7|Overall Study|Physician Decision|0
923863|NCT00963547|3046352|P6|Overall Study|Physician Decision|0
923864|NCT00963547|3046353|P5|Overall Study|Physician Decision|0
923865|NCT00963547|3046354|P4|Overall Study|Physician Decision|0
923866|NCT00963547|3046355|P3|Overall Study|Physician Decision|0
923867|NCT00963547|3046356|P2|Overall Study|Physician Decision|1
923868|NCT00963547|3046357|P1|Overall Study|Physician Decision|1
923869|NCT00963547|3046351|P7|Overall Study|Adverse Event|0
923870|NCT00963547|3046352|P6|Overall Study|Adverse Event|0
923871|NCT00963547|3046353|P5|Overall Study|Adverse Event|0
923872|NCT00963547|3046354|P4|Overall Study|Adverse Event|1
923873|NCT00963547|3046355|P3|Overall Study|Adverse Event|0
923874|NCT00963547|3046356|P2|Overall Study|Adverse Event|1
923875|NCT00963547|3046357|P1|Overall Study|Adverse Event|0
923876|NCT00963469|3046404|P3|Overall Study|Site closed (local pollen Season ended)|3
923877|NCT00963469|3046405|P2|Overall Study|Site closed (local pollen Season ended)|1
923878|NCT00963469|3046406|P1|Overall Study|Site closed (local pollen Season ended)|4
923879|NCT00963469|3046404|P3|Overall Study|Moved|0
923880|NCT00963469|3046405|P2|Overall Study|Moved|0
923881|NCT00963469|3046406|P1|Overall Study|Moved|1
923882|NCT00963469|3046404|P3|Overall Study|Pre-randomization Adverse Event|0
923883|NCT00963469|3046405|P2|Overall Study|Pre-randomization Adverse Event|2
923884|NCT00963469|3046406|P1|Overall Study|Pre-randomization Adverse Event|1
923885|NCT00963469|3046404|P3|Overall Study|Withdrawal by Subject|1
923886|NCT00963469|3046405|P2|Overall Study|Withdrawal by Subject|1
923887|NCT00963469|3046406|P1|Overall Study|Withdrawal by Subject|4
923888|NCT00963469|3046404|P3|Overall Study|Protocol Violation|3
923889|NCT00963469|3046405|P2|Overall Study|Protocol Violation|5
923890|NCT00963469|3046406|P1|Overall Study|Protocol Violation|5
923891|NCT00963469|3046404|P3|Overall Study|Lost to Follow-up|0
923892|NCT00963469|3046405|P2|Overall Study|Lost to Follow-up|1
923893|NCT00963469|3046406|P1|Overall Study|Lost to Follow-up|1
923894|NCT00963469|3046404|P3|Overall Study|Lack of Efficacy|2
923895|NCT00963469|3046405|P2|Overall Study|Lack of Efficacy|7
923896|NCT00963469|3046406|P1|Overall Study|Lack of Efficacy|10
923897|NCT00963469|3046404|P3|Overall Study|Adverse Event|1
923898|NCT00963469|3046405|P2|Overall Study|Adverse Event|11
923899|NCT00963469|3046406|P1|Overall Study|Adverse Event|15
923900|NCT00963235|3046473|P1|Overall Study|Other|1
923901|NCT00963235|3046473|P1|Overall Study|Physician Decision|2
923902|NCT00963235|3046473|P1|Overall Study|Adverse Event|5
923903|NCT00963235|3046473|P1|Overall Study|Protocol Violation|7
923904|NCT00963235|3046473|P1|Overall Study|Failed to return|9
923905|NCT00963235|3046473|P1|Overall Study|Lost to Follow-up|14
923906|NCT00963235|3046473|P1|Overall Study|Withdrawal by Subject|22
923907|NCT00962780|3046765|P2|Overall Study|Other|1
923908|NCT00962780|3046766|P1|Overall Study|Other|0
923909|NCT00962780|3046765|P2|Overall Study|Withdrawal by Subject|8
923910|NCT00962780|3046766|P1|Overall Study|Withdrawal by Subject|1
923911|NCT00962780|3046765|P2|Overall Study|Protocol Violation|4
923912|NCT00962780|3046766|P1|Overall Study|Protocol Violation|9
923913|NCT00962780|3046765|P2|Overall Study|Death|1
923914|NCT00962780|3046766|P1|Overall Study|Death|0
923915|NCT00962741|3046841|P1|Overall Study|drug ineffective+prohibited drug taken|1
923916|NCT00962741|3046841|P1|Overall Study|Lack of Efficacy|1
923917|NCT00962741|3046841|P1|Overall Study|Withdrawal by Subject|1
923918|NCT00962741|3046841|P1|Overall Study|Lost to Follow-up|2
923919|NCT00962741|3046841|P1|Overall Study|Failed to return|3
923920|NCT00962650|3046932|P1|Overall Study|Transgastric DP was not completed|2
923921|NCT00962585|3046951|P4|Overall Study|Withdrew Consent|0
923922|NCT00962585|3046952|P3|Overall Study|Withdrew Consent|0
923923|NCT00962585|3046953|P2|Overall Study|Withdrew Consent|0
923924|NCT00962585|3046954|P1|Overall Study|Withdrew Consent|2
923925|NCT00962585|3046951|P4|Overall Study|Withdrawal by Subject|0
923926|NCT00962585|3046952|P3|Overall Study|Withdrawal by Subject|0
923927|NCT00962585|3046953|P2|Overall Study|Withdrawal by Subject|0
923928|NCT00962585|3046954|P1|Overall Study|Withdrawal by Subject|1
923929|NCT00962585|3046951|P4|Overall Study|Protocol Violation|0
923930|NCT00962585|3046952|P3|Overall Study|Protocol Violation|1
923931|NCT00962585|3046953|P2|Overall Study|Protocol Violation|0
923932|NCT00962585|3046954|P1|Overall Study|Protocol Violation|0
923933|NCT00962585|3046951|P4|Overall Study|Lost to Follow-up|0
923934|NCT00962585|3046952|P3|Overall Study|Lost to Follow-up|1
923935|NCT00962585|3046953|P2|Overall Study|Lost to Follow-up|0
923936|NCT00962585|3046954|P1|Overall Study|Lost to Follow-up|3
923937|NCT00962585|3046951|P4|Overall Study|Adverse Event|0
923938|NCT00962585|3046952|P3|Overall Study|Adverse Event|1
923939|NCT00962585|3046953|P2|Overall Study|Adverse Event|2
923940|NCT00962585|3046954|P1|Overall Study|Adverse Event|0
923941|NCT00962390|3047016|P4|Overall Study|Withdrawal by Subject|0
923942|NCT00962390|3047017|P3|Overall Study|Withdrawal by Subject|1
923943|NCT00962390|3047018|P2|Overall Study|Withdrawal by Subject|1
923944|NCT00962390|3047019|P1|Overall Study|Withdrawal by Subject|1
923945|NCT00962390|3047016|P4|Overall Study|Protocol Violation|0
923946|NCT00962390|3047017|P3|Overall Study|Protocol Violation|0
923947|NCT00962390|3047018|P2|Overall Study|Protocol Violation|0
923948|NCT00962390|3047019|P1|Overall Study|Protocol Violation|1
923949|NCT00962390|3047016|P4|Overall Study|Lost to Follow-up|0
923950|NCT00962390|3047017|P3|Overall Study|Lost to Follow-up|0
923951|NCT00962390|3047018|P2|Overall Study|Lost to Follow-up|2
923952|NCT00962390|3047019|P1|Overall Study|Lost to Follow-up|2
923953|NCT00962390|3047016|P4|Overall Study|Adverse Event|1
923954|NCT00962390|3047017|P3|Overall Study|Adverse Event|3
923955|NCT00962390|3047018|P2|Overall Study|Adverse Event|0
923956|NCT00962390|3047019|P1|Overall Study|Adverse Event|0
923957|NCT00962247|3047081|P1|25% Reduction of Sedentary Activity|Withdrawal by Subject|1
923958|NCT00962247|3047081|P1|25% Reduction of Sedentary Activity|Protocol Violation|4
923959|NCT00962247|3047081|P1|Usual Sedentary|Withdrawal by Subject|5
923960|NCT00962247|3047081|P1|Usual Sedentary|Protocol Violation|13
923961|NCT00962208|3047092|P2|Overall Study|Lost to Follow-up|9
923962|NCT00962208|3047093|P1|Overall Study|Lost to Follow-up|0
923963|NCT00962208|3047092|P2|Overall Study|Contraindicated to continue study|1
923964|NCT00962208|3047093|P1|Overall Study|Contraindicated to continue study|5
923965|NCT00962208|3047092|P2|Overall Study|Could not achieve good vision|0
923966|NCT00962208|3047093|P1|Overall Study|Could not achieve good vision|9
923967|NCT00962104|3047101|P2|Overall Study|Other|0
923968|NCT00962104|3047102|P1|Overall Study|Other|2
923969|NCT00962104|3047101|P2|Overall Study|Withdrawal by Subject|6
923970|NCT00962104|3047102|P1|Overall Study|Withdrawal by Subject|10
923971|NCT00962104|3047101|P2|Overall Study|Sponsor Decision|1
923972|NCT00962104|3047102|P1|Overall Study|Sponsor Decision|0
923973|NCT00962104|3047101|P2|Overall Study|Protocol Violation|8
923974|NCT00962104|3047102|P1|Overall Study|Protocol Violation|6
923975|NCT00962104|3047101|P2|Overall Study|Physician Decision|0
923976|NCT00962104|3047102|P1|Overall Study|Physician Decision|1
923977|NCT00962104|3047101|P2|Overall Study|Lost to Follow-up|4
923978|NCT00962104|3047102|P1|Overall Study|Lost to Follow-up|10
923979|NCT00962104|3047101|P2|Overall Study|Lack of Efficacy|1
923980|NCT00962104|3047102|P1|Overall Study|Lack of Efficacy|0
923981|NCT00962104|3047101|P2|Overall Study|Entry Criteria Not Met|2
923982|NCT00962104|3047102|P1|Overall Study|Entry Criteria Not Met|1
923983|NCT00962104|3047101|P2|Overall Study|Adverse Event|3
923984|NCT00962104|3047102|P1|Overall Study|Adverse Event|10
923985|NCT00962013|3047156|P1|Overall Study|No 5 year evaluation|6
923986|NCT00962013|3047156|P1|Overall Study|Site Termination|24
923987|NCT00962013|3047156|P1|Overall Study|Removal of study device|3
923988|NCT00962013|3047156|P1|Overall Study|Withdrawal by Subject|8
923989|NCT00962013|3047156|P1|Overall Study|Unable/Unwilling to return|6
923990|NCT00962013|3047156|P1|Overall Study|Lost to Follow-up|12
923991|NCT00962013|3047156|P1|Overall Study|Death|8
923992|NCT00962013|3047156|P1|Overall Study|Did not have surgery|1
923993|NCT00961896|3047179|P3|Overall Study|Abnormal laboratory value|1
923994|NCT00961896|3047180|P2|Overall Study|Abnormal laboratory value|0
923995|NCT00961896|3047181|P1|Overall Study|Abnormal laboratory value|0
923996|NCT00961649|3047248|P4|Overall Study|Study terminated by sponsor|1
923997|NCT00961649|3047249|P3|Overall Study|Study terminated by sponsor|4
923998|NCT00961649|3047250|P2|Overall Study|Study terminated by sponsor|4
923999|NCT00961649|3047251|P1|Overall Study|Study terminated by sponsor|4
924000|NCT00961649|3047248|P4|Overall Study|Patient left to Mexico-family emergency|0
924001|NCT00961649|3047249|P3|Overall Study|Patient left to Mexico-family emergency|0
924002|NCT00961649|3047250|P2|Overall Study|Patient left to Mexico-family emergency|0
924003|NCT00961649|3047251|P1|Overall Study|Patient left to Mexico-family emergency|1
924004|NCT00961649|3047248|P4|Overall Study|Patient has travel plans during holidays|0
924005|NCT00961649|3047249|P3|Overall Study|Patient has travel plans during holidays|1
924006|NCT00961649|3047250|P2|Overall Study|Patient has travel plans during holidays|0
924007|NCT00961649|3047251|P1|Overall Study|Patient has travel plans during holidays|0
924008|NCT00961649|3047248|P4|Overall Study|Inadequate control of IOP|1
924009|NCT00961649|3047249|P3|Overall Study|Inadequate control of IOP|0
924010|NCT00961649|3047250|P2|Overall Study|Inadequate control of IOP|0
924011|NCT00961649|3047251|P1|Overall Study|Inadequate control of IOP|0
924012|NCT00961649|3047248|P4|Overall Study|Adverse Event|2
924013|NCT00961649|3047249|P3|Overall Study|Adverse Event|0
924014|NCT00961649|3047250|P2|Overall Study|Adverse Event|0
924015|NCT00961649|3047251|P1|Overall Study|Adverse Event|4
924016|NCT00961636|3047265|P3|Overall Study|Withdrawal by Subject|13
924017|NCT00961636|3047266|P2|Overall Study|Withdrawal by Subject|22
924018|NCT00961636|3047267|P1|Overall Study|Withdrawal by Subject|29
924019|NCT00961636|3047265|P3|Overall Study|Protocol Violation|1
924020|NCT00961636|3047266|P2|Overall Study|Protocol Violation|5
924021|NCT00961636|3047267|P1|Overall Study|Protocol Violation|9
924022|NCT00961636|3047265|P3|Overall Study|Physician Decision|1
924023|NCT00961636|3047266|P2|Overall Study|Physician Decision|1
924024|NCT00961636|3047267|P1|Overall Study|Physician Decision|3
924025|NCT00961636|3047265|P3|Overall Study|Lost to Follow-up|1
924026|NCT00961636|3047266|P2|Overall Study|Lost to Follow-up|3
924027|NCT00961636|3047267|P1|Overall Study|Lost to Follow-up|2
924028|NCT00961636|3047265|P3|Overall Study|Flushing Symptoms|3
924029|NCT00961636|3047266|P2|Overall Study|Flushing Symptoms|46
924030|NCT00961636|3047267|P1|Overall Study|Flushing Symptoms|29
924031|NCT00961636|3047265|P3|Overall Study|Adverse Event|13
924032|NCT00961636|3047266|P2|Overall Study|Adverse Event|54
924033|NCT00961636|3047267|P1|Overall Study|Adverse Event|35
924034|NCT00961571|3047278|P1|Overall Study|Physician Decision|39
924035|NCT00961415|3047306|P3|Maintenance Treatment Phase|Other reason|3
924036|NCT00961415|3047307|P2|Maintenance Treatment Phase|Other reason|1
924037|NCT00961415|3047308|P1|Maintenance Treatment Phase|Other reason|0
924038|NCT00961415|3047306|P3|Maintenance Treatment Phase|Withdrawal by Subject|8
924039|NCT00961415|3047307|P2|Maintenance Treatment Phase|Withdrawal by Subject|3
924040|NCT00961415|3047308|P1|Maintenance Treatment Phase|Withdrawal by Subject|0
924041|NCT00961415|3047306|P3|Maintenance Treatment Phase|Investigators decision|0
924042|NCT00961415|3047307|P2|Maintenance Treatment Phase|Investigators decision|2
924043|NCT00961415|3047308|P1|Maintenance Treatment Phase|Investigators decision|0
924044|NCT00961415|3047306|P3|Maintenance Treatment Phase|Death|34
924045|NCT00961415|3047307|P2|Maintenance Treatment Phase|Death|42
924046|NCT00961415|3047308|P1|Maintenance Treatment Phase|Death|0
924047|NCT00961415|3047306|P3|Induction Treatment Phase|Other Reason|0
924048|NCT00961415|3047307|P2|Induction Treatment Phase|Other Reason|0
924049|NCT00961415|3047308|P1|Induction Treatment Phase|Other Reason|5
924050|NCT00961415|3047306|P3|Induction Treatment Phase|Didn’t meet maintenance phase criteria|0
924051|NCT00961415|3047307|P2|Induction Treatment Phase|Didn’t meet maintenance phase criteria|0
924052|NCT00961415|3047308|P1|Induction Treatment Phase|Didn’t meet maintenance phase criteria|27
924053|NCT00961415|3047306|P3|Induction Treatment Phase|Physician Decision|0
924054|NCT00961415|3047307|P2|Induction Treatment Phase|Physician Decision|0
924055|NCT00961415|3047308|P1|Induction Treatment Phase|Physician Decision|2
924056|NCT00961415|3047306|P3|Induction Treatment Phase|Protocol Violation|0
924057|NCT00961415|3047307|P2|Induction Treatment Phase|Protocol Violation|0
924058|NCT00961415|3047308|P1|Induction Treatment Phase|Protocol Violation|1
924059|NCT00961415|3047306|P3|Induction Treatment Phase|Death|0
924060|NCT00961415|3047307|P2|Induction Treatment Phase|Death|0
924061|NCT00961415|3047308|P1|Induction Treatment Phase|Death|77
924062|NCT00961415|3047306|P3|Induction Treatment Phase|Withdrawal by Subject|0
924063|NCT00961415|3047307|P2|Induction Treatment Phase|Withdrawal by Subject|0
924064|NCT00961415|3047308|P1|Induction Treatment Phase|Withdrawal by Subject|11
924065|NCT00961350|3047348|P2|Overall Study|Misc|21
924066|NCT00961350|3047349|P1|Overall Study|Misc|16
924067|NCT00961350|3047348|P2|Overall Study|Lost to Follow-up|3
924068|NCT00961350|3047349|P1|Overall Study|Lost to Follow-up|3
924069|NCT00961350|3047348|P2|Overall Study|Withdrawal by Subject|10
924070|NCT00961350|3047349|P1|Overall Study|Withdrawal by Subject|10
924071|NCT00961350|3047348|P2|Overall Study|Adverse Event|33
924072|NCT00961350|3047349|P1|Overall Study|Adverse Event|18
924073|NCT00961298|3047370|P1|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1
924074|NCT00961298|3047370|P1|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2
924075|NCT00961298|3047370|P1|Two Week Placebo Run in|Withdrawal by Subject|1
924076|NCT00961259|3047377|P3|Washout Period of 7 Days|due to concomitant medication used|0
924077|NCT00961259|3047378|P2|Washout Period of 7 Days|due to concomitant medication used|1
924078|NCT00961259|3047379|P1|Washout Period of 7 Days|due to concomitant medication used|0
924079|NCT00961220|3047407|P1|Overall Study|Complete Response prior to 12 courses|1
924080|NCT00961220|3047407|P1|Overall Study|O6BG no longer supplied|1
924081|NCT00961220|3047407|P1|Overall Study|No IV access for O6BG|1
924082|NCT00961220|3047407|P1|Overall Study|Lack of Efficacy|1
924083|NCT00961220|3047407|P1|Overall Study|Adverse Event|3
924084|NCT00961181|3047423|P1|Overall Study|Lost to Follow-up|1
924085|NCT00961181|3047423|P1|Overall Study|Withdrawal by Subject|2
924086|NCT00961181|3047423|P1|Overall Study|Death|2
924087|NCT00961116|3047436|P2|Washout Period of 7 Days|Protocol Violation|1
924088|NCT00961116|3047437|P1|Washout Period of 7 Days|Protocol Violation|0
924089|NCT00961116|3047436|P2|Washout Period of 7 Days|Withdrawal by Subject|1
924090|NCT00961116|3047437|P1|Washout Period of 7 Days|Withdrawal by Subject|1
924091|NCT00961116|3047436|P2|Washout Period of 7 Days|Adverse Event|1
924092|NCT00961116|3047437|P1|Washout Period of 7 Days|Adverse Event|1
924093|NCT00960999|3047460|P2|Overall Study|RT dose constraints not met|0
924094|NCT00960999|3047461|P1|Overall Study|RT dose constraints not met|2
924095|NCT00960999|3047460|P2|Overall Study|Protocol Violation|2
924096|NCT00960999|3047461|P1|Overall Study|Protocol Violation|5
924097|NCT00960999|3047460|P2|Overall Study|Withdrawal by Subject|0
924098|NCT00960999|3047461|P1|Overall Study|Withdrawal by Subject|1
924099|NCT00960986|3047471|P4|Period 3 (7-week Therapy Period)|Lack of Efficacy|0
924100|NCT00960986|3047472|P3|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
924101|NCT00960986|3047473|P2|Period 3 (7-week Therapy Period)|Lack of Efficacy|2
924102|NCT00960986|3047474|P1|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
924103|NCT00960986|3047471|P4|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
924104|NCT00960986|3047472|P3|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4
924105|NCT00960986|3047473|P2|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
924106|NCT00960986|3047474|P1|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
924107|NCT00960986|3047471|P4|Period 3 (7-week Therapy Period)|Protocol Violation|11
924108|NCT00960986|3047472|P3|Period 3 (7-week Therapy Period)|Protocol Violation|3
924109|NCT00960986|3047473|P2|Period 3 (7-week Therapy Period)|Protocol Violation|4
924110|NCT00960986|3047474|P1|Period 3 (7-week Therapy Period)|Protocol Violation|10
924111|NCT00960986|3047471|P4|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
924112|NCT00960986|3047472|P3|Period 3 (7-week Therapy Period)|Lost to Follow-up|1
924113|NCT00960986|3047473|P2|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
924114|NCT00960986|3047474|P1|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
924115|NCT00960986|3047471|P4|Period 3 (7-week Therapy Period)|Death|0
924116|NCT00960986|3047472|P3|Period 3 (7-week Therapy Period)|Death|1
924117|NCT00960986|3047473|P2|Period 3 (7-week Therapy Period)|Death|0
924118|NCT00960986|3047474|P1|Period 3 (7-week Therapy Period)|Death|0
924119|NCT00960986|3047471|P4|Period 3 (7-week Therapy Period)|Adverse Event|12
924120|NCT00960986|3047472|P3|Period 3 (7-week Therapy Period)|Adverse Event|10
924121|NCT00960986|3047473|P2|Period 3 (7-week Therapy Period)|Adverse Event|15
924122|NCT00960986|3047474|P1|Period 3 (7-week Therapy Period)|Adverse Event|17
924123|NCT00960986|3047471|P4|Period 1 (Screening and Washout)|Withdrawal by Subject|1
924124|NCT00960986|3047472|P3|Period 1 (Screening and Washout)|Withdrawal by Subject|1
924125|NCT00960986|3047473|P2|Period 1 (Screening and Washout)|Withdrawal by Subject|2
924126|NCT00960986|3047474|P1|Period 1 (Screening and Washout)|Withdrawal by Subject|1
924127|NCT00960986|3047471|P4|Period 1 (Screening and Washout)|Protocol Violation|0
924128|NCT00960986|3047472|P3|Period 1 (Screening and Washout)|Protocol Violation|0
924129|NCT00960986|3047473|P2|Period 1 (Screening and Washout)|Protocol Violation|0
924130|NCT00960986|3047474|P1|Period 1 (Screening and Washout)|Protocol Violation|1
924131|NCT00960986|3047471|P4|Period 1 (Screening and Washout)|Lost to Follow-up|1
924132|NCT00960986|3047472|P3|Period 1 (Screening and Washout)|Lost to Follow-up|2
924133|NCT00960986|3047473|P2|Period 1 (Screening and Washout)|Lost to Follow-up|0
924134|NCT00960986|3047474|P1|Period 1 (Screening and Washout)|Lost to Follow-up|0
924135|NCT00960986|3047471|P4|Period 1 (Screening and Washout)|Adverse Event|1
924136|NCT00960986|3047472|P3|Period 1 (Screening and Washout)|Adverse Event|1
924137|NCT00960986|3047473|P2|Period 1 (Screening and Washout)|Adverse Event|2
924138|NCT00960986|3047474|P1|Period 1 (Screening and Washout)|Adverse Event|1
924139|NCT00960934|3047550|P6|Overall Study|Study Terminated by Sponsor|49
924140|NCT00960934|3047551|P5|Overall Study|Study Terminated by Sponsor|49
924141|NCT00960934|3047552|P4|Overall Study|Study Terminated by Sponsor|50
924142|NCT00960934|3047553|P3|Overall Study|Study Terminated by Sponsor|52
924143|NCT00960934|3047554|P2|Overall Study|Study Terminated by Sponsor|46
924144|NCT00960934|3047555|P1|Overall Study|Study Terminated by Sponsor|50
924145|NCT00960934|3047550|P6|Overall Study|Withdrawal by Subject|7
924146|NCT00960934|3047551|P5|Overall Study|Withdrawal by Subject|5
924147|NCT00960934|3047552|P4|Overall Study|Withdrawal by Subject|5
924148|NCT00960934|3047553|P3|Overall Study|Withdrawal by Subject|4
924149|NCT00960934|3047554|P2|Overall Study|Withdrawal by Subject|6
924150|NCT00960934|3047555|P1|Overall Study|Withdrawal by Subject|5
924151|NCT00960934|3047550|P6|Overall Study|Protocol Violation|2
924152|NCT00960934|3047551|P5|Overall Study|Protocol Violation|3
924153|NCT00960934|3047552|P4|Overall Study|Protocol Violation|3
924154|NCT00960934|3047553|P3|Overall Study|Protocol Violation|0
924155|NCT00960934|3047554|P2|Overall Study|Protocol Violation|4
924156|NCT00960934|3047555|P1|Overall Study|Protocol Violation|3
924157|NCT00960934|3047550|P6|Overall Study|Progressive Disease|1
924158|NCT00960934|3047551|P5|Overall Study|Progressive Disease|1
924159|NCT00960934|3047552|P4|Overall Study|Progressive Disease|0
924160|NCT00960934|3047553|P3|Overall Study|Progressive Disease|0
924161|NCT00960934|3047554|P2|Overall Study|Progressive Disease|1
924162|NCT00960934|3047555|P1|Overall Study|Progressive Disease|1
924163|NCT00960934|3047550|P6|Overall Study|Physician Decision|0
924164|NCT00960934|3047551|P5|Overall Study|Physician Decision|0
924165|NCT00960934|3047552|P4|Overall Study|Physician Decision|0
924166|NCT00960934|3047553|P3|Overall Study|Physician Decision|0
924167|NCT00960934|3047554|P2|Overall Study|Physician Decision|1
924168|NCT00960934|3047555|P1|Overall Study|Physician Decision|0
924169|NCT00960934|3047550|P6|Overall Study|Not Specified|2
924170|NCT00960934|3047551|P5|Overall Study|Not Specified|2
924171|NCT00960934|3047552|P4|Overall Study|Not Specified|4
924172|NCT00960934|3047553|P3|Overall Study|Not Specified|5
924173|NCT00960934|3047554|P2|Overall Study|Not Specified|1
924174|NCT00960934|3047555|P1|Overall Study|Not Specified|2
924175|NCT00960934|3047550|P6|Overall Study|Lost to Follow-up|0
924176|NCT00960934|3047551|P5|Overall Study|Lost to Follow-up|0
924177|NCT00960934|3047552|P4|Overall Study|Lost to Follow-up|0
924178|NCT00960934|3047553|P3|Overall Study|Lost to Follow-up|0
924179|NCT00960934|3047554|P2|Overall Study|Lost to Follow-up|1
924180|NCT00960934|3047555|P1|Overall Study|Lost to Follow-up|0
924181|NCT00960934|3047550|P6|Overall Study|Lack of Efficacy|0
924182|NCT00960934|3047551|P5|Overall Study|Lack of Efficacy|0
924183|NCT00960934|3047552|P4|Overall Study|Lack of Efficacy|0
924184|NCT00960934|3047553|P3|Overall Study|Lack of Efficacy|0
924185|NCT00960934|3047554|P2|Overall Study|Lack of Efficacy|0
924186|NCT00960934|3047555|P1|Overall Study|Lack of Efficacy|1
924187|NCT00960934|3047550|P6|Overall Study|Adverse Event|3
924188|NCT00960934|3047551|P5|Overall Study|Adverse Event|4
924189|NCT00960934|3047552|P4|Overall Study|Adverse Event|2
924190|NCT00960934|3047553|P3|Overall Study|Adverse Event|3
924191|NCT00960934|3047554|P2|Overall Study|Adverse Event|3
924192|NCT00960934|3047555|P1|Overall Study|Adverse Event|2
924193|NCT00960869|3047667|P2|Overall Study|Misc|18
924194|NCT00960869|3047668|P1|Overall Study|Misc|19
924195|NCT00960869|3047667|P2|Overall Study|Lost to Follow-up|4
924196|NCT00960869|3047668|P1|Overall Study|Lost to Follow-up|1
924197|NCT00960869|3047667|P2|Overall Study|Withdrawal by Subject|14
924198|NCT00960869|3047668|P1|Overall Study|Withdrawal by Subject|16
924199|NCT00960869|3047667|P2|Overall Study|Adverse Event|26
924200|NCT00960869|3047668|P1|Overall Study|Adverse Event|17
924201|NCT00960856|3047682|P4|Washout Period of 7 Days|Adverse Event|0
924202|NCT00960856|3047683|P3|Washout Period of 7 Days|Adverse Event|1
924203|NCT00960856|3047684|P2|Washout Period of 7 Days|Adverse Event|0
924204|NCT00960856|3047685|P1|Washout Period of 7 Days|Adverse Event|0
924205|NCT00960856|3047682|P4|Washout Period of 7 Days|Withdrawal by Subject|0
924206|NCT00960856|3047683|P3|Washout Period of 7 Days|Withdrawal by Subject|0
924207|NCT00960856|3047684|P2|Washout Period of 7 Days|Withdrawal by Subject|2
924208|NCT00960856|3047685|P1|Washout Period of 7 Days|Withdrawal by Subject|0
924209|NCT00960843|3047705|P2|Overall Study|Repeated needle dislodgment|1
924210|NCT00960843|3047706|P1|Overall Study|Repeated needle dislodgment|0
924211|NCT00960843|3047705|P2|Overall Study|Protocol Violation|4
924212|NCT00960843|3047706|P1|Overall Study|Protocol Violation|0
924213|NCT00960843|3047705|P2|Overall Study|Lost to Follow-up|0
924214|NCT00960843|3047706|P1|Overall Study|Lost to Follow-up|2
924215|NCT00960687|3047727|P2|Washout Period of 7 Days|Withdrawal by Subject|1
924216|NCT00960687|3047728|P1|Washout Period of 7 Days|Withdrawal by Subject|1
924217|NCT00960687|3047727|P2|Washout Period of 7 Days|Adverse Event|2
924218|NCT00960687|3047728|P1|Washout Period of 7 Days|Adverse Event|3
924219|NCT00960661|3047740|P3|Interventional Phase|Lack of Efficacy|0
924220|NCT00960661|3047741|P2|Interventional Phase|Lack of Efficacy|2
924221|NCT00960661|3047742|P1|Interventional Phase|Lack of Efficacy|0
924222|NCT00960661|3047740|P3|Interventional Phase|sponsor decision|0
924223|NCT00960661|3047741|P2|Interventional Phase|sponsor decision|1
924224|NCT00960661|3047742|P1|Interventional Phase|sponsor decision|0
924225|NCT00960661|3047740|P3|Interventional Phase|Physician Decision|5
924226|NCT00960661|3047741|P2|Interventional Phase|Physician Decision|3
924227|NCT00960661|3047742|P1|Interventional Phase|Physician Decision|0
924228|NCT00960661|3047740|P3|Interventional Phase|Withdrawal by Subject|29
924229|NCT00960661|3047741|P2|Interventional Phase|Withdrawal by Subject|18
924230|NCT00960661|3047742|P1|Interventional Phase|Withdrawal by Subject|0
924231|NCT00960661|3047740|P3|Interventional Phase|Protocol Violation|2
924232|NCT00960661|3047741|P2|Interventional Phase|Protocol Violation|7
924233|NCT00960661|3047742|P1|Interventional Phase|Protocol Violation|0
924234|NCT00960661|3047740|P3|Interventional Phase|entry criteria not met|0
924235|NCT00960661|3047741|P2|Interventional Phase|entry criteria not met|3
924236|NCT00960661|3047742|P1|Interventional Phase|entry criteria not met|0
924237|NCT00960661|3047740|P3|Interventional Phase|Lost to Follow-up|2
924238|NCT00960661|3047741|P2|Interventional Phase|Lost to Follow-up|0
924239|NCT00960661|3047742|P1|Interventional Phase|Lost to Follow-up|0
924240|NCT00960661|3047740|P3|Interventional Phase|Death|0
924241|NCT00960661|3047741|P2|Interventional Phase|Death|1
924242|NCT00960661|3047742|P1|Interventional Phase|Death|0
924243|NCT00960661|3047740|P3|Interventional Phase|Adverse Event|8
924244|NCT00960661|3047741|P2|Interventional Phase|Adverse Event|17
924245|NCT00960661|3047742|P1|Interventional Phase|Adverse Event|0
924246|NCT00960661|3047740|P3|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
924247|NCT00960661|3047741|P2|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
924248|NCT00960661|3047742|P1|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3
924249|NCT00960661|3047740|P3|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
924250|NCT00960661|3047741|P2|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
924251|NCT00960661|3047742|P1|Basal Insulin Optimization Phase (BIO)|Physician Decision|8
924252|NCT00960661|3047740|P3|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
924253|NCT00960661|3047741|P2|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
924254|NCT00960661|3047742|P1|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47
924255|NCT00960661|3047740|P3|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
924256|NCT00960661|3047741|P2|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
924257|NCT00960661|3047742|P1|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331
924258|NCT00960661|3047740|P3|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
924259|NCT00960661|3047741|P2|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
924260|NCT00960661|3047742|P1|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4
924261|NCT00960661|3047740|P3|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
924262|NCT00960661|3047741|P2|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
924263|NCT00960661|3047742|P1|Basal Insulin Optimization Phase (BIO)|Adverse Event|6
924264|NCT00960570|3047781|P1|1 Day Period Between Dosing|Withdrawal by Subject|1
924265|NCT00960570|3047781|P1|1 Day Period Between Dosing|Adverse Event|2
924266|NCT00960570|3047781|P1|21 Day Washout Period|Withdrawal by Subject|1
924267|NCT00960570|3047781|P1|21 Day Washout Period|Adverse Event|1
924268|NCT00960531|3047802|P10|Overall Study|Reason not Specified|1
924269|NCT00960531|3047803|P9|Overall Study|Reason not Specified|8
924270|NCT00960531|3047804|P8|Overall Study|Reason not Specified|0
924271|NCT00960531|3047805|P7|Overall Study|Reason not Specified|16
924272|NCT00960531|3047806|P6|Overall Study|Reason not Specified|0
924273|NCT00960531|3047807|P5|Overall Study|Reason not Specified|2
924274|NCT00960531|3047808|P4|Overall Study|Reason not Specified|1
924275|NCT00960531|3047809|P3|Overall Study|Reason not Specified|13
924276|NCT00960531|3047810|P2|Overall Study|Reason not Specified|1
924277|NCT00960531|3047811|P1|Overall Study|Reason not Specified|2
924278|NCT00960531|3047802|P10|Overall Study|Adverse Event (AE)|0
924279|NCT00960531|3047803|P9|Overall Study|Adverse Event (AE)|2
924280|NCT00960531|3047804|P8|Overall Study|Adverse Event (AE)|0
924281|NCT00960531|3047805|P7|Overall Study|Adverse Event (AE)|2
924282|NCT00960531|3047806|P6|Overall Study|Adverse Event (AE)|1
924283|NCT00960531|3047807|P5|Overall Study|Adverse Event (AE)|0
924284|NCT00960531|3047808|P4|Overall Study|Adverse Event (AE)|0
924285|NCT00960531|3047809|P3|Overall Study|Adverse Event (AE)|0
924286|NCT00960531|3047810|P2|Overall Study|Adverse Event (AE)|0
924287|NCT00960531|3047811|P1|Overall Study|Adverse Event (AE)|2
924288|NCT00960531|3047802|P10|Overall Study|Failed to Return|0
924289|NCT00960531|3047803|P9|Overall Study|Failed to Return|0
924290|NCT00960531|3047804|P8|Overall Study|Failed to Return|2
924291|NCT00960531|3047805|P7|Overall Study|Failed to Return|0
924292|NCT00960531|3047806|P6|Overall Study|Failed to Return|0
924293|NCT00960531|3047807|P5|Overall Study|Failed to Return|0
924294|NCT00960531|3047808|P4|Overall Study|Failed to Return|0
924295|NCT00960531|3047809|P3|Overall Study|Failed to Return|0
924296|NCT00960531|3047810|P2|Overall Study|Failed to Return|0
924297|NCT00960531|3047811|P1|Overall Study|Failed to Return|2
924298|NCT00960531|3047802|P10|Overall Study|Lost to Follow-up|0
924299|NCT00960531|3047803|P9|Overall Study|Lost to Follow-up|0
924300|NCT00960531|3047804|P8|Overall Study|Lost to Follow-up|0
924301|NCT00960531|3047805|P7|Overall Study|Lost to Follow-up|1
924302|NCT00960531|3047806|P6|Overall Study|Lost to Follow-up|0
924303|NCT00960531|3047807|P5|Overall Study|Lost to Follow-up|0
924304|NCT00960531|3047808|P4|Overall Study|Lost to Follow-up|0
924305|NCT00960531|3047809|P3|Overall Study|Lost to Follow-up|1
924306|NCT00960531|3047810|P2|Overall Study|Lost to Follow-up|0
924307|NCT00960531|3047811|P1|Overall Study|Lost to Follow-up|0
924308|NCT00960531|3047802|P10|Overall Study|Discontinuation of Study by Sponsor|0
924309|NCT00960531|3047803|P9|Overall Study|Discontinuation of Study by Sponsor|0
924310|NCT00960531|3047804|P8|Overall Study|Discontinuation of Study by Sponsor|1
924311|NCT00960531|3047805|P7|Overall Study|Discontinuation of Study by Sponsor|0
924312|NCT00960531|3047806|P6|Overall Study|Discontinuation of Study by Sponsor|0
924313|NCT00960531|3047807|P5|Overall Study|Discontinuation of Study by Sponsor|0
924314|NCT00960531|3047808|P4|Overall Study|Discontinuation of Study by Sponsor|0
924315|NCT00960531|3047809|P3|Overall Study|Discontinuation of Study by Sponsor|0
924316|NCT00960531|3047810|P2|Overall Study|Discontinuation of Study by Sponsor|0
924317|NCT00960531|3047811|P1|Overall Study|Discontinuation of Study by Sponsor|0
924318|NCT00960531|3047802|P10|Overall Study|Investigator Request|0
924319|NCT00960531|3047803|P9|Overall Study|Investigator Request|0
924320|NCT00960531|3047804|P8|Overall Study|Investigator Request|0
924321|NCT00960531|3047805|P7|Overall Study|Investigator Request|0
924322|NCT00960531|3047806|P6|Overall Study|Investigator Request|0
924323|NCT00960531|3047807|P5|Overall Study|Investigator Request|0
924324|NCT00960531|3047808|P4|Overall Study|Investigator Request|0
924325|NCT00960531|3047809|P3|Overall Study|Investigator Request|1
924326|NCT00960531|3047810|P2|Overall Study|Investigator Request|0
924327|NCT00960531|3047811|P1|Overall Study|Investigator Request|0
924328|NCT00960531|3047802|P10|Overall Study|Caregiver Request|0
924329|NCT00960531|3047803|P9|Overall Study|Caregiver Request|3
924330|NCT00960531|3047804|P8|Overall Study|Caregiver Request|1
924331|NCT00960531|3047805|P7|Overall Study|Caregiver Request|3
924332|NCT00960531|3047806|P6|Overall Study|Caregiver Request|2
924333|NCT00960531|3047807|P5|Overall Study|Caregiver Request|0
924334|NCT00960531|3047808|P4|Overall Study|Caregiver Request|5
924335|NCT00960531|3047809|P3|Overall Study|Caregiver Request|6
924336|NCT00960531|3047810|P2|Overall Study|Caregiver Request|0
924337|NCT00960531|3047811|P1|Overall Study|Caregiver Request|2
924338|NCT00960531|3047802|P10|Overall Study|Withdrawal by Subject|0
924339|NCT00960531|3047803|P9|Overall Study|Withdrawal by Subject|1
924340|NCT00960531|3047804|P8|Overall Study|Withdrawal by Subject|0
924341|NCT00960531|3047805|P7|Overall Study|Withdrawal by Subject|2
924342|NCT00960531|3047806|P6|Overall Study|Withdrawal by Subject|0
924343|NCT00960531|3047807|P5|Overall Study|Withdrawal by Subject|0
924344|NCT00960531|3047808|P4|Overall Study|Withdrawal by Subject|2
924345|NCT00960531|3047809|P3|Overall Study|Withdrawal by Subject|5
924346|NCT00960531|3047810|P2|Overall Study|Withdrawal by Subject|0
924347|NCT00960531|3047811|P1|Overall Study|Withdrawal by Subject|1
924348|NCT00960531|3047802|P10|Overall Study|Lack of Efficacy|0
924349|NCT00960531|3047803|P9|Overall Study|Lack of Efficacy|0
924350|NCT00960531|3047804|P8|Overall Study|Lack of Efficacy|0
924351|NCT00960531|3047805|P7|Overall Study|Lack of Efficacy|0
924352|NCT00960531|3047806|P6|Overall Study|Lack of Efficacy|0
924353|NCT00960531|3047807|P5|Overall Study|Lack of Efficacy|0
924354|NCT00960531|3047808|P4|Overall Study|Lack of Efficacy|0
924355|NCT00960531|3047809|P3|Overall Study|Lack of Efficacy|0
924356|NCT00960531|3047810|P2|Overall Study|Lack of Efficacy|0
924357|NCT00960531|3047811|P1|Overall Study|Lack of Efficacy|1
924358|NCT00960440|3047859|P4|Overall Study|Other|0
924359|NCT00960440|3047860|P3|Overall Study|Other|1
924360|NCT00960440|3047861|P2|Overall Study|Other|1
924361|NCT00960440|3047862|P1|Overall Study|Other|1
924362|NCT00960440|3047859|P4|Overall Study|Withdrawal by Subject|1
924363|NCT00960440|3047860|P3|Overall Study|Withdrawal by Subject|2
924364|NCT00960440|3047861|P2|Overall Study|Withdrawal by Subject|5
924365|NCT00960440|3047862|P1|Overall Study|Withdrawal by Subject|9
924366|NCT00960440|3047859|P4|Overall Study|Protocol Violation|4
924367|NCT00960440|3047860|P3|Overall Study|Protocol Violation|3
924368|NCT00960440|3047861|P2|Overall Study|Protocol Violation|8
924369|NCT00960440|3047862|P1|Overall Study|Protocol Violation|2
924370|NCT00960440|3047859|P4|Overall Study|Lack of Efficacy|8
924371|NCT00960440|3047860|P3|Overall Study|Lack of Efficacy|3
924372|NCT00960440|3047861|P2|Overall Study|Lack of Efficacy|5
924373|NCT00960440|3047862|P1|Overall Study|Lack of Efficacy|2
924374|NCT00960440|3047859|P4|Overall Study|Adverse Event|4
924375|NCT00960440|3047860|P3|Overall Study|Adverse Event|4
924376|NCT00960440|3047861|P2|Overall Study|Adverse Event|12
924377|NCT00960440|3047862|P1|Overall Study|Adverse Event|12
924378|NCT00960440|3047859|P4|Overall Study|Death|1
924379|NCT00960440|3047860|P3|Overall Study|Death|0
924380|NCT00960440|3047861|P2|Overall Study|Death|0
924381|NCT00960440|3047862|P1|Overall Study|Death|0
924382|NCT00960375|3048034|P2|Overall Study|Lost to Follow-up|22
924383|NCT00960375|3048035|P1|Overall Study|Lost to Follow-up|20
924384|NCT00960323|3048043|P1|Atorvastatin Alone|Withdrawal by Subject|1
924385|NCT00960297|3048054|P1|Overall Study|Disease progression|1
924386|NCT00960297|3048054|P1|Overall Study|Venous port infection|1
924387|NCT00960297|3048054|P1|Overall Study|Physician Decision|1
924388|NCT00960206|3048061|P3|Overall Study|Missing 10 year data|1
924389|NCT00960206|3048062|P2|Overall Study|Missing 10 year data|1
924390|NCT00960206|3048063|P1|Overall Study|Missing 10 year data|20
924391|NCT00960206|3048061|P3|Overall Study|Revision of study component|2
924392|NCT00960206|3048062|P2|Overall Study|Revision of study component|2
924393|NCT00960206|3048063|P1|Overall Study|Revision of study component|2
924394|NCT00960206|3048061|P3|Overall Study|Withdrawal by Subject|0
924395|NCT00960206|3048062|P2|Overall Study|Withdrawal by Subject|4
924396|NCT00960206|3048063|P1|Overall Study|Withdrawal by Subject|2
924397|NCT00960206|3048061|P3|Overall Study|Lost to Follow-up|8
924398|NCT00960206|3048062|P2|Overall Study|Lost to Follow-up|14
924399|NCT00960206|3048063|P1|Overall Study|Lost to Follow-up|8
924400|NCT00960206|3048061|P3|Overall Study|Unwilling/Unable to return|0
924401|NCT00960206|3048062|P2|Overall Study|Unwilling/Unable to return|2
924402|NCT00960206|3048063|P1|Overall Study|Unwilling/Unable to return|1
924403|NCT00960206|3048061|P3|Overall Study|Death|1
924404|NCT00960206|3048062|P2|Overall Study|Death|4
924405|NCT00960206|3048063|P1|Overall Study|Death|7
924406|NCT00960193|3048081|P1|14 Day Washout Period|Withdrawal by Subject|1
924407|NCT00960154|3048094|P2|Overall Study|Study termination|25
924408|NCT00960154|3048095|P1|Overall Study|Study termination|25
924409|NCT00960141|3048106|P3|Overall Study|Withdrawal by Subject|1
924410|NCT00960141|3048107|P2|Overall Study|Withdrawal by Subject|2
924411|NCT00960141|3048108|P1|Overall Study|Withdrawal by Subject|1
924412|NCT00960141|3048106|P3|Overall Study|Protocol Violation|2
924413|NCT00960141|3048107|P2|Overall Study|Protocol Violation|3
924414|NCT00960141|3048108|P1|Overall Study|Protocol Violation|1
924415|NCT00960141|3048106|P3|Overall Study|Lost to Follow-up|0
924416|NCT00960141|3048107|P2|Overall Study|Lost to Follow-up|0
924417|NCT00960141|3048108|P1|Overall Study|Lost to Follow-up|1
924418|NCT00960141|3048106|P3|Overall Study|Lack of Efficacy|2
924419|NCT00960141|3048107|P2|Overall Study|Lack of Efficacy|4
924420|NCT00960141|3048108|P1|Overall Study|Lack of Efficacy|3
924421|NCT00960141|3048106|P3|Overall Study|Adverse Event|2
924422|NCT00960141|3048107|P2|Overall Study|Adverse Event|8
924423|NCT00960141|3048108|P1|Overall Study|Adverse Event|4
924424|NCT00960115|3048133|P2|Overall Study|Ongoing treatment at data cut-off date|15
924425|NCT00960115|3048134|P1|Overall Study|Ongoing treatment at data cut-off date|19
924426|NCT00960076|3048148|P2|Overall Study|Did not attend the termination visit|1
924427|NCT00960076|3048149|P1|Overall Study|Did not attend the termination visit|0
924428|NCT00960076|3048148|P2|Overall Study|Hyperglycemia|5
924429|NCT00960076|3048149|P1|Overall Study|Hyperglycemia|1
924430|NCT00960076|3048148|P2|Overall Study|Severe non-compliance to protocol|2
924431|NCT00960076|3048149|P1|Overall Study|Severe non-compliance to protocol|1
924432|NCT00960076|3048148|P2|Overall Study|Lost to Follow-up|3
924433|NCT00960076|3048149|P1|Overall Study|Lost to Follow-up|3
924434|NCT00960076|3048148|P2|Overall Study|Withdrawal by Subject|2
924435|NCT00960076|3048149|P1|Overall Study|Withdrawal by Subject|1
924436|NCT00960076|3048148|P2|Overall Study|No longer met study criteria|5
924437|NCT00960076|3048149|P1|Overall Study|No longer met study criteria|1
924438|NCT00960076|3048148|P2|Overall Study|Adverse Event|7
924439|NCT00960076|3048149|P1|Overall Study|Adverse Event|1
924440|NCT00960063|3048164|P3|Overall Study|Progression of Disease|3
924441|NCT00960063|3048165|P2|Overall Study|Progression of Disease|0
924442|NCT00960063|3048166|P1|Overall Study|Progression of Disease|0
924443|NCT00960063|3048164|P3|Overall Study|Adverse Event|0
924444|NCT00960063|3048165|P2|Overall Study|Adverse Event|0
924445|NCT00960063|3048166|P1|Overall Study|Adverse Event|1
924446|NCT00959946|3048257|P8|Overall Study|Withdrawal by Subject|0
924447|NCT00959946|3048258|P7|Overall Study|Withdrawal by Subject|0
924448|NCT00959946|3048259|P6|Overall Study|Withdrawal by Subject|1
924449|NCT00959946|3048260|P5|Overall Study|Withdrawal by Subject|0
924450|NCT00959946|3048261|P4|Overall Study|Withdrawal by Subject|0
924451|NCT00959946|3048262|P3|Overall Study|Withdrawal by Subject|0
924452|NCT00959946|3048263|P2|Overall Study|Withdrawal by Subject|0
924453|NCT00959946|3048264|P1|Overall Study|Withdrawal by Subject|0
924454|NCT00959946|3048257|P8|Overall Study|Disease Progression|2
924455|NCT00959946|3048258|P7|Overall Study|Disease Progression|2
924456|NCT00959946|3048259|P6|Overall Study|Disease Progression|6
924457|NCT00959946|3048260|P5|Overall Study|Disease Progression|4
924458|NCT00959946|3048261|P4|Overall Study|Disease Progression|4
924459|NCT00959946|3048262|P3|Overall Study|Disease Progression|2
924460|NCT00959946|3048263|P2|Overall Study|Disease Progression|4
924461|NCT00959946|3048264|P1|Overall Study|Disease Progression|2
924462|NCT00959946|3048257|P8|Overall Study|Death|0
924463|NCT00959946|3048258|P7|Overall Study|Death|0
924464|NCT00959946|3048259|P6|Overall Study|Death|1
924465|NCT00959946|3048260|P5|Overall Study|Death|0
924466|NCT00959946|3048261|P4|Overall Study|Death|0
924467|NCT00959946|3048262|P3|Overall Study|Death|0
924468|NCT00959946|3048263|P2|Overall Study|Death|0
924469|NCT00959946|3048264|P1|Overall Study|Death|0
924470|NCT00959946|3048257|P8|Overall Study|Adverse Event|0
924471|NCT00959946|3048258|P7|Overall Study|Adverse Event|0
924472|NCT00959946|3048259|P6|Overall Study|Adverse Event|1
924473|NCT00959946|3048260|P5|Overall Study|Adverse Event|0
924474|NCT00959946|3048261|P4|Overall Study|Adverse Event|1
924475|NCT00959946|3048262|P3|Overall Study|Adverse Event|2
924476|NCT00959946|3048263|P2|Overall Study|Adverse Event|0
924477|NCT00959946|3048264|P1|Overall Study|Adverse Event|0
924478|NCT00959907|3048328|P2|Overall Study|Withdrawal by Subject|0
924479|NCT00959907|3048329|P1|Overall Study|Withdrawal by Subject|2
924480|NCT00959907|3048328|P2|Overall Study|Adverse Event|0
924481|NCT00959907|3048329|P1|Overall Study|Adverse Event|1
924482|NCT00959907|3048328|P2|Overall Study|Protocol Violation|1
924483|NCT00959907|3048329|P1|Overall Study|Protocol Violation|0
924484|NCT00959894|3048339|P1|Overall Study|Subject moved out of town|1
924485|NCT00959894|3048339|P1|Overall Study|Need for contraindicated medication|1
924486|NCT00959894|3048339|P1|Overall Study|Withdrawal by Subject|1
924487|NCT00959894|3048339|P1|Overall Study|Adverse Event|3
924488|NCT00959894|3048339|P1|Overall Study|Lost to Follow-up|10
924489|NCT00959751|3048388|P2|Overall Study|No migraine headache without aura|7
924490|NCT00959751|3048389|P1|Overall Study|No migraine headache without aura|7
924491|NCT00959751|3048388|P2|Overall Study|Non-compliance to Study Procedures|1
924492|NCT00959751|3048389|P1|Overall Study|Non-compliance to Study Procedures|0
924493|NCT00959751|3048388|P2|Overall Study|Consent Withdrawn|1
924494|NCT00959751|3048389|P1|Overall Study|Consent Withdrawn|0
924495|NCT00959751|3048388|P2|Overall Study|Lost to Follow-up|3
924496|NCT00959751|3048389|P1|Overall Study|Lost to Follow-up|2
924497|NCT00959699|3048411|P2|Follow-up Period|Withdrawal by Subject|4
924498|NCT00959699|3048412|P1|Follow-up Period|Withdrawal by Subject|3
924499|NCT00959699|3048411|P2|Follow-up Period|Lost to Follow-up|2
924500|NCT00959699|3048412|P1|Follow-up Period|Lost to Follow-up|3
924501|NCT00959699|3048411|P2|Treatment Period|Futility/crossover to boceprevir|0
924502|NCT00959699|3048412|P1|Treatment Period|Futility/crossover to boceprevir|4
924503|NCT00959699|3048411|P2|Treatment Period|Did not receive treatment|1
924504|NCT00959699|3048412|P1|Treatment Period|Did not receive treatment|0
924505|NCT00959699|3048411|P2|Treatment Period|Non-Compliance with Protocol|1
924506|NCT00959699|3048412|P1|Treatment Period|Non-Compliance with Protocol|0
924507|NCT00959699|3048411|P2|Treatment Period|Withdrawal by Subject|3
924508|NCT00959699|3048412|P1|Treatment Period|Withdrawal by Subject|1
924509|NCT00959699|3048411|P2|Treatment Period|Lost to Follow-up|1
924510|NCT00959699|3048412|P1|Treatment Period|Lost to Follow-up|0
924511|NCT00959699|3048411|P2|Treatment Period|Lack of Efficacy|6
924512|NCT00959699|3048412|P1|Treatment Period|Lack of Efficacy|15
924513|NCT00959699|3048411|P2|Treatment Period|Adverse Event|13
924514|NCT00959699|3048412|P1|Treatment Period|Adverse Event|3
924515|NCT00959647|3048458|P1|Overall Study|Withdrawal by Subject|7
924516|NCT00959647|3048458|P1|Overall Study|Study terminated by sponsor|4
924517|NCT00959647|3048458|P1|Overall Study|Progressive disease|6
924518|NCT00959647|3048458|P1|Overall Study|Adverse Event|2
924519|NCT00959374|3048463|P1|Overall Study|Physician Decision|1
924520|NCT00959374|3048463|P1|Overall Study|Implant Removed/Not Replaced|4
924521|NCT00959374|3048463|P1|Overall Study|Protocol Violation|1
924522|NCT00959374|3048463|P1|Overall Study|Death|1
924523|NCT00959374|3048463|P1|Overall Study|Lost to Follow-up|14
924524|NCT00959374|3048463|P1|Overall Study|Withdrawal by Subject|2
924525|NCT00959192|3048477|P4|Overall Study|Caregiver Request|1
924526|NCT00959192|3048478|P3|Overall Study|Caregiver Request|2
924527|NCT00959192|3048479|P2|Overall Study|Caregiver Request|0
924528|NCT00959192|3048480|P1|Overall Study|Caregiver Request|0
924529|NCT00959192|3048477|P4|Overall Study|Investigator Request|0
924530|NCT00959192|3048478|P3|Overall Study|Investigator Request|0
924531|NCT00959192|3048479|P2|Overall Study|Investigator Request|0
924532|NCT00959192|3048480|P1|Overall Study|Investigator Request|1
924533|NCT00959192|3048477|P4|Overall Study|Adverse Event|0
924534|NCT00959192|3048478|P3|Overall Study|Adverse Event|1
924535|NCT00959192|3048479|P2|Overall Study|Adverse Event|1
924536|NCT00959192|3048480|P1|Overall Study|Adverse Event|1
924537|NCT00959049|3048528|P6|Overall Study|Withdrawal by Subject|0
924538|NCT00959049|3048529|P5|Overall Study|Withdrawal by Subject|0
924539|NCT00959049|3048530|P4|Overall Study|Withdrawal by Subject|0
924540|NCT00959049|3048531|P3|Overall Study|Withdrawal by Subject|0
924541|NCT00959049|3048532|P2|Overall Study|Withdrawal by Subject|2
924542|NCT00959049|3048533|P1|Overall Study|Withdrawal by Subject|0
924543|NCT00959049|3048528|P6|Overall Study|Contraindicated medication|0
924544|NCT00959049|3048529|P5|Overall Study|Contraindicated medication|0
924545|NCT00959049|3048530|P4|Overall Study|Contraindicated medication|1
924546|NCT00959049|3048531|P3|Overall Study|Contraindicated medication|0
924547|NCT00959049|3048532|P2|Overall Study|Contraindicated medication|0
924548|NCT00959049|3048533|P1|Overall Study|Contraindicated medication|0
924549|NCT00959049|3048528|P6|Overall Study|Lost to Follow-up|1
924550|NCT00959049|3048529|P5|Overall Study|Lost to Follow-up|9
924551|NCT00959049|3048530|P4|Overall Study|Lost to Follow-up|10
924552|NCT00959049|3048531|P3|Overall Study|Lost to Follow-up|1
924553|NCT00959049|3048532|P2|Overall Study|Lost to Follow-up|5
924554|NCT00959049|3048533|P1|Overall Study|Lost to Follow-up|17
924555|NCT00959049|3048528|P6|Overall Study|Adverse Event|0
924556|NCT00959049|3048529|P5|Overall Study|Adverse Event|0
924557|NCT00959049|3048530|P4|Overall Study|Adverse Event|0
924558|NCT00959049|3048531|P3|Overall Study|Adverse Event|0
924559|NCT00959049|3048532|P2|Overall Study|Adverse Event|0
924560|NCT00959049|3048533|P1|Overall Study|Adverse Event|1
924561|NCT00958893|3048598|P1|Overall Study|Study prematurely terminated|4
924562|NCT00958880|3048604|P2|Overall Study|Lost to Follow-up|2
924563|NCT00958880|3048605|P1|Overall Study|Lost to Follow-up|2
924564|NCT00958841|3048613|P1|Overall Study|Discontinued prior to M*|28
924565|NCT00958841|3048613|P1|Overall Study|Completed M6/did not enter extension|27
924566|NCT00958841|3048613|P1|Overall Study|Unsatisfactory therapeutic effect|22
924567|NCT00958841|3048613|P1|Overall Study|Withdrawal by Subject|1
924568|NCT00958841|3048613|P1|Overall Study|New cancer therapy|5
924569|NCT00958841|3048613|P1|Overall Study|Adverse Event|8
924570|NCT00958841|3048613|P1|Overall Study|Administrative problems|1
924571|NCT00958841|3048613|P1|Overall Study|Abnormal test procedure result(s)|3
924572|NCT00958841|3048613|P1|Overall Study|Abnormal laboratory value(s)|1
924573|NCT00958828|3048631|P2|Period 2, 1 Week of Wear|Unacceptable lens fit|1
924574|NCT00958828|3048632|P1|Period 2, 1 Week of Wear|Unacceptable lens fit|0
924575|NCT00958828|3048631|P2|Period 1, 1 Week of Wear|Randomization break|1
924576|NCT00958828|3048632|P1|Period 1, 1 Week of Wear|Randomization break|0
924577|NCT00958789|3048638|P1|Overall Study|Revision|7
924578|NCT00958789|3048638|P1|Overall Study|Subject terminated|3
924579|NCT00958789|3048638|P1|Overall Study|2 yr. Knee Society Score not calculable|2
924580|NCT00958789|3048638|P1|Overall Study|No 2 yr. Knee Society Score data|12
924581|NCT00958789|3048638|P1|Overall Study|Withdrawal by Subject|16
924582|NCT00958789|3048638|P1|Overall Study|Lost to Follow-up|7
924583|NCT00958789|3048638|P1|Overall Study|Death|3
924584|NCT00958776|3048645|P2|Overall Study|Missing|1
924585|NCT00958776|3048646|P1|Overall Study|Missing|1
924586|NCT00958776|3048645|P2|Overall Study|Noncompliance; Protocol Deviations|3
924587|NCT00958776|3048646|P1|Overall Study|Noncompliance; Protocol Deviations|2
924588|NCT00958776|3048645|P2|Overall Study|Death|1
924589|NCT00958776|3048646|P1|Overall Study|Death|2
924590|NCT00958776|3048645|P2|Overall Study|Protocol Violation|1
924591|NCT00958776|3048646|P1|Overall Study|Protocol Violation|1
924592|NCT00958776|3048645|P2|Overall Study|Withdrawal by Subject|16
924593|NCT00958776|3048646|P1|Overall Study|Withdrawal by Subject|7
924594|NCT00958776|3048645|P2|Overall Study|Lost to Follow-up|6
924595|NCT00958776|3048646|P1|Overall Study|Lost to Follow-up|2
924596|NCT00958776|3048645|P2|Overall Study|Physician Decision|0
924597|NCT00958776|3048646|P1|Overall Study|Physician Decision|1
924598|NCT00958776|3048645|P2|Overall Study|Adverse Event|1
924599|NCT00958776|3048646|P1|Overall Study|Adverse Event|0
924600|NCT00958724|3048676|P1|Overall Study|Disease Progression|6
924601|NCT00958568|3048705|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
924602|NCT00958568|3048706|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1
924603|NCT00958568|3048707|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
924604|NCT00958568|3048708|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
924605|NCT00958568|3048705|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
924606|NCT00958568|3048706|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1
924607|NCT00958568|3048707|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
924608|NCT00958568|3048708|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
924609|NCT00958568|3048705|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1
924610|NCT00958568|3048706|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2
924611|NCT00958568|3048707|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
924612|NCT00958568|3048708|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
924613|NCT00958568|3048705|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4
924614|NCT00958568|3048706|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5
924615|NCT00958568|3048707|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
924616|NCT00958568|3048708|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
924617|NCT00958568|3048705|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8
924618|NCT00958568|3048706|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3
924619|NCT00958568|3048707|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
924620|NCT00958568|3048708|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
924621|NCT00958568|3048705|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5
924622|NCT00958568|3048706|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11
924623|NCT00958568|3048707|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
924624|NCT00958568|3048708|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
924625|NCT00958568|3048705|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15
924626|NCT00958568|3048706|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16
924627|NCT00958568|3048707|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
924628|NCT00958568|3048708|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
924629|NCT00958568|3048705|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10
924630|NCT00958568|3048706|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19
924631|NCT00958568|3048707|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
924632|NCT00958568|3048708|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
924633|NCT00958568|3048705|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63
924634|NCT00958568|3048706|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24
924635|NCT00958568|3048707|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
924636|NCT00958568|3048708|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
924637|NCT00958568|3048705|P4|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
924638|NCT00958568|3048706|P3|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
924639|NCT00958568|3048707|P2|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1
924640|NCT00958568|3048708|P1|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
924641|NCT00958568|3048705|P4|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
924642|NCT00958568|3048706|P3|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
924643|NCT00958568|3048707|P2|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1
924644|NCT00958568|3048708|P1|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
924645|NCT00958568|3048705|P4|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
924646|NCT00958568|3048706|P3|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
924647|NCT00958568|3048707|P2|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4
924648|NCT00958568|3048708|P1|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
924649|NCT00958568|3048705|P4|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
924650|NCT00958568|3048706|P3|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
924651|NCT00958568|3048707|P2|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5
924652|NCT00958568|3048708|P1|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
924653|NCT00958568|3048705|P4|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
924654|NCT00958568|3048706|P3|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
924655|NCT00958568|3048707|P2|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6
924656|NCT00958568|3048708|P1|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
924657|NCT00958568|3048705|P4|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
924658|NCT00958568|3048706|P3|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
924659|NCT00958568|3048707|P2|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9
924660|NCT00958568|3048708|P1|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
924661|NCT00958568|3048705|P4|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
924662|NCT00958568|3048706|P3|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
924663|NCT00958568|3048707|P2|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24
924664|NCT00958568|3048708|P1|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
924665|NCT00958568|3048705|P4|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
924666|NCT00958568|3048706|P3|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
924667|NCT00958568|3048707|P2|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41
924668|NCT00958568|3048708|P1|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
924669|NCT00958568|3048705|P4|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
924670|NCT00958568|3048706|P3|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
924671|NCT00958568|3048707|P2|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28
924672|NCT00958568|3048708|P1|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
924673|NCT00958568|3048705|P4|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
924674|NCT00958568|3048706|P3|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
924675|NCT00958568|3048707|P2|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30
924676|NCT00958568|3048708|P1|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
924677|NCT00958568|3048705|P4|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
924678|NCT00958568|3048706|P3|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
924679|NCT00958568|3048707|P2|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62
924680|NCT00958568|3048708|P1|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
924681|NCT00958568|3048705|P4|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
924682|NCT00958568|3048706|P3|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
924683|NCT00958568|3048707|P2|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
924684|NCT00958568|3048708|P1|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1
924685|NCT00958568|3048705|P4|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
924686|NCT00958568|3048706|P3|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
924687|NCT00958568|3048707|P2|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
924688|NCT00958568|3048708|P1|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8
924689|NCT00958568|3048705|P4|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
924690|NCT00958568|3048706|P3|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
924691|NCT00958568|3048707|P2|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
924692|NCT00958568|3048708|P1|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4
924693|NCT00958568|3048705|P4|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
924694|NCT00958568|3048706|P3|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
924695|NCT00958568|3048707|P2|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
924696|NCT00958568|3048708|P1|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13
924697|NCT00958568|3048705|P4|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
924698|NCT00958568|3048706|P3|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
924699|NCT00958568|3048707|P2|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
924700|NCT00958568|3048708|P1|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14
924701|NCT00958568|3048705|P4|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
924702|NCT00958568|3048706|P3|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
924703|NCT00958568|3048707|P2|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
924704|NCT00958568|3048708|P1|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39
924705|NCT00958568|3048705|P4|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
924706|NCT00958568|3048706|P3|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
924707|NCT00958568|3048707|P2|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
924708|NCT00958568|3048708|P1|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34
924709|NCT00958568|3048705|P4|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
924710|NCT00958568|3048706|P3|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
924711|NCT00958568|3048707|P2|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
924712|NCT00958568|3048708|P1|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44
924713|NCT00958568|3048705|P4|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
924714|NCT00958568|3048706|P3|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
924715|NCT00958568|3048707|P2|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
924716|NCT00958568|3048708|P1|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80
924717|NCT00958438|3048945|P3|Overall Study|Other than specified above|2
924718|NCT00958438|3048946|P2|Overall Study|Other than specified above|3
924719|NCT00958438|3048947|P1|Overall Study|Other than specified above|2
924720|NCT00958438|3048945|P3|Overall Study|Physician Decision|1
924721|NCT00958438|3048946|P2|Overall Study|Physician Decision|0
924722|NCT00958438|3048947|P1|Overall Study|Physician Decision|1
924723|NCT00958438|3048945|P3|Overall Study|Adverse Event|0
924724|NCT00958438|3048946|P2|Overall Study|Adverse Event|3
924725|NCT00958438|3048947|P1|Overall Study|Adverse Event|0
924726|NCT00958438|3048945|P3|Overall Study|Withdrawal by Subject|1
924727|NCT00958438|3048946|P2|Overall Study|Withdrawal by Subject|2
924728|NCT00958438|3048947|P1|Overall Study|Withdrawal by Subject|4
924729|NCT00958438|3048945|P3|Overall Study|Protocol Violation|2
924730|NCT00958438|3048946|P2|Overall Study|Protocol Violation|2
924731|NCT00958438|3048947|P1|Overall Study|Protocol Violation|3
924732|NCT00958360|3048972|P2|Overall Study|Lost to Follow-up|1
924733|NCT00958360|3048973|P1|Overall Study|Lost to Follow-up|0
924734|NCT00958360|3048972|P2|Overall Study|Physician Decision|1
924735|NCT00958360|3048973|P1|Overall Study|Physician Decision|2
924736|NCT00958360|3048972|P2|Overall Study|Death|7
924737|NCT00958360|3048973|P1|Overall Study|Death|6
924738|NCT00958360|3048972|P2|Overall Study|Withdrawal by Subject|1
924739|NCT00958360|3048973|P1|Overall Study|Withdrawal by Subject|3
924740|NCT00958347|3048987|P1|Overall Study|study termination|135
924741|NCT00958347|3048987|P1|Overall Study|revision/removal|10
924742|NCT00958347|3048987|P1|Overall Study|Lost to Follow-up|15
924743|NCT00958347|3048987|P1|Overall Study|Withdrawal by Subject|23
924744|NCT00958347|3048987|P1|Overall Study|Death|43
924745|NCT00958256|3049028|P1|Overall Study|Adverse Event|3
924746|NCT00958243|3049038|P6|Overall Study|Lost to Follow-up|5
924747|NCT00958243|3049039|P5|Overall Study|Lost to Follow-up|8
924748|NCT00958243|3049040|P4|Overall Study|Lost to Follow-up|2
924749|NCT00958243|3049041|P3|Overall Study|Lost to Follow-up|11
924750|NCT00958243|3049042|P2|Overall Study|Lost to Follow-up|5
924751|NCT00958243|3049043|P1|Overall Study|Lost to Follow-up|2
924752|NCT00958243|3049038|P6|Overall Study|Withdrawal by Subject|5
924753|NCT00958243|3049039|P5|Overall Study|Withdrawal by Subject|1
924754|NCT00958243|3049040|P4|Overall Study|Withdrawal by Subject|1
924755|NCT00958243|3049041|P3|Overall Study|Withdrawal by Subject|3
924756|NCT00958243|3049042|P2|Overall Study|Withdrawal by Subject|1
924757|NCT00958243|3049043|P1|Overall Study|Withdrawal by Subject|0
924758|NCT00958217|3049101|P2|Overall Study|Inpatient hospitalization|1
924759|NCT00958217|3049102|P1|Overall Study|Inpatient hospitalization|0
924760|NCT00958217|3049101|P2|Overall Study|Moved out of area|1
924761|NCT00958217|3049102|P1|Overall Study|Moved out of area|1
924762|NCT00958217|3049101|P2|Overall Study|Lost to Follow-up|19
924763|NCT00958217|3049102|P1|Overall Study|Lost to Follow-up|17
924764|NCT00958217|3049101|P2|Overall Study|Withdrawal by Subject|3
924765|NCT00958217|3049102|P1|Overall Study|Withdrawal by Subject|4
924766|NCT00958217|3049101|P2|Overall Study|Death|1
924767|NCT00958217|3049102|P1|Overall Study|Death|2
924768|NCT00958191|3049113|P1|Overall Study|No 5 yr x-rays|56
924769|NCT00958191|3049113|P1|Overall Study|Site termination|11
924770|NCT00958191|3049113|P1|Overall Study|Revision of study device|4
924771|NCT00958191|3049113|P1|Overall Study|Unable/Unwilling to Return/Withdrawal|21
924772|NCT00958191|3049113|P1|Overall Study|Inadequate 5 yr x-ray quality|10
924773|NCT00958191|3049113|P1|Overall Study|Lost to Follow-up|5
924774|NCT00958191|3049113|P1|Overall Study|Death|4
924775|NCT00958165|3049128|P1|Overall Study|Not eligible|9
924776|NCT00958165|3049128|P1|Overall Study|Lost to Follow-up|5
924777|NCT00958126|3049140|P8|Overall Study|Other Reason|0
924778|NCT00958126|3049141|P7|Overall Study|Other Reason|0
924779|NCT00958126|3049142|P6|Overall Study|Other Reason|1
924780|NCT00958126|3049143|P5|Overall Study|Other Reason|0
924781|NCT00958126|3049144|P4|Overall Study|Other Reason|1
924782|NCT00958126|3049145|P3|Overall Study|Other Reason|0
924783|NCT00958126|3049146|P2|Overall Study|Other Reason|0
924784|NCT00958126|3049147|P1|Overall Study|Other Reason|0
924785|NCT00958126|3049140|P8|Overall Study|Sponsor/Investigator decision|0
924786|NCT00958126|3049141|P7|Overall Study|Sponsor/Investigator decision|0
924787|NCT00958126|3049142|P6|Overall Study|Sponsor/Investigator decision|0
924788|NCT00958126|3049143|P5|Overall Study|Sponsor/Investigator decision|0
924789|NCT00958126|3049144|P4|Overall Study|Sponsor/Investigator decision|1
924790|NCT00958126|3049145|P3|Overall Study|Sponsor/Investigator decision|0
924791|NCT00958126|3049146|P2|Overall Study|Sponsor/Investigator decision|0
924792|NCT00958126|3049147|P1|Overall Study|Sponsor/Investigator decision|0
924793|NCT00958126|3049140|P8|Overall Study|Lost to Follow-up|0
924794|NCT00958126|3049141|P7|Overall Study|Lost to Follow-up|0
924795|NCT00958126|3049142|P6|Overall Study|Lost to Follow-up|0
924796|NCT00958126|3049143|P5|Overall Study|Lost to Follow-up|0
924797|NCT00958126|3049144|P4|Overall Study|Lost to Follow-up|8
924798|NCT00958126|3049145|P3|Overall Study|Lost to Follow-up|9
924799|NCT00958126|3049146|P2|Overall Study|Lost to Follow-up|5
924800|NCT00958126|3049147|P1|Overall Study|Lost to Follow-up|1
924801|NCT00958126|3049140|P8|Overall Study|Moved away from study area|0
924802|NCT00958126|3049141|P7|Overall Study|Moved away from study area|0
924803|NCT00958126|3049142|P6|Overall Study|Moved away from study area|0
924804|NCT00958126|3049143|P5|Overall Study|Moved away from study area|0
924805|NCT00958126|3049144|P4|Overall Study|Moved away from study area|1
924806|NCT00958126|3049145|P3|Overall Study|Moved away from study area|1
924807|NCT00958126|3049146|P2|Overall Study|Moved away from study area|0
924808|NCT00958126|3049147|P1|Overall Study|Moved away from study area|0
924809|NCT00958126|3049140|P8|Overall Study|Withdrawal by Subject|0
924810|NCT00958126|3049141|P7|Overall Study|Withdrawal by Subject|0
924811|NCT00958126|3049142|P6|Overall Study|Withdrawal by Subject|0
924812|NCT00958126|3049143|P5|Overall Study|Withdrawal by Subject|0
924813|NCT00958126|3049144|P4|Overall Study|Withdrawal by Subject|0
924814|NCT00958126|3049145|P3|Overall Study|Withdrawal by Subject|0
924815|NCT00958126|3049146|P2|Overall Study|Withdrawal by Subject|2
924816|NCT00958126|3049147|P1|Overall Study|Withdrawal by Subject|0
924817|NCT00958126|3049140|P8|Overall Study|Serious Adverse Event|0
924818|NCT00958126|3049141|P7|Overall Study|Serious Adverse Event|1
924819|NCT00958126|3049142|P6|Overall Study|Serious Adverse Event|0
924820|NCT00958126|3049143|P5|Overall Study|Serious Adverse Event|0
924821|NCT00958126|3049144|P4|Overall Study|Serious Adverse Event|0
924822|NCT00958126|3049145|P3|Overall Study|Serious Adverse Event|0
924823|NCT00958126|3049146|P2|Overall Study|Serious Adverse Event|2
924824|NCT00958126|3049147|P1|Overall Study|Serious Adverse Event|0
924825|NCT00958074|3049219|P2|Overall Study|Withdrawal by Subject|1
924826|NCT00958074|3049220|P1|Overall Study|Withdrawal by Subject|0
924827|NCT00958009|3049243|P1|Overall Study|Subject found device difficult to use|1
924828|NCT00958009|3049243|P1|Overall Study|Adverse Event|1
924829|NCT00957996|3049250|P2|Overall Study|Noncompliance; Protocol Deviations|6
924830|NCT00957996|3049251|P1|Overall Study|Noncompliance; Protocol Deviations|5
924831|NCT00957996|3049250|P2|Overall Study|Missing|0
924832|NCT00957996|3049251|P1|Overall Study|Missing|1
924833|NCT00957996|3049250|P2|Overall Study|Influenza-related complication|1
924834|NCT00957996|3049251|P1|Overall Study|Influenza-related complication|0
924835|NCT00957996|3049250|P2|Overall Study|Physician Decision|1
924836|NCT00957996|3049251|P1|Overall Study|Physician Decision|1
924837|NCT00957996|3049250|P2|Overall Study|Adverse Event|1
924838|NCT00957996|3049251|P1|Overall Study|Adverse Event|2
924839|NCT00957996|3049250|P2|Overall Study|Withdrawal by Subject|2
924840|NCT00957996|3049251|P1|Overall Study|Withdrawal by Subject|9
924841|NCT00957996|3049250|P2|Overall Study|Lost to Follow-up|7
924842|NCT00957996|3049251|P1|Overall Study|Lost to Follow-up|4
924843|NCT00957996|3049250|P2|Overall Study|Death|10
924844|NCT00957996|3049251|P1|Overall Study|Death|4
924845|NCT00957944|3049283|P2|First Intervention- 24 Hours|Withdrawal by Subject|1
924846|NCT00957944|3049284|P1|First Intervention- 24 Hours|Withdrawal by Subject|0
924847|NCT00957931|3049318|P1|Overall Study|Death|4
924848|NCT00957905|3049328|P2|Part B|Protocol Violation|1
924849|NCT00957905|3049329|P1|Part B|Protocol Violation|0
924850|NCT00957905|3049328|P2|Part B|Death|1
924851|NCT00957905|3049329|P1|Part B|Death|0
924852|NCT00957905|3049328|P2|Part B|Physician Decision|1
924853|NCT00957905|3049329|P1|Part B|Physician Decision|0
924854|NCT00957905|3049328|P2|Part B|Not Treated|1
924855|NCT00957905|3049329|P1|Part B|Not Treated|0
924856|NCT00957801|3049339|P4|Overall Study|Withdrawal by Subject|1
924857|NCT00957801|3049340|P3|Overall Study|Withdrawal by Subject|0
924858|NCT00957801|3049341|P2|Overall Study|Withdrawal by Subject|0
924859|NCT00957801|3049342|P1|Overall Study|Withdrawal by Subject|0
924860|NCT00957723|3049508|P1|Overall Study|2yr ROM Data Not Evaluable|12
924861|NCT00957723|3049508|P1|Overall Study|Intercurrent Illness|2
924862|NCT00957723|3049508|P1|Overall Study|Investigative Site Terminated|61
924863|NCT00957723|3049508|P1|Overall Study|Withdrawal by Subject|24
924864|NCT00957723|3049508|P1|Overall Study|Lost to Follow-up|8
924865|NCT00957723|3049508|P1|Overall Study|Revision/ Removal of Study Implant|3
924866|NCT00957723|3049508|P1|Overall Study|Death|3
924867|NCT00957658|3049597|P1|Overall Study|Protocol Violation|5
924868|NCT00957658|3049597|P1|Overall Study|surgery cancelled|2
924869|NCT00957658|3049597|P1|Overall Study|unwilling/unable to return|2
924870|NCT00957658|3049597|P1|Overall Study|Site termination|10
924871|NCT00957658|3049597|P1|Overall Study|Incomplete 2 yr data|28
924872|NCT00957658|3049597|P1|Overall Study|Revision|1
924873|NCT00957658|3049597|P1|Overall Study|Withdrawal by Subject|12
924874|NCT00957658|3049597|P1|Overall Study|Lost to Follow-up|4
924875|NCT00957658|3049597|P1|Overall Study|Death|1
924876|NCT00957580|3049622|P3|Overall Study|Enrolled but not treated|0
924877|NCT00957580|3049623|P2|Overall Study|Enrolled but not treated|1
924878|NCT00957580|3049624|P1|Overall Study|Enrolled but not treated|0
924879|NCT00957580|3049622|P3|Overall Study|Ongoing at data cut-off|0
924880|NCT00957580|3049623|P2|Overall Study|Ongoing at data cut-off|1
924881|NCT00957580|3049624|P1|Overall Study|Ongoing at data cut-off|0
924882|NCT00957528|3049771|P3|Overall Study|Withdrawal by Subject|1
924883|NCT00957528|3049772|P2|Overall Study|Withdrawal by Subject|0
924884|NCT00957528|3049773|P1|Overall Study|Withdrawal by Subject|0
924885|NCT00957528|3049771|P3|Overall Study|Protocol Violation|0
924886|NCT00957528|3049772|P2|Overall Study|Protocol Violation|1
924887|NCT00957528|3049773|P1|Overall Study|Protocol Violation|0
924888|NCT00957424|3049796|P1|Overall Study|Withdrawal by Subject|1
924889|NCT00957424|3049796|P1|Overall Study|Protocol Violation|3
924890|NCT00957424|3049796|P1|Overall Study|Lost to Follow-up|19
924891|NCT00957372|3049806|P4|PART II|Patient non-compliance|4
924892|NCT00957372|3049807|P3|PART II|Patient non-compliance|0
924893|NCT00957372|3049808|P2|PART II|Patient non-compliance|0
924894|NCT00957372|3049809|P1|PART II|Patient non-compliance|0
924895|NCT00957372|3049806|P4|PART II|Adverse Event|10
924896|NCT00957372|3049807|P3|PART II|Adverse Event|0
924897|NCT00957372|3049808|P2|PART II|Adverse Event|0
924898|NCT00957372|3049809|P1|PART II|Adverse Event|0
924899|NCT00957372|3049806|P4|PART II|Not Know|20
924900|NCT00957372|3049807|P3|PART II|Not Know|0
924901|NCT00957372|3049808|P2|PART II|Not Know|0
924902|NCT00957372|3049809|P1|PART II|Not Know|0
924903|NCT00957372|3049806|P4|PART II|Pregnancy|1
924904|NCT00957372|3049807|P3|PART II|Pregnancy|0
924905|NCT00957372|3049808|P2|PART II|Pregnancy|0
924906|NCT00957372|3049809|P1|PART II|Pregnancy|0
924907|NCT00957372|3049806|P4|PART II|Physician Decision|1
924908|NCT00957372|3049807|P3|PART II|Physician Decision|0
924909|NCT00957372|3049808|P2|PART II|Physician Decision|0
924910|NCT00957372|3049809|P1|PART II|Physician Decision|0
924911|NCT00957372|3049806|P4|PART II|Withdrawal by Subject|8
924912|NCT00957372|3049807|P3|PART II|Withdrawal by Subject|0
924913|NCT00957372|3049808|P2|PART II|Withdrawal by Subject|0
924914|NCT00957372|3049809|P1|PART II|Withdrawal by Subject|0
924915|NCT00957372|3049806|P4|PART I|Lost to Follow-up|0
924916|NCT00957372|3049807|P3|PART I|Lost to Follow-up|1
924917|NCT00957372|3049808|P2|PART I|Lost to Follow-up|0
924918|NCT00957372|3049809|P1|PART I|Lost to Follow-up|0
924919|NCT00957268|3049834|P5|Overall Study|Voluntary Withdrawal|0
924920|NCT00957268|3049835|P4|Overall Study|Voluntary Withdrawal|0
924921|NCT00957268|3049836|P3|Overall Study|Voluntary Withdrawal|1
924922|NCT00957268|3049837|P2|Overall Study|Voluntary Withdrawal|0
924923|NCT00957268|3049838|P1|Overall Study|Voluntary Withdrawal|0
924924|NCT00957034|3049960|P3|Overall Study|Withdrawal by Subject|0
924925|NCT00957034|3049961|P2|Overall Study|Withdrawal by Subject|2
924926|NCT00957034|3049962|P1|Overall Study|Withdrawal by Subject|0
924927|NCT00957034|3049960|P3|Overall Study|Sponsor Terminated Study|5
924928|NCT00957034|3049961|P2|Overall Study|Sponsor Terminated Study|1
924929|NCT00957034|3049962|P1|Overall Study|Sponsor Terminated Study|6
924930|NCT00957034|3049960|P3|Overall Study|Adverse Event|1
924931|NCT00957034|3049961|P2|Overall Study|Adverse Event|1
924932|NCT00957034|3049962|P1|Overall Study|Adverse Event|0
924933|NCT00957021|3049985|P1|Overall Study|Termination due to language issue|2
924934|NCT00957021|3049985|P1|Overall Study|Surgery Cancelled|9
924935|NCT00957021|3049985|P1|Overall Study|Site Termination by the 2 yr visit|16
924936|NCT00957021|3049985|P1|Overall Study|Revised study component by 2 yr visit|8
924937|NCT00957021|3049985|P1|Overall Study|No 2 yr ROM data|35
924938|NCT00957021|3049985|P1|Overall Study|Withdrawal by Subject|34
924939|NCT00957021|3049985|P1|Overall Study|Lost to Follow-up|8
924940|NCT00957021|3049985|P1|Overall Study|Death|5
924941|NCT00957008|3049998|P4|Overall Study|Relocated; Family conflict|3
924942|NCT00957008|3049999|P3|Overall Study|Relocated; Family conflict|1
924943|NCT00957008|3050000|P2|Overall Study|Relocated; Family conflict|1
924944|NCT00957008|3050001|P1|Overall Study|Relocated; Family conflict|4
924945|NCT00957008|3049998|P4|Overall Study|Physician Decision|1
924946|NCT00957008|3049999|P3|Overall Study|Physician Decision|1
924947|NCT00957008|3050000|P2|Overall Study|Physician Decision|0
924948|NCT00957008|3050001|P1|Overall Study|Physician Decision|1
924949|NCT00957008|3049998|P4|Overall Study|Lost to Follow-up|4
924950|NCT00957008|3049999|P3|Overall Study|Lost to Follow-up|3
924951|NCT00957008|3050000|P2|Overall Study|Lost to Follow-up|1
924952|NCT00957008|3050001|P1|Overall Study|Lost to Follow-up|3
924953|NCT00957008|3049998|P4|Overall Study|Withdrawal by Subject|16
924954|NCT00957008|3049999|P3|Overall Study|Withdrawal by Subject|12
924955|NCT00957008|3050000|P2|Overall Study|Withdrawal by Subject|10
924956|NCT00957008|3050001|P1|Overall Study|Withdrawal by Subject|13
924957|NCT00956943|3050029|P2|Overall Study|Lost to Follow-up|10
924958|NCT00956943|3050030|P1|Overall Study|Lost to Follow-up|9
924959|NCT00956839|3050041|P3|Overall Study|Lost to Follow-up|3
924960|NCT00956839|3050042|P2|Overall Study|Lost to Follow-up|0
924961|NCT00956839|3050043|P1|Overall Study|Lost to Follow-up|3
924962|NCT00956813|3050056|P2|Flaxseed and Placebo|Ineligible|1
924963|NCT00956813|3050057|P1|Flaxseed and Placebo|Ineligible|3
924964|NCT00956813|3050056|P2|Flaxseed and Placebo|Withdrawal by Subject|4
924965|NCT00956813|3050057|P1|Flaxseed and Placebo|Withdrawal by Subject|5
924966|NCT00956592|3050109|P2|Overall Study|Protocol Violation|3
924967|NCT00956592|3050110|P1|Overall Study|Protocol Violation|1
924968|NCT00956293|3050145|P3|Follow-up Period|Follow-up period was terminated.|0
924969|NCT00956293|3050146|P2|Follow-up Period|Follow-up period was terminated.|32
924970|NCT00956293|3050147|P1|Follow-up Period|Follow-up period was terminated.|20
924971|NCT00956293|3050145|P3|Main Period (Randomization)|Adverse Event|0
924972|NCT00956293|3050146|P2|Main Period (Randomization)|Adverse Event|15
924973|NCT00956293|3050147|P1|Main Period (Randomization)|Adverse Event|0
924974|NCT00956293|3050145|P3|Main Period (Randomization)|Lack of Efficacy|0
924975|NCT00956293|3050146|P2|Main Period (Randomization)|Lack of Efficacy|10
924976|NCT00956293|3050147|P1|Main Period (Randomization)|Lack of Efficacy|1
924977|NCT00956293|3050145|P3|Main Period (Randomization)|Abnormal laboratory value|0
924978|NCT00956293|3050146|P2|Main Period (Randomization)|Abnormal laboratory value|2
924979|NCT00956293|3050147|P1|Main Period (Randomization)|Abnormal laboratory value|0
924980|NCT00956293|3050145|P3|Main Period (Pre-randomization)|Abnormal laboratory value|44
924981|NCT00956293|3050146|P2|Main Period (Pre-randomization)|Abnormal laboratory value|0
924982|NCT00956293|3050147|P1|Main Period (Pre-randomization)|Abnormal laboratory value|0
924983|NCT00956293|3050145|P3|Main Period (Pre-randomization)|Adverse Event|36
924984|NCT00956293|3050146|P2|Main Period (Pre-randomization)|Adverse Event|0
924985|NCT00956293|3050147|P1|Main Period (Pre-randomization)|Adverse Event|0
924986|NCT00956293|3050145|P3|Main Period (Pre-randomization)|Lack of Efficacy|20
924987|NCT00956293|3050146|P2|Main Period (Pre-randomization)|Lack of Efficacy|0
924988|NCT00956293|3050147|P1|Main Period (Pre-randomization)|Lack of Efficacy|0
924989|NCT00956293|3050145|P3|Main Period (Pre-randomization)|Withdrawal by Subject|12
924990|NCT00956293|3050146|P2|Main Period (Pre-randomization)|Withdrawal by Subject|0
924991|NCT00956293|3050147|P1|Main Period (Pre-randomization)|Withdrawal by Subject|0
924992|NCT00956293|3050145|P3|Main Period (Pre-randomization)|Graft loss|7
924993|NCT00956293|3050146|P2|Main Period (Pre-randomization)|Graft loss|0
924994|NCT00956293|3050147|P1|Main Period (Pre-randomization)|Graft loss|0
924995|NCT00956293|3050145|P3|Main Period (Pre-randomization)|Administrative problems|6
924996|NCT00956293|3050146|P2|Main Period (Pre-randomization)|Administrative problems|0
924997|NCT00956293|3050147|P1|Main Period (Pre-randomization)|Administrative problems|0
924998|NCT00956293|3050145|P3|Main Period (Pre-randomization)|Abnormal test procedure result|2
924999|NCT00956293|3050146|P2|Main Period (Pre-randomization)|Abnormal test procedure result|0
925000|NCT00956293|3050147|P1|Main Period (Pre-randomization)|Abnormal test procedure result|0
925001|NCT00956293|3050145|P3|Main Period (Pre-randomization)|Protocol Violation|1
925002|NCT00956293|3050146|P2|Main Period (Pre-randomization)|Protocol Violation|0
925003|NCT00956293|3050147|P1|Main Period (Pre-randomization)|Protocol Violation|0
925004|NCT00956293|3050145|P3|Main Period (Pre-randomization)|Death|1
925005|NCT00956293|3050146|P2|Main Period (Pre-randomization)|Death|0
925006|NCT00956293|3050147|P1|Main Period (Pre-randomization)|Death|0
925007|NCT00956293|3050145|P3|Main Period (Pre-randomization)|Not specified (data missing)|1
925008|NCT00956293|3050146|P2|Main Period (Pre-randomization)|Not specified (data missing)|0
925009|NCT00956293|3050147|P1|Main Period (Pre-randomization)|Not specified (data missing)|0
925010|NCT00955968|3050202|P2|Overall Study|Site closed|52
925011|NCT00955968|3050203|P1|Overall Study|Site closed|55
925012|NCT00955968|3050202|P2|Overall Study|Lost to Follow-up|39
925013|NCT00955968|3050203|P1|Overall Study|Lost to Follow-up|45
925014|NCT00955968|3050202|P2|Overall Study|Withdrawal by Subject|31
925015|NCT00955968|3050203|P1|Overall Study|Withdrawal by Subject|35
925016|NCT00955968|3050202|P2|Overall Study|Death|4
925017|NCT00955968|3050203|P1|Overall Study|Death|2
925018|NCT00955955|3050241|P3|Overall Study|Lost to Follow-up|0
925019|NCT00955955|3050242|P2|Overall Study|Lost to Follow-up|0
925020|NCT00955955|3050243|P1|Overall Study|Lost to Follow-up|2
925021|NCT00955825|3050327|P2|Overall Study|Any other reason not above-mentioned|9
925022|NCT00955825|3050328|P1|Overall Study|Any other reason not above-mentioned|7
925023|NCT00955825|3050327|P2|Overall Study|Withdrawal by Subject|6
925024|NCT00955825|3050328|P1|Overall Study|Withdrawal by Subject|4
925025|NCT00955825|3050327|P2|Overall Study|Adverse Event|2
925026|NCT00955825|3050328|P1|Overall Study|Adverse Event|15
925027|NCT00955721|3050345|P2|Overall Study|Withdrawal by Subject|0
925028|NCT00955721|3050346|P1|Overall Study|Withdrawal by Subject|1
925029|NCT00955721|3050345|P2|Overall Study|Death|0
925030|NCT00955721|3050346|P1|Overall Study|Death|1
925031|NCT00955721|3050345|P2|Overall Study|Physician Decision|0
925032|NCT00955721|3050346|P1|Overall Study|Physician Decision|1
925033|NCT00955617|3050356|P2|Second MRA (Between Day 1 and Day 51)|conventional angiography|0
925034|NCT00955617|3050357|P1|Second MRA (Between Day 1 and Day 51)|conventional angiography|1
925035|NCT00955617|3050356|P2|Second MRA (Between Day 1 and Day 51)|technical incident|1
925036|NCT00955617|3050357|P1|Second MRA (Between Day 1 and Day 51)|technical incident|0
925037|NCT00955617|3050356|P2|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1
925038|NCT00955617|3050357|P1|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0
925039|NCT00955617|3050356|P2|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1
925040|NCT00955617|3050357|P1|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2
925041|NCT00955474|3050421|P2|Overall Study|Physician Decision|5
925042|NCT00955474|3050422|P1|Overall Study|Physician Decision|7
925043|NCT00955357|3050458|P2|Maintenance Phase|Non compliance to study procedures|0
925044|NCT00955357|3050459|P1|Maintenance Phase|Non compliance to study procedures|1
925045|NCT00955357|3050458|P2|Maintenance Phase|Patient moving out of area|1
925046|NCT00955357|3050459|P1|Maintenance Phase|Patient moving out of area|0
925047|NCT00955357|3050458|P2|Maintenance Phase|Withdrawal by Subject|4
925048|NCT00955357|3050459|P1|Maintenance Phase|Withdrawal by Subject|4
925049|NCT00955357|3050458|P2|Maintenance Phase|Lost to Follow-up|7
925050|NCT00955357|3050459|P1|Maintenance Phase|Lost to Follow-up|2
925051|NCT00955357|3050458|P2|Maintenance Phase|Protocol Violation|6
925052|NCT00955357|3050459|P1|Maintenance Phase|Protocol Violation|2
925053|NCT00955357|3050458|P2|Maintenance Phase|Lack of Efficacy|4
925054|NCT00955357|3050459|P1|Maintenance Phase|Lack of Efficacy|0
925055|NCT00955357|3050458|P2|Maintenance Phase|Adverse Event|23
925056|NCT00955357|3050459|P1|Maintenance Phase|Adverse Event|3
925057|NCT00955357|3050458|P2|Titration Phase|Non compliance to study procedures|1
925058|NCT00955357|3050459|P1|Titration Phase|Non compliance to study procedures|0
925059|NCT00955357|3050458|P2|Titration Phase|Study medication not tolerated|1
925060|NCT00955357|3050459|P1|Titration Phase|Study medication not tolerated|0
925061|NCT00955357|3050458|P2|Titration Phase|Prohibited Antiepileptic Drug change|1
925062|NCT00955357|3050459|P1|Titration Phase|Prohibited Antiepileptic Drug change|0
925063|NCT00955357|3050458|P2|Titration Phase|Withdrawal by Subject|5
925064|NCT00955357|3050459|P1|Titration Phase|Withdrawal by Subject|3
925065|NCT00955357|3050458|P2|Titration Phase|Lost to Follow-up|3
925066|NCT00955357|3050459|P1|Titration Phase|Lost to Follow-up|1
925067|NCT00955357|3050458|P2|Titration Phase|Protocol Violation|7
925068|NCT00955357|3050459|P1|Titration Phase|Protocol Violation|3
925069|NCT00955357|3050458|P2|Titration Phase|Lack of Efficacy|2
925070|NCT00955357|3050459|P1|Titration Phase|Lack of Efficacy|0
925071|NCT00955357|3050458|P2|Titration Phase|Adverse Event|46
925072|NCT00955357|3050459|P1|Titration Phase|Adverse Event|9
925073|NCT00955305|3050467|P2|Overall Study|Ineligible|7
925074|NCT00955305|3050468|P1|Overall Study|Ineligible|5
925075|NCT00955305|3050467|P2|Overall Study|Never started protocol treatment|5
925076|NCT00955305|3050468|P1|Overall Study|Never started protocol treatment|5
925077|NCT00955305|3050467|P2|Overall Study|No off-treatment reason submitted|0
925078|NCT00955305|3050468|P1|Overall Study|No off-treatment reason submitted|1
925079|NCT00955305|3050467|P2|Overall Study|Lost to Follow-up|1
925080|NCT00955305|3050468|P1|Overall Study|Lost to Follow-up|0
925081|NCT00955305|3050467|P2|Overall Study|Maximum response achieved|1
925082|NCT00955305|3050468|P1|Overall Study|Maximum response achieved|0
925083|NCT00955305|3050467|P2|Overall Study|Functional decline|0
925084|NCT00955305|3050468|P1|Overall Study|Functional decline|2
925085|NCT00955305|3050467|P2|Overall Study|Continued presence of residual disease|1
925086|NCT00955305|3050468|P1|Overall Study|Continued presence of residual disease|0
925087|NCT00955305|3050467|P2|Overall Study|Physician Decision|0
925088|NCT00955305|3050468|P1|Overall Study|Physician Decision|1
925089|NCT00955305|3050467|P2|Overall Study|Other complicating disease|4
925090|NCT00955305|3050468|P1|Overall Study|Other complicating disease|2
925091|NCT00955305|3050467|P2|Overall Study|Alternative therapy|0
925092|NCT00955305|3050468|P1|Overall Study|Alternative therapy|4
925093|NCT00955305|3050467|P2|Overall Study|Withdrawal by Subject|4
925094|NCT00955305|3050468|P1|Overall Study|Withdrawal by Subject|5
925095|NCT00955305|3050467|P2|Overall Study|Death|1
925096|NCT00955305|3050468|P1|Overall Study|Death|2
925097|NCT00955305|3050467|P2|Overall Study|Adverse Event|22
925098|NCT00955305|3050468|P1|Overall Study|Adverse Event|22
925099|NCT00955305|3050467|P2|Overall Study|Disease progression|41
925100|NCT00955305|3050468|P1|Overall Study|Disease progression|39
925101|NCT00955279|3050481|P3|Overall Study|Withdrawal by Subject|3
925102|NCT00955279|3050482|P2|Overall Study|Withdrawal by Subject|0
925103|NCT00955279|3050483|P1|Overall Study|Withdrawal by Subject|2
925104|NCT00955279|3050481|P3|Overall Study|Lost to Follow-up|1
925105|NCT00955279|3050482|P2|Overall Study|Lost to Follow-up|3
925106|NCT00955279|3050483|P1|Overall Study|Lost to Follow-up|0
925107|NCT00955279|3050481|P3|Overall Study|Death|1
925108|NCT00955279|3050482|P2|Overall Study|Death|1
925109|NCT00955279|3050483|P1|Overall Study|Death|1
925110|NCT00955279|3050481|P3|Overall Study|Other|3
925111|NCT00955279|3050482|P2|Overall Study|Other|0
925112|NCT00955279|3050483|P1|Overall Study|Other|0
925113|NCT00955110|3050520|P1|Treatment Phase|Withdrawn by physician pre-treatment|1
925114|NCT00955110|3050520|P1|Treatment Phase|Non-compliance with study restrictions|1
925115|NCT00955110|3050520|P1|Treatment Phase|Administrative reasons|2
925116|NCT00955110|3050520|P1|Treatment Phase|Adverse Event|2
925117|NCT00955110|3050520|P1|Qualification Phase|Did not meet eligibility criteria|24
925118|NCT00954941|3050567|P2|Overall Study|Adverse Event|1
925119|NCT00954941|3050568|P1|Overall Study|Adverse Event|0
925120|NCT00954941|3050567|P2|Overall Study|Ineligible|2
925121|NCT00954941|3050568|P1|Overall Study|Ineligible|2
925122|NCT00954941|3050567|P2|Overall Study|Physician Decision|2
925123|NCT00954941|3050568|P1|Overall Study|Physician Decision|2
925124|NCT00954941|3050567|P2|Overall Study|Insurance Denial|2
925125|NCT00954941|3050568|P1|Overall Study|Insurance Denial|2
925126|NCT00954941|3050567|P2|Overall Study|Withdrawal by Subject|0
925127|NCT00954941|3050568|P1|Overall Study|Withdrawal by Subject|1
925128|NCT00954941|3050567|P2|Overall Study|Received treatment at home|0
925129|NCT00954941|3050568|P1|Overall Study|Received treatment at home|1
925130|NCT00954733|3050584|P1|Overall Study|blood gas machine did not work|1
925131|NCT00954707|3050588|P1|Overall Study|Lost to Follow-up|33
925132|NCT00954707|3050588|P1|Overall Study|Withdrawal by Subject|100
925133|NCT00954707|3050588|P1|Overall Study|Death|34
925134|NCT00954538|3050610|P6|Part III|Withdrawal by Subject|0
925135|NCT00954538|3050611|P5|Part III|Withdrawal by Subject|1
925136|NCT00954538|3050612|P4|Part III|Withdrawal by Subject|0
925137|NCT00954538|3050613|P3|Part III|Withdrawal by Subject|0
925138|NCT00954538|3050614|P2|Part III|Withdrawal by Subject|0
925139|NCT00954538|3050615|P1|Part III|Withdrawal by Subject|0
925140|NCT00954512|3050632|P6|Overall Study|Progression of Disease|1
925141|NCT00954512|3050633|P5|Overall Study|Progression of Disease|1
925142|NCT00954512|3050634|P4|Overall Study|Progression of Disease|1
925143|NCT00954512|3050635|P3|Overall Study|Progression of Disease|0
925144|NCT00954512|3050636|P2|Overall Study|Progression of Disease|1
925145|NCT00954512|3050637|P1|Overall Study|Progression of Disease|2
925146|NCT00954512|3050632|P6|Overall Study|Symptomatic Deterioration|0
925147|NCT00954512|3050633|P5|Overall Study|Symptomatic Deterioration|2
925148|NCT00954512|3050634|P4|Overall Study|Symptomatic Deterioration|0
925149|NCT00954512|3050635|P3|Overall Study|Symptomatic Deterioration|0
925150|NCT00954512|3050636|P2|Overall Study|Symptomatic Deterioration|1
925151|NCT00954512|3050637|P1|Overall Study|Symptomatic Deterioration|0
925152|NCT00954512|3050632|P6|Overall Study|Physician Decision|0
925153|NCT00954512|3050633|P5|Overall Study|Physician Decision|0
925154|NCT00954512|3050634|P4|Overall Study|Physician Decision|1
925155|NCT00954512|3050635|P3|Overall Study|Physician Decision|0
925156|NCT00954512|3050636|P2|Overall Study|Physician Decision|1
925157|NCT00954512|3050637|P1|Overall Study|Physician Decision|0
925158|NCT00954512|3050632|P6|Overall Study|Adverse Event|2
925159|NCT00954512|3050633|P5|Overall Study|Adverse Event|1
925160|NCT00954512|3050634|P4|Overall Study|Adverse Event|0
925161|NCT00954512|3050635|P3|Overall Study|Adverse Event|0
925162|NCT00954512|3050636|P2|Overall Study|Adverse Event|0
925163|NCT00954512|3050637|P1|Overall Study|Adverse Event|0
925164|NCT00954512|3050632|P6|Overall Study|Withdrawal by Subject|1
925165|NCT00954512|3050633|P5|Overall Study|Withdrawal by Subject|0
925166|NCT00954512|3050634|P4|Overall Study|Withdrawal by Subject|0
925167|NCT00954512|3050635|P3|Overall Study|Withdrawal by Subject|0
925168|NCT00954512|3050636|P2|Overall Study|Withdrawal by Subject|0
925169|NCT00954512|3050637|P1|Overall Study|Withdrawal by Subject|0
925170|NCT00954447|3050658|P2|Overall Study|Other|18
925171|NCT00954447|3050659|P1|Overall Study|Other|21
925172|NCT00954447|3050658|P2|Overall Study|Withdrawal by Subject|21
925173|NCT00954447|3050659|P1|Overall Study|Withdrawal by Subject|26
925174|NCT00954447|3050658|P2|Overall Study|Lost to Follow-up|14
925175|NCT00954447|3050659|P1|Overall Study|Lost to Follow-up|8
925176|NCT00954447|3050658|P2|Overall Study|Protocol Violation|7
925177|NCT00954447|3050659|P1|Overall Study|Protocol Violation|5
925178|NCT00954447|3050658|P2|Overall Study|Lack of Efficacy|3
925179|NCT00954447|3050659|P1|Overall Study|Lack of Efficacy|17
925180|NCT00954447|3050658|P2|Overall Study|Adverse Event|25
925181|NCT00954447|3050659|P1|Overall Study|Adverse Event|33
925182|NCT00954421|3050695|P1|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1
925183|NCT00954421|3050695|P1|6 Months of DBS|Withdrawal by Subject|1
925184|NCT00954421|3050695|P1|Screening|screen failures|3
925185|NCT00954122|3050741|P1|Overall Study|Safety Reason|1
925186|NCT00954122|3050741|P1|Overall Study|Adverse Event|1
925187|NCT00954122|3050741|P1|Overall Study|Withdrawal by Subject|5
925188|NCT00953927|3050758|P2|Overall Study|Other study discontinuation|1
925189|NCT00953927|3050759|P1|Overall Study|Other study discontinuation|1
925190|NCT00953927|3050758|P2|Overall Study|Death|4
925191|NCT00953927|3050759|P1|Overall Study|Death|7
925192|NCT00953927|3050758|P2|Overall Study|Withdrawal by Subject|25
925193|NCT00953927|3050759|P1|Overall Study|Withdrawal by Subject|36
925194|NCT00953927|3050758|P2|Overall Study|Lost to Follow-up|65
925195|NCT00953927|3050759|P1|Overall Study|Lost to Follow-up|61
925196|NCT00953745|3050814|P2|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0
925197|NCT00953745|3050815|P1|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1
925198|NCT00953745|3050814|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0
925199|NCT00953745|3050815|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6
925200|NCT00953745|3050814|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0
925201|NCT00953745|3050815|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1
925202|NCT00953745|3050814|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0
925203|NCT00953745|3050815|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3
925204|NCT00953745|3050814|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0
925205|NCT00953745|3050815|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2
925206|NCT00953745|3050814|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0
925207|NCT00953745|3050815|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1
925208|NCT00953706|3050848|P4|Part B (96-Week Open-Label Extension)|Other|2
925209|NCT00953706|3050849|P3|Part B (96-Week Open-Label Extension)|Other|0
925210|NCT00953706|3050850|P2|Part B (96-Week Open-Label Extension)|Other|0
925211|NCT00953706|3050851|P1|Part B (96-Week Open-Label Extension)|Other|0
925212|NCT00953706|3050848|P4|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2
925213|NCT00953706|3050849|P3|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1
925214|NCT00953706|3050850|P2|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
925215|NCT00953706|3050851|P1|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
925292|NCT00953225|3051018|P1|Overall Study|Withdrawal by Subject|2
925216|NCT00953706|3050848|P4|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25
925217|NCT00953706|3050849|P3|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4
925218|NCT00953706|3050850|P2|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
925219|NCT00953706|3050851|P1|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
925220|NCT00953706|3050848|P4|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1
925221|NCT00953706|3050849|P3|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
925222|NCT00953706|3050850|P2|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
925223|NCT00953706|3050851|P1|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
925224|NCT00953706|3050848|P4|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1
925225|NCT00953706|3050849|P3|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
925226|NCT00953706|3050850|P2|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
925227|NCT00953706|3050851|P1|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
925228|NCT00953706|3050848|P4|Part B (96-Week Open-Label Extension)|Adverse Event|2
925229|NCT00953706|3050849|P3|Part B (96-Week Open-Label Extension)|Adverse Event|0
925230|NCT00953706|3050850|P2|Part B (96-Week Open-Label Extension)|Adverse Event|0
925231|NCT00953706|3050851|P1|Part B (96-Week Open-Label Extension)|Adverse Event|0
925232|NCT00953706|3050848|P4|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
925233|NCT00953706|3050849|P3|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
925234|NCT00953706|3050850|P2|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1
925235|NCT00953706|3050851|P1|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
925236|NCT00953706|3050848|P4|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
925237|NCT00953706|3050849|P3|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
925238|NCT00953706|3050850|P2|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1
925239|NCT00953706|3050851|P1|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
925240|NCT00953706|3050848|P4|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
925241|NCT00953706|3050849|P3|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
925242|NCT00953706|3050850|P2|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2
925243|NCT00953706|3050851|P1|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
925244|NCT00953706|3050848|P4|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
925245|NCT00953706|3050849|P3|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
925246|NCT00953706|3050850|P2|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1
925247|NCT00953706|3050851|P1|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
925248|NCT00953706|3050848|P4|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
925249|NCT00953706|3050849|P3|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
925250|NCT00953706|3050850|P2|Part A (16-Week Double-Blind Treatment)|Adverse Event|3
925251|NCT00953706|3050851|P1|Part A (16-Week Double-Blind Treatment)|Adverse Event|2
925252|NCT00953680|3050883|P2|Period 1|Withdrawal by Subject|1
925253|NCT00953680|3050884|P1|Period 1|Withdrawal by Subject|0
925254|NCT00953667|3050896|P1|Overall Study|poor venous access,unable to draw blood|4
925255|NCT00953667|3050896|P1|Overall Study|Adverse Event|10
925256|NCT00953667|3050896|P1|Overall Study|Withdrawal by Subject|63
925257|NCT00953667|3050896|P1|Overall Study|Physician Decision|35
925258|NCT00953667|3050896|P1|Overall Study|Lost to Follow-up|11
925259|NCT00953615|3050917|P1|Overall Study|Adverse Event|1
925260|NCT00953576|3050926|P2|Overall Study|Ineligible after Consent|0
925261|NCT00953576|3050927|P1|Overall Study|Ineligible after Consent|2
925262|NCT00953576|3050926|P2|Overall Study|Adverse Event|1
925263|NCT00953576|3050927|P1|Overall Study|Adverse Event|0
925264|NCT00953524|3050942|P4|Overall Study|Withdrawal by Subject|0
925265|NCT00953524|3050943|P3|Overall Study|Withdrawal by Subject|1
925266|NCT00953524|3050944|P2|Overall Study|Withdrawal by Subject|4
925267|NCT00953524|3050945|P1|Overall Study|Withdrawal by Subject|2
925268|NCT00953524|3050942|P4|Overall Study|Lost to Follow-up|0
925269|NCT00953524|3050943|P3|Overall Study|Lost to Follow-up|1
925270|NCT00953524|3050944|P2|Overall Study|Lost to Follow-up|1
925271|NCT00953524|3050945|P1|Overall Study|Lost to Follow-up|0
925272|NCT00953524|3050942|P4|Overall Study|Protocol Violation|6
925273|NCT00953524|3050943|P3|Overall Study|Protocol Violation|11
925274|NCT00953524|3050944|P2|Overall Study|Protocol Violation|10
925275|NCT00953524|3050945|P1|Overall Study|Protocol Violation|18
925276|NCT00953524|3050942|P4|Overall Study|Adverse Event|2
925277|NCT00953524|3050943|P3|Overall Study|Adverse Event|1
925278|NCT00953524|3050944|P2|Overall Study|Adverse Event|0
925279|NCT00953524|3050945|P1|Overall Study|Adverse Event|2
925280|NCT00953407|3050988|P5|Overall Study|Lost to Follow-up|0
925281|NCT00953407|3050989|P4|Overall Study|Lost to Follow-up|1
925282|NCT00953407|3050990|P3|Overall Study|Lost to Follow-up|0
925283|NCT00953407|3050991|P2|Overall Study|Lost to Follow-up|0
925284|NCT00953407|3050992|P1|Overall Study|Lost to Follow-up|0
925285|NCT00953407|3050988|P5|Overall Study|Failed inclusion criteria|1
925286|NCT00953407|3050989|P4|Overall Study|Failed inclusion criteria|1
925287|NCT00953407|3050990|P3|Overall Study|Failed inclusion criteria|1
925288|NCT00953407|3050991|P2|Overall Study|Failed inclusion criteria|1
925289|NCT00953407|3050992|P1|Overall Study|Failed inclusion criteria|1
925290|NCT00953329|3051004|P1|Overall Study|Lack of Efficacy|1
925291|NCT00953225|3051017|P2|Overall Study|Withdrawal by Subject|0
925293|NCT00953160|3051102|P1|Overall Study|Withdrawal by Subject|4
925294|NCT00953160|3051102|P1|Overall Study|Lost to Follow-up|23
925295|NCT00953147|3051111|P3|Overall Study|Other|13
925296|NCT00953147|3051112|P2|Overall Study|Other|11
925297|NCT00953147|3051113|P1|Overall Study|Other|4
925298|NCT00953147|3051111|P3|Overall Study|Physician Decision|3
925299|NCT00953147|3051112|P2|Overall Study|Physician Decision|7
925300|NCT00953147|3051113|P1|Overall Study|Physician Decision|2
925301|NCT00953147|3051111|P3|Overall Study|Lost to Follow-up|4
925302|NCT00953147|3051112|P2|Overall Study|Lost to Follow-up|9
925303|NCT00953147|3051113|P1|Overall Study|Lost to Follow-up|8
925304|NCT00953147|3051111|P3|Overall Study|Withdrawal by Subject|12
925305|NCT00953147|3051112|P2|Overall Study|Withdrawal by Subject|15
925306|NCT00953147|3051113|P1|Overall Study|Withdrawal by Subject|13
925307|NCT00953147|3051111|P3|Overall Study|Protocol Violation|4
925308|NCT00953147|3051112|P2|Overall Study|Protocol Violation|8
925309|NCT00953147|3051113|P1|Overall Study|Protocol Violation|2
925310|NCT00953147|3051111|P3|Overall Study|Adverse Event|6
925311|NCT00953147|3051112|P2|Overall Study|Adverse Event|16
925312|NCT00953147|3051113|P1|Overall Study|Adverse Event|8
925313|NCT00953056|3051191|P6|Overall Study|Serious Adverse Event|1
925314|NCT00953056|3051192|P5|Overall Study|Serious Adverse Event|0
925315|NCT00953056|3051193|P4|Overall Study|Serious Adverse Event|0
925316|NCT00953056|3051194|P3|Overall Study|Serious Adverse Event|0
925317|NCT00953056|3051195|P2|Overall Study|Serious Adverse Event|0
925318|NCT00953056|3051196|P1|Overall Study|Serious Adverse Event|0
925319|NCT00953056|3051191|P6|Overall Study|Withdrew Consent|3
925320|NCT00953056|3051192|P5|Overall Study|Withdrew Consent|2
925321|NCT00953056|3051193|P4|Overall Study|Withdrew Consent|0
925322|NCT00953056|3051194|P3|Overall Study|Withdrew Consent|0
925323|NCT00953056|3051195|P2|Overall Study|Withdrew Consent|0
925324|NCT00953056|3051196|P1|Overall Study|Withdrew Consent|0
925325|NCT00953043|3051220|P2|Overall Study|Physician Decision|2
925326|NCT00953043|3051221|P1|Overall Study|Physician Decision|0
925327|NCT00953043|3051220|P2|Overall Study|Withdrawal by Subject|0
925328|NCT00953043|3051221|P1|Overall Study|Withdrawal by Subject|4
925329|NCT00953017|3051245|P4|Overall Study|Brown stool prior to procedure|0
925330|NCT00953017|3051246|P3|Overall Study|Brown stool prior to procedure|1
925331|NCT00953017|3051247|P2|Overall Study|Brown stool prior to procedure|0
925332|NCT00953017|3051248|P1|Overall Study|Brown stool prior to procedure|0
925333|NCT00953017|3051245|P4|Overall Study|Procedure incomplete due to pain/looping|1
925334|NCT00953017|3051246|P3|Overall Study|Procedure incomplete due to pain/looping|0
925335|NCT00953017|3051247|P2|Overall Study|Procedure incomplete due to pain/looping|1
925336|NCT00953017|3051248|P1|Overall Study|Procedure incomplete due to pain/looping|0
925337|NCT00953017|3051245|P4|Overall Study|Incomplete data|0
925338|NCT00953017|3051246|P3|Overall Study|Incomplete data|0
925339|NCT00953017|3051247|P2|Overall Study|Incomplete data|1
925340|NCT00953017|3051248|P1|Overall Study|Incomplete data|1
925341|NCT00953017|3051245|P4|Overall Study|DId not show up for colonoscopy|4
925342|NCT00953017|3051246|P3|Overall Study|DId not show up for colonoscopy|5
925343|NCT00953017|3051247|P2|Overall Study|DId not show up for colonoscopy|4
925344|NCT00953017|3051248|P1|Overall Study|DId not show up for colonoscopy|4
925345|NCT00952848|3051270|P1|Overall Study|Withdrawal by Subject|4
925346|NCT00952822|3051277|P4|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
925347|NCT00952822|3051278|P3|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1
925348|NCT00952822|3051279|P2|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
925349|NCT00952822|3051280|P1|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
925350|NCT00952822|3051277|P4|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
925351|NCT00952822|3051278|P3|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
925352|NCT00952822|3051279|P2|1st Pharmacokinetic Evaluation|Lost to Follow-up|1
925353|NCT00952822|3051280|P1|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
925354|NCT00952731|3051312|P2|Overall Study|Drug supply expired|0
925355|NCT00952731|3051313|P1|Overall Study|Drug supply expired|1
925356|NCT00952705|3051332|P3|Overall Study|Exclusion criteria not met pre dose|0
925357|NCT00952705|3051333|P2|Overall Study|Exclusion criteria not met pre dose|1
925358|NCT00952705|3051334|P1|Overall Study|Exclusion criteria not met pre dose|0
925359|NCT00952705|3051332|P3|Overall Study|Incarcerated post dose|0
925360|NCT00952705|3051333|P2|Overall Study|Incarcerated post dose|0
925361|NCT00952705|3051334|P1|Overall Study|Incarcerated post dose|5
925362|NCT00952705|3051332|P3|Overall Study|Death|0
925363|NCT00952705|3051333|P2|Overall Study|Death|0
925364|NCT00952705|3051334|P1|Overall Study|Death|2
925365|NCT00952705|3051332|P3|Overall Study|Withdrawal by Subject|1
925366|NCT00952705|3051333|P2|Overall Study|Withdrawal by Subject|1
925367|NCT00952705|3051334|P1|Overall Study|Withdrawal by Subject|2
925368|NCT00952705|3051332|P3|Overall Study|Lost to Follow-up|9
925369|NCT00952705|3051333|P2|Overall Study|Lost to Follow-up|8
925370|NCT00952705|3051334|P1|Overall Study|Lost to Follow-up|24
925371|NCT00952614|3051421|P1|Overall Study|other reason|1
925372|NCT00952614|3051421|P1|Overall Study|Lost to Follow-up|3
925373|NCT00952614|3051421|P1|Overall Study|Death|3
925374|NCT00952588|3051428|P2|Overall Study|Lack of Efficacy|2
925375|NCT00952588|3051429|P1|Overall Study|Lack of Efficacy|2
925376|NCT00952588|3051428|P2|Overall Study|Physician Decision|1
925377|NCT00952588|3051429|P1|Overall Study|Physician Decision|0
925378|NCT00952588|3051428|P2|Overall Study|Lost to Follow-up|0
925379|NCT00952588|3051429|P1|Overall Study|Lost to Follow-up|2
925380|NCT00952588|3051428|P2|Overall Study|Adverse Event|3
925381|NCT00952588|3051429|P1|Overall Study|Adverse Event|2
925382|NCT00952588|3051428|P2|Overall Study|Withdrawal by Subject|5
925383|NCT00952588|3051429|P1|Overall Study|Withdrawal by Subject|2
925384|NCT00952588|3051428|P2|Overall Study|Death|13
925385|NCT00952588|3051429|P1|Overall Study|Death|28
925386|NCT00952523|3051447|P1|Overall Study|Withdrawal by Subject|7
925387|NCT00952484|3051456|P3|Overall Study|Withdrawal by Subject|0
925388|NCT00952484|3051457|P2|Overall Study|Withdrawal by Subject|1
925389|NCT00952484|3051458|P1|Overall Study|Withdrawal by Subject|0
925390|NCT00952419|3051485|P3|Overall Study|Withdrawal by Subject|0
925391|NCT00952419|3051486|P2|Overall Study|Withdrawal by Subject|3
925392|NCT00952419|3051487|P1|Overall Study|Withdrawal by Subject|1
925393|NCT00952419|3051485|P3|Overall Study|Protocol Violation|0
925394|NCT00952419|3051486|P2|Overall Study|Protocol Violation|7
925395|NCT00952419|3051487|P1|Overall Study|Protocol Violation|3
925396|NCT00952419|3051485|P3|Overall Study|Adverse Event|0
925397|NCT00952419|3051486|P2|Overall Study|Adverse Event|0
925398|NCT00952419|3051487|P1|Overall Study|Adverse Event|2
925399|NCT00952367|3051523|P1|Overall Study|Protocol Violation|3
925400|NCT00952367|3051523|P1|Overall Study|Noncoordination|1
925401|NCT00952367|3051523|P1|Overall Study|Withdrawal by Subject|2
925402|NCT00952341|3051538|P2|Cycle 2|Progressive Disease|1
925403|NCT00952341|3051539|P1|Cycle 2|Progressive Disease|0
925404|NCT00952341|3051538|P2|Cycle 2|Physician Decision|1
925405|NCT00952341|3051539|P1|Cycle 2|Physician Decision|1
925406|NCT00952341|3051538|P2|Cycle 2|Lost to Follow-up|9
925407|NCT00952341|3051539|P1|Cycle 2|Lost to Follow-up|6
925408|NCT00952341|3051538|P2|Cycle 2|Protocol Violation|0
925409|NCT00952341|3051539|P1|Cycle 2|Protocol Violation|1
925410|NCT00952341|3051538|P2|Cycle 2|Withdrawal by Subject|1
925411|NCT00952341|3051539|P1|Cycle 2|Withdrawal by Subject|1
925412|NCT00952341|3051538|P2|Cycle 1|Physician Decision|1
925413|NCT00952341|3051539|P1|Cycle 1|Physician Decision|0
925414|NCT00952341|3051538|P2|Cycle 1|Lost to Follow-up|2
925415|NCT00952341|3051539|P1|Cycle 1|Lost to Follow-up|11
925416|NCT00952341|3051538|P2|Cycle 1|Protocol Violation|1
925417|NCT00952341|3051539|P1|Cycle 1|Protocol Violation|2
925418|NCT00952341|3051538|P2|Cycle 1|Withdrawal by Subject|8
925419|NCT00952341|3051539|P1|Cycle 1|Withdrawal by Subject|3
925420|NCT00952341|3051538|P2|Cycle 1|Adverse Event|1
925421|NCT00952341|3051539|P1|Cycle 1|Adverse Event|4
925422|NCT00952289|3051561|P2|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7
925423|NCT00952289|3051562|P1|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0
925424|NCT00952289|3051561|P2|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2
925425|NCT00952289|3051562|P1|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0
925426|NCT00952289|3051561|P2|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11
925427|NCT00952289|3051562|P1|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0
925428|NCT00952289|3051561|P2|Patients Who Crossed Over to Ruxolitinib|Disease progression|15
925429|NCT00952289|3051562|P1|Patients Who Crossed Over to Ruxolitinib|Disease progression|0
925430|NCT00952289|3051561|P2|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19
925431|NCT00952289|3051562|P1|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0
925432|NCT00952289|3051561|P2|All Participants|Data lost during site relocation|1
925433|NCT00952289|3051562|P1|All Participants|Data lost during site relocation|0
925434|NCT00952289|3051561|P2|All Participants|Withdrawal by Subject|10
925435|NCT00952289|3051562|P1|All Participants|Withdrawal by Subject|1
925436|NCT00952289|3051561|P2|All Participants|Disease progression|12
925437|NCT00952289|3051562|P1|All Participants|Disease progression|3
925438|NCT00952289|3051561|P2|All Participants|Adverse Event|8
925439|NCT00952289|3051562|P1|All Participants|Adverse Event|8
925440|NCT00952289|3051561|P2|All Participants|Death|9
925441|NCT00952289|3051562|P1|All Participants|Death|9
925442|NCT00952276|3051591|P5|Overall Study|Withdrawal by Subject|0
925443|NCT00952276|3051592|P4|Overall Study|Withdrawal by Subject|1
925444|NCT00952276|3051593|P3|Overall Study|Withdrawal by Subject|0
925445|NCT00952276|3051594|P2|Overall Study|Withdrawal by Subject|0
925446|NCT00952276|3051595|P1|Overall Study|Withdrawal by Subject|1
925447|NCT00952068|3051681|P1|Overall Study|Withdrawal by Subject|4
925448|NCT00952068|3051681|P1|Overall Study|Adverse Event|3
925449|NCT00951912|3051692|P3|Overall Study|Other: Stroke|0
925450|NCT00951912|3051693|P2|Overall Study|Other: Stroke|1
925451|NCT00951912|3051694|P1|Overall Study|Other: Stroke|0
925452|NCT00951912|3051692|P3|Overall Study|Other: Colon cancer|0
925453|NCT00951912|3051693|P2|Overall Study|Other: Colon cancer|0
925454|NCT00951912|3051694|P1|Overall Study|Other: Colon cancer|1
925455|NCT00951912|3051692|P3|Overall Study|Other:Depression|0
925456|NCT00951912|3051693|P2|Overall Study|Other:Depression|0
925457|NCT00951912|3051694|P1|Overall Study|Other:Depression|1
925458|NCT00951912|3051692|P3|Overall Study|Withdrawal by Subject|0
925459|NCT00951912|3051693|P2|Overall Study|Withdrawal by Subject|1
925460|NCT00951912|3051694|P1|Overall Study|Withdrawal by Subject|1
925461|NCT00951912|3051692|P3|Overall Study|Physician Decision|1
925462|NCT00951912|3051693|P2|Overall Study|Physician Decision|0
925463|NCT00951912|3051694|P1|Overall Study|Physician Decision|1
925464|NCT00951912|3051692|P3|Overall Study|Lost to Follow-up|0
925465|NCT00951912|3051693|P2|Overall Study|Lost to Follow-up|2
931743|NCT00906399|3071566|P5|Year 1|Death|0
925466|NCT00951912|3051694|P1|Overall Study|Lost to Follow-up|2
925467|NCT00951912|3051692|P3|Overall Study|Adverse Event|1
925468|NCT00951912|3051693|P2|Overall Study|Adverse Event|1
925469|NCT00951912|3051694|P1|Overall Study|Adverse Event|0
925470|NCT00951912|3051692|P3|Overall Study|Lack of Efficacy|0
925471|NCT00951912|3051693|P2|Overall Study|Lack of Efficacy|0
925472|NCT00951912|3051694|P1|Overall Study|Lack of Efficacy|1
925473|NCT00951665|3051794|P6|Phase 2a|Disease Progression|5
925474|NCT00951665|3051795|P5|Phase 2a|Disease Progression|6
925475|NCT00951665|3051796|P4|Phase 2a|Disease Progression|0
925476|NCT00951665|3051797|P3|Phase 2a|Disease Progression|0
925477|NCT00951665|3051798|P2|Phase 2a|Disease Progression|0
925478|NCT00951665|3051799|P1|Phase 2a|Disease Progression|0
925479|NCT00951665|3051794|P6|Phase 2a|Withdrawal by Subject|0
925480|NCT00951665|3051795|P5|Phase 2a|Withdrawal by Subject|2
925481|NCT00951665|3051796|P4|Phase 2a|Withdrawal by Subject|0
925482|NCT00951665|3051797|P3|Phase 2a|Withdrawal by Subject|0
925483|NCT00951665|3051798|P2|Phase 2a|Withdrawal by Subject|0
925484|NCT00951665|3051799|P1|Phase 2a|Withdrawal by Subject|0
925485|NCT00951665|3051794|P6|Phase 2a|Physician Decision|1
925486|NCT00951665|3051795|P5|Phase 2a|Physician Decision|0
925487|NCT00951665|3051796|P4|Phase 2a|Physician Decision|0
925488|NCT00951665|3051797|P3|Phase 2a|Physician Decision|0
925489|NCT00951665|3051798|P2|Phase 2a|Physician Decision|0
925490|NCT00951665|3051799|P1|Phase 2a|Physician Decision|0
925491|NCT00951665|3051794|P6|Phase 2a|Lost to Follow-up|0
925492|NCT00951665|3051795|P5|Phase 2a|Lost to Follow-up|1
925493|NCT00951665|3051796|P4|Phase 2a|Lost to Follow-up|0
925494|NCT00951665|3051797|P3|Phase 2a|Lost to Follow-up|0
925495|NCT00951665|3051798|P2|Phase 2a|Lost to Follow-up|0
925496|NCT00951665|3051799|P1|Phase 2a|Lost to Follow-up|0
925497|NCT00951665|3051794|P6|Phase 2a|Death|1
925498|NCT00951665|3051795|P5|Phase 2a|Death|1
925499|NCT00951665|3051796|P4|Phase 2a|Death|0
925500|NCT00951665|3051797|P3|Phase 2a|Death|0
925501|NCT00951665|3051798|P2|Phase 2a|Death|0
925502|NCT00951665|3051799|P1|Phase 2a|Death|0
925503|NCT00951665|3051794|P6|Phase 2a|Adverse Event|0
925504|NCT00951665|3051795|P5|Phase 2a|Adverse Event|2
925505|NCT00951665|3051796|P4|Phase 2a|Adverse Event|0
925506|NCT00951665|3051797|P3|Phase 2a|Adverse Event|0
925507|NCT00951665|3051798|P2|Phase 2a|Adverse Event|0
925508|NCT00951665|3051799|P1|Phase 2a|Adverse Event|0
925509|NCT00951665|3051794|P6|Phase 1b|Protocol Violation|0
925510|NCT00951665|3051795|P5|Phase 1b|Protocol Violation|0
925511|NCT00951665|3051796|P4|Phase 1b|Protocol Violation|0
925512|NCT00951665|3051797|P3|Phase 1b|Protocol Violation|0
925513|NCT00951665|3051798|P2|Phase 1b|Protocol Violation|0
925514|NCT00951665|3051799|P1|Phase 1b|Protocol Violation|2
925515|NCT00951665|3051794|P6|Phase 1b|Disease Progression|0
925516|NCT00951665|3051795|P5|Phase 1b|Disease Progression|0
925517|NCT00951665|3051796|P4|Phase 1b|Disease Progression|0
925518|NCT00951665|3051797|P3|Phase 1b|Disease Progression|14
925519|NCT00951665|3051798|P2|Phase 1b|Disease Progression|2
925520|NCT00951665|3051799|P1|Phase 1b|Disease Progression|13
925521|NCT00951665|3051794|P6|Phase 1b|Withdrawal by Subject|0
925522|NCT00951665|3051795|P5|Phase 1b|Withdrawal by Subject|0
925523|NCT00951665|3051796|P4|Phase 1b|Withdrawal by Subject|0
925524|NCT00951665|3051797|P3|Phase 1b|Withdrawal by Subject|0
925525|NCT00951665|3051798|P2|Phase 1b|Withdrawal by Subject|1
925526|NCT00951665|3051799|P1|Phase 1b|Withdrawal by Subject|0
925527|NCT00951665|3051794|P6|Phase 1b|Physician Decision|0
925528|NCT00951665|3051795|P5|Phase 1b|Physician Decision|0
925529|NCT00951665|3051796|P4|Phase 1b|Physician Decision|0
925530|NCT00951665|3051797|P3|Phase 1b|Physician Decision|1
925531|NCT00951665|3051798|P2|Phase 1b|Physician Decision|0
925532|NCT00951665|3051799|P1|Phase 1b|Physician Decision|4
925533|NCT00951665|3051794|P6|Phase 1b|Death|0
925534|NCT00951665|3051795|P5|Phase 1b|Death|0
925535|NCT00951665|3051796|P4|Phase 1b|Death|0
925536|NCT00951665|3051797|P3|Phase 1b|Death|2
925537|NCT00951665|3051798|P2|Phase 1b|Death|0
925538|NCT00951665|3051799|P1|Phase 1b|Death|1
925539|NCT00951665|3051794|P6|Phase 1b|Adverse Event|0
925540|NCT00951665|3051795|P5|Phase 1b|Adverse Event|0
925541|NCT00951665|3051796|P4|Phase 1b|Adverse Event|1
925542|NCT00951665|3051797|P3|Phase 1b|Adverse Event|0
925543|NCT00951665|3051798|P2|Phase 1b|Adverse Event|1
925544|NCT00951665|3051799|P1|Phase 1b|Adverse Event|2
925545|NCT00951509|3051908|P1|Overall Study|Withdrawal by Subject|2
925546|NCT00951496|3051919|P3|Overall Study|Did not initiate study treatment|13
925547|NCT00951496|3051920|P2|Overall Study|Did not initiate study treatment|8
925548|NCT00951496|3051921|P1|Overall Study|Did not initiate study treatment|10
925549|NCT00951483|3051949|P2|Overall Study|Withdrawal by Subject|0
925550|NCT00951483|3051950|P1|Overall Study|Withdrawal by Subject|15
925551|NCT00951483|3051949|P2|Overall Study|Physician Decision|0
925552|NCT00951483|3051950|P1|Overall Study|Physician Decision|4
925553|NCT00951379|3051970|P2|Overall Study|Disease Progression|1
925554|NCT00951379|3051971|P1|Overall Study|Disease Progression|0
925555|NCT00951379|3051970|P2|Overall Study|Noncompliance|0
925556|NCT00951379|3051971|P1|Overall Study|Noncompliance|1
925557|NCT00951379|3051970|P2|Overall Study|Withdrawal by Subject|0
925558|NCT00951379|3051971|P1|Overall Study|Withdrawal by Subject|1
925559|NCT00951379|3051970|P2|Overall Study|Adverse Event|1
925560|NCT00951379|3051971|P1|Overall Study|Adverse Event|4
925561|NCT00951275|3052013|P1|Overall Study|Protocol Violation|1
925562|NCT00951275|3052013|P1|Overall Study|Withdrawal by Subject|4
925563|NCT00951275|3052013|P1|Overall Study|Adverse Event|7
925564|NCT00951275|3052013|P1|Overall Study|Administrative Reason|1
925565|NCT00951171|3052045|P2|Overall Study|Adverse Event|0
925566|NCT00951171|3052046|P1|Overall Study|Adverse Event|2
925567|NCT00951041|3052078|P2|Overall Study|Other|0
925568|NCT00951041|3052079|P1|Overall Study|Other|3
925569|NCT00951041|3052078|P2|Overall Study|Lost to Follow-up|0
925570|NCT00951041|3052079|P1|Overall Study|Lost to Follow-up|1
925571|NCT00951041|3052078|P2|Overall Study|Withdrawal by Subject|1
925572|NCT00951041|3052079|P1|Overall Study|Withdrawal by Subject|1
925573|NCT00951015|3052134|P5|Open-label Phase|Physician Decision|8
925574|NCT00951015|3052135|P4|Open-label Phase|Physician Decision|0
925575|NCT00951015|3052136|P3|Open-label Phase|Physician Decision|0
925576|NCT00951015|3052137|P2|Open-label Phase|Physician Decision|0
925577|NCT00951015|3052138|P1|Open-label Phase|Physician Decision|0
925578|NCT00951015|3052134|P5|Open-label Phase|Withdrawal by Subject|14
925579|NCT00951015|3052135|P4|Open-label Phase|Withdrawal by Subject|0
925580|NCT00951015|3052136|P3|Open-label Phase|Withdrawal by Subject|0
925581|NCT00951015|3052137|P2|Open-label Phase|Withdrawal by Subject|0
925582|NCT00951015|3052138|P1|Open-label Phase|Withdrawal by Subject|0
925583|NCT00951015|3052134|P5|Open-label Phase|Lost to Follow-up|12
925584|NCT00951015|3052135|P4|Open-label Phase|Lost to Follow-up|0
925585|NCT00951015|3052136|P3|Open-label Phase|Lost to Follow-up|0
925586|NCT00951015|3052137|P2|Open-label Phase|Lost to Follow-up|0
925587|NCT00951015|3052138|P1|Open-label Phase|Lost to Follow-up|0
925588|NCT00951015|3052134|P5|Open-label Phase|Protocol Violation|12
925589|NCT00951015|3052135|P4|Open-label Phase|Protocol Violation|0
925590|NCT00951015|3052136|P3|Open-label Phase|Protocol Violation|0
925591|NCT00951015|3052137|P2|Open-label Phase|Protocol Violation|0
925592|NCT00951015|3052138|P1|Open-label Phase|Protocol Violation|0
925593|NCT00951015|3052134|P5|Open-label Phase|Lack of Efficacy|1
925594|NCT00951015|3052135|P4|Open-label Phase|Lack of Efficacy|0
925595|NCT00951015|3052136|P3|Open-label Phase|Lack of Efficacy|0
925596|NCT00951015|3052137|P2|Open-label Phase|Lack of Efficacy|0
925597|NCT00951015|3052138|P1|Open-label Phase|Lack of Efficacy|0
925598|NCT00951015|3052134|P5|Open-label Phase|Adverse Event|3
925599|NCT00951015|3052135|P4|Open-label Phase|Adverse Event|0
925600|NCT00951015|3052136|P3|Open-label Phase|Adverse Event|0
925601|NCT00951015|3052137|P2|Open-label Phase|Adverse Event|0
925602|NCT00951015|3052138|P1|Open-label Phase|Adverse Event|0
925603|NCT00951015|3052134|P5|Randomization Phase 96 Week|Withdrawal by Subject|0
925604|NCT00951015|3052135|P4|Randomization Phase 96 Week|Withdrawal by Subject|2
925605|NCT00951015|3052136|P3|Randomization Phase 96 Week|Withdrawal by Subject|1
925606|NCT00951015|3052137|P2|Randomization Phase 96 Week|Withdrawal by Subject|1
925607|NCT00951015|3052138|P1|Randomization Phase 96 Week|Withdrawal by Subject|2
925608|NCT00951015|3052134|P5|Randomization Phase 96 Week|Lost to Follow-up|0
925609|NCT00951015|3052135|P4|Randomization Phase 96 Week|Lost to Follow-up|2
925610|NCT00951015|3052136|P3|Randomization Phase 96 Week|Lost to Follow-up|1
925611|NCT00951015|3052137|P2|Randomization Phase 96 Week|Lost to Follow-up|3
925612|NCT00951015|3052138|P1|Randomization Phase 96 Week|Lost to Follow-up|0
925613|NCT00951015|3052134|P5|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
925614|NCT00951015|3052135|P4|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1
925615|NCT00951015|3052136|P3|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
925616|NCT00951015|3052137|P2|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
925617|NCT00951015|3052138|P1|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
925618|NCT00951015|3052134|P5|Randomization Phase 96 Week|Protocol Violation|0
925619|NCT00951015|3052135|P4|Randomization Phase 96 Week|Protocol Violation|0
925620|NCT00951015|3052136|P3|Randomization Phase 96 Week|Protocol Violation|1
925621|NCT00951015|3052137|P2|Randomization Phase 96 Week|Protocol Violation|1
925622|NCT00951015|3052138|P1|Randomization Phase 96 Week|Protocol Violation|1
925623|NCT00951015|3052134|P5|Randomization Phase 96 Week|Lack of Efficacy|0
925624|NCT00951015|3052135|P4|Randomization Phase 96 Week|Lack of Efficacy|0
925625|NCT00951015|3052136|P3|Randomization Phase 96 Week|Lack of Efficacy|0
925626|NCT00951015|3052137|P2|Randomization Phase 96 Week|Lack of Efficacy|1
925627|NCT00951015|3052138|P1|Randomization Phase 96 Week|Lack of Efficacy|1
925628|NCT00951015|3052134|P5|Randomization Phase 96 Week|Adverse Event|0
925629|NCT00951015|3052135|P4|Randomization Phase 96 Week|Adverse Event|5
925630|NCT00951015|3052136|P3|Randomization Phase 96 Week|Adverse Event|2
925631|NCT00951015|3052137|P2|Randomization Phase 96 Week|Adverse Event|1
925632|NCT00951015|3052138|P1|Randomization Phase 96 Week|Adverse Event|1
925633|NCT00950963|3052235|P2|Overall Study|Lost to Follow-up|24
925634|NCT00950963|3052236|P1|Overall Study|Lost to Follow-up|29
925635|NCT00950911|3052271|P2|Overall Study|Poor performance status|1
925636|NCT00950911|3052272|P1|Overall Study|Poor performance status|0
925637|NCT00950911|3052271|P2|Overall Study|Noncompliance|0
925638|NCT00950911|3052272|P1|Overall Study|Noncompliance|1
925639|NCT00950911|3052271|P2|Overall Study|Ineligibility determined|0
925640|NCT00950911|3052272|P1|Overall Study|Ineligibility determined|1
925641|NCT00950911|3052271|P2|Overall Study|Administrative decision|1
925642|NCT00950911|3052272|P1|Overall Study|Administrative decision|3
925643|NCT00950911|3052271|P2|Overall Study|Consent withdrawn|3
925644|NCT00950911|3052272|P1|Overall Study|Consent withdrawn|1
925645|NCT00950911|3052271|P2|Overall Study|Disease progression|2
925646|NCT00950911|3052272|P1|Overall Study|Disease progression|2
925647|NCT00950911|3052271|P2|Overall Study|Death|6
925648|NCT00950911|3052272|P1|Overall Study|Death|4
925649|NCT00950911|3052271|P2|Overall Study|Adverse Event|2
925650|NCT00950911|3052272|P1|Overall Study|Adverse Event|0
925651|NCT00950872|3052278|P1|Overall Study|Did not have surgery|2
925652|NCT00950872|3052278|P1|Overall Study|Withdrawal by Subject|1
925653|NCT00950859|3052287|P2|Overall Study|Lost to Follow-up|3
925654|NCT00950859|3052288|P1|Overall Study|Lost to Follow-up|0
925655|NCT00950859|3052287|P2|Overall Study|Protocol Violation|1
925656|NCT00950859|3052288|P1|Overall Study|Protocol Violation|1
925657|NCT00950859|3052287|P2|Overall Study|Insufficient Viral Load Response|3
925658|NCT00950859|3052288|P1|Overall Study|Insufficient Viral Load Response|12
925659|NCT00950859|3052287|P2|Overall Study|Adverse Event|3
925660|NCT00950859|3052288|P1|Overall Study|Adverse Event|3
925661|NCT00950807|3052387|P10|Treatment Period 3|Adverse Event|0
925662|NCT00950807|3052388|P9|Treatment Period 3|Adverse Event|0
925663|NCT00950807|3052389|P8|Treatment Period 3|Adverse Event|0
925664|NCT00950807|3052390|P7|Treatment Period 3|Adverse Event|1
925665|NCT00950807|3052391|P6|Treatment Period 3|Adverse Event|0
925666|NCT00950807|3052392|P5|Treatment Period 3|Adverse Event|0
925667|NCT00950807|3052393|P4|Treatment Period 3|Adverse Event|0
925668|NCT00950807|3052394|P3|Treatment Period 3|Adverse Event|0
925669|NCT00950807|3052395|P2|Treatment Period 3|Adverse Event|0
925670|NCT00950807|3052396|P1|Treatment Period 3|Adverse Event|0
925671|NCT00950807|3052387|P10|Treatment Period 3|Protocol-defined Stopping Criteria|0
925672|NCT00950807|3052388|P9|Treatment Period 3|Protocol-defined Stopping Criteria|0
925673|NCT00950807|3052389|P8|Treatment Period 3|Protocol-defined Stopping Criteria|1
925674|NCT00950807|3052390|P7|Treatment Period 3|Protocol-defined Stopping Criteria|0
925675|NCT00950807|3052391|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
925676|NCT00950807|3052392|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
925677|NCT00950807|3052393|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
925678|NCT00950807|3052394|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
925679|NCT00950807|3052395|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
925680|NCT00950807|3052396|P1|Treatment Period 3|Protocol-defined Stopping Criteria|1
925681|NCT00950807|3052387|P10|Treatment Period 3|Withdrawal by Subject|1
925682|NCT00950807|3052388|P9|Treatment Period 3|Withdrawal by Subject|0
925683|NCT00950807|3052389|P8|Treatment Period 3|Withdrawal by Subject|0
925684|NCT00950807|3052390|P7|Treatment Period 3|Withdrawal by Subject|0
925685|NCT00950807|3052391|P6|Treatment Period 3|Withdrawal by Subject|0
925686|NCT00950807|3052392|P5|Treatment Period 3|Withdrawal by Subject|0
925687|NCT00950807|3052393|P4|Treatment Period 3|Withdrawal by Subject|0
925688|NCT00950807|3052394|P3|Treatment Period 3|Withdrawal by Subject|0
925689|NCT00950807|3052395|P2|Treatment Period 3|Withdrawal by Subject|0
925690|NCT00950807|3052396|P1|Treatment Period 3|Withdrawal by Subject|0
925691|NCT00950807|3052387|P10|Washout Period 2|Adverse Event|0
925692|NCT00950807|3052388|P9|Washout Period 2|Adverse Event|0
925693|NCT00950807|3052389|P8|Washout Period 2|Adverse Event|0
925694|NCT00950807|3052390|P7|Washout Period 2|Adverse Event|0
925695|NCT00950807|3052391|P6|Washout Period 2|Adverse Event|0
925696|NCT00950807|3052392|P5|Washout Period 2|Adverse Event|0
925697|NCT00950807|3052393|P4|Washout Period 2|Adverse Event|1
925698|NCT00950807|3052394|P3|Washout Period 2|Adverse Event|0
925699|NCT00950807|3052395|P2|Washout Period 2|Adverse Event|0
925700|NCT00950807|3052396|P1|Washout Period 2|Adverse Event|3
925701|NCT00950807|3052387|P10|Washout Period 2|Protocol-defined Stopping Criteria|0
925702|NCT00950807|3052388|P9|Washout Period 2|Protocol-defined Stopping Criteria|0
925703|NCT00950807|3052389|P8|Washout Period 2|Protocol-defined Stopping Criteria|1
925704|NCT00950807|3052390|P7|Washout Period 2|Protocol-defined Stopping Criteria|1
925705|NCT00950807|3052391|P6|Washout Period 2|Protocol-defined Stopping Criteria|0
925706|NCT00950807|3052392|P5|Washout Period 2|Protocol-defined Stopping Criteria|1
925707|NCT00950807|3052393|P4|Washout Period 2|Protocol-defined Stopping Criteria|0
925708|NCT00950807|3052394|P3|Washout Period 2|Protocol-defined Stopping Criteria|0
925709|NCT00950807|3052395|P2|Washout Period 2|Protocol-defined Stopping Criteria|1
925710|NCT00950807|3052396|P1|Washout Period 2|Protocol-defined Stopping Criteria|0
925711|NCT00950807|3052387|P10|Washout Period 2|Lack of Efficacy|0
925712|NCT00950807|3052388|P9|Washout Period 2|Lack of Efficacy|0
925713|NCT00950807|3052389|P8|Washout Period 2|Lack of Efficacy|0
925714|NCT00950807|3052390|P7|Washout Period 2|Lack of Efficacy|0
925715|NCT00950807|3052391|P6|Washout Period 2|Lack of Efficacy|0
925716|NCT00950807|3052392|P5|Washout Period 2|Lack of Efficacy|0
925717|NCT00950807|3052393|P4|Washout Period 2|Lack of Efficacy|0
925718|NCT00950807|3052394|P3|Washout Period 2|Lack of Efficacy|0
925719|NCT00950807|3052395|P2|Washout Period 2|Lack of Efficacy|0
925720|NCT00950807|3052396|P1|Washout Period 2|Lack of Efficacy|1
925721|NCT00950807|3052387|P10|Treatment Period 2|Adverse Event|0
925722|NCT00950807|3052388|P9|Treatment Period 2|Adverse Event|0
925723|NCT00950807|3052389|P8|Treatment Period 2|Adverse Event|1
925724|NCT00950807|3052390|P7|Treatment Period 2|Adverse Event|0
925725|NCT00950807|3052391|P6|Treatment Period 2|Adverse Event|1
925726|NCT00950807|3052392|P5|Treatment Period 2|Adverse Event|0
931744|NCT00906399|3071567|P4|Year 1|Death|0
925727|NCT00950807|3052393|P4|Treatment Period 2|Adverse Event|1
925728|NCT00950807|3052394|P3|Treatment Period 2|Adverse Event|0
925729|NCT00950807|3052395|P2|Treatment Period 2|Adverse Event|1
925730|NCT00950807|3052396|P1|Treatment Period 2|Adverse Event|0
925731|NCT00950807|3052387|P10|Treatment Period 2|Protocol-defined Stopping Criteria|0
925732|NCT00950807|3052388|P9|Treatment Period 2|Protocol-defined Stopping Criteria|0
925733|NCT00950807|3052389|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
925734|NCT00950807|3052390|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
925735|NCT00950807|3052391|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
925736|NCT00950807|3052392|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
925737|NCT00950807|3052393|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
925738|NCT00950807|3052394|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
925739|NCT00950807|3052395|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
925740|NCT00950807|3052396|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
925741|NCT00950807|3052387|P10|Treatment Period 2|Withdrawal by Subject|0
925742|NCT00950807|3052388|P9|Treatment Period 2|Withdrawal by Subject|0
925743|NCT00950807|3052389|P8|Treatment Period 2|Withdrawal by Subject|2
925744|NCT00950807|3052390|P7|Treatment Period 2|Withdrawal by Subject|1
925745|NCT00950807|3052391|P6|Treatment Period 2|Withdrawal by Subject|0
925746|NCT00950807|3052392|P5|Treatment Period 2|Withdrawal by Subject|0
925747|NCT00950807|3052393|P4|Treatment Period 2|Withdrawal by Subject|0
925748|NCT00950807|3052394|P3|Treatment Period 2|Withdrawal by Subject|0
925749|NCT00950807|3052395|P2|Treatment Period 2|Withdrawal by Subject|0
925750|NCT00950807|3052396|P1|Treatment Period 2|Withdrawal by Subject|0
925751|NCT00950807|3052387|P10|Treatment Period 2|Lack of Efficacy|0
925752|NCT00950807|3052388|P9|Treatment Period 2|Lack of Efficacy|0
925753|NCT00950807|3052389|P8|Treatment Period 2|Lack of Efficacy|0
925754|NCT00950807|3052390|P7|Treatment Period 2|Lack of Efficacy|0
925755|NCT00950807|3052391|P6|Treatment Period 2|Lack of Efficacy|0
925756|NCT00950807|3052392|P5|Treatment Period 2|Lack of Efficacy|0
925757|NCT00950807|3052393|P4|Treatment Period 2|Lack of Efficacy|0
925758|NCT00950807|3052394|P3|Treatment Period 2|Lack of Efficacy|0
925759|NCT00950807|3052395|P2|Treatment Period 2|Lack of Efficacy|0
925760|NCT00950807|3052396|P1|Treatment Period 2|Lack of Efficacy|1
925761|NCT00950807|3052387|P10|Washout Period 1|Adverse Event|0
925762|NCT00950807|3052388|P9|Washout Period 1|Adverse Event|0
925763|NCT00950807|3052389|P8|Washout Period 1|Adverse Event|0
925764|NCT00950807|3052390|P7|Washout Period 1|Adverse Event|0
925765|NCT00950807|3052391|P6|Washout Period 1|Adverse Event|0
925766|NCT00950807|3052392|P5|Washout Period 1|Adverse Event|1
925767|NCT00950807|3052393|P4|Washout Period 1|Adverse Event|1
925768|NCT00950807|3052394|P3|Washout Period 1|Adverse Event|0
925769|NCT00950807|3052395|P2|Washout Period 1|Adverse Event|0
925770|NCT00950807|3052396|P1|Washout Period 1|Adverse Event|2
925771|NCT00950807|3052387|P10|Washout Period 1|Protocol-defined Stopping Criteria|0
925772|NCT00950807|3052388|P9|Washout Period 1|Protocol-defined Stopping Criteria|0
925773|NCT00950807|3052389|P8|Washout Period 1|Protocol-defined Stopping Criteria|1
925774|NCT00950807|3052390|P7|Washout Period 1|Protocol-defined Stopping Criteria|1
925775|NCT00950807|3052391|P6|Washout Period 1|Protocol-defined Stopping Criteria|0
925776|NCT00950807|3052392|P5|Washout Period 1|Protocol-defined Stopping Criteria|0
925777|NCT00950807|3052393|P4|Washout Period 1|Protocol-defined Stopping Criteria|0
925778|NCT00950807|3052394|P3|Washout Period 1|Protocol-defined Stopping Criteria|0
925779|NCT00950807|3052395|P2|Washout Period 1|Protocol-defined Stopping Criteria|0
925780|NCT00950807|3052396|P1|Washout Period 1|Protocol-defined Stopping Criteria|3
925781|NCT00950807|3052387|P10|Washout Period 1|Withdrawal by Subject|0
925782|NCT00950807|3052388|P9|Washout Period 1|Withdrawal by Subject|1
925783|NCT00950807|3052389|P8|Washout Period 1|Withdrawal by Subject|0
925784|NCT00950807|3052390|P7|Washout Period 1|Withdrawal by Subject|0
925785|NCT00950807|3052391|P6|Washout Period 1|Withdrawal by Subject|0
925786|NCT00950807|3052392|P5|Washout Period 1|Withdrawal by Subject|0
925787|NCT00950807|3052393|P4|Washout Period 1|Withdrawal by Subject|0
925788|NCT00950807|3052394|P3|Washout Period 1|Withdrawal by Subject|0
925789|NCT00950807|3052395|P2|Washout Period 1|Withdrawal by Subject|0
925790|NCT00950807|3052396|P1|Washout Period 1|Withdrawal by Subject|0
925791|NCT00950807|3052387|P10|Washout Period 1|Lack of Efficacy|0
925792|NCT00950807|3052388|P9|Washout Period 1|Lack of Efficacy|0
925793|NCT00950807|3052389|P8|Washout Period 1|Lack of Efficacy|0
925794|NCT00950807|3052390|P7|Washout Period 1|Lack of Efficacy|1
925795|NCT00950807|3052391|P6|Washout Period 1|Lack of Efficacy|0
925796|NCT00950807|3052392|P5|Washout Period 1|Lack of Efficacy|0
925797|NCT00950807|3052393|P4|Washout Period 1|Lack of Efficacy|0
925798|NCT00950807|3052394|P3|Washout Period 1|Lack of Efficacy|0
925799|NCT00950807|3052395|P2|Washout Period 1|Lack of Efficacy|0
925800|NCT00950807|3052396|P1|Washout Period 1|Lack of Efficacy|0
925801|NCT00950807|3052387|P10|Treatment Period 1|Adverse Event|0
925802|NCT00950807|3052388|P9|Treatment Period 1|Adverse Event|0
925803|NCT00950807|3052389|P8|Treatment Period 1|Adverse Event|0
925804|NCT00950807|3052390|P7|Treatment Period 1|Adverse Event|0
925805|NCT00950807|3052391|P6|Treatment Period 1|Adverse Event|1
925806|NCT00950807|3052392|P5|Treatment Period 1|Adverse Event|0
925807|NCT00950807|3052393|P4|Treatment Period 1|Adverse Event|0
925808|NCT00950807|3052394|P3|Treatment Period 1|Adverse Event|0
925809|NCT00950807|3052395|P2|Treatment Period 1|Adverse Event|0
925810|NCT00950807|3052396|P1|Treatment Period 1|Adverse Event|0
925811|NCT00950807|3052387|P10|Treatment Period 1|Withdrawal by Subject|0
925812|NCT00950807|3052388|P9|Treatment Period 1|Withdrawal by Subject|1
925813|NCT00950807|3052389|P8|Treatment Period 1|Withdrawal by Subject|0
925814|NCT00950807|3052390|P7|Treatment Period 1|Withdrawal by Subject|0
925815|NCT00950807|3052391|P6|Treatment Period 1|Withdrawal by Subject|0
925816|NCT00950807|3052392|P5|Treatment Period 1|Withdrawal by Subject|1
925817|NCT00950807|3052393|P4|Treatment Period 1|Withdrawal by Subject|0
925818|NCT00950807|3052394|P3|Treatment Period 1|Withdrawal by Subject|0
925819|NCT00950807|3052395|P2|Treatment Period 1|Withdrawal by Subject|0
925820|NCT00950807|3052396|P1|Treatment Period 1|Withdrawal by Subject|1
925821|NCT00950807|3052387|P10|Treatment Period 1|Lost to Follow-up|0
925822|NCT00950807|3052388|P9|Treatment Period 1|Lost to Follow-up|0
925823|NCT00950807|3052389|P8|Treatment Period 1|Lost to Follow-up|0
925824|NCT00950807|3052390|P7|Treatment Period 1|Lost to Follow-up|0
925825|NCT00950807|3052391|P6|Treatment Period 1|Lost to Follow-up|0
925826|NCT00950807|3052392|P5|Treatment Period 1|Lost to Follow-up|0
925827|NCT00950807|3052393|P4|Treatment Period 1|Lost to Follow-up|0
925828|NCT00950807|3052394|P3|Treatment Period 1|Lost to Follow-up|1
925829|NCT00950807|3052395|P2|Treatment Period 1|Lost to Follow-up|0
925830|NCT00950807|3052396|P1|Treatment Period 1|Lost to Follow-up|0
925831|NCT00950807|3052387|P10|Treatment Period 1|Protocol Violation|0
925832|NCT00950807|3052388|P9|Treatment Period 1|Protocol Violation|0
925833|NCT00950807|3052389|P8|Treatment Period 1|Protocol Violation|0
925834|NCT00950807|3052390|P7|Treatment Period 1|Protocol Violation|0
925835|NCT00950807|3052391|P6|Treatment Period 1|Protocol Violation|0
925836|NCT00950807|3052392|P5|Treatment Period 1|Protocol Violation|0
925837|NCT00950807|3052393|P4|Treatment Period 1|Protocol Violation|0
925838|NCT00950807|3052394|P3|Treatment Period 1|Protocol Violation|0
925839|NCT00950807|3052395|P2|Treatment Period 1|Protocol Violation|0
925840|NCT00950807|3052396|P1|Treatment Period 1|Protocol Violation|1
925841|NCT00950807|3052387|P10|Treatment Period 1|Lack of Efficacy|0
925842|NCT00950807|3052388|P9|Treatment Period 1|Lack of Efficacy|0
925843|NCT00950807|3052389|P8|Treatment Period 1|Lack of Efficacy|0
925844|NCT00950807|3052390|P7|Treatment Period 1|Lack of Efficacy|0
925845|NCT00950807|3052391|P6|Treatment Period 1|Lack of Efficacy|1
925846|NCT00950807|3052392|P5|Treatment Period 1|Lack of Efficacy|0
925847|NCT00950807|3052393|P4|Treatment Period 1|Lack of Efficacy|0
925848|NCT00950807|3052394|P3|Treatment Period 1|Lack of Efficacy|0
925849|NCT00950807|3052395|P2|Treatment Period 1|Lack of Efficacy|0
925850|NCT00950807|3052396|P1|Treatment Period 1|Lack of Efficacy|1
925851|NCT00950755|3052438|P1|Long-Term Follow-Up|Death|8
925852|NCT00950755|3052438|P1|Long-Term Follow-Up|Lost to Follow-up|1
925853|NCT00950755|3052438|P1|Dosimetric and Therapeutic Treatment|Investigator Discretion|1
925854|NCT00950755|3052438|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6
925855|NCT00950755|3052438|P1|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1
925856|NCT00950755|3052438|P1|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1
925857|NCT00950755|3052438|P1|Dosimetric and Therapeutic Treatment|Death|1
925858|NCT00950755|3052438|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|27
925859|NCT00950755|3052438|P1|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1
925860|NCT00950755|3052438|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
925861|NCT00950742|3052464|P2|Overall Study|Dose limiting toxicity|0
925862|NCT00950742|3052465|P1|Overall Study|Dose limiting toxicity|6
925863|NCT00950742|3052464|P2|Overall Study|Progressive Disease|2
925864|NCT00950742|3052465|P1|Overall Study|Progressive Disease|6
925865|NCT00950742|3052464|P2|Overall Study|Withdrawal by Subject|0
925866|NCT00950742|3052465|P1|Overall Study|Withdrawal by Subject|3
925867|NCT00950742|3052464|P2|Overall Study|Other Adverse Event|0
925868|NCT00950742|3052465|P1|Overall Study|Other Adverse Event|1
925869|NCT00950690|3052486|P1|Overall Study|Other|163
925870|NCT00950690|3052486|P1|Overall Study|Lost to Follow-up|40
925871|NCT00950690|3052486|P1|Overall Study|Lack of Efficacy|22
925872|NCT00950690|3052486|P1|Overall Study|Adverse Event|15
925873|NCT00950690|3052486|P1|Overall Study|Death|4
925874|NCT00950664|3052493|P2|First Intervention|Withdrawal by Subject|2
925875|NCT00950664|3052494|P1|First Intervention|Withdrawal by Subject|2
925876|NCT00950664|3052493|P2|First Intervention|Lost to Follow-up|3
925877|NCT00950664|3052494|P1|First Intervention|Lost to Follow-up|1
925878|NCT00950651|3052514|P2|Overall Study|Withdrawal by Subject|9
925879|NCT00950651|3052515|P1|Overall Study|Withdrawal by Subject|8
925880|NCT00950651|3052514|P2|Overall Study|Protocol Violation|4
925881|NCT00950651|3052515|P1|Overall Study|Protocol Violation|3
925882|NCT00950651|3052514|P2|Overall Study|Lack of Efficacy|2
925883|NCT00950651|3052515|P1|Overall Study|Lack of Efficacy|2
925884|NCT00950651|3052514|P2|Overall Study|Death|0
925885|NCT00950651|3052515|P1|Overall Study|Death|1
925886|NCT00950651|3052514|P2|Overall Study|Adverse Event|20
925887|NCT00950651|3052515|P1|Overall Study|Adverse Event|17
925888|NCT00950599|3052608|P10|Follow-Up Period|Subject withdrew Consent|1
925889|NCT00950599|3052609|P9|Follow-Up Period|Subject withdrew Consent|2
925890|NCT00950599|3052610|P8|Follow-Up Period|Subject withdrew Consent|0
925891|NCT00950599|3052611|P7|Follow-Up Period|Subject withdrew Consent|0
925892|NCT00950599|3052612|P6|Follow-Up Period|Subject withdrew Consent|0
931745|NCT00906399|3071568|P3|Year 1|Death|1
925893|NCT00950599|3052613|P5|Follow-Up Period|Subject withdrew Consent|0
925894|NCT00950599|3052614|P4|Follow-Up Period|Subject withdrew Consent|0
925895|NCT00950599|3052615|P3|Follow-Up Period|Subject withdrew Consent|0
925896|NCT00950599|3052616|P2|Follow-Up Period|Subject withdrew Consent|0
925897|NCT00950599|3052617|P1|Follow-Up Period|Subject withdrew Consent|0
925898|NCT00950599|3052608|P10|Follow-Up Period|Poor/Noncompliance|0
925899|NCT00950599|3052609|P9|Follow-Up Period|Poor/Noncompliance|1
925900|NCT00950599|3052610|P8|Follow-Up Period|Poor/Noncompliance|0
925901|NCT00950599|3052611|P7|Follow-Up Period|Poor/Noncompliance|0
925902|NCT00950599|3052612|P6|Follow-Up Period|Poor/Noncompliance|0
925903|NCT00950599|3052613|P5|Follow-Up Period|Poor/Noncompliance|0
925904|NCT00950599|3052614|P4|Follow-Up Period|Poor/Noncompliance|0
925905|NCT00950599|3052615|P3|Follow-Up Period|Poor/Noncompliance|0
925906|NCT00950599|3052616|P2|Follow-Up Period|Poor/Noncompliance|0
925907|NCT00950599|3052617|P1|Follow-Up Period|Poor/Noncompliance|0
925908|NCT00950599|3052608|P10|Follow-Up Period|Physician Decision|0
925909|NCT00950599|3052609|P9|Follow-Up Period|Physician Decision|1
925910|NCT00950599|3052610|P8|Follow-Up Period|Physician Decision|0
925911|NCT00950599|3052611|P7|Follow-Up Period|Physician Decision|0
925912|NCT00950599|3052612|P6|Follow-Up Period|Physician Decision|0
925913|NCT00950599|3052613|P5|Follow-Up Period|Physician Decision|0
925914|NCT00950599|3052614|P4|Follow-Up Period|Physician Decision|0
925915|NCT00950599|3052615|P3|Follow-Up Period|Physician Decision|0
925916|NCT00950599|3052616|P2|Follow-Up Period|Physician Decision|0
925917|NCT00950599|3052617|P1|Follow-Up Period|Physician Decision|0
925918|NCT00950599|3052608|P10|Follow-Up Period|Lost to Follow-up|1
925919|NCT00950599|3052609|P9|Follow-Up Period|Lost to Follow-up|5
925920|NCT00950599|3052610|P8|Follow-Up Period|Lost to Follow-up|0
925921|NCT00950599|3052611|P7|Follow-Up Period|Lost to Follow-up|0
925922|NCT00950599|3052612|P6|Follow-Up Period|Lost to Follow-up|0
925923|NCT00950599|3052613|P5|Follow-Up Period|Lost to Follow-up|0
925924|NCT00950599|3052614|P4|Follow-Up Period|Lost to Follow-up|0
925925|NCT00950599|3052615|P3|Follow-Up Period|Lost to Follow-up|0
925926|NCT00950599|3052616|P2|Follow-Up Period|Lost to Follow-up|0
925927|NCT00950599|3052617|P1|Follow-Up Period|Lost to Follow-up|0
925928|NCT00950599|3052608|P10|Follow-Up Period|Lack of Efficacy|0
925929|NCT00950599|3052609|P9|Follow-Up Period|Lack of Efficacy|3
925930|NCT00950599|3052610|P8|Follow-Up Period|Lack of Efficacy|0
925931|NCT00950599|3052611|P7|Follow-Up Period|Lack of Efficacy|0
925932|NCT00950599|3052612|P6|Follow-Up Period|Lack of Efficacy|0
925933|NCT00950599|3052613|P5|Follow-Up Period|Lack of Efficacy|0
925934|NCT00950599|3052614|P4|Follow-Up Period|Lack of Efficacy|0
925935|NCT00950599|3052615|P3|Follow-Up Period|Lack of Efficacy|0
925936|NCT00950599|3052616|P2|Follow-Up Period|Lack of Efficacy|0
925937|NCT00950599|3052617|P1|Follow-Up Period|Lack of Efficacy|0
925938|NCT00950599|3052608|P10|Follow-Up Period|Adverse Event|0
925939|NCT00950599|3052609|P9|Follow-Up Period|Adverse Event|1
925940|NCT00950599|3052610|P8|Follow-Up Period|Adverse Event|0
925941|NCT00950599|3052611|P7|Follow-Up Period|Adverse Event|0
925942|NCT00950599|3052612|P6|Follow-Up Period|Adverse Event|0
925943|NCT00950599|3052613|P5|Follow-Up Period|Adverse Event|0
925944|NCT00950599|3052614|P4|Follow-Up Period|Adverse Event|0
925945|NCT00950599|3052615|P3|Follow-Up Period|Adverse Event|0
925946|NCT00950599|3052616|P2|Follow-Up Period|Adverse Event|0
925947|NCT00950599|3052617|P1|Follow-Up Period|Adverse Event|0
925948|NCT00950599|3052608|P10|Double-Blind Treatment Period|Subject Withdrew consent|0
925949|NCT00950599|3052609|P9|Double-Blind Treatment Period|Subject Withdrew consent|0
925950|NCT00950599|3052610|P8|Double-Blind Treatment Period|Subject Withdrew consent|3
925951|NCT00950599|3052611|P7|Double-Blind Treatment Period|Subject Withdrew consent|0
925952|NCT00950599|3052612|P6|Double-Blind Treatment Period|Subject Withdrew consent|2
925953|NCT00950599|3052613|P5|Double-Blind Treatment Period|Subject Withdrew consent|1
925954|NCT00950599|3052614|P4|Double-Blind Treatment Period|Subject Withdrew consent|1
925955|NCT00950599|3052615|P3|Double-Blind Treatment Period|Subject Withdrew consent|3
925956|NCT00950599|3052616|P2|Double-Blind Treatment Period|Subject Withdrew consent|3
925957|NCT00950599|3052617|P1|Double-Blind Treatment Period|Subject Withdrew consent|4
925958|NCT00950599|3052608|P10|Double-Blind Treatment Period|Subject no longer meets study criteria|0
925959|NCT00950599|3052609|P9|Double-Blind Treatment Period|Subject no longer meets study criteria|0
925960|NCT00950599|3052610|P8|Double-Blind Treatment Period|Subject no longer meets study criteria|0
925961|NCT00950599|3052611|P7|Double-Blind Treatment Period|Subject no longer meets study criteria|0
925962|NCT00950599|3052612|P6|Double-Blind Treatment Period|Subject no longer meets study criteria|1
925963|NCT00950599|3052613|P5|Double-Blind Treatment Period|Subject no longer meets study criteria|1
925964|NCT00950599|3052614|P4|Double-Blind Treatment Period|Subject no longer meets study criteria|0
925965|NCT00950599|3052615|P3|Double-Blind Treatment Period|Subject no longer meets study criteria|0
925966|NCT00950599|3052616|P2|Double-Blind Treatment Period|Subject no longer meets study criteria|0
925967|NCT00950599|3052617|P1|Double-Blind Treatment Period|Subject no longer meets study criteria|0
925968|NCT00950599|3052608|P10|Double-Blind Treatment Period|Poor/Noncompliance|0
925969|NCT00950599|3052609|P9|Double-Blind Treatment Period|Poor/Noncompliance|0
925970|NCT00950599|3052610|P8|Double-Blind Treatment Period|Poor/Noncompliance|1
925971|NCT00950599|3052611|P7|Double-Blind Treatment Period|Poor/Noncompliance|0
925972|NCT00950599|3052612|P6|Double-Blind Treatment Period|Poor/Noncompliance|0
925973|NCT00950599|3052613|P5|Double-Blind Treatment Period|Poor/Noncompliance|0
925974|NCT00950599|3052614|P4|Double-Blind Treatment Period|Poor/Noncompliance|0
925975|NCT00950599|3052615|P3|Double-Blind Treatment Period|Poor/Noncompliance|0
925976|NCT00950599|3052616|P2|Double-Blind Treatment Period|Poor/Noncompliance|1
925977|NCT00950599|3052617|P1|Double-Blind Treatment Period|Poor/Noncompliance|1
925978|NCT00950599|3052608|P10|Double-Blind Treatment Period|Lost to Follow-up|0
925979|NCT00950599|3052609|P9|Double-Blind Treatment Period|Lost to Follow-up|0
925980|NCT00950599|3052610|P8|Double-Blind Treatment Period|Lost to Follow-up|1
925981|NCT00950599|3052611|P7|Double-Blind Treatment Period|Lost to Follow-up|0
925982|NCT00950599|3052612|P6|Double-Blind Treatment Period|Lost to Follow-up|2
925983|NCT00950599|3052613|P5|Double-Blind Treatment Period|Lost to Follow-up|1
925984|NCT00950599|3052614|P4|Double-Blind Treatment Period|Lost to Follow-up|1
925985|NCT00950599|3052615|P3|Double-Blind Treatment Period|Lost to Follow-up|0
925986|NCT00950599|3052616|P2|Double-Blind Treatment Period|Lost to Follow-up|0
925987|NCT00950599|3052617|P1|Double-Blind Treatment Period|Lost to Follow-up|0
925988|NCT00950599|3052608|P10|Double-Blind Treatment Period|Lack of Efficacy|0
925989|NCT00950599|3052609|P9|Double-Blind Treatment Period|Lack of Efficacy|0
925990|NCT00950599|3052610|P8|Double-Blind Treatment Period|Lack of Efficacy|1
925991|NCT00950599|3052611|P7|Double-Blind Treatment Period|Lack of Efficacy|0
925992|NCT00950599|3052612|P6|Double-Blind Treatment Period|Lack of Efficacy|6
925993|NCT00950599|3052613|P5|Double-Blind Treatment Period|Lack of Efficacy|3
925994|NCT00950599|3052614|P4|Double-Blind Treatment Period|Lack of Efficacy|7
925995|NCT00950599|3052615|P3|Double-Blind Treatment Period|Lack of Efficacy|5
925996|NCT00950599|3052616|P2|Double-Blind Treatment Period|Lack of Efficacy|5
925997|NCT00950599|3052617|P1|Double-Blind Treatment Period|Lack of Efficacy|2
925998|NCT00950599|3052608|P10|Double-Blind Treatment Period|Adverse Event|0
925999|NCT00950599|3052609|P9|Double-Blind Treatment Period|Adverse Event|0
926000|NCT00950599|3052610|P8|Double-Blind Treatment Period|Adverse Event|0
926001|NCT00950599|3052611|P7|Double-Blind Treatment Period|Adverse Event|0
926002|NCT00950599|3052612|P6|Double-Blind Treatment Period|Adverse Event|1
926003|NCT00950599|3052613|P5|Double-Blind Treatment Period|Adverse Event|1
926004|NCT00950599|3052614|P4|Double-Blind Treatment Period|Adverse Event|1
926005|NCT00950599|3052615|P3|Double-Blind Treatment Period|Adverse Event|1
926006|NCT00950599|3052616|P2|Double-Blind Treatment Period|Adverse Event|1
926007|NCT00950599|3052617|P1|Double-Blind Treatment Period|Adverse Event|0
926008|NCT00950599|3052608|P10|Double-Blind Treatment Period|Administrative reason by sponsor|0
926009|NCT00950599|3052609|P9|Double-Blind Treatment Period|Administrative reason by sponsor|0
926010|NCT00950599|3052610|P8|Double-Blind Treatment Period|Administrative reason by sponsor|0
926011|NCT00950599|3052611|P7|Double-Blind Treatment Period|Administrative reason by sponsor|0
926012|NCT00950599|3052612|P6|Double-Blind Treatment Period|Administrative reason by sponsor|0
926013|NCT00950599|3052613|P5|Double-Blind Treatment Period|Administrative reason by sponsor|0
926014|NCT00950599|3052614|P4|Double-Blind Treatment Period|Administrative reason by sponsor|1
926015|NCT00950599|3052615|P3|Double-Blind Treatment Period|Administrative reason by sponsor|0
926016|NCT00950599|3052616|P2|Double-Blind Treatment Period|Administrative reason by sponsor|0
926017|NCT00950599|3052617|P1|Double-Blind Treatment Period|Administrative reason by sponsor|0
926018|NCT00950300|3053190|P2|SFU Period|Withdrawal by Subject|8
926019|NCT00950300|3053191|P1|SFU Period|Withdrawal by Subject|4
926020|NCT00950300|3053190|P2|SFU Period|Lost to Follow-up|28
926021|NCT00950300|3053191|P1|SFU Period|Lost to Follow-up|30
926022|NCT00950300|3053190|P2|SFU Period|Death|42
926023|NCT00950300|3053191|P1|SFU Period|Death|44
926024|NCT00950300|3053190|P2|TFFU Period|Not Specified|3
926025|NCT00950300|3053191|P1|TFFU Period|Not Specified|4
926026|NCT00950300|3053190|P2|TFFU Period|Recurrence of Disease|72
926027|NCT00950300|3053191|P1|TFFU Period|Recurrence of Disease|63
926028|NCT00950300|3053190|P2|TFFU Period|Failure to Return|16
926029|NCT00950300|3053191|P1|TFFU Period|Failure to Return|16
926030|NCT00950300|3053190|P2|TFFU Period|Refused Treatment|11
926031|NCT00950300|3053191|P1|TFFU Period|Refused Treatment|10
926032|NCT00950300|3053190|P2|TFFU Period|Death|1
926033|NCT00950300|3053191|P1|TFFU Period|Death|4
926034|NCT00950300|3053190|P2|TFFU Period|Adverse Event or Intercurrent Illness|4
926035|NCT00950300|3053191|P1|TFFU Period|Adverse Event or Intercurrent Illness|3
926036|NCT00950300|3053190|P2|Neoadjuvant/Adjuvant Treatment Periods|Not Specified|1
926037|NCT00950300|3053191|P1|Neoadjuvant/Adjuvant Treatment Periods|Not Specified|1
926038|NCT00950300|3053190|P2|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5
926039|NCT00950300|3053191|P1|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10
926040|NCT00950300|3053190|P2|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11
926041|NCT00950300|3053191|P1|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12
926042|NCT00950300|3053190|P2|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1
926043|NCT00950300|3053191|P1|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2
926044|NCT00950300|3053190|P2|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5
926045|NCT00950300|3053191|P1|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4
926046|NCT00950300|3053190|P2|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0
926047|NCT00950300|3053191|P1|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1
926048|NCT00950300|3053190|P2|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1
926049|NCT00950300|3053191|P1|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2
926050|NCT00950300|3053190|P2|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0
926051|NCT00950300|3053191|P1|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3
926052|NCT00950300|3053190|P2|Neoadjuvant/Adjuvant Treatment Periods|Death|3
926053|NCT00950300|3053191|P1|Neoadjuvant/Adjuvant Treatment Periods|Death|1
926054|NCT00950300|3053190|P2|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15
926055|NCT00950300|3053191|P1|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6
926056|NCT00949975|3053263|P4|Overall Study|Other|0
926057|NCT00949975|3053264|P3|Overall Study|Other|0
926058|NCT00949975|3053265|P2|Overall Study|Other|0
926059|NCT00949975|3053266|P1|Overall Study|Other|1
926060|NCT00949975|3053263|P4|Overall Study|Lost to Follow-up|3
926061|NCT00949975|3053264|P3|Overall Study|Lost to Follow-up|1
926062|NCT00949975|3053265|P2|Overall Study|Lost to Follow-up|0
926063|NCT00949975|3053266|P1|Overall Study|Lost to Follow-up|1
926064|NCT00949975|3053263|P4|Overall Study|Severe non-compliance|2
926065|NCT00949975|3053264|P3|Overall Study|Severe non-compliance|0
926066|NCT00949975|3053265|P2|Overall Study|Severe non-compliance|1
926067|NCT00949975|3053266|P1|Overall Study|Severe non-compliance|3
926068|NCT00949975|3053263|P4|Overall Study|Incorrect enrolment|7
926069|NCT00949975|3053264|P3|Overall Study|Incorrect enrolment|4
926070|NCT00949975|3053265|P2|Overall Study|Incorrect enrolment|10
926071|NCT00949975|3053266|P1|Overall Study|Incorrect enrolment|5
926072|NCT00949975|3053263|P4|Overall Study|Study-specific criteria|0
926073|NCT00949975|3053264|P3|Overall Study|Study-specific criteria|1
926074|NCT00949975|3053265|P2|Overall Study|Study-specific criteria|1
926075|NCT00949975|3053266|P1|Overall Study|Study-specific criteria|0
926076|NCT00949975|3053263|P4|Overall Study|Safety reason|0
926077|NCT00949975|3053264|P3|Overall Study|Safety reason|0
926078|NCT00949975|3053265|P2|Overall Study|Safety reason|1
926079|NCT00949975|3053266|P1|Overall Study|Safety reason|0
926080|NCT00949975|3053263|P4|Overall Study|Adverse Event|10
926081|NCT00949975|3053264|P3|Overall Study|Adverse Event|10
926082|NCT00949975|3053265|P2|Overall Study|Adverse Event|11
926083|NCT00949975|3053266|P1|Overall Study|Adverse Event|11
926084|NCT00949975|3053263|P4|Overall Study|Voluntary discontinuation|6
926085|NCT00949975|3053264|P3|Overall Study|Voluntary discontinuation|3
926086|NCT00949975|3053265|P2|Overall Study|Voluntary discontinuation|5
926087|NCT00949975|3053266|P1|Overall Study|Voluntary discontinuation|6
926088|NCT00949910|3053384|P1|Overall Study|No Data|9
926089|NCT00949910|3053384|P1|Overall Study|Other|4
926090|NCT00949910|3053384|P1|Overall Study|Physician/Participant Decision|7
926091|NCT00949910|3053384|P1|Overall Study|Serious Adverse Event|6
926092|NCT00949910|3053384|P1|Overall Study|Adverse Event|83
926093|NCT00949910|3053384|P1|Overall Study|Prolonged Dosing Interruption|4
926094|NCT00949910|3053384|P1|Overall Study|Non-Compliance|10
926095|NCT00949910|3053384|P1|Overall Study|Logistical Reasons|13
926096|NCT00949910|3053384|P1|Overall Study|Violation of Eligibility|23
926097|NCT00949910|3053384|P1|Overall Study|Switched to Commercial Treatment|4
926098|NCT00949910|3053384|P1|Overall Study|Switched to Compassionate/Other Use|174
926099|NCT00949910|3053384|P1|Overall Study|Unspecified Progression/Deterioration|13
926100|NCT00949910|3053384|P1|Overall Study|Death from Unknown Cause|5
926101|NCT00949910|3053384|P1|Overall Study|Death Due to Toxicity|3
926102|NCT00949910|3053384|P1|Overall Study|Death Due to Adverse Event|115
926103|NCT00949910|3053384|P1|Overall Study|Death Due to Progression/Deterioration|4
926104|NCT00949910|3053384|P1|Overall Study|Death Due to Malignant Disease|456
926105|NCT00949910|3053384|P1|Overall Study|Participant Refusal|390
926106|NCT00949910|3053384|P1|Overall Study|Study Drug-Related Adverse Event|315
926107|NCT00949910|3053384|P1|Overall Study|Lost to Follow-up|100
926108|NCT00949910|3053384|P1|Overall Study|Symptomatic Deterioration|1088
926109|NCT00949910|3053384|P1|Overall Study|Progressive Disease|3750
926110|NCT00949884|3053397|P3|Overall Study|Study terminated by sponsor|1
926111|NCT00949884|3053398|P2|Overall Study|Study terminated by sponsor|0
926112|NCT00949884|3053399|P1|Overall Study|Study terminated by sponsor|0
926113|NCT00949884|3053397|P3|Overall Study|Lack of Efficacy|7
926114|NCT00949884|3053398|P2|Overall Study|Lack of Efficacy|2
926115|NCT00949884|3053399|P1|Overall Study|Lack of Efficacy|4
926116|NCT00949884|3053397|P3|Overall Study|Withdrawal by Subject|16
926117|NCT00949884|3053398|P2|Overall Study|Withdrawal by Subject|4
926118|NCT00949884|3053399|P1|Overall Study|Withdrawal by Subject|13
926119|NCT00949884|3053397|P3|Overall Study|Treatment non-compliance|8
926120|NCT00949884|3053398|P2|Overall Study|Treatment non-compliance|0
926121|NCT00949884|3053399|P1|Overall Study|Treatment non-compliance|5
926122|NCT00949884|3053397|P3|Overall Study|Physician Decision|6
926123|NCT00949884|3053398|P2|Overall Study|Physician Decision|0
926124|NCT00949884|3053399|P1|Overall Study|Physician Decision|5
926125|NCT00949884|3053397|P3|Overall Study|Lost to Follow-up|5
926126|NCT00949884|3053398|P2|Overall Study|Lost to Follow-up|5
926127|NCT00949884|3053399|P1|Overall Study|Lost to Follow-up|7
926128|NCT00949884|3053397|P3|Overall Study|Did not meet inclusion/exclusion|3
926129|NCT00949884|3053398|P2|Overall Study|Did not meet inclusion/exclusion|1
926130|NCT00949884|3053399|P1|Overall Study|Did not meet inclusion/exclusion|2
926131|NCT00949884|3053397|P3|Overall Study|Adverse Event|12
926132|NCT00949884|3053398|P2|Overall Study|Adverse Event|3
926133|NCT00949884|3053399|P1|Overall Study|Adverse Event|14
926134|NCT00949715|3053454|P2|Overall Study|Missing 24 month LVEF measurement|0
926135|NCT00949715|3053455|P1|Overall Study|Missing 24 month LVEF measurement|2
926136|NCT00949715|3053454|P2|Overall Study|Lost to Follow-up|0
926137|NCT00949715|3053455|P1|Overall Study|Lost to Follow-up|1
926138|NCT00949715|3053454|P2|Overall Study|Physician Decision|0
926139|NCT00949715|3053455|P1|Overall Study|Physician Decision|1
926140|NCT00949702|3053466|P1|Overall Study|Withdrawal of consent|1
926141|NCT00949702|3053466|P1|Overall Study|Disease progression|7
926142|NCT00949702|3053466|P1|Overall Study|Death|40
926143|NCT00949650|3053483|P2|Overall Study|Other not specified above|0
926144|NCT00949650|3053484|P1|Overall Study|Other not specified above|5
926145|NCT00949650|3053483|P2|Overall Study|Not treated|4
926146|NCT00949650|3053484|P1|Overall Study|Not treated|1
926147|NCT00949650|3053483|P2|Overall Study|Refusal to continue medication|11
926148|NCT00949650|3053484|P1|Overall Study|Refusal to continue medication|7
926149|NCT00949650|3053483|P2|Overall Study|Protocol Violation|4
926150|NCT00949650|3053484|P1|Overall Study|Protocol Violation|1
926151|NCT00949650|3053483|P2|Overall Study|Other Adverse Event (AE)|17
926152|NCT00949650|3053484|P1|Overall Study|Other Adverse Event (AE)|28
926153|NCT00949650|3053483|P2|Overall Study|Completed 6 courses of chemotherapy|60
926154|NCT00949650|3053484|P1|Overall Study|Completed 6 courses of chemotherapy|0
926155|NCT00949650|3053483|P2|Overall Study|Progressive disease|19
926156|NCT00949650|3053484|P1|Overall Study|Progressive disease|188
926157|NCT00949533|3053522|P2|Overall Study|Lost to Follow-up|1
926158|NCT00949533|3053523|P1|Overall Study|Lost to Follow-up|0
926159|NCT00949117|3053541|P2|Overall Study|Adverse Event|1
926160|NCT00949117|3053542|P1|Overall Study|Adverse Event|0
926161|NCT00949117|3053541|P2|Overall Study|Protocol Violation|1
926162|NCT00949117|3053542|P1|Overall Study|Protocol Violation|1
926163|NCT00949117|3053541|P2|Overall Study|Lack of Efficacy|3
926164|NCT00949117|3053542|P1|Overall Study|Lack of Efficacy|2
926165|NCT00948974|3053583|P2|Overall Study|Lost to Follow-up|20
926166|NCT00948974|3053584|P1|Overall Study|Lost to Follow-up|23
926167|NCT00948922|3053597|P3|Overall Study|Not evaluable at time of analysis|0
926168|NCT00948922|3053598|P2|Overall Study|Not evaluable at time of analysis|3
926169|NCT00948922|3053599|P1|Overall Study|Not evaluable at time of analysis|0
926170|NCT00948922|3053597|P3|Overall Study|Transplant eligibility issues|0
926171|NCT00948922|3053598|P2|Overall Study|Transplant eligibility issues|3
926172|NCT00948922|3053599|P1|Overall Study|Transplant eligibility issues|2
926173|NCT00948922|3053597|P3|Overall Study|Insurance issues|0
926174|NCT00948922|3053598|P2|Overall Study|Insurance issues|0
926175|NCT00948922|3053599|P1|Overall Study|Insurance issues|1
926176|NCT00948922|3053597|P3|Overall Study|Disease progression|0
926177|NCT00948922|3053598|P2|Overall Study|Disease progression|1
926178|NCT00948922|3053599|P1|Overall Study|Disease progression|0
926179|NCT00948922|3053597|P3|Overall Study|Death|0
926180|NCT00948922|3053598|P2|Overall Study|Death|0
926181|NCT00948922|3053599|P1|Overall Study|Death|3
926182|NCT00948922|3053597|P3|Overall Study|Adverse Event|2
926183|NCT00948922|3053598|P2|Overall Study|Adverse Event|0
926184|NCT00948922|3053599|P1|Overall Study|Adverse Event|0
926185|NCT00948922|3053597|P3|Overall Study|Withdrawal by Subject|2
926186|NCT00948922|3053598|P2|Overall Study|Withdrawal by Subject|0
926187|NCT00948922|3053599|P1|Overall Study|Withdrawal by Subject|0
926188|NCT00948922|3053597|P3|Overall Study|Did not start study treatment|0
926189|NCT00948922|3053598|P2|Overall Study|Did not start study treatment|5
926190|NCT00948922|3053599|P1|Overall Study|Did not start study treatment|2
926191|NCT00948896|3053615|P8|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
926192|NCT00948896|3053616|P7|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
926193|NCT00948896|3053617|P6|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
926194|NCT00948896|3053618|P5|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
926195|NCT00948896|3053619|P4|24 Months of Age to 36 Months of Age|Moved out of Study Area|1
926196|NCT00948896|3053620|P3|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
926197|NCT00948896|3053621|P2|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
926198|NCT00948896|3053622|P1|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
926199|NCT00948896|3053615|P8|24 Months of Age to 36 Months of Age|Protocol Violation|0
926200|NCT00948896|3053616|P7|24 Months of Age to 36 Months of Age|Protocol Violation|0
926201|NCT00948896|3053617|P6|24 Months of Age to 36 Months of Age|Protocol Violation|1
926202|NCT00948896|3053618|P5|24 Months of Age to 36 Months of Age|Protocol Violation|0
926203|NCT00948896|3053619|P4|24 Months of Age to 36 Months of Age|Protocol Violation|0
926204|NCT00948896|3053620|P3|24 Months of Age to 36 Months of Age|Protocol Violation|1
926205|NCT00948896|3053621|P2|24 Months of Age to 36 Months of Age|Protocol Violation|0
926206|NCT00948896|3053622|P1|24 Months of Age to 36 Months of Age|Protocol Violation|0
926207|NCT00948896|3053615|P8|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
926208|NCT00948896|3053616|P7|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
926209|NCT00948896|3053617|P6|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
926210|NCT00948896|3053618|P5|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
926211|NCT00948896|3053619|P4|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
926212|NCT00948896|3053620|P3|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
926213|NCT00948896|3053621|P2|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
926214|NCT00948896|3053622|P1|24 Months of Age to 36 Months of Age|Lost to Follow-up|2
926215|NCT00948896|3053615|P8|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
926216|NCT00948896|3053616|P7|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
926217|NCT00948896|3053617|P6|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
926218|NCT00948896|3053618|P5|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
926219|NCT00948896|3053619|P4|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
926220|NCT00948896|3053620|P3|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
926221|NCT00948896|3053621|P2|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
926222|NCT00948896|3053622|P1|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
926223|NCT00948896|3053615|P8|24 Months of Age to 36 Months of Age|Death|0
926224|NCT00948896|3053616|P7|24 Months of Age to 36 Months of Age|Death|0
926225|NCT00948896|3053617|P6|24 Months of Age to 36 Months of Age|Death|1
926226|NCT00948896|3053618|P5|24 Months of Age to 36 Months of Age|Death|0
926227|NCT00948896|3053619|P4|24 Months of Age to 36 Months of Age|Death|0
926228|NCT00948896|3053620|P3|24 Months of Age to 36 Months of Age|Death|2
926229|NCT00948896|3053621|P2|24 Months of Age to 36 Months of Age|Death|2
926230|NCT00948896|3053622|P1|24 Months of Age to 36 Months of Age|Death|0
926231|NCT00948896|3053615|P8|Randomization to 24 Months of Age|Moved out of Study Area|0
926232|NCT00948896|3053616|P7|Randomization to 24 Months of Age|Moved out of Study Area|0
926233|NCT00948896|3053617|P6|Randomization to 24 Months of Age|Moved out of Study Area|2
926234|NCT00948896|3053618|P5|Randomization to 24 Months of Age|Moved out of Study Area|0
926235|NCT00948896|3053619|P4|Randomization to 24 Months of Age|Moved out of Study Area|1
926236|NCT00948896|3053620|P3|Randomization to 24 Months of Age|Moved out of Study Area|3
926237|NCT00948896|3053621|P2|Randomization to 24 Months of Age|Moved out of Study Area|3
926238|NCT00948896|3053622|P1|Randomization to 24 Months of Age|Moved out of Study Area|0
926239|NCT00948896|3053615|P8|Randomization to 24 Months of Age|Protocol Violation|1
926240|NCT00948896|3053616|P7|Randomization to 24 Months of Age|Protocol Violation|1
926241|NCT00948896|3053617|P6|Randomization to 24 Months of Age|Protocol Violation|0
926242|NCT00948896|3053618|P5|Randomization to 24 Months of Age|Protocol Violation|0
926243|NCT00948896|3053619|P4|Randomization to 24 Months of Age|Protocol Violation|1
926244|NCT00948896|3053620|P3|Randomization to 24 Months of Age|Protocol Violation|0
926245|NCT00948896|3053621|P2|Randomization to 24 Months of Age|Protocol Violation|1
926246|NCT00948896|3053622|P1|Randomization to 24 Months of Age|Protocol Violation|0
926247|NCT00948896|3053615|P8|Randomization to 24 Months of Age|Lost to Follow-up|0
926248|NCT00948896|3053616|P7|Randomization to 24 Months of Age|Lost to Follow-up|1
926249|NCT00948896|3053617|P6|Randomization to 24 Months of Age|Lost to Follow-up|0
926250|NCT00948896|3053618|P5|Randomization to 24 Months of Age|Lost to Follow-up|0
926251|NCT00948896|3053619|P4|Randomization to 24 Months of Age|Lost to Follow-up|5
926252|NCT00948896|3053620|P3|Randomization to 24 Months of Age|Lost to Follow-up|2
926253|NCT00948896|3053621|P2|Randomization to 24 Months of Age|Lost to Follow-up|4
926254|NCT00948896|3053622|P1|Randomization to 24 Months of Age|Lost to Follow-up|4
926255|NCT00948896|3053615|P8|Randomization to 24 Months of Age|Withdrawal by Subject|0
926256|NCT00948896|3053616|P7|Randomization to 24 Months of Age|Withdrawal by Subject|0
926257|NCT00948896|3053617|P6|Randomization to 24 Months of Age|Withdrawal by Subject|1
926258|NCT00948896|3053618|P5|Randomization to 24 Months of Age|Withdrawal by Subject|0
926259|NCT00948896|3053619|P4|Randomization to 24 Months of Age|Withdrawal by Subject|4
926260|NCT00948896|3053620|P3|Randomization to 24 Months of Age|Withdrawal by Subject|4
926261|NCT00948896|3053621|P2|Randomization to 24 Months of Age|Withdrawal by Subject|5
926262|NCT00948896|3053622|P1|Randomization to 24 Months of Age|Withdrawal by Subject|3
926263|NCT00948896|3053615|P8|Randomization to 24 Months of Age|Death|1
926264|NCT00948896|3053616|P7|Randomization to 24 Months of Age|Death|2
926265|NCT00948896|3053617|P6|Randomization to 24 Months of Age|Death|1
926266|NCT00948896|3053618|P5|Randomization to 24 Months of Age|Death|2
926267|NCT00948896|3053619|P4|Randomization to 24 Months of Age|Death|0
926268|NCT00948896|3053620|P3|Randomization to 24 Months of Age|Death|0
926269|NCT00948896|3053621|P2|Randomization to 24 Months of Age|Death|0
926270|NCT00948896|3053622|P1|Randomization to 24 Months of Age|Death|1
926271|NCT00948857|3053658|P2|Overall Study|Lost to Follow-up|0
926272|NCT00948857|3053659|P1|Overall Study|Lost to Follow-up|1
926273|NCT00948818|3053667|P2|Overall Study|Other Reason|5
926274|NCT00948818|3053668|P1|Overall Study|Other Reason|4
926275|NCT00948818|3053667|P2|Overall Study|Lack of Efficacy|5
926276|NCT00948818|3053668|P1|Overall Study|Lack of Efficacy|4
926277|NCT00948818|3053667|P2|Overall Study|Lost to Follow-up|17
926278|NCT00948818|3053668|P1|Overall Study|Lost to Follow-up|10
926279|NCT00948818|3053667|P2|Overall Study|Withdrawal by Subject|25
926280|NCT00948818|3053668|P1|Overall Study|Withdrawal by Subject|25
926281|NCT00948818|3053667|P2|Overall Study|Protocol Violation|10
926282|NCT00948818|3053668|P1|Overall Study|Protocol Violation|9
926283|NCT00948818|3053667|P2|Overall Study|Adverse Event|32
926284|NCT00948818|3053668|P1|Overall Study|Adverse Event|10
926285|NCT00948766|3053715|P2|Extension Study|Death|0
926286|NCT00948766|3053716|P1|Extension Study|Death|4
926287|NCT00948766|3053715|P2|Extension Study|Administrative Problems|0
926288|NCT00948766|3053716|P1|Extension Study|Administrative Problems|1
926289|NCT00948766|3053715|P2|Extension Study|Lost to Follow-up|0
926290|NCT00948766|3053716|P1|Extension Study|Lost to Follow-up|8
926291|NCT00948766|3053715|P2|Extension Study|Patient Withdrew Consent|0
926292|NCT00948766|3053716|P1|Extension Study|Patient Withdrew Consent|32
926293|NCT00948766|3053715|P2|Extension Study|Study Drug No Longer Required|0
926294|NCT00948766|3053716|P1|Extension Study|Study Drug No Longer Required|1
926295|NCT00948766|3053715|P2|Extension Study|Unsatisfactory Therapeutic Effect|0
926296|NCT00948766|3053716|P1|Extension Study|Unsatisfactory Therapeutic Effect|2
926297|NCT00948766|3053715|P2|Extension Study|Adverse Event|0
926298|NCT00948766|3053716|P1|Extension Study|Adverse Event|43
926299|NCT00948766|3053715|P2|Core Study|Protocol Deviation|10
926300|NCT00948766|3053716|P1|Core Study|Protocol Deviation|8
926301|NCT00948766|3053715|P2|Core Study|Death|1
926302|NCT00948766|3053716|P1|Core Study|Death|1
926303|NCT00948766|3053715|P2|Core Study|Administrative Problems|2
926304|NCT00948766|3053716|P1|Core Study|Administrative Problems|2
926305|NCT00948766|3053715|P2|Core Study|Lost to Follow-up|2
926306|NCT00948766|3053716|P1|Core Study|Lost to Follow-up|3
926307|NCT00948766|3053715|P2|Core Study|Patient Withdrew Consent|46
926308|NCT00948766|3053716|P1|Core Study|Patient Withdrew Consent|27
926309|NCT00948766|3053715|P2|Core Study|Unsatisfactory Therapeutic Effect|14
926310|NCT00948766|3053716|P1|Core Study|Unsatisfactory Therapeutic Effect|13
926311|NCT00948766|3053715|P2|Core Study|Adverse Event|51
926312|NCT00948766|3053716|P1|Core Study|Adverse Event|73
926313|NCT00948688|3053732|P2|Period 2: 100 mg Vorinostat|Adverse Event|1
926314|NCT00948688|3053733|P1|Period 2: 100 mg Vorinostat|Adverse Event|0
926315|NCT00948688|3053732|P2|Period 1: 200 mg Vorinostat|Protocol Violation|0
926316|NCT00948688|3053733|P1|Period 1: 200 mg Vorinostat|Protocol Violation|1
926317|NCT00948688|3053732|P2|Period 1: 200 mg Vorinostat|Adverse Event|0
926318|NCT00948688|3053733|P1|Period 1: 200 mg Vorinostat|Adverse Event|1
926319|NCT00948675|3053747|P2|Overall Study|Treatment ongoing|4
926320|NCT00948675|3053748|P1|Overall Study|Treatment ongoing|5
926321|NCT00948675|3053747|P2|Overall Study|Lost to Follow-up|0
926322|NCT00948675|3053748|P1|Overall Study|Lost to Follow-up|2
926323|NCT00948506|3053775|P2|Overall Study|Withdrawal by Subject|1
926324|NCT00948506|3053776|P1|Overall Study|Withdrawal by Subject|3
926325|NCT00948441|3053787|P2|Overall Study|no longer meet inclusion criteria|4
926326|NCT00948441|3053788|P1|Overall Study|no longer meet inclusion criteria|1
926327|NCT00948389|3053801|P5|Overall Study|Both Progression and Toxicity|0
926328|NCT00948389|3053802|P4|Overall Study|Both Progression and Toxicity|0
926329|NCT00948389|3053803|P3|Overall Study|Both Progression and Toxicity|0
926330|NCT00948389|3053804|P2|Overall Study|Both Progression and Toxicity|0
926331|NCT00948389|3053805|P1|Overall Study|Both Progression and Toxicity|1
926332|NCT00948389|3053801|P5|Overall Study|Thrombocytopenia, Grade 4|0
926333|NCT00948389|3053802|P4|Overall Study|Thrombocytopenia, Grade 4|1
926334|NCT00948389|3053803|P3|Overall Study|Thrombocytopenia, Grade 4|0
926335|NCT00948389|3053804|P2|Overall Study|Thrombocytopenia, Grade 4|0
926336|NCT00948389|3053805|P1|Overall Study|Thrombocytopenia, Grade 4|2
926337|NCT00948389|3053801|P5|Overall Study|Disease Progression/Relapse/Death|1
926338|NCT00948389|3053802|P4|Overall Study|Disease Progression/Relapse/Death|8
926339|NCT00948389|3053803|P3|Overall Study|Disease Progression/Relapse/Death|7
926340|NCT00948389|3053804|P2|Overall Study|Disease Progression/Relapse/Death|3
926341|NCT00948389|3053805|P1|Overall Study|Disease Progression/Relapse/Death|3
926342|NCT00948246|3053853|P1|Overall Study|Withdrawal by Subject|1
926343|NCT00948246|3053853|P1|Overall Study|Death|1
926344|NCT00948246|3053853|P1|Overall Study|Adverse Event|11
926345|NCT00948246|3053853|P1|Overall Study|Lost to Follow-up|11
926346|NCT00948155|3053862|P2|Washout 14 Days|Lost to Follow-up|2
926347|NCT00948155|3053863|P1|Washout 14 Days|Lost to Follow-up|1
926348|NCT00948155|3053862|P2|First Intervention 21 Days|Lost to Follow-up|2
926349|NCT00948155|3053863|P1|First Intervention 21 Days|Lost to Follow-up|2
926350|NCT00948064|3053910|P3|Phase II|Withdrawal by Subject|0
926351|NCT00948064|3053911|P2|Phase II|Withdrawal by Subject|1
926352|NCT00948064|3053912|P1|Phase II|Withdrawal by Subject|0
926353|NCT00948064|3053910|P3|Phase II|Physician Decision|1
926354|NCT00948064|3053911|P2|Phase II|Physician Decision|0
926355|NCT00948064|3053912|P1|Phase II|Physician Decision|0
926356|NCT00948064|3053910|P3|Phase I|No treatment received|0
926357|NCT00948064|3053911|P2|Phase I|No treatment received|0
926358|NCT00948064|3053912|P1|Phase I|No treatment received|1
926359|NCT00947882|3053927|P4|Overall Study|Trial Terminated by Sponsor|70
926360|NCT00947882|3053928|P3|Overall Study|Trial Terminated by Sponsor|62
926361|NCT00947882|3053929|P2|Overall Study|Trial Terminated by Sponsor|61
926362|NCT00947882|3053930|P1|Overall Study|Trial Terminated by Sponsor|62
926363|NCT00947882|3053927|P4|Overall Study|Other/Unknown|6
926364|NCT00947882|3053928|P3|Overall Study|Other/Unknown|3
926365|NCT00947882|3053929|P2|Overall Study|Other/Unknown|13
926366|NCT00947882|3053930|P1|Overall Study|Other/Unknown|10
926367|NCT00947882|3053927|P4|Overall Study|Lost to Follow-up|0
926368|NCT00947882|3053928|P3|Overall Study|Lost to Follow-up|1
926369|NCT00947882|3053929|P2|Overall Study|Lost to Follow-up|2
926370|NCT00947882|3053930|P1|Overall Study|Lost to Follow-up|0
926371|NCT00947882|3053927|P4|Overall Study|Protocol Violation|0
926372|NCT00947882|3053928|P3|Overall Study|Protocol Violation|1
926373|NCT00947882|3053929|P2|Overall Study|Protocol Violation|0
926374|NCT00947882|3053930|P1|Overall Study|Protocol Violation|0
926375|NCT00947882|3053927|P4|Overall Study|Withdrawal by Subject|2
926376|NCT00947882|3053928|P3|Overall Study|Withdrawal by Subject|8
926377|NCT00947882|3053929|P2|Overall Study|Withdrawal by Subject|0
926378|NCT00947882|3053930|P1|Overall Study|Withdrawal by Subject|2
926379|NCT00947882|3053927|P4|Overall Study|Adverse Event|4
926380|NCT00947882|3053928|P3|Overall Study|Adverse Event|4
926381|NCT00947882|3053929|P2|Overall Study|Adverse Event|1
926382|NCT00947882|3053930|P1|Overall Study|Adverse Event|0
926383|NCT00947856|3053958|P2|Follow-up Period|Withdrawal by Subject|0
926384|NCT00947856|3053959|P1|Follow-up Period|Withdrawal by Subject|1
926385|NCT00947856|3053958|P2|Follow-up Period|Patient unavailable for site visits|0
926386|NCT00947856|3053959|P1|Follow-up Period|Patient unavailable for site visits|1
926387|NCT00947856|3053958|P2|Follow-up Period|Lost to Follow-up|0
926388|NCT00947856|3053959|P1|Follow-up Period|Lost to Follow-up|7
926389|NCT00947856|3053958|P2|Follow-up Period|Re-enrolled for Retreatment|3
926390|NCT00947856|3053959|P1|Follow-up Period|Re-enrolled for Retreatment|2
926391|NCT00947856|3053958|P2|Follow-up Period|Study Stopped by Sponsor|20
926392|NCT00947856|3053959|P1|Follow-up Period|Study Stopped by Sponsor|40
926393|NCT00947856|3053958|P2|Treatment Period|Withdrawal by Subject|1
926394|NCT00947856|3053959|P1|Treatment Period|Withdrawal by Subject|12
926395|NCT00947856|3053958|P2|Treatment Period|Study Stopped by Sponsor|4
926396|NCT00947856|3053959|P1|Treatment Period|Study Stopped by Sponsor|4
926397|NCT00947856|3053958|P2|Treatment Period|Physician Decision|6
926398|NCT00947856|3053959|P1|Treatment Period|Physician Decision|14
926399|NCT00947856|3053958|P2|Treatment Period|Adverse Event|9
926400|NCT00947856|3053959|P1|Treatment Period|Adverse Event|15
926401|NCT00947856|3053958|P2|Treatment Period|Progressive Disease|12
926402|NCT00947856|3053959|P1|Treatment Period|Progressive Disease|33
926403|NCT00947544|3054048|P2|Safety-Extension Period (12 Months)|Withdrawal by Subject|0
926404|NCT00947544|3054049|P1|Safety-Extension Period (12 Months)|Withdrawal by Subject|1
926405|NCT00947531|3054075|P2|Overall Study|Other|1
926406|NCT00947531|3054076|P1|Overall Study|Other|1
926407|NCT00947531|3054075|P2|Overall Study|Lack of Efficacy|0
926408|NCT00947531|3054076|P1|Overall Study|Lack of Efficacy|1
926409|NCT00947531|3054075|P2|Overall Study|Adverse Event|2
926410|NCT00947531|3054076|P1|Overall Study|Adverse Event|2
926411|NCT00947531|3054075|P2|Overall Study|Administrative Reason|1
926412|NCT00947531|3054076|P1|Overall Study|Administrative Reason|0
926413|NCT00947531|3054075|P2|Overall Study|Withdrawal by Subject|7
926414|NCT00947531|3054076|P1|Overall Study|Withdrawal by Subject|10
926415|NCT00947427|3054112|P2|Overall Study|Protocol Violation|1
926416|NCT00947427|3054113|P1|Overall Study|Protocol Violation|0
926417|NCT00947427|3054112|P2|Overall Study|Withdrawal by Subject|3
926418|NCT00947427|3054113|P1|Overall Study|Withdrawal by Subject|1
926419|NCT00947349|3054123|P4|Overall Study Standard of Care|not specified|1
926420|NCT00947349|3054124|P3|Overall Study Standard of Care|not specified|0
926421|NCT00947349|3054125|P2|Overall Study Standard of Care|not specified|0
926422|NCT00947349|3054126|P1|Overall Study Standard of Care|not specified|0
926423|NCT00947349|3054123|P4|Overall Study Standard of Care|Withdrawal by Subject|0
926424|NCT00947349|3054124|P3|Overall Study Standard of Care|Withdrawal by Subject|1
926425|NCT00947349|3054125|P2|Overall Study Standard of Care|Withdrawal by Subject|0
926426|NCT00947349|3054126|P1|Overall Study Standard of Care|Withdrawal by Subject|0
926427|NCT00947349|3054123|P4|Overall Study Standard of Care|Lack of Efficacy|1
926428|NCT00947349|3054124|P3|Overall Study Standard of Care|Lack of Efficacy|1
926429|NCT00947349|3054125|P2|Overall Study Standard of Care|Lack of Efficacy|0
926430|NCT00947349|3054126|P1|Overall Study Standard of Care|Lack of Efficacy|0
926431|NCT00947349|3054123|P4|Triple Treatment Combination Period|Adverse Event|0
926432|NCT00947349|3054124|P3|Triple Treatment Combination Period|Adverse Event|0
926433|NCT00947349|3054125|P2|Triple Treatment Combination Period|Adverse Event|1
926434|NCT00947349|3054126|P1|Triple Treatment Combination Period|Adverse Event|0
926435|NCT00947154|3054340|P1|Overall Study|Lost to Follow-up|1
926436|NCT00947115|3054350|P3|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|8
926437|NCT00947115|3054351|P2|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|12
926438|NCT00947115|3054352|P1|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|11
926439|NCT00947115|3054350|P3|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|4
926440|NCT00947115|3054351|P2|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|3
926441|NCT00947115|3054352|P1|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|1
926442|NCT00947115|3054350|P3|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|0
926443|NCT00947115|3054351|P2|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|0
926444|NCT00947115|3054352|P1|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|2
926445|NCT00947115|3054350|P3|Year 0 (Month 0) - Year 10 (Month 120)|Death|1
926446|NCT00947115|3054351|P2|Year 0 (Month 0) - Year 10 (Month 120)|Death|1
926447|NCT00947115|3054352|P1|Year 0 (Month 0) - Year 10 (Month 120)|Death|0
926448|NCT00947115|3054350|P3|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|0
926449|NCT00947115|3054351|P2|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|2
926450|NCT00947115|3054352|P1|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|0
926451|NCT00947115|3054350|P3|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|2
926452|NCT00947115|3054351|P2|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|4
926453|NCT00947115|3054352|P1|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|3
926454|NCT00947011|3054414|P1|Overall Study|Study was terminated,PI left institution|12
926455|NCT00946998|3054424|P2|Overall Study|Exited prior to first outcome assessment|3
926456|NCT00946998|3054425|P1|Overall Study|Exited prior to first outcome assessment|5
926457|NCT00946985|3054439|P1|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2
926458|NCT00946985|3054439|P1|Stabilization Phase (25 Weeks)|Patient Moved Away|2
926459|NCT00946985|3054439|P1|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1
926460|NCT00946985|3054439|P1|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2
926461|NCT00946985|3054439|P1|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139
926462|NCT00946985|3054439|P1|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4
926463|NCT00946985|3054439|P1|Stabilization Phase (25 Weeks)|Lost to Follow-up|5
926464|NCT00946985|3054439|P1|Stabilization Phase (25 Weeks)|Lack of Efficacy|3
926465|NCT00946985|3054439|P1|Stabilization Phase (25 Weeks)|Adverse Event|4
926466|NCT00946920|3054445|P2|Overall Study|Miscellaneous reasons|3
926467|NCT00946920|3054446|P1|Overall Study|Miscellaneous reasons|18
926468|NCT00946920|3054445|P2|Overall Study|Protocol Violation|8
926469|NCT00946920|3054446|P1|Overall Study|Protocol Violation|16
926470|NCT00946920|3054445|P2|Overall Study|Adverse Event|14
926471|NCT00946920|3054446|P1|Overall Study|Adverse Event|41
926472|NCT00946920|3054445|P2|Overall Study|Physician Decision|2
926473|NCT00946920|3054446|P1|Overall Study|Physician Decision|5
926474|NCT00946920|3054445|P2|Overall Study|Lost to Follow-up|2
926475|NCT00946920|3054446|P1|Overall Study|Lost to Follow-up|2
926476|NCT00946920|3054445|P2|Overall Study|Withdrawal by Subject|15
926477|NCT00946920|3054446|P1|Overall Study|Withdrawal by Subject|28
926478|NCT00946881|3054461|P1|Retreatment|Withdrawal by Subject|1
926479|NCT00946881|3054461|P1|First Treatment|Patient relocated to another state|1
926480|NCT00946881|3054461|P1|First Treatment|Withdrawal by Subject|1
926481|NCT00946530|3054494|P4|Overall Study|Physician Decision|1
926482|NCT00946530|3054495|P3|Overall Study|Physician Decision|1
926483|NCT00946530|3054496|P2|Overall Study|Physician Decision|1
926484|NCT00946530|3054497|P1|Overall Study|Physician Decision|1
926485|NCT00946530|3054494|P4|Overall Study|Withdrawal by Subject|3
926486|NCT00946530|3054495|P3|Overall Study|Withdrawal by Subject|0
926487|NCT00946530|3054496|P2|Overall Study|Withdrawal by Subject|3
926488|NCT00946530|3054497|P1|Overall Study|Withdrawal by Subject|0
926489|NCT00946322|3054529|P1|Post-treatment|participant failure to follow up|2
926490|NCT00946322|3054529|P1|Pre-treatment|participant failure to follow up|1
926491|NCT00946309|3054542|P2|Overall Study|Procedure cancelled/discontinued|3
926492|NCT00946309|3054543|P1|Overall Study|Procedure cancelled/discontinued|0
926493|NCT00946309|3054542|P2|Overall Study|Lost to Follow-up|1
926494|NCT00946309|3054543|P1|Overall Study|Lost to Follow-up|0
926495|NCT00946309|3054542|P2|Overall Study|Protocol Violation|0
926496|NCT00946309|3054543|P1|Overall Study|Protocol Violation|1
926497|NCT00946296|3054561|P2|Overall Study|Physician Decision|0
926498|NCT00946296|3054562|P1|Overall Study|Physician Decision|3
926499|NCT00946114|3054570|P2|Overall Study|Withdrawal by Subject|0
926500|NCT00946114|3054571|P1|Overall Study|Withdrawal by Subject|2
926501|NCT00946114|3054570|P2|Overall Study|Other|0
926502|NCT00946114|3054571|P1|Overall Study|Other|1
926503|NCT00946114|3054570|P2|Overall Study|Death|2
926504|NCT00946114|3054571|P1|Overall Study|Death|5
926505|NCT00946101|3054579|P2|Overall Study|Physician Decision|1
926506|NCT00946101|3054580|P1|Overall Study|Physician Decision|0
926507|NCT00946101|3054579|P2|Overall Study|Withdrawal of consent|0
926508|NCT00946101|3054580|P1|Overall Study|Withdrawal of consent|2
926509|NCT00946101|3054579|P2|Overall Study|Lost to Follow-up|1
926510|NCT00946101|3054580|P1|Overall Study|Lost to Follow-up|2
926511|NCT00946088|3054646|P2|Overall Study|Withdrawal by Subject|1
926512|NCT00946088|3054647|P1|Overall Study|Withdrawal by Subject|0
926513|NCT00945945|3054691|P2|Overall Study|Entry Criteria Not Met|1
926514|NCT00945945|3054692|P1|Overall Study|Entry Criteria Not Met|0
926515|NCT00945945|3054691|P2|Overall Study|Protocol Violation|2
926516|NCT00945945|3054692|P1|Overall Study|Protocol Violation|4
926517|NCT00945945|3054691|P2|Overall Study|Lack of Efficacy|2
926518|NCT00945945|3054692|P1|Overall Study|Lack of Efficacy|6
926519|NCT00945945|3054691|P2|Overall Study|Lost to Follow-up|5
926520|NCT00945945|3054692|P1|Overall Study|Lost to Follow-up|4
926521|NCT00945945|3054691|P2|Overall Study|Withdrawal by Subject|10
926522|NCT00945945|3054692|P1|Overall Study|Withdrawal by Subject|7
926523|NCT00945945|3054691|P2|Overall Study|Adverse Event|35
926524|NCT00945945|3054692|P1|Overall Study|Adverse Event|15
926525|NCT00945906|3054718|P1|Overall Study|Moved to another country|2
926526|NCT00945906|3054718|P1|Overall Study|Unable to return for last visit|2
926527|NCT00945906|3054718|P1|Overall Study|Did not want to return for last visit|2
926528|NCT00945906|3054718|P1|Overall Study|Withdrawal by Subject|1
926529|NCT00945893|3054729|P2|Overall Study|Withdrawal of consent|2
926530|NCT00945893|3054730|P1|Overall Study|Withdrawal of consent|1
926531|NCT00945893|3054729|P2|Overall Study|Lost to Follow-up|8
926532|NCT00945893|3054730|P1|Overall Study|Lost to Follow-up|2
926533|NCT00945815|3054807|P1|Overall Study|Did not begin protocol therapy|1
926534|NCT00945815|3054807|P1|Overall Study|Ineligible|3
926535|NCT00945815|3054807|P1|Overall Study|Not protocol specified|1
926536|NCT00945815|3054807|P1|Overall Study|Death|3
926537|NCT00945659|3054839|P3|Overall Study|Lost to Follow-up|17
926538|NCT00945659|3054840|P2|Overall Study|Lost to Follow-up|20
926539|NCT00945659|3054841|P1|Overall Study|Lost to Follow-up|7
926540|NCT00945555|3054885|P1|Overall Study|Other|1
926541|NCT00945555|3054885|P1|Overall Study|Death|18
926542|NCT00945555|3054885|P1|Overall Study|Participant continued treatment at home|1
926543|NCT00945555|3054885|P1|Overall Study|Withdrawal by Subject|2
926544|NCT00945555|3054885|P1|Overall Study|Worsening condition, intensive care unit|1
931746|NCT00906399|3071569|P2|Year 1|Death|1
926545|NCT00945555|3054885|P1|Overall Study|Referred to another hospital|5
926546|NCT00945477|3054896|P1|Overall Study|Withdrawal by Subject|1
926547|NCT00945477|3054896|P1|Overall Study|Lack of Efficacy|2
926548|NCT00945477|3054896|P1|Overall Study|Adverse Event|3
926549|NCT00945321|3054912|P6|Period 4|Lost to Follow-up|1
926550|NCT00945321|3054913|P5|Period 4|Lost to Follow-up|0
926551|NCT00945321|3054914|P4|Period 4|Lost to Follow-up|0
926552|NCT00945321|3054915|P3|Period 4|Lost to Follow-up|0
926553|NCT00945321|3054916|P2|Period 4|Lost to Follow-up|0
926554|NCT00945321|3054917|P1|Period 4|Lost to Follow-up|0
926555|NCT00945321|3054912|P6|Period 1|Adverse Event|0
926556|NCT00945321|3054913|P5|Period 1|Adverse Event|1
926557|NCT00945321|3054914|P4|Period 1|Adverse Event|0
926558|NCT00945321|3054915|P3|Period 1|Adverse Event|0
926559|NCT00945321|3054916|P2|Period 1|Adverse Event|0
926560|NCT00945321|3054917|P1|Period 1|Adverse Event|0
926561|NCT00945243|3055050|P1|Overall Study|Study Terminated: Subjects Dispositioned|3
926562|NCT00944697|3055207|P2|Overall Study|Administrative|1
926563|NCT00944697|3055208|P1|Overall Study|Administrative|1
926564|NCT00944697|3055207|P2|Overall Study|Adverse Event|3
926565|NCT00944697|3055208|P1|Overall Study|Adverse Event|0
926566|NCT00944697|3055207|P2|Overall Study|Withdrawal by Subject|1
926567|NCT00944697|3055208|P1|Overall Study|Withdrawal by Subject|1
926568|NCT00944645|3055238|P2|Period 2|Withdrawal by Subject|6
926569|NCT00944645|3055239|P1|Period 2|Withdrawal by Subject|7
926570|NCT00944645|3055238|P2|Period 2|Lost to Follow-up|3
926571|NCT00944645|3055239|P1|Period 2|Lost to Follow-up|0
926572|NCT00944645|3055238|P2|Period 2|Adverse Event|0
926573|NCT00944645|3055239|P1|Period 2|Adverse Event|1
926574|NCT00944229|3055269|P1|Overall Study|Physician Decision|14
926575|NCT00944229|3055269|P1|Overall Study|Withdrawal by Subject|11
926576|NCT00944125|3055275|P2|6 Months to Study Completion|Withdrawal by Subject|2
926577|NCT00944125|3055276|P1|6 Months to Study Completion|Withdrawal by Subject|0
926578|NCT00944125|3055275|P2|3 to 6 Months|Withdrawal by Subject|2
926579|NCT00944125|3055276|P1|3 to 6 Months|Withdrawal by Subject|0
926580|NCT00944034|3055379|P12|Overall Study|Administrative reason|0
926581|NCT00944034|3055380|P11|Overall Study|Administrative reason|0
926582|NCT00944034|3055381|P10|Overall Study|Administrative reason|0
926583|NCT00944034|3055382|P9|Overall Study|Administrative reason|0
926584|NCT00944034|3055383|P8|Overall Study|Administrative reason|0
926585|NCT00944034|3055384|P7|Overall Study|Administrative reason|1
926586|NCT00944034|3055385|P6|Overall Study|Administrative reason|0
926587|NCT00944034|3055386|P5|Overall Study|Administrative reason|0
926588|NCT00944034|3055387|P4|Overall Study|Administrative reason|0
926589|NCT00944034|3055388|P3|Overall Study|Administrative reason|0
926590|NCT00944034|3055389|P2|Overall Study|Administrative reason|0
926591|NCT00944034|3055390|P1|Overall Study|Administrative reason|0
926592|NCT00944034|3055379|P12|Overall Study|Unable to classify|0
926593|NCT00944034|3055380|P11|Overall Study|Unable to classify|0
926594|NCT00944034|3055381|P10|Overall Study|Unable to classify|0
926595|NCT00944034|3055382|P9|Overall Study|Unable to classify|0
926596|NCT00944034|3055383|P8|Overall Study|Unable to classify|1
926597|NCT00944034|3055384|P7|Overall Study|Unable to classify|1
926598|NCT00944034|3055385|P6|Overall Study|Unable to classify|1
926599|NCT00944034|3055386|P5|Overall Study|Unable to classify|0
926600|NCT00944034|3055387|P4|Overall Study|Unable to classify|0
926601|NCT00944034|3055388|P3|Overall Study|Unable to classify|0
926602|NCT00944034|3055389|P2|Overall Study|Unable to classify|0
926603|NCT00944034|3055390|P1|Overall Study|Unable to classify|0
926604|NCT00944034|3055379|P12|Overall Study|Protocol Violation|0
926605|NCT00944034|3055380|P11|Overall Study|Protocol Violation|0
926606|NCT00944034|3055381|P10|Overall Study|Protocol Violation|4
926607|NCT00944034|3055382|P9|Overall Study|Protocol Violation|1
926608|NCT00944034|3055383|P8|Overall Study|Protocol Violation|1
926609|NCT00944034|3055384|P7|Overall Study|Protocol Violation|0
926610|NCT00944034|3055385|P6|Overall Study|Protocol Violation|3
926611|NCT00944034|3055386|P5|Overall Study|Protocol Violation|2
926612|NCT00944034|3055387|P4|Overall Study|Protocol Violation|1
926613|NCT00944034|3055388|P3|Overall Study|Protocol Violation|0
926614|NCT00944034|3055389|P2|Overall Study|Protocol Violation|0
926615|NCT00944034|3055390|P1|Overall Study|Protocol Violation|2
926616|NCT00944034|3055379|P12|Overall Study|Death|0
926617|NCT00944034|3055380|P11|Overall Study|Death|0
926618|NCT00944034|3055381|P10|Overall Study|Death|0
926619|NCT00944034|3055382|P9|Overall Study|Death|0
926620|NCT00944034|3055383|P8|Overall Study|Death|0
926621|NCT00944034|3055384|P7|Overall Study|Death|0
926622|NCT00944034|3055385|P6|Overall Study|Death|0
926623|NCT00944034|3055386|P5|Overall Study|Death|0
926624|NCT00944034|3055387|P4|Overall Study|Death|0
926625|NCT00944034|3055388|P3|Overall Study|Death|1
926626|NCT00944034|3055389|P2|Overall Study|Death|0
926627|NCT00944034|3055390|P1|Overall Study|Death|0
926628|NCT00944034|3055379|P12|Overall Study|Lost to Follow-up|0
926629|NCT00944034|3055380|P11|Overall Study|Lost to Follow-up|1
926630|NCT00944034|3055381|P10|Overall Study|Lost to Follow-up|1
926631|NCT00944034|3055382|P9|Overall Study|Lost to Follow-up|5
926632|NCT00944034|3055383|P8|Overall Study|Lost to Follow-up|1
926633|NCT00944034|3055384|P7|Overall Study|Lost to Follow-up|0
926634|NCT00944034|3055385|P6|Overall Study|Lost to Follow-up|7
926635|NCT00944034|3055386|P5|Overall Study|Lost to Follow-up|5
926636|NCT00944034|3055387|P4|Overall Study|Lost to Follow-up|0
926637|NCT00944034|3055388|P3|Overall Study|Lost to Follow-up|2
926638|NCT00944034|3055389|P2|Overall Study|Lost to Follow-up|4
926639|NCT00944034|3055390|P1|Overall Study|Lost to Follow-up|0
926640|NCT00944034|3055379|P12|Overall Study|Withdrawal by Subject|4
926641|NCT00944034|3055380|P11|Overall Study|Withdrawal by Subject|0
926642|NCT00944034|3055381|P10|Overall Study|Withdrawal by Subject|4
926643|NCT00944034|3055382|P9|Overall Study|Withdrawal by Subject|3
926644|NCT00944034|3055383|P8|Overall Study|Withdrawal by Subject|2
926645|NCT00944034|3055384|P7|Overall Study|Withdrawal by Subject|2
926646|NCT00944034|3055385|P6|Overall Study|Withdrawal by Subject|8
926647|NCT00944034|3055386|P5|Overall Study|Withdrawal by Subject|5
926648|NCT00944034|3055387|P4|Overall Study|Withdrawal by Subject|2
926649|NCT00944034|3055388|P3|Overall Study|Withdrawal by Subject|6
926650|NCT00944034|3055389|P2|Overall Study|Withdrawal by Subject|2
926651|NCT00944034|3055390|P1|Overall Study|Withdrawal by Subject|3
926652|NCT00944034|3055379|P12|Overall Study|Inappropriate enrollment|0
926653|NCT00944034|3055380|P11|Overall Study|Inappropriate enrollment|0
926654|NCT00944034|3055381|P10|Overall Study|Inappropriate enrollment|1
926655|NCT00944034|3055382|P9|Overall Study|Inappropriate enrollment|1
926656|NCT00944034|3055383|P8|Overall Study|Inappropriate enrollment|0
926657|NCT00944034|3055384|P7|Overall Study|Inappropriate enrollment|0
926658|NCT00944034|3055385|P6|Overall Study|Inappropriate enrollment|1
926659|NCT00944034|3055386|P5|Overall Study|Inappropriate enrollment|2
926660|NCT00944034|3055387|P4|Overall Study|Inappropriate enrollment|1
926661|NCT00944034|3055388|P3|Overall Study|Inappropriate enrollment|0
926662|NCT00944034|3055389|P2|Overall Study|Inappropriate enrollment|1
926663|NCT00944034|3055390|P1|Overall Study|Inappropriate enrollment|0
926664|NCT00943917|3055536|P15|Stage II Continuation|A1C elevation|0
926665|NCT00943917|3055537|P14|Stage II Continuation|A1C elevation|1
926666|NCT00943917|3055538|P13|Stage II Continuation|A1C elevation|0
926667|NCT00943917|3055539|P12|Stage II Continuation|A1C elevation|0
926668|NCT00943917|3055540|P11|Stage II Continuation|A1C elevation|0
926669|NCT00943917|3055541|P10|Stage II Continuation|A1C elevation|0
926670|NCT00943917|3055542|P9|Stage II Continuation|A1C elevation|0
926671|NCT00943917|3055543|P8|Stage II Continuation|A1C elevation|0
926672|NCT00943917|3055544|P7|Stage II Continuation|A1C elevation|0
926673|NCT00943917|3055545|P6|Stage II Continuation|A1C elevation|0
926674|NCT00943917|3055546|P5|Stage II Continuation|A1C elevation|0
926675|NCT00943917|3055547|P4|Stage II Continuation|A1C elevation|0
926676|NCT00943917|3055548|P3|Stage II Continuation|A1C elevation|0
926677|NCT00943917|3055549|P2|Stage II Continuation|A1C elevation|0
926678|NCT00943917|3055550|P1|Stage II Continuation|A1C elevation|0
926679|NCT00943917|3055536|P15|Stage II Continuation|hypoglycemia|0
926680|NCT00943917|3055537|P14|Stage II Continuation|hypoglycemia|0
926681|NCT00943917|3055538|P13|Stage II Continuation|hypoglycemia|1
926682|NCT00943917|3055539|P12|Stage II Continuation|hypoglycemia|0
926683|NCT00943917|3055540|P11|Stage II Continuation|hypoglycemia|0
926684|NCT00943917|3055541|P10|Stage II Continuation|hypoglycemia|0
926685|NCT00943917|3055542|P9|Stage II Continuation|hypoglycemia|0
926686|NCT00943917|3055543|P8|Stage II Continuation|hypoglycemia|0
926687|NCT00943917|3055544|P7|Stage II Continuation|hypoglycemia|0
926688|NCT00943917|3055545|P6|Stage II Continuation|hypoglycemia|0
926689|NCT00943917|3055546|P5|Stage II Continuation|hypoglycemia|0
926690|NCT00943917|3055547|P4|Stage II Continuation|hypoglycemia|0
926691|NCT00943917|3055548|P3|Stage II Continuation|hypoglycemia|0
926692|NCT00943917|3055549|P2|Stage II Continuation|hypoglycemia|0
926693|NCT00943917|3055550|P1|Stage II Continuation|hypoglycemia|0
926694|NCT00943917|3055536|P15|Stage II Continuation|Protocol Violation|0
926695|NCT00943917|3055537|P14|Stage II Continuation|Protocol Violation|0
926696|NCT00943917|3055538|P13|Stage II Continuation|Protocol Violation|0
926697|NCT00943917|3055539|P12|Stage II Continuation|Protocol Violation|1
926698|NCT00943917|3055540|P11|Stage II Continuation|Protocol Violation|0
926699|NCT00943917|3055541|P10|Stage II Continuation|Protocol Violation|1
926700|NCT00943917|3055542|P9|Stage II Continuation|Protocol Violation|0
926701|NCT00943917|3055543|P8|Stage II Continuation|Protocol Violation|0
926702|NCT00943917|3055544|P7|Stage II Continuation|Protocol Violation|0
926703|NCT00943917|3055545|P6|Stage II Continuation|Protocol Violation|0
926704|NCT00943917|3055546|P5|Stage II Continuation|Protocol Violation|0
926705|NCT00943917|3055547|P4|Stage II Continuation|Protocol Violation|0
926706|NCT00943917|3055548|P3|Stage II Continuation|Protocol Violation|0
926707|NCT00943917|3055549|P2|Stage II Continuation|Protocol Violation|0
926708|NCT00943917|3055550|P1|Stage II Continuation|Protocol Violation|0
926709|NCT00943917|3055536|P15|Stage II Continuation|Withdrawal by Subject|3
926710|NCT00943917|3055537|P14|Stage II Continuation|Withdrawal by Subject|1
926711|NCT00943917|3055538|P13|Stage II Continuation|Withdrawal by Subject|0
926712|NCT00943917|3055539|P12|Stage II Continuation|Withdrawal by Subject|0
926713|NCT00943917|3055540|P11|Stage II Continuation|Withdrawal by Subject|0
926714|NCT00943917|3055541|P10|Stage II Continuation|Withdrawal by Subject|0
926715|NCT00943917|3055542|P9|Stage II Continuation|Withdrawal by Subject|0
926716|NCT00943917|3055543|P8|Stage II Continuation|Withdrawal by Subject|0
926717|NCT00943917|3055544|P7|Stage II Continuation|Withdrawal by Subject|0
926718|NCT00943917|3055545|P6|Stage II Continuation|Withdrawal by Subject|0
926719|NCT00943917|3055546|P5|Stage II Continuation|Withdrawal by Subject|0
926720|NCT00943917|3055547|P4|Stage II Continuation|Withdrawal by Subject|0
926721|NCT00943917|3055548|P3|Stage II Continuation|Withdrawal by Subject|0
926722|NCT00943917|3055549|P2|Stage II Continuation|Withdrawal by Subject|0
926723|NCT00943917|3055550|P1|Stage II Continuation|Withdrawal by Subject|0
926724|NCT00943917|3055536|P15|Stage II Continuation|Adverse Event|1
926725|NCT00943917|3055537|P14|Stage II Continuation|Adverse Event|1
926726|NCT00943917|3055538|P13|Stage II Continuation|Adverse Event|2
926727|NCT00943917|3055539|P12|Stage II Continuation|Adverse Event|1
926728|NCT00943917|3055540|P11|Stage II Continuation|Adverse Event|0
926729|NCT00943917|3055541|P10|Stage II Continuation|Adverse Event|0
926730|NCT00943917|3055542|P9|Stage II Continuation|Adverse Event|0
926731|NCT00943917|3055543|P8|Stage II Continuation|Adverse Event|0
926732|NCT00943917|3055544|P7|Stage II Continuation|Adverse Event|0
926733|NCT00943917|3055545|P6|Stage II Continuation|Adverse Event|0
926734|NCT00943917|3055546|P5|Stage II Continuation|Adverse Event|0
926735|NCT00943917|3055547|P4|Stage II Continuation|Adverse Event|0
926736|NCT00943917|3055548|P3|Stage II Continuation|Adverse Event|0
926737|NCT00943917|3055549|P2|Stage II Continuation|Adverse Event|0
926738|NCT00943917|3055550|P1|Stage II Continuation|Adverse Event|0
926739|NCT00943917|3055536|P15|Stage II|Pregnancy|0
926740|NCT00943917|3055537|P14|Stage II|Pregnancy|0
926741|NCT00943917|3055538|P13|Stage II|Pregnancy|0
926742|NCT00943917|3055539|P12|Stage II|Pregnancy|0
926743|NCT00943917|3055540|P11|Stage II|Pregnancy|0
926744|NCT00943917|3055541|P10|Stage II|Pregnancy|0
926745|NCT00943917|3055542|P9|Stage II|Pregnancy|0
926746|NCT00943917|3055543|P8|Stage II|Pregnancy|0
926747|NCT00943917|3055544|P7|Stage II|Pregnancy|0
926748|NCT00943917|3055545|P6|Stage II|Pregnancy|1
926749|NCT00943917|3055546|P5|Stage II|Pregnancy|0
926750|NCT00943917|3055547|P4|Stage II|Pregnancy|0
926751|NCT00943917|3055548|P3|Stage II|Pregnancy|0
926752|NCT00943917|3055549|P2|Stage II|Pregnancy|0
926753|NCT00943917|3055550|P1|Stage II|Pregnancy|0
926754|NCT00943917|3055536|P15|Stage II|Withdrawal by Subject|0
926755|NCT00943917|3055537|P14|Stage II|Withdrawal by Subject|0
926756|NCT00943917|3055538|P13|Stage II|Withdrawal by Subject|0
926757|NCT00943917|3055539|P12|Stage II|Withdrawal by Subject|0
926758|NCT00943917|3055540|P11|Stage II|Withdrawal by Subject|0
926759|NCT00943917|3055541|P10|Stage II|Withdrawal by Subject|0
926760|NCT00943917|3055542|P9|Stage II|Withdrawal by Subject|0
926761|NCT00943917|3055543|P8|Stage II|Withdrawal by Subject|0
926762|NCT00943917|3055544|P7|Stage II|Withdrawal by Subject|0
926763|NCT00943917|3055545|P6|Stage II|Withdrawal by Subject|1
926764|NCT00943917|3055546|P5|Stage II|Withdrawal by Subject|0
926765|NCT00943917|3055547|P4|Stage II|Withdrawal by Subject|0
926766|NCT00943917|3055548|P3|Stage II|Withdrawal by Subject|0
926767|NCT00943917|3055549|P2|Stage II|Withdrawal by Subject|0
926768|NCT00943917|3055550|P1|Stage II|Withdrawal by Subject|0
926769|NCT00943917|3055536|P15|Stage II|Adverse Event|0
926770|NCT00943917|3055537|P14|Stage II|Adverse Event|0
926771|NCT00943917|3055538|P13|Stage II|Adverse Event|0
926772|NCT00943917|3055539|P12|Stage II|Adverse Event|0
926773|NCT00943917|3055540|P11|Stage II|Adverse Event|0
926774|NCT00943917|3055541|P10|Stage II|Adverse Event|0
926775|NCT00943917|3055542|P9|Stage II|Adverse Event|1
926776|NCT00943917|3055543|P8|Stage II|Adverse Event|0
926777|NCT00943917|3055544|P7|Stage II|Adverse Event|3
926778|NCT00943917|3055545|P6|Stage II|Adverse Event|1
926779|NCT00943917|3055546|P5|Stage II|Adverse Event|0
926780|NCT00943917|3055547|P4|Stage II|Adverse Event|0
926781|NCT00943917|3055548|P3|Stage II|Adverse Event|0
926782|NCT00943917|3055549|P2|Stage II|Adverse Event|0
926783|NCT00943917|3055550|P1|Stage II|Adverse Event|0
926784|NCT00943917|3055536|P15|Stage I|Withdrawal by Subject|0
926785|NCT00943917|3055537|P14|Stage I|Withdrawal by Subject|0
926786|NCT00943917|3055538|P13|Stage I|Withdrawal by Subject|0
926787|NCT00943917|3055539|P12|Stage I|Withdrawal by Subject|0
926788|NCT00943917|3055540|P11|Stage I|Withdrawal by Subject|0
926789|NCT00943917|3055541|P10|Stage I|Withdrawal by Subject|0
926790|NCT00943917|3055542|P9|Stage I|Withdrawal by Subject|0
926791|NCT00943917|3055543|P8|Stage I|Withdrawal by Subject|0
926792|NCT00943917|3055544|P7|Stage I|Withdrawal by Subject|0
926793|NCT00943917|3055545|P6|Stage I|Withdrawal by Subject|0
926794|NCT00943917|3055546|P5|Stage I|Withdrawal by Subject|0
926795|NCT00943917|3055547|P4|Stage I|Withdrawal by Subject|0
926796|NCT00943917|3055548|P3|Stage I|Withdrawal by Subject|2
926797|NCT00943917|3055549|P2|Stage I|Withdrawal by Subject|1
926798|NCT00943917|3055550|P1|Stage I|Withdrawal by Subject|2
926799|NCT00943917|3055536|P15|Stage I|A1C elevation|0
926800|NCT00943917|3055537|P14|Stage I|A1C elevation|0
926801|NCT00943917|3055538|P13|Stage I|A1C elevation|0
926802|NCT00943917|3055539|P12|Stage I|A1C elevation|0
926803|NCT00943917|3055540|P11|Stage I|A1C elevation|0
926804|NCT00943917|3055541|P10|Stage I|A1C elevation|0
926805|NCT00943917|3055542|P9|Stage I|A1C elevation|0
926806|NCT00943917|3055543|P8|Stage I|A1C elevation|0
926807|NCT00943917|3055544|P7|Stage I|A1C elevation|0
926808|NCT00943917|3055545|P6|Stage I|A1C elevation|0
926809|NCT00943917|3055546|P5|Stage I|A1C elevation|0
926810|NCT00943917|3055547|P4|Stage I|A1C elevation|0
926811|NCT00943917|3055548|P3|Stage I|A1C elevation|0
926812|NCT00943917|3055549|P2|Stage I|A1C elevation|0
926813|NCT00943917|3055550|P1|Stage I|A1C elevation|1
926814|NCT00943917|3055536|P15|Stage I|hyperglycemia|0
926815|NCT00943917|3055537|P14|Stage I|hyperglycemia|0
926816|NCT00943917|3055538|P13|Stage I|hyperglycemia|0
926817|NCT00943917|3055539|P12|Stage I|hyperglycemia|0
926818|NCT00943917|3055540|P11|Stage I|hyperglycemia|0
926819|NCT00943917|3055541|P10|Stage I|hyperglycemia|0
926820|NCT00943917|3055542|P9|Stage I|hyperglycemia|0
926821|NCT00943917|3055543|P8|Stage I|hyperglycemia|0
926822|NCT00943917|3055544|P7|Stage I|hyperglycemia|0
926823|NCT00943917|3055545|P6|Stage I|hyperglycemia|0
926824|NCT00943917|3055546|P5|Stage I|hyperglycemia|0
926825|NCT00943917|3055547|P4|Stage I|hyperglycemia|0
926826|NCT00943917|3055548|P3|Stage I|hyperglycemia|1
926827|NCT00943917|3055549|P2|Stage I|hyperglycemia|0
926828|NCT00943917|3055550|P1|Stage I|hyperglycemia|0
926829|NCT00943917|3055536|P15|Stage I|Lost to Follow-up|0
926830|NCT00943917|3055537|P14|Stage I|Lost to Follow-up|0
926831|NCT00943917|3055538|P13|Stage I|Lost to Follow-up|0
926832|NCT00943917|3055539|P12|Stage I|Lost to Follow-up|0
926833|NCT00943917|3055540|P11|Stage I|Lost to Follow-up|0
926834|NCT00943917|3055541|P10|Stage I|Lost to Follow-up|0
926835|NCT00943917|3055542|P9|Stage I|Lost to Follow-up|0
926836|NCT00943917|3055543|P8|Stage I|Lost to Follow-up|0
926837|NCT00943917|3055544|P7|Stage I|Lost to Follow-up|0
926838|NCT00943917|3055545|P6|Stage I|Lost to Follow-up|0
926839|NCT00943917|3055546|P5|Stage I|Lost to Follow-up|0
926840|NCT00943917|3055547|P4|Stage I|Lost to Follow-up|0
926841|NCT00943917|3055548|P3|Stage I|Lost to Follow-up|1
926842|NCT00943917|3055549|P2|Stage I|Lost to Follow-up|0
926843|NCT00943917|3055550|P1|Stage I|Lost to Follow-up|0
926844|NCT00943917|3055536|P15|Stage I|Adverse Event|0
926845|NCT00943917|3055537|P14|Stage I|Adverse Event|0
926846|NCT00943917|3055538|P13|Stage I|Adverse Event|0
926847|NCT00943917|3055539|P12|Stage I|Adverse Event|0
926848|NCT00943917|3055540|P11|Stage I|Adverse Event|0
926849|NCT00943917|3055541|P10|Stage I|Adverse Event|0
926850|NCT00943917|3055542|P9|Stage I|Adverse Event|0
926851|NCT00943917|3055543|P8|Stage I|Adverse Event|0
926852|NCT00943917|3055544|P7|Stage I|Adverse Event|0
926853|NCT00943917|3055545|P6|Stage I|Adverse Event|0
926854|NCT00943917|3055546|P5|Stage I|Adverse Event|0
926855|NCT00943917|3055547|P4|Stage I|Adverse Event|0
926856|NCT00943917|3055548|P3|Stage I|Adverse Event|2
926857|NCT00943917|3055549|P2|Stage I|Adverse Event|2
926858|NCT00943917|3055550|P1|Stage I|Adverse Event|1
926859|NCT00943852|3055726|P10|Washout Period After Period 4 Treatment|Trial stopped early|0
926860|NCT00943852|3055727|P9|Washout Period After Period 4 Treatment|Trial stopped early|0
926861|NCT00943852|3055728|P8|Washout Period After Period 4 Treatment|Trial stopped early|0
926862|NCT00943852|3055729|P7|Washout Period After Period 4 Treatment|Trial stopped early|1
926863|NCT00943852|3055730|P6|Washout Period After Period 4 Treatment|Trial stopped early|0
926864|NCT00943852|3055731|P5|Washout Period After Period 4 Treatment|Trial stopped early|0
926865|NCT00943852|3055732|P4|Washout Period After Period 4 Treatment|Trial stopped early|1
926866|NCT00943852|3055733|P3|Washout Period After Period 4 Treatment|Trial stopped early|1
926867|NCT00943852|3055734|P2|Washout Period After Period 4 Treatment|Trial stopped early|0
926868|NCT00943852|3055735|P1|Washout Period After Period 4 Treatment|Trial stopped early|1
926869|NCT00943852|3055726|P10|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
926870|NCT00943852|3055727|P9|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
926871|NCT00943852|3055728|P8|Washout Period After Period 4 Treatment|Not taking medication per protocol|1
926872|NCT00943852|3055729|P7|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
926873|NCT00943852|3055730|P6|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
926874|NCT00943852|3055731|P5|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
926875|NCT00943852|3055732|P4|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
926876|NCT00943852|3055733|P3|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
926877|NCT00943852|3055734|P2|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
926878|NCT00943852|3055735|P1|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
926879|NCT00943852|3055726|P10|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
926880|NCT00943852|3055727|P9|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
926881|NCT00943852|3055728|P8|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
926882|NCT00943852|3055729|P7|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1
926883|NCT00943852|3055730|P6|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
926884|NCT00943852|3055731|P5|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
926885|NCT00943852|3055732|P4|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
926886|NCT00943852|3055733|P3|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
926887|NCT00943852|3055734|P2|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
926888|NCT00943852|3055735|P1|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
926889|NCT00943852|3055726|P10|Washout Period After Period 2 Treatment|Trial stopped early|0
926890|NCT00943852|3055727|P9|Washout Period After Period 2 Treatment|Trial stopped early|0
926891|NCT00943852|3055728|P8|Washout Period After Period 2 Treatment|Trial stopped early|0
926892|NCT00943852|3055729|P7|Washout Period After Period 2 Treatment|Trial stopped early|0
926893|NCT00943852|3055730|P6|Washout Period After Period 2 Treatment|Trial stopped early|1
931747|NCT00906399|3071570|P1|Year 1|Death|2
926894|NCT00943852|3055731|P5|Washout Period After Period 2 Treatment|Trial stopped early|0
926895|NCT00943852|3055732|P4|Washout Period After Period 2 Treatment|Trial stopped early|0
926896|NCT00943852|3055733|P3|Washout Period After Period 2 Treatment|Trial stopped early|0
926897|NCT00943852|3055734|P2|Washout Period After Period 2 Treatment|Trial stopped early|0
926898|NCT00943852|3055735|P1|Washout Period After Period 2 Treatment|Trial stopped early|0
926899|NCT00943852|3055726|P10|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
926900|NCT00943852|3055727|P9|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
926901|NCT00943852|3055728|P8|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
926902|NCT00943852|3055729|P7|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
926903|NCT00943852|3055730|P6|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
926904|NCT00943852|3055731|P5|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
926905|NCT00943852|3055732|P4|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1
926906|NCT00943852|3055733|P3|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
926907|NCT00943852|3055734|P2|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
926908|NCT00943852|3055735|P1|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
926909|NCT00943826|3055748|P2|After Primary Overall Survival Analysis|Withdrew Consent|0
926910|NCT00943826|3055749|P1|After Primary Overall Survival Analysis|Withdrew Consent|4
926911|NCT00943826|3055748|P2|After Primary Overall Survival Analysis|Progression of Disease|4
926912|NCT00943826|3055749|P1|After Primary Overall Survival Analysis|Progression of Disease|2
926913|NCT00943826|3055748|P2|After Primary Overall Survival Analysis|Administrative reasons|16
926914|NCT00943826|3055749|P1|After Primary Overall Survival Analysis|Administrative reasons|10
926915|NCT00943826|3055748|P2|After Primary Overall Survival Analysis|Adverse Event|0
926916|NCT00943826|3055749|P1|After Primary Overall Survival Analysis|Adverse Event|11
926917|NCT00943826|3055748|P2|Monotherapy Phase|Failure to return|1
926918|NCT00943826|3055749|P1|Monotherapy Phase|Failure to return|2
926919|NCT00943826|3055748|P2|Monotherapy Phase|Withdrew Consent|3
926920|NCT00943826|3055749|P1|Monotherapy Phase|Withdrew Consent|2
926921|NCT00943826|3055748|P2|Monotherapy Phase|Refused treatment/ Did not cooperate|2
926922|NCT00943826|3055749|P1|Monotherapy Phase|Refused treatment/ Did not cooperate|8
926923|NCT00943826|3055748|P2|Monotherapy Phase|Administrative reasons|5
926924|NCT00943826|3055749|P1|Monotherapy Phase|Administrative reasons|11
926925|NCT00943826|3055748|P2|Monotherapy Phase|Adverse Event|5
926926|NCT00943826|3055749|P1|Monotherapy Phase|Adverse Event|42
926927|NCT00943826|3055748|P2|Maintenance Phase|Failure to return|1
926928|NCT00943826|3055749|P1|Maintenance Phase|Failure to return|0
926929|NCT00943826|3055748|P2|Maintenance Phase|Administrative reasons|1
926930|NCT00943826|3055749|P1|Maintenance Phase|Administrative reasons|4
926931|NCT00943826|3055748|P2|Maintenance Phase|Refused treatment/Did not cooperate|3
926932|NCT00943826|3055749|P1|Maintenance Phase|Refused treatment/Did not cooperate|6
926933|NCT00943826|3055748|P2|Maintenance Phase|Withdrew consent|4
926934|NCT00943826|3055749|P1|Maintenance Phase|Withdrew consent|2
926935|NCT00943826|3055748|P2|Maintenance Phase|Adverse Event|30
926936|NCT00943826|3055749|P1|Maintenance Phase|Adverse Event|31
926937|NCT00943826|3055748|P2|Concurrent Phase|Protocol Violation|0
926938|NCT00943826|3055749|P1|Concurrent Phase|Protocol Violation|1
926939|NCT00943826|3055748|P2|Concurrent Phase|Administrative reasons|1
926940|NCT00943826|3055749|P1|Concurrent Phase|Administrative reasons|2
926941|NCT00943826|3055748|P2|Concurrent Phase|Refused treatment/Did not cooperate|7
926942|NCT00943826|3055749|P1|Concurrent Phase|Refused treatment/Did not cooperate|5
926943|NCT00943826|3055748|P2|Concurrent Phase|Withdrew consent|7
926944|NCT00943826|3055749|P1|Concurrent Phase|Withdrew consent|3
926945|NCT00943826|3055748|P2|Concurrent Phase|Adverse Event|27
926946|NCT00943826|3055749|P1|Concurrent Phase|Adverse Event|50
926947|NCT00943787|3055767|P1|Overall Study|Withdrawal by Subject|3
926948|NCT00943787|3055767|P1|Overall Study|Physician Decision|4
926949|NCT00943761|3055774|P2|Overall Study|Withdrawal by Subject|1
926950|NCT00943761|3055775|P1|Overall Study|Withdrawal by Subject|2
926951|NCT00943761|3055774|P2|Overall Study|Lost to Follow-up|0
926952|NCT00943761|3055775|P1|Overall Study|Lost to Follow-up|2
926953|NCT00943735|3055787|P1|Overall Study|Other|3
926954|NCT00943735|3055787|P1|Overall Study|Other|8
926955|NCT00943735|3055787|P1|Overall Study|Death|1
926956|NCT00943735|3055787|P1|Overall Study|Withdrawal by Subject|8
926957|NCT00943735|3055787|P1|Overall Study|Adverse Event|12
926958|NCT00943722|3055825|P5|Overall Study|Withdrawal by Subject|8
926959|NCT00943722|3055826|P4|Overall Study|Withdrawal by Subject|13
926960|NCT00943722|3055827|P3|Overall Study|Withdrawal by Subject|2
926961|NCT00943722|3055828|P2|Overall Study|Withdrawal by Subject|13
926962|NCT00943722|3055829|P1|Overall Study|Withdrawal by Subject|12
926963|NCT00943722|3055825|P5|Overall Study|Protocol Violation|2
926964|NCT00943722|3055826|P4|Overall Study|Protocol Violation|0
926965|NCT00943722|3055827|P3|Overall Study|Protocol Violation|0
926966|NCT00943722|3055828|P2|Overall Study|Protocol Violation|1
926967|NCT00943722|3055829|P1|Overall Study|Protocol Violation|0
926968|NCT00943722|3055825|P5|Overall Study|Pregnancy|0
926969|NCT00943722|3055826|P4|Overall Study|Pregnancy|0
926970|NCT00943722|3055827|P3|Overall Study|Pregnancy|1
926971|NCT00943722|3055828|P2|Overall Study|Pregnancy|0
926972|NCT00943722|3055829|P1|Overall Study|Pregnancy|0
926973|NCT00943722|3055825|P5|Overall Study|Physician Decision|1
926974|NCT00943722|3055826|P4|Overall Study|Physician Decision|0
926975|NCT00943722|3055827|P3|Overall Study|Physician Decision|0
926976|NCT00943722|3055828|P2|Overall Study|Physician Decision|0
926977|NCT00943722|3055829|P1|Overall Study|Physician Decision|1
926978|NCT00943722|3055825|P5|Overall Study|Lost to Follow-up|11
926979|NCT00943722|3055826|P4|Overall Study|Lost to Follow-up|8
926980|NCT00943722|3055827|P3|Overall Study|Lost to Follow-up|10
926981|NCT00943722|3055828|P2|Overall Study|Lost to Follow-up|8
926982|NCT00943722|3055829|P1|Overall Study|Lost to Follow-up|12
926983|NCT00943722|3055825|P5|Overall Study|Adverse Event|0
926984|NCT00943722|3055826|P4|Overall Study|Adverse Event|1
926985|NCT00943722|3055827|P3|Overall Study|Adverse Event|0
926986|NCT00943722|3055828|P2|Overall Study|Adverse Event|0
926987|NCT00943722|3055829|P1|Overall Study|Adverse Event|0
926988|NCT00943683|3055859|P2|Overall Study|Patient Moved|0
926989|NCT00943683|3055860|P1|Overall Study|Patient Moved|1
926990|NCT00943683|3055859|P2|Overall Study|Withdrawal by Subject|0
926991|NCT00943683|3055860|P1|Overall Study|Withdrawal by Subject|1
926992|NCT00943683|3055859|P2|Overall Study|Protocol Violation|2
926993|NCT00943683|3055860|P1|Overall Study|Protocol Violation|1
926994|NCT00943683|3055859|P2|Overall Study|Lost to Follow-up|1
926995|NCT00943683|3055860|P1|Overall Study|Lost to Follow-up|1
926996|NCT00943683|3055859|P2|Overall Study|Adverse Event|3
926997|NCT00943683|3055860|P1|Overall Study|Adverse Event|3
926998|NCT00943670|3055866|P1|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5
926999|NCT00943670|3055866|P1|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2
927000|NCT00943670|3055866|P1|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6
927001|NCT00943670|3055866|P1|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4
927002|NCT00943670|3055866|P1|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1
927003|NCT00943670|3055866|P1|Single-agent Trastuzumab Emtansine|Early progressive disease|20
927004|NCT00943670|3055866|P1|Single-agent Trastuzumab Emtansine|Adverse Event|2
927005|NCT00943670|3055866|P1|Single-agent Trastuzumab Emtansine|Systemic progression|15
927006|NCT00943670|3055866|P1|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3
927007|NCT00943670|3055866|P1|Single-agent Trastuzumab Emtansine|Physician Decision|2
927008|NCT00943605|3055955|P2|Overall Study|Study termination|30
927009|NCT00943605|3055956|P1|Overall Study|Study termination|30
927010|NCT00943592|3055966|P1|Overall Study|Death|3
927011|NCT00943579|3055979|P2|Overall Study|Lack of Efficacy|2
927012|NCT00943579|3055980|P1|Overall Study|Lack of Efficacy|2
927013|NCT00943579|3055979|P2|Overall Study|Adverse Event|3
927014|NCT00943579|3055980|P1|Overall Study|Adverse Event|4
927015|NCT00943397|3056081|P2|Overall Study|Site terminated and other|56
927016|NCT00943397|3056082|P1|Overall Study|Site terminated and other|12
927017|NCT00943397|3056081|P2|Overall Study|Withdrawal by Subject|1
927018|NCT00943397|3056082|P1|Overall Study|Withdrawal by Subject|1
927019|NCT00943397|3056081|P2|Overall Study|Protocol Violation|5
927020|NCT00943397|3056082|P1|Overall Study|Protocol Violation|2
927021|NCT00943397|3056081|P2|Overall Study|Lost to Follow-up|4
927022|NCT00943397|3056082|P1|Overall Study|Lost to Follow-up|0
927023|NCT00943397|3056081|P2|Overall Study|Adverse Event|6
927024|NCT00943397|3056082|P1|Overall Study|Adverse Event|0
927025|NCT00943384|3056088|P1|Overall Study|Withdrawal by Subject|5
927026|NCT00943384|3056088|P1|Overall Study|Lost to Follow-up|16
927027|NCT00943384|3056088|P1|Overall Study|Treated off protocol-protocol violation|5
927028|NCT00943384|3056088|P1|Overall Study|Dispositioned prior to treatment|23
927029|NCT00943306|3056102|P1|Overall Study|Sponsor decision due to non-compliance|1
927030|NCT00943306|3056102|P1|Overall Study|Death|1
927031|NCT00943306|3056102|P1|Overall Study|Physician Decision|1
927032|NCT00943124|3056404|P2|Period 1|Personal Reasons|1
927033|NCT00943124|3056405|P1|Period 1|Personal Reasons|0
927034|NCT00943124|3056404|P2|Period 1|Did Not Follow Study Procedures|0
927035|NCT00943124|3056405|P1|Period 1|Did Not Follow Study Procedures|1
927036|NCT00943124|3056404|P2|Period 1|Withdrawal by Subject|1
927037|NCT00943124|3056405|P1|Period 1|Withdrawal by Subject|1
927038|NCT00943111|3056427|P3|5 Years Long-term Treatment Period|Other than specified above|2
927039|NCT00943111|3056428|P2|5 Years Long-term Treatment Period|Other than specified above|0
927040|NCT00943111|3056429|P1|5 Years Long-term Treatment Period|Other than specified above|0
927041|NCT00943111|3056427|P3|5 Years Long-term Treatment Period|Lost to Follow-up|1
927042|NCT00943111|3056428|P2|5 Years Long-term Treatment Period|Lost to Follow-up|0
927043|NCT00943111|3056429|P1|5 Years Long-term Treatment Period|Lost to Follow-up|0
927044|NCT00943111|3056427|P3|5 Years Long-term Treatment Period|Pregnancy|4
927045|NCT00943111|3056428|P2|5 Years Long-term Treatment Period|Pregnancy|0
927046|NCT00943111|3056429|P1|5 Years Long-term Treatment Period|Pregnancy|0
927047|NCT00943111|3056427|P3|5 Years Long-term Treatment Period|Withdrawal by Subject|8
927048|NCT00943111|3056428|P2|5 Years Long-term Treatment Period|Withdrawal by Subject|0
927049|NCT00943111|3056429|P1|5 Years Long-term Treatment Period|Withdrawal by Subject|0
927050|NCT00943111|3056427|P3|5 Years Long-term Treatment Period|Adverse Event|9
927051|NCT00943111|3056428|P2|5 Years Long-term Treatment Period|Adverse Event|0
927052|NCT00943111|3056429|P1|5 Years Long-term Treatment Period|Adverse Event|0
927053|NCT00943111|3056427|P3|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51
927054|NCT00943111|3056428|P2|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
927055|NCT00943111|3056429|P1|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
927056|NCT00943111|3056427|P3|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
927057|NCT00943111|3056428|P2|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1
927058|NCT00943111|3056429|P1|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
927059|NCT00943111|3056427|P3|52-Weeks Primary Analysis Period|Adverse Event|0
927060|NCT00943111|3056428|P2|52-Weeks Primary Analysis Period|Adverse Event|1
927061|NCT00943111|3056429|P1|52-Weeks Primary Analysis Period|Adverse Event|2
927062|NCT00943072|3056497|P2|Overall Study|Other|1
927063|NCT00943072|3056498|P1|Overall Study|Other|1
927064|NCT00943072|3056497|P2|Overall Study|Lack of Efficacy|4
927065|NCT00943072|3056498|P1|Overall Study|Lack of Efficacy|0
927066|NCT00943072|3056497|P2|Overall Study|Lost to Follow-up|2
927067|NCT00943072|3056498|P1|Overall Study|Lost to Follow-up|1
927068|NCT00943072|3056497|P2|Overall Study|Protocol Violation|1
927069|NCT00943072|3056498|P1|Overall Study|Protocol Violation|0
927070|NCT00943072|3056497|P2|Overall Study|Withdrawal by Subject|1
927071|NCT00943072|3056498|P1|Overall Study|Withdrawal by Subject|3
927072|NCT00943072|3056497|P2|Overall Study|Death|2
927073|NCT00943072|3056498|P1|Overall Study|Death|0
927074|NCT00943072|3056497|P2|Overall Study|Adverse Event|3
927075|NCT00943072|3056498|P1|Overall Study|Adverse Event|0
927076|NCT00942994|3056516|P2|Overall Study|Protocol deviation|2
927077|NCT00942994|3056517|P1|Overall Study|Protocol deviation|1
927078|NCT00942994|3056516|P2|Overall Study|Lost to Follow-up|4
927079|NCT00942994|3056517|P1|Overall Study|Lost to Follow-up|1
927080|NCT00942994|3056516|P2|Overall Study|Patient withdrew consent|8
927081|NCT00942994|3056517|P1|Overall Study|Patient withdrew consent|5
927082|NCT00942994|3056516|P2|Overall Study|Unsatisfactory therapeutic effect|1
927083|NCT00942994|3056517|P1|Overall Study|Unsatisfactory therapeutic effect|1
927084|NCT00942994|3056516|P2|Overall Study|Abnormal laboratory value(s)|0
927085|NCT00942994|3056517|P1|Overall Study|Abnormal laboratory value(s)|1
927086|NCT00942994|3056516|P2|Overall Study|Adverse Event|4
927087|NCT00942994|3056517|P1|Overall Study|Adverse Event|7
927088|NCT00942968|3056533|P1|Overall Study|Deep vein thrombosis (DVT)|2
927089|NCT00942968|3056533|P1|Overall Study|Participant required pancreatic biopsy|1
927090|NCT00942968|3056533|P1|Overall Study|Pulmonary embolism (PE)|1
927091|NCT00942968|3056533|P1|Overall Study|Inferior vena cava filter placement|4
927092|NCT00942968|3056533|P1|Overall Study|Progression of disease|12
927093|NCT00942968|3056533|P1|Overall Study|Physician Decision|11
927094|NCT00942968|3056533|P1|Overall Study|Sponsor request|5
927095|NCT00942968|3056533|P1|Overall Study|Withdrawal by Subject|44
927096|NCT00942968|3056533|P1|Overall Study|Lost to Follow-up|4
927097|NCT00942968|3056533|P1|Overall Study|Protocol Violation|9
927098|NCT00942968|3056533|P1|Overall Study|Death|76
927099|NCT00942968|3056533|P1|Overall Study|Adverse Event|60
927100|NCT00942734|3056611|P1|Overall Study|Physician Decision|1
927101|NCT00942734|3056611|P1|Overall Study|Disease Progression|2
927102|NCT00942734|3056611|P1|Overall Study|Protocol Violation|3
927103|NCT00942734|3056611|P1|Overall Study|Adverse Event|2
927104|NCT00942604|3056617|P2|Overall Study|Patient relocation|1
927105|NCT00942604|3056618|P1|Overall Study|Patient relocation|1
927106|NCT00942604|3056617|P2|Overall Study|Withdrawal by Subject|1
927107|NCT00942604|3056618|P1|Overall Study|Withdrawal by Subject|0
927108|NCT00942604|3056617|P2|Overall Study|Adverse Event|1
927109|NCT00942604|3056618|P1|Overall Study|Adverse Event|0
927110|NCT00942604|3056617|P2|Overall Study|Protocol Violation|1
927111|NCT00942604|3056618|P1|Overall Study|Protocol Violation|1
927112|NCT00942422|3056726|P1|Overall Study|Progressive diease|1
927113|NCT00942422|3056726|P1|Overall Study|Death|1
927114|NCT00942422|3056726|P1|Overall Study|Withdrawal by Subject|1
927115|NCT00942409|3056730|P1|Overall Study|study drug unavailable|2
927116|NCT00942409|3056730|P1|Overall Study|Lack of Efficacy|1
927117|NCT00942266|3056736|P2|Overall Study|medical deterioration (pneumonia)|1
927118|NCT00942266|3056737|P1|Overall Study|medical deterioration (pneumonia)|0
927119|NCT00942266|3056736|P2|Overall Study|Physician Decision|0
927120|NCT00942266|3056737|P1|Overall Study|Physician Decision|2
927121|NCT00942266|3056736|P2|Overall Study|Intercurrent illness|1
927122|NCT00942266|3056737|P1|Overall Study|Intercurrent illness|0
927123|NCT00942266|3056736|P2|Overall Study|Failure to thrive and pt withdrawal|1
927124|NCT00942266|3056737|P1|Overall Study|Failure to thrive and pt withdrawal|0
927125|NCT00942266|3056736|P2|Overall Study|Disease Progression|11
927126|NCT00942266|3056737|P1|Overall Study|Disease Progression|38
927127|NCT00942266|3056736|P2|Overall Study|Adverse Event|1
927128|NCT00942266|3056737|P1|Overall Study|Adverse Event|2
927129|NCT00942266|3056736|P2|Overall Study|Withdrawal by Subject|0
927130|NCT00942266|3056737|P1|Overall Study|Withdrawal by Subject|1
927131|NCT00942188|3056759|P4|Overall Study|Sponsor Decision|1
927132|NCT00942188|3056760|P3|Overall Study|Sponsor Decision|0
927133|NCT00942188|3056761|P2|Overall Study|Sponsor Decision|2
927134|NCT00942188|3056762|P1|Overall Study|Sponsor Decision|0
927135|NCT00942188|3056759|P4|Overall Study|Physician Decision|0
927136|NCT00942188|3056760|P3|Overall Study|Physician Decision|1
927137|NCT00942188|3056761|P2|Overall Study|Physician Decision|0
927138|NCT00942188|3056762|P1|Overall Study|Physician Decision|0
927139|NCT00942188|3056759|P4|Overall Study|Withdrawal by Subject|2
927140|NCT00942188|3056760|P3|Overall Study|Withdrawal by Subject|4
927141|NCT00942188|3056761|P2|Overall Study|Withdrawal by Subject|3
927142|NCT00942188|3056762|P1|Overall Study|Withdrawal by Subject|1
927143|NCT00942188|3056759|P4|Overall Study|Lost to Follow-up|0
927144|NCT00942188|3056760|P3|Overall Study|Lost to Follow-up|2
927145|NCT00942188|3056761|P2|Overall Study|Lost to Follow-up|1
927146|NCT00942188|3056762|P1|Overall Study|Lost to Follow-up|2
927147|NCT00942188|3056759|P4|Overall Study|Protocol Violation|0
927148|NCT00942188|3056760|P3|Overall Study|Protocol Violation|0
927149|NCT00942188|3056761|P2|Overall Study|Protocol Violation|1
927150|NCT00942188|3056762|P1|Overall Study|Protocol Violation|1
927151|NCT00942188|3056759|P4|Overall Study|Lack of Efficacy|1
927152|NCT00942188|3056760|P3|Overall Study|Lack of Efficacy|0
927153|NCT00942188|3056761|P2|Overall Study|Lack of Efficacy|0
927154|NCT00942188|3056762|P1|Overall Study|Lack of Efficacy|0
927155|NCT00942188|3056759|P4|Overall Study|Adverse Event|0
927156|NCT00942188|3056760|P3|Overall Study|Adverse Event|2
927157|NCT00942188|3056761|P2|Overall Study|Adverse Event|3
927158|NCT00942188|3056762|P1|Overall Study|Adverse Event|0
927159|NCT00942175|3056801|P4|Overall Study|Low Platelet Count|0
927160|NCT00942175|3056802|P3|Overall Study|Low Platelet Count|0
927161|NCT00942175|3056803|P2|Overall Study|Low Platelet Count|2
927162|NCT00942175|3056804|P1|Overall Study|Low Platelet Count|0
927163|NCT00942175|3056801|P4|Overall Study|Elevated Alanine Amino Transferase|1
927164|NCT00942175|3056802|P3|Overall Study|Elevated Alanine Amino Transferase|0
927165|NCT00942175|3056803|P2|Overall Study|Elevated Alanine Amino Transferase|0
927166|NCT00942175|3056804|P1|Overall Study|Elevated Alanine Amino Transferase|0
927167|NCT00942175|3056801|P4|Overall Study|Pregnancy|1
927168|NCT00942175|3056802|P3|Overall Study|Pregnancy|0
927169|NCT00942175|3056803|P2|Overall Study|Pregnancy|0
927170|NCT00942175|3056804|P1|Overall Study|Pregnancy|0
927171|NCT00942175|3056801|P4|Overall Study|Protocol Violation|0
927172|NCT00942175|3056802|P3|Overall Study|Protocol Violation|2
927173|NCT00942175|3056803|P2|Overall Study|Protocol Violation|1
927174|NCT00942175|3056804|P1|Overall Study|Protocol Violation|0
927175|NCT00942175|3056801|P4|Overall Study|Adverse Event|0
927176|NCT00942175|3056802|P3|Overall Study|Adverse Event|0
927177|NCT00942175|3056803|P2|Overall Study|Adverse Event|1
927178|NCT00942175|3056804|P1|Overall Study|Adverse Event|2
927179|NCT00942162|3056857|P3|Overall Study|Other|0
927180|NCT00942162|3056858|P2|Overall Study|Other|2
927181|NCT00942162|3056859|P1|Overall Study|Other|8
927182|NCT00942162|3056857|P3|Overall Study|Withdrawal by Subject|0
927183|NCT00942162|3056858|P2|Overall Study|Withdrawal by Subject|2
927184|NCT00942162|3056859|P1|Overall Study|Withdrawal by Subject|4
927185|NCT00942162|3056857|P3|Overall Study|Protocol Violation|0
927186|NCT00942162|3056858|P2|Overall Study|Protocol Violation|0
927187|NCT00942162|3056859|P1|Overall Study|Protocol Violation|1
927188|NCT00942162|3056857|P3|Overall Study|Adverse Event|0
927189|NCT00942162|3056858|P2|Overall Study|Adverse Event|0
927190|NCT00942162|3056859|P1|Overall Study|Adverse Event|2
927191|NCT00942162|3056857|P3|Overall Study|Disease progression|1
927192|NCT00942162|3056858|P2|Overall Study|Disease progression|43
927193|NCT00942162|3056859|P1|Overall Study|Disease progression|53
927194|NCT00942084|3056928|P1|Overall Study|Death|2
927195|NCT00941928|3056945|P1|Overall Study|Disease Progression|1
927196|NCT00941928|3056945|P1|Overall Study|Withdrawal by Subject|1
927197|NCT00941863|3056963|P5|Continued After PCD|Disease progression, recurrence, relapse|18
927198|NCT00941863|3056964|P4|Continued After PCD|Disease progression, recurrence, relapse|0
927199|NCT00941863|3056965|P3|Continued After PCD|Disease progression, recurrence, relapse|0
927200|NCT00941863|3056966|P2|Continued After PCD|Disease progression, recurrence, relapse|0
927201|NCT00941863|3056967|P1|Continued After PCD|Disease progression, recurrence, relapse|0
927202|NCT00941863|3056963|P5|Continued After PCD|Withdrawal by Subject|1
927203|NCT00941863|3056964|P4|Continued After PCD|Withdrawal by Subject|0
927204|NCT00941863|3056965|P3|Continued After PCD|Withdrawal by Subject|0
927205|NCT00941863|3056966|P2|Continued After PCD|Withdrawal by Subject|0
927206|NCT00941863|3056967|P1|Continued After PCD|Withdrawal by Subject|0
927207|NCT00941863|3056963|P5|Until Primary Completion Date (PCD)|Disease progression|73
927208|NCT00941863|3056964|P4|Until Primary Completion Date (PCD)|Disease progression|14
927209|NCT00941863|3056965|P3|Until Primary Completion Date (PCD)|Disease progression|8
927210|NCT00941863|3056966|P2|Until Primary Completion Date (PCD)|Disease progression|1
927211|NCT00941863|3056967|P1|Until Primary Completion Date (PCD)|Disease progression|6
927212|NCT00941863|3056963|P5|Until Primary Completion Date (PCD)|Death|7
927213|NCT00941863|3056964|P4|Until Primary Completion Date (PCD)|Death|2
927214|NCT00941863|3056965|P3|Until Primary Completion Date (PCD)|Death|1
927215|NCT00941863|3056966|P2|Until Primary Completion Date (PCD)|Death|0
927216|NCT00941863|3056967|P1|Until Primary Completion Date (PCD)|Death|0
927217|NCT00941863|3056963|P5|Until Primary Completion Date (PCD)|Withdrawal by Subject|8
927218|NCT00941863|3056964|P4|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
927219|NCT00941863|3056965|P3|Until Primary Completion Date (PCD)|Withdrawal by Subject|1
927220|NCT00941863|3056966|P2|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
927221|NCT00941863|3056967|P1|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
927222|NCT00941863|3056963|P5|Until Primary Completion Date (PCD)|Physician Decision|1
927223|NCT00941863|3056964|P4|Until Primary Completion Date (PCD)|Physician Decision|0
927224|NCT00941863|3056965|P3|Until Primary Completion Date (PCD)|Physician Decision|0
927225|NCT00941863|3056966|P2|Until Primary Completion Date (PCD)|Physician Decision|0
927226|NCT00941863|3056967|P1|Until Primary Completion Date (PCD)|Physician Decision|0
927227|NCT00941863|3056963|P5|Until Primary Completion Date (PCD)|Adverse Event|5
927228|NCT00941863|3056964|P4|Until Primary Completion Date (PCD)|Adverse Event|1
927229|NCT00941863|3056965|P3|Until Primary Completion Date (PCD)|Adverse Event|2
927230|NCT00941863|3056966|P2|Until Primary Completion Date (PCD)|Adverse Event|2
927231|NCT00941863|3056967|P1|Until Primary Completion Date (PCD)|Adverse Event|1
927232|NCT00941798|3056994|P2|Overall Study|Death|1
927233|NCT00941798|3056995|P1|Overall Study|Death|0
927234|NCT00941798|3056994|P2|Overall Study|Abnormal laboratory values|2
927235|NCT00941798|3056995|P1|Overall Study|Abnormal laboratory values|1
927236|NCT00941798|3056994|P2|Overall Study|Abnormal test procedure results|1
927237|NCT00941798|3056995|P1|Overall Study|Abnormal test procedure results|3
927238|NCT00941798|3056994|P2|Overall Study|Patient's inability to use device|1
927239|NCT00941798|3056995|P1|Overall Study|Patient's inability to use device|6
927240|NCT00941798|3056994|P2|Overall Study|Lack of Efficacy|17
927241|NCT00941798|3056995|P1|Overall Study|Lack of Efficacy|10
927242|NCT00941798|3056994|P2|Overall Study|Administrative problems|23
927243|NCT00941798|3056995|P1|Overall Study|Administrative problems|13
927244|NCT00941798|3056994|P2|Overall Study|Protocol Violation|20
927245|NCT00941798|3056995|P1|Overall Study|Protocol Violation|17
927246|NCT00941798|3056994|P2|Overall Study|Lost to Follow-up|23
927247|NCT00941798|3056995|P1|Overall Study|Lost to Follow-up|29
927248|NCT00941798|3056994|P2|Overall Study|Adverse Event|23
927249|NCT00941798|3056995|P1|Overall Study|Adverse Event|43
927250|NCT00941798|3056994|P2|Overall Study|Withdrawal by Subject|74
927251|NCT00941798|3056995|P1|Overall Study|Withdrawal by Subject|72
927252|NCT00941733|3057025|P2|Overall Study|Protocol Violation|6
927253|NCT00941733|3057026|P1|Overall Study|Protocol Violation|15
927254|NCT00941733|3057025|P2|Overall Study|Lost to Follow-up|2
927255|NCT00941733|3057026|P1|Overall Study|Lost to Follow-up|1
927256|NCT00941733|3057025|P2|Overall Study|Adverse Event|4
927257|NCT00941733|3057026|P1|Overall Study|Adverse Event|20
927258|NCT00941733|3057025|P2|Overall Study|Withdrawal by Subject|6
927259|NCT00941733|3057026|P1|Overall Study|Withdrawal by Subject|14
927260|NCT00941733|3057025|P2|Overall Study|Death|10
927261|NCT00941733|3057026|P1|Overall Study|Death|24
927262|NCT00941720|3057066|P1|Overall Study|ineligible|2
927263|NCT00941720|3057066|P1|Overall Study|Insurance denied participation|11
927264|NCT00941720|3057066|P1|Overall Study|Withdrawal by Subject|1
927265|NCT00941655|3057113|P2|Overall Study|non-compliant|1
927266|NCT00941655|3057114|P1|Overall Study|non-compliant|0
927267|NCT00941655|3057113|P2|Overall Study|withdrew consent|1
927268|NCT00941655|3057114|P1|Overall Study|withdrew consent|0
927269|NCT00941655|3057113|P2|Overall Study|refused further treatment|1
927270|NCT00941655|3057114|P1|Overall Study|refused further treatment|0
927271|NCT00941655|3057113|P2|Overall Study|progressed while on chemo|2
927272|NCT00941655|3057114|P1|Overall Study|progressed while on chemo|0
927273|NCT00941655|3057113|P2|Overall Study|not meet criteria for chemo foll surgery|0
927274|NCT00941655|3057114|P1|Overall Study|not meet criteria for chemo foll surgery|4
927275|NCT00941655|3057113|P2|Overall Study|received some chemo, 4 and 9 cycles|0
927276|NCT00941655|3057114|P1|Overall Study|received some chemo, 4 and 9 cycles|1
927277|NCT00941603|3057139|P6|Overall Study|Did not meet protocol eligibility|0
927278|NCT00941603|3057140|P5|Overall Study|Did not meet protocol eligibility|0
927279|NCT00941603|3057141|P4|Overall Study|Did not meet protocol eligibility|0
927280|NCT00941603|3057142|P3|Overall Study|Did not meet protocol eligibility|0
927281|NCT00941603|3057143|P2|Overall Study|Did not meet protocol eligibility|0
927282|NCT00941603|3057144|P1|Overall Study|Did not meet protocol eligibility|1
927283|NCT00941603|3057139|P6|Overall Study|Protocol Violation|0
927284|NCT00941603|3057140|P5|Overall Study|Protocol Violation|0
927285|NCT00941603|3057141|P4|Overall Study|Protocol Violation|0
927286|NCT00941603|3057142|P3|Overall Study|Protocol Violation|0
927287|NCT00941603|3057143|P2|Overall Study|Protocol Violation|1
927288|NCT00941603|3057144|P1|Overall Study|Protocol Violation|0
927289|NCT00941603|3057139|P6|Overall Study|Withdrawal by Subject|1
927290|NCT00941603|3057140|P5|Overall Study|Withdrawal by Subject|0
927291|NCT00941603|3057141|P4|Overall Study|Withdrawal by Subject|2
927292|NCT00941603|3057142|P3|Overall Study|Withdrawal by Subject|0
927293|NCT00941603|3057143|P2|Overall Study|Withdrawal by Subject|0
927294|NCT00941603|3057144|P1|Overall Study|Withdrawal by Subject|0
927295|NCT00941603|3057139|P6|Overall Study|Lost to Follow-up|2
927296|NCT00941603|3057140|P5|Overall Study|Lost to Follow-up|0
927297|NCT00941603|3057141|P4|Overall Study|Lost to Follow-up|1
927298|NCT00941603|3057142|P3|Overall Study|Lost to Follow-up|0
927299|NCT00941603|3057143|P2|Overall Study|Lost to Follow-up|0
927300|NCT00941603|3057144|P1|Overall Study|Lost to Follow-up|0
927301|NCT00941603|3057139|P6|Overall Study|Adverse Event|0
927302|NCT00941603|3057140|P5|Overall Study|Adverse Event|4
927303|NCT00941603|3057141|P4|Overall Study|Adverse Event|1
927304|NCT00941603|3057142|P3|Overall Study|Adverse Event|5
927305|NCT00941603|3057143|P2|Overall Study|Adverse Event|15
927306|NCT00941603|3057144|P1|Overall Study|Adverse Event|10
927307|NCT00941330|3057166|P2|Overall Study|Physician Decision|2
927308|NCT00941330|3057167|P1|Overall Study|Physician Decision|0
927309|NCT00941330|3057166|P2|Overall Study|Other|0
927310|NCT00941330|3057167|P1|Overall Study|Other|1
927311|NCT00941304|3057180|P5|Overall Study|Lost to Follow-up|0
927312|NCT00941304|3057181|P4|Overall Study|Lost to Follow-up|0
927313|NCT00941304|3057182|P3|Overall Study|Lost to Follow-up|0
927314|NCT00941304|3057183|P2|Overall Study|Lost to Follow-up|0
927315|NCT00941304|3057184|P1|Overall Study|Lost to Follow-up|1
927316|NCT00941070|3057246|P1|Overall Study|Patient non-compliant|1
927317|NCT00941031|3057266|P7|Maintenance Period|Lack of Efficacy|13
927318|NCT00941031|3057267|P6|Maintenance Period|Lack of Efficacy|0
927319|NCT00941031|3057268|P5|Maintenance Period|Lack of Efficacy|0
927320|NCT00941031|3057269|P4|Maintenance Period|Lack of Efficacy|0
927321|NCT00941031|3057270|P3|Maintenance Period|Lack of Efficacy|0
927322|NCT00941031|3057271|P2|Maintenance Period|Lack of Efficacy|0
927323|NCT00941031|3057272|P1|Maintenance Period|Lack of Efficacy|0
927324|NCT00941031|3057266|P7|Maintenance Period|Lost to Follow-up|7
927325|NCT00941031|3057267|P6|Maintenance Period|Lost to Follow-up|2
927326|NCT00941031|3057268|P5|Maintenance Period|Lost to Follow-up|2
927327|NCT00941031|3057269|P4|Maintenance Period|Lost to Follow-up|0
927328|NCT00941031|3057270|P3|Maintenance Period|Lost to Follow-up|0
927329|NCT00941031|3057271|P2|Maintenance Period|Lost to Follow-up|0
927330|NCT00941031|3057272|P1|Maintenance Period|Lost to Follow-up|0
927331|NCT00941031|3057266|P7|Maintenance Period|Adverse Event|8
927332|NCT00941031|3057267|P6|Maintenance Period|Adverse Event|2
927333|NCT00941031|3057268|P5|Maintenance Period|Adverse Event|0
927334|NCT00941031|3057269|P4|Maintenance Period|Adverse Event|0
927335|NCT00941031|3057270|P3|Maintenance Period|Adverse Event|0
927336|NCT00941031|3057271|P2|Maintenance Period|Adverse Event|0
927337|NCT00941031|3057272|P1|Maintenance Period|Adverse Event|0
927338|NCT00941031|3057266|P7|Maintenance Period|Protocol Violation|1
927339|NCT00941031|3057267|P6|Maintenance Period|Protocol Violation|0
927340|NCT00941031|3057268|P5|Maintenance Period|Protocol Violation|0
927341|NCT00941031|3057269|P4|Maintenance Period|Protocol Violation|0
927342|NCT00941031|3057270|P3|Maintenance Period|Protocol Violation|0
927343|NCT00941031|3057271|P2|Maintenance Period|Protocol Violation|0
927344|NCT00941031|3057272|P1|Maintenance Period|Protocol Violation|0
927345|NCT00941031|3057266|P7|Maintenance Period|Administrative Problems|1
927346|NCT00941031|3057267|P6|Maintenance Period|Administrative Problems|0
927347|NCT00941031|3057268|P5|Maintenance Period|Administrative Problems|1
927348|NCT00941031|3057269|P4|Maintenance Period|Administrative Problems|0
927349|NCT00941031|3057270|P3|Maintenance Period|Administrative Problems|0
927350|NCT00941031|3057271|P2|Maintenance Period|Administrative Problems|0
927351|NCT00941031|3057272|P1|Maintenance Period|Administrative Problems|0
927352|NCT00941031|3057266|P7|Maintenance Period|Withdrawal by Subject|13
927353|NCT00941031|3057267|P6|Maintenance Period|Withdrawal by Subject|2
927354|NCT00941031|3057268|P5|Maintenance Period|Withdrawal by Subject|6
927355|NCT00941031|3057269|P4|Maintenance Period|Withdrawal by Subject|0
927356|NCT00941031|3057270|P3|Maintenance Period|Withdrawal by Subject|0
927357|NCT00941031|3057271|P2|Maintenance Period|Withdrawal by Subject|0
927358|NCT00941031|3057272|P1|Maintenance Period|Withdrawal by Subject|0
927359|NCT00941031|3057266|P7|Induction Period|Adverse Event|0
927360|NCT00941031|3057267|P6|Induction Period|Adverse Event|0
927361|NCT00941031|3057268|P5|Induction Period|Adverse Event|0
927362|NCT00941031|3057269|P4|Induction Period|Adverse Event|2
927363|NCT00941031|3057270|P3|Induction Period|Adverse Event|3
927364|NCT00941031|3057271|P2|Induction Period|Adverse Event|0
927365|NCT00941031|3057272|P1|Induction Period|Adverse Event|1
927366|NCT00941031|3057266|P7|Induction Period|Adminstative Problems|0
927367|NCT00941031|3057267|P6|Induction Period|Adminstative Problems|0
927368|NCT00941031|3057268|P5|Induction Period|Adminstative Problems|0
927369|NCT00941031|3057269|P4|Induction Period|Adminstative Problems|0
927370|NCT00941031|3057270|P3|Induction Period|Adminstative Problems|1
927371|NCT00941031|3057271|P2|Induction Period|Adminstative Problems|1
927372|NCT00941031|3057272|P1|Induction Period|Adminstative Problems|1
927373|NCT00941031|3057266|P7|Induction Period|Withdrawal by Subject|0
927374|NCT00941031|3057267|P6|Induction Period|Withdrawal by Subject|0
927375|NCT00941031|3057268|P5|Induction Period|Withdrawal by Subject|0
927376|NCT00941031|3057269|P4|Induction Period|Withdrawal by Subject|2
927377|NCT00941031|3057270|P3|Induction Period|Withdrawal by Subject|2
927378|NCT00941031|3057271|P2|Induction Period|Withdrawal by Subject|2
927379|NCT00941031|3057272|P1|Induction Period|Withdrawal by Subject|1
927380|NCT00941031|3057266|P7|Induction Period|Lack of Efficacy|0
927381|NCT00941031|3057267|P6|Induction Period|Lack of Efficacy|0
927382|NCT00941031|3057268|P5|Induction Period|Lack of Efficacy|0
927383|NCT00941031|3057269|P4|Induction Period|Lack of Efficacy|5
927384|NCT00941031|3057270|P3|Induction Period|Lack of Efficacy|0
927385|NCT00941031|3057271|P2|Induction Period|Lack of Efficacy|1
927386|NCT00941031|3057272|P1|Induction Period|Lack of Efficacy|2
927387|NCT00940992|3057298|P3|Overall Study|Lost to Follow-up|1
927388|NCT00940992|3057299|P2|Overall Study|Lost to Follow-up|1
927389|NCT00940992|3057300|P1|Overall Study|Lost to Follow-up|0
927390|NCT00940992|3057298|P3|Overall Study|subject request|0
927391|NCT00940992|3057299|P2|Overall Study|subject request|1
927392|NCT00940992|3057300|P1|Overall Study|subject request|2
927393|NCT00940992|3057298|P3|Overall Study|Adverse Event|1
927394|NCT00940992|3057299|P2|Overall Study|Adverse Event|0
927395|NCT00940992|3057300|P1|Overall Study|Adverse Event|2
927396|NCT00940888|3057329|P1|Overall Study|Lost to Follow-up|6
927397|NCT00940888|3057329|P1|Overall Study|Withdrawn - Non-Death|364
927398|NCT00940888|3057329|P1|Overall Study|Death|461
927399|NCT00940888|3057329|P1|Overall Study|Unsuccessful Implant|4
927400|NCT00940875|3057336|P2|Post-Study Treatment|Disease Progression|2
927401|NCT00940875|3057337|P1|Post-Study Treatment|Disease Progression|0
927402|NCT00940875|3057336|P2|Post-Study Treatment|Death|1
927403|NCT00940875|3057337|P1|Post-Study Treatment|Death|0
927404|NCT00940875|3057336|P2|Treatment Phase|Physician Decision|0
927405|NCT00940875|3057337|P1|Treatment Phase|Physician Decision|1
927406|NCT00940875|3057336|P2|Treatment Phase|Disease progression|11
927407|NCT00940875|3057337|P1|Treatment Phase|Disease progression|9
927408|NCT00940875|3057336|P2|Treatment Phase|Withdrawal by Subject|0
927409|NCT00940875|3057337|P1|Treatment Phase|Withdrawal by Subject|3
927410|NCT00940875|3057336|P2|Treatment Phase|Lack of Efficacy|0
927411|NCT00940875|3057337|P1|Treatment Phase|Lack of Efficacy|1
927412|NCT00940875|3057336|P2|Treatment Phase|Death|5
927413|NCT00940875|3057337|P1|Treatment Phase|Death|3
927414|NCT00940875|3057336|P2|Treatment Phase|Adverse Event|3
927415|NCT00940875|3057337|P1|Treatment Phase|Adverse Event|9
927416|NCT00940823|3057357|P2|Overall Study|Lost to Follow-up|20
927417|NCT00940823|3057358|P1|Overall Study|Lost to Follow-up|27
927418|NCT00940823|3057357|P2|Overall Study|Death|12
927419|NCT00940823|3057358|P1|Overall Study|Death|8
927420|NCT00940498|3057415|P8|Overall Study|Not treated due to disease related pain|0
927421|NCT00940498|3057416|P7|Overall Study|Not treated due to disease related pain|0
927422|NCT00940498|3057417|P6|Overall Study|Not treated due to disease related pain|0
927423|NCT00940498|3057418|P5|Overall Study|Not treated due to disease related pain|1
927424|NCT00940498|3057419|P4|Overall Study|Not treated due to disease related pain|0
927425|NCT00940498|3057420|P3|Overall Study|Not treated due to disease related pain|0
927426|NCT00940498|3057421|P2|Overall Study|Not treated due to disease related pain|0
927427|NCT00940498|3057422|P1|Overall Study|Not treated due to disease related pain|0
927428|NCT00940498|3057415|P8|Overall Study|Physician Decision|0
927429|NCT00940498|3057416|P7|Overall Study|Physician Decision|0
927430|NCT00940498|3057417|P6|Overall Study|Physician Decision|0
927431|NCT00940498|3057418|P5|Overall Study|Physician Decision|2
927432|NCT00940498|3057419|P4|Overall Study|Physician Decision|0
927433|NCT00940498|3057420|P3|Overall Study|Physician Decision|0
927434|NCT00940498|3057421|P2|Overall Study|Physician Decision|0
927435|NCT00940498|3057422|P1|Overall Study|Physician Decision|0
927436|NCT00940498|3057415|P8|Overall Study|Disease Progression|0
927437|NCT00940498|3057416|P7|Overall Study|Disease Progression|0
927438|NCT00940498|3057417|P6|Overall Study|Disease Progression|1
927439|NCT00940498|3057418|P5|Overall Study|Disease Progression|0
927440|NCT00940498|3057419|P4|Overall Study|Disease Progression|1
927441|NCT00940498|3057420|P3|Overall Study|Disease Progression|1
927442|NCT00940498|3057421|P2|Overall Study|Disease Progression|0
927443|NCT00940498|3057422|P1|Overall Study|Disease Progression|0
927444|NCT00940498|3057415|P8|Overall Study|Lost to Follow-up|1
927445|NCT00940498|3057416|P7|Overall Study|Lost to Follow-up|0
927446|NCT00940498|3057417|P6|Overall Study|Lost to Follow-up|0
927447|NCT00940498|3057418|P5|Overall Study|Lost to Follow-up|1
927448|NCT00940498|3057419|P4|Overall Study|Lost to Follow-up|0
927449|NCT00940498|3057420|P3|Overall Study|Lost to Follow-up|2
927450|NCT00940498|3057421|P2|Overall Study|Lost to Follow-up|1
927451|NCT00940498|3057422|P1|Overall Study|Lost to Follow-up|1
927452|NCT00940498|3057415|P8|Overall Study|Death|0
927453|NCT00940498|3057416|P7|Overall Study|Death|1
927454|NCT00940498|3057417|P6|Overall Study|Death|0
927455|NCT00940498|3057418|P5|Overall Study|Death|5
927456|NCT00940498|3057419|P4|Overall Study|Death|1
927457|NCT00940498|3057420|P3|Overall Study|Death|0
927458|NCT00940498|3057421|P2|Overall Study|Death|0
927459|NCT00940498|3057422|P1|Overall Study|Death|2
927460|NCT00940485|3057540|P2|Overall Study|Others|1
927461|NCT00940485|3057541|P1|Overall Study|Others|1
927462|NCT00940485|3057540|P2|Overall Study|Withdrawal by Subject|1
927463|NCT00940485|3057541|P1|Overall Study|Withdrawal by Subject|1
927464|NCT00940485|3057540|P2|Overall Study|Adverse Event|0
927465|NCT00940485|3057541|P1|Overall Study|Adverse Event|8
927466|NCT00940485|3057540|P2|Overall Study|Lost to Follow-up|3
927467|NCT00940485|3057541|P1|Overall Study|Lost to Follow-up|2
927468|NCT00940485|3057540|P2|Overall Study|HBeAb positive at Baseline|2
927469|NCT00940485|3057541|P1|Overall Study|HBeAb positive at Baseline|3
927470|NCT00940342|3057579|P3|Overall Study|Adverse Event|1
927471|NCT00940342|3057580|P2|Overall Study|Adverse Event|2
927472|NCT00940342|3057581|P1|Overall Study|Adverse Event|0
927473|NCT00940108|3057610|P4|Overall Study|Diagnosed with H1N1|1
927474|NCT00940108|3057611|P3|Overall Study|Diagnosed with H1N1|0
927475|NCT00940108|3057612|P2|Overall Study|Diagnosed with H1N1|0
927476|NCT00940108|3057613|P1|Overall Study|Diagnosed with H1N1|0
927477|NCT00940108|3057610|P4|Overall Study|Viral illness after Dose 1|0
927478|NCT00940108|3057611|P3|Overall Study|Viral illness after Dose 1|0
927479|NCT00940108|3057612|P2|Overall Study|Viral illness after Dose 1|1
927480|NCT00940108|3057613|P1|Overall Study|Viral illness after Dose 1|0
927481|NCT00940108|3057610|P4|Overall Study|Refused - pyrexia after Dose 1|0
927482|NCT00940108|3057611|P3|Overall Study|Refused - pyrexia after Dose 1|0
927483|NCT00940108|3057612|P2|Overall Study|Refused - pyrexia after Dose 1|1
927484|NCT00940108|3057613|P1|Overall Study|Refused - pyrexia after Dose 1|0
927485|NCT00940108|3057610|P4|Overall Study|Declined further vaccination|0
927486|NCT00940108|3057611|P3|Overall Study|Declined further vaccination|3
927487|NCT00940108|3057612|P2|Overall Study|Declined further vaccination|1
927488|NCT00940108|3057613|P1|Overall Study|Declined further vaccination|0
927489|NCT00940108|3057610|P4|Overall Study|Dose 2 contraindicated|1
927490|NCT00940108|3057611|P3|Overall Study|Dose 2 contraindicated|0
927491|NCT00940108|3057612|P2|Overall Study|Dose 2 contraindicated|1
927492|NCT00940108|3057613|P1|Overall Study|Dose 2 contraindicated|1
927493|NCT00940108|3057610|P4|Overall Study|Withdrew Consent|1
927494|NCT00940108|3057611|P3|Overall Study|Withdrew Consent|0
927495|NCT00940108|3057612|P2|Overall Study|Withdrew Consent|1
927496|NCT00940108|3057613|P1|Overall Study|Withdrew Consent|2
927497|NCT00940108|3057610|P4|Overall Study|Adverse Event|2
927498|NCT00940108|3057611|P3|Overall Study|Adverse Event|0
927499|NCT00940108|3057612|P2|Overall Study|Adverse Event|4
927500|NCT00940108|3057613|P1|Overall Study|Adverse Event|2
927501|NCT00940017|3057663|P1|Overall Study|Adverse Event|1
927502|NCT00940017|3057663|P1|Overall Study|did not meet entrance criteria|3
927503|NCT00939809|3057719|P1|Overall Study|Death|1
927504|NCT00939809|3057719|P1|Overall Study|Adverse Event|2
927505|NCT00939783|3057734|P1|Overall Study|Enrolled but not treated|1
927506|NCT00939783|3057734|P1|Overall Study|Protocol Violation|3
927507|NCT00939783|3057734|P1|Overall Study|Lost to Follow-up|8
927508|NCT00939783|3057734|P1|Overall Study|Other|16
927509|NCT00939783|3057734|P1|Overall Study|Withdrawal by Subject|78
927510|NCT00939783|3057734|P1|Overall Study|Study Terminated by Sponsor|498
927511|NCT00939783|3057734|P1|Overall Study|Adverse Event|39
927512|NCT00939783|3057734|P1|Overall Study|Death|6
927513|NCT00939692|3057775|P2|Period 2 - Second Intervent - 5 Days|Protocol Violation|1
927514|NCT00939692|3057776|P1|Period 2 - Second Intervent - 5 Days|Protocol Violation|0
927515|NCT00939692|3057775|P2|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0
927516|NCT00939692|3057776|P1|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1
927517|NCT00939640|3057786|P1|Overall Study|Physician Decision|1
927518|NCT00939627|3057809|P3|Overall Study|No off-tx reason given|0
927519|NCT00939627|3057810|P2|Overall Study|No off-tx reason given|2
927520|NCT00939627|3057811|P1|Overall Study|No off-tx reason given|0
927521|NCT00939627|3057809|P3|Overall Study|Not compliant|0
927522|NCT00939627|3057810|P2|Overall Study|Not compliant|0
927523|NCT00939627|3057811|P1|Overall Study|Not compliant|2
927524|NCT00939627|3057809|P3|Overall Study|Other complicating disease|0
927525|NCT00939627|3057810|P2|Overall Study|Other complicating disease|1
927526|NCT00939627|3057811|P1|Overall Study|Other complicating disease|1
927527|NCT00939627|3057809|P3|Overall Study|Withdrawal by Subject|0
927528|NCT00939627|3057810|P2|Overall Study|Withdrawal by Subject|4
927529|NCT00939627|3057811|P1|Overall Study|Withdrawal by Subject|2
927530|NCT00939627|3057809|P3|Overall Study|Death|0
927531|NCT00939627|3057810|P2|Overall Study|Death|2
927532|NCT00939627|3057811|P1|Overall Study|Death|0
927533|NCT00939627|3057809|P3|Overall Study|Adverse Event|0
927534|NCT00939627|3057810|P2|Overall Study|Adverse Event|7
927535|NCT00939627|3057811|P1|Overall Study|Adverse Event|6
927536|NCT00939627|3057809|P3|Overall Study|Disease Progression|0
927537|NCT00939627|3057810|P2|Overall Study|Disease Progression|12
927538|NCT00939627|3057811|P1|Overall Study|Disease Progression|16
927539|NCT00939510|3057851|P1|Overall Study|Withdrawal by Subject|1
927540|NCT00939484|3057860|P3|Overall Study|Progression/Relapse|3
927541|NCT00939484|3057861|P2|Overall Study|Progression/Relapse|20
927542|NCT00939484|3057862|P1|Overall Study|Progression/Relapse|8
927543|NCT00939393|3057888|P2|Overall Study|Lost to Follow-up|0
927544|NCT00939393|3057889|P1|Overall Study|Lost to Follow-up|3
927545|NCT00939393|3057888|P2|Overall Study|Withdrawal by Subject|0
927546|NCT00939393|3057889|P1|Overall Study|Withdrawal by Subject|1
927547|NCT00939341|3057920|P1|Overall Study|Incorrect enrolment|8
927548|NCT00939341|3057920|P1|Overall Study|Protocol Violation|6
927549|NCT00939341|3057920|P1|Overall Study|Withdrawal by Subject|13
927550|NCT00939341|3057920|P1|Overall Study|Lost to Follow-up|23
927551|NCT00939341|3057920|P1|Overall Study|Pregnancy|1
927552|NCT00939341|3057920|P1|Overall Study|Adverse Event|15
927553|NCT00939185|3058007|P1|Overall Study|Randomized But Did Not Receive Treatment|10
927554|NCT00939185|3058007|P1|Overall Study|Withdrawal by Subject|2
927555|NCT00939185|3058007|P1|Overall Study|Other|3
927556|NCT00939185|3058007|P1|Overall Study|Lost to Follow-up|6
927557|NCT00939185|3058007|P1|Overall Study|Lack of Efficacy|1
927558|NCT00939185|3058007|P1|Overall Study|Adverse Event|3
927559|NCT00939107|3058045|P2|Overall Study|Lost to Follow-up|12
927560|NCT00939107|3058046|P1|Overall Study|Lost to Follow-up|14
927561|NCT00939094|3058060|P2|Overall Study|Abnormal ECG findings|0
927562|NCT00939094|3058061|P1|Overall Study|Abnormal ECG findings|1
927563|NCT00939094|3058060|P2|Overall Study|Study stopped by sponsor|2
927564|NCT00939094|3058061|P1|Overall Study|Study stopped by sponsor|0
927565|NCT00939094|3058060|P2|Overall Study|Severe non-compliance to protocol|1
927566|NCT00939094|3058061|P1|Overall Study|Severe non-compliance to protocol|0
927567|NCT00939094|3058060|P2|Overall Study|Eligibility criteria not fulfilled|0
927568|NCT00939094|3058061|P1|Overall Study|Eligibility criteria not fulfilled|2
927569|NCT00939094|3058060|P2|Overall Study|Lost to Follow-up|1
927570|NCT00939094|3058061|P1|Overall Study|Lost to Follow-up|1
927571|NCT00939094|3058060|P2|Overall Study|Withdrawal by Subject|6
927572|NCT00939094|3058061|P1|Overall Study|Withdrawal by Subject|1
927573|NCT00939094|3058060|P2|Overall Study|Adverse Event|0
927574|NCT00939094|3058061|P1|Overall Study|Adverse Event|9
927575|NCT00939055|3058083|P2|Overall Study|Discontinuation prior to procedure|0
927576|NCT00939055|3058084|P1|Overall Study|Discontinuation prior to procedure|4
927577|NCT00939029|3058094|P2|Overall Study|Adverse Event|1
927578|NCT00939029|3058095|P1|Overall Study|Adverse Event|0
927579|NCT00939029|3058094|P2|Overall Study|Lost to Follow-up|4
927580|NCT00939029|3058095|P1|Overall Study|Lost to Follow-up|3
927581|NCT00939029|3058094|P2|Overall Study|Withdrawal by Subject|7
927582|NCT00939029|3058095|P1|Overall Study|Withdrawal by Subject|3
927583|NCT00939003|3058107|P2|Open-label Treatment Period|Site Closure|4
927584|NCT00939003|3058108|P1|Open-label Treatment Period|Site Closure|3
927585|NCT00939003|3058107|P2|Open-label Treatment Period|Exclusion Criteria|0
927586|NCT00939003|3058108|P1|Open-label Treatment Period|Exclusion Criteria|1
927587|NCT00939003|3058107|P2|Open-label Treatment Period|Pregnancy|1
927588|NCT00939003|3058108|P1|Open-label Treatment Period|Pregnancy|1
927589|NCT00939003|3058107|P2|Open-label Treatment Period|Lack of Efficacy|9
927590|NCT00939003|3058108|P1|Open-label Treatment Period|Lack of Efficacy|6
927591|NCT00939003|3058107|P2|Open-label Treatment Period|Withdrawal by Subject|7
927592|NCT00939003|3058108|P1|Open-label Treatment Period|Withdrawal by Subject|14
927593|NCT00939003|3058107|P2|Open-label Treatment Period|Adverse Event|8
927594|NCT00939003|3058108|P1|Open-label Treatment Period|Adverse Event|4
927595|NCT00939003|3058107|P2|Double-blind Treatment Period|MRI Not Diagnostic|1
927596|NCT00939003|3058108|P1|Double-blind Treatment Period|MRI Not Diagnostic|1
927597|NCT00939003|3058107|P2|Double-blind Treatment Period|Pregnancy|1
927598|NCT00939003|3058108|P1|Double-blind Treatment Period|Pregnancy|0
927599|NCT00939003|3058107|P2|Double-blind Treatment Period|Lack of Efficacy|1
927600|NCT00939003|3058108|P1|Double-blind Treatment Period|Lack of Efficacy|0
927601|NCT00939003|3058107|P2|Double-blind Treatment Period|Adverse Event|1
927602|NCT00939003|3058108|P1|Double-blind Treatment Period|Adverse Event|1
927603|NCT00938964|3058145|P2|Overall Study|Found to Meet Exclusion Criteria|4
927604|NCT00938964|3058146|P1|Overall Study|Found to Meet Exclusion Criteria|3
927605|NCT00938964|3058145|P2|Overall Study|Withdrawal by Subject|18
927606|NCT00938964|3058146|P1|Overall Study|Withdrawal by Subject|22
927607|NCT00938964|3058145|P2|Overall Study|Lost to Follow-up|3
927608|NCT00938964|3058146|P1|Overall Study|Lost to Follow-up|2
927609|NCT00938964|3058145|P2|Overall Study|Death|3
927610|NCT00938964|3058146|P1|Overall Study|Death|3
927611|NCT00938886|3058210|P2|Overall Study|Lost to Follow-up|2
927612|NCT00938886|3058211|P1|Overall Study|Lost to Follow-up|3
927613|NCT00938886|3058210|P2|Overall Study|Withdrawal by Subject|7
927614|NCT00938886|3058211|P1|Overall Study|Withdrawal by Subject|4
927615|NCT00938886|3058210|P2|Overall Study|Death|1
927616|NCT00938886|3058211|P1|Overall Study|Death|0
927617|NCT00938860|3058221|P2|Overall Study|Protocol Violation|1
927618|NCT00938860|3058222|P1|Overall Study|Protocol Violation|3
927619|NCT00938860|3058221|P2|Overall Study|Death|1
927620|NCT00938860|3058222|P1|Overall Study|Death|1
927621|NCT00938860|3058221|P2|Overall Study|Administration problems|0
927622|NCT00938860|3058222|P1|Overall Study|Administration problems|2
927623|NCT00938860|3058221|P2|Overall Study|Lost to Follow-up|4
927624|NCT00938860|3058222|P1|Overall Study|Lost to Follow-up|4
927625|NCT00938860|3058221|P2|Overall Study|Withdrawal by Subject|8
927626|NCT00938860|3058222|P1|Overall Study|Withdrawal by Subject|11
927627|NCT00938860|3058221|P2|Overall Study|Abnormal laboratory values|2
927628|NCT00938860|3058222|P1|Overall Study|Abnormal laboratory values|2
927629|NCT00938860|3058221|P2|Overall Study|Adverse Event|1
927630|NCT00938860|3058222|P1|Overall Study|Adverse Event|2
927631|NCT00938717|3058255|P2|Overall Study|Other reason|2
927632|NCT00938717|3058256|P1|Overall Study|Other reason|5
927633|NCT00938717|3058255|P2|Overall Study|Lack of Efficacy|15
927634|NCT00938717|3058256|P1|Overall Study|Lack of Efficacy|33
927635|NCT00938717|3058255|P2|Overall Study|Lost to Follow-up|18
927636|NCT00938717|3058256|P1|Overall Study|Lost to Follow-up|13
927637|NCT00938717|3058255|P2|Overall Study|Withdrawal by Subject|24
927638|NCT00938717|3058256|P1|Overall Study|Withdrawal by Subject|26
927639|NCT00938717|3058255|P2|Overall Study|Protocol Violation|8
927640|NCT00938717|3058256|P1|Overall Study|Protocol Violation|11
927641|NCT00938717|3058255|P2|Overall Study|Adverse Event|41
927642|NCT00938717|3058256|P1|Overall Study|Adverse Event|10
927643|NCT00938639|3058307|P2|Overall Study|Participant noncompliance|0
927644|NCT00938639|3058308|P1|Overall Study|Participant noncompliance|1
927645|NCT00938639|3058307|P2|Overall Study|Family issues|1
927646|NCT00938639|3058308|P1|Overall Study|Family issues|1
927647|NCT00938639|3058307|P2|Overall Study|Lost to Follow-up|2
927648|NCT00938639|3058308|P1|Overall Study|Lost to Follow-up|1
927649|NCT00938639|3058307|P2|Overall Study|Moved away from study area|1
927650|NCT00938639|3058308|P1|Overall Study|Moved away from study area|0
927651|NCT00938470|3058391|P2|Overall Study|Other Reason|1
927652|NCT00938470|3058392|P1|Overall Study|Other Reason|0
927653|NCT00938470|3058391|P2|Overall Study|Death|2
927654|NCT00938470|3058392|P1|Overall Study|Death|3
927655|NCT00938470|3058391|P2|Overall Study|Alternate Treatment|0
927656|NCT00938470|3058392|P1|Overall Study|Alternate Treatment|1
927657|NCT00938470|3058391|P2|Overall Study|Disease Progression|0
927658|NCT00938470|3058392|P1|Overall Study|Disease Progression|3
927659|NCT00938431|3058422|P3|Overall Study|Reached maximum dose early|1
927660|NCT00938431|3058423|P2|Overall Study|Reached maximum dose early|0
927661|NCT00938431|3058424|P1|Overall Study|Reached maximum dose early|0
927662|NCT00938431|3058422|P3|Overall Study|Dosing compliance issue|1
927663|NCT00938431|3058423|P2|Overall Study|Dosing compliance issue|0
927664|NCT00938431|3058424|P1|Overall Study|Dosing compliance issue|0
927665|NCT00938431|3058422|P3|Overall Study|Did not up titrate to 12 mg kg/day|0
927666|NCT00938431|3058423|P2|Overall Study|Did not up titrate to 12 mg kg/day|0
927667|NCT00938431|3058424|P1|Overall Study|Did not up titrate to 12 mg kg/day|1
927668|NCT00938431|3058422|P3|Overall Study|Lack of Efficacy|0
927669|NCT00938431|3058423|P2|Overall Study|Lack of Efficacy|1
927670|NCT00938431|3058424|P1|Overall Study|Lack of Efficacy|0
927671|NCT00938431|3058422|P3|Overall Study|Adverse Event|6
927672|NCT00938431|3058423|P2|Overall Study|Adverse Event|8
927673|NCT00938431|3058424|P1|Overall Study|Adverse Event|5
927674|NCT00938392|3058451|P2|Overall Study|Lost to Follow-up|2
927675|NCT00938392|3058452|P1|Overall Study|Lost to Follow-up|2
927676|NCT00938392|3058451|P2|Overall Study|Withdrawal by Subject|1
927677|NCT00938392|3058452|P1|Overall Study|Withdrawal by Subject|0
927678|NCT00938392|3058451|P2|Overall Study|Adverse Event|1
927679|NCT00938392|3058452|P1|Overall Study|Adverse Event|0
927680|NCT00938366|3058478|P2|Overall Study|Withdrawal by Subject|0
927681|NCT00938366|3058479|P1|Overall Study|Withdrawal by Subject|1
927682|NCT00938340|3058499|P1|Overall Study|Adverse Event|1
927683|NCT00938340|3058499|P1|Overall Study|Protocol Violation|1
927684|NCT00938340|3058499|P1|Overall Study|Withdrawal by Subject|3
927685|NCT00938327|3058629|P1|Overall Study|Vaccine not received as out of stock|9
927686|NCT00938327|3058629|P1|Overall Study|2nd dose received outside of the study|7
927687|NCT00938327|3058629|P1|Overall Study|Lost to Follow-up|37
927688|NCT00938327|3058629|P1|Overall Study|Withdrawal by Subject|4
927689|NCT00938327|3058629|P1|Overall Study|Protocol Violation|1
927690|NCT00938327|3058629|P1|Overall Study|Adverse Event|2
927691|NCT00938041|3058697|P1|Overall Study|Adrenal Insufficiency|3
927692|NCT00938041|3058697|P1|Overall Study|Death|12
927693|NCT00938041|3058697|P1|Overall Study|Progressive Disease|5
927694|NCT00938041|3058697|P1|Overall Study|Received Alternative Therapy|1
927695|NCT00938041|3058697|P1|Overall Study|Lost to Follow-up|6
927696|NCT00938015|3058706|P1|Overall Study|Reason not related to Etanercept|29
927697|NCT00938015|3058706|P1|Overall Study|Non-responder|52
927698|NCT00938015|3058706|P1|Overall Study|Adverse Event|32
927699|NCT00938015|3058706|P1|Overall Study|Lost to Follow-up|32
927700|NCT00938015|3058706|P1|Overall Study|Death|2
927701|NCT00937950|3058722|P1|Overall Study|Others|18
927702|NCT00937950|3058722|P1|Overall Study|Missing confirmed|4
927703|NCT00937950|3058722|P1|Overall Study|Lost to Follow-up|144
927704|NCT00937950|3058722|P1|Overall Study|Migrated/moved from study area|27
927705|NCT00937950|3058722|P1|Overall Study|Withdrawal by Subject|23
927706|NCT00937937|3058738|P1|Overall Study|Not specified|2
927707|NCT00937937|3058738|P1|Overall Study|Death|1
927708|NCT00937937|3058738|P1|Overall Study|Progression/relapse|61
927709|NCT00937937|3058738|P1|Overall Study|Withdrawal by Subject|2
927710|NCT00937937|3058738|P1|Overall Study|Adverse Event|6
927711|NCT00937833|3058747|P2|Overall Study|Withdrawal by Subject|6
927712|NCT00937833|3058748|P1|Overall Study|Withdrawal by Subject|4
927713|NCT00937833|3058747|P2|Overall Study|Lost to Follow-up|8
927714|NCT00937833|3058748|P1|Overall Study|Lost to Follow-up|10
927715|NCT00937833|3058747|P2|Overall Study|Procedure delayed; enrollment closed|1
927716|NCT00937833|3058748|P1|Overall Study|Procedure delayed; enrollment closed|0
927717|NCT00937833|3058747|P2|Overall Study|Protocol Violation|2
927718|NCT00937833|3058748|P1|Overall Study|Protocol Violation|1
927719|NCT00937768|3058761|P2|Overall Study|No Further Funding|4
927720|NCT00937768|3058762|P1|Overall Study|No Further Funding|4
927721|NCT00937768|3058761|P2|Overall Study|Alternate Treatment|1
927722|NCT00937768|3058762|P1|Overall Study|Alternate Treatment|0
927723|NCT00937768|3058761|P2|Overall Study|Disease Progression|1
927724|NCT00937768|3058762|P1|Overall Study|Disease Progression|1
927725|NCT00937768|3058761|P2|Overall Study|Refused Further Treatment|2
927726|NCT00937768|3058762|P1|Overall Study|Refused Further Treatment|3
927727|NCT00937560|3058768|P1|Maintenance Treatment|According to protocol|1
927728|NCT00937560|3058768|P1|Maintenance Treatment|Withdraw consent|5
927729|NCT00937560|3058768|P1|Maintenance Treatment|Death|12
927730|NCT00937560|3058768|P1|Initial Treatment|No end of study page|10
927731|NCT00937560|3058768|P1|Initial Treatment|Lost to Follow-up|1
927732|NCT00937560|3058768|P1|Initial Treatment|Adverse Event|1
927733|NCT00937560|3058768|P1|Initial Treatment|Withdraw consent|3
927734|NCT00937560|3058768|P1|Initial Treatment|Death|6
927735|NCT00937547|3058779|P3|Overall Study|misdiagnosis|7
927736|NCT00937547|3058780|P2|Overall Study|misdiagnosis|6
927737|NCT00937547|3058781|P1|Overall Study|misdiagnosis|1
927738|NCT00937521|3058818|P8|Booster Phase|Protocol Deviation|0
927739|NCT00937521|3058819|P7|Booster Phase|Protocol Deviation|1
927740|NCT00937521|3058820|P6|Booster Phase|Protocol Deviation|0
927741|NCT00937521|3058821|P5|Booster Phase|Protocol Deviation|0
927742|NCT00937521|3058822|P4|Booster Phase|Protocol Deviation|0
927743|NCT00937521|3058823|P3|Booster Phase|Protocol Deviation|0
927744|NCT00937521|3058824|P2|Booster Phase|Protocol Deviation|0
927745|NCT00937521|3058825|P1|Booster Phase|Protocol Deviation|0
927746|NCT00937521|3058818|P8|Booster Phase|Administrative Reason|0
927747|NCT00937521|3058819|P7|Booster Phase|Administrative Reason|0
927748|NCT00937521|3058820|P6|Booster Phase|Administrative Reason|1
927749|NCT00937521|3058821|P5|Booster Phase|Administrative Reason|1
927750|NCT00937521|3058822|P4|Booster Phase|Administrative Reason|0
927751|NCT00937521|3058823|P3|Booster Phase|Administrative Reason|1
927752|NCT00937521|3058824|P2|Booster Phase|Administrative Reason|0
927753|NCT00937521|3058825|P1|Booster Phase|Administrative Reason|0
927754|NCT00937521|3058818|P8|Booster Phase|Lost to Follow-up|0
927755|NCT00937521|3058819|P7|Booster Phase|Lost to Follow-up|3
927756|NCT00937521|3058820|P6|Booster Phase|Lost to Follow-up|4
927757|NCT00937521|3058821|P5|Booster Phase|Lost to Follow-up|4
927758|NCT00937521|3058822|P4|Booster Phase|Lost to Follow-up|2
927759|NCT00937521|3058823|P3|Booster Phase|Lost to Follow-up|4
927760|NCT00937521|3058824|P2|Booster Phase|Lost to Follow-up|2
927761|NCT00937521|3058825|P1|Booster Phase|Lost to Follow-up|2
927762|NCT00937521|3058818|P8|Booster Phase|Withdrawal by Subject|2
927763|NCT00937521|3058819|P7|Booster Phase|Withdrawal by Subject|0
927764|NCT00937521|3058820|P6|Booster Phase|Withdrawal by Subject|0
927765|NCT00937521|3058821|P5|Booster Phase|Withdrawal by Subject|0
927766|NCT00937521|3058822|P4|Booster Phase|Withdrawal by Subject|1
927767|NCT00937521|3058823|P3|Booster Phase|Withdrawal by Subject|0
927768|NCT00937521|3058824|P2|Booster Phase|Withdrawal by Subject|0
927769|NCT00937521|3058825|P1|Booster Phase|Withdrawal by Subject|1
927770|NCT00937521|3058818|P8|Booster Phase|Adverse Event|0
927771|NCT00937521|3058819|P7|Booster Phase|Adverse Event|1
927772|NCT00937521|3058820|P6|Booster Phase|Adverse Event|0
927773|NCT00937521|3058821|P5|Booster Phase|Adverse Event|0
927774|NCT00937521|3058822|P4|Booster Phase|Adverse Event|0
927775|NCT00937521|3058823|P3|Booster Phase|Adverse Event|0
927776|NCT00937521|3058824|P2|Booster Phase|Adverse Event|0
927777|NCT00937521|3058825|P1|Booster Phase|Adverse Event|0
927778|NCT00937521|3058818|P8|Overall Study - Prior to Booster Dose|Protocol Deviation|0
927779|NCT00937521|3058819|P7|Overall Study - Prior to Booster Dose|Protocol Deviation|1
927780|NCT00937521|3058820|P6|Overall Study - Prior to Booster Dose|Protocol Deviation|0
927781|NCT00937521|3058821|P5|Overall Study - Prior to Booster Dose|Protocol Deviation|0
927782|NCT00937521|3058822|P4|Overall Study - Prior to Booster Dose|Protocol Deviation|0
927783|NCT00937521|3058823|P3|Overall Study - Prior to Booster Dose|Protocol Deviation|0
927784|NCT00937521|3058824|P2|Overall Study - Prior to Booster Dose|Protocol Deviation|0
927785|NCT00937521|3058825|P1|Overall Study - Prior to Booster Dose|Protocol Deviation|1
927786|NCT00937521|3058818|P8|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
927787|NCT00937521|3058819|P7|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
927788|NCT00937521|3058820|P6|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
927789|NCT00937521|3058821|P5|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2
927790|NCT00937521|3058822|P4|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
927791|NCT00937521|3058823|P3|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
927792|NCT00937521|3058824|P2|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4
927793|NCT00937521|3058825|P1|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
927794|NCT00937521|3058818|P8|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
927795|NCT00937521|3058819|P7|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
927796|NCT00937521|3058820|P6|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
927797|NCT00937521|3058821|P5|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
927798|NCT00937521|3058822|P4|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
927799|NCT00937521|3058823|P3|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
927800|NCT00937521|3058824|P2|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
927801|NCT00937521|3058825|P1|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
927802|NCT00937521|3058818|P8|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
927803|NCT00937521|3058819|P7|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
927804|NCT00937521|3058820|P6|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
927805|NCT00937521|3058821|P5|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
927806|NCT00937521|3058822|P4|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
927807|NCT00937521|3058823|P3|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3
927808|NCT00937521|3058824|P2|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
927809|NCT00937521|3058825|P1|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
927810|NCT00937521|3058818|P8|Overall Study - Prior to Booster Dose|Adverse Event|0
927811|NCT00937521|3058819|P7|Overall Study - Prior to Booster Dose|Adverse Event|1
927812|NCT00937521|3058820|P6|Overall Study - Prior to Booster Dose|Adverse Event|0
927813|NCT00937521|3058821|P5|Overall Study - Prior to Booster Dose|Adverse Event|0
927814|NCT00937521|3058822|P4|Overall Study - Prior to Booster Dose|Adverse Event|0
927815|NCT00937521|3058823|P3|Overall Study - Prior to Booster Dose|Adverse Event|2
927816|NCT00937521|3058824|P2|Overall Study - Prior to Booster Dose|Adverse Event|0
927817|NCT00937521|3058825|P1|Overall Study - Prior to Booster Dose|Adverse Event|0
927818|NCT00937495|3058931|P1|Overall Study|Protocol Violation|2
927819|NCT00937391|3058939|P1|Stage 2|Withdrawal by Subject|1
927820|NCT00937326|3058995|P5|Overall Study|Chest X-ray showed a suspicious shadow|0
927821|NCT00937326|3058996|P4|Overall Study|Chest X-ray showed a suspicious shadow|0
927822|NCT00937326|3058997|P3|Overall Study|Chest X-ray showed a suspicious shadow|1
927823|NCT00937326|3058998|P2|Overall Study|Chest X-ray showed a suspicious shadow|0
927824|NCT00937326|3058999|P1|Overall Study|Chest X-ray showed a suspicious shadow|0
927825|NCT00937326|3058995|P5|Overall Study|Withdrawal by Subject|3
927826|NCT00937326|3058996|P4|Overall Study|Withdrawal by Subject|4
927827|NCT00937326|3058997|P3|Overall Study|Withdrawal by Subject|1
927828|NCT00937326|3058998|P2|Overall Study|Withdrawal by Subject|4
927829|NCT00937326|3058999|P1|Overall Study|Withdrawal by Subject|3
927830|NCT00937326|3058995|P5|Overall Study|Death|0
927831|NCT00937326|3058996|P4|Overall Study|Death|0
927832|NCT00937326|3058997|P3|Overall Study|Death|1
927833|NCT00937326|3058998|P2|Overall Study|Death|0
927834|NCT00937326|3058999|P1|Overall Study|Death|0
927835|NCT00937326|3058995|P5|Overall Study|Adverse Event|2
927836|NCT00937326|3058996|P4|Overall Study|Adverse Event|1
927837|NCT00937326|3058997|P3|Overall Study|Adverse Event|1
927838|NCT00937326|3058998|P2|Overall Study|Adverse Event|3
927839|NCT00937326|3058999|P1|Overall Study|Adverse Event|0
927840|NCT00937157|3059248|P1|Overall Study|Lost to Follow-up|3
927841|NCT00937157|3059248|P1|Overall Study|Pregnancy|1
927842|NCT00937040|3059279|P2|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8
927843|NCT00937040|3059280|P1|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5
927844|NCT00937040|3059279|P2|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2
927845|NCT00937040|3059280|P1|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3
927846|NCT00937040|3059279|P2|Overall Study|Withdrawal by Subject|7
927847|NCT00937040|3059280|P1|Overall Study|Withdrawal by Subject|13
927848|NCT00937040|3059279|P2|Overall Study|Protocol Violation|0
927849|NCT00937040|3059280|P1|Overall Study|Protocol Violation|3
927850|NCT00937040|3059279|P2|Overall Study|Lost to Follow-up|12
927851|NCT00937040|3059280|P1|Overall Study|Lost to Follow-up|12
927852|NCT00937040|3059279|P2|Overall Study|Adverse Event|8
927853|NCT00937040|3059280|P1|Overall Study|Adverse Event|5
927854|NCT00936975|3059322|P1|Overall Study|Post-Tx scan uninterpretable|2
927855|NCT00936975|3059322|P1|Overall Study|Disease progression|3
927856|NCT00936975|3059322|P1|Overall Study|Withdrawal by Subject|1
927857|NCT00936910|3059331|P1|Overall Study|Lack of Efficacy|3
927858|NCT00936897|3059340|P2|Overall Study|Death|1
927859|NCT00936897|3059341|P1|Overall Study|Death|0
927860|NCT00936897|3059340|P2|Overall Study|Noncompliance|2
927861|NCT00936897|3059341|P1|Overall Study|Noncompliance|0
927862|NCT00936897|3059340|P2|Overall Study|Ineligibility Determined|3
927863|NCT00936897|3059341|P1|Overall Study|Ineligibility Determined|0
927864|NCT00936897|3059340|P2|Overall Study|Protocol Violation|1
927865|NCT00936897|3059341|P1|Overall Study|Protocol Violation|1
927866|NCT00936897|3059340|P2|Overall Study|Administrative Decision|2
927867|NCT00936897|3059341|P1|Overall Study|Administrative Decision|1
927868|NCT00936897|3059340|P2|Overall Study|Lost to Follow-up|10
927869|NCT00936897|3059341|P1|Overall Study|Lost to Follow-up|1
927870|NCT00936897|3059340|P2|Overall Study|Other|9
927871|NCT00936897|3059341|P1|Overall Study|Other|3
927872|NCT00936897|3059340|P2|Overall Study|Adverse Event|13
927873|NCT00936897|3059341|P1|Overall Study|Adverse Event|4
927874|NCT00936897|3059340|P2|Overall Study|Withdrawal by Subject|19
927875|NCT00936897|3059341|P1|Overall Study|Withdrawal by Subject|9
927876|NCT00936715|3059358|P1|Overall Study|Safety or Tolerability Reasons|4
927877|NCT00936715|3059358|P1|Overall Study|Protocol Violation|1
927878|NCT00936715|3059358|P1|Overall Study|Investigators Discretion|1
927879|NCT00936702|3059362|P1|Overall Study|Other|1
927880|NCT00936702|3059362|P1|Overall Study|Alternative Treatment|1
927881|NCT00936702|3059362|P1|Overall Study|Withdrawal by Subject|2
927882|NCT00936702|3059362|P1|Overall Study|Adverse Event|8
927883|NCT00936702|3059362|P1|Overall Study|Disease progression|34
927884|NCT00936598|3059395|P2|Overall Study|Ineligible after consent|0
927885|NCT00936598|3059396|P1|Overall Study|Ineligible after consent|1
927886|NCT00936598|3059395|P2|Overall Study|Withdrawal by Subject|0
927887|NCT00936598|3059396|P1|Overall Study|Withdrawal by Subject|1
927888|NCT00936221|3059485|P2|Overall Study|Withdrawal by Subject|1
927889|NCT00936221|3059486|P1|Overall Study|Withdrawal by Subject|1
927890|NCT00936208|3059500|P2|Overall Study|Protocol Violation|22
927891|NCT00936208|3059501|P1|Overall Study|Protocol Violation|37
927892|NCT00936117|3059519|P1|Overall Study|Unable to continue oral medication|3
927893|NCT00936117|3059519|P1|Overall Study|Adverse Event|7
927894|NCT00936065|3059527|P3|Overall Study|Withdrawal by Subject|4
927895|NCT00936065|3059528|P2|Overall Study|Withdrawal by Subject|2
927896|NCT00936065|3059529|P1|Overall Study|Withdrawal by Subject|0
927897|NCT00936065|3059527|P3|Overall Study|Protocol Violation|1
927898|NCT00936065|3059528|P2|Overall Study|Protocol Violation|2
927899|NCT00936065|3059529|P1|Overall Study|Protocol Violation|1
927900|NCT00936065|3059527|P3|Overall Study|Lost to Follow-up|0
927901|NCT00936065|3059528|P2|Overall Study|Lost to Follow-up|0
927902|NCT00936065|3059529|P1|Overall Study|Lost to Follow-up|1
927903|NCT00936065|3059527|P3|Overall Study|Lack of Efficacy|1
927904|NCT00936065|3059528|P2|Overall Study|Lack of Efficacy|0
927905|NCT00936065|3059529|P1|Overall Study|Lack of Efficacy|1
927906|NCT00936065|3059527|P3|Overall Study|Adverse Event|1
927907|NCT00936065|3059528|P2|Overall Study|Adverse Event|0
927908|NCT00936065|3059529|P1|Overall Study|Adverse Event|1
927909|NCT00935883|3059635|P2|Treatment Period|Withdrawal by Subject|2
927910|NCT00935883|3059636|P1|Treatment Period|Withdrawal by Subject|0
927911|NCT00935883|3059635|P2|Treatment Period|Physician Decision|0
927912|NCT00935883|3059636|P1|Treatment Period|Physician Decision|1
927913|NCT00935818|3059663|P2|Overall Study|Physician Decision|1
927914|NCT00935818|3059664|P1|Overall Study|Physician Decision|0
927915|NCT00935818|3059663|P2|Overall Study|Adverse Event|7
927916|NCT00935818|3059664|P1|Overall Study|Adverse Event|6
927917|NCT00935818|3059663|P2|Overall Study|Lost to Follow-up|42
927918|NCT00935818|3059664|P1|Overall Study|Lost to Follow-up|40
927919|NCT00935818|3059663|P2|Overall Study|Withdrawal by Subject|50
927920|NCT00935818|3059664|P1|Overall Study|Withdrawal by Subject|45
927921|NCT00935701|3059715|P1|Overall Study|Failure to Transition to Acupuncture|1
927922|NCT00935584|3059732|P2|Overall Study|Provider dropped out of study|4
927923|NCT00935584|3059733|P1|Overall Study|Provider dropped out of study|14
927924|NCT00935584|3059732|P2|Overall Study|Patient changed provider|0
927925|NCT00935584|3059733|P1|Overall Study|Patient changed provider|3
927926|NCT00935584|3059732|P2|Overall Study|Relocated|0
927927|NCT00935584|3059733|P1|Overall Study|Relocated|3
927928|NCT00935584|3059732|P2|Overall Study|No show|0
927929|NCT00935584|3059733|P1|Overall Study|No show|9
927930|NCT00935584|3059732|P2|Overall Study|Lost to Follow-up|0
927931|NCT00935584|3059733|P1|Overall Study|Lost to Follow-up|8
927932|NCT00935584|3059732|P2|Overall Study|Death|0
927933|NCT00935584|3059733|P1|Overall Study|Death|3
927934|NCT00935584|3059732|P2|Overall Study|Withdrawal by Subject|0
927935|NCT00935584|3059733|P1|Overall Study|Withdrawal by Subject|9
927936|NCT00935532|3059745|P2|Overall Study|Loss Glucose Control|0
927937|NCT00935532|3059746|P1|Overall Study|Loss Glucose Control|4
927938|NCT00935532|3059745|P2|Overall Study|Sponsor Decision|1
927939|NCT00935532|3059746|P1|Overall Study|Sponsor Decision|0
927940|NCT00935532|3059745|P2|Overall Study|Subject Decision|1
927941|NCT00935532|3059746|P1|Overall Study|Subject Decision|2
927942|NCT00935532|3059745|P2|Overall Study|Protocol Violation|1
927943|NCT00935532|3059746|P1|Overall Study|Protocol Violation|2
927944|NCT00935532|3059745|P2|Overall Study|Physician Decision|2
927945|NCT00935532|3059746|P1|Overall Study|Physician Decision|1
927946|NCT00935532|3059745|P2|Overall Study|Lost to Follow-up|0
927947|NCT00935532|3059746|P1|Overall Study|Lost to Follow-up|1
927948|NCT00935532|3059745|P2|Overall Study|Death|0
927949|NCT00935532|3059746|P1|Overall Study|Death|1
927950|NCT00935532|3059745|P2|Overall Study|Adverse Event|6
927951|NCT00935532|3059746|P1|Overall Study|Adverse Event|11
927952|NCT00935493|3059775|P3|Overall Study|Treatment Discontinued|0
927953|NCT00935493|3059776|P2|Overall Study|Treatment Discontinued|1
927954|NCT00935493|3059777|P1|Overall Study|Treatment Discontinued|0
927955|NCT00935493|3059775|P3|Overall Study|Lost to Follow-up|1
927956|NCT00935493|3059776|P2|Overall Study|Lost to Follow-up|1
927957|NCT00935493|3059777|P1|Overall Study|Lost to Follow-up|1
927958|NCT00935272|3059815|P2|Overall Study|Protocol Violation|1
927959|NCT00935272|3059816|P1|Overall Study|Protocol Violation|0
927960|NCT00935272|3059815|P2|Overall Study|Physician Decision|0
927961|NCT00935272|3059816|P1|Overall Study|Physician Decision|1
927962|NCT00935272|3059815|P2|Overall Study|Withdrawal by Subject|2
927963|NCT00935272|3059816|P1|Overall Study|Withdrawal by Subject|8
927964|NCT00935272|3059815|P2|Overall Study|Lost to Follow-up|3
927965|NCT00935272|3059816|P1|Overall Study|Lost to Follow-up|10
927966|NCT00935259|3059825|P2|Period 1|Administrative (scheduling conflict)|1
927967|NCT00935259|3059826|P1|Period 1|Administrative (scheduling conflict)|1
927968|NCT00935220|3059840|P1|Overall Study|Other reason (not specified)|1
927969|NCT00935220|3059840|P1|Overall Study|Adverse Event|1
927970|NCT00934947|3059871|P2|Overall Study|Adverse Event|2
927971|NCT00934947|3059872|P1|Overall Study|Adverse Event|0
927972|NCT00934856|3059901|P6|Extension Part|Non-compliance with drug|1
927973|NCT00934856|3059902|P5|Extension Part|Non-compliance with drug|0
927974|NCT00934856|3059903|P4|Extension Part|Non-compliance with drug|0
927975|NCT00934856|3059904|P3|Extension Part|Non-compliance with drug|0
927976|NCT00934856|3059905|P2|Extension Part|Non-compliance with drug|0
927977|NCT00934856|3059906|P1|Extension Part|Non-compliance with drug|0
927978|NCT00934856|3059901|P6|Extension Part|Progressive disease|0
927979|NCT00934856|3059902|P5|Extension Part|Progressive disease|0
927980|NCT00934856|3059903|P4|Extension Part|Progressive disease|1
927981|NCT00934856|3059904|P3|Extension Part|Progressive disease|0
927982|NCT00934856|3059905|P2|Extension Part|Progressive disease|0
927983|NCT00934856|3059906|P1|Extension Part|Progressive disease|0
927984|NCT00934856|3059901|P6|Extension Part|Adverse Event|4
927985|NCT00934856|3059902|P5|Extension Part|Adverse Event|4
927986|NCT00934856|3059903|P4|Extension Part|Adverse Event|1
927987|NCT00934856|3059904|P3|Extension Part|Adverse Event|0
927988|NCT00934856|3059905|P2|Extension Part|Adverse Event|0
927989|NCT00934856|3059906|P1|Extension Part|Adverse Event|0
927990|NCT00934856|3059901|P6|Feasibility Part|Withdrawal by Subject|1
927991|NCT00934856|3059902|P5|Feasibility Part|Withdrawal by Subject|0
927992|NCT00934856|3059903|P4|Feasibility Part|Withdrawal by Subject|1
927993|NCT00934856|3059904|P3|Feasibility Part|Withdrawal by Subject|0
927994|NCT00934856|3059905|P2|Feasibility Part|Withdrawal by Subject|0
927995|NCT00934856|3059906|P1|Feasibility Part|Withdrawal by Subject|0
927996|NCT00934856|3059901|P6|Feasibility Part|Adverse Event|2
927997|NCT00934856|3059902|P5|Feasibility Part|Adverse Event|0
927998|NCT00934856|3059903|P4|Feasibility Part|Adverse Event|1
927999|NCT00934856|3059904|P3|Feasibility Part|Adverse Event|0
928000|NCT00934856|3059905|P2|Feasibility Part|Adverse Event|1
928001|NCT00934856|3059906|P1|Feasibility Part|Adverse Event|1
928002|NCT00934856|3059901|P6|Feasibility Part|Physician Decision|0
928003|NCT00934856|3059902|P5|Feasibility Part|Physician Decision|0
928004|NCT00934856|3059903|P4|Feasibility Part|Physician Decision|0
928005|NCT00934856|3059904|P3|Feasibility Part|Physician Decision|1
928006|NCT00934856|3059905|P2|Feasibility Part|Physician Decision|0
928007|NCT00934856|3059906|P1|Feasibility Part|Physician Decision|0
928008|NCT00934856|3059901|P6|Feasibility Part|Progressive disease|0
928009|NCT00934856|3059902|P5|Feasibility Part|Progressive disease|0
928010|NCT00934856|3059903|P4|Feasibility Part|Progressive disease|3
928011|NCT00934856|3059904|P3|Feasibility Part|Progressive disease|2
928012|NCT00934856|3059905|P2|Feasibility Part|Progressive disease|4
928013|NCT00934856|3059906|P1|Feasibility Part|Progressive disease|4
928014|NCT00934843|3060004|P2|Overall Study|Protocol Violation|1
928015|NCT00934843|3060005|P1|Overall Study|Protocol Violation|0
928016|NCT00934791|3060021|P2|Overall Study|Withdrawal by Subject|0
928017|NCT00934791|3060022|P1|Overall Study|Withdrawal by Subject|1
928018|NCT00934661|3060030|P2|Overall Study|Failure of Combined/Spinal Epidural|0
928019|NCT00934661|3060031|P1|Overall Study|Failure of Combined/Spinal Epidural|1
928020|NCT00934648|3060051|P1|Overall Study|Withdrawal by Subject|1
928021|NCT00934648|3060051|P1|Overall Study|Failure to return|8
928022|NCT00934622|3060095|P1|Overall Study|2nd Intraoperative exclusion criteria|1
928023|NCT00934622|3060095|P1|Overall Study|Lost to Follow-up|7
928024|NCT00934544|3060133|P2|Overall Study|Entered Extension phase INC424|18
928025|NCT00934544|3060134|P1|Overall Study|Entered Extension phase INC424|29
928026|NCT00934544|3060133|P2|Overall Study|Other Reasons|7
928027|NCT00934544|3060134|P1|Overall Study|Other Reasons|7
928028|NCT00934544|3060133|P2|Overall Study|Non-compliance with study procedures|1
928029|NCT00934544|3060134|P1|Overall Study|Non-compliance with study procedures|0
928030|NCT00934544|3060133|P2|Overall Study|Non-compliance with study Medication|0
928031|NCT00934544|3060134|P1|Overall Study|Non-compliance with study Medication|2
928032|NCT00934544|3060133|P2|Overall Study|Disease Progression|3
928033|NCT00934544|3060134|P1|Overall Study|Disease Progression|1
928034|NCT00934544|3060133|P2|Overall Study|Protocol Violation|0
928035|NCT00934544|3060134|P1|Overall Study|Protocol Violation|2
928036|NCT00934544|3060133|P2|Overall Study|Withdrawal by Subject|9
928037|NCT00934544|3060134|P1|Overall Study|Withdrawal by Subject|2
928038|NCT00934544|3060133|P2|Overall Study|Adverse Event|4
928039|NCT00934544|3060134|P1|Overall Study|Adverse Event|12
928040|NCT00934440|3060148|P1|Overall Study|Lost to Follow-up|1
928041|NCT00934362|3060164|P2|Overall Study|Adverse Event|0
928042|NCT00934362|3060165|P1|Overall Study|Adverse Event|1
928043|NCT00934128|3060215|P2|Second Intervention (2 Hours)|Claustrophobia/anxiety|3
928044|NCT00934128|3060216|P1|Second Intervention (2 Hours)|Claustrophobia/anxiety|0
928045|NCT00934128|3060215|P2|Washout Period (1 Hour)|Dyspnea too low to continue|2
928046|NCT00934128|3060216|P1|Washout Period (1 Hour)|Dyspnea too low to continue|4
928047|NCT00934128|3060215|P2|Washout Period (1 Hour)|Too tired|0
928048|NCT00934128|3060216|P1|Washout Period (1 Hour)|Too tired|1
928049|NCT00934128|3060215|P2|Washout Period (1 Hour)|Pain|0
928050|NCT00934128|3060216|P1|Washout Period (1 Hour)|Pain|1
928051|NCT00934128|3060215|P2|Washout Period (1 Hour)|Patient preference|3
928052|NCT00934128|3060216|P1|Washout Period (1 Hour)|Patient preference|1
928053|NCT00934128|3060215|P2|First Intervention (2 Hours)|Treatment Delivery Order Switched|0
928054|NCT00934128|3060216|P1|First Intervention (2 Hours)|Treatment Delivery Order Switched|1
928055|NCT00934128|3060215|P2|First Intervention (2 Hours)|Adverse Event|1
928056|NCT00934128|3060216|P1|First Intervention (2 Hours)|Adverse Event|4
928057|NCT00934128|3060215|P2|First Intervention (2 Hours)|Withdrawal by Subject|1
928058|NCT00934128|3060216|P1|First Intervention (2 Hours)|Withdrawal by Subject|0
928059|NCT00934102|3060224|P3|Period 1, One Night of Wear|Personal Reasons|0
928060|NCT00934102|3060225|P2|Period 1, One Night of Wear|Personal Reasons|0
928061|NCT00934102|3060226|P1|Period 1, One Night of Wear|Personal Reasons|1
928062|NCT00934050|3060240|P6|Enrolled After 15 Dec 2009|Withdrawal by Subject|2
928063|NCT00934050|3060241|P5|Enrolled After 15 Dec 2009|Withdrawal by Subject|4
928064|NCT00934050|3060242|P4|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
928065|NCT00934050|3060243|P3|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
928066|NCT00934050|3060244|P2|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
928067|NCT00934050|3060245|P1|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
928068|NCT00934050|3060240|P6|Enrolled After 15 Dec 2009|Lost to Follow-up|1
928069|NCT00934050|3060241|P5|Enrolled After 15 Dec 2009|Lost to Follow-up|0
928070|NCT00934050|3060242|P4|Enrolled After 15 Dec 2009|Lost to Follow-up|0
928071|NCT00934050|3060243|P3|Enrolled After 15 Dec 2009|Lost to Follow-up|0
928072|NCT00934050|3060244|P2|Enrolled After 15 Dec 2009|Lost to Follow-up|0
928073|NCT00934050|3060245|P1|Enrolled After 15 Dec 2009|Lost to Follow-up|0
928074|NCT00934050|3060240|P6|Enrolled After 15 Dec 2009|Death|1
928075|NCT00934050|3060241|P5|Enrolled After 15 Dec 2009|Death|0
928076|NCT00934050|3060242|P4|Enrolled After 15 Dec 2009|Death|0
928077|NCT00934050|3060243|P3|Enrolled After 15 Dec 2009|Death|0
928078|NCT00934050|3060244|P2|Enrolled After 15 Dec 2009|Death|0
928079|NCT00934050|3060245|P1|Enrolled After 15 Dec 2009|Death|0
928080|NCT00934050|3060240|P6|Enrolled After 15 Dec 2009|Adverse Event|0
928081|NCT00934050|3060241|P5|Enrolled After 15 Dec 2009|Adverse Event|3
928082|NCT00934050|3060242|P4|Enrolled After 15 Dec 2009|Adverse Event|0
928083|NCT00934050|3060243|P3|Enrolled After 15 Dec 2009|Adverse Event|0
928084|NCT00934050|3060244|P2|Enrolled After 15 Dec 2009|Adverse Event|0
928085|NCT00934050|3060245|P1|Enrolled After 15 Dec 2009|Adverse Event|0
928086|NCT00934050|3060240|P6|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
928087|NCT00934050|3060241|P5|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
928088|NCT00934050|3060242|P4|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
928089|NCT00934050|3060243|P3|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1
928090|NCT00934050|3060244|P2|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
928091|NCT00934050|3060245|P1|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
928092|NCT00934050|3060240|P6|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
928093|NCT00934050|3060241|P5|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
928094|NCT00934050|3060242|P4|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13
928095|NCT00934050|3060243|P3|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
928096|NCT00934050|3060244|P2|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12
928097|NCT00934050|3060245|P1|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
928098|NCT00934050|3060240|P6|Enrolled Prior to 15 Dec 2009|Adverse Event|0
928099|NCT00934050|3060241|P5|Enrolled Prior to 15 Dec 2009|Adverse Event|0
928100|NCT00934050|3060242|P4|Enrolled Prior to 15 Dec 2009|Adverse Event|1
928101|NCT00934050|3060243|P3|Enrolled Prior to 15 Dec 2009|Adverse Event|0
928102|NCT00934050|3060244|P2|Enrolled Prior to 15 Dec 2009|Adverse Event|0
928103|NCT00934050|3060245|P1|Enrolled Prior to 15 Dec 2009|Adverse Event|1
928104|NCT00933933|3060260|P3|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
928105|NCT00933933|3060261|P2|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2
928106|NCT00933933|3060262|P1|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
928107|NCT00933933|3060260|P3|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
928108|NCT00933933|3060261|P2|General Population From 16 to 89 Years|Did not meet criteria for analysis|20
928109|NCT00933933|3060262|P1|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
928110|NCT00933686|3060280|P2|Overall Study|Failure to show up at endpoint visits|2
928111|NCT00933686|3060281|P1|Overall Study|Failure to show up at endpoint visits|0
928112|NCT00933686|3060280|P2|Overall Study|Physician Decision|0
928113|NCT00933686|3060281|P1|Overall Study|Physician Decision|1
928114|NCT00933686|3060280|P2|Overall Study|Adverse Event|1
928115|NCT00933686|3060281|P1|Overall Study|Adverse Event|1
928116|NCT00933686|3060280|P2|Overall Study|Withdrawal by Subject|5
928117|NCT00933686|3060281|P1|Overall Study|Withdrawal by Subject|6
928118|NCT00933686|3060280|P2|Overall Study|Lost to Follow-up|2
928119|NCT00933686|3060281|P1|Overall Study|Lost to Follow-up|2
928120|NCT00933686|3060280|P2|Overall Study|Protocol Violation|1
928121|NCT00933686|3060281|P1|Overall Study|Protocol Violation|0
928122|NCT00933608|3060301|P2|Overall Study|Physician Decision|0
928123|NCT00933608|3060302|P1|Overall Study|Physician Decision|1
928124|NCT00933608|3060301|P2|Overall Study|Adverse Event|2
928125|NCT00933608|3060302|P1|Overall Study|Adverse Event|4
928126|NCT00933543|3060310|P2|Overall Study|Other|1
928127|NCT00933543|3060311|P1|Overall Study|Other|1
928128|NCT00933543|3060310|P2|Overall Study|Lack of Efficacy|3
928129|NCT00933543|3060311|P1|Overall Study|Lack of Efficacy|0
928130|NCT00933543|3060310|P2|Overall Study|Withdrawal by Subject|1
928131|NCT00933543|3060311|P1|Overall Study|Withdrawal by Subject|0
928132|NCT00933543|3060310|P2|Overall Study|Lost to Follow-up|1
928133|NCT00933543|3060311|P1|Overall Study|Lost to Follow-up|0
928134|NCT00933543|3060310|P2|Overall Study|Adverse Event|1
928135|NCT00933543|3060311|P1|Overall Study|Adverse Event|2
928136|NCT00933335|3060380|P2|Overall Study|Co-morbid Illness|0
928137|NCT00933335|3060381|P1|Overall Study|Co-morbid Illness|1
928138|NCT00933335|3060380|P2|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1
928139|NCT00933335|3060381|P1|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0
928140|NCT00933335|3060380|P2|Overall Study|Progressive Disease|11
928141|NCT00933335|3060381|P1|Overall Study|Progressive Disease|0
928142|NCT00933335|3060380|P2|Overall Study|Withdrawal by Subject|1
928143|NCT00933335|3060381|P1|Overall Study|Withdrawal by Subject|0
928144|NCT00933335|3060380|P2|Overall Study|Lost to Follow-up|3
928145|NCT00933335|3060381|P1|Overall Study|Lost to Follow-up|1
928146|NCT00933270|3060451|P1|Overall Study|Moved or would not return|10
928147|NCT00933270|3060451|P1|Overall Study|Death|24
928148|NCT00933270|3060451|P1|Overall Study|Missed Visit|2
928149|NCT00933270|3060451|P1|Overall Study|Adverse Event|1
928150|NCT00933270|3060451|P1|Overall Study|Lost to Follow-up|14
928151|NCT00933270|3060451|P1|Overall Study|Insufficient Follow-up|10
928152|NCT00933270|3060451|P1|Overall Study|Withdrawal by Subject|26
928153|NCT00933244|3060545|P3|Overall Study|Withdrawal by Subject|3
928154|NCT00933244|3060546|P2|Overall Study|Withdrawal by Subject|1
928155|NCT00933244|3060547|P1|Overall Study|Withdrawal by Subject|5
928156|NCT00933166|3060564|P1|Overall Study|Withdrawal by Subject|1
928157|NCT00933166|3060564|P1|Overall Study|Unavailable|4
928158|NCT00933166|3060564|P1|Overall Study|Lack of Efficacy|9
928159|NCT00933166|3060564|P1|Overall Study|Lost to Follow-up|4
928160|NCT00932893|3060570|P2|Overall Study|Other|144
928161|NCT00932893|3060571|P1|Overall Study|Other|5
928162|NCT00932893|3060570|P2|Overall Study|Withdrawal by Subject|2
928163|NCT00932893|3060571|P1|Overall Study|Withdrawal by Subject|5
928164|NCT00932893|3060570|P2|Overall Study|Lost to Follow-up|0
928165|NCT00932893|3060571|P1|Overall Study|Lost to Follow-up|8
928166|NCT00932893|3060570|P2|Overall Study|Death|24
928167|NCT00932893|3060571|P1|Overall Study|Death|115
928168|NCT00932646|3060613|P4|Overall Study|Withdrawal by Subject|0
928169|NCT00932646|3060614|P3|Overall Study|Withdrawal by Subject|3
928170|NCT00932646|3060615|P2|Overall Study|Withdrawal by Subject|1
928171|NCT00932646|3060616|P1|Overall Study|Withdrawal by Subject|1
928172|NCT00932646|3060613|P4|Overall Study|Lost to Follow-up|0
928173|NCT00932646|3060614|P3|Overall Study|Lost to Follow-up|0
928174|NCT00932646|3060615|P2|Overall Study|Lost to Follow-up|1
928175|NCT00932646|3060616|P1|Overall Study|Lost to Follow-up|2
928176|NCT00932646|3060613|P4|Overall Study|Adverse Event|1
928177|NCT00932646|3060614|P3|Overall Study|Adverse Event|1
928178|NCT00932646|3060615|P2|Overall Study|Adverse Event|1
928179|NCT00932646|3060616|P1|Overall Study|Adverse Event|2
928180|NCT00932451|3060703|P1|Overall Study|Other reasons|5
928181|NCT00932451|3060703|P1|Overall Study|Death|726
928182|NCT00932451|3060703|P1|Overall Study|Lost to Follow-up|22
928183|NCT00932451|3060703|P1|Overall Study|Withdrawal by Subject|69
928184|NCT00932425|3060727|P2|Overall Study|Withdrawal by Subject|1
928185|NCT00932425|3060728|P1|Overall Study|Withdrawal by Subject|0
928186|NCT00932425|3060727|P2|Overall Study|Lost to Follow-up|1
928187|NCT00932425|3060728|P1|Overall Study|Lost to Follow-up|0
928188|NCT00932373|3060761|P11|Overall Study|Lack of Efficacy|0
928189|NCT00932373|3060762|P10|Overall Study|Lack of Efficacy|1
928190|NCT00932373|3060763|P9|Overall Study|Lack of Efficacy|0
928191|NCT00932373|3060764|P8|Overall Study|Lack of Efficacy|0
928192|NCT00932373|3060765|P7|Overall Study|Lack of Efficacy|0
928193|NCT00932373|3060766|P6|Overall Study|Lack of Efficacy|0
928194|NCT00932373|3060767|P5|Overall Study|Lack of Efficacy|0
928195|NCT00932373|3060768|P4|Overall Study|Lack of Efficacy|0
928196|NCT00932373|3060769|P3|Overall Study|Lack of Efficacy|0
928197|NCT00932373|3060770|P2|Overall Study|Lack of Efficacy|0
928198|NCT00932373|3060771|P1|Overall Study|Lack of Efficacy|0
928199|NCT00932373|3060761|P11|Overall Study|Clinical progression|0
928200|NCT00932373|3060762|P10|Overall Study|Clinical progression|0
928201|NCT00932373|3060763|P9|Overall Study|Clinical progression|0
928202|NCT00932373|3060764|P8|Overall Study|Clinical progression|0
928203|NCT00932373|3060765|P7|Overall Study|Clinical progression|1
928204|NCT00932373|3060766|P6|Overall Study|Clinical progression|0
928205|NCT00932373|3060767|P5|Overall Study|Clinical progression|0
928206|NCT00932373|3060768|P4|Overall Study|Clinical progression|0
928207|NCT00932373|3060769|P3|Overall Study|Clinical progression|0
928208|NCT00932373|3060770|P2|Overall Study|Clinical progression|0
928209|NCT00932373|3060771|P1|Overall Study|Clinical progression|0
928210|NCT00932373|3060761|P11|Overall Study|Withdrawal by Subject|0
928211|NCT00932373|3060762|P10|Overall Study|Withdrawal by Subject|0
928212|NCT00932373|3060763|P9|Overall Study|Withdrawal by Subject|1
928213|NCT00932373|3060764|P8|Overall Study|Withdrawal by Subject|0
928214|NCT00932373|3060765|P7|Overall Study|Withdrawal by Subject|0
928215|NCT00932373|3060766|P6|Overall Study|Withdrawal by Subject|0
928216|NCT00932373|3060767|P5|Overall Study|Withdrawal by Subject|0
928217|NCT00932373|3060768|P4|Overall Study|Withdrawal by Subject|0
928218|NCT00932373|3060769|P3|Overall Study|Withdrawal by Subject|0
928219|NCT00932373|3060770|P2|Overall Study|Withdrawal by Subject|0
928220|NCT00932373|3060771|P1|Overall Study|Withdrawal by Subject|0
928221|NCT00932373|3060761|P11|Overall Study|Dose limiting toxicity|0
928222|NCT00932373|3060762|P10|Overall Study|Dose limiting toxicity|0
928223|NCT00932373|3060763|P9|Overall Study|Dose limiting toxicity|0
928224|NCT00932373|3060764|P8|Overall Study|Dose limiting toxicity|0
928225|NCT00932373|3060765|P7|Overall Study|Dose limiting toxicity|0
928226|NCT00932373|3060766|P6|Overall Study|Dose limiting toxicity|1
928227|NCT00932373|3060767|P5|Overall Study|Dose limiting toxicity|0
928228|NCT00932373|3060768|P4|Overall Study|Dose limiting toxicity|0
928229|NCT00932373|3060769|P3|Overall Study|Dose limiting toxicity|0
928230|NCT00932373|3060770|P2|Overall Study|Dose limiting toxicity|0
928231|NCT00932373|3060771|P1|Overall Study|Dose limiting toxicity|0
928232|NCT00932373|3060761|P11|Overall Study|Physician Decision|0
928233|NCT00932373|3060762|P10|Overall Study|Physician Decision|1
928234|NCT00932373|3060763|P9|Overall Study|Physician Decision|0
928235|NCT00932373|3060764|P8|Overall Study|Physician Decision|0
928236|NCT00932373|3060765|P7|Overall Study|Physician Decision|0
928237|NCT00932373|3060766|P6|Overall Study|Physician Decision|0
928238|NCT00932373|3060767|P5|Overall Study|Physician Decision|2
928239|NCT00932373|3060768|P4|Overall Study|Physician Decision|0
928240|NCT00932373|3060769|P3|Overall Study|Physician Decision|1
928241|NCT00932373|3060770|P2|Overall Study|Physician Decision|0
928242|NCT00932373|3060771|P1|Overall Study|Physician Decision|0
928243|NCT00932373|3060761|P11|Overall Study|Adverse Event|1
928244|NCT00932373|3060762|P10|Overall Study|Adverse Event|2
928245|NCT00932373|3060763|P9|Overall Study|Adverse Event|0
928246|NCT00932373|3060764|P8|Overall Study|Adverse Event|1
928247|NCT00932373|3060765|P7|Overall Study|Adverse Event|0
928248|NCT00932373|3060766|P6|Overall Study|Adverse Event|1
928249|NCT00932373|3060767|P5|Overall Study|Adverse Event|2
928250|NCT00932373|3060768|P4|Overall Study|Adverse Event|0
928251|NCT00932373|3060769|P3|Overall Study|Adverse Event|0
928252|NCT00932373|3060770|P2|Overall Study|Adverse Event|0
928253|NCT00932373|3060771|P1|Overall Study|Adverse Event|0
928254|NCT00932373|3060761|P11|Overall Study|Progressive disease|2
928255|NCT00932373|3060762|P10|Overall Study|Progressive disease|9
928256|NCT00932373|3060763|P9|Overall Study|Progressive disease|1
928257|NCT00932373|3060764|P8|Overall Study|Progressive disease|2
928258|NCT00932373|3060765|P7|Overall Study|Progressive disease|0
928259|NCT00932373|3060766|P6|Overall Study|Progressive disease|1
928260|NCT00932373|3060767|P5|Overall Study|Progressive disease|10
928261|NCT00932373|3060768|P4|Overall Study|Progressive disease|0
928262|NCT00932373|3060769|P3|Overall Study|Progressive disease|0
928263|NCT00932373|3060770|P2|Overall Study|Progressive disease|1
928264|NCT00932373|3060771|P1|Overall Study|Progressive disease|3
928265|NCT00932165|3060899|P1|Overall Study|Lost to Follow-up|1
928266|NCT00932126|3060923|P8|Overall Study|Other|2
928267|NCT00932126|3060924|P7|Overall Study|Other|1
928268|NCT00932126|3060925|P6|Overall Study|Other|0
928269|NCT00932126|3060926|P5|Overall Study|Other|1
928270|NCT00932126|3060927|P4|Overall Study|Other|0
928271|NCT00932126|3060928|P3|Overall Study|Other|0
928272|NCT00932126|3060929|P2|Overall Study|Other|0
928273|NCT00932126|3060930|P1|Overall Study|Other|0
928274|NCT00932126|3060923|P8|Overall Study|Objective progression or relapse|5
928275|NCT00932126|3060924|P7|Overall Study|Objective progression or relapse|3
928276|NCT00932126|3060925|P6|Overall Study|Objective progression or relapse|3
928277|NCT00932126|3060926|P5|Overall Study|Objective progression or relapse|3
928278|NCT00932126|3060927|P4|Overall Study|Objective progression or relapse|3
928279|NCT00932126|3060928|P3|Overall Study|Objective progression or relapse|2
928280|NCT00932126|3060929|P2|Overall Study|Objective progression or relapse|3
928281|NCT00932126|3060930|P1|Overall Study|Objective progression or relapse|3
928282|NCT00932126|3060923|P8|Overall Study|Withdrawal by Subject|1
928283|NCT00932126|3060924|P7|Overall Study|Withdrawal by Subject|0
928284|NCT00932126|3060925|P6|Overall Study|Withdrawal by Subject|0
928285|NCT00932126|3060926|P5|Overall Study|Withdrawal by Subject|0
928286|NCT00932126|3060927|P4|Overall Study|Withdrawal by Subject|0
928287|NCT00932126|3060928|P3|Overall Study|Withdrawal by Subject|1
928288|NCT00932126|3060929|P2|Overall Study|Withdrawal by Subject|0
928289|NCT00932126|3060930|P1|Overall Study|Withdrawal by Subject|0
928290|NCT00932126|3060923|P8|Overall Study|Protocol Violation|0
928291|NCT00932126|3060924|P7|Overall Study|Protocol Violation|0
928292|NCT00932126|3060925|P6|Overall Study|Protocol Violation|0
928293|NCT00932126|3060926|P5|Overall Study|Protocol Violation|1
928294|NCT00932126|3060927|P4|Overall Study|Protocol Violation|0
928295|NCT00932126|3060928|P3|Overall Study|Protocol Violation|0
928296|NCT00932126|3060929|P2|Overall Study|Protocol Violation|0
928297|NCT00932126|3060930|P1|Overall Study|Protocol Violation|0
928298|NCT00932126|3060923|P8|Overall Study|Adverse Event|2
928299|NCT00932126|3060924|P7|Overall Study|Adverse Event|1
928300|NCT00932126|3060925|P6|Overall Study|Adverse Event|0
928301|NCT00932126|3060926|P5|Overall Study|Adverse Event|0
928302|NCT00932126|3060927|P4|Overall Study|Adverse Event|0
928303|NCT00932126|3060928|P3|Overall Study|Adverse Event|0
928304|NCT00932126|3060929|P2|Overall Study|Adverse Event|0
928305|NCT00932126|3060930|P1|Overall Study|Adverse Event|0
928306|NCT00932113|3060968|P2|Overall Study|Lost to Follow-up|0
928307|NCT00932113|3060969|P1|Overall Study|Lost to Follow-up|1
928308|NCT00931918|3061021|P2|Overall Study|Did not receive study drug|2
928309|NCT00931918|3061022|P1|Overall Study|Did not receive study drug|3
928310|NCT00931918|3061021|P2|Overall Study|Other Reason not Specified|4
928311|NCT00931918|3061022|P1|Overall Study|Other Reason not Specified|4
928312|NCT00931918|3061021|P2|Overall Study|Withdrawal by Patient|4
928313|NCT00931918|3061022|P1|Overall Study|Withdrawal by Patient|3
928314|NCT00931918|3061021|P2|Overall Study|Symptomatic Deterioration|0
928315|NCT00931918|3061022|P1|Overall Study|Symptomatic Deterioration|1
928316|NCT00931918|3061021|P2|Overall Study|Progressive Disease|1
928317|NCT00931918|3061022|P1|Overall Study|Progressive Disease|2
928318|NCT00931918|3061021|P2|Overall Study|Adverse Event|6
928319|NCT00931918|3061022|P1|Overall Study|Adverse Event|4
928320|NCT00931801|3061074|P3|Overall Study|Confirmed Virologic Failure|3
928321|NCT00931801|3061075|P2|Overall Study|Confirmed Virologic Failure|0
928322|NCT00931801|3061076|P1|Overall Study|Confirmed Virologic Failure|0
928323|NCT00931801|3061074|P3|Overall Study|Withdrawal by Subject|0
928324|NCT00931801|3061075|P2|Overall Study|Withdrawal by Subject|0
928325|NCT00931801|3061076|P1|Overall Study|Withdrawal by Subject|1
928326|NCT00931801|3061074|P3|Overall Study|Lost to Follow-up|0
928327|NCT00931801|3061075|P2|Overall Study|Lost to Follow-up|1
928328|NCT00931801|3061076|P1|Overall Study|Lost to Follow-up|0
928329|NCT00931801|3061074|P3|Overall Study|Adverse Event|1
928330|NCT00931801|3061075|P2|Overall Study|Adverse Event|0
928331|NCT00931801|3061076|P1|Overall Study|Adverse Event|0
928332|NCT00931723|3061099|P2|Overall Study|Late hospital discharge|0
928333|NCT00931723|3061100|P1|Overall Study|Late hospital discharge|1
928334|NCT00931723|3061099|P2|Overall Study|Sponsor decision|0
928335|NCT00931723|3061100|P1|Overall Study|Sponsor decision|1
928336|NCT00931723|3061099|P2|Overall Study|Lack or insufficient theraputic response|5
928337|NCT00931723|3061100|P1|Overall Study|Lack or insufficient theraputic response|2
928338|NCT00931723|3061099|P2|Overall Study|Took prohibited concomitant medication|1
928339|NCT00931723|3061100|P1|Overall Study|Took prohibited concomitant medication|0
928340|NCT00931723|3061099|P2|Overall Study|Safety reasons|1
928341|NCT00931723|3061100|P1|Overall Study|Safety reasons|0
928342|NCT00931723|3061099|P2|Overall Study|Severe non-compliance to protocol|0
928343|NCT00931723|3061100|P1|Overall Study|Severe non-compliance to protocol|2
928344|NCT00931723|3061099|P2|Overall Study|Study-specific discontinuation criteria|1
928345|NCT00931723|3061100|P1|Overall Study|Study-specific discontinuation criteria|1
928346|NCT00931723|3061099|P2|Overall Study|Lost to Follow-up|2
928347|NCT00931723|3061100|P1|Overall Study|Lost to Follow-up|1
928348|NCT00931723|3061099|P2|Overall Study|Condition under investigation worsened|2
928349|NCT00931723|3061100|P1|Overall Study|Condition under investigation worsened|1
928350|NCT00931723|3061099|P2|Overall Study|Lithium found in blood|1
928351|NCT00931723|3061100|P1|Overall Study|Lithium found in blood|0
928352|NCT00931723|3061099|P2|Overall Study|Adverse Event|13
928353|NCT00931723|3061100|P1|Overall Study|Adverse Event|6
928354|NCT00931723|3061099|P2|Overall Study|Withdrawal by Subject|13
928355|NCT00931723|3061100|P1|Overall Study|Withdrawal by Subject|11
928356|NCT00931710|3061148|P2|Overall Study|Protocol deviation|2
928357|NCT00931710|3061149|P1|Overall Study|Protocol deviation|1
928358|NCT00931710|3061148|P2|Overall Study|Lost to Follow-up|5
928359|NCT00931710|3061149|P1|Overall Study|Lost to Follow-up|6
928360|NCT00931710|3061148|P2|Overall Study|Patient withdrew consent|9
928361|NCT00931710|3061149|P1|Overall Study|Patient withdrew consent|4
928362|NCT00931710|3061148|P2|Overall Study|Unsatisfactory therapeutic effects|12
928363|NCT00931710|3061149|P1|Overall Study|Unsatisfactory therapeutic effects|5
928364|NCT00931710|3061148|P2|Overall Study|Abnormal test procedure results|0
928365|NCT00931710|3061149|P1|Overall Study|Abnormal test procedure results|2
928366|NCT00931710|3061148|P2|Overall Study|Adverse Event|10
928367|NCT00931710|3061149|P1|Overall Study|Adverse Event|16
928368|NCT00931632|3061167|P2|Overall Study|Adverse Event|15
928369|NCT00931632|3061168|P1|Overall Study|Adverse Event|19
928370|NCT00931632|3061167|P2|Overall Study|Withdrawal by Subject|3
928371|NCT00931632|3061168|P1|Overall Study|Withdrawal by Subject|2
928372|NCT00931528|3061190|P2|Overall Study|Assessment outside of Time Frame|23
928373|NCT00931528|3061191|P1|Overall Study|Assessment outside of Time Frame|22
928374|NCT00931528|3061190|P2|Overall Study|Lost to Follow-up|13
928375|NCT00931528|3061191|P1|Overall Study|Lost to Follow-up|6
928376|NCT00931528|3061190|P2|Overall Study|Withdrawal by Subject|12
928377|NCT00931528|3061191|P1|Overall Study|Withdrawal by Subject|4
928378|NCT00931528|3061190|P2|Overall Study|Protocol Violation|12
928379|NCT00931528|3061191|P1|Overall Study|Protocol Violation|9
928380|NCT00931515|3061211|P2|Overall Study|Lost to Follow-up|5
928381|NCT00931515|3061212|P1|Overall Study|Lost to Follow-up|2
928382|NCT00931463|3061242|P2|Overall Study|Lost to Follow-up|1
928383|NCT00931463|3061243|P1|Overall Study|Lost to Follow-up|4
928384|NCT00931463|3061242|P2|Overall Study|Withdrawal by Subject|0
928385|NCT00931463|3061243|P1|Overall Study|Withdrawal by Subject|5
928386|NCT00931463|3061242|P2|Overall Study|Death|4
928387|NCT00931463|3061243|P1|Overall Study|Death|8
928388|NCT00931411|3061259|P2|After Crossover - 14 Days (up to Day 56)|Adverse Event|1
928389|NCT00931411|3061260|P1|After Crossover - 14 Days (up to Day 56)|Adverse Event|0
928390|NCT00931411|3061259|P2|First Intervention - 42 Days|Lost to Follow-up|0
928391|NCT00931411|3061260|P1|First Intervention - 42 Days|Lost to Follow-up|2
928392|NCT00931411|3061259|P2|First Intervention - 42 Days|Adverse Event|3
928393|NCT00931411|3061260|P1|First Intervention - 42 Days|Adverse Event|2
928394|NCT00931385|3061281|P4|Overall Study|Lost to Follow-up|1
928395|NCT00931385|3061282|P3|Overall Study|Lost to Follow-up|0
928396|NCT00931385|3061283|P2|Overall Study|Lost to Follow-up|0
928397|NCT00931385|3061284|P1|Overall Study|Lost to Follow-up|0
928398|NCT00931385|3061281|P4|Overall Study|Withdrawal by Subject|1
928399|NCT00931385|3061282|P3|Overall Study|Withdrawal by Subject|0
928400|NCT00931385|3061283|P2|Overall Study|Withdrawal by Subject|1
928401|NCT00931385|3061284|P1|Overall Study|Withdrawal by Subject|0
928402|NCT00931385|3061281|P4|Overall Study|Protocol Violation|0
928403|NCT00931385|3061282|P3|Overall Study|Protocol Violation|1
928404|NCT00931385|3061283|P2|Overall Study|Protocol Violation|0
928405|NCT00931385|3061284|P1|Overall Study|Protocol Violation|0
928406|NCT00931385|3061281|P4|Overall Study|Adverse Event|3
928407|NCT00931385|3061282|P3|Overall Study|Adverse Event|0
928408|NCT00931385|3061283|P2|Overall Study|Adverse Event|1
928409|NCT00931385|3061284|P1|Overall Study|Adverse Event|2
928410|NCT00931307|3061353|P1|Overall Study|Biomicroscopy|1
928411|NCT00931307|3061353|P1|Overall Study|Lack of Efficacy|12
928412|NCT00931268|3061357|P1|Overall Study|Lost to Follow-up|6
928413|NCT00931255|3061369|P2|Overall Study|Follow up biopsy not done|3
928414|NCT00931255|3061370|P1|Overall Study|Follow up biopsy not done|2
928415|NCT00930982|3061407|P2|Overall Study|Withdrawal by Subject|1
928416|NCT00930982|3061408|P1|Overall Study|Withdrawal by Subject|1
928417|NCT00930982|3061407|P2|Overall Study|Protocol Violation|5
928418|NCT00930982|3061408|P1|Overall Study|Protocol Violation|1
928419|NCT00930982|3061407|P2|Overall Study|Adverse Event|23
928420|NCT00930982|3061408|P1|Overall Study|Adverse Event|19
928421|NCT00930969|3061442|P1|Overall Study|Withdrawal by Subject|19
928422|NCT00930969|3061442|P1|Overall Study|Physician Decision|13
928423|NCT00930969|3061442|P1|Overall Study|Lost to Follow-up|1
928424|NCT00930969|3061442|P1|Overall Study|Death|5
928425|NCT00930930|3061452|P2|Overall Study|patients not compliant|1
928426|NCT00930930|3061453|P1|Overall Study|patients not compliant|1
928427|NCT00930930|3061452|P2|Overall Study|excessive lapse btw txs, not eligible|1
928428|NCT00930930|3061453|P1|Overall Study|excessive lapse btw txs, not eligible|0
928429|NCT00930930|3061452|P2|Overall Study|Disease progression|3
928430|NCT00930930|3061453|P1|Overall Study|Disease progression|2
928431|NCT00930930|3061452|P2|Overall Study|Withdrawal by Subject|1
928432|NCT00930930|3061453|P1|Overall Study|Withdrawal by Subject|3
928433|NCT00930930|3061452|P2|Overall Study|Adverse Event|3
928434|NCT00930930|3061453|P1|Overall Study|Adverse Event|13
928435|NCT00930930|3061452|P2|Overall Study|Physician Decision|0
928436|NCT00930930|3061453|P1|Overall Study|Physician Decision|1
928437|NCT00930930|3061452|P2|Overall Study|Death|0
928438|NCT00930930|3061453|P1|Overall Study|Death|1
928439|NCT00930813|3061467|P2|Overall Study|Lost to Follow-up|4
928440|NCT00930813|3061468|P1|Overall Study|Lost to Follow-up|2
928441|NCT00930813|3061467|P2|Overall Study|Withdrawal by Subject|5
928442|NCT00930813|3061468|P1|Overall Study|Withdrawal by Subject|2
928443|NCT00930813|3061467|P2|Overall Study|Death|5
928444|NCT00930813|3061468|P1|Overall Study|Death|4
928445|NCT00930774|3061489|P4|Overall Study|Withdrawal by Subject|0
928446|NCT00930774|3061490|P3|Overall Study|Withdrawal by Subject|2
928447|NCT00930774|3061491|P2|Overall Study|Withdrawal by Subject|9
928448|NCT00930774|3061492|P1|Overall Study|Withdrawal by Subject|1
928449|NCT00930761|3061532|P2|Overall Study|less than 3 music therapy sessions|3
928450|NCT00930761|3061533|P1|Overall Study|less than 3 music therapy sessions|0
928451|NCT00930761|3061532|P2|Overall Study|3 newborns died; 1 mother quit the study|0
928452|NCT00930761|3061533|P1|Overall Study|3 newborns died; 1 mother quit the study|4
928453|NCT00930722|3061545|P1|Overall Study|Study terminated by sponsor|2
928454|NCT00930722|3061545|P1|Overall Study|No longer willing to participate|9
928455|NCT00930722|3061545|P1|Overall Study|Lost to Follow-up|16
928456|NCT00930644|3061560|P1|Overall Study|Adverse Event|16
928457|NCT00930644|3061560|P1|Overall Study|Death|1
928458|NCT00930644|3061560|P1|Overall Study|Physician Decision|2
928459|NCT00930644|3061560|P1|Overall Study|Withdrawal by Subject|4
928460|NCT00930553|3061573|P1|Overall Study|Other than specified above|28
928461|NCT00930553|3061573|P1|Overall Study|Study terminated by sponsor|24
928462|NCT00930553|3061573|P1|Overall Study|Death|9
928463|NCT00930553|3061573|P1|Overall Study|Lost to Follow-up|25
928464|NCT00930553|3061573|P1|Overall Study|Withdrawal by Subject|88
928465|NCT00930553|3061573|P1|Overall Study|Pregnancy|1
928466|NCT00930553|3061573|P1|Overall Study|Protocol Violation|1
928467|NCT00930553|3061573|P1|Overall Study|Physician Decision|39
928468|NCT00930553|3061573|P1|Overall Study|Lack of Efficacy|7
928469|NCT00930553|3061573|P1|Overall Study|Adverse Event|1
928470|NCT00930176|3061650|P1|Overall Study|Death|1
928471|NCT00929864|3061667|P2|Overall Study|Non-specified|7
928472|NCT00929864|3061668|P1|Overall Study|Non-specified|2
928473|NCT00929864|3061667|P2|Overall Study|Administrative reason by Sponsor|1
928474|NCT00929864|3061668|P1|Overall Study|Administrative reason by Sponsor|1
928475|NCT00929864|3061667|P2|Overall Study|Pregnancy|3
928476|NCT00929864|3061668|P1|Overall Study|Pregnancy|0
928477|NCT00929864|3061667|P2|Overall Study|Poor or non-compliance|3
928478|NCT00929864|3061668|P1|Overall Study|Poor or non-compliance|3
928479|NCT00929864|3061667|P2|Overall Study|No longer met criteria|1
928480|NCT00929864|3061668|P1|Overall Study|No longer met criteria|2
928481|NCT00929864|3061667|P2|Overall Study|Withdrawal by Subject|9
928482|NCT00929864|3061668|P1|Overall Study|Withdrawal by Subject|20
928483|NCT00929864|3061667|P2|Overall Study|Lost to Follow-up|12
928484|NCT00929864|3061668|P1|Overall Study|Lost to Follow-up|7
928485|NCT00929864|3061667|P2|Overall Study|Lack of Efficacy|16
928486|NCT00929864|3061668|P1|Overall Study|Lack of Efficacy|19
928487|NCT00929864|3061667|P2|Overall Study|Adverse Event|30
928488|NCT00929864|3061668|P1|Overall Study|Adverse Event|11
928489|NCT00929864|3061667|P2|Overall Study|Death|1
928490|NCT00929864|3061668|P1|Overall Study|Death|1
928491|NCT00929734|3061707|P2|Overall Study|Withdrawal by Subject|2
928492|NCT00929734|3061708|P1|Overall Study|Withdrawal by Subject|0
928493|NCT00929734|3061707|P2|Overall Study|Lost to Follow-up|1
928494|NCT00929734|3061708|P1|Overall Study|Lost to Follow-up|2
928495|NCT00929708|3061725|P5|Overall Study|Lost to Follow-up|0
928496|NCT00929708|3061726|P4|Overall Study|Lost to Follow-up|1
928497|NCT00929708|3061727|P3|Overall Study|Lost to Follow-up|0
928498|NCT00929708|3061728|P2|Overall Study|Lost to Follow-up|0
928499|NCT00929708|3061729|P1|Overall Study|Lost to Follow-up|0
928500|NCT00929708|3061725|P5|Overall Study|Physician Decision|1
928501|NCT00929708|3061726|P4|Overall Study|Physician Decision|2
928502|NCT00929708|3061727|P3|Overall Study|Physician Decision|2
928503|NCT00929708|3061728|P2|Overall Study|Physician Decision|2
928504|NCT00929708|3061729|P1|Overall Study|Physician Decision|0
928505|NCT00929708|3061725|P5|Overall Study|Adverse Event|3
928506|NCT00929708|3061726|P4|Overall Study|Adverse Event|0
928507|NCT00929708|3061727|P3|Overall Study|Adverse Event|0
928508|NCT00929708|3061728|P2|Overall Study|Adverse Event|0
928509|NCT00929708|3061729|P1|Overall Study|Adverse Event|0
928510|NCT00929708|3061725|P5|Overall Study|Withdrawal by Subject|1
928511|NCT00929708|3061726|P4|Overall Study|Withdrawal by Subject|2
928512|NCT00929708|3061727|P3|Overall Study|Withdrawal by Subject|0
928513|NCT00929708|3061728|P2|Overall Study|Withdrawal by Subject|0
928514|NCT00929708|3061729|P1|Overall Study|Withdrawal by Subject|2
928515|NCT00929708|3061725|P5|Overall Study|Protocol Violation|1
928516|NCT00929708|3061726|P4|Overall Study|Protocol Violation|1
928517|NCT00929708|3061727|P3|Overall Study|Protocol Violation|1
928518|NCT00929708|3061728|P2|Overall Study|Protocol Violation|1
928519|NCT00929708|3061729|P1|Overall Study|Protocol Violation|2
928520|NCT00929695|3061783|P2|Overall Study|incorrect stratification|0
928521|NCT00929695|3061784|P1|Overall Study|incorrect stratification|2
928522|NCT00929695|3061783|P2|Overall Study|discharge home|3
928523|NCT00929695|3061784|P1|Overall Study|discharge home|4
928524|NCT00929695|3061783|P2|Overall Study|Withdrawal by Subject|2
928525|NCT00929695|3061784|P1|Overall Study|Withdrawal by Subject|0
928526|NCT00929695|3061783|P2|Overall Study|Death|1
928527|NCT00929695|3061784|P1|Overall Study|Death|2
928528|NCT00929669|3061814|P1|Overall Study|elevated glucose levels|1
928529|NCT00929656|3061821|P2|Overall Study|Lost to Follow-up|1
928530|NCT00929656|3061822|P1|Overall Study|Lost to Follow-up|0
928531|NCT00929643|3061836|P1|Overall Study|Protocol Violation|2
928532|NCT00929526|3061858|P2|Overall Study|Other|6
928533|NCT00929526|3061859|P1|Overall Study|Other|8
928534|NCT00929526|3061858|P2|Overall Study|Lost to Follow-up|12
928535|NCT00929526|3061859|P1|Overall Study|Lost to Follow-up|8
928536|NCT00929526|3061858|P2|Overall Study|Withdrawal by Subject|11
928537|NCT00929526|3061859|P1|Overall Study|Withdrawal by Subject|1
928538|NCT00929240|3062013|P3|Maintenance Phase|Participant not treated|0
928539|NCT00929240|3062014|P2|Maintenance Phase|Participant not treated|2
928540|NCT00929240|3062015|P1|Maintenance Phase|Participant not treated|0
928541|NCT00929240|3062013|P3|Maintenance Phase|Treatment ongoing at study closure|10
928542|NCT00929240|3062014|P2|Maintenance Phase|Treatment ongoing at study closure|0
928543|NCT00929240|3062015|P1|Maintenance Phase|Treatment ongoing at study closure|0
928544|NCT00929240|3062013|P3|Maintenance Phase|Change of treatment|0
928545|NCT00929240|3062014|P2|Maintenance Phase|Change of treatment|4
928546|NCT00929240|3062015|P1|Maintenance Phase|Change of treatment|0
928547|NCT00929240|3062013|P3|Maintenance Phase|Physician Decision|1
928548|NCT00929240|3062014|P2|Maintenance Phase|Physician Decision|2
928549|NCT00929240|3062015|P1|Maintenance Phase|Physician Decision|0
928550|NCT00929240|3062013|P3|Maintenance Phase|Health authority/Study termination|2
928551|NCT00929240|3062014|P2|Maintenance Phase|Health authority/Study termination|1
928552|NCT00929240|3062015|P1|Maintenance Phase|Health authority/Study termination|0
928553|NCT00929240|3062013|P3|Maintenance Phase|Protocol Violation|0
928554|NCT00929240|3062014|P2|Maintenance Phase|Protocol Violation|1
928555|NCT00929240|3062015|P1|Maintenance Phase|Protocol Violation|0
928556|NCT00929240|3062013|P3|Maintenance Phase|Withdrawal by Subject|6
928557|NCT00929240|3062014|P2|Maintenance Phase|Withdrawal by Subject|2
928558|NCT00929240|3062015|P1|Maintenance Phase|Withdrawal by Subject|0
928559|NCT00929240|3062013|P3|Maintenance Phase|Adverse Event|12
928560|NCT00929240|3062014|P2|Maintenance Phase|Adverse Event|9
928561|NCT00929240|3062015|P1|Maintenance Phase|Adverse Event|0
928562|NCT00929240|3062013|P3|Maintenance Phase|Disease progression|60
928563|NCT00929240|3062014|P2|Maintenance Phase|Disease progression|73
928564|NCT00929240|3062015|P1|Maintenance Phase|Disease progression|0
928565|NCT00929240|3062013|P3|Initial Treatment Phase|Physician Decision|0
928566|NCT00929240|3062014|P2|Initial Treatment Phase|Physician Decision|0
928567|NCT00929240|3062015|P1|Initial Treatment Phase|Physician Decision|4
928568|NCT00929240|3062013|P3|Initial Treatment Phase|Health authority/Study termination|0
928569|NCT00929240|3062014|P2|Initial Treatment Phase|Health authority/Study termination|0
928570|NCT00929240|3062015|P1|Initial Treatment Phase|Health authority/Study termination|3
928571|NCT00929240|3062013|P3|Initial Treatment Phase|Death|0
928572|NCT00929240|3062014|P2|Initial Treatment Phase|Death|0
928573|NCT00929240|3062015|P1|Initial Treatment Phase|Death|2
928574|NCT00929240|3062013|P3|Initial Treatment Phase|Protocol Violation|0
928575|NCT00929240|3062014|P2|Initial Treatment Phase|Protocol Violation|0
928576|NCT00929240|3062015|P1|Initial Treatment Phase|Protocol Violation|5
928577|NCT00929240|3062013|P3|Initial Treatment Phase|Withdrawal by Subject|0
928578|NCT00929240|3062014|P2|Initial Treatment Phase|Withdrawal by Subject|0
928579|NCT00929240|3062015|P1|Initial Treatment Phase|Withdrawal by Subject|13
928580|NCT00929240|3062013|P3|Initial Treatment Phase|Disease progression|0
928581|NCT00929240|3062014|P2|Initial Treatment Phase|Disease progression|0
928582|NCT00929240|3062015|P1|Initial Treatment Phase|Disease progression|41
928583|NCT00929240|3062013|P3|Initial Treatment Phase|Adverse Event|0
928584|NCT00929240|3062014|P2|Initial Treatment Phase|Adverse Event|0
928585|NCT00929240|3062015|P1|Initial Treatment Phase|Adverse Event|31
928586|NCT00929201|3062042|P2|Period 1|Withdrawal by Subject|1
928587|NCT00929201|3062043|P1|Period 1|Withdrawal by Subject|0
928588|NCT00929162|3062053|P2|Overall Study|Other termination reason|6
928589|NCT00929162|3062054|P1|Overall Study|Other termination reason|5
928590|NCT00929162|3062053|P2|Overall Study|Protocol Violation|30
928591|NCT00929162|3062054|P1|Overall Study|Protocol Violation|32
928592|NCT00929162|3062053|P2|Overall Study|Withdrawal by Subject|1
928593|NCT00929162|3062054|P1|Overall Study|Withdrawal by Subject|3
928594|NCT00929162|3062053|P2|Overall Study|Adverse Event|5
928595|NCT00929162|3062054|P1|Overall Study|Adverse Event|8
928596|NCT00929110|3062067|P3|Overall Study|Patient inability to use the device|0
928597|NCT00929110|3062068|P2|Overall Study|Patient inability to use the device|1
928598|NCT00929110|3062069|P1|Overall Study|Patient inability to use the device|0
928599|NCT00929110|3062067|P3|Overall Study|Abnormal test procedure result(s)|1
928600|NCT00929110|3062068|P2|Overall Study|Abnormal test procedure result(s)|1
928601|NCT00929110|3062069|P1|Overall Study|Abnormal test procedure result(s)|0
928602|NCT00929110|3062067|P3|Overall Study|Abnormal laboratory value(s)|0
928603|NCT00929110|3062068|P2|Overall Study|Abnormal laboratory value(s)|1
928604|NCT00929110|3062069|P1|Overall Study|Abnormal laboratory value(s)|0
928605|NCT00929110|3062067|P3|Overall Study|Death|2
928606|NCT00929110|3062068|P2|Overall Study|Death|2
928607|NCT00929110|3062069|P1|Overall Study|Death|2
928608|NCT00929110|3062067|P3|Overall Study|Administrative problems|2
928609|NCT00929110|3062068|P2|Overall Study|Administrative problems|1
928610|NCT00929110|3062069|P1|Overall Study|Administrative problems|4
928611|NCT00929110|3062067|P3|Overall Study|Protocol deviation|4
928612|NCT00929110|3062068|P2|Overall Study|Protocol deviation|2
928613|NCT00929110|3062069|P1|Overall Study|Protocol deviation|5
928614|NCT00929110|3062067|P3|Overall Study|Lost to Follow-up|3
928615|NCT00929110|3062068|P2|Overall Study|Lost to Follow-up|7
928616|NCT00929110|3062069|P1|Overall Study|Lost to Follow-up|7
928617|NCT00929110|3062067|P3|Overall Study|Unsatisfactory therapeutic effect|6
928618|NCT00929110|3062068|P2|Overall Study|Unsatisfactory therapeutic effect|9
928619|NCT00929110|3062069|P1|Overall Study|Unsatisfactory therapeutic effect|20
928620|NCT00929110|3062067|P3|Overall Study|Subject withdrew consent|26
928621|NCT00929110|3062068|P2|Overall Study|Subject withdrew consent|23
928622|NCT00929110|3062069|P1|Overall Study|Subject withdrew consent|40
928623|NCT00929110|3062067|P3|Overall Study|Adverse Event|18
928624|NCT00929110|3062068|P2|Overall Study|Adverse Event|29
928625|NCT00929110|3062069|P1|Overall Study|Adverse Event|40
928626|NCT00928889|3062152|P2|Overall Study|Other|0
928627|NCT00928889|3062153|P1|Overall Study|Other|1
928628|NCT00928889|3062152|P2|Overall Study|Adverse Event|0
928629|NCT00928889|3062153|P1|Overall Study|Adverse Event|1
928630|NCT00928889|3062152|P2|Overall Study|Protocol Violation|1
928631|NCT00928889|3062153|P1|Overall Study|Protocol Violation|0
928632|NCT00928889|3062152|P2|Overall Study|Lost to Follow-up|1
928633|NCT00928889|3062153|P1|Overall Study|Lost to Follow-up|3
928634|NCT00928746|3062199|P1|Overall Study|Other|2
928635|NCT00928746|3062199|P1|Overall Study|Withdrawal by Subject|1
928636|NCT00928746|3062199|P1|Overall Study|Protocol Violation|1
928637|NCT00928746|3062199|P1|Overall Study|Adverse Event|2
928638|NCT00928668|3062256|P5|Overall Study|Other reasons not listed above|0
928639|NCT00928668|3062257|P4|Overall Study|Other reasons not listed above|1
928640|NCT00928668|3062258|P3|Overall Study|Other reasons not listed above|0
928641|NCT00928668|3062259|P2|Overall Study|Other reasons not listed above|0
928642|NCT00928668|3062260|P1|Overall Study|Other reasons not listed above|0
928643|NCT00928668|3062256|P5|Overall Study|Withdrawal by Subject|0
928644|NCT00928668|3062257|P4|Overall Study|Withdrawal by Subject|0
928645|NCT00928668|3062258|P3|Overall Study|Withdrawal by Subject|1
928646|NCT00928668|3062259|P2|Overall Study|Withdrawal by Subject|1
928647|NCT00928668|3062260|P1|Overall Study|Withdrawal by Subject|0
928648|NCT00928668|3062256|P5|Overall Study|Protocol Violation|1
928649|NCT00928668|3062257|P4|Overall Study|Protocol Violation|0
928650|NCT00928668|3062258|P3|Overall Study|Protocol Violation|0
928651|NCT00928668|3062259|P2|Overall Study|Protocol Violation|0
928652|NCT00928668|3062260|P1|Overall Study|Protocol Violation|0
928653|NCT00928668|3062256|P5|Overall Study|Adverse Event|0
928654|NCT00928668|3062257|P4|Overall Study|Adverse Event|0
928655|NCT00928668|3062258|P3|Overall Study|Adverse Event|0
928656|NCT00928668|3062259|P2|Overall Study|Adverse Event|0
928657|NCT00928668|3062260|P1|Overall Study|Adverse Event|1
928658|NCT00928512|3062316|P5|Overall Study|Administrative Problems|0
928659|NCT00928512|3062317|P4|Overall Study|Administrative Problems|0
928660|NCT00928512|3062318|P3|Overall Study|Administrative Problems|0
928661|NCT00928512|3062319|P2|Overall Study|Administrative Problems|1
928662|NCT00928512|3062320|P1|Overall Study|Administrative Problems|0
928663|NCT00928512|3062316|P5|Overall Study|Lost to Follow-up|3
928664|NCT00928512|3062317|P4|Overall Study|Lost to Follow-up|1
928665|NCT00928512|3062318|P3|Overall Study|Lost to Follow-up|2
928666|NCT00928512|3062319|P2|Overall Study|Lost to Follow-up|1
928667|NCT00928512|3062320|P1|Overall Study|Lost to Follow-up|1
928668|NCT00928512|3062316|P5|Overall Study|Withdrawal by Subject|0
928669|NCT00928512|3062317|P4|Overall Study|Withdrawal by Subject|4
928670|NCT00928512|3062318|P3|Overall Study|Withdrawal by Subject|3
928671|NCT00928512|3062319|P2|Overall Study|Withdrawal by Subject|0
928672|NCT00928512|3062320|P1|Overall Study|Withdrawal by Subject|3
928673|NCT00928512|3062316|P5|Overall Study|Protocol Violation|3
928674|NCT00928512|3062317|P4|Overall Study|Protocol Violation|1
928675|NCT00928512|3062318|P3|Overall Study|Protocol Violation|0
928676|NCT00928512|3062319|P2|Overall Study|Protocol Violation|1
928677|NCT00928512|3062320|P1|Overall Study|Protocol Violation|0
928678|NCT00928512|3062316|P5|Overall Study|Lack of Efficacy|3
928679|NCT00928512|3062317|P4|Overall Study|Lack of Efficacy|7
928680|NCT00928512|3062318|P3|Overall Study|Lack of Efficacy|4
928681|NCT00928512|3062319|P2|Overall Study|Lack of Efficacy|0
928682|NCT00928512|3062320|P1|Overall Study|Lack of Efficacy|2
928683|NCT00928512|3062316|P5|Overall Study|Adverse Event|6
928684|NCT00928512|3062317|P4|Overall Study|Adverse Event|8
928685|NCT00928512|3062318|P3|Overall Study|Adverse Event|2
928686|NCT00928512|3062319|P2|Overall Study|Adverse Event|3
928687|NCT00928512|3062320|P1|Overall Study|Adverse Event|4
928688|NCT00928486|3062421|P1|Overall Study|Withdrawal by Subject|1
928689|NCT00928486|3062421|P1|Overall Study|Disease Progression|7
928690|NCT00928486|3062421|P1|Overall Study|Adverse Event|2
928691|NCT00928434|3062430|P3|Overall Study|Other (not meeting above criteria)|2
928692|NCT00928434|3062431|P2|Overall Study|Other (not meeting above criteria)|1
928693|NCT00928434|3062432|P1|Overall Study|Other (not meeting above criteria)|5
928694|NCT00928434|3062430|P3|Overall Study|PSA failure (>2 ng/mL) on other visit|1
928695|NCT00928434|3062431|P2|Overall Study|PSA failure (>2 ng/mL) on other visit|1
928696|NCT00928434|3062432|P1|Overall Study|PSA failure (>2 ng/mL) on other visit|2
928697|NCT00928434|3062430|P3|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7
928698|NCT00928434|3062431|P2|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4
928699|NCT00928434|3062432|P1|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10
928700|NCT00928434|3062430|P3|Overall Study|Withdrawal by Subject|2
928701|NCT00928434|3062431|P2|Overall Study|Withdrawal by Subject|3
928702|NCT00928434|3062432|P1|Overall Study|Withdrawal by Subject|5
928703|NCT00928434|3062430|P3|Overall Study|Lost to Follow-up|3
928704|NCT00928434|3062431|P2|Overall Study|Lost to Follow-up|0
928705|NCT00928434|3062432|P1|Overall Study|Lost to Follow-up|1
928706|NCT00928434|3062430|P3|Overall Study|Physician Decision|3
928707|NCT00928434|3062431|P2|Overall Study|Physician Decision|0
928708|NCT00928434|3062432|P1|Overall Study|Physician Decision|2
928709|NCT00928434|3062430|P3|Overall Study|Protocol Violation|8
928710|NCT00928434|3062431|P2|Overall Study|Protocol Violation|0
928711|NCT00928434|3062432|P1|Overall Study|Protocol Violation|5
928712|NCT00928434|3062430|P3|Overall Study|Adverse Event|18
928713|NCT00928434|3062431|P2|Overall Study|Adverse Event|5
928714|NCT00928434|3062432|P1|Overall Study|Adverse Event|14
928715|NCT00928408|3062508|P1|Overall Study|Lost to Follow-up|12
928716|NCT00928408|3062508|P1|Overall Study|Death|5
928717|NCT00928408|3062508|P1|Overall Study|Withdrawal by Subject|4
928718|NCT00928408|3062508|P1|Overall Study|Other|2
928719|NCT00928252|3062554|P1|Overall Study|Physician Decision|3
928720|NCT00928187|3062563|P3|Overall Study|Protocol Violation|0
928721|NCT00928187|3062564|P2|Overall Study|Protocol Violation|1
928722|NCT00928187|3062565|P1|Overall Study|Protocol Violation|0
928723|NCT00928187|3062563|P3|Overall Study|Withdrawal by Subject|1
928724|NCT00928187|3062564|P2|Overall Study|Withdrawal by Subject|1
928725|NCT00928187|3062565|P1|Overall Study|Withdrawal by Subject|0
928726|NCT00928187|3062563|P3|Overall Study|Lost to Follow-up|1
928727|NCT00928187|3062564|P2|Overall Study|Lost to Follow-up|2
928728|NCT00928187|3062565|P1|Overall Study|Lost to Follow-up|1
928729|NCT00928187|3062563|P3|Overall Study|Death|3
928730|NCT00928187|3062564|P2|Overall Study|Death|2
928731|NCT00928187|3062565|P1|Overall Study|Death|1
928732|NCT00928070|3062735|P2|Overall Study|Other|5
928733|NCT00928070|3062736|P1|Overall Study|Other|5
928734|NCT00928070|3062735|P2|Overall Study|Randomized but not treated|2
928735|NCT00928070|3062736|P1|Overall Study|Randomized but not treated|2
928736|NCT00928070|3062735|P2|Overall Study|Protocol Violation|5
928737|NCT00928070|3062736|P1|Overall Study|Protocol Violation|6
928738|NCT00928070|3062735|P2|Overall Study|Did not meet entrance criteria|9
928739|NCT00928070|3062736|P1|Overall Study|Did not meet entrance criteria|16
928740|NCT00928070|3062735|P2|Overall Study|Lack of Efficacy|5
928741|NCT00928070|3062736|P1|Overall Study|Lack of Efficacy|9
928742|NCT00928070|3062735|P2|Overall Study|Adverse Event|26
928743|NCT00928070|3062736|P1|Overall Study|Adverse Event|14
928744|NCT00928070|3062735|P2|Overall Study|Withdrawal by Subject|3
928745|NCT00928070|3062736|P1|Overall Study|Withdrawal by Subject|10
928746|NCT00928070|3062735|P2|Overall Study|Lost to Follow-up|2
928747|NCT00928070|3062736|P1|Overall Study|Lost to Follow-up|1
928748|NCT00928057|3062794|P2|Overall Study|Protocol Violation|1
928749|NCT00928057|3062795|P1|Overall Study|Protocol Violation|0
928750|NCT00928057|3062794|P2|Overall Study|Lost to Follow-up|1
928751|NCT00928057|3062795|P1|Overall Study|Lost to Follow-up|0
928752|NCT00928057|3062794|P2|Overall Study|Withdrawal by Subject|0
928753|NCT00928057|3062795|P1|Overall Study|Withdrawal by Subject|1
928754|NCT00928057|3062794|P2|Overall Study|Adverse Event|2
928755|NCT00928057|3062795|P1|Overall Study|Adverse Event|1
928756|NCT00928018|3062820|P2|Overall Study|Withdrawal by Subject|0
928757|NCT00928018|3062821|P1|Overall Study|Withdrawal by Subject|1
928758|NCT00927953|3062851|P2|Overall Study|Death|1
928759|NCT00927953|3062852|P1|Overall Study|Death|2
928760|NCT00927940|3062866|P1|Overall Study|Death|1
928761|NCT00927927|3062886|P15|Overall Study|Withdrawal by Subject|0
928762|NCT00927927|3062887|P14|Overall Study|Withdrawal by Subject|0
928763|NCT00927927|3062888|P13|Overall Study|Withdrawal by Subject|0
928764|NCT00927927|3062889|P12|Overall Study|Withdrawal by Subject|2
928765|NCT00927927|3062890|P11|Overall Study|Withdrawal by Subject|0
928766|NCT00927927|3062891|P10|Overall Study|Withdrawal by Subject|0
928767|NCT00927927|3062892|P9|Overall Study|Withdrawal by Subject|0
928768|NCT00927927|3062893|P8|Overall Study|Withdrawal by Subject|2
928769|NCT00927927|3062894|P7|Overall Study|Withdrawal by Subject|0
928770|NCT00927927|3062895|P6|Overall Study|Withdrawal by Subject|0
928771|NCT00927927|3062896|P5|Overall Study|Withdrawal by Subject|0
928772|NCT00927927|3062897|P4|Overall Study|Withdrawal by Subject|0
928773|NCT00927927|3062898|P3|Overall Study|Withdrawal by Subject|0
928774|NCT00927927|3062899|P2|Overall Study|Withdrawal by Subject|0
928775|NCT00927927|3062900|P1|Overall Study|Withdrawal by Subject|0
928776|NCT00927901|3062947|P4|Treatment Period 4|Subject withdrew consent|0
928777|NCT00927901|3062948|P3|Treatment Period 4|Subject withdrew consent|1
928778|NCT00927901|3062949|P2|Treatment Period 4|Subject withdrew consent|0
928779|NCT00927901|3062950|P1|Treatment Period 4|Subject withdrew consent|0
928780|NCT00927901|3062947|P4|Treatment Period 4|Adverse Event|1
928781|NCT00927901|3062948|P3|Treatment Period 4|Adverse Event|0
928782|NCT00927901|3062949|P2|Treatment Period 4|Adverse Event|0
928783|NCT00927901|3062950|P1|Treatment Period 4|Adverse Event|0
928784|NCT00927901|3062947|P4|Treatment Period 1|Subject withdrew consent|0
928785|NCT00927901|3062948|P3|Treatment Period 1|Subject withdrew consent|1
928786|NCT00927901|3062949|P2|Treatment Period 1|Subject withdrew consent|0
928787|NCT00927901|3062950|P1|Treatment Period 1|Subject withdrew consent|0
928788|NCT00927862|3062991|P2|Overall Study|Missing data needed for endpt analyses|45
928789|NCT00927862|3062992|P1|Overall Study|Missing data needed for endpt analyses|27
928790|NCT00927823|3063027|P4|Continuous Dosing Period|Other|3
928791|NCT00927823|3063028|P3|Continuous Dosing Period|Other|9
928792|NCT00927823|3063029|P2|Continuous Dosing Period|Other|2
928793|NCT00927823|3063030|P1|Continuous Dosing Period|Other|1
928794|NCT00927823|3063027|P4|Continuous Dosing Period|Withdrawal by Subject|2
928795|NCT00927823|3063028|P3|Continuous Dosing Period|Withdrawal by Subject|2
928796|NCT00927823|3063029|P2|Continuous Dosing Period|Withdrawal by Subject|0
928797|NCT00927823|3063030|P1|Continuous Dosing Period|Withdrawal by Subject|1
928798|NCT00927823|3063027|P4|Continuous Dosing Period|Lost to Follow-up|0
928799|NCT00927823|3063028|P3|Continuous Dosing Period|Lost to Follow-up|9
928800|NCT00927823|3063029|P2|Continuous Dosing Period|Lost to Follow-up|1
928801|NCT00927823|3063030|P1|Continuous Dosing Period|Lost to Follow-up|1
928802|NCT00927823|3063027|P4|Continuous Dosing Period|Death|0
928803|NCT00927823|3063028|P3|Continuous Dosing Period|Death|6
928804|NCT00927823|3063029|P2|Continuous Dosing Period|Death|0
928805|NCT00927823|3063030|P1|Continuous Dosing Period|Death|0
928806|NCT00927758|3063094|P6|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
928807|NCT00927758|3063095|P5|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
928808|NCT00927758|3063096|P4|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
928809|NCT00927758|3063097|P3|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
928810|NCT00927758|3063098|P2|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
928811|NCT00927758|3063099|P1|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
928812|NCT00927758|3063094|P6|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
928813|NCT00927758|3063095|P5|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
928814|NCT00927758|3063096|P4|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
928815|NCT00927758|3063097|P3|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
928816|NCT00927758|3063098|P2|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
928817|NCT00927758|3063099|P1|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
928818|NCT00927589|3063107|P1|Overall Study|Non-compliance|1
928819|NCT00927589|3063107|P1|Overall Study|Disease Progression|8
928820|NCT00927589|3063107|P1|Overall Study|Adverse Event|2
928821|NCT00927589|3063107|P1|Overall Study|Withdrawal by Subject|3
928822|NCT00927589|3063107|P1|Overall Study|Physician Decision|1
928823|NCT00927589|3063107|P1|Overall Study|Death|1
928824|NCT00927563|3063137|P1|Overall Study|Withdrawal by Subject|1
928825|NCT00927563|3063137|P1|Overall Study|Lost to Follow-up|1
928826|NCT00927472|3063145|P2|Overall Study|Post treatment Assessment out of window|4
928827|NCT00927472|3063146|P1|Overall Study|Post treatment Assessment out of window|0
928828|NCT00927472|3063145|P2|Overall Study|Protocol Violation|1
928829|NCT00927472|3063146|P1|Overall Study|Protocol Violation|0
928830|NCT00927472|3063145|P2|Overall Study|Lost to Follow-up|6
928831|NCT00927472|3063146|P1|Overall Study|Lost to Follow-up|1
928832|NCT00927472|3063145|P2|Overall Study|Withdrawal by Subject|11
928833|NCT00927472|3063146|P1|Overall Study|Withdrawal by Subject|10
928834|NCT00927394|3063172|P2|Overall Study|Randomized in error|1
928835|NCT00927394|3063173|P1|Overall Study|Randomized in error|0
928836|NCT00927394|3063172|P2|Overall Study|Protocol deviation|13
928837|NCT00927394|3063173|P1|Overall Study|Protocol deviation|16
928838|NCT00927394|3063172|P2|Overall Study|Death|1
928839|NCT00927394|3063173|P1|Overall Study|Death|1
928840|NCT00927394|3063172|P2|Overall Study|Administrative Problem|0
928841|NCT00927394|3063173|P1|Overall Study|Administrative Problem|1
928842|NCT00927394|3063172|P2|Overall Study|Lost to Follow-up|14
928843|NCT00927394|3063173|P1|Overall Study|Lost to Follow-up|8
928844|NCT00927394|3063172|P2|Overall Study|Withdrawal by Subject|24
928845|NCT00927394|3063173|P1|Overall Study|Withdrawal by Subject|20
928846|NCT00927394|3063172|P2|Overall Study|Unsatisfactory therapeutic effect|23
928847|NCT00927394|3063173|P1|Overall Study|Unsatisfactory therapeutic effect|17
928848|NCT00927394|3063172|P2|Overall Study|Adverse Event|9
928849|NCT00927394|3063173|P1|Overall Study|Adverse Event|14
928850|NCT00927368|3063204|P3|Overall Study|cancellation of surgery|2
928851|NCT00927368|3063205|P2|Overall Study|cancellation of surgery|1
928852|NCT00927368|3063206|P1|Overall Study|cancellation of surgery|0
928853|NCT00927368|3063204|P3|Overall Study|ineligible post randomization|1
928854|NCT00927368|3063205|P2|Overall Study|ineligible post randomization|3
928855|NCT00927368|3063206|P1|Overall Study|ineligible post randomization|0
928856|NCT00927368|3063204|P3|Overall Study|equipment failure|0
928857|NCT00927368|3063205|P2|Overall Study|equipment failure|0
928858|NCT00927368|3063206|P1|Overall Study|equipment failure|1
928859|NCT00927368|3063204|P3|Overall Study|Lost to Follow-up|0
928860|NCT00927368|3063205|P2|Overall Study|Lost to Follow-up|0
928861|NCT00927368|3063206|P1|Overall Study|Lost to Follow-up|4
928862|NCT00927368|3063204|P3|Overall Study|enrollment in another study|2
928863|NCT00927368|3063205|P2|Overall Study|enrollment in another study|1
928864|NCT00927368|3063206|P1|Overall Study|enrollment in another study|1
928865|NCT00927355|3063225|P2|Overall Study|Adverse Event|1
928866|NCT00927355|3063226|P1|Overall Study|Adverse Event|1
928867|NCT00927251|3063261|P1|Overall Study|Patients not implanted with 4296 lead|8
928868|NCT00927186|3063267|P2|12 Months Primary Study|Withdrawal by Subject|1
928869|NCT00927186|3063268|P1|12 Months Primary Study|Withdrawal by Subject|1
928870|NCT00927186|3063267|P2|12 Months Primary Study|Protocol Violation|1
928871|NCT00927186|3063268|P1|12 Months Primary Study|Protocol Violation|0
928872|NCT00927186|3063267|P2|12 Months Primary Study|Lost to Follow-up|0
928873|NCT00927186|3063268|P1|12 Months Primary Study|Lost to Follow-up|1
928874|NCT00927186|3063267|P2|12 Months Primary Study|Adverse Event|2
928875|NCT00927186|3063268|P1|12 Months Primary Study|Adverse Event|5
928876|NCT00927095|3063398|P3|Overall Study|Physician Decision|1
928877|NCT00927095|3063399|P2|Overall Study|Physician Decision|2
928878|NCT00927095|3063400|P1|Overall Study|Physician Decision|1
928879|NCT00927095|3063398|P3|Overall Study|Withdrawal by Subject|1
928880|NCT00927095|3063399|P2|Overall Study|Withdrawal by Subject|1
928881|NCT00927095|3063400|P1|Overall Study|Withdrawal by Subject|2
928882|NCT00927095|3063398|P3|Overall Study|Adverse Event|0
928883|NCT00927095|3063399|P2|Overall Study|Adverse Event|1
928884|NCT00927095|3063400|P1|Overall Study|Adverse Event|3
928885|NCT00927082|3063412|P4|Overall Study|Screen fail,Participant migrated,Unknown|1
928886|NCT00927082|3063413|P3|Overall Study|Screen fail,Participant migrated,Unknown|2
928887|NCT00927082|3063414|P2|Overall Study|Screen fail,Participant migrated,Unknown|0
928888|NCT00927082|3063415|P1|Overall Study|Screen fail,Participant migrated,Unknown|0
928889|NCT00927082|3063412|P4|Overall Study|Death|0
928890|NCT00927082|3063413|P3|Overall Study|Death|1
928891|NCT00927082|3063414|P2|Overall Study|Death|0
928892|NCT00927082|3063415|P1|Overall Study|Death|0
928893|NCT00927082|3063412|P4|Overall Study|Withdrawal by Subject|2
928894|NCT00927082|3063413|P3|Overall Study|Withdrawal by Subject|7
928895|NCT00927082|3063414|P2|Overall Study|Withdrawal by Subject|2
928896|NCT00927082|3063415|P1|Overall Study|Withdrawal by Subject|3
928897|NCT00927082|3063412|P4|Overall Study|Lost to Follow-up|16
928898|NCT00927082|3063413|P3|Overall Study|Lost to Follow-up|12
928899|NCT00927082|3063414|P2|Overall Study|Lost to Follow-up|8
928900|NCT00927082|3063415|P1|Overall Study|Lost to Follow-up|9
928901|NCT00927069|3063479|P4|Week 12 to Week 24|Had a vaccination, removed from study|0
928902|NCT00927069|3063480|P3|Week 12 to Week 24|Had a vaccination, removed from study|0
928903|NCT00927069|3063481|P2|Week 12 to Week 24|Had a vaccination, removed from study|0
928904|NCT00927069|3063482|P1|Week 12 to Week 24|Had a vaccination, removed from study|1
928905|NCT00927069|3063479|P4|Week 12 to Week 24|Withdrawal by Subject|0
928906|NCT00927069|3063480|P3|Week 12 to Week 24|Withdrawal by Subject|0
928907|NCT00927069|3063481|P2|Week 12 to Week 24|Withdrawal by Subject|0
928908|NCT00927069|3063482|P1|Week 12 to Week 24|Withdrawal by Subject|1
928909|NCT00927069|3063479|P4|Week 12 to Week 24|Lost to Follow-up|0
928910|NCT00927069|3063480|P3|Week 12 to Week 24|Lost to Follow-up|1
928911|NCT00927069|3063481|P2|Week 12 to Week 24|Lost to Follow-up|0
928912|NCT00927069|3063482|P1|Week 12 to Week 24|Lost to Follow-up|0
928913|NCT00927069|3063479|P4|Week 12 to Week 24|Lack of Efficacy|3
928914|NCT00927069|3063480|P3|Week 12 to Week 24|Lack of Efficacy|2
928915|NCT00927069|3063481|P2|Week 12 to Week 24|Lack of Efficacy|0
928916|NCT00927069|3063482|P1|Week 12 to Week 24|Lack of Efficacy|0
928917|NCT00927069|3063479|P4|Week 0 to Week 12|Worsening of psoriasis|0
928918|NCT00927069|3063480|P3|Week 0 to Week 12|Worsening of psoriasis|0
928919|NCT00927069|3063481|P2|Week 0 to Week 12|Worsening of psoriasis|1
928920|NCT00927069|3063482|P1|Week 0 to Week 12|Worsening of psoriasis|1
928921|NCT00926796|3063538|P2|Overall Study|Withdrawal by Subject|0
928922|NCT00926796|3063539|P1|Overall Study|Withdrawal by Subject|1
928923|NCT00926796|3063538|P2|Overall Study|Protocol Violation|11
928924|NCT00926796|3063539|P1|Overall Study|Protocol Violation|15
928925|NCT00926796|3063538|P2|Overall Study|Lost to Follow-up|13
928926|NCT00926796|3063539|P1|Overall Study|Lost to Follow-up|22
928927|NCT00926796|3063538|P2|Overall Study|Adverse Event|14
928928|NCT00926796|3063539|P1|Overall Study|Adverse Event|7
928929|NCT00926796|3063538|P2|Overall Study|Ineligible, but positive for gonorrhea|1
928930|NCT00926796|3063539|P1|Overall Study|Ineligible, but positive for gonorrhea|1
928931|NCT00926796|3063538|P2|Overall Study|Ineligible, negative for gonorrhea|60
928932|NCT00926796|3063539|P1|Overall Study|Ineligible, negative for gonorrhea|57
928933|NCT00926796|3063538|P2|Overall Study|Did not receive randomized treatment|7
928934|NCT00926796|3063539|P1|Overall Study|Did not receive randomized treatment|4
928935|NCT00926783|3063560|P2|Overall Study|Incomplete CFAE Procedures|3
928936|NCT00926783|3063561|P1|Overall Study|Incomplete CFAE Procedures|3
928937|NCT00926575|3063588|P2|Overall Study|Withdrawal by Subject|9
928938|NCT00926575|3063589|P1|Overall Study|Withdrawal by Subject|8
928939|NCT00926575|3063588|P2|Overall Study|Protocol Violation|0
928940|NCT00926575|3063589|P1|Overall Study|Protocol Violation|1
928941|NCT00926575|3063588|P2|Overall Study|Physician Decision|2
928942|NCT00926575|3063589|P1|Overall Study|Physician Decision|1
928943|NCT00926575|3063588|P2|Overall Study|Lost to Follow-up|1
928944|NCT00926575|3063589|P1|Overall Study|Lost to Follow-up|1
928945|NCT00926575|3063588|P2|Overall Study|Death|4
928946|NCT00926575|3063589|P1|Overall Study|Death|4
928947|NCT00926575|3063588|P2|Overall Study|Adverse Event|1
928948|NCT00926575|3063589|P1|Overall Study|Adverse Event|1
928949|NCT00926536|3063601|P2|Overall Study|Physician Decision|2
928950|NCT00926536|3063602|P1|Overall Study|Physician Decision|1
928951|NCT00926393|3063623|P2|Overall Study|Adverse Event|1
928952|NCT00926393|3063624|P1|Overall Study|Adverse Event|1
928953|NCT00926393|3063623|P2|Overall Study|Withdrawal by Subject|2
928954|NCT00926393|3063624|P1|Overall Study|Withdrawal by Subject|1
928955|NCT00926367|3063669|P2|Overall Study|Skin Irritation|2
928956|NCT00926367|3063670|P1|Overall Study|Skin Irritation|1
928957|NCT00926367|3063669|P2|Overall Study|Lost to Follow-up|0
928958|NCT00926367|3063670|P1|Overall Study|Lost to Follow-up|1
928959|NCT00926367|3063669|P2|Overall Study|Withdrawal by Subject|1
928960|NCT00926367|3063670|P1|Overall Study|Withdrawal by Subject|0
928961|NCT00926328|3063712|P2|Overall Study|Lost to Follow-up|14
928962|NCT00926328|3063713|P1|Overall Study|Lost to Follow-up|12
928963|NCT00926289|3063723|P2|Overall Study|not specified|3
928964|NCT00926289|3063724|P1|Overall Study|not specified|1
928965|NCT00926289|3063723|P2|Overall Study|Withdrawal by Subject|4
928966|NCT00926289|3063724|P1|Overall Study|Withdrawal by Subject|4
928967|NCT00926289|3063723|P2|Overall Study|Lost to Follow-up|6
928968|NCT00926289|3063724|P1|Overall Study|Lost to Follow-up|3
928969|NCT00926289|3063723|P2|Overall Study|Protocol Violation|12
928970|NCT00926289|3063724|P1|Overall Study|Protocol Violation|8
928971|NCT00926289|3063723|P2|Overall Study|Adverse Event|11
928972|NCT00926289|3063724|P1|Overall Study|Adverse Event|9
928973|NCT00926211|3063792|P1|Overall Study|Lost to Follow-up|1
928974|NCT00926029|3063823|P3|Overall Study|Lost to Follow-up|1
928975|NCT00926029|3063824|P2|Overall Study|Lost to Follow-up|1
928976|NCT00926029|3063825|P1|Overall Study|Lost to Follow-up|2
928977|NCT00925990|3063838|P2|Overall Study|moved out of state, missed medication|2
928978|NCT00925990|3063839|P1|Overall Study|moved out of state, missed medication|0
928979|NCT00925990|3063838|P2|Overall Study|Physician Decision|1
928980|NCT00925990|3063839|P1|Overall Study|Physician Decision|1
928981|NCT00925990|3063838|P2|Overall Study|Lost to Follow-up|3
928982|NCT00925990|3063839|P1|Overall Study|Lost to Follow-up|1
928983|NCT00925990|3063838|P2|Overall Study|Withdrawal by Subject|2
928984|NCT00925990|3063839|P1|Overall Study|Withdrawal by Subject|2
928985|NCT00925990|3063838|P2|Overall Study|Adverse Event|3
928986|NCT00925990|3063839|P1|Overall Study|Adverse Event|1
928987|NCT00925899|3063874|P2|Part 1|Withdrawal by Subject|9
928988|NCT00925899|3063875|P1|Part 1|Withdrawal by Subject|10
928989|NCT00925899|3063874|P2|Part 1|Death|2
928990|NCT00925899|3063875|P1|Part 1|Death|1
928991|NCT00925769|3063903|P6|Overall Study|Adverse Event|0
928992|NCT00925769|3063904|P5|Overall Study|Adverse Event|1
928993|NCT00925769|3063905|P4|Overall Study|Adverse Event|0
928994|NCT00925769|3063906|P3|Overall Study|Adverse Event|0
928995|NCT00925769|3063907|P2|Overall Study|Adverse Event|0
928996|NCT00925769|3063908|P1|Overall Study|Adverse Event|0
928997|NCT00925769|3063903|P6|Overall Study|Participant is unable to swallow drug|0
928998|NCT00925769|3063904|P5|Overall Study|Participant is unable to swallow drug|0
928999|NCT00925769|3063905|P4|Overall Study|Participant is unable to swallow drug|1
929000|NCT00925769|3063906|P3|Overall Study|Participant is unable to swallow drug|0
929001|NCT00925769|3063907|P2|Overall Study|Participant is unable to swallow drug|0
929002|NCT00925769|3063908|P1|Overall Study|Participant is unable to swallow drug|0
929003|NCT00925769|3063903|P6|Overall Study|End of study visit not done|0
929004|NCT00925769|3063904|P5|Overall Study|End of study visit not done|0
929005|NCT00925769|3063905|P4|Overall Study|End of study visit not done|0
929006|NCT00925769|3063906|P3|Overall Study|End of study visit not done|1
929007|NCT00925769|3063907|P2|Overall Study|End of study visit not done|0
929008|NCT00925769|3063908|P1|Overall Study|End of study visit not done|0
929009|NCT00925769|3063903|P6|Overall Study|Missing documentation|0
929010|NCT00925769|3063904|P5|Overall Study|Missing documentation|0
929011|NCT00925769|3063905|P4|Overall Study|Missing documentation|0
929012|NCT00925769|3063906|P3|Overall Study|Missing documentation|0
929013|NCT00925769|3063907|P2|Overall Study|Missing documentation|1
929014|NCT00925769|3063908|P1|Overall Study|Missing documentation|0
929015|NCT00925769|3063903|P6|Overall Study|Physician Decision|0
929016|NCT00925769|3063904|P5|Overall Study|Physician Decision|0
929017|NCT00925769|3063905|P4|Overall Study|Physician Decision|0
929018|NCT00925769|3063906|P3|Overall Study|Physician Decision|0
929019|NCT00925769|3063907|P2|Overall Study|Physician Decision|0
929020|NCT00925769|3063908|P1|Overall Study|Physician Decision|1
929021|NCT00925769|3063903|P6|Overall Study|Death|0
929022|NCT00925769|3063904|P5|Overall Study|Death|0
929023|NCT00925769|3063905|P4|Overall Study|Death|0
929024|NCT00925769|3063906|P3|Overall Study|Death|1
929025|NCT00925769|3063907|P2|Overall Study|Death|0
929026|NCT00925769|3063908|P1|Overall Study|Death|0
929027|NCT00925769|3063903|P6|Overall Study|Disease progression|3
929028|NCT00925769|3063904|P5|Overall Study|Disease progression|2
929029|NCT00925769|3063905|P4|Overall Study|Disease progression|4
929030|NCT00925769|3063906|P3|Overall Study|Disease progression|3
929031|NCT00925769|3063907|P2|Overall Study|Disease progression|5
929032|NCT00925769|3063908|P1|Overall Study|Disease progression|4
929033|NCT00925769|3063903|P6|Overall Study|Major toxicity|0
929034|NCT00925769|3063904|P5|Overall Study|Major toxicity|0
929035|NCT00925769|3063905|P4|Overall Study|Major toxicity|1
929036|NCT00925769|3063906|P3|Overall Study|Major toxicity|1
929037|NCT00925769|3063907|P2|Overall Study|Major toxicity|0
929038|NCT00925769|3063908|P1|Overall Study|Major toxicity|1
929039|NCT00925704|3063976|P6|Third Intervention|Withdrew consent|1
929040|NCT00925704|3063977|P5|Third Intervention|Withdrew consent|0
929041|NCT00925704|3063978|P4|Third Intervention|Withdrew consent|0
929042|NCT00925704|3063979|P3|Third Intervention|Withdrew consent|0
929043|NCT00925704|3063980|P2|Third Intervention|Withdrew consent|0
929044|NCT00925704|3063981|P1|Third Intervention|Withdrew consent|0
929045|NCT00925704|3063976|P6|Second Intervention|Withdrawal by Subject|0
929046|NCT00925704|3063977|P5|Second Intervention|Withdrawal by Subject|1
929047|NCT00925704|3063978|P4|Second Intervention|Withdrawal by Subject|0
929048|NCT00925704|3063979|P3|Second Intervention|Withdrawal by Subject|0
929049|NCT00925704|3063980|P2|Second Intervention|Withdrawal by Subject|0
929050|NCT00925704|3063981|P1|Second Intervention|Withdrawal by Subject|1
929051|NCT00925704|3063976|P6|First Intervention|Withdrew consent|0
929052|NCT00925704|3063977|P5|First Intervention|Withdrew consent|1
929053|NCT00925704|3063978|P4|First Intervention|Withdrew consent|1
929054|NCT00925704|3063979|P3|First Intervention|Withdrew consent|0
929055|NCT00925704|3063980|P2|First Intervention|Withdrew consent|0
929056|NCT00925704|3063981|P1|First Intervention|Withdrew consent|0
929057|NCT00925600|3063994|P2|Overall Study|Adverse Event|2
929058|NCT00925600|3063995|P1|Overall Study|Adverse Event|1
929059|NCT00925600|3063994|P2|Overall Study|Other|1
929060|NCT00925600|3063995|P1|Overall Study|Other|3
929061|NCT00925600|3063994|P2|Overall Study|Requirement for Alternative Therapy|1
929062|NCT00925600|3063995|P1|Overall Study|Requirement for Alternative Therapy|0
929063|NCT00925600|3063994|P2|Overall Study|Protocol Deviation|1
929064|NCT00925600|3063995|P1|Overall Study|Protocol Deviation|0
929065|NCT00925600|3063994|P2|Overall Study|Ineligibility Determined|0
929066|NCT00925600|3063995|P1|Overall Study|Ineligibility Determined|2
929067|NCT00925600|3063994|P2|Overall Study|Noncompliance|0
929068|NCT00925600|3063995|P1|Overall Study|Noncompliance|2
929069|NCT00925600|3063994|P2|Overall Study|Administrative Decision|1
929070|NCT00925600|3063995|P1|Overall Study|Administrative Decision|1
929071|NCT00925600|3063994|P2|Overall Study|Disease Progression|3
929072|NCT00925600|3063995|P1|Overall Study|Disease Progression|1
929073|NCT00925600|3063994|P2|Overall Study|Lost to Follow-up|2
929074|NCT00925600|3063995|P1|Overall Study|Lost to Follow-up|2
929075|NCT00925600|3063994|P2|Overall Study|Death|3
929076|NCT00925600|3063995|P1|Overall Study|Death|4
929077|NCT00925600|3063994|P2|Overall Study|Withdrawal by Subject|14
929078|NCT00925600|3063995|P1|Overall Study|Withdrawal by Subject|16
929079|NCT00925587|3064017|P2|Overall Study|Lost to Follow-up|1
929080|NCT00925587|3064018|P1|Overall Study|Lost to Follow-up|0
929081|NCT00925587|3064017|P2|Overall Study|Adverse Event|2
929082|NCT00925587|3064018|P1|Overall Study|Adverse Event|6
929083|NCT00925587|3064017|P2|Overall Study|Death|5
929084|NCT00925587|3064018|P1|Overall Study|Death|5
929085|NCT00925587|3064017|P2|Overall Study|Withdrawal by Subject|6
929086|NCT00925587|3064018|P1|Overall Study|Withdrawal by Subject|9
929087|NCT00925587|3064017|P2|Overall Study|Protocol Violation|4
929088|NCT00925587|3064018|P1|Overall Study|Protocol Violation|6
929089|NCT00925587|3064017|P2|Overall Study|Physician Decision|1
929090|NCT00925587|3064018|P1|Overall Study|Physician Decision|4
929091|NCT00925587|3064017|P2|Overall Study|Protocol Specified Criteria|6
929092|NCT00925587|3064018|P1|Overall Study|Protocol Specified Criteria|6
929093|NCT00925548|3064132|P2|Overall Study|Discontinuation of trial by sponsor|5
929094|NCT00925548|3064133|P1|Overall Study|Discontinuation of trial by sponsor|10
929095|NCT00925353|3064163|P1|Overall Study|Failed preliminary EKG or lab criteria.|3
929096|NCT00925301|3064169|P4|12-Month Open-label Extension (Optional)|Lost to Follow-up|1
929097|NCT00925301|3064170|P3|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
929098|NCT00925301|3064171|P2|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
929099|NCT00925301|3064172|P1|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
929100|NCT00925301|3064169|P4|12-Month Open-label Extension (Optional)|Pregnancy|1
929101|NCT00925301|3064170|P3|12-Month Open-label Extension (Optional)|Pregnancy|0
929102|NCT00925301|3064171|P2|12-Month Open-label Extension (Optional)|Pregnancy|0
929103|NCT00925301|3064172|P1|12-Month Open-label Extension (Optional)|Pregnancy|0
929104|NCT00925301|3064169|P4|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1
929105|NCT00925301|3064170|P3|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
929106|NCT00925301|3064171|P2|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
929107|NCT00925301|3064172|P1|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
929108|NCT00925301|3064169|P4|6-Month Open-label (Stage 2)|Adverse Event|0
929109|NCT00925301|3064170|P3|6-Month Open-label (Stage 2)|Adverse Event|2
929110|NCT00925301|3064171|P2|6-Month Open-label (Stage 2)|Adverse Event|0
929111|NCT00925301|3064172|P1|6-Month Open-label (Stage 2)|Adverse Event|0
929112|NCT00925301|3064169|P4|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
929113|NCT00925301|3064170|P3|6-Month Open-label (Stage 2)|Withdrawal by Subject|1
929114|NCT00925301|3064171|P2|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
929115|NCT00925301|3064172|P1|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
929116|NCT00925301|3064169|P4|6-Month Double-blind (Stage 1)|Pregnancy|0
929117|NCT00925301|3064170|P3|6-Month Double-blind (Stage 1)|Pregnancy|0
929118|NCT00925301|3064171|P2|6-Month Double-blind (Stage 1)|Pregnancy|1
929119|NCT00925301|3064172|P1|6-Month Double-blind (Stage 1)|Pregnancy|0
929120|NCT00925301|3064169|P4|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
929121|NCT00925301|3064170|P3|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
929122|NCT00925301|3064171|P2|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2
929123|NCT00925301|3064172|P1|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
929124|NCT00925288|3064188|P2|Overall Study|Lost to Follow-up|7
929125|NCT00925288|3064189|P1|Overall Study|Lost to Follow-up|9
929126|NCT00925132|3064201|P5|Overall Study|Removed due to disease progression|4
929127|NCT00925132|3064202|P4|Overall Study|Removed due to disease progression|0
929128|NCT00925132|3064203|P3|Overall Study|Removed due to disease progression|0
929129|NCT00925132|3064204|P2|Overall Study|Removed due to disease progression|0
929130|NCT00925132|3064205|P1|Overall Study|Removed due to disease progression|0
929131|NCT00925132|3064201|P5|Overall Study|Withdrawal by Subject|1
929132|NCT00925132|3064202|P4|Overall Study|Withdrawal by Subject|0
929133|NCT00925132|3064203|P3|Overall Study|Withdrawal by Subject|0
929134|NCT00925132|3064204|P2|Overall Study|Withdrawal by Subject|0
929135|NCT00925132|3064205|P1|Overall Study|Withdrawal by Subject|2
929136|NCT00925015|3064224|P3|Overall Study|Withdrawal by Subject|1
929137|NCT00925015|3064225|P2|Overall Study|Withdrawal by Subject|0
929138|NCT00925015|3064226|P1|Overall Study|Withdrawal by Subject|0
929139|NCT00925015|3064224|P3|Overall Study|Progressive Disease|4
929140|NCT00925015|3064225|P2|Overall Study|Progressive Disease|3
929141|NCT00925015|3064226|P1|Overall Study|Progressive Disease|7
929142|NCT00925015|3064224|P3|Overall Study|Physician Decision|0
929143|NCT00925015|3064225|P2|Overall Study|Physician Decision|1
929144|NCT00925015|3064226|P1|Overall Study|Physician Decision|0
929145|NCT00925015|3064224|P3|Overall Study|Adverse Event|1
929146|NCT00925015|3064225|P2|Overall Study|Adverse Event|2
929147|NCT00925015|3064226|P1|Overall Study|Adverse Event|1
929148|NCT00924950|3064282|P1|Overall Study|Lost to Follow-up|2
929149|NCT00924898|3064287|P1|Overall Study|Withdrawal by Subject|2
929150|NCT00924781|3064323|P2|Overall Study|Study terminated by sponsor|10
929151|NCT00924781|3064324|P1|Overall Study|Study terminated by sponsor|12
929152|NCT00924729|3064358|P2|Overall Study|Protocol Violation|0
929153|NCT00924729|3064359|P1|Overall Study|Protocol Violation|1
929154|NCT00924729|3064358|P2|Overall Study|insufficient volume for analysis|0
929155|NCT00924729|3064359|P1|Overall Study|insufficient volume for analysis|1
929156|NCT00924651|3064369|P2|Overall Study|Incomplete Form|1
929157|NCT00924651|3064370|P1|Overall Study|Incomplete Form|2
929158|NCT00924651|3064369|P2|Overall Study|Changed Mind|1
929159|NCT00924651|3064370|P1|Overall Study|Changed Mind|10
929160|NCT00924651|3064369|P2|Overall Study|Medical|3
929161|NCT00924651|3064370|P1|Overall Study|Medical|1
929162|NCT00924651|3064369|P2|Overall Study|Noncompliant|4
929163|NCT00924651|3064370|P1|Overall Study|Noncompliant|1
929164|NCT00924651|3064369|P2|Overall Study|Overwhelmed|6
929165|NCT00924651|3064370|P1|Overall Study|Overwhelmed|6
929166|NCT00924651|3064369|P2|Overall Study|No Reason|7
929167|NCT00924651|3064370|P1|Overall Study|No Reason|3
929168|NCT00924651|3064369|P2|Overall Study|Chemo started too soon|3
929169|NCT00924651|3064370|P1|Overall Study|Chemo started too soon|2
929170|NCT00924638|3064378|P2|Overall Study|Physician Decision|3
929171|NCT00924638|3064379|P1|Overall Study|Physician Decision|3
929172|NCT00924638|3064378|P2|Overall Study|Withdrawal by Subject|7
929173|NCT00924638|3064379|P1|Overall Study|Withdrawal by Subject|5
929174|NCT00924638|3064378|P2|Overall Study|Lost to Follow-up|1
929175|NCT00924638|3064379|P1|Overall Study|Lost to Follow-up|1
929176|NCT00924638|3064378|P2|Overall Study|Death|2
929177|NCT00924638|3064379|P1|Overall Study|Death|3
929178|NCT00924560|3064401|P3|Overall Study|Miscellaneous Reasons|10
929179|NCT00924560|3064402|P2|Overall Study|Miscellaneous Reasons|10
929180|NCT00924560|3064403|P1|Overall Study|Miscellaneous Reasons|13
929181|NCT00924560|3064401|P3|Overall Study|Lost to Follow-up|45
929182|NCT00924560|3064402|P2|Overall Study|Lost to Follow-up|94
929183|NCT00924560|3064403|P1|Overall Study|Lost to Follow-up|78
929184|NCT00924560|3064401|P3|Overall Study|Pregnancy|1
929185|NCT00924560|3064402|P2|Overall Study|Pregnancy|7
929186|NCT00924560|3064403|P1|Overall Study|Pregnancy|5
929187|NCT00924560|3064401|P3|Overall Study|Adverse Event|0
929188|NCT00924560|3064402|P2|Overall Study|Adverse Event|33
929189|NCT00924560|3064403|P1|Overall Study|Adverse Event|39
929190|NCT00924560|3064401|P3|Overall Study|Withdrawal by Subject|18
929191|NCT00924560|3064402|P2|Overall Study|Withdrawal by Subject|44
929192|NCT00924560|3064403|P1|Overall Study|Withdrawal by Subject|50
929193|NCT00924560|3064401|P3|Overall Study|Physician Decision|4
929194|NCT00924560|3064402|P2|Overall Study|Physician Decision|3
929195|NCT00924560|3064403|P1|Overall Study|Physician Decision|2
929196|NCT00924560|3064401|P3|Overall Study|Non Compliance with the Protocol|4
929197|NCT00924560|3064402|P2|Overall Study|Non Compliance with the Protocol|15
929198|NCT00924560|3064403|P1|Overall Study|Non Compliance with the Protocol|20
929199|NCT00924560|3064401|P3|Overall Study|Did Not Meet Protocol Requirements|1
929200|NCT00924560|3064402|P2|Overall Study|Did Not Meet Protocol Requirements|2
929201|NCT00924560|3064403|P1|Overall Study|Did Not Meet Protocol Requirements|4
929202|NCT00924508|3064447|P1|Overall Study|Withdrawal by Subject|3
929203|NCT00924469|3064461|P2|Overall Study|Lost to Follow-up|1
929204|NCT00924469|3064462|P1|Overall Study|Lost to Follow-up|0
929205|NCT00924469|3064461|P2|Overall Study|Withdrawal by Subject|1
929206|NCT00924469|3064462|P1|Overall Study|Withdrawal by Subject|0
929207|NCT00924469|3064461|P2|Overall Study|Adverse Event|0
929208|NCT00924469|3064462|P1|Overall Study|Adverse Event|2
929209|NCT00924443|3064484|P1|Overall Study|Protocol Violation|1
929210|NCT00924443|3064484|P1|Overall Study|Physician Decision|2
929211|NCT00924404|3064494|P2|Overall Study|Lost to Follow-up|4
929212|NCT00924404|3064495|P1|Overall Study|Lost to Follow-up|6
929213|NCT00924313|3064517|P1|Overall Study|not imaged due to failed tracer imaging|1
929214|NCT00924287|3064529|P1|Overall Study|Death|1
929215|NCT00924170|3064545|P2|Overall Study|Death|0
929216|NCT00924170|3064546|P1|Overall Study|Death|1
929217|NCT00924170|3064545|P2|Overall Study|Stopped due to neutralizing antibodies|0
929218|NCT00924170|3064546|P1|Overall Study|Stopped due to neutralizing antibodies|3
929219|NCT00924170|3064545|P2|Overall Study|Progressive disease|6
929220|NCT00924170|3064546|P1|Overall Study|Progressive disease|3
929221|NCT00924170|3064545|P2|Overall Study|Physician Decision|1
929222|NCT00924170|3064546|P1|Overall Study|Physician Decision|0
929223|NCT00924170|3064545|P2|Overall Study|Refused further treatment|1
929224|NCT00924170|3064546|P1|Overall Study|Refused further treatment|0
929225|NCT00923975|3064671|P1|Overall Study|Did not meet inclusion criteria|1
929226|NCT00923936|3064690|P2|Overall Study|Continuing in follow up period|1
929227|NCT00923936|3064691|P1|Overall Study|Continuing in follow up period|2
929228|NCT00923936|3064690|P2|Overall Study|Lost to follow up|0
929229|NCT00923936|3064691|P1|Overall Study|Lost to follow up|2
929230|NCT00923936|3064690|P2|Overall Study|Adverse Event|1
929231|NCT00923936|3064691|P1|Overall Study|Adverse Event|2
929232|NCT00923936|3064690|P2|Overall Study|progressive disease on study|1
929233|NCT00923936|3064691|P1|Overall Study|progressive disease on study|2
929234|NCT00923845|3064720|P2|Induction Therapy|Poor performance status|2
929235|NCT00923845|3064721|P1|Induction Therapy|Poor performance status|0
929236|NCT00923364|3064747|P2|Overall Study|Did not go to transplant|0
929237|NCT00923364|3064748|P1|Overall Study|Did not go to transplant|1
929238|NCT00923364|3064747|P2|Overall Study|Death|0
929239|NCT00923364|3064748|P1|Overall Study|Death|3
929240|NCT00923351|3064760|P3|Overall Study|no apheresis/adequate tumor sample|12
929241|NCT00923351|3064761|P2|Overall Study|no apheresis/adequate tumor sample|0
929242|NCT00923351|3064762|P1|Overall Study|no apheresis/adequate tumor sample|0
929243|NCT00923273|3064777|P5|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
929244|NCT00923273|3064778|P4|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6
929245|NCT00923273|3064779|P3|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
929246|NCT00923273|3064780|P2|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
929247|NCT00923273|3064781|P1|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
929248|NCT00923273|3064777|P5|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
929249|NCT00923273|3064778|P4|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1
929250|NCT00923273|3064779|P3|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
929251|NCT00923273|3064780|P2|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
929252|NCT00923273|3064781|P1|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
929253|NCT00923260|3064806|P2|Overall Study|Lost to Follow-up|1
929254|NCT00923260|3064807|P1|Overall Study|Lost to Follow-up|1
929255|NCT00923195|3064970|P2|Overall Study|Death|1
929256|NCT00923195|3064971|P1|Overall Study|Death|0
929257|NCT00923156|3064982|P3|Overall Study|Lack of Efficacy|1
929258|NCT00923156|3064983|P2|Overall Study|Lack of Efficacy|0
929259|NCT00923156|3064984|P1|Overall Study|Lack of Efficacy|0
929260|NCT00923156|3064982|P3|Overall Study|Death|0
929261|NCT00923156|3064983|P2|Overall Study|Death|1
929262|NCT00923156|3064984|P1|Overall Study|Death|0
929263|NCT00923156|3064982|P3|Overall Study|Withdrawal by Subject|0
929264|NCT00923156|3064983|P2|Overall Study|Withdrawal by Subject|1
929265|NCT00923156|3064984|P1|Overall Study|Withdrawal by Subject|0
929266|NCT00923156|3064982|P3|Overall Study|Abnormal laboratory values|1
929267|NCT00923156|3064983|P2|Overall Study|Abnormal laboratory values|0
929268|NCT00923156|3064984|P1|Overall Study|Abnormal laboratory values|0
929269|NCT00923156|3064982|P3|Overall Study|Adverse Event|1
929270|NCT00923156|3064983|P2|Overall Study|Adverse Event|2
929271|NCT00923156|3064984|P1|Overall Study|Adverse Event|0
929272|NCT00923130|3065010|P1|Overall Study|Refused further treatment|2
929273|NCT00923130|3065010|P1|Overall Study|Switched to alternative treatment|2
929274|NCT00923130|3065010|P1|Overall Study|Discontinued treatment due to toxicities|3
929275|NCT00923130|3065010|P1|Overall Study|Death|1
929276|NCT00923130|3065010|P1|Overall Study|Stopped treatment due to progression|17
929277|NCT00923091|3065045|P13|Period VI (Open-Label)|Other Reason|0
929278|NCT00923091|3065046|P12|Period VI (Open-Label)|Other Reason|0
929279|NCT00923091|3065047|P11|Period VI (Open-Label)|Other Reason|0
929280|NCT00923091|3065048|P10|Period VI (Open-Label)|Other Reason|0
929281|NCT00923091|3065049|P9|Period VI (Open-Label)|Other Reason|0
929282|NCT00923091|3065050|P8|Period VI (Open-Label)|Other Reason|0
929283|NCT00923091|3065051|P7|Period VI (Open-Label)|Other Reason|0
929284|NCT00923091|3065052|P6|Period VI (Open-Label)|Other Reason|0
929285|NCT00923091|3065053|P5|Period VI (Open-Label)|Other Reason|1
929286|NCT00923091|3065054|P4|Period VI (Open-Label)|Other Reason|1
929287|NCT00923091|3065055|P3|Period VI (Open-Label)|Other Reason|0
929288|NCT00923091|3065056|P2|Period VI (Open-Label)|Other Reason|0
929289|NCT00923091|3065057|P1|Period VI (Open-Label)|Other Reason|0
929290|NCT00923091|3065045|P13|Period VI (Open-Label)|Lost to Follow-up|0
929291|NCT00923091|3065046|P12|Period VI (Open-Label)|Lost to Follow-up|0
929292|NCT00923091|3065047|P11|Period VI (Open-Label)|Lost to Follow-up|0
929293|NCT00923091|3065048|P10|Period VI (Open-Label)|Lost to Follow-up|0
929294|NCT00923091|3065049|P9|Period VI (Open-Label)|Lost to Follow-up|0
929295|NCT00923091|3065050|P8|Period VI (Open-Label)|Lost to Follow-up|0
929296|NCT00923091|3065051|P7|Period VI (Open-Label)|Lost to Follow-up|0
929297|NCT00923091|3065052|P6|Period VI (Open-Label)|Lost to Follow-up|0
929298|NCT00923091|3065053|P5|Period VI (Open-Label)|Lost to Follow-up|0
929299|NCT00923091|3065054|P4|Period VI (Open-Label)|Lost to Follow-up|0
929300|NCT00923091|3065055|P3|Period VI (Open-Label)|Lost to Follow-up|1
929301|NCT00923091|3065056|P2|Period VI (Open-Label)|Lost to Follow-up|0
929302|NCT00923091|3065057|P1|Period VI (Open-Label)|Lost to Follow-up|1
929303|NCT00923091|3065045|P13|Period VI (Open-Label)|Protocol Violation|0
929304|NCT00923091|3065046|P12|Period VI (Open-Label)|Protocol Violation|0
929305|NCT00923091|3065047|P11|Period VI (Open-Label)|Protocol Violation|0
929306|NCT00923091|3065048|P10|Period VI (Open-Label)|Protocol Violation|0
929307|NCT00923091|3065049|P9|Period VI (Open-Label)|Protocol Violation|0
929308|NCT00923091|3065050|P8|Period VI (Open-Label)|Protocol Violation|0
929309|NCT00923091|3065051|P7|Period VI (Open-Label)|Protocol Violation|0
929310|NCT00923091|3065052|P6|Period VI (Open-Label)|Protocol Violation|0
929311|NCT00923091|3065053|P5|Period VI (Open-Label)|Protocol Violation|4
929312|NCT00923091|3065054|P4|Period VI (Open-Label)|Protocol Violation|1
929313|NCT00923091|3065055|P3|Period VI (Open-Label)|Protocol Violation|3
929314|NCT00923091|3065056|P2|Period VI (Open-Label)|Protocol Violation|1
929315|NCT00923091|3065057|P1|Period VI (Open-Label)|Protocol Violation|6
929316|NCT00923091|3065045|P13|Period VI (Open-Label)|Withdrawal by Subject|0
929317|NCT00923091|3065046|P12|Period VI (Open-Label)|Withdrawal by Subject|0
929318|NCT00923091|3065047|P11|Period VI (Open-Label)|Withdrawal by Subject|0
929319|NCT00923091|3065048|P10|Period VI (Open-Label)|Withdrawal by Subject|0
929320|NCT00923091|3065049|P9|Period VI (Open-Label)|Withdrawal by Subject|0
929321|NCT00923091|3065050|P8|Period VI (Open-Label)|Withdrawal by Subject|0
929322|NCT00923091|3065051|P7|Period VI (Open-Label)|Withdrawal by Subject|0
929323|NCT00923091|3065052|P6|Period VI (Open-Label)|Withdrawal by Subject|0
929324|NCT00923091|3065053|P5|Period VI (Open-Label)|Withdrawal by Subject|1
929325|NCT00923091|3065054|P4|Period VI (Open-Label)|Withdrawal by Subject|0
929326|NCT00923091|3065055|P3|Period VI (Open-Label)|Withdrawal by Subject|5
929327|NCT00923091|3065056|P2|Period VI (Open-Label)|Withdrawal by Subject|7
929328|NCT00923091|3065057|P1|Period VI (Open-Label)|Withdrawal by Subject|15
929329|NCT00923091|3065045|P13|Period VI (Open-Label)|Adverse Event|0
929330|NCT00923091|3065046|P12|Period VI (Open-Label)|Adverse Event|0
929331|NCT00923091|3065047|P11|Period VI (Open-Label)|Adverse Event|0
929332|NCT00923091|3065048|P10|Period VI (Open-Label)|Adverse Event|0
929333|NCT00923091|3065049|P9|Period VI (Open-Label)|Adverse Event|0
929334|NCT00923091|3065050|P8|Period VI (Open-Label)|Adverse Event|0
929335|NCT00923091|3065051|P7|Period VI (Open-Label)|Adverse Event|0
929336|NCT00923091|3065052|P6|Period VI (Open-Label)|Adverse Event|0
929337|NCT00923091|3065053|P5|Period VI (Open-Label)|Adverse Event|1
929338|NCT00923091|3065054|P4|Period VI (Open-Label)|Adverse Event|1
929339|NCT00923091|3065055|P3|Period VI (Open-Label)|Adverse Event|4
929340|NCT00923091|3065056|P2|Period VI (Open-Label)|Adverse Event|0
929341|NCT00923091|3065057|P1|Period VI (Open-Label)|Adverse Event|17
929342|NCT00923091|3065045|P13|Period V (Double -Blind)|Lost to Follow-up|0
929343|NCT00923091|3065046|P12|Period V (Double -Blind)|Lost to Follow-up|0
929344|NCT00923091|3065047|P11|Period V (Double -Blind)|Lost to Follow-up|1
929345|NCT00923091|3065048|P10|Period V (Double -Blind)|Lost to Follow-up|0
929346|NCT00923091|3065049|P9|Period V (Double -Blind)|Lost to Follow-up|0
929347|NCT00923091|3065050|P8|Period V (Double -Blind)|Lost to Follow-up|0
929348|NCT00923091|3065051|P7|Period V (Double -Blind)|Lost to Follow-up|0
929349|NCT00923091|3065052|P6|Period V (Double -Blind)|Lost to Follow-up|0
929350|NCT00923091|3065053|P5|Period V (Double -Blind)|Lost to Follow-up|0
929351|NCT00923091|3065054|P4|Period V (Double -Blind)|Lost to Follow-up|0
929352|NCT00923091|3065055|P3|Period V (Double -Blind)|Lost to Follow-up|0
929353|NCT00923091|3065056|P2|Period V (Double -Blind)|Lost to Follow-up|0
929354|NCT00923091|3065057|P1|Period V (Double -Blind)|Lost to Follow-up|0
929355|NCT00923091|3065045|P13|Period V (Double -Blind)|Protocol Violation|1
929356|NCT00923091|3065046|P12|Period V (Double -Blind)|Protocol Violation|0
929357|NCT00923091|3065047|P11|Period V (Double -Blind)|Protocol Violation|0
929358|NCT00923091|3065048|P10|Period V (Double -Blind)|Protocol Violation|0
929359|NCT00923091|3065049|P9|Period V (Double -Blind)|Protocol Violation|0
929360|NCT00923091|3065050|P8|Period V (Double -Blind)|Protocol Violation|0
929361|NCT00923091|3065051|P7|Period V (Double -Blind)|Protocol Violation|0
929362|NCT00923091|3065052|P6|Period V (Double -Blind)|Protocol Violation|0
929363|NCT00923091|3065053|P5|Period V (Double -Blind)|Protocol Violation|0
929364|NCT00923091|3065054|P4|Period V (Double -Blind)|Protocol Violation|0
929365|NCT00923091|3065055|P3|Period V (Double -Blind)|Protocol Violation|0
929366|NCT00923091|3065056|P2|Period V (Double -Blind)|Protocol Violation|0
929367|NCT00923091|3065057|P1|Period V (Double -Blind)|Protocol Violation|0
929368|NCT00923091|3065045|P13|Period V (Double -Blind)|Withdrawal by Subject|1
929369|NCT00923091|3065046|P12|Period V (Double -Blind)|Withdrawal by Subject|0
929370|NCT00923091|3065047|P11|Period V (Double -Blind)|Withdrawal by Subject|0
929371|NCT00923091|3065048|P10|Period V (Double -Blind)|Withdrawal by Subject|0
929372|NCT00923091|3065049|P9|Period V (Double -Blind)|Withdrawal by Subject|1
929373|NCT00923091|3065050|P8|Period V (Double -Blind)|Withdrawal by Subject|0
929374|NCT00923091|3065051|P7|Period V (Double -Blind)|Withdrawal by Subject|0
929375|NCT00923091|3065052|P6|Period V (Double -Blind)|Withdrawal by Subject|0
929376|NCT00923091|3065053|P5|Period V (Double -Blind)|Withdrawal by Subject|0
929377|NCT00923091|3065054|P4|Period V (Double -Blind)|Withdrawal by Subject|0
929378|NCT00923091|3065055|P3|Period V (Double -Blind)|Withdrawal by Subject|0
929379|NCT00923091|3065056|P2|Period V (Double -Blind)|Withdrawal by Subject|0
929380|NCT00923091|3065057|P1|Period V (Double -Blind)|Withdrawal by Subject|0
929381|NCT00923091|3065045|P13|Period IV (Double-Blind)|Protocol Violation|0
929382|NCT00923091|3065046|P12|Period IV (Double-Blind)|Protocol Violation|0
929383|NCT00923091|3065047|P11|Period IV (Double-Blind)|Protocol Violation|0
929384|NCT00923091|3065048|P10|Period IV (Double-Blind)|Protocol Violation|0
929385|NCT00923091|3065049|P9|Period IV (Double-Blind)|Protocol Violation|0
929386|NCT00923091|3065050|P8|Period IV (Double-Blind)|Protocol Violation|0
929387|NCT00923091|3065051|P7|Period IV (Double-Blind)|Protocol Violation|0
929388|NCT00923091|3065052|P6|Period IV (Double-Blind)|Protocol Violation|0
929389|NCT00923091|3065053|P5|Period IV (Double-Blind)|Protocol Violation|0
929390|NCT00923091|3065054|P4|Period IV (Double-Blind)|Protocol Violation|0
929391|NCT00923091|3065055|P3|Period IV (Double-Blind)|Protocol Violation|0
929392|NCT00923091|3065056|P2|Period IV (Double-Blind)|Protocol Violation|1
929393|NCT00923091|3065057|P1|Period IV (Double-Blind)|Protocol Violation|0
929394|NCT00923091|3065045|P13|Period IV (Double-Blind)|Withdrawal by Subject|0
929395|NCT00923091|3065046|P12|Period IV (Double-Blind)|Withdrawal by Subject|0
929396|NCT00923091|3065047|P11|Period IV (Double-Blind)|Withdrawal by Subject|0
929397|NCT00923091|3065048|P10|Period IV (Double-Blind)|Withdrawal by Subject|0
929398|NCT00923091|3065049|P9|Period IV (Double-Blind)|Withdrawal by Subject|0
929399|NCT00923091|3065050|P8|Period IV (Double-Blind)|Withdrawal by Subject|0
929400|NCT00923091|3065051|P7|Period IV (Double-Blind)|Withdrawal by Subject|0
929401|NCT00923091|3065052|P6|Period IV (Double-Blind)|Withdrawal by Subject|0
929402|NCT00923091|3065053|P5|Period IV (Double-Blind)|Withdrawal by Subject|0
929403|NCT00923091|3065054|P4|Period IV (Double-Blind)|Withdrawal by Subject|0
929404|NCT00923091|3065055|P3|Period IV (Double-Blind)|Withdrawal by Subject|0
929405|NCT00923091|3065056|P2|Period IV (Double-Blind)|Withdrawal by Subject|1
929406|NCT00923091|3065057|P1|Period IV (Double-Blind)|Withdrawal by Subject|0
929407|NCT00923091|3065045|P13|Period IV (Double-Blind)|Adverse Event|0
929408|NCT00923091|3065046|P12|Period IV (Double-Blind)|Adverse Event|0
929409|NCT00923091|3065047|P11|Period IV (Double-Blind)|Adverse Event|0
929410|NCT00923091|3065048|P10|Period IV (Double-Blind)|Adverse Event|0
929411|NCT00923091|3065049|P9|Period IV (Double-Blind)|Adverse Event|0
929412|NCT00923091|3065050|P8|Period IV (Double-Blind)|Adverse Event|0
929413|NCT00923091|3065051|P7|Period IV (Double-Blind)|Adverse Event|0
929414|NCT00923091|3065052|P6|Period IV (Double-Blind)|Adverse Event|0
929415|NCT00923091|3065053|P5|Period IV (Double-Blind)|Adverse Event|0
929416|NCT00923091|3065054|P4|Period IV (Double-Blind)|Adverse Event|0
929417|NCT00923091|3065055|P3|Period IV (Double-Blind)|Adverse Event|0
929418|NCT00923091|3065056|P2|Period IV (Double-Blind)|Adverse Event|0
929419|NCT00923091|3065057|P1|Period IV (Double-Blind)|Adverse Event|2
929420|NCT00923091|3065045|P13|Period III (Single-Blind)|Lost to Follow-up|0
929421|NCT00923091|3065046|P12|Period III (Single-Blind)|Lost to Follow-up|0
929422|NCT00923091|3065047|P11|Period III (Single-Blind)|Lost to Follow-up|0
929423|NCT00923091|3065048|P10|Period III (Single-Blind)|Lost to Follow-up|0
929424|NCT00923091|3065049|P9|Period III (Single-Blind)|Lost to Follow-up|0
929425|NCT00923091|3065050|P8|Period III (Single-Blind)|Lost to Follow-up|0
929426|NCT00923091|3065051|P7|Period III (Single-Blind)|Lost to Follow-up|0
929427|NCT00923091|3065052|P6|Period III (Single-Blind)|Lost to Follow-up|0
929428|NCT00923091|3065053|P5|Period III (Single-Blind)|Lost to Follow-up|0
929429|NCT00923091|3065054|P4|Period III (Single-Blind)|Lost to Follow-up|0
929430|NCT00923091|3065055|P3|Period III (Single-Blind)|Lost to Follow-up|0
929431|NCT00923091|3065056|P2|Period III (Single-Blind)|Lost to Follow-up|0
929432|NCT00923091|3065057|P1|Period III (Single-Blind)|Lost to Follow-up|2
929433|NCT00923091|3065045|P13|Period III (Single-Blind)|Protocol Violation|0
929434|NCT00923091|3065046|P12|Period III (Single-Blind)|Protocol Violation|0
929435|NCT00923091|3065047|P11|Period III (Single-Blind)|Protocol Violation|0
929436|NCT00923091|3065048|P10|Period III (Single-Blind)|Protocol Violation|0
929437|NCT00923091|3065049|P9|Period III (Single-Blind)|Protocol Violation|0
929438|NCT00923091|3065050|P8|Period III (Single-Blind)|Protocol Violation|0
929439|NCT00923091|3065051|P7|Period III (Single-Blind)|Protocol Violation|0
929440|NCT00923091|3065052|P6|Period III (Single-Blind)|Protocol Violation|0
929441|NCT00923091|3065053|P5|Period III (Single-Blind)|Protocol Violation|0
929442|NCT00923091|3065054|P4|Period III (Single-Blind)|Protocol Violation|0
929443|NCT00923091|3065055|P3|Period III (Single-Blind)|Protocol Violation|0
929444|NCT00923091|3065056|P2|Period III (Single-Blind)|Protocol Violation|0
929445|NCT00923091|3065057|P1|Period III (Single-Blind)|Protocol Violation|3
929446|NCT00923091|3065045|P13|Period III (Single-Blind)|Withdrawal by Subject|0
929447|NCT00923091|3065046|P12|Period III (Single-Blind)|Withdrawal by Subject|0
929448|NCT00923091|3065047|P11|Period III (Single-Blind)|Withdrawal by Subject|0
929449|NCT00923091|3065048|P10|Period III (Single-Blind)|Withdrawal by Subject|0
929450|NCT00923091|3065049|P9|Period III (Single-Blind)|Withdrawal by Subject|0
929451|NCT00923091|3065050|P8|Period III (Single-Blind)|Withdrawal by Subject|0
929452|NCT00923091|3065051|P7|Period III (Single-Blind)|Withdrawal by Subject|0
929453|NCT00923091|3065052|P6|Period III (Single-Blind)|Withdrawal by Subject|0
929454|NCT00923091|3065053|P5|Period III (Single-Blind)|Withdrawal by Subject|0
929455|NCT00923091|3065054|P4|Period III (Single-Blind)|Withdrawal by Subject|0
929456|NCT00923091|3065055|P3|Period III (Single-Blind)|Withdrawal by Subject|0
929457|NCT00923091|3065056|P2|Period III (Single-Blind)|Withdrawal by Subject|0
929458|NCT00923091|3065057|P1|Period III (Single-Blind)|Withdrawal by Subject|10
929459|NCT00923091|3065045|P13|Period III (Single-Blind)|Adverse Event|0
929460|NCT00923091|3065046|P12|Period III (Single-Blind)|Adverse Event|0
929461|NCT00923091|3065047|P11|Period III (Single-Blind)|Adverse Event|0
929462|NCT00923091|3065048|P10|Period III (Single-Blind)|Adverse Event|0
929463|NCT00923091|3065049|P9|Period III (Single-Blind)|Adverse Event|0
929464|NCT00923091|3065050|P8|Period III (Single-Blind)|Adverse Event|0
929465|NCT00923091|3065051|P7|Period III (Single-Blind)|Adverse Event|0
929466|NCT00923091|3065052|P6|Period III (Single-Blind)|Adverse Event|0
929467|NCT00923091|3065053|P5|Period III (Single-Blind)|Adverse Event|0
929468|NCT00923091|3065054|P4|Period III (Single-Blind)|Adverse Event|0
929469|NCT00923091|3065055|P3|Period III (Single-Blind)|Adverse Event|0
929470|NCT00923091|3065056|P2|Period III (Single-Blind)|Adverse Event|0
929471|NCT00923091|3065057|P1|Period III (Single-Blind)|Adverse Event|5
929472|NCT00923091|3065045|P13|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
929473|NCT00923091|3065046|P12|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
929474|NCT00923091|3065047|P11|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
929475|NCT00923091|3065048|P10|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
929476|NCT00923091|3065049|P9|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
929477|NCT00923091|3065050|P8|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
929478|NCT00923091|3065051|P7|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
929479|NCT00923091|3065052|P6|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
929480|NCT00923091|3065053|P5|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
929481|NCT00923091|3065054|P4|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
929482|NCT00923091|3065055|P3|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
929483|NCT00923091|3065056|P2|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
929484|NCT00923091|3065057|P1|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
929485|NCT00923091|3065045|P13|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
929486|NCT00923091|3065046|P12|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
929487|NCT00923091|3065047|P11|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
929488|NCT00923091|3065048|P10|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
929489|NCT00923091|3065049|P9|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
929490|NCT00923091|3065050|P8|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
929491|NCT00923091|3065051|P7|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
929492|NCT00923091|3065052|P6|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1
929493|NCT00923091|3065053|P5|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
929494|NCT00923091|3065054|P4|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
929495|NCT00923091|3065055|P3|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
929496|NCT00923091|3065056|P2|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
929497|NCT00923091|3065057|P1|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
929498|NCT00923091|3065045|P13|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
929499|NCT00923091|3065046|P12|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
929500|NCT00923091|3065047|P11|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
929501|NCT00923091|3065048|P10|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
929502|NCT00923091|3065049|P9|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
929503|NCT00923091|3065050|P8|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3
929504|NCT00923091|3065051|P7|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
929505|NCT00923091|3065052|P6|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2
929506|NCT00923091|3065053|P5|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
929507|NCT00923091|3065054|P4|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5
929508|NCT00923091|3065055|P3|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
929509|NCT00923091|3065056|P2|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
929510|NCT00923091|3065057|P1|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
929511|NCT00923091|3065045|P13|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
929512|NCT00923091|3065046|P12|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
929513|NCT00923091|3065047|P11|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
929514|NCT00923091|3065048|P10|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
929515|NCT00923091|3065049|P9|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
929516|NCT00923091|3065050|P8|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
929517|NCT00923091|3065051|P7|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
929518|NCT00923091|3065052|P6|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
929519|NCT00923091|3065053|P5|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7
929520|NCT00923091|3065054|P4|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8
929521|NCT00923091|3065055|P3|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
929522|NCT00923091|3065056|P2|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
929523|NCT00923091|3065057|P1|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4
929524|NCT00923091|3065045|P13|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
929525|NCT00923091|3065046|P12|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
929526|NCT00923091|3065047|P11|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
929527|NCT00923091|3065048|P10|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
929528|NCT00923091|3065049|P9|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
929529|NCT00923091|3065050|P8|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17
929530|NCT00923091|3065051|P7|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9
929531|NCT00923091|3065052|P6|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5
929532|NCT00923091|3065053|P5|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10
929533|NCT00923091|3065054|P4|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13
929534|NCT00923091|3065055|P3|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7
929535|NCT00923091|3065056|P2|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3
929536|NCT00923091|3065057|P1|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11
929537|NCT00923078|3065107|P3|First Intervention (Weeks 1-4)|No intervention per protocol|20
929538|NCT00923078|3065108|P2|First Intervention (Weeks 1-4)|No intervention per protocol|0
929539|NCT00923078|3065109|P1|First Intervention (Weeks 1-4)|No intervention per protocol|0
929540|NCT00923078|3065107|P3|First Intervention (Weeks 1-4)|Withdrawal by Subject|0
929541|NCT00923078|3065108|P2|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
929542|NCT00923078|3065109|P1|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
929543|NCT00922987|3065128|P1|Overall Study|Adverse Event|1
929544|NCT00922987|3065128|P1|Overall Study|Protocol Violation|2
929545|NCT00922987|3065128|P1|Overall Study|Insufficient clinical response|1
929546|NCT00922935|3065143|P3|Overall Study|Lost to Follow-up|0
929547|NCT00922935|3065144|P2|Overall Study|Lost to Follow-up|1
929548|NCT00922935|3065145|P1|Overall Study|Lost to Follow-up|0
929549|NCT00922935|3065143|P3|Overall Study|Physician Decision|0
929550|NCT00922935|3065144|P2|Overall Study|Physician Decision|1
929551|NCT00922935|3065145|P1|Overall Study|Physician Decision|1
929552|NCT00922935|3065143|P3|Overall Study|Protocol Violation|0
929553|NCT00922935|3065144|P2|Overall Study|Protocol Violation|3
929554|NCT00922935|3065145|P1|Overall Study|Protocol Violation|0
929555|NCT00922779|3065157|P1|Overall Study|Missing|1874
929556|NCT00922779|3065157|P1|Overall Study|Other|27
929557|NCT00922779|3065157|P1|Overall Study|Lost to Follow-up|44
929558|NCT00922779|3065157|P1|Overall Study|Withdrawal by Subject|308
929559|NCT00922779|3065157|P1|Overall Study|Pregnancy|7
929560|NCT00922779|3065157|P1|Overall Study|Adverse Event|67
929561|NCT00922766|3065164|P1|Overall Study|Adverse Event|1
929562|NCT00922766|3065164|P1|Overall Study|Other|1
929563|NCT00922766|3065164|P1|Overall Study|Withdrawal by Subject|2
929564|NCT00922766|3065164|P1|Overall Study|Death|3
929565|NCT00922636|3065182|P5|Overall Study|Lost to Follow-up|4
929566|NCT00922636|3065183|P4|Overall Study|Lost to Follow-up|2
929567|NCT00922636|3065184|P3|Overall Study|Lost to Follow-up|2
929568|NCT00922636|3065185|P2|Overall Study|Lost to Follow-up|2
929569|NCT00922636|3065186|P1|Overall Study|Lost to Follow-up|1
929570|NCT00922636|3065182|P5|Overall Study|Parent/Caregiver Decision|2
929571|NCT00922636|3065183|P4|Overall Study|Parent/Caregiver Decision|5
929572|NCT00922636|3065184|P3|Overall Study|Parent/Caregiver Decision|3
929573|NCT00922636|3065185|P2|Overall Study|Parent/Caregiver Decision|4
929574|NCT00922636|3065186|P1|Overall Study|Parent/Caregiver Decision|2
929575|NCT00922636|3065182|P5|Overall Study|Entry Criteria Not Met|0
929576|NCT00922636|3065183|P4|Overall Study|Entry Criteria Not Met|1
929577|NCT00922636|3065184|P3|Overall Study|Entry Criteria Not Met|1
929578|NCT00922636|3065185|P2|Overall Study|Entry Criteria Not Met|0
929579|NCT00922636|3065186|P1|Overall Study|Entry Criteria Not Met|0
929580|NCT00922636|3065182|P5|Overall Study|Protocol Violation|0
929581|NCT00922636|3065183|P4|Overall Study|Protocol Violation|2
929582|NCT00922636|3065184|P3|Overall Study|Protocol Violation|2
929583|NCT00922636|3065185|P2|Overall Study|Protocol Violation|0
929584|NCT00922636|3065186|P1|Overall Study|Protocol Violation|0
929585|NCT00922636|3065182|P5|Overall Study|Withdrawal by Subject|4
929586|NCT00922636|3065183|P4|Overall Study|Withdrawal by Subject|2
929587|NCT00922636|3065184|P3|Overall Study|Withdrawal by Subject|5
929588|NCT00922636|3065185|P2|Overall Study|Withdrawal by Subject|0
929589|NCT00922636|3065186|P1|Overall Study|Withdrawal by Subject|0
929590|NCT00922636|3065182|P5|Overall Study|Sponsor Decision|0
929591|NCT00922636|3065183|P4|Overall Study|Sponsor Decision|0
929592|NCT00922636|3065184|P3|Overall Study|Sponsor Decision|2
929593|NCT00922636|3065185|P2|Overall Study|Sponsor Decision|0
929594|NCT00922636|3065186|P1|Overall Study|Sponsor Decision|0
929595|NCT00922636|3065182|P5|Overall Study|Lack of Efficacy|4
929596|NCT00922636|3065183|P4|Overall Study|Lack of Efficacy|2
929597|NCT00922636|3065184|P3|Overall Study|Lack of Efficacy|3
929598|NCT00922636|3065185|P2|Overall Study|Lack of Efficacy|7
929599|NCT00922636|3065186|P1|Overall Study|Lack of Efficacy|1
929600|NCT00922636|3065182|P5|Overall Study|Adverse Event|2
929601|NCT00922636|3065183|P4|Overall Study|Adverse Event|3
929602|NCT00922636|3065184|P3|Overall Study|Adverse Event|2
929603|NCT00922636|3065185|P2|Overall Study|Adverse Event|3
929604|NCT00922636|3065186|P1|Overall Study|Adverse Event|3
929605|NCT00922623|3065333|P1|Overall Study|Lost to Follow-up|1
929606|NCT00922623|3065333|P1|Overall Study|Other|4
929607|NCT00922480|3065341|P2|Extension Study|Others|1
929608|NCT00922480|3065342|P1|Extension Study|Others|0
929609|NCT00922480|3065341|P2|Extension Study|Withdrawal by Subject|1
929610|NCT00922480|3065342|P1|Extension Study|Withdrawal by Subject|1
929611|NCT00922480|3065341|P2|Extension Study|Adverse Event|1
929612|NCT00922480|3065342|P1|Extension Study|Adverse Event|1
929613|NCT00922480|3065341|P2|Extension Study|Protocol Violation|0
929614|NCT00922480|3065342|P1|Extension Study|Protocol Violation|3
929615|NCT00922480|3065341|P2|Main Study|Physician Decision|1
929616|NCT00922480|3065342|P1|Main Study|Physician Decision|0
929617|NCT00922480|3065341|P2|Main Study|Lost to Follow-up|0
929618|NCT00922480|3065342|P1|Main Study|Lost to Follow-up|5
929619|NCT00922480|3065341|P2|Main Study|Withdrawal by Subject|15
929620|NCT00922480|3065342|P1|Main Study|Withdrawal by Subject|20
929621|NCT00922480|3065341|P2|Main Study|Lack of Efficacy|0
929622|NCT00922480|3065342|P1|Main Study|Lack of Efficacy|3
929623|NCT00922480|3065341|P2|Main Study|Adverse Event|7
929624|NCT00922480|3065342|P1|Main Study|Adverse Event|6
929625|NCT00922480|3065341|P2|Main Study|Protocol Violation|6
929626|NCT00922480|3065342|P1|Main Study|Protocol Violation|3
929627|NCT00922441|3065353|P3|Overall Study|Withdrawal by Subject|1
929628|NCT00922441|3065354|P2|Overall Study|Withdrawal by Subject|0
929629|NCT00922441|3065355|P1|Overall Study|Withdrawal by Subject|0
929630|NCT00922441|3065353|P3|Overall Study|Protocol Violation|2
929631|NCT00922441|3065354|P2|Overall Study|Protocol Violation|0
929632|NCT00922441|3065355|P1|Overall Study|Protocol Violation|0
929633|NCT00922428|3065363|P1|Overall Study|no medication use or questionable use|13
929634|NCT00922428|3065363|P1|Overall Study|retrospective/extremely implausible data|2
929635|NCT00922272|3065392|P2|Double-blind Phase|Positive urine drug screen|1
929636|NCT00922272|3065393|P1|Double-blind Phase|Positive urine drug screen|1
929637|NCT00922272|3065392|P2|Double-blind Phase|Noncompliance|1
929638|NCT00922272|3065393|P1|Double-blind Phase|Noncompliance|1
929639|NCT00922272|3065392|P2|Double-blind Phase|Withdrawal criteria met|1
929640|NCT00922272|3065393|P1|Double-blind Phase|Withdrawal criteria met|1
929641|NCT00922272|3065392|P2|Double-blind Phase|Lost to Follow-up|1
929642|NCT00922272|3065393|P1|Double-blind Phase|Lost to Follow-up|2
929643|NCT00922272|3065392|P2|Double-blind Phase|Withdrawal by Subject|1
929644|NCT00922272|3065393|P1|Double-blind Phase|Withdrawal by Subject|1
929645|NCT00922272|3065392|P2|Double-blind Phase|Adverse Event|1
929646|NCT00922272|3065393|P1|Double-blind Phase|Adverse Event|1
929647|NCT00922272|3065392|P2|Open-label Phase|Withdrawal criteria met|0
929648|NCT00922272|3065393|P1|Open-label Phase|Withdrawal criteria met|5
929649|NCT00922272|3065392|P2|Open-label Phase|Failure to meet randomization criteria|0
929650|NCT00922272|3065393|P1|Open-label Phase|Failure to meet randomization criteria|1
929651|NCT00922272|3065392|P2|Open-label Phase|Withdrawal by Subject|0
929652|NCT00922272|3065393|P1|Open-label Phase|Withdrawal by Subject|11
929653|NCT00922272|3065392|P2|Open-label Phase|Protocol Violation|0
929654|NCT00922272|3065393|P1|Open-label Phase|Protocol Violation|1
929655|NCT00922272|3065392|P2|Open-label Phase|Adverse Event|0
929656|NCT00922272|3065393|P1|Open-label Phase|Adverse Event|5
929657|NCT00922207|3065458|P3|Overall Study|Abnormality of Laboratory Test|1
929658|NCT00922207|3065459|P2|Overall Study|Abnormality of Laboratory Test|1
929659|NCT00922207|3065460|P1|Overall Study|Abnormality of Laboratory Test|0
929660|NCT00922207|3065458|P3|Overall Study|Withdrew Consent|2
929661|NCT00922207|3065459|P2|Overall Study|Withdrew Consent|5
929662|NCT00922207|3065460|P1|Overall Study|Withdrew Consent|2
929663|NCT00922207|3065458|P3|Overall Study|Refused Treatment/Did Not Cooperate|0
929664|NCT00922207|3065459|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
929665|NCT00922207|3065460|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
929666|NCT00922207|3065458|P3|Overall Study|Violation of Selection Criteria at Entry|0
929667|NCT00922207|3065459|P2|Overall Study|Violation of Selection Criteria at Entry|1
929668|NCT00922207|3065460|P1|Overall Study|Violation of Selection Criteria at Entry|0
929669|NCT00922207|3065458|P3|Overall Study|Insufficient Therapeutic Response|1
929670|NCT00922207|3065459|P2|Overall Study|Insufficient Therapeutic Response|0
929671|NCT00922207|3065460|P1|Overall Study|Insufficient Therapeutic Response|0
929672|NCT00922207|3065458|P3|Overall Study|Adverse Event/Intercurrent Illness|0
929673|NCT00922207|3065459|P2|Overall Study|Adverse Event/Intercurrent Illness|0
929674|NCT00922207|3065460|P1|Overall Study|Adverse Event/Intercurrent Illness|3
929675|NCT00922116|3065496|P1|Overall Study|Other|5
929676|NCT00922116|3065496|P1|Overall Study|Withdrawal by Subject|4
929677|NCT00922116|3065496|P1|Overall Study|Lost to Follow-up|1
929678|NCT00922116|3065496|P1|Overall Study|Death|1
929679|NCT00922116|3065496|P1|Overall Study|Adverse Event|4
929680|NCT00921557|3065541|P3|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
929681|NCT00921557|3065542|P2|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
929682|NCT00921557|3065543|P1|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2
929683|NCT00921557|3065541|P3|Weeks 96-144 (Off Study Treatment)|Site closure|0
929684|NCT00921557|3065542|P2|Weeks 96-144 (Off Study Treatment)|Site closure|0
929685|NCT00921557|3065543|P1|Weeks 96-144 (Off Study Treatment)|Site closure|1
929686|NCT00921557|3065541|P3|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1
929687|NCT00921557|3065542|P2|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
929688|NCT00921557|3065543|P1|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
929689|NCT00921557|3065541|P3|Weeks 48-96 (on Study Treatment)|Site Closure|0
929690|NCT00921557|3065542|P2|Weeks 48-96 (on Study Treatment)|Site Closure|1
929691|NCT00921557|3065543|P1|Weeks 48-96 (on Study Treatment)|Site Closure|0
929692|NCT00921557|3065541|P3|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
929693|NCT00921557|3065542|P2|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
929694|NCT00921557|3065543|P1|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2
929695|NCT00921024|3065645|P2|Overall Study|Withdrawal by Subject|3
929696|NCT00921024|3065646|P1|Overall Study|Withdrawal by Subject|0
929697|NCT00921024|3065645|P2|Overall Study|Received concomittant therapy|0
929698|NCT00921024|3065646|P1|Overall Study|Received concomittant therapy|2
929699|NCT00921024|3065645|P2|Overall Study|Lost to Follow-up|0
929700|NCT00921024|3065646|P1|Overall Study|Lost to Follow-up|2
929701|NCT00920907|3065656|P2|Maintenance Period|Adverse Event|1
929702|NCT00920907|3065657|P1|Maintenance Period|Adverse Event|0
929703|NCT00920907|3065656|P2|Maintenance Period|Withdrawal by Subject|0
929704|NCT00920907|3065657|P1|Maintenance Period|Withdrawal by Subject|1
929705|NCT00920907|3065656|P2|Maintenance Period|Death|1
929706|NCT00920907|3065657|P1|Maintenance Period|Death|1
929707|NCT00920907|3065656|P2|Maintenance Period|Study Drug Toxicity|2
929708|NCT00920907|3065657|P1|Maintenance Period|Study Drug Toxicity|0
929709|NCT00920907|3065656|P2|Maintenance Period|Administrative (study closure)|2
929710|NCT00920907|3065657|P1|Maintenance Period|Administrative (study closure)|7
929711|NCT00920907|3065656|P2|Maintenance Period|Disease Progression|7
929712|NCT00920907|3065657|P1|Maintenance Period|Disease Progression|3
929713|NCT00920907|3065656|P2|Induction Period|Withdrawal by Subject|1
929714|NCT00920907|3065657|P1|Induction Period|Withdrawal by Subject|1
929715|NCT00920907|3065656|P2|Induction Period|No longer meets study criteria|1
929716|NCT00920907|3065657|P1|Induction Period|No longer meets study criteria|0
929717|NCT00920907|3065656|P2|Induction Period|Study Drug Toxicity|6
929718|NCT00920907|3065657|P1|Induction Period|Study Drug Toxicity|8
929719|NCT00920907|3065656|P2|Induction Period|Disease Progression|11
929720|NCT00920907|3065657|P1|Induction Period|Disease Progression|12
929721|NCT00920907|3065656|P2|Induction Period|Death|1
929722|NCT00920907|3065657|P1|Induction Period|Death|1
929723|NCT00920907|3065656|P2|Induction Period|Adverse Event|2
929724|NCT00920907|3065657|P1|Induction Period|Adverse Event|0
929725|NCT00920855|3065698|P3|Overall Study|Response plateau; started maintenance|1
929726|NCT00920855|3065699|P2|Overall Study|Response plateau; started maintenance|0
929727|NCT00920855|3065700|P1|Overall Study|Response plateau; started maintenance|0
929728|NCT00920855|3065698|P3|Overall Study|Noncompliance to study medication|1
929729|NCT00920855|3065699|P2|Overall Study|Noncompliance to study medication|0
929730|NCT00920855|3065700|P1|Overall Study|Noncompliance to study medication|0
929731|NCT00920855|3065698|P3|Overall Study|Disease progression|10
929732|NCT00920855|3065699|P2|Overall Study|Disease progression|1
929733|NCT00920855|3065700|P1|Overall Study|Disease progression|2
929734|NCT00920855|3065698|P3|Overall Study|Withdrawal by Subject|6
929735|NCT00920855|3065699|P2|Overall Study|Withdrawal by Subject|1
929736|NCT00920855|3065700|P1|Overall Study|Withdrawal by Subject|2
929737|NCT00920855|3065698|P3|Overall Study|Adverse Event|4
929738|NCT00920855|3065699|P2|Overall Study|Adverse Event|1
929739|NCT00920855|3065700|P1|Overall Study|Adverse Event|1
929740|NCT00920829|3065726|P4|Available for Analysis|Required more treatment|1
929741|NCT00920829|3065727|P3|Available for Analysis|Required more treatment|0
929742|NCT00920829|3065728|P2|Available for Analysis|Required more treatment|2
929743|NCT00920829|3065729|P1|Available for Analysis|Required more treatment|0
929744|NCT00920829|3065726|P4|Available for Analysis|Protocol Violation|0
929745|NCT00920829|3065727|P3|Available for Analysis|Protocol Violation|1
929746|NCT00920829|3065728|P2|Available for Analysis|Protocol Violation|0
929747|NCT00920829|3065729|P1|Available for Analysis|Protocol Violation|0
929748|NCT00920829|3065726|P4|Available for Analysis|Death|0
929749|NCT00920829|3065727|P3|Available for Analysis|Death|0
929750|NCT00920829|3065728|P2|Available for Analysis|Death|0
929751|NCT00920829|3065729|P1|Available for Analysis|Death|1
929752|NCT00920829|3065726|P4|Available for Analysis|Adverse Event|0
929753|NCT00920829|3065727|P3|Available for Analysis|Adverse Event|1
929754|NCT00920829|3065728|P2|Available for Analysis|Adverse Event|2
929755|NCT00920829|3065729|P1|Available for Analysis|Adverse Event|1
929756|NCT00920829|3065726|P4|Available for Analysis|Required Medical Treatment|0
929757|NCT00920829|3065727|P3|Available for Analysis|Required Medical Treatment|2
929758|NCT00920829|3065728|P2|Available for Analysis|Required Medical Treatment|1
929759|NCT00920829|3065729|P1|Available for Analysis|Required Medical Treatment|0
929760|NCT00920829|3065726|P4|Available for Analysis|Withdrawal by Subject|10
929761|NCT00920829|3065727|P3|Available for Analysis|Withdrawal by Subject|6
929762|NCT00920829|3065728|P2|Available for Analysis|Withdrawal by Subject|6
929763|NCT00920829|3065729|P1|Available for Analysis|Withdrawal by Subject|6
929764|NCT00920829|3065726|P4|Allocation|No post randomization data|2
929765|NCT00920829|3065727|P3|Allocation|No post randomization data|0
929766|NCT00920829|3065728|P2|Allocation|No post randomization data|1
929767|NCT00920829|3065729|P1|Allocation|No post randomization data|3
929768|NCT00920816|3065743|P4|Overall Study|Ongoing|36
929769|NCT00920816|3065744|P3|Overall Study|Ongoing|70
929770|NCT00920816|3065745|P2|Overall Study|Ongoing|56
929771|NCT00920816|3065746|P1|Overall Study|Ongoing|106
929772|NCT00920816|3065743|P4|Overall Study|Withdrawal by Subject|1
929773|NCT00920816|3065744|P3|Overall Study|Withdrawal by Subject|1
929774|NCT00920816|3065745|P2|Overall Study|Withdrawal by Subject|2
929775|NCT00920816|3065746|P1|Overall Study|Withdrawal by Subject|7
929776|NCT00920816|3065743|P4|Overall Study|Objective progression or relapse|0
929777|NCT00920816|3065744|P3|Overall Study|Objective progression or relapse|2
929778|NCT00920816|3065745|P2|Overall Study|Objective progression or relapse|0
929779|NCT00920816|3065746|P1|Overall Study|Objective progression or relapse|0
929780|NCT00920816|3065743|P4|Overall Study|Lost to Follow-up|4
929781|NCT00920816|3065744|P3|Overall Study|Lost to Follow-up|3
929782|NCT00920816|3065745|P2|Overall Study|Lost to Follow-up|2
929783|NCT00920816|3065746|P1|Overall Study|Lost to Follow-up|1
929784|NCT00920816|3065743|P4|Overall Study|Adverse Event|0
929785|NCT00920816|3065744|P3|Overall Study|Adverse Event|1
929786|NCT00920816|3065745|P2|Overall Study|Adverse Event|0
929787|NCT00920816|3065746|P1|Overall Study|Adverse Event|1
929788|NCT00920816|3065743|P4|Overall Study|Death|28
929789|NCT00920816|3065744|P3|Overall Study|Death|58
929790|NCT00920816|3065745|P2|Overall Study|Death|36
929791|NCT00920816|3065746|P1|Overall Study|Death|77
929792|NCT00920790|3065784|P1|Overall Study|aggravation of general condition|14
929793|NCT00920699|3065796|P3|Overall Study|Lost to Follow-up|2
929794|NCT00920699|3065797|P2|Overall Study|Lost to Follow-up|0
929795|NCT00920699|3065798|P1|Overall Study|Lost to Follow-up|0
929796|NCT00920699|3065796|P3|Overall Study|no longer met eligibility|0
929797|NCT00920699|3065797|P2|Overall Study|no longer met eligibility|1
929798|NCT00920699|3065798|P1|Overall Study|no longer met eligibility|0
929799|NCT00920699|3065796|P3|Overall Study|Withdrawal by Subject|2
929800|NCT00920699|3065797|P2|Overall Study|Withdrawal by Subject|0
929801|NCT00920699|3065798|P1|Overall Study|Withdrawal by Subject|2
929802|NCT00920686|3065815|P3|Overall Study|Study drug dosing criteria not met|12
929803|NCT00920686|3065816|P2|Overall Study|Study drug dosing criteria not met|19
929804|NCT00920686|3065817|P1|Overall Study|Study drug dosing criteria not met|17
929805|NCT00920686|3065815|P3|Overall Study|Lost to Follow-up|1
929806|NCT00920686|3065816|P2|Overall Study|Lost to Follow-up|3
929807|NCT00920686|3065817|P1|Overall Study|Lost to Follow-up|2
929808|NCT00920621|3065896|P4|Overall Study|Blood sample not collected|0
929809|NCT00920621|3065897|P3|Overall Study|Blood sample not collected|0
929810|NCT00920621|3065898|P2|Overall Study|Blood sample not collected|14
929811|NCT00920621|3065899|P1|Overall Study|Blood sample not collected|22
929812|NCT00920621|3065896|P4|Overall Study|Fetal/neonatal deaths|14
929813|NCT00920621|3065897|P3|Overall Study|Fetal/neonatal deaths|16
929814|NCT00920621|3065898|P2|Overall Study|Fetal/neonatal deaths|14
929815|NCT00920621|3065899|P1|Overall Study|Fetal/neonatal deaths|16
929816|NCT00920621|3065896|P4|Overall Study|Lost to Follow-up|21
929817|NCT00920621|3065897|P3|Overall Study|Lost to Follow-up|19
929818|NCT00920621|3065898|P2|Overall Study|Lost to Follow-up|17
929819|NCT00920621|3065899|P1|Overall Study|Lost to Follow-up|16
929820|NCT00920426|3065933|P4|ITZ111451|Adverse Event|0
929821|NCT00920426|3065934|P3|ITZ111451|Adverse Event|0
929822|NCT00920426|3065935|P2|ITZ111451|Adverse Event|0
929823|NCT00920426|3065936|P1|ITZ111451|Adverse Event|1
929824|NCT00920218|3066056|P4|Overall Study|Not specified|0
929825|NCT00920218|3066057|P3|Overall Study|Not specified|1
929826|NCT00920218|3066058|P2|Overall Study|Not specified|0
929827|NCT00920218|3066059|P1|Overall Study|Not specified|0
929828|NCT00920218|3066056|P4|Overall Study|Transplant failed/malignancy recurrence|3
929829|NCT00920218|3066057|P3|Overall Study|Transplant failed/malignancy recurrence|2
929830|NCT00920218|3066058|P2|Overall Study|Transplant failed/malignancy recurrence|1
929831|NCT00920218|3066059|P1|Overall Study|Transplant failed/malignancy recurrence|0
929832|NCT00920218|3066056|P4|Overall Study|Lost to Follow-up|3
929833|NCT00920218|3066057|P3|Overall Study|Lost to Follow-up|0
929834|NCT00920218|3066058|P2|Overall Study|Lost to Follow-up|1
929835|NCT00920218|3066059|P1|Overall Study|Lost to Follow-up|0
929836|NCT00920218|3066056|P4|Overall Study|Migrated/moved from study area|0
929837|NCT00920218|3066057|P3|Overall Study|Migrated/moved from study area|1
929838|NCT00920218|3066058|P2|Overall Study|Migrated/moved from study area|0
929839|NCT00920218|3066059|P1|Overall Study|Migrated/moved from study area|0
929840|NCT00920218|3066056|P4|Overall Study|Withdrawal by Subject|0
929841|NCT00920218|3066057|P3|Overall Study|Withdrawal by Subject|2
929842|NCT00920218|3066058|P2|Overall Study|Withdrawal by Subject|3
929843|NCT00920218|3066059|P1|Overall Study|Withdrawal by Subject|0
929844|NCT00920218|3066056|P4|Overall Study|Serious Adverse Event|1
929845|NCT00920218|3066057|P3|Overall Study|Serious Adverse Event|2
929846|NCT00920218|3066058|P2|Overall Study|Serious Adverse Event|0
929847|NCT00920218|3066059|P1|Overall Study|Serious Adverse Event|2
929848|NCT00920140|3066162|P5|Phase 2|Withdrawal by Subject|1
929849|NCT00920140|3066163|P4|Phase 2|Withdrawal by Subject|2
929850|NCT00920140|3066164|P3|Phase 2|Withdrawal by Subject|4
929851|NCT00920140|3066165|P2|Phase 2|Withdrawal by Subject|0
929852|NCT00920140|3066166|P1|Phase 2|Withdrawal by Subject|0
929853|NCT00920140|3066162|P5|Phase 2|Physician Decision|2
929854|NCT00920140|3066163|P4|Phase 2|Physician Decision|3
929855|NCT00920140|3066164|P3|Phase 2|Physician Decision|3
929856|NCT00920140|3066165|P2|Phase 2|Physician Decision|0
929857|NCT00920140|3066166|P1|Phase 2|Physician Decision|0
929858|NCT00920140|3066162|P5|Phase 2|Lost to Follow-up|0
929859|NCT00920140|3066163|P4|Phase 2|Lost to Follow-up|1
929860|NCT00920140|3066164|P3|Phase 2|Lost to Follow-up|0
929861|NCT00920140|3066165|P2|Phase 2|Lost to Follow-up|0
929862|NCT00920140|3066166|P1|Phase 2|Lost to Follow-up|0
929863|NCT00920140|3066162|P5|Phase 2|Lack of Efficacy|5
929864|NCT00920140|3066163|P4|Phase 2|Lack of Efficacy|14
929865|NCT00920140|3066164|P3|Phase 2|Lack of Efficacy|29
929866|NCT00920140|3066165|P2|Phase 2|Lack of Efficacy|0
929867|NCT00920140|3066166|P1|Phase 2|Lack of Efficacy|0
929868|NCT00920140|3066162|P5|Phase 2|Adverse Event|3
929869|NCT00920140|3066163|P4|Phase 2|Adverse Event|2
929870|NCT00920140|3066164|P3|Phase 2|Adverse Event|14
929871|NCT00920140|3066165|P2|Phase 2|Adverse Event|0
929872|NCT00920140|3066166|P1|Phase 2|Adverse Event|0
929873|NCT00920140|3066162|P5|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
929874|NCT00920140|3066163|P4|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
929875|NCT00920140|3066164|P3|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
929876|NCT00920140|3066165|P2|Phase 1 (Dose Escalation)|Withdrawal by Subject|2
929877|NCT00920140|3066166|P1|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
929878|NCT00920140|3066162|P5|Phase 1 (Dose Escalation)|Lack of Efficacy|0
929879|NCT00920140|3066163|P4|Phase 1 (Dose Escalation)|Lack of Efficacy|0
929880|NCT00920140|3066164|P3|Phase 1 (Dose Escalation)|Lack of Efficacy|0
929881|NCT00920140|3066165|P2|Phase 1 (Dose Escalation)|Lack of Efficacy|4
929882|NCT00920140|3066166|P1|Phase 1 (Dose Escalation)|Lack of Efficacy|2
929883|NCT00920140|3066162|P5|Phase 1 (Dose Escalation)|Adverse Event|0
929884|NCT00920140|3066163|P4|Phase 1 (Dose Escalation)|Adverse Event|0
929885|NCT00920140|3066164|P3|Phase 1 (Dose Escalation)|Adverse Event|0
929886|NCT00920140|3066165|P2|Phase 1 (Dose Escalation)|Adverse Event|3
929887|NCT00920140|3066166|P1|Phase 1 (Dose Escalation)|Adverse Event|3
929888|NCT00919893|3066228|P2|Overall Study|Protocol Violation|9
929889|NCT00919893|3066229|P1|Overall Study|Protocol Violation|19
929890|NCT00919867|3066241|P6|First Intervention|Physician Decision|1
929891|NCT00919867|3066242|P5|First Intervention|Physician Decision|0
929892|NCT00919867|3066243|P4|First Intervention|Physician Decision|0
929893|NCT00919867|3066244|P3|First Intervention|Physician Decision|0
929894|NCT00919867|3066245|P2|First Intervention|Physician Decision|0
929895|NCT00919867|3066246|P1|First Intervention|Physician Decision|0
929896|NCT00919867|3066241|P6|First Intervention|Withdrawal by Subject|0
929897|NCT00919867|3066242|P5|First Intervention|Withdrawal by Subject|0
929898|NCT00919867|3066243|P4|First Intervention|Withdrawal by Subject|0
929899|NCT00919867|3066244|P3|First Intervention|Withdrawal by Subject|1
929900|NCT00919867|3066245|P2|First Intervention|Withdrawal by Subject|0
929901|NCT00919867|3066246|P1|First Intervention|Withdrawal by Subject|0
929902|NCT00919854|3066267|P1|Overall Study|Adverse Event|1
929903|NCT00919711|3066305|P2|Overall Study|Noncompliance|0
929904|NCT00919711|3066306|P1|Overall Study|Noncompliance|1
929905|NCT00919711|3066305|P2|Overall Study|Death|0
929906|NCT00919711|3066306|P1|Overall Study|Death|1
929907|NCT00919711|3066305|P2|Overall Study|Lost to Follow-up|0
929908|NCT00919711|3066306|P1|Overall Study|Lost to Follow-up|2
929909|NCT00919711|3066305|P2|Overall Study|Administrative Decision|1
929910|NCT00919711|3066306|P1|Overall Study|Administrative Decision|0
929911|NCT00919711|3066305|P2|Overall Study|Other|2
929912|NCT00919711|3066306|P1|Overall Study|Other|1
929913|NCT00919711|3066305|P2|Overall Study|Adverse Event|3
929914|NCT00919711|3066306|P1|Overall Study|Adverse Event|13
929915|NCT00919711|3066305|P2|Overall Study|Withdrawal by Subject|7
929916|NCT00919711|3066306|P1|Overall Study|Withdrawal by Subject|15
929917|NCT00919633|3066322|P4|Overall Study|Viral rebound outside protocol timepoint|0
929918|NCT00919633|3066323|P3|Overall Study|Viral rebound outside protocol timepoint|1
929919|NCT00919633|3066324|P2|Overall Study|Viral rebound outside protocol timepoint|0
929920|NCT00919633|3066325|P1|Overall Study|Viral rebound outside protocol timepoint|0
929921|NCT00919633|3066322|P4|Overall Study|Request of withdrawal w/o future contact|0
929922|NCT00919633|3066323|P3|Overall Study|Request of withdrawal w/o future contact|1
929923|NCT00919633|3066324|P2|Overall Study|Request of withdrawal w/o future contact|0
929924|NCT00919633|3066325|P1|Overall Study|Request of withdrawal w/o future contact|0
929925|NCT00919633|3066322|P4|Overall Study|Physician Decision|1
929926|NCT00919633|3066323|P3|Overall Study|Physician Decision|0
929927|NCT00919633|3066324|P2|Overall Study|Physician Decision|0
929928|NCT00919633|3066325|P1|Overall Study|Physician Decision|0
929929|NCT00919633|3066322|P4|Overall Study|Protocol Violation|1
929930|NCT00919633|3066323|P3|Overall Study|Protocol Violation|0
929931|NCT00919633|3066324|P2|Overall Study|Protocol Violation|0
929932|NCT00919633|3066325|P1|Overall Study|Protocol Violation|0
929933|NCT00919633|3066322|P4|Overall Study|Withdraw consent post transition to SOC|1
929934|NCT00919633|3066323|P3|Overall Study|Withdraw consent post transition to SOC|1
929935|NCT00919633|3066324|P2|Overall Study|Withdraw consent post transition to SOC|0
929936|NCT00919633|3066325|P1|Overall Study|Withdraw consent post transition to SOC|0
929937|NCT00919633|3066322|P4|Overall Study|Lost to Follow-up|2
929938|NCT00919633|3066323|P3|Overall Study|Lost to Follow-up|0
929939|NCT00919633|3066324|P2|Overall Study|Lost to Follow-up|1
929940|NCT00919633|3066325|P1|Overall Study|Lost to Follow-up|3
929941|NCT00919633|3066322|P4|Overall Study|Withdrawal by Subject|3
929942|NCT00919633|3066323|P3|Overall Study|Withdrawal by Subject|4
929943|NCT00919633|3066324|P2|Overall Study|Withdrawal by Subject|2
929944|NCT00919633|3066325|P1|Overall Study|Withdrawal by Subject|1
929945|NCT00919633|3066322|P4|Overall Study|Lack of Efficacy|3
929946|NCT00919633|3066323|P3|Overall Study|Lack of Efficacy|2
929947|NCT00919633|3066324|P2|Overall Study|Lack of Efficacy|3
929948|NCT00919633|3066325|P1|Overall Study|Lack of Efficacy|17
929949|NCT00919633|3066322|P4|Overall Study|Death|0
929950|NCT00919633|3066323|P3|Overall Study|Death|2
929951|NCT00919633|3066324|P2|Overall Study|Death|0
929952|NCT00919633|3066325|P1|Overall Study|Death|0
929953|NCT00919633|3066322|P4|Overall Study|Adverse Event|10
929954|NCT00919633|3066323|P3|Overall Study|Adverse Event|12
929955|NCT00919633|3066324|P2|Overall Study|Adverse Event|9
929956|NCT00919633|3066325|P1|Overall Study|Adverse Event|1
929957|NCT00919061|3066423|P1|Overall Study|Withdrawal by Subject|1
929958|NCT00919061|3066423|P1|Overall Study|Adverse Event|1
929959|NCT00918957|3066436|P2|Overall Study|Withdrawal by Subject|0
929960|NCT00918957|3066437|P1|Overall Study|Withdrawal by Subject|1
929961|NCT00918957|3066436|P2|Overall Study|Adverse Event|0
929962|NCT00918957|3066437|P1|Overall Study|Adverse Event|2
929963|NCT00918879|3066470|P2|Overall Study|Severe non-compliance to protocol|1
929964|NCT00918879|3066471|P1|Overall Study|Severe non-compliance to protocol|1
929965|NCT00918879|3066470|P2|Overall Study|Lost to Follow-up|1
929966|NCT00918879|3066471|P1|Overall Study|Lost to Follow-up|1
929967|NCT00918879|3066470|P2|Overall Study|Withdrawal by Subject|4
929968|NCT00918879|3066471|P1|Overall Study|Withdrawal by Subject|4
929969|NCT00918749|3066503|P3|Overall Study|No Study Medication Taken|0
929970|NCT00918749|3066504|P2|Overall Study|No Study Medication Taken|0
929971|NCT00918749|3066505|P1|Overall Study|No Study Medication Taken|1
929972|NCT00918749|3066503|P3|Overall Study|Withdrawal by Subject|5
929973|NCT00918749|3066504|P2|Overall Study|Withdrawal by Subject|3
929974|NCT00918749|3066505|P1|Overall Study|Withdrawal by Subject|5
929975|NCT00918749|3066503|P3|Overall Study|Lost to Follow-up|1
929976|NCT00918749|3066504|P2|Overall Study|Lost to Follow-up|0
929977|NCT00918749|3066505|P1|Overall Study|Lost to Follow-up|0
929978|NCT00918749|3066503|P3|Overall Study|Adverse Event|1
929979|NCT00918749|3066504|P2|Overall Study|Adverse Event|0
929980|NCT00918749|3066505|P1|Overall Study|Adverse Event|1
929981|NCT00918736|3066537|P1|Overall Study|Withdrawal by Subject|4
929982|NCT00918684|3066550|P1|Treatment Phase|Withdrawal by Subject|8
929983|NCT00918684|3066550|P1|Treatment Phase|Protocol Violation|1
929984|NCT00918684|3066550|P1|Treatment Phase|Physician Decision|8
929985|NCT00918684|3066550|P1|Treatment Phase|Lost to Follow-up|2
929986|NCT00918684|3066550|P1|Treatment Phase|Lack of Efficacy|6
929987|NCT00918684|3066550|P1|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16
929988|NCT00918645|3066561|P1|Overall Study|Withdrawal by Subject|1
929989|NCT00918580|3066567|P1|After 6-month FU to 1-year FU|Failed to Return|2
929990|NCT00918580|3066567|P1|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58
929991|NCT00918580|3066567|P1|Up to 6-month Follow-up(FU)|Failed to Return|1
929992|NCT00918580|3066567|P1|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2
929993|NCT00918580|3066567|P1|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2
929994|NCT00918580|3066567|P1|Up to 6-month Follow-up(FU)|Lost to Follow-up|5
929995|NCT00918580|3066567|P1|Up to 6-month Follow-up(FU)|Adverse Event|1
929996|NCT00918463|3066585|P1|Overall Study|Lack of Efficacy|1
929997|NCT00918463|3066585|P1|Overall Study|Death|1
929998|NCT00918385|3066593|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7
929999|NCT00918385|3066594|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
930000|NCT00918385|3066593|P2|Combination Nilutamide and Dasatinib|Complicating illness|0
930001|NCT00918385|3066594|P1|Combination Nilutamide and Dasatinib|Complicating illness|1
930002|NCT00918385|3066593|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0
930003|NCT00918385|3066594|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
930004|NCT00918385|3066593|P2|Combination Nilutamide and Dasatinib|Adverse Event|1
930005|NCT00918385|3066594|P1|Combination Nilutamide and Dasatinib|Adverse Event|1
930006|NCT00918385|3066593|P2|Monotherapy|Complicating illness|0
930007|NCT00918385|3066594|P1|Monotherapy|Complicating illness|1
930008|NCT00918385|3066593|P2|Monotherapy|Adverse Event|6
930009|NCT00918385|3066594|P1|Monotherapy|Adverse Event|1
930010|NCT00918346|3066603|P2|First Treatment Period (4 Weeks)|Lack of Efficacy|1
930011|NCT00918346|3066604|P1|First Treatment Period (4 Weeks)|Lack of Efficacy|0
930012|NCT00918333|3066620|P2|Overall Study|Withdrawal by Subject|1
930013|NCT00918333|3066621|P1|Overall Study|Withdrawal by Subject|0
930014|NCT00918333|3066620|P2|Overall Study|Ineligible|0
930015|NCT00918333|3066621|P1|Overall Study|Ineligible|1
930016|NCT00918333|3066620|P2|Overall Study|Inadequate amount of drugs provided|4
930017|NCT00918333|3066621|P1|Overall Study|Inadequate amount of drugs provided|1
930018|NCT00918333|3066620|P2|Overall Study|Drug not taken per protocol|0
930019|NCT00918333|3066621|P1|Overall Study|Drug not taken per protocol|1
930020|NCT00918281|3066641|P1|Overall Study|Physician Decision|29
930021|NCT00918255|3066651|P3|Overall Study|Investigator discretion|0
930022|NCT00918255|3066652|P2|Overall Study|Investigator discretion|0
930023|NCT00918255|3066653|P1|Overall Study|Investigator discretion|1
930024|NCT00918255|3066651|P3|Overall Study|Non-compliance|0
930025|NCT00918255|3066652|P2|Overall Study|Non-compliance|0
930026|NCT00918255|3066653|P1|Overall Study|Non-compliance|1
930027|NCT00918255|3066651|P3|Overall Study|Exceeded allowed number of interventions|1
930028|NCT00918255|3066652|P2|Overall Study|Exceeded allowed number of interventions|0
930029|NCT00918255|3066653|P1|Overall Study|Exceeded allowed number of interventions|0
930030|NCT00918255|3066651|P3|Overall Study|Lost to Follow-up|2
930031|NCT00918255|3066652|P2|Overall Study|Lost to Follow-up|0
930032|NCT00918255|3066653|P1|Overall Study|Lost to Follow-up|1
930033|NCT00918255|3066651|P3|Overall Study|Lack of Efficacy|0
930034|NCT00918255|3066652|P2|Overall Study|Lack of Efficacy|0
930035|NCT00918255|3066653|P1|Overall Study|Lack of Efficacy|1
930036|NCT00918255|3066651|P3|Overall Study|Withdrawal by Subject|2
930037|NCT00918255|3066652|P2|Overall Study|Withdrawal by Subject|0
930038|NCT00918255|3066653|P1|Overall Study|Withdrawal by Subject|1
930039|NCT00918255|3066651|P3|Overall Study|Adverse Event|0
930040|NCT00918255|3066652|P2|Overall Study|Adverse Event|0
930041|NCT00918255|3066653|P1|Overall Study|Adverse Event|1
930042|NCT00918203|3066686|P3|Crossover to Olaratumab Monotherapy|Other Therapy Started|1
930043|NCT00918203|3066687|P2|Crossover to Olaratumab Monotherapy|Other Therapy Started|0
930044|NCT00918203|3066688|P1|Crossover to Olaratumab Monotherapy|Other Therapy Started|0
930045|NCT00918203|3066686|P3|Crossover to Olaratumab Monotherapy|Withdrawal by Subject|2
930046|NCT00918203|3066687|P2|Crossover to Olaratumab Monotherapy|Withdrawal by Subject|0
930047|NCT00918203|3066688|P1|Crossover to Olaratumab Monotherapy|Withdrawal by Subject|0
930048|NCT00918203|3066686|P3|Treatment With or Without Olaratumab|On Treatment|0
930049|NCT00918203|3066687|P2|Treatment With or Without Olaratumab|On Treatment|0
930050|NCT00918203|3066688|P1|Treatment With or Without Olaratumab|On Treatment|1
930051|NCT00918203|3066686|P3|Treatment With or Without Olaratumab|Physician Decision|0
930052|NCT00918203|3066687|P2|Treatment With or Without Olaratumab|Physician Decision|1
930053|NCT00918203|3066688|P1|Treatment With or Without Olaratumab|Physician Decision|0
930054|NCT00918203|3066686|P3|Treatment With or Without Olaratumab|Off Study Treatment/Alive|0
930055|NCT00918203|3066687|P2|Treatment With or Without Olaratumab|Off Study Treatment/Alive|1
930056|NCT00918203|3066688|P1|Treatment With or Without Olaratumab|Off Study Treatment/Alive|0
930057|NCT00918203|3066686|P3|Treatment With or Without Olaratumab|Never Treated|0
930058|NCT00918203|3066687|P2|Treatment With or Without Olaratumab|Never Treated|1
930059|NCT00918203|3066688|P1|Treatment With or Without Olaratumab|Never Treated|2
930060|NCT00918203|3066686|P3|Treatment With or Without Olaratumab|Adverse Event|0
930061|NCT00918203|3066687|P2|Treatment With or Without Olaratumab|Adverse Event|1
930062|NCT00918203|3066688|P1|Treatment With or Without Olaratumab|Adverse Event|1
930063|NCT00918203|3066686|P3|Treatment With or Without Olaratumab|Other Therapy Started|0
930064|NCT00918203|3066687|P2|Treatment With or Without Olaratumab|Other Therapy Started|1
930065|NCT00918203|3066688|P1|Treatment With or Without Olaratumab|Other Therapy Started|2
930066|NCT00918203|3066686|P3|Treatment With or Without Olaratumab|Lost to Follow-up|0
930067|NCT00918203|3066687|P2|Treatment With or Without Olaratumab|Lost to Follow-up|0
930068|NCT00918203|3066688|P1|Treatment With or Without Olaratumab|Lost to Follow-up|1
930069|NCT00918203|3066686|P3|Treatment With or Without Olaratumab|Withdrawal by Subject|0
930070|NCT00918203|3066687|P2|Treatment With or Without Olaratumab|Withdrawal by Subject|9
930071|NCT00918203|3066688|P1|Treatment With or Without Olaratumab|Withdrawal by Subject|0
930072|NCT00918138|3066719|P2|Overall Study|Death|0
930073|NCT00918138|3066720|P1|Overall Study|Death|1
930074|NCT00918138|3066719|P2|Overall Study|Subject withdrew consent|1
930075|NCT00918138|3066720|P1|Overall Study|Subject withdrew consent|1
930076|NCT00917852|3066759|P1|Overall Study|Death|6
930077|NCT00917644|3066777|P2|Period 2: Second Intervention|family emergency|0
930078|NCT00917644|3066778|P1|Period 2: Second Intervention|family emergency|1
930079|NCT00917644|3066777|P2|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0
930080|NCT00917644|3066778|P1|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1
930081|NCT00917644|3066777|P2|Period: Washout Period of > = 2 Weeks|Protocol Violation|0
930082|NCT00917644|3066778|P1|Period: Washout Period of > = 2 Weeks|Protocol Violation|1
930083|NCT00917579|3066792|P2|Washout >= 2 Weeks|Withdrawal by Subject|0
930084|NCT00917579|3066793|P1|Washout >= 2 Weeks|Withdrawal by Subject|1
930085|NCT00917579|3066792|P2|Washout >= 2 Weeks|Adverse Event|0
930086|NCT00917579|3066793|P1|Washout >= 2 Weeks|Adverse Event|1
930087|NCT00917553|3066809|P2|Overall Study|Lost to Follow-up|1
930088|NCT00917553|3066810|P1|Overall Study|Lost to Follow-up|2
930089|NCT00917501|3066826|P2|Overall Study|trouble swollowing capsules|1
930090|NCT00917501|3066827|P1|Overall Study|trouble swollowing capsules|0
930091|NCT00917501|3066826|P2|Overall Study|Lack of Efficacy|2
930092|NCT00917501|3066827|P1|Overall Study|Lack of Efficacy|1
930093|NCT00917501|3066826|P2|Overall Study|Withdrawal by Subject|1
930094|NCT00917501|3066827|P1|Overall Study|Withdrawal by Subject|3
930095|NCT00917501|3066826|P2|Overall Study|Lost to Follow-up|1
930096|NCT00917501|3066827|P1|Overall Study|Lost to Follow-up|4
930097|NCT00917384|3066835|P2|Overall Study|Withdrawal by Subject|2
930098|NCT00917384|3066836|P1|Overall Study|Withdrawal by Subject|10
930099|NCT00917384|3066835|P2|Overall Study|Lost to Follow-up|2
930100|NCT00917384|3066836|P1|Overall Study|Lost to Follow-up|4
930101|NCT00917267|3066860|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
930102|NCT00917267|3066861|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
930103|NCT00917267|3066860|P2|Overall Study|Sponsor Decision|5
930104|NCT00917267|3066861|P1|Overall Study|Sponsor Decision|5
930105|NCT00917267|3066860|P2|Overall Study|Entry Criteria Not Met|0
930106|NCT00917267|3066861|P1|Overall Study|Entry Criteria Not Met|1
930107|NCT00917267|3066860|P2|Overall Study|Lost to follow up|2
930108|NCT00917267|3066861|P1|Overall Study|Lost to follow up|0
930109|NCT00917267|3066860|P2|Overall Study|Withdrawal by Subject|12
930110|NCT00917267|3066861|P1|Overall Study|Withdrawal by Subject|5
930111|NCT00917267|3066860|P2|Overall Study|Protocol Violation|18
930112|NCT00917267|3066861|P1|Overall Study|Protocol Violation|9
930113|NCT00917267|3066860|P2|Overall Study|Physician Decision|4
930114|NCT00917267|3066861|P1|Overall Study|Physician Decision|2
930115|NCT00917267|3066860|P2|Overall Study|Adverse Event|36
930116|NCT00917267|3066861|P1|Overall Study|Adverse Event|15
930117|NCT00917124|3066889|P2|Overall Study|Protocol Violation|6
930118|NCT00917124|3066890|P1|Overall Study|Protocol Violation|4
930119|NCT00916929|3066900|P2|Overall Study|Device unable to process impedance data|7
930120|NCT00916929|3066901|P1|Overall Study|Device unable to process impedance data|0
930121|NCT00916929|3066900|P2|Overall Study|Moved to another state|1
930122|NCT00916929|3066901|P1|Overall Study|Moved to another state|0
930123|NCT00916929|3066900|P2|Overall Study|System explant|0
930124|NCT00916929|3066901|P1|Overall Study|System explant|1
930125|NCT00916929|3066900|P2|Overall Study|Transferred to hospice care|1
930126|NCT00916929|3066901|P1|Overall Study|Transferred to hospice care|1
930127|NCT00916929|3066900|P2|Overall Study|Left ventricular epicardial lead|2
930128|NCT00916929|3066901|P1|Overall Study|Left ventricular epicardial lead|1
930129|NCT00916929|3066900|P2|Overall Study|Withdrawal by Subject|5
930130|NCT00916929|3066901|P1|Overall Study|Withdrawal by Subject|1
930131|NCT00916929|3066900|P2|Overall Study|Death|10
930132|NCT00916929|3066901|P1|Overall Study|Death|5
930133|NCT00916929|3066900|P2|Overall Study|Lost to Follow-up|3
930134|NCT00916929|3066901|P1|Overall Study|Lost to Follow-up|1
930135|NCT00916721|3066911|P2|Overall Study|Protocol Violation|4
930136|NCT00916721|3066912|P1|Overall Study|Protocol Violation|2
930137|NCT00916721|3066911|P2|Overall Study|Withdrawal by Subject|2
930138|NCT00916721|3066912|P1|Overall Study|Withdrawal by Subject|2
930139|NCT00916721|3066911|P2|Overall Study|Adverse Event|3
930140|NCT00916721|3066912|P1|Overall Study|Adverse Event|6
930141|NCT00916721|3066911|P2|Overall Study|Lost to Follow-up|1
930142|NCT00916721|3066912|P1|Overall Study|Lost to Follow-up|0
930143|NCT00916617|3066935|P4|Overall Study|Not specified|2
930144|NCT00916617|3066936|P3|Overall Study|Not specified|0
930145|NCT00916617|3066937|P2|Overall Study|Not specified|0
930146|NCT00916617|3066938|P1|Overall Study|Not specified|2
930147|NCT00916617|3066935|P4|Overall Study|Lack of Efficacy|0
930148|NCT00916617|3066936|P3|Overall Study|Lack of Efficacy|0
930149|NCT00916617|3066937|P2|Overall Study|Lack of Efficacy|0
930150|NCT00916617|3066938|P1|Overall Study|Lack of Efficacy|1
930151|NCT00916617|3066935|P4|Overall Study|Lost to Follow-up|0
930152|NCT00916617|3066936|P3|Overall Study|Lost to Follow-up|0
930153|NCT00916617|3066937|P2|Overall Study|Lost to Follow-up|1
930154|NCT00916617|3066938|P1|Overall Study|Lost to Follow-up|2
930155|NCT00916617|3066935|P4|Overall Study|Discontinuation of Study by Sponsor|1
930156|NCT00916617|3066936|P3|Overall Study|Discontinuation of Study by Sponsor|3
930157|NCT00916617|3066937|P2|Overall Study|Discontinuation of Study by Sponsor|13
930158|NCT00916617|3066938|P1|Overall Study|Discontinuation of Study by Sponsor|8
930159|NCT00916617|3066935|P4|Overall Study|Physician Decision|0
930160|NCT00916617|3066936|P3|Overall Study|Physician Decision|0
930161|NCT00916617|3066937|P2|Overall Study|Physician Decision|1
930162|NCT00916617|3066938|P1|Overall Study|Physician Decision|1
930163|NCT00916617|3066935|P4|Overall Study|Caregiver Request|0
930164|NCT00916617|3066936|P3|Overall Study|Caregiver Request|1
930165|NCT00916617|3066937|P2|Overall Study|Caregiver Request|2
930166|NCT00916617|3066938|P1|Overall Study|Caregiver Request|3
930167|NCT00916617|3066935|P4|Overall Study|Withdrawal by Subject|1
930168|NCT00916617|3066936|P3|Overall Study|Withdrawal by Subject|0
930169|NCT00916617|3066937|P2|Overall Study|Withdrawal by Subject|2
930170|NCT00916617|3066938|P1|Overall Study|Withdrawal by Subject|3
930171|NCT00916617|3066935|P4|Overall Study|Adverse Event|3
930172|NCT00916617|3066936|P3|Overall Study|Adverse Event|6
930173|NCT00916617|3066937|P2|Overall Study|Adverse Event|2
930174|NCT00916617|3066938|P1|Overall Study|Adverse Event|3
930175|NCT00916578|3066952|P1|Overall Study|Insurance Denial|2
930176|NCT00916578|3066952|P1|Overall Study|Withdrawal by Subject|3
930177|NCT00916578|3066952|P1|Overall Study|Physician Decision|2
930178|NCT00916383|3066981|P1|Overall Study|Protocol Violation|1
930179|NCT00916383|3066981|P1|Overall Study|Death|1
930180|NCT00916383|3066981|P1|Overall Study|Adverse Event|1
930181|NCT00916370|3067009|P2|Overall Study|Physician Decision|1
930182|NCT00916370|3067010|P1|Overall Study|Physician Decision|0
930183|NCT00916370|3067009|P2|Overall Study|Withdrawal by Subject|0
930184|NCT00916370|3067010|P1|Overall Study|Withdrawal by Subject|2
930185|NCT00916370|3067009|P2|Overall Study|Death|1
930186|NCT00916370|3067010|P1|Overall Study|Death|3
930187|NCT00916357|3067184|P6|Period 2|Weight loss > 3 kilograms (kg)|0
930188|NCT00916357|3067185|P5|Period 2|Weight loss > 3 kilograms (kg)|0
930189|NCT00916357|3067186|P4|Period 2|Weight loss > 3 kilograms (kg)|1
930190|NCT00916357|3067187|P3|Period 2|Weight loss > 3 kilograms (kg)|0
930191|NCT00916357|3067188|P2|Period 2|Weight loss > 3 kilograms (kg)|0
930192|NCT00916357|3067189|P1|Period 2|Weight loss > 3 kilograms (kg)|0
930193|NCT00916357|3067184|P6|Period 1|Withdrawal by Subject|0
930194|NCT00916357|3067185|P5|Period 1|Withdrawal by Subject|0
930195|NCT00916357|3067186|P4|Period 1|Withdrawal by Subject|0
930196|NCT00916357|3067187|P3|Period 1|Withdrawal by Subject|0
930197|NCT00916357|3067188|P2|Period 1|Withdrawal by Subject|0
930198|NCT00916357|3067189|P1|Period 1|Withdrawal by Subject|1
930199|NCT00916344|3067227|P1|Overall Study|Drop-out|5
930200|NCT00916344|3067227|P1|Overall Study|ICD upgrade|1
930201|NCT00916344|3067227|P1|Overall Study|Death|2
930202|NCT00916305|3067234|P2|Overall Study|Withdrawal by Subject|1
930203|NCT00916305|3067235|P1|Overall Study|Withdrawal by Subject|0
930204|NCT00916305|3067234|P2|Overall Study|Lost to Follow-up|27
930205|NCT00916305|3067235|P1|Overall Study|Lost to Follow-up|21
930206|NCT00916279|3067243|P1|Overall Study|Lost to Follow-up|2
930207|NCT00916279|3067243|P1|Overall Study|Death|2
930208|NCT00916149|3067254|P3|Overall Study|Unable to place scalp EEG leads|0
930209|NCT00916149|3067255|P2|Overall Study|Unable to place scalp EEG leads|0
930210|NCT00916149|3067256|P1|Overall Study|Unable to place scalp EEG leads|1
930211|NCT00916149|3067254|P3|Overall Study|Lost to Follow-up|0
930212|NCT00916149|3067255|P2|Overall Study|Lost to Follow-up|2
930213|NCT00916149|3067256|P1|Overall Study|Lost to Follow-up|3
930214|NCT00916006|3067379|P2|Overall Study|Protocol Violation|1
930215|NCT00916006|3067380|P1|Overall Study|Protocol Violation|0
930216|NCT00916006|3067379|P2|Overall Study|Withdrawal by Subject|5
930217|NCT00916006|3067380|P1|Overall Study|Withdrawal by Subject|2
930218|NCT00916006|3067379|P2|Overall Study|Adverse Event|1
930219|NCT00916006|3067380|P1|Overall Study|Adverse Event|1
930220|NCT00915876|3067401|P2|Overall Study|Adverse Event|1
930221|NCT00915876|3067402|P1|Overall Study|Adverse Event|0
930222|NCT00915772|3067438|P3|Overall Study|Any other reason|7
930223|NCT00915772|3067439|P2|Overall Study|Any other reason|7
930224|NCT00915772|3067440|P1|Overall Study|Any other reason|4
930225|NCT00915772|3067438|P3|Overall Study|Refused to continue trial medication|4
930226|NCT00915772|3067439|P2|Overall Study|Refused to continue trial medication|8
930227|NCT00915772|3067440|P1|Overall Study|Refused to continue trial medication|6
930228|NCT00915772|3067438|P3|Overall Study|Lack of Efficacy|3
930229|NCT00915772|3067439|P2|Overall Study|Lack of Efficacy|15
930230|NCT00915772|3067440|P1|Overall Study|Lack of Efficacy|9
930231|NCT00915772|3067438|P3|Overall Study|Lost to Follow-up|2
930232|NCT00915772|3067439|P2|Overall Study|Lost to Follow-up|2
930233|NCT00915772|3067440|P1|Overall Study|Lost to Follow-up|1
930234|NCT00915772|3067438|P3|Overall Study|Protocol Violation|2
930235|NCT00915772|3067439|P2|Overall Study|Protocol Violation|1
930236|NCT00915772|3067440|P1|Overall Study|Protocol Violation|4
930237|NCT00915772|3067438|P3|Overall Study|Adverse Event|11
930238|NCT00915772|3067439|P2|Overall Study|Adverse Event|13
930239|NCT00915772|3067440|P1|Overall Study|Adverse Event|12
930240|NCT00915551|3067539|P2|Overall Study|Withdrawal by Subject|1
930241|NCT00915551|3067540|P1|Overall Study|Withdrawal by Subject|0
930242|NCT00915525|3067550|P2|Overall Study|Patient Moved|9
930243|NCT00915525|3067551|P1|Overall Study|Patient Moved|15
930244|NCT00915525|3067550|P2|Overall Study|Non-Compliance|1
930245|NCT00915525|3067551|P1|Overall Study|Non-Compliance|3
930246|NCT00915525|3067550|P2|Overall Study|Study Burden|12
930247|NCT00915525|3067551|P1|Overall Study|Study Burden|28
930248|NCT00915525|3067550|P2|Overall Study|Retreat Request >Wk 144 (exclusionary)|5
930249|NCT00915525|3067551|P1|Overall Study|Retreat Request >Wk 144 (exclusionary)|4
930250|NCT00915525|3067550|P2|Overall Study|Site Closed|9
930251|NCT00915525|3067551|P1|Overall Study|Site Closed|27
930252|NCT00915525|3067550|P2|Overall Study|Other Reason|12
930253|NCT00915525|3067551|P1|Overall Study|Other Reason|35
930254|NCT00915525|3067550|P2|Overall Study|Missing|1
930255|NCT00915525|3067551|P1|Overall Study|Missing|12
930256|NCT00915525|3067550|P2|Overall Study|Adverse Event|13
930257|NCT00915525|3067551|P1|Overall Study|Adverse Event|29
930258|NCT00915525|3067550|P2|Overall Study|Lack of Efficacy|32
930259|NCT00915525|3067551|P1|Overall Study|Lack of Efficacy|15
930260|NCT00915525|3067550|P2|Overall Study|Pregnancy|0
930261|NCT00915525|3067551|P1|Overall Study|Pregnancy|2
930262|NCT00915525|3067550|P2|Overall Study|Lost to Follow-up|16
930263|NCT00915525|3067551|P1|Overall Study|Lost to Follow-up|27
930264|NCT00915525|3067550|P2|Overall Study|Withdrawal by Subject|21
930265|NCT00915525|3067551|P1|Overall Study|Withdrawal by Subject|59
930266|NCT00915525|3067550|P2|Overall Study|Protocol Violation|4
930267|NCT00915525|3067551|P1|Overall Study|Protocol Violation|9
930268|NCT00915473|3067665|P2|4-week Follow Up|Lost to Follow-up|5
930269|NCT00915473|3067666|P1|4-week Follow Up|Lost to Follow-up|1
930270|NCT00915473|3067665|P2|Screening|Withdrawal by Subject|0
930271|NCT00915473|3067666|P1|Screening|Withdrawal by Subject|1
930272|NCT00915356|3067683|P5|Overall Study|Withdrawal by Subject|0
930273|NCT00915356|3067684|P4|Overall Study|Withdrawal by Subject|0
930274|NCT00915356|3067685|P3|Overall Study|Withdrawal by Subject|0
930275|NCT00915356|3067686|P2|Overall Study|Withdrawal by Subject|0
930276|NCT00915356|3067687|P1|Overall Study|Withdrawal by Subject|1
930277|NCT00915343|3067749|P3|Part B - Open Label Period|Did not attend the last visit|1
930278|NCT00915343|3067750|P2|Part B - Open Label Period|Did not attend the last visit|0
930279|NCT00915343|3067751|P1|Part B - Open Label Period|Did not attend the last visit|0
930280|NCT00915343|3067749|P3|Part B - Open Label Period|Treatment switch|1
930281|NCT00915343|3067750|P2|Part B - Open Label Period|Treatment switch|0
930282|NCT00915343|3067751|P1|Part B - Open Label Period|Treatment switch|0
930283|NCT00915278|3067836|P6|Overall Study|Admission to hospice|0
930284|NCT00915278|3067837|P5|Overall Study|Admission to hospice|0
930285|NCT00915278|3067838|P4|Overall Study|Admission to hospice|0
930286|NCT00915278|3067839|P3|Overall Study|Admission to hospice|1
930287|NCT00915278|3067840|P2|Overall Study|Admission to hospice|0
930288|NCT00915278|3067841|P1|Overall Study|Admission to hospice|0
930289|NCT00915278|3067836|P6|Overall Study|Infusion related AEs|2
930290|NCT00915278|3067837|P5|Overall Study|Infusion related AEs|0
930291|NCT00915278|3067838|P4|Overall Study|Infusion related AEs|0
930292|NCT00915278|3067839|P3|Overall Study|Infusion related AEs|0
930293|NCT00915278|3067840|P2|Overall Study|Infusion related AEs|0
930294|NCT00915278|3067841|P1|Overall Study|Infusion related AEs|0
930295|NCT00915278|3067836|P6|Overall Study|Progressive disease/clinical progression|2
930296|NCT00915278|3067837|P5|Overall Study|Progressive disease/clinical progression|1
930297|NCT00915278|3067838|P4|Overall Study|Progressive disease/clinical progression|3
930298|NCT00915278|3067839|P3|Overall Study|Progressive disease/clinical progression|0
930299|NCT00915278|3067840|P2|Overall Study|Progressive disease/clinical progression|0
930300|NCT00915278|3067841|P1|Overall Study|Progressive disease/clinical progression|0
930301|NCT00915278|3067836|P6|Overall Study|Adverse Event|0
930302|NCT00915278|3067837|P5|Overall Study|Adverse Event|0
930303|NCT00915278|3067838|P4|Overall Study|Adverse Event|0
930304|NCT00915278|3067839|P3|Overall Study|Adverse Event|0
930305|NCT00915278|3067840|P2|Overall Study|Adverse Event|1
930306|NCT00915278|3067841|P1|Overall Study|Adverse Event|4
930307|NCT00915278|3067836|P6|Overall Study|Withdrawal by Subject|4
930308|NCT00915278|3067837|P5|Overall Study|Withdrawal by Subject|1
930309|NCT00915278|3067838|P4|Overall Study|Withdrawal by Subject|0
930310|NCT00915278|3067839|P3|Overall Study|Withdrawal by Subject|0
930311|NCT00915278|3067840|P2|Overall Study|Withdrawal by Subject|1
930312|NCT00915278|3067841|P1|Overall Study|Withdrawal by Subject|0
930313|NCT00915278|3067836|P6|Overall Study|Lost to Follow-up|0
930314|NCT00915278|3067837|P5|Overall Study|Lost to Follow-up|0
930315|NCT00915278|3067838|P4|Overall Study|Lost to Follow-up|0
930316|NCT00915278|3067839|P3|Overall Study|Lost to Follow-up|0
930317|NCT00915278|3067840|P2|Overall Study|Lost to Follow-up|1
930318|NCT00915278|3067841|P1|Overall Study|Lost to Follow-up|0
930319|NCT00915278|3067836|P6|Overall Study|Death|0
930320|NCT00915278|3067837|P5|Overall Study|Death|0
930321|NCT00915278|3067838|P4|Overall Study|Death|0
930322|NCT00915278|3067839|P3|Overall Study|Death|0
930323|NCT00915278|3067840|P2|Overall Study|Death|0
930324|NCT00915278|3067841|P1|Overall Study|Death|1
930325|NCT00915018|3067994|P2|Overall Study|By Sponsor due to Protocol Amendment|105
930326|NCT00915018|3067995|P1|Overall Study|By Sponsor due to Protocol Amendment|92
930327|NCT00915018|3067994|P2|Overall Study|Withdrawal by Subject|27
930328|NCT00915018|3067995|P1|Overall Study|Withdrawal by Subject|38
930329|NCT00915018|3067994|P2|Overall Study|Lost to Follow-up|5
930330|NCT00915018|3067995|P1|Overall Study|Lost to Follow-up|10
930331|NCT00915018|3067994|P2|Overall Study|Death|70
930332|NCT00915018|3067995|P1|Overall Study|Death|75
930333|NCT00914966|3068009|P1|Step 2: 2000 Units|Withdrawal by Subject|1
930334|NCT00914966|3068009|P1|Step 1: 1500 Units|Physician Decision|1
930335|NCT00914966|3068009|P1|Step 1: 1500 Units|Withdrawal by Subject|1
930336|NCT00914927|3068028|P7|Overall Study|Administrative/Other|0
930337|NCT00914927|3068029|P6|Overall Study|Administrative/Other|0
930338|NCT00914927|3068030|P5|Overall Study|Administrative/Other|1
930339|NCT00914927|3068031|P4|Overall Study|Administrative/Other|0
930340|NCT00914927|3068032|P3|Overall Study|Administrative/Other|0
930341|NCT00914927|3068033|P2|Overall Study|Administrative/Other|1
930342|NCT00914927|3068034|P1|Overall Study|Administrative/Other|2
930343|NCT00914927|3068028|P7|Overall Study|Lost to Follow-up|0
930344|NCT00914927|3068029|P6|Overall Study|Lost to Follow-up|0
930345|NCT00914927|3068030|P5|Overall Study|Lost to Follow-up|0
930346|NCT00914927|3068031|P4|Overall Study|Lost to Follow-up|1
930347|NCT00914927|3068032|P3|Overall Study|Lost to Follow-up|0
930348|NCT00914927|3068033|P2|Overall Study|Lost to Follow-up|0
930349|NCT00914927|3068034|P1|Overall Study|Lost to Follow-up|0
930350|NCT00914927|3068028|P7|Overall Study|Withdrawal by Subject|0
930351|NCT00914927|3068029|P6|Overall Study|Withdrawal by Subject|0
930352|NCT00914927|3068030|P5|Overall Study|Withdrawal by Subject|0
930353|NCT00914927|3068031|P4|Overall Study|Withdrawal by Subject|1
930354|NCT00914927|3068032|P3|Overall Study|Withdrawal by Subject|0
930355|NCT00914927|3068033|P2|Overall Study|Withdrawal by Subject|1
930356|NCT00914927|3068034|P1|Overall Study|Withdrawal by Subject|0
930357|NCT00914927|3068028|P7|Overall Study|Adverse Event|0
930358|NCT00914927|3068029|P6|Overall Study|Adverse Event|0
930359|NCT00914927|3068030|P5|Overall Study|Adverse Event|1
930360|NCT00914927|3068031|P4|Overall Study|Adverse Event|0
930361|NCT00914927|3068032|P3|Overall Study|Adverse Event|0
930362|NCT00914927|3068033|P2|Overall Study|Adverse Event|0
930363|NCT00914927|3068034|P1|Overall Study|Adverse Event|0
930364|NCT00914849|3068161|P2|Overall Study|Not eligible|1
930365|NCT00914849|3068162|P1|Overall Study|Not eligible|0
930366|NCT00914849|3068161|P2|Overall Study|Withdrawal by Subject|0
930367|NCT00914849|3068162|P1|Overall Study|Withdrawal by Subject|1
930368|NCT00914810|3068196|P2|Overall Study|Hospitalized and unable to follow up.|1
930369|NCT00914810|3068197|P1|Overall Study|Hospitalized and unable to follow up.|0
930370|NCT00914810|3068196|P2|Overall Study|Relocated out of state|0
930371|NCT00914810|3068197|P1|Overall Study|Relocated out of state|1
930372|NCT00914810|3068196|P2|Overall Study|Withdrawal by Subject|0
930373|NCT00914810|3068197|P1|Overall Study|Withdrawal by Subject|1
930374|NCT00914589|3068208|P3|Overall Study|Death|1
930375|NCT00914589|3068209|P2|Overall Study|Death|1
930376|NCT00914589|3068210|P1|Overall Study|Death|0
930377|NCT00914589|3068208|P3|Overall Study|unclassified|7
930378|NCT00914589|3068209|P2|Overall Study|unclassified|9
930379|NCT00914589|3068210|P1|Overall Study|unclassified|16
930380|NCT00914589|3068208|P3|Overall Study|Protocol Violation|3
930381|NCT00914589|3068209|P2|Overall Study|Protocol Violation|6
930382|NCT00914589|3068210|P1|Overall Study|Protocol Violation|8
930383|NCT00914589|3068208|P3|Overall Study|Adverse Event|1
930384|NCT00914589|3068209|P2|Overall Study|Adverse Event|0
930385|NCT00914589|3068210|P1|Overall Study|Adverse Event|1
930386|NCT00914459|3068236|P2|Overall Study|Parent/Legal guardian request|0
930387|NCT00914459|3068237|P1|Overall Study|Parent/Legal guardian request|1
930388|NCT00914459|3068236|P2|Overall Study|Protocol Violation|1
930389|NCT00914459|3068237|P1|Overall Study|Protocol Violation|0
930390|NCT00914316|3068267|P4|Phase 2|Withdrawal by Subject|0
930391|NCT00914316|3068268|P3|Phase 2|Withdrawal by Subject|1
930392|NCT00914316|3068269|P2|Phase 2|Withdrawal by Subject|0
930393|NCT00914316|3068270|P1|Phase 2|Withdrawal by Subject|1
930394|NCT00914316|3068267|P4|Phase 1|Adverse Event|0
930395|NCT00914316|3068268|P3|Phase 1|Adverse Event|0
930396|NCT00914316|3068269|P2|Phase 1|Adverse Event|0
930397|NCT00914316|3068270|P1|Phase 1|Adverse Event|1
930398|NCT00914316|3068267|P4|Phase 1|Withdrawal by Subject|0
930399|NCT00914316|3068268|P3|Phase 1|Withdrawal by Subject|4
930400|NCT00914316|3068269|P2|Phase 1|Withdrawal by Subject|2
930401|NCT00914316|3068270|P1|Phase 1|Withdrawal by Subject|0
930402|NCT00914316|3068267|P4|Phase 1|Physician Decision|2
930403|NCT00914316|3068268|P3|Phase 1|Physician Decision|1
930404|NCT00914316|3068269|P2|Phase 1|Physician Decision|0
930405|NCT00914316|3068270|P1|Phase 1|Physician Decision|4
930406|NCT00913835|3068349|P2|Lip Dox: Olaratumab Monotherapy|Not Specified|3
930407|NCT00913835|3068350|P1|Lip Dox: Olaratumab Monotherapy|Not Specified|0
930408|NCT00913835|3068349|P2|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
930409|NCT00913835|3068350|P1|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
930410|NCT00913835|3068349|P2|Olara+Lip Dox and Lip Dox Monotherapy|Not Specified|3
930411|NCT00913835|3068350|P1|Olara+Lip Dox and Lip Dox Monotherapy|Not Specified|4
930412|NCT00913835|3068349|P2|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0
930413|NCT00913835|3068350|P1|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1
930414|NCT00913835|3068349|P2|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3
930415|NCT00913835|3068350|P1|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2
930416|NCT00913770|3068389|P3|Overall Study|Refused|8
930417|NCT00913770|3068390|P2|Overall Study|Refused|10
930418|NCT00913770|3068391|P1|Overall Study|Refused|11
930419|NCT00913770|3068389|P3|Overall Study|Unable to contact|13
930420|NCT00913770|3068390|P2|Overall Study|Unable to contact|19
930421|NCT00913770|3068391|P1|Overall Study|Unable to contact|24
930422|NCT00913744|3068404|P2|Overall Study|Death|0
930423|NCT00913744|3068405|P1|Overall Study|Death|1
930424|NCT00913744|3068404|P2|Overall Study|Withdrawal by Subject|1
930425|NCT00913744|3068405|P1|Overall Study|Withdrawal by Subject|2
930426|NCT00913744|3068404|P2|Overall Study|Adverse Event|0
930427|NCT00913744|3068405|P1|Overall Study|Adverse Event|2
930428|NCT00913692|3068411|P1|Treatment Phase 1 (5 Months)|Physician Decision|1
930429|NCT00913692|3068411|P1|Screening (4 Months)|Not eligible after screening phase.|6
930430|NCT00913692|3068411|P1|Screening (4 Months)|Physician Decision|3
930431|NCT00913523|3068505|P3|Overall Study|Inadequate Number of Tampons Used|3
930432|NCT00913523|3068506|P2|Overall Study|Inadequate Number of Tampons Used|2
930433|NCT00913523|3068507|P1|Overall Study|Inadequate Number of Tampons Used|7
930434|NCT00913523|3068505|P3|Overall Study|Pregnancy|0
930435|NCT00913523|3068506|P2|Overall Study|Pregnancy|3
930436|NCT00913523|3068507|P1|Overall Study|Pregnancy|1
930437|NCT00913523|3068505|P3|Overall Study|Protocol Violation|8
930438|NCT00913523|3068506|P2|Overall Study|Protocol Violation|8
930439|NCT00913523|3068507|P1|Overall Study|Protocol Violation|5
930440|NCT00913523|3068505|P3|Overall Study|Adverse Event|0
930441|NCT00913523|3068506|P2|Overall Study|Adverse Event|0
930442|NCT00913523|3068507|P1|Overall Study|Adverse Event|1
930443|NCT00913523|3068505|P3|Overall Study|Lost to Follow-up|1
930444|NCT00913523|3068506|P2|Overall Study|Lost to Follow-up|1
930445|NCT00913523|3068507|P1|Overall Study|Lost to Follow-up|1
930446|NCT00913523|3068505|P3|Overall Study|Withdrawal by Subject|2
930447|NCT00913523|3068506|P2|Overall Study|Withdrawal by Subject|2
930448|NCT00913523|3068507|P1|Overall Study|Withdrawal by Subject|3
930449|NCT00913458|3068539|P7|Phase 3|Unsatisfactory Response per Investigator|4
930450|NCT00913458|3068540|P6|Phase 3|Unsatisfactory Response per Investigator|11
930451|NCT00913458|3068541|P5|Phase 3|Unsatisfactory Response per Investigator|14
930452|NCT00913458|3068542|P4|Phase 3|Unsatisfactory Response per Investigator|0
930453|NCT00913458|3068543|P3|Phase 3|Unsatisfactory Response per Investigator|0
930454|NCT00913458|3068544|P2|Phase 3|Unsatisfactory Response per Investigator|0
930455|NCT00913458|3068545|P1|Phase 3|Unsatisfactory Response per Investigator|0
930456|NCT00913458|3068539|P7|Phase 3|Withdrawal by Subject|0
930457|NCT00913458|3068540|P6|Phase 3|Withdrawal by Subject|2
930458|NCT00913458|3068541|P5|Phase 3|Withdrawal by Subject|1
930459|NCT00913458|3068542|P4|Phase 3|Withdrawal by Subject|0
930460|NCT00913458|3068543|P3|Phase 3|Withdrawal by Subject|0
930461|NCT00913458|3068544|P2|Phase 3|Withdrawal by Subject|0
930462|NCT00913458|3068545|P1|Phase 3|Withdrawal by Subject|0
930463|NCT00913458|3068539|P7|Phase 3|Non-Responder|3
930464|NCT00913458|3068540|P6|Phase 3|Non-Responder|1
930465|NCT00913458|3068541|P5|Phase 3|Non-Responder|0
930466|NCT00913458|3068542|P4|Phase 3|Non-Responder|0
930467|NCT00913458|3068543|P3|Phase 3|Non-Responder|0
930468|NCT00913458|3068544|P2|Phase 3|Non-Responder|0
930469|NCT00913458|3068545|P1|Phase 3|Non-Responder|0
930470|NCT00913458|3068539|P7|Phase 3|Lost to Follow-up|0
930471|NCT00913458|3068540|P6|Phase 3|Lost to Follow-up|0
930472|NCT00913458|3068541|P5|Phase 3|Lost to Follow-up|2
930473|NCT00913458|3068542|P4|Phase 3|Lost to Follow-up|0
930474|NCT00913458|3068543|P3|Phase 3|Lost to Follow-up|0
930475|NCT00913458|3068544|P2|Phase 3|Lost to Follow-up|0
930476|NCT00913458|3068545|P1|Phase 3|Lost to Follow-up|0
930477|NCT00913458|3068539|P7|Phase 3|Adverse Event|1
930478|NCT00913458|3068540|P6|Phase 3|Adverse Event|4
930479|NCT00913458|3068541|P5|Phase 3|Adverse Event|5
930480|NCT00913458|3068542|P4|Phase 3|Adverse Event|0
930481|NCT00913458|3068543|P3|Phase 3|Adverse Event|0
930482|NCT00913458|3068544|P2|Phase 3|Adverse Event|0
930483|NCT00913458|3068545|P1|Phase 3|Adverse Event|0
930484|NCT00913458|3068539|P7|Phase 2|Unsatisfactory Response per Investigator|0
930485|NCT00913458|3068540|P6|Phase 2|Unsatisfactory Response per Investigator|0
930486|NCT00913458|3068541|P5|Phase 2|Unsatisfactory Response per Investigator|0
930487|NCT00913458|3068542|P4|Phase 2|Unsatisfactory Response per Investigator|17
930488|NCT00913458|3068543|P3|Phase 2|Unsatisfactory Response per Investigator|11
930489|NCT00913458|3068544|P2|Phase 2|Unsatisfactory Response per Investigator|0
930490|NCT00913458|3068545|P1|Phase 2|Unsatisfactory Response per Investigator|0
930491|NCT00913458|3068539|P7|Phase 2|Protocol Violation|0
930492|NCT00913458|3068540|P6|Phase 2|Protocol Violation|0
930493|NCT00913458|3068541|P5|Phase 2|Protocol Violation|0
930494|NCT00913458|3068542|P4|Phase 2|Protocol Violation|0
930495|NCT00913458|3068543|P3|Phase 2|Protocol Violation|0
930496|NCT00913458|3068544|P2|Phase 2|Protocol Violation|2
930497|NCT00913458|3068545|P1|Phase 2|Protocol Violation|0
930498|NCT00913458|3068539|P7|Phase 2|Lost to Follow-up|0
930499|NCT00913458|3068540|P6|Phase 2|Lost to Follow-up|0
930500|NCT00913458|3068541|P5|Phase 2|Lost to Follow-up|0
930501|NCT00913458|3068542|P4|Phase 2|Lost to Follow-up|1
930502|NCT00913458|3068543|P3|Phase 2|Lost to Follow-up|0
930503|NCT00913458|3068544|P2|Phase 2|Lost to Follow-up|0
930504|NCT00913458|3068545|P1|Phase 2|Lost to Follow-up|0
930505|NCT00913458|3068539|P7|Phase 2|Adverse Event|0
930506|NCT00913458|3068540|P6|Phase 2|Adverse Event|0
930507|NCT00913458|3068541|P5|Phase 2|Adverse Event|0
930508|NCT00913458|3068542|P4|Phase 2|Adverse Event|1
930509|NCT00913458|3068543|P3|Phase 2|Adverse Event|0
930510|NCT00913458|3068544|P2|Phase 2|Adverse Event|3
930511|NCT00913458|3068545|P1|Phase 2|Adverse Event|0
930512|NCT00913458|3068539|P7|Phase 2|Subject Request|0
930513|NCT00913458|3068540|P6|Phase 2|Subject Request|0
930514|NCT00913458|3068541|P5|Phase 2|Subject Request|0
930515|NCT00913458|3068542|P4|Phase 2|Subject Request|2
930516|NCT00913458|3068543|P3|Phase 2|Subject Request|1
930517|NCT00913458|3068544|P2|Phase 2|Subject Request|0
930518|NCT00913458|3068545|P1|Phase 2|Subject Request|0
930519|NCT00913458|3068539|P7|Phase 2|Non-Responder|0
930520|NCT00913458|3068540|P6|Phase 2|Non-Responder|0
930521|NCT00913458|3068541|P5|Phase 2|Non-Responder|0
930522|NCT00913458|3068542|P4|Phase 2|Non-Responder|12
930523|NCT00913458|3068543|P3|Phase 2|Non-Responder|7
930524|NCT00913458|3068544|P2|Phase 2|Non-Responder|5
930525|NCT00913458|3068545|P1|Phase 2|Non-Responder|0
930526|NCT00913458|3068539|P7|Phase 1|Unsatisfactory Response per Investigator|0
930527|NCT00913458|3068540|P6|Phase 1|Unsatisfactory Response per Investigator|0
930528|NCT00913458|3068541|P5|Phase 1|Unsatisfactory Response per Investigator|0
930529|NCT00913458|3068542|P4|Phase 1|Unsatisfactory Response per Investigator|0
930530|NCT00913458|3068543|P3|Phase 1|Unsatisfactory Response per Investigator|0
930531|NCT00913458|3068544|P2|Phase 1|Unsatisfactory Response per Investigator|0
930532|NCT00913458|3068545|P1|Phase 1|Unsatisfactory Response per Investigator|7
930533|NCT00913458|3068539|P7|Phase 1|Sponsor|0
930534|NCT00913458|3068540|P6|Phase 1|Sponsor|0
930535|NCT00913458|3068541|P5|Phase 1|Sponsor|0
930536|NCT00913458|3068542|P4|Phase 1|Sponsor|0
930537|NCT00913458|3068543|P3|Phase 1|Sponsor|0
930538|NCT00913458|3068544|P2|Phase 1|Sponsor|0
930539|NCT00913458|3068545|P1|Phase 1|Sponsor|2
930540|NCT00913458|3068539|P7|Phase 1|Protocol Violation|0
930541|NCT00913458|3068540|P6|Phase 1|Protocol Violation|0
930542|NCT00913458|3068541|P5|Phase 1|Protocol Violation|0
930543|NCT00913458|3068542|P4|Phase 1|Protocol Violation|0
930544|NCT00913458|3068543|P3|Phase 1|Protocol Violation|0
930545|NCT00913458|3068544|P2|Phase 1|Protocol Violation|0
930546|NCT00913458|3068545|P1|Phase 1|Protocol Violation|10
930547|NCT00913458|3068539|P7|Phase 1|Lost to Follow-up|0
930548|NCT00913458|3068540|P6|Phase 1|Lost to Follow-up|0
930549|NCT00913458|3068541|P5|Phase 1|Lost to Follow-up|0
930550|NCT00913458|3068542|P4|Phase 1|Lost to Follow-up|0
930551|NCT00913458|3068543|P3|Phase 1|Lost to Follow-up|0
930552|NCT00913458|3068544|P2|Phase 1|Lost to Follow-up|0
930553|NCT00913458|3068545|P1|Phase 1|Lost to Follow-up|2
930554|NCT00913458|3068539|P7|Phase 1|Adverse Event|0
930555|NCT00913458|3068540|P6|Phase 1|Adverse Event|0
930556|NCT00913458|3068541|P5|Phase 1|Adverse Event|0
930557|NCT00913458|3068542|P4|Phase 1|Adverse Event|0
930558|NCT00913458|3068543|P3|Phase 1|Adverse Event|0
930559|NCT00913458|3068544|P2|Phase 1|Adverse Event|0
930560|NCT00913458|3068545|P1|Phase 1|Adverse Event|20
930561|NCT00913458|3068539|P7|Phase 1|Subject Request|0
930562|NCT00913458|3068540|P6|Phase 1|Subject Request|0
930563|NCT00913458|3068541|P5|Phase 1|Subject Request|0
930564|NCT00913458|3068542|P4|Phase 1|Subject Request|0
930565|NCT00913458|3068543|P3|Phase 1|Subject Request|0
930566|NCT00913458|3068544|P2|Phase 1|Subject Request|0
930567|NCT00913458|3068545|P1|Phase 1|Subject Request|17
930568|NCT00913458|3068539|P7|Phase 1|Non-Responder|0
930569|NCT00913458|3068540|P6|Phase 1|Non-Responder|0
930570|NCT00913458|3068541|P5|Phase 1|Non-Responder|0
930571|NCT00913458|3068542|P4|Phase 1|Non-Responder|0
930572|NCT00913458|3068543|P3|Phase 1|Non-Responder|0
930573|NCT00913458|3068544|P2|Phase 1|Non-Responder|0
930574|NCT00913458|3068545|P1|Phase 1|Non-Responder|54
930575|NCT00913380|3068638|P2|Clinical Outcomes|Lost to Follow-up|6
930576|NCT00913380|3068639|P1|Clinical Outcomes|Lost to Follow-up|6
930577|NCT00912964|3068705|P3|Overall Study|Randomized but never received study drug|0
930578|NCT00912964|3068706|P2|Overall Study|Randomized but never received study drug|1
930579|NCT00912964|3068707|P1|Overall Study|Randomized but never received study drug|0
930580|NCT00912964|3068705|P3|Overall Study|Violation of exclusion criterion|2
930581|NCT00912964|3068706|P2|Overall Study|Violation of exclusion criterion|0
930582|NCT00912964|3068707|P1|Overall Study|Violation of exclusion criterion|0
930583|NCT00912964|3068705|P3|Overall Study|Non-compliance with study procedures|0
930584|NCT00912964|3068706|P2|Overall Study|Non-compliance with study procedures|0
930585|NCT00912964|3068707|P1|Overall Study|Non-compliance with study procedures|2
930586|NCT00912964|3068705|P3|Overall Study|Medical History|0
930587|NCT00912964|3068706|P2|Overall Study|Medical History|0
930588|NCT00912964|3068707|P1|Overall Study|Medical History|1
930589|NCT00912964|3068705|P3|Overall Study|Taking exclusionary medications|8
930590|NCT00912964|3068706|P2|Overall Study|Taking exclusionary medications|4
930591|NCT00912964|3068707|P1|Overall Study|Taking exclusionary medications|7
930592|NCT00912964|3068705|P3|Overall Study|Protocol Violation|8
930593|NCT00912964|3068706|P2|Overall Study|Protocol Violation|3
930594|NCT00912964|3068707|P1|Overall Study|Protocol Violation|5
930595|NCT00912964|3068705|P3|Overall Study|Lost to Follow-up|3
930596|NCT00912964|3068706|P2|Overall Study|Lost to Follow-up|3
930597|NCT00912964|3068707|P1|Overall Study|Lost to Follow-up|4
930598|NCT00912964|3068705|P3|Overall Study|Withdrawal by Subject|18
930599|NCT00912964|3068706|P2|Overall Study|Withdrawal by Subject|12
930600|NCT00912964|3068707|P1|Overall Study|Withdrawal by Subject|20
930601|NCT00912964|3068705|P3|Overall Study|Lack of Efficacy|3
930602|NCT00912964|3068706|P2|Overall Study|Lack of Efficacy|4
930603|NCT00912964|3068707|P1|Overall Study|Lack of Efficacy|11
930604|NCT00912964|3068705|P3|Overall Study|Adverse Event|12
930605|NCT00912964|3068706|P2|Overall Study|Adverse Event|18
930606|NCT00912964|3068707|P1|Overall Study|Adverse Event|15
930607|NCT00912964|3068705|P3|Overall Study|Eligibility criterion not met|0
930608|NCT00912964|3068706|P2|Overall Study|Eligibility criterion not met|1
930609|NCT00912964|3068707|P1|Overall Study|Eligibility criterion not met|1
930610|NCT00912912|3068850|P1|Overall Study|Disease Progression|3
930611|NCT00912912|3068850|P1|Overall Study|Withdrawal by Subject|1
930612|NCT00912808|3068856|P2|Second Intervention (6 Weeks)|Withdrawal by Subject|0
930613|NCT00912808|3068857|P1|Second Intervention (6 Weeks)|Withdrawal by Subject|1
930614|NCT00912808|3068856|P2|Second Intervention (6 Weeks)|Adverse Event|1
930615|NCT00912808|3068857|P1|Second Intervention (6 Weeks)|Adverse Event|0
930616|NCT00912808|3068856|P2|Washout|Withdrawal by Subject|1
930617|NCT00912808|3068857|P1|Washout|Withdrawal by Subject|0
930618|NCT00912808|3068856|P2|First Intervention (6 Weeks)|Adverse Event|1
930619|NCT00912808|3068857|P1|First Intervention (6 Weeks)|Adverse Event|2
930620|NCT00912782|3068882|P2|Overall Study|Relocated before study completion|1
930621|NCT00912782|3068883|P1|Overall Study|Relocated before study completion|0
930622|NCT00912782|3068882|P2|Overall Study|Did not receive vascular access type|2
930623|NCT00912782|3068883|P1|Overall Study|Did not receive vascular access type|1
930624|NCT00912782|3068882|P2|Overall Study|Lost to Follow-up|1
930625|NCT00912782|3068883|P1|Overall Study|Lost to Follow-up|0
930626|NCT00912782|3068882|P2|Overall Study|Death|1
930627|NCT00912782|3068883|P1|Overall Study|Death|2
930628|NCT00912743|3068893|P2|Overall Study|End of treatment form was not collected|0
930629|NCT00912743|3068894|P1|Overall Study|End of treatment form was not collected|1
930630|NCT00912743|3068893|P2|Overall Study|Toxicity|1
930631|NCT00912743|3068894|P1|Overall Study|Toxicity|0
930632|NCT00912743|3068893|P2|Overall Study|Lack of Efficacy|18
930633|NCT00912743|3068894|P1|Overall Study|Lack of Efficacy|9
930634|NCT00912743|3068893|P2|Overall Study|Adverse Event|1
930635|NCT00912743|3068894|P1|Overall Study|Adverse Event|3
930636|NCT00912509|3068906|P2|Overall Study|Lack of Efficacy|3
930637|NCT00912509|3068907|P1|Overall Study|Lack of Efficacy|4
930638|NCT00912509|3068906|P2|Overall Study|Lost to Follow-up|0
930639|NCT00912509|3068907|P1|Overall Study|Lost to Follow-up|1
930640|NCT00912405|3068915|P1|Overall Study|Lost to Follow-up|5
930641|NCT00912288|3068949|P2|Overall Study|Other|0
930642|NCT00912288|3068950|P1|Overall Study|Other|1
930643|NCT00912288|3068949|P2|Overall Study|Study terminated by sponsor|35
930644|NCT00912288|3068950|P1|Overall Study|Study terminated by sponsor|34
930645|NCT00912288|3068949|P2|Overall Study|Withdrawal by Subject|3
930646|NCT00912288|3068950|P1|Overall Study|Withdrawal by Subject|3
930647|NCT00912288|3068949|P2|Overall Study|Protocol Violation|0
930648|NCT00912288|3068950|P1|Overall Study|Protocol Violation|1
930649|NCT00912288|3068949|P2|Overall Study|Lost to Follow-up|0
930650|NCT00912288|3068950|P1|Overall Study|Lost to Follow-up|1
930651|NCT00912288|3068949|P2|Overall Study|Adverse Event|1
930652|NCT00912288|3068950|P1|Overall Study|Adverse Event|1
930653|NCT00912288|3068949|P2|Overall Study|Death|1
930654|NCT00912288|3068950|P1|Overall Study|Death|0
930655|NCT00912223|3068972|P1|Overall Study|Transformed disease|1
930656|NCT00912223|3068972|P1|Overall Study|Not transplanted|1
930657|NCT00912223|3068972|P1|Overall Study|Withdrawal by Subject|1
930658|NCT00912093|3069003|P5|The Controlled Phase|Lost to Follow-up|1
930659|NCT00912093|3069004|P4|The Controlled Phase|Lost to Follow-up|0
930660|NCT00912093|3069005|P3|The Controlled Phase|Lost to Follow-up|0
930661|NCT00912093|3069006|P2|The Controlled Phase|Lost to Follow-up|0
930662|NCT00912093|3069007|P1|The Controlled Phase|Lost to Follow-up|0
930663|NCT00912093|3069003|P5|The Controlled Phase|Medical Condition|0
930664|NCT00912093|3069004|P4|The Controlled Phase|Medical Condition|0
930665|NCT00912093|3069005|P3|The Controlled Phase|Medical Condition|0
930666|NCT00912093|3069006|P2|The Controlled Phase|Medical Condition|1
930667|NCT00912093|3069007|P1|The Controlled Phase|Medical Condition|0
930668|NCT00912093|3069003|P5|The Controlled Phase|Death|0
930669|NCT00912093|3069004|P4|The Controlled Phase|Death|0
930670|NCT00912093|3069005|P3|The Controlled Phase|Death|0
930671|NCT00912093|3069006|P2|The Controlled Phase|Death|1
930672|NCT00912093|3069007|P1|The Controlled Phase|Death|0
930673|NCT00912028|3069026|P5|Overall Study|Withdrawal by Subject|0
930674|NCT00912028|3069027|P4|Overall Study|Withdrawal by Subject|0
930675|NCT00912028|3069028|P3|Overall Study|Withdrawal by Subject|0
930676|NCT00912028|3069029|P2|Overall Study|Withdrawal by Subject|0
930677|NCT00912028|3069030|P1|Overall Study|Withdrawal by Subject|3
930678|NCT00912028|3069026|P5|Overall Study|Lost to Follow-up|3
930679|NCT00912028|3069027|P4|Overall Study|Lost to Follow-up|1
930680|NCT00912028|3069028|P3|Overall Study|Lost to Follow-up|0
930681|NCT00912028|3069029|P2|Overall Study|Lost to Follow-up|3
930682|NCT00912028|3069030|P1|Overall Study|Lost to Follow-up|2
930683|NCT00912015|3069059|P4|Overall Study|Adverse Event|1
930684|NCT00912015|3069060|P3|Overall Study|Adverse Event|0
930685|NCT00912015|3069061|P2|Overall Study|Adverse Event|0
930686|NCT00912015|3069062|P1|Overall Study|Adverse Event|6
930687|NCT00912015|3069059|P4|Overall Study|Protocol Violation|1
930688|NCT00912015|3069060|P3|Overall Study|Protocol Violation|0
930689|NCT00912015|3069061|P2|Overall Study|Protocol Violation|0
930690|NCT00912015|3069062|P1|Overall Study|Protocol Violation|1
930691|NCT00912015|3069059|P4|Overall Study|Withdrawal by Subject|0
930692|NCT00912015|3069060|P3|Overall Study|Withdrawal by Subject|3
930693|NCT00912015|3069061|P2|Overall Study|Withdrawal by Subject|8
930694|NCT00912015|3069062|P1|Overall Study|Withdrawal by Subject|8
930695|NCT00912015|3069059|P4|Overall Study|Lack of Efficacy|0
930696|NCT00912015|3069060|P3|Overall Study|Lack of Efficacy|0
930697|NCT00912015|3069061|P2|Overall Study|Lack of Efficacy|0
930698|NCT00912015|3069062|P1|Overall Study|Lack of Efficacy|1
930699|NCT00911989|3069078|P1|Overall Study|Adverse Event|1
930700|NCT00911937|3069084|P2|Overall Study|Other|5
930701|NCT00911937|3069085|P1|Overall Study|Other|9
930702|NCT00911937|3069084|P2|Overall Study|Randomized but not treated|13
930703|NCT00911937|3069085|P1|Overall Study|Randomized but not treated|13
930704|NCT00911937|3069084|P2|Overall Study|Protocol Violation|23
930705|NCT00911937|3069085|P1|Overall Study|Protocol Violation|14
930706|NCT00911937|3069084|P2|Overall Study|Did not meet inclusion criteria|11
930707|NCT00911937|3069085|P1|Overall Study|Did not meet inclusion criteria|9
930708|NCT00911937|3069084|P2|Overall Study|Lack of Efficacy|6
930709|NCT00911937|3069085|P1|Overall Study|Lack of Efficacy|11
930710|NCT00911937|3069084|P2|Overall Study|Adverse Event|25
930711|NCT00911937|3069085|P1|Overall Study|Adverse Event|11
930712|NCT00911937|3069084|P2|Overall Study|Withdrawn due to pregnancy|0
930713|NCT00911937|3069085|P1|Overall Study|Withdrawn due to pregnancy|1
930714|NCT00911937|3069084|P2|Overall Study|Withdrawal by Subject|7
930715|NCT00911937|3069085|P1|Overall Study|Withdrawal by Subject|10
930716|NCT00911937|3069084|P2|Overall Study|Lost to Follow-up|5
930717|NCT00911937|3069085|P1|Overall Study|Lost to Follow-up|8
930718|NCT00911937|3069084|P2|Overall Study|Death|0
930719|NCT00911937|3069085|P1|Overall Study|Death|1
930720|NCT00911859|3069152|P3|Follow-up Period|Study terminated by sponsor|27
930721|NCT00911859|3069153|P2|Follow-up Period|Study terminated by sponsor|33
930722|NCT00911859|3069154|P1|Follow-up Period|Study terminated by sponsor|5
930723|NCT00911859|3069152|P3|Follow-up Period|Withdrawal by Subject|4
930724|NCT00911859|3069153|P2|Follow-up Period|Withdrawal by Subject|4
930725|NCT00911859|3069154|P1|Follow-up Period|Withdrawal by Subject|0
930726|NCT00911859|3069152|P3|Follow-up Period|Lost to Follow-up|0
930727|NCT00911859|3069153|P2|Follow-up Period|Lost to Follow-up|1
930728|NCT00911859|3069154|P1|Follow-up Period|Lost to Follow-up|1
930729|NCT00911859|3069152|P3|Follow-up Period|Death|10
930730|NCT00911859|3069153|P2|Follow-up Period|Death|8
930731|NCT00911859|3069154|P1|Follow-up Period|Death|5
930732|NCT00911859|3069152|P3|Maintainance Period|Withdrawal by Subject|3
930733|NCT00911859|3069153|P2|Maintainance Period|Withdrawal by Subject|0
930734|NCT00911859|3069154|P1|Maintainance Period|Withdrawal by Subject|0
930735|NCT00911859|3069152|P3|Maintainance Period|Physician Decision|9
930736|NCT00911859|3069153|P2|Maintainance Period|Physician Decision|0
930737|NCT00911859|3069154|P1|Maintainance Period|Physician Decision|0
930738|NCT00911859|3069152|P3|Maintainance Period|Lack of Efficacy|9
930739|NCT00911859|3069153|P2|Maintainance Period|Lack of Efficacy|0
930740|NCT00911859|3069154|P1|Maintainance Period|Lack of Efficacy|0
930741|NCT00911859|3069152|P3|Treatment Period|Did not receive study treatment|0
930742|NCT00911859|3069153|P2|Treatment Period|Did not receive study treatment|1
930743|NCT00911859|3069154|P1|Treatment Period|Did not receive study treatment|0
930744|NCT00911859|3069152|P3|Treatment Period|Withdrawal by Subject|5
930745|NCT00911859|3069153|P2|Treatment Period|Withdrawal by Subject|4
930746|NCT00911859|3069154|P1|Treatment Period|Withdrawal by Subject|0
930747|NCT00911859|3069152|P3|Treatment Period|Physician Decision|3
930748|NCT00911859|3069153|P2|Treatment Period|Physician Decision|3
930749|NCT00911859|3069154|P1|Treatment Period|Physician Decision|3
930750|NCT00911859|3069152|P3|Treatment Period|Lack of Efficacy|5
930751|NCT00911859|3069153|P2|Treatment Period|Lack of Efficacy|7
930752|NCT00911859|3069154|P1|Treatment Period|Lack of Efficacy|1
930753|NCT00911859|3069152|P3|Treatment Period|Death|5
930754|NCT00911859|3069153|P2|Treatment Period|Death|3
930755|NCT00911859|3069154|P1|Treatment Period|Death|1
930756|NCT00911859|3069152|P3|Treatment Period|Adverse Event|7
930757|NCT00911859|3069153|P2|Treatment Period|Adverse Event|3
930758|NCT00911859|3069154|P1|Treatment Period|Adverse Event|3
930759|NCT00911820|3069180|P2|Overall Study|Withdraw before Receive Treatment|2
930760|NCT00911820|3069181|P1|Overall Study|Withdraw before Receive Treatment|0
930761|NCT00911820|3069180|P2|Overall Study|Pathology Not Confirmed|0
930762|NCT00911820|3069181|P1|Overall Study|Pathology Not Confirmed|1
930763|NCT00911820|3069180|P2|Overall Study|Still on Therapy|2
930764|NCT00911820|3069181|P1|Overall Study|Still on Therapy|2
930765|NCT00911820|3069180|P2|Overall Study|Pursue Radiation|0
930766|NCT00911820|3069181|P1|Overall Study|Pursue Radiation|1
930767|NCT00911820|3069180|P2|Overall Study|Pursue surgery|1
930768|NCT00911820|3069181|P1|Overall Study|Pursue surgery|1
930769|NCT00911820|3069180|P2|Overall Study|Death|2
930770|NCT00911820|3069181|P1|Overall Study|Death|1
930771|NCT00911820|3069180|P2|Overall Study|Withdrawal by Subject|4
930772|NCT00911820|3069181|P1|Overall Study|Withdrawal by Subject|3
930773|NCT00911820|3069180|P2|Overall Study|Decline in Performance Status|2
930774|NCT00911820|3069181|P1|Overall Study|Decline in Performance Status|4
930775|NCT00911820|3069180|P2|Overall Study|Physician Decision|9
930776|NCT00911820|3069181|P1|Overall Study|Physician Decision|5
930777|NCT00911820|3069180|P2|Overall Study|Clinical Progression|5
930778|NCT00911820|3069181|P1|Overall Study|Clinical Progression|7
930779|NCT00911820|3069180|P2|Overall Study|Adverse Event|8
930780|NCT00911820|3069181|P1|Overall Study|Adverse Event|8
930781|NCT00911820|3069180|P2|Overall Study|RECIST progression|8
930782|NCT00911820|3069181|P1|Overall Study|RECIST progression|12
930783|NCT00911807|3069198|P3|Overall Study|Organizational reasons|1
930784|NCT00911807|3069199|P2|Overall Study|Organizational reasons|3
930785|NCT00911807|3069200|P1|Overall Study|Organizational reasons|1
930786|NCT00911807|3069198|P3|Overall Study|Withdrawal by Subject|7
930787|NCT00911807|3069199|P2|Overall Study|Withdrawal by Subject|10
930788|NCT00911807|3069200|P1|Overall Study|Withdrawal by Subject|8
930789|NCT00911807|3069198|P3|Overall Study|Protocol Violation|9
930790|NCT00911807|3069199|P2|Overall Study|Protocol Violation|4
930791|NCT00911807|3069200|P1|Overall Study|Protocol Violation|6
930792|NCT00911807|3069198|P3|Overall Study|Death|1
930793|NCT00911807|3069199|P2|Overall Study|Death|0
930794|NCT00911807|3069200|P1|Overall Study|Death|0
930795|NCT00911807|3069198|P3|Overall Study|Adverse Event|5
930796|NCT00911807|3069199|P2|Overall Study|Adverse Event|1
930797|NCT00911807|3069200|P1|Overall Study|Adverse Event|2
930798|NCT00911768|3069210|P2|Overall Study|Withdrawal by Subject|0
930799|NCT00911768|3069211|P1|Overall Study|Withdrawal by Subject|1
930800|NCT00911768|3069210|P2|Overall Study|Protocol Violation|4
930801|NCT00911768|3069211|P1|Overall Study|Protocol Violation|5
930802|NCT00911625|3069240|P2|Overall Study|Lost to Follow-up|0
930803|NCT00911625|3069241|P1|Overall Study|Lost to Follow-up|7
930804|NCT00911547|3069270|P4|Overall Study|Withdrawal by Subject|8
930805|NCT00911547|3069271|P3|Overall Study|Withdrawal by Subject|4
930806|NCT00911547|3069272|P2|Overall Study|Withdrawal by Subject|10
930807|NCT00911547|3069273|P1|Overall Study|Withdrawal by Subject|3
930808|NCT00911547|3069270|P4|Overall Study|Protocol Violation|1
930809|NCT00911547|3069271|P3|Overall Study|Protocol Violation|5
930810|NCT00911547|3069272|P2|Overall Study|Protocol Violation|5
930811|NCT00911547|3069273|P1|Overall Study|Protocol Violation|0
930812|NCT00911547|3069270|P4|Overall Study|Lost to Follow-up|1
930813|NCT00911547|3069271|P3|Overall Study|Lost to Follow-up|2
930814|NCT00911547|3069272|P2|Overall Study|Lost to Follow-up|0
930815|NCT00911547|3069273|P1|Overall Study|Lost to Follow-up|0
930816|NCT00911547|3069270|P4|Overall Study|Adverse Event|6
930817|NCT00911547|3069271|P3|Overall Study|Adverse Event|11
930818|NCT00911547|3069272|P2|Overall Study|Adverse Event|27
930819|NCT00911547|3069273|P1|Overall Study|Adverse Event|8
930820|NCT00911534|3069301|P2|Overall Study|Not specified|2
930821|NCT00911534|3069302|P1|Overall Study|Not specified|2
930822|NCT00911534|3069301|P2|Overall Study|Withdrawal of consent|4
930823|NCT00911534|3069302|P1|Overall Study|Withdrawal of consent|1
930824|NCT00911534|3069301|P2|Overall Study|Lack of Efficacy|1
930825|NCT00911534|3069302|P1|Overall Study|Lack of Efficacy|4
930826|NCT00911534|3069301|P2|Overall Study|Withdrawal by Subject|1
930827|NCT00911534|3069302|P1|Overall Study|Withdrawal by Subject|2
930828|NCT00911534|3069301|P2|Overall Study|Lost to Follow-up|4
930829|NCT00911534|3069302|P1|Overall Study|Lost to Follow-up|2
930830|NCT00911534|3069301|P2|Overall Study|Adverse Event|4
930831|NCT00911534|3069302|P1|Overall Study|Adverse Event|4
930832|NCT00911300|3069357|P2|Overall Study|Randomized; No Study Medication Received|2
930833|NCT00911300|3069358|P1|Overall Study|Randomized; No Study Medication Received|0
930834|NCT00911300|3069357|P2|Overall Study|Treatment Stopped by Mistake|1
930835|NCT00911300|3069358|P1|Overall Study|Treatment Stopped by Mistake|0
930836|NCT00911300|3069357|P2|Overall Study|Physician Decision|1
930837|NCT00911300|3069358|P1|Overall Study|Physician Decision|0
930838|NCT00911300|3069357|P2|Overall Study|Underlying Disease (Myocarditis)|1
930839|NCT00911300|3069358|P1|Overall Study|Underlying Disease (Myocarditis)|0
930840|NCT00911300|3069357|P2|Overall Study|Participant Refused Hospital Consulation|1
930841|NCT00911300|3069358|P1|Overall Study|Participant Refused Hospital Consulation|0
930842|NCT00911300|3069357|P2|Overall Study|International Normalized Ratio Too High|1
930843|NCT00911300|3069358|P1|Overall Study|International Normalized Ratio Too High|0
930844|NCT00911300|3069357|P2|Overall Study|Investigator's Decision; New AF Episode|1
930845|NCT00911300|3069358|P1|Overall Study|Investigator's Decision; New AF Episode|0
930846|NCT00911300|3069357|P2|Overall Study|Participant Could Not Stay in Hospital|1
930847|NCT00911300|3069358|P1|Overall Study|Participant Could Not Stay in Hospital|0
930848|NCT00911300|3069357|P2|Overall Study|CV Unsuccessful; Phenprocoumon Received|0
930849|NCT00911300|3069358|P1|Overall Study|CV Unsuccessful; Phenprocoumon Received|1
930850|NCT00911300|3069357|P2|Overall Study|Nurse Unavailable in Participant's City|0
930851|NCT00911300|3069358|P1|Overall Study|Nurse Unavailable in Participant's City|1
930852|NCT00911300|3069357|P2|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
930853|NCT00911300|3069358|P1|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
930854|NCT00911300|3069357|P2|Overall Study|Recurrent Tachyarrhythmia|1
930855|NCT00911300|3069358|P1|Overall Study|Recurrent Tachyarrhythmia|1
930856|NCT00911300|3069357|P2|Overall Study|Received Commercial Treatment|0
930857|NCT00911300|3069358|P1|Overall Study|Received Commercial Treatment|1
930858|NCT00911300|3069357|P2|Overall Study|Atrial Fibrillation (AF) Recurrence|3
930859|NCT00911300|3069358|P1|Overall Study|Atrial Fibrillation (AF) Recurrence|3
930860|NCT00911300|3069357|P2|Overall Study|Coronary Angiography Performed|0
930861|NCT00911300|3069358|P1|Overall Study|Coronary Angiography Performed|1
930862|NCT00911300|3069357|P2|Overall Study|Consent Withdrawn|12
930863|NCT00911300|3069358|P1|Overall Study|Consent Withdrawn|4
930864|NCT00911300|3069357|P2|Overall Study|Protocol Violation|2
930865|NCT00911300|3069358|P1|Overall Study|Protocol Violation|3
930866|NCT00911300|3069357|P2|Overall Study|Adverse Event|6
930867|NCT00911300|3069358|P1|Overall Study|Adverse Event|14
930868|NCT00911300|3069357|P2|Overall Study|Thrombus Persistant in Second TEE|7
930869|NCT00911300|3069358|P1|Overall Study|Thrombus Persistant in Second TEE|3
930870|NCT00911300|3069357|P2|Overall Study|Death|0
930871|NCT00911300|3069358|P1|Overall Study|Death|1
930872|NCT00911300|3069357|P2|Overall Study|Primary Endpoint Component Occurred|2
930873|NCT00911300|3069358|P1|Overall Study|Primary Endpoint Component Occurred|1
930874|NCT00911170|3069395|P2|Long Term Follow-Up|Death|121
930875|NCT00911170|3069396|P1|Long Term Follow-Up|Death|116
930876|NCT00911170|3069395|P2|Long Term Follow-Up|Lost to Follow-up|7
930877|NCT00911170|3069396|P1|Long Term Follow-Up|Lost to Follow-up|8
930878|NCT00911170|3069395|P2|Long Term Follow-Up|Physician Decision|4
930879|NCT00911170|3069396|P1|Long Term Follow-Up|Physician Decision|5
930880|NCT00911170|3069395|P2|Long Term Follow-Up|Withdrawal by Subject|21
930881|NCT00911170|3069396|P1|Long Term Follow-Up|Withdrawal by Subject|20
930882|NCT00911170|3069395|P2|Long Term Follow-Up|Continuing in study|269
930883|NCT00911170|3069396|P1|Long Term Follow-Up|Continuing in study|274
930884|NCT00911170|3069395|P2|Treatment Period|Death|9
930885|NCT00911170|3069396|P1|Treatment Period|Death|6
930886|NCT00911170|3069395|P2|Treatment Period|Lost to Follow-up|1
930887|NCT00911170|3069396|P1|Treatment Period|Lost to Follow-up|0
930888|NCT00911170|3069395|P2|Treatment Period|Physician Decision|5
930889|NCT00911170|3069396|P1|Treatment Period|Physician Decision|5
930890|NCT00911170|3069395|P2|Treatment Period|Disease progression|2
930891|NCT00911170|3069396|P1|Treatment Period|Disease progression|0
930892|NCT00911170|3069395|P2|Treatment Period|Withdrawal by Subject|4
930893|NCT00911170|3069396|P1|Treatment Period|Withdrawal by Subject|4
930894|NCT00911170|3069395|P2|Treatment Period|Adverse Event|10
930895|NCT00911170|3069396|P1|Treatment Period|Adverse Event|9
930896|NCT00911170|3069395|P2|Treatment Period|Protocol deviation|2
930897|NCT00911170|3069396|P1|Treatment Period|Protocol deviation|1
930898|NCT00911170|3069395|P2|Treatment Period|Ineligibility determined|3
930899|NCT00911170|3069396|P1|Treatment Period|Ineligibility determined|1
930900|NCT00911170|3069395|P2|Treatment Period|Randomized in error|1
930901|NCT00911170|3069396|P1|Treatment Period|Randomized in error|1
930902|NCT00911157|3069420|P2|Overall Study|Need to treat for lung cancer|0
930903|NCT00911157|3069421|P1|Overall Study|Need to treat for lung cancer|1
930904|NCT00911157|3069420|P2|Overall Study|Need for prohibited drug (heparin)|0
930905|NCT00911157|3069421|P1|Overall Study|Need for prohibited drug (heparin)|1
930906|NCT00911157|3069420|P2|Overall Study|Withdrawal by Subject|1
930907|NCT00911157|3069421|P1|Overall Study|Withdrawal by Subject|1
930908|NCT00911157|3069420|P2|Overall Study|Adverse Event|1
930909|NCT00911157|3069421|P1|Overall Study|Adverse Event|4
930910|NCT00911144|3069437|P2|Overall Study|Withdrawal by Subject|5
930911|NCT00911144|3069438|P1|Overall Study|Withdrawal by Subject|16
930912|NCT00910988|3069466|P4|Overall Study|Lost to Follow-up|0
930913|NCT00910988|3069467|P3|Overall Study|Lost to Follow-up|3
930914|NCT00910988|3069468|P2|Overall Study|Lost to Follow-up|4
930915|NCT00910988|3069469|P1|Overall Study|Lost to Follow-up|2
930916|NCT00910962|3069514|P3|Overall Study|Reached defined stopping criteria|17
930917|NCT00910962|3069515|P2|Overall Study|Reached defined stopping criteria|14
930918|NCT00910962|3069516|P1|Overall Study|Reached defined stopping criteria|12
930919|NCT00910962|3069514|P3|Overall Study|Withdrawal by Subject|32
930920|NCT00910962|3069515|P2|Overall Study|Withdrawal by Subject|32
930921|NCT00910962|3069516|P1|Overall Study|Withdrawal by Subject|25
930922|NCT00910962|3069514|P3|Overall Study|Physician Decision|6
930923|NCT00910962|3069515|P2|Overall Study|Physician Decision|6
930924|NCT00910962|3069516|P1|Overall Study|Physician Decision|0
930925|NCT00910962|3069514|P3|Overall Study|Lost to Follow-up|1
930926|NCT00910962|3069515|P2|Overall Study|Lost to Follow-up|3
930927|NCT00910962|3069516|P1|Overall Study|Lost to Follow-up|0
930928|NCT00910962|3069514|P3|Overall Study|Protocol Violation|3
930929|NCT00910962|3069515|P2|Overall Study|Protocol Violation|3
930930|NCT00910962|3069516|P1|Overall Study|Protocol Violation|1
930931|NCT00910962|3069514|P3|Overall Study|Adverse Event|17
930932|NCT00910962|3069515|P2|Overall Study|Adverse Event|20
930933|NCT00910962|3069516|P1|Overall Study|Adverse Event|5
930934|NCT00910910|3069608|P2|Overall Study|Untreated before cycle 1|2
930935|NCT00910910|3069609|P1|Overall Study|Untreated before cycle 1|1
930936|NCT00910910|3069608|P2|Overall Study|Other|32
930937|NCT00910910|3069609|P1|Overall Study|Other|114
930938|NCT00910910|3069608|P2|Overall Study|Completed 13 cycles of treatment|118
930939|NCT00910910|3069609|P1|Overall Study|Completed 13 cycles of treatment|0
930940|NCT00910910|3069608|P2|Overall Study|Protocol Violation|2
930941|NCT00910910|3069609|P1|Overall Study|Protocol Violation|2
930942|NCT00910910|3069608|P2|Overall Study|Death|3
930943|NCT00910910|3069609|P1|Overall Study|Death|9
930944|NCT00910910|3069608|P2|Overall Study|Lost to Follow-up|2
930945|NCT00910910|3069609|P1|Overall Study|Lost to Follow-up|2
930946|NCT00910910|3069608|P2|Overall Study|Withdrawal by Subject|5
930947|NCT00910910|3069609|P1|Overall Study|Withdrawal by Subject|7
930948|NCT00910910|3069608|P2|Overall Study|PD with histologic change|2
930949|NCT00910910|3069609|P1|Overall Study|PD with histologic change|0
930950|NCT00910910|3069608|P2|Overall Study|PD without histologic change|23
930951|NCT00910910|3069609|P1|Overall Study|PD without histologic change|27
930952|NCT00910910|3069608|P2|Overall Study|Adverse Event|35
930953|NCT00910910|3069609|P1|Overall Study|Adverse Event|63
930954|NCT00910871|3069643|P1|Overall Study|Undefined|1
930955|NCT00910871|3069643|P1|Overall Study|Subject didn’t meet eligibility criteria|5
930956|NCT00910871|3069643|P1|Overall Study|Withdrawal by Subject|12
930957|NCT00910871|3069643|P1|Overall Study|Protocol Violation|11
930958|NCT00910871|3069643|P1|Overall Study|Lost to Follow-up|8
930959|NCT00910871|3069643|P1|Overall Study|Death|12
930960|NCT00910871|3069643|P1|Overall Study|Adverse Event|5
930961|NCT00910858|3069651|P3|Combined Treatment Phase|Other|1
930962|NCT00910858|3069652|P2|Combined Treatment Phase|Other|2
930963|NCT00910858|3069653|P1|Combined Treatment Phase|Other|0
930964|NCT00910858|3069651|P3|Combined Treatment Phase|Protocol Violation|0
930965|NCT00910858|3069652|P2|Combined Treatment Phase|Protocol Violation|0
930966|NCT00910858|3069653|P1|Combined Treatment Phase|Protocol Violation|1
930967|NCT00910858|3069651|P3|Combined Treatment Phase|Withdrawal by Subject|0
930968|NCT00910858|3069652|P2|Combined Treatment Phase|Withdrawal by Subject|2
930969|NCT00910858|3069653|P1|Combined Treatment Phase|Withdrawal by Subject|0
930970|NCT00910858|3069651|P3|Combined Treatment Phase|Lack of therapeutic effect|3
930971|NCT00910858|3069652|P2|Combined Treatment Phase|Lack of therapeutic effect|6
930972|NCT00910858|3069653|P1|Combined Treatment Phase|Lack of therapeutic effect|8
930973|NCT00910858|3069651|P3|Monotherapy Phase|Other|2
930974|NCT00910858|3069652|P2|Monotherapy Phase|Other|4
930975|NCT00910858|3069653|P1|Monotherapy Phase|Other|3
930976|NCT00910858|3069651|P3|Monotherapy Phase|Protocol Violation|0
930977|NCT00910858|3069652|P2|Monotherapy Phase|Protocol Violation|0
930978|NCT00910858|3069653|P1|Monotherapy Phase|Protocol Violation|1
930979|NCT00910858|3069651|P3|Monotherapy Phase|Withdrawal by Subject|1
930980|NCT00910858|3069652|P2|Monotherapy Phase|Withdrawal by Subject|3
930981|NCT00910858|3069653|P1|Monotherapy Phase|Withdrawal by Subject|1
930982|NCT00910858|3069651|P3|Monotherapy Phase|Lack of therapeutic effect|4
930983|NCT00910858|3069652|P2|Monotherapy Phase|Lack of therapeutic effect|6
930984|NCT00910858|3069653|P1|Monotherapy Phase|Lack of therapeutic effect|9
930985|NCT00910858|3069651|P3|Monotherapy Phase|Adverse Event|0
930986|NCT00910858|3069652|P2|Monotherapy Phase|Adverse Event|2
930987|NCT00910858|3069653|P1|Monotherapy Phase|Adverse Event|3
930988|NCT00910858|3069651|P3|Pharmacokinetic Phase|Adverse Event|0
930989|NCT00910858|3069652|P2|Pharmacokinetic Phase|Adverse Event|0
930990|NCT00910858|3069653|P1|Pharmacokinetic Phase|Adverse Event|1
930991|NCT00910728|3069698|P9|Overall Study|Adverse Event|1
930992|NCT00910728|3069699|P8|Overall Study|Adverse Event|1
930993|NCT00910728|3069700|P7|Overall Study|Adverse Event|2
930994|NCT00910728|3069701|P6|Overall Study|Adverse Event|0
930995|NCT00910728|3069702|P5|Overall Study|Adverse Event|0
930996|NCT00910728|3069703|P4|Overall Study|Adverse Event|1
930997|NCT00910728|3069704|P3|Overall Study|Adverse Event|1
930998|NCT00910728|3069705|P2|Overall Study|Adverse Event|0
930999|NCT00910728|3069706|P1|Overall Study|Adverse Event|2
931000|NCT00910728|3069698|P9|Overall Study|(not specified)|0
931001|NCT00910728|3069699|P8|Overall Study|(not specified)|0
931002|NCT00910728|3069700|P7|Overall Study|(not specified)|0
931003|NCT00910728|3069701|P6|Overall Study|(not specified)|0
931004|NCT00910728|3069702|P5|Overall Study|(not specified)|1
931005|NCT00910728|3069703|P4|Overall Study|(not specified)|0
931006|NCT00910728|3069704|P3|Overall Study|(not specified)|1
931007|NCT00910728|3069705|P2|Overall Study|(not specified)|0
931008|NCT00910728|3069706|P1|Overall Study|(not specified)|2
931009|NCT00910728|3069698|P9|Overall Study|Withdrawal by Subject|0
931010|NCT00910728|3069699|P8|Overall Study|Withdrawal by Subject|0
931011|NCT00910728|3069700|P7|Overall Study|Withdrawal by Subject|2
931012|NCT00910728|3069701|P6|Overall Study|Withdrawal by Subject|1
931013|NCT00910728|3069702|P5|Overall Study|Withdrawal by Subject|3
931014|NCT00910728|3069703|P4|Overall Study|Withdrawal by Subject|0
931015|NCT00910728|3069704|P3|Overall Study|Withdrawal by Subject|0
931016|NCT00910728|3069705|P2|Overall Study|Withdrawal by Subject|0
931017|NCT00910728|3069706|P1|Overall Study|Withdrawal by Subject|0
931018|NCT00910728|3069698|P9|Overall Study|Lack of Efficacy|2
931019|NCT00910728|3069699|P8|Overall Study|Lack of Efficacy|2
931020|NCT00910728|3069700|P7|Overall Study|Lack of Efficacy|2
931021|NCT00910728|3069701|P6|Overall Study|Lack of Efficacy|0
931022|NCT00910728|3069702|P5|Overall Study|Lack of Efficacy|1
931023|NCT00910728|3069703|P4|Overall Study|Lack of Efficacy|2
931024|NCT00910728|3069704|P3|Overall Study|Lack of Efficacy|1
931025|NCT00910728|3069705|P2|Overall Study|Lack of Efficacy|3
931026|NCT00910728|3069706|P1|Overall Study|Lack of Efficacy|2
931027|NCT00910715|3069828|P3|Overall Study|Lost to Follow-up|0
931028|NCT00910715|3069829|P2|Overall Study|Lost to Follow-up|26
931029|NCT00910715|3069830|P1|Overall Study|Lost to Follow-up|22
931030|NCT00910689|3069844|P4|Months 11- 16: Evaluation Period II|Physician Decision|0
931031|NCT00910689|3069845|P3|Months 11- 16: Evaluation Period II|Physician Decision|1
931032|NCT00910689|3069846|P2|Months 11- 16: Evaluation Period II|Physician Decision|2
931033|NCT00910689|3069847|P1|Months 11- 16: Evaluation Period II|Physician Decision|0
931034|NCT00910689|3069844|P4|Months 11- 16: Evaluation Period II|Perceived Improvement|1
931035|NCT00910689|3069845|P3|Months 11- 16: Evaluation Period II|Perceived Improvement|0
931036|NCT00910689|3069846|P2|Months 11- 16: Evaluation Period II|Perceived Improvement|0
931037|NCT00910689|3069847|P1|Months 11- 16: Evaluation Period II|Perceived Improvement|0
931038|NCT00910689|3069844|P4|Months 11- 16: Evaluation Period II|Time Demands|0
931039|NCT00910689|3069845|P3|Months 11- 16: Evaluation Period II|Time Demands|0
931040|NCT00910689|3069846|P2|Months 11- 16: Evaluation Period II|Time Demands|1
931041|NCT00910689|3069847|P1|Months 11- 16: Evaluation Period II|Time Demands|2
931042|NCT00910689|3069844|P4|Months 11- 16: Evaluation Period II|Lack of Efficacy|1
931043|NCT00910689|3069845|P3|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
931044|NCT00910689|3069846|P2|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
931045|NCT00910689|3069847|P1|Months 11- 16: Evaluation Period II|Lack of Efficacy|2
931046|NCT00910689|3069844|P4|Months 11- 16: Evaluation Period II|Pregnancy|0
931047|NCT00910689|3069845|P3|Months 11- 16: Evaluation Period II|Pregnancy|0
931048|NCT00910689|3069846|P2|Months 11- 16: Evaluation Period II|Pregnancy|0
931049|NCT00910689|3069847|P1|Months 11- 16: Evaluation Period II|Pregnancy|1
931050|NCT00910689|3069844|P4|Months 11- 16: Evaluation Period II|Adverse Event|2
931051|NCT00910689|3069845|P3|Months 11- 16: Evaluation Period II|Adverse Event|2
931052|NCT00910689|3069846|P2|Months 11- 16: Evaluation Period II|Adverse Event|4
931053|NCT00910689|3069847|P1|Months 11- 16: Evaluation Period II|Adverse Event|2
931054|NCT00910689|3069844|P4|Months 11- 16: Evaluation Period II|Lost to Follow-up|2
931055|NCT00910689|3069845|P3|Months 11- 16: Evaluation Period II|Lost to Follow-up|1
931056|NCT00910689|3069846|P2|Months 11- 16: Evaluation Period II|Lost to Follow-up|0
931057|NCT00910689|3069847|P1|Months 11- 16: Evaluation Period II|Lost to Follow-up|3
931058|NCT00910689|3069844|P4|Months 5 - 10: Evaluation Period I|Time Demands|1
931059|NCT00910689|3069845|P3|Months 5 - 10: Evaluation Period I|Time Demands|1
931060|NCT00910689|3069846|P2|Months 5 - 10: Evaluation Period I|Time Demands|0
931061|NCT00910689|3069847|P1|Months 5 - 10: Evaluation Period I|Time Demands|0
931062|NCT00910689|3069844|P4|Months 5 - 10: Evaluation Period I|Pregnancy|0
931063|NCT00910689|3069845|P3|Months 5 - 10: Evaluation Period I|Pregnancy|2
931064|NCT00910689|3069846|P2|Months 5 - 10: Evaluation Period I|Pregnancy|0
931065|NCT00910689|3069847|P1|Months 5 - 10: Evaluation Period I|Pregnancy|0
931066|NCT00910689|3069844|P4|Months 5 - 10: Evaluation Period I|Protocol Violation|0
931067|NCT00910689|3069845|P3|Months 5 - 10: Evaluation Period I|Protocol Violation|0
931068|NCT00910689|3069846|P2|Months 5 - 10: Evaluation Period I|Protocol Violation|1
931069|NCT00910689|3069847|P1|Months 5 - 10: Evaluation Period I|Protocol Violation|1
931070|NCT00910689|3069844|P4|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
931071|NCT00910689|3069845|P3|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
931072|NCT00910689|3069846|P2|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
931073|NCT00910689|3069847|P1|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0
931074|NCT00910689|3069844|P4|Months 5 - 10: Evaluation Period I|Adverse Event|4
931075|NCT00910689|3069845|P3|Months 5 - 10: Evaluation Period I|Adverse Event|2
931076|NCT00910689|3069846|P2|Months 5 - 10: Evaluation Period I|Adverse Event|0
931077|NCT00910689|3069847|P1|Months 5 - 10: Evaluation Period I|Adverse Event|1
931078|NCT00910689|3069844|P4|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
931079|NCT00910689|3069845|P3|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
931080|NCT00910689|3069846|P2|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5
931081|NCT00910689|3069847|P1|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2
931082|NCT00910689|3069844|P4|Month 2- 4: Treatment Period|Protocol Violation|0
931083|NCT00910689|3069845|P3|Month 2- 4: Treatment Period|Protocol Violation|0
931084|NCT00910689|3069846|P2|Month 2- 4: Treatment Period|Protocol Violation|0
931085|NCT00910689|3069847|P1|Month 2- 4: Treatment Period|Protocol Violation|1
931086|NCT00910689|3069844|P4|Month 2- 4: Treatment Period|Pregnancy|0
931087|NCT00910689|3069845|P3|Month 2- 4: Treatment Period|Pregnancy|0
931088|NCT00910689|3069846|P2|Month 2- 4: Treatment Period|Pregnancy|2
931089|NCT00910689|3069847|P1|Month 2- 4: Treatment Period|Pregnancy|0
931090|NCT00910689|3069844|P4|Month 2- 4: Treatment Period|Perceived Improvement|0
931091|NCT00910689|3069845|P3|Month 2- 4: Treatment Period|Perceived Improvement|1
931092|NCT00910689|3069846|P2|Month 2- 4: Treatment Period|Perceived Improvement|0
931093|NCT00910689|3069847|P1|Month 2- 4: Treatment Period|Perceived Improvement|0
931094|NCT00910689|3069844|P4|Month 2- 4: Treatment Period|Lack of Efficacy|0
931095|NCT00910689|3069845|P3|Month 2- 4: Treatment Period|Lack of Efficacy|0
931096|NCT00910689|3069846|P2|Month 2- 4: Treatment Period|Lack of Efficacy|1
931097|NCT00910689|3069847|P1|Month 2- 4: Treatment Period|Lack of Efficacy|2
931098|NCT00910689|3069844|P4|Month 2- 4: Treatment Period|Time Demands|8
931099|NCT00910689|3069845|P3|Month 2- 4: Treatment Period|Time Demands|4
931100|NCT00910689|3069846|P2|Month 2- 4: Treatment Period|Time Demands|0
931101|NCT00910689|3069847|P1|Month 2- 4: Treatment Period|Time Demands|1
931102|NCT00910689|3069844|P4|Month 2- 4: Treatment Period|Adverse Event|0
931103|NCT00910689|3069845|P3|Month 2- 4: Treatment Period|Adverse Event|2
931104|NCT00910689|3069846|P2|Month 2- 4: Treatment Period|Adverse Event|3
931105|NCT00910689|3069847|P1|Month 2- 4: Treatment Period|Adverse Event|2
931106|NCT00910689|3069844|P4|Month 2- 4: Treatment Period|Lost to Follow-up|3
931107|NCT00910689|3069845|P3|Month 2- 4: Treatment Period|Lost to Follow-up|1
931108|NCT00910689|3069846|P2|Month 2- 4: Treatment Period|Lost to Follow-up|4
931109|NCT00910689|3069847|P1|Month 2- 4: Treatment Period|Lost to Follow-up|3
931110|NCT00910689|3069844|P4|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10
931111|NCT00910689|3069845|P3|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5
931112|NCT00910689|3069846|P2|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1
931113|NCT00910689|3069847|P1|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2
931114|NCT00910663|3069879|P2|Period 1|Withdrawal by Subject|1
931115|NCT00910663|3069880|P1|Period 1|Withdrawal by Subject|0
931116|NCT00910624|3069894|P4|Follow-Up Phase|Administrative|0
931117|NCT00910624|3069895|P3|Follow-Up Phase|Administrative|1
931118|NCT00910624|3069896|P2|Follow-Up Phase|Administrative|1
931119|NCT00910624|3069897|P1|Follow-Up Phase|Administrative|0
931120|NCT00910624|3069894|P4|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
931121|NCT00910624|3069895|P3|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
931122|NCT00910624|3069896|P2|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
931123|NCT00910624|3069897|P1|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1
931124|NCT00910624|3069894|P4|Follow-Up Phase|Withdrawal by Subject|0
931125|NCT00910624|3069895|P3|Follow-Up Phase|Withdrawal by Subject|0
931126|NCT00910624|3069896|P2|Follow-Up Phase|Withdrawal by Subject|0
931127|NCT00910624|3069897|P1|Follow-Up Phase|Withdrawal by Subject|1
931128|NCT00910624|3069894|P4|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
931129|NCT00910624|3069895|P3|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
931130|NCT00910624|3069896|P2|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2
931131|NCT00910624|3069897|P1|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1
931132|NCT00910624|3069894|P4|Follow-Up Phase|Lost to Follow-up|0
931133|NCT00910624|3069895|P3|Follow-Up Phase|Lost to Follow-up|2
931134|NCT00910624|3069896|P2|Follow-Up Phase|Lost to Follow-up|1
931135|NCT00910624|3069897|P1|Follow-Up Phase|Lost to Follow-up|3
931136|NCT00910624|3069894|P4|Follow-Up Phase|Adverse Event|0
931137|NCT00910624|3069895|P3|Follow-Up Phase|Adverse Event|1
931138|NCT00910624|3069896|P2|Follow-Up Phase|Adverse Event|0
931139|NCT00910624|3069897|P1|Follow-Up Phase|Adverse Event|0
931140|NCT00910624|3069894|P4|Treatment Phase|Non-Compliance With Protocol|0
931141|NCT00910624|3069895|P3|Treatment Phase|Non-Compliance With Protocol|1
931142|NCT00910624|3069896|P2|Treatment Phase|Non-Compliance With Protocol|1
931143|NCT00910624|3069897|P1|Treatment Phase|Non-Compliance With Protocol|0
931144|NCT00910624|3069894|P4|Treatment Phase|Withdrawal by Subject|0
931145|NCT00910624|3069895|P3|Treatment Phase|Withdrawal by Subject|0
931146|NCT00910624|3069896|P2|Treatment Phase|Withdrawal by Subject|1
931147|NCT00910624|3069897|P1|Treatment Phase|Withdrawal by Subject|2
931148|NCT00910624|3069894|P4|Treatment Phase|Reasons Unrelated To Assigned Treatment|0
931149|NCT00910624|3069895|P3|Treatment Phase|Reasons Unrelated To Assigned Treatment|1
931150|NCT00910624|3069896|P2|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
931151|NCT00910624|3069897|P1|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
931152|NCT00910624|3069894|P4|Treatment Phase|Lost to Follow-up|0
931153|NCT00910624|3069895|P3|Treatment Phase|Lost to Follow-up|1
931154|NCT00910624|3069896|P2|Treatment Phase|Lost to Follow-up|0
931155|NCT00910624|3069897|P1|Treatment Phase|Lost to Follow-up|0
931156|NCT00910624|3069894|P4|Treatment Phase|Treatment Failure|0
931157|NCT00910624|3069895|P3|Treatment Phase|Treatment Failure|0
931158|NCT00910624|3069896|P2|Treatment Phase|Treatment Failure|10
931159|NCT00910624|3069897|P1|Treatment Phase|Treatment Failure|23
931160|NCT00910624|3069894|P4|Treatment Phase|Adverse Event|0
931161|NCT00910624|3069895|P3|Treatment Phase|Adverse Event|6
931162|NCT00910624|3069896|P2|Treatment Phase|Adverse Event|6
931163|NCT00910624|3069897|P1|Treatment Phase|Adverse Event|2
931164|NCT00910299|3069924|P2|Overall Study|Didn't receive any study drug|1
931165|NCT00910299|3069925|P1|Overall Study|Didn't receive any study drug|2
931166|NCT00910299|3069924|P2|Overall Study|Sponsor Decision|60
931167|NCT00910299|3069925|P1|Overall Study|Sponsor Decision|58
931168|NCT00910299|3069924|P2|Overall Study|Withdrawal by Subject|13
931169|NCT00910299|3069925|P1|Overall Study|Withdrawal by Subject|16
931170|NCT00910273|3069937|P2|Overall Study|Lost to Follow-up|1
931171|NCT00910273|3069938|P1|Overall Study|Lost to Follow-up|1
931172|NCT00910273|3069937|P2|Overall Study|Protocol Violation|0
931173|NCT00910273|3069938|P1|Overall Study|Protocol Violation|1
931174|NCT00910273|3069937|P2|Overall Study|Discontinuation of study by sponsor|2
931175|NCT00910273|3069938|P1|Overall Study|Discontinuation of study by sponsor|8
931176|NCT00910273|3069937|P2|Overall Study|Withdrawal by Subject|0
931177|NCT00910273|3069938|P1|Overall Study|Withdrawal by Subject|1
931178|NCT00910273|3069937|P2|Overall Study|Adverse Event|1
931179|NCT00910273|3069938|P1|Overall Study|Adverse Event|1
931180|NCT00910273|3069937|P2|Overall Study|Lack of Efficacy|9
931181|NCT00910273|3069938|P1|Overall Study|Lack of Efficacy|6
931182|NCT00910247|3069988|P1|Overall Study|Not collected|4
931183|NCT00910247|3069988|P1|Overall Study|Withdrawal by Subject|25
931184|NCT00910247|3069988|P1|Overall Study|Protocol Violation|10
931185|NCT00910247|3069988|P1|Overall Study|Physician Decision|3
931186|NCT00910247|3069988|P1|Overall Study|Lost to Follow-up|10
931187|NCT00910247|3069988|P1|Overall Study|Death|2
931188|NCT00910247|3069988|P1|Overall Study|Adverse Event|15
931189|NCT00910091|3070010|P2|Treatment and Survival|Adverse Event|0
931190|NCT00910091|3070011|P1|Treatment and Survival|Adverse Event|1
931191|NCT00910091|3070010|P2|Treatment and Survival|Withdrawal by Subject|4
931192|NCT00910091|3070011|P1|Treatment and Survival|Withdrawal by Subject|3
931193|NCT00910091|3070010|P2|Pre-assignment|Withdrawal by Subject|2
931194|NCT00910091|3070011|P1|Pre-assignment|Withdrawal by Subject|0
931195|NCT00910039|3070039|P1|Overall Study|Physician Decision|1
931196|NCT00910000|3070056|P6|Overall Study|Withdrawal by Subject|0
931197|NCT00910000|3070057|P5|Overall Study|Withdrawal by Subject|1
931198|NCT00910000|3070058|P4|Overall Study|Withdrawal by Subject|0
931199|NCT00910000|3070059|P3|Overall Study|Withdrawal by Subject|1
931200|NCT00910000|3070060|P2|Overall Study|Withdrawal by Subject|0
931201|NCT00910000|3070061|P1|Overall Study|Withdrawal by Subject|0
931202|NCT00910000|3070056|P6|Overall Study|Adverse Event|1
931203|NCT00910000|3070057|P5|Overall Study|Adverse Event|0
931204|NCT00910000|3070058|P4|Overall Study|Adverse Event|2
931205|NCT00910000|3070059|P3|Overall Study|Adverse Event|2
931206|NCT00910000|3070060|P2|Overall Study|Adverse Event|3
931207|NCT00910000|3070061|P1|Overall Study|Adverse Event|0
931208|NCT00909870|3070079|P2|Overall Study|Other|5
931209|NCT00909870|3070080|P1|Overall Study|Other|1
931210|NCT00909870|3070079|P2|Overall Study|Physician Decision|2
931211|NCT00909870|3070080|P1|Overall Study|Physician Decision|0
931212|NCT00909870|3070079|P2|Overall Study|Lost to Follow-up|3
931213|NCT00909870|3070080|P1|Overall Study|Lost to Follow-up|3
931214|NCT00909870|3070079|P2|Overall Study|Withdrawal by Subject|8
931215|NCT00909870|3070080|P1|Overall Study|Withdrawal by Subject|5
931216|NCT00909870|3070079|P2|Overall Study|Protocol Violation|2
931217|NCT00909870|3070080|P1|Overall Study|Protocol Violation|1
931218|NCT00909870|3070079|P2|Overall Study|Adverse Event|7
931219|NCT00909870|3070080|P1|Overall Study|Adverse Event|13
931220|NCT00909857|3070092|P2|Overall Study|Did not receive study medication|24
931221|NCT00909857|3070093|P1|Overall Study|Did not receive study medication|19
931222|NCT00909857|3070092|P2|Overall Study|Other|0
931223|NCT00909857|3070093|P1|Overall Study|Other|1
931224|NCT00909857|3070092|P2|Overall Study|Pregnancy|0
931225|NCT00909857|3070093|P1|Overall Study|Pregnancy|1
931226|NCT00909857|3070092|P2|Overall Study|Protocol Violation|1
931227|NCT00909857|3070093|P1|Overall Study|Protocol Violation|2
931228|NCT00909857|3070092|P2|Overall Study|Lost to Follow-up|5
931229|NCT00909857|3070093|P1|Overall Study|Lost to Follow-up|2
931230|NCT00909857|3070092|P2|Overall Study|Adverse Event|5
931231|NCT00909857|3070093|P1|Overall Study|Adverse Event|5
931232|NCT00909857|3070092|P2|Overall Study|Withdrawal by Subject|10
931233|NCT00909857|3070093|P1|Overall Study|Withdrawal by Subject|6
931234|NCT00909844|3070233|P1|Overall Study|Lost to Follow-up|2
931235|NCT00909844|3070233|P1|Overall Study|Withdrawal by Subject|1
931236|NCT00909844|3070233|P1|Overall Study|Adverse Event|1
931237|NCT00909792|3070251|P2|Period 2|Lost to Follow-up|1
931238|NCT00909792|3070252|P1|Period 2|Lost to Follow-up|0
931239|NCT00909792|3070251|P2|Period 2|Biomicroscopy|0
931240|NCT00909792|3070252|P1|Period 2|Biomicroscopy|1
931241|NCT00909792|3070251|P2|Period 1|Did not meet inclusion criteria|1
931242|NCT00909792|3070252|P1|Period 1|Did not meet inclusion criteria|0
931243|NCT00909779|3070260|P2|Overall Study|Randomized in error|1
931244|NCT00909779|3070261|P1|Overall Study|Randomized in error|1
931245|NCT00909779|3070260|P2|Overall Study|Noncompliance|1
931246|NCT00909779|3070261|P1|Overall Study|Noncompliance|1
931247|NCT00909779|3070260|P2|Overall Study|Medical Monitor Decision|0
931248|NCT00909779|3070261|P1|Overall Study|Medical Monitor Decision|1
931249|NCT00909779|3070260|P2|Overall Study|Site Ceasing Operation|2
931250|NCT00909779|3070261|P1|Overall Study|Site Ceasing Operation|2
931251|NCT00909779|3070260|P2|Overall Study|Withdrawal by Subject|80
931252|NCT00909779|3070261|P1|Overall Study|Withdrawal by Subject|116
931253|NCT00909779|3070260|P2|Overall Study|Protocol Violation|5
931254|NCT00909779|3070261|P1|Overall Study|Protocol Violation|2
931255|NCT00909779|3070260|P2|Overall Study|Physician Decision|2
931256|NCT00909779|3070261|P1|Overall Study|Physician Decision|8
931257|NCT00909779|3070260|P2|Overall Study|Lost to Follow-up|15
931258|NCT00909779|3070261|P1|Overall Study|Lost to Follow-up|19
931259|NCT00909779|3070260|P2|Overall Study|Lack of Efficacy|4
931260|NCT00909779|3070261|P1|Overall Study|Lack of Efficacy|7
931261|NCT00909779|3070260|P2|Overall Study|Adverse Event|55
931262|NCT00909779|3070261|P1|Overall Study|Adverse Event|53
931263|NCT00909753|3070285|P2|Period: Second Intervention|Protocol Violation|0
931264|NCT00909753|3070286|P1|Period: Second Intervention|Protocol Violation|1
931265|NCT00909753|3070285|P2|Period: Washout of 28 Days|Protocol Violation|3
931266|NCT00909753|3070286|P1|Period: Washout of 28 Days|Protocol Violation|2
931267|NCT00909727|3070306|P2|Overall Study|Prohibited Medication|0
931268|NCT00909727|3070307|P1|Overall Study|Prohibited Medication|1
931269|NCT00909727|3070306|P2|Overall Study|Withdrawal of Consent|0
931270|NCT00909727|3070307|P1|Overall Study|Withdrawal of Consent|1
931271|NCT00909727|3070306|P2|Overall Study|Wrong Genotype|0
931272|NCT00909727|3070307|P1|Overall Study|Wrong Genotype|1
931273|NCT00909727|3070306|P2|Overall Study|Adverse Event|0
931274|NCT00909727|3070307|P1|Overall Study|Adverse Event|1
931275|NCT00909610|3070330|P2|Period: Second Intervention|Adverse Event|0
931276|NCT00909610|3070331|P1|Period: Second Intervention|Adverse Event|1
931277|NCT00909610|3070330|P2|Period: Washout of 28 Days|Withdrawal by Subject|6
931278|NCT00909610|3070331|P1|Period: Washout of 28 Days|Withdrawal by Subject|3
931279|NCT00909610|3070330|P2|Period: First Intervention|Adverse Event|1
931280|NCT00909610|3070331|P1|Period: First Intervention|Adverse Event|0
931281|NCT00909532|3070492|P2|Overall Study|Increased Lab Draws, Difficult Lab Stick|0
931282|NCT00909532|3070493|P1|Overall Study|Increased Lab Draws, Difficult Lab Stick|1
931283|NCT00909532|3070492|P2|Overall Study|Wrong Genotype|0
931284|NCT00909532|3070493|P1|Overall Study|Wrong Genotype|1
931285|NCT00909532|3070492|P2|Overall Study|Physician Decision|0
931286|NCT00909532|3070493|P1|Overall Study|Physician Decision|1
931287|NCT00909532|3070492|P2|Overall Study|Noncompliance with Study Requirements|2
931288|NCT00909532|3070493|P1|Overall Study|Noncompliance with Study Requirements|0
931289|NCT00909532|3070492|P2|Overall Study|Withdrawal of Consent|1
931290|NCT00909532|3070493|P1|Overall Study|Withdrawal of Consent|1
931291|NCT00909532|3070492|P2|Overall Study|Prohibited Medication|1
931292|NCT00909532|3070493|P1|Overall Study|Prohibited Medication|2
931293|NCT00909532|3070492|P2|Overall Study|Pregnancy|1
931294|NCT00909532|3070493|P1|Overall Study|Pregnancy|0
931295|NCT00909532|3070492|P2|Overall Study|Adverse Event|1
931296|NCT00909532|3070493|P1|Overall Study|Adverse Event|4
931297|NCT00909480|3070511|P2|Overall Study|Unclassified|19
931298|NCT00909480|3070512|P1|Overall Study|Unclassified|18
931299|NCT00909480|3070511|P2|Overall Study|Withdrawal criteria|11
931300|NCT00909480|3070512|P1|Overall Study|Withdrawal criteria|9
931301|NCT00909480|3070511|P2|Overall Study|Protocol Violation|8
931302|NCT00909480|3070512|P1|Overall Study|Protocol Violation|6
931303|NCT00909480|3070511|P2|Overall Study|Adverse Event|3
931304|NCT00909480|3070512|P1|Overall Study|Adverse Event|5
931305|NCT00909428|3070547|P3|Overall Study|Lost to Follow-up|9
931306|NCT00909428|3070548|P2|Overall Study|Lost to Follow-up|10
931307|NCT00909428|3070549|P1|Overall Study|Lost to Follow-up|13
931308|NCT00909389|3070556|P1|Overall Study|No Information|103
931309|NCT00909389|3070556|P1|Overall Study|Lost to Follow-up|4
931310|NCT00909389|3070556|P1|Overall Study|Poor Compliance|16
931311|NCT00909389|3070556|P1|Overall Study|Death|4
931312|NCT00909389|3070556|P1|Overall Study|Adverse Event|6
931313|NCT00909181|3070590|P3|Overall Study|Lost to Follow-up|33
931314|NCT00909181|3070591|P2|Overall Study|Lost to Follow-up|18
931315|NCT00909181|3070592|P1|Overall Study|Lost to Follow-up|39
931316|NCT00909038|3070622|P1|Overall Study|Non-evaluable Subjects|230
931317|NCT00909038|3070622|P1|Overall Study|Protocol Violation|187
931318|NCT00908960|3070634|P3|Overall Study|Presence VTE dx or Absent VTE eval|2
931319|NCT00908960|3070635|P2|Overall Study|Presence VTE dx or Absent VTE eval|1
931320|NCT00908960|3070636|P1|Overall Study|Presence VTE dx or Absent VTE eval|1
931321|NCT00908895|3070658|P2|Overall Study|Adverse Event|1
931322|NCT00908895|3070659|P1|Overall Study|Adverse Event|1
931323|NCT00908895|3070658|P2|Overall Study|algodystrophy|2
931324|NCT00908895|3070659|P1|Overall Study|algodystrophy|2
931325|NCT00908895|3070658|P2|Overall Study|Lost to Follow-up|3
931326|NCT00908895|3070659|P1|Overall Study|Lost to Follow-up|1
931327|NCT00908596|3070743|P4|Overall Study|Withdrawal by Subject|1
931328|NCT00908596|3070744|P3|Overall Study|Withdrawal by Subject|3
931329|NCT00908596|3070745|P2|Overall Study|Withdrawal by Subject|1
931330|NCT00908596|3070746|P1|Overall Study|Withdrawal by Subject|0
931331|NCT00908596|3070743|P4|Overall Study|Protocol Violation|0
931332|NCT00908596|3070744|P3|Overall Study|Protocol Violation|0
931333|NCT00908596|3070745|P2|Overall Study|Protocol Violation|0
931334|NCT00908596|3070746|P1|Overall Study|Protocol Violation|1
931335|NCT00908596|3070743|P4|Overall Study|Death|32
931336|NCT00908596|3070744|P3|Overall Study|Death|57
931337|NCT00908596|3070745|P2|Overall Study|Death|5
931338|NCT00908596|3070746|P1|Overall Study|Death|0
931339|NCT00908596|3070743|P4|Overall Study|Lost to Follow-up|4
931340|NCT00908596|3070744|P3|Overall Study|Lost to Follow-up|12
931341|NCT00908596|3070745|P2|Overall Study|Lost to Follow-up|1
931342|NCT00908596|3070746|P1|Overall Study|Lost to Follow-up|0
931343|NCT00908596|3070743|P4|Overall Study|Other reasons|0
931344|NCT00908596|3070744|P3|Overall Study|Other reasons|2
931345|NCT00908596|3070745|P2|Overall Study|Other reasons|6
931346|NCT00908596|3070746|P1|Overall Study|Other reasons|46
931347|NCT00908583|3070776|P1|Phase 5|Adverse Event|3
931348|NCT00908583|3070776|P1|Phase 4|Physician Decision|1
931349|NCT00908583|3070776|P1|Phase 4|Adverse Event|1
931350|NCT00908583|3070776|P1|Phase 3|Adverse Event|2
931351|NCT00908583|3070776|P1|Phase 2|Adverse Event|1
931352|NCT00908583|3070776|P1|Phase 2|Physician Decision|1
931353|NCT00908583|3070776|P1|Phase 1|Adverse Event|4
931354|NCT00908583|3070776|P1|Phase 1|Withdrawal by Subject|1
931355|NCT00908375|3070813|P2|Overall Study|Lost to Follow-up|6
931356|NCT00908375|3070814|P1|Overall Study|Lost to Follow-up|8
931357|NCT00908375|3070813|P2|Overall Study|Withdrawal by Subject|4
931358|NCT00908375|3070814|P1|Overall Study|Withdrawal by Subject|2
931359|NCT00908349|3070824|P1|Overall Study|Various|6
931360|NCT00908349|3070824|P1|Overall Study|Lost to Follow-up|5
931361|NCT00908349|3070824|P1|Overall Study|Physician Decision|5
931362|NCT00908349|3070824|P1|Overall Study|Withdrawal by Subject|9
931363|NCT00908349|3070824|P1|Overall Study|Adverse Event|10
931364|NCT00908310|3070828|P1|Overall Study|Other reasons|4
931365|NCT00908310|3070828|P1|Overall Study|Screening failure|5
931366|NCT00908310|3070828|P1|Overall Study|Lost to Follow-up|7
931367|NCT00908310|3070828|P1|Overall Study|Withdrawal by Subject|7
931368|NCT00908310|3070828|P1|Overall Study|Death|37
931369|NCT00908232|3070832|P4|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
931370|NCT00908232|3070833|P3|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
931371|NCT00908232|3070834|P2|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
931372|NCT00908232|3070835|P1|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1
931373|NCT00908232|3070832|P4|Randomization (Cycle 5) to Cycle 8|Other|0
931374|NCT00908232|3070833|P3|Randomization (Cycle 5) to Cycle 8|Other|0
931375|NCT00908232|3070834|P2|Randomization (Cycle 5) to Cycle 8|Other|1
931376|NCT00908232|3070835|P1|Randomization (Cycle 5) to Cycle 8|Other|3
931377|NCT00908232|3070832|P4|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
931378|NCT00908232|3070833|P3|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
931379|NCT00908232|3070834|P2|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
931380|NCT00908232|3070835|P1|Randomization (Cycle 5) to Cycle 8|Physician Decision|2
931381|NCT00908232|3070832|P4|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
931382|NCT00908232|3070833|P3|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
931383|NCT00908232|3070834|P2|Randomization (Cycle 5) to Cycle 8|Adverse Event|2
931384|NCT00908232|3070835|P1|Randomization (Cycle 5) to Cycle 8|Adverse Event|17
931385|NCT00908232|3070832|P4|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
931386|NCT00908232|3070833|P3|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1
931387|NCT00908232|3070834|P2|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
931388|NCT00908232|3070835|P1|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4
931389|NCT00908232|3070832|P4|Randomization (Cycle 5) to Cycle 8|Death|0
931390|NCT00908232|3070833|P3|Randomization (Cycle 5) to Cycle 8|Death|0
931391|NCT00908232|3070834|P2|Randomization (Cycle 5) to Cycle 8|Death|0
931392|NCT00908232|3070835|P1|Randomization (Cycle 5) to Cycle 8|Death|2
931393|NCT00908232|3070832|P4|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
931394|NCT00908232|3070833|P3|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
931395|NCT00908232|3070834|P2|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
931396|NCT00908232|3070835|P1|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5
931397|NCT00908232|3070832|P4|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
931398|NCT00908232|3070833|P3|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
931399|NCT00908232|3070834|P2|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
931400|NCT00908232|3070835|P1|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1
931401|NCT00908232|3070832|P4|Cycle 1 to 4|not specified|0
931402|NCT00908232|3070833|P3|Cycle 1 to 4|not specified|0
931403|NCT00908232|3070834|P2|Cycle 1 to 4|not specified|0
931404|NCT00908232|3070835|P1|Cycle 1 to 4|not specified|1
931405|NCT00908232|3070832|P4|Cycle 1 to 4|Adverse Event|0
931406|NCT00908232|3070833|P3|Cycle 1 to 4|Adverse Event|0
931407|NCT00908232|3070834|P2|Cycle 1 to 4|Adverse Event|0
931408|NCT00908232|3070835|P1|Cycle 1 to 4|Adverse Event|12
931409|NCT00908232|3070832|P4|Cycle 1 to 4|Progressive Disease|0
931410|NCT00908232|3070833|P3|Cycle 1 to 4|Progressive Disease|0
931411|NCT00908232|3070834|P2|Cycle 1 to 4|Progressive Disease|0
931412|NCT00908232|3070835|P1|Cycle 1 to 4|Progressive Disease|6
931413|NCT00908232|3070832|P4|Cycle 1 to 4|Withdrawal by Subject|0
931414|NCT00908232|3070833|P3|Cycle 1 to 4|Withdrawal by Subject|0
931415|NCT00908232|3070834|P2|Cycle 1 to 4|Withdrawal by Subject|0
931416|NCT00908232|3070835|P1|Cycle 1 to 4|Withdrawal by Subject|4
931417|NCT00908232|3070832|P4|Cycle 1 to 4|Death|0
931418|NCT00908232|3070833|P3|Cycle 1 to 4|Death|0
931419|NCT00908232|3070834|P2|Cycle 1 to 4|Death|0
931420|NCT00908232|3070835|P1|Cycle 1 to 4|Death|5
931421|NCT00908141|3070853|P2|Overall Study|Withdrawal by Subject|1
931422|NCT00908141|3070854|P1|Overall Study|Withdrawal by Subject|0
931423|NCT00908115|3070871|P1|Overall Study|Other|14
931424|NCT00908076|3070879|P2|Overall Study|Lack of Efficacy|1
931425|NCT00908076|3070880|P1|Overall Study|Lack of Efficacy|1
931426|NCT00908037|3070893|P12|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
931427|NCT00908037|3070894|P11|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2
931428|NCT00908037|3070895|P10|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
931429|NCT00908037|3070896|P9|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
931430|NCT00908037|3070897|P8|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
931431|NCT00908037|3070898|P7|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
931432|NCT00908037|3070899|P6|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
931433|NCT00908037|3070900|P5|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
931434|NCT00908037|3070901|P4|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
931435|NCT00908037|3070902|P3|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
931436|NCT00908037|3070903|P2|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
931437|NCT00908037|3070904|P1|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
931438|NCT00908037|3070893|P12|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
931439|NCT00908037|3070894|P11|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
931440|NCT00908037|3070895|P10|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1
931441|NCT00908037|3070896|P9|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
931442|NCT00908037|3070897|P8|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
931443|NCT00908037|3070898|P7|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
931444|NCT00908037|3070899|P6|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
931445|NCT00908037|3070900|P5|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
931446|NCT00908037|3070901|P4|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
931447|NCT00908037|3070902|P3|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
931448|NCT00908037|3070903|P2|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
931449|NCT00908037|3070904|P1|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
931450|NCT00908037|3070893|P12|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
931451|NCT00908037|3070894|P11|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2
931452|NCT00908037|3070895|P10|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
931453|NCT00908037|3070896|P9|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
931454|NCT00908037|3070897|P8|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
931455|NCT00908037|3070898|P7|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
931456|NCT00908037|3070899|P6|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
931457|NCT00908037|3070900|P5|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
931458|NCT00908037|3070901|P4|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
931459|NCT00908037|3070902|P3|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
931460|NCT00908037|3070903|P2|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
931461|NCT00908037|3070904|P1|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
931462|NCT00908037|3070893|P12|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
931463|NCT00908037|3070894|P11|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
931464|NCT00908037|3070895|P10|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1
931465|NCT00908037|3070896|P9|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
931466|NCT00908037|3070897|P8|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
931467|NCT00908037|3070898|P7|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
931468|NCT00908037|3070899|P6|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
931469|NCT00908037|3070900|P5|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
931470|NCT00908037|3070901|P4|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
931471|NCT00908037|3070902|P3|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
931472|NCT00908037|3070903|P2|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
931473|NCT00908037|3070904|P1|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
931474|NCT00908037|3070893|P12|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2
931475|NCT00908037|3070894|P11|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
931476|NCT00908037|3070895|P10|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1
931477|NCT00908037|3070896|P9|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
931478|NCT00908037|3070897|P8|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
931479|NCT00908037|3070898|P7|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
931480|NCT00908037|3070899|P6|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
931481|NCT00908037|3070900|P5|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
931482|NCT00908037|3070901|P4|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
931483|NCT00908037|3070902|P3|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
931484|NCT00908037|3070903|P2|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
931485|NCT00908037|3070904|P1|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
931486|NCT00908037|3070893|P12|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1
931487|NCT00908037|3070894|P11|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
931488|NCT00908037|3070895|P10|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
931489|NCT00908037|3070896|P9|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
931490|NCT00908037|3070897|P8|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
931491|NCT00908037|3070898|P7|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
931492|NCT00908037|3070899|P6|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
931493|NCT00908037|3070900|P5|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
931494|NCT00908037|3070901|P4|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
931495|NCT00908037|3070902|P3|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
931496|NCT00908037|3070903|P2|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
931497|NCT00908037|3070904|P1|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
931498|NCT00908037|3070893|P12|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
931499|NCT00908037|3070894|P11|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
931500|NCT00908037|3070895|P10|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
931501|NCT00908037|3070896|P9|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
931502|NCT00908037|3070897|P8|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
931503|NCT00908037|3070898|P7|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
931504|NCT00908037|3070899|P6|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
931505|NCT00908037|3070900|P5|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
931506|NCT00908037|3070901|P4|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
931507|NCT00908037|3070902|P3|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
931508|NCT00908037|3070903|P2|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
931509|NCT00908037|3070904|P1|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
931510|NCT00908037|3070893|P12|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
931511|NCT00908037|3070894|P11|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
931512|NCT00908037|3070895|P10|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
931513|NCT00908037|3070896|P9|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4
931514|NCT00908037|3070897|P8|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
931515|NCT00908037|3070898|P7|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
931516|NCT00908037|3070899|P6|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
931517|NCT00908037|3070900|P5|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2
931518|NCT00908037|3070901|P4|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
931519|NCT00908037|3070902|P3|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
931520|NCT00908037|3070903|P2|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
931521|NCT00908037|3070904|P1|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
931522|NCT00908037|3070893|P12|Part 2 (7 Week Randomized Period)|Protocol Violation|0
931523|NCT00908037|3070894|P11|Part 2 (7 Week Randomized Period)|Protocol Violation|0
931524|NCT00908037|3070895|P10|Part 2 (7 Week Randomized Period)|Protocol Violation|0
931525|NCT00908037|3070896|P9|Part 2 (7 Week Randomized Period)|Protocol Violation|1
931526|NCT00908037|3070897|P8|Part 2 (7 Week Randomized Period)|Protocol Violation|0
931527|NCT00908037|3070898|P7|Part 2 (7 Week Randomized Period)|Protocol Violation|3
931528|NCT00908037|3070899|P6|Part 2 (7 Week Randomized Period)|Protocol Violation|0
931529|NCT00908037|3070900|P5|Part 2 (7 Week Randomized Period)|Protocol Violation|1
931530|NCT00908037|3070901|P4|Part 2 (7 Week Randomized Period)|Protocol Violation|0
931531|NCT00908037|3070902|P3|Part 2 (7 Week Randomized Period)|Protocol Violation|0
931532|NCT00908037|3070903|P2|Part 2 (7 Week Randomized Period)|Protocol Violation|0
931533|NCT00908037|3070904|P1|Part 2 (7 Week Randomized Period)|Protocol Violation|0
931534|NCT00908011|3071053|P2|Overall Study|Withdrawal by Subject|2
931535|NCT00908011|3071054|P1|Overall Study|Withdrawal by Subject|2
931536|NCT00907881|3071071|P1|Overall Study|Missing discontinuation information|15
931537|NCT00907881|3071071|P1|Overall Study|Protocol Violation|1
931538|NCT00907881|3071071|P1|Overall Study|Withdrawal by Subject|5
931539|NCT00907881|3071071|P1|Overall Study|Noncompliance|5
931540|NCT00907881|3071071|P1|Overall Study|Lost to Follow-up|59
931541|NCT00907803|3071081|P3|Overall Study|Protocol Violation|0
931542|NCT00907803|3071082|P2|Overall Study|Protocol Violation|1
931543|NCT00907803|3071083|P1|Overall Study|Protocol Violation|0
931544|NCT00907803|3071081|P3|Overall Study|Lost to Follow-up|0
931545|NCT00907803|3071082|P2|Overall Study|Lost to Follow-up|1
931546|NCT00907803|3071083|P1|Overall Study|Lost to Follow-up|0
931547|NCT00907803|3071081|P3|Overall Study|Withdrawal by Subject|0
931548|NCT00907803|3071082|P2|Overall Study|Withdrawal by Subject|1
931549|NCT00907803|3071083|P1|Overall Study|Withdrawal by Subject|0
931550|NCT00907803|3071081|P3|Overall Study|Adverse Event|0
931551|NCT00907803|3071082|P2|Overall Study|Adverse Event|0
931552|NCT00907803|3071083|P1|Overall Study|Adverse Event|2
931553|NCT00907803|3071081|P3|Overall Study|Withdrawal of consent - long commute|0
931554|NCT00907803|3071082|P2|Overall Study|Withdrawal of consent - long commute|0
931555|NCT00907803|3071083|P1|Overall Study|Withdrawal of consent - long commute|1
931556|NCT00907777|3071114|P2|Overall Study|Withdrawal by Subject|1
931557|NCT00907777|3071115|P1|Overall Study|Withdrawal by Subject|0
931558|NCT00907738|3071142|P5|Overall Study|Disease progression|2
931559|NCT00907738|3071143|P4|Overall Study|Disease progression|4
931560|NCT00907738|3071144|P3|Overall Study|Disease progression|6
931561|NCT00907738|3071145|P2|Overall Study|Disease progression|1
931562|NCT00907738|3071146|P1|Overall Study|Disease progression|8
931563|NCT00907738|3071142|P5|Overall Study|not specified or withdrew consent|0
931564|NCT00907738|3071143|P4|Overall Study|not specified or withdrew consent|0
931565|NCT00907738|3071144|P3|Overall Study|not specified or withdrew consent|0
931566|NCT00907738|3071145|P2|Overall Study|not specified or withdrew consent|0
931567|NCT00907738|3071146|P1|Overall Study|not specified or withdrew consent|3
931568|NCT00907738|3071142|P5|Overall Study|Adverse Event|0
931569|NCT00907738|3071143|P4|Overall Study|Adverse Event|0
931570|NCT00907738|3071144|P3|Overall Study|Adverse Event|1
931571|NCT00907738|3071145|P2|Overall Study|Adverse Event|0
931572|NCT00907738|3071146|P1|Overall Study|Adverse Event|2
931573|NCT00907621|3071164|P2|Overall Study|intercurrent febrile illness|1
931574|NCT00907621|3071165|P1|Overall Study|intercurrent febrile illness|1
931575|NCT00907621|3071164|P2|Overall Study|Lost to Follow-up|3
931576|NCT00907621|3071165|P1|Overall Study|Lost to Follow-up|6
931577|NCT00907517|3071178|P5|Overall Study|Symptomatic Deterioration|1
931578|NCT00907517|3071179|P4|Overall Study|Symptomatic Deterioration|0
931579|NCT00907517|3071180|P3|Overall Study|Symptomatic Deterioration|0
931580|NCT00907517|3071181|P2|Overall Study|Symptomatic Deterioration|0
931581|NCT00907517|3071182|P1|Overall Study|Symptomatic Deterioration|0
931582|NCT00907517|3071178|P5|Overall Study|Progressive Disease|4
931583|NCT00907517|3071179|P4|Overall Study|Progressive Disease|4
931584|NCT00907517|3071180|P3|Overall Study|Progressive Disease|4
931585|NCT00907517|3071181|P2|Overall Study|Progressive Disease|3
931586|NCT00907517|3071182|P1|Overall Study|Progressive Disease|3
931587|NCT00907478|3071207|P3|Overall Study|Other|1
931588|NCT00907478|3071208|P2|Overall Study|Other|0
931589|NCT00907478|3071209|P1|Overall Study|Other|3
931590|NCT00907478|3071207|P3|Overall Study|Lost to Follow-up|0
931591|NCT00907478|3071208|P2|Overall Study|Lost to Follow-up|0
931592|NCT00907478|3071209|P1|Overall Study|Lost to Follow-up|1
931593|NCT00907478|3071207|P3|Overall Study|Pregnancy|1
931594|NCT00907478|3071208|P2|Overall Study|Pregnancy|1
931595|NCT00907478|3071209|P1|Overall Study|Pregnancy|0
931596|NCT00907478|3071207|P3|Overall Study|Protocol-specified criteria|3
931597|NCT00907478|3071208|P2|Overall Study|Protocol-specified criteria|2
931598|NCT00907478|3071209|P1|Overall Study|Protocol-specified criteria|5
931599|NCT00907478|3071207|P3|Overall Study|Death|1
931600|NCT00907478|3071208|P2|Overall Study|Death|2
931601|NCT00907478|3071209|P1|Overall Study|Death|4
931602|NCT00907478|3071207|P3|Overall Study|Physician Decision|3
931603|NCT00907478|3071208|P2|Overall Study|Physician Decision|0
931604|NCT00907478|3071209|P1|Overall Study|Physician Decision|2
931605|NCT00907478|3071207|P3|Overall Study|Requirement for alternative therapy|3
931606|NCT00907478|3071208|P2|Overall Study|Requirement for alternative therapy|2
931607|NCT00907478|3071209|P1|Overall Study|Requirement for alternative therapy|1
931608|NCT00907478|3071207|P3|Overall Study|Withdrawal by Subject|6
931609|NCT00907478|3071208|P2|Overall Study|Withdrawal by Subject|9
931610|NCT00907478|3071209|P1|Overall Study|Withdrawal by Subject|8
931611|NCT00907478|3071207|P3|Overall Study|Adverse Event|2
931612|NCT00907478|3071208|P2|Overall Study|Adverse Event|1
931613|NCT00907478|3071209|P1|Overall Study|Adverse Event|3
931614|NCT00907478|3071207|P3|Overall Study|Noncompliance|1
931615|NCT00907478|3071208|P2|Overall Study|Noncompliance|0
931616|NCT00907478|3071209|P1|Overall Study|Noncompliance|0
931617|NCT00907478|3071207|P3|Overall Study|Ineligibility determined|1
931618|NCT00907478|3071208|P2|Overall Study|Ineligibility determined|0
931619|NCT00907478|3071209|P1|Overall Study|Ineligibility determined|0
931620|NCT00907374|3071259|P2|Overall Study|Noncompliant w/study protocol at <3 mos|2
931621|NCT00907374|3071260|P1|Overall Study|Noncompliant w/study protocol at <3 mos|2
931622|NCT00907335|3071274|P2|Overall Study|Lost to Follow-up|0
931623|NCT00907335|3071275|P1|Overall Study|Lost to Follow-up|2
931624|NCT00907335|3071274|P2|Overall Study|Adverse Event|1
931625|NCT00907335|3071275|P1|Overall Study|Adverse Event|4
931626|NCT00907335|3071274|P2|Overall Study|Withdrawal by Subject|0
931627|NCT00907335|3071275|P1|Overall Study|Withdrawal by Subject|2
931628|NCT00907257|3071293|P2|Overall Study|Personal Reasons|1
931629|NCT00907257|3071294|P1|Overall Study|Personal Reasons|6
931630|NCT00907257|3071293|P2|Overall Study|Moved|0
931631|NCT00907257|3071294|P1|Overall Study|Moved|1
931632|NCT00907257|3071293|P2|Overall Study|Per IRB-Subject became vulnerable|0
931633|NCT00907257|3071294|P1|Overall Study|Per IRB-Subject became vulnerable|1
931634|NCT00907257|3071293|P2|Overall Study|Withdrawal by Subject|2
931635|NCT00907257|3071294|P1|Overall Study|Withdrawal by Subject|1
931636|NCT00907257|3071293|P2|Overall Study|Lost to Follow-up|3
931637|NCT00907257|3071294|P1|Overall Study|Lost to Follow-up|3
931638|NCT00907257|3071293|P2|Overall Study|Protocol Violation|2
931639|NCT00907257|3071294|P1|Overall Study|Protocol Violation|1
931640|NCT00907257|3071293|P2|Overall Study|Adverse Event|4
931641|NCT00907257|3071294|P1|Overall Study|Adverse Event|0
931642|NCT00907153|3071316|P2|Overall Study|Withdrawal by Subject|3
931643|NCT00907153|3071317|P1|Overall Study|Withdrawal by Subject|1
931644|NCT00907153|3071316|P2|Overall Study|Lost to Follow-up|1
931645|NCT00907153|3071317|P1|Overall Study|Lost to Follow-up|1
931646|NCT00906971|3071378|P2|Overall Study|Lost to Follow-up|1
931647|NCT00906971|3071379|P1|Overall Study|Lost to Follow-up|0
931648|NCT00906971|3071378|P2|Overall Study|Withdrawal by Subject|2
931649|NCT00906971|3071379|P1|Overall Study|Withdrawal by Subject|8
931650|NCT00906945|3071392|P6|Overall Study|Physician Decision|1
931651|NCT00906945|3071393|P5|Overall Study|Physician Decision|0
931652|NCT00906945|3071394|P4|Overall Study|Physician Decision|0
931653|NCT00906945|3071395|P3|Overall Study|Physician Decision|0
931654|NCT00906945|3071396|P2|Overall Study|Physician Decision|0
931655|NCT00906945|3071397|P1|Overall Study|Physician Decision|0
931656|NCT00906945|3071392|P6|Overall Study|Found to be not eligible|1
931657|NCT00906945|3071393|P5|Overall Study|Found to be not eligible|1
931658|NCT00906945|3071394|P4|Overall Study|Found to be not eligible|1
931659|NCT00906945|3071395|P3|Overall Study|Found to be not eligible|0
931660|NCT00906945|3071396|P2|Overall Study|Found to be not eligible|0
931661|NCT00906945|3071397|P1|Overall Study|Found to be not eligible|0
931662|NCT00906698|3071457|P6|Overall Study|incl. non compliance, lost to follow-up|0
931663|NCT00906698|3071458|P5|Overall Study|incl. non compliance, lost to follow-up|0
931664|NCT00906698|3071459|P4|Overall Study|incl. non compliance, lost to follow-up|0
931665|NCT00906698|3071460|P3|Overall Study|incl. non compliance, lost to follow-up|0
931666|NCT00906698|3071461|P2|Overall Study|incl. non compliance, lost to follow-up|1
931667|NCT00906698|3071462|P1|Overall Study|incl. non compliance, lost to follow-up|0
931668|NCT00906698|3071457|P6|Overall Study|Withdrawal by Subject|0
931669|NCT00906698|3071458|P5|Overall Study|Withdrawal by Subject|1
931670|NCT00906698|3071459|P4|Overall Study|Withdrawal by Subject|0
931671|NCT00906698|3071460|P3|Overall Study|Withdrawal by Subject|0
931672|NCT00906698|3071461|P2|Overall Study|Withdrawal by Subject|0
931673|NCT00906698|3071462|P1|Overall Study|Withdrawal by Subject|0
931674|NCT00906698|3071457|P6|Overall Study|Disease progression|4
931675|NCT00906698|3071458|P5|Overall Study|Disease progression|12
931676|NCT00906698|3071459|P4|Overall Study|Disease progression|4
931677|NCT00906698|3071460|P3|Overall Study|Disease progression|4
931678|NCT00906698|3071461|P2|Overall Study|Disease progression|12
931679|NCT00906698|3071462|P1|Overall Study|Disease progression|3
931680|NCT00906698|3071457|P6|Overall Study|Adverse Event|1
931681|NCT00906698|3071458|P5|Overall Study|Adverse Event|4
931682|NCT00906698|3071459|P4|Overall Study|Adverse Event|0
931683|NCT00906698|3071460|P3|Overall Study|Adverse Event|2
931684|NCT00906698|3071461|P2|Overall Study|Adverse Event|0
931685|NCT00906698|3071462|P1|Overall Study|Adverse Event|0
931686|NCT00906698|3071457|P6|Overall Study|Dose-limiting toxicity (DLT)|0
931687|NCT00906698|3071458|P5|Overall Study|Dose-limiting toxicity (DLT)|1
931688|NCT00906698|3071459|P4|Overall Study|Dose-limiting toxicity (DLT)|0
931689|NCT00906698|3071460|P3|Overall Study|Dose-limiting toxicity (DLT)|0
931690|NCT00906698|3071461|P2|Overall Study|Dose-limiting toxicity (DLT)|6
931691|NCT00906698|3071462|P1|Overall Study|Dose-limiting toxicity (DLT)|0
931692|NCT00906399|3071564|P7|Year 2|Not specified|0
931693|NCT00906399|3071565|P6|Year 2|Not specified|1
931694|NCT00906399|3071566|P5|Year 2|Not specified|3
931695|NCT00906399|3071567|P4|Year 2|Not specified|2
931696|NCT00906399|3071568|P3|Year 2|Not specified|0
931697|NCT00906399|3071569|P2|Year 2|Not specified|0
931698|NCT00906399|3071570|P1|Year 2|Not specified|0
931699|NCT00906399|3071564|P7|Year 2|Death|3
931700|NCT00906399|3071565|P6|Year 2|Death|0
931701|NCT00906399|3071566|P5|Year 2|Death|0
931702|NCT00906399|3071567|P4|Year 2|Death|1
931703|NCT00906399|3071568|P3|Year 2|Death|0
931704|NCT00906399|3071569|P2|Year 2|Death|0
931705|NCT00906399|3071570|P1|Year 2|Death|0
931706|NCT00906399|3071564|P7|Year 2|Physician Decision|3
931707|NCT00906399|3071565|P6|Year 2|Physician Decision|6
931708|NCT00906399|3071566|P5|Year 2|Physician Decision|2
931709|NCT00906399|3071567|P4|Year 2|Physician Decision|0
931710|NCT00906399|3071568|P3|Year 2|Physician Decision|0
931711|NCT00906399|3071569|P2|Year 2|Physician Decision|0
931712|NCT00906399|3071570|P1|Year 2|Physician Decision|0
931713|NCT00906399|3071564|P7|Year 2|Withdrawal by Subject|13
931714|NCT00906399|3071565|P6|Year 2|Withdrawal by Subject|27
931715|NCT00906399|3071566|P5|Year 2|Withdrawal by Subject|18
931716|NCT00906399|3071567|P4|Year 2|Withdrawal by Subject|17
931717|NCT00906399|3071568|P3|Year 2|Withdrawal by Subject|0
931718|NCT00906399|3071569|P2|Year 2|Withdrawal by Subject|0
931719|NCT00906399|3071570|P1|Year 2|Withdrawal by Subject|0
931720|NCT00906399|3071564|P7|Year 2|Lost to Follow-up|4
931721|NCT00906399|3071565|P6|Year 2|Lost to Follow-up|2
931722|NCT00906399|3071566|P5|Year 2|Lost to Follow-up|4
931723|NCT00906399|3071567|P4|Year 2|Lost to Follow-up|1
931724|NCT00906399|3071568|P3|Year 2|Lost to Follow-up|0
931725|NCT00906399|3071569|P2|Year 2|Lost to Follow-up|0
931726|NCT00906399|3071570|P1|Year 2|Lost to Follow-up|0
931727|NCT00906399|3071564|P7|Year 2|Adverse Event|6
931728|NCT00906399|3071565|P6|Year 2|Adverse Event|11
931729|NCT00906399|3071566|P5|Year 2|Adverse Event|8
931730|NCT00906399|3071567|P4|Year 2|Adverse Event|9
931731|NCT00906399|3071568|P3|Year 2|Adverse Event|0
931732|NCT00906399|3071569|P2|Year 2|Adverse Event|0
931733|NCT00906399|3071570|P1|Year 2|Adverse Event|0
931734|NCT00906399|3071564|P7|Year 1|Not specified|0
931735|NCT00906399|3071565|P6|Year 1|Not specified|0
931736|NCT00906399|3071566|P5|Year 1|Not specified|0
931737|NCT00906399|3071567|P4|Year 1|Not specified|0
931738|NCT00906399|3071568|P3|Year 1|Not specified|7
931739|NCT00906399|3071569|P2|Year 1|Not specified|2
931740|NCT00906399|3071570|P1|Year 1|Not specified|4
931741|NCT00906399|3071564|P7|Year 1|Death|0
931742|NCT00906399|3071565|P6|Year 1|Death|0
931748|NCT00906399|3071564|P7|Year 1|Physician Decision|0
931749|NCT00906399|3071565|P6|Year 1|Physician Decision|0
931750|NCT00906399|3071566|P5|Year 1|Physician Decision|0
931751|NCT00906399|3071567|P4|Year 1|Physician Decision|0
931752|NCT00906399|3071568|P3|Year 1|Physician Decision|3
931753|NCT00906399|3071569|P2|Year 1|Physician Decision|1
931754|NCT00906399|3071570|P1|Year 1|Physician Decision|0
931755|NCT00906399|3071564|P7|Year 1|Withdrawal by Subject|0
931756|NCT00906399|3071565|P6|Year 1|Withdrawal by Subject|0
931757|NCT00906399|3071566|P5|Year 1|Withdrawal by Subject|0
931758|NCT00906399|3071567|P4|Year 1|Withdrawal by Subject|0
931759|NCT00906399|3071568|P3|Year 1|Withdrawal by Subject|36
931760|NCT00906399|3071569|P2|Year 1|Withdrawal by Subject|32
931761|NCT00906399|3071570|P1|Year 1|Withdrawal by Subject|30
931762|NCT00906399|3071564|P7|Year 1|Lost to Follow-up|0
931763|NCT00906399|3071565|P6|Year 1|Lost to Follow-up|0
931764|NCT00906399|3071566|P5|Year 1|Lost to Follow-up|0
931765|NCT00906399|3071567|P4|Year 1|Lost to Follow-up|0
931766|NCT00906399|3071568|P3|Year 1|Lost to Follow-up|2
931767|NCT00906399|3071569|P2|Year 1|Lost to Follow-up|4
931768|NCT00906399|3071570|P1|Year 1|Lost to Follow-up|4
931769|NCT00906399|3071564|P7|Year 1|Adverse Event|0
931770|NCT00906399|3071565|P6|Year 1|Adverse Event|0
931771|NCT00906399|3071566|P5|Year 1|Adverse Event|0
931772|NCT00906399|3071567|P4|Year 1|Adverse Event|0
931773|NCT00906399|3071568|P3|Year 1|Adverse Event|24
931774|NCT00906399|3071569|P2|Year 1|Adverse Event|22
931775|NCT00906399|3071570|P1|Year 1|Adverse Event|4
931776|NCT00906399|3071564|P7|Year 1|Randomized But Not Treated|0
931777|NCT00906399|3071565|P6|Year 1|Randomized But Not Treated|0
931778|NCT00906399|3071566|P5|Year 1|Randomized But Not Treated|0
931779|NCT00906399|3071567|P4|Year 1|Randomized But Not Treated|0
931780|NCT00906399|3071568|P3|Year 1|Randomized But Not Treated|3
931781|NCT00906399|3071569|P2|Year 1|Randomized But Not Treated|1
931782|NCT00906399|3071570|P1|Year 1|Randomized But Not Treated|0
931783|NCT00906373|3071593|P2|Overall Study|Still on treatment at cutoff date|2
931784|NCT00906373|3071594|P1|Overall Study|Still on treatment at cutoff date|0
931785|NCT00906373|3071593|P2|Overall Study|Other|1
931786|NCT00906373|3071594|P1|Overall Study|Other|0
931787|NCT00906373|3071593|P2|Overall Study|Withdrawal by Subject|5
931788|NCT00906373|3071594|P1|Overall Study|Withdrawal by Subject|0
931789|NCT00906347|3071633|P2|Received Study Drug|Uterine tachysystole or hypertonus|0
931790|NCT00906347|3071634|P1|Received Study Drug|Uterine tachysystole or hypertonus|8
931791|NCT00906347|3071633|P2|Received Study Drug|Refused study drug|0
931792|NCT00906347|3071634|P1|Received Study Drug|Refused study drug|1
931793|NCT00906347|3071633|P2|Received Study Drug|Nonreassuring fetal heart rate|1
931794|NCT00906347|3071634|P1|Received Study Drug|Nonreassuring fetal heart rate|13
931795|NCT00906347|3071633|P2|Received Study Drug|8 cm prior to initiation of study drug|30
931796|NCT00906347|3071634|P1|Received Study Drug|8 cm prior to initiation of study drug|18
931797|NCT00906282|3071654|P1|Preoperative Chemotherapy|Toxicity|1
931798|NCT00906282|3071654|P1|Preoperative Chemotherapy|Progressive disease|6
931799|NCT00906282|3071654|P1|Preoperative Chemotherapy|Not surgical candidates, off study|10
931800|NCT00906282|3071654|P1|Preoperative Chemotherapy|Withdrawal by Subject|2
931801|NCT00906204|3071668|P2|Secondary Endpoints (Long-term Safety)|Death|1
931802|NCT00906204|3071669|P1|Secondary Endpoints (Long-term Safety)|Death|0
931803|NCT00906204|3071668|P2|Secondary Endpoints (Long-term Safety)|Adverse Event|2
931804|NCT00906204|3071669|P1|Secondary Endpoints (Long-term Safety)|Adverse Event|2
931805|NCT00906204|3071668|P2|Primary Endpoint (Early Safety)|Withdrawal by Subject|0
931806|NCT00906204|3071669|P1|Primary Endpoint (Early Safety)|Withdrawal by Subject|1
931807|NCT00906204|3071668|P2|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1
931808|NCT00906204|3071669|P1|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0
931809|NCT00906204|3071668|P2|Primary Endpoint (Early Safety)|Physician Decision|0
931810|NCT00906204|3071669|P1|Primary Endpoint (Early Safety)|Physician Decision|1
931811|NCT00906087|3071700|P1|Initial Washout|Physician Decision|1
931812|NCT00906087|3071700|P1|Initial Washout|Withdrawal by Subject|1
931813|NCT00906035|3071737|P3|Overall Study|Withdrawal by Subject|0
931814|NCT00906035|3071738|P2|Overall Study|Withdrawal by Subject|3
931815|NCT00906035|3071739|P1|Overall Study|Withdrawal by Subject|2
931816|NCT00905840|3071753|P1|Overall Study|Adverse Event|1
931817|NCT00905840|3071753|P1|Overall Study|Withdrawal by Subject|1
931818|NCT00905840|3071753|P1|Overall Study|Death|3
931819|NCT00905840|3071753|P1|Overall Study|Lost to Follow-up|11
931820|NCT00905632|3071784|P7|Overall Study|Adverse Event|4
931821|NCT00905632|3071785|P6|Overall Study|Adverse Event|1
931822|NCT00905632|3071786|P5|Overall Study|Adverse Event|0
931823|NCT00905632|3071787|P4|Overall Study|Adverse Event|0
931824|NCT00905632|3071788|P3|Overall Study|Adverse Event|0
931825|NCT00905632|3071789|P2|Overall Study|Adverse Event|0
931826|NCT00905632|3071790|P1|Overall Study|Adverse Event|0
931827|NCT00905606|3071928|P2|Washout|Withdrawal by Subject|0
931828|NCT00905606|3071929|P1|Washout|Withdrawal by Subject|1
931829|NCT00905606|3071928|P2|Period 1|Adverse Event|1
931830|NCT00905606|3071929|P1|Period 1|Adverse Event|0
931831|NCT00905567|3071954|P2|Washout|Withdrawal by Subject|1
931832|NCT00905567|3071955|P1|Washout|Withdrawal by Subject|0
931833|NCT00905489|3071987|P1|Optional Extension Phase (OEP)|Adverse Event|1
931834|NCT00905489|3071987|P1|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3
931835|NCT00905489|3071987|P1|Pharmaco-kinetic (PK) Phase|Protocol Violation|2
931836|NCT00905437|3072036|P2|Overall Study|Other|6
931837|NCT00905437|3072037|P1|Overall Study|Other|5
931838|NCT00905437|3072036|P2|Overall Study|Withdrawal by Subject|1
931839|NCT00905437|3072037|P1|Overall Study|Withdrawal by Subject|0
931840|NCT00905437|3072036|P2|Overall Study|Lost to Follow-up|1
931841|NCT00905437|3072037|P1|Overall Study|Lost to Follow-up|0
931842|NCT00905437|3072036|P2|Overall Study|Adverse Event|2
931843|NCT00905437|3072037|P1|Overall Study|Adverse Event|3
931844|NCT00905424|3072057|P2|Overall Study|Non-adherence to visit schedule|1
931845|NCT00905424|3072058|P1|Overall Study|Non-adherence to visit schedule|0
931846|NCT00905424|3072057|P2|Overall Study|Positive urine drug screen|1
931847|NCT00905424|3072058|P1|Overall Study|Positive urine drug screen|0
931848|NCT00905424|3072057|P2|Overall Study|Sponsor decision|0
931849|NCT00905424|3072058|P1|Overall Study|Sponsor decision|1
931850|NCT00905424|3072057|P2|Overall Study|Non-compliance with study medication|0
931851|NCT00905424|3072058|P1|Overall Study|Non-compliance with study medication|2
931852|NCT00905424|3072057|P2|Overall Study|Adverse Event|2
931853|NCT00905424|3072058|P1|Overall Study|Adverse Event|4
931854|NCT00905424|3072057|P2|Overall Study|Withdrawal by Subject|2
931855|NCT00905424|3072058|P1|Overall Study|Withdrawal by Subject|1
931856|NCT00905424|3072057|P2|Overall Study|Lost to Follow-up|3
931857|NCT00905424|3072058|P1|Overall Study|Lost to Follow-up|3
931858|NCT00905359|3072100|P2|Overall Study|Withdrawal consent|6
931859|NCT00905359|3072101|P1|Overall Study|Withdrawal consent|5
931860|NCT00905359|3072100|P2|Overall Study|Death|0
931861|NCT00905359|3072101|P1|Overall Study|Death|2
931862|NCT00905359|3072100|P2|Overall Study|Lost to Follow-up|10
931863|NCT00905359|3072101|P1|Overall Study|Lost to Follow-up|17
931864|NCT00905346|3072137|P2|Period 1|Withdrawal by Subject|0
931865|NCT00905346|3072138|P1|Period 1|Withdrawal by Subject|1
931866|NCT00905307|3072152|P6|Overall Study|Lack of Efficacy|8
931867|NCT00905307|3072153|P5|Overall Study|Lack of Efficacy|4
931868|NCT00905307|3072154|P4|Overall Study|Lack of Efficacy|4
931869|NCT00905307|3072155|P3|Overall Study|Lack of Efficacy|5
931870|NCT00905307|3072156|P2|Overall Study|Lack of Efficacy|3
931871|NCT00905307|3072157|P1|Overall Study|Lack of Efficacy|6
931872|NCT00905307|3072152|P6|Overall Study|Protocol Violation|0
931873|NCT00905307|3072153|P5|Overall Study|Protocol Violation|0
931874|NCT00905307|3072154|P4|Overall Study|Protocol Violation|0
931875|NCT00905307|3072155|P3|Overall Study|Protocol Violation|1
931876|NCT00905307|3072156|P2|Overall Study|Protocol Violation|0
931877|NCT00905307|3072157|P1|Overall Study|Protocol Violation|1
931878|NCT00905307|3072152|P6|Overall Study|Withdrawal by Subject|13
931879|NCT00905307|3072153|P5|Overall Study|Withdrawal by Subject|4
931880|NCT00905307|3072154|P4|Overall Study|Withdrawal by Subject|11
931881|NCT00905307|3072155|P3|Overall Study|Withdrawal by Subject|15
931882|NCT00905307|3072156|P2|Overall Study|Withdrawal by Subject|13
931883|NCT00905307|3072157|P1|Overall Study|Withdrawal by Subject|5
931884|NCT00905307|3072152|P6|Overall Study|Adverse Event|5
931885|NCT00905307|3072153|P5|Overall Study|Adverse Event|3
931886|NCT00905307|3072154|P4|Overall Study|Adverse Event|11
931887|NCT00905307|3072155|P3|Overall Study|Adverse Event|5
931888|NCT00905307|3072156|P2|Overall Study|Adverse Event|4
931889|NCT00905307|3072157|P1|Overall Study|Adverse Event|3
931890|NCT00905307|3072152|P6|Overall Study|Lost to Follow-up|1
931891|NCT00905307|3072153|P5|Overall Study|Lost to Follow-up|1
931892|NCT00905307|3072154|P4|Overall Study|Lost to Follow-up|0
931893|NCT00905307|3072155|P3|Overall Study|Lost to Follow-up|0
931894|NCT00905307|3072156|P2|Overall Study|Lost to Follow-up|0
931895|NCT00905307|3072157|P1|Overall Study|Lost to Follow-up|0
931896|NCT00905307|3072152|P6|Overall Study|Switched to Open Label Rescue|15
931897|NCT00905307|3072153|P5|Overall Study|Switched to Open Label Rescue|4
931898|NCT00905307|3072154|P4|Overall Study|Switched to Open Label Rescue|11
931899|NCT00905307|3072155|P3|Overall Study|Switched to Open Label Rescue|11
931900|NCT00905307|3072156|P2|Overall Study|Switched to Open Label Rescue|17
931901|NCT00905307|3072157|P1|Overall Study|Switched to Open Label Rescue|7
931902|NCT00905255|3072252|P2|Overall Study|Familial and Personal Reasons|0
931903|NCT00905255|3072253|P1|Overall Study|Familial and Personal Reasons|1
931904|NCT00905255|3072252|P2|Overall Study|Withdrawal by Subject|4
931905|NCT00905255|3072253|P1|Overall Study|Withdrawal by Subject|5
931906|NCT00905255|3072252|P2|Overall Study|Adverse Event|5
931907|NCT00905255|3072253|P1|Overall Study|Adverse Event|7
931908|NCT00905164|3072271|P2|Period 1|Protocol Violation|1
931909|NCT00905164|3072272|P1|Period 1|Protocol Violation|0
931910|NCT00905034|3072319|P1|Overall Study|Withdrawal by Subject|1
931911|NCT00905021|3072323|P1|Overall Study|Adverse Event|2
931912|NCT00904982|3072341|P4|Overall Study|Withdrawal by Subject|0
931913|NCT00904982|3072342|P3|Overall Study|Withdrawal by Subject|0
931914|NCT00904982|3072343|P2|Overall Study|Withdrawal by Subject|0
931915|NCT00904982|3072344|P1|Overall Study|Withdrawal by Subject|2
931916|NCT00904969|3072354|P1|Overall Study|Case Aborted; Subject Exited|1
931917|NCT00904969|3072354|P1|Overall Study|Additional Treatments|11
931918|NCT00904969|3072354|P1|Overall Study|Withdrawal by Subject|3
931919|NCT00904969|3072354|P1|Overall Study|Lost to Follow-up|4
931920|NCT00904917|3072419|P4|Overall Study|Lost to Follow-up|2
931921|NCT00904917|3072420|P3|Overall Study|Lost to Follow-up|2
931922|NCT00904917|3072421|P2|Overall Study|Lost to Follow-up|2
931923|NCT00904917|3072422|P1|Overall Study|Lost to Follow-up|2
931924|NCT00904839|3072440|P3|Overall Study|Other than above|7
931925|NCT00904839|3072441|P2|Overall Study|Other than above|9
931926|NCT00904839|3072442|P1|Overall Study|Other than above|0
931927|NCT00904839|3072440|P3|Overall Study|Not treated|1
931928|NCT00904839|3072441|P2|Overall Study|Not treated|0
931929|NCT00904839|3072442|P1|Overall Study|Not treated|1
931930|NCT00904839|3072440|P3|Overall Study|Withdrawal by Subject|0
931931|NCT00904839|3072441|P2|Overall Study|Withdrawal by Subject|2
931932|NCT00904839|3072442|P1|Overall Study|Withdrawal by Subject|0
931933|NCT00904839|3072440|P3|Overall Study|Lost to Follow-up|2
931934|NCT00904839|3072441|P2|Overall Study|Lost to Follow-up|1
931935|NCT00904839|3072442|P1|Overall Study|Lost to Follow-up|0
931936|NCT00904839|3072440|P3|Overall Study|Protocol Violation|1
931937|NCT00904839|3072441|P2|Overall Study|Protocol Violation|1
931938|NCT00904839|3072442|P1|Overall Study|Protocol Violation|0
931939|NCT00904839|3072440|P3|Overall Study|Adverse Event|4
931940|NCT00904839|3072441|P2|Overall Study|Adverse Event|5
931941|NCT00904839|3072442|P1|Overall Study|Adverse Event|0
931942|NCT00904748|3072488|P6|Overall Study|Adverse Event|0
931943|NCT00904748|3072489|P5|Overall Study|Adverse Event|1
931944|NCT00904748|3072490|P4|Overall Study|Adverse Event|0
931945|NCT00904748|3072491|P3|Overall Study|Adverse Event|0
931946|NCT00904748|3072492|P2|Overall Study|Adverse Event|0
931947|NCT00904748|3072493|P1|Overall Study|Adverse Event|0
931948|NCT00904748|3072488|P6|Overall Study|Withdrawal by Subject|0
931949|NCT00904748|3072489|P5|Overall Study|Withdrawal by Subject|0
931950|NCT00904748|3072490|P4|Overall Study|Withdrawal by Subject|2
931951|NCT00904748|3072491|P3|Overall Study|Withdrawal by Subject|1
931952|NCT00904748|3072492|P2|Overall Study|Withdrawal by Subject|1
931953|NCT00904748|3072493|P1|Overall Study|Withdrawal by Subject|1
931954|NCT00904722|3072517|P1|Overall Study|Physician Decision|1
931955|NCT00904670|3072522|P2|Open Label Phase|Lost to Follow-up|0
931956|NCT00904670|3072523|P1|Open Label Phase|Lost to Follow-up|1
931957|NCT00904670|3072522|P2|Open Label Phase|Lack of Efficacy|0
931958|NCT00904670|3072523|P1|Open Label Phase|Lack of Efficacy|1
931959|NCT00904670|3072522|P2|Open Label Phase|Adverse Event|0
931960|NCT00904670|3072523|P1|Open Label Phase|Adverse Event|2
931961|NCT00904670|3072522|P2|Open Label Phase|Withdrawal by Subject|0
931962|NCT00904670|3072523|P1|Open Label Phase|Withdrawal by Subject|2
931963|NCT00904371|3072593|P1|Overall Study|Continued with Tritace|1
931964|NCT00904371|3072593|P1|Overall Study|Discontinued at target blood pressure|2
931965|NCT00904371|3072593|P1|Overall Study|Lost to Follow-up|4
931966|NCT00904371|3072593|P1|Overall Study|Adverse Event|2
931967|NCT00904215|3072607|P1|Overall Study|Other|28
931968|NCT00904215|3072607|P1|Overall Study|Withdrawal by Subject|9
931969|NCT00904215|3072607|P1|Overall Study|Lost to Follow-up|63
931970|NCT00904215|3072607|P1|Overall Study|Protocol Violation|10
931971|NCT00904215|3072607|P1|Overall Study|Adverse Event|25
931972|NCT00904150|3072621|P2|Saliva Samples (DNA)|Australian samples of different genotype|145
931973|NCT00904150|3072622|P1|Saliva Samples (DNA)|Australian samples of different genotype|0
931974|NCT00904150|3072621|P2|Saliva Samples (DNA)|saliva samples not suitable for assay|0
931975|NCT00904150|3072622|P1|Saliva Samples (DNA)|saliva samples not suitable for assay|3
931976|NCT00903968|3072651|P8|Overall Study|Lack of Efficacy|3
931977|NCT00903968|3072652|P7|Overall Study|Lack of Efficacy|0
931978|NCT00903968|3072653|P6|Overall Study|Lack of Efficacy|0
931979|NCT00903968|3072654|P5|Overall Study|Lack of Efficacy|0
931980|NCT00903968|3072655|P4|Overall Study|Lack of Efficacy|0
931981|NCT00903968|3072656|P3|Overall Study|Lack of Efficacy|0
931982|NCT00903968|3072657|P2|Overall Study|Lack of Efficacy|0
931983|NCT00903968|3072658|P1|Overall Study|Lack of Efficacy|0
931984|NCT00903968|3072651|P8|Overall Study|Progressive Disease|18
931985|NCT00903968|3072652|P7|Overall Study|Progressive Disease|0
931986|NCT00903968|3072653|P6|Overall Study|Progressive Disease|3
931987|NCT00903968|3072654|P5|Overall Study|Progressive Disease|3
931988|NCT00903968|3072655|P4|Overall Study|Progressive Disease|3
931989|NCT00903968|3072656|P3|Overall Study|Progressive Disease|2
931990|NCT00903968|3072657|P2|Overall Study|Progressive Disease|3
931991|NCT00903968|3072658|P1|Overall Study|Progressive Disease|2
931992|NCT00903968|3072651|P8|Overall Study|Physician Decision|0
931993|NCT00903968|3072652|P7|Overall Study|Physician Decision|0
931994|NCT00903968|3072653|P6|Overall Study|Physician Decision|1
931995|NCT00903968|3072654|P5|Overall Study|Physician Decision|0
931996|NCT00903968|3072655|P4|Overall Study|Physician Decision|0
931997|NCT00903968|3072656|P3|Overall Study|Physician Decision|0
931998|NCT00903968|3072657|P2|Overall Study|Physician Decision|0
931999|NCT00903968|3072658|P1|Overall Study|Physician Decision|0
932000|NCT00903968|3072651|P8|Overall Study|Non-Compliance|0
932001|NCT00903968|3072652|P7|Overall Study|Non-Compliance|0
932002|NCT00903968|3072653|P6|Overall Study|Non-Compliance|1
932003|NCT00903968|3072654|P5|Overall Study|Non-Compliance|0
932004|NCT00903968|3072655|P4|Overall Study|Non-Compliance|0
932005|NCT00903968|3072656|P3|Overall Study|Non-Compliance|0
932006|NCT00903968|3072657|P2|Overall Study|Non-Compliance|0
932007|NCT00903968|3072658|P1|Overall Study|Non-Compliance|0
932008|NCT00903968|3072651|P8|Overall Study|Withdrawal by Subject|4
932009|NCT00903968|3072652|P7|Overall Study|Withdrawal by Subject|0
932010|NCT00903968|3072653|P6|Overall Study|Withdrawal by Subject|1
932011|NCT00903968|3072654|P5|Overall Study|Withdrawal by Subject|1
932012|NCT00903968|3072655|P4|Overall Study|Withdrawal by Subject|0
932013|NCT00903968|3072656|P3|Overall Study|Withdrawal by Subject|1
932014|NCT00903968|3072657|P2|Overall Study|Withdrawal by Subject|0
932015|NCT00903968|3072658|P1|Overall Study|Withdrawal by Subject|1
932016|NCT00903968|3072651|P8|Overall Study|DLT|0
932017|NCT00903968|3072652|P7|Overall Study|DLT|2
932018|NCT00903968|3072653|P6|Overall Study|DLT|0
932019|NCT00903968|3072654|P5|Overall Study|DLT|0
932020|NCT00903968|3072655|P4|Overall Study|DLT|0
932021|NCT00903968|3072656|P3|Overall Study|DLT|0
932022|NCT00903968|3072657|P2|Overall Study|DLT|0
932023|NCT00903968|3072658|P1|Overall Study|DLT|0
932024|NCT00903968|3072651|P8|Overall Study|Adverse Event|8
932025|NCT00903968|3072652|P7|Overall Study|Adverse Event|1
932026|NCT00903968|3072653|P6|Overall Study|Adverse Event|0
932027|NCT00903968|3072654|P5|Overall Study|Adverse Event|0
932028|NCT00903968|3072655|P4|Overall Study|Adverse Event|0
932029|NCT00903968|3072656|P3|Overall Study|Adverse Event|0
932030|NCT00903968|3072657|P2|Overall Study|Adverse Event|0
932031|NCT00903968|3072658|P1|Overall Study|Adverse Event|0
932032|NCT00903929|3072688|P4|Overall Study|Adverse Event|1
932033|NCT00903929|3072689|P3|Overall Study|Adverse Event|0
932034|NCT00903929|3072690|P2|Overall Study|Adverse Event|0
932035|NCT00903929|3072691|P1|Overall Study|Adverse Event|0
932036|NCT00903929|3072688|P4|Overall Study|Withdrawal by Subject|2
932037|NCT00903929|3072689|P3|Overall Study|Withdrawal by Subject|1
932038|NCT00903929|3072690|P2|Overall Study|Withdrawal by Subject|0
932039|NCT00903929|3072691|P1|Overall Study|Withdrawal by Subject|0
932040|NCT00903877|3072697|P1|Overall Study|Participation put on hold|4
932041|NCT00903877|3072697|P1|Overall Study|Lost to Follow-up|1
932042|NCT00903877|3072697|P1|Overall Study|Adverse Event|2
932043|NCT00903877|3072697|P1|Overall Study|Withdrawal by Subject|3
932044|NCT00903877|3072697|P1|Overall Study|Did not meet study criteria|33
932045|NCT00903786|3072701|P1|Overall Study|Reason other than lack of efficacy|4
932046|NCT00903786|3072701|P1|Overall Study|Lack of Efficacy|5
932047|NCT00903786|3072701|P1|Overall Study|Physician Decision|6
932048|NCT00903760|3072711|P2|Overall Study|Off treatment for long period|1
932049|NCT00903760|3072712|P1|Overall Study|Off treatment for long period|0
932050|NCT00903760|3072711|P2|Overall Study|Withdrawal by Subject|2
932051|NCT00903760|3072712|P1|Overall Study|Withdrawal by Subject|1
932052|NCT00903760|3072711|P2|Overall Study|Lost to Follow-up|0
932053|NCT00903760|3072712|P1|Overall Study|Lost to Follow-up|1
932054|NCT00903760|3072711|P2|Overall Study|Death|1
932055|NCT00903760|3072712|P1|Overall Study|Death|0
932056|NCT00903760|3072711|P2|Overall Study|Physician Decision|2
932057|NCT00903760|3072712|P1|Overall Study|Physician Decision|1
932058|NCT00903760|3072711|P2|Overall Study|Stem Cell Transplant|4
932059|NCT00903760|3072712|P1|Overall Study|Stem Cell Transplant|8
932060|NCT00903760|3072711|P2|Overall Study|Disease Progression/Death|6
932061|NCT00903760|3072712|P1|Overall Study|Disease Progression/Death|8
932062|NCT00903695|3072722|P2|Overall Study|lung cancer|0
932063|NCT00903695|3072723|P1|Overall Study|lung cancer|1
932064|NCT00903695|3072722|P2|Overall Study|medical exclusion after 1st testing|0
932065|NCT00903695|3072723|P1|Overall Study|medical exclusion after 1st testing|1
932066|NCT00903682|3072745|P2|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0
932067|NCT00903682|3072746|P1|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1
932068|NCT00903682|3072745|P2|Overall Study|Patient Couldn't Come For The Visit Due|0
932069|NCT00903682|3072746|P1|Overall Study|Patient Couldn't Come For The Visit Due|1
932070|NCT00903682|3072745|P2|Overall Study|Subject Non-Compliant|0
932071|NCT00903682|3072746|P1|Overall Study|Subject Non-Compliant|1
932072|NCT00903682|3072745|P2|Overall Study|Subject Reached A Virologic Endpoint|1
932073|NCT00903682|3072746|P1|Overall Study|Subject Reached A Virologic Endpoint|1
932074|NCT00903682|3072745|P2|Overall Study|Pregnancy|1
932075|NCT00903682|3072746|P1|Overall Study|Pregnancy|0
932076|NCT00903682|3072745|P2|Overall Study|Withdrawal by Subject|0
932077|NCT00903682|3072746|P1|Overall Study|Withdrawal by Subject|5
932078|NCT00903682|3072745|P2|Overall Study|Lost to Follow-up|0
932079|NCT00903682|3072746|P1|Overall Study|Lost to Follow-up|1
932080|NCT00903682|3072745|P2|Overall Study|Adverse Event|13
932081|NCT00903682|3072746|P1|Overall Study|Adverse Event|6
932082|NCT00903630|3072767|P3|Phase 2|Adverse Event|1
932083|NCT00903630|3072768|P2|Phase 2|Adverse Event|0
932084|NCT00903630|3072769|P1|Phase 2|Adverse Event|0
932085|NCT00903617|3072787|P4|Overall Study|Withdrawal by Subject|0
932086|NCT00903617|3072788|P3|Overall Study|Withdrawal by Subject|3
932087|NCT00903617|3072789|P2|Overall Study|Withdrawal by Subject|2
932088|NCT00903617|3072790|P1|Overall Study|Withdrawal by Subject|1
932089|NCT00903617|3072787|P4|Overall Study|Lost to Follow-up|1
932090|NCT00903617|3072788|P3|Overall Study|Lost to Follow-up|1
932091|NCT00903617|3072789|P2|Overall Study|Lost to Follow-up|0
932092|NCT00903617|3072790|P1|Overall Study|Lost to Follow-up|2
932093|NCT00903617|3072787|P4|Overall Study|Protocol-defined stopping criteria|0
932094|NCT00903617|3072788|P3|Overall Study|Protocol-defined stopping criteria|0
932095|NCT00903617|3072789|P2|Overall Study|Protocol-defined stopping criteria|2
932096|NCT00903617|3072790|P1|Overall Study|Protocol-defined stopping criteria|0
932097|NCT00903617|3072787|P4|Overall Study|Adverse Event|0
932098|NCT00903617|3072788|P3|Overall Study|Adverse Event|1
932099|NCT00903617|3072789|P2|Overall Study|Adverse Event|1
932100|NCT00903617|3072790|P1|Overall Study|Adverse Event|0
932101|NCT00903409|3072893|P2|Overall Study|Lost to Follow-up|6
932102|NCT00903409|3072894|P1|Overall Study|Lost to Follow-up|2
932103|NCT00903409|3072893|P2|Overall Study|Not specified|3
932104|NCT00903409|3072894|P1|Overall Study|Not specified|2
932105|NCT00903409|3072893|P2|Overall Study|Withdrawal by Subject|8
932106|NCT00903409|3072894|P1|Overall Study|Withdrawal by Subject|8
932107|NCT00903409|3072893|P2|Overall Study|Laboratory Abnormality|0
932108|NCT00903409|3072894|P1|Overall Study|Laboratory Abnormality|2
932109|NCT00903409|3072893|P2|Overall Study|Non-compliance with Protocol|1
932110|NCT00903409|3072894|P1|Overall Study|Non-compliance with Protocol|1
932111|NCT00903409|3072893|P2|Overall Study|Adverse Event|9
932112|NCT00903409|3072894|P1|Overall Study|Adverse Event|11
932113|NCT00903383|3072945|P4|Overall Study|Patient Decision|1
932114|NCT00903383|3072946|P3|Overall Study|Patient Decision|0
932115|NCT00903383|3072947|P2|Overall Study|Patient Decision|0
932116|NCT00903383|3072948|P1|Overall Study|Patient Decision|0
932117|NCT00903383|3072945|P4|Overall Study|Patient Decision - Lack of Efficacy|0
932118|NCT00903383|3072946|P3|Overall Study|Patient Decision - Lack of Efficacy|0
932119|NCT00903383|3072947|P2|Overall Study|Patient Decision - Lack of Efficacy|1
932120|NCT00903383|3072948|P1|Overall Study|Patient Decision - Lack of Efficacy|0
932121|NCT00903383|3072945|P4|Overall Study|Withdrawal by Subject|2
932122|NCT00903383|3072946|P3|Overall Study|Withdrawal by Subject|0
932123|NCT00903383|3072947|P2|Overall Study|Withdrawal by Subject|1
932124|NCT00903383|3072948|P1|Overall Study|Withdrawal by Subject|4
932125|NCT00903383|3072945|P4|Overall Study|Decision of Sponsor|0
932126|NCT00903383|3072946|P3|Overall Study|Decision of Sponsor|0
932127|NCT00903383|3072947|P2|Overall Study|Decision of Sponsor|0
932128|NCT00903383|3072948|P1|Overall Study|Decision of Sponsor|1
932129|NCT00903383|3072945|P4|Overall Study|Lost to Follow-up|1
932130|NCT00903383|3072946|P3|Overall Study|Lost to Follow-up|0
932131|NCT00903383|3072947|P2|Overall Study|Lost to Follow-up|0
932132|NCT00903383|3072948|P1|Overall Study|Lost to Follow-up|0
932133|NCT00903383|3072945|P4|Overall Study|Physician Decision|0
932134|NCT00903383|3072946|P3|Overall Study|Physician Decision|0
932135|NCT00903383|3072947|P2|Overall Study|Physician Decision|2
932136|NCT00903383|3072948|P1|Overall Study|Physician Decision|1
932137|NCT00903383|3072945|P4|Overall Study|Adverse Event|1
932138|NCT00903383|3072946|P3|Overall Study|Adverse Event|3
932139|NCT00903383|3072947|P2|Overall Study|Adverse Event|2
932140|NCT00903383|3072948|P1|Overall Study|Adverse Event|1
932141|NCT00903370|3072980|P2|Overall Study|Lost to Follow-up|8
932142|NCT00903370|3072981|P1|Overall Study|Lost to Follow-up|6
932143|NCT00903370|3072980|P2|Overall Study|Withdrawal by Subject|6
932144|NCT00903370|3072981|P1|Overall Study|Withdrawal by Subject|9
932145|NCT00903370|3072980|P2|Overall Study|Death|10
932146|NCT00903370|3072981|P1|Overall Study|Death|13
932147|NCT00903357|3072989|P2|Second Intervention|Lost to Follow-up|0
932148|NCT00903357|3072990|P1|Second Intervention|Lost to Follow-up|1
932149|NCT00903357|3072989|P2|Wash Out Period of 2 Weeks|Flu|1
932150|NCT00903357|3072990|P1|Wash Out Period of 2 Weeks|Flu|0
932151|NCT00903357|3072989|P2|First Intervention|Flu|1
932152|NCT00903357|3072990|P1|First Intervention|Flu|0
932153|NCT00903357|3072989|P2|First Intervention|Withdrawal by Subject|3
932154|NCT00903357|3072990|P1|First Intervention|Withdrawal by Subject|5
932155|NCT00903344|3073002|P2|Overall Study|Lost to Follow-up|0
932156|NCT00903344|3073003|P1|Overall Study|Lost to Follow-up|3
932157|NCT00903344|3073002|P2|Overall Study|Pregnancy|3
932158|NCT00903344|3073003|P1|Overall Study|Pregnancy|2
932159|NCT00903331|3073021|P2|Overall Study|Lung transplant|2
932160|NCT00903331|3073022|P1|Overall Study|Lung transplant|0
932161|NCT00903331|3073021|P2|Overall Study|Withdrawal of consent|8
932162|NCT00903331|3073022|P1|Overall Study|Withdrawal of consent|1
932163|NCT00903331|3073021|P2|Overall Study|Death|8
932164|NCT00903331|3073022|P1|Overall Study|Death|4
932165|NCT00903201|3073033|P3|Overall Study|Withdrawal by Subject|1
932166|NCT00903201|3073034|P2|Overall Study|Withdrawal by Subject|0
932167|NCT00903201|3073035|P1|Overall Study|Withdrawal by Subject|1
932168|NCT00903201|3073033|P3|Overall Study|Physician Decision|1
932169|NCT00903201|3073034|P2|Overall Study|Physician Decision|0
932170|NCT00903201|3073035|P1|Overall Study|Physician Decision|1
932171|NCT00903201|3073033|P3|Overall Study|Lost to Follow-up|0
932172|NCT00903201|3073034|P2|Overall Study|Lost to Follow-up|1
932173|NCT00903201|3073035|P1|Overall Study|Lost to Follow-up|0
932174|NCT00903201|3073033|P3|Overall Study|Protocol Violation|0
932175|NCT00903201|3073034|P2|Overall Study|Protocol Violation|1
932176|NCT00903201|3073035|P1|Overall Study|Protocol Violation|2
932177|NCT00903201|3073033|P3|Overall Study|Adverse Event|0
932178|NCT00903201|3073034|P2|Overall Study|Adverse Event|4
932179|NCT00903201|3073035|P1|Overall Study|Adverse Event|1
932180|NCT00903175|3073093|P2|Period 2 - Second Line|Death|2
932181|NCT00903175|3073094|P1|Period 2 - Second Line|Death|5
932182|NCT00903175|3073093|P2|Period 2 - Second Line|Administrative problems|9
932183|NCT00903175|3073094|P1|Period 2 - Second Line|Administrative problems|19
932184|NCT00903175|3073093|P2|Period 2 - Second Line|Lost to Follow-up|0
932185|NCT00903175|3073094|P1|Period 2 - Second Line|Lost to Follow-up|1
932186|NCT00903175|3073093|P2|Period 2 - Second Line|Withdrawal by Subject|5
932187|NCT00903175|3073094|P1|Period 2 - Second Line|Withdrawal by Subject|7
932188|NCT00903175|3073093|P2|Period 2 - Second Line|Adverse Event|20
932189|NCT00903175|3073094|P1|Period 2 - Second Line|Adverse Event|16
932190|NCT00903175|3073093|P2|Period 2 - Second Line|Missing|0
932191|NCT00903175|3073094|P1|Period 2 - Second Line|Missing|1
932192|NCT00903175|3073093|P2|Period 1 - First Line|Death|10
932193|NCT00903175|3073094|P1|Period 1 - First Line|Death|17
932194|NCT00903175|3073093|P2|Period 1 - First Line|Administrative problems|13
932195|NCT00903175|3073094|P1|Period 1 - First Line|Administrative problems|12
932196|NCT00903175|3073093|P2|Period 1 - First Line|Withdrawal by Subject|12
932197|NCT00903175|3073094|P1|Period 1 - First Line|Withdrawal by Subject|8
932198|NCT00903175|3073093|P2|Period 1 - First Line|Protocol Violation|3
932199|NCT00903175|3073094|P1|Period 1 - First Line|Protocol Violation|3
932200|NCT00903175|3073093|P2|Period 1 - First Line|Abnormal test procedure result(s)|0
932201|NCT00903175|3073094|P1|Period 1 - First Line|Abnormal test procedure result(s)|1
932202|NCT00903175|3073093|P2|Period 1 - First Line|Abnormal lab value(s)|1
932203|NCT00903175|3073094|P1|Period 1 - First Line|Abnormal lab value(s)|0
932204|NCT00903175|3073093|P2|Period 1 - First Line|Adverse Event|50
932205|NCT00903175|3073094|P1|Period 1 - First Line|Adverse Event|36
932206|NCT00903032|3073132|P2|Overall Study|Lost to Follow-up|2
932207|NCT00903032|3073133|P1|Overall Study|Lost to Follow-up|2
932208|NCT00903032|3073132|P2|Overall Study|Withdrawal by Subject|3
932209|NCT00903032|3073133|P1|Overall Study|Withdrawal by Subject|5
932210|NCT00903006|3073143|P4|Overall Study|Progressive Disease|0
932211|NCT00903006|3073144|P3|Overall Study|Progressive Disease|1
932212|NCT00903006|3073145|P2|Overall Study|Progressive Disease|3
932213|NCT00903006|3073146|P1|Overall Study|Progressive Disease|0
932214|NCT00903006|3073143|P4|Overall Study|Withdrawal by Subject|0
932215|NCT00903006|3073144|P3|Overall Study|Withdrawal by Subject|0
932216|NCT00903006|3073145|P2|Overall Study|Withdrawal by Subject|0
932217|NCT00903006|3073146|P1|Overall Study|Withdrawal by Subject|2
932218|NCT00902850|3073158|P2|Overall Study|Physician Decision|2
932219|NCT00902850|3073159|P1|Overall Study|Physician Decision|2
932220|NCT00902746|3073165|P1|Overall Study|Physician Decision|2
932221|NCT00902746|3073165|P1|Overall Study|Lost to Follow-up|3
932222|NCT00902746|3073165|P1|Overall Study|Adverse Event|8
932223|NCT00902746|3073165|P1|Overall Study|Withdrawal by Subject|16
932224|NCT00902746|3073165|P1|Overall Study|Protocol Violation|7
932225|NCT00902668|3073170|P1|Overall Study|Protocol stopped due to slow accrual.|3
932226|NCT00902564|3073174|P1|Overall Study|Withdrawal by Subject|2
932227|NCT00902538|3073189|P6|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
932228|NCT00902538|3073190|P5|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
932229|NCT00902538|3073191|P4|4-Randomized Double-blind 2 Treatments|Protocol Violation|3
932230|NCT00902538|3073192|P3|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
932231|NCT00902538|3073193|P2|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
932232|NCT00902538|3073194|P1|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
932233|NCT00902538|3073189|P6|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
932234|NCT00902538|3073190|P5|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1
932235|NCT00902538|3073191|P4|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3
932236|NCT00902538|3073192|P3|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
932237|NCT00902538|3073193|P2|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
932238|NCT00902538|3073194|P1|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
932239|NCT00902538|3073189|P6|4-Randomized Double-blind 2 Treatments|Adverse Event|1
932240|NCT00902538|3073190|P5|4-Randomized Double-blind 2 Treatments|Adverse Event|1
932241|NCT00902538|3073191|P4|4-Randomized Double-blind 2 Treatments|Adverse Event|3
932242|NCT00902538|3073192|P3|4-Randomized Double-blind 2 Treatments|Adverse Event|0
932243|NCT00902538|3073193|P2|4-Randomized Double-blind 2 Treatments|Adverse Event|0
932244|NCT00902538|3073194|P1|4-Randomized Double-blind 2 Treatments|Adverse Event|0
932245|NCT00902538|3073189|P6|3-Single-blind, Single Treatment|Lost to Follow-up|0
932246|NCT00902538|3073190|P5|3-Single-blind, Single Treatment|Lost to Follow-up|0
932247|NCT00902538|3073191|P4|3-Single-blind, Single Treatment|Lost to Follow-up|0
932248|NCT00902538|3073192|P3|3-Single-blind, Single Treatment|Lost to Follow-up|0
932249|NCT00902538|3073193|P2|3-Single-blind, Single Treatment|Lost to Follow-up|1
932250|NCT00902538|3073194|P1|3-Single-blind, Single Treatment|Lost to Follow-up|0
932251|NCT00902538|3073189|P6|3-Single-blind, Single Treatment|Withdrawal by Subject|0
932252|NCT00902538|3073190|P5|3-Single-blind, Single Treatment|Withdrawal by Subject|0
932253|NCT00902538|3073191|P4|3-Single-blind, Single Treatment|Withdrawal by Subject|0
932254|NCT00902538|3073192|P3|3-Single-blind, Single Treatment|Withdrawal by Subject|0
932255|NCT00902538|3073193|P2|3-Single-blind, Single Treatment|Withdrawal by Subject|4
932256|NCT00902538|3073194|P1|3-Single-blind, Single Treatment|Withdrawal by Subject|0
932257|NCT00902538|3073189|P6|3-Single-blind, Single Treatment|Protocol Violation|0
932258|NCT00902538|3073190|P5|3-Single-blind, Single Treatment|Protocol Violation|0
932259|NCT00902538|3073191|P4|3-Single-blind, Single Treatment|Protocol Violation|0
932260|NCT00902538|3073192|P3|3-Single-blind, Single Treatment|Protocol Violation|0
932261|NCT00902538|3073193|P2|3-Single-blind, Single Treatment|Protocol Violation|5
932262|NCT00902538|3073194|P1|3-Single-blind, Single Treatment|Protocol Violation|0
932263|NCT00902538|3073189|P6|3-Single-blind, Single Treatment|Adverse Event|0
932264|NCT00902538|3073190|P5|3-Single-blind, Single Treatment|Adverse Event|0
932265|NCT00902538|3073191|P4|3-Single-blind, Single Treatment|Adverse Event|0
932266|NCT00902538|3073192|P3|3-Single-blind, Single Treatment|Adverse Event|0
932267|NCT00902538|3073193|P2|3-Single-blind, Single Treatment|Adverse Event|5
932268|NCT00902538|3073194|P1|3-Single-blind, Single Treatment|Adverse Event|0
932269|NCT00902538|3073189|P6|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
932270|NCT00902538|3073190|P5|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
932271|NCT00902538|3073191|P4|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
932272|NCT00902538|3073192|P3|2-Randomized Double-blind 3 Treatments|Protocol Violation|2
932273|NCT00902538|3073193|P2|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
932274|NCT00902538|3073194|P1|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
932275|NCT00902538|3073189|P6|2-Randomized Double-blind 3 Treatments|Other|0
932276|NCT00902538|3073190|P5|2-Randomized Double-blind 3 Treatments|Other|0
932277|NCT00902538|3073191|P4|2-Randomized Double-blind 3 Treatments|Other|0
932278|NCT00902538|3073192|P3|2-Randomized Double-blind 3 Treatments|Other|0
932279|NCT00902538|3073193|P2|2-Randomized Double-blind 3 Treatments|Other|1
932280|NCT00902538|3073194|P1|2-Randomized Double-blind 3 Treatments|Other|2
932281|NCT00902538|3073189|P6|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
932282|NCT00902538|3073190|P5|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
932283|NCT00902538|3073191|P4|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
932284|NCT00902538|3073192|P3|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2
932285|NCT00902538|3073193|P2|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
932286|NCT00902538|3073194|P1|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1
932287|NCT00902538|3073189|P6|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
932288|NCT00902538|3073190|P5|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
932289|NCT00902538|3073191|P4|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
932290|NCT00902538|3073192|P3|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
932291|NCT00902538|3073193|P2|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2
932292|NCT00902538|3073194|P1|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
932293|NCT00902538|3073189|P6|2-Randomized Double-blind 3 Treatments|Adverse Event|0
932294|NCT00902538|3073190|P5|2-Randomized Double-blind 3 Treatments|Adverse Event|0
932295|NCT00902538|3073191|P4|2-Randomized Double-blind 3 Treatments|Adverse Event|0
932296|NCT00902538|3073192|P3|2-Randomized Double-blind 3 Treatments|Adverse Event|3
932297|NCT00902538|3073193|P2|2-Randomized Double-blind 3 Treatments|Adverse Event|2
932298|NCT00902538|3073194|P1|2-Randomized Double-blind 3 Treatments|Adverse Event|4
932299|NCT00902538|3073189|P6|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
932300|NCT00902538|3073190|P5|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
932301|NCT00902538|3073191|P4|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
932302|NCT00902538|3073192|P3|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
932303|NCT00902538|3073193|P2|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
932304|NCT00902538|3073194|P1|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4
932305|NCT00902538|3073189|P6|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
932306|NCT00902538|3073190|P5|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
932307|NCT00902538|3073191|P4|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
932308|NCT00902538|3073192|P3|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
932309|NCT00902538|3073193|P2|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
932310|NCT00902538|3073194|P1|1-Single-blind, Run-in, Single-Treatment|Other Reason|13
932311|NCT00902538|3073189|P6|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
932312|NCT00902538|3073190|P5|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
932313|NCT00902538|3073191|P4|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
932314|NCT00902538|3073192|P3|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
932315|NCT00902538|3073193|P2|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
932316|NCT00902538|3073194|P1|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22
932317|NCT00902538|3073189|P6|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
932318|NCT00902538|3073190|P5|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
932319|NCT00902538|3073191|P4|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
932320|NCT00902538|3073192|P3|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
932321|NCT00902538|3073193|P2|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
932322|NCT00902538|3073194|P1|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30
932323|NCT00902538|3073189|P6|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
932324|NCT00902538|3073190|P5|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
932325|NCT00902538|3073191|P4|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
932326|NCT00902538|3073192|P3|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
932327|NCT00902538|3073193|P2|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
932328|NCT00902538|3073194|P1|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49
932329|NCT00902486|3073228|P6|Follow-up (After Week 24)|Lost to Follow-up|0
932330|NCT00902486|3073229|P5|Follow-up (After Week 24)|Lost to Follow-up|0
932331|NCT00902486|3073230|P4|Follow-up (After Week 24)|Lost to Follow-up|1
932332|NCT00902486|3073231|P3|Follow-up (After Week 24)|Lost to Follow-up|0
932333|NCT00902486|3073232|P2|Follow-up (After Week 24)|Lost to Follow-up|0
932334|NCT00902486|3073233|P1|Follow-up (After Week 24)|Lost to Follow-up|0
932335|NCT00902486|3073228|P6|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
932336|NCT00902486|3073229|P5|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
932337|NCT00902486|3073230|P4|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
932338|NCT00902486|3073231|P3|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1
932339|NCT00902486|3073232|P2|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
932340|NCT00902486|3073233|P1|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
932341|NCT00902486|3073228|P6|Extension Period (Weeks 12 Through 24)|Disease Progression|0
932342|NCT00902486|3073229|P5|Extension Period (Weeks 12 Through 24)|Disease Progression|0
932343|NCT00902486|3073230|P4|Extension Period (Weeks 12 Through 24)|Disease Progression|1
932344|NCT00902486|3073231|P3|Extension Period (Weeks 12 Through 24)|Disease Progression|0
932345|NCT00902486|3073232|P2|Extension Period (Weeks 12 Through 24)|Disease Progression|0
932346|NCT00902486|3073233|P1|Extension Period (Weeks 12 Through 24)|Disease Progression|0
932347|NCT00902486|3073228|P6|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1
932348|NCT00902486|3073229|P5|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
932349|NCT00902486|3073230|P4|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
932350|NCT00902486|3073231|P3|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
932351|NCT00902486|3073232|P2|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
932352|NCT00902486|3073233|P1|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
932353|NCT00902486|3073228|P6|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
932354|NCT00902486|3073229|P5|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
932355|NCT00902486|3073230|P4|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
932356|NCT00902486|3073231|P3|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
932357|NCT00902486|3073232|P2|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
932358|NCT00902486|3073233|P1|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
932359|NCT00902486|3073228|P6|Extension Period (Weeks 12 Through 24)|Adverse Event|2
932360|NCT00902486|3073229|P5|Extension Period (Weeks 12 Through 24)|Adverse Event|1
932361|NCT00902486|3073230|P4|Extension Period (Weeks 12 Through 24)|Adverse Event|0
932362|NCT00902486|3073231|P3|Extension Period (Weeks 12 Through 24)|Adverse Event|0
932363|NCT00902486|3073232|P2|Extension Period (Weeks 12 Through 24)|Adverse Event|0
932364|NCT00902486|3073233|P1|Extension Period (Weeks 12 Through 24)|Adverse Event|0
932365|NCT00902486|3073228|P6|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
932366|NCT00902486|3073229|P5|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
932367|NCT00902486|3073230|P4|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1
932368|NCT00902486|3073231|P3|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
932369|NCT00902486|3073232|P2|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
932370|NCT00902486|3073233|P1|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
932371|NCT00902486|3073228|P6|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
932372|NCT00902486|3073229|P5|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
932373|NCT00902486|3073230|P4|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1
932374|NCT00902486|3073231|P3|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
932375|NCT00902486|3073232|P2|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
932376|NCT00902486|3073233|P1|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
932377|NCT00902486|3073228|P6|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
932378|NCT00902486|3073229|P5|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
932379|NCT00902486|3073230|P4|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
932380|NCT00902486|3073231|P3|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
932381|NCT00902486|3073232|P2|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
932382|NCT00902486|3073233|P1|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
932383|NCT00902486|3073228|P6|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2
932384|NCT00902486|3073229|P5|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
932385|NCT00902486|3073230|P4|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
932386|NCT00902486|3073231|P3|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
932387|NCT00902486|3073232|P2|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
932388|NCT00902486|3073233|P1|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1
932389|NCT00902486|3073228|P6|Treatment Period (Weeks 0 Through 12)|Adverse Event|2
932390|NCT00902486|3073229|P5|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
932391|NCT00902486|3073230|P4|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
932392|NCT00902486|3073231|P3|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
932393|NCT00902486|3073232|P2|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
932394|NCT00902486|3073233|P1|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
932395|NCT00902330|3073371|P2|Overall Study|No post baseline data|0
932396|NCT00902330|3073372|P1|Overall Study|No post baseline data|1
932397|NCT00902330|3073371|P2|Overall Study|Adverse Event|0
932398|NCT00902330|3073372|P1|Overall Study|Adverse Event|1
932399|NCT00902330|3073371|P2|Overall Study|Too overwhelmed by treatment|5
932400|NCT00902330|3073372|P1|Overall Study|Too overwhelmed by treatment|2
932401|NCT00902304|3073409|P3|Overall Study|includes pregnancy|2
932402|NCT00902304|3073410|P2|Overall Study|includes pregnancy|9
932403|NCT00902304|3073411|P1|Overall Study|includes pregnancy|3
932404|NCT00902304|3073409|P3|Overall Study|Withdrawal by Subject|43
932405|NCT00902304|3073410|P2|Overall Study|Withdrawal by Subject|22
932406|NCT00902304|3073411|P1|Overall Study|Withdrawal by Subject|32
932407|NCT00902304|3073409|P3|Overall Study|Protocol Violation|20
932408|NCT00902304|3073410|P2|Overall Study|Protocol Violation|18
932409|NCT00902304|3073411|P1|Overall Study|Protocol Violation|9
932410|NCT00902304|3073409|P3|Overall Study|Lost to Follow-up|7
932411|NCT00902304|3073410|P2|Overall Study|Lost to Follow-up|7
932412|NCT00902304|3073411|P1|Overall Study|Lost to Follow-up|7
932413|NCT00902304|3073409|P3|Overall Study|Investigator discretion|13
932414|NCT00902304|3073410|P2|Overall Study|Investigator discretion|5
932415|NCT00902304|3073411|P1|Overall Study|Investigator discretion|3
932416|NCT00902304|3073409|P3|Overall Study|Adverse Event|25
932417|NCT00902304|3073410|P2|Overall Study|Adverse Event|10
932418|NCT00902304|3073411|P1|Overall Study|Adverse Event|4
932419|NCT00902278|3073461|P5|Overall Study|Lost to Follow-up|1
932420|NCT00902278|3073462|P4|Overall Study|Lost to Follow-up|0
932421|NCT00902278|3073463|P3|Overall Study|Lost to Follow-up|3
932422|NCT00902278|3073464|P2|Overall Study|Lost to Follow-up|2
932423|NCT00902278|3073465|P1|Overall Study|Lost to Follow-up|3
932424|NCT00902278|3073461|P5|Overall Study|Physician Decision|1
932425|NCT00902278|3073462|P4|Overall Study|Physician Decision|0
932426|NCT00902278|3073463|P3|Overall Study|Physician Decision|2
932427|NCT00902278|3073464|P2|Overall Study|Physician Decision|0
932428|NCT00902278|3073465|P1|Overall Study|Physician Decision|1
932429|NCT00902265|3073482|P1|Overall Study|Protocol Violation|1
932430|NCT00902265|3073482|P1|Overall Study|Lack of Efficacy|2
932431|NCT00902265|3073482|P1|Overall Study|Adverse Event|2
932432|NCT00902265|3073482|P1|Overall Study|Lost to Follow-up Prior to First Visit|1
932433|NCT00902174|3073506|P2|Overall Study|Administration problem|1
932434|NCT00902174|3073507|P1|Overall Study|Administration problem|0
932435|NCT00902174|3073506|P2|Overall Study|Protocol Violation|1
932436|NCT00902174|3073507|P1|Overall Study|Protocol Violation|1
932437|NCT00902174|3073506|P2|Overall Study|Abnormal labs|1
932438|NCT00902174|3073507|P1|Overall Study|Abnormal labs|1
932439|NCT00902174|3073506|P2|Overall Study|Withdrawal by Subject|1
932440|NCT00902174|3073507|P1|Overall Study|Withdrawal by Subject|2
932441|NCT00902174|3073506|P2|Overall Study|Death|2
932442|NCT00902174|3073507|P1|Overall Study|Death|2
932443|NCT00902174|3073506|P2|Overall Study|Lack of Efficacy|5
932444|NCT00902174|3073507|P1|Overall Study|Lack of Efficacy|1
932445|NCT00902174|3073506|P2|Overall Study|Adverse Event|7
932446|NCT00902174|3073507|P1|Overall Study|Adverse Event|27
932447|NCT00901901|3073564|P2|Follow-up Period|Lost to Follow-up|8
932448|NCT00901901|3073565|P1|Follow-up Period|Lost to Follow-up|12
932449|NCT00901901|3073564|P2|Follow-up Period|Withdrawal by Subject|9
932450|NCT00901901|3073565|P1|Follow-up Period|Withdrawal by Subject|6
932451|NCT00901901|3073564|P2|Follow-up Period|Protocol driven decision point|35
932452|NCT00901901|3073565|P1|Follow-up Period|Protocol driven decision point|47
932453|NCT00901901|3073564|P2|Follow-up Period|Death|207
932454|NCT00901901|3073565|P1|Follow-up Period|Death|181
932455|NCT00901901|3073564|P2|Treatment Period|Never treated|3
932456|NCT00901901|3073565|P1|Treatment Period|Never treated|0
932457|NCT00901901|3073564|P2|Treatment Period|Missing|1
932458|NCT00901901|3073565|P1|Treatment Period|Missing|1
932459|NCT00901901|3073564|P2|Treatment Period|Protocol Violation|9
932460|NCT00901901|3073565|P1|Treatment Period|Protocol Violation|4
932461|NCT00901901|3073564|P2|Treatment Period|Noncompliance with study medication|1
932462|NCT00901901|3073565|P1|Treatment Period|Noncompliance with study medication|4
932463|NCT00901901|3073564|P2|Treatment Period|Lost to Follow-up|5
932464|NCT00901901|3073565|P1|Treatment Period|Lost to Follow-up|3
932465|NCT00901901|3073564|P2|Treatment Period|Physician Decision|2
932466|NCT00901901|3073565|P1|Treatment Period|Physician Decision|2
932467|NCT00901901|3073564|P2|Treatment Period|Withdrawal by Subject|24
932468|NCT00901901|3073565|P1|Treatment Period|Withdrawal by Subject|26
932469|NCT00901901|3073564|P2|Treatment Period|Adverse Event|123
932470|NCT00901901|3073565|P1|Treatment Period|Adverse Event|117
932471|NCT00901628|3073587|P2|Overall Study|peroneal nerve palsy|1
932472|NCT00901628|3073588|P1|Overall Study|peroneal nerve palsy|0
932473|NCT00901628|3073587|P2|Overall Study|disconnection of drain|1
932474|NCT00901628|3073588|P1|Overall Study|disconnection of drain|0
932475|NCT00901628|3073587|P2|Overall Study|disconnection of catheter|8
932476|NCT00901628|3073588|P1|Overall Study|disconnection of catheter|4
932477|NCT00901576|3073610|P6|Second Intervention|Physician Decision|0
932478|NCT00901576|3073611|P5|Second Intervention|Physician Decision|0
932479|NCT00901576|3073612|P4|Second Intervention|Physician Decision|0
932480|NCT00901576|3073613|P3|Second Intervention|Physician Decision|0
932481|NCT00901576|3073614|P2|Second Intervention|Physician Decision|0
932482|NCT00901576|3073615|P1|Second Intervention|Physician Decision|1
932483|NCT00901576|3073610|P6|Second Intervention|Withdrawal by Subject|1
932484|NCT00901576|3073611|P5|Second Intervention|Withdrawal by Subject|0
932485|NCT00901576|3073612|P4|Second Intervention|Withdrawal by Subject|1
932486|NCT00901576|3073613|P3|Second Intervention|Withdrawal by Subject|0
932487|NCT00901576|3073614|P2|Second Intervention|Withdrawal by Subject|0
932488|NCT00901576|3073615|P1|Second Intervention|Withdrawal by Subject|0
932489|NCT00901459|3073636|P1|Overall Study|Withdrawal by Subject|6
932490|NCT00901342|3073647|P1|Overall Study|Withdrawal by Subject|9
932491|NCT00901342|3073647|P1|Overall Study|Disease progression|1
932492|NCT00901342|3073647|P1|Overall Study|Death|4
932493|NCT00901342|3073647|P1|Overall Study|Adverse Event|1
932494|NCT00901186|3073680|P2|Overall Study|Protocol deviations|4
932495|NCT00901186|3073681|P1|Overall Study|Protocol deviations|5
932496|NCT00901186|3073680|P2|Overall Study|Administration problems|1
932497|NCT00901186|3073681|P1|Overall Study|Administration problems|0
932498|NCT00901186|3073680|P2|Overall Study|Adverse Event|4
932499|NCT00901186|3073681|P1|Overall Study|Adverse Event|2
932500|NCT00901186|3073680|P2|Overall Study|Lost to Follow-up|0
932501|NCT00901186|3073681|P1|Overall Study|Lost to Follow-up|2
932502|NCT00901186|3073680|P2|Overall Study|Abnormal laboratory values|1
932503|NCT00901186|3073681|P1|Overall Study|Abnormal laboratory values|0
932504|NCT00901186|3073680|P2|Overall Study|Lack of Efficacy|1
932505|NCT00901186|3073681|P1|Overall Study|Lack of Efficacy|0
932506|NCT00900796|3073721|P1|Phase 2|Lost to Follow-up|5
932507|NCT00900796|3073721|P1|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110
932508|NCT00900796|3073721|P1|Phase 1|Missing information at Week 16|7
932509|NCT00900796|3073721|P1|Phase 1|Lacked sufficient information|4
932510|NCT00900757|3073731|P1|Overall Study|screen failure|19
932511|NCT00900731|3073741|P2|Overall Study|Death|2
932512|NCT00900731|3073742|P1|Overall Study|Death|0
932513|NCT00900731|3073741|P2|Overall Study|Lack of Efficacy|3
932514|NCT00900731|3073742|P1|Overall Study|Lack of Efficacy|1
932515|NCT00900731|3073741|P2|Overall Study|Lost to Follow-up|3
932516|NCT00900731|3073742|P1|Overall Study|Lost to Follow-up|2
932517|NCT00900731|3073741|P2|Overall Study|Abnormal Laboratory Value(s)|4
932518|NCT00900731|3073742|P1|Overall Study|Abnormal Laboratory Value(s)|2
932519|NCT00900731|3073741|P2|Overall Study|Abnormal Test Procedure Result(s)|0
932520|NCT00900731|3073742|P1|Overall Study|Abnormal Test Procedure Result(s)|3
932521|NCT00900731|3073741|P2|Overall Study|Administrative Problems|4
932522|NCT00900731|3073742|P1|Overall Study|Administrative Problems|5
932523|NCT00900731|3073741|P2|Overall Study|Protocol Deviation|11
932524|NCT00900731|3073742|P1|Overall Study|Protocol Deviation|8
932525|NCT00900731|3073741|P2|Overall Study|Withdrawal by Subject|7
932526|NCT00900731|3073742|P1|Overall Study|Withdrawal by Subject|8
932527|NCT00900731|3073741|P2|Overall Study|Adverse Event|27
932528|NCT00900731|3073742|P1|Overall Study|Adverse Event|31
932529|NCT00900627|3073779|P6|Overall Study|Death|24
932530|NCT00900627|3073780|P5|Overall Study|Death|28
932531|NCT00900627|3073781|P4|Overall Study|Death|0
932532|NCT00900627|3073782|P3|Overall Study|Death|0
932533|NCT00900627|3073783|P2|Overall Study|Death|0
932534|NCT00900627|3073784|P1|Overall Study|Death|0
932535|NCT00900627|3073779|P6|Overall Study|Adverse Event|0
932536|NCT00900627|3073780|P5|Overall Study|Adverse Event|0
932537|NCT00900627|3073781|P4|Overall Study|Adverse Event|3
932538|NCT00900627|3073782|P3|Overall Study|Adverse Event|0
932539|NCT00900627|3073783|P2|Overall Study|Adverse Event|2
932540|NCT00900627|3073784|P1|Overall Study|Adverse Event|1
932541|NCT00900627|3073779|P6|Overall Study|Withdrawal by Subject|2
932542|NCT00900627|3073780|P5|Overall Study|Withdrawal by Subject|1
932543|NCT00900627|3073781|P4|Overall Study|Withdrawal by Subject|0
932544|NCT00900627|3073782|P3|Overall Study|Withdrawal by Subject|1
932545|NCT00900627|3073783|P2|Overall Study|Withdrawal by Subject|0
932546|NCT00900627|3073784|P1|Overall Study|Withdrawal by Subject|1
932547|NCT00900627|3073779|P6|Overall Study|Condition under investigation worsened|0
932548|NCT00900627|3073780|P5|Overall Study|Condition under investigation worsened|0
932549|NCT00900627|3073781|P4|Overall Study|Condition under investigation worsened|3
932550|NCT00900627|3073782|P3|Overall Study|Condition under investigation worsened|5
932551|NCT00900627|3073783|P2|Overall Study|Condition under investigation worsened|0
932552|NCT00900627|3073784|P1|Overall Study|Condition under investigation worsened|4
932553|NCT00900601|3073802|P1|Overall Study|Physician Decision|1
932554|NCT00900159|3073821|P2|Second Intervention|disempanelled for inappropriate behavior|0
932555|NCT00900159|3073822|P1|Second Intervention|disempanelled for inappropriate behavior|1
932556|NCT00900146|3073841|P5|Intermediate: Period III|Administrative problems|163
932557|NCT00900146|3073842|P4|Intermediate: Period III|Administrative problems|90
932558|NCT00900146|3073843|P3|Intermediate: Period III|Administrative problems|84
932559|NCT00900146|3073844|P2|Intermediate: Period III|Administrative problems|92
932560|NCT00900146|3073845|P1|Intermediate: Period III|Administrative problems|85
932561|NCT00900146|3073841|P5|Intermediate: Period III|Lost to Follow-up|1
932562|NCT00900146|3073842|P4|Intermediate: Period III|Lost to Follow-up|0
932563|NCT00900146|3073843|P3|Intermediate: Period III|Lost to Follow-up|0
932564|NCT00900146|3073844|P2|Intermediate: Period III|Lost to Follow-up|0
932565|NCT00900146|3073845|P1|Intermediate: Period III|Lost to Follow-up|2
932566|NCT00900146|3073841|P5|Intermediate: Period III|Withdrawal by Subject|3
932567|NCT00900146|3073842|P4|Intermediate: Period III|Withdrawal by Subject|0
932568|NCT00900146|3073843|P3|Intermediate: Period III|Withdrawal by Subject|0
932569|NCT00900146|3073844|P2|Intermediate: Period III|Withdrawal by Subject|1
932570|NCT00900146|3073845|P1|Intermediate: Period III|Withdrawal by Subject|0
932571|NCT00900146|3073841|P5|Dose Finding: Period II (4 Months)|Administrative problems|0
932572|NCT00900146|3073842|P4|Dose Finding: Period II (4 Months)|Administrative problems|0
932573|NCT00900146|3073843|P3|Dose Finding: Period II (4 Months)|Administrative problems|0
932574|NCT00900146|3073844|P2|Dose Finding: Period II (4 Months)|Administrative problems|0
932575|NCT00900146|3073845|P1|Dose Finding: Period II (4 Months)|Administrative problems|1
932576|NCT00900146|3073841|P5|Dose Finding: Period II (4 Months)|Lost to Follow-up|3
932577|NCT00900146|3073842|P4|Dose Finding: Period II (4 Months)|Lost to Follow-up|1
932578|NCT00900146|3073843|P3|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
932579|NCT00900146|3073844|P2|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
932580|NCT00900146|3073845|P1|Dose Finding: Period II (4 Months)|Lost to Follow-up|2
932581|NCT00900146|3073841|P5|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9
932582|NCT00900146|3073842|P4|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1
932583|NCT00900146|3073843|P3|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5
932584|NCT00900146|3073844|P2|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
932585|NCT00900146|3073845|P1|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
932586|NCT00900029|3073962|P5|Overall Study|Death|0
932587|NCT00900029|3073963|P4|Overall Study|Death|1
932588|NCT00900029|3073964|P3|Overall Study|Death|0
932589|NCT00900029|3073965|P2|Overall Study|Death|0
932590|NCT00900029|3073966|P1|Overall Study|Death|1
932591|NCT00900029|3073962|P5|Overall Study|Adverse Event|1
932592|NCT00900029|3073963|P4|Overall Study|Adverse Event|1
932593|NCT00900029|3073964|P3|Overall Study|Adverse Event|1
932594|NCT00900029|3073965|P2|Overall Study|Adverse Event|0
932595|NCT00900029|3073966|P1|Overall Study|Adverse Event|0
932596|NCT00900029|3073962|P5|Overall Study|Withdrawal by Subject|1
932597|NCT00900029|3073963|P4|Overall Study|Withdrawal by Subject|1
932598|NCT00900029|3073964|P3|Overall Study|Withdrawal by Subject|1
932599|NCT00900029|3073965|P2|Overall Study|Withdrawal by Subject|2
932600|NCT00900029|3073966|P1|Overall Study|Withdrawal by Subject|2
932601|NCT00900029|3073962|P5|Overall Study|Lost to Follow-up|4
932602|NCT00900029|3073963|P4|Overall Study|Lost to Follow-up|4
932603|NCT00900029|3073964|P3|Overall Study|Lost to Follow-up|1
932604|NCT00900029|3073965|P2|Overall Study|Lost to Follow-up|2
932605|NCT00900029|3073966|P1|Overall Study|Lost to Follow-up|0
932606|NCT00899847|3073983|P1|Overall Study|Lack of suitable allogeneic donor|2
932607|NCT00899678|3074014|P3|Maintenance Period (Weeks 8 to 62)|Other reason|2
932608|NCT00899678|3074015|P2|Maintenance Period (Weeks 8 to 62)|Other reason|2
932609|NCT00899678|3074016|P1|Maintenance Period (Weeks 8 to 62)|Other reason|0
932610|NCT00899678|3074014|P3|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2
932611|NCT00899678|3074015|P2|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1
932612|NCT00899678|3074016|P1|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0
932613|NCT00899678|3074014|P3|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
932614|NCT00899678|3074015|P2|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
932615|NCT00899678|3074016|P1|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0
932616|NCT00899678|3074014|P3|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18
932617|NCT00899678|3074015|P2|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11
932618|NCT00899678|3074016|P1|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0
932619|NCT00899678|3074014|P3|Maintenance Period (Weeks 8 to 62)|Adverse Event|5
932620|NCT00899678|3074015|P2|Maintenance Period (Weeks 8 to 62)|Adverse Event|10
932621|NCT00899678|3074016|P1|Maintenance Period (Weeks 8 to 62)|Adverse Event|0
932622|NCT00899678|3074014|P3|Induction Period (Weeks 0 to 6)|Other reason|0
932623|NCT00899678|3074015|P2|Induction Period (Weeks 0 to 6)|Other reason|0
932624|NCT00899678|3074016|P1|Induction Period (Weeks 0 to 6)|Other reason|1
932625|NCT00899678|3074014|P3|Induction Period (Weeks 0 to 6)|Protocol Violation|0
932626|NCT00899678|3074015|P2|Induction Period (Weeks 0 to 6)|Protocol Violation|0
932627|NCT00899678|3074016|P1|Induction Period (Weeks 0 to 6)|Protocol Violation|1
932628|NCT00899678|3074014|P3|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
932629|NCT00899678|3074015|P2|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
932630|NCT00899678|3074016|P1|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17
932631|NCT00899678|3074014|P3|Induction Period (Weeks 0 to 6)|Adverse Event|0
932632|NCT00899678|3074015|P2|Induction Period (Weeks 0 to 6)|Adverse Event|0
932633|NCT00899678|3074016|P1|Induction Period (Weeks 0 to 6)|Adverse Event|6
932634|NCT00899392|3074147|P2|Overall Study|Subject didn't finish/partial pilot data|24
932635|NCT00899392|3074148|P1|Overall Study|Subject didn't finish/partial pilot data|21
932636|NCT00899379|3074165|P5|Overall Study|Inc/Exc Criteria Not Met|0
932637|NCT00899379|3074166|P4|Overall Study|Inc/Exc Criteria Not Met|0
932638|NCT00899379|3074167|P3|Overall Study|Inc/Exc Criteria Not Met|1
932639|NCT00899379|3074168|P2|Overall Study|Inc/Exc Criteria Not Met|0
932640|NCT00899379|3074169|P1|Overall Study|Inc/Exc Criteria Not Met|0
932641|NCT00899379|3074165|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
932642|NCT00899379|3074166|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
932643|NCT00899379|3074167|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
932644|NCT00899379|3074168|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
932645|NCT00899379|3074169|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
932646|NCT00899379|3074165|P5|Overall Study|No Attack Pretreatment|4
932647|NCT00899379|3074166|P4|Overall Study|No Attack Pretreatment|6
932648|NCT00899379|3074167|P3|Overall Study|No Attack Pretreatment|5
932649|NCT00899379|3074168|P2|Overall Study|No Attack Pretreatment|5
932650|NCT00899379|3074169|P1|Overall Study|No Attack Pretreatment|3
932651|NCT00899379|3074165|P5|Overall Study|Abnormal Baseline ECG|0
932652|NCT00899379|3074166|P4|Overall Study|Abnormal Baseline ECG|1
932653|NCT00899379|3074167|P3|Overall Study|Abnormal Baseline ECG|1
932654|NCT00899379|3074168|P2|Overall Study|Abnormal Baseline ECG|0
932655|NCT00899379|3074169|P1|Overall Study|Abnormal Baseline ECG|0
932656|NCT00899379|3074165|P5|Overall Study|Abnormal Prestudy Labs|2
932657|NCT00899379|3074166|P4|Overall Study|Abnormal Prestudy Labs|0
932658|NCT00899379|3074167|P3|Overall Study|Abnormal Prestudy Labs|0
932659|NCT00899379|3074168|P2|Overall Study|Abnormal Prestudy Labs|0
932660|NCT00899379|3074169|P1|Overall Study|Abnormal Prestudy Labs|0
932661|NCT00899379|3074165|P5|Overall Study|Patient Uncooperative|0
932662|NCT00899379|3074166|P4|Overall Study|Patient Uncooperative|1
932663|NCT00899379|3074167|P3|Overall Study|Patient Uncooperative|0
932664|NCT00899379|3074168|P2|Overall Study|Patient Uncooperative|0
932665|NCT00899379|3074169|P1|Overall Study|Patient Uncooperative|0
932666|NCT00899379|3074165|P5|Overall Study|Pregnancy|0
932667|NCT00899379|3074166|P4|Overall Study|Pregnancy|0
932668|NCT00899379|3074167|P3|Overall Study|Pregnancy|0
932669|NCT00899379|3074168|P2|Overall Study|Pregnancy|0
932670|NCT00899379|3074169|P1|Overall Study|Pregnancy|1
932671|NCT00899379|3074165|P5|Overall Study|Withdrawal by Subject|2
932672|NCT00899379|3074166|P4|Overall Study|Withdrawal by Subject|7
932673|NCT00899379|3074167|P3|Overall Study|Withdrawal by Subject|4
932674|NCT00899379|3074168|P2|Overall Study|Withdrawal by Subject|7
932675|NCT00899379|3074169|P1|Overall Study|Withdrawal by Subject|4
932676|NCT00899379|3074165|P5|Overall Study|Lost to Follow-up|5
932677|NCT00899379|3074166|P4|Overall Study|Lost to Follow-up|2
932678|NCT00899379|3074167|P3|Overall Study|Lost to Follow-up|0
932679|NCT00899379|3074168|P2|Overall Study|Lost to Follow-up|1
932680|NCT00899379|3074169|P1|Overall Study|Lost to Follow-up|3
932681|NCT00899379|3074165|P5|Overall Study|Study Terminated|1
932682|NCT00899379|3074166|P4|Overall Study|Study Terminated|3
932683|NCT00899379|3074167|P3|Overall Study|Study Terminated|3
932684|NCT00899379|3074168|P2|Overall Study|Study Terminated|0
932685|NCT00899379|3074169|P1|Overall Study|Study Terminated|3
932686|NCT00899379|3074165|P5|Overall Study|Not Completed/Entered Extn|3
932687|NCT00899379|3074166|P4|Overall Study|Not Completed/Entered Extn|4
932688|NCT00899379|3074167|P3|Overall Study|Not Completed/Entered Extn|6
932689|NCT00899379|3074168|P2|Overall Study|Not Completed/Entered Extn|1
932690|NCT00899379|3074169|P1|Overall Study|Not Completed/Entered Extn|5
932691|NCT00899379|3074165|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
932692|NCT00899379|3074166|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
932693|NCT00899379|3074167|P3|Overall Study|No Longer Met Inc/Exc Criteria|1
932694|NCT00899379|3074168|P2|Overall Study|No Longer Met Inc/Exc Criteria|1
932695|NCT00899379|3074169|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
932696|NCT00899379|3074165|P5|Overall Study|Abnormal Baseline ECG|0
932697|NCT00899379|3074166|P4|Overall Study|Abnormal Baseline ECG|1
932698|NCT00899379|3074167|P3|Overall Study|Abnormal Baseline ECG|0
932699|NCT00899379|3074168|P2|Overall Study|Abnormal Baseline ECG|0
932700|NCT00899379|3074169|P1|Overall Study|Abnormal Baseline ECG|0
932701|NCT00899379|3074165|P5|Overall Study|Patient Uncooperative|2
932702|NCT00899379|3074166|P4|Overall Study|Patient Uncooperative|1
932703|NCT00899379|3074167|P3|Overall Study|Patient Uncooperative|0
932704|NCT00899379|3074168|P2|Overall Study|Patient Uncooperative|1
932705|NCT00899379|3074169|P1|Overall Study|Patient Uncooperative|0
932706|NCT00899379|3074165|P5|Overall Study|Pregnancy|1
932707|NCT00899379|3074166|P4|Overall Study|Pregnancy|0
932708|NCT00899379|3074167|P3|Overall Study|Pregnancy|1
932709|NCT00899379|3074168|P2|Overall Study|Pregnancy|0
932710|NCT00899379|3074169|P1|Overall Study|Pregnancy|0
932711|NCT00899379|3074165|P5|Overall Study|Withdrawal by Subject|6
932712|NCT00899379|3074166|P4|Overall Study|Withdrawal by Subject|3
932713|NCT00899379|3074167|P3|Overall Study|Withdrawal by Subject|2
932714|NCT00899379|3074168|P2|Overall Study|Withdrawal by Subject|4
932715|NCT00899379|3074169|P1|Overall Study|Withdrawal by Subject|2
932716|NCT00899379|3074165|P5|Overall Study|Protocol Violation|0
932717|NCT00899379|3074166|P4|Overall Study|Protocol Violation|1
932718|NCT00899379|3074167|P3|Overall Study|Protocol Violation|1
932719|NCT00899379|3074168|P2|Overall Study|Protocol Violation|0
932720|NCT00899379|3074169|P1|Overall Study|Protocol Violation|0
932721|NCT00899379|3074165|P5|Overall Study|Lost to Follow-up|2
932722|NCT00899379|3074166|P4|Overall Study|Lost to Follow-up|6
932723|NCT00899379|3074167|P3|Overall Study|Lost to Follow-up|0
932724|NCT00899379|3074168|P2|Overall Study|Lost to Follow-up|3
932725|NCT00899379|3074169|P1|Overall Study|Lost to Follow-up|9
932726|NCT00899379|3074165|P5|Overall Study|Lack of Efficacy|1
932727|NCT00899379|3074166|P4|Overall Study|Lack of Efficacy|0
932728|NCT00899379|3074167|P3|Overall Study|Lack of Efficacy|3
932729|NCT00899379|3074168|P2|Overall Study|Lack of Efficacy|4
932730|NCT00899379|3074169|P1|Overall Study|Lack of Efficacy|0
932731|NCT00899379|3074165|P5|Overall Study|Adverse Event|2
932732|NCT00899379|3074166|P4|Overall Study|Adverse Event|1
932733|NCT00899379|3074167|P3|Overall Study|Adverse Event|1
932734|NCT00899379|3074168|P2|Overall Study|Adverse Event|2
932735|NCT00899379|3074169|P1|Overall Study|Adverse Event|2
932736|NCT00899353|3074181|P1|Overall Study|Withdrawal by Subject|2
932737|NCT00899353|3074181|P1|Overall Study|Lost to Follow-up|1
932738|NCT00899353|3074181|P1|Overall Study|Adverse Event|2
932739|NCT00898807|3074217|P2|Overall Study|Death|1
932740|NCT00898807|3074218|P1|Overall Study|Death|0
932741|NCT00898807|3074217|P2|Overall Study|Lost to Follow-up|3
932742|NCT00898807|3074218|P1|Overall Study|Lost to Follow-up|1
932743|NCT00898807|3074217|P2|Overall Study|Family pressure to discontinue|2
932744|NCT00898807|3074218|P1|Overall Study|Family pressure to discontinue|2
932745|NCT00898807|3074217|P2|Overall Study|Withdrawal by Subject|3
932746|NCT00898807|3074218|P1|Overall Study|Withdrawal by Subject|5
932747|NCT00898677|3074234|P4|Overall Study|Not Treated: Other (Not Specified)|0
932748|NCT00898677|3074235|P3|Overall Study|Not Treated: Other (Not Specified)|2
932749|NCT00898677|3074236|P2|Overall Study|Not Treated: Other (Not Specified)|0
932750|NCT00898677|3074237|P1|Overall Study|Not Treated: Other (Not Specified)|0
932751|NCT00898677|3074234|P4|Overall Study|Not Treated: Lack of Migraine Attack|12
932752|NCT00898677|3074235|P3|Overall Study|Not Treated: Lack of Migraine Attack|43
932753|NCT00898677|3074236|P2|Overall Study|Not Treated: Lack of Migraine Attack|39
932754|NCT00898677|3074237|P1|Overall Study|Not Treated: Lack of Migraine Attack|9
932755|NCT00898677|3074234|P4|Overall Study|Not Treated: No Longer Met Inc Criteria|0
932756|NCT00898677|3074235|P3|Overall Study|Not Treated: No Longer Met Inc Criteria|1
932757|NCT00898677|3074236|P2|Overall Study|Not Treated: No Longer Met Inc Criteria|3
932758|NCT00898677|3074237|P1|Overall Study|Not Treated: No Longer Met Inc Criteria|0
932759|NCT00898677|3074234|P4|Overall Study|Not Treated: Abnormal Baseline ECG|0
932760|NCT00898677|3074235|P3|Overall Study|Not Treated: Abnormal Baseline ECG|0
932761|NCT00898677|3074236|P2|Overall Study|Not Treated: Abnormal Baseline ECG|0
932762|NCT00898677|3074237|P1|Overall Study|Not Treated: Abnormal Baseline ECG|1
932763|NCT00898677|3074234|P4|Overall Study|Not Treated: Abnormal Prestudy Labs|1
932764|NCT00898677|3074235|P3|Overall Study|Not Treated: Abnormal Prestudy Labs|0
932765|NCT00898677|3074236|P2|Overall Study|Not Treated: Abnormal Prestudy Labs|0
932766|NCT00898677|3074237|P1|Overall Study|Not Treated: Abnormal Prestudy Labs|0
932767|NCT00898677|3074234|P4|Overall Study|Not Treated: Patient uncooperative|0
932768|NCT00898677|3074235|P3|Overall Study|Not Treated: Patient uncooperative|1
932769|NCT00898677|3074236|P2|Overall Study|Not Treated: Patient uncooperative|3
932770|NCT00898677|3074237|P1|Overall Study|Not Treated: Patient uncooperative|2
932771|NCT00898677|3074234|P4|Overall Study|Not Treated: Withdraw by Subject|3
932772|NCT00898677|3074235|P3|Overall Study|Not Treated: Withdraw by Subject|11
932773|NCT00898677|3074236|P2|Overall Study|Not Treated: Withdraw by Subject|16
932774|NCT00898677|3074237|P1|Overall Study|Not Treated: Withdraw by Subject|2
932775|NCT00898677|3074234|P4|Overall Study|Not Treated: Protocol Violation|0
932776|NCT00898677|3074235|P3|Overall Study|Not Treated: Protocol Violation|2
932777|NCT00898677|3074236|P2|Overall Study|Not Treated: Protocol Violation|0
932778|NCT00898677|3074237|P1|Overall Study|Not Treated: Protocol Violation|2
932779|NCT00898677|3074234|P4|Overall Study|Not Treated: Pregnancy|0
932780|NCT00898677|3074235|P3|Overall Study|Not Treated: Pregnancy|1
932781|NCT00898677|3074236|P2|Overall Study|Not Treated: Pregnancy|0
932782|NCT00898677|3074237|P1|Overall Study|Not Treated: Pregnancy|0
932783|NCT00898677|3074234|P4|Overall Study|Not Treated: Lost to Follow-Up|2
932784|NCT00898677|3074235|P3|Overall Study|Not Treated: Lost to Follow-Up|5
932785|NCT00898677|3074236|P2|Overall Study|Not Treated: Lost to Follow-Up|5
932786|NCT00898677|3074237|P1|Overall Study|Not Treated: Lost to Follow-Up|0
932787|NCT00898677|3074234|P4|Overall Study|Not Treated: Adverse Event|0
932788|NCT00898677|3074235|P3|Overall Study|Not Treated: Adverse Event|1
932789|NCT00898677|3074236|P2|Overall Study|Not Treated: Adverse Event|2
932790|NCT00898677|3074237|P1|Overall Study|Not Treated: Adverse Event|0
932791|NCT00898677|3074234|P4|Overall Study|Withdrawal by Subject|1
932792|NCT00898677|3074235|P3|Overall Study|Withdrawal by Subject|0
932793|NCT00898677|3074236|P2|Overall Study|Withdrawal by Subject|0
932794|NCT00898677|3074237|P1|Overall Study|Withdrawal by Subject|0
932795|NCT00898677|3074234|P4|Overall Study|Protocol Violation|0
932796|NCT00898677|3074235|P3|Overall Study|Protocol Violation|2
932797|NCT00898677|3074236|P2|Overall Study|Protocol Violation|1
932798|NCT00898677|3074237|P1|Overall Study|Protocol Violation|1
932799|NCT00898677|3074234|P4|Overall Study|Lost to Follow-up|0
932800|NCT00898677|3074235|P3|Overall Study|Lost to Follow-up|2
932801|NCT00898677|3074236|P2|Overall Study|Lost to Follow-up|0
932802|NCT00898677|3074237|P1|Overall Study|Lost to Follow-up|0
932803|NCT00898677|3074234|P4|Overall Study|Adverse Event|0
932804|NCT00898677|3074235|P3|Overall Study|Adverse Event|1
932805|NCT00898677|3074236|P2|Overall Study|Adverse Event|0
932806|NCT00898677|3074237|P1|Overall Study|Adverse Event|0
932807|NCT00898443|3074275|P2|Overall Study|Withdrawal by Subject|0
932808|NCT00898443|3074276|P1|Overall Study|Withdrawal by Subject|1
932809|NCT00897949|3074291|P3|Overall Study|Did not take study drug|4
932810|NCT00897949|3074292|P2|Overall Study|Did not take study drug|3
932811|NCT00897949|3074293|P1|Overall Study|Did not take study drug|9
932812|NCT00897949|3074291|P3|Overall Study|Lack of Migraine Attack|19
932813|NCT00897949|3074292|P2|Overall Study|Lack of Migraine Attack|30
932814|NCT00897949|3074293|P1|Overall Study|Lack of Migraine Attack|29
932815|NCT00897949|3074291|P3|Overall Study|Need for Concom. Med.|1
932816|NCT00897949|3074292|P2|Overall Study|Need for Concom. Med.|1
932817|NCT00897949|3074293|P1|Overall Study|Need for Concom. Med.|0
932818|NCT00897949|3074291|P3|Overall Study|Abnormal Baseline ECG|4
932819|NCT00897949|3074292|P2|Overall Study|Abnormal Baseline ECG|2
932820|NCT00897949|3074293|P1|Overall Study|Abnormal Baseline ECG|2
932821|NCT00897949|3074291|P3|Overall Study|Abnormal Prestudy Labs|4
932822|NCT00897949|3074292|P2|Overall Study|Abnormal Prestudy Labs|3
932823|NCT00897949|3074293|P1|Overall Study|Abnormal Prestudy Labs|2
932824|NCT00897949|3074291|P3|Overall Study|Withdrawal by Subject|17
932825|NCT00897949|3074292|P2|Overall Study|Withdrawal by Subject|31
932826|NCT00897949|3074293|P1|Overall Study|Withdrawal by Subject|24
932827|NCT00897949|3074291|P3|Overall Study|Lost to Follow-up|17
932828|NCT00897949|3074292|P2|Overall Study|Lost to Follow-up|23
932829|NCT00897949|3074293|P1|Overall Study|Lost to Follow-up|30
932830|NCT00897949|3074291|P3|Overall Study|Patient Uncoorperative|1
932831|NCT00897949|3074292|P2|Overall Study|Patient Uncoorperative|2
932832|NCT00897949|3074293|P1|Overall Study|Patient Uncoorperative|0
932833|NCT00897949|3074291|P3|Overall Study|Withdrawal by Subject|0
932834|NCT00897949|3074292|P2|Overall Study|Withdrawal by Subject|2
932835|NCT00897949|3074293|P1|Overall Study|Withdrawal by Subject|1
932836|NCT00897949|3074291|P3|Overall Study|Protocol Violation|1
932837|NCT00897949|3074292|P2|Overall Study|Protocol Violation|3
932838|NCT00897949|3074293|P1|Overall Study|Protocol Violation|6
932839|NCT00897949|3074291|P3|Overall Study|Lost to Follow-up|1
932840|NCT00897949|3074292|P2|Overall Study|Lost to Follow-up|2
932841|NCT00897949|3074293|P1|Overall Study|Lost to Follow-up|0
932842|NCT00897949|3074291|P3|Overall Study|Adverse Event|0
932843|NCT00897949|3074292|P2|Overall Study|Adverse Event|1
932844|NCT00897949|3074293|P1|Overall Study|Adverse Event|1
932845|NCT00897715|3074327|P2|Overall Study|increased risk of infection|0
932846|NCT00897715|3074328|P1|Overall Study|increased risk of infection|1
932847|NCT00897715|3074327|P2|Overall Study|Physician Decision|0
932848|NCT00897715|3074328|P1|Overall Study|Physician Decision|1
932849|NCT00897715|3074327|P2|Overall Study|Lost to Follow-up|1
932850|NCT00897715|3074328|P1|Overall Study|Lost to Follow-up|0
932851|NCT00897390|3074353|P1|Overall Study|Did not Return for the Clinic Visit|2
932852|NCT00897390|3074353|P1|Overall Study|Personal Reasons|1
932853|NCT00897390|3074353|P1|Overall Study|No Longer Met Study Criteria|1
932854|NCT00897390|3074353|P1|Overall Study|Adverse Event|2
932855|NCT00897104|3074443|P3|Overall Study|Withdrawal by Subject|1
932856|NCT00897104|3074444|P2|Overall Study|Withdrawal by Subject|0
932857|NCT00897104|3074445|P1|Overall Study|Withdrawal by Subject|0
932858|NCT00897104|3074443|P3|Overall Study|Protocol Violation|0
932859|NCT00897104|3074444|P2|Overall Study|Protocol Violation|0
932860|NCT00897104|3074445|P1|Overall Study|Protocol Violation|1
932861|NCT00897104|3074443|P3|Overall Study|Not Specified|0
932862|NCT00897104|3074444|P2|Overall Study|Not Specified|0
932863|NCT00897104|3074445|P1|Overall Study|Not Specified|3
932864|NCT00897104|3074443|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
932865|NCT00897104|3074444|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
932866|NCT00897104|3074445|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
932867|NCT00897104|3074443|P3|Overall Study|Lack of Migraine Attack|1
932868|NCT00897104|3074444|P2|Overall Study|Lack of Migraine Attack|22
932869|NCT00897104|3074445|P1|Overall Study|Lack of Migraine Attack|20
932870|NCT00897104|3074443|P3|Overall Study|Need for Concom. Med.|1
932871|NCT00897104|3074444|P2|Overall Study|Need for Concom. Med.|1
932872|NCT00897104|3074445|P1|Overall Study|Need for Concom. Med.|0
932873|NCT00897104|3074443|P3|Overall Study|Abnormal Baseline ECG|0
932874|NCT00897104|3074444|P2|Overall Study|Abnormal Baseline ECG|2
932875|NCT00897104|3074445|P1|Overall Study|Abnormal Baseline ECG|2
932876|NCT00897104|3074443|P3|Overall Study|Abnormal Prestudy Labs|0
932877|NCT00897104|3074444|P2|Overall Study|Abnormal Prestudy Labs|0
932878|NCT00897104|3074445|P1|Overall Study|Abnormal Prestudy Labs|2
932879|NCT00897104|3074443|P3|Overall Study|Withdrawal by Subject|3
932880|NCT00897104|3074444|P2|Overall Study|Withdrawal by Subject|27
932881|NCT00897104|3074445|P1|Overall Study|Withdrawal by Subject|23
932882|NCT00897104|3074443|P3|Overall Study|Protocol Violation|0
932883|NCT00897104|3074444|P2|Overall Study|Protocol Violation|1
932884|NCT00897104|3074445|P1|Overall Study|Protocol Violation|0
932885|NCT00897104|3074443|P3|Overall Study|Pregnancy|0
932886|NCT00897104|3074444|P2|Overall Study|Pregnancy|1
932887|NCT00897104|3074445|P1|Overall Study|Pregnancy|0
932888|NCT00897104|3074443|P3|Overall Study|Lost to Follow-up|2
932889|NCT00897104|3074444|P2|Overall Study|Lost to Follow-up|17
932890|NCT00897104|3074445|P1|Overall Study|Lost to Follow-up|12
932891|NCT00896649|3074480|P1|Overall Study|technical difficulties|2
932892|NCT00896649|3074480|P1|Overall Study|missing documentation|1
932893|NCT00896649|3074480|P1|Overall Study|Pregnancy|1
932894|NCT00896649|3074480|P1|Overall Study|Physician Decision|1
932895|NCT00896454|3074485|P1|Overall Study|Withdrawal by Subject|1
932896|NCT00896454|3074485|P1|Overall Study|Ongoing in study|2
932897|NCT00896454|3074485|P1|Overall Study|Requirement for alternative therapy|3
932898|NCT00896454|3074485|P1|Overall Study|Other|4
932899|NCT00896454|3074485|P1|Overall Study|Disease Progression|5
932900|NCT00896454|3074485|P1|Overall Study|Adverse Event|8
932901|NCT00896454|3074485|P1|Overall Study|Death|10
932902|NCT00896363|3074524|P3|Overall Study|Withdrawal by Subject|5
932903|NCT00896363|3074525|P2|Overall Study|Withdrawal by Subject|5
932904|NCT00896363|3074526|P1|Overall Study|Withdrawal by Subject|3
932905|NCT00896363|3074524|P3|Overall Study|Lack of Efficacy|1
932906|NCT00896363|3074525|P2|Overall Study|Lack of Efficacy|2
932907|NCT00896363|3074526|P1|Overall Study|Lack of Efficacy|0
932908|NCT00896363|3074524|P3|Overall Study|Adverse Event|2
932909|NCT00896363|3074525|P2|Overall Study|Adverse Event|4
932910|NCT00896363|3074526|P1|Overall Study|Adverse Event|3
932911|NCT00896337|3074578|P1|Overall Study|Lost to Follow-up|11
932912|NCT00896337|3074578|P1|Overall Study|Withdrawal by Subject|7
932913|NCT00896337|3074578|P1|Overall Study|Death|7
932914|NCT00896233|3074645|P1|Overall Study|Claustrophobia during MRI|1
932915|NCT00896168|3074658|P2|Overall Study|Other|1
932916|NCT00896168|3074659|P1|Overall Study|Other|1
932917|NCT00896168|3074658|P2|Overall Study|Lost to Follow-up|1
932918|NCT00896168|3074659|P1|Overall Study|Lost to Follow-up|1
932919|NCT00896168|3074658|P2|Overall Study|Treatment failure|10
932920|NCT00896168|3074659|P1|Overall Study|Treatment failure|8
932921|NCT00896168|3074658|P2|Overall Study|Adverse Event|7
932922|NCT00896168|3074659|P1|Overall Study|Adverse Event|4
932923|NCT00896051|3074720|P2|Overall Study|Not specified|1
932924|NCT00896051|3074721|P1|Overall Study|Not specified|1
932925|NCT00896051|3074720|P2|Overall Study|Subject noncompliant|3
932926|NCT00896051|3074721|P1|Overall Study|Subject noncompliant|1
932927|NCT00896051|3074720|P2|Overall Study|Withdrawal by Subject|2
932928|NCT00896051|3074721|P1|Overall Study|Withdrawal by Subject|3
932929|NCT00896051|3074720|P2|Overall Study|Lost to Follow-up|2
932930|NCT00896051|3074721|P1|Overall Study|Lost to Follow-up|3
932931|NCT00896051|3074720|P2|Overall Study|Adverse Event|1
932932|NCT00896051|3074721|P1|Overall Study|Adverse Event|2
932933|NCT00895947|3074808|P2|Overall Study|Withdrawal by Subject|0
932934|NCT00895947|3074809|P1|Overall Study|Withdrawal by Subject|2
932935|NCT00895947|3074808|P2|Overall Study|Protocol Violation|2
932936|NCT00895947|3074809|P1|Overall Study|Protocol Violation|4
932937|NCT00895947|3074808|P2|Overall Study|Lost to Follow-up|4
932938|NCT00895947|3074809|P1|Overall Study|Lost to Follow-up|3
932939|NCT00895947|3074808|P2|Overall Study|Adverse Event|4
932940|NCT00895947|3074809|P1|Overall Study|Adverse Event|3
932941|NCT00895934|3074827|P2|Overall Study|ineligible|0
932942|NCT00895934|3074828|P1|Overall Study|ineligible|1
932943|NCT00895934|3074827|P2|Overall Study|Death|1
932944|NCT00895934|3074828|P1|Overall Study|Death|0
932945|NCT00895934|3074827|P2|Overall Study|Lack of Efficacy|24
932946|NCT00895934|3074828|P1|Overall Study|Lack of Efficacy|5
932947|NCT00895895|3074839|P5|Period 2|unsatisfactory response-efficacy|0
932948|NCT00895895|3074840|P4|Period 2|unsatisfactory response-efficacy|0
932949|NCT00895895|3074841|P3|Period 2|unsatisfactory response-efficacy|0
932950|NCT00895895|3074842|P2|Period 2|unsatisfactory response-efficacy|1
932951|NCT00895895|3074843|P1|Period 2|unsatisfactory response-efficacy|2
932952|NCT00895895|3074839|P5|Period 2|Withdrawal by Subject|5
932953|NCT00895895|3074840|P4|Period 2|Withdrawal by Subject|3
932954|NCT00895895|3074841|P3|Period 2|Withdrawal by Subject|0
932955|NCT00895895|3074842|P2|Period 2|Withdrawal by Subject|2
932956|NCT00895895|3074843|P1|Period 2|Withdrawal by Subject|0
932957|NCT00895895|3074839|P5|Period 2|Protocol Violation|1
932958|NCT00895895|3074840|P4|Period 2|Protocol Violation|1
932959|NCT00895895|3074841|P3|Period 2|Protocol Violation|1
932960|NCT00895895|3074842|P2|Period 2|Protocol Violation|0
932961|NCT00895895|3074843|P1|Period 2|Protocol Violation|1
932962|NCT00895895|3074839|P5|Period 2|Other|1
932963|NCT00895895|3074840|P4|Period 2|Other|1
932964|NCT00895895|3074841|P3|Period 2|Other|3
932965|NCT00895895|3074842|P2|Period 2|Other|1
932966|NCT00895895|3074843|P1|Period 2|Other|1
932967|NCT00895895|3074839|P5|Period 2|Lost to Follow-up|0
932968|NCT00895895|3074840|P4|Period 2|Lost to Follow-up|1
932969|NCT00895895|3074841|P3|Period 2|Lost to Follow-up|1
932970|NCT00895895|3074842|P2|Period 2|Lost to Follow-up|2
932971|NCT00895895|3074843|P1|Period 2|Lost to Follow-up|1
932972|NCT00895895|3074839|P5|Period 2|investigator request|0
932973|NCT00895895|3074840|P4|Period 2|investigator request|0
932974|NCT00895895|3074841|P3|Period 2|investigator request|0
932975|NCT00895895|3074842|P2|Period 2|investigator request|0
932976|NCT00895895|3074843|P1|Period 2|investigator request|2
932977|NCT00895895|3074839|P5|Period 2|failed to return|0
932978|NCT00895895|3074840|P4|Period 2|failed to return|0
932979|NCT00895895|3074841|P3|Period 2|failed to return|0
932980|NCT00895895|3074842|P2|Period 2|failed to return|0
932981|NCT00895895|3074843|P1|Period 2|failed to return|2
932982|NCT00895895|3074839|P5|Period 2|discontinued by sponsor|37
932983|NCT00895895|3074840|P4|Period 2|discontinued by sponsor|46
932984|NCT00895895|3074841|P3|Period 2|discontinued by sponsor|38
932985|NCT00895895|3074842|P2|Period 2|discontinued by sponsor|44
932986|NCT00895895|3074843|P1|Period 2|discontinued by sponsor|44
932987|NCT00895895|3074839|P5|Period 2|Death|0
932988|NCT00895895|3074840|P4|Period 2|Death|0
932989|NCT00895895|3074841|P3|Period 2|Death|1
932990|NCT00895895|3074842|P2|Period 2|Death|0
932991|NCT00895895|3074843|P1|Period 2|Death|0
932992|NCT00895895|3074839|P5|Period 2|Adverse Event|5
932993|NCT00895895|3074840|P4|Period 2|Adverse Event|2
932994|NCT00895895|3074841|P3|Period 2|Adverse Event|5
932995|NCT00895895|3074842|P2|Period 2|Adverse Event|3
932996|NCT00895895|3074843|P1|Period 2|Adverse Event|3
932997|NCT00895895|3074839|P5|After Period 1, Prior to Period 2|Withdrawal by Subject|1
932998|NCT00895895|3074840|P4|After Period 1, Prior to Period 2|Withdrawal by Subject|0
932999|NCT00895895|3074841|P3|After Period 1, Prior to Period 2|Withdrawal by Subject|0
933000|NCT00895895|3074842|P2|After Period 1, Prior to Period 2|Withdrawal by Subject|0
933001|NCT00895895|3074843|P1|After Period 1, Prior to Period 2|Withdrawal by Subject|0
933002|NCT00895895|3074839|P5|After Period 1, Prior to Period 2|Protocol Violation|1
933003|NCT00895895|3074840|P4|After Period 1, Prior to Period 2|Protocol Violation|0
933004|NCT00895895|3074841|P3|After Period 1, Prior to Period 2|Protocol Violation|0
933005|NCT00895895|3074842|P2|After Period 1, Prior to Period 2|Protocol Violation|0
933006|NCT00895895|3074843|P1|After Period 1, Prior to Period 2|Protocol Violation|0
933007|NCT00895895|3074839|P5|After Period 1, Prior to Period 2|Other|0
933008|NCT00895895|3074840|P4|After Period 1, Prior to Period 2|Other|0
933009|NCT00895895|3074841|P3|After Period 1, Prior to Period 2|Other|1
933010|NCT00895895|3074842|P2|After Period 1, Prior to Period 2|Other|0
933011|NCT00895895|3074843|P1|After Period 1, Prior to Period 2|Other|0
933012|NCT00895895|3074839|P5|After Period 1, Prior to Period 2|Adverse Event|0
933013|NCT00895895|3074840|P4|After Period 1, Prior to Period 2|Adverse Event|0
933014|NCT00895895|3074841|P3|After Period 1, Prior to Period 2|Adverse Event|1
933015|NCT00895895|3074842|P2|After Period 1, Prior to Period 2|Adverse Event|0
933016|NCT00895895|3074843|P1|After Period 1, Prior to Period 2|Adverse Event|0
933017|NCT00895895|3074839|P5|Period 1|randomized and not treated|2
933018|NCT00895895|3074840|P4|Period 1|randomized and not treated|1
933019|NCT00895895|3074841|P3|Period 1|randomized and not treated|1
933020|NCT00895895|3074842|P2|Period 1|randomized and not treated|3
933021|NCT00895895|3074843|P1|Period 1|randomized and not treated|1
933022|NCT00895895|3074839|P5|Period 1|unsatisfactory response-efficacy|0
933023|NCT00895895|3074840|P4|Period 1|unsatisfactory response-efficacy|0
933024|NCT00895895|3074841|P3|Period 1|unsatisfactory response-efficacy|0
933025|NCT00895895|3074842|P2|Period 1|unsatisfactory response-efficacy|0
933026|NCT00895895|3074843|P1|Period 1|unsatisfactory response-efficacy|2
933027|NCT00895895|3074839|P5|Period 1|Withdrawal by Subject|4
933028|NCT00895895|3074840|P4|Period 1|Withdrawal by Subject|2
933029|NCT00895895|3074841|P3|Period 1|Withdrawal by Subject|8
933030|NCT00895895|3074842|P2|Period 1|Withdrawal by Subject|6
933031|NCT00895895|3074843|P1|Period 1|Withdrawal by Subject|6
933032|NCT00895895|3074839|P5|Period 1|Protocol Violation|0
933033|NCT00895895|3074840|P4|Period 1|Protocol Violation|0
933034|NCT00895895|3074841|P3|Period 1|Protocol Violation|0
933035|NCT00895895|3074842|P2|Period 1|Protocol Violation|1
933036|NCT00895895|3074843|P1|Period 1|Protocol Violation|0
933037|NCT00895895|3074839|P5|Period 1|Other|1
933038|NCT00895895|3074840|P4|Period 1|Other|1
933039|NCT00895895|3074841|P3|Period 1|Other|1
933040|NCT00895895|3074842|P2|Period 1|Other|2
933041|NCT00895895|3074843|P1|Period 1|Other|1
933042|NCT00895895|3074839|P5|Period 1|Lost to Follow-up|3
933043|NCT00895895|3074840|P4|Period 1|Lost to Follow-up|2
933044|NCT00895895|3074841|P3|Period 1|Lost to Follow-up|3
933045|NCT00895895|3074842|P2|Period 1|Lost to Follow-up|1
933046|NCT00895895|3074843|P1|Period 1|Lost to Follow-up|2
933047|NCT00895895|3074839|P5|Period 1|investigator request|0
933048|NCT00895895|3074840|P4|Period 1|investigator request|0
933049|NCT00895895|3074841|P3|Period 1|investigator request|0
933050|NCT00895895|3074842|P2|Period 1|investigator request|1
933051|NCT00895895|3074843|P1|Period 1|investigator request|0
933052|NCT00895895|3074839|P5|Period 1|failed to return|1
933053|NCT00895895|3074840|P4|Period 1|failed to return|0
933054|NCT00895895|3074841|P3|Period 1|failed to return|1
933055|NCT00895895|3074842|P2|Period 1|failed to return|0
933056|NCT00895895|3074843|P1|Period 1|failed to return|0
933057|NCT00895895|3074839|P5|Period 1|discontinued by sponsor|1
933058|NCT00895895|3074840|P4|Period 1|discontinued by sponsor|1
933059|NCT00895895|3074841|P3|Period 1|discontinued by sponsor|2
933060|NCT00895895|3074842|P2|Period 1|discontinued by sponsor|1
933061|NCT00895895|3074843|P1|Period 1|discontinued by sponsor|2
933062|NCT00895895|3074839|P5|Period 1|Death|1
933063|NCT00895895|3074840|P4|Period 1|Death|0
933064|NCT00895895|3074841|P3|Period 1|Death|0
933065|NCT00895895|3074842|P2|Period 1|Death|0
933066|NCT00895895|3074843|P1|Period 1|Death|0
933067|NCT00895895|3074839|P5|Period 1|Adverse Event|7
933068|NCT00895895|3074840|P4|Period 1|Adverse Event|6
933069|NCT00895895|3074841|P3|Period 1|Adverse Event|4
933070|NCT00895895|3074842|P2|Period 1|Adverse Event|6
933071|NCT00895895|3074843|P1|Period 1|Adverse Event|7
933072|NCT00895843|3074957|P2|Overall Study|Protocol Violation|12
933073|NCT00895843|3074958|P1|Overall Study|Protocol Violation|12
933074|NCT00895661|3075005|P1|Overall Study|reason unknown|2
933075|NCT00895661|3075005|P1|Overall Study|Death|1
933076|NCT00895622|3075015|P3|Overall Study|Protocol Violation|4
933077|NCT00895622|3075016|P2|Overall Study|Protocol Violation|4
933078|NCT00895622|3075017|P1|Overall Study|Protocol Violation|5
933079|NCT00895583|3075040|P2|Overall Study|Not specified|1
933080|NCT00895583|3075041|P1|Overall Study|Not specified|0
933081|NCT00895583|3075040|P2|Overall Study|Lack of Efficacy|0
933082|NCT00895583|3075041|P1|Overall Study|Lack of Efficacy|5
933083|NCT00895583|3075040|P2|Overall Study|Withdrawal by Subject|2
933084|NCT00895583|3075041|P1|Overall Study|Withdrawal by Subject|4
933085|NCT00895583|3075040|P2|Overall Study|Protocol Violation|0
933086|NCT00895583|3075041|P1|Overall Study|Protocol Violation|1
933087|NCT00895583|3075040|P2|Overall Study|Lost to Follow-up|3
933088|NCT00895583|3075041|P1|Overall Study|Lost to Follow-up|1
933089|NCT00895583|3075040|P2|Overall Study|Physician Decision|1
933090|NCT00895583|3075041|P1|Overall Study|Physician Decision|3
933091|NCT00895583|3075040|P2|Overall Study|Death|1
933092|NCT00895583|3075041|P1|Overall Study|Death|2
933093|NCT00895583|3075040|P2|Overall Study|Adverse Event|4
933094|NCT00895583|3075041|P1|Overall Study|Adverse Event|28
933095|NCT00895453|3075131|P3|Overall Study|Lost to Follow-up|23
933096|NCT00895453|3075132|P2|Overall Study|Lost to Follow-up|25
933097|NCT00895453|3075133|P1|Overall Study|Lost to Follow-up|25
933098|NCT00895310|3075141|P1|Overall Study|Withdrawal by Subject|1
933099|NCT00895245|3075157|P1|Overall Study|Lack of Efficacy|6
933100|NCT00895037|3075236|P3|Overall Study|Death|1
933101|NCT00895037|3075237|P2|Overall Study|Death|2
933102|NCT00895037|3075238|P1|Overall Study|Death|0
933103|NCT00895011|3075269|P3|Overall Study|schedule conflict|0
933104|NCT00895011|3075270|P2|Overall Study|schedule conflict|0
933105|NCT00895011|3075271|P1|Overall Study|schedule conflict|1
933106|NCT00895011|3075269|P3|Overall Study|Adverse Event|2
933107|NCT00895011|3075270|P2|Overall Study|Adverse Event|2
933108|NCT00895011|3075271|P1|Overall Study|Adverse Event|1
933109|NCT00895011|3075269|P3|Overall Study|Protocol Violation|3
933110|NCT00895011|3075270|P2|Overall Study|Protocol Violation|1
933111|NCT00895011|3075271|P1|Overall Study|Protocol Violation|3
933112|NCT00895011|3075269|P3|Overall Study|Lost to Follow-up|1
933113|NCT00895011|3075270|P2|Overall Study|Lost to Follow-up|4
933114|NCT00895011|3075271|P1|Overall Study|Lost to Follow-up|5
933115|NCT00895011|3075269|P3|Overall Study|Withdrawal by Subject|2
933116|NCT00895011|3075270|P2|Overall Study|Withdrawal by Subject|7
933117|NCT00895011|3075271|P1|Overall Study|Withdrawal by Subject|14
933118|NCT00894933|3075285|P1|Overall Study|Did not meeting incl/excl criteria|1
933119|NCT00894933|3075285|P1|Overall Study|Cancelled Procedure|1
933120|NCT00894933|3075285|P1|Overall Study|Lost to Follow-up|2
933121|NCT00894803|3075303|P2|Overall Study|Lost to Follow-up|1
933122|NCT00894803|3075304|P1|Overall Study|Lost to Follow-up|0
933123|NCT00894803|3075303|P2|Overall Study|Death|4
933124|NCT00894803|3075304|P1|Overall Study|Death|20
933125|NCT00894790|3075340|P2|Overall Study|Did not meet entrance criteria|0
933126|NCT00894790|3075341|P1|Overall Study|Did not meet entrance criteria|1
933127|NCT00894790|3075340|P2|Overall Study|Lost to Follow-up|1
933128|NCT00894790|3075341|P1|Overall Study|Lost to Follow-up|0
933129|NCT00894790|3075340|P2|Overall Study|Protocol Violation|1
933130|NCT00894790|3075341|P1|Overall Study|Protocol Violation|0
933131|NCT00894647|3075374|P2|Overall Study|Other, not due to AE|2
933132|NCT00894647|3075375|P1|Overall Study|Other, not due to AE|1
933133|NCT00894647|3075374|P2|Overall Study|Non-compliance with study procedures|2
933134|NCT00894647|3075375|P1|Overall Study|Non-compliance with study procedures|0
933135|NCT00894647|3075374|P2|Overall Study|Lost to Follow-up|2
933136|NCT00894647|3075375|P1|Overall Study|Lost to Follow-up|0
933137|NCT00894647|3075374|P2|Overall Study|Withdrawal by Subject|4
933138|NCT00894647|3075375|P1|Overall Study|Withdrawal by Subject|4
933139|NCT00894647|3075374|P2|Overall Study|Adverse Event|4
933140|NCT00894647|3075375|P1|Overall Study|Adverse Event|5
933141|NCT00894556|3075388|P4|Treatment Phase|Lack of Qualifying Event|0
933142|NCT00894556|3075389|P3|Treatment Phase|Lack of Qualifying Event|0
933143|NCT00894556|3075390|P2|Treatment Phase|Lack of Qualifying Event|1
933144|NCT00894556|3075391|P1|Treatment Phase|Lack of Qualifying Event|2
933145|NCT00894556|3075388|P4|Treatment Phase|Lost to Follow-up|0
933146|NCT00894556|3075389|P3|Treatment Phase|Lost to Follow-up|1
933147|NCT00894556|3075390|P2|Treatment Phase|Lost to Follow-up|3
933148|NCT00894556|3075391|P1|Treatment Phase|Lost to Follow-up|2
933149|NCT00894556|3075388|P4|Baseline Phase|Did not meet Randomization Criteria|85
933150|NCT00894556|3075389|P3|Baseline Phase|Did not meet Randomization Criteria|0
933151|NCT00894556|3075390|P2|Baseline Phase|Did not meet Randomization Criteria|0
933152|NCT00894556|3075391|P1|Baseline Phase|Did not meet Randomization Criteria|0
933153|NCT00894543|3075402|P2|Week 4 to Week 8|No diary or lost or withdrew|2
933154|NCT00894543|3075403|P1|Week 4 to Week 8|No diary or lost or withdrew|4
933155|NCT00894543|3075402|P2|Baseline to Week 4|No diary or lost or withdrew|2
933156|NCT00894543|3075403|P1|Baseline to Week 4|No diary or lost or withdrew|3
933157|NCT00894387|3075469|P2|Overall Study|GCP non-compliance|2
933158|NCT00894387|3075470|P1|Overall Study|GCP non-compliance|0
933159|NCT00894387|3075469|P2|Overall Study|Mis-randomized|9
933160|NCT00894387|3075470|P1|Overall Study|Mis-randomized|13
933161|NCT00894387|3075469|P2|Overall Study|Other (Missing)|3
933162|NCT00894387|3075470|P1|Overall Study|Other (Missing)|5
933163|NCT00894387|3075469|P2|Overall Study|Patient's request|30
933164|NCT00894387|3075470|P1|Overall Study|Patient's request|25
933165|NCT00894387|3075469|P2|Overall Study|Protocol Deviation|0
933166|NCT00894387|3075470|P1|Overall Study|Protocol Deviation|4
933167|NCT00894387|3075469|P2|Overall Study|Death|76
933168|NCT00894387|3075470|P1|Overall Study|Death|77
933169|NCT00894387|3075469|P2|Overall Study|Administrative problems|2
933170|NCT00894387|3075470|P1|Overall Study|Administrative problems|2
933171|NCT00894387|3075469|P2|Overall Study|Lost to Follow-up|5
933172|NCT00894387|3075470|P1|Overall Study|Lost to Follow-up|3
933173|NCT00894387|3075469|P2|Overall Study|Unsatisfactory therapeutic effect|1
933174|NCT00894387|3075470|P1|Overall Study|Unsatisfactory therapeutic effect|0
933175|NCT00894387|3075469|P2|Overall Study|Abnormal Laboratory values|2
933176|NCT00894387|3075470|P1|Overall Study|Abnormal Laboratory values|2
933177|NCT00894387|3075469|P2|Overall Study|Adverse Event|45
933178|NCT00894387|3075470|P1|Overall Study|Adverse Event|44
933179|NCT00894361|3075490|P2|Overall Study|deaths and less than 2 yr followup|64
933180|NCT00894361|3075491|P1|Overall Study|deaths and less than 2 yr followup|24
933181|NCT00894322|3075500|P3|Overall Study|Withdrawal by Subject|0
933182|NCT00894322|3075501|P2|Overall Study|Withdrawal by Subject|0
933183|NCT00894322|3075502|P1|Overall Study|Withdrawal by Subject|1
933184|NCT00894166|3075553|P8|Overall Study|Death|0
933185|NCT00894166|3075554|P7|Overall Study|Death|0
933186|NCT00894166|3075555|P6|Overall Study|Death|0
933187|NCT00894166|3075556|P5|Overall Study|Death|0
933188|NCT00894166|3075557|P4|Overall Study|Death|1
933189|NCT00894166|3075558|P3|Overall Study|Death|0
933190|NCT00894166|3075559|P2|Overall Study|Death|0
933191|NCT00894166|3075560|P1|Overall Study|Death|0
933192|NCT00894166|3075553|P8|Overall Study|Withdrew or Lost to Follow-Up|34
933193|NCT00894166|3075554|P7|Overall Study|Withdrew or Lost to Follow-Up|16
933194|NCT00894166|3075555|P6|Overall Study|Withdrew or Lost to Follow-Up|16
933195|NCT00894166|3075556|P5|Overall Study|Withdrew or Lost to Follow-Up|24
933196|NCT00894166|3075557|P4|Overall Study|Withdrew or Lost to Follow-Up|68
933197|NCT00894166|3075558|P3|Overall Study|Withdrew or Lost to Follow-Up|62
933198|NCT00894166|3075559|P2|Overall Study|Withdrew or Lost to Follow-Up|63
933199|NCT00894166|3075560|P1|Overall Study|Withdrew or Lost to Follow-Up|61
933200|NCT00893971|3075599|P1|Overall Study|Physician Decision|3
933201|NCT00893789|3075717|P4|Overall Study|Lost to Follow-up|1
933202|NCT00893789|3075718|P3|Overall Study|Lost to Follow-up|0
933203|NCT00893789|3075719|P2|Overall Study|Lost to Follow-up|0
933204|NCT00893789|3075720|P1|Overall Study|Lost to Follow-up|0
933205|NCT00893789|3075717|P4|Overall Study|Protocol Violation|4
933206|NCT00893789|3075718|P3|Overall Study|Protocol Violation|1
933207|NCT00893789|3075719|P2|Overall Study|Protocol Violation|1
933208|NCT00893789|3075720|P1|Overall Study|Protocol Violation|0
933209|NCT00893789|3075717|P4|Overall Study|Adverse Event|5
933210|NCT00893789|3075718|P3|Overall Study|Adverse Event|1
933211|NCT00893789|3075719|P2|Overall Study|Adverse Event|2
933212|NCT00893789|3075720|P1|Overall Study|Adverse Event|0
933213|NCT00893789|3075717|P4|Overall Study|Taking Excluded Concomitant Medication|0
933214|NCT00893789|3075718|P3|Overall Study|Taking Excluded Concomitant Medication|1
933215|NCT00893789|3075719|P2|Overall Study|Taking Excluded Concomitant Medication|0
933216|NCT00893789|3075720|P1|Overall Study|Taking Excluded Concomitant Medication|1
933217|NCT00893789|3075717|P4|Overall Study|Noncompliance With Study Procedures|0
933218|NCT00893789|3075718|P3|Overall Study|Noncompliance With Study Procedures|0
933219|NCT00893789|3075719|P2|Overall Study|Noncompliance With Study Procedures|0
933220|NCT00893789|3075720|P1|Overall Study|Noncompliance With Study Procedures|1
933221|NCT00893789|3075717|P4|Overall Study|Noncompliance With Study Drug|2
933222|NCT00893789|3075718|P3|Overall Study|Noncompliance With Study Drug|1
933223|NCT00893789|3075719|P2|Overall Study|Noncompliance With Study Drug|0
933224|NCT00893789|3075720|P1|Overall Study|Noncompliance With Study Drug|1
933225|NCT00893789|3075717|P4|Overall Study|Withdrawal by Subject|1
933226|NCT00893789|3075718|P3|Overall Study|Withdrawal by Subject|3
933227|NCT00893789|3075719|P2|Overall Study|Withdrawal by Subject|1
933228|NCT00893789|3075720|P1|Overall Study|Withdrawal by Subject|3
933229|NCT00893763|3075804|P2|Overall Study|extubated|110
933230|NCT00893763|3075805|P1|Overall Study|extubated|110
933231|NCT00893737|3075813|P1|Overall Study|Lost to Follow-up|6
933232|NCT00893737|3075813|P1|Overall Study|Withdrawal by Subject|2
933233|NCT00893737|3075813|P1|Overall Study|Adverse Event|4
933234|NCT00893464|3075827|P8|Overall Study|Did not complete therapy/experience PD|2
933235|NCT00893464|3075828|P7|Overall Study|Did not complete therapy/experience PD|2
933236|NCT00893464|3075829|P6|Overall Study|Did not complete therapy/experience PD|0
933237|NCT00893464|3075830|P5|Overall Study|Did not complete therapy/experience PD|0
933238|NCT00893464|3075831|P4|Overall Study|Did not complete therapy/experience PD|0
933239|NCT00893464|3075832|P3|Overall Study|Did not complete therapy/experience PD|0
933240|NCT00893464|3075833|P2|Overall Study|Did not complete therapy/experience PD|0
933241|NCT00893464|3075834|P1|Overall Study|Did not complete therapy/experience PD|0
933242|NCT00893113|3075961|P2|Overall Study|Withdrew Consent|7
933243|NCT00893113|3075962|P1|Overall Study|Withdrew Consent|8
933244|NCT00893113|3075961|P2|Overall Study|Early Termination|1
933245|NCT00893113|3075962|P1|Overall Study|Early Termination|1
933246|NCT00893113|3075961|P2|Overall Study|Lost to Follow-up|8
933247|NCT00893113|3075962|P1|Overall Study|Lost to Follow-up|4
933248|NCT00892957|3075992|P2|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2
933249|NCT00892957|3075993|P1|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0
933250|NCT00892957|3075992|P2|Between Postoperative Day 1 and Day 14|Death|2
933251|NCT00892957|3075993|P1|Between Postoperative Day 1 and Day 14|Death|0
933252|NCT00892775|3076081|P2|Overall Study|Lost to Follow-up|0
933253|NCT00892775|3076082|P1|Overall Study|Lost to Follow-up|1
933254|NCT00892775|3076081|P2|Overall Study|Withdrawal by Subject|1
933255|NCT00892775|3076082|P1|Overall Study|Withdrawal by Subject|0
933256|NCT00892775|3076081|P2|Overall Study|Migrated/ moved from study area|0
933257|NCT00892775|3076082|P1|Overall Study|Migrated/ moved from study area|1
933258|NCT00892775|3076081|P2|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0
933259|NCT00892775|3076082|P1|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1
933260|NCT00892775|3076081|P2|Overall Study|Subject difficulties with blood drawing|0
933261|NCT00892775|3076082|P1|Overall Study|Subject difficulties with blood drawing|1
933262|NCT00892775|3076081|P2|Overall Study|Protocol Violation|0
933263|NCT00892775|3076082|P1|Overall Study|Protocol Violation|1
933264|NCT00892723|3076109|P3|Overall Study|Withdrawal by Subject|1
933265|NCT00892723|3076110|P2|Overall Study|Withdrawal by Subject|1
933266|NCT00892723|3076111|P1|Overall Study|Withdrawal by Subject|1
933267|NCT00892723|3076109|P3|Overall Study|Lost to Follow-up|1
933268|NCT00892723|3076110|P2|Overall Study|Lost to Follow-up|3
933269|NCT00892723|3076111|P1|Overall Study|Lost to Follow-up|1
933270|NCT00892437|3076200|P2|Open-Label Extension Phase|Withdrew Consent|1
933271|NCT00892437|3076201|P1|Open-Label Extension Phase|Withdrew Consent|3
933272|NCT00892437|3076200|P2|Open-Label Extension Phase|Investigator's Discretion|0
933273|NCT00892437|3076201|P1|Open-Label Extension Phase|Investigator's Discretion|1
933274|NCT00892437|3076200|P2|Open-Label Extension Phase|Lost to Follow-up|1
933275|NCT00892437|3076201|P1|Open-Label Extension Phase|Lost to Follow-up|3
933276|NCT00892437|3076200|P2|Open-Label Extension Phase|Lack of Efficacy|0
933277|NCT00892437|3076201|P1|Open-Label Extension Phase|Lack of Efficacy|1
933278|NCT00892437|3076200|P2|Open-Label Extension Phase|Adverse Event|2
933279|NCT00892437|3076201|P1|Open-Label Extension Phase|Adverse Event|4
933280|NCT00892437|3076200|P2|Randomized Phase|Withdrew Consent|0
933281|NCT00892437|3076201|P1|Randomized Phase|Withdrew Consent|1
933282|NCT00892437|3076200|P2|Randomized Phase|Investigator’s Discretion|0
933283|NCT00892437|3076201|P1|Randomized Phase|Investigator’s Discretion|1
933284|NCT00892437|3076200|P2|Randomized Phase|Lost to Follow-up|3
933285|NCT00892437|3076201|P1|Randomized Phase|Lost to Follow-up|1
933286|NCT00892437|3076200|P2|Randomized Phase|Adverse Event|2
933287|NCT00892437|3076201|P1|Randomized Phase|Adverse Event|2
933288|NCT00892437|3076200|P2|Randomized Phase|Randomized but not treated|0
933289|NCT00892437|3076201|P1|Randomized Phase|Randomized but not treated|6
933290|NCT00892281|3076220|P2|Overall Study|Visit 4 date out of window|0
933291|NCT00892281|3076221|P1|Overall Study|Visit 4 date out of window|1
933292|NCT00892281|3076220|P2|Overall Study|Rash on hand|0
933293|NCT00892281|3076221|P1|Overall Study|Rash on hand|1
933294|NCT00892281|3076220|P2|Overall Study|Subject had history of drug abuse|0
933295|NCT00892281|3076221|P1|Overall Study|Subject had history of drug abuse|1
933296|NCT00892281|3076220|P2|Overall Study|Non-compliant with visits as scheduled|0
933297|NCT00892281|3076221|P1|Overall Study|Non-compliant with visits as scheduled|1
933298|NCT00892281|3076220|P2|Overall Study|Missed visits rescheduled out of window|0
933299|NCT00892281|3076221|P1|Overall Study|Missed visits rescheduled out of window|1
933300|NCT00892281|3076220|P2|Overall Study|Missed multiple visits|0
933301|NCT00892281|3076221|P1|Overall Study|Missed multiple visits|1
933302|NCT00892281|3076220|P2|Overall Study|No show Visit 2; prescription not filled|0
933303|NCT00892281|3076221|P1|Overall Study|No show Visit 2; prescription not filled|1
933304|NCT00892281|3076220|P2|Overall Study|Subject not seen by PI at final visit|0
933305|NCT00892281|3076221|P1|Overall Study|Subject not seen by PI at final visit|1
933306|NCT00892281|3076220|P2|Overall Study|Lack of efficacy of study product|0
933307|NCT00892281|3076221|P1|Overall Study|Lack of efficacy of study product|2
933308|NCT00892281|3076220|P2|Overall Study|Death in family|0
933309|NCT00892281|3076221|P1|Overall Study|Death in family|1
933310|NCT00892281|3076220|P2|Overall Study|Bad taste in mouth after taking Oracea®|1
933311|NCT00892281|3076221|P1|Overall Study|Bad taste in mouth after taking Oracea®|0
933312|NCT00892281|3076220|P2|Overall Study|Subject lost interest in program|1
933313|NCT00892281|3076221|P1|Overall Study|Subject lost interest in program|0
933314|NCT00892281|3076220|P2|Overall Study|PI complained of inadequate compensation|0
933315|NCT00892281|3076221|P1|Overall Study|PI complained of inadequate compensation|3
933316|NCT00892281|3076220|P2|Overall Study|Scheduled for knee replacement|1
933317|NCT00892281|3076221|P1|Overall Study|Scheduled for knee replacement|0
933318|NCT00892281|3076220|P2|Overall Study|Missed Visit 4 and off meds for 65 days|1
933319|NCT00892281|3076221|P1|Overall Study|Missed Visit 4 and off meds for 65 days|1
933320|NCT00892281|3076220|P2|Overall Study|Subject missed several visits/lost meds|0
933321|NCT00892281|3076221|P1|Overall Study|Subject missed several visits/lost meds|1
933322|NCT00892281|3076220|P2|Overall Study|Subject did not return for any visits|0
933323|NCT00892281|3076221|P1|Overall Study|Subject did not return for any visits|1
933324|NCT00892281|3076220|P2|Overall Study|Subject not good candidate for study|0
933325|NCT00892281|3076221|P1|Overall Study|Subject not good candidate for study|1
933326|NCT00892281|3076220|P2|Overall Study|Unable to redeem the drug voucher|0
933327|NCT00892281|3076221|P1|Overall Study|Unable to redeem the drug voucher|1
933328|NCT00892281|3076220|P2|Overall Study|Rosacea cleared; subject D/C'd self|0
933329|NCT00892281|3076221|P1|Overall Study|Rosacea cleared; subject D/C'd self|1
933330|NCT00892281|3076220|P2|Overall Study|Did not meet incl/excl criteria|0
933331|NCT00892281|3076221|P1|Overall Study|Did not meet incl/excl criteria|1
933332|NCT00892281|3076220|P2|Overall Study|Last visit not done - death in family|0
933333|NCT00892281|3076221|P1|Overall Study|Last visit not done - death in family|1
933334|NCT00892281|3076220|P2|Overall Study|Family emergency|0
933335|NCT00892281|3076221|P1|Overall Study|Family emergency|1
933336|NCT00892281|3076220|P2|Overall Study|Subject completed day after study closed|0
933337|NCT00892281|3076221|P1|Overall Study|Subject completed day after study closed|1
933338|NCT00892281|3076220|P2|Overall Study|Final visit completed 4 weeks late|1
933339|NCT00892281|3076221|P1|Overall Study|Final visit completed 4 weeks late|0
933340|NCT00892281|3076220|P2|Overall Study|Subject unable to keep follow-up visits|0
933341|NCT00892281|3076221|P1|Overall Study|Subject unable to keep follow-up visits|1
933342|NCT00892281|3076220|P2|Overall Study|Subject failed to return for final visit|0
933343|NCT00892281|3076221|P1|Overall Study|Subject failed to return for final visit|2
933344|NCT00892281|3076220|P2|Overall Study|Withdrawal by Subject|14
933345|NCT00892281|3076221|P1|Overall Study|Withdrawal by Subject|86
933346|NCT00892281|3076220|P2|Overall Study|Protocol Violation|2
933347|NCT00892281|3076221|P1|Overall Study|Protocol Violation|7
933348|NCT00892281|3076220|P2|Overall Study|Pregnancy|0
933349|NCT00892281|3076221|P1|Overall Study|Pregnancy|1
933350|NCT00892281|3076220|P2|Overall Study|Lost to Follow-up|8
933351|NCT00892281|3076221|P1|Overall Study|Lost to Follow-up|81
933352|NCT00892281|3076220|P2|Overall Study|Adverse Event|8
933353|NCT00892281|3076221|P1|Overall Study|Adverse Event|65
933354|NCT00892177|3076234|P6|Phase II|Withdrawal by Subject|1
933355|NCT00892177|3076235|P5|Phase II|Withdrawal by Subject|4
933356|NCT00892177|3076236|P4|Phase II|Withdrawal by Subject|0
933357|NCT00892177|3076237|P3|Phase II|Withdrawal by Subject|0
933358|NCT00892177|3076238|P2|Phase II|Withdrawal by Subject|0
933359|NCT00892177|3076239|P1|Phase II|Withdrawal by Subject|0
933360|NCT00892177|3076234|P6|Phase II|Ineligible|1
933361|NCT00892177|3076235|P5|Phase II|Ineligible|1
933362|NCT00892177|3076236|P4|Phase II|Ineligible|0
933363|NCT00892177|3076237|P3|Phase II|Ineligible|0
933364|NCT00892177|3076238|P2|Phase II|Ineligible|0
933365|NCT00892177|3076239|P1|Phase II|Ineligible|0
933366|NCT00892151|3076264|P1|Overall Study|Protocol Violation|1
933367|NCT00892099|3076273|P3|Overall Study|Lost to Follow-up|1
933368|NCT00892099|3076274|P2|Overall Study|Lost to Follow-up|0
933369|NCT00892099|3076275|P1|Overall Study|Lost to Follow-up|0
933370|NCT00892099|3076273|P3|Overall Study|investigator decision|1
933371|NCT00892099|3076274|P2|Overall Study|investigator decision|0
933372|NCT00892099|3076275|P1|Overall Study|investigator decision|0
933373|NCT00892099|3076273|P3|Overall Study|kidney function recovered|0
933374|NCT00892099|3076274|P2|Overall Study|kidney function recovered|1
933375|NCT00892099|3076275|P1|Overall Study|kidney function recovered|0
933376|NCT00892099|3076273|P3|Overall Study|no further details|1
933377|NCT00892099|3076274|P2|Overall Study|no further details|0
933378|NCT00892099|3076275|P1|Overall Study|no further details|1
933379|NCT00892099|3076273|P3|Overall Study|Prolonged hospitalization|1
933380|NCT00892099|3076274|P2|Overall Study|Prolonged hospitalization|0
933381|NCT00892099|3076275|P1|Overall Study|Prolonged hospitalization|1
933382|NCT00892099|3076273|P3|Overall Study|replocated|2
933383|NCT00892099|3076274|P2|Overall Study|replocated|0
933384|NCT00892099|3076275|P1|Overall Study|replocated|1
933385|NCT00892099|3076273|P3|Overall Study|Adverse Event|0
933386|NCT00892099|3076274|P2|Overall Study|Adverse Event|0
933387|NCT00892099|3076275|P1|Overall Study|Adverse Event|1
933388|NCT00892099|3076273|P3|Overall Study|Death|1
933389|NCT00892099|3076274|P2|Overall Study|Death|0
933390|NCT00892099|3076275|P1|Overall Study|Death|1
933391|NCT00892047|3076300|P2|Overall Study|Lack of Efficacy|2
933392|NCT00892047|3076301|P1|Overall Study|Lack of Efficacy|0
933393|NCT00892047|3076300|P2|Overall Study|subject burden|3
933394|NCT00892047|3076301|P1|Overall Study|subject burden|2
933395|NCT00892047|3076300|P2|Overall Study|Adverse Event|2
933396|NCT00892047|3076301|P1|Overall Study|Adverse Event|2
933397|NCT00892008|3076317|P1|Overall Study|Adverse Event|37
933398|NCT00892008|3076317|P1|Overall Study|Other|378
933399|NCT00892008|3076317|P1|Overall Study|Lost to Follow-up|142
933400|NCT00892008|3076317|P1|Overall Study|Lack of Efficacy|3
933401|NCT00892008|3076317|P1|Overall Study|Death|5
933402|NCT00891930|3076403|P1|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1
933403|NCT00891930|3076403|P1|Part 2: Panitumumab + Ganitumab|Death|30
933404|NCT00891930|3076403|P1|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1
933405|NCT00891930|3076403|P1|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1
933406|NCT00891930|3076403|P1|Part 1: Panitumumab +Irinotecan|Death|38
933407|NCT00891904|3076424|P1|Overall Study|Adverse Event|1
933408|NCT00891904|3076424|P1|Overall Study|Death|1
933409|NCT00891839|3076450|P1|Overall Study|Disease progression|3
933410|NCT00891839|3076450|P1|Overall Study|Withdrawal by Subject|2
933411|NCT00891839|3076450|P1|Overall Study|Adverse Event|2
933412|NCT00891813|3076459|P1|Overall Study|Protocol Violation|2
933413|NCT00891813|3076459|P1|Overall Study|Patient Noncompliance|6
933414|NCT00891813|3076459|P1|Overall Study|Withdrawal by Subject|1
933415|NCT00891813|3076459|P1|Overall Study|Adverse Event|3
933416|NCT00891774|3076465|P1|Overall Study|Protocol Violation|4
933417|NCT00891774|3076465|P1|Overall Study|Withdrawal by Subject|2
933418|NCT00891774|3076465|P1|Overall Study|Illness (Self/Mother)|3
933419|NCT00891774|3076465|P1|Overall Study|Lost to Follow-up|5
933420|NCT00891735|3076473|P4|Overall Study|Patient's decision to withdraw|8
933421|NCT00891735|3076474|P3|Overall Study|Patient's decision to withdraw|4
933422|NCT00891735|3076475|P2|Overall Study|Patient's decision to withdraw|9
933423|NCT00891735|3076476|P1|Overall Study|Patient's decision to withdraw|4
933424|NCT00891735|3076473|P4|Overall Study|Physician's decision to withdraw patient|0
933425|NCT00891735|3076474|P3|Overall Study|Physician's decision to withdraw patient|0
933426|NCT00891735|3076475|P2|Overall Study|Physician's decision to withdraw patient|0
933427|NCT00891735|3076476|P1|Overall Study|Physician's decision to withdraw patient|1
933428|NCT00891735|3076473|P4|Overall Study|Lost to Follow-up|2
933429|NCT00891735|3076474|P3|Overall Study|Lost to Follow-up|2
933430|NCT00891735|3076475|P2|Overall Study|Lost to Follow-up|2
933431|NCT00891735|3076476|P1|Overall Study|Lost to Follow-up|2
933432|NCT00891735|3076473|P4|Overall Study|Death|5
933433|NCT00891735|3076474|P3|Overall Study|Death|4
933434|NCT00891735|3076475|P2|Overall Study|Death|5
933435|NCT00891735|3076476|P1|Overall Study|Death|8
933436|NCT00891735|3076473|P4|Overall Study|Adverse Event|0
933437|NCT00891735|3076474|P3|Overall Study|Adverse Event|2
933438|NCT00891735|3076475|P2|Overall Study|Adverse Event|0
933439|NCT00891735|3076476|P1|Overall Study|Adverse Event|2
933440|NCT00891657|3076516|P2|Overall Study|Withdrawal by Subject|1
933441|NCT00891657|3076517|P1|Overall Study|Withdrawal by Subject|1
933442|NCT00891618|3076529|P1|Overall Study|Withdrawal by Subject|1
933443|NCT00891527|3076533|P1|Overall Study|Withdrawal by Subject|2
933444|NCT00891462|3076542|P3|Overall Study|Lost to Follow-up|0
933445|NCT00891462|3076543|P2|Overall Study|Lost to Follow-up|2
933446|NCT00891462|3076544|P1|Overall Study|Lost to Follow-up|0
933447|NCT00891462|3076542|P3|Overall Study|Inclusion/exclusion criteria|2
933448|NCT00891462|3076543|P2|Overall Study|Inclusion/exclusion criteria|2
933449|NCT00891462|3076544|P1|Overall Study|Inclusion/exclusion criteria|0
933450|NCT00891462|3076542|P3|Overall Study|Protocol Violation|3
933451|NCT00891462|3076543|P2|Overall Study|Protocol Violation|1
933452|NCT00891462|3076544|P1|Overall Study|Protocol Violation|2
933453|NCT00891462|3076542|P3|Overall Study|Other Reason|3
933454|NCT00891462|3076543|P2|Overall Study|Other Reason|5
933455|NCT00891462|3076544|P1|Overall Study|Other Reason|2
933456|NCT00891462|3076542|P3|Overall Study|COPD exacerbation|1
933457|NCT00891462|3076543|P2|Overall Study|COPD exacerbation|4
933458|NCT00891462|3076544|P1|Overall Study|COPD exacerbation|7
933459|NCT00891462|3076542|P3|Overall Study|Lack of Efficacy|1
933460|NCT00891462|3076543|P2|Overall Study|Lack of Efficacy|5
933461|NCT00891462|3076544|P1|Overall Study|Lack of Efficacy|10
933462|NCT00891462|3076542|P3|Overall Study|Adverse Event|7
933463|NCT00891462|3076543|P2|Overall Study|Adverse Event|8
933464|NCT00891462|3076544|P1|Overall Study|Adverse Event|7
933465|NCT00891462|3076542|P3|Overall Study|Withdrawal by Subject|7
933466|NCT00891462|3076543|P2|Overall Study|Withdrawal by Subject|6
933467|NCT00891462|3076544|P1|Overall Study|Withdrawal by Subject|9
933468|NCT00891371|3076566|P1|Treatment|Lost to Follow-up|1
933469|NCT00891371|3076566|P1|Treatment|Death|1
933470|NCT00891371|3076566|P1|Treatment|Adverse Event|2
933471|NCT00891371|3076566|P1|Treatment|Lack of Efficacy|5
933472|NCT00891371|3076566|P1|Pre-assignment|Consent withdrawal|1
933473|NCT00891371|3076566|P1|Pre-assignment|Inclusion/exclusion|5
933474|NCT00891293|3076588|P1|Overall Study|Sponsor termination|62
933475|NCT00891293|3076588|P1|Overall Study|Subject withdrew consent|7
933476|NCT00891293|3076588|P1|Overall Study|Lost to Follow-up|7
933477|NCT00891293|3076588|P1|Overall Study|Laboratory abnormality|4
933478|NCT00891293|3076588|P1|Overall Study|Protocol Violation|2
933479|NCT00891293|3076588|P1|Overall Study|Adverse Event|2
933480|NCT00891228|3076603|P3|Overall Study|Pregnancy|0
933481|NCT00891228|3076604|P2|Overall Study|Pregnancy|1
933482|NCT00891228|3076605|P1|Overall Study|Pregnancy|0
933483|NCT00891228|3076603|P3|Overall Study|Lost to Follow-up|5
933484|NCT00891228|3076604|P2|Overall Study|Lost to Follow-up|4
933485|NCT00891228|3076605|P1|Overall Study|Lost to Follow-up|4
933486|NCT00891228|3076603|P3|Overall Study|Physician Decision|0
933487|NCT00891228|3076604|P2|Overall Study|Physician Decision|1
933488|NCT00891228|3076605|P1|Overall Study|Physician Decision|2
933489|NCT00891228|3076603|P3|Overall Study|Protocol Violation|2
933490|NCT00891228|3076604|P2|Overall Study|Protocol Violation|1
933491|NCT00891228|3076605|P1|Overall Study|Protocol Violation|3
933492|NCT00891228|3076603|P3|Overall Study|Withdrawal by Subject|5
933493|NCT00891228|3076604|P2|Overall Study|Withdrawal by Subject|4
933494|NCT00891228|3076605|P1|Overall Study|Withdrawal by Subject|2
933495|NCT00891228|3076603|P3|Overall Study|Adverse Event|3
933496|NCT00891228|3076604|P2|Overall Study|Adverse Event|2
933497|NCT00891228|3076605|P1|Overall Study|Adverse Event|0
933498|NCT00891202|3076627|P4|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5
933499|NCT00891202|3076628|P3|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2
933500|NCT00891202|3076629|P2|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
933501|NCT00891202|3076630|P1|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
933502|NCT00891202|3076627|P4|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
933503|NCT00891202|3076628|P3|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1
933504|NCT00891202|3076629|P2|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
933505|NCT00891202|3076630|P1|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
933506|NCT00891202|3076627|P4|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
933507|NCT00891202|3076628|P3|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4
933508|NCT00891202|3076629|P2|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
933509|NCT00891202|3076630|P1|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
933510|NCT00891202|3076627|P4|PAP (Up To Week 39)|Withdrawal by Subject|0
933511|NCT00891202|3076628|P3|PAP (Up To Week 39)|Withdrawal by Subject|0
933512|NCT00891202|3076629|P2|PAP (Up To Week 39)|Withdrawal by Subject|0
933513|NCT00891202|3076630|P1|PAP (Up To Week 39)|Withdrawal by Subject|1
933514|NCT00891046|3076806|P5|Overall Study|Lost to Follow-up|1
933515|NCT00891046|3076807|P4|Overall Study|Lost to Follow-up|0
933516|NCT00891046|3076808|P3|Overall Study|Lost to Follow-up|0
933517|NCT00891046|3076809|P2|Overall Study|Lost to Follow-up|0
933518|NCT00891046|3076810|P1|Overall Study|Lost to Follow-up|0
933519|NCT00891046|3076806|P5|Overall Study|Withdrawal by Subject|1
933520|NCT00891046|3076807|P4|Overall Study|Withdrawal by Subject|1
933521|NCT00891046|3076808|P3|Overall Study|Withdrawal by Subject|2
933522|NCT00891046|3076809|P2|Overall Study|Withdrawal by Subject|1
933523|NCT00891046|3076810|P1|Overall Study|Withdrawal by Subject|2
933524|NCT00891046|3076806|P5|Overall Study|Adverse Event|14
933525|NCT00891046|3076807|P4|Overall Study|Adverse Event|0
933526|NCT00891046|3076808|P3|Overall Study|Adverse Event|2
933527|NCT00891046|3076809|P2|Overall Study|Adverse Event|3
933528|NCT00891046|3076810|P1|Overall Study|Adverse Event|4
933529|NCT00891046|3076806|P5|Overall Study|Participant no longer required drug|1
933530|NCT00891046|3076807|P4|Overall Study|Participant no longer required drug|0
933531|NCT00891046|3076808|P3|Overall Study|Participant no longer required drug|0
933532|NCT00891046|3076809|P2|Overall Study|Participant no longer required drug|2
933533|NCT00891046|3076810|P1|Overall Study|Participant no longer required drug|0
933534|NCT00891046|3076806|P5|Overall Study|Administrative problems|1
933535|NCT00891046|3076807|P4|Overall Study|Administrative problems|0
933536|NCT00891046|3076808|P3|Overall Study|Administrative problems|0
933537|NCT00891046|3076809|P2|Overall Study|Administrative problems|0
933538|NCT00891046|3076810|P1|Overall Study|Administrative problems|0
933539|NCT00891046|3076806|P5|Overall Study|Unsatisfactory therapeutic effect|20
933540|NCT00891046|3076807|P4|Overall Study|Unsatisfactory therapeutic effect|2
933541|NCT00891046|3076808|P3|Overall Study|Unsatisfactory therapeutic effect|19
933542|NCT00891046|3076809|P2|Overall Study|Unsatisfactory therapeutic effect|2
933543|NCT00891046|3076810|P1|Overall Study|Unsatisfactory therapeutic effect|5
933544|NCT00891046|3076806|P5|Overall Study|Protocol Violation|1
933545|NCT00891046|3076807|P4|Overall Study|Protocol Violation|0
933546|NCT00891046|3076808|P3|Overall Study|Protocol Violation|0
933547|NCT00891046|3076809|P2|Overall Study|Protocol Violation|1
933548|NCT00891046|3076810|P1|Overall Study|Protocol Violation|1
933549|NCT00891020|3076886|P3|Long-term Extension Period|Administrative|2
933550|NCT00891020|3076887|P2|Long-term Extension Period|Administrative|2
933551|NCT00891020|3076888|P1|Long-term Extension Period|Administrative|1
933552|NCT00891020|3076886|P3|Long-term Extension Period|Failure to return|3
933553|NCT00891020|3076887|P2|Long-term Extension Period|Failure to return|2
933554|NCT00891020|3076888|P1|Long-term Extension Period|Failure to return|0
933555|NCT00891020|3076886|P3|Long-term Extension Period|Refused treatment/did not cooperate|4
933556|NCT00891020|3076887|P2|Long-term Extension Period|Refused treatment/did not cooperate|6
933557|NCT00891020|3076888|P1|Long-term Extension Period|Refused treatment/did not cooperate|1
933558|NCT00891020|3076886|P3|Long-term Extension Period|Protocol Violation|1
933559|NCT00891020|3076887|P2|Long-term Extension Period|Protocol Violation|1
933560|NCT00891020|3076888|P1|Long-term Extension Period|Protocol Violation|0
933561|NCT00891020|3076886|P3|Long-term Extension Period|Insufficient therapeutic response|2
933562|NCT00891020|3076887|P2|Long-term Extension Period|Insufficient therapeutic response|2
933563|NCT00891020|3076888|P1|Long-term Extension Period|Insufficient therapeutic response|3
933564|NCT00891020|3076886|P3|Long-term Extension Period|Death|1
933565|NCT00891020|3076887|P2|Long-term Extension Period|Death|0
933566|NCT00891020|3076888|P1|Long-term Extension Period|Death|0
933567|NCT00891020|3076886|P3|Long-term Extension Period|Adverse Event|10
933568|NCT00891020|3076887|P2|Long-term Extension Period|Adverse Event|11
933569|NCT00891020|3076888|P1|Long-term Extension Period|Adverse Event|1
933570|NCT00891020|3076886|P3|24 Week Treatment Period|Administrative/Other|1
933571|NCT00891020|3076887|P2|24 Week Treatment Period|Administrative/Other|6
933572|NCT00891020|3076888|P1|24 Week Treatment Period|Administrative/Other|5
933573|NCT00891020|3076886|P3|24 Week Treatment Period|Withdrew consent|15
933574|NCT00891020|3076887|P2|24 Week Treatment Period|Withdrew consent|3
933575|NCT00891020|3076888|P1|24 Week Treatment Period|Withdrew consent|6
933576|NCT00891020|3076886|P3|24 Week Treatment Period|Refused treatment/did not cooperate|1
933577|NCT00891020|3076887|P2|24 Week Treatment Period|Refused treatment/did not cooperate|2
933578|NCT00891020|3076888|P1|24 Week Treatment Period|Refused treatment/did not cooperate|3
933579|NCT00891020|3076886|P3|24 Week Treatment Period|Other protocol violation|2
933580|NCT00891020|3076887|P2|24 Week Treatment Period|Other protocol violation|1
933581|NCT00891020|3076888|P1|24 Week Treatment Period|Other protocol violation|1
933582|NCT00891020|3076886|P3|24 Week Treatment Period|Violation of selection criteria at entry|2
933583|NCT00891020|3076887|P2|24 Week Treatment Period|Violation of selection criteria at entry|0
933584|NCT00891020|3076888|P1|24 Week Treatment Period|Violation of selection criteria at entry|1
933585|NCT00891020|3076886|P3|24 Week Treatment Period|Failure to return|5
933586|NCT00891020|3076887|P2|24 Week Treatment Period|Failure to return|5
933587|NCT00891020|3076888|P1|24 Week Treatment Period|Failure to return|4
933588|NCT00891020|3076886|P3|24 Week Treatment Period|Insufficient therapeutic response|15
933589|NCT00891020|3076887|P2|24 Week Treatment Period|Insufficient therapeutic response|9
933590|NCT00891020|3076888|P1|24 Week Treatment Period|Insufficient therapeutic response|6
933591|NCT00891020|3076886|P3|24 Week Treatment Period|Death|0
933592|NCT00891020|3076887|P2|24 Week Treatment Period|Death|2
933593|NCT00891020|3076888|P1|24 Week Treatment Period|Death|0
933594|NCT00891020|3076886|P3|24 Week Treatment Period|Adverse event or intercurrent illness|17
933595|NCT00891020|3076887|P2|24 Week Treatment Period|Adverse event or intercurrent illness|32
933596|NCT00891020|3076888|P1|24 Week Treatment Period|Adverse event or intercurrent illness|11
933597|NCT00890929|3076952|P1|Overall Study|Physician Decision|1
933598|NCT00890929|3076952|P1|Overall Study|Withdrawal by Subject|3
933599|NCT00890929|3076952|P1|Overall Study|Death before treatment|2
933600|NCT00890825|3076970|P2|Overall Study|Alive at data cut off (DCO)|14
933601|NCT00890825|3076971|P1|Overall Study|Alive at data cut off (DCO)|13
933602|NCT00890825|3076970|P2|Overall Study|Withdrawal by Subject|0
933603|NCT00890825|3076971|P1|Overall Study|Withdrawal by Subject|1
933604|NCT00890695|3077000|P2|Overall Study|Protocol Violation|0
933605|NCT00890695|3077001|P1|Overall Study|Protocol Violation|1
933606|NCT00890591|3077030|P1|Overall Study|Lack of Efficacy|20
933607|NCT00890552|3077036|P1|On-treatment|Early prog disease/ death|10
933608|NCT00890552|3077036|P1|Enrollment and Pre-treatment|Death/ lost to follow up|1
933609|NCT00890409|3077045|P2|Overall Study|Lost to Follow-up|21
933610|NCT00890409|3077046|P1|Overall Study|Lost to Follow-up|20
933611|NCT00890201|3077056|P2|Overall Study|Protocol Violation|56
933612|NCT00890201|3077057|P1|Overall Study|Protocol Violation|5
933613|NCT00890097|3077066|P3|Overall Study|Protocol Deviation|1
933614|NCT00890097|3077067|P2|Overall Study|Protocol Deviation|1
933615|NCT00890097|3077068|P1|Overall Study|Protocol Deviation|1
933616|NCT00890097|3077066|P3|Overall Study|Subject Moved|0
933617|NCT00890097|3077067|P2|Overall Study|Subject Moved|4
933618|NCT00890097|3077068|P1|Overall Study|Subject Moved|0
933619|NCT00890097|3077066|P3|Overall Study|Transportation|0
933620|NCT00890097|3077067|P2|Overall Study|Transportation|2
933621|NCT00890097|3077068|P1|Overall Study|Transportation|0
933622|NCT00890097|3077066|P3|Overall Study|Failed inclusion criteria|0
933623|NCT00890097|3077067|P2|Overall Study|Failed inclusion criteria|4
933624|NCT00890097|3077068|P1|Overall Study|Failed inclusion criteria|3
933625|NCT00890097|3077066|P3|Overall Study|Randomization Error|0
933626|NCT00890097|3077067|P2|Overall Study|Randomization Error|0
933627|NCT00890097|3077068|P1|Overall Study|Randomization Error|2
933628|NCT00890097|3077066|P3|Overall Study|Subject Decision|6
933629|NCT00890097|3077067|P2|Overall Study|Subject Decision|2
933630|NCT00890097|3077068|P1|Overall Study|Subject Decision|3
933631|NCT00890097|3077066|P3|Overall Study|Did not attend final visit|0
933632|NCT00890097|3077067|P2|Overall Study|Did not attend final visit|3
933633|NCT00890097|3077068|P1|Overall Study|Did not attend final visit|2
933634|NCT00890097|3077066|P3|Overall Study|Sponsor Decision|7
933635|NCT00890097|3077067|P2|Overall Study|Sponsor Decision|11
933636|NCT00890097|3077068|P1|Overall Study|Sponsor Decision|7
933637|NCT00890097|3077066|P3|Overall Study|Noncompliance|4
933638|NCT00890097|3077067|P2|Overall Study|Noncompliance|4
933639|NCT00890097|3077068|P1|Overall Study|Noncompliance|0
933640|NCT00890097|3077066|P3|Overall Study|Lost to Follow-up|5
933641|NCT00890097|3077067|P2|Overall Study|Lost to Follow-up|5
933642|NCT00890097|3077068|P1|Overall Study|Lost to Follow-up|5
933643|NCT00890097|3077066|P3|Overall Study|Withdrew Consent|9
933644|NCT00890097|3077067|P2|Overall Study|Withdrew Consent|6
933645|NCT00890097|3077068|P1|Overall Study|Withdrew Consent|9
933646|NCT00890097|3077066|P3|Overall Study|Decision Unrelated to an Adverse Event|17
933647|NCT00890097|3077067|P2|Overall Study|Decision Unrelated to an Adverse Event|12
933648|NCT00890097|3077068|P1|Overall Study|Decision Unrelated to an Adverse Event|15
933649|NCT00890097|3077066|P3|Overall Study|Adverse Event|28
933650|NCT00890097|3077067|P2|Overall Study|Adverse Event|32
933651|NCT00890097|3077068|P1|Overall Study|Adverse Event|21
933652|NCT00890084|3077076|P1|Overall Study|Lost to Follow-up|126
933653|NCT00890084|3077076|P1|Overall Study|Adverse Event|16
933654|NCT00889863|3077116|P2|Part II: Randomized Double Blind|Protocol deviation|1
933655|NCT00889863|3077117|P1|Part II: Randomized Double Blind|Protocol deviation|0
933656|NCT00889863|3077116|P2|Part II: Randomized Double Blind|Withdrawal by Subject|1
933657|NCT00889863|3077117|P1|Part II: Randomized Double Blind|Withdrawal by Subject|0
933658|NCT00889863|3077116|P2|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20
933659|NCT00889863|3077117|P1|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11
933660|NCT00889863|3077116|P2|Part II: Randomized Double Blind|Adverse Event|4
933661|NCT00889863|3077117|P1|Part II: Randomized Double Blind|Adverse Event|0
933662|NCT00889863|3077116|P2|Part I: Open Label|Unsatisfactory therapeutic effect|0
933663|NCT00889863|3077117|P1|Part I: Open Label|Unsatisfactory therapeutic effect|72
933664|NCT00889863|3077116|P2|Part I: Open Label|Adverse Event|0
933665|NCT00889863|3077117|P1|Part I: Open Label|Adverse Event|4
933666|NCT00889863|3077116|P2|Part I: Open Label|Death|0
933667|NCT00889863|3077117|P1|Part I: Open Label|Death|1
933668|NCT00889720|3077143|P1|Overall Study|Other|4
933669|NCT00889720|3077143|P1|Overall Study|Withdrawal by Subject|4
933670|NCT00889707|3077170|P2|Overall Study|Lack of Efficacy|5
933671|NCT00889707|3077171|P1|Overall Study|Lack of Efficacy|2
933672|NCT00889707|3077170|P2|Overall Study|Lost to Follow-up|2
933673|NCT00889707|3077171|P1|Overall Study|Lost to Follow-up|0
933674|NCT00889707|3077170|P2|Overall Study|Withdrawal by Subject|3
933675|NCT00889707|3077171|P1|Overall Study|Withdrawal by Subject|4
933676|NCT00889707|3077170|P2|Overall Study|Adverse Event|0
933677|NCT00889707|3077171|P1|Overall Study|Adverse Event|1
933678|NCT00889681|3077179|P1|Overall Study|Insurance disapproval|1
933679|NCT00889681|3077179|P1|Overall Study|Not meeting qualification Criteria|2
933680|NCT00889603|3077186|P1|Overall Study|Not Specified|4
933681|NCT00889603|3077186|P1|Overall Study|No longer willing to participant in stud|4
933682|NCT00889603|3077186|P1|Overall Study|Lost to Follow-up|19
933683|NCT00889603|3077186|P1|Overall Study|Death|3
933684|NCT00889603|3077186|P1|Overall Study|Adverse Event|7
933685|NCT00889421|3077208|P1|Overall Study|Lack of Efficacy|3
933686|NCT00889265|3077249|P1|Overall Study|Protocol Violation|1
933687|NCT00889265|3077249|P1|Overall Study|Lost to Follow-up|5
933688|NCT00889265|3077249|P1|Overall Study|Adverse Event|1
933689|NCT00889252|3077256|P2|Overall Study|Protocol Violation|0
933690|NCT00889252|3077257|P1|Overall Study|Protocol Violation|2
933691|NCT00889252|3077256|P2|Overall Study|Withdrawal by Subject|0
933692|NCT00889252|3077257|P1|Overall Study|Withdrawal by Subject|3
933693|NCT00889252|3077256|P2|Overall Study|Adverse Event|4
933694|NCT00889252|3077257|P1|Overall Study|Adverse Event|2
933695|NCT00889005|3077323|P2|Overall Study|Withdrawal by Subject|0
933696|NCT00889005|3077324|P1|Overall Study|Withdrawal by Subject|4
933697|NCT00889005|3077323|P2|Overall Study|Lost to Follow-up|2
933698|NCT00889005|3077324|P1|Overall Study|Lost to Follow-up|4
933699|NCT00888940|3077338|P2|Overall Study|Randomized Not Treated|13
933700|NCT00888940|3077339|P1|Overall Study|Randomized Not Treated|11
933701|NCT00888940|3077338|P2|Overall Study|Lost to Follow-up|5
933702|NCT00888940|3077339|P1|Overall Study|Lost to Follow-up|5
933703|NCT00888940|3077338|P2|Overall Study|Adverse Event|3
933704|NCT00888940|3077339|P1|Overall Study|Adverse Event|12
933705|NCT00888849|3077349|P2|Overall Study|Lost to Follow-up|2
933706|NCT00888849|3077350|P1|Overall Study|Lost to Follow-up|1
933707|NCT00888849|3077349|P2|Overall Study|Death|7
933708|NCT00888849|3077350|P1|Overall Study|Death|4
933709|NCT00888654|3077360|P1|Overall Study|Stopped meds due to headaches|1
933710|NCT00888654|3077360|P1|Overall Study|Change in surg date|1
933711|NCT00888654|3077360|P1|Overall Study|Inelig. due to contraindication of med|1
933712|NCT00888654|3077360|P1|Overall Study|Withdrawal by Subject|1
933713|NCT00888654|3077360|P1|Overall Study|Surgery aborted|2
933714|NCT00888654|3077360|P1|Overall Study|Not enough oral meds before surgery|3
933715|NCT00888654|3077360|P1|Overall Study|Problems swallowing oral meds.|1
933716|NCT00888433|3077389|P2|Overall Study|Missed Visit|1
933717|NCT00888433|3077390|P1|Overall Study|Missed Visit|2
933718|NCT00888433|3077389|P2|Overall Study|Withdrawal by Subject|2
933719|NCT00888433|3077390|P1|Overall Study|Withdrawal by Subject|1
933720|NCT00888381|3077398|P2|Overall Study|Lost to Follow-up|1
933721|NCT00888381|3077399|P1|Overall Study|Lost to Follow-up|0
933722|NCT00888355|3077419|P4|Overall Study|Withdrawal by Subject|3
933723|NCT00888355|3077420|P3|Overall Study|Withdrawal by Subject|1
933724|NCT00888355|3077421|P2|Overall Study|Withdrawal by Subject|3
933725|NCT00888355|3077422|P1|Overall Study|Withdrawal by Subject|0
933726|NCT00888355|3077419|P4|Overall Study|Protocol Violation|2
933727|NCT00888355|3077420|P3|Overall Study|Protocol Violation|1
933728|NCT00888355|3077421|P2|Overall Study|Protocol Violation|2
933729|NCT00888355|3077422|P1|Overall Study|Protocol Violation|3
933730|NCT00888355|3077419|P4|Overall Study|Lost to Follow-up|0
933731|NCT00888355|3077420|P3|Overall Study|Lost to Follow-up|2
933732|NCT00888355|3077421|P2|Overall Study|Lost to Follow-up|2
933733|NCT00888355|3077422|P1|Overall Study|Lost to Follow-up|0
933734|NCT00888355|3077419|P4|Overall Study|Lack of Efficacy|2
933735|NCT00888355|3077420|P3|Overall Study|Lack of Efficacy|5
933736|NCT00888355|3077421|P2|Overall Study|Lack of Efficacy|2
933737|NCT00888355|3077422|P1|Overall Study|Lack of Efficacy|9
933738|NCT00888355|3077419|P4|Overall Study|Adverse Event|3
933739|NCT00888355|3077420|P3|Overall Study|Adverse Event|3
933740|NCT00888355|3077421|P2|Overall Study|Adverse Event|0
933741|NCT00888355|3077422|P1|Overall Study|Adverse Event|10
933742|NCT00888329|3077478|P2|Overall Study|Physician Decision|9
933743|NCT00888329|3077479|P1|Overall Study|Physician Decision|6
933744|NCT00888238|3077485|P3|Washout Period After Period 2|Adverse Event|1
933745|NCT00888238|3077486|P2|Washout Period After Period 2|Adverse Event|0
933746|NCT00888238|3077487|P1|Washout Period After Period 2|Adverse Event|0
933747|NCT00888173|3077495|P1|Overall Study|Ineligible: required test not done|1
933748|NCT00888173|3077495|P1|Overall Study|Wrong Primary|1
933749|NCT00888134|3077503|P1|Follow-up|being followed for long-term survival|1
933750|NCT00888134|3077503|P1|Treatment With Study Drug|Withdrawal by Subject|1
933751|NCT00887978|3077513|P2|Overall Study|Lost to Follow-up|1
933752|NCT00887978|3077514|P1|Overall Study|Lost to Follow-up|0
933753|NCT00887978|3077513|P2|Overall Study|Withdrawal by Subject|2
933754|NCT00887978|3077514|P1|Overall Study|Withdrawal by Subject|1
933755|NCT00887978|3077513|P2|Overall Study|Death|3
933756|NCT00887978|3077514|P1|Overall Study|Death|2
933757|NCT00887978|3077513|P2|Overall Study|Clinical Worsening|4
933758|NCT00887978|3077514|P1|Overall Study|Clinical Worsening|4
933759|NCT00887978|3077513|P2|Overall Study|Adverse Event|5
933760|NCT00887978|3077514|P1|Overall Study|Adverse Event|18
933761|NCT00887913|3077580|P1|Overall Study|Withdrawal by Subject|6
933762|NCT00887822|3077588|P2|Overall Study|Randomized but not treated|1
933763|NCT00887822|3077589|P1|Overall Study|Randomized but not treated|0
933764|NCT00887822|3077588|P2|Overall Study|Protocol Violation|1
933765|NCT00887822|3077589|P1|Overall Study|Protocol Violation|0
933766|NCT00887822|3077588|P2|Overall Study|Death|3
933767|NCT00887822|3077589|P1|Overall Study|Death|2
933768|NCT00887822|3077588|P2|Overall Study|Administrative/Other than specified|4
933769|NCT00887822|3077589|P1|Overall Study|Administrative/Other than specified|5
933770|NCT00887822|3077588|P2|Overall Study|Refused treatment/Did not cooperate|10
933771|NCT00887822|3077589|P1|Overall Study|Refused treatment/Did not cooperate|12
933772|NCT00887822|3077588|P2|Overall Study|Failure to return|11
933773|NCT00887822|3077589|P1|Overall Study|Failure to return|11
933774|NCT00887822|3077588|P2|Overall Study|Adverse Event|17
933775|NCT00887822|3077589|P1|Overall Study|Adverse Event|14
933776|NCT00887822|3077588|P2|Overall Study|Insufficient therapeutic response|55
933777|NCT00887822|3077589|P1|Overall Study|Insufficient therapeutic response|53
933778|NCT00887809|3077621|P2|Overall Study|Death|0
933779|NCT00887809|3077622|P1|Overall Study|Death|1
933780|NCT00887809|3077621|P2|Overall Study|Patient Not Treated|0
933781|NCT00887809|3077622|P1|Overall Study|Patient Not Treated|3
933782|NCT00887744|3077628|P1|Overall Study|Various reasons|9
933783|NCT00887744|3077628|P1|Overall Study|Withdrawal by Subject|18
933784|NCT00887744|3077628|P1|Overall Study|Lost to Follow-up|3
933785|NCT00887744|3077628|P1|Overall Study|Death|1
933786|NCT00887744|3077628|P1|Overall Study|Adverse Event|3
933787|NCT00887679|3077637|P1|Overall Study|Physician Decision|5
933788|NCT00887679|3077637|P1|Overall Study|Lost to Follow-up|4
933789|NCT00887679|3077637|P1|Overall Study|Withdrawal by Subject|1
933790|NCT00887588|3077667|P2|Extension Period|Lost to Follow-up|0
933791|NCT00887588|3077668|P1|Extension Period|Lost to Follow-up|1
933792|NCT00887588|3077667|P2|Extension Period|Protocol deviation|0
933793|NCT00887588|3077668|P1|Extension Period|Protocol deviation|1
933794|NCT00887588|3077667|P2|Extension Period|Death|1
933795|NCT00887588|3077668|P1|Extension Period|Death|0
933796|NCT00887588|3077667|P2|Extension Period|Adverse Event|4
933797|NCT00887588|3077668|P1|Extension Period|Adverse Event|4
933798|NCT00887588|3077667|P2|Core Period|Adverse Event|11
933799|NCT00887588|3077668|P1|Core Period|Adverse Event|9
933800|NCT00887588|3077667|P2|Core Period|Withdrawal by Subject|8
933801|NCT00887588|3077668|P1|Core Period|Withdrawal by Subject|6
933802|NCT00887588|3077667|P2|Core Period|Lost to Follow-up|1
933803|NCT00887588|3077668|P1|Core Period|Lost to Follow-up|3
933804|NCT00887588|3077667|P2|Core Period|Death|1
933805|NCT00887588|3077668|P1|Core Period|Death|1
933806|NCT00887549|3077749|P1|Maintenance Therapy|Death due to adverse event|1
933807|NCT00887549|3077749|P1|Maintenance Therapy|Progressive Disease|25
933808|NCT00887549|3077749|P1|Maintenance Therapy|Physician Decision|1
933809|NCT00887549|3077749|P1|Maintenance Therapy|Adverse Event|16
933810|NCT00887549|3077749|P1|Induction Therapy|Death due to Study Drug Toxicity|1
933811|NCT00887549|3077749|P1|Induction Therapy|Death due to Study Disease|4
933812|NCT00887549|3077749|P1|Induction Therapy|Progressive Disease|13
933813|NCT00887549|3077749|P1|Induction Therapy|Physician Decision|1
933814|NCT00887549|3077749|P1|Induction Therapy|Adverse Event|8
933815|NCT00887484|3077767|P1|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1
933816|NCT00887484|3077767|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
933817|NCT00887484|3077767|P1|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1
933818|NCT00887354|3077855|P2|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
933819|NCT00887354|3077856|P1|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
933820|NCT00887354|3077855|P2|Open Label Phase (Week 26 to Week 78)|Adverse Event|0
933821|NCT00887354|3077856|P1|Open Label Phase (Week 26 to Week 78)|Adverse Event|1
933822|NCT00887354|3077855|P2|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2
933823|NCT00887354|3077856|P1|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1
933824|NCT00887354|3077855|P2|Open Label Phase (Week 26 to Week 78)|Physician Decision|1
933825|NCT00887354|3077856|P1|Open Label Phase (Week 26 to Week 78)|Physician Decision|0
933826|NCT00887354|3077855|P2|Open Label Phase (Week 26 to Week 78)|Death|2
933827|NCT00887354|3077856|P1|Open Label Phase (Week 26 to Week 78)|Death|0
933828|NCT00887354|3077855|P2|Treatment Phase (Week 0 to Week 26)|Not Treated|3
933829|NCT00887354|3077856|P1|Treatment Phase (Week 0 to Week 26)|Not Treated|5
933830|NCT00887354|3077855|P2|Treatment Phase (Week 0 to Week 26)|No efficacy data|25
933831|NCT00887354|3077856|P1|Treatment Phase (Week 0 to Week 26)|No efficacy data|20
933832|NCT00887354|3077855|P2|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2
933833|NCT00887354|3077856|P1|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1
933834|NCT00887354|3077855|P2|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
933835|NCT00887354|3077856|P1|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
933836|NCT00887354|3077855|P2|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1
933837|NCT00887354|3077856|P1|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2
933838|NCT00887354|3077855|P2|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
933839|NCT00887354|3077856|P1|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
933840|NCT00887354|3077855|P2|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8
933841|NCT00887354|3077856|P1|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14
933842|NCT00887354|3077855|P2|Treatment Phase (Week 0 to Week 26)|Physician Decision|1
933843|NCT00887354|3077856|P1|Treatment Phase (Week 0 to Week 26)|Physician Decision|2
933844|NCT00887354|3077855|P2|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
933845|NCT00887354|3077856|P1|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
933846|NCT00887354|3077855|P2|Treatment Phase (Week 0 to Week 26)|Death|1
933847|NCT00887354|3077856|P1|Treatment Phase (Week 0 to Week 26)|Death|0
933848|NCT00887341|3077876|P2|Overall Study|Lost to Follow-up|1
933849|NCT00887341|3077877|P1|Overall Study|Lost to Follow-up|0
933850|NCT00887341|3077876|P2|Overall Study|Adverse Event|1
933851|NCT00887341|3077877|P1|Overall Study|Adverse Event|0
933852|NCT00887341|3077876|P2|Overall Study|Withdrawal by Subject|1
933853|NCT00887341|3077877|P1|Overall Study|Withdrawal by Subject|1
933854|NCT00887341|3077876|P2|Overall Study|Refused treatment|0
933855|NCT00887341|3077877|P1|Overall Study|Refused treatment|1
933856|NCT00887315|3077913|P2|Overall Study|Study termination|4
933857|NCT00887315|3077914|P1|Overall Study|Study termination|7
933858|NCT00887289|3077922|P1|Overall Study|not specified|20
933859|NCT00887289|3077922|P1|Overall Study|Lost to Follow-up|8
933860|NCT00887289|3077922|P1|Overall Study|Withdrawal by Subject|26
933861|NCT00887289|3077922|P1|Overall Study|Adverse Event|27
933862|NCT00887289|3077922|P1|Overall Study|Lack of Efficacy|14
933863|NCT00887250|3077934|P3|Overall Study|Patient uncooperative|1
933864|NCT00887250|3077935|P2|Overall Study|Patient uncooperative|0
933865|NCT00887250|3077936|P1|Overall Study|Patient uncooperative|0
933866|NCT00887250|3077934|P3|Overall Study|Withdrawal by Subject|2
933867|NCT00887250|3077935|P2|Overall Study|Withdrawal by Subject|1
933868|NCT00887250|3077936|P1|Overall Study|Withdrawal by Subject|2
933869|NCT00887250|3077934|P3|Overall Study|Protocol Violation|1
933870|NCT00887250|3077935|P2|Overall Study|Protocol Violation|2
933871|NCT00887250|3077936|P1|Overall Study|Protocol Violation|2
933872|NCT00887250|3077934|P3|Overall Study|Lost to Follow-up|1
933873|NCT00887250|3077935|P2|Overall Study|Lost to Follow-up|3
933874|NCT00887250|3077936|P1|Overall Study|Lost to Follow-up|2
933875|NCT00887250|3077934|P3|Overall Study|Lack of Efficacy|1
933876|NCT00887250|3077935|P2|Overall Study|Lack of Efficacy|6
933877|NCT00887250|3077936|P1|Overall Study|Lack of Efficacy|9
933878|NCT00887250|3077934|P3|Overall Study|Adverse Event|7
933879|NCT00887250|3077935|P2|Overall Study|Adverse Event|0
933880|NCT00887250|3077936|P1|Overall Study|Adverse Event|3
933881|NCT00887224|3077959|P3|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11
933882|NCT00887224|3077960|P2|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8
933883|NCT00887224|3077961|P1|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0
933884|NCT00887224|3077959|P3|DB Taper Phase / Post Study Follow Up|Protocol Violation|1
933885|NCT00887224|3077960|P2|DB Taper Phase / Post Study Follow Up|Protocol Violation|4
933886|NCT00887224|3077961|P1|DB Taper Phase / Post Study Follow Up|Protocol Violation|0
933887|NCT00887224|3077959|P3|DB Taper Phase / Post Study Follow Up|Other|12
933888|NCT00887224|3077960|P2|DB Taper Phase / Post Study Follow Up|Other|11
933889|NCT00887224|3077961|P1|DB Taper Phase / Post Study Follow Up|Other|0
933890|NCT00887224|3077959|P3|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
933891|NCT00887224|3077960|P2|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
933892|NCT00887224|3077961|P1|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0
933893|NCT00887224|3077959|P3|DB Taper Phase / Post Study Follow Up|Physician Decision|0
933894|NCT00887224|3077960|P2|DB Taper Phase / Post Study Follow Up|Physician Decision|6
933895|NCT00887224|3077961|P1|DB Taper Phase / Post Study Follow Up|Physician Decision|0
933896|NCT00887224|3077959|P3|DB Taper Phase / Post Study Follow Up|Failed to return|4
933897|NCT00887224|3077960|P2|DB Taper Phase / Post Study Follow Up|Failed to return|5
933898|NCT00887224|3077961|P1|DB Taper Phase / Post Study Follow Up|Failed to return|0
933899|NCT00887224|3077959|P3|DB Taper Phase / Post Study Follow Up|Adverse Event|0
933900|NCT00887224|3077960|P2|DB Taper Phase / Post Study Follow Up|Adverse Event|5
933901|NCT00887224|3077961|P1|DB Taper Phase / Post Study Follow Up|Adverse Event|0
933902|NCT00887224|3077959|P3|Double-blind (DB) Phase|Withdrawal by Subject|12
933903|NCT00887224|3077960|P2|Double-blind (DB) Phase|Withdrawal by Subject|6
933904|NCT00887224|3077961|P1|Double-blind (DB) Phase|Withdrawal by Subject|0
933905|NCT00887224|3077959|P3|Double-blind (DB) Phase|Protocol Violation|5
933906|NCT00887224|3077960|P2|Double-blind (DB) Phase|Protocol Violation|8
933907|NCT00887224|3077961|P1|Double-blind (DB) Phase|Protocol Violation|0
933908|NCT00887224|3077959|P3|Double-blind (DB) Phase|Other|0
933909|NCT00887224|3077960|P2|Double-blind (DB) Phase|Other|2
933910|NCT00887224|3077961|P1|Double-blind (DB) Phase|Other|0
933911|NCT00887224|3077959|P3|Double-blind (DB) Phase|Lost to Follow-up|8
933912|NCT00887224|3077960|P2|Double-blind (DB) Phase|Lost to Follow-up|8
933913|NCT00887224|3077961|P1|Double-blind (DB) Phase|Lost to Follow-up|0
933914|NCT00887224|3077959|P3|Double-blind (DB) Phase|Lack of Efficacy|33
933915|NCT00887224|3077960|P2|Double-blind (DB) Phase|Lack of Efficacy|67
933916|NCT00887224|3077961|P1|Double-blind (DB) Phase|Lack of Efficacy|0
933917|NCT00887224|3077959|P3|Double-blind (DB) Phase|Failed to return|2
933918|NCT00887224|3077960|P2|Double-blind (DB) Phase|Failed to return|2
933919|NCT00887224|3077961|P1|Double-blind (DB) Phase|Failed to return|0
933920|NCT00887224|3077959|P3|Double-blind (DB) Phase|Adverse Event|2
933921|NCT00887224|3077960|P2|Double-blind (DB) Phase|Adverse Event|7
933922|NCT00887224|3077961|P1|Double-blind (DB) Phase|Adverse Event|0
933923|NCT00887224|3077959|P3|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
933924|NCT00887224|3077960|P2|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
933925|NCT00887224|3077961|P1|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48
933926|NCT00887224|3077959|P3|OL Taper Phase / OL Follow Up|Protocol Violation|0
933927|NCT00887224|3077960|P2|OL Taper Phase / OL Follow Up|Protocol Violation|0
933928|NCT00887224|3077961|P1|OL Taper Phase / OL Follow Up|Protocol Violation|3
933929|NCT00887224|3077959|P3|OL Taper Phase / OL Follow Up|Other|0
933930|NCT00887224|3077960|P2|OL Taper Phase / OL Follow Up|Other|0
933931|NCT00887224|3077961|P1|OL Taper Phase / OL Follow Up|Other|30
933932|NCT00887224|3077959|P3|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
933933|NCT00887224|3077960|P2|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
933934|NCT00887224|3077961|P1|OL Taper Phase / OL Follow Up|Lost to Follow-up|8
933935|NCT00887224|3077959|P3|OL Taper Phase / OL Follow Up|Physician Decision|0
933936|NCT00887224|3077960|P2|OL Taper Phase / OL Follow Up|Physician Decision|0
933937|NCT00887224|3077961|P1|OL Taper Phase / OL Follow Up|Physician Decision|10
933938|NCT00887224|3077959|P3|OL Taper Phase / OL Follow Up|Failed to return|0
933939|NCT00887224|3077960|P2|OL Taper Phase / OL Follow Up|Failed to return|0
933940|NCT00887224|3077961|P1|OL Taper Phase / OL Follow Up|Failed to return|17
933941|NCT00887224|3077959|P3|OL Taper Phase / OL Follow Up|Adverse Event|0
933942|NCT00887224|3077960|P2|OL Taper Phase / OL Follow Up|Adverse Event|0
933943|NCT00887224|3077961|P1|OL Taper Phase / OL Follow Up|Adverse Event|28
933944|NCT00887224|3077959|P3|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
933945|NCT00887224|3077960|P2|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
933946|NCT00887224|3077961|P1|Open-label Stability (OLS) Phase|Withdrawal by Subject|19
933947|NCT00887224|3077959|P3|Open-label Stability (OLS) Phase|Protocol Violation|0
933948|NCT00887224|3077960|P2|Open-label Stability (OLS) Phase|Protocol Violation|0
933949|NCT00887224|3077961|P1|Open-label Stability (OLS) Phase|Protocol Violation|13
933950|NCT00887224|3077959|P3|Open-label Stability (OLS) Phase|Other|0
933951|NCT00887224|3077960|P2|Open-label Stability (OLS) Phase|Other|0
933952|NCT00887224|3077961|P1|Open-label Stability (OLS) Phase|Other|1
933953|NCT00887224|3077959|P3|Open-label Stability (OLS) Phase|Lost to Follow-up|0
933954|NCT00887224|3077960|P2|Open-label Stability (OLS) Phase|Lost to Follow-up|0
933955|NCT00887224|3077961|P1|Open-label Stability (OLS) Phase|Lost to Follow-up|9
933956|NCT00887224|3077959|P3|Open-label Stability (OLS) Phase|Lack of Efficacy|0
933957|NCT00887224|3077960|P2|Open-label Stability (OLS) Phase|Lack of Efficacy|0
933958|NCT00887224|3077961|P1|Open-label Stability (OLS) Phase|Lack of Efficacy|16
933959|NCT00887224|3077959|P3|Open-label Stability (OLS) Phase|Failed to return|0
933960|NCT00887224|3077960|P2|Open-label Stability (OLS) Phase|Failed to return|0
933961|NCT00887224|3077961|P1|Open-label Stability (OLS) Phase|Failed to return|3
933962|NCT00887224|3077959|P3|Open-label Stability (OLS) Phase|Adverse Event|0
933963|NCT00887224|3077960|P2|Open-label Stability (OLS) Phase|Adverse Event|0
933964|NCT00887224|3077961|P1|Open-label Stability (OLS) Phase|Adverse Event|22
933965|NCT00887224|3077959|P3|Open-label Response (OLR) Phase|Withdrawal by Subject|0
933966|NCT00887224|3077960|P2|Open-label Response (OLR) Phase|Withdrawal by Subject|0
933967|NCT00887224|3077961|P1|Open-label Response (OLR) Phase|Withdrawal by Subject|15
933968|NCT00887224|3077959|P3|Open-label Response (OLR) Phase|Protocol Violation|0
933969|NCT00887224|3077960|P2|Open-label Response (OLR) Phase|Protocol Violation|0
933970|NCT00887224|3077961|P1|Open-label Response (OLR) Phase|Protocol Violation|12
933971|NCT00887224|3077959|P3|Open-label Response (OLR) Phase|Other|0
933972|NCT00887224|3077960|P2|Open-label Response (OLR) Phase|Other|0
933973|NCT00887224|3077961|P1|Open-label Response (OLR) Phase|Other|1
933974|NCT00887224|3077959|P3|Open-label Response (OLR) Phase|Lost to Follow-up|0
933975|NCT00887224|3077960|P2|Open-label Response (OLR) Phase|Lost to Follow-up|0
933976|NCT00887224|3077961|P1|Open-label Response (OLR) Phase|Lost to Follow-up|16
933977|NCT00887224|3077959|P3|Open-label Response (OLR) Phase|Lack of Efficacy|0
933978|NCT00887224|3077960|P2|Open-label Response (OLR) Phase|Lack of Efficacy|0
933979|NCT00887224|3077961|P1|Open-label Response (OLR) Phase|Lack of Efficacy|26
933980|NCT00887224|3077959|P3|Open-label Response (OLR) Phase|Failed to return|0
933981|NCT00887224|3077960|P2|Open-label Response (OLR) Phase|Failed to return|0
933982|NCT00887224|3077961|P1|Open-label Response (OLR) Phase|Failed to return|6
933983|NCT00887224|3077959|P3|Open-label Response (OLR) Phase|Adverse Event|0
933984|NCT00887224|3077960|P2|Open-label Response (OLR) Phase|Adverse Event|0
933985|NCT00887224|3077961|P1|Open-label Response (OLR) Phase|Adverse Event|46
933986|NCT00887198|3077988|P3|Cross Over (Placebo to AA)|Other|19
933987|NCT00887198|3077989|P2|Cross Over (Placebo to AA)|Other|0
933988|NCT00887198|3077990|P1|Cross Over (Placebo to AA)|Other|0
933989|NCT00887198|3077988|P3|Cross Over (Placebo to AA)|Progressive disease|20
933990|NCT00887198|3077989|P2|Cross Over (Placebo to AA)|Progressive disease|0
933991|NCT00887198|3077990|P1|Cross Over (Placebo to AA)|Progressive disease|0
933992|NCT00887198|3077988|P3|Cross Over (Placebo to AA)|Withdrawal by Subject|2
933993|NCT00887198|3077989|P2|Cross Over (Placebo to AA)|Withdrawal by Subject|0
933994|NCT00887198|3077990|P1|Cross Over (Placebo to AA)|Withdrawal by Subject|0
933995|NCT00887198|3077988|P3|Cross Over (Placebo to AA)|Adverse Event|9
933996|NCT00887198|3077989|P2|Cross Over (Placebo to AA)|Adverse Event|0
933997|NCT00887198|3077990|P1|Cross Over (Placebo to AA)|Adverse Event|0
933998|NCT00887198|3077988|P3|Cross Over (Placebo to AA)|Ongoing|35
933999|NCT00887198|3077989|P2|Cross Over (Placebo to AA)|Ongoing|0
934000|NCT00887198|3077990|P1|Cross Over (Placebo to AA)|Ongoing|0
934001|NCT00887198|3077988|P3|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8
934002|NCT00887198|3077989|P2|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
934003|NCT00887198|3077990|P1|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
934004|NCT00887198|3077988|P3|Randomized Period|Randomized, Not treated|0
934005|NCT00887198|3077989|P2|Randomized Period|Randomized, Not treated|2
934006|NCT00887198|3077990|P1|Randomized Period|Randomized, Not treated|4
934007|NCT00887198|3077988|P3|Randomized Period|Other|0
934008|NCT00887198|3077989|P2|Randomized Period|Other|30
934009|NCT00887198|3077990|P1|Randomized Period|Other|42
934010|NCT00887198|3077988|P3|Randomized Period|Progressive disease|0
934011|NCT00887198|3077989|P2|Randomized Period|Progressive disease|370
934012|NCT00887198|3077990|P1|Randomized Period|Progressive disease|366
934013|NCT00887198|3077988|P3|Randomized Period|Withdrawal by Subject|0
934014|NCT00887198|3077989|P2|Randomized Period|Withdrawal by Subject|56
934015|NCT00887198|3077990|P1|Randomized Period|Withdrawal by Subject|41
934016|NCT00887198|3077988|P3|Randomized Period|Cross-over to AA (under amendment 3)|0
934017|NCT00887198|3077989|P2|Randomized Period|Cross-over to AA (under amendment 3)|51
934018|NCT00887198|3077990|P1|Randomized Period|Cross-over to AA (under amendment 3)|0
934019|NCT00887198|3077988|P3|Randomized Period|Lost to Follow-up|0
934020|NCT00887198|3077989|P2|Randomized Period|Lost to Follow-up|0
934021|NCT00887198|3077990|P1|Randomized Period|Lost to Follow-up|1
934022|NCT00887198|3077988|P3|Randomized Period|Adverse Event|0
934023|NCT00887198|3077989|P2|Randomized Period|Adverse Event|33
934024|NCT00887198|3077990|P1|Randomized Period|Adverse Event|50
934025|NCT00887198|3077988|P3|Randomized Period|Ongoing|0
934026|NCT00887198|3077989|P2|Randomized Period|Ongoing|0
934027|NCT00887198|3077990|P1|Randomized Period|Ongoing|42
934028|NCT00887159|3078021|P3|Overall Study|Never started assigned therapy|4
934029|NCT00887159|3078022|P2|Overall Study|Never started assigned therapy|3
934030|NCT00887159|3078023|P1|Overall Study|Never started assigned therapy|3
934031|NCT00887159|3078021|P3|Overall Study|Ineligible|0
934032|NCT00887159|3078022|P2|Overall Study|Ineligible|1
934033|NCT00887159|3078023|P1|Overall Study|Ineligible|5
934034|NCT00887159|3078021|P3|Overall Study|Received more tx instead of observation|0
934035|NCT00887159|3078022|P2|Overall Study|Received more tx instead of observation|0
934036|NCT00887159|3078023|P1|Overall Study|Received more tx instead of observation|1
934037|NCT00887159|3078021|P3|Overall Study|Pt had PD but was SD when re-measured|0
934038|NCT00887159|3078022|P2|Overall Study|Pt had PD but was SD when re-measured|1
934039|NCT00887159|3078023|P1|Overall Study|Pt had PD but was SD when re-measured|0
934040|NCT00887159|3078021|P3|Overall Study|Treatment delayed|0
934041|NCT00887159|3078022|P2|Overall Study|Treatment delayed|1
934042|NCT00887159|3078023|P1|Overall Study|Treatment delayed|1
934043|NCT00887159|3078021|P3|Overall Study|Sympomatic deterioration|0
934044|NCT00887159|3078022|P2|Overall Study|Sympomatic deterioration|0
934045|NCT00887159|3078023|P1|Overall Study|Sympomatic deterioration|1
934046|NCT00887159|3078021|P3|Overall Study|Physician Decision|0
934047|NCT00887159|3078022|P2|Overall Study|Physician Decision|1
934048|NCT00887159|3078023|P1|Overall Study|Physician Decision|1
934049|NCT00887159|3078021|P3|Overall Study|Alternative therapy|0
934050|NCT00887159|3078022|P2|Overall Study|Alternative therapy|0
934051|NCT00887159|3078023|P1|Overall Study|Alternative therapy|2
934052|NCT00887159|3078021|P3|Overall Study|Withdrawal by Subject|2
934053|NCT00887159|3078022|P2|Overall Study|Withdrawal by Subject|4
934054|NCT00887159|3078023|P1|Overall Study|Withdrawal by Subject|4
934055|NCT00887159|3078021|P3|Overall Study|Death|0
934056|NCT00887159|3078022|P2|Overall Study|Death|2
934057|NCT00887159|3078023|P1|Overall Study|Death|2
934058|NCT00887159|3078021|P3|Overall Study|Adverse Event|17
934059|NCT00887159|3078022|P2|Overall Study|Adverse Event|4
934060|NCT00887159|3078023|P1|Overall Study|Adverse Event|3
934061|NCT00887159|3078021|P3|Overall Study|Disease progression|33
934062|NCT00887159|3078022|P2|Overall Study|Disease progression|39
934063|NCT00887159|3078023|P1|Overall Study|Disease progression|6
934064|NCT00886938|3078039|P1|Overall Study|Withdrawal by Subject|1
934065|NCT00886938|3078039|P1|Overall Study|Adverse Event|1
934066|NCT00886834|3078052|P2|Overall Study|Protocol Violation|3
934067|NCT00886834|3078053|P1|Overall Study|Protocol Violation|0
934068|NCT00886821|3078075|P14|Stage 2|Lost to Follow-up|1
934069|NCT00886821|3078076|P13|Stage 2|Lost to Follow-up|2
934070|NCT00886821|3078077|P12|Stage 2|Lost to Follow-up|0
934071|NCT00886821|3078078|P11|Stage 2|Lost to Follow-up|0
934072|NCT00886821|3078079|P10|Stage 2|Lost to Follow-up|0
934073|NCT00886821|3078080|P9|Stage 2|Lost to Follow-up|0
934074|NCT00886821|3078081|P8|Stage 2|Lost to Follow-up|0
934075|NCT00886821|3078082|P7|Stage 2|Lost to Follow-up|0
934076|NCT00886821|3078083|P6|Stage 2|Lost to Follow-up|0
934077|NCT00886821|3078084|P5|Stage 2|Lost to Follow-up|0
934078|NCT00886821|3078085|P4|Stage 2|Lost to Follow-up|0
934079|NCT00886821|3078086|P3|Stage 2|Lost to Follow-up|0
934080|NCT00886821|3078087|P2|Stage 2|Lost to Follow-up|0
934081|NCT00886821|3078088|P1|Stage 2|Lost to Follow-up|0
934082|NCT00886821|3078075|P14|Stage 2|Adverse Event|0
934083|NCT00886821|3078076|P13|Stage 2|Adverse Event|3
934084|NCT00886821|3078077|P12|Stage 2|Adverse Event|1
934085|NCT00886821|3078078|P11|Stage 2|Adverse Event|0
934086|NCT00886821|3078079|P10|Stage 2|Adverse Event|0
934087|NCT00886821|3078080|P9|Stage 2|Adverse Event|0
934088|NCT00886821|3078081|P8|Stage 2|Adverse Event|0
934089|NCT00886821|3078082|P7|Stage 2|Adverse Event|0
934090|NCT00886821|3078083|P6|Stage 2|Adverse Event|0
934091|NCT00886821|3078084|P5|Stage 2|Adverse Event|0
934092|NCT00886821|3078085|P4|Stage 2|Adverse Event|0
934093|NCT00886821|3078086|P3|Stage 2|Adverse Event|0
934094|NCT00886821|3078087|P2|Stage 2|Adverse Event|0
934095|NCT00886821|3078088|P1|Stage 2|Adverse Event|0
934096|NCT00886795|3078313|P1|Overall Study|Lack of Efficacy|1
934097|NCT00886769|3078320|P2|Overall Study|Unsatisfactory therapeutic effect|37
934098|NCT00886769|3078321|P1|Overall Study|Unsatisfactory therapeutic effect|6
934099|NCT00886743|3078345|P1|Overall Study|Other|1
934100|NCT00886743|3078345|P1|Overall Study|Adverse Event|3
934101|NCT00886639|3078383|P1|Overall Study|non-compliance|2
934102|NCT00886639|3078383|P1|Overall Study|acute exacerbation|14
934103|NCT00886613|3078397|P3|Overall Study|Subject withdrew consent (Part A)|2
934104|NCT00886613|3078398|P2|Overall Study|Subject withdrew consent (Part A)|0
934105|NCT00886613|3078399|P1|Overall Study|Subject withdrew consent (Part A)|0
934106|NCT00886613|3078397|P3|Overall Study|Lost to follow-up (Part B)|1
934107|NCT00886613|3078398|P2|Overall Study|Lost to follow-up (Part B)|0
934108|NCT00886613|3078399|P1|Overall Study|Lost to follow-up (Part B)|1
934109|NCT00886613|3078397|P3|Overall Study|Protocol deviation (Part B)|0
934110|NCT00886613|3078398|P2|Overall Study|Protocol deviation (Part B)|0
934111|NCT00886613|3078399|P1|Overall Study|Protocol deviation (Part B)|1
934112|NCT00886600|3078421|P4|Combination Therapy Period|Protocol Violation|0
934113|NCT00886600|3078422|P3|Combination Therapy Period|Protocol Violation|1
934114|NCT00886600|3078423|P2|Combination Therapy Period|Protocol Violation|0
934115|NCT00886600|3078424|P1|Combination Therapy Period|Protocol Violation|0
934116|NCT00886600|3078421|P4|Combination Therapy Period|Adverse Event|0
934117|NCT00886600|3078422|P3|Combination Therapy Period|Adverse Event|1
934118|NCT00886600|3078423|P2|Combination Therapy Period|Adverse Event|0
934119|NCT00886600|3078424|P1|Combination Therapy Period|Adverse Event|0
934120|NCT00886600|3078421|P4|Double-blind Monotherapy|Withdrawal by Subject|0
934121|NCT00886600|3078422|P3|Double-blind Monotherapy|Withdrawal by Subject|0
934122|NCT00886600|3078423|P2|Double-blind Monotherapy|Withdrawal by Subject|0
934123|NCT00886600|3078424|P1|Double-blind Monotherapy|Withdrawal by Subject|1
934124|NCT00886600|3078421|P4|Double-blind Monotherapy|Protocol Violation|1
934125|NCT00886600|3078422|P3|Double-blind Monotherapy|Protocol Violation|0
934126|NCT00886600|3078423|P2|Double-blind Monotherapy|Protocol Violation|0
934127|NCT00886600|3078424|P1|Double-blind Monotherapy|Protocol Violation|0
934128|NCT00886600|3078421|P4|Double-blind Monotherapy|Adverse Event|1
934129|NCT00886600|3078422|P3|Double-blind Monotherapy|Adverse Event|1
934130|NCT00886600|3078423|P2|Double-blind Monotherapy|Adverse Event|1
934131|NCT00886600|3078424|P1|Double-blind Monotherapy|Adverse Event|1
934132|NCT00886587|3078448|P2|Overall Study|Withdrawal by Subject|1
934133|NCT00886587|3078449|P1|Overall Study|Withdrawal by Subject|0
934134|NCT00886587|3078448|P2|Overall Study|Protocol Violation|0
934135|NCT00886587|3078449|P1|Overall Study|Protocol Violation|2
934136|NCT00886587|3078448|P2|Overall Study|Adverse Event|1
934137|NCT00886587|3078449|P1|Overall Study|Adverse Event|2
934138|NCT00886483|3078463|P2|Overall Study|Distance to center, poor grades|0
934139|NCT00886483|3078464|P1|Overall Study|Distance to center, poor grades|1
934140|NCT00886483|3078463|P2|Overall Study|Pursue medications|2
934141|NCT00886483|3078464|P1|Overall Study|Pursue medications|1
934142|NCT00886483|3078463|P2|Overall Study|Lost to Follow-up|1
934143|NCT00886483|3078464|P1|Overall Study|Lost to Follow-up|0
934144|NCT00886340|3078482|P2|Overall Study|Withdrawal by Subject|7
934145|NCT00886340|3078483|P1|Overall Study|Withdrawal by Subject|0
934146|NCT00886288|3078491|P2|Overall Study|Lost to Follow-up|0
934147|NCT00886288|3078492|P1|Overall Study|Lost to Follow-up|86
934148|NCT00886288|3078491|P2|Overall Study|no respect of the 12 weeks period|227
934149|NCT00886288|3078492|P1|Overall Study|no respect of the 12 weeks period|657
934150|NCT00886119|3078548|P2|Period 1|Did not meet inclusion criteria|0
934151|NCT00886119|3078549|P1|Period 1|Did not meet inclusion criteria|1
934152|NCT00886015|3078557|P2|Overall Study|Death|2
934153|NCT00886015|3078558|P1|Overall Study|Death|0
934154|NCT00885846|3078577|P3|Overall Study|Withdrawal by Subject|2
934155|NCT00885846|3078578|P2|Overall Study|Withdrawal by Subject|5
934156|NCT00885846|3078579|P1|Overall Study|Withdrawal by Subject|2
934157|NCT00885755|3078594|P3|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
934158|NCT00885755|3078595|P2|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
934159|NCT00885755|3078596|P1|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5
934160|NCT00885755|3078594|P3|Part I: Trastuzumab+Taxane|Death|1
934161|NCT00885755|3078595|P2|Part I: Trastuzumab+Taxane|Death|0
934162|NCT00885755|3078596|P1|Part I: Trastuzumab+Taxane|Death|0
934163|NCT00885755|3078594|P3|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
934164|NCT00885755|3078595|P2|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
934165|NCT00885755|3078596|P1|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1
934166|NCT00885755|3078594|P3|Part I: Trastuzumab+Taxane|Unknown Reason|0
934167|NCT00885755|3078595|P2|Part I: Trastuzumab+Taxane|Unknown Reason|0
934168|NCT00885755|3078596|P1|Part I: Trastuzumab+Taxane|Unknown Reason|16
934169|NCT00885755|3078594|P3|Part I: Trastuzumab+Taxane|Adverse Event|0
934170|NCT00885755|3078595|P2|Part I: Trastuzumab+Taxane|Adverse Event|0
934171|NCT00885755|3078596|P1|Part I: Trastuzumab+Taxane|Adverse Event|1
934172|NCT00885703|3078639|P7|Overall Study|Ineligible (no CM)|1
934173|NCT00885703|3078640|P6|Overall Study|Ineligible (no CM)|3
934174|NCT00885703|3078641|P5|Overall Study|Ineligible (no CM)|2
934175|NCT00885703|3078642|P4|Overall Study|Ineligible (no CM)|1
934176|NCT00885703|3078643|P3|Overall Study|Ineligible (no CM)|2
934177|NCT00885703|3078644|P2|Overall Study|Ineligible (no CM)|3
934178|NCT00885703|3078645|P1|Overall Study|Ineligible (no CM)|1
934179|NCT00885703|3078639|P7|Overall Study|Withdrawal by Subject|1
934180|NCT00885703|3078640|P6|Overall Study|Withdrawal by Subject|1
934181|NCT00885703|3078641|P5|Overall Study|Withdrawal by Subject|3
934182|NCT00885703|3078642|P4|Overall Study|Withdrawal by Subject|1
934183|NCT00885703|3078643|P3|Overall Study|Withdrawal by Subject|0
934184|NCT00885703|3078644|P2|Overall Study|Withdrawal by Subject|0
934185|NCT00885703|3078645|P1|Overall Study|Withdrawal by Subject|0
934186|NCT00885703|3078639|P7|Overall Study|Lost to Follow-up|0
934187|NCT00885703|3078640|P6|Overall Study|Lost to Follow-up|1
934188|NCT00885703|3078641|P5|Overall Study|Lost to Follow-up|0
934189|NCT00885703|3078642|P4|Overall Study|Lost to Follow-up|0
934190|NCT00885703|3078643|P3|Overall Study|Lost to Follow-up|1
934191|NCT00885703|3078644|P2|Overall Study|Lost to Follow-up|0
934192|NCT00885703|3078645|P1|Overall Study|Lost to Follow-up|0
934193|NCT00885703|3078639|P7|Overall Study|Death|4
934194|NCT00885703|3078640|P6|Overall Study|Death|8
934195|NCT00885703|3078641|P5|Overall Study|Death|7
934196|NCT00885703|3078642|P4|Overall Study|Death|7
934197|NCT00885703|3078643|P3|Overall Study|Death|8
934198|NCT00885703|3078644|P2|Overall Study|Death|7
934199|NCT00885703|3078645|P1|Overall Study|Death|9
934200|NCT00885677|3078703|P2|Overall Study|Inclusion/exclusion not met|27
934201|NCT00885677|3078704|P1|Overall Study|Inclusion/exclusion not met|25
934202|NCT00885677|3078703|P2|Overall Study|Heart transplantation|0
934203|NCT00885677|3078704|P1|Overall Study|Heart transplantation|1
934204|NCT00885677|3078703|P2|Overall Study|device/lead revision or replacement|6
934205|NCT00885677|3078704|P1|Overall Study|device/lead revision or replacement|7
934206|NCT00885677|3078703|P2|Overall Study|premature study closure|44
934207|NCT00885677|3078704|P1|Overall Study|premature study closure|41
934208|NCT00885677|3078703|P2|Overall Study|Protocol Violation|54
934209|NCT00885677|3078704|P1|Overall Study|Protocol Violation|54
934210|NCT00885677|3078703|P2|Overall Study|Lost to Follow-up|13
934211|NCT00885677|3078704|P1|Overall Study|Lost to Follow-up|15
934212|NCT00885677|3078703|P2|Overall Study|Death|34
934213|NCT00885677|3078704|P1|Overall Study|Death|40
934214|NCT00885534|3078720|P1|Overall Study|Patient deemed ineligible|1
934215|NCT00885482|3078724|P1|Overall Study|low Therapeutic drug monitoring (TDM)|1
934216|NCT00885482|3078724|P1|Overall Study|Death|1
934217|NCT00885482|3078724|P1|Overall Study|Lack of Efficacy|1
934218|NCT00885482|3078724|P1|Overall Study|Pregnancy|1
934219|NCT00885378|3078730|P2|Overall Study|Protocol Violation|0
934220|NCT00885378|3078731|P1|Overall Study|Protocol Violation|2
934221|NCT00885378|3078730|P2|Overall Study|Poor/Noncompliance|2
934222|NCT00885378|3078731|P1|Overall Study|Poor/Noncompliance|2
934223|NCT00885378|3078730|P2|Overall Study|Lost to Follow-up|2
934224|NCT00885378|3078731|P1|Overall Study|Lost to Follow-up|1
934225|NCT00885378|3078730|P2|Overall Study|Withdrawal by Subject|2
934226|NCT00885378|3078731|P1|Overall Study|Withdrawal by Subject|1
934227|NCT00885378|3078730|P2|Overall Study|Lack of Efficacy|2
934228|NCT00885378|3078731|P1|Overall Study|Lack of Efficacy|2
934229|NCT00885365|3078761|P2|4 Weeks ON Treatment|Withdrawal by Subject|0
934230|NCT00885365|3078762|P1|4 Weeks ON Treatment|Withdrawal by Subject|1
934231|NCT00885365|3078761|P2|4 Weeks ON Treatment|Protocol Violation|2
934232|NCT00885365|3078762|P1|4 Weeks ON Treatment|Protocol Violation|1
934233|NCT00885365|3078761|P2|4 Weeks ON Treatment|Adverse Event|4
934234|NCT00885365|3078762|P1|4 Weeks ON Treatment|Adverse Event|2
934235|NCT00885352|3078798|P2|Overall Study|Lab abnormalities|1
934236|NCT00885352|3078799|P1|Overall Study|Lab abnormalities|1
934237|NCT00885352|3078798|P2|Overall Study|Excluded medication|2
934238|NCT00885352|3078799|P1|Overall Study|Excluded medication|2
934239|NCT00885352|3078798|P2|Overall Study|Contradiction to study medication|2
934240|NCT00885352|3078799|P1|Overall Study|Contradiction to study medication|0
934241|NCT00885352|3078798|P2|Overall Study|Withdrawal by Subject|5
934242|NCT00885352|3078799|P1|Overall Study|Withdrawal by Subject|1
934243|NCT00885352|3078798|P2|Overall Study|Protocol Violation|2
934244|NCT00885352|3078799|P1|Overall Study|Protocol Violation|0
934245|NCT00885352|3078798|P2|Overall Study|Physician Decision|3
934246|NCT00885352|3078799|P1|Overall Study|Physician Decision|0
934247|NCT00885352|3078798|P2|Overall Study|Lost to Follow-up|2
934248|NCT00885352|3078799|P1|Overall Study|Lost to Follow-up|2
934249|NCT00885352|3078798|P2|Overall Study|Adverse Event|3
934250|NCT00885352|3078799|P1|Overall Study|Adverse Event|2
934251|NCT00885170|3078811|P2|Overall Study|Withdrawal by Subject|13
934252|NCT00885170|3078812|P1|Overall Study|Withdrawal by Subject|13
934253|NCT00885170|3078811|P2|Overall Study|Protocol Violation|1
934254|NCT00885170|3078812|P1|Overall Study|Protocol Violation|3
934255|NCT00885170|3078811|P2|Overall Study|Physician Decision|1
934256|NCT00885170|3078812|P1|Overall Study|Physician Decision|2
934257|NCT00885170|3078811|P2|Overall Study|Lost to Follow-up|1
934258|NCT00885170|3078812|P1|Overall Study|Lost to Follow-up|2
934259|NCT00885170|3078811|P2|Overall Study|Excessive bone loss|3
934260|NCT00885170|3078812|P1|Overall Study|Excessive bone loss|6
934261|NCT00885170|3078811|P2|Overall Study|Adverse Event|4
934262|NCT00885170|3078812|P1|Overall Study|Adverse Event|12
934263|NCT00885118|3078871|P5|Overall Study|Other reason not defined above|0
934264|NCT00885118|3078872|P4|Overall Study|Other reason not defined above|0
934265|NCT00885118|3078873|P3|Overall Study|Other reason not defined above|1
934266|NCT00885118|3078874|P2|Overall Study|Other reason not defined above|0
934267|NCT00885118|3078875|P1|Overall Study|Other reason not defined above|0
934268|NCT00885118|3078871|P5|Overall Study|Withdrawal by Subject|1
934269|NCT00885118|3078872|P4|Overall Study|Withdrawal by Subject|0
934270|NCT00885118|3078873|P3|Overall Study|Withdrawal by Subject|0
934271|NCT00885118|3078874|P2|Overall Study|Withdrawal by Subject|0
934272|NCT00885118|3078875|P1|Overall Study|Withdrawal by Subject|0
934273|NCT00885118|3078871|P5|Overall Study|Adverse Event|0
934274|NCT00885118|3078872|P4|Overall Study|Adverse Event|0
934275|NCT00885118|3078873|P3|Overall Study|Adverse Event|0
934276|NCT00885118|3078874|P2|Overall Study|Adverse Event|0
934277|NCT00885118|3078875|P1|Overall Study|Adverse Event|1
934278|NCT00885105|3079014|P2|Overall Study|Protocol Violation|2
934279|NCT00885105|3079015|P1|Overall Study|Protocol Violation|0
934280|NCT00885105|3079014|P2|Overall Study|Adverse Event|0
934281|NCT00885105|3079015|P1|Overall Study|Adverse Event|1
934282|NCT00885105|3079014|P2|Overall Study|Withdrawal by Subject|8
934283|NCT00885105|3079015|P1|Overall Study|Withdrawal by Subject|0
934284|NCT00884949|3079055|P1|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1
934285|NCT00884949|3079055|P1|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1
934286|NCT00884832|3079090|P2|Overall Study|Withdrawal by Subject|1
934287|NCT00884832|3079091|P1|Overall Study|Withdrawal by Subject|0
934288|NCT00884793|3079126|P1|Overall Study|Withdrawal by Subject|1
934289|NCT00884741|3079145|P4|Randomization|Protocol Violation|8
934290|NCT00884741|3079146|P3|Randomization|Protocol Violation|8
934291|NCT00884741|3079147|P2|Randomization|Protocol Violation|0
934292|NCT00884741|3079148|P1|Randomization|Protocol Violation|0
934293|NCT00884741|3079145|P4|Step 2 Registration: Tissue Analysis|Disease Progression|0
934294|NCT00884741|3079146|P3|Step 2 Registration: Tissue Analysis|Disease Progression|0
934295|NCT00884741|3079147|P2|Step 2 Registration: Tissue Analysis|Disease Progression|4
934296|NCT00884741|3079148|P1|Step 2 Registration: Tissue Analysis|Disease Progression|0
934297|NCT00884741|3079145|P4|Step 2 Registration: Tissue Analysis|Patient refusal|0
934298|NCT00884741|3079146|P3|Step 2 Registration: Tissue Analysis|Patient refusal|0
934299|NCT00884741|3079147|P2|Step 2 Registration: Tissue Analysis|Patient refusal|7
934300|NCT00884741|3079148|P1|Step 2 Registration: Tissue Analysis|Patient refusal|0
934301|NCT00884741|3079145|P4|Step 2 Registration: Tissue Analysis|Adverse Event|0
934302|NCT00884741|3079146|P3|Step 2 Registration: Tissue Analysis|Adverse Event|0
934303|NCT00884741|3079147|P2|Step 2 Registration: Tissue Analysis|Adverse Event|2
934304|NCT00884741|3079148|P1|Step 2 Registration: Tissue Analysis|Adverse Event|0
934305|NCT00884741|3079145|P4|Step 2 Registration: Tissue Analysis|Death|0
934306|NCT00884741|3079146|P3|Step 2 Registration: Tissue Analysis|Death|0
934307|NCT00884741|3079147|P2|Step 2 Registration: Tissue Analysis|Death|1
934308|NCT00884741|3079148|P1|Step 2 Registration: Tissue Analysis|Death|0
934309|NCT00884741|3079145|P4|Step 2 Registration: Tissue Analysis|Protocol Violation|0
934310|NCT00884741|3079146|P3|Step 2 Registration: Tissue Analysis|Protocol Violation|0
934311|NCT00884741|3079147|P2|Step 2 Registration: Tissue Analysis|Protocol Violation|15
934312|NCT00884741|3079148|P1|Step 2 Registration: Tissue Analysis|Protocol Violation|0
934313|NCT00884741|3079145|P4|Step 1 Registration: Tissue Screening|Patient refusal|0
934314|NCT00884741|3079146|P3|Step 1 Registration: Tissue Screening|Patient refusal|0
934315|NCT00884741|3079147|P2|Step 1 Registration: Tissue Screening|Patient refusal|0
934316|NCT00884741|3079148|P1|Step 1 Registration: Tissue Screening|Patient refusal|32
934317|NCT00884741|3079145|P4|Step 1 Registration: Tissue Screening|Disease progression|0
934318|NCT00884741|3079146|P3|Step 1 Registration: Tissue Screening|Disease progression|0
934319|NCT00884741|3079147|P2|Step 1 Registration: Tissue Screening|Disease progression|0
934320|NCT00884741|3079148|P1|Step 1 Registration: Tissue Screening|Disease progression|12
934321|NCT00884741|3079145|P4|Step 1 Registration: Tissue Screening|Insufficient tissue|0
934322|NCT00884741|3079146|P3|Step 1 Registration: Tissue Screening|Insufficient tissue|0
934323|NCT00884741|3079147|P2|Step 1 Registration: Tissue Screening|Insufficient tissue|0
934324|NCT00884741|3079148|P1|Step 1 Registration: Tissue Screening|Insufficient tissue|105
934325|NCT00884741|3079145|P4|Step 1 Registration: Tissue Screening|Physician Decision|0
934326|NCT00884741|3079146|P3|Step 1 Registration: Tissue Screening|Physician Decision|0
934327|NCT00884741|3079147|P2|Step 1 Registration: Tissue Screening|Physician Decision|0
934328|NCT00884741|3079148|P1|Step 1 Registration: Tissue Screening|Physician Decision|3
934329|NCT00884741|3079145|P4|Step 1 Registration: Tissue Screening|Death|0
934330|NCT00884741|3079146|P3|Step 1 Registration: Tissue Screening|Death|0
934331|NCT00884741|3079147|P2|Step 1 Registration: Tissue Screening|Death|0
934332|NCT00884741|3079148|P1|Step 1 Registration: Tissue Screening|Death|3
934333|NCT00884741|3079145|P4|Step 1 Registration: Tissue Screening|Protocol Violation|0
934334|NCT00884741|3079146|P3|Step 1 Registration: Tissue Screening|Protocol Violation|0
934335|NCT00884741|3079147|P2|Step 1 Registration: Tissue Screening|Protocol Violation|0
934336|NCT00884741|3079148|P1|Step 1 Registration: Tissue Screening|Protocol Violation|157
934337|NCT00884390|3079198|P2|Overall Study|Not specified|1
934338|NCT00884390|3079199|P1|Overall Study|Not specified|11
934339|NCT00884390|3079198|P2|Overall Study|Discontinuation of Study by Sponsor|2
934340|NCT00884390|3079199|P1|Overall Study|Discontinuation of Study by Sponsor|2
934341|NCT00884390|3079198|P2|Overall Study|Withdrawal by Subject|1
934342|NCT00884390|3079199|P1|Overall Study|Withdrawal by Subject|4
934343|NCT00884390|3079198|P2|Overall Study|Protocol Violation|1
934344|NCT00884390|3079199|P1|Overall Study|Protocol Violation|4
934345|NCT00884390|3079198|P2|Overall Study|Physician Decision|1
934346|NCT00884390|3079199|P1|Overall Study|Physician Decision|2
934347|NCT00884390|3079198|P2|Overall Study|Lost to Follow-up|1
934348|NCT00884390|3079199|P1|Overall Study|Lost to Follow-up|0
934349|NCT00884390|3079198|P2|Overall Study|Adverse Event|1
934350|NCT00884390|3079199|P1|Overall Study|Adverse Event|0
934351|NCT00884377|3079217|P2|Overall Study|Physician Decision|1
934352|NCT00884377|3079218|P1|Overall Study|Physician Decision|0
934353|NCT00884377|3079217|P2|Overall Study|Could not confirm diagnosis|0
934354|NCT00884377|3079218|P1|Overall Study|Could not confirm diagnosis|1
934355|NCT00884377|3079217|P2|Overall Study|Withdrawal by Subject|0
934356|NCT00884377|3079218|P1|Overall Study|Withdrawal by Subject|1
934357|NCT00884325|3079240|P2|Overall Study|Not provided|0
934358|NCT00884325|3079241|P1|Overall Study|Not provided|1
934359|NCT00884325|3079240|P2|Overall Study|Withdrawal by Subject|1
934360|NCT00884325|3079241|P1|Overall Study|Withdrawal by Subject|1
934361|NCT00884325|3079240|P2|Overall Study|Lack of Efficacy|1
934362|NCT00884325|3079241|P1|Overall Study|Lack of Efficacy|0
934363|NCT00884325|3079240|P2|Overall Study|Lost to Follow-up|2
934364|NCT00884325|3079241|P1|Overall Study|Lost to Follow-up|1
934365|NCT00884312|3079251|P2|Overall Study|Did Not Receive Study Drug|1
934366|NCT00884312|3079252|P1|Overall Study|Did Not Receive Study Drug|0
934367|NCT00884312|3079251|P2|Overall Study|Other|4
934368|NCT00884312|3079252|P1|Overall Study|Other|0
934369|NCT00884312|3079251|P2|Overall Study|Physician Decision|1
934370|NCT00884312|3079252|P1|Overall Study|Physician Decision|0
934371|NCT00884312|3079251|P2|Overall Study|Withdrawal by Subject|6
934372|NCT00884312|3079252|P1|Overall Study|Withdrawal by Subject|0
934373|NCT00884312|3079251|P2|Overall Study|Fatal Adverse Event|4
934374|NCT00884312|3079252|P1|Overall Study|Fatal Adverse Event|1
934375|NCT00884312|3079251|P2|Overall Study|Non-fatal Adverse Event|0
934376|NCT00884312|3079252|P1|Overall Study|Non-fatal Adverse Event|1
934377|NCT00884312|3079251|P2|Overall Study|Fatal Progressive Disease|1
934378|NCT00884312|3079252|P1|Overall Study|Fatal Progressive Disease|0
934379|NCT00884312|3079251|P2|Overall Study|Non-fatal Progressive Disease|8
934380|NCT00884312|3079252|P1|Overall Study|Non-fatal Progressive Disease|0
934381|NCT00884286|3079268|P2|Overall Study|Comprised lung carcinoma|1
934382|NCT00884286|3079269|P1|Overall Study|Comprised lung carcinoma|0
934383|NCT00884286|3079268|P2|Overall Study|Not treated|1
934384|NCT00884286|3079269|P1|Overall Study|Not treated|2
934385|NCT00884286|3079268|P2|Overall Study|Thrombus in right auricle|0
934386|NCT00884286|3079269|P1|Overall Study|Thrombus in right auricle|1
934387|NCT00884286|3079268|P2|Overall Study|Septic shock|0
934388|NCT00884286|3079269|P1|Overall Study|Septic shock|1
934389|NCT00884286|3079268|P2|Overall Study|Physician Decision|0
934390|NCT00884286|3079269|P1|Overall Study|Physician Decision|1
934391|NCT00884286|3079268|P2|Overall Study|Death|2
934392|NCT00884286|3079269|P1|Overall Study|Death|2
934393|NCT00884286|3079268|P2|Overall Study|Toxicity|1
934394|NCT00884286|3079269|P1|Overall Study|Toxicity|4
934395|NCT00884286|3079268|P2|Overall Study|Progressive disease|28
934396|NCT00884286|3079269|P1|Overall Study|Progressive disease|21
934397|NCT00884273|3079283|P2|Overall Study|Practical reasons|0
934398|NCT00884273|3079284|P1|Overall Study|Practical reasons|1
934399|NCT00884273|3079283|P2|Overall Study|Protocol Violation|3
934400|NCT00884273|3079284|P1|Overall Study|Protocol Violation|1
934401|NCT00884273|3079283|P2|Overall Study|Adverse Event|2
934402|NCT00884273|3079284|P1|Overall Study|Adverse Event|0
934403|NCT00884221|3079310|P2|Overall Study|Cancellation of Cycle and Other Reason|13
934404|NCT00884221|3079311|P1|Overall Study|Cancellation of Cycle and Other Reason|12
934405|NCT00884221|3079310|P2|Overall Study|Protocol Violation|13
934406|NCT00884221|3079311|P1|Overall Study|Protocol Violation|16
934407|NCT00884221|3079310|P2|Overall Study|Adverse Event|3
934408|NCT00884221|3079311|P1|Overall Study|Adverse Event|6
934409|NCT00884221|3079310|P2|Overall Study|Withdrawal by Subject|3
934410|NCT00884221|3079311|P1|Overall Study|Withdrawal by Subject|0
934411|NCT00884117|3079347|P1|Overall Study|Not Specified|12
934412|NCT00884117|3079347|P1|Overall Study|Lost to Follow-up|143
934413|NCT00884117|3079347|P1|Overall Study|Death|3
934414|NCT00884117|3079347|P1|Overall Study|Withdrawal by Subject|89
934415|NCT00884117|3079347|P1|Overall Study|Adverse Event|2
934416|NCT00884039|3079410|P2|Overall Study|Lack of Efficacy|0
934417|NCT00884039|3079411|P1|Overall Study|Lack of Efficacy|2
934418|NCT00884039|3079410|P2|Overall Study|Withdrawal by Subject|1
934419|NCT00884039|3079411|P1|Overall Study|Withdrawal by Subject|0
934420|NCT00883779|3079419|P2|Off-study Phase|Other|21
934421|NCT00883779|3079420|P1|Off-study Phase|Other|18
934422|NCT00883779|3079419|P2|Off-study Phase|Failure to return|6
934423|NCT00883779|3079420|P1|Off-study Phase|Failure to return|5
934424|NCT00883779|3079419|P2|Off-study Phase|Refused treatment|1
934425|NCT00883779|3079420|P1|Off-study Phase|Refused treatment|1
934426|NCT00883779|3079419|P2|Off-study Phase|Death|174
934427|NCT00883779|3079420|P1|Off-study Phase|Death|185
934428|NCT00883779|3079419|P2|Post-Study Treatment Phase|Ongoing in the study|6
934429|NCT00883779|3079420|P1|Post-Study Treatment Phase|Ongoing in the study|0
934430|NCT00883779|3079419|P2|Post-Study Treatment Phase|Other|0
934431|NCT00883779|3079420|P1|Post-Study Treatment Phase|Other|3
934432|NCT00883779|3079419|P2|Post-Study Treatment Phase|Disease progression|122
934433|NCT00883779|3079420|P1|Post-Study Treatment Phase|Disease progression|103
934434|NCT00883779|3079419|P2|Post-Study Treatment Phase|Refused Treatment|0
934435|NCT00883779|3079420|P1|Post-Study Treatment Phase|Refused Treatment|3
934436|NCT00883779|3079419|P2|Post-Study Treatment Phase|Protocol Violation|1
934437|NCT00883779|3079420|P1|Post-Study Treatment Phase|Protocol Violation|0
934438|NCT00883779|3079419|P2|Post-Study Treatment Phase|Death|3
934439|NCT00883779|3079420|P1|Post-Study Treatment Phase|Death|1
934440|NCT00883779|3079419|P2|Post-Study Treatment Phase|Adverse Event|3
934441|NCT00883779|3079420|P1|Post-Study Treatment Phase|Adverse Event|2
934442|NCT00883779|3079419|P2|Primary Study Treatment Phase|Other|0
934443|NCT00883779|3079420|P1|Primary Study Treatment Phase|Other|3
934444|NCT00883779|3079419|P2|Primary Study Treatment Phase|Refused Treatment|4
934445|NCT00883779|3079420|P1|Primary Study Treatment Phase|Refused Treatment|5
934446|NCT00883779|3079419|P2|Primary Study Treatment Phase|Death|3
934447|NCT00883779|3079420|P1|Primary Study Treatment Phase|Death|2
934448|NCT00883779|3079419|P2|Primary Study Treatment Phase|Adverse Event|16
934449|NCT00883779|3079420|P1|Primary Study Treatment Phase|Adverse Event|16
934450|NCT00883779|3079419|P2|Primary Study Treatment Phase|Disease progression|59
934451|NCT00883779|3079420|P1|Primary Study Treatment Phase|Disease progression|75
934452|NCT00883779|3079419|P2|Primary Study Treatment Phase|Did not receive allocated intervention|4
934453|NCT00883779|3079420|P1|Primary Study Treatment Phase|Did not receive allocated intervention|4
934454|NCT00883753|3079456|P1|Overall Study|Administrative/Other|8
934455|NCT00883753|3079456|P1|Overall Study|Investigator's decision|17
934456|NCT00883753|3079456|P1|Overall Study|Withdrew consent|10
934457|NCT00883753|3079456|P1|Overall Study|Refused treatment|4
934458|NCT00883753|3079456|P1|Overall Study|Protocol Violation|2
934459|NCT00883753|3079456|P1|Overall Study|Violation of selection criteria at entry|7
934460|NCT00883753|3079456|P1|Overall Study|Lost to Follow-up|4
934461|NCT00883753|3079456|P1|Overall Study|Insufficient therapeutic response|16
934462|NCT00883753|3079456|P1|Overall Study|Death|2
934463|NCT00883753|3079456|P1|Overall Study|Adverse Event|37
934464|NCT00883740|3079496|P2|Second Intervention|No longer willing to participate|1
934465|NCT00883740|3079497|P1|Second Intervention|No longer willing to participate|0
934466|NCT00883740|3079496|P2|Second Intervention|Protocol Violation|0
934467|NCT00883740|3079497|P1|Second Intervention|Protocol Violation|1
934468|NCT00883740|3079496|P2|First Intervention|Adverse Event|2
934469|NCT00883740|3079497|P1|First Intervention|Adverse Event|1
934470|NCT00883740|3079496|P2|First Intervention|Protocol Violation|6
934471|NCT00883740|3079497|P1|First Intervention|Protocol Violation|3
934472|NCT00883740|3079496|P2|First Intervention|No longer willing to participate|0
934473|NCT00883740|3079497|P1|First Intervention|No longer willing to participate|2
934474|NCT00883740|3079496|P2|First Intervention|Lost to Follow-up|0
934475|NCT00883740|3079497|P1|First Intervention|Lost to Follow-up|1
934476|NCT00883558|3079541|P3|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1
934477|NCT00883558|3079542|P2|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
934478|NCT00883558|3079543|P1|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
934479|NCT00883558|3079541|P3|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
934480|NCT00883558|3079542|P2|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1
934481|NCT00883558|3079543|P1|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
934482|NCT00883558|3079541|P3|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
934483|NCT00883558|3079542|P2|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
934484|NCT00883558|3079543|P1|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0
934485|NCT00883558|3079541|P3|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
934486|NCT00883558|3079542|P2|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1
934487|NCT00883558|3079543|P1|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
934488|NCT00883558|3079541|P3|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
934489|NCT00883558|3079542|P2|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
934490|NCT00883558|3079543|P1|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2
934491|NCT00883493|3079555|P2|Overall Study|Not specified|3
934492|NCT00883493|3079556|P1|Overall Study|Not specified|5
934493|NCT00883493|3079555|P2|Overall Study|Study specific disc. criteria|0
934494|NCT00883493|3079556|P1|Overall Study|Study specific disc. criteria|2
934495|NCT00883493|3079555|P2|Overall Study|Eligibility Criteria not fullfilled|6
934496|NCT00883493|3079556|P1|Overall Study|Eligibility Criteria not fullfilled|6
934497|NCT00883493|3079555|P2|Overall Study|Withdrawal by Subject|20
934498|NCT00883493|3079556|P1|Overall Study|Withdrawal by Subject|11
934499|NCT00883493|3079555|P2|Overall Study|Lost to Follow-up|6
934500|NCT00883493|3079556|P1|Overall Study|Lost to Follow-up|7
934501|NCT00883493|3079555|P2|Overall Study|Lack of Efficacy|3
934502|NCT00883493|3079556|P1|Overall Study|Lack of Efficacy|4
934503|NCT00883493|3079555|P2|Overall Study|Adverse Event|12
934504|NCT00883493|3079556|P1|Overall Study|Adverse Event|11
934505|NCT00883337|3079587|P3|Extension Treatment Period|Other than above|5
934506|NCT00883337|3079588|P2|Extension Treatment Period|Other than above|9
934507|NCT00883337|3079589|P1|Extension Treatment Period|Other than above|10
934508|NCT00883337|3079587|P3|Extension Treatment Period|Lost to Follow-up|0
934509|NCT00883337|3079588|P2|Extension Treatment Period|Lost to Follow-up|0
934510|NCT00883337|3079589|P1|Extension Treatment Period|Lost to Follow-up|1
934511|NCT00883337|3079587|P3|Extension Treatment Period|Poor compliance to protocol|1
934512|NCT00883337|3079588|P2|Extension Treatment Period|Poor compliance to protocol|1
934513|NCT00883337|3079589|P1|Extension Treatment Period|Poor compliance to protocol|1
934514|NCT00883337|3079587|P3|Extension Treatment Period|Lack of Efficacy|8
934515|NCT00883337|3079588|P2|Extension Treatment Period|Lack of Efficacy|8
934516|NCT00883337|3079589|P1|Extension Treatment Period|Lack of Efficacy|8
934517|NCT00883337|3079587|P3|Extension Treatment Period|Adverse Event|5
934518|NCT00883337|3079588|P2|Extension Treatment Period|Adverse Event|5
934519|NCT00883337|3079589|P1|Extension Treatment Period|Adverse Event|8
934520|NCT00883337|3079587|P3|Core Treatment Period|Other than above|1
934521|NCT00883337|3079588|P2|Core Treatment Period|Other than above|1
934522|NCT00883337|3079589|P1|Core Treatment Period|Other than above|0
934523|NCT00883337|3079587|P3|Core Treatment Period|Poor compliance to protocol|1
934524|NCT00883337|3079588|P2|Core Treatment Period|Poor compliance to protocol|0
934525|NCT00883337|3079589|P1|Core Treatment Period|Poor compliance to protocol|0
934526|NCT00883337|3079587|P3|Core Treatment Period|Wish to be pregnant|1
934527|NCT00883337|3079588|P2|Core Treatment Period|Wish to be pregnant|2
934528|NCT00883337|3079589|P1|Core Treatment Period|Wish to be pregnant|1
934529|NCT00883337|3079587|P3|Core Treatment Period|Withdrawal by Subject|6
934530|NCT00883337|3079588|P2|Core Treatment Period|Withdrawal by Subject|2
934531|NCT00883337|3079589|P1|Core Treatment Period|Withdrawal by Subject|2
934532|NCT00883337|3079587|P3|Core Treatment Period|Lost to Follow-up|0
934533|NCT00883337|3079588|P2|Core Treatment Period|Lost to Follow-up|1
934534|NCT00883337|3079589|P1|Core Treatment Period|Lost to Follow-up|1
934535|NCT00883337|3079587|P3|Core Treatment Period|Lack of Efficacy|2
934536|NCT00883337|3079588|P2|Core Treatment Period|Lack of Efficacy|4
934537|NCT00883337|3079589|P1|Core Treatment Period|Lack of Efficacy|7
934538|NCT00883337|3079587|P3|Core Treatment Period|Adverse Event|22
934539|NCT00883337|3079588|P2|Core Treatment Period|Adverse Event|12
934540|NCT00883337|3079589|P1|Core Treatment Period|Adverse Event|9
934541|NCT00883181|3079656|P1|Overall Study|Noncompliance|3
934542|NCT00883181|3079656|P1|Overall Study|Protocol Deviation|3
934543|NCT00883181|3079656|P1|Overall Study|Other|38
934544|NCT00883181|3079656|P1|Overall Study|Death|31
934545|NCT00883181|3079656|P1|Overall Study|Withdrawal by Subject|4
934546|NCT00883181|3079656|P1|Overall Study|Administrative Reason|24
934547|NCT00883181|3079656|P1|Overall Study|Disease Progression|94
934548|NCT00883181|3079656|P1|Overall Study|Non-hematological Adverse Event|55
934549|NCT00883181|3079656|P1|Overall Study|Hematological Adverse Event|26
934550|NCT00883129|3079892|P2|Overall Study|Defined Treatment Failure|2
934551|NCT00883129|3079893|P1|Overall Study|Defined Treatment Failure|0
934552|NCT00883129|3079892|P2|Overall Study|Death|2
934553|NCT00883129|3079893|P1|Overall Study|Death|1
934554|NCT00883129|3079892|P2|Overall Study|Lost to Follow-up|2
934555|NCT00883129|3079893|P1|Overall Study|Lost to Follow-up|1
934556|NCT00883129|3079892|P2|Overall Study|Non-compliance|6
934557|NCT00883129|3079893|P1|Overall Study|Non-compliance|3
934558|NCT00883129|3079892|P2|Overall Study|Withdrawal by Subject|9
934559|NCT00883129|3079893|P1|Overall Study|Withdrawal by Subject|8
934560|NCT00883129|3079892|P2|Overall Study|Adverse Event|15
934561|NCT00883129|3079893|P1|Overall Study|Adverse Event|7
934562|NCT00883116|3079917|P2|Overall Study|No longer meets study criteria|2
934563|NCT00883116|3079918|P1|Overall Study|No longer meets study criteria|2
934564|NCT00883116|3079917|P2|Overall Study|Withdrawal by Subject|8
934565|NCT00883116|3079918|P1|Overall Study|Withdrawal by Subject|14
934566|NCT00883116|3079917|P2|Overall Study|Study drug toxicity|16
934567|NCT00883116|3079918|P1|Overall Study|Study drug toxicity|36
934568|NCT00883116|3079917|P2|Overall Study|Not identified|6
934569|NCT00883116|3079918|P1|Overall Study|Not identified|3
934570|NCT00883116|3079917|P2|Overall Study|Maximum clinical benefit|46
934571|NCT00883116|3079918|P1|Overall Study|Maximum clinical benefit|13
934572|NCT00883116|3079917|P2|Overall Study|Lost to Follow-up|1
934573|NCT00883116|3079918|P1|Overall Study|Lost to Follow-up|0
934574|NCT00883116|3079917|P2|Overall Study|Disease progression|128
934575|NCT00883116|3079918|P1|Overall Study|Disease progression|130
934576|NCT00883116|3079917|P2|Overall Study|Death|2
934577|NCT00883116|3079918|P1|Overall Study|Death|6
934578|NCT00883116|3079917|P2|Overall Study|Adverse event unrelated to study drug|10
934579|NCT00883116|3079918|P1|Overall Study|Adverse event unrelated to study drug|5
934580|NCT00883090|3079940|P1|Overall Study|Withdrawal by Subject|1
934581|NCT00883090|3079940|P1|Overall Study|Sponsor's decision|1
934582|NCT00882999|3079962|P7|Overall Study|Physician Decision|1
934583|NCT00882999|3079963|P6|Overall Study|Physician Decision|1
934584|NCT00882999|3079964|P5|Overall Study|Physician Decision|0
934585|NCT00882999|3079965|P4|Overall Study|Physician Decision|0
934586|NCT00882999|3079966|P3|Overall Study|Physician Decision|0
934587|NCT00882999|3079967|P2|Overall Study|Physician Decision|0
934588|NCT00882999|3079968|P1|Overall Study|Physician Decision|1
934589|NCT00882999|3079962|P7|Overall Study|Lost to Follow-up|2
934590|NCT00882999|3079963|P6|Overall Study|Lost to Follow-up|1
934591|NCT00882999|3079964|P5|Overall Study|Lost to Follow-up|1
934592|NCT00882999|3079965|P4|Overall Study|Lost to Follow-up|2
934593|NCT00882999|3079966|P3|Overall Study|Lost to Follow-up|1
934594|NCT00882999|3079967|P2|Overall Study|Lost to Follow-up|1
934595|NCT00882999|3079968|P1|Overall Study|Lost to Follow-up|0
934596|NCT00882999|3079962|P7|Overall Study|Withdrawal by Subject|5
934597|NCT00882999|3079963|P6|Overall Study|Withdrawal by Subject|5
934598|NCT00882999|3079964|P5|Overall Study|Withdrawal by Subject|6
934599|NCT00882999|3079965|P4|Overall Study|Withdrawal by Subject|3
934600|NCT00882999|3079966|P3|Overall Study|Withdrawal by Subject|3
934601|NCT00882999|3079967|P2|Overall Study|Withdrawal by Subject|6
934602|NCT00882999|3079968|P1|Overall Study|Withdrawal by Subject|7
934603|NCT00882999|3079962|P7|Overall Study|Death|0
934604|NCT00882999|3079963|P6|Overall Study|Death|0
934605|NCT00882999|3079964|P5|Overall Study|Death|0
934606|NCT00882999|3079965|P4|Overall Study|Death|0
934607|NCT00882999|3079966|P3|Overall Study|Death|0
934608|NCT00882999|3079967|P2|Overall Study|Death|1
934609|NCT00882999|3079968|P1|Overall Study|Death|0
934610|NCT00882999|3079962|P7|Overall Study|Adverse Event|0
934611|NCT00882999|3079963|P6|Overall Study|Adverse Event|0
934612|NCT00882999|3079964|P5|Overall Study|Adverse Event|1
934613|NCT00882999|3079965|P4|Overall Study|Adverse Event|0
934614|NCT00882999|3079966|P3|Overall Study|Adverse Event|0
934615|NCT00882999|3079967|P2|Overall Study|Adverse Event|0
934616|NCT00882999|3079968|P1|Overall Study|Adverse Event|0
934617|NCT00882921|3080095|P1|Overall Study|Withdrawal Of Consent|1
934618|NCT00882921|3080095|P1|Overall Study|Termination By Investigator|3
934619|NCT00882921|3080095|P1|Overall Study|Lost to Follow-up|2
934620|NCT00882921|3080095|P1|Overall Study|Not specified|3
934621|NCT00882921|3080095|P1|Overall Study|Death|2
934622|NCT00882908|3080105|P5|Overall Study|Study terminated in error|0
934623|NCT00882908|3080106|P4|Overall Study|Study terminated in error|1
934624|NCT00882908|3080107|P3|Overall Study|Study terminated in error|0
934625|NCT00882908|3080108|P2|Overall Study|Study terminated in error|0
934626|NCT00882908|3080109|P1|Overall Study|Study terminated in error|0
934627|NCT00882908|3080105|P5|Overall Study|Subject reached a virologic endpoint|1
934628|NCT00882908|3080106|P4|Overall Study|Subject reached a virologic endpoint|0
934629|NCT00882908|3080107|P3|Overall Study|Subject reached a virologic endpoint|0
934630|NCT00882908|3080108|P2|Overall Study|Subject reached a virologic endpoint|0
934631|NCT00882908|3080109|P1|Overall Study|Subject reached a virologic endpoint|0
934632|NCT00882908|3080105|P5|Overall Study|Withdrawal by Subject|2
934633|NCT00882908|3080106|P4|Overall Study|Withdrawal by Subject|5
934634|NCT00882908|3080107|P3|Overall Study|Withdrawal by Subject|3
934635|NCT00882908|3080108|P2|Overall Study|Withdrawal by Subject|0
934636|NCT00882908|3080109|P1|Overall Study|Withdrawal by Subject|0
934637|NCT00882908|3080105|P5|Overall Study|Protocol Violation|0
934638|NCT00882908|3080106|P4|Overall Study|Protocol Violation|0
934639|NCT00882908|3080107|P3|Overall Study|Protocol Violation|0
934640|NCT00882908|3080108|P2|Overall Study|Protocol Violation|1
934641|NCT00882908|3080109|P1|Overall Study|Protocol Violation|0
934642|NCT00882908|3080105|P5|Overall Study|Lost to Follow-up|2
934643|NCT00882908|3080106|P4|Overall Study|Lost to Follow-up|1
934644|NCT00882908|3080107|P3|Overall Study|Lost to Follow-up|3
934645|NCT00882908|3080108|P2|Overall Study|Lost to Follow-up|5
934646|NCT00882908|3080109|P1|Overall Study|Lost to Follow-up|3
934647|NCT00882908|3080105|P5|Overall Study|Adverse Event|1
934648|NCT00882908|3080106|P4|Overall Study|Adverse Event|0
934649|NCT00882908|3080107|P3|Overall Study|Adverse Event|1
934650|NCT00882908|3080108|P2|Overall Study|Adverse Event|0
934651|NCT00882908|3080109|P1|Overall Study|Adverse Event|0
934652|NCT00882713|3080215|P1|Overall Study|Other - Reasons|2
934653|NCT00882713|3080215|P1|Overall Study|Failure to return|2
934654|NCT00882713|3080215|P1|Overall Study|Insufficient therapeutic response|3
934655|NCT00882713|3080215|P1|Overall Study|Blood transfusion|2
934656|NCT00882713|3080215|P1|Overall Study|refused treatment/withdrew consent|4
934657|NCT00882713|3080215|P1|Overall Study|Administrative reasons|4
934658|NCT00882713|3080215|P1|Overall Study|Death|3
934659|NCT00882713|3080215|P1|Overall Study|Adverse Event|2
934660|NCT00882583|3080308|P2|Overall Study|Adverse Event|1
934661|NCT00882583|3080309|P1|Overall Study|Adverse Event|0
934662|NCT00882583|3080308|P2|Overall Study|Physician Decision|0
934663|NCT00882583|3080309|P1|Overall Study|Physician Decision|1
934664|NCT00882557|3080317|P2|Overall Study|Randomized Not Treated|1
934665|NCT00882557|3080318|P1|Overall Study|Randomized Not Treated|0
934666|NCT00882557|3080317|P2|Overall Study|Trouble with Vein Access|0
934667|NCT00882557|3080318|P1|Overall Study|Trouble with Vein Access|1
934668|NCT00882557|3080317|P2|Overall Study|Withdrawal by Subject|0
934669|NCT00882557|3080318|P1|Overall Study|Withdrawal by Subject|1
934670|NCT00882518|3080338|P2|Overall Study|Allocating random number by mistake|1
934671|NCT00882518|3080339|P1|Overall Study|Allocating random number by mistake|0
934672|NCT00882518|3080338|P2|Overall Study|Central lab closure for National day|0
934673|NCT00882518|3080339|P1|Overall Study|Central lab closure for National day|1
934674|NCT00882518|3080338|P2|Overall Study|Incorrect enrolment|2
934675|NCT00882518|3080339|P1|Overall Study|Incorrect enrolment|4
934676|NCT00882518|3080338|P2|Overall Study|Severe non-compliance to protocol|1
934677|NCT00882518|3080339|P1|Overall Study|Severe non-compliance to protocol|3
934678|NCT00882518|3080338|P2|Overall Study|Lack of Efficacy|9
934679|NCT00882518|3080339|P1|Overall Study|Lack of Efficacy|12
934680|NCT00882518|3080338|P2|Overall Study|Withdrawal by Subject|13
934681|NCT00882518|3080339|P1|Overall Study|Withdrawal by Subject|9
934682|NCT00882518|3080338|P2|Overall Study|Adverse Event|18
934683|NCT00882518|3080339|P1|Overall Study|Adverse Event|9
934684|NCT00882440|3080368|P7|Overall Study|Patient Uncooperative|0
934685|NCT00882440|3080369|P6|Overall Study|Patient Uncooperative|0
934686|NCT00882440|3080370|P5|Overall Study|Patient Uncooperative|1
934687|NCT00882440|3080371|P4|Overall Study|Patient Uncooperative|0
934688|NCT00882440|3080372|P3|Overall Study|Patient Uncooperative|0
934689|NCT00882440|3080373|P2|Overall Study|Patient Uncooperative|0
934690|NCT00882440|3080374|P1|Overall Study|Patient Uncooperative|2
934691|NCT00882440|3080368|P7|Overall Study|Withdrawal by Subject|1
934692|NCT00882440|3080369|P6|Overall Study|Withdrawal by Subject|0
934693|NCT00882440|3080370|P5|Overall Study|Withdrawal by Subject|6
934694|NCT00882440|3080371|P4|Overall Study|Withdrawal by Subject|0
934695|NCT00882440|3080372|P3|Overall Study|Withdrawal by Subject|1
934696|NCT00882440|3080373|P2|Overall Study|Withdrawal by Subject|1
934697|NCT00882440|3080374|P1|Overall Study|Withdrawal by Subject|2
934698|NCT00882440|3080368|P7|Overall Study|Protocol Violation|0
934699|NCT00882440|3080369|P6|Overall Study|Protocol Violation|0
934700|NCT00882440|3080370|P5|Overall Study|Protocol Violation|1
934701|NCT00882440|3080371|P4|Overall Study|Protocol Violation|1
934702|NCT00882440|3080372|P3|Overall Study|Protocol Violation|1
934703|NCT00882440|3080373|P2|Overall Study|Protocol Violation|0
934704|NCT00882440|3080374|P1|Overall Study|Protocol Violation|0
934705|NCT00882440|3080368|P7|Overall Study|Lost to Follow-up|1
934706|NCT00882440|3080369|P6|Overall Study|Lost to Follow-up|0
934707|NCT00882440|3080370|P5|Overall Study|Lost to Follow-up|1
934708|NCT00882440|3080371|P4|Overall Study|Lost to Follow-up|1
934709|NCT00882440|3080372|P3|Overall Study|Lost to Follow-up|1
934710|NCT00882440|3080373|P2|Overall Study|Lost to Follow-up|0
934711|NCT00882440|3080374|P1|Overall Study|Lost to Follow-up|2
934712|NCT00882440|3080368|P7|Overall Study|Lack of Efficacy|0
934713|NCT00882440|3080369|P6|Overall Study|Lack of Efficacy|3
934714|NCT00882440|3080370|P5|Overall Study|Lack of Efficacy|0
934715|NCT00882440|3080371|P4|Overall Study|Lack of Efficacy|0
934716|NCT00882440|3080372|P3|Overall Study|Lack of Efficacy|2
934717|NCT00882440|3080373|P2|Overall Study|Lack of Efficacy|5
934718|NCT00882440|3080374|P1|Overall Study|Lack of Efficacy|3
934719|NCT00882440|3080368|P7|Overall Study|Adverse Event|2
934720|NCT00882440|3080369|P6|Overall Study|Adverse Event|4
934721|NCT00882440|3080370|P5|Overall Study|Adverse Event|1
934722|NCT00882440|3080371|P4|Overall Study|Adverse Event|1
934723|NCT00882440|3080372|P3|Overall Study|Adverse Event|2
934724|NCT00882440|3080373|P2|Overall Study|Adverse Event|2
934725|NCT00882440|3080374|P1|Overall Study|Adverse Event|2
934726|NCT00882362|3080399|P2|Overall Study|change of residence or other commitments|0
934727|NCT00882362|3080400|P1|Overall Study|change of residence or other commitments|5
934728|NCT00882362|3080399|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
934729|NCT00882362|3080400|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2
934730|NCT00882362|3080399|P2|Overall Study|Physician Decision|1
934731|NCT00882362|3080400|P1|Overall Study|Physician Decision|5
934732|NCT00882362|3080399|P2|Overall Study|Pregnancy|0
934733|NCT00882362|3080400|P1|Overall Study|Pregnancy|1
934734|NCT00882362|3080399|P2|Overall Study|Protocol Violation|2
934735|NCT00882362|3080400|P1|Overall Study|Protocol Violation|7
934736|NCT00882362|3080399|P2|Overall Study|Lack of Efficacy|0
934737|NCT00882362|3080400|P1|Overall Study|Lack of Efficacy|3
934738|NCT00882362|3080399|P2|Overall Study|Withdrawal by Subject|10
934739|NCT00882362|3080400|P1|Overall Study|Withdrawal by Subject|13
934740|NCT00882362|3080399|P2|Overall Study|Adverse Event|10
934741|NCT00882362|3080400|P1|Overall Study|Adverse Event|13
934742|NCT00882310|3080406|P1|Overall Study|Adverse Event|1
934743|NCT00882310|3080406|P1|Overall Study|Progression of disease|4
934744|NCT00882310|3080406|P1|Overall Study|Death|6
934745|NCT00882310|3080406|P1|Overall Study|Never received treatment|1
934746|NCT00882310|3080406|P1|Overall Study|Screen Failure|10
934747|NCT00882115|3080419|P1|Overall Study|did not respond to DEP challe|6
934748|NCT00882115|3080419|P1|Overall Study|Withdrawal by Subject|3
934749|NCT00881959|3080429|P2|Overall Study|Lost to Follow-up|4
934750|NCT00881959|3080430|P1|Overall Study|Lost to Follow-up|2
934751|NCT00881894|3080438|P2|Overall Study|Other reasons for premature termination|2
934752|NCT00881894|3080439|P1|Overall Study|Other reasons for premature termination|1
934753|NCT00881894|3080438|P2|Overall Study|Consent withdrawn|1
934754|NCT00881894|3080439|P1|Overall Study|Consent withdrawn|0
934755|NCT00881868|3080471|P2|Overall Study|Protocol Violation|0
934756|NCT00881868|3080472|P1|Overall Study|Protocol Violation|2
934757|NCT00881868|3080471|P2|Overall Study|Physician Decision|0
934758|NCT00881868|3080472|P1|Overall Study|Physician Decision|4
934759|NCT00881868|3080471|P2|Overall Study|Lost to Follow-up|1
934760|NCT00881868|3080472|P1|Overall Study|Lost to Follow-up|2
934761|NCT00881868|3080471|P2|Overall Study|Adverse Event|1
934762|NCT00881868|3080472|P1|Overall Study|Adverse Event|0
934763|NCT00881751|3080486|P2|Overall Study|Withdrawal by Subject|2
934764|NCT00881751|3080487|P1|Overall Study|Withdrawal by Subject|0
934765|NCT00881751|3080486|P2|Overall Study|Adverse Event|2
934766|NCT00881751|3080487|P1|Overall Study|Adverse Event|0
934767|NCT00881751|3080486|P2|Overall Study|Physician Decision|1
934768|NCT00881751|3080487|P1|Overall Study|Physician Decision|0
934769|NCT00881712|3080502|P3|Overall Study|Withdrawal by Subject|0
934770|NCT00881712|3080503|P2|Overall Study|Withdrawal by Subject|0
934771|NCT00881712|3080504|P1|Overall Study|Withdrawal by Subject|1
934772|NCT00881712|3080502|P3|Overall Study|Death|0
934773|NCT00881712|3080503|P2|Overall Study|Death|0
934774|NCT00881712|3080504|P1|Overall Study|Death|1
934775|NCT00881621|3080537|P1|Overall Study|Physician Decision|34
934776|NCT00881608|3080549|P1|Overall Study|Study prematurely terminated|11
934777|NCT00881530|3080572|P6|Overall Study|Other reason not defined above|2
934778|NCT00881530|3080573|P5|Overall Study|Other reason not defined above|0
934779|NCT00881530|3080574|P4|Overall Study|Other reason not defined above|0
934780|NCT00881530|3080575|P3|Overall Study|Other reason not defined above|2
934781|NCT00881530|3080576|P2|Overall Study|Other reason not defined above|1
934782|NCT00881530|3080577|P1|Overall Study|Other reason not defined above|1
934783|NCT00881530|3080572|P6|Overall Study|Refused to continue medication|0
934784|NCT00881530|3080573|P5|Overall Study|Refused to continue medication|0
934785|NCT00881530|3080574|P4|Overall Study|Refused to continue medication|2
934786|NCT00881530|3080575|P3|Overall Study|Refused to continue medication|1
934787|NCT00881530|3080576|P2|Overall Study|Refused to continue medication|2
934788|NCT00881530|3080577|P1|Overall Study|Refused to continue medication|7
934789|NCT00881530|3080572|P6|Overall Study|Lost to Follow-up|0
934790|NCT00881530|3080573|P5|Overall Study|Lost to Follow-up|1
934791|NCT00881530|3080574|P4|Overall Study|Lost to Follow-up|3
934792|NCT00881530|3080575|P3|Overall Study|Lost to Follow-up|1
934793|NCT00881530|3080576|P2|Overall Study|Lost to Follow-up|1
934794|NCT00881530|3080577|P1|Overall Study|Lost to Follow-up|0
934795|NCT00881530|3080572|P6|Overall Study|Not compliant with the protocol|0
934796|NCT00881530|3080573|P5|Overall Study|Not compliant with the protocol|2
934797|NCT00881530|3080574|P4|Overall Study|Not compliant with the protocol|0
934798|NCT00881530|3080575|P3|Overall Study|Not compliant with the protocol|0
934799|NCT00881530|3080576|P2|Overall Study|Not compliant with the protocol|0
934800|NCT00881530|3080577|P1|Overall Study|Not compliant with the protocol|0
934801|NCT00881530|3080572|P6|Overall Study|Lack of Efficacy|1
934802|NCT00881530|3080573|P5|Overall Study|Lack of Efficacy|1
934803|NCT00881530|3080574|P4|Overall Study|Lack of Efficacy|0
934804|NCT00881530|3080575|P3|Overall Study|Lack of Efficacy|0
934805|NCT00881530|3080576|P2|Overall Study|Lack of Efficacy|0
934806|NCT00881530|3080577|P1|Overall Study|Lack of Efficacy|1
934807|NCT00881530|3080572|P6|Overall Study|Adverse Event|2
934808|NCT00881530|3080573|P5|Overall Study|Adverse Event|10
934809|NCT00881530|3080574|P4|Overall Study|Adverse Event|4
934810|NCT00881530|3080575|P3|Overall Study|Adverse Event|1
934811|NCT00881530|3080576|P2|Overall Study|Adverse Event|1
934812|NCT00881530|3080577|P1|Overall Study|Adverse Event|5
934813|NCT00881504|3080633|P1|Overall Study|Withdrawal by Subject|1
934814|NCT00881335|3080653|P2|Overall Study|Lost to Follow-up|2
934815|NCT00881335|3080654|P1|Overall Study|Lost to Follow-up|3
934816|NCT00881205|3080674|P2|Overall Study|Condition no longer requires drug|0
934817|NCT00881205|3080675|P1|Overall Study|Condition no longer requires drug|1
934818|NCT00881205|3080674|P2|Overall Study|Administrative problems|1
934819|NCT00881205|3080675|P1|Overall Study|Administrative problems|1
934820|NCT00881205|3080674|P2|Overall Study|Lost to Follow-up|1
934821|NCT00881205|3080675|P1|Overall Study|Lost to Follow-up|0
934822|NCT00881205|3080674|P2|Overall Study|Withdrawal by Subject|2
934823|NCT00881205|3080675|P1|Overall Study|Withdrawal by Subject|1
934824|NCT00881205|3080674|P2|Overall Study|Adverse Event|3
934825|NCT00881205|3080675|P1|Overall Study|Adverse Event|8
934826|NCT00880906|3080721|P2|Overall Study|Did not meet criteria following patholog|6
934827|NCT00880906|3080722|P1|Overall Study|Did not meet criteria following patholog|12
934828|NCT00880906|3080721|P2|Overall Study|Lost to Follow-up|1
934829|NCT00880906|3080722|P1|Overall Study|Lost to Follow-up|0
934830|NCT00880763|3080734|P4|Extension Period (Part 2)|Lack of Efficacy|1
934831|NCT00880763|3080735|P3|Extension Period (Part 2)|Lack of Efficacy|0
934832|NCT00880763|3080736|P2|Extension Period (Part 2)|Lack of Efficacy|0
934833|NCT00880763|3080737|P1|Extension Period (Part 2)|Lack of Efficacy|0
934834|NCT00880763|3080734|P4|Extension Period (Part 2)|Physician Decision|0
934835|NCT00880763|3080735|P3|Extension Period (Part 2)|Physician Decision|1
934836|NCT00880763|3080736|P2|Extension Period (Part 2)|Physician Decision|1
934837|NCT00880763|3080737|P1|Extension Period (Part 2)|Physician Decision|0
934838|NCT00880763|3080734|P4|Extension Period (Part 2)|Withdrawal by Subject|1
934839|NCT00880763|3080735|P3|Extension Period (Part 2)|Withdrawal by Subject|1
934840|NCT00880763|3080736|P2|Extension Period (Part 2)|Withdrawal by Subject|2
934841|NCT00880763|3080737|P1|Extension Period (Part 2)|Withdrawal by Subject|0
934842|NCT00880763|3080734|P4|Extension Period (Part 2)|Adverse Event|1
934843|NCT00880763|3080735|P3|Extension Period (Part 2)|Adverse Event|1
934844|NCT00880763|3080736|P2|Extension Period (Part 2)|Adverse Event|0
934845|NCT00880763|3080737|P1|Extension Period (Part 2)|Adverse Event|0
934846|NCT00880750|3080769|P2|Second Intervention|Unable to collect urine|0
934847|NCT00880750|3080770|P1|Second Intervention|Unable to collect urine|1
934848|NCT00880750|3080769|P2|Second Intervention|Protocol Violation|0
934849|NCT00880750|3080770|P1|Second Intervention|Protocol Violation|1
934850|NCT00880750|3080769|P2|Second Intervention|Withdrawal by Subject|2
934851|NCT00880750|3080770|P1|Second Intervention|Withdrawal by Subject|2
934852|NCT00880750|3080769|P2|First Intervention|Lost to Follow-up|0
934853|NCT00880750|3080770|P1|First Intervention|Lost to Follow-up|2
934854|NCT00880750|3080769|P2|First Intervention|Withdrawal by Subject|0
934855|NCT00880750|3080770|P1|First Intervention|Withdrawal by Subject|2
934856|NCT00880750|3080769|P2|First Intervention|Non-compliance with meals|1
934857|NCT00880750|3080770|P1|First Intervention|Non-compliance with meals|0
934858|NCT00880750|3080769|P2|First Intervention|Unable to collect urine|0
934859|NCT00880750|3080770|P1|First Intervention|Unable to collect urine|4
934860|NCT00880750|3080769|P2|First Intervention|Adverse Event|0
934861|NCT00880750|3080770|P1|First Intervention|Adverse Event|1
934862|NCT00880698|3080788|P4|Overall Study|Lost to Follow-up|1
934863|NCT00880698|3080789|P3|Overall Study|Lost to Follow-up|0
934864|NCT00880698|3080790|P2|Overall Study|Lost to Follow-up|3
934865|NCT00880698|3080791|P1|Overall Study|Lost to Follow-up|1
934866|NCT00880698|3080788|P4|Overall Study|Death|2
934867|NCT00880698|3080789|P3|Overall Study|Death|1
934868|NCT00880698|3080790|P2|Overall Study|Death|0
934869|NCT00880698|3080791|P1|Overall Study|Death|0
934870|NCT00880685|3080817|P1|Memantine 20mg|Withdrawal by Subject|1
934871|NCT00880685|3080817|P1|Memantine 10mg|Lost to Follow-up|2
934872|NCT00880620|3080829|P4|Overall Study|Not specified|2
934873|NCT00880620|3080830|P3|Overall Study|Not specified|2
934874|NCT00880620|3080831|P2|Overall Study|Not specified|1
934875|NCT00880620|3080832|P1|Overall Study|Not specified|1
934876|NCT00880620|3080829|P4|Overall Study|Noncompliance|1
934877|NCT00880620|3080830|P3|Overall Study|Noncompliance|1
934878|NCT00880620|3080831|P2|Overall Study|Noncompliance|0
934879|NCT00880620|3080832|P1|Overall Study|Noncompliance|0
934880|NCT00880620|3080829|P4|Overall Study|Withdrawal by Subject|3
934881|NCT00880620|3080830|P3|Overall Study|Withdrawal by Subject|1
934882|NCT00880620|3080831|P2|Overall Study|Withdrawal by Subject|3
934883|NCT00880620|3080832|P1|Overall Study|Withdrawal by Subject|4
934884|NCT00880620|3080829|P4|Overall Study|Protocol Violation|2
934885|NCT00880620|3080830|P3|Overall Study|Protocol Violation|0
934886|NCT00880620|3080831|P2|Overall Study|Protocol Violation|1
934887|NCT00880620|3080832|P1|Overall Study|Protocol Violation|0
934888|NCT00880620|3080829|P4|Overall Study|Lost to Follow-up|0
934889|NCT00880620|3080830|P3|Overall Study|Lost to Follow-up|1
934890|NCT00880620|3080831|P2|Overall Study|Lost to Follow-up|1
934891|NCT00880620|3080832|P1|Overall Study|Lost to Follow-up|0
934892|NCT00880620|3080829|P4|Overall Study|Lack of Efficacy|1
934893|NCT00880620|3080830|P3|Overall Study|Lack of Efficacy|0
934894|NCT00880620|3080831|P2|Overall Study|Lack of Efficacy|4
934895|NCT00880620|3080832|P1|Overall Study|Lack of Efficacy|12
934896|NCT00880620|3080829|P4|Overall Study|Death|0
934897|NCT00880620|3080830|P3|Overall Study|Death|1
934898|NCT00880620|3080831|P2|Overall Study|Death|0
934899|NCT00880620|3080832|P1|Overall Study|Death|0
934900|NCT00880620|3080829|P4|Overall Study|Adverse Event|15
934901|NCT00880620|3080830|P3|Overall Study|Adverse Event|15
934902|NCT00880620|3080831|P2|Overall Study|Adverse Event|5
934903|NCT00880620|3080832|P1|Overall Study|Adverse Event|4
934904|NCT00880568|3080860|P9|Overall Study|Withdrawal by Subject|0
934905|NCT00880568|3080861|P8|Overall Study|Withdrawal by Subject|1
934906|NCT00880568|3080862|P7|Overall Study|Withdrawal by Subject|0
934907|NCT00880568|3080863|P6|Overall Study|Withdrawal by Subject|0
934908|NCT00880568|3080864|P5|Overall Study|Withdrawal by Subject|0
934909|NCT00880568|3080865|P4|Overall Study|Withdrawal by Subject|0
934910|NCT00880568|3080866|P3|Overall Study|Withdrawal by Subject|0
934911|NCT00880568|3080867|P2|Overall Study|Withdrawal by Subject|0
934912|NCT00880568|3080868|P1|Overall Study|Withdrawal by Subject|0
934913|NCT00880568|3080860|P9|Overall Study|Adverse Event|0
934914|NCT00880568|3080861|P8|Overall Study|Adverse Event|1
934915|NCT00880568|3080862|P7|Overall Study|Adverse Event|1
934916|NCT00880568|3080863|P6|Overall Study|Adverse Event|0
934917|NCT00880568|3080864|P5|Overall Study|Adverse Event|0
934918|NCT00880568|3080865|P4|Overall Study|Adverse Event|0
934919|NCT00880568|3080866|P3|Overall Study|Adverse Event|0
934920|NCT00880568|3080867|P2|Overall Study|Adverse Event|0
934921|NCT00880568|3080868|P1|Overall Study|Adverse Event|0
934922|NCT00880568|3080860|P9|Overall Study|Disease progression|3
934923|NCT00880568|3080861|P8|Overall Study|Disease progression|0
934924|NCT00880568|3080862|P7|Overall Study|Disease progression|5
934925|NCT00880568|3080863|P6|Overall Study|Disease progression|3
934926|NCT00880568|3080864|P5|Overall Study|Disease progression|3
934927|NCT00880568|3080865|P4|Overall Study|Disease progression|1
934928|NCT00880568|3080866|P3|Overall Study|Disease progression|3
934929|NCT00880568|3080867|P2|Overall Study|Disease progression|3
934930|NCT00880568|3080868|P1|Overall Study|Disease progression|3
934931|NCT00880555|3080914|P6|Overall Study|Lost to Follow-up|0
934932|NCT00880555|3080915|P5|Overall Study|Lost to Follow-up|0
934933|NCT00880555|3080916|P4|Overall Study|Lost to Follow-up|0
934934|NCT00880555|3080917|P3|Overall Study|Lost to Follow-up|0
934935|NCT00880555|3080918|P2|Overall Study|Lost to Follow-up|1
934936|NCT00880555|3080919|P1|Overall Study|Lost to Follow-up|0
934937|NCT00880555|3080914|P6|Overall Study|Death|1
934938|NCT00880555|3080915|P5|Overall Study|Death|0
934939|NCT00880555|3080916|P4|Overall Study|Death|0
934940|NCT00880555|3080917|P3|Overall Study|Death|0
934941|NCT00880555|3080918|P2|Overall Study|Death|0
934942|NCT00880555|3080919|P1|Overall Study|Death|0
934943|NCT00880555|3080914|P6|Overall Study|Lack of resources (hired rater)|0
934944|NCT00880555|3080915|P5|Overall Study|Lack of resources (hired rater)|0
934945|NCT00880555|3080916|P4|Overall Study|Lack of resources (hired rater)|0
934946|NCT00880555|3080917|P3|Overall Study|Lack of resources (hired rater)|5
934947|NCT00880555|3080918|P2|Overall Study|Lack of resources (hired rater)|7
934948|NCT00880555|3080919|P1|Overall Study|Lack of resources (hired rater)|9
934949|NCT00880555|3080914|P6|Overall Study|Withdrawal by Subject|0
934950|NCT00880555|3080915|P5|Overall Study|Withdrawal by Subject|0
934951|NCT00880555|3080916|P4|Overall Study|Withdrawal by Subject|0
934952|NCT00880555|3080917|P3|Overall Study|Withdrawal by Subject|0
934953|NCT00880555|3080918|P2|Overall Study|Withdrawal by Subject|1
934954|NCT00880555|3080919|P1|Overall Study|Withdrawal by Subject|1
934955|NCT00880555|3080914|P6|Overall Study|Physician Decision|0
934956|NCT00880555|3080915|P5|Overall Study|Physician Decision|1
934957|NCT00880555|3080916|P4|Overall Study|Physician Decision|2
934958|NCT00880555|3080917|P3|Overall Study|Physician Decision|0
934959|NCT00880555|3080918|P2|Overall Study|Physician Decision|8
934960|NCT00880555|3080919|P1|Overall Study|Physician Decision|0
934961|NCT00880542|3080930|P1|REP: Surgical Resection|progressive disease|1
934962|NCT00880542|3080930|P1|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2
934963|NCT00880542|3080930|P1|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1
934964|NCT00880399|3080947|P3|Overall Study|Withdrawal by Subject|3
934965|NCT00880399|3080948|P2|Overall Study|Withdrawal by Subject|3
934966|NCT00880399|3080949|P1|Overall Study|Withdrawal by Subject|6
934967|NCT00880399|3080947|P3|Overall Study|Physician Decision|3
934968|NCT00880399|3080948|P2|Overall Study|Physician Decision|0
934969|NCT00880399|3080949|P1|Overall Study|Physician Decision|5
934970|NCT00880399|3080947|P3|Overall Study|Lost to Follow-up|3
934971|NCT00880399|3080948|P2|Overall Study|Lost to Follow-up|5
934972|NCT00880399|3080949|P1|Overall Study|Lost to Follow-up|8
934973|NCT00880399|3080947|P3|Overall Study|Study closed/terminated|4
934974|NCT00880399|3080948|P2|Overall Study|Study closed/terminated|7
934975|NCT00880399|3080949|P1|Overall Study|Study closed/terminated|3
934976|NCT00880399|3080947|P3|Overall Study|Protocol Violation|6
934977|NCT00880399|3080948|P2|Overall Study|Protocol Violation|4
934978|NCT00880399|3080949|P1|Overall Study|Protocol Violation|4
934979|NCT00880399|3080947|P3|Overall Study|Lack of Efficacy|2
934980|NCT00880399|3080948|P2|Overall Study|Lack of Efficacy|4
934981|NCT00880399|3080949|P1|Overall Study|Lack of Efficacy|1
934982|NCT00880399|3080947|P3|Overall Study|Adverse Event|5
934983|NCT00880399|3080948|P2|Overall Study|Adverse Event|6
934984|NCT00880399|3080949|P1|Overall Study|Adverse Event|4
934985|NCT00880334|3081012|P2|Randomized Phase|Crossover Participants|37
934986|NCT00880334|3081013|P1|Randomized Phase|Crossover Participants|0
934987|NCT00880334|3081012|P2|Randomized Phase|Brain Metastasis|1
934988|NCT00880334|3081013|P1|Randomized Phase|Brain Metastasis|0
934989|NCT00880334|3081012|P2|Randomized Phase|Inadequate Labs|1
934990|NCT00880334|3081013|P1|Randomized Phase|Inadequate Labs|1
934991|NCT00880334|3081012|P2|Randomized Phase|Withdrawal by Subject|1
934992|NCT00880334|3081013|P1|Randomized Phase|Withdrawal by Subject|2
934993|NCT00880334|3081012|P2|Randomized Phase|Physician Decision|0
934994|NCT00880334|3081013|P1|Randomized Phase|Physician Decision|1
934995|NCT00880269|3081030|P2|Overall Study|Adverse Event|9
934996|NCT00880269|3081031|P1|Overall Study|Adverse Event|10
934997|NCT00880269|3081030|P2|Overall Study|Withdrawal by Subject|4
934998|NCT00880269|3081031|P1|Overall Study|Withdrawal by Subject|3
934999|NCT00880269|3081030|P2|Overall Study|Lost to Follow-up|1
935000|NCT00880269|3081031|P1|Overall Study|Lost to Follow-up|0
935001|NCT00880269|3081030|P2|Overall Study|Death|2
935002|NCT00880269|3081031|P1|Overall Study|Death|4
935003|NCT00880269|3081030|P2|Overall Study|New Cancer Therapy|0
935004|NCT00880269|3081031|P1|Overall Study|New Cancer Therapy|1
935005|NCT00880269|3081030|P2|Overall Study|Disease Progression|11
935006|NCT00880269|3081031|P1|Overall Study|Disease Progression|13
935007|NCT00880269|3081030|P2|Overall Study|Protocol Violation|0
935008|NCT00880269|3081031|P1|Overall Study|Protocol Violation|1
935009|NCT00880256|3081047|P1|Overall Study|Lost to Follow-up|28
935010|NCT00880191|3081074|P2|Overall Study|Hospitalization/efficacy|1
935011|NCT00880191|3081075|P1|Overall Study|Hospitalization/efficacy|1
935012|NCT00880191|3081074|P2|Overall Study|Adverse Event|6
935013|NCT00880191|3081075|P1|Overall Study|Adverse Event|8
935014|NCT00880191|3081074|P2|Overall Study|Refused further treatment|1
935015|NCT00880191|3081075|P1|Overall Study|Refused further treatment|4
935016|NCT00880165|3081095|P2|Overall Study|Lost to follow|15
935017|NCT00880165|3081096|P1|Overall Study|Lost to follow|9
935018|NCT00880165|3081095|P2|Overall Study|Required BIPAP or oxygen treatment|4
935019|NCT00880165|3081096|P1|Overall Study|Required BIPAP or oxygen treatment|12
935020|NCT00880165|3081095|P2|Overall Study|Not diagnosed with OSA|8
935021|NCT00880165|3081096|P1|Overall Study|Not diagnosed with OSA|14
935022|NCT00880165|3081095|P2|Overall Study|Withdrawal by Subject|23
935023|NCT00880165|3081096|P1|Overall Study|Withdrawal by Subject|27
935024|NCT00880100|3081106|P1|Treatment Phase With Ultrase® MT12|Protocol Violation|2
935025|NCT00880100|3081106|P1|Treatment Phase With Ultrase® MT12|Adverse Event|1
935026|NCT00880100|3081106|P1|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1
935027|NCT00880087|3081119|P2|Overall Study|Lost to Follow-up|2
935028|NCT00880087|3081120|P1|Overall Study|Lost to Follow-up|0
935029|NCT00880048|3081135|P3|Overall Study|Study closed/terminated|6
935030|NCT00880048|3081136|P2|Overall Study|Study closed/terminated|7
935031|NCT00880048|3081137|P1|Overall Study|Study closed/terminated|9
935032|NCT00880048|3081135|P3|Overall Study|Withdrawal by Subject|5
935033|NCT00880048|3081136|P2|Overall Study|Withdrawal by Subject|8
935034|NCT00880048|3081137|P1|Overall Study|Withdrawal by Subject|5
935035|NCT00880048|3081135|P3|Overall Study|Physician Decision|7
935036|NCT00880048|3081136|P2|Overall Study|Physician Decision|1
935037|NCT00880048|3081137|P1|Overall Study|Physician Decision|1
935038|NCT00880048|3081135|P3|Overall Study|Lost to Follow-up|5
935039|NCT00880048|3081136|P2|Overall Study|Lost to Follow-up|6
935040|NCT00880048|3081137|P1|Overall Study|Lost to Follow-up|6
935041|NCT00880048|3081135|P3|Overall Study|Protocol Violation|5
935042|NCT00880048|3081136|P2|Overall Study|Protocol Violation|6
935043|NCT00880048|3081137|P1|Overall Study|Protocol Violation|4
935044|NCT00880048|3081135|P3|Overall Study|Lack of Efficacy|2
935045|NCT00880048|3081136|P2|Overall Study|Lack of Efficacy|2
935046|NCT00880048|3081137|P1|Overall Study|Lack of Efficacy|1
935047|NCT00880048|3081135|P3|Overall Study|Adverse Event|5
935048|NCT00880048|3081136|P2|Overall Study|Adverse Event|3
935049|NCT00880048|3081137|P1|Overall Study|Adverse Event|2
935050|NCT00880009|3081204|P1|Overall Study|Protocol Violation|1
935051|NCT00880009|3081204|P1|Overall Study|Withdrawal by Subject|1
935052|NCT00880009|3081204|P1|Overall Study|Study terminated by sponsor|14
935053|NCT00879996|3081228|P2|Overall Study|put on parole|0
935054|NCT00879996|3081229|P1|Overall Study|put on parole|1
935055|NCT00879996|3081228|P2|Overall Study|psychiatric problem|1
935056|NCT00879996|3081229|P1|Overall Study|psychiatric problem|0
935057|NCT00879996|3081228|P2|Overall Study|Physician Decision|2
935058|NCT00879996|3081229|P1|Overall Study|Physician Decision|1
935059|NCT00879996|3081228|P2|Overall Study|non-compliance|4
935060|NCT00879996|3081229|P1|Overall Study|non-compliance|6
935061|NCT00879996|3081228|P2|Overall Study|Lost to Follow-up|6
935062|NCT00879996|3081229|P1|Overall Study|Lost to Follow-up|7
935063|NCT00879970|3081244|P5|Period 2 Vitamin D Randomization|Death|0
935064|NCT00879970|3081245|P4|Period 2 Vitamin D Randomization|Death|2
935065|NCT00879970|3081246|P3|Period 2 Vitamin D Randomization|Death|0
935066|NCT00879970|3081247|P2|Period 2 Vitamin D Randomization|Death|0
935067|NCT00879970|3081248|P1|Period 2 Vitamin D Randomization|Death|0
935068|NCT00879970|3081244|P5|Period 2 Vitamin D Randomization|Lost to Follow-up|1
935069|NCT00879970|3081245|P4|Period 2 Vitamin D Randomization|Lost to Follow-up|0
935070|NCT00879970|3081246|P3|Period 2 Vitamin D Randomization|Lost to Follow-up|0
935071|NCT00879970|3081247|P2|Period 2 Vitamin D Randomization|Lost to Follow-up|0
935072|NCT00879970|3081248|P1|Period 2 Vitamin D Randomization|Lost to Follow-up|0
935073|NCT00879970|3081244|P5|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6
935074|NCT00879970|3081245|P4|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2
935075|NCT00879970|3081246|P3|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
935076|NCT00879970|3081247|P2|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
935077|NCT00879970|3081248|P1|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
935078|NCT00879970|3081244|P5|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
935079|NCT00879970|3081245|P4|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
935080|NCT00879970|3081246|P3|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1
935081|NCT00879970|3081247|P2|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
935082|NCT00879970|3081248|P1|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2
935083|NCT00879970|3081244|P5|Period 1 TZD Randomization|Death|0
935084|NCT00879970|3081245|P4|Period 1 TZD Randomization|Death|0
935085|NCT00879970|3081246|P3|Period 1 TZD Randomization|Death|0
935086|NCT00879970|3081247|P2|Period 1 TZD Randomization|Death|1
935087|NCT00879970|3081248|P1|Period 1 TZD Randomization|Death|2
935088|NCT00879970|3081244|P5|Period 1 TZD Randomization|Lost to Follow-up|0
935089|NCT00879970|3081245|P4|Period 1 TZD Randomization|Lost to Follow-up|0
935090|NCT00879970|3081246|P3|Period 1 TZD Randomization|Lost to Follow-up|1
935091|NCT00879970|3081247|P2|Period 1 TZD Randomization|Lost to Follow-up|0
935092|NCT00879970|3081248|P1|Period 1 TZD Randomization|Lost to Follow-up|1
935093|NCT00879970|3081244|P5|Period 1 TZD Randomization|Refused to Attend Final Visit|0
935094|NCT00879970|3081245|P4|Period 1 TZD Randomization|Refused to Attend Final Visit|0
935095|NCT00879970|3081246|P3|Period 1 TZD Randomization|Refused to Attend Final Visit|4
935096|NCT00879970|3081247|P2|Period 1 TZD Randomization|Refused to Attend Final Visit|3
935097|NCT00879970|3081248|P1|Period 1 TZD Randomization|Refused to Attend Final Visit|3
935098|NCT00879879|3081330|P1|Overall Study|Physician Decision|1
935099|NCT00879879|3081330|P1|Overall Study|Withdrawal by Subject|1
935100|NCT00879879|3081330|P1|Overall Study|Death|1
935101|NCT00879814|3081338|P4|Overall Study|Other|0
935102|NCT00879814|3081339|P3|Overall Study|Other|1
935103|NCT00879814|3081340|P2|Overall Study|Other|0
935104|NCT00879814|3081341|P1|Overall Study|Other|0
935105|NCT00879814|3081338|P4|Overall Study|Physician Decision|0
935106|NCT00879814|3081339|P3|Overall Study|Physician Decision|1
935107|NCT00879814|3081340|P2|Overall Study|Physician Decision|0
935108|NCT00879814|3081341|P1|Overall Study|Physician Decision|0
935109|NCT00879814|3081338|P4|Overall Study|Withdrawal by Subject|2
935110|NCT00879814|3081339|P3|Overall Study|Withdrawal by Subject|1
935111|NCT00879814|3081340|P2|Overall Study|Withdrawal by Subject|1
935112|NCT00879814|3081341|P1|Overall Study|Withdrawal by Subject|3
935113|NCT00879814|3081338|P4|Overall Study|Participant Failed to Return|1
935114|NCT00879814|3081339|P3|Overall Study|Participant Failed to Return|0
935115|NCT00879814|3081340|P2|Overall Study|Participant Failed to Return|0
935116|NCT00879814|3081341|P1|Overall Study|Participant Failed to Return|0
935117|NCT00879814|3081338|P4|Overall Study|Lost to Follow-up|2
935118|NCT00879814|3081339|P3|Overall Study|Lost to Follow-up|0
935119|NCT00879814|3081340|P2|Overall Study|Lost to Follow-up|0
935120|NCT00879814|3081341|P1|Overall Study|Lost to Follow-up|1
935121|NCT00879814|3081338|P4|Overall Study|Adverse Event|0
935122|NCT00879814|3081339|P3|Overall Study|Adverse Event|0
935123|NCT00879814|3081340|P2|Overall Study|Adverse Event|1
935124|NCT00879814|3081341|P1|Overall Study|Adverse Event|0
935125|NCT00879775|3081449|P2|Overall Study|Lost to Follow-up|1
935126|NCT00879775|3081450|P1|Overall Study|Lost to Follow-up|2
935127|NCT00879710|3081466|P4|Phase 1 - 6 Weeks|Adverse Event|0
935128|NCT00879710|3081467|P3|Phase 1 - 6 Weeks|Adverse Event|1
935129|NCT00879710|3081468|P2|Phase 1 - 6 Weeks|Adverse Event|0
935130|NCT00879710|3081469|P1|Phase 1 - 6 Weeks|Adverse Event|0
935131|NCT00879710|3081466|P4|Phase 1 - 6 Weeks|Lost to Follow-up|4
935132|NCT00879710|3081467|P3|Phase 1 - 6 Weeks|Lost to Follow-up|1
935133|NCT00879710|3081468|P2|Phase 1 - 6 Weeks|Lost to Follow-up|3
935134|NCT00879710|3081469|P1|Phase 1 - 6 Weeks|Lost to Follow-up|2
935135|NCT00879697|3081479|P2|Overall Study|Physician Decision|2
935136|NCT00879697|3081480|P1|Overall Study|Physician Decision|2
935137|NCT00879684|3081486|P7|Stage 2: Expanded Cohort|Investigator declined participation|1
935138|NCT00879684|3081487|P6|Stage 2: Expanded Cohort|Investigator declined participation|0
935139|NCT00879684|3081488|P5|Stage 2: Expanded Cohort|Investigator declined participation|0
935140|NCT00879684|3081489|P4|Stage 2: Expanded Cohort|Investigator declined participation|0
935141|NCT00879684|3081490|P3|Stage 2: Expanded Cohort|Investigator declined participation|0
935142|NCT00879684|3081491|P2|Stage 2: Expanded Cohort|Investigator declined participation|0
935143|NCT00879684|3081492|P1|Stage 2: Expanded Cohort|Investigator declined participation|0
935144|NCT00879684|3081486|P7|Stage 2: Expanded Cohort|Progressive Disease|11
935145|NCT00879684|3081487|P6|Stage 2: Expanded Cohort|Progressive Disease|0
935146|NCT00879684|3081488|P5|Stage 2: Expanded Cohort|Progressive Disease|0
935147|NCT00879684|3081489|P4|Stage 2: Expanded Cohort|Progressive Disease|0
935148|NCT00879684|3081490|P3|Stage 2: Expanded Cohort|Progressive Disease|0
935149|NCT00879684|3081491|P2|Stage 2: Expanded Cohort|Progressive Disease|0
935150|NCT00879684|3081492|P1|Stage 2: Expanded Cohort|Progressive Disease|0
935151|NCT00879684|3081486|P7|Stage 2: Expanded Cohort|Lost to Follow-up|1
935152|NCT00879684|3081487|P6|Stage 2: Expanded Cohort|Lost to Follow-up|0
935153|NCT00879684|3081488|P5|Stage 2: Expanded Cohort|Lost to Follow-up|0
935154|NCT00879684|3081489|P4|Stage 2: Expanded Cohort|Lost to Follow-up|0
935155|NCT00879684|3081490|P3|Stage 2: Expanded Cohort|Lost to Follow-up|0
935156|NCT00879684|3081491|P2|Stage 2: Expanded Cohort|Lost to Follow-up|0
935157|NCT00879684|3081492|P1|Stage 2: Expanded Cohort|Lost to Follow-up|0
935158|NCT00879684|3081486|P7|Stage 1: Dose Escalation|Death|0
935159|NCT00879684|3081487|P6|Stage 1: Dose Escalation|Death|0
935160|NCT00879684|3081488|P5|Stage 1: Dose Escalation|Death|0
935161|NCT00879684|3081489|P4|Stage 1: Dose Escalation|Death|0
935162|NCT00879684|3081490|P3|Stage 1: Dose Escalation|Death|1
935163|NCT00879684|3081491|P2|Stage 1: Dose Escalation|Death|0
935164|NCT00879684|3081492|P1|Stage 1: Dose Escalation|Death|0
935165|NCT00879684|3081486|P7|Stage 1: Dose Escalation|Investigator declined participation|0
935166|NCT00879684|3081487|P6|Stage 1: Dose Escalation|Investigator declined participation|0
935167|NCT00879684|3081488|P5|Stage 1: Dose Escalation|Investigator declined participation|0
935168|NCT00879684|3081489|P4|Stage 1: Dose Escalation|Investigator declined participation|2
935169|NCT00879684|3081490|P3|Stage 1: Dose Escalation|Investigator declined participation|2
935170|NCT00879684|3081491|P2|Stage 1: Dose Escalation|Investigator declined participation|0
935171|NCT00879684|3081492|P1|Stage 1: Dose Escalation|Investigator declined participation|0
935172|NCT00879684|3081486|P7|Stage 1: Dose Escalation|Progressive Disease|0
935173|NCT00879684|3081487|P6|Stage 1: Dose Escalation|Progressive Disease|3
935174|NCT00879684|3081488|P5|Stage 1: Dose Escalation|Progressive Disease|3
935175|NCT00879684|3081489|P4|Stage 1: Dose Escalation|Progressive Disease|4
935176|NCT00879684|3081490|P3|Stage 1: Dose Escalation|Progressive Disease|0
935177|NCT00879684|3081491|P2|Stage 1: Dose Escalation|Progressive Disease|3
935178|NCT00879684|3081492|P1|Stage 1: Dose Escalation|Progressive Disease|2
935179|NCT00879684|3081486|P7|Stage 1: Dose Escalation|Adverse Event|0
935180|NCT00879684|3081487|P6|Stage 1: Dose Escalation|Adverse Event|0
935181|NCT00879684|3081488|P5|Stage 1: Dose Escalation|Adverse Event|0
935182|NCT00879684|3081489|P4|Stage 1: Dose Escalation|Adverse Event|0
935183|NCT00879684|3081490|P3|Stage 1: Dose Escalation|Adverse Event|0
935184|NCT00879684|3081491|P2|Stage 1: Dose Escalation|Adverse Event|0
935185|NCT00879684|3081492|P1|Stage 1: Dose Escalation|Adverse Event|1
935186|NCT00879645|3081558|P4|Overall Study|Adverse Event|0
935187|NCT00879645|3081559|P3|Overall Study|Adverse Event|0
935188|NCT00879645|3081560|P2|Overall Study|Adverse Event|0
935189|NCT00879645|3081561|P1|Overall Study|Adverse Event|1
935190|NCT00879411|3081588|P1|Overall Study|lost to follow-up (non-AE)|162
935191|NCT00879398|3081594|P1|Overall Study|Other Reasons|171
935192|NCT00879398|3081594|P1|Overall Study|Adverse Event|41
935193|NCT00879398|3081594|P1|Overall Study|Lack of Efficacy|64
935194|NCT00879398|3081594|P1|Overall Study|Visit Stop|399
935195|NCT00879333|3081612|P2|Overall Study|Protocol Violation|1
935196|NCT00879333|3081613|P1|Overall Study|Protocol Violation|1
935197|NCT00879333|3081612|P2|Overall Study|Disease Progression|169
935198|NCT00879333|3081613|P1|Overall Study|Disease Progression|292
935199|NCT00879333|3081612|P2|Overall Study|Death|5
935200|NCT00879333|3081613|P1|Overall Study|Death|16
935201|NCT00879333|3081612|P2|Overall Study|Administrative Problems|0
935202|NCT00879333|3081613|P1|Overall Study|Administrative Problems|2
935203|NCT00879333|3081612|P2|Overall Study|Lost to Follow-up|1
935204|NCT00879333|3081613|P1|Overall Study|Lost to Follow-up|2
935205|NCT00879333|3081612|P2|Overall Study|Withdrawal by Subject|7
935206|NCT00879333|3081613|P1|Overall Study|Withdrawal by Subject|20
935207|NCT00879333|3081612|P2|Overall Study|Abnormal Laboratory Value|0
935208|NCT00879333|3081613|P1|Overall Study|Abnormal Laboratory Value|1
935209|NCT00879333|3081612|P2|Overall Study|Adverse Event|34
935210|NCT00879333|3081613|P1|Overall Study|Adverse Event|94
935211|NCT00879229|3081646|P2|Overall Study|Other|0
935212|NCT00879229|3081647|P1|Overall Study|Other|1
935213|NCT00879229|3081646|P2|Overall Study|Clinical status did not improve|0
935214|NCT00879229|3081647|P1|Overall Study|Clinical status did not improve|1
935215|NCT00879229|3081646|P2|Overall Study|Withdrawal by Subject|0
935216|NCT00879229|3081647|P1|Overall Study|Withdrawal by Subject|1
935217|NCT00879229|3081646|P2|Overall Study|Adverse Event|0
935218|NCT00879229|3081647|P1|Overall Study|Adverse Event|2
935219|NCT00879229|3081646|P2|Overall Study|Death|2
935220|NCT00879229|3081647|P1|Overall Study|Death|4
935221|NCT00879229|3081646|P2|Overall Study|Study terminated by Sponsor|12
935222|NCT00879229|3081647|P1|Overall Study|Study terminated by Sponsor|13
935223|NCT00878995|3081695|P2|Baseline Study - Midpoint Study|Withdrawal by Subject|2
935224|NCT00878995|3081696|P1|Baseline Study - Midpoint Study|Withdrawal by Subject|0
935225|NCT00878969|3081797|P3|Overall Study|Pregnancy|0
935226|NCT00878969|3081798|P2|Overall Study|Pregnancy|1
935227|NCT00878969|3081799|P1|Overall Study|Pregnancy|0
935228|NCT00878969|3081797|P3|Overall Study|Death|2
935229|NCT00878969|3081798|P2|Overall Study|Death|0
935230|NCT00878969|3081799|P1|Overall Study|Death|0
935231|NCT00878969|3081797|P3|Overall Study|Protocol Violation|0
935232|NCT00878969|3081798|P2|Overall Study|Protocol Violation|0
935233|NCT00878969|3081799|P1|Overall Study|Protocol Violation|2
935234|NCT00878969|3081797|P3|Overall Study|Lost to Follow-up|0
935235|NCT00878969|3081798|P2|Overall Study|Lost to Follow-up|1
935236|NCT00878969|3081799|P1|Overall Study|Lost to Follow-up|2
935237|NCT00878969|3081797|P3|Overall Study|Adverse Event|2
935238|NCT00878969|3081798|P2|Overall Study|Adverse Event|1
935239|NCT00878969|3081799|P1|Overall Study|Adverse Event|3
935240|NCT00878969|3081797|P3|Overall Study|kidney transplant|2
935241|NCT00878969|3081798|P2|Overall Study|kidney transplant|3
935242|NCT00878969|3081799|P1|Overall Study|kidney transplant|2
935243|NCT00878969|3081797|P3|Overall Study|Withdrawal by Subject|3
935244|NCT00878969|3081798|P2|Overall Study|Withdrawal by Subject|6
935245|NCT00878969|3081799|P1|Overall Study|Withdrawal by Subject|1
935246|NCT00878969|3081797|P3|Overall Study|Physician Decision|2
935247|NCT00878969|3081798|P2|Overall Study|Physician Decision|3
935248|NCT00878969|3081799|P1|Overall Study|Physician Decision|5
935249|NCT00878800|3081847|P5|Overall Study|Other|1
935250|NCT00878800|3081848|P4|Overall Study|Other|0
935251|NCT00878800|3081849|P3|Overall Study|Other|0
935252|NCT00878800|3081850|P2|Overall Study|Other|1
935253|NCT00878800|3081851|P1|Overall Study|Other|1
935254|NCT00878800|3081847|P5|Overall Study|Death|0
935255|NCT00878800|3081848|P4|Overall Study|Death|0
935256|NCT00878800|3081849|P3|Overall Study|Death|1
935257|NCT00878800|3081850|P2|Overall Study|Death|0
935258|NCT00878800|3081851|P1|Overall Study|Death|0
935259|NCT00878800|3081847|P5|Overall Study|Withdrew consent|1
935260|NCT00878800|3081848|P4|Overall Study|Withdrew consent|1
935261|NCT00878800|3081849|P3|Overall Study|Withdrew consent|0
935262|NCT00878800|3081850|P2|Overall Study|Withdrew consent|1
935263|NCT00878800|3081851|P1|Overall Study|Withdrew consent|1
935264|NCT00878800|3081847|P5|Overall Study|Progressive disease|13
935265|NCT00878800|3081848|P4|Overall Study|Progressive disease|5
935266|NCT00878800|3081849|P3|Overall Study|Progressive disease|6
935267|NCT00878800|3081850|P2|Overall Study|Progressive disease|5
935268|NCT00878800|3081851|P1|Overall Study|Progressive disease|1
935269|NCT00878800|3081847|P5|Overall Study|Adverse Event|1
935270|NCT00878800|3081848|P4|Overall Study|Adverse Event|0
935271|NCT00878800|3081849|P3|Overall Study|Adverse Event|2
935272|NCT00878800|3081850|P2|Overall Study|Adverse Event|0
935273|NCT00878800|3081851|P1|Overall Study|Adverse Event|0
935274|NCT00878722|3081886|P8|Overall Study|Relapse|0
935275|NCT00878722|3081887|P7|Overall Study|Relapse|0
935276|NCT00878722|3081888|P6|Overall Study|Relapse|0
935277|NCT00878722|3081889|P5|Overall Study|Relapse|0
935278|NCT00878722|3081890|P4|Overall Study|Relapse|1
935279|NCT00878722|3081891|P3|Overall Study|Relapse|0
935280|NCT00878722|3081892|P2|Overall Study|Relapse|0
935281|NCT00878722|3081893|P1|Overall Study|Relapse|0
935282|NCT00878722|3081886|P8|Overall Study|Withdrawal by Subject|2
935283|NCT00878722|3081887|P7|Overall Study|Withdrawal by Subject|0
935284|NCT00878722|3081888|P6|Overall Study|Withdrawal by Subject|0
935285|NCT00878722|3081889|P5|Overall Study|Withdrawal by Subject|0
935286|NCT00878722|3081890|P4|Overall Study|Withdrawal by Subject|0
935287|NCT00878722|3081891|P3|Overall Study|Withdrawal by Subject|0
935288|NCT00878722|3081892|P2|Overall Study|Withdrawal by Subject|0
935289|NCT00878722|3081893|P1|Overall Study|Withdrawal by Subject|0
935290|NCT00878722|3081886|P8|Overall Study|Adverse Event|0
935291|NCT00878722|3081887|P7|Overall Study|Adverse Event|2
935292|NCT00878722|3081888|P6|Overall Study|Adverse Event|0
935293|NCT00878722|3081889|P5|Overall Study|Adverse Event|0
935294|NCT00878722|3081890|P4|Overall Study|Adverse Event|0
935295|NCT00878722|3081891|P3|Overall Study|Adverse Event|0
935296|NCT00878722|3081892|P2|Overall Study|Adverse Event|0
935297|NCT00878722|3081893|P1|Overall Study|Adverse Event|0
935298|NCT00878722|3081886|P8|Overall Study|Death|2
935299|NCT00878722|3081887|P7|Overall Study|Death|0
935300|NCT00878722|3081888|P6|Overall Study|Death|1
935301|NCT00878722|3081889|P5|Overall Study|Death|0
935302|NCT00878722|3081890|P4|Overall Study|Death|1
935303|NCT00878722|3081891|P3|Overall Study|Death|0
935304|NCT00878722|3081892|P2|Overall Study|Death|0
935305|NCT00878722|3081893|P1|Overall Study|Death|0
935306|NCT00878722|3081886|P8|Overall Study|Progressive disease|3
935307|NCT00878722|3081887|P7|Overall Study|Progressive disease|4
935308|NCT00878722|3081888|P6|Overall Study|Progressive disease|1
935309|NCT00878722|3081889|P5|Overall Study|Progressive disease|7
935310|NCT00878722|3081890|P4|Overall Study|Progressive disease|7
935311|NCT00878722|3081891|P3|Overall Study|Progressive disease|3
935312|NCT00878722|3081892|P2|Overall Study|Progressive disease|3
935313|NCT00878722|3081893|P1|Overall Study|Progressive disease|3
935314|NCT00878709|3081978|P2|Overall Study|Other Reasons|84
935315|NCT00878709|3081979|P1|Overall Study|Other Reasons|93
935316|NCT00878709|3081978|P2|Overall Study|Lost to Follow-up|33
935317|NCT00878709|3081979|P1|Overall Study|Lost to Follow-up|35
935318|NCT00878709|3081978|P2|Overall Study|Withdrawal by Subject|120
935319|NCT00878709|3081979|P1|Overall Study|Withdrawal by Subject|197
935320|NCT00878553|3082039|P5|PK Study|Withdrawal by Subject|0
935321|NCT00878553|3082040|P4|PK Study|Withdrawal by Subject|1
935322|NCT00878553|3082041|P3|PK Study|Withdrawal by Subject|0
935323|NCT00878553|3082042|P2|PK Study|Withdrawal by Subject|0
935324|NCT00878553|3082043|P1|PK Study|Withdrawal by Subject|0
935325|NCT00878553|3082039|P5|Sleep Study|family emergency|0
935326|NCT00878553|3082040|P4|Sleep Study|family emergency|0
935327|NCT00878553|3082041|P3|Sleep Study|family emergency|0
935328|NCT00878553|3082042|P2|Sleep Study|family emergency|0
935329|NCT00878553|3082043|P1|Sleep Study|family emergency|1
935330|NCT00878553|3082039|P5|Sleep Study|car accident|0
935331|NCT00878553|3082040|P4|Sleep Study|car accident|0
935332|NCT00878553|3082041|P3|Sleep Study|car accident|0
935333|NCT00878553|3082042|P2|Sleep Study|car accident|0
935334|NCT00878553|3082043|P1|Sleep Study|car accident|1
935335|NCT00878553|3082039|P5|Sleep Study|Lost to Follow-up|0
935336|NCT00878553|3082040|P4|Sleep Study|Lost to Follow-up|0
935337|NCT00878553|3082041|P3|Sleep Study|Lost to Follow-up|0
935338|NCT00878553|3082042|P2|Sleep Study|Lost to Follow-up|0
935339|NCT00878553|3082043|P1|Sleep Study|Lost to Follow-up|1
935340|NCT00878553|3082039|P5|Sleep Study|Withdrawal by Subject|0
935341|NCT00878553|3082040|P4|Sleep Study|Withdrawal by Subject|0
935342|NCT00878553|3082041|P3|Sleep Study|Withdrawal by Subject|0
935343|NCT00878553|3082042|P2|Sleep Study|Withdrawal by Subject|0
935344|NCT00878553|3082043|P1|Sleep Study|Withdrawal by Subject|2
935345|NCT00878501|3082102|P3|Overall Study|Administrative|1
935346|NCT00878501|3082103|P2|Overall Study|Administrative|0
935347|NCT00878501|3082104|P1|Overall Study|Administrative|0
935348|NCT00878501|3082102|P3|Overall Study|Mis-randomisation of patient|0
935349|NCT00878501|3082103|P2|Overall Study|Mis-randomisation of patient|0
935350|NCT00878501|3082104|P1|Overall Study|Mis-randomisation of patient|1
935351|NCT00878501|3082102|P3|Overall Study|Intake of prohibited concom. medication|1
935352|NCT00878501|3082103|P2|Overall Study|Intake of prohibited concom. medication|0
935353|NCT00878501|3082104|P1|Overall Study|Intake of prohibited concom. medication|0
935354|NCT00878501|3082102|P3|Overall Study|Incorrect enrolment|0
935355|NCT00878501|3082103|P2|Overall Study|Incorrect enrolment|2
935356|NCT00878501|3082104|P1|Overall Study|Incorrect enrolment|1
935357|NCT00878501|3082102|P3|Overall Study|Protocol Violation|1
935358|NCT00878501|3082103|P2|Overall Study|Protocol Violation|0
935359|NCT00878501|3082104|P1|Overall Study|Protocol Violation|0
935360|NCT00878501|3082102|P3|Overall Study|Withdrawal by Subject|2
935361|NCT00878501|3082103|P2|Overall Study|Withdrawal by Subject|1
935362|NCT00878501|3082104|P1|Overall Study|Withdrawal by Subject|2
935363|NCT00878501|3082102|P3|Overall Study|Lack of Efficacy|0
935364|NCT00878501|3082103|P2|Overall Study|Lack of Efficacy|1
935365|NCT00878501|3082104|P1|Overall Study|Lack of Efficacy|2
935366|NCT00878501|3082102|P3|Overall Study|Adverse Event|3
935367|NCT00878501|3082103|P2|Overall Study|Adverse Event|3
935368|NCT00878501|3082104|P1|Overall Study|Adverse Event|11
935369|NCT00878215|3082153|P4|Overall Study|Determined to be ineligible|0
935370|NCT00878215|3082154|P3|Overall Study|Determined to be ineligible|0
935371|NCT00878215|3082155|P2|Overall Study|Determined to be ineligible|10
935372|NCT00878215|3082156|P1|Overall Study|Determined to be ineligible|0
935373|NCT00877929|3082168|P2|Overall Study|Other reason (not specified)|6
935374|NCT00877929|3082169|P1|Overall Study|Other reason (not specified)|2
935375|NCT00877929|3082168|P2|Overall Study|Lack of Efficacy|1
935376|NCT00877929|3082169|P1|Overall Study|Lack of Efficacy|0
935377|NCT00877929|3082168|P2|Overall Study|Withdrawal by Subject|4
935378|NCT00877929|3082169|P1|Overall Study|Withdrawal by Subject|4
935379|NCT00877929|3082168|P2|Overall Study|Lost to Follow-up|1
935380|NCT00877929|3082169|P1|Overall Study|Lost to Follow-up|0
935381|NCT00877929|3082168|P2|Overall Study|Protocol Violation|3
935382|NCT00877929|3082169|P1|Overall Study|Protocol Violation|3
935383|NCT00877929|3082168|P2|Overall Study|Adverse Event|20
935384|NCT00877929|3082169|P1|Overall Study|Adverse Event|11
935385|NCT00877890|3082257|P2|Overall Study|Loss of Glucose Control|4
935386|NCT00877890|3082258|P1|Overall Study|Loss of Glucose Control|3
935387|NCT00877890|3082257|P2|Overall Study|Investigator Decision|2
935388|NCT00877890|3082258|P1|Overall Study|Investigator Decision|0
935389|NCT00877890|3082257|P2|Overall Study|Withdrawal of Consent|12
935390|NCT00877890|3082258|P1|Overall Study|Withdrawal of Consent|6
935391|NCT00877890|3082257|P2|Overall Study|Protocol Violation|1
935392|NCT00877890|3082258|P1|Overall Study|Protocol Violation|0
935393|NCT00877890|3082257|P2|Overall Study|Lost to Follow-up|5
935394|NCT00877890|3082258|P1|Overall Study|Lost to Follow-up|5
935395|NCT00877890|3082257|P2|Overall Study|Adverse Event|6
935396|NCT00877890|3082258|P1|Overall Study|Adverse Event|6
935397|NCT00877799|3082323|P5|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
935398|NCT00877799|3082324|P4|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
935399|NCT00877799|3082325|P3|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
935400|NCT00877799|3082326|P2|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
935401|NCT00877799|3082327|P1|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
935402|NCT00877799|3082323|P5|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
935403|NCT00877799|3082324|P4|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1
935404|NCT00877799|3082325|P3|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
935405|NCT00877799|3082326|P2|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
935406|NCT00877799|3082327|P1|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
935407|NCT00877799|3082323|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
935408|NCT00877799|3082324|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
935409|NCT00877799|3082325|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
935410|NCT00877799|3082326|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3
935411|NCT00877799|3082327|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
935412|NCT00877799|3082323|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
935413|NCT00877799|3082324|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
935414|NCT00877799|3082325|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2
935415|NCT00877799|3082326|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
935416|NCT00877799|3082327|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
935417|NCT00877799|3082323|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
935418|NCT00877799|3082324|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
935419|NCT00877799|3082325|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
935420|NCT00877799|3082326|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
935421|NCT00877799|3082327|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2
935422|NCT00877773|3082342|P1|Overall Study|Disease Progression|44
935423|NCT00877487|3082355|P2|Double-blind Randomized Withdrawal Phase|Moved out of state|0
935424|NCT00877487|3082356|P1|Double-blind Randomized Withdrawal Phase|Moved out of state|1
935425|NCT00877487|3082355|P2|Double-blind Randomized Withdrawal Phase|Protocol Violation|1
935426|NCT00877487|3082356|P1|Double-blind Randomized Withdrawal Phase|Protocol Violation|0
935427|NCT00877487|3082355|P2|Double-blind Randomized Withdrawal Phase|Adverse Event|1
935428|NCT00877487|3082356|P1|Double-blind Randomized Withdrawal Phase|Adverse Event|0
935429|NCT00877487|3082355|P2|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45
935430|NCT00877487|3082356|P1|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5
935431|NCT00877487|3082355|P2|Open-label Treatment Phase|Out of country for business|0
935432|NCT00877487|3082356|P1|Open-label Treatment Phase|Out of country for business|1
935433|NCT00877487|3082355|P2|Open-label Treatment Phase|Lost to Follow-up|0
935434|NCT00877487|3082356|P1|Open-label Treatment Phase|Lost to Follow-up|1
935435|NCT00877487|3082355|P2|Open-label Treatment Phase|Withdrawal by Subject|0
935436|NCT00877487|3082356|P1|Open-label Treatment Phase|Withdrawal by Subject|1
935437|NCT00877487|3082355|P2|Open-label Treatment Phase|Protocol Violation|0
935438|NCT00877487|3082356|P1|Open-label Treatment Phase|Protocol Violation|3
935439|NCT00877487|3082355|P2|Open-label Treatment Phase|Adverse Event|0
935440|NCT00877487|3082356|P1|Open-label Treatment Phase|Adverse Event|1
935441|NCT00877383|3082404|P2|Overall Study|Death|2
935442|NCT00877383|3082405|P1|Overall Study|Death|1
935443|NCT00877383|3082404|P2|Overall Study|Unsatisfactory therapeutic effect|0
935444|NCT00877383|3082405|P1|Overall Study|Unsatisfactory therapeutic effect|1
935445|NCT00877383|3082404|P2|Overall Study|Protocol deviation|6
935446|NCT00877383|3082405|P1|Overall Study|Protocol deviation|2
935447|NCT00877383|3082404|P2|Overall Study|Administrative problems|0
935448|NCT00877383|3082405|P1|Overall Study|Administrative problems|2
935449|NCT00877383|3082404|P2|Overall Study|Subject no longer requires study drug|0
935450|NCT00877383|3082405|P1|Overall Study|Subject no longer requires study drug|2
935451|NCT00877383|3082404|P2|Overall Study|Subject withdrew consent|12
935452|NCT00877383|3082405|P1|Overall Study|Subject withdrew consent|3
935453|NCT00877383|3082404|P2|Overall Study|Lost to Follow-up|3
935454|NCT00877383|3082405|P1|Overall Study|Lost to Follow-up|5
935455|NCT00877383|3082404|P2|Overall Study|Adverse Event|14
935456|NCT00877383|3082405|P1|Overall Study|Adverse Event|13
935457|NCT00877071|3082425|P1|Overall Study|disease progression|2
935458|NCT00877032|3082458|P7|Overall Study|Did not meet entrance criteria|2
935459|NCT00877032|3082459|P6|Overall Study|Did not meet entrance criteria|0
935460|NCT00877032|3082460|P5|Overall Study|Did not meet entrance criteria|0
935461|NCT00877032|3082461|P4|Overall Study|Did not meet entrance criteria|1
935462|NCT00877032|3082462|P3|Overall Study|Did not meet entrance criteria|0
935463|NCT00877032|3082463|P2|Overall Study|Did not meet entrance criteria|0
935464|NCT00877032|3082464|P1|Overall Study|Did not meet entrance criteria|0
935465|NCT00877006|3082565|P2|Long-Term Follow-up Period|Not specified|9
935466|NCT00877006|3082566|P1|Long-Term Follow-up Period|Not specified|7
935467|NCT00877006|3082565|P2|Long-Term Follow-up Period|Death|18
935468|NCT00877006|3082566|P1|Long-Term Follow-up Period|Death|26
935469|NCT00877006|3082565|P2|Long-Term Follow-up Period|Lost to Follow-up|9
935470|NCT00877006|3082566|P1|Long-Term Follow-up Period|Lost to Follow-up|8
935471|NCT00877006|3082565|P2|Long-Term Follow-up Period|Withdrawal by Subject|19
935472|NCT00877006|3082566|P1|Long-Term Follow-up Period|Withdrawal by Subject|12
935473|NCT00877006|3082565|P2|Treatment Period|Randomized but Not Treated|8
935474|NCT00877006|3082566|P1|Treatment Period|Randomized but Not Treated|3
935475|NCT00877006|3082565|P2|Treatment Period|Not Specified|4
935476|NCT00877006|3082566|P1|Treatment Period|Not Specified|4
935477|NCT00877006|3082565|P2|Treatment Period|Started New Treatment Regimen|5
935478|NCT00877006|3082566|P1|Treatment Period|Started New Treatment Regimen|2
935479|NCT00877006|3082565|P2|Treatment Period|Disease Progression|2
935480|NCT00877006|3082566|P1|Treatment Period|Disease Progression|1
935481|NCT00877006|3082565|P2|Treatment Period|Lost to Follow-up|1
935482|NCT00877006|3082566|P1|Treatment Period|Lost to Follow-up|0
935483|NCT00877006|3082565|P2|Treatment Period|Protocol Violation|0
935484|NCT00877006|3082566|P1|Treatment Period|Protocol Violation|1
935485|NCT00877006|3082565|P2|Treatment Period|Withdrawal by Subject|3
935486|NCT00877006|3082566|P1|Treatment Period|Withdrawal by Subject|2
935487|NCT00877006|3082565|P2|Treatment Period|Adverse Event|3
935488|NCT00877006|3082566|P1|Treatment Period|Adverse Event|10
935489|NCT00877006|3082565|P2|Treatment Period|Death|1
935490|NCT00877006|3082566|P1|Treatment Period|Death|2
935491|NCT00876928|3082606|P2|Overall Study|Hypokalemia-affects insulin secretion|0
935492|NCT00876928|3082607|P1|Overall Study|Hypokalemia-affects insulin secretion|1
935493|NCT00876928|3082606|P2|Overall Study|Lost to Follow-up|5
935494|NCT00876928|3082607|P1|Overall Study|Lost to Follow-up|2
935495|NCT00876733|3082644|P4|Overall Study|Data not available|1
935496|NCT00876733|3082645|P3|Overall Study|Data not available|7
935497|NCT00876733|3082646|P2|Overall Study|Data not available|3
935498|NCT00876733|3082647|P1|Overall Study|Data not available|14
935499|NCT00876733|3082644|P4|Overall Study|Lost to Follow-up|2
935500|NCT00876733|3082645|P3|Overall Study|Lost to Follow-up|3
935501|NCT00876733|3082646|P2|Overall Study|Lost to Follow-up|10
935502|NCT00876733|3082647|P1|Overall Study|Lost to Follow-up|26
935503|NCT00876733|3082644|P4|Overall Study|Lack of Efficacy|1
935504|NCT00876733|3082645|P3|Overall Study|Lack of Efficacy|10
935505|NCT00876733|3082646|P2|Overall Study|Lack of Efficacy|9
935506|NCT00876733|3082647|P1|Overall Study|Lack of Efficacy|17
935507|NCT00876733|3082644|P4|Overall Study|Adverse Event|3
935508|NCT00876733|3082645|P3|Overall Study|Adverse Event|10
935509|NCT00876733|3082646|P2|Overall Study|Adverse Event|20
935510|NCT00876733|3082647|P1|Overall Study|Adverse Event|34
935511|NCT00876694|3082755|P2|Overall Study|Death|0
935512|NCT00876694|3082756|P1|Overall Study|Death|1
935513|NCT00876694|3082755|P2|Overall Study|Administrative problems|1
935514|NCT00876694|3082756|P1|Overall Study|Administrative problems|1
935515|NCT00876694|3082755|P2|Overall Study|Abnormal test procedure result(s)|0
935516|NCT00876694|3082756|P1|Overall Study|Abnormal test procedure result(s)|1
935517|NCT00876694|3082755|P2|Overall Study|Unsatisfactory therapeutic effect|0
935518|NCT00876694|3082756|P1|Overall Study|Unsatisfactory therapeutic effect|2
935519|NCT00876694|3082755|P2|Overall Study|Subject withdrew consent|4
935520|NCT00876694|3082756|P1|Overall Study|Subject withdrew consent|6
935521|NCT00876694|3082755|P2|Overall Study|Adverse Event|7
935522|NCT00876694|3082756|P1|Overall Study|Adverse Event|10
935523|NCT00876460|3082782|P8|Mono Therapy Phase|Adverse Event|0
935524|NCT00876460|3082783|P7|Mono Therapy Phase|Adverse Event|0
935525|NCT00876460|3082784|P6|Mono Therapy Phase|Adverse Event|0
935526|NCT00876460|3082785|P5|Mono Therapy Phase|Adverse Event|0
935527|NCT00876460|3082786|P4|Mono Therapy Phase|Adverse Event|1
935528|NCT00876460|3082787|P3|Mono Therapy Phase|Adverse Event|0
935529|NCT00876460|3082788|P2|Mono Therapy Phase|Adverse Event|0
935530|NCT00876460|3082789|P1|Mono Therapy Phase|Adverse Event|0
935531|NCT00876460|3082782|P8|Mono Therapy Phase|Withdrawal by Subject|0
935532|NCT00876460|3082783|P7|Mono Therapy Phase|Withdrawal by Subject|0
935533|NCT00876460|3082784|P6|Mono Therapy Phase|Withdrawal by Subject|0
935534|NCT00876460|3082785|P5|Mono Therapy Phase|Withdrawal by Subject|0
935535|NCT00876460|3082786|P4|Mono Therapy Phase|Withdrawal by Subject|0
935536|NCT00876460|3082787|P3|Mono Therapy Phase|Withdrawal by Subject|0
935537|NCT00876460|3082788|P2|Mono Therapy Phase|Withdrawal by Subject|1
935538|NCT00876460|3082789|P1|Mono Therapy Phase|Withdrawal by Subject|0
935539|NCT00876460|3082782|P8|Mono Therapy Phase|Progressive disease|3
935540|NCT00876460|3082783|P7|Mono Therapy Phase|Progressive disease|1
935541|NCT00876460|3082784|P6|Mono Therapy Phase|Progressive disease|0
935542|NCT00876460|3082785|P5|Mono Therapy Phase|Progressive disease|2
935543|NCT00876460|3082786|P4|Mono Therapy Phase|Progressive disease|0
935544|NCT00876460|3082787|P3|Mono Therapy Phase|Progressive disease|0
935545|NCT00876460|3082788|P2|Mono Therapy Phase|Progressive disease|0
935546|NCT00876460|3082789|P1|Mono Therapy Phase|Progressive disease|0
935547|NCT00876460|3082782|P8|Combination Therapy Phase|Not treated|0
935548|NCT00876460|3082783|P7|Combination Therapy Phase|Not treated|1
935549|NCT00876460|3082784|P6|Combination Therapy Phase|Not treated|0
935550|NCT00876460|3082785|P5|Combination Therapy Phase|Not treated|0
935551|NCT00876460|3082786|P4|Combination Therapy Phase|Not treated|0
935552|NCT00876460|3082787|P3|Combination Therapy Phase|Not treated|0
935553|NCT00876460|3082788|P2|Combination Therapy Phase|Not treated|0
935554|NCT00876460|3082789|P1|Combination Therapy Phase|Not treated|0
935555|NCT00876460|3082782|P8|Combination Therapy Phase|Other reason not defined above|2
935556|NCT00876460|3082783|P7|Combination Therapy Phase|Other reason not defined above|1
935557|NCT00876460|3082784|P6|Combination Therapy Phase|Other reason not defined above|0
935558|NCT00876460|3082785|P5|Combination Therapy Phase|Other reason not defined above|0
935559|NCT00876460|3082786|P4|Combination Therapy Phase|Other reason not defined above|0
935560|NCT00876460|3082787|P3|Combination Therapy Phase|Other reason not defined above|0
935561|NCT00876460|3082788|P2|Combination Therapy Phase|Other reason not defined above|0
935562|NCT00876460|3082789|P1|Combination Therapy Phase|Other reason not defined above|0
935563|NCT00876460|3082782|P8|Combination Therapy Phase|Withdrawal by Subject|0
935564|NCT00876460|3082783|P7|Combination Therapy Phase|Withdrawal by Subject|0
935565|NCT00876460|3082784|P6|Combination Therapy Phase|Withdrawal by Subject|0
935566|NCT00876460|3082785|P5|Combination Therapy Phase|Withdrawal by Subject|1
935567|NCT00876460|3082786|P4|Combination Therapy Phase|Withdrawal by Subject|0
935568|NCT00876460|3082787|P3|Combination Therapy Phase|Withdrawal by Subject|0
935569|NCT00876460|3082788|P2|Combination Therapy Phase|Withdrawal by Subject|1
935570|NCT00876460|3082789|P1|Combination Therapy Phase|Withdrawal by Subject|1
935571|NCT00876460|3082782|P8|Combination Therapy Phase|Adverse Event|2
935572|NCT00876460|3082783|P7|Combination Therapy Phase|Adverse Event|3
935573|NCT00876460|3082784|P6|Combination Therapy Phase|Adverse Event|0
935574|NCT00876460|3082785|P5|Combination Therapy Phase|Adverse Event|2
935575|NCT00876460|3082786|P4|Combination Therapy Phase|Adverse Event|2
935576|NCT00876460|3082787|P3|Combination Therapy Phase|Adverse Event|0
935577|NCT00876460|3082788|P2|Combination Therapy Phase|Adverse Event|2
935578|NCT00876460|3082789|P1|Combination Therapy Phase|Adverse Event|0
935579|NCT00876460|3082782|P8|Combination Therapy Phase|Dose limiting toxicity|1
935580|NCT00876460|3082783|P7|Combination Therapy Phase|Dose limiting toxicity|2
935581|NCT00876460|3082784|P6|Combination Therapy Phase|Dose limiting toxicity|2
935582|NCT00876460|3082785|P5|Combination Therapy Phase|Dose limiting toxicity|1
935583|NCT00876460|3082786|P4|Combination Therapy Phase|Dose limiting toxicity|1
935584|NCT00876460|3082787|P3|Combination Therapy Phase|Dose limiting toxicity|0
935585|NCT00876460|3082788|P2|Combination Therapy Phase|Dose limiting toxicity|1
935586|NCT00876460|3082789|P1|Combination Therapy Phase|Dose limiting toxicity|0
935587|NCT00876460|3082782|P8|Combination Therapy Phase|Progressive disease|1
935588|NCT00876460|3082783|P7|Combination Therapy Phase|Progressive disease|1
935589|NCT00876460|3082784|P6|Combination Therapy Phase|Progressive disease|1
935590|NCT00876460|3082785|P5|Combination Therapy Phase|Progressive disease|3
935591|NCT00876460|3082786|P4|Combination Therapy Phase|Progressive disease|3
935592|NCT00876460|3082787|P3|Combination Therapy Phase|Progressive disease|3
935593|NCT00876460|3082788|P2|Combination Therapy Phase|Progressive disease|3
935594|NCT00876460|3082789|P1|Combination Therapy Phase|Progressive disease|2
935595|NCT00876447|3082861|P2|Overall Study|Adverse Event|8
935596|NCT00876447|3082862|P1|Overall Study|Adverse Event|4
935597|NCT00876447|3082861|P2|Overall Study|Lack of Efficacy|3
935598|NCT00876447|3082862|P1|Overall Study|Lack of Efficacy|5
935599|NCT00876447|3082861|P2|Overall Study|Pregnancy|2
935600|NCT00876447|3082862|P1|Overall Study|Pregnancy|4
935601|NCT00876447|3082861|P2|Overall Study|Lost to Follow-up|15
935602|NCT00876447|3082862|P1|Overall Study|Lost to Follow-up|6
935603|NCT00876447|3082861|P2|Overall Study|Personal reasons|28
935604|NCT00876447|3082862|P1|Overall Study|Personal reasons|30
935605|NCT00876447|3082861|P2|Overall Study|Protocol Violation|3
935606|NCT00876447|3082862|P1|Overall Study|Protocol Violation|9
935607|NCT00876447|3082861|P2|Overall Study|Site closure|14
935608|NCT00876447|3082862|P1|Overall Study|Site closure|19
935609|NCT00876447|3082861|P2|Overall Study|Other miscellaneous reasons|8
935610|NCT00876447|3082862|P1|Overall Study|Other miscellaneous reasons|3
935611|NCT00876343|3082923|P3|Overall Study|Change of residence or other commitments|3
935612|NCT00876343|3082924|P2|Overall Study|Change of residence or other commitments|2
935613|NCT00876343|3082925|P1|Overall Study|Change of residence or other commitments|2
935614|NCT00876343|3082923|P3|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
935615|NCT00876343|3082924|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
935616|NCT00876343|3082925|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
935617|NCT00876343|3082923|P3|Overall Study|Physician Decision|1
935618|NCT00876343|3082924|P2|Overall Study|Physician Decision|1
935619|NCT00876343|3082925|P1|Overall Study|Physician Decision|0
935620|NCT00876343|3082923|P3|Overall Study|Protocol Violation|1
935621|NCT00876343|3082924|P2|Overall Study|Protocol Violation|1
935622|NCT00876343|3082925|P1|Overall Study|Protocol Violation|4
935623|NCT00876343|3082923|P3|Overall Study|Lack of Efficacy|1
935624|NCT00876343|3082924|P2|Overall Study|Lack of Efficacy|0
935625|NCT00876343|3082925|P1|Overall Study|Lack of Efficacy|0
935626|NCT00876343|3082923|P3|Overall Study|Withdrawal by Subject|3
935627|NCT00876343|3082924|P2|Overall Study|Withdrawal by Subject|4
935628|NCT00876343|3082925|P1|Overall Study|Withdrawal by Subject|4
935629|NCT00876343|3082923|P3|Overall Study|Adverse Event|2
935630|NCT00876343|3082924|P2|Overall Study|Adverse Event|8
935631|NCT00876343|3082925|P1|Overall Study|Adverse Event|7
935632|NCT00876265|3082939|P1|Overall Study|Withdrawal by Subject|2
935633|NCT00876265|3082939|P1|Overall Study|Lost to Follow-up|6
935634|NCT00876265|3082939|P1|Overall Study|Miscellaneous reasons|4
935635|NCT00876018|3082948|P3|Overall Study|Withdrew Consent due to Adverse Event|2
935636|NCT00876018|3082949|P2|Overall Study|Withdrew Consent due to Adverse Event|4
935637|NCT00876018|3082950|P1|Overall Study|Withdrew Consent due to Adverse Event|5
935638|NCT00876018|3082948|P3|Overall Study|Lost to Follow-up|1
935639|NCT00876018|3082949|P2|Overall Study|Lost to Follow-up|1
935640|NCT00876018|3082950|P1|Overall Study|Lost to Follow-up|0
935641|NCT00875979|3083005|P2|Dose Expansion Phase - 3.6 mg/kg|Death|1
935642|NCT00875979|3083006|P1|Dose Expansion Phase - 3.6 mg/kg|Death|0
935643|NCT00875979|3083005|P2|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3
935644|NCT00875979|3083006|P1|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0
935645|NCT00875979|3083005|P2|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3
935646|NCT00875979|3083006|P1|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0
935647|NCT00875979|3083005|P2|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3
935648|NCT00875979|3083006|P1|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0
935649|NCT00875979|3083005|P2|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37
935650|NCT00875979|3083006|P1|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0
935651|NCT00875979|3083005|P2|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6
935652|NCT00875979|3083006|P1|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0
935653|NCT00875979|3083005|P2|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0
935654|NCT00875979|3083006|P1|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1
935655|NCT00875979|3083005|P2|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0
935656|NCT00875979|3083006|P1|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1
935657|NCT00875979|3083005|P2|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0
935658|NCT00875979|3083006|P1|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1
935659|NCT00875810|3083029|P1|Overall Study|Device explanted|1
935660|NCT00875810|3083029|P1|Overall Study|Patient enroled but not implanted|2
935661|NCT00875810|3083029|P1|Overall Study|Lost to Follow-up|39
935662|NCT00875810|3083029|P1|Overall Study|Physician Decision|3
935663|NCT00875810|3083029|P1|Overall Study|Withdrawal by Subject|1
935664|NCT00875797|3083038|P2|Overall Study|Protocol Violation|3
935665|NCT00875797|3083039|P1|Overall Study|Protocol Violation|6
935666|NCT00875706|3083052|P3|Overall Study|Withdrawal by Subject|0
935667|NCT00875706|3083053|P2|Overall Study|Withdrawal by Subject|0
935668|NCT00875706|3083054|P1|Overall Study|Withdrawal by Subject|1
935669|NCT00875615|3083071|P1|Overall Study|Withdrawal by Subject|1
935670|NCT00875563|3083085|P1|Overall Study|Still be eligible for follow-up|7
935671|NCT00875563|3083085|P1|Overall Study|No long-term (3-5 year) consent|6
935672|NCT00875563|3083085|P1|Overall Study|Withdrawal by Subject|7
935673|NCT00875563|3083085|P1|Overall Study|Death|4
935674|NCT00875485|3083110|P2|Challenge Dose Epoch|Pregnancy|0
935675|NCT00875485|3083111|P1|Challenge Dose Epoch|Pregnancy|1
935676|NCT00875433|3083151|P1|Overall Study|Not specified|3
935677|NCT00875433|3083151|P1|Overall Study|Withdrawal by Subject|2
935678|NCT00875433|3083151|P1|Overall Study|Other Adverse Event|14
935679|NCT00875433|3083151|P1|Overall Study|Progressive disease|41
935680|NCT00875420|3083181|P5|Overall Study|Withdrawal by Subject|0
935681|NCT00875420|3083182|P4|Overall Study|Withdrawal by Subject|0
935682|NCT00875420|3083183|P3|Overall Study|Withdrawal by Subject|1
935683|NCT00875420|3083184|P2|Overall Study|Withdrawal by Subject|0
935684|NCT00875420|3083185|P1|Overall Study|Withdrawal by Subject|0
935685|NCT00875420|3083181|P5|Overall Study|Sponsor decision|0
935686|NCT00875420|3083182|P4|Overall Study|Sponsor decision|0
935687|NCT00875420|3083183|P3|Overall Study|Sponsor decision|0
935688|NCT00875420|3083184|P2|Overall Study|Sponsor decision|1
935689|NCT00875420|3083185|P1|Overall Study|Sponsor decision|0
935690|NCT00875420|3083181|P5|Overall Study|Prohibited medication|0
935691|NCT00875420|3083182|P4|Overall Study|Prohibited medication|1
935692|NCT00875420|3083183|P3|Overall Study|Prohibited medication|0
935693|NCT00875420|3083184|P2|Overall Study|Prohibited medication|0
935694|NCT00875420|3083185|P1|Overall Study|Prohibited medication|0
935695|NCT00875420|3083181|P5|Overall Study|Personal reason|1
935696|NCT00875420|3083182|P4|Overall Study|Personal reason|0
935697|NCT00875420|3083183|P3|Overall Study|Personal reason|0
935698|NCT00875420|3083184|P2|Overall Study|Personal reason|0
935699|NCT00875420|3083185|P1|Overall Study|Personal reason|0
935700|NCT00875420|3083181|P5|Overall Study|Lost to Follow-up|0
935701|NCT00875420|3083182|P4|Overall Study|Lost to Follow-up|0
935702|NCT00875420|3083183|P3|Overall Study|Lost to Follow-up|0
935703|NCT00875420|3083184|P2|Overall Study|Lost to Follow-up|0
935704|NCT00875420|3083185|P1|Overall Study|Lost to Follow-up|1
935705|NCT00875420|3083181|P5|Overall Study|Inability to complete study procedures|1
935706|NCT00875420|3083182|P4|Overall Study|Inability to complete study procedures|1
935707|NCT00875420|3083183|P3|Overall Study|Inability to complete study procedures|1
935708|NCT00875420|3083184|P2|Overall Study|Inability to complete study procedures|0
935709|NCT00875420|3083185|P1|Overall Study|Inability to complete study procedures|1
935710|NCT00875420|3083181|P5|Overall Study|Adverse Event|0
935711|NCT00875420|3083182|P4|Overall Study|Adverse Event|0
935712|NCT00875420|3083183|P3|Overall Study|Adverse Event|1
935713|NCT00875420|3083184|P2|Overall Study|Adverse Event|1
935714|NCT00875420|3083185|P1|Overall Study|Adverse Event|0
935715|NCT00875017|3083246|P6|Fourth Intervention|Inability to comply with fasting|1
935716|NCT00875017|3083247|P5|Fourth Intervention|Inability to comply with fasting|0
935717|NCT00875017|3083248|P4|Fourth Intervention|Inability to comply with fasting|0
935718|NCT00875017|3083249|P3|Fourth Intervention|Inability to comply with fasting|0
935719|NCT00875017|3083250|P2|Fourth Intervention|Inability to comply with fasting|0
935720|NCT00875017|3083251|P1|Fourth Intervention|Inability to comply with fasting|0
935721|NCT00875017|3083246|P6|Washout|Withdrawal by Subject|0
935722|NCT00875017|3083247|P5|Washout|Withdrawal by Subject|1
935723|NCT00875017|3083248|P4|Washout|Withdrawal by Subject|0
935724|NCT00875017|3083249|P3|Washout|Withdrawal by Subject|0
935725|NCT00875017|3083250|P2|Washout|Withdrawal by Subject|0
935726|NCT00875017|3083251|P1|Washout|Withdrawal by Subject|0
935727|NCT00875017|3083246|P6|Third Intervention|Adverse Event|0
935728|NCT00875017|3083247|P5|Third Intervention|Adverse Event|0
935729|NCT00875017|3083248|P4|Third Intervention|Adverse Event|0
935730|NCT00875017|3083249|P3|Third Intervention|Adverse Event|1
935731|NCT00875017|3083250|P2|Third Intervention|Adverse Event|1
935732|NCT00875017|3083251|P1|Third Intervention|Adverse Event|0
935733|NCT00875017|3083246|P6|Washout|Problems collecting rectal effluent|0
935734|NCT00875017|3083247|P5|Washout|Problems collecting rectal effluent|0
935735|NCT00875017|3083248|P4|Washout|Problems collecting rectal effluent|0
935736|NCT00875017|3083249|P3|Washout|Problems collecting rectal effluent|0
935737|NCT00875017|3083250|P2|Washout|Problems collecting rectal effluent|1
935738|NCT00875017|3083251|P1|Washout|Problems collecting rectal effluent|0
935739|NCT00875017|3083246|P6|Second Intervention|Adverse Event|0
935740|NCT00875017|3083247|P5|Second Intervention|Adverse Event|0
935741|NCT00875017|3083248|P4|Second Intervention|Adverse Event|1
935742|NCT00875017|3083249|P3|Second Intervention|Adverse Event|0
935743|NCT00875017|3083250|P2|Second Intervention|Adverse Event|0
935744|NCT00875017|3083251|P1|Second Intervention|Adverse Event|0
935745|NCT00875017|3083246|P6|Washout|Problem collecting rectal effluent|0
935746|NCT00875017|3083247|P5|Washout|Problem collecting rectal effluent|0
935747|NCT00875017|3083248|P4|Washout|Problem collecting rectal effluent|0
935748|NCT00875017|3083249|P3|Washout|Problem collecting rectal effluent|1
935749|NCT00875017|3083250|P2|Washout|Problem collecting rectal effluent|0
935750|NCT00875017|3083251|P1|Washout|Problem collecting rectal effluent|0
935751|NCT00875017|3083246|P6|First Intervention|Intolerance to nasogastric tube|0
935752|NCT00875017|3083247|P5|First Intervention|Intolerance to nasogastric tube|1
935753|NCT00875017|3083248|P4|First Intervention|Intolerance to nasogastric tube|0
935754|NCT00875017|3083249|P3|First Intervention|Intolerance to nasogastric tube|0
935755|NCT00875017|3083250|P2|First Intervention|Intolerance to nasogastric tube|0
935756|NCT00875017|3083251|P1|First Intervention|Intolerance to nasogastric tube|0
935757|NCT00875017|3083246|P6|First Intervention|Problems collecting rectal effluent|0
935758|NCT00875017|3083247|P5|First Intervention|Problems collecting rectal effluent|0
935759|NCT00875017|3083248|P4|First Intervention|Problems collecting rectal effluent|0
935760|NCT00875017|3083249|P3|First Intervention|Problems collecting rectal effluent|0
935761|NCT00875017|3083250|P2|First Intervention|Problems collecting rectal effluent|0
935762|NCT00875017|3083251|P1|First Intervention|Problems collecting rectal effluent|1
935763|NCT00875017|3083246|P6|First Intervention|Adverse Event|0
935764|NCT00875017|3083247|P5|First Intervention|Adverse Event|0
935765|NCT00875017|3083248|P4|First Intervention|Adverse Event|1
935766|NCT00875017|3083249|P3|First Intervention|Adverse Event|0
935767|NCT00875017|3083250|P2|First Intervention|Adverse Event|0
935768|NCT00875017|3083251|P1|First Intervention|Adverse Event|0
935769|NCT00875017|3083246|P6|First Intervention|Withdrawal by Subject|0
935770|NCT00875017|3083247|P5|First Intervention|Withdrawal by Subject|0
935771|NCT00875017|3083248|P4|First Intervention|Withdrawal by Subject|0
935772|NCT00875017|3083249|P3|First Intervention|Withdrawal by Subject|1
935773|NCT00875017|3083250|P2|First Intervention|Withdrawal by Subject|0
935774|NCT00875017|3083251|P1|First Intervention|Withdrawal by Subject|1
935775|NCT00874939|3083265|P1|Overall Study|Study terminated|4
935776|NCT00874848|3083298|P2|Overall Study|Physician Decision|2
935777|NCT00874848|3083299|P1|Overall Study|Physician Decision|0
935778|NCT00874848|3083298|P2|Overall Study|Failure to comply with protocol|1
935779|NCT00874848|3083299|P1|Overall Study|Failure to comply with protocol|0
935780|NCT00874848|3083298|P2|Overall Study|Noncompliance|1
935781|NCT00874848|3083299|P1|Overall Study|Noncompliance|1
935782|NCT00874848|3083298|P2|Overall Study|Withdrawal by Subject|4
935783|NCT00874848|3083299|P1|Overall Study|Withdrawal by Subject|7
935784|NCT00874848|3083298|P2|Overall Study|Progressive neoplastic disease|18
935785|NCT00874848|3083299|P1|Overall Study|Progressive neoplastic disease|38
935786|NCT00874848|3083298|P2|Overall Study|Adverse Event|2
935787|NCT00874848|3083299|P1|Overall Study|Adverse Event|13
935788|NCT00874822|3083315|P1|Overall Study|excluded by criteria|8
935789|NCT00874770|3083323|P4|Overall Study|Subject no Longer Meets Study Criteria|0
935790|NCT00874770|3083324|P3|Overall Study|Subject no Longer Meets Study Criteria|0
935791|NCT00874770|3083325|P2|Overall Study|Subject no Longer Meets Study Criteria|0
935792|NCT00874770|3083326|P1|Overall Study|Subject no Longer Meets Study Criteria|1
935793|NCT00874770|3083323|P4|Overall Study|Lost to Follow-up|1
935794|NCT00874770|3083324|P3|Overall Study|Lost to Follow-up|0
935795|NCT00874770|3083325|P2|Overall Study|Lost to Follow-up|0
935796|NCT00874770|3083326|P1|Overall Study|Lost to Follow-up|1
935797|NCT00874770|3083323|P4|Overall Study|Adverse Event|2
935798|NCT00874770|3083324|P3|Overall Study|Adverse Event|4
935799|NCT00874770|3083325|P2|Overall Study|Adverse Event|1
935800|NCT00874770|3083326|P1|Overall Study|Adverse Event|1
935801|NCT00874770|3083323|P4|Overall Study|Lack of Efficacy|2
935802|NCT00874770|3083324|P3|Overall Study|Lack of Efficacy|0
935803|NCT00874770|3083325|P2|Overall Study|Lack of Efficacy|0
935804|NCT00874770|3083326|P1|Overall Study|Lack of Efficacy|2
935805|NCT00874549|3083372|P4|Overall Study|Withdrawal by Subject|1
935806|NCT00874549|3083373|P3|Overall Study|Withdrawal by Subject|0
935807|NCT00874549|3083374|P2|Overall Study|Withdrawal by Subject|1
935808|NCT00874549|3083375|P1|Overall Study|Withdrawal by Subject|0
935809|NCT00874549|3083372|P4|Overall Study|Lost to Follow-up|0
935810|NCT00874549|3083373|P3|Overall Study|Lost to Follow-up|1
935811|NCT00874549|3083374|P2|Overall Study|Lost to Follow-up|0
935812|NCT00874549|3083375|P1|Overall Study|Lost to Follow-up|0
935813|NCT00874549|3083372|P4|Overall Study|Protocol Violation|1
935814|NCT00874549|3083373|P3|Overall Study|Protocol Violation|2
935815|NCT00874549|3083374|P2|Overall Study|Protocol Violation|0
935816|NCT00874549|3083375|P1|Overall Study|Protocol Violation|1
935817|NCT00874549|3083372|P4|Overall Study|Adverse Event|0
935818|NCT00874549|3083373|P3|Overall Study|Adverse Event|1
935819|NCT00874549|3083374|P2|Overall Study|Adverse Event|0
935820|NCT00874549|3083375|P1|Overall Study|Adverse Event|0
935821|NCT00874497|3083452|P2|Overall Study|Withdrawal by Subject|4
935822|NCT00874497|3083453|P1|Overall Study|Withdrawal by Subject|5
935823|NCT00874497|3083452|P2|Overall Study|Physician Decision|1
935824|NCT00874497|3083453|P1|Overall Study|Physician Decision|1
935825|NCT00874497|3083452|P2|Overall Study|Met Withdrawal Criteria|2
935826|NCT00874497|3083453|P1|Overall Study|Met Withdrawal Criteria|4
935827|NCT00874497|3083452|P2|Overall Study|Sponsor Discontinued Trial|3
935828|NCT00874497|3083453|P1|Overall Study|Sponsor Discontinued Trial|7
935829|NCT00874497|3083452|P2|Overall Study|Adverse Event|4
935830|NCT00874497|3083453|P1|Overall Study|Adverse Event|9
935831|NCT00874497|3083452|P2|Overall Study|Lost to Follow-up|4
935832|NCT00874497|3083453|P1|Overall Study|Lost to Follow-up|2
935833|NCT00874276|3083493|P2|Overall Study|Withdrawal by Subject|1
935834|NCT00874276|3083494|P1|Overall Study|Withdrawal by Subject|1
935835|NCT00874120|3083516|P2|Second Intervention|Protocol Violation|0
935836|NCT00874120|3083517|P1|Second Intervention|Protocol Violation|1
935837|NCT00874120|3083516|P2|Second Intervention|Withdrawal by Subject|0
935838|NCT00874120|3083517|P1|Second Intervention|Withdrawal by Subject|1
935839|NCT00874120|3083516|P2|First Intervention|positive drug test|0
935840|NCT00874120|3083517|P1|First Intervention|positive drug test|1
935841|NCT00874120|3083516|P2|First Intervention|Protocol Violation|0
935842|NCT00874120|3083517|P1|First Intervention|Protocol Violation|3
935843|NCT00874120|3083516|P2|First Intervention|Lost to Follow-up|1
935844|NCT00874120|3083517|P1|First Intervention|Lost to Follow-up|0
935845|NCT00874120|3083516|P2|First Intervention|Withdrawal by Subject|0
935846|NCT00874120|3083517|P1|First Intervention|Withdrawal by Subject|2
935847|NCT00874120|3083516|P2|First Intervention|Adverse Event|1
935848|NCT00874120|3083517|P1|First Intervention|Adverse Event|0
935849|NCT00874029|3083530|P1|Overall Study|Lost to Follow-up|5
935850|NCT00874029|3083530|P1|Overall Study|Adverse Event|1
935851|NCT00874029|3083530|P1|Overall Study|Physician Decision|1
935852|NCT00874029|3083530|P1|Overall Study|Pregnancy|4
935853|NCT00874029|3083530|P1|Overall Study|Withdrawal by Subject|10
935854|NCT00873912|3083546|P2|Overall Study|Lost to Follow-up|0
935855|NCT00873912|3083547|P1|Overall Study|Lost to Follow-up|2
935856|NCT00873912|3083546|P2|Overall Study|Withdrawal by Subject|0
935857|NCT00873912|3083547|P1|Overall Study|Withdrawal by Subject|1
935858|NCT00873860|3083586|P4|Overall Study|Other|0
935859|NCT00873860|3083587|P3|Overall Study|Other|1
935860|NCT00873860|3083588|P2|Overall Study|Other|0
935861|NCT00873860|3083589|P1|Overall Study|Other|1
935862|NCT00873860|3083586|P4|Overall Study|Death|0
935863|NCT00873860|3083587|P3|Overall Study|Death|0
935864|NCT00873860|3083588|P2|Overall Study|Death|0
935865|NCT00873860|3083589|P1|Overall Study|Death|1
935866|NCT00873860|3083586|P4|Overall Study|Withdrawal by Subject|0
935867|NCT00873860|3083587|P3|Overall Study|Withdrawal by Subject|2
935868|NCT00873860|3083588|P2|Overall Study|Withdrawal by Subject|0
935869|NCT00873860|3083589|P1|Overall Study|Withdrawal by Subject|1
935870|NCT00873860|3083586|P4|Overall Study|Lost to Follow-up|1
935871|NCT00873860|3083587|P3|Overall Study|Lost to Follow-up|0
935872|NCT00873860|3083588|P2|Overall Study|Lost to Follow-up|0
935873|NCT00873860|3083589|P1|Overall Study|Lost to Follow-up|1
935874|NCT00873730|3083677|P2|Overall Study|Sponsor decision|0
935875|NCT00873730|3083678|P1|Overall Study|Sponsor decision|1
935876|NCT00873730|3083677|P2|Overall Study|Withdrawal by Subject|1
935877|NCT00873730|3083678|P1|Overall Study|Withdrawal by Subject|0
935878|NCT00873730|3083677|P2|Overall Study|Adverse Event|2
935879|NCT00873730|3083678|P1|Overall Study|Adverse Event|0
935880|NCT00873730|3083677|P2|Overall Study|Protocol Deviation|2
935881|NCT00873730|3083678|P1|Overall Study|Protocol Deviation|5
935882|NCT00873366|3083721|P1|Overall Study|Refused to continue DM-BT testing|3
935883|NCT00873366|3083721|P1|Overall Study|Off tamoxifen due to side effects|2
935884|NCT00873366|3083721|P1|Overall Study|Off tamoxifen for reconstructive surgery|1
935885|NCT00873119|3083746|P2|Overall Study|Not treated|0
935886|NCT00873119|3083747|P1|Overall Study|Not treated|2
935887|NCT00873119|3083746|P2|Overall Study|Other|5
935888|NCT00873119|3083747|P1|Overall Study|Other|2
935889|NCT00873119|3083746|P2|Overall Study|Death|1
935890|NCT00873119|3083747|P1|Overall Study|Death|2
935891|NCT00873119|3083746|P2|Overall Study|Progressive disease|18
935892|NCT00873119|3083747|P1|Overall Study|Progressive disease|26
935893|NCT00873119|3083746|P2|Overall Study|Adverse Event|0
935894|NCT00873119|3083747|P1|Overall Study|Adverse Event|8
935895|NCT00873119|3083746|P2|Overall Study|Patient request|2
935896|NCT00873119|3083747|P1|Overall Study|Patient request|4
935897|NCT00873093|3083768|P5|Overall Study|Ineligible|0
935898|NCT00873093|3083769|P4|Overall Study|Ineligible|1
935899|NCT00873093|3083770|P3|Overall Study|Ineligible|0
935900|NCT00873093|3083771|P2|Overall Study|Ineligible|1
935901|NCT00873093|3083772|P1|Overall Study|Ineligible|0
935902|NCT00873093|3083768|P5|Overall Study|Withdrawal by Subject|0
935903|NCT00873093|3083769|P4|Overall Study|Withdrawal by Subject|0
935904|NCT00873093|3083770|P3|Overall Study|Withdrawal by Subject|4
935905|NCT00873093|3083771|P2|Overall Study|Withdrawal by Subject|4
935906|NCT00873093|3083772|P1|Overall Study|Withdrawal by Subject|1
935907|NCT00873093|3083768|P5|Overall Study|Physician Decision|2
935908|NCT00873093|3083769|P4|Overall Study|Physician Decision|10
935909|NCT00873093|3083770|P3|Overall Study|Physician Decision|10
935910|NCT00873093|3083771|P2|Overall Study|Physician Decision|17
935911|NCT00873093|3083772|P1|Overall Study|Physician Decision|0
935912|NCT00873093|3083768|P5|Overall Study|Death|0
935913|NCT00873093|3083769|P4|Overall Study|Death|0
935914|NCT00873093|3083770|P3|Overall Study|Death|2
935915|NCT00873093|3083771|P2|Overall Study|Death|3
935916|NCT00873093|3083772|P1|Overall Study|Death|0
935917|NCT00873093|3083768|P5|Overall Study|Adverse Event|0
935918|NCT00873093|3083769|P4|Overall Study|Adverse Event|0
935919|NCT00873093|3083770|P3|Overall Study|Adverse Event|0
935920|NCT00873093|3083771|P2|Overall Study|Adverse Event|2
935921|NCT00873093|3083772|P1|Overall Study|Adverse Event|0
935922|NCT00873041|3083829|P3|Extension Study|Administrative reasons|1
935923|NCT00873041|3083830|P2|Extension Study|Administrative reasons|0
935924|NCT00873041|3083831|P1|Extension Study|Administrative reasons|0
935925|NCT00873041|3083829|P3|Extension Study|Adverse Event|1
935926|NCT00873041|3083830|P2|Extension Study|Adverse Event|0
935927|NCT00873041|3083831|P1|Extension Study|Adverse Event|1
935928|NCT00873041|3083829|P3|Core Study|Protocol deviation|1
935929|NCT00873041|3083830|P2|Core Study|Protocol deviation|0
935930|NCT00873041|3083831|P1|Core Study|Protocol deviation|1
935931|NCT00873041|3083829|P3|Core Study|Abnormal laboratory value|1
935932|NCT00873041|3083830|P2|Core Study|Abnormal laboratory value|0
935933|NCT00873041|3083831|P1|Core Study|Abnormal laboratory value|0
935934|NCT00873041|3083829|P3|Core Study|Lost to Follow-up|0
935935|NCT00873041|3083830|P2|Core Study|Lost to Follow-up|1
935936|NCT00873041|3083831|P1|Core Study|Lost to Follow-up|3
935937|NCT00873041|3083829|P3|Core Study|Withdrawal by Subject|2
935938|NCT00873041|3083830|P2|Core Study|Withdrawal by Subject|2
935939|NCT00873041|3083831|P1|Core Study|Withdrawal by Subject|1
935940|NCT00873041|3083829|P3|Core Study|Adverse Event|1
935941|NCT00873041|3083830|P2|Core Study|Adverse Event|3
935942|NCT00873041|3083831|P1|Core Study|Adverse Event|2
935943|NCT00873015|3083889|P4|Overall Study|Withdrawal by Subject|0
935944|NCT00873015|3083890|P3|Overall Study|Withdrawal by Subject|0
935945|NCT00873015|3083891|P2|Overall Study|Withdrawal by Subject|1
935946|NCT00873015|3083892|P1|Overall Study|Withdrawal by Subject|0
935947|NCT00872989|3083901|P2|Overall Study|Not protocol specified|8
935948|NCT00872989|3083902|P1|Overall Study|Not protocol specified|3
935949|NCT00872989|3083901|P2|Overall Study|Progression/relapse|35
935950|NCT00872989|3083902|P1|Overall Study|Progression/relapse|47
935951|NCT00872989|3083901|P2|Overall Study|Withdrawal by Subject|5
935952|NCT00872989|3083902|P1|Overall Study|Withdrawal by Subject|8
935953|NCT00872989|3083901|P2|Overall Study|Adverse Event|15
935954|NCT00872989|3083902|P1|Overall Study|Adverse Event|7
935955|NCT00872898|3083921|P2|Part Two - Double Blind|Other reasons|0
935956|NCT00872898|3083922|P1|Part Two - Double Blind|Other reasons|2
935957|NCT00872898|3083921|P2|Part Two - Double Blind|Lost to Follow-up|2
935958|NCT00872898|3083922|P1|Part Two - Double Blind|Lost to Follow-up|0
935959|NCT00872898|3083921|P2|Part Two - Double Blind|Withdrawal by Subject|1
935960|NCT00872898|3083922|P1|Part Two - Double Blind|Withdrawal by Subject|3
935961|NCT00872898|3083921|P2|Part Two - Double Blind|Protocol Violation|0
935962|NCT00872898|3083922|P1|Part Two - Double Blind|Protocol Violation|1
935963|NCT00872898|3083921|P2|Part Two - Double Blind|Lack of Efficacy|0
935964|NCT00872898|3083922|P1|Part Two - Double Blind|Lack of Efficacy|1
935965|NCT00872898|3083921|P2|Part Two - Double Blind|Adverse Event|3
935966|NCT00872898|3083922|P1|Part Two - Double Blind|Adverse Event|4
935967|NCT00872599|3083996|P2|Second Washout Period|Adverse Event|1
935968|NCT00872599|3083997|P1|Second Washout Period|Adverse Event|1
935969|NCT00872521|3084017|P3|Secondary Endpoint Analysis|Efficacy data unavailable|1
935970|NCT00872521|3084018|P2|Secondary Endpoint Analysis|Efficacy data unavailable|2
935971|NCT00872521|3084019|P1|Secondary Endpoint Analysis|Efficacy data unavailable|0
935972|NCT00872521|3084017|P3|Completed 3-month Follow up|Physician Decision|0
935973|NCT00872521|3084018|P2|Completed 3-month Follow up|Physician Decision|1
935974|NCT00872521|3084019|P1|Completed 3-month Follow up|Physician Decision|0
935975|NCT00872521|3084017|P3|Completed 3-month Follow up|Not specified|0
935976|NCT00872521|3084018|P2|Completed 3-month Follow up|Not specified|2
935977|NCT00872521|3084019|P1|Completed 3-month Follow up|Not specified|0
935978|NCT00872521|3084017|P3|Primary Endpoint Analysis|Patient response missing|1
935979|NCT00872521|3084018|P2|Primary Endpoint Analysis|Patient response missing|0
935980|NCT00872521|3084019|P1|Primary Endpoint Analysis|Patient response missing|0
935981|NCT00872521|3084017|P3|Primary Endpoint Analysis|Efficacy data unavailable|0
935982|NCT00872521|3084018|P2|Primary Endpoint Analysis|Efficacy data unavailable|2
935983|NCT00872521|3084019|P1|Primary Endpoint Analysis|Efficacy data unavailable|0
935984|NCT00872521|3084017|P3|Primary Endpoint Analysis|Patient choice|0
935985|NCT00872521|3084018|P2|Primary Endpoint Analysis|Patient choice|1
935986|NCT00872521|3084019|P1|Primary Endpoint Analysis|Patient choice|0
935987|NCT00872521|3084017|P3|Primary Endpoint Analysis|Not specified|0
935988|NCT00872521|3084018|P2|Primary Endpoint Analysis|Not specified|2
935989|NCT00872521|3084019|P1|Primary Endpoint Analysis|Not specified|1
935990|NCT00872521|3084017|P3|Completed PAD Induction|Death|0
935991|NCT00872521|3084018|P2|Completed PAD Induction|Death|1
935992|NCT00872521|3084019|P1|Completed PAD Induction|Death|1
935993|NCT00872521|3084017|P3|Completed PAD Induction|Adverse Event|0
935994|NCT00872521|3084018|P2|Completed PAD Induction|Adverse Event|0
935995|NCT00872521|3084019|P1|Completed PAD Induction|Adverse Event|4
935996|NCT00872521|3084017|P3|Completed PAD Induction|Disease progression|0
935997|NCT00872521|3084018|P2|Completed PAD Induction|Disease progression|2
935998|NCT00872521|3084019|P1|Completed PAD Induction|Disease progression|0
935999|NCT00872521|3084017|P3|Completed PAD Induction|Patient choice|0
936000|NCT00872521|3084018|P2|Completed PAD Induction|Patient choice|1
936001|NCT00872521|3084019|P1|Completed PAD Induction|Patient choice|0
936002|NCT00872170|3084090|P2|Overall Study|Adverse Event|0
936003|NCT00872170|3084091|P1|Overall Study|Adverse Event|1
936004|NCT00872001|3084121|P2|Overall Study|Administrative|15
936005|NCT00872001|3084122|P1|Overall Study|Administrative|23
936006|NCT00872001|3084121|P2|Overall Study|Did Not Meet Protocol Eligibility|36
936007|NCT00872001|3084122|P1|Overall Study|Did Not Meet Protocol Eligibility|38
936008|NCT00872001|3084121|P2|Overall Study|Protocol Violation|8
936009|NCT00872001|3084122|P1|Overall Study|Protocol Violation|5
936010|NCT00872001|3084121|P2|Overall Study|Withdrawal by Subject|30
936011|NCT00872001|3084122|P1|Overall Study|Withdrawal by Subject|18
936012|NCT00872001|3084121|P2|Overall Study|Lost to Follow-up|12
936013|NCT00872001|3084122|P1|Overall Study|Lost to Follow-up|13
936014|NCT00872001|3084121|P2|Overall Study|Protocol Defined Clinical Event|7
936015|NCT00872001|3084122|P1|Overall Study|Protocol Defined Clinical Event|5
936016|NCT00872001|3084121|P2|Overall Study|Adverse Event|23
936017|NCT00872001|3084122|P1|Overall Study|Adverse Event|34
936018|NCT00871975|3084130|P1|Overall Study|Motion artifact, tracing uninterpretable|5
936019|NCT00871975|3084130|P1|Overall Study|Patient unable to void/insufficient vol|13
936020|NCT00871975|3084130|P1|Overall Study|Catheters could not be inserted|1
936021|NCT00871975|3084130|P1|Overall Study|Technical difficulty w155-1ith equipment|3
936022|NCT00871871|3084136|P4|Part II|Protocol Violation|1
936023|NCT00871871|3084137|P3|Part II|Protocol Violation|0
936024|NCT00871871|3084138|P2|Part II|Protocol Violation|0
936025|NCT00871871|3084139|P1|Part II|Protocol Violation|0
936026|NCT00871871|3084136|P4|Part II|Adverse Event|2
936027|NCT00871871|3084137|P3|Part II|Adverse Event|1
936028|NCT00871871|3084138|P2|Part II|Adverse Event|0
936029|NCT00871871|3084139|P1|Part II|Adverse Event|0
936030|NCT00871871|3084136|P4|Part II|Withdrawal by Subject|1
936031|NCT00871871|3084137|P3|Part II|Withdrawal by Subject|2
936032|NCT00871871|3084138|P2|Part II|Withdrawal by Subject|0
936033|NCT00871871|3084139|P1|Part II|Withdrawal by Subject|0
936034|NCT00871871|3084136|P4|Part II|Lack of Efficacy|0
936035|NCT00871871|3084137|P3|Part II|Lack of Efficacy|1
936036|NCT00871871|3084138|P2|Part II|Lack of Efficacy|0
936037|NCT00871871|3084139|P1|Part II|Lack of Efficacy|0
936038|NCT00871871|3084136|P4|Part I|Laboratory abnormality|0
936039|NCT00871871|3084137|P3|Part I|Laboratory abnormality|0
936040|NCT00871871|3084138|P2|Part I|Laboratory abnormality|1
936041|NCT00871871|3084139|P1|Part I|Laboratory abnormality|0
936042|NCT00871871|3084136|P4|Part I|Withdrawal by Subject|0
936043|NCT00871871|3084137|P3|Part I|Withdrawal by Subject|0
936044|NCT00871871|3084138|P2|Part I|Withdrawal by Subject|0
936045|NCT00871871|3084139|P1|Part I|Withdrawal by Subject|3
936046|NCT00871871|3084136|P4|Part I|Adverse Event|0
936047|NCT00871871|3084137|P3|Part I|Adverse Event|0
936048|NCT00871871|3084138|P2|Part I|Adverse Event|2
936049|NCT00871871|3084139|P1|Part I|Adverse Event|0
936050|NCT00871780|3084176|P1|Overall Study|Physician Decision|1
936051|NCT00871780|3084176|P1|Overall Study|Death|1
936052|NCT00871780|3084176|P1|Overall Study|Voluntary Discontinuation|4
936053|NCT00871780|3084176|P1|Overall Study|Adverse Event|6
936054|NCT00871780|3084176|P1|Overall Study|Withdrawal by Subject|9
936055|NCT00871780|3084176|P1|Overall Study|Enrolled But Not Treated|6
936056|NCT00871741|3084196|P2|Overall Study|Premature study termination|7
936057|NCT00871741|3084197|P1|Overall Study|Premature study termination|9
936058|NCT00871728|3084211|P1|Overall Study|Withdrawal of Informed Consent|5
936059|NCT00871728|3084211|P1|Overall Study|Participant Non-compliance|1
936060|NCT00871728|3084211|P1|Overall Study|Failed to Visit Hospital|4
936061|NCT00871728|3084211|P1|Overall Study|Lost to Follow-up|2
936062|NCT00871728|3084211|P1|Overall Study|Protocol Violation|7
936063|NCT00871728|3084211|P1|Overall Study|Adverse Event|1
936064|NCT00871715|3084224|P3|Overall Study|Lost to Follow-up|9
936065|NCT00871715|3084225|P2|Overall Study|Lost to Follow-up|6
936066|NCT00871715|3084226|P1|Overall Study|Lost to Follow-up|3
936067|NCT00871715|3084224|P3|Overall Study|Physician Decision|2
936068|NCT00871715|3084225|P2|Overall Study|Physician Decision|0
936069|NCT00871715|3084226|P1|Overall Study|Physician Decision|6
936070|NCT00871715|3084224|P3|Overall Study|Withdrawal by Subject|15
936071|NCT00871715|3084225|P2|Overall Study|Withdrawal by Subject|10
936072|NCT00871715|3084226|P1|Overall Study|Withdrawal by Subject|6
936073|NCT00871572|3084270|P4|Overall Study|Withdrawal by Subject|1
936074|NCT00871572|3084271|P3|Overall Study|Withdrawal by Subject|3
936075|NCT00871572|3084272|P2|Overall Study|Withdrawal by Subject|2
936076|NCT00871572|3084273|P1|Overall Study|Withdrawal by Subject|1
936077|NCT00871572|3084270|P4|Overall Study|Sponsor Decision|0
936078|NCT00871572|3084271|P3|Overall Study|Sponsor Decision|0
936079|NCT00871572|3084272|P2|Overall Study|Sponsor Decision|0
936080|NCT00871572|3084273|P1|Overall Study|Sponsor Decision|1
936081|NCT00871572|3084270|P4|Overall Study|Protocol Violation|1
936082|NCT00871572|3084271|P3|Overall Study|Protocol Violation|1
936083|NCT00871572|3084272|P2|Overall Study|Protocol Violation|0
936084|NCT00871572|3084273|P1|Overall Study|Protocol Violation|0
936085|NCT00871572|3084270|P4|Overall Study|Lost to Follow-up|1
936086|NCT00871572|3084271|P3|Overall Study|Lost to Follow-up|0
936087|NCT00871572|3084272|P2|Overall Study|Lost to Follow-up|1
936088|NCT00871572|3084273|P1|Overall Study|Lost to Follow-up|0
936089|NCT00871572|3084270|P4|Overall Study|Investigator Decision|1
936090|NCT00871572|3084271|P3|Overall Study|Investigator Decision|0
936091|NCT00871572|3084272|P2|Overall Study|Investigator Decision|1
936092|NCT00871572|3084273|P1|Overall Study|Investigator Decision|0
936093|NCT00871572|3084270|P4|Overall Study|Adverse Event|3
936094|NCT00871572|3084271|P3|Overall Study|Adverse Event|0
936095|NCT00871572|3084272|P2|Overall Study|Adverse Event|2
936096|NCT00871572|3084273|P1|Overall Study|Adverse Event|0
936097|NCT00871494|3084343|P1|Overall Study|Lost to Follow-up|1
936098|NCT00871494|3084343|P1|Overall Study|Adverse Event|4
936099|NCT00871494|3084343|P1|Overall Study|Lack of Efficacy|4
936100|NCT00871494|3084343|P1|Overall Study|Protocol Violation|5
936101|NCT00871429|3084350|P1|Overall Study|Questionnaire not completed|1
936102|NCT00871429|3084350|P1|Overall Study|Withdrawal by Subject|17
936103|NCT00871429|3084350|P1|Overall Study|Lost to Follow-up|6
936104|NCT00871403|3084361|P3|Monotherapy Treatment Phase|Adverse Event|0
936105|NCT00871403|3084362|P2|Monotherapy Treatment Phase|Adverse Event|4
936106|NCT00871403|3084363|P1|Monotherapy Treatment Phase|Adverse Event|0
936107|NCT00871403|3084361|P3|Monotherapy Treatment Phase|Disease Progression|1
936108|NCT00871403|3084362|P2|Monotherapy Treatment Phase|Disease Progression|9
936109|NCT00871403|3084363|P1|Monotherapy Treatment Phase|Disease Progression|0
936110|NCT00871403|3084361|P3|Combination Treatment Phase|Physician Decision|3
936111|NCT00871403|3084362|P2|Combination Treatment Phase|Physician Decision|1
936112|NCT00871403|3084363|P1|Combination Treatment Phase|Physician Decision|0
936113|NCT00871403|3084361|P3|Combination Treatment Phase|Withdrawal by Subject|1
936114|NCT00871403|3084362|P2|Combination Treatment Phase|Withdrawal by Subject|3
936115|NCT00871403|3084363|P1|Combination Treatment Phase|Withdrawal by Subject|0
936116|NCT00871403|3084361|P3|Combination Treatment Phase|Disease Progression|5
936117|NCT00871403|3084362|P2|Combination Treatment Phase|Disease Progression|8
936118|NCT00871403|3084363|P1|Combination Treatment Phase|Disease Progression|0
936119|NCT00871403|3084361|P3|Combination Treatment Phase|Adverse Event|2
936120|NCT00871403|3084362|P2|Combination Treatment Phase|Adverse Event|17
936121|NCT00871403|3084363|P1|Combination Treatment Phase|Adverse Event|0
936122|NCT00871403|3084361|P3|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0
936123|NCT00871403|3084362|P2|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19
936124|NCT00871403|3084363|P1|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8
936125|NCT00871403|3084361|P3|Combination Treatment Phase|Randomized but Not Treated|1
936126|NCT00871403|3084362|P2|Combination Treatment Phase|Randomized but Not Treated|1
936127|NCT00871403|3084363|P1|Combination Treatment Phase|Randomized but Not Treated|1
936128|NCT00871377|3084376|P6|Third Intervention (10 Weeks)|Death|0
936129|NCT00871377|3084377|P5|Third Intervention (10 Weeks)|Death|0
936130|NCT00871377|3084378|P4|Third Intervention (10 Weeks)|Death|1
936131|NCT00871377|3084379|P3|Third Intervention (10 Weeks)|Death|0
936132|NCT00871377|3084380|P2|Third Intervention (10 Weeks)|Death|0
936133|NCT00871377|3084381|P1|Third Intervention (10 Weeks)|Death|0
936134|NCT00871377|3084376|P6|Washout (6 Weeks)|Withdrawal by Subject|1
936135|NCT00871377|3084377|P5|Washout (6 Weeks)|Withdrawal by Subject|0
936136|NCT00871377|3084378|P4|Washout (6 Weeks)|Withdrawal by Subject|0
936137|NCT00871377|3084379|P3|Washout (6 Weeks)|Withdrawal by Subject|0
936138|NCT00871377|3084380|P2|Washout (6 Weeks)|Withdrawal by Subject|0
936139|NCT00871377|3084381|P1|Washout (6 Weeks)|Withdrawal by Subject|0
936140|NCT00871377|3084376|P6|Washout (6 Weeks)|Withdrawal by Subject|0
936141|NCT00871377|3084377|P5|Washout (6 Weeks)|Withdrawal by Subject|0
936142|NCT00871377|3084378|P4|Washout (6 Weeks)|Withdrawal by Subject|0
936143|NCT00871377|3084379|P3|Washout (6 Weeks)|Withdrawal by Subject|0
936144|NCT00871377|3084380|P2|Washout (6 Weeks)|Withdrawal by Subject|0
936145|NCT00871377|3084381|P1|Washout (6 Weeks)|Withdrawal by Subject|1
936146|NCT00871377|3084376|P6|First Intervention (10 Weeks)|Lost to Follow-up|1
936147|NCT00871377|3084377|P5|First Intervention (10 Weeks)|Lost to Follow-up|0
936148|NCT00871377|3084378|P4|First Intervention (10 Weeks)|Lost to Follow-up|0
936149|NCT00871377|3084379|P3|First Intervention (10 Weeks)|Lost to Follow-up|0
936150|NCT00871377|3084380|P2|First Intervention (10 Weeks)|Lost to Follow-up|0
936151|NCT00871377|3084381|P1|First Intervention (10 Weeks)|Lost to Follow-up|0
936152|NCT00871377|3084376|P6|First Intervention (10 Weeks)|Withdrawal by Subject|0
936153|NCT00871377|3084377|P5|First Intervention (10 Weeks)|Withdrawal by Subject|0
936154|NCT00871377|3084378|P4|First Intervention (10 Weeks)|Withdrawal by Subject|0
936155|NCT00871377|3084379|P3|First Intervention (10 Weeks)|Withdrawal by Subject|1
936156|NCT00871377|3084380|P2|First Intervention (10 Weeks)|Withdrawal by Subject|0
936157|NCT00871377|3084381|P1|First Intervention (10 Weeks)|Withdrawal by Subject|0
936158|NCT00871351|3084392|P3|Overall Study|Adverse Event|0
936159|NCT00871351|3084393|P2|Overall Study|Adverse Event|1
936160|NCT00871351|3084394|P1|Overall Study|Adverse Event|3
936161|NCT00871351|3084392|P3|Overall Study|Withdrawal by Subject|0
936162|NCT00871351|3084393|P2|Overall Study|Withdrawal by Subject|0
936163|NCT00871351|3084394|P1|Overall Study|Withdrawal by Subject|1
936164|NCT00871338|3084416|P2|Prior to Booster|Lost to Follow-up|0
936165|NCT00871338|3084417|P1|Prior to Booster|Lost to Follow-up|1
936166|NCT00871338|3084416|P2|Prior to Booster|Withdrawal by Subject|3
936167|NCT00871338|3084417|P1|Prior to Booster|Withdrawal by Subject|1
936168|NCT00871234|3084506|P1|Overall Study|Lost to Follow-up|3
936169|NCT00871234|3084506|P1|Overall Study|Adverse Event|2
936170|NCT00871169|3084510|P1|Overall Study|Patient did not receive study treatment|2
936171|NCT00871169|3084510|P1|Overall Study|Protocol Violation|1
936172|NCT00871117|3084538|P2|Overall Study|Other|4
936173|NCT00871117|3084539|P1|Overall Study|Other|0
936174|NCT00871117|3084538|P2|Overall Study|Lost to Follow-up|6
936175|NCT00871117|3084539|P1|Overall Study|Lost to Follow-up|5
936176|NCT00871000|3084573|P2|Overall Study|Withdrawal by Subject|0
936177|NCT00871000|3084574|P1|Overall Study|Withdrawal by Subject|1
936178|NCT00870870|3084626|P4|Overall Study|Adverse Event|2
936179|NCT00870870|3084627|P3|Overall Study|Adverse Event|2
936180|NCT00870870|3084628|P2|Overall Study|Adverse Event|0
936181|NCT00870870|3084629|P1|Overall Study|Adverse Event|0
936182|NCT00870870|3084626|P4|Overall Study|Withdrawal by Subject|3
936183|NCT00870870|3084627|P3|Overall Study|Withdrawal by Subject|1
936184|NCT00870870|3084628|P2|Overall Study|Withdrawal by Subject|1
936185|NCT00870870|3084629|P1|Overall Study|Withdrawal by Subject|0
936186|NCT00870740|3084673|P6|Overall Study|Not Specified|5
936187|NCT00870740|3084674|P5|Overall Study|Not Specified|3
936188|NCT00870740|3084675|P4|Overall Study|Not Specified|4
936189|NCT00870740|3084676|P3|Overall Study|Not Specified|2
936190|NCT00870740|3084677|P2|Overall Study|Not Specified|5
936191|NCT00870740|3084678|P1|Overall Study|Not Specified|2
936192|NCT00870740|3084673|P6|Overall Study|Death|0
936193|NCT00870740|3084674|P5|Overall Study|Death|1
936194|NCT00870740|3084675|P4|Overall Study|Death|0
936195|NCT00870740|3084676|P3|Overall Study|Death|0
936196|NCT00870740|3084677|P2|Overall Study|Death|0
936197|NCT00870740|3084678|P1|Overall Study|Death|0
936198|NCT00870740|3084673|P6|Overall Study|Subject Non-compliance|1
936199|NCT00870740|3084674|P5|Overall Study|Subject Non-compliance|0
936200|NCT00870740|3084675|P4|Overall Study|Subject Non-compliance|0
936201|NCT00870740|3084676|P3|Overall Study|Subject Non-compliance|0
936202|NCT00870740|3084677|P2|Overall Study|Subject Non-compliance|0
936203|NCT00870740|3084678|P1|Overall Study|Subject Non-compliance|0
936204|NCT00870740|3084673|P6|Overall Study|Investigator Decision|0
936205|NCT00870740|3084674|P5|Overall Study|Investigator Decision|0
936206|NCT00870740|3084675|P4|Overall Study|Investigator Decision|0
936207|NCT00870740|3084676|P3|Overall Study|Investigator Decision|1
936208|NCT00870740|3084677|P2|Overall Study|Investigator Decision|0
936209|NCT00870740|3084678|P1|Overall Study|Investigator Decision|2
936210|NCT00870740|3084673|P6|Overall Study|Consent Withdrawn|5
936211|NCT00870740|3084674|P5|Overall Study|Consent Withdrawn|6
936212|NCT00870740|3084675|P4|Overall Study|Consent Withdrawn|6
936213|NCT00870740|3084676|P3|Overall Study|Consent Withdrawn|4
936214|NCT00870740|3084677|P2|Overall Study|Consent Withdrawn|3
936215|NCT00870740|3084678|P1|Overall Study|Consent Withdrawn|6
936216|NCT00870740|3084673|P6|Overall Study|Adverse Event|6
936217|NCT00870740|3084674|P5|Overall Study|Adverse Event|1
936218|NCT00870740|3084675|P4|Overall Study|Adverse Event|2
936219|NCT00870740|3084676|P3|Overall Study|Adverse Event|3
936220|NCT00870740|3084677|P2|Overall Study|Adverse Event|1
936221|NCT00870740|3084678|P1|Overall Study|Adverse Event|2
936222|NCT00870727|3084754|P2|Overall Study|Adverse Event|1
936223|NCT00870727|3084755|P1|Overall Study|Adverse Event|0
936224|NCT00870727|3084754|P2|Overall Study|Lack of Efficacy|3
936225|NCT00870727|3084755|P1|Overall Study|Lack of Efficacy|1
936226|NCT00870727|3084754|P2|Overall Study|Lost to Follow-up|1
936227|NCT00870727|3084755|P1|Overall Study|Lost to Follow-up|0
936228|NCT00870688|3084771|P1|Overall Study|Granules in the Stools|1
936229|NCT00870688|3084771|P1|Overall Study|Death, Unrelated|1
936230|NCT00870688|3084771|P1|Overall Study|Lost to Follow-up|2
936231|NCT00870584|3084776|P2|Overall Study|Protocol Deviation|2
936232|NCT00870584|3084777|P1|Overall Study|Protocol Deviation|2
936233|NCT00870584|3084776|P2|Overall Study|Lost to Follow-up|1
936234|NCT00870584|3084777|P1|Overall Study|Lost to Follow-up|5
936235|NCT00870584|3084776|P2|Overall Study|Withdrawal by Subject|7
936236|NCT00870584|3084777|P1|Overall Study|Withdrawal by Subject|6
936237|NCT00870584|3084776|P2|Overall Study|Adverse Event|3
936238|NCT00870584|3084777|P1|Overall Study|Adverse Event|3
936239|NCT00870233|3084886|P1|Overall Study|Death|1
936240|NCT00870233|3084886|P1|Overall Study|Incompatible internet browser|2
936241|NCT00870233|3084886|P1|Overall Study|Did not undergo laparotomy|3
936242|NCT00870233|3084886|P1|Overall Study|Withdrawal by Subject|18
936243|NCT00870194|3084895|P2|Overall Study|Subject Decision|2
936244|NCT00870194|3084896|P1|Overall Study|Subject Decision|7
936245|NCT00870194|3084895|P2|Overall Study|Entry Criteria Not Met|2
936246|NCT00870194|3084896|P1|Overall Study|Entry Criteria Not Met|1
936247|NCT00870194|3084895|P2|Overall Study|Protocol Violation|3
936248|NCT00870194|3084896|P1|Overall Study|Protocol Violation|3
936249|NCT00870194|3084895|P2|Overall Study|Physician Decision|1
936250|NCT00870194|3084896|P1|Overall Study|Physician Decision|3
936251|NCT00870194|3084895|P2|Overall Study|Lost to Follow-up|0
936252|NCT00870194|3084896|P1|Overall Study|Lost to Follow-up|2
936253|NCT00870194|3084895|P2|Overall Study|Lack of Efficacy|1
936254|NCT00870194|3084896|P1|Overall Study|Lack of Efficacy|0
936255|NCT00870194|3084895|P2|Overall Study|Adverse Event|5
936256|NCT00870194|3084896|P1|Overall Study|Adverse Event|10
936257|NCT00870103|3084934|P1|Overall Study|Lost to Follow-up|2
936258|NCT00870103|3084934|P1|Overall Study|Physician Decision|2
936259|NCT00869999|3084939|P1|Overall Study|removed prior to starting therapy|1
936260|NCT00869999|3084939|P1|Overall Study|Withdrawal by Subject|1
936261|NCT00869960|3084945|P1|Overall Study|Lost to Follow-up|2
936262|NCT00869778|3084994|P3|Overall Study|Unblinding|0
936263|NCT00869778|3084995|P2|Overall Study|Unblinding|0
936264|NCT00869778|3084996|P1|Overall Study|Unblinding|1
936265|NCT00869778|3084994|P3|Overall Study|Protocol Violation|5
936266|NCT00869778|3084995|P2|Overall Study|Protocol Violation|3
936267|NCT00869778|3084996|P1|Overall Study|Protocol Violation|5
936268|NCT00869778|3084994|P3|Overall Study|Pregnancy|0
936269|NCT00869778|3084995|P2|Overall Study|Pregnancy|0
936270|NCT00869778|3084996|P1|Overall Study|Pregnancy|1
936271|NCT00869778|3084994|P3|Overall Study|Withdrawal by Subject|5
936272|NCT00869778|3084995|P2|Overall Study|Withdrawal by Subject|4
936273|NCT00869778|3084996|P1|Overall Study|Withdrawal by Subject|3
936274|NCT00869778|3084994|P3|Overall Study|Adverse Event|0
936275|NCT00869778|3084995|P2|Overall Study|Adverse Event|0
936276|NCT00869778|3084996|P1|Overall Study|Adverse Event|2
936277|NCT00869557|3085071|P2|Extension Phase|Withdrew Consent|0
936278|NCT00869557|3085072|P1|Extension Phase|Withdrew Consent|2
936279|NCT00869557|3085071|P2|Extension Phase|Investigator's Discretion|0
936280|NCT00869557|3085072|P1|Extension Phase|Investigator's Discretion|2
936281|NCT00869557|3085071|P2|Extension Phase|Lost to Follow-up|1
936282|NCT00869557|3085072|P1|Extension Phase|Lost to Follow-up|3
936283|NCT00869557|3085071|P2|Extension Phase|Lack of Efficacy|0
936284|NCT00869557|3085072|P1|Extension Phase|Lack of Efficacy|1
936285|NCT00869557|3085071|P2|Extension Phase|Adverse Event|2
936286|NCT00869557|3085072|P1|Extension Phase|Adverse Event|2
936287|NCT00869557|3085071|P2|Randomized Phase|Withdrew Consent|1
936288|NCT00869557|3085072|P1|Randomized Phase|Withdrew Consent|0
936289|NCT00869557|3085071|P2|Randomized Phase|Investigator's Discretion|0
936290|NCT00869557|3085072|P1|Randomized Phase|Investigator's Discretion|1
936291|NCT00869557|3085071|P2|Randomized Phase|Lost to Follow-up|1
936292|NCT00869557|3085072|P1|Randomized Phase|Lost to Follow-up|2
936293|NCT00869518|3085091|P2|Overall Study|Lost to Follow-up|1
936294|NCT00869518|3085092|P1|Overall Study|Lost to Follow-up|1
936295|NCT00869401|3085120|P5|Overall Study|Withdrawal by Subject|3
936296|NCT00869401|3085121|P4|Overall Study|Withdrawal by Subject|5
936297|NCT00869401|3085122|P3|Overall Study|Withdrawal by Subject|0
936298|NCT00869401|3085123|P2|Overall Study|Withdrawal by Subject|0
936299|NCT00869401|3085124|P1|Overall Study|Withdrawal by Subject|0
936300|NCT00869362|3085153|P2|Overall Study|Lost to Follow-up|3
936301|NCT00869362|3085154|P1|Overall Study|Lost to Follow-up|1
936302|NCT00869362|3085153|P2|Overall Study|Death|2
936303|NCT00869362|3085154|P1|Overall Study|Death|0
936304|NCT00869323|3085175|P1|Maintenance Therapy|concurrent illness|1
936305|NCT00869258|3085183|P1|Overall Study|Physician Decision|1
936306|NCT00869128|3085248|P2|Overall Study|lack of Compliance|6
936307|NCT00869128|3085249|P1|Overall Study|lack of Compliance|6
936308|NCT00869089|3085253|P1|Overall Study|Screen Fail|1
936309|NCT00869089|3085253|P1|Overall Study|Withdrawal by Subject|1
936310|NCT00869089|3085253|P1|Overall Study|Lost to Follow-up|1
936311|NCT00869050|3085257|P1|Overall Study|Screen Failure|3
936312|NCT00868998|3085262|P1|Overall Study|Death|1
936313|NCT00868998|3085262|P1|Overall Study|Progression of disease|2
936314|NCT00868998|3085262|P1|Overall Study|Withdrawal by Subject|1
936315|NCT00868998|3085262|P1|Overall Study|Screen Failure|1
936316|NCT00868790|3085273|P14|Post-study|Excluded Medication|0
936317|NCT00868790|3085274|P13|Post-study|Excluded Medication|0
936318|NCT00868790|3085275|P12|Post-study|Excluded Medication|0
936319|NCT00868790|3085276|P11|Post-study|Excluded Medication|0
936320|NCT00868790|3085277|P10|Post-study|Excluded Medication|1
936321|NCT00868790|3085278|P9|Post-study|Excluded Medication|0
936322|NCT00868790|3085279|P8|Post-study|Excluded Medication|2
936323|NCT00868790|3085280|P7|Post-study|Excluded Medication|0
936324|NCT00868790|3085281|P6|Post-study|Excluded Medication|0
936325|NCT00868790|3085282|P5|Post-study|Excluded Medication|0
936326|NCT00868790|3085283|P4|Post-study|Excluded Medication|0
936327|NCT00868790|3085284|P3|Post-study|Excluded Medication|0
936328|NCT00868790|3085285|P2|Post-study|Excluded Medication|0
936329|NCT00868790|3085286|P1|Post-study|Excluded Medication|0
936330|NCT00868790|3085273|P14|Post-study|Withdrawal by Subject|0
936331|NCT00868790|3085274|P13|Post-study|Withdrawal by Subject|0
936332|NCT00868790|3085275|P12|Post-study|Withdrawal by Subject|0
936333|NCT00868790|3085276|P11|Post-study|Withdrawal by Subject|0
936334|NCT00868790|3085277|P10|Post-study|Withdrawal by Subject|0
936335|NCT00868790|3085278|P9|Post-study|Withdrawal by Subject|0
936336|NCT00868790|3085279|P8|Post-study|Withdrawal by Subject|0
936337|NCT00868790|3085280|P7|Post-study|Withdrawal by Subject|0
936338|NCT00868790|3085281|P6|Post-study|Withdrawal by Subject|0
936339|NCT00868790|3085282|P5|Post-study|Withdrawal by Subject|1
936340|NCT00868790|3085283|P4|Post-study|Withdrawal by Subject|0
936341|NCT00868790|3085284|P3|Post-study|Withdrawal by Subject|0
936342|NCT00868790|3085285|P2|Post-study|Withdrawal by Subject|0
936343|NCT00868790|3085286|P1|Post-study|Withdrawal by Subject|0
936344|NCT00868790|3085273|P14|Period 4|Abnormal ALT/AST|0
936345|NCT00868790|3085274|P13|Period 4|Abnormal ALT/AST|0
936346|NCT00868790|3085275|P12|Period 4|Abnormal ALT/AST|0
936347|NCT00868790|3085276|P11|Period 4|Abnormal ALT/AST|0
936348|NCT00868790|3085277|P10|Period 4|Abnormal ALT/AST|0
936349|NCT00868790|3085278|P9|Period 4|Abnormal ALT/AST|0
936350|NCT00868790|3085279|P8|Period 4|Abnormal ALT/AST|0
936351|NCT00868790|3085280|P7|Period 4|Abnormal ALT/AST|0
936352|NCT00868790|3085281|P6|Period 4|Abnormal ALT/AST|0
936353|NCT00868790|3085282|P5|Period 4|Abnormal ALT/AST|0
936354|NCT00868790|3085283|P4|Period 4|Abnormal ALT/AST|0
936355|NCT00868790|3085284|P3|Period 4|Abnormal ALT/AST|1
936356|NCT00868790|3085285|P2|Period 4|Abnormal ALT/AST|0
936357|NCT00868790|3085286|P1|Period 4|Abnormal ALT/AST|0
936358|NCT00868790|3085273|P14|Period 4|Study Terminated by Sponsor|1
936359|NCT00868790|3085274|P13|Period 4|Study Terminated by Sponsor|0
936360|NCT00868790|3085275|P12|Period 4|Study Terminated by Sponsor|1
936361|NCT00868790|3085276|P11|Period 4|Study Terminated by Sponsor|2
936362|NCT00868790|3085277|P10|Period 4|Study Terminated by Sponsor|0
936363|NCT00868790|3085278|P9|Period 4|Study Terminated by Sponsor|2
936364|NCT00868790|3085279|P8|Period 4|Study Terminated by Sponsor|1
936365|NCT00868790|3085280|P7|Period 4|Study Terminated by Sponsor|0
936366|NCT00868790|3085281|P6|Period 4|Study Terminated by Sponsor|0
936367|NCT00868790|3085282|P5|Period 4|Study Terminated by Sponsor|0
936368|NCT00868790|3085283|P4|Period 4|Study Terminated by Sponsor|0
936369|NCT00868790|3085284|P3|Period 4|Study Terminated by Sponsor|0
936370|NCT00868790|3085285|P2|Period 4|Study Terminated by Sponsor|0
936371|NCT00868790|3085286|P1|Period 4|Study Terminated by Sponsor|2
936372|NCT00868790|3085273|P14|Period 4|Lost to Follow-up|0
936373|NCT00868790|3085274|P13|Period 4|Lost to Follow-up|0
936374|NCT00868790|3085275|P12|Period 4|Lost to Follow-up|0
936375|NCT00868790|3085276|P11|Period 4|Lost to Follow-up|0
936376|NCT00868790|3085277|P10|Period 4|Lost to Follow-up|0
936377|NCT00868790|3085278|P9|Period 4|Lost to Follow-up|0
936378|NCT00868790|3085279|P8|Period 4|Lost to Follow-up|1
936379|NCT00868790|3085280|P7|Period 4|Lost to Follow-up|0
936380|NCT00868790|3085281|P6|Period 4|Lost to Follow-up|0
936381|NCT00868790|3085282|P5|Period 4|Lost to Follow-up|0
936382|NCT00868790|3085283|P4|Period 4|Lost to Follow-up|0
936383|NCT00868790|3085284|P3|Period 4|Lost to Follow-up|0
936384|NCT00868790|3085285|P2|Period 4|Lost to Follow-up|0
936385|NCT00868790|3085286|P1|Period 4|Lost to Follow-up|0
936386|NCT00868790|3085273|P14|Period 4|Adverse Event|0
936387|NCT00868790|3085274|P13|Period 4|Adverse Event|1
936388|NCT00868790|3085275|P12|Period 4|Adverse Event|0
936389|NCT00868790|3085276|P11|Period 4|Adverse Event|1
936390|NCT00868790|3085277|P10|Period 4|Adverse Event|0
936391|NCT00868790|3085278|P9|Period 4|Adverse Event|0
936392|NCT00868790|3085279|P8|Period 4|Adverse Event|1
936393|NCT00868790|3085280|P7|Period 4|Adverse Event|0
936394|NCT00868790|3085281|P6|Period 4|Adverse Event|0
936395|NCT00868790|3085282|P5|Period 4|Adverse Event|0
936396|NCT00868790|3085283|P4|Period 4|Adverse Event|0
936397|NCT00868790|3085284|P3|Period 4|Adverse Event|0
936398|NCT00868790|3085285|P2|Period 4|Adverse Event|0
936399|NCT00868790|3085286|P1|Period 4|Adverse Event|0
936400|NCT00868790|3085273|P14|Period 3|Study Terminated by Sponsor|0
936401|NCT00868790|3085274|P13|Period 3|Study Terminated by Sponsor|0
936402|NCT00868790|3085275|P12|Period 3|Study Terminated by Sponsor|0
936403|NCT00868790|3085276|P11|Period 3|Study Terminated by Sponsor|0
936404|NCT00868790|3085277|P10|Period 3|Study Terminated by Sponsor|0
936405|NCT00868790|3085278|P9|Period 3|Study Terminated by Sponsor|0
936406|NCT00868790|3085279|P8|Period 3|Study Terminated by Sponsor|0
936407|NCT00868790|3085280|P7|Period 3|Study Terminated by Sponsor|0
936408|NCT00868790|3085281|P6|Period 3|Study Terminated by Sponsor|0
936409|NCT00868790|3085282|P5|Period 3|Study Terminated by Sponsor|0
936410|NCT00868790|3085283|P4|Period 3|Study Terminated by Sponsor|1
936411|NCT00868790|3085284|P3|Period 3|Study Terminated by Sponsor|0
936412|NCT00868790|3085285|P2|Period 3|Study Terminated by Sponsor|0
936413|NCT00868790|3085286|P1|Period 3|Study Terminated by Sponsor|0
936414|NCT00868790|3085273|P14|Period 3|Protocol Violation|0
936415|NCT00868790|3085274|P13|Period 3|Protocol Violation|0
936416|NCT00868790|3085275|P12|Period 3|Protocol Violation|0
936417|NCT00868790|3085276|P11|Period 3|Protocol Violation|1
936418|NCT00868790|3085277|P10|Period 3|Protocol Violation|0
936419|NCT00868790|3085278|P9|Period 3|Protocol Violation|0
936420|NCT00868790|3085279|P8|Period 3|Protocol Violation|0
936421|NCT00868790|3085280|P7|Period 3|Protocol Violation|0
936422|NCT00868790|3085281|P6|Period 3|Protocol Violation|0
936423|NCT00868790|3085282|P5|Period 3|Protocol Violation|0
936424|NCT00868790|3085283|P4|Period 3|Protocol Violation|0
936425|NCT00868790|3085284|P3|Period 3|Protocol Violation|0
936426|NCT00868790|3085285|P2|Period 3|Protocol Violation|0
936427|NCT00868790|3085286|P1|Period 3|Protocol Violation|0
936428|NCT00868790|3085273|P14|Period 3|Adverse Event|0
936429|NCT00868790|3085274|P13|Period 3|Adverse Event|0
936430|NCT00868790|3085275|P12|Period 3|Adverse Event|0
936431|NCT00868790|3085276|P11|Period 3|Adverse Event|0
936432|NCT00868790|3085277|P10|Period 3|Adverse Event|1
936433|NCT00868790|3085278|P9|Period 3|Adverse Event|0
936434|NCT00868790|3085279|P8|Period 3|Adverse Event|0
936435|NCT00868790|3085280|P7|Period 3|Adverse Event|0
936436|NCT00868790|3085281|P6|Period 3|Adverse Event|0
936437|NCT00868790|3085282|P5|Period 3|Adverse Event|0
936438|NCT00868790|3085283|P4|Period 3|Adverse Event|0
936439|NCT00868790|3085284|P3|Period 3|Adverse Event|0
936440|NCT00868790|3085285|P2|Period 3|Adverse Event|0
936441|NCT00868790|3085286|P1|Period 3|Adverse Event|0
936442|NCT00868790|3085273|P14|Period 2|Withdrawal by Subject|1
936443|NCT00868790|3085274|P13|Period 2|Withdrawal by Subject|0
936444|NCT00868790|3085275|P12|Period 2|Withdrawal by Subject|0
936445|NCT00868790|3085276|P11|Period 2|Withdrawal by Subject|0
936446|NCT00868790|3085277|P10|Period 2|Withdrawal by Subject|0
936447|NCT00868790|3085278|P9|Period 2|Withdrawal by Subject|1
936448|NCT00868790|3085279|P8|Period 2|Withdrawal by Subject|0
936449|NCT00868790|3085280|P7|Period 2|Withdrawal by Subject|0
936450|NCT00868790|3085281|P6|Period 2|Withdrawal by Subject|0
936451|NCT00868790|3085282|P5|Period 2|Withdrawal by Subject|0
936452|NCT00868790|3085283|P4|Period 2|Withdrawal by Subject|0
936453|NCT00868790|3085284|P3|Period 2|Withdrawal by Subject|0
936454|NCT00868790|3085285|P2|Period 2|Withdrawal by Subject|0
936455|NCT00868790|3085286|P1|Period 2|Withdrawal by Subject|0
936456|NCT00868790|3085273|P14|Period 2|Lost to Follow-up|0
936457|NCT00868790|3085274|P13|Period 2|Lost to Follow-up|0
936458|NCT00868790|3085275|P12|Period 2|Lost to Follow-up|0
936459|NCT00868790|3085276|P11|Period 2|Lost to Follow-up|0
936460|NCT00868790|3085277|P10|Period 2|Lost to Follow-up|0
936461|NCT00868790|3085278|P9|Period 2|Lost to Follow-up|0
936462|NCT00868790|3085279|P8|Period 2|Lost to Follow-up|0
936463|NCT00868790|3085280|P7|Period 2|Lost to Follow-up|0
936464|NCT00868790|3085281|P6|Period 2|Lost to Follow-up|1
936465|NCT00868790|3085282|P5|Period 2|Lost to Follow-up|0
936466|NCT00868790|3085283|P4|Period 2|Lost to Follow-up|0
936467|NCT00868790|3085284|P3|Period 2|Lost to Follow-up|0
936468|NCT00868790|3085285|P2|Period 2|Lost to Follow-up|1
936469|NCT00868790|3085286|P1|Period 2|Lost to Follow-up|0
936470|NCT00868790|3085273|P14|Period 2|Adverse Event|0
936471|NCT00868790|3085274|P13|Period 2|Adverse Event|0
936472|NCT00868790|3085275|P12|Period 2|Adverse Event|0
936473|NCT00868790|3085276|P11|Period 2|Adverse Event|0
936474|NCT00868790|3085277|P10|Period 2|Adverse Event|0
936475|NCT00868790|3085278|P9|Period 2|Adverse Event|1
936476|NCT00868790|3085279|P8|Period 2|Adverse Event|0
936477|NCT00868790|3085280|P7|Period 2|Adverse Event|0
936478|NCT00868790|3085281|P6|Period 2|Adverse Event|0
936479|NCT00868790|3085282|P5|Period 2|Adverse Event|0
936480|NCT00868790|3085283|P4|Period 2|Adverse Event|0
936481|NCT00868790|3085284|P3|Period 2|Adverse Event|0
936482|NCT00868790|3085285|P2|Period 2|Adverse Event|0
936483|NCT00868790|3085286|P1|Period 2|Adverse Event|0
936484|NCT00868790|3085273|P14|Period 1|Lost to Follow-up|0
936485|NCT00868790|3085274|P13|Period 1|Lost to Follow-up|0
936486|NCT00868790|3085275|P12|Period 1|Lost to Follow-up|0
936487|NCT00868790|3085276|P11|Period 1|Lost to Follow-up|0
936488|NCT00868790|3085277|P10|Period 1|Lost to Follow-up|0
936489|NCT00868790|3085278|P9|Period 1|Lost to Follow-up|0
936490|NCT00868790|3085279|P8|Period 1|Lost to Follow-up|0
936491|NCT00868790|3085280|P7|Period 1|Lost to Follow-up|0
936492|NCT00868790|3085281|P6|Period 1|Lost to Follow-up|1
936493|NCT00868790|3085282|P5|Period 1|Lost to Follow-up|0
936494|NCT00868790|3085283|P4|Period 1|Lost to Follow-up|0
936495|NCT00868790|3085284|P3|Period 1|Lost to Follow-up|0
936496|NCT00868790|3085285|P2|Period 1|Lost to Follow-up|0
936497|NCT00868790|3085286|P1|Period 1|Lost to Follow-up|0
936498|NCT00868790|3085273|P14|Period 1|Abnormal Triglycerides|0
936499|NCT00868790|3085274|P13|Period 1|Abnormal Triglycerides|0
936500|NCT00868790|3085275|P12|Period 1|Abnormal Triglycerides|0
936501|NCT00868790|3085276|P11|Period 1|Abnormal Triglycerides|0
936502|NCT00868790|3085277|P10|Period 1|Abnormal Triglycerides|0
936503|NCT00868790|3085278|P9|Period 1|Abnormal Triglycerides|0
936504|NCT00868790|3085279|P8|Period 1|Abnormal Triglycerides|0
936505|NCT00868790|3085280|P7|Period 1|Abnormal Triglycerides|0
936506|NCT00868790|3085281|P6|Period 1|Abnormal Triglycerides|0
936507|NCT00868790|3085282|P5|Period 1|Abnormal Triglycerides|1
936508|NCT00868790|3085283|P4|Period 1|Abnormal Triglycerides|0
936509|NCT00868790|3085284|P3|Period 1|Abnormal Triglycerides|0
936510|NCT00868790|3085285|P2|Period 1|Abnormal Triglycerides|0
936511|NCT00868790|3085286|P1|Period 1|Abnormal Triglycerides|0
936512|NCT00868790|3085273|P14|Period 1|Withdrawal by Subject|1
936513|NCT00868790|3085274|P13|Period 1|Withdrawal by Subject|0
936514|NCT00868790|3085275|P12|Period 1|Withdrawal by Subject|0
936515|NCT00868790|3085276|P11|Period 1|Withdrawal by Subject|0
936516|NCT00868790|3085277|P10|Period 1|Withdrawal by Subject|0
936517|NCT00868790|3085278|P9|Period 1|Withdrawal by Subject|0
936518|NCT00868790|3085279|P8|Period 1|Withdrawal by Subject|0
936519|NCT00868790|3085280|P7|Period 1|Withdrawal by Subject|0
936520|NCT00868790|3085281|P6|Period 1|Withdrawal by Subject|0
936521|NCT00868790|3085282|P5|Period 1|Withdrawal by Subject|0
936522|NCT00868790|3085283|P4|Period 1|Withdrawal by Subject|0
936523|NCT00868790|3085284|P3|Period 1|Withdrawal by Subject|0
936524|NCT00868790|3085285|P2|Period 1|Withdrawal by Subject|1
936525|NCT00868790|3085286|P1|Period 1|Withdrawal by Subject|0
936526|NCT00868790|3085273|P14|Period 1|Protocol Violation|0
936527|NCT00868790|3085274|P13|Period 1|Protocol Violation|0
936528|NCT00868790|3085275|P12|Period 1|Protocol Violation|0
936529|NCT00868790|3085276|P11|Period 1|Protocol Violation|0
936530|NCT00868790|3085277|P10|Period 1|Protocol Violation|0
936531|NCT00868790|3085278|P9|Period 1|Protocol Violation|0
936532|NCT00868790|3085279|P8|Period 1|Protocol Violation|0
936533|NCT00868790|3085280|P7|Period 1|Protocol Violation|0
936534|NCT00868790|3085281|P6|Period 1|Protocol Violation|0
936535|NCT00868790|3085282|P5|Period 1|Protocol Violation|0
936536|NCT00868790|3085283|P4|Period 1|Protocol Violation|0
936537|NCT00868790|3085284|P3|Period 1|Protocol Violation|0
936538|NCT00868790|3085285|P2|Period 1|Protocol Violation|0
936539|NCT00868790|3085286|P1|Period 1|Protocol Violation|1
936540|NCT00868790|3085273|P14|Period 1|Adverse Event|1
936541|NCT00868790|3085274|P13|Period 1|Adverse Event|0
936542|NCT00868790|3085275|P12|Period 1|Adverse Event|0
936543|NCT00868790|3085276|P11|Period 1|Adverse Event|0
936544|NCT00868790|3085277|P10|Period 1|Adverse Event|0
936545|NCT00868790|3085278|P9|Period 1|Adverse Event|1
936546|NCT00868790|3085279|P8|Period 1|Adverse Event|3
936547|NCT00868790|3085280|P7|Period 1|Adverse Event|0
936548|NCT00868790|3085281|P6|Period 1|Adverse Event|0
936549|NCT00868790|3085282|P5|Period 1|Adverse Event|0
936550|NCT00868790|3085283|P4|Period 1|Adverse Event|0
936551|NCT00868790|3085284|P3|Period 1|Adverse Event|0
936552|NCT00868790|3085285|P2|Period 1|Adverse Event|0
936553|NCT00868790|3085286|P1|Period 1|Adverse Event|1
936554|NCT00868608|3085369|P3|Overall Study|Other - Unspecified|0
936555|NCT00868608|3085370|P2|Overall Study|Other - Unspecified|0
936556|NCT00868608|3085371|P1|Overall Study|Other - Unspecified|1
936557|NCT00868608|3085369|P3|Overall Study|Death|4
936558|NCT00868608|3085370|P2|Overall Study|Death|2
936559|NCT00868608|3085371|P1|Overall Study|Death|16
936560|NCT00868608|3085369|P3|Overall Study|Lost to Follow-up|1
936561|NCT00868608|3085370|P2|Overall Study|Lost to Follow-up|0
936562|NCT00868608|3085371|P1|Overall Study|Lost to Follow-up|3
936563|NCT00868608|3085369|P3|Overall Study|Withdrawal by Subject|0
936564|NCT00868608|3085370|P2|Overall Study|Withdrawal by Subject|1
936565|NCT00868608|3085371|P1|Overall Study|Withdrawal by Subject|3
936566|NCT00868530|3085395|P1|Overall Study|Lost to Follow-up|1
936567|NCT00868530|3085395|P1|Overall Study|Adverse Event|3
936568|NCT00868517|3085410|P3|Overall Study|Protocol Violation|0
936569|NCT00868517|3085411|P2|Overall Study|Protocol Violation|1
936570|NCT00868517|3085412|P1|Overall Study|Protocol Violation|1
936571|NCT00868517|3085410|P3|Overall Study|Withdrawal by Subject|2
936572|NCT00868517|3085411|P2|Overall Study|Withdrawal by Subject|3
936573|NCT00868517|3085412|P1|Overall Study|Withdrawal by Subject|3
936574|NCT00868439|3085450|P2|Overall Study|Withdrawal by Subject|1
936575|NCT00868439|3085451|P1|Overall Study|Withdrawal by Subject|0
936576|NCT00868439|3085450|P2|Overall Study|Physician Decision|0
936577|NCT00868439|3085451|P1|Overall Study|Physician Decision|1
936578|NCT00868439|3085450|P2|Overall Study|Protocol Violation|1
936579|NCT00868439|3085451|P1|Overall Study|Protocol Violation|1
936580|NCT00868439|3085450|P2|Overall Study|Death|1
936581|NCT00868439|3085451|P1|Overall Study|Death|0
936582|NCT00868439|3085450|P2|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3
936583|NCT00868439|3085451|P1|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2
936584|NCT00868439|3085450|P2|Overall Study|Adverse Event|3
936585|NCT00868439|3085451|P1|Overall Study|Adverse Event|4
936586|NCT00868296|3085508|P2|Overall Study|Withdrawal by Subject|1
936587|NCT00868296|3085509|P1|Overall Study|Withdrawal by Subject|0
936588|NCT00868296|3085508|P2|Overall Study|Adverse Event|2
936589|NCT00868296|3085509|P1|Overall Study|Adverse Event|0
936590|NCT00868231|3085517|P6|Treatment Period 3|Adverse Event|0
936591|NCT00868231|3085518|P5|Treatment Period 3|Adverse Event|0
936592|NCT00868231|3085519|P4|Treatment Period 3|Adverse Event|0
936593|NCT00868231|3085520|P3|Treatment Period 3|Adverse Event|1
936594|NCT00868231|3085521|P2|Treatment Period 3|Adverse Event|0
936595|NCT00868231|3085522|P1|Treatment Period 3|Adverse Event|0
936596|NCT00868231|3085517|P6|Treatment Period 2|Adverse Event|0
936597|NCT00868231|3085518|P5|Treatment Period 2|Adverse Event|0
936598|NCT00868231|3085519|P4|Treatment Period 2|Adverse Event|0
936599|NCT00868231|3085520|P3|Treatment Period 2|Adverse Event|0
936600|NCT00868231|3085521|P2|Treatment Period 2|Adverse Event|0
936601|NCT00868231|3085522|P1|Treatment Period 2|Adverse Event|1
936602|NCT00868231|3085517|P6|Treatment Period 1|Adverse Event|0
936603|NCT00868231|3085518|P5|Treatment Period 1|Adverse Event|1
936604|NCT00868231|3085519|P4|Treatment Period 1|Adverse Event|0
936605|NCT00868231|3085520|P3|Treatment Period 1|Adverse Event|0
936606|NCT00868231|3085521|P2|Treatment Period 1|Adverse Event|0
936607|NCT00868231|3085522|P1|Treatment Period 1|Adverse Event|0
936608|NCT00868192|3085588|P1|Overall Study|Ineligible|4
936609|NCT00867568|3085650|P1|Overall Study|Withdrawal by Subject|1
936610|NCT00867568|3085650|P1|Overall Study|Adverse Event|4
936611|NCT00867568|3085650|P1|Overall Study|Lack of Efficacy|10
936612|NCT00867503|3085667|P1|Overall Study|Withdrawal by Subject|1
936613|NCT00867490|3085673|P1|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1
936614|NCT00867490|3085673|P1|Phase 2 - Aliskiren+HCTZ|Adverse Event|2
936615|NCT00867490|3085673|P1|Phase 1 - Candesartan+HCTZ|Administrative Problems|1
936616|NCT00867490|3085673|P1|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4
936617|NCT00867490|3085673|P1|Phase 1 - Candesartan+HCTZ|Adverse Event|5
936618|NCT00867360|3085715|P2|Overall Study|Physician Decision|1
936619|NCT00867360|3085716|P1|Overall Study|Physician Decision|0
936620|NCT00867360|3085715|P2|Overall Study|Withdrawal by Subject|0
936621|NCT00867360|3085716|P1|Overall Study|Withdrawal by Subject|1
936622|NCT00867308|3085754|P2|Overall Study|Withdrawal by Subject|2
936623|NCT00867308|3085755|P1|Overall Study|Withdrawal by Subject|1
936624|NCT00867308|3085754|P2|Overall Study|Lack of Efficacy|12
936625|NCT00867308|3085755|P1|Overall Study|Lack of Efficacy|6
936626|NCT00867308|3085754|P2|Overall Study|Adverse Event|4
936627|NCT00867308|3085755|P1|Overall Study|Adverse Event|1
936628|NCT00867308|3085754|P2|Overall Study|Death|0
936629|NCT00867308|3085755|P1|Overall Study|Death|1
936630|NCT00867165|3085774|P2|Overall Study|Withdrawal by Subject|0
936631|NCT00867165|3085775|P1|Overall Study|Withdrawal by Subject|1
936632|NCT00867165|3085774|P2|Overall Study|Adverse Event|0
936633|NCT00867165|3085775|P1|Overall Study|Adverse Event|3
936634|NCT00867113|3085923|P1|Post Treatment After Survival Follow-up|Administrative problems|4
936635|NCT00867113|3085923|P1|Post Treatment After Survival Follow-up|Lost to Follow-up|5
936636|NCT00867113|3085923|P1|Post Treatment After Survival Follow-up|Withdrawal by Subject|1
936637|NCT00867113|3085923|P1|Post Treatment After Survival Follow-up|Death|1
936638|NCT00867113|3085923|P1|Treatment Period|Protocol Violation|4
936639|NCT00867113|3085923|P1|Treatment Period|Disease progression/relapse|1
936640|NCT00867113|3085923|P1|Treatment Period|Administrative problems|1
936641|NCT00867113|3085923|P1|Treatment Period|Lost to Follow-up|3
936642|NCT00867113|3085923|P1|Treatment Period|Withdrawal by Subject|19
936643|NCT00867113|3085923|P1|Treatment Period|Death|2
936644|NCT00867113|3085923|P1|Treatment Period|Adverse Event|15
936645|NCT00867087|3085930|P1|Overall Study|Death|37
936646|NCT00867087|3085930|P1|Overall Study|Withdrawal by Subject|4
936647|NCT00867087|3085930|P1|Overall Study|Other|1
936648|NCT00867035|3085946|P2|Baseline to 1 Week|Withdrawal by Subject|0
936649|NCT00867035|3085947|P1|Baseline to 1 Week|Withdrawal by Subject|1
936650|NCT00867035|3085946|P2|Baseline to 1 Hour|Withdrawal by Subject|1
936651|NCT00867035|3085947|P1|Baseline to 1 Hour|Withdrawal by Subject|1
936652|NCT00867009|3085973|P1|Maintenance Period|On-going in the Study at Data Cut-off|4
936653|NCT00867009|3085973|P1|Induction Period|Progressive Disease (PD)|25
936654|NCT00867009|3085973|P1|Induction Period|Physician Decision|3
936655|NCT00867009|3085973|P1|Induction Period|Withdrawal by Subject|8
936656|NCT00867009|3085973|P1|Induction Period|Protocol Violation|1
936657|NCT00867009|3085973|P1|Induction Period|Death due to Study Disease|4
936658|NCT00867009|3085973|P1|Induction Period|Death due to serious adverse event|6
936659|NCT00867009|3085973|P1|Induction Period|Serious Adverse Event|10
936660|NCT00867009|3085973|P1|Induction Period|Nonserious Adverse Event|5
936661|NCT00866918|3085982|P2|Overall Study|Secondary malignancy|0
936662|NCT00866918|3085983|P1|Overall Study|Secondary malignancy|1
936663|NCT00866918|3085982|P2|Overall Study|Inevaluable- RQPCR negative at diagnosi|0
936664|NCT00866918|3085983|P1|Overall Study|Inevaluable- RQPCR negative at diagnosi|1
936665|NCT00866918|3085982|P2|Overall Study|Ineligible|4
936666|NCT00866918|3085983|P1|Overall Study|Ineligible|2
936667|NCT00866918|3085982|P2|Overall Study|Physician Decision|2
936668|NCT00866918|3085983|P1|Overall Study|Physician Decision|10
936669|NCT00866918|3085982|P2|Overall Study|Lack of Efficacy|1
936670|NCT00866918|3085983|P1|Overall Study|Lack of Efficacy|1
936671|NCT00866918|3085982|P2|Overall Study|Death|5
936672|NCT00866918|3085983|P1|Overall Study|Death|1
936673|NCT00866814|3086000|P1|Overall Study|Moved to area without study site|1
936674|NCT00866814|3086000|P1|Overall Study|Unable to meet follow-up requirements|2
936675|NCT00866814|3086000|P1|Overall Study|No longer wished to participate|1
936676|NCT00866814|3086000|P1|Overall Study|Death|1
936677|NCT00866814|3086000|P1|Overall Study|Physician Decision|1
936678|NCT00866814|3086000|P1|Overall Study|Adverse Event|2
936679|NCT00866814|3086000|P1|Overall Study|Lost to Follow-up|12
936680|NCT00866788|3086013|P4|Overall Study|Physician Decision|1
936681|NCT00866788|3086014|P3|Overall Study|Physician Decision|1
936682|NCT00866788|3086015|P2|Overall Study|Physician Decision|0
936683|NCT00866788|3086016|P1|Overall Study|Physician Decision|0
936684|NCT00866788|3086013|P4|Overall Study|Disease progression|0
936685|NCT00866788|3086014|P3|Overall Study|Disease progression|1
936686|NCT00866788|3086015|P2|Overall Study|Disease progression|1
936687|NCT00866788|3086016|P1|Overall Study|Disease progression|3
936688|NCT00866788|3086013|P4|Overall Study|Pregnancy|0
936689|NCT00866788|3086014|P3|Overall Study|Pregnancy|0
936690|NCT00866788|3086015|P2|Overall Study|Pregnancy|1
936691|NCT00866788|3086016|P1|Overall Study|Pregnancy|0
936692|NCT00866788|3086013|P4|Overall Study|Withdrawal by Subject|1
936693|NCT00866788|3086014|P3|Overall Study|Withdrawal by Subject|0
936694|NCT00866788|3086015|P2|Overall Study|Withdrawal by Subject|1
936695|NCT00866788|3086016|P1|Overall Study|Withdrawal by Subject|2
936696|NCT00866788|3086013|P4|Overall Study|Lost to Follow-up|2
936697|NCT00866788|3086014|P3|Overall Study|Lost to Follow-up|0
936698|NCT00866788|3086015|P2|Overall Study|Lost to Follow-up|1
936699|NCT00866788|3086016|P1|Overall Study|Lost to Follow-up|1
936700|NCT00866788|3086013|P4|Overall Study|Adverse Event|1
936701|NCT00866788|3086014|P3|Overall Study|Adverse Event|0
936702|NCT00866788|3086015|P2|Overall Study|Adverse Event|2
936703|NCT00866788|3086016|P1|Overall Study|Adverse Event|0
936704|NCT00866775|3086064|P2|Overall Study|discontinued due to communication error|1
936705|NCT00866775|3086065|P1|Overall Study|discontinued due to communication error|0
936706|NCT00866775|3086064|P2|Overall Study|met exit criteria|17
936707|NCT00866775|3086065|P1|Overall Study|met exit criteria|23
936708|NCT00866775|3086064|P2|Overall Study|Withdrawal by Subject|4
936709|NCT00866775|3086065|P1|Overall Study|Withdrawal by Subject|4
936710|NCT00866775|3086064|P2|Overall Study|Protocol Violation|4
936711|NCT00866775|3086065|P1|Overall Study|Protocol Violation|3
936712|NCT00866775|3086064|P2|Overall Study|Physician Decision|3
936713|NCT00866775|3086065|P1|Overall Study|Physician Decision|0
936714|NCT00866775|3086064|P2|Overall Study|Lost to Follow-up|4
936715|NCT00866775|3086065|P1|Overall Study|Lost to Follow-up|0
936716|NCT00866775|3086064|P2|Overall Study|Death|0
936717|NCT00866775|3086065|P1|Overall Study|Death|1
936718|NCT00866775|3086064|P2|Overall Study|Adverse Event|19
936719|NCT00866775|3086065|P1|Overall Study|Adverse Event|5
936720|NCT00866723|3086101|P1|Overall Study|Disease Progression|4
936721|NCT00866723|3086101|P1|Overall Study|Withdrawal by Subject|1
936722|NCT00866697|3086108|P2|Overall Study|Withdrawal by Subject|57
936723|NCT00866697|3086109|P1|Overall Study|Withdrawal by Subject|33
936724|NCT00866697|3086108|P2|Overall Study|Physician Decision|5
936725|NCT00866697|3086109|P1|Overall Study|Physician Decision|3
936726|NCT00866697|3086108|P2|Overall Study|Lost to Follow-up|28
936727|NCT00866697|3086109|P1|Overall Study|Lost to Follow-up|22
936728|NCT00866697|3086108|P2|Overall Study|Study closed/terminated|138
936729|NCT00866697|3086109|P1|Overall Study|Study closed/terminated|156
936730|NCT00866658|3086151|P2|Overall Study|Familial and Personal Reasons|5
936731|NCT00866658|3086152|P1|Overall Study|Familial and Personal Reasons|4
936732|NCT00866658|3086151|P2|Overall Study|Protocol Violation|1
936733|NCT00866658|3086152|P1|Overall Study|Protocol Violation|1
936734|NCT00866658|3086151|P2|Overall Study|Withdrawal by Subject|0
936735|NCT00866658|3086152|P1|Overall Study|Withdrawal by Subject|1
936736|NCT00866658|3086151|P2|Overall Study|Lack of Efficacy|1
936737|NCT00866658|3086152|P1|Overall Study|Lack of Efficacy|2
936738|NCT00866658|3086151|P2|Overall Study|Adverse Event|14
936739|NCT00866658|3086152|P1|Overall Study|Adverse Event|5
936740|NCT00866606|3086180|P1|Overall Study|Adverse Event|1
936741|NCT00866606|3086180|P1|Overall Study|Lost to Follow-up|3
936742|NCT00866359|3086194|P4|Extension Phase (Day 86 to 169)|Adverse Event|3
936743|NCT00866359|3086195|P3|Extension Phase (Day 86 to 169)|Adverse Event|1
936744|NCT00866359|3086196|P2|Extension Phase (Day 86 to 169)|Adverse Event|0
936745|NCT00866359|3086197|P1|Extension Phase (Day 86 to 169)|Adverse Event|0
936746|NCT00866359|3086194|P4|Treatment Phase (Days 1 to 85)|Other|0
936747|NCT00866359|3086195|P3|Treatment Phase (Days 1 to 85)|Other|0
936748|NCT00866359|3086196|P2|Treatment Phase (Days 1 to 85)|Other|0
936749|NCT00866359|3086197|P1|Treatment Phase (Days 1 to 85)|Other|1
936750|NCT00866359|3086194|P4|Treatment Phase (Days 1 to 85)|Protocol Violation|0
936751|NCT00866359|3086195|P3|Treatment Phase (Days 1 to 85)|Protocol Violation|0
936752|NCT00866359|3086196|P2|Treatment Phase (Days 1 to 85)|Protocol Violation|1
936753|NCT00866359|3086197|P1|Treatment Phase (Days 1 to 85)|Protocol Violation|1
936754|NCT00866359|3086194|P4|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
936755|NCT00866359|3086195|P3|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
936756|NCT00866359|3086196|P2|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
936757|NCT00866359|3086197|P1|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1
936758|NCT00866359|3086194|P4|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
936759|NCT00866359|3086195|P3|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
936760|NCT00866359|3086196|P2|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
936761|NCT00866359|3086197|P1|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3
936762|NCT00866359|3086194|P4|Treatment Phase (Days 1 to 85)|Adverse Event|0
936763|NCT00866359|3086195|P3|Treatment Phase (Days 1 to 85)|Adverse Event|0
936764|NCT00866359|3086196|P2|Treatment Phase (Days 1 to 85)|Adverse Event|4
936765|NCT00866359|3086197|P1|Treatment Phase (Days 1 to 85)|Adverse Event|5
936766|NCT00866320|3086250|P1|Overall Study|Death|2
936767|NCT00866320|3086250|P1|Overall Study|Withdrawal by Subject|4
936768|NCT00866307|3086257|P3|Consolidation/Maintenance|Patient moved to non-participating inst|0
936769|NCT00866307|3086258|P2|Consolidation/Maintenance|Patient moved to non-participating inst|1
936770|NCT00866307|3086259|P1|Consolidation/Maintenance|Patient moved to non-participating inst|0
936771|NCT00866307|3086257|P3|Consolidation/Maintenance|Non-compliance|1
936772|NCT00866307|3086258|P2|Consolidation/Maintenance|Non-compliance|0
936773|NCT00866307|3086259|P1|Consolidation/Maintenance|Non-compliance|0
936774|NCT00866307|3086257|P3|Consolidation/Maintenance|Therapy error|0
936775|NCT00866307|3086258|P2|Consolidation/Maintenance|Therapy error|1
936776|NCT00866307|3086259|P1|Consolidation/Maintenance|Therapy error|0
936777|NCT00866307|3086257|P3|Consolidation/Maintenance|Recurrent leukemia following remission|1
936778|NCT00866307|3086258|P2|Consolidation/Maintenance|Recurrent leukemia following remission|3
936779|NCT00866307|3086259|P1|Consolidation/Maintenance|Recurrent leukemia following remission|0
936780|NCT00866307|3086257|P3|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2
936781|NCT00866307|3086258|P2|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
936782|NCT00866307|3086259|P1|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
936783|NCT00866307|3086257|P3|Consolidation/Maintenance|Withdrawal by Subject|1
936784|NCT00866307|3086258|P2|Consolidation/Maintenance|Withdrawal by Subject|1
936785|NCT00866307|3086259|P1|Consolidation/Maintenance|Withdrawal by Subject|0
936786|NCT00866307|3086257|P3|Consolidation/Maintenance|Physician Decision|2
936787|NCT00866307|3086258|P2|Consolidation/Maintenance|Physician Decision|3
936788|NCT00866307|3086259|P1|Consolidation/Maintenance|Physician Decision|0
936789|NCT00866307|3086257|P3|Consolidation/Maintenance|Death|1
936790|NCT00866307|3086258|P2|Consolidation/Maintenance|Death|0
936791|NCT00866307|3086259|P1|Consolidation/Maintenance|Death|0
936792|NCT00866307|3086257|P3|Consolidation/Maintenance|Adverse Event|8
936793|NCT00866307|3086258|P2|Consolidation/Maintenance|Adverse Event|0
936794|NCT00866307|3086259|P1|Consolidation/Maintenance|Adverse Event|0
936795|NCT00866307|3086257|P3|Induction|Study was closed at the time|0
936796|NCT00866307|3086258|P2|Induction|Study was closed at the time|0
936797|NCT00866307|3086259|P1|Induction|Study was closed at the time|1
936798|NCT00866307|3086257|P3|Induction|Improper post-induction consent|0
936799|NCT00866307|3086258|P2|Induction|Improper post-induction consent|0
936800|NCT00866307|3086259|P1|Induction|Improper post-induction consent|2
936801|NCT00866307|3086257|P3|Induction|Inadequate cytognetic samples th|0
936802|NCT00866307|3086258|P2|Induction|Inadequate cytognetic samples th|0
936803|NCT00866307|3086259|P1|Induction|Inadequate cytognetic samples th|1
936804|NCT00866307|3086257|P3|Induction|Identification of Patients with Day 29 M|0
936805|NCT00866307|3086258|P2|Induction|Identification of Patients with Day 29 M|0
936806|NCT00866307|3086259|P1|Induction|Identification of Patients with Day 29 M|3
936807|NCT00866307|3086257|P3|Induction|Progressive Disease|0
936808|NCT00866307|3086258|P2|Induction|Progressive Disease|0
936809|NCT00866307|3086259|P1|Induction|Progressive Disease|1
936810|NCT00866307|3086257|P3|Induction|Physician Decision|0
936811|NCT00866307|3086258|P2|Induction|Physician Decision|0
936812|NCT00866307|3086259|P1|Induction|Physician Decision|5
936813|NCT00866307|3086257|P3|Induction|Death|0
936814|NCT00866307|3086258|P2|Induction|Death|0
936815|NCT00866307|3086259|P1|Induction|Death|2
936816|NCT00866307|3086257|P3|Induction|Adverse Event|0
936817|NCT00866307|3086258|P2|Induction|Adverse Event|0
936818|NCT00866307|3086259|P1|Induction|Adverse Event|5
936819|NCT00866294|3086269|P3|Overall Study|Physician Decision|1
936820|NCT00866294|3086270|P2|Overall Study|Physician Decision|2
936821|NCT00866294|3086271|P1|Overall Study|Physician Decision|6
936822|NCT00866294|3086269|P3|Overall Study|Lost to Follow-up|0
936823|NCT00866294|3086270|P2|Overall Study|Lost to Follow-up|3
936824|NCT00866294|3086271|P1|Overall Study|Lost to Follow-up|1
936825|NCT00866294|3086269|P3|Overall Study|Met Protocol-defined Stopping Criteria|1
936826|NCT00866294|3086270|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
936827|NCT00866294|3086271|P1|Overall Study|Met Protocol-defined Stopping Criteria|5
936828|NCT00866294|3086269|P3|Overall Study|Protocol Violation|0
936829|NCT00866294|3086270|P2|Overall Study|Protocol Violation|0
936830|NCT00866294|3086271|P1|Overall Study|Protocol Violation|2
936831|NCT00866294|3086269|P3|Overall Study|Lack of Efficacy|0
936832|NCT00866294|3086270|P2|Overall Study|Lack of Efficacy|1
936833|NCT00866294|3086271|P1|Overall Study|Lack of Efficacy|7
936834|NCT00866294|3086269|P3|Overall Study|Adverse Event|9
936835|NCT00866294|3086270|P2|Overall Study|Adverse Event|13
936836|NCT00866294|3086271|P1|Overall Study|Adverse Event|12
936837|NCT00866281|3086300|P2|Overall Study|New cancer therapy|4
936838|NCT00866281|3086301|P1|Overall Study|New cancer therapy|0
936839|NCT00866281|3086300|P2|Overall Study|Disease progression|11
936840|NCT00866281|3086301|P1|Overall Study|Disease progression|3
936841|NCT00866281|3086300|P2|Overall Study|Withdrawal by participants|0
936842|NCT00866281|3086301|P1|Overall Study|Withdrawal by participants|3
936843|NCT00866281|3086300|P2|Overall Study|Adverse Event|0
936844|NCT00866281|3086301|P1|Overall Study|Adverse Event|1
936845|NCT00866177|3086317|P1|Overall Study|Not Treated|151
936846|NCT00866177|3086317|P1|Overall Study|Withdrawal by Subject|1
936847|NCT00866047|3086321|P1|Follow-up Period|Lost to Follow-up|5
936848|NCT00866047|3086321|P1|Treatment Period|Withdrawal by Subject|5
936849|NCT00866047|3086321|P1|Treatment Period|Physician Decision|14
936850|NCT00866047|3086321|P1|Treatment Period|Adverse Event|16
936851|NCT00866047|3086321|P1|Treatment Period|Progressive disease|13
936852|NCT00865904|3086353|P5|Overall Study|Randomized but not Treated|1
936853|NCT00865904|3086354|P4|Overall Study|Randomized but not Treated|1
936854|NCT00865904|3086355|P3|Overall Study|Randomized but not Treated|0
936855|NCT00865904|3086356|P2|Overall Study|Randomized but not Treated|0
936856|NCT00865904|3086357|P1|Overall Study|Randomized but not Treated|2
936857|NCT00865709|3086414|P2|Treatment|Surgery|3
936858|NCT00865709|3086415|P1|Treatment|Surgery|8
936859|NCT00865709|3086414|P2|Treatment|Physician Decision|2
936860|NCT00865709|3086415|P1|Treatment|Physician Decision|3
936861|NCT00865709|3086414|P2|Treatment|Withdrawal by Subject|7
936862|NCT00865709|3086415|P1|Treatment|Withdrawal by Subject|10
936863|NCT00865709|3086414|P2|Treatment|Adverse Event|6
936864|NCT00865709|3086415|P1|Treatment|Adverse Event|9
936865|NCT00865514|3086431|P1|Overall Study|Infusion cost exceeded funding|2
936866|NCT00865345|3086436|P1|Overall Study|Withdrawal by Subject|2
936867|NCT00865306|3086443|P2|Controlled Trial|Withdrawal by Subject|1
936868|NCT00865306|3086444|P1|Controlled Trial|Withdrawal by Subject|0
936869|NCT00865306|3086443|P2|Controlled Trial|Sought treatment for conduct disorder|0
936870|NCT00865306|3086444|P1|Controlled Trial|Sought treatment for conduct disorder|1
936871|NCT00865306|3086443|P2|Controlled Trial|Improved btw baseline and first session|0
936872|NCT00865306|3086444|P1|Controlled Trial|Improved btw baseline and first session|1
936873|NCT00865306|3086443|P2|Controlled Trial|Difficulty commuting|0
936874|NCT00865306|3086444|P1|Controlled Trial|Difficulty commuting|2
936875|NCT00865306|3086443|P2|Controlled Trial|Lost to Follow-up|1
936876|NCT00865306|3086444|P1|Controlled Trial|Lost to Follow-up|1
936877|NCT00865189|3086473|P2|Overall Study|Withdrawal by Subject|0
936878|NCT00865189|3086474|P1|Overall Study|Withdrawal by Subject|1
936879|NCT00865189|3086473|P2|Overall Study|Lost to Follow-up|6
936880|NCT00865189|3086474|P1|Overall Study|Lost to Follow-up|6
936881|NCT00865189|3086473|P2|Overall Study|Death|11
936882|NCT00865189|3086474|P1|Overall Study|Death|4
936883|NCT00865189|3086473|P2|Overall Study|Other|2
936884|NCT00865189|3086474|P1|Overall Study|Other|1
936885|NCT00865124|3086502|P3|Overall Study|Withdrawn consent|0
936886|NCT00865124|3086503|P2|Overall Study|Withdrawn consent|0
936887|NCT00865124|3086504|P1|Overall Study|Withdrawn consent|2
936888|NCT00865124|3086502|P3|Overall Study|Physician Decision|0
936889|NCT00865124|3086503|P2|Overall Study|Physician Decision|1
936890|NCT00865124|3086504|P1|Overall Study|Physician Decision|2
936891|NCT00865098|3086521|P1|Overall Study|Progressive disease|1
936892|NCT00865046|3086533|P3|Overall Study|Withdrawal by Subject|0
936893|NCT00865046|3086534|P2|Overall Study|Withdrawal by Subject|0
936894|NCT00865046|3086535|P1|Overall Study|Withdrawal by Subject|5
936895|NCT00865046|3086533|P3|Overall Study|Death|1
936896|NCT00865046|3086534|P2|Overall Study|Death|1
936897|NCT00865046|3086535|P1|Overall Study|Death|0
936898|NCT00865046|3086533|P3|Overall Study|Lost to Follow-up|0
936899|NCT00865046|3086534|P2|Overall Study|Lost to Follow-up|4
936900|NCT00865046|3086535|P1|Overall Study|Lost to Follow-up|1
936901|NCT00865020|3086545|P2|Overall Study|Randomized but discontinued|4
936902|NCT00865020|3086546|P1|Overall Study|Randomized but discontinued|2
936903|NCT00865020|3086545|P2|Overall Study|Death|1
936904|NCT00865020|3086546|P1|Overall Study|Death|0
936905|NCT00865020|3086545|P2|Overall Study|Abnormal laboratory value(s)|1
936906|NCT00865020|3086546|P1|Overall Study|Abnormal laboratory value(s)|0
936907|NCT00865020|3086545|P2|Overall Study|Administrative problems|2
936908|NCT00865020|3086546|P1|Overall Study|Administrative problems|0
936909|NCT00865020|3086545|P2|Overall Study|Protocol deviation|1
936910|NCT00865020|3086546|P1|Overall Study|Protocol deviation|4
936911|NCT00865020|3086545|P2|Overall Study|Lost to Follow-up|4
936912|NCT00865020|3086546|P1|Overall Study|Lost to Follow-up|6
936913|NCT00865020|3086545|P2|Overall Study|Abnormal test procedure result(s)|8
936914|NCT00865020|3086546|P1|Overall Study|Abnormal test procedure result(s)|6
936915|NCT00865020|3086545|P2|Overall Study|Adverse Event|14
936916|NCT00865020|3086546|P1|Overall Study|Adverse Event|9
936917|NCT00865020|3086545|P2|Overall Study|Withdrawal by Subject|16
936918|NCT00865020|3086546|P1|Overall Study|Withdrawal by Subject|22
936919|NCT00864916|3086562|P2|Overall Study|Withdrawal by Subject|0
936920|NCT00864916|3086563|P1|Overall Study|Withdrawal by Subject|1
936921|NCT00864916|3086562|P2|Overall Study|Protocol Violation|0
936922|NCT00864916|3086563|P1|Overall Study|Protocol Violation|1
936923|NCT00864916|3086562|P2|Overall Study|Lost to Follow-up|4
936924|NCT00864916|3086563|P1|Overall Study|Lost to Follow-up|4
936925|NCT00864851|3086572|P3|Overall Study|Patient uncooperative|0
936926|NCT00864851|3086573|P2|Overall Study|Patient uncooperative|0
936927|NCT00864851|3086574|P1|Overall Study|Patient uncooperative|1
936928|NCT00864851|3086572|P3|Overall Study|Death|0
936929|NCT00864851|3086573|P2|Overall Study|Death|0
936930|NCT00864851|3086574|P1|Overall Study|Death|1
936931|NCT00864851|3086572|P3|Overall Study|Physician Decision|0
936932|NCT00864851|3086573|P2|Overall Study|Physician Decision|0
936933|NCT00864851|3086574|P1|Overall Study|Physician Decision|1
936934|NCT00864851|3086572|P3|Overall Study|Withdrawal by Subject|0
936935|NCT00864851|3086573|P2|Overall Study|Withdrawal by Subject|1
936936|NCT00864851|3086574|P1|Overall Study|Withdrawal by Subject|0
936937|NCT00864721|3086608|P1|Overall Study|Adverse Event|21
936938|NCT00864721|3086608|P1|Overall Study|Drug hold/delay more than 4 weeks|1
936939|NCT00864721|3086608|P1|Overall Study|Hospitalized|1
936940|NCT00864721|3086608|P1|Overall Study|Patient request|11
936941|NCT00864682|3086628|P3|Overall Study|Protocol Violation|2
936942|NCT00864682|3086629|P2|Overall Study|Protocol Violation|1
936943|NCT00864682|3086630|P1|Overall Study|Protocol Violation|2
936944|NCT00864513|3086669|P1|Overall Study|Withdrawal by Subject|3
936945|NCT00864253|3086715|P2|Overall Study|Untreated|7
936946|NCT00864253|3086716|P1|Overall Study|Untreated|7
936947|NCT00864253|3086715|P2|Overall Study|Ongoing|3
936948|NCT00864253|3086716|P1|Overall Study|Ongoing|2
936949|NCT00864253|3086715|P2|Overall Study|Death|0
936950|NCT00864253|3086716|P1|Overall Study|Death|1
936951|NCT00864253|3086715|P2|Overall Study|Withdrawal by Subject|18
936952|NCT00864253|3086716|P1|Overall Study|Withdrawal by Subject|18
936953|NCT00864253|3086715|P2|Overall Study|Lost to Follow-up|1
936954|NCT00864253|3086716|P1|Overall Study|Lost to Follow-up|1
936955|NCT00864253|3086715|P2|Overall Study|Protocol Violation|2
936956|NCT00864253|3086716|P1|Overall Study|Protocol Violation|0
936957|NCT00864253|3086715|P2|Overall Study|Physician Decision|15
936958|NCT00864253|3086716|P1|Overall Study|Physician Decision|11
936959|NCT00864253|3086715|P2|Overall Study|Unrelated Adverse Event|1
936960|NCT00864253|3086716|P1|Overall Study|Unrelated Adverse Event|3
936961|NCT00864253|3086715|P2|Overall Study|Adverse Event|11
936962|NCT00864253|3086716|P1|Overall Study|Adverse Event|56
936963|NCT00864227|3086746|P1|Overall Study|Disease Relapse/Progression|3
936964|NCT00864227|3086746|P1|Overall Study|Withdrawal by Subject|1
936965|NCT00863798|3086808|P3|Overall Study|Randomized not treated|3
936966|NCT00863798|3086809|P2|Overall Study|Randomized not treated|2
936967|NCT00863798|3086810|P1|Overall Study|Randomized not treated|4
936968|NCT00863798|3086808|P3|Overall Study|Withdrawal by Subject|4
936969|NCT00863798|3086809|P2|Overall Study|Withdrawal by Subject|7
936970|NCT00863798|3086810|P1|Overall Study|Withdrawal by Subject|8
936971|NCT00863798|3086808|P3|Overall Study|Protocol Violation|1
936972|NCT00863798|3086809|P2|Overall Study|Protocol Violation|1
936973|NCT00863798|3086810|P1|Overall Study|Protocol Violation|0
936974|NCT00863798|3086808|P3|Overall Study|Other|1
936975|NCT00863798|3086809|P2|Overall Study|Other|3
936976|NCT00863798|3086810|P1|Overall Study|Other|2
936977|NCT00863798|3086808|P3|Overall Study|Lost to Follow-up|5
936978|NCT00863798|3086809|P2|Overall Study|Lost to Follow-up|9
936979|NCT00863798|3086810|P1|Overall Study|Lost to Follow-up|6
936980|NCT00863798|3086808|P3|Overall Study|Lack of Efficacy|6
936981|NCT00863798|3086809|P2|Overall Study|Lack of Efficacy|3
936982|NCT00863798|3086810|P1|Overall Study|Lack of Efficacy|4
936983|NCT00863798|3086808|P3|Overall Study|Investigator request|1
936984|NCT00863798|3086809|P2|Overall Study|Investigator request|2
936985|NCT00863798|3086810|P1|Overall Study|Investigator request|1
936986|NCT00863798|3086808|P3|Overall Study|Participant failed to return|0
936987|NCT00863798|3086809|P2|Overall Study|Participant failed to return|1
936988|NCT00863798|3086810|P1|Overall Study|Participant failed to return|2
936989|NCT00863798|3086808|P3|Overall Study|Adverse Event|4
936990|NCT00863798|3086809|P2|Overall Study|Adverse Event|2
936991|NCT00863798|3086810|P1|Overall Study|Adverse Event|5
936992|NCT00863746|3086862|P2|Survival Follow up|Consent Withdrawn|8
936993|NCT00863746|3086863|P1|Survival Follow up|Consent Withdrawn|7
936994|NCT00863746|3086862|P2|Survival Follow up|Lost to Follow-up|1
936995|NCT00863746|3086863|P1|Survival Follow up|Lost to Follow-up|2
936996|NCT00863746|3086862|P2|Survival Follow up|Death|271
936997|NCT00863746|3086863|P1|Survival Follow up|Death|244
936998|NCT00863746|3086862|P2|Treatment|not available|0
936999|NCT00863746|3086863|P1|Treatment|not available|1
937000|NCT00863746|3086862|P2|Treatment|Protocol Violation|3
937001|NCT00863746|3086863|P1|Treatment|Protocol Violation|5
937002|NCT00863746|3086862|P2|Treatment|Lost to Follow-up|0
937003|NCT00863746|3086863|P1|Treatment|Lost to Follow-up|1
937004|NCT00863746|3086862|P2|Treatment|Consent withdrawn|14
937005|NCT00863746|3086863|P1|Treatment|Consent withdrawn|15
937006|NCT00863746|3086862|P2|Treatment|non-compliant with study medication|0
937007|NCT00863746|3086863|P1|Treatment|non-compliant with study medication|4
937008|NCT00863746|3086862|P2|Treatment|Adverse Event|16
937009|NCT00863746|3086863|P1|Treatment|Adverse Event|41
937010|NCT00863746|3086862|P2|Treatment|Not treated|2
937011|NCT00863746|3086863|P1|Treatment|Not treated|4
937012|NCT00863707|3086889|P2|Overall Study|Randomized, but drug not received|3
937013|NCT00863707|3086890|P1|Overall Study|Randomized, but drug not received|4
937014|NCT00863655|3086898|P2|Overall Study|Treatment completed as per protocol|1
937015|NCT00863655|3086899|P1|Overall Study|Treatment completed as per protocol|5
937016|NCT00863655|3086898|P2|Overall Study|Disease progression|221
937017|NCT00863655|3086899|P1|Overall Study|Disease progression|364
937018|NCT00863655|3086898|P2|Overall Study|New cancer therapy|1
937019|NCT00863655|3086899|P1|Overall Study|New cancer therapy|5
937020|NCT00863655|3086898|P2|Overall Study|Death|1
937021|NCT00863655|3086899|P1|Overall Study|Death|7
937022|NCT00863655|3086898|P2|Overall Study|Administrative problems|0
937023|NCT00863655|3086899|P1|Overall Study|Administrative problems|1
937024|NCT00863655|3086898|P2|Overall Study|Withdrawal by Subject|7
937025|NCT00863655|3086899|P1|Overall Study|Withdrawal by Subject|47
937026|NCT00863655|3086898|P2|Overall Study|Adverse Event|8
937027|NCT00863655|3086899|P1|Overall Study|Adverse Event|52
937028|NCT00863655|3086898|P2|Overall Study|Protocol Violation|0
937029|NCT00863655|3086899|P1|Overall Study|Protocol Violation|4
937030|NCT00863512|3086936|P2|Overall Study|Physician Decision|0
937031|NCT00863512|3086937|P1|Overall Study|Physician Decision|1
937032|NCT00863512|3086936|P2|Overall Study|Withdrawal by Subject|0
937033|NCT00863512|3086937|P1|Overall Study|Withdrawal by Subject|11
937034|NCT00863512|3086936|P2|Overall Study|Adverse Event|0
937035|NCT00863512|3086937|P1|Overall Study|Adverse Event|2
937036|NCT00863330|3086968|P1|Overall Study|study terminated early due to administra|6
937037|NCT00863317|3086974|P2|Overall Study|Lost to Follow-up|9
937038|NCT00863317|3086975|P1|Overall Study|Lost to Follow-up|8
937039|NCT00863057|3087030|P4|Period 2 (Weeks 6-10)|Physician Decision|1
937040|NCT00863057|3087031|P3|Period 2 (Weeks 6-10)|Physician Decision|0
937041|NCT00863057|3087032|P2|Period 2 (Weeks 6-10)|Physician Decision|0
937042|NCT00863057|3087033|P1|Period 2 (Weeks 6-10)|Physician Decision|0
937043|NCT00863057|3087030|P4|Period 2 (Weeks 6-10)|Adverse Event|0
937044|NCT00863057|3087031|P3|Period 2 (Weeks 6-10)|Adverse Event|1
937045|NCT00863057|3087032|P2|Period 2 (Weeks 6-10)|Adverse Event|1
937046|NCT00863057|3087033|P1|Period 2 (Weeks 6-10)|Adverse Event|0
937047|NCT00863057|3087030|P4|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
937048|NCT00863057|3087031|P3|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
937049|NCT00863057|3087032|P2|Milestones Period 1 (Weeks 0-5)|Physician Decision|1
937050|NCT00863057|3087033|P1|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
937051|NCT00863057|3087030|P4|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
937052|NCT00863057|3087031|P3|Milestones Period 1 (Weeks 0-5)|Adverse Event|0
937053|NCT00863057|3087032|P2|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
937054|NCT00863057|3087033|P1|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
937055|NCT00862979|3087083|P2|Overall Study|Death|1
937056|NCT00862979|3087084|P1|Overall Study|Death|0
937057|NCT00862979|3087083|P2|Overall Study|Administrative problems|1
937058|NCT00862979|3087084|P1|Overall Study|Administrative problems|0
937059|NCT00862979|3087083|P2|Overall Study|Patient withdrew consent|1
937060|NCT00862979|3087084|P1|Overall Study|Patient withdrew consent|2
937061|NCT00862979|3087083|P2|Overall Study|Protocol Violation|1
937062|NCT00862979|3087084|P1|Overall Study|Protocol Violation|0
937063|NCT00862979|3087083|P2|Overall Study|Adverse Event|3
937064|NCT00862979|3087084|P1|Overall Study|Adverse Event|6
937065|NCT00862940|3087102|P2|Overall Study|Administrative or other reason(s)|3
937066|NCT00862940|3087103|P1|Overall Study|Administrative or other reason(s)|4
937067|NCT00862940|3087102|P2|Overall Study|Lost to Follow-up|1
937068|NCT00862940|3087103|P1|Overall Study|Lost to Follow-up|0
937069|NCT00862940|3087102|P2|Overall Study|Non-compliance|0
937070|NCT00862940|3087103|P1|Overall Study|Non-compliance|4
937071|NCT00862940|3087102|P2|Overall Study|Withdrawal by Subject|6
937072|NCT00862940|3087103|P1|Overall Study|Withdrawal by Subject|4
937073|NCT00862940|3087102|P2|Overall Study|Protocol Violation|5
937074|NCT00862940|3087103|P1|Overall Study|Protocol Violation|2
937075|NCT00862940|3087102|P2|Overall Study|Lack of Efficacy|3
937076|NCT00862940|3087103|P1|Overall Study|Lack of Efficacy|1
937077|NCT00862940|3087102|P2|Overall Study|Adverse Event|12
937078|NCT00862940|3087103|P1|Overall Study|Adverse Event|15
937079|NCT00862849|3087115|P6|Washout 2 (3 to 14 Days)|Protocol Violation|0
937080|NCT00862849|3087116|P5|Washout 2 (3 to 14 Days)|Protocol Violation|0
937081|NCT00862849|3087117|P4|Washout 2 (3 to 14 Days)|Protocol Violation|0
937082|NCT00862849|3087118|P3|Washout 2 (3 to 14 Days)|Protocol Violation|0
937083|NCT00862849|3087119|P2|Washout 2 (3 to 14 Days)|Protocol Violation|1
937084|NCT00862849|3087120|P1|Washout 2 (3 to 14 Days)|Protocol Violation|0
937085|NCT00862849|3087115|P6|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
937086|NCT00862849|3087116|P5|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
937087|NCT00862849|3087117|P4|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
937088|NCT00862849|3087118|P3|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
937089|NCT00862849|3087119|P2|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1
937090|NCT00862849|3087120|P1|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
937091|NCT00862836|3087143|P1|Overall Study|Withdrawal by Subject|1
937092|NCT00862823|3087154|P2|First Intervention|Withdrawal by Subject|1
937093|NCT00862823|3087155|P1|First Intervention|Withdrawal by Subject|1
937094|NCT00862719|3087204|P4|Overall Study|Veno-Occlusive Disease|0
937095|NCT00862719|3087205|P3|Overall Study|Veno-Occlusive Disease|1
937096|NCT00862719|3087206|P2|Overall Study|Veno-Occlusive Disease|0
937097|NCT00862719|3087207|P1|Overall Study|Veno-Occlusive Disease|0
937098|NCT00862719|3087204|P4|Overall Study|Engraftment failure|0
937099|NCT00862719|3087205|P3|Overall Study|Engraftment failure|1
937100|NCT00862719|3087206|P2|Overall Study|Engraftment failure|0
937101|NCT00862719|3087207|P1|Overall Study|Engraftment failure|0
937102|NCT00862719|3087204|P4|Overall Study|Death|1
937103|NCT00862719|3087205|P3|Overall Study|Death|1
937104|NCT00862719|3087206|P2|Overall Study|Death|6
937105|NCT00862719|3087207|P1|Overall Study|Death|5
937106|NCT00862719|3087204|P4|Overall Study|Disease Progression|0
937107|NCT00862719|3087205|P3|Overall Study|Disease Progression|1
937108|NCT00862719|3087206|P2|Overall Study|Disease Progression|0
937109|NCT00862719|3087207|P1|Overall Study|Disease Progression|5
937110|NCT00862654|3087230|P4|Overall Study|Included after end of inclusions|0
937111|NCT00862654|3087231|P3|Overall Study|Included after end of inclusions|1
937112|NCT00862654|3087232|P2|Overall Study|Included after end of inclusions|0
937113|NCT00862654|3087233|P1|Overall Study|Included after end of inclusions|0
937114|NCT00862654|3087230|P4|Overall Study|Never used study drugs|0
937115|NCT00862654|3087231|P3|Overall Study|Never used study drugs|0
937116|NCT00862654|3087232|P2|Overall Study|Never used study drugs|0
937117|NCT00862654|3087233|P1|Overall Study|Never used study drugs|1
937118|NCT00862654|3087230|P4|Overall Study|Familly constraint|0
937119|NCT00862654|3087231|P3|Overall Study|Familly constraint|0
937120|NCT00862654|3087232|P2|Overall Study|Familly constraint|1
937121|NCT00862654|3087233|P1|Overall Study|Familly constraint|0
937122|NCT00862654|3087230|P4|Overall Study|Subject mistake|0
937123|NCT00862654|3087231|P3|Overall Study|Subject mistake|0
937124|NCT00862654|3087232|P2|Overall Study|Subject mistake|1
937125|NCT00862654|3087233|P1|Overall Study|Subject mistake|0
937126|NCT00862654|3087230|P4|Overall Study|Withdrawal by Subject|3
937127|NCT00862654|3087231|P3|Overall Study|Withdrawal by Subject|2
937128|NCT00862654|3087232|P2|Overall Study|Withdrawal by Subject|2
937129|NCT00862654|3087233|P1|Overall Study|Withdrawal by Subject|2
937130|NCT00862654|3087230|P4|Overall Study|Pregnancy|0
937131|NCT00862654|3087231|P3|Overall Study|Pregnancy|0
937132|NCT00862654|3087232|P2|Overall Study|Pregnancy|1
937133|NCT00862654|3087233|P1|Overall Study|Pregnancy|1
937134|NCT00862654|3087230|P4|Overall Study|Adverse Event|0
937135|NCT00862654|3087231|P3|Overall Study|Adverse Event|1
937136|NCT00862654|3087232|P2|Overall Study|Adverse Event|1
937137|NCT00862654|3087233|P1|Overall Study|Adverse Event|0
937138|NCT00862654|3087230|P4|Overall Study|Lost to Follow-up|3
937139|NCT00862654|3087231|P3|Overall Study|Lost to Follow-up|1
937140|NCT00862654|3087232|P2|Overall Study|Lost to Follow-up|2
937141|NCT00862654|3087233|P1|Overall Study|Lost to Follow-up|1
937142|NCT00862654|3087230|P4|Overall Study|Lack of Efficacy|0
937143|NCT00862654|3087231|P3|Overall Study|Lack of Efficacy|1
937144|NCT00862654|3087232|P2|Overall Study|Lack of Efficacy|0
937145|NCT00862654|3087233|P1|Overall Study|Lack of Efficacy|1
937146|NCT00862641|3087247|P4|Overall Study|Randomized, but drug not received|4
937147|NCT00862641|3087248|P3|Overall Study|Randomized, but drug not received|1
937148|NCT00862641|3087249|P2|Overall Study|Randomized, but drug not received|4
937149|NCT00862641|3087250|P1|Overall Study|Randomized, but drug not received|1
937150|NCT00862459|3087344|P3|Overall Study|Administrative problems|0
937151|NCT00862459|3087345|P2|Overall Study|Administrative problems|1
937152|NCT00862459|3087346|P1|Overall Study|Administrative problems|0
937153|NCT00862459|3087344|P3|Overall Study|Inclusion/exclusion criteria not met|0
937154|NCT00862459|3087345|P2|Overall Study|Inclusion/exclusion criteria not met|1
937155|NCT00862459|3087346|P1|Overall Study|Inclusion/exclusion criteria not met|0
937156|NCT00862459|3087344|P3|Overall Study|Unable to hold still for imaging|0
937157|NCT00862459|3087345|P2|Overall Study|Unable to hold still for imaging|1
937158|NCT00862459|3087346|P1|Overall Study|Unable to hold still for imaging|0
937159|NCT00862459|3087344|P3|Overall Study|Intravenous (IV) site problems|1
937160|NCT00862459|3087345|P2|Overall Study|Intravenous (IV) site problems|0
937161|NCT00862459|3087346|P1|Overall Study|Intravenous (IV) site problems|1
937162|NCT00862459|3087344|P3|Overall Study|Operation|0
937163|NCT00862459|3087345|P2|Overall Study|Operation|1
937164|NCT00862459|3087346|P1|Overall Study|Operation|1
937165|NCT00862459|3087344|P3|Overall Study|Personal reasons|0
937166|NCT00862459|3087345|P2|Overall Study|Personal reasons|0
937167|NCT00862459|3087346|P1|Overall Study|Personal reasons|1
937168|NCT00862459|3087344|P3|Overall Study|Adverse Event|0
937169|NCT00862459|3087345|P2|Overall Study|Adverse Event|1
937170|NCT00862459|3087346|P1|Overall Study|Adverse Event|0
937171|NCT00862459|3087344|P3|Overall Study|Withdrawal by Subject|3
937172|NCT00862459|3087345|P2|Overall Study|Withdrawal by Subject|1
937173|NCT00862459|3087346|P1|Overall Study|Withdrawal by Subject|1
937174|NCT00862459|3087344|P3|Overall Study|Protocol Violation|0
937175|NCT00862459|3087345|P2|Overall Study|Protocol Violation|0
937176|NCT00862459|3087346|P1|Overall Study|Protocol Violation|1
937177|NCT00862459|3087344|P3|Overall Study|Lost to Follow-up|2
937178|NCT00862459|3087345|P2|Overall Study|Lost to Follow-up|2
937179|NCT00862459|3087346|P1|Overall Study|Lost to Follow-up|1
937180|NCT00862277|3087493|P3|Overall Study|Protocol Violation|5
937181|NCT00862277|3087494|P2|Overall Study|Protocol Violation|2
937182|NCT00862277|3087495|P1|Overall Study|Protocol Violation|1
937183|NCT00862251|3087509|P3|Overall Study|Withdrawal by Subject|6
937184|NCT00862251|3087510|P2|Overall Study|Withdrawal by Subject|2
937185|NCT00862251|3087511|P1|Overall Study|Withdrawal by Subject|9
937186|NCT00862251|3087509|P3|Overall Study|Protocol Violation|1
937187|NCT00862251|3087510|P2|Overall Study|Protocol Violation|0
937188|NCT00862251|3087511|P1|Overall Study|Protocol Violation|2
937189|NCT00862251|3087509|P3|Overall Study|Lost to Follow-up|1
937190|NCT00862251|3087510|P2|Overall Study|Lost to Follow-up|0
937191|NCT00862251|3087511|P1|Overall Study|Lost to Follow-up|0
937192|NCT00862251|3087509|P3|Overall Study|Adverse Event|1
937193|NCT00862251|3087510|P2|Overall Study|Adverse Event|3
937194|NCT00862251|3087511|P1|Overall Study|Adverse Event|8
937195|NCT00862134|3087571|P2|Overall Study|Withdrew prior to dosing|0
937196|NCT00862134|3087572|P1|Overall Study|Withdrew prior to dosing|2
937197|NCT00862134|3087571|P2|Overall Study|Adverse Event|2
937198|NCT00862134|3087572|P1|Overall Study|Adverse Event|2
937199|NCT00862134|3087571|P2|Overall Study|Sponsor terminated study|7
937200|NCT00862134|3087572|P1|Overall Study|Sponsor terminated study|5
937201|NCT00862134|3087571|P2|Overall Study|Withdrawal by Subject|2
937202|NCT00862134|3087572|P1|Overall Study|Withdrawal by Subject|1
937203|NCT00862134|3087571|P2|Overall Study|Physician Decision|1
937204|NCT00862134|3087572|P1|Overall Study|Physician Decision|0
937205|NCT00862134|3087571|P2|Overall Study|Death|0
937206|NCT00862134|3087572|P1|Overall Study|Death|1
937207|NCT00862121|3087584|P2|Overall Study|Incorrect randomisation|1
937208|NCT00862121|3087585|P1|Overall Study|Incorrect randomisation|0
937209|NCT00862121|3087584|P2|Overall Study|Exclusion criterion violation|1
937210|NCT00862121|3087585|P1|Overall Study|Exclusion criterion violation|0
937211|NCT00862121|3087584|P2|Overall Study|Protocol Violation|1
937212|NCT00862121|3087585|P1|Overall Study|Protocol Violation|0
937213|NCT00862121|3087584|P2|Overall Study|Lack of Efficacy|3
937214|NCT00862121|3087585|P1|Overall Study|Lack of Efficacy|0
937215|NCT00862121|3087584|P2|Overall Study|Adverse Event|2
937216|NCT00862121|3087585|P1|Overall Study|Adverse Event|1
937217|NCT00862082|3087603|P2|Overall Study|Withdrawal by Subject|1
937218|NCT00862082|3087604|P1|Overall Study|Withdrawal by Subject|0
937219|NCT00862082|3087603|P2|Overall Study|Sponsor decision to terminate the study|0
937220|NCT00862082|3087604|P1|Overall Study|Sponsor decision to terminate the study|5
937221|NCT00861757|3087659|P4|Overall Study|Withdrawal by Subject|2
937222|NCT00861757|3087660|P3|Overall Study|Withdrawal by Subject|5
937223|NCT00861757|3087661|P2|Overall Study|Withdrawal by Subject|5
937224|NCT00861757|3087662|P1|Overall Study|Withdrawal by Subject|1
937225|NCT00861757|3087659|P4|Overall Study|Protocol Violation|1
937226|NCT00861757|3087660|P3|Overall Study|Protocol Violation|4
937227|NCT00861757|3087661|P2|Overall Study|Protocol Violation|2
937228|NCT00861757|3087662|P1|Overall Study|Protocol Violation|2
937229|NCT00861757|3087659|P4|Overall Study|Physician Decision|1
937230|NCT00861757|3087660|P3|Overall Study|Physician Decision|0
937231|NCT00861757|3087661|P2|Overall Study|Physician Decision|0
937232|NCT00861757|3087662|P1|Overall Study|Physician Decision|0
937233|NCT00861757|3087659|P4|Overall Study|Lost to Follow-up|1
937234|NCT00861757|3087660|P3|Overall Study|Lost to Follow-up|1
937235|NCT00861757|3087661|P2|Overall Study|Lost to Follow-up|0
937236|NCT00861757|3087662|P1|Overall Study|Lost to Follow-up|1
937237|NCT00861757|3087659|P4|Overall Study|Lack of Efficacy|1
937238|NCT00861757|3087660|P3|Overall Study|Lack of Efficacy|0
937239|NCT00861757|3087661|P2|Overall Study|Lack of Efficacy|1
937240|NCT00861757|3087662|P1|Overall Study|Lack of Efficacy|3
937241|NCT00861757|3087659|P4|Overall Study|Entry Criteria Not Met|1
937242|NCT00861757|3087660|P3|Overall Study|Entry Criteria Not Met|1
937243|NCT00861757|3087661|P2|Overall Study|Entry Criteria Not Met|2
937244|NCT00861757|3087662|P1|Overall Study|Entry Criteria Not Met|1
937245|NCT00861757|3087659|P4|Overall Study|Adverse Event|2
937246|NCT00861757|3087660|P3|Overall Study|Adverse Event|7
937247|NCT00861757|3087661|P2|Overall Study|Adverse Event|5
937248|NCT00861757|3087662|P1|Overall Study|Adverse Event|1
937249|NCT00861744|3087720|P4|Overall Study|Blood draws|1
937250|NCT00861744|3087721|P3|Overall Study|Blood draws|0
937251|NCT00861744|3087722|P2|Overall Study|Blood draws|0
937252|NCT00861744|3087723|P1|Overall Study|Blood draws|0
937253|NCT00861744|3087720|P4|Overall Study|Migration from study area|0
937254|NCT00861744|3087721|P3|Overall Study|Migration from study area|1
937255|NCT00861744|3087722|P2|Overall Study|Migration from study area|3
937256|NCT00861744|3087723|P1|Overall Study|Migration from study area|0
937257|NCT00861744|3087720|P4|Overall Study|Protocol Violation|0
937258|NCT00861744|3087721|P3|Overall Study|Protocol Violation|0
937259|NCT00861744|3087722|P2|Overall Study|Protocol Violation|1
937260|NCT00861744|3087723|P1|Overall Study|Protocol Violation|0
937261|NCT00861744|3087720|P4|Overall Study|Withdrawal by Subject|19
937262|NCT00861744|3087721|P3|Overall Study|Withdrawal by Subject|6
937263|NCT00861744|3087722|P2|Overall Study|Withdrawal by Subject|6
937264|NCT00861744|3087723|P1|Overall Study|Withdrawal by Subject|10
937265|NCT00861744|3087720|P4|Overall Study|Lost to Follow-up|12
937266|NCT00861744|3087721|P3|Overall Study|Lost to Follow-up|17
937267|NCT00861744|3087722|P2|Overall Study|Lost to Follow-up|19
937268|NCT00861744|3087723|P1|Overall Study|Lost to Follow-up|7
937269|NCT00861744|3087720|P4|Overall Study|Adverse Event|1
937270|NCT00861744|3087721|P3|Overall Study|Adverse Event|0
937271|NCT00861744|3087722|P2|Overall Study|Adverse Event|0
937272|NCT00861744|3087723|P1|Overall Study|Adverse Event|0
937273|NCT00861705|3087905|P4|Overall Study|Never Began Treatment|1
937274|NCT00861705|3087906|P3|Overall Study|Never Began Treatment|0
937275|NCT00861705|3087907|P2|Overall Study|Never Began Treatment|3
937276|NCT00861705|3087908|P1|Overall Study|Never Began Treatment|7
937277|NCT00861692|3087924|P1|Overall Study|Death|6
937278|NCT00861614|3087936|P2|Overall Study|Other|22
937279|NCT00861614|3087937|P1|Overall Study|Other|17
937280|NCT00861614|3087936|P2|Overall Study|Withdrawal by Subject|35
937281|NCT00861614|3087937|P1|Overall Study|Withdrawal by Subject|34
937282|NCT00861614|3087936|P2|Overall Study|Adverse Event|23
937283|NCT00861614|3087937|P1|Overall Study|Adverse Event|27
937284|NCT00861614|3087936|P2|Overall Study|Death|19
937285|NCT00861614|3087937|P1|Overall Study|Death|32
937286|NCT00861614|3087936|P2|Overall Study|Study Drug Toxicity|6
937287|NCT00861614|3087937|P1|Overall Study|Study Drug Toxicity|79
937288|NCT00861614|3087936|P2|Overall Study|Disease Progression|263
937289|NCT00861614|3087937|P1|Overall Study|Disease Progression|182
937290|NCT00861471|3088022|P1|Overall Study|Physician Decision|2
937291|NCT00861471|3088022|P1|Overall Study|treatment for lumbar laminectomy|1
937292|NCT00861471|3088022|P1|Overall Study|Lack of Efficacy|3
937293|NCT00861471|3088022|P1|Overall Study|Adverse Event|2
937294|NCT00861471|3088022|P1|Overall Study|Withdrawal by Subject|1
937295|NCT00861341|3088030|P1|Overall Study|Withdrawal by Subject|2
937296|NCT00861198|3088039|P1|Overall Study|SpyGlass Failed|5
937297|NCT00860951|3088056|P1|Overall Study|Lost to Follow-up|5
937298|NCT00860951|3088056|P1|Overall Study|Withdrawal by Subject|2
937299|NCT00860743|3088098|P2|Overall Study|Withdrawal by Subject|0
937300|NCT00860743|3088099|P1|Overall Study|Withdrawal by Subject|3
937301|NCT00860470|3088112|P2|Overall Study|Lost to Follow-up|39
937302|NCT00860470|3088113|P1|Overall Study|Lost to Follow-up|34
937303|NCT00860470|3088112|P2|Overall Study|Moved away|10
937304|NCT00860470|3088113|P1|Overall Study|Moved away|8
937305|NCT00860470|3088112|P2|Overall Study|Death|10
937306|NCT00860470|3088113|P1|Overall Study|Death|6
937307|NCT00860405|3088143|P2|Overall Study|Main reason: Follow-up data not complete|4
937308|NCT00860405|3088144|P1|Overall Study|Main reason: Follow-up data not complete|5
937309|NCT00860262|3088184|P3|Overall Study|Not Specified|1
937310|NCT00860262|3088185|P2|Overall Study|Not Specified|3
937311|NCT00860262|3088186|P1|Overall Study|Not Specified|5
937312|NCT00860262|3088184|P3|Overall Study|Lack of Efficacy|3
937313|NCT00860262|3088185|P2|Overall Study|Lack of Efficacy|4
937314|NCT00860262|3088186|P1|Overall Study|Lack of Efficacy|0
937315|NCT00860262|3088184|P3|Overall Study|Withdrawal by Subject|6
937316|NCT00860262|3088185|P2|Overall Study|Withdrawal by Subject|8
937317|NCT00860262|3088186|P1|Overall Study|Withdrawal by Subject|4
937318|NCT00860262|3088184|P3|Overall Study|Lost to Follow-up|1
937319|NCT00860262|3088185|P2|Overall Study|Lost to Follow-up|0
937320|NCT00860262|3088186|P1|Overall Study|Lost to Follow-up|2
937321|NCT00860262|3088184|P3|Overall Study|Protocol Violation|0
937322|NCT00860262|3088185|P2|Overall Study|Protocol Violation|1
937323|NCT00860262|3088186|P1|Overall Study|Protocol Violation|0
937324|NCT00860262|3088184|P3|Overall Study|Adverse Event|7
937325|NCT00860262|3088185|P2|Overall Study|Adverse Event|6
937326|NCT00860262|3088186|P1|Overall Study|Adverse Event|9
937327|NCT00860249|3088299|P3|Overall Study|trial was terminated prior to completion|21
937328|NCT00860249|3088300|P2|Overall Study|trial was terminated prior to completion|18
937329|NCT00860249|3088301|P1|Overall Study|trial was terminated prior to completion|21
937330|NCT00860158|3088319|P1|Overall Study|Study Terminated|1
937331|NCT00860067|3088331|P3|Overall Study|Pregnancy|0
937332|NCT00860067|3088332|P2|Overall Study|Pregnancy|0
937333|NCT00860067|3088333|P1|Overall Study|Pregnancy|1
937334|NCT00860067|3088331|P3|Overall Study|Withdrawal by Subject|0
937335|NCT00860067|3088332|P2|Overall Study|Withdrawal by Subject|0
937336|NCT00860067|3088333|P1|Overall Study|Withdrawal by Subject|4
937337|NCT00860067|3088331|P3|Overall Study|Lost to Follow-up|9
937338|NCT00860067|3088332|P2|Overall Study|Lost to Follow-up|9
937339|NCT00860067|3088333|P1|Overall Study|Lost to Follow-up|46
937340|NCT00860028|3088393|P2|Placebo Controlled Pretreatment Period|No longer interested in treatment|1
937341|NCT00860028|3088394|P1|Placebo Controlled Pretreatment Period|No longer interested in treatment|2
937342|NCT00859937|3088415|P2|Overall Study|Protocol Violation|0
937343|NCT00859937|3088416|P1|Overall Study|Protocol Violation|1
937344|NCT00859898|3088431|P3|Overall Study|non-specified|1
937345|NCT00859898|3088432|P2|Overall Study|non-specified|1
937346|NCT00859898|3088433|P1|Overall Study|non-specified|1
937347|NCT00859898|3088431|P3|Overall Study|No longer meets criteria|0
937348|NCT00859898|3088432|P2|Overall Study|No longer meets criteria|1
937349|NCT00859898|3088433|P1|Overall Study|No longer meets criteria|0
937350|NCT00859898|3088431|P3|Overall Study|poor/non-compliance|0
937351|NCT00859898|3088432|P2|Overall Study|poor/non-compliance|0
937352|NCT00859898|3088433|P1|Overall Study|poor/non-compliance|2
937353|NCT00859898|3088431|P3|Overall Study|Lost to Follow-up|5
937354|NCT00859898|3088432|P2|Overall Study|Lost to Follow-up|11
937355|NCT00859898|3088433|P1|Overall Study|Lost to Follow-up|10
937356|NCT00859898|3088431|P3|Overall Study|Death|1
937357|NCT00859898|3088432|P2|Overall Study|Death|0
937358|NCT00859898|3088433|P1|Overall Study|Death|0
937359|NCT00859898|3088431|P3|Overall Study|Withdrawal by Subject|11
937360|NCT00859898|3088432|P2|Overall Study|Withdrawal by Subject|8
937361|NCT00859898|3088433|P1|Overall Study|Withdrawal by Subject|11
937362|NCT00859898|3088431|P3|Overall Study|Adverse Event|8
937363|NCT00859898|3088432|P2|Overall Study|Adverse Event|9
937364|NCT00859898|3088433|P1|Overall Study|Adverse Event|4
937365|NCT00859898|3088431|P3|Overall Study|Lack of Efficacy|1
937366|NCT00859898|3088432|P2|Overall Study|Lack of Efficacy|1
937367|NCT00859898|3088433|P1|Overall Study|Lack of Efficacy|0
937368|NCT00859638|3088492|P2|Overall Study|Ill health|1
937369|NCT00859638|3088493|P1|Overall Study|Ill health|1
937370|NCT00859638|3088492|P2|Overall Study|Withdrawal by Subject|2
937371|NCT00859638|3088493|P1|Overall Study|Withdrawal by Subject|3
937372|NCT00859638|3088492|P2|Overall Study|Lost to Follow-up|1
937373|NCT00859638|3088493|P1|Overall Study|Lost to Follow-up|6
937374|NCT00859586|3088499|P1|Overall Study|Donors|4
937375|NCT00859573|3088505|P2|Overall Study|Physician Decision|1
937376|NCT00859573|3088506|P1|Overall Study|Physician Decision|1
937377|NCT00859573|3088505|P2|Overall Study|Withdrawal by Subject|1
937378|NCT00859573|3088506|P1|Overall Study|Withdrawal by Subject|4
937379|NCT00859547|3088512|P1|Overall Study|Parent withdrew consent|1
937380|NCT00859547|3088512|P1|Overall Study|Lost to Follow-up|1
937381|NCT00859521|3088525|P2|Washout|Withdrawal by Subject|1
937382|NCT00859521|3088526|P1|Washout|Withdrawal by Subject|0
937383|NCT00859469|3088543|P1|Overall Study|Death|16
937384|NCT00859469|3088543|P1|Overall Study|Withdrawal by Subject|1
937385|NCT00859469|3088543|P1|Overall Study|Lack of Efficacy|9
937386|NCT00859469|3088543|P1|Overall Study|Adverse Event|2
937387|NCT00859430|3088551|P2|First Intervention|Withdrawal by Subject|1
937388|NCT00859430|3088552|P1|First Intervention|Withdrawal by Subject|0
937389|NCT00859313|3088568|P1|Overall Study|staff error|1
937390|NCT00859313|3088568|P1|Overall Study|Adverse Event|1
937391|NCT00859313|3088568|P1|Overall Study|Lack of Efficacy|2
937392|NCT00859222|3088575|P5|Overall Study|DLT|0
937393|NCT00859222|3088576|P4|Overall Study|DLT|0
937394|NCT00859222|3088577|P3|Overall Study|DLT|0
937395|NCT00859222|3088578|P2|Overall Study|DLT|0
937396|NCT00859222|3088579|P1|Overall Study|DLT|1
937397|NCT00859222|3088575|P5|Overall Study|Adverse Event|15
937398|NCT00859222|3088576|P4|Overall Study|Adverse Event|24
937399|NCT00859222|3088577|P3|Overall Study|Adverse Event|6
937400|NCT00859222|3088578|P2|Overall Study|Adverse Event|3
937401|NCT00859222|3088579|P1|Overall Study|Adverse Event|2
937402|NCT00859014|3088701|P1|Overall Study|Lost to Follow-up|1
937403|NCT00859014|3088701|P1|Overall Study|Death|4
937404|NCT00858845|3088716|P2|Overall Study|Patient underwent heart transplant.|1
937405|NCT00858845|3088717|P1|Overall Study|Patient underwent heart transplant.|0
937406|NCT00858832|3088729|P2|Overall Study|Adverse Event|1
937407|NCT00858832|3088730|P1|Overall Study|Adverse Event|0
937408|NCT00858832|3088729|P2|Overall Study|became ineligible: delivered vaginally|0
937409|NCT00858832|3088730|P1|Overall Study|became ineligible: delivered vaginally|1
937410|NCT00858780|3088736|P5|OL Re-Treatment (Failure to Week 48)|Other|1
937411|NCT00858780|3088737|P4|OL Re-Treatment (Failure to Week 48)|Other|0
937412|NCT00858780|3088738|P3|OL Re-Treatment (Failure to Week 48)|Other|0
937413|NCT00858780|3088739|P2|OL Re-Treatment (Failure to Week 48)|Other|0
937414|NCT00858780|3088740|P1|OL Re-Treatment (Failure to Week 48)|Other|0
937415|NCT00858780|3088736|P5|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1
937416|NCT00858780|3088737|P4|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
937417|NCT00858780|3088738|P3|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
937418|NCT00858780|3088739|P2|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
937419|NCT00858780|3088740|P1|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
937420|NCT00858780|3088736|P5|Double-Blind (Week 0 to Failure/Week 48)|Other|0
937421|NCT00858780|3088737|P4|Double-Blind (Week 0 to Failure/Week 48)|Other|0
937422|NCT00858780|3088738|P3|Double-Blind (Week 0 to Failure/Week 48)|Other|0
937423|NCT00858780|3088739|P2|Double-Blind (Week 0 to Failure/Week 48)|Other|1
937424|NCT00858780|3088740|P1|Double-Blind (Week 0 to Failure/Week 48)|Other|0
937425|NCT00858780|3088736|P5|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
937426|NCT00858780|3088737|P4|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
937427|NCT00858780|3088738|P3|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
937428|NCT00858780|3088739|P2|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
937429|NCT00858780|3088740|P1|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
937430|NCT00858780|3088736|P5|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
937431|NCT00858780|3088737|P4|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
937432|NCT00858780|3088738|P3|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1
937433|NCT00858780|3088739|P2|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
937434|NCT00858780|3088740|P1|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
937435|NCT00858780|3088736|P5|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
937436|NCT00858780|3088737|P4|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
937437|NCT00858780|3088738|P3|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
937438|NCT00858780|3088739|P2|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
937439|NCT00858780|3088740|P1|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18
937440|NCT00858702|3088815|P2|Overall Study|Withdrawal by Subject|0
937441|NCT00858702|3088816|P1|Overall Study|Withdrawal by Subject|1
937442|NCT00858702|3088815|P2|Overall Study|Other|1
937443|NCT00858702|3088816|P1|Overall Study|Other|2
937444|NCT00858702|3088815|P2|Overall Study|Protocol Violation|1
937445|NCT00858702|3088816|P1|Overall Study|Protocol Violation|1
937446|NCT00858702|3088815|P2|Overall Study|Lack of Efficacy|0
937447|NCT00858702|3088816|P1|Overall Study|Lack of Efficacy|1
937448|NCT00858637|3088831|P6|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1
937449|NCT00858637|3088832|P5|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
937450|NCT00858637|3088833|P4|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
937451|NCT00858637|3088834|P3|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
937452|NCT00858637|3088835|P2|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
937453|NCT00858637|3088836|P1|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
937454|NCT00858637|3088831|P6|Placebo-controlled Withdrawal Phase|Death|0
937455|NCT00858637|3088832|P5|Placebo-controlled Withdrawal Phase|Death|1
937456|NCT00858637|3088833|P4|Placebo-controlled Withdrawal Phase|Death|0
937457|NCT00858637|3088834|P3|Placebo-controlled Withdrawal Phase|Death|1
937458|NCT00858637|3088835|P2|Placebo-controlled Withdrawal Phase|Death|0
937459|NCT00858637|3088836|P1|Placebo-controlled Withdrawal Phase|Death|0
937460|NCT00858637|3088831|P6|Active Comparison Phase|Other Reasons|0
937461|NCT00858637|3088832|P5|Active Comparison Phase|Other Reasons|0
937462|NCT00858637|3088833|P4|Active Comparison Phase|Other Reasons|1
937463|NCT00858637|3088834|P3|Active Comparison Phase|Other Reasons|0
937464|NCT00858637|3088835|P2|Active Comparison Phase|Other Reasons|0
937465|NCT00858637|3088836|P1|Active Comparison Phase|Other Reasons|1
937466|NCT00858637|3088831|P6|Active Comparison Phase|Withdrawal by Subject|0
937467|NCT00858637|3088832|P5|Active Comparison Phase|Withdrawal by Subject|0
937468|NCT00858637|3088833|P4|Active Comparison Phase|Withdrawal by Subject|6
937469|NCT00858637|3088834|P3|Active Comparison Phase|Withdrawal by Subject|0
937470|NCT00858637|3088835|P2|Active Comparison Phase|Withdrawal by Subject|0
937471|NCT00858637|3088836|P1|Active Comparison Phase|Withdrawal by Subject|7
937472|NCT00858637|3088831|P6|Active Comparison Phase|Physician Decision|0
937473|NCT00858637|3088832|P5|Active Comparison Phase|Physician Decision|0
937474|NCT00858637|3088833|P4|Active Comparison Phase|Physician Decision|1
937475|NCT00858637|3088834|P3|Active Comparison Phase|Physician Decision|0
937476|NCT00858637|3088835|P2|Active Comparison Phase|Physician Decision|0
937477|NCT00858637|3088836|P1|Active Comparison Phase|Physician Decision|1
937478|NCT00858637|3088831|P6|Active Comparison Phase|Death|0
937479|NCT00858637|3088832|P5|Active Comparison Phase|Death|0
937480|NCT00858637|3088833|P4|Active Comparison Phase|Death|1
937481|NCT00858637|3088834|P3|Active Comparison Phase|Death|0
937482|NCT00858637|3088835|P2|Active Comparison Phase|Death|0
937483|NCT00858637|3088836|P1|Active Comparison Phase|Death|1
937484|NCT00858637|3088831|P6|Active Comparison Phase|Adverse Event|0
937485|NCT00858637|3088832|P5|Active Comparison Phase|Adverse Event|0
937486|NCT00858637|3088833|P4|Active Comparison Phase|Adverse Event|9
937487|NCT00858637|3088834|P3|Active Comparison Phase|Adverse Event|0
937488|NCT00858637|3088835|P2|Active Comparison Phase|Adverse Event|0
937489|NCT00858637|3088836|P1|Active Comparison Phase|Adverse Event|14
937490|NCT00858442|3088877|P2|Compression:Start to Finish|Lost to Follow-up|3
937491|NCT00858442|3088878|P1|Compression:Start to Finish|Lost to Follow-up|1
937492|NCT00858403|3088888|P1|Overall Study|Disease Progression|1
937493|NCT00858403|3088888|P1|Overall Study|Death|3
937494|NCT00858403|3088888|P1|Overall Study|Withdrawal by Subject|1
937495|NCT00858364|3088909|P2|Overall Study|Still on-study|247
937496|NCT00858364|3088910|P1|Overall Study|Still on-study|114
937497|NCT00858364|3088909|P2|Overall Study|Missing|1
937498|NCT00858364|3088910|P1|Overall Study|Missing|1
937499|NCT00858364|3088909|P2|Overall Study|Other|17
937500|NCT00858364|3088910|P1|Overall Study|Other|9
937501|NCT00858364|3088909|P2|Overall Study|Protocol Deviation|2
937502|NCT00858364|3088910|P1|Overall Study|Protocol Deviation|0
937503|NCT00858364|3088909|P2|Overall Study|Noncompliance|4
937504|NCT00858364|3088910|P1|Overall Study|Noncompliance|3
937505|NCT00858364|3088909|P2|Overall Study|Lost to Follow-up|54
937506|NCT00858364|3088910|P1|Overall Study|Lost to Follow-up|24
937507|NCT00858364|3088909|P2|Overall Study|Ineligibility Determined|10
937508|NCT00858364|3088910|P1|Overall Study|Ineligibility Determined|1
937509|NCT00858364|3088909|P2|Overall Study|Withdrawal by Subject|118
937510|NCT00858364|3088910|P1|Overall Study|Withdrawal by Subject|44
937511|NCT00858364|3088909|P2|Overall Study|Adverse Event|2
937512|NCT00858364|3088910|P1|Overall Study|Adverse Event|5
937513|NCT00858364|3088909|P2|Overall Study|Administrative Decision|2
937514|NCT00858364|3088910|P1|Overall Study|Administrative Decision|3
937515|NCT00858247|3088932|P2|Week 12 Follow-up|Withdrawal by Subject|1
937516|NCT00858247|3088933|P1|Week 12 Follow-up|Withdrawal by Subject|0
937517|NCT00858247|3088932|P2|Baseline Assessment|Protocol Violation|1
937518|NCT00858247|3088933|P1|Baseline Assessment|Protocol Violation|0
937519|NCT00858247|3088932|P2|Baseline Assessment|Poor IV access|0
937520|NCT00858247|3088933|P1|Baseline Assessment|Poor IV access|1
937521|NCT00858247|3088932|P2|Baseline Assessment|Withdrawal by Subject|1
937522|NCT00858247|3088933|P1|Baseline Assessment|Withdrawal by Subject|1
937523|NCT00858208|3088949|P1|Overall Study|Other|10
937524|NCT00858208|3088949|P1|Overall Study|Participant refused|40
937525|NCT00858208|3088949|P1|Overall Study|Lost to Follow-up|26
937526|NCT00858208|3088949|P1|Overall Study|Adverse Event|3
937527|NCT00858143|3088966|P1|Overall Study|Other|23
937528|NCT00858143|3088966|P1|Overall Study|Death|7
937529|NCT00858143|3088966|P1|Overall Study|Lack of Efficacy|4
937530|NCT00858143|3088966|P1|Overall Study|Adverse Event|16
937531|NCT00857948|3089078|P4|Overall Study|Protocol Violation|0
937532|NCT00857948|3089079|P3|Overall Study|Protocol Violation|1
937533|NCT00857948|3089080|P2|Overall Study|Protocol Violation|0
937534|NCT00857948|3089081|P1|Overall Study|Protocol Violation|1
937535|NCT00857948|3089078|P4|Overall Study|Withdrawal by Subject|0
937536|NCT00857948|3089079|P3|Overall Study|Withdrawal by Subject|0
937537|NCT00857948|3089080|P2|Overall Study|Withdrawal by Subject|0
937538|NCT00857948|3089081|P1|Overall Study|Withdrawal by Subject|2
937539|NCT00857896|3089103|P1|Baseline to Week 4|Withdrawal by Subject|1
937540|NCT00857818|3089259|P2|Overall Study|Investigator decision|0
937541|NCT00857818|3089260|P1|Overall Study|Investigator decision|1
937542|NCT00857818|3089259|P2|Overall Study|Sponsor terminated study|4
937543|NCT00857818|3089260|P1|Overall Study|Sponsor terminated study|6
937544|NCT00857818|3089259|P2|Overall Study|Withdrawal by Subject|4
937545|NCT00857818|3089260|P1|Overall Study|Withdrawal by Subject|0
937546|NCT00857818|3089259|P2|Overall Study|Adverse Event|0
937547|NCT00857818|3089260|P1|Overall Study|Adverse Event|3
937548|NCT00857818|3089259|P2|Overall Study|Lack of Efficacy|0
937549|NCT00857818|3089260|P1|Overall Study|Lack of Efficacy|1
937550|NCT00857792|3089288|P1|Overall Study|inadequate image quality for analysis|12
937551|NCT00857766|3089294|P2|Overall Study|Participant Withdrew Consent|4
937552|NCT00857766|3089295|P1|Overall Study|Participant Withdrew Consent|4
937553|NCT00857766|3089294|P2|Overall Study|Investigator Discretion|3
937554|NCT00857766|3089295|P1|Overall Study|Investigator Discretion|2
937555|NCT00857766|3089294|P2|Overall Study|Lost to Follow-up|0
937556|NCT00857766|3089295|P1|Overall Study|Lost to Follow-up|1
937557|NCT00857766|3089294|P2|Overall Study|Protocol Violation|11
937558|NCT00857766|3089295|P1|Overall Study|Protocol Violation|11
937559|NCT00857766|3089294|P2|Overall Study|Adverse Event|12
937560|NCT00857766|3089295|P1|Overall Study|Adverse Event|13
937561|NCT00857649|3089337|P2|Overall Study|Other Reasons|3
937562|NCT00857649|3089338|P1|Overall Study|Other Reasons|1
937563|NCT00857649|3089337|P2|Overall Study|Nursing Home Placement|9
937564|NCT00857649|3089338|P1|Overall Study|Nursing Home Placement|2
937565|NCT00857649|3089337|P2|Overall Study|Withdrawal of Consent|7
937566|NCT00857649|3089338|P1|Overall Study|Withdrawal of Consent|10
937567|NCT00857649|3089337|P2|Overall Study|Protocol Violation|2
937568|NCT00857649|3089338|P1|Overall Study|Protocol Violation|2
937569|NCT00857649|3089337|P2|Overall Study|Non-compliance|1
937570|NCT00857649|3089338|P1|Overall Study|Non-compliance|1
937571|NCT00857649|3089337|P2|Overall Study|Adverse Event|10
937572|NCT00857649|3089338|P1|Overall Study|Adverse Event|15
937573|NCT00857623|3089354|P2|Overall Study|Positive for HEP C|1
937574|NCT00857623|3089355|P1|Overall Study|Positive for HEP C|0
937575|NCT00857623|3089354|P2|Overall Study|Intake of prohibited medication|1
937576|NCT00857623|3089355|P1|Overall Study|Intake of prohibited medication|0
937577|NCT00857623|3089354|P2|Overall Study|Severe non-compliance to protocol|1
937578|NCT00857623|3089355|P1|Overall Study|Severe non-compliance to protocol|1
937579|NCT00857623|3089354|P2|Overall Study|Lack of Efficacy|1
937580|NCT00857623|3089355|P1|Overall Study|Lack of Efficacy|1
937581|NCT00857623|3089354|P2|Overall Study|Withdrawal by Subject|1
937582|NCT00857623|3089355|P1|Overall Study|Withdrawal by Subject|2
937583|NCT00857623|3089354|P2|Overall Study|Study-specific discontinuation criteria|3
937584|NCT00857623|3089355|P1|Overall Study|Study-specific discontinuation criteria|5
937585|NCT00857623|3089354|P2|Overall Study|Adverse Event|2
937586|NCT00857623|3089355|P1|Overall Study|Adverse Event|5
937587|NCT00857584|3089379|P2|Overall Study|Physician Decision|1
937588|NCT00857584|3089380|P1|Overall Study|Physician Decision|1
937589|NCT00857584|3089379|P2|Overall Study|Adverse Event|2
937590|NCT00857584|3089380|P1|Overall Study|Adverse Event|2
937591|NCT00857584|3089379|P2|Overall Study|Lack of Efficacy|2
937592|NCT00857584|3089380|P1|Overall Study|Lack of Efficacy|1
937593|NCT00857454|3089472|P1|Overall Study|MTE09 enrollment criteria not met|6
937594|NCT00857454|3089472|P1|Overall Study|Total Testosterone <300 ng/dL|8
937595|NCT00857454|3089472|P1|Overall Study|Total Testosterone >1050 ng/dL|1
937596|NCT00857454|3089472|P1|Overall Study|Adverse Event|2
937597|NCT00857454|3089472|P1|Overall Study|Lost to Follow-up|1
937598|NCT00857454|3089472|P1|Overall Study|Withdrawal by Subject|2
937599|NCT00857415|3089485|P2|Overall Study|Deceased with no autopsy|0
937600|NCT00857415|3089486|P1|Overall Study|Deceased with no autopsy|2
937601|NCT00857415|3089485|P2|Overall Study|Subject still living at end of study|0
937602|NCT00857415|3089486|P1|Overall Study|Subject still living at end of study|110
937603|NCT00857415|3089485|P2|Overall Study|Invalid image or not imaged|0
937604|NCT00857415|3089486|P1|Overall Study|Invalid image or not imaged|3
937605|NCT00857415|3089485|P2|Overall Study|Image acquisition failure|0
937606|NCT00857415|3089486|P1|Overall Study|Image acquisition failure|2
937607|NCT00857311|3089497|P4|Overall Study|Lost to Follow-up|0
937608|NCT00857311|3089498|P3|Overall Study|Lost to Follow-up|0
937609|NCT00857311|3089499|P2|Overall Study|Lost to Follow-up|0
937610|NCT00857311|3089500|P1|Overall Study|Lost to Follow-up|1
937611|NCT00857285|3089512|P2|Overall Study|Randomization criteria not met|1
937612|NCT00857285|3089513|P1|Overall Study|Randomization criteria not met|1
937613|NCT00857285|3089512|P2|Overall Study|Withdrawal by Subject|0
937614|NCT00857285|3089513|P1|Overall Study|Withdrawal by Subject|4
937615|NCT00857285|3089512|P2|Overall Study|Protocol Violation|1
937616|NCT00857285|3089513|P1|Overall Study|Protocol Violation|3
937617|NCT00857285|3089512|P2|Overall Study|Lack of Efficacy|2
937618|NCT00857285|3089513|P1|Overall Study|Lack of Efficacy|0
937619|NCT00857285|3089512|P2|Overall Study|Adverse Event|2
937620|NCT00857285|3089513|P1|Overall Study|Adverse Event|4
937621|NCT00857259|3089529|P3|Overall Study|Protocol Violation|1
937622|NCT00857259|3089530|P2|Overall Study|Protocol Violation|0
937623|NCT00857259|3089531|P1|Overall Study|Protocol Violation|1
937624|NCT00857246|3089541|P1|ChemoRT|Adverse Event|2
937625|NCT00857246|3089541|P1|ChemoRT|Withdrawal by Subject|1
937626|NCT00857246|3089541|P1|Surgery (Curative)|disease progression|6
937627|NCT00857246|3089541|P1|Induction Regimen|Withdrawal by Subject|1
937628|NCT00857246|3089541|P1|Induction Regimen|disease-related complications|1
937629|NCT00857246|3089541|P1|Induction Regimen|Adverse Event|1
937630|NCT00857233|3089551|P1|Overall Study|Other Reasons|2
937631|NCT00857233|3089551|P1|Overall Study|Nursing Home Placement|14
937632|NCT00857233|3089551|P1|Overall Study|Lost to Follow-up|4
937633|NCT00857233|3089551|P1|Overall Study|Withdrawal of Consent|9
937634|NCT00857233|3089551|P1|Overall Study|Non-compliance|1
937635|NCT00857233|3089551|P1|Overall Study|Lack of Efficacy|1
937636|NCT00857233|3089551|P1|Overall Study|Adverse Event|24
937637|NCT00857220|3089560|P1|Overall Study|Miscellaneous|8
937638|NCT00857220|3089560|P1|Overall Study|Site Closed|5
937639|NCT00857220|3089560|P1|Overall Study|Clinical Hold|6
937640|NCT00857220|3089560|P1|Overall Study|Withdrawal by Subject|67
937641|NCT00857220|3089560|P1|Overall Study|Protocol Violation|16
937642|NCT00857220|3089560|P1|Overall Study|Physician Decision|4
937643|NCT00857220|3089560|P1|Overall Study|Lost to Follow-up|30
937644|NCT00857220|3089560|P1|Overall Study|Lack of Efficacy|11
937645|NCT00857220|3089560|P1|Overall Study|Death|1
937646|NCT00857220|3089560|P1|Overall Study|Adverse Event|35
937647|NCT00856986|3089582|P5|Extension Period, Weeks 26-52|Unclassified|0
937648|NCT00856986|3089583|P4|Extension Period, Weeks 26-52|Unclassified|0
937649|NCT00856986|3089584|P3|Extension Period, Weeks 26-52|Unclassified|11
937650|NCT00856986|3089585|P2|Extension Period, Weeks 26-52|Unclassified|2
937651|NCT00856986|3089586|P1|Extension Period, Weeks 26-52|Unclassified|4
937652|NCT00856986|3089582|P5|Extension Period, Weeks 26-52|Lack of Efficacy|0
937653|NCT00856986|3089583|P4|Extension Period, Weeks 26-52|Lack of Efficacy|0
937654|NCT00856986|3089584|P3|Extension Period, Weeks 26-52|Lack of Efficacy|2
937655|NCT00856986|3089585|P2|Extension Period, Weeks 26-52|Lack of Efficacy|2
937656|NCT00856986|3089586|P1|Extension Period, Weeks 26-52|Lack of Efficacy|4
937657|NCT00856986|3089582|P5|Extension Period, Weeks 26-52|Lost to Follow-up|0
937658|NCT00856986|3089583|P4|Extension Period, Weeks 26-52|Lost to Follow-up|0
937659|NCT00856986|3089584|P3|Extension Period, Weeks 26-52|Lost to Follow-up|2
937660|NCT00856986|3089585|P2|Extension Period, Weeks 26-52|Lost to Follow-up|5
937661|NCT00856986|3089586|P1|Extension Period, Weeks 26-52|Lost to Follow-up|0
937662|NCT00856986|3089582|P5|Extension Period, Weeks 26-52|Withdrawal Criteria|0
937663|NCT00856986|3089583|P4|Extension Period, Weeks 26-52|Withdrawal Criteria|0
937664|NCT00856986|3089584|P3|Extension Period, Weeks 26-52|Withdrawal Criteria|8
937665|NCT00856986|3089585|P2|Extension Period, Weeks 26-52|Withdrawal Criteria|0
937666|NCT00856986|3089586|P1|Extension Period, Weeks 26-52|Withdrawal Criteria|2
937667|NCT00856986|3089582|P5|Extension Period, Weeks 26-52|Protocol Violation|0
937668|NCT00856986|3089583|P4|Extension Period, Weeks 26-52|Protocol Violation|0
937669|NCT00856986|3089584|P3|Extension Period, Weeks 26-52|Protocol Violation|5
937670|NCT00856986|3089585|P2|Extension Period, Weeks 26-52|Protocol Violation|2
937671|NCT00856986|3089586|P1|Extension Period, Weeks 26-52|Protocol Violation|6
937672|NCT00856986|3089582|P5|Extension Period, Weeks 26-52|Adverse Event|0
937673|NCT00856986|3089583|P4|Extension Period, Weeks 26-52|Adverse Event|0
937674|NCT00856986|3089584|P3|Extension Period, Weeks 26-52|Adverse Event|10
937675|NCT00856986|3089585|P2|Extension Period, Weeks 26-52|Adverse Event|3
937676|NCT00856986|3089586|P1|Extension Period, Weeks 26-52|Adverse Event|3
937677|NCT00856986|3089582|P5|Main Period, Weeks 0-26|Unclassified|0
937678|NCT00856986|3089583|P4|Main Period, Weeks 0-26|Unclassified|0
937679|NCT00856986|3089584|P3|Main Period, Weeks 0-26|Unclassified|7
937680|NCT00856986|3089585|P2|Main Period, Weeks 0-26|Unclassified|6
937681|NCT00856986|3089586|P1|Main Period, Weeks 0-26|Unclassified|7
937682|NCT00856986|3089582|P5|Main Period, Weeks 0-26|Lack of Efficacy|0
937683|NCT00856986|3089583|P4|Main Period, Weeks 0-26|Lack of Efficacy|0
937684|NCT00856986|3089584|P3|Main Period, Weeks 0-26|Lack of Efficacy|0
937685|NCT00856986|3089585|P2|Main Period, Weeks 0-26|Lack of Efficacy|2
937686|NCT00856986|3089586|P1|Main Period, Weeks 0-26|Lack of Efficacy|5
937687|NCT00856986|3089582|P5|Main Period, Weeks 0-26|Lost to Follow-up|0
937688|NCT00856986|3089583|P4|Main Period, Weeks 0-26|Lost to Follow-up|0
937689|NCT00856986|3089584|P3|Main Period, Weeks 0-26|Lost to Follow-up|2
937690|NCT00856986|3089585|P2|Main Period, Weeks 0-26|Lost to Follow-up|1
937691|NCT00856986|3089586|P1|Main Period, Weeks 0-26|Lost to Follow-up|1
937692|NCT00856986|3089582|P5|Main Period, Weeks 0-26|Withdrawal Criteria|0
937693|NCT00856986|3089583|P4|Main Period, Weeks 0-26|Withdrawal Criteria|0
937694|NCT00856986|3089584|P3|Main Period, Weeks 0-26|Withdrawal Criteria|3
937695|NCT00856986|3089585|P2|Main Period, Weeks 0-26|Withdrawal Criteria|0
937696|NCT00856986|3089586|P1|Main Period, Weeks 0-26|Withdrawal Criteria|11
937697|NCT00856986|3089582|P5|Main Period, Weeks 0-26|Protocol Violation|0
937698|NCT00856986|3089583|P4|Main Period, Weeks 0-26|Protocol Violation|0
937699|NCT00856986|3089584|P3|Main Period, Weeks 0-26|Protocol Violation|7
937700|NCT00856986|3089585|P2|Main Period, Weeks 0-26|Protocol Violation|5
937701|NCT00856986|3089586|P1|Main Period, Weeks 0-26|Protocol Violation|4
937702|NCT00856986|3089582|P5|Main Period, Weeks 0-26|Adverse Event|0
937703|NCT00856986|3089583|P4|Main Period, Weeks 0-26|Adverse Event|0
937704|NCT00856986|3089584|P3|Main Period, Weeks 0-26|Adverse Event|9
937705|NCT00856986|3089585|P2|Main Period, Weeks 0-26|Adverse Event|4
937706|NCT00856986|3089586|P1|Main Period, Weeks 0-26|Adverse Event|6
937707|NCT00856986|3089582|P5|Run-in Period, Weeks -12-0|Unclassified|0
937708|NCT00856986|3089583|P4|Run-in Period, Weeks -12-0|Unclassified|24
937709|NCT00856986|3089584|P3|Run-in Period, Weeks -12-0|Unclassified|0
937710|NCT00856986|3089585|P2|Run-in Period, Weeks -12-0|Unclassified|0
937711|NCT00856986|3089586|P1|Run-in Period, Weeks -12-0|Unclassified|0
937712|NCT00856986|3089582|P5|Run-in Period, Weeks -12-0|Lack of Efficacy|0
937713|NCT00856986|3089583|P4|Run-in Period, Weeks -12-0|Lack of Efficacy|6
937714|NCT00856986|3089584|P3|Run-in Period, Weeks -12-0|Lack of Efficacy|0
937715|NCT00856986|3089585|P2|Run-in Period, Weeks -12-0|Lack of Efficacy|0
937716|NCT00856986|3089586|P1|Run-in Period, Weeks -12-0|Lack of Efficacy|0
937717|NCT00856986|3089582|P5|Run-in Period, Weeks -12-0|Lost to Follow-up|0
937718|NCT00856986|3089583|P4|Run-in Period, Weeks -12-0|Lost to Follow-up|11
937719|NCT00856986|3089584|P3|Run-in Period, Weeks -12-0|Lost to Follow-up|0
937720|NCT00856986|3089585|P2|Run-in Period, Weeks -12-0|Lost to Follow-up|0
937721|NCT00856986|3089586|P1|Run-in Period, Weeks -12-0|Lost to Follow-up|0
937722|NCT00856986|3089582|P5|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
937723|NCT00856986|3089583|P4|Run-in Period, Weeks -12-0|Withdrawal Criteria|10
937724|NCT00856986|3089584|P3|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
937725|NCT00856986|3089585|P2|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
937726|NCT00856986|3089586|P1|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
937727|NCT00856986|3089582|P5|Run-in Period, Weeks -12-0|Protocol Violation|0
937728|NCT00856986|3089583|P4|Run-in Period, Weeks -12-0|Protocol Violation|24
937729|NCT00856986|3089584|P3|Run-in Period, Weeks -12-0|Protocol Violation|0
937730|NCT00856986|3089585|P2|Run-in Period, Weeks -12-0|Protocol Violation|0
937731|NCT00856986|3089586|P1|Run-in Period, Weeks -12-0|Protocol Violation|0
937732|NCT00856986|3089582|P5|Run-in Period, Weeks -12-0|Adverse Event|0
937733|NCT00856986|3089583|P4|Run-in Period, Weeks -12-0|Adverse Event|92
937734|NCT00856986|3089584|P3|Run-in Period, Weeks -12-0|Adverse Event|0
937735|NCT00856986|3089585|P2|Run-in Period, Weeks -12-0|Adverse Event|0
937736|NCT00856986|3089586|P1|Run-in Period, Weeks -12-0|Adverse Event|0
937737|NCT00856973|3089756|P3|Overall Study|Other|13
937738|NCT00856973|3089757|P2|Overall Study|Other|12
937739|NCT00856973|3089758|P1|Overall Study|Other|11
937740|NCT00856973|3089756|P3|Overall Study|Withdrawal by Subject|15
937741|NCT00856973|3089757|P2|Overall Study|Withdrawal by Subject|16
937742|NCT00856973|3089758|P1|Overall Study|Withdrawal by Subject|13
937743|NCT00856973|3089756|P3|Overall Study|Protocol Violation|1
937744|NCT00856973|3089757|P2|Overall Study|Protocol Violation|2
937745|NCT00856973|3089758|P1|Overall Study|Protocol Violation|1
937746|NCT00856973|3089756|P3|Overall Study|Physician Decision|1
937747|NCT00856973|3089757|P2|Overall Study|Physician Decision|3
937748|NCT00856973|3089758|P1|Overall Study|Physician Decision|0
937749|NCT00856973|3089756|P3|Overall Study|Lost to Follow-up|5
937750|NCT00856973|3089757|P2|Overall Study|Lost to Follow-up|3
937751|NCT00856973|3089758|P1|Overall Study|Lost to Follow-up|6
937752|NCT00856973|3089756|P3|Overall Study|Adverse Event|3
937753|NCT00856973|3089757|P2|Overall Study|Adverse Event|5
937754|NCT00856973|3089758|P1|Overall Study|Adverse Event|5
937755|NCT00856908|3089838|P2|Overall Study|Lost to Follow-up|0
937756|NCT00856908|3089839|P1|Overall Study|Lost to Follow-up|1
937757|NCT00856843|3089866|P2|Overall Study|Lack of Efficacy|0
937758|NCT00856843|3089867|P1|Overall Study|Lack of Efficacy|1
937759|NCT00856843|3089866|P2|Overall Study|Withdrawal by Subject|5
937760|NCT00856843|3089867|P1|Overall Study|Withdrawal by Subject|1
937761|NCT00856830|3089903|P4|Irinotecan & Bendamustine|Physician Decision|1
937762|NCT00856830|3089904|P3|Irinotecan & Bendamustine|Physician Decision|0
937763|NCT00856830|3089905|P2|Irinotecan & Bendamustine|Physician Decision|0
937764|NCT00856830|3089906|P1|Irinotecan & Bendamustine|Physician Decision|0
937765|NCT00856830|3089903|P4|Irinotecan & Bendamustine|Death|2
937766|NCT00856830|3089904|P3|Irinotecan & Bendamustine|Death|0
937767|NCT00856830|3089905|P2|Irinotecan & Bendamustine|Death|0
937768|NCT00856830|3089906|P1|Irinotecan & Bendamustine|Death|0
937769|NCT00856778|3089917|P1|Overall Study|Lost to Follow-up|5
937770|NCT00856778|3089917|P1|Overall Study|Study deviation|2
937771|NCT00856778|3089917|P1|Overall Study|Withdrawal by Subject|10
937772|NCT00856778|3089917|P1|Overall Study|Adverse Event|7
937773|NCT00856661|3089960|P2|Overall Study|Physician Judgement|5
937774|NCT00856661|3089961|P1|Overall Study|Physician Judgement|8
937775|NCT00856661|3089960|P2|Overall Study|Lost to Follow-up|3
937776|NCT00856661|3089961|P1|Overall Study|Lost to Follow-up|1
937777|NCT00856661|3089960|P2|Overall Study|Withdrawal by Subject|2
937778|NCT00856661|3089961|P1|Overall Study|Withdrawal by Subject|1
937779|NCT00856661|3089960|P2|Overall Study|Protocol Violation|1
937780|NCT00856661|3089961|P1|Overall Study|Protocol Violation|2
937781|NCT00856661|3089960|P2|Overall Study|Death|18
937782|NCT00856661|3089961|P1|Overall Study|Death|15
937783|NCT00856635|3089975|P2|Overall Study|Discontinued at Randomization|2
937784|NCT00856635|3089976|P1|Overall Study|Discontinued at Randomization|2
937785|NCT00856635|3089975|P2|Overall Study|Other|0
937786|NCT00856635|3089976|P1|Overall Study|Other|1
937787|NCT00856635|3089975|P2|Overall Study|Serious Adverse Event|0
937788|NCT00856635|3089976|P1|Overall Study|Serious Adverse Event|1
937789|NCT00856635|3089975|P2|Overall Study|Withdrawal by Subject|1
937790|NCT00856635|3089976|P1|Overall Study|Withdrawal by Subject|3
937791|NCT00856635|3089975|P2|Overall Study|Pregnancy|0
937792|NCT00856635|3089976|P1|Overall Study|Pregnancy|1
937793|NCT00856635|3089975|P2|Overall Study|Lost to Follow-up|5
937794|NCT00856635|3089976|P1|Overall Study|Lost to Follow-up|2
937795|NCT00856609|3089986|P2|Overall Study|Adverse Event|0
937796|NCT00856609|3089987|P1|Overall Study|Adverse Event|1
937797|NCT00856583|3089999|P2|Overall Study|Non-evaluable: Patient on Polytherapy|604
937798|NCT00856583|3090000|P1|Overall Study|Non-evaluable: Patient on Polytherapy|694
937799|NCT00856583|3089999|P2|Overall Study|Other|104
937800|NCT00856583|3090000|P1|Overall Study|Other|92
937801|NCT00856583|3089999|P2|Overall Study|Pregnancy|5
937802|NCT00856583|3090000|P1|Overall Study|Pregnancy|14
937803|NCT00856583|3089999|P2|Overall Study|Physician Decision|82
937804|NCT00856583|3090000|P1|Overall Study|Physician Decision|59
937805|NCT00856583|3089999|P2|Overall Study|Withdrawal by Subject|919
937806|NCT00856583|3090000|P1|Overall Study|Withdrawal by Subject|1092
937807|NCT00856583|3089999|P2|Overall Study|Non-compliance|262
937808|NCT00856583|3090000|P1|Overall Study|Non-compliance|305
937809|NCT00856583|3089999|P2|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179
937810|NCT00856583|3090000|P1|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393
937811|NCT00856583|3089999|P2|Overall Study|Serious Adverse Event (SAE)|65
937812|NCT00856583|3090000|P1|Overall Study|Serious Adverse Event (SAE)|99
937813|NCT00856583|3089999|P2|Overall Study|Lack of Efficacy|377
937814|NCT00856583|3090000|P1|Overall Study|Lack of Efficacy|389
937815|NCT00856557|3090030|P2|Overall Study|No patients with contextual flags|16
937816|NCT00856557|3090031|P1|Overall Study|No patients with contextual flags|12
937817|NCT00856544|3090045|P4|Overall Study|Withdrawal by Subject|1
937818|NCT00856544|3090046|P3|Overall Study|Withdrawal by Subject|0
937819|NCT00856544|3090047|P2|Overall Study|Withdrawal by Subject|5
937820|NCT00856544|3090048|P1|Overall Study|Withdrawal by Subject|8
937821|NCT00856544|3090045|P4|Overall Study|Lost to Follow-up|0
937822|NCT00856544|3090046|P3|Overall Study|Lost to Follow-up|2
937823|NCT00856544|3090047|P2|Overall Study|Lost to Follow-up|2
937824|NCT00856544|3090048|P1|Overall Study|Lost to Follow-up|1
937825|NCT00856544|3090045|P4|Overall Study|Other|6
937826|NCT00856544|3090046|P3|Overall Study|Other|1
937827|NCT00856544|3090047|P2|Overall Study|Other|16
937828|NCT00856544|3090048|P1|Overall Study|Other|9
937829|NCT00856544|3090045|P4|Overall Study|Lack of Efficacy|3
937830|NCT00856544|3090046|P3|Overall Study|Lack of Efficacy|3
937831|NCT00856544|3090047|P2|Overall Study|Lack of Efficacy|12
937832|NCT00856544|3090048|P1|Overall Study|Lack of Efficacy|16
937833|NCT00856544|3090045|P4|Overall Study|Adverse Event|3
937834|NCT00856544|3090046|P3|Overall Study|Adverse Event|2
937835|NCT00856544|3090047|P2|Overall Study|Adverse Event|29
937836|NCT00856544|3090048|P1|Overall Study|Adverse Event|20
937837|NCT00856544|3090045|P4|Overall Study|Death|0
937838|NCT00856544|3090046|P3|Overall Study|Death|0
937839|NCT00856544|3090047|P2|Overall Study|Death|2
937840|NCT00856544|3090048|P1|Overall Study|Death|0
937841|NCT00856544|3090045|P4|Overall Study|Randomized but not treated|0
937842|NCT00856544|3090046|P3|Overall Study|Randomized but not treated|0
937843|NCT00856544|3090047|P2|Overall Study|Randomized but not treated|0
937844|NCT00856544|3090048|P1|Overall Study|Randomized but not treated|3
937845|NCT00856518|3090227|P2|Overall Study|Lost to Follow-up|2
937846|NCT00856518|3090228|P1|Overall Study|Lost to Follow-up|4
937847|NCT00856492|3090241|P3|Overall Study|Ineligible or withdrew consent|2
937848|NCT00856492|3090242|P2|Overall Study|Ineligible or withdrew consent|1
937849|NCT00856492|3090243|P1|Overall Study|Ineligible or withdrew consent|1
937850|NCT00856388|3090265|P1|Overall Study|Not Specified|1
937851|NCT00856349|3090276|P1|Overall Study|Subject changed Dr, insurance issue, etc|130
937852|NCT00856349|3090276|P1|Overall Study|Site closure|78
937853|NCT00856349|3090276|P1|Overall Study|Device explant|33
937854|NCT00856349|3090276|P1|Overall Study|Subject relocation|104
937855|NCT00856349|3090276|P1|Overall Study|Physician Decision|13
937856|NCT00856349|3090276|P1|Overall Study|Protocol Violation|38
937857|NCT00856349|3090276|P1|Overall Study|Lost to Follow-up|91
937858|NCT00856349|3090276|P1|Overall Study|Withdrawal by Subject|116
937859|NCT00856349|3090276|P1|Overall Study|Death|418
937860|NCT00856323|3090285|P1|Overall Study|Withdrawal by Subject|2
937861|NCT00856297|3090297|P5|Overall Study|Unable to classify|0
937862|NCT00856297|3090298|P4|Overall Study|Unable to classify|0
937863|NCT00856297|3090299|P3|Overall Study|Unable to classify|0
937864|NCT00856297|3090300|P2|Overall Study|Unable to classify|0
937865|NCT00856297|3090301|P1|Overall Study|Unable to classify|2
937866|NCT00856284|3090334|P3|Overall Study|Randomized in error|1
937867|NCT00856284|3090335|P2|Overall Study|Randomized in error|0
937868|NCT00856284|3090336|P1|Overall Study|Randomized in error|0
937869|NCT00856284|3090334|P3|Overall Study|Other|14
937870|NCT00856284|3090335|P2|Overall Study|Other|17
937871|NCT00856284|3090336|P1|Overall Study|Other|15
937872|NCT00856284|3090334|P3|Overall Study|Investigator discretion|10
937873|NCT00856284|3090335|P2|Overall Study|Investigator discretion|8
937874|NCT00856284|3090336|P1|Overall Study|Investigator discretion|9
937875|NCT00856284|3090334|P3|Overall Study|Pregnancy|0
937876|NCT00856284|3090335|P2|Overall Study|Pregnancy|2
937877|NCT00856284|3090336|P1|Overall Study|Pregnancy|1
937878|NCT00856284|3090334|P3|Overall Study|Voluntary withdrawal|62
937879|NCT00856284|3090335|P2|Overall Study|Voluntary withdrawal|52
937880|NCT00856284|3090336|P1|Overall Study|Voluntary withdrawal|48
937881|NCT00856284|3090334|P3|Overall Study|Lost to Follow-up|28
937882|NCT00856284|3090335|P2|Overall Study|Lost to Follow-up|22
937883|NCT00856284|3090336|P1|Overall Study|Lost to Follow-up|20
937884|NCT00856284|3090334|P3|Overall Study|Major protocol deviation|15
937885|NCT00856284|3090335|P2|Overall Study|Major protocol deviation|16
937886|NCT00856284|3090336|P1|Overall Study|Major protocol deviation|24
937887|NCT00856284|3090334|P3|Overall Study|Adverse Event|82
937888|NCT00856284|3090335|P2|Overall Study|Adverse Event|74
937889|NCT00856284|3090336|P1|Overall Study|Adverse Event|60
937890|NCT00856284|3090334|P3|Overall Study|Hyperglycemic rescue|235
937891|NCT00856284|3090335|P2|Overall Study|Hyperglycemic rescue|201
937892|NCT00856284|3090336|P1|Overall Study|Hyperglycemic rescue|231
937893|NCT00856245|3090362|P1|Overall Study|Was not transplanted|5
937894|NCT00856206|3090385|P2|Overall Study|Other than specified above|10
937895|NCT00856206|3090386|P1|Overall Study|Other than specified above|3
937896|NCT00856206|3090385|P2|Overall Study|Decision by the Sponsor|8
937897|NCT00856206|3090386|P1|Overall Study|Decision by the Sponsor|4
937898|NCT00856206|3090385|P2|Overall Study|Death|2
937899|NCT00856206|3090386|P1|Overall Study|Death|2
937900|NCT00856206|3090385|P2|Overall Study|Lost to Follow-up|39
937901|NCT00856206|3090386|P1|Overall Study|Lost to Follow-up|13
937902|NCT00856206|3090385|P2|Overall Study|Withdrawal by Subject|36
937903|NCT00856206|3090386|P1|Overall Study|Withdrawal by Subject|15
937904|NCT00856206|3090385|P2|Overall Study|Lack of Efficacy|2
937905|NCT00856206|3090386|P1|Overall Study|Lack of Efficacy|1
937906|NCT00856206|3090385|P2|Overall Study|Adverse Event|46
937907|NCT00856206|3090386|P1|Overall Study|Adverse Event|10
937908|NCT00856206|3090385|P2|Overall Study|Protocol Violation|18
937909|NCT00856206|3090386|P1|Overall Study|Protocol Violation|6
937910|NCT00856193|3090400|P2|Period 2|Lost to Follow-up|1
937911|NCT00856193|3090401|P1|Period 2|Lost to Follow-up|0
937912|NCT00856193|3090400|P2|Period 2|Abnormal test procedure results|1
937913|NCT00856193|3090401|P1|Period 2|Abnormal test procedure results|0
937914|NCT00856180|3090413|P1|Overall Study|Progressive Disease|16
937915|NCT00856180|3090413|P1|Overall Study|Adverse Event|4
937916|NCT00855959|3090438|P1|Overall Study|Incorrect enrolment|1
937917|NCT00855959|3090438|P1|Overall Study|Pregnancy|1
937918|NCT00855959|3090438|P1|Overall Study|Withdrawal by Subject|3
937919|NCT00855959|3090438|P1|Overall Study|Lost to Follow-up|2
937920|NCT00855959|3090438|P1|Overall Study|Adverse Event|2
937921|NCT00855933|3090455|P2|Overall Study|Withdrawal by Subject|1
937922|NCT00855933|3090456|P1|Overall Study|Withdrawal by Subject|0
937923|NCT00855920|3090465|P3|Overall Study|Other than specified above|1
937924|NCT00855920|3090466|P2|Overall Study|Other than specified above|1
937925|NCT00855920|3090467|P1|Overall Study|Other than specified above|1
937926|NCT00855920|3090465|P3|Overall Study|Decision by the sponsor|1
937927|NCT00855920|3090466|P2|Overall Study|Decision by the sponsor|1
937928|NCT00855920|3090467|P1|Overall Study|Decision by the sponsor|0
937929|NCT00855920|3090465|P3|Overall Study|Death|0
937930|NCT00855920|3090466|P2|Overall Study|Death|1
937931|NCT00855920|3090467|P1|Overall Study|Death|0
937932|NCT00855920|3090465|P3|Overall Study|Lost to Follow-up|2
937933|NCT00855920|3090466|P2|Overall Study|Lost to Follow-up|0
937934|NCT00855920|3090467|P1|Overall Study|Lost to Follow-up|1
937935|NCT00855920|3090465|P3|Overall Study|Withdrawal by Subject|2
937936|NCT00855920|3090466|P2|Overall Study|Withdrawal by Subject|3
937937|NCT00855920|3090467|P1|Overall Study|Withdrawal by Subject|2
937938|NCT00855920|3090465|P3|Overall Study|Lack of Efficacy|2
937939|NCT00855920|3090466|P2|Overall Study|Lack of Efficacy|2
937940|NCT00855920|3090467|P1|Overall Study|Lack of Efficacy|2
937941|NCT00855920|3090465|P3|Overall Study|Adverse Event|1
937942|NCT00855920|3090466|P2|Overall Study|Adverse Event|1
937943|NCT00855920|3090467|P1|Overall Study|Adverse Event|2
937944|NCT00855920|3090465|P3|Overall Study|Protocol Violation|2
937945|NCT00855920|3090466|P2|Overall Study|Protocol Violation|0
937946|NCT00855920|3090467|P1|Overall Study|Protocol Violation|0
937947|NCT00855894|3090484|P1|Overall Study|Disease progression|1
937948|NCT00855894|3090484|P1|Overall Study|Patient's decision|1
937949|NCT00855894|3090484|P1|Overall Study|Death|31
937950|NCT00855816|3090507|P2|Overall Study|Became ineligible|1
937951|NCT00855816|3090508|P1|Overall Study|Became ineligible|0
937952|NCT00855816|3090507|P2|Overall Study|Death|0
937953|NCT00855816|3090508|P1|Overall Study|Death|1
937954|NCT00855816|3090507|P2|Overall Study|Lost to Follow-up|5
937955|NCT00855816|3090508|P1|Overall Study|Lost to Follow-up|3
937956|NCT00855816|3090507|P2|Overall Study|Withdrawal by Subject|15
937957|NCT00855816|3090508|P1|Overall Study|Withdrawal by Subject|22
937958|NCT00855738|3090514|P1|Overall Study|Death|1
937959|NCT00855738|3090514|P1|Overall Study|Subject Defaulted|1
937960|NCT00855738|3090514|P1|Overall Study|Adverse Event|1
937961|NCT00855738|3090514|P1|Overall Study|Lost to Follow-up|2
937962|NCT00855595|3090542|P2|Overall Study|patient left country|1
937963|NCT00855595|3090543|P1|Overall Study|patient left country|0
937964|NCT00855595|3090542|P2|Overall Study|patient moved out of state|0
937965|NCT00855595|3090543|P1|Overall Study|patient moved out of state|1
937966|NCT00855595|3090542|P2|Overall Study|Adverse Event|1
937967|NCT00855595|3090543|P1|Overall Study|Adverse Event|1
937968|NCT00855595|3090542|P2|Overall Study|Lost to Follow-up|3
937969|NCT00855595|3090543|P1|Overall Study|Lost to Follow-up|3
937970|NCT00855595|3090542|P2|Overall Study|Withdrawal by Subject|2
937971|NCT00855595|3090543|P1|Overall Study|Withdrawal by Subject|1
937972|NCT00855582|3090582|P3|Overall Study|Withdrawal by Subject|8
937973|NCT00855582|3090583|P2|Overall Study|Withdrawal by Subject|4
937974|NCT00855582|3090584|P1|Overall Study|Withdrawal by Subject|7
937975|NCT00855582|3090582|P3|Overall Study|Entry Criteria Not Met|3
937976|NCT00855582|3090583|P2|Overall Study|Entry Criteria Not Met|6
937977|NCT00855582|3090584|P1|Overall Study|Entry Criteria Not Met|8
937978|NCT00855582|3090582|P3|Overall Study|Protocol Violation|6
937979|NCT00855582|3090583|P2|Overall Study|Protocol Violation|2
937980|NCT00855582|3090584|P1|Overall Study|Protocol Violation|6
937981|NCT00855582|3090582|P3|Overall Study|Physician Decision|1
937982|NCT00855582|3090583|P2|Overall Study|Physician Decision|0
937983|NCT00855582|3090584|P1|Overall Study|Physician Decision|0
937984|NCT00855582|3090582|P3|Overall Study|Lost to Follow-up|1
937985|NCT00855582|3090583|P2|Overall Study|Lost to Follow-up|3
937986|NCT00855582|3090584|P1|Overall Study|Lost to Follow-up|1
937987|NCT00855582|3090582|P3|Overall Study|Lack of Efficacy|8
937988|NCT00855582|3090583|P2|Overall Study|Lack of Efficacy|3
937989|NCT00855582|3090584|P1|Overall Study|Lack of Efficacy|1
937990|NCT00855582|3090582|P3|Overall Study|Death|0
937991|NCT00855582|3090583|P2|Overall Study|Death|0
937992|NCT00855582|3090584|P1|Overall Study|Death|1
937993|NCT00855582|3090582|P3|Overall Study|Adverse Event|3
937994|NCT00855582|3090583|P2|Overall Study|Adverse Event|6
937995|NCT00855582|3090584|P1|Overall Study|Adverse Event|2
937996|NCT00855465|3090673|P2|Follow-up Period (FUP)|Missing|0
937997|NCT00855465|3090674|P1|Follow-up Period (FUP)|Missing|1
937998|NCT00855465|3090673|P2|Follow-up Period (FUP)|Withdrawal by Subject|0
937999|NCT00855465|3090674|P1|Follow-up Period (FUP)|Withdrawal by Subject|4
938000|NCT00855465|3090673|P2|Follow-up Period (FUP)|Lost to Follow-up|0
938001|NCT00855465|3090674|P1|Follow-up Period (FUP)|Lost to Follow-up|3
938002|NCT00855465|3090673|P2|Follow-up Period (FUP)|Death|1
938003|NCT00855465|3090674|P1|Follow-up Period (FUP)|Death|0
938004|NCT00855465|3090673|P2|Follow-up Period (FUP)|Adverse Event|1
938005|NCT00855465|3090674|P1|Follow-up Period (FUP)|Adverse Event|0
938006|NCT00855465|3090673|P2|Treatment Period|Not treated|0
938007|NCT00855465|3090674|P1|Treatment Period|Not treated|1
938008|NCT00855465|3090673|P2|Treatment Period|Withdrawal by Subject|0
938009|NCT00855465|3090674|P1|Treatment Period|Withdrawal by Subject|2
938010|NCT00855465|3090673|P2|Treatment Period|Protocol Violation|0
938011|NCT00855465|3090674|P1|Treatment Period|Protocol Violation|2
938012|NCT00855465|3090673|P2|Treatment Period|Non-compliance|0
938013|NCT00855465|3090674|P1|Treatment Period|Non-compliance|1
938014|NCT00855465|3090673|P2|Treatment Period|Lack of Efficacy|1
938015|NCT00855465|3090674|P1|Treatment Period|Lack of Efficacy|2
938016|NCT00855465|3090673|P2|Treatment Period|Death|2
938017|NCT00855465|3090674|P1|Treatment Period|Death|2
938018|NCT00855465|3090673|P2|Treatment Period|Adverse Event|2
938019|NCT00855465|3090674|P1|Treatment Period|Adverse Event|4
938020|NCT00855439|3090764|P2|Overall Study|Pregnancy|0
938021|NCT00855439|3090765|P1|Overall Study|Pregnancy|1
938022|NCT00855439|3090764|P2|Overall Study|Withdrawal by Subject|0
938023|NCT00855439|3090765|P1|Overall Study|Withdrawal by Subject|2
938024|NCT00855335|3090823|P5|Overall Study|Other|1
938025|NCT00855335|3090824|P4|Overall Study|Other|5
938026|NCT00855335|3090825|P3|Overall Study|Other|2
938027|NCT00855335|3090826|P2|Overall Study|Other|1
938028|NCT00855335|3090827|P1|Overall Study|Other|2
938029|NCT00855335|3090823|P5|Overall Study|Physician Decision|0
938030|NCT00855335|3090824|P4|Overall Study|Physician Decision|0
938031|NCT00855335|3090825|P3|Overall Study|Physician Decision|0
938032|NCT00855335|3090826|P2|Overall Study|Physician Decision|1
938033|NCT00855335|3090827|P1|Overall Study|Physician Decision|1
938034|NCT00855335|3090823|P5|Overall Study|Adverse Event|0
938035|NCT00855335|3090824|P4|Overall Study|Adverse Event|0
938036|NCT00855335|3090825|P3|Overall Study|Adverse Event|0
938037|NCT00855335|3090826|P2|Overall Study|Adverse Event|0
938038|NCT00855335|3090827|P1|Overall Study|Adverse Event|2
938039|NCT00855335|3090823|P5|Overall Study|Withdrawal by Subject|0
938040|NCT00855335|3090824|P4|Overall Study|Withdrawal by Subject|1
938041|NCT00855335|3090825|P3|Overall Study|Withdrawal by Subject|0
938042|NCT00855335|3090826|P2|Overall Study|Withdrawal by Subject|0
938043|NCT00855335|3090827|P1|Overall Study|Withdrawal by Subject|0
938044|NCT00855335|3090823|P5|Overall Study|Lost to Follow-up|0
938045|NCT00855335|3090824|P4|Overall Study|Lost to Follow-up|1
938046|NCT00855335|3090825|P3|Overall Study|Lost to Follow-up|3
938047|NCT00855335|3090826|P2|Overall Study|Lost to Follow-up|0
938048|NCT00855335|3090827|P1|Overall Study|Lost to Follow-up|0
938049|NCT00855309|3090914|P2|Overall Study|patient never recieved drug|0
938050|NCT00855309|3090915|P1|Overall Study|patient never recieved drug|1
938051|NCT00855218|3090923|P2|Overall Study|Clinical endpoint reached|13
938052|NCT00855218|3090924|P1|Overall Study|Clinical endpoint reached|10
938053|NCT00855218|3090923|P2|Overall Study|Progression measurement proven|15
938054|NCT00855218|3090924|P1|Overall Study|Progression measurement proven|7
938055|NCT00855218|3090923|P2|Overall Study|Second malignancy|1
938056|NCT00855218|3090924|P1|Overall Study|Second malignancy|0
938057|NCT00855218|3090923|P2|Overall Study|Untreatable disease progression|67
938058|NCT00855218|3090924|P1|Overall Study|Untreatable disease progression|54
938059|NCT00855218|3090923|P2|Overall Study|Still treated with study medication|1
938060|NCT00855218|3090924|P1|Overall Study|Still treated with study medication|0
938061|NCT00855218|3090923|P2|Overall Study|technical problems|1
938062|NCT00855218|3090924|P1|Overall Study|technical problems|2
938063|NCT00855218|3090923|P2|Overall Study|patient convenience|0
938064|NCT00855218|3090924|P1|Overall Study|patient convenience|2
938065|NCT00855218|3090923|P2|Overall Study|non-compliant with study drug|1
938066|NCT00855218|3090924|P1|Overall Study|non-compliant with study drug|3
938067|NCT00855218|3090923|P2|Overall Study|Protocol Violation|9
938068|NCT00855218|3090924|P1|Overall Study|Protocol Violation|5
938069|NCT00855218|3090923|P2|Overall Study|Lost to Follow-up|1
938070|NCT00855218|3090924|P1|Overall Study|Lost to Follow-up|0
938071|NCT00855218|3090923|P2|Overall Study|Physician Decision|11
938072|NCT00855218|3090924|P1|Overall Study|Physician Decision|18
938073|NCT00855218|3090923|P2|Overall Study|Withdrawal by Subject|6
938074|NCT00855218|3090924|P1|Overall Study|Withdrawal by Subject|10
938075|NCT00855218|3090923|P2|Overall Study|Adverse Event|27
938076|NCT00855218|3090924|P1|Overall Study|Adverse Event|43
938077|NCT00855166|3090942|P2|Overall Study|Subject no longer meets study criteria|1
938078|NCT00855166|3090943|P1|Overall Study|Subject no longer meets study criteria|1
938079|NCT00855166|3090942|P2|Overall Study|Administrative reasons by sponsor|0
938080|NCT00855166|3090943|P1|Overall Study|Administrative reasons by sponsor|1
938081|NCT00855166|3090942|P2|Overall Study|Poor/non-compliance|0
938082|NCT00855166|3090943|P1|Overall Study|Poor/non-compliance|2
938083|NCT00855166|3090942|P2|Overall Study|Withdrawal by Subject|4
938084|NCT00855166|3090943|P1|Overall Study|Withdrawal by Subject|1
938085|NCT00855166|3090942|P2|Overall Study|Death|1
938086|NCT00855166|3090943|P1|Overall Study|Death|0
938087|NCT00855166|3090942|P2|Overall Study|Adverse Event|2
938088|NCT00855166|3090943|P1|Overall Study|Adverse Event|0
938180|NCT00853970|3091304|P2|Overall Study|Cancelled surgery|2
938089|NCT00855062|3090963|P2|Step2|Initiation of antiretroviral therapy/ART|1
938090|NCT00855062|3090964|P1|Step2|Initiation of antiretroviral therapy/ART|0
938091|NCT00855062|3090963|P2|Step2|Adverse Event|3
938092|NCT00855062|3090964|P1|Step2|Adverse Event|0
938093|NCT00855062|3090963|P2|Step2|Early Study Closure|2
938094|NCT00855062|3090964|P1|Step2|Early Study Closure|6
938095|NCT00855062|3090963|P2|Step1|Withdrawal by Subject|3
938096|NCT00855062|3090964|P1|Step1|Withdrawal by Subject|2
938097|NCT00855062|3090963|P2|Step1|Pregnancy|0
938098|NCT00855062|3090964|P1|Step1|Pregnancy|1
938099|NCT00855062|3090963|P2|Step1|Protocol Violation|0
938100|NCT00855062|3090964|P1|Step1|Protocol Violation|1
938101|NCT00855062|3090963|P2|Step1|Adverse Event|1
938102|NCT00855062|3090964|P1|Step1|Adverse Event|1
938103|NCT00855062|3090963|P2|Step1|Early Study Closure|7
938104|NCT00855062|3090964|P1|Step1|Early Study Closure|5
938105|NCT00854906|3091013|P1|Overall Study|One person had no ocular history|1
938106|NCT00854724|3091022|P2|Second Intervention|Physician Decision|1
938107|NCT00854724|3091023|P1|Second Intervention|Physician Decision|0
938108|NCT00854724|3091022|P2|Second Intervention|Protocol Violation|0
938109|NCT00854724|3091023|P1|Second Intervention|Protocol Violation|1
938110|NCT00854724|3091022|P2|Washout|Withdrawal by Subject|1
938111|NCT00854724|3091023|P1|Washout|Withdrawal by Subject|0
938112|NCT00854724|3091022|P2|Washout|Protocol Violation|0
938113|NCT00854724|3091023|P1|Washout|Protocol Violation|1
938114|NCT00854724|3091022|P2|First Intervention|Withdrawal by Subject|1
938115|NCT00854724|3091023|P1|First Intervention|Withdrawal by Subject|1
938116|NCT00854620|3091029|P1|Overall Study|Adverse Event|1
938117|NCT00854607|3091033|P1|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65
938118|NCT00854581|3091081|P1|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3
938119|NCT00854581|3091081|P1|Induction (Up to Day 21)|Physician Decision|1
938120|NCT00854581|3091081|P1|Induction (Up to Day 21)|Death|1
938121|NCT00854581|3091081|P1|Induction (Up to Day 21)|Lack of Efficacy|4
938122|NCT00854373|3091096|P2|Overall Study|Forgot to take study drug|1
938123|NCT00854373|3091097|P1|Overall Study|Forgot to take study drug|1
938124|NCT00854373|3091096|P2|Overall Study|Withdrawal by Subject|3
938125|NCT00854373|3091097|P1|Overall Study|Withdrawal by Subject|1
938126|NCT00854360|3091111|P4|Overall Study|Other|3
938127|NCT00854360|3091112|P3|Overall Study|Other|0
938128|NCT00854360|3091113|P2|Overall Study|Other|0
938129|NCT00854360|3091114|P1|Overall Study|Other|0
938130|NCT00854360|3091111|P4|Overall Study|Lack of Efficacy|0
938131|NCT00854360|3091112|P3|Overall Study|Lack of Efficacy|0
938132|NCT00854360|3091113|P2|Overall Study|Lack of Efficacy|1
938133|NCT00854360|3091114|P1|Overall Study|Lack of Efficacy|2
938134|NCT00854360|3091111|P4|Overall Study|Pregnancy|0
938135|NCT00854360|3091112|P3|Overall Study|Pregnancy|0
938136|NCT00854360|3091113|P2|Overall Study|Pregnancy|1
938137|NCT00854360|3091114|P1|Overall Study|Pregnancy|0
938138|NCT00854360|3091111|P4|Overall Study|Withdrawal by Subject|1
938139|NCT00854360|3091112|P3|Overall Study|Withdrawal by Subject|0
938140|NCT00854360|3091113|P2|Overall Study|Withdrawal by Subject|0
938141|NCT00854360|3091114|P1|Overall Study|Withdrawal by Subject|0
938142|NCT00854360|3091111|P4|Overall Study|Adverse Event|6
938143|NCT00854360|3091112|P3|Overall Study|Adverse Event|2
938144|NCT00854360|3091113|P2|Overall Study|Adverse Event|1
938145|NCT00854360|3091114|P1|Overall Study|Adverse Event|0
938146|NCT00854308|3091146|P2|Overall Study|Sponsor's decision to terminate study|1
938147|NCT00854308|3091147|P1|Overall Study|Sponsor's decision to terminate study|0
938148|NCT00854308|3091146|P2|Overall Study|Withdrawal by Subject|2
938149|NCT00854308|3091147|P1|Overall Study|Withdrawal by Subject|4
938150|NCT00854308|3091146|P2|Overall Study|Physician Decision|6
938151|NCT00854308|3091147|P1|Overall Study|Physician Decision|6
938152|NCT00854308|3091146|P2|Overall Study|Death|5
938153|NCT00854308|3091147|P1|Overall Study|Death|2
938154|NCT00854308|3091146|P2|Overall Study|Adverse Event|3
938155|NCT00854308|3091147|P1|Overall Study|Adverse Event|8
938156|NCT00854308|3091146|P2|Overall Study|Disease progression|50
938157|NCT00854308|3091147|P1|Overall Study|Disease progression|42
938158|NCT00854113|3091172|P11|Overall Study|Withdrawal by Subject|0
938159|NCT00854113|3091173|P10|Overall Study|Withdrawal by Subject|0
938160|NCT00854113|3091174|P9|Overall Study|Withdrawal by Subject|1
938161|NCT00854113|3091175|P8|Overall Study|Withdrawal by Subject|1
938162|NCT00854113|3091176|P7|Overall Study|Withdrawal by Subject|0
938163|NCT00854113|3091177|P6|Overall Study|Withdrawal by Subject|0
938164|NCT00854113|3091178|P5|Overall Study|Withdrawal by Subject|0
938165|NCT00854113|3091179|P4|Overall Study|Withdrawal by Subject|0
938166|NCT00854113|3091180|P3|Overall Study|Withdrawal by Subject|0
938167|NCT00854113|3091181|P2|Overall Study|Withdrawal by Subject|0
938168|NCT00854113|3091182|P1|Overall Study|Withdrawal by Subject|0
938169|NCT00854113|3091172|P11|Overall Study|Adverse Event|0
938170|NCT00854113|3091173|P10|Overall Study|Adverse Event|0
938171|NCT00854113|3091174|P9|Overall Study|Adverse Event|0
938172|NCT00854113|3091175|P8|Overall Study|Adverse Event|2
938173|NCT00854113|3091176|P7|Overall Study|Adverse Event|0
938174|NCT00854113|3091177|P6|Overall Study|Adverse Event|0
938175|NCT00854113|3091178|P5|Overall Study|Adverse Event|0
938176|NCT00854113|3091179|P4|Overall Study|Adverse Event|0
938177|NCT00854113|3091180|P3|Overall Study|Adverse Event|0
938178|NCT00854113|3091181|P2|Overall Study|Adverse Event|0
938179|NCT00854113|3091182|P1|Overall Study|Adverse Event|0
938181|NCT00853970|3091305|P1|Overall Study|Cancelled surgery|4
938182|NCT00853970|3091304|P2|Overall Study|Withdrawal by Subject|1
938183|NCT00853970|3091305|P1|Overall Study|Withdrawal by Subject|2
938184|NCT00853957|3091315|P2|Overall Study|Protocol deviation|3
938185|NCT00853957|3091316|P1|Overall Study|Protocol deviation|0
938186|NCT00853957|3091315|P2|Overall Study|Lost to Follow-up|6
938187|NCT00853957|3091316|P1|Overall Study|Lost to Follow-up|1
938188|NCT00853957|3091315|P2|Overall Study|Subject withdrew consent|5
938189|NCT00853957|3091316|P1|Overall Study|Subject withdrew consent|4
938190|NCT00853957|3091315|P2|Overall Study|Unsatisfactory therapeutic effect|2
938191|NCT00853957|3091316|P1|Overall Study|Unsatisfactory therapeutic effect|0
938192|NCT00853957|3091315|P2|Overall Study|Adverse Event|3
938193|NCT00853957|3091316|P1|Overall Study|Adverse Event|9
938194|NCT00853905|3091334|P2|Overall Study|never had surgery|0
938195|NCT00853905|3091335|P1|Overall Study|never had surgery|1
938196|NCT00853905|3091334|P2|Overall Study|Withdrawal by Subject|1
938197|NCT00853905|3091335|P1|Overall Study|Withdrawal by Subject|0
938198|NCT00853905|3091334|P2|Overall Study|Lost to Follow-up|3
938199|NCT00853905|3091335|P1|Overall Study|Lost to Follow-up|1
938200|NCT00853827|3091367|P2|Double Blind Period (103 Weeks)|Death|6
938201|NCT00853827|3091368|P1|Double Blind Period (103 Weeks)|Death|1
938202|NCT00853827|3091367|P2|Double Blind Period (103 Weeks)|Administrative problems|56
938203|NCT00853827|3091368|P1|Double Blind Period (103 Weeks)|Administrative problems|45
938204|NCT00853827|3091367|P2|Double Blind Period (103 Weeks)|Lost to Follow-up|10
938205|NCT00853827|3091368|P1|Double Blind Period (103 Weeks)|Lost to Follow-up|8
938206|NCT00853827|3091367|P2|Double Blind Period (103 Weeks)|Withdrawal by Subject|18
938207|NCT00853827|3091368|P1|Double Blind Period (103 Weeks)|Withdrawal by Subject|19
938208|NCT00853827|3091367|P2|Double Blind Period (103 Weeks)|Protocol Violation|1
938209|NCT00853827|3091368|P1|Double Blind Period (103 Weeks)|Protocol Violation|2
938210|NCT00853827|3091367|P2|Double Blind Period (103 Weeks)|Patient’s no longer requires study drug|1
938211|NCT00853827|3091368|P1|Double Blind Period (103 Weeks)|Patient’s no longer requires study drug|3
938212|NCT00853827|3091367|P2|Double Blind Period (103 Weeks)|Lack of Efficacy|0
938213|NCT00853827|3091368|P1|Double Blind Period (103 Weeks)|Lack of Efficacy|1
938214|NCT00853827|3091367|P2|Double Blind Period (103 Weeks)|Abnormal laboratory values|3
938215|NCT00853827|3091368|P1|Double Blind Period (103 Weeks)|Abnormal laboratory values|0
938216|NCT00853827|3091367|P2|Double Blind Period (103 Weeks)|Adverse Event|14
938217|NCT00853827|3091368|P1|Double Blind Period (103 Weeks)|Adverse Event|25
938218|NCT00853827|3091367|P2|Single Blind Period (1 Week)|Protocol Violation|0
938219|NCT00853827|3091368|P1|Single Blind Period (1 Week)|Protocol Violation|12
938220|NCT00853827|3091367|P2|Single Blind Period (1 Week)|Lost to Follow-up|0
938221|NCT00853827|3091368|P1|Single Blind Period (1 Week)|Lost to Follow-up|1
938222|NCT00853827|3091367|P2|Single Blind Period (1 Week)|Withdrawal by Subject|0
938223|NCT00853827|3091368|P1|Single Blind Period (1 Week)|Withdrawal by Subject|9
938224|NCT00853827|3091367|P2|Single Blind Period (1 Week)|Abnormal test procedure result|0
938225|NCT00853827|3091368|P1|Single Blind Period (1 Week)|Abnormal test procedure result|1
938226|NCT00853827|3091367|P2|Single Blind Period (1 Week)|Abnormal laboratory value|0
938227|NCT00853827|3091368|P1|Single Blind Period (1 Week)|Abnormal laboratory value|3
938228|NCT00853827|3091367|P2|Single Blind Period (1 Week)|Adverse Event|0
938229|NCT00853827|3091368|P1|Single Blind Period (1 Week)|Adverse Event|9
938230|NCT00853827|3091367|P2|Single Blind Period (1 Week)|Other|0
938231|NCT00853827|3091368|P1|Single Blind Period (1 Week)|Other|4
938232|NCT00853762|3091384|P4|Overall Study|Randomised but not Treated|0
938233|NCT00853762|3091385|P3|Overall Study|Randomised but not Treated|2
938234|NCT00853762|3091386|P2|Overall Study|Randomised but not Treated|2
938235|NCT00853762|3091387|P1|Overall Study|Randomised but not Treated|0
938236|NCT00853762|3091384|P4|Overall Study|Other|0
938237|NCT00853762|3091385|P3|Overall Study|Other|0
938238|NCT00853762|3091386|P2|Overall Study|Other|2
938239|NCT00853762|3091387|P1|Overall Study|Other|0
938240|NCT00853762|3091384|P4|Overall Study|Withdrawal by Subject|0
938241|NCT00853762|3091385|P3|Overall Study|Withdrawal by Subject|1
938242|NCT00853762|3091386|P2|Overall Study|Withdrawal by Subject|0
938243|NCT00853762|3091387|P1|Overall Study|Withdrawal by Subject|0
938244|NCT00853762|3091384|P4|Overall Study|Protocol Violation|1
938245|NCT00853762|3091385|P3|Overall Study|Protocol Violation|0
938246|NCT00853762|3091386|P2|Overall Study|Protocol Violation|0
938247|NCT00853762|3091387|P1|Overall Study|Protocol Violation|0
938248|NCT00853762|3091384|P4|Overall Study|Premature Termination|21
938249|NCT00853762|3091385|P3|Overall Study|Premature Termination|14
938250|NCT00853762|3091386|P2|Overall Study|Premature Termination|15
938251|NCT00853762|3091387|P1|Overall Study|Premature Termination|16
938252|NCT00853749|3091455|P2|Overall Study|Lost to Follow-up|1
938253|NCT00853749|3091456|P1|Overall Study|Lost to Follow-up|0
938254|NCT00853723|3091477|P3|Overall Study|Protocol Violation|1
938255|NCT00853723|3091478|P2|Overall Study|Protocol Violation|2
938256|NCT00853723|3091479|P1|Overall Study|Protocol Violation|1
938257|NCT00853723|3091477|P3|Overall Study|Withdrawal by Subject|0
938258|NCT00853723|3091478|P2|Overall Study|Withdrawal by Subject|1
938259|NCT00853723|3091479|P1|Overall Study|Withdrawal by Subject|2
938260|NCT00853723|3091477|P3|Overall Study|Adverse Event|1
938261|NCT00853723|3091478|P2|Overall Study|Adverse Event|4
938262|NCT00853723|3091479|P1|Overall Study|Adverse Event|3
938263|NCT00853658|3091526|P3|Overall Study|Missing study completion information|6
938264|NCT00853658|3091527|P2|Overall Study|Missing study completion information|4
938265|NCT00853658|3091528|P1|Overall Study|Missing study completion information|5
938266|NCT00853658|3091526|P3|Overall Study|Patient's request|11
938267|NCT00853658|3091527|P2|Overall Study|Patient's request|17
938268|NCT00853658|3091528|P1|Overall Study|Patient's request|21
938269|NCT00853658|3091526|P3|Overall Study|Vital Status at study end N/A|10
938270|NCT00853658|3091527|P2|Overall Study|Vital Status at study end N/A|10
938271|NCT00853658|3091528|P1|Overall Study|Vital Status at study end N/A|8
938272|NCT00853658|3091526|P3|Overall Study|Vital Status unknown at study end|0
938273|NCT00853658|3091527|P2|Overall Study|Vital Status unknown at study end|1
938274|NCT00853658|3091528|P1|Overall Study|Vital Status unknown at study end|1
938275|NCT00853658|3091526|P3|Overall Study|Vital Status known (alive) at study end|3
938276|NCT00853658|3091527|P2|Overall Study|Vital Status known (alive) at study end|3
938277|NCT00853658|3091528|P1|Overall Study|Vital Status known (alive) at study end|2
938278|NCT00853658|3091526|P3|Overall Study|IRB request|2
938279|NCT00853658|3091527|P2|Overall Study|IRB request|0
938280|NCT00853658|3091528|P1|Overall Study|IRB request|0
938281|NCT00853658|3091526|P3|Overall Study|H.A. Request|19
938282|NCT00853658|3091527|P2|Overall Study|H.A. Request|23
938283|NCT00853658|3091528|P1|Overall Study|H.A. Request|26
938284|NCT00853658|3091526|P3|Overall Study|Lost to Follow-up|11
938285|NCT00853658|3091527|P2|Overall Study|Lost to Follow-up|6
938286|NCT00853658|3091528|P1|Overall Study|Lost to Follow-up|11
938287|NCT00853658|3091526|P3|Overall Study|Death|753
938288|NCT00853658|3091527|P2|Overall Study|Death|768
938289|NCT00853658|3091528|P1|Overall Study|Death|713
938290|NCT00853593|3091548|P1|Overall Study|Implant not attempted|4
938291|NCT00853593|3091548|P1|Overall Study|Model 4396 lead not attempted|29
938292|NCT00853593|3091548|P1|Overall Study|Subjects did not receive a 4396 lead|12
938293|NCT00853580|3091575|P2|Overall Study|Commenced contraindicated therapy|2
938294|NCT00853580|3091576|P1|Overall Study|Commenced contraindicated therapy|0
938295|NCT00853580|3091575|P2|Overall Study|Withdrawal by Subject|8
938296|NCT00853580|3091576|P1|Overall Study|Withdrawal by Subject|2
938297|NCT00853580|3091575|P2|Overall Study|Protocol Violation|1
938298|NCT00853580|3091576|P1|Overall Study|Protocol Violation|2
938299|NCT00853580|3091575|P2|Overall Study|Lost to Follow-up|5
938300|NCT00853580|3091576|P1|Overall Study|Lost to Follow-up|3
938301|NCT00853567|3091623|P1|Overall Study|Study prematurely terminated|71
938302|NCT00853489|3091633|P2|Overall Study|Lost to Follow-up|2
938303|NCT00853489|3091634|P1|Overall Study|Lost to Follow-up|5
938304|NCT00853385|3091649|P5|Overall Study|Other|12
938305|NCT00853385|3091650|P4|Overall Study|Other|4
938306|NCT00853385|3091651|P3|Overall Study|Other|4
938307|NCT00853385|3091652|P2|Overall Study|Other|9
938308|NCT00853385|3091653|P1|Overall Study|Other|18
938309|NCT00853385|3091649|P5|Overall Study|Withdrawal by Subject|1
938310|NCT00853385|3091650|P4|Overall Study|Withdrawal by Subject|1
938311|NCT00853385|3091651|P3|Overall Study|Withdrawal by Subject|0
938312|NCT00853385|3091652|P2|Overall Study|Withdrawal by Subject|2
938313|NCT00853385|3091653|P1|Overall Study|Withdrawal by Subject|4
938314|NCT00853385|3091649|P5|Overall Study|Lost to Follow-up|0
938315|NCT00853385|3091650|P4|Overall Study|Lost to Follow-up|0
938316|NCT00853385|3091651|P3|Overall Study|Lost to Follow-up|0
938317|NCT00853385|3091652|P2|Overall Study|Lost to Follow-up|1
938318|NCT00853385|3091653|P1|Overall Study|Lost to Follow-up|2
938319|NCT00853385|3091649|P5|Overall Study|Lack of Efficacy|6
938320|NCT00853385|3091650|P4|Overall Study|Lack of Efficacy|3
938321|NCT00853385|3091651|P3|Overall Study|Lack of Efficacy|3
938322|NCT00853385|3091652|P2|Overall Study|Lack of Efficacy|7
938323|NCT00853385|3091653|P1|Overall Study|Lack of Efficacy|6
938324|NCT00853385|3091649|P5|Overall Study|Adverse Event|22
938325|NCT00853385|3091650|P4|Overall Study|Adverse Event|5
938326|NCT00853385|3091651|P3|Overall Study|Adverse Event|2
938327|NCT00853385|3091652|P2|Overall Study|Adverse Event|24
938328|NCT00853385|3091653|P1|Overall Study|Adverse Event|24
938329|NCT00853385|3091649|P5|Overall Study|Death|1
938330|NCT00853385|3091650|P4|Overall Study|Death|0
938331|NCT00853385|3091651|P3|Overall Study|Death|0
938332|NCT00853385|3091652|P2|Overall Study|Death|0
938333|NCT00853385|3091653|P1|Overall Study|Death|0
938334|NCT00853307|3091881|P2|Overall Study|Reason Not Specified|1
938335|NCT00853307|3091882|P1|Overall Study|Reason Not Specified|0
938336|NCT00853307|3091881|P2|Overall Study|Withdrawal by Subject|2
938337|NCT00853307|3091882|P1|Overall Study|Withdrawal by Subject|1
938338|NCT00853307|3091881|P2|Overall Study|Adverse Event|2
938339|NCT00853307|3091882|P1|Overall Study|Adverse Event|1
938340|NCT00853242|3091909|P7|Overall Study|Other|2
938341|NCT00853242|3091910|P6|Overall Study|Other|1
938342|NCT00853242|3091911|P5|Overall Study|Other|0
938343|NCT00853242|3091912|P4|Overall Study|Other|0
938344|NCT00853242|3091913|P3|Overall Study|Other|2
938345|NCT00853242|3091914|P2|Overall Study|Other|0
938346|NCT00853242|3091915|P1|Overall Study|Other|2
938347|NCT00853242|3091909|P7|Overall Study|Withdrawal by Subject|2
938348|NCT00853242|3091910|P6|Overall Study|Withdrawal by Subject|0
938349|NCT00853242|3091911|P5|Overall Study|Withdrawal by Subject|0
938350|NCT00853242|3091912|P4|Overall Study|Withdrawal by Subject|4
938351|NCT00853242|3091913|P3|Overall Study|Withdrawal by Subject|0
938352|NCT00853242|3091914|P2|Overall Study|Withdrawal by Subject|2
938353|NCT00853242|3091915|P1|Overall Study|Withdrawal by Subject|1
938354|NCT00853242|3091909|P7|Overall Study|Noncompliant|0
938355|NCT00853242|3091910|P6|Overall Study|Noncompliant|0
938356|NCT00853242|3091911|P5|Overall Study|Noncompliant|1
938357|NCT00853242|3091912|P4|Overall Study|Noncompliant|0
938358|NCT00853242|3091913|P3|Overall Study|Noncompliant|0
938359|NCT00853242|3091914|P2|Overall Study|Noncompliant|0
938360|NCT00853242|3091915|P1|Overall Study|Noncompliant|0
938361|NCT00853242|3091909|P7|Overall Study|Adverse Event|1
938362|NCT00853242|3091910|P6|Overall Study|Adverse Event|1
938363|NCT00853242|3091911|P5|Overall Study|Adverse Event|3
938364|NCT00853242|3091912|P4|Overall Study|Adverse Event|0
938365|NCT00853242|3091913|P3|Overall Study|Adverse Event|1
938366|NCT00853242|3091914|P2|Overall Study|Adverse Event|1
938367|NCT00853242|3091915|P1|Overall Study|Adverse Event|0
938368|NCT00853229|3091957|P2|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
938369|NCT00853229|3091958|P1|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
938370|NCT00853151|3091968|P4|Overall Study|Sponsor Decision|0
938371|NCT00853151|3091969|P3|Overall Study|Sponsor Decision|0
938372|NCT00853151|3091970|P2|Overall Study|Sponsor Decision|3
938373|NCT00853151|3091971|P1|Overall Study|Sponsor Decision|0
938374|NCT00853151|3091968|P4|Overall Study|Physician Decision|0
938375|NCT00853151|3091969|P3|Overall Study|Physician Decision|1
938376|NCT00853151|3091970|P2|Overall Study|Physician Decision|2
938377|NCT00853151|3091971|P1|Overall Study|Physician Decision|0
938378|NCT00853151|3091968|P4|Overall Study|Withdrawal by Subject|1
938379|NCT00853151|3091969|P3|Overall Study|Withdrawal by Subject|2
938380|NCT00853151|3091970|P2|Overall Study|Withdrawal by Subject|4
938381|NCT00853151|3091971|P1|Overall Study|Withdrawal by Subject|5
938382|NCT00853151|3091968|P4|Overall Study|Protocol Violation|1
938383|NCT00853151|3091969|P3|Overall Study|Protocol Violation|0
938384|NCT00853151|3091970|P2|Overall Study|Protocol Violation|0
938385|NCT00853151|3091971|P1|Overall Study|Protocol Violation|0
938386|NCT00853151|3091968|P4|Overall Study|Death|1
938387|NCT00853151|3091969|P3|Overall Study|Death|0
938388|NCT00853151|3091970|P2|Overall Study|Death|0
938389|NCT00853151|3091971|P1|Overall Study|Death|1
938390|NCT00853151|3091968|P4|Overall Study|Lost to Follow-up|0
938391|NCT00853151|3091969|P3|Overall Study|Lost to Follow-up|3
938392|NCT00853151|3091970|P2|Overall Study|Lost to Follow-up|0
938393|NCT00853151|3091971|P1|Overall Study|Lost to Follow-up|2
938394|NCT00853151|3091968|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
938395|NCT00853151|3091969|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
938396|NCT00853151|3091970|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
938397|NCT00853151|3091971|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
938398|NCT00853151|3091968|P4|Overall Study|Adverse Event|0
938399|NCT00853151|3091969|P3|Overall Study|Adverse Event|2
938400|NCT00853151|3091970|P2|Overall Study|Adverse Event|4
938401|NCT00853151|3091971|P1|Overall Study|Adverse Event|1
938402|NCT00853112|3092120|P7|Overall Study|Randomized but not treated|1
938403|NCT00853112|3092121|P6|Overall Study|Randomized but not treated|0
938404|NCT00853112|3092122|P5|Overall Study|Randomized but not treated|0
938405|NCT00853112|3092123|P4|Overall Study|Randomized but not treated|2
938406|NCT00853112|3092124|P3|Overall Study|Randomized but not treated|0
938407|NCT00853112|3092125|P2|Overall Study|Randomized but not treated|1
938408|NCT00853112|3092126|P1|Overall Study|Randomized but not treated|0
938409|NCT00853099|3092236|P4|Double-blind + Open-label Periods|Not Specified|6
938410|NCT00853099|3092237|P3|Double-blind + Open-label Periods|Not Specified|0
938411|NCT00853099|3092238|P2|Double-blind + Open-label Periods|Not Specified|0
938412|NCT00853099|3092239|P1|Double-blind + Open-label Periods|Not Specified|0
938413|NCT00853099|3092236|P4|Double-blind + Open-label Periods|Withdrawal by Subject|20
938414|NCT00853099|3092237|P3|Double-blind + Open-label Periods|Withdrawal by Subject|0
938415|NCT00853099|3092238|P2|Double-blind + Open-label Periods|Withdrawal by Subject|0
938416|NCT00853099|3092239|P1|Double-blind + Open-label Periods|Withdrawal by Subject|0
938417|NCT00853099|3092236|P4|Double-blind + Open-label Periods|Adverse Event|47
938418|NCT00853099|3092237|P3|Double-blind + Open-label Periods|Adverse Event|0
938419|NCT00853099|3092238|P2|Double-blind + Open-label Periods|Adverse Event|0
938420|NCT00853099|3092239|P1|Double-blind + Open-label Periods|Adverse Event|0
938421|NCT00853099|3092236|P4|Double-blind + Open-label Periods|Lack of Efficacy|74
938422|NCT00853099|3092237|P3|Double-blind + Open-label Periods|Lack of Efficacy|0
938423|NCT00853099|3092238|P2|Double-blind + Open-label Periods|Lack of Efficacy|0
938424|NCT00853099|3092239|P1|Double-blind + Open-label Periods|Lack of Efficacy|0
938425|NCT00853099|3092236|P4|Double-blind Period|Mistreated with rescue study drug|0
938426|NCT00853099|3092237|P3|Double-blind Period|Mistreated with rescue study drug|1
938427|NCT00853099|3092238|P2|Double-blind Period|Mistreated with rescue study drug|0
938428|NCT00853099|3092239|P1|Double-blind Period|Mistreated with rescue study drug|0
938429|NCT00853099|3092236|P4|Double-blind Period|Not Specified|0
938430|NCT00853099|3092237|P3|Double-blind Period|Not Specified|1
938431|NCT00853099|3092238|P2|Double-blind Period|Not Specified|0
938432|NCT00853099|3092239|P1|Double-blind Period|Not Specified|0
938433|NCT00853099|3092236|P4|Double-blind Period|Lack of Efficacy|0
938434|NCT00853099|3092237|P3|Double-blind Period|Lack of Efficacy|16
938435|NCT00853099|3092238|P2|Double-blind Period|Lack of Efficacy|17
938436|NCT00853099|3092239|P1|Double-blind Period|Lack of Efficacy|14
938437|NCT00853099|3092236|P4|Double-blind Period|Withdrawal by Subject|0
938438|NCT00853099|3092237|P3|Double-blind Period|Withdrawal by Subject|0
938439|NCT00853099|3092238|P2|Double-blind Period|Withdrawal by Subject|3
938440|NCT00853099|3092239|P1|Double-blind Period|Withdrawal by Subject|2
938441|NCT00853099|3092236|P4|Double-blind Period|Adverse Event|0
938442|NCT00853099|3092237|P3|Double-blind Period|Adverse Event|13
938443|NCT00853099|3092238|P2|Double-blind Period|Adverse Event|9
938444|NCT00853099|3092239|P1|Double-blind Period|Adverse Event|7
938445|NCT00853073|3092281|P2|Overall Study|Withdrawal by Subject|2
938446|NCT00853073|3092282|P1|Overall Study|Withdrawal by Subject|3
938447|NCT00853021|3092290|P1|Overall Study|Death|1
938448|NCT00853021|3092290|P1|Overall Study|Withdrawal by Subject|2
938449|NCT00853021|3092290|P1|Overall Study|Adverse Event|2
938450|NCT00852995|3092302|P5|Overall Study|Moved Out of Area|0
938451|NCT00852995|3092303|P4|Overall Study|Moved Out of Area|0
938452|NCT00852995|3092304|P3|Overall Study|Moved Out of Area|0
938453|NCT00852995|3092305|P2|Overall Study|Moved Out of Area|0
938454|NCT00852995|3092306|P1|Overall Study|Moved Out of Area|1
938455|NCT00852995|3092302|P5|Overall Study|Protocol Violation|1
938456|NCT00852995|3092303|P4|Overall Study|Protocol Violation|0
938457|NCT00852995|3092304|P3|Overall Study|Protocol Violation|0
938458|NCT00852995|3092305|P2|Overall Study|Protocol Violation|0
938459|NCT00852995|3092306|P1|Overall Study|Protocol Violation|0
938460|NCT00852995|3092302|P5|Overall Study|Physician Decision|0
938461|NCT00852995|3092303|P4|Overall Study|Physician Decision|0
938462|NCT00852995|3092304|P3|Overall Study|Physician Decision|0
938463|NCT00852995|3092305|P2|Overall Study|Physician Decision|0
938464|NCT00852995|3092306|P1|Overall Study|Physician Decision|1
938465|NCT00852995|3092302|P5|Overall Study|Progressive Disease|1
938466|NCT00852995|3092303|P4|Overall Study|Progressive Disease|2
938467|NCT00852995|3092304|P3|Overall Study|Progressive Disease|0
938468|NCT00852995|3092305|P2|Overall Study|Progressive Disease|0
938469|NCT00852995|3092306|P1|Overall Study|Progressive Disease|1
938470|NCT00852995|3092302|P5|Overall Study|Non-Compliance|0
938471|NCT00852995|3092303|P4|Overall Study|Non-Compliance|2
938472|NCT00852995|3092304|P3|Overall Study|Non-Compliance|0
938473|NCT00852995|3092305|P2|Overall Study|Non-Compliance|0
938474|NCT00852995|3092306|P1|Overall Study|Non-Compliance|0
938475|NCT00852995|3092302|P5|Overall Study|Withdrawal by Subject|2
938476|NCT00852995|3092303|P4|Overall Study|Withdrawal by Subject|1
938477|NCT00852995|3092304|P3|Overall Study|Withdrawal by Subject|0
938478|NCT00852995|3092305|P2|Overall Study|Withdrawal by Subject|0
938479|NCT00852995|3092306|P1|Overall Study|Withdrawal by Subject|4
938480|NCT00852995|3092302|P5|Overall Study|Lost to Follow-up|0
938481|NCT00852995|3092303|P4|Overall Study|Lost to Follow-up|0
938482|NCT00852995|3092304|P3|Overall Study|Lost to Follow-up|1
938483|NCT00852995|3092305|P2|Overall Study|Lost to Follow-up|1
938484|NCT00852995|3092306|P1|Overall Study|Lost to Follow-up|0
938485|NCT00852995|3092302|P5|Overall Study|Adverse Event|0
938486|NCT00852995|3092303|P4|Overall Study|Adverse Event|0
938487|NCT00852995|3092304|P3|Overall Study|Adverse Event|4
938488|NCT00852995|3092305|P2|Overall Study|Adverse Event|0
938489|NCT00852995|3092306|P1|Overall Study|Adverse Event|1
938490|NCT00852969|3092350|P2|Overall Study|Lost to Follow-up|1
938491|NCT00852969|3092351|P1|Overall Study|Lost to Follow-up|0
938492|NCT00852969|3092350|P2|Overall Study|Adverse Event|1
938493|NCT00852969|3092351|P1|Overall Study|Adverse Event|0
938494|NCT00852930|3092362|P3|Overall Study|Physician Decision|1
938495|NCT00852930|3092363|P2|Overall Study|Physician Decision|0
938496|NCT00852930|3092364|P1|Overall Study|Physician Decision|0
938497|NCT00852930|3092362|P3|Overall Study|Withdrawal by Subject|1
938498|NCT00852930|3092363|P2|Overall Study|Withdrawal by Subject|1
938499|NCT00852930|3092364|P1|Overall Study|Withdrawal by Subject|1
938500|NCT00852917|3092385|P4|Overall Study|Death|1
938501|NCT00852917|3092386|P3|Overall Study|Death|0
938502|NCT00852917|3092387|P2|Overall Study|Death|0
938503|NCT00852917|3092388|P1|Overall Study|Death|0
938504|NCT00852917|3092385|P4|Overall Study|Physician Decision|19
938505|NCT00852917|3092386|P3|Overall Study|Physician Decision|2
938506|NCT00852917|3092387|P2|Overall Study|Physician Decision|7
938507|NCT00852917|3092388|P1|Overall Study|Physician Decision|6
938508|NCT00852917|3092385|P4|Overall Study|Withdrawal by Subject|9
938509|NCT00852917|3092386|P3|Overall Study|Withdrawal by Subject|10
938510|NCT00852917|3092387|P2|Overall Study|Withdrawal by Subject|8
938511|NCT00852917|3092388|P1|Overall Study|Withdrawal by Subject|4
938512|NCT00852917|3092385|P4|Overall Study|Lack of Efficacy|47
938513|NCT00852917|3092386|P3|Overall Study|Lack of Efficacy|11
938514|NCT00852917|3092387|P2|Overall Study|Lack of Efficacy|11
938515|NCT00852917|3092388|P1|Overall Study|Lack of Efficacy|21
938516|NCT00852917|3092385|P4|Overall Study|Adverse Event|17
938517|NCT00852917|3092386|P3|Overall Study|Adverse Event|35
938518|NCT00852917|3092387|P2|Overall Study|Adverse Event|20
938519|NCT00852917|3092388|P1|Overall Study|Adverse Event|13
938520|NCT00852540|3092516|P2|Overall Study|Did Not Receive Study Drug|3
938521|NCT00852540|3092517|P1|Overall Study|Did Not Receive Study Drug|3
938522|NCT00852540|3092516|P2|Overall Study|Withdrawal by Subject|1
938523|NCT00852540|3092517|P1|Overall Study|Withdrawal by Subject|3
938524|NCT00852540|3092516|P2|Overall Study|Investigator Discretion|3
938525|NCT00852540|3092517|P1|Overall Study|Investigator Discretion|2
938526|NCT00852540|3092516|P2|Overall Study|Lost to Follow-up|3
938527|NCT00852540|3092517|P1|Overall Study|Lost to Follow-up|2
938528|NCT00852540|3092516|P2|Overall Study|Protocol Violation|2
938529|NCT00852540|3092517|P1|Overall Study|Protocol Violation|1
938530|NCT00852540|3092516|P2|Overall Study|Lack of Efficacy|3
938531|NCT00852540|3092517|P1|Overall Study|Lack of Efficacy|15
938532|NCT00852540|3092516|P2|Overall Study|Adverse Event|3
938533|NCT00852540|3092517|P1|Overall Study|Adverse Event|10
938534|NCT00852475|3092551|P2|Overall Study|Lost to Follow-up|4
938535|NCT00852475|3092552|P1|Overall Study|Lost to Follow-up|3
938536|NCT00852397|3092563|P3|Overall Study|Protocol Violation|1
938537|NCT00852397|3092564|P2|Overall Study|Protocol Violation|0
938538|NCT00852397|3092565|P1|Overall Study|Protocol Violation|0
938539|NCT00852397|3092563|P3|Overall Study|Difficulty in study site visit|0
938540|NCT00852397|3092564|P2|Overall Study|Difficulty in study site visit|0
938541|NCT00852397|3092565|P1|Overall Study|Difficulty in study site visit|1
938542|NCT00852397|3092563|P3|Overall Study|Study terminated by sponsor|6
938543|NCT00852397|3092564|P2|Overall Study|Study terminated by sponsor|1
938544|NCT00852397|3092565|P1|Overall Study|Study terminated by sponsor|2
938545|NCT00852397|3092563|P3|Overall Study|Withdrawal by Subject|2
938546|NCT00852397|3092564|P2|Overall Study|Withdrawal by Subject|1
938547|NCT00852397|3092565|P1|Overall Study|Withdrawal by Subject|4
938548|NCT00852397|3092563|P3|Overall Study|Death|1
938549|NCT00852397|3092564|P2|Overall Study|Death|0
938550|NCT00852397|3092565|P1|Overall Study|Death|0
938551|NCT00852397|3092563|P3|Overall Study|Adverse Event|4
938552|NCT00852397|3092564|P2|Overall Study|Adverse Event|6
938553|NCT00852397|3092565|P1|Overall Study|Adverse Event|4
938554|NCT00852241|3092594|P1|Overall Study|Physician Decision|18
938555|NCT00852202|3092601|P3|Overall Study|pregnancy,moving away and surgery|2
938556|NCT00852202|3092602|P2|Overall Study|pregnancy,moving away and surgery|0
938557|NCT00852202|3092603|P1|Overall Study|pregnancy,moving away and surgery|1
938558|NCT00852202|3092601|P3|Overall Study|Lost to Follow-up|6
938559|NCT00852202|3092602|P2|Overall Study|Lost to Follow-up|5
938560|NCT00852202|3092603|P1|Overall Study|Lost to Follow-up|5
938561|NCT00852202|3092601|P3|Overall Study|Withdrawal by Subject|2
938562|NCT00852202|3092602|P2|Overall Study|Withdrawal by Subject|1
938563|NCT00852202|3092603|P1|Overall Study|Withdrawal by Subject|3
938564|NCT00852202|3092601|P3|Overall Study|Protocol Violation|7
938565|NCT00852202|3092602|P2|Overall Study|Protocol Violation|2
938566|NCT00852202|3092603|P1|Overall Study|Protocol Violation|2
938567|NCT00852202|3092601|P3|Overall Study|Lack of Efficacy|2
938568|NCT00852202|3092602|P2|Overall Study|Lack of Efficacy|1
938569|NCT00852202|3092603|P1|Overall Study|Lack of Efficacy|4
938570|NCT00852202|3092601|P3|Overall Study|Adverse Event|7
938571|NCT00852202|3092602|P2|Overall Study|Adverse Event|3
938572|NCT00852202|3092603|P1|Overall Study|Adverse Event|2
938573|NCT00851903|3092645|P1|Overall Study|Withdrawal by Subject|2
938574|NCT00851890|3092659|P4|Overall Study|Lost to Follow-up|1
938575|NCT00851890|3092660|P3|Overall Study|Lost to Follow-up|0
938576|NCT00851890|3092661|P2|Overall Study|Lost to Follow-up|1
938577|NCT00851890|3092662|P1|Overall Study|Lost to Follow-up|0
938578|NCT00851877|3092719|P3|Phase II|Withdrawal by Subject|3
938579|NCT00851877|3092720|P2|Phase II|Withdrawal by Subject|0
938580|NCT00851877|3092721|P1|Phase II|Withdrawal by Subject|0
938581|NCT00851877|3092719|P3|Phase I-1|Death|0
938582|NCT00851877|3092720|P2|Phase I-1|Death|0
938583|NCT00851877|3092721|P1|Phase I-1|Death|1
938584|NCT00851799|3092731|P3|Overall Study|Completed protocol due to pregnancy|1
938585|NCT00851799|3092732|P2|Overall Study|Completed protocol due to pregnancy|0
938586|NCT00851799|3092733|P1|Overall Study|Completed protocol due to pregnancy|0
938587|NCT00851799|3092731|P3|Overall Study|Severe Debilitation|0
938588|NCT00851799|3092732|P2|Overall Study|Severe Debilitation|1
938589|NCT00851799|3092733|P1|Overall Study|Severe Debilitation|0
938590|NCT00851799|3092731|P3|Overall Study|Withdrew consent prior study completion|1
938591|NCT00851799|3092732|P2|Overall Study|Withdrew consent prior study completion|2
938592|NCT00851799|3092733|P1|Overall Study|Withdrew consent prior study completion|1
938593|NCT00851799|3092731|P3|Overall Study|Not willing to adhere to requirements|2
938594|NCT00851799|3092732|P2|Overall Study|Not willing to adhere to requirements|2
938595|NCT00851799|3092733|P1|Overall Study|Not willing to adhere to requirements|1
938596|NCT00851799|3092731|P3|Overall Study|Not able to get to clinic|9
938597|NCT00851799|3092732|P2|Overall Study|Not able to get to clinic|5
938598|NCT00851799|3092733|P1|Overall Study|Not able to get to clinic|8
938599|NCT00851799|3092731|P3|Overall Study|Lost to Follow-up|10
938600|NCT00851799|3092732|P2|Overall Study|Lost to Follow-up|3
938601|NCT00851799|3092733|P1|Overall Study|Lost to Follow-up|5
938602|NCT00851799|3092731|P3|Overall Study|Death|1
938603|NCT00851799|3092732|P2|Overall Study|Death|0
938604|NCT00851799|3092733|P1|Overall Study|Death|1
938605|NCT00851786|3092821|P2|Overall Study|Cannot Adhere to Protocol Requirement|0
938606|NCT00851786|3092822|P1|Overall Study|Cannot Adhere to Protocol Requirement|2
938607|NCT00851786|3092821|P2|Overall Study|Site Closure|0
938608|NCT00851786|3092822|P1|Overall Study|Site Closure|1
938609|NCT00851786|3092821|P2|Overall Study|Incarceration|0
938610|NCT00851786|3092822|P1|Overall Study|Incarceration|1
938611|NCT00851786|3092821|P2|Overall Study|Lost to Follow-up|0
938612|NCT00851786|3092822|P1|Overall Study|Lost to Follow-up|1
938613|NCT00851786|3092821|P2|Overall Study|Protocol Violation|1
938614|NCT00851786|3092822|P1|Overall Study|Protocol Violation|0
938615|NCT00851786|3092821|P2|Overall Study|Withdrawal by Subject|1
938616|NCT00851786|3092822|P1|Overall Study|Withdrawal by Subject|0
938617|NCT00851747|3092835|P3|Overall Study|Physician Decision|6
938618|NCT00851747|3092836|P2|Overall Study|Physician Decision|6
938619|NCT00851747|3092837|P1|Overall Study|Physician Decision|6
938620|NCT00851721|3092846|P2|Overall Study|Adverse Event|1
938621|NCT00851721|3092847|P1|Overall Study|Adverse Event|0
938622|NCT00851721|3092846|P2|Overall Study|Death|0
938623|NCT00851721|3092847|P1|Overall Study|Death|1
938624|NCT00851721|3092846|P2|Overall Study|planned surgery|0
938625|NCT00851721|3092847|P1|Overall Study|planned surgery|1
938626|NCT00851682|3092937|P2|Overall Study|screen failure|0
938627|NCT00851682|3092938|P1|Overall Study|screen failure|5
938628|NCT00851643|3092952|P6|Extension Study (Up to 36 Months)|Moved|1
938629|NCT00851643|3092953|P5|Extension Study (Up to 36 Months)|Moved|0
938630|NCT00851643|3092954|P4|Extension Study (Up to 36 Months)|Moved|1
938631|NCT00851643|3092955|P3|Extension Study (Up to 36 Months)|Moved|1
938632|NCT00851643|3092956|P2|Extension Study (Up to 36 Months)|Moved|2
938633|NCT00851643|3092957|P1|Extension Study (Up to 36 Months)|Moved|0
938634|NCT00851643|3092952|P6|Extension Study (Up to 36 Months)|Lost to Follow-up|0
938635|NCT00851643|3092953|P5|Extension Study (Up to 36 Months)|Lost to Follow-up|2
938636|NCT00851643|3092954|P4|Extension Study (Up to 36 Months)|Lost to Follow-up|1
938637|NCT00851643|3092955|P3|Extension Study (Up to 36 Months)|Lost to Follow-up|4
938638|NCT00851643|3092956|P2|Extension Study (Up to 36 Months)|Lost to Follow-up|2
938639|NCT00851643|3092957|P1|Extension Study (Up to 36 Months)|Lost to Follow-up|4
938640|NCT00851643|3092952|P6|Base Study (Up to 12 Months)|Other|1
938641|NCT00851643|3092953|P5|Base Study (Up to 12 Months)|Other|0
938642|NCT00851643|3092954|P4|Base Study (Up to 12 Months)|Other|0
938643|NCT00851643|3092955|P3|Base Study (Up to 12 Months)|Other|0
938644|NCT00851643|3092956|P2|Base Study (Up to 12 Months)|Other|0
938645|NCT00851643|3092957|P1|Base Study (Up to 12 Months)|Other|0
938646|NCT00851643|3092952|P6|Base Study (Up to 12 Months)|Withdrawal by Subject|0
938647|NCT00851643|3092953|P5|Base Study (Up to 12 Months)|Withdrawal by Subject|0
938648|NCT00851643|3092954|P4|Base Study (Up to 12 Months)|Withdrawal by Subject|0
938649|NCT00851643|3092955|P3|Base Study (Up to 12 Months)|Withdrawal by Subject|0
938650|NCT00851643|3092956|P2|Base Study (Up to 12 Months)|Withdrawal by Subject|0
938651|NCT00851643|3092957|P1|Base Study (Up to 12 Months)|Withdrawal by Subject|1
938652|NCT00851630|3092978|P2|Overall Study|Clinical failure|1
938653|NCT00851630|3092979|P1|Overall Study|Clinical failure|0
938654|NCT00851630|3092978|P2|Overall Study|Death|1
938655|NCT00851630|3092979|P1|Overall Study|Death|2
938656|NCT00851591|3092993|P2|Overall Study|Withdrawal by Subject|0
938657|NCT00851591|3092994|P1|Overall Study|Withdrawal by Subject|2
938658|NCT00851552|3093000|P1|Overall Study|Disease Progression|4
938659|NCT00851552|3093000|P1|Overall Study|Adverse Event|1
938660|NCT00851552|3093000|P1|Overall Study|Death|2
938661|NCT00851318|3093014|P4|Overall Study|Physician Decision|1
938662|NCT00851318|3093015|P3|Overall Study|Physician Decision|1
938663|NCT00851318|3093016|P2|Overall Study|Physician Decision|0
938664|NCT00851318|3093017|P1|Overall Study|Physician Decision|0
938665|NCT00851318|3093014|P4|Overall Study|Non-compliance with Study Procedures|0
938666|NCT00851318|3093015|P3|Overall Study|Non-compliance with Study Procedures|1
938667|NCT00851318|3093016|P2|Overall Study|Non-compliance with Study Procedures|0
938668|NCT00851318|3093017|P1|Overall Study|Non-compliance with Study Procedures|2
938669|NCT00851318|3093014|P4|Overall Study|Lack of Efficacy|2
938670|NCT00851318|3093015|P3|Overall Study|Lack of Efficacy|4
938671|NCT00851318|3093016|P2|Overall Study|Lack of Efficacy|2
938672|NCT00851318|3093017|P1|Overall Study|Lack of Efficacy|8
938673|NCT00851318|3093014|P4|Overall Study|Pregnancy|1
938674|NCT00851318|3093015|P3|Overall Study|Pregnancy|1
938675|NCT00851318|3093016|P2|Overall Study|Pregnancy|0
938676|NCT00851318|3093017|P1|Overall Study|Pregnancy|0
938677|NCT00851318|3093014|P4|Overall Study|Adverse Event|12
938678|NCT00851318|3093015|P3|Overall Study|Adverse Event|9
938679|NCT00851318|3093016|P2|Overall Study|Adverse Event|2
938680|NCT00851318|3093017|P1|Overall Study|Adverse Event|13
938681|NCT00851318|3093014|P4|Overall Study|Withdrawal by Subject|3
938682|NCT00851318|3093015|P3|Overall Study|Withdrawal by Subject|5
938683|NCT00851318|3093016|P2|Overall Study|Withdrawal by Subject|1
938684|NCT00851318|3093017|P1|Overall Study|Withdrawal by Subject|7
938685|NCT00851253|3093053|P2|Overall Study|Disease Progression|0
938686|NCT00851253|3093054|P1|Overall Study|Disease Progression|1
938687|NCT00851084|3093064|P2|Overall Study|Not specified|1
938688|NCT00851084|3093065|P1|Overall Study|Not specified|7
938689|NCT00851084|3093064|P2|Overall Study|Metastatic surgery|6
938690|NCT00851084|3093065|P1|Overall Study|Metastatic surgery|6
938691|NCT00851084|3093064|P2|Overall Study|Withdrawal by Subject|12
938692|NCT00851084|3093065|P1|Overall Study|Withdrawal by Subject|11
938693|NCT00851084|3093064|P2|Overall Study|Consent withdrawn|2
938694|NCT00851084|3093065|P1|Overall Study|Consent withdrawn|0
938695|NCT00851084|3093064|P2|Overall Study|Physician Decision|14
938696|NCT00851084|3093065|P1|Overall Study|Physician Decision|13
938697|NCT00851084|3093064|P2|Overall Study|Poor compliance to protocol|1
938698|NCT00851084|3093065|P1|Overall Study|Poor compliance to protocol|1
938699|NCT00851084|3093064|P2|Overall Study|Disease progression|47
938700|NCT00851084|3093065|P1|Overall Study|Disease progression|52
938701|NCT00851084|3093064|P2|Overall Study|Adverse Event|36
938702|NCT00851084|3093065|P1|Overall Study|Adverse Event|26
938703|NCT00851084|3093064|P2|Overall Study|Randomized but not treated|0
938704|NCT00851084|3093065|P1|Overall Study|Randomized but not treated|1
938705|NCT00850759|3093125|P4|Overall Study|Lost to Follow-up|3
938706|NCT00850759|3093126|P3|Overall Study|Lost to Follow-up|5
938707|NCT00850759|3093127|P2|Overall Study|Lost to Follow-up|5
938708|NCT00850759|3093128|P1|Overall Study|Lost to Follow-up|7
938709|NCT00850564|3093209|P1|Overall Study|Withdrawal by Subject|2
938710|NCT00850538|3093214|P1|Overall Study|Protocol Violation|2
938711|NCT00850538|3093214|P1|Overall Study|radiology error|2
938712|NCT00850538|3093214|P1|Overall Study|Withdrawal by Subject|3
938713|NCT00850538|3093214|P1|Overall Study|specimen unusable|7
938714|NCT00850538|3093214|P1|Overall Study|specimen missed due to scheduling error|14
938715|NCT00850538|3093214|P1|Overall Study|unable/unwilling to complete MRI|13
938716|NCT00850499|3093220|P2|Overall Study|Lack of Efficacy|1
938717|NCT00850499|3093221|P1|Overall Study|Lack of Efficacy|0
938718|NCT00850499|3093220|P2|Overall Study|Adverse Event|1
938719|NCT00850499|3093221|P1|Overall Study|Adverse Event|3
938720|NCT00850460|3093235|P2|Overall Study|Lost to Follow-up|4
938721|NCT00850460|3093236|P1|Overall Study|Lost to Follow-up|4
938722|NCT00850395|3093250|P1|Overall Study|Other|5
938723|NCT00850395|3093250|P1|Overall Study|Insufficient clinical response|3
938724|NCT00850395|3093250|P1|Overall Study|Adverse Event|1
938725|NCT00850395|3093250|P1|Overall Study|Death|1
938726|NCT00850343|3093270|P4|Overall Study|Physician Decision|1
938727|NCT00850343|3093271|P3|Overall Study|Physician Decision|1
938728|NCT00850343|3093272|P2|Overall Study|Physician Decision|1
938729|NCT00850343|3093273|P1|Overall Study|Physician Decision|2
938730|NCT00850343|3093270|P4|Overall Study|Non-compliance with Study Procedures|1
938731|NCT00850343|3093271|P3|Overall Study|Non-compliance with Study Procedures|1
938732|NCT00850343|3093272|P2|Overall Study|Non-compliance with Study Procedures|0
938733|NCT00850343|3093273|P1|Overall Study|Non-compliance with Study Procedures|1
938734|NCT00850343|3093270|P4|Overall Study|Lack of Efficacy|2
938735|NCT00850343|3093271|P3|Overall Study|Lack of Efficacy|3
938736|NCT00850343|3093272|P2|Overall Study|Lack of Efficacy|0
938737|NCT00850343|3093273|P1|Overall Study|Lack of Efficacy|17
938738|NCT00850343|3093270|P4|Overall Study|Pregnancy|1
938739|NCT00850343|3093271|P3|Overall Study|Pregnancy|0
938740|NCT00850343|3093272|P2|Overall Study|Pregnancy|0
938741|NCT00850343|3093273|P1|Overall Study|Pregnancy|0
938742|NCT00850343|3093270|P4|Overall Study|Adverse Event|6
938743|NCT00850343|3093271|P3|Overall Study|Adverse Event|6
938744|NCT00850343|3093272|P2|Overall Study|Adverse Event|2
938745|NCT00850343|3093273|P1|Overall Study|Adverse Event|15
938746|NCT00850343|3093270|P4|Overall Study|Withdrawal by Subject|2
938747|NCT00850343|3093271|P3|Overall Study|Withdrawal by Subject|3
938748|NCT00850343|3093272|P2|Overall Study|Withdrawal by Subject|0
938749|NCT00850343|3093273|P1|Overall Study|Withdrawal by Subject|11
938750|NCT00850200|3093303|P1|Overall Study|Withdrawal by Subject|1
938751|NCT00850174|3093311|P2|Second Intervention|Withdrawal by Subject|0
938752|NCT00850174|3093312|P1|Second Intervention|Withdrawal by Subject|1
938753|NCT00850174|3093311|P2|Washout: One Week|Withdrawal by Subject|2
938754|NCT00850174|3093312|P1|Washout: One Week|Withdrawal by Subject|0
938755|NCT00850135|3093326|P1|Overall Study|Physician Decision|1
938756|NCT00850070|3093345|P2|Overall Study|Adverse Event|0
938757|NCT00850070|3093346|P1|Overall Study|Adverse Event|2
938758|NCT00850070|3093345|P2|Overall Study|Lack of Efficacy|1
938759|NCT00850070|3093346|P1|Overall Study|Lack of Efficacy|1
938760|NCT00849940|3093375|P1|Overall Study|Physician Decision|4
938761|NCT00849901|3093386|P3|Extension Phase|Lack of Efficacy|1
938762|NCT00849901|3093387|P2|Extension Phase|Lack of Efficacy|4
938763|NCT00849901|3093388|P1|Extension Phase|Lack of Efficacy|2
938764|NCT00849901|3093386|P3|Extension Phase|Physician Decision|0
938765|NCT00849901|3093387|P2|Extension Phase|Physician Decision|2
938766|NCT00849901|3093388|P1|Extension Phase|Physician Decision|1
938767|NCT00849901|3093386|P3|Extension Phase|Parent or Caregiver Decision|4
938768|NCT00849901|3093387|P2|Extension Phase|Parent or Caregiver Decision|4
938769|NCT00849901|3093388|P1|Extension Phase|Parent or Caregiver Decision|10
938770|NCT00849901|3093386|P3|Extension Phase|Withdrawal by Subject|3
938771|NCT00849901|3093387|P2|Extension Phase|Withdrawal by Subject|6
938772|NCT00849901|3093388|P1|Extension Phase|Withdrawal by Subject|7
938773|NCT00849901|3093386|P3|Extension Phase|Protocol Violation|4
938774|NCT00849901|3093387|P2|Extension Phase|Protocol Violation|2
938775|NCT00849901|3093388|P1|Extension Phase|Protocol Violation|2
938776|NCT00849901|3093386|P3|Extension Phase|Lost to Follow-up|1
938777|NCT00849901|3093387|P2|Extension Phase|Lost to Follow-up|0
938778|NCT00849901|3093388|P1|Extension Phase|Lost to Follow-up|3
938779|NCT00849901|3093386|P3|Extension Phase|Adverse Event|4
938780|NCT00849901|3093387|P2|Extension Phase|Adverse Event|8
938781|NCT00849901|3093388|P1|Extension Phase|Adverse Event|2
938782|NCT00849901|3093386|P3|Acute Treatment Phase|Lack of Efficacy|2
938783|NCT00849901|3093387|P2|Acute Treatment Phase|Lack of Efficacy|3
938784|NCT00849901|3093388|P1|Acute Treatment Phase|Lack of Efficacy|2
938785|NCT00849901|3093386|P3|Acute Treatment Phase|Sponsor Decision|0
938786|NCT00849901|3093387|P2|Acute Treatment Phase|Sponsor Decision|0
938787|NCT00849901|3093388|P1|Acute Treatment Phase|Sponsor Decision|1
938788|NCT00849901|3093386|P3|Acute Treatment Phase|Physician Decision|1
938789|NCT00849901|3093387|P2|Acute Treatment Phase|Physician Decision|1
938790|NCT00849901|3093388|P1|Acute Treatment Phase|Physician Decision|1
938791|NCT00849901|3093386|P3|Acute Treatment Phase|Parent or Caregiver Decision|4
938792|NCT00849901|3093387|P2|Acute Treatment Phase|Parent or Caregiver Decision|5
938793|NCT00849901|3093388|P1|Acute Treatment Phase|Parent or Caregiver Decision|11
938794|NCT00849901|3093386|P3|Acute Treatment Phase|Withdrawal by Subject|4
938795|NCT00849901|3093387|P2|Acute Treatment Phase|Withdrawal by Subject|10
938796|NCT00849901|3093388|P1|Acute Treatment Phase|Withdrawal by Subject|4
938797|NCT00849901|3093386|P3|Acute Treatment Phase|Protocol Violation|1
938798|NCT00849901|3093387|P2|Acute Treatment Phase|Protocol Violation|2
938799|NCT00849901|3093388|P1|Acute Treatment Phase|Protocol Violation|0
938800|NCT00849901|3093386|P3|Acute Treatment Phase|Lost to Follow-up|1
938801|NCT00849901|3093387|P2|Acute Treatment Phase|Lost to Follow-up|4
938802|NCT00849901|3093388|P1|Acute Treatment Phase|Lost to Follow-up|2
938803|NCT00849901|3093386|P3|Acute Treatment Phase|Adverse Event|3
938804|NCT00849901|3093387|P2|Acute Treatment Phase|Adverse Event|1
938805|NCT00849901|3093388|P1|Acute Treatment Phase|Adverse Event|9
938806|NCT00849875|3093435|P1|Overall Study|Lost to Follow-up|2
938807|NCT00849875|3093435|P1|Overall Study|Others|6
938808|NCT00849875|3093435|P1|Overall Study|Ongoing (unknown completion status)|11
938809|NCT00849875|3093435|P1|Overall Study|Death|28
938810|NCT00849797|3093532|P2|Washout: One Week|Withdrawal by Subject|2
938811|NCT00849797|3093533|P1|Washout: One Week|Withdrawal by Subject|0
938812|NCT00849797|3093532|P2|First Intervention|Adverse Event|1
938813|NCT00849797|3093533|P1|First Intervention|Adverse Event|0
938814|NCT00849797|3093532|P2|First Intervention|bad veins|0
938815|NCT00849797|3093533|P1|First Intervention|bad veins|1
938816|NCT00849693|3093551|P4|Extension Phase|Lack of Efficacy|1
938817|NCT00849693|3093552|P3|Extension Phase|Lack of Efficacy|2
938818|NCT00849693|3093553|P2|Extension Phase|Lack of Efficacy|2
938819|NCT00849693|3093554|P1|Extension Phase|Lack of Efficacy|2
938820|NCT00849693|3093551|P4|Extension Phase|Sponsor decision|1
938821|NCT00849693|3093552|P3|Extension Phase|Sponsor decision|0
938822|NCT00849693|3093553|P2|Extension Phase|Sponsor decision|0
938823|NCT00849693|3093554|P1|Extension Phase|Sponsor decision|1
938824|NCT00849693|3093551|P4|Extension Phase|Physician Decision|0
938825|NCT00849693|3093552|P3|Extension Phase|Physician Decision|2
938826|NCT00849693|3093553|P2|Extension Phase|Physician Decision|1
938827|NCT00849693|3093554|P1|Extension Phase|Physician Decision|1
938828|NCT00849693|3093551|P4|Extension Phase|Parent or caregiver decision|5
938829|NCT00849693|3093552|P3|Extension Phase|Parent or caregiver decision|10
938830|NCT00849693|3093553|P2|Extension Phase|Parent or caregiver decision|4
938831|NCT00849693|3093554|P1|Extension Phase|Parent or caregiver decision|9
938832|NCT00849693|3093551|P4|Extension Phase|Withdrawal by Subject|15
938833|NCT00849693|3093552|P3|Extension Phase|Withdrawal by Subject|10
938834|NCT00849693|3093553|P2|Extension Phase|Withdrawal by Subject|9
938835|NCT00849693|3093554|P1|Extension Phase|Withdrawal by Subject|6
938836|NCT00849693|3093551|P4|Extension Phase|Protocol Violation|3
938837|NCT00849693|3093552|P3|Extension Phase|Protocol Violation|2
938838|NCT00849693|3093553|P2|Extension Phase|Protocol Violation|3
938839|NCT00849693|3093554|P1|Extension Phase|Protocol Violation|0
938840|NCT00849693|3093551|P4|Extension Phase|Lost to Follow-up|6
938841|NCT00849693|3093552|P3|Extension Phase|Lost to Follow-up|6
938842|NCT00849693|3093553|P2|Extension Phase|Lost to Follow-up|5
938843|NCT00849693|3093554|P1|Extension Phase|Lost to Follow-up|7
938844|NCT00849693|3093551|P4|Extension Phase|Adverse Event|7
938845|NCT00849693|3093552|P3|Extension Phase|Adverse Event|3
938846|NCT00849693|3093553|P2|Extension Phase|Adverse Event|6
938847|NCT00849693|3093554|P1|Extension Phase|Adverse Event|4
938848|NCT00849693|3093551|P4|Acute Treatment Phase|Lack of Efficacy|2
938849|NCT00849693|3093552|P3|Acute Treatment Phase|Lack of Efficacy|1
938850|NCT00849693|3093553|P2|Acute Treatment Phase|Lack of Efficacy|3
938851|NCT00849693|3093554|P1|Acute Treatment Phase|Lack of Efficacy|1
938852|NCT00849693|3093551|P4|Acute Treatment Phase|Sponsor decision|0
938853|NCT00849693|3093552|P3|Acute Treatment Phase|Sponsor decision|1
938854|NCT00849693|3093553|P2|Acute Treatment Phase|Sponsor decision|0
938855|NCT00849693|3093554|P1|Acute Treatment Phase|Sponsor decision|0
938856|NCT00849693|3093551|P4|Acute Treatment Phase|Physician Decision|1
938857|NCT00849693|3093552|P3|Acute Treatment Phase|Physician Decision|2
938858|NCT00849693|3093553|P2|Acute Treatment Phase|Physician Decision|1
938859|NCT00849693|3093554|P1|Acute Treatment Phase|Physician Decision|2
938860|NCT00849693|3093551|P4|Acute Treatment Phase|Parent or caregiver decision|7
938861|NCT00849693|3093552|P3|Acute Treatment Phase|Parent or caregiver decision|7
938862|NCT00849693|3093553|P2|Acute Treatment Phase|Parent or caregiver decision|6
938863|NCT00849693|3093554|P1|Acute Treatment Phase|Parent or caregiver decision|7
938864|NCT00849693|3093551|P4|Acute Treatment Phase|Withdrawal by Subject|8
938865|NCT00849693|3093552|P3|Acute Treatment Phase|Withdrawal by Subject|3
938866|NCT00849693|3093553|P2|Acute Treatment Phase|Withdrawal by Subject|5
938867|NCT00849693|3093554|P1|Acute Treatment Phase|Withdrawal by Subject|5
938868|NCT00849693|3093551|P4|Acute Treatment Phase|Protocol Violation|6
938869|NCT00849693|3093552|P3|Acute Treatment Phase|Protocol Violation|2
938870|NCT00849693|3093553|P2|Acute Treatment Phase|Protocol Violation|5
938871|NCT00849693|3093554|P1|Acute Treatment Phase|Protocol Violation|1
938872|NCT00849693|3093551|P4|Acute Treatment Phase|Lost to Follow-up|9
938873|NCT00849693|3093552|P3|Acute Treatment Phase|Lost to Follow-up|11
938874|NCT00849693|3093553|P2|Acute Treatment Phase|Lost to Follow-up|8
938875|NCT00849693|3093554|P1|Acute Treatment Phase|Lost to Follow-up|5
938876|NCT00849693|3093551|P4|Acute Treatment Phase|Adverse Event|4
938877|NCT00849693|3093552|P3|Acute Treatment Phase|Adverse Event|6
938878|NCT00849693|3093553|P2|Acute Treatment Phase|Adverse Event|7
938879|NCT00849693|3093554|P1|Acute Treatment Phase|Adverse Event|12
938880|NCT00849680|3093621|P8|Overall Study|Subject unable to comply with protocol|0
938881|NCT00849680|3093622|P7|Overall Study|Subject unable to comply with protocol|0
938882|NCT00849680|3093623|P6|Overall Study|Subject unable to comply with protocol|0
938883|NCT00849680|3093624|P5|Overall Study|Subject unable to comply with protocol|0
938884|NCT00849680|3093625|P4|Overall Study|Subject unable to comply with protocol|0
938885|NCT00849680|3093626|P3|Overall Study|Subject unable to comply with protocol|0
938886|NCT00849680|3093627|P2|Overall Study|Subject unable to comply with protocol|0
938887|NCT00849680|3093628|P1|Overall Study|Subject unable to comply with protocol|1
938888|NCT00849680|3093621|P8|Overall Study|Withdrawal by Subject|1
938889|NCT00849680|3093622|P7|Overall Study|Withdrawal by Subject|1
938890|NCT00849680|3093623|P6|Overall Study|Withdrawal by Subject|2
938891|NCT00849680|3093624|P5|Overall Study|Withdrawal by Subject|2
938892|NCT00849680|3093625|P4|Overall Study|Withdrawal by Subject|2
938893|NCT00849680|3093626|P3|Overall Study|Withdrawal by Subject|0
938894|NCT00849680|3093627|P2|Overall Study|Withdrawal by Subject|0
938895|NCT00849680|3093628|P1|Overall Study|Withdrawal by Subject|2
938896|NCT00849680|3093621|P8|Overall Study|Subject moved|2
938897|NCT00849680|3093622|P7|Overall Study|Subject moved|2
938898|NCT00849680|3093623|P6|Overall Study|Subject moved|2
938899|NCT00849680|3093624|P5|Overall Study|Subject moved|0
938900|NCT00849680|3093625|P4|Overall Study|Subject moved|1
938901|NCT00849680|3093626|P3|Overall Study|Subject moved|3
938902|NCT00849680|3093627|P2|Overall Study|Subject moved|0
938903|NCT00849680|3093628|P1|Overall Study|Subject moved|1
938904|NCT00849680|3093621|P8|Overall Study|Lost to Follow-up|5
938905|NCT00849680|3093622|P7|Overall Study|Lost to Follow-up|12
938906|NCT00849680|3093623|P6|Overall Study|Lost to Follow-up|11
938907|NCT00849680|3093624|P5|Overall Study|Lost to Follow-up|8
938908|NCT00849680|3093625|P4|Overall Study|Lost to Follow-up|11
938909|NCT00849680|3093626|P3|Overall Study|Lost to Follow-up|12
938910|NCT00849680|3093627|P2|Overall Study|Lost to Follow-up|3
938911|NCT00849680|3093628|P1|Overall Study|Lost to Follow-up|7
938912|NCT00849680|3093621|P8|Overall Study|Adverse Event|0
938913|NCT00849680|3093622|P7|Overall Study|Adverse Event|2
938914|NCT00849680|3093623|P6|Overall Study|Adverse Event|0
938915|NCT00849680|3093624|P5|Overall Study|Adverse Event|0
938916|NCT00849680|3093625|P4|Overall Study|Adverse Event|0
938917|NCT00849680|3093626|P3|Overall Study|Adverse Event|0
938918|NCT00849680|3093627|P2|Overall Study|Adverse Event|0
938919|NCT00849680|3093628|P1|Overall Study|Adverse Event|0
938920|NCT00849524|3093670|P1|Overall Study|Lack of Efficacy|3
938921|NCT00849472|3093687|P1|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1
938922|NCT00849472|3093687|P1|Pazopanib Postsurgery Treatment|Moved|1
938923|NCT00849472|3093687|P1|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5
938924|NCT00849472|3093687|P1|Pazopanib Postsurgery Treatment|Adverse Event|19
938925|NCT00849472|3093687|P1|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1
938926|NCT00849472|3093687|P1|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1
938927|NCT00849472|3093687|P1|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4
938928|NCT00849472|3093687|P1|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52
938929|NCT00849472|3093687|P1|Weekly Paclitaxel|Physician Decision|3
938930|NCT00849472|3093687|P1|Weekly Paclitaxel|Withdrawal by Subject|1
938931|NCT00849472|3093687|P1|Weekly Paclitaxel|Adverse Event|11
938932|NCT00849472|3093687|P1|Weekly Paclitaxel|Disease Progression|1
938933|NCT00849472|3093687|P1|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1
938934|NCT00849472|3093687|P1|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1
938935|NCT00849472|3093687|P1|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1
938936|NCT00849472|3093687|P1|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1
938937|NCT00849472|3093687|P1|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2
938938|NCT00849381|3093701|P1|Overall Study|Other|4
938939|NCT00849381|3093701|P1|Overall Study|Withdrawal by Subject|6
938940|NCT00849381|3093701|P1|Overall Study|Protocol Violation|5
938941|NCT00849381|3093701|P1|Overall Study|Lost to Follow-up|129
938942|NCT00849381|3093701|P1|Overall Study|Adverse Event|1
938943|NCT00849290|3093707|P1|Overall Study|Disease Progression|20
938944|NCT00849290|3093707|P1|Overall Study|Protocol Violation|5
938945|NCT00849290|3093707|P1|Overall Study|Lost to Follow-up|2
938946|NCT00849290|3093707|P1|Overall Study|Withdrawal by Subject|11
938947|NCT00849290|3093707|P1|Overall Study|Death|14
938948|NCT00849290|3093707|P1|Overall Study|Adverse Event|3
938949|NCT00849212|3093718|P1|Overall Study|Miscellaneous|1
938950|NCT00849212|3093718|P1|Overall Study|Adverse Event|2
938951|NCT00849212|3093718|P1|Overall Study|Withdrawal by Subject|3
938952|NCT00849212|3093718|P1|Overall Study|Lack of Efficacy|1
938953|NCT00849186|3093723|P1|Overall Study|Other|1
938954|NCT00849186|3093723|P1|Overall Study|not treated|6
938955|NCT00849186|3093723|P1|Overall Study|Withdrawal by Subject|1
938956|NCT00849186|3093723|P1|Overall Study|Adverse Event|2
938957|NCT00849147|3093729|P1|Overall Study|Disease Relapse/Progression|2
938958|NCT00849147|3093729|P1|Overall Study|Protocol Violation|2
938959|NCT00849147|3093729|P1|Overall Study|Withdrawal by Subject|1
938960|NCT00849108|3093762|P2|Cohort 2 Efficacy|Not specified|9
938961|NCT00849108|3093763|P1|Cohort 2 Efficacy|Not specified|0
938962|NCT00849108|3093762|P2|Cohort 2 Efficacy|Adverse Event|1
938963|NCT00849108|3093763|P1|Cohort 2 Efficacy|Adverse Event|0
938964|NCT00849108|3093762|P2|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0
938965|NCT00849108|3093763|P1|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1
938966|NCT00849056|3093773|P2|Follow-up Period (FUP) (8 Weeks)|Early Termination|0
938967|NCT00849056|3093774|P1|Follow-up Period (FUP) (8 Weeks)|Early Termination|1
938968|NCT00849056|3093773|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4
938969|NCT00849056|3093774|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1
938970|NCT00849056|3093773|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
938971|NCT00849056|3093774|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
938972|NCT00849056|3093773|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7
938973|NCT00849056|3093774|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9
938974|NCT00849056|3093773|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9
938975|NCT00849056|3093774|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14
938976|NCT00849056|3093773|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
938977|NCT00849056|3093774|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
938978|NCT00849056|3093773|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3
938979|NCT00849056|3093774|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
938980|NCT00849056|3093773|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|0
938981|NCT00849056|3093774|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|1
938982|NCT00849056|3093773|P2|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0
938983|NCT00849056|3093774|P1|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1
938984|NCT00849056|3093773|P2|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4
938985|NCT00849056|3093774|P1|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1
938986|NCT00849056|3093773|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|3
938987|NCT00849056|3093774|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|3
938988|NCT00849056|3093773|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18
938989|NCT00849056|3093774|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31
938990|NCT00849056|3093773|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5
938991|NCT00849056|3093774|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
938992|NCT00849056|3093773|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|3
938993|NCT00849056|3093774|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|3
938994|NCT00849056|3093773|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|6
938995|NCT00849056|3093774|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|3
938996|NCT00849056|3093773|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|11
938997|NCT00849056|3093774|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|13
938998|NCT00849017|3093799|P3|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
938999|NCT00849017|3093800|P2|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
939000|NCT00849017|3093801|P1|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1
939001|NCT00849017|3093799|P3|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
939002|NCT00849017|3093800|P2|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
939003|NCT00849017|3093801|P1|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3
939004|NCT00849017|3093799|P3|Follow-up Period (8 Weeks)|Physician Decision|1
939005|NCT00849017|3093800|P2|Follow-up Period (8 Weeks)|Physician Decision|1
939006|NCT00849017|3093801|P1|Follow-up Period (8 Weeks)|Physician Decision|0
939007|NCT00849017|3093799|P3|Follow-up Period (8 Weeks)|Withdrawal by Subject|3
939008|NCT00849017|3093800|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
939009|NCT00849017|3093801|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
939010|NCT00849017|3093799|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4
939011|NCT00849017|3093800|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
939012|NCT00849017|3093801|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
939013|NCT00849017|3093799|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|16
939014|NCT00849017|3093800|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
939015|NCT00849017|3093801|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|13
939016|NCT00849017|3093799|P3|Follow-up Period (8 Weeks)|Noncompliance|0
939017|NCT00849017|3093800|P2|Follow-up Period (8 Weeks)|Noncompliance|1
939018|NCT00849017|3093801|P1|Follow-up Period (8 Weeks)|Noncompliance|2
939019|NCT00849017|3093799|P3|Follow-up Period (8 Weeks)|Adverse Event|0
939020|NCT00849017|3093800|P2|Follow-up Period (8 Weeks)|Adverse Event|0
939021|NCT00849017|3093801|P1|Follow-up Period (8 Weeks)|Adverse Event|1
939022|NCT00849017|3093799|P3|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1
939023|NCT00849017|3093800|P2|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
939024|NCT00849017|3093801|P1|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
939025|NCT00849017|3093799|P3|Treatment Period (156 Weeks)|Pregnancy|1
939026|NCT00849017|3093800|P2|Treatment Period (156 Weeks)|Pregnancy|0
939027|NCT00849017|3093801|P1|Treatment Period (156 Weeks)|Pregnancy|1
939028|NCT00849017|3093799|P3|Treatment Period (156 Weeks)|Participant Moved to Africa|0
939029|NCT00849017|3093800|P2|Treatment Period (156 Weeks)|Participant Moved to Africa|0
939030|NCT00849017|3093801|P1|Treatment Period (156 Weeks)|Participant Moved to Africa|1
939031|NCT00849017|3093799|P3|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
939032|NCT00849017|3093800|P2|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
939033|NCT00849017|3093801|P1|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1
939034|NCT00849017|3093799|P3|Treatment Period (156 Weeks)|Increased Calcitonin|0
939035|NCT00849017|3093800|P2|Treatment Period (156 Weeks)|Increased Calcitonin|0
939036|NCT00849017|3093801|P1|Treatment Period (156 Weeks)|Increased Calcitonin|1
939037|NCT00849017|3093799|P3|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
939038|NCT00849017|3093800|P2|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
939039|NCT00849017|3093801|P1|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3
939040|NCT00849017|3093799|P3|Treatment Period (156 Weeks)|Physician Decision|1
939041|NCT00849017|3093800|P2|Treatment Period (156 Weeks)|Physician Decision|2
939042|NCT00849017|3093801|P1|Treatment Period (156 Weeks)|Physician Decision|0
939043|NCT00849017|3093799|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|11
939044|NCT00849017|3093800|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|14
939045|NCT00849017|3093801|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|18
939046|NCT00849017|3093799|P3|Treatment Period (156 Weeks)|Lost to Follow-up|8
939047|NCT00849017|3093800|P2|Treatment Period (156 Weeks)|Lost to Follow-up|7
939048|NCT00849017|3093801|P1|Treatment Period (156 Weeks)|Lost to Follow-up|10
939049|NCT00849017|3093799|P3|Treatment Period (156 Weeks)|Noncompliance|4
939050|NCT00849017|3093800|P2|Treatment Period (156 Weeks)|Noncompliance|3
939051|NCT00849017|3093801|P1|Treatment Period (156 Weeks)|Noncompliance|3
939052|NCT00849017|3093799|P3|Treatment Period (156 Weeks)|Adverse Event|15
939053|NCT00849017|3093800|P2|Treatment Period (156 Weeks)|Adverse Event|6
939054|NCT00849017|3093801|P1|Treatment Period (156 Weeks)|Adverse Event|5
939055|NCT00848965|3093844|P1|Overall Study|Withdrawal by Subject|1
939056|NCT00848965|3093844|P1|Overall Study|Adverse Event|1
939057|NCT00848926|3093886|P1|Follow-up Period|Not specified|2
939058|NCT00848926|3093886|P1|Follow-up Period|Withdrawal by Subject|3
939059|NCT00848926|3093886|P1|Follow-up Period|Lost to Follow-up|7
939060|NCT00848926|3093886|P1|Treatment Period|Withdrawal by Subject|7
939061|NCT00848926|3093886|P1|Treatment Period|Physician Decision|12
939062|NCT00848926|3093886|P1|Treatment Period|Adverse Event|20
939063|NCT00848926|3093886|P1|Treatment Period|Progressive disease|45
939064|NCT00848549|3093925|P2|E2090-E044-314 (Extension Study)|Not Specified|6
939065|NCT00848549|3093926|P1|E2090-E044-314 (Extension Study)|Not Specified|5
939066|NCT00848549|3093925|P2|E2090-E044-314 (Extension Study)|Physician Decision|2
939067|NCT00848549|3093926|P1|E2090-E044-314 (Extension Study)|Physician Decision|0
939068|NCT00848549|3093925|P2|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
939069|NCT00848549|3093926|P1|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
939070|NCT00848549|3093925|P2|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12
939071|NCT00848549|3093926|P1|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8
939072|NCT00848549|3093925|P2|E2090-E044-314 (Extension Study)|Protocol Violation|2
939073|NCT00848549|3093926|P1|E2090-E044-314 (Extension Study)|Protocol Violation|1
939074|NCT00848549|3093925|P2|E2090-E044-314 (Extension Study)|Adverse Event|1
939075|NCT00848549|3093926|P1|E2090-E044-314 (Extension Study)|Adverse Event|2
939076|NCT00848549|3093925|P2|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34
939077|NCT00848549|3093926|P1|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24
939078|NCT00848549|3093925|P2|E2090-E044-310 (Base Study) Disposition|Not Specified|3
939079|NCT00848549|3093926|P1|E2090-E044-310 (Base Study) Disposition|Not Specified|4
939080|NCT00848549|3093925|P2|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11
939081|NCT00848549|3093926|P1|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21
939082|NCT00848549|3093925|P2|E2090-E044-310 (Base Study) Disposition|Physician Decision|5
939083|NCT00848549|3093926|P1|E2090-E044-310 (Base Study) Disposition|Physician Decision|4
939084|NCT00848549|3093925|P2|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8
939085|NCT00848549|3093926|P1|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3
939086|NCT00848549|3093925|P2|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
939087|NCT00848549|3093926|P1|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
939088|NCT00848549|3093925|P2|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24
939089|NCT00848549|3093926|P1|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35
939090|NCT00848549|3093925|P2|E2090-E044-310 (Base Study) Disposition|Adverse Event|35
939091|NCT00848549|3093926|P1|E2090-E044-310 (Base Study) Disposition|Adverse Event|31
939092|NCT00848536|3093944|P2|Overall Study|Patient Moved|2
939093|NCT00848536|3093945|P1|Overall Study|Patient Moved|0
939094|NCT00848536|3093944|P2|Overall Study|Inadequate Control of IOP|1
939095|NCT00848536|3093945|P1|Overall Study|Inadequate Control of IOP|1
939096|NCT00848536|3093944|P2|Overall Study|Noncompliance|0
939097|NCT00848536|3093945|P1|Overall Study|Noncompliance|1
939098|NCT00848536|3093944|P2|Overall Study|Protocol Violation|1
939099|NCT00848536|3093945|P1|Overall Study|Protocol Violation|0
939100|NCT00848536|3093944|P2|Overall Study|Withdrawal by Subject|1
939101|NCT00848536|3093945|P1|Overall Study|Withdrawal by Subject|0
939102|NCT00848536|3093944|P2|Overall Study|Adverse Event|2
939103|NCT00848536|3093945|P1|Overall Study|Adverse Event|2
939104|NCT00848497|3094010|P2|Overall Study|Withdrawal by Subject|1
939105|NCT00848497|3094011|P1|Overall Study|Withdrawal by Subject|0
939106|NCT00848497|3094010|P2|Overall Study|Screen failure|0
939107|NCT00848497|3094011|P1|Overall Study|Screen failure|2
939108|NCT00848484|3094025|P2|Second Intervention (Treatment Period 2)|Lost to Follow-up|1
939109|NCT00848484|3094026|P1|Second Intervention (Treatment Period 2)|Lost to Follow-up|0
939110|NCT00848484|3094025|P2|Washout Period of Two Weeks|Withdrawal by Subject|3
939111|NCT00848484|3094026|P1|Washout Period of Two Weeks|Withdrawal by Subject|0
939112|NCT00848484|3094025|P2|First Intervention (Treatment Period 1)|Withdrawal by Subject|1
939113|NCT00848484|3094026|P1|First Intervention (Treatment Period 1)|Withdrawal by Subject|0
939114|NCT00848484|3094025|P2|First Intervention (Treatment Period 1)|Physician Decision|1
939115|NCT00848484|3094026|P1|First Intervention (Treatment Period 1)|Physician Decision|0
939116|NCT00848484|3094025|P2|First Intervention (Treatment Period 1)|Adverse Event|1
939117|NCT00848484|3094026|P1|First Intervention (Treatment Period 1)|Adverse Event|2
939118|NCT00848393|3094045|P3|Overall Study|surgical complications unrelated to stud|2
939119|NCT00848393|3094046|P2|Overall Study|surgical complications unrelated to stud|0
939120|NCT00848393|3094047|P1|Overall Study|surgical complications unrelated to stud|0
939121|NCT00848393|3094045|P3|Overall Study|Protocol Violation|1
939122|NCT00848393|3094046|P2|Overall Study|Protocol Violation|0
939123|NCT00848393|3094047|P1|Overall Study|Protocol Violation|0
939124|NCT00848354|3094086|P2|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0
939125|NCT00848354|3094087|P1|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2
939126|NCT00848354|3094086|P2|Phase 2 Year 2|Subject Request|1
939127|NCT00848354|3094087|P1|Phase 2 Year 2|Subject Request|1
939128|NCT00848354|3094086|P2|Phase 2 Year 2|Protocol Violation|1
939129|NCT00848354|3094087|P1|Phase 2 Year 2|Protocol Violation|1
939130|NCT00848354|3094086|P2|Phase 2 Year 2|Unspecified Reason|0
939131|NCT00848354|3094087|P1|Phase 2 Year 2|Unspecified Reason|1
939132|NCT00848354|3094086|P2|Phase 2 Year 2|Lost to Follow-up|3
939133|NCT00848354|3094087|P1|Phase 2 Year 2|Lost to Follow-up|1
939134|NCT00848354|3094086|P2|Phase 2 Year 2|Failed to return|0
939135|NCT00848354|3094087|P1|Phase 2 Year 2|Failed to return|3
939136|NCT00848354|3094086|P2|Phase 2 Year 2|Death|0
939137|NCT00848354|3094087|P1|Phase 2 Year 2|Death|2
939138|NCT00848354|3094086|P2|Phase 2 Year 2|Adverse Event|2
939139|NCT00848354|3094087|P1|Phase 2 Year 2|Adverse Event|12
939140|NCT00848354|3094086|P2|Phase 2 Year 1|Subject Request|2
939141|NCT00848354|3094087|P1|Phase 2 Year 1|Subject Request|1
939142|NCT00848354|3094086|P2|Phase 2 Year 1|Protocol Violation|1
939143|NCT00848354|3094087|P1|Phase 2 Year 1|Protocol Violation|4
939144|NCT00848354|3094086|P2|Phase 2 Year 1|Unspecified Reason|0
939145|NCT00848354|3094087|P1|Phase 2 Year 1|Unspecified Reason|3
939146|NCT00848354|3094086|P2|Phase 2 Year 1|Lost to Follow-up|0
939147|NCT00848354|3094087|P1|Phase 2 Year 1|Lost to Follow-up|1
939148|NCT00848354|3094086|P2|Phase 2 Year 1|Failed to Return|1
939149|NCT00848354|3094087|P1|Phase 2 Year 1|Failed to Return|1
939150|NCT00848354|3094086|P2|Phase 2 Year 1|Death|0
939151|NCT00848354|3094087|P1|Phase 2 Year 1|Death|1
939152|NCT00848354|3094086|P2|Phase 2 Year 1|Adverse Event|2
939153|NCT00848354|3094087|P1|Phase 2 Year 1|Adverse Event|7
939154|NCT00848354|3094086|P2|Phase 1|Lack of Efficacy|1
939155|NCT00848354|3094087|P1|Phase 1|Lack of Efficacy|0
939156|NCT00848354|3094086|P2|Phase 1|Withdrawal by Subject|4
939157|NCT00848354|3094087|P1|Phase 1|Withdrawal by Subject|2
939158|NCT00848354|3094086|P2|Phase 1|Protocol Violation|1
939159|NCT00848354|3094087|P1|Phase 1|Protocol Violation|1
939160|NCT00848354|3094086|P2|Phase 1|Unspecified Reason|1
939161|NCT00848354|3094087|P1|Phase 1|Unspecified Reason|1
939162|NCT00848354|3094086|P2|Phase 1|Lost to Follow-up|1
939163|NCT00848354|3094087|P1|Phase 1|Lost to Follow-up|1
939164|NCT00848354|3094086|P2|Phase 1|Failed to return|1
939165|NCT00848354|3094087|P1|Phase 1|Failed to return|0
939166|NCT00848354|3094086|P2|Phase 1|Discontinuation of study by sponsor|1
939167|NCT00848354|3094087|P1|Phase 1|Discontinuation of study by sponsor|2
939168|NCT00848354|3094086|P2|Phase 1|Adverse Event|4
939169|NCT00848354|3094087|P1|Phase 1|Adverse Event|5
939170|NCT00848250|3094239|P2|Overall Study|surgery was completed without cardiopulm|1
939171|NCT00848250|3094240|P1|Overall Study|surgery was completed without cardiopulm|0
939172|NCT00848211|3094271|P4|Overall Study|Adverse Event|0
939173|NCT00848211|3094272|P3|Overall Study|Adverse Event|0
939174|NCT00848211|3094273|P2|Overall Study|Adverse Event|0
939175|NCT00848211|3094274|P1|Overall Study|Adverse Event|0
939176|NCT00848211|3094271|P4|Overall Study|Protocol Violation|0
939177|NCT00848211|3094272|P3|Overall Study|Protocol Violation|1
939178|NCT00848211|3094273|P2|Overall Study|Protocol Violation|1
939179|NCT00848211|3094274|P1|Overall Study|Protocol Violation|0
939180|NCT00848198|3094292|P1|Overall Study|Incomplete Case Report Forms|15
939181|NCT00848120|3094357|P1|Overall Study|Adverse Event|1
939182|NCT00848107|3094369|P1|Overall Study|Pregnancy|1
939183|NCT00848107|3094369|P1|Overall Study|Death|1
939184|NCT00848107|3094369|P1|Overall Study|Adverse Event|9
939185|NCT00848107|3094369|P1|Overall Study|Withdrawal by Subject|8
939186|NCT00848107|3094369|P1|Overall Study|Lost to Follow-up|2
939187|NCT00848081|3094379|P2|Overall Study|Withdrawal by Subject|3
939188|NCT00848081|3094380|P1|Overall Study|Withdrawal by Subject|5
939189|NCT00848081|3094379|P2|Overall Study|Physician Decision|3
939190|NCT00848081|3094380|P1|Overall Study|Physician Decision|0
939191|NCT00848081|3094379|P2|Overall Study|Lost to Follow-up|0
939192|NCT00848081|3094380|P1|Overall Study|Lost to Follow-up|1
939193|NCT00848081|3094379|P2|Overall Study|Protocol Violation|5
939194|NCT00848081|3094380|P1|Overall Study|Protocol Violation|8
939195|NCT00848081|3094379|P2|Overall Study|Adverse Event|7
939196|NCT00848081|3094380|P1|Overall Study|Adverse Event|6
939197|NCT00848042|3094397|P3|Overall Study|Other Therapy|0
939198|NCT00848042|3094398|P2|Overall Study|Other Therapy|0
939199|NCT00848042|3094399|P1|Overall Study|Other Therapy|3
939200|NCT00848042|3094397|P3|Overall Study|Death|0
939201|NCT00848042|3094398|P2|Overall Study|Death|2
939202|NCT00848042|3094399|P1|Overall Study|Death|1
939203|NCT00847912|3094418|P2|Overall Study|Withdrawal by Subject|6
939204|NCT00847912|3094419|P1|Overall Study|Withdrawal by Subject|3
939205|NCT00847912|3094418|P2|Overall Study|Protocol Violation|7
939206|NCT00847912|3094419|P1|Overall Study|Protocol Violation|6
939207|NCT00847886|3094429|P2|Overall Study|Adverse Event|1
939208|NCT00847886|3094430|P1|Overall Study|Adverse Event|0
939209|NCT00847808|3094456|P1|Overall Study|Participant Took Excluded Medication|1
939210|NCT00847808|3094456|P1|Overall Study|Participant Reported Lack of Efficacy|1
939211|NCT00847808|3094456|P1|Overall Study|Withdrawal by Subject|4
939212|NCT00847808|3094456|P1|Overall Study|Lost to Follow-up|1
939213|NCT00847808|3094456|P1|Overall Study|Protocol Violation|1
939214|NCT00847808|3094456|P1|Overall Study|Adverse Event|7
939215|NCT00847704|3094473|P1|Overall Study|Withdrawal by Subject|1
939216|NCT00847665|3094484|P2|Overall Study|Withdrawal by Subject|0
939217|NCT00847665|3094485|P1|Overall Study|Withdrawal by Subject|1
939218|NCT00847626|3094508|P11|Overall Study|Other|3
939219|NCT00847626|3094509|P10|Overall Study|Other|1
939220|NCT00847626|3094510|P9|Overall Study|Other|1
939221|NCT00847626|3094511|P8|Overall Study|Other|3
939222|NCT00847626|3094512|P7|Overall Study|Other|2
939223|NCT00847626|3094513|P6|Overall Study|Other|2
939224|NCT00847626|3094514|P5|Overall Study|Other|2
939225|NCT00847626|3094515|P4|Overall Study|Other|1
939226|NCT00847626|3094516|P3|Overall Study|Other|4
939227|NCT00847626|3094517|P2|Overall Study|Other|5
939228|NCT00847626|3094518|P1|Overall Study|Other|1
939229|NCT00847626|3094508|P11|Overall Study|Lack of Efficacy|7
939230|NCT00847626|3094509|P10|Overall Study|Lack of Efficacy|1
939231|NCT00847626|3094510|P9|Overall Study|Lack of Efficacy|5
939232|NCT00847626|3094511|P8|Overall Study|Lack of Efficacy|2
939233|NCT00847626|3094512|P7|Overall Study|Lack of Efficacy|6
939234|NCT00847626|3094513|P6|Overall Study|Lack of Efficacy|0
939235|NCT00847626|3094514|P5|Overall Study|Lack of Efficacy|2
939236|NCT00847626|3094515|P4|Overall Study|Lack of Efficacy|1
939237|NCT00847626|3094516|P3|Overall Study|Lack of Efficacy|0
939238|NCT00847626|3094517|P2|Overall Study|Lack of Efficacy|1
939239|NCT00847626|3094518|P1|Overall Study|Lack of Efficacy|3
939240|NCT00847626|3094508|P11|Overall Study|Withdrawal by Subject|2
939241|NCT00847626|3094509|P10|Overall Study|Withdrawal by Subject|5
939242|NCT00847626|3094510|P9|Overall Study|Withdrawal by Subject|4
939243|NCT00847626|3094511|P8|Overall Study|Withdrawal by Subject|4
939244|NCT00847626|3094512|P7|Overall Study|Withdrawal by Subject|8
939245|NCT00847626|3094513|P6|Overall Study|Withdrawal by Subject|9
939246|NCT00847626|3094514|P5|Overall Study|Withdrawal by Subject|12
939247|NCT00847626|3094515|P4|Overall Study|Withdrawal by Subject|8
939248|NCT00847626|3094516|P3|Overall Study|Withdrawal by Subject|3
939249|NCT00847626|3094517|P2|Overall Study|Withdrawal by Subject|5
939250|NCT00847626|3094518|P1|Overall Study|Withdrawal by Subject|5
939251|NCT00847626|3094508|P11|Overall Study|Lost to Follow-up|1
939252|NCT00847626|3094509|P10|Overall Study|Lost to Follow-up|0
939253|NCT00847626|3094510|P9|Overall Study|Lost to Follow-up|1
939254|NCT00847626|3094511|P8|Overall Study|Lost to Follow-up|3
939255|NCT00847626|3094512|P7|Overall Study|Lost to Follow-up|1
939256|NCT00847626|3094513|P6|Overall Study|Lost to Follow-up|3
939257|NCT00847626|3094514|P5|Overall Study|Lost to Follow-up|0
939258|NCT00847626|3094515|P4|Overall Study|Lost to Follow-up|1
939259|NCT00847626|3094516|P3|Overall Study|Lost to Follow-up|1
939260|NCT00847626|3094517|P2|Overall Study|Lost to Follow-up|1
939261|NCT00847626|3094518|P1|Overall Study|Lost to Follow-up|0
939262|NCT00847626|3094508|P11|Overall Study|Protocol Violation|1
939263|NCT00847626|3094509|P10|Overall Study|Protocol Violation|1
939264|NCT00847626|3094510|P9|Overall Study|Protocol Violation|0
939265|NCT00847626|3094511|P8|Overall Study|Protocol Violation|1
939266|NCT00847626|3094512|P7|Overall Study|Protocol Violation|1
939267|NCT00847626|3094513|P6|Overall Study|Protocol Violation|1
939268|NCT00847626|3094514|P5|Overall Study|Protocol Violation|1
939269|NCT00847626|3094515|P4|Overall Study|Protocol Violation|1
939270|NCT00847626|3094516|P3|Overall Study|Protocol Violation|2
939271|NCT00847626|3094517|P2|Overall Study|Protocol Violation|1
939272|NCT00847626|3094518|P1|Overall Study|Protocol Violation|2
939273|NCT00847626|3094508|P11|Overall Study|Adverse Event|6
939274|NCT00847626|3094509|P10|Overall Study|Adverse Event|6
939275|NCT00847626|3094510|P9|Overall Study|Adverse Event|3
939276|NCT00847626|3094511|P8|Overall Study|Adverse Event|6
939277|NCT00847626|3094512|P7|Overall Study|Adverse Event|4
939278|NCT00847626|3094513|P6|Overall Study|Adverse Event|22
939279|NCT00847626|3094514|P5|Overall Study|Adverse Event|11
939280|NCT00847626|3094515|P4|Overall Study|Adverse Event|19
939281|NCT00847626|3094516|P3|Overall Study|Adverse Event|6
939282|NCT00847626|3094517|P2|Overall Study|Adverse Event|10
939283|NCT00847626|3094518|P1|Overall Study|Adverse Event|10
939284|NCT00847613|3094717|P4|Overall Study|Other|0
939285|NCT00847613|3094718|P3|Overall Study|Other|2
939286|NCT00847613|3094719|P2|Overall Study|Other|1
939287|NCT00847613|3094720|P1|Overall Study|Other|1
939288|NCT00847613|3094717|P4|Overall Study|Randomized, but not treated|0
939289|NCT00847613|3094718|P3|Overall Study|Randomized, but not treated|0
939290|NCT00847613|3094719|P2|Overall Study|Randomized, but not treated|3
939291|NCT00847613|3094720|P1|Overall Study|Randomized, but not treated|0
939292|NCT00847613|3094717|P4|Overall Study|Sponsor request|0
939293|NCT00847613|3094718|P3|Overall Study|Sponsor request|0
939294|NCT00847613|3094719|P2|Overall Study|Sponsor request|1
939295|NCT00847613|3094720|P1|Overall Study|Sponsor request|0
939296|NCT00847613|3094717|P4|Overall Study|Participant moved|0
939297|NCT00847613|3094718|P3|Overall Study|Participant moved|0
939298|NCT00847613|3094719|P2|Overall Study|Participant moved|1
939299|NCT00847613|3094720|P1|Overall Study|Participant moved|4
939300|NCT00847613|3094717|P4|Overall Study|Withdrawal by Subject|2
939301|NCT00847613|3094718|P3|Overall Study|Withdrawal by Subject|2
939302|NCT00847613|3094719|P2|Overall Study|Withdrawal by Subject|11
939303|NCT00847613|3094720|P1|Overall Study|Withdrawal by Subject|8
939304|NCT00847613|3094717|P4|Overall Study|Site closure|1
939305|NCT00847613|3094718|P3|Overall Study|Site closure|0
939306|NCT00847613|3094719|P2|Overall Study|Site closure|0
939307|NCT00847613|3094720|P1|Overall Study|Site closure|1
939308|NCT00847613|3094717|P4|Overall Study|Pregnancy|0
939309|NCT00847613|3094718|P3|Overall Study|Pregnancy|0
939310|NCT00847613|3094719|P2|Overall Study|Pregnancy|1
939311|NCT00847613|3094720|P1|Overall Study|Pregnancy|1
939312|NCT00847613|3094717|P4|Overall Study|Protocol Violation|1
939313|NCT00847613|3094718|P3|Overall Study|Protocol Violation|3
939314|NCT00847613|3094719|P2|Overall Study|Protocol Violation|6
939315|NCT00847613|3094720|P1|Overall Study|Protocol Violation|6
939316|NCT00847613|3094717|P4|Overall Study|Lost to Follow-up|3
939317|NCT00847613|3094718|P3|Overall Study|Lost to Follow-up|0
939318|NCT00847613|3094719|P2|Overall Study|Lost to Follow-up|0
939319|NCT00847613|3094720|P1|Overall Study|Lost to Follow-up|5
939320|NCT00847613|3094717|P4|Overall Study|Study terminated by Sponsor|1
939321|NCT00847613|3094718|P3|Overall Study|Study terminated by Sponsor|2
939322|NCT00847613|3094719|P2|Overall Study|Study terminated by Sponsor|0
939323|NCT00847613|3094720|P1|Overall Study|Study terminated by Sponsor|1
939324|NCT00847613|3094717|P4|Overall Study|Lack of Efficacy|1
939325|NCT00847613|3094718|P3|Overall Study|Lack of Efficacy|3
939326|NCT00847613|3094719|P2|Overall Study|Lack of Efficacy|3
939327|NCT00847613|3094720|P1|Overall Study|Lack of Efficacy|7
939328|NCT00847613|3094717|P4|Overall Study|Adverse Event|6
939329|NCT00847613|3094718|P3|Overall Study|Adverse Event|5
939330|NCT00847613|3094719|P2|Overall Study|Adverse Event|26
939331|NCT00847613|3094720|P1|Overall Study|Adverse Event|36
939332|NCT00847613|3094717|P4|Overall Study|Death|0
939333|NCT00847613|3094718|P3|Overall Study|Death|0
939334|NCT00847613|3094719|P2|Overall Study|Death|1
939335|NCT00847613|3094720|P1|Overall Study|Death|1
939336|NCT00847613|3094717|P4|Overall Study|Ongoing at cut-off date|64
939337|NCT00847613|3094718|P3|Overall Study|Ongoing at cut-off date|64
939338|NCT00847613|3094719|P2|Overall Study|Ongoing at cut-off date|265
939339|NCT00847613|3094720|P1|Overall Study|Ongoing at cut-off date|250
939340|NCT00847561|3094971|P2|Overall Study|Unable to schedule|1
939341|NCT00847561|3094972|P1|Overall Study|Unable to schedule|9
939342|NCT00847561|3094971|P2|Overall Study|Withdrawal by Subject|3
939343|NCT00847561|3094972|P1|Overall Study|Withdrawal by Subject|4
939344|NCT00847535|3094978|P3|Overall Study|Lost to Follow-up|0
939345|NCT00847535|3094979|P2|Overall Study|Lost to Follow-up|1
939346|NCT00847535|3094980|P1|Overall Study|Lost to Follow-up|0
939347|NCT00847535|3094978|P3|Overall Study|Withdrawal by Subject|1
939348|NCT00847535|3094979|P2|Overall Study|Withdrawal by Subject|1
939349|NCT00847535|3094980|P1|Overall Study|Withdrawal by Subject|2
939350|NCT00847405|3094999|P2|Washout of 7 Days|Withdrawal by Subject|0
939351|NCT00847405|3095000|P1|Washout of 7 Days|Withdrawal by Subject|1
939352|NCT00847405|3094999|P2|First Intervention|Adverse Event|1
939353|NCT00847405|3095000|P1|First Intervention|Adverse Event|0
939354|NCT00847301|3095008|P1|Overall Study|Other reason not defined above|1
939355|NCT00847301|3095008|P1|Overall Study|No prescription after hospital discharge|1
939356|NCT00847301|3095008|P1|Overall Study|Lost to Follow-up|1
939357|NCT00847301|3095008|P1|Overall Study|Switch to other anticoagulants|16
939358|NCT00847301|3095008|P1|Overall Study|Adverse Event|35
939359|NCT00847197|3095056|P2|Overall Study|Withdrawal by Subject|1
939360|NCT00847197|3095057|P1|Overall Study|Withdrawal by Subject|3
939361|NCT00847197|3095056|P2|Overall Study|Protocol Violation|1
939362|NCT00847197|3095057|P1|Overall Study|Protocol Violation|0
939363|NCT00847197|3095056|P2|Overall Study|Adverse Event|3
939364|NCT00847197|3095057|P1|Overall Study|Adverse Event|21
939365|NCT00847145|3095081|P8|Overall Study|Protocol Violation|1
939366|NCT00847145|3095082|P7|Overall Study|Protocol Violation|0
939367|NCT00847145|3095083|P6|Overall Study|Protocol Violation|0
939368|NCT00847145|3095084|P5|Overall Study|Protocol Violation|1
939369|NCT00847145|3095085|P4|Overall Study|Protocol Violation|0
939370|NCT00847145|3095086|P3|Overall Study|Protocol Violation|3
939371|NCT00847145|3095087|P2|Overall Study|Protocol Violation|0
939372|NCT00847145|3095088|P1|Overall Study|Protocol Violation|0
939373|NCT00847145|3095081|P8|Overall Study|Inappropriate enrollment|0
939374|NCT00847145|3095082|P7|Overall Study|Inappropriate enrollment|0
939375|NCT00847145|3095083|P6|Overall Study|Inappropriate enrollment|0
939376|NCT00847145|3095084|P5|Overall Study|Inappropriate enrollment|1
939377|NCT00847145|3095085|P4|Overall Study|Inappropriate enrollment|0
939378|NCT00847145|3095086|P3|Overall Study|Inappropriate enrollment|0
939379|NCT00847145|3095087|P2|Overall Study|Inappropriate enrollment|0
939380|NCT00847145|3095088|P1|Overall Study|Inappropriate enrollment|0
939381|NCT00847145|3095081|P8|Overall Study|Lost to Follow-up|2
939382|NCT00847145|3095082|P7|Overall Study|Lost to Follow-up|8
939383|NCT00847145|3095083|P6|Overall Study|Lost to Follow-up|4
939384|NCT00847145|3095084|P5|Overall Study|Lost to Follow-up|4
939385|NCT00847145|3095085|P4|Overall Study|Lost to Follow-up|0
939386|NCT00847145|3095086|P3|Overall Study|Lost to Follow-up|1
939387|NCT00847145|3095087|P2|Overall Study|Lost to Follow-up|1
939388|NCT00847145|3095088|P1|Overall Study|Lost to Follow-up|3
939389|NCT00847145|3095081|P8|Overall Study|Withdrawal by Subject|1
939390|NCT00847145|3095082|P7|Overall Study|Withdrawal by Subject|1
939391|NCT00847145|3095083|P6|Overall Study|Withdrawal by Subject|0
939392|NCT00847145|3095084|P5|Overall Study|Withdrawal by Subject|0
939393|NCT00847145|3095085|P4|Overall Study|Withdrawal by Subject|1
939394|NCT00847145|3095086|P3|Overall Study|Withdrawal by Subject|6
939395|NCT00847145|3095087|P2|Overall Study|Withdrawal by Subject|4
939396|NCT00847145|3095088|P1|Overall Study|Withdrawal by Subject|3
939397|NCT00847145|3095081|P8|Overall Study|AE or Death|0
939398|NCT00847145|3095082|P7|Overall Study|AE or Death|0
939399|NCT00847145|3095083|P6|Overall Study|AE or Death|0
939400|NCT00847145|3095084|P5|Overall Study|AE or Death|0
939401|NCT00847145|3095085|P4|Overall Study|AE or Death|0
939402|NCT00847145|3095086|P3|Overall Study|AE or Death|1
939403|NCT00847145|3095087|P2|Overall Study|AE or Death|1
939404|NCT00847145|3095088|P1|Overall Study|AE or Death|0
939405|NCT00847132|3095138|P2|Overall Study|Death|1
939406|NCT00847132|3095139|P1|Overall Study|Death|1
939407|NCT00847015|3095147|P1|Overall Study|partial cystectomy vs radical cystectomy|1
939408|NCT00847015|3095147|P1|Overall Study|declined any surgery|1
939409|NCT00847015|3095147|P1|Overall Study|Withdrawal by Subject|1
939410|NCT00846846|3095175|P1|Overall Study|Withdrawal by Subject|19
939411|NCT00846846|3095175|P1|Overall Study|Death|56
939412|NCT00846807|3095180|P1|Overall Study|Other|60
939413|NCT00846807|3095180|P1|Overall Study|No prescription after hospital discharge|56
939414|NCT00846807|3095180|P1|Overall Study|Switch to other anticoagulants|89
939415|NCT00846807|3095180|P1|Overall Study|Non compliant with European label|7
939416|NCT00846807|3095180|P1|Overall Study|Withdrawal by Subject|56
939417|NCT00846807|3095180|P1|Overall Study|Lost to Follow-up|94
939418|NCT00846807|3095180|P1|Overall Study|Adverse Event|270
939419|NCT00846768|3095188|P4|Overall Study|Adverse Event|0
939420|NCT00846768|3095189|P3|Overall Study|Adverse Event|0
939421|NCT00846768|3095190|P2|Overall Study|Adverse Event|1
939422|NCT00846768|3095191|P1|Overall Study|Adverse Event|0
939423|NCT00846586|3095282|P2|Overall Study|Unsatisfactory therapeutic effect|1
939424|NCT00846586|3095283|P1|Overall Study|Unsatisfactory therapeutic effect|0
939425|NCT00846586|3095282|P2|Overall Study|Lost to Follow-up|4
939426|NCT00846586|3095283|P1|Overall Study|Lost to Follow-up|1
939427|NCT00846586|3095282|P2|Overall Study|Abnormal test procedure result(s)|0
939428|NCT00846586|3095283|P1|Overall Study|Abnormal test procedure result(s)|1
939429|NCT00846586|3095282|P2|Overall Study|Protocol deviation|6
939430|NCT00846586|3095283|P1|Overall Study|Protocol deviation|2
939431|NCT00846586|3095282|P2|Overall Study|Death|0
939432|NCT00846586|3095283|P1|Overall Study|Death|2
939433|NCT00846586|3095282|P2|Overall Study|Administrative problems|4
939434|NCT00846586|3095283|P1|Overall Study|Administrative problems|5
939435|NCT00846586|3095282|P2|Overall Study|Subject withdrew consent|10
939436|NCT00846586|3095283|P1|Overall Study|Subject withdrew consent|8
939437|NCT00846586|3095282|P2|Overall Study|Adverse Event|10
939438|NCT00846586|3095283|P1|Overall Study|Adverse Event|20
939439|NCT00846521|3095317|P1|Overall Study|Protocol Violation|1
939440|NCT00846521|3095317|P1|Overall Study|Did not meet OGTT/ CGMS criteria|5
939441|NCT00846521|3095317|P1|Overall Study|Withdrawal by Subject|5
939442|NCT00846495|3095324|P2|Overall Study|Physician Decision|0
939443|NCT00846495|3095325|P1|Overall Study|Physician Decision|1
939444|NCT00846495|3095324|P2|Overall Study|Lack of Efficacy|2
939445|NCT00846495|3095325|P1|Overall Study|Lack of Efficacy|1
939446|NCT00846495|3095324|P2|Overall Study|Adverse Event|1
939447|NCT00846495|3095325|P1|Overall Study|Adverse Event|5
939448|NCT00846495|3095324|P2|Overall Study|Lost to Follow-up|0
939449|NCT00846495|3095325|P1|Overall Study|Lost to Follow-up|1
939450|NCT00846391|3095348|P3|Overall Study|Study Terminated by Sponsor|2
939451|NCT00846391|3095349|P2|Overall Study|Study Terminated by Sponsor|2
939452|NCT00846391|3095350|P1|Overall Study|Study Terminated by Sponsor|1
939453|NCT00846391|3095348|P3|Overall Study|Physician Decision|1
939454|NCT00846391|3095349|P2|Overall Study|Physician Decision|0
939455|NCT00846391|3095350|P1|Overall Study|Physician Decision|0
939456|NCT00846365|3095361|P3|Overall Study|Other|6
939457|NCT00846365|3095362|P2|Overall Study|Other|1
939458|NCT00846365|3095363|P1|Overall Study|Other|9
939459|NCT00846365|3095361|P3|Overall Study|Lack of Efficacy|2
939460|NCT00846365|3095362|P2|Overall Study|Lack of Efficacy|1
939461|NCT00846365|3095363|P1|Overall Study|Lack of Efficacy|1
939462|NCT00846365|3095361|P3|Overall Study|Pregnancy|0
939463|NCT00846365|3095362|P2|Overall Study|Pregnancy|0
939464|NCT00846365|3095363|P1|Overall Study|Pregnancy|1
939465|NCT00846365|3095361|P3|Overall Study|Withdrawal by Subject|9
939466|NCT00846365|3095362|P2|Overall Study|Withdrawal by Subject|11
939467|NCT00846365|3095363|P1|Overall Study|Withdrawal by Subject|11
939468|NCT00846365|3095361|P3|Overall Study|Lost to Follow-up|5
939469|NCT00846365|3095362|P2|Overall Study|Lost to Follow-up|2
939470|NCT00846365|3095363|P1|Overall Study|Lost to Follow-up|8
939471|NCT00846365|3095361|P3|Overall Study|Protocol Violation|0
939472|NCT00846365|3095362|P2|Overall Study|Protocol Violation|4
939473|NCT00846365|3095363|P1|Overall Study|Protocol Violation|5
939474|NCT00846365|3095361|P3|Overall Study|Adverse Event|11
939475|NCT00846365|3095362|P2|Overall Study|Adverse Event|30
939476|NCT00846365|3095363|P1|Overall Study|Adverse Event|20
939477|NCT00846053|3095444|P2|Overall Study|Physician Decision|0
939478|NCT00846053|3095445|P1|Overall Study|Physician Decision|3
939479|NCT00846027|3095453|P1|Overall Study|Subject Not Treated|7
939480|NCT00846027|3095453|P1|Overall Study|Protocol Violation|2
939481|NCT00846027|3095453|P1|Overall Study|Investigator Discretion|29
939482|NCT00846027|3095453|P1|Overall Study|Patient Decision|7
939483|NCT00846027|3095453|P1|Overall Study|Toxicity|12
939484|NCT00846027|3095453|P1|Overall Study|Disease Progression|30
939485|NCT00846027|3095453|P1|Overall Study|Death|3
939486|NCT00845897|3095476|P3|Overall Study|Too ill to participate|0
939487|NCT00845897|3095477|P2|Overall Study|Too ill to participate|1
939488|NCT00845897|3095478|P1|Overall Study|Too ill to participate|0
939489|NCT00845897|3095476|P3|Overall Study|Ulcer did not heal|1
939490|NCT00845897|3095477|P2|Overall Study|Ulcer did not heal|0
939491|NCT00845897|3095478|P1|Overall Study|Ulcer did not heal|1
939492|NCT00845897|3095476|P3|Overall Study|Withdrawal by Subject|2
939493|NCT00845897|3095477|P2|Overall Study|Withdrawal by Subject|3
939494|NCT00845897|3095478|P1|Overall Study|Withdrawal by Subject|0
939495|NCT00845897|3095476|P3|Overall Study|Lost to Follow-up|0
939496|NCT00845897|3095477|P2|Overall Study|Lost to Follow-up|1
939497|NCT00845897|3095478|P1|Overall Study|Lost to Follow-up|1
939498|NCT00845858|3095492|P3|Overall Study|not eligible|2
939499|NCT00845858|3095493|P2|Overall Study|not eligible|3
939500|NCT00845858|3095494|P1|Overall Study|not eligible|0
939501|NCT00845858|3095492|P3|Overall Study|Protocol Violation|1
939502|NCT00845858|3095493|P2|Overall Study|Protocol Violation|0
939503|NCT00845858|3095494|P1|Overall Study|Protocol Violation|0
939504|NCT00845858|3095492|P3|Overall Study|Adverse Event|4
939505|NCT00845858|3095493|P2|Overall Study|Adverse Event|8
939506|NCT00845858|3095494|P1|Overall Study|Adverse Event|3
939507|NCT00845858|3095492|P3|Overall Study|Withdrawal by Subject|1
939508|NCT00845858|3095493|P2|Overall Study|Withdrawal by Subject|1
939509|NCT00845858|3095494|P1|Overall Study|Withdrawal by Subject|5
939510|NCT00845845|3095507|P2|Overall Study|Lost to Follow-up|4
939511|NCT00845845|3095508|P1|Overall Study|Lost to Follow-up|0
939512|NCT00845832|3095519|P3|Extended Safety Follow-Up|Withdrawal by Subject|7
939513|NCT00845832|3095520|P2|Extended Safety Follow-Up|Withdrawal by Subject|0
939514|NCT00845832|3095521|P1|Extended Safety Follow-Up|Withdrawal by Subject|0
939515|NCT00845832|3095519|P3|Safety Follow-Up|Withdrawal by Subject|0
939516|NCT00845832|3095520|P2|Safety Follow-Up|Withdrawal by Subject|0
939517|NCT00845832|3095521|P1|Safety Follow-Up|Withdrawal by Subject|1
939518|NCT00845832|3095519|P3|Treatment Period|Protocol Violation|0
939519|NCT00845832|3095520|P2|Treatment Period|Protocol Violation|1
939520|NCT00845832|3095521|P1|Treatment Period|Protocol Violation|1
939521|NCT00845832|3095519|P3|Treatment Period|Adverse Event|0
939522|NCT00845832|3095520|P2|Treatment Period|Adverse Event|2
939523|NCT00845832|3095521|P1|Treatment Period|Adverse Event|0
939524|NCT00845728|3095567|P2|Overall Study|Withdrawal by Subject|108
939525|NCT00845728|3095568|P1|Overall Study|Withdrawal by Subject|105
939526|NCT00845728|3095567|P2|Overall Study|Adverse Event|96
939527|NCT00845728|3095568|P1|Overall Study|Adverse Event|101
939528|NCT00845728|3095567|P2|Overall Study|Lack of Efficacy|39
939529|NCT00845728|3095568|P1|Overall Study|Lack of Efficacy|51
939530|NCT00845728|3095567|P2|Overall Study|Protocol Violation|24
939531|NCT00845728|3095568|P1|Overall Study|Protocol Violation|36
939532|NCT00845728|3095567|P2|Overall Study|Administrative Problems|26
939533|NCT00845728|3095568|P1|Overall Study|Administrative Problems|34
939534|NCT00845728|3095567|P2|Overall Study|Death|26
939535|NCT00845728|3095568|P1|Overall Study|Death|24
939536|NCT00845728|3095567|P2|Overall Study|Lost to Follow-up|13
939537|NCT00845728|3095568|P1|Overall Study|Lost to Follow-up|22
939538|NCT00845728|3095567|P2|Overall Study|Abnormal test procedure result (s)|2
939539|NCT00845728|3095568|P1|Overall Study|Abnormal test procedure result (s)|7
939540|NCT00845728|3095567|P2|Overall Study|Patient's inability to use the device|6
939541|NCT00845728|3095568|P1|Overall Study|Patient's inability to use the device|4
939542|NCT00845728|3095567|P2|Overall Study|Abnormal laboratory value (s)|2
939543|NCT00845728|3095568|P1|Overall Study|Abnormal laboratory value (s)|2
939544|NCT00845676|3095582|P1|Overall Study|Adverse Event|1
939545|NCT00845676|3095582|P1|Overall Study|Virologic breakthrough at week 20|1
939546|NCT00845650|3095643|P6|Overall Study|Unable to access IV line|0
939547|NCT00845650|3095644|P5|Overall Study|Unable to access IV line|0
939548|NCT00845650|3095645|P4|Overall Study|Unable to access IV line|0
939549|NCT00845650|3095646|P3|Overall Study|Unable to access IV line|0
939550|NCT00845650|3095647|P2|Overall Study|Unable to access IV line|0
939551|NCT00845650|3095648|P1|Overall Study|Unable to access IV line|1
939552|NCT00845650|3095643|P6|Overall Study|Sponsor hold on dosing|1
939553|NCT00845650|3095644|P5|Overall Study|Sponsor hold on dosing|1
939554|NCT00845650|3095645|P4|Overall Study|Sponsor hold on dosing|0
939555|NCT00845650|3095646|P3|Overall Study|Sponsor hold on dosing|0
939556|NCT00845650|3095647|P2|Overall Study|Sponsor hold on dosing|0
939557|NCT00845650|3095648|P1|Overall Study|Sponsor hold on dosing|0
939558|NCT00845650|3095643|P6|Overall Study|Lost to Follow-up|1
939559|NCT00845650|3095644|P5|Overall Study|Lost to Follow-up|0
939560|NCT00845650|3095645|P4|Overall Study|Lost to Follow-up|1
939561|NCT00845650|3095646|P3|Overall Study|Lost to Follow-up|3
939562|NCT00845650|3095647|P2|Overall Study|Lost to Follow-up|0
939563|NCT00845650|3095648|P1|Overall Study|Lost to Follow-up|0
939564|NCT00845650|3095643|P6|Overall Study|Withdrawal by Subject|0
939565|NCT00845650|3095644|P5|Overall Study|Withdrawal by Subject|2
939566|NCT00845650|3095645|P4|Overall Study|Withdrawal by Subject|0
939567|NCT00845650|3095646|P3|Overall Study|Withdrawal by Subject|0
939568|NCT00845650|3095647|P2|Overall Study|Withdrawal by Subject|0
939569|NCT00845650|3095648|P1|Overall Study|Withdrawal by Subject|0
939570|NCT00845520|3095686|P3|Overall Study|Adverse Event|1
939571|NCT00845520|3095687|P2|Overall Study|Adverse Event|0
939572|NCT00845520|3095688|P1|Overall Study|Adverse Event|0
939573|NCT00845520|3095686|P3|Overall Study|Lost to Follow-up|0
939574|NCT00845520|3095687|P2|Overall Study|Lost to Follow-up|0
939575|NCT00845520|3095688|P1|Overall Study|Lost to Follow-up|1
939576|NCT00845520|3095686|P3|Overall Study|Death|0
939577|NCT00845520|3095687|P2|Overall Study|Death|2
939578|NCT00845520|3095688|P1|Overall Study|Death|1
939579|NCT00845429|3095725|P3|Overall Study|Serious adverse event|1
939580|NCT00845429|3095726|P2|Overall Study|Serious adverse event|0
939581|NCT00845429|3095727|P1|Overall Study|Serious adverse event|0
939582|NCT00845429|3095725|P3|Overall Study|Withdrawal by Subject|2
939583|NCT00845429|3095726|P2|Overall Study|Withdrawal by Subject|2
939584|NCT00845429|3095727|P1|Overall Study|Withdrawal by Subject|2
939585|NCT00845429|3095725|P3|Overall Study|Lost to Follow-up|10
939586|NCT00845429|3095726|P2|Overall Study|Lost to Follow-up|9
939587|NCT00845429|3095727|P1|Overall Study|Lost to Follow-up|7
939588|NCT00845429|3095725|P3|Overall Study|Protocol Violation|7
939589|NCT00845429|3095726|P2|Overall Study|Protocol Violation|4
939590|NCT00845429|3095727|P1|Overall Study|Protocol Violation|5
939591|NCT00845182|3095762|P3|Overall Study|Physician Decision|1
939592|NCT00845182|3095763|P2|Overall Study|Physician Decision|0
939593|NCT00845182|3095764|P1|Overall Study|Physician Decision|0
939594|NCT00845182|3095762|P3|Overall Study|Adverse Event|1
939595|NCT00845182|3095763|P2|Overall Study|Adverse Event|1
939596|NCT00845182|3095764|P1|Overall Study|Adverse Event|0
939597|NCT00845182|3095762|P3|Overall Study|Lost to Follow-up|4
939598|NCT00845182|3095763|P2|Overall Study|Lost to Follow-up|3
939599|NCT00845182|3095764|P1|Overall Study|Lost to Follow-up|3
939600|NCT00845065|3095789|P2|Overall Study|Non-Medical Reasons|11
939601|NCT00845065|3095790|P1|Overall Study|Non-Medical Reasons|1
939602|NCT00845065|3095789|P2|Overall Study|Lack of Efficacy|21
939603|NCT00845065|3095790|P1|Overall Study|Lack of Efficacy|43
939604|NCT00845065|3095789|P2|Overall Study|Adverse Event|23
939605|NCT00845065|3095790|P1|Overall Study|Adverse Event|3
939606|NCT00844896|3095858|P2|Overall Study|Parents did not have time to complete|1
939607|NCT00844896|3095859|P1|Overall Study|Parents did not have time to complete|0
939608|NCT00844896|3095858|P2|Overall Study|Lost to Follow-up|16
939609|NCT00844896|3095859|P1|Overall Study|Lost to Follow-up|12
939610|NCT00844883|3095881|P1|Overall Study|Bridged to resection|1
939611|NCT00844883|3095881|P1|Overall Study|Bridged to liver transplant|3
939612|NCT00844857|3095893|P2|Overall Study|Good Clinical Practice Violations|11
939613|NCT00844857|3095894|P1|Overall Study|Good Clinical Practice Violations|21
939614|NCT00844857|3095893|P2|Overall Study|Did Not Take Study Drug|1
939615|NCT00844857|3095894|P1|Overall Study|Did Not Take Study Drug|3
939616|NCT00844857|3095893|P2|Overall Study|Lost to Follow-up|3
939617|NCT00844857|3095894|P1|Overall Study|Lost to Follow-up|2
939618|NCT00844857|3095893|P2|Overall Study|Entry Criteria Not Met|1
939619|NCT00844857|3095894|P1|Overall Study|Entry Criteria Not Met|0
939620|NCT00844857|3095893|P2|Overall Study|Clinical Relapse|1
939621|NCT00844857|3095894|P1|Overall Study|Clinical Relapse|0
939622|NCT00844857|3095893|P2|Overall Study|Lack of Efficacy|5
939623|NCT00844857|3095894|P1|Overall Study|Lack of Efficacy|5
939624|NCT00844857|3095893|P2|Overall Study|Protocol Violation|0
939625|NCT00844857|3095894|P1|Overall Study|Protocol Violation|6
939626|NCT00844857|3095893|P2|Overall Study|Withdrawal by Subject|7
939627|NCT00844857|3095894|P1|Overall Study|Withdrawal by Subject|8
939628|NCT00844857|3095893|P2|Overall Study|Parent/Caregiver Decision|2
939629|NCT00844857|3095894|P1|Overall Study|Parent/Caregiver Decision|6
939630|NCT00844857|3095893|P2|Overall Study|Physician Decision|0
939631|NCT00844857|3095894|P1|Overall Study|Physician Decision|2
939632|NCT00844857|3095893|P2|Overall Study|Sponsor Decision|1
939633|NCT00844857|3095894|P1|Overall Study|Sponsor Decision|1
939634|NCT00844857|3095893|P2|Overall Study|Adverse Event|5
939635|NCT00844857|3095894|P1|Overall Study|Adverse Event|24
939636|NCT00844844|3095938|P1|Post Treatment Period|Withdrawal by Subject|1
939637|NCT00844844|3095938|P1|Extension Treatment Period|Adverse Event|2
939638|NCT00844844|3095938|P1|Treatment Period (26 Weeks)|Protocol Violation|1
939639|NCT00844844|3095938|P1|Treatment Period (26 Weeks)|Adverse Event|1
939640|NCT00844831|3095952|P1|Overall Study|Physician Decision|1
939641|NCT00844831|3095952|P1|Overall Study|Adverse Event|1
939642|NCT00844831|3095952|P1|Overall Study|Withdrawal by Subject|4
939643|NCT00844805|3095962|P4|Follow-Up Phase|Did Not Meet Protocol Eligibility|1
939644|NCT00844805|3095963|P3|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
939645|NCT00844805|3095964|P2|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
939646|NCT00844805|3095965|P1|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
939647|NCT00844805|3095962|P4|Follow-Up Phase|Relapse/Recurrence|4
939648|NCT00844805|3095963|P3|Follow-Up Phase|Relapse/Recurrence|2
939649|NCT00844805|3095964|P2|Follow-Up Phase|Relapse/Recurrence|0
939650|NCT00844805|3095965|P1|Follow-Up Phase|Relapse/Recurrence|0
939651|NCT00844805|3095962|P4|Follow-Up Phase|Noncompliance With Protocol|1
939652|NCT00844805|3095963|P3|Follow-Up Phase|Noncompliance With Protocol|0
939653|NCT00844805|3095964|P2|Follow-Up Phase|Noncompliance With Protocol|0
939654|NCT00844805|3095965|P1|Follow-Up Phase|Noncompliance With Protocol|0
939655|NCT00844805|3095962|P4|Follow-Up Phase|Withdrawal by Subject|3
939656|NCT00844805|3095963|P3|Follow-Up Phase|Withdrawal by Subject|6
939657|NCT00844805|3095964|P2|Follow-Up Phase|Withdrawal by Subject|0
939658|NCT00844805|3095965|P1|Follow-Up Phase|Withdrawal by Subject|0
939659|NCT00844805|3095962|P4|Follow-Up Phase|Adverse Event|0
939660|NCT00844805|3095963|P3|Follow-Up Phase|Adverse Event|1
939661|NCT00844805|3095964|P2|Follow-Up Phase|Adverse Event|0
939662|NCT00844805|3095965|P1|Follow-Up Phase|Adverse Event|0
939663|NCT00844805|3095962|P4|Treatment Phase|Did Not Meet Protocol Eligibility|0
939664|NCT00844805|3095963|P3|Treatment Phase|Did Not Meet Protocol Eligibility|0
939665|NCT00844805|3095964|P2|Treatment Phase|Did Not Meet Protocol Eligibility|2
939666|NCT00844805|3095965|P1|Treatment Phase|Did Not Meet Protocol Eligibility|1
939667|NCT00844805|3095962|P4|Treatment Phase|Noncompliance With Protocol|0
939668|NCT00844805|3095963|P3|Treatment Phase|Noncompliance With Protocol|0
939669|NCT00844805|3095964|P2|Treatment Phase|Noncompliance With Protocol|0
939670|NCT00844805|3095965|P1|Treatment Phase|Noncompliance With Protocol|1
939671|NCT00844805|3095962|P4|Treatment Phase|Withdrawal by Subject|0
939672|NCT00844805|3095963|P3|Treatment Phase|Withdrawal by Subject|0
939673|NCT00844805|3095964|P2|Treatment Phase|Withdrawal by Subject|4
939674|NCT00844805|3095965|P1|Treatment Phase|Withdrawal by Subject|3
939675|NCT00844805|3095962|P4|Treatment Phase|Adverse Event|0
939676|NCT00844805|3095963|P3|Treatment Phase|Adverse Event|0
939677|NCT00844805|3095964|P2|Treatment Phase|Adverse Event|1
939678|NCT00844805|3095965|P1|Treatment Phase|Adverse Event|5
939679|NCT00844753|3096009|P4|Overall Study|Withdrawal by Subject|3
939680|NCT00844753|3096010|P3|Overall Study|Withdrawal by Subject|0
939681|NCT00844753|3096011|P2|Overall Study|Withdrawal by Subject|0
939682|NCT00844753|3096012|P1|Overall Study|Withdrawal by Subject|1
939683|NCT00844753|3096009|P4|Overall Study|could not swallow medication|0
939684|NCT00844753|3096010|P3|Overall Study|could not swallow medication|0
939685|NCT00844753|3096011|P2|Overall Study|could not swallow medication|0
939686|NCT00844753|3096012|P1|Overall Study|could not swallow medication|2
939687|NCT00844753|3096009|P4|Overall Study|Lost to Follow-up|1
939688|NCT00844753|3096010|P3|Overall Study|Lost to Follow-up|0
939689|NCT00844753|3096011|P2|Overall Study|Lost to Follow-up|1
939690|NCT00844753|3096012|P1|Overall Study|Lost to Follow-up|1
939691|NCT00844753|3096009|P4|Overall Study|Adverse Event|5
939692|NCT00844753|3096010|P3|Overall Study|Adverse Event|5
939693|NCT00844753|3096011|P2|Overall Study|Adverse Event|2
939694|NCT00844753|3096012|P1|Overall Study|Adverse Event|3
939695|NCT00844753|3096009|P4|Overall Study|Lack of Efficacy|2
939696|NCT00844753|3096010|P3|Overall Study|Lack of Efficacy|2
939697|NCT00844753|3096011|P2|Overall Study|Lack of Efficacy|0
939698|NCT00844753|3096012|P1|Overall Study|Lack of Efficacy|1
939699|NCT00844649|3096030|P2|Overall Study|Withdrew prior to starting treatment|27
939700|NCT00844649|3096031|P1|Overall Study|Withdrew prior to starting treatment|11
939701|NCT00844649|3096030|P2|Overall Study|Other|10
939702|NCT00844649|3096031|P1|Overall Study|Other|7
939703|NCT00844649|3096030|P2|Overall Study|Withdrawal by Subject|39
939704|NCT00844649|3096031|P1|Overall Study|Withdrawal by Subject|28
939705|NCT00844649|3096030|P2|Overall Study|Protocol Violation|6
939706|NCT00844649|3096031|P1|Overall Study|Protocol Violation|10
939707|NCT00844649|3096030|P2|Overall Study|Physician Decision|18
939708|NCT00844649|3096031|P1|Overall Study|Physician Decision|25
939709|NCT00844649|3096030|P2|Overall Study|Adverse Event|73
939710|NCT00844649|3096031|P1|Overall Study|Adverse Event|128
939711|NCT00844649|3096030|P2|Overall Study|Progressive Disease|245
939712|NCT00844649|3096031|P1|Overall Study|Progressive Disease|196
939713|NCT00844597|3096055|P6|Overall Study|Adverse Event|0
939714|NCT00844597|3096056|P5|Overall Study|Adverse Event|0
939715|NCT00844597|3096057|P4|Overall Study|Adverse Event|1
939716|NCT00844597|3096058|P3|Overall Study|Adverse Event|0
939717|NCT00844597|3096059|P2|Overall Study|Adverse Event|0
939718|NCT00844597|3096060|P1|Overall Study|Adverse Event|0
939719|NCT00844558|3096080|P2|Overall Study|Physician Decision|0
939720|NCT00844558|3096081|P1|Overall Study|Physician Decision|1
939721|NCT00844558|3096080|P2|Overall Study|Lost to Follow-up|1
939722|NCT00844558|3096081|P1|Overall Study|Lost to Follow-up|0
939723|NCT00844558|3096080|P2|Overall Study|Protocol Violation|1
939724|NCT00844558|3096081|P1|Overall Study|Protocol Violation|1
939725|NCT00844558|3096080|P2|Overall Study|Death|0
939726|NCT00844558|3096081|P1|Overall Study|Death|1
939727|NCT00844558|3096080|P2|Overall Study|Withdrawal by Subject|2
939728|NCT00844558|3096081|P1|Overall Study|Withdrawal by Subject|9
939729|NCT00844545|3096097|P1|Post Treatment Period|Withdrawal by Subject|1
939730|NCT00844545|3096097|P1|Extension Treatment Period|Adverse Event|2
939731|NCT00844545|3096097|P1|Treatment Period (26 Weeks)|Protocol Violation|1
939732|NCT00844545|3096097|P1|Treatment Period (26 Weeks)|Adverse Event|1
939733|NCT00844532|3096111|P1|Overall Study|Lost to Follow-up|7
939734|NCT00844532|3096111|P1|Overall Study|Withdrawal by Subject|16
939735|NCT00844532|3096111|P1|Overall Study|Death|16
939736|NCT00844519|3096197|P2|Overall Study|Adverse Event|0
939737|NCT00844519|3096198|P1|Overall Study|Adverse Event|1
939738|NCT00844519|3096197|P2|Overall Study|Withdrawal by Subject|1
939739|NCT00844519|3096198|P1|Overall Study|Withdrawal by Subject|1
939740|NCT00844480|3096206|P2|Overall Study|Withdrawal by Subject|3
939741|NCT00844480|3096207|P1|Overall Study|Withdrawal by Subject|2
939742|NCT00844428|3096215|P1|Post Treatment Period (Patients Who Disc|Death|1
939743|NCT00844428|3096215|P1|Extension Treatment Period|Death|1
939744|NCT00844428|3096215|P1|Screening Period|Screen Failure|3
939745|NCT00844415|3096231|P1|Overall Study|Withdrawal by Subject|1
939746|NCT00844376|3096245|P2|Period 1: First Intervention|Withdrawal by Subject|0
939747|NCT00844376|3096246|P1|Period 1: First Intervention|Withdrawal by Subject|1
939748|NCT00844194|3096270|P2|Overall Study|Other reason (not specified)|0
939749|NCT00844194|3096271|P1|Overall Study|Other reason (not specified)|1
939750|NCT00844194|3096270|P2|Overall Study|Lack of Efficacy|0
939751|NCT00844194|3096271|P1|Overall Study|Lack of Efficacy|3
939752|NCT00844194|3096270|P2|Overall Study|Withdrawal by Subject|1
939753|NCT00844194|3096271|P1|Overall Study|Withdrawal by Subject|2
939754|NCT00844194|3096270|P2|Overall Study|Lost to Follow-up|1
939755|NCT00844194|3096271|P1|Overall Study|Lost to Follow-up|1
939756|NCT00844194|3096270|P2|Overall Study|Protocol Violation|1
939757|NCT00844194|3096271|P1|Overall Study|Protocol Violation|1
939758|NCT00844194|3096270|P2|Overall Study|Adverse Event|5
939759|NCT00844194|3096271|P1|Overall Study|Adverse Event|17
939760|NCT00843843|3096526|P2|Overall Study|Protocol Violation|1
939761|NCT00843843|3096527|P1|Overall Study|Protocol Violation|1
939762|NCT00843843|3096526|P2|Overall Study|Physician Decision|1
939763|NCT00843843|3096527|P1|Overall Study|Physician Decision|1
939764|NCT00843778|3096540|P1|Overall Study|Withdrawal by Subject|4
939765|NCT00843778|3096540|P1|Overall Study|Loss of efficacy|2
939766|NCT00843778|3096540|P1|Overall Study|Lack of Efficacy|14
939767|NCT00843778|3096540|P1|Overall Study|Adverse Event|15
939768|NCT00843635|3096585|P3|Overall Study|Adverse Event|0
939769|NCT00843635|3096586|P2|Overall Study|Adverse Event|2
939770|NCT00843635|3096587|P1|Overall Study|Adverse Event|2
939771|NCT00843518|3096616|P2|Period 2 (Double-blind Treatment)|Caregiver decision|7
939772|NCT00843518|3096617|P1|Period 2 (Double-blind Treatment)|Caregiver decision|7
939773|NCT00843518|3096616|P2|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0
939774|NCT00843518|3096617|P1|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2
939775|NCT00843518|3096616|P2|Period 2 (Double-blind Treatment)|Protocol Violation|5
939776|NCT00843518|3096617|P1|Period 2 (Double-blind Treatment)|Protocol Violation|2
939777|NCT00843518|3096616|P2|Period 2 (Double-blind Treatment)|Physician Decision|1
939778|NCT00843518|3096617|P1|Period 2 (Double-blind Treatment)|Physician Decision|2
939779|NCT00843518|3096616|P2|Period 2 (Double-blind Treatment)|Lost to Follow-up|3
939780|NCT00843518|3096617|P1|Period 2 (Double-blind Treatment)|Lost to Follow-up|2
939781|NCT00843518|3096616|P2|Period 2 (Double-blind Treatment)|Death|1
939782|NCT00843518|3096617|P1|Period 2 (Double-blind Treatment)|Death|0
939783|NCT00843518|3096616|P2|Period 2 (Double-blind Treatment)|Adverse Event|3
939784|NCT00843518|3096617|P1|Period 2 (Double-blind Treatment)|Adverse Event|5
939785|NCT00843492|3096647|P2|Overall Study|Deep-vein Thrombosis|0
939786|NCT00843492|3096648|P1|Overall Study|Deep-vein Thrombosis|1
939787|NCT00843492|3096647|P2|Overall Study|Visit Not Performed|0
939788|NCT00843492|3096648|P1|Overall Study|Visit Not Performed|1
939789|NCT00843492|3096647|P2|Overall Study|Orthopedic Surgery|2
939790|NCT00843492|3096648|P1|Overall Study|Orthopedic Surgery|0
939791|NCT00843492|3096647|P2|Overall Study|Investigator/Orthopedic Surgeon Decision|1
939792|NCT00843492|3096648|P1|Overall Study|Investigator/Orthopedic Surgeon Decision|1
939793|NCT00843492|3096647|P2|Overall Study|Immobilization Stopped|0
939794|NCT00843492|3096648|P1|Overall Study|Immobilization Stopped|1
939795|NCT00843492|3096647|P2|Overall Study|Withdrawal by Subject|4
939796|NCT00843492|3096648|P1|Overall Study|Withdrawal by Subject|0
939797|NCT00843492|3096647|P2|Overall Study|Lost to Follow-up|4
939798|NCT00843492|3096648|P1|Overall Study|Lost to Follow-up|4
939799|NCT00843492|3096647|P2|Overall Study|Adverse Event|3
939800|NCT00843492|3096648|P1|Overall Study|Adverse Event|0
939801|NCT00843284|3096719|P1|Overall Study|Death|3
939802|NCT00843284|3096719|P1|Overall Study|Withdrawal by Subject|4
939803|NCT00843284|3096719|P1|Overall Study|Other|10
939804|NCT00843284|3096719|P1|Overall Study|Lost to Follow-up|11
939805|NCT00843284|3096719|P1|Overall Study|Lack of Efficacy|5
939806|NCT00843284|3096719|P1|Overall Study|Adverse Event|39
939807|NCT00843193|3096729|P2|Overall Study|Withdrawal by Subject|3
939808|NCT00843193|3096730|P1|Overall Study|Withdrawal by Subject|3
939809|NCT00843193|3096729|P2|Overall Study|Physician Decision|1
939810|NCT00843193|3096730|P1|Overall Study|Physician Decision|0
939811|NCT00843193|3096729|P2|Overall Study|Lost to Follow-up|0
939812|NCT00843193|3096730|P1|Overall Study|Lost to Follow-up|1
939813|NCT00843193|3096729|P2|Overall Study|Protocol Violation|2
939814|NCT00843193|3096730|P1|Overall Study|Protocol Violation|1
939815|NCT00843193|3096729|P2|Overall Study|Lack of Efficacy|1
939816|NCT00843193|3096730|P1|Overall Study|Lack of Efficacy|1
939817|NCT00843193|3096729|P2|Overall Study|Adverse Event|4
939818|NCT00843193|3096730|P1|Overall Study|Adverse Event|2
939819|NCT00843167|3096781|P2|Treatment Period|Withdrawal by Subject|3
939820|NCT00843167|3096782|P1|Treatment Period|Withdrawal by Subject|2
939821|NCT00843167|3096781|P2|Treatment Period|Adverse Event|5
939822|NCT00843167|3096782|P1|Treatment Period|Adverse Event|1
939823|NCT00843115|3096795|P1|Overall Study|Syndrome De Glissement|1
939824|NCT00843115|3096795|P1|Overall Study|week 12 not done|1
939825|NCT00843115|3096795|P1|Overall Study|hospitalized due to deterioration|1
939826|NCT00843115|3096795|P1|Overall Study|patient never took the medication|1
939827|NCT00843115|3096795|P1|Overall Study|patient took for 2 days then stopped|1
939828|NCT00843115|3096795|P1|Overall Study|Family discontinued meds|1
939829|NCT00843115|3096795|P1|Overall Study|Physician Decision|1
939830|NCT00843115|3096795|P1|Overall Study|Does not meet entrance criteria|1
939831|NCT00843115|3096795|P1|Overall Study|Patient forgot to take meds|1
939832|NCT00843115|3096795|P1|Overall Study|Family does not want continuation|1
939833|NCT00843115|3096795|P1|Overall Study|Family wanted meds stopped|1
939834|NCT00843115|3096795|P1|Overall Study|Withdrawal by Subject|17
939835|NCT00843115|3096795|P1|Overall Study|Lost to Follow-up|4
939836|NCT00843115|3096795|P1|Overall Study|Adverse Event|30
939837|NCT00843115|3096795|P1|Overall Study|Death|4
939838|NCT00843024|3096851|P6|Double-blind Treatment Phase|Lack of Efficacy|0
939839|NCT00843024|3096852|P5|Double-blind Treatment Phase|Lack of Efficacy|1
939840|NCT00843024|3096853|P4|Double-blind Treatment Phase|Lack of Efficacy|0
939841|NCT00843024|3096854|P3|Double-blind Treatment Phase|Lack of Efficacy|0
939842|NCT00843024|3096855|P2|Double-blind Treatment Phase|Lack of Efficacy|0
939843|NCT00843024|3096856|P1|Double-blind Treatment Phase|Lack of Efficacy|0
939844|NCT00843024|3096851|P6|Double-blind Treatment Phase|Adverse Event|1
939845|NCT00843024|3096852|P5|Double-blind Treatment Phase|Adverse Event|1
939846|NCT00843024|3096853|P4|Double-blind Treatment Phase|Adverse Event|0
939847|NCT00843024|3096854|P3|Double-blind Treatment Phase|Adverse Event|0
939848|NCT00843024|3096855|P2|Double-blind Treatment Phase|Adverse Event|0
939849|NCT00843024|3096856|P1|Double-blind Treatment Phase|Adverse Event|0
939850|NCT00843024|3096851|P6|Double-blind Treatment Phase|Physician Decision|1
939851|NCT00843024|3096852|P5|Double-blind Treatment Phase|Physician Decision|1
939852|NCT00843024|3096853|P4|Double-blind Treatment Phase|Physician Decision|3
939853|NCT00843024|3096854|P3|Double-blind Treatment Phase|Physician Decision|0
939854|NCT00843024|3096855|P2|Double-blind Treatment Phase|Physician Decision|0
939855|NCT00843024|3096856|P1|Double-blind Treatment Phase|Physician Decision|0
939856|NCT00843024|3096851|P6|Double-blind Treatment Phase|Protocol Violation|3
939857|NCT00843024|3096852|P5|Double-blind Treatment Phase|Protocol Violation|0
939858|NCT00843024|3096853|P4|Double-blind Treatment Phase|Protocol Violation|0
939859|NCT00843024|3096854|P3|Double-blind Treatment Phase|Protocol Violation|3
939860|NCT00843024|3096855|P2|Double-blind Treatment Phase|Protocol Violation|0
939861|NCT00843024|3096856|P1|Double-blind Treatment Phase|Protocol Violation|0
939862|NCT00843024|3096851|P6|Double-blind Treatment Phase|Withdrawal by Subject|2
939863|NCT00843024|3096852|P5|Double-blind Treatment Phase|Withdrawal by Subject|0
939864|NCT00843024|3096853|P4|Double-blind Treatment Phase|Withdrawal by Subject|6
939865|NCT00843024|3096854|P3|Double-blind Treatment Phase|Withdrawal by Subject|0
939866|NCT00843024|3096855|P2|Double-blind Treatment Phase|Withdrawal by Subject|0
939867|NCT00843024|3096856|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
939868|NCT00843024|3096851|P6|Double-blind Treatment Phase|Lost to Follow-up|4
939869|NCT00843024|3096852|P5|Double-blind Treatment Phase|Lost to Follow-up|4
939870|NCT00843024|3096853|P4|Double-blind Treatment Phase|Lost to Follow-up|4
939871|NCT00843024|3096854|P3|Double-blind Treatment Phase|Lost to Follow-up|8
939872|NCT00843024|3096855|P2|Double-blind Treatment Phase|Lost to Follow-up|0
939873|NCT00843024|3096856|P1|Double-blind Treatment Phase|Lost to Follow-up|0
939874|NCT00843024|3096851|P6|Double-blind Treatment Phase|No opportunity to treat migraine|14
939875|NCT00843024|3096852|P5|Double-blind Treatment Phase|No opportunity to treat migraine|13
939876|NCT00843024|3096853|P4|Double-blind Treatment Phase|No opportunity to treat migraine|10
939877|NCT00843024|3096854|P3|Double-blind Treatment Phase|No opportunity to treat migraine|20
939878|NCT00843024|3096855|P2|Double-blind Treatment Phase|No opportunity to treat migraine|0
939879|NCT00843024|3096856|P1|Double-blind Treatment Phase|No opportunity to treat migraine|0
939880|NCT00843024|3096851|P6|Single-blind Placebo Run-In Phase|Other|0
939881|NCT00843024|3096852|P5|Single-blind Placebo Run-In Phase|Other|0
939882|NCT00843024|3096853|P4|Single-blind Placebo Run-In Phase|Other|0
939883|NCT00843024|3096854|P3|Single-blind Placebo Run-In Phase|Other|0
939884|NCT00843024|3096855|P2|Single-blind Placebo Run-In Phase|Other|1
939885|NCT00843024|3096856|P1|Single-blind Placebo Run-In Phase|Other|0
939886|NCT00843024|3096851|P6|Single-blind Placebo Run-In Phase|Adverse Event|0
939887|NCT00843024|3096852|P5|Single-blind Placebo Run-In Phase|Adverse Event|0
939888|NCT00843024|3096853|P4|Single-blind Placebo Run-In Phase|Adverse Event|0
939889|NCT00843024|3096854|P3|Single-blind Placebo Run-In Phase|Adverse Event|0
939890|NCT00843024|3096855|P2|Single-blind Placebo Run-In Phase|Adverse Event|1
939891|NCT00843024|3096856|P1|Single-blind Placebo Run-In Phase|Adverse Event|0
939892|NCT00843024|3096851|P6|Single-blind Placebo Run-In Phase|Physician Decision|0
939893|NCT00843024|3096852|P5|Single-blind Placebo Run-In Phase|Physician Decision|0
939894|NCT00843024|3096853|P4|Single-blind Placebo Run-In Phase|Physician Decision|0
939895|NCT00843024|3096854|P3|Single-blind Placebo Run-In Phase|Physician Decision|0
939896|NCT00843024|3096855|P2|Single-blind Placebo Run-In Phase|Physician Decision|6
939897|NCT00843024|3096856|P1|Single-blind Placebo Run-In Phase|Physician Decision|2
939898|NCT00843024|3096851|P6|Single-blind Placebo Run-In Phase|Protocol Violation|0
939899|NCT00843024|3096852|P5|Single-blind Placebo Run-In Phase|Protocol Violation|0
939900|NCT00843024|3096853|P4|Single-blind Placebo Run-In Phase|Protocol Violation|0
939901|NCT00843024|3096854|P3|Single-blind Placebo Run-In Phase|Protocol Violation|0
939902|NCT00843024|3096855|P2|Single-blind Placebo Run-In Phase|Protocol Violation|5
939903|NCT00843024|3096856|P1|Single-blind Placebo Run-In Phase|Protocol Violation|4
939904|NCT00843024|3096851|P6|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
939905|NCT00843024|3096852|P5|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
939906|NCT00843024|3096853|P4|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
939907|NCT00843024|3096854|P3|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
939908|NCT00843024|3096855|P2|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18
939909|NCT00843024|3096856|P1|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19
939910|NCT00843024|3096851|P6|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
939911|NCT00843024|3096852|P5|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
939912|NCT00843024|3096853|P4|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
939913|NCT00843024|3096854|P3|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
939914|NCT00843024|3096855|P2|Single-blind Placebo Run-In Phase|Lost to Follow-up|31
939915|NCT00843024|3096856|P1|Single-blind Placebo Run-In Phase|Lost to Follow-up|36
939916|NCT00843024|3096851|P6|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
939917|NCT00843024|3096852|P5|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
939918|NCT00843024|3096853|P4|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
939919|NCT00843024|3096854|P3|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
939920|NCT00843024|3096855|P2|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74
939921|NCT00843024|3096856|P1|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79
939922|NCT00842985|3096921|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
939923|NCT00842985|3096921|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
939924|NCT00842985|3096921|P1|First Intervention|Protocol Violation|3
939925|NCT00842985|3096921|P1|First Intervention|Withdrawal by Subject|3
939926|NCT00842985|3096921|P1|Screening|Did not meet entrance requirements|27
939927|NCT00842829|3096939|P3|Continuation Period|Non-compliance to study drug|1
939928|NCT00842829|3096940|P2|Continuation Period|Non-compliance to study drug|0
939929|NCT00842829|3096941|P1|Continuation Period|Non-compliance to study drug|0
939930|NCT00842829|3096939|P3|Continuation Period|Non-compliance to study procedures|2
939931|NCT00842829|3096940|P2|Continuation Period|Non-compliance to study procedures|0
939932|NCT00842829|3096941|P1|Continuation Period|Non-compliance to study procedures|0
939933|NCT00842829|3096939|P3|Continuation Period|Not specified|7
939934|NCT00842829|3096940|P2|Continuation Period|Not specified|0
939935|NCT00842829|3096941|P1|Continuation Period|Not specified|0
939936|NCT00842829|3096939|P3|Continuation Period|Withdrawal by Subject|10
939937|NCT00842829|3096940|P2|Continuation Period|Withdrawal by Subject|0
939938|NCT00842829|3096941|P1|Continuation Period|Withdrawal by Subject|0
939939|NCT00842829|3096939|P3|Continuation Period|Unstable persistent cancer pain|3
939940|NCT00842829|3096940|P2|Continuation Period|Unstable persistent cancer pain|0
939941|NCT00842829|3096941|P1|Continuation Period|Unstable persistent cancer pain|0
939942|NCT00842829|3096939|P3|Continuation Period|Lack of Efficacy|6
939943|NCT00842829|3096940|P2|Continuation Period|Lack of Efficacy|0
939944|NCT00842829|3096941|P1|Continuation Period|Lack of Efficacy|0
939945|NCT00842829|3096939|P3|Continuation Period|Adverse Event|32
939946|NCT00842829|3096940|P2|Continuation Period|Adverse Event|0
939947|NCT00842829|3096941|P1|Continuation Period|Adverse Event|0
939948|NCT00842829|3096939|P3|Treatment Period|Unclear completion status|1
939949|NCT00842829|3096940|P2|Treatment Period|Unclear completion status|0
939950|NCT00842829|3096941|P1|Treatment Period|Unclear completion status|0
939951|NCT00842829|3096939|P3|Treatment Period|Non-compliance to study procedures|4
939952|NCT00842829|3096940|P2|Treatment Period|Non-compliance to study procedures|0
939953|NCT00842829|3096941|P1|Treatment Period|Non-compliance to study procedures|0
939954|NCT00842829|3096939|P3|Treatment Period|Not specified|18
939955|NCT00842829|3096940|P2|Treatment Period|Not specified|0
939956|NCT00842829|3096941|P1|Treatment Period|Not specified|0
939957|NCT00842829|3096939|P3|Treatment Period|Protocol Violation|2
939958|NCT00842829|3096940|P2|Treatment Period|Protocol Violation|0
939959|NCT00842829|3096941|P1|Treatment Period|Protocol Violation|0
939960|NCT00842829|3096939|P3|Treatment Period|Consistently >4 BTP episodes daily|1
939961|NCT00842829|3096940|P2|Treatment Period|Consistently >4 BTP episodes daily|0
939962|NCT00842829|3096941|P1|Treatment Period|Consistently >4 BTP episodes daily|0
939963|NCT00842829|3096939|P3|Treatment Period|Withdrawal by Subject|11
939964|NCT00842829|3096940|P2|Treatment Period|Withdrawal by Subject|0
939965|NCT00842829|3096941|P1|Treatment Period|Withdrawal by Subject|0
939966|NCT00842829|3096939|P3|Treatment Period|Unstable persistent cancer pain|5
939967|NCT00842829|3096940|P2|Treatment Period|Unstable persistent cancer pain|0
939968|NCT00842829|3096941|P1|Treatment Period|Unstable persistent cancer pain|0
939969|NCT00842829|3096939|P3|Treatment Period|Lack of Efficacy|6
939970|NCT00842829|3096940|P2|Treatment Period|Lack of Efficacy|0
939971|NCT00842829|3096941|P1|Treatment Period|Lack of Efficacy|0
939972|NCT00842829|3096939|P3|Treatment Period|Adverse Event|15
939973|NCT00842829|3096940|P2|Treatment Period|Adverse Event|0
939974|NCT00842829|3096941|P1|Treatment Period|Adverse Event|0
939975|NCT00842829|3096939|P3|Dose Titration Period|Non-compliance to study drug|0
939976|NCT00842829|3096940|P2|Dose Titration Period|Non-compliance to study drug|1
939977|NCT00842829|3096941|P1|Dose Titration Period|Non-compliance to study drug|2
939978|NCT00842829|3096939|P3|Dose Titration Period|Non-compliance to study procedures|0
939979|NCT00842829|3096940|P2|Dose Titration Period|Non-compliance to study procedures|1
939980|NCT00842829|3096941|P1|Dose Titration Period|Non-compliance to study procedures|1
939981|NCT00842829|3096939|P3|Dose Titration Period|Not specified|0
939982|NCT00842829|3096940|P2|Dose Titration Period|Not specified|4
939983|NCT00842829|3096941|P1|Dose Titration Period|Not specified|5
939984|NCT00842829|3096939|P3|Dose Titration Period|Withdrawal by Subject|0
939985|NCT00842829|3096940|P2|Dose Titration Period|Withdrawal by Subject|6
939986|NCT00842829|3096941|P1|Dose Titration Period|Withdrawal by Subject|2
939987|NCT00842829|3096939|P3|Dose Titration Period|Unstable persistent cancer pain|0
939988|NCT00842829|3096940|P2|Dose Titration Period|Unstable persistent cancer pain|0
939989|NCT00842829|3096941|P1|Dose Titration Period|Unstable persistent cancer pain|1
939990|NCT00842829|3096939|P3|Dose Titration Period|Lack of Efficacy|0
939991|NCT00842829|3096940|P2|Dose Titration Period|Lack of Efficacy|1
939992|NCT00842829|3096941|P1|Dose Titration Period|Lack of Efficacy|4
939993|NCT00842829|3096939|P3|Dose Titration Period|Adverse Event|0
939994|NCT00842829|3096940|P2|Dose Titration Period|Adverse Event|10
939995|NCT00842829|3096941|P1|Dose Titration Period|Adverse Event|11
939996|NCT00842712|3096996|P7|Randomized Part|Ongoing at cut-off date|2
939997|NCT00842712|3096997|P6|Randomized Part|Ongoing at cut-off date|0
939998|NCT00842712|3096998|P5|Randomized Part|Ongoing at cut-off date|0
939999|NCT00842712|3096999|P4|Randomized Part|Ongoing at cut-off date|0
940000|NCT00842712|3097000|P3|Randomized Part|Ongoing at cut-off date|0
940001|NCT00842712|3097001|P2|Randomized Part|Ongoing at cut-off date|0
940002|NCT00842712|3097002|P1|Randomized Part|Ongoing at cut-off date|0
940003|NCT00842712|3096996|P7|Randomized Part|Randomized but not treated|4
940004|NCT00842712|3096997|P6|Randomized Part|Randomized but not treated|1
940005|NCT00842712|3096998|P5|Randomized Part|Randomized but not treated|0
940006|NCT00842712|3096999|P4|Randomized Part|Randomized but not treated|0
940007|NCT00842712|3097000|P3|Randomized Part|Randomized but not treated|0
940008|NCT00842712|3097001|P2|Randomized Part|Randomized but not treated|0
940009|NCT00842712|3097002|P1|Randomized Part|Randomized but not treated|0
940010|NCT00842712|3096996|P7|Safety Run-in Part|Progressive disease|0
940011|NCT00842712|3096997|P6|Safety Run-in Part|Progressive disease|0
940012|NCT00842712|3096998|P5|Safety Run-in Part|Progressive disease|0
940013|NCT00842712|3096999|P4|Safety Run-in Part|Progressive disease|1
940014|NCT00842712|3097000|P3|Safety Run-in Part|Progressive disease|0
940015|NCT00842712|3097001|P2|Safety Run-in Part|Progressive disease|1
940016|NCT00842712|3097002|P1|Safety Run-in Part|Progressive disease|3
940017|NCT00842712|3096996|P7|Safety Run-in Part|Adverse Event|0
940018|NCT00842712|3096997|P6|Safety Run-in Part|Adverse Event|0
940019|NCT00842712|3096998|P5|Safety Run-in Part|Adverse Event|0
940020|NCT00842712|3096999|P4|Safety Run-in Part|Adverse Event|0
940021|NCT00842712|3097000|P3|Safety Run-in Part|Adverse Event|0
940022|NCT00842712|3097001|P2|Safety Run-in Part|Adverse Event|1
940023|NCT00842712|3097002|P1|Safety Run-in Part|Adverse Event|0
940024|NCT00842543|3097059|P4|Overall Study|Withdrawal by Subject|4
940025|NCT00842543|3097060|P3|Overall Study|Withdrawal by Subject|3
940026|NCT00842543|3097061|P2|Overall Study|Withdrawal by Subject|0
940027|NCT00842543|3097062|P1|Overall Study|Withdrawal by Subject|2
940028|NCT00842361|3097076|P2|Overall Study|Unclassified|2
940029|NCT00842361|3097077|P1|Overall Study|Unclassified|0
940030|NCT00842361|3097076|P2|Overall Study|Protocol Violation|0
940031|NCT00842361|3097077|P1|Overall Study|Protocol Violation|1
940032|NCT00842348|3097097|P2|Study 729|Surgical resection|0
940033|NCT00842348|3097098|P1|Study 729|Surgical resection|1
940034|NCT00842348|3097097|P2|Study 729|Sponsor's decision|0
940035|NCT00842348|3097098|P1|Study 729|Sponsor's decision|1
940036|NCT00842348|3097097|P2|Study 729|Due to non-availability of IP|1
940037|NCT00842348|3097098|P1|Study 729|Due to non-availability of IP|0
940038|NCT00842348|3097097|P2|Study 729|Due to Sponsor stopping the study|1
940039|NCT00842348|3097098|P1|Study 729|Due to Sponsor stopping the study|1
940040|NCT00842348|3097097|P2|Study 729|Withdrawal by Subject|4
940041|NCT00842348|3097098|P1|Study 729|Withdrawal by Subject|2
940042|NCT00842348|3097097|P2|Study 729|Protocol Violation|1
940043|NCT00842348|3097098|P1|Study 729|Protocol Violation|1
940044|NCT00842348|3097097|P2|Study 729|Adverse Event|1
940045|NCT00842348|3097098|P1|Study 729|Adverse Event|1
940046|NCT00842348|3097097|P2|Study 729|Disease progression/death|30
940047|NCT00842348|3097098|P1|Study 729|Disease progression/death|19
940048|NCT00842348|3097097|P2|Patients Randomised in Study 726|Did not enter Study 729|56
940049|NCT00842348|3097098|P1|Patients Randomised in Study 726|Did not enter Study 729|59
940050|NCT00842257|3097141|P1|Overall Study|Adverse Event|1
940051|NCT00842244|3097148|P1|Overall Study|Other|17
940052|NCT00842244|3097148|P1|Overall Study|Withdrawal by Subject|1
940053|NCT00842244|3097148|P1|Overall Study|Death|3
940054|NCT00842153|3097175|P2|Overall Study|Lost to Follow-up|2
940055|NCT00842153|3097176|P1|Overall Study|Lost to Follow-up|1
940056|NCT00842153|3097175|P2|Overall Study|Adverse Event|1
940057|NCT00842153|3097176|P1|Overall Study|Adverse Event|0
940058|NCT00841906|3097251|P2|Overall Study|Withdrawal by Subject|0
940059|NCT00841906|3097252|P1|Overall Study|Withdrawal by Subject|2
940060|NCT00841815|3097277|P2|Washout|Withdrawal by Subject|1
940061|NCT00841815|3097278|P1|Washout|Withdrawal by Subject|0
940062|NCT00841776|3097288|P2|Overall Study|Withdrawal by Subject|1
940063|NCT00841776|3097289|P1|Overall Study|Withdrawal by Subject|0
940064|NCT00841776|3097288|P2|Overall Study|Lost to Follow-up|1
940065|NCT00841776|3097289|P1|Overall Study|Lost to Follow-up|2
940066|NCT00841776|3097288|P2|Overall Study|Lack of Efficacy|1
940067|NCT00841776|3097289|P1|Overall Study|Lack of Efficacy|0
940068|NCT00841763|3097307|P4|Overall Study|Unable to Classify|0
940069|NCT00841763|3097308|P3|Overall Study|Unable to Classify|0
940070|NCT00841763|3097309|P2|Overall Study|Unable to Classify|1
940071|NCT00841763|3097310|P1|Overall Study|Unable to Classify|7
940072|NCT00841763|3097307|P4|Overall Study|Administrative Reasons|0
940073|NCT00841763|3097308|P3|Overall Study|Administrative Reasons|0
940074|NCT00841763|3097309|P2|Overall Study|Administrative Reasons|1
940075|NCT00841763|3097310|P1|Overall Study|Administrative Reasons|3
940076|NCT00841763|3097307|P4|Overall Study|Protocol Violation|0
940077|NCT00841763|3097308|P3|Overall Study|Protocol Violation|1
940078|NCT00841763|3097309|P2|Overall Study|Protocol Violation|3
940079|NCT00841763|3097310|P1|Overall Study|Protocol Violation|20
940080|NCT00841763|3097307|P4|Overall Study|Lost to Follow-up|0
940081|NCT00841763|3097308|P3|Overall Study|Lost to Follow-up|0
940082|NCT00841763|3097309|P2|Overall Study|Lost to Follow-up|25
940083|NCT00841763|3097310|P1|Overall Study|Lost to Follow-up|63
940084|NCT00841763|3097307|P4|Overall Study|Adverse Event|2
940085|NCT00841763|3097308|P3|Overall Study|Adverse Event|3
940086|NCT00841763|3097309|P2|Overall Study|Adverse Event|10
940087|NCT00841763|3097310|P1|Overall Study|Adverse Event|9
940088|NCT00841763|3097307|P4|Overall Study|Withdrawal by Subject|1
940089|NCT00841763|3097308|P3|Overall Study|Withdrawal by Subject|4
940090|NCT00841763|3097309|P2|Overall Study|Withdrawal by Subject|17
940091|NCT00841763|3097310|P1|Overall Study|Withdrawal by Subject|60
940092|NCT00841698|3097372|P2|First Intervention|Withdrawal by Subject|0
940093|NCT00841698|3097373|P1|First Intervention|Withdrawal by Subject|1
940094|NCT00841672|3097383|P2|Overall Study|Protocol Deviation|1
940095|NCT00841672|3097384|P1|Overall Study|Protocol Deviation|0
940096|NCT00841672|3097383|P2|Overall Study|Misrandomized|0
940097|NCT00841672|3097384|P1|Overall Study|Misrandomized|1
940098|NCT00841672|3097383|P2|Overall Study|Administrative problems|9
940099|NCT00841672|3097384|P1|Overall Study|Administrative problems|9
940100|NCT00841672|3097383|P2|Overall Study|Lost to Follow-up|1
940101|NCT00841672|3097384|P1|Overall Study|Lost to Follow-up|1
940102|NCT00841672|3097383|P2|Overall Study|Subject withdrew consent|4
940103|NCT00841672|3097384|P1|Overall Study|Subject withdrew consent|2
940104|NCT00841672|3097383|P2|Overall Study|Abnormal test procedure result(s)|1
940105|NCT00841672|3097384|P1|Overall Study|Abnormal test procedure result(s)|0
940106|NCT00841672|3097383|P2|Overall Study|Adverse Event|16
940107|NCT00841672|3097384|P1|Overall Study|Adverse Event|7
940108|NCT00841659|3097400|P2|Washout: 2 Weeks|Protocol Violation|0
940109|NCT00841659|3097401|P1|Washout: 2 Weeks|Protocol Violation|1
940110|NCT00841568|3097409|P1|Overall Study|Creatinine over the withdrawal criteria|1
940111|NCT00841568|3097409|P1|Overall Study|Withdrawal by Subject|2
940112|NCT00841568|3097409|P1|Overall Study|Death|1
940113|NCT00841568|3097409|P1|Overall Study|Adverse Event|1
940114|NCT00841542|3097437|P2|Period 1|Adverse Event|0
940115|NCT00841542|3097438|P1|Period 1|Adverse Event|1
940116|NCT00841321|3097453|P2|Overall Study|Adverse Event|2
940117|NCT00841321|3097454|P1|Overall Study|Adverse Event|0
940118|NCT00841321|3097453|P2|Overall Study|Lost to Follow-up|1
940119|NCT00841321|3097454|P1|Overall Study|Lost to Follow-up|1
940120|NCT00841035|3097522|P1|Phase 1 Overall Study|Physician Decision|13
940121|NCT00840996|3097529|P2|Overall Study|Withdrawal by Subject|0
940122|NCT00840996|3097530|P1|Overall Study|Withdrawal by Subject|1
940123|NCT00840879|3097550|P2|Second Intervention|Withdrawal by Subject|0
940124|NCT00840879|3097551|P1|Second Intervention|Withdrawal by Subject|1
940125|NCT00840658|3097591|P4|Overall Study|Lost to Follow-up|1
940126|NCT00840658|3097592|P3|Overall Study|Lost to Follow-up|2
940127|NCT00840658|3097593|P2|Overall Study|Lost to Follow-up|1
940128|NCT00840658|3097594|P1|Overall Study|Lost to Follow-up|3
940129|NCT00840658|3097591|P4|Overall Study|Death|3
940130|NCT00840658|3097592|P3|Overall Study|Death|3
940131|NCT00840658|3097593|P2|Overall Study|Death|2
940132|NCT00840658|3097594|P1|Overall Study|Death|2
940133|NCT00840632|3097606|P2|Washout|Withdrawal by Subject|1
940134|NCT00840632|3097607|P1|Washout|Withdrawal by Subject|1
940135|NCT00840632|3097606|P2|First Intervention|Withdrawal by Subject|1
940136|NCT00840632|3097607|P1|First Intervention|Withdrawal by Subject|0
940137|NCT00840450|3097632|P1|Overall Study|Lack of Efficacy|2
940138|NCT00840450|3097632|P1|Overall Study|Adverse Event|1
940139|NCT00840411|3097640|P2|Washout|Withdrawal by Subject|0
940140|NCT00840411|3097641|P1|Washout|Withdrawal by Subject|1
940141|NCT00840411|3097640|P2|First Intervention|Adverse Event|0
940142|NCT00840411|3097641|P1|First Intervention|Adverse Event|1
940143|NCT00840294|3097655|P2|Overall Study|Illness|1
940144|NCT00840294|3097656|P1|Overall Study|Illness|0
940145|NCT00840294|3097655|P2|Overall Study|Protocol Violation|3
940146|NCT00840294|3097656|P1|Overall Study|Protocol Violation|1
940147|NCT00840294|3097655|P2|Overall Study|Withdrawal by Subject|1
940148|NCT00840294|3097656|P1|Overall Study|Withdrawal by Subject|2
940149|NCT00840216|3097677|P2|Washout: 7 Days|Withdrawal by Subject|0
940150|NCT00840216|3097678|P1|Washout: 7 Days|Withdrawal by Subject|1
940151|NCT00840203|3097688|P2|Washout|Protocol Violation|0
940152|NCT00840203|3097689|P1|Washout|Protocol Violation|1
940153|NCT00840203|3097688|P2|First Intervention|Protocol Violation|1
940154|NCT00840203|3097689|P1|First Intervention|Protocol Violation|1
940155|NCT00840086|3097720|P1|Overall Study|Lost to Follow-up|1
940156|NCT00840086|3097720|P1|Overall Study|Protocol Violation|2
940157|NCT00840086|3097720|P1|Overall Study|Adverse Event|1
940158|NCT00840073|3097729|P2|Second Intervention|Missed 72 hour blood draw|1
940159|NCT00840073|3097730|P1|Second Intervention|Missed 72 hour blood draw|1
940160|NCT00840060|3097744|P2|Overall Study|Change in emotional/behavioral status|1
940161|NCT00840060|3097745|P1|Overall Study|Change in emotional/behavioral status|0
940162|NCT00840060|3097744|P2|Overall Study|Withdrawal by Subject|0
940163|NCT00840060|3097745|P1|Overall Study|Withdrawal by Subject|1
940164|NCT00840034|3097755|P2|Taper Phase|Withdrawal by Subject|1
940165|NCT00840034|3097756|P1|Taper Phase|Withdrawal by Subject|1
940166|NCT00840034|3097755|P2|Taper Phase|Lost to Follow-up|1
940167|NCT00840034|3097756|P1|Taper Phase|Lost to Follow-up|1
940168|NCT00840034|3097755|P2|Taper Phase|Adverse Event|0
940169|NCT00840034|3097756|P1|Taper Phase|Adverse Event|1
940170|NCT00840034|3097755|P2|Acute Treatment Phase|Withdrawal by Subject|11
940171|NCT00840034|3097756|P1|Acute Treatment Phase|Withdrawal by Subject|6
940172|NCT00840034|3097755|P2|Acute Treatment Phase|Protocol Violation|4
940173|NCT00840034|3097756|P1|Acute Treatment Phase|Protocol Violation|2
940174|NCT00840034|3097755|P2|Acute Treatment Phase|Physician Decision|1
940175|NCT00840034|3097756|P1|Acute Treatment Phase|Physician Decision|0
940176|NCT00840034|3097755|P2|Acute Treatment Phase|Lost to Follow-up|12
940177|NCT00840034|3097756|P1|Acute Treatment Phase|Lost to Follow-up|5
940178|NCT00840034|3097755|P2|Acute Treatment Phase|Lack of Efficacy|0
940179|NCT00840034|3097756|P1|Acute Treatment Phase|Lack of Efficacy|2
940180|NCT00840034|3097755|P2|Acute Treatment Phase|Adverse Event|8
940181|NCT00840034|3097756|P1|Acute Treatment Phase|Adverse Event|6
940182|NCT00839956|3097809|P1|Overall Study|Withdrawal by Subject|3
940183|NCT00839956|3097809|P1|Overall Study|Physician Decision|1
940184|NCT00839956|3097809|P1|Overall Study|Lack of Efficacy|6
940185|NCT00839956|3097809|P1|Overall Study|Adverse Event|2
940186|NCT00839917|3097829|P2|Overall Study|Did not receive vaccine|1
940187|NCT00839917|3097830|P1|Overall Study|Did not receive vaccine|0
940188|NCT00839917|3097829|P2|Overall Study|Lost to Follow-up|0
940189|NCT00839917|3097830|P1|Overall Study|Lost to Follow-up|1
940190|NCT00839800|3097868|P2|Overall Study|Severe Non-Compliance to Protocol|7
940191|NCT00839800|3097869|P1|Overall Study|Severe Non-Compliance to Protocol|7
940192|NCT00839800|3097868|P2|Overall Study|Not Specified|14
940193|NCT00839800|3097869|P1|Overall Study|Not Specified|8
940194|NCT00839800|3097868|P2|Overall Study|Safety Reasons|1
940195|NCT00839800|3097869|P1|Overall Study|Safety Reasons|2
940196|NCT00839800|3097868|P2|Overall Study|Study-Specific Discontinuation Criteria|13
940197|NCT00839800|3097869|P1|Overall Study|Study-Specific Discontinuation Criteria|6
940198|NCT00839800|3097868|P2|Overall Study|Incorrect Enrolment|3
940199|NCT00839800|3097869|P1|Overall Study|Incorrect Enrolment|3
940200|NCT00839800|3097868|P2|Overall Study|Withdrawal by Subject|34
940201|NCT00839800|3097869|P1|Overall Study|Withdrawal by Subject|28
940202|NCT00839800|3097868|P2|Overall Study|Lost to Follow-up|26
940203|NCT00839800|3097869|P1|Overall Study|Lost to Follow-up|31
940204|NCT00839800|3097868|P2|Overall Study|Adverse Event|12
940205|NCT00839800|3097869|P1|Overall Study|Adverse Event|8
940206|NCT00839527|3097915|P3|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
940207|NCT00839527|3097916|P2|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
940208|NCT00839527|3097917|P1|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0
940209|NCT00839527|3097915|P3|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
940210|NCT00839527|3097916|P2|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1
940211|NCT00839527|3097917|P1|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
940212|NCT00839527|3097915|P3|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
940213|NCT00839527|3097916|P2|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0
940214|NCT00839527|3097917|P1|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
940215|NCT00839527|3097915|P3|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
940216|NCT00839527|3097916|P2|Follow-up Period (FUP) (8 Weeks)|Site Closed|1
940217|NCT00839527|3097917|P1|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
940218|NCT00839527|3097915|P3|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
940219|NCT00839527|3097916|P2|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
940220|NCT00839527|3097917|P1|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1
940221|NCT00839527|3097915|P3|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
940222|NCT00839527|3097916|P2|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
940223|NCT00839527|3097917|P1|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1
940224|NCT00839527|3097915|P3|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5
940225|NCT00839527|3097916|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10
940226|NCT00839527|3097917|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3
940227|NCT00839527|3097915|P3|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
940228|NCT00839527|3097916|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
940229|NCT00839527|3097917|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
940230|NCT00839527|3097915|P3|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19
940231|NCT00839527|3097916|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21
940232|NCT00839527|3097917|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12
940233|NCT00839527|3097915|P3|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29
940234|NCT00839527|3097916|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20
940235|NCT00839527|3097917|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8
940236|NCT00839527|3097915|P3|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5
940237|NCT00839527|3097916|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
940238|NCT00839527|3097917|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
940239|NCT00839527|3097915|P3|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
940240|NCT00839527|3097916|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2
940241|NCT00839527|3097917|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
940242|NCT00839527|3097915|P3|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1
940243|NCT00839527|3097916|P2|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
940244|NCT00839527|3097917|P1|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
940245|NCT00839527|3097915|P3|Treatment Period (TP) (156 Weeks)|Site Closed|0
940246|NCT00839527|3097916|P2|Treatment Period (TP) (156 Weeks)|Site Closed|2
940247|NCT00839527|3097917|P1|Treatment Period (TP) (156 Weeks)|Site Closed|1
940248|NCT00839527|3097915|P3|Treatment Period (TP) (156 Weeks)|Pregnancy|1
940249|NCT00839527|3097916|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|1
940250|NCT00839527|3097917|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|0
940251|NCT00839527|3097915|P3|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1
940252|NCT00839527|3097916|P2|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
940253|NCT00839527|3097917|P1|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
940254|NCT00839527|3097915|P3|Treatment Period (TP) (156 Weeks)|Missing|0
940255|NCT00839527|3097916|P2|Treatment Period (TP) (156 Weeks)|Missing|1
940256|NCT00839527|3097917|P1|Treatment Period (TP) (156 Weeks)|Missing|0
940257|NCT00839527|3097915|P3|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5
940258|NCT00839527|3097916|P2|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8
940259|NCT00839527|3097917|P1|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3
940260|NCT00839527|3097915|P3|Treatment Period (TP) (156 Weeks)|Physician Decision|1
940261|NCT00839527|3097916|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|6
940262|NCT00839527|3097917|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|1
940263|NCT00839527|3097915|P3|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64
940264|NCT00839527|3097916|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46
940265|NCT00839527|3097917|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32
940266|NCT00839527|3097915|P3|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
940267|NCT00839527|3097916|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12
940268|NCT00839527|3097917|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3
940269|NCT00839527|3097915|P3|Treatment Period (TP) (156 Weeks)|Noncompliance|16
940270|NCT00839527|3097916|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|6
940271|NCT00839527|3097917|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|5
940272|NCT00839527|3097915|P3|Treatment Period (TP) (156 Weeks)|Protocol Violation|1
940273|NCT00839527|3097916|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|7
940274|NCT00839527|3097917|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|4
940275|NCT00839527|3097915|P3|Treatment Period (TP) (156 Weeks)|Adverse Event|22
940276|NCT00839527|3097916|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|29
940277|NCT00839527|3097917|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|11
940278|NCT00839436|3097952|P3|Overall Study|Study drug no longer available|1
940279|NCT00839436|3097953|P2|Overall Study|Study drug no longer available|0
940280|NCT00839436|3097954|P1|Overall Study|Study drug no longer available|0
940281|NCT00839436|3097952|P3|Overall Study|Withdrawal by Subject|0
940282|NCT00839436|3097953|P2|Overall Study|Withdrawal by Subject|1
940283|NCT00839436|3097954|P1|Overall Study|Withdrawal by Subject|0
940284|NCT00839436|3097952|P3|Overall Study|Developed exclusionary condition|0
940285|NCT00839436|3097953|P2|Overall Study|Developed exclusionary condition|0
940286|NCT00839436|3097954|P1|Overall Study|Developed exclusionary condition|1
940287|NCT00839423|3097966|P4|Overall Study|Administrative or other reasons|0
940288|NCT00839423|3097967|P3|Overall Study|Administrative or other reasons|1
940289|NCT00839423|3097968|P2|Overall Study|Administrative or other reasons|0
940290|NCT00839423|3097969|P1|Overall Study|Administrative or other reasons|3
940291|NCT00839423|3097966|P4|Overall Study|Lost to Follow-up|0
940292|NCT00839423|3097967|P3|Overall Study|Lost to Follow-up|1
940293|NCT00839423|3097968|P2|Overall Study|Lost to Follow-up|0
940294|NCT00839423|3097969|P1|Overall Study|Lost to Follow-up|1
940295|NCT00839423|3097966|P4|Overall Study|Withdrawal of consent|1
940296|NCT00839423|3097967|P3|Overall Study|Withdrawal of consent|4
940297|NCT00839423|3097968|P2|Overall Study|Withdrawal of consent|0
940298|NCT00839423|3097969|P1|Overall Study|Withdrawal of consent|4
940299|NCT00839423|3097966|P4|Overall Study|Protocol Violation|0
940300|NCT00839423|3097967|P3|Overall Study|Protocol Violation|2
940301|NCT00839423|3097968|P2|Overall Study|Protocol Violation|1
940302|NCT00839423|3097969|P1|Overall Study|Protocol Violation|0
940303|NCT00839423|3097966|P4|Overall Study|Non-compliance|1
940304|NCT00839423|3097967|P3|Overall Study|Non-compliance|0
940305|NCT00839423|3097968|P2|Overall Study|Non-compliance|0
940306|NCT00839423|3097969|P1|Overall Study|Non-compliance|0
940307|NCT00839423|3097966|P4|Overall Study|Lack of Efficacy|2
940308|NCT00839423|3097967|P3|Overall Study|Lack of Efficacy|3
940309|NCT00839423|3097968|P2|Overall Study|Lack of Efficacy|6
940310|NCT00839423|3097969|P1|Overall Study|Lack of Efficacy|6
940311|NCT00839423|3097966|P4|Overall Study|Adverse Event|16
940312|NCT00839423|3097967|P3|Overall Study|Adverse Event|7
940313|NCT00839423|3097968|P2|Overall Study|Adverse Event|3
940314|NCT00839423|3097969|P1|Overall Study|Adverse Event|4
940315|NCT00839332|3098010|P3|Phase 2|Lost to Follow-up|1
940316|NCT00839332|3098011|P2|Phase 2|Lost to Follow-up|0
940317|NCT00839332|3098012|P1|Phase 2|Lost to Follow-up|0
940318|NCT00839332|3098010|P3|Phase 2|Physician Decision|1
940319|NCT00839332|3098011|P2|Phase 2|Physician Decision|4
940320|NCT00839332|3098012|P1|Phase 2|Physician Decision|0
940321|NCT00839332|3098010|P3|Phase 2|Withdrawal by Subject|8
940322|NCT00839332|3098011|P2|Phase 2|Withdrawal by Subject|5
940323|NCT00839332|3098012|P1|Phase 2|Withdrawal by Subject|0
940324|NCT00839332|3098010|P3|Phase 2|Death|2
940325|NCT00839332|3098011|P2|Phase 2|Death|4
940326|NCT00839332|3098012|P1|Phase 2|Death|0
940327|NCT00839332|3098010|P3|Phase 2|Adverse Event|6
940328|NCT00839332|3098011|P2|Phase 2|Adverse Event|8
940329|NCT00839332|3098012|P1|Phase 2|Adverse Event|0
940330|NCT00839332|3098010|P3|Phase 2|Disease Progression|21
940331|NCT00839332|3098011|P2|Phase 2|Disease Progression|46
940332|NCT00839332|3098012|P1|Phase 2|Disease Progression|0
940333|NCT00839332|3098010|P3|Phase 2|Protocol Violation|0
940334|NCT00839332|3098011|P2|Phase 2|Protocol Violation|1
940335|NCT00839332|3098012|P1|Phase 2|Protocol Violation|0
940336|NCT00839332|3098010|P3|Phase 1|Physician Decision|0
940337|NCT00839332|3098011|P2|Phase 1|Physician Decision|0
940338|NCT00839332|3098012|P1|Phase 1|Physician Decision|2
940339|NCT00839332|3098010|P3|Phase 1|Withdrawal by Subject|0
940340|NCT00839332|3098011|P2|Phase 1|Withdrawal by Subject|0
940341|NCT00839332|3098012|P1|Phase 1|Withdrawal by Subject|4
940342|NCT00839332|3098010|P3|Phase 1|Adverse Event|0
940343|NCT00839332|3098011|P2|Phase 1|Adverse Event|0
940344|NCT00839332|3098012|P1|Phase 1|Adverse Event|6
940345|NCT00839332|3098010|P3|Phase 1|Disease Progression|0
940346|NCT00839332|3098011|P2|Phase 1|Disease Progression|0
940347|NCT00839332|3098012|P1|Phase 1|Disease Progression|38
940348|NCT00839306|3098073|P2|Overall Study|Not specified|18
940349|NCT00839306|3098074|P1|Overall Study|Not specified|6
940350|NCT00839306|3098073|P2|Overall Study|Lack of Efficacy|4
940351|NCT00839306|3098074|P1|Overall Study|Lack of Efficacy|5
940352|NCT00839306|3098073|P2|Overall Study|Withdrawal by Subject|7
940353|NCT00839306|3098074|P1|Overall Study|Withdrawal by Subject|5
940354|NCT00839306|3098073|P2|Overall Study|Lost to Follow-up|9
940355|NCT00839306|3098074|P1|Overall Study|Lost to Follow-up|6
940356|NCT00839306|3098073|P2|Overall Study|Adverse Event|5
940357|NCT00839306|3098074|P1|Overall Study|Adverse Event|3
940358|NCT00839098|3098172|P3|Overall Study|Withdrawal by Subject|7
940359|NCT00839098|3098173|P2|Overall Study|Withdrawal by Subject|1
940360|NCT00839098|3098174|P1|Overall Study|Withdrawal by Subject|2
940361|NCT00839072|3098200|P2|Second Intervention Period|Withdrawal by Subject|0
940362|NCT00839072|3098201|P1|Second Intervention Period|Withdrawal by Subject|1
940363|NCT00839072|3098200|P2|First Intervention Period|Adverse Event|1
940364|NCT00839072|3098201|P1|First Intervention Period|Adverse Event|1
940365|NCT00839072|3098200|P2|First Intervention Period|Withdrawal by Subject|0
940366|NCT00839072|3098201|P1|First Intervention Period|Withdrawal by Subject|1
940367|NCT00838929|3098245|P3|Overall Study|Disease progression|1
940368|NCT00838929|3098246|P2|Overall Study|Disease progression|2
940369|NCT00838929|3098247|P1|Overall Study|Disease progression|0
940370|NCT00838929|3098245|P3|Overall Study|Protocol Violation|0
940371|NCT00838929|3098246|P2|Overall Study|Protocol Violation|1
940372|NCT00838929|3098247|P1|Overall Study|Protocol Violation|0
940373|NCT00838916|3098255|P2|Follow-up Period (8 Weeks)|Missing|0
940374|NCT00838916|3098256|P1|Follow-up Period (8 Weeks)|Missing|3
940375|NCT00838916|3098255|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|0
940376|NCT00838916|3098256|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
940377|NCT00838916|3098255|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
940378|NCT00838916|3098256|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2
940379|NCT00838916|3098255|P2|Follow-up Period (8 Weeks)|Physician Decision|0
940380|NCT00838916|3098256|P1|Follow-up Period (8 Weeks)|Physician Decision|2
940381|NCT00838916|3098255|P2|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12
940382|NCT00838916|3098256|P1|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26
940383|NCT00838916|3098255|P2|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
940384|NCT00838916|3098256|P1|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
940385|NCT00838916|3098255|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|22
940386|NCT00838916|3098256|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|38
940387|NCT00838916|3098255|P2|Follow-up Period (8 Weeks)|Noncompliance|5
940388|NCT00838916|3098256|P1|Follow-up Period (8 Weeks)|Noncompliance|6
940389|NCT00838916|3098255|P2|Follow-up Period (8 Weeks)|Adverse Event|5
940390|NCT00838916|3098256|P1|Follow-up Period (8 Weeks)|Adverse Event|10
940391|NCT00838916|3098255|P2|Treatment Period (156 Weeks)|Pregnancy|0
940392|NCT00838916|3098256|P1|Treatment Period (156 Weeks)|Pregnancy|2
940393|NCT00838916|3098255|P2|Treatment Period (156 Weeks)|Missing|1
940394|NCT00838916|3098256|P1|Treatment Period (156 Weeks)|Missing|3
940395|NCT00838916|3098255|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0
940396|NCT00838916|3098256|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1
940397|NCT00838916|3098255|P2|Treatment Period (156 Weeks)|Physician Decision|1
940398|NCT00838916|3098256|P1|Treatment Period (156 Weeks)|Physician Decision|6
940399|NCT00838916|3098255|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|29
940400|NCT00838916|3098256|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|81
940401|NCT00838916|3098255|P2|Treatment Period (156 Weeks)|Lost to Follow-up|18
940402|NCT00838916|3098256|P1|Treatment Period (156 Weeks)|Lost to Follow-up|19
940403|NCT00838916|3098255|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
940404|NCT00838916|3098256|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
940405|NCT00838916|3098255|P2|Treatment Period (156 Weeks)|Noncompliance|14
940406|NCT00838916|3098256|P1|Treatment Period (156 Weeks)|Noncompliance|21
940407|NCT00838916|3098255|P2|Treatment Period (156 Weeks)|Protocol Violation|3
940408|NCT00838916|3098256|P1|Treatment Period (156 Weeks)|Protocol Violation|12
940409|NCT00838916|3098255|P2|Treatment Period (156 Weeks)|Adverse Event|11
940410|NCT00838916|3098256|P1|Treatment Period (156 Weeks)|Adverse Event|50
940411|NCT00838903|3098285|P4|Follow-up Period (8 Weeks)|Missing|1
940412|NCT00838903|3098286|P3|Follow-up Period (8 Weeks)|Missing|1
940413|NCT00838903|3098287|P2|Follow-up Period (8 Weeks)|Missing|2
940414|NCT00838903|3098288|P1|Follow-up Period (8 Weeks)|Missing|1
940415|NCT00838903|3098285|P4|Follow-up Period (8 Weeks)|Subject Moved out of Town|1
940416|NCT00838903|3098286|P3|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
940417|NCT00838903|3098287|P2|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
940418|NCT00838903|3098288|P1|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
940419|NCT00838903|3098285|P4|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
940420|NCT00838903|3098286|P3|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
940421|NCT00838903|3098287|P2|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1
940422|NCT00838903|3098288|P1|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
940423|NCT00838903|3098285|P4|Follow-up Period (8 Weeks)|ICF Withdrawn|0
940424|NCT00838903|3098286|P3|Follow-up Period (8 Weeks)|ICF Withdrawn|0
940425|NCT00838903|3098287|P2|Follow-up Period (8 Weeks)|ICF Withdrawn|1
940426|NCT00838903|3098288|P1|Follow-up Period (8 Weeks)|ICF Withdrawn|0
940427|NCT00838903|3098285|P4|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
940428|NCT00838903|3098286|P3|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6
940429|NCT00838903|3098287|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
940430|NCT00838903|3098288|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3
940431|NCT00838903|3098285|P4|Follow-up Period (8 Weeks)|Physician Decision|1
940432|NCT00838903|3098286|P3|Follow-up Period (8 Weeks)|Physician Decision|1
940433|NCT00838903|3098287|P2|Follow-up Period (8 Weeks)|Physician Decision|1
940434|NCT00838903|3098288|P1|Follow-up Period (8 Weeks)|Physician Decision|1
940435|NCT00838903|3098285|P4|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
940436|NCT00838903|3098286|P3|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
940437|NCT00838903|3098287|P2|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13
940438|NCT00838903|3098288|P1|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8
940439|NCT00838903|3098285|P4|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
940440|NCT00838903|3098286|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12
940441|NCT00838903|3098287|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
940442|NCT00838903|3098288|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5
940443|NCT00838903|3098285|P4|Follow-up Period (8 Weeks)|Lost to Follow-up|24
940444|NCT00838903|3098286|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|22
940445|NCT00838903|3098287|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|28
940446|NCT00838903|3098288|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|6
940447|NCT00838903|3098285|P4|Follow-up Period (8 Weeks)|Noncompliance|5
940448|NCT00838903|3098286|P3|Follow-up Period (8 Weeks)|Noncompliance|5
940449|NCT00838903|3098287|P2|Follow-up Period (8 Weeks)|Noncompliance|8
940450|NCT00838903|3098288|P1|Follow-up Period (8 Weeks)|Noncompliance|2
940451|NCT00838903|3098285|P4|Follow-up Period (8 Weeks)|Adverse Event|1
940452|NCT00838903|3098286|P3|Follow-up Period (8 Weeks)|Adverse Event|3
940453|NCT00838903|3098287|P2|Follow-up Period (8 Weeks)|Adverse Event|0
940454|NCT00838903|3098288|P1|Follow-up Period (8 Weeks)|Adverse Event|0
940455|NCT00838903|3098285|P4|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
940456|NCT00838903|3098286|P3|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
940457|NCT00838903|3098287|P2|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
940458|NCT00838903|3098288|P1|Treatment Period (156 Weeks)|Missing Active Treatment Status|1
940459|NCT00838903|3098285|P4|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
940460|NCT00838903|3098286|P3|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
940461|NCT00838903|3098287|P2|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
940462|NCT00838903|3098288|P1|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
940463|NCT00838903|3098285|P4|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
940464|NCT00838903|3098286|P3|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
940465|NCT00838903|3098287|P2|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
940466|NCT00838903|3098288|P1|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1
940467|NCT00838903|3098285|P4|Treatment Period (156 Weeks)|Site closed|0
940468|NCT00838903|3098286|P3|Treatment Period (156 Weeks)|Site closed|1
940469|NCT00838903|3098287|P2|Treatment Period (156 Weeks)|Site closed|0
940470|NCT00838903|3098288|P1|Treatment Period (156 Weeks)|Site closed|0
940471|NCT00838903|3098285|P4|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
940472|NCT00838903|3098286|P3|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1
940473|NCT00838903|3098287|P2|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
940474|NCT00838903|3098288|P1|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
940475|NCT00838903|3098285|P4|Treatment Period (156 Weeks)|Pregnancy|0
940476|NCT00838903|3098286|P3|Treatment Period (156 Weeks)|Pregnancy|1
940477|NCT00838903|3098287|P2|Treatment Period (156 Weeks)|Pregnancy|0
940478|NCT00838903|3098288|P1|Treatment Period (156 Weeks)|Pregnancy|0
940479|NCT00838903|3098285|P4|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
940480|NCT00838903|3098286|P3|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
940481|NCT00838903|3098287|P2|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
940482|NCT00838903|3098288|P1|Treatment Period (156 Weeks)|Poor Therapeutic Response|1
940483|NCT00838903|3098285|P4|Treatment Period (156 Weeks)|Poor Glycemic Control|1
940484|NCT00838903|3098286|P3|Treatment Period (156 Weeks)|Poor Glycemic Control|0
940485|NCT00838903|3098287|P2|Treatment Period (156 Weeks)|Poor Glycemic Control|0
940486|NCT00838903|3098288|P1|Treatment Period (156 Weeks)|Poor Glycemic Control|0
940487|NCT00838903|3098285|P4|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
940488|NCT00838903|3098286|P3|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
940489|NCT00838903|3098287|P2|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1
940490|NCT00838903|3098288|P1|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
940491|NCT00838903|3098285|P4|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4
940492|NCT00838903|3098286|P3|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
940493|NCT00838903|3098287|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
940494|NCT00838903|3098288|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3
940495|NCT00838903|3098285|P4|Treatment Period (156 Weeks)|Physician Decision|2
940496|NCT00838903|3098286|P3|Treatment Period (156 Weeks)|Physician Decision|1
940497|NCT00838903|3098287|P2|Treatment Period (156 Weeks)|Physician Decision|2
940498|NCT00838903|3098288|P1|Treatment Period (156 Weeks)|Physician Decision|1
940499|NCT00838903|3098285|P4|Treatment Period (156 Weeks)|Withdrawal by Subject|53
940500|NCT00838903|3098286|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|56
940501|NCT00838903|3098287|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|55
940502|NCT00838903|3098288|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|20
940503|NCT00838903|3098285|P4|Treatment Period (156 Weeks)|Lost to Follow-up|13
940504|NCT00838903|3098286|P3|Treatment Period (156 Weeks)|Lost to Follow-up|15
940505|NCT00838903|3098287|P2|Treatment Period (156 Weeks)|Lost to Follow-up|16
940506|NCT00838903|3098288|P1|Treatment Period (156 Weeks)|Lost to Follow-up|4
940507|NCT00838903|3098285|P4|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
940508|NCT00838903|3098286|P3|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
940509|NCT00838903|3098287|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
940510|NCT00838903|3098288|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
940511|NCT00838903|3098285|P4|Treatment Period (156 Weeks)|Noncompliance|6
940512|NCT00838903|3098286|P3|Treatment Period (156 Weeks)|Noncompliance|12
940513|NCT00838903|3098287|P2|Treatment Period (156 Weeks)|Noncompliance|13
940514|NCT00838903|3098288|P1|Treatment Period (156 Weeks)|Noncompliance|9
940515|NCT00838903|3098285|P4|Treatment Period (156 Weeks)|Protocol Violation|5
940516|NCT00838903|3098286|P3|Treatment Period (156 Weeks)|Protocol Violation|6
940517|NCT00838903|3098287|P2|Treatment Period (156 Weeks)|Protocol Violation|6
940518|NCT00838903|3098288|P1|Treatment Period (156 Weeks)|Protocol Violation|1
940519|NCT00838903|3098285|P4|Treatment Period (156 Weeks)|Adverse Event|25
940520|NCT00838903|3098286|P3|Treatment Period (156 Weeks)|Adverse Event|17
940521|NCT00838903|3098287|P2|Treatment Period (156 Weeks)|Adverse Event|13
940522|NCT00838903|3098288|P1|Treatment Period (156 Weeks)|Adverse Event|5
940523|NCT00838682|3098343|P2|Overall Study|Withdrawal by Subject|1
940524|NCT00838682|3098344|P1|Overall Study|Withdrawal by Subject|0
940525|NCT00838682|3098343|P2|Overall Study|Protocol Violation|1
940526|NCT00838682|3098344|P1|Overall Study|Protocol Violation|0
940527|NCT00838682|3098343|P2|Overall Study|detection of exclusion criteria|3
940528|NCT00838682|3098344|P1|Overall Study|detection of exclusion criteria|4
940529|NCT00838682|3098343|P2|Overall Study|Lost to Follow-up|14
940530|NCT00838682|3098344|P1|Overall Study|Lost to Follow-up|21
940531|NCT00838630|3098362|P2|Washout: 7 Days|Protocol Violation|0
940532|NCT00838630|3098363|P1|Washout: 7 Days|Protocol Violation|1
940533|NCT00838630|3098362|P2|First Intervention|Adverse Event|0
940534|NCT00838630|3098363|P1|First Intervention|Adverse Event|1
940535|NCT00838578|3098371|P1|Overall Study|Protocol Violation|2
940536|NCT00838565|3098385|P6|Overall Study|Randomized but not Treated|0
940537|NCT00838565|3098386|P5|Overall Study|Randomized but not Treated|0
940538|NCT00838565|3098387|P4|Overall Study|Randomized but not Treated|0
940539|NCT00838565|3098388|P3|Overall Study|Randomized but not Treated|0
940540|NCT00838565|3098389|P2|Overall Study|Randomized but not Treated|1
940541|NCT00838565|3098390|P1|Overall Study|Randomized but not Treated|0
940542|NCT00838565|3098385|P6|Overall Study|Other|0
940543|NCT00838565|3098386|P5|Overall Study|Other|0
940544|NCT00838565|3098387|P4|Overall Study|Other|0
940545|NCT00838565|3098388|P3|Overall Study|Other|0
940546|NCT00838565|3098389|P2|Overall Study|Other|2
940547|NCT00838565|3098390|P1|Overall Study|Other|0
940548|NCT00838565|3098385|P6|Overall Study|Withdrawal by Subject|2
940549|NCT00838565|3098386|P5|Overall Study|Withdrawal by Subject|0
940550|NCT00838565|3098387|P4|Overall Study|Withdrawal by Subject|0
940551|NCT00838565|3098388|P3|Overall Study|Withdrawal by Subject|1
940552|NCT00838565|3098389|P2|Overall Study|Withdrawal by Subject|0
940553|NCT00838565|3098390|P1|Overall Study|Withdrawal by Subject|0
940554|NCT00838539|3098495|P12|Overall Study|Symptomatic Deterioration|0
940555|NCT00838539|3098496|P11|Overall Study|Symptomatic Deterioration|0
940556|NCT00838539|3098497|P10|Overall Study|Symptomatic Deterioration|1
940557|NCT00838539|3098498|P9|Overall Study|Symptomatic Deterioration|0
940558|NCT00838539|3098499|P8|Overall Study|Symptomatic Deterioration|0
940559|NCT00838539|3098500|P7|Overall Study|Symptomatic Deterioration|0
940560|NCT00838539|3098501|P6|Overall Study|Symptomatic Deterioration|1
940561|NCT00838539|3098502|P5|Overall Study|Symptomatic Deterioration|0
940562|NCT00838539|3098503|P4|Overall Study|Symptomatic Deterioration|1
940563|NCT00838539|3098504|P3|Overall Study|Symptomatic Deterioration|1
940564|NCT00838539|3098505|P2|Overall Study|Symptomatic Deterioration|0
940565|NCT00838539|3098506|P1|Overall Study|Symptomatic Deterioration|0
940566|NCT00838539|3098495|P12|Overall Study|Clinical Progression|0
940567|NCT00838539|3098496|P11|Overall Study|Clinical Progression|0
940568|NCT00838539|3098497|P10|Overall Study|Clinical Progression|0
940569|NCT00838539|3098498|P9|Overall Study|Clinical Progression|0
940570|NCT00838539|3098499|P8|Overall Study|Clinical Progression|0
940571|NCT00838539|3098500|P7|Overall Study|Clinical Progression|1
940572|NCT00838539|3098501|P6|Overall Study|Clinical Progression|0
940573|NCT00838539|3098502|P5|Overall Study|Clinical Progression|0
940574|NCT00838539|3098503|P4|Overall Study|Clinical Progression|0
940575|NCT00838539|3098504|P3|Overall Study|Clinical Progression|0
940576|NCT00838539|3098505|P2|Overall Study|Clinical Progression|0
940577|NCT00838539|3098506|P1|Overall Study|Clinical Progression|0
940578|NCT00838539|3098495|P12|Overall Study|Physician Decision|0
940579|NCT00838539|3098496|P11|Overall Study|Physician Decision|0
940580|NCT00838539|3098497|P10|Overall Study|Physician Decision|0
940581|NCT00838539|3098498|P9|Overall Study|Physician Decision|1
940582|NCT00838539|3098499|P8|Overall Study|Physician Decision|0
940583|NCT00838539|3098500|P7|Overall Study|Physician Decision|0
940584|NCT00838539|3098501|P6|Overall Study|Physician Decision|0
940585|NCT00838539|3098502|P5|Overall Study|Physician Decision|0
940586|NCT00838539|3098503|P4|Overall Study|Physician Decision|0
940587|NCT00838539|3098504|P3|Overall Study|Physician Decision|0
940588|NCT00838539|3098505|P2|Overall Study|Physician Decision|0
940589|NCT00838539|3098506|P1|Overall Study|Physician Decision|0
940590|NCT00838539|3098495|P12|Overall Study|Death|0
940591|NCT00838539|3098496|P11|Overall Study|Death|0
940592|NCT00838539|3098497|P10|Overall Study|Death|0
940593|NCT00838539|3098498|P9|Overall Study|Death|0
940594|NCT00838539|3098499|P8|Overall Study|Death|0
940595|NCT00838539|3098500|P7|Overall Study|Death|1
940596|NCT00838539|3098501|P6|Overall Study|Death|0
940597|NCT00838539|3098502|P5|Overall Study|Death|0
940598|NCT00838539|3098503|P4|Overall Study|Death|0
940599|NCT00838539|3098504|P3|Overall Study|Death|0
940600|NCT00838539|3098505|P2|Overall Study|Death|0
940601|NCT00838539|3098506|P1|Overall Study|Death|0
940602|NCT00838539|3098495|P12|Overall Study|Withdrawal by Subject|0
940603|NCT00838539|3098496|P11|Overall Study|Withdrawal by Subject|2
940604|NCT00838539|3098497|P10|Overall Study|Withdrawal by Subject|1
940605|NCT00838539|3098498|P9|Overall Study|Withdrawal by Subject|0
940606|NCT00838539|3098499|P8|Overall Study|Withdrawal by Subject|0
940607|NCT00838539|3098500|P7|Overall Study|Withdrawal by Subject|0
940608|NCT00838539|3098501|P6|Overall Study|Withdrawal by Subject|0
940609|NCT00838539|3098502|P5|Overall Study|Withdrawal by Subject|0
940610|NCT00838539|3098503|P4|Overall Study|Withdrawal by Subject|0
940611|NCT00838539|3098504|P3|Overall Study|Withdrawal by Subject|0
940612|NCT00838539|3098505|P2|Overall Study|Withdrawal by Subject|1
940613|NCT00838539|3098506|P1|Overall Study|Withdrawal by Subject|0
940614|NCT00838539|3098495|P12|Overall Study|Adverse Event|0
940615|NCT00838539|3098496|P11|Overall Study|Adverse Event|2
940616|NCT00838539|3098497|P10|Overall Study|Adverse Event|1
940617|NCT00838539|3098498|P9|Overall Study|Adverse Event|0
940618|NCT00838539|3098499|P8|Overall Study|Adverse Event|2
940619|NCT00838539|3098500|P7|Overall Study|Adverse Event|0
940620|NCT00838539|3098501|P6|Overall Study|Adverse Event|1
940621|NCT00838539|3098502|P5|Overall Study|Adverse Event|2
940622|NCT00838539|3098503|P4|Overall Study|Adverse Event|1
940623|NCT00838539|3098504|P3|Overall Study|Adverse Event|1
940624|NCT00838539|3098505|P2|Overall Study|Adverse Event|1
940625|NCT00838539|3098506|P1|Overall Study|Adverse Event|1
940626|NCT00838539|3098495|P12|Overall Study|Disease Progression|4
940627|NCT00838539|3098496|P11|Overall Study|Disease Progression|1
940628|NCT00838539|3098497|P10|Overall Study|Disease Progression|5
940629|NCT00838539|3098498|P9|Overall Study|Disease Progression|4
940630|NCT00838539|3098499|P8|Overall Study|Disease Progression|4
940631|NCT00838539|3098500|P7|Overall Study|Disease Progression|3
940632|NCT00838539|3098501|P6|Overall Study|Disease Progression|2
940633|NCT00838539|3098502|P5|Overall Study|Disease Progression|4
940634|NCT00838539|3098503|P4|Overall Study|Disease Progression|2
940635|NCT00838539|3098504|P3|Overall Study|Disease Progression|3
940636|NCT00838539|3098505|P2|Overall Study|Disease Progression|4
940637|NCT00838539|3098506|P1|Overall Study|Disease Progression|2
940638|NCT00838526|3098556|P2|Overall Study|Not specified|7
940639|NCT00838526|3098557|P1|Overall Study|Not specified|11
940640|NCT00838526|3098556|P2|Overall Study|Lack of Efficacy|3
940641|NCT00838526|3098557|P1|Overall Study|Lack of Efficacy|2
940642|NCT00838526|3098556|P2|Overall Study|Withdrawal by Subject|5
940643|NCT00838526|3098557|P1|Overall Study|Withdrawal by Subject|4
940644|NCT00838526|3098556|P2|Overall Study|Lost to Follow-up|12
940645|NCT00838526|3098557|P1|Overall Study|Lost to Follow-up|4
940646|NCT00838526|3098556|P2|Overall Study|Adverse Event|12
940647|NCT00838526|3098557|P1|Overall Study|Adverse Event|3
940648|NCT00838513|3098565|P1|Post Treatment Period (Patients Who Disc|Death|1
940649|NCT00838513|3098565|P1|Extension Treatment Period|Death|1
940650|NCT00838513|3098565|P1|Screening Period|Screen Failure|3
940651|NCT00838331|3098581|P1|Aged Blood Transfusion|Withdrawal by Subject|9
940652|NCT00838279|3098587|P2|Washout|Withdrawal by Subject|1
940653|NCT00838279|3098588|P1|Washout|Withdrawal by Subject|0
940654|NCT00838279|3098587|P2|Washout|Protocol Violation|0
940655|NCT00838279|3098588|P1|Washout|Protocol Violation|1
940656|NCT00838201|3098598|P2|Overall Study|Death|13
940657|NCT00838201|3098599|P1|Overall Study|Death|11
940658|NCT00838201|3098598|P2|Overall Study|Adverse Event|9
940659|NCT00838201|3098599|P1|Overall Study|Adverse Event|5
940660|NCT00838201|3098598|P2|Overall Study|Lost to Follow-up|3
940661|NCT00838201|3098599|P1|Overall Study|Lost to Follow-up|4
940662|NCT00838201|3098598|P2|Overall Study|Consent withdrawn|19
940663|NCT00838201|3098599|P1|Overall Study|Consent withdrawn|16
940664|NCT00838201|3098598|P2|Overall Study|Disease progression|3
940665|NCT00838201|3098599|P1|Overall Study|Disease progression|3
940666|NCT00838201|3098598|P2|Overall Study|Administrative decision|2
940667|NCT00838201|3098599|P1|Overall Study|Administrative decision|1
940668|NCT00838201|3098598|P2|Overall Study|Noncompliance|1
940669|NCT00838201|3098599|P1|Overall Study|Noncompliance|0
940670|NCT00838201|3098598|P2|Overall Study|Investigator decision, or other reasons|3
940671|NCT00838201|3098599|P1|Overall Study|Investigator decision, or other reasons|2
940672|NCT00838110|3098667|P4|Overall Study|Randomized but not treated|0
940673|NCT00838110|3098668|P3|Overall Study|Randomized but not treated|0
940674|NCT00838110|3098669|P2|Overall Study|Randomized but not treated|1
940675|NCT00838110|3098670|P1|Overall Study|Randomized but not treated|0
940676|NCT00838110|3098667|P4|Overall Study|Did not meet eligibility criteria|2
940677|NCT00838110|3098668|P3|Overall Study|Did not meet eligibility criteria|1
940678|NCT00838110|3098669|P2|Overall Study|Did not meet eligibility criteria|0
940679|NCT00838110|3098670|P1|Overall Study|Did not meet eligibility criteria|0
940680|NCT00838110|3098667|P4|Overall Study|Lost to Follow-up|0
940681|NCT00838110|3098668|P3|Overall Study|Lost to Follow-up|0
940682|NCT00838110|3098669|P2|Overall Study|Lost to Follow-up|0
940683|NCT00838110|3098670|P1|Overall Study|Lost to Follow-up|3
940684|NCT00838110|3098667|P4|Overall Study|Protocol Violation|1
940685|NCT00838110|3098668|P3|Overall Study|Protocol Violation|1
940686|NCT00838110|3098669|P2|Overall Study|Protocol Violation|2
940687|NCT00838110|3098670|P1|Overall Study|Protocol Violation|0
940688|NCT00838110|3098667|P4|Overall Study|Other|2
940689|NCT00838110|3098668|P3|Overall Study|Other|3
940690|NCT00838110|3098669|P2|Overall Study|Other|3
940691|NCT00838110|3098670|P1|Overall Study|Other|3
940692|NCT00838110|3098667|P4|Overall Study|Withdrawal by Subject|4
940693|NCT00838110|3098668|P3|Overall Study|Withdrawal by Subject|3
940694|NCT00838110|3098669|P2|Overall Study|Withdrawal by Subject|6
940695|NCT00838110|3098670|P1|Overall Study|Withdrawal by Subject|5
940696|NCT00838110|3098667|P4|Overall Study|Adverse Event|7
940697|NCT00838110|3098668|P3|Overall Study|Adverse Event|8
940698|NCT00838110|3098669|P2|Overall Study|Adverse Event|10
940699|NCT00838110|3098670|P1|Overall Study|Adverse Event|11
940700|NCT00838110|3098667|P4|Overall Study|Death|2
940701|NCT00838110|3098668|P3|Overall Study|Death|1
940702|NCT00838110|3098669|P2|Overall Study|Death|0
940703|NCT00838110|3098670|P1|Overall Study|Death|0
940704|NCT00838097|3098690|P1|Overall Study|Protocol-specified criteria|142
940705|NCT00838097|3098690|P1|Overall Study|Death|6
940706|NCT00838097|3098690|P1|Overall Study|Lost to Follow-up|11
940707|NCT00838097|3098690|P1|Overall Study|Physician Decision|4
940708|NCT00838097|3098690|P1|Overall Study|Requirement for alternative therapy|2
940709|NCT00838097|3098690|P1|Overall Study|Withdrawal by Subject|3
940710|NCT00838097|3098690|P1|Overall Study|Adverse Event|2
940711|NCT00838097|3098690|P1|Overall Study|Ineligibility determined|6
940712|NCT00837967|3098698|P2|Washout Period of 7 - 14 Days|Adverse Event|0
940713|NCT00837967|3098699|P1|Washout Period of 7 - 14 Days|Adverse Event|2
940714|NCT00837876|3098725|P1|Overall Study|disease progression|24
940715|NCT00837876|3098725|P1|Overall Study|Withdrawal by Subject|3
940716|NCT00837876|3098725|P1|Overall Study|Physician Decision|1
940717|NCT00837876|3098725|P1|Overall Study|Adverse Event|7
940718|NCT00837876|3098725|P1|Overall Study|Death|2
940719|NCT00837811|3098747|P3|Overall Study|Sponsor Decision|0
940720|NCT00837811|3098748|P2|Overall Study|Sponsor Decision|2
940721|NCT00837811|3098749|P1|Overall Study|Sponsor Decision|0
940722|NCT00837811|3098747|P3|Overall Study|Withdrawal by Subject|0
940723|NCT00837811|3098748|P2|Overall Study|Withdrawal by Subject|9
940724|NCT00837811|3098749|P1|Overall Study|Withdrawal by Subject|1
940725|NCT00837811|3098747|P3|Overall Study|Physician Decision|1
940726|NCT00837811|3098748|P2|Overall Study|Physician Decision|2
940727|NCT00837811|3098749|P1|Overall Study|Physician Decision|0
940728|NCT00837811|3098747|P3|Overall Study|Lost to Follow-up|0
940729|NCT00837811|3098748|P2|Overall Study|Lost to Follow-up|3
940730|NCT00837811|3098749|P1|Overall Study|Lost to Follow-up|1
940731|NCT00837811|3098747|P3|Overall Study|Lack of Efficacy|0
940732|NCT00837811|3098748|P2|Overall Study|Lack of Efficacy|11
940733|NCT00837811|3098749|P1|Overall Study|Lack of Efficacy|0
940734|NCT00837811|3098747|P3|Overall Study|Death|0
940735|NCT00837811|3098748|P2|Overall Study|Death|1
940736|NCT00837811|3098749|P1|Overall Study|Death|1
940737|NCT00837811|3098747|P3|Overall Study|Adverse Event|0
940738|NCT00837811|3098748|P2|Overall Study|Adverse Event|6
940739|NCT00837811|3098749|P1|Overall Study|Adverse Event|4
940740|NCT00837759|3098834|P1|Overall Study|Lost to Follow-up|1
940741|NCT00837759|3098834|P1|Overall Study|Protocol Violation|3
940742|NCT00837616|3098845|P2|Overall Study|Withdrawal by Subject|1
940743|NCT00837616|3098846|P1|Overall Study|Withdrawal by Subject|0
940744|NCT00837577|3098872|P2|Open-label Period|Other Reason|1
940745|NCT00837577|3098873|P1|Open-label Period|Other Reason|1
940746|NCT00837577|3098872|P2|Open-label Period|Withdrawal by Subject|2
940747|NCT00837577|3098873|P1|Open-label Period|Withdrawal by Subject|1
940748|NCT00837577|3098872|P2|Open-label Period|Lack of Efficacy|3
940749|NCT00837577|3098873|P1|Open-label Period|Lack of Efficacy|4
940750|NCT00837577|3098872|P2|Open-label Period|Laboratory Adverse Event|1
940751|NCT00837577|3098873|P1|Open-label Period|Laboratory Adverse Event|0
940752|NCT00837577|3098872|P2|Open-label Period|Clinical Adverse Event|2
940753|NCT00837577|3098873|P1|Open-label Period|Clinical Adverse Event|2
940754|NCT00837577|3098872|P2|Double-blind Period|Withdrawal by Subject|0
940755|NCT00837577|3098873|P1|Double-blind Period|Withdrawal by Subject|1
940756|NCT00837577|3098872|P2|Double-blind Period|Clinical Adverse Event|0
940757|NCT00837577|3098873|P1|Double-blind Period|Clinical Adverse Event|1
940758|NCT00837486|3098893|P2|Long-term Follow-up Phase - Open Label|Death|0
940759|NCT00837486|3098894|P1|Long-term Follow-up Phase - Open Label|Death|1
940760|NCT00837486|3098893|P2|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0
940761|NCT00837486|3098894|P1|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2
940762|NCT00837486|3098893|P2|Long-term Follow-up Phase - Open Label|Physician Decision|0
940763|NCT00837486|3098894|P1|Long-term Follow-up Phase - Open Label|Physician Decision|2
940764|NCT00837486|3098893|P2|Blinded-treatment Phase|Physician Decision|0
940765|NCT00837486|3098894|P1|Blinded-treatment Phase|Physician Decision|1
940766|NCT00837473|3098906|P1|Overall Study|Withdrawal by Subject|2
940767|NCT00837473|3098906|P1|Overall Study|Lost to Follow-up|1
940768|NCT00837434|3098926|P2|Overall Study|Unable to obtain study drug|0
940769|NCT00837434|3098927|P1|Overall Study|Unable to obtain study drug|1
940770|NCT00837434|3098926|P2|Overall Study|Baseline assessments not done in time|0
940771|NCT00837434|3098927|P1|Overall Study|Baseline assessments not done in time|1
940772|NCT00837434|3098926|P2|Overall Study|Noncompliant|0
940773|NCT00837434|3098927|P1|Overall Study|Noncompliant|2
940774|NCT00837434|3098926|P2|Overall Study|Withdrawn by sponsor/regulatory agency|0
940775|NCT00837434|3098927|P1|Overall Study|Withdrawn by sponsor/regulatory agency|1
940776|NCT00837434|3098926|P2|Overall Study|Lost to Follow-up|1
940777|NCT00837434|3098927|P1|Overall Study|Lost to Follow-up|1
940778|NCT00837434|3098926|P2|Overall Study|Physician Decision|0
940779|NCT00837434|3098927|P1|Overall Study|Physician Decision|3
940780|NCT00837330|3098947|P2|Overall Study|Lost to Follow-up|3
940781|NCT00837330|3098948|P1|Overall Study|Lost to Follow-up|1
940782|NCT00837213|3098971|P2|Overall Study|not stated|1
940783|NCT00837213|3098972|P1|Overall Study|not stated|1
940784|NCT00837213|3098971|P2|Overall Study|Withdrawal by Subject|2
940785|NCT00837213|3098972|P1|Overall Study|Withdrawal by Subject|2
940786|NCT00837213|3098971|P2|Overall Study|Lost to Follow-up|2
940787|NCT00837213|3098972|P1|Overall Study|Lost to Follow-up|3
940788|NCT00837161|3098998|P1|Overall Study|refused hysterectomy|2
940789|NCT00837148|3099006|P1|Overall Study|Death|1
940790|NCT00837148|3099006|P1|Overall Study|Adverse Event|1
940791|NCT00836953|3099016|P1|Overall Study|Lost to Follow-up|1
940792|NCT00836953|3099016|P1|Overall Study|Withdrawal by Subject|1
940793|NCT00836927|3099027|P5|Overall Study|Withdrawal by Subject|0
940794|NCT00836927|3099028|P4|Overall Study|Withdrawal by Subject|0
940795|NCT00836927|3099029|P3|Overall Study|Withdrawal by Subject|0
940796|NCT00836927|3099030|P2|Overall Study|Withdrawal by Subject|0
940797|NCT00836927|3099031|P1|Overall Study|Withdrawal by Subject|1
940798|NCT00836927|3099027|P5|Overall Study|Study drug terminated by sponsor|0
940799|NCT00836927|3099028|P4|Overall Study|Study drug terminated by sponsor|0
940800|NCT00836927|3099029|P3|Overall Study|Study drug terminated by sponsor|1
940801|NCT00836927|3099030|P2|Overall Study|Study drug terminated by sponsor|1
940802|NCT00836927|3099031|P1|Overall Study|Study drug terminated by sponsor|0
940803|NCT00836927|3099027|P5|Overall Study|Progressive disease|1
940804|NCT00836927|3099028|P4|Overall Study|Progressive disease|1
940805|NCT00836927|3099029|P3|Overall Study|Progressive disease|0
940806|NCT00836927|3099030|P2|Overall Study|Progressive disease|0
940807|NCT00836927|3099031|P1|Overall Study|Progressive disease|2
940808|NCT00836901|3099065|P2|First Intervention|Withdrawal by Subject|0
940809|NCT00836901|3099066|P1|First Intervention|Withdrawal by Subject|1
940810|NCT00836875|3099082|P2|Overall Study|Withdrawal by Subject|1
940811|NCT00836875|3099083|P1|Overall Study|Withdrawal by Subject|0
940812|NCT00836875|3099082|P2|Overall Study|Death|2
940813|NCT00836875|3099083|P1|Overall Study|Death|3
940814|NCT00836810|3099099|P2|Overall Study|New diagnosis|0
940815|NCT00836810|3099100|P1|Overall Study|New diagnosis|1
940816|NCT00836745|3099116|P1|Overall Study|Other|2
940817|NCT00836745|3099116|P1|Overall Study|Objective progression or relapse|4
940818|NCT00836745|3099116|P1|Overall Study|Adverse Event|3
940819|NCT00836745|3099116|P1|Overall Study|Lost to Follow-up|10
940820|NCT00836745|3099116|P1|Overall Study|Death|2
940821|NCT00836706|3099130|P2|Washout: 7 Days|Withdrawal by Subject|1
940822|NCT00836706|3099131|P1|Washout: 7 Days|Withdrawal by Subject|0
940823|NCT00836693|3099141|P2|Overall Study|Lost to Follow-up|0
940824|NCT00836693|3099142|P1|Overall Study|Lost to Follow-up|1
940825|NCT00836693|3099141|P2|Overall Study|Protocol Violation|0
940826|NCT00836693|3099142|P1|Overall Study|Protocol Violation|1
940827|NCT00836693|3099141|P2|Overall Study|Withdrawal by Subject|4
940828|NCT00836693|3099142|P1|Overall Study|Withdrawal by Subject|9
940829|NCT00836693|3099141|P2|Overall Study|Physician Decision|0
940830|NCT00836693|3099142|P1|Overall Study|Physician Decision|2
940831|NCT00836693|3099141|P2|Overall Study|Sponsor Decision|1
940832|NCT00836693|3099142|P1|Overall Study|Sponsor Decision|0
940833|NCT00836693|3099141|P2|Overall Study|Adverse Event|1
940834|NCT00836693|3099142|P1|Overall Study|Adverse Event|4
940835|NCT00836498|3099194|P2|Overall Study|Withdrawal by Subject|1
940836|NCT00836498|3099195|P1|Overall Study|Withdrawal by Subject|2
940837|NCT00836498|3099194|P2|Overall Study|Lost to Follow-up|0
940838|NCT00836498|3099195|P1|Overall Study|Lost to Follow-up|1
940839|NCT00836498|3099194|P2|Overall Study|Adverse Event|0
940840|NCT00836498|3099195|P1|Overall Study|Adverse Event|1
940841|NCT00836472|3099227|P2|Washout|Withdrawal by Subject|1
940842|NCT00836472|3099228|P1|Washout|Withdrawal by Subject|1
940843|NCT00836472|3099227|P2|Washout|Adverse Event|2
940844|NCT00836472|3099228|P1|Washout|Adverse Event|1
940845|NCT00836277|3099305|P1|Overall Study|Not evaluable for response|6
940846|NCT00836095|3099315|P2|Overall Study|Physician Decision|3
940847|NCT00836095|3099316|P1|Overall Study|Physician Decision|0
940848|NCT00836056|3099326|P2|First Intervention|Adverse Event|0
940849|NCT00836056|3099327|P1|First Intervention|Adverse Event|1
940850|NCT00835991|3099356|P2|Washout|Withdrawal by Subject|1
940851|NCT00835991|3099357|P1|Washout|Withdrawal by Subject|3
940852|NCT00835991|3099356|P2|Washout|Protocol Violation|2
940853|NCT00835991|3099357|P1|Washout|Protocol Violation|0
940854|NCT00835991|3099356|P2|First Intervention|Adverse Event|1
940855|NCT00835991|3099357|P1|First Intervention|Adverse Event|0
940856|NCT00835978|3099375|P4|Overall Study|Study terminated by sponsor|0
940857|NCT00835978|3099376|P3|Overall Study|Study terminated by sponsor|30
940858|NCT00835978|3099377|P2|Overall Study|Study terminated by sponsor|8
940859|NCT00835978|3099378|P1|Overall Study|Study terminated by sponsor|12
940860|NCT00835978|3099375|P4|Overall Study|Withdrawal by Subject|5
940861|NCT00835978|3099376|P3|Overall Study|Withdrawal by Subject|0
940862|NCT00835978|3099377|P2|Overall Study|Withdrawal by Subject|3
940863|NCT00835978|3099378|P1|Overall Study|Withdrawal by Subject|0
940864|NCT00835978|3099375|P4|Overall Study|Adverse Event|0
940865|NCT00835978|3099376|P3|Overall Study|Adverse Event|1
940866|NCT00835978|3099377|P2|Overall Study|Adverse Event|0
940867|NCT00835978|3099378|P1|Overall Study|Adverse Event|1
940868|NCT00835978|3099375|P4|Overall Study|Objective progression or relapse|0
940869|NCT00835978|3099376|P3|Overall Study|Objective progression or relapse|1
940870|NCT00835978|3099377|P2|Overall Study|Objective progression or relapse|0
940871|NCT00835978|3099378|P1|Overall Study|Objective progression or relapse|2
940872|NCT00835978|3099375|P4|Overall Study|Not Specified|0
940873|NCT00835978|3099376|P3|Overall Study|Not Specified|8
940874|NCT00835978|3099377|P2|Overall Study|Not Specified|1
940875|NCT00835978|3099378|P1|Overall Study|Not Specified|5
940876|NCT00835978|3099375|P4|Overall Study|Lost to Follow-up|1
940877|NCT00835978|3099376|P3|Overall Study|Lost to Follow-up|2
940878|NCT00835978|3099377|P2|Overall Study|Lost to Follow-up|4
940879|NCT00835978|3099378|P1|Overall Study|Lost to Follow-up|3
940880|NCT00835978|3099375|P4|Overall Study|Death|4
940881|NCT00835978|3099376|P3|Overall Study|Death|49
940882|NCT00835978|3099377|P2|Overall Study|Death|40
940883|NCT00835978|3099378|P1|Overall Study|Death|33
940884|NCT00835796|3099489|P2|First Intervention|Withdrawal by Subject|1
940885|NCT00835796|3099490|P1|First Intervention|Withdrawal by Subject|0
940886|NCT00835731|3099500|P2|Overall Study|Physician Decision|1
940887|NCT00835731|3099501|P1|Overall Study|Physician Decision|1
940888|NCT00835731|3099500|P2|Overall Study|Withdrawal by Subject|0
940889|NCT00835731|3099501|P1|Overall Study|Withdrawal by Subject|1
940890|NCT00835705|3099521|P2|Second Intervention|Difficulty with vein|0
940891|NCT00835705|3099522|P1|Second Intervention|Difficulty with vein|1
940892|NCT00835705|3099521|P2|First Intervention|Difficulty with vein|0
940893|NCT00835705|3099522|P1|First Intervention|Difficulty with vein|1
940894|NCT00835692|3099538|P2|First Intervention|Withdrawal by Subject|0
940895|NCT00835692|3099539|P1|First Intervention|Withdrawal by Subject|1
940896|NCT00835679|3099551|P4|Overall Study|Withdrawal by Subject|0
940897|NCT00835679|3099552|P3|Overall Study|Withdrawal by Subject|0
940898|NCT00835679|3099553|P2|Overall Study|Withdrawal by Subject|0
940899|NCT00835679|3099554|P1|Overall Study|Withdrawal by Subject|1
940900|NCT00835666|3099578|P2|Washout|Withdrawal by Subject|0
940901|NCT00835666|3099579|P1|Washout|Withdrawal by Subject|1
940902|NCT00835666|3099578|P2|Washout|Protocol Violation|0
940903|NCT00835666|3099579|P1|Washout|Protocol Violation|1
940904|NCT00835640|3099589|P2|Second Intervention|Protocol Violation|0
940905|NCT00835640|3099590|P1|Second Intervention|Protocol Violation|1
940906|NCT00835575|3099622|P2|Washout of 14 Days|Withdrawal by Subject|0
940907|NCT00835575|3099623|P1|Washout of 14 Days|Withdrawal by Subject|1
940908|NCT00835549|3099633|P2|Washout of 7 Days|Withdrawal by Subject|0
940909|NCT00835549|3099634|P1|Washout of 7 Days|Withdrawal by Subject|2
940910|NCT00835536|3099644|P2|Washout of 5 Weeks|Withdrawal by Subject|0
940911|NCT00835536|3099645|P1|Washout of 5 Weeks|Withdrawal by Subject|1
940912|NCT00835406|3099706|P2|Period: Washout of 7 Days|Withdrawal by Subject|2
940913|NCT00835406|3099707|P1|Period: Washout of 7 Days|Withdrawal by Subject|0
940914|NCT00835406|3099706|P2|Period: First Intervention|Withdrawal by Subject|0
940915|NCT00835406|3099707|P1|Period: First Intervention|Withdrawal by Subject|2
940916|NCT00835406|3099706|P2|Period: First Intervention|Adverse Event|1
940917|NCT00835406|3099707|P1|Period: First Intervention|Adverse Event|0
940918|NCT00835380|3099713|P1|Overall Study|Withdrawal by Subject|2
940919|NCT00835367|3099720|P2|Second Intervention|Adverse Event|1
940920|NCT00835367|3099721|P1|Second Intervention|Adverse Event|1
940921|NCT00835367|3099720|P2|Washout|Withdrawal by Subject|0
940922|NCT00835367|3099721|P1|Washout|Withdrawal by Subject|1
940923|NCT00835367|3099720|P2|Washout|Adverse Event|0
940924|NCT00835367|3099721|P1|Washout|Adverse Event|2
940925|NCT00835354|3099743|P2|First Intervention|Adverse Event|1
940926|NCT00835354|3099744|P1|First Intervention|Adverse Event|0
940927|NCT00835341|3099754|P2|Overall Study|Lost to Follow-up|12
940928|NCT00835341|3099755|P1|Overall Study|Lost to Follow-up|3
940929|NCT00835263|3099774|P2|Second Intervention|Adverse Event|0
940930|NCT00835263|3099775|P1|Second Intervention|Adverse Event|1
940931|NCT00835237|3099785|P2|Overall Study|Withdrawal by Subject|0
940932|NCT00835237|3099786|P1|Overall Study|Withdrawal by Subject|2
940933|NCT00835237|3099785|P2|Overall Study|Lost to Follow-up|0
940934|NCT00835237|3099786|P1|Overall Study|Lost to Follow-up|4
940935|NCT00835211|3099826|P2|Washout: 7 Days|Withdrawal by Subject|0
940936|NCT00835211|3099827|P1|Washout: 7 Days|Withdrawal by Subject|1
940937|NCT00835211|3099826|P2|Washout: 7 Days|Adverse Event|1
940938|NCT00835211|3099827|P1|Washout: 7 Days|Adverse Event|2
940939|NCT00835211|3099826|P2|First Intervention|Withdrawal by Subject|1
940940|NCT00835211|3099827|P1|First Intervention|Withdrawal by Subject|0
940941|NCT00835172|3099873|P2|Washout|Protocol Violation|1
940942|NCT00835172|3099874|P1|Washout|Protocol Violation|0
940943|NCT00835120|3099900|P1|Overall Study|Withdrawal by Subject|2
940944|NCT00835120|3099900|P1|Overall Study|Adverse Event|2
940945|NCT00835120|3099900|P1|Overall Study|Lost to Follow-up|3
940946|NCT00835120|3099900|P1|Overall Study|Lack of Efficacy|1
940947|NCT00835081|3099910|P2|Washout of 7 Days|Withdrawal by Subject|0
940948|NCT00835081|3099911|P1|Washout of 7 Days|Withdrawal by Subject|1
940949|NCT00835068|3099921|P2|Overall Study|Withdrawal by Subject|0
940950|NCT00835068|3099922|P1|Overall Study|Withdrawal by Subject|1
940951|NCT00835068|3099921|P2|Overall Study|Other|0
940952|NCT00835068|3099922|P1|Overall Study|Other|8
940953|NCT00835068|3099921|P2|Overall Study|Adverse Event|1
940954|NCT00835068|3099922|P1|Overall Study|Adverse Event|0
940955|NCT00835068|3099921|P2|Overall Study|Death|0
940956|NCT00835068|3099922|P1|Overall Study|Death|1
940957|NCT00835042|3099942|P2|Washout of 21 Days|Withdrawal by Subject|2
940958|NCT00835042|3099943|P1|Washout of 21 Days|Withdrawal by Subject|0
940959|NCT00835042|3099942|P2|First Intervention|Adverse Event|2
940960|NCT00835042|3099943|P1|First Intervention|Adverse Event|1
940961|NCT00835042|3099942|P2|First Intervention|Withdrawal by Subject|0
940962|NCT00835042|3099943|P1|First Intervention|Withdrawal by Subject|3
940963|NCT00834912|3100029|P6|Treatment Period 2|Withdrawal by Subject|0
940964|NCT00834912|3100030|P5|Treatment Period 2|Withdrawal by Subject|1
940965|NCT00834912|3100031|P4|Treatment Period 2|Withdrawal by Subject|0
940966|NCT00834912|3100032|P3|Treatment Period 2|Withdrawal by Subject|1
940967|NCT00834912|3100033|P2|Treatment Period 2|Withdrawal by Subject|0
940968|NCT00834912|3100034|P1|Treatment Period 2|Withdrawal by Subject|0
940969|NCT00834912|3100029|P6|Treatment Period 1|Adverse Event|0
940970|NCT00834912|3100030|P5|Treatment Period 1|Adverse Event|0
940971|NCT00834912|3100031|P4|Treatment Period 1|Adverse Event|1
940972|NCT00834912|3100032|P3|Treatment Period 1|Adverse Event|0
940973|NCT00834912|3100033|P2|Treatment Period 1|Adverse Event|1
940974|NCT00834912|3100034|P1|Treatment Period 1|Adverse Event|0
940975|NCT00834899|3100056|P2|Overall Study|Withdrawal by Subject|1
940976|NCT00834899|3100057|P1|Overall Study|Withdrawal by Subject|1
940977|NCT00834873|3100096|P2|First Intervention|Adverse Event|1
940978|NCT00834873|3100097|P1|First Intervention|Adverse Event|0
940979|NCT00834834|3100107|P2|Overall Study|Withdrawal by Subject|3
940980|NCT00834834|3100108|P1|Overall Study|Withdrawal by Subject|4
940981|NCT00834795|3100143|P2|Second Intervention|Adverse Event|0
940982|NCT00834795|3100144|P1|Second Intervention|Adverse Event|1
940983|NCT00834795|3100143|P2|Washout: 7 Days|Withdrawal by Subject|1
940984|NCT00834795|3100144|P1|Washout: 7 Days|Withdrawal by Subject|0
940985|NCT00834756|3100154|P2|Washout: 21 Days|Withdrawal by Subject|0
940986|NCT00834756|3100155|P1|Washout: 21 Days|Withdrawal by Subject|1
940987|NCT00834756|3100154|P2|First Intervention|Adverse Event|0
940988|NCT00834756|3100155|P1|First Intervention|Adverse Event|1
940989|NCT00834743|3100165|P2|Second Intervention|Withdrawal by Subject|0
940990|NCT00834743|3100166|P1|Second Intervention|Withdrawal by Subject|1
940991|NCT00834717|3100176|P2|First Intervention|Withdrawal by Subject|1
940992|NCT00834717|3100177|P1|First Intervention|Withdrawal by Subject|0
940993|NCT00834717|3100176|P2|First Intervention|Adverse Event|0
940994|NCT00834717|3100177|P1|First Intervention|Adverse Event|1
940995|NCT00834639|3100208|P2|Second Intervention|Physician Decision|2
940996|NCT00834639|3100209|P1|Second Intervention|Physician Decision|0
940997|NCT00834613|3100226|P2|First Intervention|Protocol Violation|0
940998|NCT00834613|3100227|P1|First Intervention|Protocol Violation|1
940999|NCT00834587|3100237|P2|Washout: 7 Days|Withdrawal by Subject|0
941000|NCT00834587|3100238|P1|Washout: 7 Days|Withdrawal by Subject|1
941001|NCT00834522|3100287|P2|Washout|Withdrawal by Subject|1
941002|NCT00834522|3100288|P1|Washout|Withdrawal by Subject|2
941003|NCT00834522|3100287|P2|Washout|Adverse Event|0
941004|NCT00834522|3100288|P1|Washout|Adverse Event|1
941005|NCT00834444|3100311|P2|Second Intervention|Adverse Event|0
941006|NCT00834444|3100312|P1|Second Intervention|Adverse Event|1
941007|NCT00834444|3100311|P2|Washout of 7 Days|Withdrawal by Subject|1
941008|NCT00834444|3100312|P1|Washout of 7 Days|Withdrawal by Subject|0
941009|NCT00834444|3100311|P2|First Intervention|Intolerance to Venopuncture|1
941010|NCT00834444|3100312|P1|First Intervention|Intolerance to Venopuncture|0
941011|NCT00834444|3100311|P2|First Intervention|Adverse Event|0
941012|NCT00834444|3100312|P1|First Intervention|Adverse Event|1
941013|NCT00834431|3100322|P2|Washout of 7 Days|Withdrawal by Subject|1
941014|NCT00834431|3100323|P1|Washout of 7 Days|Withdrawal by Subject|0
941015|NCT00834431|3100322|P2|First Intervention|Adverse Event|1
941016|NCT00834431|3100323|P1|First Intervention|Adverse Event|0
941017|NCT00834418|3100333|P2|Overall Study|Adverse Event|2
941018|NCT00834418|3100334|P1|Overall Study|Adverse Event|0
941019|NCT00834366|3100351|P2|Treatment Period 1|Adverse Event|1
941020|NCT00834366|3100352|P1|Treatment Period 1|Adverse Event|1
941021|NCT00834340|3100368|P2|Washout|Withdrawal by Subject|0
941022|NCT00834340|3100369|P1|Washout|Withdrawal by Subject|1
941023|NCT00834340|3100368|P2|Washout|Adverse Event|0
941024|NCT00834340|3100369|P1|Washout|Adverse Event|1
941025|NCT00834249|3100413|P2|Second Intervention|Adverse Event|0
941026|NCT00834249|3100414|P1|Second Intervention|Adverse Event|1
941027|NCT00834249|3100413|P2|Washout: 7 Days|Withdrawal by Subject|1
941028|NCT00834249|3100414|P1|Washout: 7 Days|Withdrawal by Subject|1
941029|NCT00834080|3100510|P1|Overall Study|Subject Relocated|1
941030|NCT00834080|3100510|P1|Overall Study|Physician Decision|1
941031|NCT00834080|3100510|P1|Overall Study|Other - False positive tests of the UDS|1
941032|NCT00834080|3100510|P1|Overall Study|Other - Pregnancy|1
941033|NCT00834080|3100510|P1|Overall Study|Withdrawal by Subject|5
941034|NCT00834080|3100510|P1|Overall Study|Lost to Follow-up|7
941035|NCT00834080|3100510|P1|Overall Study|Adverse Event|7
941036|NCT00834067|3100516|P2|Washout of 21 Days|Protocol Violation|1
941037|NCT00834067|3100517|P1|Washout of 21 Days|Protocol Violation|0
941038|NCT00834041|3100539|P2|Overall Study|Lost to Follow-up|1
941039|NCT00834041|3100540|P1|Overall Study|Lost to Follow-up|0
941040|NCT00834041|3100539|P2|Overall Study|Withdrawal by Subject|0
941041|NCT00834041|3100540|P1|Overall Study|Withdrawal by Subject|1
941042|NCT00833989|3100558|P4|Overall Study|Withdrawal by Subject|1
941043|NCT00833989|3100559|P3|Overall Study|Withdrawal by Subject|1
941044|NCT00833989|3100560|P2|Overall Study|Withdrawal by Subject|0
941045|NCT00833989|3100561|P1|Overall Study|Withdrawal by Subject|3
941046|NCT00833989|3100558|P4|Overall Study|Physician Decision|1
941047|NCT00833989|3100559|P3|Overall Study|Physician Decision|0
941048|NCT00833989|3100560|P2|Overall Study|Physician Decision|0
941049|NCT00833989|3100561|P1|Overall Study|Physician Decision|0
941050|NCT00833976|3100665|P1|Overall Study|Physician Decision|1
941051|NCT00833976|3100665|P1|Overall Study|Did not meet eligibility criteria|41
941052|NCT00833976|3100665|P1|Overall Study|Lost to Follow-up|4
941053|NCT00833976|3100665|P1|Overall Study|Withdrawal by Subject|5
941054|NCT00833937|3100673|P2|Washout|Withdrawal by Subject|0
941055|NCT00833937|3100674|P1|Washout|Withdrawal by Subject|1
941056|NCT00833924|3100682|P1|Overall Study|In study follow-up|71
941057|NCT00833924|3100682|P1|Overall Study|Withdrawal by Subject|13
941058|NCT00833924|3100682|P1|Overall Study|Lost to Follow-up|2
941059|NCT00833924|3100682|P1|Overall Study|Conversion|2
941060|NCT00833924|3100682|P1|Overall Study|Death|21
941061|NCT00833911|3100687|P1|Maintenance Phase II|Lack of Efficacy|1
941062|NCT00833911|3100687|P1|Maintenance Phase II|Withdrawal by Subject|1
941063|NCT00833911|3100687|P1|Maintenance Phase II|Physician Decision|2
941064|NCT00833911|3100687|P1|Maintenance Phase II|Adverse Event|6
941065|NCT00833911|3100687|P1|Maintenance Phase I|Lack of Efficacy|4
941066|NCT00833911|3100687|P1|Maintenance Phase I|Physician Decision|10
941067|NCT00833911|3100687|P1|Maintenance Phase I|Withdrawal by Subject|11
941068|NCT00833911|3100687|P1|Maintenance Phase I|Adverse Event|73
941069|NCT00833911|3100687|P1|Titration|Withdrawal by Subject|3
941070|NCT00833911|3100687|P1|Titration|Adverse Event|18
941071|NCT00833898|3100697|P2|Overall Study|Patient did not receive transplant|2
941072|NCT00833898|3100698|P1|Overall Study|Patient did not receive transplant|0
941073|NCT00833898|3100697|P2|Overall Study|Lost to Follow-up|7
941074|NCT00833898|3100698|P1|Overall Study|Lost to Follow-up|7
941075|NCT00833898|3100697|P2|Overall Study|Withdrawal by Subject|27
941076|NCT00833898|3100698|P1|Overall Study|Withdrawal by Subject|33
941077|NCT00833833|3100757|P6|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1
941078|NCT00833833|3100758|P5|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
941079|NCT00833833|3100759|P4|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
941080|NCT00833833|3100760|P3|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
941081|NCT00833833|3100761|P2|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
941082|NCT00833833|3100762|P1|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
941083|NCT00833833|3100757|P6|Phase 2 (as of 01 April 2011)|Other|3
941084|NCT00833833|3100758|P5|Phase 2 (as of 01 April 2011)|Other|4
941085|NCT00833833|3100759|P4|Phase 2 (as of 01 April 2011)|Other|0
941086|NCT00833833|3100760|P3|Phase 2 (as of 01 April 2011)|Other|0
941087|NCT00833833|3100761|P2|Phase 2 (as of 01 April 2011)|Other|0
941088|NCT00833833|3100762|P1|Phase 2 (as of 01 April 2011)|Other|0
941089|NCT00833833|3100757|P6|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7
941090|NCT00833833|3100758|P5|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5
941091|NCT00833833|3100759|P4|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
941092|NCT00833833|3100760|P3|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
941093|NCT00833833|3100761|P2|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
941094|NCT00833833|3100762|P1|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
941095|NCT00833833|3100757|P6|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6
941096|NCT00833833|3100758|P5|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7
941097|NCT00833833|3100759|P4|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
941098|NCT00833833|3100760|P3|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
941099|NCT00833833|3100761|P2|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
941100|NCT00833833|3100762|P1|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
941101|NCT00833833|3100757|P6|Phase 2 (as of 01 April 2011)|Death|9
941102|NCT00833833|3100758|P5|Phase 2 (as of 01 April 2011)|Death|8
941103|NCT00833833|3100759|P4|Phase 2 (as of 01 April 2011)|Death|0
941104|NCT00833833|3100760|P3|Phase 2 (as of 01 April 2011)|Death|0
941105|NCT00833833|3100761|P2|Phase 2 (as of 01 April 2011)|Death|0
941106|NCT00833833|3100762|P1|Phase 2 (as of 01 April 2011)|Death|0
941107|NCT00833833|3100757|P6|Phase 2 (as of 01 April 2011)|Adverse Event|13
941108|NCT00833833|3100758|P5|Phase 2 (as of 01 April 2011)|Adverse Event|8
941109|NCT00833833|3100759|P4|Phase 2 (as of 01 April 2011)|Adverse Event|0
941110|NCT00833833|3100760|P3|Phase 2 (as of 01 April 2011)|Adverse Event|0
941111|NCT00833833|3100761|P2|Phase 2 (as of 01 April 2011)|Adverse Event|0
941112|NCT00833833|3100762|P1|Phase 2 (as of 01 April 2011)|Adverse Event|0
941113|NCT00833833|3100757|P6|Phase 2 (as of 01 April 2011)|Still active in study|22
941114|NCT00833833|3100758|P5|Phase 2 (as of 01 April 2011)|Still active in study|23
941115|NCT00833833|3100759|P4|Phase 2 (as of 01 April 2011)|Still active in study|0
941116|NCT00833833|3100760|P3|Phase 2 (as of 01 April 2011)|Still active in study|0
941117|NCT00833833|3100761|P2|Phase 2 (as of 01 April 2011)|Still active in study|0
941118|NCT00833833|3100762|P1|Phase 2 (as of 01 April 2011)|Still active in study|0
941119|NCT00833833|3100757|P6|Phase 1 (as of 01 April 2011)|Other|0
941120|NCT00833833|3100758|P5|Phase 1 (as of 01 April 2011)|Other|0
941121|NCT00833833|3100759|P4|Phase 1 (as of 01 April 2011)|Other|1
941122|NCT00833833|3100760|P3|Phase 1 (as of 01 April 2011)|Other|0
941123|NCT00833833|3100761|P2|Phase 1 (as of 01 April 2011)|Other|3
941124|NCT00833833|3100762|P1|Phase 1 (as of 01 April 2011)|Other|1
941125|NCT00833833|3100757|P6|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
941126|NCT00833833|3100758|P5|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
941127|NCT00833833|3100759|P4|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
941128|NCT00833833|3100760|P3|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
941129|NCT00833833|3100761|P2|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
941130|NCT00833833|3100762|P1|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
941131|NCT00833833|3100757|P6|Phase 1 (as of 01 April 2011)|Death|0
941132|NCT00833833|3100758|P5|Phase 1 (as of 01 April 2011)|Death|0
941133|NCT00833833|3100759|P4|Phase 1 (as of 01 April 2011)|Death|0
941134|NCT00833833|3100760|P3|Phase 1 (as of 01 April 2011)|Death|2
941135|NCT00833833|3100761|P2|Phase 1 (as of 01 April 2011)|Death|1
941136|NCT00833833|3100762|P1|Phase 1 (as of 01 April 2011)|Death|0
941137|NCT00833833|3100757|P6|Phase 1 (as of 01 April 2011)|Adverse Event|0
941138|NCT00833833|3100758|P5|Phase 1 (as of 01 April 2011)|Adverse Event|0
941139|NCT00833833|3100759|P4|Phase 1 (as of 01 April 2011)|Adverse Event|1
941140|NCT00833833|3100760|P3|Phase 1 (as of 01 April 2011)|Adverse Event|2
941141|NCT00833833|3100761|P2|Phase 1 (as of 01 April 2011)|Adverse Event|0
941142|NCT00833833|3100762|P1|Phase 1 (as of 01 April 2011)|Adverse Event|1
941143|NCT00833833|3100757|P6|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
941144|NCT00833833|3100758|P5|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
941145|NCT00833833|3100759|P4|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
941146|NCT00833833|3100760|P3|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
941147|NCT00833833|3100761|P2|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
941148|NCT00833833|3100762|P1|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
941149|NCT00833833|3100757|P6|Phase 1 (as of 01 April 2011)|Still active in study|0
941150|NCT00833833|3100758|P5|Phase 1 (as of 01 April 2011)|Still active in study|0
941151|NCT00833833|3100759|P4|Phase 1 (as of 01 April 2011)|Still active in study|2
941152|NCT00833833|3100760|P3|Phase 1 (as of 01 April 2011)|Still active in study|2
941153|NCT00833833|3100761|P2|Phase 1 (as of 01 April 2011)|Still active in study|0
941154|NCT00833833|3100762|P1|Phase 1 (as of 01 April 2011)|Still active in study|0
941155|NCT00833794|3100802|P2|Double-blind Phase|Administrative reason|3
941156|NCT00833794|3100803|P1|Double-blind Phase|Administrative reason|1
941157|NCT00833794|3100802|P2|Double-blind Phase|Physician Decision|7
941158|NCT00833794|3100803|P1|Double-blind Phase|Physician Decision|4
941159|NCT00833794|3100802|P2|Double-blind Phase|Withdrawal by Subject|6
941160|NCT00833794|3100803|P1|Double-blind Phase|Withdrawal by Subject|23
941161|NCT00833794|3100802|P2|Double-blind Phase|Lack of Efficacy|22
941162|NCT00833794|3100803|P1|Double-blind Phase|Lack of Efficacy|34
941163|NCT00833794|3100802|P2|Double-blind Phase|Adverse Event|11
941164|NCT00833794|3100803|P1|Double-blind Phase|Adverse Event|44
941165|NCT00833794|3100802|P2|Open-label Phase|enrolled in error (immediately D/C)|0
941166|NCT00833794|3100803|P1|Open-label Phase|enrolled in error (immediately D/C)|1
941167|NCT00833794|3100802|P2|Open-label Phase|Did not complete wash-out period|0
941168|NCT00833794|3100803|P1|Open-label Phase|Did not complete wash-out period|12
941169|NCT00833794|3100802|P2|Open-label Phase|Protocol Violation|0
941170|NCT00833794|3100803|P1|Open-label Phase|Protocol Violation|47
941171|NCT00833794|3100802|P2|Open-label Phase|Administrative reason|0
941172|NCT00833794|3100803|P1|Open-label Phase|Administrative reason|1
941173|NCT00833794|3100802|P2|Open-label Phase|Physician Decision|0
941174|NCT00833794|3100803|P1|Open-label Phase|Physician Decision|20
941175|NCT00833794|3100802|P2|Open-label Phase|Withdrawal by Subject|0
941176|NCT00833794|3100803|P1|Open-label Phase|Withdrawal by Subject|48
941177|NCT00833794|3100802|P2|Open-label Phase|Lack of Efficacy|0
941178|NCT00833794|3100803|P1|Open-label Phase|Lack of Efficacy|28
941179|NCT00833794|3100802|P2|Open-label Phase|Adverse Event|0
941180|NCT00833794|3100803|P1|Open-label Phase|Adverse Event|225
941181|NCT00833755|3100847|P4|Overall Study|Subject had scheduling issues|0
941182|NCT00833755|3100848|P3|Overall Study|Subject had scheduling issues|0
941183|NCT00833755|3100849|P2|Overall Study|Subject had scheduling issues|1
941184|NCT00833755|3100850|P1|Overall Study|Subject had scheduling issues|0
941185|NCT00833755|3100847|P4|Overall Study|Physician Decision|6
941186|NCT00833755|3100848|P3|Overall Study|Physician Decision|2
941187|NCT00833755|3100849|P2|Overall Study|Physician Decision|4
941188|NCT00833755|3100850|P1|Overall Study|Physician Decision|4
941189|NCT00833703|3100870|P2|Overall Study|Parent(s)/guardian(s)'s request|1
941190|NCT00833703|3100871|P1|Overall Study|Parent(s)/guardian(s)'s request|0
941191|NCT00833690|3100884|P3|Overall Study|Discontinued study drug|0
941192|NCT00833690|3100885|P2|Overall Study|Discontinued study drug|2
941193|NCT00833690|3100886|P1|Overall Study|Discontinued study drug|3
941194|NCT00833690|3100884|P3|Overall Study|Withdrawal by Subject|0
941195|NCT00833690|3100885|P2|Overall Study|Withdrawal by Subject|0
941196|NCT00833690|3100886|P1|Overall Study|Withdrawal by Subject|1
941197|NCT00833638|3101022|P3|Phase 3: Open-label Extension Phase|Protocol Violation|2
941198|NCT00833638|3101023|P2|Phase 3: Open-label Extension Phase|Protocol Violation|1
941199|NCT00833638|3101024|P1|Phase 3: Open-label Extension Phase|Protocol Violation|0
941200|NCT00833638|3101022|P3|Phase 3: Open-label Extension Phase|Lost to Follow-up|0
941201|NCT00833638|3101023|P2|Phase 3: Open-label Extension Phase|Lost to Follow-up|2
941202|NCT00833638|3101024|P1|Phase 3: Open-label Extension Phase|Lost to Follow-up|1
941203|NCT00833638|3101022|P3|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2
941204|NCT00833638|3101023|P2|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
941205|NCT00833638|3101024|P1|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
941206|NCT00833638|3101022|P3|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2
941207|NCT00833638|3101023|P2|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
941208|NCT00833638|3101024|P1|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
941209|NCT00833638|3101022|P3|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
941210|NCT00833638|3101023|P2|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
941211|NCT00833638|3101024|P1|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
941212|NCT00833638|3101022|P3|Phase 2: Double-blind Treatment Phase|Physician Decision|0
941213|NCT00833638|3101023|P2|Phase 2: Double-blind Treatment Phase|Physician Decision|0
941214|NCT00833638|3101024|P1|Phase 2: Double-blind Treatment Phase|Physician Decision|1
941215|NCT00833638|3101022|P3|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
941216|NCT00833638|3101023|P2|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2
941217|NCT00833638|3101024|P1|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
941218|NCT00833638|3101022|P3|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1
941219|NCT00833638|3101023|P2|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2
941220|NCT00833638|3101024|P1|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3
941221|NCT00833638|3101022|P3|Phase 2: Double-blind Treatment Phase|Adverse Event|0
941222|NCT00833638|3101023|P2|Phase 2: Double-blind Treatment Phase|Adverse Event|2
941223|NCT00833638|3101024|P1|Phase 2: Double-blind Treatment Phase|Adverse Event|1
941224|NCT00833560|3101075|P1|Overall Study|Not specified|5
941225|NCT00833560|3101075|P1|Overall Study|Pregression of other disease|1
941226|NCT00833560|3101075|P1|Overall Study|Death|2
941227|NCT00833560|3101075|P1|Overall Study|Lack of Efficacy|4
941228|NCT00833560|3101075|P1|Overall Study|Protocol Violation|6
941229|NCT00833560|3101075|P1|Overall Study|Adverse Event|11
941230|NCT00833560|3101075|P1|Overall Study|Toxicity|13
941231|NCT00833547|3101084|P2|Overall Study|Withdrawal by Subject|2
941232|NCT00833547|3101085|P1|Overall Study|Withdrawal by Subject|2
941233|NCT00833482|3101106|P6|Days 21-30|Withdrawal by Subject|0
941234|NCT00833482|3101107|P5|Days 21-30|Withdrawal by Subject|1
941235|NCT00833482|3101108|P4|Days 21-30|Withdrawal by Subject|0
941236|NCT00833482|3101109|P3|Days 21-30|Withdrawal by Subject|0
941237|NCT00833482|3101110|P2|Days 21-30|Withdrawal by Subject|0
941238|NCT00833482|3101111|P1|Days 21-30|Withdrawal by Subject|0
941239|NCT00833482|3101106|P6|Days 21-30|Adverse Event|0
941240|NCT00833482|3101107|P5|Days 21-30|Adverse Event|0
941241|NCT00833482|3101108|P4|Days 21-30|Adverse Event|0
941242|NCT00833482|3101109|P3|Days 21-30|Adverse Event|1
941243|NCT00833482|3101110|P2|Days 21-30|Adverse Event|0
941244|NCT00833482|3101111|P1|Days 21-30|Adverse Event|0
941245|NCT00833482|3101106|P6|Days 11-20|Withdrawal by Subject|0
941246|NCT00833482|3101107|P5|Days 11-20|Withdrawal by Subject|0
941247|NCT00833482|3101108|P4|Days 11-20|Withdrawal by Subject|0
941248|NCT00833482|3101109|P3|Days 11-20|Withdrawal by Subject|0
941249|NCT00833482|3101110|P2|Days 11-20|Withdrawal by Subject|1
941250|NCT00833482|3101111|P1|Days 11-20|Withdrawal by Subject|0
941251|NCT00833482|3101106|P6|Days 11-20|Adverse Event|0
941252|NCT00833482|3101107|P5|Days 11-20|Adverse Event|0
941253|NCT00833482|3101108|P4|Days 11-20|Adverse Event|0
941254|NCT00833482|3101109|P3|Days 11-20|Adverse Event|0
941255|NCT00833482|3101110|P2|Days 11-20|Adverse Event|2
941256|NCT00833482|3101111|P1|Days 11-20|Adverse Event|0
941257|NCT00833469|3101167|P1|Overall Study|Lost to Follow-up|1
941258|NCT00833469|3101167|P1|Overall Study|Withdrawal by Subject|1
941259|NCT00833417|3101190|P2|Overall Study|Reason Not Specified|1
941260|NCT00833417|3101191|P1|Overall Study|Reason Not Specified|0
941261|NCT00833417|3101190|P2|Overall Study|Disease Progression|17
941262|NCT00833417|3101191|P1|Overall Study|Disease Progression|18
941263|NCT00833417|3101190|P2|Overall Study|Sponsor Decision to Terminate Study|2
941264|NCT00833417|3101191|P1|Overall Study|Sponsor Decision to Terminate Study|1
941265|NCT00833417|3101190|P2|Overall Study|Patient Decision to Withdraw|23
941266|NCT00833417|3101191|P1|Overall Study|Patient Decision to Withdraw|4
941267|NCT00833417|3101190|P2|Overall Study|Physician Decision to Withdraw Patient|7
941268|NCT00833417|3101191|P1|Overall Study|Physician Decision to Withdraw Patient|3
941269|NCT00833417|3101190|P2|Overall Study|Lost to Follow-up|2
941270|NCT00833417|3101191|P1|Overall Study|Lost to Follow-up|1
941271|NCT00833417|3101190|P2|Overall Study|Death|3
941272|NCT00833417|3101191|P1|Overall Study|Death|1
941273|NCT00833417|3101190|P2|Overall Study|Adverse Event|16
941274|NCT00833417|3101191|P1|Overall Study|Adverse Event|5
941275|NCT00833248|3101217|P2|Overall Study|Withdrawal by Subject|1
941276|NCT00833248|3101218|P1|Overall Study|Withdrawal by Subject|0
941277|NCT00833248|3101217|P2|Overall Study|Protocol Violation|2
941278|NCT00833248|3101218|P1|Overall Study|Protocol Violation|1
941279|NCT00833248|3101217|P2|Overall Study|Adverse Event|0
941280|NCT00833248|3101218|P1|Overall Study|Adverse Event|3
941281|NCT00833092|3101242|P2|Overall Study|constipation|1
941282|NCT00833092|3101243|P1|Overall Study|constipation|0
941283|NCT00833092|3101242|P2|Overall Study|Diarrhea|2
941284|NCT00833092|3101243|P1|Overall Study|Diarrhea|0
941285|NCT00833092|3101242|P2|Overall Study|Protocol Violation|1
941286|NCT00833092|3101243|P1|Overall Study|Protocol Violation|2
941287|NCT00833092|3101242|P2|Overall Study|Withdrawal by Subject|3
941288|NCT00833092|3101243|P1|Overall Study|Withdrawal by Subject|2
941289|NCT00833053|3101251|P2|Overall Study|Protocol Violation|1
941290|NCT00833053|3101252|P1|Overall Study|Protocol Violation|2
941291|NCT00833053|3101251|P2|Overall Study|Withdrawal by Subject|1
941292|NCT00833053|3101252|P1|Overall Study|Withdrawal by Subject|0
941293|NCT00833053|3101251|P2|Overall Study|Treatment Failure|1
941294|NCT00833053|3101252|P1|Overall Study|Treatment Failure|3
941295|NCT00833053|3101251|P2|Overall Study|Adverse Event|0
941296|NCT00833053|3101252|P1|Overall Study|Adverse Event|4
941297|NCT00833040|3101270|P6|Overall Study|Adverse Event|1
941298|NCT00833040|3101271|P5|Overall Study|Adverse Event|0
941299|NCT00833040|3101272|P4|Overall Study|Adverse Event|0
941300|NCT00833040|3101273|P3|Overall Study|Adverse Event|0
941301|NCT00833040|3101274|P2|Overall Study|Adverse Event|0
941302|NCT00833040|3101275|P1|Overall Study|Adverse Event|0
941303|NCT00833027|3101280|P1|Overall Study|Missing|10
941304|NCT00833027|3101280|P1|Overall Study|Withdrawal by Subject|16
941305|NCT00833027|3101280|P1|Overall Study|Protocol Violation|115
941306|NCT00833027|3101280|P1|Overall Study|Lost to Follow-up|24
941307|NCT00833027|3101280|P1|Overall Study|Lack of Efficacy|12
941308|NCT00833027|3101280|P1|Overall Study|Death|1
941309|NCT00833027|3101280|P1|Overall Study|Adverse Event|33
941310|NCT00832975|3101285|P1|Overall Study|Other reasons|14
941311|NCT00832975|3101285|P1|Overall Study|Withdrawal by Subject|3
941312|NCT00832975|3101285|P1|Overall Study|Physician Decision|4
941313|NCT00832975|3101285|P1|Overall Study|Death|5
941314|NCT00832975|3101285|P1|Overall Study|Protocol Violation|6
941315|NCT00832975|3101285|P1|Overall Study|Lost to Follow-up|7
941316|NCT00832819|3101299|P3|Overall Study|Protocol Violation|1
941317|NCT00832819|3101300|P2|Overall Study|Protocol Violation|0
941318|NCT00832819|3101301|P1|Overall Study|Protocol Violation|0
941319|NCT00832819|3101299|P3|Overall Study|Adverse Event|0
941320|NCT00832819|3101300|P2|Overall Study|Adverse Event|1
941321|NCT00832819|3101301|P1|Overall Study|Adverse Event|0
941322|NCT00832780|3101307|P1|Overall Study|Physician Decision|1
941323|NCT00832780|3101307|P1|Overall Study|other complicating condition|2
941324|NCT00832780|3101307|P1|Overall Study|no reason given|2
941325|NCT00832780|3101307|P1|Overall Study|Lost to Follow-up|4
941326|NCT00832780|3101307|P1|Overall Study|Death|16
941327|NCT00832650|3101349|P3|Overall Study|Randomized but not treated|1
941328|NCT00832650|3101350|P2|Overall Study|Randomized but not treated|0
941329|NCT00832650|3101351|P1|Overall Study|Randomized but not treated|0
941330|NCT00832624|3101391|P1|Overall Study|Study Terminated|10
941331|NCT00832585|3101401|P1|Overall Study|Lost to Follow-up|1
941332|NCT00832585|3101401|P1|Overall Study|Withdrawal by Subject|1
941333|NCT00832455|3101426|P1|Overall Study|Patient moved|1
941334|NCT00832455|3101426|P1|Overall Study|No improvement|3
941335|NCT00832455|3101426|P1|Overall Study|Parent dissatisfied|1
941336|NCT00832455|3101426|P1|Overall Study|Parent misunderstood study|1
941337|NCT00832455|3101426|P1|Overall Study|Stopped Medication|4
941338|NCT00832455|3101426|P1|Overall Study|Screening Failure|2
941339|NCT00832455|3101426|P1|Overall Study|Withdrawal by Subject|17
941340|NCT00832455|3101426|P1|Overall Study|Protocol Violation|4
941341|NCT00832455|3101426|P1|Overall Study|Lost to Follow-up|26
941342|NCT00832455|3101426|P1|Overall Study|Adverse Event|13
941343|NCT00832416|3101450|P4|Overall Study|Death|0
941344|NCT00832416|3101451|P3|Overall Study|Death|0
941345|NCT00832416|3101452|P2|Overall Study|Death|0
941346|NCT00832416|3101453|P1|Overall Study|Death|1
941347|NCT00832416|3101450|P4|Overall Study|Adverse Event|10
941348|NCT00832416|3101451|P3|Overall Study|Adverse Event|41
941349|NCT00832416|3101452|P2|Overall Study|Adverse Event|19
941350|NCT00832416|3101453|P1|Overall Study|Adverse Event|21
941351|NCT00832416|3101450|P4|Overall Study|Administrative|1
941352|NCT00832416|3101451|P3|Overall Study|Administrative|0
941353|NCT00832416|3101452|P2|Overall Study|Administrative|0
941354|NCT00832416|3101453|P1|Overall Study|Administrative|0
941355|NCT00832416|3101450|P4|Overall Study|Physician Decision|10
941356|NCT00832416|3101451|P3|Overall Study|Physician Decision|5
941357|NCT00832416|3101452|P2|Overall Study|Physician Decision|12
941358|NCT00832416|3101453|P1|Overall Study|Physician Decision|2
941359|NCT00832416|3101450|P4|Overall Study|Withdrawal by Subject|10
941360|NCT00832416|3101451|P3|Overall Study|Withdrawal by Subject|2
941361|NCT00832416|3101452|P2|Overall Study|Withdrawal by Subject|7
941362|NCT00832416|3101453|P1|Overall Study|Withdrawal by Subject|5
941363|NCT00832416|3101450|P4|Overall Study|Lack of Efficacy|52
941364|NCT00832416|3101451|P3|Overall Study|Lack of Efficacy|13
941365|NCT00832416|3101452|P2|Overall Study|Lack of Efficacy|15
941366|NCT00832416|3101453|P1|Overall Study|Lack of Efficacy|17
941367|NCT00832377|3101504|P1|Overall Study|Protocol Violation|1
941368|NCT00832117|3101550|P1|Overall Study|Disease Progression|11
941369|NCT00832117|3101550|P1|Overall Study|Death|1
941370|NCT00832091|3101569|P2|Overall Study|Prohibited Medication|0
941371|NCT00832091|3101570|P1|Overall Study|Prohibited Medication|1
941372|NCT00832091|3101569|P2|Overall Study|Withdrawal by Subject|1
941373|NCT00832091|3101570|P1|Overall Study|Withdrawal by Subject|2
941374|NCT00832091|3101569|P2|Overall Study|Protocol Violation|0
941375|NCT00832091|3101570|P1|Overall Study|Protocol Violation|1
941376|NCT00832091|3101569|P2|Overall Study|Adverse Event|1
941377|NCT00832091|3101570|P1|Overall Study|Adverse Event|1
941378|NCT00832078|3101578|P2|Test Day 2 - 2 Period|Lack of Efficacy|0
941379|NCT00832078|3101579|P1|Test Day 2 - 2 Period|Lack of Efficacy|1
941380|NCT00832078|3101578|P2|Test Day 1-2 Period|Lack of Efficacy|2
941381|NCT00832078|3101579|P1|Test Day 1-2 Period|Lack of Efficacy|0
941382|NCT00832000|3101585|P2|Overall Study|No calls to IVR in period 2|0
941383|NCT00832000|3101586|P1|Overall Study|No calls to IVR in period 2|2
941384|NCT00832000|3101585|P2|Overall Study|No calls to IVR in either period|1
941385|NCT00832000|3101586|P1|Overall Study|No calls to IVR in either period|1
941386|NCT00832000|3101585|P2|Overall Study|Withdrawal by Subject|0
941387|NCT00832000|3101586|P1|Overall Study|Withdrawal by Subject|1
941388|NCT00832000|3101585|P2|Overall Study|Adverse Event|0
941389|NCT00832000|3101586|P1|Overall Study|Adverse Event|2
941390|NCT00831844|3101647|P10|Overall Study|Ineligible|0
941391|NCT00831844|3101648|P9|Overall Study|Ineligible|0
941392|NCT00831844|3101649|P8|Overall Study|Ineligible|0
941393|NCT00831844|3101650|P7|Overall Study|Ineligible|0
941394|NCT00831844|3101651|P6|Overall Study|Ineligible|0
941395|NCT00831844|3101652|P5|Overall Study|Ineligible|1
941396|NCT00831844|3101653|P4|Overall Study|Ineligible|0
941397|NCT00831844|3101654|P3|Overall Study|Ineligible|1
941398|NCT00831844|3101655|P2|Overall Study|Ineligible|1
941399|NCT00831844|3101656|P1|Overall Study|Ineligible|0
941400|NCT00831844|3101647|P10|Overall Study|Withdrawal by Subject|0
941401|NCT00831844|3101648|P9|Overall Study|Withdrawal by Subject|1
941402|NCT00831844|3101649|P8|Overall Study|Withdrawal by Subject|1
941403|NCT00831844|3101650|P7|Overall Study|Withdrawal by Subject|0
941404|NCT00831844|3101651|P6|Overall Study|Withdrawal by Subject|0
941405|NCT00831844|3101652|P5|Overall Study|Withdrawal by Subject|0
941406|NCT00831844|3101653|P4|Overall Study|Withdrawal by Subject|0
941407|NCT00831844|3101654|P3|Overall Study|Withdrawal by Subject|1
941408|NCT00831844|3101655|P2|Overall Study|Withdrawal by Subject|0
941409|NCT00831844|3101656|P1|Overall Study|Withdrawal by Subject|0
941410|NCT00831844|3101647|P10|Overall Study|Physician Decision|0
941411|NCT00831844|3101648|P9|Overall Study|Physician Decision|1
941412|NCT00831844|3101649|P8|Overall Study|Physician Decision|0
941413|NCT00831844|3101650|P7|Overall Study|Physician Decision|0
941414|NCT00831844|3101651|P6|Overall Study|Physician Decision|1
941415|NCT00831844|3101652|P5|Overall Study|Physician Decision|1
941416|NCT00831844|3101653|P4|Overall Study|Physician Decision|1
941417|NCT00831844|3101654|P3|Overall Study|Physician Decision|3
941418|NCT00831844|3101655|P2|Overall Study|Physician Decision|1
941419|NCT00831844|3101656|P1|Overall Study|Physician Decision|0
941420|NCT00831844|3101647|P10|Overall Study|Lack of Efficacy|0
941421|NCT00831844|3101648|P9|Overall Study|Lack of Efficacy|7
941422|NCT00831844|3101649|P8|Overall Study|Lack of Efficacy|9
941423|NCT00831844|3101650|P7|Overall Study|Lack of Efficacy|8
941424|NCT00831844|3101651|P6|Overall Study|Lack of Efficacy|17
941425|NCT00831844|3101652|P5|Overall Study|Lack of Efficacy|11
941426|NCT00831844|3101653|P4|Overall Study|Lack of Efficacy|8
941427|NCT00831844|3101654|P3|Overall Study|Lack of Efficacy|15
941428|NCT00831844|3101655|P2|Overall Study|Lack of Efficacy|10
941429|NCT00831844|3101656|P1|Overall Study|Lack of Efficacy|8
941430|NCT00831844|3101647|P10|Overall Study|Death|0
941431|NCT00831844|3101648|P9|Overall Study|Death|0
941432|NCT00831844|3101649|P8|Overall Study|Death|0
941433|NCT00831844|3101650|P7|Overall Study|Death|0
941434|NCT00831844|3101651|P6|Overall Study|Death|0
941435|NCT00831844|3101652|P5|Overall Study|Death|0
941436|NCT00831844|3101653|P4|Overall Study|Death|1
941437|NCT00831844|3101654|P3|Overall Study|Death|0
941438|NCT00831844|3101655|P2|Overall Study|Death|0
941439|NCT00831844|3101656|P1|Overall Study|Death|0
941440|NCT00831844|3101647|P10|Overall Study|Adverse Event|0
941441|NCT00831844|3101648|P9|Overall Study|Adverse Event|0
941442|NCT00831844|3101649|P8|Overall Study|Adverse Event|0
941443|NCT00831844|3101650|P7|Overall Study|Adverse Event|2
941444|NCT00831844|3101651|P6|Overall Study|Adverse Event|1
941445|NCT00831844|3101652|P5|Overall Study|Adverse Event|1
941446|NCT00831844|3101653|P4|Overall Study|Adverse Event|0
941447|NCT00831844|3101654|P3|Overall Study|Adverse Event|0
941448|NCT00831844|3101655|P2|Overall Study|Adverse Event|0
941449|NCT00831844|3101656|P1|Overall Study|Adverse Event|2
941450|NCT00831779|3101680|P2|Overall Study|No longer met criteria|1
941451|NCT00831779|3101681|P1|Overall Study|No longer met criteria|0
941452|NCT00831779|3101680|P2|Overall Study|Lost to Follow-up|0
941453|NCT00831779|3101681|P1|Overall Study|Lost to Follow-up|1
941454|NCT00831701|3101718|P2|Overall Study|Lost to Follow-up|3
941455|NCT00831701|3101719|P1|Overall Study|Lost to Follow-up|1
941456|NCT00831701|3101718|P2|Overall Study|Stone expulsion before first medication|2
941457|NCT00831701|3101719|P1|Overall Study|Stone expulsion before first medication|2
941458|NCT00831701|3101718|P2|Overall Study|Withdrawal by Subject|0
941459|NCT00831701|3101719|P1|Overall Study|Withdrawal by Subject|2
941460|NCT00831493|3101748|P1|Overall Study|Intractable nausea and vomiting|1
941461|NCT00831441|3101758|P2|Follow Up (30 Days)|missing end of study status|1
941462|NCT00831441|3101759|P1|Follow Up (30 Days)|missing end of study status|0
941463|NCT00831441|3101758|P2|Follow Up (30 Days)|non-specified|26
941464|NCT00831441|3101759|P1|Follow Up (30 Days)|non-specified|16
941465|NCT00831441|3101758|P2|Follow Up (30 Days)|Death|86
941466|NCT00831441|3101759|P1|Follow Up (30 Days)|Death|63
941467|NCT00831441|3101758|P2|Follow Up (30 Days)|Lost to Follow-up|27
941468|NCT00831441|3101759|P1|Follow Up (30 Days)|Lost to Follow-up|13
941469|NCT00831441|3101758|P2|Follow Up (30 Days)|Withdrawal by Subject|34
941470|NCT00831441|3101759|P1|Follow Up (30 Days)|Withdrawal by Subject|41
941471|NCT00831441|3101758|P2|Randomized|non-specified|266
941472|NCT00831441|3101759|P1|Randomized|non-specified|276
941473|NCT00831441|3101758|P2|Randomized|poor/non-compliance|38
941474|NCT00831441|3101759|P1|Randomized|poor/non-compliance|30
941475|NCT00831441|3101758|P2|Randomized|Administrative reason by sponsor|2671
941476|NCT00831441|3101759|P1|Randomized|Administrative reason by sponsor|2780
941477|NCT00831441|3101758|P2|Randomized|Lost to Follow-up|35
941478|NCT00831441|3101759|P1|Randomized|Lost to Follow-up|26
941479|NCT00831441|3101758|P2|Randomized|Withdrawal by Subject|212
941480|NCT00831441|3101759|P1|Randomized|Withdrawal by Subject|178
941481|NCT00831441|3101758|P2|Randomized|No longer met criteria|19
941482|NCT00831441|3101759|P1|Randomized|No longer met criteria|13
941483|NCT00831441|3101758|P2|Randomized|Physician Decision|35
941484|NCT00831441|3101759|P1|Randomized|Physician Decision|26
941485|NCT00831441|3101758|P2|Randomized|Elective procedure|25
941486|NCT00831441|3101759|P1|Randomized|Elective procedure|26
941487|NCT00831441|3101758|P2|Randomized|Emergency procedure|2
941488|NCT00831441|3101759|P1|Randomized|Emergency procedure|2
941489|NCT00831441|3101758|P2|Randomized|Adverse Event|321
941490|NCT00831441|3101759|P1|Randomized|Adverse Event|248
941491|NCT00831441|3101758|P2|Randomized|Death|81
941492|NCT00831441|3101759|P1|Randomized|Death|82
941493|NCT00831415|3101791|P1|Overall Study|Death|1
941494|NCT00831415|3101791|P1|Overall Study|Unsatisfactory response - Efficacy|4
941495|NCT00831415|3101791|P1|Overall Study|Withdrawal by Subject|35
941496|NCT00831415|3101791|P1|Overall Study|Protocol Violation|3
941497|NCT00831415|3101791|P1|Overall Study|Lost to Follow-up|9
941498|NCT00831415|3101791|P1|Overall Study|Physician Decision|6
941499|NCT00831415|3101791|P1|Overall Study|Failed to return|3
941500|NCT00831415|3101791|P1|Overall Study|Adverse Event|14
941501|NCT00831389|3101800|P2|Overall Study|Withdrawal by Subject|1
941502|NCT00831389|3101801|P1|Overall Study|Withdrawal by Subject|0
941503|NCT00831311|3101827|P2|Overall Study|Withdrawal by Subject|4
941504|NCT00831311|3101828|P1|Overall Study|Withdrawal by Subject|6
941505|NCT00831311|3101827|P2|Overall Study|Physician Decision|1
941506|NCT00831311|3101828|P1|Overall Study|Physician Decision|0
941507|NCT00831311|3101827|P2|Overall Study|Lost to Follow-up|0
941508|NCT00831311|3101828|P1|Overall Study|Lost to Follow-up|3
941509|NCT00831311|3101827|P2|Overall Study|Definitive Contraindication|3
941510|NCT00831311|3101828|P1|Overall Study|Definitive Contraindication|3
941511|NCT00831233|3101865|P2|Overall Study|Selection Criteria Not Met|0
941512|NCT00831233|3101866|P1|Overall Study|Selection Criteria Not Met|2
941513|NCT00831233|3101865|P2|Overall Study|Protocol Violation|0
941514|NCT00831233|3101866|P1|Overall Study|Protocol Violation|1
941515|NCT00831233|3101865|P2|Overall Study|Adverse Event|1
941516|NCT00831233|3101866|P1|Overall Study|Adverse Event|0
941517|NCT00831181|3101890|P1|Overall Study|Adverse Event|12
941518|NCT00831129|3101903|P2|Overall Study|9 lost to follow-up reasons uknown|9
941519|NCT00831129|3101904|P1|Overall Study|9 lost to follow-up reasons uknown|0
941520|NCT00831129|3101903|P2|Overall Study|Adverse Event|1
941521|NCT00831129|3101904|P1|Overall Study|Adverse Event|0
941522|NCT00830960|3101946|P6|Overall Study|No study drug received|7
941523|NCT00830960|3101947|P5|Overall Study|No study drug received|5
941524|NCT00830960|3101948|P4|Overall Study|No study drug received|3
941525|NCT00830960|3101949|P3|Overall Study|No study drug received|4
941526|NCT00830960|3101950|P2|Overall Study|No study drug received|2
941527|NCT00830960|3101951|P1|Overall Study|No study drug received|7
941528|NCT00830960|3101946|P6|Overall Study|Sponsor Decision|7
941529|NCT00830960|3101947|P5|Overall Study|Sponsor Decision|5
941530|NCT00830960|3101948|P4|Overall Study|Sponsor Decision|4
941531|NCT00830960|3101949|P3|Overall Study|Sponsor Decision|3
941532|NCT00830960|3101950|P2|Overall Study|Sponsor Decision|2
941533|NCT00830960|3101951|P1|Overall Study|Sponsor Decision|1
941534|NCT00830960|3101946|P6|Overall Study|Withdrawal by Subject|21
941535|NCT00830960|3101947|P5|Overall Study|Withdrawal by Subject|16
941536|NCT00830960|3101948|P4|Overall Study|Withdrawal by Subject|23
941537|NCT00830960|3101949|P3|Overall Study|Withdrawal by Subject|18
941538|NCT00830960|3101950|P2|Overall Study|Withdrawal by Subject|19
941539|NCT00830960|3101951|P1|Overall Study|Withdrawal by Subject|19
941540|NCT00830960|3101946|P6|Overall Study|Lost to Follow-up|1
941541|NCT00830960|3101947|P5|Overall Study|Lost to Follow-up|0
941542|NCT00830960|3101948|P4|Overall Study|Lost to Follow-up|0
941543|NCT00830960|3101949|P3|Overall Study|Lost to Follow-up|1
941544|NCT00830960|3101950|P2|Overall Study|Lost to Follow-up|1
941545|NCT00830960|3101951|P1|Overall Study|Lost to Follow-up|1
941546|NCT00830960|3101946|P6|Overall Study|Death|1
941547|NCT00830960|3101947|P5|Overall Study|Death|6
941548|NCT00830960|3101948|P4|Overall Study|Death|2
941549|NCT00830960|3101949|P3|Overall Study|Death|3
941550|NCT00830960|3101950|P2|Overall Study|Death|4
941551|NCT00830960|3101951|P1|Overall Study|Death|5
941552|NCT00830947|3102067|P2|Overall Study|Lost to Follow-up|4
941553|NCT00830947|3102068|P1|Overall Study|Lost to Follow-up|4
941554|NCT00830804|3102074|P1|Overall Study|Unwilling to adhere to study requirement|1
941555|NCT00830804|3102074|P1|Overall Study|Consent withdrawn|2
941556|NCT00830804|3102074|P1|Overall Study|Unable to get to clinic|7
941557|NCT00830804|3102074|P1|Overall Study|Death|1
941558|NCT00830804|3102074|P1|Overall Study|Lost to Follow-up|4
941559|NCT00830765|3102154|P2|Overall Study|Protocol Violation|2
941560|NCT00830765|3102155|P1|Overall Study|Protocol Violation|3
941561|NCT00830518|3102188|P2|Overall Study|Reason not Specified|1
941562|NCT00830518|3102189|P1|Overall Study|Reason not Specified|8
941563|NCT00830518|3102188|P2|Overall Study|Withdrawal by Patient|0
941564|NCT00830518|3102189|P1|Overall Study|Withdrawal by Patient|2
941565|NCT00830518|3102188|P2|Overall Study|Adverse Event|1
941566|NCT00830518|3102189|P1|Overall Study|Adverse Event|14
941567|NCT00830518|3102188|P2|Overall Study|Symptomatic Deterioration|1
941568|NCT00830518|3102189|P1|Overall Study|Symptomatic Deterioration|4
941569|NCT00830518|3102188|P2|Overall Study|Progressive Disease|8
941570|NCT00830518|3102189|P1|Overall Study|Progressive Disease|18
941571|NCT00830440|3102208|P2|Overall Study|Adverse Event|0
941572|NCT00830440|3102209|P1|Overall Study|Adverse Event|2
941573|NCT00830440|3102208|P2|Overall Study|unsuccessful procedure|0
941574|NCT00830440|3102209|P1|Overall Study|unsuccessful procedure|4
941575|NCT00830440|3102208|P2|Overall Study|Withdrawal by Subject|0
941576|NCT00830440|3102209|P1|Overall Study|Withdrawal by Subject|1
941577|NCT00830440|3102208|P2|Overall Study|Protocol Violation|0
941578|NCT00830440|3102209|P1|Overall Study|Protocol Violation|1
941579|NCT00830375|3102224|P1|Overall Study|Lost to Follow-up|1
941580|NCT00830336|3102239|P2|Washout: 21 Days|Withdrawal by Subject|0
941581|NCT00830336|3102240|P1|Washout: 21 Days|Withdrawal by Subject|1
941582|NCT00830258|3102267|P2|Washout: 7 Days|Protocol Violation|0
941583|NCT00830258|3102268|P1|Washout: 7 Days|Protocol Violation|1
941584|NCT00830258|3102267|P2|First Intervention|Adverse Event|0
941585|NCT00830258|3102268|P1|First Intervention|Adverse Event|1
941586|NCT00830219|3102287|P2|Washout of 7 Days|Withdrawal by Subject|1
941587|NCT00830219|3102288|P1|Washout of 7 Days|Withdrawal by Subject|1
941588|NCT00830206|3102298|P2|Washout: 21 Days|Withdrawal by Subject|1
941589|NCT00830206|3102299|P1|Washout: 21 Days|Withdrawal by Subject|1
941590|NCT00830167|3102309|P2|Overall Study|Other|2
941591|NCT00830167|3102310|P1|Overall Study|Other|2
941592|NCT00830167|3102309|P2|Overall Study|Protocol Violation|1
941593|NCT00830167|3102310|P1|Overall Study|Protocol Violation|0
941594|NCT00830167|3102309|P2|Overall Study|Lost to Follow-up|1
941595|NCT00830167|3102310|P1|Overall Study|Lost to Follow-up|0
941596|NCT00830167|3102309|P2|Overall Study|Withdrawal by Subject|0
941597|NCT00830167|3102310|P1|Overall Study|Withdrawal by Subject|2
941598|NCT00830167|3102309|P2|Overall Study|Not meeting entrance criteria|5
941599|NCT00830167|3102310|P1|Overall Study|Not meeting entrance criteria|2
941600|NCT00830167|3102309|P2|Overall Study|Adverse Event|24
941601|NCT00830167|3102310|P1|Overall Study|Adverse Event|8
941602|NCT00830167|3102309|P2|Overall Study|Lack of Efficacy|10
941603|NCT00830167|3102310|P1|Overall Study|Lack of Efficacy|26
941604|NCT00830128|3102380|P1|Overall Study|Operating a vehicle|1
941605|NCT00830128|3102380|P1|Overall Study|Work obligation|1
941606|NCT00830128|3102380|P1|Overall Study|Relocation|1
941607|NCT00830128|3102380|P1|Overall Study|Family obligation|1
941608|NCT00830128|3102380|P1|Overall Study|Withdrawal by Subject|2
941609|NCT00830128|3102380|P1|Overall Study|Protocol Violation|1
941610|NCT00830128|3102380|P1|Overall Study|Lack of Efficacy|7
941611|NCT00830128|3102380|P1|Overall Study|Adverse Event|5
941612|NCT00830115|3102395|P1|Overall Study|Improvement/recovery|1
941613|NCT00830115|3102395|P1|Overall Study|Adverse Event|2
941614|NCT00830037|3102422|P2|Overall Study|Active when terminated by DSMB|14
941615|NCT00830037|3102423|P1|Overall Study|Active when terminated by DSMB|15
941616|NCT00830037|3102422|P2|Overall Study|Lost to Follow-up|2
941617|NCT00830037|3102423|P1|Overall Study|Lost to Follow-up|1
941618|NCT00830037|3102422|P2|Overall Study|Withdrawal by Subject|3
941619|NCT00830037|3102423|P1|Overall Study|Withdrawal by Subject|2
941620|NCT00830024|3102433|P2|Washout: 7 Days|Withdrawal by Subject|0
941621|NCT00830024|3102434|P1|Washout: 7 Days|Withdrawal by Subject|1
941622|NCT00829998|3102444|P2|Washout|Adverse Event|1
941623|NCT00829998|3102445|P1|Washout|Adverse Event|0
941624|NCT00829933|3102474|P4|Overall Study|withdrew before treatment started|9
941625|NCT00829933|3102475|P3|Overall Study|withdrew before treatment started|2
941626|NCT00829933|3102476|P2|Overall Study|withdrew before treatment started|1
941627|NCT00829933|3102477|P1|Overall Study|withdrew before treatment started|5
941628|NCT00829933|3102474|P4|Overall Study|Protocol Violation|0
941629|NCT00829933|3102475|P3|Overall Study|Protocol Violation|0
941630|NCT00829933|3102476|P2|Overall Study|Protocol Violation|1
941631|NCT00829933|3102477|P1|Overall Study|Protocol Violation|2
941632|NCT00829933|3102474|P4|Overall Study|Pregnancy|2
941633|NCT00829933|3102475|P3|Overall Study|Pregnancy|0
941634|NCT00829933|3102476|P2|Overall Study|Pregnancy|0
941635|NCT00829933|3102477|P1|Overall Study|Pregnancy|0
941636|NCT00829933|3102474|P4|Overall Study|Physician Decision|1
941637|NCT00829933|3102475|P3|Overall Study|Physician Decision|8
941638|NCT00829933|3102476|P2|Overall Study|Physician Decision|7
941639|NCT00829933|3102477|P1|Overall Study|Physician Decision|5
941640|NCT00829933|3102474|P4|Overall Study|Lack of Efficacy|0
941641|NCT00829933|3102475|P3|Overall Study|Lack of Efficacy|0
941642|NCT00829933|3102476|P2|Overall Study|Lack of Efficacy|1
941643|NCT00829933|3102477|P1|Overall Study|Lack of Efficacy|0
941644|NCT00829933|3102474|P4|Overall Study|Death|1
941645|NCT00829933|3102475|P3|Overall Study|Death|1
941646|NCT00829933|3102476|P2|Overall Study|Death|0
941647|NCT00829933|3102477|P1|Overall Study|Death|0
941648|NCT00829933|3102474|P4|Overall Study|Adverse Event|1
941649|NCT00829933|3102475|P3|Overall Study|Adverse Event|2
941650|NCT00829933|3102476|P2|Overall Study|Adverse Event|3
941651|NCT00829933|3102477|P1|Overall Study|Adverse Event|2
941652|NCT00829868|3102489|P2|Washout|Physician Decision|0
941653|NCT00829868|3102490|P1|Washout|Physician Decision|1
941654|NCT00829829|3102501|P3|Overall Study|Other than specified above|1
941655|NCT00829829|3102502|P2|Overall Study|Other than specified above|2
941656|NCT00829829|3102503|P1|Overall Study|Other than specified above|2
941657|NCT00829829|3102501|P3|Overall Study|Lost to Follow-up|3
941658|NCT00829829|3102502|P2|Overall Study|Lost to Follow-up|3
941659|NCT00829829|3102503|P1|Overall Study|Lost to Follow-up|7
941660|NCT00829829|3102501|P3|Overall Study|Decision by the Sponsor|2
941661|NCT00829829|3102502|P2|Overall Study|Decision by the Sponsor|0
941662|NCT00829829|3102503|P1|Overall Study|Decision by the Sponsor|1
941663|NCT00829829|3102501|P3|Overall Study|Withdrawal by Subject|2
941664|NCT00829829|3102502|P2|Overall Study|Withdrawal by Subject|4
941665|NCT00829829|3102503|P1|Overall Study|Withdrawal by Subject|8
941666|NCT00829829|3102501|P3|Overall Study|Adverse Event|3
941667|NCT00829829|3102502|P2|Overall Study|Adverse Event|4
941668|NCT00829829|3102503|P1|Overall Study|Adverse Event|4
941669|NCT00829829|3102501|P3|Overall Study|Protocol Violation|0
941670|NCT00829829|3102502|P2|Overall Study|Protocol Violation|3
941671|NCT00829829|3102503|P1|Overall Study|Protocol Violation|0
941672|NCT00829790|3102528|P2|Washout of 14 Days|Withdrawal by Subject|1
941673|NCT00829790|3102529|P1|Washout of 14 Days|Withdrawal by Subject|0
941674|NCT00829764|3102539|P2|First Intervention|Withdrawal by Subject|1
941675|NCT00829764|3102540|P1|First Intervention|Withdrawal by Subject|1
941676|NCT00829764|3102539|P2|First Intervention|Adverse Event|0
941677|NCT00829764|3102540|P1|First Intervention|Adverse Event|1
941678|NCT00829712|3102566|P2|Washout of 7 Days|Withdrawal by Subject|1
941679|NCT00829712|3102567|P1|Washout of 7 Days|Withdrawal by Subject|0
941680|NCT00829673|3102586|P2|Washout of 7 Days|Withdrawal by Subject|0
941681|NCT00829673|3102587|P1|Washout of 7 Days|Withdrawal by Subject|1
941682|NCT00829621|3102597|P2|Overall Study|Lost to Follow-up|4
941683|NCT00829621|3102598|P1|Overall Study|Lost to Follow-up|3
941684|NCT00829621|3102597|P2|Overall Study|Death|0
941685|NCT00829621|3102598|P1|Overall Study|Death|1
941686|NCT00829530|3102606|P2|Second Intervention|Intolerance to Venopuncture|0
941687|NCT00829530|3102607|P1|Second Intervention|Intolerance to Venopuncture|1
941688|NCT00829530|3102606|P2|First Intervention|Intolerance to Venopuncture|1
941689|NCT00829530|3102607|P1|First Intervention|Intolerance to Venopuncture|0
941690|NCT00829530|3102606|P2|First Intervention|Adverse Event|1
941691|NCT00829530|3102607|P1|First Intervention|Adverse Event|0
941692|NCT00829504|3102621|P2|Second Intervention|Physician Decision|0
941693|NCT00829504|3102622|P1|Second Intervention|Physician Decision|1
941694|NCT00829504|3102621|P2|Washout of 7 Days|Withdrawal by Subject|0
941695|NCT00829504|3102622|P1|Washout of 7 Days|Withdrawal by Subject|1
941696|NCT00829504|3102621|P2|First Intervention|Adverse Event|0
941697|NCT00829504|3102622|P1|First Intervention|Adverse Event|1
941698|NCT00829452|3102632|P2|Second Intervention|Physician Decision|1
941699|NCT00829452|3102633|P1|Second Intervention|Physician Decision|0
941700|NCT00829452|3102632|P2|Washout of 42 Days|Withdrawal by Subject|1
941701|NCT00829452|3102633|P1|Washout of 42 Days|Withdrawal by Subject|0
941702|NCT00829452|3102632|P2|First Intervention|Withdrawal by Subject|1
941703|NCT00829452|3102633|P1|First Intervention|Withdrawal by Subject|0
941704|NCT00829439|3102645|P4|Overall Study|Adverse Event|0
941705|NCT00829439|3102646|P3|Overall Study|Adverse Event|1
941706|NCT00829439|3102647|P2|Overall Study|Adverse Event|0
941707|NCT00829439|3102648|P1|Overall Study|Adverse Event|0
941708|NCT00829426|3102654|P2|Washout: 7 Days|Withdrawal by Subject|0
941709|NCT00829426|3102655|P1|Washout: 7 Days|Withdrawal by Subject|1
941710|NCT00829413|3102663|P1|Overall Study|Indeterminate diagnosis from truth stand|3
941711|NCT00829413|3102663|P1|Overall Study|Technically inadequate truth standard|2
941712|NCT00829413|3102663|P1|Overall Study|No truth standard procedure available|9
941713|NCT00829413|3102663|P1|Overall Study|Training Patients|67
941714|NCT00829413|3102663|P1|Overall Study|No study drug admimnistered|13
941715|NCT00829387|3102712|P2|Overall Study|Disqualified by PI|0
941716|NCT00829387|3102713|P1|Overall Study|Disqualified by PI|1
941717|NCT00829387|3102712|P2|Overall Study|Withdrawal by Subject|3
941718|NCT00829387|3102713|P1|Overall Study|Withdrawal by Subject|2
941719|NCT00829309|3102731|P2|Washout: 7 Days|Protocol Violation|0
941720|NCT00829309|3102732|P1|Washout: 7 Days|Protocol Violation|1
941721|NCT00829296|3102742|P2|Overall Study|Adverse Event|4
941722|NCT00829296|3102743|P1|Overall Study|Adverse Event|5
941723|NCT00829283|3102757|P2|Overall Study|Lost to Follow-up|25
941724|NCT00829283|3102758|P1|Overall Study|Lost to Follow-up|7
941725|NCT00829244|3102768|P2|Overall Study|No embryo cleavage|2
941726|NCT00829244|3102769|P1|Overall Study|No embryo cleavage|0
941727|NCT00829244|3102768|P2|Overall Study|All embryos discarded|3
941728|NCT00829244|3102769|P1|Overall Study|All embryos discarded|0
941729|NCT00829244|3102768|P2|Overall Study|No fertilization|2
941730|NCT00829244|3102769|P1|Overall Study|No fertilization|2
941731|NCT00829244|3102768|P2|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6
941732|NCT00829244|3102769|P1|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1
941733|NCT00829244|3102768|P2|Overall Study|Lack of ovarian response to stimulation|5
941734|NCT00829244|3102769|P1|Overall Study|Lack of ovarian response to stimulation|9
941735|NCT00829244|3102768|P2|Overall Study|Protocol Violation|0
941736|NCT00829244|3102769|P1|Overall Study|Protocol Violation|1
941737|NCT00829244|3102768|P2|Overall Study|Adverse Event|3
941738|NCT00829244|3102769|P1|Overall Study|Adverse Event|1
941739|NCT00829179|3102799|P1|Overall Study|Withdrawal by Subject|1
941740|NCT00829166|3102805|P2|Overall Study|Reason Not Specified|3
941741|NCT00829166|3102806|P1|Overall Study|Reason Not Specified|3
941742|NCT00829166|3102805|P2|Overall Study|Sponsor’s Decision|98
941743|NCT00829166|3102806|P1|Overall Study|Sponsor’s Decision|137
941744|NCT00829166|3102805|P2|Overall Study|Subject's Decision|55
941745|NCT00829166|3102806|P1|Overall Study|Subject's Decision|41
941746|NCT00829166|3102805|P2|Overall Study|Physician's Decision|3
941747|NCT00829166|3102806|P1|Overall Study|Physician's Decision|4
941748|NCT00829166|3102805|P2|Overall Study|Lost to Follow-up|4
941749|NCT00829166|3102806|P1|Overall Study|Lost to Follow-up|5
941750|NCT00829166|3102805|P2|Overall Study|Death|333
941751|NCT00829166|3102806|P1|Overall Study|Death|305
941752|NCT00829010|3102869|P5|Overall Study|Migrated/Moved from study area|0
941753|NCT00829010|3102870|P4|Overall Study|Migrated/Moved from study area|5
941754|NCT00829010|3102871|P3|Overall Study|Migrated/Moved from study area|0
941755|NCT00829010|3102872|P2|Overall Study|Migrated/Moved from study area|4
941756|NCT00829010|3102873|P1|Overall Study|Migrated/Moved from study area|3
941757|NCT00829010|3102869|P5|Overall Study|Fatality|0
941758|NCT00829010|3102870|P4|Overall Study|Fatality|3
941759|NCT00829010|3102871|P3|Overall Study|Fatality|0
941760|NCT00829010|3102872|P2|Overall Study|Fatality|4
941761|NCT00829010|3102873|P1|Overall Study|Fatality|5
941762|NCT00829010|3102869|P5|Overall Study|Lost to Follow-up|0
941763|NCT00829010|3102870|P4|Overall Study|Lost to Follow-up|0
941764|NCT00829010|3102871|P3|Overall Study|Lost to Follow-up|2
941765|NCT00829010|3102872|P2|Overall Study|Lost to Follow-up|0
941766|NCT00829010|3102873|P1|Overall Study|Lost to Follow-up|1
941767|NCT00829010|3102869|P5|Overall Study|Withdrawal by Subject|2
941768|NCT00829010|3102870|P4|Overall Study|Withdrawal by Subject|0
941769|NCT00829010|3102871|P3|Overall Study|Withdrawal by Subject|1
941770|NCT00829010|3102872|P2|Overall Study|Withdrawal by Subject|1
941771|NCT00829010|3102873|P1|Overall Study|Withdrawal by Subject|0
941772|NCT00829010|3102869|P5|Overall Study|Adverse Event|0
941773|NCT00829010|3102870|P4|Overall Study|Adverse Event|0
941774|NCT00829010|3102871|P3|Overall Study|Adverse Event|0
941775|NCT00829010|3102872|P2|Overall Study|Adverse Event|0
941776|NCT00829010|3102873|P1|Overall Study|Adverse Event|1
941777|NCT00828984|3103038|P3|Overall Study|ConMed|1
941778|NCT00828984|3103039|P2|Overall Study|ConMed|1
941779|NCT00828984|3103040|P1|Overall Study|ConMed|1
941780|NCT00828984|3103038|P3|Overall Study|Noncompliant|3
941781|NCT00828984|3103039|P2|Overall Study|Noncompliant|2
941782|NCT00828984|3103040|P1|Overall Study|Noncompliant|1
941783|NCT00828984|3103038|P3|Overall Study|Medical Contraindication|0
941784|NCT00828984|3103039|P2|Overall Study|Medical Contraindication|1
941785|NCT00828984|3103040|P1|Overall Study|Medical Contraindication|0
941786|NCT00828984|3103038|P3|Overall Study|Ineligable|0
941787|NCT00828984|3103039|P2|Overall Study|Ineligable|2
941788|NCT00828984|3103040|P1|Overall Study|Ineligable|1
941789|NCT00828984|3103038|P3|Overall Study|Withdrawal by Subject|4
941790|NCT00828984|3103039|P2|Overall Study|Withdrawal by Subject|4
941791|NCT00828984|3103040|P1|Overall Study|Withdrawal by Subject|4
941792|NCT00828984|3103038|P3|Overall Study|Lost to Follow-up|1
941793|NCT00828984|3103039|P2|Overall Study|Lost to Follow-up|3
941794|NCT00828984|3103040|P1|Overall Study|Lost to Follow-up|5
941795|NCT00828984|3103038|P3|Overall Study|Adverse Event|0
941796|NCT00828984|3103039|P2|Overall Study|Adverse Event|3
941797|NCT00828984|3103040|P1|Overall Study|Adverse Event|2
941798|NCT00828945|3103063|P1|Overall Study|Other|36
941799|NCT00828945|3103063|P1|Overall Study|Participant was missing|1
941800|NCT00828945|3103063|P1|Overall Study|Death|4
941801|NCT00828750|3103095|P1|Overall Study|Normal PC Remained While No Treatment|1
941802|NCT00828750|3103095|P1|Overall Study|Lack of Efficacy|3
941803|NCT00828711|3103109|P3|Overall Study|Lost to Follow-up|0
941804|NCT00828711|3103110|P2|Overall Study|Lost to Follow-up|0
941805|NCT00828711|3103111|P1|Overall Study|Lost to Follow-up|1
941806|NCT00828568|3103143|P3|Treated - Received at Least One Dose|Protocol Violation|3
941807|NCT00828568|3103144|P2|Treated - Received at Least One Dose|Protocol Violation|5
941808|NCT00828568|3103145|P1|Treated - Received at Least One Dose|Protocol Violation|9
941809|NCT00828568|3103143|P3|Treated - Received at Least One Dose|Lost to Follow-up|1
941810|NCT00828568|3103144|P2|Treated - Received at Least One Dose|Lost to Follow-up|5
941811|NCT00828568|3103145|P1|Treated - Received at Least One Dose|Lost to Follow-up|1
941812|NCT00828568|3103143|P3|Treated - Received at Least One Dose|Withdrawal by Subject|0
941813|NCT00828568|3103144|P2|Treated - Received at Least One Dose|Withdrawal by Subject|11
941814|NCT00828568|3103145|P1|Treated - Received at Least One Dose|Withdrawal by Subject|9
941815|NCT00828568|3103143|P3|Treated - Received at Least One Dose|Adverse Event|1
941816|NCT00828568|3103144|P2|Treated - Received at Least One Dose|Adverse Event|8
941817|NCT00828568|3103145|P1|Treated - Received at Least One Dose|Adverse Event|11
941818|NCT00828568|3103143|P3|Randomized|Withdrawal by Subject|2
941819|NCT00828568|3103144|P2|Randomized|Withdrawal by Subject|0
941820|NCT00828568|3103145|P1|Randomized|Withdrawal by Subject|1
941821|NCT00828516|3103167|P1|Clinical Phase: Series 1|Withdrawal by Subject|2
941822|NCT00828464|3103172|P1|Overall Study|Withdrawal by Subject|1
941823|NCT00828451|3103189|P1|Overall Study|Deterioration in clinical status|1
941824|NCT00828451|3103189|P1|Overall Study|Withdrawal by Subject|1
941825|NCT00828451|3103189|P1|Overall Study|Lack of intravenous line|7
941826|NCT00828451|3103189|P1|Overall Study|Death|2
941827|NCT00828321|3103215|P2|Second Intervention|Protocol Violation|1
941828|NCT00828321|3103216|P1|Second Intervention|Protocol Violation|0
941829|NCT00828321|3103215|P2|Washout of 42 Days|Withdrawal by Subject|0
941830|NCT00828321|3103216|P1|Washout of 42 Days|Withdrawal by Subject|2
941831|NCT00828204|3103245|P2|Extension Study|Physician Decision|2
941832|NCT00828204|3103246|P1|Extension Study|Physician Decision|0
941833|NCT00828204|3103245|P2|Extension Study|Lost to Follow-up|1
941834|NCT00828204|3103246|P1|Extension Study|Lost to Follow-up|0
941835|NCT00828204|3103245|P2|Main Study: After Study Restart|Noncompliance|1
941836|NCT00828204|3103246|P1|Main Study: After Study Restart|Noncompliance|0
941837|NCT00828204|3103245|P2|Main Study: After Study Restart|Adverse Event|2
941838|NCT00828204|3103246|P1|Main Study: After Study Restart|Adverse Event|0
941839|NCT00828204|3103245|P2|Main Study: Prior to Study Suspension|Study Suspension|0
941840|NCT00828204|3103246|P1|Main Study: Prior to Study Suspension|Study Suspension|11
941841|NCT00828204|3103245|P2|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0
941842|NCT00828204|3103246|P1|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2
941843|NCT00828204|3103245|P2|Main Study: Prior to Study Suspension|Adverse Event|0
941844|NCT00828204|3103246|P1|Main Study: Prior to Study Suspension|Adverse Event|1
941845|NCT00828139|3103293|P4|Overall Study|Not specified|2
941846|NCT00828139|3103294|P3|Overall Study|Not specified|5
941847|NCT00828139|3103295|P2|Overall Study|Not specified|2
941848|NCT00828139|3103296|P1|Overall Study|Not specified|4
941849|NCT00828139|3103293|P4|Overall Study|Disease Progression|39
941850|NCT00828139|3103294|P3|Overall Study|Disease Progression|35
941851|NCT00828139|3103295|P2|Overall Study|Disease Progression|33
941852|NCT00828139|3103296|P1|Overall Study|Disease Progression|24
941853|NCT00828139|3103293|P4|Overall Study|Refusal unrelated to toxicity|3
941854|NCT00828139|3103294|P3|Overall Study|Refusal unrelated to toxicity|5
941855|NCT00828139|3103295|P2|Overall Study|Refusal unrelated to toxicity|4
941856|NCT00828139|3103296|P1|Overall Study|Refusal unrelated to toxicity|3
941857|NCT00828139|3103293|P4|Overall Study|Death|2
941858|NCT00828139|3103294|P3|Overall Study|Death|0
941859|NCT00828139|3103295|P2|Overall Study|Death|1
941860|NCT00828139|3103296|P1|Overall Study|Death|2
941861|NCT00828139|3103293|P4|Overall Study|Adverse Event|5
941862|NCT00828139|3103294|P3|Overall Study|Adverse Event|10
941863|NCT00828139|3103295|P2|Overall Study|Adverse Event|1
941864|NCT00828139|3103296|P1|Overall Study|Adverse Event|8
941865|NCT00828113|3103316|P2|Overall Study|Lost to Follow-up|5
941866|NCT00828113|3103317|P1|Overall Study|Lost to Follow-up|3
941867|NCT00828113|3103316|P2|Overall Study|Withdrawal by Subject|26
941868|NCT00828113|3103317|P1|Overall Study|Withdrawal by Subject|27
941869|NCT00827931|3103391|P2|Overall Study|Other|0
941870|NCT00827931|3103392|P1|Overall Study|Other|1
941871|NCT00827931|3103391|P2|Overall Study|Withdrawal by Subject|1
941872|NCT00827931|3103392|P1|Overall Study|Withdrawal by Subject|0
941873|NCT00827931|3103391|P2|Overall Study|Lost to Follow-up|0
941874|NCT00827931|3103392|P1|Overall Study|Lost to Follow-up|1
941875|NCT00827931|3103391|P2|Overall Study|Adverse Event|0
941876|NCT00827931|3103392|P1|Overall Study|Adverse Event|1
941877|NCT00827931|3103391|P2|Overall Study|Death|5
941878|NCT00827931|3103392|P1|Overall Study|Death|3
941879|NCT00827918|3103413|P3|Overall Study|Withdrawal by Subject|6
941880|NCT00827918|3103414|P2|Overall Study|Withdrawal by Subject|2
941881|NCT00827918|3103415|P1|Overall Study|Withdrawal by Subject|6
941882|NCT00827918|3103413|P3|Overall Study|Protocol Violation|0
941883|NCT00827918|3103414|P2|Overall Study|Protocol Violation|1
941884|NCT00827918|3103415|P1|Overall Study|Protocol Violation|0
941885|NCT00827918|3103413|P3|Overall Study|Progressive Disease|0
941886|NCT00827918|3103414|P2|Overall Study|Progressive Disease|1
941887|NCT00827918|3103415|P1|Overall Study|Progressive Disease|1
941888|NCT00827918|3103413|P3|Overall Study|Pregnancy|0
941889|NCT00827918|3103414|P2|Overall Study|Pregnancy|1
941890|NCT00827918|3103415|P1|Overall Study|Pregnancy|0
941891|NCT00827918|3103413|P3|Overall Study|Physician Decision|0
941892|NCT00827918|3103414|P2|Overall Study|Physician Decision|0
941893|NCT00827918|3103415|P1|Overall Study|Physician Decision|1
941894|NCT00827918|3103413|P3|Overall Study|Lack of Efficacy|15
941895|NCT00827918|3103414|P2|Overall Study|Lack of Efficacy|4
941896|NCT00827918|3103415|P1|Overall Study|Lack of Efficacy|16
941897|NCT00827918|3103413|P3|Overall Study|Adverse Event|0
941898|NCT00827918|3103414|P2|Overall Study|Adverse Event|0
941899|NCT00827918|3103415|P1|Overall Study|Adverse Event|4
941900|NCT00827827|3103443|P2|Overall Study|Burned with water at home|0
941901|NCT00827827|3103444|P1|Overall Study|Burned with water at home|1
941902|NCT00827827|3103443|P2|Overall Study|Transportation issues|0
941903|NCT00827827|3103444|P1|Overall Study|Transportation issues|1
941904|NCT00827827|3103443|P2|Overall Study|Gout|0
941905|NCT00827827|3103444|P1|Overall Study|Gout|1
941906|NCT00827827|3103443|P2|Overall Study|Another cerebrovascular accident (CVA)|0
941907|NCT00827827|3103444|P1|Overall Study|Another cerebrovascular accident (CVA)|1
941908|NCT00827827|3103443|P2|Overall Study|Fall at home- hospitalization|0
941909|NCT00827827|3103444|P1|Overall Study|Fall at home- hospitalization|1
941910|NCT00827827|3103443|P2|Overall Study|Lost to Follow-up|0
941911|NCT00827827|3103444|P1|Overall Study|Lost to Follow-up|3
941912|NCT00827632|3103488|P2|Overall Study|Early withdrawal|11
941913|NCT00827632|3103489|P1|Overall Study|Early withdrawal|14
941914|NCT00827632|3103488|P2|Overall Study|Lost to Follow-up|12
941915|NCT00827632|3103489|P1|Overall Study|Lost to Follow-up|8
941916|NCT00827606|3103497|P2|Overall Study|Adverse Event|2
941917|NCT00827606|3103498|P1|Overall Study|Adverse Event|4
941918|NCT00827606|3103497|P2|Overall Study|LDL below 2.59 mmol/L|12
941919|NCT00827606|3103498|P1|Overall Study|LDL below 2.59 mmol/L|4
941920|NCT00827606|3103497|P2|Overall Study|Not specified|13
941921|NCT00827606|3103498|P1|Overall Study|Not specified|5
941922|NCT00827606|3103497|P2|Overall Study|Pregnancy|1
941923|NCT00827606|3103498|P1|Overall Study|Pregnancy|0
941924|NCT00827606|3103497|P2|Overall Study|Withdrawal by Subject|6
941925|NCT00827606|3103498|P1|Overall Study|Withdrawal by Subject|7
941926|NCT00827606|3103497|P2|Overall Study|Lost to Follow-up|1
941927|NCT00827606|3103498|P1|Overall Study|Lost to Follow-up|3
941928|NCT00827606|3103497|P2|Overall Study|Protocol Violation|3
941929|NCT00827606|3103498|P1|Overall Study|Protocol Violation|4
941930|NCT00827567|3103559|P1|Overall Study|Progression of Disease/Screen Failure|4
941931|NCT00827541|3103565|P2|Overall Study|Lack of effectiveness|0
941932|NCT00827541|3103566|P1|Overall Study|Lack of effectiveness|1
941933|NCT00827541|3103565|P2|Overall Study|Pathogen not susceptible|0
941934|NCT00827541|3103566|P1|Overall Study|Pathogen not susceptible|1
941935|NCT00827541|3103565|P2|Overall Study|Other|3
941936|NCT00827541|3103566|P1|Overall Study|Other|1
941937|NCT00827541|3103565|P2|Overall Study|Exitus|8
941938|NCT00827541|3103566|P1|Overall Study|Exitus|1
941939|NCT00827502|3103578|P1|Overall Study|Withdrawal by Subject|5
941940|NCT00827502|3103578|P1|Overall Study|Lost to Follow-up|4
941941|NCT00827502|3103578|P1|Overall Study|Adverse Event|1
941942|NCT00827502|3103578|P1|Overall Study|randomized but not treated|11
941943|NCT00827372|3103584|P1|Overall Study|Lack of Efficacy|3
941944|NCT00827372|3103584|P1|Overall Study|Adverse Event|5
941945|NCT00827242|3103599|P2|Overall Study|Lack of Efficacy|0
941946|NCT00827242|3103600|P1|Overall Study|Lack of Efficacy|1
941947|NCT00827242|3103599|P2|Overall Study|Death|0
941948|NCT00827242|3103600|P1|Overall Study|Death|1
941949|NCT00827242|3103599|P2|Overall Study|Physician Decision|0
941950|NCT00827242|3103600|P1|Overall Study|Physician Decision|2
941951|NCT00827242|3103599|P2|Overall Study|Entry Criteria Not Met|1
941952|NCT00827242|3103600|P1|Overall Study|Entry Criteria Not Met|4
941953|NCT00827242|3103599|P2|Overall Study|Adverse Event Excluding Death|1
941954|NCT00827242|3103600|P1|Overall Study|Adverse Event Excluding Death|2
941955|NCT00827242|3103599|P2|Overall Study|Lost to Follow-up|3
941956|NCT00827242|3103600|P1|Overall Study|Lost to Follow-up|0
941957|NCT00827242|3103599|P2|Overall Study|Protocol Violation|3
941958|NCT00827242|3103600|P1|Overall Study|Protocol Violation|1
941959|NCT00827242|3103599|P2|Overall Study|Withdrawal by Subject|4
941960|NCT00827242|3103600|P1|Overall Study|Withdrawal by Subject|2
941961|NCT00827112|3103638|P2|Overall Study|Other|3
941962|NCT00827112|3103639|P1|Overall Study|Other|1
941963|NCT00827112|3103638|P2|Overall Study|Randomized but not treated|3
941964|NCT00827112|3103639|P1|Overall Study|Randomized but not treated|5
941965|NCT00827112|3103638|P2|Overall Study|Withdrawal by Subject|1
941966|NCT00827112|3103639|P1|Overall Study|Withdrawal by Subject|2
941967|NCT00827112|3103638|P2|Overall Study|Protocol Violation|2
941968|NCT00827112|3103639|P1|Overall Study|Protocol Violation|0
941969|NCT00827112|3103638|P2|Overall Study|Pregnancy|1
941970|NCT00827112|3103639|P1|Overall Study|Pregnancy|0
941971|NCT00827112|3103638|P2|Overall Study|Lost to Follow-up|2
941972|NCT00827112|3103639|P1|Overall Study|Lost to Follow-up|3
941973|NCT00827112|3103638|P2|Overall Study|Lack of Efficacy|0
941974|NCT00827112|3103639|P1|Overall Study|Lack of Efficacy|2
941975|NCT00827112|3103638|P2|Overall Study|Adverse Event|0
941976|NCT00827112|3103639|P1|Overall Study|Adverse Event|2
941977|NCT00826943|3103692|P6|Overall Study|Withdrawal by Subject|0
941978|NCT00826943|3103693|P5|Overall Study|Withdrawal by Subject|1
941979|NCT00826943|3103694|P4|Overall Study|Withdrawal by Subject|0
941980|NCT00826943|3103695|P3|Overall Study|Withdrawal by Subject|0
941981|NCT00826943|3103696|P2|Overall Study|Withdrawal by Subject|0
941982|NCT00826943|3103697|P1|Overall Study|Withdrawal by Subject|0
941983|NCT00826748|3103718|P3|Overall Study|Samples Did Not pass QC|1
941984|NCT00826748|3103719|P2|Overall Study|Samples Did Not pass QC|0
941985|NCT00826748|3103720|P1|Overall Study|Samples Did Not pass QC|0
941986|NCT00826748|3103718|P3|Overall Study|Physician Decision|1
941987|NCT00826748|3103719|P2|Overall Study|Physician Decision|0
941988|NCT00826748|3103720|P1|Overall Study|Physician Decision|0
941989|NCT00826748|3103718|P3|Overall Study|Withdrawal by Subject|2
941990|NCT00826748|3103719|P2|Overall Study|Withdrawal by Subject|0
941991|NCT00826748|3103720|P1|Overall Study|Withdrawal by Subject|0
941992|NCT00826618|3103728|P1|Overall Study|Withdrawal by Subject|1
941993|NCT00826540|3103732|P1|Overall Study|Withdrawal by Subject|1
941994|NCT00826540|3103732|P1|Overall Study|ineligible|3
941995|NCT00826449|3103738|P1|Overall Study|Withdrawal by Subject|1
941996|NCT00826449|3103738|P1|Overall Study|Disease Progression|4
941997|NCT00826280|3103747|P3|Overall Study|One or more non-interpretable scan|1
941998|NCT00826280|3103748|P2|Overall Study|One or more non-interpretable scan|1
941999|NCT00826280|3103749|P1|Overall Study|One or more non-interpretable scan|0
942000|NCT00826280|3103747|P3|Overall Study|Machine Failure|0
942001|NCT00826280|3103748|P2|Overall Study|Machine Failure|1
942002|NCT00826280|3103749|P1|Overall Study|Machine Failure|1
942003|NCT00826280|3103747|P3|Overall Study|Interpretation Failure|0
942004|NCT00826280|3103748|P2|Overall Study|Interpretation Failure|0
942005|NCT00826280|3103749|P1|Overall Study|Interpretation Failure|1
942006|NCT00826280|3103747|P3|Overall Study|Reversible ischemic defect not present|44
942007|NCT00826280|3103748|P2|Overall Study|Reversible ischemic defect not present|40
942008|NCT00826280|3103749|P1|Overall Study|Reversible ischemic defect not present|43
942009|NCT00826280|3103747|P3|Overall Study|Sponsor discontinued subject or study|0
942010|NCT00826280|3103748|P2|Overall Study|Sponsor discontinued subject or study|0
942011|NCT00826280|3103749|P1|Overall Study|Sponsor discontinued subject or study|1
942012|NCT00826280|3103747|P3|Overall Study|Lost to Follow-up|0
942013|NCT00826280|3103748|P2|Overall Study|Lost to Follow-up|1
942014|NCT00826280|3103749|P1|Overall Study|Lost to Follow-up|0
942015|NCT00826280|3103747|P3|Overall Study|Adverse Event|0
942016|NCT00826280|3103748|P2|Overall Study|Adverse Event|3
942017|NCT00826280|3103749|P1|Overall Study|Adverse Event|1
942018|NCT00826280|3103747|P3|Overall Study|Randomized but drug not received|1
942019|NCT00826280|3103748|P2|Overall Study|Randomized but drug not received|0
942020|NCT00826280|3103749|P1|Overall Study|Randomized but drug not received|1
942021|NCT00826267|3103778|P3|Overall Study|Other Adverse Event|0
942022|NCT00826267|3103779|P2|Overall Study|Other Adverse Event|0
942023|NCT00826267|3103780|P1|Overall Study|Other Adverse Event|1
942024|NCT00826228|3103798|P1|Overall Study|Withdrawal by Subject|1
942025|NCT00826176|3103820|P2|Overall Study|Administrative|0
942026|NCT00826176|3103821|P1|Overall Study|Administrative|9
942027|NCT00826176|3103820|P2|Overall Study|Subject Withdrew Consent|0
942028|NCT00826176|3103821|P1|Overall Study|Subject Withdrew Consent|3
942029|NCT00826176|3103820|P2|Overall Study|Lost to Follow-up|0
942030|NCT00826176|3103821|P1|Overall Study|Lost to Follow-up|1
942031|NCT00826111|3103833|P2|Overall Study|Physician Decision|1
942032|NCT00826111|3103834|P1|Overall Study|Physician Decision|1
942033|NCT00826111|3103833|P2|Overall Study|Withdrawal by Subject|0
942034|NCT00826111|3103834|P1|Overall Study|Withdrawal by Subject|5
942035|NCT00826111|3103833|P2|Overall Study|Protocol Violation|0
942036|NCT00826111|3103834|P1|Overall Study|Protocol Violation|1
942037|NCT00826111|3103833|P2|Overall Study|Lost to Follow-up|1
942038|NCT00826111|3103834|P1|Overall Study|Lost to Follow-up|0
942039|NCT00825994|3103864|P1|Overall Study|Placebo Responder at V2|1
942040|NCT00825994|3103864|P1|Overall Study|Protocol Violation|1
942041|NCT00825994|3103864|P1|Overall Study|Lost to Follow-up|1
942042|NCT00825994|3103864|P1|Overall Study|Withdrawal by Subject|2
942043|NCT00825916|3103872|P3|Overall Study|Lost to Follow-up|1
942044|NCT00825916|3103873|P2|Overall Study|Lost to Follow-up|2
942045|NCT00825916|3103874|P1|Overall Study|Lost to Follow-up|4
942046|NCT00825825|3103915|P6|Third Medication Period (14 Days)|poor data quality|0
942047|NCT00825825|3103916|P5|Third Medication Period (14 Days)|poor data quality|0
942048|NCT00825825|3103917|P4|Third Medication Period (14 Days)|poor data quality|0
942049|NCT00825825|3103918|P3|Third Medication Period (14 Days)|poor data quality|0
942050|NCT00825825|3103919|P2|Third Medication Period (14 Days)|poor data quality|1
942051|NCT00825825|3103920|P1|Third Medication Period (14 Days)|poor data quality|0
942052|NCT00825825|3103915|P6|Third Medication Period (14 Days)|Protocol Violation|2
942053|NCT00825825|3103916|P5|Third Medication Period (14 Days)|Protocol Violation|0
942054|NCT00825825|3103917|P4|Third Medication Period (14 Days)|Protocol Violation|0
942055|NCT00825825|3103918|P3|Third Medication Period (14 Days)|Protocol Violation|0
942056|NCT00825825|3103919|P2|Third Medication Period (14 Days)|Protocol Violation|0
942057|NCT00825825|3103920|P1|Third Medication Period (14 Days)|Protocol Violation|0
942058|NCT00825825|3103915|P6|Third Medication Period (14 Days)|Adverse Event|0
942059|NCT00825825|3103916|P5|Third Medication Period (14 Days)|Adverse Event|0
942060|NCT00825825|3103917|P4|Third Medication Period (14 Days)|Adverse Event|0
942061|NCT00825825|3103918|P3|Third Medication Period (14 Days)|Adverse Event|0
942062|NCT00825825|3103919|P2|Third Medication Period (14 Days)|Adverse Event|1
942063|NCT00825825|3103920|P1|Third Medication Period (14 Days)|Adverse Event|0
942064|NCT00825825|3103915|P6|Second Medication Period (14 Days)|Protocol Violation|0
942065|NCT00825825|3103916|P5|Second Medication Period (14 Days)|Protocol Violation|1
942066|NCT00825825|3103917|P4|Second Medication Period (14 Days)|Protocol Violation|0
942067|NCT00825825|3103918|P3|Second Medication Period (14 Days)|Protocol Violation|0
942068|NCT00825825|3103919|P2|Second Medication Period (14 Days)|Protocol Violation|0
942069|NCT00825825|3103920|P1|Second Medication Period (14 Days)|Protocol Violation|1
942070|NCT00825825|3103915|P6|Second Medication Period (14 Days)|Physician Decision|0
942071|NCT00825825|3103916|P5|Second Medication Period (14 Days)|Physician Decision|0
942072|NCT00825825|3103917|P4|Second Medication Period (14 Days)|Physician Decision|2
942073|NCT00825825|3103918|P3|Second Medication Period (14 Days)|Physician Decision|0
942074|NCT00825825|3103919|P2|Second Medication Period (14 Days)|Physician Decision|0
942075|NCT00825825|3103920|P1|Second Medication Period (14 Days)|Physician Decision|1
942076|NCT00825825|3103915|P6|First Medication Period (14 Days)|Physician Decision|1
942077|NCT00825825|3103916|P5|First Medication Period (14 Days)|Physician Decision|0
942078|NCT00825825|3103917|P4|First Medication Period (14 Days)|Physician Decision|0
942079|NCT00825825|3103918|P3|First Medication Period (14 Days)|Physician Decision|1
942080|NCT00825825|3103919|P2|First Medication Period (14 Days)|Physician Decision|0
942081|NCT00825825|3103920|P1|First Medication Period (14 Days)|Physician Decision|2
942082|NCT00825825|3103915|P6|First Medication Period (14 Days)|Adverse Event|1
942083|NCT00825825|3103916|P5|First Medication Period (14 Days)|Adverse Event|0
942084|NCT00825825|3103917|P4|First Medication Period (14 Days)|Adverse Event|0
942085|NCT00825825|3103918|P3|First Medication Period (14 Days)|Adverse Event|0
942086|NCT00825825|3103919|P2|First Medication Period (14 Days)|Adverse Event|0
942087|NCT00825825|3103920|P1|First Medication Period (14 Days)|Adverse Event|1
942088|NCT00825812|3103936|P4|Overall Study|Administrative|5
942089|NCT00825812|3103937|P3|Overall Study|Administrative|3
942090|NCT00825812|3103938|P2|Overall Study|Administrative|1
942091|NCT00825812|3103939|P1|Overall Study|Administrative|0
942092|NCT00825812|3103936|P4|Overall Study|Non-compliance with protocol|1
942093|NCT00825812|3103937|P3|Overall Study|Non-compliance with protocol|0
942094|NCT00825812|3103938|P2|Overall Study|Non-compliance with protocol|0
942095|NCT00825812|3103939|P1|Overall Study|Non-compliance with protocol|0
942096|NCT00825812|3103936|P4|Overall Study|Subject withdrew consent|2
942097|NCT00825812|3103937|P3|Overall Study|Subject withdrew consent|3
942098|NCT00825812|3103938|P2|Overall Study|Subject withdrew consent|0
942099|NCT00825812|3103939|P1|Overall Study|Subject withdrew consent|0
942100|NCT00825812|3103936|P4|Overall Study|Adverse Event|1
942101|NCT00825812|3103937|P3|Overall Study|Adverse Event|0
942102|NCT00825812|3103938|P2|Overall Study|Adverse Event|0
942103|NCT00825812|3103939|P1|Overall Study|Adverse Event|0
942104|NCT00825812|3103936|P4|Overall Study|Never entered follow up|1
942105|NCT00825812|3103937|P3|Overall Study|Never entered follow up|0
942106|NCT00825812|3103938|P2|Overall Study|Never entered follow up|0
942107|NCT00825812|3103939|P1|Overall Study|Never entered follow up|0
942108|NCT00825682|3103986|P2|Overall Study|personal reasons/ inconvenience|5
942109|NCT00825682|3103987|P1|Overall Study|personal reasons/ inconvenience|13
942110|NCT00825305|3104078|P2|Overall Study|Can not be classified|1
942111|NCT00825305|3104079|P1|Overall Study|Can not be classified|0
942112|NCT00825305|3104078|P2|Overall Study|Protocol Violation|9
942113|NCT00825305|3104079|P1|Overall Study|Protocol Violation|9
942114|NCT00825305|3104078|P2|Overall Study|Inappropriate inclusion|0
942115|NCT00825305|3104079|P1|Overall Study|Inappropriate inclusion|1
942116|NCT00825305|3104078|P2|Overall Study|Withdrawal by Subject|12
942117|NCT00825305|3104079|P1|Overall Study|Withdrawal by Subject|6
942118|NCT00825305|3104078|P2|Overall Study|Adverse Event|1
942119|NCT00825305|3104079|P1|Overall Study|Adverse Event|1
942120|NCT00825175|3104119|P2|Overall Study|Withdrawal by Subject|5
942121|NCT00825175|3104120|P1|Overall Study|Withdrawal by Subject|0
942122|NCT00825162|3104129|P3|Overall Study|Unable to attend the study visit|0
942123|NCT00825162|3104130|P2|Overall Study|Unable to attend the study visit|2
942124|NCT00825162|3104131|P1|Overall Study|Unable to attend the study visit|5
942125|NCT00825162|3104129|P3|Overall Study|Move away from the study area|0
942126|NCT00825162|3104130|P2|Overall Study|Move away from the study area|0
942127|NCT00825162|3104131|P1|Overall Study|Move away from the study area|1
942128|NCT00825162|3104129|P3|Overall Study|Physician Decision|0
942129|NCT00825162|3104130|P2|Overall Study|Physician Decision|0
942130|NCT00825162|3104131|P1|Overall Study|Physician Decision|2
942131|NCT00825162|3104129|P3|Overall Study|Lost to Follow-up|3
942132|NCT00825162|3104130|P2|Overall Study|Lost to Follow-up|6
942133|NCT00825162|3104131|P1|Overall Study|Lost to Follow-up|9
942134|NCT00825162|3104129|P3|Overall Study|Withdrawal by Subject|3
942135|NCT00825162|3104130|P2|Overall Study|Withdrawal by Subject|13
942136|NCT00825162|3104131|P1|Overall Study|Withdrawal by Subject|11
942137|NCT00824993|3104157|P2|Overall Study|Death|3
942138|NCT00824993|3104158|P1|Overall Study|Death|0
942139|NCT00824993|3104157|P2|Overall Study|Insurance Issue|1
942140|NCT00824993|3104158|P1|Overall Study|Insurance Issue|2
942141|NCT00824993|3104157|P2|Overall Study|Non-Compliant|1
942142|NCT00824993|3104158|P1|Overall Study|Non-Compliant|2
942143|NCT00824993|3104157|P2|Overall Study|Rapid Bone Loss|1
942144|NCT00824993|3104158|P1|Overall Study|Rapid Bone Loss|0
942145|NCT00824993|3104157|P2|Overall Study|Malignancy Relapse|10
942146|NCT00824993|3104158|P1|Overall Study|Malignancy Relapse|9
942147|NCT00824993|3104157|P2|Overall Study|Withdrawal by Subject|1
942148|NCT00824993|3104158|P1|Overall Study|Withdrawal by Subject|1
942149|NCT00824850|3104166|P2|Overall Study|Withdrawal by Subject|1
942150|NCT00824850|3104167|P1|Overall Study|Withdrawal by Subject|0
942151|NCT00824772|3104220|P1|Overall Study|Withdrawal by Subject|8
942152|NCT00824720|3104240|P3|Overall Study|Protocol Violation|1
942153|NCT00824720|3104241|P2|Overall Study|Protocol Violation|0
942154|NCT00824720|3104242|P1|Overall Study|Protocol Violation|0
942155|NCT00824720|3104240|P3|Overall Study|failed plug insertion|0
942156|NCT00824720|3104241|P2|Overall Study|failed plug insertion|1
942157|NCT00824720|3104242|P1|Overall Study|failed plug insertion|3
942158|NCT00824655|3104258|P2|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0
942159|NCT00824655|3104259|P1|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1
942160|NCT00824655|3104258|P2|Toddler Dose (12 Months of Age)|Adverse Event|0
942161|NCT00824655|3104259|P1|Toddler Dose (12 Months of Age)|Adverse Event|1
942162|NCT00824616|3104279|P2|Overall Study|Withdrawal by Subject|1
942163|NCT00824616|3104280|P1|Overall Study|Withdrawal by Subject|1
942164|NCT00824616|3104279|P2|Overall Study|Lost to Follow-up|1
942165|NCT00824616|3104280|P1|Overall Study|Lost to Follow-up|0
942166|NCT00824616|3104279|P2|Overall Study|Lack of Efficacy|1
942167|NCT00824616|3104280|P1|Overall Study|Lack of Efficacy|2
942168|NCT00824616|3104279|P2|Overall Study|Hyperglycemia|1
942169|NCT00824616|3104280|P1|Overall Study|Hyperglycemia|1
942170|NCT00824616|3104279|P2|Overall Study|Creatinine/Creatinine Clearance|2
942171|NCT00824616|3104280|P1|Overall Study|Creatinine/Creatinine Clearance|0
942172|NCT00824616|3104279|P2|Overall Study|Adverse Event|1
942173|NCT00824616|3104280|P1|Overall Study|Adverse Event|2
942174|NCT00824564|3104290|P2|Overall Study|Randomized, but not treated|0
942175|NCT00824564|3104291|P1|Overall Study|Randomized, but not treated|1
942176|NCT00824564|3104290|P2|Overall Study|Other|2
942177|NCT00824564|3104291|P1|Overall Study|Other|1
942178|NCT00824564|3104290|P2|Overall Study|Withdrawal by Subject|1
942179|NCT00824564|3104291|P1|Overall Study|Withdrawal by Subject|1
942180|NCT00824564|3104290|P2|Overall Study|Lost to Follow-up|7
942181|NCT00824564|3104291|P1|Overall Study|Lost to Follow-up|5
942182|NCT00824473|3104370|P2|Overall Study|Other|1
942183|NCT00824473|3104371|P1|Overall Study|Other|1
942184|NCT00824473|3104370|P2|Overall Study|Withdrawal by Subject|3
942185|NCT00824473|3104371|P1|Overall Study|Withdrawal by Subject|2
942186|NCT00824473|3104370|P2|Overall Study|Non-Compliance|2
942187|NCT00824473|3104371|P1|Overall Study|Non-Compliance|4
942188|NCT00824473|3104370|P2|Overall Study|Protocol Violation|0
942189|NCT00824473|3104371|P1|Overall Study|Protocol Violation|2
942190|NCT00824473|3104370|P2|Overall Study|Lack of Efficacy|2
942191|NCT00824473|3104371|P1|Overall Study|Lack of Efficacy|2
942192|NCT00824473|3104370|P2|Overall Study|Adverse Event|5
942193|NCT00824473|3104371|P1|Overall Study|Adverse Event|4
942194|NCT00824421|3104452|P3|Overall Study|Other|0
942195|NCT00824421|3104453|P2|Overall Study|Other|1
942196|NCT00824421|3104454|P1|Overall Study|Other|0
942197|NCT00824421|3104452|P3|Overall Study|Randomized but not Treated|0
942198|NCT00824421|3104453|P2|Overall Study|Randomized but not Treated|1
942199|NCT00824421|3104454|P1|Overall Study|Randomized but not Treated|1
942200|NCT00824421|3104452|P3|Overall Study|Withdrawal by Subject|3
942201|NCT00824421|3104453|P2|Overall Study|Withdrawal by Subject|3
942202|NCT00824421|3104454|P1|Overall Study|Withdrawal by Subject|2
942203|NCT00824421|3104452|P3|Overall Study|Pregnancy|1
942204|NCT00824421|3104453|P2|Overall Study|Pregnancy|0
942205|NCT00824421|3104454|P1|Overall Study|Pregnancy|1
942206|NCT00824421|3104452|P3|Overall Study|Lost to Follow-up|0
942207|NCT00824421|3104453|P2|Overall Study|Lost to Follow-up|3
942208|NCT00824421|3104454|P1|Overall Study|Lost to Follow-up|2
942209|NCT00824421|3104452|P3|Overall Study|Lack of Efficacy|4
942210|NCT00824421|3104453|P2|Overall Study|Lack of Efficacy|7
942211|NCT00824421|3104454|P1|Overall Study|Lack of Efficacy|5
942212|NCT00824421|3104452|P3|Overall Study|Death|0
942213|NCT00824421|3104453|P2|Overall Study|Death|1
942214|NCT00824421|3104454|P1|Overall Study|Death|0
942215|NCT00824421|3104452|P3|Overall Study|Adverse Event|6
942216|NCT00824421|3104453|P2|Overall Study|Adverse Event|6
942217|NCT00824421|3104454|P1|Overall Study|Adverse Event|6
942218|NCT00824408|3104505|P5|Randomized Phase|Other reason not defined above|4
942219|NCT00824408|3104506|P4|Randomized Phase|Other reason not defined above|2
942220|NCT00824408|3104507|P3|Randomized Phase|Other reason not defined above|4
942221|NCT00824408|3104508|P2|Randomized Phase|Other reason not defined above|0
942222|NCT00824408|3104509|P1|Randomized Phase|Other reason not defined above|0
942223|NCT00824408|3104505|P5|Randomized Phase|Refused to continue medication|2
942224|NCT00824408|3104506|P4|Randomized Phase|Refused to continue medication|2
942225|NCT00824408|3104507|P3|Randomized Phase|Refused to continue medication|2
942226|NCT00824408|3104508|P2|Randomized Phase|Refused to continue medication|0
942227|NCT00824408|3104509|P1|Randomized Phase|Refused to continue medication|0
942228|NCT00824408|3104505|P5|Randomized Phase|Adverse Event|5
942229|NCT00824408|3104506|P4|Randomized Phase|Adverse Event|5
942230|NCT00824408|3104507|P3|Randomized Phase|Adverse Event|4
942231|NCT00824408|3104508|P2|Randomized Phase|Adverse Event|0
942232|NCT00824408|3104509|P1|Randomized Phase|Adverse Event|0
942233|NCT00824408|3104505|P5|Randomized Phase|Progressive disease|34
942234|NCT00824408|3104506|P4|Randomized Phase|Progressive disease|36
942235|NCT00824408|3104507|P3|Randomized Phase|Progressive disease|25
942236|NCT00824408|3104508|P2|Randomized Phase|Progressive disease|0
942237|NCT00824408|3104509|P1|Randomized Phase|Progressive disease|0
942238|NCT00824408|3104505|P5|Randomized Phase|Not treated|1
942239|NCT00824408|3104506|P4|Randomized Phase|Not treated|1
942240|NCT00824408|3104507|P3|Randomized Phase|Not treated|1
942241|NCT00824408|3104508|P2|Randomized Phase|Not treated|0
942242|NCT00824408|3104509|P1|Randomized Phase|Not treated|0
942243|NCT00824408|3104505|P5|Run-in Phase|Other reason not defined above|0
942244|NCT00824408|3104506|P4|Run-in Phase|Other reason not defined above|0
942245|NCT00824408|3104507|P3|Run-in Phase|Other reason not defined above|0
942246|NCT00824408|3104508|P2|Run-in Phase|Other reason not defined above|1
942247|NCT00824408|3104509|P1|Run-in Phase|Other reason not defined above|0
942248|NCT00824408|3104505|P5|Run-in Phase|Refused to continue medication|0
942249|NCT00824408|3104506|P4|Run-in Phase|Refused to continue medication|0
942250|NCT00824408|3104507|P3|Run-in Phase|Refused to continue medication|0
942251|NCT00824408|3104508|P2|Run-in Phase|Refused to continue medication|0
942252|NCT00824408|3104509|P1|Run-in Phase|Refused to continue medication|1
942253|NCT00824408|3104505|P5|Run-in Phase|Adverse Event|0
942254|NCT00824408|3104506|P4|Run-in Phase|Adverse Event|0
942255|NCT00824408|3104507|P3|Run-in Phase|Adverse Event|0
942256|NCT00824408|3104508|P2|Run-in Phase|Adverse Event|1
942257|NCT00824408|3104509|P1|Run-in Phase|Adverse Event|1
942258|NCT00824408|3104505|P5|Run-in Phase|Progressive disease|0
942259|NCT00824408|3104506|P4|Run-in Phase|Progressive disease|0
942260|NCT00824408|3104507|P3|Run-in Phase|Progressive disease|0
942261|NCT00824408|3104508|P2|Run-in Phase|Progressive disease|4
942262|NCT00824408|3104509|P1|Run-in Phase|Progressive disease|4
942263|NCT00824382|3104561|P4|Overall Study|Investigator's decision|0
942264|NCT00824382|3104562|P3|Overall Study|Investigator's decision|2
942265|NCT00824382|3104563|P2|Overall Study|Investigator's decision|1
942266|NCT00824382|3104564|P1|Overall Study|Investigator's decision|0
942267|NCT00824382|3104561|P4|Overall Study|Protocol Violation|1
942268|NCT00824382|3104562|P3|Overall Study|Protocol Violation|0
942269|NCT00824382|3104563|P2|Overall Study|Protocol Violation|0
942270|NCT00824382|3104564|P1|Overall Study|Protocol Violation|1
942271|NCT00824382|3104561|P4|Overall Study|Adverse Event|4
942272|NCT00824382|3104562|P3|Overall Study|Adverse Event|1
942273|NCT00824382|3104563|P2|Overall Study|Adverse Event|1
942274|NCT00824382|3104564|P1|Overall Study|Adverse Event|4
942275|NCT00824369|3104640|P6|Overall Study|Lost to Follow-up|0
942276|NCT00824369|3104641|P5|Overall Study|Lost to Follow-up|1
942277|NCT00824369|3104642|P4|Overall Study|Lost to Follow-up|0
942278|NCT00824369|3104643|P3|Overall Study|Lost to Follow-up|0
942279|NCT00824369|3104644|P2|Overall Study|Lost to Follow-up|0
942280|NCT00824369|3104645|P1|Overall Study|Lost to Follow-up|0
942281|NCT00824369|3104640|P6|Overall Study|Nolonger willing to participate in study|1
942282|NCT00824369|3104641|P5|Overall Study|Nolonger willing to participate in study|0
942283|NCT00824369|3104642|P4|Overall Study|Nolonger willing to participate in study|2
942284|NCT00824369|3104643|P3|Overall Study|Nolonger willing to participate in study|1
942285|NCT00824369|3104644|P2|Overall Study|Nolonger willing to participate in study|0
942286|NCT00824369|3104645|P1|Overall Study|Nolonger willing to participate in study|1
942287|NCT00824291|3104685|P2|Overall Study|Participant on prohibited medication|0
942288|NCT00824291|3104686|P1|Overall Study|Participant on prohibited medication|1
942289|NCT00824291|3104685|P2|Overall Study|Lack of Efficacy|8
942290|NCT00824291|3104686|P1|Overall Study|Lack of Efficacy|7
942291|NCT00824291|3104685|P2|Overall Study|Withdrawal by Subject|8
942292|NCT00824291|3104686|P1|Overall Study|Withdrawal by Subject|14
942293|NCT00824291|3104685|P2|Overall Study|Protocol Violation|1
942294|NCT00824291|3104686|P1|Overall Study|Protocol Violation|4
942295|NCT00824291|3104685|P2|Overall Study|Non-compliance|1
942296|NCT00824291|3104686|P1|Overall Study|Non-compliance|1
942297|NCT00824291|3104685|P2|Overall Study|Lost to Follow-up|9
942298|NCT00824291|3104686|P1|Overall Study|Lost to Follow-up|11
942299|NCT00824291|3104685|P2|Overall Study|Discontinuation of Study by Sponsor|2
942300|NCT00824291|3104686|P1|Overall Study|Discontinuation of Study by Sponsor|1
942301|NCT00824291|3104685|P2|Overall Study|Adverse Event|6
942302|NCT00824291|3104686|P1|Overall Study|Adverse Event|15
942303|NCT00824265|3104708|P2|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16
942304|NCT00824265|3104709|P1|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9
942305|NCT00824265|3104708|P2|Follow-up Phase|w/drew consent, no f/u, or MD choice|31
942306|NCT00824265|3104709|P1|Follow-up Phase|w/drew consent, no f/u, or MD choice|18
942307|NCT00824265|3104708|P2|Treatment Phase|Withdrawal by Subject|15
942308|NCT00824265|3104709|P1|Treatment Phase|Withdrawal by Subject|6
942309|NCT00824265|3104708|P2|Treatment Phase|Physician Decision|12
942310|NCT00824265|3104709|P1|Treatment Phase|Physician Decision|6
942311|NCT00824265|3104708|P2|Treatment Phase|Lost to Follow-up|1
942312|NCT00824265|3104709|P1|Treatment Phase|Lost to Follow-up|1
942313|NCT00824265|3104708|P2|Treatment Phase|Protocol Violation|0
942314|NCT00824265|3104709|P1|Treatment Phase|Protocol Violation|1
942315|NCT00824265|3104708|P2|Treatment Phase|Adverse Event,non-fatal|52
942316|NCT00824265|3104709|P1|Treatment Phase|Adverse Event,non-fatal|50
942317|NCT00824161|3104770|P1|Overall Study|Screen Failure|1
942318|NCT00824161|3104770|P1|Overall Study|Withdrawal by Subject|1
942319|NCT00824005|3104836|P2|Overall Study|Lost to Follow-up|1
942320|NCT00824005|3104837|P1|Overall Study|Lost to Follow-up|0
942321|NCT00824005|3104836|P2|Overall Study|Death|1
942322|NCT00824005|3104837|P1|Overall Study|Death|0
942323|NCT00823979|3104872|P3|Overall Study|Study Terminated by Sponsor|7
942324|NCT00823979|3104873|P2|Overall Study|Study Terminated by Sponsor|5
942325|NCT00823979|3104874|P1|Overall Study|Study Terminated by Sponsor|5
942326|NCT00823979|3104872|P3|Overall Study|Randomized but not Treated|1
942327|NCT00823979|3104873|P2|Overall Study|Randomized but not Treated|3
942328|NCT00823979|3104874|P1|Overall Study|Randomized but not Treated|4
942329|NCT00823979|3104872|P3|Overall Study|Other|1
942330|NCT00823979|3104873|P2|Overall Study|Other|0
942331|NCT00823979|3104874|P1|Overall Study|Other|2
942332|NCT00823979|3104872|P3|Overall Study|Adverse Event|4
942333|NCT00823979|3104873|P2|Overall Study|Adverse Event|2
942334|NCT00823979|3104874|P1|Overall Study|Adverse Event|0
942335|NCT00823979|3104872|P3|Overall Study|Pregnancy|0
942336|NCT00823979|3104873|P2|Overall Study|Pregnancy|1
942337|NCT00823979|3104874|P1|Overall Study|Pregnancy|0
942338|NCT00823979|3104872|P3|Overall Study|Protocol Violation|0
942339|NCT00823979|3104873|P2|Overall Study|Protocol Violation|1
942340|NCT00823979|3104874|P1|Overall Study|Protocol Violation|1
942341|NCT00823979|3104872|P3|Overall Study|Withdrawal by Subject|2
942342|NCT00823979|3104873|P2|Overall Study|Withdrawal by Subject|3
942343|NCT00823979|3104874|P1|Overall Study|Withdrawal by Subject|2
942344|NCT00823979|3104872|P3|Overall Study|Lost to Follow-up|0
942345|NCT00823979|3104873|P2|Overall Study|Lost to Follow-up|1
942346|NCT00823979|3104874|P1|Overall Study|Lost to Follow-up|2
942347|NCT00823979|3104872|P3|Overall Study|Lack of Efficacy|9
942348|NCT00823979|3104873|P2|Overall Study|Lack of Efficacy|16
942349|NCT00823979|3104874|P1|Overall Study|Lack of Efficacy|13
942350|NCT00823901|3104919|P2|Overall Study|Lost to Follow-up|1
942351|NCT00823901|3104920|P1|Overall Study|Lost to Follow-up|2
942352|NCT00823901|3104919|P2|Overall Study|Lack of Efficacy|0
942353|NCT00823901|3104920|P1|Overall Study|Lack of Efficacy|1
942354|NCT00823901|3104919|P2|Overall Study|Adverse Event|1
942355|NCT00823901|3104920|P1|Overall Study|Adverse Event|1
942356|NCT00823836|3104928|P2|Long-term Phase|Withdrawal by Subject|1
942357|NCT00823836|3104929|P1|Long-term Phase|Withdrawal by Subject|1
942358|NCT00823836|3104928|P2|Long-term Phase|Physician Decision|2
942359|NCT00823836|3104929|P1|Long-term Phase|Physician Decision|1
942360|NCT00823836|3104928|P2|Long-term Phase|Adverse Event|2
942361|NCT00823836|3104929|P1|Long-term Phase|Adverse Event|3
942362|NCT00823836|3104928|P2|NV and PR/XR Switching Phases|Withdrawal by Subject|5
942363|NCT00823836|3104929|P1|NV and PR/XR Switching Phases|Withdrawal by Subject|4
942364|NCT00823836|3104928|P2|NV and PR/XR Switching Phases|Physician Decision|2
942365|NCT00823836|3104929|P1|NV and PR/XR Switching Phases|Physician Decision|5
942366|NCT00823836|3104928|P2|NV and PR/XR Switching Phases|Protocol Violation|1
942367|NCT00823836|3104929|P1|NV and PR/XR Switching Phases|Protocol Violation|1
942368|NCT00823836|3104928|P2|NV and PR/XR Switching Phases|Adverse Event|21
942369|NCT00823836|3104929|P1|NV and PR/XR Switching Phases|Adverse Event|22
942370|NCT00823823|3105035|P2|Overall Study|Protocol Violation|5
942371|NCT00823823|3105036|P1|Overall Study|Protocol Violation|5
942372|NCT00823823|3105035|P2|Overall Study|Lost to Follow-up|1
942373|NCT00823823|3105036|P1|Overall Study|Lost to Follow-up|3
942374|NCT00823719|3105060|P2|Overall Study|Disease Progression|4
942375|NCT00823719|3105061|P1|Overall Study|Disease Progression|4
942376|NCT00823719|3105060|P2|Overall Study|Withdrawal by Subject|1
942377|NCT00823719|3105061|P1|Overall Study|Withdrawal by Subject|0
942378|NCT00823719|3105060|P2|Overall Study|Physician Decision|4
942379|NCT00823719|3105061|P1|Overall Study|Physician Decision|1
942380|NCT00823719|3105060|P2|Overall Study|Adverse Event|2
942381|NCT00823719|3105061|P1|Overall Study|Adverse Event|1
942382|NCT00823615|3105114|P2|Period 2|Time/Job Conflict|2
942383|NCT00823615|3105115|P1|Period 2|Time/Job Conflict|1
942384|NCT00823615|3105114|P2|Period 2|Lost to Follow-up|0
942385|NCT00823615|3105115|P1|Period 2|Lost to Follow-up|2
942386|NCT00823472|3105125|P2|Overall Study|Physician Decision|28
942387|NCT00823472|3105126|P1|Overall Study|Physician Decision|24
942388|NCT00823264|3105145|P2|Overall Study|Protocol Violation|0
942389|NCT00823264|3105146|P1|Overall Study|Protocol Violation|2
942390|NCT00823212|3105154|P2|Overall Study|Missed 12-month visit|21
942391|NCT00823212|3105155|P1|Overall Study|Missed 12-month visit|21
942392|NCT00823212|3105154|P2|Overall Study|Incarcerated|1
942393|NCT00823212|3105155|P1|Overall Study|Incarcerated|0
942394|NCT00823212|3105154|P2|Overall Study|Withdrawal by Subject|1
942395|NCT00823212|3105155|P1|Overall Study|Withdrawal by Subject|6
942396|NCT00823212|3105154|P2|Overall Study|Death|10
942397|NCT00823212|3105155|P1|Overall Study|Death|8
942398|NCT00823199|3105237|P1|Overall Study|Withdrawal by Subject|2
942399|NCT00822926|3105306|P2|Second Injection Visit|Withdrawal by Subject|1
942400|NCT00822926|3105307|P1|Second Injection Visit|Withdrawal by Subject|0
942401|NCT00822926|3105306|P2|Second Injection Visit|Lost to Follow-up|0
942402|NCT00822926|3105307|P1|Second Injection Visit|Lost to Follow-up|1
942403|NCT00822900|3105321|P2|Overall Study|Became a ward of the state|1
942404|NCT00822900|3105322|P1|Overall Study|Became a ward of the state|2
942405|NCT00822900|3105321|P2|Overall Study|Death|69
942406|NCT00822900|3105322|P1|Overall Study|Death|83
942407|NCT00822900|3105321|P2|Overall Study|Lost to Follow-up|9
942408|NCT00822900|3105322|P1|Overall Study|Lost to Follow-up|9
942409|NCT00822900|3105321|P2|Overall Study|Withdrawal by Subject|14
942410|NCT00822900|3105322|P1|Overall Study|Withdrawal by Subject|14
942411|NCT00822692|3105369|P2|Overall Study|Lost to Follow-up|25
942412|NCT00822692|3105370|P1|Overall Study|Lost to Follow-up|17
942413|NCT00822237|3105508|P2|Dose 2 Vaccination|Lost to Follow-up|9
942414|NCT00822237|3105509|P1|Dose 2 Vaccination|Lost to Follow-up|2
942415|NCT00822237|3105508|P2|Dose 2 Vaccination|Withdrawal by Subject|2
942416|NCT00822237|3105509|P1|Dose 2 Vaccination|Withdrawal by Subject|2
942417|NCT00822237|3105508|P2|Dose 1 Vaccination|Lost to Follow-up|12
942418|NCT00822237|3105509|P1|Dose 1 Vaccination|Lost to Follow-up|9
942419|NCT00822237|3105508|P2|Dose 1 Vaccination|Withdrawal by Subject|14
942420|NCT00822237|3105509|P1|Dose 1 Vaccination|Withdrawal by Subject|13
942421|NCT00822237|3105508|P2|Dose 1 Vaccination|Not vaccinated|0
942422|NCT00822237|3105509|P1|Dose 1 Vaccination|Not vaccinated|3
942423|NCT00822172|3105590|P2|Overall Study|Other|1
942424|NCT00822172|3105591|P1|Overall Study|Other|0
942425|NCT00822172|3105590|P2|Overall Study|site closed|1
942426|NCT00822172|3105591|P1|Overall Study|site closed|0
942427|NCT00822172|3105590|P2|Overall Study|Withdrawal by Subject|4
942428|NCT00822172|3105591|P1|Overall Study|Withdrawal by Subject|1
942429|NCT00822172|3105590|P2|Overall Study|Lost to Follow-up|1
942430|NCT00822172|3105591|P1|Overall Study|Lost to Follow-up|3
942431|NCT00822172|3105590|P2|Overall Study|Death|0
942432|NCT00822172|3105591|P1|Overall Study|Death|1
942433|NCT00822172|3105590|P2|Overall Study|Adverse Event|12
942434|NCT00822172|3105591|P1|Overall Study|Adverse Event|10
942435|NCT00822120|3105599|P6|PET-directed Therapy|Protocol Violation|0
942436|NCT00822120|3105600|P5|PET-directed Therapy|Protocol Violation|0
942437|NCT00822120|3105601|P4|PET-directed Therapy|Protocol Violation|6
942438|NCT00822120|3105602|P3|PET-directed Therapy|Protocol Violation|0
942439|NCT00822120|3105603|P2|PET-directed Therapy|Protocol Violation|0
942440|NCT00822120|3105604|P1|PET-directed Therapy|Protocol Violation|0
942441|NCT00822120|3105599|P6|PET-directed Therapy|Death|0
942442|NCT00822120|3105600|P5|PET-directed Therapy|Death|0
942443|NCT00822120|3105601|P4|PET-directed Therapy|Death|2
942444|NCT00822120|3105602|P3|PET-directed Therapy|Death|0
942445|NCT00822120|3105603|P2|PET-directed Therapy|Death|0
942446|NCT00822120|3105604|P1|PET-directed Therapy|Death|0
942447|NCT00822120|3105599|P6|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
942448|NCT00822120|3105600|P5|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
942449|NCT00822120|3105601|P4|PET-directed Therapy|Refusal Unrelated to Adverse Event|1
942450|NCT00822120|3105602|P3|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
942451|NCT00822120|3105603|P2|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
942452|NCT00822120|3105604|P1|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
942453|NCT00822120|3105599|P6|PET-directed Therapy|Adverse Event|0
942454|NCT00822120|3105600|P5|PET-directed Therapy|Adverse Event|0
942455|NCT00822120|3105601|P4|PET-directed Therapy|Adverse Event|1
942456|NCT00822120|3105602|P3|PET-directed Therapy|Adverse Event|0
942457|NCT00822120|3105603|P2|PET-directed Therapy|Adverse Event|0
942458|NCT00822120|3105604|P1|PET-directed Therapy|Adverse Event|0
942459|NCT00822120|3105599|P6|Initial Registration|Ineligible|0
942460|NCT00822120|3105600|P5|Initial Registration|Ineligible|0
942461|NCT00822120|3105601|P4|Initial Registration|Ineligible|0
942462|NCT00822120|3105602|P3|Initial Registration|Ineligible|0
942463|NCT00822120|3105603|P2|Initial Registration|Ineligible|1
942464|NCT00822120|3105604|P1|Initial Registration|Ineligible|22
942465|NCT00822120|3105599|P6|Initial Registration|Reasons not Protocol Specified|0
942466|NCT00822120|3105600|P5|Initial Registration|Reasons not Protocol Specified|0
942467|NCT00822120|3105601|P4|Initial Registration|Reasons not Protocol Specified|0
942468|NCT00822120|3105602|P3|Initial Registration|Reasons not Protocol Specified|0
942469|NCT00822120|3105603|P2|Initial Registration|Reasons not Protocol Specified|0
942470|NCT00822120|3105604|P1|Initial Registration|Reasons not Protocol Specified|2
942471|NCT00822120|3105599|P6|Initial Registration|Refusal Unrelated to Adverse Event|0
942472|NCT00822120|3105600|P5|Initial Registration|Refusal Unrelated to Adverse Event|0
942473|NCT00822120|3105601|P4|Initial Registration|Refusal Unrelated to Adverse Event|0
942474|NCT00822120|3105602|P3|Initial Registration|Refusal Unrelated to Adverse Event|0
942475|NCT00822120|3105603|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
942476|NCT00822120|3105604|P1|Initial Registration|Refusal Unrelated to Adverse Event|1
942477|NCT00822120|3105599|P6|Initial Registration|Adverse Event|0
942478|NCT00822120|3105600|P5|Initial Registration|Adverse Event|0
942479|NCT00822120|3105601|P4|Initial Registration|Adverse Event|0
942480|NCT00822120|3105602|P3|Initial Registration|Adverse Event|0
942481|NCT00822120|3105603|P2|Initial Registration|Adverse Event|0
942482|NCT00822120|3105604|P1|Initial Registration|Adverse Event|1
942483|NCT00821873|3105666|P1|Overall Study|Lost to Follow-up|4
942484|NCT00821678|3105687|P2|Overall Study|Death|2
942485|NCT00821678|3105688|P1|Overall Study|Death|0
942486|NCT00821678|3105687|P2|Overall Study|Lost to Follow-up|12
942487|NCT00821678|3105688|P1|Overall Study|Lost to Follow-up|13
942488|NCT00821678|3105687|P2|Overall Study|Withdrawal by Subject|0
942489|NCT00821678|3105688|P1|Overall Study|Withdrawal by Subject|8
942490|NCT00821587|3105706|P2|Overall Study|Physician Decision|1
942491|NCT00821587|3105707|P1|Overall Study|Physician Decision|0
942492|NCT00821509|3105716|P3|Overall Study|Withdrawal by Subject|34
942493|NCT00821509|3105717|P2|Overall Study|Withdrawal by Subject|11
942494|NCT00821509|3105718|P1|Overall Study|Withdrawal by Subject|12
942495|NCT00821431|3105731|P2|Overall Study|Physician Decision|1
942496|NCT00821431|3105732|P1|Overall Study|Physician Decision|0
942497|NCT00821431|3105731|P2|Overall Study|Protocol Violation|1
942498|NCT00821431|3105732|P1|Overall Study|Protocol Violation|3
942499|NCT00821431|3105731|P2|Overall Study|Lost to Follow-up|0
942500|NCT00821431|3105732|P1|Overall Study|Lost to Follow-up|1
942501|NCT00821431|3105731|P2|Overall Study|Withdrawal by Subject|0
942502|NCT00821431|3105732|P1|Overall Study|Withdrawal by Subject|5
942503|NCT00821431|3105731|P2|Overall Study|Adverse Event|3
942504|NCT00821431|3105732|P1|Overall Study|Adverse Event|6
942505|NCT00821327|3105740|P1|Overall Study|Other/Unknown|5
942506|NCT00821327|3105740|P1|Overall Study|Disease Progression|13
942507|NCT00821327|3105740|P1|Overall Study|Sponsor Request|1
942508|NCT00821327|3105740|P1|Overall Study|Investigator Request|2
942509|NCT00821327|3105740|P1|Overall Study|Patient Request|1
942510|NCT00821327|3105740|P1|Overall Study|Adverse Event|13
942511|NCT00821236|3105749|P1|Overall Study|Lost to Follow-up|3
942512|NCT00821093|3105789|P2|Overall Study|Administrative problems|2
942513|NCT00821093|3105790|P1|Overall Study|Administrative problems|1
942514|NCT00821093|3105789|P2|Overall Study|Abnormal test procedure result(s)|1
942515|NCT00821093|3105790|P1|Overall Study|Abnormal test procedure result(s)|1
942516|NCT00821093|3105789|P2|Overall Study|Death|1
942517|NCT00821093|3105790|P1|Overall Study|Death|2
942518|NCT00821093|3105789|P2|Overall Study|Lack of Efficacy|2
942519|NCT00821093|3105790|P1|Overall Study|Lack of Efficacy|2
942520|NCT00821093|3105789|P2|Overall Study|Abnormal laboratory value(s)|0
942521|NCT00821093|3105790|P1|Overall Study|Abnormal laboratory value(s)|2
942522|NCT00821093|3105789|P2|Overall Study|Protocol deviation|6
942523|NCT00821093|3105790|P1|Overall Study|Protocol deviation|3
942524|NCT00821093|3105789|P2|Overall Study|Lost to Follow-up|3
942525|NCT00821093|3105790|P1|Overall Study|Lost to Follow-up|9
942526|NCT00821093|3105789|P2|Overall Study|Withdrawal by Subject|13
942527|NCT00821093|3105790|P1|Overall Study|Withdrawal by Subject|9
942528|NCT00821093|3105789|P2|Overall Study|Adverse Event|12
942529|NCT00821093|3105790|P1|Overall Study|Adverse Event|20
942530|NCT00820898|3105809|P1|Overall Study|Inelgible - wrong primary site|1
942531|NCT00820755|3105823|P3|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
942532|NCT00820755|3105824|P2|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
942533|NCT00820755|3105825|P1|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0
942534|NCT00820755|3105823|P3|Period 1: Combination Therapy Phase|Other|0
942535|NCT00820755|3105824|P2|Period 1: Combination Therapy Phase|Other|0
942536|NCT00820755|3105825|P1|Period 1: Combination Therapy Phase|Other|11
942537|NCT00820755|3105823|P3|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
942538|NCT00820755|3105824|P2|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
942539|NCT00820755|3105825|P1|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14
942540|NCT00820755|3105823|P3|Period 1: Combination Therapy Phase|Progressive disease|0
942541|NCT00820755|3105824|P2|Period 1: Combination Therapy Phase|Progressive disease|0
942542|NCT00820755|3105825|P1|Period 1: Combination Therapy Phase|Progressive disease|114
942543|NCT00820755|3105823|P3|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
942544|NCT00820755|3105824|P2|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
942545|NCT00820755|3105825|P1|Period 1: Combination Therapy Phase|Withdrawal by Subject|21
942546|NCT00820755|3105823|P3|Period 1: Combination Therapy Phase|Lost to Follow-up|0
942547|NCT00820755|3105824|P2|Period 1: Combination Therapy Phase|Lost to Follow-up|0
942548|NCT00820755|3105825|P1|Period 1: Combination Therapy Phase|Lost to Follow-up|1
942549|NCT00820755|3105823|P3|Period 1: Combination Therapy Phase|Protocol Violation|0
942550|NCT00820755|3105824|P2|Period 1: Combination Therapy Phase|Protocol Violation|0
942551|NCT00820755|3105825|P1|Period 1: Combination Therapy Phase|Protocol Violation|4
942552|NCT00820755|3105823|P3|Period 1: Combination Therapy Phase|Death|0
942553|NCT00820755|3105824|P2|Period 1: Combination Therapy Phase|Death|0
942554|NCT00820755|3105825|P1|Period 1: Combination Therapy Phase|Death|28
942555|NCT00820755|3105823|P3|Period 1: Combination Therapy Phase|Adverse Event|0
942556|NCT00820755|3105824|P2|Period 1: Combination Therapy Phase|Adverse Event|0
942557|NCT00820755|3105825|P1|Period 1: Combination Therapy Phase|Adverse Event|77
942558|NCT00820248|3105918|P2|Overall Study|No treated|1
942559|NCT00820248|3105919|P1|Overall Study|No treated|4
942560|NCT00820222|3105929|P2|Overall Study|Ongoing|191
942561|NCT00820222|3105930|P1|Overall Study|Ongoing|185
942562|NCT00820222|3105929|P2|Overall Study|Sponsor Terminated Study|1
942563|NCT00820222|3105930|P1|Overall Study|Sponsor Terminated Study|0
942564|NCT00820222|3105929|P2|Overall Study|Physician Decision|6
942565|NCT00820222|3105930|P1|Overall Study|Physician Decision|4
942566|NCT00820222|3105929|P2|Overall Study|Withdrawal by Subject|9
942567|NCT00820222|3105930|P1|Overall Study|Withdrawal by Subject|8
942568|NCT00820222|3105929|P2|Overall Study|Lost to Follow-up|4
942569|NCT00820222|3105930|P1|Overall Study|Lost to Follow-up|4
942570|NCT00819910|3105960|P4|Overall Study|Lost to Follow-up|0
942571|NCT00819910|3105961|P3|Overall Study|Lost to Follow-up|0
942572|NCT00819910|3105962|P2|Overall Study|Lost to Follow-up|0
942573|NCT00819910|3105963|P1|Overall Study|Lost to Follow-up|1
942574|NCT00819910|3105960|P4|Overall Study|Withdrawal by Subject|0
942575|NCT00819910|3105961|P3|Overall Study|Withdrawal by Subject|1
942576|NCT00819910|3105962|P2|Overall Study|Withdrawal by Subject|1
942577|NCT00819910|3105963|P1|Overall Study|Withdrawal by Subject|1
942578|NCT00819910|3105960|P4|Overall Study|Adverse Event|1
942579|NCT00819910|3105961|P3|Overall Study|Adverse Event|2
942580|NCT00819910|3105962|P2|Overall Study|Adverse Event|0
942581|NCT00819910|3105963|P1|Overall Study|Adverse Event|0
942582|NCT00819832|3105995|P6|Overall Study|Sponsor Termination of Study|0
942583|NCT00819832|3105996|P5|Overall Study|Sponsor Termination of Study|0
942584|NCT00819832|3105997|P4|Overall Study|Sponsor Termination of Study|0
942585|NCT00819832|3105998|P3|Overall Study|Sponsor Termination of Study|0
942586|NCT00819832|3105999|P2|Overall Study|Sponsor Termination of Study|0
942587|NCT00819832|3106000|P1|Overall Study|Sponsor Termination of Study|3
942588|NCT00819780|3106016|P2|Overall Study|Still in treatment|17
942589|NCT00819780|3106017|P1|Overall Study|Still in treatment|25
942590|NCT00819780|3106016|P2|Overall Study|Did not receive study drug|4
942591|NCT00819780|3106017|P1|Overall Study|Did not receive study drug|3
942592|NCT00819767|3106051|P2|Overall Study|Unsatisfactory therapeutic effect|2
942593|NCT00819767|3106052|P1|Overall Study|Unsatisfactory therapeutic effect|1
942594|NCT00819741|3106064|P2|Overall Study|Reasons unknown|3
942595|NCT00819741|3106065|P1|Overall Study|Reasons unknown|3
942596|NCT00819741|3106064|P2|Overall Study|Unclassified|0
942597|NCT00819741|3106065|P1|Overall Study|Unclassified|6
942598|NCT00819741|3106064|P2|Overall Study|Withdrawal by Subject|2
942599|NCT00819741|3106065|P1|Overall Study|Withdrawal by Subject|2
942600|NCT00819741|3106064|P2|Overall Study|Protocol Violation|4
942601|NCT00819741|3106065|P1|Overall Study|Protocol Violation|3
942602|NCT00819741|3106064|P2|Overall Study|Lost to Follow-up|1
942603|NCT00819741|3106065|P1|Overall Study|Lost to Follow-up|3
942604|NCT00819741|3106064|P2|Overall Study|Lack of Efficacy|2
942605|NCT00819741|3106065|P1|Overall Study|Lack of Efficacy|0
942606|NCT00819741|3106064|P2|Overall Study|Adverse Event|2
942607|NCT00819741|3106065|P1|Overall Study|Adverse Event|5
942608|NCT00819585|3106119|P11|Extension Study|Death|0
942609|NCT00819585|3106120|P10|Extension Study|Death|0
942610|NCT00819585|3106121|P9|Extension Study|Death|2
942611|NCT00819585|3106122|P8|Extension Study|Death|0
942612|NCT00819585|3106123|P7|Extension Study|Death|0
942613|NCT00819585|3106124|P6|Extension Study|Death|0
942614|NCT00819585|3106125|P5|Extension Study|Death|0
942615|NCT00819585|3106126|P4|Extension Study|Death|0
942616|NCT00819585|3106127|P3|Extension Study|Death|0
942617|NCT00819585|3106128|P2|Extension Study|Death|0
942618|NCT00819585|3106129|P1|Extension Study|Death|0
942619|NCT00819585|3106119|P11|Extension Study|Lost to Follow-up|1
942620|NCT00819585|3106120|P10|Extension Study|Lost to Follow-up|1
942621|NCT00819585|3106121|P9|Extension Study|Lost to Follow-up|2
942622|NCT00819585|3106122|P8|Extension Study|Lost to Follow-up|0
942623|NCT00819585|3106123|P7|Extension Study|Lost to Follow-up|0
942624|NCT00819585|3106124|P6|Extension Study|Lost to Follow-up|0
942625|NCT00819585|3106125|P5|Extension Study|Lost to Follow-up|0
942626|NCT00819585|3106126|P4|Extension Study|Lost to Follow-up|0
942627|NCT00819585|3106127|P3|Extension Study|Lost to Follow-up|0
942628|NCT00819585|3106128|P2|Extension Study|Lost to Follow-up|0
942629|NCT00819585|3106129|P1|Extension Study|Lost to Follow-up|0
942630|NCT00819585|3106119|P11|Extension Study|Subject Withdrew Consent|1
942631|NCT00819585|3106120|P10|Extension Study|Subject Withdrew Consent|0
942632|NCT00819585|3106121|P9|Extension Study|Subject Withdrew Consent|3
942633|NCT00819585|3106122|P8|Extension Study|Subject Withdrew Consent|0
942634|NCT00819585|3106123|P7|Extension Study|Subject Withdrew Consent|0
942635|NCT00819585|3106124|P6|Extension Study|Subject Withdrew Consent|0
942636|NCT00819585|3106125|P5|Extension Study|Subject Withdrew Consent|0
942637|NCT00819585|3106126|P4|Extension Study|Subject Withdrew Consent|0
942638|NCT00819585|3106127|P3|Extension Study|Subject Withdrew Consent|0
942639|NCT00819585|3106128|P2|Extension Study|Subject Withdrew Consent|0
942640|NCT00819585|3106129|P1|Extension Study|Subject Withdrew Consent|0
942641|NCT00819585|3106119|P11|Extension Study|Abnormal Laboratory Value(s)|0
942642|NCT00819585|3106120|P10|Extension Study|Abnormal Laboratory Value(s)|0
942643|NCT00819585|3106121|P9|Extension Study|Abnormal Laboratory Value(s)|1
942644|NCT00819585|3106122|P8|Extension Study|Abnormal Laboratory Value(s)|0
942645|NCT00819585|3106123|P7|Extension Study|Abnormal Laboratory Value(s)|0
942646|NCT00819585|3106124|P6|Extension Study|Abnormal Laboratory Value(s)|0
942647|NCT00819585|3106125|P5|Extension Study|Abnormal Laboratory Value(s)|0
942648|NCT00819585|3106126|P4|Extension Study|Abnormal Laboratory Value(s)|0
942649|NCT00819585|3106127|P3|Extension Study|Abnormal Laboratory Value(s)|0
942650|NCT00819585|3106128|P2|Extension Study|Abnormal Laboratory Value(s)|0
942651|NCT00819585|3106129|P1|Extension Study|Abnormal Laboratory Value(s)|0
942652|NCT00819585|3106119|P11|Core Study|Protocol Violation|0
942653|NCT00819585|3106120|P10|Core Study|Protocol Violation|0
942654|NCT00819585|3106121|P9|Core Study|Protocol Violation|0
942655|NCT00819585|3106122|P8|Core Study|Protocol Violation|0
942656|NCT00819585|3106123|P7|Core Study|Protocol Violation|3
942657|NCT00819585|3106124|P6|Core Study|Protocol Violation|1
942658|NCT00819585|3106125|P5|Core Study|Protocol Violation|0
942659|NCT00819585|3106126|P4|Core Study|Protocol Violation|0
942660|NCT00819585|3106127|P3|Core Study|Protocol Violation|1
942661|NCT00819585|3106128|P2|Core Study|Protocol Violation|0
942662|NCT00819585|3106129|P1|Core Study|Protocol Violation|0
942663|NCT00819585|3106119|P11|Core Study|Death|0
942664|NCT00819585|3106120|P10|Core Study|Death|0
942665|NCT00819585|3106121|P9|Core Study|Death|0
942666|NCT00819585|3106122|P8|Core Study|Death|0
942667|NCT00819585|3106123|P7|Core Study|Death|1
942668|NCT00819585|3106124|P6|Core Study|Death|0
942669|NCT00819585|3106125|P5|Core Study|Death|0
942670|NCT00819585|3106126|P4|Core Study|Death|0
942671|NCT00819585|3106127|P3|Core Study|Death|0
942672|NCT00819585|3106128|P2|Core Study|Death|0
942673|NCT00819585|3106129|P1|Core Study|Death|0
942674|NCT00819585|3106119|P11|Core Study|Administrative Problems|0
942675|NCT00819585|3106120|P10|Core Study|Administrative Problems|0
942676|NCT00819585|3106121|P9|Core Study|Administrative Problems|0
942677|NCT00819585|3106122|P8|Core Study|Administrative Problems|0
942678|NCT00819585|3106123|P7|Core Study|Administrative Problems|2
942679|NCT00819585|3106124|P6|Core Study|Administrative Problems|0
942680|NCT00819585|3106125|P5|Core Study|Administrative Problems|0
942681|NCT00819585|3106126|P4|Core Study|Administrative Problems|0
942682|NCT00819585|3106127|P3|Core Study|Administrative Problems|0
942683|NCT00819585|3106128|P2|Core Study|Administrative Problems|0
942684|NCT00819585|3106129|P1|Core Study|Administrative Problems|0
942685|NCT00819585|3106119|P11|Core Study|Lost to Follow-up|0
942686|NCT00819585|3106120|P10|Core Study|Lost to Follow-up|0
942687|NCT00819585|3106121|P9|Core Study|Lost to Follow-up|0
942688|NCT00819585|3106122|P8|Core Study|Lost to Follow-up|0
942689|NCT00819585|3106123|P7|Core Study|Lost to Follow-up|1
942690|NCT00819585|3106124|P6|Core Study|Lost to Follow-up|1
942691|NCT00819585|3106125|P5|Core Study|Lost to Follow-up|1
942692|NCT00819585|3106126|P4|Core Study|Lost to Follow-up|0
942693|NCT00819585|3106127|P3|Core Study|Lost to Follow-up|2
942694|NCT00819585|3106128|P2|Core Study|Lost to Follow-up|1
942695|NCT00819585|3106129|P1|Core Study|Lost to Follow-up|2
942696|NCT00819585|3106119|P11|Core Study|Subject Withdrew Consent|0
942697|NCT00819585|3106120|P10|Core Study|Subject Withdrew Consent|0
942698|NCT00819585|3106121|P9|Core Study|Subject Withdrew Consent|0
942699|NCT00819585|3106122|P8|Core Study|Subject Withdrew Consent|0
942700|NCT00819585|3106123|P7|Core Study|Subject Withdrew Consent|3
942701|NCT00819585|3106124|P6|Core Study|Subject Withdrew Consent|0
942702|NCT00819585|3106125|P5|Core Study|Subject Withdrew Consent|0
942703|NCT00819585|3106126|P4|Core Study|Subject Withdrew Consent|1
942704|NCT00819585|3106127|P3|Core Study|Subject Withdrew Consent|2
942705|NCT00819585|3106128|P2|Core Study|Subject Withdrew Consent|3
942706|NCT00819585|3106129|P1|Core Study|Subject Withdrew Consent|0
942707|NCT00819585|3106119|P11|Core Study|Subject No Longer Requires Study Drug|0
942708|NCT00819585|3106120|P10|Core Study|Subject No Longer Requires Study Drug|0
942709|NCT00819585|3106121|P9|Core Study|Subject No Longer Requires Study Drug|0
942710|NCT00819585|3106122|P8|Core Study|Subject No Longer Requires Study Drug|0
942711|NCT00819585|3106123|P7|Core Study|Subject No Longer Requires Study Drug|0
942712|NCT00819585|3106124|P6|Core Study|Subject No Longer Requires Study Drug|0
942713|NCT00819585|3106125|P5|Core Study|Subject No Longer Requires Study Drug|1
942714|NCT00819585|3106126|P4|Core Study|Subject No Longer Requires Study Drug|0
942715|NCT00819585|3106127|P3|Core Study|Subject No Longer Requires Study Drug|0
942716|NCT00819585|3106128|P2|Core Study|Subject No Longer Requires Study Drug|0
942717|NCT00819585|3106129|P1|Core Study|Subject No Longer Requires Study Drug|0
942718|NCT00819585|3106119|P11|Core Study|Unsatisfactory Therapeutic Effect|0
942719|NCT00819585|3106120|P10|Core Study|Unsatisfactory Therapeutic Effect|0
942720|NCT00819585|3106121|P9|Core Study|Unsatisfactory Therapeutic Effect|0
942721|NCT00819585|3106122|P8|Core Study|Unsatisfactory Therapeutic Effect|0
942722|NCT00819585|3106123|P7|Core Study|Unsatisfactory Therapeutic Effect|1
942723|NCT00819585|3106124|P6|Core Study|Unsatisfactory Therapeutic Effect|0
942724|NCT00819585|3106125|P5|Core Study|Unsatisfactory Therapeutic Effect|0
942725|NCT00819585|3106126|P4|Core Study|Unsatisfactory Therapeutic Effect|0
942726|NCT00819585|3106127|P3|Core Study|Unsatisfactory Therapeutic Effect|0
942727|NCT00819585|3106128|P2|Core Study|Unsatisfactory Therapeutic Effect|1
942728|NCT00819585|3106129|P1|Core Study|Unsatisfactory Therapeutic Effect|0
942729|NCT00819585|3106119|P11|Core Study|Abnormal Laboratory Value(s)|0
942730|NCT00819585|3106120|P10|Core Study|Abnormal Laboratory Value(s)|0
942731|NCT00819585|3106121|P9|Core Study|Abnormal Laboratory Value(s)|0
942732|NCT00819585|3106122|P8|Core Study|Abnormal Laboratory Value(s)|0
942733|NCT00819585|3106123|P7|Core Study|Abnormal Laboratory Value(s)|0
942734|NCT00819585|3106124|P6|Core Study|Abnormal Laboratory Value(s)|0
942735|NCT00819585|3106125|P5|Core Study|Abnormal Laboratory Value(s)|0
942736|NCT00819585|3106126|P4|Core Study|Abnormal Laboratory Value(s)|0
942737|NCT00819585|3106127|P3|Core Study|Abnormal Laboratory Value(s)|0
942738|NCT00819585|3106128|P2|Core Study|Abnormal Laboratory Value(s)|0
942739|NCT00819585|3106129|P1|Core Study|Abnormal Laboratory Value(s)|2
942740|NCT00819585|3106119|P11|Core Study|Adverse Event|0
942741|NCT00819585|3106120|P10|Core Study|Adverse Event|0
942742|NCT00819585|3106121|P9|Core Study|Adverse Event|0
942743|NCT00819585|3106122|P8|Core Study|Adverse Event|0
942744|NCT00819585|3106123|P7|Core Study|Adverse Event|2
942745|NCT00819585|3106124|P6|Core Study|Adverse Event|0
942746|NCT00819585|3106125|P5|Core Study|Adverse Event|1
942747|NCT00819585|3106126|P4|Core Study|Adverse Event|4
942748|NCT00819585|3106127|P3|Core Study|Adverse Event|1
942749|NCT00819585|3106128|P2|Core Study|Adverse Event|1
942750|NCT00819585|3106129|P1|Core Study|Adverse Event|2
942751|NCT00819390|3106220|P4|Overall Study|Adverse Event|0
942752|NCT00819390|3106221|P3|Overall Study|Adverse Event|1
942753|NCT00819390|3106222|P2|Overall Study|Adverse Event|0
942754|NCT00819390|3106223|P1|Overall Study|Adverse Event|0
942755|NCT00819390|3106220|P4|Overall Study|Withdrawal by Subject|0
942756|NCT00819390|3106221|P3|Overall Study|Withdrawal by Subject|0
942757|NCT00819390|3106222|P2|Overall Study|Withdrawal by Subject|0
942758|NCT00819390|3106223|P1|Overall Study|Withdrawal by Subject|2
942759|NCT00819390|3106220|P4|Overall Study|Lost to Follow-up|0
942760|NCT00819390|3106221|P3|Overall Study|Lost to Follow-up|0
942761|NCT00819390|3106222|P2|Overall Study|Lost to Follow-up|1
942762|NCT00819390|3106223|P1|Overall Study|Lost to Follow-up|1
942763|NCT00819247|3106359|P3|Overall Study|not specified|0
942764|NCT00819247|3106360|P2|Overall Study|not specified|0
942765|NCT00819247|3106361|P1|Overall Study|not specified|1
942766|NCT00819247|3106359|P3|Overall Study|Bad prostate-specific antigen response|0
942767|NCT00819247|3106360|P2|Overall Study|Bad prostate-specific antigen response|2
942768|NCT00819247|3106361|P1|Overall Study|Bad prostate-specific antigen response|3
942769|NCT00819247|3106359|P3|Overall Study|Mistakenly withdrawn|0
942770|NCT00819247|3106360|P2|Overall Study|Mistakenly withdrawn|1
942771|NCT00819247|3106361|P1|Overall Study|Mistakenly withdrawn|0
942772|NCT00819247|3106359|P3|Overall Study|Protocol Violation|1
942773|NCT00819247|3106360|P2|Overall Study|Protocol Violation|0
942774|NCT00819247|3106361|P1|Overall Study|Protocol Violation|1
942775|NCT00819247|3106359|P3|Overall Study|Withdrawal by Subject|0
942776|NCT00819247|3106360|P2|Overall Study|Withdrawal by Subject|0
942777|NCT00819247|3106361|P1|Overall Study|Withdrawal by Subject|1
942778|NCT00819247|3106359|P3|Overall Study|Insufficient testosterone response|10
942779|NCT00819247|3106360|P2|Overall Study|Insufficient testosterone response|8
942780|NCT00819247|3106361|P1|Overall Study|Insufficient testosterone response|5
942781|NCT00819247|3106359|P3|Overall Study|Adverse Event|3
942782|NCT00819247|3106360|P2|Overall Study|Adverse Event|5
942783|NCT00819247|3106361|P1|Overall Study|Adverse Event|0
942784|NCT00819234|3106387|P10|Overall Study|Lost to Follow-up|2
942785|NCT00819234|3106388|P9|Overall Study|Lost to Follow-up|1
942786|NCT00819234|3106389|P8|Overall Study|Lost to Follow-up|1
942787|NCT00819234|3106390|P7|Overall Study|Lost to Follow-up|1
942788|NCT00819234|3106391|P6|Overall Study|Lost to Follow-up|1
942789|NCT00819234|3106392|P5|Overall Study|Lost to Follow-up|1
942790|NCT00819234|3106393|P4|Overall Study|Lost to Follow-up|2
942791|NCT00819234|3106394|P3|Overall Study|Lost to Follow-up|0
942792|NCT00819234|3106395|P2|Overall Study|Lost to Follow-up|2
942793|NCT00819234|3106396|P1|Overall Study|Lost to Follow-up|2
942794|NCT00819234|3106387|P10|Overall Study|Protocol Violation|0
942795|NCT00819234|3106388|P9|Overall Study|Protocol Violation|0
942796|NCT00819234|3106389|P8|Overall Study|Protocol Violation|0
942797|NCT00819234|3106390|P7|Overall Study|Protocol Violation|0
942798|NCT00819234|3106391|P6|Overall Study|Protocol Violation|0
942799|NCT00819234|3106392|P5|Overall Study|Protocol Violation|0
942800|NCT00819234|3106393|P4|Overall Study|Protocol Violation|0
942801|NCT00819234|3106394|P3|Overall Study|Protocol Violation|1
942802|NCT00819234|3106395|P2|Overall Study|Protocol Violation|0
942803|NCT00819234|3106396|P1|Overall Study|Protocol Violation|0
942804|NCT00819234|3106387|P10|Overall Study|Physician Decision|2
942805|NCT00819234|3106388|P9|Overall Study|Physician Decision|0
942806|NCT00819234|3106389|P8|Overall Study|Physician Decision|0
942807|NCT00819234|3106390|P7|Overall Study|Physician Decision|0
942808|NCT00819234|3106391|P6|Overall Study|Physician Decision|0
942809|NCT00819234|3106392|P5|Overall Study|Physician Decision|0
942810|NCT00819234|3106393|P4|Overall Study|Physician Decision|1
942811|NCT00819234|3106394|P3|Overall Study|Physician Decision|0
942812|NCT00819234|3106395|P2|Overall Study|Physician Decision|0
942813|NCT00819234|3106396|P1|Overall Study|Physician Decision|0
942814|NCT00819234|3106387|P10|Overall Study|Adverse Event|0
942815|NCT00819234|3106388|P9|Overall Study|Adverse Event|0
942816|NCT00819234|3106389|P8|Overall Study|Adverse Event|0
942817|NCT00819234|3106390|P7|Overall Study|Adverse Event|0
942818|NCT00819234|3106391|P6|Overall Study|Adverse Event|2
942819|NCT00819234|3106392|P5|Overall Study|Adverse Event|0
942820|NCT00819234|3106393|P4|Overall Study|Adverse Event|0
942821|NCT00819234|3106394|P3|Overall Study|Adverse Event|1
942822|NCT00819234|3106395|P2|Overall Study|Adverse Event|0
942823|NCT00819234|3106396|P1|Overall Study|Adverse Event|0
942824|NCT00819234|3106387|P10|Overall Study|Withdrawal by Subject|3
942825|NCT00819234|3106388|P9|Overall Study|Withdrawal by Subject|5
942826|NCT00819234|3106389|P8|Overall Study|Withdrawal by Subject|8
942827|NCT00819234|3106390|P7|Overall Study|Withdrawal by Subject|4
942828|NCT00819234|3106391|P6|Overall Study|Withdrawal by Subject|4
942829|NCT00819234|3106392|P5|Overall Study|Withdrawal by Subject|0
942830|NCT00819234|3106393|P4|Overall Study|Withdrawal by Subject|3
942831|NCT00819234|3106394|P3|Overall Study|Withdrawal by Subject|6
942832|NCT00819234|3106395|P2|Overall Study|Withdrawal by Subject|13
942833|NCT00819234|3106396|P1|Overall Study|Withdrawal by Subject|8
942834|NCT00819156|3106595|P6|Overall Study|Prostate-specific antigen progression|0
942835|NCT00819156|3106596|P5|Overall Study|Prostate-specific antigen progression|1
942836|NCT00819156|3106597|P4|Overall Study|Prostate-specific antigen progression|0
942837|NCT00819156|3106598|P3|Overall Study|Prostate-specific antigen progression|0
942838|NCT00819156|3106599|P2|Overall Study|Prostate-specific antigen progression|0
942839|NCT00819156|3106600|P1|Overall Study|Prostate-specific antigen progression|0
942840|NCT00819156|3106595|P6|Overall Study|Testosterone >=.5ng/ml 2 visits|0
942841|NCT00819156|3106596|P5|Overall Study|Testosterone >=.5ng/ml 2 visits|1
942842|NCT00819156|3106597|P4|Overall Study|Testosterone >=.5ng/ml 2 visits|0
942843|NCT00819156|3106598|P3|Overall Study|Testosterone >=.5ng/ml 2 visits|0
942844|NCT00819156|3106599|P2|Overall Study|Testosterone >=.5ng/ml 2 visits|0
942845|NCT00819156|3106600|P1|Overall Study|Testosterone >=.5ng/ml 2 visits|3
942846|NCT00819156|3106595|P6|Overall Study|Testosterone >1ng/ml from Day 28+|2
942847|NCT00819156|3106596|P5|Overall Study|Testosterone >1ng/ml from Day 28+|1
942848|NCT00819156|3106597|P4|Overall Study|Testosterone >1ng/ml from Day 28+|1
942849|NCT00819156|3106598|P3|Overall Study|Testosterone >1ng/ml from Day 28+|1
942850|NCT00819156|3106599|P2|Overall Study|Testosterone >1ng/ml from Day 28+|2
942851|NCT00819156|3106600|P1|Overall Study|Testosterone >1ng/ml from Day 28+|5
942852|NCT00819156|3106595|P6|Overall Study|Lost to Follow-up|2
942853|NCT00819156|3106596|P5|Overall Study|Lost to Follow-up|0
942854|NCT00819156|3106597|P4|Overall Study|Lost to Follow-up|0
942855|NCT00819156|3106598|P3|Overall Study|Lost to Follow-up|0
942856|NCT00819156|3106599|P2|Overall Study|Lost to Follow-up|1
942857|NCT00819156|3106600|P1|Overall Study|Lost to Follow-up|0
942858|NCT00819156|3106595|P6|Overall Study|Protocol Violation|1
942859|NCT00819156|3106596|P5|Overall Study|Protocol Violation|0
942860|NCT00819156|3106597|P4|Overall Study|Protocol Violation|0
942861|NCT00819156|3106598|P3|Overall Study|Protocol Violation|1
942862|NCT00819156|3106599|P2|Overall Study|Protocol Violation|0
942863|NCT00819156|3106600|P1|Overall Study|Protocol Violation|1
942864|NCT00819156|3106595|P6|Overall Study|Withdrawal by Subject|0
942865|NCT00819156|3106596|P5|Overall Study|Withdrawal by Subject|1
942866|NCT00819156|3106597|P4|Overall Study|Withdrawal by Subject|0
942867|NCT00819156|3106598|P3|Overall Study|Withdrawal by Subject|2
942868|NCT00819156|3106599|P2|Overall Study|Withdrawal by Subject|3
942869|NCT00819156|3106600|P1|Overall Study|Withdrawal by Subject|0
942870|NCT00819156|3106595|P6|Overall Study|Adverse Event|3
942871|NCT00819156|3106596|P5|Overall Study|Adverse Event|2
942872|NCT00819156|3106597|P4|Overall Study|Adverse Event|1
942873|NCT00819156|3106598|P3|Overall Study|Adverse Event|2
942874|NCT00819156|3106599|P2|Overall Study|Adverse Event|4
942875|NCT00819156|3106600|P1|Overall Study|Adverse Event|1
942876|NCT00819091|3106690|P2|Overall Study|Not Specified|2
942877|NCT00819091|3106691|P1|Overall Study|Not Specified|1
942878|NCT00819091|3106690|P2|Overall Study|Withdrawal by Subject|2
942879|NCT00819091|3106691|P1|Overall Study|Withdrawal by Subject|1
942880|NCT00819091|3106690|P2|Overall Study|Lost to Follow-up|0
942881|NCT00819091|3106691|P1|Overall Study|Lost to Follow-up|2
942882|NCT00819091|3106690|P2|Overall Study|Protocol Violation|1
942883|NCT00819091|3106691|P1|Overall Study|Protocol Violation|0
942884|NCT00819091|3106690|P2|Overall Study|Adverse Event|5
942885|NCT00819091|3106691|P1|Overall Study|Adverse Event|3
942886|NCT00819052|3106717|P2|Overall Study|Death or events leading to death|0
942887|NCT00819052|3106718|P1|Overall Study|Death or events leading to death|1
942888|NCT00819052|3106717|P2|Overall Study|Pregnancy|2
942889|NCT00819052|3106718|P1|Overall Study|Pregnancy|1
942890|NCT00819052|3106717|P2|Overall Study|Lack of Efficacy|1
942891|NCT00819052|3106718|P1|Overall Study|Lack of Efficacy|1
942892|NCT00819052|3106717|P2|Overall Study|Withdrawal by Subject|2
942893|NCT00819052|3106718|P1|Overall Study|Withdrawal by Subject|1
942894|NCT00819052|3106717|P2|Overall Study|Lost to Follow-up|2
942895|NCT00819052|3106718|P1|Overall Study|Lost to Follow-up|1
942896|NCT00819052|3106717|P2|Overall Study|Protocol Violation|2
942897|NCT00819052|3106718|P1|Overall Study|Protocol Violation|1
942898|NCT00819052|3106717|P2|Overall Study|Adverse Event|5
942899|NCT00819052|3106718|P1|Overall Study|Adverse Event|0
942900|NCT00819039|3106833|P3|Overall Study|Protocol Violation|0
942901|NCT00819039|3106834|P2|Overall Study|Protocol Violation|0
942902|NCT00819039|3106835|P1|Overall Study|Protocol Violation|1
942903|NCT00819039|3106833|P3|Overall Study|Physician Decision|1
942904|NCT00819039|3106834|P2|Overall Study|Physician Decision|0
942905|NCT00819039|3106835|P1|Overall Study|Physician Decision|1
942906|NCT00819013|3106865|P4|Overall Study|Death|1
942907|NCT00819013|3106866|P3|Overall Study|Death|0
942908|NCT00819013|3106867|P2|Overall Study|Death|0
942909|NCT00819013|3106868|P1|Overall Study|Death|0
942910|NCT00819013|3106865|P4|Overall Study|Lost to Follow-up|2
942911|NCT00819013|3106866|P3|Overall Study|Lost to Follow-up|1
942912|NCT00819013|3106867|P2|Overall Study|Lost to Follow-up|0
942913|NCT00819013|3106868|P1|Overall Study|Lost to Follow-up|0
942914|NCT00819013|3106865|P4|Overall Study|Withdrawal by Subject|0
942915|NCT00819013|3106866|P3|Overall Study|Withdrawal by Subject|1
942916|NCT00819013|3106867|P2|Overall Study|Withdrawal by Subject|0
942917|NCT00819013|3106868|P1|Overall Study|Withdrawal by Subject|1
942918|NCT00819013|3106865|P4|Overall Study|Adverse Event|0
942919|NCT00819013|3106866|P3|Overall Study|Adverse Event|1
942920|NCT00819013|3106867|P2|Overall Study|Adverse Event|0
942921|NCT00819013|3106868|P1|Overall Study|Adverse Event|0
942922|NCT00819013|3106865|P4|Overall Study|Not meeting continuing study eligibility|1
942923|NCT00819013|3106866|P3|Overall Study|Not meeting continuing study eligibility|2
942924|NCT00819013|3106867|P2|Overall Study|Not meeting continuing study eligibility|1
942925|NCT00819013|3106868|P1|Overall Study|Not meeting continuing study eligibility|2
942926|NCT00818883|3106934|P2|Overall Study|Other|7
942927|NCT00818883|3106935|P1|Overall Study|Other|2
942928|NCT00818883|3106934|P2|Overall Study|Lack of Efficacy|2
942929|NCT00818883|3106935|P1|Overall Study|Lack of Efficacy|0
942930|NCT00818883|3106934|P2|Overall Study|Withdrawal by Subject|14
942931|NCT00818883|3106935|P1|Overall Study|Withdrawal by Subject|16
942932|NCT00818883|3106934|P2|Overall Study|Lost to Follow-up|2
942933|NCT00818883|3106935|P1|Overall Study|Lost to Follow-up|3
942934|NCT00818883|3106934|P2|Overall Study|Protocol Violation|2
942935|NCT00818883|3106935|P1|Overall Study|Protocol Violation|2
942936|NCT00818883|3106934|P2|Overall Study|Adverse Event|19
942937|NCT00818883|3106935|P1|Overall Study|Adverse Event|28
942938|NCT00818779|3106982|P2|Overall Study|Adverse Event|1
942939|NCT00818779|3106983|P1|Overall Study|Adverse Event|4
942940|NCT00818779|3106982|P2|Overall Study|Lost to Follow-up|0
942941|NCT00818779|3106983|P1|Overall Study|Lost to Follow-up|1
942942|NCT00818779|3106982|P2|Overall Study|Protocol Violation|0
942943|NCT00818779|3106983|P1|Overall Study|Protocol Violation|1
942944|NCT00818766|3106999|P2|Overall Study|Did not Receive Allocated Intervention|0
942945|NCT00818766|3107000|P1|Overall Study|Did not Receive Allocated Intervention|3
942946|NCT00818766|3106999|P2|Overall Study|Death|0
942947|NCT00818766|3107000|P1|Overall Study|Death|1
942948|NCT00818766|3106999|P2|Overall Study|Could not be Contacted on Day 28|10
942949|NCT00818766|3107000|P1|Overall Study|Could not be Contacted on Day 28|11
942950|NCT00818753|3107029|P3|Overall Study|Randomised and not treated|0
942951|NCT00818753|3107030|P2|Overall Study|Randomised and not treated|0
942952|NCT00818753|3107031|P1|Overall Study|Randomised and not treated|2
942953|NCT00818753|3107029|P3|Overall Study|Other reason (not specified)|1
942954|NCT00818753|3107030|P2|Overall Study|Other reason (not specified)|0
942955|NCT00818753|3107031|P1|Overall Study|Other reason (not specified)|0
942956|NCT00818753|3107029|P3|Overall Study|Protocol Violation|0
942957|NCT00818753|3107030|P2|Overall Study|Protocol Violation|0
942958|NCT00818753|3107031|P1|Overall Study|Protocol Violation|1
942959|NCT00818662|3107055|P4|Overall Study|Admitted to long term nursing care|0
942960|NCT00818662|3107056|P3|Overall Study|Admitted to long term nursing care|0
942961|NCT00818662|3107057|P2|Overall Study|Admitted to long term nursing care|1
942962|NCT00818662|3107058|P1|Overall Study|Admitted to long term nursing care|0
942963|NCT00818662|3107055|P4|Overall Study|Study partner decision|1
942964|NCT00818662|3107056|P3|Overall Study|Study partner decision|0
942965|NCT00818662|3107057|P2|Overall Study|Study partner decision|0
942966|NCT00818662|3107058|P1|Overall Study|Study partner decision|0
942967|NCT00818662|3107055|P4|Overall Study|Change in living situation|1
942968|NCT00818662|3107056|P3|Overall Study|Change in living situation|0
942969|NCT00818662|3107057|P2|Overall Study|Change in living situation|0
942970|NCT00818662|3107058|P1|Overall Study|Change in living situation|0
942971|NCT00818662|3107055|P4|Overall Study|Declined move to another study site|0
942972|NCT00818662|3107056|P3|Overall Study|Declined move to another study site|0
942973|NCT00818662|3107057|P2|Overall Study|Declined move to another study site|0
942974|NCT00818662|3107058|P1|Overall Study|Declined move to another study site|1
942975|NCT00818662|3107055|P4|Overall Study|Moving out of state|1
942976|NCT00818662|3107056|P3|Overall Study|Moving out of state|0
942977|NCT00818662|3107057|P2|Overall Study|Moving out of state|0
942978|NCT00818662|3107058|P1|Overall Study|Moving out of state|0
942979|NCT00818662|3107055|P4|Overall Study|Caregiver to pursue other treatment|0
942980|NCT00818662|3107056|P3|Overall Study|Caregiver to pursue other treatment|0
942981|NCT00818662|3107057|P2|Overall Study|Caregiver to pursue other treatment|1
942982|NCT00818662|3107058|P1|Overall Study|Caregiver to pursue other treatment|0
942983|NCT00818662|3107055|P4|Overall Study|Participant's health declined|1
942984|NCT00818662|3107056|P3|Overall Study|Participant's health declined|0
942985|NCT00818662|3107057|P2|Overall Study|Participant's health declined|0
942986|NCT00818662|3107058|P1|Overall Study|Participant's health declined|0
942987|NCT00818662|3107055|P4|Overall Study|Study Partner Unwilling or Unable|1
942988|NCT00818662|3107056|P3|Overall Study|Study Partner Unwilling or Unable|1
942989|NCT00818662|3107057|P2|Overall Study|Study Partner Unwilling or Unable|2
942990|NCT00818662|3107058|P1|Overall Study|Study Partner Unwilling or Unable|3
942991|NCT00818662|3107055|P4|Overall Study|Safety Risk|1
942992|NCT00818662|3107056|P3|Overall Study|Safety Risk|0
942993|NCT00818662|3107057|P2|Overall Study|Safety Risk|1
942994|NCT00818662|3107058|P1|Overall Study|Safety Risk|1
942995|NCT00818662|3107055|P4|Overall Study|Requires a Prohibited Medication|0
942996|NCT00818662|3107056|P3|Overall Study|Requires a Prohibited Medication|0
942997|NCT00818662|3107057|P2|Overall Study|Requires a Prohibited Medication|0
942998|NCT00818662|3107058|P1|Overall Study|Requires a Prohibited Medication|1
942999|NCT00818662|3107055|P4|Overall Study|Protocol Violation|0
943000|NCT00818662|3107056|P3|Overall Study|Protocol Violation|0
943001|NCT00818662|3107057|P2|Overall Study|Protocol Violation|1
943002|NCT00818662|3107058|P1|Overall Study|Protocol Violation|1
943003|NCT00818662|3107055|P4|Overall Study|Unwilling or Unable to Participate|4
943004|NCT00818662|3107056|P3|Overall Study|Unwilling or Unable to Participate|2
943005|NCT00818662|3107057|P2|Overall Study|Unwilling or Unable to Participate|6
943006|NCT00818662|3107058|P1|Overall Study|Unwilling or Unable to Participate|4
943007|NCT00818662|3107055|P4|Overall Study|Lost to Follow-up|1
943008|NCT00818662|3107056|P3|Overall Study|Lost to Follow-up|0
943009|NCT00818662|3107057|P2|Overall Study|Lost to Follow-up|0
943010|NCT00818662|3107058|P1|Overall Study|Lost to Follow-up|0
943011|NCT00818662|3107055|P4|Overall Study|Physician Decision|0
943012|NCT00818662|3107056|P3|Overall Study|Physician Decision|0
943013|NCT00818662|3107057|P2|Overall Study|Physician Decision|0
943014|NCT00818662|3107058|P1|Overall Study|Physician Decision|1
943015|NCT00818662|3107055|P4|Overall Study|Death|0
943016|NCT00818662|3107056|P3|Overall Study|Death|0
943017|NCT00818662|3107057|P2|Overall Study|Death|3
943018|NCT00818662|3107058|P1|Overall Study|Death|1
943019|NCT00818662|3107055|P4|Overall Study|Withdrawal by Subject|2
943020|NCT00818662|3107056|P3|Overall Study|Withdrawal by Subject|2
943021|NCT00818662|3107057|P2|Overall Study|Withdrawal by Subject|4
943022|NCT00818662|3107058|P1|Overall Study|Withdrawal by Subject|5
943023|NCT00818662|3107055|P4|Overall Study|Adverse Event|3
943024|NCT00818662|3107056|P3|Overall Study|Adverse Event|4
943025|NCT00818662|3107057|P2|Overall Study|Adverse Event|14
943026|NCT00818662|3107058|P1|Overall Study|Adverse Event|5
943027|NCT00818649|3107144|P1|Overall Study|Adverse Event|1
943028|NCT00818649|3107144|P1|Overall Study|Unrelated hip fracture-unable to proceed|1
943029|NCT00818649|3107144|P1|Overall Study|Declining performance status|2
943030|NCT00818623|3107158|P8|Overall Study|Disease progression|0
943031|NCT00818623|3107159|P7|Overall Study|Disease progression|1
943032|NCT00818623|3107160|P6|Overall Study|Disease progression|0
943033|NCT00818623|3107161|P5|Overall Study|Disease progression|0
943034|NCT00818623|3107162|P4|Overall Study|Disease progression|0
943035|NCT00818623|3107163|P3|Overall Study|Disease progression|0
943036|NCT00818623|3107164|P2|Overall Study|Disease progression|0
943037|NCT00818623|3107165|P1|Overall Study|Disease progression|0
943038|NCT00818623|3107158|P8|Overall Study|Lack of trial drug at site|0
943039|NCT00818623|3107159|P7|Overall Study|Lack of trial drug at site|1
943040|NCT00818623|3107160|P6|Overall Study|Lack of trial drug at site|0
943041|NCT00818623|3107161|P5|Overall Study|Lack of trial drug at site|2
943042|NCT00818623|3107162|P4|Overall Study|Lack of trial drug at site|0
943043|NCT00818623|3107163|P3|Overall Study|Lack of trial drug at site|0
943044|NCT00818623|3107164|P2|Overall Study|Lack of trial drug at site|0
943045|NCT00818623|3107165|P1|Overall Study|Lack of trial drug at site|0
943046|NCT00818623|3107158|P8|Overall Study|Need of additional treatment|0
943047|NCT00818623|3107159|P7|Overall Study|Need of additional treatment|0
943048|NCT00818623|3107160|P6|Overall Study|Need of additional treatment|0
943049|NCT00818623|3107161|P5|Overall Study|Need of additional treatment|1
943050|NCT00818623|3107162|P4|Overall Study|Need of additional treatment|0
943051|NCT00818623|3107163|P3|Overall Study|Need of additional treatment|0
943052|NCT00818623|3107164|P2|Overall Study|Need of additional treatment|0
943053|NCT00818623|3107165|P1|Overall Study|Need of additional treatment|0
943054|NCT00818623|3107158|P8|Overall Study|Protocol Violation|0
943055|NCT00818623|3107159|P7|Overall Study|Protocol Violation|1
943056|NCT00818623|3107160|P6|Overall Study|Protocol Violation|0
943057|NCT00818623|3107161|P5|Overall Study|Protocol Violation|1
943058|NCT00818623|3107162|P4|Overall Study|Protocol Violation|0
943059|NCT00818623|3107163|P3|Overall Study|Protocol Violation|0
943060|NCT00818623|3107164|P2|Overall Study|Protocol Violation|0
943061|NCT00818623|3107165|P1|Overall Study|Protocol Violation|1
943062|NCT00818623|3107158|P8|Overall Study|Withdrawal by Subject|1
943063|NCT00818623|3107159|P7|Overall Study|Withdrawal by Subject|1
943064|NCT00818623|3107160|P6|Overall Study|Withdrawal by Subject|1
943065|NCT00818623|3107161|P5|Overall Study|Withdrawal by Subject|0
943066|NCT00818623|3107162|P4|Overall Study|Withdrawal by Subject|0
943067|NCT00818623|3107163|P3|Overall Study|Withdrawal by Subject|1
943068|NCT00818623|3107164|P2|Overall Study|Withdrawal by Subject|1
943069|NCT00818623|3107165|P1|Overall Study|Withdrawal by Subject|0
943070|NCT00818623|3107158|P8|Overall Study|Bad prostate specific antigen response|0
943071|NCT00818623|3107159|P7|Overall Study|Bad prostate specific antigen response|0
943072|NCT00818623|3107160|P6|Overall Study|Bad prostate specific antigen response|1
943073|NCT00818623|3107161|P5|Overall Study|Bad prostate specific antigen response|0
943074|NCT00818623|3107162|P4|Overall Study|Bad prostate specific antigen response|5
943075|NCT00818623|3107163|P3|Overall Study|Bad prostate specific antigen response|2
943076|NCT00818623|3107164|P2|Overall Study|Bad prostate specific antigen response|3
943077|NCT00818623|3107165|P1|Overall Study|Bad prostate specific antigen response|0
943078|NCT00818623|3107158|P8|Overall Study|Adverse Event|0
943079|NCT00818623|3107159|P7|Overall Study|Adverse Event|0
943080|NCT00818623|3107160|P6|Overall Study|Adverse Event|1
943081|NCT00818623|3107161|P5|Overall Study|Adverse Event|0
943082|NCT00818623|3107162|P4|Overall Study|Adverse Event|0
943083|NCT00818623|3107163|P3|Overall Study|Adverse Event|1
943084|NCT00818623|3107164|P2|Overall Study|Adverse Event|0
943085|NCT00818623|3107165|P1|Overall Study|Adverse Event|1
943086|NCT00818519|3107241|P2|Overall Study|participant will leave for long tme|0
943087|NCT00818519|3107242|P1|Overall Study|participant will leave for long tme|1
943088|NCT00818519|3107241|P2|Overall Study|participant recovered completely|0
943089|NCT00818519|3107242|P1|Overall Study|participant recovered completely|1
943090|NCT00818519|3107241|P2|Overall Study|Withdrawal by Subject|9
943091|NCT00818519|3107242|P1|Overall Study|Withdrawal by Subject|4
943092|NCT00818519|3107241|P2|Overall Study|Pregnancy|1
943093|NCT00818519|3107242|P1|Overall Study|Pregnancy|0
943094|NCT00818519|3107241|P2|Overall Study|Protocol Violation|1
943095|NCT00818519|3107242|P1|Overall Study|Protocol Violation|2
943096|NCT00818519|3107241|P2|Overall Study|Lost to Follow-up|6
943097|NCT00818519|3107242|P1|Overall Study|Lost to Follow-up|4
943098|NCT00818519|3107241|P2|Overall Study|Adverse Event|2
943099|NCT00818519|3107242|P1|Overall Study|Adverse Event|2
943100|NCT00818454|3107272|P4|Treatment Period 3|Adverse Event|1
943101|NCT00818454|3107273|P3|Treatment Period 3|Adverse Event|0
943102|NCT00818454|3107274|P2|Treatment Period 3|Adverse Event|0
943103|NCT00818454|3107275|P1|Treatment Period 3|Adverse Event|0
943104|NCT00818454|3107272|P4|Treatment Period 2|not specified|0
943105|NCT00818454|3107273|P3|Treatment Period 2|not specified|0
943106|NCT00818454|3107274|P2|Treatment Period 2|not specified|1
943107|NCT00818454|3107275|P1|Treatment Period 2|not specified|2
943108|NCT00818454|3107272|P4|Washout Period of 1 Week|not specified|0
943109|NCT00818454|3107273|P3|Washout Period of 1 Week|not specified|0
943110|NCT00818454|3107274|P2|Washout Period of 1 Week|not specified|2
943111|NCT00818454|3107275|P1|Washout Period of 1 Week|not specified|1
943112|NCT00818454|3107272|P4|Washout Period of 1 Week|Protocol Violation|0
943113|NCT00818454|3107273|P3|Washout Period of 1 Week|Protocol Violation|0
943114|NCT00818454|3107274|P2|Washout Period of 1 Week|Protocol Violation|0
943115|NCT00818454|3107275|P1|Washout Period of 1 Week|Protocol Violation|2
943116|NCT00818454|3107272|P4|Washout Period of 1 Week|Adverse Event|0
943117|NCT00818454|3107273|P3|Washout Period of 1 Week|Adverse Event|0
943118|NCT00818454|3107274|P2|Washout Period of 1 Week|Adverse Event|1
943119|NCT00818454|3107275|P1|Washout Period of 1 Week|Adverse Event|1
943120|NCT00818454|3107272|P4|Treatment Period 1|not specified|0
943121|NCT00818454|3107273|P3|Treatment Period 1|not specified|0
943122|NCT00818454|3107274|P2|Treatment Period 1|not specified|0
943123|NCT00818454|3107275|P1|Treatment Period 1|not specified|3
943124|NCT00818454|3107272|P4|Treatment Period 1|Adverse Event|0
943125|NCT00818454|3107273|P3|Treatment Period 1|Adverse Event|0
943126|NCT00818454|3107274|P2|Treatment Period 1|Adverse Event|1
943127|NCT00818454|3107275|P1|Treatment Period 1|Adverse Event|0
943128|NCT00818441|3107303|P2|Overall Study|Study terminated by sponsor|2
943129|NCT00818441|3107304|P1|Overall Study|Study terminated by sponsor|11
943130|NCT00818441|3107303|P2|Overall Study|Adverse Event|1
943131|NCT00818441|3107304|P1|Overall Study|Adverse Event|0
943132|NCT00818441|3107303|P2|Overall Study|Withdrawal by Subject|0
943133|NCT00818441|3107304|P1|Overall Study|Withdrawal by Subject|2
943134|NCT00818441|3107303|P2|Overall Study|Lost to Follow-up|1
943135|NCT00818441|3107304|P1|Overall Study|Lost to Follow-up|2
943136|NCT00818441|3107303|P2|Overall Study|Other|0
943137|NCT00818441|3107304|P1|Overall Study|Other|5
943138|NCT00818441|3107303|P2|Overall Study|Death|26
943139|NCT00818441|3107304|P1|Overall Study|Death|69
943140|NCT00818389|3107326|P2|Overall Study|Adverse Event|1
943141|NCT00818389|3107327|P1|Overall Study|Adverse Event|0
943142|NCT00818389|3107326|P2|Overall Study|Withdrawal by Subject|2
943143|NCT00818389|3107327|P1|Overall Study|Withdrawal by Subject|2
943144|NCT00818389|3107326|P2|Overall Study|ALS Disease Progression|0
943145|NCT00818389|3107327|P1|Overall Study|ALS Disease Progression|1
943146|NCT00818389|3107326|P2|Overall Study|Death|3
943147|NCT00818389|3107327|P1|Overall Study|Death|1
943148|NCT00818259|3107362|P9|Part V|Adverse Event|0
943149|NCT00818259|3107363|P8|Part V|Adverse Event|1
943150|NCT00818259|3107364|P7|Part V|Adverse Event|0
943151|NCT00818259|3107365|P6|Part V|Adverse Event|0
943152|NCT00818259|3107366|P5|Part V|Adverse Event|0
943153|NCT00818259|3107367|P4|Part V|Adverse Event|0
943154|NCT00818259|3107368|P3|Part V|Adverse Event|0
943155|NCT00818259|3107369|P2|Part V|Adverse Event|0
943156|NCT00818259|3107370|P1|Part V|Adverse Event|0
943157|NCT00818259|3107362|P9|Part IV|Physician Decision|0
943158|NCT00818259|3107363|P8|Part IV|Physician Decision|0
943159|NCT00818259|3107364|P7|Part IV|Physician Decision|0
943160|NCT00818259|3107365|P6|Part IV|Physician Decision|1
943161|NCT00818259|3107366|P5|Part IV|Physician Decision|0
943162|NCT00818259|3107367|P4|Part IV|Physician Decision|0
943163|NCT00818259|3107368|P3|Part IV|Physician Decision|0
943164|NCT00818259|3107369|P2|Part IV|Physician Decision|0
943165|NCT00818259|3107370|P1|Part IV|Physician Decision|0
943166|NCT00818259|3107362|P9|Part II|Not Treated|0
943167|NCT00818259|3107363|P8|Part II|Not Treated|0
943168|NCT00818259|3107364|P7|Part II|Not Treated|0
943169|NCT00818259|3107365|P6|Part II|Not Treated|0
943170|NCT00818259|3107366|P5|Part II|Not Treated|0
943171|NCT00818259|3107367|P4|Part II|Not Treated|1
943172|NCT00818259|3107368|P3|Part II|Not Treated|0
943173|NCT00818259|3107369|P2|Part II|Not Treated|0
943174|NCT00818259|3107370|P1|Part II|Not Treated|0
943175|NCT00818259|3107362|P9|Part II|Lack of Efficacy|0
943176|NCT00818259|3107363|P8|Part II|Lack of Efficacy|0
943177|NCT00818259|3107364|P7|Part II|Lack of Efficacy|0
943178|NCT00818259|3107365|P6|Part II|Lack of Efficacy|0
943179|NCT00818259|3107366|P5|Part II|Lack of Efficacy|0
943180|NCT00818259|3107367|P4|Part II|Lack of Efficacy|1
943181|NCT00818259|3107368|P3|Part II|Lack of Efficacy|0
943182|NCT00818259|3107369|P2|Part II|Lack of Efficacy|0
943183|NCT00818259|3107370|P1|Part II|Lack of Efficacy|0
943184|NCT00818259|3107362|P9|Part II|Physician Decision|0
943185|NCT00818259|3107363|P8|Part II|Physician Decision|0
943186|NCT00818259|3107364|P7|Part II|Physician Decision|0
943187|NCT00818259|3107365|P6|Part II|Physician Decision|0
943188|NCT00818259|3107366|P5|Part II|Physician Decision|0
943189|NCT00818259|3107367|P4|Part II|Physician Decision|0
943190|NCT00818259|3107368|P3|Part II|Physician Decision|1
943191|NCT00818259|3107369|P2|Part II|Physician Decision|0
943192|NCT00818259|3107370|P1|Part II|Physician Decision|0
943193|NCT00818259|3107362|P9|Part I|Withdrawal by Subject|0
943194|NCT00818259|3107363|P8|Part I|Withdrawal by Subject|0
943195|NCT00818259|3107364|P7|Part I|Withdrawal by Subject|0
943196|NCT00818259|3107365|P6|Part I|Withdrawal by Subject|0
943197|NCT00818259|3107366|P5|Part I|Withdrawal by Subject|0
943198|NCT00818259|3107367|P4|Part I|Withdrawal by Subject|0
943199|NCT00818259|3107368|P3|Part I|Withdrawal by Subject|0
943200|NCT00818259|3107369|P2|Part I|Withdrawal by Subject|0
943201|NCT00818259|3107370|P1|Part I|Withdrawal by Subject|1
943202|NCT00818246|3107442|P1|Overall Study|Impossible to match pictures|5
943203|NCT00818207|3107451|P2|Overall Study|Death|5
943204|NCT00818207|3107452|P1|Overall Study|Death|3
943205|NCT00818207|3107451|P2|Overall Study|Withdrawal by Subject|104
943206|NCT00818207|3107452|P1|Overall Study|Withdrawal by Subject|42
943207|NCT00818207|3107451|P2|Overall Study|Multiple reasons|12
943208|NCT00818207|3107452|P1|Overall Study|Multiple reasons|11
943209|NCT00818207|3107451|P2|Overall Study|Lost to Follow-up|146
943210|NCT00818207|3107452|P1|Overall Study|Lost to Follow-up|160
943211|NCT00818207|3107451|P2|Overall Study|Adverse Event|0
943212|NCT00818207|3107452|P1|Overall Study|Adverse Event|6
943213|NCT00818168|3107466|P1|Overall Study|Participant Moved|2
943214|NCT00818168|3107466|P1|Overall Study|Reason for Non-completion Not reported|6
943215|NCT00818168|3107466|P1|Overall Study|Adverse Event|19
943216|NCT00818168|3107466|P1|Overall Study|Lost to Follow-up|7
943217|NCT00818168|3107466|P1|Overall Study|Withdrawal by Subject|16
943218|NCT00818168|3107466|P1|Overall Study|Pregnancy|2
943219|NCT00818168|3107466|P1|Overall Study|Lack of Efficacy|18
943220|NCT00817778|3107506|P2|Overall Study|Poor venous access|0
943221|NCT00817778|3107507|P1|Overall Study|Poor venous access|1
943222|NCT00817778|3107506|P2|Overall Study|Study-specific discontinuation criteria|1
943223|NCT00817778|3107507|P1|Overall Study|Study-specific discontinuation criteria|0
943224|NCT00817778|3107506|P2|Overall Study|Protocol Violation|1
943225|NCT00817778|3107507|P1|Overall Study|Protocol Violation|0
943226|NCT00817778|3107506|P2|Overall Study|Withdrawal by Subject|1
943227|NCT00817778|3107507|P1|Overall Study|Withdrawal by Subject|1
943228|NCT00817778|3107506|P2|Overall Study|Adverse Event|0
943229|NCT00817778|3107507|P1|Overall Study|Adverse Event|1
943230|NCT00817531|3107536|P1|Overall Study|Lack of Efficacy|1
943231|NCT00817531|3107536|P1|Overall Study|Adverse Event|1
943232|NCT00817479|3107542|P2|Overall Study|Physician Decision|1
943233|NCT00817479|3107543|P1|Overall Study|Physician Decision|1
943234|NCT00817336|3107553|P2|Overall Study|Withdrawal by Subject|1
943235|NCT00817336|3107554|P1|Overall Study|Withdrawal by Subject|1
943236|NCT00817206|3107580|P2|Overall Study|Physician Decision|0
943237|NCT00817206|3107581|P1|Overall Study|Physician Decision|2
943238|NCT00817206|3107580|P2|Overall Study|Withdrawal by Subject|3
943239|NCT00817206|3107581|P1|Overall Study|Withdrawal by Subject|7
943240|NCT00817206|3107580|P2|Overall Study|Death|0
943241|NCT00817206|3107581|P1|Overall Study|Death|2
943242|NCT00817206|3107580|P2|Overall Study|Lost to Follow-up|1
943243|NCT00817206|3107581|P1|Overall Study|Lost to Follow-up|0
943244|NCT00817206|3107580|P2|Overall Study|Protocol Violation|2
943245|NCT00817206|3107581|P1|Overall Study|Protocol Violation|0
943246|NCT00817206|3107580|P2|Overall Study|Adverse Event|3
943247|NCT00817206|3107581|P1|Overall Study|Adverse Event|10
943248|NCT00817063|3107589|P2|Overall Study|Abnormality of Laboratory Test|1
943249|NCT00817063|3107590|P1|Overall Study|Abnormality of Laboratory Test|2
943250|NCT00817063|3107589|P2|Overall Study|Administrative|4
943251|NCT00817063|3107590|P1|Overall Study|Administrative|10
943252|NCT00817063|3107589|P2|Overall Study|Early Improvement|4
943253|NCT00817063|3107590|P1|Overall Study|Early Improvement|19
943254|NCT00817063|3107589|P2|Overall Study|Withdrawal by Subject|37
943255|NCT00817063|3107590|P1|Overall Study|Withdrawal by Subject|17
943256|NCT00817063|3107589|P2|Overall Study|Protocol Violation|8
943257|NCT00817063|3107590|P1|Overall Study|Protocol Violation|3
943258|NCT00817063|3107589|P2|Overall Study|Violation of Selection at Entry|4
943259|NCT00817063|3107590|P1|Overall Study|Violation of Selection at Entry|7
943260|NCT00817063|3107589|P2|Overall Study|Failure to Return|12
943261|NCT00817063|3107590|P1|Overall Study|Failure to Return|13
943262|NCT00817063|3107589|P2|Overall Study|Lack of Efficacy|86
943263|NCT00817063|3107590|P1|Overall Study|Lack of Efficacy|33
943264|NCT00817063|3107589|P2|Overall Study|Death|1
943265|NCT00817063|3107590|P1|Overall Study|Death|1
943266|NCT00817063|3107589|P2|Overall Study|Adverse Event|13
943267|NCT00817063|3107590|P1|Overall Study|Adverse Event|32
943268|NCT00816595|3107707|P2|Overall Study|Withdrawal by Subject|0
943269|NCT00816595|3107708|P1|Overall Study|Withdrawal by Subject|2
943270|NCT00816556|3107721|P3|Overall Study|Lost to Follow-up|1
943271|NCT00816556|3107722|P2|Overall Study|Lost to Follow-up|0
943272|NCT00816556|3107723|P1|Overall Study|Lost to Follow-up|0
943273|NCT00816556|3107721|P3|Overall Study|Withdrawal by Subject|1
943274|NCT00816556|3107722|P2|Overall Study|Withdrawal by Subject|1
943275|NCT00816556|3107723|P1|Overall Study|Withdrawal by Subject|1
943276|NCT00816556|3107721|P3|Overall Study|Adverse Event|1
943277|NCT00816556|3107722|P2|Overall Study|Adverse Event|1
943278|NCT00816556|3107723|P1|Overall Study|Adverse Event|1
943279|NCT00816400|3107746|P9|Overall Study|In hospice care at the end of the study|0
943280|NCT00816400|3107747|P8|Overall Study|In hospice care at the end of the study|0
943281|NCT00816400|3107748|P7|Overall Study|In hospice care at the end of the study|0
943282|NCT00816400|3107749|P6|Overall Study|In hospice care at the end of the study|0
943283|NCT00816400|3107750|P5|Overall Study|In hospice care at the end of the study|0
943284|NCT00816400|3107751|P4|Overall Study|In hospice care at the end of the study|0
943285|NCT00816400|3107752|P3|Overall Study|In hospice care at the end of the study|2
943286|NCT00816400|3107753|P2|Overall Study|In hospice care at the end of the study|0
943287|NCT00816400|3107754|P1|Overall Study|In hospice care at the end of the study|0
943288|NCT00816400|3107746|P9|Overall Study|Death|6
943289|NCT00816400|3107747|P8|Overall Study|Death|5
943290|NCT00816400|3107748|P7|Overall Study|Death|2
943291|NCT00816400|3107749|P6|Overall Study|Death|3
943292|NCT00816400|3107750|P5|Overall Study|Death|2
943293|NCT00816400|3107751|P4|Overall Study|Death|3
943294|NCT00816400|3107752|P3|Overall Study|Death|3
943295|NCT00816400|3107753|P2|Overall Study|Death|3
943296|NCT00816400|3107754|P1|Overall Study|Death|2
943297|NCT00816166|3107944|P2|Overall Study|Death|2
943298|NCT00816166|3107945|P1|Overall Study|Death|4
943299|NCT00816166|3107944|P2|Overall Study|Lost to Follow-up|10
943300|NCT00816166|3107945|P1|Overall Study|Lost to Follow-up|6
943301|NCT00816036|3107977|P2|Overall Study|Withdrawal by Subject|23
943302|NCT00816036|3107978|P1|Overall Study|Withdrawal by Subject|54
943303|NCT00816036|3107977|P2|Overall Study|Lost to Follow-up|57
943304|NCT00816036|3107978|P1|Overall Study|Lost to Follow-up|75
943305|NCT00816036|3107977|P2|Overall Study|Death|28
943306|NCT00816036|3107978|P1|Overall Study|Death|47
943307|NCT00816023|3107992|P4|Overall Study|Randomized Not Treated|11
943308|NCT00816023|3107993|P3|Overall Study|Randomized Not Treated|6
943309|NCT00816023|3107994|P2|Overall Study|Randomized Not Treated|4
943310|NCT00816023|3107995|P1|Overall Study|Randomized Not Treated|6
943311|NCT00816023|3107992|P4|Overall Study|assessments complete prior to window|1
943312|NCT00816023|3107993|P3|Overall Study|assessments complete prior to window|2
943313|NCT00816023|3107994|P2|Overall Study|assessments complete prior to window|1
943314|NCT00816023|3107995|P1|Overall Study|assessments complete prior to window|1
943315|NCT00816023|3107992|P4|Overall Study|Physician Decision|0
943316|NCT00816023|3107993|P3|Overall Study|Physician Decision|1
943317|NCT00816023|3107994|P2|Overall Study|Physician Decision|0
943318|NCT00816023|3107995|P1|Overall Study|Physician Decision|0
943319|NCT00816023|3107992|P4|Overall Study|Withdrawal by Subject|0
943320|NCT00816023|3107993|P3|Overall Study|Withdrawal by Subject|0
943321|NCT00816023|3107994|P2|Overall Study|Withdrawal by Subject|0
943322|NCT00816023|3107995|P1|Overall Study|Withdrawal by Subject|1
943323|NCT00816023|3107992|P4|Overall Study|Lost to Follow-up|0
943324|NCT00816023|3107993|P3|Overall Study|Lost to Follow-up|0
943325|NCT00816023|3107994|P2|Overall Study|Lost to Follow-up|1
943326|NCT00816023|3107995|P1|Overall Study|Lost to Follow-up|1
943327|NCT00815919|3108009|P1|Overall Study|Lack of Efficacy|2
943328|NCT00815919|3108009|P1|Overall Study|AML Relapse|1
943329|NCT00815919|3108009|P1|Overall Study|Unrelated Fungal Infection|1
943330|NCT00815659|3108052|P1|Overall Study|Protocol Violation|1
943331|NCT00815659|3108052|P1|Overall Study|Lost to Follow-up|4
943332|NCT00815659|3108052|P1|Overall Study|Withdrawal by Subject|9
943333|NCT00815659|3108052|P1|Overall Study|Adverse Event|9
943334|NCT00815633|3108095|P1|Overall Study|study terminated|1
943335|NCT00815516|3108102|P2|Overall Study|Physician Decision|0
943336|NCT00815516|3108103|P1|Overall Study|Physician Decision|1
943337|NCT00815516|3108102|P2|Overall Study|Death|1
943338|NCT00815516|3108103|P1|Overall Study|Death|3
943339|NCT00815308|3108168|P1|Overall Study|Protocol Violation|6
943340|NCT00815308|3108168|P1|Overall Study|Withdrawal by Subject|0
943341|NCT00815308|3108168|P1|Overall Study|Adverse Event|4
943342|NCT00815295|3108177|P3|Overall Study|Cetuximab hypersensitivity reaction|3
943343|NCT00815295|3108178|P2|Overall Study|Cetuximab hypersensitivity reaction|1
943344|NCT00815295|3108179|P1|Overall Study|Cetuximab hypersensitivity reaction|0
943345|NCT00815191|3108191|P2|Overall Study|Protocol Violation|1
943346|NCT00815191|3108192|P1|Overall Study|Protocol Violation|1
943347|NCT00814983|3108229|P2|Overall Study|Graft failure|0
943348|NCT00814983|3108230|P1|Overall Study|Graft failure|1
943349|NCT00814983|3108229|P2|Overall Study|Withdrawal by Subject|0
943350|NCT00814983|3108230|P1|Overall Study|Withdrawal by Subject|1
943351|NCT00814983|3108229|P2|Overall Study|Screen failure|0
943352|NCT00814983|3108230|P1|Overall Study|Screen failure|1
943353|NCT00814892|3108261|P1|Overall Study|Study Termination|1
943354|NCT00814892|3108261|P1|Overall Study|Disease Progression|1
943355|NCT00814879|3108273|P2|By Week 48|Death|1
943356|NCT00814879|3108274|P1|By Week 48|Death|0
943357|NCT00814879|3108273|P2|By Week 48|Lost to Follow-up|2
943358|NCT00814879|3108274|P1|By Week 48|Lost to Follow-up|2
943359|NCT00814879|3108273|P2|By Week 24|Incarceration|1
943360|NCT00814879|3108274|P1|By Week 24|Incarceration|0
943361|NCT00814879|3108273|P2|By Week 24|Cancer Diagnosis|0
943362|NCT00814879|3108274|P1|By Week 24|Cancer Diagnosis|1
943363|NCT00814801|3108293|P3|Overall Study|Not specified|4
943364|NCT00814801|3108294|P2|Overall Study|Not specified|6
943365|NCT00814801|3108295|P1|Overall Study|Not specified|2
943366|NCT00814801|3108293|P3|Overall Study|Non-compliance|1
943367|NCT00814801|3108294|P2|Overall Study|Non-compliance|1
943368|NCT00814801|3108295|P1|Overall Study|Non-compliance|0
943369|NCT00814801|3108293|P3|Overall Study|Missing or change of caregiver|4
943370|NCT00814801|3108294|P2|Overall Study|Missing or change of caregiver|2
943371|NCT00814801|3108295|P1|Overall Study|Missing or change of caregiver|6
943372|NCT00814801|3108293|P3|Overall Study|Change of patients for CIBIC plus-J|0
943373|NCT00814801|3108294|P2|Overall Study|Change of patients for CIBIC plus-J|1
943374|NCT00814801|3108295|P1|Overall Study|Change of patients for CIBIC plus-J|1
943375|NCT00814801|3108293|P3|Overall Study|Inappropriate as a subject|1
943376|NCT00814801|3108294|P2|Overall Study|Inappropriate as a subject|1
943377|NCT00814801|3108295|P1|Overall Study|Inappropriate as a subject|1
943378|NCT00814801|3108293|P3|Overall Study|Withdrawal by Subject|14
943379|NCT00814801|3108294|P2|Overall Study|Withdrawal by Subject|11
943380|NCT00814801|3108295|P1|Overall Study|Withdrawal by Subject|9
943381|NCT00814801|3108293|P3|Overall Study|Adverse Event|19
943382|NCT00814801|3108294|P2|Overall Study|Adverse Event|16
943383|NCT00814801|3108295|P1|Overall Study|Adverse Event|15
943384|NCT00814710|3108334|P2|Overall Study|Lost to Follow-up|3
943385|NCT00814710|3108335|P1|Overall Study|Lost to Follow-up|7
943386|NCT00814710|3108334|P2|Overall Study|Adverse Event|0
943387|NCT00814710|3108335|P1|Overall Study|Adverse Event|1
943388|NCT00814658|3108403|P2|Overall Study|Adverse Event|3
943389|NCT00814658|3108404|P1|Overall Study|Adverse Event|3
943390|NCT00814658|3108403|P2|Overall Study|Physician Decision|0
943391|NCT00814658|3108404|P1|Overall Study|Physician Decision|1
943392|NCT00814658|3108403|P2|Overall Study|Lost to Follow-up|1
943393|NCT00814658|3108404|P1|Overall Study|Lost to Follow-up|0
943394|NCT00814632|3108470|P1|Overall Study|Lack of Efficacy|2
943395|NCT00814580|3108476|P2|Overall Study|Did Not Take Drug|2
943396|NCT00814580|3108477|P1|Overall Study|Did Not Take Drug|2
943397|NCT00814580|3108476|P2|Overall Study|Other|3
943398|NCT00814580|3108477|P1|Overall Study|Other|1
943399|NCT00814580|3108476|P2|Overall Study|Withdrawal by Subject|2
943400|NCT00814580|3108477|P1|Overall Study|Withdrawal by Subject|2
943401|NCT00814580|3108476|P2|Overall Study|Protocol Violation|0
943402|NCT00814580|3108477|P1|Overall Study|Protocol Violation|2
943403|NCT00814580|3108476|P2|Overall Study|Lack of Efficacy|25
943404|NCT00814580|3108477|P1|Overall Study|Lack of Efficacy|18
943405|NCT00814580|3108476|P2|Overall Study|Adverse Event|15
943406|NCT00814580|3108477|P1|Overall Study|Adverse Event|6
943407|NCT00814502|3108607|P2|Overall Study|Withdrawal by Subject|2
943408|NCT00814502|3108608|P1|Overall Study|Withdrawal by Subject|0
943409|NCT00814502|3108607|P2|Overall Study|Adverse Event|0
943410|NCT00814502|3108608|P1|Overall Study|Adverse Event|1
943411|NCT00814489|3108621|P3|Overall Study|Other|1
943412|NCT00814489|3108622|P2|Overall Study|Other|0
943413|NCT00814489|3108623|P1|Overall Study|Other|2
943414|NCT00814463|3108655|P1|Overall Study|Lost to Follow-up|1
943415|NCT00814346|3108661|P2|Open Phase (17 Months)|Not otherwise specified|0
943416|NCT00814346|3108662|P1|Open Phase (17 Months)|Not otherwise specified|1
943417|NCT00814346|3108661|P2|Open Phase (17 Months)|Lost to Follow-up|0
943418|NCT00814346|3108662|P1|Open Phase (17 Months)|Lost to Follow-up|2
943419|NCT00814346|3108661|P2|Open Phase (17 Months)|Consent|0
943420|NCT00814346|3108662|P1|Open Phase (17 Months)|Consent|2
943421|NCT00814346|3108661|P2|Open Phase (17 Months)|Adverse Event|0
943422|NCT00814346|3108662|P1|Open Phase (17 Months)|Adverse Event|5
943423|NCT00814346|3108661|P2|Double-blind Phase (4 Weeks)|Not otherwise specified|2
943424|NCT00814346|3108662|P1|Double-blind Phase (4 Weeks)|Not otherwise specified|0
943425|NCT00814346|3108661|P2|Double-blind Phase (4 Weeks)|Adverse Event|1
943426|NCT00814346|3108662|P1|Double-blind Phase (4 Weeks)|Adverse Event|0
943427|NCT00814333|3108728|P2|Enrollment|Lost to Follow-up|0
943428|NCT00814333|3108729|P1|Enrollment|Lost to Follow-up|1
943429|NCT00814320|3108737|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3
943430|NCT00814320|3108738|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0
943431|NCT00814320|3108737|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1
943432|NCT00814320|3108738|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0
943433|NCT00814320|3108737|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1
943434|NCT00814320|3108738|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0
943435|NCT00814320|3108737|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1
943436|NCT00814320|3108738|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2
943437|NCT00814320|3108737|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4
943438|NCT00814320|3108738|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1
943439|NCT00814320|3108737|P2|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0
943440|NCT00814320|3108738|P1|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1
943441|NCT00814320|3108737|P2|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0
943442|NCT00814320|3108738|P1|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1
943443|NCT00814320|3108737|P2|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1
943444|NCT00814320|3108738|P1|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0
943445|NCT00814320|3108737|P2|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2
943446|NCT00814320|3108738|P1|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0
943447|NCT00814320|3108737|P2|Epoch 1 (IV Treatment)|Withdrawal by Subject|0
943448|NCT00814320|3108738|P1|Epoch 1 (IV Treatment)|Withdrawal by Subject|1
943449|NCT00814307|3108870|P4|Overall Study|Death|0
943450|NCT00814307|3108871|P3|Overall Study|Death|0
943451|NCT00814307|3108872|P2|Overall Study|Death|1
943452|NCT00814307|3108873|P1|Overall Study|Death|0
943453|NCT00814307|3108870|P4|Overall Study|Withdrawal by Subject|2
943454|NCT00814307|3108871|P3|Overall Study|Withdrawal by Subject|0
943455|NCT00814307|3108872|P2|Overall Study|Withdrawal by Subject|6
943456|NCT00814307|3108873|P1|Overall Study|Withdrawal by Subject|4
943457|NCT00814307|3108870|P4|Overall Study|Protocol Violation|1
943458|NCT00814307|3108871|P3|Overall Study|Protocol Violation|1
943459|NCT00814307|3108872|P2|Overall Study|Protocol Violation|8
943460|NCT00814307|3108873|P1|Overall Study|Protocol Violation|2
943461|NCT00814307|3108870|P4|Overall Study|Other|1
943462|NCT00814307|3108871|P3|Overall Study|Other|0
943463|NCT00814307|3108872|P2|Overall Study|Other|2
943464|NCT00814307|3108873|P1|Overall Study|Other|1
943465|NCT00814307|3108870|P4|Overall Study|Lack of Efficacy|4
943466|NCT00814307|3108871|P3|Overall Study|Lack of Efficacy|3
943467|NCT00814307|3108872|P2|Overall Study|Lack of Efficacy|1
943468|NCT00814307|3108873|P1|Overall Study|Lack of Efficacy|1
943469|NCT00814307|3108870|P4|Overall Study|Adverse Event|2
943470|NCT00814307|3108871|P3|Overall Study|Adverse Event|3
943471|NCT00814307|3108872|P2|Overall Study|Adverse Event|9
943472|NCT00814307|3108873|P1|Overall Study|Adverse Event|3
943473|NCT00814307|3108870|P4|Overall Study|Randomized but not treated|0
943474|NCT00814307|3108871|P3|Overall Study|Randomized but not treated|0
943475|NCT00814307|3108872|P2|Overall Study|Randomized but not treated|0
943476|NCT00814307|3108873|P1|Overall Study|Randomized but not treated|1
943477|NCT00814164|3109069|P1|Overall Study|Death|5
943478|NCT00814164|3109069|P1|Overall Study|not stated|7
943479|NCT00814164|3109069|P1|Overall Study|Progression|7
943480|NCT00813995|3109103|P2|Overall Study|Withdrawal by Subject|5
943481|NCT00813995|3109104|P1|Overall Study|Withdrawal by Subject|0
943482|NCT00813995|3109103|P2|Overall Study|Subject moved|0
943483|NCT00813995|3109104|P1|Overall Study|Subject moved|4
943484|NCT00813995|3109103|P2|Overall Study|Protocol Violation|2
943485|NCT00813995|3109104|P1|Overall Study|Protocol Violation|3
943486|NCT00813995|3109103|P2|Overall Study|Other reason|2
943487|NCT00813995|3109104|P1|Overall Study|Other reason|2
943488|NCT00813995|3109103|P2|Overall Study|Lost to Follow-up|2
943489|NCT00813995|3109104|P1|Overall Study|Lost to Follow-up|4
943490|NCT00813995|3109103|P2|Overall Study|Lack of Efficacy|0
943491|NCT00813995|3109104|P1|Overall Study|Lack of Efficacy|1
943492|NCT00813995|3109103|P2|Overall Study|Laboratory adverse event|2
943493|NCT00813995|3109104|P1|Overall Study|Laboratory adverse event|0
943494|NCT00813995|3109103|P2|Overall Study|Clinical adverse event|3
943495|NCT00813995|3109104|P1|Overall Study|Clinical adverse event|9
943496|NCT00813943|3109127|P3|Overall Study|Ongoing at cut-off date|3
943497|NCT00813943|3109128|P2|Overall Study|Ongoing at cut-off date|5
943498|NCT00813943|3109129|P1|Overall Study|Ongoing at cut-off date|5
943499|NCT00813917|3109159|P2|Overall Study|Lost to Follow-up|1
943500|NCT00813917|3109160|P1|Overall Study|Lost to Follow-up|3
943501|NCT00813917|3109159|P2|Overall Study|Withdrawal by Subject|4
943502|NCT00813917|3109160|P1|Overall Study|Withdrawal by Subject|3
943503|NCT00813917|3109159|P2|Overall Study|Adverse Event|1
943504|NCT00813917|3109160|P1|Overall Study|Adverse Event|0
943505|NCT00813904|3109166|P1|Overall Study|Death|1
943506|NCT00813865|3109172|P1|Overall Study|Withdrawal by Subject|1
943507|NCT00813865|3109172|P1|Overall Study|Lost to Follow-up|3
943508|NCT00813865|3109172|P1|Overall Study|Failure to Respond|3
943509|NCT00813813|3109180|P2|Overall Study|Other|1
943510|NCT00813813|3109181|P1|Overall Study|Other|0
943511|NCT00813813|3109180|P2|Overall Study|Lost to Follow-up|7
943512|NCT00813813|3109181|P1|Overall Study|Lost to Follow-up|2
943513|NCT00813813|3109180|P2|Overall Study|Withdrawal by Subject|1
943514|NCT00813813|3109181|P1|Overall Study|Withdrawal by Subject|1
943515|NCT00813800|3109197|P1|Overall Study|Physician Decision|1
943516|NCT00813800|3109197|P1|Overall Study|Worsening of depression|2
943517|NCT00813800|3109197|P1|Overall Study|Adverse Event|1
943518|NCT00813800|3109197|P1|Overall Study|Screen Failure after Consent|2
943519|NCT00813761|3109205|P4|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
943520|NCT00813761|3109206|P3|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6
943521|NCT00813761|3109207|P2|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
943522|NCT00813761|3109208|P1|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9
943523|NCT00813761|3109205|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3
943524|NCT00813761|3109206|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0
943525|NCT00813761|3109207|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4
943526|NCT00813761|3109208|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1
943527|NCT00813761|3109205|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0
943528|NCT00813761|3109206|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
943529|NCT00813761|3109207|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
943530|NCT00813761|3109208|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
943531|NCT00813761|3109205|P4|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
943532|NCT00813761|3109206|P3|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
943533|NCT00813761|3109207|P2|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
943534|NCT00813761|3109208|P1|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
943535|NCT00813761|3109205|P4|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1
943536|NCT00813761|3109206|P3|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2
943537|NCT00813761|3109207|P2|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0
943538|NCT00813761|3109208|P1|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3
943539|NCT00813761|3109205|P4|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
943540|NCT00813761|3109206|P3|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
943541|NCT00813761|3109207|P2|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3
943542|NCT00813761|3109208|P1|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2
943543|NCT00813761|3109205|P4|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
943544|NCT00813761|3109206|P3|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
943545|NCT00813761|3109207|P2|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1
943546|NCT00813761|3109208|P1|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
943547|NCT00813761|3109205|P4|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
943548|NCT00813761|3109206|P3|Phase 1 (Baseline to 4 Weeks)|poor comfort|5
943549|NCT00813761|3109207|P2|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
943550|NCT00813761|3109208|P1|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
943551|NCT00813761|3109205|P4|Phase 1 (Baseline to 4 Weeks)|poor vision|0
943552|NCT00813761|3109206|P3|Phase 1 (Baseline to 4 Weeks)|poor vision|3
943553|NCT00813761|3109207|P2|Phase 1 (Baseline to 4 Weeks)|poor vision|0
943554|NCT00813761|3109208|P1|Phase 1 (Baseline to 4 Weeks)|poor vision|0
943555|NCT00813761|3109205|P4|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0
943556|NCT00813761|3109206|P3|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
943557|NCT00813761|3109207|P2|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
943558|NCT00813761|3109208|P1|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
943559|NCT00813761|3109205|P4|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1
943560|NCT00813761|3109206|P3|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3
943561|NCT00813761|3109207|P2|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
943562|NCT00813761|3109208|P1|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
943563|NCT00813761|3109205|P4|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
943564|NCT00813761|3109206|P3|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
943565|NCT00813761|3109207|P2|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
943566|NCT00813761|3109208|P1|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2
943567|NCT00813748|3109258|P2|Skin Test Substudy|Physician Decision|1
943568|NCT00813748|3109259|P1|Skin Test Substudy|Physician Decision|0
943569|NCT00813709|3109288|P6|Open Label Period|Other|6
943570|NCT00813709|3109289|P5|Open Label Period|Other|5
943571|NCT00813709|3109290|P4|Open Label Period|Other|11
943572|NCT00813709|3109291|P3|Open Label Period|Other|0
943573|NCT00813709|3109292|P2|Open Label Period|Other|0
943574|NCT00813709|3109293|P1|Open Label Period|Other|0
943575|NCT00813709|3109288|P6|Open Label Period|Randomized but not treated|1
943576|NCT00813709|3109289|P5|Open Label Period|Randomized but not treated|0
943577|NCT00813709|3109290|P4|Open Label Period|Randomized but not treated|1
943578|NCT00813709|3109291|P3|Open Label Period|Randomized but not treated|0
943579|NCT00813709|3109292|P2|Open Label Period|Randomized but not treated|0
943580|NCT00813709|3109293|P1|Open Label Period|Randomized but not treated|0
943581|NCT00813709|3109288|P6|Open Label Period|Lack of Efficacy|1
943582|NCT00813709|3109289|P5|Open Label Period|Lack of Efficacy|1
943583|NCT00813709|3109290|P4|Open Label Period|Lack of Efficacy|3
943584|NCT00813709|3109291|P3|Open Label Period|Lack of Efficacy|0
943585|NCT00813709|3109292|P2|Open Label Period|Lack of Efficacy|0
943586|NCT00813709|3109293|P1|Open Label Period|Lack of Efficacy|0
943587|NCT00813709|3109288|P6|Open Label Period|Adverse Event|3
943588|NCT00813709|3109289|P5|Open Label Period|Adverse Event|4
943589|NCT00813709|3109290|P4|Open Label Period|Adverse Event|5
943590|NCT00813709|3109291|P3|Open Label Period|Adverse Event|0
943591|NCT00813709|3109292|P2|Open Label Period|Adverse Event|0
943592|NCT00813709|3109293|P1|Open Label Period|Adverse Event|0
943593|NCT00813709|3109288|P6|Double Blind Period|Other|0
943594|NCT00813709|3109289|P5|Double Blind Period|Other|0
943595|NCT00813709|3109290|P4|Double Blind Period|Other|0
943596|NCT00813709|3109291|P3|Double Blind Period|Other|6
943597|NCT00813709|3109292|P2|Double Blind Period|Other|9
943598|NCT00813709|3109293|P1|Double Blind Period|Other|14
943599|NCT00813709|3109288|P6|Double Blind Period|Randomized but not treated|0
943600|NCT00813709|3109289|P5|Double Blind Period|Randomized but not treated|0
943601|NCT00813709|3109290|P4|Double Blind Period|Randomized but not treated|0
943602|NCT00813709|3109291|P3|Double Blind Period|Randomized but not treated|1
943603|NCT00813709|3109292|P2|Double Blind Period|Randomized but not treated|3
943604|NCT00813709|3109293|P1|Double Blind Period|Randomized but not treated|1
943605|NCT00813709|3109288|P6|Double Blind Period|Switched to open label phase|0
943606|NCT00813709|3109289|P5|Double Blind Period|Switched to open label phase|0
943607|NCT00813709|3109290|P4|Double Blind Period|Switched to open label phase|0
943608|NCT00813709|3109291|P3|Double Blind Period|Switched to open label phase|18
943609|NCT00813709|3109292|P2|Double Blind Period|Switched to open label phase|26
943610|NCT00813709|3109293|P1|Double Blind Period|Switched to open label phase|9
943611|NCT00813709|3109288|P6|Double Blind Period|Lost to Follow-up|0
943612|NCT00813709|3109289|P5|Double Blind Period|Lost to Follow-up|0
943613|NCT00813709|3109290|P4|Double Blind Period|Lost to Follow-up|0
943614|NCT00813709|3109291|P3|Double Blind Period|Lost to Follow-up|2
943615|NCT00813709|3109292|P2|Double Blind Period|Lost to Follow-up|2
943616|NCT00813709|3109293|P1|Double Blind Period|Lost to Follow-up|3
943617|NCT00813709|3109288|P6|Double Blind Period|Adverse Event|0
943618|NCT00813709|3109289|P5|Double Blind Period|Adverse Event|0
943619|NCT00813709|3109290|P4|Double Blind Period|Adverse Event|0
943620|NCT00813709|3109291|P3|Double Blind Period|Adverse Event|4
943621|NCT00813709|3109292|P2|Double Blind Period|Adverse Event|1
943622|NCT00813709|3109293|P1|Double Blind Period|Adverse Event|4
943623|NCT00813592|3109373|P1|Overall Study|Disease assessment was not completed per|2
943624|NCT00813488|3109382|P2|Open-label Extension|Not specified|0
943625|NCT00813488|3109383|P1|Open-label Extension|Not specified|1
943626|NCT00813488|3109382|P2|Open-label Extension|Non-compliance study procedures|1
943627|NCT00813488|3109383|P1|Open-label Extension|Non-compliance study procedures|2
943628|NCT00813488|3109382|P2|Open-label Extension|Non-compliance study medication|0
943629|NCT00813488|3109383|P1|Open-label Extension|Non-compliance study medication|4
943630|NCT00813488|3109382|P2|Open-label Extension|Protocol Violation|2
943631|NCT00813488|3109383|P1|Open-label Extension|Protocol Violation|1
943632|NCT00813488|3109382|P2|Open-label Extension|Withdrawal by Subject|2
943633|NCT00813488|3109383|P1|Open-label Extension|Withdrawal by Subject|0
943634|NCT00813488|3109382|P2|Open-label Extension|Lack of Efficacy|0
943635|NCT00813488|3109383|P1|Open-label Extension|Lack of Efficacy|3
943636|NCT00813488|3109382|P2|Open-label Extension|Adverse Event|2
943637|NCT00813488|3109383|P1|Open-label Extension|Adverse Event|1
943638|NCT00813488|3109382|P2|Double-blind Treatment Period 2|Not Specified|0
943639|NCT00813488|3109383|P1|Double-blind Treatment Period 2|Not Specified|1
943640|NCT00813488|3109382|P2|Double-blind Treatment Period 2|Protocol Violation|0
943641|NCT00813488|3109383|P1|Double-blind Treatment Period 2|Protocol Violation|2
943642|NCT00813488|3109382|P2|Double-blind Treatment Period 2|Withdrawal by Subject|1
943643|NCT00813488|3109383|P1|Double-blind Treatment Period 2|Withdrawal by Subject|1
943644|NCT00813488|3109382|P2|Double-blind Treatment Period 2|Adverse Event|0
943645|NCT00813488|3109383|P1|Double-blind Treatment Period 2|Adverse Event|1
943646|NCT00813488|3109382|P2|Double-blind Treatment Period 1|Lost to Follow-up|1
943647|NCT00813488|3109383|P1|Double-blind Treatment Period 1|Lost to Follow-up|0
943648|NCT00813488|3109382|P2|Double-blind Treatment Period 1|Protocol Violation|2
943649|NCT00813488|3109383|P1|Double-blind Treatment Period 1|Protocol Violation|0
943650|NCT00813488|3109382|P2|Double-blind Treatment Period 1|Withdrawal by Subject|1
943651|NCT00813488|3109383|P1|Double-blind Treatment Period 1|Withdrawal by Subject|0
943652|NCT00813488|3109382|P2|Double-blind Treatment Period 1|Adverse Event|1
943653|NCT00813488|3109383|P1|Double-blind Treatment Period 1|Adverse Event|1
943654|NCT00813488|3109382|P2|Titration Period 2|Non-compliance with study procedures|1
943655|NCT00813488|3109383|P1|Titration Period 2|Non-compliance with study procedures|2
943656|NCT00813488|3109382|P2|Titration Period 2|Lost to Follow-up|0
943657|NCT00813488|3109383|P1|Titration Period 2|Lost to Follow-up|1
943658|NCT00813488|3109382|P2|Titration Period 2|Protocol Violation|2
943659|NCT00813488|3109383|P1|Titration Period 2|Protocol Violation|3
943660|NCT00813488|3109382|P2|Titration Period 2|Lack of Efficacy|4
943661|NCT00813488|3109383|P1|Titration Period 2|Lack of Efficacy|8
943662|NCT00813488|3109382|P2|Titration Period 2|Adverse Event|3
943663|NCT00813488|3109383|P1|Titration Period 2|Adverse Event|2
943664|NCT00813488|3109382|P2|Titration Period 1|Technical Difficulties|1
943665|NCT00813488|3109383|P1|Titration Period 1|Technical Difficulties|0
943666|NCT00813488|3109382|P2|Titration Period 1|Non-compliance to study procedures|2
943667|NCT00813488|3109383|P1|Titration Period 1|Non-compliance to study procedures|2
943668|NCT00813488|3109382|P2|Titration Period 1|Non-compliance to study medication|1
943669|NCT00813488|3109383|P1|Titration Period 1|Non-compliance to study medication|4
943670|NCT00813488|3109382|P2|Titration Period 1|Protocol Violation|3
943671|NCT00813488|3109383|P1|Titration Period 1|Protocol Violation|4
943672|NCT00813488|3109382|P2|Titration Period 1|Withdrawal by Subject|2
943673|NCT00813488|3109383|P1|Titration Period 1|Withdrawal by Subject|2
943674|NCT00813488|3109382|P2|Titration Period 1|Lack of Efficacy|7
943675|NCT00813488|3109383|P1|Titration Period 1|Lack of Efficacy|9
943676|NCT00813488|3109382|P2|Titration Period 1|Adverse Event|1
943677|NCT00813488|3109383|P1|Titration Period 1|Adverse Event|6
943678|NCT00813150|3109513|P2|Long Term Follow-up|Progression/Relapse|24
943679|NCT00813150|3109514|P1|Long Term Follow-up|Progression/Relapse|22
943680|NCT00813150|3109513|P2|Long Term Follow-up|Lost to Follow-up|0
943681|NCT00813150|3109514|P1|Long Term Follow-up|Lost to Follow-up|2
943682|NCT00813150|3109513|P2|Long Term Follow-up|Not specified|3
943683|NCT00813150|3109514|P1|Long Term Follow-up|Not specified|0
943684|NCT00813150|3109513|P2|Long Term Follow-up|Death|4
943685|NCT00813150|3109514|P1|Long Term Follow-up|Death|0
943686|NCT00813150|3109513|P2|Treatment Period|Data not available|2
943687|NCT00813150|3109514|P1|Treatment Period|Data not available|1
943688|NCT00813150|3109513|P2|Treatment Period|Reason not specified|4
943689|NCT00813150|3109514|P1|Treatment Period|Reason not specified|3
943690|NCT00813150|3109513|P2|Treatment Period|Non compliance|1
943691|NCT00813150|3109514|P1|Treatment Period|Non compliance|0
943692|NCT00813150|3109513|P2|Treatment Period|Withdrawal by Subject|3
943693|NCT00813150|3109514|P1|Treatment Period|Withdrawal by Subject|5
943694|NCT00813150|3109513|P2|Treatment Period|Protocol Violation|4
943695|NCT00813150|3109514|P1|Treatment Period|Protocol Violation|3
943696|NCT00813150|3109513|P2|Treatment Period|Stable disease|2
943697|NCT00813150|3109514|P1|Treatment Period|Stable disease|1
943698|NCT00813150|3109513|P2|Treatment Period|Complete response|1
943699|NCT00813150|3109514|P1|Treatment Period|Complete response|0
943700|NCT00813150|3109513|P2|Treatment Period|Progressive disease|0
943701|NCT00813150|3109514|P1|Treatment Period|Progressive disease|1
943702|NCT00813150|3109513|P2|Treatment Period|Death|0
943703|NCT00813150|3109514|P1|Treatment Period|Death|2
943704|NCT00813150|3109513|P2|Treatment Period|Adverse Event|15
943705|NCT00813150|3109514|P1|Treatment Period|Adverse Event|16
943706|NCT00813098|3109538|P3|Overall Study|Withdrew Consent|0
943707|NCT00813098|3109539|P2|Overall Study|Withdrew Consent|1
943708|NCT00813098|3109540|P1|Overall Study|Withdrew Consent|0
943709|NCT00813098|3109538|P3|Overall Study|Principal Investigator decision|0
943710|NCT00813098|3109539|P2|Overall Study|Principal Investigator decision|1
943711|NCT00813098|3109540|P1|Overall Study|Principal Investigator decision|0
943712|NCT00813098|3109538|P3|Overall Study|Protocol Violation|1
943713|NCT00813098|3109539|P2|Overall Study|Protocol Violation|0
943714|NCT00813098|3109540|P1|Overall Study|Protocol Violation|0
943715|NCT00813098|3109538|P3|Overall Study|Lost to Follow-up|0
943716|NCT00813098|3109539|P2|Overall Study|Lost to Follow-up|1
943717|NCT00813098|3109540|P1|Overall Study|Lost to Follow-up|0
943718|NCT00813098|3109538|P3|Overall Study|Inability to complete study procedures|0
943719|NCT00813098|3109539|P2|Overall Study|Inability to complete study procedures|0
943720|NCT00813098|3109540|P1|Overall Study|Inability to complete study procedures|1
943721|NCT00813098|3109538|P3|Overall Study|Withdrawal by Subject|0
943722|NCT00813098|3109539|P2|Overall Study|Withdrawal by Subject|1
943723|NCT00813098|3109540|P1|Overall Study|Withdrawal by Subject|0
943724|NCT00813098|3109538|P3|Overall Study|Adverse Event|1
943725|NCT00813098|3109539|P2|Overall Study|Adverse Event|4
943726|NCT00813098|3109540|P1|Overall Study|Adverse Event|2
943727|NCT00812981|3109565|P2|Overall Study|Other|1
943728|NCT00812981|3109566|P1|Overall Study|Other|0
943729|NCT00812968|3109604|P1|Overall Study|Study closed due to marketing approval|3
943730|NCT00812968|3109604|P1|Overall Study|No further treatment required|1
943731|NCT00812968|3109604|P1|Overall Study|Disease progression|1
943732|NCT00812968|3109604|P1|Overall Study|Relapse after erythroid response|6
943733|NCT00812955|3109639|P4|Overall Study|randomized in error|0
943734|NCT00812955|3109640|P3|Overall Study|randomized in error|1
943735|NCT00812955|3109641|P2|Overall Study|randomized in error|0
943736|NCT00812955|3109642|P1|Overall Study|randomized in error|0
943737|NCT00812955|3109639|P4|Overall Study|Withdrawal by Subject|2
943738|NCT00812955|3109640|P3|Overall Study|Withdrawal by Subject|1
943739|NCT00812955|3109641|P2|Overall Study|Withdrawal by Subject|0
943740|NCT00812955|3109642|P1|Overall Study|Withdrawal by Subject|1
943741|NCT00812955|3109639|P4|Overall Study|Lost to Follow-up|2
943742|NCT00812955|3109640|P3|Overall Study|Lost to Follow-up|1
943743|NCT00812955|3109641|P2|Overall Study|Lost to Follow-up|1
943744|NCT00812955|3109642|P1|Overall Study|Lost to Follow-up|2
943745|NCT00812955|3109639|P4|Overall Study|Adverse Event|4
943746|NCT00812955|3109640|P3|Overall Study|Adverse Event|3
943747|NCT00812955|3109641|P2|Overall Study|Adverse Event|6
943748|NCT00812955|3109642|P1|Overall Study|Adverse Event|7
943749|NCT00812929|3109662|P10|Washout Period 3 (7 Days)|Adverse Event|0
943750|NCT00812929|3109663|P9|Washout Period 3 (7 Days)|Adverse Event|0
943751|NCT00812929|3109664|P8|Washout Period 3 (7 Days)|Adverse Event|0
943752|NCT00812929|3109665|P7|Washout Period 3 (7 Days)|Adverse Event|0
943753|NCT00812929|3109666|P6|Washout Period 3 (7 Days)|Adverse Event|1
943754|NCT00812929|3109667|P5|Washout Period 3 (7 Days)|Adverse Event|0
943755|NCT00812929|3109668|P4|Washout Period 3 (7 Days)|Adverse Event|0
943756|NCT00812929|3109669|P3|Washout Period 3 (7 Days)|Adverse Event|0
943757|NCT00812929|3109670|P2|Washout Period 3 (7 Days)|Adverse Event|0
943758|NCT00812929|3109671|P1|Washout Period 3 (7 Days)|Adverse Event|0
943759|NCT00812929|3109662|P10|Washout Period 2 (7 Days)|Physician Decision|1
943760|NCT00812929|3109663|P9|Washout Period 2 (7 Days)|Physician Decision|0
943761|NCT00812929|3109664|P8|Washout Period 2 (7 Days)|Physician Decision|0
943762|NCT00812929|3109665|P7|Washout Period 2 (7 Days)|Physician Decision|0
943763|NCT00812929|3109666|P6|Washout Period 2 (7 Days)|Physician Decision|0
943764|NCT00812929|3109667|P5|Washout Period 2 (7 Days)|Physician Decision|0
943765|NCT00812929|3109668|P4|Washout Period 2 (7 Days)|Physician Decision|0
943766|NCT00812929|3109669|P3|Washout Period 2 (7 Days)|Physician Decision|0
943767|NCT00812929|3109670|P2|Washout Period 2 (7 Days)|Physician Decision|0
943768|NCT00812929|3109671|P1|Washout Period 2 (7 Days)|Physician Decision|0
943769|NCT00812929|3109662|P10|Washout Period 1 (7 Days)|Physician Decision|0
943770|NCT00812929|3109663|P9|Washout Period 1 (7 Days)|Physician Decision|0
943771|NCT00812929|3109664|P8|Washout Period 1 (7 Days)|Physician Decision|0
943772|NCT00812929|3109665|P7|Washout Period 1 (7 Days)|Physician Decision|0
943773|NCT00812929|3109666|P6|Washout Period 1 (7 Days)|Physician Decision|0
943774|NCT00812929|3109667|P5|Washout Period 1 (7 Days)|Physician Decision|0
943775|NCT00812929|3109668|P4|Washout Period 1 (7 Days)|Physician Decision|0
943776|NCT00812929|3109669|P3|Washout Period 1 (7 Days)|Physician Decision|1
943777|NCT00812929|3109670|P2|Washout Period 1 (7 Days)|Physician Decision|0
943778|NCT00812929|3109671|P1|Washout Period 1 (7 Days)|Physician Decision|0
943779|NCT00812812|3109809|P2|Overall Study|Withdrawal by Subject|2
943780|NCT00812812|3109810|P1|Overall Study|Withdrawal by Subject|0
943781|NCT00812812|3109809|P2|Overall Study|Lost to Follow-up|1
943782|NCT00812812|3109810|P1|Overall Study|Lost to Follow-up|0
943783|NCT00812812|3109809|P2|Overall Study|Lack of Efficacy|0
943784|NCT00812812|3109810|P1|Overall Study|Lack of Efficacy|1
943785|NCT00812812|3109809|P2|Overall Study|Adverse Event|1
943786|NCT00812812|3109810|P1|Overall Study|Adverse Event|2
943787|NCT00812708|3109823|P1|Overall Study|Signed consent but later withdrew|3
943788|NCT00812708|3109823|P1|Overall Study|Surgery cancelled due to uveitis|1
943789|NCT00812708|3109823|P1|Overall Study|Switched to another study|1
943790|NCT00812708|3109823|P1|Overall Study|Lack of medical insurance|1
943791|NCT00812708|3109823|P1|Overall Study|Device could not be implanted|2
943792|NCT00812565|3109851|P8|Overall Study|Reason Not Specified|0
943793|NCT00812565|3109852|P7|Overall Study|Reason Not Specified|0
943794|NCT00812565|3109853|P6|Overall Study|Reason Not Specified|1
943795|NCT00812565|3109854|P5|Overall Study|Reason Not Specified|0
943796|NCT00812565|3109855|P4|Overall Study|Reason Not Specified|0
943797|NCT00812565|3109856|P3|Overall Study|Reason Not Specified|0
943798|NCT00812565|3109857|P2|Overall Study|Reason Not Specified|0
943799|NCT00812565|3109858|P1|Overall Study|Reason Not Specified|0
943800|NCT00812565|3109851|P8|Overall Study|Withdrawal of Consent|0
943801|NCT00812565|3109852|P7|Overall Study|Withdrawal of Consent|0
943802|NCT00812565|3109853|P6|Overall Study|Withdrawal of Consent|0
943803|NCT00812565|3109854|P5|Overall Study|Withdrawal of Consent|1
943804|NCT00812565|3109855|P4|Overall Study|Withdrawal of Consent|0
943805|NCT00812565|3109856|P3|Overall Study|Withdrawal of Consent|0
943806|NCT00812565|3109857|P2|Overall Study|Withdrawal of Consent|0
943807|NCT00812565|3109858|P1|Overall Study|Withdrawal of Consent|1
943808|NCT00812565|3109851|P8|Overall Study|Did Not Come to Study Visit|0
943809|NCT00812565|3109852|P7|Overall Study|Did Not Come to Study Visit|0
943810|NCT00812565|3109853|P6|Overall Study|Did Not Come to Study Visit|0
943811|NCT00812565|3109854|P5|Overall Study|Did Not Come to Study Visit|0
943812|NCT00812565|3109855|P4|Overall Study|Did Not Come to Study Visit|0
943813|NCT00812565|3109856|P3|Overall Study|Did Not Come to Study Visit|0
943814|NCT00812565|3109857|P2|Overall Study|Did Not Come to Study Visit|0
943815|NCT00812565|3109858|P1|Overall Study|Did Not Come to Study Visit|1
943816|NCT00812565|3109851|P8|Overall Study|Adverse Event|1
943817|NCT00812565|3109852|P7|Overall Study|Adverse Event|0
943818|NCT00812565|3109853|P6|Overall Study|Adverse Event|0
943819|NCT00812565|3109854|P5|Overall Study|Adverse Event|0
943820|NCT00812565|3109855|P4|Overall Study|Adverse Event|2
943821|NCT00812565|3109856|P3|Overall Study|Adverse Event|0
943822|NCT00812565|3109857|P2|Overall Study|Adverse Event|0
943823|NCT00812565|3109858|P1|Overall Study|Adverse Event|0
943824|NCT00812565|3109851|P8|Overall Study|Did Not Receive Study Medication|0
943825|NCT00812565|3109852|P7|Overall Study|Did Not Receive Study Medication|0
943826|NCT00812565|3109853|P6|Overall Study|Did Not Receive Study Medication|0
943827|NCT00812565|3109854|P5|Overall Study|Did Not Receive Study Medication|0
943828|NCT00812565|3109855|P4|Overall Study|Did Not Receive Study Medication|0
943829|NCT00812565|3109856|P3|Overall Study|Did Not Receive Study Medication|0
943830|NCT00812565|3109857|P2|Overall Study|Did Not Receive Study Medication|1
943831|NCT00812565|3109858|P1|Overall Study|Did Not Receive Study Medication|1
943832|NCT00812487|3109982|P2|Overall Study|Protocol Violation|1
943833|NCT00812487|3109983|P1|Overall Study|Protocol Violation|0
943834|NCT00812487|3109982|P2|Overall Study|Transfer to ICU prior to intervention|0
943835|NCT00812487|3109983|P1|Overall Study|Transfer to ICU prior to intervention|1
943836|NCT00812487|3109982|P2|Overall Study|Withdrawal by Subject|2
943837|NCT00812487|3109983|P1|Overall Study|Withdrawal by Subject|3
943838|NCT00812487|3109982|P2|Overall Study|Lost to Follow-up|0
943839|NCT00812487|3109983|P1|Overall Study|Lost to Follow-up|2
943840|NCT00812461|3110009|P2|All Treated Patients|Other Reason|21
943841|NCT00812461|3110010|P1|All Treated Patients|Other Reason|13
943842|NCT00812461|3110009|P2|All Treated Patients|Lost to Follow-up|14
943843|NCT00812461|3110010|P1|All Treated Patients|Lost to Follow-up|11
943844|NCT00812461|3110009|P2|All Treated Patients|Withdrawal by Subject|54
943845|NCT00812461|3110010|P1|All Treated Patients|Withdrawal by Subject|45
943846|NCT00812461|3110009|P2|All Treated Patients|Protocol Violation|27
943847|NCT00812461|3110010|P1|All Treated Patients|Protocol Violation|36
943848|NCT00812461|3110009|P2|All Treated Patients|Non-compliance|9
943849|NCT00812461|3110010|P1|All Treated Patients|Non-compliance|6
943850|NCT00812461|3110009|P2|All Treated Patients|Lack of Efficacy|7
943851|NCT00812461|3110010|P1|All Treated Patients|Lack of Efficacy|13
943852|NCT00812461|3110009|P2|All Treated Patients|Adverse Event|15
943853|NCT00812461|3110010|P1|All Treated Patients|Adverse Event|8
943854|NCT00812461|3110009|P2|All Randomised Patients|Did not receive placebo/nalmefene|17
943855|NCT00812461|3110010|P1|All Randomised Patients|Did not receive placebo/nalmefene|23
943856|NCT00812331|3110033|P5|Overall Study|Adverse Event|0
943857|NCT00812331|3110034|P4|Overall Study|Adverse Event|0
943858|NCT00812331|3110035|P3|Overall Study|Adverse Event|0
943859|NCT00812331|3110036|P2|Overall Study|Adverse Event|0
943860|NCT00812331|3110037|P1|Overall Study|Adverse Event|1
943861|NCT00812253|3110112|P2|Overall Study|Lost to Follow-up|0
943862|NCT00812253|3110113|P1|Overall Study|Lost to Follow-up|2
943863|NCT00812253|3110112|P2|Overall Study|Protocol Violation|1
943864|NCT00812253|3110113|P1|Overall Study|Protocol Violation|1
943865|NCT00812253|3110112|P2|Overall Study|Withdrawal by Subject|2
943866|NCT00812253|3110113|P1|Overall Study|Withdrawal by Subject|3
943867|NCT00812097|3110138|P4|Overall Study|Unknown reasons and patient/doctor moves|5
943868|NCT00812097|3110139|P3|Overall Study|Unknown reasons and patient/doctor moves|15
943869|NCT00812097|3110140|P2|Overall Study|Unknown reasons and patient/doctor moves|24
943870|NCT00812097|3110141|P1|Overall Study|Unknown reasons and patient/doctor moves|111
943871|NCT00812097|3110138|P4|Overall Study|Explantation of study device(s)|20
943872|NCT00812097|3110139|P3|Overall Study|Explantation of study device(s)|14
943873|NCT00812097|3110140|P2|Overall Study|Explantation of study device(s)|29
943874|NCT00812097|3110141|P1|Overall Study|Explantation of study device(s)|27
943875|NCT00812097|3110138|P4|Overall Study|Lost to Follow-up|5
943876|NCT00812097|3110139|P3|Overall Study|Lost to Follow-up|17
943877|NCT00812097|3110140|P2|Overall Study|Lost to Follow-up|14
943878|NCT00812097|3110141|P1|Overall Study|Lost to Follow-up|90
943879|NCT00812097|3110138|P4|Overall Study|Withdrawal by Subject|2
943880|NCT00812097|3110139|P3|Overall Study|Withdrawal by Subject|8
943881|NCT00812097|3110140|P2|Overall Study|Withdrawal by Subject|12
943882|NCT00812097|3110141|P1|Overall Study|Withdrawal by Subject|14
943883|NCT00812097|3110138|P4|Overall Study|Death|3
943884|NCT00812097|3110139|P3|Overall Study|Death|3
943885|NCT00812097|3110140|P2|Overall Study|Death|10
943886|NCT00812097|3110141|P1|Overall Study|Death|3
943887|NCT00812006|3110170|P3|Overall Study|Lack of Qualifying Event|2
943888|NCT00812006|3110171|P2|Overall Study|Lack of Qualifying Event|2
943889|NCT00812006|3110172|P1|Overall Study|Lack of Qualifying Event|4
943890|NCT00812006|3110170|P3|Overall Study|Withdrawal by Subject|1
943891|NCT00812006|3110171|P2|Overall Study|Withdrawal by Subject|1
943892|NCT00812006|3110172|P1|Overall Study|Withdrawal by Subject|2
943893|NCT00812006|3110170|P3|Overall Study|Physician Decision|1
943894|NCT00812006|3110171|P2|Overall Study|Physician Decision|0
943895|NCT00812006|3110172|P1|Overall Study|Physician Decision|0
943896|NCT00812006|3110170|P3|Overall Study|Lost to Follow-up|2
943897|NCT00812006|3110171|P2|Overall Study|Lost to Follow-up|0
943898|NCT00812006|3110172|P1|Overall Study|Lost to Follow-up|0
943899|NCT00811954|3110189|P3|Overall Study|Complete Protocol: No follow-up|1
943900|NCT00811954|3110190|P2|Overall Study|Complete Protocol: No follow-up|0
943901|NCT00811954|3110191|P1|Overall Study|Complete Protocol: No follow-up|0
943902|NCT00811954|3110189|P3|Overall Study|Severe Debilitation|1
943903|NCT00811954|3110190|P2|Overall Study|Severe Debilitation|0
943904|NCT00811954|3110191|P1|Overall Study|Severe Debilitation|2
943905|NCT00811954|3110189|P3|Overall Study|Site Closure|1
943906|NCT00811954|3110190|P2|Overall Study|Site Closure|0
943907|NCT00811954|3110191|P1|Overall Study|Site Closure|4
943908|NCT00811954|3110189|P3|Overall Study|Withdraw consent prior study completion|5
943909|NCT00811954|3110190|P2|Overall Study|Withdraw consent prior study completion|6
943910|NCT00811954|3110191|P1|Overall Study|Withdraw consent prior study completion|4
943911|NCT00811954|3110189|P3|Overall Study|Not willing to adhere to requirements|16
943912|NCT00811954|3110190|P2|Overall Study|Not willing to adhere to requirements|2
943913|NCT00811954|3110191|P1|Overall Study|Not willing to adhere to requirements|12
943914|NCT00811954|3110189|P3|Overall Study|Not able to get to clinic|30
943915|NCT00811954|3110190|P2|Overall Study|Not able to get to clinic|35
943916|NCT00811954|3110191|P1|Overall Study|Not able to get to clinic|28
943917|NCT00811954|3110189|P3|Overall Study|Lost to Follow-up|34
943918|NCT00811954|3110190|P2|Overall Study|Lost to Follow-up|23
943919|NCT00811954|3110191|P1|Overall Study|Lost to Follow-up|29
943920|NCT00811954|3110189|P3|Overall Study|Death|13
943921|NCT00811954|3110190|P2|Overall Study|Death|6
943922|NCT00811954|3110191|P1|Overall Study|Death|10
943923|NCT00811941|3110255|P2|All Treated Patients|Other Reason|14
943924|NCT00811941|3110256|P1|All Treated Patients|Other Reason|4
943925|NCT00811941|3110255|P2|All Treated Patients|Lost to Follow-up|12
943926|NCT00811941|3110256|P1|All Treated Patients|Lost to Follow-up|3
943927|NCT00811941|3110255|P2|All Treated Patients|Withdrawal by Subject|94
943928|NCT00811941|3110256|P1|All Treated Patients|Withdrawal by Subject|35
943929|NCT00811941|3110255|P2|All Treated Patients|Protocol Violation|17
943930|NCT00811941|3110256|P1|All Treated Patients|Protocol Violation|5
943931|NCT00811941|3110255|P2|All Treated Patients|Non-compliance|8
943932|NCT00811941|3110256|P1|All Treated Patients|Non-compliance|1
943933|NCT00811941|3110255|P2|All Treated Patients|Lack of Efficacy|3
943934|NCT00811941|3110256|P1|All Treated Patients|Lack of Efficacy|2
943935|NCT00811941|3110255|P2|All Treated Patients|Adverse Event|43
943936|NCT00811941|3110256|P1|All Treated Patients|Adverse Event|2
943937|NCT00811941|3110255|P2|All Randomised Patients|Did not receive placebo/nalmefene|8
943938|NCT00811941|3110256|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
943939|NCT00811928|3110294|P2|Overall Study|Poor Compliance|5
943940|NCT00811928|3110295|P1|Overall Study|Poor Compliance|2
943941|NCT00811928|3110294|P2|Overall Study|Investigator Decision|1
943942|NCT00811928|3110295|P1|Overall Study|Investigator Decision|2
943943|NCT00811928|3110294|P2|Overall Study|Without Primary Efficacy Endpoint Data|4
943944|NCT00811928|3110295|P1|Overall Study|Without Primary Efficacy Endpoint Data|7
943945|NCT00811928|3110294|P2|Overall Study|Did Not Take Study Drug|0
943946|NCT00811928|3110295|P1|Overall Study|Did Not Take Study Drug|3
943947|NCT00811928|3110294|P2|Overall Study|Withdrawal by Subject|12
943948|NCT00811928|3110295|P1|Overall Study|Withdrawal by Subject|18
943949|NCT00811928|3110294|P2|Overall Study|AEs and SAEs Including Death|11
943950|NCT00811928|3110295|P1|Overall Study|AEs and SAEs Including Death|7
943951|NCT00811733|3110339|P2|Overall Study|Withdrawal by Subject|2
943952|NCT00811733|3110340|P1|Overall Study|Withdrawal by Subject|1
943953|NCT00811733|3110339|P2|Overall Study|Investigator Discretion|8
943954|NCT00811733|3110340|P1|Overall Study|Investigator Discretion|10
943955|NCT00811720|3110388|P2|All Treated Patients|Other Reason|4
943956|NCT00811720|3110389|P1|All Treated Patients|Other Reason|7
943957|NCT00811720|3110388|P2|All Treated Patients|Lost to Follow-up|16
943958|NCT00811720|3110389|P1|All Treated Patients|Lost to Follow-up|10
943959|NCT00811720|3110388|P2|All Treated Patients|Withdrawal by Subject|34
943960|NCT00811720|3110389|P1|All Treated Patients|Withdrawal by Subject|28
943961|NCT00811720|3110388|P2|All Treated Patients|Protocol Violation|16
943962|NCT00811720|3110389|P1|All Treated Patients|Protocol Violation|9
943963|NCT00811720|3110388|P2|All Treated Patients|Non-compliance|14
943964|NCT00811720|3110389|P1|All Treated Patients|Non-compliance|0
943965|NCT00811720|3110388|P2|All Treated Patients|Lack of Efficacy|18
943966|NCT00811720|3110389|P1|All Treated Patients|Lack of Efficacy|22
943967|NCT00811720|3110388|P2|All Treated Patients|Adverse Event|62
943968|NCT00811720|3110389|P1|All Treated Patients|Adverse Event|20
943969|NCT00811720|3110388|P2|All Randomised Patients|Did not receive placebo/nalmefene|4
943970|NCT00811720|3110389|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
943971|NCT00811655|3110407|P1|Overall Study|Physician Decision|1
943972|NCT00811642|3110419|P1|Overall Study|Cumulative use of antifungal agent|2
943973|NCT00811642|3110419|P1|Overall Study|Withdrawal by Subject|7
943974|NCT00811642|3110419|P1|Overall Study|Death|2
943975|NCT00811642|3110419|P1|Overall Study|Protocol Violation|1
943976|NCT00811642|3110419|P1|Overall Study|Adverse Event|3
943977|NCT00811577|3110435|P2|Overall Study|Withdrawal by Subject|0
943978|NCT00811577|3110436|P1|Overall Study|Withdrawal by Subject|3
943979|NCT00811577|3110435|P2|Overall Study|Lost to Follow-up|1
943980|NCT00811577|3110436|P1|Overall Study|Lost to Follow-up|7
943981|NCT00811473|3110496|P2|Overall Study|Safety Reasons|0
943982|NCT00811473|3110497|P1|Overall Study|Safety Reasons|1
943983|NCT00811473|3110496|P2|Overall Study|Incorrect Enrollment|0
943984|NCT00811473|3110497|P1|Overall Study|Incorrect Enrollment|1
943985|NCT00811473|3110496|P2|Overall Study|Other 2|1
943986|NCT00811473|3110497|P1|Overall Study|Other 2|4
943987|NCT00811473|3110496|P2|Overall Study|Condition under investigation worsened|3
943988|NCT00811473|3110497|P1|Overall Study|Condition under investigation worsened|1
943989|NCT00811473|3110496|P2|Overall Study|Lack of therapeutic response|1
943990|NCT00811473|3110497|P1|Overall Study|Lack of therapeutic response|4
943991|NCT00811473|3110496|P2|Overall Study|Severe non-compliance to protocol|4
943992|NCT00811473|3110497|P1|Overall Study|Severe non-compliance to protocol|2
943993|NCT00811473|3110496|P2|Overall Study|Withdrawal by Subject|4
943994|NCT00811473|3110497|P1|Overall Study|Withdrawal by Subject|2
943995|NCT00811473|3110496|P2|Overall Study|Lost to Follow-up|1
943996|NCT00811473|3110497|P1|Overall Study|Lost to Follow-up|5
943997|NCT00811473|3110496|P2|Overall Study|Adverse Event|12
943998|NCT00811473|3110497|P1|Overall Study|Adverse Event|3
943999|NCT00811395|3110528|P6|Extension Treatment|Other than above|0
944000|NCT00811395|3110529|P5|Extension Treatment|Other than above|0
944001|NCT00811395|3110530|P4|Extension Treatment|Other than above|0
944002|NCT00811395|3110531|P3|Extension Treatment|Other than above|1
944003|NCT00811395|3110532|P2|Extension Treatment|Other than above|0
944004|NCT00811395|3110533|P1|Extension Treatment|Other than above|0
944005|NCT00811395|3110528|P6|Extension Treatment|Participant did not wish to continue|1
944006|NCT00811395|3110529|P5|Extension Treatment|Participant did not wish to continue|0
944007|NCT00811395|3110530|P4|Extension Treatment|Participant did not wish to continue|1
944008|NCT00811395|3110531|P3|Extension Treatment|Participant did not wish to continue|0
944009|NCT00811395|3110532|P2|Extension Treatment|Participant did not wish to continue|3
944010|NCT00811395|3110533|P1|Extension Treatment|Participant did not wish to continue|0
944011|NCT00811395|3110528|P6|Extension Treatment|Progressive disease|0
944012|NCT00811395|3110529|P5|Extension Treatment|Progressive disease|0
944013|NCT00811395|3110530|P4|Extension Treatment|Progressive disease|0
944014|NCT00811395|3110531|P3|Extension Treatment|Progressive disease|0
944015|NCT00811395|3110532|P2|Extension Treatment|Progressive disease|1
944016|NCT00811395|3110533|P1|Extension Treatment|Progressive disease|1
944017|NCT00811395|3110528|P6|Extension Treatment|Adverse Event|1
944018|NCT00811395|3110529|P5|Extension Treatment|Adverse Event|0
944019|NCT00811395|3110530|P4|Extension Treatment|Adverse Event|2
944020|NCT00811395|3110531|P3|Extension Treatment|Adverse Event|2
944021|NCT00811395|3110532|P2|Extension Treatment|Adverse Event|2
944022|NCT00811395|3110533|P1|Extension Treatment|Adverse Event|1
944023|NCT00811252|3110639|P3|Overall Study|Administrative or Other Reasons|2
944024|NCT00811252|3110640|P2|Overall Study|Administrative or Other Reasons|3
944025|NCT00811252|3110641|P1|Overall Study|Administrative or Other Reasons|0
944026|NCT00811252|3110639|P3|Overall Study|Lost to Follow-up|2
944027|NCT00811252|3110640|P2|Overall Study|Lost to Follow-up|0
944028|NCT00811252|3110641|P1|Overall Study|Lost to Follow-up|0
944029|NCT00811252|3110639|P3|Overall Study|Withdrawal of Consent|2
944030|NCT00811252|3110640|P2|Overall Study|Withdrawal of Consent|2
944031|NCT00811252|3110641|P1|Overall Study|Withdrawal of Consent|1
944032|NCT00811252|3110639|P3|Overall Study|Protocol Violation|2
944033|NCT00811252|3110640|P2|Overall Study|Protocol Violation|3
944034|NCT00811252|3110641|P1|Overall Study|Protocol Violation|3
944035|NCT00811252|3110639|P3|Overall Study|Lack of Efficacy|0
944036|NCT00811252|3110640|P2|Overall Study|Lack of Efficacy|2
944037|NCT00811252|3110641|P1|Overall Study|Lack of Efficacy|7
944038|NCT00811252|3110639|P3|Overall Study|Adverse Event|15
944039|NCT00811252|3110640|P2|Overall Study|Adverse Event|10
944040|NCT00811252|3110641|P1|Overall Study|Adverse Event|6
944041|NCT00811174|3110685|P1|Overall Study|Sponsors Decision|1
944042|NCT00811174|3110685|P1|Overall Study|Protocol Violation|2
944043|NCT00811135|3110696|P1|Overall Study|Ongoing|59
944044|NCT00811135|3110696|P1|Overall Study|Administrative/Other Unspecified|11
944045|NCT00811135|3110696|P1|Overall Study|Withdrawal by Subject|3
944046|NCT00811135|3110696|P1|Overall Study|Refused Treatment|1
944047|NCT00811135|3110696|P1|Overall Study|Violation of Selection Criteria|1
944048|NCT00811135|3110696|P1|Overall Study|Protocol Violation|2
944049|NCT00811135|3110696|P1|Overall Study|Death|3
944050|NCT00811135|3110696|P1|Overall Study|Adverse Event/Intercurrent Illness|8
944051|NCT00811070|3110714|P6|Overall Study|Physician Decision|1
944052|NCT00811070|3110715|P5|Overall Study|Physician Decision|0
944053|NCT00811070|3110716|P4|Overall Study|Physician Decision|0
944054|NCT00811070|3110717|P3|Overall Study|Physician Decision|0
944055|NCT00811070|3110718|P2|Overall Study|Physician Decision|0
944056|NCT00811070|3110719|P1|Overall Study|Physician Decision|0
944057|NCT00811070|3110714|P6|Overall Study|Withdrawal by Subject|0
944058|NCT00811070|3110715|P5|Overall Study|Withdrawal by Subject|0
944059|NCT00811070|3110716|P4|Overall Study|Withdrawal by Subject|0
944060|NCT00811070|3110717|P3|Overall Study|Withdrawal by Subject|0
944061|NCT00811070|3110718|P2|Overall Study|Withdrawal by Subject|1
944062|NCT00811070|3110719|P1|Overall Study|Withdrawal by Subject|0
944063|NCT00811070|3110714|P6|Overall Study|Other|0
944064|NCT00811070|3110715|P5|Overall Study|Other|0
944065|NCT00811070|3110716|P4|Overall Study|Other|0
944066|NCT00811070|3110717|P3|Overall Study|Other|0
944067|NCT00811070|3110718|P2|Overall Study|Other|0
944068|NCT00811070|3110719|P1|Overall Study|Other|1
944069|NCT00811070|3110714|P6|Overall Study|Death|0
944070|NCT00811070|3110715|P5|Overall Study|Death|5
944071|NCT00811070|3110716|P4|Overall Study|Death|2
944072|NCT00811070|3110717|P3|Overall Study|Death|0
944073|NCT00811070|3110718|P2|Overall Study|Death|0
944074|NCT00811070|3110719|P1|Overall Study|Death|0
944075|NCT00811057|3110779|P3|Overall Study|Protocol Violation|10
944076|NCT00811057|3110780|P2|Overall Study|Protocol Violation|10
944077|NCT00811057|3110781|P1|Overall Study|Protocol Violation|5
944078|NCT00811018|3110792|P1|Overall Study|Other|26
944079|NCT00811018|3110792|P1|Overall Study|WHO FC deterioration and 6MWD decrease|9
944080|NCT00811018|3110792|P1|Overall Study|Withdrawal by Subject|70
944081|NCT00811018|3110792|P1|Overall Study|Sponsor Decision|450
944082|NCT00811018|3110792|P1|Overall Study|Pregnancy|6
944083|NCT00811018|3110792|P1|Overall Study|Lost to Follow-up|19
944084|NCT00811018|3110792|P1|Overall Study|Investigator Decision|57
944085|NCT00811018|3110792|P1|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70
944086|NCT00811018|3110792|P1|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4
944087|NCT00811018|3110792|P1|Overall Study|Death|147
944088|NCT00811018|3110792|P1|Overall Study|Adverse Event|79
944089|NCT00811018|3110792|P1|Overall Study|Additional Chronic Treatment|31
944090|NCT00810901|3110810|P2|Overall Study|Lost to Follow-up|58
944091|NCT00810901|3110811|P1|Overall Study|Lost to Follow-up|88
944092|NCT00810810|3110857|P4|Overall Study|Physician Decision|5
944093|NCT00810810|3110858|P3|Overall Study|Physician Decision|1
944094|NCT00810810|3110859|P2|Overall Study|Physician Decision|3
944095|NCT00810810|3110860|P1|Overall Study|Physician Decision|0
944096|NCT00810810|3110857|P4|Overall Study|Withdrawal by Subject|8
944097|NCT00810810|3110858|P3|Overall Study|Withdrawal by Subject|10
944098|NCT00810810|3110859|P2|Overall Study|Withdrawal by Subject|8
944099|NCT00810810|3110860|P1|Overall Study|Withdrawal by Subject|0
944100|NCT00810693|3110908|P3|Follow-up Period (FUP)|Withdrawal by Subject|0
944101|NCT00810693|3110909|P2|Follow-up Period (FUP)|Withdrawal by Subject|1
944102|NCT00810693|3110910|P1|Follow-up Period (FUP)|Withdrawal by Subject|2
944103|NCT00810693|3110908|P3|Follow-up Period (FUP)|Protocol Violation|0
944104|NCT00810693|3110909|P2|Follow-up Period (FUP)|Protocol Violation|1
944105|NCT00810693|3110910|P1|Follow-up Period (FUP)|Protocol Violation|0
944106|NCT00810693|3110908|P3|Follow-up Period (FUP)|Lost to Follow-up|2
944107|NCT00810693|3110909|P2|Follow-up Period (FUP)|Lost to Follow-up|0
944108|NCT00810693|3110910|P1|Follow-up Period (FUP)|Lost to Follow-up|1
944109|NCT00810693|3110908|P3|Follow-up Period (FUP)|Death|1
944110|NCT00810693|3110909|P2|Follow-up Period (FUP)|Death|0
944111|NCT00810693|3110910|P1|Follow-up Period (FUP)|Death|2
944112|NCT00810693|3110908|P3|Follow-up Period (FUP)|Adverse Event|1
944113|NCT00810693|3110909|P2|Follow-up Period (FUP)|Adverse Event|1
944114|NCT00810693|3110910|P1|Follow-up Period (FUP)|Adverse Event|3
944115|NCT00810693|3110908|P3|Treatment Period|Not treated|1
944116|NCT00810693|3110909|P2|Treatment Period|Not treated|1
944117|NCT00810693|3110910|P1|Treatment Period|Not treated|0
944118|NCT00810693|3110908|P3|Treatment Period|Withdrawal by Subject|3
944119|NCT00810693|3110909|P2|Treatment Period|Withdrawal by Subject|2
944120|NCT00810693|3110910|P1|Treatment Period|Withdrawal by Subject|6
944121|NCT00810693|3110908|P3|Treatment Period|Protocol Violation|2
944122|NCT00810693|3110909|P2|Treatment Period|Protocol Violation|2
944123|NCT00810693|3110910|P1|Treatment Period|Protocol Violation|1
944124|NCT00810693|3110908|P3|Treatment Period|Non-compliance|0
944125|NCT00810693|3110909|P2|Treatment Period|Non-compliance|0
944126|NCT00810693|3110910|P1|Treatment Period|Non-compliance|1
944127|NCT00810693|3110908|P3|Treatment Period|Lost to Follow-up|0
944128|NCT00810693|3110909|P2|Treatment Period|Lost to Follow-up|0
944129|NCT00810693|3110910|P1|Treatment Period|Lost to Follow-up|1
944130|NCT00810693|3110908|P3|Treatment Period|Lack of Efficacy|1
944131|NCT00810693|3110909|P2|Treatment Period|Lack of Efficacy|0
944132|NCT00810693|3110910|P1|Treatment Period|Lack of Efficacy|0
944133|NCT00810693|3110908|P3|Treatment Period|Death|2
944134|NCT00810693|3110909|P2|Treatment Period|Death|1
944135|NCT00810693|3110910|P1|Treatment Period|Death|0
944136|NCT00810693|3110908|P3|Treatment Period|Adverse Event|7
944137|NCT00810693|3110909|P2|Treatment Period|Adverse Event|1
944138|NCT00810693|3110910|P1|Treatment Period|Adverse Event|8
944139|NCT00810641|3110942|P3|Overall Study|Withdrawal by Subject|2
944140|NCT00810641|3110943|P2|Overall Study|Withdrawal by Subject|1
944141|NCT00810641|3110944|P1|Overall Study|Withdrawal by Subject|0
944142|NCT00810615|3110954|P2|Overall Study|Withdrawal by Subject|1
944143|NCT00810615|3110955|P1|Overall Study|Withdrawal by Subject|1
944144|NCT00810602|3111005|P2|Overall Study|Withdrawal by Subject|3
944145|NCT00810602|3111006|P1|Overall Study|Withdrawal by Subject|8
944146|NCT00810511|3111019|P2|Overall Study|deposits on contact lens|1
944147|NCT00810511|3111020|P1|Overall Study|deposits on contact lens|0
944148|NCT00810511|3111019|P2|Overall Study|Lost to Follow-up|0
944149|NCT00810511|3111020|P1|Overall Study|Lost to Follow-up|1
944150|NCT00810511|3111019|P2|Overall Study|death in the family|1
944151|NCT00810511|3111020|P1|Overall Study|death in the family|0
944152|NCT00810511|3111019|P2|Overall Study|Lack of Efficacy|1
944153|NCT00810511|3111020|P1|Overall Study|Lack of Efficacy|9
944154|NCT00810511|3111019|P2|Overall Study|Protocol Violation|1
944155|NCT00810511|3111020|P1|Overall Study|Protocol Violation|0
944156|NCT00810394|3111026|P1|Overall Study|Withdrawal by Subject|3
944157|NCT00810368|3111034|P2|Overall Study|Lack of Efficacy|0
944158|NCT00810368|3111035|P1|Overall Study|Lack of Efficacy|2
944159|NCT00810368|3111034|P2|Overall Study|Lost to Follow-up|2
944160|NCT00810368|3111035|P1|Overall Study|Lost to Follow-up|4
944161|NCT00810355|3111056|P3|Overall Study|Withdrawal by Subject|0
944162|NCT00810355|3111057|P2|Overall Study|Withdrawal by Subject|0
944163|NCT00810355|3111058|P1|Overall Study|Withdrawal by Subject|1
944164|NCT00810355|3111056|P3|Overall Study|Lost to Follow-up|11
944165|NCT00810355|3111057|P2|Overall Study|Lost to Follow-up|17
944166|NCT00810355|3111058|P1|Overall Study|Lost to Follow-up|13
944167|NCT00810342|3111074|P2|12-month Followup|Lost to Follow-up|1
944168|NCT00810342|3111075|P1|12-month Followup|Lost to Follow-up|3
944169|NCT00810342|3111074|P2|12-month Followup|Pregnancy|10
944170|NCT00810342|3111075|P1|12-month Followup|Pregnancy|9
944171|NCT00810342|3111074|P2|6-month Follow-up|Pregnancy|2
944172|NCT00810342|3111075|P1|6-month Follow-up|Pregnancy|6
944173|NCT00810342|3111074|P2|6-month Follow-up|Lost to Follow-up|6
944174|NCT00810342|3111075|P1|6-month Follow-up|Lost to Follow-up|18
944175|NCT00810342|3111074|P2|Month 1 Follow-up|Pregnancy|0
944176|NCT00810342|3111075|P1|Month 1 Follow-up|Pregnancy|1
944177|NCT00810342|3111074|P2|Month 1 Follow-up|Lost to Follow-up|2
944178|NCT00810342|3111075|P1|Month 1 Follow-up|Lost to Follow-up|4
944179|NCT00810277|3111108|P1|Overall Study|Adverse Event|1
944180|NCT00810199|3111123|P2|Overall Study|Did not receive study drug|1
944181|NCT00810199|3111124|P1|Overall Study|Did not receive study drug|2
944182|NCT00810199|3111123|P2|Overall Study|Failure to return|4
944183|NCT00810199|3111124|P1|Overall Study|Failure to return|1
944184|NCT00810199|3111123|P2|Overall Study|Protocol Violation|6
944185|NCT00810199|3111124|P1|Overall Study|Protocol Violation|2
944186|NCT00810199|3111123|P2|Overall Study|Administrative/Other|6
944187|NCT00810199|3111124|P1|Overall Study|Administrative/Other|5
944188|NCT00810199|3111123|P2|Overall Study|Refused treatment/Did not cooperate|7
944189|NCT00810199|3111124|P1|Overall Study|Refused treatment/Did not cooperate|7
944190|NCT00810199|3111123|P2|Overall Study|Insufficient therapeutic response|14
944191|NCT00810199|3111124|P1|Overall Study|Insufficient therapeutic response|5
944192|NCT00810199|3111123|P2|Overall Study|Withdrew consent|12
944193|NCT00810199|3111124|P1|Overall Study|Withdrew consent|9
944194|NCT00810199|3111123|P2|Overall Study|Death|6
944195|NCT00810199|3111124|P1|Overall Study|Death|4
944196|NCT00810199|3111123|P2|Overall Study|Adverse Event|26
944197|NCT00810199|3111124|P1|Overall Study|Adverse Event|24
944198|NCT00810108|3111202|P2|Overall Study|Withdrawal by Subject|0
944199|NCT00810108|3111203|P1|Overall Study|Withdrawal by Subject|1
944200|NCT00810082|3111217|P2|Overall Study|Lost to Follow-up|4
944201|NCT00810082|3111218|P1|Overall Study|Lost to Follow-up|0
944202|NCT00810069|3111226|P3|Double-Blind Period II|Protocol Violation|6
944203|NCT00810069|3111227|P2|Double-Blind Period II|Protocol Violation|7
944204|NCT00810069|3111228|P1|Double-Blind Period II|Protocol Violation|0
944205|NCT00810069|3111226|P3|Double-Blind Period II|Clinical relapse|0
944206|NCT00810069|3111227|P2|Double-Blind Period II|Clinical relapse|3
944207|NCT00810069|3111228|P1|Double-Blind Period II|Clinical relapse|0
944208|NCT00810069|3111226|P3|Double-Blind Period II|Protocol entry criterion not met|1
944209|NCT00810069|3111227|P2|Double-Blind Period II|Protocol entry criterion not met|0
944210|NCT00810069|3111228|P1|Double-Blind Period II|Protocol entry criterion not met|0
944211|NCT00810069|3111226|P3|Double-Blind Period II|Withdrawal by Subject|35
944212|NCT00810069|3111227|P2|Double-Blind Period II|Withdrawal by Subject|21
944213|NCT00810069|3111228|P1|Double-Blind Period II|Withdrawal by Subject|0
944214|NCT00810069|3111226|P3|Double-Blind Period II|Physician Decision|1
944215|NCT00810069|3111227|P2|Double-Blind Period II|Physician Decision|0
944216|NCT00810069|3111228|P1|Double-Blind Period II|Physician Decision|0
944217|NCT00810069|3111226|P3|Double-Blind Period II|Lost to Follow-up|9
944218|NCT00810069|3111227|P2|Double-Blind Period II|Lost to Follow-up|9
944219|NCT00810069|3111228|P1|Double-Blind Period II|Lost to Follow-up|0
944220|NCT00810069|3111226|P3|Double-Blind Period II|Lack of Efficacy|12
944221|NCT00810069|3111227|P2|Double-Blind Period II|Lack of Efficacy|7
944222|NCT00810069|3111228|P1|Double-Blind Period II|Lack of Efficacy|0
944223|NCT00810069|3111226|P3|Double-Blind Period II|Adverse Event|8
944224|NCT00810069|3111227|P2|Double-Blind Period II|Adverse Event|9
944225|NCT00810069|3111228|P1|Double-Blind Period II|Adverse Event|0
944226|NCT00810069|3111226|P3|Lead-in Period I|Randomization criteria not met|0
944227|NCT00810069|3111227|P2|Lead-in Period I|Randomization criteria not met|0
944228|NCT00810069|3111228|P1|Lead-in Period I|Randomization criteria not met|158
944229|NCT00810069|3111226|P3|Lead-in Period I|Protocol entry criterion not met|0
944230|NCT00810069|3111227|P2|Lead-in Period I|Protocol entry criterion not met|0
944231|NCT00810069|3111228|P1|Lead-in Period I|Protocol entry criterion not met|5
944232|NCT00810069|3111226|P3|Lead-in Period I|Withdrawal by Subject|0
944233|NCT00810069|3111227|P2|Lead-in Period I|Withdrawal by Subject|0
944234|NCT00810069|3111228|P1|Lead-in Period I|Withdrawal by Subject|46
944235|NCT00810069|3111226|P3|Lead-in Period I|Protocol Violation|0
944236|NCT00810069|3111227|P2|Lead-in Period I|Protocol Violation|0
944237|NCT00810069|3111228|P1|Lead-in Period I|Protocol Violation|1
944238|NCT00810069|3111226|P3|Lead-in Period I|Physician Decision|0
944239|NCT00810069|3111227|P2|Lead-in Period I|Physician Decision|0
944240|NCT00810069|3111228|P1|Lead-in Period I|Physician Decision|1
944241|NCT00810069|3111226|P3|Lead-in Period I|Lost to Follow-up|0
944242|NCT00810069|3111227|P2|Lead-in Period I|Lost to Follow-up|0
944243|NCT00810069|3111228|P1|Lead-in Period I|Lost to Follow-up|19
944244|NCT00810069|3111226|P3|Lead-in Period I|Lack of Efficacy|0
944245|NCT00810069|3111227|P2|Lead-in Period I|Lack of Efficacy|0
944246|NCT00810069|3111228|P1|Lead-in Period I|Lack of Efficacy|1
944247|NCT00810069|3111226|P3|Lead-in Period I|Adverse Event|0
944248|NCT00810069|3111227|P2|Lead-in Period I|Adverse Event|0
944249|NCT00810069|3111228|P1|Lead-in Period I|Adverse Event|43
944250|NCT00810043|3111273|P3|Overall Study|No longer met enrollment criteria|3
944251|NCT00810043|3111274|P2|Overall Study|No longer met enrollment criteria|0
944252|NCT00810043|3111275|P1|Overall Study|No longer met enrollment criteria|0
944253|NCT00810043|3111273|P3|Overall Study|Non-medical problem|1
944254|NCT00810043|3111274|P2|Overall Study|Non-medical problem|0
944255|NCT00810043|3111275|P1|Overall Study|Non-medical problem|0
944256|NCT00810043|3111273|P3|Overall Study|Unrelated medical problem|0
944257|NCT00810043|3111274|P2|Overall Study|Unrelated medical problem|1
944258|NCT00810043|3111275|P1|Overall Study|Unrelated medical problem|0
944259|NCT00810043|3111273|P3|Overall Study|Death|0
944260|NCT00810043|3111274|P2|Overall Study|Death|0
944261|NCT00810043|3111275|P1|Overall Study|Death|2
944262|NCT00810043|3111273|P3|Overall Study|Physician Decision|2
944263|NCT00810043|3111274|P2|Overall Study|Physician Decision|0
944264|NCT00810043|3111275|P1|Overall Study|Physician Decision|0
944265|NCT00810043|3111273|P3|Overall Study|Lost to Follow-up|0
944266|NCT00810043|3111274|P2|Overall Study|Lost to Follow-up|0
944267|NCT00810043|3111275|P1|Overall Study|Lost to Follow-up|1
944268|NCT00810043|3111273|P3|Overall Study|Withdrawal by Subject|2
944269|NCT00810043|3111274|P2|Overall Study|Withdrawal by Subject|0
944270|NCT00810043|3111275|P1|Overall Study|Withdrawal by Subject|1
944271|NCT00809965|3111297|P3|Overall Study|Other Reason|189
944272|NCT00809965|3111298|P2|Overall Study|Other Reason|170
944273|NCT00809965|3111299|P1|Overall Study|Other Reason|167
944274|NCT00809965|3111297|P3|Overall Study|Withdrawal by Subject|441
944275|NCT00809965|3111298|P2|Overall Study|Withdrawal by Subject|448
944276|NCT00809965|3111299|P1|Overall Study|Withdrawal by Subject|405
944277|NCT00809965|3111297|P3|Overall Study|Lost to Follow-up|18
944278|NCT00809965|3111298|P2|Overall Study|Lost to Follow-up|10
944279|NCT00809965|3111299|P1|Overall Study|Lost to Follow-up|17
944280|NCT00809965|3111297|P3|Overall Study|Death|196
944281|NCT00809965|3111298|P2|Overall Study|Death|147
944282|NCT00809965|3111299|P1|Overall Study|Death|194
944283|NCT00809926|3111321|P2|Overall Study|Protocol deviation|2
944284|NCT00809926|3111322|P1|Overall Study|Protocol deviation|0
944285|NCT00809926|3111321|P2|Overall Study|Administrative Problems|1
944286|NCT00809926|3111322|P1|Overall Study|Administrative Problems|0
944287|NCT00809926|3111321|P2|Overall Study|Lost to Follow-up|1
944288|NCT00809926|3111322|P1|Overall Study|Lost to Follow-up|2
944289|NCT00809926|3111321|P2|Overall Study|Patient withdrew consent|6
944290|NCT00809926|3111322|P1|Overall Study|Patient withdrew consent|8
944291|NCT00809926|3111321|P2|Overall Study|Unsatisfactory therapeutic effect|3
944292|NCT00809926|3111322|P1|Overall Study|Unsatisfactory therapeutic effect|3
944293|NCT00809926|3111321|P2|Overall Study|Adverse Event|10
944294|NCT00809926|3111322|P1|Overall Study|Adverse Event|18
944295|NCT00809835|3111376|P4|Overall Study|Withdrawal by Subject|0
944296|NCT00809835|3111377|P3|Overall Study|Withdrawal by Subject|1
944297|NCT00809835|3111378|P2|Overall Study|Withdrawal by Subject|1
944298|NCT00809835|3111379|P1|Overall Study|Withdrawal by Subject|1
944299|NCT00809835|3111376|P4|Overall Study|Lost to Follow-up|2
944300|NCT00809835|3111377|P3|Overall Study|Lost to Follow-up|10
944301|NCT00809835|3111378|P2|Overall Study|Lost to Follow-up|6
944302|NCT00809835|3111379|P1|Overall Study|Lost to Follow-up|7
944303|NCT00809757|3111409|P3|Overall Study|Noncompliance with Medication|1
944304|NCT00809757|3111410|P2|Overall Study|Noncompliance with Medication|0
944305|NCT00809757|3111411|P1|Overall Study|Noncompliance with Medication|0
944306|NCT00809757|3111409|P3|Overall Study|Subject Uncooperative|2
944307|NCT00809757|3111410|P2|Overall Study|Subject Uncooperative|0
944308|NCT00809757|3111411|P1|Overall Study|Subject Uncooperative|1
944309|NCT00809757|3111409|P3|Overall Study|Withdrawal by Subject|3
944310|NCT00809757|3111410|P2|Overall Study|Withdrawal by Subject|1
944311|NCT00809757|3111411|P1|Overall Study|Withdrawal by Subject|2
944312|NCT00809757|3111409|P3|Overall Study|Protocol Violation|1
944313|NCT00809757|3111410|P2|Overall Study|Protocol Violation|1
944314|NCT00809757|3111411|P1|Overall Study|Protocol Violation|1
944315|NCT00809757|3111409|P3|Overall Study|Lost to Follow-up|1
944316|NCT00809757|3111410|P2|Overall Study|Lost to Follow-up|0
944317|NCT00809757|3111411|P1|Overall Study|Lost to Follow-up|0
944318|NCT00809757|3111409|P3|Overall Study|Adverse Event|3
944319|NCT00809757|3111410|P2|Overall Study|Adverse Event|3
944320|NCT00809757|3111411|P1|Overall Study|Adverse Event|2
944321|NCT00809614|3111496|P2|Overall Study|Withdrawal by Subject|1
944322|NCT00809614|3111497|P1|Overall Study|Withdrawal by Subject|1
944323|NCT00809614|3111496|P2|Overall Study|Lack of Efficacy|3
944324|NCT00809614|3111497|P1|Overall Study|Lack of Efficacy|2
944325|NCT00809471|3111541|P3|Overall Study|Requirement for restricted medication|0
944326|NCT00809471|3111542|P2|Overall Study|Requirement for restricted medication|1
944327|NCT00809471|3111543|P1|Overall Study|Requirement for restricted medication|1
944328|NCT00809471|3111541|P3|Overall Study|Adverse Event|2
944329|NCT00809471|3111542|P2|Overall Study|Adverse Event|2
944330|NCT00809471|3111543|P1|Overall Study|Adverse Event|0
944331|NCT00809471|3111541|P3|Overall Study|Lost to Follow-up|9
944332|NCT00809471|3111542|P2|Overall Study|Lost to Follow-up|2
944333|NCT00809471|3111543|P1|Overall Study|Lost to Follow-up|4
944334|NCT00809471|3111541|P3|Overall Study|Protocol non-compliance|6
944335|NCT00809471|3111542|P2|Overall Study|Protocol non-compliance|15
944336|NCT00809471|3111543|P1|Overall Study|Protocol non-compliance|15
944337|NCT00809445|3111573|P3|6 Month Follow-up|Withdrew consent|1
944338|NCT00809445|3111574|P2|6 Month Follow-up|Withdrew consent|0
944339|NCT00809445|3111575|P1|6 Month Follow-up|Withdrew consent|0
944340|NCT00809445|3111573|P3|6 Month Follow-up|Incarcerated|8
944341|NCT00809445|3111574|P2|6 Month Follow-up|Incarcerated|8
944342|NCT00809445|3111575|P1|6 Month Follow-up|Incarcerated|6
944343|NCT00809445|3111573|P3|6 Month Follow-up|Death|1
944344|NCT00809445|3111574|P2|6 Month Follow-up|Death|1
944345|NCT00809445|3111575|P1|6 Month Follow-up|Death|2
944346|NCT00809445|3111573|P3|6 Month Follow-up|Lost contact|14
944347|NCT00809445|3111574|P2|6 Month Follow-up|Lost contact|14
944348|NCT00809445|3111575|P1|6 Month Follow-up|Lost contact|16
944349|NCT00809445|3111573|P3|1 Month Follow-up|Incarcerated|1
944350|NCT00809445|3111574|P2|1 Month Follow-up|Incarcerated|0
944351|NCT00809445|3111575|P1|1 Month Follow-up|Incarcerated|0
944352|NCT00809445|3111573|P3|1 Month Follow-up|Death|1
944353|NCT00809445|3111574|P2|1 Month Follow-up|Death|1
944354|NCT00809445|3111575|P1|1 Month Follow-up|Death|0
944355|NCT00809445|3111573|P3|1 Month Follow-up|Withdrew consent|1
944356|NCT00809445|3111574|P2|1 Month Follow-up|Withdrew consent|1
944357|NCT00809445|3111575|P1|1 Month Follow-up|Withdrew consent|1
944358|NCT00809445|3111573|P3|1 Month Follow-up|Lost contact|1
944359|NCT00809445|3111574|P2|1 Month Follow-up|Lost contact|2
944360|NCT00809445|3111575|P1|1 Month Follow-up|Lost contact|1
944361|NCT00809341|3111594|P2|Overall Study|Physician Decision|1
944362|NCT00809341|3111595|P1|Overall Study|Physician Decision|0
944363|NCT00809328|3111603|P1|Overall Study|Withdrawal by Subject|2
944364|NCT00809328|3111603|P1|Overall Study|Protocol Violation|3
944365|NCT00809328|3111603|P1|Overall Study|Adverse Event|6
944366|NCT00809328|3111603|P1|Overall Study|Lack of Efficacy|18
944367|NCT00809159|3111623|P6|Part 1 and 2|Withdrawal by Subject|1
944368|NCT00809159|3111624|P5|Part 1 and 2|Withdrawal by Subject|0
944369|NCT00809159|3111625|P4|Part 1 and 2|Withdrawal by Subject|0
944370|NCT00809159|3111626|P3|Part 1 and 2|Withdrawal by Subject|4
944371|NCT00809159|3111627|P2|Part 1 and 2|Withdrawal by Subject|0
944372|NCT00809159|3111628|P1|Part 1 and 2|Withdrawal by Subject|0
944373|NCT00809159|3111623|P6|Part 1 and 2|Lost to Follow-up|0
944374|NCT00809159|3111624|P5|Part 1 and 2|Lost to Follow-up|0
944375|NCT00809159|3111625|P4|Part 1 and 2|Lost to Follow-up|1
944376|NCT00809159|3111626|P3|Part 1 and 2|Lost to Follow-up|1
944377|NCT00809159|3111627|P2|Part 1 and 2|Lost to Follow-up|0
944378|NCT00809159|3111628|P1|Part 1 and 2|Lost to Follow-up|0
944379|NCT00809159|3111623|P6|Part 1 and 2|Adverse Event|1
944380|NCT00809159|3111624|P5|Part 1 and 2|Adverse Event|1
944381|NCT00809159|3111625|P4|Part 1 and 2|Adverse Event|0
944382|NCT00809159|3111626|P3|Part 1 and 2|Adverse Event|1
944383|NCT00809159|3111627|P2|Part 1 and 2|Adverse Event|0
944384|NCT00809159|3111628|P1|Part 1 and 2|Adverse Event|0
944385|NCT00809159|3111623|P6|Part 1 and 2|Administrative problems|0
944386|NCT00809159|3111624|P5|Part 1 and 2|Administrative problems|0
944387|NCT00809159|3111625|P4|Part 1 and 2|Administrative problems|1
944388|NCT00809159|3111626|P3|Part 1 and 2|Administrative problems|0
944389|NCT00809159|3111627|P2|Part 1 and 2|Administrative problems|0
944390|NCT00809159|3111628|P1|Part 1 and 2|Administrative problems|0
944391|NCT00809159|3111623|P6|Part 1 and 2|Unsatisfactory therapeutic effect|1
944392|NCT00809159|3111624|P5|Part 1 and 2|Unsatisfactory therapeutic effect|5
944393|NCT00809159|3111625|P4|Part 1 and 2|Unsatisfactory therapeutic effect|3
944394|NCT00809159|3111626|P3|Part 1 and 2|Unsatisfactory therapeutic effect|4
944395|NCT00809159|3111627|P2|Part 1 and 2|Unsatisfactory therapeutic effect|0
944396|NCT00809159|3111628|P1|Part 1 and 2|Unsatisfactory therapeutic effect|0
944397|NCT00809159|3111623|P6|Part 1|Unsatisfactory therapeutic effect|0
944398|NCT00809159|3111624|P5|Part 1|Unsatisfactory therapeutic effect|0
944399|NCT00809159|3111625|P4|Part 1|Unsatisfactory therapeutic effect|0
944400|NCT00809159|3111626|P3|Part 1|Unsatisfactory therapeutic effect|0
944401|NCT00809159|3111627|P2|Part 1|Unsatisfactory therapeutic effect|1
944402|NCT00809159|3111628|P1|Part 1|Unsatisfactory therapeutic effect|3
944403|NCT00809159|3111623|P6|Part 1|Withdrawal by Subject|0
944404|NCT00809159|3111624|P5|Part 1|Withdrawal by Subject|0
944405|NCT00809159|3111625|P4|Part 1|Withdrawal by Subject|0
944406|NCT00809159|3111626|P3|Part 1|Withdrawal by Subject|0
944407|NCT00809159|3111627|P2|Part 1|Withdrawal by Subject|1
944408|NCT00809159|3111628|P1|Part 1|Withdrawal by Subject|3
944409|NCT00809159|3111623|P6|Part 1|Lost to Follow-up|0
944410|NCT00809159|3111624|P5|Part 1|Lost to Follow-up|0
944411|NCT00809159|3111625|P4|Part 1|Lost to Follow-up|0
944412|NCT00809159|3111626|P3|Part 1|Lost to Follow-up|0
944413|NCT00809159|3111627|P2|Part 1|Lost to Follow-up|0
944414|NCT00809159|3111628|P1|Part 1|Lost to Follow-up|1
944415|NCT00809159|3111623|P6|Part 1|Adverse Event|0
944416|NCT00809159|3111624|P5|Part 1|Adverse Event|0
944417|NCT00809159|3111625|P4|Part 1|Adverse Event|0
944418|NCT00809159|3111626|P3|Part 1|Adverse Event|0
944419|NCT00809159|3111627|P2|Part 1|Adverse Event|1
944420|NCT00809159|3111628|P1|Part 1|Adverse Event|1
944421|NCT00809133|3111733|P14|Overall Study|Other not mentioned above|0
944422|NCT00809133|3111734|P13|Overall Study|Other not mentioned above|0
944423|NCT00809133|3111735|P12|Overall Study|Other not mentioned above|0
944424|NCT00809133|3111736|P11|Overall Study|Other not mentioned above|0
944425|NCT00809133|3111737|P10|Overall Study|Other not mentioned above|0
944426|NCT00809133|3111738|P9|Overall Study|Other not mentioned above|0
944427|NCT00809133|3111739|P8|Overall Study|Other not mentioned above|0
944428|NCT00809133|3111740|P7|Overall Study|Other not mentioned above|0
944429|NCT00809133|3111741|P6|Overall Study|Other not mentioned above|1
944430|NCT00809133|3111742|P5|Overall Study|Other not mentioned above|0
944431|NCT00809133|3111743|P4|Overall Study|Other not mentioned above|0
944432|NCT00809133|3111744|P3|Overall Study|Other not mentioned above|0
944433|NCT00809133|3111745|P2|Overall Study|Other not mentioned above|1
944434|NCT00809133|3111746|P1|Overall Study|Other not mentioned above|0
944435|NCT00809133|3111733|P14|Overall Study|Consent withdrawn|0
944436|NCT00809133|3111734|P13|Overall Study|Consent withdrawn|0
944437|NCT00809133|3111735|P12|Overall Study|Consent withdrawn|0
944438|NCT00809133|3111736|P11|Overall Study|Consent withdrawn|0
944439|NCT00809133|3111737|P10|Overall Study|Consent withdrawn|0
944440|NCT00809133|3111738|P9|Overall Study|Consent withdrawn|0
944441|NCT00809133|3111739|P8|Overall Study|Consent withdrawn|0
944442|NCT00809133|3111740|P7|Overall Study|Consent withdrawn|0
944443|NCT00809133|3111741|P6|Overall Study|Consent withdrawn|0
944444|NCT00809133|3111742|P5|Overall Study|Consent withdrawn|1
944445|NCT00809133|3111743|P4|Overall Study|Consent withdrawn|0
944446|NCT00809133|3111744|P3|Overall Study|Consent withdrawn|0
944447|NCT00809133|3111745|P2|Overall Study|Consent withdrawn|0
944448|NCT00809133|3111746|P1|Overall Study|Consent withdrawn|0
944449|NCT00809133|3111733|P14|Overall Study|Lost to Follow-up|0
944450|NCT00809133|3111734|P13|Overall Study|Lost to Follow-up|0
944451|NCT00809133|3111735|P12|Overall Study|Lost to Follow-up|0
944452|NCT00809133|3111736|P11|Overall Study|Lost to Follow-up|0
944453|NCT00809133|3111737|P10|Overall Study|Lost to Follow-up|0
944454|NCT00809133|3111738|P9|Overall Study|Lost to Follow-up|0
944455|NCT00809133|3111739|P8|Overall Study|Lost to Follow-up|0
944456|NCT00809133|3111740|P7|Overall Study|Lost to Follow-up|0
944457|NCT00809133|3111741|P6|Overall Study|Lost to Follow-up|1
944458|NCT00809133|3111742|P5|Overall Study|Lost to Follow-up|0
944459|NCT00809133|3111743|P4|Overall Study|Lost to Follow-up|0
944460|NCT00809133|3111744|P3|Overall Study|Lost to Follow-up|0
944461|NCT00809133|3111745|P2|Overall Study|Lost to Follow-up|0
944462|NCT00809133|3111746|P1|Overall Study|Lost to Follow-up|0
944463|NCT00809133|3111733|P14|Overall Study|Other adverse event|1
944464|NCT00809133|3111734|P13|Overall Study|Other adverse event|0
944465|NCT00809133|3111735|P12|Overall Study|Other adverse event|1
944466|NCT00809133|3111736|P11|Overall Study|Other adverse event|1
944467|NCT00809133|3111737|P10|Overall Study|Other adverse event|0
944468|NCT00809133|3111738|P9|Overall Study|Other adverse event|0
944469|NCT00809133|3111739|P8|Overall Study|Other adverse event|4
944470|NCT00809133|3111740|P7|Overall Study|Other adverse event|2
944471|NCT00809133|3111741|P6|Overall Study|Other adverse event|3
944472|NCT00809133|3111742|P5|Overall Study|Other adverse event|0
944473|NCT00809133|3111743|P4|Overall Study|Other adverse event|0
944474|NCT00809133|3111744|P3|Overall Study|Other adverse event|1
944475|NCT00809133|3111745|P2|Overall Study|Other adverse event|1
944476|NCT00809133|3111746|P1|Overall Study|Other adverse event|1
944477|NCT00809133|3111733|P14|Overall Study|Dose Limiting Toxicity (DLT)|2
944478|NCT00809133|3111734|P13|Overall Study|Dose Limiting Toxicity (DLT)|0
944479|NCT00809133|3111735|P12|Overall Study|Dose Limiting Toxicity (DLT)|0
944480|NCT00809133|3111736|P11|Overall Study|Dose Limiting Toxicity (DLT)|0
944481|NCT00809133|3111737|P10|Overall Study|Dose Limiting Toxicity (DLT)|0
944482|NCT00809133|3111738|P9|Overall Study|Dose Limiting Toxicity (DLT)|0
944483|NCT00809133|3111739|P8|Overall Study|Dose Limiting Toxicity (DLT)|1
944484|NCT00809133|3111740|P7|Overall Study|Dose Limiting Toxicity (DLT)|1
944485|NCT00809133|3111741|P6|Overall Study|Dose Limiting Toxicity (DLT)|1
944486|NCT00809133|3111742|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
944487|NCT00809133|3111743|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
944488|NCT00809133|3111744|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
944489|NCT00809133|3111745|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
944490|NCT00809133|3111746|P1|Overall Study|Dose Limiting Toxicity (DLT)|0
944491|NCT00809133|3111733|P14|Overall Study|Progressive disease|4
944492|NCT00809133|3111734|P13|Overall Study|Progressive disease|5
944493|NCT00809133|3111735|P12|Overall Study|Progressive disease|7
944494|NCT00809133|3111736|P11|Overall Study|Progressive disease|5
944495|NCT00809133|3111737|P10|Overall Study|Progressive disease|9
944496|NCT00809133|3111738|P9|Overall Study|Progressive disease|3
944497|NCT00809133|3111739|P8|Overall Study|Progressive disease|3
944498|NCT00809133|3111740|P7|Overall Study|Progressive disease|3
944499|NCT00809133|3111741|P6|Overall Study|Progressive disease|1
944500|NCT00809133|3111742|P5|Overall Study|Progressive disease|4
944501|NCT00809133|3111743|P4|Overall Study|Progressive disease|3
944502|NCT00809133|3111744|P3|Overall Study|Progressive disease|5
944503|NCT00809133|3111745|P2|Overall Study|Progressive disease|5
944504|NCT00809133|3111746|P1|Overall Study|Progressive disease|2
944505|NCT00809094|3111900|P2|Overall Study|Lost to Follow-up|1
944506|NCT00809094|3111901|P1|Overall Study|Lost to Follow-up|0
944507|NCT00808899|3111946|P1|Overall Study|Physician Decision|3
944508|NCT00808899|3111946|P1|Overall Study|Death|1
944509|NCT00808808|3111960|P3|Overall Study|Employee was not vaccinated.|2255
944510|NCT00808808|3111961|P2|Overall Study|Employee was not vaccinated.|2268
944511|NCT00808808|3111962|P1|Overall Study|Employee was not vaccinated.|2686
944512|NCT00808808|3111960|P3|Overall Study|Vaccinated; survey not completed|302
944513|NCT00808808|3111961|P2|Overall Study|Vaccinated; survey not completed|169
944514|NCT00808808|3111962|P1|Overall Study|Vaccinated; survey not completed|131
944515|NCT00808665|3111997|P2|Overall Study|Medication stopped by resident|1
944516|NCT00808665|3111998|P1|Overall Study|Medication stopped by resident|0
944517|NCT00808665|3111997|P2|Overall Study|Physician Decision|1
944518|NCT00808665|3111998|P1|Overall Study|Physician Decision|3
944519|NCT00808665|3111997|P2|Overall Study|required an additional procedure|1
944520|NCT00808665|3111998|P1|Overall Study|required an additional procedure|0
944521|NCT00808665|3111997|P2|Overall Study|surgery cancelled|0
944522|NCT00808665|3111998|P1|Overall Study|surgery cancelled|1
944523|NCT00808665|3111997|P2|Overall Study|only required minimally invasive surgery|0
944524|NCT00808665|3111998|P1|Overall Study|only required minimally invasive surgery|1
944525|NCT00808665|3111997|P2|Overall Study|Withdrawal by Subject|0
944526|NCT00808665|3111998|P1|Overall Study|Withdrawal by Subject|1
944527|NCT00808639|3112004|P1|Overall Study|Disease progression before surgery.|1
944528|NCT00808509|3112012|P2|Randomized Phase|Patient refused rescue therapy|3
944529|NCT00808509|3112013|P1|Randomized Phase|Patient refused rescue therapy|0
944530|NCT00808509|3112012|P2|Randomized Phase|Reduced methotrexate dose|2
944531|NCT00808509|3112013|P1|Randomized Phase|Reduced methotrexate dose|1
944532|NCT00808509|3112012|P2|Randomized Phase|Did not meet eligibility criteria|0
944533|NCT00808509|3112013|P1|Randomized Phase|Did not meet eligibility criteria|1
944534|NCT00808483|3112111|P2|From 5 Months to 12 Months|Lack of Efficacy|0
944535|NCT00808483|3112112|P1|From 5 Months to 12 Months|Lack of Efficacy|1
944536|NCT00808483|3112111|P2|From 3 to 5 Months After Surgery|Lack of Efficacy|0
944537|NCT00808483|3112112|P1|From 3 to 5 Months After Surgery|Lack of Efficacy|1
944538|NCT00808483|3112111|P2|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
944539|NCT00808483|3112112|P1|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
944540|NCT00808444|3112149|P2|Overall Study|Lost to Follow-up|1
944541|NCT00808444|3112150|P1|Overall Study|Lost to Follow-up|0
944542|NCT00808444|3112149|P2|Overall Study|Withdrawal by Subject|0
944543|NCT00808444|3112150|P1|Overall Study|Withdrawal by Subject|1
944544|NCT00808249|3112225|P4|Overall Study|All other reasons|1
944545|NCT00808249|3112226|P3|Overall Study|All other reasons|3
944546|NCT00808249|3112227|P2|Overall Study|All other reasons|1
944547|NCT00808249|3112228|P1|Overall Study|All other reasons|2
944548|NCT00808249|3112225|P4|Overall Study|study specific discontinuation criteria|0
944549|NCT00808249|3112226|P3|Overall Study|study specific discontinuation criteria|1
944550|NCT00808249|3112227|P2|Overall Study|study specific discontinuation criteria|0
944551|NCT00808249|3112228|P1|Overall Study|study specific discontinuation criteria|1
944552|NCT00808249|3112225|P4|Overall Study|Lack of Efficacy|0
944553|NCT00808249|3112226|P3|Overall Study|Lack of Efficacy|0
944554|NCT00808249|3112227|P2|Overall Study|Lack of Efficacy|1
944555|NCT00808249|3112228|P1|Overall Study|Lack of Efficacy|1
944556|NCT00808249|3112225|P4|Overall Study|Protocol Violation|0
944557|NCT00808249|3112226|P3|Overall Study|Protocol Violation|3
944558|NCT00808249|3112227|P2|Overall Study|Protocol Violation|3
944559|NCT00808249|3112228|P1|Overall Study|Protocol Violation|3
944560|NCT00808249|3112225|P4|Overall Study|Withdrawal by Subject|4
944561|NCT00808249|3112226|P3|Overall Study|Withdrawal by Subject|2
944562|NCT00808249|3112227|P2|Overall Study|Withdrawal by Subject|0
944563|NCT00808249|3112228|P1|Overall Study|Withdrawal by Subject|4
944564|NCT00808249|3112225|P4|Overall Study|Lost to Follow-up|5
944565|NCT00808249|3112226|P3|Overall Study|Lost to Follow-up|3
944566|NCT00808249|3112227|P2|Overall Study|Lost to Follow-up|3
944567|NCT00808249|3112228|P1|Overall Study|Lost to Follow-up|2
944568|NCT00808249|3112225|P4|Overall Study|Adverse Event|6
944569|NCT00808249|3112226|P3|Overall Study|Adverse Event|10
944570|NCT00808249|3112227|P2|Overall Study|Adverse Event|7
944571|NCT00808249|3112228|P1|Overall Study|Adverse Event|4
944572|NCT00808236|3112256|P2|Overall Study|Death|30
944573|NCT00808236|3112257|P1|Overall Study|Death|18
944574|NCT00808236|3112256|P2|Overall Study|Physician Decision|1
944575|NCT00808236|3112257|P1|Overall Study|Physician Decision|0
944576|NCT00808236|3112256|P2|Overall Study|Lost to Follow-up|1
944577|NCT00808236|3112257|P1|Overall Study|Lost to Follow-up|1
944578|NCT00808236|3112256|P2|Overall Study|Pre-defined exclusion|3
944579|NCT00808236|3112257|P1|Overall Study|Pre-defined exclusion|13
944580|NCT00808236|3112256|P2|Overall Study|Was not resuscitated|56
944581|NCT00808236|3112257|P1|Overall Study|Was not resuscitated|50
944582|NCT00808132|3112290|P5|Overall Study|Unsatisfactory response|12
944583|NCT00808132|3112291|P4|Overall Study|Unsatisfactory response|4
944584|NCT00808132|3112292|P3|Overall Study|Unsatisfactory response|6
944585|NCT00808132|3112293|P2|Overall Study|Unsatisfactory response|6
944586|NCT00808132|3112294|P1|Overall Study|Unsatisfactory response|5
944587|NCT00808132|3112290|P5|Overall Study|Randomized, but not treated|9
944588|NCT00808132|3112291|P4|Overall Study|Randomized, but not treated|8
944589|NCT00808132|3112292|P3|Overall Study|Randomized, but not treated|9
944590|NCT00808132|3112293|P2|Overall Study|Randomized, but not treated|7
944591|NCT00808132|3112294|P1|Overall Study|Randomized, but not treated|10
944592|NCT00808132|3112290|P5|Overall Study|Other|15
944593|NCT00808132|3112291|P4|Overall Study|Other|2
944594|NCT00808132|3112292|P3|Overall Study|Other|6
944595|NCT00808132|3112293|P2|Overall Study|Other|4
944596|NCT00808132|3112294|P1|Overall Study|Other|6
944597|NCT00808132|3112290|P5|Overall Study|Withdrawal by Subject|16
944598|NCT00808132|3112291|P4|Overall Study|Withdrawal by Subject|7
944599|NCT00808132|3112292|P3|Overall Study|Withdrawal by Subject|2
944600|NCT00808132|3112293|P2|Overall Study|Withdrawal by Subject|18
944601|NCT00808132|3112294|P1|Overall Study|Withdrawal by Subject|27
944602|NCT00808132|3112290|P5|Overall Study|Protocol Violation|5
944603|NCT00808132|3112291|P4|Overall Study|Protocol Violation|9
944604|NCT00808132|3112292|P3|Overall Study|Protocol Violation|4
944605|NCT00808132|3112293|P2|Overall Study|Protocol Violation|9
944606|NCT00808132|3112294|P1|Overall Study|Protocol Violation|8
944607|NCT00808132|3112290|P5|Overall Study|Lost to Follow-up|9
944608|NCT00808132|3112291|P4|Overall Study|Lost to Follow-up|8
944609|NCT00808132|3112292|P3|Overall Study|Lost to Follow-up|11
944610|NCT00808132|3112293|P2|Overall Study|Lost to Follow-up|10
944611|NCT00808132|3112294|P1|Overall Study|Lost to Follow-up|8
944612|NCT00808132|3112290|P5|Overall Study|Physician Decision|0
944613|NCT00808132|3112291|P4|Overall Study|Physician Decision|0
944614|NCT00808132|3112292|P3|Overall Study|Physician Decision|0
944615|NCT00808132|3112293|P2|Overall Study|Physician Decision|1
944616|NCT00808132|3112294|P1|Overall Study|Physician Decision|0
944617|NCT00808132|3112290|P5|Overall Study|Death|1
944618|NCT00808132|3112291|P4|Overall Study|Death|0
944619|NCT00808132|3112292|P3|Overall Study|Death|0
944620|NCT00808132|3112293|P2|Overall Study|Death|0
944621|NCT00808132|3112294|P1|Overall Study|Death|0
944622|NCT00808132|3112290|P5|Overall Study|Adverse Event|33
944623|NCT00808132|3112291|P4|Overall Study|Adverse Event|31
944624|NCT00808132|3112292|P3|Overall Study|Adverse Event|16
944625|NCT00808132|3112293|P2|Overall Study|Adverse Event|33
944626|NCT00808132|3112294|P1|Overall Study|Adverse Event|34
944627|NCT00808080|3112366|P1|Overall Study|Patients Became Ineligible for infusion|6
944628|NCT00808067|3112372|P2|Overall Study|Excluded from analysis|19
944629|NCT00808067|3112373|P1|Overall Study|Excluded from analysis|13
944630|NCT00808067|3112372|P2|Overall Study|Other reason not defined above|5
944631|NCT00808067|3112373|P1|Overall Study|Other reason not defined above|5
944632|NCT00808067|3112372|P2|Overall Study|Site closed for cause|19
944633|NCT00808067|3112373|P1|Overall Study|Site closed for cause|19
944634|NCT00808067|3112372|P2|Overall Study|Patient elected|9
944635|NCT00808067|3112373|P1|Overall Study|Patient elected|7
944636|NCT00808067|3112372|P2|Overall Study|Protocol Violation|11
944637|NCT00808067|3112373|P1|Overall Study|Protocol Violation|3
944638|NCT00808067|3112372|P2|Overall Study|Physician Decision|38
944639|NCT00808067|3112373|P1|Overall Study|Physician Decision|47
944640|NCT00808067|3112372|P2|Overall Study|Site closed|3
944641|NCT00808067|3112373|P1|Overall Study|Site closed|4
944642|NCT00808067|3112372|P2|Overall Study|Withdrawal by Subject|25
944643|NCT00808067|3112373|P1|Overall Study|Withdrawal by Subject|21
944644|NCT00808067|3112372|P2|Overall Study|Procedure|7
944645|NCT00808067|3112373|P1|Overall Study|Procedure|6
944646|NCT00808067|3112372|P2|Overall Study|Death|1
944647|NCT00808067|3112373|P1|Overall Study|Death|1
944648|NCT00808067|3112372|P2|Overall Study|Missing|0
944649|NCT00808067|3112373|P1|Overall Study|Missing|1
944650|NCT00808067|3112372|P2|Overall Study|Patient refused to take study medication|76
944651|NCT00808067|3112373|P1|Overall Study|Patient refused to take study medication|65
944652|NCT00808067|3112372|P2|Overall Study|Elevated LFT results|3
944653|NCT00808067|3112373|P1|Overall Study|Elevated LFT results|7
944654|NCT00808067|3112372|P2|Overall Study|Reduced creatinine clearance|55
944655|NCT00808067|3112373|P1|Overall Study|Reduced creatinine clearance|53
944656|NCT00808067|3112372|P2|Overall Study|Hospitalization due to surgery|40
944657|NCT00808067|3112373|P1|Overall Study|Hospitalization due to surgery|37
944658|NCT00808067|3112372|P2|Overall Study|Hospitalization (not including surgery)|17
944659|NCT00808067|3112373|P1|Overall Study|Hospitalization (not including surgery)|18
944660|NCT00808067|3112372|P2|Overall Study|Adverse Event|121
944661|NCT00808067|3112373|P1|Overall Study|Adverse Event|111
944662|NCT00808067|3112372|P2|Overall Study|Outcome event - other|25
944663|NCT00808067|3112373|P1|Overall Study|Outcome event - other|33
944664|NCT00808067|3112372|P2|Overall Study|Major/minor bleed|44
944665|NCT00808067|3112373|P1|Overall Study|Major/minor bleed|30
944666|NCT00808028|3112409|P4|Stage 2 (Followed up to 48 Months )|Non-compliance|0
944667|NCT00808028|3112410|P3|Stage 2 (Followed up to 48 Months )|Non-compliance|1
944668|NCT00808028|3112411|P2|Stage 2 (Followed up to 48 Months )|Non-compliance|0
944669|NCT00808028|3112412|P1|Stage 2 (Followed up to 48 Months )|Non-compliance|0
944670|NCT00808028|3112409|P4|Stage 2 (Followed up to 48 Months )|Death|0
944671|NCT00808028|3112410|P3|Stage 2 (Followed up to 48 Months )|Death|1
944672|NCT00808028|3112411|P2|Stage 2 (Followed up to 48 Months )|Death|0
944673|NCT00808028|3112412|P1|Stage 2 (Followed up to 48 Months )|Death|0
944674|NCT00808028|3112409|P4|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
944675|NCT00808028|3112410|P3|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2
944676|NCT00808028|3112411|P2|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
944677|NCT00808028|3112412|P1|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
944678|NCT00808028|3112409|P4|Stage 2 (Followed up to 48 Months )|Other|1
944679|NCT00808028|3112410|P3|Stage 2 (Followed up to 48 Months )|Other|1
944680|NCT00808028|3112411|P2|Stage 2 (Followed up to 48 Months )|Other|0
944681|NCT00808028|3112412|P1|Stage 2 (Followed up to 48 Months )|Other|0
944682|NCT00808028|3112409|P4|Stage 2 (Followed up to 48 Months )|Adverse Event|0
944683|NCT00808028|3112410|P3|Stage 2 (Followed up to 48 Months )|Adverse Event|1
944684|NCT00808028|3112411|P2|Stage 2 (Followed up to 48 Months )|Adverse Event|0
944685|NCT00808028|3112412|P1|Stage 2 (Followed up to 48 Months )|Adverse Event|1
944686|NCT00808028|3112409|P4|Stage 2 (Followed up to 48 Months )|Failed to return|4
944687|NCT00808028|3112410|P3|Stage 2 (Followed up to 48 Months )|Failed to return|5
944688|NCT00808028|3112411|P2|Stage 2 (Followed up to 48 Months )|Failed to return|0
944689|NCT00808028|3112412|P1|Stage 2 (Followed up to 48 Months )|Failed to return|2
944690|NCT00808028|3112409|P4|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7
944691|NCT00808028|3112410|P3|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8
944692|NCT00808028|3112411|P2|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0
944693|NCT00808028|3112412|P1|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2
944694|NCT00808028|3112409|P4|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
944695|NCT00808028|3112410|P3|Stage 2 (Followed up to 48 Months )|Protocol Violation|1
944696|NCT00808028|3112411|P2|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
944697|NCT00808028|3112412|P1|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
944698|NCT00808028|3112409|P4|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11
944699|NCT00808028|3112410|P3|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9
944700|NCT00808028|3112411|P2|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0
944701|NCT00808028|3112412|P1|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6
944702|NCT00808028|3112409|P4|Stage 1 (6 Months)|Protocol Violation|1
944703|NCT00808028|3112410|P3|Stage 1 (6 Months)|Protocol Violation|0
944704|NCT00808028|3112411|P2|Stage 1 (6 Months)|Protocol Violation|0
944705|NCT00808028|3112412|P1|Stage 1 (6 Months)|Protocol Violation|0
944706|NCT00808028|3112409|P4|Stage 1 (6 Months)|Lost to Follow-up|0
944707|NCT00808028|3112410|P3|Stage 1 (6 Months)|Lost to Follow-up|1
944708|NCT00808028|3112411|P2|Stage 1 (6 Months)|Lost to Follow-up|0
944709|NCT00808028|3112412|P1|Stage 1 (6 Months)|Lost to Follow-up|1
944710|NCT00808028|3112409|P4|Stage 1 (6 Months)|Adverse Event|2
944711|NCT00808028|3112410|P3|Stage 1 (6 Months)|Adverse Event|1
944712|NCT00808028|3112411|P2|Stage 1 (6 Months)|Adverse Event|0
944713|NCT00808028|3112412|P1|Stage 1 (6 Months)|Adverse Event|0
944714|NCT00808028|3112409|P4|Stage 1 (6 Months)|Parent/legal guardian request|3
944715|NCT00808028|3112410|P3|Stage 1 (6 Months)|Parent/legal guardian request|1
944716|NCT00808028|3112411|P2|Stage 1 (6 Months)|Parent/legal guardian request|1
944717|NCT00808028|3112412|P1|Stage 1 (6 Months)|Parent/legal guardian request|0
944718|NCT00808028|3112409|P4|Stage 1 (6 Months)|Other|4
944719|NCT00808028|3112410|P3|Stage 1 (6 Months)|Other|2
944720|NCT00808028|3112411|P2|Stage 1 (6 Months)|Other|0
944721|NCT00808028|3112412|P1|Stage 1 (6 Months)|Other|1
944722|NCT00808028|3112409|P4|Stage 1 (6 Months)|Withdrawal by Subject|5
944723|NCT00808028|3112410|P3|Stage 1 (6 Months)|Withdrawal by Subject|2
944724|NCT00808028|3112411|P2|Stage 1 (6 Months)|Withdrawal by Subject|0
944725|NCT00808028|3112412|P1|Stage 1 (6 Months)|Withdrawal by Subject|3
944726|NCT00808015|3112448|P1|Overall Study|Enrolled but not treated|4
944727|NCT00808015|3112448|P1|Overall Study|Other|25
944728|NCT00808015|3112448|P1|Overall Study|Adverse Event|22
944729|NCT00808015|3112448|P1|Overall Study|Participants not willing to participate|158
944730|NCT00808015|3112448|P1|Overall Study|Lost to Follow-up|76
944731|NCT00808015|3112448|P1|Overall Study|Lack of Efficacy|58
944732|NCT00808015|3112448|P1|Overall Study|Death|1
944733|NCT00807937|3112477|P4|Overall Study|All other reasons (not provided)|1
944734|NCT00807937|3112478|P3|Overall Study|All other reasons (not provided)|0
944735|NCT00807937|3112479|P2|Overall Study|All other reasons (not provided)|4
944736|NCT00807937|3112480|P1|Overall Study|All other reasons (not provided)|2
944737|NCT00807937|3112477|P4|Overall Study|Intake of prohibited medicine|0
944738|NCT00807937|3112478|P3|Overall Study|Intake of prohibited medicine|2
944739|NCT00807937|3112479|P2|Overall Study|Intake of prohibited medicine|0
944740|NCT00807937|3112480|P1|Overall Study|Intake of prohibited medicine|0
944741|NCT00807937|3112477|P4|Overall Study|Lack of Efficacy|2
944742|NCT00807937|3112478|P3|Overall Study|Lack of Efficacy|1
944743|NCT00807937|3112479|P2|Overall Study|Lack of Efficacy|0
944744|NCT00807937|3112480|P1|Overall Study|Lack of Efficacy|0
944745|NCT00807937|3112477|P4|Overall Study|Lost to Follow-up|1
944746|NCT00807937|3112478|P3|Overall Study|Lost to Follow-up|2
944747|NCT00807937|3112479|P2|Overall Study|Lost to Follow-up|0
944748|NCT00807937|3112480|P1|Overall Study|Lost to Follow-up|4
944749|NCT00807937|3112477|P4|Overall Study|Withdrawal by Subject|4
944750|NCT00807937|3112478|P3|Overall Study|Withdrawal by Subject|1
944751|NCT00807937|3112479|P2|Overall Study|Withdrawal by Subject|4
944752|NCT00807937|3112480|P1|Overall Study|Withdrawal by Subject|5
944753|NCT00807937|3112477|P4|Overall Study|Protocol Violation|3
944754|NCT00807937|3112478|P3|Overall Study|Protocol Violation|3
944755|NCT00807937|3112479|P2|Overall Study|Protocol Violation|5
944756|NCT00807937|3112480|P1|Overall Study|Protocol Violation|4
944757|NCT00807937|3112477|P4|Overall Study|Adverse Event|4
944758|NCT00807937|3112478|P3|Overall Study|Adverse Event|5
944759|NCT00807937|3112479|P2|Overall Study|Adverse Event|12
944760|NCT00807937|3112480|P1|Overall Study|Adverse Event|12
944761|NCT00807885|3112515|P9|Overall Study|Lost to Follow-up|0
944762|NCT00807885|3112516|P8|Overall Study|Lost to Follow-up|0
944763|NCT00807885|3112517|P7|Overall Study|Lost to Follow-up|0
944764|NCT00807885|3112518|P6|Overall Study|Lost to Follow-up|1
944765|NCT00807885|3112519|P5|Overall Study|Lost to Follow-up|0
944766|NCT00807885|3112520|P4|Overall Study|Lost to Follow-up|0
944767|NCT00807885|3112521|P3|Overall Study|Lost to Follow-up|0
944768|NCT00807885|3112522|P2|Overall Study|Lost to Follow-up|0
944769|NCT00807885|3112523|P1|Overall Study|Lost to Follow-up|0
944770|NCT00807846|3112572|P2|Overall Study|Not Specified|2
944771|NCT00807846|3112573|P1|Overall Study|Not Specified|1
944772|NCT00807846|3112572|P2|Overall Study|Withdrawal by Subject|1
944773|NCT00807846|3112573|P1|Overall Study|Withdrawal by Subject|2
944774|NCT00807846|3112572|P2|Overall Study|Protocol Violation|1
944775|NCT00807846|3112573|P1|Overall Study|Protocol Violation|2
944776|NCT00807846|3112572|P2|Overall Study|Lack of Efficacy|0
944777|NCT00807846|3112573|P1|Overall Study|Lack of Efficacy|2
944778|NCT00807846|3112572|P2|Overall Study|Adverse Event|0
944779|NCT00807846|3112573|P1|Overall Study|Adverse Event|5
944780|NCT00807573|3112637|P1|Overall Study|Adverse Event|1
944781|NCT00807573|3112637|P1|Overall Study|Withdrawal by Subject|1
944782|NCT00807495|3112683|P5|Overall Study|Reason Not Specified|3
944783|NCT00807495|3112684|P4|Overall Study|Reason Not Specified|0
944784|NCT00807495|3112685|P3|Overall Study|Reason Not Specified|2
944785|NCT00807495|3112686|P2|Overall Study|Reason Not Specified|3
944786|NCT00807495|3112687|P1|Overall Study|Reason Not Specified|0
944787|NCT00807495|3112683|P5|Overall Study|Withdrawal by Patient|0
944788|NCT00807495|3112684|P4|Overall Study|Withdrawal by Patient|0
944789|NCT00807495|3112685|P3|Overall Study|Withdrawal by Patient|1
944790|NCT00807495|3112686|P2|Overall Study|Withdrawal by Patient|0
944791|NCT00807495|3112687|P1|Overall Study|Withdrawal by Patient|2
944792|NCT00807495|3112683|P5|Overall Study|Adverse Event|2
944793|NCT00807495|3112684|P4|Overall Study|Adverse Event|1
944794|NCT00807495|3112685|P3|Overall Study|Adverse Event|1
944795|NCT00807495|3112686|P2|Overall Study|Adverse Event|3
944796|NCT00807495|3112687|P1|Overall Study|Adverse Event|6
944797|NCT00807365|3112733|P1|Overall Study|Study Terminated|5
944798|NCT00807248|3112741|P4|Overall Study|Other Reason|0
944799|NCT00807248|3112742|P3|Overall Study|Other Reason|2
944800|NCT00807248|3112743|P2|Overall Study|Other Reason|0
944801|NCT00807248|3112744|P1|Overall Study|Other Reason|0
944802|NCT00807248|3112741|P4|Overall Study|Lost to Follow-up|0
944803|NCT00807248|3112742|P3|Overall Study|Lost to Follow-up|0
944804|NCT00807248|3112743|P2|Overall Study|Lost to Follow-up|0
944805|NCT00807248|3112744|P1|Overall Study|Lost to Follow-up|1
944806|NCT00807248|3112741|P4|Overall Study|Withdrawal of Consent|5
944807|NCT00807248|3112742|P3|Overall Study|Withdrawal of Consent|5
944808|NCT00807248|3112743|P2|Overall Study|Withdrawal of Consent|5
944809|NCT00807248|3112744|P1|Overall Study|Withdrawal of Consent|5
944810|NCT00807248|3112741|P4|Overall Study|Protocol Violation|0
944811|NCT00807248|3112742|P3|Overall Study|Protocol Violation|1
944812|NCT00807248|3112743|P2|Overall Study|Protocol Violation|1
944813|NCT00807248|3112744|P1|Overall Study|Protocol Violation|0
944814|NCT00807248|3112741|P4|Overall Study|Lack of Efficacy|3
944815|NCT00807248|3112742|P3|Overall Study|Lack of Efficacy|8
944816|NCT00807248|3112743|P2|Overall Study|Lack of Efficacy|4
944817|NCT00807248|3112744|P1|Overall Study|Lack of Efficacy|14
944818|NCT00807248|3112741|P4|Overall Study|Adverse Event|6
944819|NCT00807248|3112742|P3|Overall Study|Adverse Event|2
944820|NCT00807248|3112743|P2|Overall Study|Adverse Event|2
944821|NCT00807248|3112744|P1|Overall Study|Adverse Event|1
944822|NCT00807235|3112788|P2|Overall Study|Adverse Event|0
944823|NCT00807235|3112789|P1|Overall Study|Adverse Event|1
944824|NCT00807092|3112834|P2|Overall Study|CGMS data collection failed|1
944825|NCT00807092|3112835|P1|Overall Study|CGMS data collection failed|0
944826|NCT00807092|3112834|P2|Overall Study|Withdrawal by Subject|0
944827|NCT00807092|3112835|P1|Overall Study|Withdrawal by Subject|1
944828|NCT00807092|3112834|P2|Overall Study|Protocol Violation|2
944829|NCT00807092|3112835|P1|Overall Study|Protocol Violation|0
944830|NCT00807092|3112834|P2|Overall Study|Adverse Event|1
944831|NCT00807092|3112835|P1|Overall Study|Adverse Event|0
944832|NCT00807040|3112865|P2|Overall Study|Lost to Follow-up|6
944833|NCT00807040|3112866|P1|Overall Study|Lost to Follow-up|4
944834|NCT00807040|3112865|P2|Overall Study|Withdrawal by Subject|6
944835|NCT00807040|3112866|P1|Overall Study|Withdrawal by Subject|8
944836|NCT00807040|3112865|P2|Overall Study|Death|29
944837|NCT00807040|3112866|P1|Overall Study|Death|24
944838|NCT00807014|3112876|P2|Overall Study|Missed Visit 2 Due to Personal Reasons|1
944839|NCT00807014|3112877|P1|Overall Study|Missed Visit 2 Due to Personal Reasons|0
944840|NCT00807014|3112876|P2|Overall Study|Recovery|0
944841|NCT00807014|3112877|P1|Overall Study|Recovery|1
944842|NCT00807014|3112876|P2|Overall Study|Lost to Follow-up|7
944843|NCT00807014|3112877|P1|Overall Study|Lost to Follow-up|9
944844|NCT00807014|3112876|P2|Overall Study|Adverse Event|2
944845|NCT00807014|3112877|P1|Overall Study|Adverse Event|0
944846|NCT00807014|3112876|P2|Overall Study|Protocol Violation|8
944847|NCT00807014|3112877|P1|Overall Study|Protocol Violation|2
944848|NCT00807014|3112876|P2|Overall Study|Participant Considered Disease Not Cured|7
944849|NCT00807014|3112877|P1|Overall Study|Participant Considered Disease Not Cured|2
944850|NCT00807014|3112876|P2|Overall Study|Participant Considered Disease Cured|2
944851|NCT00807014|3112877|P1|Overall Study|Participant Considered Disease Cured|13
944852|NCT00807001|3112908|P5|Overall Study|Non-compliance|0
944853|NCT00807001|3112909|P4|Overall Study|Non-compliance|0
944854|NCT00807001|3112910|P3|Overall Study|Non-compliance|0
944855|NCT00807001|3112911|P2|Overall Study|Non-compliance|1
944856|NCT00807001|3112912|P1|Overall Study|Non-compliance|0
944857|NCT00806988|3112931|P2|Overall Study|Lost to Follow-up|19
944858|NCT00806988|3112932|P1|Overall Study|Lost to Follow-up|4
944859|NCT00806988|3112931|P2|Overall Study|Withdrawal by Subject|8
944860|NCT00806988|3112932|P1|Overall Study|Withdrawal by Subject|8
944861|NCT00806988|3112931|P2|Overall Study|Death|16
944862|NCT00806988|3112932|P1|Overall Study|Death|15
944863|NCT00806819|3112942|P2|Overall Study|Reasons other than stated above|41
944864|NCT00806819|3112943|P1|Overall Study|Reasons other than stated above|25
944865|NCT00806819|3112942|P2|Overall Study|Not treated|3
944866|NCT00806819|3112943|P1|Overall Study|Not treated|6
944867|NCT00806819|3112942|P2|Overall Study|Withdrawal by Subject|29
944868|NCT00806819|3112943|P1|Overall Study|Withdrawal by Subject|32
944869|NCT00806819|3112942|P2|Overall Study|Lost to Follow-up|0
944870|NCT00806819|3112943|P1|Overall Study|Lost to Follow-up|1
944871|NCT00806819|3112942|P2|Overall Study|Protocol Violation|4
944872|NCT00806819|3112943|P1|Overall Study|Protocol Violation|9
944873|NCT00806819|3112942|P2|Overall Study|Other AE|40
944874|NCT00806819|3112943|P1|Overall Study|Other AE|38
944875|NCT00806819|3112942|P2|Overall Study|Worsening or AE of underlying disease|25
944876|NCT00806819|3112943|P1|Overall Study|Worsening or AE of underlying disease|18
944877|NCT00806819|3112942|P2|Overall Study|progressive disease (modified RECIST )|216
944878|NCT00806819|3112943|P1|Overall Study|progressive disease (modified RECIST )|217
944879|NCT00806624|3113012|P3|Overall Study|discontinued before start of treatment|1
944880|NCT00806624|3113013|P2|Overall Study|discontinued before start of treatment|0
944881|NCT00806624|3113014|P1|Overall Study|discontinued before start of treatment|0
944882|NCT00806624|3113012|P3|Overall Study|Withdrawal by Subject|3
944883|NCT00806624|3113013|P2|Overall Study|Withdrawal by Subject|3
944884|NCT00806624|3113014|P1|Overall Study|Withdrawal by Subject|6
944885|NCT00806624|3113012|P3|Overall Study|Lost to Follow-up|1
944886|NCT00806624|3113013|P2|Overall Study|Lost to Follow-up|0
944887|NCT00806624|3113014|P1|Overall Study|Lost to Follow-up|1
944888|NCT00806624|3113012|P3|Overall Study|Death|1
944889|NCT00806624|3113013|P2|Overall Study|Death|1
944890|NCT00806624|3113014|P1|Overall Study|Death|0
944891|NCT00806624|3113012|P3|Overall Study|Adverse Event|0
944892|NCT00806624|3113013|P2|Overall Study|Adverse Event|8
944893|NCT00806624|3113014|P1|Overall Study|Adverse Event|2
944894|NCT00806585|3113031|P5|Overall Study|Completion status unknown|12
944895|NCT00806585|3113032|P4|Overall Study|Completion status unknown|4
944896|NCT00806585|3113033|P3|Overall Study|Completion status unknown|12
944897|NCT00806585|3113034|P2|Overall Study|Completion status unknown|14
944898|NCT00806585|3113035|P1|Overall Study|Completion status unknown|15
944899|NCT00806585|3113031|P5|Overall Study|Withdrawal by Subject|11
944900|NCT00806585|3113032|P4|Overall Study|Withdrawal by Subject|3
944901|NCT00806585|3113033|P3|Overall Study|Withdrawal by Subject|9
944902|NCT00806585|3113034|P2|Overall Study|Withdrawal by Subject|8
944903|NCT00806585|3113035|P1|Overall Study|Withdrawal by Subject|10
944904|NCT00806585|3113031|P5|Overall Study|Adverse Event|2
944905|NCT00806585|3113032|P4|Overall Study|Adverse Event|4
944906|NCT00806585|3113033|P3|Overall Study|Adverse Event|3
944907|NCT00806585|3113034|P2|Overall Study|Adverse Event|5
944908|NCT00806585|3113035|P1|Overall Study|Adverse Event|1
944909|NCT00806585|3113031|P5|Overall Study|Lack of Efficacy|0
944910|NCT00806585|3113032|P4|Overall Study|Lack of Efficacy|0
944911|NCT00806585|3113033|P3|Overall Study|Lack of Efficacy|0
944912|NCT00806585|3113034|P2|Overall Study|Lack of Efficacy|0
944913|NCT00806585|3113035|P1|Overall Study|Lack of Efficacy|1
944914|NCT00806585|3113031|P5|Overall Study|Lost to Follow-up|5
944915|NCT00806585|3113032|P4|Overall Study|Lost to Follow-up|2
944916|NCT00806585|3113033|P3|Overall Study|Lost to Follow-up|2
944917|NCT00806585|3113034|P2|Overall Study|Lost to Follow-up|1
944918|NCT00806585|3113035|P1|Overall Study|Lost to Follow-up|2
944919|NCT00806585|3113031|P5|Overall Study|Physician Decision|1
944920|NCT00806585|3113032|P4|Overall Study|Physician Decision|0
944921|NCT00806585|3113033|P3|Overall Study|Physician Decision|3
944922|NCT00806585|3113034|P2|Overall Study|Physician Decision|2
944923|NCT00806585|3113035|P1|Overall Study|Physician Decision|0
944924|NCT00806585|3113031|P5|Overall Study|Protocol Violation|0
944925|NCT00806585|3113032|P4|Overall Study|Protocol Violation|0
944926|NCT00806585|3113033|P3|Overall Study|Protocol Violation|2
944927|NCT00806585|3113034|P2|Overall Study|Protocol Violation|1
944928|NCT00806585|3113035|P1|Overall Study|Protocol Violation|3
944929|NCT00806585|3113031|P5|Overall Study|Study terminated by Sponsor|0
944930|NCT00806585|3113032|P4|Overall Study|Study terminated by Sponsor|2
944931|NCT00806585|3113033|P3|Overall Study|Study terminated by Sponsor|1
944932|NCT00806585|3113034|P2|Overall Study|Study terminated by Sponsor|0
944933|NCT00806585|3113035|P1|Overall Study|Study terminated by Sponsor|0
944934|NCT00806546|3113067|P1|Overall Study|Various|42
944935|NCT00806546|3113067|P1|Overall Study|Protocol Violation|49
944936|NCT00806546|3113067|P1|Overall Study|Withdrawal by Subject|75
944937|NCT00806546|3113067|P1|Overall Study|Adverse Event|74
944938|NCT00806546|3113067|P1|Overall Study|Lost to Follow-up|32
944939|NCT00806546|3113067|P1|Overall Study|Enrolled, not treated|35
944940|NCT00806494|3113071|P1|Overall Study|Withdrawal by Subject|5
944941|NCT00806494|3113071|P1|Overall Study|Other|30
944942|NCT00806494|3113071|P1|Overall Study|Lost to Follow-up|10
944943|NCT00806494|3113071|P1|Overall Study|Lack of Efficacy|6
944944|NCT00806494|3113071|P1|Overall Study|Adverse Event|29
944945|NCT00806442|3113095|P2|Overall Study|Withdrawal by Subject|5
944946|NCT00806442|3113096|P1|Overall Study|Withdrawal by Subject|1
944947|NCT00806442|3113095|P2|Overall Study|Lost to Follow-up|2
944948|NCT00806442|3113096|P1|Overall Study|Lost to Follow-up|3
944949|NCT00806416|3113118|P4|Period 1 - Part II|Withdrawal by Subject|2
944950|NCT00806416|3113119|P3|Period 1 - Part II|Withdrawal by Subject|0
944951|NCT00806416|3113120|P2|Period 1 - Part II|Withdrawal by Subject|0
944952|NCT00806416|3113121|P1|Period 1 - Part II|Withdrawal by Subject|0
944953|NCT00806416|3113118|P4|Period 1 - Part I|Withdrawal by Subject|0
944954|NCT00806416|3113119|P3|Period 1 - Part I|Withdrawal by Subject|0
944955|NCT00806416|3113120|P2|Period 1 - Part I|Withdrawal by Subject|1
944956|NCT00806416|3113121|P1|Period 1 - Part I|Withdrawal by Subject|3
944957|NCT00806416|3113118|P4|Period 1 - Part I|Lost to Follow-up|0
944958|NCT00806416|3113119|P3|Period 1 - Part I|Lost to Follow-up|0
944959|NCT00806416|3113120|P2|Period 1 - Part I|Lost to Follow-up|2
944960|NCT00806416|3113121|P1|Period 1 - Part I|Lost to Follow-up|0
944961|NCT00806416|3113118|P4|Period 1 - Part I|Adverse Event|0
944962|NCT00806416|3113119|P3|Period 1 - Part I|Adverse Event|0
944963|NCT00806416|3113120|P2|Period 1 - Part I|Adverse Event|1
944964|NCT00806416|3113121|P1|Period 1 - Part I|Adverse Event|0
944965|NCT00806403|3113134|P2|Overall Study|Death|3
944966|NCT00806403|3113135|P1|Overall Study|Death|4
944967|NCT00806351|3113158|P2|Overall Study|Death|4
944968|NCT00806351|3113159|P1|Overall Study|Death|5
944969|NCT00806260|3113196|P6|Period 3|Pregnancy|0
944970|NCT00806260|3113197|P5|Period 3|Pregnancy|0
944971|NCT00806260|3113198|P4|Period 3|Pregnancy|0
944972|NCT00806260|3113199|P3|Period 3|Pregnancy|0
944973|NCT00806260|3113200|P2|Period 3|Pregnancy|0
944974|NCT00806260|3113201|P1|Period 3|Pregnancy|1
944975|NCT00806260|3113196|P6|Period 3|Protocol Violation|0
944976|NCT00806260|3113197|P5|Period 3|Protocol Violation|0
944977|NCT00806260|3113198|P4|Period 3|Protocol Violation|0
944978|NCT00806260|3113199|P3|Period 3|Protocol Violation|1
944979|NCT00806260|3113200|P2|Period 3|Protocol Violation|1
944980|NCT00806260|3113201|P1|Period 3|Protocol Violation|0
944981|NCT00806260|3113196|P6|Period 2|sponsor request|0
944982|NCT00806260|3113197|P5|Period 2|sponsor request|0
944983|NCT00806260|3113198|P4|Period 2|sponsor request|1
944984|NCT00806260|3113199|P3|Period 2|sponsor request|1
944985|NCT00806260|3113200|P2|Period 2|sponsor request|0
944986|NCT00806260|3113201|P1|Period 2|sponsor request|0
944987|NCT00806260|3113196|P6|Period 2|Need to take concomitant medication|0
944988|NCT00806260|3113197|P5|Period 2|Need to take concomitant medication|0
944989|NCT00806260|3113198|P4|Period 2|Need to take concomitant medication|0
944990|NCT00806260|3113199|P3|Period 2|Need to take concomitant medication|0
944991|NCT00806260|3113200|P2|Period 2|Need to take concomitant medication|0
944992|NCT00806260|3113201|P1|Period 2|Need to take concomitant medication|1
944993|NCT00806260|3113196|P6|Period 2|Protocol Violation|0
944994|NCT00806260|3113197|P5|Period 2|Protocol Violation|0
944995|NCT00806260|3113198|P4|Period 2|Protocol Violation|0
944996|NCT00806260|3113199|P3|Period 2|Protocol Violation|1
944997|NCT00806260|3113200|P2|Period 2|Protocol Violation|0
944998|NCT00806260|3113201|P1|Period 2|Protocol Violation|1
944999|NCT00806260|3113196|P6|Period 2|Adverse Event|0
945000|NCT00806260|3113197|P5|Period 2|Adverse Event|0
945001|NCT00806260|3113198|P4|Period 2|Adverse Event|1
945002|NCT00806260|3113199|P3|Period 2|Adverse Event|0
945003|NCT00806260|3113200|P2|Period 2|Adverse Event|0
945004|NCT00806260|3113201|P1|Period 2|Adverse Event|0
945005|NCT00806260|3113196|P6|Period 1 (1 Day)|Adverse Event|0
945006|NCT00806260|3113197|P5|Period 1 (1 Day)|Adverse Event|3
945007|NCT00806260|3113198|P4|Period 1 (1 Day)|Adverse Event|0
945008|NCT00806260|3113199|P3|Period 1 (1 Day)|Adverse Event|0
945009|NCT00806260|3113200|P2|Period 1 (1 Day)|Adverse Event|0
945010|NCT00806260|3113201|P1|Period 1 (1 Day)|Adverse Event|0
945011|NCT00806195|3113246|P4|Overall Study|Protocol Violation|9
945012|NCT00806195|3113247|P3|Overall Study|Protocol Violation|26
945013|NCT00806195|3113248|P2|Overall Study|Protocol Violation|24
945014|NCT00806195|3113249|P1|Overall Study|Protocol Violation|34
945015|NCT00806195|3113246|P4|Overall Study|Administrative Reason|26
945016|NCT00806195|3113247|P3|Overall Study|Administrative Reason|66
945017|NCT00806195|3113248|P2|Overall Study|Administrative Reason|35
945018|NCT00806195|3113249|P1|Overall Study|Administrative Reason|113
945019|NCT00806195|3113246|P4|Overall Study|Inappropriate Enrollment|0
945020|NCT00806195|3113247|P3|Overall Study|Inappropriate Enrollment|0
945021|NCT00806195|3113248|P2|Overall Study|Inappropriate Enrollment|1
945022|NCT00806195|3113249|P1|Overall Study|Inappropriate Enrollment|0
945023|NCT00806195|3113246|P4|Overall Study|Lost to Follow-up|34
945024|NCT00806195|3113247|P3|Overall Study|Lost to Follow-up|90
945025|NCT00806195|3113248|P2|Overall Study|Lost to Follow-up|66
945026|NCT00806195|3113249|P1|Overall Study|Lost to Follow-up|217
945027|NCT00806195|3113246|P4|Overall Study|Withdrawal by Subject|35
945028|NCT00806195|3113247|P3|Overall Study|Withdrawal by Subject|76
945029|NCT00806195|3113248|P2|Overall Study|Withdrawal by Subject|31
945030|NCT00806195|3113249|P1|Overall Study|Withdrawal by Subject|119
945031|NCT00806195|3113246|P4|Overall Study|Adverse Event|2
945032|NCT00806195|3113247|P3|Overall Study|Adverse Event|11
945033|NCT00806195|3113248|P2|Overall Study|Adverse Event|5
945034|NCT00806195|3113249|P1|Overall Study|Adverse Event|25
945035|NCT00806195|3113246|P4|Overall Study|Death|0
945036|NCT00806195|3113247|P3|Overall Study|Death|1
945037|NCT00806195|3113248|P2|Overall Study|Death|0
945038|NCT00806195|3113249|P1|Overall Study|Death|6
945039|NCT00806026|3113280|P6|Overall Study|Adverse Event|9
945040|NCT00806026|3113281|P5|Overall Study|Adverse Event|9
945041|NCT00806026|3113282|P4|Overall Study|Adverse Event|17
945042|NCT00806026|3113283|P3|Overall Study|Adverse Event|44
945043|NCT00806026|3113284|P2|Overall Study|Adverse Event|35
945044|NCT00806026|3113285|P1|Overall Study|Adverse Event|52
945045|NCT00806026|3113280|P6|Overall Study|Protocol Violation|3
945046|NCT00806026|3113281|P5|Overall Study|Protocol Violation|2
945047|NCT00806026|3113282|P4|Overall Study|Protocol Violation|0
945048|NCT00806026|3113283|P3|Overall Study|Protocol Violation|9
945049|NCT00806026|3113284|P2|Overall Study|Protocol Violation|9
945050|NCT00806026|3113285|P1|Overall Study|Protocol Violation|6
945051|NCT00806026|3113280|P6|Overall Study|Other|4
945052|NCT00806026|3113281|P5|Overall Study|Other|0
945053|NCT00806026|3113282|P4|Overall Study|Other|2
945054|NCT00806026|3113283|P3|Overall Study|Other|8
945055|NCT00806026|3113284|P2|Overall Study|Other|6
945056|NCT00806026|3113285|P1|Overall Study|Other|3
945057|NCT00806026|3113280|P6|Overall Study|Withdrawal by Subject|3
945058|NCT00806026|3113281|P5|Overall Study|Withdrawal by Subject|5
945059|NCT00806026|3113282|P4|Overall Study|Withdrawal by Subject|2
945060|NCT00806026|3113283|P3|Overall Study|Withdrawal by Subject|9
945061|NCT00806026|3113284|P2|Overall Study|Withdrawal by Subject|17
945062|NCT00806026|3113285|P1|Overall Study|Withdrawal by Subject|14
945063|NCT00806026|3113280|P6|Overall Study|Lost to Follow-up|6
945064|NCT00806026|3113281|P5|Overall Study|Lost to Follow-up|6
945065|NCT00806026|3113282|P4|Overall Study|Lost to Follow-up|2
945066|NCT00806026|3113283|P3|Overall Study|Lost to Follow-up|8
945067|NCT00806026|3113284|P2|Overall Study|Lost to Follow-up|15
945068|NCT00806026|3113285|P1|Overall Study|Lost to Follow-up|8
945069|NCT00806026|3113280|P6|Overall Study|Lack of Efficacy|7
945070|NCT00806026|3113281|P5|Overall Study|Lack of Efficacy|8
945071|NCT00806026|3113282|P4|Overall Study|Lack of Efficacy|4
945072|NCT00806026|3113283|P3|Overall Study|Lack of Efficacy|13
945073|NCT00806026|3113284|P2|Overall Study|Lack of Efficacy|18
945074|NCT00806026|3113285|P1|Overall Study|Lack of Efficacy|5
945075|NCT00806026|3113280|P6|Overall Study|Did not meet entrance criteria|0
945076|NCT00806026|3113281|P5|Overall Study|Did not meet entrance criteria|0
945077|NCT00806026|3113282|P4|Overall Study|Did not meet entrance criteria|1
945078|NCT00806026|3113283|P3|Overall Study|Did not meet entrance criteria|2
945079|NCT00806026|3113284|P2|Overall Study|Did not meet entrance criteria|1
945080|NCT00806026|3113285|P1|Overall Study|Did not meet entrance criteria|4
945081|NCT00806026|3113280|P6|Overall Study|Death|0
945082|NCT00806026|3113281|P5|Overall Study|Death|0
945083|NCT00806026|3113282|P4|Overall Study|Death|1
945084|NCT00806026|3113283|P3|Overall Study|Death|0
945085|NCT00806026|3113284|P2|Overall Study|Death|0
945086|NCT00806026|3113285|P1|Overall Study|Death|0
945087|NCT00805961|3113380|P1|Maintenance Treatment|Withdrawn Consent|1
945088|NCT00805961|3113380|P1|Maintenance Treatment|Symptomatic Deterioration|2
945089|NCT00805961|3113380|P1|Maintenance Treatment|Withdrawal by Subject|5
945090|NCT00805961|3113380|P1|Maintenance Treatment|Adverse Event|6
945091|NCT00805961|3113380|P1|Maintenance Treatment|Intercurrent Illness|7
945092|NCT00805961|3113380|P1|Maintenance Treatment|Lack of Efficacy|13
945093|NCT00805961|3113380|P1|Treatment-Free Interval|Lack of Efficacy|1
945094|NCT00805961|3113380|P1|Treatment-Free Interval|Physician Decision|1
945095|NCT00805961|3113380|P1|Treatment-Free Interval|Intercurrent Illness|2
945096|NCT00805961|3113380|P1|Treatment-Free Interval|Adverse Event|3
945097|NCT00805961|3113380|P1|Modality Therapy|Disease Progression|2
945098|NCT00805961|3113380|P1|Modality Therapy|Adverse Event|1
945099|NCT00805961|3113380|P1|Modality Therapy|Withdrawal by Subject|1
945100|NCT00805935|3113390|P4|Overall Study|Serious Adverse Event-congenital anomaly|0
945101|NCT00805935|3113391|P3|Overall Study|Serious Adverse Event-congenital anomaly|0
945102|NCT00805935|3113392|P2|Overall Study|Serious Adverse Event-congenital anomaly|1
945103|NCT00805935|3113393|P1|Overall Study|Serious Adverse Event-congenital anomaly|0
945104|NCT00805935|3113390|P4|Overall Study|Ectopic pregnancy|0
945105|NCT00805935|3113391|P3|Overall Study|Ectopic pregnancy|1
945106|NCT00805935|3113392|P2|Overall Study|Ectopic pregnancy|0
945107|NCT00805935|3113393|P1|Overall Study|Ectopic pregnancy|0
945108|NCT00805935|3113390|P4|Overall Study|Chemical pregnancy|2
945109|NCT00805935|3113391|P3|Overall Study|Chemical pregnancy|3
945110|NCT00805935|3113392|P2|Overall Study|Chemical pregnancy|5
945111|NCT00805935|3113393|P1|Overall Study|Chemical pregnancy|0
945112|NCT00805935|3113390|P4|Overall Study|Biochemical pregnancy|0
945113|NCT00805935|3113391|P3|Overall Study|Biochemical pregnancy|0
945114|NCT00805935|3113392|P2|Overall Study|Biochemical pregnancy|1
945115|NCT00805935|3113393|P1|Overall Study|Biochemical pregnancy|0
945116|NCT00805935|3113390|P4|Overall Study|Pregnancy loss/miscarriage|0
945117|NCT00805935|3113391|P3|Overall Study|Pregnancy loss/miscarriage|0
945118|NCT00805935|3113392|P2|Overall Study|Pregnancy loss/miscarriage|0
945119|NCT00805935|3113393|P1|Overall Study|Pregnancy loss/miscarriage|2
945120|NCT00805935|3113390|P4|Overall Study|Pregnancy not confirmed by ultrasound|1
945121|NCT00805935|3113391|P3|Overall Study|Pregnancy not confirmed by ultrasound|0
945122|NCT00805935|3113392|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
945123|NCT00805935|3113393|P1|Overall Study|Pregnancy not confirmed by ultrasound|0
945124|NCT00805935|3113390|P4|Overall Study|No positive serum pregnancy|5
945125|NCT00805935|3113391|P3|Overall Study|No positive serum pregnancy|6
945126|NCT00805935|3113392|P2|Overall Study|No positive serum pregnancy|7
945127|NCT00805935|3113393|P1|Overall Study|No positive serum pregnancy|8
945128|NCT00805935|3113390|P4|Overall Study|Lost to Follow-up|0
945129|NCT00805935|3113391|P3|Overall Study|Lost to Follow-up|0
945130|NCT00805935|3113392|P2|Overall Study|Lost to Follow-up|0
945131|NCT00805935|3113393|P1|Overall Study|Lost to Follow-up|1
945132|NCT00805935|3113390|P4|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1
945133|NCT00805935|3113391|P3|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
945134|NCT00805935|3113392|P2|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
945135|NCT00805935|3113393|P1|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
945136|NCT00805935|3113390|P4|Overall Study|Cycle cancellation for risk of OHSS|0
945137|NCT00805935|3113391|P3|Overall Study|Cycle cancellation for risk of OHSS|1
945138|NCT00805935|3113392|P2|Overall Study|Cycle cancellation for risk of OHSS|0
945139|NCT00805935|3113393|P1|Overall Study|Cycle cancellation for risk of OHSS|1
945140|NCT00805935|3113390|P4|Overall Study|Cycle cancelled|0
945141|NCT00805935|3113391|P3|Overall Study|Cycle cancelled|2
945142|NCT00805935|3113392|P2|Overall Study|Cycle cancelled|0
945143|NCT00805935|3113393|P1|Overall Study|Cycle cancelled|0
945144|NCT00805935|3113390|P4|Overall Study|Stimulation Failure|2
945145|NCT00805935|3113391|P3|Overall Study|Stimulation Failure|2
945146|NCT00805935|3113392|P2|Overall Study|Stimulation Failure|5
945147|NCT00805935|3113393|P1|Overall Study|Stimulation Failure|1
945148|NCT00805792|3113460|P1|Overall Study|Lost to Follow-up|2
945149|NCT00805792|3113460|P1|Overall Study|Death|3
945150|NCT00805766|3113468|P1|Increased Dose Period|Withdrawal by Subject|1
945151|NCT00805766|3113468|P1|Increased Dose Period|Pregnancy|1
945152|NCT00805766|3113468|P1|Increased Dose Period|Lack of Efficacy|7
945153|NCT00805766|3113468|P1|Increased Dose Period|Adverse Event|4
945154|NCT00805766|3113468|P1|Screening Period|Responder|2
945155|NCT00805766|3113468|P1|Screening Period|Pregnancy|1
945156|NCT00805766|3113468|P1|Screening Period|Lack of Efficacy|2
945157|NCT00805766|3113468|P1|Screening Period|Adverse Event|1
945158|NCT00805740|3113482|P2|Overall Study|Randomized, but not treated|0
945159|NCT00805740|3113483|P1|Overall Study|Randomized, but not treated|2
945160|NCT00805740|3113482|P2|Overall Study|Lost to Follow-up|0
945161|NCT00805740|3113483|P1|Overall Study|Lost to Follow-up|1
945162|NCT00805740|3113482|P2|Overall Study|Withdrawal by Subject|0
945163|NCT00805740|3113483|P1|Overall Study|Withdrawal by Subject|1
945164|NCT00805740|3113482|P2|Overall Study|Death|4
945165|NCT00805740|3113483|P1|Overall Study|Death|7
945166|NCT00805675|3113508|P3|Overall Study|Adverse Event|1
945167|NCT00805675|3113509|P2|Overall Study|Adverse Event|0
945168|NCT00805675|3113510|P1|Overall Study|Adverse Event|0
945169|NCT00805545|3113544|P2|Overall Study|Protocol Violation|1
945170|NCT00805545|3113545|P1|Overall Study|Protocol Violation|3
945171|NCT00805545|3113544|P2|Overall Study|Protocol Violation|2
945172|NCT00805545|3113545|P1|Overall Study|Protocol Violation|3
945173|NCT00805532|3113553|P2|Overall Study|invalid data|1
945174|NCT00805532|3113554|P1|Overall Study|invalid data|0
945175|NCT00805480|3113588|P4|Overall Study|Adverse Event|0
945176|NCT00805480|3113589|P3|Overall Study|Adverse Event|1
945177|NCT00805480|3113590|P2|Overall Study|Adverse Event|0
945178|NCT00805480|3113591|P1|Overall Study|Adverse Event|0
945179|NCT00805480|3113588|P4|Overall Study|Lost to Follow-up|0
945180|NCT00805480|3113589|P3|Overall Study|Lost to Follow-up|0
945181|NCT00805480|3113590|P2|Overall Study|Lost to Follow-up|2
945182|NCT00805480|3113591|P1|Overall Study|Lost to Follow-up|1
945183|NCT00805480|3113588|P4|Overall Study|Withdrawal by Subject|5
945184|NCT00805480|3113589|P3|Overall Study|Withdrawal by Subject|11
945185|NCT00805480|3113590|P2|Overall Study|Withdrawal by Subject|5
945186|NCT00805480|3113591|P1|Overall Study|Withdrawal by Subject|13
945187|NCT00805467|3113620|P4|Overall Study|Not reported|7
945188|NCT00805467|3113621|P3|Overall Study|Not reported|3
945189|NCT00805467|3113622|P2|Overall Study|Not reported|0
945190|NCT00805467|3113623|P1|Overall Study|Not reported|0
945191|NCT00805467|3113620|P4|Overall Study|Physician Decision|6
945192|NCT00805467|3113621|P3|Overall Study|Physician Decision|2
945193|NCT00805467|3113622|P2|Overall Study|Physician Decision|1
945194|NCT00805467|3113623|P1|Overall Study|Physician Decision|0
945195|NCT00805467|3113620|P4|Overall Study|Death|5
945196|NCT00805467|3113621|P3|Overall Study|Death|7
945197|NCT00805467|3113622|P2|Overall Study|Death|2
945198|NCT00805467|3113623|P1|Overall Study|Death|0
945199|NCT00805467|3113620|P4|Overall Study|Adverse Event|57
945200|NCT00805467|3113621|P3|Overall Study|Adverse Event|26
945201|NCT00805467|3113622|P2|Overall Study|Adverse Event|13
945202|NCT00805467|3113623|P1|Overall Study|Adverse Event|0
945203|NCT00805467|3113620|P4|Overall Study|Protocol Violation|5
945204|NCT00805467|3113621|P3|Overall Study|Protocol Violation|0
945205|NCT00805467|3113622|P2|Overall Study|Protocol Violation|3
945206|NCT00805467|3113623|P1|Overall Study|Protocol Violation|0
945207|NCT00805467|3113620|P4|Overall Study|Withdrawal by Subject|50
945208|NCT00805467|3113621|P3|Overall Study|Withdrawal by Subject|45
945209|NCT00805467|3113622|P2|Overall Study|Withdrawal by Subject|6
945210|NCT00805467|3113623|P1|Overall Study|Withdrawal by Subject|0
945211|NCT00805467|3113620|P4|Overall Study|Lost to Follow-up|21
945212|NCT00805467|3113621|P3|Overall Study|Lost to Follow-up|7
945213|NCT00805467|3113622|P2|Overall Study|Lost to Follow-up|1
945214|NCT00805467|3113623|P1|Overall Study|Lost to Follow-up|0
945215|NCT00805467|3113620|P4|Overall Study|Lack of Efficacy|86
945216|NCT00805467|3113621|P3|Overall Study|Lack of Efficacy|13
945217|NCT00805467|3113622|P2|Overall Study|Lack of Efficacy|8
945218|NCT00805467|3113623|P1|Overall Study|Lack of Efficacy|0
945219|NCT00805441|3113643|P2|Overall Study|Acute Alcohol Withdrawal|1
945220|NCT00805441|3113644|P1|Overall Study|Acute Alcohol Withdrawal|0
945221|NCT00805441|3113643|P2|Overall Study|Physician Decision|1
945222|NCT00805441|3113644|P1|Overall Study|Physician Decision|0
945223|NCT00805441|3113643|P2|Overall Study|Withdrawal by Subject|9
945224|NCT00805441|3113644|P1|Overall Study|Withdrawal by Subject|15
945225|NCT00805441|3113643|P2|Overall Study|Lost to Follow-up|13
945226|NCT00805441|3113644|P1|Overall Study|Lost to Follow-up|10
945227|NCT00805441|3113643|P2|Overall Study|Protocol Violation|8
945228|NCT00805441|3113644|P1|Overall Study|Protocol Violation|4
945229|NCT00805441|3113643|P2|Overall Study|Lack of Efficacy|2
945230|NCT00805441|3113644|P1|Overall Study|Lack of Efficacy|0
945231|NCT00805441|3113643|P2|Overall Study|Adverse Event|2
945232|NCT00805441|3113644|P1|Overall Study|Adverse Event|5
945233|NCT00805389|3113679|P5|Overall Study|Withdrawal by Subject|4
945234|NCT00805389|3113680|P4|Overall Study|Withdrawal by Subject|5
945235|NCT00805389|3113681|P3|Overall Study|Withdrawal by Subject|4
945236|NCT00805389|3113682|P2|Overall Study|Withdrawal by Subject|2
945237|NCT00805389|3113683|P1|Overall Study|Withdrawal by Subject|3
945238|NCT00805389|3113679|P5|Overall Study|Protocol Violation|0
945239|NCT00805389|3113680|P4|Overall Study|Protocol Violation|0
945240|NCT00805389|3113681|P3|Overall Study|Protocol Violation|1
945241|NCT00805389|3113682|P2|Overall Study|Protocol Violation|0
945242|NCT00805389|3113683|P1|Overall Study|Protocol Violation|0
945243|NCT00805389|3113679|P5|Overall Study|Lost to Follow-up|9
945244|NCT00805389|3113680|P4|Overall Study|Lost to Follow-up|10
945245|NCT00805389|3113681|P3|Overall Study|Lost to Follow-up|6
945246|NCT00805389|3113682|P2|Overall Study|Lost to Follow-up|3
945247|NCT00805389|3113683|P1|Overall Study|Lost to Follow-up|4
945248|NCT00805389|3113679|P5|Overall Study|Adverse Event|0
945249|NCT00805389|3113680|P4|Overall Study|Adverse Event|2
945250|NCT00805389|3113681|P3|Overall Study|Adverse Event|1
945251|NCT00805389|3113682|P2|Overall Study|Adverse Event|0
945252|NCT00805389|3113683|P1|Overall Study|Adverse Event|0
945253|NCT00805285|3113930|P1|Overall Study|Lack of Efficacy|1
945254|NCT00805207|3113947|P9|Overall Study|Withdrawal by Subject|0
945255|NCT00805207|3113948|P8|Overall Study|Withdrawal by Subject|0
945256|NCT00805207|3113949|P7|Overall Study|Withdrawal by Subject|0
945257|NCT00805207|3113950|P6|Overall Study|Withdrawal by Subject|2
945258|NCT00805207|3113951|P5|Overall Study|Withdrawal by Subject|1
945259|NCT00805207|3113952|P4|Overall Study|Withdrawal by Subject|0
945260|NCT00805207|3113953|P3|Overall Study|Withdrawal by Subject|0
945261|NCT00805207|3113954|P2|Overall Study|Withdrawal by Subject|1
945262|NCT00805207|3113955|P1|Overall Study|Withdrawal by Subject|0
945263|NCT00805207|3113947|P9|Overall Study|Physician Decision|0
945264|NCT00805207|3113948|P8|Overall Study|Physician Decision|0
945265|NCT00805207|3113949|P7|Overall Study|Physician Decision|0
945266|NCT00805207|3113950|P6|Overall Study|Physician Decision|1
945267|NCT00805207|3113951|P5|Overall Study|Physician Decision|0
945268|NCT00805207|3113952|P4|Overall Study|Physician Decision|0
945269|NCT00805207|3113953|P3|Overall Study|Physician Decision|0
945270|NCT00805207|3113954|P2|Overall Study|Physician Decision|1
945271|NCT00805207|3113955|P1|Overall Study|Physician Decision|0
945272|NCT00805207|3113947|P9|Overall Study|Protocol Violation|0
945273|NCT00805207|3113948|P8|Overall Study|Protocol Violation|0
945274|NCT00805207|3113949|P7|Overall Study|Protocol Violation|0
945275|NCT00805207|3113950|P6|Overall Study|Protocol Violation|0
945276|NCT00805207|3113951|P5|Overall Study|Protocol Violation|0
945277|NCT00805207|3113952|P4|Overall Study|Protocol Violation|0
945278|NCT00805207|3113953|P3|Overall Study|Protocol Violation|1
945279|NCT00805207|3113954|P2|Overall Study|Protocol Violation|0
945280|NCT00805207|3113955|P1|Overall Study|Protocol Violation|0
945281|NCT00805194|3114013|P2|Overall Study|Reasons other than stated above|16
945282|NCT00805194|3114014|P1|Overall Study|Reasons other than stated above|20
945283|NCT00805194|3114013|P2|Overall Study|Not treated|4
945284|NCT00805194|3114014|P1|Overall Study|Not treated|3
945285|NCT00805194|3114013|P2|Overall Study|Withdrawal by Subject|42
945286|NCT00805194|3114014|P1|Overall Study|Withdrawal by Subject|60
945287|NCT00805194|3114013|P2|Overall Study|Lost to Follow-up|5
945288|NCT00805194|3114014|P1|Overall Study|Lost to Follow-up|5
945289|NCT00805194|3114013|P2|Overall Study|Protocol Violation|9
945290|NCT00805194|3114014|P1|Overall Study|Protocol Violation|9
945291|NCT00805194|3114013|P2|Overall Study|Other AE|73
945292|NCT00805194|3114014|P1|Overall Study|Other AE|84
945293|NCT00805194|3114013|P2|Overall Study|Worsening or AE of underlying disease|70
945294|NCT00805194|3114014|P1|Overall Study|Worsening or AE of underlying disease|64
945295|NCT00805194|3114013|P2|Overall Study|Progressive disease (modified RECIST)|435
945296|NCT00805194|3114014|P1|Overall Study|Progressive disease (modified RECIST)|404
945297|NCT00805142|3114048|P2|Maintenance Period|Other|1
945298|NCT00805142|3114049|P1|Maintenance Period|Other|0
945299|NCT00805142|3114048|P2|Maintenance Period|Adverse Event|1
945300|NCT00805142|3114049|P1|Maintenance Period|Adverse Event|0
945301|NCT00805142|3114048|P2|Titration Period|Other|3
945302|NCT00805142|3114049|P1|Titration Period|Other|0
945303|NCT00805142|3114048|P2|Titration Period|Withdrawal of consent|1
945304|NCT00805142|3114049|P1|Titration Period|Withdrawal of consent|0
945305|NCT00805142|3114048|P2|Titration Period|Disease Progression|1
945306|NCT00805142|3114049|P1|Titration Period|Disease Progression|2
945307|NCT00805142|3114048|P2|Titration Period|Lost to Follow-up|1
945308|NCT00805142|3114049|P1|Titration Period|Lost to Follow-up|0
945309|NCT00805142|3114048|P2|Titration Period|Lack of Efficacy|1
945310|NCT00805142|3114049|P1|Titration Period|Lack of Efficacy|1
945311|NCT00805142|3114048|P2|Titration Period|Adverse Event|3
945312|NCT00805142|3114049|P1|Titration Period|Adverse Event|3
945313|NCT00805025|3114082|P1|Overall Study|Physician Decision|1
945314|NCT00805025|3114082|P1|Overall Study|Withdrawal by Subject|2
945315|NCT00805025|3114082|P1|Overall Study|Adverse Event|4
945316|NCT00805025|3114082|P1|Overall Study|Screened but not enrolled/treated|42
945317|NCT00804986|3114111|P6|Overall Study|Physician Decision|0
945318|NCT00804986|3114112|P5|Overall Study|Physician Decision|0
945319|NCT00804986|3114113|P4|Overall Study|Physician Decision|0
945320|NCT00804986|3114114|P3|Overall Study|Physician Decision|0
945321|NCT00804986|3114115|P2|Overall Study|Physician Decision|0
945322|NCT00804986|3114116|P1|Overall Study|Physician Decision|1
945323|NCT00804986|3114111|P6|Overall Study|Sponsor Decision|0
945324|NCT00804986|3114112|P5|Overall Study|Sponsor Decision|0
945325|NCT00804986|3114113|P4|Overall Study|Sponsor Decision|0
945326|NCT00804986|3114114|P3|Overall Study|Sponsor Decision|0
945327|NCT00804986|3114115|P2|Overall Study|Sponsor Decision|1
945328|NCT00804986|3114116|P1|Overall Study|Sponsor Decision|0
945329|NCT00804986|3114111|P6|Overall Study|Inclusion/Exclusion criteria not met|1
945330|NCT00804986|3114112|P5|Overall Study|Inclusion/Exclusion criteria not met|0
945331|NCT00804986|3114113|P4|Overall Study|Inclusion/Exclusion criteria not met|1
945332|NCT00804986|3114114|P3|Overall Study|Inclusion/Exclusion criteria not met|0
945333|NCT00804986|3114115|P2|Overall Study|Inclusion/Exclusion criteria not met|2
945334|NCT00804986|3114116|P1|Overall Study|Inclusion/Exclusion criteria not met|0
945335|NCT00804986|3114111|P6|Overall Study|Withdrawal by Subject|3
945336|NCT00804986|3114112|P5|Overall Study|Withdrawal by Subject|5
945337|NCT00804986|3114113|P4|Overall Study|Withdrawal by Subject|3
945338|NCT00804986|3114114|P3|Overall Study|Withdrawal by Subject|0
945339|NCT00804986|3114115|P2|Overall Study|Withdrawal by Subject|3
945340|NCT00804986|3114116|P1|Overall Study|Withdrawal by Subject|0
945341|NCT00804986|3114111|P6|Overall Study|Protocol Violation|0
945342|NCT00804986|3114112|P5|Overall Study|Protocol Violation|0
945343|NCT00804986|3114113|P4|Overall Study|Protocol Violation|1
945344|NCT00804986|3114114|P3|Overall Study|Protocol Violation|0
945345|NCT00804986|3114115|P2|Overall Study|Protocol Violation|1
945346|NCT00804986|3114116|P1|Overall Study|Protocol Violation|0
945347|NCT00804986|3114111|P6|Overall Study|Lost to Follow-up|3
945348|NCT00804986|3114112|P5|Overall Study|Lost to Follow-up|1
945349|NCT00804986|3114113|P4|Overall Study|Lost to Follow-up|1
945350|NCT00804986|3114114|P3|Overall Study|Lost to Follow-up|0
945351|NCT00804986|3114115|P2|Overall Study|Lost to Follow-up|0
945352|NCT00804986|3114116|P1|Overall Study|Lost to Follow-up|0
945353|NCT00804986|3114111|P6|Overall Study|Lack of Efficacy|3
945354|NCT00804986|3114112|P5|Overall Study|Lack of Efficacy|0
945355|NCT00804986|3114113|P4|Overall Study|Lack of Efficacy|1
945356|NCT00804986|3114114|P3|Overall Study|Lack of Efficacy|0
945357|NCT00804986|3114115|P2|Overall Study|Lack of Efficacy|0
945358|NCT00804986|3114116|P1|Overall Study|Lack of Efficacy|0
945359|NCT00804986|3114111|P6|Overall Study|Adverse Event|0
945360|NCT00804986|3114112|P5|Overall Study|Adverse Event|3
945361|NCT00804986|3114113|P4|Overall Study|Adverse Event|1
945362|NCT00804986|3114114|P3|Overall Study|Adverse Event|2
945363|NCT00804986|3114115|P2|Overall Study|Adverse Event|1
945364|NCT00804986|3114116|P1|Overall Study|Adverse Event|0
945365|NCT00804908|3114211|P3|Overall Study|Not specified|114
945366|NCT00804908|3114212|P2|Overall Study|Not specified|116
945367|NCT00804908|3114213|P1|Overall Study|Not specified|115
945368|NCT00804843|3114244|P2|Overall Study|Withdrawal by Subject|2
945369|NCT00804843|3114245|P1|Overall Study|Withdrawal by Subject|1
945370|NCT00804843|3114244|P2|Overall Study|Adverse Event|5
945371|NCT00804843|3114245|P1|Overall Study|Adverse Event|8
945372|NCT00804843|3114244|P2|Overall Study|Protocol Violation|0
945373|NCT00804843|3114245|P1|Overall Study|Protocol Violation|1
945374|NCT00804687|3114263|P6|Period 5: Treatment Period|Positive drug test|0
945375|NCT00804687|3114264|P5|Period 5: Treatment Period|Positive drug test|0
945376|NCT00804687|3114265|P4|Period 5: Treatment Period|Positive drug test|0
945377|NCT00804687|3114266|P3|Period 5: Treatment Period|Positive drug test|0
945378|NCT00804687|3114267|P2|Period 5: Treatment Period|Positive drug test|0
945379|NCT00804687|3114268|P1|Period 5: Treatment Period|Positive drug test|1
945380|NCT00804687|3114263|P6|Period 5: Treatment Period|Positive drugs of abuse|0
945381|NCT00804687|3114264|P5|Period 5: Treatment Period|Positive drugs of abuse|0
945382|NCT00804687|3114265|P4|Period 5: Treatment Period|Positive drugs of abuse|0
945383|NCT00804687|3114266|P3|Period 5: Treatment Period|Positive drugs of abuse|1
945384|NCT00804687|3114267|P2|Period 5: Treatment Period|Positive drugs of abuse|0
945385|NCT00804687|3114268|P1|Period 5: Treatment Period|Positive drugs of abuse|0
945386|NCT00804687|3114263|P6|Period 5: Treatment Period|Withdrawal by Subject|0
945387|NCT00804687|3114264|P5|Period 5: Treatment Period|Withdrawal by Subject|1
945388|NCT00804687|3114265|P4|Period 5: Treatment Period|Withdrawal by Subject|0
945389|NCT00804687|3114266|P3|Period 5: Treatment Period|Withdrawal by Subject|0
945390|NCT00804687|3114267|P2|Period 5: Treatment Period|Withdrawal by Subject|0
945391|NCT00804687|3114268|P1|Period 5: Treatment Period|Withdrawal by Subject|0
945392|NCT00804687|3114263|P6|Period 3: Treatment Period|Positive Drug screen|0
945393|NCT00804687|3114264|P5|Period 3: Treatment Period|Positive Drug screen|0
945394|NCT00804687|3114265|P4|Period 3: Treatment Period|Positive Drug screen|1
945395|NCT00804687|3114266|P3|Period 3: Treatment Period|Positive Drug screen|0
945396|NCT00804687|3114267|P2|Period 3: Treatment Period|Positive Drug screen|0
945397|NCT00804687|3114268|P1|Period 3: Treatment Period|Positive Drug screen|0
945398|NCT00804570|3114347|P2|Overall Study|Withdrawal by Subject|38
945399|NCT00804570|3114348|P1|Overall Study|Withdrawal by Subject|21
945400|NCT00804570|3114347|P2|Overall Study|Sponsor decision|4
945401|NCT00804570|3114348|P1|Overall Study|Sponsor decision|1
945402|NCT00804570|3114347|P2|Overall Study|Physician Decision|2
945403|NCT00804570|3114348|P1|Overall Study|Physician Decision|1
945404|NCT00804570|3114347|P2|Overall Study|Protocol Violation|16
945405|NCT00804570|3114348|P1|Overall Study|Protocol Violation|12
945406|NCT00804570|3114347|P2|Overall Study|Entry criteria not met|5
945407|NCT00804570|3114348|P1|Overall Study|Entry criteria not met|5
945408|NCT00804570|3114347|P2|Overall Study|Lost to Follow-up|21
945409|NCT00804570|3114348|P1|Overall Study|Lost to Follow-up|18
945410|NCT00804570|3114347|P2|Overall Study|Lack of Efficacy|1
945411|NCT00804570|3114348|P1|Overall Study|Lack of Efficacy|0
945412|NCT00804570|3114347|P2|Overall Study|Adverse Event|7
945413|NCT00804570|3114348|P1|Overall Study|Adverse Event|14
945414|NCT00804193|3114407|P3|Overall Study|Withdrawal by Subject|2
945415|NCT00804193|3114408|P2|Overall Study|Withdrawal by Subject|1
945416|NCT00804193|3114409|P1|Overall Study|Withdrawal by Subject|3
945417|NCT00804193|3114407|P3|Overall Study|Lost to Follow-up|4
945418|NCT00804193|3114408|P2|Overall Study|Lost to Follow-up|3
945419|NCT00804193|3114409|P1|Overall Study|Lost to Follow-up|3
945420|NCT00804193|3114407|P3|Overall Study|Protocol Violation|2
945421|NCT00804193|3114408|P2|Overall Study|Protocol Violation|8
945422|NCT00804193|3114409|P1|Overall Study|Protocol Violation|0
945423|NCT00804193|3114407|P3|Overall Study|Lack of Efficacy|3
945424|NCT00804193|3114408|P2|Overall Study|Lack of Efficacy|1
945425|NCT00804193|3114409|P1|Overall Study|Lack of Efficacy|1
945426|NCT00804193|3114407|P3|Overall Study|Adverse Event|2
945427|NCT00804193|3114408|P2|Overall Study|Adverse Event|0
945428|NCT00804193|3114409|P1|Overall Study|Adverse Event|0
945429|NCT00804193|3114407|P3|Overall Study|Lack of baseline fungus|19
945430|NCT00804193|3114408|P2|Overall Study|Lack of baseline fungus|31
945431|NCT00804193|3114409|P1|Overall Study|Lack of baseline fungus|32
945432|NCT00803790|3114458|P4|Period 2|Positive Drug Screen or Personal Reasons|0
945433|NCT00803790|3114459|P3|Period 2|Positive Drug Screen or Personal Reasons|0
945434|NCT00803790|3114460|P2|Period 2|Positive Drug Screen or Personal Reasons|0
945435|NCT00803790|3114461|P1|Period 2|Positive Drug Screen or Personal Reasons|1
945436|NCT00803790|3114458|P4|Period 2|Withdrawal by Subject|0
945437|NCT00803790|3114459|P3|Period 2|Withdrawal by Subject|0
945438|NCT00803790|3114460|P2|Period 2|Withdrawal by Subject|0
945439|NCT00803790|3114461|P1|Period 2|Withdrawal by Subject|1
945440|NCT00803790|3114458|P4|Period 2|Adverse Event|1
945441|NCT00803790|3114459|P3|Period 2|Adverse Event|1
945442|NCT00803790|3114460|P2|Period 2|Adverse Event|0
945443|NCT00803790|3114461|P1|Period 2|Adverse Event|0
945444|NCT00803790|3114458|P4|Period 1|Protocol Violation|0
945445|NCT00803790|3114459|P3|Period 1|Protocol Violation|1
945446|NCT00803790|3114460|P2|Period 1|Protocol Violation|0
945447|NCT00803790|3114461|P1|Period 1|Protocol Violation|0
945448|NCT00803790|3114458|P4|Period 1|positive drug screen or personal reasons|4
945449|NCT00803790|3114459|P3|Period 1|positive drug screen or personal reasons|0
945450|NCT00803790|3114460|P2|Period 1|positive drug screen or personal reasons|3
945451|NCT00803790|3114461|P1|Period 1|positive drug screen or personal reasons|0
945452|NCT00803790|3114458|P4|Period 1|Withdrawal by Subject|0
945453|NCT00803790|3114459|P3|Period 1|Withdrawal by Subject|0
945454|NCT00803790|3114460|P2|Period 1|Withdrawal by Subject|6
945455|NCT00803790|3114461|P1|Period 1|Withdrawal by Subject|8
945456|NCT00803790|3114458|P4|Period 1|Lost to Follow-up|0
945457|NCT00803790|3114459|P3|Period 1|Lost to Follow-up|0
945458|NCT00803790|3114460|P2|Period 1|Lost to Follow-up|2
945459|NCT00803790|3114461|P1|Period 1|Lost to Follow-up|1
945460|NCT00803790|3114458|P4|Period 1|Adverse Event|0
945461|NCT00803790|3114459|P3|Period 1|Adverse Event|0
945462|NCT00803790|3114460|P2|Period 1|Adverse Event|1
945463|NCT00803790|3114461|P1|Period 1|Adverse Event|0
945464|NCT00803738|3114501|P2|Overall Study|Positive Results for STD or abnormal PAP|8
945465|NCT00803738|3114502|P1|Overall Study|Positive Results for STD or abnormal PAP|2
945466|NCT00803738|3114501|P2|Overall Study|Negative Baseline Culture of Candida|63
945467|NCT00803738|3114502|P1|Overall Study|Negative Baseline Culture of Candida|56
945468|NCT00803738|3114501|P2|Overall Study|Lack of Efficacy|16
945469|NCT00803738|3114502|P1|Overall Study|Lack of Efficacy|10
945470|NCT00803738|3114501|P2|Overall Study|Withdrawal by Subject|4
945471|NCT00803738|3114502|P1|Overall Study|Withdrawal by Subject|1
945472|NCT00803738|3114501|P2|Overall Study|Protocol Violation|10
945473|NCT00803738|3114502|P1|Overall Study|Protocol Violation|18
945474|NCT00803738|3114501|P2|Overall Study|Lost to Follow-up|4
945475|NCT00803738|3114502|P1|Overall Study|Lost to Follow-up|4
945476|NCT00803738|3114501|P2|Overall Study|Adverse Event|5
945477|NCT00803738|3114502|P1|Overall Study|Adverse Event|3
945478|NCT00803712|3114514|P2|Overall Study|Protocol criteria (parathyroidectomy)|1
945479|NCT00803712|3114515|P1|Overall Study|Protocol criteria (parathyroidectomy)|1
945480|NCT00803712|3114514|P2|Overall Study|Administrative decision|3
945481|NCT00803712|3114515|P1|Overall Study|Administrative decision|2
945482|NCT00803712|3114514|P2|Overall Study|Protocol criteria (renal transplant)|8
945483|NCT00803712|3114515|P1|Overall Study|Protocol criteria (renal transplant)|12
945484|NCT00803712|3114514|P2|Overall Study|Protocol criteria (other)|2
945485|NCT00803712|3114515|P1|Overall Study|Protocol criteria (other)|0
945486|NCT00803712|3114514|P2|Overall Study|"Other in electronic Case Report Form"|1
945487|NCT00803712|3114515|P1|Overall Study|"Other in electronic Case Report Form"|0
945488|NCT00803712|3114514|P2|Overall Study|Withdrawal by Subject|4
945489|NCT00803712|3114515|P1|Overall Study|Withdrawal by Subject|2
945490|NCT00803712|3114514|P2|Overall Study|Lost to Follow-up|1
945491|NCT00803712|3114515|P1|Overall Study|Lost to Follow-up|3
945492|NCT00803712|3114514|P2|Overall Study|Death|7
945493|NCT00803712|3114515|P1|Overall Study|Death|8
945494|NCT00803712|3114514|P2|Overall Study|Adverse Event|0
945495|NCT00803712|3114515|P1|Overall Study|Adverse Event|5
945496|NCT00803712|3114514|P2|Overall Study|Noncompliance|0
945497|NCT00803712|3114515|P1|Overall Study|Noncompliance|3
945498|NCT00803634|3114614|P2|Overall Study|Death|2
945499|NCT00803634|3114615|P1|Overall Study|Death|3
945500|NCT00803634|3114614|P2|Overall Study|Lost to Follow-up|3
945501|NCT00803634|3114615|P1|Overall Study|Lost to Follow-up|2
945502|NCT00803634|3114614|P2|Overall Study|Withdrew Consent|0
945503|NCT00803634|3114615|P1|Overall Study|Withdrew Consent|1
945504|NCT00803595|3114644|P3|Overall Study|Withdrawal by Subject|3
945505|NCT00803595|3114645|P2|Overall Study|Withdrawal by Subject|2
945506|NCT00803595|3114646|P1|Overall Study|Withdrawal by Subject|5
945507|NCT00803595|3114644|P3|Overall Study|Protocol Violation|12
945508|NCT00803595|3114645|P2|Overall Study|Protocol Violation|2
945509|NCT00803595|3114646|P1|Overall Study|Protocol Violation|7
945510|NCT00803595|3114644|P3|Overall Study|Adverse Event|1
945511|NCT00803595|3114645|P2|Overall Study|Adverse Event|4
945512|NCT00803595|3114646|P1|Overall Study|Adverse Event|3
945513|NCT00803452|3114683|P2|Overall Study|Lost to Follow-up|3
945514|NCT00803452|3114684|P1|Overall Study|Lost to Follow-up|0
945515|NCT00803452|3114683|P2|Overall Study|Adverse Event|2
945516|NCT00803452|3114684|P1|Overall Study|Adverse Event|0
945517|NCT00803361|3114722|P2|Overall Study|Withdrawal by Subject|6
945518|NCT00803361|3114723|P1|Overall Study|Withdrawal by Subject|5
945519|NCT00803361|3114722|P2|Overall Study|Protocol Violation|4
945520|NCT00803361|3114723|P1|Overall Study|Protocol Violation|2
945521|NCT00803361|3114722|P2|Overall Study|Physician Decision|0
945522|NCT00803361|3114723|P1|Overall Study|Physician Decision|1
945523|NCT00803361|3114722|P2|Overall Study|Lost to Follow-up|2
945524|NCT00803361|3114723|P1|Overall Study|Lost to Follow-up|1
945525|NCT00803361|3114722|P2|Overall Study|Lack of Efficacy|13
945526|NCT00803361|3114723|P1|Overall Study|Lack of Efficacy|4
945527|NCT00803361|3114722|P2|Overall Study|Adverse Event|3
945528|NCT00803361|3114723|P1|Overall Study|Adverse Event|13
945529|NCT00803270|3114770|P2|Overall Study|Lost to Follow-up|2
945530|NCT00803270|3114771|P1|Overall Study|Lost to Follow-up|1
945531|NCT00803244|3114781|P2|Overall Study|Any other reason not above-mentioned|10
945532|NCT00803244|3114782|P1|Overall Study|Any other reason not above-mentioned|4
945533|NCT00803244|3114781|P2|Overall Study|Withdrawal by Subject|3
945534|NCT00803244|3114782|P1|Overall Study|Withdrawal by Subject|2
945535|NCT00803244|3114781|P2|Overall Study|Adverse Event|2
945536|NCT00803244|3114782|P1|Overall Study|Adverse Event|1
945537|NCT00803179|3114790|P1|Overall Study|Lost to Follow-up|3
945538|NCT00803101|3114809|P2|Overall Study|Patient did not have surgery|1
945539|NCT00803101|3114810|P1|Overall Study|Patient did not have surgery|1
945540|NCT00803101|3114809|P2|Overall Study|Patient did not attend scheduled visit|1
945541|NCT00803101|3114810|P1|Overall Study|Patient did not attend scheduled visit|2
945542|NCT00803101|3114809|P2|Overall Study|Patient died outside SAE report period|0
945543|NCT00803101|3114810|P1|Overall Study|Patient died outside SAE report period|1
945544|NCT00803101|3114809|P2|Overall Study|Surgery finished outside protocol window|1
945545|NCT00803101|3114810|P1|Overall Study|Surgery finished outside protocol window|1
945546|NCT00803101|3114809|P2|Overall Study|Protocol Violation|7
945547|NCT00803101|3114810|P1|Overall Study|Protocol Violation|1
945548|NCT00803101|3114809|P2|Overall Study|Lost to Follow-up|2
945549|NCT00803101|3114810|P1|Overall Study|Lost to Follow-up|2
945550|NCT00803101|3114809|P2|Overall Study|Withdrawal by Subject|4
945551|NCT00803101|3114810|P1|Overall Study|Withdrawal by Subject|6
945552|NCT00803101|3114809|P2|Overall Study|Death / Serious Adverse Event|6
945553|NCT00803101|3114810|P1|Overall Study|Death / Serious Adverse Event|4
945554|NCT00803049|3114861|P4|Overall Study|Other than Specified Above|5
945555|NCT00803049|3114862|P3|Overall Study|Other than Specified Above|2
945556|NCT00803049|3114863|P2|Overall Study|Other than Specified Above|9
945557|NCT00803049|3114864|P1|Overall Study|Other than Specified Above|3
945558|NCT00803049|3114861|P4|Overall Study|Randomized and Not Treated|2
945559|NCT00803049|3114862|P3|Overall Study|Randomized and Not Treated|0
945560|NCT00803049|3114863|P2|Overall Study|Randomized and Not Treated|0
945561|NCT00803049|3114864|P1|Overall Study|Randomized and Not Treated|0
945562|NCT00803049|3114861|P4|Overall Study|Protocol Violation|0
945563|NCT00803049|3114862|P3|Overall Study|Protocol Violation|1
945564|NCT00803049|3114863|P2|Overall Study|Protocol Violation|1
945565|NCT00803049|3114864|P1|Overall Study|Protocol Violation|0
945566|NCT00803049|3114861|P4|Overall Study|Withdrawal by Subject|44
945567|NCT00803049|3114862|P3|Overall Study|Withdrawal by Subject|16
945568|NCT00803049|3114863|P2|Overall Study|Withdrawal by Subject|43
945569|NCT00803049|3114864|P1|Overall Study|Withdrawal by Subject|19
945570|NCT00803049|3114861|P4|Overall Study|Progressive Disease|6
945571|NCT00803049|3114862|P3|Overall Study|Progressive Disease|6
945572|NCT00803049|3114863|P2|Overall Study|Progressive Disease|10
945573|NCT00803049|3114864|P1|Overall Study|Progressive Disease|6
945574|NCT00803049|3114861|P4|Overall Study|Death|2
945575|NCT00803049|3114862|P3|Overall Study|Death|0
945576|NCT00803049|3114863|P2|Overall Study|Death|1
945577|NCT00803049|3114864|P1|Overall Study|Death|2
945578|NCT00803049|3114861|P4|Overall Study|Lost to Follow-up|3
945579|NCT00803049|3114862|P3|Overall Study|Lost to Follow-up|0
945580|NCT00803049|3114863|P2|Overall Study|Lost to Follow-up|2
945581|NCT00803049|3114864|P1|Overall Study|Lost to Follow-up|0
945582|NCT00803049|3114861|P4|Overall Study|Lack of Efficacy|13
945583|NCT00803049|3114862|P3|Overall Study|Lack of Efficacy|6
945584|NCT00803049|3114863|P2|Overall Study|Lack of Efficacy|19
945585|NCT00803049|3114864|P1|Overall Study|Lack of Efficacy|10
945586|NCT00803049|3114861|P4|Overall Study|Adverse Event|27
945587|NCT00803049|3114862|P3|Overall Study|Adverse Event|13
945588|NCT00803049|3114863|P2|Overall Study|Adverse Event|33
945589|NCT00803049|3114864|P1|Overall Study|Adverse Event|21
945590|NCT00803023|3114898|P4|Overall Study|Lack of Efficacy|1
945591|NCT00803023|3114899|P3|Overall Study|Lack of Efficacy|1
945592|NCT00803023|3114900|P2|Overall Study|Lack of Efficacy|1
945593|NCT00803023|3114901|P1|Overall Study|Lack of Efficacy|0
945594|NCT00803023|3114898|P4|Overall Study|Lost to Follow-up|1
945595|NCT00803023|3114899|P3|Overall Study|Lost to Follow-up|2
945596|NCT00803023|3114900|P2|Overall Study|Lost to Follow-up|1
945597|NCT00803023|3114901|P1|Overall Study|Lost to Follow-up|0
945598|NCT00803023|3114898|P4|Overall Study|Withdrawal by Subject|0
945599|NCT00803023|3114899|P3|Overall Study|Withdrawal by Subject|0
945600|NCT00803023|3114900|P2|Overall Study|Withdrawal by Subject|2
945601|NCT00803023|3114901|P1|Overall Study|Withdrawal by Subject|0
945602|NCT00803023|3114898|P4|Overall Study|Adverse Event|6
945603|NCT00803023|3114899|P3|Overall Study|Adverse Event|8
945604|NCT00803023|3114900|P2|Overall Study|Adverse Event|4
945605|NCT00803023|3114901|P1|Overall Study|Adverse Event|5
945606|NCT00802945|3114939|P2|Overall Study|Terminated by sponsor|12
945607|NCT00802945|3114940|P1|Overall Study|Terminated by sponsor|8
945608|NCT00802945|3114939|P2|Overall Study|Death|23
945609|NCT00802945|3114940|P1|Overall Study|Death|27
945610|NCT00802893|3114971|P1|Overall Study|study terminated|3
945611|NCT00802867|3114995|P1|Overall Study|Withdrawal by Subject|1
945612|NCT00802867|3114995|P1|Overall Study|Protocol Violation|6
945613|NCT00802867|3114995|P1|Overall Study|Lost to Follow-up|6
945614|NCT00802841|3115018|P2|Overall Study|Treatment duration completed|76
945615|NCT00802841|3115019|P1|Overall Study|Treatment duration completed|66
945616|NCT00802841|3115018|P2|Overall Study|Protocol deviation|6
945617|NCT00802841|3115019|P1|Overall Study|Protocol deviation|2
945618|NCT00802841|3115018|P2|Overall Study|Withdrawal by Subject|5
945619|NCT00802841|3115019|P1|Overall Study|Withdrawal by Subject|9
945620|NCT00802841|3115018|P2|Overall Study|Disease progression|3
945621|NCT00802841|3115019|P1|Overall Study|Disease progression|7
945622|NCT00802841|3115018|P2|Overall Study|Adverse Event|2
945623|NCT00802841|3115019|P1|Overall Study|Adverse Event|8
945624|NCT00802841|3115018|P2|Overall Study|Death|2
945625|NCT00802841|3115019|P1|Overall Study|Death|1
945626|NCT00802841|3115018|P2|Overall Study|Lost to Follow-up|1
945627|NCT00802841|3115019|P1|Overall Study|Lost to Follow-up|2
945628|NCT00802841|3115018|P2|Overall Study|Administrative problems|0
945629|NCT00802841|3115019|P1|Overall Study|Administrative problems|1
945630|NCT00802737|3115044|P3|Overall Study|Participant too Unwell|0
945631|NCT00802737|3115045|P2|Overall Study|Participant too Unwell|2
945632|NCT00802737|3115046|P1|Overall Study|Participant too Unwell|0
945633|NCT00802737|3115044|P3|Overall Study|Ongoing CLL-Treatment|0
945634|NCT00802737|3115045|P2|Overall Study|Ongoing CLL-Treatment|1
945635|NCT00802737|3115046|P1|Overall Study|Ongoing CLL-Treatment|0
945636|NCT00802737|3115044|P3|Overall Study|Received Prohibited Therapy|0
945637|NCT00802737|3115045|P2|Overall Study|Received Prohibited Therapy|0
945638|NCT00802737|3115046|P1|Overall Study|Received Prohibited Therapy|1
945639|NCT00802737|3115044|P3|Overall Study|Adverse Event|0
945640|NCT00802737|3115045|P2|Overall Study|Adverse Event|0
945641|NCT00802737|3115046|P1|Overall Study|Adverse Event|1
945642|NCT00802737|3115044|P3|Overall Study|Death|1
945643|NCT00802737|3115045|P2|Overall Study|Death|5
945644|NCT00802737|3115046|P1|Overall Study|Death|6
945645|NCT00802737|3115044|P3|Overall Study|Withdrawn due to Disease Progression|0
945646|NCT00802737|3115045|P2|Overall Study|Withdrawn due to Disease Progression|3
945647|NCT00802737|3115046|P1|Overall Study|Withdrawn due to Disease Progression|9
945648|NCT00802672|3115106|P3|Overall Study|other|2
945649|NCT00802672|3115107|P2|Overall Study|other|1
945650|NCT00802672|3115108|P1|Overall Study|other|3
945651|NCT00802672|3115106|P3|Overall Study|Withdrawal by Subject|2
945652|NCT00802672|3115107|P2|Overall Study|Withdrawal by Subject|1
945653|NCT00802672|3115108|P1|Overall Study|Withdrawal by Subject|1
945654|NCT00802672|3115106|P3|Overall Study|Lost to Follow-up|3
945655|NCT00802672|3115107|P2|Overall Study|Lost to Follow-up|5
945656|NCT00802672|3115108|P1|Overall Study|Lost to Follow-up|5
945657|NCT00802672|3115106|P3|Overall Study|Protocol Violation|1
945658|NCT00802672|3115107|P2|Overall Study|Protocol Violation|1
945659|NCT00802672|3115108|P1|Overall Study|Protocol Violation|2
945660|NCT00802672|3115106|P3|Overall Study|Adverse Event|1
945661|NCT00802672|3115107|P2|Overall Study|Adverse Event|1
945662|NCT00802672|3115108|P1|Overall Study|Adverse Event|1
945663|NCT00802672|3115106|P3|Overall Study|Lack of fungal pathogen at baseline|25
945664|NCT00802672|3115107|P2|Overall Study|Lack of fungal pathogen at baseline|43
945665|NCT00802672|3115108|P1|Overall Study|Lack of fungal pathogen at baseline|56
945666|NCT00802659|3115126|P4|Overall Study|Physician Decision|0
945667|NCT00802659|3115127|P3|Overall Study|Physician Decision|0
945668|NCT00802659|3115128|P2|Overall Study|Physician Decision|1
945669|NCT00802659|3115129|P1|Overall Study|Physician Decision|0
945670|NCT00802529|3115168|P2|Overall Study|Lost to Follow-up|1
945671|NCT00802529|3115169|P1|Overall Study|Lost to Follow-up|0
945672|NCT00802464|3115208|P4|Month 8 - Month 14|Lost to Follow-up|0
945673|NCT00802464|3115209|P3|Month 8 - Month 14|Lost to Follow-up|1
945674|NCT00802464|3115210|P2|Month 8 - Month 14|Lost to Follow-up|0
945675|NCT00802464|3115211|P1|Month 8 - Month 14|Lost to Follow-up|0
945676|NCT00802464|3115208|P4|Month 8 - Month 14|Withdrawal by Subject|0
945677|NCT00802464|3115209|P3|Month 8 - Month 14|Withdrawal by Subject|0
945678|NCT00802464|3115210|P2|Month 8 - Month 14|Withdrawal by Subject|1
945679|NCT00802464|3115211|P1|Month 8 - Month 14|Withdrawal by Subject|1
945680|NCT00802464|3115208|P4|Month 8 - Month 14|Adverse Event|0
945681|NCT00802464|3115209|P3|Month 8 - Month 14|Adverse Event|0
945682|NCT00802464|3115210|P2|Month 8 - Month 14|Adverse Event|1
945683|NCT00802464|3115211|P1|Month 8 - Month 14|Adverse Event|0
945684|NCT00802464|3115208|P4|Month 0 - Month 8|Not specified|0
945685|NCT00802464|3115209|P3|Month 0 - Month 8|Not specified|1
945686|NCT00802464|3115210|P2|Month 0 - Month 8|Not specified|0
945687|NCT00802464|3115211|P1|Month 0 - Month 8|Not specified|0
945688|NCT00802464|3115208|P4|Month 0 - Month 8|Lost to Follow-up|2
945689|NCT00802464|3115209|P3|Month 0 - Month 8|Lost to Follow-up|2
945690|NCT00802464|3115210|P2|Month 0 - Month 8|Lost to Follow-up|1
945691|NCT00802464|3115211|P1|Month 0 - Month 8|Lost to Follow-up|0
945692|NCT00802464|3115208|P4|Month 0 - Month 8|Withdrawal by Subject|5
945693|NCT00802464|3115209|P3|Month 0 - Month 8|Withdrawal by Subject|2
945694|NCT00802464|3115210|P2|Month 0 - Month 8|Withdrawal by Subject|1
945695|NCT00802464|3115211|P1|Month 0 - Month 8|Withdrawal by Subject|0
945696|NCT00802464|3115208|P4|Month 0 - Month 8|Protocol Violation|0
945697|NCT00802464|3115209|P3|Month 0 - Month 8|Protocol Violation|1
945698|NCT00802464|3115210|P2|Month 0 - Month 8|Protocol Violation|0
945699|NCT00802464|3115211|P1|Month 0 - Month 8|Protocol Violation|0
945700|NCT00802464|3115208|P4|Month 0 - Month 8|Adverse Event|2
945701|NCT00802464|3115209|P3|Month 0 - Month 8|Adverse Event|1
945702|NCT00802464|3115210|P2|Month 0 - Month 8|Adverse Event|1
945703|NCT00802464|3115211|P1|Month 0 - Month 8|Adverse Event|0
945704|NCT00802438|3115297|P1|Overall Study|Physician Decision|1
945705|NCT00802438|3115297|P1|Overall Study|Withdrawal by Subject|7
945706|NCT00802438|3115297|P1|Overall Study|Screen Failure|20
945707|NCT00802360|3115317|P4|Overall Study|Other|3
945708|NCT00802360|3115318|P3|Overall Study|Other|6
945709|NCT00802360|3115319|P2|Overall Study|Other|3
945710|NCT00802360|3115320|P1|Overall Study|Other|2
945711|NCT00802360|3115317|P4|Overall Study|Pregnancy loss/miscarriage|3
945712|NCT00802360|3115318|P3|Overall Study|Pregnancy loss/miscarriage|0
945713|NCT00802360|3115319|P2|Overall Study|Pregnancy loss/miscarriage|2
945714|NCT00802360|3115320|P1|Overall Study|Pregnancy loss/miscarriage|0
945715|NCT00802360|3115317|P4|Overall Study|Pregnancy not confirmed by ultrasound|0
945716|NCT00802360|3115318|P3|Overall Study|Pregnancy not confirmed by ultrasound|1
945717|NCT00802360|3115319|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
945718|NCT00802360|3115320|P1|Overall Study|Pregnancy not confirmed by ultrasound|1
945719|NCT00802360|3115317|P4|Overall Study|No positive serum pregnancy|10
945720|NCT00802360|3115318|P3|Overall Study|No positive serum pregnancy|14
945721|NCT00802360|3115319|P2|Overall Study|No positive serum pregnancy|20
945722|NCT00802360|3115320|P1|Overall Study|No positive serum pregnancy|17
945723|NCT00802360|3115317|P4|Overall Study|Risk of ovarian hyperstimulation syndrom|1
945724|NCT00802360|3115318|P3|Overall Study|Risk of ovarian hyperstimulation syndrom|0
945725|NCT00802360|3115319|P2|Overall Study|Risk of ovarian hyperstimulation syndrom|0
945726|NCT00802360|3115320|P1|Overall Study|Risk of ovarian hyperstimulation syndrom|0
945727|NCT00802360|3115317|P4|Overall Study|Cycle cancelled|1
945728|NCT00802360|3115318|P3|Overall Study|Cycle cancelled|1
945729|NCT00802360|3115319|P2|Overall Study|Cycle cancelled|1
945730|NCT00802360|3115320|P1|Overall Study|Cycle cancelled|0
945731|NCT00802360|3115317|P4|Overall Study|Inadequate number of oocytes retrieved|1
945732|NCT00802360|3115318|P3|Overall Study|Inadequate number of oocytes retrieved|0
945733|NCT00802360|3115319|P2|Overall Study|Inadequate number of oocytes retrieved|0
945734|NCT00802360|3115320|P1|Overall Study|Inadequate number of oocytes retrieved|0
945735|NCT00802360|3115317|P4|Overall Study|Stimulation failure|3
945736|NCT00802360|3115318|P3|Overall Study|Stimulation failure|3
945737|NCT00802360|3115319|P2|Overall Study|Stimulation failure|0
945738|NCT00802360|3115320|P1|Overall Study|Stimulation failure|4
945739|NCT00802178|3115387|P1|Overall Study|Patients wish and other reason|1
945740|NCT00802178|3115387|P1|Overall Study|IT and patient wish|8
945741|NCT00802178|3115387|P1|Overall Study|Lack of efficacy and patient wish|1
945742|NCT00802178|3115387|P1|Overall Study|Other|32
945743|NCT00802178|3115387|P1|Overall Study|Withdrawal by Subject|18
945744|NCT00802178|3115387|P1|Overall Study|Insufficient tolerability (IT)|17
945745|NCT00802178|3115387|P1|Overall Study|Lack of Efficacy|36
945746|NCT00802074|3115414|P6|Overall Study|Withdrawal by Subject|0
945747|NCT00802074|3115415|P5|Overall Study|Withdrawal by Subject|0
945748|NCT00802074|3115416|P4|Overall Study|Withdrawal by Subject|0
945749|NCT00802074|3115417|P3|Overall Study|Withdrawal by Subject|0
945750|NCT00802074|3115418|P2|Overall Study|Withdrawal by Subject|0
945751|NCT00802074|3115419|P1|Overall Study|Withdrawal by Subject|1
945752|NCT00802074|3115414|P6|Overall Study|Adverse Event|0
945753|NCT00802074|3115415|P5|Overall Study|Adverse Event|0
945754|NCT00802074|3115416|P4|Overall Study|Adverse Event|0
945755|NCT00802074|3115417|P3|Overall Study|Adverse Event|1
945756|NCT00802074|3115418|P2|Overall Study|Adverse Event|1
945757|NCT00802074|3115419|P1|Overall Study|Adverse Event|1
945758|NCT00801983|3115453|P2|Period 2|Withdrawal by Subject|1
945759|NCT00801983|3115454|P1|Period 2|Withdrawal by Subject|2
945760|NCT00801983|3115453|P2|Period 1|Withdrawal by Subject|8
945761|NCT00801983|3115454|P1|Period 1|Withdrawal by Subject|2
945762|NCT00801983|3115453|P2|Period 1|Lost to Follow-up|0
945763|NCT00801983|3115454|P1|Period 1|Lost to Follow-up|2
945764|NCT00801892|3115462|P2|Sham Crossover Period|Lost to Follow-up|2
945765|NCT00801892|3115463|P1|Sham Crossover Period|Lost to Follow-up|0
945766|NCT00801892|3115462|P2|Main Study Period|Withdrawal by Subject|1
945767|NCT00801892|3115463|P1|Main Study Period|Withdrawal by Subject|0
945768|NCT00801632|3115510|P1|Overall Study|Re-transplant|1
945769|NCT00801242|3115521|P1|Overall Study|Miscellaneous reasons|20
945770|NCT00801242|3115521|P1|Overall Study|Lost to Follow-up|1
945771|NCT00801242|3115521|P1|Overall Study|Physician Decision|3
945772|NCT00801242|3115521|P1|Overall Study|Protocol Violation|5
945773|NCT00801242|3115521|P1|Overall Study|Withdrawal by Subject|13
945774|NCT00801242|3115521|P1|Overall Study|Adverse Event|10
945775|NCT00801229|3115534|P2|Received Study Drug/Placebo|Adverse Event|1
945776|NCT00801229|3115535|P1|Received Study Drug/Placebo|Adverse Event|1
945777|NCT00801229|3115534|P2|Received Study Drug/Placebo|Lost to Follow-up|1
945778|NCT00801229|3115535|P1|Received Study Drug/Placebo|Lost to Follow-up|0
945779|NCT00801229|3115534|P2|Received Study Drug/Placebo|Withdrawal by Subject|0
945780|NCT00801229|3115535|P1|Received Study Drug/Placebo|Withdrawal by Subject|1
945781|NCT00801229|3115534|P2|Received Study Drug/Placebo|Simulator sickness|1
945782|NCT00801229|3115535|P1|Received Study Drug/Placebo|Simulator sickness|1
945783|NCT00801229|3115534|P2|Received Study Drug/Placebo|Sub-threshold ADHD|1
945784|NCT00801229|3115535|P1|Received Study Drug/Placebo|Sub-threshold ADHD|0
945785|NCT00801229|3115534|P2|Received Study Drug/Placebo|Elevated SGOT level|0
945786|NCT00801229|3115535|P1|Received Study Drug/Placebo|Elevated SGOT level|1
945787|NCT00801229|3115534|P2|Signed Consent|Found Ineligible|1
945788|NCT00801229|3115535|P1|Signed Consent|Found Ineligible|1
945789|NCT00801229|3115534|P2|Signed Consent|Withdrawal by Subject|2
945790|NCT00801229|3115535|P1|Signed Consent|Withdrawal by Subject|2
945791|NCT00801099|3115570|P1|Overall Study|Lost to Follow-up|101
945792|NCT00800982|3115576|P2|Overall Study|Patient moved out of state|0
945793|NCT00800982|3115577|P1|Overall Study|Patient moved out of state|1
945794|NCT00800982|3115576|P2|Overall Study|Withdrawal by Subject|1
945795|NCT00800982|3115577|P1|Overall Study|Withdrawal by Subject|0
945796|NCT00800982|3115576|P2|Overall Study|Lost to Follow-up|2
945797|NCT00800982|3115577|P1|Overall Study|Lost to Follow-up|1
945798|NCT00800735|3115603|P1|Overall Study|Withdrew Consent|3
945799|NCT00800735|3115603|P1|Overall Study|Violation of Selection Criteria at Entry|7
945800|NCT00800735|3115603|P1|Overall Study|Insufficient Therapeutic Response|2
945801|NCT00800735|3115603|P1|Overall Study|Administrative/Other|2
945802|NCT00800683|3115609|P2|Overall Study|Not specified|2
945803|NCT00800683|3115610|P1|Overall Study|Not specified|1
945804|NCT00800683|3115609|P2|Overall Study|Lack of Efficacy|1
945805|NCT00800683|3115610|P1|Overall Study|Lack of Efficacy|1
945806|NCT00800683|3115609|P2|Overall Study|Withdrawal by Subject|7
945807|NCT00800683|3115610|P1|Overall Study|Withdrawal by Subject|1
945808|NCT00800683|3115609|P2|Overall Study|Lost to Follow-up|1
945809|NCT00800683|3115610|P1|Overall Study|Lost to Follow-up|3
945810|NCT00800683|3115609|P2|Overall Study|Adverse Event|8
945811|NCT00800683|3115610|P1|Overall Study|Adverse Event|11
945812|NCT00800540|3115656|P2|Period 2: 6 Weeks|Adverse Event|1
945813|NCT00800540|3115657|P1|Period 2: 6 Weeks|Adverse Event|0
945814|NCT00800540|3115656|P2|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1
945815|NCT00800540|3115657|P1|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0
945816|NCT00800540|3115656|P2|Period One: 6 Weeks|Noncompliance|0
945817|NCT00800540|3115657|P1|Period One: 6 Weeks|Noncompliance|1
945818|NCT00800436|3115692|P7|Overall Study|Withdrawal by Subject|0
945819|NCT00800436|3115693|P6|Overall Study|Withdrawal by Subject|0
945820|NCT00800436|3115694|P5|Overall Study|Withdrawal by Subject|0
945821|NCT00800436|3115695|P4|Overall Study|Withdrawal by Subject|1
945822|NCT00800436|3115696|P3|Overall Study|Withdrawal by Subject|1
945823|NCT00800436|3115697|P2|Overall Study|Withdrawal by Subject|0
945824|NCT00800436|3115698|P1|Overall Study|Withdrawal by Subject|0
945825|NCT00800384|3115744|P2|Overall Study|Lost to Follow-up|26
945826|NCT00800384|3115745|P1|Overall Study|Lost to Follow-up|17
945827|NCT00800384|3115744|P2|Overall Study|Withdrawal by Subject|17
945828|NCT00800384|3115745|P1|Overall Study|Withdrawal by Subject|24
945829|NCT00800202|3115783|P2|Overall Study|Disease Progression|18
945830|NCT00800202|3115784|P1|Overall Study|Disease Progression|54
945831|NCT00800202|3115783|P2|Overall Study|Other|0
945832|NCT00800202|3115784|P1|Overall Study|Other|5
945833|NCT00800202|3115783|P2|Overall Study|Death|0
945834|NCT00800202|3115784|P1|Overall Study|Death|1
945835|NCT00800202|3115783|P2|Overall Study|Adverse Event|6
945836|NCT00800202|3115784|P1|Overall Study|Adverse Event|7
945837|NCT00799903|3115804|P2|Overall Study|Lost to Follow-up|80
945838|NCT00799903|3115805|P1|Overall Study|Lost to Follow-up|69
945839|NCT00799903|3115804|P2|Overall Study|Withdrawal by Subject|175
945840|NCT00799903|3115805|P1|Overall Study|Withdrawal by Subject|179
945841|NCT00799903|3115804|P2|Overall Study|Investigator Site Closed|23
945842|NCT00799903|3115805|P1|Overall Study|Investigator Site Closed|25
945843|NCT00799825|3115825|P1|Overall Study|Pregnancy|3
945844|NCT00799825|3115825|P1|Overall Study|Lost to Follow-up|38
945845|NCT00799825|3115825|P1|Overall Study|Withdrawal by Subject|6
945846|NCT00799825|3115825|P1|Overall Study|Adverse Event|1
945847|NCT00799708|3115865|P3|Overall Study|non-compliance|0
945848|NCT00799708|3115866|P2|Overall Study|non-compliance|0
945849|NCT00799708|3115867|P1|Overall Study|non-compliance|1
945850|NCT00799617|3115890|P2|Anemia Trial|Withdrawal by Subject|3
945851|NCT00799617|3115891|P1|Anemia Trial|Withdrawal by Subject|3
945852|NCT00799617|3115890|P2|Cognitive Function Trial|Lost to Follow-up|1
945853|NCT00799617|3115891|P1|Cognitive Function Trial|Lost to Follow-up|0
945854|NCT00799617|3115890|P2|Bone Trial|Month 12 scan not available|16
945855|NCT00799617|3115891|P1|Bone Trial|Month 12 scan not available|6
945856|NCT00799617|3115890|P2|Cardiovascular Trial|Baseline scan not analyzable|2
945857|NCT00799617|3115891|P1|Cardiovascular Trial|Baseline scan not analyzable|0
945858|NCT00799617|3115890|P2|Cardiovascular Trial|Month 12 scan not available|15
945859|NCT00799617|3115891|P1|Cardiovascular Trial|Month 12 scan not available|15
945860|NCT00799617|3115890|P2|Vitality Trial|Lost to Follow-up|22
945861|NCT00799617|3115891|P1|Vitality Trial|Lost to Follow-up|7
945862|NCT00799617|3115890|P2|Physical Function Trial|Lost to Follow-up|11
945863|NCT00799617|3115891|P1|Physical Function Trial|Lost to Follow-up|6
945864|NCT00799617|3115890|P2|Sexual Funtion Trial|No Baseline Data|7
945865|NCT00799617|3115891|P1|Sexual Funtion Trial|No Baseline Data|4
945866|NCT00799617|3115890|P2|Sexual Funtion Trial|Lost to Follow-up|14
945867|NCT00799617|3115891|P1|Sexual Funtion Trial|Lost to Follow-up|12
945868|NCT00799617|3115890|P2|Main Testosterone Trial|Lost to Follow-up|20
945869|NCT00799617|3115891|P1|Main Testosterone Trial|Lost to Follow-up|18
945870|NCT00799617|3115890|P2|Main Testosterone Trial|Randomized in error|1
945871|NCT00799617|3115891|P1|Main Testosterone Trial|Randomized in error|1
945872|NCT00799591|3115998|P1|Overall Study|Infectious origin not probable|1
945873|NCT00799591|3115998|P1|Overall Study|Antibiotic changed, no apparent reason|1
945874|NCT00799591|3115998|P1|Overall Study|Persistance of fever undetermined origin|1
945875|NCT00799591|3115998|P1|Overall Study|Resistance germ and technical failure|2
945876|NCT00799591|3115998|P1|Overall Study|New infection|4
945877|NCT00799591|3115998|P1|Overall Study|Resistant germ|11
945878|NCT00799591|3115998|P1|Overall Study|Technical failure|12
945879|NCT00799591|3115998|P1|Overall Study|Death|14
945880|NCT00799591|3115998|P1|Overall Study|De-escalation of doses|20
945881|NCT00799487|3116016|P3|Double-Blind Assessment Period|Overslept and missed lab day 2|0
945882|NCT00799487|3116017|P2|Double-Blind Assessment Period|Overslept and missed lab day 2|1
945883|NCT00799487|3116018|P1|Double-Blind Assessment Period|Overslept and missed lab day 2|0
945884|NCT00799487|3116016|P3|Double-Blind Assessment Period|Subject was out of the state|1
945885|NCT00799487|3116017|P2|Double-Blind Assessment Period|Subject was out of the state|0
945886|NCT00799487|3116018|P1|Double-Blind Assessment Period|Subject was out of the state|0
945887|NCT00799487|3116016|P3|Double-Blind Assessment Period|Lost to Follow-up|1
945888|NCT00799487|3116017|P2|Double-Blind Assessment Period|Lost to Follow-up|0
945889|NCT00799487|3116018|P1|Double-Blind Assessment Period|Lost to Follow-up|0
945890|NCT00799487|3116016|P3|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
945891|NCT00799487|3116017|P2|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
945892|NCT00799487|3116018|P1|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2
945893|NCT00799487|3116016|P3|Dose Adjustment Period|Missed laboratory day 1|0
945894|NCT00799487|3116017|P2|Dose Adjustment Period|Missed laboratory day 1|0
945895|NCT00799487|3116018|P1|Dose Adjustment Period|Missed laboratory day 1|1
945896|NCT00799487|3116016|P3|Dose Adjustment Period|Child too young (exclusion)|0
945897|NCT00799487|3116017|P2|Dose Adjustment Period|Child too young (exclusion)|0
945898|NCT00799487|3116018|P1|Dose Adjustment Period|Child too young (exclusion)|1
945899|NCT00799487|3116016|P3|Dose Adjustment Period|Parent to home school child (exclusion)|0
945900|NCT00799487|3116017|P2|Dose Adjustment Period|Parent to home school child (exclusion)|0
945901|NCT00799487|3116018|P1|Dose Adjustment Period|Parent to home school child (exclusion)|1
945902|NCT00799487|3116016|P3|Dose Adjustment Period|Withdrawal by Subject|0
945903|NCT00799487|3116017|P2|Dose Adjustment Period|Withdrawal by Subject|0
945904|NCT00799487|3116018|P1|Dose Adjustment Period|Withdrawal by Subject|3
945905|NCT00799487|3116016|P3|Dose Adjustment Period|Investigator Discretion|0
945906|NCT00799487|3116017|P2|Dose Adjustment Period|Investigator Discretion|0
945907|NCT00799487|3116018|P1|Dose Adjustment Period|Investigator Discretion|2
945908|NCT00799487|3116016|P3|Dose Adjustment Period|Optimal Dose Not Achieved|0
945909|NCT00799487|3116017|P2|Dose Adjustment Period|Optimal Dose Not Achieved|0
945910|NCT00799487|3116018|P1|Dose Adjustment Period|Optimal Dose Not Achieved|8
945911|NCT00799487|3116016|P3|Dose Adjustment Period|Adverse Event|0
945912|NCT00799487|3116017|P2|Dose Adjustment Period|Adverse Event|0
945913|NCT00799487|3116018|P1|Dose Adjustment Period|Adverse Event|2
945914|NCT00799487|3116016|P3|Dose Adjustment Period|Lost to Follow-up|0
945915|NCT00799487|3116017|P2|Dose Adjustment Period|Lost to Follow-up|0
945916|NCT00799487|3116018|P1|Dose Adjustment Period|Lost to Follow-up|1
945917|NCT00799422|3116113|P6|First Week of Wear|Adverse Event|0
945918|NCT00799422|3116114|P5|First Week of Wear|Adverse Event|0
945919|NCT00799422|3116115|P4|First Week of Wear|Adverse Event|1
945920|NCT00799422|3116116|P3|First Week of Wear|Adverse Event|0
945921|NCT00799422|3116117|P2|First Week of Wear|Adverse Event|0
945922|NCT00799422|3116118|P1|First Week of Wear|Adverse Event|0
945923|NCT00799422|3116113|P6|First Week of Wear|Lost to Follow-up|0
945924|NCT00799422|3116114|P5|First Week of Wear|Lost to Follow-up|0
945925|NCT00799422|3116115|P4|First Week of Wear|Lost to Follow-up|0
945926|NCT00799422|3116116|P3|First Week of Wear|Lost to Follow-up|1
945927|NCT00799422|3116117|P2|First Week of Wear|Lost to Follow-up|0
945928|NCT00799422|3116118|P1|First Week of Wear|Lost to Follow-up|0
945929|NCT00799409|3116135|P3|Overall Study|medication compliance|0
945930|NCT00799409|3116136|P2|Overall Study|medication compliance|0
945931|NCT00799409|3116137|P1|Overall Study|medication compliance|1
945932|NCT00799409|3116135|P3|Overall Study|Did not attend lab school day 1|0
945933|NCT00799409|3116136|P2|Overall Study|Did not attend lab school day 1|0
945934|NCT00799409|3116137|P1|Overall Study|Did not attend lab school day 1|1
945935|NCT00799409|3116135|P3|Overall Study|Failure to follow study protocol)|0
945936|NCT00799409|3116136|P2|Overall Study|Failure to follow study protocol)|0
945937|NCT00799409|3116137|P1|Overall Study|Failure to follow study protocol)|1
945938|NCT00799409|3116135|P3|Overall Study|Optimal Dose Not Achieved|0
945939|NCT00799409|3116136|P2|Overall Study|Optimal Dose Not Achieved|0
945940|NCT00799409|3116137|P1|Overall Study|Optimal Dose Not Achieved|2
945941|NCT00799409|3116135|P3|Overall Study|Lost to Follow-up|0
945942|NCT00799409|3116136|P2|Overall Study|Lost to Follow-up|0
945943|NCT00799409|3116137|P1|Overall Study|Lost to Follow-up|1
945944|NCT00799409|3116135|P3|Overall Study|Withdrawal by Subject|0
945945|NCT00799409|3116136|P2|Overall Study|Withdrawal by Subject|0
945946|NCT00799409|3116137|P1|Overall Study|Withdrawal by Subject|1
945947|NCT00799396|3116217|P1|Clopidogrel Plus Aspirin|Physician Decision|4
945948|NCT00799396|3116217|P1|Clopidogrel Plus Aspirin|Adverse Event|2
945949|NCT00799396|3116217|P1|Clopidogrel Treatment|Withdrawal by Subject|2
945950|NCT00799396|3116217|P1|Clopidogrel Treatment|Physician Decision|5
945951|NCT00799396|3116217|P1|Clopidogrel Treatment|Adverse Event|6
945952|NCT00799383|3116224|P2|Overall Study|Withdrawal by Subject|1
945953|NCT00799383|3116225|P1|Overall Study|Withdrawal by Subject|0
945954|NCT00799383|3116224|P2|Overall Study|Urinary Calcium/Creatinine > 0.2|1
945955|NCT00799383|3116225|P1|Overall Study|Urinary Calcium/Creatinine > 0.2|1
945956|NCT00799383|3116224|P2|Overall Study|Lost to Follow-up|2
945957|NCT00799383|3116225|P1|Overall Study|Lost to Follow-up|1
945958|NCT00799383|3116224|P2|Overall Study|Adverse Event|1
945959|NCT00799383|3116225|P1|Overall Study|Adverse Event|0
945960|NCT00799383|3116224|P2|Overall Study|Protocol Violation|1
945961|NCT00799383|3116225|P1|Overall Study|Protocol Violation|1
945962|NCT00798967|3116261|P2|Overall Study|Randomized in error by site|0
945963|NCT00798967|3116262|P1|Overall Study|Randomized in error by site|1
945964|NCT00798967|3116261|P2|Overall Study|Physician Decision|0
945965|NCT00798967|3116262|P1|Overall Study|Physician Decision|1
945966|NCT00798967|3116261|P2|Overall Study|Withdrawal by Subject|1
945967|NCT00798967|3116262|P1|Overall Study|Withdrawal by Subject|0
945968|NCT00798967|3116261|P2|Overall Study|Adverse Event|3
945969|NCT00798967|3116262|P1|Overall Study|Adverse Event|2
945970|NCT00798889|3116270|P1|Overall Study|Enrolled, Not treated|3
945971|NCT00798889|3116270|P1|Overall Study|Decision of Sponsor|11
945972|NCT00798889|3116270|P1|Overall Study|Lack of Efficacy|213
945973|NCT00798889|3116270|P1|Overall Study|Lost to Follow-up|1
945974|NCT00798889|3116270|P1|Overall Study|Withdrawal by Subject|31
945975|NCT00798889|3116270|P1|Overall Study|Protocol Violation|2
945976|NCT00798889|3116270|P1|Overall Study|Adverse Event|53
945977|NCT00798759|3116276|P2|Overall Study|Not specified|1
945978|NCT00798759|3116277|P1|Overall Study|Not specified|0
945979|NCT00798759|3116276|P2|Overall Study|Protocol Violation|8
945980|NCT00798759|3116277|P1|Overall Study|Protocol Violation|4
945981|NCT00798759|3116276|P2|Overall Study|Lost to Follow-up|1
945982|NCT00798759|3116277|P1|Overall Study|Lost to Follow-up|1
945983|NCT00798759|3116276|P2|Overall Study|Adverse Event|3
945984|NCT00798759|3116277|P1|Overall Study|Adverse Event|3
945985|NCT00798707|3116295|P3|Overall Study|Randomized not treated|1
945986|NCT00798707|3116296|P2|Overall Study|Randomized not treated|5
945987|NCT00798707|3116297|P1|Overall Study|Randomized not treated|4
945988|NCT00798707|3116295|P3|Overall Study|Withdrawal by Subject|2
945989|NCT00798707|3116296|P2|Overall Study|Withdrawal by Subject|8
945990|NCT00798707|3116297|P1|Overall Study|Withdrawal by Subject|3
945991|NCT00798707|3116295|P3|Overall Study|Protocol Violation|2
945992|NCT00798707|3116296|P2|Overall Study|Protocol Violation|0
945993|NCT00798707|3116297|P1|Overall Study|Protocol Violation|4
945994|NCT00798707|3116295|P3|Overall Study|Other|0
945995|NCT00798707|3116296|P2|Overall Study|Other|1
945996|NCT00798707|3116297|P1|Overall Study|Other|0
945997|NCT00798707|3116295|P3|Overall Study|Lost to Follow-up|6
945998|NCT00798707|3116296|P2|Overall Study|Lost to Follow-up|6
945999|NCT00798707|3116297|P1|Overall Study|Lost to Follow-up|5
946000|NCT00798707|3116295|P3|Overall Study|Lack of Efficacy|1
946001|NCT00798707|3116296|P2|Overall Study|Lack of Efficacy|2
946002|NCT00798707|3116297|P1|Overall Study|Lack of Efficacy|2
946003|NCT00798707|3116295|P3|Overall Study|Investigator|2
946004|NCT00798707|3116296|P2|Overall Study|Investigator|1
946005|NCT00798707|3116297|P1|Overall Study|Investigator|0
946006|NCT00798707|3116295|P3|Overall Study|Failed to return|0
946007|NCT00798707|3116296|P2|Overall Study|Failed to return|2
946008|NCT00798707|3116297|P1|Overall Study|Failed to return|2
946009|NCT00798707|3116295|P3|Overall Study|Adverse Event|8
946010|NCT00798707|3116296|P2|Overall Study|Adverse Event|8
946011|NCT00798707|3116297|P1|Overall Study|Adverse Event|6
946012|NCT00798694|3116349|P2|Overall Study|Physician Decision|0
946013|NCT00798694|3116350|P1|Overall Study|Physician Decision|1
946014|NCT00798694|3116349|P2|Overall Study|Lost to Follow-up|1
946015|NCT00798694|3116350|P1|Overall Study|Lost to Follow-up|1
946016|NCT00798655|3116374|P1|Overall Study|Did not receive at least one dose of pan|2
946017|NCT00798603|3116379|P1|Overall Study|Lack of insurance coverage|1
946018|NCT00798603|3116379|P1|Overall Study|Physician Decision|1
946019|NCT00798603|3116379|P1|Overall Study|Adverse Event|22
946020|NCT00798603|3116379|P1|Overall Study|Withdrawal by Subject|10
946021|NCT00798603|3116379|P1|Overall Study|Still on treatment as of 11/6/2012|1
946022|NCT00798590|3116401|P2|Overall Study|P.I, Left institution. Study terminated|8
946023|NCT00798590|3116402|P1|Overall Study|P.I, Left institution. Study terminated|11
946024|NCT00798434|3116436|P2|Open-Label|Not Treated|1
946025|NCT00798434|3116437|P1|Open-Label|Not Treated|0
946026|NCT00798434|3116436|P2|Open-Label|Not Specified|2
946027|NCT00798434|3116437|P1|Open-Label|Not Specified|1
946028|NCT00798434|3116436|P2|Open-Label|Protocol Violation|0
946029|NCT00798434|3116437|P1|Open-Label|Protocol Violation|1
946030|NCT00798434|3116436|P2|Open-Label|Withdrawal by Subject|7
946031|NCT00798434|3116437|P1|Open-Label|Withdrawal by Subject|2
946032|NCT00798434|3116436|P2|Open-Label|Lack of Efficacy|11
946033|NCT00798434|3116437|P1|Open-Label|Lack of Efficacy|5
946034|NCT00798434|3116436|P2|Open-Label|Adverse Event|11
946035|NCT00798434|3116437|P1|Open-Label|Adverse Event|33
946036|NCT00798434|3116436|P2|Double-Blind|Not Treated|6
946037|NCT00798434|3116437|P1|Double-Blind|Not Treated|3
946038|NCT00798434|3116436|P2|Double-Blind|Not Specified|0
946039|NCT00798434|3116437|P1|Double-Blind|Not Specified|1
946040|NCT00798434|3116436|P2|Double-Blind|Did Not Meet Entrance Criteria|1
946041|NCT00798434|3116437|P1|Double-Blind|Did Not Meet Entrance Criteria|2
946042|NCT00798434|3116436|P2|Double-Blind|Protocol Violation|4
946043|NCT00798434|3116437|P1|Double-Blind|Protocol Violation|1
946044|NCT00798434|3116436|P2|Double-Blind|Withdrawal by Subject|14
946045|NCT00798434|3116437|P1|Double-Blind|Withdrawal by Subject|17
946046|NCT00798434|3116436|P2|Double-Blind|Lack of Efficacy|12
946047|NCT00798434|3116437|P1|Double-Blind|Lack of Efficacy|8
946048|NCT00798434|3116436|P2|Double-Blind|Lost to Follow-up|0
946049|NCT00798434|3116437|P1|Double-Blind|Lost to Follow-up|1
946050|NCT00798434|3116436|P2|Double-Blind|Death|1
946051|NCT00798434|3116437|P1|Double-Blind|Death|0
946052|NCT00798434|3116436|P2|Double-Blind|Adverse Event|46
946053|NCT00798434|3116437|P1|Double-Blind|Adverse Event|22
946054|NCT00798369|3116523|P6|Overall Study|Adminstrative problems|1
946055|NCT00798369|3116524|P5|Overall Study|Adminstrative problems|0
946056|NCT00798369|3116525|P4|Overall Study|Adminstrative problems|0
946057|NCT00798369|3116526|P3|Overall Study|Adminstrative problems|0
946058|NCT00798369|3116527|P2|Overall Study|Adminstrative problems|0
946059|NCT00798369|3116528|P1|Overall Study|Adminstrative problems|0
946060|NCT00798369|3116523|P6|Overall Study|Lost to Follow-up|0
946061|NCT00798369|3116524|P5|Overall Study|Lost to Follow-up|1
946062|NCT00798369|3116525|P4|Overall Study|Lost to Follow-up|0
946063|NCT00798369|3116526|P3|Overall Study|Lost to Follow-up|1
946064|NCT00798369|3116527|P2|Overall Study|Lost to Follow-up|1
946065|NCT00798369|3116528|P1|Overall Study|Lost to Follow-up|1
946066|NCT00798369|3116523|P6|Overall Study|Subject withdrew consent|2
946067|NCT00798369|3116524|P5|Overall Study|Subject withdrew consent|0
946068|NCT00798369|3116525|P4|Overall Study|Subject withdrew consent|1
946069|NCT00798369|3116526|P3|Overall Study|Subject withdrew consent|1
946070|NCT00798369|3116527|P2|Overall Study|Subject withdrew consent|0
946071|NCT00798369|3116528|P1|Overall Study|Subject withdrew consent|0
946072|NCT00798317|3116575|P2|Overall Study|Death|0
946073|NCT00798317|3116576|P1|Overall Study|Death|1
946074|NCT00798317|3116575|P2|Overall Study|Adverse Event|0
946075|NCT00798317|3116576|P1|Overall Study|Adverse Event|2
946076|NCT00798317|3116575|P2|Overall Study|Lost to Follow-up|2
946077|NCT00798317|3116576|P1|Overall Study|Lost to Follow-up|2
946078|NCT00798317|3116575|P2|Overall Study|Withdrawal by Subject|4
946079|NCT00798317|3116576|P1|Overall Study|Withdrawal by Subject|5
946080|NCT00798317|3116575|P2|Overall Study|Physician Decision|1
946081|NCT00798317|3116576|P1|Overall Study|Physician Decision|0
946082|NCT00798304|3116587|P3|Overall Study|Discontinuation by Sponsor|9
946083|NCT00798304|3116588|P2|Overall Study|Discontinuation by Sponsor|21
946084|NCT00798304|3116589|P1|Overall Study|Discontinuation by Sponsor|14
946085|NCT00798304|3116587|P3|Overall Study|Adverse Event|1
946086|NCT00798304|3116588|P2|Overall Study|Adverse Event|1
946087|NCT00798304|3116589|P1|Overall Study|Adverse Event|0
946088|NCT00798174|3116615|P2|Overall Study|Inability to sedate for DFT testing|0
946089|NCT00798174|3116616|P1|Overall Study|Inability to sedate for DFT testing|1
946090|NCT00798174|3116615|P2|Overall Study|inability to implant azygos coil|3
946091|NCT00798174|3116616|P1|Overall Study|inability to implant azygos coil|3
946092|NCT00798161|3116627|P7|Overall Study|Other reason (incl. lack of efficacy)|5
946093|NCT00798161|3116628|P6|Overall Study|Other reason (incl. lack of efficacy)|4
946094|NCT00798161|3116629|P5|Overall Study|Other reason (incl. lack of efficacy)|2
946095|NCT00798161|3116630|P4|Overall Study|Other reason (incl. lack of efficacy)|5
946096|NCT00798161|3116631|P3|Overall Study|Other reason (incl. lack of efficacy)|3
946097|NCT00798161|3116632|P2|Overall Study|Other reason (incl. lack of efficacy)|5
946098|NCT00798161|3116633|P1|Overall Study|Other reason (incl. lack of efficacy)|7
946099|NCT00798161|3116627|P7|Overall Study|Withdrawal by Subject|1
946100|NCT00798161|3116628|P6|Overall Study|Withdrawal by Subject|3
946101|NCT00798161|3116629|P5|Overall Study|Withdrawal by Subject|2
946102|NCT00798161|3116630|P4|Overall Study|Withdrawal by Subject|4
946103|NCT00798161|3116631|P3|Overall Study|Withdrawal by Subject|5
946104|NCT00798161|3116632|P2|Overall Study|Withdrawal by Subject|4
946105|NCT00798161|3116633|P1|Overall Study|Withdrawal by Subject|5
946106|NCT00798161|3116627|P7|Overall Study|Lost to Follow-up|0
946107|NCT00798161|3116628|P6|Overall Study|Lost to Follow-up|0
946108|NCT00798161|3116629|P5|Overall Study|Lost to Follow-up|4
946109|NCT00798161|3116630|P4|Overall Study|Lost to Follow-up|3
946110|NCT00798161|3116631|P3|Overall Study|Lost to Follow-up|4
946111|NCT00798161|3116632|P2|Overall Study|Lost to Follow-up|3
946112|NCT00798161|3116633|P1|Overall Study|Lost to Follow-up|1
946113|NCT00798161|3116627|P7|Overall Study|Protocol Violation|0
946114|NCT00798161|3116628|P6|Overall Study|Protocol Violation|2
946115|NCT00798161|3116629|P5|Overall Study|Protocol Violation|3
946116|NCT00798161|3116630|P4|Overall Study|Protocol Violation|3
946117|NCT00798161|3116631|P3|Overall Study|Protocol Violation|3
946118|NCT00798161|3116632|P2|Overall Study|Protocol Violation|1
946119|NCT00798161|3116633|P1|Overall Study|Protocol Violation|2
946120|NCT00798161|3116627|P7|Overall Study|Adverse Event|4
946121|NCT00798161|3116628|P6|Overall Study|Adverse Event|2
946122|NCT00798161|3116629|P5|Overall Study|Adverse Event|5
946123|NCT00798161|3116630|P4|Overall Study|Adverse Event|6
946124|NCT00798161|3116631|P3|Overall Study|Adverse Event|6
946125|NCT00798161|3116632|P2|Overall Study|Adverse Event|4
946126|NCT00798161|3116633|P1|Overall Study|Adverse Event|3
946127|NCT00798135|3116740|P1|Overall Study|Physician Decision|1
946128|NCT00798135|3116740|P1|Overall Study|Disease progression, refractory|1
946129|NCT00798135|3116740|P1|Overall Study|Disease progression, relapse|11
946130|NCT00798096|3116746|P1|Overall Study|Ongoing|2
946131|NCT00797966|3116774|P6|Phase A+|Protocol deviation|4
946132|NCT00797966|3116775|P5|Phase A+|Protocol deviation|0
946133|NCT00797966|3116776|P4|Phase A+|Protocol deviation|0
946134|NCT00797966|3116777|P3|Phase A+|Protocol deviation|0
946135|NCT00797966|3116778|P2|Phase A+|Protocol deviation|0
946136|NCT00797966|3116779|P1|Phase A+|Protocol deviation|0
946137|NCT00797966|3116774|P6|Phase A+|Adverse Event|4
946138|NCT00797966|3116775|P5|Phase A+|Adverse Event|0
946139|NCT00797966|3116776|P4|Phase A+|Adverse Event|0
946140|NCT00797966|3116777|P3|Phase A+|Adverse Event|0
946141|NCT00797966|3116778|P2|Phase A+|Adverse Event|0
946142|NCT00797966|3116779|P1|Phase A+|Adverse Event|0
946143|NCT00797966|3116774|P6|Phase A+|Withdrawal by Subject|6
946144|NCT00797966|3116775|P5|Phase A+|Withdrawal by Subject|0
946145|NCT00797966|3116776|P4|Phase A+|Withdrawal by Subject|0
946146|NCT00797966|3116777|P3|Phase A+|Withdrawal by Subject|0
946147|NCT00797966|3116778|P2|Phase A+|Withdrawal by Subject|0
946148|NCT00797966|3116779|P1|Phase A+|Withdrawal by Subject|0
946149|NCT00797966|3116774|P6|Phase A+|Met withdrawal criteria|5
946150|NCT00797966|3116775|P5|Phase A+|Met withdrawal criteria|0
946151|NCT00797966|3116776|P4|Phase A+|Met withdrawal criteria|0
946152|NCT00797966|3116777|P3|Phase A+|Met withdrawal criteria|0
946153|NCT00797966|3116778|P2|Phase A+|Met withdrawal criteria|0
946154|NCT00797966|3116779|P1|Phase A+|Met withdrawal criteria|0
946155|NCT00797966|3116774|P6|Phase A+|Lost to Follow-up|9
946156|NCT00797966|3116775|P5|Phase A+|Lost to Follow-up|0
946157|NCT00797966|3116776|P4|Phase A+|Lost to Follow-up|0
946158|NCT00797966|3116777|P3|Phase A+|Lost to Follow-up|0
946159|NCT00797966|3116778|P2|Phase A+|Lost to Follow-up|0
946160|NCT00797966|3116779|P1|Phase A+|Lost to Follow-up|0
946161|NCT00797966|3116774|P6|Phase B|Lack of Efficacy|0
946162|NCT00797966|3116775|P5|Phase B|Lack of Efficacy|0
946163|NCT00797966|3116776|P4|Phase B|Lack of Efficacy|4
946164|NCT00797966|3116777|P3|Phase B|Lack of Efficacy|1
946165|NCT00797966|3116778|P2|Phase B|Lack of Efficacy|1
946166|NCT00797966|3116779|P1|Phase B|Lack of Efficacy|0
946167|NCT00797966|3116774|P6|Phase B|Protocol Deviation|0
946168|NCT00797966|3116775|P5|Phase B|Protocol Deviation|0
946169|NCT00797966|3116776|P4|Phase B|Protocol Deviation|6
946170|NCT00797966|3116777|P3|Phase B|Protocol Deviation|2
946171|NCT00797966|3116778|P2|Phase B|Protocol Deviation|8
946172|NCT00797966|3116779|P1|Phase B|Protocol Deviation|4
946173|NCT00797966|3116774|P6|Phase B|Withdrawal by Subject|0
946174|NCT00797966|3116775|P5|Phase B|Withdrawal by Subject|0
946175|NCT00797966|3116776|P4|Phase B|Withdrawal by Subject|3
946176|NCT00797966|3116777|P3|Phase B|Withdrawal by Subject|3
946177|NCT00797966|3116778|P2|Phase B|Withdrawal by Subject|4
946178|NCT00797966|3116779|P1|Phase B|Withdrawal by Subject|1
946179|NCT00797966|3116774|P6|Phase B|Physician Decision|0
946180|NCT00797966|3116775|P5|Phase B|Physician Decision|0
946181|NCT00797966|3116776|P4|Phase B|Physician Decision|1
946182|NCT00797966|3116777|P3|Phase B|Physician Decision|3
946183|NCT00797966|3116778|P2|Phase B|Physician Decision|0
946184|NCT00797966|3116779|P1|Phase B|Physician Decision|1
946185|NCT00797966|3116774|P6|Phase B|Met Withdrawal Criteria|0
946186|NCT00797966|3116775|P5|Phase B|Met Withdrawal Criteria|0
946187|NCT00797966|3116776|P4|Phase B|Met Withdrawal Criteria|1
946188|NCT00797966|3116777|P3|Phase B|Met Withdrawal Criteria|6
946189|NCT00797966|3116778|P2|Phase B|Met Withdrawal Criteria|3
946190|NCT00797966|3116779|P1|Phase B|Met Withdrawal Criteria|3
946191|NCT00797966|3116774|P6|Phase B|Adverse Event|0
946192|NCT00797966|3116775|P5|Phase B|Adverse Event|0
946193|NCT00797966|3116776|P4|Phase B|Adverse Event|1
946194|NCT00797966|3116777|P3|Phase B|Adverse Event|3
946195|NCT00797966|3116778|P2|Phase B|Adverse Event|1
946196|NCT00797966|3116779|P1|Phase B|Adverse Event|2
946197|NCT00797966|3116774|P6|Phase B|Lost to Follow-up|0
946198|NCT00797966|3116775|P5|Phase B|Lost to Follow-up|0
946199|NCT00797966|3116776|P4|Phase B|Lost to Follow-up|0
946200|NCT00797966|3116777|P3|Phase B|Lost to Follow-up|3
946201|NCT00797966|3116778|P2|Phase B|Lost to Follow-up|1
946202|NCT00797966|3116779|P1|Phase B|Lost to Follow-up|0
946203|NCT00797966|3116774|P6|Phase A|Protocol deviation|0
946204|NCT00797966|3116775|P5|Phase A|Protocol deviation|56
946205|NCT00797966|3116776|P4|Phase A|Protocol deviation|0
946206|NCT00797966|3116777|P3|Phase A|Protocol deviation|0
946207|NCT00797966|3116778|P2|Phase A|Protocol deviation|0
946208|NCT00797966|3116779|P1|Phase A|Protocol deviation|0
946209|NCT00797966|3116774|P6|Phase A|Withdrawal by Subject|0
946210|NCT00797966|3116775|P5|Phase A|Withdrawal by Subject|33
946211|NCT00797966|3116776|P4|Phase A|Withdrawal by Subject|0
946212|NCT00797966|3116777|P3|Phase A|Withdrawal by Subject|0
946213|NCT00797966|3116778|P2|Phase A|Withdrawal by Subject|0
946214|NCT00797966|3116779|P1|Phase A|Withdrawal by Subject|0
946215|NCT00797966|3116774|P6|Phase A|Physician Decision|0
946216|NCT00797966|3116775|P5|Phase A|Physician Decision|13
946217|NCT00797966|3116776|P4|Phase A|Physician Decision|0
946218|NCT00797966|3116777|P3|Phase A|Physician Decision|0
946219|NCT00797966|3116778|P2|Phase A|Physician Decision|0
946220|NCT00797966|3116779|P1|Phase A|Physician Decision|0
946221|NCT00797966|3116774|P6|Phase A|Met withdrawal criteria|0
946222|NCT00797966|3116775|P5|Phase A|Met withdrawal criteria|4
946223|NCT00797966|3116776|P4|Phase A|Met withdrawal criteria|0
946224|NCT00797966|3116777|P3|Phase A|Met withdrawal criteria|0
946225|NCT00797966|3116778|P2|Phase A|Met withdrawal criteria|0
946226|NCT00797966|3116779|P1|Phase A|Met withdrawal criteria|0
946227|NCT00797966|3116774|P6|Phase A|Adverse Event|0
946228|NCT00797966|3116775|P5|Phase A|Adverse Event|46
946229|NCT00797966|3116776|P4|Phase A|Adverse Event|0
946230|NCT00797966|3116777|P3|Phase A|Adverse Event|0
946231|NCT00797966|3116778|P2|Phase A|Adverse Event|0
946232|NCT00797966|3116779|P1|Phase A|Adverse Event|0
946233|NCT00797966|3116774|P6|Phase A|Lost to Follow-up|0
946234|NCT00797966|3116775|P5|Phase A|Lost to Follow-up|33
946235|NCT00797966|3116776|P4|Phase A|Lost to Follow-up|0
946236|NCT00797966|3116777|P3|Phase A|Lost to Follow-up|0
946237|NCT00797966|3116778|P2|Phase A|Lost to Follow-up|0
946238|NCT00797966|3116779|P1|Phase A|Lost to Follow-up|0
946239|NCT00797862|3116844|P3|Overall Study|Mis-randomized|1
946240|NCT00797862|3116845|P2|Overall Study|Mis-randomized|3
946241|NCT00797862|3116846|P1|Overall Study|Mis-randomized|3
946242|NCT00797862|3116844|P3|Overall Study|Protocol Violation|8
946243|NCT00797862|3116845|P2|Overall Study|Protocol Violation|6
946244|NCT00797862|3116846|P1|Overall Study|Protocol Violation|4
946245|NCT00797862|3116844|P3|Overall Study|Administrative Problem|0
946246|NCT00797862|3116845|P2|Overall Study|Administrative Problem|0
946247|NCT00797862|3116846|P1|Overall Study|Administrative Problem|4
946248|NCT00797862|3116844|P3|Overall Study|Lost to Follow-up|5
946249|NCT00797862|3116845|P2|Overall Study|Lost to Follow-up|0
946250|NCT00797862|3116846|P1|Overall Study|Lost to Follow-up|11
946251|NCT00797862|3116844|P3|Overall Study|Withdrawal by Subject|7
946252|NCT00797862|3116845|P2|Overall Study|Withdrawal by Subject|7
946253|NCT00797862|3116846|P1|Overall Study|Withdrawal by Subject|14
946254|NCT00797862|3116844|P3|Overall Study|No longer required study medication|0
946255|NCT00797862|3116845|P2|Overall Study|No longer required study medication|0
946256|NCT00797862|3116846|P1|Overall Study|No longer required study medication|1
946257|NCT00797862|3116844|P3|Overall Study|Lack of Efficacy|6
946258|NCT00797862|3116845|P2|Overall Study|Lack of Efficacy|7
946259|NCT00797862|3116846|P1|Overall Study|Lack of Efficacy|1
946260|NCT00797862|3116844|P3|Overall Study|Abnormal Test Procedure Result|1
946261|NCT00797862|3116845|P2|Overall Study|Abnormal Test Procedure Result|1
946262|NCT00797862|3116846|P1|Overall Study|Abnormal Test Procedure Result|0
946263|NCT00797862|3116844|P3|Overall Study|Adverse Event|58
946264|NCT00797862|3116845|P2|Overall Study|Adverse Event|44
946265|NCT00797862|3116846|P1|Overall Study|Adverse Event|86
946266|NCT00797823|3116875|P3|First Period (Initial Randomization)|Physician Decision|0
946267|NCT00797823|3116876|P2|First Period (Initial Randomization)|Physician Decision|0
946268|NCT00797823|3116877|P1|First Period (Initial Randomization)|Physician Decision|1
946269|NCT00797732|3116899|P3|Overall Study|Refused to Participate|123
946270|NCT00797732|3116900|P2|Overall Study|Refused to Participate|0
946271|NCT00797732|3116901|P1|Overall Study|Refused to Participate|0
946272|NCT00797732|3116899|P3|Overall Study|Excluded due to time constraints|24
946273|NCT00797732|3116900|P2|Overall Study|Excluded due to time constraints|0
946274|NCT00797732|3116901|P1|Overall Study|Excluded due to time constraints|0
946275|NCT00797732|3116899|P3|Overall Study|Not meet inclusion criteria|7
946276|NCT00797732|3116900|P2|Overall Study|Not meet inclusion criteria|0
946277|NCT00797732|3116901|P1|Overall Study|Not meet inclusion criteria|0
946278|NCT00797732|3116899|P3|Overall Study|Death|0
946279|NCT00797732|3116900|P2|Overall Study|Death|0
946280|NCT00797732|3116901|P1|Overall Study|Death|1
946281|NCT00797732|3116899|P3|Overall Study|Lost to Follow-up|0
946282|NCT00797732|3116900|P2|Overall Study|Lost to Follow-up|0
946283|NCT00797732|3116901|P1|Overall Study|Lost to Follow-up|1
946284|NCT00797732|3116899|P3|Overall Study|Withdrawal by Subject|0
946285|NCT00797732|3116900|P2|Overall Study|Withdrawal by Subject|3
946286|NCT00797732|3116901|P1|Overall Study|Withdrawal by Subject|3
946287|NCT00797667|3116916|P3|Overall Study|Adverse Event|8
946288|NCT00797667|3116917|P2|Overall Study|Adverse Event|8
946289|NCT00797667|3116918|P1|Overall Study|Adverse Event|19
946290|NCT00797667|3116916|P3|Overall Study|Withdrawal by Subject|2
946291|NCT00797667|3116917|P2|Overall Study|Withdrawal by Subject|14
946292|NCT00797667|3116918|P1|Overall Study|Withdrawal by Subject|9
946293|NCT00797667|3116916|P3|Overall Study|Study Terminated by Sponsor|115
946294|NCT00797667|3116917|P2|Overall Study|Study Terminated by Sponsor|216
946295|NCT00797667|3116918|P1|Overall Study|Study Terminated by Sponsor|217
946296|NCT00797667|3116916|P3|Overall Study|Protocol Violation|0
946297|NCT00797667|3116917|P2|Overall Study|Protocol Violation|7
946298|NCT00797667|3116918|P1|Overall Study|Protocol Violation|2
946299|NCT00797667|3116916|P3|Overall Study|Pregnancy|0
946300|NCT00797667|3116917|P2|Overall Study|Pregnancy|0
946301|NCT00797667|3116918|P1|Overall Study|Pregnancy|2
946302|NCT00797667|3116916|P3|Overall Study|Physician Decision|0
946303|NCT00797667|3116917|P2|Overall Study|Physician Decision|1
946304|NCT00797667|3116918|P1|Overall Study|Physician Decision|3
946305|NCT00797667|3116916|P3|Overall Study|Lost to Follow-up|2
946306|NCT00797667|3116917|P2|Overall Study|Lost to Follow-up|12
946307|NCT00797667|3116918|P1|Overall Study|Lost to Follow-up|8
946308|NCT00797667|3116916|P3|Overall Study|Lack of Efficacy|0
946309|NCT00797667|3116917|P2|Overall Study|Lack of Efficacy|1
946310|NCT00797667|3116918|P1|Overall Study|Lack of Efficacy|0
946311|NCT00797563|3116944|P1|Overall Study|Adverse Event|1
946312|NCT00797511|3116950|P1|Overall Study|Withdrawal by Subject|1
946313|NCT00797316|3116968|P2|Overall Study|Unsatisfactory therapeutic effect|13
946314|NCT00797316|3116969|P1|Overall Study|Unsatisfactory therapeutic effect|0
946315|NCT00797316|3116968|P2|Overall Study|Patient withdrew consent|6
946316|NCT00797316|3116969|P1|Overall Study|Patient withdrew consent|12
946317|NCT00797316|3116968|P2|Overall Study|Protocol Deviation|2
946318|NCT00797316|3116969|P1|Overall Study|Protocol Deviation|1
946319|NCT00797316|3116968|P2|Overall Study|Lost to Follow-up|8
946320|NCT00797316|3116969|P1|Overall Study|Lost to Follow-up|4
946321|NCT00797316|3116968|P2|Overall Study|Adverse Event|3
946322|NCT00797316|3116969|P1|Overall Study|Adverse Event|5
946323|NCT00797316|3116968|P2|Overall Study|Administrative problems|0
946324|NCT00797316|3116969|P1|Overall Study|Administrative problems|1
946325|NCT00797225|3116998|P8|Weeks 13 to 24|Sponsor Decision|0
946326|NCT00797225|3116999|P7|Weeks 13 to 24|Sponsor Decision|1
946327|NCT00797225|3117000|P6|Weeks 13 to 24|Sponsor Decision|0
946328|NCT00797225|3117001|P5|Weeks 13 to 24|Sponsor Decision|0
946329|NCT00797225|3117002|P4|Weeks 13 to 24|Sponsor Decision|0
946330|NCT00797225|3117003|P3|Weeks 13 to 24|Sponsor Decision|0
946331|NCT00797225|3117004|P2|Weeks 13 to 24|Sponsor Decision|0
946332|NCT00797225|3117005|P1|Weeks 13 to 24|Sponsor Decision|0
946333|NCT00797225|3116998|P8|Weeks 13 to 24|Adverse Event|0
946334|NCT00797225|3116999|P7|Weeks 13 to 24|Adverse Event|1
946335|NCT00797225|3117000|P6|Weeks 13 to 24|Adverse Event|0
946336|NCT00797225|3117001|P5|Weeks 13 to 24|Adverse Event|0
946337|NCT00797225|3117002|P4|Weeks 13 to 24|Adverse Event|0
946338|NCT00797225|3117003|P3|Weeks 13 to 24|Adverse Event|0
946339|NCT00797225|3117004|P2|Weeks 13 to 24|Adverse Event|1
946340|NCT00797225|3117005|P1|Weeks 13 to 24|Adverse Event|0
946341|NCT00797225|3116998|P8|Weeks 13 to 24|Lost to Follow-up|0
946342|NCT00797225|3116999|P7|Weeks 13 to 24|Lost to Follow-up|0
946343|NCT00797225|3117000|P6|Weeks 13 to 24|Lost to Follow-up|0
946344|NCT00797225|3117001|P5|Weeks 13 to 24|Lost to Follow-up|1
946345|NCT00797225|3117002|P4|Weeks 13 to 24|Lost to Follow-up|0
946346|NCT00797225|3117003|P3|Weeks 13 to 24|Lost to Follow-up|1
946347|NCT00797225|3117004|P2|Weeks 13 to 24|Lost to Follow-up|0
946348|NCT00797225|3117005|P1|Weeks 13 to 24|Lost to Follow-up|0
946349|NCT00797225|3116998|P8|Weeks 13 to 24|Withdrawal by Subject|0
946350|NCT00797225|3116999|P7|Weeks 13 to 24|Withdrawal by Subject|0
946351|NCT00797225|3117000|P6|Weeks 13 to 24|Withdrawal by Subject|0
946352|NCT00797225|3117001|P5|Weeks 13 to 24|Withdrawal by Subject|0
946353|NCT00797225|3117002|P4|Weeks 13 to 24|Withdrawal by Subject|0
946354|NCT00797225|3117003|P3|Weeks 13 to 24|Withdrawal by Subject|1
946355|NCT00797225|3117004|P2|Weeks 13 to 24|Withdrawal by Subject|1
946356|NCT00797225|3117005|P1|Weeks 13 to 24|Withdrawal by Subject|0
946357|NCT00797225|3116998|P8|Weeks 13 to 24|Non-compliance|0
946358|NCT00797225|3116999|P7|Weeks 13 to 24|Non-compliance|0
946359|NCT00797225|3117000|P6|Weeks 13 to 24|Non-compliance|0
946360|NCT00797225|3117001|P5|Weeks 13 to 24|Non-compliance|0
946361|NCT00797225|3117002|P4|Weeks 13 to 24|Non-compliance|0
946362|NCT00797225|3117003|P3|Weeks 13 to 24|Non-compliance|0
946363|NCT00797225|3117004|P2|Weeks 13 to 24|Non-compliance|2
946364|NCT00797225|3117005|P1|Weeks 13 to 24|Non-compliance|0
946365|NCT00797225|3116998|P8|Weeks 1 to 12|Sponsor Decision|0
946366|NCT00797225|3116999|P7|Weeks 1 to 12|Sponsor Decision|0
946367|NCT00797225|3117000|P6|Weeks 1 to 12|Sponsor Decision|0
946368|NCT00797225|3117001|P5|Weeks 1 to 12|Sponsor Decision|0
946369|NCT00797225|3117002|P4|Weeks 1 to 12|Sponsor Decision|0
946370|NCT00797225|3117003|P3|Weeks 1 to 12|Sponsor Decision|0
946371|NCT00797225|3117004|P2|Weeks 1 to 12|Sponsor Decision|0
946372|NCT00797225|3117005|P1|Weeks 1 to 12|Sponsor Decision|1
946373|NCT00797225|3116998|P8|Weeks 1 to 12|Lack of Efficacy|0
946374|NCT00797225|3116999|P7|Weeks 1 to 12|Lack of Efficacy|0
946375|NCT00797225|3117000|P6|Weeks 1 to 12|Lack of Efficacy|0
946376|NCT00797225|3117001|P5|Weeks 1 to 12|Lack of Efficacy|0
946377|NCT00797225|3117002|P4|Weeks 1 to 12|Lack of Efficacy|0
946378|NCT00797225|3117003|P3|Weeks 1 to 12|Lack of Efficacy|0
946379|NCT00797225|3117004|P2|Weeks 1 to 12|Lack of Efficacy|0
946380|NCT00797225|3117005|P1|Weeks 1 to 12|Lack of Efficacy|1
946381|NCT00797225|3116998|P8|Weeks 1 to 12|Non-compliance|0
946382|NCT00797225|3116999|P7|Weeks 1 to 12|Non-compliance|0
946383|NCT00797225|3117000|P6|Weeks 1 to 12|Non-compliance|0
946384|NCT00797225|3117001|P5|Weeks 1 to 12|Non-compliance|0
946385|NCT00797225|3117002|P4|Weeks 1 to 12|Non-compliance|0
946386|NCT00797225|3117003|P3|Weeks 1 to 12|Non-compliance|0
946387|NCT00797225|3117004|P2|Weeks 1 to 12|Non-compliance|1
946388|NCT00797225|3117005|P1|Weeks 1 to 12|Non-compliance|0
946389|NCT00797225|3116998|P8|Weeks 1 to 12|Adverse Event|0
946390|NCT00797225|3116999|P7|Weeks 1 to 12|Adverse Event|0
946391|NCT00797225|3117000|P6|Weeks 1 to 12|Adverse Event|0
946392|NCT00797225|3117001|P5|Weeks 1 to 12|Adverse Event|0
946393|NCT00797225|3117002|P4|Weeks 1 to 12|Adverse Event|0
946394|NCT00797225|3117003|P3|Weeks 1 to 12|Adverse Event|1
946395|NCT00797225|3117004|P2|Weeks 1 to 12|Adverse Event|0
946396|NCT00797225|3117005|P1|Weeks 1 to 12|Adverse Event|0
946397|NCT00797108|3117122|P3|Overall Study|Randomized but not Treated|0
946398|NCT00797108|3117123|P2|Overall Study|Randomized but not Treated|0
946399|NCT00797108|3117124|P1|Overall Study|Randomized but not Treated|2
946400|NCT00797108|3117122|P3|Overall Study|Other|2
946401|NCT00797108|3117123|P2|Overall Study|Other|0
946402|NCT00797108|3117124|P1|Overall Study|Other|0
946403|NCT00797108|3117122|P3|Overall Study|Lack of Efficacy|1
946404|NCT00797108|3117123|P2|Overall Study|Lack of Efficacy|0
946405|NCT00797108|3117124|P1|Overall Study|Lack of Efficacy|1
946406|NCT00797108|3117122|P3|Overall Study|Global Deterioration of Health Status|0
946407|NCT00797108|3117123|P2|Overall Study|Global Deterioration of Health Status|1
946408|NCT00797108|3117124|P1|Overall Study|Global Deterioration of Health Status|0
946409|NCT00797108|3117122|P3|Overall Study|Did Not Meet Entrance Criteria|0
946410|NCT00797108|3117123|P2|Overall Study|Did Not Meet Entrance Criteria|1
946411|NCT00797108|3117124|P1|Overall Study|Did Not Meet Entrance Criteria|0
946412|NCT00797108|3117122|P3|Overall Study|Adverse Event|3
946413|NCT00797108|3117123|P2|Overall Study|Adverse Event|0
946414|NCT00797108|3117124|P1|Overall Study|Adverse Event|1
946415|NCT00796991|3117159|P3|Overall Study|Withdrawal by Subject|1
946416|NCT00796991|3117160|P2|Overall Study|Withdrawal by Subject|0
946417|NCT00796991|3117161|P1|Overall Study|Withdrawal by Subject|0
946418|NCT00796991|3117159|P3|Overall Study|Study Drug Toxicity|5
946419|NCT00796991|3117160|P2|Overall Study|Study Drug Toxicity|3
946420|NCT00796991|3117161|P1|Overall Study|Study Drug Toxicity|3
946421|NCT00796991|3117159|P3|Overall Study|Disease Progression|7
946422|NCT00796991|3117160|P2|Overall Study|Disease Progression|9
946423|NCT00796991|3117161|P1|Overall Study|Disease Progression|10
946424|NCT00796991|3117159|P3|Overall Study|Death|0
946425|NCT00796991|3117160|P2|Overall Study|Death|0
946426|NCT00796991|3117161|P1|Overall Study|Death|2
946427|NCT00796991|3117159|P3|Overall Study|Adverse Event|1
946428|NCT00796991|3117160|P2|Overall Study|Adverse Event|0
946429|NCT00796991|3117161|P1|Overall Study|Adverse Event|0
946430|NCT00796861|3117268|P1|Overall Study|Death|2
946431|NCT00796861|3117268|P1|Overall Study|Withdrawal by Subject|2
946432|NCT00796822|3117274|P2|Overall Study|Adverse Event|0
946433|NCT00796822|3117275|P1|Overall Study|Adverse Event|1
946434|NCT00796822|3117274|P2|Overall Study|Lost to Follow-up|0
946435|NCT00796822|3117275|P1|Overall Study|Lost to Follow-up|2
946436|NCT00796757|3117283|P1|Overall Study|Not specified|7
946437|NCT00796757|3117283|P1|Overall Study|Investigator's decision|2
946438|NCT00796757|3117283|P1|Overall Study|Participant noncompliance|1
946439|NCT00796757|3117283|P1|Overall Study|Protocol Violation|1
946440|NCT00796757|3117283|P1|Overall Study|Death|61
946441|NCT00796757|3117283|P1|Overall Study|Withdrawal by Subject|14
946442|NCT00796718|3117317|P1|Overall Study|Withdrawal by Informed Consent|1
946443|NCT00796718|3117317|P1|Overall Study|Lost to Follow-up|5
946444|NCT00796718|3117317|P1|Overall Study|Exclusion Criteria|1
946445|NCT00796718|3117317|P1|Overall Study|Adverse Event|2
946446|NCT00796666|3117369|P2|Overall Study|Randomized and not treated|0
946447|NCT00796666|3117370|P1|Overall Study|Randomized and not treated|1
946448|NCT00796666|3117369|P2|Overall Study|Terminated by sponsor|55
946449|NCT00796666|3117370|P1|Overall Study|Terminated by sponsor|53
946450|NCT00796666|3117369|P2|Overall Study|Other|0
946451|NCT00796666|3117370|P1|Overall Study|Other|1
946452|NCT00796666|3117369|P2|Overall Study|Protocol Violation|0
946453|NCT00796666|3117370|P1|Overall Study|Protocol Violation|1
946454|NCT00796666|3117369|P2|Overall Study|Adverse Event|5
946455|NCT00796666|3117370|P1|Overall Study|Adverse Event|7
946456|NCT00796666|3117369|P2|Overall Study|Withdrawal by Subject|0
946457|NCT00796666|3117370|P1|Overall Study|Withdrawal by Subject|2
946458|NCT00796666|3117369|P2|Overall Study|Death|4
946459|NCT00796666|3117370|P1|Overall Study|Death|2
946460|NCT00796653|3117404|P4|Overall Study|Other reason not described above|4
946461|NCT00796653|3117405|P3|Overall Study|Other reason not described above|7
946462|NCT00796653|3117406|P2|Overall Study|Other reason not described above|9
946463|NCT00796653|3117407|P1|Overall Study|Other reason not described above|4
946464|NCT00796653|3117404|P4|Overall Study|Non compliance with protocol|2
946465|NCT00796653|3117405|P3|Overall Study|Non compliance with protocol|0
946466|NCT00796653|3117406|P2|Overall Study|Non compliance with protocol|2
946467|NCT00796653|3117407|P1|Overall Study|Non compliance with protocol|2
946468|NCT00796653|3117404|P4|Overall Study|Lack of Efficacy|2
946469|NCT00796653|3117405|P3|Overall Study|Lack of Efficacy|3
946470|NCT00796653|3117406|P2|Overall Study|Lack of Efficacy|1
946471|NCT00796653|3117407|P1|Overall Study|Lack of Efficacy|8
946472|NCT00796653|3117404|P4|Overall Study|Withdrawal by Subject|13
946473|NCT00796653|3117405|P3|Overall Study|Withdrawal by Subject|8
946474|NCT00796653|3117406|P2|Overall Study|Withdrawal by Subject|8
946475|NCT00796653|3117407|P1|Overall Study|Withdrawal by Subject|16
946476|NCT00796653|3117404|P4|Overall Study|Lost to Follow-up|3
946477|NCT00796653|3117405|P3|Overall Study|Lost to Follow-up|2
946478|NCT00796653|3117406|P2|Overall Study|Lost to Follow-up|1
946479|NCT00796653|3117407|P1|Overall Study|Lost to Follow-up|2
946480|NCT00796653|3117404|P4|Overall Study|Adverse Event|16
946481|NCT00796653|3117405|P3|Overall Study|Adverse Event|16
946482|NCT00796653|3117406|P2|Overall Study|Adverse Event|16
946483|NCT00796653|3117407|P1|Overall Study|Adverse Event|19
946484|NCT00796614|3117692|P4|Overall Study|Other than stated|0
946485|NCT00796614|3117693|P3|Overall Study|Other than stated|0
946486|NCT00796614|3117694|P2|Overall Study|Other than stated|0
946487|NCT00796614|3117695|P1|Overall Study|Other than stated|1
946488|NCT00796614|3117692|P4|Overall Study|Withdrawal by Subject|1
946489|NCT00796614|3117693|P3|Overall Study|Withdrawal by Subject|0
946490|NCT00796614|3117694|P2|Overall Study|Withdrawal by Subject|0
946491|NCT00796614|3117695|P1|Overall Study|Withdrawal by Subject|1
946492|NCT00796614|3117692|P4|Overall Study|Lost to Follow-up|0
946493|NCT00796614|3117693|P3|Overall Study|Lost to Follow-up|1
946494|NCT00796614|3117694|P2|Overall Study|Lost to Follow-up|2
946495|NCT00796614|3117695|P1|Overall Study|Lost to Follow-up|2
946496|NCT00796614|3117692|P4|Overall Study|Protocol Violation|0
946497|NCT00796614|3117693|P3|Overall Study|Protocol Violation|2
946498|NCT00796614|3117694|P2|Overall Study|Protocol Violation|0
946499|NCT00796614|3117695|P1|Overall Study|Protocol Violation|0
946500|NCT00796614|3117692|P4|Overall Study|Adverse Event|0
946501|NCT00796614|3117693|P3|Overall Study|Adverse Event|0
946502|NCT00796614|3117694|P2|Overall Study|Adverse Event|2
946503|NCT00796614|3117695|P1|Overall Study|Adverse Event|1
946504|NCT00796549|3117737|P1|Overall Study|Progressive disease|56
946505|NCT00796549|3117737|P1|Overall Study|Other|2
946506|NCT00796549|3117737|P1|Overall Study|not entered|149
946507|NCT00796549|3117737|P1|Overall Study|Adverse Event|11
946508|NCT00796523|3117754|P2|Overall Study|Lost to Follow-up|7
946509|NCT00796523|3117755|P1|Overall Study|Lost to Follow-up|9
946510|NCT00796510|3117765|P2|Overall Study|Study Terminated|0
946511|NCT00796510|3117766|P1|Overall Study|Study Terminated|2
946512|NCT00796510|3117765|P2|Overall Study|Death|0
946513|NCT00796510|3117766|P1|Overall Study|Death|1
946514|NCT00796419|3117778|P2|Overall Study|Death|1
946515|NCT00796419|3117779|P1|Overall Study|Death|0
946516|NCT00796367|3117792|P3|Overall Study|other|3
946517|NCT00796367|3117793|P2|Overall Study|other|4
946518|NCT00796367|3117794|P1|Overall Study|other|2
946519|NCT00796367|3117792|P3|Overall Study|Requirement for restricted medication|2
946520|NCT00796367|3117793|P2|Overall Study|Requirement for restricted medication|0
946521|NCT00796367|3117794|P1|Overall Study|Requirement for restricted medication|2
946522|NCT00796367|3117792|P3|Overall Study|Pregnancy|1
946523|NCT00796367|3117793|P2|Overall Study|Pregnancy|0
946524|NCT00796367|3117794|P1|Overall Study|Pregnancy|1
946525|NCT00796367|3117792|P3|Overall Study|non compliance|1
946526|NCT00796367|3117793|P2|Overall Study|non compliance|1
946527|NCT00796367|3117794|P1|Overall Study|non compliance|3
946528|NCT00796367|3117792|P3|Overall Study|Lack of Efficacy|0
946529|NCT00796367|3117793|P2|Overall Study|Lack of Efficacy|1
946530|NCT00796367|3117794|P1|Overall Study|Lack of Efficacy|2
946531|NCT00796367|3117792|P3|Overall Study|Withdrawal by Subject|12
946532|NCT00796367|3117793|P2|Overall Study|Withdrawal by Subject|11
946533|NCT00796367|3117794|P1|Overall Study|Withdrawal by Subject|9
946534|NCT00796367|3117792|P3|Overall Study|Lost to Follow-up|21
946535|NCT00796367|3117793|P2|Overall Study|Lost to Follow-up|4
946536|NCT00796367|3117794|P1|Overall Study|Lost to Follow-up|5
946537|NCT00796367|3117792|P3|Overall Study|Adverse Event|7
946538|NCT00796367|3117793|P2|Overall Study|Adverse Event|4
946539|NCT00796367|3117794|P1|Overall Study|Adverse Event|6
946540|NCT00796328|3117805|P1|Overall Study|experienced hypotension requiring tx|6
946541|NCT00796315|3117809|P3|Overall Study|Protocol Violation|0
946542|NCT00796315|3117810|P2|Overall Study|Protocol Violation|1
946543|NCT00796315|3117811|P1|Overall Study|Protocol Violation|0
946544|NCT00796224|3117839|P2|Overall Study|Protocol Violation|1
946545|NCT00796224|3117840|P1|Overall Study|Protocol Violation|0
946546|NCT00796224|3117839|P2|Overall Study|Adverse Event|0
946547|NCT00796224|3117840|P1|Overall Study|Adverse Event|1
946548|NCT00796120|3117860|P2|Overall Study|Randomized but not treated|3
946549|NCT00796120|3117861|P1|Overall Study|Randomized but not treated|0
946550|NCT00796120|3117860|P2|Overall Study|Physician Decision|17
946551|NCT00796120|3117861|P1|Overall Study|Physician Decision|16
946552|NCT00796120|3117860|P2|Overall Study|Other|17
946553|NCT00796120|3117861|P1|Overall Study|Other|6
946554|NCT00796120|3117860|P2|Overall Study|Participant refusal|4
946555|NCT00796120|3117861|P1|Overall Study|Participant refusal|3
946556|NCT00796120|3117860|P2|Overall Study|Progressive disease|13
946557|NCT00796120|3117861|P1|Overall Study|Progressive disease|22
946558|NCT00796120|3117860|P2|Overall Study|Adverse Event|6
946559|NCT00796120|3117861|P1|Overall Study|Adverse Event|11
946560|NCT00796120|3117860|P2|Overall Study|Death|0
946561|NCT00796120|3117861|P1|Overall Study|Death|3
946562|NCT00796003|3117877|P2|Overall Study|Participants Not treated|2
946563|NCT00796003|3117878|P1|Overall Study|Participants Not treated|0
946564|NCT00796003|3117877|P2|Overall Study|Other|1
946565|NCT00796003|3117878|P1|Overall Study|Other|0
946566|NCT00796003|3117877|P2|Overall Study|Withdrawal by Subject|1
946567|NCT00796003|3117878|P1|Overall Study|Withdrawal by Subject|0
946568|NCT00796003|3117877|P2|Overall Study|Physician Decision|4
946569|NCT00796003|3117878|P1|Overall Study|Physician Decision|0
946570|NCT00796003|3117877|P2|Overall Study|Specified organ function not met|1
946571|NCT00796003|3117878|P1|Overall Study|Specified organ function not met|0
946572|NCT00796003|3117877|P2|Overall Study|Adverse Event|7
946573|NCT00796003|3117878|P1|Overall Study|Adverse Event|1
946574|NCT00796003|3117877|P2|Overall Study|Disease Progression|13
946575|NCT00796003|3117878|P1|Overall Study|Disease Progression|2
946576|NCT00795951|3117899|P1|Overall Study|Withdrawal by Subject|1
946577|NCT00795951|3117899|P1|Overall Study|Lost to Follow-up|1
946578|NCT00795886|3117936|P1|Overall Study|Death|10
946579|NCT00795821|3117944|P2|Taper Phase|Withdrawal by Subject|0
946580|NCT00795821|3117945|P1|Taper Phase|Withdrawal by Subject|4
946581|NCT00795821|3117944|P2|Taper Phase|Physician Decision|0
946582|NCT00795821|3117945|P1|Taper Phase|Physician Decision|2
946583|NCT00795821|3117944|P2|Taper Phase|Lost to Follow-up|0
946584|NCT00795821|3117945|P1|Taper Phase|Lost to Follow-up|1
946585|NCT00795821|3117944|P2|Taper Phase|Adverse Event|0
946586|NCT00795821|3117945|P1|Taper Phase|Adverse Event|2
946587|NCT00795821|3117944|P2|Long-term Extension Phase|Withdrawal by Subject|25
946588|NCT00795821|3117945|P1|Long-term Extension Phase|Withdrawal by Subject|25
946589|NCT00795821|3117944|P2|Long-term Extension Phase|Protocol Violation|5
946590|NCT00795821|3117945|P1|Long-term Extension Phase|Protocol Violation|3
946591|NCT00795821|3117944|P2|Long-term Extension Phase|Physician Decision|2
946592|NCT00795821|3117945|P1|Long-term Extension Phase|Physician Decision|1
946593|NCT00795821|3117944|P2|Long-term Extension Phase|Lost to Follow-up|16
946594|NCT00795821|3117945|P1|Long-term Extension Phase|Lost to Follow-up|20
946595|NCT00795821|3117944|P2|Long-term Extension Phase|Lack of Efficacy|12
946596|NCT00795821|3117945|P1|Long-term Extension Phase|Lack of Efficacy|16
946597|NCT00795821|3117944|P2|Long-term Extension Phase|Adverse Event|32
946598|NCT00795821|3117945|P1|Long-term Extension Phase|Adverse Event|25
946599|NCT00795821|3117944|P2|Acute Treatment Phase|Withdrawal by Subject|10
946600|NCT00795821|3117945|P1|Acute Treatment Phase|Withdrawal by Subject|16
946601|NCT00795821|3117944|P2|Acute Treatment Phase|Protocol Violation|2
946602|NCT00795821|3117945|P1|Acute Treatment Phase|Protocol Violation|1
946603|NCT00795821|3117944|P2|Acute Treatment Phase|Physician Decision|1
946604|NCT00795821|3117945|P1|Acute Treatment Phase|Physician Decision|1
946605|NCT00795821|3117944|P2|Acute Treatment Phase|Lost to Follow-up|12
946606|NCT00795821|3117945|P1|Acute Treatment Phase|Lost to Follow-up|9
946607|NCT00795821|3117944|P2|Acute Treatment Phase|Lack of Efficacy|2
946608|NCT00795821|3117945|P1|Acute Treatment Phase|Lack of Efficacy|5
946609|NCT00795821|3117944|P2|Acute Treatment Phase|Death|0
946610|NCT00795821|3117945|P1|Acute Treatment Phase|Death|1
946611|NCT00795821|3117944|P2|Acute Treatment Phase|Adverse Event|4
946612|NCT00795821|3117945|P1|Acute Treatment Phase|Adverse Event|23
946613|NCT00795717|3118020|P2|Phase II|too busy|1
946614|NCT00795717|3118021|P1|Phase II|too busy|0
946615|NCT00795717|3118020|P2|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1
946616|NCT00795717|3118021|P1|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0
946617|NCT00795717|3118020|P2|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
946618|NCT00795717|3118021|P1|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
946619|NCT00795717|3118020|P2|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0
946620|NCT00795717|3118021|P1|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1
946621|NCT00795704|3118033|P2|Overall Study|Adverse Event|1
946622|NCT00795704|3118034|P1|Overall Study|Adverse Event|1
946623|NCT00795704|3118033|P2|Overall Study|Withdrawal by Subject|2
946624|NCT00795704|3118034|P1|Overall Study|Withdrawal by Subject|3
946625|NCT00795639|3118046|P2|Overall Study|Randomized and not treated|1
946626|NCT00795639|3118047|P1|Overall Study|Randomized and not treated|0
946627|NCT00795639|3118046|P2|Overall Study|Terminated by sponsor|12
946628|NCT00795639|3118047|P1|Overall Study|Terminated by sponsor|13
946629|NCT00795639|3118046|P2|Overall Study|Other|2
946630|NCT00795639|3118047|P1|Overall Study|Other|0
946631|NCT00795639|3118046|P2|Overall Study|Adverse Event|2
946632|NCT00795639|3118047|P1|Overall Study|Adverse Event|5
946633|NCT00795639|3118046|P2|Overall Study|Pregnancy|0
946634|NCT00795639|3118047|P1|Overall Study|Pregnancy|1
946635|NCT00795639|3118046|P2|Overall Study|Withdrawal by Subject|3
946636|NCT00795639|3118047|P1|Overall Study|Withdrawal by Subject|1
946637|NCT00795639|3118046|P2|Overall Study|Death|6
946638|NCT00795639|3118047|P1|Overall Study|Death|1
946639|NCT00795600|3118059|P2|Overall Study|Unclassified|1
946640|NCT00795600|3118060|P1|Overall Study|Unclassified|1
946641|NCT00795600|3118059|P2|Overall Study|Withdrawal by Subject|0
946642|NCT00795600|3118060|P1|Overall Study|Withdrawal by Subject|1
946643|NCT00795600|3118059|P2|Overall Study|Protocol Violation|2
946644|NCT00795600|3118060|P1|Overall Study|Protocol Violation|1
946645|NCT00795600|3118059|P2|Overall Study|Adverse Event|1
946646|NCT00795600|3118060|P1|Overall Study|Adverse Event|1
946647|NCT00795535|3118180|P1|Overall Study|incomplete data and technical problems|20
946648|NCT00795509|3118187|P1|Overall Study|Protocol Violation|31
946649|NCT00795184|3118243|P2|Overall Study|Tissue sampling incomplete/conclusive|13
946650|NCT00795184|3118244|P1|Overall Study|Tissue sampling incomplete/conclusive|8
946651|NCT00795132|3118305|P1|Overall Study|Relapse|2
946652|NCT00795132|3118305|P1|Overall Study|Death|1
946653|NCT00794963|3118332|P2|Overall Study|Withdrawal by Subject|4
946654|NCT00794963|3118333|P1|Overall Study|Withdrawal by Subject|1
946655|NCT00794924|3118341|P2|Overall Study|Adverse Event|2
946656|NCT00794924|3118342|P1|Overall Study|Adverse Event|6
946657|NCT00794924|3118341|P2|Overall Study|Withdrawal by Subject|60
946658|NCT00794924|3118342|P1|Overall Study|Withdrawal by Subject|48
946659|NCT00794924|3118341|P2|Overall Study|Lost to Follow-up|8
946660|NCT00794924|3118342|P1|Overall Study|Lost to Follow-up|6
946661|NCT00794820|3118346|P1|Overall Study|Ineligible/Screen Failure|1
946662|NCT00794820|3118346|P1|Overall Study|Resistant Disease|2
946663|NCT00794820|3118346|P1|Overall Study|Secondary Malignancies|2
946664|NCT00794820|3118346|P1|Overall Study|Adverse Event|11
946665|NCT00794677|3118354|P2|First Intervention|Withdrawal by Subject|0
946666|NCT00794677|3118355|P1|First Intervention|Withdrawal by Subject|2
946667|NCT00794664|3118377|P2|Follow-up Period|Protocol non-compliance|1
946668|NCT00794664|3118378|P1|Follow-up Period|Protocol non-compliance|0
946669|NCT00794664|3118377|P2|Follow-up Period|Withdrawal by Subject|2
946670|NCT00794664|3118378|P1|Follow-up Period|Withdrawal by Subject|0
946671|NCT00794664|3118377|P2|Follow-up Period|Not specified|2
946672|NCT00794664|3118378|P1|Follow-up Period|Not specified|1
946673|NCT00794664|3118377|P2|Treatment Period|Adverse Event|8
946674|NCT00794664|3118378|P1|Treatment Period|Adverse Event|1
946675|NCT00794664|3118377|P2|Treatment Period|Not specified|1
946676|NCT00794664|3118378|P1|Treatment Period|Not specified|0
946677|NCT00794664|3118377|P2|Treatment Period|Protocol non-compliance|1
946678|NCT00794664|3118378|P1|Treatment Period|Protocol non-compliance|0
946679|NCT00794664|3118377|P2|Treatment Period|Withdrawal by Subject|2
946680|NCT00794664|3118378|P1|Treatment Period|Withdrawal by Subject|0
946681|NCT00794365|3118463|P1|Overall Study|Lack of Efficacy|3
946682|NCT00794365|3118463|P1|Overall Study|Adverse Event|10
946683|NCT00794365|3118463|P1|Overall Study|Poor Compliance|11
946684|NCT00794365|3118463|P1|Overall Study|Other|17
946685|NCT00794365|3118463|P1|Overall Study|Lost to Follow-up|38
946686|NCT00794196|3118484|P2|Overall Study|Lost to Follow-up|23
946687|NCT00794196|3118485|P1|Overall Study|Lost to Follow-up|5
946688|NCT00794157|3118505|P3|Overall Study|Protocol deviation|1
946689|NCT00794157|3118506|P2|Overall Study|Protocol deviation|1
946690|NCT00794157|3118507|P1|Overall Study|Protocol deviation|0
946691|NCT00794157|3118505|P3|Overall Study|Abnormal test procedure result(s)|0
946692|NCT00794157|3118506|P2|Overall Study|Abnormal test procedure result(s)|1
946693|NCT00794157|3118507|P1|Overall Study|Abnormal test procedure result(s)|0
946694|NCT00794157|3118505|P3|Overall Study|Administrative problems|4
946695|NCT00794157|3118506|P2|Overall Study|Administrative problems|7
946696|NCT00794157|3118507|P1|Overall Study|Administrative problems|1
946697|NCT00794157|3118505|P3|Overall Study|Unsatisfactory therapeutic effect|2
946698|NCT00794157|3118506|P2|Overall Study|Unsatisfactory therapeutic effect|0
946699|NCT00794157|3118507|P1|Overall Study|Unsatisfactory therapeutic effect|1
946700|NCT00794157|3118505|P3|Overall Study|Lost to Follow-up|1
946701|NCT00794157|3118506|P2|Overall Study|Lost to Follow-up|0
946702|NCT00794157|3118507|P1|Overall Study|Lost to Follow-up|2
946703|NCT00794157|3118505|P3|Overall Study|Subject withdrew consent|3
946704|NCT00794157|3118506|P2|Overall Study|Subject withdrew consent|0
946705|NCT00794157|3118507|P1|Overall Study|Subject withdrew consent|2
946706|NCT00794157|3118505|P3|Overall Study|Adverse Event|8
946707|NCT00794157|3118506|P2|Overall Study|Adverse Event|1
946708|NCT00794157|3118507|P1|Overall Study|Adverse Event|4
946709|NCT00794118|3118536|P1|Overall Study|Changed hospital center|2
946710|NCT00794118|3118536|P1|Overall Study|Withdrawal by Subject|9
946711|NCT00794118|3118536|P1|Overall Study|Lost to Follow-up|16
946712|NCT00793910|3118594|P2|Overall Study|Withdrawal by Subject|1
946713|NCT00793910|3118595|P1|Overall Study|Withdrawal by Subject|0
946714|NCT00793910|3118594|P2|Overall Study|decided to undergo LASIK instead of PRK|1
946715|NCT00793910|3118595|P1|Overall Study|decided to undergo LASIK instead of PRK|2
946716|NCT00793910|3118594|P2|Overall Study|ineligible based on entry criteria|3
946717|NCT00793910|3118595|P1|Overall Study|ineligible based on entry criteria|2
946718|NCT00793910|3118594|P2|Overall Study|did not pick up medications|1
946719|NCT00793910|3118595|P1|Overall Study|did not pick up medications|1
946720|NCT00793910|3118594|P2|Overall Study|discarded study pills|1
946721|NCT00793910|3118595|P1|Overall Study|discarded study pills|0
946722|NCT00793871|3118609|P1|Overall Study|Study terminated by the Sponsor|7
946723|NCT00793871|3118609|P1|Overall Study|Lost to Follow-up|3
946724|NCT00793871|3118609|P1|Overall Study|Death|50
946725|NCT00793819|3118623|P2|Overall Study|Lost to Follow-up|1
946726|NCT00793819|3118624|P1|Overall Study|Lost to Follow-up|1
946727|NCT00793819|3118623|P2|Overall Study|Withdrawal by Subject|3
946728|NCT00793819|3118624|P1|Overall Study|Withdrawal by Subject|4
946729|NCT00793819|3118623|P2|Overall Study|Lack of Efficacy|1
946730|NCT00793819|3118624|P1|Overall Study|Lack of Efficacy|1
946731|NCT00793819|3118623|P2|Overall Study|Adverse Event|4
946732|NCT00793819|3118624|P1|Overall Study|Adverse Event|8
946733|NCT00793793|3118642|P12|Overall Study|reason not specified|4
946734|NCT00793793|3118643|P11|Overall Study|reason not specified|2
946735|NCT00793793|3118644|P10|Overall Study|reason not specified|6
946736|NCT00793793|3118645|P9|Overall Study|reason not specified|7
946737|NCT00793793|3118646|P8|Overall Study|reason not specified|0
946738|NCT00793793|3118647|P7|Overall Study|reason not specified|2
946739|NCT00793793|3118648|P6|Overall Study|reason not specified|1
946740|NCT00793793|3118649|P5|Overall Study|reason not specified|1
946741|NCT00793793|3118650|P4|Overall Study|reason not specified|1
946742|NCT00793793|3118651|P3|Overall Study|reason not specified|0
946743|NCT00793793|3118652|P2|Overall Study|reason not specified|1
946744|NCT00793793|3118653|P1|Overall Study|reason not specified|0
946745|NCT00793793|3118642|P12|Overall Study|Withdrawal by Subject|0
946746|NCT00793793|3118643|P11|Overall Study|Withdrawal by Subject|0
946747|NCT00793793|3118644|P10|Overall Study|Withdrawal by Subject|0
946748|NCT00793793|3118645|P9|Overall Study|Withdrawal by Subject|1
946749|NCT00793793|3118646|P8|Overall Study|Withdrawal by Subject|0
946750|NCT00793793|3118647|P7|Overall Study|Withdrawal by Subject|0
946751|NCT00793793|3118648|P6|Overall Study|Withdrawal by Subject|0
946752|NCT00793793|3118649|P5|Overall Study|Withdrawal by Subject|1
946753|NCT00793793|3118650|P4|Overall Study|Withdrawal by Subject|0
946754|NCT00793793|3118651|P3|Overall Study|Withdrawal by Subject|0
946755|NCT00793793|3118652|P2|Overall Study|Withdrawal by Subject|0
946756|NCT00793793|3118653|P1|Overall Study|Withdrawal by Subject|0
946757|NCT00793793|3118642|P12|Overall Study|Lost to Follow-up|0
946758|NCT00793793|3118643|P11|Overall Study|Lost to Follow-up|1
946759|NCT00793793|3118644|P10|Overall Study|Lost to Follow-up|3
946760|NCT00793793|3118645|P9|Overall Study|Lost to Follow-up|1
946761|NCT00793793|3118646|P8|Overall Study|Lost to Follow-up|0
946762|NCT00793793|3118647|P7|Overall Study|Lost to Follow-up|0
946763|NCT00793793|3118648|P6|Overall Study|Lost to Follow-up|0
946764|NCT00793793|3118649|P5|Overall Study|Lost to Follow-up|0
946765|NCT00793793|3118650|P4|Overall Study|Lost to Follow-up|0
946766|NCT00793793|3118651|P3|Overall Study|Lost to Follow-up|1
946767|NCT00793793|3118652|P2|Overall Study|Lost to Follow-up|0
946768|NCT00793793|3118653|P1|Overall Study|Lost to Follow-up|0
946769|NCT00793793|3118642|P12|Overall Study|Protocol Violation|0
946770|NCT00793793|3118643|P11|Overall Study|Protocol Violation|0
946771|NCT00793793|3118644|P10|Overall Study|Protocol Violation|0
946772|NCT00793793|3118645|P9|Overall Study|Protocol Violation|0
946773|NCT00793793|3118646|P8|Overall Study|Protocol Violation|0
946774|NCT00793793|3118647|P7|Overall Study|Protocol Violation|0
946775|NCT00793793|3118648|P6|Overall Study|Protocol Violation|0
946776|NCT00793793|3118649|P5|Overall Study|Protocol Violation|0
946777|NCT00793793|3118650|P4|Overall Study|Protocol Violation|1
946778|NCT00793793|3118651|P3|Overall Study|Protocol Violation|0
946779|NCT00793793|3118652|P2|Overall Study|Protocol Violation|0
946780|NCT00793793|3118653|P1|Overall Study|Protocol Violation|0
946781|NCT00793793|3118642|P12|Overall Study|Adverse Event|2
946782|NCT00793793|3118643|P11|Overall Study|Adverse Event|0
946783|NCT00793793|3118644|P10|Overall Study|Adverse Event|0
946784|NCT00793793|3118645|P9|Overall Study|Adverse Event|0
946785|NCT00793793|3118646|P8|Overall Study|Adverse Event|0
946786|NCT00793793|3118647|P7|Overall Study|Adverse Event|2
946787|NCT00793793|3118648|P6|Overall Study|Adverse Event|1
946788|NCT00793793|3118649|P5|Overall Study|Adverse Event|0
946789|NCT00793793|3118650|P4|Overall Study|Adverse Event|1
946790|NCT00793793|3118651|P3|Overall Study|Adverse Event|1
946791|NCT00793793|3118652|P2|Overall Study|Adverse Event|0
946792|NCT00793793|3118653|P1|Overall Study|Adverse Event|0
946793|NCT00793780|3119028|P2|Overall Study|Withdrawal by Subject|1
946794|NCT00793780|3119029|P1|Overall Study|Withdrawal by Subject|2
946795|NCT00793624|3119060|P4|Overall Study|Other reason not described above|3
946796|NCT00793624|3119061|P3|Overall Study|Other reason not described above|6
946797|NCT00793624|3119062|P2|Overall Study|Other reason not described above|4
946798|NCT00793624|3119063|P1|Overall Study|Other reason not described above|6
946799|NCT00793624|3119060|P4|Overall Study|Non compliance with protocol|3
946800|NCT00793624|3119061|P3|Overall Study|Non compliance with protocol|2
946801|NCT00793624|3119062|P2|Overall Study|Non compliance with protocol|3
946802|NCT00793624|3119063|P1|Overall Study|Non compliance with protocol|2
946803|NCT00793624|3119060|P4|Overall Study|Lack of Efficacy|3
946804|NCT00793624|3119061|P3|Overall Study|Lack of Efficacy|1
946805|NCT00793624|3119062|P2|Overall Study|Lack of Efficacy|2
946806|NCT00793624|3119063|P1|Overall Study|Lack of Efficacy|9
946807|NCT00793624|3119060|P4|Overall Study|Withdrawal by Subject|14
946808|NCT00793624|3119061|P3|Overall Study|Withdrawal by Subject|11
946809|NCT00793624|3119062|P2|Overall Study|Withdrawal by Subject|9
946810|NCT00793624|3119063|P1|Overall Study|Withdrawal by Subject|20
946811|NCT00793624|3119060|P4|Overall Study|Lost to Follow-up|0
946812|NCT00793624|3119061|P3|Overall Study|Lost to Follow-up|4
946813|NCT00793624|3119062|P2|Overall Study|Lost to Follow-up|2
946814|NCT00793624|3119063|P1|Overall Study|Lost to Follow-up|2
946815|NCT00793624|3119060|P4|Overall Study|Adverse Event|20
946816|NCT00793624|3119061|P3|Overall Study|Adverse Event|15
946817|NCT00793624|3119062|P2|Overall Study|Adverse Event|16
946818|NCT00793624|3119063|P1|Overall Study|Adverse Event|18
946819|NCT00793585|3119344|P2|Overall Study|Protocol Violation|2
946820|NCT00793585|3119345|P1|Overall Study|Protocol Violation|1
946821|NCT00793585|3119344|P2|Overall Study|Adverse Event|1
946822|NCT00793585|3119345|P1|Overall Study|Adverse Event|1
946823|NCT00793546|3119364|P2|Overall Study|Other|0
946824|NCT00793546|3119365|P1|Overall Study|Other|1
946825|NCT00793546|3119364|P2|Overall Study|Study Terminated by Sponsor|27
946826|NCT00793546|3119365|P1|Overall Study|Study Terminated by Sponsor|8
946827|NCT00793546|3119364|P2|Overall Study|Withdrawal by Subject|1
946828|NCT00793546|3119365|P1|Overall Study|Withdrawal by Subject|1
946829|NCT00793546|3119364|P2|Overall Study|Lost to Follow-up|0
946830|NCT00793546|3119365|P1|Overall Study|Lost to Follow-up|1
946831|NCT00793546|3119364|P2|Overall Study|Death|0
946832|NCT00793546|3119365|P1|Overall Study|Death|3
946833|NCT00793403|3119415|P1|Overall Study|Other|73
946834|NCT00793325|3119462|P1|Overall Study|Lost to Follow-up|1
946835|NCT00793325|3119462|P1|Overall Study|Protocol Violation|18
946836|NCT00793104|3119494|P1|Overall Study|Lost to Follow-up|1
946837|NCT00792948|3119502|P1|Overall Study|Protocol Violation|1
946838|NCT00792948|3119502|P1|Overall Study|Physician Decision|11
946839|NCT00792948|3119502|P1|Overall Study|Insurance denial - not treated|1
946840|NCT00792948|3119502|P1|Overall Study|Ineligible|2
946841|NCT00792948|3119502|P1|Overall Study|Withdrawal by Subject|3
946842|NCT00792948|3119502|P1|Overall Study|Death|4
946843|NCT00792948|3119502|P1|Overall Study|Adverse Event|6
946844|NCT00792935|3119513|P2|Overall Study|Withdrawal by Subject|1
946845|NCT00792935|3119514|P1|Overall Study|Withdrawal by Subject|0
946846|NCT00792935|3119513|P2|Overall Study|Protocol Violation|0
946847|NCT00792935|3119514|P1|Overall Study|Protocol Violation|2
946848|NCT00792935|3119513|P2|Overall Study|Lost to Follow-up|1
946849|NCT00792935|3119514|P1|Overall Study|Lost to Follow-up|0
946850|NCT00792935|3119513|P2|Overall Study|Adverse Event|1
946851|NCT00792935|3119514|P1|Overall Study|Adverse Event|2
946852|NCT00792909|3119546|P3|Overall Study|Withdrawal by Subject|0
946853|NCT00792909|3119547|P2|Overall Study|Withdrawal by Subject|1
946854|NCT00792909|3119548|P1|Overall Study|Withdrawal by Subject|0
946855|NCT00792805|3119604|P3|Overall Study|Protocol deviation|1
946856|NCT00792805|3119605|P2|Overall Study|Protocol deviation|1
946857|NCT00792805|3119606|P1|Overall Study|Protocol deviation|0
946858|NCT00792805|3119604|P3|Overall Study|Abnormal laboratory value(s)|1
946859|NCT00792805|3119605|P2|Overall Study|Abnormal laboratory value(s)|0
946860|NCT00792805|3119606|P1|Overall Study|Abnormal laboratory value(s)|0
946861|NCT00792805|3119604|P3|Overall Study|Lost to Follow-up|6
946862|NCT00792805|3119605|P2|Overall Study|Lost to Follow-up|1
946863|NCT00792805|3119606|P1|Overall Study|Lost to Follow-up|1
946864|NCT00792805|3119604|P3|Overall Study|Unsatisfactory therapeutic effect|6
946865|NCT00792805|3119605|P2|Overall Study|Unsatisfactory therapeutic effect|6
946866|NCT00792805|3119606|P1|Overall Study|Unsatisfactory therapeutic effect|1
946867|NCT00792805|3119604|P3|Overall Study|Abnormal test procedure result(s)|0
946868|NCT00792805|3119605|P2|Overall Study|Abnormal test procedure result(s)|2
946869|NCT00792805|3119606|P1|Overall Study|Abnormal test procedure result(s)|1
946870|NCT00792805|3119604|P3|Overall Study|Administrative problems|4
946871|NCT00792805|3119605|P2|Overall Study|Administrative problems|0
946872|NCT00792805|3119606|P1|Overall Study|Administrative problems|2
946873|NCT00792805|3119604|P3|Overall Study|Subject withdrew consent|5
946874|NCT00792805|3119605|P2|Overall Study|Subject withdrew consent|6
946875|NCT00792805|3119606|P1|Overall Study|Subject withdrew consent|5
946876|NCT00792805|3119604|P3|Overall Study|Adverse Event|10
946877|NCT00792805|3119605|P2|Overall Study|Adverse Event|10
946878|NCT00792805|3119606|P1|Overall Study|Adverse Event|12
946879|NCT00792701|3119616|P2|Overall Study|Not protocol specified|0
946880|NCT00792701|3119617|P1|Overall Study|Not protocol specified|17
946881|NCT00792701|3119616|P2|Overall Study|Withdrawal by Subject|19
946882|NCT00792701|3119617|P1|Overall Study|Withdrawal by Subject|1
946883|NCT00792701|3119616|P2|Overall Study|Ineligible|3
946884|NCT00792701|3119617|P1|Overall Study|Ineligible|1
946885|NCT00792701|3119616|P2|Overall Study|Adverse Event|22
946886|NCT00792701|3119617|P1|Overall Study|Adverse Event|0
946887|NCT00792636|3119647|P3|Overall Study|Investigator Discretion|2
946888|NCT00792636|3119648|P2|Overall Study|Investigator Discretion|0
946889|NCT00792636|3119649|P1|Overall Study|Investigator Discretion|2
946890|NCT00792636|3119647|P3|Overall Study|Adverse Event|3
946891|NCT00792636|3119648|P2|Overall Study|Adverse Event|2
946892|NCT00792636|3119649|P1|Overall Study|Adverse Event|4
946893|NCT00792636|3119647|P3|Overall Study|Lack of Efficacy|13
946894|NCT00792636|3119648|P2|Overall Study|Lack of Efficacy|4
946895|NCT00792636|3119649|P1|Overall Study|Lack of Efficacy|3
946896|NCT00792636|3119647|P3|Overall Study|Withdrew Consent|9
946897|NCT00792636|3119648|P2|Overall Study|Withdrew Consent|13
946898|NCT00792636|3119649|P1|Overall Study|Withdrew Consent|10
946899|NCT00792636|3119647|P3|Overall Study|Lost to Follow-up|14
946900|NCT00792636|3119648|P2|Overall Study|Lost to Follow-up|19
946901|NCT00792636|3119649|P1|Overall Study|Lost to Follow-up|13
946902|NCT00792636|3119647|P3|Overall Study|Met Protocol-defined Stopping Criteria|20
946903|NCT00792636|3119648|P2|Overall Study|Met Protocol-defined Stopping Criteria|20
946904|NCT00792636|3119649|P1|Overall Study|Met Protocol-defined Stopping Criteria|19
946905|NCT00792636|3119647|P3|Overall Study|Protocol Violation|20
946906|NCT00792636|3119648|P2|Overall Study|Protocol Violation|23
946907|NCT00792636|3119649|P1|Overall Study|Protocol Violation|17
946908|NCT00792623|3119686|P1|Overall Study|Withdrawal by Subject|5
946909|NCT00792623|3119686|P1|Overall Study|Adverse Event|2
946910|NCT00792298|3119714|P8|Treatment Period 2|Withdrawal by Subject|2
946911|NCT00792298|3119715|P7|Treatment Period 2|Withdrawal by Subject|0
946912|NCT00792298|3119716|P6|Treatment Period 2|Withdrawal by Subject|0
946913|NCT00792298|3119717|P5|Treatment Period 2|Withdrawal by Subject|1
946914|NCT00792298|3119718|P4|Treatment Period 2|Withdrawal by Subject|2
946915|NCT00792298|3119719|P3|Treatment Period 2|Withdrawal by Subject|0
946916|NCT00792298|3119720|P2|Treatment Period 2|Withdrawal by Subject|1
946917|NCT00792298|3119721|P1|Treatment Period 2|Withdrawal by Subject|1
946918|NCT00792298|3119714|P8|Treatment Period 2|Pregnancy|0
946919|NCT00792298|3119715|P7|Treatment Period 2|Pregnancy|0
946920|NCT00792298|3119716|P6|Treatment Period 2|Pregnancy|0
946921|NCT00792298|3119717|P5|Treatment Period 2|Pregnancy|0
946922|NCT00792298|3119718|P4|Treatment Period 2|Pregnancy|0
946923|NCT00792298|3119719|P3|Treatment Period 2|Pregnancy|1
946924|NCT00792298|3119720|P2|Treatment Period 2|Pregnancy|0
946925|NCT00792298|3119721|P1|Treatment Period 2|Pregnancy|0
946926|NCT00792298|3119714|P8|Treatment Period 2|Physician Decision|0
946927|NCT00792298|3119715|P7|Treatment Period 2|Physician Decision|1
946928|NCT00792298|3119716|P6|Treatment Period 2|Physician Decision|0
946929|NCT00792298|3119717|P5|Treatment Period 2|Physician Decision|0
946930|NCT00792298|3119718|P4|Treatment Period 2|Physician Decision|0
946931|NCT00792298|3119719|P3|Treatment Period 2|Physician Decision|0
946932|NCT00792298|3119720|P2|Treatment Period 2|Physician Decision|0
946933|NCT00792298|3119721|P1|Treatment Period 2|Physician Decision|0
946934|NCT00792298|3119714|P8|Treatment Period 2|Lack of Efficacy|0
946935|NCT00792298|3119715|P7|Treatment Period 2|Lack of Efficacy|0
946936|NCT00792298|3119716|P6|Treatment Period 2|Lack of Efficacy|0
946937|NCT00792298|3119717|P5|Treatment Period 2|Lack of Efficacy|1
946938|NCT00792298|3119718|P4|Treatment Period 2|Lack of Efficacy|0
946939|NCT00792298|3119719|P3|Treatment Period 2|Lack of Efficacy|0
946940|NCT00792298|3119720|P2|Treatment Period 2|Lack of Efficacy|0
946941|NCT00792298|3119721|P1|Treatment Period 2|Lack of Efficacy|0
946942|NCT00792298|3119714|P8|Washout|Withdrawal by Subject|0
946943|NCT00792298|3119715|P7|Washout|Withdrawal by Subject|0
946944|NCT00792298|3119716|P6|Washout|Withdrawal by Subject|1
946945|NCT00792298|3119717|P5|Washout|Withdrawal by Subject|0
946946|NCT00792298|3119718|P4|Washout|Withdrawal by Subject|0
946947|NCT00792298|3119719|P3|Washout|Withdrawal by Subject|1
946948|NCT00792298|3119720|P2|Washout|Withdrawal by Subject|0
946949|NCT00792298|3119721|P1|Washout|Withdrawal by Subject|0
946950|NCT00792298|3119714|P8|Washout|Adverse Event|0
946951|NCT00792298|3119715|P7|Washout|Adverse Event|0
946952|NCT00792298|3119716|P6|Washout|Adverse Event|1
946953|NCT00792298|3119717|P5|Washout|Adverse Event|0
946954|NCT00792298|3119718|P4|Washout|Adverse Event|0
946955|NCT00792298|3119719|P3|Washout|Adverse Event|0
946956|NCT00792298|3119720|P2|Washout|Adverse Event|0
946957|NCT00792298|3119721|P1|Washout|Adverse Event|0
946958|NCT00792298|3119714|P8|Treatment Period 1|Protocol Violation|1
946959|NCT00792298|3119715|P7|Treatment Period 1|Protocol Violation|0
946960|NCT00792298|3119716|P6|Treatment Period 1|Protocol Violation|0
946961|NCT00792298|3119717|P5|Treatment Period 1|Protocol Violation|0
946962|NCT00792298|3119718|P4|Treatment Period 1|Protocol Violation|0
946963|NCT00792298|3119719|P3|Treatment Period 1|Protocol Violation|0
946964|NCT00792298|3119720|P2|Treatment Period 1|Protocol Violation|0
946965|NCT00792298|3119721|P1|Treatment Period 1|Protocol Violation|0
946966|NCT00792298|3119714|P8|Treatment Period 1|Physician Decision|0
946967|NCT00792298|3119715|P7|Treatment Period 1|Physician Decision|1
946968|NCT00792298|3119716|P6|Treatment Period 1|Physician Decision|0
946969|NCT00792298|3119717|P5|Treatment Period 1|Physician Decision|0
946970|NCT00792298|3119718|P4|Treatment Period 1|Physician Decision|1
946971|NCT00792298|3119719|P3|Treatment Period 1|Physician Decision|0
946972|NCT00792298|3119720|P2|Treatment Period 1|Physician Decision|0
946973|NCT00792298|3119721|P1|Treatment Period 1|Physician Decision|0
946974|NCT00792298|3119714|P8|Treatment Period 1|Lost to Follow-up|0
946975|NCT00792298|3119715|P7|Treatment Period 1|Lost to Follow-up|1
946976|NCT00792298|3119716|P6|Treatment Period 1|Lost to Follow-up|0
946977|NCT00792298|3119717|P5|Treatment Period 1|Lost to Follow-up|0
946978|NCT00792298|3119718|P4|Treatment Period 1|Lost to Follow-up|0
946979|NCT00792298|3119719|P3|Treatment Period 1|Lost to Follow-up|0
946980|NCT00792298|3119720|P2|Treatment Period 1|Lost to Follow-up|0
946981|NCT00792298|3119721|P1|Treatment Period 1|Lost to Follow-up|0
946982|NCT00792298|3119714|P8|Treatment Period 1|Withdrawal by Subject|0
946983|NCT00792298|3119715|P7|Treatment Period 1|Withdrawal by Subject|1
946984|NCT00792298|3119716|P6|Treatment Period 1|Withdrawal by Subject|2
946985|NCT00792298|3119717|P5|Treatment Period 1|Withdrawal by Subject|0
946986|NCT00792298|3119718|P4|Treatment Period 1|Withdrawal by Subject|2
946987|NCT00792298|3119719|P3|Treatment Period 1|Withdrawal by Subject|1
946988|NCT00792298|3119720|P2|Treatment Period 1|Withdrawal by Subject|0
946989|NCT00792298|3119721|P1|Treatment Period 1|Withdrawal by Subject|1
946990|NCT00792298|3119714|P8|Treatment Period 1|Lack of Efficacy|0
946991|NCT00792298|3119715|P7|Treatment Period 1|Lack of Efficacy|0
946992|NCT00792298|3119716|P6|Treatment Period 1|Lack of Efficacy|0
946993|NCT00792298|3119717|P5|Treatment Period 1|Lack of Efficacy|0
946994|NCT00792298|3119718|P4|Treatment Period 1|Lack of Efficacy|0
946995|NCT00792298|3119719|P3|Treatment Period 1|Lack of Efficacy|1
946996|NCT00792298|3119720|P2|Treatment Period 1|Lack of Efficacy|0
946997|NCT00792298|3119721|P1|Treatment Period 1|Lack of Efficacy|0
946998|NCT00792298|3119714|P8|Treatment Period 1|Adverse Event|0
946999|NCT00792298|3119715|P7|Treatment Period 1|Adverse Event|1
947000|NCT00792298|3119716|P6|Treatment Period 1|Adverse Event|1
947001|NCT00792298|3119717|P5|Treatment Period 1|Adverse Event|0
947002|NCT00792298|3119718|P4|Treatment Period 1|Adverse Event|1
947003|NCT00792298|3119719|P3|Treatment Period 1|Adverse Event|0
947004|NCT00792298|3119720|P2|Treatment Period 1|Adverse Event|1
947005|NCT00792298|3119721|P1|Treatment Period 1|Adverse Event|0
947006|NCT00792259|3119751|P3|Overall Study|Poor Quality Scans|0
947007|NCT00792259|3119752|P2|Overall Study|Poor Quality Scans|0
947008|NCT00792259|3119753|P1|Overall Study|Poor Quality Scans|1
947009|NCT00792116|3119763|P2|Overall Study|Discontnued intervention|0
947010|NCT00792116|3119764|P1|Overall Study|Discontnued intervention|1
947011|NCT00792116|3119763|P2|Overall Study|Lost to Follow-up|1
947012|NCT00792116|3119764|P1|Overall Study|Lost to Follow-up|0
947013|NCT00792103|3119774|P1|Overall Study|Did not apply 6 patches in 1st 3 mths|14
947014|NCT00792103|3119774|P1|Overall Study|Protocol Violation|10
947015|NCT00792103|3119774|P1|Overall Study|Withdrawal by Subject|52
947016|NCT00792103|3119774|P1|Overall Study|Adverse Event|25
947017|NCT00792103|3119774|P1|Overall Study|Lost to Follow-up|17
947018|NCT00792103|3119774|P1|Overall Study|Enrolled, not treated|15
947019|NCT00791999|3119786|P4|Overall Study|Reason other than those above|0
947020|NCT00791999|3119787|P3|Overall Study|Reason other than those above|1
947021|NCT00791999|3119788|P2|Overall Study|Reason other than those above|0
947022|NCT00791999|3119789|P1|Overall Study|Reason other than those above|1
947023|NCT00791999|3119786|P4|Overall Study|Lack of Efficacy|2
947024|NCT00791999|3119787|P3|Overall Study|Lack of Efficacy|0
947025|NCT00791999|3119788|P2|Overall Study|Lack of Efficacy|1
947026|NCT00791999|3119789|P1|Overall Study|Lack of Efficacy|0
947027|NCT00791999|3119786|P4|Overall Study|Adverse Event|3
947028|NCT00791999|3119787|P3|Overall Study|Adverse Event|7
947029|NCT00791999|3119788|P2|Overall Study|Adverse Event|3
947030|NCT00791999|3119789|P1|Overall Study|Adverse Event|3
947031|NCT00791999|3119786|P4|Overall Study|Protocol Violation|0
947032|NCT00791999|3119787|P3|Overall Study|Protocol Violation|1
947033|NCT00791999|3119788|P2|Overall Study|Protocol Violation|0
947034|NCT00791999|3119789|P1|Overall Study|Protocol Violation|3
947035|NCT00791999|3119786|P4|Overall Study|Withdrawal by Subject|2
947036|NCT00791999|3119787|P3|Overall Study|Withdrawal by Subject|0
947037|NCT00791999|3119788|P2|Overall Study|Withdrawal by Subject|1
947038|NCT00791999|3119789|P1|Overall Study|Withdrawal by Subject|0
947039|NCT00791999|3119786|P4|Overall Study|Protocol planed withdrawal|45
947040|NCT00791999|3119787|P3|Overall Study|Protocol planed withdrawal|11
947041|NCT00791999|3119788|P2|Overall Study|Protocol planed withdrawal|11
947042|NCT00791999|3119789|P1|Overall Study|Protocol planed withdrawal|14
947043|NCT00791934|3119814|P1|Overall Study|Did not consent for extended follow-up|13
947044|NCT00791934|3119814|P1|Overall Study|Withdrawal by Subject|2
947045|NCT00791921|3119824|P2|Overall Study|Reason other than those above|1
947046|NCT00791921|3119825|P1|Overall Study|Reason other than those above|0
947047|NCT00791921|3119824|P2|Overall Study|Lack of study drug administration|1
947048|NCT00791921|3119825|P1|Overall Study|Lack of study drug administration|1
947049|NCT00791921|3119824|P2|Overall Study|Lack of Efficacy|2
947050|NCT00791921|3119825|P1|Overall Study|Lack of Efficacy|0
947051|NCT00791921|3119824|P2|Overall Study|Adverse Event|2
947052|NCT00791921|3119825|P1|Overall Study|Adverse Event|8
947053|NCT00791921|3119824|P2|Overall Study|Withdrawal by Subject|2
947054|NCT00791921|3119825|P1|Overall Study|Withdrawal by Subject|1
947055|NCT00791921|3119824|P2|Overall Study|Protocol planed|88
947056|NCT00791921|3119825|P1|Overall Study|Protocol planed|24
947057|NCT00791778|3119852|P2|Follow-up|Lost to Follow-up|1
947058|NCT00791778|3119853|P1|Follow-up|Lost to Follow-up|2
947059|NCT00791778|3119852|P2|Follow-up|Withdrawal by Subject|0
947060|NCT00791778|3119853|P1|Follow-up|Withdrawal by Subject|3
947061|NCT00791778|3119852|P2|Double-blind Treatment|Non-compliant with study medication|0
947062|NCT00791778|3119853|P1|Double-blind Treatment|Non-compliant with study medication|2
947063|NCT00791778|3119852|P2|Double-blind Treatment|Withdrawal by Subject|9
947064|NCT00791778|3119853|P1|Double-blind Treatment|Withdrawal by Subject|20
947065|NCT00791778|3119852|P2|Double-blind Treatment|Protocol Violation|4
947066|NCT00791778|3119853|P1|Double-blind Treatment|Protocol Violation|0
947067|NCT00791778|3119852|P2|Double-blind Treatment|Physician Decision|26
947068|NCT00791778|3119853|P1|Double-blind Treatment|Physician Decision|6
947069|NCT00791778|3119852|P2|Double-blind Treatment|Adverse Event|9
947070|NCT00791778|3119853|P1|Double-blind Treatment|Adverse Event|49
947071|NCT00791765|3119907|P2|Weeks 13 to 24|Other|1
947072|NCT00791765|3119908|P1|Weeks 13 to 24|Other|0
947073|NCT00791765|3119907|P2|Weeks 13 to 24|Lost to Follow-up|2
947074|NCT00791765|3119908|P1|Weeks 13 to 24|Lost to Follow-up|1
947075|NCT00791765|3119907|P2|Weeks 13 to 24|Disease progression|1
947076|NCT00791765|3119908|P1|Weeks 13 to 24|Disease progression|0
947077|NCT00791765|3119907|P2|Weeks 13 to 24|Withdrawal by Subject|1
947078|NCT00791765|3119908|P1|Weeks 13 to 24|Withdrawal by Subject|2
947079|NCT00791765|3119907|P2|Weeks 13 to 24|Adverse Event|3
947080|NCT00791765|3119908|P1|Weeks 13 to 24|Adverse Event|0
947081|NCT00791765|3119907|P2|Weeks 13 to 24|Protocol deviation|0
947082|NCT00791765|3119908|P1|Weeks 13 to 24|Protocol deviation|2
947083|NCT00791765|3119907|P2|Weeks 1 to 12|Ineligibility determined|3
947084|NCT00791765|3119908|P1|Weeks 1 to 12|Ineligibility determined|0
947085|NCT00791765|3119907|P2|Weeks 1 to 12|Disease progression|0
947086|NCT00791765|3119908|P1|Weeks 1 to 12|Disease progression|3
947087|NCT00791765|3119907|P2|Weeks 1 to 12|Physician Decision|0
947088|NCT00791765|3119908|P1|Weeks 1 to 12|Physician Decision|1
947089|NCT00791765|3119907|P2|Weeks 1 to 12|Withdrawal by Subject|0
947090|NCT00791765|3119908|P1|Weeks 1 to 12|Withdrawal by Subject|3
947091|NCT00791765|3119907|P2|Weeks 1 to 12|Lost to Follow-up|0
947092|NCT00791765|3119908|P1|Weeks 1 to 12|Lost to Follow-up|1
947093|NCT00791765|3119907|P2|Weeks 1 to 12|Adverse Event|1
947094|NCT00791765|3119908|P1|Weeks 1 to 12|Adverse Event|0
947095|NCT00791700|3119923|P4|Overall Study|Blood sampling not done before Stage 1|1
947096|NCT00791700|3119924|P3|Overall Study|Blood sampling not done before Stage 1|0
947097|NCT00791700|3119925|P2|Overall Study|Blood sampling not done before Stage 1|0
947098|NCT00791700|3119926|P1|Overall Study|Blood sampling not done before Stage 1|0
947099|NCT00791700|3119923|P4|Overall Study|Non-compliance with study treatment|2
947100|NCT00791700|3119924|P3|Overall Study|Non-compliance with study treatment|0
947101|NCT00791700|3119925|P2|Overall Study|Non-compliance with study treatment|0
947102|NCT00791700|3119926|P1|Overall Study|Non-compliance with study treatment|1
947103|NCT00791700|3119923|P4|Overall Study|No longer willing to participate|1
947104|NCT00791700|3119924|P3|Overall Study|No longer willing to participate|0
947105|NCT00791700|3119925|P2|Overall Study|No longer willing to participate|1
947106|NCT00791700|3119926|P1|Overall Study|No longer willing to participate|0
947107|NCT00791700|3119923|P4|Overall Study|Adverse Event|1
947108|NCT00791700|3119924|P3|Overall Study|Adverse Event|1
947109|NCT00791700|3119925|P2|Overall Study|Adverse Event|0
947110|NCT00791700|3119926|P1|Overall Study|Adverse Event|0
947111|NCT00791700|3119923|P4|Overall Study|Insufficient clinical response|13
947112|NCT00791700|3119924|P3|Overall Study|Insufficient clinical response|3
947113|NCT00791700|3119925|P2|Overall Study|Insufficient clinical response|4
947114|NCT00791700|3119926|P1|Overall Study|Insufficient clinical response|3
947115|NCT00791661|3120014|P3|7 Day Wash-out|Abnormal Clinical Laboratory Test|1
947116|NCT00791661|3120015|P2|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
947117|NCT00791661|3120016|P1|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
947118|NCT00791661|3120014|P3|7 Day Wash-out|Adverse Event|1
947119|NCT00791661|3120015|P2|7 Day Wash-out|Adverse Event|0
947120|NCT00791661|3120016|P1|7 Day Wash-out|Adverse Event|0
947121|NCT00791648|3120109|P2|Overall Study|Withdrawal by Subject|1
947122|NCT00791648|3120110|P1|Overall Study|Withdrawal by Subject|0
947123|NCT00791648|3120109|P2|Overall Study|Physician Decision|1
947124|NCT00791648|3120110|P1|Overall Study|Physician Decision|0
947125|NCT00791557|3120126|P1|Overall Study|Adverse Event|1
947126|NCT00791518|3120130|P1|Overall Study|Protocol Violation|93
947127|NCT00791492|3120158|P2|Overall Study|Liver transplantation|1
947128|NCT00791492|3120159|P1|Overall Study|Liver transplantation|5
947129|NCT00791492|3120158|P2|Overall Study|Withdrawal by Subject|2
947130|NCT00791492|3120159|P1|Overall Study|Withdrawal by Subject|1
947131|NCT00791479|3120207|P6|Overall Study|Withdrawal by Subject|1
947132|NCT00791479|3120208|P5|Overall Study|Withdrawal by Subject|0
947133|NCT00791479|3120209|P4|Overall Study|Withdrawal by Subject|1
947134|NCT00791479|3120210|P3|Overall Study|Withdrawal by Subject|0
947135|NCT00791479|3120211|P2|Overall Study|Withdrawal by Subject|0
947136|NCT00791479|3120212|P1|Overall Study|Withdrawal by Subject|0
947137|NCT00791479|3120207|P6|Overall Study|Protocol Violation|0
947138|NCT00791479|3120208|P5|Overall Study|Protocol Violation|0
947139|NCT00791479|3120209|P4|Overall Study|Protocol Violation|1
947140|NCT00791479|3120210|P3|Overall Study|Protocol Violation|0
947141|NCT00791479|3120211|P2|Overall Study|Protocol Violation|1
947142|NCT00791479|3120212|P1|Overall Study|Protocol Violation|2
947143|NCT00791479|3120207|P6|Overall Study|Lost to Follow-up|1
947144|NCT00791479|3120208|P5|Overall Study|Lost to Follow-up|0
947145|NCT00791479|3120209|P4|Overall Study|Lost to Follow-up|0
947146|NCT00791479|3120210|P3|Overall Study|Lost to Follow-up|0
947147|NCT00791479|3120211|P2|Overall Study|Lost to Follow-up|1
947148|NCT00791479|3120212|P1|Overall Study|Lost to Follow-up|0
947149|NCT00791479|3120207|P6|Overall Study|Adverse Event|1
947150|NCT00791479|3120208|P5|Overall Study|Adverse Event|0
947151|NCT00791479|3120209|P4|Overall Study|Adverse Event|2
947152|NCT00791479|3120210|P3|Overall Study|Adverse Event|0
947153|NCT00791479|3120211|P2|Overall Study|Adverse Event|1
947154|NCT00791479|3120212|P1|Overall Study|Adverse Event|0
947155|NCT00791479|3120207|P6|Overall Study|Dose Discontinued per Sponsor Decision|0
947156|NCT00791479|3120208|P5|Overall Study|Dose Discontinued per Sponsor Decision|3
947157|NCT00791479|3120209|P4|Overall Study|Dose Discontinued per Sponsor Decision|0
947158|NCT00791479|3120210|P3|Overall Study|Dose Discontinued per Sponsor Decision|0
947159|NCT00791479|3120211|P2|Overall Study|Dose Discontinued per Sponsor Decision|0
947160|NCT00791479|3120212|P1|Overall Study|Dose Discontinued per Sponsor Decision|0
947161|NCT00791388|3120311|P5|Period 4 - 400 mg Dose Group|Adverse Event|4
947162|NCT00791388|3120312|P4|Period 4 - 400 mg Dose Group|Adverse Event|0
947163|NCT00791388|3120313|P3|Period 4 - 400 mg Dose Group|Adverse Event|0
947164|NCT00791388|3120314|P2|Period 4 - 400 mg Dose Group|Adverse Event|0
947165|NCT00791388|3120315|P1|Period 4 - 400 mg Dose Group|Adverse Event|0
947166|NCT00791388|3120311|P5|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
947167|NCT00791388|3120312|P4|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
947168|NCT00791388|3120313|P3|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
947169|NCT00791388|3120314|P2|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
947170|NCT00791388|3120315|P1|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1
947171|NCT00791388|3120311|P5|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
947172|NCT00791388|3120312|P4|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
947173|NCT00791388|3120313|P3|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
947174|NCT00791388|3120314|P2|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1
947175|NCT00791388|3120315|P1|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
947176|NCT00791258|3120357|P1|Overall Study|Lack of Efficacy|1
947177|NCT00791258|3120357|P1|Overall Study|Subject required restricted medication|1
947178|NCT00791258|3120357|P1|Overall Study|Subject incarcerated|1
947179|NCT00791258|3120357|P1|Overall Study|non-compliance|3
947180|NCT00791258|3120357|P1|Overall Study|subject left area|2
947181|NCT00791258|3120357|P1|Overall Study|Did not take medication for >3 days|1
947182|NCT00791258|3120357|P1|Overall Study|Withdrawal by Subject|40
947183|NCT00791258|3120357|P1|Overall Study|Protocol Violation|109
947184|NCT00791258|3120357|P1|Overall Study|Lost to Follow-up|18
947185|NCT00791258|3120357|P1|Overall Study|Adverse Event|87
947186|NCT00791128|3120419|P1|Overall Study|abdominal tumor, unrelated to device|1
947187|NCT00791128|3120419|P1|Overall Study|non-compliance by subject|2
947188|NCT00791128|3120419|P1|Overall Study|Device migration|2
947189|NCT00791128|3120419|P1|Overall Study|Adverse Event|4
947190|NCT00791076|3120450|P1|Overall Study|Study was terminated,PI left institution|8
947191|NCT00790907|3120468|P3|Overall Study|Did Not Receive Study Drug|0
947192|NCT00790907|3120469|P2|Overall Study|Did Not Receive Study Drug|0
947193|NCT00790907|3120470|P1|Overall Study|Did Not Receive Study Drug|10
947194|NCT00790907|3120468|P3|Overall Study|Verbatim Reason on the Case Report Form|29
947195|NCT00790907|3120469|P2|Overall Study|Verbatim Reason on the Case Report Form|20
947196|NCT00790907|3120470|P1|Overall Study|Verbatim Reason on the Case Report Form|74
947197|NCT00790907|3120468|P3|Overall Study|Qualifying Condition Not Present|16
947198|NCT00790907|3120469|P2|Overall Study|Qualifying Condition Not Present|14
947199|NCT00790907|3120470|P1|Overall Study|Qualifying Condition Not Present|29
947200|NCT00790907|3120468|P3|Overall Study|Required Protocol-prohibited Therapy|7
947201|NCT00790907|3120469|P2|Overall Study|Required Protocol-prohibited Therapy|5
947202|NCT00790907|3120470|P1|Overall Study|Required Protocol-prohibited Therapy|17
947203|NCT00790907|3120468|P3|Overall Study|Bleeding Event|21
947204|NCT00790907|3120469|P2|Overall Study|Bleeding Event|16
947205|NCT00790907|3120470|P1|Overall Study|Bleeding Event|11
947206|NCT00790907|3120468|P3|Overall Study|Withdrawal by Subject|5
947207|NCT00790907|3120469|P2|Overall Study|Withdrawal by Subject|7
947208|NCT00790907|3120470|P1|Overall Study|Withdrawal by Subject|1
947209|NCT00790907|3120468|P3|Overall Study|Physician Decision|255
947210|NCT00790907|3120469|P2|Overall Study|Physician Decision|271
947211|NCT00790907|3120470|P1|Overall Study|Physician Decision|304
947212|NCT00790907|3120468|P3|Overall Study|Adverse Event|6
947213|NCT00790907|3120469|P2|Overall Study|Adverse Event|7
947214|NCT00790907|3120470|P1|Overall Study|Adverse Event|9
947215|NCT00790868|3120493|P2|Overall Study|Lost to Follow-up|12
947216|NCT00790868|3120494|P1|Overall Study|Lost to Follow-up|2
947217|NCT00790868|3120493|P2|Overall Study|Withdrawal by Subject|5
947218|NCT00790868|3120494|P1|Overall Study|Withdrawal by Subject|4
947219|NCT00790842|3120516|P11|Expansion Cohort|Study Closure|0
947220|NCT00790842|3120517|P10|Expansion Cohort|Study Closure|0
947221|NCT00790842|3120518|P9|Expansion Cohort|Study Closure|0
947222|NCT00790842|3120519|P8|Expansion Cohort|Study Closure|0
947223|NCT00790842|3120520|P7|Expansion Cohort|Study Closure|0
947224|NCT00790842|3120521|P6|Expansion Cohort|Study Closure|0
947225|NCT00790842|3120522|P5|Expansion Cohort|Study Closure|0
947226|NCT00790842|3120523|P4|Expansion Cohort|Study Closure|0
947227|NCT00790842|3120524|P3|Expansion Cohort|Study Closure|1
947228|NCT00790842|3120525|P2|Expansion Cohort|Study Closure|0
947229|NCT00790842|3120526|P1|Expansion Cohort|Study Closure|0
947230|NCT00790842|3120516|P11|Expansion Cohort|Withdrawal by Subject|0
947231|NCT00790842|3120517|P10|Expansion Cohort|Withdrawal by Subject|0
947232|NCT00790842|3120518|P9|Expansion Cohort|Withdrawal by Subject|0
947233|NCT00790842|3120519|P8|Expansion Cohort|Withdrawal by Subject|0
947234|NCT00790842|3120520|P7|Expansion Cohort|Withdrawal by Subject|0
947235|NCT00790842|3120521|P6|Expansion Cohort|Withdrawal by Subject|0
947236|NCT00790842|3120522|P5|Expansion Cohort|Withdrawal by Subject|0
947237|NCT00790842|3120523|P4|Expansion Cohort|Withdrawal by Subject|0
947238|NCT00790842|3120524|P3|Expansion Cohort|Withdrawal by Subject|3
947239|NCT00790842|3120525|P2|Expansion Cohort|Withdrawal by Subject|0
947240|NCT00790842|3120526|P1|Expansion Cohort|Withdrawal by Subject|0
947241|NCT00790842|3120516|P11|Expansion Cohort|Physician Decision|0
947242|NCT00790842|3120517|P10|Expansion Cohort|Physician Decision|0
947243|NCT00790842|3120518|P9|Expansion Cohort|Physician Decision|0
947244|NCT00790842|3120519|P8|Expansion Cohort|Physician Decision|0
947245|NCT00790842|3120520|P7|Expansion Cohort|Physician Decision|0
947246|NCT00790842|3120521|P6|Expansion Cohort|Physician Decision|0
947247|NCT00790842|3120522|P5|Expansion Cohort|Physician Decision|0
947248|NCT00790842|3120523|P4|Expansion Cohort|Physician Decision|0
947249|NCT00790842|3120524|P3|Expansion Cohort|Physician Decision|1
947250|NCT00790842|3120525|P2|Expansion Cohort|Physician Decision|0
947251|NCT00790842|3120526|P1|Expansion Cohort|Physician Decision|0
947252|NCT00790842|3120516|P11|Expansion Cohort|Death|0
947253|NCT00790842|3120517|P10|Expansion Cohort|Death|0
947254|NCT00790842|3120518|P9|Expansion Cohort|Death|0
947255|NCT00790842|3120519|P8|Expansion Cohort|Death|0
947256|NCT00790842|3120520|P7|Expansion Cohort|Death|0
947257|NCT00790842|3120521|P6|Expansion Cohort|Death|0
947258|NCT00790842|3120522|P5|Expansion Cohort|Death|0
947259|NCT00790842|3120523|P4|Expansion Cohort|Death|0
947260|NCT00790842|3120524|P3|Expansion Cohort|Death|2
947261|NCT00790842|3120525|P2|Expansion Cohort|Death|0
947262|NCT00790842|3120526|P1|Expansion Cohort|Death|0
947263|NCT00790842|3120516|P11|Expansion Cohort|Adverse Event|0
947264|NCT00790842|3120517|P10|Expansion Cohort|Adverse Event|0
947265|NCT00790842|3120518|P9|Expansion Cohort|Adverse Event|0
947266|NCT00790842|3120519|P8|Expansion Cohort|Adverse Event|0
947267|NCT00790842|3120520|P7|Expansion Cohort|Adverse Event|1
947268|NCT00790842|3120521|P6|Expansion Cohort|Adverse Event|0
947269|NCT00790842|3120522|P5|Expansion Cohort|Adverse Event|0
947270|NCT00790842|3120523|P4|Expansion Cohort|Adverse Event|0
947271|NCT00790842|3120524|P3|Expansion Cohort|Adverse Event|0
947272|NCT00790842|3120525|P2|Expansion Cohort|Adverse Event|0
947273|NCT00790842|3120526|P1|Expansion Cohort|Adverse Event|0
947274|NCT00790842|3120516|P11|Dose Level 4|Withdrawal by Subject|1
947275|NCT00790842|3120517|P10|Dose Level 4|Withdrawal by Subject|0
947276|NCT00790842|3120518|P9|Dose Level 4|Withdrawal by Subject|0
947277|NCT00790842|3120519|P8|Dose Level 4|Withdrawal by Subject|0
947278|NCT00790842|3120520|P7|Dose Level 4|Withdrawal by Subject|0
947279|NCT00790842|3120521|P6|Dose Level 4|Withdrawal by Subject|0
947280|NCT00790842|3120522|P5|Dose Level 4|Withdrawal by Subject|0
947281|NCT00790842|3120523|P4|Dose Level 4|Withdrawal by Subject|0
947282|NCT00790842|3120524|P3|Dose Level 4|Withdrawal by Subject|0
947283|NCT00790842|3120525|P2|Dose Level 4|Withdrawal by Subject|0
947284|NCT00790842|3120526|P1|Dose Level 4|Withdrawal by Subject|0
947285|NCT00790842|3120516|P11|Dose Level 4|Physician Decision|1
947286|NCT00790842|3120517|P10|Dose Level 4|Physician Decision|0
947287|NCT00790842|3120518|P9|Dose Level 4|Physician Decision|0
947288|NCT00790842|3120519|P8|Dose Level 4|Physician Decision|0
947289|NCT00790842|3120520|P7|Dose Level 4|Physician Decision|1
947290|NCT00790842|3120521|P6|Dose Level 4|Physician Decision|0
947291|NCT00790842|3120522|P5|Dose Level 4|Physician Decision|0
947292|NCT00790842|3120523|P4|Dose Level 4|Physician Decision|0
947293|NCT00790842|3120524|P3|Dose Level 4|Physician Decision|0
947294|NCT00790842|3120525|P2|Dose Level 4|Physician Decision|0
947295|NCT00790842|3120526|P1|Dose Level 4|Physician Decision|0
947296|NCT00790842|3120516|P11|Dose Level 4|Adverse Event|0
947297|NCT00790842|3120517|P10|Dose Level 4|Adverse Event|0
947298|NCT00790842|3120518|P9|Dose Level 4|Adverse Event|0
947299|NCT00790842|3120519|P8|Dose Level 4|Adverse Event|0
947300|NCT00790842|3120520|P7|Dose Level 4|Adverse Event|1
947301|NCT00790842|3120521|P6|Dose Level 4|Adverse Event|0
947302|NCT00790842|3120522|P5|Dose Level 4|Adverse Event|0
947303|NCT00790842|3120523|P4|Dose Level 4|Adverse Event|0
947304|NCT00790842|3120524|P3|Dose Level 4|Adverse Event|0
947305|NCT00790842|3120525|P2|Dose Level 4|Adverse Event|0
947306|NCT00790842|3120526|P1|Dose Level 4|Adverse Event|0
947307|NCT00790842|3120516|P11|Dose Level 3|Ineligible/Withdrew before Treatment|0
947308|NCT00790842|3120517|P10|Dose Level 3|Ineligible/Withdrew before Treatment|0
947309|NCT00790842|3120518|P9|Dose Level 3|Ineligible/Withdrew before Treatment|0
947310|NCT00790842|3120519|P8|Dose Level 3|Ineligible/Withdrew before Treatment|0
947311|NCT00790842|3120520|P7|Dose Level 3|Ineligible/Withdrew before Treatment|0
947312|NCT00790842|3120521|P6|Dose Level 3|Ineligible/Withdrew before Treatment|0
947313|NCT00790842|3120522|P5|Dose Level 3|Ineligible/Withdrew before Treatment|0
947314|NCT00790842|3120523|P4|Dose Level 3|Ineligible/Withdrew before Treatment|0
947315|NCT00790842|3120524|P3|Dose Level 3|Ineligible/Withdrew before Treatment|1
947316|NCT00790842|3120525|P2|Dose Level 3|Ineligible/Withdrew before Treatment|0
947317|NCT00790842|3120526|P1|Dose Level 3|Ineligible/Withdrew before Treatment|0
947318|NCT00790842|3120516|P11|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
947319|NCT00790842|3120517|P10|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
947320|NCT00790842|3120518|P9|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
947321|NCT00790842|3120519|P8|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
947322|NCT00790842|3120520|P7|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
947323|NCT00790842|3120521|P6|Dose Level 3|Intercurrent Illness/Alternative Therapy|1
947324|NCT00790842|3120522|P5|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
947325|NCT00790842|3120523|P4|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
947326|NCT00790842|3120524|P3|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
947327|NCT00790842|3120525|P2|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
947328|NCT00790842|3120526|P1|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
947329|NCT00790842|3120516|P11|Dose Level 3|Withdrawal by Subject|0
947330|NCT00790842|3120517|P10|Dose Level 3|Withdrawal by Subject|2
947331|NCT00790842|3120518|P9|Dose Level 3|Withdrawal by Subject|0
947332|NCT00790842|3120519|P8|Dose Level 3|Withdrawal by Subject|0
947333|NCT00790842|3120520|P7|Dose Level 3|Withdrawal by Subject|0
947334|NCT00790842|3120521|P6|Dose Level 3|Withdrawal by Subject|0
947335|NCT00790842|3120522|P5|Dose Level 3|Withdrawal by Subject|0
947336|NCT00790842|3120523|P4|Dose Level 3|Withdrawal by Subject|0
947337|NCT00790842|3120524|P3|Dose Level 3|Withdrawal by Subject|3
947338|NCT00790842|3120525|P2|Dose Level 3|Withdrawal by Subject|0
947339|NCT00790842|3120526|P1|Dose Level 3|Withdrawal by Subject|0
947340|NCT00790842|3120516|P11|Dose Level 3|Adverse Event|0
947341|NCT00790842|3120517|P10|Dose Level 3|Adverse Event|0
947342|NCT00790842|3120518|P9|Dose Level 3|Adverse Event|0
947343|NCT00790842|3120519|P8|Dose Level 3|Adverse Event|0
947344|NCT00790842|3120520|P7|Dose Level 3|Adverse Event|0
947345|NCT00790842|3120521|P6|Dose Level 3|Adverse Event|0
947346|NCT00790842|3120522|P5|Dose Level 3|Adverse Event|0
947347|NCT00790842|3120523|P4|Dose Level 3|Adverse Event|0
947348|NCT00790842|3120524|P3|Dose Level 3|Adverse Event|1
947349|NCT00790842|3120525|P2|Dose Level 3|Adverse Event|0
947350|NCT00790842|3120526|P1|Dose Level 3|Adverse Event|0
947351|NCT00790842|3120516|P11|Dose Level 2|Intercurrent Illness/Other Treatment|0
947352|NCT00790842|3120517|P10|Dose Level 2|Intercurrent Illness/Other Treatment|0
947353|NCT00790842|3120518|P9|Dose Level 2|Intercurrent Illness/Other Treatment|2
947354|NCT00790842|3120519|P8|Dose Level 2|Intercurrent Illness/Other Treatment|0
947355|NCT00790842|3120520|P7|Dose Level 2|Intercurrent Illness/Other Treatment|0
947356|NCT00790842|3120521|P6|Dose Level 2|Intercurrent Illness/Other Treatment|0
947357|NCT00790842|3120522|P5|Dose Level 2|Intercurrent Illness/Other Treatment|0
947358|NCT00790842|3120523|P4|Dose Level 2|Intercurrent Illness/Other Treatment|0
947359|NCT00790842|3120524|P3|Dose Level 2|Intercurrent Illness/Other Treatment|0
947360|NCT00790842|3120525|P2|Dose Level 2|Intercurrent Illness/Other Treatment|0
947361|NCT00790842|3120526|P1|Dose Level 2|Intercurrent Illness/Other Treatment|0
947362|NCT00790842|3120516|P11|Dose Level 2|Withdrawal by Subject|0
947363|NCT00790842|3120517|P10|Dose Level 2|Withdrawal by Subject|0
947364|NCT00790842|3120518|P9|Dose Level 2|Withdrawal by Subject|0
947365|NCT00790842|3120519|P8|Dose Level 2|Withdrawal by Subject|0
947366|NCT00790842|3120520|P7|Dose Level 2|Withdrawal by Subject|0
947367|NCT00790842|3120521|P6|Dose Level 2|Withdrawal by Subject|0
947368|NCT00790842|3120522|P5|Dose Level 2|Withdrawal by Subject|0
947369|NCT00790842|3120523|P4|Dose Level 2|Withdrawal by Subject|0
947370|NCT00790842|3120524|P3|Dose Level 2|Withdrawal by Subject|0
947371|NCT00790842|3120525|P2|Dose Level 2|Withdrawal by Subject|1
947372|NCT00790842|3120526|P1|Dose Level 2|Withdrawal by Subject|0
947373|NCT00790842|3120516|P11|Dose Level 2|Physician Decision|0
947374|NCT00790842|3120517|P10|Dose Level 2|Physician Decision|0
947375|NCT00790842|3120518|P9|Dose Level 2|Physician Decision|0
947376|NCT00790842|3120519|P8|Dose Level 2|Physician Decision|0
947377|NCT00790842|3120520|P7|Dose Level 2|Physician Decision|0
947378|NCT00790842|3120521|P6|Dose Level 2|Physician Decision|0
947379|NCT00790842|3120522|P5|Dose Level 2|Physician Decision|0
947380|NCT00790842|3120523|P4|Dose Level 2|Physician Decision|0
947381|NCT00790842|3120524|P3|Dose Level 2|Physician Decision|0
947382|NCT00790842|3120525|P2|Dose Level 2|Physician Decision|1
947383|NCT00790842|3120526|P1|Dose Level 2|Physician Decision|0
947384|NCT00790842|3120516|P11|Dose Level 2|Death|0
947385|NCT00790842|3120517|P10|Dose Level 2|Death|0
947386|NCT00790842|3120518|P9|Dose Level 2|Death|0
947387|NCT00790842|3120519|P8|Dose Level 2|Death|0
947388|NCT00790842|3120520|P7|Dose Level 2|Death|0
947389|NCT00790842|3120521|P6|Dose Level 2|Death|0
947390|NCT00790842|3120522|P5|Dose Level 2|Death|1
947391|NCT00790842|3120523|P4|Dose Level 2|Death|0
947392|NCT00790842|3120524|P3|Dose Level 2|Death|0
947393|NCT00790842|3120525|P2|Dose Level 2|Death|1
947394|NCT00790842|3120526|P1|Dose Level 2|Death|0
947395|NCT00790842|3120516|P11|Dose Level 1|Withdrawal by Subject|0
947396|NCT00790842|3120517|P10|Dose Level 1|Withdrawal by Subject|0
947397|NCT00790842|3120518|P9|Dose Level 1|Withdrawal by Subject|0
947398|NCT00790842|3120519|P8|Dose Level 1|Withdrawal by Subject|0
947399|NCT00790842|3120520|P7|Dose Level 1|Withdrawal by Subject|0
947400|NCT00790842|3120521|P6|Dose Level 1|Withdrawal by Subject|0
947401|NCT00790842|3120522|P5|Dose Level 1|Withdrawal by Subject|0
947402|NCT00790842|3120523|P4|Dose Level 1|Withdrawal by Subject|0
947403|NCT00790842|3120524|P3|Dose Level 1|Withdrawal by Subject|0
947404|NCT00790842|3120525|P2|Dose Level 1|Withdrawal by Subject|0
947405|NCT00790842|3120526|P1|Dose Level 1|Withdrawal by Subject|1
947406|NCT00790842|3120516|P11|Dose Level 1|Physician Decision|0
947407|NCT00790842|3120517|P10|Dose Level 1|Physician Decision|0
947408|NCT00790842|3120518|P9|Dose Level 1|Physician Decision|0
947409|NCT00790842|3120519|P8|Dose Level 1|Physician Decision|1
947410|NCT00790842|3120520|P7|Dose Level 1|Physician Decision|0
947411|NCT00790842|3120521|P6|Dose Level 1|Physician Decision|0
947412|NCT00790842|3120522|P5|Dose Level 1|Physician Decision|0
947413|NCT00790842|3120523|P4|Dose Level 1|Physician Decision|0
947414|NCT00790842|3120524|P3|Dose Level 1|Physician Decision|0
947415|NCT00790842|3120525|P2|Dose Level 1|Physician Decision|0
947416|NCT00790842|3120526|P1|Dose Level 1|Physician Decision|1
947417|NCT00790842|3120516|P11|Dose Level 1|Adverse Event|0
947418|NCT00790842|3120517|P10|Dose Level 1|Adverse Event|0
947419|NCT00790842|3120518|P9|Dose Level 1|Adverse Event|0
947420|NCT00790842|3120519|P8|Dose Level 1|Adverse Event|1
947421|NCT00790842|3120520|P7|Dose Level 1|Adverse Event|0
947422|NCT00790842|3120521|P6|Dose Level 1|Adverse Event|0
947423|NCT00790842|3120522|P5|Dose Level 1|Adverse Event|0
947424|NCT00790842|3120523|P4|Dose Level 1|Adverse Event|2
947425|NCT00790842|3120524|P3|Dose Level 1|Adverse Event|0
947426|NCT00790842|3120525|P2|Dose Level 1|Adverse Event|0
947427|NCT00790842|3120526|P1|Dose Level 1|Adverse Event|1
947428|NCT00790790|3120594|P3|Study Period 2: Therapy Phase|Physician Decision|0
947429|NCT00790790|3120595|P2|Study Period 2: Therapy Phase|Physician Decision|1
947430|NCT00790790|3120596|P1|Study Period 2: Therapy Phase|Physician Decision|0
947431|NCT00790790|3120594|P3|Study Period 2: Therapy Phase|Lack of Efficacy|3
947432|NCT00790790|3120595|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
947433|NCT00790790|3120596|P1|Study Period 2: Therapy Phase|Lack of Efficacy|1
947434|NCT00790790|3120594|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|2
947435|NCT00790790|3120595|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|0
947436|NCT00790790|3120596|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|7
947437|NCT00790790|3120594|P3|Study Period 2: Therapy Phase|Protocol Violation|0
947438|NCT00790790|3120595|P2|Study Period 2: Therapy Phase|Protocol Violation|1
947439|NCT00790790|3120596|P1|Study Period 2: Therapy Phase|Protocol Violation|1
947440|NCT00790790|3120594|P3|Study Period 2: Therapy Phase|Adverse Event|16
947441|NCT00790790|3120595|P2|Study Period 2: Therapy Phase|Adverse Event|16
947442|NCT00790790|3120596|P1|Study Period 2: Therapy Phase|Adverse Event|3
947443|NCT00790751|3120673|P4|Overall Study|Physician Decision|1
947444|NCT00790751|3120674|P3|Overall Study|Physician Decision|0
947445|NCT00790751|3120675|P2|Overall Study|Physician Decision|0
947446|NCT00790751|3120676|P1|Overall Study|Physician Decision|0
947447|NCT00790751|3120673|P4|Overall Study|Death|0
947448|NCT00790751|3120674|P3|Overall Study|Death|1
947449|NCT00790751|3120675|P2|Overall Study|Death|0
947450|NCT00790751|3120676|P1|Overall Study|Death|0
947451|NCT00790751|3120673|P4|Overall Study|Requirement for restricted medication|0
947452|NCT00790751|3120674|P3|Overall Study|Requirement for restricted medication|0
947453|NCT00790751|3120675|P2|Overall Study|Requirement for restricted medication|2
947454|NCT00790751|3120676|P1|Overall Study|Requirement for restricted medication|0
947455|NCT00790751|3120673|P4|Overall Study|Adverse Event|4
947456|NCT00790751|3120674|P3|Overall Study|Adverse Event|5
947457|NCT00790751|3120675|P2|Overall Study|Adverse Event|3
947458|NCT00790751|3120676|P1|Overall Study|Adverse Event|5
947459|NCT00790751|3120673|P4|Overall Study|Lost to Follow-up|5
947460|NCT00790751|3120674|P3|Overall Study|Lost to Follow-up|4
947461|NCT00790751|3120675|P2|Overall Study|Lost to Follow-up|9
947462|NCT00790751|3120676|P1|Overall Study|Lost to Follow-up|4
947463|NCT00790751|3120673|P4|Overall Study|Protocol non-compliance|11
947464|NCT00790751|3120674|P3|Overall Study|Protocol non-compliance|10
947465|NCT00790751|3120675|P2|Overall Study|Protocol non-compliance|16
947466|NCT00790751|3120676|P1|Overall Study|Protocol non-compliance|16
947467|NCT00790647|3120724|P1|Overall Study|Adverse Event|1
947468|NCT00790569|3120734|P3|End of Study (12 Month Interview)|Lost to Follow-up|50
947469|NCT00790569|3120735|P2|End of Study (12 Month Interview)|Lost to Follow-up|19
947470|NCT00790569|3120736|P1|End of Study (12 Month Interview)|Lost to Follow-up|66
947471|NCT00790569|3120734|P3|End of Treatment (6 Month Interview)|Incarcerated|3
947472|NCT00790569|3120735|P2|End of Treatment (6 Month Interview)|Incarcerated|0
947473|NCT00790569|3120736|P1|End of Treatment (6 Month Interview)|Incarcerated|0
947474|NCT00790569|3120734|P3|End of Treatment (6 Month Interview)|Residential Treatment|2
947475|NCT00790569|3120735|P2|End of Treatment (6 Month Interview)|Residential Treatment|0
947476|NCT00790569|3120736|P1|End of Treatment (6 Month Interview)|Residential Treatment|0
947477|NCT00790569|3120734|P3|End of Treatment (6 Month Interview)|Hospitalized|0
947478|NCT00790569|3120735|P2|End of Treatment (6 Month Interview)|Hospitalized|0
947479|NCT00790569|3120736|P1|End of Treatment (6 Month Interview)|Hospitalized|2
947480|NCT00790569|3120734|P3|End of Treatment (6 Month Interview)|Death|1
947481|NCT00790569|3120735|P2|End of Treatment (6 Month Interview)|Death|2
947482|NCT00790569|3120736|P1|End of Treatment (6 Month Interview)|Death|0
947483|NCT00790569|3120734|P3|End of Treatment (6 Month Interview)|Lost to Follow-up|20
947484|NCT00790569|3120735|P2|End of Treatment (6 Month Interview)|Lost to Follow-up|8
947485|NCT00790569|3120736|P1|End of Treatment (6 Month Interview)|Lost to Follow-up|20
947486|NCT00790556|3120777|P2|Treatment Period 1|Withdrawal by Subject|0
947487|NCT00790556|3120778|P1|Treatment Period 1|Withdrawal by Subject|1
947488|NCT00790556|3120777|P2|Treatment Period 1|Physician Decision|0
947489|NCT00790556|3120778|P1|Treatment Period 1|Physician Decision|1
947490|NCT00790452|3120790|P2|Overall Study|Drug supply issue|0
947491|NCT00790452|3120791|P1|Overall Study|Drug supply issue|1
947492|NCT00790400|3120799|P2|Everolimus Period (Core or Extension)|New treatment|0
947493|NCT00790400|3120800|P1|Everolimus Period (Core or Extension)|New treatment|2
947494|NCT00790400|3120799|P2|Everolimus Period (Core or Extension)|Protocol Violation|0
947495|NCT00790400|3120800|P1|Everolimus Period (Core or Extension)|Protocol Violation|1
947496|NCT00790400|3120799|P2|Everolimus Period (Core or Extension)|Disease progression|0
947497|NCT00790400|3120800|P1|Everolimus Period (Core or Extension)|Disease progression|5
947498|NCT00790400|3120799|P2|Everolimus Period (Core or Extension)|Death|0
947499|NCT00790400|3120800|P1|Everolimus Period (Core or Extension)|Death|1
947500|NCT00790400|3120799|P2|Everolimus Period (Core or Extension)|Administrative problems|0
947501|NCT00790400|3120800|P1|Everolimus Period (Core or Extension)|Administrative problems|2
947502|NCT00790400|3120799|P2|Everolimus Period (Core or Extension)|Lost to Follow-up|0
947503|NCT00790400|3120800|P1|Everolimus Period (Core or Extension)|Lost to Follow-up|1
947504|NCT00790400|3120799|P2|Everolimus Period (Core or Extension)|Withdrawal by Subject|0
947505|NCT00790400|3120800|P1|Everolimus Period (Core or Extension)|Withdrawal by Subject|7
947506|NCT00790400|3120799|P2|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0
947507|NCT00790400|3120800|P1|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1
947508|NCT00790400|3120799|P2|Everolimus Period (Core or Extension)|Adverse Event|0
947509|NCT00790400|3120800|P1|Everolimus Period (Core or Extension)|Adverse Event|9
947510|NCT00790400|3120799|P2|Double-blind Period (Core Phase)|Death|0
947511|NCT00790400|3120800|P1|Double-blind Period (Core Phase)|Death|1
947512|NCT00790400|3120799|P2|Double-blind Period (Core Phase)|Administrative problems|0
947513|NCT00790400|3120800|P1|Double-blind Period (Core Phase)|Administrative problems|1
947514|NCT00790400|3120799|P2|Double-blind Period (Core Phase)|Withdrawal by Subject|0
947515|NCT00790400|3120800|P1|Double-blind Period (Core Phase)|Withdrawal by Subject|1
947516|NCT00790400|3120799|P2|Double-blind Period (Core Phase)|Abnormal lab value (s)|0
947517|NCT00790400|3120800|P1|Double-blind Period (Core Phase)|Abnormal lab value (s)|1
947518|NCT00790400|3120799|P2|Double-blind Period (Core Phase)|Adverse Event|4
947519|NCT00790400|3120800|P1|Double-blind Period (Core Phase)|Adverse Event|2
947520|NCT00790400|3120799|P2|Double-blind Period (Core Phase)|Progressive disease|9
947521|NCT00790400|3120800|P1|Double-blind Period (Core Phase)|Progressive disease|0
947522|NCT00790400|3120799|P2|Double-blind Period (Core Phase)|Protocol Violation|0
947523|NCT00790400|3120800|P1|Double-blind Period (Core Phase)|Protocol Violation|1
947524|NCT00790296|3120890|P2|Overall Study|Adverse Event|1
947525|NCT00790296|3120891|P1|Overall Study|Adverse Event|0
947526|NCT00790296|3120890|P2|Overall Study|Did not meet study eligibility criteria|1
947527|NCT00790296|3120891|P1|Overall Study|Did not meet study eligibility criteria|1
947528|NCT00790218|3120913|P3|Overall Study|Death|0
947529|NCT00790218|3120914|P2|Overall Study|Death|0
947530|NCT00790218|3120915|P1|Overall Study|Death|1
947531|NCT00790205|3120925|P2|Overall Study|Withdrawal by Subject|363
947532|NCT00790205|3120926|P1|Overall Study|Withdrawal by Subject|299
947533|NCT00790205|3120925|P2|Overall Study|Lost to Follow-up|71
947534|NCT00790205|3120926|P1|Overall Study|Lost to Follow-up|61
947535|NCT00790036|3121023|P2|Overall Study|Subject/guardian decision|7
947536|NCT00790036|3121024|P1|Overall Study|Subject/guardian decision|20
947537|NCT00790036|3121023|P2|Overall Study|Withdrawal by Subject|7
947538|NCT00790036|3121024|P1|Overall Study|Withdrawal by Subject|18
947539|NCT00790036|3121023|P2|Overall Study|Protocol Violation|2
947540|NCT00790036|3121024|P1|Overall Study|Protocol Violation|10
947541|NCT00790036|3121023|P2|Overall Study|Lost to Follow-up|2
947542|NCT00790036|3121024|P1|Overall Study|Lost to Follow-up|1
947543|NCT00790036|3121023|P2|Overall Study|Disease progression|48
947544|NCT00790036|3121024|P1|Overall Study|Disease progression|24
947545|NCT00790036|3121023|P2|Overall Study|Death|0
947546|NCT00790036|3121024|P1|Overall Study|Death|1
947547|NCT00790036|3121023|P2|Overall Study|Adverse Event|44
947548|NCT00790036|3121024|P1|Overall Study|Adverse Event|113
947549|NCT00790036|3121023|P2|Overall Study|Administrative problems|9
947550|NCT00790036|3121024|P1|Overall Study|Administrative problems|5
947551|NCT00790036|3121023|P2|Overall Study|Abnormal lab values|2
947552|NCT00790036|3121024|P1|Overall Study|Abnormal lab values|3
947553|NCT00790023|3121038|P3|Overall Study|Not specified|8
947554|NCT00790023|3121039|P2|Overall Study|Not specified|5
947555|NCT00790023|3121040|P1|Overall Study|Not specified|5
947556|NCT00790023|3121038|P3|Overall Study|Lost to Follow-up|1
947557|NCT00790023|3121039|P2|Overall Study|Lost to Follow-up|0
947558|NCT00790023|3121040|P1|Overall Study|Lost to Follow-up|0
947559|NCT00790023|3121038|P3|Overall Study|Withdrawal by Subject|6
947560|NCT00790023|3121039|P2|Overall Study|Withdrawal by Subject|0
947561|NCT00790023|3121040|P1|Overall Study|Withdrawal by Subject|2
947562|NCT00790023|3121038|P3|Overall Study|Protocol Violation|2
947563|NCT00790023|3121039|P2|Overall Study|Protocol Violation|4
947564|NCT00790023|3121040|P1|Overall Study|Protocol Violation|2
947565|NCT00790023|3121038|P3|Overall Study|Adverse Event|4
947566|NCT00790023|3121039|P2|Overall Study|Adverse Event|1
947567|NCT00790023|3121040|P1|Overall Study|Adverse Event|2
947568|NCT00789958|3121139|P1|Overall Study|Not eligible/not analyzable|26
947569|NCT00789958|3121139|P1|Overall Study|not protocol specified|1
947570|NCT00789958|3121139|P1|Overall Study|Progression|3
947571|NCT00789958|3121139|P1|Overall Study|Withdrawal by Subject|4
947572|NCT00789958|3121139|P1|Overall Study|Adverse Event|3
947573|NCT00789880|3121158|P6|Overall Study|Withdrawal by Subject|0
947574|NCT00789880|3121159|P5|Overall Study|Withdrawal by Subject|2
947575|NCT00789880|3121160|P4|Overall Study|Withdrawal by Subject|0
947576|NCT00789880|3121161|P3|Overall Study|Withdrawal by Subject|0
947577|NCT00789880|3121162|P2|Overall Study|Withdrawal by Subject|0
947578|NCT00789880|3121163|P1|Overall Study|Withdrawal by Subject|1
947579|NCT00789880|3121158|P6|Overall Study|Protocol Violation|0
947580|NCT00789880|3121159|P5|Overall Study|Protocol Violation|0
947581|NCT00789880|3121160|P4|Overall Study|Protocol Violation|1
947582|NCT00789880|3121161|P3|Overall Study|Protocol Violation|0
947583|NCT00789880|3121162|P2|Overall Study|Protocol Violation|1
947584|NCT00789880|3121163|P1|Overall Study|Protocol Violation|0
947585|NCT00789880|3121158|P6|Overall Study|Adverse Event|0
947586|NCT00789880|3121159|P5|Overall Study|Adverse Event|1
947587|NCT00789880|3121160|P4|Overall Study|Adverse Event|0
947588|NCT00789880|3121161|P3|Overall Study|Adverse Event|0
947589|NCT00789880|3121162|P2|Overall Study|Adverse Event|0
947590|NCT00789880|3121163|P1|Overall Study|Adverse Event|0
947591|NCT00789854|3121192|P3|Overall Study|Other|5
947592|NCT00789854|3121193|P2|Overall Study|Other|0
947593|NCT00789854|3121194|P1|Overall Study|Other|6
947594|NCT00789854|3121192|P3|Overall Study|Safety reasons|2
947595|NCT00789854|3121193|P2|Overall Study|Safety reasons|0
947596|NCT00789854|3121194|P1|Overall Study|Safety reasons|0
947597|NCT00789854|3121192|P3|Overall Study|Severe non-compliance to the protocol|0
947598|NCT00789854|3121193|P2|Overall Study|Severe non-compliance to the protocol|0
947599|NCT00789854|3121194|P1|Overall Study|Severe non-compliance to the protocol|3
947600|NCT00789854|3121192|P3|Overall Study|Eligibility criteria not fulfilled|1
947601|NCT00789854|3121193|P2|Overall Study|Eligibility criteria not fulfilled|5
947602|NCT00789854|3121194|P1|Overall Study|Eligibility criteria not fulfilled|2
947603|NCT00789854|3121192|P3|Overall Study|Withdrawal by Subject|17
947604|NCT00789854|3121193|P2|Overall Study|Withdrawal by Subject|6
947605|NCT00789854|3121194|P1|Overall Study|Withdrawal by Subject|9
947606|NCT00789854|3121192|P3|Overall Study|Lost to Follow-up|4
947607|NCT00789854|3121193|P2|Overall Study|Lost to Follow-up|1
947608|NCT00789854|3121194|P1|Overall Study|Lost to Follow-up|1
947609|NCT00789854|3121192|P3|Overall Study|Adverse Event|18
947610|NCT00789854|3121193|P2|Overall Study|Adverse Event|23
947611|NCT00789854|3121194|P1|Overall Study|Adverse Event|28
947612|NCT00789828|3121291|P2|Open-label Extension Period (4 Years)|New treatment for indication under study|0
947613|NCT00789828|3121292|P1|Open-label Extension Period (4 Years)|New treatment for indication under study|1
947614|NCT00789828|3121291|P2|Open-label Extension Period (4 Years)|Disease progression|0
947615|NCT00789828|3121292|P1|Open-label Extension Period (4 Years)|Disease progression|1
947616|NCT00789828|3121291|P2|Open-label Extension Period (4 Years)|Death|0
947617|NCT00789828|3121292|P1|Open-label Extension Period (4 Years)|Death|1
947618|NCT00789828|3121291|P2|Open-label Extension Period (4 Years)|Administrative problems|0
947619|NCT00789828|3121292|P1|Open-label Extension Period (4 Years)|Administrative problems|7
947620|NCT00789828|3121291|P2|Open-label Extension Period (4 Years)|Lost to Follow-up|0
947621|NCT00789828|3121292|P1|Open-label Extension Period (4 Years)|Lost to Follow-up|3
947622|NCT00789828|3121291|P2|Open-label Extension Period (4 Years)|Withdrawal by Subject|0
947623|NCT00789828|3121292|P1|Open-label Extension Period (4 Years)|Withdrawal by Subject|6
947624|NCT00789828|3121291|P2|Open-label Extension Period (4 Years)|Adverse Event|0
947625|NCT00789828|3121292|P1|Open-label Extension Period (4 Years)|Adverse Event|10
947626|NCT00789828|3121291|P2|Core Period (48 Weeks)|Lost to Follow-up|1
947627|NCT00789828|3121292|P1|Core Period (48 Weeks)|Lost to Follow-up|0
947628|NCT00789828|3121291|P2|Core Period (48 Weeks)|Withdrawal by Subject|4
947629|NCT00789828|3121292|P1|Core Period (48 Weeks)|Withdrawal by Subject|0
947630|NCT00789828|3121291|P2|Core Period (48 Weeks)|Administrative problems|1
947631|NCT00789828|3121292|P1|Core Period (48 Weeks)|Administrative problems|0
947632|NCT00789815|3121326|P2|Overall Study|Intubation due to massive bleeding|0
947633|NCT00789815|3121327|P1|Overall Study|Intubation due to massive bleeding|1
947634|NCT00789815|3121326|P2|Overall Study|Protocol Violation|1
947635|NCT00789815|3121327|P1|Overall Study|Protocol Violation|6
947636|NCT00789737|3121437|P2|Overall Study|not specified|7
947637|NCT00789737|3121438|P1|Overall Study|not specified|11
947638|NCT00789737|3121437|P2|Overall Study|hyperglycemia that met protocol-specifie|4
947639|NCT00789737|3121438|P1|Overall Study|hyperglycemia that met protocol-specifie|0
947640|NCT00789737|3121437|P2|Overall Study|Lack of Efficacy|0
947641|NCT00789737|3121438|P1|Overall Study|Lack of Efficacy|3
947642|NCT00789737|3121437|P2|Overall Study|Protocol Violation|0
947643|NCT00789737|3121438|P1|Overall Study|Protocol Violation|3
947644|NCT00789737|3121437|P2|Overall Study|Adverse Event|8
947645|NCT00789737|3121438|P1|Overall Study|Adverse Event|8
947646|NCT00789737|3121437|P2|Overall Study|Lost to Follow-up|14
947647|NCT00789737|3121438|P1|Overall Study|Lost to Follow-up|10
947648|NCT00789737|3121437|P2|Overall Study|Withdrawal by Subject|22
947649|NCT00789737|3121438|P1|Overall Study|Withdrawal by Subject|13
947650|NCT00789698|3121481|P4|Overall Study|Administrative|1
947651|NCT00789698|3121482|P3|Overall Study|Administrative|3
947652|NCT00789698|3121483|P2|Overall Study|Administrative|3
947653|NCT00789698|3121484|P1|Overall Study|Administrative|0
947654|NCT00789698|3121481|P4|Overall Study|Withdrawal by Subject|19
947655|NCT00789698|3121482|P3|Overall Study|Withdrawal by Subject|12
947656|NCT00789698|3121483|P2|Overall Study|Withdrawal by Subject|15
947657|NCT00789698|3121484|P1|Overall Study|Withdrawal by Subject|14
947658|NCT00789698|3121481|P4|Overall Study|Protocol Violation|1
947659|NCT00789698|3121482|P3|Overall Study|Protocol Violation|2
947660|NCT00789698|3121483|P2|Overall Study|Protocol Violation|1
947661|NCT00789698|3121484|P1|Overall Study|Protocol Violation|6
947662|NCT00789698|3121481|P4|Overall Study|Lost to Follow-up|9
947663|NCT00789698|3121482|P3|Overall Study|Lost to Follow-up|2
947664|NCT00789698|3121483|P2|Overall Study|Lost to Follow-up|5
947665|NCT00789698|3121484|P1|Overall Study|Lost to Follow-up|5
947666|NCT00789698|3121481|P4|Overall Study|Adverse Event|4
947667|NCT00789698|3121482|P3|Overall Study|Adverse Event|3
947668|NCT00789698|3121483|P2|Overall Study|Adverse Event|5
947669|NCT00789698|3121484|P1|Overall Study|Adverse Event|5
947670|NCT00789698|3121481|P4|Overall Study|Lack of Efficacy|18
947671|NCT00789698|3121482|P3|Overall Study|Lack of Efficacy|5
947672|NCT00789698|3121483|P2|Overall Study|Lack of Efficacy|4
947673|NCT00789698|3121484|P1|Overall Study|Lack of Efficacy|10
947674|NCT00789581|3121539|P2|Adjuvant Therapy|Not Specified|1
947675|NCT00789581|3121540|P1|Adjuvant Therapy|Not Specified|0
947676|NCT00789581|3121539|P2|Adjuvant Therapy|Protocol Violation|1
947677|NCT00789581|3121540|P1|Adjuvant Therapy|Protocol Violation|1
947678|NCT00789581|3121539|P2|Adjuvant Therapy|Intercurrent Illness|3
947679|NCT00789581|3121540|P1|Adjuvant Therapy|Intercurrent Illness|1
947680|NCT00789581|3121539|P2|Adjuvant Therapy|Disease recurrence|1
947681|NCT00789581|3121540|P1|Adjuvant Therapy|Disease recurrence|2
947682|NCT00789581|3121539|P2|Adjuvant Therapy|Withdrawal by Subject|5
947683|NCT00789581|3121540|P1|Adjuvant Therapy|Withdrawal by Subject|14
947684|NCT00789581|3121539|P2|Adjuvant Therapy|Adverse Event|44
947685|NCT00789581|3121540|P1|Adjuvant Therapy|Adverse Event|20
947686|NCT00789581|3121539|P2|Adjuvant Therapy|Never treated|2
947687|NCT00789581|3121540|P1|Adjuvant Therapy|Never treated|2
947688|NCT00789581|3121539|P2|AC Therapy|Not specified|2
947689|NCT00789581|3121540|P1|AC Therapy|Not specified|0
947690|NCT00789581|3121539|P2|AC Therapy|Never Treated|4
947691|NCT00789581|3121540|P1|AC Therapy|Never Treated|1
947692|NCT00789581|3121539|P2|AC Therapy|Intercurrent Illness|0
947693|NCT00789581|3121540|P1|AC Therapy|Intercurrent Illness|1
947694|NCT00789581|3121539|P2|AC Therapy|Disease recurrence|1
947695|NCT00789581|3121540|P1|AC Therapy|Disease recurrence|3
947696|NCT00789581|3121539|P2|AC Therapy|Withdrawal by Subject|7
947697|NCT00789581|3121540|P1|AC Therapy|Withdrawal by Subject|4
947698|NCT00789581|3121539|P2|AC Therapy|Adverse Event|3
947699|NCT00789581|3121540|P1|AC Therapy|Adverse Event|2
947700|NCT00789555|3121551|P3|Overall Study|Protocol Violation|13
947701|NCT00789555|3121552|P2|Overall Study|Protocol Violation|9
947702|NCT00789555|3121553|P1|Overall Study|Protocol Violation|6
947703|NCT00789555|3121551|P3|Overall Study|Treatment failure|12
947704|NCT00789555|3121552|P2|Overall Study|Treatment failure|8
947705|NCT00789555|3121553|P1|Overall Study|Treatment failure|11
947706|NCT00789555|3121551|P3|Overall Study|Patient decision unnrelated to adv event|26
947707|NCT00789555|3121552|P2|Overall Study|Patient decision unnrelated to adv event|29
947708|NCT00789555|3121553|P1|Overall Study|Patient decision unnrelated to adv event|38
947709|NCT00789555|3121551|P3|Overall Study|Lost to Follow-up|18
947710|NCT00789555|3121552|P2|Overall Study|Lost to Follow-up|10
947711|NCT00789555|3121553|P1|Overall Study|Lost to Follow-up|9
947712|NCT00789555|3121551|P3|Overall Study|Adverse Event|10
947713|NCT00789555|3121552|P2|Overall Study|Adverse Event|7
947714|NCT00789555|3121553|P1|Overall Study|Adverse Event|17
947715|NCT00789555|3121551|P3|Overall Study|Protocol Amendment|80
947716|NCT00789555|3121552|P2|Overall Study|Protocol Amendment|76
947717|NCT00789555|3121553|P1|Overall Study|Protocol Amendment|78
947718|NCT00789529|3121578|P2|Overall Study|Other Reason|0
947719|NCT00789529|3121579|P1|Overall Study|Other Reason|1
947720|NCT00789529|3121578|P2|Overall Study|Withdrawal by Subject|1
947721|NCT00789529|3121579|P1|Overall Study|Withdrawal by Subject|0
947722|NCT00789477|3121592|P5|Overall Study|Other|0
947723|NCT00789477|3121593|P4|Overall Study|Other|3
947724|NCT00789477|3121594|P3|Overall Study|Other|1
947725|NCT00789477|3121595|P2|Overall Study|Other|0
947726|NCT00789477|3121596|P1|Overall Study|Other|2
947727|NCT00789477|3121592|P5|Overall Study|Lack of Efficacy|0
947728|NCT00789477|3121593|P4|Overall Study|Lack of Efficacy|0
947729|NCT00789477|3121594|P3|Overall Study|Lack of Efficacy|0
947730|NCT00789477|3121595|P2|Overall Study|Lack of Efficacy|0
947731|NCT00789477|3121596|P1|Overall Study|Lack of Efficacy|2
947732|NCT00789477|3121592|P5|Overall Study|Lost to Follow-up|4
947733|NCT00789477|3121593|P4|Overall Study|Lost to Follow-up|2
947734|NCT00789477|3121594|P3|Overall Study|Lost to Follow-up|4
947735|NCT00789477|3121595|P2|Overall Study|Lost to Follow-up|1
947736|NCT00789477|3121596|P1|Overall Study|Lost to Follow-up|0
947737|NCT00789477|3121592|P5|Overall Study|Death|0
947738|NCT00789477|3121593|P4|Overall Study|Death|2
947739|NCT00789477|3121594|P3|Overall Study|Death|2
947740|NCT00789477|3121595|P2|Overall Study|Death|1
947741|NCT00789477|3121596|P1|Overall Study|Death|1
947742|NCT00789477|3121592|P5|Overall Study|Adverse Event|0
947743|NCT00789477|3121593|P4|Overall Study|Adverse Event|0
947744|NCT00789477|3121594|P3|Overall Study|Adverse Event|1
947745|NCT00789477|3121595|P2|Overall Study|Adverse Event|3
947746|NCT00789477|3121596|P1|Overall Study|Adverse Event|3
947747|NCT00789477|3121592|P5|Overall Study|Protocol Violation|0
947748|NCT00789477|3121593|P4|Overall Study|Protocol Violation|1
947749|NCT00789477|3121594|P3|Overall Study|Protocol Violation|0
947750|NCT00789477|3121595|P2|Overall Study|Protocol Violation|0
947751|NCT00789477|3121596|P1|Overall Study|Protocol Violation|1
947752|NCT00789477|3121592|P5|Overall Study|Withdrawal by Subject|3
947753|NCT00789477|3121593|P4|Overall Study|Withdrawal by Subject|2
947754|NCT00789477|3121594|P3|Overall Study|Withdrawal by Subject|3
947755|NCT00789477|3121595|P2|Overall Study|Withdrawal by Subject|1
947756|NCT00789477|3121596|P1|Overall Study|Withdrawal by Subject|2
947757|NCT00789373|3121641|P3|Maintenance|Participants On-Going at Data Cut-Off|0
947758|NCT00789373|3121642|P2|Maintenance|Participants On-Going at Data Cut-Off|4
947759|NCT00789373|3121643|P1|Maintenance|Participants On-Going at Data Cut-Off|0
947760|NCT00789373|3121641|P3|Maintenance|Sponsor Decision|2
947761|NCT00789373|3121642|P2|Maintenance|Sponsor Decision|0
947762|NCT00789373|3121643|P1|Maintenance|Sponsor Decision|0
947763|NCT00789373|3121641|P3|Maintenance|Withdrawal by Subject|8
947764|NCT00789373|3121642|P2|Maintenance|Withdrawal by Subject|21
947765|NCT00789373|3121643|P1|Maintenance|Withdrawal by Subject|0
947766|NCT00789373|3121641|P3|Maintenance|Progressive Disease|152
947767|NCT00789373|3121642|P2|Maintenance|Progressive Disease|253
947768|NCT00789373|3121643|P1|Maintenance|Progressive Disease|0
947769|NCT00789373|3121641|P3|Maintenance|Lost to Follow-up|0
947770|NCT00789373|3121642|P2|Maintenance|Lost to Follow-up|2
947771|NCT00789373|3121643|P1|Maintenance|Lost to Follow-up|0
947772|NCT00789373|3121641|P3|Maintenance|Protocol entry criteria not met|0
947773|NCT00789373|3121642|P2|Maintenance|Protocol entry criteria not met|2
947774|NCT00789373|3121643|P1|Maintenance|Protocol entry criteria not met|0
947775|NCT00789373|3121641|P3|Maintenance|Investigator Decision|2
947776|NCT00789373|3121642|P2|Maintenance|Investigator Decision|4
947777|NCT00789373|3121643|P1|Maintenance|Investigator Decision|0
947778|NCT00789373|3121641|P3|Maintenance|Death due to toxicity|2
947779|NCT00789373|3121642|P2|Maintenance|Death due to toxicity|1
947780|NCT00789373|3121643|P1|Maintenance|Death due to toxicity|0
947781|NCT00789373|3121641|P3|Maintenance|Death due to adverse event|1
947782|NCT00789373|3121642|P2|Maintenance|Death due to adverse event|4
947783|NCT00789373|3121643|P1|Maintenance|Death due to adverse event|0
947784|NCT00789373|3121641|P3|Maintenance|Death due to study disease|1
947785|NCT00789373|3121642|P2|Maintenance|Death due to study disease|3
947786|NCT00789373|3121643|P1|Maintenance|Death due to study disease|0
947787|NCT00789373|3121641|P3|Maintenance|Adverse Event|12
947788|NCT00789373|3121642|P2|Maintenance|Adverse Event|65
947789|NCT00789373|3121643|P1|Maintenance|Adverse Event|0
947790|NCT00789373|3121641|P3|Induction|Withdrawal by Subject|0
947791|NCT00789373|3121642|P2|Induction|Withdrawal by Subject|0
947792|NCT00789373|3121643|P1|Induction|Withdrawal by Subject|37
947793|NCT00789373|3121641|P3|Induction|Progressive Disease|0
947794|NCT00789373|3121642|P2|Induction|Progressive Disease|0
947795|NCT00789373|3121643|P1|Induction|Progressive Disease|220
947796|NCT00789373|3121641|P3|Induction|Protocol Violation|0
947797|NCT00789373|3121642|P2|Induction|Protocol Violation|0
947798|NCT00789373|3121643|P1|Induction|Protocol Violation|1
947799|NCT00789373|3121641|P3|Induction|Lost to Follow-up|0
947800|NCT00789373|3121642|P2|Induction|Lost to Follow-up|0
947801|NCT00789373|3121643|P1|Induction|Lost to Follow-up|6
947802|NCT00789373|3121641|P3|Induction|Protocol entry criteria not met|0
947803|NCT00789373|3121642|P2|Induction|Protocol entry criteria not met|0
947804|NCT00789373|3121643|P1|Induction|Protocol entry criteria not met|9
947805|NCT00789373|3121641|P3|Induction|Investigator decision|0
947806|NCT00789373|3121642|P2|Induction|Investigator decision|0
947807|NCT00789373|3121643|P1|Induction|Investigator decision|7
947808|NCT00789373|3121641|P3|Induction|Death due to procedure|0
947809|NCT00789373|3121642|P2|Induction|Death due to procedure|0
947810|NCT00789373|3121643|P1|Induction|Death due to procedure|1
947811|NCT00789373|3121641|P3|Induction|Death due to toxicity|0
947812|NCT00789373|3121642|P2|Induction|Death due to toxicity|0
947813|NCT00789373|3121643|P1|Induction|Death due to toxicity|11
947814|NCT00789373|3121641|P3|Induction|Death due to adverse event|0
947815|NCT00789373|3121642|P2|Induction|Death due to adverse event|0
947816|NCT00789373|3121643|P1|Induction|Death due to adverse event|19
947817|NCT00789373|3121641|P3|Induction|Death Due to study disease|0
947818|NCT00789373|3121642|P2|Induction|Death Due to study disease|0
947819|NCT00789373|3121643|P1|Induction|Death Due to study disease|24
947820|NCT00789373|3121641|P3|Induction|Adverse Event|0
947821|NCT00789373|3121642|P2|Induction|Adverse Event|0
947822|NCT00789373|3121643|P1|Induction|Adverse Event|64
947823|NCT00789321|3121670|P2|Overall Study|Adverse Event|1
947824|NCT00789321|3121671|P1|Overall Study|Adverse Event|0
947825|NCT00789191|3121693|P2|Overall Study|Unclassified|3
947826|NCT00789191|3121694|P1|Overall Study|Unclassified|5
947827|NCT00789191|3121693|P2|Overall Study|Withdrawal Criteria|4
947828|NCT00789191|3121694|P1|Overall Study|Withdrawal Criteria|2
947829|NCT00789191|3121693|P2|Overall Study|Protocol Violation|3
947830|NCT00789191|3121694|P1|Overall Study|Protocol Violation|5
947831|NCT00789191|3121693|P2|Overall Study|Lack of Efficacy|5
947832|NCT00789191|3121694|P1|Overall Study|Lack of Efficacy|0
947833|NCT00789191|3121693|P2|Overall Study|Adverse Event|4
947834|NCT00789191|3121694|P1|Overall Study|Adverse Event|2
947835|NCT00789035|3121751|P5|Overall Study|Other reason not defined above|1
947836|NCT00789035|3121752|P4|Overall Study|Other reason not defined above|0
947837|NCT00789035|3121753|P3|Overall Study|Other reason not defined above|1
947838|NCT00789035|3121754|P2|Overall Study|Other reason not defined above|3
947839|NCT00789035|3121755|P1|Overall Study|Other reason not defined above|2
947840|NCT00789035|3121751|P5|Overall Study|Withdrawal by Subject|0
947841|NCT00789035|3121752|P4|Overall Study|Withdrawal by Subject|0
947842|NCT00789035|3121753|P3|Overall Study|Withdrawal by Subject|0
947843|NCT00789035|3121754|P2|Overall Study|Withdrawal by Subject|2
947844|NCT00789035|3121755|P1|Overall Study|Withdrawal by Subject|0
947845|NCT00789035|3121751|P5|Overall Study|Protocol Violation|0
947846|NCT00789035|3121752|P4|Overall Study|Protocol Violation|0
947847|NCT00789035|3121753|P3|Overall Study|Protocol Violation|0
947848|NCT00789035|3121754|P2|Overall Study|Protocol Violation|0
947849|NCT00789035|3121755|P1|Overall Study|Protocol Violation|1
947850|NCT00789035|3121751|P5|Overall Study|Lack of Efficacy|2
947851|NCT00789035|3121752|P4|Overall Study|Lack of Efficacy|0
947852|NCT00789035|3121753|P3|Overall Study|Lack of Efficacy|0
947853|NCT00789035|3121754|P2|Overall Study|Lack of Efficacy|0
947854|NCT00789035|3121755|P1|Overall Study|Lack of Efficacy|3
947855|NCT00789035|3121751|P5|Overall Study|Adverse Event|3
947856|NCT00789035|3121752|P4|Overall Study|Adverse Event|1
947857|NCT00789035|3121753|P3|Overall Study|Adverse Event|0
947858|NCT00789035|3121754|P2|Overall Study|Adverse Event|2
947859|NCT00789035|3121755|P1|Overall Study|Adverse Event|0
947860|NCT00788957|3121814|P6|Part 3|On-study at time of data cut-off|0
947861|NCT00788957|3121815|P5|Part 3|On-study at time of data cut-off|1
947862|NCT00788957|3121816|P4|Part 3|On-study at time of data cut-off|0
947863|NCT00788957|3121817|P3|Part 3|On-study at time of data cut-off|0
947864|NCT00788957|3121818|P2|Part 3|On-study at time of data cut-off|0
947865|NCT00788957|3121819|P1|Part 3|On-study at time of data cut-off|0
947866|NCT00788957|3121814|P6|Part 3|Death|9
947867|NCT00788957|3121815|P5|Part 3|Death|8
947868|NCT00788957|3121816|P4|Part 3|Death|0
947869|NCT00788957|3121817|P3|Part 3|Death|0
947870|NCT00788957|3121818|P2|Part 3|Death|0
947871|NCT00788957|3121819|P1|Part 3|Death|0
947872|NCT00788957|3121814|P6|Part 3|Withdrawal by Subject|2
947873|NCT00788957|3121815|P5|Part 3|Withdrawal by Subject|0
947874|NCT00788957|3121816|P4|Part 3|Withdrawal by Subject|0
947875|NCT00788957|3121817|P3|Part 3|Withdrawal by Subject|0
947876|NCT00788957|3121818|P2|Part 3|Withdrawal by Subject|0
947877|NCT00788957|3121819|P1|Part 3|Withdrawal by Subject|0
947878|NCT00788957|3121814|P6|Part 2|On-study at time of data cut-off|0
947879|NCT00788957|3121815|P5|Part 2|On-study at time of data cut-off|0
947880|NCT00788957|3121816|P4|Part 2|On-study at time of data cut-off|1
947881|NCT00788957|3121817|P3|Part 2|On-study at time of data cut-off|1
947882|NCT00788957|3121818|P2|Part 2|On-study at time of data cut-off|1
947883|NCT00788957|3121819|P1|Part 2|On-study at time of data cut-off|0
947884|NCT00788957|3121814|P6|Part 2|Lost to Follow-up|0
947885|NCT00788957|3121815|P5|Part 2|Lost to Follow-up|0
947886|NCT00788957|3121816|P4|Part 2|Lost to Follow-up|0
947887|NCT00788957|3121817|P3|Part 2|Lost to Follow-up|3
947888|NCT00788957|3121818|P2|Part 2|Lost to Follow-up|0
947889|NCT00788957|3121819|P1|Part 2|Lost to Follow-up|0
947890|NCT00788957|3121814|P6|Part 2|Death|0
947891|NCT00788957|3121815|P5|Part 2|Death|0
947892|NCT00788957|3121816|P4|Part 2|Death|37
947893|NCT00788957|3121817|P3|Part 2|Death|35
947894|NCT00788957|3121818|P2|Part 2|Death|32
947895|NCT00788957|3121819|P1|Part 2|Death|0
947896|NCT00788957|3121814|P6|Part 2|Withdrawal by Subject|0
947897|NCT00788957|3121815|P5|Part 2|Withdrawal by Subject|0
947898|NCT00788957|3121816|P4|Part 2|Withdrawal by Subject|3
947899|NCT00788957|3121817|P3|Part 2|Withdrawal by Subject|5
947900|NCT00788957|3121818|P2|Part 2|Withdrawal by Subject|9
947901|NCT00788957|3121819|P1|Part 2|Withdrawal by Subject|0
947902|NCT00788957|3121814|P6|Part 1|Lost to Follow-up|0
947903|NCT00788957|3121815|P5|Part 1|Lost to Follow-up|0
947904|NCT00788957|3121816|P4|Part 1|Lost to Follow-up|0
947905|NCT00788957|3121817|P3|Part 1|Lost to Follow-up|0
947906|NCT00788957|3121818|P2|Part 1|Lost to Follow-up|0
947907|NCT00788957|3121819|P1|Part 1|Lost to Follow-up|1
947908|NCT00788957|3121814|P6|Part 1|Death|0
947909|NCT00788957|3121815|P5|Part 1|Death|0
947910|NCT00788957|3121816|P4|Part 1|Death|0
947911|NCT00788957|3121817|P3|Part 1|Death|0
947912|NCT00788957|3121818|P2|Part 1|Death|0
947913|NCT00788957|3121819|P1|Part 1|Death|8
947914|NCT00788775|3121894|P2|Overall Study|Patient's measurable disease resected.|0
947915|NCT00788775|3121895|P1|Overall Study|Patient's measurable disease resected.|1
947916|NCT00788775|3121894|P2|Overall Study|Patient Non-Compliance|0
947917|NCT00788775|3121895|P1|Overall Study|Patient Non-Compliance|1
947918|NCT00788775|3121894|P2|Overall Study|Withdrawal by Subject|2
947919|NCT00788775|3121895|P1|Overall Study|Withdrawal by Subject|0
947920|NCT00788775|3121894|P2|Overall Study|Progressive Disease|6
947921|NCT00788775|3121895|P1|Overall Study|Progressive Disease|8
947922|NCT00788710|3121910|P3|Overall Study|Withdrawal by Subject|0
947923|NCT00788710|3121911|P2|Overall Study|Withdrawal by Subject|2
947924|NCT00788710|3121912|P1|Overall Study|Withdrawal by Subject|2
947925|NCT00788710|3121910|P3|Overall Study|Protocol Violation|1
947926|NCT00788710|3121911|P2|Overall Study|Protocol Violation|1
947927|NCT00788710|3121912|P1|Overall Study|Protocol Violation|0
947928|NCT00788710|3121910|P3|Overall Study|Physician Decision|0
947929|NCT00788710|3121911|P2|Overall Study|Physician Decision|1
947930|NCT00788710|3121912|P1|Overall Study|Physician Decision|2
947931|NCT00788710|3121910|P3|Overall Study|Lost to Follow-up|0
947932|NCT00788710|3121911|P2|Overall Study|Lost to Follow-up|1
947933|NCT00788710|3121912|P1|Overall Study|Lost to Follow-up|0
947934|NCT00788710|3121910|P3|Overall Study|Lack of Efficacy|1
947935|NCT00788710|3121911|P2|Overall Study|Lack of Efficacy|0
947936|NCT00788710|3121912|P1|Overall Study|Lack of Efficacy|0
947937|NCT00788710|3121910|P3|Overall Study|Adverse Event|4
947938|NCT00788710|3121911|P2|Overall Study|Adverse Event|3
947939|NCT00788710|3121912|P1|Overall Study|Adverse Event|1
947940|NCT00788697|3121926|P1|Overall Study|Indeterminate diagnosis from truth stand|17
947941|NCT00788697|3121926|P1|Overall Study|Technically inadequate truth standard|1
947942|NCT00788697|3121926|P1|Overall Study|no truth standard procedure available|5
947943|NCT00788697|3121926|P1|Overall Study|Training Patients|74
947944|NCT00788697|3121926|P1|Overall Study|No study drug administered|12
947945|NCT00788593|3121973|P3|Second Intervention Period|Other|1
947946|NCT00788593|3121974|P2|Second Intervention Period|Other|0
947947|NCT00788593|3121975|P1|Second Intervention Period|Other|0
947948|NCT00788593|3121973|P3|Second Intervention Period|Lost to Follow-up|0
947949|NCT00788593|3121974|P2|Second Intervention Period|Lost to Follow-up|1
947950|NCT00788593|3121975|P1|Second Intervention Period|Lost to Follow-up|0
947951|NCT00788593|3121973|P3|First Intervention Period|Adverse Event|0
947952|NCT00788593|3121974|P2|First Intervention Period|Adverse Event|1
947953|NCT00788593|3121975|P1|First Intervention Period|Adverse Event|0
947954|NCT00788593|3121973|P3|Placebo Run-in Phase|Protocol Violation|0
947955|NCT00788593|3121974|P2|Placebo Run-in Phase|Protocol Violation|0
947956|NCT00788593|3121975|P1|Placebo Run-in Phase|Protocol Violation|2
947957|NCT00788593|3121973|P3|Placebo Run-in Phase|Withdrawal by Subject|0
947958|NCT00788593|3121974|P2|Placebo Run-in Phase|Withdrawal by Subject|0
947959|NCT00788593|3121975|P1|Placebo Run-in Phase|Withdrawal by Subject|2
947960|NCT00788593|3121973|P3|Placebo Run-in Phase|Adverse Event|0
947961|NCT00788593|3121974|P2|Placebo Run-in Phase|Adverse Event|0
947962|NCT00788593|3121975|P1|Placebo Run-in Phase|Adverse Event|2
947963|NCT00788372|3121992|P1|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1
947964|NCT00788372|3121992|P1|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9
947965|NCT00788372|3121992|P1|Period 2 (Week 4 to Week 52)|Physician Decision|9
947966|NCT00788372|3121992|P1|Period 2 (Week 4 to Week 52)|Adverse Event|13
947967|NCT00788372|3121992|P1|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4
947968|NCT00788372|3121992|P1|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9
947969|NCT00788372|3121992|P1|Period 1 (up to 4 Weeks)|Adverse Event|18
947970|NCT00788073|3122021|P2|Placebo Then STX209|Protocol Violation|1
947971|NCT00788073|3122022|P1|Placebo Then STX209|Protocol Violation|0
947972|NCT00788073|3122021|P2|Placebo Then STX209|Adverse Event|0
947973|NCT00788073|3122022|P1|Placebo Then STX209|Adverse Event|2
947974|NCT00788073|3122021|P2|STX209 Then Placebo|unable to return due to travel|1
947975|NCT00788073|3122022|P1|STX209 Then Placebo|unable to return due to travel|0
947976|NCT00788073|3122021|P2|STX209 Then Placebo|Withdrawal by Subject|1
947977|NCT00788073|3122022|P1|STX209 Then Placebo|Withdrawal by Subject|0
947978|NCT00788073|3122021|P2|STX209 Then Placebo|Lost to Follow-up|1
947979|NCT00788073|3122022|P1|STX209 Then Placebo|Lost to Follow-up|0
947980|NCT00788073|3122021|P2|STX209 Then Placebo|Adverse Event|0
947981|NCT00788073|3122022|P1|STX209 Then Placebo|Adverse Event|1
947982|NCT00787930|3122047|P1|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3
947983|NCT00787917|3122062|P2|Open Label|Administrative problems|0
947984|NCT00787917|3122063|P1|Open Label|Administrative problems|3
947985|NCT00787917|3122062|P2|Open Label|Unsatisfactory therapeutic effect|0
947986|NCT00787917|3122063|P1|Open Label|Unsatisfactory therapeutic effect|1
947987|NCT00787917|3122062|P2|Blinded Treatment|Administrative problems|2
947988|NCT00787917|3122063|P1|Blinded Treatment|Administrative problems|3
947989|NCT00787917|3122062|P2|Blinded Treatment|Lack of Efficacy|0
947990|NCT00787917|3122063|P1|Blinded Treatment|Lack of Efficacy|1
947991|NCT00787917|3122062|P2|Blinded Treatment|Adverse Event|0
947992|NCT00787917|3122063|P1|Blinded Treatment|Adverse Event|1
947993|NCT00787891|3122093|P2|Maintenance Double-blind Phase (Part 2)|Not specified|2
947994|NCT00787891|3122094|P1|Maintenance Double-blind Phase (Part 2)|Not specified|5
947995|NCT00787891|3122093|P2|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3
947996|NCT00787891|3122094|P1|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1
947997|NCT00787891|3122093|P2|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
947998|NCT00787891|3122094|P1|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
947999|NCT00787891|3122093|P2|Maintenance Double-blind Phase (Part 2)|Adverse Event|1
948084|NCT00787202|3122398|P3|Overall Study|Lost to Follow-up|0
948000|NCT00787891|3122094|P1|Maintenance Double-blind Phase (Part 2)|Adverse Event|0
948001|NCT00787891|3122093|P2|Short-term Double-blind Phase (Part 1)|Not specified|2
948002|NCT00787891|3122094|P1|Short-term Double-blind Phase (Part 1)|Not specified|0
948003|NCT00787891|3122093|P2|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2
948004|NCT00787891|3122094|P1|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6
948005|NCT00787891|3122093|P2|Short-term Double-blind Phase (Part 1)|Physician Decision|0
948006|NCT00787891|3122094|P1|Short-term Double-blind Phase (Part 1)|Physician Decision|1
948007|NCT00787891|3122093|P2|Short-term Double-blind Phase (Part 1)|Protocol Violation|1
948008|NCT00787891|3122094|P1|Short-term Double-blind Phase (Part 1)|Protocol Violation|0
948009|NCT00787891|3122093|P2|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
948010|NCT00787891|3122094|P1|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
948011|NCT00787891|3122093|P2|Short-term Double-blind Phase (Part 1)|Adverse Event|2
948012|NCT00787891|3122094|P1|Short-term Double-blind Phase (Part 1)|Adverse Event|1
948013|NCT00787839|3122121|P1|Overall Study|Failure to have the OGTT was most common|404
948014|NCT00787800|3122144|P2|Overall Study|Death|2
948015|NCT00787800|3122145|P1|Overall Study|Death|0
948016|NCT00787800|3122144|P2|Overall Study|Withdrawal by Subject|5
948017|NCT00787800|3122145|P1|Overall Study|Withdrawal by Subject|3
948018|NCT00787787|3122161|P1|Overall Study|Adverse Event|3
948019|NCT00787787|3122161|P1|Overall Study|Lack of Efficacy|4
948020|NCT00787644|3122180|P2|Overall Study|Withdrawal by Subject|1
948021|NCT00787644|3122181|P1|Overall Study|Withdrawal by Subject|1
948022|NCT00787644|3122180|P2|Overall Study|Lost to Follow-up|1
948023|NCT00787644|3122181|P1|Overall Study|Lost to Follow-up|1
948024|NCT00787605|3122202|P2|Overall Study|Lack of Efficacy|9
948025|NCT00787605|3122203|P1|Overall Study|Lack of Efficacy|13
948026|NCT00787605|3122202|P2|Overall Study|Withdrawal by Subject|13
948027|NCT00787605|3122203|P1|Overall Study|Withdrawal by Subject|6
948028|NCT00787605|3122202|P2|Overall Study|Protocol Violation|3
948029|NCT00787605|3122203|P1|Overall Study|Protocol Violation|7
948030|NCT00787605|3122202|P2|Overall Study|Lost to Follow-up|6
948031|NCT00787605|3122203|P1|Overall Study|Lost to Follow-up|3
948032|NCT00787605|3122202|P2|Overall Study|Adverse Event|25
948033|NCT00787605|3122203|P1|Overall Study|Adverse Event|14
948034|NCT00787605|3122202|P2|Overall Study|Administrative Problems|0
948035|NCT00787605|3122203|P1|Overall Study|Administrative Problems|3
948036|NCT00787566|3122222|P3|Overall Study|AE related to chemotherapy|0
948037|NCT00787566|3122223|P2|Overall Study|AE related to chemotherapy|1
948038|NCT00787566|3122224|P1|Overall Study|AE related to chemotherapy|0
948039|NCT00787527|3122232|P1|Overall Study|Toxicity|3
948040|NCT00787319|3122249|P1|Overall Study|Inactive disease|5
948041|NCT00787319|3122249|P1|Overall Study|Stabilized disease findings|3
948042|NCT00787319|3122249|P1|Overall Study|No health insurance reimbursement|2
948043|NCT00787319|3122249|P1|Overall Study|Unresponsiveness to visit invitation|1
948044|NCT00787319|3122249|P1|Overall Study|Budget exhausted/exceeded|1
948045|NCT00787319|3122249|P1|Overall Study|Lack of Efficacy|1
948046|NCT00787319|3122249|P1|Overall Study|Objective progression or relapse|30
948047|NCT00787319|3122249|P1|Overall Study|Adverse Event|3
948048|NCT00787319|3122249|P1|Overall Study|Withdrawal by Subject|15
948049|NCT00787319|3122249|P1|Overall Study|Lost to Follow-up|2
948050|NCT00787267|3122261|P1|Overall Study|Withdrawal by Subject|1
948051|NCT00787267|3122261|P1|Overall Study|No Reason Provided|1
948052|NCT00787267|3122261|P1|Overall Study|Screen failure/Ineligible|10
948053|NCT00787254|3122271|P2|Overall Study|Physician Decision|8
948054|NCT00787254|3122272|P1|Overall Study|Physician Decision|4
948055|NCT00787254|3122271|P2|Overall Study|Institution closed|0
948056|NCT00787254|3122272|P1|Overall Study|Institution closed|1
948057|NCT00787254|3122271|P2|Overall Study|NSAIDs discontinuation|2
948058|NCT00787254|3122272|P1|Overall Study|NSAIDs discontinuation|1
948059|NCT00787254|3122271|P2|Overall Study|Lack of Efficacy|15
948060|NCT00787254|3122272|P1|Overall Study|Lack of Efficacy|4
948061|NCT00787254|3122271|P2|Overall Study|Withdrawal by Subject|11
948062|NCT00787254|3122272|P1|Overall Study|Withdrawal by Subject|16
948063|NCT00787254|3122271|P2|Overall Study|Protocol Violation|23
948064|NCT00787254|3122272|P1|Overall Study|Protocol Violation|26
948065|NCT00787254|3122271|P2|Overall Study|Adverse Event|23
948066|NCT00787254|3122272|P1|Overall Study|Adverse Event|24
948067|NCT00787202|3122396|P5|Overall Study|Randomized, not treated|0
948068|NCT00787202|3122397|P4|Overall Study|Randomized, not treated|0
948069|NCT00787202|3122398|P3|Overall Study|Randomized, not treated|0
948070|NCT00787202|3122399|P2|Overall Study|Randomized, not treated|0
948071|NCT00787202|3122400|P1|Overall Study|Randomized, not treated|1
948072|NCT00787202|3122396|P5|Overall Study|Protocol Violation|1
948073|NCT00787202|3122397|P4|Overall Study|Protocol Violation|0
948074|NCT00787202|3122398|P3|Overall Study|Protocol Violation|0
948075|NCT00787202|3122399|P2|Overall Study|Protocol Violation|1
948076|NCT00787202|3122400|P1|Overall Study|Protocol Violation|2
948077|NCT00787202|3122396|P5|Overall Study|Withdrawal by Subject|0
948078|NCT00787202|3122397|P4|Overall Study|Withdrawal by Subject|0
948079|NCT00787202|3122398|P3|Overall Study|Withdrawal by Subject|2
948080|NCT00787202|3122399|P2|Overall Study|Withdrawal by Subject|2
948081|NCT00787202|3122400|P1|Overall Study|Withdrawal by Subject|2
948082|NCT00787202|3122396|P5|Overall Study|Lost to Follow-up|0
948083|NCT00787202|3122397|P4|Overall Study|Lost to Follow-up|0
948085|NCT00787202|3122399|P2|Overall Study|Lost to Follow-up|0
948086|NCT00787202|3122400|P1|Overall Study|Lost to Follow-up|1
948087|NCT00787202|3122396|P5|Overall Study|Lack of Efficacy|1
948088|NCT00787202|3122397|P4|Overall Study|Lack of Efficacy|2
948089|NCT00787202|3122398|P3|Overall Study|Lack of Efficacy|5
948090|NCT00787202|3122399|P2|Overall Study|Lack of Efficacy|6
948091|NCT00787202|3122400|P1|Overall Study|Lack of Efficacy|5
948092|NCT00787202|3122396|P5|Overall Study|Adverse Event|2
948093|NCT00787202|3122397|P4|Overall Study|Adverse Event|0
948094|NCT00787202|3122398|P3|Overall Study|Adverse Event|0
948095|NCT00787202|3122399|P2|Overall Study|Adverse Event|2
948096|NCT00787202|3122400|P1|Overall Study|Adverse Event|3
948097|NCT00787189|3122453|P2|Overall Study|Lost to Follow-up|2
948098|NCT00787189|3122454|P1|Overall Study|Lost to Follow-up|2
948099|NCT00787150|3122463|P3|Overall Study|Dosing incorrect study durg|0
948100|NCT00787150|3122464|P2|Overall Study|Dosing incorrect study durg|0
948101|NCT00787150|3122465|P1|Overall Study|Dosing incorrect study durg|2
948102|NCT00787150|3122463|P3|Overall Study|Withdrawal by Subject|0
948103|NCT00787150|3122464|P2|Overall Study|Withdrawal by Subject|1
948104|NCT00787150|3122465|P1|Overall Study|Withdrawal by Subject|2
948105|NCT00787150|3122463|P3|Overall Study|Physician Decision|1
948106|NCT00787150|3122464|P2|Overall Study|Physician Decision|2
948107|NCT00787150|3122465|P1|Overall Study|Physician Decision|1
948108|NCT00787150|3122463|P3|Overall Study|Adverse Event|4
948109|NCT00787150|3122464|P2|Overall Study|Adverse Event|4
948110|NCT00787150|3122465|P1|Overall Study|Adverse Event|4
948111|NCT00787137|3122510|P3|Overall Study|Study Termination|1
948112|NCT00787137|3122511|P2|Overall Study|Study Termination|0
948113|NCT00787137|3122512|P1|Overall Study|Study Termination|0
948114|NCT00786864|3122587|P2|Overall Study|Sustained serious back injury|0
948115|NCT00786864|3122588|P1|Overall Study|Sustained serious back injury|1
948116|NCT00786864|3122587|P2|Overall Study|Lost to Follow-up|1
948117|NCT00786864|3122588|P1|Overall Study|Lost to Follow-up|0
948118|NCT00786838|3122600|P1|Overall Study|Withdrawal by Subject|4
948119|NCT00786838|3122600|P1|Overall Study|Progressive disease|31
948120|NCT00786838|3122600|P1|Overall Study|Adverse Event|6
948121|NCT00786838|3122600|P1|Overall Study|Death|4
948122|NCT00786838|3122600|P1|Overall Study|Physician Decision|4
948123|NCT00786799|3122627|P2|Overall Study|Lost to Follow-up|1
948124|NCT00786799|3122628|P1|Overall Study|Lost to Follow-up|1
948125|NCT00786565|3122658|P1|Post Surgery|Adapt AO implanted posterior side up|1
948126|NCT00786565|3122658|P1|Post Surgery|Abnormal macular pucker|1
948127|NCT00786565|3122658|P1|Enrollment Prior to Surgery|Protocol Violation|3
948128|NCT00786565|3122658|P1|Enrollment Prior to Surgery|Site Closed|3
948129|NCT00786474|3122715|P2|Overall Study|Not Specified|4
948130|NCT00786474|3122716|P1|Overall Study|Not Specified|4
948131|NCT00786474|3122715|P2|Overall Study|Physician Decision|1
948132|NCT00786474|3122716|P1|Overall Study|Physician Decision|2
948133|NCT00786474|3122715|P2|Overall Study|Lost to Follow-up|3
948134|NCT00786474|3122716|P1|Overall Study|Lost to Follow-up|3
948135|NCT00786474|3122715|P2|Overall Study|Withdrawal by Subject|31
948136|NCT00786474|3122716|P1|Overall Study|Withdrawal by Subject|23
948137|NCT00786474|3122715|P2|Overall Study|Death|4
948138|NCT00786474|3122716|P1|Overall Study|Death|5
948139|NCT00786422|3122728|P1|Follow-up Period|End-of-study done up to 4 days early|2
948140|NCT00786422|3122728|P1|Follow-up Period|Death|1
948141|NCT00786422|3122728|P1|Rivaroxaban Treatment|Adverse Event|2
948142|NCT00786422|3122728|P1|Rivaroxaban Treatment|Non-compliance with study drug treatment|1
948143|NCT00786422|3122728|P1|Rivaroxaban Treatment|Withdrawal by Subject|1
948144|NCT00786422|3122728|P1|Rivaroxaban Treatment|Physician Decision|1
948145|NCT00786422|3122728|P1|Rivaroxaban Treatment|Lack of Efficacy|1
948146|NCT00786422|3122728|P1|Rivaroxaban Treatment|Final visit earlier than planned|3
948147|NCT00786422|3122728|P1|Rivaroxaban Treatment|Death|2
948148|NCT00786409|3122744|P1|Overall Study|Lost to Follow-up|1
948149|NCT00786409|3122744|P1|Overall Study|Pregnancy|2
948150|NCT00786409|3122744|P1|Overall Study|Adverse Event|2
948151|NCT00786409|3122744|P1|Overall Study|Withdrawal by Subject|2
948152|NCT00786188|3122761|P2|Overall Study|Withdrawal by Subject|0
948153|NCT00786188|3122762|P1|Overall Study|Withdrawal by Subject|2
948154|NCT00786188|3122761|P2|Overall Study|Adverse Event|1
948155|NCT00786188|3122762|P1|Overall Study|Adverse Event|3
948156|NCT00786032|3122788|P1|Overall Study|Did not complete in the timeframe|6
948157|NCT00786032|3122788|P1|Overall Study|Withdrawal by Subject|14
948158|NCT00786032|3122788|P1|Overall Study|Death|4
948159|NCT00785980|3122809|P1|7 Day Washout Period|Protocol Violation|3
948160|NCT00785928|3122827|P7|Treatment Phase|Withdrawal by Subject|0
948161|NCT00785928|3122828|P6|Treatment Phase|Withdrawal by Subject|0
948162|NCT00785928|3122829|P5|Treatment Phase|Withdrawal by Subject|1
948163|NCT00785928|3122830|P4|Treatment Phase|Withdrawal by Subject|0
948164|NCT00785928|3122831|P3|Treatment Phase|Withdrawal by Subject|0
948165|NCT00785928|3122832|P2|Treatment Phase|Withdrawal by Subject|2
948166|NCT00785928|3122833|P1|Treatment Phase|Withdrawal by Subject|1
948167|NCT00785928|3122827|P7|Treatment Phase|Sponsor Decision|1
948168|NCT00785928|3122828|P6|Treatment Phase|Sponsor Decision|0
948169|NCT00785928|3122829|P5|Treatment Phase|Sponsor Decision|0
948170|NCT00785928|3122830|P4|Treatment Phase|Sponsor Decision|0
948171|NCT00785928|3122831|P3|Treatment Phase|Sponsor Decision|0
948172|NCT00785928|3122832|P2|Treatment Phase|Sponsor Decision|0
948173|NCT00785928|3122833|P1|Treatment Phase|Sponsor Decision|1
948174|NCT00785928|3122827|P7|Treatment Phase|Physician Decision|0
948175|NCT00785928|3122828|P6|Treatment Phase|Physician Decision|0
948176|NCT00785928|3122829|P5|Treatment Phase|Physician Decision|1
948177|NCT00785928|3122830|P4|Treatment Phase|Physician Decision|0
948178|NCT00785928|3122831|P3|Treatment Phase|Physician Decision|0
948179|NCT00785928|3122832|P2|Treatment Phase|Physician Decision|0
948180|NCT00785928|3122833|P1|Treatment Phase|Physician Decision|0
948181|NCT00785928|3122827|P7|Treatment Phase|Lack of Efficacy|0
948182|NCT00785928|3122828|P6|Treatment Phase|Lack of Efficacy|0
948183|NCT00785928|3122829|P5|Treatment Phase|Lack of Efficacy|0
948184|NCT00785928|3122830|P4|Treatment Phase|Lack of Efficacy|0
948185|NCT00785928|3122831|P3|Treatment Phase|Lack of Efficacy|1
948186|NCT00785928|3122832|P2|Treatment Phase|Lack of Efficacy|1
948187|NCT00785928|3122833|P1|Treatment Phase|Lack of Efficacy|0
948188|NCT00785928|3122827|P7|Treatment Phase|Inadequate Response|0
948189|NCT00785928|3122828|P6|Treatment Phase|Inadequate Response|0
948190|NCT00785928|3122829|P5|Treatment Phase|Inadequate Response|0
948191|NCT00785928|3122830|P4|Treatment Phase|Inadequate Response|0
948192|NCT00785928|3122831|P3|Treatment Phase|Inadequate Response|0
948193|NCT00785928|3122832|P2|Treatment Phase|Inadequate Response|1
948194|NCT00785928|3122833|P1|Treatment Phase|Inadequate Response|0
948195|NCT00785928|3122827|P7|Treatment Phase|Adverse Event|2
948196|NCT00785928|3122828|P6|Treatment Phase|Adverse Event|0
948197|NCT00785928|3122829|P5|Treatment Phase|Adverse Event|0
948198|NCT00785928|3122830|P4|Treatment Phase|Adverse Event|0
948199|NCT00785928|3122831|P3|Treatment Phase|Adverse Event|2
948200|NCT00785928|3122832|P2|Treatment Phase|Adverse Event|1
948201|NCT00785928|3122833|P1|Treatment Phase|Adverse Event|1
948202|NCT00785785|3122980|P2|Optional Extension Phase|Study terminated by sponsor|37
948203|NCT00785785|3122981|P1|Optional Extension Phase|Study terminated by sponsor|3
948204|NCT00785785|3122980|P2|Optional Extension Phase|Protocol deviation|2
948205|NCT00785785|3122981|P1|Optional Extension Phase|Protocol deviation|0
948206|NCT00785785|3122980|P2|Optional Extension Phase|Disease progression|70
948207|NCT00785785|3122981|P1|Optional Extension Phase|Disease progression|22
948208|NCT00785785|3122980|P2|Optional Extension Phase|Death|5
948209|NCT00785785|3122981|P1|Optional Extension Phase|Death|1
948210|NCT00785785|3122980|P2|Optional Extension Phase|Administrative problems|0
948211|NCT00785785|3122981|P1|Optional Extension Phase|Administrative problems|2
948212|NCT00785785|3122980|P2|Optional Extension Phase|Lost to Follow-up|0
948213|NCT00785785|3122981|P1|Optional Extension Phase|Lost to Follow-up|1
948214|NCT00785785|3122980|P2|Optional Extension Phase|Withdrawal by Subject|6
948215|NCT00785785|3122981|P1|Optional Extension Phase|Withdrawal by Subject|6
948216|NCT00785785|3122980|P2|Optional Extension Phase|Adverse Event|5
948217|NCT00785785|3122981|P1|Optional Extension Phase|Adverse Event|4
948218|NCT00785785|3122980|P2|Core Phase up to 36 Months|Study terminated by sponsor|133
948219|NCT00785785|3122981|P1|Core Phase up to 36 Months|Study terminated by sponsor|116
948220|NCT00785785|3122980|P2|Core Phase up to 36 Months|Protocol deviation|6
948221|NCT00785785|3122981|P1|Core Phase up to 36 Months|Protocol deviation|5
948222|NCT00785785|3122980|P2|Core Phase up to 36 Months|Disease progression|119
948223|NCT00785785|3122981|P1|Core Phase up to 36 Months|Disease progression|139
948224|NCT00785785|3122980|P2|Core Phase up to 36 Months|Death|8
948225|NCT00785785|3122981|P1|Core Phase up to 36 Months|Death|5
948226|NCT00785785|3122980|P2|Core Phase up to 36 Months|Administrative problems|3
948227|NCT00785785|3122981|P1|Core Phase up to 36 Months|Administrative problems|3
948228|NCT00785785|3122980|P2|Core Phase up to 36 Months|Lost to Follow-up|7
948229|NCT00785785|3122981|P1|Core Phase up to 36 Months|Lost to Follow-up|3
948230|NCT00785785|3122980|P2|Core Phase up to 36 Months|Withdrawal by Subject|17
948231|NCT00785785|3122981|P1|Core Phase up to 36 Months|Withdrawal by Subject|16
948232|NCT00785785|3122980|P2|Core Phase up to 36 Months|Abnormal test procedure result|2
948233|NCT00785785|3122981|P1|Core Phase up to 36 Months|Abnormal test procedure result|2
948234|NCT00785785|3122980|P2|Core Phase up to 36 Months|Abnormal laboratory value|0
948235|NCT00785785|3122981|P1|Core Phase up to 36 Months|Abnormal laboratory value|1
948236|NCT00785785|3122980|P2|Core Phase up to 36 Months|Adverse Event|21
948237|NCT00785785|3122981|P1|Core Phase up to 36 Months|Adverse Event|31
948238|NCT00785785|3122980|P2|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4
948239|NCT00785785|3122981|P1|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3
948240|NCT00785707|3122995|P1|Overall Study|Lost to Follow-up|7
948241|NCT00785629|3123004|P4|Overall Study|Withdrawal by Subject|2
948242|NCT00785629|3123005|P3|Overall Study|Withdrawal by Subject|2
948243|NCT00785629|3123006|P2|Overall Study|Withdrawal by Subject|1
948244|NCT00785629|3123007|P1|Overall Study|Withdrawal by Subject|0
948245|NCT00785629|3123004|P4|Overall Study|administrative decision|4
948246|NCT00785629|3123005|P3|Overall Study|administrative decision|3
948247|NCT00785629|3123006|P2|Overall Study|administrative decision|1
948248|NCT00785629|3123007|P1|Overall Study|administrative decision|5
948249|NCT00785629|3123004|P4|Overall Study|Protocol Violation|5
948250|NCT00785629|3123005|P3|Overall Study|Protocol Violation|4
948251|NCT00785629|3123006|P2|Overall Study|Protocol Violation|2
948252|NCT00785629|3123007|P1|Overall Study|Protocol Violation|1
948253|NCT00785629|3123004|P4|Overall Study|Adverse Event|5
948254|NCT00785629|3123005|P3|Overall Study|Adverse Event|1
948255|NCT00785629|3123006|P2|Overall Study|Adverse Event|1
948256|NCT00785629|3123007|P1|Overall Study|Adverse Event|2
948257|NCT00785577|3123020|P5|Study Period 3: 1-Week Washout Phase|Death|1
948258|NCT00785577|3123021|P4|Study Period 3: 1-Week Washout Phase|Death|0
948259|NCT00785577|3123022|P3|Study Period 3: 1-Week Washout Phase|Death|0
948260|NCT00785577|3123023|P2|Study Period 3: 1-Week Washout Phase|Death|0
948261|NCT00785577|3123024|P1|Study Period 3: 1-Week Washout Phase|Death|0
948262|NCT00785577|3123020|P5|Study Period 3: 1-Week Washout Phase|Adverse Event|0
948263|NCT00785577|3123021|P4|Study Period 3: 1-Week Washout Phase|Adverse Event|1
948264|NCT00785577|3123022|P3|Study Period 3: 1-Week Washout Phase|Adverse Event|0
948265|NCT00785577|3123023|P2|Study Period 3: 1-Week Washout Phase|Adverse Event|0
948266|NCT00785577|3123024|P1|Study Period 3: 1-Week Washout Phase|Adverse Event|0
948267|NCT00785577|3123020|P5|Study Period 2: Therapy Phase|Sponsor Decision|0
948268|NCT00785577|3123021|P4|Study Period 2: Therapy Phase|Sponsor Decision|1
948269|NCT00785577|3123022|P3|Study Period 2: Therapy Phase|Sponsor Decision|1
948270|NCT00785577|3123023|P2|Study Period 2: Therapy Phase|Sponsor Decision|0
948271|NCT00785577|3123024|P1|Study Period 2: Therapy Phase|Sponsor Decision|1
948272|NCT00785577|3123020|P5|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
948273|NCT00785577|3123021|P4|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
948274|NCT00785577|3123022|P3|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
948275|NCT00785577|3123023|P2|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
948276|NCT00785577|3123024|P1|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
948277|NCT00785577|3123020|P5|Study Period 2: Therapy Phase|Withdrawal by Subject|1
948278|NCT00785577|3123021|P4|Study Period 2: Therapy Phase|Withdrawal by Subject|0
948279|NCT00785577|3123022|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|1
948280|NCT00785577|3123023|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|1
948281|NCT00785577|3123024|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|2
948282|NCT00785577|3123020|P5|Study Period 2: Therapy Phase|Protocol Violation|1
948283|NCT00785577|3123021|P4|Study Period 2: Therapy Phase|Protocol Violation|0
948284|NCT00785577|3123022|P3|Study Period 2: Therapy Phase|Protocol Violation|1
948285|NCT00785577|3123023|P2|Study Period 2: Therapy Phase|Protocol Violation|1
948286|NCT00785577|3123024|P1|Study Period 2: Therapy Phase|Protocol Violation|1
948287|NCT00785577|3123020|P5|Study Period 2: Therapy Phase|Physician Decision|0
948288|NCT00785577|3123021|P4|Study Period 2: Therapy Phase|Physician Decision|0
948289|NCT00785577|3123022|P3|Study Period 2: Therapy Phase|Physician Decision|0
948290|NCT00785577|3123023|P2|Study Period 2: Therapy Phase|Physician Decision|0
948291|NCT00785577|3123024|P1|Study Period 2: Therapy Phase|Physician Decision|1
948292|NCT00785577|3123020|P5|Study Period 2: Therapy Phase|Lost to Follow-up|0
948293|NCT00785577|3123021|P4|Study Period 2: Therapy Phase|Lost to Follow-up|1
948294|NCT00785577|3123022|P3|Study Period 2: Therapy Phase|Lost to Follow-up|0
948295|NCT00785577|3123023|P2|Study Period 2: Therapy Phase|Lost to Follow-up|0
948296|NCT00785577|3123024|P1|Study Period 2: Therapy Phase|Lost to Follow-up|0
948297|NCT00785577|3123020|P5|Study Period 2: Therapy Phase|Lack of Efficacy|1
948298|NCT00785577|3123021|P4|Study Period 2: Therapy Phase|Lack of Efficacy|0
948299|NCT00785577|3123022|P3|Study Period 2: Therapy Phase|Lack of Efficacy|0
948300|NCT00785577|3123023|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
948301|NCT00785577|3123024|P1|Study Period 2: Therapy Phase|Lack of Efficacy|0
948302|NCT00785577|3123020|P5|Study Period 2: Therapy Phase|Adverse Event|17
948303|NCT00785577|3123021|P4|Study Period 2: Therapy Phase|Adverse Event|10
948304|NCT00785577|3123022|P3|Study Period 2: Therapy Phase|Adverse Event|14
948305|NCT00785577|3123023|P2|Study Period 2: Therapy Phase|Adverse Event|7
948306|NCT00785577|3123024|P1|Study Period 2: Therapy Phase|Adverse Event|5
948307|NCT00785538|3123164|P4|Treatment Period|Withdrawal by Subject|1
948308|NCT00785538|3123165|P3|Treatment Period|Withdrawal by Subject|0
948309|NCT00785538|3123166|P2|Treatment Period|Withdrawal by Subject|0
948310|NCT00785538|3123167|P1|Treatment Period|Withdrawal by Subject|0
948311|NCT00785538|3123164|P4|Treatment Period|Adverse Event|0
948312|NCT00785538|3123165|P3|Treatment Period|Adverse Event|2
948313|NCT00785538|3123166|P2|Treatment Period|Adverse Event|2
948314|NCT00785538|3123167|P1|Treatment Period|Adverse Event|1
948315|NCT00785512|3123215|P2|Overall Study|Lack of compliance|1
948316|NCT00785512|3123216|P1|Overall Study|Lack of compliance|0
948317|NCT00785512|3123215|P2|Overall Study|Physician Decision|0
948318|NCT00785512|3123216|P1|Overall Study|Physician Decision|0
948319|NCT00785512|3123215|P2|Overall Study|IVRS Programing Error|0
948320|NCT00785512|3123216|P1|Overall Study|IVRS Programing Error|0
948321|NCT00785512|3123215|P2|Overall Study|Precedure Refused|0
948322|NCT00785512|3123216|P1|Overall Study|Precedure Refused|0
948323|NCT00785512|3123215|P2|Overall Study|Lost to Follow-up|0
948324|NCT00785512|3123216|P1|Overall Study|Lost to Follow-up|3
948325|NCT00785512|3123215|P2|Overall Study|Withdrawal by Subject|1
948326|NCT00785512|3123216|P1|Overall Study|Withdrawal by Subject|0
948327|NCT00785512|3123215|P2|Overall Study|Lack of Efficacy|2
948328|NCT00785512|3123216|P1|Overall Study|Lack of Efficacy|0
948329|NCT00785512|3123215|P2|Overall Study|Adverse Event|0
948330|NCT00785512|3123216|P1|Overall Study|Adverse Event|0
948331|NCT00785512|3123215|P2|Overall Study|Inclusion/Exclusion not meet|0
948332|NCT00785512|3123216|P1|Overall Study|Inclusion/Exclusion not meet|0
948333|NCT00785486|3123225|P1|Midazolam Alone|Withdrawal by Subject|1
948334|NCT00785356|3123249|P1|Overall Study|Study prematurely terminated|8
948335|NCT00785291|3123260|P3|Overall Study|Other Medical Reasons|15
948336|NCT00785291|3123261|P2|Overall Study|Other Medical Reasons|25
948337|NCT00785291|3123262|P1|Overall Study|Other Medical Reasons|29
948338|NCT00785291|3123260|P3|Overall Study|Complicating illness|4
948339|NCT00785291|3123261|P2|Overall Study|Complicating illness|4
948340|NCT00785291|3123262|P1|Overall Study|Complicating illness|6
948341|NCT00785291|3123260|P3|Overall Study|Alternative Therapy|7
948342|NCT00785291|3123261|P2|Overall Study|Alternative Therapy|6
948343|NCT00785291|3123262|P1|Overall Study|Alternative Therapy|12
948344|NCT00785291|3123260|P3|Overall Study|Withdrawal by Subject|17
948345|NCT00785291|3123261|P2|Overall Study|Withdrawal by Subject|36
948346|NCT00785291|3123262|P1|Overall Study|Withdrawal by Subject|35
948347|NCT00785291|3123260|P3|Overall Study|Death|3
948348|NCT00785291|3123261|P2|Overall Study|Death|4
948349|NCT00785291|3123262|P1|Overall Study|Death|7
948350|NCT00785291|3123260|P3|Overall Study|Adverse Event|56
948351|NCT00785291|3123261|P2|Overall Study|Adverse Event|70
948352|NCT00785291|3123262|P1|Overall Study|Adverse Event|39
948353|NCT00785291|3123260|P3|Overall Study|Never began treatment|4
948354|NCT00785291|3123261|P2|Overall Study|Never began treatment|4
948355|NCT00785291|3123262|P1|Overall Study|Never began treatment|8
948356|NCT00785213|3123282|P1|Rosiglitazone With Quinine Sulfate|Adverse Event|1
948357|NCT00785213|3123282|P1|Quinine Sulfate Alone|Adverse Event|4
948358|NCT00785044|3123293|P1|Overall Study|Withdrawal by Subject|1
948359|NCT00785044|3123293|P1|Overall Study|Lost to Follow-up|266
948360|NCT00785044|3123293|P1|Overall Study|Death|77
948361|NCT00785044|3123293|P1|Overall Study|Dosed at non-participating sites|152
948362|NCT00784979|3123298|P1|Overall Study|incomplete data|6
948363|NCT00784927|3123302|P1|Overall Study|Ineligible|1
948364|NCT00784927|3123302|P1|Overall Study|Protocol Violation|1
948365|NCT00784927|3123302|P1|Overall Study|Cancel Prior to Initiating Treatment|1
948366|NCT00784875|3123314|P4|Period D|Lost to Follow-up|1
948367|NCT00784875|3123315|P3|Period D|Lost to Follow-up|1
948368|NCT00784875|3123316|P2|Period D|Lost to Follow-up|0
948369|NCT00784875|3123317|P1|Period D|Lost to Follow-up|1
948370|NCT00784875|3123314|P4|Period D|Sponsor Decision|0
948371|NCT00784875|3123315|P3|Period D|Sponsor Decision|1
948372|NCT00784875|3123316|P2|Period D|Sponsor Decision|1
948373|NCT00784875|3123317|P1|Period D|Sponsor Decision|1
948374|NCT00784875|3123314|P4|Period D|Physician Decision|0
948375|NCT00784875|3123315|P3|Period D|Physician Decision|0
948376|NCT00784875|3123316|P2|Period D|Physician Decision|1
948377|NCT00784875|3123317|P1|Period D|Physician Decision|0
948378|NCT00784875|3123314|P4|Period D|Withdrawal by Subject|0
948379|NCT00784875|3123315|P3|Period D|Withdrawal by Subject|2
948380|NCT00784875|3123316|P2|Period D|Withdrawal by Subject|0
948381|NCT00784875|3123317|P1|Period D|Withdrawal by Subject|2
948382|NCT00784875|3123314|P4|Period D|Protocol Violation|0
948383|NCT00784875|3123315|P3|Period D|Protocol Violation|0
948384|NCT00784875|3123316|P2|Period D|Protocol Violation|0
948385|NCT00784875|3123317|P1|Period D|Protocol Violation|1
948386|NCT00784875|3123314|P4|Period D|Adverse Event|0
948387|NCT00784875|3123315|P3|Period D|Adverse Event|2
948388|NCT00784875|3123316|P2|Period D|Adverse Event|2
948389|NCT00784875|3123317|P1|Period D|Adverse Event|0
948390|NCT00784875|3123314|P4|Period C|Sponsor Decision|2
948391|NCT00784875|3123315|P3|Period C|Sponsor Decision|4
948392|NCT00784875|3123316|P2|Period C|Sponsor Decision|5
948393|NCT00784875|3123317|P1|Period C|Sponsor Decision|5
948394|NCT00784875|3123314|P4|Period C|Physician Decision|1
948395|NCT00784875|3123315|P3|Period C|Physician Decision|1
948396|NCT00784875|3123316|P2|Period C|Physician Decision|0
948397|NCT00784875|3123317|P1|Period C|Physician Decision|0
948398|NCT00784875|3123314|P4|Period C|Withdrawal by Subject|0
948399|NCT00784875|3123315|P3|Period C|Withdrawal by Subject|2
948400|NCT00784875|3123316|P2|Period C|Withdrawal by Subject|1
948401|NCT00784875|3123317|P1|Period C|Withdrawal by Subject|1
948402|NCT00784875|3123314|P4|Period C|Lack of Efficacy|0
948403|NCT00784875|3123315|P3|Period C|Lack of Efficacy|1
948404|NCT00784875|3123316|P2|Period C|Lack of Efficacy|0
948405|NCT00784875|3123317|P1|Period C|Lack of Efficacy|0
948406|NCT00784875|3123314|P4|Period C|Protocol Violation|2
948407|NCT00784875|3123315|P3|Period C|Protocol Violation|1
948408|NCT00784875|3123316|P2|Period C|Protocol Violation|0
948409|NCT00784875|3123317|P1|Period C|Protocol Violation|0
948410|NCT00784875|3123314|P4|Period C|Adverse Event|2
948411|NCT00784875|3123315|P3|Period C|Adverse Event|4
948412|NCT00784875|3123316|P2|Period C|Adverse Event|0
948413|NCT00784875|3123317|P1|Period C|Adverse Event|1
948414|NCT00784875|3123314|P4|Period B - Efficacy Endpoint|Lost to Follow-up|0
948415|NCT00784875|3123315|P3|Period B - Efficacy Endpoint|Lost to Follow-up|1
948416|NCT00784875|3123316|P2|Period B - Efficacy Endpoint|Lost to Follow-up|0
948417|NCT00784875|3123317|P1|Period B - Efficacy Endpoint|Lost to Follow-up|0
948418|NCT00784875|3123314|P4|Period B - Efficacy Endpoint|Sponsor Decision|12
948419|NCT00784875|3123315|P3|Period B - Efficacy Endpoint|Sponsor Decision|12
948420|NCT00784875|3123316|P2|Period B - Efficacy Endpoint|Sponsor Decision|6
948421|NCT00784875|3123317|P1|Period B - Efficacy Endpoint|Sponsor Decision|9
948422|NCT00784875|3123314|P4|Period B - Efficacy Endpoint|Physician Decision|0
948423|NCT00784875|3123315|P3|Period B - Efficacy Endpoint|Physician Decision|1
948424|NCT00784875|3123316|P2|Period B - Efficacy Endpoint|Physician Decision|0
948425|NCT00784875|3123317|P1|Period B - Efficacy Endpoint|Physician Decision|0
948426|NCT00784875|3123314|P4|Period B - Efficacy Endpoint|Withdrawal by Subject|2
948427|NCT00784875|3123315|P3|Period B - Efficacy Endpoint|Withdrawal by Subject|1
948428|NCT00784875|3123316|P2|Period B - Efficacy Endpoint|Withdrawal by Subject|1
948429|NCT00784875|3123317|P1|Period B - Efficacy Endpoint|Withdrawal by Subject|4
948430|NCT00784875|3123314|P4|Period B - Efficacy Endpoint|Lack of Efficacy|0
948431|NCT00784875|3123315|P3|Period B - Efficacy Endpoint|Lack of Efficacy|0
948432|NCT00784875|3123316|P2|Period B - Efficacy Endpoint|Lack of Efficacy|1
948433|NCT00784875|3123317|P1|Period B - Efficacy Endpoint|Lack of Efficacy|0
948434|NCT00784875|3123314|P4|Period B - Efficacy Endpoint|Protocol Violation|3
948435|NCT00784875|3123315|P3|Period B - Efficacy Endpoint|Protocol Violation|2
948436|NCT00784875|3123316|P2|Period B - Efficacy Endpoint|Protocol Violation|1
948437|NCT00784875|3123317|P1|Period B - Efficacy Endpoint|Protocol Violation|1
948438|NCT00784875|3123314|P4|Period B - Efficacy Endpoint|Adverse Event|1
948439|NCT00784875|3123315|P3|Period B - Efficacy Endpoint|Adverse Event|2
948440|NCT00784875|3123316|P2|Period B - Efficacy Endpoint|Adverse Event|3
948441|NCT00784875|3123317|P1|Period B - Efficacy Endpoint|Adverse Event|0
948442|NCT00784875|3123314|P4|Period B - Efficacy Endpoint|Entry Criteria Not Met|1
948443|NCT00784875|3123315|P3|Period B - Efficacy Endpoint|Entry Criteria Not Met|2
948444|NCT00784875|3123316|P2|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
948445|NCT00784875|3123317|P1|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
948446|NCT00784875|3123314|P4|Period A - Baseline|Lost to Follow-up|2
948447|NCT00784875|3123315|P3|Period A - Baseline|Lost to Follow-up|0
948448|NCT00784875|3123316|P2|Period A - Baseline|Lost to Follow-up|0
948449|NCT00784875|3123317|P1|Period A - Baseline|Lost to Follow-up|0
948450|NCT00784875|3123314|P4|Period A - Baseline|Sponsor Decision|113
948451|NCT00784875|3123315|P3|Period A - Baseline|Sponsor Decision|0
948452|NCT00784875|3123316|P2|Period A - Baseline|Sponsor Decision|0
948453|NCT00784875|3123317|P1|Period A - Baseline|Sponsor Decision|0
948454|NCT00784875|3123314|P4|Period A - Baseline|Physician Decision|2
948455|NCT00784875|3123315|P3|Period A - Baseline|Physician Decision|0
948456|NCT00784875|3123316|P2|Period A - Baseline|Physician Decision|0
948457|NCT00784875|3123317|P1|Period A - Baseline|Physician Decision|0
948458|NCT00784875|3123314|P4|Period A - Baseline|Withdrawal by Subject|27
948459|NCT00784875|3123315|P3|Period A - Baseline|Withdrawal by Subject|0
948460|NCT00784875|3123316|P2|Period A - Baseline|Withdrawal by Subject|0
948461|NCT00784875|3123317|P1|Period A - Baseline|Withdrawal by Subject|0
948462|NCT00784875|3123314|P4|Period A - Baseline|Protocol Violation|25
948463|NCT00784875|3123315|P3|Period A - Baseline|Protocol Violation|0
948464|NCT00784875|3123316|P2|Period A - Baseline|Protocol Violation|0
948465|NCT00784875|3123317|P1|Period A - Baseline|Protocol Violation|0
948466|NCT00784875|3123314|P4|Period A - Baseline|Adverse Event|8
948467|NCT00784875|3123315|P3|Period A - Baseline|Adverse Event|0
948468|NCT00784875|3123316|P2|Period A - Baseline|Adverse Event|0
948469|NCT00784875|3123317|P1|Period A - Baseline|Adverse Event|0
948470|NCT00784875|3123314|P4|Period A - Baseline|Entry Criteria Not Met|5
948471|NCT00784875|3123315|P3|Period A - Baseline|Entry Criteria Not Met|0
948472|NCT00784875|3123316|P2|Period A - Baseline|Entry Criteria Not Met|0
948473|NCT00784875|3123317|P1|Period A - Baseline|Entry Criteria Not Met|0
948474|NCT00784836|3123437|P1|Overall Study|Early Study Termination|3
948475|NCT00784810|3123444|P2|Overall Study|Lost to Follow-up|1
948476|NCT00784810|3123445|P1|Overall Study|Lost to Follow-up|1
948477|NCT00784810|3123444|P2|Overall Study|Administrative|8
948478|NCT00784810|3123445|P1|Overall Study|Administrative|5
948479|NCT00784810|3123444|P2|Overall Study|Withdrawal by Subject|9
948480|NCT00784810|3123445|P1|Overall Study|Withdrawal by Subject|11
948481|NCT00784810|3123444|P2|Overall Study|Lack of Efficacy|11
948482|NCT00784810|3123445|P1|Overall Study|Lack of Efficacy|14
948483|NCT00784810|3123444|P2|Overall Study|Adverse Event|20
948484|NCT00784810|3123445|P1|Overall Study|Adverse Event|32
948485|NCT00784784|3123455|P2|Overall Study|Withdrawal by Subject|2
948486|NCT00784784|3123456|P1|Overall Study|Withdrawal by Subject|2
948487|NCT00784719|3123471|P7|Overall Study|Withdrawal by Subject|1
948488|NCT00784719|3123472|P6|Overall Study|Withdrawal by Subject|0
948489|NCT00784719|3123473|P5|Overall Study|Withdrawal by Subject|2
948490|NCT00784719|3123474|P4|Overall Study|Withdrawal by Subject|0
948491|NCT00784719|3123475|P3|Overall Study|Withdrawal by Subject|0
948492|NCT00784719|3123476|P2|Overall Study|Withdrawal by Subject|0
948493|NCT00784719|3123477|P1|Overall Study|Withdrawal by Subject|1
948494|NCT00784719|3123471|P7|Overall Study|Other|3
948495|NCT00784719|3123472|P6|Overall Study|Other|1
948496|NCT00784719|3123473|P5|Overall Study|Other|2
948497|NCT00784719|3123474|P4|Overall Study|Other|0
948498|NCT00784719|3123475|P3|Overall Study|Other|1
948499|NCT00784719|3123476|P2|Overall Study|Other|1
948500|NCT00784719|3123477|P1|Overall Study|Other|2
948501|NCT00784719|3123471|P7|Overall Study|Lost to Follow-up|0
948502|NCT00784719|3123472|P6|Overall Study|Lost to Follow-up|1
948503|NCT00784719|3123473|P5|Overall Study|Lost to Follow-up|1
948504|NCT00784719|3123474|P4|Overall Study|Lost to Follow-up|0
948505|NCT00784719|3123475|P3|Overall Study|Lost to Follow-up|0
948506|NCT00784719|3123476|P2|Overall Study|Lost to Follow-up|0
948507|NCT00784719|3123477|P1|Overall Study|Lost to Follow-up|0
948508|NCT00784719|3123471|P7|Overall Study|Adverse Event|1
948509|NCT00784719|3123472|P6|Overall Study|Adverse Event|1
948510|NCT00784719|3123473|P5|Overall Study|Adverse Event|1
948511|NCT00784719|3123474|P4|Overall Study|Adverse Event|0
948512|NCT00784719|3123475|P3|Overall Study|Adverse Event|0
948513|NCT00784719|3123476|P2|Overall Study|Adverse Event|2
948514|NCT00784719|3123477|P1|Overall Study|Adverse Event|0
948515|NCT00784654|3123647|P3|Randomized Withdrawal Period|Family reasons|1
948516|NCT00784654|3123648|P2|Randomized Withdrawal Period|Family reasons|0
948517|NCT00784654|3123649|P1|Randomized Withdrawal Period|Family reasons|0
948518|NCT00784654|3123647|P3|Randomized Withdrawal Period|Did not complete a visit|0
948519|NCT00784654|3123648|P2|Randomized Withdrawal Period|Did not complete a visit|1
948520|NCT00784654|3123649|P1|Randomized Withdrawal Period|Did not complete a visit|0
948521|NCT00784654|3123647|P3|Randomized Withdrawal Period|Adverse Event|1
948522|NCT00784654|3123648|P2|Randomized Withdrawal Period|Adverse Event|1
948523|NCT00784654|3123649|P1|Randomized Withdrawal Period|Adverse Event|0
948524|NCT00784654|3123647|P3|Randomized Withdrawal Period|Protocol Violation|1
948525|NCT00784654|3123648|P2|Randomized Withdrawal Period|Protocol Violation|2
948526|NCT00784654|3123649|P1|Randomized Withdrawal Period|Protocol Violation|0
948527|NCT00784654|3123647|P3|Randomized Withdrawal Period|Withdrawal by Subject|7
948528|NCT00784654|3123648|P2|Randomized Withdrawal Period|Withdrawal by Subject|1
948529|NCT00784654|3123649|P1|Randomized Withdrawal Period|Withdrawal by Subject|0
948530|NCT00784654|3123647|P3|Randomized Withdrawal Period|Lack of Efficacy|18
948531|NCT00784654|3123648|P2|Randomized Withdrawal Period|Lack of Efficacy|5
948532|NCT00784654|3123649|P1|Randomized Withdrawal Period|Lack of Efficacy|0
948533|NCT00784654|3123647|P3|Randomized Withdrawal Period|Met relapse criteria per investigator|35
948534|NCT00784654|3123648|P2|Randomized Withdrawal Period|Met relapse criteria per investigator|8
948535|NCT00784654|3123649|P1|Randomized Withdrawal Period|Met relapse criteria per investigator|0
948536|NCT00784654|3123647|P3|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
948537|NCT00784654|3123648|P2|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
948538|NCT00784654|3123649|P1|Open-Label Period (Non-Randomized)|Did not provide end of study page|1
948539|NCT00784654|3123647|P3|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
948540|NCT00784654|3123648|P2|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
948541|NCT00784654|3123649|P1|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1
948542|NCT00784654|3123647|P3|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
948543|NCT00784654|3123648|P2|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
948544|NCT00784654|3123649|P1|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1
948545|NCT00784654|3123647|P3|Open-Label Period (Non-Randomized)|Home situation intolerable|0
948546|NCT00784654|3123648|P2|Open-Label Period (Non-Randomized)|Home situation intolerable|0
948547|NCT00784654|3123649|P1|Open-Label Period (Non-Randomized)|Home situation intolerable|1
948548|NCT00784654|3123647|P3|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
948549|NCT00784654|3123648|P2|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
948550|NCT00784654|3123649|P1|Open-Label Period (Non-Randomized)|Decision of medical monitor|1
948551|NCT00784654|3123647|P3|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
948552|NCT00784654|3123648|P2|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
948553|NCT00784654|3123649|P1|Open-Label Period (Non-Randomized)|Mother is a drug addict|1
948554|NCT00784654|3123647|P3|Open-Label Period (Non-Randomized)|Protocol Violation|0
948555|NCT00784654|3123648|P2|Open-Label Period (Non-Randomized)|Protocol Violation|0
948556|NCT00784654|3123649|P1|Open-Label Period (Non-Randomized)|Protocol Violation|7
948557|NCT00784654|3123647|P3|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
948558|NCT00784654|3123648|P2|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
948559|NCT00784654|3123649|P1|Open-Label Period (Non-Randomized)|Lost to Follow-up|11
948560|NCT00784654|3123647|P3|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
948561|NCT00784654|3123648|P2|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
948562|NCT00784654|3123649|P1|Open-Label Period (Non-Randomized)|Lack of Efficacy|21
948563|NCT00784654|3123647|P3|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
948564|NCT00784654|3123648|P2|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
948565|NCT00784654|3123649|P1|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22
948566|NCT00784654|3123647|P3|Open-Label Period (Non-Randomized)|Adverse Event|0
948567|NCT00784654|3123648|P2|Open-Label Period (Non-Randomized)|Adverse Event|0
948568|NCT00784654|3123649|P1|Open-Label Period (Non-Randomized)|Adverse Event|44
948569|NCT00784563|3123684|P3|Year 3|Adverse Event|1
948570|NCT00784563|3123685|P2|Year 3|Adverse Event|0
948571|NCT00784563|3123686|P1|Year 3|Adverse Event|0
948572|NCT00784563|3123684|P3|Year 3|Withdrawal by Subject|2
948573|NCT00784563|3123685|P2|Year 3|Withdrawal by Subject|0
948574|NCT00784563|3123686|P1|Year 3|Withdrawal by Subject|0
948575|NCT00784563|3123684|P3|Years 1 & 2|Adverse Event|0
948576|NCT00784563|3123685|P2|Years 1 & 2|Adverse Event|3
948577|NCT00784563|3123686|P1|Years 1 & 2|Adverse Event|0
948578|NCT00784563|3123684|P3|Years 1 & 2|Withdrawal by Subject|0
948579|NCT00784563|3123685|P2|Years 1 & 2|Withdrawal by Subject|2
948580|NCT00784563|3123686|P1|Years 1 & 2|Withdrawal by Subject|3
948581|NCT00784550|3123704|P2|Overall Study|Withdrawal by Subject|13
948582|NCT00784550|3123705|P1|Overall Study|Withdrawal by Subject|4
948583|NCT00784550|3123704|P2|Overall Study|Physician Decision|3
948584|NCT00784550|3123705|P1|Overall Study|Physician Decision|2
948585|NCT00784550|3123704|P2|Overall Study|Lost to Follow-up|5
948586|NCT00784550|3123705|P1|Overall Study|Lost to Follow-up|8
948587|NCT00784550|3123704|P2|Overall Study|Protocol Violation|10
948588|NCT00784550|3123705|P1|Overall Study|Protocol Violation|10
948589|NCT00784550|3123704|P2|Overall Study|Lack of Efficacy|1
948590|NCT00784550|3123705|P1|Overall Study|Lack of Efficacy|0
948591|NCT00784550|3123704|P2|Overall Study|Adverse Event|10
948592|NCT00784550|3123705|P1|Overall Study|Adverse Event|12
948593|NCT00784459|3123723|P2|Overall Study|Adverse Event|2
948594|NCT00784459|3123724|P1|Overall Study|Adverse Event|0
948595|NCT00784368|3123735|P3|Overall Study|Withdrawal of informed consent|0
948596|NCT00784368|3123736|P2|Overall Study|Withdrawal of informed consent|1
948597|NCT00784368|3123737|P1|Overall Study|Withdrawal of informed consent|0
948598|NCT00784368|3123735|P3|Overall Study|Worsening of symptoms|0
948599|NCT00784368|3123736|P2|Overall Study|Worsening of symptoms|1
948600|NCT00784368|3123737|P1|Overall Study|Worsening of symptoms|0
948601|NCT00784368|3123735|P3|Overall Study|Worsening of complications|1
948602|NCT00784368|3123736|P2|Overall Study|Worsening of complications|0
948603|NCT00784368|3123737|P1|Overall Study|Worsening of complications|0
948604|NCT00784368|3123735|P3|Overall Study|Diagnosis of fever|1
948605|NCT00784368|3123736|P2|Overall Study|Diagnosis of fever|0
948606|NCT00784368|3123737|P1|Overall Study|Diagnosis of fever|0
948607|NCT00784368|3123735|P3|Overall Study|Adverse Event|2
948608|NCT00784368|3123736|P2|Overall Study|Adverse Event|9
948609|NCT00784368|3123737|P1|Overall Study|Adverse Event|6
948610|NCT00784368|3123735|P3|Overall Study|Lack of Efficacy|1
948611|NCT00784368|3123736|P2|Overall Study|Lack of Efficacy|0
948612|NCT00784368|3123737|P1|Overall Study|Lack of Efficacy|2
948613|NCT00784368|3123735|P3|Overall Study|Physician Decision|6
948614|NCT00784368|3123736|P2|Overall Study|Physician Decision|0
948615|NCT00784368|3123737|P1|Overall Study|Physician Decision|0
948616|NCT00784277|3123775|P7|ER Treatment|Other|2
948617|NCT00784277|3123776|P6|ER Treatment|Other|3
948618|NCT00784277|3123777|P5|ER Treatment|Other|1
948619|NCT00784277|3123778|P4|ER Treatment|Other|0
948620|NCT00784277|3123779|P3|ER Treatment|Other|0
948621|NCT00784277|3123780|P2|ER Treatment|Other|0
948622|NCT00784277|3123781|P1|ER Treatment|Other|0
948623|NCT00784277|3123775|P7|ER Treatment|Study Medication Non-Compliant|3
948624|NCT00784277|3123776|P6|ER Treatment|Study Medication Non-Compliant|3
948625|NCT00784277|3123777|P5|ER Treatment|Study Medication Non-Compliant|2
948626|NCT00784277|3123778|P4|ER Treatment|Study Medication Non-Compliant|0
948627|NCT00784277|3123779|P3|ER Treatment|Study Medication Non-Compliant|0
948628|NCT00784277|3123780|P2|ER Treatment|Study Medication Non-Compliant|0
948629|NCT00784277|3123781|P1|ER Treatment|Study Medication Non-Compliant|0
948630|NCT00784277|3123775|P7|ER Treatment|Withdrawal by Subject|3
948631|NCT00784277|3123776|P6|ER Treatment|Withdrawal by Subject|5
948632|NCT00784277|3123777|P5|ER Treatment|Withdrawal by Subject|2
948633|NCT00784277|3123778|P4|ER Treatment|Withdrawal by Subject|0
948634|NCT00784277|3123779|P3|ER Treatment|Withdrawal by Subject|0
948635|NCT00784277|3123780|P2|ER Treatment|Withdrawal by Subject|0
948636|NCT00784277|3123781|P1|ER Treatment|Withdrawal by Subject|0
948637|NCT00784277|3123775|P7|ER Treatment|Lost to Follow-up|0
948638|NCT00784277|3123776|P6|ER Treatment|Lost to Follow-up|2
948639|NCT00784277|3123777|P5|ER Treatment|Lost to Follow-up|0
948640|NCT00784277|3123778|P4|ER Treatment|Lost to Follow-up|0
948641|NCT00784277|3123779|P3|ER Treatment|Lost to Follow-up|0
948642|NCT00784277|3123780|P2|ER Treatment|Lost to Follow-up|0
948643|NCT00784277|3123781|P1|ER Treatment|Lost to Follow-up|0
948644|NCT00784277|3123775|P7|ER Treatment|Lack of Efficacy|0
948645|NCT00784277|3123776|P6|ER Treatment|Lack of Efficacy|4
948646|NCT00784277|3123777|P5|ER Treatment|Lack of Efficacy|3
948647|NCT00784277|3123778|P4|ER Treatment|Lack of Efficacy|0
948648|NCT00784277|3123779|P3|ER Treatment|Lack of Efficacy|0
948649|NCT00784277|3123780|P2|ER Treatment|Lack of Efficacy|0
948650|NCT00784277|3123781|P1|ER Treatment|Lack of Efficacy|0
948651|NCT00784277|3123775|P7|ER Treatment|Adverse Event|7
948652|NCT00784277|3123776|P6|ER Treatment|Adverse Event|7
948653|NCT00784277|3123777|P5|ER Treatment|Adverse Event|1
948654|NCT00784277|3123778|P4|ER Treatment|Adverse Event|0
948655|NCT00784277|3123779|P3|ER Treatment|Adverse Event|0
948656|NCT00784277|3123780|P2|ER Treatment|Adverse Event|0
948657|NCT00784277|3123781|P1|ER Treatment|Adverse Event|0
948658|NCT00784277|3123775|P7|IR Treatment|Other|0
948659|NCT00784277|3123776|P6|IR Treatment|Other|0
948660|NCT00784277|3123777|P5|IR Treatment|Other|0
948661|NCT00784277|3123778|P4|IR Treatment|Other|2
948662|NCT00784277|3123779|P3|IR Treatment|Other|3
948663|NCT00784277|3123780|P2|IR Treatment|Other|3
948664|NCT00784277|3123781|P1|IR Treatment|Other|2
948665|NCT00784277|3123775|P7|IR Treatment|Resolution Of Pain|0
948666|NCT00784277|3123776|P6|IR Treatment|Resolution Of Pain|0
948667|NCT00784277|3123777|P5|IR Treatment|Resolution Of Pain|0
948668|NCT00784277|3123778|P4|IR Treatment|Resolution Of Pain|0
948669|NCT00784277|3123779|P3|IR Treatment|Resolution Of Pain|0
948670|NCT00784277|3123780|P2|IR Treatment|Resolution Of Pain|1
948671|NCT00784277|3123781|P1|IR Treatment|Resolution Of Pain|0
948672|NCT00784277|3123775|P7|IR Treatment|Withdrawal by Subject|0
948673|NCT00784277|3123776|P6|IR Treatment|Withdrawal by Subject|0
948674|NCT00784277|3123777|P5|IR Treatment|Withdrawal by Subject|0
948675|NCT00784277|3123778|P4|IR Treatment|Withdrawal by Subject|6
948676|NCT00784277|3123779|P3|IR Treatment|Withdrawal by Subject|4
948677|NCT00784277|3123780|P2|IR Treatment|Withdrawal by Subject|1
948678|NCT00784277|3123781|P1|IR Treatment|Withdrawal by Subject|5
948679|NCT00784277|3123775|P7|IR Treatment|Lost to Follow-up|0
948680|NCT00784277|3123776|P6|IR Treatment|Lost to Follow-up|0
948681|NCT00784277|3123777|P5|IR Treatment|Lost to Follow-up|0
948682|NCT00784277|3123778|P4|IR Treatment|Lost to Follow-up|0
948683|NCT00784277|3123779|P3|IR Treatment|Lost to Follow-up|1
948684|NCT00784277|3123780|P2|IR Treatment|Lost to Follow-up|0
948685|NCT00784277|3123781|P1|IR Treatment|Lost to Follow-up|1
948686|NCT00784277|3123775|P7|IR Treatment|Lack of Efficacy|0
948687|NCT00784277|3123776|P6|IR Treatment|Lack of Efficacy|0
948688|NCT00784277|3123777|P5|IR Treatment|Lack of Efficacy|0
948689|NCT00784277|3123778|P4|IR Treatment|Lack of Efficacy|0
948690|NCT00784277|3123779|P3|IR Treatment|Lack of Efficacy|1
948691|NCT00784277|3123780|P2|IR Treatment|Lack of Efficacy|4
948692|NCT00784277|3123781|P1|IR Treatment|Lack of Efficacy|4
948693|NCT00784277|3123775|P7|IR Treatment|Adverse Event|0
948694|NCT00784277|3123776|P6|IR Treatment|Adverse Event|0
948695|NCT00784277|3123777|P5|IR Treatment|Adverse Event|0
948696|NCT00784277|3123778|P4|IR Treatment|Adverse Event|35
948697|NCT00784277|3123779|P3|IR Treatment|Adverse Event|19
948698|NCT00784277|3123780|P2|IR Treatment|Adverse Event|8
948699|NCT00784277|3123781|P1|IR Treatment|Adverse Event|4
948700|NCT00784238|3123798|P1|Overall Study|Other|14
948701|NCT00784238|3123798|P1|Overall Study|Withdrawal by Subject|26
948702|NCT00784238|3123798|P1|Overall Study|Pregnancy|1
948703|NCT00784238|3123798|P1|Overall Study|Lost to Follow-up|29
948704|NCT00784238|3123798|P1|Overall Study|Lack of Efficacy|33
948705|NCT00784238|3123798|P1|Overall Study|Death|2
948706|NCT00784238|3123798|P1|Overall Study|Adverse Event|14
948707|NCT00784147|3123841|P2|Overall Study|Death|0
948708|NCT00784147|3123842|P1|Overall Study|Death|2
948709|NCT00784147|3123841|P2|Overall Study|Protocol Violation|1
948710|NCT00784147|3123842|P1|Overall Study|Protocol Violation|1
948711|NCT00784147|3123841|P2|Overall Study|Physician Decision|1
948712|NCT00784147|3123842|P1|Overall Study|Physician Decision|2
948713|NCT00784147|3123841|P2|Overall Study|Withdrawal by Subject|3
948714|NCT00784147|3123842|P1|Overall Study|Withdrawal by Subject|1
948715|NCT00784147|3123841|P2|Overall Study|Lost to Follow-up|4
948716|NCT00784147|3123842|P1|Overall Study|Lost to Follow-up|2
948717|NCT00784134|3123862|P2|Overall Study|Lost to Follow-up|6
948718|NCT00784134|3123863|P1|Overall Study|Lost to Follow-up|3
948719|NCT00784043|3123986|P2|Overall Study|Protocol Terminated|1
948720|NCT00784043|3123987|P1|Overall Study|Protocol Terminated|23
948721|NCT00784043|3123986|P2|Overall Study|Withdrawal by Subject|5
948722|NCT00784043|3123987|P1|Overall Study|Withdrawal by Subject|8
948723|NCT00783835|3124022|P1|Overall Study|Participant not Adherent|3
948724|NCT00783835|3124022|P1|Overall Study|Lost to Follow-up|1
948725|NCT00783835|3124022|P1|Overall Study|Withdrawal by Subject|2
948726|NCT00783835|3124022|P1|Overall Study|Medical Criteria|1
948727|NCT00783835|3124022|P1|Overall Study|Adverse Event|3
948728|NCT00783796|3124034|P1|Overall Study|Received commercial XIENCE V stent|1
948729|NCT00783796|3124034|P1|Overall Study|Received non-XIENCE V stent|1
948730|NCT00783796|3124034|P1|Overall Study|Did not receive any stent|4
948731|NCT00783718|3124139|P7|Maintenance Phase|Lost to Follow-up|2
948732|NCT00783718|3124140|P6|Maintenance Phase|Lost to Follow-up|0
948733|NCT00783718|3124141|P5|Maintenance Phase|Lost to Follow-up|2
948734|NCT00783718|3124142|P4|Maintenance Phase|Lost to Follow-up|0
948735|NCT00783718|3124143|P3|Maintenance Phase|Lost to Follow-up|0
948736|NCT00783718|3124144|P2|Maintenance Phase|Lost to Follow-up|0
948737|NCT00783718|3124145|P1|Maintenance Phase|Lost to Follow-up|3
948738|NCT00783718|3124139|P7|Maintenance Phase|Withdrawal by Subject|20
948739|NCT00783718|3124140|P6|Maintenance Phase|Withdrawal by Subject|2
948740|NCT00783718|3124141|P5|Maintenance Phase|Withdrawal by Subject|5
948741|NCT00783718|3124142|P4|Maintenance Phase|Withdrawal by Subject|2
948742|NCT00783718|3124143|P3|Maintenance Phase|Withdrawal by Subject|0
948743|NCT00783718|3124144|P2|Maintenance Phase|Withdrawal by Subject|0
948744|NCT00783718|3124145|P1|Maintenance Phase|Withdrawal by Subject|6
948745|NCT00783718|3124139|P7|Maintenance Phase|Lack of Efficacy|155
948746|NCT00783718|3124140|P6|Maintenance Phase|Lack of Efficacy|33
948747|NCT00783718|3124141|P5|Maintenance Phase|Lack of Efficacy|31
948748|NCT00783718|3124142|P4|Maintenance Phase|Lack of Efficacy|61
948749|NCT00783718|3124143|P3|Maintenance Phase|Lack of Efficacy|0
948750|NCT00783718|3124144|P2|Maintenance Phase|Lack of Efficacy|0
948751|NCT00783718|3124145|P1|Maintenance Phase|Lack of Efficacy|83
948752|NCT00783718|3124139|P7|Maintenance Phase|Protocol Violation|2
948753|NCT00783718|3124140|P6|Maintenance Phase|Protocol Violation|0
948754|NCT00783718|3124141|P5|Maintenance Phase|Protocol Violation|0
948755|NCT00783718|3124142|P4|Maintenance Phase|Protocol Violation|0
948756|NCT00783718|3124143|P3|Maintenance Phase|Protocol Violation|0
948757|NCT00783718|3124144|P2|Maintenance Phase|Protocol Violation|0
948758|NCT00783718|3124145|P1|Maintenance Phase|Protocol Violation|1
948759|NCT00783718|3124139|P7|Maintenance Phase|Adverse Event|16
948760|NCT00783718|3124140|P6|Maintenance Phase|Adverse Event|6
948761|NCT00783718|3124141|P5|Maintenance Phase|Adverse Event|7
948762|NCT00783718|3124142|P4|Maintenance Phase|Adverse Event|15
948763|NCT00783718|3124143|P3|Maintenance Phase|Adverse Event|0
948764|NCT00783718|3124144|P2|Maintenance Phase|Adverse Event|0
948765|NCT00783718|3124145|P1|Maintenance Phase|Adverse Event|12
948766|NCT00783718|3124139|P7|Induction Phase|Lost to Follow-up|0
948767|NCT00783718|3124140|P6|Induction Phase|Lost to Follow-up|0
948768|NCT00783718|3124141|P5|Induction Phase|Lost to Follow-up|0
948769|NCT00783718|3124142|P4|Induction Phase|Lost to Follow-up|0
948770|NCT00783718|3124143|P3|Induction Phase|Lost to Follow-up|1
948771|NCT00783718|3124144|P2|Induction Phase|Lost to Follow-up|0
948772|NCT00783718|3124145|P1|Induction Phase|Lost to Follow-up|1
948773|NCT00783718|3124139|P7|Induction Phase|Withdrawal by Subject|0
948774|NCT00783718|3124140|P6|Induction Phase|Withdrawal by Subject|0
948775|NCT00783718|3124141|P5|Induction Phase|Withdrawal by Subject|0
948776|NCT00783718|3124142|P4|Induction Phase|Withdrawal by Subject|0
948777|NCT00783718|3124143|P3|Induction Phase|Withdrawal by Subject|8
948778|NCT00783718|3124144|P2|Induction Phase|Withdrawal by Subject|4
948779|NCT00783718|3124145|P1|Induction Phase|Withdrawal by Subject|3
948780|NCT00783718|3124139|P7|Induction Phase|Lack of Efficacy|0
948781|NCT00783718|3124140|P6|Induction Phase|Lack of Efficacy|0
948782|NCT00783718|3124141|P5|Induction Phase|Lack of Efficacy|0
948783|NCT00783718|3124142|P4|Induction Phase|Lack of Efficacy|0
948784|NCT00783718|3124143|P3|Induction Phase|Lack of Efficacy|14
948785|NCT00783718|3124144|P2|Induction Phase|Lack of Efficacy|2
948786|NCT00783718|3124145|P1|Induction Phase|Lack of Efficacy|5
948787|NCT00783718|3124139|P7|Induction Phase|Protocol Violation|0
948788|NCT00783718|3124140|P6|Induction Phase|Protocol Violation|0
948789|NCT00783718|3124141|P5|Induction Phase|Protocol Violation|0
948790|NCT00783718|3124142|P4|Induction Phase|Protocol Violation|0
948791|NCT00783718|3124143|P3|Induction Phase|Protocol Violation|6
948792|NCT00783718|3124144|P2|Induction Phase|Protocol Violation|1
948793|NCT00783718|3124145|P1|Induction Phase|Protocol Violation|1
948794|NCT00783718|3124139|P7|Induction Phase|Adverse Event|0
948795|NCT00783718|3124140|P6|Induction Phase|Adverse Event|0
948796|NCT00783718|3124141|P5|Induction Phase|Adverse Event|0
948797|NCT00783718|3124142|P4|Induction Phase|Adverse Event|0
948798|NCT00783718|3124143|P3|Induction Phase|Adverse Event|7
948799|NCT00783718|3124144|P2|Induction Phase|Adverse Event|0
948800|NCT00783718|3124145|P1|Induction Phase|Adverse Event|4
948801|NCT00783705|3124173|P2|Overall Study|Lost to Follow-up|3
948802|NCT00783705|3124174|P1|Overall Study|Lost to Follow-up|1
948803|NCT00783705|3124173|P2|Overall Study|Withdrawal by Subject|2
948804|NCT00783705|3124174|P1|Overall Study|Withdrawal by Subject|3
948805|NCT00783705|3124173|P2|Overall Study|Adverse Event|0
948806|NCT00783705|3124174|P1|Overall Study|Adverse Event|2
948807|NCT00783692|3124221|P7|Maintenance Phase|Other|1
948808|NCT00783692|3124222|P6|Maintenance Phase|Other|1
948809|NCT00783692|3124223|P5|Maintenance Phase|Other|0
948810|NCT00783692|3124224|P4|Maintenance Phase|Other|1
948811|NCT00783692|3124225|P3|Maintenance Phase|Other|0
948812|NCT00783692|3124226|P2|Maintenance Phase|Other|0
948813|NCT00783692|3124227|P1|Maintenance Phase|Other|0
948814|NCT00783692|3124221|P7|Maintenance Phase|Lost to Follow-up|5
948815|NCT00783692|3124222|P6|Maintenance Phase|Lost to Follow-up|2
948816|NCT00783692|3124223|P5|Maintenance Phase|Lost to Follow-up|3
948817|NCT00783692|3124224|P4|Maintenance Phase|Lost to Follow-up|1
948818|NCT00783692|3124225|P3|Maintenance Phase|Lost to Follow-up|0
948819|NCT00783692|3124226|P2|Maintenance Phase|Lost to Follow-up|0
948820|NCT00783692|3124227|P1|Maintenance Phase|Lost to Follow-up|2
948821|NCT00783692|3124221|P7|Maintenance Phase|Withdrawal by Subject|24
948822|NCT00783692|3124222|P6|Maintenance Phase|Withdrawal by Subject|9
948823|NCT00783692|3124223|P5|Maintenance Phase|Withdrawal by Subject|6
948824|NCT00783692|3124224|P4|Maintenance Phase|Withdrawal by Subject|7
948825|NCT00783692|3124225|P3|Maintenance Phase|Withdrawal by Subject|0
948826|NCT00783692|3124226|P2|Maintenance Phase|Withdrawal by Subject|0
948827|NCT00783692|3124227|P1|Maintenance Phase|Withdrawal by Subject|7
948828|NCT00783692|3124221|P7|Maintenance Phase|Lack of Efficacy|177
948829|NCT00783692|3124222|P6|Maintenance Phase|Lack of Efficacy|48
948830|NCT00783692|3124223|P5|Maintenance Phase|Lack of Efficacy|58
948831|NCT00783692|3124224|P4|Maintenance Phase|Lack of Efficacy|64
948832|NCT00783692|3124225|P3|Maintenance Phase|Lack of Efficacy|0
948833|NCT00783692|3124226|P2|Maintenance Phase|Lack of Efficacy|0
948834|NCT00783692|3124227|P1|Maintenance Phase|Lack of Efficacy|79
948835|NCT00783692|3124221|P7|Maintenance Phase|Protocol Violation|4
948836|NCT00783692|3124222|P6|Maintenance Phase|Protocol Violation|3
948837|NCT00783692|3124223|P5|Maintenance Phase|Protocol Violation|2
948838|NCT00783692|3124224|P4|Maintenance Phase|Protocol Violation|1
948839|NCT00783692|3124225|P3|Maintenance Phase|Protocol Violation|0
948840|NCT00783692|3124226|P2|Maintenance Phase|Protocol Violation|0
948841|NCT00783692|3124227|P1|Maintenance Phase|Protocol Violation|0
948842|NCT00783692|3124221|P7|Maintenance Phase|Adverse Event|38
948843|NCT00783692|3124222|P6|Maintenance Phase|Adverse Event|9
948844|NCT00783692|3124223|P5|Maintenance Phase|Adverse Event|12
948845|NCT00783692|3124224|P4|Maintenance Phase|Adverse Event|15
948846|NCT00783692|3124225|P3|Maintenance Phase|Adverse Event|0
948847|NCT00783692|3124226|P2|Maintenance Phase|Adverse Event|0
948848|NCT00783692|3124227|P1|Maintenance Phase|Adverse Event|7
948849|NCT00783692|3124221|P7|Induction Phase|Other|0
948850|NCT00783692|3124222|P6|Induction Phase|Other|0
948851|NCT00783692|3124223|P5|Induction Phase|Other|0
948852|NCT00783692|3124224|P4|Induction Phase|Other|0
948853|NCT00783692|3124225|P3|Induction Phase|Other|2
948854|NCT00783692|3124226|P2|Induction Phase|Other|0
948855|NCT00783692|3124227|P1|Induction Phase|Other|0
948856|NCT00783692|3124221|P7|Induction Phase|Lost to Follow-up|0
948857|NCT00783692|3124222|P6|Induction Phase|Lost to Follow-up|0
948858|NCT00783692|3124223|P5|Induction Phase|Lost to Follow-up|0
948859|NCT00783692|3124224|P4|Induction Phase|Lost to Follow-up|0
948860|NCT00783692|3124225|P3|Induction Phase|Lost to Follow-up|3
948861|NCT00783692|3124226|P2|Induction Phase|Lost to Follow-up|0
948862|NCT00783692|3124227|P1|Induction Phase|Lost to Follow-up|0
948863|NCT00783692|3124221|P7|Induction Phase|Withdrawal by Subject|0
948864|NCT00783692|3124222|P6|Induction Phase|Withdrawal by Subject|0
948865|NCT00783692|3124223|P5|Induction Phase|Withdrawal by Subject|0
948866|NCT00783692|3124224|P4|Induction Phase|Withdrawal by Subject|0
948867|NCT00783692|3124225|P3|Induction Phase|Withdrawal by Subject|16
948868|NCT00783692|3124226|P2|Induction Phase|Withdrawal by Subject|9
948869|NCT00783692|3124227|P1|Induction Phase|Withdrawal by Subject|3
948870|NCT00783692|3124221|P7|Induction Phase|Lack of Efficacy|0
948871|NCT00783692|3124222|P6|Induction Phase|Lack of Efficacy|0
948872|NCT00783692|3124223|P5|Induction Phase|Lack of Efficacy|0
948873|NCT00783692|3124224|P4|Induction Phase|Lack of Efficacy|0
948874|NCT00783692|3124225|P3|Induction Phase|Lack of Efficacy|28
948875|NCT00783692|3124226|P2|Induction Phase|Lack of Efficacy|3
948876|NCT00783692|3124227|P1|Induction Phase|Lack of Efficacy|1
948877|NCT00783692|3124221|P7|Induction Phase|Protocol Violation|0
948878|NCT00783692|3124222|P6|Induction Phase|Protocol Violation|0
948879|NCT00783692|3124223|P5|Induction Phase|Protocol Violation|0
948880|NCT00783692|3124224|P4|Induction Phase|Protocol Violation|0
948881|NCT00783692|3124225|P3|Induction Phase|Protocol Violation|1
948882|NCT00783692|3124226|P2|Induction Phase|Protocol Violation|0
948883|NCT00783692|3124227|P1|Induction Phase|Protocol Violation|0
948884|NCT00783692|3124221|P7|Induction Phase|Adverse Event|0
948885|NCT00783692|3124222|P6|Induction Phase|Adverse Event|0
948886|NCT00783692|3124223|P5|Induction Phase|Adverse Event|0
948887|NCT00783692|3124224|P4|Induction Phase|Adverse Event|0
948888|NCT00783692|3124225|P3|Induction Phase|Adverse Event|24
948889|NCT00783692|3124226|P2|Induction Phase|Adverse Event|9
948890|NCT00783692|3124227|P1|Induction Phase|Adverse Event|7
948891|NCT00783432|3124273|P2|Overall Study|Protocol Violation|9
948892|NCT00783432|3124274|P1|Overall Study|Protocol Violation|6
948893|NCT00783432|3124273|P2|Overall Study|subject moved|5
948894|NCT00783432|3124274|P1|Overall Study|subject moved|3
948895|NCT00783432|3124273|P2|Overall Study|Withdrawal by Subject|20
948896|NCT00783432|3124274|P1|Overall Study|Withdrawal by Subject|23
948897|NCT00783432|3124273|P2|Overall Study|Lost to Follow-up|6
948898|NCT00783432|3124274|P1|Overall Study|Lost to Follow-up|11
948899|NCT00783432|3124273|P2|Overall Study|Lack of Efficacy|21
948900|NCT00783432|3124274|P1|Overall Study|Lack of Efficacy|20
948901|NCT00783432|3124273|P2|Overall Study|Adverse Event|17
948902|NCT00783432|3124274|P1|Overall Study|Adverse Event|22
948903|NCT00783302|3124284|P1|Overall Study|Withdrawal by Subject|3
948904|NCT00783302|3124284|P1|Overall Study|Physician Decision|1
948905|NCT00783302|3124284|P1|Overall Study|Protocol Violation|3
948906|NCT00783302|3124284|P1|Overall Study|Technical Problems|11
948907|NCT00783302|3124284|P1|Overall Study|Lost to Follow-up|17
948908|NCT00783263|3124306|P4|Overall Study|Withdrawal by Subject|2
948909|NCT00783263|3124307|P3|Overall Study|Withdrawal by Subject|1
948910|NCT00783263|3124308|P2|Overall Study|Withdrawal by Subject|1
948911|NCT00783263|3124309|P1|Overall Study|Withdrawal by Subject|0
948912|NCT00783263|3124306|P4|Overall Study|Lost to Follow-up|0
948913|NCT00783263|3124307|P3|Overall Study|Lost to Follow-up|0
948914|NCT00783263|3124308|P2|Overall Study|Lost to Follow-up|1
948915|NCT00783263|3124309|P1|Overall Study|Lost to Follow-up|1
948916|NCT00783263|3124306|P4|Overall Study|Adverse Event|1
948917|NCT00783263|3124307|P3|Overall Study|Adverse Event|2
948918|NCT00783263|3124308|P2|Overall Study|Adverse Event|0
948919|NCT00783263|3124309|P1|Overall Study|Adverse Event|3
948920|NCT00783224|3124339|P4|Overall Study|Inappropriate as a study subject|1
948921|NCT00783224|3124340|P3|Overall Study|Inappropriate as a study subject|0
948922|NCT00783224|3124341|P2|Overall Study|Inappropriate as a study subject|0
948923|NCT00783224|3124342|P1|Overall Study|Inappropriate as a study subject|0
948924|NCT00783224|3124339|P4|Overall Study|Discarded the Investigational Drug Used|1
948925|NCT00783224|3124340|P3|Overall Study|Discarded the Investigational Drug Used|0
948926|NCT00783224|3124341|P2|Overall Study|Discarded the Investigational Drug Used|0
948927|NCT00783224|3124342|P1|Overall Study|Discarded the Investigational Drug Used|0
948928|NCT00783224|3124339|P4|Overall Study|Adverse Event|0
948929|NCT00783224|3124340|P3|Overall Study|Adverse Event|1
948930|NCT00783224|3124341|P2|Overall Study|Adverse Event|0
948931|NCT00783224|3124342|P1|Overall Study|Adverse Event|0
948932|NCT00783198|3124354|P3|Overall Study|Administrative|2
948933|NCT00783198|3124355|P2|Overall Study|Administrative|1
948934|NCT00783198|3124356|P1|Overall Study|Administrative|2
948935|NCT00783198|3124354|P3|Overall Study|Did not meet protocol eligibility|0
948936|NCT00783198|3124355|P2|Overall Study|Did not meet protocol eligibility|1
948937|NCT00783198|3124356|P1|Overall Study|Did not meet protocol eligibility|0
948938|NCT00783198|3124354|P3|Overall Study|Noncompliance with protocol|10
948939|NCT00783198|3124355|P2|Overall Study|Noncompliance with protocol|7
948940|NCT00783198|3124356|P1|Overall Study|Noncompliance with protocol|7
948941|NCT00783198|3124354|P3|Overall Study|Withdrawal by Subject|20
948942|NCT00783198|3124355|P2|Overall Study|Withdrawal by Subject|14
948943|NCT00783198|3124356|P1|Overall Study|Withdrawal by Subject|22
948944|NCT00783198|3124354|P3|Overall Study|Lost to Follow-up|7
948945|NCT00783198|3124355|P2|Overall Study|Lost to Follow-up|1
948946|NCT00783198|3124356|P1|Overall Study|Lost to Follow-up|11
948947|NCT00783198|3124354|P3|Overall Study|Adverse Event|3
948948|NCT00783198|3124355|P2|Overall Study|Adverse Event|19
948949|NCT00783198|3124356|P1|Overall Study|Adverse Event|15
948950|NCT00783094|3124379|P3|Open-Label Extension Period|Lack of Efficacy|0
948951|NCT00783094|3124380|P2|Open-Label Extension Period|Lack of Efficacy|4
948952|NCT00783094|3124381|P1|Open-Label Extension Period|Lack of Efficacy|1
948953|NCT00783094|3124379|P3|Open-Label Extension Period|Physician Decision|3
948954|NCT00783094|3124380|P2|Open-Label Extension Period|Physician Decision|2
948955|NCT00783094|3124381|P1|Open-Label Extension Period|Physician Decision|4
948956|NCT00783094|3124379|P3|Open-Label Extension Period|Withdrawal by Subject|3
948957|NCT00783094|3124380|P2|Open-Label Extension Period|Withdrawal by Subject|1
948958|NCT00783094|3124381|P1|Open-Label Extension Period|Withdrawal by Subject|1
948959|NCT00783094|3124379|P3|Open-Label Extension Period|Protocol Violation|7
948960|NCT00783094|3124380|P2|Open-Label Extension Period|Protocol Violation|5
948961|NCT00783094|3124381|P1|Open-Label Extension Period|Protocol Violation|4
948962|NCT00783094|3124379|P3|Open-Label Extension Period|Death|1
948963|NCT00783094|3124380|P2|Open-Label Extension Period|Death|0
948964|NCT00783094|3124381|P1|Open-Label Extension Period|Death|0
948965|NCT00783094|3124379|P3|Open-Label Extension Period|Adverse Event|16
948966|NCT00783094|3124380|P2|Open-Label Extension Period|Adverse Event|7
948967|NCT00783094|3124381|P1|Open-Label Extension Period|Adverse Event|12
948968|NCT00783094|3124379|P3|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
948969|NCT00783094|3124380|P2|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1
948970|NCT00783094|3124381|P1|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
948971|NCT00783094|3124379|P3|Randomized Double-Blind Treatment Period|Protocol Violation|1
948972|NCT00783094|3124380|P2|Randomized Double-Blind Treatment Period|Protocol Violation|2
948973|NCT00783094|3124381|P1|Randomized Double-Blind Treatment Period|Protocol Violation|1
948974|NCT00783094|3124379|P3|Randomized Double-Blind Treatment Period|Physician Decision|0
948975|NCT00783094|3124380|P2|Randomized Double-Blind Treatment Period|Physician Decision|2
948976|NCT00783094|3124381|P1|Randomized Double-Blind Treatment Period|Physician Decision|0
948977|NCT00783094|3124379|P3|Randomized Double-Blind Treatment Period|Lack of Efficacy|1
948978|NCT00783094|3124380|P2|Randomized Double-Blind Treatment Period|Lack of Efficacy|2
948979|NCT00783094|3124381|P1|Randomized Double-Blind Treatment Period|Lack of Efficacy|0
948980|NCT00783094|3124379|P3|Randomized Double-Blind Treatment Period|Adverse Event|5
948981|NCT00783094|3124380|P2|Randomized Double-Blind Treatment Period|Adverse Event|5
948982|NCT00783094|3124381|P1|Randomized Double-Blind Treatment Period|Adverse Event|4
948983|NCT00782834|3124457|P1|Treatment Phase|fibrous tumor not GIST|1
948984|NCT00782795|3124497|P2|Overall Study|Withdrawal by Subject|2
948985|NCT00782795|3124498|P1|Overall Study|Withdrawal by Subject|1
948986|NCT00782717|3124538|P2|Overall Study|Exited in error|2
948987|NCT00782717|3124539|P1|Overall Study|Exited in error|0
948988|NCT00782717|3124538|P2|Overall Study|Did not meet entrance criteria|3
948989|NCT00782717|3124539|P1|Overall Study|Did not meet entrance criteria|1
948990|NCT00782717|3124538|P2|Overall Study|Enrollment close prior to surgery|0
948991|NCT00782717|3124539|P1|Overall Study|Enrollment close prior to surgery|1
948992|NCT00782717|3124538|P2|Overall Study|Treatment failure|14
948993|NCT00782717|3124539|P1|Overall Study|Treatment failure|3
948994|NCT00782717|3124538|P2|Overall Study|Noncompliance|1
948995|NCT00782717|3124539|P1|Overall Study|Noncompliance|2
948996|NCT00782717|3124538|P2|Overall Study|Patient decision unrelated to AE|3
948997|NCT00782717|3124539|P1|Overall Study|Patient decision unrelated to AE|6
948998|NCT00782717|3124538|P2|Overall Study|Adverse Event|5
948999|NCT00782717|3124539|P1|Overall Study|Adverse Event|2
949000|NCT00782626|3124566|P1|Overall Study|Other Complicating Disease|1
949001|NCT00782626|3124566|P1|Overall Study|Progressive Disease|5
949002|NCT00782626|3124566|P1|Overall Study|Adverse Event|1
949003|NCT00782509|3124573|P3|Overall Study|Lack of Efficacy|2
949004|NCT00782509|3124574|P2|Overall Study|Lack of Efficacy|5
949005|NCT00782509|3124575|P1|Overall Study|Lack of Efficacy|10
949006|NCT00782509|3124573|P3|Overall Study|Other reasons not stated above|3
949007|NCT00782509|3124574|P2|Overall Study|Other reasons not stated above|2
949008|NCT00782509|3124575|P1|Overall Study|Other reasons not stated above|5
949009|NCT00782509|3124573|P3|Overall Study|Non compliance with protocol|0
949010|NCT00782509|3124574|P2|Overall Study|Non compliance with protocol|0
949011|NCT00782509|3124575|P1|Overall Study|Non compliance with protocol|2
949012|NCT00782509|3124573|P3|Overall Study|Withdrawal by Subject|8
949013|NCT00782509|3124574|P2|Overall Study|Withdrawal by Subject|5
949014|NCT00782509|3124575|P1|Overall Study|Withdrawal by Subject|3
949015|NCT00782509|3124573|P3|Overall Study|Lost to Follow-up|3
949016|NCT00782509|3124574|P2|Overall Study|Lost to Follow-up|2
949017|NCT00782509|3124575|P1|Overall Study|Lost to Follow-up|1
949018|NCT00782509|3124573|P3|Overall Study|Adverse Event|20
949019|NCT00782509|3124574|P2|Overall Study|Adverse Event|10
949020|NCT00782509|3124575|P1|Overall Study|Adverse Event|20
949021|NCT00782496|3124768|P2|Overall Study|Lost to Follow-up|15
949022|NCT00782496|3124769|P1|Overall Study|Lost to Follow-up|14
949023|NCT00782483|3124776|P1|Overall Study|Early Termination of Protocol - PI Reloc|6
949024|NCT00782418|3124780|P7|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
949025|NCT00782418|3124781|P6|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
949026|NCT00782418|3124782|P5|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
949027|NCT00782418|3124783|P4|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
949028|NCT00782418|3124784|P3|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
949029|NCT00782418|3124785|P2|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
949030|NCT00782418|3124786|P1|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
949031|NCT00782418|3124780|P7|Period 1 Procedure/Treatment Groups|Adverse Event|0
949032|NCT00782418|3124781|P6|Period 1 Procedure/Treatment Groups|Adverse Event|0
949033|NCT00782418|3124782|P5|Period 1 Procedure/Treatment Groups|Adverse Event|0
949034|NCT00782418|3124783|P4|Period 1 Procedure/Treatment Groups|Adverse Event|0
949035|NCT00782418|3124784|P3|Period 1 Procedure/Treatment Groups|Adverse Event|0
949036|NCT00782418|3124785|P2|Period 1 Procedure/Treatment Groups|Adverse Event|0
949037|NCT00782418|3124786|P1|Period 1 Procedure/Treatment Groups|Adverse Event|1
949038|NCT00782340|3124823|P3|Open Label Titration|Randomized in error|0
949039|NCT00782340|3124824|P2|Open Label Titration|Randomized in error|0
949040|NCT00782340|3124825|P1|Open Label Titration|Randomized in error|6
949041|NCT00782340|3124823|P3|Open Label Titration|Lost to Follow-up|0
949042|NCT00782340|3124824|P2|Open Label Titration|Lost to Follow-up|0
949043|NCT00782340|3124825|P1|Open Label Titration|Lost to Follow-up|5
949044|NCT00782340|3124823|P3|Open Label Titration|Did not meet responder criteria|0
949045|NCT00782340|3124824|P2|Open Label Titration|Did not meet responder criteria|0
949046|NCT00782340|3124825|P1|Open Label Titration|Did not meet responder criteria|2
949047|NCT00782340|3124823|P3|Open Label Titration|Enrollment capped|0
949048|NCT00782340|3124824|P2|Open Label Titration|Enrollment capped|0
949049|NCT00782340|3124825|P1|Open Label Titration|Enrollment capped|16
949050|NCT00782340|3124823|P3|Open Label Titration|Withdrawal by Subject|0
949051|NCT00782340|3124824|P2|Open Label Titration|Withdrawal by Subject|0
949052|NCT00782340|3124825|P1|Open Label Titration|Withdrawal by Subject|5
949053|NCT00782340|3124823|P3|Open Label Titration|Protocol Violation|0
949054|NCT00782340|3124824|P2|Open Label Titration|Protocol Violation|0
949055|NCT00782340|3124825|P1|Open Label Titration|Protocol Violation|5
949056|NCT00782340|3124823|P3|Open Label Titration|Treatment failure|0
949057|NCT00782340|3124824|P2|Open Label Titration|Treatment failure|0
949058|NCT00782340|3124825|P1|Open Label Titration|Treatment failure|50
949059|NCT00782340|3124823|P3|Open Label Titration|Adverse Event|0
949060|NCT00782340|3124824|P2|Open Label Titration|Adverse Event|0
949061|NCT00782340|3124825|P1|Open Label Titration|Adverse Event|12
949062|NCT00782275|3124895|P1|Overall Study|Other|3
949063|NCT00782275|3124895|P1|Overall Study|Not started treatment|1
949064|NCT00782275|3124895|P1|Overall Study|Physician Decision|4
949065|NCT00782275|3124895|P1|Overall Study|Progressive Disease|21
949066|NCT00782275|3124895|P1|Overall Study|Withdrawal by Subject|1
949067|NCT00782275|3124895|P1|Overall Study|Adverse Event|11
949068|NCT00782210|3124904|P3|Overall Study|Other reason not described above|3
949069|NCT00782210|3124905|P2|Overall Study|Other reason not described above|2
949070|NCT00782210|3124906|P1|Overall Study|Other reason not described above|3
949071|NCT00782210|3124904|P3|Overall Study|Lack of Efficacy|1
949072|NCT00782210|3124905|P2|Overall Study|Lack of Efficacy|4
949073|NCT00782210|3124906|P1|Overall Study|Lack of Efficacy|13
949074|NCT00782210|3124904|P3|Overall Study|Non compliance with protocol|2
949075|NCT00782210|3124905|P2|Overall Study|Non compliance with protocol|3
949076|NCT00782210|3124906|P1|Overall Study|Non compliance with protocol|0
949077|NCT00782210|3124904|P3|Overall Study|Withdrawal by Subject|11
949078|NCT00782210|3124905|P2|Overall Study|Withdrawal by Subject|8
949079|NCT00782210|3124906|P1|Overall Study|Withdrawal by Subject|11
949080|NCT00782210|3124904|P3|Overall Study|Lost to Follow-up|2
949081|NCT00782210|3124905|P2|Overall Study|Lost to Follow-up|1
949082|NCT00782210|3124906|P1|Overall Study|Lost to Follow-up|2
949083|NCT00782210|3124904|P3|Overall Study|Adverse Event|16
949084|NCT00782210|3124905|P2|Overall Study|Adverse Event|17
949085|NCT00782210|3124906|P1|Overall Study|Adverse Event|21
949086|NCT00782184|3125099|P2|Overall Study|Withdrawal by Subject|2
949087|NCT00782184|3125100|P1|Overall Study|Withdrawal by Subject|3
949088|NCT00782184|3125099|P2|Overall Study|Protocol Violation|1
949089|NCT00782184|3125100|P1|Overall Study|Protocol Violation|0
949090|NCT00782184|3125099|P2|Overall Study|Adverse Event|2
949091|NCT00782184|3125100|P1|Overall Study|Adverse Event|1
949092|NCT00782171|3125137|P2|Overall Study|not eligible|6
949093|NCT00782171|3125138|P1|Overall Study|not eligible|8
949094|NCT00782171|3125137|P2|Overall Study|others|9
949095|NCT00782171|3125138|P1|Overall Study|others|7
949096|NCT00782171|3125137|P2|Overall Study|complications|1
949097|NCT00782171|3125138|P1|Overall Study|complications|3
949098|NCT00782171|3125137|P2|Overall Study|Withdrawal by Subject|1
949099|NCT00782171|3125138|P1|Overall Study|Withdrawal by Subject|2
949100|NCT00782171|3125137|P2|Overall Study|Lost to Follow-up|2
949101|NCT00782171|3125138|P1|Overall Study|Lost to Follow-up|2
949102|NCT00782067|3125170|P1|Overall Study|Protocol deviation|2
949103|NCT00782067|3125170|P1|Overall Study|Disease progression|43
949104|NCT00782067|3125170|P1|Overall Study|Death|9
949105|NCT00782067|3125170|P1|Overall Study|Administrative problems|14
949106|NCT00782067|3125170|P1|Overall Study|Lost to Follow-up|2
949107|NCT00782067|3125170|P1|Overall Study|Subject withdrew consent|11
949108|NCT00782067|3125170|P1|Overall Study|Adverse Event|35
949109|NCT00781963|3125183|P3|Overall Study|Refused follow-up|0
949110|NCT00781963|3125184|P2|Overall Study|Refused follow-up|5
949111|NCT00781963|3125185|P1|Overall Study|Refused follow-up|4
949112|NCT00781963|3125183|P3|Overall Study|Withdrawal by Subject|1
949113|NCT00781963|3125184|P2|Overall Study|Withdrawal by Subject|3
949114|NCT00781963|3125185|P1|Overall Study|Withdrawal by Subject|0
949115|NCT00781963|3125183|P3|Overall Study|Lost to Follow-up|1
949116|NCT00781963|3125184|P2|Overall Study|Lost to Follow-up|1
949117|NCT00781963|3125185|P1|Overall Study|Lost to Follow-up|1
949118|NCT00781963|3125183|P3|Overall Study|Death|0
949119|NCT00781963|3125184|P2|Overall Study|Death|0
949120|NCT00781963|3125185|P1|Overall Study|Death|3
949121|NCT00781937|3125206|P2|Follow up Period (Week 56-68)|Unclassified|4
949122|NCT00781937|3125207|P1|Follow up Period (Week 56-68)|Unclassified|5
949123|NCT00781937|3125206|P2|Follow up Period (Week 56-68)|Protocol Violation|1
949124|NCT00781937|3125207|P1|Follow up Period (Week 56-68)|Protocol Violation|1
949125|NCT00781937|3125206|P2|Main Trial Period Through Week 56|Unclassified|15
949126|NCT00781937|3125207|P1|Main Trial Period Through Week 56|Unclassified|10
949127|NCT00781937|3125206|P2|Main Trial Period Through Week 56|Withdrawal by Subject|24
949128|NCT00781937|3125207|P1|Main Trial Period Through Week 56|Withdrawal by Subject|17
949129|NCT00781937|3125206|P2|Main Trial Period Through Week 56|Protocol Violation|5
949130|NCT00781937|3125207|P1|Main Trial Period Through Week 56|Protocol Violation|8
949131|NCT00781937|3125206|P2|Main Trial Period Through Week 56|Lack of Efficacy|2
949132|NCT00781937|3125207|P1|Main Trial Period Through Week 56|Lack of Efficacy|0
949133|NCT00781937|3125206|P2|Main Trial Period Through Week 56|Adverse Event|18
949134|NCT00781937|3125207|P1|Main Trial Period Through Week 56|Adverse Event|18
949135|NCT00781911|3125265|P2|Overall Study|Sponsor Decision|0
949136|NCT00781911|3125266|P1|Overall Study|Sponsor Decision|1
949137|NCT00781911|3125265|P2|Overall Study|Physician Decision|2
949138|NCT00781911|3125266|P1|Overall Study|Physician Decision|0
949139|NCT00781911|3125265|P2|Overall Study|Withdrawal by Subject|2
949140|NCT00781911|3125266|P1|Overall Study|Withdrawal by Subject|1
949141|NCT00781911|3125265|P2|Overall Study|Adverse Event|4
949142|NCT00781911|3125266|P1|Overall Study|Adverse Event|4
949143|NCT00781859|3125303|P2|Overall Study|Death|0
949144|NCT00781859|3125304|P1|Overall Study|Death|3
949145|NCT00781859|3125303|P2|Overall Study|Lost to Follow-up|3
949146|NCT00781859|3125304|P1|Overall Study|Lost to Follow-up|6
949147|NCT00781859|3125303|P2|Overall Study|Withdrawal by Subject|4
949148|NCT00781859|3125304|P1|Overall Study|Withdrawal by Subject|8
949149|NCT00781859|3125303|P2|Overall Study|Adverse Event|2
949150|NCT00781859|3125304|P1|Overall Study|Adverse Event|2
949151|NCT00781768|3125314|P2|Overall Study|Not transplanted.|2
949152|NCT00781768|3125315|P1|Overall Study|Not transplanted.|0
949153|NCT00781599|3125323|P2|Overall Study|Lost to Follow-up|4
949154|NCT00781599|3125324|P1|Overall Study|Lost to Follow-up|7
949155|NCT00781456|3125349|P2|Overall Study|Other Reason, Unknown|1
949156|NCT00781456|3125350|P1|Overall Study|Other Reason, Unknown|0
949157|NCT00781456|3125349|P2|Overall Study|Lost to Follow-up|5
949158|NCT00781456|3125350|P1|Overall Study|Lost to Follow-up|10
949159|NCT00781456|3125349|P2|Overall Study|Noncompliance With Protocol|1
949160|NCT00781456|3125350|P1|Overall Study|Noncompliance With Protocol|1
949161|NCT00781456|3125349|P2|Overall Study|Protocol Violation|1
949162|NCT00781456|3125350|P1|Overall Study|Protocol Violation|4
949163|NCT00781456|3125349|P2|Overall Study|Withdrawal by Subject|5
949164|NCT00781456|3125350|P1|Overall Study|Withdrawal by Subject|3
949165|NCT00781456|3125349|P2|Overall Study|Adverse Event|3
949166|NCT00781456|3125350|P1|Overall Study|Adverse Event|3
949167|NCT00781391|3125373|P3|Overall Study|Lost to Follow-up|1
949168|NCT00781391|3125374|P2|Overall Study|Lost to Follow-up|0
949169|NCT00781391|3125375|P1|Overall Study|Lost to Follow-up|0
949170|NCT00781391|3125373|P3|Overall Study|Withdrawal by Subject|25
949171|NCT00781391|3125374|P2|Overall Study|Withdrawal by Subject|37
949172|NCT00781391|3125375|P1|Overall Study|Withdrawal by Subject|47
949173|NCT00781391|3125373|P3|Overall Study|Death|706
949174|NCT00781391|3125374|P2|Overall Study|Death|730
949175|NCT00781391|3125375|P1|Overall Study|Death|789
949176|NCT00781391|3125373|P3|Overall Study|Protocol Violation|20
949177|NCT00781391|3125374|P2|Overall Study|Protocol Violation|17
949178|NCT00781391|3125375|P1|Overall Study|Protocol Violation|19
949179|NCT00781391|3125373|P3|Overall Study|never received study drug|32
949180|NCT00781391|3125374|P2|Overall Study|never received study drug|23
949181|NCT00781391|3125375|P1|Overall Study|never received study drug|24
949182|NCT00781365|3125409|P2|Overall Study|Language barrier|0
949183|NCT00781365|3125410|P1|Overall Study|Language barrier|1
949184|NCT00781365|3125409|P2|Overall Study|Did Not Attend Visit|28
949185|NCT00781365|3125410|P1|Overall Study|Did Not Attend Visit|20
949186|NCT00781365|3125409|P2|Overall Study|Withdrawal by Subject|8
949187|NCT00781365|3125410|P1|Overall Study|Withdrawal by Subject|13
949188|NCT00781326|3125420|P1|Phase I|Physician Decision|2
949189|NCT00781326|3125420|P1|Phase I|Withdrawal by Subject|1
949190|NCT00781326|3125420|P1|Phase I|Adverse Event|1
949191|NCT00781274|3125424|P1|Overall Study|Withdrawal by Subject|2
949192|NCT00780910|3125456|P1|Overall Study|Adverse Event|2
949193|NCT00780416|3125561|P2|Overall Study|Withdrawal by Subject|6
949194|NCT00780416|3125562|P1|Overall Study|Withdrawal by Subject|8
949195|NCT00780416|3125561|P2|Overall Study|Protocol Violation|0
949196|NCT00780416|3125562|P1|Overall Study|Protocol Violation|1
949197|NCT00780416|3125561|P2|Overall Study|Physician Decision|3
949198|NCT00780416|3125562|P1|Overall Study|Physician Decision|3
949199|NCT00780273|3125607|P1|Overall Study|Lost to Follow-up|1
949200|NCT00780273|3125607|P1|Overall Study|Death|1
949201|NCT00780143|3125621|P1|Overall Study|Adverse Event|1
949202|NCT00780143|3125621|P1|Overall Study|Toxicity|1
949203|NCT00780143|3125621|P1|Overall Study|Progressive disease|1
949204|NCT00779909|3125652|P4|Overall Study|Withdrawal by Subject|0
949205|NCT00779909|3125653|P3|Overall Study|Withdrawal by Subject|0
949206|NCT00779909|3125654|P2|Overall Study|Withdrawal by Subject|1
949207|NCT00779909|3125655|P1|Overall Study|Withdrawal by Subject|0
949208|NCT00779909|3125652|P4|Overall Study|Lost to Follow-up|1
949209|NCT00779909|3125653|P3|Overall Study|Lost to Follow-up|0
949210|NCT00779909|3125654|P2|Overall Study|Lost to Follow-up|0
949211|NCT00779909|3125655|P1|Overall Study|Lost to Follow-up|1
949212|NCT00779857|3125697|P1|Overall Study|Missed Visit|2
949213|NCT00779857|3125697|P1|Overall Study|Withdrawal by Subject|3
949214|NCT00779857|3125697|P1|Overall Study|Death|1
949215|NCT00779779|3125702|P1|Overall Study|Lost to Follow-up|5
949216|NCT00779779|3125702|P1|Overall Study|Withdrawal by Subject|4
949217|NCT00779779|3125702|P1|Overall Study|Protocol Violation|14
949218|NCT00779779|3125702|P1|Overall Study|Adverse Event|1
949219|NCT00779766|3125711|P2|Overall Study|Withdrawal by Subject|67
949220|NCT00779766|3125712|P1|Overall Study|Withdrawal by Subject|84
949221|NCT00779766|3125711|P2|Overall Study|Protocol Violation|1
949222|NCT00779766|3125712|P1|Overall Study|Protocol Violation|1
949223|NCT00779675|3125794|P1|Extended Treatment Period|Lost to Follow-up|6
949224|NCT00779675|3125794|P1|Extended Treatment Period|Protocol defined clinical event|1
949225|NCT00779675|3125794|P1|Extended Treatment Period|Treatment Failure|11
949226|NCT00779675|3125794|P1|Extended Treatment Period|Adverse Event|6
949227|NCT00779675|3125794|P1|Extended Treatment Period|Protocol Violation|13
949228|NCT00779675|3125794|P1|Extended Treatment Period|Reasons unrelated to study treatment|9
949229|NCT00779675|3125794|P1|Treatment Period|Administrative|3
949230|NCT00779675|3125794|P1|Treatment Period|Did Not Meet Protocol Eligibility|1
949231|NCT00779675|3125794|P1|Treatment Period|Protocol Violation|54
949232|NCT00779675|3125794|P1|Treatment Period|Withdrawal by Subject|46
949233|NCT00779675|3125794|P1|Treatment Period|Lost to Follow-up|23
949234|NCT00779675|3125794|P1|Treatment Period|Transferred to Another Study|38
949235|NCT00779675|3125794|P1|Treatment Period|Treatment Failure|80
949236|NCT00779675|3125794|P1|Treatment Period|Adverse Event|87
949237|NCT00779584|3125822|P9|Overall Study|Ongoing in Study|0
949238|NCT00779584|3125823|P8|Overall Study|Ongoing in Study|0
949239|NCT00779584|3125824|P7|Overall Study|Ongoing in Study|0
949240|NCT00779584|3125825|P6|Overall Study|Ongoing in Study|1
949241|NCT00779584|3125826|P5|Overall Study|Ongoing in Study|1
949242|NCT00779584|3125827|P4|Overall Study|Ongoing in Study|0
949243|NCT00779584|3125828|P3|Overall Study|Ongoing in Study|0
949244|NCT00779584|3125829|P2|Overall Study|Ongoing in Study|0
949245|NCT00779584|3125830|P1|Overall Study|Ongoing in Study|0
949246|NCT00779584|3125822|P9|Overall Study|Symptomatic Deterioration|0
949247|NCT00779584|3125823|P8|Overall Study|Symptomatic Deterioration|0
949248|NCT00779584|3125824|P7|Overall Study|Symptomatic Deterioration|1
949249|NCT00779584|3125825|P6|Overall Study|Symptomatic Deterioration|1
949250|NCT00779584|3125826|P5|Overall Study|Symptomatic Deterioration|0
949251|NCT00779584|3125827|P4|Overall Study|Symptomatic Deterioration|0
949252|NCT00779584|3125828|P3|Overall Study|Symptomatic Deterioration|1
949253|NCT00779584|3125829|P2|Overall Study|Symptomatic Deterioration|1
949254|NCT00779584|3125830|P1|Overall Study|Symptomatic Deterioration|1
949255|NCT00779584|3125822|P9|Overall Study|Adverse Event|1
949256|NCT00779584|3125823|P8|Overall Study|Adverse Event|1
949257|NCT00779584|3125824|P7|Overall Study|Adverse Event|2
949258|NCT00779584|3125825|P6|Overall Study|Adverse Event|0
949259|NCT00779584|3125826|P5|Overall Study|Adverse Event|0
949260|NCT00779584|3125827|P4|Overall Study|Adverse Event|0
949261|NCT00779584|3125828|P3|Overall Study|Adverse Event|2
949262|NCT00779584|3125829|P2|Overall Study|Adverse Event|0
949263|NCT00779584|3125830|P1|Overall Study|Adverse Event|1
949264|NCT00779584|3125822|P9|Overall Study|Progression of Disease|1
949265|NCT00779584|3125823|P8|Overall Study|Progression of Disease|2
949266|NCT00779584|3125824|P7|Overall Study|Progression of Disease|4
949267|NCT00779584|3125825|P6|Overall Study|Progression of Disease|1
949268|NCT00779584|3125826|P5|Overall Study|Progression of Disease|5
949269|NCT00779584|3125827|P4|Overall Study|Progression of Disease|6
949270|NCT00779584|3125828|P3|Overall Study|Progression of Disease|2
949271|NCT00779584|3125829|P2|Overall Study|Progression of Disease|1
949272|NCT00779584|3125830|P1|Overall Study|Progression of Disease|0
949273|NCT00779584|3125822|P9|Overall Study|Lost to Follow-up|0
949274|NCT00779584|3125823|P8|Overall Study|Lost to Follow-up|0
949275|NCT00779584|3125824|P7|Overall Study|Lost to Follow-up|0
949276|NCT00779584|3125825|P6|Overall Study|Lost to Follow-up|0
949277|NCT00779584|3125826|P5|Overall Study|Lost to Follow-up|1
949278|NCT00779584|3125827|P4|Overall Study|Lost to Follow-up|0
949279|NCT00779584|3125828|P3|Overall Study|Lost to Follow-up|0
949280|NCT00779584|3125829|P2|Overall Study|Lost to Follow-up|0
949281|NCT00779584|3125830|P1|Overall Study|Lost to Follow-up|0
949282|NCT00779584|3125822|P9|Overall Study|Withdrawal by Subject|0
949283|NCT00779584|3125823|P8|Overall Study|Withdrawal by Subject|0
949284|NCT00779584|3125824|P7|Overall Study|Withdrawal by Subject|1
949285|NCT00779584|3125825|P6|Overall Study|Withdrawal by Subject|2
949286|NCT00779584|3125826|P5|Overall Study|Withdrawal by Subject|0
949287|NCT00779584|3125827|P4|Overall Study|Withdrawal by Subject|0
949288|NCT00779584|3125828|P3|Overall Study|Withdrawal by Subject|2
949289|NCT00779584|3125829|P2|Overall Study|Withdrawal by Subject|1
949290|NCT00779584|3125830|P1|Overall Study|Withdrawal by Subject|1
949291|NCT00779584|3125822|P9|Overall Study|Protocol Violation|0
949292|NCT00779584|3125823|P8|Overall Study|Protocol Violation|0
949293|NCT00779584|3125824|P7|Overall Study|Protocol Violation|0
949294|NCT00779584|3125825|P6|Overall Study|Protocol Violation|1
949295|NCT00779584|3125826|P5|Overall Study|Protocol Violation|0
949296|NCT00779584|3125827|P4|Overall Study|Protocol Violation|0
949297|NCT00779584|3125828|P3|Overall Study|Protocol Violation|0
949298|NCT00779584|3125829|P2|Overall Study|Protocol Violation|0
949299|NCT00779584|3125830|P1|Overall Study|Protocol Violation|0
949300|NCT00779506|3125921|P1|Overall Study|Lost to Follow-up|1
949301|NCT00779506|3125921|P1|Overall Study|Withdrawal by Subject|6
949302|NCT00779506|3125921|P1|Overall Study|Protocol Violation|5
949303|NCT00779506|3125921|P1|Overall Study|Lack of Efficacy|11
949304|NCT00779506|3125921|P1|Overall Study|Adverse Event|4
949305|NCT00779506|3125921|P1|Overall Study|Screening Failed|2
949306|NCT00779467|3125935|P4|Overall Study|unavailable research staff|1
949307|NCT00779467|3125936|P3|Overall Study|unavailable research staff|0
949308|NCT00779467|3125937|P2|Overall Study|unavailable research staff|0
949309|NCT00779467|3125938|P1|Overall Study|unavailable research staff|0
949310|NCT00779467|3125935|P4|Overall Study|technical issue|1
949311|NCT00779467|3125936|P3|Overall Study|technical issue|2
949312|NCT00779467|3125937|P2|Overall Study|technical issue|0
949313|NCT00779467|3125938|P1|Overall Study|technical issue|0
949314|NCT00779467|3125935|P4|Overall Study|missing data|4
949315|NCT00779467|3125936|P3|Overall Study|missing data|1
949316|NCT00779467|3125937|P2|Overall Study|missing data|0
949317|NCT00779467|3125938|P1|Overall Study|missing data|1
949318|NCT00779467|3125935|P4|Overall Study|failed inclusion criteria|2
949319|NCT00779467|3125936|P3|Overall Study|failed inclusion criteria|1
949320|NCT00779467|3125937|P2|Overall Study|failed inclusion criteria|3
949321|NCT00779467|3125938|P1|Overall Study|failed inclusion criteria|3
949322|NCT00779467|3125935|P4|Overall Study|Lack of Efficacy|11
949323|NCT00779467|3125936|P3|Overall Study|Lack of Efficacy|6
949324|NCT00779467|3125937|P2|Overall Study|Lack of Efficacy|2
949325|NCT00779467|3125938|P1|Overall Study|Lack of Efficacy|11
949326|NCT00779402|3125978|P2|Long-term Follow-up|Completed Protocol Visits|2
949327|NCT00779402|3125979|P1|Long-term Follow-up|Completed Protocol Visits|6
949328|NCT00779402|3125978|P2|Long-term Follow-up|Closure of Study|4
949329|NCT00779402|3125979|P1|Long-term Follow-up|Closure of Study|8
949330|NCT00779402|3125978|P2|Long-term Follow-up|Not specified|0
949331|NCT00779402|3125979|P1|Long-term Follow-up|Not specified|5
949332|NCT00779402|3125978|P2|Long-term Follow-up|Patient refused to continue|0
949333|NCT00779402|3125979|P1|Long-term Follow-up|Patient refused to continue|2
949334|NCT00779402|3125978|P2|Surveillance Phase|Completed Protocol Visits|2
949335|NCT00779402|3125979|P1|Surveillance Phase|Completed Protocol Visits|3
949336|NCT00779402|3125978|P2|Surveillance Phase|Closure of study|6
949337|NCT00779402|3125979|P1|Surveillance Phase|Closure of study|5
949338|NCT00779402|3125978|P2|Surveillance Phase|Withdrawal by Subject|1
949339|NCT00779402|3125979|P1|Surveillance Phase|Withdrawal by Subject|4
949340|NCT00779402|3125978|P2|Surveillance Phase|Not specified|5
949341|NCT00779402|3125979|P1|Surveillance Phase|Not specified|5
949342|NCT00779402|3125978|P2|Surveillance Phase|Intercurrent Illness|0
949343|NCT00779402|3125979|P1|Surveillance Phase|Intercurrent Illness|2
949344|NCT00779402|3125978|P2|Surveillance Phase|Death|1
949345|NCT00779402|3125979|P1|Surveillance Phase|Death|0
949346|NCT00779402|3125978|P2|Surveillance Phase|Lost to Follow-up|1
949347|NCT00779402|3125979|P1|Surveillance Phase|Lost to Follow-up|2
949348|NCT00779402|3125978|P2|Surveillance Phase|Patient refused to continue|14
949349|NCT00779402|3125979|P1|Surveillance Phase|Patient refused to continue|22
949350|NCT00779402|3125978|P2|Surveillance Phase|Protocol Violation|1
949351|NCT00779402|3125979|P1|Surveillance Phase|Protocol Violation|0
949352|NCT00779402|3125978|P2|Treatment Phase 1|Completed Protocol Visits|6
949353|NCT00779402|3125979|P1|Treatment Phase 1|Completed Protocol Visits|3
949354|NCT00779402|3125978|P2|Treatment Phase 1|Closure of Study|2
949355|NCT00779402|3125979|P1|Treatment Phase 1|Closure of Study|3
949356|NCT00779402|3125978|P2|Treatment Phase 1|Not Specified|2
949357|NCT00779402|3125979|P1|Treatment Phase 1|Not Specified|4
949358|NCT00779402|3125978|P2|Treatment Phase 1|Withdrawal by Subject|0
949359|NCT00779402|3125979|P1|Treatment Phase 1|Withdrawal by Subject|1
949360|NCT00779402|3125978|P2|Treatment Phase 1|Intercurrent Illness|1
949361|NCT00779402|3125979|P1|Treatment Phase 1|Intercurrent Illness|1
949362|NCT00779402|3125978|P2|Treatment Phase 1|Death|1
949363|NCT00779402|3125979|P1|Treatment Phase 1|Death|0
949364|NCT00779402|3125978|P2|Treatment Phase 1|Lost to Follow-up|1
949365|NCT00779402|3125979|P1|Treatment Phase 1|Lost to Follow-up|0
949366|NCT00779402|3125978|P2|Treatment Phase 1|Patient Refused to Continue|2
949367|NCT00779402|3125979|P1|Treatment Phase 1|Patient Refused to Continue|17
949368|NCT00779402|3125978|P2|Treatment Phase 1|Protocol Violation|0
949369|NCT00779402|3125979|P1|Treatment Phase 1|Protocol Violation|1
949370|NCT00779402|3125978|P2|Treatment Phase 1|Adverse Event|0
949371|NCT00779402|3125979|P1|Treatment Phase 1|Adverse Event|2
949372|NCT00779402|3125978|P2|Treatment Phase 1|Disease Progression|0
949373|NCT00779402|3125979|P1|Treatment Phase 1|Disease Progression|1
949374|NCT00779259|3126022|P1|Quinine Alone|Adverse Event|2
949375|NCT00779246|3126043|P2|Overall Study|Missing sufficient data for analysis|53
949376|NCT00779246|3126044|P1|Overall Study|Missing sufficient data for analysis|33
949377|NCT00779142|3126063|P1|Overall Study|Screen Failures|3
949378|NCT00779038|3126077|P1|Overall Study|Study Prematurely Terminated|13
949379|NCT00779025|3126086|P1|Overall Study|Withdrawal by Subject|1
949380|NCT00778999|3126097|P2|Overall Study|Did not receive recFSH|20
949381|NCT00778999|3126098|P1|Overall Study|Did not receive recFSH|14
949382|NCT00778999|3126097|P2|Overall Study|Discontinuation: no embryo transfer|14
949383|NCT00778999|3126098|P1|Overall Study|Discontinuation: no embryo transfer|14
949384|NCT00778921|3126107|P3|Overall Study|Not treated|2
949385|NCT00778921|3126108|P2|Overall Study|Not treated|2
949386|NCT00778921|3126109|P1|Overall Study|Not treated|0
949387|NCT00778921|3126107|P3|Overall Study|Protocol Violation|2
949388|NCT00778921|3126108|P2|Overall Study|Protocol Violation|0
949389|NCT00778921|3126109|P1|Overall Study|Protocol Violation|3
949390|NCT00778921|3126107|P3|Overall Study|Administrative Problems|0
949391|NCT00778921|3126108|P2|Overall Study|Administrative Problems|2
949392|NCT00778921|3126109|P1|Overall Study|Administrative Problems|1
949393|NCT00778921|3126107|P3|Overall Study|Lost to Follow-up|1
949394|NCT00778921|3126108|P2|Overall Study|Lost to Follow-up|2
949395|NCT00778921|3126109|P1|Overall Study|Lost to Follow-up|0
949396|NCT00778921|3126107|P3|Overall Study|Patient withdrew request|6
949397|NCT00778921|3126108|P2|Overall Study|Patient withdrew request|1
949398|NCT00778921|3126109|P1|Overall Study|Patient withdrew request|3
949399|NCT00778921|3126107|P3|Overall Study|Patient No Longer Requires Study Drug|0
949400|NCT00778921|3126108|P2|Overall Study|Patient No Longer Requires Study Drug|1
949401|NCT00778921|3126109|P1|Overall Study|Patient No Longer Requires Study Drug|0
949402|NCT00778921|3126107|P3|Overall Study|Unsatisfactory therapeutic response|1
949403|NCT00778921|3126108|P2|Overall Study|Unsatisfactory therapeutic response|1
949404|NCT00778921|3126109|P1|Overall Study|Unsatisfactory therapeutic response|1
949405|NCT00778921|3126107|P3|Overall Study|Abnormal Test Procedure Result(s)|2
949406|NCT00778921|3126108|P2|Overall Study|Abnormal Test Procedure Result(s)|0
949407|NCT00778921|3126109|P1|Overall Study|Abnormal Test Procedure Result(s)|0
949408|NCT00778921|3126107|P3|Overall Study|Abnormal Laboratory Value(s)|0
949409|NCT00778921|3126108|P2|Overall Study|Abnormal Laboratory Value(s)|0
949410|NCT00778921|3126109|P1|Overall Study|Abnormal Laboratory Value(s)|1
949411|NCT00778921|3126107|P3|Overall Study|Adverse Event|14
949412|NCT00778921|3126108|P2|Overall Study|Adverse Event|10
949413|NCT00778921|3126109|P1|Overall Study|Adverse Event|9
949414|NCT00778895|3126126|P3|ESFU Phase|Other|0
949415|NCT00778895|3126127|P2|ESFU Phase|Other|0
949416|NCT00778895|3126128|P1|ESFU Phase|Other|2
949417|NCT00778895|3126126|P3|ESFU Phase|Lost to Follow-up|2
949418|NCT00778895|3126127|P2|ESFU Phase|Lost to Follow-up|7
949419|NCT00778895|3126128|P1|ESFU Phase|Lost to Follow-up|6
949420|NCT00778895|3126126|P3|ESFU Phase|Withdrawal by Subject|0
949421|NCT00778895|3126127|P2|ESFU Phase|Withdrawal by Subject|4
949422|NCT00778895|3126128|P1|ESFU Phase|Withdrawal by Subject|1
949423|NCT00778895|3126126|P3|ESFU Phase|Adverse Event|0
949424|NCT00778895|3126127|P2|ESFU Phase|Adverse Event|1
949425|NCT00778895|3126128|P1|ESFU Phase|Adverse Event|2
949426|NCT00778895|3126126|P3|Active Phase|Other|0
949427|NCT00778895|3126127|P2|Active Phase|Other|0
949428|NCT00778895|3126128|P1|Active Phase|Other|2
949429|NCT00778895|3126126|P3|Active Phase|Lost to Follow-up|0
949430|NCT00778895|3126127|P2|Active Phase|Lost to Follow-up|1
949431|NCT00778895|3126128|P1|Active Phase|Lost to Follow-up|1
949432|NCT00778895|3126126|P3|Active Phase|Withdrawal by Subject|0
949433|NCT00778895|3126127|P2|Active Phase|Withdrawal by Subject|4
949434|NCT00778895|3126128|P1|Active Phase|Withdrawal by Subject|1
949435|NCT00778895|3126126|P3|Active Phase|Adverse Event|0
949436|NCT00778895|3126127|P2|Active Phase|Adverse Event|1
949437|NCT00778895|3126128|P1|Active Phase|Adverse Event|3
949438|NCT00778830|3126172|P2|Overall Study|Ongoing at data cut-off|1
949439|NCT00778830|3126173|P1|Overall Study|Ongoing at data cut-off|0
949440|NCT00778817|3126185|P1|Overall Study|Withdrawal by Subject|2
949441|NCT00778817|3126185|P1|Overall Study|Adverse Event|2
949442|NCT00778622|3126212|P3|Overall Study|Other|1
949443|NCT00778622|3126213|P2|Overall Study|Other|0
949444|NCT00778622|3126214|P1|Overall Study|Other|1
949445|NCT00778622|3126212|P3|Overall Study|immigration|0
949446|NCT00778622|3126213|P2|Overall Study|immigration|0
949447|NCT00778622|3126214|P1|Overall Study|immigration|1
949448|NCT00778622|3126212|P3|Overall Study|Lack of Efficacy|0
949449|NCT00778622|3126213|P2|Overall Study|Lack of Efficacy|0
949450|NCT00778622|3126214|P1|Overall Study|Lack of Efficacy|2
949451|NCT00778622|3126212|P3|Overall Study|Protocol Violation|0
949452|NCT00778622|3126213|P2|Overall Study|Protocol Violation|3
949453|NCT00778622|3126214|P1|Overall Study|Protocol Violation|0
949454|NCT00778622|3126212|P3|Overall Study|Lost to Follow-up|2
949455|NCT00778622|3126213|P2|Overall Study|Lost to Follow-up|3
949456|NCT00778622|3126214|P1|Overall Study|Lost to Follow-up|3
949457|NCT00778622|3126212|P3|Overall Study|Withdrawal by Subject|5
949458|NCT00778622|3126213|P2|Overall Study|Withdrawal by Subject|5
949459|NCT00778622|3126214|P1|Overall Study|Withdrawal by Subject|4
949460|NCT00778622|3126212|P3|Overall Study|Adverse Event|7
949461|NCT00778622|3126213|P2|Overall Study|Adverse Event|4
949462|NCT00778622|3126214|P1|Overall Study|Adverse Event|5
949463|NCT00778375|3126267|P1|Overall Study|Ineligible|3
949464|NCT00778336|3126281|P4|3 Month Follow Up|Death|0
949465|NCT00778336|3126282|P3|3 Month Follow Up|Death|2
949466|NCT00778336|3126283|P2|3 Month Follow Up|Death|3
949467|NCT00778336|3126284|P1|3 Month Follow Up|Death|8
949468|NCT00778336|3126281|P4|3 Month Follow Up|Lost to Follow-up|0
949469|NCT00778336|3126282|P3|3 Month Follow Up|Lost to Follow-up|3
949470|NCT00778336|3126283|P2|3 Month Follow Up|Lost to Follow-up|20
949471|NCT00778336|3126284|P1|3 Month Follow Up|Lost to Follow-up|15
949472|NCT00778336|3126281|P4|Index Procedure-Discharge|Death|0
949473|NCT00778336|3126282|P3|Index Procedure-Discharge|Death|2
949474|NCT00778336|3126283|P2|Index Procedure-Discharge|Death|3
949475|NCT00778336|3126284|P1|Index Procedure-Discharge|Death|6
949476|NCT00778258|3126322|P9|Overall Study|Other|0
949477|NCT00778258|3126323|P8|Overall Study|Other|0
949478|NCT00778258|3126324|P7|Overall Study|Other|1
949479|NCT00778258|3126325|P6|Overall Study|Other|0
949480|NCT00778258|3126326|P5|Overall Study|Other|0
949481|NCT00778258|3126327|P4|Overall Study|Other|0
949482|NCT00778258|3126328|P3|Overall Study|Other|0
949483|NCT00778258|3126329|P2|Overall Study|Other|0
949484|NCT00778258|3126330|P1|Overall Study|Other|0
949485|NCT00778258|3126322|P9|Overall Study|Non-compliance|0
949486|NCT00778258|3126323|P8|Overall Study|Non-compliance|0
949487|NCT00778258|3126324|P7|Overall Study|Non-compliance|0
949488|NCT00778258|3126325|P6|Overall Study|Non-compliance|0
949489|NCT00778258|3126326|P5|Overall Study|Non-compliance|0
949490|NCT00778258|3126327|P4|Overall Study|Non-compliance|1
949491|NCT00778258|3126328|P3|Overall Study|Non-compliance|0
949492|NCT00778258|3126329|P2|Overall Study|Non-compliance|0
949493|NCT00778258|3126330|P1|Overall Study|Non-compliance|0
949494|NCT00778258|3126322|P9|Overall Study|New Contraindication|0
949495|NCT00778258|3126323|P8|Overall Study|New Contraindication|1
949496|NCT00778258|3126324|P7|Overall Study|New Contraindication|0
949497|NCT00778258|3126325|P6|Overall Study|New Contraindication|0
949498|NCT00778258|3126326|P5|Overall Study|New Contraindication|0
949499|NCT00778258|3126327|P4|Overall Study|New Contraindication|0
949500|NCT00778258|3126328|P3|Overall Study|New Contraindication|0
949501|NCT00778258|3126329|P2|Overall Study|New Contraindication|0
949502|NCT00778258|3126330|P1|Overall Study|New Contraindication|0
949503|NCT00778258|3126322|P9|Overall Study|Withdrawal by Subject|4
949504|NCT00778258|3126323|P8|Overall Study|Withdrawal by Subject|12
949505|NCT00778258|3126324|P7|Overall Study|Withdrawal by Subject|12
949506|NCT00778258|3126325|P6|Overall Study|Withdrawal by Subject|6
949507|NCT00778258|3126326|P5|Overall Study|Withdrawal by Subject|0
949508|NCT00778258|3126327|P4|Overall Study|Withdrawal by Subject|2
949509|NCT00778258|3126328|P3|Overall Study|Withdrawal by Subject|8
949510|NCT00778258|3126329|P2|Overall Study|Withdrawal by Subject|2
949511|NCT00778258|3126330|P1|Overall Study|Withdrawal by Subject|6
949512|NCT00778258|3126322|P9|Overall Study|Lost to Follow-up|0
949513|NCT00778258|3126323|P8|Overall Study|Lost to Follow-up|2
949514|NCT00778258|3126324|P7|Overall Study|Lost to Follow-up|2
949515|NCT00778258|3126325|P6|Overall Study|Lost to Follow-up|3
949516|NCT00778258|3126326|P5|Overall Study|Lost to Follow-up|0
949517|NCT00778258|3126327|P4|Overall Study|Lost to Follow-up|0
949518|NCT00778258|3126328|P3|Overall Study|Lost to Follow-up|2
949519|NCT00778258|3126329|P2|Overall Study|Lost to Follow-up|0
949520|NCT00778258|3126330|P1|Overall Study|Lost to Follow-up|0
949521|NCT00778258|3126322|P9|Overall Study|Adverse Event|0
949522|NCT00778258|3126323|P8|Overall Study|Adverse Event|0
949523|NCT00778258|3126324|P7|Overall Study|Adverse Event|0
949524|NCT00778258|3126325|P6|Overall Study|Adverse Event|1
949525|NCT00778258|3126326|P5|Overall Study|Adverse Event|0
949526|NCT00778258|3126327|P4|Overall Study|Adverse Event|0
949527|NCT00778258|3126328|P3|Overall Study|Adverse Event|0
949528|NCT00778258|3126329|P2|Overall Study|Adverse Event|0
949529|NCT00778258|3126330|P1|Overall Study|Adverse Event|1
949530|NCT00778102|3126397|P2|Overall Study|Administrative Reason|10
949531|NCT00778102|3126398|P1|Overall Study|Administrative Reason|7
949532|NCT00778102|3126397|P2|Overall Study|Withdrawal by Subject|1
949533|NCT00778102|3126398|P1|Overall Study|Withdrawal by Subject|1
949534|NCT00778102|3126397|P2|Overall Study|Refused Treatment|3
949535|NCT00778102|3126398|P1|Overall Study|Refused Treatment|2
949536|NCT00778102|3126397|P2|Overall Study|Protocol Violation|1
949537|NCT00778102|3126398|P1|Overall Study|Protocol Violation|0
949538|NCT00778102|3126397|P2|Overall Study|Violation of Selection Criteria|1
949539|NCT00778102|3126398|P1|Overall Study|Violation of Selection Criteria|1
949540|NCT00778102|3126397|P2|Overall Study|Lost to Follow-up|0
949541|NCT00778102|3126398|P1|Overall Study|Lost to Follow-up|1
949542|NCT00778102|3126397|P2|Overall Study|Death|1
949543|NCT00778102|3126398|P1|Overall Study|Death|1
949544|NCT00778102|3126397|P2|Overall Study|Adverse Event|5
949545|NCT00778102|3126398|P1|Overall Study|Adverse Event|8
949546|NCT00777946|3126433|P3|Overall Study|Randomized in error|0
949547|NCT00777946|3126434|P2|Overall Study|Randomized in error|1
949548|NCT00777946|3126435|P1|Overall Study|Randomized in error|1
949549|NCT00777946|3126433|P3|Overall Study|Protocol deviation|1
949550|NCT00777946|3126434|P2|Overall Study|Protocol deviation|1
949551|NCT00777946|3126435|P1|Overall Study|Protocol deviation|2
949552|NCT00777946|3126433|P3|Overall Study|Lost to Follow-up|0
949553|NCT00777946|3126434|P2|Overall Study|Lost to Follow-up|1
949554|NCT00777946|3126435|P1|Overall Study|Lost to Follow-up|3
949555|NCT00777946|3126433|P3|Overall Study|Patient withdrew consent|3
949556|NCT00777946|3126434|P2|Overall Study|Patient withdrew consent|2
949557|NCT00777946|3126435|P1|Overall Study|Patient withdrew consent|3
949558|NCT00777946|3126433|P3|Overall Study|Condition no longer required study drug|0
949559|NCT00777946|3126434|P2|Overall Study|Condition no longer required study drug|0
949560|NCT00777946|3126435|P1|Overall Study|Condition no longer required study drug|1
949561|NCT00777946|3126433|P3|Overall Study|Lack of Efficacy|9
949562|NCT00777946|3126434|P2|Overall Study|Lack of Efficacy|0
949563|NCT00777946|3126435|P1|Overall Study|Lack of Efficacy|0
949564|NCT00777946|3126433|P3|Overall Study|Adverse Event|3
949565|NCT00777946|3126434|P2|Overall Study|Adverse Event|1
949566|NCT00777946|3126435|P1|Overall Study|Adverse Event|11
949567|NCT00777803|3126470|P2|Overall Study|Non-compliance|2
949568|NCT00777803|3126471|P1|Overall Study|Non-compliance|2
949569|NCT00777803|3126470|P2|Overall Study|Adverse Event|0
949570|NCT00777803|3126471|P1|Overall Study|Adverse Event|1
949571|NCT00777803|3126470|P2|Overall Study|Lost to Follow-up|5
949572|NCT00777803|3126471|P1|Overall Study|Lost to Follow-up|12
949573|NCT00777608|3126550|P2|Overall Study|Investigator Decision|2
949574|NCT00777608|3126551|P1|Overall Study|Investigator Decision|1
949575|NCT00777608|3126550|P2|Overall Study|Protocol Violation|0
949576|NCT00777608|3126551|P1|Overall Study|Protocol Violation|1
949577|NCT00777608|3126550|P2|Overall Study|Withdrawal by Subject|3
949578|NCT00777608|3126551|P1|Overall Study|Withdrawal by Subject|1
949579|NCT00777608|3126550|P2|Overall Study|Lost to Follow-up|1
949580|NCT00777608|3126551|P1|Overall Study|Lost to Follow-up|1
949581|NCT00777556|3126561|P1|Overall Study|Did not complete all 3 follow-up visits|20
949582|NCT00777556|3126561|P1|Overall Study|Dispensed but did not use product|12
949583|NCT00777556|3126561|P1|Overall Study|Inappropriate self-selection|34
949584|NCT00777257|3126582|P3|Overall Study|Withdrawal by Subject|5
949585|NCT00777257|3126583|P2|Overall Study|Withdrawal by Subject|6
949586|NCT00777257|3126584|P1|Overall Study|Withdrawal by Subject|3
949587|NCT00777257|3126582|P3|Overall Study|Protocol Violation|2
949588|NCT00777257|3126583|P2|Overall Study|Protocol Violation|2
949589|NCT00777257|3126584|P1|Overall Study|Protocol Violation|2
949590|NCT00777257|3126582|P3|Overall Study|Lost to Follow-up|2
949591|NCT00777257|3126583|P2|Overall Study|Lost to Follow-up|3
949592|NCT00777257|3126584|P1|Overall Study|Lost to Follow-up|3
949593|NCT00777257|3126582|P3|Overall Study|Adverse Event|0
949594|NCT00777257|3126583|P2|Overall Study|Adverse Event|1
949595|NCT00777257|3126584|P1|Overall Study|Adverse Event|3
949596|NCT00777205|3126603|P2|Overall Study|Protocol Violation|56
949597|NCT00777205|3126604|P1|Overall Study|Protocol Violation|0
949598|NCT00777205|3126603|P2|Overall Study|Death|2
949599|NCT00777205|3126604|P1|Overall Study|Death|0
949600|NCT00777205|3126603|P2|Overall Study|Withdrawal by Subject|4
949601|NCT00777205|3126604|P1|Overall Study|Withdrawal by Subject|6
949602|NCT00777205|3126603|P2|Overall Study|Lost to Follow-up|9
949603|NCT00777205|3126604|P1|Overall Study|Lost to Follow-up|25
949604|NCT00777153|3126638|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|1
949605|NCT00777153|3126639|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|5
949606|NCT00777153|3126640|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|1
949607|NCT00777153|3126638|P3|Overall Study|Withdrawal by Subject|3
949608|NCT00777153|3126639|P2|Overall Study|Withdrawal by Subject|4
949609|NCT00777153|3126640|P1|Overall Study|Withdrawal by Subject|3
949610|NCT00777153|3126638|P3|Overall Study|Death|33
949611|NCT00777153|3126639|P2|Overall Study|Death|73
949612|NCT00777153|3126640|P1|Overall Study|Death|85
949613|NCT00777153|3126638|P3|Overall Study|Lost to Follow-up|0
949614|NCT00777153|3126639|P2|Overall Study|Lost to Follow-up|1
949615|NCT00777153|3126640|P1|Overall Study|Lost to Follow-up|1
949616|NCT00777101|3126665|P2|Overall Study|Failed to Return|1
949617|NCT00777101|3126666|P1|Overall Study|Failed to Return|0
949618|NCT00777101|3126665|P2|Overall Study|Discontinuation of Study by Sponsor|0
949619|NCT00777101|3126666|P1|Overall Study|Discontinuation of Study by Sponsor|1
949620|NCT00777101|3126665|P2|Overall Study|Lost to Follow-up|1
949621|NCT00777101|3126666|P1|Overall Study|Lost to Follow-up|2
949622|NCT00777101|3126665|P2|Overall Study|Withdrawal by Subject|6
949623|NCT00777101|3126666|P1|Overall Study|Withdrawal by Subject|11
949624|NCT00777101|3126665|P2|Overall Study|Death|43
949625|NCT00777101|3126666|P1|Overall Study|Death|48
949626|NCT00777088|3126684|P1|Overall Study|PED Treatment not attempted|1
949627|NCT00777049|3126709|P2|Overall Study|No treatment (elevated liver enzymes)|1
949628|NCT00777049|3126710|P1|Overall Study|No treatment (elevated liver enzymes)|0
949629|NCT00777049|3126709|P2|Overall Study|Withdrawal by Subject|0
949630|NCT00777049|3126710|P1|Overall Study|Withdrawal by Subject|1
949631|NCT00777036|3126719|P3|Follow-Up|Death|0
949632|NCT00777036|3126720|P2|Follow-Up|Death|8
949633|NCT00777036|3126721|P1|Follow-Up|Death|1
949634|NCT00777036|3126719|P3|Follow-Up|Withdrawal by Subject|4
949635|NCT00777036|3126720|P2|Follow-Up|Withdrawal by Subject|0
949636|NCT00777036|3126721|P1|Follow-Up|Withdrawal by Subject|1
949637|NCT00777036|3126719|P3|Follow-Up|Reason Not Specified|0
949638|NCT00777036|3126720|P2|Follow-Up|Reason Not Specified|0
949639|NCT00777036|3126721|P1|Follow-Up|Reason Not Specified|2
949640|NCT00777036|3126719|P3|Follow-Up|Lost to Follow-up|0
949641|NCT00777036|3126720|P2|Follow-Up|Lost to Follow-up|0
949642|NCT00777036|3126721|P1|Follow-Up|Lost to Follow-up|1
949643|NCT00777036|3126719|P3|On Treatment|Progressive Disease|6
949644|NCT00777036|3126720|P2|On Treatment|Progressive Disease|4
949645|NCT00777036|3126721|P1|On Treatment|Progressive Disease|5
949646|NCT00777036|3126719|P3|On Treatment|Study Drug Toxicity|1
949647|NCT00777036|3126720|P2|On Treatment|Study Drug Toxicity|0
949648|NCT00777036|3126721|P1|On Treatment|Study Drug Toxicity|0
949649|NCT00777036|3126719|P3|On Treatment|Death|0
949650|NCT00777036|3126720|P2|On Treatment|Death|2
949651|NCT00777036|3126721|P1|On Treatment|Death|0
949652|NCT00777036|3126719|P3|On Treatment|Withdrawal by Subject|3
949653|NCT00777036|3126720|P2|On Treatment|Withdrawal by Subject|2
949654|NCT00777036|3126721|P1|On Treatment|Withdrawal by Subject|3
949655|NCT00777036|3126719|P3|On Treatment|Maximum Clinical Benefit|1
949656|NCT00777036|3126720|P2|On Treatment|Maximum Clinical Benefit|0
949657|NCT00777036|3126721|P1|On Treatment|Maximum Clinical Benefit|2
949658|NCT00777036|3126719|P3|On Treatment|Non-compliance with Study Drug|0
949659|NCT00777036|3126720|P2|On Treatment|Non-compliance with Study Drug|0
949660|NCT00777036|3126721|P1|On Treatment|Non-compliance with Study Drug|1
949661|NCT00777036|3126719|P3|On Treatment|Failure to Meet Study Criteria|0
949662|NCT00777036|3126720|P2|On Treatment|Failure to Meet Study Criteria|1
949663|NCT00777036|3126721|P1|On Treatment|Failure to Meet Study Criteria|0
949664|NCT00777036|3126719|P3|On Treatment|Reason Not Specified|12
949665|NCT00777036|3126720|P2|On Treatment|Reason Not Specified|7
949666|NCT00777036|3126721|P1|On Treatment|Reason Not Specified|4
949667|NCT00777023|3126817|P3|Overall Study|Last dose date unknown|1
949668|NCT00777023|3126818|P2|Overall Study|Last dose date unknown|3
949669|NCT00777023|3126819|P1|Overall Study|Last dose date unknown|3
949670|NCT00777023|3126817|P3|Overall Study|Reasons not specified|2
949671|NCT00777023|3126818|P2|Overall Study|Reasons not specified|4
949672|NCT00777023|3126819|P1|Overall Study|Reasons not specified|4
949673|NCT00777023|3126817|P3|Overall Study|Missing data|0
949674|NCT00777023|3126818|P2|Overall Study|Missing data|1
949675|NCT00777023|3126819|P1|Overall Study|Missing data|1
949676|NCT00777023|3126817|P3|Overall Study|Withdrawal by Subject|8
949677|NCT00777023|3126818|P2|Overall Study|Withdrawal by Subject|7
949678|NCT00777023|3126819|P1|Overall Study|Withdrawal by Subject|7
949679|NCT00777023|3126817|P3|Overall Study|Death|0
949680|NCT00777023|3126818|P2|Overall Study|Death|1
949681|NCT00777023|3126819|P1|Overall Study|Death|0
949682|NCT00777023|3126817|P3|Overall Study|Lost to Follow-up|3
949683|NCT00777023|3126818|P2|Overall Study|Lost to Follow-up|3
949684|NCT00777023|3126819|P1|Overall Study|Lost to Follow-up|2
949685|NCT00777023|3126817|P3|Overall Study|Protocol Violation|1
949686|NCT00777023|3126818|P2|Overall Study|Protocol Violation|1
949687|NCT00777023|3126819|P1|Overall Study|Protocol Violation|2
949688|NCT00777023|3126817|P3|Overall Study|Lack of Efficacy|14
949689|NCT00777023|3126818|P2|Overall Study|Lack of Efficacy|0
949690|NCT00777023|3126819|P1|Overall Study|Lack of Efficacy|1
949691|NCT00777023|3126817|P3|Overall Study|Adverse Event|8
949692|NCT00777023|3126818|P2|Overall Study|Adverse Event|21
949693|NCT00777023|3126819|P1|Overall Study|Adverse Event|15
949694|NCT00776997|3126836|P1|Overall Study|Adverse Event|2
949695|NCT00776984|3126845|P2|Overall Study|Other|9
949696|NCT00776984|3126846|P1|Overall Study|Other|5
949697|NCT00776984|3126845|P2|Overall Study|Lack of Efficacy|1
949698|NCT00776984|3126846|P1|Overall Study|Lack of Efficacy|0
949699|NCT00776984|3126845|P2|Overall Study|Withdrawal by Subject|7
949700|NCT00776984|3126846|P1|Overall Study|Withdrawal by Subject|12
949701|NCT00776984|3126845|P2|Overall Study|Lost to Follow-up|0
949702|NCT00776984|3126846|P1|Overall Study|Lost to Follow-up|2
949703|NCT00776984|3126845|P2|Overall Study|Protocol Violation|2
949704|NCT00776984|3126846|P1|Overall Study|Protocol Violation|4
949705|NCT00776984|3126845|P2|Overall Study|Adverse Event|2
949706|NCT00776984|3126846|P1|Overall Study|Adverse Event|8
949707|NCT00776919|3126920|P4|Overall Study|Other: Lack of Efficacy/Lost Medication|2
949708|NCT00776919|3126921|P3|Overall Study|Other: Lack of Efficacy/Lost Medication|4
949709|NCT00776919|3126922|P2|Overall Study|Other: Lack of Efficacy/Lost Medication|5
949710|NCT00776919|3126923|P1|Overall Study|Other: Lack of Efficacy/Lost Medication|1
949711|NCT00776919|3126920|P4|Overall Study|Protocol Violation|1
949712|NCT00776919|3126921|P3|Overall Study|Protocol Violation|0
949713|NCT00776919|3126922|P2|Overall Study|Protocol Violation|2
949714|NCT00776919|3126923|P1|Overall Study|Protocol Violation|1
949715|NCT00776919|3126920|P4|Overall Study|Adverse Event|2
949716|NCT00776919|3126921|P3|Overall Study|Adverse Event|2
949717|NCT00776919|3126922|P2|Overall Study|Adverse Event|0
949718|NCT00776919|3126923|P1|Overall Study|Adverse Event|1
949719|NCT00776919|3126920|P4|Overall Study|Lost to Follow-up|8
949720|NCT00776919|3126921|P3|Overall Study|Lost to Follow-up|11
949721|NCT00776919|3126922|P2|Overall Study|Lost to Follow-up|12
949722|NCT00776919|3126923|P1|Overall Study|Lost to Follow-up|8
949723|NCT00776919|3126920|P4|Overall Study|Withdrawal by Subject|26
949724|NCT00776919|3126921|P3|Overall Study|Withdrawal by Subject|15
949725|NCT00776919|3126922|P2|Overall Study|Withdrawal by Subject|14
949726|NCT00776919|3126923|P1|Overall Study|Withdrawal by Subject|16
949727|NCT00776789|3126987|P2|Overall Study|Poor quality video|1
949728|NCT00776789|3126988|P1|Overall Study|Poor quality video|1
949729|NCT00776789|3126987|P2|Overall Study|Consent refusal|2
949730|NCT00776789|3126988|P1|Overall Study|Consent refusal|2
949731|NCT00776659|3127000|P1|Overall Study|Study Terminated by Sponsor|1
949732|NCT00776659|3127000|P1|Overall Study|Withdrawal by Subject|10
949733|NCT00776659|3127000|P1|Overall Study|Lost to Follow-up|15
949734|NCT00776555|3127027|P2|Overall Study|Study terminated|0
949735|NCT00776555|3127028|P1|Overall Study|Study terminated|3
949736|NCT00776230|3127046|P3|Overall Study|Subject missed Visit 4|0
949737|NCT00776230|3127047|P2|Overall Study|Subject missed Visit 4|1
949738|NCT00776230|3127048|P1|Overall Study|Subject missed Visit 4|0
949739|NCT00776230|3127046|P3|Overall Study|Withdrawal by Subject|0
949740|NCT00776230|3127047|P2|Overall Study|Withdrawal by Subject|1
949741|NCT00776230|3127048|P1|Overall Study|Withdrawal by Subject|0
949742|NCT00776230|3127046|P3|Overall Study|Not vaccinated at Day 0|0
949743|NCT00776230|3127047|P2|Overall Study|Not vaccinated at Day 0|0
949744|NCT00776230|3127048|P1|Overall Study|Not vaccinated at Day 0|1
949745|NCT00776230|3127046|P3|Overall Study|Lost to Follow-up|5
949746|NCT00776230|3127047|P2|Overall Study|Lost to Follow-up|1
949747|NCT00776230|3127048|P1|Overall Study|Lost to Follow-up|2
949748|NCT00776100|3127058|P2|Overall Study|Disease Progression|0
949749|NCT00776100|3127059|P1|Overall Study|Disease Progression|1
949750|NCT00776009|3127081|P6|Period 3: Third Intervention|Withdrawal by Subject|0
949751|NCT00776009|3127082|P5|Period 3: Third Intervention|Withdrawal by Subject|0
949752|NCT00776009|3127083|P4|Period 3: Third Intervention|Withdrawal by Subject|0
949753|NCT00776009|3127084|P3|Period 3: Third Intervention|Withdrawal by Subject|0
949754|NCT00776009|3127085|P2|Period 3: Third Intervention|Withdrawal by Subject|0
949755|NCT00776009|3127086|P1|Period 3: Third Intervention|Withdrawal by Subject|1
949756|NCT00776009|3127081|P6|Period 2: Second Intervention|Protocol Violation|0
949757|NCT00776009|3127082|P5|Period 2: Second Intervention|Protocol Violation|0
949758|NCT00776009|3127083|P4|Period 2: Second Intervention|Protocol Violation|0
949759|NCT00776009|3127084|P3|Period 2: Second Intervention|Protocol Violation|1
949760|NCT00776009|3127085|P2|Period 2: Second Intervention|Protocol Violation|0
949761|NCT00776009|3127086|P1|Period 2: Second Intervention|Protocol Violation|1
949762|NCT00776009|3127081|P6|Period 2: Second Intervention|Withdrawal by Subject|1
949763|NCT00776009|3127082|P5|Period 2: Second Intervention|Withdrawal by Subject|0
949764|NCT00776009|3127083|P4|Period 2: Second Intervention|Withdrawal by Subject|0
949765|NCT00776009|3127084|P3|Period 2: Second Intervention|Withdrawal by Subject|0
949766|NCT00776009|3127085|P2|Period 2: Second Intervention|Withdrawal by Subject|0
949767|NCT00776009|3127086|P1|Period 2: Second Intervention|Withdrawal by Subject|0
949768|NCT00776009|3127081|P6|Period 1: First Intervention|Protocol Violation|0
949769|NCT00776009|3127082|P5|Period 1: First Intervention|Protocol Violation|1
949770|NCT00776009|3127083|P4|Period 1: First Intervention|Protocol Violation|0
949771|NCT00776009|3127084|P3|Period 1: First Intervention|Protocol Violation|0
949772|NCT00776009|3127085|P2|Period 1: First Intervention|Protocol Violation|1
949773|NCT00776009|3127086|P1|Period 1: First Intervention|Protocol Violation|0
949774|NCT00776009|3127081|P6|Period 1: First Intervention|Withdrawal by Subject|0
949775|NCT00776009|3127082|P5|Period 1: First Intervention|Withdrawal by Subject|1
949776|NCT00776009|3127083|P4|Period 1: First Intervention|Withdrawal by Subject|0
949777|NCT00776009|3127084|P3|Period 1: First Intervention|Withdrawal by Subject|1
949778|NCT00776009|3127085|P2|Period 1: First Intervention|Withdrawal by Subject|0
949779|NCT00776009|3127086|P1|Period 1: First Intervention|Withdrawal by Subject|0
949780|NCT00775983|3127108|P2|Overall Study|Protocol Violation|2
949781|NCT00775983|3127109|P1|Overall Study|Protocol Violation|1
949782|NCT00775606|3127220|P2|Overall Study|Study sponsor terminated funding|0
949783|NCT00775606|3127221|P1|Overall Study|Study sponsor terminated funding|3
949784|NCT00775593|3127231|P1|Overall Study|Death|1
949785|NCT00775593|3127231|P1|Overall Study|Unmet eligibility criteria|6
949786|NCT00775528|3127238|P1|Overall Study|Protocol Violation|1
949787|NCT00775463|3127247|P2|Overall Study|Lack of Efficacy|1
949788|NCT00775463|3127248|P1|Overall Study|Lack of Efficacy|1
949789|NCT00775463|3127247|P2|Overall Study|Lost to Follow-up|0
949790|NCT00775463|3127248|P1|Overall Study|Lost to Follow-up|1
949791|NCT00775463|3127247|P2|Overall Study|Protocol Violation|2
949792|NCT00775463|3127248|P1|Overall Study|Protocol Violation|2
949793|NCT00775463|3127247|P2|Overall Study|Adverse Event|9
949794|NCT00775463|3127248|P1|Overall Study|Adverse Event|7
949795|NCT00775463|3127247|P2|Overall Study|Withdrawal by Subject|1
949796|NCT00775463|3127248|P1|Overall Study|Withdrawal by Subject|0
949797|NCT00775450|3127285|P5|Overall Study|Withdrawal by Subject|1
949798|NCT00775450|3127286|P4|Overall Study|Withdrawal by Subject|0
949799|NCT00775450|3127287|P3|Overall Study|Withdrawal by Subject|0
949800|NCT00775450|3127288|P2|Overall Study|Withdrawal by Subject|0
949801|NCT00775450|3127289|P1|Overall Study|Withdrawal by Subject|1
949802|NCT00775450|3127285|P5|Overall Study|Protocol Violation|1
949803|NCT00775450|3127286|P4|Overall Study|Protocol Violation|0
949804|NCT00775450|3127287|P3|Overall Study|Protocol Violation|0
949805|NCT00775450|3127288|P2|Overall Study|Protocol Violation|0
949806|NCT00775450|3127289|P1|Overall Study|Protocol Violation|0
949807|NCT00775450|3127285|P5|Overall Study|Serious Adverse Event|0
949808|NCT00775450|3127286|P4|Overall Study|Serious Adverse Event|0
949809|NCT00775450|3127287|P3|Overall Study|Serious Adverse Event|0
949810|NCT00775450|3127288|P2|Overall Study|Serious Adverse Event|0
949811|NCT00775450|3127289|P1|Overall Study|Serious Adverse Event|2
949812|NCT00775437|3127316|P1|Overall Study|Lost to Follow-up|1
949813|NCT00775437|3127316|P1|Overall Study|Withdrawal by Subject|3
949814|NCT00775437|3127316|P1|Overall Study|Loss of efficacy|2
949815|NCT00775203|3127391|P2|Overall Study|Physician Decision|1
949816|NCT00775203|3127392|P1|Overall Study|Physician Decision|0
949817|NCT00775203|3127391|P2|Overall Study|Entered other study|0
949818|NCT00775203|3127392|P1|Overall Study|Entered other study|1
949819|NCT00775203|3127391|P2|Overall Study|Protocol Violation|1
949820|NCT00775203|3127392|P1|Overall Study|Protocol Violation|0
949821|NCT00775203|3127391|P2|Overall Study|Noncompliance|2
949822|NCT00775203|3127392|P1|Overall Study|Noncompliance|4
949823|NCT00775203|3127391|P2|Overall Study|Administrative reason|0
949824|NCT00775203|3127392|P1|Overall Study|Administrative reason|2
949825|NCT00775203|3127391|P2|Overall Study|Lost to Follow-up|15
949826|NCT00775203|3127392|P1|Overall Study|Lost to Follow-up|11
949827|NCT00775203|3127391|P2|Overall Study|Withdrawal by Subject|9
949828|NCT00775203|3127392|P1|Overall Study|Withdrawal by Subject|11
949829|NCT00775203|3127391|P2|Overall Study|Lack of Efficacy|9
949830|NCT00775203|3127392|P1|Overall Study|Lack of Efficacy|8
949831|NCT00775203|3127391|P2|Overall Study|Adverse Event|6
949832|NCT00775203|3127392|P1|Overall Study|Adverse Event|25
949833|NCT00775190|3127426|P2|Overall Study|Protocol Violation|0
949834|NCT00775190|3127427|P1|Overall Study|Protocol Violation|1
949835|NCT00775190|3127426|P2|Overall Study|Withdrawal by Subject|2
949836|NCT00775190|3127427|P1|Overall Study|Withdrawal by Subject|1
949837|NCT00775190|3127426|P2|Overall Study|Lost to Follow-up|3
949838|NCT00775190|3127427|P1|Overall Study|Lost to Follow-up|2
949839|NCT00775021|3127449|P2|Second Intervention|Adverse Event|1
949840|NCT00775021|3127450|P1|Second Intervention|Adverse Event|0
949841|NCT00775021|3127449|P2|First Intervention|Lost to Follow-up|0
949842|NCT00775021|3127450|P1|First Intervention|Lost to Follow-up|1
949843|NCT00774995|3127468|P4|Overall Study|Protocol Violation|0
949844|NCT00774995|3127469|P3|Overall Study|Protocol Violation|1
949845|NCT00774995|3127470|P2|Overall Study|Protocol Violation|0
949846|NCT00774995|3127471|P1|Overall Study|Protocol Violation|0
949847|NCT00774930|3127511|P2|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1
949848|NCT00774930|3127512|P1|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0
949849|NCT00774930|3127511|P2|LTOLE Phase|Tumour Progression of Hepatic Metastases|1
949850|NCT00774930|3127512|P1|LTOLE Phase|Tumour Progression of Hepatic Metastases|0
949851|NCT00774930|3127511|P2|LTOLE Phase|Disease Progression|5
949852|NCT00774930|3127512|P1|LTOLE Phase|Disease Progression|2
949853|NCT00774930|3127511|P2|LTOLE Phase|Sponsor decision|1
949854|NCT00774930|3127512|P1|LTOLE Phase|Sponsor decision|2
949855|NCT00774930|3127511|P2|LTOLE Phase|Physician Decision|1
949856|NCT00774930|3127512|P1|LTOLE Phase|Physician Decision|4
949857|NCT00774930|3127511|P2|LTOLE Phase|Subject decision|5
949858|NCT00774930|3127512|P1|LTOLE Phase|Subject decision|0
949859|NCT00774930|3127511|P2|LTOLE Phase|Adverse Event|3
949860|NCT00774930|3127512|P1|LTOLE Phase|Adverse Event|7
949861|NCT00774930|3127511|P2|IOL Phase|Brain radiation|1
949862|NCT00774930|3127512|P1|IOL Phase|Brain radiation|0
949863|NCT00774930|3127511|P2|IOL Phase|Other|0
949864|NCT00774930|3127512|P1|IOL Phase|Other|1
949865|NCT00774930|3127511|P2|IOL Phase|Peptide Receptor Radionuclide Therapy|1
949866|NCT00774930|3127512|P1|IOL Phase|Peptide Receptor Radionuclide Therapy|0
949867|NCT00774930|3127511|P2|IOL Phase|Subject Consumed Prohibited Medication|0
949868|NCT00774930|3127512|P1|IOL Phase|Subject Consumed Prohibited Medication|1
949869|NCT00774930|3127511|P2|IOL Phase|Disease Progression|1
949870|NCT00774930|3127512|P1|IOL Phase|Disease Progression|2
949871|NCT00774930|3127511|P2|IOL Phase|Sponsor Decision|0
949872|NCT00774930|3127512|P1|IOL Phase|Sponsor Decision|1
949873|NCT00774930|3127511|P2|IOL Phase|Physician Decision|2
949874|NCT00774930|3127512|P1|IOL Phase|Physician Decision|3
949875|NCT00774930|3127511|P2|IOL Phase|Subject Decision|3
949876|NCT00774930|3127512|P1|IOL Phase|Subject Decision|4
949877|NCT00774930|3127511|P2|IOL Phase|Adverse Event|1
949878|NCT00774930|3127512|P1|IOL Phase|Adverse Event|1
949879|NCT00774930|3127511|P2|DB Phase|Started Nonprotocol Radiation therapy|1
949880|NCT00774930|3127512|P1|DB Phase|Started Nonprotocol Radiation therapy|0
949881|NCT00774930|3127511|P2|DB Phase|Disease Progression|1
949882|NCT00774930|3127512|P1|DB Phase|Disease Progression|1
949883|NCT00774930|3127511|P2|DB Phase|Sponsor Decision|1
949884|NCT00774930|3127512|P1|DB Phase|Sponsor Decision|0
949885|NCT00774930|3127511|P2|DB Phase|Subject Decision|5
949886|NCT00774930|3127512|P1|DB Phase|Subject Decision|1
949887|NCT00774930|3127511|P2|DB Phase|Adverse Event|2
949888|NCT00774930|3127512|P1|DB Phase|Adverse Event|1
949889|NCT00774930|3127511|P2|DB Phase|Early Roll Over (ERO) to IOL phase|12
949890|NCT00774930|3127512|P1|DB Phase|Early Roll Over (ERO) to IOL phase|11
949891|NCT00774852|3127540|P2|Overall Study|Subject received prohibited medication|0
949892|NCT00774852|3127541|P1|Overall Study|Subject received prohibited medication|1
949893|NCT00774852|3127540|P2|Overall Study|Protocol Violation|0
949894|NCT00774852|3127541|P1|Overall Study|Protocol Violation|1
949895|NCT00774852|3127540|P2|Overall Study|Subject non-compliance|1
949896|NCT00774852|3127541|P1|Overall Study|Subject non-compliance|0
949897|NCT00774852|3127540|P2|Overall Study|Non-responder|11
949898|NCT00774852|3127541|P1|Overall Study|Non-responder|15
949899|NCT00774852|3127540|P2|Overall Study|Withdrawal by Subject|2
949900|NCT00774852|3127541|P1|Overall Study|Withdrawal by Subject|2
949901|NCT00774852|3127540|P2|Overall Study|Pregnancy|2
949902|NCT00774852|3127541|P1|Overall Study|Pregnancy|1
949903|NCT00774852|3127540|P2|Overall Study|Physician Decision|6
949904|NCT00774852|3127541|P1|Overall Study|Physician Decision|2
949905|NCT00774852|3127540|P2|Overall Study|Lost to Follow-up|5
949906|NCT00774852|3127541|P1|Overall Study|Lost to Follow-up|9
949907|NCT00774852|3127540|P2|Overall Study|Lack of Efficacy|7
949908|NCT00774852|3127541|P1|Overall Study|Lack of Efficacy|3
949909|NCT00774852|3127540|P2|Overall Study|Death|1
949910|NCT00774852|3127541|P1|Overall Study|Death|2
949911|NCT00774852|3127540|P2|Overall Study|Adverse Event|6
949912|NCT00774852|3127541|P1|Overall Study|Adverse Event|9
949913|NCT00774800|3127589|P1|Intervention 4|Withdrawal by Subject|1
949914|NCT00774787|3127611|P1|Overall Study|Lost to Follow-up|1
949915|NCT00774748|3127618|P1|Overall Study|Lost to Follow-up|3
949916|NCT00774397|3127633|P7|Overall Study|Other than those stated above|1
949917|NCT00774397|3127634|P6|Overall Study|Other than those stated above|0
949918|NCT00774397|3127635|P5|Overall Study|Other than those stated above|2
949919|NCT00774397|3127636|P4|Overall Study|Other than those stated above|2
949920|NCT00774397|3127637|P3|Overall Study|Other than those stated above|3
949921|NCT00774397|3127638|P2|Overall Study|Other than those stated above|1
949922|NCT00774397|3127639|P1|Overall Study|Other than those stated above|1
949923|NCT00774397|3127633|P7|Overall Study|Not treated|1
949924|NCT00774397|3127634|P6|Overall Study|Not treated|0
949925|NCT00774397|3127635|P5|Overall Study|Not treated|1
949926|NCT00774397|3127636|P4|Overall Study|Not treated|0
949927|NCT00774397|3127637|P3|Overall Study|Not treated|0
949928|NCT00774397|3127638|P2|Overall Study|Not treated|0
949929|NCT00774397|3127639|P1|Overall Study|Not treated|0
949930|NCT00774397|3127633|P7|Overall Study|Refused to continue trial medication|3
949931|NCT00774397|3127634|P6|Overall Study|Refused to continue trial medication|2
949932|NCT00774397|3127635|P5|Overall Study|Refused to continue trial medication|6
949933|NCT00774397|3127636|P4|Overall Study|Refused to continue trial medication|2
949934|NCT00774397|3127637|P3|Overall Study|Refused to continue trial medication|2
949935|NCT00774397|3127638|P2|Overall Study|Refused to continue trial medication|3
949936|NCT00774397|3127639|P1|Overall Study|Refused to continue trial medication|1
949937|NCT00774397|3127633|P7|Overall Study|Lost to Follow-up|0
949938|NCT00774397|3127634|P6|Overall Study|Lost to Follow-up|1
949939|NCT00774397|3127635|P5|Overall Study|Lost to Follow-up|0
949940|NCT00774397|3127636|P4|Overall Study|Lost to Follow-up|1
949941|NCT00774397|3127637|P3|Overall Study|Lost to Follow-up|1
949942|NCT00774397|3127638|P2|Overall Study|Lost to Follow-up|1
949943|NCT00774397|3127639|P1|Overall Study|Lost to Follow-up|0
949944|NCT00774397|3127633|P7|Overall Study|Protocol Violation|0
949945|NCT00774397|3127634|P6|Overall Study|Protocol Violation|1
949946|NCT00774397|3127635|P5|Overall Study|Protocol Violation|2
949947|NCT00774397|3127636|P4|Overall Study|Protocol Violation|1
949948|NCT00774397|3127637|P3|Overall Study|Protocol Violation|3
949949|NCT00774397|3127638|P2|Overall Study|Protocol Violation|1
949950|NCT00774397|3127639|P1|Overall Study|Protocol Violation|0
949951|NCT00774397|3127633|P7|Overall Study|Lack of Efficacy|9
949952|NCT00774397|3127634|P6|Overall Study|Lack of Efficacy|15
949953|NCT00774397|3127635|P5|Overall Study|Lack of Efficacy|27
949954|NCT00774397|3127636|P4|Overall Study|Lack of Efficacy|3
949955|NCT00774397|3127637|P3|Overall Study|Lack of Efficacy|5
949956|NCT00774397|3127638|P2|Overall Study|Lack of Efficacy|4
949957|NCT00774397|3127639|P1|Overall Study|Lack of Efficacy|11
949958|NCT00774397|3127633|P7|Overall Study|Adverse Event|16
949959|NCT00774397|3127634|P6|Overall Study|Adverse Event|3
949960|NCT00774397|3127635|P5|Overall Study|Adverse Event|8
949961|NCT00774397|3127636|P4|Overall Study|Adverse Event|8
949962|NCT00774397|3127637|P3|Overall Study|Adverse Event|16
949963|NCT00774397|3127638|P2|Overall Study|Adverse Event|3
949964|NCT00774397|3127639|P1|Overall Study|Adverse Event|1
949965|NCT00774306|3127875|P4|Overall Study|Death|0
949966|NCT00774306|3127876|P3|Overall Study|Death|0
949967|NCT00774306|3127877|P2|Overall Study|Death|1
949968|NCT00774306|3127878|P1|Overall Study|Death|1
949969|NCT00774306|3127875|P4|Overall Study|Lost to Follow-up|5
949970|NCT00774306|3127876|P3|Overall Study|Lost to Follow-up|4
949971|NCT00774306|3127877|P2|Overall Study|Lost to Follow-up|0
949972|NCT00774306|3127878|P1|Overall Study|Lost to Follow-up|6
949973|NCT00774306|3127875|P4|Overall Study|Withdrawal by Subject|0
949974|NCT00774306|3127876|P3|Overall Study|Withdrawal by Subject|1
949975|NCT00774306|3127877|P2|Overall Study|Withdrawal by Subject|1
949976|NCT00774306|3127878|P1|Overall Study|Withdrawal by Subject|6
949977|NCT00774306|3127875|P4|Overall Study|Protocol Violation|0
949978|NCT00774306|3127876|P3|Overall Study|Protocol Violation|3
949979|NCT00774306|3127877|P2|Overall Study|Protocol Violation|0
949980|NCT00774306|3127878|P1|Overall Study|Protocol Violation|2
949981|NCT00774306|3127875|P4|Overall Study|Adverse Event|0
949982|NCT00774306|3127876|P3|Overall Study|Adverse Event|0
949983|NCT00774306|3127877|P2|Overall Study|Adverse Event|0
949984|NCT00774306|3127878|P1|Overall Study|Adverse Event|3
949985|NCT00774046|3127959|P1|Stem Cell Mobilization|Count too low (2), sudden death (1)|3
949986|NCT00774046|3127959|P1|Enrollment|Desired other therapy/refused|28
949987|NCT00774046|3127959|P1|Screening|Not eligible|56
949988|NCT00773968|3127969|P1|Overall Study|Other|8
949989|NCT00773968|3127969|P1|Overall Study|Screen Failure|17
949990|NCT00773968|3127969|P1|Overall Study|Withdrawal by Subject|11
949991|NCT00773968|3127969|P1|Overall Study|Protocol Violation|1
949992|NCT00773968|3127969|P1|Overall Study|Lack of Efficacy|3
949993|NCT00773968|3127969|P1|Overall Study|Failure to Return|2
949994|NCT00773968|3127969|P1|Overall Study|Death|1
949995|NCT00773968|3127969|P1|Overall Study|Adverse Event|2
949996|NCT00773734|3128000|P6|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
949997|NCT00773734|3128001|P5|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
949998|NCT00773734|3128002|P4|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
949999|NCT00773734|3128003|P3|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
950000|NCT00773734|3128004|P2|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
950001|NCT00773734|3128005|P1|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
950002|NCT00773734|3128000|P6|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
950003|NCT00773734|3128001|P5|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
950004|NCT00773734|3128002|P4|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3
950005|NCT00773734|3128003|P3|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6
950006|NCT00773734|3128004|P2|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
950007|NCT00773734|3128005|P1|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
950008|NCT00773734|3128000|P6|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
950009|NCT00773734|3128001|P5|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
950010|NCT00773734|3128002|P4|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4
950011|NCT00773734|3128003|P3|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2
950012|NCT00773734|3128004|P2|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
950013|NCT00773734|3128005|P1|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
950014|NCT00773734|3128000|P6|LTE Period: Week 52 to 6 Years|Adverse Event|0
950015|NCT00773734|3128001|P5|LTE Period: Week 52 to 6 Years|Adverse Event|0
950016|NCT00773734|3128002|P4|LTE Period: Week 52 to 6 Years|Adverse Event|1
950017|NCT00773734|3128003|P3|LTE Period: Week 52 to 6 Years|Adverse Event|0
950018|NCT00773734|3128004|P2|LTE Period: Week 52 to 6 Years|Adverse Event|0
950019|NCT00773734|3128005|P1|LTE Period: Week 52 to 6 Years|Adverse Event|0
950020|NCT00773734|3128000|P6|Extension: Active Treatment Week 24-52|Other|1
950021|NCT00773734|3128001|P5|Extension: Active Treatment Week 24-52|Other|0
950022|NCT00773734|3128002|P4|Extension: Active Treatment Week 24-52|Other|2
950023|NCT00773734|3128003|P3|Extension: Active Treatment Week 24-52|Other|1
950024|NCT00773734|3128004|P2|Extension: Active Treatment Week 24-52|Other|0
950025|NCT00773734|3128005|P1|Extension: Active Treatment Week 24-52|Other|0
950026|NCT00773734|3128000|P6|Extension: Active Treatment Week 24-52|Lost to Follow-up|1
950027|NCT00773734|3128001|P5|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
950028|NCT00773734|3128002|P4|Extension: Active Treatment Week 24-52|Lost to Follow-up|3
950029|NCT00773734|3128003|P3|Extension: Active Treatment Week 24-52|Lost to Follow-up|5
950030|NCT00773734|3128004|P2|Extension: Active Treatment Week 24-52|Lost to Follow-up|2
950031|NCT00773734|3128005|P1|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
950032|NCT00773734|3128000|P6|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
950033|NCT00773734|3128001|P5|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
950034|NCT00773734|3128002|P4|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
950035|NCT00773734|3128003|P3|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1
950036|NCT00773734|3128004|P2|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
950037|NCT00773734|3128005|P1|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0
950038|NCT00773734|3128000|P6|Extension: Active Treatment Week 24-52|Lack of Efficacy|2
950039|NCT00773734|3128001|P5|Extension: Active Treatment Week 24-52|Lack of Efficacy|1
950040|NCT00773734|3128002|P4|Extension: Active Treatment Week 24-52|Lack of Efficacy|3
950041|NCT00773734|3128003|P3|Extension: Active Treatment Week 24-52|Lack of Efficacy|10
950042|NCT00773734|3128004|P2|Extension: Active Treatment Week 24-52|Lack of Efficacy|8
950043|NCT00773734|3128005|P1|Extension: Active Treatment Week 24-52|Lack of Efficacy|0
950044|NCT00773734|3128000|P6|Extension: Active Treatment Week 24-52|Adverse Event|1
950045|NCT00773734|3128001|P5|Extension: Active Treatment Week 24-52|Adverse Event|2
950046|NCT00773734|3128002|P4|Extension: Active Treatment Week 24-52|Adverse Event|0
950047|NCT00773734|3128003|P3|Extension: Active Treatment Week 24-52|Adverse Event|0
950048|NCT00773734|3128004|P2|Extension: Active Treatment Week 24-52|Adverse Event|0
950049|NCT00773734|3128005|P1|Extension: Active Treatment Week 24-52|Adverse Event|0
950050|NCT00773734|3128000|P6|Core: Active Treatment Phase Week 16-24|Other|0
950051|NCT00773734|3128001|P5|Core: Active Treatment Phase Week 16-24|Other|0
950052|NCT00773734|3128002|P4|Core: Active Treatment Phase Week 16-24|Other|0
950053|NCT00773734|3128003|P3|Core: Active Treatment Phase Week 16-24|Other|0
950054|NCT00773734|3128004|P2|Core: Active Treatment Phase Week 16-24|Other|1
950055|NCT00773734|3128005|P1|Core: Active Treatment Phase Week 16-24|Other|0
950056|NCT00773734|3128000|P6|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
950057|NCT00773734|3128001|P5|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
950058|NCT00773734|3128002|P4|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
950059|NCT00773734|3128003|P3|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
950060|NCT00773734|3128004|P2|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
950061|NCT00773734|3128005|P1|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
950062|NCT00773734|3128000|P6|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
950063|NCT00773734|3128001|P5|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
950064|NCT00773734|3128002|P4|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
950065|NCT00773734|3128003|P3|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
950066|NCT00773734|3128004|P2|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
950067|NCT00773734|3128005|P1|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
950068|NCT00773734|3128000|P6|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2
950069|NCT00773734|3128001|P5|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
950070|NCT00773734|3128002|P4|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
950071|NCT00773734|3128003|P3|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
950072|NCT00773734|3128004|P2|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
950073|NCT00773734|3128005|P1|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
950074|NCT00773734|3128000|P6|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
950075|NCT00773734|3128001|P5|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
950076|NCT00773734|3128002|P4|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1
950077|NCT00773734|3128003|P3|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
950078|NCT00773734|3128004|P2|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
950079|NCT00773734|3128005|P1|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
950080|NCT00773734|3128000|P6|Core: Active Treatment Phase Week 16-24|Adverse Event|2
950081|NCT00773734|3128001|P5|Core: Active Treatment Phase Week 16-24|Adverse Event|1
950082|NCT00773734|3128002|P4|Core: Active Treatment Phase Week 16-24|Adverse Event|0
950083|NCT00773734|3128003|P3|Core: Active Treatment Phase Week 16-24|Adverse Event|0
950084|NCT00773734|3128004|P2|Core: Active Treatment Phase Week 16-24|Adverse Event|4
950085|NCT00773734|3128005|P1|Core: Active Treatment Phase Week 16-24|Adverse Event|0
950086|NCT00773734|3128000|P6|Core: Placebo Controlled Phase Week 0-16|Other|0
950087|NCT00773734|3128001|P5|Core: Placebo Controlled Phase Week 0-16|Other|0
950088|NCT00773734|3128002|P4|Core: Placebo Controlled Phase Week 0-16|Other|1
950089|NCT00773734|3128003|P3|Core: Placebo Controlled Phase Week 0-16|Other|1
950090|NCT00773734|3128004|P2|Core: Placebo Controlled Phase Week 0-16|Other|1
950091|NCT00773734|3128005|P1|Core: Placebo Controlled Phase Week 0-16|Other|1
950092|NCT00773734|3128000|P6|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
950093|NCT00773734|3128001|P5|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
950094|NCT00773734|3128002|P4|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
950095|NCT00773734|3128003|P3|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4
950096|NCT00773734|3128004|P2|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3
950097|NCT00773734|3128005|P1|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1
950098|NCT00773734|3128000|P6|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
950099|NCT00773734|3128001|P5|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
950100|NCT00773734|3128002|P4|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1
950101|NCT00773734|3128003|P3|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
950102|NCT00773734|3128004|P2|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
950103|NCT00773734|3128005|P1|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2
950104|NCT00773734|3128000|P6|Core: Placebo Controlled Phase Week 0-16|Death|0
950105|NCT00773734|3128001|P5|Core: Placebo Controlled Phase Week 0-16|Death|0
950106|NCT00773734|3128002|P4|Core: Placebo Controlled Phase Week 0-16|Death|0
950107|NCT00773734|3128003|P3|Core: Placebo Controlled Phase Week 0-16|Death|0
950108|NCT00773734|3128004|P2|Core: Placebo Controlled Phase Week 0-16|Death|0
950109|NCT00773734|3128005|P1|Core: Placebo Controlled Phase Week 0-16|Death|1
950110|NCT00773734|3128000|P6|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
950111|NCT00773734|3128001|P5|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
950112|NCT00773734|3128002|P4|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4
950113|NCT00773734|3128003|P3|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6
950114|NCT00773734|3128004|P2|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
950115|NCT00773734|3128005|P1|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
950116|NCT00773734|3128000|P6|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
950117|NCT00773734|3128001|P5|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
950118|NCT00773734|3128002|P4|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
950119|NCT00773734|3128003|P3|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
950120|NCT00773734|3128004|P2|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3
950121|NCT00773734|3128005|P1|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4
950122|NCT00773734|3128000|P6|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
950123|NCT00773734|3128001|P5|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
950124|NCT00773734|3128002|P4|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10
950125|NCT00773734|3128003|P3|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8
950126|NCT00773734|3128004|P2|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1
950127|NCT00773734|3128005|P1|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5
950128|NCT00773513|3128569|P2|Overall Study|Death|545
950129|NCT00773513|3128570|P1|Overall Study|Death|531
950130|NCT00773513|3128569|P2|Overall Study|Reason Not Specified|126
950131|NCT00773513|3128570|P1|Overall Study|Reason Not Specified|159
950132|NCT00773513|3128569|P2|Overall Study|Insufficient Therapeutic Response|18
950133|NCT00773513|3128570|P1|Overall Study|Insufficient Therapeutic Response|1
950134|NCT00773513|3128569|P2|Overall Study|Failure to Return|8
950135|NCT00773513|3128570|P1|Overall Study|Failure to Return|22
950136|NCT00773513|3128569|P2|Overall Study|Refused Treatment / Did not Cooperate|32
950137|NCT00773513|3128570|P1|Overall Study|Refused Treatment / Did not Cooperate|26
950138|NCT00773513|3128569|P2|Overall Study|Withdrew Consent|69
950139|NCT00773513|3128570|P1|Overall Study|Withdrew Consent|68
950140|NCT00773513|3128569|P2|Overall Study|Adverse Event / Intercurrent Illness|48
950141|NCT00773513|3128570|P1|Overall Study|Adverse Event / Intercurrent Illness|40
950142|NCT00773513|3128569|P2|Overall Study|Renal Transplant|263
950143|NCT00773513|3128570|P1|Overall Study|Renal Transplant|254
950144|NCT00773461|3128599|P2|Overall Study|Withdrawal by Subject|1
950145|NCT00773461|3128600|P1|Overall Study|Withdrawal by Subject|4
950146|NCT00773461|3128599|P2|Overall Study|Adverse Event|3
950147|NCT00773461|3128600|P1|Overall Study|Adverse Event|1
950148|NCT00773383|3128654|P1|Overall Study|No study dose received|1
950149|NCT00773383|3128654|P1|Overall Study|not specified|2
950150|NCT00773383|3128654|P1|Overall Study|Progression of Disease|23
950151|NCT00773383|3128654|P1|Overall Study|Death|1
950152|NCT00773383|3128654|P1|Overall Study|Adverse Event|4
950153|NCT00773279|3128689|P2|Period 2|Unclassified|2
950154|NCT00773279|3128690|P1|Period 2|Unclassified|2
950155|NCT00773279|3128689|P2|Period 2|Protocol Violation|3
950156|NCT00773279|3128690|P1|Period 2|Protocol Violation|0
950157|NCT00773279|3128689|P2|Period 2|Lack of Efficacy|0
950158|NCT00773279|3128690|P1|Period 2|Lack of Efficacy|1
950159|NCT00773279|3128689|P2|Period 2|Adverse Event|1
950160|NCT00773279|3128690|P1|Period 2|Adverse Event|0
950161|NCT00773279|3128689|P2|Period 1|Unclassified|1
950162|NCT00773279|3128690|P1|Period 1|Unclassified|5
950163|NCT00773279|3128689|P2|Period 1|Lack of Efficacy|2
950164|NCT00773279|3128690|P1|Period 1|Lack of Efficacy|0
950165|NCT00773279|3128689|P2|Period 1|Adverse Event|1
950166|NCT00773279|3128690|P1|Period 1|Adverse Event|2
950167|NCT00773253|3128711|P2|First Intervention (Week 0-24)|Frontalis Test Negative|1
950168|NCT00773253|3128712|P1|First Intervention (Week 0-24)|Frontalis Test Negative|0
950169|NCT00773175|3128720|P2|Overall Study|Consent Withdrawn|2
950170|NCT00773175|3128721|P1|Overall Study|Consent Withdrawn|0
950171|NCT00773175|3128720|P2|Overall Study|Adverse Event|0
950172|NCT00773175|3128721|P1|Overall Study|Adverse Event|2
950173|NCT00773136|3128813|P1|Overall Study|Physician Decision|2
950174|NCT00773097|3128818|P1|Overall Study|Physician Decision|6
950175|NCT00773097|3128818|P1|Overall Study|Withdrawal by Subject|1
950176|NCT00772967|3128824|P6|Crossover Treatment 3|Adverse Event|0
950177|NCT00772967|3128825|P5|Crossover Treatment 3|Adverse Event|1
950178|NCT00772967|3128826|P4|Crossover Treatment 3|Adverse Event|0
950179|NCT00772967|3128827|P3|Crossover Treatment 3|Adverse Event|0
950180|NCT00772967|3128828|P2|Crossover Treatment 3|Adverse Event|0
950181|NCT00772967|3128829|P1|Crossover Treatment 3|Adverse Event|0
950182|NCT00772967|3128824|P6|Break 1 (4-7 Days)|Withdrawal by Subject|0
950183|NCT00772967|3128825|P5|Break 1 (4-7 Days)|Withdrawal by Subject|0
950184|NCT00772967|3128826|P4|Break 1 (4-7 Days)|Withdrawal by Subject|0
950185|NCT00772967|3128827|P3|Break 1 (4-7 Days)|Withdrawal by Subject|0
950186|NCT00772967|3128828|P2|Break 1 (4-7 Days)|Withdrawal by Subject|1
950187|NCT00772967|3128829|P1|Break 1 (4-7 Days)|Withdrawal by Subject|0
950188|NCT00772967|3128824|P6|Crossover Treatment 1|Adverse Event (Pain)|0
950189|NCT00772967|3128825|P5|Crossover Treatment 1|Adverse Event (Pain)|0
950190|NCT00772967|3128826|P4|Crossover Treatment 1|Adverse Event (Pain)|1
950191|NCT00772967|3128827|P3|Crossover Treatment 1|Adverse Event (Pain)|0
950192|NCT00772967|3128828|P2|Crossover Treatment 1|Adverse Event (Pain)|0
950193|NCT00772967|3128829|P1|Crossover Treatment 1|Adverse Event (Pain)|0
950194|NCT00772954|3128849|P3|Overall Study|Adverse Event|1
950195|NCT00772954|3128850|P2|Overall Study|Adverse Event|0
950196|NCT00772954|3128851|P1|Overall Study|Adverse Event|0
950197|NCT00772941|3128859|P1|Overall Study|GPSP Violation|90
950198|NCT00772941|3128859|P1|Overall Study|Poor Compliance|7
950199|NCT00772941|3128859|P1|Overall Study|Missed Visits|374
950200|NCT00772941|3128859|P1|Overall Study|Study not completed|16
950201|NCT00772941|3128859|P1|Overall Study|CRFs not available|195
950202|NCT00772928|3128890|P2|Overall Study|Did not receive vaccine|1
950203|NCT00772928|3128891|P1|Overall Study|Did not receive vaccine|0
950204|NCT00772928|3128890|P2|Overall Study|Withdrawal by Subject|22
950205|NCT00772928|3128891|P1|Overall Study|Withdrawal by Subject|25
950206|NCT00772928|3128890|P2|Overall Study|Protocol Violation|12
950207|NCT00772928|3128891|P1|Overall Study|Protocol Violation|10
950208|NCT00772928|3128890|P2|Overall Study|Lost to Follow-up|6
950209|NCT00772928|3128891|P1|Overall Study|Lost to Follow-up|9
950210|NCT00772889|3128908|P3|Overall Study|Lost to Follow-up|7
950211|NCT00772889|3128909|P2|Overall Study|Lost to Follow-up|6
950212|NCT00772889|3128910|P1|Overall Study|Lost to Follow-up|6
950213|NCT00772889|3128908|P3|Overall Study|Withdrawal by Subject|9
950214|NCT00772889|3128909|P2|Overall Study|Withdrawal by Subject|8
950215|NCT00772889|3128910|P1|Overall Study|Withdrawal by Subject|9
950216|NCT00772889|3128908|P3|Overall Study|Adverse Event|0
950217|NCT00772889|3128909|P2|Overall Study|Adverse Event|4
950218|NCT00772889|3128910|P1|Overall Study|Adverse Event|7
950219|NCT00772707|3128968|P1|Overall Study|Withdrawn|3
950220|NCT00772668|3128973|P1|Overall Study|Physician Decision|3
950221|NCT00772629|3128982|P2|Overall Study|Subject was not vaccinated|0
950222|NCT00772629|3128983|P1|Overall Study|Subject was not vaccinated|1
950223|NCT00772603|3128992|P3|Overall Study|Other|2
950224|NCT00772603|3128993|P2|Overall Study|Other|0
950225|NCT00772603|3128994|P1|Overall Study|Other|2
950226|NCT00772603|3128992|P3|Overall Study|Physician Decision|1
950227|NCT00772603|3128993|P2|Overall Study|Physician Decision|0
950228|NCT00772603|3128994|P1|Overall Study|Physician Decision|0
950229|NCT00772603|3128992|P3|Overall Study|Lost to Follow-up|2
950230|NCT00772603|3128993|P2|Overall Study|Lost to Follow-up|5
950231|NCT00772603|3128994|P1|Overall Study|Lost to Follow-up|1
950232|NCT00772603|3128992|P3|Overall Study|Protocol Violation|1
950233|NCT00772603|3128993|P2|Overall Study|Protocol Violation|1
950234|NCT00772603|3128994|P1|Overall Study|Protocol Violation|0
950235|NCT00772603|3128992|P3|Overall Study|Subject Non-compliance|4
950236|NCT00772603|3128993|P2|Overall Study|Subject Non-compliance|6
950237|NCT00772603|3128994|P1|Overall Study|Subject Non-compliance|1
950238|NCT00772603|3128992|P3|Overall Study|Adverse Event|10
950239|NCT00772603|3128993|P2|Overall Study|Adverse Event|18
950240|NCT00772603|3128994|P1|Overall Study|Adverse Event|37
950241|NCT00772603|3128992|P3|Overall Study|Withdrawal by Subject|6
950242|NCT00772603|3128993|P2|Overall Study|Withdrawal by Subject|10
950243|NCT00772603|3128994|P1|Overall Study|Withdrawal by Subject|11
950244|NCT00772577|3129033|P2|Overall Study|Protocol Deviation|2
950245|NCT00772577|3129034|P1|Overall Study|Protocol Deviation|3
950246|NCT00772577|3129033|P2|Overall Study|Administrative problems|1
950247|NCT00772577|3129034|P1|Overall Study|Administrative problems|2
950248|NCT00772577|3129033|P2|Overall Study|Lost to Follow-up|3
950249|NCT00772577|3129034|P1|Overall Study|Lost to Follow-up|4
950250|NCT00772577|3129033|P2|Overall Study|Patient withdrew consent|5
950251|NCT00772577|3129034|P1|Overall Study|Patient withdrew consent|8
950252|NCT00772577|3129033|P2|Overall Study|Unsatisfactory therapeutic effect|8
950253|NCT00772577|3129034|P1|Overall Study|Unsatisfactory therapeutic effect|0
950254|NCT00772577|3129033|P2|Overall Study|Abnormal laboratory values|1
950255|NCT00772577|3129034|P1|Overall Study|Abnormal laboratory values|0
950256|NCT00772577|3129033|P2|Overall Study|Adverse Event|3
950257|NCT00772577|3129034|P1|Overall Study|Adverse Event|6
950258|NCT00772538|3129050|P2|Overall Study|Other|7
950259|NCT00772538|3129051|P1|Overall Study|Other|7
950260|NCT00772538|3129050|P2|Overall Study|Lack of Efficacy|1
950261|NCT00772538|3129051|P1|Overall Study|Lack of Efficacy|0
950262|NCT00772538|3129050|P2|Overall Study|Withdrawal by Subject|8
950263|NCT00772538|3129051|P1|Overall Study|Withdrawal by Subject|3
950264|NCT00772538|3129050|P2|Overall Study|Lost to Follow-up|1
950265|NCT00772538|3129051|P1|Overall Study|Lost to Follow-up|1
950266|NCT00772538|3129050|P2|Overall Study|Protocol Violation|3
950267|NCT00772538|3129051|P1|Overall Study|Protocol Violation|3
950268|NCT00772538|3129050|P2|Overall Study|Adverse Event|6
950269|NCT00772538|3129051|P1|Overall Study|Adverse Event|6
950270|NCT00772447|3129123|P2|Overall Study|all others|2
950271|NCT00772447|3129124|P1|Overall Study|all others|2
950272|NCT00772447|3129123|P2|Overall Study|Protocol Violation|1
950273|NCT00772447|3129124|P1|Overall Study|Protocol Violation|0
950274|NCT00772447|3129123|P2|Overall Study|incorrect enrolment|4
950275|NCT00772447|3129124|P1|Overall Study|incorrect enrolment|3
950276|NCT00772447|3129123|P2|Overall Study|Lost to Follow-up|4
950277|NCT00772447|3129124|P1|Overall Study|Lost to Follow-up|2
950278|NCT00772447|3129123|P2|Overall Study|Physician Decision|8
950279|NCT00772447|3129124|P1|Overall Study|Physician Decision|4
950280|NCT00772447|3129123|P2|Overall Study|Withdrawal by Subject|5
950281|NCT00772447|3129124|P1|Overall Study|Withdrawal by Subject|9
950282|NCT00772382|3129152|P1|Overall Study|Other Reasons|10
950283|NCT00772382|3129152|P1|Overall Study|Withdrawal by Subject|10
950284|NCT00772382|3129152|P1|Overall Study|Protocol Violation|1
950285|NCT00772382|3129152|P1|Overall Study|Physician Decision|5
950286|NCT00772382|3129152|P1|Overall Study|Lack of Efficacy|4
950287|NCT00772382|3129152|P1|Overall Study|Death|6
950288|NCT00772382|3129152|P1|Overall Study|Adverse Event|19
950289|NCT00772369|3129157|P1|Overall Study|Did not return record release form|1
950290|NCT00772148|3129168|P2|Maintenance Phase (Week 52)|Administrative/other|2
950291|NCT00772148|3129169|P1|Maintenance Phase (Week 52)|Administrative/other|1
950292|NCT00772148|3129168|P2|Maintenance Phase (Week 52)|Withdrawal by Subject|1
950293|NCT00772148|3129169|P1|Maintenance Phase (Week 52)|Withdrawal by Subject|0
950294|NCT00772148|3129168|P2|Maintenance Phase (Week 52)|Adverse Event|0
950295|NCT00772148|3129169|P1|Maintenance Phase (Week 52)|Adverse Event|1
950296|NCT00772148|3129168|P2|Maintenance Phase (Week 52)|Death|2
950297|NCT00772148|3129169|P1|Maintenance Phase (Week 52)|Death|2
950298|NCT00772148|3129168|P2|Pharmacokinetic Phase (14 Days)|Administrative/other|0
950299|NCT00772148|3129169|P1|Pharmacokinetic Phase (14 Days)|Administrative/other|2
950300|NCT00772148|3129168|P2|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5
950301|NCT00772148|3129169|P1|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3
950302|NCT00772148|3129168|P2|Pharmacokinetic Phase (14 Days)|Adverse Event|1
950303|NCT00772148|3129169|P1|Pharmacokinetic Phase (14 Days)|Adverse Event|3
950304|NCT00772109|3129189|P4|Overall Study|Withdrawal by Subject|16
950305|NCT00772109|3129190|P3|Overall Study|Withdrawal by Subject|6
950306|NCT00772109|3129191|P2|Overall Study|Withdrawal by Subject|8
950307|NCT00772109|3129192|P1|Overall Study|Withdrawal by Subject|8
950308|NCT00772109|3129189|P4|Overall Study|Lost to Follow-up|9
950309|NCT00772109|3129190|P3|Overall Study|Lost to Follow-up|5
950310|NCT00772109|3129191|P2|Overall Study|Lost to Follow-up|3
950311|NCT00772109|3129192|P1|Overall Study|Lost to Follow-up|7
950312|NCT00772109|3129189|P4|Overall Study|Protocol Violation|6
950313|NCT00772109|3129190|P3|Overall Study|Protocol Violation|7
950314|NCT00772109|3129191|P2|Overall Study|Protocol Violation|8
950315|NCT00772109|3129192|P1|Overall Study|Protocol Violation|5
950316|NCT00772109|3129189|P4|Overall Study|Serious adverse event|0
950317|NCT00772109|3129190|P3|Overall Study|Serious adverse event|1
950318|NCT00772109|3129191|P2|Overall Study|Serious adverse event|0
950319|NCT00772109|3129192|P1|Overall Study|Serious adverse event|1
950320|NCT00772070|3129216|P2|Overall Study|Vaccination error-wrong dose/expired lot|0
950321|NCT00772070|3129217|P1|Overall Study|Vaccination error-wrong dose/expired lot|2
950322|NCT00772070|3129216|P2|Overall Study|Withdrawal by Subject|2
950323|NCT00772070|3129217|P1|Overall Study|Withdrawal by Subject|0
950324|NCT00772070|3129216|P2|Overall Study|Lost to Follow-up|8
950325|NCT00772070|3129217|P1|Overall Study|Lost to Follow-up|0
950326|NCT00772031|3129229|P2|Overall Study|Lost to Follow-up|33
950327|NCT00772031|3129230|P1|Overall Study|Lost to Follow-up|20
950328|NCT00772031|3129229|P2|Overall Study|Early termination of trial|10
950329|NCT00772031|3129230|P1|Overall Study|Early termination of trial|12
950330|NCT00772005|3129256|P4|Overall Study|Non-compliance with drug administration|1
950331|NCT00772005|3129257|P3|Overall Study|Non-compliance with drug administration|1
950332|NCT00772005|3129258|P2|Overall Study|Non-compliance with drug administration|0
950333|NCT00772005|3129259|P1|Overall Study|Non-compliance with drug administration|3
950334|NCT00772005|3129256|P4|Overall Study|Non-compliance with study procedures|1
950335|NCT00772005|3129257|P3|Overall Study|Non-compliance with study procedures|0
950336|NCT00772005|3129258|P2|Overall Study|Non-compliance with study procedures|1
950337|NCT00772005|3129259|P1|Overall Study|Non-compliance with study procedures|1
950338|NCT00772005|3129256|P4|Overall Study|Lost to Follow-up|3
950339|NCT00772005|3129257|P3|Overall Study|Lost to Follow-up|6
950340|NCT00772005|3129258|P2|Overall Study|Lost to Follow-up|3
950341|NCT00772005|3129259|P1|Overall Study|Lost to Follow-up|7
950342|NCT00772005|3129256|P4|Overall Study|Protocol Violation|6
950343|NCT00772005|3129257|P3|Overall Study|Protocol Violation|1
950344|NCT00772005|3129258|P2|Overall Study|Protocol Violation|4
950345|NCT00772005|3129259|P1|Overall Study|Protocol Violation|2
950346|NCT00772005|3129256|P4|Overall Study|Withdrawal by Subject|2
950347|NCT00772005|3129257|P3|Overall Study|Withdrawal by Subject|10
950348|NCT00772005|3129258|P2|Overall Study|Withdrawal by Subject|7
950349|NCT00772005|3129259|P1|Overall Study|Withdrawal by Subject|3
950350|NCT00772005|3129256|P4|Overall Study|Lack of Efficacy|0
950351|NCT00772005|3129257|P3|Overall Study|Lack of Efficacy|0
950352|NCT00772005|3129258|P2|Overall Study|Lack of Efficacy|1
950353|NCT00772005|3129259|P1|Overall Study|Lack of Efficacy|0
950354|NCT00772005|3129256|P4|Overall Study|Adverse Event|13
950355|NCT00772005|3129257|P3|Overall Study|Adverse Event|10
950356|NCT00772005|3129258|P2|Overall Study|Adverse Event|14
950357|NCT00772005|3129259|P1|Overall Study|Adverse Event|9
950358|NCT00771953|3129947|P2|Overall Study|Withdrawal by Subject|3
950359|NCT00771953|3129948|P1|Overall Study|Withdrawal by Subject|0
950360|NCT00771953|3129947|P2|Overall Study|Other complicating disease|0
950361|NCT00771953|3129948|P1|Overall Study|Other complicating disease|1
950362|NCT00771953|3129947|P2|Overall Study|Sponsor decision|0
950363|NCT00771953|3129948|P1|Overall Study|Sponsor decision|1
950364|NCT00771953|3129947|P2|Overall Study|Progression before active Tx|2
950365|NCT00771953|3129948|P1|Overall Study|Progression before active Tx|1
950366|NCT00771953|3129947|P2|Overall Study|Death|2
950367|NCT00771953|3129948|P1|Overall Study|Death|2
950368|NCT00771953|3129947|P2|Overall Study|Adverse Event|3
950369|NCT00771953|3129948|P1|Overall Study|Adverse Event|5
950370|NCT00771927|3129958|P2|Overall Study|Other reason|27
950371|NCT00771927|3129959|P1|Overall Study|Other reason|23
950372|NCT00771927|3129958|P2|Overall Study|Withdrawal by Subject|17
950373|NCT00771927|3129959|P1|Overall Study|Withdrawal by Subject|16
950374|NCT00771927|3129958|P2|Overall Study|Lost to Follow-up|46
950375|NCT00771927|3129959|P1|Overall Study|Lost to Follow-up|46
950376|NCT00771927|3129958|P2|Overall Study|Lack of Efficacy|42
950377|NCT00771927|3129959|P1|Overall Study|Lack of Efficacy|70
950378|NCT00771927|3129958|P2|Overall Study|Adverse Event|105
950379|NCT00771927|3129959|P1|Overall Study|Adverse Event|100
950380|NCT00771914|3129971|P4|Overall Study|Lost to Follow-up|1
950381|NCT00771914|3129972|P3|Overall Study|Lost to Follow-up|0
950382|NCT00771914|3129973|P2|Overall Study|Lost to Follow-up|0
950383|NCT00771914|3129974|P1|Overall Study|Lost to Follow-up|0
950384|NCT00771914|3129971|P4|Overall Study|Physician Decision|1
950385|NCT00771914|3129972|P3|Overall Study|Physician Decision|0
950386|NCT00771914|3129973|P2|Overall Study|Physician Decision|0
950387|NCT00771914|3129974|P1|Overall Study|Physician Decision|0
950388|NCT00771901|3129987|P3|Overall Study|Dissat w/# of study medication (40/day)|4
950389|NCT00771901|3129988|P2|Overall Study|Dissat w/# of study medication (40/day)|0
950390|NCT00771901|3129989|P1|Overall Study|Dissat w/# of study medication (40/day)|0
950391|NCT00771849|3130036|P2|Overall Study|Not vaccinated|1
950392|NCT00771849|3130037|P1|Overall Study|Not vaccinated|0
950393|NCT00771849|3130036|P2|Overall Study|Withdrawal by Subject|1
950394|NCT00771849|3130037|P1|Overall Study|Withdrawal by Subject|1
950395|NCT00771849|3130036|P2|Overall Study|Lost to Follow-up|2
950396|NCT00771849|3130037|P1|Overall Study|Lost to Follow-up|1
950397|NCT00771810|3130048|P3|Overall Study|Other|1
950398|NCT00771810|3130049|P2|Overall Study|Other|0
950399|NCT00771810|3130050|P1|Overall Study|Other|0
950400|NCT00771810|3130048|P3|Overall Study|Withdrawal by Subject|0
950401|NCT00771810|3130049|P2|Overall Study|Withdrawal by Subject|2
950402|NCT00771810|3130050|P1|Overall Study|Withdrawal by Subject|1
950403|NCT00771810|3130048|P3|Overall Study|Protocol Violation|1
950404|NCT00771810|3130049|P2|Overall Study|Protocol Violation|1
950405|NCT00771810|3130050|P1|Overall Study|Protocol Violation|0
950406|NCT00771810|3130048|P3|Overall Study|Physician Decision|2
950407|NCT00771810|3130049|P2|Overall Study|Physician Decision|2
950408|NCT00771810|3130050|P1|Overall Study|Physician Decision|1
950409|NCT00771810|3130048|P3|Overall Study|Lost to Follow-up|1
950410|NCT00771810|3130049|P2|Overall Study|Lost to Follow-up|0
950411|NCT00771810|3130050|P1|Overall Study|Lost to Follow-up|0
950412|NCT00771810|3130048|P3|Overall Study|Adverse Event|2
950413|NCT00771810|3130049|P2|Overall Study|Adverse Event|0
950414|NCT00771810|3130050|P1|Overall Study|Adverse Event|3
950415|NCT00771758|3130088|P3|Overall Study|Other|0
950416|NCT00771758|3130089|P2|Overall Study|Other|2
950417|NCT00771758|3130090|P1|Overall Study|Other|3
950418|NCT00771758|3130088|P3|Overall Study|Withdrawal by Subject|0
950419|NCT00771758|3130089|P2|Overall Study|Withdrawal by Subject|0
950420|NCT00771758|3130090|P1|Overall Study|Withdrawal by Subject|1
950421|NCT00771758|3130088|P3|Overall Study|Protocol Violation|0
950422|NCT00771758|3130089|P2|Overall Study|Protocol Violation|0
950423|NCT00771758|3130090|P1|Overall Study|Protocol Violation|1
950424|NCT00771758|3130088|P3|Overall Study|Lost to Follow-up|0
950425|NCT00771758|3130089|P2|Overall Study|Lost to Follow-up|0
950426|NCT00771758|3130090|P1|Overall Study|Lost to Follow-up|1
950427|NCT00771758|3130088|P3|Overall Study|Lack of Efficacy|1
950428|NCT00771758|3130089|P2|Overall Study|Lack of Efficacy|2
950429|NCT00771758|3130090|P1|Overall Study|Lack of Efficacy|0
950430|NCT00771758|3130088|P3|Overall Study|Adverse Event|1
950431|NCT00771758|3130089|P2|Overall Study|Adverse Event|8
950432|NCT00771758|3130090|P1|Overall Study|Adverse Event|2
950433|NCT00771667|3130251|P10|Maintenance Phase|Other|3
950434|NCT00771667|3130252|P9|Maintenance Phase|Other|3
950435|NCT00771667|3130253|P8|Maintenance Phase|Other|2
950436|NCT00771667|3130254|P7|Maintenance Phase|Other|2
950437|NCT00771667|3130255|P6|Maintenance Phase|Other|1
950438|NCT00771667|3130256|P5|Maintenance Phase|Other|0
950439|NCT00771667|3130257|P4|Maintenance Phase|Other|0
950440|NCT00771667|3130258|P3|Maintenance Phase|Other|0
950441|NCT00771667|3130259|P2|Maintenance Phase|Other|0
950442|NCT00771667|3130260|P1|Maintenance Phase|Other|0
950443|NCT00771667|3130251|P10|Maintenance Phase|Lack of Efficacy|7
950444|NCT00771667|3130252|P9|Maintenance Phase|Lack of Efficacy|11
950445|NCT00771667|3130253|P8|Maintenance Phase|Lack of Efficacy|2
950446|NCT00771667|3130254|P7|Maintenance Phase|Lack of Efficacy|3
950447|NCT00771667|3130255|P6|Maintenance Phase|Lack of Efficacy|3
950448|NCT00771667|3130256|P5|Maintenance Phase|Lack of Efficacy|1
950449|NCT00771667|3130257|P4|Maintenance Phase|Lack of Efficacy|0
950450|NCT00771667|3130258|P3|Maintenance Phase|Lack of Efficacy|0
950451|NCT00771667|3130259|P2|Maintenance Phase|Lack of Efficacy|0
950452|NCT00771667|3130260|P1|Maintenance Phase|Lack of Efficacy|0
950453|NCT00771667|3130251|P10|Maintenance Phase|Adverse Event|7
950454|NCT00771667|3130252|P9|Maintenance Phase|Adverse Event|8
950455|NCT00771667|3130253|P8|Maintenance Phase|Adverse Event|1
950456|NCT00771667|3130254|P7|Maintenance Phase|Adverse Event|5
950457|NCT00771667|3130255|P6|Maintenance Phase|Adverse Event|3
950458|NCT00771667|3130256|P5|Maintenance Phase|Adverse Event|1
950459|NCT00771667|3130257|P4|Maintenance Phase|Adverse Event|0
950460|NCT00771667|3130258|P3|Maintenance Phase|Adverse Event|0
950461|NCT00771667|3130259|P2|Maintenance Phase|Adverse Event|0
950462|NCT00771667|3130260|P1|Maintenance Phase|Adverse Event|0
950463|NCT00771667|3130251|P10|Induction Phase|Other|0
950464|NCT00771667|3130252|P9|Induction Phase|Other|0
950465|NCT00771667|3130253|P8|Induction Phase|Other|0
950466|NCT00771667|3130254|P7|Induction Phase|Other|0
950467|NCT00771667|3130255|P6|Induction Phase|Other|0
950468|NCT00771667|3130256|P5|Induction Phase|Other|0
950469|NCT00771667|3130257|P4|Induction Phase|Other|4
950470|NCT00771667|3130258|P3|Induction Phase|Other|3
950471|NCT00771667|3130259|P2|Induction Phase|Other|6
950472|NCT00771667|3130260|P1|Induction Phase|Other|4
950473|NCT00771667|3130251|P10|Induction Phase|Lost to Follow-up|0
950474|NCT00771667|3130252|P9|Induction Phase|Lost to Follow-up|0
950475|NCT00771667|3130253|P8|Induction Phase|Lost to Follow-up|0
950476|NCT00771667|3130254|P7|Induction Phase|Lost to Follow-up|0
950477|NCT00771667|3130255|P6|Induction Phase|Lost to Follow-up|0
950478|NCT00771667|3130256|P5|Induction Phase|Lost to Follow-up|0
950479|NCT00771667|3130257|P4|Induction Phase|Lost to Follow-up|0
950480|NCT00771667|3130258|P3|Induction Phase|Lost to Follow-up|1
950481|NCT00771667|3130259|P2|Induction Phase|Lost to Follow-up|0
950482|NCT00771667|3130260|P1|Induction Phase|Lost to Follow-up|1
950483|NCT00771667|3130251|P10|Induction Phase|Lack of Efficacy|0
950484|NCT00771667|3130252|P9|Induction Phase|Lack of Efficacy|0
950485|NCT00771667|3130253|P8|Induction Phase|Lack of Efficacy|0
950486|NCT00771667|3130254|P7|Induction Phase|Lack of Efficacy|0
950487|NCT00771667|3130255|P6|Induction Phase|Lack of Efficacy|0
950488|NCT00771667|3130256|P5|Induction Phase|Lack of Efficacy|0
950489|NCT00771667|3130257|P4|Induction Phase|Lack of Efficacy|3
950490|NCT00771667|3130258|P3|Induction Phase|Lack of Efficacy|4
950491|NCT00771667|3130259|P2|Induction Phase|Lack of Efficacy|2
950492|NCT00771667|3130260|P1|Induction Phase|Lack of Efficacy|9
950493|NCT00771667|3130251|P10|Induction Phase|Adverse Event|0
950494|NCT00771667|3130252|P9|Induction Phase|Adverse Event|0
950495|NCT00771667|3130253|P8|Induction Phase|Adverse Event|0
950496|NCT00771667|3130254|P7|Induction Phase|Adverse Event|0
950497|NCT00771667|3130255|P6|Induction Phase|Adverse Event|0
950498|NCT00771667|3130256|P5|Induction Phase|Adverse Event|0
950499|NCT00771667|3130257|P4|Induction Phase|Adverse Event|1
950500|NCT00771667|3130258|P3|Induction Phase|Adverse Event|4
950501|NCT00771667|3130259|P2|Induction Phase|Adverse Event|2
950502|NCT00771667|3130260|P1|Induction Phase|Adverse Event|5
950503|NCT00771615|3130305|P9|Overall Study|Lost to Follow-up|0
950504|NCT00771615|3130306|P8|Overall Study|Lost to Follow-up|0
950505|NCT00771615|3130307|P7|Overall Study|Lost to Follow-up|1
950506|NCT00771615|3130308|P6|Overall Study|Lost to Follow-up|1
950507|NCT00771615|3130309|P5|Overall Study|Lost to Follow-up|0
950508|NCT00771615|3130310|P4|Overall Study|Lost to Follow-up|1
950509|NCT00771615|3130311|P3|Overall Study|Lost to Follow-up|1
950510|NCT00771615|3130312|P2|Overall Study|Lost to Follow-up|1
950511|NCT00771615|3130313|P1|Overall Study|Lost to Follow-up|1
950512|NCT00771615|3130305|P9|Overall Study|Withdrawal by Subject|0
950513|NCT00771615|3130306|P8|Overall Study|Withdrawal by Subject|1
950514|NCT00771615|3130307|P7|Overall Study|Withdrawal by Subject|0
950515|NCT00771615|3130308|P6|Overall Study|Withdrawal by Subject|0
950516|NCT00771615|3130309|P5|Overall Study|Withdrawal by Subject|0
950517|NCT00771615|3130310|P4|Overall Study|Withdrawal by Subject|0
950518|NCT00771615|3130311|P3|Overall Study|Withdrawal by Subject|0
950519|NCT00771615|3130312|P2|Overall Study|Withdrawal by Subject|1
950520|NCT00771615|3130313|P1|Overall Study|Withdrawal by Subject|0
950521|NCT00771472|3130574|P2|Overall Study|Protocol Violation|0
950522|NCT00771472|3130575|P1|Overall Study|Protocol Violation|1
950523|NCT00771472|3130574|P2|Overall Study|Progressive Disease|1
950524|NCT00771472|3130575|P1|Overall Study|Progressive Disease|3
950525|NCT00771472|3130574|P2|Overall Study|Physician Decision|3
950526|NCT00771472|3130575|P1|Overall Study|Physician Decision|2
950527|NCT00771316|3130595|P2|Overall Study|Discontinued due to early termination|0
950528|NCT00771316|3130596|P1|Overall Study|Discontinued due to early termination|1
950529|NCT00771316|3130595|P2|Overall Study|Patient withdrew consent|0
950530|NCT00771316|3130596|P1|Overall Study|Patient withdrew consent|1
950531|NCT00771316|3130595|P2|Overall Study|Adverse Event|1
950532|NCT00771316|3130596|P1|Overall Study|Adverse Event|0
950533|NCT00770991|3130648|P2|Overall Study|Pregnancy|0
950534|NCT00770991|3130649|P1|Overall Study|Pregnancy|1
950535|NCT00770991|3130648|P2|Overall Study|Adverse Event|5
950536|NCT00770991|3130649|P1|Overall Study|Adverse Event|1
950537|NCT00770991|3130648|P2|Overall Study|Withdrawal by Subject|0
950538|NCT00770991|3130649|P1|Overall Study|Withdrawal by Subject|1
950539|NCT00770991|3130648|P2|Overall Study|Physician Decision|0
950540|NCT00770991|3130649|P1|Overall Study|Physician Decision|2
950541|NCT00770965|3130665|P4|Excluded Set|Withdrawal by Subject|3
950542|NCT00770965|3130666|P3|Excluded Set|Withdrawal by Subject|2
950543|NCT00770965|3130667|P2|Excluded Set|Withdrawal by Subject|1
950544|NCT00770965|3130668|P1|Excluded Set|Withdrawal by Subject|1
950545|NCT00770965|3130665|P4|Excluded Set|Administrative problems|10
950546|NCT00770965|3130666|P3|Excluded Set|Administrative problems|12
950547|NCT00770965|3130667|P2|Excluded Set|Administrative problems|12
950548|NCT00770965|3130668|P1|Excluded Set|Administrative problems|14
950549|NCT00770965|3130665|P4|Safety Set|Protocol deviation|0
950550|NCT00770965|3130666|P3|Safety Set|Protocol deviation|1
950551|NCT00770965|3130667|P2|Safety Set|Protocol deviation|0
950552|NCT00770965|3130668|P1|Safety Set|Protocol deviation|0
950553|NCT00770965|3130665|P4|Safety Set|Withdrawal by Subject|1
950554|NCT00770965|3130666|P3|Safety Set|Withdrawal by Subject|0
950555|NCT00770965|3130667|P2|Safety Set|Withdrawal by Subject|0
950556|NCT00770965|3130668|P1|Safety Set|Withdrawal by Subject|0
950557|NCT00770913|3130689|P3|Overall Study|Incorrect drug was allocated|0
950558|NCT00770913|3130690|P2|Overall Study|Incorrect drug was allocated|0
950559|NCT00770913|3130691|P1|Overall Study|Incorrect drug was allocated|1
950560|NCT00770913|3130689|P3|Overall Study|Protocol Violation|1
950561|NCT00770913|3130690|P2|Overall Study|Protocol Violation|0
950562|NCT00770913|3130691|P1|Overall Study|Protocol Violation|3
950563|NCT00770913|3130689|P3|Overall Study|Physician Decision|1
950564|NCT00770913|3130690|P2|Overall Study|Physician Decision|1
950565|NCT00770913|3130691|P1|Overall Study|Physician Decision|0
950566|NCT00770913|3130689|P3|Overall Study|Refusal to continue participation|5
950567|NCT00770913|3130690|P2|Overall Study|Refusal to continue participation|4
950568|NCT00770913|3130691|P1|Overall Study|Refusal to continue participation|6
950569|NCT00770913|3130689|P3|Overall Study|Adverse Event|6
950570|NCT00770913|3130690|P2|Overall Study|Adverse Event|3
950571|NCT00770913|3130691|P1|Overall Study|Adverse Event|1
950572|NCT00770809|3130713|P3|Overall Study|Other Medical Reasons|3
950573|NCT00770809|3130714|P2|Overall Study|Other Medical Reasons|4
950574|NCT00770809|3130715|P1|Overall Study|Other Medical Reasons|2
950575|NCT00770809|3130713|P3|Overall Study|Complicating illness|1
950576|NCT00770809|3130714|P2|Overall Study|Complicating illness|0
950577|NCT00770809|3130715|P1|Overall Study|Complicating illness|0
950578|NCT00770809|3130713|P3|Overall Study|Progression|0
950579|NCT00770809|3130714|P2|Overall Study|Progression|2
950580|NCT00770809|3130715|P1|Overall Study|Progression|2
950581|NCT00770809|3130713|P3|Overall Study|Withdrawal by Subject|7
950582|NCT00770809|3130714|P2|Overall Study|Withdrawal by Subject|3
950583|NCT00770809|3130715|P1|Overall Study|Withdrawal by Subject|3
950584|NCT00770809|3130713|P3|Overall Study|Death|0
950585|NCT00770809|3130714|P2|Overall Study|Death|0
950586|NCT00770809|3130715|P1|Overall Study|Death|1
950587|NCT00770809|3130713|P3|Overall Study|Adverse Event|12
950588|NCT00770809|3130714|P2|Overall Study|Adverse Event|1
950589|NCT00770809|3130715|P1|Overall Study|Adverse Event|9
950590|NCT00770770|3130725|P2|Overall Study|Study Terminated|0
950591|NCT00770770|3130726|P1|Overall Study|Study Terminated|8
950592|NCT00770770|3130725|P2|Overall Study|Death|1
950593|NCT00770770|3130726|P1|Overall Study|Death|0
950594|NCT00770770|3130725|P2|Overall Study|Withdrawal by Subject|0
950595|NCT00770770|3130726|P1|Overall Study|Withdrawal by Subject|1
950596|NCT00770770|3130725|P2|Overall Study|Lost to Follow-up|0
950597|NCT00770770|3130726|P1|Overall Study|Lost to Follow-up|1
950598|NCT00770692|3130744|P4|Overall Study|Investigator judgment|1
950599|NCT00770692|3130745|P3|Overall Study|Investigator judgment|1
950600|NCT00770692|3130746|P2|Overall Study|Investigator judgment|0
950601|NCT00770692|3130747|P1|Overall Study|Investigator judgment|2
950602|NCT00770692|3130744|P4|Overall Study|Adverse Event|4
950603|NCT00770692|3130745|P3|Overall Study|Adverse Event|4
950604|NCT00770692|3130746|P2|Overall Study|Adverse Event|0
950605|NCT00770692|3130747|P1|Overall Study|Adverse Event|3
950606|NCT00770692|3130744|P4|Overall Study|Withdrawal by Subject|6
950607|NCT00770692|3130745|P3|Overall Study|Withdrawal by Subject|9
950608|NCT00770692|3130746|P2|Overall Study|Withdrawal by Subject|9
950609|NCT00770692|3130747|P1|Overall Study|Withdrawal by Subject|7
950610|NCT00770679|3130773|P1|Overall Study|Follow-up LDL measurement not collected|3
950611|NCT00770679|3130773|P1|Overall Study|Lost to Follow-up|3
950612|NCT00770653|3130781|P2|Overall Study|Physician Decision|0
950613|NCT00770653|3130782|P1|Overall Study|Physician Decision|1
950614|NCT00770653|3130781|P2|Overall Study|Lost to Follow-up|2
950615|NCT00770653|3130782|P1|Overall Study|Lost to Follow-up|1
950616|NCT00770653|3130781|P2|Overall Study|> Three Moderate Hypoglycemic Episodes|2
950617|NCT00770653|3130782|P1|Overall Study|> Three Moderate Hypoglycemic Episodes|0
950618|NCT00770653|3130781|P2|Overall Study|Fasting Glucose > 240 mg/dL|1
950619|NCT00770653|3130782|P1|Overall Study|Fasting Glucose > 240 mg/dL|2
950620|NCT00770653|3130781|P2|Overall Study|Worsening of Glycosolated Hemoglobin|2
950621|NCT00770653|3130782|P1|Overall Study|Worsening of Glycosolated Hemoglobin|2
950622|NCT00770653|3130781|P2|Overall Study|Lack of Compliance|4
950623|NCT00770653|3130782|P1|Overall Study|Lack of Compliance|1
950624|NCT00770653|3130781|P2|Overall Study|Withdrawal by Subject|7
950625|NCT00770653|3130782|P1|Overall Study|Withdrawal by Subject|4
950626|NCT00770653|3130781|P2|Overall Study|Protocol Violation|6
950627|NCT00770653|3130782|P1|Overall Study|Protocol Violation|8
950628|NCT00770653|3130781|P2|Overall Study|Adverse Event|5
950629|NCT00770653|3130782|P1|Overall Study|Adverse Event|13
950630|NCT00770588|3130852|P2|Overall Study|Withdrawal by Subject|1
950631|NCT00770588|3130853|P1|Overall Study|Withdrawal by Subject|1
950632|NCT00770588|3130852|P2|Overall Study|Lost to Follow-up|1
950633|NCT00770588|3130853|P1|Overall Study|Lost to Follow-up|1
950634|NCT00770588|3130852|P2|Overall Study|Death caused by progression of disease|91
950635|NCT00770588|3130853|P1|Overall Study|Death caused by progression of disease|70
950636|NCT00770588|3130852|P2|Overall Study|Adverse Event|2
950637|NCT00770588|3130853|P1|Overall Study|Adverse Event|9
950638|NCT00770562|3130869|P2|Overall Study|Did not take treatment|1
950639|NCT00770562|3130870|P1|Overall Study|Did not take treatment|1
950640|NCT00770510|3130881|P1|Overall Study|Withdrawal by Subject|2
950641|NCT00770510|3130881|P1|Overall Study|Pregnancy|1
950642|NCT00770510|3130881|P1|Overall Study|Lost to Follow-up|2
950643|NCT00770484|3130920|P2|Overall Study|Withdrawal by Subject|0
950644|NCT00770484|3130921|P1|Overall Study|Withdrawal by Subject|1
950645|NCT00770432|3130929|P2|Overall Study|Non-compliance|1
950646|NCT00770432|3130930|P1|Overall Study|Non-compliance|0
950647|NCT00770432|3130929|P2|Overall Study|Not specified|6
950648|NCT00770432|3130930|P1|Overall Study|Not specified|4
950649|NCT00770367|3130938|P2|Second Intervention|Lost to Follow-up|0
950650|NCT00770367|3130939|P1|Second Intervention|Lost to Follow-up|2
950651|NCT00770367|3130938|P2|Washout Period of 4 Weeks|Withdrawal by Subject|1
950652|NCT00770367|3130939|P1|Washout Period of 4 Weeks|Withdrawal by Subject|0
950653|NCT00770367|3130938|P2|First Intervention|Withdrawal by Subject|2
950654|NCT00770367|3130939|P1|First Intervention|Withdrawal by Subject|0
950655|NCT00770341|3130950|P3|Overall Study|Not treated|0
950656|NCT00770341|3130951|P2|Overall Study|Not treated|0
950657|NCT00770341|3130952|P1|Overall Study|Not treated|1
950658|NCT00770341|3130950|P3|Overall Study|Not specified|0
950659|NCT00770341|3130951|P2|Overall Study|Not specified|0
950660|NCT00770341|3130952|P1|Overall Study|Not specified|1
950661|NCT00770341|3130950|P3|Overall Study|Lack of Efficacy|1
950662|NCT00770341|3130951|P2|Overall Study|Lack of Efficacy|0
950663|NCT00770341|3130952|P1|Overall Study|Lack of Efficacy|3
950664|NCT00770341|3130950|P3|Overall Study|Laboratory adverse event|0
950665|NCT00770341|3130951|P2|Overall Study|Laboratory adverse event|3
950666|NCT00770341|3130952|P1|Overall Study|Laboratory adverse event|3
950667|NCT00770341|3130950|P3|Overall Study|Clinical Adverse Event|2
950668|NCT00770341|3130951|P2|Overall Study|Clinical Adverse Event|1
950669|NCT00770341|3130952|P1|Overall Study|Clinical Adverse Event|3
950670|NCT00770341|3130950|P3|Overall Study|Withdrawal by Subject|0
950671|NCT00770341|3130951|P2|Overall Study|Withdrawal by Subject|1
950672|NCT00770341|3130952|P1|Overall Study|Withdrawal by Subject|0
950673|NCT00770341|3130950|P3|Overall Study|Did not meet eligibility criteria|0
950674|NCT00770341|3130951|P2|Overall Study|Did not meet eligibility criteria|0
950675|NCT00770341|3130952|P1|Overall Study|Did not meet eligibility criteria|1
950676|NCT00770328|3130978|P2|Overall Study|Lost to Follow-up|2
950677|NCT00770328|3130979|P1|Overall Study|Lost to Follow-up|2
950678|NCT00770328|3130978|P2|Overall Study|Adverse Event|2
950679|NCT00770328|3130979|P1|Overall Study|Adverse Event|11
950680|NCT00770315|3130995|P4|Overall Study|Noncompliance with Protocol|9
950681|NCT00770315|3130996|P3|Overall Study|Noncompliance with Protocol|7
950682|NCT00770315|3130997|P2|Overall Study|Noncompliance with Protocol|4
950683|NCT00770315|3130998|P1|Overall Study|Noncompliance with Protocol|7
950684|NCT00770315|3130995|P4|Overall Study|Withdrawal by Subject|20
950685|NCT00770315|3130996|P3|Overall Study|Withdrawal by Subject|24
950686|NCT00770315|3130997|P2|Overall Study|Withdrawal by Subject|17
950687|NCT00770315|3130998|P1|Overall Study|Withdrawal by Subject|13
950688|NCT00770315|3130995|P4|Overall Study|Lost to Follow-up|3
950689|NCT00770315|3130996|P3|Overall Study|Lost to Follow-up|10
950690|NCT00770315|3130997|P2|Overall Study|Lost to Follow-up|5
950691|NCT00770315|3130998|P1|Overall Study|Lost to Follow-up|9
950692|NCT00770315|3130995|P4|Overall Study|Adverse Event|6
950693|NCT00770315|3130996|P3|Overall Study|Adverse Event|16
950694|NCT00770315|3130997|P2|Overall Study|Adverse Event|17
950695|NCT00770315|3130998|P1|Overall Study|Adverse Event|11
950696|NCT00770289|3131024|P1|Overall Study|Other|6
950697|NCT00770224|3131033|P2|Step 2: Maintenance|Ineligible|2
950698|NCT00770224|3131034|P1|Step 2: Maintenance|Ineligible|0
950699|NCT00770224|3131033|P2|Step 2: Maintenance|Other reason not protocol specified|7
950700|NCT00770224|3131034|P1|Step 2: Maintenance|Other reason not protocol specified|0
950701|NCT00770224|3131033|P2|Step 2: Maintenance|Death|2
950702|NCT00770224|3131034|P1|Step 2: Maintenance|Death|0
950703|NCT00770224|3131033|P2|Step 2: Maintenance|Progression/relapse|1
950704|NCT00770224|3131034|P1|Step 2: Maintenance|Progression/relapse|0
950705|NCT00770224|3131033|P2|Step 2: Maintenance|Refusal unrelated to adverse event|8
950706|NCT00770224|3131034|P1|Step 2: Maintenance|Refusal unrelated to adverse event|0
950707|NCT00770224|3131033|P2|Step 2: Maintenance|Adverse Event|10
950708|NCT00770224|3131034|P1|Step 2: Maintenance|Adverse Event|0
950709|NCT00770224|3131033|P2|Step 1: Induction|No protocol treatment given|0
950710|NCT00770224|3131034|P1|Step 1: Induction|No protocol treatment given|1
950711|NCT00770224|3131033|P2|Step 1: Induction|Ineligible|0
950712|NCT00770224|3131034|P1|Step 1: Induction|Ineligible|2
950713|NCT00770224|3131033|P2|Step 1: Induction|Other reason not protocol specified|0
950714|NCT00770224|3131034|P1|Step 1: Induction|Other reason not protocol specified|2
950715|NCT00770224|3131033|P2|Step 1: Induction|Refusal unrelated to adverse event|0
950716|NCT00770224|3131034|P1|Step 1: Induction|Refusal unrelated to adverse event|6
950717|NCT00770224|3131033|P2|Step 1: Induction|Adverse Event|0
950718|NCT00770224|3131034|P1|Step 1: Induction|Adverse Event|3
950719|NCT00770211|3131046|P2|Overall Study|Withdrawal by Subject|2
950720|NCT00770211|3131047|P1|Overall Study|Withdrawal by Subject|0
950721|NCT00770211|3131046|P2|Overall Study|Lost to Follow-up|0
950722|NCT00770211|3131047|P1|Overall Study|Lost to Follow-up|1
950723|NCT00770146|3131063|P2|Follow-up Period|Other|5
950724|NCT00770146|3131064|P1|Follow-up Period|Other|4
950725|NCT00770146|3131063|P2|Follow-up Period|Adverse Event|2
950726|NCT00770146|3131064|P1|Follow-up Period|Adverse Event|0
950727|NCT00770146|3131063|P2|Follow-up Period|Withdrawal by Subject|13
950728|NCT00770146|3131064|P1|Follow-up Period|Withdrawal by Subject|7
950729|NCT00770146|3131063|P2|Treatment Period|Protocol non-compliance|1
950730|NCT00770146|3131064|P1|Treatment Period|Protocol non-compliance|0
950731|NCT00770146|3131063|P2|Treatment Period|Other|5
950732|NCT00770146|3131064|P1|Treatment Period|Other|1
950733|NCT00770146|3131063|P2|Treatment Period|Adverse Event|26
950734|NCT00770146|3131064|P1|Treatment Period|Adverse Event|2
950735|NCT00770146|3131063|P2|Treatment Period|Withdrawal by Subject|13
950736|NCT00770146|3131064|P1|Treatment Period|Withdrawal by Subject|6
950737|NCT00770120|3131108|P1|Overall Study|Reason under Review|1
950738|NCT00770120|3131108|P1|Overall Study|Never Received Treatment/Not Analyzable|1
950739|NCT00770120|3131108|P1|Overall Study|Ineligible|1
950740|NCT00770120|3131108|P1|Overall Study|Withdrawal by Subject|2
950741|NCT00770120|3131108|P1|Overall Study|Death|3
950742|NCT00770120|3131108|P1|Overall Study|Not Protocol Specified|11
950743|NCT00770120|3131108|P1|Overall Study|Adverse Event|11
950744|NCT00770120|3131108|P1|Overall Study|Progression|31
950745|NCT00770029|3131117|P2|Overall Study|Adverse Event|0
950746|NCT00770029|3131118|P1|Overall Study|Adverse Event|1
950747|NCT00770029|3131117|P2|Overall Study|Withdrawal by Subject|3
950748|NCT00770029|3131118|P1|Overall Study|Withdrawal by Subject|3
950749|NCT00770029|3131117|P2|Overall Study|Lost to Follow-up|0
950750|NCT00770029|3131118|P1|Overall Study|Lost to Follow-up|2
950751|NCT00769860|3131134|P2|Overall Study|Withdrawal by Subject|0
950752|NCT00769860|3131135|P1|Overall Study|Withdrawal by Subject|2
950753|NCT00769704|3131163|P2|Overall Study|Other|2
950754|NCT00769704|3131164|P1|Overall Study|Other|1
950755|NCT00769704|3131163|P2|Overall Study|Withdrawal by Subject|5
950756|NCT00769704|3131164|P1|Overall Study|Withdrawal by Subject|12
950757|NCT00769704|3131163|P2|Overall Study|Death|190
950758|NCT00769704|3131164|P1|Overall Study|Death|95
950759|NCT00769704|3131163|P2|Overall Study|Lost to Follow-up|2
950760|NCT00769704|3131164|P1|Overall Study|Lost to Follow-up|3
950761|NCT00769561|3131197|P2|Overall Study|Lost to Follow-up|3
950762|NCT00769561|3131198|P1|Overall Study|Lost to Follow-up|1
950763|NCT00769561|3131197|P2|Overall Study|Withdrawal by Subject|2
950764|NCT00769561|3131198|P1|Overall Study|Withdrawal by Subject|2
950765|NCT00769184|3131247|P2|No Treatment (6 Weeks)|Adverse Event|1
950766|NCT00769184|3131248|P1|No Treatment (6 Weeks)|Adverse Event|1
950767|NCT00769184|3131247|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1
950768|NCT00769184|3131248|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0
950769|NCT00769184|3131247|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0
950770|NCT00769184|3131248|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1
950771|NCT00769132|3131256|P4|Period 4|Withdrawal by Subject|0
950772|NCT00769132|3131257|P3|Period 4|Withdrawal by Subject|0
950773|NCT00769132|3131258|P2|Period 4|Withdrawal by Subject|1
950774|NCT00769132|3131259|P1|Period 4|Withdrawal by Subject|0
950775|NCT00769132|3131256|P4|Period 3|Withdrawal by Subject|0
950776|NCT00769132|3131257|P3|Period 3|Withdrawal by Subject|0
950777|NCT00769132|3131258|P2|Period 3|Withdrawal by Subject|0
950778|NCT00769132|3131259|P1|Period 3|Withdrawal by Subject|1
950779|NCT00769132|3131256|P4|Period 2|Withdrawal by Subject|1
950780|NCT00769132|3131257|P3|Period 2|Withdrawal by Subject|0
950781|NCT00769132|3131258|P2|Period 2|Withdrawal by Subject|0
950782|NCT00769132|3131259|P1|Period 2|Withdrawal by Subject|0
950783|NCT00769132|3131256|P4|Period 1|Adverse Event|1
950784|NCT00769132|3131257|P3|Period 1|Adverse Event|0
950785|NCT00769132|3131258|P2|Period 1|Adverse Event|0
950786|NCT00769132|3131259|P1|Period 1|Adverse Event|1
950787|NCT00769119|3131275|P2|Overall Study|Disallowed medication|0
950788|NCT00769119|3131276|P1|Overall Study|Disallowed medication|1
950789|NCT00769119|3131275|P2|Overall Study|Adverse Event|1
950790|NCT00769119|3131276|P1|Overall Study|Adverse Event|1
950791|NCT00769119|3131275|P2|Overall Study|Voluntary discontinuation|2
950792|NCT00769119|3131276|P1|Overall Study|Voluntary discontinuation|0
950793|NCT00769067|3131322|P2|Overall Study|Withdrawal by Subject|1
950794|NCT00769067|3131323|P1|Overall Study|Withdrawal by Subject|0
950795|NCT00769067|3131322|P2|Overall Study|Other|3
950796|NCT00769067|3131323|P1|Overall Study|Other|1
950797|NCT00769067|3131322|P2|Overall Study|Study terminated by sponsor|3
950798|NCT00769067|3131323|P1|Overall Study|Study terminated by sponsor|1
950799|NCT00769067|3131322|P2|Overall Study|Lost to Follow-up|1
950800|NCT00769067|3131323|P1|Overall Study|Lost to Follow-up|3
950801|NCT00769067|3131322|P2|Overall Study|Death|86
950802|NCT00769067|3131323|P1|Overall Study|Death|89
950803|NCT00768989|3131371|P2|On or After Week 36|Sponsor Termination|26
950804|NCT00768989|3131372|P1|On or After Week 36|Sponsor Termination|45
950805|NCT00768989|3131371|P2|On or After Week 36|Did not attend termination visit|0
950806|NCT00768989|3131372|P1|On or After Week 36|Did not attend termination visit|2
950807|NCT00768989|3131371|P2|On or After Week 36|Protocol Violation|0
950808|NCT00768989|3131372|P1|On or After Week 36|Protocol Violation|1
950809|NCT00768989|3131371|P2|On or After Week 36|Poor Compliance|0
950810|NCT00768989|3131372|P1|On or After Week 36|Poor Compliance|1
950811|NCT00768989|3131371|P2|On or After Week 36|Lost to Follow-up|0
950812|NCT00768989|3131372|P1|On or After Week 36|Lost to Follow-up|1
950813|NCT00768989|3131371|P2|On or After Week 36|Adverse Event|1
950814|NCT00768989|3131372|P1|On or After Week 36|Adverse Event|0
950815|NCT00768989|3131371|P2|On or After Week 36|Lack of Efficacy|0
950816|NCT00768989|3131372|P1|On or After Week 36|Lack of Efficacy|1
950817|NCT00768989|3131371|P2|Week 24 to Prior to Week 36|Withdrawal by Subject|0
950818|NCT00768989|3131372|P1|Week 24 to Prior to Week 36|Withdrawal by Subject|1
950819|NCT00768989|3131371|P2|Week 24 to Prior to Week 36|Lack of Efficacy|0
950820|NCT00768989|3131372|P1|Week 24 to Prior to Week 36|Lack of Efficacy|6
950821|NCT00768989|3131371|P2|Week 24 to Prior to Week 36|Adverse Event|0
950822|NCT00768989|3131372|P1|Week 24 to Prior to Week 36|Adverse Event|1
950823|NCT00768989|3131371|P2|Prior to Week 24|Protocol Violation|2
950824|NCT00768989|3131372|P1|Prior to Week 24|Protocol Violation|0
950825|NCT00768989|3131371|P2|Prior to Week 24|Lost to Follow-up|1
950826|NCT00768989|3131372|P1|Prior to Week 24|Lost to Follow-up|0
950827|NCT00768989|3131371|P2|Prior to Week 24|Adverse Event|0
950828|NCT00768989|3131372|P1|Prior to Week 24|Adverse Event|3
950829|NCT00768989|3131371|P2|Prior to Week 24|Withdrawal by Subject|0
950830|NCT00768989|3131372|P1|Prior to Week 24|Withdrawal by Subject|1
950831|NCT00768898|3131420|P1|Overall Study|Headache|1
950832|NCT00768898|3131420|P1|Overall Study|Unrelated injury|1
950833|NCT00768755|3131444|P4|Phase 2|Randomized but not treated|2
950834|NCT00768755|3131445|P3|Phase 2|Randomized but not treated|0
950835|NCT00768755|3131446|P2|Phase 2|Randomized but not treated|0
950836|NCT00768755|3131447|P1|Phase 2|Randomized but not treated|0
950837|NCT00768755|3131444|P4|Phase 2|Study Terminated by Sponsor|14
950838|NCT00768755|3131445|P3|Phase 2|Study Terminated by Sponsor|7
950839|NCT00768755|3131446|P2|Phase 2|Study Terminated by Sponsor|13
950840|NCT00768755|3131447|P1|Phase 2|Study Terminated by Sponsor|0
950841|NCT00768755|3131444|P4|Phase 2|Other|4
950842|NCT00768755|3131445|P3|Phase 2|Other|2
950843|NCT00768755|3131446|P2|Phase 2|Other|1
950844|NCT00768755|3131447|P1|Phase 2|Other|0
950845|NCT00768755|3131444|P4|Phase 2|Withdrawal by Subject|1
950846|NCT00768755|3131445|P3|Phase 2|Withdrawal by Subject|0
950847|NCT00768755|3131446|P2|Phase 2|Withdrawal by Subject|1
950848|NCT00768755|3131447|P1|Phase 2|Withdrawal by Subject|0
950849|NCT00768755|3131444|P4|Phase 2|Lost to Follow-up|4
950850|NCT00768755|3131445|P3|Phase 2|Lost to Follow-up|1
950851|NCT00768755|3131446|P2|Phase 2|Lost to Follow-up|1
950852|NCT00768755|3131447|P1|Phase 2|Lost to Follow-up|0
950853|NCT00768755|3131444|P4|Phase 2|Protocol Violation|1
950854|NCT00768755|3131445|P3|Phase 2|Protocol Violation|0
950855|NCT00768755|3131446|P2|Phase 2|Protocol Violation|2
950856|NCT00768755|3131447|P1|Phase 2|Protocol Violation|0
950857|NCT00768755|3131444|P4|Phase 2|Death|31
950858|NCT00768755|3131445|P3|Phase 2|Death|48
950859|NCT00768755|3131446|P2|Phase 2|Death|37
950860|NCT00768755|3131447|P1|Phase 2|Death|0
950861|NCT00768755|3131444|P4|Phase 1|Other|0
950862|NCT00768755|3131445|P3|Phase 1|Other|0
950863|NCT00768755|3131446|P2|Phase 1|Other|0
950864|NCT00768755|3131447|P1|Phase 1|Other|4
950865|NCT00768755|3131444|P4|Phase 1|Death|0
950866|NCT00768755|3131445|P3|Phase 1|Death|0
950867|NCT00768755|3131446|P2|Phase 1|Death|0
950868|NCT00768755|3131447|P1|Phase 1|Death|6
950869|NCT00768651|3131471|P1|Overall Study|Withdrawal by Subject|1
950870|NCT00768560|3131510|P6|Intervention Set 1|Adverse Event|0
950871|NCT00768560|3131511|P5|Intervention Set 1|Adverse Event|0
950872|NCT00768560|3131512|P4|Intervention Set 1|Adverse Event|0
950873|NCT00768560|3131513|P3|Intervention Set 1|Adverse Event|0
950874|NCT00768560|3131514|P2|Intervention Set 1|Adverse Event|1
950875|NCT00768560|3131515|P1|Intervention Set 1|Adverse Event|0
950876|NCT00768469|3131552|P2|Overall Study|Withdrawal by Subject|1
950877|NCT00768469|3131553|P1|Overall Study|Withdrawal by Subject|0
950878|NCT00768469|3131552|P2|Overall Study|Disease Progression|4
950879|NCT00768469|3131553|P1|Overall Study|Disease Progression|3
950880|NCT00768469|3131552|P2|Overall Study|Adverse Event|2
950881|NCT00768469|3131553|P1|Overall Study|Adverse Event|0
950882|NCT00768430|3131568|P2|7 Day Endpoint|Withdrawal by Subject|3
950883|NCT00768430|3131569|P1|7 Day Endpoint|Withdrawal by Subject|2
950884|NCT00768300|3131577|P2|Overall Study|Missing data|0
950885|NCT00768300|3131578|P1|Overall Study|Missing data|1
950886|NCT00768300|3131577|P2|Overall Study|Treated but never dosed with Study drug|0
950887|NCT00768300|3131578|P1|Overall Study|Treated but never dosed with Study drug|1
950888|NCT00768300|3131577|P2|Overall Study|Began prohibited concomitant medication|1
950889|NCT00768300|3131578|P1|Overall Study|Began prohibited concomitant medication|0
950890|NCT00768300|3131577|P2|Overall Study|Lost to Follow-up|1
950891|NCT00768300|3131578|P1|Overall Study|Lost to Follow-up|0
950892|NCT00768300|3131577|P2|Overall Study|Received lung transplant|1
950893|NCT00768300|3131578|P1|Overall Study|Received lung transplant|1
950894|NCT00768300|3131577|P2|Overall Study|Screen failure following randomization|0
950895|NCT00768300|3131578|P1|Overall Study|Screen failure following randomization|1
950896|NCT00768300|3131577|P2|Overall Study|Subject moved to pursue lung transplant|1
950897|NCT00768300|3131578|P1|Overall Study|Subject moved to pursue lung transplant|1
950898|NCT00768300|3131577|P2|Overall Study|Death|5
950899|NCT00768300|3131578|P1|Overall Study|Death|21
950900|NCT00768300|3131577|P2|Overall Study|Study discontinued by Sponsor|140
950901|NCT00768300|3131578|P1|Overall Study|Study discontinued by Sponsor|271
950902|NCT00768300|3131577|P2|Overall Study|Physician Decision|3
950903|NCT00768300|3131578|P1|Overall Study|Physician Decision|2
950904|NCT00768300|3131577|P2|Overall Study|Withdrawal by Subject|7
950905|NCT00768300|3131578|P1|Overall Study|Withdrawal by Subject|13
950906|NCT00768300|3131577|P2|Overall Study|Protocol Violation|1
950907|NCT00768300|3131578|P1|Overall Study|Protocol Violation|6
950908|NCT00768300|3131577|P2|Overall Study|Adverse Event|2
950909|NCT00768300|3131578|P1|Overall Study|Adverse Event|10
950910|NCT00768300|3131577|P2|Overall Study|Randomized but not treated|1
950911|NCT00768300|3131578|P1|Overall Study|Randomized but not treated|1
950912|NCT00768222|3131662|P2|Overall Study|Protocol Violation|2
950913|NCT00768222|3131663|P1|Overall Study|Protocol Violation|0
950914|NCT00768222|3131662|P2|Overall Study|Withdrawal by Subject|1
950915|NCT00768222|3131663|P1|Overall Study|Withdrawal by Subject|3
950916|NCT00768222|3131662|P2|Overall Study|Lost to Follow-up|1
950917|NCT00768222|3131663|P1|Overall Study|Lost to Follow-up|1
950918|NCT00768144|3131685|P1|Overall Study|Pt Withdrew Consent|1
950919|NCT00768144|3131685|P1|Overall Study|Patient or MD Decision to End Treatment|1
950920|NCT00768144|3131685|P1|Overall Study|Progressive Disease|21
950921|NCT00768144|3131685|P1|Overall Study|Adverse Event|13
950922|NCT00768066|3131698|P3|Overall Study|Did not receive study product injection.|0
950923|NCT00768066|3131699|P2|Overall Study|Did not receive study product injection.|3
950924|NCT00768066|3131700|P1|Overall Study|Did not receive study product injection.|3
950925|NCT00768053|3131732|P1|Overall Study|Lost to Follow-up|1
950926|NCT00768053|3131732|P1|Overall Study|Adverse Event|10
950927|NCT00768040|3131763|P2|Overall Study|Abnormal laboratory value|1
950928|NCT00768040|3131764|P1|Overall Study|Abnormal laboratory value|1
950929|NCT00768040|3131763|P2|Overall Study|Adverse Event|2
950930|NCT00768040|3131764|P1|Overall Study|Adverse Event|3
950931|NCT00767806|3131772|P2|Overall Study|Sponsor Decision|1
950932|NCT00767806|3131773|P1|Overall Study|Sponsor Decision|0
950933|NCT00767806|3131772|P2|Overall Study|Entry Criteria Not Met|1
950934|NCT00767806|3131773|P1|Overall Study|Entry Criteria Not Met|1
950935|NCT00767806|3131772|P2|Overall Study|Lost to Follow-up|4
950936|NCT00767806|3131773|P1|Overall Study|Lost to Follow-up|1
950937|NCT00767806|3131772|P2|Overall Study|Physician Decision|3
950938|NCT00767806|3131773|P1|Overall Study|Physician Decision|4
950939|NCT00767806|3131772|P2|Overall Study|Lack of Efficacy|9
950940|NCT00767806|3131773|P1|Overall Study|Lack of Efficacy|1
950941|NCT00767806|3131772|P2|Overall Study|Protocol Violation|5
950942|NCT00767806|3131773|P1|Overall Study|Protocol Violation|6
950943|NCT00767806|3131772|P2|Overall Study|Withdrawal by Subject|13
950944|NCT00767806|3131773|P1|Overall Study|Withdrawal by Subject|8
950945|NCT00767806|3131772|P2|Overall Study|Adverse Event|11
950946|NCT00767806|3131773|P1|Overall Study|Adverse Event|30
950947|NCT00767676|3131850|P1|Overall Study|Investigator error|54
950948|NCT00767520|3131873|P2|Overall Study|Randomized in error and Never treated|2
950949|NCT00767520|3131874|P1|Overall Study|Randomized in error and Never treated|0
950950|NCT00767520|3131873|P2|Overall Study|Participants still on treatment|15
950951|NCT00767520|3131874|P1|Overall Study|Participants still on treatment|11
950952|NCT00767455|3131927|P1|Overall Study|Investigator error|19
950953|NCT00767325|3131961|P1|Overall Study|Missed visit due to family reasons|1
950954|NCT00767325|3131961|P1|Overall Study|No longer met study criteria|2
950955|NCT00767325|3131961|P1|Overall Study|Lost to Follow-up|3
950956|NCT00767325|3131961|P1|Overall Study|Adverse Event|7
950957|NCT00767325|3131961|P1|Overall Study|Lack of Efficacy|2
950958|NCT00767104|3131972|P2|Overall Study|Lost to Follow-up|2
950959|NCT00767104|3131973|P1|Overall Study|Lost to Follow-up|1
950960|NCT00767039|3131983|P2|Overall Study|Death|2
950961|NCT00767039|3131984|P1|Overall Study|Death|5
950962|NCT00767000|3132015|P5|Optional 104-week Extension|Study terminated by sponsor|4
950963|NCT00767000|3132016|P4|Optional 104-week Extension|Study terminated by sponsor|2
950964|NCT00767000|3132017|P3|Optional 104-week Extension|Study terminated by sponsor|7
950965|NCT00767000|3132018|P2|Optional 104-week Extension|Study terminated by sponsor|3
950966|NCT00767000|3132019|P1|Optional 104-week Extension|Study terminated by sponsor|7
950967|NCT00767000|3132015|P5|54-week Study|Reason not reported|0
950968|NCT00767000|3132016|P4|54-week Study|Reason not reported|1
950969|NCT00767000|3132017|P3|54-week Study|Reason not reported|0
950970|NCT00767000|3132018|P2|54-week Study|Reason not reported|0
950971|NCT00767000|3132019|P1|54-week Study|Reason not reported|0
950972|NCT00767000|3132015|P5|54-week Study|Study terminated by sponsor|194
950973|NCT00767000|3132016|P4|54-week Study|Study terminated by sponsor|196
950974|NCT00767000|3132017|P3|54-week Study|Study terminated by sponsor|89
950975|NCT00767000|3132018|P2|54-week Study|Study terminated by sponsor|102
950976|NCT00767000|3132019|P1|54-week Study|Study terminated by sponsor|90
950977|NCT00767000|3132015|P5|54-week Study|Withdrawal by Subject|13
950978|NCT00767000|3132016|P4|54-week Study|Withdrawal by Subject|11
950979|NCT00767000|3132017|P3|54-week Study|Withdrawal by Subject|5
950980|NCT00767000|3132018|P2|54-week Study|Withdrawal by Subject|3
950981|NCT00767000|3132019|P1|54-week Study|Withdrawal by Subject|2
950982|NCT00767000|3132015|P5|54-week Study|Protocol Violation|0
950983|NCT00767000|3132016|P4|54-week Study|Protocol Violation|2
950984|NCT00767000|3132017|P3|54-week Study|Protocol Violation|1
950985|NCT00767000|3132018|P2|54-week Study|Protocol Violation|0
950986|NCT00767000|3132019|P1|54-week Study|Protocol Violation|0
950987|NCT00767000|3132015|P5|54-week Study|Progressive disease|0
950988|NCT00767000|3132016|P4|54-week Study|Progressive disease|0
950989|NCT00767000|3132017|P3|54-week Study|Progressive disease|1
950990|NCT00767000|3132018|P2|54-week Study|Progressive disease|0
950991|NCT00767000|3132019|P1|54-week Study|Progressive disease|0
950992|NCT00767000|3132015|P5|54-week Study|Physician Decision|1
950993|NCT00767000|3132016|P4|54-week Study|Physician Decision|1
950994|NCT00767000|3132017|P3|54-week Study|Physician Decision|1
950995|NCT00767000|3132018|P2|54-week Study|Physician Decision|0
950996|NCT00767000|3132019|P1|54-week Study|Physician Decision|4
950997|NCT00767000|3132015|P5|54-week Study|Lost to Follow-up|2
950998|NCT00767000|3132016|P4|54-week Study|Lost to Follow-up|4
950999|NCT00767000|3132017|P3|54-week Study|Lost to Follow-up|1
951000|NCT00767000|3132018|P2|54-week Study|Lost to Follow-up|0
951001|NCT00767000|3132019|P1|54-week Study|Lost to Follow-up|4
951002|NCT00767000|3132015|P5|54-week Study|Lack of Efficacy|5
951003|NCT00767000|3132016|P4|54-week Study|Lack of Efficacy|0
951004|NCT00767000|3132017|P3|54-week Study|Lack of Efficacy|1
951005|NCT00767000|3132018|P2|54-week Study|Lack of Efficacy|0
951006|NCT00767000|3132019|P1|54-week Study|Lack of Efficacy|2
951007|NCT00767000|3132015|P5|54-week Study|Interruption of study medication|0
951008|NCT00767000|3132016|P4|54-week Study|Interruption of study medication|0
951009|NCT00767000|3132017|P3|54-week Study|Interruption of study medication|1
951010|NCT00767000|3132018|P2|54-week Study|Interruption of study medication|0
951011|NCT00767000|3132019|P1|54-week Study|Interruption of study medication|0
951012|NCT00767000|3132015|P5|54-week Study|Hypoglycemia|0
951013|NCT00767000|3132016|P4|54-week Study|Hypoglycemia|0
951014|NCT00767000|3132017|P3|54-week Study|Hypoglycemia|0
951015|NCT00767000|3132018|P2|54-week Study|Hypoglycemia|1
951016|NCT00767000|3132019|P1|54-week Study|Hypoglycemia|0
951017|NCT00767000|3132015|P5|54-week Study|Hyperglycemia|1
951018|NCT00767000|3132016|P4|54-week Study|Hyperglycemia|0
951019|NCT00767000|3132017|P3|54-week Study|Hyperglycemia|1
951020|NCT00767000|3132018|P2|54-week Study|Hyperglycemia|0
951021|NCT00767000|3132019|P1|54-week Study|Hyperglycemia|0
951022|NCT00767000|3132015|P5|54-week Study|Creaninine/creatinine clearance|4
951023|NCT00767000|3132016|P4|54-week Study|Creaninine/creatinine clearance|2
951024|NCT00767000|3132017|P3|54-week Study|Creaninine/creatinine clearance|2
951025|NCT00767000|3132018|P2|54-week Study|Creaninine/creatinine clearance|1
951026|NCT00767000|3132019|P1|54-week Study|Creaninine/creatinine clearance|2
951027|NCT00767000|3132015|P5|54-week Study|Adverse Event|4
951028|NCT00767000|3132016|P4|54-week Study|Adverse Event|8
951029|NCT00767000|3132017|P3|54-week Study|Adverse Event|6
951030|NCT00767000|3132018|P2|54-week Study|Adverse Event|6
951031|NCT00767000|3132019|P1|54-week Study|Adverse Event|4
951032|NCT00766831|3132061|P1|Overall Study|Not specified|28
951033|NCT00766831|3132061|P1|Overall Study|Non cooperation by participants|14
951034|NCT00766831|3132061|P1|Overall Study|Withdrawal of consent|26
951035|NCT00766831|3132061|P1|Overall Study|Physician Decision|5
951036|NCT00766831|3132061|P1|Overall Study|Protocol Violation|15
951037|NCT00766831|3132061|P1|Overall Study|Adverse Event|20
951038|NCT00766831|3132061|P1|Overall Study|Lost to Follow-up|3
951039|NCT00766831|3132061|P1|Overall Study|Withdrawal by Subject|4
951040|NCT00766675|3132091|P1|Overall Study|Insufficient therapy|1
951041|NCT00766675|3132091|P1|Overall Study|Receive other anti-neoplastic treatment|1
951042|NCT00766675|3132091|P1|Overall Study|Participant took prohibited medication|1
951043|NCT00766675|3132091|P1|Overall Study|Protocol Violation|8
951044|NCT00766675|3132091|P1|Overall Study|Withdrawal by Subject|11
951045|NCT00766675|3132091|P1|Overall Study|Lost to Follow-up|2
951046|NCT00766675|3132091|P1|Overall Study|Adverse Event|16
951047|NCT00766636|3132118|P2|Overall Study|Disease Progression|0
951048|NCT00766636|3132119|P1|Overall Study|Disease Progression|1
951049|NCT00766636|3132118|P2|Overall Study|Adverse Event|0
951050|NCT00766636|3132119|P1|Overall Study|Adverse Event|1
951051|NCT00766636|3132118|P2|Overall Study|Incomplete Treatment|1
951052|NCT00766636|3132119|P1|Overall Study|Incomplete Treatment|0
951053|NCT00766636|3132118|P2|Overall Study|Withdrawal by Subject|1
951054|NCT00766636|3132119|P1|Overall Study|Withdrawal by Subject|1
951055|NCT00766597|3132125|P1|Overall Study|Without CCR5-tropic virus|5
951056|NCT00766597|3132125|P1|Overall Study|Unexpected closure of study|4
951057|NCT00766532|3132137|P1|Overall Study|Protocol Violation|2
951058|NCT00766506|3132143|P2|Overall Study|Other|2
951059|NCT00766506|3132144|P1|Overall Study|Other|2
951060|NCT00766506|3132143|P2|Overall Study|Use rescue medication after 3 hours|0
951061|NCT00766506|3132144|P1|Overall Study|Use rescue medication after 3 hours|3
951062|NCT00766493|3132168|P1|30 Days Post-Procedure|Missed Visit - No Phone Contact|1
951063|NCT00766493|3132168|P1|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4
951064|NCT00766493|3132168|P1|30 Days Post-Procedure|Discontinued|7
951065|NCT00766467|3132178|P2|Overall Study|Physician Decision|0
951066|NCT00766467|3132179|P1|Overall Study|Physician Decision|1
951067|NCT00766467|3132178|P2|Overall Study|Tumor Progression on Study|1
951068|NCT00766467|3132179|P1|Overall Study|Tumor Progression on Study|0
951069|NCT00766467|3132178|P2|Overall Study|Protocol Violation|4
951070|NCT00766467|3132179|P1|Overall Study|Protocol Violation|2
951071|NCT00766467|3132178|P2|Overall Study|Adverse Event|1
951072|NCT00766467|3132179|P1|Overall Study|Adverse Event|1
951073|NCT00766467|3132178|P2|Overall Study|Withdrawal by Subject|2
951074|NCT00766467|3132179|P1|Overall Study|Withdrawal by Subject|7
951075|NCT00766415|3132191|P2|Overall Study|Withdrawal by Subject|1
951076|NCT00766415|3132192|P1|Overall Study|Withdrawal by Subject|0
951077|NCT00766376|3132240|P1|Overall Study|Withdrawal by Subject|27
951078|NCT00766363|3132249|P4|Overall Study|Adverse Event Prior to Randomization|0
951079|NCT00766363|3132250|P3|Overall Study|Adverse Event Prior to Randomization|0
951080|NCT00766363|3132251|P2|Overall Study|Adverse Event Prior to Randomization|1
951081|NCT00766363|3132252|P1|Overall Study|Adverse Event Prior to Randomization|0
951082|NCT00766363|3132249|P4|Overall Study|Withdrawal by Subject|0
951083|NCT00766363|3132250|P3|Overall Study|Withdrawal by Subject|0
951084|NCT00766363|3132251|P2|Overall Study|Withdrawal by Subject|0
951085|NCT00766363|3132252|P1|Overall Study|Withdrawal by Subject|1
951086|NCT00766090|3132291|P12|Treatment Period 3 (28 Days)|Lost to Follow-up|0
951087|NCT00766090|3132292|P11|Treatment Period 3 (28 Days)|Lost to Follow-up|0
951088|NCT00766090|3132293|P10|Treatment Period 3 (28 Days)|Lost to Follow-up|0
951089|NCT00766090|3132294|P9|Treatment Period 3 (28 Days)|Lost to Follow-up|0
951090|NCT00766090|3132295|P8|Treatment Period 3 (28 Days)|Lost to Follow-up|0
951091|NCT00766090|3132296|P7|Treatment Period 3 (28 Days)|Lost to Follow-up|0
951092|NCT00766090|3132297|P6|Treatment Period 3 (28 Days)|Lost to Follow-up|0
951093|NCT00766090|3132298|P5|Treatment Period 3 (28 Days)|Lost to Follow-up|1
951094|NCT00766090|3132299|P4|Treatment Period 3 (28 Days)|Lost to Follow-up|0
951095|NCT00766090|3132300|P3|Treatment Period 3 (28 Days)|Lost to Follow-up|0
951096|NCT00766090|3132301|P2|Treatment Period 3 (28 Days)|Lost to Follow-up|0
951097|NCT00766090|3132302|P1|Treatment Period 3 (28 Days)|Lost to Follow-up|0
951098|NCT00766090|3132291|P12|Treatment Period 3 (28 Days)|Lack of Efficacy|1
951099|NCT00766090|3132292|P11|Treatment Period 3 (28 Days)|Lack of Efficacy|0
951100|NCT00766090|3132293|P10|Treatment Period 3 (28 Days)|Lack of Efficacy|0
951101|NCT00766090|3132294|P9|Treatment Period 3 (28 Days)|Lack of Efficacy|0
951102|NCT00766090|3132295|P8|Treatment Period 3 (28 Days)|Lack of Efficacy|0
951103|NCT00766090|3132296|P7|Treatment Period 3 (28 Days)|Lack of Efficacy|0
951104|NCT00766090|3132297|P6|Treatment Period 3 (28 Days)|Lack of Efficacy|0
951105|NCT00766090|3132298|P5|Treatment Period 3 (28 Days)|Lack of Efficacy|0
951106|NCT00766090|3132299|P4|Treatment Period 3 (28 Days)|Lack of Efficacy|1
951107|NCT00766090|3132300|P3|Treatment Period 3 (28 Days)|Lack of Efficacy|0
951108|NCT00766090|3132301|P2|Treatment Period 3 (28 Days)|Lack of Efficacy|1
951109|NCT00766090|3132302|P1|Treatment Period 3 (28 Days)|Lack of Efficacy|0
951110|NCT00766090|3132291|P12|Treatment Period 3 (28 Days)|Protocol Violation|0
951111|NCT00766090|3132292|P11|Treatment Period 3 (28 Days)|Protocol Violation|0
951112|NCT00766090|3132293|P10|Treatment Period 3 (28 Days)|Protocol Violation|0
951113|NCT00766090|3132294|P9|Treatment Period 3 (28 Days)|Protocol Violation|0
951114|NCT00766090|3132295|P8|Treatment Period 3 (28 Days)|Protocol Violation|0
951115|NCT00766090|3132296|P7|Treatment Period 3 (28 Days)|Protocol Violation|0
951116|NCT00766090|3132297|P6|Treatment Period 3 (28 Days)|Protocol Violation|1
951117|NCT00766090|3132298|P5|Treatment Period 3 (28 Days)|Protocol Violation|0
951118|NCT00766090|3132299|P4|Treatment Period 3 (28 Days)|Protocol Violation|0
951119|NCT00766090|3132300|P3|Treatment Period 3 (28 Days)|Protocol Violation|0
951120|NCT00766090|3132301|P2|Treatment Period 3 (28 Days)|Protocol Violation|0
951121|NCT00766090|3132302|P1|Treatment Period 3 (28 Days)|Protocol Violation|0
951122|NCT00766090|3132291|P12|Washout Period 2 (14 Days)|Physician Decision|0
951123|NCT00766090|3132292|P11|Washout Period 2 (14 Days)|Physician Decision|0
951124|NCT00766090|3132293|P10|Washout Period 2 (14 Days)|Physician Decision|0
951125|NCT00766090|3132294|P9|Washout Period 2 (14 Days)|Physician Decision|0
951126|NCT00766090|3132295|P8|Washout Period 2 (14 Days)|Physician Decision|0
951127|NCT00766090|3132296|P7|Washout Period 2 (14 Days)|Physician Decision|0
951128|NCT00766090|3132297|P6|Washout Period 2 (14 Days)|Physician Decision|0
951129|NCT00766090|3132298|P5|Washout Period 2 (14 Days)|Physician Decision|0
951130|NCT00766090|3132299|P4|Washout Period 2 (14 Days)|Physician Decision|0
951131|NCT00766090|3132300|P3|Washout Period 2 (14 Days)|Physician Decision|1
951132|NCT00766090|3132301|P2|Washout Period 2 (14 Days)|Physician Decision|0
951133|NCT00766090|3132302|P1|Washout Period 2 (14 Days)|Physician Decision|0
951134|NCT00766090|3132291|P12|Treatment Period 2 (28 Days)|Lack of Efficacy|0
951135|NCT00766090|3132292|P11|Treatment Period 2 (28 Days)|Lack of Efficacy|0
951136|NCT00766090|3132293|P10|Treatment Period 2 (28 Days)|Lack of Efficacy|0
951137|NCT00766090|3132294|P9|Treatment Period 2 (28 Days)|Lack of Efficacy|0
951138|NCT00766090|3132295|P8|Treatment Period 2 (28 Days)|Lack of Efficacy|0
951139|NCT00766090|3132296|P7|Treatment Period 2 (28 Days)|Lack of Efficacy|0
951140|NCT00766090|3132297|P6|Treatment Period 2 (28 Days)|Lack of Efficacy|0
951141|NCT00766090|3132298|P5|Treatment Period 2 (28 Days)|Lack of Efficacy|0
951142|NCT00766090|3132299|P4|Treatment Period 2 (28 Days)|Lack of Efficacy|0
951143|NCT00766090|3132300|P3|Treatment Period 2 (28 Days)|Lack of Efficacy|1
951144|NCT00766090|3132301|P2|Treatment Period 2 (28 Days)|Lack of Efficacy|0
951145|NCT00766090|3132302|P1|Treatment Period 2 (28 Days)|Lack of Efficacy|0
951146|NCT00766090|3132291|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
951147|NCT00766090|3132292|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
951148|NCT00766090|3132293|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
951149|NCT00766090|3132294|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
951150|NCT00766090|3132295|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
951151|NCT00766090|3132296|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
951152|NCT00766090|3132297|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
951153|NCT00766090|3132298|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|2
951154|NCT00766090|3132299|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
951155|NCT00766090|3132300|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
951156|NCT00766090|3132301|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|0
951157|NCT00766090|3132302|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
951158|NCT00766090|3132291|P12|Washout Period 1 (14 Days)|Protocol Violation|0
951159|NCT00766090|3132292|P11|Washout Period 1 (14 Days)|Protocol Violation|0
951160|NCT00766090|3132293|P10|Washout Period 1 (14 Days)|Protocol Violation|0
951161|NCT00766090|3132294|P9|Washout Period 1 (14 Days)|Protocol Violation|0
951162|NCT00766090|3132295|P8|Washout Period 1 (14 Days)|Protocol Violation|0
951163|NCT00766090|3132296|P7|Washout Period 1 (14 Days)|Protocol Violation|0
951164|NCT00766090|3132297|P6|Washout Period 1 (14 Days)|Protocol Violation|0
951165|NCT00766090|3132298|P5|Washout Period 1 (14 Days)|Protocol Violation|0
951166|NCT00766090|3132299|P4|Washout Period 1 (14 Days)|Protocol Violation|0
951167|NCT00766090|3132300|P3|Washout Period 1 (14 Days)|Protocol Violation|1
951168|NCT00766090|3132301|P2|Washout Period 1 (14 Days)|Protocol Violation|0
951169|NCT00766090|3132302|P1|Washout Period 1 (14 Days)|Protocol Violation|0
951170|NCT00766090|3132291|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
951171|NCT00766090|3132292|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
951172|NCT00766090|3132293|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
951173|NCT00766090|3132294|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
951174|NCT00766090|3132295|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
951175|NCT00766090|3132296|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
951176|NCT00766090|3132297|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
951177|NCT00766090|3132298|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
951178|NCT00766090|3132299|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
951179|NCT00766090|3132300|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
951180|NCT00766090|3132301|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
951181|NCT00766090|3132302|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
951182|NCT00766090|3132291|P12|Treatment Period 1 (28 Days)|Lack of Efficacy|0
951183|NCT00766090|3132292|P11|Treatment Period 1 (28 Days)|Lack of Efficacy|0
951184|NCT00766090|3132293|P10|Treatment Period 1 (28 Days)|Lack of Efficacy|0
951185|NCT00766090|3132294|P9|Treatment Period 1 (28 Days)|Lack of Efficacy|0
951186|NCT00766090|3132295|P8|Treatment Period 1 (28 Days)|Lack of Efficacy|0
951187|NCT00766090|3132296|P7|Treatment Period 1 (28 Days)|Lack of Efficacy|0
951188|NCT00766090|3132297|P6|Treatment Period 1 (28 Days)|Lack of Efficacy|0
951189|NCT00766090|3132298|P5|Treatment Period 1 (28 Days)|Lack of Efficacy|0
951190|NCT00766090|3132299|P4|Treatment Period 1 (28 Days)|Lack of Efficacy|0
951191|NCT00766090|3132300|P3|Treatment Period 1 (28 Days)|Lack of Efficacy|0
951192|NCT00766090|3132301|P2|Treatment Period 1 (28 Days)|Lack of Efficacy|0
951193|NCT00766090|3132302|P1|Treatment Period 1 (28 Days)|Lack of Efficacy|2
951194|NCT00766090|3132291|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
951195|NCT00766090|3132292|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|0
951196|NCT00766090|3132293|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
951197|NCT00766090|3132294|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|1
951198|NCT00766090|3132295|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
951199|NCT00766090|3132296|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
951200|NCT00766090|3132297|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
951201|NCT00766090|3132298|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
951202|NCT00766090|3132299|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
951203|NCT00766090|3132300|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
951204|NCT00766090|3132301|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
951205|NCT00766090|3132302|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
951206|NCT00766051|3132343|P2|Overall Study|Withdrawal by Subject|0
951207|NCT00766051|3132344|P1|Overall Study|Withdrawal by Subject|2
951208|NCT00765882|3132375|P3|Overall Study|Other Reason|2
951209|NCT00765882|3132376|P2|Overall Study|Other Reason|1
951210|NCT00765882|3132377|P1|Overall Study|Other Reason|3
951211|NCT00765882|3132375|P3|Overall Study|Lost to Follow-up|6
951212|NCT00765882|3132376|P2|Overall Study|Lost to Follow-up|9
951213|NCT00765882|3132377|P1|Overall Study|Lost to Follow-up|1
951214|NCT00765882|3132375|P3|Overall Study|Withdrawal by Subject|6
951215|NCT00765882|3132376|P2|Overall Study|Withdrawal by Subject|6
951216|NCT00765882|3132377|P1|Overall Study|Withdrawal by Subject|2
951217|NCT00765882|3132375|P3|Overall Study|Protocol Violation|1
951218|NCT00765882|3132376|P2|Overall Study|Protocol Violation|3
951219|NCT00765882|3132377|P1|Overall Study|Protocol Violation|4
951220|NCT00765882|3132375|P3|Overall Study|Lack of Efficacy|1
951221|NCT00765882|3132376|P2|Overall Study|Lack of Efficacy|0
951222|NCT00765882|3132377|P1|Overall Study|Lack of Efficacy|4
951223|NCT00765882|3132375|P3|Overall Study|Adverse Event|20
951224|NCT00765882|3132376|P2|Overall Study|Adverse Event|21
951225|NCT00765882|3132377|P1|Overall Study|Adverse Event|10
951226|NCT00765843|3132409|P3|Overall Study|Adverse Event|1
951227|NCT00765843|3132410|P2|Overall Study|Adverse Event|0
951228|NCT00765843|3132411|P1|Overall Study|Adverse Event|0
951229|NCT00765843|3132409|P3|Overall Study|did not return to receive intervention|0
951230|NCT00765843|3132410|P2|Overall Study|did not return to receive intervention|1
951231|NCT00765843|3132411|P1|Overall Study|did not return to receive intervention|0
951232|NCT00765843|3132409|P3|Overall Study|Lost to Follow-up|2
951233|NCT00765843|3132410|P2|Overall Study|Lost to Follow-up|3
951234|NCT00765843|3132411|P1|Overall Study|Lost to Follow-up|1
951235|NCT00765817|3132421|P2|Overall Study|Subject decision|11
951236|NCT00765817|3132422|P1|Overall Study|Subject decision|7
951237|NCT00765817|3132421|P2|Overall Study|Protocol Violation|1
951238|NCT00765817|3132422|P1|Overall Study|Protocol Violation|1
951239|NCT00765817|3132421|P2|Overall Study|Physician Decision|1
951240|NCT00765817|3132422|P1|Overall Study|Physician Decision|2
951241|NCT00765817|3132421|P2|Overall Study|Lost to Follow-up|3
951242|NCT00765817|3132422|P1|Overall Study|Lost to Follow-up|1
951243|NCT00765817|3132421|P2|Overall Study|Loss of glucose control|2
951244|NCT00765817|3132422|P1|Overall Study|Loss of glucose control|0
951245|NCT00765817|3132421|P2|Overall Study|Entry criteria not met|2
951246|NCT00765817|3132422|P1|Overall Study|Entry criteria not met|2
951247|NCT00765817|3132421|P2|Overall Study|Death|1
951248|NCT00765817|3132422|P1|Overall Study|Death|0
951249|NCT00765817|3132421|P2|Overall Study|Adverse Event|1
951250|NCT00765817|3132422|P1|Overall Study|Adverse Event|13
951251|NCT00765726|3132470|P1|Overall Study|Discontinuation of study by sponsor|8
951252|NCT00765726|3132470|P1|Overall Study|Withdrawal by Subject|1
951343|NCT00764946|3132750|P3|Overall Study|Physician Decision|0
951253|NCT00765674|3132478|P4|Overall Study|Randomized in Error - No Study Drug|1
951254|NCT00765674|3132479|P3|Overall Study|Randomized in Error - No Study Drug|0
951255|NCT00765674|3132480|P2|Overall Study|Randomized in Error - No Study Drug|1
951256|NCT00765674|3132481|P1|Overall Study|Randomized in Error - No Study Drug|0
951257|NCT00765674|3132478|P4|Overall Study|Lost to Follow-up|1
951258|NCT00765674|3132479|P3|Overall Study|Lost to Follow-up|2
951259|NCT00765674|3132480|P2|Overall Study|Lost to Follow-up|6
951260|NCT00765674|3132481|P1|Overall Study|Lost to Follow-up|4
951261|NCT00765674|3132478|P4|Overall Study|Withdrawal by Subject|8
951262|NCT00765674|3132479|P3|Overall Study|Withdrawal by Subject|3
951263|NCT00765674|3132480|P2|Overall Study|Withdrawal by Subject|7
951264|NCT00765674|3132481|P1|Overall Study|Withdrawal by Subject|5
951265|NCT00765674|3132478|P4|Overall Study|Protocol Violation|0
951266|NCT00765674|3132479|P3|Overall Study|Protocol Violation|1
951267|NCT00765674|3132480|P2|Overall Study|Protocol Violation|0
951268|NCT00765674|3132481|P1|Overall Study|Protocol Violation|2
951269|NCT00765674|3132478|P4|Overall Study|Lack of Efficacy|2
951270|NCT00765674|3132479|P3|Overall Study|Lack of Efficacy|1
951271|NCT00765674|3132480|P2|Overall Study|Lack of Efficacy|3
951272|NCT00765674|3132481|P1|Overall Study|Lack of Efficacy|2
951273|NCT00765674|3132478|P4|Overall Study|Abnormal Test Procedure Result(s)|2
951274|NCT00765674|3132479|P3|Overall Study|Abnormal Test Procedure Result(s)|1
951275|NCT00765674|3132480|P2|Overall Study|Abnormal Test Procedure Result(s)|3
951276|NCT00765674|3132481|P1|Overall Study|Abnormal Test Procedure Result(s)|1
951277|NCT00765674|3132478|P4|Overall Study|Abnormal Laboratory Value(s)|0
951278|NCT00765674|3132479|P3|Overall Study|Abnormal Laboratory Value(s)|1
951279|NCT00765674|3132480|P2|Overall Study|Abnormal Laboratory Value(s)|0
951280|NCT00765674|3132481|P1|Overall Study|Abnormal Laboratory Value(s)|0
951281|NCT00765674|3132478|P4|Overall Study|Adverse Event|11
951282|NCT00765674|3132479|P3|Overall Study|Adverse Event|8
951283|NCT00765674|3132480|P2|Overall Study|Adverse Event|2
951284|NCT00765674|3132481|P1|Overall Study|Adverse Event|7
951285|NCT00765388|3132548|P2|Period 1|Hip operation|1
951286|NCT00765388|3132549|P1|Period 1|Hip operation|0
951287|NCT00765388|3132548|P2|Period 1|Herpes Zoster|1
951288|NCT00765388|3132549|P1|Period 1|Herpes Zoster|0
951289|NCT00765388|3132548|P2|Period 1|Lost to Follow-up|1
951290|NCT00765388|3132549|P1|Period 1|Lost to Follow-up|0
951291|NCT00765388|3132548|P2|Period 1|Lack of Efficacy|2
951292|NCT00765388|3132549|P1|Period 1|Lack of Efficacy|1
951293|NCT00765362|3132583|P1|Overall Study|Lost to Follow-up|95
951294|NCT00765362|3132583|P1|Overall Study|Withdrawal by Subject|13
951295|NCT00765362|3132583|P1|Overall Study|Protocol Violation|18
951296|NCT00765362|3132583|P1|Overall Study|Adverse Event|2
951297|NCT00765362|3132583|P1|Overall Study|Death|9
951298|NCT00765336|3132591|P2|Overall Study|Adverse Event|1
951299|NCT00765336|3132592|P1|Overall Study|Adverse Event|2
951300|NCT00765336|3132591|P2|Overall Study|Lost to Follow-up|9
951301|NCT00765336|3132592|P1|Overall Study|Lost to Follow-up|7
951302|NCT00765336|3132591|P2|Overall Study|Withdrawal by Subject|4
951303|NCT00765336|3132592|P1|Overall Study|Withdrawal by Subject|6
951304|NCT00765336|3132591|P2|Overall Study|Protocol Violation|2
951305|NCT00765336|3132592|P1|Overall Study|Protocol Violation|4
951306|NCT00765245|3132600|P2|Overall Study|Death|0
951307|NCT00765245|3132601|P1|Overall Study|Death|1
951308|NCT00765245|3132600|P2|Overall Study|Physician Decision|0
951309|NCT00765245|3132601|P1|Overall Study|Physician Decision|1
951310|NCT00765245|3132600|P2|Overall Study|Adverse Event|0
951311|NCT00765245|3132601|P1|Overall Study|Adverse Event|5
951312|NCT00765245|3132600|P2|Overall Study|Withdrawal by Subject|0
951313|NCT00765245|3132601|P1|Overall Study|Withdrawal by Subject|3
951314|NCT00765245|3132600|P2|Overall Study|disease progression|2
951315|NCT00765245|3132601|P1|Overall Study|disease progression|3
951316|NCT00765102|3132647|P1|Overall Study|Protocol Violation|1
951317|NCT00765102|3132647|P1|Overall Study|Withdrawal by Subject|2
951318|NCT00765102|3132647|P1|Overall Study|Physician Decision|4
951319|NCT00765102|3132647|P1|Overall Study|Adverse Event|6
951320|NCT00765102|3132647|P1|Overall Study|Progressive disease|18
951321|NCT00765076|3132672|P3|Overall Study|Withdrawal by Subject|1
951322|NCT00765076|3132673|P2|Overall Study|Withdrawal by Subject|0
951323|NCT00765076|3132674|P1|Overall Study|Withdrawal by Subject|0
951324|NCT00765076|3132672|P3|Overall Study|Adverse Event|0
951325|NCT00765076|3132673|P2|Overall Study|Adverse Event|0
951326|NCT00765076|3132674|P1|Overall Study|Adverse Event|1
951327|NCT00765063|3132727|P1|Overall Study|Adverse Event|4
951328|NCT00765063|3132727|P1|Overall Study|Protocol Violation|6
951329|NCT00765063|3132727|P1|Overall Study|Other|16
951330|NCT00765063|3132727|P1|Overall Study|Withdrawal by Subject|1
951331|NCT00765063|3132727|P1|Overall Study|Lack of Efficacy|5
951332|NCT00765037|3132743|P1|Overall Study|Adverse Event|1
951333|NCT00765037|3132743|P1|Overall Study|Lost to Follow-up|5
951334|NCT00764946|3132750|P3|Overall Study|Never Treated|1
951335|NCT00764946|3132751|P2|Overall Study|Never Treated|1
951336|NCT00764946|3132752|P1|Overall Study|Never Treated|1
951337|NCT00764946|3132750|P3|Overall Study|Withdrawal by Subject|2
951338|NCT00764946|3132751|P2|Overall Study|Withdrawal by Subject|6
951339|NCT00764946|3132752|P1|Overall Study|Withdrawal by Subject|3
951340|NCT00764946|3132750|P3|Overall Study|Adverse Event|1
951341|NCT00764946|3132751|P2|Overall Study|Adverse Event|2
951342|NCT00764946|3132752|P1|Overall Study|Adverse Event|3
951344|NCT00764946|3132751|P2|Overall Study|Physician Decision|4
951345|NCT00764946|3132752|P1|Overall Study|Physician Decision|2
951346|NCT00764946|3132750|P3|Overall Study|Lost to Follow-up|0
951347|NCT00764946|3132751|P2|Overall Study|Lost to Follow-up|4
951348|NCT00764946|3132752|P1|Overall Study|Lost to Follow-up|3
951349|NCT00764946|3132750|P3|Overall Study|Lack of Efficacy|0
951350|NCT00764946|3132751|P2|Overall Study|Lack of Efficacy|0
951351|NCT00764946|3132752|P1|Overall Study|Lack of Efficacy|1
951352|NCT00764881|3132780|P2|Overall Study|no treatment or no observation|2
951353|NCT00764881|3132781|P1|Overall Study|no treatment or no observation|2
951354|NCT00764881|3132780|P2|Overall Study|Possibly noncompliant (study drug)|2
951355|NCT00764881|3132781|P1|Overall Study|Possibly noncompliant (study drug)|0
951356|NCT00764881|3132780|P2|Overall Study|Carcinoma detected|0
951357|NCT00764881|3132781|P1|Overall Study|Carcinoma detected|1
951358|NCT00764881|3132780|P2|Overall Study|Wished to become pregnant|0
951359|NCT00764881|3132781|P1|Overall Study|Wished to become pregnant|1
951360|NCT00764881|3132780|P2|Overall Study|Accidentally discontinued study drug|0
951361|NCT00764881|3132781|P1|Overall Study|Accidentally discontinued study drug|1
951362|NCT00764881|3132780|P2|Overall Study|Noncompliant|0
951363|NCT00764881|3132781|P1|Overall Study|Noncompliant|1
951364|NCT00764881|3132780|P2|Overall Study|Lost to Follow-up|0
951365|NCT00764881|3132781|P1|Overall Study|Lost to Follow-up|2
951366|NCT00764881|3132780|P2|Overall Study|Protocol Violation|2
951367|NCT00764881|3132781|P1|Overall Study|Protocol Violation|2
951368|NCT00764881|3132780|P2|Overall Study|Withdrawal by Subject|3
951369|NCT00764881|3132781|P1|Overall Study|Withdrawal by Subject|1
951370|NCT00764881|3132780|P2|Overall Study|Adverse Event|1
951371|NCT00764881|3132781|P1|Overall Study|Adverse Event|5
951372|NCT00764868|3133005|P1|Overall Study|Sponsor requested withdrawal|1
951373|NCT00764868|3133005|P1|Overall Study|Positive drug screen|2
951374|NCT00764868|3133005|P1|Overall Study|Met an exclusion criteria|1
951375|NCT00764868|3133005|P1|Overall Study|Subject sent to boarding school|1
951376|NCT00764868|3133005|P1|Overall Study|Misuse and compliance of study drug|1
951377|NCT00764868|3133005|P1|Overall Study|Out of town|1
951378|NCT00764868|3133005|P1|Overall Study|Prohibited medication|1
951379|NCT00764868|3133005|P1|Overall Study|Pregnancy|3
951380|NCT00764868|3133005|P1|Overall Study|Subject moved|7
951381|NCT00764868|3133005|P1|Overall Study|Lack of Efficacy|5
951382|NCT00764868|3133005|P1|Overall Study|Lost to Follow-up|25
951383|NCT00764868|3133005|P1|Overall Study|Non-compliance|16
951384|NCT00764868|3133005|P1|Overall Study|Withdrawal by Subject|31
951385|NCT00764868|3133005|P1|Overall Study|Adverse Event|18
951386|NCT00764790|3133014|P3|Overall Study|Lost to Follow-up|23
951387|NCT00764790|3133015|P2|Overall Study|Lost to Follow-up|29
951388|NCT00764790|3133016|P1|Overall Study|Lost to Follow-up|28
951389|NCT00764790|3133014|P3|Overall Study|Withdrawal by Subject|6
951390|NCT00764790|3133015|P2|Overall Study|Withdrawal by Subject|12
951391|NCT00764790|3133016|P1|Overall Study|Withdrawal by Subject|10
951392|NCT00764790|3133014|P3|Overall Study|Protocol Violation|1
951393|NCT00764790|3133015|P2|Overall Study|Protocol Violation|0
951394|NCT00764790|3133016|P1|Overall Study|Protocol Violation|0
951395|NCT00764699|3133048|P1|Overall Study|PI left and study terminated|3
951396|NCT00764673|3133052|P1|Overall Study|Revision of Device|2
951397|NCT00764673|3133052|P1|Overall Study|Withdrawal by Subject|6
951398|NCT00764673|3133052|P1|Overall Study|Lost to Follow-up|3
951399|NCT00764673|3133052|P1|Overall Study|Death|1
951400|NCT00764660|3133062|P2|Overall Study|Did Not Meet Protocol Eligibility|0
951401|NCT00764660|3133063|P1|Overall Study|Did Not Meet Protocol Eligibility|1
951402|NCT00764660|3133062|P2|Overall Study|Noncompliance With Protocol|1
951403|NCT00764660|3133063|P1|Overall Study|Noncompliance With Protocol|5
951404|NCT00764660|3133062|P2|Overall Study|Withdrawal by Subject|3
951405|NCT00764660|3133063|P1|Overall Study|Withdrawal by Subject|7
951406|NCT00764660|3133062|P2|Overall Study|Lost to Follow-up|4
951407|NCT00764660|3133063|P1|Overall Study|Lost to Follow-up|3
951408|NCT00764660|3133062|P2|Overall Study|Adverse Event|3
951409|NCT00764660|3133063|P1|Overall Study|Adverse Event|6
951410|NCT00764517|3133097|P2|Overall Study|Physician Decision|0
951411|NCT00764517|3133098|P1|Overall Study|Physician Decision|3
951412|NCT00764517|3133097|P2|Overall Study|Death|11
951413|NCT00764517|3133098|P1|Overall Study|Death|3
951414|NCT00764517|3133097|P2|Overall Study|Adverse Event|3
951415|NCT00764517|3133098|P1|Overall Study|Adverse Event|9
951416|NCT00764504|3133119|P3|Overall Study|Lost to Follow-up|72
951417|NCT00764504|3133120|P2|Overall Study|Lost to Follow-up|34
951418|NCT00764504|3133121|P1|Overall Study|Lost to Follow-up|40
951419|NCT00764504|3133119|P3|Overall Study|Withdrawal by Subject|4
951420|NCT00764504|3133120|P2|Overall Study|Withdrawal by Subject|7
951421|NCT00764504|3133121|P1|Overall Study|Withdrawal by Subject|1
951422|NCT00764504|3133119|P3|Overall Study|Physician Decision|0
951423|NCT00764504|3133120|P2|Overall Study|Physician Decision|0
951424|NCT00764504|3133121|P1|Overall Study|Physician Decision|1
951425|NCT00764504|3133119|P3|Overall Study|Revision of Device|14
951426|NCT00764504|3133120|P2|Overall Study|Revision of Device|23
951427|NCT00764504|3133121|P1|Overall Study|Revision of Device|12
951428|NCT00764504|3133119|P3|Overall Study|Death|13
951429|NCT00764504|3133120|P2|Overall Study|Death|6
951430|NCT00764504|3133121|P1|Overall Study|Death|12
951431|NCT00764478|3133150|P3|Overall Study|Protocol Violation|1
951432|NCT00764478|3133151|P2|Overall Study|Protocol Violation|1
951433|NCT00764478|3133152|P1|Overall Study|Protocol Violation|0
951434|NCT00764478|3133150|P3|Overall Study|Lost to Follow-up|5
951435|NCT00764478|3133151|P2|Overall Study|Lost to Follow-up|8
951436|NCT00764478|3133152|P1|Overall Study|Lost to Follow-up|7
951437|NCT00764478|3133150|P3|Overall Study|Withdrawal by Subject|1
951438|NCT00764478|3133151|P2|Overall Study|Withdrawal by Subject|12
951439|NCT00764478|3133152|P1|Overall Study|Withdrawal by Subject|7
951440|NCT00764478|3133150|P3|Overall Study|Adverse Event|1
951441|NCT00764478|3133151|P2|Overall Study|Adverse Event|1
951442|NCT00764478|3133152|P1|Overall Study|Adverse Event|1
951443|NCT00764465|3133232|P6|Overall Study|Withdrawal by Subject|0
951444|NCT00764465|3133233|P5|Overall Study|Withdrawal by Subject|0
951445|NCT00764465|3133234|P4|Overall Study|Withdrawal by Subject|0
951446|NCT00764465|3133235|P3|Overall Study|Withdrawal by Subject|1
951447|NCT00764465|3133236|P2|Overall Study|Withdrawal by Subject|1
951448|NCT00764465|3133237|P1|Overall Study|Withdrawal by Subject|0
951449|NCT00764465|3133232|P6|Overall Study|Adverse Event|1
951450|NCT00764465|3133233|P5|Overall Study|Adverse Event|1
951451|NCT00764465|3133234|P4|Overall Study|Adverse Event|1
951452|NCT00764465|3133235|P3|Overall Study|Adverse Event|0
951453|NCT00764465|3133236|P2|Overall Study|Adverse Event|0
951454|NCT00764465|3133237|P1|Overall Study|Adverse Event|2
951455|NCT00764361|3133265|P2|Overall Study|Adverse Event|1
951456|NCT00764361|3133266|P1|Overall Study|Adverse Event|0
951457|NCT00764361|3133265|P2|Overall Study|Withdrawal by Subject|3
951458|NCT00764361|3133266|P1|Overall Study|Withdrawal by Subject|2
951459|NCT00764322|3133274|P1|Overall Study|No CYP2D6 genotyping|9
951460|NCT00764322|3133274|P1|Overall Study|Withdrawal by Subject|11
951461|NCT00763971|3133301|P3|Overall Study|Participation in 489-326 required|0
951462|NCT00763971|3133302|P2|Overall Study|Participation in 489-326 required|0
951463|NCT00763971|3133303|P1|Overall Study|Participation in 489-326 required|1
951464|NCT00763971|3133301|P3|Overall Study|Performed final visit on phone|0
951465|NCT00763971|3133302|P2|Overall Study|Performed final visit on phone|1
951466|NCT00763971|3133303|P1|Overall Study|Performed final visit on phone|0
951467|NCT00763971|3133301|P3|Overall Study|Lack of availability|0
951468|NCT00763971|3133302|P2|Overall Study|Lack of availability|1
951469|NCT00763971|3133303|P1|Overall Study|Lack of availability|0
951470|NCT00763971|3133301|P3|Overall Study|Subject wanted dose reduction|0
951471|NCT00763971|3133302|P2|Overall Study|Subject wanted dose reduction|1
951472|NCT00763971|3133303|P1|Overall Study|Subject wanted dose reduction|0
951473|NCT00763971|3133301|P3|Overall Study|Moved to another country|0
951474|NCT00763971|3133302|P2|Overall Study|Moved to another country|1
951475|NCT00763971|3133303|P1|Overall Study|Moved to another country|0
951476|NCT00763971|3133301|P3|Overall Study|Medical monitor decision|1
951477|NCT00763971|3133302|P2|Overall Study|Medical monitor decision|0
951478|NCT00763971|3133303|P1|Overall Study|Medical monitor decision|0
951479|NCT00763971|3133301|P3|Overall Study|Randomization error|1
951480|NCT00763971|3133302|P2|Overall Study|Randomization error|0
951481|NCT00763971|3133303|P1|Overall Study|Randomization error|0
951482|NCT00763971|3133301|P3|Overall Study|Due to holiday season|1
951483|NCT00763971|3133302|P2|Overall Study|Due to holiday season|0
951484|NCT00763971|3133303|P1|Overall Study|Due to holiday season|2
951485|NCT00763971|3133301|P3|Overall Study|Sponsor decision|0
951486|NCT00763971|3133302|P2|Overall Study|Sponsor decision|0
951487|NCT00763971|3133303|P1|Overall Study|Sponsor decision|1
951488|NCT00763971|3133301|P3|Overall Study|Exclusion criteria met|0
951489|NCT00763971|3133302|P2|Overall Study|Exclusion criteria met|0
951490|NCT00763971|3133303|P1|Overall Study|Exclusion criteria met|1
951491|NCT00763971|3133301|P3|Overall Study|Personal reason|0
951492|NCT00763971|3133302|P2|Overall Study|Personal reason|0
951493|NCT00763971|3133303|P1|Overall Study|Personal reason|3
951494|NCT00763971|3133301|P3|Overall Study|Unable to swallow capsule|1
951495|NCT00763971|3133302|P2|Overall Study|Unable to swallow capsule|1
951496|NCT00763971|3133303|P1|Overall Study|Unable to swallow capsule|2
951497|NCT00763971|3133301|P3|Overall Study|Lack of Efficacy|54
951498|NCT00763971|3133302|P2|Overall Study|Lack of Efficacy|22
951499|NCT00763971|3133303|P1|Overall Study|Lack of Efficacy|11
951500|NCT00763971|3133301|P3|Overall Study|Lost to Follow-up|0
951501|NCT00763971|3133302|P2|Overall Study|Lost to Follow-up|1
951502|NCT00763971|3133303|P1|Overall Study|Lost to Follow-up|0
951503|NCT00763971|3133301|P3|Overall Study|Withdrawal by Subject|5
951504|NCT00763971|3133302|P2|Overall Study|Withdrawal by Subject|5
951505|NCT00763971|3133303|P1|Overall Study|Withdrawal by Subject|4
951506|NCT00763971|3133301|P3|Overall Study|Protocol Violation|2
951507|NCT00763971|3133302|P2|Overall Study|Protocol Violation|3
951508|NCT00763971|3133303|P1|Overall Study|Protocol Violation|3
951509|NCT00763971|3133301|P3|Overall Study|Adverse Event|4
951510|NCT00763971|3133302|P2|Overall Study|Adverse Event|2
951511|NCT00763971|3133303|P1|Overall Study|Adverse Event|5
951512|NCT00763958|3133334|P2|Overall Study|Believed they were receiving placebo|5
951513|NCT00763958|3133335|P1|Overall Study|Believed they were receiving placebo|0
951514|NCT00763958|3133334|P2|Overall Study|Lost to Follow-up|2
951515|NCT00763958|3133335|P1|Overall Study|Lost to Follow-up|10
951516|NCT00763958|3133334|P2|Overall Study|did not meet final criteria|4
951517|NCT00763958|3133335|P1|Overall Study|did not meet final criteria|4
951518|NCT00763815|3133470|P2|Overall Study|Sponsor's Decision|1
951519|NCT00763815|3133471|P1|Overall Study|Sponsor's Decision|0
951520|NCT00763815|3133470|P2|Overall Study|Protocol Violation|5
951521|NCT00763815|3133471|P1|Overall Study|Protocol Violation|2
951522|NCT00763815|3133470|P2|Overall Study|Withdrawal by Subject|12
951523|NCT00763815|3133471|P1|Overall Study|Withdrawal by Subject|7
951524|NCT00763815|3133470|P2|Overall Study|Physician Decision|0
951525|NCT00763815|3133471|P1|Overall Study|Physician Decision|1
951526|NCT00763815|3133470|P2|Overall Study|Familial and Personal Reasons|16
951527|NCT00763815|3133471|P1|Overall Study|Familial and Personal Reasons|9
951528|NCT00763815|3133470|P2|Overall Study|Early Termination|0
951529|NCT00763815|3133471|P1|Overall Study|Early Termination|1
951530|NCT00763815|3133470|P2|Overall Study|Lost to Follow-up|4
951531|NCT00763815|3133471|P1|Overall Study|Lost to Follow-up|2
951532|NCT00763815|3133470|P2|Overall Study|Poor Compliance to Protocol|6
951533|NCT00763815|3133471|P1|Overall Study|Poor Compliance to Protocol|6
951534|NCT00763815|3133470|P2|Overall Study|Lack of Efficacy|11
951535|NCT00763815|3133471|P1|Overall Study|Lack of Efficacy|10
951536|NCT00763815|3133470|P2|Overall Study|Adverse Event|29
951537|NCT00763815|3133471|P1|Overall Study|Adverse Event|14
951538|NCT00763698|3133499|P1|Overall Study|Withdrawal by Subject|1
951539|NCT00763698|3133499|P1|Overall Study|Death|4
951540|NCT00763698|3133499|P1|Overall Study|Unsuccessful Implant|5
951541|NCT00763451|3133516|P4|Overall Study|Study Site Reason|1
951542|NCT00763451|3133517|P3|Overall Study|Study Site Reason|1
951543|NCT00763451|3133518|P2|Overall Study|Study Site Reason|1
951544|NCT00763451|3133519|P1|Overall Study|Study Site Reason|0
951545|NCT00763451|3133516|P4|Overall Study|Randomized but not Treated|0
951546|NCT00763451|3133517|P3|Overall Study|Randomized but not Treated|0
951547|NCT00763451|3133518|P2|Overall Study|Randomized but not Treated|1
951548|NCT00763451|3133519|P1|Overall Study|Randomized but not Treated|1
951549|NCT00763451|3133516|P4|Overall Study|Familial and Personal Reasons|4
951550|NCT00763451|3133517|P3|Overall Study|Familial and Personal Reasons|5
951551|NCT00763451|3133518|P2|Overall Study|Familial and Personal Reasons|3
951552|NCT00763451|3133519|P1|Overall Study|Familial and Personal Reasons|5
951553|NCT00763451|3133516|P4|Overall Study|Poor Compliance to Protocol|2
951554|NCT00763451|3133517|P3|Overall Study|Poor Compliance to Protocol|2
951555|NCT00763451|3133518|P2|Overall Study|Poor Compliance to Protocol|1
951556|NCT00763451|3133519|P1|Overall Study|Poor Compliance to Protocol|1
951557|NCT00763451|3133516|P4|Overall Study|Protocol Violation|0
951558|NCT00763451|3133517|P3|Overall Study|Protocol Violation|1
951559|NCT00763451|3133518|P2|Overall Study|Protocol Violation|0
951560|NCT00763451|3133519|P1|Overall Study|Protocol Violation|0
951561|NCT00763451|3133516|P4|Overall Study|Withdrawal by Subject|7
951562|NCT00763451|3133517|P3|Overall Study|Withdrawal by Subject|9
951563|NCT00763451|3133518|P2|Overall Study|Withdrawal by Subject|6
951564|NCT00763451|3133519|P1|Overall Study|Withdrawal by Subject|1
951565|NCT00763451|3133516|P4|Overall Study|Lack of Efficacy|2
951566|NCT00763451|3133517|P3|Overall Study|Lack of Efficacy|3
951567|NCT00763451|3133518|P2|Overall Study|Lack of Efficacy|4
951568|NCT00763451|3133519|P1|Overall Study|Lack of Efficacy|1
951569|NCT00763451|3133516|P4|Overall Study|Adverse Event|14
951570|NCT00763451|3133517|P3|Overall Study|Adverse Event|19
951571|NCT00763451|3133518|P2|Overall Study|Adverse Event|6
951572|NCT00763451|3133519|P1|Overall Study|Adverse Event|4
951573|NCT00763386|3133578|P2|Overall Study|Study Prosthesis Removed|0
951574|NCT00763386|3133579|P1|Overall Study|Study Prosthesis Removed|1
951575|NCT00763386|3133578|P2|Overall Study|CRF missing|1
951576|NCT00763386|3133579|P1|Overall Study|CRF missing|0
951577|NCT00763386|3133578|P2|Overall Study|Withdrawal by Subject|1
951578|NCT00763386|3133579|P1|Overall Study|Withdrawal by Subject|0
951579|NCT00763386|3133578|P2|Overall Study|Lost to Follow-up|3
951580|NCT00763386|3133579|P1|Overall Study|Lost to Follow-up|3
951581|NCT00763386|3133578|P2|Overall Study|Death|2
951582|NCT00763386|3133579|P1|Overall Study|Death|1
951583|NCT00763386|3133578|P2|Overall Study|Adverse Event|33
951584|NCT00763386|3133579|P1|Overall Study|Adverse Event|43
951585|NCT00763321|3133612|P3|Double-blind Period|Not specified|3
951586|NCT00763321|3133613|P2|Double-blind Period|Not specified|2
951587|NCT00763321|3133614|P1|Double-blind Period|Not specified|0
951588|NCT00763321|3133612|P3|Double-blind Period|Withdrawal by Subject|3
951589|NCT00763321|3133613|P2|Double-blind Period|Withdrawal by Subject|2
951590|NCT00763321|3133614|P1|Double-blind Period|Withdrawal by Subject|0
951591|NCT00763321|3133612|P3|Double-blind Period|Lost to Follow-up|2
951592|NCT00763321|3133613|P2|Double-blind Period|Lost to Follow-up|4
951593|NCT00763321|3133614|P1|Double-blind Period|Lost to Follow-up|0
951594|NCT00763321|3133612|P3|Double-blind Period|Adverse Event|4
951595|NCT00763321|3133613|P2|Double-blind Period|Adverse Event|4
951596|NCT00763321|3133614|P1|Double-blind Period|Adverse Event|0
951597|NCT00763321|3133612|P3|Double-blind Period|Lack of Efficacy|17
951598|NCT00763321|3133613|P2|Double-blind Period|Lack of Efficacy|9
951599|NCT00763321|3133614|P1|Double-blind Period|Lack of Efficacy|0
951600|NCT00763321|3133612|P3|Open-label Period|Not specified|0
951601|NCT00763321|3133613|P2|Open-label Period|Not specified|0
951602|NCT00763321|3133614|P1|Open-label Period|Not specified|4
951603|NCT00763321|3133612|P3|Open-label Period|Lack of Efficacy|0
951604|NCT00763321|3133613|P2|Open-label Period|Lack of Efficacy|0
951605|NCT00763321|3133614|P1|Open-label Period|Lack of Efficacy|2
951767|NCT00762411|3134243|P1|Delayed Start|Caregiver Decision|1
951606|NCT00763321|3133612|P3|Open-label Period|Did not meet DB randomization criteria|0
951607|NCT00763321|3133613|P2|Open-label Period|Did not meet DB randomization criteria|0
951608|NCT00763321|3133614|P1|Open-label Period|Did not meet DB randomization criteria|5
951609|NCT00763321|3133612|P3|Open-label Period|Subject noncompliant|0
951610|NCT00763321|3133613|P2|Open-label Period|Subject noncompliant|0
951611|NCT00763321|3133614|P1|Open-label Period|Subject noncompliant|7
951612|NCT00763321|3133612|P3|Open-label Period|Withdrawal by Subject|0
951613|NCT00763321|3133613|P2|Open-label Period|Withdrawal by Subject|0
951614|NCT00763321|3133614|P1|Open-label Period|Withdrawal by Subject|7
951615|NCT00763321|3133612|P3|Open-label Period|Lost to Follow-up|0
951616|NCT00763321|3133613|P2|Open-label Period|Lost to Follow-up|0
951617|NCT00763321|3133614|P1|Open-label Period|Lost to Follow-up|14
951618|NCT00763321|3133612|P3|Open-label Period|Adverse Event|0
951619|NCT00763321|3133613|P2|Open-label Period|Adverse Event|0
951620|NCT00763321|3133614|P1|Open-label Period|Adverse Event|24
951621|NCT00763282|3133625|P2|Overall Study|Lost to Follow-up|26
951622|NCT00763282|3133626|P1|Overall Study|Lost to Follow-up|22
951623|NCT00763282|3133625|P2|Overall Study|Death|3
951624|NCT00763282|3133626|P1|Overall Study|Death|4
951625|NCT00763282|3133625|P2|Overall Study|Withdrawal by Subject|5
951626|NCT00763282|3133626|P1|Overall Study|Withdrawal by Subject|6
951627|NCT00763269|3133642|P2|Overall Study|Lost to Follow-up|13
951628|NCT00763269|3133643|P1|Overall Study|Lost to Follow-up|12
951629|NCT00763256|3133657|P2|Overall Study|Didn't return for appointments|10
951630|NCT00763256|3133658|P1|Overall Study|Didn't return for appointments|7
951631|NCT00763139|3133694|P2|Overall Study|med change not allowed by protocol|0
951632|NCT00763139|3133695|P1|Overall Study|med change not allowed by protocol|1
951633|NCT00763139|3133694|P2|Overall Study|Withdrawal by Subject|1
951634|NCT00763139|3133695|P1|Overall Study|Withdrawal by Subject|0
951635|NCT00763139|3133694|P2|Overall Study|Adverse Event|2
951636|NCT00763139|3133695|P1|Overall Study|Adverse Event|4
951637|NCT00763035|3133757|P2|Second Intervention|Physician Decision|0
951638|NCT00763035|3133758|P1|Second Intervention|Physician Decision|2
951639|NCT00763035|3133757|P2|Second Intervention|Adverse Event|0
951640|NCT00763035|3133758|P1|Second Intervention|Adverse Event|1
951641|NCT00763035|3133757|P2|First Intervention|Adverse Event|1
951642|NCT00763035|3133758|P1|First Intervention|Adverse Event|0
951643|NCT00763035|3133757|P2|First Intervention|Did not meeting inclusion/exclusion|0
951644|NCT00763035|3133758|P1|First Intervention|Did not meeting inclusion/exclusion|1
951645|NCT00763009|3133776|P1|Overall Study|Coronary Anatomy unsuitable|1
951646|NCT00762996|3133781|P4|Period One|Withdrawal by Subject|0
951647|NCT00762996|3133782|P3|Period One|Withdrawal by Subject|1
951648|NCT00762996|3133783|P2|Period One|Withdrawal by Subject|0
951649|NCT00762996|3133784|P1|Period One|Withdrawal by Subject|0
951650|NCT00762996|3133781|P4|Period One|Adverse Event|0
951651|NCT00762996|3133782|P3|Period One|Adverse Event|1
951652|NCT00762996|3133783|P2|Period One|Adverse Event|0
951653|NCT00762996|3133784|P1|Period One|Adverse Event|0
951654|NCT00762996|3133781|P4|Period One|ineligible|1
951655|NCT00762996|3133782|P3|Period One|ineligible|1
951656|NCT00762996|3133783|P2|Period One|ineligible|0
951657|NCT00762996|3133784|P1|Period One|ineligible|0
951658|NCT00762996|3133781|P4|Period One|Protocol Violation|0
951659|NCT00762996|3133782|P3|Period One|Protocol Violation|1
951660|NCT00762996|3133783|P2|Period One|Protocol Violation|0
951661|NCT00762996|3133784|P1|Period One|Protocol Violation|0
951662|NCT00762970|3133797|P3|Overall Study|Difficulty of handling lens|0
951663|NCT00762970|3133798|P2|Overall Study|Difficulty of handling lens|2
951664|NCT00762970|3133799|P1|Overall Study|Difficulty of handling lens|1
951665|NCT00762970|3133797|P3|Overall Study|Lost to Follow-up|0
951666|NCT00762970|3133798|P2|Overall Study|Lost to Follow-up|2
951667|NCT00762970|3133799|P1|Overall Study|Lost to Follow-up|1
951668|NCT00762970|3133797|P3|Overall Study|Protocol Violation|1
951669|NCT00762970|3133798|P2|Overall Study|Protocol Violation|1
951670|NCT00762970|3133799|P1|Overall Study|Protocol Violation|3
951671|NCT00762970|3133797|P3|Overall Study|Withdrawal by Subject|0
951672|NCT00762970|3133798|P2|Overall Study|Withdrawal by Subject|4
951673|NCT00762970|3133799|P1|Overall Study|Withdrawal by Subject|7
951674|NCT00762892|3133817|P2|Overall Study|Incarceration|0
951675|NCT00762892|3133818|P1|Overall Study|Incarceration|1
951676|NCT00762892|3133817|P2|Overall Study|Pregnancy|0
951677|NCT00762892|3133818|P1|Overall Study|Pregnancy|1
951678|NCT00762892|3133817|P2|Overall Study|Death|0
951679|NCT00762892|3133818|P1|Overall Study|Death|1
951680|NCT00762892|3133817|P2|Overall Study|Withdrawal by Subject|1
951681|NCT00762892|3133818|P1|Overall Study|Withdrawal by Subject|0
951682|NCT00762892|3133817|P2|Overall Study|Lost to Follow-up|5
951683|NCT00762892|3133818|P1|Overall Study|Lost to Follow-up|2
951684|NCT00762788|3133847|P6|Overall Study|Lost to Follow-up|21
951685|NCT00762788|3133848|P5|Overall Study|Lost to Follow-up|13
951686|NCT00762788|3133849|P4|Overall Study|Lost to Follow-up|26
951687|NCT00762788|3133850|P3|Overall Study|Lost to Follow-up|21
951688|NCT00762788|3133851|P2|Overall Study|Lost to Follow-up|37
951689|NCT00762788|3133852|P1|Overall Study|Lost to Follow-up|26
951690|NCT00762762|3133874|P2|Overall Study|Did not report for appointments|10
951691|NCT00762762|3133875|P1|Overall Study|Did not report for appointments|8
951692|NCT00762723|3133892|P3|Overall Study|Study Terminated slow enrollement|3
951693|NCT00762723|3133893|P2|Overall Study|Study Terminated slow enrollement|5
951694|NCT00762723|3133894|P1|Overall Study|Study Terminated slow enrollement|5
951695|NCT00762606|3134058|P2|Overall Study|Lost to Follow-up|13
951696|NCT00762606|3134059|P1|Overall Study|Lost to Follow-up|18
951697|NCT00762502|3134104|P3|Month 3 to Month 6 (Period 2)|Pregnancy|0
951698|NCT00762502|3134105|P2|Month 3 to Month 6 (Period 2)|Pregnancy|1
951699|NCT00762502|3134106|P1|Month 3 to Month 6 (Period 2)|Pregnancy|0
951700|NCT00762502|3134104|P3|Baseline to Month 3 (Period 1)|Lost to Follow-up|13
951701|NCT00762502|3134105|P2|Baseline to Month 3 (Period 1)|Lost to Follow-up|3
951702|NCT00762502|3134106|P1|Baseline to Month 3 (Period 1)|Lost to Follow-up|6
951703|NCT00762502|3134104|P3|Baseline to Month 3 (Period 1)|Adverse Event|6
951704|NCT00762502|3134105|P2|Baseline to Month 3 (Period 1)|Adverse Event|3
951705|NCT00762502|3134106|P1|Baseline to Month 3 (Period 1)|Adverse Event|4
951706|NCT00762476|3134120|P2|Overall Study|Seasonal allergies|0
951707|NCT00762476|3134121|P1|Overall Study|Seasonal allergies|1
951708|NCT00762476|3134120|P2|Overall Study|non-compliance with study visits|2
951709|NCT00762476|3134121|P1|Overall Study|non-compliance with study visits|0
951710|NCT00762476|3134120|P2|Overall Study|antibiotic use|1
951711|NCT00762476|3134121|P1|Overall Study|antibiotic use|0
951712|NCT00762476|3134120|P2|Overall Study|Withdrawal by Subject|12
951713|NCT00762476|3134121|P1|Overall Study|Withdrawal by Subject|6
951714|NCT00762476|3134120|P2|Overall Study|Physician Decision|14
951715|NCT00762476|3134121|P1|Overall Study|Physician Decision|2
951716|NCT00762476|3134120|P2|Overall Study|Protocol Violation|6
951717|NCT00762476|3134121|P1|Overall Study|Protocol Violation|5
951718|NCT00762476|3134120|P2|Overall Study|Lost to Follow-up|0
951719|NCT00762476|3134121|P1|Overall Study|Lost to Follow-up|2
951720|NCT00762476|3134120|P2|Overall Study|Adverse Event|1
951721|NCT00762476|3134121|P1|Overall Study|Adverse Event|7
951722|NCT00762463|3134133|P4|Extension Phase (Week 6 to Week 12)|Not specified|1
951723|NCT00762463|3134134|P3|Extension Phase (Week 6 to Week 12)|Not specified|0
951724|NCT00762463|3134135|P2|Extension Phase (Week 6 to Week 12)|Not specified|0
951725|NCT00762463|3134136|P1|Extension Phase (Week 6 to Week 12)|Not specified|0
951726|NCT00762463|3134133|P4|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
951727|NCT00762463|3134134|P3|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3
951728|NCT00762463|3134135|P2|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
951729|NCT00762463|3134136|P1|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1
951730|NCT00762463|3134133|P4|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
951731|NCT00762463|3134134|P3|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0
951732|NCT00762463|3134135|P2|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
951733|NCT00762463|3134136|P1|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
951734|NCT00762463|3134133|P4|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
951735|NCT00762463|3134134|P3|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
951736|NCT00762463|3134135|P2|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
951737|NCT00762463|3134136|P1|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
951738|NCT00762463|3134133|P4|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
951739|NCT00762463|3134134|P3|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
951740|NCT00762463|3134135|P2|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1
951741|NCT00762463|3134136|P1|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4
951742|NCT00762463|3134133|P4|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
951743|NCT00762463|3134134|P3|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
951744|NCT00762463|3134135|P2|Double-blind Phase (Baseline to Week 6)|Adverse Event|4
951745|NCT00762463|3134136|P1|Double-blind Phase (Baseline to Week 6)|Adverse Event|2
951746|NCT00762463|3134133|P4|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
951747|NCT00762463|3134134|P3|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
951748|NCT00762463|3134135|P2|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4
951749|NCT00762463|3134136|P1|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3
951750|NCT00762463|3134133|P4|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
951751|NCT00762463|3134134|P3|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
951752|NCT00762463|3134135|P2|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
951753|NCT00762463|3134136|P1|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
951754|NCT00762411|3134242|P2|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54
951755|NCT00762411|3134243|P1|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48
951756|NCT00762411|3134242|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
951757|NCT00762411|3134243|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
951758|NCT00762411|3134242|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
951759|NCT00762411|3134243|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6
951760|NCT00762411|3134242|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46
951761|NCT00762411|3134243|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21
951762|NCT00762411|3134242|P2|Safety Follow Up (SFU)-Optional|Adverse Event|1
951763|NCT00762411|3134243|P1|Safety Follow Up (SFU)-Optional|Adverse Event|0
951764|NCT00762411|3134242|P2|Safety Follow Up (SFU)-Optional|Death|8
951765|NCT00762411|3134243|P1|Safety Follow Up (SFU)-Optional|Death|1
951766|NCT00762411|3134242|P2|Delayed Start|Caregiver Decision|1
951768|NCT00762411|3134242|P2|Delayed Start|Sponsor Decision|20
951769|NCT00762411|3134243|P1|Delayed Start|Sponsor Decision|16
951770|NCT00762411|3134242|P2|Delayed Start|Protocol Violation|1
951771|NCT00762411|3134243|P1|Delayed Start|Protocol Violation|0
951772|NCT00762411|3134242|P2|Delayed Start|Adverse Event|4
951773|NCT00762411|3134243|P1|Delayed Start|Adverse Event|0
951774|NCT00762411|3134242|P2|Initial Treatment|Entry Criteria Exclusion|1
951775|NCT00762411|3134243|P1|Initial Treatment|Entry Criteria Exclusion|0
951776|NCT00762411|3134242|P2|Initial Treatment|Abnormal Lab/ECG Result|4
951777|NCT00762411|3134243|P1|Initial Treatment|Abnormal Lab/ECG Result|6
951778|NCT00762411|3134242|P2|Initial Treatment|Caregiver Decision|16
951779|NCT00762411|3134243|P1|Initial Treatment|Caregiver Decision|21
951780|NCT00762411|3134242|P2|Initial Treatment|Lost to Follow-up|0
951781|NCT00762411|3134243|P1|Initial Treatment|Lost to Follow-up|5
951782|NCT00762411|3134242|P2|Initial Treatment|Sponsor Decision|401
951783|NCT00762411|3134243|P1|Initial Treatment|Sponsor Decision|293
951784|NCT00762411|3134242|P2|Initial Treatment|Physician Decision|0
951785|NCT00762411|3134243|P1|Initial Treatment|Physician Decision|1
951786|NCT00762411|3134242|P2|Initial Treatment|Withdrawal by Subject|52
951787|NCT00762411|3134243|P1|Initial Treatment|Withdrawal by Subject|65
951788|NCT00762411|3134242|P2|Initial Treatment|Protocol Violation|1
951789|NCT00762411|3134243|P1|Initial Treatment|Protocol Violation|4
951790|NCT00762411|3134242|P2|Initial Treatment|Adverse Event|40
951791|NCT00762411|3134243|P1|Initial Treatment|Adverse Event|132
951792|NCT00762411|3134242|P2|Initial Treatment|Death|6
951793|NCT00762411|3134243|P1|Initial Treatment|Death|7
951794|NCT00762385|3134307|P2|Second Intervention|Protocol Violation|3
951795|NCT00762385|3134308|P1|Second Intervention|Protocol Violation|3
951796|NCT00762385|3134307|P2|First Intervention|Protocol Violation|1
951797|NCT00762385|3134308|P1|First Intervention|Protocol Violation|0
951798|NCT00762385|3134307|P2|First Intervention|Ineligible|0
951799|NCT00762385|3134308|P1|First Intervention|Ineligible|1
951800|NCT00762385|3134307|P2|First Intervention|Lost to Follow-up|2
951801|NCT00762385|3134308|P1|First Intervention|Lost to Follow-up|0
951802|NCT00762385|3134307|P2|First Intervention|Lens Issue|1
951803|NCT00762385|3134308|P1|First Intervention|Lens Issue|1
951804|NCT00762359|3134320|P2|Overall Study|Withdrew consent|0
951805|NCT00762359|3134321|P1|Overall Study|Withdrew consent|1
951806|NCT00762359|3134320|P2|Overall Study|Removal|1
951807|NCT00762359|3134321|P1|Overall Study|Removal|0
951808|NCT00762359|3134320|P2|Overall Study|Physician Decision|3
951809|NCT00762359|3134321|P1|Overall Study|Physician Decision|2
951810|NCT00762359|3134320|P2|Overall Study|Institution closed|3
951811|NCT00762359|3134321|P1|Overall Study|Institution closed|2
951812|NCT00762359|3134320|P2|Overall Study|Lack of Efficacy|4
951813|NCT00762359|3134321|P1|Overall Study|Lack of Efficacy|0
951814|NCT00762359|3134320|P2|Overall Study|Withdrawal by Subject|10
951815|NCT00762359|3134321|P1|Overall Study|Withdrawal by Subject|13
951816|NCT00762359|3134320|P2|Overall Study|Protocol Violation|13
951817|NCT00762359|3134321|P1|Overall Study|Protocol Violation|21
951818|NCT00762359|3134320|P2|Overall Study|Adverse Event|23
951819|NCT00762359|3134321|P1|Overall Study|Adverse Event|20
951820|NCT00762268|3134438|P2|Overall Study|Protocol Violation|2
951821|NCT00762268|3134439|P1|Overall Study|Protocol Violation|1
951822|NCT00762229|3134447|P2|Overall Study|did not recveive intervention|1
951823|NCT00762229|3134448|P1|Overall Study|did not recveive intervention|0
951824|NCT00762229|3134447|P2|Overall Study|Lost to Follow-up|1
951825|NCT00762229|3134448|P1|Overall Study|Lost to Follow-up|1
951826|NCT00762164|3134545|P2|Overall Study|Withdrawal by Subject|1
951827|NCT00762164|3134546|P1|Overall Study|Withdrawal by Subject|0
951828|NCT00762164|3134545|P2|Overall Study|Discontinued medication|0
951829|NCT00762164|3134546|P1|Overall Study|Discontinued medication|2
951830|NCT00762164|3134545|P2|Overall Study|Lost to Follow-up|1
951831|NCT00762164|3134546|P1|Overall Study|Lost to Follow-up|1
951832|NCT00762086|3134556|P2|Overall Study|Ineligible to participate in the study|0
951833|NCT00762086|3134557|P1|Overall Study|Ineligible to participate in the study|1
951834|NCT00762086|3134556|P2|Overall Study|Withdrawal by Subject|2
951835|NCT00762086|3134557|P1|Overall Study|Withdrawal by Subject|2
951836|NCT00762086|3134556|P2|Overall Study|Non compliance|0
951837|NCT00762086|3134557|P1|Overall Study|Non compliance|1
951838|NCT00762086|3134556|P2|Overall Study|Lost to Follow-up|2
951839|NCT00762086|3134557|P1|Overall Study|Lost to Follow-up|0
951840|NCT00762086|3134556|P2|Overall Study|Adverse Event|0
951841|NCT00762086|3134557|P1|Overall Study|Adverse Event|2
951842|NCT00762073|3134567|P4|Overall Study|Not on treatment for >/= 77 days|0
951843|NCT00762073|3134568|P3|Overall Study|Not on treatment for >/= 77 days|0
951844|NCT00762073|3134569|P2|Overall Study|Not on treatment for >/= 77 days|0
951845|NCT00762073|3134570|P1|Overall Study|Not on treatment for >/= 77 days|1
951846|NCT00762073|3134567|P4|Overall Study|Withdrawal by Subject|1
951847|NCT00762073|3134568|P3|Overall Study|Withdrawal by Subject|1
951848|NCT00762073|3134569|P2|Overall Study|Withdrawal by Subject|2
951849|NCT00762073|3134570|P1|Overall Study|Withdrawal by Subject|1
951850|NCT00762073|3134567|P4|Overall Study|Significant Subject Noncompliance|1
951851|NCT00762073|3134568|P3|Overall Study|Significant Subject Noncompliance|0
951852|NCT00762073|3134569|P2|Overall Study|Significant Subject Noncompliance|1
951853|NCT00762073|3134570|P1|Overall Study|Significant Subject Noncompliance|0
951854|NCT00762073|3134567|P4|Overall Study|Adverse Event|1
951855|NCT00762073|3134568|P3|Overall Study|Adverse Event|1
951856|NCT00762073|3134569|P2|Overall Study|Adverse Event|0
951857|NCT00762073|3134570|P1|Overall Study|Adverse Event|1
951858|NCT00762073|3134567|P4|Overall Study|Lack of Efficacy|0
951859|NCT00762073|3134568|P3|Overall Study|Lack of Efficacy|0
951860|NCT00762073|3134569|P2|Overall Study|Lack of Efficacy|1
951861|NCT00762073|3134570|P1|Overall Study|Lack of Efficacy|1
951862|NCT00762034|3134634|P2|Maintenance Period|Other|1
951863|NCT00762034|3134635|P1|Maintenance Period|Other|1
951864|NCT00762034|3134634|P2|Maintenance Period|Death due to study disease|3
951865|NCT00762034|3134635|P1|Maintenance Period|Death due to study disease|3
951866|NCT00762034|3134634|P2|Maintenance Period|Death not due to study disease|5
951867|NCT00762034|3134635|P1|Maintenance Period|Death not due to study disease|2
951868|NCT00762034|3134634|P2|Maintenance Period|Withdrawal by Subject|14
951869|NCT00762034|3134635|P1|Maintenance Period|Withdrawal by Subject|34
951870|NCT00762034|3134634|P2|Maintenance Period|Physician Decision|20
951871|NCT00762034|3134635|P1|Maintenance Period|Physician Decision|25
951872|NCT00762034|3134634|P2|Maintenance Period|Progressive Disease|224
951873|NCT00762034|3134635|P1|Maintenance Period|Progressive Disease|186
951874|NCT00762034|3134634|P2|Maintenance Period|Adverse Event|26
951875|NCT00762034|3134635|P1|Maintenance Period|Adverse Event|42
951876|NCT00762034|3134634|P2|Maintenance Period|Entry Criterion Not Met|2
951877|NCT00762034|3134635|P1|Maintenance Period|Entry Criterion Not Met|0
951878|NCT00762034|3134634|P2|Maintenance Period|Protocol Violation|3
951879|NCT00762034|3134635|P1|Maintenance Period|Protocol Violation|1
951880|NCT00762034|3134634|P2|Induction Period|Deaths Due to Study Disease|9
951881|NCT00762034|3134635|P1|Induction Period|Deaths Due to Study Disease|9
951882|NCT00762034|3134634|P2|Induction Period|Deaths Not Due to Study Disease|14
951883|NCT00762034|3134635|P1|Induction Period|Deaths Not Due to Study Disease|19
951884|NCT00762034|3134634|P2|Induction Period|Withdrawal by Subject|19
951885|NCT00762034|3134635|P1|Induction Period|Withdrawal by Subject|15
951886|NCT00762034|3134634|P2|Induction Period|Physician Decision|20
951887|NCT00762034|3134635|P1|Induction Period|Physician Decision|21
951888|NCT00762034|3134634|P2|Induction Period|Progressive Disease|55
951889|NCT00762034|3134635|P1|Induction Period|Progressive Disease|73
951890|NCT00762034|3134634|P2|Induction Period|Lost to Follow-up|1
951891|NCT00762034|3134635|P1|Induction Period|Lost to Follow-up|1
951892|NCT00762034|3134634|P2|Induction Period|Adverse Event|38
951893|NCT00762034|3134635|P1|Induction Period|Adverse Event|27
951894|NCT00762034|3134634|P2|Induction Period|Entry Criterion Not Met|11
951895|NCT00762034|3134635|P1|Induction Period|Entry Criterion Not Met|12
951896|NCT00762034|3134634|P2|Induction Period|Protocol Violation|2
951897|NCT00762034|3134635|P1|Induction Period|Protocol Violation|1
951898|NCT00761969|3134707|P2|Overall Study|Lost to Follow-up|93
951899|NCT00761969|3134708|P1|Overall Study|Lost to Follow-up|88
951900|NCT00761969|3134707|P2|Overall Study|Death|47
951901|NCT00761969|3134708|P1|Overall Study|Death|112
951902|NCT00761956|3134718|P2|Overall Study|Adverse Event|34
951903|NCT00761956|3134719|P1|Overall Study|Adverse Event|26
951904|NCT00761956|3134718|P2|Overall Study|Death|1
951905|NCT00761956|3134719|P1|Overall Study|Death|0
951906|NCT00761956|3134718|P2|Overall Study|Withdrawal by Subject|8
951907|NCT00761956|3134719|P1|Overall Study|Withdrawal by Subject|3
951908|NCT00761956|3134718|P2|Overall Study|Lost to Follow-up|11
951909|NCT00761956|3134719|P1|Overall Study|Lost to Follow-up|6
951910|NCT00761865|3134748|P2|Overall Study|Lost to Follow-up|7
951911|NCT00761865|3134749|P1|Overall Study|Lost to Follow-up|8
951912|NCT00761774|3134770|P1|Overall Study|IP stopped by hospital physician|1
951913|NCT00761774|3134770|P1|Overall Study|Subject IP non-compliance|1
951914|NCT00761774|3134770|P1|Overall Study|Coordinator leaving site|1
951915|NCT00761774|3134770|P1|Overall Study|Patient moved out of study area|1
951916|NCT00761774|3134770|P1|Overall Study|Investigator clinical judgement|1
951917|NCT00761774|3134770|P1|Overall Study|Sponsor decision|1
951918|NCT00761774|3134770|P1|Overall Study|Medical decision to read SUSAR reports|1
951919|NCT00761774|3134770|P1|Overall Study|Reclassification of seizures|1
951920|NCT00761774|3134770|P1|Overall Study|End of study|2
951921|NCT00761774|3134770|P1|Overall Study|Non-compliance|4
951922|NCT00761774|3134770|P1|Overall Study|Withdrawal by Subject|9
951923|NCT00761774|3134770|P1|Overall Study|Lost to Follow-up|2
951924|NCT00761774|3134770|P1|Overall Study|Lack of Efficacy|37
951925|NCT00761774|3134770|P1|Overall Study|Adverse Event|17
951926|NCT00761761|3134781|P2|Overall Study|Withdrawal by Subject|0
951927|NCT00761761|3134782|P1|Overall Study|Withdrawal by Subject|3
951928|NCT00761761|3134781|P2|Overall Study|Lost to Follow-up|1
951929|NCT00761761|3134782|P1|Overall Study|Lost to Follow-up|3
951930|NCT00761748|3134794|P2|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3
951931|NCT00761748|3134795|P1|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0
951932|NCT00761748|3134794|P2|First Intervention (21 +/- 3 Days)|Adverse Event|0
951933|NCT00761748|3134795|P1|First Intervention (21 +/- 3 Days)|Adverse Event|3
951934|NCT00761735|3134801|P1|Overall Study|Administrative|1
951935|NCT00761735|3134801|P1|Overall Study|Non-compliance with protocol|1
951936|NCT00761735|3134801|P1|Overall Study|Withdrawal by Subject|6
951937|NCT00761735|3134801|P1|Overall Study|Lost to Follow-up|6
951938|NCT00761631|3134817|P6|Overall Study|Other|1
951939|NCT00761631|3134818|P5|Overall Study|Other|1
951940|NCT00761631|3134819|P4|Overall Study|Other|0
951941|NCT00761631|3134820|P3|Overall Study|Other|0
951942|NCT00761631|3134821|P2|Overall Study|Other|0
951943|NCT00761631|3134822|P1|Overall Study|Other|0
951944|NCT00761631|3134817|P6|Overall Study|Physician Decision|0
951945|NCT00761631|3134818|P5|Overall Study|Physician Decision|0
951946|NCT00761631|3134819|P4|Overall Study|Physician Decision|0
951947|NCT00761631|3134820|P3|Overall Study|Physician Decision|0
951948|NCT00761631|3134821|P2|Overall Study|Physician Decision|0
951949|NCT00761631|3134822|P1|Overall Study|Physician Decision|1
951950|NCT00761631|3134817|P6|Overall Study|Failed to return|2
951951|NCT00761631|3134818|P5|Overall Study|Failed to return|5
951952|NCT00761631|3134819|P4|Overall Study|Failed to return|1
951953|NCT00761631|3134820|P3|Overall Study|Failed to return|1
951954|NCT00761631|3134821|P2|Overall Study|Failed to return|0
951955|NCT00761631|3134822|P1|Overall Study|Failed to return|1
951956|NCT00761631|3134817|P6|Overall Study|Randomized, not treated|0
951957|NCT00761631|3134818|P5|Overall Study|Randomized, not treated|0
951958|NCT00761631|3134819|P4|Overall Study|Randomized, not treated|0
951959|NCT00761631|3134820|P3|Overall Study|Randomized, not treated|0
951960|NCT00761631|3134821|P2|Overall Study|Randomized, not treated|0
951961|NCT00761631|3134822|P1|Overall Study|Randomized, not treated|1
951962|NCT00761631|3134817|P6|Overall Study|Protocol Violation|1
951963|NCT00761631|3134818|P5|Overall Study|Protocol Violation|5
951964|NCT00761631|3134819|P4|Overall Study|Protocol Violation|1
951965|NCT00761631|3134820|P3|Overall Study|Protocol Violation|0
951966|NCT00761631|3134821|P2|Overall Study|Protocol Violation|0
951967|NCT00761631|3134822|P1|Overall Study|Protocol Violation|2
951968|NCT00761631|3134817|P6|Overall Study|Lost to Follow-up|1
951969|NCT00761631|3134818|P5|Overall Study|Lost to Follow-up|6
951970|NCT00761631|3134819|P4|Overall Study|Lost to Follow-up|1
951971|NCT00761631|3134820|P3|Overall Study|Lost to Follow-up|7
951972|NCT00761631|3134821|P2|Overall Study|Lost to Follow-up|4
951973|NCT00761631|3134822|P1|Overall Study|Lost to Follow-up|2
951974|NCT00761631|3134817|P6|Overall Study|Parent/legal guardian request|0
951975|NCT00761631|3134818|P5|Overall Study|Parent/legal guardian request|5
951976|NCT00761631|3134819|P4|Overall Study|Parent/legal guardian request|0
951977|NCT00761631|3134820|P3|Overall Study|Parent/legal guardian request|8
951978|NCT00761631|3134821|P2|Overall Study|Parent/legal guardian request|3
951979|NCT00761631|3134822|P1|Overall Study|Parent/legal guardian request|8
951980|NCT00761605|3134857|P1|Overall Study|Other|21
951981|NCT00761605|3134857|P1|Overall Study|Withdrawal by Subject|37
951982|NCT00761605|3134857|P1|Overall Study|Lost to Follow-up|29
951983|NCT00761605|3134857|P1|Overall Study|Lack of Efficacy|26
951984|NCT00761605|3134857|P1|Overall Study|Death|2
951985|NCT00761605|3134857|P1|Overall Study|Adverse Event|26
951986|NCT00761579|3134901|P1|Overall Study|Intake of prohibited concomitant drug|1
951987|NCT00761579|3134901|P1|Overall Study|Lost survey form|1
951988|NCT00761579|3134901|P1|Overall Study|Aggravation of symptoms by changing drug|1
951989|NCT00761579|3134901|P1|Overall Study|Aggravation of depression|1
951990|NCT00761579|3134901|P1|Overall Study|Drug overdose|1
951991|NCT00761579|3134901|P1|Overall Study|Protocol deviation|1
951992|NCT00761579|3134901|P1|Overall Study|Lack of compliance|2
951993|NCT00761579|3134901|P1|Overall Study|Withdrawal by Subject|34
951994|NCT00761579|3134901|P1|Overall Study|Pregnancy|1
951995|NCT00761579|3134901|P1|Overall Study|Lost to Follow-up|16
951996|NCT00761579|3134901|P1|Overall Study|Lack of Efficacy|21
951997|NCT00761579|3134901|P1|Overall Study|Death|2
951998|NCT00761579|3134901|P1|Overall Study|Adverse Event|10
951999|NCT00761527|3134934|P1|Overall Study|Unknown reason|2
952000|NCT00761527|3134934|P1|Overall Study|Lost to Follow-up|9
952001|NCT00761527|3134934|P1|Overall Study|Poor Compliance|8
952002|NCT00761527|3134934|P1|Overall Study|Adverse Event|3
952003|NCT00761514|3134941|P1|Overall Study|Unable to pay for medications|1
952004|NCT00761514|3134941|P1|Overall Study|Problem complying with study visit|1
952005|NCT00761514|3134941|P1|Overall Study|Health insurance didn't cover study drug|1
952006|NCT00761514|3134941|P1|Overall Study|Lost to Follow-up|1
952007|NCT00761514|3134941|P1|Overall Study|Withdrawal by Subject|2
952008|NCT00761514|3134941|P1|Overall Study|Adverse Event|1
952009|NCT00761462|3134948|P2|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21
952010|NCT00761462|3134949|P1|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75
952011|NCT00761462|3134948|P2|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30
952012|NCT00761462|3134949|P1|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75
952013|NCT00761462|3134948|P2|2 or 5 Years Long-term Safety Follow-up|Death|0
952014|NCT00761462|3134949|P1|2 or 5 Years Long-term Safety Follow-up|Death|4
952015|NCT00761462|3134948|P2|Treatment|Subjects never received study medication|12
952016|NCT00761462|3134949|P1|Treatment|Subjects never received study medication|23
952017|NCT00761319|3134963|P2|Overall Study|Missing|0
952018|NCT00761319|3134964|P1|Overall Study|Missing|1
952019|NCT00761319|3134963|P2|Overall Study|Nonspecified|2
952020|NCT00761319|3134964|P1|Overall Study|Nonspecified|2
952021|NCT00761319|3134963|P2|Overall Study|Lost to Follow-up|1
952022|NCT00761319|3134964|P1|Overall Study|Lost to Follow-up|1
952023|NCT00761319|3134963|P2|Overall Study|Noncompliance|3
952024|NCT00761319|3134964|P1|Overall Study|Noncompliance|4
952025|NCT00761319|3134963|P2|Overall Study|Withdrawal by Subject|7
952026|NCT00761319|3134964|P1|Overall Study|Withdrawal by Subject|8
952027|NCT00761319|3134963|P2|Overall Study|Adverse Event|7
952028|NCT00761319|3134964|P1|Overall Study|Adverse Event|11
952029|NCT00761319|3134963|P2|Overall Study|Protocol Violation|14
952030|NCT00761319|3134964|P1|Overall Study|Protocol Violation|21
952031|NCT00761306|3134972|P1|Overall Study|Administrative or Other Reasons|5
952032|NCT00761306|3134972|P1|Overall Study|Lost to Follow-up|1
952033|NCT00761306|3134972|P1|Overall Study|Withdrawal of Consent|3
952034|NCT00761306|3134972|P1|Overall Study|Protocol Violation|2
952035|NCT00761306|3134972|P1|Overall Study|Lack of Efficacy|4
952036|NCT00761306|3134972|P1|Overall Study|Adverse Event|5
952037|NCT00761280|3134983|P2|First Dose to End of Study|Lost to Follow-up|1
952038|NCT00761280|3134984|P1|First Dose to End of Study|Lost to Follow-up|0
952039|NCT00761280|3134983|P2|First Dose to End of Study|Death|0
952040|NCT00761280|3134984|P1|First Dose to End of Study|Death|1
952041|NCT00761280|3134983|P2|First Dose to End of Study|Sponsor decision|2
952042|NCT00761280|3134984|P1|First Dose to End of Study|Sponsor decision|1
952043|NCT00761280|3134983|P2|First Dose to End of Study|Progressive disease|3
952044|NCT00761280|3134984|P1|First Dose to End of Study|Progressive disease|5
952045|NCT00761280|3134983|P2|First Dose to End of Study|End of trial|5
952046|NCT00761280|3134984|P1|First Dose to End of Study|End of trial|5
952047|NCT00761280|3134983|P2|Randomization to First Dose|Other|0
952048|NCT00761280|3134984|P1|Randomization to First Dose|Other|1
952049|NCT00761280|3134983|P2|Randomization to First Dose|Sponsor decision|0
952050|NCT00761280|3134984|P1|Randomization to First Dose|Sponsor decision|1
952051|NCT00761280|3134983|P2|Randomization to First Dose|Withdrawal by Subject|2
952052|NCT00761280|3134984|P1|Randomization to First Dose|Withdrawal by Subject|0
952053|NCT00761267|3135015|P3|Overall Study|Withdrawal by Subject|0
952054|NCT00761267|3135016|P2|Overall Study|Withdrawal by Subject|1
952055|NCT00761267|3135017|P1|Overall Study|Withdrawal by Subject|0
952056|NCT00761267|3135015|P3|Overall Study|Randomized but not treated|0
952057|NCT00761267|3135016|P2|Overall Study|Randomized but not treated|1
952058|NCT00761267|3135017|P1|Overall Study|Randomized but not treated|1
952059|NCT00761267|3135015|P3|Overall Study|Lost to Follow-up|1
952060|NCT00761267|3135016|P2|Overall Study|Lost to Follow-up|0
952061|NCT00761267|3135017|P1|Overall Study|Lost to Follow-up|0
952062|NCT00761267|3135015|P3|Overall Study|Death|5
952063|NCT00761267|3135016|P2|Overall Study|Death|2
952064|NCT00761267|3135017|P1|Overall Study|Death|1
952065|NCT00761215|3135047|P3|Overall Study|Bacteremia|0
952066|NCT00761215|3135048|P2|Overall Study|Bacteremia|0
952067|NCT00761215|3135049|P1|Overall Study|Bacteremia|1
952068|NCT00761215|3135047|P3|Overall Study|Withdrawal by Subject|0
952069|NCT00761215|3135048|P2|Overall Study|Withdrawal by Subject|0
952070|NCT00761215|3135049|P1|Overall Study|Withdrawal by Subject|1
952071|NCT00761215|3135047|P3|Overall Study|Lost to Follow-up|6
952072|NCT00761215|3135048|P2|Overall Study|Lost to Follow-up|3
952073|NCT00761215|3135049|P1|Overall Study|Lost to Follow-up|6
952074|NCT00761215|3135047|P3|Overall Study|Randomized but didn't receive drug|2
952075|NCT00761215|3135048|P2|Overall Study|Randomized but didn't receive drug|1
952076|NCT00761215|3135049|P1|Overall Study|Randomized but didn't receive drug|1
952077|NCT00761189|3135091|P1|Overall Study|Other|13
952078|NCT00761189|3135091|P1|Overall Study|Withdrawal by Subject|49
952079|NCT00761189|3135091|P1|Overall Study|Lost to Follow-up|36
952080|NCT00761189|3135091|P1|Overall Study|Lack of Efficacy|45
952081|NCT00761189|3135091|P1|Overall Study|Adverse Event|42
952082|NCT00761176|3135108|P2|Overall Study|Withdrawal by Subject|1
952083|NCT00761176|3135109|P1|Overall Study|Withdrawal by Subject|1
952084|NCT00761176|3135108|P2|Overall Study|Death|0
952085|NCT00761176|3135109|P1|Overall Study|Death|1
952086|NCT00761150|3135118|P3|Double-blind Period|Not specified|3
952087|NCT00761150|3135119|P2|Double-blind Period|Not specified|3
952088|NCT00761150|3135120|P1|Double-blind Period|Not specified|0
952089|NCT00761150|3135118|P3|Double-blind Period|Noncompliance|0
952090|NCT00761150|3135119|P2|Double-blind Period|Noncompliance|1
952091|NCT00761150|3135120|P1|Double-blind Period|Noncompliance|0
952092|NCT00761150|3135118|P3|Double-blind Period|Did not meet DB randomization criteria|1
952093|NCT00761150|3135119|P2|Double-blind Period|Did not meet DB randomization criteria|0
952094|NCT00761150|3135120|P1|Double-blind Period|Did not meet DB randomization criteria|0
952095|NCT00761150|3135118|P3|Double-blind Period|Lost to Follow-up|1
952096|NCT00761150|3135119|P2|Double-blind Period|Lost to Follow-up|2
952097|NCT00761150|3135120|P1|Double-blind Period|Lost to Follow-up|0
952098|NCT00761150|3135118|P3|Double-blind Period|Withdrawal by Subject|2
952099|NCT00761150|3135119|P2|Double-blind Period|Withdrawal by Subject|3
952100|NCT00761150|3135120|P1|Double-blind Period|Withdrawal by Subject|0
952101|NCT00761150|3135118|P3|Double-blind Period|Adverse Event|3
952102|NCT00761150|3135119|P2|Double-blind Period|Adverse Event|3
952103|NCT00761150|3135120|P1|Double-blind Period|Adverse Event|0
952104|NCT00761150|3135118|P3|Double-blind Period|Lack of Efficacy|19
952105|NCT00761150|3135119|P2|Double-blind Period|Lack of Efficacy|2
952106|NCT00761150|3135120|P1|Double-blind Period|Lack of Efficacy|0
952107|NCT00761150|3135118|P3|Open-label Period|Not specified|0
952108|NCT00761150|3135119|P2|Open-label Period|Not specified|0
952109|NCT00761150|3135120|P1|Open-label Period|Not specified|5
952110|NCT00761150|3135118|P3|Open-label Period|Noncompliance|0
952111|NCT00761150|3135119|P2|Open-label Period|Noncompliance|0
952112|NCT00761150|3135120|P1|Open-label Period|Noncompliance|2
952113|NCT00761150|3135118|P3|Open-label Period|Withdrawal by Subject|0
952114|NCT00761150|3135119|P2|Open-label Period|Withdrawal by Subject|0
952115|NCT00761150|3135120|P1|Open-label Period|Withdrawal by Subject|5
952116|NCT00761150|3135118|P3|Open-label Period|Lack of Efficacy|0
952117|NCT00761150|3135119|P2|Open-label Period|Lack of Efficacy|0
952118|NCT00761150|3135120|P1|Open-label Period|Lack of Efficacy|4
952119|NCT00761150|3135118|P3|Open-label Period|Lost to Follow-up|0
952120|NCT00761150|3135119|P2|Open-label Period|Lost to Follow-up|0
952121|NCT00761150|3135120|P1|Open-label Period|Lost to Follow-up|7
952122|NCT00761150|3135118|P3|Open-label Period|Did not meet DB randomization criteria|0
952123|NCT00761150|3135119|P2|Open-label Period|Did not meet DB randomization criteria|0
952124|NCT00761150|3135120|P1|Open-label Period|Did not meet DB randomization criteria|11
952125|NCT00761150|3135118|P3|Open-label Period|Adverse Event|0
952126|NCT00761150|3135119|P2|Open-label Period|Adverse Event|0
952127|NCT00761150|3135120|P1|Open-label Period|Adverse Event|36
952128|NCT00760877|3135171|P2|Overall Study|Treatment failure|0
952129|NCT00760877|3135172|P1|Overall Study|Treatment failure|1
952130|NCT00760877|3135171|P2|Overall Study|Participants transferred to AMN107A2408|1
952131|NCT00760877|3135172|P1|Overall Study|Participants transferred to AMN107A2408|11
952132|NCT00760877|3135171|P2|Overall Study|Physician Decision|2
952133|NCT00760877|3135172|P1|Overall Study|Physician Decision|1
952134|NCT00760877|3135171|P2|Overall Study|Participant not eligible to cross-over|1
952135|NCT00760877|3135172|P1|Overall Study|Participant not eligible to cross-over|0
952136|NCT00760877|3135171|P2|Overall Study|Participant diagnosed with AML|1
952137|NCT00760877|3135172|P1|Overall Study|Participant diagnosed with AML|0
952138|NCT00760877|3135171|P2|Overall Study|Adverse Event|12
952139|NCT00760877|3135172|P1|Overall Study|Adverse Event|19
952140|NCT00760877|3135171|P2|Overall Study|Withdrawal by Subject|3
952141|NCT00760877|3135172|P1|Overall Study|Withdrawal by Subject|7
952142|NCT00760877|3135171|P2|Overall Study|Death|1
952143|NCT00760877|3135172|P1|Overall Study|Death|2
952144|NCT00760877|3135171|P2|Overall Study|Pregnancy|4
952145|NCT00760877|3135172|P1|Overall Study|Pregnancy|1
952146|NCT00760877|3135171|P2|Overall Study|Non-compliance with protocol treatment|1
952147|NCT00760877|3135172|P1|Overall Study|Non-compliance with protocol treatment|2
952148|NCT00760877|3135171|P2|Overall Study|Protocol Violation|0
952149|NCT00760877|3135172|P1|Overall Study|Protocol Violation|1
952150|NCT00760838|3135190|P2|Overall Study|Withdrawal by Subject|1
952151|NCT00760838|3135191|P1|Overall Study|Withdrawal by Subject|1
952152|NCT00760838|3135190|P2|Overall Study|Lost to Follow-up|0
952153|NCT00760838|3135191|P1|Overall Study|Lost to Follow-up|2
952154|NCT00760838|3135190|P2|Overall Study|Lack of Efficacy|0
952155|NCT00760838|3135191|P1|Overall Study|Lack of Efficacy|1
952156|NCT00760838|3135190|P2|Overall Study|Adverse Event|1
952157|NCT00760838|3135191|P1|Overall Study|Adverse Event|1
952158|NCT00760747|3135209|P2|Study Period III|Physician Decision|1
952159|NCT00760747|3135210|P1|Study Period III|Physician Decision|0
952160|NCT00760747|3135209|P2|Study Period III|Protocol Violation|1
952161|NCT00760747|3135210|P1|Study Period III|Protocol Violation|1
952162|NCT00760747|3135209|P2|Study Period III|Parent/Caregiver Decision|1
952163|NCT00760747|3135210|P1|Study Period III|Parent/Caregiver Decision|0
952164|NCT00760747|3135209|P2|Study Period III|Lack of Efficacy|0
952165|NCT00760747|3135210|P1|Study Period III|Lack of Efficacy|1
952166|NCT00760747|3135209|P2|Study Period III|Adverse Event|0
952167|NCT00760747|3135210|P1|Study Period III|Adverse Event|1
952168|NCT00760747|3135209|P2|Study Period II|No drug administered|1
952169|NCT00760747|3135210|P1|Study Period II|No drug administered|0
952170|NCT00760747|3135209|P2|Study Period II|Withdrawal by Subject|0
952171|NCT00760747|3135210|P1|Study Period II|Withdrawal by Subject|1
952172|NCT00760747|3135209|P2|Study Period II|Protocol Violation|3
952173|NCT00760747|3135210|P1|Study Period II|Protocol Violation|6
952174|NCT00760747|3135209|P2|Study Period II|Parent/Caregiver Decision|0
952175|NCT00760747|3135210|P1|Study Period II|Parent/Caregiver Decision|3
952176|NCT00760747|3135209|P2|Study Period II|Lack of Efficacy|6
952177|NCT00760747|3135210|P1|Study Period II|Lack of Efficacy|0
952178|NCT00760747|3135209|P2|Study Period II|Adverse Event|4
952179|NCT00760747|3135210|P1|Study Period II|Adverse Event|3
952180|NCT00760669|3135238|P1|Overall Study|Took drug before entering in contract|5
952181|NCT00760669|3135238|P1|Overall Study|Participants with overlapping cases|1
952182|NCT00760669|3135238|P1|Overall Study|Participants missing efficacy assessment|6
952183|NCT00760669|3135238|P1|Overall Study|Not assessed for overall improvement|18
952184|NCT00760617|3135255|P3|Overall Study|Lost to Follow-up|5
952185|NCT00760617|3135256|P2|Overall Study|Lost to Follow-up|0
952186|NCT00760617|3135257|P1|Overall Study|Lost to Follow-up|0
952187|NCT00760617|3135255|P3|Overall Study|Adverse Event|0
952188|NCT00760617|3135256|P2|Overall Study|Adverse Event|2
952189|NCT00760617|3135257|P1|Overall Study|Adverse Event|5
952190|NCT00760552|3135371|P2|Overall Study|Lost to Follow-up|10
952191|NCT00760552|3135372|P1|Overall Study|Lost to Follow-up|11
952192|NCT00760552|3135371|P2|Overall Study|Death|0
952193|NCT00760552|3135372|P1|Overall Study|Death|2
952194|NCT00760487|3135406|P1|Overall Study|Unilateral implantation|3
952195|NCT00760474|3135412|P2|Period 2 (P2)|Adverse Event|1
952196|NCT00760474|3135413|P1|Period 2 (P2)|Adverse Event|0
952197|NCT00760474|3135412|P2|Period 2 (P2)|Lost to Follow-up|0
952198|NCT00760474|3135413|P1|Period 2 (P2)|Lost to Follow-up|1
952199|NCT00760474|3135412|P2|Placebo Washout Period|Other|1
952200|NCT00760474|3135413|P1|Placebo Washout Period|Other|0
952201|NCT00760474|3135412|P2|Period 1 (P1)|Discontinued then re-entered|1
952202|NCT00760474|3135413|P1|Period 1 (P1)|Discontinued then re-entered|1
952203|NCT00760383|3135470|P2|Overall Study|moved away; withdrew; medical reasons|7
952204|NCT00760383|3135471|P1|Overall Study|moved away; withdrew; medical reasons|5
952205|NCT00760266|3135483|P2|Overall Study|Administrative Problems|1
952206|NCT00760266|3135484|P1|Overall Study|Administrative Problems|0
952207|NCT00760266|3135483|P2|Overall Study|Lost to Follow-up|1
952208|NCT00760266|3135484|P1|Overall Study|Lost to Follow-up|2
952209|NCT00760266|3135483|P2|Overall Study|Patient withdrew consent|3
952210|NCT00760266|3135484|P1|Overall Study|Patient withdrew consent|3
952211|NCT00760266|3135483|P2|Overall Study|Protocol deviation|4
952212|NCT00760266|3135484|P1|Overall Study|Protocol deviation|2
952213|NCT00760266|3135483|P2|Overall Study|Lack of Efficacy|2
952214|NCT00760266|3135484|P1|Overall Study|Lack of Efficacy|2
952215|NCT00760266|3135483|P2|Overall Study|Abnormal test procedure result(s)|0
952216|NCT00760266|3135484|P1|Overall Study|Abnormal test procedure result(s)|1
952217|NCT00760266|3135483|P2|Overall Study|Abnormal laboratory value(s)|0
952218|NCT00760266|3135484|P1|Overall Study|Abnormal laboratory value(s)|1
952219|NCT00760266|3135483|P2|Overall Study|Adverse Event|7
952220|NCT00760266|3135484|P1|Overall Study|Adverse Event|13
952221|NCT00760214|3135501|P3|Overall Study|Other|6
952222|NCT00760214|3135502|P2|Overall Study|Other|4
952223|NCT00760214|3135503|P1|Overall Study|Other|3
952224|NCT00760214|3135501|P3|Overall Study|Physician Decision|1
952225|NCT00760214|3135502|P2|Overall Study|Physician Decision|1
952226|NCT00760214|3135503|P1|Overall Study|Physician Decision|1
952227|NCT00760214|3135501|P3|Overall Study|Pregnancy|1
952228|NCT00760214|3135502|P2|Overall Study|Pregnancy|0
952229|NCT00760214|3135503|P1|Overall Study|Pregnancy|0
952230|NCT00760214|3135501|P3|Overall Study|Lack of Efficacy|4
952231|NCT00760214|3135502|P2|Overall Study|Lack of Efficacy|2
952232|NCT00760214|3135503|P1|Overall Study|Lack of Efficacy|3
952233|NCT00760214|3135501|P3|Overall Study|Withdrawal by Subject|13
952234|NCT00760214|3135502|P2|Overall Study|Withdrawal by Subject|14
952235|NCT00760214|3135503|P1|Overall Study|Withdrawal by Subject|12
952236|NCT00760214|3135501|P3|Overall Study|Lost to Follow-up|1
952237|NCT00760214|3135502|P2|Overall Study|Lost to Follow-up|0
952238|NCT00760214|3135503|P1|Overall Study|Lost to Follow-up|0
952239|NCT00760214|3135501|P3|Overall Study|Protocol Violation|3
952240|NCT00760214|3135502|P2|Overall Study|Protocol Violation|0
952241|NCT00760214|3135503|P1|Overall Study|Protocol Violation|3
952242|NCT00760214|3135501|P3|Overall Study|Adverse Event|12
952243|NCT00760214|3135502|P2|Overall Study|Adverse Event|9
952244|NCT00760214|3135503|P1|Overall Study|Adverse Event|8
952245|NCT00760084|3135544|P1|Overall Study|Progressive Disease|3
952246|NCT00760084|3135544|P1|Overall Study|Withdrawal by Subject|2
952247|NCT00760084|3135544|P1|Overall Study|Physician Decision|5
952248|NCT00759954|3135587|P2|Overall Study|Adverse Event|2
952249|NCT00759954|3135588|P1|Overall Study|Adverse Event|1
952250|NCT00759954|3135587|P2|Overall Study|Personal reason|0
952251|NCT00759954|3135588|P1|Overall Study|Personal reason|1
952252|NCT00759941|3135602|P2|Overall Study|Exited in error by site|1
952253|NCT00759941|3135603|P1|Overall Study|Exited in error by site|1
952254|NCT00759941|3135602|P2|Overall Study|Adverse Event|0
952255|NCT00759941|3135603|P1|Overall Study|Adverse Event|1
952256|NCT00759941|3135602|P2|Overall Study|Use of medication|0
952257|NCT00759941|3135603|P1|Overall Study|Use of medication|1
952258|NCT00759915|3135617|P2|Overall Study|Adverse Event|1
952259|NCT00759915|3135618|P1|Overall Study|Adverse Event|0
952260|NCT00759915|3135617|P2|Overall Study|Withdrawal by Subject|0
952261|NCT00759915|3135618|P1|Overall Study|Withdrawal by Subject|1
952262|NCT00759902|3135632|P2|Overall Study|Adverse Event|1
952263|NCT00759902|3135633|P1|Overall Study|Adverse Event|0
952264|NCT00759863|3135647|P2|Overall Study|Death, moved, or lost contact|18
952265|NCT00759863|3135648|P1|Overall Study|Death, moved, or lost contact|20
952266|NCT00759785|3135669|P2|Overall Study|Withdrawal by Subject|1
952267|NCT00759785|3135670|P1|Overall Study|Withdrawal by Subject|0
952268|NCT00759785|3135669|P2|Overall Study|Physician Decision|1
952269|NCT00759785|3135670|P1|Overall Study|Physician Decision|0
952270|NCT00759785|3135669|P2|Overall Study|Protocol Violation|0
952271|NCT00759785|3135670|P1|Overall Study|Protocol Violation|1
952272|NCT00759785|3135669|P2|Overall Study|Participant sample lost|1
952273|NCT00759785|3135670|P1|Overall Study|Participant sample lost|0
952274|NCT00759785|3135669|P2|Overall Study|Participant sample not evaluable|2
952275|NCT00759785|3135670|P1|Overall Study|Participant sample not evaluable|11
952276|NCT00759759|3135693|P2|Overall Study|Withdrawal by Subject|1
952277|NCT00759759|3135694|P1|Overall Study|Withdrawal by Subject|2
952278|NCT00759759|3135693|P2|Overall Study|Didn't receive drug in period 2|0
952279|NCT00759759|3135694|P1|Overall Study|Didn't receive drug in period 2|1
952280|NCT00759759|3135693|P2|Overall Study|didn't return for period 2|0
952281|NCT00759759|3135694|P1|Overall Study|didn't return for period 2|1
952282|NCT00759681|3135712|P2|Overall Study|Lost to Follow-up|5
952283|NCT00759681|3135713|P1|Overall Study|Lost to Follow-up|8
952284|NCT00759681|3135712|P2|Overall Study|Death|5
952285|NCT00759681|3135713|P1|Overall Study|Death|2
952286|NCT00759655|3135740|P1|Overall Study|Termination of the study by sponsor|1
952287|NCT00759564|3135768|P5|Washout Period (at Least 14 Days)|Adverse Event|1
952288|NCT00759564|3135769|P4|Washout Period (at Least 14 Days)|Adverse Event|0
952289|NCT00759564|3135770|P3|Washout Period (at Least 14 Days)|Adverse Event|0
952290|NCT00759564|3135771|P2|Washout Period (at Least 14 Days)|Adverse Event|0
952291|NCT00759564|3135772|P1|Washout Period (at Least 14 Days)|Adverse Event|0
952292|NCT00759395|3135949|P2|Overall Study|Lack of Efficacy|2
952293|NCT00759395|3135950|P1|Overall Study|Lack of Efficacy|0
952294|NCT00759395|3135949|P2|Overall Study|Withdrawal by Subject|0
952295|NCT00759395|3135950|P1|Overall Study|Withdrawal by Subject|1
952296|NCT00759395|3135949|P2|Overall Study|Adverse Event|0
952297|NCT00759395|3135950|P1|Overall Study|Adverse Event|1
952298|NCT00759356|3135966|P2|Overall Study|Subject was unable to return|0
952299|NCT00759356|3135967|P1|Overall Study|Subject was unable to return|1
952300|NCT00759356|3135966|P2|Overall Study|Withdrawal by Subject|2
952301|NCT00759356|3135967|P1|Overall Study|Withdrawal by Subject|0
952302|NCT00759356|3135966|P2|Overall Study|Adverse Event|1
952303|NCT00759356|3135967|P1|Overall Study|Adverse Event|0
952304|NCT00759174|3136047|P2|Overall Study|Other|2
952305|NCT00759174|3136048|P1|Overall Study|Other|0
952306|NCT00759148|3136072|P2|Overall Study|Reason not given|0
952307|NCT00759148|3136073|P1|Overall Study|Reason not given|1
952308|NCT00759148|3136072|P2|Overall Study|Treatment Failure|10
952309|NCT00759148|3136073|P1|Overall Study|Treatment Failure|6
952310|NCT00759148|3136072|P2|Overall Study|Lost to Follow-up|9
952311|NCT00759148|3136073|P1|Overall Study|Lost to Follow-up|3
952312|NCT00759148|3136072|P2|Overall Study|Withdrawal by Subject|7
952313|NCT00759148|3136073|P1|Overall Study|Withdrawal by Subject|3
952314|NCT00759148|3136072|P2|Overall Study|Adverse Event|6
952315|NCT00759148|3136073|P1|Overall Study|Adverse Event|1
952316|NCT00759109|3136083|P2|Overall Study|Lost during study|0
952317|NCT00759109|3136084|P1|Overall Study|Lost during study|1
952318|NCT00759109|3136083|P2|Overall Study|Participant had a liver transplant|1
952319|NCT00759109|3136084|P1|Overall Study|Participant had a liver transplant|0
952320|NCT00759109|3136083|P2|Overall Study|Participant moved to a different city|1
952321|NCT00759109|3136084|P1|Overall Study|Participant moved to a different city|0
952322|NCT00759109|3136083|P2|Overall Study|HCV RNA negative|0
952323|NCT00759109|3136084|P1|Overall Study|HCV RNA negative|1
952324|NCT00759109|3136083|P2|Overall Study|Started new therapy|6
952325|NCT00759109|3136084|P1|Overall Study|Started new therapy|2
952326|NCT00759109|3136083|P2|Overall Study|Lost to Follow-up|6
952327|NCT00759109|3136084|P1|Overall Study|Lost to Follow-up|4
952328|NCT00759109|3136083|P2|Overall Study|Death|3
952329|NCT00759109|3136084|P1|Overall Study|Death|4
952330|NCT00759109|3136083|P2|Overall Study|Withdrawal by Subject|5
952331|NCT00759109|3136084|P1|Overall Study|Withdrawal by Subject|9
952332|NCT00759109|3136083|P2|Overall Study|Inability to comply|1
952333|NCT00759109|3136084|P1|Overall Study|Inability to comply|1
952334|NCT00759109|3136083|P2|Overall Study|Adverse Event|12
952335|NCT00759109|3136084|P1|Overall Study|Adverse Event|17
952336|NCT00759031|3136106|P2|First Intervention (1 Day)|Screening failure|0
952337|NCT00759031|3136107|P1|First Intervention (1 Day)|Screening failure|1
952338|NCT00759031|3136106|P2|First Intervention (1 Day)|Withdrawal by Subject|1
952339|NCT00759031|3136107|P1|First Intervention (1 Day)|Withdrawal by Subject|0
952340|NCT00759031|3136106|P2|First Intervention (1 Day)|Physician Decision|0
952341|NCT00759031|3136107|P1|First Intervention (1 Day)|Physician Decision|1
952342|NCT00758771|3136160|P2|Overall Study|Did not meet eligibility criteria|4
952343|NCT00758771|3136161|P1|Overall Study|Did not meet eligibility criteria|2
952344|NCT00758771|3136160|P2|Overall Study|Withdrawal by Subject|1
952345|NCT00758771|3136161|P1|Overall Study|Withdrawal by Subject|1
952346|NCT00758706|3136219|P2|Overall Study|Adverse Event|4
952347|NCT00758706|3136220|P1|Overall Study|Adverse Event|4
952348|NCT00758680|3136256|P10|Overall Study|Withdrawal by Subject|0
952349|NCT00758680|3136257|P9|Overall Study|Withdrawal by Subject|1
952350|NCT00758680|3136258|P8|Overall Study|Withdrawal by Subject|0
952351|NCT00758680|3136259|P7|Overall Study|Withdrawal by Subject|1
952352|NCT00758680|3136260|P6|Overall Study|Withdrawal by Subject|0
952353|NCT00758680|3136261|P5|Overall Study|Withdrawal by Subject|0
952354|NCT00758680|3136262|P4|Overall Study|Withdrawal by Subject|0
952355|NCT00758680|3136263|P3|Overall Study|Withdrawal by Subject|0
952356|NCT00758680|3136264|P2|Overall Study|Withdrawal by Subject|0
952357|NCT00758680|3136265|P1|Overall Study|Withdrawal by Subject|0
952358|NCT00758680|3136256|P10|Overall Study|Laboratory Adverse Event|0
952359|NCT00758680|3136257|P9|Overall Study|Laboratory Adverse Event|1
952360|NCT00758680|3136258|P8|Overall Study|Laboratory Adverse Event|0
952361|NCT00758680|3136259|P7|Overall Study|Laboratory Adverse Event|0
952362|NCT00758680|3136260|P6|Overall Study|Laboratory Adverse Event|0
952363|NCT00758680|3136261|P5|Overall Study|Laboratory Adverse Event|0
952364|NCT00758680|3136262|P4|Overall Study|Laboratory Adverse Event|0
952365|NCT00758680|3136263|P3|Overall Study|Laboratory Adverse Event|0
952366|NCT00758680|3136264|P2|Overall Study|Laboratory Adverse Event|0
952367|NCT00758680|3136265|P1|Overall Study|Laboratory Adverse Event|0
952368|NCT00758680|3136256|P10|Overall Study|Adverse Event|1
952369|NCT00758680|3136257|P9|Overall Study|Adverse Event|0
952370|NCT00758680|3136258|P8|Overall Study|Adverse Event|1
952371|NCT00758680|3136259|P7|Overall Study|Adverse Event|0
952372|NCT00758680|3136260|P6|Overall Study|Adverse Event|0
952373|NCT00758680|3136261|P5|Overall Study|Adverse Event|0
952374|NCT00758680|3136262|P4|Overall Study|Adverse Event|0
952375|NCT00758680|3136263|P3|Overall Study|Adverse Event|0
952376|NCT00758680|3136264|P2|Overall Study|Adverse Event|0
952377|NCT00758680|3136265|P1|Overall Study|Adverse Event|0
952378|NCT00758602|3136318|P2|Overall Study|Reason not specified|3
952379|NCT00758602|3136319|P1|Overall Study|Reason not specified|3
952380|NCT00758602|3136318|P2|Overall Study|Death|1
952381|NCT00758602|3136319|P1|Overall Study|Death|0
952382|NCT00758602|3136318|P2|Overall Study|Protocol Violation|2
952383|NCT00758602|3136319|P1|Overall Study|Protocol Violation|0
952384|NCT00758602|3136318|P2|Overall Study|Withdrawal by Subject|3
952385|NCT00758602|3136319|P1|Overall Study|Withdrawal by Subject|1
952386|NCT00758602|3136318|P2|Overall Study|Lost to Follow-up|3
952387|NCT00758602|3136319|P1|Overall Study|Lost to Follow-up|4
952388|NCT00758602|3136318|P2|Overall Study|Adverse Event|10
952389|NCT00758602|3136319|P1|Overall Study|Adverse Event|11
952390|NCT00758589|3136345|P4|Overall Study|Palm stopped to work|1
952391|NCT00758589|3136346|P3|Overall Study|Palm stopped to work|0
952392|NCT00758589|3136347|P2|Overall Study|Palm stopped to work|0
952393|NCT00758589|3136348|P1|Overall Study|Palm stopped to work|0
952394|NCT00758589|3136345|P4|Overall Study|Withdrawal by Subject|1
952395|NCT00758589|3136346|P3|Overall Study|Withdrawal by Subject|1
952396|NCT00758589|3136347|P2|Overall Study|Withdrawal by Subject|1
952397|NCT00758589|3136348|P1|Overall Study|Withdrawal by Subject|0
952398|NCT00758589|3136345|P4|Overall Study|Adverse Event|4
952399|NCT00758589|3136346|P3|Overall Study|Adverse Event|5
952400|NCT00758589|3136347|P2|Overall Study|Adverse Event|2
952401|NCT00758589|3136348|P1|Overall Study|Adverse Event|3
952402|NCT00758498|3136441|P3|Overall Study|Noncompliance to study procedures|1
952403|NCT00758498|3136442|P2|Overall Study|Noncompliance to study procedures|0
952404|NCT00758498|3136443|P1|Overall Study|Noncompliance to study procedures|0
952405|NCT00758498|3136441|P3|Overall Study|Withdrawal by Subject|1
952406|NCT00758498|3136442|P2|Overall Study|Withdrawal by Subject|0
952407|NCT00758498|3136443|P1|Overall Study|Withdrawal by Subject|0
952408|NCT00758498|3136441|P3|Overall Study|Subject legally detained out of state|0
952409|NCT00758498|3136442|P2|Overall Study|Subject legally detained out of state|0
952410|NCT00758498|3136443|P1|Overall Study|Subject legally detained out of state|1
952411|NCT00758498|3136441|P3|Overall Study|Adverse Event|3
952412|NCT00758498|3136442|P2|Overall Study|Adverse Event|2
952413|NCT00758498|3136443|P1|Overall Study|Adverse Event|2
952414|NCT00758485|3136528|P2|Overall Study|Not Treated|2
952415|NCT00758485|3136529|P1|Overall Study|Not Treated|1
952416|NCT00758485|3136528|P2|Overall Study|Lost to Follow-up|1
952417|NCT00758485|3136529|P1|Overall Study|Lost to Follow-up|0
952418|NCT00758459|3136541|P2|Overall Study|Withdrawal by Subject|1
952419|NCT00758459|3136542|P1|Overall Study|Withdrawal by Subject|0
952420|NCT00758459|3136541|P2|Overall Study|Protocol Violation|1
952421|NCT00758459|3136542|P1|Overall Study|Protocol Violation|0
952422|NCT00758459|3136541|P2|Overall Study|Adverse Event|2
952423|NCT00758459|3136542|P1|Overall Study|Adverse Event|3
952424|NCT00758394|3136587|P4|3rd Intervention|Lost to Follow-up|1
952425|NCT00758394|3136588|P3|3rd Intervention|Lost to Follow-up|0
952426|NCT00758394|3136589|P2|3rd Intervention|Lost to Follow-up|0
952427|NCT00758394|3136590|P1|3rd Intervention|Lost to Follow-up|1
952428|NCT00758394|3136587|P4|2nd Intervention Order|Lost to Follow-up|0
952429|NCT00758394|3136588|P3|2nd Intervention Order|Lost to Follow-up|0
952430|NCT00758394|3136589|P2|2nd Intervention Order|Lost to Follow-up|1
952431|NCT00758394|3136590|P1|2nd Intervention Order|Lost to Follow-up|0
952432|NCT00758264|3136619|P3|Active Phase|Not specified|4
952433|NCT00758264|3136620|P2|Active Phase|Not specified|0
952434|NCT00758264|3136621|P1|Active Phase|Not specified|0
952435|NCT00758264|3136619|P3|Active Phase|Lost to Follow-up|0
952436|NCT00758264|3136620|P2|Active Phase|Lost to Follow-up|0
952437|NCT00758264|3136621|P1|Active Phase|Lost to Follow-up|1
952438|NCT00758264|3136619|P3|Active Phase|Withdrawal by Subject|1
952439|NCT00758264|3136620|P2|Active Phase|Withdrawal by Subject|0
952440|NCT00758264|3136621|P1|Active Phase|Withdrawal by Subject|0
952441|NCT00758160|3136680|P1|Overall Study|Withdrawal by Subject|8
952442|NCT00758160|3136680|P1|Overall Study|Protocol Violation|12
952443|NCT00758160|3136680|P1|Overall Study|Lost to Follow-up|14
952444|NCT00758160|3136680|P1|Overall Study|Lack of Efficacy|10
952445|NCT00758160|3136680|P1|Overall Study|Adverse Event|15
952446|NCT00758160|3136680|P1|Overall Study|Administration Problems|3
952447|NCT00758160|3136680|P1|Overall Study|No Longer Requires Study Medication|4
952448|NCT00758069|3136701|P3|Overall Study|Incorrect Study Drug|0
952449|NCT00758069|3136702|P2|Overall Study|Incorrect Study Drug|0
952450|NCT00758069|3136703|P1|Overall Study|Incorrect Study Drug|1
952451|NCT00758069|3136701|P3|Overall Study|Lack of Efficacy|1
952452|NCT00758069|3136702|P2|Overall Study|Lack of Efficacy|0
952453|NCT00758069|3136703|P1|Overall Study|Lack of Efficacy|0
952454|NCT00758043|3136718|P4|Overall Study|Other Reasons|5
952455|NCT00758043|3136719|P3|Overall Study|Other Reasons|0
952456|NCT00758043|3136720|P2|Overall Study|Other Reasons|1
952457|NCT00758043|3136721|P1|Overall Study|Other Reasons|0
952458|NCT00758043|3136718|P4|Overall Study|Non-Compliant With study Drug|1
952459|NCT00758043|3136719|P3|Overall Study|Non-Compliant With study Drug|0
952460|NCT00758043|3136720|P2|Overall Study|Non-Compliant With study Drug|0
952461|NCT00758043|3136721|P1|Overall Study|Non-Compliant With study Drug|0
952462|NCT00758043|3136718|P4|Overall Study|Required Prohibited Medication|3
952463|NCT00758043|3136719|P3|Overall Study|Required Prohibited Medication|1
952464|NCT00758043|3136720|P2|Overall Study|Required Prohibited Medication|0
952465|NCT00758043|3136721|P1|Overall Study|Required Prohibited Medication|0
952466|NCT00758043|3136718|P4|Overall Study|Withdrawal by Subject|4
952467|NCT00758043|3136719|P3|Overall Study|Withdrawal by Subject|1
952468|NCT00758043|3136720|P2|Overall Study|Withdrawal by Subject|1
952469|NCT00758043|3136721|P1|Overall Study|Withdrawal by Subject|0
952470|NCT00758043|3136718|P4|Overall Study|Lost to Follow-up|5
952471|NCT00758043|3136719|P3|Overall Study|Lost to Follow-up|2
952472|NCT00758043|3136720|P2|Overall Study|Lost to Follow-up|2
952473|NCT00758043|3136721|P1|Overall Study|Lost to Follow-up|0
952474|NCT00758043|3136718|P4|Overall Study|Refused Further Treatment|8
952475|NCT00758043|3136719|P3|Overall Study|Refused Further Treatment|5
952476|NCT00758043|3136720|P2|Overall Study|Refused Further Treatment|11
952477|NCT00758043|3136721|P1|Overall Study|Refused Further Treatment|0
952478|NCT00758043|3136718|P4|Overall Study|Lack of Efficacy|12
952479|NCT00758043|3136719|P3|Overall Study|Lack of Efficacy|18
952480|NCT00758043|3136720|P2|Overall Study|Lack of Efficacy|6
952481|NCT00758043|3136721|P1|Overall Study|Lack of Efficacy|0
952482|NCT00758043|3136718|P4|Overall Study|Adverse Event|62
952483|NCT00758043|3136719|P3|Overall Study|Adverse Event|12
952484|NCT00758043|3136720|P2|Overall Study|Adverse Event|20
952485|NCT00758043|3136721|P1|Overall Study|Adverse Event|1
952486|NCT00757848|3136749|P2|Overall Study|Incorrect enrolment|0
952487|NCT00757848|3136750|P1|Overall Study|Incorrect enrolment|1
952488|NCT00757848|3136749|P2|Overall Study|Adverse Event|2
952489|NCT00757848|3136750|P1|Overall Study|Adverse Event|1
952490|NCT00757848|3136749|P2|Overall Study|Voluntary discontinuation|0
952491|NCT00757848|3136750|P1|Overall Study|Voluntary discontinuation|1
952492|NCT00757783|3136819|P2|Overall Study|Other|2
952493|NCT00757783|3136820|P1|Overall Study|Other|1
952494|NCT00757783|3136819|P2|Overall Study|Withdrawal by Subject|1
952495|NCT00757783|3136820|P1|Overall Study|Withdrawal by Subject|2
952496|NCT00757783|3136819|P2|Overall Study|Protocol Violation|0
952497|NCT00757783|3136820|P1|Overall Study|Protocol Violation|1
952498|NCT00757783|3136819|P2|Overall Study|Lost to Follow-up|1
952499|NCT00757783|3136820|P1|Overall Study|Lost to Follow-up|1
952500|NCT00757783|3136819|P2|Overall Study|Adverse Event|2
952501|NCT00757783|3136820|P1|Overall Study|Adverse Event|0
952502|NCT00757705|3136856|P1|Overall Study|Other|18
952503|NCT00757705|3136856|P1|Overall Study|Non-compliant|9
952504|NCT00757705|3136856|P1|Overall Study|Ineligible to continue|8
952505|NCT00757705|3136856|P1|Overall Study|Insufficient Response|26
952506|NCT00757705|3136856|P1|Overall Study|Withdrawal by Subject|25
952507|NCT00757705|3136856|P1|Overall Study|Lost to Follow-up|16
952508|NCT00757705|3136856|P1|Overall Study|Adverse Event|19
952509|NCT00757627|3136885|P1|Overall Study|Other|1
952510|NCT00757627|3136885|P1|Overall Study|Withdrawal by Subject|27
952511|NCT00757627|3136885|P1|Overall Study|Lost to Follow-up|28
952512|NCT00757627|3136885|P1|Overall Study|Lack of Efficacy|10
952513|NCT00757627|3136885|P1|Overall Study|Adverse Event|15
952514|NCT00757588|3137020|P2|Period 2: Long-term (52-week) Phase|Not specified|0
952515|NCT00757588|3137021|P1|Period 2: Long-term (52-week) Phase|Not specified|1
952516|NCT00757588|3137020|P2|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4
952517|NCT00757588|3137021|P1|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5
952518|NCT00757588|3137020|P2|Period 2: Long-term (52-week) Phase|Pregnancy|0
952519|NCT00757588|3137021|P1|Period 2: Long-term (52-week) Phase|Pregnancy|1
952520|NCT00757588|3137020|P2|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2
952521|NCT00757588|3137021|P1|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5
952522|NCT00757588|3137020|P2|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
952523|NCT00757588|3137021|P1|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
952524|NCT00757588|3137020|P2|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2
952525|NCT00757588|3137021|P1|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4
952526|NCT00757588|3137020|P2|Period 2: Long-term (52-week) Phase|Adverse Event|0
952527|NCT00757588|3137021|P1|Period 2: Long-term (52-week) Phase|Adverse Event|4
952528|NCT00757588|3137020|P2|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0
952529|NCT00757588|3137021|P1|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1
952530|NCT00757588|3137020|P2|Period 1: Short-term (24-week) Phase|Not specified|1
952531|NCT00757588|3137021|P1|Period 1: Short-term (24-week) Phase|Not specified|0
952532|NCT00757588|3137020|P2|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0
952533|NCT00757588|3137021|P1|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5
952534|NCT00757588|3137020|P2|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1
952535|NCT00757588|3137021|P1|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5
952536|NCT00757588|3137020|P2|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5
952537|NCT00757588|3137021|P1|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3
952538|NCT00757588|3137020|P2|Period 1: Short-term (24-week) Phase|Death|0
952539|NCT00757588|3137021|P1|Period 1: Short-term (24-week) Phase|Death|1
952540|NCT00757588|3137020|P2|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5
952541|NCT00757588|3137021|P1|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13
952542|NCT00757588|3137020|P2|Period 1: Short-term (24-week) Phase|Adverse Event|3
952543|NCT00757588|3137021|P1|Period 1: Short-term (24-week) Phase|Adverse Event|6
952544|NCT00757588|3137020|P2|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2
952545|NCT00757588|3137021|P1|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3
952546|NCT00757237|3137062|P2|Overall Study|Other|2
952547|NCT00757237|3137063|P1|Overall Study|Other|0
952548|NCT00757237|3137062|P2|Overall Study|Safety or Tolerability|5
952549|NCT00757237|3137063|P1|Overall Study|Safety or Tolerability|3
952550|NCT00757237|3137062|P2|Overall Study|Withdrawal by Subject|12
952551|NCT00757237|3137063|P1|Overall Study|Withdrawal by Subject|8
952552|NCT00757237|3137062|P2|Overall Study|Physician Decision|3
952553|NCT00757237|3137063|P1|Overall Study|Physician Decision|2
952554|NCT00757237|3137062|P2|Overall Study|Protocol Violation|2
952555|NCT00757237|3137063|P1|Overall Study|Protocol Violation|0
952556|NCT00757237|3137062|P2|Overall Study|Lost to Follow-up|1
952557|NCT00757237|3137063|P1|Overall Study|Lost to Follow-up|0
952558|NCT00757172|3137091|P1|Overall Study|Progression|4
952559|NCT00757172|3137091|P1|Overall Study|Physician Decision|3
952560|NCT00757172|3137091|P1|Overall Study|Withdrawal by Subject|4
952561|NCT00757003|3137099|P1|Overall Study|Not implanted|1
952562|NCT00757003|3137099|P1|Overall Study|Surgically explanted|2
952563|NCT00757003|3137099|P1|Overall Study|Withdrawal by Subject|4
952564|NCT00757003|3137099|P1|Overall Study|Lost to Follow-up|9
952565|NCT00757003|3137099|P1|Overall Study|Death|33
952566|NCT00756938|3137146|P4|Optional Extension|Adverse Event|1
952567|NCT00756938|3137147|P3|Optional Extension|Adverse Event|0
952568|NCT00756938|3137148|P2|Optional Extension|Adverse Event|0
952569|NCT00756938|3137149|P1|Optional Extension|Adverse Event|0
952570|NCT00756938|3137146|P4|Optional Extension|Withdrawal by Subject|10
952571|NCT00756938|3137147|P3|Optional Extension|Withdrawal by Subject|0
952572|NCT00756938|3137148|P2|Optional Extension|Withdrawal by Subject|0
952573|NCT00756938|3137149|P1|Optional Extension|Withdrawal by Subject|0
952574|NCT00756938|3137146|P4|Optional Extension|Protocol Violation|1
952575|NCT00756938|3137147|P3|Optional Extension|Protocol Violation|0
952576|NCT00756938|3137148|P2|Optional Extension|Protocol Violation|0
952577|NCT00756938|3137149|P1|Optional Extension|Protocol Violation|0
952578|NCT00756938|3137146|P4|Optional Extension|Lost to Follow-up|1
952579|NCT00756938|3137147|P3|Optional Extension|Lost to Follow-up|0
952580|NCT00756938|3137148|P2|Optional Extension|Lost to Follow-up|0
952581|NCT00756938|3137149|P1|Optional Extension|Lost to Follow-up|0
952582|NCT00756938|3137146|P4|Optional Extension|Physician Decision|3
952583|NCT00756938|3137147|P3|Optional Extension|Physician Decision|0
952584|NCT00756938|3137148|P2|Optional Extension|Physician Decision|0
952585|NCT00756938|3137149|P1|Optional Extension|Physician Decision|0
952586|NCT00756938|3137146|P4|Optional Extension|Protocol-specific criteria met|9
952587|NCT00756938|3137147|P3|Optional Extension|Protocol-specific criteria met|0
952588|NCT00756938|3137148|P2|Optional Extension|Protocol-specific criteria met|0
952589|NCT00756938|3137149|P1|Optional Extension|Protocol-specific criteria met|0
952590|NCT00756938|3137146|P4|Optional Extension|End of Study|11
952591|NCT00756938|3137147|P3|Optional Extension|End of Study|0
952592|NCT00756938|3137148|P2|Optional Extension|End of Study|0
952593|NCT00756938|3137149|P1|Optional Extension|End of Study|0
952594|NCT00756938|3137146|P4|Optional Extension|Lack of Efficacy|1
952595|NCT00756938|3137147|P3|Optional Extension|Lack of Efficacy|0
952596|NCT00756938|3137148|P2|Optional Extension|Lack of Efficacy|0
952597|NCT00756938|3137149|P1|Optional Extension|Lack of Efficacy|0
952598|NCT00756938|3137146|P4|12-week Base Study|Lost to Follow-up|0
952599|NCT00756938|3137147|P3|12-week Base Study|Lost to Follow-up|0
952600|NCT00756938|3137148|P2|12-week Base Study|Lost to Follow-up|0
952601|NCT00756938|3137149|P1|12-week Base Study|Lost to Follow-up|1
952602|NCT00756938|3137146|P4|12-week Base Study|Protocol Violation|0
952603|NCT00756938|3137147|P3|12-week Base Study|Protocol Violation|1
952604|NCT00756938|3137148|P2|12-week Base Study|Protocol Violation|0
952605|NCT00756938|3137149|P1|12-week Base Study|Protocol Violation|0
952606|NCT00756938|3137146|P4|12-week Base Study|Protocol-specific Criteria Met|0
952607|NCT00756938|3137147|P3|12-week Base Study|Protocol-specific Criteria Met|1
952608|NCT00756938|3137148|P2|12-week Base Study|Protocol-specific Criteria Met|0
952609|NCT00756938|3137149|P1|12-week Base Study|Protocol-specific Criteria Met|1
952610|NCT00756886|3137177|P2|Overall Study|Ineligible|4
952611|NCT00756886|3137178|P1|Overall Study|Ineligible|9
952612|NCT00756886|3137177|P2|Overall Study|Lack of Efficacy|0
952613|NCT00756886|3137178|P1|Overall Study|Lack of Efficacy|1
952614|NCT00756886|3137177|P2|Overall Study|Adverse Event|3
952615|NCT00756886|3137178|P1|Overall Study|Adverse Event|0
952616|NCT00756886|3137177|P2|Overall Study|Lost to Follow-up|0
952617|NCT00756886|3137178|P1|Overall Study|Lost to Follow-up|1
952618|NCT00756730|3137186|P2|Overall Study|persistent low-level viremmia|1
952619|NCT00756730|3137187|P1|Overall Study|persistent low-level viremmia|0
952620|NCT00756730|3137186|P2|Overall Study|discontinued due to rash prior to week 4|1
952621|NCT00756730|3137187|P1|Overall Study|discontinued due to rash prior to week 4|0
952622|NCT00756574|3137220|P2|Overall Study|Lost to Follow-up|4
952623|NCT00756574|3137221|P1|Overall Study|Lost to Follow-up|4
952624|NCT00756574|3137220|P2|Overall Study|Withdrawal by Subject|7
952625|NCT00756574|3137221|P1|Overall Study|Withdrawal by Subject|9
952626|NCT00756470|3137265|P1|Overall Study|Adverse Event|4
952627|NCT00756470|3137265|P1|Overall Study|Withdrawal by Subject|1
952628|NCT00756457|3137272|P2|Overall Study|Lost to Follow-up|2
952629|NCT00756457|3137273|P1|Overall Study|Lost to Follow-up|1
952630|NCT00756444|3137303|P2|Overall Study|Ineligibility Determined|0
952631|NCT00756444|3137304|P1|Overall Study|Ineligibility Determined|1
952632|NCT00756444|3137303|P2|Overall Study|Disease Progression|7
952633|NCT00756444|3137304|P1|Overall Study|Disease Progression|2
952634|NCT00756444|3137303|P2|Overall Study|Death|4
952635|NCT00756444|3137304|P1|Overall Study|Death|5
952636|NCT00756444|3137303|P2|Overall Study|Lost to Follow-up|1
952637|NCT00756444|3137304|P1|Overall Study|Lost to Follow-up|0
952638|NCT00756444|3137303|P2|Overall Study|Withdrawal by Subject|8
952639|NCT00756444|3137304|P1|Overall Study|Withdrawal by Subject|6
952640|NCT00756444|3137303|P2|Overall Study|Adverse Event|1
952641|NCT00756444|3137304|P1|Overall Study|Adverse Event|1
952642|NCT00756314|3137315|P2|Overall Study|Lost to Follow-up|59
952643|NCT00756314|3137316|P1|Overall Study|Lost to Follow-up|2
952644|NCT00756275|3137332|P2|Overall Study|Withdrawal by Subject|7
952645|NCT00756275|3137333|P1|Overall Study|Withdrawal by Subject|4
952646|NCT00756275|3137332|P2|Overall Study|Lost to Follow-up|21
952647|NCT00756275|3137333|P1|Overall Study|Lost to Follow-up|25
952648|NCT00756002|3137385|P2|Double-Blind Treatment Period|Not Specified|2
952649|NCT00756002|3137386|P1|Double-Blind Treatment Period|Not Specified|2
952650|NCT00756002|3137385|P2|Double-Blind Treatment Period|Protocol Violation|5
952651|NCT00756002|3137386|P1|Double-Blind Treatment Period|Protocol Violation|6
952652|NCT00756002|3137385|P2|Double-Blind Treatment Period|Withdrawal by Subject|6
952653|NCT00756002|3137386|P1|Double-Blind Treatment Period|Withdrawal by Subject|6
952654|NCT00756002|3137385|P2|Double-Blind Treatment Period|Lost to Follow-up|1
952655|NCT00756002|3137386|P1|Double-Blind Treatment Period|Lost to Follow-up|0
952656|NCT00756002|3137385|P2|Double-Blind Treatment Period|Lack of Efficacy|1
952657|NCT00756002|3137386|P1|Double-Blind Treatment Period|Lack of Efficacy|1
952658|NCT00755937|3137480|P1|Observational Follow-up|Lost to Follow-up|148
952659|NCT00755937|3137480|P1|Recruitment|Unknown if infliximab received|164
952660|NCT00755846|3137507|P6|Overall Study|Participant Non-compliance|0
952661|NCT00755846|3137508|P5|Overall Study|Participant Non-compliance|1
952662|NCT00755846|3137509|P4|Overall Study|Participant Non-compliance|0
952663|NCT00755846|3137510|P3|Overall Study|Participant Non-compliance|0
952664|NCT00755846|3137511|P2|Overall Study|Participant Non-compliance|0
952665|NCT00755846|3137512|P1|Overall Study|Participant Non-compliance|0
952666|NCT00755846|3137507|P6|Overall Study|Administrative Error|0
952667|NCT00755846|3137508|P5|Overall Study|Administrative Error|0
952668|NCT00755846|3137509|P4|Overall Study|Administrative Error|0
952669|NCT00755846|3137510|P3|Overall Study|Administrative Error|0
952670|NCT00755846|3137511|P2|Overall Study|Administrative Error|1
952671|NCT00755846|3137512|P1|Overall Study|Administrative Error|0
952672|NCT00755846|3137507|P6|Overall Study|Physician Decision|1
952673|NCT00755846|3137508|P5|Overall Study|Physician Decision|0
952674|NCT00755846|3137509|P4|Overall Study|Physician Decision|1
952675|NCT00755846|3137510|P3|Overall Study|Physician Decision|0
952676|NCT00755846|3137511|P2|Overall Study|Physician Decision|3
952677|NCT00755846|3137512|P1|Overall Study|Physician Decision|1
952678|NCT00755846|3137507|P6|Overall Study|Hyperglycemic Rescue|7
952679|NCT00755846|3137508|P5|Overall Study|Hyperglycemic Rescue|8
952680|NCT00755846|3137509|P4|Overall Study|Hyperglycemic Rescue|8
952681|NCT00755846|3137510|P3|Overall Study|Hyperglycemic Rescue|5
952682|NCT00755846|3137511|P2|Overall Study|Hyperglycemic Rescue|7
952683|NCT00755846|3137512|P1|Overall Study|Hyperglycemic Rescue|21
952684|NCT00755846|3137507|P6|Overall Study|Withdrawal by Subject|1
952685|NCT00755846|3137508|P5|Overall Study|Withdrawal by Subject|0
952686|NCT00755846|3137509|P4|Overall Study|Withdrawal by Subject|2
952687|NCT00755846|3137510|P3|Overall Study|Withdrawal by Subject|5
952688|NCT00755846|3137511|P2|Overall Study|Withdrawal by Subject|3
952689|NCT00755846|3137512|P1|Overall Study|Withdrawal by Subject|2
952690|NCT00755846|3137507|P6|Overall Study|Lost to Follow-up|2
952691|NCT00755846|3137508|P5|Overall Study|Lost to Follow-up|4
952692|NCT00755846|3137509|P4|Overall Study|Lost to Follow-up|0
952693|NCT00755846|3137510|P3|Overall Study|Lost to Follow-up|1
952694|NCT00755846|3137511|P2|Overall Study|Lost to Follow-up|2
952695|NCT00755846|3137512|P1|Overall Study|Lost to Follow-up|0
952696|NCT00755846|3137507|P6|Overall Study|Protocol Violation|1
952697|NCT00755846|3137508|P5|Overall Study|Protocol Violation|1
952698|NCT00755846|3137509|P4|Overall Study|Protocol Violation|1
952699|NCT00755846|3137510|P3|Overall Study|Protocol Violation|1
952700|NCT00755846|3137511|P2|Overall Study|Protocol Violation|1
952701|NCT00755846|3137512|P1|Overall Study|Protocol Violation|1
952702|NCT00755846|3137507|P6|Overall Study|Adverse Event|2
952703|NCT00755846|3137508|P5|Overall Study|Adverse Event|3
952704|NCT00755846|3137509|P4|Overall Study|Adverse Event|1
952705|NCT00755846|3137510|P3|Overall Study|Adverse Event|0
952706|NCT00755846|3137511|P2|Overall Study|Adverse Event|0
952707|NCT00755846|3137512|P1|Overall Study|Adverse Event|0
952708|NCT00755807|3137612|P2|Open-label Extension Phase|Sponsor Decision|1
952709|NCT00755807|3137613|P1|Open-label Extension Phase|Sponsor Decision|0
952710|NCT00755807|3137612|P2|Open-label Extension Phase|Lost to Follow-up|0
952711|NCT00755807|3137613|P1|Open-label Extension Phase|Lost to Follow-up|2
952712|NCT00755807|3137612|P2|Open-label Extension Phase|Withdrawal by Subject|3
952713|NCT00755807|3137613|P1|Open-label Extension Phase|Withdrawal by Subject|1
952714|NCT00755807|3137612|P2|Open-label Extension Phase|Lack of Efficacy|3
952715|NCT00755807|3137613|P1|Open-label Extension Phase|Lack of Efficacy|3
952716|NCT00755807|3137612|P2|Open-label Extension Phase|Protocol Violation|2
952717|NCT00755807|3137613|P1|Open-label Extension Phase|Protocol Violation|5
952718|NCT00755807|3137612|P2|Open-label Extension Phase|Adverse Event|7
952719|NCT00755807|3137613|P1|Open-label Extension Phase|Adverse Event|7
952720|NCT00755807|3137612|P2|Acute Phase|Physician Decision|1
952721|NCT00755807|3137613|P1|Acute Phase|Physician Decision|0
952722|NCT00755807|3137612|P2|Acute Phase|Lack of Efficacy|1
952723|NCT00755807|3137613|P1|Acute Phase|Lack of Efficacy|0
952724|NCT00755807|3137612|P2|Acute Phase|Withdrawal by Subject|2
952725|NCT00755807|3137613|P1|Acute Phase|Withdrawal by Subject|1
952726|NCT00755807|3137612|P2|Acute Phase|Protocol Violation|3
952727|NCT00755807|3137613|P1|Acute Phase|Protocol Violation|1
952728|NCT00755807|3137612|P2|Acute Phase|Adverse Event|5
952729|NCT00755807|3137613|P1|Acute Phase|Adverse Event|16
952730|NCT00755716|3137693|P3|Overall Study|work schedule issues|1
952731|NCT00755716|3137694|P2|Overall Study|work schedule issues|1
952732|NCT00755716|3137695|P1|Overall Study|work schedule issues|0
952733|NCT00755716|3137693|P3|Overall Study|Lost to Follow-up|1
952734|NCT00755716|3137694|P2|Overall Study|Lost to Follow-up|3
952735|NCT00755716|3137695|P1|Overall Study|Lost to Follow-up|5
952736|NCT00755716|3137693|P3|Overall Study|Lack of Efficacy|0
952737|NCT00755716|3137694|P2|Overall Study|Lack of Efficacy|0
952738|NCT00755716|3137695|P1|Overall Study|Lack of Efficacy|2
952739|NCT00755716|3137693|P3|Overall Study|Adverse Event|1
952740|NCT00755716|3137694|P2|Overall Study|Adverse Event|4
952741|NCT00755716|3137695|P1|Overall Study|Adverse Event|1
952742|NCT00755417|3137709|P3|Overall Study|Not specified or missing data|12
952743|NCT00755417|3137710|P2|Overall Study|Not specified or missing data|18
952744|NCT00755417|3137711|P1|Overall Study|Not specified or missing data|9
952745|NCT00755417|3137709|P3|Overall Study|Withdrawal by Subject|12
952746|NCT00755417|3137710|P2|Overall Study|Withdrawal by Subject|12
952747|NCT00755417|3137711|P1|Overall Study|Withdrawal by Subject|12
952748|NCT00755417|3137709|P3|Overall Study|Lost to Follow-up|1
952749|NCT00755417|3137710|P2|Overall Study|Lost to Follow-up|0
952750|NCT00755417|3137711|P1|Overall Study|Lost to Follow-up|3
952751|NCT00755417|3137709|P3|Overall Study|Protocol Violation|1
952752|NCT00755417|3137710|P2|Overall Study|Protocol Violation|1
952753|NCT00755417|3137711|P1|Overall Study|Protocol Violation|2
952754|NCT00755417|3137709|P3|Overall Study|Lack of Efficacy|9
952755|NCT00755417|3137710|P2|Overall Study|Lack of Efficacy|4
952756|NCT00755417|3137711|P1|Overall Study|Lack of Efficacy|8
952757|NCT00755417|3137709|P3|Overall Study|Adverse Event|7
952758|NCT00755417|3137710|P2|Overall Study|Adverse Event|20
952759|NCT00755417|3137711|P1|Overall Study|Adverse Event|28
952760|NCT00755222|3137768|P2|Overall Study|Protocol Violation|0
952761|NCT00755222|3137769|P1|Overall Study|Protocol Violation|2
952762|NCT00755222|3137768|P2|Overall Study|Adverse Event|0
952763|NCT00755222|3137769|P1|Overall Study|Adverse Event|2
952764|NCT00755222|3137768|P2|Overall Study|Withdrawal by Subject|2
952765|NCT00755222|3137769|P1|Overall Study|Withdrawal by Subject|4
952766|NCT00755196|3137783|P1|Overall Study|Lack of Efficiency|1
952767|NCT00755196|3137783|P1|Overall Study|Lost to Follow-up|1
952768|NCT00755105|3137804|P3|Overall Study|Withdrawal by Subject|4
952769|NCT00755105|3137805|P2|Overall Study|Withdrawal by Subject|11
952770|NCT00755105|3137806|P1|Overall Study|Withdrawal by Subject|9
952771|NCT00755079|3137816|P2|Overall Study|Withdrawal by Subject|2
952772|NCT00755079|3137817|P1|Overall Study|Withdrawal by Subject|0
952773|NCT00755079|3137816|P2|Overall Study|Adverse Event|1
952774|NCT00755079|3137817|P1|Overall Study|Adverse Event|0
952775|NCT00755079|3137816|P2|Overall Study|Lost to Follow-up|3
952776|NCT00755079|3137817|P1|Overall Study|Lost to Follow-up|1
952777|NCT00754793|3137869|P2|Overall Study|voluntary withdrawn from study|1
952778|NCT00754793|3137870|P1|Overall Study|voluntary withdrawn from study|0
952779|NCT00754741|3137888|P3|Overall Study|Died or disenrolled|54
952780|NCT00754741|3137889|P2|Overall Study|Died or disenrolled|69
952781|NCT00754741|3137890|P1|Overall Study|Died or disenrolled|57
952782|NCT00754650|3137937|P1|Overall Study|Disease Progression|2
952783|NCT00754624|3137942|P1|Overall Study|Lost to Follow-up|3
952784|NCT00754624|3137942|P1|Overall Study|Various|12
952785|NCT00754624|3137942|P1|Overall Study|Withdrawal by Subject|28
952786|NCT00754624|3137942|P1|Overall Study|Protocol Violation|1
952787|NCT00754624|3137942|P1|Overall Study|Physician Decision|8
952788|NCT00754624|3137942|P1|Overall Study|Death|1
952789|NCT00754624|3137942|P1|Overall Study|Adverse Event|16
952790|NCT00754572|3137952|P1|Overall Study|Lost to Follow-up|1
952791|NCT00754572|3137952|P1|Overall Study|Administrative Reason|3
952792|NCT00754572|3137952|P1|Overall Study|Death|1
952793|NCT00754572|3137952|P1|Overall Study|Lack of Efficacy|2
952794|NCT00754572|3137952|P1|Overall Study|Withdrawal by Subject|3
952795|NCT00754572|3137952|P1|Overall Study|Protocol Violation|3
952796|NCT00754572|3137952|P1|Overall Study|Other|39
952797|NCT00754572|3137952|P1|Overall Study|Adverse Event|19
952798|NCT00754559|3137979|P1|Overall Study|Withdrawal by Subject|3
952799|NCT00754559|3137979|P1|Overall Study|Other|5
952800|NCT00754559|3137979|P1|Overall Study|Administrative reason|1
952801|NCT00754559|3137979|P1|Overall Study|Lost to Follow-up|2
952802|NCT00754559|3137979|P1|Overall Study|Lack of Efficacy|10
952803|NCT00754559|3137979|P1|Overall Study|Protocol Violation|11
952804|NCT00754559|3137979|P1|Overall Study|Adverse Event|15
952805|NCT00754442|3138079|P2|Overall Study|Withdrawal by Subject|3
952806|NCT00754442|3138080|P1|Overall Study|Withdrawal by Subject|5
952807|NCT00754390|3138087|P1|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1
952808|NCT00754390|3138087|P1|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1
952809|NCT00754390|3138087|P1|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2
952810|NCT00754390|3138087|P1|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3
952811|NCT00754338|3138109|P4|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
952812|NCT00754338|3138110|P3|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
952813|NCT00754338|3138111|P2|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
952814|NCT00754338|3138112|P1|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
952815|NCT00754338|3138109|P4|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
952816|NCT00754338|3138110|P3|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
952817|NCT00754338|3138111|P2|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
952818|NCT00754338|3138112|P1|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
952819|NCT00754325|3138144|P2|Initial Treatment|Disease Progression|35
952820|NCT00754325|3138145|P1|Initial Treatment|Disease Progression|35
952821|NCT00754325|3138144|P2|Initial Treatment|Sponsor Request|1
952822|NCT00754325|3138145|P1|Initial Treatment|Sponsor Request|0
952823|NCT00754325|3138144|P2|Initial Treatment|Physician Decision|0
952824|NCT00754325|3138145|P1|Initial Treatment|Physician Decision|2
952825|NCT00754325|3138144|P2|Initial Treatment|Withdrawal by Subject|2
952826|NCT00754325|3138145|P1|Initial Treatment|Withdrawal by Subject|2
952827|NCT00754325|3138144|P2|Initial Treatment|Adverse Event|6
952828|NCT00754325|3138145|P1|Initial Treatment|Adverse Event|7
952829|NCT00754325|3138144|P2|Initial Treatment|Continuing Active Treatment|5
952830|NCT00754325|3138145|P1|Initial Treatment|Continuing Active Treatment|4
952831|NCT00754234|3138164|P1|Overall Study|Withdrawal by Subject|3
952832|NCT00754065|3138250|P2|Overall Study|Reason not specified or unknown, etc.|27
952833|NCT00754065|3138251|P1|Overall Study|Reason not specified or unknown, etc.|21
952834|NCT00754065|3138250|P2|Overall Study|Pregnancy|0
952835|NCT00754065|3138251|P1|Overall Study|Pregnancy|6
952836|NCT00754065|3138250|P2|Overall Study|Withdrawal by Subject|5
952837|NCT00754065|3138251|P1|Overall Study|Withdrawal by Subject|4
952838|NCT00754065|3138250|P2|Overall Study|Protocol Violation|10
952839|NCT00754065|3138251|P1|Overall Study|Protocol Violation|12
952840|NCT00754065|3138250|P2|Overall Study|Lost to Follow-up|11
952841|NCT00754065|3138251|P1|Overall Study|Lost to Follow-up|7
952842|NCT00754065|3138250|P2|Overall Study|Adverse Event|25
952843|NCT00754065|3138251|P1|Overall Study|Adverse Event|19
952844|NCT00754065|3138250|P2|Overall Study|Never received treatment|2
952845|NCT00754065|3138251|P1|Overall Study|Never received treatment|12
952846|NCT00754052|3138491|P2|Overall Study|Study terminated by Sponsor|3
952847|NCT00754052|3138492|P1|Overall Study|Study terminated by Sponsor|5
952848|NCT00754013|3138506|P2|Overall Study|didn't return after study termed|4
952849|NCT00754013|3138507|P1|Overall Study|didn't return after study termed|3
952850|NCT00754013|3138506|P2|Overall Study|Lost to Follow-up|1
952851|NCT00754013|3138507|P1|Overall Study|Lost to Follow-up|1
952852|NCT00753922|3138541|P4|Overall Study|Discontinuation Due to Explantation|4
952853|NCT00753922|3138542|P3|Overall Study|Discontinuation Due to Explantation|14
952854|NCT00753922|3138543|P2|Overall Study|Discontinuation Due to Explantation|14
952855|NCT00753922|3138544|P1|Overall Study|Discontinuation Due to Explantation|14
952856|NCT00753922|3138541|P4|Overall Study|Death|1
952857|NCT00753922|3138542|P3|Overall Study|Death|2
952858|NCT00753922|3138543|P2|Overall Study|Death|23
952859|NCT00753922|3138544|P1|Overall Study|Death|2
952860|NCT00753922|3138541|P4|Overall Study|Patients Not Completing Visit|0
952861|NCT00753922|3138542|P3|Overall Study|Patients Not Completing Visit|1
952862|NCT00753922|3138543|P2|Overall Study|Patients Not Completing Visit|0
952863|NCT00753922|3138544|P1|Overall Study|Patients Not Completing Visit|11
952864|NCT00753922|3138541|P4|Overall Study|Patient Non-compliance|11
952865|NCT00753922|3138542|P3|Overall Study|Patient Non-compliance|14
952866|NCT00753922|3138543|P2|Overall Study|Patient Non-compliance|22
952867|NCT00753922|3138544|P1|Overall Study|Patient Non-compliance|55
952868|NCT00753922|3138541|P4|Overall Study|Withdrawal by Subject|2
952869|NCT00753922|3138542|P3|Overall Study|Withdrawal by Subject|4
952870|NCT00753922|3138543|P2|Overall Study|Withdrawal by Subject|11
952871|NCT00753922|3138544|P1|Overall Study|Withdrawal by Subject|9
952872|NCT00753922|3138541|P4|Overall Study|Lost to Follow-up|5
952873|NCT00753922|3138542|P3|Overall Study|Lost to Follow-up|28
952874|NCT00753922|3138543|P2|Overall Study|Lost to Follow-up|24
952875|NCT00753922|3138544|P1|Overall Study|Lost to Follow-up|155
952876|NCT00753896|3138574|P1|Overall Study|Entry Criteria Not Met|4
952877|NCT00753896|3138574|P1|Overall Study|Withdrawal by Subject|4
952878|NCT00753896|3138574|P1|Overall Study|Protocol Violation|1
952879|NCT00753896|3138574|P1|Overall Study|Lost to Follow-up|2
952880|NCT00753896|3138574|P1|Overall Study|Death|1
952881|NCT00753896|3138574|P1|Overall Study|Adverse Event|4
952882|NCT00753766|3138590|P2|Overall Study|Physician Decision|0
952883|NCT00753766|3138591|P1|Overall Study|Physician Decision|1
952884|NCT00753714|3138601|P2|Overall Study|not specified|5
952885|NCT00753714|3138602|P1|Overall Study|not specified|7
952886|NCT00753714|3138601|P2|Overall Study|Death|3
952887|NCT00753714|3138602|P1|Overall Study|Death|3
952888|NCT00753714|3138601|P2|Overall Study|Withdrawal by Subject|1
952889|NCT00753714|3138602|P1|Overall Study|Withdrawal by Subject|2
952890|NCT00753714|3138601|P2|Overall Study|Lost to Follow-up|1
952891|NCT00753714|3138602|P1|Overall Study|Lost to Follow-up|0
952892|NCT00753714|3138601|P2|Overall Study|Protocol Violation|0
952893|NCT00753714|3138602|P1|Overall Study|Protocol Violation|1
952894|NCT00753714|3138601|P2|Overall Study|Adverse Event|18
952895|NCT00753714|3138602|P1|Overall Study|Adverse Event|26
952896|NCT00753714|3138601|P2|Overall Study|Lack of Efficacy|34
952897|NCT00753714|3138602|P1|Overall Study|Lack of Efficacy|21
952898|NCT00753688|3138618|P2|Overall Study|Adverse Event|1
952899|NCT00753688|3138619|P1|Overall Study|Adverse Event|0
952900|NCT00753688|3138618|P2|Overall Study|Ongoing - in Follow-up|31
952901|NCT00753688|3138619|P1|Overall Study|Ongoing - in Follow-up|15
952902|NCT00753688|3138618|P2|Overall Study|Participant Withdrew Consent|2
952903|NCT00753688|3138619|P1|Overall Study|Participant Withdrew Consent|2
952904|NCT00753688|3138618|P2|Overall Study|Missing|9
952905|NCT00753688|3138619|P1|Overall Study|Missing|4
952906|NCT00753688|3138618|P2|Overall Study|Death|203
952907|NCT00753688|3138619|P1|Overall Study|Death|102
952908|NCT00753675|3138648|P3|Overall Study|Lost to Follow-up|0
952909|NCT00753675|3138649|P2|Overall Study|Lost to Follow-up|0
952910|NCT00753675|3138650|P1|Overall Study|Lost to Follow-up|1
952911|NCT00753675|3138648|P3|Overall Study|Withdrawal by Subject|0
952912|NCT00753675|3138649|P2|Overall Study|Withdrawal by Subject|1
952913|NCT00753675|3138650|P1|Overall Study|Withdrawal by Subject|0
952914|NCT00753675|3138648|P3|Overall Study|Objective progression of disease|35
952915|NCT00753675|3138649|P2|Overall Study|Objective progression of disease|35
952916|NCT00753675|3138650|P1|Overall Study|Objective progression of disease|35
952917|NCT00753675|3138648|P3|Overall Study|Adverse Event|4
952918|NCT00753675|3138649|P2|Overall Study|Adverse Event|9
952919|NCT00753675|3138650|P1|Overall Study|Adverse Event|11
952920|NCT00753675|3138648|P3|Overall Study|Death|4
952921|NCT00753675|3138649|P2|Overall Study|Death|2
952922|NCT00753675|3138650|P1|Overall Study|Death|1
952923|NCT00753675|3138648|P3|Overall Study|other reason|13
952924|NCT00753675|3138649|P2|Overall Study|other reason|12
952925|NCT00753675|3138650|P1|Overall Study|other reason|11
952926|NCT00753649|3138672|P2|Overall Study|Protocol Violation|0
952927|NCT00753649|3138673|P1|Overall Study|Protocol Violation|2
952928|NCT00753649|3138672|P2|Overall Study|Lost to follow-up-complete vaccination|0
952929|NCT00753649|3138673|P1|Overall Study|Lost to follow-up-complete vaccination|1
952930|NCT00753649|3138672|P2|Overall Study|Lost to follow-up-incomplete vaccination|0
952931|NCT00753649|3138673|P1|Overall Study|Lost to follow-up-incomplete vaccination|3
952932|NCT00753649|3138672|P2|Overall Study|Migrated/moved from study area|0
952933|NCT00753649|3138673|P1|Overall Study|Migrated/moved from study area|1
952934|NCT00753623|3138705|P2|Phase II (14 Days)|Physician Decision|1
952935|NCT00753623|3138706|P1|Phase II (14 Days)|Physician Decision|0
952936|NCT00753623|3138705|P2|Washout (7 Days)|Physician Decision|0
952937|NCT00753623|3138706|P1|Washout (7 Days)|Physician Decision|1
952938|NCT00753623|3138705|P2|Phase I (14 Days)|Adverse Event|1
952939|NCT00753623|3138706|P1|Phase I (14 Days)|Adverse Event|0
952940|NCT00753623|3138705|P2|Phase I (14 Days)|Physician Decision|2
952941|NCT00753623|3138706|P1|Phase I (14 Days)|Physician Decision|1
952942|NCT00753623|3138705|P2|Phase I (14 Days)|Withdrawal by Subject|1
952943|NCT00753623|3138706|P1|Phase I (14 Days)|Withdrawal by Subject|1
952944|NCT00753545|3138714|P2|Overall Study|Voluntary Discontinuation of Patient|3
952945|NCT00753545|3138715|P1|Overall Study|Voluntary Discontinuation of Patient|7
952946|NCT00753545|3138714|P2|Overall Study|Protocol Violation|0
952947|NCT00753545|3138715|P1|Overall Study|Protocol Violation|1
952948|NCT00753545|3138714|P2|Overall Study|Lost to Follow-up|3
952949|NCT00753545|3138715|P1|Overall Study|Lost to Follow-up|2
952950|NCT00753545|3138714|P2|Overall Study|Death|112
952951|NCT00753545|3138715|P1|Overall Study|Death|98
952952|NCT00753519|3138753|P2|Overall Study|Withdrawal by Subject|2
952953|NCT00753519|3138754|P1|Overall Study|Withdrawal by Subject|0
952954|NCT00753506|3138776|P2|Overall Study|Other reason|1
952955|NCT00753506|3138777|P1|Overall Study|Other reason|1
952956|NCT00753506|3138776|P2|Overall Study|Lost to Follow-up|0
952957|NCT00753506|3138777|P1|Overall Study|Lost to Follow-up|2
952958|NCT00753506|3138776|P2|Overall Study|Withdrawal by Subject|1
952959|NCT00753506|3138777|P1|Overall Study|Withdrawal by Subject|4
952960|NCT00753454|3138783|P1|Overall Study|Investigator Decision|1
952961|NCT00753454|3138783|P1|Overall Study|Withdrawal by Subject|5
952962|NCT00753454|3138783|P1|Overall Study|Lost to Follow-up|3
952963|NCT00753454|3138783|P1|Overall Study|Lack of Efficacy|1
952964|NCT00753454|3138783|P1|Overall Study|Adverse Event|4
952965|NCT00753415|3138817|P10|Part B|Disease progression|1
952966|NCT00753415|3138818|P9|Part B|Disease progression|2
952967|NCT00753415|3138819|P8|Part B|Disease progression|0
952968|NCT00753415|3138820|P7|Part B|Disease progression|0
952969|NCT00753415|3138821|P6|Part B|Disease progression|0
952970|NCT00753415|3138822|P5|Part B|Disease progression|0
952971|NCT00753415|3138823|P4|Part B|Disease progression|0
952972|NCT00753415|3138824|P3|Part B|Disease progression|0
952973|NCT00753415|3138825|P2|Part B|Disease progression|0
952974|NCT00753415|3138826|P1|Part B|Disease progression|0
952975|NCT00753415|3138817|P10|Part B|Lost to Follow-up|0
952976|NCT00753415|3138818|P9|Part B|Lost to Follow-up|1
952977|NCT00753415|3138819|P8|Part B|Lost to Follow-up|1
952978|NCT00753415|3138820|P7|Part B|Lost to Follow-up|0
952979|NCT00753415|3138821|P6|Part B|Lost to Follow-up|0
952980|NCT00753415|3138822|P5|Part B|Lost to Follow-up|0
952981|NCT00753415|3138823|P4|Part B|Lost to Follow-up|0
952982|NCT00753415|3138824|P3|Part B|Lost to Follow-up|0
952983|NCT00753415|3138825|P2|Part B|Lost to Follow-up|0
952984|NCT00753415|3138826|P1|Part B|Lost to Follow-up|0
952985|NCT00753415|3138817|P10|Part A|Withdrawal by Subject|0
952986|NCT00753415|3138818|P9|Part A|Withdrawal by Subject|0
952987|NCT00753415|3138819|P8|Part A|Withdrawal by Subject|0
952988|NCT00753415|3138820|P7|Part A|Withdrawal by Subject|0
952989|NCT00753415|3138821|P6|Part A|Withdrawal by Subject|0
952990|NCT00753415|3138822|P5|Part A|Withdrawal by Subject|0
952991|NCT00753415|3138823|P4|Part A|Withdrawal by Subject|0
952992|NCT00753415|3138824|P3|Part A|Withdrawal by Subject|1
952993|NCT00753415|3138825|P2|Part A|Withdrawal by Subject|0
952994|NCT00753415|3138826|P1|Part A|Withdrawal by Subject|0
952995|NCT00753415|3138817|P10|Part A|Disease progression|0
952996|NCT00753415|3138818|P9|Part A|Disease progression|0
952997|NCT00753415|3138819|P8|Part A|Disease progression|0
952998|NCT00753415|3138820|P7|Part A|Disease progression|0
952999|NCT00753415|3138821|P6|Part A|Disease progression|0
953000|NCT00753415|3138822|P5|Part A|Disease progression|0
953001|NCT00753415|3138823|P4|Part A|Disease progression|2
953002|NCT00753415|3138824|P3|Part A|Disease progression|1
953003|NCT00753415|3138825|P2|Part A|Disease progression|0
953004|NCT00753415|3138826|P1|Part A|Disease progression|1
953005|NCT00753272|3138916|P2|Overall Study|Other|1088
953006|NCT00753272|3138917|P1|Overall Study|Other|1104
953007|NCT00753272|3138916|P2|Overall Study|Lost to Follow-up|497
953008|NCT00753272|3138917|P1|Overall Study|Lost to Follow-up|491
953009|NCT00753272|3138916|P2|Overall Study|Withdrawal by Subject|2407
953010|NCT00753272|3138917|P1|Overall Study|Withdrawal by Subject|2481
953011|NCT00753272|3138916|P2|Overall Study|Protocol Violation|46
953012|NCT00753272|3138917|P1|Overall Study|Protocol Violation|28
953013|NCT00753272|3138916|P2|Overall Study|Adverse Event|869
953014|NCT00753272|3138917|P1|Overall Study|Adverse Event|878
953015|NCT00753012|3139001|P2|Overall Study|Confounded endpoint data|0
953016|NCT00753012|3139002|P1|Overall Study|Confounded endpoint data|1
953017|NCT00753012|3139001|P2|Overall Study|Lost to Follow-up|0
953018|NCT00753012|3139002|P1|Overall Study|Lost to Follow-up|4
953019|NCT00753012|3139001|P2|Overall Study|Withdrawal by Subject|1
953020|NCT00753012|3139002|P1|Overall Study|Withdrawal by Subject|0
953021|NCT00753012|3139001|P2|Overall Study|Adverse Event|0
953022|NCT00753012|3139002|P1|Overall Study|Adverse Event|2
953023|NCT00753012|3139001|P2|Overall Study|Ineligible, abnormal cardiac histo|0
953024|NCT00753012|3139002|P1|Overall Study|Ineligible, abnormal cardiac histo|1
953025|NCT00752986|3139015|P3|Overall Study|Protocol Violation|0
953026|NCT00752986|3139016|P2|Overall Study|Protocol Violation|0
953027|NCT00752986|3139017|P1|Overall Study|Protocol Violation|3
953028|NCT00752986|3139015|P3|Overall Study|Withdrawal by Subject|2
953029|NCT00752986|3139016|P2|Overall Study|Withdrawal by Subject|1
953030|NCT00752986|3139017|P1|Overall Study|Withdrawal by Subject|2
953031|NCT00752895|3139046|P2|Overall Study|Withdrawal by Subject|3
953032|NCT00752895|3139047|P1|Overall Study|Withdrawal by Subject|8
953033|NCT00752791|3139055|P1|Overall Study|Protocol deviation|1
953034|NCT00752791|3139055|P1|Overall Study|Switched to hemodialysis|2
953035|NCT00752791|3139055|P1|Overall Study|Renal transplant|3
953036|NCT00752791|3139055|P1|Overall Study|Death|1
953037|NCT00752791|3139055|P1|Overall Study|Physician Decision|1
953038|NCT00752791|3139055|P1|Overall Study|Withdrawal by Subject|1
953039|NCT00752791|3139055|P1|Overall Study|Adverse Event|7
953040|NCT00752726|3139067|P2|Overall Study|Other Reason|2
953041|NCT00752726|3139068|P1|Overall Study|Other Reason|1
953042|NCT00752726|3139067|P2|Overall Study|Withdrawal by Subject|10
953043|NCT00752726|3139068|P1|Overall Study|Withdrawal by Subject|5
953044|NCT00752726|3139067|P2|Overall Study|Adverse Event|0
953045|NCT00752726|3139068|P1|Overall Study|Adverse Event|3
953046|NCT00752726|3139067|P2|Overall Study|Lost to Follow-up|1
953047|NCT00752726|3139068|P1|Overall Study|Lost to Follow-up|2
953048|NCT00752622|3139093|P1|Interventional Phase|Premature Study Termination|5
953049|NCT00752622|3139093|P1|Interventional Phase|Physician Decision|1
953050|NCT00752622|3139093|P1|Interventional Phase|Non-responder|2
953051|NCT00752622|3139093|P1|Observational Phase|Other|2
953052|NCT00752622|3139093|P1|Observational Phase|Adverse Event|1
953053|NCT00752622|3139093|P1|Observational Phase|Withdrawal by Subject|2
953054|NCT00752622|3139093|P1|Observational Phase|Non-responder|2
953055|NCT00752622|3139093|P1|Observational Phase|Premature Study Termination|36
953056|NCT00752622|3139093|P1|Induction Phase|Premature study termination|14
953057|NCT00752622|3139093|P1|Induction Phase|Withdrawal by Subject|1
953058|NCT00752622|3139093|P1|Induction Phase|Non-responder|14
953059|NCT00752622|3139093|P1|Induction Phase|Other|3
953060|NCT00752622|3139093|P1|Induction Phase|Adverse Event|3
953061|NCT00752609|3139106|P2|Overall Study|Received Aranesp in error|0
953062|NCT00752609|3139107|P1|Overall Study|Received Aranesp in error|1
953063|NCT00752609|3139106|P2|Overall Study|Met exclusion criteria|0
953064|NCT00752609|3139107|P1|Overall Study|Met exclusion criteria|1
953065|NCT00752609|3139106|P2|Overall Study|Death|0
953066|NCT00752609|3139107|P1|Overall Study|Death|1
953067|NCT00752609|3139106|P2|Overall Study|Physician Decision|0
953068|NCT00752609|3139107|P1|Overall Study|Physician Decision|1
953069|NCT00752609|3139106|P2|Overall Study|Withdrawal by Subject|0
953070|NCT00752609|3139107|P1|Overall Study|Withdrawal by Subject|3
953071|NCT00752609|3139106|P2|Overall Study|Adverse Event|2
953072|NCT00752609|3139107|P1|Overall Study|Adverse Event|2
953073|NCT00752232|3139133|P7|Overall Study|Caregiver could not attend the subject|0
953074|NCT00752232|3139134|P6|Overall Study|Caregiver could not attend the subject|0
953075|NCT00752232|3139135|P5|Overall Study|Caregiver could not attend the subject|1
953076|NCT00752232|3139136|P4|Overall Study|Caregiver could not attend the subject|0
953077|NCT00752232|3139137|P3|Overall Study|Caregiver could not attend the subject|0
953078|NCT00752232|3139138|P2|Overall Study|Caregiver could not attend the subject|0
953079|NCT00752232|3139139|P1|Overall Study|Caregiver could not attend the subject|0
953080|NCT00752232|3139133|P7|Overall Study|Group home admission|0
953081|NCT00752232|3139134|P6|Overall Study|Group home admission|0
953082|NCT00752232|3139135|P5|Overall Study|Group home admission|0
953083|NCT00752232|3139136|P4|Overall Study|Group home admission|1
953084|NCT00752232|3139137|P3|Overall Study|Group home admission|0
953085|NCT00752232|3139138|P2|Overall Study|Group home admission|0
953086|NCT00752232|3139139|P1|Overall Study|Group home admission|0
953087|NCT00752232|3139133|P7|Overall Study|Subject request|0
953088|NCT00752232|3139134|P6|Overall Study|Subject request|0
953089|NCT00752232|3139135|P5|Overall Study|Subject request|0
953090|NCT00752232|3139136|P4|Overall Study|Subject request|0
953091|NCT00752232|3139137|P3|Overall Study|Subject request|1
953092|NCT00752232|3139138|P2|Overall Study|Subject request|0
953093|NCT00752232|3139139|P1|Overall Study|Subject request|0
953094|NCT00752232|3139133|P7|Overall Study|Investigator request|0
953095|NCT00752232|3139134|P6|Overall Study|Investigator request|0
953096|NCT00752232|3139135|P5|Overall Study|Investigator request|1
953097|NCT00752232|3139136|P4|Overall Study|Investigator request|0
953098|NCT00752232|3139137|P3|Overall Study|Investigator request|0
953099|NCT00752232|3139138|P2|Overall Study|Investigator request|0
953100|NCT00752232|3139139|P1|Overall Study|Investigator request|0
953101|NCT00752232|3139133|P7|Overall Study|Caregiver request|0
953102|NCT00752232|3139134|P6|Overall Study|Caregiver request|0
953103|NCT00752232|3139135|P5|Overall Study|Caregiver request|1
953104|NCT00752232|3139136|P4|Overall Study|Caregiver request|0
953105|NCT00752232|3139137|P3|Overall Study|Caregiver request|0
953106|NCT00752232|3139138|P2|Overall Study|Caregiver request|0
953107|NCT00752232|3139139|P1|Overall Study|Caregiver request|2
953108|NCT00752232|3139133|P7|Overall Study|Protocol Violation|0
953109|NCT00752232|3139134|P6|Overall Study|Protocol Violation|1
953110|NCT00752232|3139135|P5|Overall Study|Protocol Violation|0
953111|NCT00752232|3139136|P4|Overall Study|Protocol Violation|0
953112|NCT00752232|3139137|P3|Overall Study|Protocol Violation|0
953113|NCT00752232|3139138|P2|Overall Study|Protocol Violation|0
953114|NCT00752232|3139139|P1|Overall Study|Protocol Violation|0
953115|NCT00752219|3139213|P2|Overall Study|Other|0
953116|NCT00752219|3139214|P1|Overall Study|Other|3
953117|NCT00752219|3139213|P2|Overall Study|Randomized but not treated|0
953118|NCT00752219|3139214|P1|Overall Study|Randomized but not treated|1
953119|NCT00752219|3139213|P2|Overall Study|Lost to Follow-up|2
953120|NCT00752219|3139214|P1|Overall Study|Lost to Follow-up|1
953121|NCT00752219|3139213|P2|Overall Study|Protocol deviation|0
953122|NCT00752219|3139214|P1|Overall Study|Protocol deviation|1
953123|NCT00752219|3139213|P2|Overall Study|Adverse Event|3
953124|NCT00752219|3139214|P1|Overall Study|Adverse Event|5
953125|NCT00752219|3139213|P2|Overall Study|Clinical failure|1
953126|NCT00752219|3139214|P1|Overall Study|Clinical failure|0
953127|NCT00752128|3139238|P1|Overall Study|Withdrawal by Subject|4
953128|NCT00752089|3139252|P1|Overall Study|Cannot continue the study|1
953129|NCT00752089|3139252|P1|Overall Study|Not capable of wearing partial denture|1
953130|NCT00752089|3139252|P1|Overall Study|Could not attend visit 9|1
953131|NCT00752089|3139252|P1|Overall Study|Protocol Deviation|2
953132|NCT00752089|3139252|P1|Overall Study|Adverse Event|1
953133|NCT00751998|3139266|P1|Overall Study|Withdrawal by Subject|2
953134|NCT00751998|3139266|P1|Overall Study|Death|11
953135|NCT00751998|3139266|P1|Overall Study|Lost to Follow-up|7
953136|NCT00751933|3139285|P4|Overall Study|Physician Decision|1
953137|NCT00751933|3139286|P3|Overall Study|Physician Decision|1
953138|NCT00751933|3139287|P2|Overall Study|Physician Decision|0
953139|NCT00751933|3139288|P1|Overall Study|Physician Decision|0
953140|NCT00751933|3139285|P4|Overall Study|Withdrawal by Subject|0
953141|NCT00751933|3139286|P3|Overall Study|Withdrawal by Subject|0
953142|NCT00751933|3139287|P2|Overall Study|Withdrawal by Subject|1
953143|NCT00751933|3139288|P1|Overall Study|Withdrawal by Subject|0
953144|NCT00751881|3139296|P3|Extension Study Period|Other than specified above|18
953145|NCT00751881|3139297|P2|Extension Study Period|Other than specified above|30
953146|NCT00751881|3139298|P1|Extension Study Period|Other than specified above|26
953147|NCT00751881|3139296|P3|Extension Study Period|Poor Compliance to Protocol|1
953148|NCT00751881|3139297|P2|Extension Study Period|Poor Compliance to Protocol|2
953149|NCT00751881|3139298|P1|Extension Study Period|Poor Compliance to Protocol|3
953150|NCT00751881|3139296|P3|Extension Study Period|Lost to Follow-up|6
953151|NCT00751881|3139297|P2|Extension Study Period|Lost to Follow-up|9
953152|NCT00751881|3139298|P1|Extension Study Period|Lost to Follow-up|4
953153|NCT00751881|3139296|P3|Extension Study Period|Lack of Efficacy|20
953154|NCT00751881|3139297|P2|Extension Study Period|Lack of Efficacy|10
953155|NCT00751881|3139298|P1|Extension Study Period|Lack of Efficacy|14
953156|NCT00751881|3139296|P3|Extension Study Period|Adverse Event|21
953157|NCT00751881|3139297|P2|Extension Study Period|Adverse Event|20
953158|NCT00751881|3139298|P1|Extension Study Period|Adverse Event|18
953159|NCT00751881|3139296|P3|Core Treatment Period|Other:participant's decision/unspecified|16
953160|NCT00751881|3139297|P2|Core Treatment Period|Other:participant's decision/unspecified|22
953161|NCT00751881|3139298|P1|Core Treatment Period|Other:participant's decision/unspecified|19
953162|NCT00751881|3139296|P3|Core Treatment Period|Other: tolerability complaints|0
953163|NCT00751881|3139297|P2|Core Treatment Period|Other: tolerability complaints|0
953164|NCT00751881|3139298|P1|Core Treatment Period|Other: tolerability complaints|2
953165|NCT00751881|3139296|P3|Core Treatment Period|Other: MS treatment change|4
953166|NCT00751881|3139297|P2|Core Treatment Period|Other: MS treatment change|4
953167|NCT00751881|3139298|P1|Core Treatment Period|Other: MS treatment change|6
953168|NCT00751881|3139296|P3|Core Treatment Period|Other: personal/family constraints|10
953169|NCT00751881|3139297|P2|Core Treatment Period|Other: personal/family constraints|7
953170|NCT00751881|3139298|P1|Core Treatment Period|Other: personal/family constraints|6
953171|NCT00751881|3139296|P3|Core Treatment Period|Other: wish to parent|4
953172|NCT00751881|3139297|P2|Core Treatment Period|Other: wish to parent|7
953173|NCT00751881|3139298|P1|Core Treatment Period|Other: wish to parent|5
953174|NCT00751881|3139296|P3|Core Treatment Period|Other: protocol deviation|7
953175|NCT00751881|3139297|P2|Core Treatment Period|Other: protocol deviation|3
953176|NCT00751881|3139298|P1|Core Treatment Period|Other: protocol deviation|3
953177|NCT00751881|3139296|P3|Core Treatment Period|Lost to Follow-up|3
953178|NCT00751881|3139297|P2|Core Treatment Period|Lost to Follow-up|4
953179|NCT00751881|3139298|P1|Core Treatment Period|Lost to Follow-up|6
953180|NCT00751881|3139296|P3|Core Treatment Period|Poor compliance to protocol|4
953181|NCT00751881|3139297|P2|Core Treatment Period|Poor compliance to protocol|3
953182|NCT00751881|3139298|P1|Core Treatment Period|Poor compliance to protocol|15
953183|NCT00751881|3139296|P3|Core Treatment Period|Lack of Efficacy|20
953184|NCT00751881|3139297|P2|Core Treatment Period|Lack of Efficacy|30
953185|NCT00751881|3139298|P1|Core Treatment Period|Lack of Efficacy|37
953186|NCT00751881|3139296|P3|Core Treatment Period|Adverse Event|58
953187|NCT00751881|3139297|P2|Core Treatment Period|Adverse Event|54
953188|NCT00751881|3139298|P1|Core Treatment Period|Adverse Event|26
953189|NCT00751881|3139296|P3|Core Treatment Period|Not treated|2
953190|NCT00751881|3139297|P2|Core Treatment Period|Not treated|1
953191|NCT00751881|3139298|P1|Core Treatment Period|Not treated|1
953192|NCT00751790|3139345|P1|Overall Study|Withdrawal by Subject|1
953193|NCT00751790|3139345|P1|Overall Study|Death|3
953194|NCT00751790|3139345|P1|Overall Study|Lost to Follow-up|1
953195|NCT00751621|3139370|P1|Overall Study|Poor adherence to asthma treatment|1
953196|NCT00751621|3139370|P1|Overall Study|Subject moved to another country|1
953197|NCT00751621|3139370|P1|Overall Study|Withdrawal by Subject|1
953198|NCT00751621|3139370|P1|Overall Study|Adverse Event|1
953199|NCT00751400|3139404|P1|Overall Study|Lost to Follow-up|10
953200|NCT00751348|3139419|P2|Overall Study|Migration from study area|0
953201|NCT00751348|3139420|P1|Overall Study|Migration from study area|1
953202|NCT00751348|3139419|P2|Overall Study|Withdrawal by Subject|2
953203|NCT00751348|3139420|P1|Overall Study|Withdrawal by Subject|5
953204|NCT00751296|3139442|P1|Overall Study|Adverse Event|2
953205|NCT00751140|3139470|P1|Overall Study|benign angioma excluded from analysis|1
953206|NCT00751114|3139480|P2|Overall Study|Move to another city|0
953207|NCT00751114|3139481|P1|Overall Study|Move to another city|1
953208|NCT00751114|3139480|P2|Overall Study|Out of country for 2 months|0
953209|NCT00751114|3139481|P1|Overall Study|Out of country for 2 months|1
953210|NCT00751114|3139480|P2|Overall Study|Not Treated|1
953211|NCT00751114|3139481|P1|Overall Study|Not Treated|13
953212|NCT00751114|3139480|P2|Overall Study|Lack of Efficacy|7
953213|NCT00751114|3139481|P1|Overall Study|Lack of Efficacy|0
953214|NCT00751114|3139480|P2|Overall Study|Lost to Follow-up|7
953215|NCT00751114|3139481|P1|Overall Study|Lost to Follow-up|4
953216|NCT00751114|3139480|P2|Overall Study|Withdrawal by Subject|4
953217|NCT00751114|3139481|P1|Overall Study|Withdrawal by Subject|9
953218|NCT00751114|3139480|P2|Overall Study|Protocol Violation|9
953219|NCT00751114|3139481|P1|Overall Study|Protocol Violation|8
953220|NCT00751114|3139480|P2|Overall Study|Adverse Event|4
953221|NCT00751114|3139481|P1|Overall Study|Adverse Event|2
953222|NCT00751036|3139506|P2|Overall Study|Missing end of Treatment Page|3
953223|NCT00751036|3139507|P1|Overall Study|Missing end of Treatment Page|2
953224|NCT00751036|3139506|P2|Overall Study|Protocol Violation|0
953225|NCT00751036|3139507|P1|Overall Study|Protocol Violation|1
953226|NCT00751036|3139506|P2|Overall Study|Lost to Follow-up|1
953227|NCT00751036|3139507|P1|Overall Study|Lost to Follow-up|0
953228|NCT00751036|3139506|P2|Overall Study|Death|3
953229|NCT00751036|3139507|P1|Overall Study|Death|3
953230|NCT00751036|3139506|P2|Overall Study|Withdrawal by Subject|2
953231|NCT00751036|3139507|P1|Overall Study|Withdrawal by Subject|5
953232|NCT00751036|3139506|P2|Overall Study|Administrative Problems|4
953233|NCT00751036|3139507|P1|Overall Study|Administrative Problems|3
953234|NCT00751036|3139506|P2|Overall Study|Adverse Event|4
953235|NCT00751036|3139507|P1|Overall Study|Adverse Event|6
953236|NCT00751036|3139506|P2|Overall Study|Disease Progression|29
953237|NCT00751036|3139507|P1|Overall Study|Disease Progression|28
953238|NCT00750919|3139519|P1|Overall Study|Other|36
953239|NCT00750919|3139519|P1|Overall Study|Could not cooperate, unrelated to trial|4
953240|NCT00750919|3139519|P1|Overall Study|Lack of Efficacy|8
953241|NCT00750919|3139519|P1|Overall Study|Withdrawal by Subject|1
953242|NCT00750919|3139519|P1|Overall Study|Adverse Event|9
953243|NCT00750893|3139527|P1|Overall Study|Other|17
953244|NCT00750893|3139527|P1|Overall Study|Lost to Follow-up|510
953245|NCT00750893|3139527|P1|Overall Study|Withdrawal by Subject|10
953246|NCT00750893|3139527|P1|Overall Study|Adverse Event|5
953247|NCT00750880|3139542|P1|Overall Study|Administrative|11
953248|NCT00750880|3139542|P1|Overall Study|Physician Decision|20
953249|NCT00750880|3139542|P1|Overall Study|Withdrawal by Subject|33
953250|NCT00750880|3139542|P1|Overall Study|Protocol Violation|15
953251|NCT00750880|3139542|P1|Overall Study|Lost to Follow-up|10
953252|NCT00750880|3139542|P1|Overall Study|Lack of Efficacy|46
953253|NCT00750880|3139542|P1|Overall Study|Death|4
953254|NCT00750880|3139542|P1|Overall Study|Adverse Event|76
953255|NCT00750867|3139565|P1|Overall Study|Adverse Event|2
953256|NCT00750737|3139586|P2|Overall Study|Withdrawal by Subject|3
953257|NCT00750737|3139587|P1|Overall Study|Withdrawal by Subject|3
953258|NCT00750308|3139647|P12|Third Treatment|Withdrawal by Subject|0
953259|NCT00750308|3139648|P11|Third Treatment|Withdrawal by Subject|0
953260|NCT00750308|3139649|P10|Third Treatment|Withdrawal by Subject|0
953261|NCT00750308|3139650|P9|Third Treatment|Withdrawal by Subject|0
953262|NCT00750308|3139651|P8|Third Treatment|Withdrawal by Subject|0
953263|NCT00750308|3139652|P7|Third Treatment|Withdrawal by Subject|0
953264|NCT00750308|3139653|P6|Third Treatment|Withdrawal by Subject|0
953265|NCT00750308|3139654|P5|Third Treatment|Withdrawal by Subject|0
953266|NCT00750308|3139655|P4|Third Treatment|Withdrawal by Subject|0
953267|NCT00750308|3139656|P3|Third Treatment|Withdrawal by Subject|0
953268|NCT00750308|3139657|P2|Third Treatment|Withdrawal by Subject|1
953269|NCT00750308|3139658|P1|Third Treatment|Withdrawal by Subject|0
953270|NCT00750308|3139647|P12|Second Treatment|Withdrawal by Subject|0
953271|NCT00750308|3139648|P11|Second Treatment|Withdrawal by Subject|0
953272|NCT00750308|3139649|P10|Second Treatment|Withdrawal by Subject|0
953273|NCT00750308|3139650|P9|Second Treatment|Withdrawal by Subject|0
953274|NCT00750308|3139651|P8|Second Treatment|Withdrawal by Subject|0
953275|NCT00750308|3139652|P7|Second Treatment|Withdrawal by Subject|0
953276|NCT00750308|3139653|P6|Second Treatment|Withdrawal by Subject|0
953277|NCT00750308|3139654|P5|Second Treatment|Withdrawal by Subject|1
953278|NCT00750308|3139655|P4|Second Treatment|Withdrawal by Subject|0
953279|NCT00750308|3139656|P3|Second Treatment|Withdrawal by Subject|0
953280|NCT00750308|3139657|P2|Second Treatment|Withdrawal by Subject|0
953281|NCT00750308|3139658|P1|Second Treatment|Withdrawal by Subject|0
953282|NCT00750308|3139647|P12|Second Treatment|Adverse Event|0
953283|NCT00750308|3139648|P11|Second Treatment|Adverse Event|0
953284|NCT00750308|3139649|P10|Second Treatment|Adverse Event|0
953285|NCT00750308|3139650|P9|Second Treatment|Adverse Event|1
953286|NCT00750308|3139651|P8|Second Treatment|Adverse Event|0
953287|NCT00750308|3139652|P7|Second Treatment|Adverse Event|0
953288|NCT00750308|3139653|P6|Second Treatment|Adverse Event|1
953289|NCT00750308|3139654|P5|Second Treatment|Adverse Event|0
953290|NCT00750308|3139655|P4|Second Treatment|Adverse Event|0
953291|NCT00750308|3139656|P3|Second Treatment|Adverse Event|0
953292|NCT00750308|3139657|P2|Second Treatment|Adverse Event|0
953293|NCT00750308|3139658|P1|Second Treatment|Adverse Event|0
953294|NCT00750308|3139647|P12|First Treatment|Withdrawal by Subject|0
953295|NCT00750308|3139648|P11|First Treatment|Withdrawal by Subject|0
953296|NCT00750308|3139649|P10|First Treatment|Withdrawal by Subject|0
953297|NCT00750308|3139650|P9|First Treatment|Withdrawal by Subject|0
953298|NCT00750308|3139651|P8|First Treatment|Withdrawal by Subject|1
953299|NCT00750308|3139652|P7|First Treatment|Withdrawal by Subject|0
953300|NCT00750308|3139653|P6|First Treatment|Withdrawal by Subject|0
953301|NCT00750308|3139654|P5|First Treatment|Withdrawal by Subject|0
953302|NCT00750308|3139655|P4|First Treatment|Withdrawal by Subject|1
953303|NCT00750308|3139656|P3|First Treatment|Withdrawal by Subject|0
953304|NCT00750308|3139657|P2|First Treatment|Withdrawal by Subject|0
953305|NCT00750308|3139658|P1|First Treatment|Withdrawal by Subject|0
953306|NCT00750308|3139647|P12|First Treatment|Adverse Event|1
953307|NCT00750308|3139648|P11|First Treatment|Adverse Event|1
953308|NCT00750308|3139649|P10|First Treatment|Adverse Event|0
953309|NCT00750308|3139650|P9|First Treatment|Adverse Event|0
953310|NCT00750308|3139651|P8|First Treatment|Adverse Event|0
953311|NCT00750308|3139652|P7|First Treatment|Adverse Event|0
953312|NCT00750308|3139653|P6|First Treatment|Adverse Event|0
953313|NCT00750308|3139654|P5|First Treatment|Adverse Event|0
953314|NCT00750308|3139655|P4|First Treatment|Adverse Event|0
953315|NCT00750308|3139656|P3|First Treatment|Adverse Event|0
953316|NCT00750308|3139657|P2|First Treatment|Adverse Event|1
953317|NCT00750308|3139658|P1|First Treatment|Adverse Event|0
953318|NCT00750269|3139708|P5|Overall Study|Fiducials could not be placed|1
953319|NCT00750269|3139709|P4|Overall Study|Fiducials could not be placed|0
953320|NCT00750269|3139710|P3|Overall Study|Fiducials could not be placed|0
953321|NCT00750269|3139711|P2|Overall Study|Fiducials could not be placed|0
953322|NCT00750269|3139712|P1|Overall Study|Fiducials could not be placed|0
953323|NCT00750269|3139708|P5|Overall Study|SBRT plan could not be drawn|1
953324|NCT00750269|3139709|P4|Overall Study|SBRT plan could not be drawn|0
953325|NCT00750269|3139710|P3|Overall Study|SBRT plan could not be drawn|0
953326|NCT00750269|3139711|P2|Overall Study|SBRT plan could not be drawn|0
953327|NCT00750269|3139712|P1|Overall Study|SBRT plan could not be drawn|0
953328|NCT00750269|3139708|P5|Overall Study|Site error|0
953329|NCT00750269|3139709|P4|Overall Study|Site error|1
953330|NCT00750269|3139710|P3|Overall Study|Site error|0
953331|NCT00750269|3139711|P2|Overall Study|Site error|0
953332|NCT00750269|3139712|P1|Overall Study|Site error|0
953333|NCT00750269|3139708|P5|Overall Study|Patient too large for positioning|0
953334|NCT00750269|3139709|P4|Overall Study|Patient too large for positioning|0
953335|NCT00750269|3139710|P3|Overall Study|Patient too large for positioning|1
953336|NCT00750269|3139711|P2|Overall Study|Patient too large for positioning|0
953337|NCT00750269|3139712|P1|Overall Study|Patient too large for positioning|0
953338|NCT00750269|3139708|P5|Overall Study|Physician Decision|2
953339|NCT00750269|3139709|P4|Overall Study|Physician Decision|0
953340|NCT00750269|3139710|P3|Overall Study|Physician Decision|0
953341|NCT00750269|3139711|P2|Overall Study|Physician Decision|0
953342|NCT00750269|3139712|P1|Overall Study|Physician Decision|0
953343|NCT00750269|3139708|P5|Overall Study|Withdrawal by Subject|2
953344|NCT00750269|3139709|P4|Overall Study|Withdrawal by Subject|2
953345|NCT00750269|3139710|P3|Overall Study|Withdrawal by Subject|2
953346|NCT00750269|3139711|P2|Overall Study|Withdrawal by Subject|0
953347|NCT00750269|3139712|P1|Overall Study|Withdrawal by Subject|0
953348|NCT00750269|3139708|P5|Overall Study|Protocol Violation|4
953349|NCT00750269|3139709|P4|Overall Study|Protocol Violation|2
953350|NCT00750269|3139710|P3|Overall Study|Protocol Violation|1
953351|NCT00750269|3139711|P2|Overall Study|Protocol Violation|1
953352|NCT00750269|3139712|P1|Overall Study|Protocol Violation|0
953353|NCT00750204|3139759|P2|Overall Study|study halted prematurely|1
953354|NCT00750204|3139760|P1|Overall Study|study halted prematurely|1
953355|NCT00750152|3139783|P2|Overall Study|Not specified|8
953356|NCT00750152|3139784|P1|Overall Study|Not specified|7
953357|NCT00750152|3139783|P2|Overall Study|Termination by sponsor|0
953358|NCT00750152|3139784|P1|Overall Study|Termination by sponsor|1
953359|NCT00750152|3139783|P2|Overall Study|Non-compliance|1
953360|NCT00750152|3139784|P1|Overall Study|Non-compliance|0
953361|NCT00750152|3139783|P2|Overall Study|Physician Decision|1
953362|NCT00750152|3139784|P1|Overall Study|Physician Decision|1
953363|NCT00750152|3139783|P2|Overall Study|Withdrawal by Subject|3
953364|NCT00750152|3139784|P1|Overall Study|Withdrawal by Subject|3
953365|NCT00750152|3139783|P2|Overall Study|Lost to Follow-up|13
953366|NCT00750152|3139784|P1|Overall Study|Lost to Follow-up|8
953367|NCT00750152|3139783|P2|Overall Study|Adverse Event|1
953368|NCT00750152|3139784|P1|Overall Study|Adverse Event|2
953369|NCT00750139|3139796|P4|Overall Study|Non-specific|33
953370|NCT00750139|3139797|P3|Overall Study|Non-specific|79
953371|NCT00750139|3139798|P2|Overall Study|Non-specific|42
953372|NCT00750139|3139799|P1|Overall Study|Non-specific|62
953373|NCT00750139|3139796|P4|Overall Study|Termination by sponsor|1
953374|NCT00750139|3139797|P3|Overall Study|Termination by sponsor|0
953375|NCT00750139|3139798|P2|Overall Study|Termination by sponsor|0
953376|NCT00750139|3139799|P1|Overall Study|Termination by sponsor|4
953377|NCT00750139|3139796|P4|Overall Study|Non-compliance|3
953378|NCT00750139|3139797|P3|Overall Study|Non-compliance|1
953379|NCT00750139|3139798|P2|Overall Study|Non-compliance|0
953380|NCT00750139|3139799|P1|Overall Study|Non-compliance|1
953381|NCT00750139|3139796|P4|Overall Study|Physician Decision|0
953382|NCT00750139|3139797|P3|Overall Study|Physician Decision|0
953383|NCT00750139|3139798|P2|Overall Study|Physician Decision|1
953384|NCT00750139|3139799|P1|Overall Study|Physician Decision|1
953385|NCT00750139|3139796|P4|Overall Study|Withdrawal by Subject|2
953386|NCT00750139|3139797|P3|Overall Study|Withdrawal by Subject|6
953387|NCT00750139|3139798|P2|Overall Study|Withdrawal by Subject|2
953388|NCT00750139|3139799|P1|Overall Study|Withdrawal by Subject|3
953389|NCT00750139|3139796|P4|Overall Study|Lost to Follow-up|6
953390|NCT00750139|3139797|P3|Overall Study|Lost to Follow-up|15
953391|NCT00750139|3139798|P2|Overall Study|Lost to Follow-up|12
953392|NCT00750139|3139799|P1|Overall Study|Lost to Follow-up|17
953393|NCT00750139|3139796|P4|Overall Study|Adverse Event|1
953394|NCT00750139|3139797|P3|Overall Study|Adverse Event|0
953395|NCT00750139|3139798|P2|Overall Study|Adverse Event|2
953396|NCT00750139|3139799|P1|Overall Study|Adverse Event|1
953397|NCT00750061|3139815|P2|Overall Study|Physician Decision|1
953398|NCT00750061|3139816|P1|Overall Study|Physician Decision|0
953399|NCT00750061|3139815|P2|Overall Study|Withdrawal by Subject|1
953400|NCT00750061|3139816|P1|Overall Study|Withdrawal by Subject|0
953401|NCT00750061|3139815|P2|Overall Study|Adverse Event|0
953402|NCT00750061|3139816|P1|Overall Study|Adverse Event|2
953403|NCT00749996|3139826|P2|Overall Study|Death|0
953404|NCT00749996|3139827|P1|Overall Study|Death|1
953405|NCT00749996|3139826|P2|Overall Study|Adverse Event|0
953406|NCT00749996|3139827|P1|Overall Study|Adverse Event|1
953407|NCT00749996|3139826|P2|Overall Study|Pregnancy|2
953408|NCT00749996|3139827|P1|Overall Study|Pregnancy|0
953409|NCT00749996|3139826|P2|Overall Study|Physician Decision|0
953410|NCT00749996|3139827|P1|Overall Study|Physician Decision|2
953411|NCT00749996|3139826|P2|Overall Study|Protocol Violation|3
953412|NCT00749996|3139827|P1|Overall Study|Protocol Violation|2
953413|NCT00749996|3139826|P2|Overall Study|Withdrawal by Subject|4
953414|NCT00749996|3139827|P1|Overall Study|Withdrawal by Subject|5
953415|NCT00749996|3139826|P2|Overall Study|Lost to Follow-up|4
953416|NCT00749996|3139827|P1|Overall Study|Lost to Follow-up|7
953417|NCT00749944|3139850|P2|Overall Study|Withdrawal by Subject|0
953418|NCT00749944|3139851|P1|Overall Study|Withdrawal by Subject|2
953419|NCT00749944|3139850|P2|Overall Study|Not specified|0
953420|NCT00749944|3139851|P1|Overall Study|Not specified|1
953421|NCT00749944|3139850|P2|Overall Study|Lost to Follow-up|1
953422|NCT00749944|3139851|P1|Overall Study|Lost to Follow-up|2
953423|NCT00749775|3139930|P1|Overall Study|No drug administration|3
953424|NCT00749775|3139930|P1|Overall Study|No visit after first day of treatment|44
953425|NCT00749775|3139930|P1|Overall Study|Lost to Follow-up|36
953426|NCT00749775|3139930|P1|Overall Study|Protocol Violation|24
953427|NCT00749684|3139946|P1|Overall Study|Missing|9
953428|NCT00749684|3139946|P1|Overall Study|AE+discontinuation on participants wish|1
953429|NCT00749684|3139946|P1|Overall Study|Therapy according to protocol + AE|2
953430|NCT00749684|3139946|P1|Overall Study|Progressive Desease|31
953431|NCT00749684|3139946|P1|Overall Study|Not Documented|1
953432|NCT00749684|3139946|P1|Overall Study|Participant's Wish|10
953433|NCT00749684|3139946|P1|Overall Study|Adverse Event|27
953434|NCT00749684|3139946|P1|Overall Study|Death|1
953435|NCT00749580|3139985|P2|Overall Study|Adverse Event|1
953436|NCT00749580|3139986|P1|Overall Study|Adverse Event|0
953437|NCT00749580|3139985|P2|Overall Study|Lost to Follow-up|8
953438|NCT00749580|3139986|P1|Overall Study|Lost to Follow-up|4
953439|NCT00749463|3140001|P3|Overall Study|Withdrawal by Subject|0
953440|NCT00749463|3140002|P2|Overall Study|Withdrawal by Subject|0
953441|NCT00749463|3140003|P1|Overall Study|Withdrawal by Subject|1
953442|NCT00749463|3140001|P3|Overall Study|Adverse Event|1
953443|NCT00749463|3140002|P2|Overall Study|Adverse Event|4
953444|NCT00749463|3140003|P1|Overall Study|Adverse Event|0
953445|NCT00749398|3140029|P1|Overall Study|Unknown reason|1
953446|NCT00749398|3140029|P1|Overall Study|Reason not specified|2
953447|NCT00749398|3140029|P1|Overall Study|Lost to Follow-up|11
953448|NCT00749398|3140029|P1|Overall Study|Withdrawal by Subject|17
953449|NCT00749398|3140029|P1|Overall Study|Serious adverse event|11
953450|NCT00749398|3140029|P1|Overall Study|Adverse Event|4
953451|NCT00749398|3140029|P1|Overall Study|Lack of Efficacy|7
953452|NCT00749203|3140072|P2|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1
953453|NCT00749203|3140073|P1|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0
953454|NCT00749203|3140072|P2|Second Infusion at 2 Weeks|Protocol Violation|1
953455|NCT00749203|3140073|P1|Second Infusion at 2 Weeks|Protocol Violation|0
953456|NCT00749203|3140072|P2|no Infusion at Week 1|low baseline PTSD symptoms level|1
953457|NCT00749203|3140073|P1|no Infusion at Week 1|low baseline PTSD symptoms level|0
953458|NCT00749203|3140072|P2|no Infusion at Week 1|delayed-onset sedation|1
953459|NCT00749203|3140073|P1|no Infusion at Week 1|delayed-onset sedation|0
953460|NCT00749203|3140072|P2|no Infusion at Week 1|Withdrawal by Subject|1
953461|NCT00749203|3140073|P1|no Infusion at Week 1|Withdrawal by Subject|0
953462|NCT00749203|3140072|P2|no Infusion at Week 1|Lost to Follow-up|1
953463|NCT00749203|3140073|P1|no Infusion at Week 1|Lost to Follow-up|0
953464|NCT00749190|3140094|P7|Overall Study|Other reason not defined above|0
953465|NCT00749190|3140095|P6|Overall Study|Other reason not defined above|0
953466|NCT00749190|3140096|P5|Overall Study|Other reason not defined above|0
953467|NCT00749190|3140097|P4|Overall Study|Other reason not defined above|1
953468|NCT00749190|3140098|P3|Overall Study|Other reason not defined above|0
953469|NCT00749190|3140099|P2|Overall Study|Other reason not defined above|0
953470|NCT00749190|3140100|P1|Overall Study|Other reason not defined above|0
953471|NCT00749190|3140094|P7|Overall Study|Protocol Violation|1
953472|NCT00749190|3140095|P6|Overall Study|Protocol Violation|0
953473|NCT00749190|3140096|P5|Overall Study|Protocol Violation|0
953474|NCT00749190|3140097|P4|Overall Study|Protocol Violation|0
953475|NCT00749190|3140098|P3|Overall Study|Protocol Violation|0
953476|NCT00749190|3140099|P2|Overall Study|Protocol Violation|1
953477|NCT00749190|3140100|P1|Overall Study|Protocol Violation|0
953478|NCT00749190|3140094|P7|Overall Study|Withdrawal by Subject|0
953479|NCT00749190|3140095|P6|Overall Study|Withdrawal by Subject|1
953480|NCT00749190|3140096|P5|Overall Study|Withdrawal by Subject|0
953481|NCT00749190|3140097|P4|Overall Study|Withdrawal by Subject|0
953482|NCT00749190|3140098|P3|Overall Study|Withdrawal by Subject|0
953483|NCT00749190|3140099|P2|Overall Study|Withdrawal by Subject|1
953484|NCT00749190|3140100|P1|Overall Study|Withdrawal by Subject|2
953485|NCT00749190|3140094|P7|Overall Study|Lack of Efficacy|0
953486|NCT00749190|3140095|P6|Overall Study|Lack of Efficacy|1
953487|NCT00749190|3140096|P5|Overall Study|Lack of Efficacy|0
953488|NCT00749190|3140097|P4|Overall Study|Lack of Efficacy|0
953489|NCT00749190|3140098|P3|Overall Study|Lack of Efficacy|1
953490|NCT00749190|3140099|P2|Overall Study|Lack of Efficacy|1
953491|NCT00749190|3140100|P1|Overall Study|Lack of Efficacy|3
953492|NCT00749190|3140094|P7|Overall Study|Adverse Event|0
953493|NCT00749190|3140095|P6|Overall Study|Adverse Event|3
953494|NCT00749190|3140096|P5|Overall Study|Adverse Event|0
953495|NCT00749190|3140097|P4|Overall Study|Adverse Event|4
953496|NCT00749190|3140098|P3|Overall Study|Adverse Event|0
953497|NCT00749190|3140099|P2|Overall Study|Adverse Event|2
953498|NCT00749190|3140100|P1|Overall Study|Adverse Event|0
953499|NCT00748969|3140209|P2|Overall Study|Withdrawal by Subject|1
953500|NCT00748969|3140210|P1|Overall Study|Withdrawal by Subject|0
953501|NCT00748969|3140209|P2|Overall Study|Withdrawal by Subject|0
953502|NCT00748969|3140210|P1|Overall Study|Withdrawal by Subject|1
953503|NCT00748709|3140260|P1|Overall Study|Other Reasons|1
953504|NCT00748709|3140260|P1|Overall Study|Withdrawal by Subject|1
953505|NCT00748709|3140260|P1|Overall Study|Other Adverse Event|1
953506|NCT00748709|3140260|P1|Overall Study|Drug reducing Toxity|2
953507|NCT00748709|3140260|P1|Overall Study|Progressive disease|15
953508|NCT00748566|3140293|P1|Overall Study|Other|9
953509|NCT00748566|3140293|P1|Overall Study|Study terminated by sponsor|5
953510|NCT00748566|3140293|P1|Overall Study|Withdrawal by Subject|22
953511|NCT00748566|3140293|P1|Overall Study|Protocol Violation|13
953512|NCT00748566|3140293|P1|Overall Study|Lost to Follow-up|1
953513|NCT00748566|3140293|P1|Overall Study|Lack of Efficacy|12
953514|NCT00748566|3140293|P1|Overall Study|Death|1
953515|NCT00748566|3140293|P1|Overall Study|Adverse Event|49
953516|NCT00748553|3140323|P2|Overall Study|noncompliance|0
953517|NCT00748553|3140324|P1|Overall Study|noncompliance|1
953518|NCT00748553|3140323|P2|Overall Study|disease progression|0
953519|NCT00748553|3140324|P1|Overall Study|disease progression|2
953520|NCT00748553|3140323|P2|Overall Study|Adverse Event|1
953521|NCT00748553|3140324|P1|Overall Study|Adverse Event|0
953522|NCT00748540|3140331|P1|Overall Study|Physician Decision|1
953523|NCT00748241|3140357|P1|Overall Study|Death|2
953524|NCT00748241|3140357|P1|Overall Study|Lost to Follow-up|5
953525|NCT00748241|3140357|P1|Overall Study|Implant failure|1
953526|NCT00748189|3140367|P2|Overall Study|Ongoing|162
953527|NCT00748189|3140368|P1|Overall Study|Ongoing|155
953528|NCT00748189|3140367|P2|Overall Study|Study terminated by Sponsor|1
953529|NCT00748189|3140368|P1|Overall Study|Study terminated by Sponsor|0
953530|NCT00748189|3140367|P2|Overall Study|Lost to Follow-up|4
953531|NCT00748189|3140368|P1|Overall Study|Lost to Follow-up|2
953532|NCT00748189|3140367|P2|Overall Study|Physician Decision|4
953533|NCT00748189|3140368|P1|Overall Study|Physician Decision|13
953534|NCT00748189|3140367|P2|Overall Study|Withdrawal by Subject|16
953535|NCT00748189|3140368|P1|Overall Study|Withdrawal by Subject|15
953536|NCT00748189|3140367|P2|Overall Study|Death|34
953537|NCT00748189|3140368|P1|Overall Study|Death|40
953538|NCT00748098|3140422|P2|Second Treatment Intervention Period|Withdrawal by Subject|1
953539|NCT00748098|3140423|P1|Second Treatment Intervention Period|Withdrawal by Subject|1
953540|NCT00748098|3140422|P2|Second Treatment Intervention Period|Lost to Follow-up|1
953541|NCT00748098|3140423|P1|Second Treatment Intervention Period|Lost to Follow-up|1
953542|NCT00748098|3140422|P2|Second Treatment Intervention Period|Adverse Event|1
953543|NCT00748098|3140423|P1|Second Treatment Intervention Period|Adverse Event|4
953544|NCT00748098|3140422|P2|1-Week Washout Period|Withdrawal by Subject|0
953545|NCT00748098|3140423|P1|1-Week Washout Period|Withdrawal by Subject|2
953546|NCT00748098|3140422|P2|1-Week Washout Period|Adverse Event|1
953547|NCT00748098|3140423|P1|1-Week Washout Period|Adverse Event|0
953548|NCT00748098|3140422|P2|First Taper Period|Protocol Stopping Criteria Met|1
953549|NCT00748098|3140423|P1|First Taper Period|Protocol Stopping Criteria Met|0
953550|NCT00748098|3140422|P2|First Taper Period|Withdrawal by Subject|0
953551|NCT00748098|3140423|P1|First Taper Period|Withdrawal by Subject|2
953552|NCT00748098|3140422|P2|First Taper Period|Protocol Violation|0
953553|NCT00748098|3140423|P1|First Taper Period|Protocol Violation|1
953554|NCT00748098|3140422|P2|First Treatment Intervention Period|Withdrawal by Subject|0
953555|NCT00748098|3140423|P1|First Treatment Intervention Period|Withdrawal by Subject|2
953556|NCT00748098|3140422|P2|First Treatment Intervention Period|Lost to Follow-up|0
953557|NCT00748098|3140423|P1|First Treatment Intervention Period|Lost to Follow-up|1
953558|NCT00748098|3140422|P2|First Treatment Intervention Period|Protocol Violation|0
953559|NCT00748098|3140423|P1|First Treatment Intervention Period|Protocol Violation|1
953560|NCT00748098|3140422|P2|First Treatment Intervention Period|Adverse Event|1
953561|NCT00748098|3140423|P1|First Treatment Intervention Period|Adverse Event|1
953562|NCT00747812|3140504|P2|Overall Study|Research Site Staff Relocation|3
953563|NCT00747812|3140505|P1|Overall Study|Research Site Staff Relocation|5
953564|NCT00747643|3140543|P2|Overall Study|Withdrawal by Subject|27
953565|NCT00747643|3140544|P1|Overall Study|Withdrawal by Subject|36
953566|NCT00747617|3140558|P2|Overall Study|Lost to Follow-up|1
953567|NCT00747617|3140559|P1|Overall Study|Lost to Follow-up|3
953568|NCT00747565|3140569|P2|Overall Study|Lost to Follow-up|1
953569|NCT00747565|3140570|P1|Overall Study|Lost to Follow-up|4
953570|NCT00747565|3140569|P2|Overall Study|Withdrawal by Subject|6
953571|NCT00747565|3140570|P1|Overall Study|Withdrawal by Subject|10
953572|NCT00747474|3140583|P12|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
953573|NCT00747474|3140584|P11|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
953574|NCT00747474|3140585|P10|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
953575|NCT00747474|3140586|P9|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
953576|NCT00747474|3140587|P8|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1
953577|NCT00747474|3140588|P7|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
953578|NCT00747474|3140589|P6|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
953579|NCT00747474|3140590|P5|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
953580|NCT00747474|3140591|P4|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
953581|NCT00747474|3140592|P3|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
953582|NCT00747474|3140593|P2|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
953583|NCT00747474|3140594|P1|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
953584|NCT00747461|3140620|P1|Overall Study|study terminated by sponsor|5
953585|NCT00747435|3140625|P1|Overall Study|Still undergoing follow up|1
953586|NCT00747435|3140625|P1|Overall Study|Withdrawal by Subject|3
953587|NCT00747435|3140625|P1|Overall Study|Lost to Follow-up|2
953588|NCT00747344|3140635|P4|After Controlled Period|Adverse Event|1
953589|NCT00747344|3140636|P3|After Controlled Period|Adverse Event|0
953590|NCT00747344|3140637|P2|After Controlled Period|Adverse Event|0
953591|NCT00747344|3140638|P1|After Controlled Period|Adverse Event|0
953592|NCT00747344|3140635|P4|Controlled Period|Other|0
953593|NCT00747344|3140636|P3|Controlled Period|Other|0
953594|NCT00747344|3140637|P2|Controlled Period|Other|3
953595|NCT00747344|3140638|P1|Controlled Period|Other|0
953596|NCT00747344|3140635|P4|Controlled Period|Lack of Efficacy|0
953597|NCT00747344|3140636|P3|Controlled Period|Lack of Efficacy|0
953598|NCT00747344|3140637|P2|Controlled Period|Lack of Efficacy|1
953599|NCT00747344|3140638|P1|Controlled Period|Lack of Efficacy|2
953600|NCT00747344|3140635|P4|Controlled Period|Adverse Event|0
953601|NCT00747344|3140636|P3|Controlled Period|Adverse Event|0
953602|NCT00747344|3140637|P2|Controlled Period|Adverse Event|0
953603|NCT00747344|3140638|P1|Controlled Period|Adverse Event|3
953604|NCT00747227|3140652|P2|Overall Study|Illness|1
953605|NCT00747227|3140653|P1|Overall Study|Illness|1
953606|NCT00747227|3140652|P2|Overall Study|Lost to Follow-up|2
953607|NCT00747227|3140653|P1|Overall Study|Lost to Follow-up|1
953608|NCT00747227|3140652|P2|Overall Study|Withdrawal by Subject|0
953609|NCT00747227|3140653|P1|Overall Study|Withdrawal by Subject|1
953610|NCT00747227|3140652|P2|Overall Study|Death|1
953611|NCT00747227|3140653|P1|Overall Study|Death|3
953612|NCT00747149|3140682|P2|Overall Study|Not reported|4
953613|NCT00747149|3140683|P1|Overall Study|Not reported|1
953614|NCT00747149|3140682|P2|Overall Study|Severe non-compliance to protocol|1
953615|NCT00747149|3140683|P1|Overall Study|Severe non-compliance to protocol|0
953616|NCT00747149|3140682|P2|Overall Study|Incorrect enrollment|6
953617|NCT00747149|3140683|P1|Overall Study|Incorrect enrollment|0
953618|NCT00747149|3140682|P2|Overall Study|Did not receive treatment|1
953619|NCT00747149|3140683|P1|Overall Study|Did not receive treatment|0
953620|NCT00747149|3140682|P2|Overall Study|Withdrawal by Subject|6
953621|NCT00747149|3140683|P1|Overall Study|Withdrawal by Subject|0
953622|NCT00747149|3140682|P2|Overall Study|Lost to Follow-up|10
953623|NCT00747149|3140683|P1|Overall Study|Lost to Follow-up|0
953624|NCT00747149|3140682|P2|Overall Study|Adverse Event|15
953625|NCT00747149|3140683|P1|Overall Study|Adverse Event|0
953626|NCT00747006|3140698|P3|Overall Study|Physician Decision|1
953627|NCT00747006|3140699|P2|Overall Study|Physician Decision|0
953628|NCT00747006|3140700|P1|Overall Study|Physician Decision|2
953629|NCT00747006|3140698|P3|Overall Study|Lost to Follow-up|0
953630|NCT00747006|3140699|P2|Overall Study|Lost to Follow-up|1
953631|NCT00747006|3140700|P1|Overall Study|Lost to Follow-up|0
953632|NCT00747006|3140698|P3|Overall Study|Adverse Event|0
953633|NCT00747006|3140699|P2|Overall Study|Adverse Event|0
953634|NCT00747006|3140700|P1|Overall Study|Adverse Event|1
953635|NCT00746941|3140778|P4|Overall Study|Adverse Event|1
953636|NCT00746941|3140779|P3|Overall Study|Adverse Event|0
953637|NCT00746941|3140780|P2|Overall Study|Adverse Event|0
953638|NCT00746941|3140781|P1|Overall Study|Adverse Event|0
953639|NCT00746941|3140778|P4|Overall Study|Other, reason not provided|4
953640|NCT00746941|3140779|P3|Overall Study|Other, reason not provided|0
953641|NCT00746941|3140780|P2|Overall Study|Other, reason not provided|4
953642|NCT00746941|3140781|P1|Overall Study|Other, reason not provided|2
953643|NCT00746941|3140778|P4|Overall Study|Withdrawal by Subject|2
953644|NCT00746941|3140779|P3|Overall Study|Withdrawal by Subject|0
953645|NCT00746941|3140780|P2|Overall Study|Withdrawal by Subject|0
953646|NCT00746941|3140781|P1|Overall Study|Withdrawal by Subject|3
953647|NCT00746941|3140778|P4|Overall Study|Physician Decision|0
953648|NCT00746941|3140779|P3|Overall Study|Physician Decision|2
953649|NCT00746941|3140780|P2|Overall Study|Physician Decision|0
953650|NCT00746941|3140781|P1|Overall Study|Physician Decision|0
953651|NCT00746941|3140778|P4|Overall Study|Death|6
953652|NCT00746941|3140779|P3|Overall Study|Death|0
953653|NCT00746941|3140780|P2|Overall Study|Death|0
953654|NCT00746941|3140781|P1|Overall Study|Death|2
953655|NCT00746798|3140839|P4|Overall Study|Participant unable to return for visit|0
953656|NCT00746798|3140840|P3|Overall Study|Participant unable to return for visit|0
953657|NCT00746798|3140841|P2|Overall Study|Participant unable to return for visit|0
953658|NCT00746798|3140842|P1|Overall Study|Participant unable to return for visit|1
953659|NCT00746798|3140839|P4|Overall Study|Death|0
953660|NCT00746798|3140840|P3|Overall Study|Death|2
953661|NCT00746798|3140841|P2|Overall Study|Death|0
953662|NCT00746798|3140842|P1|Overall Study|Death|0
953663|NCT00746798|3140839|P4|Overall Study|Withdrawal by Subject|0
953664|NCT00746798|3140840|P3|Overall Study|Withdrawal by Subject|1
953665|NCT00746798|3140841|P2|Overall Study|Withdrawal by Subject|1
953666|NCT00746798|3140842|P1|Overall Study|Withdrawal by Subject|0
953667|NCT00746798|3140839|P4|Overall Study|Protocol Violation|0
953668|NCT00746798|3140840|P3|Overall Study|Protocol Violation|0
953669|NCT00746798|3140841|P2|Overall Study|Protocol Violation|1
953670|NCT00746798|3140842|P1|Overall Study|Protocol Violation|0
953671|NCT00746785|3140867|P3|Overall Study|Lost to Follow-up|27
953672|NCT00746785|3140868|P2|Overall Study|Lost to Follow-up|25
953673|NCT00746785|3140869|P1|Overall Study|Lost to Follow-up|29
953674|NCT00746733|3140877|P2|Third Intervention|Withdrawal by Subject|1
953675|NCT00746733|3140878|P1|Third Intervention|Withdrawal by Subject|1
953676|NCT00746733|3140877|P2|Second Intervention|Adverse Event|0
953677|NCT00746733|3140878|P1|Second Intervention|Adverse Event|1
953678|NCT00746590|3140962|P1|Overall Study|Death|1
953679|NCT00746564|3140966|P1|Overall Study|Required Pacemaker/ICD Implant|2
953680|NCT00746551|3140981|P2|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8
953681|NCT00746551|3140982|P1|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6
953682|NCT00746551|3140981|P2|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7
953683|NCT00746551|3140982|P1|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9
953684|NCT00746551|3140981|P2|At Gestational Age of 36 Weeks|Lost to Follow-up|4
953685|NCT00746551|3140982|P1|At Gestational Age of 36 Weeks|Lost to Follow-up|2
953686|NCT00746356|3141033|P2|Overall Study|Patient relocated|0
953687|NCT00746356|3141034|P1|Overall Study|Patient relocated|1
953688|NCT00746356|3141033|P2|Overall Study|Removal of Device|1
953689|NCT00746356|3141034|P1|Overall Study|Removal of Device|0
953690|NCT00746356|3141033|P2|Overall Study|Lost to Follow-up|0
953691|NCT00746356|3141034|P1|Overall Study|Lost to Follow-up|1
953692|NCT00746356|3141033|P2|Overall Study|Death|3
953693|NCT00746356|3141034|P1|Overall Study|Death|7
953694|NCT00746356|3141033|P2|Overall Study|Withdrawal by Subject|3
953695|NCT00746356|3141034|P1|Overall Study|Withdrawal by Subject|2
953696|NCT00746330|3141046|P4|Period 1|Abnormal test procedure result|0
953697|NCT00746330|3141047|P3|Period 1|Abnormal test procedure result|1
953698|NCT00746330|3141048|P2|Period 1|Abnormal test procedure result|0
953699|NCT00746330|3141049|P1|Period 1|Abnormal test procedure result|0
953700|NCT00746252|3141079|P2|Overall Study|weight gain >7.5 %|2
953701|NCT00746252|3141080|P1|Overall Study|weight gain >7.5 %|1
953702|NCT00746096|3141102|P2|Overall Study|No study drug treatment|1
953703|NCT00746096|3141103|P1|Overall Study|No study drug treatment|1
953704|NCT00746096|3141102|P2|Overall Study|Protocol Violation|0
953705|NCT00746096|3141103|P1|Overall Study|Protocol Violation|1
953706|NCT00746096|3141102|P2|Overall Study|Lost to Follow-up|1
953707|NCT00746096|3141103|P1|Overall Study|Lost to Follow-up|2
953708|NCT00746096|3141102|P2|Overall Study|Withdrawal by Subject|1
953709|NCT00746096|3141103|P1|Overall Study|Withdrawal by Subject|5
953710|NCT00746096|3141102|P2|Overall Study|Adverse Event|0
953711|NCT00746096|3141103|P1|Overall Study|Adverse Event|1
953712|NCT00745901|3141134|P2|Overall Study|Patient didn't take any study medication|3
953713|NCT00745901|3141135|P1|Overall Study|Patient didn't take any study medication|7
953714|NCT00745901|3141134|P2|Overall Study|Chlamydia test at Visit 1 was positive|1
953715|NCT00745901|3141135|P1|Overall Study|Chlamydia test at Visit 1 was positive|1
953716|NCT00745901|3141134|P2|Overall Study|Results of Pap smear at Vis 1 malignant|2
953717|NCT00745901|3141135|P1|Overall Study|Results of Pap smear at Vis 1 malignant|0
953718|NCT00745901|3141134|P2|Overall Study|Patient's next menses did not start with|0
953719|NCT00745901|3141135|P1|Overall Study|Patient's next menses did not start with|1
953720|NCT00745901|3141134|P2|Overall Study|Lack of compliance|2
953721|NCT00745901|3141135|P1|Overall Study|Lack of compliance|2
953722|NCT00745901|3141134|P2|Overall Study|Pregnancy|4
953723|NCT00745901|3141135|P1|Overall Study|Pregnancy|2
953724|NCT00745901|3141134|P2|Overall Study|Lost to Follow-up|4
953725|NCT00745901|3141135|P1|Overall Study|Lost to Follow-up|7
953726|NCT00745901|3141134|P2|Overall Study|Withdrawal by Subject|0
953727|NCT00745901|3141135|P1|Overall Study|Withdrawal by Subject|1
953728|NCT00745901|3141134|P2|Overall Study|Protocol Violation|1
953729|NCT00745901|3141135|P1|Overall Study|Protocol Violation|0
953730|NCT00745901|3141134|P2|Overall Study|Adverse Event|4
953731|NCT00745901|3141135|P1|Overall Study|Adverse Event|3
953732|NCT00745875|3141181|P2|Overall Study|Continuing study treatment|4
953733|NCT00745875|3141182|P1|Overall Study|Continuing study treatment|4
953734|NCT00745823|3141192|P2|Overall Study|Study Terminated by Sponsor|349
953735|NCT00745823|3141193|P1|Overall Study|Study Terminated by Sponsor|326
953736|NCT00745823|3141192|P2|Overall Study|Withdrawal by Subject|8
953737|NCT00745823|3141193|P1|Overall Study|Withdrawal by Subject|14
953738|NCT00745823|3141192|P2|Overall Study|Pregnancy|4
953739|NCT00745823|3141193|P1|Overall Study|Pregnancy|0
953740|NCT00745823|3141192|P2|Overall Study|Physician Decision|5
953741|NCT00745823|3141193|P1|Overall Study|Physician Decision|10
953742|NCT00745823|3141192|P2|Overall Study|Lost to Follow-up|11
953743|NCT00745823|3141193|P1|Overall Study|Lost to Follow-up|10
953744|NCT00745823|3141192|P2|Overall Study|Lack of Efficacy|6
953745|NCT00745823|3141193|P1|Overall Study|Lack of Efficacy|20
953746|NCT00745823|3141192|P2|Overall Study|Adverse Event|3
953747|NCT00745823|3141193|P1|Overall Study|Adverse Event|5
953748|NCT00745498|3141220|P3|Overall Study|Edophthalmitis after preoperative IVB|0
953749|NCT00745498|3141221|P2|Overall Study|Edophthalmitis after preoperative IVB|0
953750|NCT00745498|3141222|P1|Overall Study|Edophthalmitis after preoperative IVB|1
953751|NCT00745498|3141220|P3|Overall Study|Non-PDR related VH|1
953752|NCT00745498|3141221|P2|Overall Study|Non-PDR related VH|1
953753|NCT00745498|3141222|P1|Overall Study|Non-PDR related VH|0
953754|NCT00745498|3141220|P3|Overall Study|Injection of intravitreal silicone oil o|4
953755|NCT00745498|3141221|P2|Overall Study|Injection of intravitreal silicone oil o|4
953756|NCT00745498|3141222|P1|Overall Study|Injection of intravitreal silicone oil o|3
953757|NCT00745498|3141220|P3|Overall Study|Lost to Follow-up|3
953758|NCT00745498|3141221|P2|Overall Study|Lost to Follow-up|1
953759|NCT00745498|3141222|P1|Overall Study|Lost to Follow-up|1
953760|NCT00745420|3141236|P1|Overall Study|Ineligible|1
953761|NCT00745368|3141253|P1|Overall Study|Unable to provide sample|3
953762|NCT00745251|3141275|P2|Overall Study|Withdrawal by Subject|1
953763|NCT00745251|3141276|P1|Overall Study|Withdrawal by Subject|1
953764|NCT00745251|3141275|P2|Overall Study|Adverse Event|2
953765|NCT00745251|3141276|P1|Overall Study|Adverse Event|1
953766|NCT00745095|3141290|P6|Overall Study|Ineligible due to GFR criteria|28
953767|NCT00745095|3141291|P5|Overall Study|Ineligible due to GFR criteria|30
953768|NCT00745095|3141292|P4|Overall Study|Ineligible due to GFR criteria|3
953769|NCT00745095|3141293|P3|Overall Study|Ineligible due to GFR criteria|3
953770|NCT00745095|3141294|P2|Overall Study|Ineligible due to GFR criteria|2
953771|NCT00745095|3141295|P1|Overall Study|Ineligible due to GFR criteria|0
953772|NCT00745095|3141290|P6|Overall Study|Declined to participate|95
953773|NCT00745095|3141291|P5|Overall Study|Declined to participate|92
953774|NCT00745095|3141292|P4|Overall Study|Declined to participate|0
953775|NCT00745095|3141293|P3|Overall Study|Declined to participate|0
953776|NCT00745095|3141294|P2|Overall Study|Declined to participate|0
953777|NCT00745095|3141295|P1|Overall Study|Declined to participate|1
953778|NCT00744978|3141326|P2|Period 2|Adverse Event|1
953779|NCT00744978|3141327|P1|Period 2|Adverse Event|0
953780|NCT00744978|3141326|P2|Period 1|Randomized but not Treated|1
953781|NCT00744978|3141327|P1|Period 1|Randomized but not Treated|1
953782|NCT00744978|3141326|P2|Period 1|Adverse Event|0
953783|NCT00744978|3141327|P1|Period 1|Adverse Event|4
953784|NCT00744978|3141326|P2|Period 1|Other|2
953785|NCT00744978|3141327|P1|Period 1|Other|0
953786|NCT00744978|3141326|P2|Period 1|Withdrawal by Subject|2
953787|NCT00744978|3141327|P1|Period 1|Withdrawal by Subject|0
953788|NCT00744978|3141326|P2|Period 1|Lost to Follow-up|0
953789|NCT00744978|3141327|P1|Period 1|Lost to Follow-up|1
953790|NCT00744939|3141379|P1|Overall Study|incorrect race|1
953791|NCT00744939|3141379|P1|Overall Study|coma|1
953792|NCT00744939|3141379|P1|Overall Study|Failed inclusion/exclusion criteria|19
953793|NCT00744939|3141379|P1|Overall Study|Did not receive Magnevist|7
953794|NCT00744939|3141379|P1|Overall Study|Medical history exclusionary|1
953795|NCT00744939|3141379|P1|Overall Study|Lost to Follow-up|12
953796|NCT00744939|3141379|P1|Overall Study|distance|4
953797|NCT00744939|3141379|P1|Overall Study|Death|24
953798|NCT00744939|3141379|P1|Overall Study|Protocol Violation|13
953799|NCT00744939|3141379|P1|Overall Study|Withdrawal by Subject|9
953800|NCT00744874|3141415|P1|Overall Study|Unable to accomodate schedule|1
953801|NCT00744874|3141415|P1|Overall Study|Study Device not available at procedure|1
953802|NCT00744874|3141415|P1|Overall Study|Withdrawal by Subject|1
953803|NCT00744874|3141415|P1|Overall Study|Lost to Follow-up|1
953804|NCT00744757|3141440|P1|Overall Study|Adverse Event|2
953805|NCT00744757|3141440|P1|Overall Study|Death|6
953806|NCT00744757|3141440|P1|Overall Study|Withdrawal by Subject|1
953807|NCT00744757|3141440|P1|Overall Study|Physician Decision|5
953808|NCT00744757|3141440|P1|Overall Study|Objective disease progression|7
953809|NCT00744653|3141465|P1|Overall Study|Physician Decision|3
953810|NCT00744653|3141465|P1|Overall Study|Lost to Follow-up|1
953811|NCT00744653|3141465|P1|Overall Study|Death|1
953812|NCT00744653|3141465|P1|Overall Study|antineoplastic treatment|11
953813|NCT00744627|3141473|P2|Overall Study|Other|0
953814|NCT00744627|3141474|P1|Overall Study|Other|1
953815|NCT00744627|3141473|P2|Overall Study|Lost to Follow-up|1
953816|NCT00744627|3141474|P1|Overall Study|Lost to Follow-up|2
953817|NCT00744627|3141473|P2|Overall Study|Voluntary Withdrawal|6
953818|NCT00744627|3141474|P1|Overall Study|Voluntary Withdrawal|9
953819|NCT00744627|3141473|P2|Overall Study|Protocol Deviations|2
953820|NCT00744627|3141474|P1|Overall Study|Protocol Deviations|0
953821|NCT00744627|3141473|P2|Overall Study|Noncompliance|1
953822|NCT00744627|3141474|P1|Overall Study|Noncompliance|0
953823|NCT00744627|3141473|P2|Overall Study|Lack of Efficacy|3
953824|NCT00744627|3141474|P1|Overall Study|Lack of Efficacy|7
953825|NCT00744627|3141473|P2|Overall Study|Adverse Event|9
953826|NCT00744627|3141474|P1|Overall Study|Adverse Event|6
953827|NCT00744523|3141530|P2|30 Days After the Procedure|Insufficient follow-up|5
953828|NCT00744523|3141531|P1|30 Days After the Procedure|Insufficient follow-up|0
953829|NCT00744497|3141551|P2|Overall Study|Not defined|13
953830|NCT00744497|3141552|P1|Overall Study|Not defined|19
953831|NCT00744497|3141551|P2|Overall Study|Maximum clinical benefit|142
953832|NCT00744497|3141552|P1|Overall Study|Maximum clinical benefit|141
953833|NCT00744497|3141551|P2|Overall Study|Patient requested to stop study drug|80
953834|NCT00744497|3141552|P1|Overall Study|Patient requested to stop study drug|65
953835|NCT00744497|3141551|P2|Overall Study|Adverse event unrelated to study drug|122
953836|NCT00744497|3141552|P1|Overall Study|Adverse event unrelated to study drug|78
953837|NCT00744497|3141551|P2|Overall Study|Study drug toxicity|141
953838|NCT00744497|3141552|P1|Overall Study|Study drug toxicity|68
953839|NCT00744497|3141551|P2|Overall Study|Disease progression|219
953840|NCT00744497|3141552|P1|Overall Study|Disease progression|312
953841|NCT00744497|3141551|P2|Overall Study|Administrative Reason By Sponsor|8
953842|NCT00744497|3141552|P1|Overall Study|Administrative Reason By Sponsor|25
953843|NCT00744497|3141551|P2|Overall Study|No longer meets study criteria|3
953844|NCT00744497|3141552|P1|Overall Study|No longer meets study criteria|7
953845|NCT00744497|3141551|P2|Overall Study|Poor compliance/noncompliance|5
953846|NCT00744497|3141552|P1|Overall Study|Poor compliance/noncompliance|9
953847|NCT00744497|3141551|P2|Overall Study|Lost to Follow-up|2
953848|NCT00744497|3141552|P1|Overall Study|Lost to Follow-up|4
953849|NCT00744497|3141551|P2|Overall Study|Death|9
953850|NCT00744497|3141552|P1|Overall Study|Death|11
953851|NCT00744497|3141551|P2|Overall Study|Withdrawal by Subject|18
953852|NCT00744497|3141552|P1|Overall Study|Withdrawal by Subject|21
953853|NCT00744328|3141612|P3|Overall Study|Found ineligible after randomization|1
953854|NCT00744328|3141613|P2|Overall Study|Found ineligible after randomization|0
953855|NCT00744328|3141614|P1|Overall Study|Found ineligible after randomization|0
953856|NCT00744328|3141612|P3|Overall Study|Withdrawal by Subject|4
953857|NCT00744328|3141613|P2|Overall Study|Withdrawal by Subject|3
953858|NCT00744328|3141614|P1|Overall Study|Withdrawal by Subject|5
953859|NCT00744328|3141612|P3|Overall Study|Lost to Follow-up|3
953860|NCT00744328|3141613|P2|Overall Study|Lost to Follow-up|5
953861|NCT00744328|3141614|P1|Overall Study|Lost to Follow-up|2
953862|NCT00744263|3141624|P2|Overall Study|Other|2
953863|NCT00744263|3141625|P1|Overall Study|Other|2
953864|NCT00744263|3141624|P2|Overall Study|Adverse Event|0
953865|NCT00744263|3141625|P1|Overall Study|Adverse Event|1
953866|NCT00744263|3141624|P2|Overall Study|Protocol Violation|5
953867|NCT00744263|3141625|P1|Overall Study|Protocol Violation|3
953868|NCT00744263|3141624|P2|Overall Study|Physician Decision|23
953869|NCT00744263|3141625|P1|Overall Study|Physician Decision|20
953870|NCT00744263|3141624|P2|Overall Study|Withdrawal by Subject|150
953871|NCT00744263|3141625|P1|Overall Study|Withdrawal by Subject|166
953872|NCT00744263|3141624|P2|Overall Study|Lost to Follow-up|2135
953873|NCT00744263|3141625|P1|Overall Study|Lost to Follow-up|2038
953874|NCT00744263|3141624|P2|Overall Study|Death|3005
953875|NCT00744263|3141625|P1|Overall Study|Death|3006
953876|NCT00744237|3141648|P3|Overall Study|Adverse Event|5
953877|NCT00744237|3141649|P2|Overall Study|Adverse Event|13
953878|NCT00744237|3141650|P1|Overall Study|Adverse Event|9
953879|NCT00744237|3141648|P3|Overall Study|Administrative. Site Closed|1
953880|NCT00744237|3141649|P2|Overall Study|Administrative. Site Closed|1
953881|NCT00744237|3141650|P1|Overall Study|Administrative. Site Closed|1
953882|NCT00744237|3141648|P3|Overall Study|Poor Compliance|0
953883|NCT00744237|3141649|P2|Overall Study|Poor Compliance|2
953884|NCT00744237|3141650|P1|Overall Study|Poor Compliance|0
953885|NCT00744237|3141648|P3|Overall Study|Prohibited Concomitant Medication|1
953886|NCT00744237|3141649|P2|Overall Study|Prohibited Concomitant Medication|0
953887|NCT00744237|3141650|P1|Overall Study|Prohibited Concomitant Medication|0
953888|NCT00744237|3141648|P3|Overall Study|Study Drug Error|0
953889|NCT00744237|3141649|P2|Overall Study|Study Drug Error|0
953890|NCT00744237|3141650|P1|Overall Study|Study Drug Error|1
953891|NCT00744237|3141648|P3|Overall Study|Dosing Error|1
953892|NCT00744237|3141649|P2|Overall Study|Dosing Error|0
953893|NCT00744237|3141650|P1|Overall Study|Dosing Error|1
953894|NCT00744237|3141648|P3|Overall Study|Inclusion/Exclusion criteria not met|0
953895|NCT00744237|3141649|P2|Overall Study|Inclusion/Exclusion criteria not met|0
953896|NCT00744237|3141650|P1|Overall Study|Inclusion/Exclusion criteria not met|1
953897|NCT00744237|3141648|P3|Overall Study|Protocol Violation|3
953898|NCT00744237|3141649|P2|Overall Study|Protocol Violation|4
953899|NCT00744237|3141650|P1|Overall Study|Protocol Violation|3
953900|NCT00744237|3141648|P3|Overall Study|Lost to Follow-up|1
953901|NCT00744237|3141649|P2|Overall Study|Lost to Follow-up|1
953902|NCT00744237|3141650|P1|Overall Study|Lost to Follow-up|1
953903|NCT00744237|3141648|P3|Overall Study|Withdrawal by Subject|3
953904|NCT00744237|3141649|P2|Overall Study|Withdrawal by Subject|5
953905|NCT00744237|3141650|P1|Overall Study|Withdrawal by Subject|9
953906|NCT00744237|3141648|P3|Overall Study|Lack of Efficacy|0
953907|NCT00744237|3141649|P2|Overall Study|Lack of Efficacy|1
953908|NCT00744237|3141650|P1|Overall Study|Lack of Efficacy|1
953909|NCT00744055|3141684|P2|Overall Study|Lost to Follow-up|1
953910|NCT00744055|3141685|P1|Overall Study|Lost to Follow-up|0
953911|NCT00744055|3141684|P2|Overall Study|Protocol Violation|1
953912|NCT00744055|3141685|P1|Overall Study|Protocol Violation|1
953913|NCT00744055|3141684|P2|Overall Study|Physician Decision|2
953914|NCT00744055|3141685|P1|Overall Study|Physician Decision|0
953915|NCT00744055|3141684|P2|Overall Study|Lack of Efficacy|1
953916|NCT00744055|3141685|P1|Overall Study|Lack of Efficacy|0
953917|NCT00744055|3141684|P2|Overall Study|Withdrawal by Subject|9
953918|NCT00744055|3141685|P1|Overall Study|Withdrawal by Subject|6
953919|NCT00744042|3141693|P1|Overall Study|Withdrawal by Subject|1
953920|NCT00743652|3141739|P5|Overall Study|Lost to Follow-up|0
953921|NCT00743652|3141740|P4|Overall Study|Lost to Follow-up|0
953922|NCT00743652|3141741|P3|Overall Study|Lost to Follow-up|0
953923|NCT00743652|3141742|P2|Overall Study|Lost to Follow-up|0
953924|NCT00743652|3141743|P1|Overall Study|Lost to Follow-up|1
953925|NCT00743652|3141739|P5|Overall Study|Other|0
953926|NCT00743652|3141740|P4|Overall Study|Other|0
953927|NCT00743652|3141741|P3|Overall Study|Other|0
953928|NCT00743652|3141742|P2|Overall Study|Other|1
953929|NCT00743652|3141743|P1|Overall Study|Other|1
953930|NCT00743652|3141739|P5|Overall Study|Investigator Request|0
953931|NCT00743652|3141740|P4|Overall Study|Investigator Request|2
953932|NCT00743652|3141741|P3|Overall Study|Investigator Request|0
953933|NCT00743652|3141742|P2|Overall Study|Investigator Request|0
953934|NCT00743652|3141743|P1|Overall Study|Investigator Request|0
953935|NCT00743652|3141739|P5|Overall Study|Death|0
953936|NCT00743652|3141740|P4|Overall Study|Death|0
953937|NCT00743652|3141741|P3|Overall Study|Death|0
953938|NCT00743652|3141742|P2|Overall Study|Death|0
953939|NCT00743652|3141743|P1|Overall Study|Death|2
953940|NCT00743652|3141739|P5|Overall Study|Adverse Event|0
953941|NCT00743652|3141740|P4|Overall Study|Adverse Event|0
953942|NCT00743652|3141741|P3|Overall Study|Adverse Event|0
953943|NCT00743652|3141742|P2|Overall Study|Adverse Event|0
953944|NCT00743652|3141743|P1|Overall Study|Adverse Event|3
953945|NCT00743652|3141739|P5|Overall Study|Parent/Legal Guardian Request|0
953946|NCT00743652|3141740|P4|Overall Study|Parent/Legal Guardian Request|2
953947|NCT00743652|3141741|P3|Overall Study|Parent/Legal Guardian Request|2
953948|NCT00743652|3141742|P2|Overall Study|Parent/Legal Guardian Request|2
953949|NCT00743652|3141743|P1|Overall Study|Parent/Legal Guardian Request|3
953950|NCT00743509|3141827|P1|Overall Study|Withdrawal by Subject|2
953951|NCT00743483|3141832|P1|Treatment Period|Adverse Event|1
953952|NCT00743483|3141832|P1|Baseline Period|Physician Decision|1
953953|NCT00743444|3141836|P2|Washout Period|Adverse Event|1
953954|NCT00743444|3141837|P1|Washout Period|Adverse Event|0
953955|NCT00743444|3141836|P2|First Intervention|Catheter placement problems|1
953956|NCT00743444|3141837|P1|First Intervention|Catheter placement problems|0
953957|NCT00743431|3141846|P1|Overall Study|No documentation available|13
953958|NCT00743431|3141846|P1|Overall Study|Reason for discontinuation not specified|29
953959|NCT00743431|3141846|P1|Overall Study|Death|9
953960|NCT00743431|3141846|P1|Overall Study|Withdrawal by Subject|13
953961|NCT00743431|3141846|P1|Overall Study|Tumor progression|56
953962|NCT00743431|3141846|P1|Overall Study|Toxicity|6
953963|NCT00743366|3141850|P2|Intervention 1 (8 Days)|Withdrawal by Subject|3
953964|NCT00743366|3141851|P1|Intervention 1 (8 Days)|Withdrawal by Subject|3
953965|NCT00743340|3141857|P1|Overall Study|Participant Relocated|1
953966|NCT00743340|3141857|P1|Overall Study|Rolled over to other Gilead Study|23
953967|NCT00743340|3141857|P1|Overall Study|Pregnancy|1
953968|NCT00743340|3141857|P1|Overall Study|Virologic failure|8
953969|NCT00743340|3141857|P1|Overall Study|Protocol Violation|1
953970|NCT00743340|3141857|P1|Overall Study|Withdrawal from the Study|5
953971|NCT00743340|3141857|P1|Overall Study|Lost to Follow-up|1
953972|NCT00743340|3141857|P1|Overall Study|Study medication non-compliance|1
953973|NCT00743288|3141861|P7|Overall Study|Worsening of condition (Not PD)|0
953974|NCT00743288|3141862|P6|Overall Study|Worsening of condition (Not PD)|0
953975|NCT00743288|3141863|P5|Overall Study|Worsening of condition (Not PD)|0
953976|NCT00743288|3141864|P4|Overall Study|Worsening of condition (Not PD)|1
953977|NCT00743288|3141865|P3|Overall Study|Worsening of condition (Not PD)|1
953978|NCT00743288|3141866|P2|Overall Study|Worsening of condition (Not PD)|2
953979|NCT00743288|3141867|P1|Overall Study|Worsening of condition (Not PD)|0
953980|NCT00743288|3141861|P7|Overall Study|Progressive disease (PD)|6
953981|NCT00743288|3141862|P6|Overall Study|Progressive disease (PD)|3
953982|NCT00743288|3141863|P5|Overall Study|Progressive disease (PD)|5
953983|NCT00743288|3141864|P4|Overall Study|Progressive disease (PD)|4
953984|NCT00743288|3141865|P3|Overall Study|Progressive disease (PD)|1
953985|NCT00743288|3141866|P2|Overall Study|Progressive disease (PD)|0
953986|NCT00743288|3141867|P1|Overall Study|Progressive disease (PD)|2
953987|NCT00743288|3141861|P7|Overall Study|Withdrawal by Subject|1
953988|NCT00743288|3141862|P6|Overall Study|Withdrawal by Subject|1
953989|NCT00743288|3141863|P5|Overall Study|Withdrawal by Subject|0
953990|NCT00743288|3141864|P4|Overall Study|Withdrawal by Subject|0
953991|NCT00743288|3141865|P3|Overall Study|Withdrawal by Subject|1
953992|NCT00743288|3141866|P2|Overall Study|Withdrawal by Subject|0
953993|NCT00743288|3141867|P1|Overall Study|Withdrawal by Subject|0
953994|NCT00743288|3141861|P7|Overall Study|Adverse Event|2
953995|NCT00743288|3141862|P6|Overall Study|Adverse Event|1
953996|NCT00743288|3141863|P5|Overall Study|Adverse Event|1
953997|NCT00743288|3141864|P4|Overall Study|Adverse Event|2
953998|NCT00743288|3141865|P3|Overall Study|Adverse Event|2
953999|NCT00743288|3141866|P2|Overall Study|Adverse Event|1
954000|NCT00743288|3141867|P1|Overall Study|Adverse Event|1
954001|NCT00743275|3141881|P2|Overall Study|Protocol Violation|1
954002|NCT00743275|3141882|P1|Overall Study|Protocol Violation|0
954003|NCT00743249|3141902|P2|Overall Study|Unsuccessful insertion of stent|1
954004|NCT00743249|3141903|P1|Overall Study|Unsuccessful insertion of stent|2
954005|NCT00743249|3141902|P2|Overall Study|Patient Decision Unrelated to Ad Event|1
954006|NCT00743249|3141903|P1|Overall Study|Patient Decision Unrelated to Ad Event|0
954007|NCT00743249|3141902|P2|Overall Study|Adverse Event|4
954008|NCT00743249|3141903|P1|Overall Study|Adverse Event|0
954009|NCT00743197|3141913|P2|Overall Study|Study terminated due to departure of PI.|2
954010|NCT00743197|3141914|P1|Overall Study|Study terminated due to departure of PI.|1
954011|NCT00743145|3141920|P1|Overall Study|Pregnancy|1
954012|NCT00743145|3141920|P1|Overall Study|Adverse Event|2
954013|NCT00743145|3141920|P1|Overall Study|Withdrawal by Subject|1
954014|NCT00743119|3141934|P1|Overall Study|Withdrawal by Subject|1
954015|NCT00743119|3141934|P1|Overall Study|unreliable|3
954016|NCT00743106|3141948|P2|Overall Study|Met intraoperative exclusion criterion|5
954017|NCT00743106|3141949|P1|Overall Study|Met intraoperative exclusion criterion|8
954018|NCT00742924|3141976|P4|Overall Study|Withdrawal by Subject|0
954019|NCT00742924|3141977|P3|Overall Study|Withdrawal by Subject|1
954020|NCT00742924|3141978|P2|Overall Study|Withdrawal by Subject|1
954021|NCT00742924|3141979|P1|Overall Study|Withdrawal by Subject|0
954022|NCT00742924|3141976|P4|Overall Study|Physician Decision|1
954023|NCT00742924|3141977|P3|Overall Study|Physician Decision|0
954024|NCT00742924|3141978|P2|Overall Study|Physician Decision|0
954025|NCT00742924|3141979|P1|Overall Study|Physician Decision|0
954026|NCT00742924|3141976|P4|Overall Study|Lack of Efficacy|4
954027|NCT00742924|3141977|P3|Overall Study|Lack of Efficacy|2
954028|NCT00742924|3141978|P2|Overall Study|Lack of Efficacy|1
954029|NCT00742924|3141979|P1|Overall Study|Lack of Efficacy|5
954030|NCT00742924|3141976|P4|Overall Study|Adverse Event|1
954031|NCT00742924|3141977|P3|Overall Study|Adverse Event|1
954032|NCT00742924|3141978|P2|Overall Study|Adverse Event|0
954033|NCT00742924|3141979|P1|Overall Study|Adverse Event|0
954034|NCT00742885|3141991|P2|Overall Study|Lost to Follow-up|0
954035|NCT00742885|3141992|P1|Overall Study|Lost to Follow-up|1
954036|NCT00742859|3142051|P4|Overall Study|Site error|1
954037|NCT00742859|3142052|P3|Overall Study|Site error|1
954038|NCT00742859|3142053|P2|Overall Study|Site error|0
954039|NCT00742859|3142054|P1|Overall Study|Site error|0
954040|NCT00742859|3142051|P4|Overall Study|Sponsor request patient out of town|1
954041|NCT00742859|3142052|P3|Overall Study|Sponsor request patient out of town|1
954042|NCT00742859|3142053|P2|Overall Study|Sponsor request patient out of town|0
954043|NCT00742859|3142054|P1|Overall Study|Sponsor request patient out of town|0
954044|NCT00742859|3142051|P4|Overall Study|Sponsor req visit schedule noncompliance|1
954045|NCT00742859|3142052|P3|Overall Study|Sponsor req visit schedule noncompliance|0
954046|NCT00742859|3142053|P2|Overall Study|Sponsor req visit schedule noncompliance|0
954047|NCT00742859|3142054|P1|Overall Study|Sponsor req visit schedule noncompliance|0
954048|NCT00742859|3142051|P4|Overall Study|Amendment 2 patient off study drug >4wks|0
954049|NCT00742859|3142052|P3|Overall Study|Amendment 2 patient off study drug >4wks|1
954050|NCT00742859|3142053|P2|Overall Study|Amendment 2 patient off study drug >4wks|1
954051|NCT00742859|3142054|P1|Overall Study|Amendment 2 patient off study drug >4wks|0
954052|NCT00742859|3142051|P4|Overall Study|Endpoint|2
954053|NCT00742859|3142052|P3|Overall Study|Endpoint|1
954054|NCT00742859|3142053|P2|Overall Study|Endpoint|1
954055|NCT00742859|3142054|P1|Overall Study|Endpoint|0
954056|NCT00742859|3142051|P4|Overall Study|Withdrawal by Subject|1
954057|NCT00742859|3142052|P3|Overall Study|Withdrawal by Subject|4
954058|NCT00742859|3142053|P2|Overall Study|Withdrawal by Subject|2
954059|NCT00742859|3142054|P1|Overall Study|Withdrawal by Subject|4
954060|NCT00742859|3142051|P4|Overall Study|Physician Decision|0
954061|NCT00742859|3142052|P3|Overall Study|Physician Decision|0
954062|NCT00742859|3142053|P2|Overall Study|Physician Decision|2
954063|NCT00742859|3142054|P1|Overall Study|Physician Decision|1
954064|NCT00742859|3142051|P4|Overall Study|Death|1
954065|NCT00742859|3142052|P3|Overall Study|Death|0
954066|NCT00742859|3142053|P2|Overall Study|Death|0
954067|NCT00742859|3142054|P1|Overall Study|Death|1
954068|NCT00742859|3142051|P4|Overall Study|Adverse Event|1
954069|NCT00742859|3142052|P3|Overall Study|Adverse Event|3
954070|NCT00742859|3142053|P2|Overall Study|Adverse Event|6
954071|NCT00742859|3142054|P1|Overall Study|Adverse Event|5
954072|NCT00742781|3142068|P1|Overall Study|Withdrawal by Subject|3
954073|NCT00742625|3142077|P1|Consolidation|Non protocol therapy|13
954074|NCT00742625|3142077|P1|Consolidation|Refused|1
954075|NCT00742625|3142077|P1|Consolidation|Death|1
954076|NCT00742625|3142077|P1|Consolidation|Adverse Event|1
954077|NCT00742625|3142077|P1|Consolidation|Progression|5
954078|NCT00742625|3142077|P1|Remission Induction|Other, not specified|5
954079|NCT00742625|3142077|P1|Remission Induction|Non protocol treatment|17
954080|NCT00742625|3142077|P1|Remission Induction|Refusal|5
954081|NCT00742625|3142077|P1|Remission Induction|Death|10
954082|NCT00742625|3142077|P1|Remission Induction|Adverse Event|3
954083|NCT00742625|3142077|P1|Remission Induction|Failed induction|8
954084|NCT00742625|3142077|P1|Remission Induction|Progression|6
954085|NCT00742560|3142091|P5|Overall Study|MIssing|1
954086|NCT00742560|3142092|P4|Overall Study|MIssing|0
954087|NCT00742560|3142093|P3|Overall Study|MIssing|0
954088|NCT00742560|3142094|P2|Overall Study|MIssing|0
954089|NCT00742560|3142095|P1|Overall Study|MIssing|0
954090|NCT00742560|3142091|P5|Overall Study|Not Specified|9
954091|NCT00742560|3142092|P4|Overall Study|Not Specified|9
954092|NCT00742560|3142093|P3|Overall Study|Not Specified|8
954093|NCT00742560|3142094|P2|Overall Study|Not Specified|1
954094|NCT00742560|3142095|P1|Overall Study|Not Specified|0
954095|NCT00742560|3142091|P5|Overall Study|New Multiple Myeloma Therapy|4
954096|NCT00742560|3142092|P4|Overall Study|New Multiple Myeloma Therapy|3
954097|NCT00742560|3142093|P3|Overall Study|New Multiple Myeloma Therapy|2
954098|NCT00742560|3142094|P2|Overall Study|New Multiple Myeloma Therapy|0
954099|NCT00742560|3142095|P1|Overall Study|New Multiple Myeloma Therapy|1
954100|NCT00742560|3142091|P5|Overall Study|Disease Progression|16
954101|NCT00742560|3142092|P4|Overall Study|Disease Progression|17
954102|NCT00742560|3142093|P3|Overall Study|Disease Progression|5
954103|NCT00742560|3142094|P2|Overall Study|Disease Progression|0
954104|NCT00742560|3142095|P1|Overall Study|Disease Progression|1
954105|NCT00742560|3142091|P5|Overall Study|Investigator's Decision|0
954106|NCT00742560|3142092|P4|Overall Study|Investigator's Decision|1
954107|NCT00742560|3142093|P3|Overall Study|Investigator's Decision|4
954108|NCT00742560|3142094|P2|Overall Study|Investigator's Decision|0
954109|NCT00742560|3142095|P1|Overall Study|Investigator's Decision|0
954110|NCT00742560|3142091|P5|Overall Study|Subject's Decision|3
954111|NCT00742560|3142092|P4|Overall Study|Subject's Decision|3
954112|NCT00742560|3142093|P3|Overall Study|Subject's Decision|2
954113|NCT00742560|3142094|P2|Overall Study|Subject's Decision|0
954114|NCT00742560|3142095|P1|Overall Study|Subject's Decision|1
954115|NCT00742560|3142091|P5|Overall Study|Death|3
954116|NCT00742560|3142092|P4|Overall Study|Death|2
954117|NCT00742560|3142093|P3|Overall Study|Death|0
954118|NCT00742560|3142094|P2|Overall Study|Death|2
954119|NCT00742560|3142095|P1|Overall Study|Death|0
954120|NCT00742560|3142091|P5|Overall Study|Adverse Event|1
954121|NCT00742560|3142092|P4|Overall Study|Adverse Event|1
954122|NCT00742560|3142093|P3|Overall Study|Adverse Event|1
954123|NCT00742560|3142094|P2|Overall Study|Adverse Event|0
954124|NCT00742560|3142095|P1|Overall Study|Adverse Event|0
954125|NCT00742508|3142169|P2|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1
954126|NCT00742508|3142170|P1|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0
954127|NCT00742508|3142169|P2|8-Week Primary Evaluation Period|Withdrawal by Subject|2
954128|NCT00742508|3142170|P1|8-Week Primary Evaluation Period|Withdrawal by Subject|0
954129|NCT00742508|3142169|P2|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5
954130|NCT00742508|3142170|P1|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8
954131|NCT00742508|3142169|P2|8-Week Primary Evaluation Period|Protocol Violation|0
954132|NCT00742508|3142170|P1|8-Week Primary Evaluation Period|Protocol Violation|1
954133|NCT00742508|3142169|P2|8-Week Primary Evaluation Period|Adverse Event|4
954134|NCT00742508|3142170|P1|8-Week Primary Evaluation Period|Adverse Event|2
954135|NCT00742417|3142234|P2|Intensive Period|Adverse Event|0
954136|NCT00742417|3142235|P1|Intensive Period|Adverse Event|2
954137|NCT00742417|3142234|P2|Intensive Period|Withdrawal by Subject|1
954138|NCT00742417|3142235|P1|Intensive Period|Withdrawal by Subject|1
954139|NCT00742417|3142234|P2|Randomized|Physician Decision|0
954140|NCT00742417|3142235|P1|Randomized|Physician Decision|1
954141|NCT00742417|3142234|P2|Randomized|Withdrawal by Subject|0
954142|NCT00742417|3142235|P1|Randomized|Withdrawal by Subject|1
954143|NCT00742417|3142234|P2|Randomized|Withdrawal by legal representative|1
954144|NCT00742417|3142235|P1|Randomized|Withdrawal by legal representative|0
954145|NCT00742391|3142259|P2|Overall Study|Protocol Violation|0
954146|NCT00742391|3142260|P1|Overall Study|Protocol Violation|1
954147|NCT00742391|3142259|P2|Overall Study|Lost to Follow-up|0
954148|NCT00742391|3142260|P1|Overall Study|Lost to Follow-up|1
954149|NCT00742391|3142259|P2|Overall Study|Adverse Event|1
954150|NCT00742391|3142260|P1|Overall Study|Adverse Event|2
954151|NCT00742326|3142270|P2|Overall Study|Physician Decision|1
954152|NCT00742326|3142271|P1|Overall Study|Physician Decision|0
954153|NCT00742274|3142290|P2|Overall Study|Removed for medical reasons|1
954154|NCT00742274|3142291|P1|Overall Study|Removed for medical reasons|1
954155|NCT00742274|3142290|P2|Overall Study|Withdrawal by Subject|2
954156|NCT00742274|3142291|P1|Overall Study|Withdrawal by Subject|1
954157|NCT00742274|3142290|P2|Overall Study|Death|0
954158|NCT00742274|3142291|P1|Overall Study|Death|1
954159|NCT00742235|3142299|P2|Overall Study|Lost to Follow-up|31
954160|NCT00742235|3142300|P1|Overall Study|Lost to Follow-up|0
954161|NCT00742209|3142313|P5|Overall Study|Investigator Discretion|1
954162|NCT00742209|3142314|P4|Overall Study|Investigator Discretion|1
954163|NCT00742209|3142315|P3|Overall Study|Investigator Discretion|5
954164|NCT00742209|3142316|P2|Overall Study|Investigator Discretion|0
954165|NCT00742209|3142317|P1|Overall Study|Investigator Discretion|0
954166|NCT00742209|3142313|P5|Overall Study|Lack of Efficacy|1
954167|NCT00742209|3142314|P4|Overall Study|Lack of Efficacy|3
954168|NCT00742209|3142315|P3|Overall Study|Lack of Efficacy|1
954169|NCT00742209|3142316|P2|Overall Study|Lack of Efficacy|1
954170|NCT00742209|3142317|P1|Overall Study|Lack of Efficacy|6
954171|NCT00742209|3142313|P5|Overall Study|Lost to Follow-up|3
954172|NCT00742209|3142314|P4|Overall Study|Lost to Follow-up|5
954173|NCT00742209|3142315|P3|Overall Study|Lost to Follow-up|5
954174|NCT00742209|3142316|P2|Overall Study|Lost to Follow-up|4
954175|NCT00742209|3142317|P1|Overall Study|Lost to Follow-up|3
954176|NCT00742209|3142313|P5|Overall Study|Protocol Violation|3
954177|NCT00742209|3142314|P4|Overall Study|Protocol Violation|5
954178|NCT00742209|3142315|P3|Overall Study|Protocol Violation|4
954179|NCT00742209|3142316|P2|Overall Study|Protocol Violation|5
954180|NCT00742209|3142317|P1|Overall Study|Protocol Violation|6
954181|NCT00742209|3142313|P5|Overall Study|Participant Withdrew Consent|4
954182|NCT00742209|3142314|P4|Overall Study|Participant Withdrew Consent|7
954183|NCT00742209|3142315|P3|Overall Study|Participant Withdrew Consent|14
954184|NCT00742209|3142316|P2|Overall Study|Participant Withdrew Consent|4
954185|NCT00742209|3142317|P1|Overall Study|Participant Withdrew Consent|8
954186|NCT00742209|3142313|P5|Overall Study|Adverse Event|13
954187|NCT00742209|3142314|P4|Overall Study|Adverse Event|16
954188|NCT00742209|3142315|P3|Overall Study|Adverse Event|17
954189|NCT00742209|3142316|P2|Overall Study|Adverse Event|4
954190|NCT00742209|3142317|P1|Overall Study|Adverse Event|11
954191|NCT00742183|3142420|P2|Overall Study|Lack of Efficacy|3
954192|NCT00742183|3142421|P1|Overall Study|Lack of Efficacy|0
954193|NCT00742183|3142420|P2|Overall Study|Withdrawal by Subject|0
954194|NCT00742183|3142421|P1|Overall Study|Withdrawal by Subject|1
954195|NCT00742183|3142420|P2|Overall Study|Required skin-graft|1
954196|NCT00742183|3142421|P1|Overall Study|Required skin-graft|1
954197|NCT00742183|3142420|P2|Overall Study|Lost to Follow-up|4
954198|NCT00742183|3142421|P1|Overall Study|Lost to Follow-up|4
954199|NCT00742183|3142420|P2|Overall Study|Physician Decision|2
954200|NCT00742183|3142421|P1|Overall Study|Physician Decision|0
954201|NCT00742183|3142420|P2|Overall Study|Death|0
954202|NCT00742183|3142421|P1|Overall Study|Death|1
954203|NCT00742183|3142420|P2|Overall Study|Adverse Event|2
954204|NCT00742183|3142421|P1|Overall Study|Adverse Event|2
954205|NCT00742079|3142440|P2|Overall Study|Lost to Follow-up|1
954206|NCT00742079|3142441|P1|Overall Study|Lost to Follow-up|0
954207|NCT00741988|3142461|P2|Overall Study|Lack of Efficacy|0
954208|NCT00741988|3142462|P1|Overall Study|Lack of Efficacy|2
954209|NCT00741988|3142461|P2|Overall Study|Adverse Event|4
954210|NCT00741988|3142462|P1|Overall Study|Adverse Event|2
954211|NCT00741936|3142474|P2|Overall Study|Low compliance|0
954212|NCT00741936|3142475|P1|Overall Study|Low compliance|3
954213|NCT00741936|3142474|P2|Overall Study|Lack of Efficacy|2
954214|NCT00741936|3142475|P1|Overall Study|Lack of Efficacy|0
954215|NCT00741936|3142474|P2|Overall Study|Protocol Violation|0
954216|NCT00741936|3142475|P1|Overall Study|Protocol Violation|2
954217|NCT00741936|3142474|P2|Overall Study|Pregnancy|1
954218|NCT00741936|3142475|P1|Overall Study|Pregnancy|0
954219|NCT00741936|3142474|P2|Overall Study|Adverse Event|4
954220|NCT00741936|3142475|P1|Overall Study|Adverse Event|3
954221|NCT00741936|3142474|P2|Overall Study|Lost to Follow-up|1
954222|NCT00741936|3142475|P1|Overall Study|Lost to Follow-up|1
954223|NCT00741819|3142510|P1|Overall Study|Disease progression|1
954224|NCT00741819|3142510|P1|Overall Study|Death|1
954225|NCT00741819|3142510|P1|Overall Study|Withdrawal by Subject|3
954226|NCT00741819|3142510|P1|Overall Study|Adverse Event|3
954227|NCT00741611|3142524|P3|Overall Study|Withdrawal by Subject|2
954228|NCT00741611|3142525|P2|Overall Study|Withdrawal by Subject|2
954229|NCT00741611|3142526|P1|Overall Study|Withdrawal by Subject|0
954230|NCT00741611|3142524|P3|Overall Study|Death|1
954231|NCT00741611|3142525|P2|Overall Study|Death|0
954232|NCT00741611|3142526|P1|Overall Study|Death|0
954233|NCT00741598|3142545|P2|Overall Study|Withdrawal by Subject|2
954234|NCT00741598|3142546|P1|Overall Study|Withdrawal by Subject|3
954235|NCT00741598|3142545|P2|Overall Study|Pregnancy|0
954236|NCT00741598|3142546|P1|Overall Study|Pregnancy|1
954237|NCT00741598|3142545|P2|Overall Study|Physician Decision|1
954238|NCT00741598|3142546|P1|Overall Study|Physician Decision|1
954239|NCT00741598|3142545|P2|Overall Study|Lack of Efficacy|2
954240|NCT00741598|3142546|P1|Overall Study|Lack of Efficacy|1
954241|NCT00741598|3142545|P2|Overall Study|Lost to Follow-up|4
954242|NCT00741598|3142546|P1|Overall Study|Lost to Follow-up|3
954243|NCT00741338|3142592|P2|Overall Study|Adverse Event|1
954244|NCT00741338|3142593|P1|Overall Study|Adverse Event|0
954245|NCT00741286|3142603|P2|Overall Study|Primary Outcome|1
954246|NCT00741286|3142604|P1|Overall Study|Primary Outcome|1
954247|NCT00741286|3142603|P2|Overall Study|Protocol Violation|2
954248|NCT00741286|3142604|P1|Overall Study|Protocol Violation|3
954249|NCT00741286|3142603|P2|Overall Study|Adverse Event|6
954250|NCT00741286|3142604|P1|Overall Study|Adverse Event|1
954251|NCT00741286|3142603|P2|Overall Study|Lost to Follow-up|10
954252|NCT00741286|3142604|P1|Overall Study|Lost to Follow-up|15
954253|NCT00741260|3142638|P7|Overall Study|Not Specified|1
954254|NCT00741260|3142639|P6|Overall Study|Not Specified|3
954255|NCT00741260|3142640|P5|Overall Study|Not Specified|1
954256|NCT00741260|3142641|P4|Overall Study|Not Specified|2
954257|NCT00741260|3142642|P3|Overall Study|Not Specified|1
954258|NCT00741260|3142643|P2|Overall Study|Not Specified|1
954259|NCT00741260|3142644|P1|Overall Study|Not Specified|2
954260|NCT00741260|3142638|P7|Overall Study|Physician Decision|0
954261|NCT00741260|3142639|P6|Overall Study|Physician Decision|0
954262|NCT00741260|3142640|P5|Overall Study|Physician Decision|0
954263|NCT00741260|3142641|P4|Overall Study|Physician Decision|0
954264|NCT00741260|3142642|P3|Overall Study|Physician Decision|0
954265|NCT00741260|3142643|P2|Overall Study|Physician Decision|1
954266|NCT00741260|3142644|P1|Overall Study|Physician Decision|1
954267|NCT00741260|3142638|P7|Overall Study|Withdrawal by Subject|1
954268|NCT00741260|3142639|P6|Overall Study|Withdrawal by Subject|3
954269|NCT00741260|3142640|P5|Overall Study|Withdrawal by Subject|1
954270|NCT00741260|3142641|P4|Overall Study|Withdrawal by Subject|0
954271|NCT00741260|3142642|P3|Overall Study|Withdrawal by Subject|0
954272|NCT00741260|3142643|P2|Overall Study|Withdrawal by Subject|0
954273|NCT00741260|3142644|P1|Overall Study|Withdrawal by Subject|0
954274|NCT00741260|3142638|P7|Overall Study|Death|1
954275|NCT00741260|3142639|P6|Overall Study|Death|2
954276|NCT00741260|3142640|P5|Overall Study|Death|2
954277|NCT00741260|3142641|P4|Overall Study|Death|1
954278|NCT00741260|3142642|P3|Overall Study|Death|0
954279|NCT00741260|3142643|P2|Overall Study|Death|1
954280|NCT00741260|3142644|P1|Overall Study|Death|0
954281|NCT00741260|3142638|P7|Overall Study|Disease Progression|4
954282|NCT00741260|3142639|P6|Overall Study|Disease Progression|37
954283|NCT00741260|3142640|P5|Overall Study|Disease Progression|5
954284|NCT00741260|3142641|P4|Overall Study|Disease Progression|3
954285|NCT00741260|3142642|P3|Overall Study|Disease Progression|3
954286|NCT00741260|3142643|P2|Overall Study|Disease Progression|5
954287|NCT00741260|3142644|P1|Overall Study|Disease Progression|3
954288|NCT00741091|3142693|P1|Overall Study|Missed Visit|22
954289|NCT00741091|3142693|P1|Overall Study|Withdrawal by Subject|6
954290|NCT00741091|3142693|P1|Overall Study|Lost to Follow-up|16
954291|NCT00741091|3142693|P1|Overall Study|Death|13
954292|NCT00741039|3142703|P2|Overall Study|Patient non-compliance|0
954293|NCT00741039|3142704|P1|Overall Study|Patient non-compliance|2
954294|NCT00741013|3142741|P3|Overall Study|Discovered failed screen after enrolled|0
954295|NCT00741013|3142742|P2|Overall Study|Discovered failed screen after enrolled|2
954296|NCT00741013|3142743|P1|Overall Study|Discovered failed screen after enrolled|0
954297|NCT00741013|3142741|P3|Overall Study|Withdrawal by Subject|1
954298|NCT00741013|3142742|P2|Overall Study|Withdrawal by Subject|0
954299|NCT00741013|3142743|P1|Overall Study|Withdrawal by Subject|0
954300|NCT00741013|3142741|P3|Overall Study|Adverse Event|0
954301|NCT00741013|3142742|P2|Overall Study|Adverse Event|0
954302|NCT00741013|3142743|P1|Overall Study|Adverse Event|1
954303|NCT00740870|3142754|P1|Overall Study|Further testing contraindicated implant|17
954304|NCT00740870|3142754|P1|Overall Study|Not Catheterized|4
954305|NCT00740857|3142769|P3|Overall Study|Withdrawal by Subject|0
954306|NCT00740857|3142770|P2|Overall Study|Withdrawal by Subject|0
954307|NCT00740857|3142771|P1|Overall Study|Withdrawal by Subject|1
954308|NCT00740792|3142826|P4|Overall Study|administrative|2
954309|NCT00740792|3142827|P3|Overall Study|administrative|8
954310|NCT00740792|3142828|P2|Overall Study|administrative|3
954311|NCT00740792|3142829|P1|Overall Study|administrative|3
954312|NCT00740792|3142826|P4|Overall Study|Withdrawal by Subject|0
954313|NCT00740792|3142827|P3|Overall Study|Withdrawal by Subject|0
954314|NCT00740792|3142828|P2|Overall Study|Withdrawal by Subject|1
954315|NCT00740792|3142829|P1|Overall Study|Withdrawal by Subject|1
954316|NCT00740792|3142826|P4|Overall Study|Protocol Violation|2
954317|NCT00740792|3142827|P3|Overall Study|Protocol Violation|0
954318|NCT00740792|3142828|P2|Overall Study|Protocol Violation|1
954319|NCT00740792|3142829|P1|Overall Study|Protocol Violation|0
954320|NCT00740792|3142826|P4|Overall Study|Lost to Follow-up|0
954321|NCT00740792|3142827|P3|Overall Study|Lost to Follow-up|0
954322|NCT00740792|3142828|P2|Overall Study|Lost to Follow-up|1
954323|NCT00740792|3142829|P1|Overall Study|Lost to Follow-up|2
954324|NCT00740792|3142826|P4|Overall Study|Lack of Efficacy|3
954325|NCT00740792|3142827|P3|Overall Study|Lack of Efficacy|0
954326|NCT00740792|3142828|P2|Overall Study|Lack of Efficacy|1
954327|NCT00740792|3142829|P1|Overall Study|Lack of Efficacy|1
954328|NCT00740792|3142826|P4|Overall Study|Adverse Event|3
954329|NCT00740792|3142827|P3|Overall Study|Adverse Event|1
954330|NCT00740792|3142828|P2|Overall Study|Adverse Event|1
954331|NCT00740792|3142829|P1|Overall Study|Adverse Event|3
954332|NCT00740779|3142850|P3|Overall Study|Lost to Follow-up|5
954333|NCT00740779|3142851|P2|Overall Study|Lost to Follow-up|3
954334|NCT00740779|3142852|P1|Overall Study|Lost to Follow-up|2
954335|NCT00740779|3142850|P3|Overall Study|Withdrawal by Subject|2
954336|NCT00740779|3142851|P2|Overall Study|Withdrawal by Subject|4
954337|NCT00740779|3142852|P1|Overall Study|Withdrawal by Subject|2
954338|NCT00740779|3142850|P3|Overall Study|Lack of Efficacy|2
954339|NCT00740779|3142851|P2|Overall Study|Lack of Efficacy|0
954340|NCT00740779|3142852|P1|Overall Study|Lack of Efficacy|0
954341|NCT00740779|3142850|P3|Overall Study|Protocol Violation|1
954342|NCT00740779|3142851|P2|Overall Study|Protocol Violation|1
954343|NCT00740779|3142852|P1|Overall Study|Protocol Violation|1
954344|NCT00740779|3142850|P3|Overall Study|Adverse Event|3
954345|NCT00740779|3142851|P2|Overall Study|Adverse Event|6
954346|NCT00740779|3142852|P1|Overall Study|Adverse Event|4
954347|NCT00740714|3142869|P3|Overall Study|Withdrawal by Subject|29
954348|NCT00740714|3142870|P2|Overall Study|Withdrawal by Subject|19
954349|NCT00740714|3142871|P1|Overall Study|Withdrawal by Subject|17
954350|NCT00740636|3142947|P2|Overall Study|Death|0
954351|NCT00740636|3142948|P1|Overall Study|Death|1
954352|NCT00740636|3142947|P2|Overall Study|Progressive Disease|0
954353|NCT00740636|3142948|P1|Overall Study|Progressive Disease|1
954354|NCT00740636|3142947|P2|Overall Study|Patient Not Treated|1
954355|NCT00740636|3142948|P1|Overall Study|Patient Not Treated|0
954356|NCT00740636|3142947|P2|Overall Study|Patient Ineligible|1
954357|NCT00740636|3142948|P1|Overall Study|Patient Ineligible|0
954358|NCT00740636|3142947|P2|Overall Study|Adverse Event|2
954359|NCT00740636|3142948|P1|Overall Study|Adverse Event|0
954360|NCT00740597|3142954|P1|Overall Study|insurance would not cover treatment|1
954361|NCT00740584|3142958|P1|Overall Study|Withdrawal by Subject|1
954362|NCT00740480|3142963|P1|Overall Study|Physician Decision|1
954363|NCT00740480|3142963|P1|Overall Study|Adverse Event|1
954364|NCT00740220|3142967|P1|Overall Study|screen failures (non-COPD patients)|9
954365|NCT00740051|3142992|P2|Overall Study|Other reason (not specified)|1
954366|NCT00740051|3142993|P1|Overall Study|Other reason (not specified)|4
954367|NCT00740051|3142992|P2|Overall Study|Withdrawal by Subject|8
954368|NCT00740051|3142993|P1|Overall Study|Withdrawal by Subject|6
954369|NCT00740051|3142992|P2|Overall Study|Lost to Follow-up|8
954370|NCT00740051|3142993|P1|Overall Study|Lost to Follow-up|3
954371|NCT00740051|3142992|P2|Overall Study|Protocol Violation|6
954372|NCT00740051|3142993|P1|Overall Study|Protocol Violation|2
954373|NCT00740051|3142992|P2|Overall Study|Adverse Event|4
954374|NCT00740051|3142993|P1|Overall Study|Adverse Event|1
954375|NCT00740051|3142992|P2|Overall Study|Lack of Efficacy|5
954376|NCT00740051|3142993|P1|Overall Study|Lack of Efficacy|2
954377|NCT00739973|3143096|P9|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
954378|NCT00739973|3143097|P8|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
954379|NCT00739973|3143098|P7|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2
954380|NCT00739973|3143099|P6|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
954381|NCT00739973|3143100|P5|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
954382|NCT00739973|3143101|P4|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
954383|NCT00739973|3143102|P3|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
954384|NCT00739973|3143103|P2|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1
954385|NCT00739973|3143104|P1|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
954386|NCT00739973|3143096|P9|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
954387|NCT00739973|3143097|P8|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
954388|NCT00739973|3143098|P7|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
954389|NCT00739973|3143099|P6|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
954390|NCT00739973|3143100|P5|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
954391|NCT00739973|3143101|P4|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
954392|NCT00739973|3143102|P3|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
954393|NCT00739973|3143103|P2|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
954394|NCT00739973|3143104|P1|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5
954395|NCT00739973|3143096|P9|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
954396|NCT00739973|3143097|P8|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
954397|NCT00739973|3143098|P7|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1
954398|NCT00739973|3143099|P6|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
954399|NCT00739973|3143100|P5|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
954400|NCT00739973|3143101|P4|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
954401|NCT00739973|3143102|P3|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
954402|NCT00739973|3143103|P2|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
954403|NCT00739973|3143104|P1|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
954404|NCT00739973|3143096|P9|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
954405|NCT00739973|3143097|P8|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3
954406|NCT00739973|3143098|P7|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
954407|NCT00739973|3143099|P6|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
954408|NCT00739973|3143100|P5|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
954409|NCT00739973|3143101|P4|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
954410|NCT00739973|3143102|P3|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4
954411|NCT00739973|3143103|P2|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
954412|NCT00739973|3143104|P1|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
954413|NCT00739973|3143096|P9|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
954414|NCT00739973|3143097|P8|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
954415|NCT00739973|3143098|P7|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
954416|NCT00739973|3143099|P6|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
954417|NCT00739973|3143100|P5|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
954418|NCT00739973|3143101|P4|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
954419|NCT00739973|3143102|P3|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
954420|NCT00739973|3143103|P2|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
954421|NCT00739973|3143104|P1|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
954422|NCT00739973|3143096|P9|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
954423|NCT00739973|3143097|P8|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
954424|NCT00739973|3143098|P7|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
954425|NCT00739973|3143099|P6|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
954426|NCT00739973|3143100|P5|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
954427|NCT00739973|3143101|P4|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
954428|NCT00739973|3143102|P3|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1
954429|NCT00739973|3143103|P2|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
954430|NCT00739973|3143104|P1|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
954431|NCT00739973|3143096|P9|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
954432|NCT00739973|3143097|P8|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
954433|NCT00739973|3143098|P7|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
954434|NCT00739973|3143099|P6|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
954435|NCT00739973|3143100|P5|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
954436|NCT00739973|3143101|P4|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4
954437|NCT00739973|3143102|P3|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
954438|NCT00739973|3143103|P2|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
954439|NCT00739973|3143104|P1|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17
954591|NCT00739674|3143296|P1|Overall Study|Screening failures|19
954440|NCT00739973|3143096|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
954441|NCT00739973|3143097|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
954442|NCT00739973|3143098|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
954443|NCT00739973|3143099|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
954444|NCT00739973|3143100|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
954445|NCT00739973|3143101|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
954446|NCT00739973|3143102|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
954447|NCT00739973|3143103|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
954448|NCT00739973|3143104|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
954449|NCT00739973|3143096|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
954450|NCT00739973|3143097|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
954451|NCT00739973|3143098|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
954452|NCT00739973|3143099|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
954453|NCT00739973|3143100|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
954454|NCT00739973|3143101|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
954455|NCT00739973|3143102|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
954456|NCT00739973|3143103|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
954457|NCT00739973|3143104|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
954458|NCT00739973|3143096|P9|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
954459|NCT00739973|3143097|P8|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
954460|NCT00739973|3143098|P7|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
954461|NCT00739973|3143099|P6|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
954462|NCT00739973|3143100|P5|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7
954463|NCT00739973|3143101|P4|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2
954464|NCT00739973|3143102|P3|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
954465|NCT00739973|3143103|P2|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
954466|NCT00739973|3143104|P1|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
954467|NCT00739973|3143096|P9|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
954468|NCT00739973|3143097|P8|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
954469|NCT00739973|3143098|P7|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
954470|NCT00739973|3143099|P6|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
954471|NCT00739973|3143100|P5|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
954472|NCT00739973|3143101|P4|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
954473|NCT00739973|3143102|P3|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
954474|NCT00739973|3143103|P2|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
954475|NCT00739973|3143104|P1|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11
954476|NCT00739973|3143096|P9|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
954477|NCT00739973|3143097|P8|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
954478|NCT00739973|3143098|P7|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
954479|NCT00739973|3143099|P6|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
954480|NCT00739973|3143100|P5|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
954481|NCT00739973|3143101|P4|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
954482|NCT00739973|3143102|P3|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
954483|NCT00739973|3143103|P2|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
954484|NCT00739973|3143104|P1|Single-blind Period (2 to 4 Weeks)|Administrative problems|12
954485|NCT00739973|3143096|P9|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
954486|NCT00739973|3143097|P8|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
954487|NCT00739973|3143098|P7|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
954488|NCT00739973|3143099|P6|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
954489|NCT00739973|3143100|P5|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
954490|NCT00739973|3143101|P4|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
954491|NCT00739973|3143102|P3|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
954492|NCT00739973|3143103|P2|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
954493|NCT00739973|3143104|P1|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17
954494|NCT00739973|3143096|P9|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
954495|NCT00739973|3143097|P8|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
954496|NCT00739973|3143098|P7|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
954497|NCT00739973|3143099|P6|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
954498|NCT00739973|3143100|P5|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
954499|NCT00739973|3143101|P4|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
954500|NCT00739973|3143102|P3|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
954501|NCT00739973|3143103|P2|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
954502|NCT00739973|3143104|P1|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86
954503|NCT00739973|3143096|P9|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
954504|NCT00739973|3143097|P8|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
954505|NCT00739973|3143098|P7|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
954506|NCT00739973|3143099|P6|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
954507|NCT00739973|3143100|P5|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
954508|NCT00739973|3143101|P4|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
954509|NCT00739973|3143102|P3|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
954510|NCT00739973|3143103|P2|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
954511|NCT00739973|3143104|P1|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810
954512|NCT00739973|3143096|P9|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
954513|NCT00739973|3143097|P8|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
954514|NCT00739973|3143098|P7|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
954515|NCT00739973|3143099|P6|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
954516|NCT00739973|3143100|P5|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
954517|NCT00739973|3143101|P4|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
954518|NCT00739973|3143102|P3|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
954519|NCT00739973|3143103|P2|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
954520|NCT00739973|3143104|P1|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38
954521|NCT00739973|3143096|P9|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
954522|NCT00739973|3143097|P8|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
954523|NCT00739973|3143098|P7|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
954524|NCT00739973|3143099|P6|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
954525|NCT00739973|3143100|P5|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
954526|NCT00739973|3143101|P4|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
954527|NCT00739973|3143102|P3|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
954528|NCT00739973|3143103|P2|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
954529|NCT00739973|3143104|P1|Single-blind Period (2 to 4 Weeks)|Adverse Event|35
954530|NCT00739934|3143190|P1|Voriconazole Oral|Other|3
954531|NCT00739934|3143190|P1|Voriconazole IV|Adverse Event|6
954532|NCT00739908|3143212|P2|Overall Study|Relocation|1
954533|NCT00739908|3143213|P1|Overall Study|Relocation|0
954534|NCT00739908|3143212|P2|Overall Study|Lack of Efficacy|1
954535|NCT00739908|3143213|P1|Overall Study|Lack of Efficacy|0
954536|NCT00739908|3143212|P2|Overall Study|Non-Compliance With Study Medication|3
954537|NCT00739908|3143213|P1|Overall Study|Non-Compliance With Study Medication|0
954538|NCT00739908|3143212|P2|Overall Study|Non-Compliance With Study Procedures|3
954539|NCT00739908|3143213|P1|Overall Study|Non-Compliance With Study Procedures|2
954540|NCT00739908|3143212|P2|Overall Study|Lost to Follow-up|9
954541|NCT00739908|3143213|P1|Overall Study|Lost to Follow-up|14
954542|NCT00739908|3143212|P2|Overall Study|Withdrawal by Subject|2
954543|NCT00739908|3143213|P1|Overall Study|Withdrawal by Subject|4
954544|NCT00739908|3143212|P2|Overall Study|Adverse Event|6
954545|NCT00739908|3143213|P1|Overall Study|Adverse Event|5
954546|NCT00739882|3143233|P2|Open-label Period|Other|5
954547|NCT00739882|3143234|P1|Open-label Period|Other|9
954548|NCT00739882|3143233|P2|Open-label Period|Adverse Event|0
954549|NCT00739882|3143234|P1|Open-label Period|Adverse Event|1
954550|NCT00739882|3143233|P2|Double-blind Period|Not specified|8
954551|NCT00739882|3143234|P1|Double-blind Period|Not specified|16
954552|NCT00739882|3143233|P2|Double-blind Period|Lack of Efficacy|1
954553|NCT00739882|3143234|P1|Double-blind Period|Lack of Efficacy|1
954554|NCT00739882|3143233|P2|Double-blind Period|Protocol Violation|0
954555|NCT00739882|3143234|P1|Double-blind Period|Protocol Violation|1
954556|NCT00739882|3143233|P2|Double-blind Period|Adverse Event|2
954557|NCT00739882|3143234|P1|Double-blind Period|Adverse Event|1
954558|NCT00739674|3143295|P2|Overall Study|Erectile dysfunction|1
954559|NCT00739674|3143296|P1|Overall Study|Erectile dysfunction|0
954560|NCT00739674|3143295|P2|Overall Study|Home monitoring off meds|0
954561|NCT00739674|3143296|P1|Overall Study|Home monitoring off meds|1
954562|NCT00739674|3143295|P2|Overall Study|Unable to attend visit|1
954563|NCT00739674|3143296|P1|Overall Study|Unable to attend visit|3
954564|NCT00739674|3143295|P2|Overall Study|Non compliant|0
954565|NCT00739674|3143296|P1|Overall Study|Non compliant|4
954566|NCT00739674|3143295|P2|Overall Study|Patient moved|2
954567|NCT00739674|3143296|P1|Overall Study|Patient moved|3
954568|NCT00739674|3143295|P2|Overall Study|Clinic closed|4
954569|NCT00739674|3143296|P1|Overall Study|Clinic closed|6
954570|NCT00739674|3143295|P2|Overall Study|Reason missing|0
954571|NCT00739674|3143296|P1|Overall Study|Reason missing|2
954572|NCT00739674|3143295|P2|Overall Study|Withdrawal by Subject|9
954573|NCT00739674|3143296|P1|Overall Study|Withdrawal by Subject|9
954574|NCT00739674|3143295|P2|Overall Study|Protocol Violation|5
954575|NCT00739674|3143296|P1|Overall Study|Protocol Violation|5
954576|NCT00739674|3143295|P2|Overall Study|Lost to Follow-up|30
954577|NCT00739674|3143296|P1|Overall Study|Lost to Follow-up|52
954578|NCT00739674|3143295|P2|Overall Study|Lack of Efficacy|0
954579|NCT00739674|3143296|P1|Overall Study|Lack of Efficacy|1
954580|NCT00739674|3143295|P2|Overall Study|Death|0
954581|NCT00739674|3143296|P1|Overall Study|Death|1
954582|NCT00739674|3143295|P2|Overall Study|Adverse Event|13
954583|NCT00739674|3143296|P1|Overall Study|Adverse Event|22
954584|NCT00739674|3143295|P2|Overall Study|Dietician consultation >30 days|9
954585|NCT00739674|3143296|P1|Overall Study|Dietician consultation >30 days|1
954586|NCT00739674|3143295|P2|Overall Study|No follow-up data|18
954587|NCT00739674|3143296|P1|Overall Study|No follow-up data|33
954588|NCT00739674|3143295|P2|Overall Study|Site 212 removal|13
954589|NCT00739674|3143296|P1|Overall Study|Site 212 removal|19
954590|NCT00739674|3143295|P2|Overall Study|Screening failures|17
954592|NCT00739661|3143324|P2|Overall Study|Reason for discontinuation not available|1
954593|NCT00739661|3143325|P1|Overall Study|Reason for discontinuation not available|1
954594|NCT00739661|3143324|P2|Overall Study|Disease progression, radiographic|37
954595|NCT00739661|3143325|P1|Overall Study|Disease progression, radiographic|33
954596|NCT00739661|3143324|P2|Overall Study|Patient decision to withdraw|4
954597|NCT00739661|3143325|P1|Overall Study|Patient decision to withdraw|9
954598|NCT00739661|3143324|P2|Overall Study|Physician decision to withdraw patient|0
954599|NCT00739661|3143325|P1|Overall Study|Physician decision to withdraw patient|1
954600|NCT00739661|3143324|P2|Overall Study|Adverse Event|0
954601|NCT00739661|3143325|P1|Overall Study|Adverse Event|2
954602|NCT00739648|3143337|P2|Overall Study|Do not know|6
954603|NCT00739648|3143338|P1|Overall Study|Do not know|4
954604|NCT00739648|3143337|P2|Overall Study|Death|0
954605|NCT00739648|3143338|P1|Overall Study|Death|2
954606|NCT00739648|3143337|P2|Overall Study|Lost to Follow-up|7
954607|NCT00739648|3143338|P1|Overall Study|Lost to Follow-up|4
954608|NCT00739648|3143337|P2|Overall Study|Withdrawal by Subject|25
954609|NCT00739648|3143338|P1|Overall Study|Withdrawal by Subject|13
954610|NCT00739648|3143337|P2|Overall Study|Adverse Event|15
954611|NCT00739648|3143338|P1|Overall Study|Adverse Event|3
954612|NCT00739596|3143352|P2|Overall Study|Protocol Deviation|1
954613|NCT00739596|3143353|P1|Overall Study|Protocol Deviation|1
954614|NCT00739596|3143352|P2|Overall Study|Lost to Follow-up|2
954615|NCT00739596|3143353|P1|Overall Study|Lost to Follow-up|0
954616|NCT00739596|3143352|P2|Overall Study|Patient Withdrew Consent|8
954617|NCT00739596|3143353|P1|Overall Study|Patient Withdrew Consent|8
954618|NCT00739596|3143352|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
954619|NCT00739596|3143353|P1|Overall Study|Unsatisfactory Therapeutic Effect|4
954620|NCT00739596|3143352|P2|Overall Study|Adverse Event|6
954621|NCT00739596|3143353|P1|Overall Study|Adverse Event|12
954622|NCT00739310|3143395|P1|Overall Study|Lost to Follow-up|2
954623|NCT00739310|3143395|P1|Overall Study|Withdrawal by Subject|1
954624|NCT00739310|3143395|P1|Overall Study|Poor adherance to prescribed therapy|4
954625|NCT00739297|3143400|P7|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
954626|NCT00739297|3143401|P6|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
954627|NCT00739297|3143402|P5|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
954628|NCT00739297|3143403|P4|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
954629|NCT00739297|3143404|P3|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
954630|NCT00739297|3143405|P2|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
954631|NCT00739297|3143406|P1|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
954632|NCT00739297|3143400|P7|First Washout Period of 4-7 Days|Adverse Event|2
954633|NCT00739297|3143401|P6|First Washout Period of 4-7 Days|Adverse Event|0
954634|NCT00739297|3143402|P5|First Washout Period of 4-7 Days|Adverse Event|0
954635|NCT00739297|3143403|P4|First Washout Period of 4-7 Days|Adverse Event|2
954636|NCT00739297|3143404|P3|First Washout Period of 4-7 Days|Adverse Event|0
954637|NCT00739297|3143405|P2|First Washout Period of 4-7 Days|Adverse Event|0
954638|NCT00739297|3143406|P1|First Washout Period of 4-7 Days|Adverse Event|0
954639|NCT00739102|3143434|P1|Overall Study|Withdrawal by Subject|10
954640|NCT00739102|3143434|P1|Overall Study|Death|5
954641|NCT00739063|3143450|P1|Overall Study|Screen failures|8
954642|NCT00738894|3143495|P2|Overall Study|Death|0
954643|NCT00738894|3143496|P1|Overall Study|Death|2
954644|NCT00738894|3143495|P2|Overall Study|Physician Decision|5
954645|NCT00738894|3143496|P1|Overall Study|Physician Decision|4
954646|NCT00738894|3143495|P2|Overall Study|Withdrawal by Subject|15
954647|NCT00738894|3143496|P1|Overall Study|Withdrawal by Subject|10
954648|NCT00738894|3143495|P2|Overall Study|Lost to Follow-up|13
954649|NCT00738894|3143496|P1|Overall Study|Lost to Follow-up|23
954650|NCT00738881|3143509|P2|Overall Study|Withdrawal by Subject|2
954651|NCT00738881|3143510|P1|Overall Study|Withdrawal by Subject|0
954652|NCT00738699|3143524|P2|Overall Study|Not specified|0
954653|NCT00738699|3143525|P1|Overall Study|Not specified|2
954654|NCT00738699|3143524|P2|Overall Study|Discontinuation of study by Sponsor|72
954655|NCT00738699|3143525|P1|Overall Study|Discontinuation of study by Sponsor|123
954656|NCT00738699|3143524|P2|Overall Study|Death|68
954657|NCT00738699|3143525|P1|Overall Study|Death|144
954658|NCT00738699|3143524|P2|Overall Study|Lost to Follow-up|0
954659|NCT00738699|3143525|P1|Overall Study|Lost to Follow-up|1
954660|NCT00738699|3143524|P2|Overall Study|Withdrawal by Subject|0
954661|NCT00738699|3143525|P1|Overall Study|Withdrawal by Subject|5
954662|NCT00738673|3143543|P2|Overall Study|Withdrawal by Subject|1
954663|NCT00738673|3143544|P1|Overall Study|Withdrawal by Subject|3
954664|NCT00738673|3143543|P2|Overall Study|Protocol Violation|2
954665|NCT00738673|3143544|P1|Overall Study|Protocol Violation|1
954666|NCT00738673|3143543|P2|Overall Study|Lack of Efficacy|8
954667|NCT00738673|3143544|P1|Overall Study|Lack of Efficacy|19
954668|NCT00738673|3143543|P2|Overall Study|Adverse Event|0
954669|NCT00738673|3143544|P1|Overall Study|Adverse Event|1
954670|NCT00738530|3143582|P2|Overall Study|Withdrawal by Subject|8
954671|NCT00738530|3143583|P1|Overall Study|Withdrawal by Subject|6
954672|NCT00738530|3143582|P2|Overall Study|Lost to Follow-up|6
954673|NCT00738530|3143583|P1|Overall Study|Lost to Follow-up|8
954674|NCT00738530|3143582|P2|Overall Study|Death|224
954675|NCT00738530|3143583|P1|Overall Study|Death|220
954676|NCT00738400|3143618|P2|Overall Study|Non-compliant with study medication|1
954677|NCT00738400|3143619|P1|Overall Study|Non-compliant with study medication|0
954678|NCT00738400|3143618|P2|Overall Study|Protocol Violation|0
954679|NCT00738400|3143619|P1|Overall Study|Protocol Violation|1
954680|NCT00738400|3143618|P2|Overall Study|Lost to Follow-up|3
954681|NCT00738400|3143619|P1|Overall Study|Lost to Follow-up|0
954682|NCT00738400|3143618|P2|Overall Study|Lack of Efficacy|1
954683|NCT00738400|3143619|P1|Overall Study|Lack of Efficacy|0
954684|NCT00738400|3143618|P2|Overall Study|Withdrawal by Subject|1
954685|NCT00738400|3143619|P1|Overall Study|Withdrawal by Subject|0
954686|NCT00738400|3143618|P2|Overall Study|Adverse Event|1
954687|NCT00738400|3143619|P1|Overall Study|Adverse Event|3
954688|NCT00738374|3143640|P4|Maintenance Treatment/Observation Phase|Not Specified|0
954689|NCT00738374|3143641|P3|Maintenance Treatment/Observation Phase|Not Specified|0
954690|NCT00738374|3143642|P2|Maintenance Treatment/Observation Phase|Not Specified|1
954691|NCT00738374|3143643|P1|Maintenance Treatment/Observation Phase|Not Specified|0
954692|NCT00738374|3143640|P4|Maintenance Treatment/Observation Phase|Protocol Violation|0
954693|NCT00738374|3143641|P3|Maintenance Treatment/Observation Phase|Protocol Violation|0
954694|NCT00738374|3143642|P2|Maintenance Treatment/Observation Phase|Protocol Violation|1
954695|NCT00738374|3143643|P1|Maintenance Treatment/Observation Phase|Protocol Violation|0
954696|NCT00738374|3143640|P4|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1
954697|NCT00738374|3143641|P3|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
954698|NCT00738374|3143642|P2|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
954699|NCT00738374|3143643|P1|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
954700|NCT00738374|3143640|P4|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11
954701|NCT00738374|3143641|P3|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5
954702|NCT00738374|3143642|P2|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4
954703|NCT00738374|3143643|P1|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0
954704|NCT00738374|3143640|P4|Maintenance Treatment/Observation Phase|Adverse Event|0
954705|NCT00738374|3143641|P3|Maintenance Treatment/Observation Phase|Adverse Event|2
954706|NCT00738374|3143642|P2|Maintenance Treatment/Observation Phase|Adverse Event|1
954707|NCT00738374|3143643|P1|Maintenance Treatment/Observation Phase|Adverse Event|0
954708|NCT00738374|3143640|P4|Induction Treatment Phase|Withdrawal by Subject|0
954709|NCT00738374|3143641|P3|Induction Treatment Phase|Withdrawal by Subject|0
954710|NCT00738374|3143642|P2|Induction Treatment Phase|Withdrawal by Subject|0
954711|NCT00738374|3143643|P1|Induction Treatment Phase|Withdrawal by Subject|1
954712|NCT00738374|3143640|P4|Induction Treatment Phase|Non-compliance|0
954713|NCT00738374|3143641|P3|Induction Treatment Phase|Non-compliance|0
954714|NCT00738374|3143642|P2|Induction Treatment Phase|Non-compliance|0
954715|NCT00738374|3143643|P1|Induction Treatment Phase|Non-compliance|1
954716|NCT00738374|3143640|P4|Induction Treatment Phase|Protocol Violation|0
954717|NCT00738374|3143641|P3|Induction Treatment Phase|Protocol Violation|0
954718|NCT00738374|3143642|P2|Induction Treatment Phase|Protocol Violation|0
954719|NCT00738374|3143643|P1|Induction Treatment Phase|Protocol Violation|2
954720|NCT00738374|3143640|P4|Induction Treatment Phase|Physician Decision|0
954721|NCT00738374|3143641|P3|Induction Treatment Phase|Physician Decision|0
954722|NCT00738374|3143642|P2|Induction Treatment Phase|Physician Decision|0
954723|NCT00738374|3143643|P1|Induction Treatment Phase|Physician Decision|2
954724|NCT00738374|3143640|P4|Induction Treatment Phase|Disease progression/relapse/stable|0
954725|NCT00738374|3143641|P3|Induction Treatment Phase|Disease progression/relapse/stable|0
954726|NCT00738374|3143642|P2|Induction Treatment Phase|Disease progression/relapse/stable|0
954727|NCT00738374|3143643|P1|Induction Treatment Phase|Disease progression/relapse/stable|4
954728|NCT00738374|3143640|P4|Induction Treatment Phase|Adverse Event|0
954729|NCT00738374|3143641|P3|Induction Treatment Phase|Adverse Event|0
954730|NCT00738374|3143642|P2|Induction Treatment Phase|Adverse Event|0
954731|NCT00738374|3143643|P1|Induction Treatment Phase|Adverse Event|14
954732|NCT00738283|3143681|P1|Overall Study|Discharge home prior to end of study|1
954733|NCT00738283|3143681|P1|Overall Study|Transfer to another facility|2
954734|NCT00738283|3143681|P1|Overall Study|Death|1
954735|NCT00738062|3143688|P3|Open-Label Extension|Study Terminated|0
954736|NCT00738062|3143689|P2|Open-Label Extension|Study Terminated|0
954737|NCT00738062|3143690|P1|Open-Label Extension|Study Terminated|2
954738|NCT00738062|3143688|P3|Open-Label Extension|Protocol Violation|0
954739|NCT00738062|3143689|P2|Open-Label Extension|Protocol Violation|0
954740|NCT00738062|3143690|P1|Open-Label Extension|Protocol Violation|1
954741|NCT00738062|3143688|P3|Open-Label Extension|Withdrawal by Subject|0
954742|NCT00738062|3143689|P2|Open-Label Extension|Withdrawal by Subject|0
954743|NCT00738062|3143690|P1|Open-Label Extension|Withdrawal by Subject|6
954744|NCT00738062|3143688|P3|Open-Label Extension|Lack of Efficacy|0
954745|NCT00738062|3143689|P2|Open-Label Extension|Lack of Efficacy|0
954746|NCT00738062|3143690|P1|Open-Label Extension|Lack of Efficacy|2
954747|NCT00738062|3143688|P3|Open-Label Extension|Physician Decision|0
954748|NCT00738062|3143689|P2|Open-Label Extension|Physician Decision|0
954749|NCT00738062|3143690|P1|Open-Label Extension|Physician Decision|1
954750|NCT00738062|3143688|P3|Open-Label Extension|Adverse Event|0
954751|NCT00738062|3143689|P2|Open-Label Extension|Adverse Event|0
954752|NCT00738062|3143690|P1|Open-Label Extension|Adverse Event|5
954753|NCT00738062|3143688|P3|Open Label Treatment|Investigator Decision|0
954754|NCT00738062|3143689|P2|Open Label Treatment|Investigator Decision|0
954755|NCT00738062|3143690|P1|Open Label Treatment|Investigator Decision|1
954756|NCT00738062|3143688|P3|Open Label Treatment|Withdrawal by Subject|0
954757|NCT00738062|3143689|P2|Open Label Treatment|Withdrawal by Subject|0
954758|NCT00738062|3143690|P1|Open Label Treatment|Withdrawal by Subject|9
954759|NCT00738062|3143688|P3|Open Label Treatment|Protocol Violation|0
954760|NCT00738062|3143689|P2|Open Label Treatment|Protocol Violation|0
954761|NCT00738062|3143690|P1|Open Label Treatment|Protocol Violation|2
954762|NCT00738062|3143688|P3|Open Label Treatment|Adverse Event|0
954763|NCT00738062|3143689|P2|Open Label Treatment|Adverse Event|0
954764|NCT00738062|3143690|P1|Open Label Treatment|Adverse Event|11
954765|NCT00738062|3143688|P3|Open Label Treatment|Lack of Efficacy|0
954766|NCT00738062|3143689|P2|Open Label Treatment|Lack of Efficacy|0
954767|NCT00738062|3143690|P1|Open Label Treatment|Lack of Efficacy|5
954768|NCT00737711|3143752|P1|Overall Study|Other|5
954769|NCT00737711|3143752|P1|Overall Study|Blood transfusion|6
954770|NCT00737711|3143752|P1|Overall Study|Withdrawal by Subject|5
954771|NCT00737711|3143752|P1|Overall Study|Protocol Violation|1
954772|NCT00737711|3143752|P1|Overall Study|Failure to return|4
954773|NCT00737711|3143752|P1|Overall Study|Death|8
954774|NCT00737711|3143752|P1|Overall Study|Adverse Event|2
954775|NCT00737672|3143785|P2|Overall Study|Physician Decision|2
954776|NCT00737672|3143786|P1|Overall Study|Physician Decision|0
954777|NCT00737672|3143785|P2|Overall Study|Miscellaneous|1
954778|NCT00737672|3143786|P1|Overall Study|Miscellaneous|7
954779|NCT00737672|3143785|P2|Overall Study|Lost to Follow-up|0
954780|NCT00737672|3143786|P1|Overall Study|Lost to Follow-up|1
954781|NCT00737672|3143785|P2|Overall Study|Withdrawal by Subject|2
954782|NCT00737672|3143786|P1|Overall Study|Withdrawal by Subject|1
954783|NCT00737672|3143785|P2|Overall Study|Death|22
954784|NCT00737672|3143786|P1|Overall Study|Death|23
954785|NCT00737672|3143785|P2|Overall Study|Graft Abandonment|56
954786|NCT00737672|3143786|P1|Overall Study|Graft Abandonment|48
954787|NCT00737633|3143824|P2|Overall Study|protocol non-compliance|1
954788|NCT00737633|3143825|P1|Overall Study|protocol non-compliance|0
954789|NCT00737633|3143824|P2|Overall Study|Lost to Follow-up|1
954790|NCT00737633|3143825|P1|Overall Study|Lost to Follow-up|0
954791|NCT00737633|3143824|P2|Overall Study|Study terminated by sponsor|55
954792|NCT00737633|3143825|P1|Overall Study|Study terminated by sponsor|44
954793|NCT00737568|3143848|P2|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0
954794|NCT00737568|3143849|P1|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1
954795|NCT00737568|3143848|P2|Treatment-Free Follow-up (TFFU) Period|Death|1
954796|NCT00737568|3143849|P1|Treatment-Free Follow-up (TFFU) Period|Death|0
954797|NCT00737568|3143848|P2|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17
954798|NCT00737568|3143849|P1|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25
954799|NCT00737568|3143848|P2|Treatment Period Through Week 240|Study Discontinued by Sponsor|0
954800|NCT00737568|3143849|P1|Treatment Period Through Week 240|Study Discontinued by Sponsor|1
954801|NCT00737568|3143848|P2|Treatment Period Through Week 240|Protocol Violation|3
954802|NCT00737568|3143849|P1|Treatment Period Through Week 240|Protocol Violation|2
954803|NCT00737568|3143848|P2|Treatment Period Through Week 240|Lost to Follow-up|3
954804|NCT00737568|3143849|P1|Treatment Period Through Week 240|Lost to Follow-up|3
954805|NCT00737568|3143848|P2|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4
954806|NCT00737568|3143849|P1|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3
954807|NCT00737568|3143848|P2|Treatment Period Through Week 240|Withdrew Consent|6
954808|NCT00737568|3143849|P1|Treatment Period Through Week 240|Withdrew Consent|5
954809|NCT00737568|3143848|P2|Treatment Period Through Week 240|Investigator’s Discretion|5
954810|NCT00737568|3143849|P1|Treatment Period Through Week 240|Investigator’s Discretion|6
954811|NCT00737529|3143879|P1|Overall Study|Other|2
954812|NCT00737529|3143879|P1|Overall Study|Protocol Violation|1
954813|NCT00737529|3143879|P1|Overall Study|Death|3
954814|NCT00737529|3143879|P1|Overall Study|Withdrawal by Subject|3
954815|NCT00737529|3143879|P1|Overall Study|Adverse Event|23
954816|NCT00737529|3143879|P1|Overall Study|Disease Progression|80
954817|NCT00737477|3143893|P1|Overall Study|Not Specified|4
954818|NCT00737477|3143893|P1|Overall Study|Renal Transplantation|10
954819|NCT00737477|3143893|P1|Overall Study|Withdrawal by Subject|1
954820|NCT00737477|3143893|P1|Overall Study|Treatment Refusal|1
954821|NCT00737477|3143893|P1|Overall Study|Death|9
954822|NCT00737477|3143893|P1|Overall Study|Adverse Event|9
954823|NCT00737464|3143909|P1|Overall Study|Other reasons|4
954824|NCT00737464|3143909|P1|Overall Study|Refused Treatment / Withdrew Consent|6
954825|NCT00737464|3143909|P1|Overall Study|Other - Failure to Return|1
954826|NCT00737464|3143909|P1|Overall Study|Death|6
954827|NCT00737464|3143909|P1|Overall Study|Adverse Event|1
954828|NCT00737438|3143930|P1|Overall Study|Patient ineligible|1
954829|NCT00737438|3143930|P1|Overall Study|Withdrawal by Subject|2
954830|NCT00737282|3143943|P1|Overall Study|Study prematurely terminated|175
954831|NCT00737100|3143986|P3|Overall Study|Reason discontinued not explained above|1
954832|NCT00737100|3143987|P2|Overall Study|Reason discontinued not explained above|1
954833|NCT00737100|3143988|P1|Overall Study|Reason discontinued not explained above|1
954834|NCT00737100|3143986|P3|Overall Study|Withdrawal by Subject|3
954835|NCT00737100|3143987|P2|Overall Study|Withdrawal by Subject|0
954836|NCT00737100|3143988|P1|Overall Study|Withdrawal by Subject|0
954837|NCT00737100|3143986|P3|Overall Study|Lost to Follow-up|0
954838|NCT00737100|3143987|P2|Overall Study|Lost to Follow-up|1
954839|NCT00737100|3143988|P1|Overall Study|Lost to Follow-up|0
954840|NCT00737100|3143986|P3|Overall Study|Adverse Event|3
954841|NCT00737100|3143987|P2|Overall Study|Adverse Event|5
954842|NCT00737100|3143988|P1|Overall Study|Adverse Event|6
954843|NCT00737061|3144032|P1|1 Year Wearing Period|Terminated for protocol non-compliance|1
954844|NCT00737061|3144032|P1|1 Year Wearing Period|Discontinued reilance|3
954845|NCT00737061|3144032|P1|1 Year Wearing Period|Withdrawal by Subject|2
954846|NCT00737061|3144032|P1|1 Year Wearing Period|Lost to Follow-up|11
954847|NCT00737061|3144032|P1|Waiting Period|Elected surgical tubal ligation|5
954848|NCT00737061|3144032|P1|Waiting Period|Alternative contraception failure|3
954849|NCT00737061|3144032|P1|Waiting Period|Deemed patent following HSG|26
954850|NCT00737061|3144032|P1|Waiting Period|Bilateral placement failure|34
954851|NCT00737061|3144032|P1|Waiting Period|Withdrawal by Subject|1
954852|NCT00737061|3144032|P1|Waiting Period|Lost to Follow-up|6
954853|NCT00737048|3144049|P3|Overall Study|Worsening of the symptoms|3
954854|NCT00737048|3144050|P2|Overall Study|Worsening of the symptoms|5
954855|NCT00737048|3144051|P1|Overall Study|Worsening of the symptoms|3
954856|NCT00737048|3144049|P3|Overall Study|Adverse Event|0
954857|NCT00737048|3144050|P2|Overall Study|Adverse Event|1
954858|NCT00737048|3144051|P1|Overall Study|Adverse Event|0
954859|NCT00737048|3144049|P3|Overall Study|Physician Decision|1
954860|NCT00737048|3144050|P2|Overall Study|Physician Decision|0
954861|NCT00737048|3144051|P1|Overall Study|Physician Decision|0
954862|NCT00736996|3144095|P3|Overall Study|Lost to Follow-up|2
954863|NCT00736996|3144096|P2|Overall Study|Lost to Follow-up|9
954864|NCT00736996|3144097|P1|Overall Study|Lost to Follow-up|1
954865|NCT00736957|3144111|P1|Overall Study|Physician Decision|5
954866|NCT00736957|3144111|P1|Overall Study|not eligible for Treatment Period I|22
954867|NCT00736957|3144111|P1|Overall Study|did not attend hospital appointments|1
954868|NCT00736957|3144111|P1|Overall Study|violation of eligibility criteria|2
954869|NCT00736957|3144111|P1|Overall Study|Withdrawal by Subject|49
954870|NCT00736957|3144111|P1|Overall Study|Adverse Event|43
954871|NCT00736944|3144121|P1|Definitive Treatment|Physician Decision|1
954872|NCT00736944|3144121|P1|Induction|Death|1
954873|NCT00736879|3144152|P4|Follow up Period - No Drug Treatment|non-specified|0
954874|NCT00736879|3144153|P3|Follow up Period - No Drug Treatment|non-specified|0
954875|NCT00736879|3144154|P2|Follow up Period - No Drug Treatment|non-specified|2
954876|NCT00736879|3144155|P1|Follow up Period - No Drug Treatment|non-specified|1
954877|NCT00736879|3144152|P4|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
954878|NCT00736879|3144153|P3|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
954879|NCT00736879|3144154|P2|Follow up Period - No Drug Treatment|Withdrawal by Subject|1
954880|NCT00736879|3144155|P1|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
954881|NCT00736879|3144152|P4|Double Blind Treatment Period|non-specified|0
954882|NCT00736879|3144153|P3|Double Blind Treatment Period|non-specified|0
954883|NCT00736879|3144154|P2|Double Blind Treatment Period|non-specified|1
954884|NCT00736879|3144155|P1|Double Blind Treatment Period|non-specified|0
954885|NCT00736879|3144152|P4|Double Blind Treatment Period|No longer met criteria|0
954886|NCT00736879|3144153|P3|Double Blind Treatment Period|No longer met criteria|0
954887|NCT00736879|3144154|P2|Double Blind Treatment Period|No longer met criteria|1
954888|NCT00736879|3144155|P1|Double Blind Treatment Period|No longer met criteria|0
954889|NCT00736879|3144152|P4|Double Blind Treatment Period|Poor non-compliance|1
954890|NCT00736879|3144153|P3|Double Blind Treatment Period|Poor non-compliance|1
954891|NCT00736879|3144154|P2|Double Blind Treatment Period|Poor non-compliance|0
954892|NCT00736879|3144155|P1|Double Blind Treatment Period|Poor non-compliance|0
954893|NCT00736879|3144152|P4|Double Blind Treatment Period|Lost to Follow-up|1
954894|NCT00736879|3144153|P3|Double Blind Treatment Period|Lost to Follow-up|2
954895|NCT00736879|3144154|P2|Double Blind Treatment Period|Lost to Follow-up|0
954896|NCT00736879|3144155|P1|Double Blind Treatment Period|Lost to Follow-up|0
954897|NCT00736879|3144152|P4|Double Blind Treatment Period|Withdrawal by Subject|3
954898|NCT00736879|3144153|P3|Double Blind Treatment Period|Withdrawal by Subject|3
954899|NCT00736879|3144154|P2|Double Blind Treatment Period|Withdrawal by Subject|1
954900|NCT00736879|3144155|P1|Double Blind Treatment Period|Withdrawal by Subject|2
954901|NCT00736879|3144152|P4|Double Blind Treatment Period|Adverse Event|0
954902|NCT00736879|3144153|P3|Double Blind Treatment Period|Adverse Event|1
954903|NCT00736879|3144154|P2|Double Blind Treatment Period|Adverse Event|1
954904|NCT00736879|3144155|P1|Double Blind Treatment Period|Adverse Event|0
954905|NCT00736879|3144152|P4|Double Blind Treatment Period|Lack of Efficacy|0
954906|NCT00736879|3144153|P3|Double Blind Treatment Period|Lack of Efficacy|0
954907|NCT00736879|3144154|P2|Double Blind Treatment Period|Lack of Efficacy|0
954908|NCT00736879|3144155|P1|Double Blind Treatment Period|Lack of Efficacy|1
954909|NCT00736853|3144209|P3|Double-Blind Period|Ineligible to participate the study|0
954910|NCT00736853|3144210|P2|Double-Blind Period|Ineligible to participate the study|1
954911|NCT00736853|3144211|P1|Double-Blind Period|Ineligible to participate the study|0
954912|NCT00736853|3144209|P3|Double-Blind Period|Withdrawal by Subject|4
954913|NCT00736853|3144210|P2|Double-Blind Period|Withdrawal by Subject|1
954914|NCT00736853|3144211|P1|Double-Blind Period|Withdrawal by Subject|0
954915|NCT00736853|3144209|P3|Double-Blind Period|Adverse Event|2
954916|NCT00736853|3144210|P2|Double-Blind Period|Adverse Event|3
954917|NCT00736853|3144211|P1|Double-Blind Period|Adverse Event|0
954918|NCT00736853|3144209|P3|Double-Blind Period|Lack of Efficacy|42
954919|NCT00736853|3144210|P2|Double-Blind Period|Lack of Efficacy|19
954920|NCT00736853|3144211|P1|Double-Blind Period|Lack of Efficacy|0
954921|NCT00736853|3144209|P3|Open-Label Period|Unable to attend hospital appointments|0
954922|NCT00736853|3144210|P2|Open-Label Period|Unable to attend hospital appointments|0
954923|NCT00736853|3144211|P1|Open-Label Period|Unable to attend hospital appointments|1
954924|NCT00736853|3144209|P3|Open-Label Period|Failed to meet the transfer criteria|0
954925|NCT00736853|3144210|P2|Open-Label Period|Failed to meet the transfer criteria|0
954926|NCT00736853|3144211|P1|Open-Label Period|Failed to meet the transfer criteria|40
954927|NCT00736853|3144209|P3|Open-Label Period|Started but not treated|0
954928|NCT00736853|3144210|P2|Open-Label Period|Started but not treated|0
954929|NCT00736853|3144211|P1|Open-Label Period|Started but not treated|42
954930|NCT00736853|3144209|P3|Open-Label Period|Withdrawal by Subject|0
954931|NCT00736853|3144210|P2|Open-Label Period|Withdrawal by Subject|0
954932|NCT00736853|3144211|P1|Open-Label Period|Withdrawal by Subject|16
954933|NCT00736853|3144209|P3|Open-Label Period|Adverse Event|0
954934|NCT00736853|3144210|P2|Open-Label Period|Adverse Event|0
954935|NCT00736853|3144211|P1|Open-Label Period|Adverse Event|31
954936|NCT00736853|3144209|P3|Open-Label Period|Physician Decision|0
954937|NCT00736853|3144210|P2|Open-Label Period|Physician Decision|0
954938|NCT00736853|3144211|P1|Open-Label Period|Physician Decision|2
954939|NCT00736840|3144251|P1|Overall Study|Lost to Follow-up|13
954940|NCT00736723|3144258|P2|Overall Study|Withdrawal by Subject|3
954941|NCT00736723|3144259|P1|Overall Study|Withdrawal by Subject|4
954942|NCT00736645|3144269|P4|Overall Study|Adverse Event|0
954943|NCT00736645|3144270|P3|Overall Study|Adverse Event|0
954944|NCT00736645|3144271|P2|Overall Study|Adverse Event|2
954945|NCT00736645|3144272|P1|Overall Study|Adverse Event|0
954946|NCT00736502|3144295|P1|Overall Study|Lost to Follow-up|27
954947|NCT00736502|3144295|P1|Overall Study|Lack of Efficacy|16
954948|NCT00736502|3144295|P1|Overall Study|Adverse Event|22
954949|NCT00736489|3144301|P6|Period 1|Withdrawal by Subject|1
954950|NCT00736489|3144302|P5|Period 1|Withdrawal by Subject|0
954951|NCT00736489|3144303|P4|Period 1|Withdrawal by Subject|0
954952|NCT00736489|3144304|P3|Period 1|Withdrawal by Subject|0
954953|NCT00736489|3144305|P2|Period 1|Withdrawal by Subject|0
954954|NCT00736489|3144306|P1|Period 1|Withdrawal by Subject|0
954955|NCT00736489|3144301|P6|Period 1|Lost to Follow-up|0
954956|NCT00736489|3144302|P5|Period 1|Lost to Follow-up|0
954957|NCT00736489|3144303|P4|Period 1|Lost to Follow-up|0
954958|NCT00736489|3144304|P3|Period 1|Lost to Follow-up|0
954959|NCT00736489|3144305|P2|Period 1|Lost to Follow-up|0
954960|NCT00736489|3144306|P1|Period 1|Lost to Follow-up|1
954961|NCT00736476|3144460|P2|Overall Study|Adverse Event|0
954962|NCT00736476|3144461|P1|Overall Study|Adverse Event|1
954963|NCT00736450|3144481|P1|Overall Study|Physician Decision|1
954964|NCT00736450|3144481|P1|Overall Study|Withdrawal by Subject|5
954965|NCT00736450|3144481|P1|Overall Study|Not ABC gene eligible|19
954966|NCT00736385|3144489|P2|Overall Study|Adverse Event|1
954967|NCT00736385|3144490|P1|Overall Study|Adverse Event|0
954968|NCT00736385|3144489|P2|Overall Study|Withdrawal by Subject|2
954969|NCT00736385|3144490|P1|Overall Study|Withdrawal by Subject|2
954970|NCT00736333|3144502|P1|Overall Study|Not Specified|4
954971|NCT00736333|3144502|P1|Overall Study|Death|7
954972|NCT00736333|3144502|P1|Overall Study|Withdrawal by Subject|10
954973|NCT00736333|3144502|P1|Overall Study|Toxicity|6
954974|NCT00736333|3144502|P1|Overall Study|Tumor Progression|75
954975|NCT00736333|3144502|P1|Overall Study|Data Missing|2
954976|NCT00736333|3144502|P1|Overall Study|Did Not Receive Drug or Not Documented|7
954977|NCT00736255|3144513|P2|Overall Study|Non-compliance|1
954978|NCT00736255|3144514|P1|Overall Study|Non-compliance|1
954979|NCT00736255|3144513|P2|Overall Study|Physician Decision|0
954980|NCT00736255|3144514|P1|Overall Study|Physician Decision|1
954981|NCT00736255|3144513|P2|Overall Study|Adverse Event|0
954982|NCT00736255|3144514|P1|Overall Study|Adverse Event|1
954983|NCT00736190|3144561|P1|Overall Study|Adverse Event|1
954984|NCT00736190|3144561|P1|Overall Study|Withdrawal by Subject|1
954985|NCT00736190|3144561|P1|Overall Study|Pregnancy|1
954986|NCT00736099|3144587|P2|Overall Study|Other reason|10
954987|NCT00736099|3144588|P1|Overall Study|Other reason|43
954988|NCT00736099|3144587|P2|Overall Study|Lack of Efficacy|8
954989|NCT00736099|3144588|P1|Overall Study|Lack of Efficacy|15
954990|NCT00736099|3144587|P2|Overall Study|Withdrawal by Subject|13
954991|NCT00736099|3144588|P1|Overall Study|Withdrawal by Subject|42
954992|NCT00736099|3144587|P2|Overall Study|Lost to Follow-up|5
954993|NCT00736099|3144588|P1|Overall Study|Lost to Follow-up|12
954994|NCT00736099|3144587|P2|Overall Study|Protocol Violation|4
954995|NCT00736099|3144588|P1|Overall Study|Protocol Violation|10
954996|NCT00736099|3144587|P2|Overall Study|Adverse Event|18
954997|NCT00736099|3144588|P1|Overall Study|Adverse Event|61
954998|NCT00736034|3144697|P1|Overall Study|Adverse Event|2
954999|NCT00735943|3144705|P1|Overall Study|Adverse Event|1
955000|NCT00735943|3144705|P1|Overall Study|Lost to Follow-up|1
955001|NCT00735904|3144730|P1|Overall Study|Other|8
955002|NCT00735904|3144730|P1|Overall Study|Study Terminated by Sponsor|5
955003|NCT00735904|3144730|P1|Overall Study|Withdrawal by Subject|1
955004|NCT00735904|3144730|P1|Overall Study|Protocol Violation|1
955005|NCT00735904|3144730|P1|Overall Study|Death|20
955006|NCT00735904|3144730|P1|Overall Study|Adverse Event|3
955007|NCT00735878|3144740|P3|Phase I- Dose Determination|Withdrawal by Subject|1
955008|NCT00735878|3144741|P2|Phase I- Dose Determination|Withdrawal by Subject|0
955009|NCT00735878|3144742|P1|Phase I- Dose Determination|Withdrawal by Subject|0
955010|NCT00735709|3144821|P4|Overall Study|Excluded medication|1
955011|NCT00735709|3144822|P3|Overall Study|Excluded medication|0
955012|NCT00735709|3144823|P2|Overall Study|Excluded medication|0
955013|NCT00735709|3144824|P1|Overall Study|Excluded medication|1
955014|NCT00735709|3144821|P4|Overall Study|Lost to Follow-up|1
955015|NCT00735709|3144822|P3|Overall Study|Lost to Follow-up|1
955016|NCT00735709|3144823|P2|Overall Study|Lost to Follow-up|1
955017|NCT00735709|3144824|P1|Overall Study|Lost to Follow-up|0
955018|NCT00735709|3144821|P4|Overall Study|Voluntary Withdrawal|7
955019|NCT00735709|3144822|P3|Overall Study|Voluntary Withdrawal|5
955020|NCT00735709|3144823|P2|Overall Study|Voluntary Withdrawal|3
955021|NCT00735709|3144824|P1|Overall Study|Voluntary Withdrawal|1
955022|NCT00735709|3144821|P4|Overall Study|Protocol deviations|1
955023|NCT00735709|3144822|P3|Overall Study|Protocol deviations|1
955024|NCT00735709|3144823|P2|Overall Study|Protocol deviations|2
955025|NCT00735709|3144824|P1|Overall Study|Protocol deviations|1
955026|NCT00735709|3144821|P4|Overall Study|Noncompliance|0
955027|NCT00735709|3144822|P3|Overall Study|Noncompliance|1
955028|NCT00735709|3144823|P2|Overall Study|Noncompliance|0
955029|NCT00735709|3144824|P1|Overall Study|Noncompliance|0
955030|NCT00735709|3144821|P4|Overall Study|Lack of Efficacy|3
955031|NCT00735709|3144822|P3|Overall Study|Lack of Efficacy|2
955032|NCT00735709|3144823|P2|Overall Study|Lack of Efficacy|4
955033|NCT00735709|3144824|P1|Overall Study|Lack of Efficacy|8
955034|NCT00735709|3144821|P4|Overall Study|Adverse Event|5
955035|NCT00735709|3144822|P3|Overall Study|Adverse Event|1
955036|NCT00735709|3144823|P2|Overall Study|Adverse Event|3
955037|NCT00735709|3144824|P1|Overall Study|Adverse Event|2
955038|NCT00735696|3144934|P1|Overall Study|Enrolled but never Treated|1
955039|NCT00735696|3144934|P1|Overall Study|Withdrawal by Subject|1
955040|NCT00735644|3144962|P5|Overall Study|Withdrawal by Subject|0
955041|NCT00735644|3144963|P4|Overall Study|Withdrawal by Subject|1
955042|NCT00735644|3144964|P3|Overall Study|Withdrawal by Subject|1
955043|NCT00735644|3144965|P2|Overall Study|Withdrawal by Subject|1
955044|NCT00735644|3144966|P1|Overall Study|Withdrawal by Subject|0
955045|NCT00735644|3144962|P5|Overall Study|Did not receive study vaccine|0
955046|NCT00735644|3144963|P4|Overall Study|Did not receive study vaccine|0
955047|NCT00735644|3144964|P3|Overall Study|Did not receive study vaccine|0
955048|NCT00735644|3144965|P2|Overall Study|Did not receive study vaccine|1
955049|NCT00735644|3144966|P1|Overall Study|Did not receive study vaccine|0
955050|NCT00735553|3145010|P1|Overall Study|Study prematurely terminated|77
955051|NCT00735475|3145020|P2|Overall Study|Withdrawal by Subject|5
955052|NCT00735475|3145021|P1|Overall Study|Withdrawal by Subject|4
955053|NCT00735475|3145020|P2|Overall Study|Physician Decision|1
955054|NCT00735475|3145021|P1|Overall Study|Physician Decision|0
955055|NCT00735475|3145020|P2|Overall Study|Lost to Follow-up|3
955056|NCT00735475|3145021|P1|Overall Study|Lost to Follow-up|3
955057|NCT00735475|3145020|P2|Overall Study|Death|1
955058|NCT00735475|3145021|P1|Overall Study|Death|1
955059|NCT00735475|3145020|P2|Overall Study|Adverse Event|1
955060|NCT00735475|3145021|P1|Overall Study|Adverse Event|0
955061|NCT00735397|3145081|P1|Overall Study|Administrative/Other|502
955062|NCT00735397|3145081|P1|Overall Study|Inadequate therapeutic effect|202
955063|NCT00735397|3145081|P1|Overall Study|Participant choice|252
955064|NCT00735397|3145081|P1|Overall Study|Lost to Follow-up|33
955065|NCT00735397|3145081|P1|Overall Study|Adverse Event|194
955066|NCT00735371|3145095|P4|Overall Study|Exclusion criteria|0
955067|NCT00735371|3145096|P3|Overall Study|Exclusion criteria|0
955068|NCT00735371|3145097|P2|Overall Study|Exclusion criteria|0
955069|NCT00735371|3145098|P1|Overall Study|Exclusion criteria|1
955070|NCT00735371|3145095|P4|Overall Study|Prior Vyvanse Exposure|0
955071|NCT00735371|3145096|P3|Overall Study|Prior Vyvanse Exposure|0
955072|NCT00735371|3145097|P2|Overall Study|Prior Vyvanse Exposure|1
955073|NCT00735371|3145098|P1|Overall Study|Prior Vyvanse Exposure|1
955074|NCT00735371|3145095|P4|Overall Study|Protocol Violation|0
955075|NCT00735371|3145096|P3|Overall Study|Protocol Violation|2
955076|NCT00735371|3145097|P2|Overall Study|Protocol Violation|1
955077|NCT00735371|3145098|P1|Overall Study|Protocol Violation|0
955078|NCT00735371|3145095|P4|Overall Study|Sponsor Decision|1
955079|NCT00735371|3145096|P3|Overall Study|Sponsor Decision|0
955080|NCT00735371|3145097|P2|Overall Study|Sponsor Decision|1
955081|NCT00735371|3145098|P1|Overall Study|Sponsor Decision|3
955082|NCT00735371|3145095|P4|Overall Study|Lack of Efficacy|4
955083|NCT00735371|3145096|P3|Overall Study|Lack of Efficacy|0
955084|NCT00735371|3145097|P2|Overall Study|Lack of Efficacy|2
955085|NCT00735371|3145098|P1|Overall Study|Lack of Efficacy|4
955086|NCT00735371|3145095|P4|Overall Study|Lost to Follow-up|1
955087|NCT00735371|3145096|P3|Overall Study|Lost to Follow-up|3
955088|NCT00735371|3145097|P2|Overall Study|Lost to Follow-up|1
955089|NCT00735371|3145098|P1|Overall Study|Lost to Follow-up|1
955090|NCT00735371|3145095|P4|Overall Study|Withdrawal by Subject|0
955091|NCT00735371|3145096|P3|Overall Study|Withdrawal by Subject|2
955092|NCT00735371|3145097|P2|Overall Study|Withdrawal by Subject|2
955093|NCT00735371|3145098|P1|Overall Study|Withdrawal by Subject|0
955094|NCT00735371|3145095|P4|Overall Study|Protocol Violation|3
955095|NCT00735371|3145096|P3|Overall Study|Protocol Violation|0
955096|NCT00735371|3145097|P2|Overall Study|Protocol Violation|2
955097|NCT00735371|3145098|P1|Overall Study|Protocol Violation|2
955098|NCT00735371|3145095|P4|Overall Study|Adverse Event|1
955099|NCT00735371|3145096|P3|Overall Study|Adverse Event|4
955100|NCT00735371|3145097|P2|Overall Study|Adverse Event|3
955101|NCT00735371|3145098|P1|Overall Study|Adverse Event|3
955102|NCT00735254|3145126|P4|Overall Study|Protocol Violation|0
955103|NCT00735254|3145127|P3|Overall Study|Protocol Violation|1
955104|NCT00735254|3145128|P2|Overall Study|Protocol Violation|1
955105|NCT00735254|3145129|P1|Overall Study|Protocol Violation|1
955106|NCT00735072|3145141|P2|Overall Study|Subject interrupted ARVs (non-adherence)|1
955107|NCT00735072|3145142|P1|Overall Study|Subject interrupted ARVs (non-adherence)|0
955108|NCT00735072|3145141|P2|Overall Study|interrupted study med during ARV change|0
955109|NCT00735072|3145142|P1|Overall Study|interrupted study med during ARV change|1
955110|NCT00735007|3145148|P1|Overall Study|Protocol Violation|1
955111|NCT00735007|3145148|P1|Overall Study|Adverse Event|4
955112|NCT00734994|3145173|P1|Overall Study|Withdrawal by Subject|1
955113|NCT00734929|3145193|P2|Overall Study|No intervention/ screen fail|3
955114|NCT00734929|3145194|P1|Overall Study|No intervention/ screen fail|5
955115|NCT00734929|3145193|P2|Overall Study|Lost to Follow-up|2
955116|NCT00734929|3145194|P1|Overall Study|Lost to Follow-up|1
955117|NCT00734851|3145251|P1|Overall Study|Physician Decision|18
955118|NCT00734851|3145251|P1|Overall Study|Lost to Follow-up|1
955119|NCT00734851|3145251|P1|Overall Study|Withdrawal by Subject|2
955120|NCT00734747|3145272|P1|6 Month Follow-up|Did not meet inclusion criteria|3
955121|NCT00734747|3145272|P1|SRS Procedure|No staples placed|3
955122|NCT00734656|3145286|P4|Lab Session 4|Withdrawal by Subject|1
955123|NCT00734656|3145287|P3|Lab Session 4|Withdrawal by Subject|0
955124|NCT00734656|3145288|P2|Lab Session 4|Withdrawal by Subject|0
955125|NCT00734656|3145289|P1|Lab Session 4|Withdrawal by Subject|0
955126|NCT00734656|3145286|P4|Washout 3|Withdrawal by Subject|1
955127|NCT00734656|3145287|P3|Washout 3|Withdrawal by Subject|0
955128|NCT00734656|3145288|P2|Washout 3|Withdrawal by Subject|0
955129|NCT00734656|3145289|P1|Washout 3|Withdrawal by Subject|1
955130|NCT00734656|3145286|P4|Washout 2|Withdrawal by Subject|0
955131|NCT00734656|3145287|P3|Washout 2|Withdrawal by Subject|1
955132|NCT00734656|3145288|P2|Washout 2|Withdrawal by Subject|1
955133|NCT00734656|3145289|P1|Washout 2|Withdrawal by Subject|1
955134|NCT00734656|3145286|P4|Lab Session 2|Withdrawal by Subject|1
955135|NCT00734656|3145287|P3|Lab Session 2|Withdrawal by Subject|0
955136|NCT00734656|3145288|P2|Lab Session 2|Withdrawal by Subject|0
955137|NCT00734656|3145289|P1|Lab Session 2|Withdrawal by Subject|1
955138|NCT00734656|3145286|P4|Washout 1|Withdrawal by Subject|3
955139|NCT00734656|3145287|P3|Washout 1|Withdrawal by Subject|2
955140|NCT00734656|3145288|P2|Washout 1|Withdrawal by Subject|5
955141|NCT00734656|3145289|P1|Washout 1|Withdrawal by Subject|1
955142|NCT00734656|3145286|P4|Lab Session 1|Withdrawal by Subject|0
955143|NCT00734656|3145287|P3|Lab Session 1|Withdrawal by Subject|0
955144|NCT00734656|3145288|P2|Lab Session 1|Withdrawal by Subject|0
955145|NCT00734656|3145289|P1|Lab Session 1|Withdrawal by Subject|2
955146|NCT00734630|3145313|P2|Overall Study|Poor Compliance|1
955147|NCT00734630|3145314|P1|Overall Study|Poor Compliance|1
955148|NCT00734630|3145313|P2|Overall Study|Tested Positive for Illegal Drug Use|1
955149|NCT00734630|3145314|P1|Overall Study|Tested Positive for Illegal Drug Use|1
955150|NCT00734630|3145313|P2|Overall Study|Randomized in Error|1
955151|NCT00734630|3145314|P1|Overall Study|Randomized in Error|0
955152|NCT00734630|3145313|P2|Overall Study|Adverse Event|6
955153|NCT00734630|3145314|P1|Overall Study|Adverse Event|3
955154|NCT00734630|3145313|P2|Overall Study|Inclusion/Exclusion criteria not met|1
955155|NCT00734630|3145314|P1|Overall Study|Inclusion/Exclusion criteria not met|0
955156|NCT00734630|3145313|P2|Overall Study|Protocol Violation|3
955157|NCT00734630|3145314|P1|Overall Study|Protocol Violation|0
955158|NCT00734630|3145313|P2|Overall Study|Lost to Follow-up|7
955159|NCT00734630|3145314|P1|Overall Study|Lost to Follow-up|13
955160|NCT00734630|3145313|P2|Overall Study|Withdrawal by Subject|9
955161|NCT00734630|3145314|P1|Overall Study|Withdrawal by Subject|7
955162|NCT00734630|3145313|P2|Overall Study|Lack of Efficacy|4
955163|NCT00734630|3145314|P1|Overall Study|Lack of Efficacy|4
955164|NCT00734617|3145324|P2|Overall Study|Withdrawal by Subject|95
955165|NCT00734617|3145325|P1|Overall Study|Withdrawal by Subject|103
955166|NCT00734617|3145324|P2|Overall Study|Adverse Event|7
955167|NCT00734617|3145325|P1|Overall Study|Adverse Event|4
955168|NCT00734604|3145337|P6|Overall Study|Lack of Efficacy|0
955169|NCT00734604|3145338|P5|Overall Study|Lack of Efficacy|0
955170|NCT00734604|3145339|P4|Overall Study|Lack of Efficacy|0
955171|NCT00734604|3145340|P3|Overall Study|Lack of Efficacy|1
955172|NCT00734604|3145341|P2|Overall Study|Lack of Efficacy|1
955173|NCT00734604|3145342|P1|Overall Study|Lack of Efficacy|0
955174|NCT00734604|3145337|P6|Overall Study|Withdrawal by Subject|1
955175|NCT00734604|3145338|P5|Overall Study|Withdrawal by Subject|2
955176|NCT00734604|3145339|P4|Overall Study|Withdrawal by Subject|1
955177|NCT00734604|3145340|P3|Overall Study|Withdrawal by Subject|0
955178|NCT00734604|3145341|P2|Overall Study|Withdrawal by Subject|2
955179|NCT00734604|3145342|P1|Overall Study|Withdrawal by Subject|0
955180|NCT00734604|3145337|P6|Overall Study|Sponsor Decision|0
955181|NCT00734604|3145338|P5|Overall Study|Sponsor Decision|2
955182|NCT00734604|3145339|P4|Overall Study|Sponsor Decision|0
955183|NCT00734604|3145340|P3|Overall Study|Sponsor Decision|1
955184|NCT00734604|3145341|P2|Overall Study|Sponsor Decision|2
955185|NCT00734604|3145342|P1|Overall Study|Sponsor Decision|1
955186|NCT00734604|3145337|P6|Overall Study|Protocol Violation|0
955187|NCT00734604|3145338|P5|Overall Study|Protocol Violation|1
955188|NCT00734604|3145339|P4|Overall Study|Protocol Violation|0
955189|NCT00734604|3145340|P3|Overall Study|Protocol Violation|0
955190|NCT00734604|3145341|P2|Overall Study|Protocol Violation|2
955191|NCT00734604|3145342|P1|Overall Study|Protocol Violation|0
955192|NCT00734604|3145337|P6|Overall Study|Physician Decision|0
955193|NCT00734604|3145338|P5|Overall Study|Physician Decision|0
955194|NCT00734604|3145339|P4|Overall Study|Physician Decision|0
955195|NCT00734604|3145340|P3|Overall Study|Physician Decision|1
955196|NCT00734604|3145341|P2|Overall Study|Physician Decision|1
955197|NCT00734604|3145342|P1|Overall Study|Physician Decision|0
955198|NCT00734604|3145337|P6|Overall Study|Lost to Follow-up|3
955199|NCT00734604|3145338|P5|Overall Study|Lost to Follow-up|2
955200|NCT00734604|3145339|P4|Overall Study|Lost to Follow-up|4
955201|NCT00734604|3145340|P3|Overall Study|Lost to Follow-up|2
955202|NCT00734604|3145341|P2|Overall Study|Lost to Follow-up|2
955203|NCT00734604|3145342|P1|Overall Study|Lost to Follow-up|1
955204|NCT00734604|3145337|P6|Overall Study|Serious Adverse Event|1
955205|NCT00734604|3145338|P5|Overall Study|Serious Adverse Event|0
955206|NCT00734604|3145339|P4|Overall Study|Serious Adverse Event|2
955207|NCT00734604|3145340|P3|Overall Study|Serious Adverse Event|1
955208|NCT00734604|3145341|P2|Overall Study|Serious Adverse Event|0
955209|NCT00734604|3145342|P1|Overall Study|Serious Adverse Event|1
955210|NCT00734604|3145337|P6|Overall Study|Adverse Event|1
955211|NCT00734604|3145338|P5|Overall Study|Adverse Event|1
955212|NCT00734604|3145339|P4|Overall Study|Adverse Event|2
955213|NCT00734604|3145340|P3|Overall Study|Adverse Event|0
955214|NCT00734604|3145341|P2|Overall Study|Adverse Event|2
955215|NCT00734604|3145342|P1|Overall Study|Adverse Event|0
955216|NCT00734591|3145392|P2|Prospective Period|Other|2
955217|NCT00734591|3145393|P1|Prospective Period|Other|2
955218|NCT00734591|3145392|P2|Prospective Period|Study Terminated|0
955219|NCT00734591|3145393|P1|Prospective Period|Study Terminated|1
955220|NCT00734591|3145392|P2|Prospective Period|Lost to Follow-up|33
955221|NCT00734591|3145393|P1|Prospective Period|Lost to Follow-up|37
955222|NCT00734591|3145392|P2|Prospective Period|Withdrawal by Subject|9
955223|NCT00734591|3145393|P1|Prospective Period|Withdrawal by Subject|11
955224|NCT00734591|3145392|P2|Screening for Prospective Period|Patient at partic. site not enrolled|803
955225|NCT00734591|3145393|P1|Screening for Prospective Period|Patient at partic. site not enrolled|913
955226|NCT00734591|3145392|P2|Screening for Prospective Period|Site did not participate|1488
955227|NCT00734591|3145393|P1|Screening for Prospective Period|Site did not participate|1604
955228|NCT00734578|3145408|P3|Overall Study|Exclusion criteria|0
955229|NCT00734578|3145409|P2|Overall Study|Exclusion criteria|0
955230|NCT00734578|3145410|P1|Overall Study|Exclusion criteria|1
955231|NCT00734578|3145408|P3|Overall Study|Randomized in error|0
955232|NCT00734578|3145409|P2|Overall Study|Randomized in error|0
955233|NCT00734578|3145410|P1|Overall Study|Randomized in error|1
955234|NCT00734578|3145408|P3|Overall Study|Lack of Efficacy|5
955235|NCT00734578|3145409|P2|Overall Study|Lack of Efficacy|2
955236|NCT00734578|3145410|P1|Overall Study|Lack of Efficacy|3
955237|NCT00734578|3145408|P3|Overall Study|Lost to Follow-up|5
955238|NCT00734578|3145409|P2|Overall Study|Lost to Follow-up|3
955239|NCT00734578|3145410|P1|Overall Study|Lost to Follow-up|9
955240|NCT00734578|3145408|P3|Overall Study|Withdrawal by Subject|11
955241|NCT00734578|3145409|P2|Overall Study|Withdrawal by Subject|8
955242|NCT00734578|3145410|P1|Overall Study|Withdrawal by Subject|7
955243|NCT00734578|3145408|P3|Overall Study|Protocol Violation|3
955244|NCT00734578|3145409|P2|Overall Study|Protocol Violation|6
955245|NCT00734578|3145410|P1|Overall Study|Protocol Violation|8
955246|NCT00734578|3145408|P3|Overall Study|Adverse Event|1
955247|NCT00734578|3145409|P2|Overall Study|Adverse Event|6
955248|NCT00734578|3145410|P1|Overall Study|Adverse Event|4
955249|NCT00734539|3145444|P2|Main Study|Enrolled in error; ineligible|0
955250|NCT00734539|3145445|P1|Main Study|Enrolled in error; ineligible|1
955251|NCT00734539|3145444|P2|Main Study|Withdrawal by Subject|3
955252|NCT00734539|3145445|P1|Main Study|Withdrawal by Subject|1
955253|NCT00734539|3145444|P2|Main Study|Physician Decision|0
955254|NCT00734539|3145445|P1|Main Study|Physician Decision|2
955255|NCT00734539|3145444|P2|Main Study|Death|32
955256|NCT00734539|3145445|P1|Main Study|Death|33
955257|NCT00734474|3145487|P9|Overall Study|Lack of Efficacy|6
955258|NCT00734474|3145488|P8|Overall Study|Lack of Efficacy|4
955259|NCT00734474|3145489|P7|Overall Study|Lack of Efficacy|0
955260|NCT00734474|3145490|P6|Overall Study|Lack of Efficacy|0
955261|NCT00734474|3145491|P5|Overall Study|Lack of Efficacy|0
955262|NCT00734474|3145492|P4|Overall Study|Lack of Efficacy|0
955263|NCT00734474|3145493|P3|Overall Study|Lack of Efficacy|4
955264|NCT00734474|3145494|P2|Overall Study|Lack of Efficacy|0
955265|NCT00734474|3145495|P1|Overall Study|Lack of Efficacy|0
955266|NCT00734474|3145487|P9|Overall Study|Death|1
955267|NCT00734474|3145488|P8|Overall Study|Death|2
955268|NCT00734474|3145489|P7|Overall Study|Death|0
955269|NCT00734474|3145490|P6|Overall Study|Death|0
955270|NCT00734474|3145491|P5|Overall Study|Death|0
955271|NCT00734474|3145492|P4|Overall Study|Death|0
955272|NCT00734474|3145493|P3|Overall Study|Death|1
955273|NCT00734474|3145494|P2|Overall Study|Death|0
955274|NCT00734474|3145495|P1|Overall Study|Death|0
955275|NCT00734474|3145487|P9|Overall Study|Sponsor Decision|0
955276|NCT00734474|3145488|P8|Overall Study|Sponsor Decision|0
955277|NCT00734474|3145489|P7|Overall Study|Sponsor Decision|0
955278|NCT00734474|3145490|P6|Overall Study|Sponsor Decision|0
955279|NCT00734474|3145491|P5|Overall Study|Sponsor Decision|2
955280|NCT00734474|3145492|P4|Overall Study|Sponsor Decision|0
955281|NCT00734474|3145493|P3|Overall Study|Sponsor Decision|0
955282|NCT00734474|3145494|P2|Overall Study|Sponsor Decision|0
955283|NCT00734474|3145495|P1|Overall Study|Sponsor Decision|0
955284|NCT00734474|3145487|P9|Overall Study|Sponsor Decision, Arm Discontinued|0
955285|NCT00734474|3145488|P8|Overall Study|Sponsor Decision, Arm Discontinued|0
955286|NCT00734474|3145489|P7|Overall Study|Sponsor Decision, Arm Discontinued|23
955287|NCT00734474|3145490|P6|Overall Study|Sponsor Decision, Arm Discontinued|21
955288|NCT00734474|3145491|P5|Overall Study|Sponsor Decision, Arm Discontinued|0
955289|NCT00734474|3145492|P4|Overall Study|Sponsor Decision, Arm Discontinued|8
955290|NCT00734474|3145493|P3|Overall Study|Sponsor Decision, Arm Discontinued|0
955291|NCT00734474|3145494|P2|Overall Study|Sponsor Decision, Arm Discontinued|25
955292|NCT00734474|3145495|P1|Overall Study|Sponsor Decision, Arm Discontinued|8
955293|NCT00734474|3145487|P9|Overall Study|Protocol Violation|1
955294|NCT00734474|3145488|P8|Overall Study|Protocol Violation|3
955295|NCT00734474|3145489|P7|Overall Study|Protocol Violation|0
955296|NCT00734474|3145490|P6|Overall Study|Protocol Violation|0
955297|NCT00734474|3145491|P5|Overall Study|Protocol Violation|3
955298|NCT00734474|3145492|P4|Overall Study|Protocol Violation|0
955299|NCT00734474|3145493|P3|Overall Study|Protocol Violation|4
955300|NCT00734474|3145494|P2|Overall Study|Protocol Violation|0
955301|NCT00734474|3145495|P1|Overall Study|Protocol Violation|0
955302|NCT00734474|3145487|P9|Overall Study|Adverse Event|39
955303|NCT00734474|3145488|P8|Overall Study|Adverse Event|65
955304|NCT00734474|3145489|P7|Overall Study|Adverse Event|1
955305|NCT00734474|3145490|P6|Overall Study|Adverse Event|0
955306|NCT00734474|3145491|P5|Overall Study|Adverse Event|64
955307|NCT00734474|3145492|P4|Overall Study|Adverse Event|1
955308|NCT00734474|3145493|P3|Overall Study|Adverse Event|63
955309|NCT00734474|3145494|P2|Overall Study|Adverse Event|4
955310|NCT00734474|3145495|P1|Overall Study|Adverse Event|4
955311|NCT00734474|3145487|P9|Overall Study|Physician Decision|9
955312|NCT00734474|3145488|P8|Overall Study|Physician Decision|9
955313|NCT00734474|3145489|P7|Overall Study|Physician Decision|0
955314|NCT00734474|3145490|P6|Overall Study|Physician Decision|0
955315|NCT00734474|3145491|P5|Overall Study|Physician Decision|11
955316|NCT00734474|3145492|P4|Overall Study|Physician Decision|1
955317|NCT00734474|3145493|P3|Overall Study|Physician Decision|4
955318|NCT00734474|3145494|P2|Overall Study|Physician Decision|0
955319|NCT00734474|3145495|P1|Overall Study|Physician Decision|0
955320|NCT00734474|3145487|P9|Overall Study|Withdrawal by Subject|21
955321|NCT00734474|3145488|P8|Overall Study|Withdrawal by Subject|36
955322|NCT00734474|3145489|P7|Overall Study|Withdrawal by Subject|0
955323|NCT00734474|3145490|P6|Overall Study|Withdrawal by Subject|2
955324|NCT00734474|3145491|P5|Overall Study|Withdrawal by Subject|24
955325|NCT00734474|3145492|P4|Overall Study|Withdrawal by Subject|0
955326|NCT00734474|3145493|P3|Overall Study|Withdrawal by Subject|18
955327|NCT00734474|3145494|P2|Overall Study|Withdrawal by Subject|1
955328|NCT00734474|3145495|P1|Overall Study|Withdrawal by Subject|2
955329|NCT00734474|3145487|P9|Overall Study|Lost to Follow-up|4
955330|NCT00734474|3145488|P8|Overall Study|Lost to Follow-up|9
955331|NCT00734474|3145489|P7|Overall Study|Lost to Follow-up|0
955332|NCT00734474|3145490|P6|Overall Study|Lost to Follow-up|1
955333|NCT00734474|3145491|P5|Overall Study|Lost to Follow-up|11
955334|NCT00734474|3145492|P4|Overall Study|Lost to Follow-up|0
955335|NCT00734474|3145493|P3|Overall Study|Lost to Follow-up|13
955336|NCT00734474|3145494|P2|Overall Study|Lost to Follow-up|0
955337|NCT00734474|3145495|P1|Overall Study|Lost to Follow-up|1
955338|NCT00734474|3145487|P9|Overall Study|Entry Criteria Not Met|1
955339|NCT00734474|3145488|P8|Overall Study|Entry Criteria Not Met|1
955340|NCT00734474|3145489|P7|Overall Study|Entry Criteria Not Met|0
955341|NCT00734474|3145490|P6|Overall Study|Entry Criteria Not Met|1
955342|NCT00734474|3145491|P5|Overall Study|Entry Criteria Not Met|3
955343|NCT00734474|3145492|P4|Overall Study|Entry Criteria Not Met|0
955344|NCT00734474|3145493|P3|Overall Study|Entry Criteria Not Met|5
955345|NCT00734474|3145494|P2|Overall Study|Entry Criteria Not Met|0
955346|NCT00734474|3145495|P1|Overall Study|Entry Criteria Not Met|0
955347|NCT00734214|3145785|P2|Overall Study|MD withdrawal|0
955348|NCT00734214|3145786|P1|Overall Study|MD withdrawal|1
955349|NCT00734214|3145785|P2|Overall Study|Withdrawal by Subject|4
955350|NCT00734214|3145786|P1|Overall Study|Withdrawal by Subject|3
955351|NCT00734162|3145796|P4|Open-Label Phase|Did Not Meet Entrance Criteria|1
955352|NCT00734162|3145797|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
955353|NCT00734162|3145798|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
955354|NCT00734162|3145799|P1|Open-Label Phase|Did Not Meet Entrance Criteria|0
955355|NCT00734162|3145796|P4|Open-Label Phase|Lost to Follow-up|1
955356|NCT00734162|3145797|P3|Open-Label Phase|Lost to Follow-up|0
955357|NCT00734162|3145798|P2|Open-Label Phase|Lost to Follow-up|2
955358|NCT00734162|3145799|P1|Open-Label Phase|Lost to Follow-up|1
955359|NCT00734162|3145796|P4|Open-Label Phase|Withdrew Consent|1
955360|NCT00734162|3145797|P3|Open-Label Phase|Withdrew Consent|1
955361|NCT00734162|3145798|P2|Open-Label Phase|Withdrew Consent|0
955362|NCT00734162|3145799|P1|Open-Label Phase|Withdrew Consent|1
955363|NCT00734162|3145796|P4|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
955364|NCT00734162|3145797|P3|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
955365|NCT00734162|3145798|P2|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
955366|NCT00734162|3145799|P1|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1
955367|NCT00734162|3145796|P4|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2
955368|NCT00734162|3145797|P3|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
955369|NCT00734162|3145798|P2|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
955370|NCT00734162|3145799|P1|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
955371|NCT00734162|3145796|P4|Randomized Phase (Through Week 72)|Investigator's Discretion|2
955372|NCT00734162|3145797|P3|Randomized Phase (Through Week 72)|Investigator's Discretion|0
955373|NCT00734162|3145798|P2|Randomized Phase (Through Week 72)|Investigator's Discretion|1
955374|NCT00734162|3145799|P1|Randomized Phase (Through Week 72)|Investigator's Discretion|0
955375|NCT00734149|3146023|P1|Overall Study|Withdrawal by Subject|1
955376|NCT00734097|3146030|P1|Open Label|Protocol Violation|4
955377|NCT00734097|3146030|P1|Open Label|Withdrawal by Subject|5
955378|NCT00734097|3146030|P1|Open Label|Lost to Follow-up|7
955379|NCT00734097|3146030|P1|Screening|Unconfirmed pregnancy|1
955380|NCT00734097|3146030|P1|Screening|Lost to Follow-up|2
955381|NCT00734097|3146030|P1|Screening|Withdrawal by Subject|5
955382|NCT00734097|3146030|P1|Screening|Protocol Violation|12
955383|NCT00734071|3146047|P2|Overall Study|Other|2
955384|NCT00734071|3146048|P1|Overall Study|Other|1
955385|NCT00734071|3146047|P2|Overall Study|Lost to Follow-up|8
955386|NCT00734071|3146048|P1|Overall Study|Lost to Follow-up|16
955387|NCT00734071|3146047|P2|Overall Study|Voluntary Withdrawal|7
955388|NCT00734071|3146048|P1|Overall Study|Voluntary Withdrawal|9
955389|NCT00734071|3146047|P2|Overall Study|Protocol Deviations|4
955390|NCT00734071|3146048|P1|Overall Study|Protocol Deviations|3
955391|NCT00734071|3146047|P2|Overall Study|Noncompliance|2
955392|NCT00734071|3146048|P1|Overall Study|Noncompliance|2
955393|NCT00734071|3146047|P2|Overall Study|Lack of Efficacy|1
955394|NCT00734071|3146048|P1|Overall Study|Lack of Efficacy|3
955395|NCT00734071|3146047|P2|Overall Study|Adverse Event|3
955396|NCT00734071|3146048|P1|Overall Study|Adverse Event|4
955397|NCT00734032|3146106|P4|Overall Study|Adverse Event|0
955398|NCT00734032|3146107|P3|Overall Study|Adverse Event|0
955399|NCT00734032|3146108|P2|Overall Study|Adverse Event|1
955400|NCT00734032|3146109|P1|Overall Study|Adverse Event|0
955401|NCT00733980|3146165|P2|Overall Study|Withdrawal by Subject|2
955402|NCT00733980|3146166|P1|Overall Study|Withdrawal by Subject|6
955403|NCT00733980|3146165|P2|Overall Study|Physician Decision|3
955404|NCT00733980|3146166|P1|Overall Study|Physician Decision|2
955405|NCT00733980|3146165|P2|Overall Study|Lost to Follow-up|11
955406|NCT00733980|3146166|P1|Overall Study|Lost to Follow-up|6
955407|NCT00733980|3146165|P2|Overall Study|Protocol defined stopping criteria reach|1
955408|NCT00733980|3146166|P1|Overall Study|Protocol defined stopping criteria reach|1
955409|NCT00733980|3146165|P2|Overall Study|Protocol Violation|1
955410|NCT00733980|3146166|P1|Overall Study|Protocol Violation|2
955411|NCT00733980|3146165|P2|Overall Study|Lack of Efficacy|1
955412|NCT00733980|3146166|P1|Overall Study|Lack of Efficacy|0
955413|NCT00733980|3146165|P2|Overall Study|Adverse Event|2
955414|NCT00733980|3146166|P1|Overall Study|Adverse Event|5
955415|NCT00733954|3146210|P2|Overall Study|Withdrawal by Subject|0
955416|NCT00733954|3146211|P1|Overall Study|Withdrawal by Subject|2
955417|NCT00733954|3146210|P2|Overall Study|Protocol Violation|0
955418|NCT00733954|3146211|P1|Overall Study|Protocol Violation|1
955419|NCT00733954|3146210|P2|Overall Study|Lost to Follow-up|2
955420|NCT00733954|3146211|P1|Overall Study|Lost to Follow-up|5
955421|NCT00733824|3146258|P5|Phase I|Withdrawal by Subject|0
955422|NCT00733824|3146259|P4|Phase I|Withdrawal by Subject|0
955423|NCT00733824|3146260|P3|Phase I|Withdrawal by Subject|0
955424|NCT00733824|3146261|P2|Phase I|Withdrawal by Subject|0
955425|NCT00733824|3146262|P1|Phase I|Withdrawal by Subject|1
955426|NCT00733746|3146281|P1|Overall Study|Ineligible|5
955427|NCT00733499|3146296|P2|24 Months Follow-up|Death|1
955428|NCT00733499|3146297|P1|24 Months Follow-up|Death|0
955429|NCT00733499|3146296|P2|12 Months Follow-up|Death|1
955430|NCT00733499|3146297|P1|12 Months Follow-up|Death|2
955431|NCT00733499|3146296|P2|6 Months Follow-up|Adverse Event|1
955432|NCT00733499|3146297|P1|6 Months Follow-up|Adverse Event|0
955433|NCT00733499|3146296|P2|6 Months Follow-up|Death|2
955434|NCT00733499|3146297|P1|6 Months Follow-up|Death|0
955435|NCT00733499|3146296|P2|3 Months Follow-up|Death|2
955436|NCT00733499|3146297|P1|3 Months Follow-up|Death|1
955437|NCT00733499|3146296|P2|Pre-operative|Protocol Violation|1
955438|NCT00733499|3146297|P1|Pre-operative|Protocol Violation|0
955439|NCT00733421|3146305|P2|Overall Study|Withdrawal by Subject|1
955440|NCT00733421|3146306|P1|Overall Study|Withdrawal by Subject|1
955441|NCT00733369|3146330|P2|Overall Study|Protocol Violation|4
955442|NCT00733369|3146331|P1|Overall Study|Protocol Violation|4
955443|NCT00733369|3146330|P2|Overall Study|Adverse Event|4
955444|NCT00733369|3146331|P1|Overall Study|Adverse Event|4
955445|NCT00733369|3146330|P2|Overall Study|Lost to Follow-up|1
955446|NCT00733369|3146331|P1|Overall Study|Lost to Follow-up|2
955447|NCT00733304|3146539|P3|Overall Study|Withdrawal by Subject|0
955448|NCT00733304|3146540|P2|Overall Study|Withdrawal by Subject|1
955449|NCT00733304|3146541|P1|Overall Study|Withdrawal by Subject|1
955450|NCT00733304|3146539|P3|Overall Study|Physician Decision|3
955451|NCT00733304|3146540|P2|Overall Study|Physician Decision|1
955452|NCT00733304|3146541|P1|Overall Study|Physician Decision|3
955453|NCT00733304|3146539|P3|Overall Study|Lost to Follow-up|0
955454|NCT00733304|3146540|P2|Overall Study|Lost to Follow-up|1
955455|NCT00733304|3146541|P1|Overall Study|Lost to Follow-up|0
955456|NCT00733304|3146539|P3|Overall Study|Lack of Efficacy|2
955457|NCT00733304|3146540|P2|Overall Study|Lack of Efficacy|0
955458|NCT00733304|3146541|P1|Overall Study|Lack of Efficacy|0
955459|NCT00733304|3146539|P3|Overall Study|Adverse Event|0
955460|NCT00733304|3146540|P2|Overall Study|Adverse Event|0
955461|NCT00733304|3146541|P1|Overall Study|Adverse Event|3
955462|NCT00733291|3146623|P4|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
955463|NCT00733291|3146624|P3|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
955464|NCT00733291|3146625|P2|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
955465|NCT00733291|3146626|P1|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1
955466|NCT00733226|3146655|P2|Overall Study|moved to another place|0
955467|NCT00733226|3146656|P1|Overall Study|moved to another place|2
955468|NCT00733226|3146655|P2|Overall Study|Lost to Follow-up|0
955469|NCT00733226|3146656|P1|Overall Study|Lost to Follow-up|2
955470|NCT00733226|3146655|P2|Overall Study|Withdrawal by Subject|0
955471|NCT00733226|3146656|P1|Overall Study|Withdrawal by Subject|1
955472|NCT00733005|3146705|P2|Overall Study|Protocol Violation|0
955473|NCT00733005|3146706|P1|Overall Study|Protocol Violation|2
955474|NCT00733005|3146705|P2|Overall Study|Withdrawal by Subject|1
955475|NCT00733005|3146706|P1|Overall Study|Withdrawal by Subject|0
955476|NCT00733005|3146705|P2|Overall Study|Treatment Failure|1
955477|NCT00733005|3146706|P1|Overall Study|Treatment Failure|0
955478|NCT00733005|3146705|P2|Overall Study|Adverse Event|1
955479|NCT00733005|3146706|P1|Overall Study|Adverse Event|0
955480|NCT00732992|3146716|P2|Overall Study|Withdrawal by Subject|0
955481|NCT00732992|3146717|P1|Overall Study|Withdrawal by Subject|1
955482|NCT00732992|3146716|P2|Overall Study|Global Deterioration of Health Status|0
955483|NCT00732992|3146717|P1|Overall Study|Global Deterioration of Health Status|1
955484|NCT00732992|3146716|P2|Overall Study|Objective Progression or Relapse|5
955485|NCT00732992|3146717|P1|Overall Study|Objective Progression or Relapse|3
955486|NCT00732992|3146716|P2|Overall Study|Adverse Event|1
955487|NCT00732992|3146717|P1|Overall Study|Adverse Event|1
955488|NCT00732940|3146736|P2|Overall Study|Lost to Follow-up|0
955489|NCT00732940|3146737|P1|Overall Study|Lost to Follow-up|1
955490|NCT00732940|3146736|P2|Overall Study|Adverse Event|1
955491|NCT00732940|3146737|P1|Overall Study|Adverse Event|0
955492|NCT00732940|3146736|P2|Overall Study|Withdrawal by Subject|2
955493|NCT00732940|3146737|P1|Overall Study|Withdrawal by Subject|1
955494|NCT00732875|3146818|P1|Overall Study|Lack of Efficacy|13
955495|NCT00732875|3146818|P1|Overall Study|Withdrawal by Subject|6
955496|NCT00732875|3146818|P1|Overall Study|Adverse Event|16
955497|NCT00732758|3146826|P2|Overall Study|Lost to Follow-up|16
955498|NCT00732758|3146827|P1|Overall Study|Lost to Follow-up|8
955499|NCT00732641|3146867|P2|Overall Study|Not Specified|5
955500|NCT00732641|3146868|P1|Overall Study|Not Specified|18
955501|NCT00732641|3146867|P2|Overall Study|Unable to Complete|1
955502|NCT00732641|3146868|P1|Overall Study|Unable to Complete|1
955503|NCT00732641|3146867|P2|Overall Study|Withdrawal by Subject|2
955504|NCT00732641|3146868|P1|Overall Study|Withdrawal by Subject|4
955505|NCT00732641|3146867|P2|Overall Study|Physician Decision|0
955506|NCT00732641|3146868|P1|Overall Study|Physician Decision|6
955507|NCT00732641|3146867|P2|Overall Study|Serious Adverse Events|3
955508|NCT00732641|3146868|P1|Overall Study|Serious Adverse Events|12
955509|NCT00732641|3146867|P2|Overall Study|Relapse or Progressive Disease|101
955510|NCT00732641|3146868|P1|Overall Study|Relapse or Progressive Disease|65
955511|NCT00732615|3146888|P2|Overall Study|Non-Compliance, Subject/Physician Dec.|1
955512|NCT00732615|3146889|P1|Overall Study|Non-Compliance, Subject/Physician Dec.|1
955513|NCT00732615|3146888|P2|Overall Study|Physician Decision|0
955514|NCT00732615|3146889|P1|Overall Study|Physician Decision|3
955515|NCT00732615|3146888|P2|Overall Study|Adverse Event|2
955516|NCT00732615|3146889|P1|Overall Study|Adverse Event|0
955517|NCT00732615|3146888|P2|Overall Study|Lost to Follow-up|1
955518|NCT00732615|3146889|P1|Overall Study|Lost to Follow-up|0
955519|NCT00732615|3146888|P2|Overall Study|Withdrawal by Subject|1
955520|NCT00732615|3146889|P1|Overall Study|Withdrawal by Subject|3
955521|NCT00732472|3146905|P4|Overall Study|Withdrawal by Subject|1
955522|NCT00732472|3146906|P3|Overall Study|Withdrawal by Subject|0
955523|NCT00732472|3146907|P2|Overall Study|Withdrawal by Subject|2
955524|NCT00732472|3146908|P1|Overall Study|Withdrawal by Subject|0
955525|NCT00732472|3146905|P4|Overall Study|Protocol Violation|1
955526|NCT00732472|3146906|P3|Overall Study|Protocol Violation|0
955527|NCT00732472|3146907|P2|Overall Study|Protocol Violation|0
955528|NCT00732472|3146908|P1|Overall Study|Protocol Violation|0
955529|NCT00732472|3146905|P4|Overall Study|Adverse Event|1
955530|NCT00732472|3146906|P3|Overall Study|Adverse Event|1
955531|NCT00732472|3146907|P2|Overall Study|Adverse Event|1
955532|NCT00732472|3146908|P1|Overall Study|Adverse Event|0
955533|NCT00732381|3147008|P2|Overall Study|Treatment Failure|1
955534|NCT00732381|3147009|P1|Overall Study|Treatment Failure|1
955535|NCT00732381|3147008|P2|Overall Study|Adverse Event|0
955536|NCT00732381|3147009|P1|Overall Study|Adverse Event|1
955537|NCT00732303|3147017|P1|Overall Study|Study Terminated|2
955538|NCT00732251|3147023|P1|Overall Study|Early Term due to Site Closure|1
955539|NCT00732251|3147023|P1|Overall Study|Withdrawal by Subject|3
955540|NCT00732251|3147023|P1|Overall Study|Lost to Follow-up|3
955541|NCT00732238|3147029|P2|Overall Study|Asymptomatic bacteriuria|0
955542|NCT00732238|3147030|P1|Overall Study|Asymptomatic bacteriuria|1
955543|NCT00732238|3147029|P2|Overall Study|Bacteremia|1
955544|NCT00732238|3147030|P1|Overall Study|Bacteremia|4
955545|NCT00732199|3147131|P2|Overall Study|sleep apnea, inadequate signals/sleep|8
955546|NCT00732199|3147132|P1|Overall Study|sleep apnea, inadequate signals/sleep|9
955547|NCT00732199|3147131|P2|Overall Study|Withdrawal by Subject|18
955548|NCT00732199|3147132|P1|Overall Study|Withdrawal by Subject|25
955549|NCT00732160|3147147|P4|Overall Study|scheduling|1
955550|NCT00732160|3147148|P3|Overall Study|scheduling|2
955551|NCT00732160|3147149|P2|Overall Study|scheduling|4
955552|NCT00732160|3147150|P1|Overall Study|scheduling|4
955553|NCT00732160|3147147|P4|Overall Study|Adverse Event|1
955554|NCT00732160|3147148|P3|Overall Study|Adverse Event|1
955555|NCT00732160|3147149|P2|Overall Study|Adverse Event|0
955556|NCT00732160|3147150|P1|Overall Study|Adverse Event|1
955557|NCT00732069|3147164|P6|Washout After First Study Drug|Adverse Event|0
955558|NCT00732069|3147165|P5|Washout After First Study Drug|Adverse Event|0
955559|NCT00732069|3147166|P4|Washout After First Study Drug|Adverse Event|0
955560|NCT00732069|3147167|P3|Washout After First Study Drug|Adverse Event|0
955561|NCT00732069|3147168|P2|Washout After First Study Drug|Adverse Event|0
955562|NCT00732069|3147169|P1|Washout After First Study Drug|Adverse Event|1
955563|NCT00731939|3147187|P1|Overall Study|Did not meet enrollment criteria|2
955564|NCT00731939|3147187|P1|Overall Study|Withdrawal by Subject|2
955565|NCT00731939|3147187|P1|Overall Study|Not implanted with study device|9
955566|NCT00731939|3147187|P1|Overall Study|Lost to Follow-up|15
955567|NCT00731939|3147187|P1|Overall Study|Adverse Event|6
955568|NCT00731822|3147264|P2|Overall Study|Lost to Follow-up|0
955569|NCT00731822|3147265|P1|Overall Study|Lost to Follow-up|1
955570|NCT00731822|3147264|P2|Overall Study|Protocol Violation|0
955571|NCT00731822|3147265|P1|Overall Study|Protocol Violation|1
955572|NCT00731822|3147264|P2|Overall Study|Adverse Event|1
955573|NCT00731822|3147265|P1|Overall Study|Adverse Event|2
955574|NCT00731783|3147279|P2|12 Month Follow-Up Visit|Lost to Follow-up|7
955575|NCT00731783|3147280|P1|12 Month Follow-Up Visit|Lost to Follow-up|6
955576|NCT00731783|3147279|P2|Six Month Follow-Up Visit|Lost to Follow-up|3
955577|NCT00731783|3147280|P1|Six Month Follow-Up Visit|Lost to Follow-up|6
955578|NCT00731783|3147279|P2|Three Month Follow-Up Visit|Lost to Follow-up|16
955579|NCT00731783|3147280|P1|Three Month Follow-Up Visit|Lost to Follow-up|7
955580|NCT00731783|3147279|P2|One Month Follow-Up Visit|Lost to Follow-up|22
955581|NCT00731783|3147280|P1|One Month Follow-Up Visit|Lost to Follow-up|14
955582|NCT00731731|3147303|P3|Overall Study|Cancel prior to treatment|2
955583|NCT00731731|3147304|P2|Overall Study|Cancel prior to treatment|0
955584|NCT00731731|3147305|P1|Overall Study|Cancel prior to treatment|0
955585|NCT00731731|3147303|P3|Overall Study|Protocol Violation|1
955586|NCT00731731|3147304|P2|Overall Study|Protocol Violation|0
955587|NCT00731731|3147305|P1|Overall Study|Protocol Violation|0
955588|NCT00731692|3147323|P3|Extension Phase|Adverse Event|15
955589|NCT00731692|3147324|P2|Extension Phase|Adverse Event|1
955590|NCT00731692|3147325|P1|Extension Phase|Adverse Event|1
955591|NCT00731692|3147323|P3|Extension Phase|Withdrawal by Subject|3
955592|NCT00731692|3147324|P2|Extension Phase|Withdrawal by Subject|5
955593|NCT00731692|3147325|P1|Extension Phase|Withdrawal by Subject|4
955594|NCT00731692|3147323|P3|Extension Phase|Lost to Follow-up|4
955595|NCT00731692|3147324|P2|Extension Phase|Lost to Follow-up|1
955596|NCT00731692|3147325|P1|Extension Phase|Lost to Follow-up|0
955597|NCT00731692|3147323|P3|Extension Phase|Abnormal lab values|1
955598|NCT00731692|3147324|P2|Extension Phase|Abnormal lab values|0
955599|NCT00731692|3147325|P1|Extension Phase|Abnormal lab values|0
955600|NCT00731692|3147323|P3|Extension Phase|Abnormal test procedure|1
955601|NCT00731692|3147324|P2|Extension Phase|Abnormal test procedure|0
955602|NCT00731692|3147325|P1|Extension Phase|Abnormal test procedure|0
955603|NCT00731692|3147323|P3|Extension Phase|Admin Problems: Terminated # patients|277
955604|NCT00731692|3147324|P2|Extension Phase|Admin Problems: Terminated # patients|189
955605|NCT00731692|3147325|P1|Extension Phase|Admin Problems: Terminated # patients|69
955606|NCT00731692|3147323|P3|Core Study (36 Months)|Withdrawal by Subject|46
955607|NCT00731692|3147324|P2|Core Study (36 Months)|Withdrawal by Subject|32
955608|NCT00731692|3147325|P1|Core Study (36 Months)|Withdrawal by Subject|12
955609|NCT00731692|3147323|P3|Core Study (36 Months)|Adverse Event|29
955610|NCT00731692|3147324|P2|Core Study (36 Months)|Adverse Event|28
955611|NCT00731692|3147325|P1|Core Study (36 Months)|Adverse Event|25
955612|NCT00731692|3147323|P3|Core Study (36 Months)|Abnormal Lab values|5
955613|NCT00731692|3147324|P2|Core Study (36 Months)|Abnormal Lab values|19
955614|NCT00731692|3147325|P1|Core Study (36 Months)|Abnormal Lab values|6
955615|NCT00731692|3147323|P3|Core Study (36 Months)|Protocol Violation|8
955616|NCT00731692|3147324|P2|Core Study (36 Months)|Protocol Violation|5
955617|NCT00731692|3147325|P1|Core Study (36 Months)|Protocol Violation|4
955618|NCT00731692|3147323|P3|Core Study (36 Months)|Abnormal Test Procedure Result|5
955619|NCT00731692|3147324|P2|Core Study (36 Months)|Abnormal Test Procedure Result|3
955620|NCT00731692|3147325|P1|Core Study (36 Months)|Abnormal Test Procedure Result|4
955621|NCT00731692|3147323|P3|Core Study (36 Months)|Administrative|6
955622|NCT00731692|3147324|P2|Core Study (36 Months)|Administrative|2
955623|NCT00731692|3147325|P1|Core Study (36 Months)|Administrative|2
955624|NCT00731692|3147323|P3|Core Study (36 Months)|Lost to Follow-up|3
955625|NCT00731692|3147324|P2|Core Study (36 Months)|Lost to Follow-up|3
955626|NCT00731692|3147325|P1|Core Study (36 Months)|Lost to Follow-up|1
955627|NCT00731692|3147323|P3|Core Study (36 Months)|Death|2
955628|NCT00731692|3147324|P2|Core Study (36 Months)|Death|1
955629|NCT00731692|3147325|P1|Core Study (36 Months)|Death|2
955630|NCT00731692|3147323|P3|Core Study (36 Months)|Physician Decision|2
955631|NCT00731692|3147324|P2|Core Study (36 Months)|Physician Decision|0
955632|NCT00731692|3147325|P1|Core Study (36 Months)|Physician Decision|1
955633|NCT00731692|3147323|P3|Core Study (36 Months)|Lack of Efficacy|64
955634|NCT00731692|3147324|P2|Core Study (36 Months)|Lack of Efficacy|23
955635|NCT00731692|3147325|P1|Core Study (36 Months)|Lack of Efficacy|11
955636|NCT00731679|3147371|P2|Overall Study|Pregnancy|1
955637|NCT00731679|3147372|P1|Overall Study|Pregnancy|0
955638|NCT00731679|3147371|P2|Overall Study|Noncompliance|1
955639|NCT00731679|3147372|P1|Overall Study|Noncompliance|0
955640|NCT00731679|3147371|P2|Overall Study|Lost to Follow-up|8
955641|NCT00731679|3147372|P1|Overall Study|Lost to Follow-up|7
955642|NCT00731679|3147371|P2|Overall Study|Withdrawal by Subject|8
955643|NCT00731679|3147372|P1|Overall Study|Withdrawal by Subject|8
955644|NCT00731679|3147371|P2|Overall Study|Adverse Event|8
955645|NCT00731679|3147372|P1|Overall Study|Adverse Event|7
955646|NCT00731666|3147380|P1|Overall Study|Withdrawal by Subject|2
955647|NCT00731666|3147380|P1|Overall Study|Lost to Follow-up|8
955648|NCT00731666|3147380|P1|Overall Study|Adverse Event|2
955649|NCT00731549|3147414|P1|Overall Study|Lack of efficacy without AE|6
955650|NCT00731549|3147414|P1|Overall Study|Lack of efficacy with AE|37
955651|NCT00731549|3147414|P1|Overall Study|Adverse Event|31
955652|NCT00731549|3147414|P1|Overall Study|Protocol deviation|1
955653|NCT00731549|3147414|P1|Overall Study|Withdrawal by Subject|89
955654|NCT00731549|3147414|P1|Overall Study|Physician Decision|16
955655|NCT00731549|3147414|P1|Overall Study|Met withdrawal criteria|24
955656|NCT00731549|3147414|P1|Overall Study|Lost to Follow-up|19
955657|NCT00731133|3147454|P1|Overall Study|Withdrawal by Subject|10
955658|NCT00731120|3147462|P3|Overall Study|Other|1
955659|NCT00731120|3147463|P2|Overall Study|Other|0
955660|NCT00731120|3147464|P1|Overall Study|Other|4
955661|NCT00731120|3147462|P3|Overall Study|Lost to Follow-up|17
955662|NCT00731120|3147463|P2|Overall Study|Lost to Follow-up|15
955663|NCT00731120|3147464|P1|Overall Study|Lost to Follow-up|10
955664|NCT00731120|3147462|P3|Overall Study|Withdrawal of Consent|4
955665|NCT00731120|3147463|P2|Overall Study|Withdrawal of Consent|8
955666|NCT00731120|3147464|P1|Overall Study|Withdrawal of Consent|13
955667|NCT00731120|3147462|P3|Overall Study|Protocol Deviations|1
955668|NCT00731120|3147463|P2|Overall Study|Protocol Deviations|6
955669|NCT00731120|3147464|P1|Overall Study|Protocol Deviations|1
955670|NCT00731120|3147462|P3|Overall Study|Noncompliance with Study Drug|1
955671|NCT00731120|3147463|P2|Overall Study|Noncompliance with Study Drug|3
955672|NCT00731120|3147464|P1|Overall Study|Noncompliance with Study Drug|3
955673|NCT00731120|3147462|P3|Overall Study|Lack of Efficacy|4
955674|NCT00731120|3147463|P2|Overall Study|Lack of Efficacy|5
955675|NCT00731120|3147464|P1|Overall Study|Lack of Efficacy|4
955676|NCT00731120|3147462|P3|Overall Study|Adverse Event|8
955677|NCT00731120|3147463|P2|Overall Study|Adverse Event|6
955678|NCT00731120|3147464|P1|Overall Study|Adverse Event|7
955679|NCT00731042|3147581|P2|Second Intervention|Did not meet inclusion criteria|2
955680|NCT00731042|3147582|P1|Second Intervention|Did not meet inclusion criteria|0
955681|NCT00730925|3147593|P1|Overall Study|Other|1
955682|NCT00730925|3147593|P1|Overall Study|Switch to combination therapy|8
955683|NCT00730925|3147593|P1|Overall Study|Withdrawal by Subject|1
955684|NCT00730925|3147593|P1|Overall Study|Protocol Violation|1
955685|NCT00730925|3147593|P1|Overall Study|Other Averse Event|7
955686|NCT00730925|3147593|P1|Overall Study|Dose reducing Event|2
955687|NCT00730925|3147593|P1|Overall Study|Progressive Disease|21
955688|NCT00730912|3147603|P3|Overall Study|Discontinued|1
955689|NCT00730912|3147604|P2|Overall Study|Discontinued|0
955690|NCT00730912|3147605|P1|Overall Study|Discontinued|0
955691|NCT00730886|3147618|P2|Overall Study|Physician Decision|0
955692|NCT00730886|3147619|P1|Overall Study|Physician Decision|1
955693|NCT00730886|3147618|P2|Overall Study|Lost to Follow-up|0
955694|NCT00730886|3147619|P1|Overall Study|Lost to Follow-up|1
955695|NCT00730847|3147643|P1|Overall Study|Other|24
955696|NCT00730847|3147643|P1|Overall Study|Unknown completion status|21
955697|NCT00730847|3147643|P1|Overall Study|Lost to Follow-up|67
955698|NCT00730847|3147643|P1|Overall Study|Withdrawal by Subject|16
955699|NCT00730847|3147643|P1|Overall Study|Protocol Violation|2
955700|NCT00730847|3147643|P1|Overall Study|Adverse Event|1
955701|NCT00730756|3147652|P2|Overall Study|Withdrew Consent|1
955702|NCT00730756|3147653|P1|Overall Study|Withdrew Consent|0
955703|NCT00730756|3147652|P2|Overall Study|Lost to Follow-up|1
955704|NCT00730756|3147653|P1|Overall Study|Lost to Follow-up|0
955705|NCT00730756|3147652|P2|Overall Study|Protocol Deviation|2
955706|NCT00730756|3147653|P1|Overall Study|Protocol Deviation|1
955707|NCT00730756|3147652|P2|Overall Study|Lack of Efficacy|1
955708|NCT00730756|3147653|P1|Overall Study|Lack of Efficacy|1
955709|NCT00730756|3147652|P2|Overall Study|Adverse Event|0
955710|NCT00730756|3147653|P1|Overall Study|Adverse Event|2
955711|NCT00730691|3147687|P5|Overall Study|Other|2
955712|NCT00730691|3147688|P4|Overall Study|Other|2
955713|NCT00730691|3147689|P3|Overall Study|Other|1
955714|NCT00730691|3147690|P2|Overall Study|Other|1
955715|NCT00730691|3147691|P1|Overall Study|Other|1
955716|NCT00730691|3147687|P5|Overall Study|Lost to Follow-up|13
955717|NCT00730691|3147688|P4|Overall Study|Lost to Follow-up|15
955718|NCT00730691|3147689|P3|Overall Study|Lost to Follow-up|13
955719|NCT00730691|3147690|P2|Overall Study|Lost to Follow-up|8
955720|NCT00730691|3147691|P1|Overall Study|Lost to Follow-up|11
955721|NCT00730691|3147687|P5|Overall Study|Withdrawal of Consent|3
955722|NCT00730691|3147688|P4|Overall Study|Withdrawal of Consent|6
955723|NCT00730691|3147689|P3|Overall Study|Withdrawal of Consent|3
955724|NCT00730691|3147690|P2|Overall Study|Withdrawal of Consent|9
955725|NCT00730691|3147691|P1|Overall Study|Withdrawal of Consent|7
955726|NCT00730691|3147687|P5|Overall Study|Protocol Deviations|5
955727|NCT00730691|3147688|P4|Overall Study|Protocol Deviations|7
955728|NCT00730691|3147689|P3|Overall Study|Protocol Deviations|3
955729|NCT00730691|3147690|P2|Overall Study|Protocol Deviations|5
955730|NCT00730691|3147691|P1|Overall Study|Protocol Deviations|3
955731|NCT00730691|3147687|P5|Overall Study|Non-compliance with Study Drug|3
955732|NCT00730691|3147688|P4|Overall Study|Non-compliance with Study Drug|3
955733|NCT00730691|3147689|P3|Overall Study|Non-compliance with Study Drug|6
955734|NCT00730691|3147690|P2|Overall Study|Non-compliance with Study Drug|1
955735|NCT00730691|3147691|P1|Overall Study|Non-compliance with Study Drug|6
955736|NCT00730691|3147687|P5|Overall Study|Lack of Efficacy|1
955737|NCT00730691|3147688|P4|Overall Study|Lack of Efficacy|1
955738|NCT00730691|3147689|P3|Overall Study|Lack of Efficacy|2
955739|NCT00730691|3147690|P2|Overall Study|Lack of Efficacy|4
955740|NCT00730691|3147691|P1|Overall Study|Lack of Efficacy|4
955741|NCT00730691|3147687|P5|Overall Study|Adverse Event|23
955742|NCT00730691|3147688|P4|Overall Study|Adverse Event|11
955743|NCT00730691|3147689|P3|Overall Study|Adverse Event|11
955744|NCT00730691|3147690|P2|Overall Study|Adverse Event|8
955745|NCT00730691|3147691|P1|Overall Study|Adverse Event|4
955746|NCT00730639|3147783|P5|Overall Study|Treatment on-going|4
955747|NCT00730639|3147784|P4|Overall Study|Treatment on-going|4
955748|NCT00730639|3147785|P3|Overall Study|Treatment on-going|5
955749|NCT00730639|3147786|P2|Overall Study|Treatment on-going|5
955750|NCT00730639|3147787|P1|Overall Study|Treatment on-going|2
955751|NCT00730639|3147783|P5|Overall Study|Withdrawal by Subject|4
955752|NCT00730639|3147784|P4|Overall Study|Withdrawal by Subject|3
955753|NCT00730639|3147785|P3|Overall Study|Withdrawal by Subject|6
955754|NCT00730639|3147786|P2|Overall Study|Withdrawal by Subject|0
955755|NCT00730639|3147787|P1|Overall Study|Withdrawal by Subject|0
955756|NCT00730639|3147783|P5|Overall Study|Protocol Violation|0
955757|NCT00730639|3147784|P4|Overall Study|Protocol Violation|0
955758|NCT00730639|3147785|P3|Overall Study|Protocol Violation|1
955759|NCT00730639|3147786|P2|Overall Study|Protocol Violation|0
955760|NCT00730639|3147787|P1|Overall Study|Protocol Violation|0
955761|NCT00730639|3147783|P5|Overall Study|non-specified|3
955762|NCT00730639|3147784|P4|Overall Study|non-specified|2
955763|NCT00730639|3147785|P3|Overall Study|non-specified|4
955764|NCT00730639|3147786|P2|Overall Study|non-specified|0
955765|NCT00730639|3147787|P1|Overall Study|non-specified|0
955766|NCT00730639|3147783|P5|Overall Study|Disease Progression|88
955767|NCT00730639|3147784|P4|Overall Study|Disease Progression|32
955768|NCT00730639|3147785|P3|Overall Study|Disease Progression|48
955769|NCT00730639|3147786|P2|Overall Study|Disease Progression|13
955770|NCT00730639|3147787|P1|Overall Study|Disease Progression|12
955771|NCT00730639|3147783|P5|Overall Study|Death|2
955772|NCT00730639|3147784|P4|Overall Study|Death|0
955773|NCT00730639|3147785|P3|Overall Study|Death|0
955774|NCT00730639|3147786|P2|Overall Study|Death|0
955775|NCT00730639|3147787|P1|Overall Study|Death|0
955776|NCT00730639|3147783|P5|Overall Study|Completed Maximum Cycles|6
955777|NCT00730639|3147784|P4|Overall Study|Completed Maximum Cycles|3
955778|NCT00730639|3147785|P3|Overall Study|Completed Maximum Cycles|11
955779|NCT00730639|3147786|P2|Overall Study|Completed Maximum Cycles|0
955780|NCT00730639|3147787|P1|Overall Study|Completed Maximum Cycles|0
955781|NCT00730639|3147783|P5|Overall Study|Complete Response|1
955782|NCT00730639|3147784|P4|Overall Study|Complete Response|2
955783|NCT00730639|3147785|P3|Overall Study|Complete Response|2
955784|NCT00730639|3147786|P2|Overall Study|Complete Response|0
955785|NCT00730639|3147787|P1|Overall Study|Complete Response|0
955786|NCT00730639|3147783|P5|Overall Study|Adverse Event|23
955787|NCT00730639|3147784|P4|Overall Study|Adverse Event|8
955788|NCT00730639|3147785|P3|Overall Study|Adverse Event|9
955789|NCT00730639|3147786|P2|Overall Study|Adverse Event|0
955790|NCT00730639|3147787|P1|Overall Study|Adverse Event|3
955791|NCT00730405|3147864|P5|Overall Study-follow-up Phase|Atrial fibrillation history|0
955792|NCT00730405|3147865|P4|Overall Study-follow-up Phase|Atrial fibrillation history|0
955793|NCT00730405|3147866|P3|Overall Study-follow-up Phase|Atrial fibrillation history|0
955794|NCT00730405|3147867|P2|Overall Study-follow-up Phase|Atrial fibrillation history|0
955795|NCT00730405|3147868|P1|Overall Study-follow-up Phase|Atrial fibrillation history|1
955796|NCT00730405|3147864|P5|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
955797|NCT00730405|3147865|P4|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1
955798|NCT00730405|3147866|P3|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
955799|NCT00730405|3147867|P2|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
955800|NCT00730405|3147868|P1|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
955801|NCT00730405|3147864|P5|Overall Study-follow-up Phase|Other Protocol violation|0
955802|NCT00730405|3147865|P4|Overall Study-follow-up Phase|Other Protocol violation|0
955803|NCT00730405|3147866|P3|Overall Study-follow-up Phase|Other Protocol violation|1
955804|NCT00730405|3147867|P2|Overall Study-follow-up Phase|Other Protocol violation|0
955805|NCT00730405|3147868|P1|Overall Study-follow-up Phase|Other Protocol violation|0
955806|NCT00730405|3147864|P5|Overall Study-follow-up Phase|Mis-randomized|0
955807|NCT00730405|3147865|P4|Overall Study-follow-up Phase|Mis-randomized|0
955808|NCT00730405|3147866|P3|Overall Study-follow-up Phase|Mis-randomized|0
955809|NCT00730405|3147867|P2|Overall Study-follow-up Phase|Mis-randomized|1
955810|NCT00730405|3147868|P1|Overall Study-follow-up Phase|Mis-randomized|0
955811|NCT00730405|3147864|P5|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
955812|NCT00730405|3147865|P4|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
955813|NCT00730405|3147866|P3|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1
955814|NCT00730405|3147867|P2|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
955815|NCT00730405|3147868|P1|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
955816|NCT00730405|3147864|P5|Overall Study-follow-up Phase|Use an exclusionary medication|1
955817|NCT00730405|3147865|P4|Overall Study-follow-up Phase|Use an exclusionary medication|0
955818|NCT00730405|3147866|P3|Overall Study-follow-up Phase|Use an exclusionary medication|0
955819|NCT00730405|3147867|P2|Overall Study-follow-up Phase|Use an exclusionary medication|0
955820|NCT00730405|3147868|P1|Overall Study-follow-up Phase|Use an exclusionary medication|0
955821|NCT00730405|3147864|P5|Overall Study-follow-up Phase|Missing|0
955822|NCT00730405|3147865|P4|Overall Study-follow-up Phase|Missing|0
955823|NCT00730405|3147866|P3|Overall Study-follow-up Phase|Missing|2
955824|NCT00730405|3147867|P2|Overall Study-follow-up Phase|Missing|0
955825|NCT00730405|3147868|P1|Overall Study-follow-up Phase|Missing|0
955826|NCT00730405|3147864|P5|Overall Study-follow-up Phase|Non-compliance|0
955827|NCT00730405|3147865|P4|Overall Study-follow-up Phase|Non-compliance|0
955828|NCT00730405|3147866|P3|Overall Study-follow-up Phase|Non-compliance|2
955829|NCT00730405|3147867|P2|Overall Study-follow-up Phase|Non-compliance|0
955830|NCT00730405|3147868|P1|Overall Study-follow-up Phase|Non-compliance|1
955831|NCT00730405|3147864|P5|Overall Study-follow-up Phase|Use of restricted medication|0
955832|NCT00730405|3147865|P4|Overall Study-follow-up Phase|Use of restricted medication|0
955833|NCT00730405|3147866|P3|Overall Study-follow-up Phase|Use of restricted medication|0
955834|NCT00730405|3147867|P2|Overall Study-follow-up Phase|Use of restricted medication|1
955835|NCT00730405|3147868|P1|Overall Study-follow-up Phase|Use of restricted medication|0
955836|NCT00730405|3147864|P5|Overall Study-follow-up Phase|Declined to continue with follow-up|0
955837|NCT00730405|3147865|P4|Overall Study-follow-up Phase|Declined to continue with follow-up|0
955838|NCT00730405|3147866|P3|Overall Study-follow-up Phase|Declined to continue with follow-up|0
955839|NCT00730405|3147867|P2|Overall Study-follow-up Phase|Declined to continue with follow-up|1
955840|NCT00730405|3147868|P1|Overall Study-follow-up Phase|Declined to continue with follow-up|1
955841|NCT00730405|3147864|P5|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
955842|NCT00730405|3147865|P4|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
955843|NCT00730405|3147866|P3|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
955844|NCT00730405|3147867|P2|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
955845|NCT00730405|3147868|P1|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
955846|NCT00730405|3147864|P5|Overall Study-follow-up Phase|Refused follow-up due to AE|0
955847|NCT00730405|3147865|P4|Overall Study-follow-up Phase|Refused follow-up due to AE|1
955848|NCT00730405|3147866|P3|Overall Study-follow-up Phase|Refused follow-up due to AE|0
955849|NCT00730405|3147867|P2|Overall Study-follow-up Phase|Refused follow-up due to AE|0
955850|NCT00730405|3147868|P1|Overall Study-follow-up Phase|Refused follow-up due to AE|0
955851|NCT00730405|3147864|P5|Overall Study-follow-up Phase|Prohibited concomitant medication|0
955852|NCT00730405|3147865|P4|Overall Study-follow-up Phase|Prohibited concomitant medication|0
955853|NCT00730405|3147866|P3|Overall Study-follow-up Phase|Prohibited concomitant medication|0
955854|NCT00730405|3147867|P2|Overall Study-follow-up Phase|Prohibited concomitant medication|0
955855|NCT00730405|3147868|P1|Overall Study-follow-up Phase|Prohibited concomitant medication|1
955856|NCT00730405|3147864|P5|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1
955857|NCT00730405|3147865|P4|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
955858|NCT00730405|3147866|P3|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
955859|NCT00730405|3147867|P2|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
955860|NCT00730405|3147868|P1|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
955861|NCT00730405|3147864|P5|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
955862|NCT00730405|3147865|P4|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
955863|NCT00730405|3147866|P3|Overall Study-follow-up Phase|Participant meets exclusion criteria|1
955937|NCT00730405|3147865|P4|Overall Study-Treatment Phase|Misrandomized|0
955864|NCT00730405|3147867|P2|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
955865|NCT00730405|3147868|P1|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
955866|NCT00730405|3147864|P5|Overall Study-follow-up Phase|Non-compliance with study treatment|0
955867|NCT00730405|3147865|P4|Overall Study-follow-up Phase|Non-compliance with study treatment|0
955868|NCT00730405|3147866|P3|Overall Study-follow-up Phase|Non-compliance with study treatment|1
955869|NCT00730405|3147867|P2|Overall Study-follow-up Phase|Non-compliance with study treatment|0
955870|NCT00730405|3147868|P1|Overall Study-follow-up Phase|Non-compliance with study treatment|0
955871|NCT00730405|3147864|P5|Overall Study-follow-up Phase|Did not met eligibility|0
955872|NCT00730405|3147865|P4|Overall Study-follow-up Phase|Did not met eligibility|0
955873|NCT00730405|3147866|P3|Overall Study-follow-up Phase|Did not met eligibility|1
955874|NCT00730405|3147867|P2|Overall Study-follow-up Phase|Did not met eligibility|0
955875|NCT00730405|3147868|P1|Overall Study-follow-up Phase|Did not met eligibility|0
955876|NCT00730405|3147864|P5|Overall Study-follow-up Phase|Change of location|0
955877|NCT00730405|3147865|P4|Overall Study-follow-up Phase|Change of location|1
955878|NCT00730405|3147866|P3|Overall Study-follow-up Phase|Change of location|0
955879|NCT00730405|3147867|P2|Overall Study-follow-up Phase|Change of location|1
955880|NCT00730405|3147868|P1|Overall Study-follow-up Phase|Change of location|1
955881|NCT00730405|3147864|P5|Overall Study-follow-up Phase|Death|0
955882|NCT00730405|3147865|P4|Overall Study-follow-up Phase|Death|1
955883|NCT00730405|3147866|P3|Overall Study-follow-up Phase|Death|0
955884|NCT00730405|3147867|P2|Overall Study-follow-up Phase|Death|1
955885|NCT00730405|3147868|P1|Overall Study-follow-up Phase|Death|0
955886|NCT00730405|3147864|P5|Overall Study-follow-up Phase|Withdrawal by Subject|10
955887|NCT00730405|3147865|P4|Overall Study-follow-up Phase|Withdrawal by Subject|6
955888|NCT00730405|3147866|P3|Overall Study-follow-up Phase|Withdrawal by Subject|3
955889|NCT00730405|3147867|P2|Overall Study-follow-up Phase|Withdrawal by Subject|3
955890|NCT00730405|3147868|P1|Overall Study-follow-up Phase|Withdrawal by Subject|7
955891|NCT00730405|3147864|P5|Overall Study-follow-up Phase|Lost to Follow-up|6
955892|NCT00730405|3147865|P4|Overall Study-follow-up Phase|Lost to Follow-up|4
955893|NCT00730405|3147866|P3|Overall Study-follow-up Phase|Lost to Follow-up|8
955894|NCT00730405|3147867|P2|Overall Study-follow-up Phase|Lost to Follow-up|6
955895|NCT00730405|3147868|P1|Overall Study-follow-up Phase|Lost to Follow-up|7
955896|NCT00730405|3147864|P5|Overall Study-follow-up Phase|Adverse Event|4
955897|NCT00730405|3147865|P4|Overall Study-follow-up Phase|Adverse Event|3
955898|NCT00730405|3147866|P3|Overall Study-follow-up Phase|Adverse Event|2
955899|NCT00730405|3147867|P2|Overall Study-follow-up Phase|Adverse Event|6
955900|NCT00730405|3147868|P1|Overall Study-follow-up Phase|Adverse Event|2
955901|NCT00730405|3147864|P5|Overall Study-Treatment Phase|Atrial fibrillation history|0
955902|NCT00730405|3147865|P4|Overall Study-Treatment Phase|Atrial fibrillation history|0
955903|NCT00730405|3147866|P3|Overall Study-Treatment Phase|Atrial fibrillation history|0
955904|NCT00730405|3147867|P2|Overall Study-Treatment Phase|Atrial fibrillation history|0
955905|NCT00730405|3147868|P1|Overall Study-Treatment Phase|Atrial fibrillation history|1
955906|NCT00730405|3147864|P5|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1
955907|NCT00730405|3147865|P4|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
955908|NCT00730405|3147866|P3|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
955909|NCT00730405|3147867|P2|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
955910|NCT00730405|3147868|P1|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
955911|NCT00730405|3147864|P5|Overall Study-Treatment Phase|Pregnancy|0
955912|NCT00730405|3147865|P4|Overall Study-Treatment Phase|Pregnancy|0
955913|NCT00730405|3147866|P3|Overall Study-Treatment Phase|Pregnancy|0
955914|NCT00730405|3147867|P2|Overall Study-Treatment Phase|Pregnancy|1
955915|NCT00730405|3147868|P1|Overall Study-Treatment Phase|Pregnancy|0
955916|NCT00730405|3147864|P5|Overall Study-Treatment Phase|Change of location|0
955917|NCT00730405|3147865|P4|Overall Study-Treatment Phase|Change of location|1
955918|NCT00730405|3147866|P3|Overall Study-Treatment Phase|Change of location|0
955919|NCT00730405|3147867|P2|Overall Study-Treatment Phase|Change of location|0
955920|NCT00730405|3147868|P1|Overall Study-Treatment Phase|Change of location|0
955921|NCT00730405|3147864|P5|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
955922|NCT00730405|3147865|P4|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
955923|NCT00730405|3147866|P3|Overall Study-Treatment Phase|Protocol violation due to eligibility|1
955924|NCT00730405|3147867|P2|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
955925|NCT00730405|3147868|P1|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
955926|NCT00730405|3147864|P5|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
955927|NCT00730405|3147865|P4|Overall Study-Treatment Phase|Due to in-vitro fertilization|1
955928|NCT00730405|3147866|P3|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
955929|NCT00730405|3147867|P2|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
955930|NCT00730405|3147868|P1|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
955931|NCT00730405|3147864|P5|Overall Study-Treatment Phase|Study drug interrupted|0
955932|NCT00730405|3147865|P4|Overall Study-Treatment Phase|Study drug interrupted|0
955933|NCT00730405|3147866|P3|Overall Study-Treatment Phase|Study drug interrupted|0
955934|NCT00730405|3147867|P2|Overall Study-Treatment Phase|Study drug interrupted|1
955935|NCT00730405|3147868|P1|Overall Study-Treatment Phase|Study drug interrupted|0
955936|NCT00730405|3147864|P5|Overall Study-Treatment Phase|Misrandomized|0
955938|NCT00730405|3147866|P3|Overall Study-Treatment Phase|Misrandomized|0
955939|NCT00730405|3147867|P2|Overall Study-Treatment Phase|Misrandomized|1
955940|NCT00730405|3147868|P1|Overall Study-Treatment Phase|Misrandomized|0
955941|NCT00730405|3147864|P5|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
955942|NCT00730405|3147865|P4|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
955943|NCT00730405|3147866|P3|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1
955944|NCT00730405|3147867|P2|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
955945|NCT00730405|3147868|P1|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
955946|NCT00730405|3147864|P5|Overall Study-Treatment Phase|Use of prohibited medication|2
955947|NCT00730405|3147865|P4|Overall Study-Treatment Phase|Use of prohibited medication|0
955948|NCT00730405|3147866|P3|Overall Study-Treatment Phase|Use of prohibited medication|0
955949|NCT00730405|3147867|P2|Overall Study-Treatment Phase|Use of prohibited medication|1
955950|NCT00730405|3147868|P1|Overall Study-Treatment Phase|Use of prohibited medication|0
955951|NCT00730405|3147864|P5|Overall Study-Treatment Phase|Withdrew from study treatment|0
955952|NCT00730405|3147865|P4|Overall Study-Treatment Phase|Withdrew from study treatment|0
955953|NCT00730405|3147866|P3|Overall Study-Treatment Phase|Withdrew from study treatment|0
955954|NCT00730405|3147867|P2|Overall Study-Treatment Phase|Withdrew from study treatment|1
955955|NCT00730405|3147868|P1|Overall Study-Treatment Phase|Withdrew from study treatment|0
955956|NCT00730405|3147864|P5|Overall Study-Treatment Phase|Prohibited concomitant medication|0
955957|NCT00730405|3147865|P4|Overall Study-Treatment Phase|Prohibited concomitant medication|0
955958|NCT00730405|3147866|P3|Overall Study-Treatment Phase|Prohibited concomitant medication|0
955959|NCT00730405|3147867|P2|Overall Study-Treatment Phase|Prohibited concomitant medication|0
955960|NCT00730405|3147868|P1|Overall Study-Treatment Phase|Prohibited concomitant medication|1
955961|NCT00730405|3147864|P5|Overall Study-Treatment Phase|Participant meets exclusion|0
955962|NCT00730405|3147865|P4|Overall Study-Treatment Phase|Participant meets exclusion|0
955963|NCT00730405|3147866|P3|Overall Study-Treatment Phase|Participant meets exclusion|1
955964|NCT00730405|3147867|P2|Overall Study-Treatment Phase|Participant meets exclusion|0
955965|NCT00730405|3147868|P1|Overall Study-Treatment Phase|Participant meets exclusion|0
955966|NCT00730405|3147864|P5|Overall Study-Treatment Phase|Did not met eligibility|0
955967|NCT00730405|3147865|P4|Overall Study-Treatment Phase|Did not met eligibility|0
955968|NCT00730405|3147866|P3|Overall Study-Treatment Phase|Did not met eligibility|1
955969|NCT00730405|3147867|P2|Overall Study-Treatment Phase|Did not met eligibility|0
955970|NCT00730405|3147868|P1|Overall Study-Treatment Phase|Did not met eligibility|0
955971|NCT00730405|3147864|P5|Overall Study-Treatment Phase|Withdrawal by Subject|8
955972|NCT00730405|3147865|P4|Overall Study-Treatment Phase|Withdrawal by Subject|5
955973|NCT00730405|3147866|P3|Overall Study-Treatment Phase|Withdrawal by Subject|2
955974|NCT00730405|3147867|P2|Overall Study-Treatment Phase|Withdrawal by Subject|1
955975|NCT00730405|3147868|P1|Overall Study-Treatment Phase|Withdrawal by Subject|7
955976|NCT00730405|3147864|P5|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
955977|NCT00730405|3147865|P4|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
955978|NCT00730405|3147866|P3|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5
955979|NCT00730405|3147867|P2|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
955980|NCT00730405|3147868|P1|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
955981|NCT00730405|3147864|P5|Overall Study-Treatment Phase|Lost to Follow-up|4
955982|NCT00730405|3147865|P4|Overall Study-Treatment Phase|Lost to Follow-up|4
955983|NCT00730405|3147866|P3|Overall Study-Treatment Phase|Lost to Follow-up|6
955984|NCT00730405|3147867|P2|Overall Study-Treatment Phase|Lost to Follow-up|5
955985|NCT00730405|3147868|P1|Overall Study-Treatment Phase|Lost to Follow-up|4
955986|NCT00730405|3147864|P5|Overall Study-Treatment Phase|Adverse Event|4
955987|NCT00730405|3147865|P4|Overall Study-Treatment Phase|Adverse Event|8
955988|NCT00730405|3147866|P3|Overall Study-Treatment Phase|Adverse Event|4
955989|NCT00730405|3147867|P2|Overall Study-Treatment Phase|Adverse Event|10
955990|NCT00730405|3147868|P1|Overall Study-Treatment Phase|Adverse Event|5
955991|NCT00730327|3147915|P2|Overall Study|Subject withdrew (reason not specified)|7
955992|NCT00730327|3147916|P1|Overall Study|Subject withdrew (reason not specified)|2
955993|NCT00730327|3147915|P2|Overall Study|Withdrawal by Subject|13
955994|NCT00730327|3147916|P1|Overall Study|Withdrawal by Subject|3
955995|NCT00730327|3147915|P2|Overall Study|Adverse Event|1
955996|NCT00730327|3147916|P1|Overall Study|Adverse Event|8
955997|NCT00730327|3147915|P2|Overall Study|Lost to Follow-up|16
955998|NCT00730327|3147916|P1|Overall Study|Lost to Follow-up|14
955999|NCT00730275|3147941|P4|Overall Study|Withdrawal by Subject|1
956000|NCT00730275|3147942|P3|Overall Study|Withdrawal by Subject|0
956001|NCT00730275|3147943|P2|Overall Study|Withdrawal by Subject|0
956002|NCT00730275|3147944|P1|Overall Study|Withdrawal by Subject|0
956003|NCT00730236|3147970|P1|Overall Study|Non-compliance|1
956004|NCT00730236|3147970|P1|Overall Study|Withdrawal by Subject|1
956005|NCT00730236|3147970|P1|Overall Study|Adverse Event|4
956006|NCT00730171|3147985|P1|Overall Study|Not Specified|61
956007|NCT00730171|3147985|P1|Overall Study|Insufficient Therapeutic Response|141
956008|NCT00730171|3147985|P1|Overall Study|Lost to Follow-up|121
956009|NCT00730171|3147985|P1|Overall Study|Withdrawal by Subject|202
956010|NCT00730171|3147985|P1|Overall Study|Protocol Violation|48
956011|NCT00730171|3147985|P1|Overall Study|Adverse Event|193
956012|NCT00730171|3147985|P1|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5
956013|NCT00730132|3147993|P1|Overall Study|Death|1
956014|NCT00730132|3147993|P1|Overall Study|Protocol Violation|154
956015|NCT00730041|3148011|P2|Overall Study|Lost to Follow-up|2
956016|NCT00730041|3148012|P1|Overall Study|Lost to Follow-up|0
956017|NCT00730028|3148035|P5|Overall Study|Randomization Error|2
956018|NCT00730028|3148036|P4|Overall Study|Randomization Error|0
956019|NCT00730028|3148037|P3|Overall Study|Randomization Error|0
956020|NCT00730028|3148038|P2|Overall Study|Randomization Error|0
956021|NCT00730028|3148039|P1|Overall Study|Randomization Error|1
956022|NCT00730028|3148035|P5|Overall Study|Treatment Failure|1
956023|NCT00730028|3148036|P4|Overall Study|Treatment Failure|0
956024|NCT00730028|3148037|P3|Overall Study|Treatment Failure|0
956025|NCT00730028|3148038|P2|Overall Study|Treatment Failure|5
956026|NCT00730028|3148039|P1|Overall Study|Treatment Failure|5
956027|NCT00730028|3148035|P5|Overall Study|Physician Decision|2
956028|NCT00730028|3148036|P4|Overall Study|Physician Decision|3
956029|NCT00730028|3148037|P3|Overall Study|Physician Decision|2
956030|NCT00730028|3148038|P2|Overall Study|Physician Decision|3
956031|NCT00730028|3148039|P1|Overall Study|Physician Decision|3
956032|NCT00730028|3148035|P5|Overall Study|Withdrawal by Subject|9
956033|NCT00730028|3148036|P4|Overall Study|Withdrawal by Subject|5
956034|NCT00730028|3148037|P3|Overall Study|Withdrawal by Subject|4
956035|NCT00730028|3148038|P2|Overall Study|Withdrawal by Subject|5
956036|NCT00730028|3148039|P1|Overall Study|Withdrawal by Subject|9
956037|NCT00730028|3148035|P5|Overall Study|Protocol Violation|0
956038|NCT00730028|3148036|P4|Overall Study|Protocol Violation|2
956039|NCT00730028|3148037|P3|Overall Study|Protocol Violation|1
956040|NCT00730028|3148038|P2|Overall Study|Protocol Violation|1
956041|NCT00730028|3148039|P1|Overall Study|Protocol Violation|6
956042|NCT00730028|3148035|P5|Overall Study|Lost to Follow-up|25
956043|NCT00730028|3148036|P4|Overall Study|Lost to Follow-up|26
956044|NCT00730028|3148037|P3|Overall Study|Lost to Follow-up|22
956045|NCT00730028|3148038|P2|Overall Study|Lost to Follow-up|26
956046|NCT00730028|3148039|P1|Overall Study|Lost to Follow-up|13
956047|NCT00730028|3148035|P5|Overall Study|Adverse Event|43
956048|NCT00730028|3148036|P4|Overall Study|Adverse Event|20
956049|NCT00730028|3148037|P3|Overall Study|Adverse Event|16
956050|NCT00730028|3148038|P2|Overall Study|Adverse Event|26
956051|NCT00730028|3148039|P1|Overall Study|Adverse Event|23
956052|NCT00730015|3148089|P3|Overall Study|Other Reason|1
956053|NCT00730015|3148090|P2|Overall Study|Other Reason|0
956054|NCT00730015|3148091|P1|Overall Study|Other Reason|1
956055|NCT00730015|3148089|P3|Overall Study|Lack of Efficacy|8
956056|NCT00730015|3148090|P2|Overall Study|Lack of Efficacy|2
956057|NCT00730015|3148091|P1|Overall Study|Lack of Efficacy|1
956058|NCT00730015|3148089|P3|Overall Study|Lost to Follow-up|3
956059|NCT00730015|3148090|P2|Overall Study|Lost to Follow-up|10
956060|NCT00730015|3148091|P1|Overall Study|Lost to Follow-up|4
956061|NCT00730015|3148089|P3|Overall Study|Withdrawal by Subject|8
956062|NCT00730015|3148090|P2|Overall Study|Withdrawal by Subject|12
956063|NCT00730015|3148091|P1|Overall Study|Withdrawal by Subject|12
956064|NCT00730015|3148089|P3|Overall Study|Protocol Violation|4
956065|NCT00730015|3148090|P2|Overall Study|Protocol Violation|6
956066|NCT00730015|3148091|P1|Overall Study|Protocol Violation|2
956067|NCT00730015|3148089|P3|Overall Study|Adverse Event|8
956068|NCT00730015|3148090|P2|Overall Study|Adverse Event|10
956069|NCT00730015|3148091|P1|Overall Study|Adverse Event|11
956070|NCT00729937|3148131|P6|Overall Study|Incarcerated|0
956071|NCT00729937|3148132|P5|Overall Study|Incarcerated|0
956072|NCT00729937|3148133|P4|Overall Study|Incarcerated|1
956073|NCT00729937|3148134|P3|Overall Study|Incarcerated|1
956074|NCT00729937|3148135|P2|Overall Study|Incarcerated|2
956075|NCT00729937|3148136|P1|Overall Study|Incarcerated|0
956076|NCT00729937|3148131|P6|Overall Study|Did not meet eligibility criteria|0
956077|NCT00729937|3148132|P5|Overall Study|Did not meet eligibility criteria|0
956078|NCT00729937|3148133|P4|Overall Study|Did not meet eligibility criteria|0
956079|NCT00729937|3148134|P3|Overall Study|Did not meet eligibility criteria|0
956080|NCT00729937|3148135|P2|Overall Study|Did not meet eligibility criteria|1
956081|NCT00729937|3148136|P1|Overall Study|Did not meet eligibility criteria|2
956082|NCT00729937|3148131|P6|Overall Study|Randomized but not treated|3
956083|NCT00729937|3148132|P5|Overall Study|Randomized but not treated|1
956084|NCT00729937|3148133|P4|Overall Study|Randomized but not treated|0
956085|NCT00729937|3148134|P3|Overall Study|Randomized but not treated|1
956086|NCT00729937|3148135|P2|Overall Study|Randomized but not treated|6
956087|NCT00729937|3148136|P1|Overall Study|Randomized but not treated|12
956088|NCT00729937|3148131|P6|Overall Study|Withdrawal by Subject|2
956089|NCT00729937|3148132|P5|Overall Study|Withdrawal by Subject|4
956090|NCT00729937|3148133|P4|Overall Study|Withdrawal by Subject|0
956091|NCT00729937|3148134|P3|Overall Study|Withdrawal by Subject|6
956092|NCT00729937|3148135|P2|Overall Study|Withdrawal by Subject|5
956093|NCT00729937|3148136|P1|Overall Study|Withdrawal by Subject|3
956094|NCT00729937|3148131|P6|Overall Study|Death|1
956095|NCT00729937|3148132|P5|Overall Study|Death|0
956096|NCT00729937|3148133|P4|Overall Study|Death|0
956097|NCT00729937|3148134|P3|Overall Study|Death|1
956098|NCT00729937|3148135|P2|Overall Study|Death|0
956099|NCT00729937|3148136|P1|Overall Study|Death|1
956100|NCT00729937|3148131|P6|Overall Study|Physician Decision|8
956101|NCT00729937|3148132|P5|Overall Study|Physician Decision|5
956102|NCT00729937|3148133|P4|Overall Study|Physician Decision|0
956103|NCT00729937|3148134|P3|Overall Study|Physician Decision|2
956104|NCT00729937|3148135|P2|Overall Study|Physician Decision|16
956105|NCT00729937|3148136|P1|Overall Study|Physician Decision|7
956106|NCT00729937|3148131|P6|Overall Study|Lost to Follow-up|23
956107|NCT00729937|3148132|P5|Overall Study|Lost to Follow-up|18
956108|NCT00729937|3148133|P4|Overall Study|Lost to Follow-up|33
956109|NCT00729937|3148134|P3|Overall Study|Lost to Follow-up|18
956110|NCT00729937|3148135|P2|Overall Study|Lost to Follow-up|58
956111|NCT00729937|3148136|P1|Overall Study|Lost to Follow-up|49
956112|NCT00729859|3148340|P3|Overall Study|Withdrawal by Subject|0
956113|NCT00729859|3148341|P2|Overall Study|Withdrawal by Subject|1
956114|NCT00729859|3148342|P1|Overall Study|Withdrawal by Subject|0
956115|NCT00729859|3148340|P3|Overall Study|Adverse Event|0
956116|NCT00729859|3148341|P2|Overall Study|Adverse Event|1
956117|NCT00729859|3148342|P1|Overall Study|Adverse Event|0
956118|NCT00729833|3148386|P4|Overall Study|Unspecified Reasons|1
956119|NCT00729833|3148387|P3|Overall Study|Unspecified Reasons|5
956120|NCT00729833|3148388|P2|Overall Study|Unspecified Reasons|5
956121|NCT00729833|3148389|P1|Overall Study|Unspecified Reasons|11
956122|NCT00729833|3148386|P4|Overall Study|Withdrawal by Subject|0
956123|NCT00729833|3148387|P3|Overall Study|Withdrawal by Subject|3
956124|NCT00729833|3148388|P2|Overall Study|Withdrawal by Subject|1
956125|NCT00729833|3148389|P1|Overall Study|Withdrawal by Subject|3
956126|NCT00729833|3148386|P4|Overall Study|Lost to Follow-up|0
956127|NCT00729833|3148387|P3|Overall Study|Lost to Follow-up|0
956128|NCT00729833|3148388|P2|Overall Study|Lost to Follow-up|0
956129|NCT00729833|3148389|P1|Overall Study|Lost to Follow-up|1
956130|NCT00729833|3148386|P4|Overall Study|Study Terminated by Sponsor|0
956131|NCT00729833|3148387|P3|Overall Study|Study Terminated by Sponsor|1
956132|NCT00729833|3148388|P2|Overall Study|Study Terminated by Sponsor|0
956133|NCT00729833|3148389|P1|Overall Study|Study Terminated by Sponsor|0
956134|NCT00729833|3148386|P4|Overall Study|Death|5
956135|NCT00729833|3148387|P3|Overall Study|Death|3
956136|NCT00729833|3148388|P2|Overall Study|Death|1
956137|NCT00729833|3148389|P1|Overall Study|Death|5
956138|NCT00729690|3148441|P3|Overall Study|IT Catheter Malfunction|2
956139|NCT00729690|3148442|P2|Overall Study|IT Catheter Malfunction|2
956140|NCT00729690|3148443|P1|Overall Study|IT Catheter Malfunction|0
956141|NCT00729651|3148473|P2|Overall Study|Subject’s private reason|0
956142|NCT00729651|3148474|P1|Overall Study|Subject’s private reason|2
956143|NCT00729651|3148473|P2|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4
956144|NCT00729651|3148474|P1|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0
956145|NCT00729651|3148473|P2|Overall Study|Adverse Event|3
956146|NCT00729651|3148474|P1|Overall Study|Adverse Event|7
956147|NCT00729651|3148473|P2|Overall Study|Protocol Violation|1
956148|NCT00729651|3148474|P1|Overall Study|Protocol Violation|0
956149|NCT00729651|3148473|P2|Overall Study|Lost to Follow-up|4
956150|NCT00729651|3148474|P1|Overall Study|Lost to Follow-up|5
956151|NCT00729651|3148473|P2|Overall Study|Withdrawal by Subject|6
956152|NCT00729651|3148474|P1|Overall Study|Withdrawal by Subject|5
956153|NCT00729612|3148486|P1|Overall Study|Non evaluable for response|10
956154|NCT00729586|3148495|P2|Overall Study|never treated|0
956155|NCT00729586|3148496|P1|Overall Study|never treated|1
956156|NCT00729586|3148495|P2|Overall Study|Ineligible|1
956157|NCT00729586|3148496|P1|Overall Study|Ineligible|0
956158|NCT00729560|3148509|P1|Overall Study|Withdrawal by Subject|3
956159|NCT00729469|3148535|P2|Overall Study|Other-Not mentioned|4
956160|NCT00729469|3148536|P1|Overall Study|Other-Not mentioned|9
956161|NCT00729469|3148535|P2|Overall Study|Withdrawal by Subject|8
956162|NCT00729469|3148536|P1|Overall Study|Withdrawal by Subject|19
956163|NCT00729469|3148535|P2|Overall Study|Protocol Violation|1
956164|NCT00729469|3148536|P1|Overall Study|Protocol Violation|2
956165|NCT00729469|3148535|P2|Overall Study|Lost to Follow-up|9
956166|NCT00729469|3148536|P1|Overall Study|Lost to Follow-up|9
956167|NCT00729469|3148535|P2|Overall Study|Adverse Event|25
956168|NCT00729469|3148536|P1|Overall Study|Adverse Event|14
956169|NCT00729378|3148589|P2|36-months|Lost to Follow-up|6
956170|NCT00729378|3148590|P1|36-months|Lost to Follow-up|15
956171|NCT00729378|3148589|P2|24-months|Lost to Follow-up|51
956172|NCT00729378|3148590|P1|24-months|Lost to Follow-up|72
956173|NCT00729378|3148589|P2|12-months|Lost to Follow-up|65
956174|NCT00729378|3148590|P1|12-months|Lost to Follow-up|100
956175|NCT00729378|3148589|P2|Baseline|Withdrawal by Subject|59
956176|NCT00729378|3148590|P1|Baseline|Withdrawal by Subject|66
956177|NCT00729378|3148589|P2|Baseline|Did not complete study measurements|33
956178|NCT00729378|3148590|P1|Baseline|Did not complete study measurements|72
956179|NCT00729365|3148789|P3|Overall Study|Physician Decision|7
956180|NCT00729365|3148790|P2|Overall Study|Physician Decision|6
956181|NCT00729365|3148791|P1|Overall Study|Physician Decision|33
956182|NCT00729326|3148804|P2|Overall Study|Sponsor Decision|2
956183|NCT00729326|3148805|P1|Overall Study|Sponsor Decision|1
956184|NCT00729326|3148804|P2|Overall Study|Subject Decision|4
956185|NCT00729326|3148805|P1|Overall Study|Subject Decision|4
956186|NCT00729326|3148804|P2|Overall Study|Protocol Violation|2
956187|NCT00729326|3148805|P1|Overall Study|Protocol Violation|3
956188|NCT00729326|3148804|P2|Overall Study|Physician Decision|1
956189|NCT00729326|3148805|P1|Overall Study|Physician Decision|0
956190|NCT00729326|3148804|P2|Overall Study|Lost to Follow-up|0
956191|NCT00729326|3148805|P1|Overall Study|Lost to Follow-up|2
956192|NCT00729248|3148847|P1|Overall Study|Physician Decision|2
956193|NCT00729183|3148854|P2|Overall Study|Withdrawal by Subject|7
956194|NCT00729183|3148855|P1|Overall Study|Withdrawal by Subject|9
956195|NCT00729183|3148854|P2|Overall Study|Protocol Violation|0
956196|NCT00729183|3148855|P1|Overall Study|Protocol Violation|1
956197|NCT00729183|3148854|P2|Overall Study|Physician Decision|1
956198|NCT00729183|3148855|P1|Overall Study|Physician Decision|1
956199|NCT00729183|3148854|P2|Overall Study|Lost to Follow-up|1
956200|NCT00729183|3148855|P1|Overall Study|Lost to Follow-up|3
956201|NCT00729183|3148854|P2|Overall Study|Lack of Efficacy|1
956202|NCT00729183|3148855|P1|Overall Study|Lack of Efficacy|0
956203|NCT00729183|3148854|P2|Overall Study|Adverse Event|5
956204|NCT00729183|3148855|P1|Overall Study|Adverse Event|11
956205|NCT00729157|3148887|P1|Overall Study|Withdrawal by Subject|1
956206|NCT00728988|3148930|P2|Overall Study|Withdrawal by Subject|6
956207|NCT00728988|3148931|P1|Overall Study|Withdrawal by Subject|2
956208|NCT00728988|3148930|P2|Overall Study|Other|77
956209|NCT00728988|3148931|P1|Overall Study|Other|85
956210|NCT00728988|3148930|P2|Overall Study|Adverse Event|2
956211|NCT00728988|3148931|P1|Overall Study|Adverse Event|3
956212|NCT00728988|3148930|P2|Overall Study|Death|1
956213|NCT00728988|3148931|P1|Overall Study|Death|1
956214|NCT00728988|3148930|P2|Overall Study|Not Treated|2
956215|NCT00728988|3148931|P1|Overall Study|Not Treated|2
956216|NCT00728962|3148949|P1|Two Year Post Placement Follow-up|Lost to Follow-up|3
956217|NCT00728962|3148949|P1|Permanent Prosthesis Placement|Adverse Event|3
956218|NCT00728962|3148949|P1|Implant Placement Surgery|Protocol Violation|1
956219|NCT00728962|3148949|P1|Implant Placement Surgery|Lost to Follow-up|1
956220|NCT00728962|3148949|P1|Implant Placement Surgery|Adverse Event|8
956221|NCT00728949|3148955|P2|Overall Study|On treatment at cutoff date|0
956222|NCT00728949|3148956|P1|Overall Study|On treatment at cutoff date|1
956223|NCT00728949|3148955|P2|Overall Study|Abnormal Lab Results|2
956224|NCT00728949|3148956|P1|Overall Study|Abnormal Lab Results|0
956225|NCT00728949|3148955|P2|Overall Study|Withdrawal by Subject|2
956226|NCT00728949|3148956|P1|Overall Study|Withdrawal by Subject|2
956227|NCT00728949|3148955|P2|Overall Study|Adverse Event|0
956228|NCT00728949|3148956|P1|Overall Study|Adverse Event|8
956229|NCT00728884|3148991|P1|One Year Post Placement Follow-up|Lost to Follow-up|4
956230|NCT00728884|3148991|P1|Permanent Prosthesis Placement|Lost to Follow-up|13
956231|NCT00728754|3149027|P2|One Year Post Placement Follow-up|Adverse Event|0
956232|NCT00728754|3149028|P1|One Year Post Placement Follow-up|Adverse Event|1
956233|NCT00728754|3149027|P2|Permanent Prosthesis Placement|Lost to Follow-up|3
956234|NCT00728754|3149028|P1|Permanent Prosthesis Placement|Lost to Follow-up|3
956235|NCT00728754|3149027|P2|Permanent Prosthesis Placement|Adverse Event|1
956236|NCT00728754|3149028|P1|Permanent Prosthesis Placement|Adverse Event|1
956237|NCT00728689|3149057|P2|Washout Period (Days 4 - 10)|Death in family|0
956238|NCT00728689|3149058|P1|Washout Period (Days 4 - 10)|Death in family|1
956239|NCT00728494|3149087|P2|Overall Study|No data available|1
956240|NCT00728494|3149088|P1|Overall Study|No data available|0
956241|NCT00728494|3149087|P2|Overall Study|Lack of Efficacy|4
956242|NCT00728494|3149088|P1|Overall Study|Lack of Efficacy|2
956243|NCT00728494|3149087|P2|Overall Study|Withdrawal by Subject|2
956244|NCT00728494|3149088|P1|Overall Study|Withdrawal by Subject|0
956245|NCT00728494|3149087|P2|Overall Study|Adverse Event|0
956246|NCT00728494|3149088|P1|Overall Study|Adverse Event|7
956247|NCT00728481|3149106|P2|Overall Study|Incorrectly assigned to opposite arm|0
956248|NCT00728481|3149107|P1|Overall Study|Incorrectly assigned to opposite arm|1
956249|NCT00728481|3149106|P2|Overall Study|Study medication non-compliance|2
956250|NCT00728481|3149107|P1|Overall Study|Study medication non-compliance|0
956251|NCT00728481|3149106|P2|Overall Study|Adverse Event|1
956252|NCT00728481|3149107|P1|Overall Study|Adverse Event|0
956253|NCT00728481|3149106|P2|Overall Study|Withdrawal by Subject|1
956254|NCT00728481|3149107|P1|Overall Study|Withdrawal by Subject|0
956255|NCT00728468|3149123|P1|Overall Study|Study terminated by sponsor|1
956256|NCT00728468|3149123|P1|Overall Study|Objective progression or relapse|9
956257|NCT00728468|3149123|P1|Overall Study|Protocol Violation|4
956258|NCT00728468|3149123|P1|Overall Study|Death|1
956259|NCT00728468|3149123|P1|Overall Study|Enrolled but not treated|1
956260|NCT00728416|3149147|P2|Overall Study|Withdrawal by Subject|0
956261|NCT00728416|3149148|P1|Overall Study|Withdrawal by Subject|1
956262|NCT00728416|3149147|P2|Overall Study|Treatment Failure|1
956263|NCT00728416|3149148|P1|Overall Study|Treatment Failure|0
956264|NCT00728416|3149147|P2|Overall Study|Adverse Event|1
956265|NCT00728416|3149148|P1|Overall Study|Adverse Event|1
956266|NCT00728182|3149164|P2|Overall Study|Protocol Noncompliance|1
956267|NCT00728182|3149165|P1|Overall Study|Protocol Noncompliance|0
956268|NCT00728182|3149164|P2|Overall Study|Death|2
956269|NCT00728182|3149165|P1|Overall Study|Death|0
956270|NCT00728182|3149164|P2|Overall Study|Lost to Follow-up|0
956271|NCT00728182|3149165|P1|Overall Study|Lost to Follow-up|2
956272|NCT00728182|3149164|P2|Overall Study|Adverse Event|0
956273|NCT00728182|3149165|P1|Overall Study|Adverse Event|1
956274|NCT00728130|3149193|P1|Overall Study|Physician Decision|1
956275|NCT00728130|3149193|P1|Overall Study|Paperwork not completed in time|1
956276|NCT00728130|3149193|P1|Overall Study|Withdrawal by Subject|1
956277|NCT00727961|3149198|P1|Overall Study|Progression|30
956278|NCT00727961|3149198|P1|Overall Study|Patient's refusal|2
956279|NCT00727961|3149198|P1|Overall Study|Adverse Event|4
956280|NCT00727961|3149198|P1|Overall Study|Lost to Follow-up|1
956281|NCT00727909|3149208|P4|Overall Study|Death|0
956282|NCT00727909|3149209|P3|Overall Study|Death|1
956283|NCT00727909|3149210|P2|Overall Study|Death|0
956284|NCT00727909|3149211|P1|Overall Study|Death|0
956285|NCT00727909|3149208|P4|Overall Study|Withdrawal by Subject|5
956286|NCT00727909|3149209|P3|Overall Study|Withdrawal by Subject|8
956287|NCT00727909|3149210|P2|Overall Study|Withdrawal by Subject|11
956288|NCT00727909|3149211|P1|Overall Study|Withdrawal by Subject|5
956289|NCT00727844|3149308|P4|Initial Randomization|Physician Decision|0
956290|NCT00727844|3149309|P3|Initial Randomization|Physician Decision|0
956291|NCT00727844|3149310|P2|Initial Randomization|Physician Decision|0
956292|NCT00727844|3149311|P1|Initial Randomization|Physician Decision|2
956293|NCT00727714|3149325|P1|Overall Study|Lost to Follow-up|2
956294|NCT00727649|3149335|P2|Second Intervention (4-weeks)|Withdrawal by Subject|2
956295|NCT00727649|3149336|P1|Second Intervention (4-weeks)|Withdrawal by Subject|0
956296|NCT00727649|3149335|P2|Second Intervention (4-weeks)|Lost to Follow-up|1
956297|NCT00727649|3149336|P1|Second Intervention (4-weeks)|Lost to Follow-up|0
956298|NCT00727649|3149335|P2|Second Intervention (4-weeks)|Death|0
956299|NCT00727649|3149336|P1|Second Intervention (4-weeks)|Death|1
956300|NCT00727649|3149335|P2|Wash-out (2-weeks)|Withdrawal by Subject|2
956301|NCT00727649|3149336|P1|Wash-out (2-weeks)|Withdrawal by Subject|1
956302|NCT00727649|3149335|P2|Wash-out (2-weeks)|Lost to Follow-up|1
956303|NCT00727649|3149336|P1|Wash-out (2-weeks)|Lost to Follow-up|3
956304|NCT00727649|3149335|P2|First Intervention (4-weeks)|Withdrawal by Subject|1
956305|NCT00727649|3149336|P1|First Intervention (4-weeks)|Withdrawal by Subject|2
956306|NCT00727649|3149335|P2|First Intervention (4-weeks)|Lost to Follow-up|2
956307|NCT00727649|3149336|P1|First Intervention (4-weeks)|Lost to Follow-up|1
956308|NCT00727571|3149378|P4|Overall Study|Other|0
956309|NCT00727571|3149379|P3|Overall Study|Other|6
956310|NCT00727571|3149380|P2|Overall Study|Other|4
956311|NCT00727571|3149381|P1|Overall Study|Other|0
956312|NCT00727571|3149378|P4|Overall Study|AE not leading to hospitalization|0
956313|NCT00727571|3149379|P3|Overall Study|AE not leading to hospitalization|2
956314|NCT00727571|3149380|P2|Overall Study|AE not leading to hospitalization|0
956315|NCT00727571|3149381|P1|Overall Study|AE not leading to hospitalization|0
956316|NCT00727571|3149378|P4|Overall Study|Hospitalization|1
956317|NCT00727571|3149379|P3|Overall Study|Hospitalization|0
956318|NCT00727571|3149380|P2|Overall Study|Hospitalization|1
956319|NCT00727571|3149381|P1|Overall Study|Hospitalization|0
956320|NCT00727571|3149378|P4|Overall Study|Dismissed from nursing home|0
956321|NCT00727571|3149379|P3|Overall Study|Dismissed from nursing home|5
956322|NCT00727571|3149380|P2|Overall Study|Dismissed from nursing home|9
956323|NCT00727571|3149381|P1|Overall Study|Dismissed from nursing home|0
956324|NCT00727571|3149378|P4|Overall Study|Subject Non Compliance|4
956325|NCT00727571|3149379|P3|Overall Study|Subject Non Compliance|0
956326|NCT00727571|3149380|P2|Overall Study|Subject Non Compliance|6
956327|NCT00727571|3149381|P1|Overall Study|Subject Non Compliance|0
956328|NCT00727571|3149378|P4|Overall Study|Withdrawal by Subject|0
956329|NCT00727571|3149379|P3|Overall Study|Withdrawal by Subject|11
956330|NCT00727571|3149380|P2|Overall Study|Withdrawal by Subject|10
956331|NCT00727571|3149381|P1|Overall Study|Withdrawal by Subject|0
956332|NCT00727571|3149378|P4|Overall Study|Physician Decision|0
956333|NCT00727571|3149379|P3|Overall Study|Physician Decision|0
956334|NCT00727571|3149380|P2|Overall Study|Physician Decision|5
956335|NCT00727571|3149381|P1|Overall Study|Physician Decision|0
956336|NCT00727571|3149378|P4|Overall Study|Death|1
956337|NCT00727571|3149379|P3|Overall Study|Death|5
956338|NCT00727571|3149380|P2|Overall Study|Death|19
956339|NCT00727571|3149381|P1|Overall Study|Death|0
956340|NCT00727571|3149378|P4|Overall Study|Ineligibility determined|0
956341|NCT00727571|3149379|P3|Overall Study|Ineligibility determined|1
956342|NCT00727571|3149380|P2|Overall Study|Ineligibility determined|1
956343|NCT00727571|3149381|P1|Overall Study|Ineligibility determined|1
956344|NCT00727558|3149408|P2|Overall Study|Lost to Follow-up|0
956345|NCT00727558|3149409|P1|Overall Study|Lost to Follow-up|1
956346|NCT00727558|3149408|P2|Overall Study|Subject unable to return for follow-up|1
956347|NCT00727558|3149409|P1|Overall Study|Subject unable to return for follow-up|1
956348|NCT00727558|3149408|P2|Overall Study|Adverse Event|1
956349|NCT00727558|3149409|P1|Overall Study|Adverse Event|0
956350|NCT00727558|3149408|P2|Overall Study|Lens issue|1
956351|NCT00727558|3149409|P1|Overall Study|Lens issue|0
956352|NCT00727506|3149433|P6|Overall Study|Other reason not described above|1
956353|NCT00727506|3149434|P5|Overall Study|Other reason not described above|1
956354|NCT00727506|3149435|P4|Overall Study|Other reason not described above|4
956355|NCT00727506|3149436|P3|Overall Study|Other reason not described above|1
956356|NCT00727506|3149437|P2|Overall Study|Other reason not described above|0
956357|NCT00727506|3149438|P1|Overall Study|Other reason not described above|0
956358|NCT00727506|3149433|P6|Overall Study|Refused to continue medication|2
956359|NCT00727506|3149434|P5|Overall Study|Refused to continue medication|1
956360|NCT00727506|3149435|P4|Overall Study|Refused to continue medication|3
956361|NCT00727506|3149436|P3|Overall Study|Refused to continue medication|2
956362|NCT00727506|3149437|P2|Overall Study|Refused to continue medication|1
956363|NCT00727506|3149438|P1|Overall Study|Refused to continue medication|0
956364|NCT00727506|3149433|P6|Overall Study|Progressive disease|28
956365|NCT00727506|3149434|P5|Overall Study|Progressive disease|38
956366|NCT00727506|3149435|P4|Overall Study|Progressive disease|28
956367|NCT00727506|3149436|P3|Overall Study|Progressive disease|9
956368|NCT00727506|3149437|P2|Overall Study|Progressive disease|7
956369|NCT00727506|3149438|P1|Overall Study|Progressive disease|4
956370|NCT00727506|3149433|P6|Overall Study|Dose Limiting Toxicity (DLT)|0
956371|NCT00727506|3149434|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
956372|NCT00727506|3149435|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
956373|NCT00727506|3149436|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
956374|NCT00727506|3149437|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
956375|NCT00727506|3149438|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
956376|NCT00727506|3149433|P6|Overall Study|Adverse Event|8
956377|NCT00727506|3149434|P5|Overall Study|Adverse Event|1
956378|NCT00727506|3149435|P4|Overall Study|Adverse Event|4
956379|NCT00727506|3149436|P3|Overall Study|Adverse Event|4
956380|NCT00727506|3149437|P2|Overall Study|Adverse Event|0
956381|NCT00727506|3149438|P1|Overall Study|Adverse Event|0
956382|NCT00727402|3149531|P1|Overall Study|Physician Decision|116
956383|NCT00727311|3149560|P1|Overall Study|Multiple reasons|39
956384|NCT00727311|3149560|P1|Overall Study|not specified|97
956385|NCT00727311|3149560|P1|Overall Study|Withdrawal by Subject|77
956386|NCT00727311|3149560|P1|Overall Study|Lost to Follow-up|73
956387|NCT00727311|3149560|P1|Overall Study|Lack of Efficacy|242
956388|NCT00727311|3149560|P1|Overall Study|Adverse Event|58
956389|NCT00727311|3149560|P1|Overall Study|Missing end of therapy data|205
956390|NCT00727311|3149560|P1|Overall Study|Did not receive drug|316
956391|NCT00727272|3149573|P3|Washout Period B|Withdrawal by Subject|1
956392|NCT00727272|3149574|P2|Washout Period B|Withdrawal by Subject|0
956393|NCT00727272|3149575|P1|Washout Period B|Withdrawal by Subject|0
956394|NCT00727272|3149573|P3|Washout Period A|Adverse Event|1
956395|NCT00727272|3149574|P2|Washout Period A|Adverse Event|0
956396|NCT00727272|3149575|P1|Washout Period A|Adverse Event|0
956397|NCT00727259|3149592|P1|Overall Study|Not all questionnaires completed|1055
956398|NCT00727246|3149601|P4|Overall Study|withdrawn|0
956399|NCT00727246|3149602|P3|Overall Study|withdrawn|1
956400|NCT00727246|3149603|P2|Overall Study|withdrawn|0
956401|NCT00727246|3149604|P1|Overall Study|withdrawn|0
956402|NCT00727246|3149601|P4|Overall Study|incidental finding|1
956403|NCT00727246|3149602|P3|Overall Study|incidental finding|0
956404|NCT00727246|3149603|P2|Overall Study|incidental finding|0
956405|NCT00727246|3149604|P1|Overall Study|incidental finding|0
956406|NCT00727246|3149601|P4|Overall Study|could not complete MRI|1
956407|NCT00727246|3149602|P3|Overall Study|could not complete MRI|0
956408|NCT00727246|3149603|P2|Overall Study|could not complete MRI|1
956409|NCT00727246|3149604|P1|Overall Study|could not complete MRI|0
956410|NCT00727194|3149627|P3|Treatment Period 2|Lack of Efficacy|0
956411|NCT00727194|3149628|P2|Treatment Period 2|Lack of Efficacy|1
956412|NCT00727194|3149629|P1|Treatment Period 2|Lack of Efficacy|0
956413|NCT00727194|3149627|P3|Screening Period|History of thymoma|1
956414|NCT00727194|3149628|P2|Screening Period|History of thymoma|0
956415|NCT00727194|3149629|P1|Screening Period|History of thymoma|0
956416|NCT00727194|3149627|P3|Screening Period|Severe infections|2
956417|NCT00727194|3149628|P2|Screening Period|Severe infections|0
956418|NCT00727194|3149629|P1|Screening Period|Severe infections|0
956419|NCT00727194|3149627|P3|Screening Period|Not stable on concomitant MG therapy|2
956420|NCT00727194|3149628|P2|Screening Period|Not stable on concomitant MG therapy|0
956421|NCT00727194|3149629|P1|Screening Period|Not stable on concomitant MG therapy|0
956422|NCT00727194|3149627|P3|Screening Period|Lacked AChR antibodies|5
956423|NCT00727194|3149628|P2|Screening Period|Lacked AChR antibodies|0
956424|NCT00727194|3149629|P1|Screening Period|Lacked AChR antibodies|0
956425|NCT00727194|3149627|P3|Screening Period|Low QMG scores|6
956426|NCT00727194|3149628|P2|Screening Period|Low QMG scores|0
956427|NCT00727194|3149629|P1|Screening Period|Low QMG scores|0
956428|NCT00727025|3149701|P1|Overall Study|Physician Decision|23
956429|NCT00726999|3149713|P2|Overall Study|Protocol Violation|0
956430|NCT00726999|3149714|P1|Overall Study|Protocol Violation|1
956431|NCT00726999|3149713|P2|Overall Study|Withdrawal by Subject|0
956432|NCT00726999|3149714|P1|Overall Study|Withdrawal by Subject|2
956433|NCT00726999|3149713|P2|Overall Study|Physician Decision|1
956434|NCT00726999|3149714|P1|Overall Study|Physician Decision|0
956435|NCT00726986|3149724|P1|Maintenance Phase|Lack of Efficacy|2
956436|NCT00726986|3149724|P1|Maintenance Phase|Adverse Event|1
956437|NCT00726986|3149724|P1|Induction Phase|Secondary Disease|2
956438|NCT00726986|3149724|P1|Induction Phase|Lack of Efficacy|5
956439|NCT00726986|3149724|P1|Induction Phase|Death|2
956440|NCT00726986|3149724|P1|Induction Phase|Withdrawal by Subject|2
956441|NCT00726986|3149724|P1|Induction Phase|Adverse Event|4
956442|NCT00726895|3149731|P2|Washout Period of 7 Days|Withdrawal by Subject|1
956443|NCT00726895|3149732|P1|Washout Period of 7 Days|Withdrawal by Subject|0
956444|NCT00726882|3149745|P1|Overall Study|Not Specified|10
956445|NCT00726882|3149745|P1|Overall Study|Lost to Follow-up|7
956446|NCT00726882|3149745|P1|Overall Study|Withdrawal by Subject|5
956447|NCT00726752|3149760|P1|Overall Study|Lack of Efficacy|6
956448|NCT00726661|3149822|P2|Overall Study|Not specified|35
956449|NCT00726661|3149823|P1|Overall Study|Not specified|47
956450|NCT00726661|3149822|P2|Overall Study|Physician Decision|13
956451|NCT00726661|3149823|P1|Overall Study|Physician Decision|25
956452|NCT00726661|3149822|P2|Overall Study|Death|159
956453|NCT00726661|3149823|P1|Overall Study|Death|475
956454|NCT00726661|3149822|P2|Overall Study|Trial terminated by sponsor|187
956455|NCT00726661|3149823|P1|Overall Study|Trial terminated by sponsor|214
956456|NCT00726661|3149822|P2|Overall Study|Withdrawal by Subject|13
956457|NCT00726661|3149823|P1|Overall Study|Withdrawal by Subject|17
956458|NCT00726661|3149822|P2|Overall Study|Lost to Follow-up|11
956459|NCT00726661|3149823|P1|Overall Study|Lost to Follow-up|36
956460|NCT00726622|3149840|P2|Overall Study|Metastasis|0
956461|NCT00726622|3149841|P1|Overall Study|Metastasis|2
956462|NCT00726622|3149840|P2|Overall Study|Physician Decision|1
956463|NCT00726622|3149841|P1|Overall Study|Physician Decision|0
956464|NCT00726622|3149840|P2|Overall Study|Withdrawal by Subject|2
956465|NCT00726622|3149841|P1|Overall Study|Withdrawal by Subject|16
956466|NCT00726609|3149859|P1|Overall Study|Other|3
956467|NCT00726609|3149859|P1|Overall Study|Missing|42
956468|NCT00726609|3149859|P1|Overall Study|Not specified|16
956469|NCT00726609|3149859|P1|Overall Study|Lack of Efficacy|25
956470|NCT00726609|3149859|P1|Overall Study|Withdrawal by Subject|2
956471|NCT00726609|3149859|P1|Overall Study|Adverse Event|10
956472|NCT00726557|3149863|P1|Overall Study|Inclusion criteria not met|15
956473|NCT00726557|3149863|P1|Overall Study|Treatment less than 3 months|17
956474|NCT00726557|3149863|P1|Overall Study|No follow-up documentation available|55
956475|NCT00726557|3149863|P1|Overall Study|No end of treatment documentation|37
956476|NCT00726557|3149863|P1|Overall Study|Screening failure|4
956477|NCT00726453|3149870|P2|38 mm Length Group|Death|3
956478|NCT00726453|3149871|P1|38 mm Length Group|Death|0
956479|NCT00726453|3149870|P2|Primary Enrollment Group|Withdrawal by Subject|0
956480|NCT00726453|3149871|P1|Primary Enrollment Group|Withdrawal by Subject|13
956481|NCT00726453|3149870|P2|Primary Enrollment Group|Death|0
956482|NCT00726453|3149871|P1|Primary Enrollment Group|Death|18
956483|NCT00726323|3149899|P2|Overall Study|Metastatic lesions inferred cyst|1
956484|NCT00726323|3149900|P1|Overall Study|Metastatic lesions inferred cyst|0
956485|NCT00726323|3149899|P2|Overall Study|Participant wished to discontinue|1
956486|NCT00726323|3149900|P1|Overall Study|Participant wished to discontinue|0
956487|NCT00726323|3149899|P2|Overall Study|Death|0
956488|NCT00726323|3149900|P1|Overall Study|Death|1
956489|NCT00726323|3149899|P2|Overall Study|Adverse Event|9
956490|NCT00726323|3149900|P1|Overall Study|Adverse Event|9
956491|NCT00726323|3149899|P2|Overall Study|Clinical progression|3
956492|NCT00726323|3149900|P1|Overall Study|Clinical progression|0
956493|NCT00726323|3149899|P2|Overall Study|Progressive disease|16
956494|NCT00726323|3149900|P1|Overall Study|Progressive disease|23
956495|NCT00726323|3149899|P2|Overall Study|Physician Decision|0
956496|NCT00726323|3149900|P1|Overall Study|Physician Decision|1
956497|NCT00726323|3149899|P2|Overall Study|Withdrawal by Subject|1
956498|NCT00726323|3149900|P1|Overall Study|Withdrawal by Subject|3
956499|NCT00726232|3149930|P6|Overall Study|No response|1
956500|NCT00726232|3149931|P5|Overall Study|No response|3
956501|NCT00726232|3149932|P4|Overall Study|No response|0
956502|NCT00726232|3149933|P3|Overall Study|No response|0
956503|NCT00726232|3149934|P2|Overall Study|No response|0
956504|NCT00726232|3149935|P1|Overall Study|No response|1
956505|NCT00726232|3149930|P6|Overall Study|Disease progression|0
956506|NCT00726232|3149931|P5|Overall Study|Disease progression|0
956507|NCT00726232|3149932|P4|Overall Study|Disease progression|0
956508|NCT00726232|3149933|P3|Overall Study|Disease progression|0
956509|NCT00726232|3149934|P2|Overall Study|Disease progression|0
956510|NCT00726232|3149935|P1|Overall Study|Disease progression|1
956511|NCT00726232|3149930|P6|Overall Study|Adverse Event|1
956512|NCT00726232|3149931|P5|Overall Study|Adverse Event|2
956513|NCT00726232|3149932|P4|Overall Study|Adverse Event|1
956514|NCT00726232|3149933|P3|Overall Study|Adverse Event|0
956515|NCT00726232|3149934|P2|Overall Study|Adverse Event|1
956516|NCT00726232|3149935|P1|Overall Study|Adverse Event|1
956517|NCT00726232|3149930|P6|Overall Study|Withdrawal by Subject|2
956518|NCT00726232|3149931|P5|Overall Study|Withdrawal by Subject|0
956519|NCT00726232|3149932|P4|Overall Study|Withdrawal by Subject|0
956520|NCT00726232|3149933|P3|Overall Study|Withdrawal by Subject|0
956521|NCT00726232|3149934|P2|Overall Study|Withdrawal by Subject|0
956522|NCT00726232|3149935|P1|Overall Study|Withdrawal by Subject|2
956523|NCT00726063|3149985|P2|Overall Study|Adverse Event|7
956524|NCT00726063|3149986|P1|Overall Study|Adverse Event|9
956525|NCT00725985|3150000|P12|LTFU (No Cladribine Treatment)|Other|14
956526|NCT00725985|3150001|P11|LTFU (No Cladribine Treatment)|Other|36
956527|NCT00725985|3150002|P10|LTFU (No Cladribine Treatment)|Other|34
956528|NCT00725985|3150003|P9|LTFU (No Cladribine Treatment)|Other|0
956529|NCT00725985|3150004|P8|LTFU (No Cladribine Treatment)|Other|0
956530|NCT00725985|3150005|P7|LTFU (No Cladribine Treatment)|Other|0
956531|NCT00725985|3150006|P6|LTFU (No Cladribine Treatment)|Other|0
956532|NCT00725985|3150007|P5|LTFU (No Cladribine Treatment)|Other|0
956533|NCT00725985|3150008|P4|LTFU (No Cladribine Treatment)|Other|0
956534|NCT00725985|3150009|P3|LTFU (No Cladribine Treatment)|Other|0
956535|NCT00725985|3150010|P2|LTFU (No Cladribine Treatment)|Other|0
956536|NCT00725985|3150011|P1|LTFU (No Cladribine Treatment)|Other|0
956537|NCT00725985|3150000|P12|LTFU (With Cladribine Treatment)|Other|0
956538|NCT00725985|3150001|P11|LTFU (With Cladribine Treatment)|Other|0
956539|NCT00725985|3150002|P10|LTFU (With Cladribine Treatment)|Other|0
956540|NCT00725985|3150003|P9|LTFU (With Cladribine Treatment)|Other|16
956541|NCT00725985|3150004|P8|LTFU (With Cladribine Treatment)|Other|8
956542|NCT00725985|3150005|P7|LTFU (With Cladribine Treatment)|Other|9
956543|NCT00725985|3150006|P6|LTFU (With Cladribine Treatment)|Other|0
956544|NCT00725985|3150007|P5|LTFU (With Cladribine Treatment)|Other|0
956545|NCT00725985|3150008|P4|LTFU (With Cladribine Treatment)|Other|0
956546|NCT00725985|3150009|P3|LTFU (With Cladribine Treatment)|Other|0
956547|NCT00725985|3150010|P2|LTFU (With Cladribine Treatment)|Other|0
956548|NCT00725985|3150011|P1|LTFU (With Cladribine Treatment)|Other|0
956549|NCT00725985|3150000|P12|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
956550|NCT00725985|3150001|P11|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
956551|NCT00725985|3150002|P10|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
956552|NCT00725985|3150003|P9|LTFU (With Cladribine Treatment)|Lost to Follow-up|1
956553|NCT00725985|3150004|P8|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
956554|NCT00725985|3150005|P7|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
956555|NCT00725985|3150006|P6|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
956556|NCT00725985|3150007|P5|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
956557|NCT00725985|3150008|P4|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
956558|NCT00725985|3150009|P3|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
956559|NCT00725985|3150010|P2|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
956560|NCT00725985|3150011|P1|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
956561|NCT00725985|3150000|P12|LTFU (With Cladribine Treatment)|Adverse Event|0
956562|NCT00725985|3150001|P11|LTFU (With Cladribine Treatment)|Adverse Event|0
956563|NCT00725985|3150002|P10|LTFU (With Cladribine Treatment)|Adverse Event|0
956564|NCT00725985|3150003|P9|LTFU (With Cladribine Treatment)|Adverse Event|0
956565|NCT00725985|3150004|P8|LTFU (With Cladribine Treatment)|Adverse Event|1
956566|NCT00725985|3150005|P7|LTFU (With Cladribine Treatment)|Adverse Event|0
956567|NCT00725985|3150006|P6|LTFU (With Cladribine Treatment)|Adverse Event|0
956568|NCT00725985|3150007|P5|LTFU (With Cladribine Treatment)|Adverse Event|0
956569|NCT00725985|3150008|P4|LTFU (With Cladribine Treatment)|Adverse Event|0
956570|NCT00725985|3150009|P3|LTFU (With Cladribine Treatment)|Adverse Event|0
956571|NCT00725985|3150010|P2|LTFU (With Cladribine Treatment)|Adverse Event|0
956572|NCT00725985|3150011|P1|LTFU (With Cladribine Treatment)|Adverse Event|0
956573|NCT00725985|3150000|P12|OLMP|Other|0
956574|NCT00725985|3150001|P11|OLMP|Other|0
956575|NCT00725985|3150002|P10|OLMP|Other|0
956576|NCT00725985|3150003|P9|OLMP|Other|0
956577|NCT00725985|3150004|P8|OLMP|Other|0
956578|NCT00725985|3150005|P7|OLMP|Other|0
956579|NCT00725985|3150006|P6|OLMP|Other|44
956580|NCT00725985|3150007|P5|OLMP|Other|20
956581|NCT00725985|3150008|P4|OLMP|Other|15
956582|NCT00725985|3150009|P3|OLMP|Other|0
956583|NCT00725985|3150010|P2|OLMP|Other|0
956584|NCT00725985|3150011|P1|OLMP|Other|0
956585|NCT00725985|3150000|P12|OLMP|Disease progression|0
956586|NCT00725985|3150001|P11|OLMP|Disease progression|0
956587|NCT00725985|3150002|P10|OLMP|Disease progression|0
956588|NCT00725985|3150003|P9|OLMP|Disease progression|0
956589|NCT00725985|3150004|P8|OLMP|Disease progression|0
956590|NCT00725985|3150005|P7|OLMP|Disease progression|0
956591|NCT00725985|3150006|P6|OLMP|Disease progression|4
956592|NCT00725985|3150007|P5|OLMP|Disease progression|0
956593|NCT00725985|3150008|P4|OLMP|Disease progression|0
956594|NCT00725985|3150009|P3|OLMP|Disease progression|0
956595|NCT00725985|3150010|P2|OLMP|Disease progression|0
956596|NCT00725985|3150011|P1|OLMP|Disease progression|0
956597|NCT00725985|3150000|P12|OLMP|Lost to Follow-up|0
956598|NCT00725985|3150001|P11|OLMP|Lost to Follow-up|0
956599|NCT00725985|3150002|P10|OLMP|Lost to Follow-up|0
956600|NCT00725985|3150003|P9|OLMP|Lost to Follow-up|0
956601|NCT00725985|3150004|P8|OLMP|Lost to Follow-up|0
956602|NCT00725985|3150005|P7|OLMP|Lost to Follow-up|0
956603|NCT00725985|3150006|P6|OLMP|Lost to Follow-up|0
956604|NCT00725985|3150007|P5|OLMP|Lost to Follow-up|0
956605|NCT00725985|3150008|P4|OLMP|Lost to Follow-up|1
956606|NCT00725985|3150009|P3|OLMP|Lost to Follow-up|0
956607|NCT00725985|3150010|P2|OLMP|Lost to Follow-up|0
956608|NCT00725985|3150011|P1|OLMP|Lost to Follow-up|0
956609|NCT00725985|3150000|P12|OLMP|Death|0
956610|NCT00725985|3150001|P11|OLMP|Death|0
956611|NCT00725985|3150002|P10|OLMP|Death|0
956612|NCT00725985|3150003|P9|OLMP|Death|0
956613|NCT00725985|3150004|P8|OLMP|Death|0
956614|NCT00725985|3150005|P7|OLMP|Death|0
956615|NCT00725985|3150006|P6|OLMP|Death|0
956616|NCT00725985|3150007|P5|OLMP|Death|1
956617|NCT00725985|3150008|P4|OLMP|Death|0
956618|NCT00725985|3150009|P3|OLMP|Death|0
956619|NCT00725985|3150010|P2|OLMP|Death|0
956620|NCT00725985|3150011|P1|OLMP|Death|0
956621|NCT00725985|3150000|P12|OLMP|Adverse Event|0
956622|NCT00725985|3150001|P11|OLMP|Adverse Event|0
956623|NCT00725985|3150002|P10|OLMP|Adverse Event|0
956624|NCT00725985|3150003|P9|OLMP|Adverse Event|0
956625|NCT00725985|3150004|P8|OLMP|Adverse Event|0
956626|NCT00725985|3150005|P7|OLMP|Adverse Event|0
956627|NCT00725985|3150006|P6|OLMP|Adverse Event|5
956628|NCT00725985|3150007|P5|OLMP|Adverse Event|2
956629|NCT00725985|3150008|P4|OLMP|Adverse Event|2
956630|NCT00725985|3150009|P3|OLMP|Adverse Event|0
956631|NCT00725985|3150010|P2|OLMP|Adverse Event|0
956632|NCT00725985|3150011|P1|OLMP|Adverse Event|0
956633|NCT00725985|3150000|P12|ITP (Up to 96 Weeks)|Other|0
956634|NCT00725985|3150001|P11|ITP (Up to 96 Weeks)|Other|0
956635|NCT00725985|3150002|P10|ITP (Up to 96 Weeks)|Other|0
956636|NCT00725985|3150003|P9|ITP (Up to 96 Weeks)|Other|0
956637|NCT00725985|3150004|P8|ITP (Up to 96 Weeks)|Other|0
956638|NCT00725985|3150005|P7|ITP (Up to 96 Weeks)|Other|0
956639|NCT00725985|3150006|P6|ITP (Up to 96 Weeks)|Other|0
956640|NCT00725985|3150007|P5|ITP (Up to 96 Weeks)|Other|0
956641|NCT00725985|3150008|P4|ITP (Up to 96 Weeks)|Other|0
956642|NCT00725985|3150009|P3|ITP (Up to 96 Weeks)|Other|24
956643|NCT00725985|3150010|P2|ITP (Up to 96 Weeks)|Other|38
956644|NCT00725985|3150011|P1|ITP (Up to 96 Weeks)|Other|50
956645|NCT00725985|3150000|P12|ITP (Up to 96 Weeks)|Converted to CDMS|0
956646|NCT00725985|3150001|P11|ITP (Up to 96 Weeks)|Converted to CDMS|0
956647|NCT00725985|3150002|P10|ITP (Up to 96 Weeks)|Converted to CDMS|0
956648|NCT00725985|3150003|P9|ITP (Up to 96 Weeks)|Converted to CDMS|0
956649|NCT00725985|3150004|P8|ITP (Up to 96 Weeks)|Converted to CDMS|0
956650|NCT00725985|3150005|P7|ITP (Up to 96 Weeks)|Converted to CDMS|0
956651|NCT00725985|3150006|P6|ITP (Up to 96 Weeks)|Converted to CDMS|0
956652|NCT00725985|3150007|P5|ITP (Up to 96 Weeks)|Converted to CDMS|0
956653|NCT00725985|3150008|P4|ITP (Up to 96 Weeks)|Converted to CDMS|0
956654|NCT00725985|3150009|P3|ITP (Up to 96 Weeks)|Converted to CDMS|71
956655|NCT00725985|3150010|P2|ITP (Up to 96 Weeks)|Converted to CDMS|27
956656|NCT00725985|3150011|P1|ITP (Up to 96 Weeks)|Converted to CDMS|30
956657|NCT00725985|3150000|P12|ITP (Up to 96 Weeks)|Randomized but not treated|0
956658|NCT00725985|3150001|P11|ITP (Up to 96 Weeks)|Randomized but not treated|0
956659|NCT00725985|3150002|P10|ITP (Up to 96 Weeks)|Randomized but not treated|0
956660|NCT00725985|3150003|P9|ITP (Up to 96 Weeks)|Randomized but not treated|0
956661|NCT00725985|3150004|P8|ITP (Up to 96 Weeks)|Randomized but not treated|0
956662|NCT00725985|3150005|P7|ITP (Up to 96 Weeks)|Randomized but not treated|0
956663|NCT00725985|3150006|P6|ITP (Up to 96 Weeks)|Randomized but not treated|0
956664|NCT00725985|3150007|P5|ITP (Up to 96 Weeks)|Randomized but not treated|0
956665|NCT00725985|3150008|P4|ITP (Up to 96 Weeks)|Randomized but not treated|0
956666|NCT00725985|3150009|P3|ITP (Up to 96 Weeks)|Randomized but not treated|0
956667|NCT00725985|3150010|P2|ITP (Up to 96 Weeks)|Randomized but not treated|0
956668|NCT00725985|3150011|P1|ITP (Up to 96 Weeks)|Randomized but not treated|1
956669|NCT00725985|3150000|P12|ITP (Up to 96 Weeks)|Lost to Follow-up|0
956670|NCT00725985|3150001|P11|ITP (Up to 96 Weeks)|Lost to Follow-up|0
956671|NCT00725985|3150002|P10|ITP (Up to 96 Weeks)|Lost to Follow-up|0
956672|NCT00725985|3150003|P9|ITP (Up to 96 Weeks)|Lost to Follow-up|0
956673|NCT00725985|3150004|P8|ITP (Up to 96 Weeks)|Lost to Follow-up|0
956674|NCT00725985|3150005|P7|ITP (Up to 96 Weeks)|Lost to Follow-up|0
956675|NCT00725985|3150006|P6|ITP (Up to 96 Weeks)|Lost to Follow-up|0
956676|NCT00725985|3150007|P5|ITP (Up to 96 Weeks)|Lost to Follow-up|0
956677|NCT00725985|3150008|P4|ITP (Up to 96 Weeks)|Lost to Follow-up|0
956678|NCT00725985|3150009|P3|ITP (Up to 96 Weeks)|Lost to Follow-up|2
956679|NCT00725985|3150010|P2|ITP (Up to 96 Weeks)|Lost to Follow-up|0
956680|NCT00725985|3150011|P1|ITP (Up to 96 Weeks)|Lost to Follow-up|0
956681|NCT00725985|3150000|P12|ITP (Up to 96 Weeks)|Adverse Event|0
956682|NCT00725985|3150001|P11|ITP (Up to 96 Weeks)|Adverse Event|0
956683|NCT00725985|3150002|P10|ITP (Up to 96 Weeks)|Adverse Event|0
956684|NCT00725985|3150003|P9|ITP (Up to 96 Weeks)|Adverse Event|0
956685|NCT00725985|3150004|P8|ITP (Up to 96 Weeks)|Adverse Event|0
956686|NCT00725985|3150005|P7|ITP (Up to 96 Weeks)|Adverse Event|0
956687|NCT00725985|3150006|P6|ITP (Up to 96 Weeks)|Adverse Event|0
956688|NCT00725985|3150007|P5|ITP (Up to 96 Weeks)|Adverse Event|0
956689|NCT00725985|3150008|P4|ITP (Up to 96 Weeks)|Adverse Event|0
956690|NCT00725985|3150009|P3|ITP (Up to 96 Weeks)|Adverse Event|5
956691|NCT00725985|3150010|P2|ITP (Up to 96 Weeks)|Adverse Event|10
956692|NCT00725985|3150011|P1|ITP (Up to 96 Weeks)|Adverse Event|20
956693|NCT00725920|3150048|P2|Overall Study|Lack of Efficacy|6
956694|NCT00725920|3150049|P1|Overall Study|Lack of Efficacy|3
956695|NCT00725842|3150055|P1|Overall Study|No Visit 1 data|1
956696|NCT00725842|3150055|P1|Overall Study|Inclusion criterion not met|1
956697|NCT00725842|3150055|P1|Overall Study|Consent date prior to study start date|5
956698|NCT00725842|3150055|P1|Overall Study|Positive HCV-RNA at Visit 2|13
956699|NCT00725842|3150055|P1|Overall Study|Death|1
956700|NCT00725842|3150055|P1|Overall Study|Lost to Follow-up|19
956701|NCT00725764|3150062|P1|Overall Study|Decline in performance status|1
956702|NCT00725764|3150062|P1|Overall Study|Participant non compliant with protocol|1
956703|NCT00725764|3150062|P1|Overall Study|Death|1
956704|NCT00725764|3150062|P1|Overall Study|Lost to Follow-up|1
956705|NCT00725764|3150062|P1|Overall Study|Progressive Disease|7
956706|NCT00725764|3150062|P1|Overall Study|Physician Decision|1
956707|NCT00725764|3150062|P1|Overall Study|Withdrawal by Subject|2
956708|NCT00725725|3150095|P3|Overall Study|Protocol Violation|0
956709|NCT00725725|3150096|P2|Overall Study|Protocol Violation|1
956710|NCT00725725|3150097|P1|Overall Study|Protocol Violation|0
956711|NCT00725725|3150095|P3|Overall Study|Withdrawal by Subject|1
956712|NCT00725725|3150096|P2|Overall Study|Withdrawal by Subject|0
956713|NCT00725725|3150097|P1|Overall Study|Withdrawal by Subject|1
956714|NCT00725725|3150095|P3|Overall Study|Lost to Follow-up|2
956715|NCT00725725|3150096|P2|Overall Study|Lost to Follow-up|0
956716|NCT00725725|3150097|P1|Overall Study|Lost to Follow-up|2
956717|NCT00725725|3150095|P3|Overall Study|Adverse Event|2
956718|NCT00725725|3150096|P2|Overall Study|Adverse Event|3
956719|NCT00725725|3150097|P1|Overall Study|Adverse Event|1
956720|NCT00725712|3150140|P2|Overall Study|Hospitalized, unable to continue|1
956721|NCT00725712|3150141|P1|Overall Study|Hospitalized, unable to continue|0
956722|NCT00725712|3150140|P2|Overall Study|Other: Death|0
956723|NCT00725712|3150141|P1|Overall Study|Other: Death|1
956724|NCT00725712|3150140|P2|Overall Study|Death|0
956725|NCT00725712|3150141|P1|Overall Study|Death|2
956726|NCT00725712|3150140|P2|Overall Study|Adverse Event|5
956727|NCT00725712|3150141|P1|Overall Study|Adverse Event|5
956728|NCT00725712|3150140|P2|Overall Study|Clinical progression not based on RECIST|3
956729|NCT00725712|3150141|P1|Overall Study|Clinical progression not based on RECIST|0
956730|NCT00725712|3150140|P2|Overall Study|Progressive disease|16
956731|NCT00725712|3150141|P1|Overall Study|Progressive disease|37
956732|NCT00725712|3150140|P2|Overall Study|Protocol Violation|0
956733|NCT00725712|3150141|P1|Overall Study|Protocol Violation|1
956734|NCT00725712|3150140|P2|Overall Study|Withdrawal by Subject|1
956735|NCT00725712|3150141|P1|Overall Study|Withdrawal by Subject|2
956736|NCT00725621|3150177|P1|Overall Study|Reason not specified|55
956737|NCT00725621|3150177|P1|Overall Study|Prepared for elective surgery|1
956738|NCT00725621|3150177|P1|Overall Study|Switched to other drug|1
956739|NCT00725621|3150177|P1|Overall Study|Switched to other study|1
956740|NCT00725621|3150177|P1|Overall Study|Continued treatment by other physician|6
956741|NCT00725621|3150177|P1|Overall Study|Non-compliance|8
956742|NCT00725621|3150177|P1|Overall Study|Lost to Follow-up|52
956743|NCT00725621|3150177|P1|Overall Study|Physician Decision|19
956744|NCT00725621|3150177|P1|Overall Study|Withdrawal by Subject|57
956745|NCT00725621|3150177|P1|Overall Study|Lack of Efficacy|46
956746|NCT00725621|3150177|P1|Overall Study|Adverse Event|25
956747|NCT00725608|3150200|P1|Overall Study|Other|7
956748|NCT00725608|3150200|P1|Overall Study|Individual reasons|86
956749|NCT00725608|3150200|P1|Overall Study|Adverse Event|14
956750|NCT00725608|3150200|P1|Overall Study|Lost to Follow-up|60
956751|NCT00725543|3150206|P1|Overall Study|Not specified|119
956752|NCT00725543|3150206|P1|Overall Study|Non-compliance|2
956753|NCT00725543|3150206|P1|Overall Study|Lost to Follow-up|4
956754|NCT00725543|3150206|P1|Overall Study|Physician Decision|5
956755|NCT00725543|3150206|P1|Overall Study|Withdrawal by Subject|10
956756|NCT00725543|3150206|P1|Overall Study|Lack of Efficacy|3
956757|NCT00725543|3150206|P1|Overall Study|Adverse Event|10
956758|NCT00725491|3150231|P2|Overall Study|No/too few embryos/ bad quality embryos|2
956759|NCT00725491|3150232|P1|Overall Study|No/too few embryos/ bad quality embryos|3
956760|NCT00725491|3150231|P2|Overall Study|Fertilization failure|1
956761|NCT00725491|3150232|P1|Overall Study|Fertilization failure|0
956762|NCT00725491|3150231|P2|Overall Study|No/too few oocytes/bad quality oocytes|1
956763|NCT00725491|3150232|P1|Overall Study|No/too few oocytes/bad quality oocytes|1
956764|NCT00725491|3150231|P2|Overall Study|Risk for hyperstimulation|9
956765|NCT00725491|3150232|P1|Overall Study|Risk for hyperstimulation|2
956766|NCT00725491|3150231|P2|Overall Study|Pregnancy|3
956767|NCT00725491|3150232|P1|Overall Study|Pregnancy|0
956768|NCT00725491|3150231|P2|Overall Study|Adverse Event|2
956769|NCT00725491|3150232|P1|Overall Study|Adverse Event|3
956770|NCT00725452|3150238|P1|Overall Study|Lost to Follow-up|1
956771|NCT00725452|3150238|P1|Overall Study|Withdrawal by Subject|3
956772|NCT00725452|3150238|P1|Overall Study|Physician Decision|1
956773|NCT00725452|3150238|P1|Overall Study|Reason not specified|1
956774|NCT00725452|3150238|P1|Overall Study|Lack of Efficacy|2
956775|NCT00725452|3150238|P1|Overall Study|Adverse Event|3
956776|NCT00725322|3150257|P2|Washout (28 Days)|Protocol Violation|1
956777|NCT00725322|3150258|P1|Washout (28 Days)|Protocol Violation|0
956778|NCT00725322|3150257|P2|Washout (28 Days)|Withdrawal by Subject|0
956779|NCT00725322|3150258|P1|Washout (28 Days)|Withdrawal by Subject|2
956780|NCT00725296|3150266|P1|Overall Study|Not Specified|38
956781|NCT00725296|3150266|P1|Overall Study|Lost to Follow-up|1
956782|NCT00725296|3150266|P1|Overall Study|Non-Compliance|2
956783|NCT00725296|3150266|P1|Overall Study|Withdrawal by Subject|3
956784|NCT00725296|3150266|P1|Overall Study|Lack of Efficacy|7
956785|NCT00725296|3150266|P1|Overall Study|Adverse Event|11
956786|NCT00725283|3150275|P1|Overall Study|Withdrawal by Subject|10
956787|NCT00725283|3150275|P1|Overall Study|Not specified|6
956788|NCT00725283|3150275|P1|Overall Study|Death|5
956789|NCT00725283|3150275|P1|Overall Study|Missing Code|3
956790|NCT00725205|3150296|P1|Overall Study|Treatment Failure|41
956791|NCT00725205|3150296|P1|Overall Study|Protocol Defined Clinical Event|1
956792|NCT00725205|3150296|P1|Overall Study|Other|8
956793|NCT00725205|3150296|P1|Overall Study|Non-compliance With Protocol|14
956794|NCT00725205|3150296|P1|Overall Study|Investigator Discontinued|1
956795|NCT00725205|3150296|P1|Overall Study|Adverse Event|22
956796|NCT00725101|3150309|P1|Overall Study|not specified/no reason given|11
956797|NCT00725101|3150309|P1|Overall Study|Withdrawal by Subject|127
956798|NCT00725101|3150309|P1|Overall Study|Protocol Violation|1
956799|NCT00725101|3150309|P1|Overall Study|Lost to Follow-up|353
956800|NCT00725101|3150309|P1|Overall Study|Death|3
956801|NCT00725075|3150332|P3|Overall Study|Other|0
956802|NCT00725075|3150333|P2|Overall Study|Other|0
956803|NCT00725075|3150334|P1|Overall Study|Other|1
956804|NCT00725075|3150332|P3|Overall Study|Inclusion/Exclusion Criteria|1
956805|NCT00725075|3150333|P2|Overall Study|Inclusion/Exclusion Criteria|0
956806|NCT00725075|3150334|P1|Overall Study|Inclusion/Exclusion Criteria|1
956807|NCT00725075|3150332|P3|Overall Study|Worsening of Disease|2
956808|NCT00725075|3150333|P2|Overall Study|Worsening of Disease|1
956809|NCT00725075|3150334|P1|Overall Study|Worsening of Disease|2
956810|NCT00725075|3150332|P3|Overall Study|Adverse Event|1
956811|NCT00725075|3150333|P2|Overall Study|Adverse Event|1
956812|NCT00725075|3150334|P1|Overall Study|Adverse Event|2
956813|NCT00725075|3150332|P3|Overall Study|Withdrawal by Subject|4
956814|NCT00725075|3150333|P2|Overall Study|Withdrawal by Subject|5
956815|NCT00725075|3150334|P1|Overall Study|Withdrawal by Subject|4
956816|NCT00725075|3150332|P3|Overall Study|Lost to Follow-up|0
956817|NCT00725075|3150333|P2|Overall Study|Lost to Follow-up|0
956818|NCT00725075|3150334|P1|Overall Study|Lost to Follow-up|1
956819|NCT00725075|3150332|P3|Overall Study|Protocol Violation|1
956820|NCT00725075|3150333|P2|Overall Study|Protocol Violation|0
956821|NCT00725075|3150334|P1|Overall Study|Protocol Violation|0
956822|NCT00725075|3150332|P3|Overall Study|Use of Excluded Medication|0
956823|NCT00725075|3150333|P2|Overall Study|Use of Excluded Medication|1
956824|NCT00725075|3150334|P1|Overall Study|Use of Excluded Medication|0
956825|NCT00725010|3150387|P1|Overall Study|Intensified treatment scheme: 3 on 1 off|2
956826|NCT00725010|3150387|P1|Overall Study|No further documentation|1
956827|NCT00725010|3150387|P1|Overall Study|Suspect lymph nodes neck thorax abdomen|1
956828|NCT00725010|3150387|P1|Overall Study|Hepatopathy probably not Temodal-related|1
956829|NCT00725010|3150387|P1|Overall Study|Lost to Follow-up|1
956830|NCT00725010|3150387|P1|Overall Study|Death|1
956831|NCT00725010|3150387|P1|Overall Study|Withdrawal by Subject|2
956832|NCT00725010|3150387|P1|Overall Study|Tumor Progression|7
956833|NCT00725010|3150387|P1|Overall Study|Toxicity|9
956834|NCT00724958|3150420|P1|Overall Study|No documentation for end of therapy|13
956835|NCT00724958|3150420|P1|Overall Study|Other Reason|76
956836|NCT00724958|3150420|P1|Overall Study|Remission|7
956837|NCT00724958|3150420|P1|Overall Study|No Response|18
956838|NCT00724958|3150420|P1|Overall Study|Loss of Response|40
956839|NCT00724958|3150420|P1|Overall Study|Adverse Event|28
956840|NCT00724945|3150429|P2|Period 2|lens physiology issue|0
956841|NCT00724945|3150430|P1|Period 2|lens physiology issue|1
956842|NCT00724945|3150429|P2|Period 2|lens comfort issue|0
956843|NCT00724945|3150430|P1|Period 2|lens comfort issue|3
956844|NCT00724945|3150429|P2|Period 1|Lost to Follow-up|0
956845|NCT00724945|3150430|P1|Period 1|Lost to Follow-up|1
956846|NCT00724945|3150429|P2|Period 1|Adverse Event|1
956847|NCT00724945|3150430|P1|Period 1|Adverse Event|1
956848|NCT00724945|3150429|P2|Period 1|non-compliance|0
956849|NCT00724945|3150430|P1|Period 1|non-compliance|1
956850|NCT00724932|3150442|P2|Overall Study|Not treated|3
956851|NCT00724932|3150443|P1|Overall Study|Not treated|4
956852|NCT00724932|3150442|P2|Overall Study|Lost to Follow-up|0
956853|NCT00724932|3150443|P1|Overall Study|Lost to Follow-up|1
956854|NCT00724893|3150514|P2|Overall Study|Unknown, missing data|1
956855|NCT00724893|3150515|P1|Overall Study|Unknown, missing data|1
956856|NCT00724893|3150514|P2|Overall Study|Lost to Follow-up|52
956857|NCT00724893|3150515|P1|Overall Study|Lost to Follow-up|0
956858|NCT00724893|3150514|P2|Overall Study|Assigned shorter treatment|2
956859|NCT00724893|3150515|P1|Overall Study|Assigned shorter treatment|0
956860|NCT00724893|3150514|P2|Overall Study|Financial reasons|2
956861|NCT00724893|3150515|P1|Overall Study|Financial reasons|0
956862|NCT00724893|3150514|P2|Overall Study|Substance abuse|3
956863|NCT00724893|3150515|P1|Overall Study|Substance abuse|0
956864|NCT00724893|3150514|P2|Overall Study|Incarceration|9
956865|NCT00724893|3150515|P1|Overall Study|Incarceration|0
956866|NCT00724893|3150514|P2|Overall Study|Geographic reasons|11
956867|NCT00724893|3150515|P1|Overall Study|Geographic reasons|0
956868|NCT00724893|3150514|P2|Overall Study|Patient choice|26
956869|NCT00724893|3150515|P1|Overall Study|Patient choice|0
956870|NCT00724893|3150514|P2|Overall Study|Reason not specified|7
956871|NCT00724893|3150515|P1|Overall Study|Reason not specified|193
956872|NCT00724893|3150514|P2|Overall Study|Lack of virologic response|202
956873|NCT00724893|3150515|P1|Overall Study|Lack of virologic response|94
956874|NCT00724893|3150514|P2|Overall Study|Withdrawal by Subject|1
956875|NCT00724893|3150515|P1|Overall Study|Withdrawal by Subject|0
956876|NCT00724893|3150514|P2|Overall Study|Adverse Event|142
956877|NCT00724893|3150515|P1|Overall Study|Adverse Event|76
956878|NCT00724867|3150583|P1|Overall Study|Elected to exit due to site closure|2
956879|NCT00724867|3150583|P1|Overall Study|Subject moved out of state|1
956880|NCT00724867|3150583|P1|Overall Study|Developed withdrawal criteria- pregnancy|4
956881|NCT00724867|3150583|P1|Overall Study|Subject incarcerated|1
956882|NCT00724867|3150583|P1|Overall Study|Sponsor decision to end study|14
956883|NCT00724867|3150583|P1|Overall Study|Withdrawal by Subject|31
956884|NCT00724867|3150583|P1|Overall Study|Protocol Violation|1
956885|NCT00724867|3150583|P1|Overall Study|Physician Decision|17
956886|NCT00724867|3150583|P1|Overall Study|Non-compliance with study drug|6
956887|NCT00724867|3150583|P1|Overall Study|Lost to Follow-up|12
956888|NCT00724867|3150583|P1|Overall Study|Lack of Efficacy|14
956889|NCT00724867|3150583|P1|Overall Study|Adverse Event|25
956890|NCT00724854|3150623|P2|Overall Study|Adverse event + lack of efficacy|1
956891|NCT00724854|3150624|P1|Overall Study|Adverse event + lack of efficacy|2
956892|NCT00724854|3150623|P2|Overall Study|Withdrawal by Subject|0
956893|NCT00724854|3150624|P1|Overall Study|Withdrawal by Subject|5
956894|NCT00724854|3150623|P2|Overall Study|Change of treatment|0
956895|NCT00724854|3150624|P1|Overall Study|Change of treatment|7
956896|NCT00724854|3150623|P2|Overall Study|Death|0
956897|NCT00724854|3150624|P1|Overall Study|Death|11
956898|NCT00724854|3150623|P2|Overall Study|Not specified|3
956899|NCT00724854|3150624|P1|Overall Study|Not specified|42
956900|NCT00724854|3150623|P2|Overall Study|Adverse Event|4
956901|NCT00724854|3150624|P1|Overall Study|Adverse Event|62
956902|NCT00724854|3150623|P2|Overall Study|Lost to Follow-up|10
956903|NCT00724854|3150624|P1|Overall Study|Lost to Follow-up|87
956904|NCT00724854|3150623|P2|Overall Study|Lack of Efficacy|13
956905|NCT00724854|3150624|P1|Overall Study|Lack of Efficacy|187
956906|NCT00724815|3150641|P2|Overall Study|Other Various|5
956907|NCT00724815|3150642|P1|Overall Study|Other Various|3
956908|NCT00724815|3150641|P2|Overall Study|Lost to Follow-up|1
956909|NCT00724815|3150642|P1|Overall Study|Lost to Follow-up|4
956910|NCT00724815|3150641|P2|Overall Study|Adverse Event|3
956911|NCT00724815|3150642|P1|Overall Study|Adverse Event|5
956912|NCT00724815|3150641|P2|Overall Study|Randomized, not treated|30
956913|NCT00724815|3150642|P1|Overall Study|Randomized, not treated|31
956914|NCT00724711|3150675|P2|Overall Study|Protocol Violation|0
956915|NCT00724711|3150676|P1|Overall Study|Protocol Violation|1
956916|NCT00724711|3150675|P2|Overall Study|Lost to Follow-up|5
956917|NCT00724711|3150676|P1|Overall Study|Lost to Follow-up|4
956918|NCT00724711|3150675|P2|Overall Study|Withdrawal by Subject|4
956919|NCT00724711|3150676|P1|Overall Study|Withdrawal by Subject|5
956920|NCT00724711|3150675|P2|Overall Study|Physician Decision|3
956921|NCT00724711|3150676|P1|Overall Study|Physician Decision|0
956922|NCT00724711|3150675|P2|Overall Study|Lack of Efficacy|1
956923|NCT00724711|3150676|P1|Overall Study|Lack of Efficacy|0
956924|NCT00724711|3150675|P2|Overall Study|Pregnancy|1
956925|NCT00724711|3150676|P1|Overall Study|Pregnancy|0
956926|NCT00724711|3150675|P2|Overall Study|Adverse Event|3
956927|NCT00724711|3150676|P1|Overall Study|Adverse Event|7
956928|NCT00724698|3150708|P1|Overall Study|No Info|25
956929|NCT00724698|3150708|P1|Overall Study|Lost to Follow-up|36
956930|NCT00724698|3150708|P1|Overall Study|Poor Compliance|16
956931|NCT00724698|3150708|P1|Overall Study|Failure of Therapy|4
956932|NCT00724698|3150708|P1|Overall Study|Adverse Event|9
956933|NCT00724451|3150775|P1|Overall Study|Investigator + Participant Decision|13
956934|NCT00724451|3150775|P1|Overall Study|Withdrawal by Subject|45
956935|NCT00724451|3150775|P1|Overall Study|Physician Decision|116
956936|NCT00724451|3150775|P1|Overall Study|Unknown; No Data Sources Available|9
956937|NCT00724451|3150775|P1|Overall Study|Never Started Treatment|89
956938|NCT00724451|3150775|P1|Overall Study|Participant Refused Treatment|89
956939|NCT00724451|3150775|P1|Overall Study|Not Eligible for Treatment|431
956940|NCT00724451|3150775|P1|Overall Study|Excluded - Hepatitis C Virus Negative|3
956941|NCT00724451|3150775|P1|Overall Study|Excluded - Prior Use of Peginterferon|7
956942|NCT00724373|3150781|P1|Overall Study|Tolerability|23
956943|NCT00724373|3150781|P1|Overall Study|Drug Relapse|1
956944|NCT00724373|3150781|P1|Overall Study|Acute HCV infection|1
956945|NCT00724373|3150781|P1|Overall Study|Viral Relapse|1
956946|NCT00724373|3150781|P1|Overall Study|Only to have 24 week regimen|1
956947|NCT00724373|3150781|P1|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2
956948|NCT00724373|3150781|P1|Overall Study|Participant moved away|1
956949|NCT00724373|3150781|P1|Overall Study|HCV RNA negative after 4 weeks|9
956950|NCT00724373|3150781|P1|Overall Study|Non-compliance|2
956951|NCT00724373|3150781|P1|Overall Study|Lost to Follow-up|7
956952|NCT00724373|3150781|P1|Overall Study|Lack of Efficacy|82
956953|NCT00724373|3150781|P1|Overall Study|Adverse Event|41
956954|NCT00724282|3150798|P1|Overall Study|Physician Decision|1
956955|NCT00724282|3150798|P1|Overall Study|Withdrawal by Subject|3
956956|NCT00724243|3150802|P1|Overall Study|Adverse Event|5
956957|NCT00724243|3150802|P1|Overall Study|Lack of Efficacy|10
956958|NCT00724152|3150812|P3|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
956959|NCT00724152|3150813|P2|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2
956960|NCT00724152|3150814|P1|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
956961|NCT00724152|3150812|P3|Two-arm Study Period|Withdrawal by Subject|0
956962|NCT00724152|3150813|P2|Two-arm Study Period|Withdrawal by Subject|2
956963|NCT00724152|3150814|P1|Two-arm Study Period|Withdrawal by Subject|3
956964|NCT00724126|3150831|P2|Overall Study|Subject had to leave vicinity of site|1
956965|NCT00724126|3150832|P1|Overall Study|Subject had to leave vicinity of site|0
956966|NCT00724126|3150831|P2|Overall Study|Subject randomized although ineligible|1
956967|NCT00724126|3150832|P1|Overall Study|Subject randomized although ineligible|1
956968|NCT00724126|3150831|P2|Overall Study|Noncompliance|1
956969|NCT00724126|3150832|P1|Overall Study|Noncompliance|2
956970|NCT00724126|3150831|P2|Overall Study|Lost to Follow-up|6
956971|NCT00724126|3150832|P1|Overall Study|Lost to Follow-up|6
956972|NCT00724126|3150831|P2|Overall Study|Withdrawal by Subject|6
956973|NCT00724126|3150832|P1|Overall Study|Withdrawal by Subject|8
956974|NCT00724126|3150831|P2|Overall Study|Adverse Event|0
956975|NCT00724126|3150832|P1|Overall Study|Adverse Event|2
956976|NCT00724061|3150840|P1|Dose Escalation Phase|Disease Progression|3
956977|NCT00724061|3150840|P1|Dose Escalation Phase|Adverse Event|2
956978|NCT00723957|3150857|P2|Overall Study|Never received treatment|3
956979|NCT00723957|3150858|P1|Overall Study|Never received treatment|3
956980|NCT00723957|3150857|P2|Overall Study|Reason not analyzed|0
956981|NCT00723957|3150858|P1|Overall Study|Reason not analyzed|1
956982|NCT00723957|3150857|P2|Overall Study|Withdrawal by Subject|5
956983|NCT00723957|3150858|P1|Overall Study|Withdrawal by Subject|7
956984|NCT00723957|3150857|P2|Overall Study|Study drug toxicity|6
956985|NCT00723957|3150858|P1|Overall Study|Study drug toxicity|4
956986|NCT00723957|3150857|P2|Overall Study|Investigator decision|1
956987|NCT00723957|3150858|P1|Overall Study|Investigator decision|1
956988|NCT00723957|3150857|P2|Overall Study|Maximum clinical benefit|5
956989|NCT00723957|3150858|P1|Overall Study|Maximum clinical benefit|4
956990|NCT00723957|3150857|P2|Overall Study|Disease progression|25
956991|NCT00723957|3150858|P1|Overall Study|Disease progression|27
956992|NCT00723957|3150857|P2|Overall Study|Death|4
956993|NCT00723957|3150858|P1|Overall Study|Death|3
956994|NCT00723957|3150857|P2|Overall Study|Adverse event unrelated to study drug|4
956995|NCT00723957|3150858|P1|Overall Study|Adverse event unrelated to study drug|1
956996|NCT00723944|3150882|P2|One Year Post Placement Follow-up|Lost to Follow-up|4
956997|NCT00723944|3150883|P1|One Year Post Placement Follow-up|Lost to Follow-up|1
956998|NCT00723944|3150882|P2|Permanent Prosthesis Placement|Lost to Follow-up|2
956999|NCT00723944|3150883|P1|Permanent Prosthesis Placement|Lost to Follow-up|2
957000|NCT00723944|3150882|P2|Permanent Prosthesis Placement|Adverse Event|7
957001|NCT00723944|3150883|P1|Permanent Prosthesis Placement|Adverse Event|1
957002|NCT00723892|3150896|P2|Overall Study|Drug addiction|0
957003|NCT00723892|3150897|P1|Overall Study|Drug addiction|1
957004|NCT00723892|3150896|P2|Overall Study|Intercurrent infection|0
957005|NCT00723892|3150897|P1|Overall Study|Intercurrent infection|2
957006|NCT00723892|3150896|P2|Overall Study|Alcohol abuse|1
957007|NCT00723892|3150897|P1|Overall Study|Alcohol abuse|0
957008|NCT00723892|3150896|P2|Overall Study|Weight loss|3
957009|NCT00723892|3150897|P1|Overall Study|Weight loss|1
957010|NCT00723892|3150896|P2|Overall Study|Study end|3
957011|NCT00723892|3150897|P1|Overall Study|Study end|1
957012|NCT00723892|3150896|P2|Overall Study|Not specified|3
957013|NCT00723892|3150897|P1|Overall Study|Not specified|6
957014|NCT00723892|3150896|P2|Overall Study|Multiple reasons|12
957015|NCT00723892|3150897|P1|Overall Study|Multiple reasons|17
957016|NCT00723892|3150896|P2|Overall Study|Bad tolerance|5
957017|NCT00723892|3150897|P1|Overall Study|Bad tolerance|5
957018|NCT00723892|3150896|P2|Overall Study|End planned|7
957019|NCT00723892|3150897|P1|Overall Study|End planned|11
957020|NCT00723892|3150896|P2|Overall Study|Withdrawal by Subject|9
957021|NCT00723892|3150897|P1|Overall Study|Withdrawal by Subject|6
957022|NCT00723892|3150896|P2|Overall Study|Virological criterion|9
957023|NCT00723892|3150897|P1|Overall Study|Virological criterion|24
957024|NCT00723892|3150896|P2|Overall Study|Participant not tracked|35
957025|NCT00723892|3150897|P1|Overall Study|Participant not tracked|33
957026|NCT00723840|3150904|P1|Overall Study|Unspecified reason|2
957027|NCT00723840|3150904|P1|Overall Study|Other Medical Event|2
957028|NCT00723840|3150904|P1|Overall Study|Serious Adverse Events|3
957029|NCT00723840|3150904|P1|Overall Study|Withdrawal by Subject|55
957030|NCT00723840|3150904|P1|Overall Study|Failure to return|18
957031|NCT00723840|3150904|P1|Overall Study|Lost to Follow-up|2
957032|NCT00723801|3150925|P2|Overall Study|Protocol Violation|1
957033|NCT00723801|3150926|P1|Overall Study|Protocol Violation|2
957034|NCT00723801|3150925|P2|Overall Study|Lost to Follow-up|2
957035|NCT00723801|3150926|P1|Overall Study|Lost to Follow-up|1
957036|NCT00723710|3150951|P1|Overall Study|Physician Decision|2
957037|NCT00723710|3150951|P1|Overall Study|Withdrawal by Subject|36
957038|NCT00723710|3150951|P1|Overall Study|Adverse Event|88
957039|NCT00723710|3150951|P1|Overall Study|Disease progression|48
957040|NCT00723697|3150955|P1|Overall Study|Other exclusion criteria applied|6
957041|NCT00723697|3150955|P1|Overall Study|Missing Informed Consent Form|10
957042|NCT00723697|3150955|P1|Overall Study|Physician questionnaires not received|2
957043|NCT00723606|3150976|P2|Overall Study|Withdrawal by Subject|2
957044|NCT00723606|3150977|P1|Overall Study|Withdrawal by Subject|0
957045|NCT00723606|3150976|P2|Overall Study|Other|0
957046|NCT00723606|3150977|P1|Overall Study|Other|2
957047|NCT00723606|3150976|P2|Overall Study|Adverse Event|5
957048|NCT00723606|3150977|P1|Overall Study|Adverse Event|2
957049|NCT00723554|3150997|P1|Overall Study|Non-compliance|1
957050|NCT00723554|3150997|P1|Overall Study|Lost to Follow-up|1
957051|NCT00723554|3150997|P1|Overall Study|Not specified|3
957052|NCT00723554|3150997|P1|Overall Study|Withdrawal of consent|3
957053|NCT00723554|3150997|P1|Overall Study|Inhaled medication other than iloprost|4
957054|NCT00723554|3150997|P1|Overall Study|Investigator's judgement|5
957055|NCT00723554|3150997|P1|Overall Study|Adverse Event|12
957056|NCT00723528|3151047|P7|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1
957057|NCT00723528|3151048|P6|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
957058|NCT00723528|3151049|P5|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
957059|NCT00723528|3151050|P4|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
957060|NCT00723528|3151051|P3|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
957061|NCT00723528|3151052|P2|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
957062|NCT00723528|3151053|P1|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
957063|NCT00723528|3151047|P7|Period 2: After Controlled Period|Use of prohibited concomitant medication|1
957064|NCT00723528|3151048|P6|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
957065|NCT00723528|3151049|P5|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
957066|NCT00723528|3151050|P4|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
957138|NCT00723489|3151116|P3|Overall Study|Prohibited Medication|0
957067|NCT00723528|3151051|P3|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
957068|NCT00723528|3151052|P2|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
957069|NCT00723528|3151053|P1|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
957070|NCT00723528|3151047|P7|Period 2: After Controlled Period|Adverse Event|1
957071|NCT00723528|3151048|P6|Period 2: After Controlled Period|Adverse Event|0
957072|NCT00723528|3151049|P5|Period 2: After Controlled Period|Adverse Event|1
957073|NCT00723528|3151050|P4|Period 2: After Controlled Period|Adverse Event|0
957074|NCT00723528|3151051|P3|Period 2: After Controlled Period|Adverse Event|0
957075|NCT00723528|3151052|P2|Period 2: After Controlled Period|Adverse Event|0
957076|NCT00723528|3151053|P1|Period 2: After Controlled Period|Adverse Event|0
957077|NCT00723528|3151047|P7|Period 2: After Controlled Period|Other|0
957078|NCT00723528|3151048|P6|Period 2: After Controlled Period|Other|4
957079|NCT00723528|3151049|P5|Period 2: After Controlled Period|Other|1
957080|NCT00723528|3151050|P4|Period 2: After Controlled Period|Other|0
957081|NCT00723528|3151051|P3|Period 2: After Controlled Period|Other|0
957082|NCT00723528|3151052|P2|Period 2: After Controlled Period|Other|0
957083|NCT00723528|3151053|P1|Period 2: After Controlled Period|Other|0
957084|NCT00723528|3151047|P7|Period 2: After Controlled Period|Onset of tuberculosis infection|0
957085|NCT00723528|3151048|P6|Period 2: After Controlled Period|Onset of tuberculosis infection|1
957086|NCT00723528|3151049|P5|Period 2: After Controlled Period|Onset of tuberculosis infection|0
957087|NCT00723528|3151050|P4|Period 2: After Controlled Period|Onset of tuberculosis infection|0
957088|NCT00723528|3151051|P3|Period 2: After Controlled Period|Onset of tuberculosis infection|0
957089|NCT00723528|3151052|P2|Period 2: After Controlled Period|Onset of tuberculosis infection|0
957090|NCT00723528|3151053|P1|Period 2: After Controlled Period|Onset of tuberculosis infection|0
957091|NCT00723528|3151047|P7|Period 2: After Controlled Period|Withdrawal by Subject|1
957092|NCT00723528|3151048|P6|Period 2: After Controlled Period|Withdrawal by Subject|1
957093|NCT00723528|3151049|P5|Period 2: After Controlled Period|Withdrawal by Subject|0
957094|NCT00723528|3151050|P4|Period 2: After Controlled Period|Withdrawal by Subject|1
957095|NCT00723528|3151051|P3|Period 2: After Controlled Period|Withdrawal by Subject|0
957096|NCT00723528|3151052|P2|Period 2: After Controlled Period|Withdrawal by Subject|0
957097|NCT00723528|3151053|P1|Period 2: After Controlled Period|Withdrawal by Subject|0
957098|NCT00723528|3151047|P7|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
957099|NCT00723528|3151048|P6|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
957100|NCT00723528|3151049|P5|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
957101|NCT00723528|3151050|P4|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
957102|NCT00723528|3151051|P3|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1
957103|NCT00723528|3151052|P2|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
957104|NCT00723528|3151053|P1|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2
957105|NCT00723528|3151047|P7|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
957106|NCT00723528|3151048|P6|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
957107|NCT00723528|3151049|P5|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
957108|NCT00723528|3151050|P4|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
957109|NCT00723528|3151051|P3|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1
957110|NCT00723528|3151052|P2|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
957111|NCT00723528|3151053|P1|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
957112|NCT00723528|3151047|P7|Period 1: Controlled Period (CP)|Physician Decision|0
957113|NCT00723528|3151048|P6|Period 1: Controlled Period (CP)|Physician Decision|0
957114|NCT00723528|3151049|P5|Period 1: Controlled Period (CP)|Physician Decision|0
957115|NCT00723528|3151050|P4|Period 1: Controlled Period (CP)|Physician Decision|0
957116|NCT00723528|3151051|P3|Period 1: Controlled Period (CP)|Physician Decision|1
957117|NCT00723528|3151052|P2|Period 1: Controlled Period (CP)|Physician Decision|0
957118|NCT00723528|3151053|P1|Period 1: Controlled Period (CP)|Physician Decision|0
957119|NCT00723528|3151047|P7|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
957120|NCT00723528|3151048|P6|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
957121|NCT00723528|3151049|P5|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
957122|NCT00723528|3151050|P4|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
957123|NCT00723528|3151051|P3|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
957124|NCT00723528|3151052|P2|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
957125|NCT00723528|3151053|P1|Period 1: Controlled Period (CP)|Withdrawal by Subject|2
957126|NCT00723528|3151047|P7|Period 1: Controlled Period (CP)|Adverse Event|0
957127|NCT00723528|3151048|P6|Period 1: Controlled Period (CP)|Adverse Event|0
957128|NCT00723528|3151049|P5|Period 1: Controlled Period (CP)|Adverse Event|0
957129|NCT00723528|3151050|P4|Period 1: Controlled Period (CP)|Adverse Event|0
957130|NCT00723528|3151051|P3|Period 1: Controlled Period (CP)|Adverse Event|1
957131|NCT00723528|3151052|P2|Period 1: Controlled Period (CP)|Adverse Event|0
957132|NCT00723528|3151053|P1|Period 1: Controlled Period (CP)|Adverse Event|0
957133|NCT00723489|3151115|P4|Overall Study|Samples Collected Out of Window|0
957134|NCT00723489|3151116|P3|Overall Study|Samples Collected Out of Window|0
957135|NCT00723489|3151117|P2|Overall Study|Samples Collected Out of Window|3
957136|NCT00723489|3151118|P1|Overall Study|Samples Collected Out of Window|0
957137|NCT00723489|3151115|P4|Overall Study|Prohibited Medication|1
957139|NCT00723489|3151117|P2|Overall Study|Prohibited Medication|0
957140|NCT00723489|3151118|P1|Overall Study|Prohibited Medication|0
957141|NCT00723489|3151115|P4|Overall Study|Seropositive at baseline|0
957142|NCT00723489|3151116|P3|Overall Study|Seropositive at baseline|0
957143|NCT00723489|3151117|P2|Overall Study|Seropositive at baseline|0
957144|NCT00723489|3151118|P1|Overall Study|Seropositive at baseline|1
957145|NCT00723489|3151115|P4|Overall Study|Withdrawal by Subject|1
957146|NCT00723489|3151116|P3|Overall Study|Withdrawal by Subject|0
957147|NCT00723489|3151117|P2|Overall Study|Withdrawal by Subject|0
957148|NCT00723489|3151118|P1|Overall Study|Withdrawal by Subject|0
957149|NCT00723489|3151115|P4|Overall Study|Pregnancy|1
957150|NCT00723489|3151116|P3|Overall Study|Pregnancy|0
957151|NCT00723489|3151117|P2|Overall Study|Pregnancy|0
957152|NCT00723489|3151118|P1|Overall Study|Pregnancy|0
957153|NCT00723489|3151115|P4|Overall Study|Physician Decision|0
957154|NCT00723489|3151116|P3|Overall Study|Physician Decision|0
957155|NCT00723489|3151117|P2|Overall Study|Physician Decision|1
957156|NCT00723489|3151118|P1|Overall Study|Physician Decision|0
957157|NCT00723450|3151146|P3|Randomized Phase|Withdrawal by Subject|22
957158|NCT00723450|3151147|P2|Randomized Phase|Withdrawal by Subject|14
957159|NCT00723450|3151148|P1|Randomized Phase|Withdrawal by Subject|0
957160|NCT00723450|3151146|P3|Randomized Phase|Physician Decision|1
957161|NCT00723450|3151147|P2|Randomized Phase|Physician Decision|3
957162|NCT00723450|3151148|P1|Randomized Phase|Physician Decision|0
957163|NCT00723450|3151146|P3|Randomized Phase|Lost to Follow-up|3
957164|NCT00723450|3151147|P2|Randomized Phase|Lost to Follow-up|2
957165|NCT00723450|3151148|P1|Randomized Phase|Lost to Follow-up|0
957166|NCT00723450|3151146|P3|Randomized Phase|Protocol Violation|13
957167|NCT00723450|3151147|P2|Randomized Phase|Protocol Violation|9
957168|NCT00723450|3151148|P1|Randomized Phase|Protocol Violation|0
957169|NCT00723450|3151146|P3|Randomized Phase|Lack of Efficacy|11
957170|NCT00723450|3151147|P2|Randomized Phase|Lack of Efficacy|11
957171|NCT00723450|3151148|P1|Randomized Phase|Lack of Efficacy|0
957172|NCT00723450|3151146|P3|Randomized Phase|Adverse Event|17
957173|NCT00723450|3151147|P2|Randomized Phase|Adverse Event|26
957174|NCT00723450|3151148|P1|Randomized Phase|Adverse Event|0
957175|NCT00723450|3151146|P3|Open-Label Phase|Withdrawal by Subject|0
957176|NCT00723450|3151147|P2|Open-Label Phase|Withdrawal by Subject|0
957177|NCT00723450|3151148|P1|Open-Label Phase|Withdrawal by Subject|37
957178|NCT00723450|3151146|P3|Open-Label Phase|Physician Decision|0
957179|NCT00723450|3151147|P2|Open-Label Phase|Physician Decision|0
957180|NCT00723450|3151148|P1|Open-Label Phase|Physician Decision|2
957181|NCT00723450|3151146|P3|Open-Label Phase|Lost to Follow-up|0
957182|NCT00723450|3151147|P2|Open-Label Phase|Lost to Follow-up|0
957183|NCT00723450|3151148|P1|Open-Label Phase|Lost to Follow-up|7
957184|NCT00723450|3151146|P3|Open-Label Phase|Protocol Violation|0
957185|NCT00723450|3151147|P2|Open-Label Phase|Protocol Violation|0
957186|NCT00723450|3151148|P1|Open-Label Phase|Protocol Violation|35
957187|NCT00723450|3151146|P3|Open-Label Phase|Lack of Efficacy|0
957188|NCT00723450|3151147|P2|Open-Label Phase|Lack of Efficacy|0
957189|NCT00723450|3151148|P1|Open-Label Phase|Lack of Efficacy|18
957190|NCT00723450|3151146|P3|Open-Label Phase|Adverse Event|0
957191|NCT00723450|3151147|P2|Open-Label Phase|Adverse Event|0
957192|NCT00723450|3151148|P1|Open-Label Phase|Adverse Event|26
957193|NCT00723398|3151194|P5|Overall Study|Lost to Follow-up|0
957194|NCT00723398|3151195|P4|Overall Study|Lost to Follow-up|0
957195|NCT00723398|3151196|P3|Overall Study|Lost to Follow-up|0
957196|NCT00723398|3151197|P2|Overall Study|Lost to Follow-up|1
957197|NCT00723398|3151198|P1|Overall Study|Lost to Follow-up|0
957198|NCT00723398|3151194|P5|Overall Study|Adverse Event|4
957199|NCT00723398|3151195|P4|Overall Study|Adverse Event|1
957200|NCT00723398|3151196|P3|Overall Study|Adverse Event|3
957201|NCT00723398|3151197|P2|Overall Study|Adverse Event|5
957202|NCT00723398|3151198|P1|Overall Study|Adverse Event|0
957203|NCT00723398|3151194|P5|Overall Study|Physician Decision|1
957204|NCT00723398|3151195|P4|Overall Study|Physician Decision|0
957205|NCT00723398|3151196|P3|Overall Study|Physician Decision|5
957206|NCT00723398|3151197|P2|Overall Study|Physician Decision|2
957207|NCT00723398|3151198|P1|Overall Study|Physician Decision|2
957208|NCT00723398|3151194|P5|Overall Study|Protocol Violation|0
957209|NCT00723398|3151195|P4|Overall Study|Protocol Violation|0
957210|NCT00723398|3151196|P3|Overall Study|Protocol Violation|5
957211|NCT00723398|3151197|P2|Overall Study|Protocol Violation|1
957212|NCT00723398|3151198|P1|Overall Study|Protocol Violation|2
957213|NCT00723398|3151194|P5|Overall Study|Withdrawal by Subject|4
957214|NCT00723398|3151195|P4|Overall Study|Withdrawal by Subject|4
957215|NCT00723398|3151196|P3|Overall Study|Withdrawal by Subject|4
957216|NCT00723398|3151197|P2|Overall Study|Withdrawal by Subject|6
957217|NCT00723398|3151198|P1|Overall Study|Withdrawal by Subject|2
957218|NCT00723294|3151260|P1|Overall Study|No treatment due to probe failure|1
957219|NCT00723294|3151260|P1|Overall Study|Withdrawal by Subject|1
957220|NCT00723294|3151260|P1|Overall Study|Benign lesion|1
957221|NCT00723294|3151260|P1|Overall Study|Treated by non-credentialed surgeon|1
957222|NCT00723294|3151260|P1|Overall Study|Treated prior to registration|1
957223|NCT00723294|3151260|P1|Overall Study|Did not undergo surgery|1
957224|NCT00723294|3151260|P1|Overall Study|No cryoabalation|2
957225|NCT00723294|3151260|P1|Overall Study|1.0-Tesla MRI|1
957226|NCT00723294|3151260|P1|Overall Study|No MRI tumor enhancement|1
957227|NCT00723294|3151260|P1|Overall Study|>25% intraductal component|1
957228|NCT00723294|3151260|P1|Overall Study|Lobular histology|2
957229|NCT00723255|3151265|P1|Overall Study|Ineligible: Wrong Primary|2
957230|NCT00723255|3151265|P1|Overall Study|Ineligible: Second primary|1
957231|NCT00723255|3151265|P1|Overall Study|Ineligible: Inadequate pathology|1
957232|NCT00723229|3151292|P2|First Intervention|Lost to Follow-up|3
957233|NCT00723229|3151293|P1|First Intervention|Lost to Follow-up|7
957234|NCT00723203|3151305|P1|Overall Study|Withdrawal by Subject|3
957235|NCT00723190|3151309|P1|Overall Study|Other-Not included in safety population|2
957236|NCT00723190|3151309|P1|Overall Study|Other-Premature Discontinuation|9
957237|NCT00723190|3151309|P1|Overall Study|Protocol Violation|15
957238|NCT00723190|3151309|P1|Overall Study|Lack of Efficacy|16
957239|NCT00723190|3151309|P1|Overall Study|Adverse Event|18
957240|NCT00723190|3151309|P1|Overall Study|Lost to Follow-up|37
957241|NCT00723190|3151309|P1|Overall Study|Withdrawal by Subject|45
957242|NCT00723125|3151342|P2|Overall Study|Adverse Event|0
957243|NCT00723125|3151343|P1|Overall Study|Adverse Event|2
957244|NCT00723125|3151342|P2|Overall Study|Withdrawal by Subject|6
957245|NCT00723125|3151343|P1|Overall Study|Withdrawal by Subject|15
957246|NCT00723125|3151342|P2|Overall Study|Met Dx|0
957247|NCT00723125|3151343|P1|Overall Study|Met Dx|1
957248|NCT00723021|3151380|P5|Intervention Period 4|Adverse Event|1
957249|NCT00723021|3151381|P4|Intervention Period 4|Adverse Event|0
957250|NCT00723021|3151382|P3|Intervention Period 4|Adverse Event|0
957251|NCT00723021|3151383|P2|Intervention Period 4|Adverse Event|0
957252|NCT00723021|3151384|P1|Intervention Period 4|Adverse Event|0
957253|NCT00723008|3151438|P2|4-Week Unblinded Treatment|Lost to Follow-up|1
957254|NCT00723008|3151439|P1|4-Week Unblinded Treatment|Lost to Follow-up|0
957255|NCT00723008|3151438|P2|4-Week Unblinded Treatment|Adverse Event|0
957256|NCT00723008|3151439|P1|4-Week Unblinded Treatment|Adverse Event|1
957257|NCT00723008|3151438|P2|4-Week Double Blinded|Lost to Follow-up|3
957258|NCT00723008|3151439|P1|4-Week Double Blinded|Lost to Follow-up|4
957259|NCT00723008|3151438|P2|4-Week Double Blinded|Withdrawal by Subject|1
957260|NCT00723008|3151439|P1|4-Week Double Blinded|Withdrawal by Subject|1
957261|NCT00723008|3151438|P2|4-Week Double Blinded|Lack of Efficacy|1
957262|NCT00723008|3151439|P1|4-Week Double Blinded|Lack of Efficacy|0
957263|NCT00723008|3151438|P2|Enrollment|Lost to Follow-up|0
957264|NCT00723008|3151439|P1|Enrollment|Lost to Follow-up|1
957265|NCT00722800|3151471|P2|Overall Study|Physician Decision|0
957266|NCT00722800|3151472|P1|Overall Study|Physician Decision|1
957267|NCT00722800|3151471|P2|Overall Study|Withdrawal by Subject|0
957268|NCT00722800|3151472|P1|Overall Study|Withdrawal by Subject|1
957269|NCT00722761|3151484|P2|Overall Study|Withdrawal by Subject|2
957270|NCT00722761|3151485|P1|Overall Study|Withdrawal by Subject|5
957271|NCT00722761|3151484|P2|Overall Study|Lost to Follow-up|4
957272|NCT00722761|3151485|P1|Overall Study|Lost to Follow-up|1
957273|NCT00722423|3151542|P2|Overall Study|Protocol Violation|1
957274|NCT00722423|3151543|P1|Overall Study|Protocol Violation|0
957275|NCT00722371|3151558|P7|Overall Study|Withdrawal by Subject|26
957276|NCT00722371|3151559|P6|Overall Study|Withdrawal by Subject|18
957277|NCT00722371|3151560|P5|Overall Study|Withdrawal by Subject|19
957278|NCT00722371|3151561|P4|Overall Study|Withdrawal by Subject|23
957279|NCT00722371|3151562|P3|Overall Study|Withdrawal by Subject|19
957280|NCT00722371|3151563|P2|Overall Study|Withdrawal by Subject|27
957281|NCT00722371|3151564|P1|Overall Study|Withdrawal by Subject|18
957282|NCT00722371|3151558|P7|Overall Study|Protocol Violation|1
957283|NCT00722371|3151559|P6|Overall Study|Protocol Violation|2
957284|NCT00722371|3151560|P5|Overall Study|Protocol Violation|4
957285|NCT00722371|3151561|P4|Overall Study|Protocol Violation|1
957286|NCT00722371|3151562|P3|Overall Study|Protocol Violation|0
957287|NCT00722371|3151563|P2|Overall Study|Protocol Violation|1
957288|NCT00722371|3151564|P1|Overall Study|Protocol Violation|6
957289|NCT00722371|3151558|P7|Overall Study|Pregnancy|0
957290|NCT00722371|3151559|P6|Overall Study|Pregnancy|1
957291|NCT00722371|3151560|P5|Overall Study|Pregnancy|0
957292|NCT00722371|3151561|P4|Overall Study|Pregnancy|0
957293|NCT00722371|3151562|P3|Overall Study|Pregnancy|0
957294|NCT00722371|3151563|P2|Overall Study|Pregnancy|1
957295|NCT00722371|3151564|P1|Overall Study|Pregnancy|1
957296|NCT00722371|3151558|P7|Overall Study|Physician Decision|4
957297|NCT00722371|3151559|P6|Overall Study|Physician Decision|3
957298|NCT00722371|3151560|P5|Overall Study|Physician Decision|2
957299|NCT00722371|3151561|P4|Overall Study|Physician Decision|5
957300|NCT00722371|3151562|P3|Overall Study|Physician Decision|2
957301|NCT00722371|3151563|P2|Overall Study|Physician Decision|2
957302|NCT00722371|3151564|P1|Overall Study|Physician Decision|5
957303|NCT00722371|3151558|P7|Overall Study|Lost to Follow-up|13
957304|NCT00722371|3151559|P6|Overall Study|Lost to Follow-up|16
957305|NCT00722371|3151560|P5|Overall Study|Lost to Follow-up|8
957306|NCT00722371|3151561|P4|Overall Study|Lost to Follow-up|13
957307|NCT00722371|3151562|P3|Overall Study|Lost to Follow-up|21
957308|NCT00722371|3151563|P2|Overall Study|Lost to Follow-up|14
957309|NCT00722371|3151564|P1|Overall Study|Lost to Follow-up|11
957310|NCT00722371|3151558|P7|Overall Study|Lack of Efficacy|0
957311|NCT00722371|3151559|P6|Overall Study|Lack of Efficacy|3
957312|NCT00722371|3151560|P5|Overall Study|Lack of Efficacy|2
957313|NCT00722371|3151561|P4|Overall Study|Lack of Efficacy|6
957314|NCT00722371|3151562|P3|Overall Study|Lack of Efficacy|6
957315|NCT00722371|3151563|P2|Overall Study|Lack of Efficacy|6
957316|NCT00722371|3151564|P1|Overall Study|Lack of Efficacy|4
957317|NCT00722371|3151558|P7|Overall Study|Hypoglycemia|0
957318|NCT00722371|3151559|P6|Overall Study|Hypoglycemia|0
957319|NCT00722371|3151560|P5|Overall Study|Hypoglycemia|0
957320|NCT00722371|3151561|P4|Overall Study|Hypoglycemia|0
957321|NCT00722371|3151562|P3|Overall Study|Hypoglycemia|0
957322|NCT00722371|3151563|P2|Overall Study|Hypoglycemia|0
957323|NCT00722371|3151564|P1|Overall Study|Hypoglycemia|1
957324|NCT00722371|3151558|P7|Overall Study|Hyperglycemia|1
957325|NCT00722371|3151559|P6|Overall Study|Hyperglycemia|1
957326|NCT00722371|3151560|P5|Overall Study|Hyperglycemia|5
957327|NCT00722371|3151561|P4|Overall Study|Hyperglycemia|2
957328|NCT00722371|3151562|P3|Overall Study|Hyperglycemia|4
957329|NCT00722371|3151563|P2|Overall Study|Hyperglycemia|6
957330|NCT00722371|3151564|P1|Overall Study|Hyperglycemia|2
957331|NCT00722371|3151558|P7|Overall Study|Excluded medication|1
957332|NCT00722371|3151559|P6|Overall Study|Excluded medication|0
957333|NCT00722371|3151560|P5|Overall Study|Excluded medication|0
957334|NCT00722371|3151561|P4|Overall Study|Excluded medication|0
957335|NCT00722371|3151562|P3|Overall Study|Excluded medication|1
957336|NCT00722371|3151563|P2|Overall Study|Excluded medication|1
957337|NCT00722371|3151564|P1|Overall Study|Excluded medication|0
957338|NCT00722371|3151558|P7|Overall Study|Creatinine / Creatinine clearance|1
957339|NCT00722371|3151559|P6|Overall Study|Creatinine / Creatinine clearance|1
957340|NCT00722371|3151560|P5|Overall Study|Creatinine / Creatinine clearance|2
957341|NCT00722371|3151561|P4|Overall Study|Creatinine / Creatinine clearance|3
957342|NCT00722371|3151562|P3|Overall Study|Creatinine / Creatinine clearance|2
957343|NCT00722371|3151563|P2|Overall Study|Creatinine / Creatinine clearance|1
957344|NCT00722371|3151564|P1|Overall Study|Creatinine / Creatinine clearance|2
957345|NCT00722371|3151558|P7|Overall Study|Contraindication|0
957346|NCT00722371|3151559|P6|Overall Study|Contraindication|0
957347|NCT00722371|3151560|P5|Overall Study|Contraindication|0
957348|NCT00722371|3151561|P4|Overall Study|Contraindication|0
957349|NCT00722371|3151562|P3|Overall Study|Contraindication|1
957350|NCT00722371|3151563|P2|Overall Study|Contraindication|0
957351|NCT00722371|3151564|P1|Overall Study|Contraindication|0
957352|NCT00722371|3151558|P7|Overall Study|Adverse Event|4
957353|NCT00722371|3151559|P6|Overall Study|Adverse Event|8
957354|NCT00722371|3151560|P5|Overall Study|Adverse Event|6
957355|NCT00722371|3151561|P4|Overall Study|Adverse Event|10
957356|NCT00722371|3151562|P3|Overall Study|Adverse Event|9
957357|NCT00722371|3151563|P2|Overall Study|Adverse Event|13
957358|NCT00722371|3151564|P1|Overall Study|Adverse Event|6
957359|NCT00722137|3151617|P2|Overall Study|Randomized But Not Treated|3
957360|NCT00722137|3151618|P1|Overall Study|Randomized But Not Treated|2
957361|NCT00722137|3151617|P2|Overall Study|Other Reason Unknown|4
957362|NCT00722137|3151618|P1|Overall Study|Other Reason Unknown|3
957363|NCT00722137|3151617|P2|Overall Study|Withdrawal by Subject|9
957364|NCT00722137|3151618|P1|Overall Study|Withdrawal by Subject|6
957365|NCT00722137|3151617|P2|Overall Study|Death|7
957366|NCT00722137|3151618|P1|Overall Study|Death|12
957367|NCT00722137|3151617|P2|Overall Study|Adverse Event|21
957368|NCT00722137|3151618|P1|Overall Study|Adverse Event|17
957369|NCT00722137|3151617|P2|Overall Study|Overt Disease Progression|4
957370|NCT00722137|3151618|P1|Overall Study|Overt Disease Progression|5
957371|NCT00721968|3151688|P2|Overall Study|Lost to Follow-up|0
957372|NCT00721968|3151689|P1|Overall Study|Lost to Follow-up|2
957373|NCT00721955|3151700|P3|Overall Study|Adverse Event|2
957374|NCT00721955|3151701|P2|Overall Study|Adverse Event|0
957375|NCT00721955|3151702|P1|Overall Study|Adverse Event|0
957376|NCT00721799|3151716|P1|Overall Study|withdraw by subject after scan 1|1
957377|NCT00721799|3151716|P1|Overall Study|Withdrawal by Subject|7
957378|NCT00721734|3151756|P5|Overall Study|Other|0
957379|NCT00721734|3151757|P4|Overall Study|Other|1
957380|NCT00721734|3151758|P3|Overall Study|Other|0
957381|NCT00721734|3151759|P2|Overall Study|Other|0
957382|NCT00721734|3151760|P1|Overall Study|Other|0
957383|NCT00721734|3151756|P5|Overall Study|Withdrawal by Subject|1
957384|NCT00721734|3151757|P4|Overall Study|Withdrawal by Subject|0
957385|NCT00721734|3151758|P3|Overall Study|Withdrawal by Subject|0
957386|NCT00721734|3151759|P2|Overall Study|Withdrawal by Subject|1
957387|NCT00721734|3151760|P1|Overall Study|Withdrawal by Subject|2
957388|NCT00721734|3151756|P5|Overall Study|Adverse Event|3
957389|NCT00721734|3151757|P4|Overall Study|Adverse Event|0
957390|NCT00721734|3151758|P3|Overall Study|Adverse Event|4
957391|NCT00721734|3151759|P2|Overall Study|Adverse Event|1
957392|NCT00721734|3151760|P1|Overall Study|Adverse Event|3
957393|NCT00721734|3151756|P5|Overall Study|Progressive Disease|2
957394|NCT00721734|3151757|P4|Overall Study|Progressive Disease|5
957395|NCT00721734|3151758|P3|Overall Study|Progressive Disease|4
957396|NCT00721734|3151759|P2|Overall Study|Progressive Disease|10
957397|NCT00721734|3151760|P1|Overall Study|Progressive Disease|3
957398|NCT00721630|3151872|P1|Overall Study|Participant found to be ineligible|1
957399|NCT00721578|3151901|P2|Overall Study|Withdrawal by Subject|1
957400|NCT00721578|3151902|P1|Overall Study|Withdrawal by Subject|1
957401|NCT00721578|3151901|P2|Overall Study|Death|1
957402|NCT00721578|3151902|P1|Overall Study|Death|1
957403|NCT00721409|3151945|P3|Overall Study|Death|0
957404|NCT00721409|3151946|P2|Overall Study|Death|1
957405|NCT00721409|3151947|P1|Overall Study|Death|0
957406|NCT00721409|3151945|P3|Overall Study|Adverse Event|2
957407|NCT00721409|3151946|P2|Overall Study|Adverse Event|11
957408|NCT00721409|3151947|P1|Overall Study|Adverse Event|0
957409|NCT00721409|3151945|P3|Overall Study|Reason not specified|5
957410|NCT00721409|3151946|P2|Overall Study|Reason not specified|1
957411|NCT00721409|3151947|P1|Overall Study|Reason not specified|0
957412|NCT00721409|3151945|P3|Overall Study|Withdrawal by Subject|6
957413|NCT00721409|3151946|P2|Overall Study|Withdrawal by Subject|5
957414|NCT00721409|3151947|P1|Overall Study|Withdrawal by Subject|1
957415|NCT00721409|3151945|P3|Overall Study|Objective progression or relapse|57
957416|NCT00721409|3151946|P2|Overall Study|Objective progression or relapse|42
957417|NCT00721409|3151947|P1|Overall Study|Objective progression or relapse|7
957418|NCT00721409|3151945|P3|Overall Study|Global deterioration of health status|3
957419|NCT00721409|3151946|P2|Overall Study|Global deterioration of health status|5
957420|NCT00721409|3151947|P1|Overall Study|Global deterioration of health status|2
957421|NCT00721409|3151945|P3|Overall Study|Ongoing at date of cutoff|8
957422|NCT00721409|3151946|P2|Overall Study|Ongoing at date of cutoff|19
957423|NCT00721409|3151947|P1|Overall Study|Ongoing at date of cutoff|2
957424|NCT00721396|3152074|P4|Overall Study|Administrative reason|0
957425|NCT00721396|3152075|P3|Overall Study|Administrative reason|1
957426|NCT00721396|3152076|P2|Overall Study|Administrative reason|0
957427|NCT00721396|3152077|P1|Overall Study|Administrative reason|3
957428|NCT00721396|3152074|P4|Overall Study|Inappropriate enrollment|0
957429|NCT00721396|3152075|P3|Overall Study|Inappropriate enrollment|0
957430|NCT00721396|3152076|P2|Overall Study|Inappropriate enrollment|2
957431|NCT00721396|3152077|P1|Overall Study|Inappropriate enrollment|0
957432|NCT00721396|3152074|P4|Overall Study|Protocol Violation|0
957433|NCT00721396|3152075|P3|Overall Study|Protocol Violation|1
957434|NCT00721396|3152076|P2|Overall Study|Protocol Violation|3
957435|NCT00721396|3152077|P1|Overall Study|Protocol Violation|4
957436|NCT00721396|3152074|P4|Overall Study|Lost to Follow-up|3
957437|NCT00721396|3152075|P3|Overall Study|Lost to Follow-up|3
957438|NCT00721396|3152076|P2|Overall Study|Lost to Follow-up|9
957439|NCT00721396|3152077|P1|Overall Study|Lost to Follow-up|7
957440|NCT00721396|3152074|P4|Overall Study|Withdrawal by Subject|7
957441|NCT00721396|3152075|P3|Overall Study|Withdrawal by Subject|3
957442|NCT00721396|3152076|P2|Overall Study|Withdrawal by Subject|15
957443|NCT00721396|3152077|P1|Overall Study|Withdrawal by Subject|12
957444|NCT00721396|3152074|P4|Overall Study|Adverse Event|0
957445|NCT00721396|3152075|P3|Overall Study|Adverse Event|2
957446|NCT00721396|3152076|P2|Overall Study|Adverse Event|7
957447|NCT00721396|3152077|P1|Overall Study|Adverse Event|4
957448|NCT00721279|3152124|P2|Overall Study|Other|16
957449|NCT00721279|3152125|P1|Overall Study|Other|12
957450|NCT00721279|3152124|P2|Overall Study|Withdrawal by Subject|3
957451|NCT00721279|3152125|P1|Overall Study|Withdrawal by Subject|13
957452|NCT00721279|3152124|P2|Overall Study|Tolerability insufficient|2
957453|NCT00721279|3152125|P1|Overall Study|Tolerability insufficient|5
957454|NCT00721279|3152124|P2|Overall Study|Lack of Efficacy|3
957455|NCT00721279|3152125|P1|Overall Study|Lack of Efficacy|6
957456|NCT00721227|3152153|P2|Overall Study|Noncompliance with scheduled visits.|0
957457|NCT00721227|3152154|P1|Overall Study|Noncompliance with scheduled visits.|1
957458|NCT00721227|3152153|P2|Overall Study|Lost to Follow-up|0
957459|NCT00721227|3152154|P1|Overall Study|Lost to Follow-up|3
957460|NCT00721214|3152164|P1|Overall Study|Death|3
957461|NCT00721214|3152164|P1|Overall Study|Chose another center for transplant|1
957462|NCT00721149|3152214|P1|Overall Study|Physician Decision|1
957463|NCT00721123|3152248|P1|Overall Study|Withdrawal by Subject|5
957464|NCT00721123|3152248|P1|Overall Study|Failure to Return|9
957465|NCT00721123|3152248|P1|Overall Study|Refused Treatment|41
957466|NCT00721123|3152248|P1|Overall Study|Protocol Violation|1
957467|NCT00721123|3152248|P1|Overall Study|Insufficient Therapeutic Response|21
957468|NCT00721123|3152248|P1|Overall Study|Death|10
957469|NCT00721123|3152248|P1|Overall Study|Adverse Event|96
957470|NCT00721110|3152326|P4|Overall Study|vertical incision|0
957471|NCT00721110|3152327|P3|Overall Study|vertical incision|1
957472|NCT00721110|3152328|P2|Overall Study|vertical incision|0
957473|NCT00721110|3152329|P1|Overall Study|vertical incision|0
957474|NCT00721110|3152326|P4|Overall Study|Ultram use|0
957475|NCT00721110|3152327|P3|Overall Study|Ultram use|0
957476|NCT00721110|3152328|P2|Overall Study|Ultram use|0
957477|NCT00721110|3152329|P1|Overall Study|Ultram use|1
957478|NCT00720941|3152357|P2|Overall Study|Ongoing|23
957479|NCT00720941|3152358|P1|Overall Study|Ongoing|34
957480|NCT00720941|3152357|P2|Overall Study|Withdrawal by Subject|35
957481|NCT00720941|3152358|P1|Overall Study|Withdrawal by Subject|27
957482|NCT00720941|3152357|P2|Overall Study|Physician Decision|5
957483|NCT00720941|3152358|P1|Overall Study|Physician Decision|1
957484|NCT00720941|3152357|P2|Overall Study|Lost to Follow-up|15
957485|NCT00720941|3152358|P1|Overall Study|Lost to Follow-up|17
957486|NCT00720941|3152357|P2|Overall Study|Protocol Violation|2
957487|NCT00720941|3152358|P1|Overall Study|Protocol Violation|0
957488|NCT00720941|3152357|P2|Overall Study|Death|335
957489|NCT00720941|3152358|P1|Overall Study|Death|334
957490|NCT00720876|3152398|P1|Overall Study|found to be ineligible after starting tx|2
957491|NCT00720798|3152404|P1|Overall Study|Reason not Specified|83
957492|NCT00720798|3152404|P1|Overall Study|Failure to Return|46
957493|NCT00720798|3152404|P1|Overall Study|Refused Treatment|151
957494|NCT00720798|3152404|P1|Overall Study|Protocol Violation|4
957495|NCT00720798|3152404|P1|Overall Study|Insufficient Therapeutic Response|129
957496|NCT00720798|3152404|P1|Overall Study|Death|39
957497|NCT00720798|3152404|P1|Overall Study|Adverse Event|304
957498|NCT00720759|3152427|P4|Overall Study|Lost to Follow-up|0
957499|NCT00720759|3152428|P3|Overall Study|Lost to Follow-up|1
957500|NCT00720759|3152429|P2|Overall Study|Lost to Follow-up|1
957501|NCT00720759|3152430|P1|Overall Study|Lost to Follow-up|0
957502|NCT00720499|3152450|P2|Treatment Period 2 (4 Weeks)|Adverse Event|3
957503|NCT00720499|3152451|P1|Treatment Period 2 (4 Weeks)|Adverse Event|2
957504|NCT00720499|3152450|P2|Treatment Period 1 (4 Weeks)|Protocol Violation|2
957505|NCT00720499|3152451|P1|Treatment Period 1 (4 Weeks)|Protocol Violation|1
957506|NCT00720499|3152450|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
957507|NCT00720499|3152451|P1|Treatment Period 1 (4 Weeks)|Adverse Event|2
957508|NCT00720434|3152544|P4|Open-Label Period (Week 5-72)|Other|2
957509|NCT00720434|3152545|P3|Open-Label Period (Week 5-72)|Other|3
957510|NCT00720434|3152546|P2|Open-Label Period (Week 5-72)|Other|3
957511|NCT00720434|3152547|P1|Open-Label Period (Week 5-72)|Other|4
957512|NCT00720434|3152544|P4|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
957513|NCT00720434|3152545|P3|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
957514|NCT00720434|3152546|P2|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
957515|NCT00720434|3152547|P1|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
957516|NCT00720434|3152544|P4|Open-Label Period (Week 5-72)|Lost to Follow-up|0
957517|NCT00720434|3152545|P3|Open-Label Period (Week 5-72)|Lost to Follow-up|0
957518|NCT00720434|3152546|P2|Open-Label Period (Week 5-72)|Lost to Follow-up|0
957519|NCT00720434|3152547|P1|Open-Label Period (Week 5-72)|Lost to Follow-up|1
957520|NCT00720434|3152544|P4|Open-Label Period (Week 5-72)|Adverse Event|2
957521|NCT00720434|3152545|P3|Open-Label Period (Week 5-72)|Adverse Event|0
957522|NCT00720434|3152546|P2|Open-Label Period (Week 5-72)|Adverse Event|0
957523|NCT00720434|3152547|P1|Open-Label Period (Week 5-72)|Adverse Event|0
957524|NCT00720434|3152544|P4|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
957525|NCT00720434|3152545|P3|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
957526|NCT00720434|3152546|P2|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1
957527|NCT00720434|3152547|P1|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
957528|NCT00720382|3152571|P2|Overall Study|administrative|5
957529|NCT00720382|3152572|P1|Overall Study|administrative|14
957530|NCT00720382|3152571|P2|Overall Study|Lost to Follow-up|14
957531|NCT00720382|3152572|P1|Overall Study|Lost to Follow-up|28
957532|NCT00720382|3152571|P2|Overall Study|Withdrawal by Subject|11
957533|NCT00720382|3152572|P1|Overall Study|Withdrawal by Subject|47
957534|NCT00720382|3152571|P2|Overall Study|Non-Compliance|5
957535|NCT00720382|3152572|P1|Overall Study|Non-Compliance|15
957536|NCT00720382|3152571|P2|Overall Study|Lack of Efficacy|7
957537|NCT00720382|3152572|P1|Overall Study|Lack of Efficacy|18
957538|NCT00720382|3152571|P2|Overall Study|Adverse Event|17
957539|NCT00720382|3152572|P1|Overall Study|Adverse Event|54
957540|NCT00720356|3152591|P1|Follow up Until Death|Alive at last data collection|4
957541|NCT00720356|3152591|P1|Follow up Until Death|Withdrawal by Subject|1
957542|NCT00720356|3152591|P1|Went on to be Treated Cycle 3|Physician Decision|1
957543|NCT00720356|3152591|P1|Went on to be Treated Cycle 3|Adverse Event|1
957544|NCT00720356|3152591|P1|Reached 1st Response/2 Cycles|Withdrawal by Subject|1
957545|NCT00720356|3152591|P1|Reached 1st Response/2 Cycles|Progressive Disease|1
957546|NCT00720356|3152591|P1|Registration to Study|Determined to have methylated MGMT|67
957547|NCT00720343|3152605|P1|Overall Study|No data|3
957548|NCT00720343|3152605|P1|Overall Study|Physician Decision|3
957549|NCT00720278|3152639|P3|Overall Study|eligibility criteria violation|1
957550|NCT00720278|3152640|P2|Overall Study|eligibility criteria violation|0
957551|NCT00720278|3152641|P1|Overall Study|eligibility criteria violation|1
957552|NCT00720278|3152639|P3|Overall Study|Non-compliance|0
957553|NCT00720278|3152640|P2|Overall Study|Non-compliance|0
957554|NCT00720278|3152641|P1|Overall Study|Non-compliance|1
957555|NCT00720278|3152639|P3|Overall Study|Lost to Follow-up|1
957556|NCT00720278|3152640|P2|Overall Study|Lost to Follow-up|0
957557|NCT00720278|3152641|P1|Overall Study|Lost to Follow-up|0
957558|NCT00720278|3152639|P3|Overall Study|Withdrawal by Subject|0
957559|NCT00720278|3152640|P2|Overall Study|Withdrawal by Subject|1
957560|NCT00720278|3152641|P1|Overall Study|Withdrawal by Subject|0
957561|NCT00720278|3152639|P3|Overall Study|Adverse Event|4
957562|NCT00720278|3152640|P2|Overall Study|Adverse Event|3
957563|NCT00720278|3152641|P1|Overall Study|Adverse Event|5
957564|NCT00720226|3152663|P2|Overall Study|Withdrawal by Subject|4
957565|NCT00720226|3152664|P1|Overall Study|Withdrawal by Subject|7
957566|NCT00720122|3152672|P1|Overall Study|Withdrawal by Subject|7
957567|NCT00720122|3152672|P1|Overall Study|Physician Decision|1
957568|NCT00720122|3152672|P1|Overall Study|Lost to Follow-up|1
957569|NCT00720109|3152676|P3|Risk Stratification Period|Development of second malignant neoplasm|0
957570|NCT00720109|3152677|P2|Risk Stratification Period|Development of second malignant neoplasm|1
957571|NCT00720109|3152678|P1|Risk Stratification Period|Development of second malignant neoplasm|0
957572|NCT00720109|3152676|P3|Risk Stratification Period|Disease progression or relapse|0
957573|NCT00720109|3152677|P2|Risk Stratification Period|Disease progression or relapse|2
957574|NCT00720109|3152678|P1|Risk Stratification Period|Disease progression or relapse|0
957575|NCT00720109|3152676|P3|Risk Stratification Period|Bone marrow transplant|7
957576|NCT00720109|3152677|P2|Risk Stratification Period|Bone marrow transplant|9
957577|NCT00720109|3152678|P1|Risk Stratification Period|Bone marrow transplant|0
957578|NCT00720109|3152676|P3|Risk Stratification Period|Physician Decision|1
957579|NCT00720109|3152677|P2|Risk Stratification Period|Physician Decision|2
957580|NCT00720109|3152678|P1|Risk Stratification Period|Physician Decision|0
957581|NCT00720109|3152676|P3|Risk Stratification Period|Adverse Event|0
957582|NCT00720109|3152677|P2|Risk Stratification Period|Adverse Event|1
957583|NCT00720109|3152678|P1|Risk Stratification Period|Adverse Event|0
957584|NCT00720109|3152676|P3|Induction Period|Physician Decision|0
957585|NCT00720109|3152677|P2|Induction Period|Physician Decision|0
957586|NCT00720109|3152678|P1|Induction Period|Physician Decision|1
957587|NCT00720109|3152676|P3|Induction Period|Bone Marrow Transplant|0
957588|NCT00720109|3152677|P2|Induction Period|Bone Marrow Transplant|0
957589|NCT00720109|3152678|P1|Induction Period|Bone Marrow Transplant|2
957590|NCT00720109|3152676|P3|Induction Period|Did not meet eligibility criteria|0
957591|NCT00720109|3152677|P2|Induction Period|Did not meet eligibility criteria|0
957592|NCT00720109|3152678|P1|Induction Period|Did not meet eligibility criteria|3
957593|NCT00720096|3152698|P2|Overall Study|Withdrawal by Subject|2
957594|NCT00720096|3152699|P1|Overall Study|Withdrawal by Subject|0
957595|NCT00720083|3152711|P2|Overall Study|Ineligible|2
957596|NCT00720083|3152712|P1|Overall Study|Ineligible|1
957597|NCT00720057|3152720|P2|Overall Study|Withdrawal by Subject|1
957598|NCT00720057|3152721|P1|Overall Study|Withdrawal by Subject|0
957599|NCT00720057|3152720|P2|Overall Study|Protocol Violation|0
957600|NCT00720057|3152721|P1|Overall Study|Protocol Violation|1
957601|NCT00720057|3152720|P2|Overall Study|Lost to Follow-up|2
957602|NCT00720057|3152721|P1|Overall Study|Lost to Follow-up|0
957603|NCT00719953|3152737|P1|Overall Study|Adverse Event|4
957604|NCT00719901|3152750|P1|Overall Study|Availability of Study Drug|1
957605|NCT00719901|3152750|P1|Overall Study|Disease Progression|3
957606|NCT00719901|3152750|P1|Overall Study|Alternate Treatment|1
957607|NCT00719901|3152750|P1|Overall Study|Withdrawal by Subject|1
957608|NCT00719901|3152750|P1|Overall Study|Adverse Event|5
957609|NCT00719862|3152762|P2|Overall Study|Other|3
957610|NCT00719862|3152763|P1|Overall Study|Other|2
957611|NCT00719862|3152762|P2|Overall Study|Lost to Follow-up|1
957612|NCT00719862|3152763|P1|Overall Study|Lost to Follow-up|0
957613|NCT00719862|3152762|P2|Overall Study|Withdrawal by Subject|0
957614|NCT00719862|3152763|P1|Overall Study|Withdrawal by Subject|1
957615|NCT00719862|3152762|P2|Overall Study|Non-Compliance|0
957616|NCT00719862|3152763|P1|Overall Study|Non-Compliance|1
957617|NCT00719862|3152762|P2|Overall Study|Lack of Efficacy|0
957618|NCT00719862|3152763|P1|Overall Study|Lack of Efficacy|3
957619|NCT00719862|3152762|P2|Overall Study|Adverse Event|2
957620|NCT00719862|3152763|P1|Overall Study|Adverse Event|1
957621|NCT00719849|3152781|P2|Overall Study|Death|1
957622|NCT00719849|3152782|P1|Overall Study|Death|0
957623|NCT00719810|3152821|P3|Overall Study|Withdrawal by Subject|2
957624|NCT00719810|3152822|P2|Overall Study|Withdrawal by Subject|1
957625|NCT00719810|3152823|P1|Overall Study|Withdrawal by Subject|1
957626|NCT00719810|3152821|P3|Overall Study|Physician Decision|0
957627|NCT00719810|3152822|P2|Overall Study|Physician Decision|1
957628|NCT00719810|3152823|P1|Overall Study|Physician Decision|0
957629|NCT00719810|3152821|P3|Overall Study|Lost to Follow-up|3
957630|NCT00719810|3152822|P2|Overall Study|Lost to Follow-up|0
957631|NCT00719810|3152823|P1|Overall Study|Lost to Follow-up|2
957632|NCT00719810|3152821|P3|Overall Study|Adverse Event|3
957633|NCT00719810|3152822|P2|Overall Study|Adverse Event|2
957634|NCT00719810|3152823|P1|Overall Study|Adverse Event|0
957635|NCT00719732|3152834|P1|Overall Study|Illness not associated with device|1
957636|NCT00719732|3152834|P1|Overall Study|Unilateral (not bilateral) implantation|1
957637|NCT00719732|3152834|P1|Overall Study|Lost to Follow-up|20
957638|NCT00719706|3152840|P2|Overall Study|Protocol Violation|0
957639|NCT00719706|3152841|P1|Overall Study|Protocol Violation|3
957640|NCT00719706|3152840|P2|Overall Study|Withdrawal by Subject|2
957641|NCT00719706|3152841|P1|Overall Study|Withdrawal by Subject|1
957642|NCT00719706|3152840|P2|Overall Study|Adverse Event|4
957643|NCT00719706|3152841|P1|Overall Study|Adverse Event|5
957644|NCT00719680|3152855|P1|Overall Study|Withdrawal by Subject|3
957645|NCT00719680|3152855|P1|Overall Study|Lost to Follow-up|1
957646|NCT00719680|3152855|P1|Overall Study|Adverse Event|1
957647|NCT00719563|3152911|P2|Overall Study|Lost to Follow-up|3
957648|NCT00719563|3152912|P1|Overall Study|Lost to Follow-up|5
957649|NCT00719563|3152911|P2|Overall Study|Noncompliant|1
957650|NCT00719563|3152912|P1|Overall Study|Noncompliant|1
957651|NCT00719563|3152911|P2|Overall Study|Unknown reasons|6
957652|NCT00719563|3152912|P1|Overall Study|Unknown reasons|4
957653|NCT00719563|3152911|P2|Overall Study|Personal reasons|7
957654|NCT00719563|3152912|P1|Overall Study|Personal reasons|6
957655|NCT00719563|3152911|P2|Overall Study|Lack of Efficacy|7
957656|NCT00719563|3152912|P1|Overall Study|Lack of Efficacy|3
957657|NCT00719563|3152911|P2|Overall Study|Medical condition changed|5
957658|NCT00719563|3152912|P1|Overall Study|Medical condition changed|3
957659|NCT00719563|3152911|P2|Overall Study|Adverse Event|13
957660|NCT00719563|3152912|P1|Overall Study|Adverse Event|16
957661|NCT00719537|3152944|P2|Overall Study|Lost to Follow-up|1
957662|NCT00719537|3152945|P1|Overall Study|Lost to Follow-up|0
957663|NCT00719537|3152944|P2|Overall Study|Withdrawal by Subject|0
957664|NCT00719537|3152945|P1|Overall Study|Withdrawal by Subject|1
957665|NCT00719472|3152951|P1|Received Cycle 2 Treatment|Various Reasons|25
957666|NCT00719472|3152951|P1|Received Cycle 2 Treatment|Subject decision to withdraw|6
957667|NCT00719472|3152951|P1|Received Cycle 2 Treatment|Physician decision to withdraw patient|13
957668|NCT00719472|3152951|P1|Received Cycle 2 Treatment|Lost to Follow-up|3
957669|NCT00719472|3152951|P1|Received Cycle 2 Treatment|Disease progression|3
957670|NCT00719472|3152951|P1|Received Cycle 2 Treatment|Death|6
957671|NCT00719472|3152951|P1|Received Cycle 2 Treatment|Adverse Event|12
957672|NCT00719472|3152951|P1|Received Cycle 1 Treatment|Various Reasons|13
957673|NCT00719472|3152951|P1|Received Cycle 1 Treatment|Subject decision to withdraw|9
957674|NCT00719472|3152951|P1|Received Cycle 1 Treatment|Physician decision to withdraw patient|7
957675|NCT00719472|3152951|P1|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11
957676|NCT00719472|3152951|P1|Received Cycle 1 Treatment|Death|5
957677|NCT00719472|3152951|P1|Received Cycle 1 Treatment|Adverse Event|8
957678|NCT00719472|3152951|P1|Enrolled in Study|Various Reasons|17
957679|NCT00719472|3152951|P1|Enrolled in Study|Subject decision to withdraw|8
957680|NCT00719472|3152951|P1|Enrolled in Study|Physician decision to withdraw patient|1
957681|NCT00719355|3152962|P2|Overall Study|Moved|1
957682|NCT00719355|3152963|P1|Overall Study|Moved|0
957683|NCT00719355|3152962|P2|Overall Study|Compliance|6
957684|NCT00719355|3152963|P1|Overall Study|Compliance|4
957685|NCT00719355|3152962|P2|Overall Study|Medical|5
957686|NCT00719355|3152963|P1|Overall Study|Medical|14
957687|NCT00719355|3152962|P2|Overall Study|Death|1
957688|NCT00719355|3152963|P1|Overall Study|Death|0
957689|NCT00719264|3152992|P2|Overall Study|Disease Progression|107
957690|NCT00719264|3152993|P1|Overall Study|Disease Progression|104
957691|NCT00719264|3152992|P2|Overall Study|New Cancer Therapy|2
957692|NCT00719264|3152993|P1|Overall Study|New Cancer Therapy|4
957693|NCT00719264|3152992|P2|Overall Study|Protocol Deviation|3
957694|NCT00719264|3152993|P1|Overall Study|Protocol Deviation|1
957695|NCT00719264|3152992|P2|Overall Study|Withdrawal by Subject|7
957696|NCT00719264|3152993|P1|Overall Study|Withdrawal by Subject|12
957697|NCT00719264|3152992|P2|Overall Study|Lost to Follow-up|1
957698|NCT00719264|3152993|P1|Overall Study|Lost to Follow-up|1
957699|NCT00719264|3152992|P2|Overall Study|Administrative Problems|4
957700|NCT00719264|3152993|P1|Overall Study|Administrative Problems|6
957701|NCT00719264|3152992|P2|Overall Study|Death|10
957702|NCT00719264|3152993|P1|Overall Study|Death|13
957703|NCT00719264|3152992|P2|Overall Study|Adverse Event|49
957704|NCT00719264|3152993|P1|Overall Study|Adverse Event|41
957705|NCT00719212|3153012|P1|Overall Study|Withdrawal by Subject|1
957706|NCT00719212|3153012|P1|Overall Study|Lost to Follow-up|2
957707|NCT00719212|3153012|P1|Overall Study|Death|41
957708|NCT00719043|3153060|P7|Overall Study|Withdrawal by Subject|14
957709|NCT00719043|3153061|P6|Overall Study|Withdrawal by Subject|18
957710|NCT00719043|3153062|P5|Overall Study|Withdrawal by Subject|16
957711|NCT00719043|3153063|P4|Overall Study|Withdrawal by Subject|10
957712|NCT00719043|3153064|P3|Overall Study|Withdrawal by Subject|9
957713|NCT00719043|3153065|P2|Overall Study|Withdrawal by Subject|14
957714|NCT00719043|3153066|P1|Overall Study|Withdrawal by Subject|12
957715|NCT00719043|3153060|P7|Overall Study|Other|1
957716|NCT00719043|3153061|P6|Overall Study|Other|2
957717|NCT00719043|3153062|P5|Overall Study|Other|0
957718|NCT00719043|3153063|P4|Overall Study|Other|2
957719|NCT00719043|3153064|P3|Overall Study|Other|1
957720|NCT00719043|3153065|P2|Overall Study|Other|0
957721|NCT00719043|3153066|P1|Overall Study|Other|1
957722|NCT00719043|3153060|P7|Overall Study|Protocol Violation|0
957723|NCT00719043|3153061|P6|Overall Study|Protocol Violation|1
957724|NCT00719043|3153062|P5|Overall Study|Protocol Violation|0
957725|NCT00719043|3153063|P4|Overall Study|Protocol Violation|0
957726|NCT00719043|3153064|P3|Overall Study|Protocol Violation|0
957727|NCT00719043|3153065|P2|Overall Study|Protocol Violation|0
957728|NCT00719043|3153066|P1|Overall Study|Protocol Violation|0
957729|NCT00719043|3153060|P7|Overall Study|Lost to Follow-up|9
957730|NCT00719043|3153061|P6|Overall Study|Lost to Follow-up|9
957731|NCT00719043|3153062|P5|Overall Study|Lost to Follow-up|10
957732|NCT00719043|3153063|P4|Overall Study|Lost to Follow-up|9
957733|NCT00719043|3153064|P3|Overall Study|Lost to Follow-up|8
957734|NCT00719043|3153065|P2|Overall Study|Lost to Follow-up|10
957735|NCT00719043|3153066|P1|Overall Study|Lost to Follow-up|14
957736|NCT00719043|3153060|P7|Overall Study|Adverse Event|4
957737|NCT00719043|3153061|P6|Overall Study|Adverse Event|4
957738|NCT00719043|3153062|P5|Overall Study|Adverse Event|1
957739|NCT00719043|3153063|P4|Overall Study|Adverse Event|2
957740|NCT00719043|3153064|P3|Overall Study|Adverse Event|2
957741|NCT00719043|3153065|P2|Overall Study|Adverse Event|1
957742|NCT00719043|3153066|P1|Overall Study|Adverse Event|5
957743|NCT00718887|3153190|P2|Overall Study|Not identified|7
957744|NCT00718887|3153191|P1|Overall Study|Not identified|2
957745|NCT00718887|3153190|P2|Overall Study|Withdrawal by Subject|2
957746|NCT00718887|3153191|P1|Overall Study|Withdrawal by Subject|3
957747|NCT00718861|3153215|P2|Overall Study|Death|5
957748|NCT00718861|3153216|P1|Overall Study|Death|1
957749|NCT00718861|3153215|P2|Overall Study|Administrative Problems|1
957750|NCT00718861|3153216|P1|Overall Study|Administrative Problems|1
957751|NCT00718861|3153215|P2|Overall Study|Lost to Follow-up|1
957752|NCT00718861|3153216|P1|Overall Study|Lost to Follow-up|2
957753|NCT00718861|3153215|P2|Overall Study|Adverse Event|1
957754|NCT00718861|3153216|P1|Overall Study|Adverse Event|2
957755|NCT00718861|3153215|P2|Overall Study|Withdrawal by Subject|10
957756|NCT00718861|3153216|P1|Overall Study|Withdrawal by Subject|15
957757|NCT00718809|3153244|P2|Overall Study|Noncompliance|0
957758|NCT00718809|3153245|P1|Overall Study|Noncompliance|1
957759|NCT00718809|3153244|P2|Overall Study|Lost to Follow-up|0
957760|NCT00718809|3153245|P1|Overall Study|Lost to Follow-up|1
957761|NCT00718809|3153244|P2|Overall Study|Withdrawal by Subject|1
957762|NCT00718809|3153245|P1|Overall Study|Withdrawal by Subject|0
957763|NCT00718809|3153244|P2|Overall Study|Adverse Event|1
957764|NCT00718809|3153245|P1|Overall Study|Adverse Event|1
957765|NCT00718809|3153244|P2|Overall Study|Disease progression|7
957766|NCT00718809|3153245|P1|Overall Study|Disease progression|9
957767|NCT00718770|3153259|P1|Overall Study|Adverse Event|1
957768|NCT00718770|3153259|P1|Overall Study|Lack of Efficacy|1
957769|NCT00718770|3153259|P1|Overall Study|Adverse Event|1
957770|NCT00718770|3153259|P1|Overall Study|Lack of Efficacy|1
957771|NCT00718770|3153259|P1|Overall Study|Adverse Event|1
957772|NCT00718770|3153259|P1|Overall Study|Lack of Efficacy|1
957773|NCT00718770|3153259|P1|Overall Study|Lack of Efficacy|1
957774|NCT00718770|3153259|P1|Overall Study|Adverse Event|1
957775|NCT00718718|3153270|P10|Week 12 to End of Study|Other|0
957776|NCT00718718|3153271|P9|Week 12 to End of Study|Other|0
957777|NCT00718718|3153272|P8|Week 12 to End of Study|Other|0
957778|NCT00718718|3153273|P7|Week 12 to End of Study|Other|1
957779|NCT00718718|3153274|P6|Week 12 to End of Study|Other|0
957780|NCT00718718|3153275|P5|Week 12 to End of Study|Other|0
957781|NCT00718718|3153276|P4|Week 12 to End of Study|Other|1
957782|NCT00718718|3153277|P3|Week 12 to End of Study|Other|0
957783|NCT00718718|3153278|P2|Week 12 to End of Study|Other|1
957784|NCT00718718|3153279|P1|Week 12 to End of Study|Other|0
957785|NCT00718718|3153270|P10|Week 12 to End of Study|Lost to Follow-up|0
957786|NCT00718718|3153271|P9|Week 12 to End of Study|Lost to Follow-up|1
957787|NCT00718718|3153272|P8|Week 12 to End of Study|Lost to Follow-up|0
957788|NCT00718718|3153273|P7|Week 12 to End of Study|Lost to Follow-up|0
957789|NCT00718718|3153274|P6|Week 12 to End of Study|Lost to Follow-up|0
957790|NCT00718718|3153275|P5|Week 12 to End of Study|Lost to Follow-up|0
957791|NCT00718718|3153276|P4|Week 12 to End of Study|Lost to Follow-up|0
957792|NCT00718718|3153277|P3|Week 12 to End of Study|Lost to Follow-up|0
957793|NCT00718718|3153278|P2|Week 12 to End of Study|Lost to Follow-up|0
957794|NCT00718718|3153279|P1|Week 12 to End of Study|Lost to Follow-up|0
957795|NCT00718718|3153270|P10|Week 12 to End of Study|Withdrawal by Subject|0
957796|NCT00718718|3153271|P9|Week 12 to End of Study|Withdrawal by Subject|0
957797|NCT00718718|3153272|P8|Week 12 to End of Study|Withdrawal by Subject|0
957798|NCT00718718|3153273|P7|Week 12 to End of Study|Withdrawal by Subject|1
957799|NCT00718718|3153274|P6|Week 12 to End of Study|Withdrawal by Subject|2
957800|NCT00718718|3153275|P5|Week 12 to End of Study|Withdrawal by Subject|0
957801|NCT00718718|3153276|P4|Week 12 to End of Study|Withdrawal by Subject|0
957802|NCT00718718|3153277|P3|Week 12 to End of Study|Withdrawal by Subject|0
957803|NCT00718718|3153278|P2|Week 12 to End of Study|Withdrawal by Subject|0
957804|NCT00718718|3153279|P1|Week 12 to End of Study|Withdrawal by Subject|0
957805|NCT00718718|3153270|P10|Week 12 to End of Study|Death|0
957806|NCT00718718|3153271|P9|Week 12 to End of Study|Death|0
957807|NCT00718718|3153272|P8|Week 12 to End of Study|Death|0
957808|NCT00718718|3153273|P7|Week 12 to End of Study|Death|0
957809|NCT00718718|3153274|P6|Week 12 to End of Study|Death|1
957810|NCT00718718|3153275|P5|Week 12 to End of Study|Death|0
957811|NCT00718718|3153276|P4|Week 12 to End of Study|Death|0
957812|NCT00718718|3153277|P3|Week 12 to End of Study|Death|0
957813|NCT00718718|3153278|P2|Week 12 to End of Study|Death|0
957814|NCT00718718|3153279|P1|Week 12 to End of Study|Death|0
957815|NCT00718718|3153270|P10|Week 12 to End of Study|Adverse Event|0
957816|NCT00718718|3153271|P9|Week 12 to End of Study|Adverse Event|0
957817|NCT00718718|3153272|P8|Week 12 to End of Study|Adverse Event|1
957818|NCT00718718|3153273|P7|Week 12 to End of Study|Adverse Event|0
957819|NCT00718718|3153274|P6|Week 12 to End of Study|Adverse Event|0
957820|NCT00718718|3153275|P5|Week 12 to End of Study|Adverse Event|0
957821|NCT00718718|3153276|P4|Week 12 to End of Study|Adverse Event|0
957822|NCT00718718|3153277|P3|Week 12 to End of Study|Adverse Event|0
957823|NCT00718718|3153278|P2|Week 12 to End of Study|Adverse Event|0
957824|NCT00718718|3153279|P1|Week 12 to End of Study|Adverse Event|0
957825|NCT00718718|3153270|P10|Prior to Week 12|Other|0
957826|NCT00718718|3153271|P9|Prior to Week 12|Other|0
957827|NCT00718718|3153272|P8|Prior to Week 12|Other|0
957828|NCT00718718|3153273|P7|Prior to Week 12|Other|0
957829|NCT00718718|3153274|P6|Prior to Week 12|Other|0
957830|NCT00718718|3153275|P5|Prior to Week 12|Other|0
957831|NCT00718718|3153276|P4|Prior to Week 12|Other|0
957832|NCT00718718|3153277|P3|Prior to Week 12|Other|1
957833|NCT00718718|3153278|P2|Prior to Week 12|Other|0
957834|NCT00718718|3153279|P1|Prior to Week 12|Other|1
957835|NCT00718718|3153270|P10|Prior to Week 12|Withdrawal by Subject|0
957836|NCT00718718|3153271|P9|Prior to Week 12|Withdrawal by Subject|1
957837|NCT00718718|3153272|P8|Prior to Week 12|Withdrawal by Subject|1
957838|NCT00718718|3153273|P7|Prior to Week 12|Withdrawal by Subject|1
957839|NCT00718718|3153274|P6|Prior to Week 12|Withdrawal by Subject|0
957840|NCT00718718|3153275|P5|Prior to Week 12|Withdrawal by Subject|3
957841|NCT00718718|3153276|P4|Prior to Week 12|Withdrawal by Subject|0
957842|NCT00718718|3153277|P3|Prior to Week 12|Withdrawal by Subject|0
957843|NCT00718718|3153278|P2|Prior to Week 12|Withdrawal by Subject|0
957844|NCT00718718|3153279|P1|Prior to Week 12|Withdrawal by Subject|0
957845|NCT00718718|3153270|P10|Prior to Week 12|Adverse Event|0
957846|NCT00718718|3153271|P9|Prior to Week 12|Adverse Event|1
957847|NCT00718718|3153272|P8|Prior to Week 12|Adverse Event|1
957848|NCT00718718|3153273|P7|Prior to Week 12|Adverse Event|0
957849|NCT00718718|3153274|P6|Prior to Week 12|Adverse Event|0
957850|NCT00718718|3153275|P5|Prior to Week 12|Adverse Event|0
957851|NCT00718718|3153276|P4|Prior to Week 12|Adverse Event|0
957852|NCT00718718|3153277|P3|Prior to Week 12|Adverse Event|0
957853|NCT00718718|3153278|P2|Prior to Week 12|Adverse Event|0
957854|NCT00718718|3153279|P1|Prior to Week 12|Adverse Event|0
957855|NCT00718666|3153322|P3|Booster Phase Year 5|Lost to Follow-up|4
957856|NCT00718666|3153323|P2|Booster Phase Year 5|Lost to Follow-up|0
957857|NCT00718666|3153324|P1|Booster Phase Year 5|Lost to Follow-up|1
957858|NCT00718666|3153322|P3|Booster Phase Year 5|Withdrawal by Subject|1
957859|NCT00718666|3153323|P2|Booster Phase Year 5|Withdrawal by Subject|0
957860|NCT00718666|3153324|P1|Booster Phase Year 5|Withdrawal by Subject|0
957861|NCT00718666|3153322|P3|Booster Phase Year 5|Declined v-4 serology|0
957862|NCT00718666|3153323|P2|Booster Phase Year 5|Declined v-4 serology|0
957863|NCT00718666|3153324|P1|Booster Phase Year 5|Declined v-4 serology|1
957864|NCT00718666|3153322|P3|Booster Phase Year 5|No active participation request|1
957865|NCT00718666|3153323|P2|Booster Phase Year 5|No active participation request|0
957866|NCT00718666|3153324|P1|Booster Phase Year 5|No active participation request|0
957867|NCT00718640|3153408|P1|Overall Study|Unresolved toxicity after 2 weeks|2
957868|NCT00718640|3153408|P1|Overall Study|Death|1
957869|NCT00718640|3153408|P1|Overall Study|Adverse Event|4
957870|NCT00718549|3153420|P3|Maintenance/ Observation Phase|Relapse|2
957871|NCT00718549|3153421|P2|Maintenance/ Observation Phase|Relapse|3
957872|NCT00718549|3153422|P1|Maintenance/ Observation Phase|Relapse|0
957873|NCT00718549|3153420|P3|Maintenance/ Observation Phase|Progression|14
957874|NCT00718549|3153421|P2|Maintenance/ Observation Phase|Progression|5
957875|NCT00718549|3153422|P1|Maintenance/ Observation Phase|Progression|0
957876|NCT00718549|3153420|P3|Maintenance/ Observation Phase|Lost to Follow-up|4
957877|NCT00718549|3153421|P2|Maintenance/ Observation Phase|Lost to Follow-up|4
957878|NCT00718549|3153422|P1|Maintenance/ Observation Phase|Lost to Follow-up|0
957879|NCT00718549|3153420|P3|Maintenance/ Observation Phase|Death|2
957880|NCT00718549|3153421|P2|Maintenance/ Observation Phase|Death|1
957881|NCT00718549|3153422|P1|Maintenance/ Observation Phase|Death|0
957882|NCT00718549|3153420|P3|Maintenance/ Observation Phase|Early Termination - No Additional Info|8
957883|NCT00718549|3153421|P2|Maintenance/ Observation Phase|Early Termination - No Additional Info|15
957884|NCT00718549|3153422|P1|Maintenance/ Observation Phase|Early Termination - No Additional Info|0
957885|NCT00718549|3153420|P3|Induction Phase|Early Termination - No Additional Info|0
957886|NCT00718549|3153421|P2|Induction Phase|Early Termination - No Additional Info|0
957887|NCT00718549|3153422|P1|Induction Phase|Early Termination - No Additional Info|59
957888|NCT00718549|3153420|P3|Induction Phase|Eligibility Criteria Violation|0
957889|NCT00718549|3153421|P2|Induction Phase|Eligibility Criteria Violation|0
957890|NCT00718549|3153422|P1|Induction Phase|Eligibility Criteria Violation|2
957891|NCT00718549|3153420|P3|Induction Phase|Disease Progression|0
957892|NCT00718549|3153421|P2|Induction Phase|Disease Progression|0
957893|NCT00718549|3153422|P1|Induction Phase|Disease Progression|1
957894|NCT00718523|3153447|P2|Overall Study|Death|17
957895|NCT00718523|3153448|P1|Overall Study|Death|13
957896|NCT00718523|3153447|P2|Overall Study|Withdrawal by Subject|7
957897|NCT00718523|3153448|P1|Overall Study|Withdrawal by Subject|5
957898|NCT00718510|3153460|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|0
957899|NCT00718510|3153461|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|1
957900|NCT00718510|3153460|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
957901|NCT00718510|3153461|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
957902|NCT00718328|3153473|P2|Overall Study|Lost to Follow-up|0
957903|NCT00718328|3153474|P1|Overall Study|Lost to Follow-up|1
957904|NCT00718315|3153483|P3|Overall Study|Use of ATB and Corticoids|2
957905|NCT00718315|3153484|P2|Overall Study|Use of ATB and Corticoids|1
957906|NCT00718315|3153485|P1|Overall Study|Use of ATB and Corticoids|0
957907|NCT00718315|3153483|P3|Overall Study|Other|1
957908|NCT00718315|3153484|P2|Overall Study|Other|0
957909|NCT00718315|3153485|P1|Overall Study|Other|0
957910|NCT00718315|3153483|P3|Overall Study|Disease progression|1
957911|NCT00718315|3153484|P2|Overall Study|Disease progression|1
957912|NCT00718315|3153485|P1|Overall Study|Disease progression|0
957913|NCT00718315|3153483|P3|Overall Study|Use of Minocyclin|1
957914|NCT00718315|3153484|P2|Overall Study|Use of Minocyclin|1
957915|NCT00718315|3153485|P1|Overall Study|Use of Minocyclin|1
957916|NCT00718315|3153483|P3|Overall Study|Erlotinib dose decreased|1
957917|NCT00718315|3153484|P2|Overall Study|Erlotinib dose decreased|3
957918|NCT00718315|3153485|P1|Overall Study|Erlotinib dose decreased|4
957919|NCT00718315|3153483|P3|Overall Study|Protocol Violation|3
957920|NCT00718315|3153484|P2|Overall Study|Protocol Violation|5
957921|NCT00718315|3153485|P1|Overall Study|Protocol Violation|5
957922|NCT00718315|3153483|P3|Overall Study|Lost to Follow-up|4
957923|NCT00718315|3153484|P2|Overall Study|Lost to Follow-up|3
957924|NCT00718315|3153485|P1|Overall Study|Lost to Follow-up|2
957925|NCT00718315|3153483|P3|Overall Study|Death|5
957926|NCT00718315|3153484|P2|Overall Study|Death|6
957927|NCT00718315|3153485|P1|Overall Study|Death|6
957928|NCT00718315|3153483|P3|Overall Study|Adverse Event|3
957929|NCT00718315|3153484|P2|Overall Study|Adverse Event|2
957930|NCT00718315|3153485|P1|Overall Study|Adverse Event|1
957931|NCT00718237|3153536|P2|Overall Study|Withdrawal by Subject|10
957932|NCT00718237|3153537|P1|Overall Study|Withdrawal by Subject|9
957933|NCT00718237|3153536|P2|Overall Study|Physician Decision|0
957934|NCT00718237|3153537|P1|Overall Study|Physician Decision|1
957935|NCT00718237|3153536|P2|Overall Study|Lost to Follow-up|2
957936|NCT00718237|3153537|P1|Overall Study|Lost to Follow-up|2
957937|NCT00718237|3153536|P2|Overall Study|Adverse Event|3
957938|NCT00718237|3153537|P1|Overall Study|Adverse Event|1
957939|NCT00718159|3153554|P7|Overall Study|Investigator Decision|1
957940|NCT00718159|3153555|P6|Overall Study|Investigator Decision|1
957941|NCT00718159|3153556|P5|Overall Study|Investigator Decision|0
957942|NCT00718159|3153557|P4|Overall Study|Investigator Decision|0
957943|NCT00718159|3153558|P3|Overall Study|Investigator Decision|0
957944|NCT00718159|3153559|P2|Overall Study|Investigator Decision|0
957945|NCT00718159|3153560|P1|Overall Study|Investigator Decision|0
957946|NCT00718159|3153554|P7|Overall Study|Death due to Study Drug Toxicity|0
957947|NCT00718159|3153555|P6|Overall Study|Death due to Study Drug Toxicity|0
957948|NCT00718159|3153556|P5|Overall Study|Death due to Study Drug Toxicity|0
957949|NCT00718159|3153557|P4|Overall Study|Death due to Study Drug Toxicity|2
957950|NCT00718159|3153558|P3|Overall Study|Death due to Study Drug Toxicity|1
957951|NCT00718159|3153559|P2|Overall Study|Death due to Study Drug Toxicity|0
957952|NCT00718159|3153560|P1|Overall Study|Death due to Study Drug Toxicity|0
957953|NCT00718159|3153554|P7|Overall Study|Death due to Adverse Event|0
957954|NCT00718159|3153555|P6|Overall Study|Death due to Adverse Event|0
957955|NCT00718159|3153556|P5|Overall Study|Death due to Adverse Event|2
957956|NCT00718159|3153557|P4|Overall Study|Death due to Adverse Event|2
957957|NCT00718159|3153558|P3|Overall Study|Death due to Adverse Event|0
957958|NCT00718159|3153559|P2|Overall Study|Death due to Adverse Event|0
957959|NCT00718159|3153560|P1|Overall Study|Death due to Adverse Event|0
957960|NCT00718159|3153554|P7|Overall Study|Progressive Disease|0
957961|NCT00718159|3153555|P6|Overall Study|Progressive Disease|0
957962|NCT00718159|3153556|P5|Overall Study|Progressive Disease|6
957963|NCT00718159|3153557|P4|Overall Study|Progressive Disease|0
957964|NCT00718159|3153558|P3|Overall Study|Progressive Disease|2
957965|NCT00718159|3153559|P2|Overall Study|Progressive Disease|3
957966|NCT00718159|3153560|P1|Overall Study|Progressive Disease|3
957967|NCT00718081|3153617|P3|Overall Study|Lack of Efficacy|21
957968|NCT00718081|3153618|P2|Overall Study|Lack of Efficacy|3
957969|NCT00718081|3153619|P1|Overall Study|Lack of Efficacy|7
957970|NCT00718081|3153617|P3|Overall Study|Adverse Event|0
957971|NCT00718081|3153618|P2|Overall Study|Adverse Event|1
957972|NCT00718081|3153619|P1|Overall Study|Adverse Event|0
957973|NCT00718042|3153636|P6|Donor Follow-up|Lost to Follow-up|0
957974|NCT00718042|3153637|P5|Donor Follow-up|Lost to Follow-up|19
957975|NCT00718042|3153638|P4|Donor Follow-up|Lost to Follow-up|0
957976|NCT00718042|3153639|P3|Donor Follow-up|Lost to Follow-up|0
957977|NCT00718042|3153640|P2|Donor Follow-up|Lost to Follow-up|0
957978|NCT00718042|3153641|P1|Donor Follow-up|Lost to Follow-up|13
957979|NCT00718042|3153636|P6|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
957980|NCT00718042|3153637|P5|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
957981|NCT00718042|3153638|P4|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
957982|NCT00718042|3153639|P3|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
957983|NCT00718042|3153640|P2|ABBOTT PRISM Chagas Testing|No result on comparator assay|1
957984|NCT00718042|3153641|P1|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
957985|NCT00718042|3153636|P6|ABBOTT PRISM Chagas Testing|Insufficient sample|0
957986|NCT00718042|3153637|P5|ABBOTT PRISM Chagas Testing|Insufficient sample|0
957987|NCT00718042|3153638|P4|ABBOTT PRISM Chagas Testing|Insufficient sample|0
957988|NCT00718042|3153639|P3|ABBOTT PRISM Chagas Testing|Insufficient sample|1
957989|NCT00718042|3153640|P2|ABBOTT PRISM Chagas Testing|Insufficient sample|1
957990|NCT00718042|3153641|P1|ABBOTT PRISM Chagas Testing|Insufficient sample|0
957991|NCT00718042|3153636|P6|ABBOTT PRISM Chagas Testing|Protocol Violation|0
957992|NCT00718042|3153637|P5|ABBOTT PRISM Chagas Testing|Protocol Violation|36
957993|NCT00718042|3153638|P4|ABBOTT PRISM Chagas Testing|Protocol Violation|0
957994|NCT00718042|3153639|P3|ABBOTT PRISM Chagas Testing|Protocol Violation|0
957995|NCT00718042|3153640|P2|ABBOTT PRISM Chagas Testing|Protocol Violation|0
957996|NCT00718042|3153641|P1|ABBOTT PRISM Chagas Testing|Protocol Violation|64
957997|NCT00718042|3153636|P6|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
957998|NCT00718042|3153637|P5|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2
957999|NCT00718042|3153638|P4|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
958000|NCT00718042|3153639|P3|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
958001|NCT00718042|3153640|P2|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
958002|NCT00718042|3153641|P1|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
958003|NCT00717886|3153697|P1|Overall Study|Treatment Failure|1
958004|NCT00717886|3153697|P1|Overall Study|Withdrawal by Subject|3
958005|NCT00717860|3153712|P2|Overall Study|Withdrew consent|3
958006|NCT00717860|3153713|P1|Overall Study|Withdrew consent|7
958007|NCT00717860|3153712|P2|Overall Study|Discontinued for other reason|1
958008|NCT00717860|3153713|P1|Overall Study|Discontinued for other reason|6
958009|NCT00717860|3153712|P2|Overall Study|Lack of Efficacy|13
958010|NCT00717860|3153713|P1|Overall Study|Lack of Efficacy|7
958011|NCT00717860|3153712|P2|Overall Study|Laboratory adverse experience|2
958012|NCT00717860|3153713|P1|Overall Study|Laboratory adverse experience|2
958013|NCT00717860|3153712|P2|Overall Study|Clinical adverse experience|9
958014|NCT00717860|3153713|P1|Overall Study|Clinical adverse experience|5
958015|NCT00717756|3153723|P1|Overall Study|Withdrawal by Subject|1
958016|NCT00717522|3153736|P1|Overall Study|Death|1
958017|NCT00717522|3153736|P1|Overall Study|Adverse Event|1
958018|NCT00717522|3153736|P1|Overall Study|Disease Progression|5
958019|NCT00717366|3153772|P2|Extension Period (52 Weeks)|Withdrew consent|1
958020|NCT00717366|3153773|P1|Extension Period (52 Weeks)|Withdrew consent|1
958021|NCT00717366|3153772|P2|Extension Period (52 Weeks)|Admin/Other than specified|2
958022|NCT00717366|3153773|P1|Extension Period (52 Weeks)|Admin/Other than specified|0
958023|NCT00717366|3153772|P2|Extension Period (52 Weeks)|Renal transplant|13
958024|NCT00717366|3153773|P1|Extension Period (52 Weeks)|Renal transplant|3
958025|NCT00717366|3153772|P2|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1
958026|NCT00717366|3153773|P1|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0
958027|NCT00717366|3153772|P2|Core Study Period (20 Weeks)|Death|1
958028|NCT00717366|3153773|P1|Core Study Period (20 Weeks)|Death|0
958029|NCT00717366|3153772|P2|Core Study Period (20 Weeks)|Admin/Other than specified|2
958030|NCT00717366|3153773|P1|Core Study Period (20 Weeks)|Admin/Other than specified|0
958031|NCT00717366|3153772|P2|Core Study Period (20 Weeks)|Renal transplant|9
958032|NCT00717366|3153773|P1|Core Study Period (20 Weeks)|Renal transplant|4
958033|NCT00717314|3153797|P2|Overall Study|Withdrawal by Subject|3
958034|NCT00717314|3153798|P1|Overall Study|Withdrawal by Subject|1
958035|NCT00717314|3153797|P2|Overall Study|Lost to Follow-up|5
958036|NCT00717314|3153798|P1|Overall Study|Lost to Follow-up|1
958037|NCT00717314|3153797|P2|Overall Study|Protocol Violation|0
958038|NCT00717314|3153798|P1|Overall Study|Protocol Violation|1
958039|NCT00717314|3153797|P2|Overall Study|Adverse Event|2
958040|NCT00717314|3153798|P1|Overall Study|Adverse Event|3
958041|NCT00717275|3153835|P1|Overall Study|Premature study termination.|3
958042|NCT00717249|3153841|P2|Overall Study|Headaches|0
958043|NCT00717249|3153842|P1|Overall Study|Headaches|1
958044|NCT00717249|3153841|P2|Overall Study|Subject relocated|0
958045|NCT00717249|3153842|P1|Overall Study|Subject relocated|1
958046|NCT00717249|3153841|P2|Overall Study|Diagnosed with Multiple Scletosis|0
958047|NCT00717249|3153842|P1|Overall Study|Diagnosed with Multiple Scletosis|1
958048|NCT00717249|3153841|P2|Overall Study|Diagnosed with Diabetes|0
958049|NCT00717249|3153842|P1|Overall Study|Diagnosed with Diabetes|1
958050|NCT00717249|3153841|P2|Overall Study|Gastric Surgery|1
958051|NCT00717249|3153842|P1|Overall Study|Gastric Surgery|0
958052|NCT00717249|3153841|P2|Overall Study|Unsatisfactory Physiological Response|1
958053|NCT00717249|3153842|P1|Overall Study|Unsatisfactory Physiological Response|0
958054|NCT00717249|3153841|P2|Overall Study|Subject became Ineligible|1
958055|NCT00717249|3153842|P1|Overall Study|Subject became Ineligible|1
958056|NCT00717249|3153841|P2|Overall Study|Protocol Violation|2
958057|NCT00717249|3153842|P1|Overall Study|Protocol Violation|0
958058|NCT00717249|3153841|P2|Overall Study|Pregnancy|3
958059|NCT00717249|3153842|P1|Overall Study|Pregnancy|6
958060|NCT00717249|3153841|P2|Overall Study|Withdrawal by Subject|2
958061|NCT00717249|3153842|P1|Overall Study|Withdrawal by Subject|1
958062|NCT00717249|3153841|P2|Overall Study|Lost to Follow-up|0
958063|NCT00717249|3153842|P1|Overall Study|Lost to Follow-up|2
958064|NCT00717249|3153841|P2|Overall Study|Adverse Event|2
958065|NCT00717249|3153842|P1|Overall Study|Adverse Event|4
958066|NCT00717249|3153841|P2|Overall Study|Unsatisfactory visual Response|2
958067|NCT00717249|3153842|P1|Overall Study|Unsatisfactory visual Response|0
958068|NCT00717249|3153841|P2|Overall Study|Lens Discomfort|1
958069|NCT00717249|3153842|P1|Overall Study|Lens Discomfort|4
958070|NCT00717236|3153856|P2|Open-Label Period|Other: Medical Monitor Recommendation|0
958071|NCT00717236|3153857|P1|Open-Label Period|Other: Medical Monitor Recommendation|1
958072|NCT00717236|3153856|P2|Open-Label Period|Other: Completion Accidently Performed|0
958073|NCT00717236|3153857|P1|Open-Label Period|Other: Completion Accidently Performed|1
958074|NCT00717236|3153856|P2|Open-Label Period|Other: Administration of Golimumab|0
958075|NCT00717236|3153857|P1|Open-Label Period|Other: Administration of Golimumab|1
958076|NCT00717236|3153856|P2|Open-Label Period|Other: Cataract Surgery|0
958077|NCT00717236|3153857|P1|Open-Label Period|Other: Cataract Surgery|1
958078|NCT00717236|3153856|P2|Open-Label Period|Other: Sponsor Request|0
958079|NCT00717236|3153857|P1|Open-Label Period|Other: Sponsor Request|3
958080|NCT00717236|3153856|P2|Open-Label Period|Other: Loss of Staff (unblinded)|0
958081|NCT00717236|3153857|P1|Open-Label Period|Other: Loss of Staff (unblinded)|1
958082|NCT00717236|3153856|P2|Open-Label Period|Other: Investigator Decision|0
958083|NCT00717236|3153857|P1|Open-Label Period|Other: Investigator Decision|1
958084|NCT00717236|3153856|P2|Open-Label Period|Other: Moved|0
958085|NCT00717236|3153857|P1|Open-Label Period|Other: Moved|1
958086|NCT00717236|3153856|P2|Open-Label Period|Other: History of Basal Cell Carcinoma|0
958087|NCT00717236|3153857|P1|Open-Label Period|Other: History of Basal Cell Carcinoma|1
958088|NCT00717236|3153856|P2|Open-Label Period|Other: Lack of Compliance|1
958089|NCT00717236|3153857|P1|Open-Label Period|Other: Lack of Compliance|1
958090|NCT00717236|3153856|P2|Open-Label Period|Other: Peripheral Neuropathy|1
958091|NCT00717236|3153857|P1|Open-Label Period|Other: Peripheral Neuropathy|0
958092|NCT00717236|3153856|P2|Open-Label Period|Loss of Efficacy|1
958093|NCT00717236|3153857|P1|Open-Label Period|Loss of Efficacy|6
958094|NCT00717236|3153856|P2|Open-Label Period|Withdrawal by Subject|2
958095|NCT00717236|3153857|P1|Open-Label Period|Withdrawal by Subject|20
958096|NCT00717236|3153856|P2|Open-Label Period|Lost to Follow-up|4
958097|NCT00717236|3153857|P1|Open-Label Period|Lost to Follow-up|28
958098|NCT00717236|3153856|P2|Open-Label Period|Lack of Efficacy|8
958099|NCT00717236|3153857|P1|Open-Label Period|Lack of Efficacy|30
958100|NCT00717236|3153856|P2|Open-Label Period|Adverse Event|4
958101|NCT00717236|3153857|P1|Open-Label Period|Adverse Event|29
958102|NCT00717236|3153856|P2|Double-Blind Period|Other: Investigator Decision|1
958103|NCT00717236|3153857|P1|Double-Blind Period|Other: Investigator Decision|0
958104|NCT00717236|3153856|P2|Double-Blind Period|Other: Transportation problems|1
958105|NCT00717236|3153857|P1|Double-Blind Period|Other: Transportation problems|0
958106|NCT00717236|3153856|P2|Double-Blind Period|Other: Prohibited medication taken|2
958107|NCT00717236|3153857|P1|Double-Blind Period|Other: Prohibited medication taken|2
958108|NCT00717236|3153856|P2|Double-Blind Period|Other: Stopped taking DMARD|0
958109|NCT00717236|3153857|P1|Double-Blind Period|Other: Stopped taking DMARD|1
958110|NCT00717236|3153856|P2|Double-Blind Period|Other: Subject moved|1
958111|NCT00717236|3153857|P1|Double-Blind Period|Other: Subject moved|1
958112|NCT00717236|3153856|P2|Double-Blind Period|Other: Detection of Hepatitis C Virus|0
958113|NCT00717236|3153857|P1|Double-Blind Period|Other: Detection of Hepatitis C Virus|1
958114|NCT00717236|3153856|P2|Double-Blind Period|Other: Inappropriate randomization|0
958115|NCT00717236|3153857|P1|Double-Blind Period|Other: Inappropriate randomization|1
958116|NCT00717236|3153856|P2|Double-Blind Period|Other: Sponsor request|0
958117|NCT00717236|3153857|P1|Double-Blind Period|Other: Sponsor request|1
958118|NCT00717236|3153856|P2|Double-Blind Period|Other: History of cancer|0
958119|NCT00717236|3153857|P1|Double-Blind Period|Other: History of cancer|1
958120|NCT00717236|3153856|P2|Double-Blind Period|Other: History of adenoid grown|0
958121|NCT00717236|3153857|P1|Double-Blind Period|Other: History of adenoid grown|1
958122|NCT00717236|3153856|P2|Double-Blind Period|Other: Abnormal chest X-ray|1
958123|NCT00717236|3153857|P1|Double-Blind Period|Other: Abnormal chest X-ray|2
958124|NCT00717236|3153856|P2|Double-Blind Period|Other: subject withdrew consent|1
958125|NCT00717236|3153857|P1|Double-Blind Period|Other: subject withdrew consent|1
958126|NCT00717236|3153856|P2|Double-Blind Period|Other: Screening failure|0
958127|NCT00717236|3153857|P1|Double-Blind Period|Other: Screening failure|1
958128|NCT00717236|3153856|P2|Double-Blind Period|Other: Site withdrew|0
958129|NCT00717236|3153857|P1|Double-Blind Period|Other: Site withdrew|2
958130|NCT00717236|3153856|P2|Double-Blind Period|Other: Inclusion/Exclusion criteria|2
958131|NCT00717236|3153857|P1|Double-Blind Period|Other: Inclusion/Exclusion criteria|6
958132|NCT00717236|3153856|P2|Double-Blind Period|Other: Protocol Violation|0
958133|NCT00717236|3153857|P1|Double-Blind Period|Other: Protocol Violation|2
958134|NCT00717236|3153856|P2|Double-Blind Period|Other: Pregnancy|0
958135|NCT00717236|3153857|P1|Double-Blind Period|Other: Pregnancy|1
958136|NCT00717236|3153856|P2|Double-Blind Period|Other: Death|0
958137|NCT00717236|3153857|P1|Double-Blind Period|Other: Death|1
958138|NCT00717236|3153856|P2|Double-Blind Period|Loss of efficacy|0
958139|NCT00717236|3153857|P1|Double-Blind Period|Loss of efficacy|3
958140|NCT00717236|3153856|P2|Double-Blind Period|Withdrawal by Subject|2
958141|NCT00717236|3153857|P1|Double-Blind Period|Withdrawal by Subject|10
958142|NCT00717236|3153856|P2|Double-Blind Period|Lost to Follow-up|5
958143|NCT00717236|3153857|P1|Double-Blind Period|Lost to Follow-up|3
958144|NCT00717236|3153856|P2|Double-Blind Period|Lack of Efficacy|6
958145|NCT00717236|3153857|P1|Double-Blind Period|Lack of Efficacy|6
958146|NCT00717236|3153856|P2|Double-Blind Period|Adverse Event|6
958147|NCT00717236|3153857|P1|Double-Blind Period|Adverse Event|33
958148|NCT00717197|3153926|P1|Overall Study|Physician Decision|1
958149|NCT00717197|3153926|P1|Overall Study|Tumor Progression|1
958150|NCT00717197|3153926|P1|Overall Study|Unable to purchase study drug|5
958151|NCT00717093|3153932|P2|Overall Study|Randomized but not treated|0
958152|NCT00717093|3153933|P1|Overall Study|Randomized but not treated|1
958153|NCT00717093|3153932|P2|Overall Study|Other|1
958154|NCT00717093|3153933|P1|Overall Study|Other|0
958155|NCT00717093|3153932|P2|Overall Study|Withdrawal by Subject|19
958156|NCT00717093|3153933|P1|Overall Study|Withdrawal by Subject|12
958157|NCT00717093|3153932|P2|Overall Study|Lost to Follow-up|6
958158|NCT00717093|3153933|P1|Overall Study|Lost to Follow-up|9
958159|NCT00717093|3153932|P2|Overall Study|Lack of Efficacy|13
958160|NCT00717093|3153933|P1|Overall Study|Lack of Efficacy|3
958161|NCT00717093|3153932|P2|Overall Study|Adverse Event|9
958162|NCT00717093|3153933|P1|Overall Study|Adverse Event|19
958163|NCT00717067|3153950|P5|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
958164|NCT00717067|3153951|P4|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
958165|NCT00717067|3153952|P3|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1
958166|NCT00717067|3153953|P2|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
958167|NCT00717067|3153954|P1|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
958168|NCT00716976|3154061|P2|Overall Study|Ineligibles|2
958169|NCT00716976|3154062|P1|Overall Study|Ineligibles|4
958170|NCT00716976|3154061|P2|Overall Study|Radiation during protocol|0
958171|NCT00716976|3154062|P1|Overall Study|Radiation during protocol|1
958172|NCT00716976|3154061|P2|Overall Study|Premature discontinuation cisplatin|4
958173|NCT00716976|3154062|P1|Overall Study|Premature discontinuation cisplatin|5
958174|NCT00716976|3154061|P2|Overall Study|Withdrawal by Subject|1
958175|NCT00716976|3154062|P1|Overall Study|Withdrawal by Subject|5
958176|NCT00716976|3154061|P2|Overall Study|Physician Decision|2
958177|NCT00716976|3154062|P1|Overall Study|Physician Decision|2
958178|NCT00716976|3154061|P2|Overall Study|Death|0
958179|NCT00716976|3154062|P1|Overall Study|Death|1
958180|NCT00716976|3154061|P2|Overall Study|Adverse Event|0
958181|NCT00716976|3154062|P1|Overall Study|Adverse Event|2
958182|NCT00716859|3154102|P2|Overall Study|Not treated|1
958183|NCT00716859|3154103|P1|Overall Study|Not treated|1
958184|NCT00716859|3154102|P2|Overall Study|Withdrawal by Subject|3
958185|NCT00716859|3154103|P1|Overall Study|Withdrawal by Subject|1
958186|NCT00716859|3154102|P2|Overall Study|Lack of Efficacy|0
958187|NCT00716859|3154103|P1|Overall Study|Lack of Efficacy|3
958188|NCT00716859|3154102|P2|Overall Study|Adverse Event|1
958189|NCT00716859|3154103|P1|Overall Study|Adverse Event|4
958190|NCT00716625|3154188|P1|Overall Study|Safety was not Assessable|1
958191|NCT00716482|3154213|P1|Overall Study|inclusion/exclusion criteria not met|25
958192|NCT00716482|3154213|P1|Overall Study|technical/machine error|28
958193|NCT00716482|3154213|P1|Overall Study|no pathology obtained|10
958194|NCT00716482|3154213|P1|Overall Study|Inadequate acquisition or analysis|50
958195|NCT00716482|3154213|P1|Overall Study|Lost to Follow-up|6
958196|NCT00716456|3154226|P3|Overall Study|Adverse Event|0
958197|NCT00716456|3154227|P2|Overall Study|Adverse Event|2
958198|NCT00716456|3154228|P1|Overall Study|Adverse Event|0
958199|NCT00716417|3154279|P10|Overall Study|On patient request due to toxicities|0
958200|NCT00716417|3154280|P9|Overall Study|On patient request due to toxicities|0
958201|NCT00716417|3154281|P8|Overall Study|On patient request due to toxicities|1
958202|NCT00716417|3154282|P7|Overall Study|On patient request due to toxicities|0
958203|NCT00716417|3154283|P6|Overall Study|On patient request due to toxicities|0
958204|NCT00716417|3154284|P5|Overall Study|On patient request due to toxicities|0
958205|NCT00716417|3154285|P4|Overall Study|On patient request due to toxicities|0
958206|NCT00716417|3154286|P3|Overall Study|On patient request due to toxicities|0
958207|NCT00716417|3154287|P2|Overall Study|On patient request due to toxicities|0
958208|NCT00716417|3154288|P1|Overall Study|On patient request due to toxicities|0
958209|NCT00716417|3154279|P10|Overall Study|Dose limiting toxicity (DLT)|0
958210|NCT00716417|3154280|P9|Overall Study|Dose limiting toxicity (DLT)|0
958211|NCT00716417|3154281|P8|Overall Study|Dose limiting toxicity (DLT)|0
958212|NCT00716417|3154282|P7|Overall Study|Dose limiting toxicity (DLT)|0
958213|NCT00716417|3154283|P6|Overall Study|Dose limiting toxicity (DLT)|0
958214|NCT00716417|3154284|P5|Overall Study|Dose limiting toxicity (DLT)|1
958215|NCT00716417|3154285|P4|Overall Study|Dose limiting toxicity (DLT)|0
958216|NCT00716417|3154286|P3|Overall Study|Dose limiting toxicity (DLT)|0
958217|NCT00716417|3154287|P2|Overall Study|Dose limiting toxicity (DLT)|0
958218|NCT00716417|3154288|P1|Overall Study|Dose limiting toxicity (DLT)|0
958219|NCT00716417|3154279|P10|Overall Study|Progressive disease|0
958220|NCT00716417|3154280|P9|Overall Study|Progressive disease|5
958221|NCT00716417|3154281|P8|Overall Study|Progressive disease|1
958222|NCT00716417|3154282|P7|Overall Study|Progressive disease|3
958223|NCT00716417|3154283|P6|Overall Study|Progressive disease|3
958224|NCT00716417|3154284|P5|Overall Study|Progressive disease|0
958225|NCT00716417|3154285|P4|Overall Study|Progressive disease|8
958226|NCT00716417|3154286|P3|Overall Study|Progressive disease|3
958227|NCT00716417|3154287|P2|Overall Study|Progressive disease|5
958228|NCT00716417|3154288|P1|Overall Study|Progressive disease|3
958229|NCT00716417|3154279|P10|Overall Study|Withdrawal by Subject|0
958230|NCT00716417|3154280|P9|Overall Study|Withdrawal by Subject|0
958231|NCT00716417|3154281|P8|Overall Study|Withdrawal by Subject|0
958232|NCT00716417|3154282|P7|Overall Study|Withdrawal by Subject|1
958233|NCT00716417|3154283|P6|Overall Study|Withdrawal by Subject|0
958234|NCT00716417|3154284|P5|Overall Study|Withdrawal by Subject|0
958235|NCT00716417|3154285|P4|Overall Study|Withdrawal by Subject|2
958236|NCT00716417|3154286|P3|Overall Study|Withdrawal by Subject|0
958237|NCT00716417|3154287|P2|Overall Study|Withdrawal by Subject|1
958238|NCT00716417|3154288|P1|Overall Study|Withdrawal by Subject|0
958239|NCT00716417|3154279|P10|Overall Study|Adverse Event|3
958240|NCT00716417|3154280|P9|Overall Study|Adverse Event|0
958241|NCT00716417|3154281|P8|Overall Study|Adverse Event|1
958242|NCT00716417|3154282|P7|Overall Study|Adverse Event|3
958243|NCT00716417|3154283|P6|Overall Study|Adverse Event|0
958244|NCT00716417|3154284|P5|Overall Study|Adverse Event|0
958245|NCT00716417|3154285|P4|Overall Study|Adverse Event|1
958246|NCT00716417|3154286|P3|Overall Study|Adverse Event|2
958247|NCT00716417|3154287|P2|Overall Study|Adverse Event|0
958248|NCT00716417|3154288|P1|Overall Study|Adverse Event|0
958249|NCT00716274|3154335|P6|Study Period III (16-Weeks)|Adverse Event|0
958250|NCT00716274|3154336|P5|Study Period III (16-Weeks)|Adverse Event|1
958251|NCT00716274|3154337|P4|Study Period III (16-Weeks)|Adverse Event|0
958252|NCT00716274|3154338|P3|Study Period III (16-Weeks)|Adverse Event|0
958253|NCT00716274|3154339|P2|Study Period III (16-Weeks)|Adverse Event|0
958254|NCT00716274|3154340|P1|Study Period III (16-Weeks)|Adverse Event|0
958255|NCT00716274|3154335|P6|Study Period III (16-Weeks)|Parent Caregiver Decision|0
958256|NCT00716274|3154336|P5|Study Period III (16-Weeks)|Parent Caregiver Decision|1
958257|NCT00716274|3154337|P4|Study Period III (16-Weeks)|Parent Caregiver Decision|1
958258|NCT00716274|3154338|P3|Study Period III (16-Weeks)|Parent Caregiver Decision|0
958259|NCT00716274|3154339|P2|Study Period III (16-Weeks)|Parent Caregiver Decision|0
958260|NCT00716274|3154340|P1|Study Period III (16-Weeks)|Parent Caregiver Decision|0
958261|NCT00716274|3154335|P6|Study Period III (16-Weeks)|Physician Decision|0
958262|NCT00716274|3154336|P5|Study Period III (16-Weeks)|Physician Decision|1
958263|NCT00716274|3154337|P4|Study Period III (16-Weeks)|Physician Decision|0
958264|NCT00716274|3154338|P3|Study Period III (16-Weeks)|Physician Decision|0
958265|NCT00716274|3154339|P2|Study Period III (16-Weeks)|Physician Decision|0
958266|NCT00716274|3154340|P1|Study Period III (16-Weeks)|Physician Decision|0
958267|NCT00716274|3154335|P6|Study Period III (16-Weeks)|Withdrawal by Subject|0
958268|NCT00716274|3154336|P5|Study Period III (16-Weeks)|Withdrawal by Subject|0
958269|NCT00716274|3154337|P4|Study Period III (16-Weeks)|Withdrawal by Subject|0
958270|NCT00716274|3154338|P3|Study Period III (16-Weeks)|Withdrawal by Subject|2
958271|NCT00716274|3154339|P2|Study Period III (16-Weeks)|Withdrawal by Subject|0
958272|NCT00716274|3154340|P1|Study Period III (16-Weeks)|Withdrawal by Subject|0
958273|NCT00716274|3154335|P6|Study Period II (16-Weeks)|Lost to Follow-up|0
958274|NCT00716274|3154336|P5|Study Period II (16-Weeks)|Lost to Follow-up|0
958275|NCT00716274|3154337|P4|Study Period II (16-Weeks)|Lost to Follow-up|0
958276|NCT00716274|3154338|P3|Study Period II (16-Weeks)|Lost to Follow-up|0
958277|NCT00716274|3154339|P2|Study Period II (16-Weeks)|Lost to Follow-up|2
958278|NCT00716274|3154340|P1|Study Period II (16-Weeks)|Lost to Follow-up|0
958279|NCT00716274|3154335|P6|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
958280|NCT00716274|3154336|P5|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
958281|NCT00716274|3154337|P4|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
958282|NCT00716274|3154338|P3|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
958283|NCT00716274|3154339|P2|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
958284|NCT00716274|3154340|P1|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
958285|NCT00716274|3154335|P6|Study Period II (16-Weeks)|Physician Decision|1
958286|NCT00716274|3154336|P5|Study Period II (16-Weeks)|Physician Decision|0
958287|NCT00716274|3154337|P4|Study Period II (16-Weeks)|Physician Decision|0
958288|NCT00716274|3154338|P3|Study Period II (16-Weeks)|Physician Decision|0
958289|NCT00716274|3154339|P2|Study Period II (16-Weeks)|Physician Decision|1
958290|NCT00716274|3154340|P1|Study Period II (16-Weeks)|Physician Decision|3
958291|NCT00716274|3154335|P6|Study Period II (16-Weeks)|Withdrawal by Subject|0
958292|NCT00716274|3154336|P5|Study Period II (16-Weeks)|Withdrawal by Subject|0
958293|NCT00716274|3154337|P4|Study Period II (16-Weeks)|Withdrawal by Subject|0
958294|NCT00716274|3154338|P3|Study Period II (16-Weeks)|Withdrawal by Subject|0
958295|NCT00716274|3154339|P2|Study Period II (16-Weeks)|Withdrawal by Subject|0
958296|NCT00716274|3154340|P1|Study Period II (16-Weeks)|Withdrawal by Subject|1
958297|NCT00716274|3154335|P6|Study Period II (16-Weeks)|Protocol Violation|1
958298|NCT00716274|3154336|P5|Study Period II (16-Weeks)|Protocol Violation|0
958299|NCT00716274|3154337|P4|Study Period II (16-Weeks)|Protocol Violation|0
958300|NCT00716274|3154338|P3|Study Period II (16-Weeks)|Protocol Violation|0
958301|NCT00716274|3154339|P2|Study Period II (16-Weeks)|Protocol Violation|3
958302|NCT00716274|3154340|P1|Study Period II (16-Weeks)|Protocol Violation|0
958303|NCT00716274|3154335|P6|Study Period II (16-Weeks)|Entry Criteria Not Met|0
958304|NCT00716274|3154336|P5|Study Period II (16-Weeks)|Entry Criteria Not Met|0
958305|NCT00716274|3154337|P4|Study Period II (16-Weeks)|Entry Criteria Not Met|0
958306|NCT00716274|3154338|P3|Study Period II (16-Weeks)|Entry Criteria Not Met|0
958307|NCT00716274|3154339|P2|Study Period II (16-Weeks)|Entry Criteria Not Met|0
958308|NCT00716274|3154340|P1|Study Period II (16-Weeks)|Entry Criteria Not Met|2
958309|NCT00716144|3154474|P4|Overall Study|Clinical Depression|0
958310|NCT00716144|3154475|P3|Overall Study|Clinical Depression|0
958311|NCT00716144|3154476|P2|Overall Study|Clinical Depression|1
958312|NCT00716144|3154477|P1|Overall Study|Clinical Depression|0
958313|NCT00716144|3154474|P4|Overall Study|Adverse event: left foot pain|0
958314|NCT00716144|3154475|P3|Overall Study|Adverse event: left foot pain|0
958315|NCT00716144|3154476|P2|Overall Study|Adverse event: left foot pain|1
958316|NCT00716144|3154477|P1|Overall Study|Adverse event: left foot pain|0
958317|NCT00716144|3154474|P4|Overall Study|Withdrew consent, allowed use of data|0
958318|NCT00716144|3154475|P3|Overall Study|Withdrew consent, allowed use of data|1
958319|NCT00716144|3154476|P2|Overall Study|Withdrew consent, allowed use of data|0
958320|NCT00716144|3154477|P1|Overall Study|Withdrew consent, allowed use of data|0
958321|NCT00716144|3154474|P4|Overall Study|Intercurrent illness|0
958322|NCT00716144|3154475|P3|Overall Study|Intercurrent illness|1
958323|NCT00716144|3154476|P2|Overall Study|Intercurrent illness|0
958324|NCT00716144|3154477|P1|Overall Study|Intercurrent illness|0
958325|NCT00716144|3154474|P4|Overall Study|Physician Decision|2
958326|NCT00716144|3154475|P3|Overall Study|Physician Decision|2
958327|NCT00716144|3154476|P2|Overall Study|Physician Decision|1
958328|NCT00716144|3154477|P1|Overall Study|Physician Decision|0
958329|NCT00716144|3154474|P4|Overall Study|Protocol Violation|0
958330|NCT00716144|3154475|P3|Overall Study|Protocol Violation|1
958331|NCT00716144|3154476|P2|Overall Study|Protocol Violation|0
958332|NCT00716144|3154477|P1|Overall Study|Protocol Violation|2
958333|NCT00716144|3154474|P4|Overall Study|Non-compliance|0
958334|NCT00716144|3154475|P3|Overall Study|Non-compliance|0
958335|NCT00716144|3154476|P2|Overall Study|Non-compliance|0
958336|NCT00716144|3154477|P1|Overall Study|Non-compliance|1
958337|NCT00716144|3154474|P4|Overall Study|Adverse Event|2
958338|NCT00716144|3154475|P3|Overall Study|Adverse Event|0
958339|NCT00716144|3154476|P2|Overall Study|Adverse Event|0
958340|NCT00716144|3154477|P1|Overall Study|Adverse Event|0
958341|NCT00716144|3154474|P4|Overall Study|Lost to Follow-up|2
958342|NCT00716144|3154475|P3|Overall Study|Lost to Follow-up|1
958343|NCT00716144|3154476|P2|Overall Study|Lost to Follow-up|2
958344|NCT00716144|3154477|P1|Overall Study|Lost to Follow-up|2
958345|NCT00716144|3154474|P4|Overall Study|Withdrawal by Subject|6
958346|NCT00716144|3154475|P3|Overall Study|Withdrawal by Subject|6
958347|NCT00716144|3154476|P2|Overall Study|Withdrawal by Subject|2
958348|NCT00716144|3154477|P1|Overall Study|Withdrawal by Subject|4
958349|NCT00716092|3154502|P3|Overall Study|Other incl. Lack of Efficacy|0
958350|NCT00716092|3154503|P2|Overall Study|Other incl. Lack of Efficacy|1
958351|NCT00716092|3154504|P1|Overall Study|Other incl. Lack of Efficacy|2
958352|NCT00715949|3154557|P1|Overall Study|could not finish first test|4
958353|NCT00715910|3154565|P6|Booster and ESFU Phase|Other|0
958354|NCT00715910|3154566|P5|Booster and ESFU Phase|Other|1
958355|NCT00715910|3154567|P4|Booster and ESFU Phase|Other|5
958356|NCT00715910|3154568|P3|Booster and ESFU Phase|Other|0
958357|NCT00715910|3154569|P2|Booster and ESFU Phase|Other|0
958358|NCT00715910|3154570|P1|Booster and ESFU Phase|Other|0
958359|NCT00715910|3154565|P6|Booster and ESFU Phase|Lost to Follow-up|13
958360|NCT00715910|3154566|P5|Booster and ESFU Phase|Lost to Follow-up|1
958361|NCT00715910|3154567|P4|Booster and ESFU Phase|Lost to Follow-up|6
958362|NCT00715910|3154568|P3|Booster and ESFU Phase|Lost to Follow-up|0
958363|NCT00715910|3154569|P2|Booster and ESFU Phase|Lost to Follow-up|0
958364|NCT00715910|3154570|P1|Booster and ESFU Phase|Lost to Follow-up|0
958365|NCT00715793|3154689|P2|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2
958366|NCT00715793|3154690|P1|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0
958367|NCT00715793|3154689|P2|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0
958368|NCT00715793|3154690|P1|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1
958369|NCT00715676|3154751|P3|Overall Study|Elevated Blood Glucose|0
958370|NCT00715676|3154752|P2|Overall Study|Elevated Blood Glucose|1
958371|NCT00715676|3154753|P1|Overall Study|Elevated Blood Glucose|0
958372|NCT00715676|3154751|P3|Overall Study|Use of Exclusionary Medication|1
958373|NCT00715676|3154752|P2|Overall Study|Use of Exclusionary Medication|0
958374|NCT00715676|3154753|P1|Overall Study|Use of Exclusionary Medication|0
958375|NCT00715676|3154751|P3|Overall Study|Did Not Meet Entry Criteria|1
958376|NCT00715676|3154752|P2|Overall Study|Did Not Meet Entry Criteria|0
958377|NCT00715676|3154753|P1|Overall Study|Did Not Meet Entry Criteria|0
958378|NCT00715676|3154751|P3|Overall Study|Terminated by Sponsor|0
958379|NCT00715676|3154752|P2|Overall Study|Terminated by Sponsor|0
958380|NCT00715676|3154753|P1|Overall Study|Terminated by Sponsor|1
958381|NCT00715676|3154751|P3|Overall Study|Lost to Follow-up|1
958382|NCT00715676|3154752|P2|Overall Study|Lost to Follow-up|2
958383|NCT00715676|3154753|P1|Overall Study|Lost to Follow-up|1
958384|NCT00715676|3154751|P3|Overall Study|Withdrawal by Subject|8
958385|NCT00715676|3154752|P2|Overall Study|Withdrawal by Subject|3
958386|NCT00715676|3154753|P1|Overall Study|Withdrawal by Subject|1
958387|NCT00715676|3154751|P3|Overall Study|Adverse Event|21
958388|NCT00715676|3154752|P2|Overall Study|Adverse Event|5
958389|NCT00715676|3154753|P1|Overall Study|Adverse Event|3
958390|NCT00715624|3154796|P2|Overall Study|Other|1
958391|NCT00715624|3154797|P1|Overall Study|Other|0
958392|NCT00715624|3154796|P2|Overall Study|Incorrect randomization (not treated)|1
958393|NCT00715624|3154797|P1|Overall Study|Incorrect randomization (not treated)|0
958394|NCT00715624|3154796|P2|Overall Study|Sponsor decision|4
958395|NCT00715624|3154797|P1|Overall Study|Sponsor decision|0
958396|NCT00715624|3154796|P2|Overall Study|Poor compliance|13
958397|NCT00715624|3154797|P1|Overall Study|Poor compliance|6
958398|NCT00715624|3154796|P2|Overall Study|Familial and personal reasons|22
958399|NCT00715624|3154797|P1|Overall Study|Familial and personal reasons|10
958400|NCT00715624|3154796|P2|Overall Study|Withdrawal by Subject|25
958401|NCT00715624|3154797|P1|Overall Study|Withdrawal by Subject|11
958402|NCT00715624|3154796|P2|Overall Study|Protocol Violation|0
958403|NCT00715624|3154797|P1|Overall Study|Protocol Violation|1
958404|NCT00715624|3154796|P2|Overall Study|Lost to Follow-up|2
958405|NCT00715624|3154797|P1|Overall Study|Lost to Follow-up|1
958406|NCT00715624|3154796|P2|Overall Study|Lack of Efficacy|11
958407|NCT00715624|3154797|P1|Overall Study|Lack of Efficacy|11
958408|NCT00715624|3154796|P2|Overall Study|Adverse Event|37
958409|NCT00715624|3154797|P1|Overall Study|Adverse Event|12
958410|NCT00715559|3154825|P1|Overall Study|medication not tolerated - nausea|1
958411|NCT00715520|3154835|P3|Overall Study|Withdrawal by Subject|1
958412|NCT00715520|3154836|P2|Overall Study|Withdrawal by Subject|0
958413|NCT00715520|3154837|P1|Overall Study|Withdrawal by Subject|2
958414|NCT00715520|3154835|P3|Overall Study|Screen failure|1
958415|NCT00715520|3154836|P2|Overall Study|Screen failure|1
958416|NCT00715520|3154837|P1|Overall Study|Screen failure|8
958417|NCT00715403|3154857|P7|Overall Study|Other reason not defined above|0
958418|NCT00715403|3154858|P6|Overall Study|Other reason not defined above|1
958419|NCT00715403|3154859|P5|Overall Study|Other reason not defined above|1
958420|NCT00715403|3154860|P4|Overall Study|Other reason not defined above|0
958421|NCT00715403|3154861|P3|Overall Study|Other reason not defined above|1
958422|NCT00715403|3154862|P2|Overall Study|Other reason not defined above|0
958423|NCT00715403|3154863|P1|Overall Study|Other reason not defined above|0
958424|NCT00715403|3154857|P7|Overall Study|Protocol Violation|0
958425|NCT00715403|3154858|P6|Overall Study|Protocol Violation|1
958426|NCT00715403|3154859|P5|Overall Study|Protocol Violation|0
958427|NCT00715403|3154860|P4|Overall Study|Protocol Violation|0
958428|NCT00715403|3154861|P3|Overall Study|Protocol Violation|0
958429|NCT00715403|3154862|P2|Overall Study|Protocol Violation|0
958430|NCT00715403|3154863|P1|Overall Study|Protocol Violation|0
958431|NCT00715403|3154857|P7|Overall Study|Other Adverse Event than DLT|0
958432|NCT00715403|3154858|P6|Overall Study|Other Adverse Event than DLT|2
958433|NCT00715403|3154859|P5|Overall Study|Other Adverse Event than DLT|0
958434|NCT00715403|3154860|P4|Overall Study|Other Adverse Event than DLT|0
958435|NCT00715403|3154861|P3|Overall Study|Other Adverse Event than DLT|0
958436|NCT00715403|3154862|P2|Overall Study|Other Adverse Event than DLT|0
958437|NCT00715403|3154863|P1|Overall Study|Other Adverse Event than DLT|1
958438|NCT00715403|3154857|P7|Overall Study|Dose limiting Toxicity (DLT)|0
958439|NCT00715403|3154858|P6|Overall Study|Dose limiting Toxicity (DLT)|1
958440|NCT00715403|3154859|P5|Overall Study|Dose limiting Toxicity (DLT)|0
958441|NCT00715403|3154860|P4|Overall Study|Dose limiting Toxicity (DLT)|0
958442|NCT00715403|3154861|P3|Overall Study|Dose limiting Toxicity (DLT)|0
958443|NCT00715403|3154862|P2|Overall Study|Dose limiting Toxicity (DLT)|0
958444|NCT00715403|3154863|P1|Overall Study|Dose limiting Toxicity (DLT)|0
958445|NCT00715403|3154857|P7|Overall Study|Progressive disease|1
958446|NCT00715403|3154858|P6|Overall Study|Progressive disease|14
958447|NCT00715403|3154859|P5|Overall Study|Progressive disease|5
958448|NCT00715403|3154860|P4|Overall Study|Progressive disease|9
958449|NCT00715403|3154861|P3|Overall Study|Progressive disease|3
958450|NCT00715403|3154862|P2|Overall Study|Progressive disease|1
958451|NCT00715403|3154863|P1|Overall Study|Progressive disease|0
958452|NCT00715299|3155002|P1|Overall Study|failed the pre-screen exercise test|2
958453|NCT00715299|3155002|P1|Overall Study|Adverse Event|3
958454|NCT00715299|3155002|P1|Overall Study|Withdrawal by Subject|1
958455|NCT00715208|3155008|P2|Overall Study|Lack of Efficacy|2
958456|NCT00715208|3155009|P1|Overall Study|Lack of Efficacy|0
958457|NCT00715208|3155008|P2|Overall Study|Adverse Event|6
958458|NCT00715208|3155009|P1|Overall Study|Adverse Event|0
958459|NCT00715208|3155008|P2|Overall Study|Withdrawal by Subject|1
958460|NCT00715208|3155009|P1|Overall Study|Withdrawal by Subject|1
958461|NCT00715117|3155025|P2|Overall Study|Crohn's flare and rescue with steroids|1
958462|NCT00715117|3155026|P1|Overall Study|Crohn's flare and rescue with steroids|0
958463|NCT00715078|3155094|P3|Overall Study|Unable to start due to disease prog.|1
958464|NCT00715078|3155095|P2|Overall Study|Unable to start due to disease prog.|0
958465|NCT00715078|3155096|P1|Overall Study|Unable to start due to disease prog.|0
958466|NCT00715078|3155094|P3|Overall Study|Withdrawal by Subject|1
958467|NCT00715078|3155095|P2|Overall Study|Withdrawal by Subject|0
958468|NCT00715078|3155096|P1|Overall Study|Withdrawal by Subject|1
958469|NCT00715078|3155094|P3|Overall Study|Death|36
958470|NCT00715078|3155095|P2|Overall Study|Death|36
958471|NCT00715078|3155096|P1|Overall Study|Death|29
958472|NCT00715026|3155104|P1|Overall Study|Surgery done on non-study consented hip|1
958473|NCT00715026|3155104|P1|Overall Study|Protocol Violation|1
958474|NCT00715026|3155104|P1|Overall Study|Lost to Follow-up|3
958475|NCT00715026|3155104|P1|Overall Study|Withdrawal by Subject|5
958476|NCT00714948|3155109|P1|Overall Study|Adverse Event|2
958477|NCT00714870|3155115|P2|Overall Study|did not attend minimum of 4 sessions|0
958478|NCT00714870|3155116|P1|Overall Study|did not attend minimum of 4 sessions|4
958479|NCT00714870|3155115|P2|Overall Study|patient unable to come b/c back pain|0
958480|NCT00714870|3155116|P1|Overall Study|patient unable to come b/c back pain|1
958481|NCT00714870|3155115|P2|Overall Study|Lost to Follow-up|5
958482|NCT00714870|3155116|P1|Overall Study|Lost to Follow-up|22
958483|NCT00714714|3155140|P1|Overall Study|Adverse Event|1
958484|NCT00714688|3155149|P3|Overall Study|Other|5
958485|NCT00714688|3155150|P2|Overall Study|Other|6
958486|NCT00714688|3155151|P1|Overall Study|Other|1
958487|NCT00714688|3155149|P3|Overall Study|Sponsor's Decision|0
958488|NCT00714688|3155150|P2|Overall Study|Sponsor's Decision|2
958489|NCT00714688|3155151|P1|Overall Study|Sponsor's Decision|0
958490|NCT00714688|3155149|P3|Overall Study|Ineligible to Continue the Study|1
958491|NCT00714688|3155150|P2|Overall Study|Ineligible to Continue the Study|1
958492|NCT00714688|3155151|P1|Overall Study|Ineligible to Continue the Study|0
958493|NCT00714688|3155149|P3|Overall Study|Subject Non-compliant|5
958494|NCT00714688|3155150|P2|Overall Study|Subject Non-compliant|5
958495|NCT00714688|3155151|P1|Overall Study|Subject Non-compliant|3
958496|NCT00714688|3155149|P3|Overall Study|Adverse Event|19
958497|NCT00714688|3155150|P2|Overall Study|Adverse Event|15
958498|NCT00714688|3155151|P1|Overall Study|Adverse Event|2
958499|NCT00714688|3155149|P3|Overall Study|Lost to Follow-up|0
958500|NCT00714688|3155150|P2|Overall Study|Lost to Follow-up|2
958501|NCT00714688|3155151|P1|Overall Study|Lost to Follow-up|5
958502|NCT00714688|3155149|P3|Overall Study|Withdrawal by Subject|3
958503|NCT00714688|3155150|P2|Overall Study|Withdrawal by Subject|3
958504|NCT00714688|3155151|P1|Overall Study|Withdrawal by Subject|4
958505|NCT00714688|3155149|P3|Overall Study|Lack of Efficacy|4
958506|NCT00714688|3155150|P2|Overall Study|Lack of Efficacy|1
958507|NCT00714688|3155151|P1|Overall Study|Lack of Efficacy|14
958508|NCT00714493|3155193|P1|Overall Study|OTHER|2
958509|NCT00714493|3155193|P1|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8
958510|NCT00714493|3155193|P1|Overall Study|Protocol Violation|12
958511|NCT00714493|3155193|P1|Overall Study|Lost to Follow-up|3
958512|NCT00714493|3155193|P1|Overall Study|Lack of Efficacy|10
958513|NCT00714493|3155193|P1|Overall Study|Death|3
958514|NCT00714493|3155193|P1|Overall Study|Adverse Event|11
958515|NCT00714415|3155205|P2|Overall Study|Death|0
958516|NCT00714415|3155206|P1|Overall Study|Death|1
958517|NCT00714415|3155205|P2|Overall Study|Lack of Efficacy|0
958518|NCT00714415|3155206|P1|Overall Study|Lack of Efficacy|1
958519|NCT00714285|3155256|P4|Overall Study|Migrated/moved from study area|0
958520|NCT00714285|3155257|P3|Overall Study|Migrated/moved from study area|0
958521|NCT00714285|3155258|P2|Overall Study|Migrated/moved from study area|1
958522|NCT00714285|3155259|P1|Overall Study|Migrated/moved from study area|0
958523|NCT00714285|3155256|P4|Overall Study|Lost to Follow-up|1
958524|NCT00714285|3155257|P3|Overall Study|Lost to Follow-up|0
958525|NCT00714285|3155258|P2|Overall Study|Lost to Follow-up|2
958526|NCT00714285|3155259|P1|Overall Study|Lost to Follow-up|0
958527|NCT00714259|3155309|P1|Overall Study|Death|2
958528|NCT00714168|3155355|P2|Overall Study|Non-study medical condition|2
958529|NCT00714168|3155356|P1|Overall Study|Non-study medical condition|3
958530|NCT00714168|3155355|P2|Overall Study|Relocation|3
958531|NCT00714168|3155356|P1|Overall Study|Relocation|4
958532|NCT00714168|3155355|P2|Overall Study|Lost to Follow-up|50
958533|NCT00714168|3155356|P1|Overall Study|Lost to Follow-up|32
958534|NCT00714168|3155355|P2|Overall Study|Pregnancy|4
958535|NCT00714168|3155356|P1|Overall Study|Pregnancy|5
958536|NCT00714051|3155372|P2|Overall Study|Death|1
958537|NCT00714051|3155373|P1|Overall Study|Death|0
958538|NCT00714051|3155372|P2|Overall Study|Withdrawal by Subject|0
958539|NCT00714051|3155373|P1|Overall Study|Withdrawal by Subject|1
958540|NCT00713830|3155381|P2|Overall Study|Sponsor Decision|10
958541|NCT00713830|3155382|P1|Overall Study|Sponsor Decision|4
958542|NCT00713830|3155381|P2|Overall Study|Familial and Personal Reasons|34
958543|NCT00713830|3155382|P1|Overall Study|Familial and Personal Reasons|9
958544|NCT00713830|3155381|P2|Overall Study|Poor Compliance to Protocol|14
958545|NCT00713830|3155382|P1|Overall Study|Poor Compliance to Protocol|7
958546|NCT00713830|3155381|P2|Overall Study|Withdrawal by Subject|23
958547|NCT00713830|3155382|P1|Overall Study|Withdrawal by Subject|13
958548|NCT00713830|3155381|P2|Overall Study|Lost to Follow-up|9
958549|NCT00713830|3155382|P1|Overall Study|Lost to Follow-up|2
958550|NCT00713830|3155381|P2|Overall Study|Lack of Efficacy|16
958551|NCT00713830|3155382|P1|Overall Study|Lack of Efficacy|24
958552|NCT00713830|3155381|P2|Overall Study|Adverse Event|71
958553|NCT00713830|3155382|P1|Overall Study|Adverse Event|23
958554|NCT00713700|3155439|P1|Overall Study|Withdrawal by Subject|1
958555|NCT00713700|3155439|P1|Overall Study|Lost to Follow-up|3
958556|NCT00713648|3155465|P1|Overall Study|Development of antibodies|3
958557|NCT00713648|3155465|P1|Overall Study|According to Protocol|2
958558|NCT00713648|3155465|P1|Overall Study|Unclassified|2
958559|NCT00713648|3155465|P1|Overall Study|Adverse Event|1
958560|NCT00713609|3155478|P6|Overall Study|Protocol Violation|0
958561|NCT00713609|3155479|P5|Overall Study|Protocol Violation|2
958562|NCT00713609|3155480|P4|Overall Study|Protocol Violation|1
958563|NCT00713609|3155481|P3|Overall Study|Protocol Violation|1
958564|NCT00713609|3155482|P2|Overall Study|Protocol Violation|3
958565|NCT00713609|3155483|P1|Overall Study|Protocol Violation|6
958566|NCT00713609|3155478|P6|Overall Study|Withdrawal by Subject|7
958567|NCT00713609|3155479|P5|Overall Study|Withdrawal by Subject|5
958568|NCT00713609|3155480|P4|Overall Study|Withdrawal by Subject|1
958569|NCT00713609|3155481|P3|Overall Study|Withdrawal by Subject|5
958570|NCT00713609|3155482|P2|Overall Study|Withdrawal by Subject|1
958571|NCT00713609|3155483|P1|Overall Study|Withdrawal by Subject|6
958572|NCT00713609|3155478|P6|Overall Study|Non-Compliance with Study Treatment|0
958573|NCT00713609|3155479|P5|Overall Study|Non-Compliance with Study Treatment|1
958574|NCT00713609|3155480|P4|Overall Study|Non-Compliance with Study Treatment|0
958575|NCT00713609|3155481|P3|Overall Study|Non-Compliance with Study Treatment|2
958576|NCT00713609|3155482|P2|Overall Study|Non-Compliance with Study Treatment|1
958577|NCT00713609|3155483|P1|Overall Study|Non-Compliance with Study Treatment|1
958578|NCT00713609|3155478|P6|Overall Study|Lack of Efficacy|0
958579|NCT00713609|3155479|P5|Overall Study|Lack of Efficacy|1
958580|NCT00713609|3155480|P4|Overall Study|Lack of Efficacy|0
958581|NCT00713609|3155481|P3|Overall Study|Lack of Efficacy|0
958582|NCT00713609|3155482|P2|Overall Study|Lack of Efficacy|3
958583|NCT00713609|3155483|P1|Overall Study|Lack of Efficacy|1
958584|NCT00713609|3155478|P6|Overall Study|Lost to Follow-up|0
958585|NCT00713609|3155479|P5|Overall Study|Lost to Follow-up|7
958586|NCT00713609|3155480|P4|Overall Study|Lost to Follow-up|5
958587|NCT00713609|3155481|P3|Overall Study|Lost to Follow-up|5
958588|NCT00713609|3155482|P2|Overall Study|Lost to Follow-up|7
958589|NCT00713609|3155483|P1|Overall Study|Lost to Follow-up|5
958590|NCT00713609|3155478|P6|Overall Study|Adverse Event|1
958591|NCT00713609|3155479|P5|Overall Study|Adverse Event|3
958592|NCT00713609|3155480|P4|Overall Study|Adverse Event|2
958593|NCT00713609|3155481|P3|Overall Study|Adverse Event|2
958594|NCT00713609|3155482|P2|Overall Study|Adverse Event|0
958595|NCT00713609|3155483|P1|Overall Study|Adverse Event|2
958596|NCT00713596|3155518|P3|Overall Study|Study was terminated|2
958597|NCT00713596|3155519|P2|Overall Study|Study was terminated|3
958598|NCT00713596|3155520|P1|Overall Study|Study was terminated|2
958599|NCT00713544|3155546|P6|Overall Study|Hepatotoxicity - not an AE|0
958600|NCT00713544|3155547|P5|Overall Study|Hepatotoxicity - not an AE|1
958601|NCT00713544|3155548|P4|Overall Study|Hepatotoxicity - not an AE|0
958602|NCT00713544|3155549|P3|Overall Study|Hepatotoxicity - not an AE|0
958603|NCT00713544|3155550|P2|Overall Study|Hepatotoxicity - not an AE|0
958604|NCT00713544|3155551|P1|Overall Study|Hepatotoxicity - not an AE|0
958605|NCT00713544|3155546|P6|Overall Study|Incorrect enrollment|0
958606|NCT00713544|3155547|P5|Overall Study|Incorrect enrollment|0
958607|NCT00713544|3155548|P4|Overall Study|Incorrect enrollment|0
958608|NCT00713544|3155549|P3|Overall Study|Incorrect enrollment|0
958609|NCT00713544|3155550|P2|Overall Study|Incorrect enrollment|1
958610|NCT00713544|3155551|P1|Overall Study|Incorrect enrollment|0
958611|NCT00713544|3155546|P6|Overall Study|AZ decision - Hepatitis C ab reactive|0
958612|NCT00713544|3155547|P5|Overall Study|AZ decision - Hepatitis C ab reactive|0
958613|NCT00713544|3155548|P4|Overall Study|AZ decision - Hepatitis C ab reactive|0
958614|NCT00713544|3155549|P3|Overall Study|AZ decision - Hepatitis C ab reactive|0
958615|NCT00713544|3155550|P2|Overall Study|AZ decision - Hepatitis C ab reactive|1
958616|NCT00713544|3155551|P1|Overall Study|AZ decision - Hepatitis C ab reactive|0
958617|NCT00713544|3155546|P6|Overall Study|Lost to Follow-up|0
958618|NCT00713544|3155547|P5|Overall Study|Lost to Follow-up|0
958619|NCT00713544|3155548|P4|Overall Study|Lost to Follow-up|0
958620|NCT00713544|3155549|P3|Overall Study|Lost to Follow-up|1
958621|NCT00713544|3155550|P2|Overall Study|Lost to Follow-up|0
958622|NCT00713544|3155551|P1|Overall Study|Lost to Follow-up|0
958623|NCT00713544|3155546|P6|Overall Study|Lack of Efficacy|0
958624|NCT00713544|3155547|P5|Overall Study|Lack of Efficacy|1
958625|NCT00713544|3155548|P4|Overall Study|Lack of Efficacy|1
958626|NCT00713544|3155549|P3|Overall Study|Lack of Efficacy|0
958627|NCT00713544|3155550|P2|Overall Study|Lack of Efficacy|1
958628|NCT00713544|3155551|P1|Overall Study|Lack of Efficacy|0
958629|NCT00713544|3155546|P6|Overall Study|Physician Decision|2
958630|NCT00713544|3155547|P5|Overall Study|Physician Decision|0
958631|NCT00713544|3155548|P4|Overall Study|Physician Decision|0
958632|NCT00713544|3155549|P3|Overall Study|Physician Decision|0
958633|NCT00713544|3155550|P2|Overall Study|Physician Decision|0
958634|NCT00713544|3155551|P1|Overall Study|Physician Decision|0
958635|NCT00713544|3155546|P6|Overall Study|Protocol Violation|1
958636|NCT00713544|3155547|P5|Overall Study|Protocol Violation|0
958637|NCT00713544|3155548|P4|Overall Study|Protocol Violation|0
958638|NCT00713544|3155549|P3|Overall Study|Protocol Violation|0
958639|NCT00713544|3155550|P2|Overall Study|Protocol Violation|0
958640|NCT00713544|3155551|P1|Overall Study|Protocol Violation|0
958641|NCT00713544|3155546|P6|Overall Study|Withdrawal by Subject|1
958642|NCT00713544|3155547|P5|Overall Study|Withdrawal by Subject|3
958643|NCT00713544|3155548|P4|Overall Study|Withdrawal by Subject|2
958644|NCT00713544|3155549|P3|Overall Study|Withdrawal by Subject|3
958645|NCT00713544|3155550|P2|Overall Study|Withdrawal by Subject|0
958646|NCT00713544|3155551|P1|Overall Study|Withdrawal by Subject|2
958647|NCT00713544|3155546|P6|Overall Study|Adverse Event|5
958648|NCT00713544|3155547|P5|Overall Study|Adverse Event|3
958649|NCT00713544|3155548|P4|Overall Study|Adverse Event|7
958650|NCT00713544|3155549|P3|Overall Study|Adverse Event|7
958651|NCT00713544|3155550|P2|Overall Study|Adverse Event|3
958652|NCT00713544|3155551|P1|Overall Study|Adverse Event|5
958653|NCT00713349|3155602|P1|Overall Study|Protocol Violation|1
958654|NCT00713323|3155608|P1|Overall Study|Treatment that may interact with Sativex|1
958655|NCT00713323|3155608|P1|Overall Study|Subject travelling to Dominica Republic|1
958656|NCT00713323|3155608|P1|Overall Study|Subject travelling to USA|1
958657|NCT00713323|3155608|P1|Overall Study|Pain resolved|1
958658|NCT00713323|3155608|P1|Overall Study|Non-compliance|1
958659|NCT00713323|3155608|P1|Overall Study|Pain free|1
958660|NCT00713323|3155608|P1|Overall Study|Surgery cured allodynic pain|1
958661|NCT00713323|3155608|P1|Overall Study|Withdrawn due to exclusion criteria 11|1
958662|NCT00713323|3155608|P1|Overall Study|Low creatine clearance at screening|1
958663|NCT00713323|3155608|P1|Overall Study|Lack of Efficacy|36
958664|NCT00713323|3155608|P1|Overall Study|Lost to Follow-up|11
958665|NCT00713323|3155608|P1|Overall Study|Withdrawal by Subject|15
958666|NCT00713323|3155608|P1|Overall Study|Adverse Event|75
958667|NCT00713310|3155621|P2|Overall Study|Withdrawal by Subject|2
958668|NCT00713310|3155622|P1|Overall Study|Withdrawal by Subject|0
958669|NCT00713310|3155621|P2|Overall Study|Lack of Efficacy|2
958670|NCT00713310|3155622|P1|Overall Study|Lack of Efficacy|0
958671|NCT00713310|3155621|P2|Overall Study|Adverse Event|2
958672|NCT00713310|3155622|P1|Overall Study|Adverse Event|5
958673|NCT00713258|3155632|P2|Overall Study|Other|1
958674|NCT00713258|3155633|P1|Overall Study|Other|1
958675|NCT00713258|3155632|P2|Overall Study|Non-Compliance|1
958676|NCT00713258|3155633|P1|Overall Study|Non-Compliance|2
958677|NCT00713258|3155632|P2|Overall Study|Adverse Event|4
958678|NCT00713258|3155633|P1|Overall Study|Adverse Event|2
958679|NCT00713219|3155641|P1|Overall Study|Protocol Violation|1
958680|NCT00713219|3155641|P1|Overall Study|Death|1
958681|NCT00713206|3155647|P2|Overall Study|Adverse Event|1
958682|NCT00713206|3155648|P1|Overall Study|Adverse Event|2
958683|NCT00713206|3155647|P2|Overall Study|Lost to Follow-up|2
958684|NCT00713206|3155648|P1|Overall Study|Lost to Follow-up|5
958685|NCT00712985|3155654|P1|Overall Study|Lack of Efficacy|3
958686|NCT00712985|3155654|P1|Overall Study|1 patient moved out of state|1
958687|NCT00712985|3155654|P1|Overall Study|1 withdrew prior to start of drug|1
958688|NCT00712959|3155660|P2|Overall Study|Withdrawal by Subject|0
958689|NCT00712959|3155661|P1|Overall Study|Withdrawal by Subject|3
958690|NCT00712959|3155660|P2|Overall Study|Lost to Follow-up|2
958691|NCT00712959|3155661|P1|Overall Study|Lost to Follow-up|13
958692|NCT00712959|3155660|P2|Overall Study|Protocol Violation|1
958693|NCT00712959|3155661|P1|Overall Study|Protocol Violation|3
958694|NCT00712933|3155679|P1|Overall Study|Withdrawal by Subject|151
958695|NCT00712933|3155679|P1|Overall Study|Protocol Violation|4
958696|NCT00712933|3155679|P1|Overall Study|Physician Decision|36
958697|NCT00712933|3155679|P1|Overall Study|Participant received medication|1
958698|NCT00712933|3155679|P1|Overall Study|Not committed to contraception|1
958699|NCT00712933|3155679|P1|Overall Study|Other Physician decision|1
958700|NCT00712933|3155679|P1|Overall Study|Death of patient|1
958701|NCT00712933|3155679|P1|Overall Study|Participant travelled overseas|2
958702|NCT00712933|3155679|P1|Overall Study|Participant hospitalized|1
958703|NCT00712933|3155679|P1|Overall Study|Involved in Clinical research|3
958704|NCT00712933|3155679|P1|Overall Study|Hip replacement surgery|1
958705|NCT00712933|3155679|P1|Overall Study|Withdrew consent|4
958706|NCT00712933|3155679|P1|Overall Study|Sponsor decision|14
958707|NCT00712933|3155679|P1|Overall Study|Other Pregnancy|37
958708|NCT00712933|3155679|P1|Overall Study|Non-compliance with study drug|13
958709|NCT00712933|3155679|P1|Overall Study|Lost to Follow-up|22
958710|NCT00712933|3155679|P1|Overall Study|Lack of Efficacy|6
958711|NCT00712933|3155679|P1|Overall Study|Adverse Event|69
958712|NCT00712920|3155709|P3|Overall Study|Non-compliance|0
958713|NCT00712920|3155710|P2|Overall Study|Non-compliance|0
958714|NCT00712920|3155711|P1|Overall Study|Non-compliance|3
958715|NCT00712920|3155709|P3|Overall Study|Other|3
958716|NCT00712920|3155710|P2|Overall Study|Other|7
958717|NCT00712920|3155711|P1|Overall Study|Other|5
958718|NCT00712920|3155709|P3|Overall Study|Lack of Efficacy|1
958719|NCT00712920|3155710|P2|Overall Study|Lack of Efficacy|0
958720|NCT00712920|3155711|P1|Overall Study|Lack of Efficacy|1
958721|NCT00712920|3155709|P3|Overall Study|Lost to Follow-up|0
958722|NCT00712920|3155710|P2|Overall Study|Lost to Follow-up|4
958723|NCT00712920|3155711|P1|Overall Study|Lost to Follow-up|1
958724|NCT00712920|3155709|P3|Overall Study|Withdrawal by Subject|1
958725|NCT00712920|3155710|P2|Overall Study|Withdrawal by Subject|2
958726|NCT00712920|3155711|P1|Overall Study|Withdrawal by Subject|4
958727|NCT00712920|3155709|P3|Overall Study|Adverse Event|7
958728|NCT00712920|3155710|P2|Overall Study|Adverse Event|4
958729|NCT00712920|3155711|P1|Overall Study|Adverse Event|3
958730|NCT00712725|3155739|P8|Overall Study|Protocol Specified Criteria|1
958731|NCT00712725|3155740|P7|Overall Study|Protocol Specified Criteria|2
958732|NCT00712725|3155741|P6|Overall Study|Protocol Specified Criteria|0
958733|NCT00712725|3155742|P5|Overall Study|Protocol Specified Criteria|1
958734|NCT00712725|3155743|P4|Overall Study|Protocol Specified Criteria|2
958735|NCT00712725|3155744|P3|Overall Study|Protocol Specified Criteria|1
958736|NCT00712725|3155745|P2|Overall Study|Protocol Specified Criteria|0
958737|NCT00712725|3155746|P1|Overall Study|Protocol Specified Criteria|3
958738|NCT00712725|3155739|P8|Overall Study|Lack of Qualifying Event|6
958739|NCT00712725|3155740|P7|Overall Study|Lack of Qualifying Event|11
958740|NCT00712725|3155741|P6|Overall Study|Lack of Qualifying Event|13
958741|NCT00712725|3155742|P5|Overall Study|Lack of Qualifying Event|11
958742|NCT00712725|3155743|P4|Overall Study|Lack of Qualifying Event|8
958743|NCT00712725|3155744|P3|Overall Study|Lack of Qualifying Event|6
958744|NCT00712725|3155745|P2|Overall Study|Lack of Qualifying Event|2
958745|NCT00712725|3155746|P1|Overall Study|Lack of Qualifying Event|16
958746|NCT00712725|3155739|P8|Overall Study|Withdrawal by Subject|2
958747|NCT00712725|3155740|P7|Overall Study|Withdrawal by Subject|1
958748|NCT00712725|3155741|P6|Overall Study|Withdrawal by Subject|1
958749|NCT00712725|3155742|P5|Overall Study|Withdrawal by Subject|1
958750|NCT00712725|3155743|P4|Overall Study|Withdrawal by Subject|2
958751|NCT00712725|3155744|P3|Overall Study|Withdrawal by Subject|1
958752|NCT00712725|3155745|P2|Overall Study|Withdrawal by Subject|1
958753|NCT00712725|3155746|P1|Overall Study|Withdrawal by Subject|2
958754|NCT00712725|3155739|P8|Overall Study|Protocol Violation|1
958755|NCT00712725|3155740|P7|Overall Study|Protocol Violation|1
958756|NCT00712725|3155741|P6|Overall Study|Protocol Violation|0
958757|NCT00712725|3155742|P5|Overall Study|Protocol Violation|2
958758|NCT00712725|3155743|P4|Overall Study|Protocol Violation|3
958759|NCT00712725|3155744|P3|Overall Study|Protocol Violation|1
958760|NCT00712725|3155745|P2|Overall Study|Protocol Violation|0
958761|NCT00712725|3155746|P1|Overall Study|Protocol Violation|2
958762|NCT00712725|3155739|P8|Overall Study|Pregnancy|0
958763|NCT00712725|3155740|P7|Overall Study|Pregnancy|2
958764|NCT00712725|3155741|P6|Overall Study|Pregnancy|0
958765|NCT00712725|3155742|P5|Overall Study|Pregnancy|1
958766|NCT00712725|3155743|P4|Overall Study|Pregnancy|0
958767|NCT00712725|3155744|P3|Overall Study|Pregnancy|0
958768|NCT00712725|3155745|P2|Overall Study|Pregnancy|1
958769|NCT00712725|3155746|P1|Overall Study|Pregnancy|0
958770|NCT00712725|3155739|P8|Overall Study|Physician Decision|0
958771|NCT00712725|3155740|P7|Overall Study|Physician Decision|2
958772|NCT00712725|3155741|P6|Overall Study|Physician Decision|0
958773|NCT00712725|3155742|P5|Overall Study|Physician Decision|1
958774|NCT00712725|3155743|P4|Overall Study|Physician Decision|0
958775|NCT00712725|3155744|P3|Overall Study|Physician Decision|0
958776|NCT00712725|3155745|P2|Overall Study|Physician Decision|0
958777|NCT00712725|3155746|P1|Overall Study|Physician Decision|2
958778|NCT00712725|3155739|P8|Overall Study|Lost to Follow-up|1
958779|NCT00712725|3155740|P7|Overall Study|Lost to Follow-up|3
958780|NCT00712725|3155741|P6|Overall Study|Lost to Follow-up|2
958781|NCT00712725|3155742|P5|Overall Study|Lost to Follow-up|2
958782|NCT00712725|3155743|P4|Overall Study|Lost to Follow-up|1
958783|NCT00712725|3155744|P3|Overall Study|Lost to Follow-up|1
958784|NCT00712725|3155745|P2|Overall Study|Lost to Follow-up|2
958785|NCT00712725|3155746|P1|Overall Study|Lost to Follow-up|3
958786|NCT00712725|3155739|P8|Overall Study|Adverse Event|0
958787|NCT00712725|3155740|P7|Overall Study|Adverse Event|0
958788|NCT00712725|3155741|P6|Overall Study|Adverse Event|0
958789|NCT00712725|3155742|P5|Overall Study|Adverse Event|0
958790|NCT00712725|3155743|P4|Overall Study|Adverse Event|1
958791|NCT00712725|3155744|P3|Overall Study|Adverse Event|0
958792|NCT00712725|3155745|P2|Overall Study|Adverse Event|0
958793|NCT00712725|3155746|P1|Overall Study|Adverse Event|1
958794|NCT00712673|3155807|P4|Overall Study|Protocol Violation|0
958795|NCT00712673|3155808|P3|Overall Study|Protocol Violation|2
958796|NCT00712673|3155809|P2|Overall Study|Protocol Violation|0
958797|NCT00712673|3155810|P1|Overall Study|Protocol Violation|0
958798|NCT00712673|3155807|P4|Overall Study|Investigator's Decision|0
958799|NCT00712673|3155808|P3|Overall Study|Investigator's Decision|0
958800|NCT00712673|3155809|P2|Overall Study|Investigator's Decision|0
958801|NCT00712673|3155810|P1|Overall Study|Investigator's Decision|1
958802|NCT00712673|3155807|P4|Overall Study|Familial and Personal Reasons|2
958803|NCT00712673|3155808|P3|Overall Study|Familial and Personal Reasons|5
958804|NCT00712673|3155809|P2|Overall Study|Familial and Personal Reasons|0
958805|NCT00712673|3155810|P1|Overall Study|Familial and Personal Reasons|5
958806|NCT00712673|3155807|P4|Overall Study|Withdrawal by Subject|20
958807|NCT00712673|3155808|P3|Overall Study|Withdrawal by Subject|15
958808|NCT00712673|3155809|P2|Overall Study|Withdrawal by Subject|7
958809|NCT00712673|3155810|P1|Overall Study|Withdrawal by Subject|6
958810|NCT00712673|3155807|P4|Overall Study|Lost to Follow-up|0
958811|NCT00712673|3155808|P3|Overall Study|Lost to Follow-up|2
958812|NCT00712673|3155809|P2|Overall Study|Lost to Follow-up|0
958813|NCT00712673|3155810|P1|Overall Study|Lost to Follow-up|1
958814|NCT00712673|3155807|P4|Overall Study|Poor Compliance to Protocol|16
958815|NCT00712673|3155808|P3|Overall Study|Poor Compliance to Protocol|4
958816|NCT00712673|3155809|P2|Overall Study|Poor Compliance to Protocol|3
958817|NCT00712673|3155810|P1|Overall Study|Poor Compliance to Protocol|3
958818|NCT00712673|3155807|P4|Overall Study|Lack of Efficacy|6
958819|NCT00712673|3155808|P3|Overall Study|Lack of Efficacy|8
958820|NCT00712673|3155809|P2|Overall Study|Lack of Efficacy|8
958821|NCT00712673|3155810|P1|Overall Study|Lack of Efficacy|2
958822|NCT00712673|3155807|P4|Overall Study|Adverse Event|26
958823|NCT00712673|3155808|P3|Overall Study|Adverse Event|21
958824|NCT00712673|3155809|P2|Overall Study|Adverse Event|3
958825|NCT00712673|3155810|P1|Overall Study|Adverse Event|3
958826|NCT00712543|3155874|P2|Day 8-14|Lost to Follow-up|2
958827|NCT00712543|3155875|P1|Day 8-14|Lost to Follow-up|0
958828|NCT00712348|3155909|P1|Overall Study|Withdrawal by Subject|1
958829|NCT00712335|3155921|P5|Overall Study|Other Reason|0
958830|NCT00712335|3155922|P4|Overall Study|Other Reason|0
958831|NCT00712335|3155923|P3|Overall Study|Other Reason|1
958832|NCT00712335|3155924|P2|Overall Study|Other Reason|3
958833|NCT00712335|3155925|P1|Overall Study|Other Reason|0
958834|NCT00712335|3155921|P5|Overall Study|Lack of Efficacy|0
958835|NCT00712335|3155922|P4|Overall Study|Lack of Efficacy|1
958836|NCT00712335|3155923|P3|Overall Study|Lack of Efficacy|1
958837|NCT00712335|3155924|P2|Overall Study|Lack of Efficacy|0
958838|NCT00712335|3155925|P1|Overall Study|Lack of Efficacy|0
958839|NCT00712335|3155921|P5|Overall Study|Protocol Violation|0
958840|NCT00712335|3155922|P4|Overall Study|Protocol Violation|0
958841|NCT00712335|3155923|P3|Overall Study|Protocol Violation|1
958842|NCT00712335|3155924|P2|Overall Study|Protocol Violation|2
958843|NCT00712335|3155925|P1|Overall Study|Protocol Violation|1
958844|NCT00712335|3155921|P5|Overall Study|Lost to Follow-up|0
958845|NCT00712335|3155922|P4|Overall Study|Lost to Follow-up|1
958846|NCT00712335|3155923|P3|Overall Study|Lost to Follow-up|0
958847|NCT00712335|3155924|P2|Overall Study|Lost to Follow-up|5
958848|NCT00712335|3155925|P1|Overall Study|Lost to Follow-up|2
958849|NCT00712335|3155921|P5|Overall Study|Withdrawal by Subject|0
958850|NCT00712335|3155922|P4|Overall Study|Withdrawal by Subject|3
958851|NCT00712335|3155923|P3|Overall Study|Withdrawal by Subject|2
958852|NCT00712335|3155924|P2|Overall Study|Withdrawal by Subject|7
958853|NCT00712335|3155925|P1|Overall Study|Withdrawal by Subject|0
958854|NCT00712166|3156022|P2|Overall Study|Noncompliance|1
958855|NCT00712166|3156023|P1|Overall Study|Noncompliance|0
958856|NCT00712010|3156066|P1|Washout (7 Days)|Withdrawal by Subject|1
958857|NCT00711971|3156105|P3|Overall Study|Lost to Follow-up|1
958858|NCT00711971|3156106|P2|Overall Study|Lost to Follow-up|4
958859|NCT00711971|3156107|P1|Overall Study|Lost to Follow-up|3
958860|NCT00711958|3156141|P2|Overall Study|Progression of disease|0
958861|NCT00711958|3156142|P1|Overall Study|Progression of disease|1
958862|NCT00711958|3156141|P2|Overall Study|Death|5
958863|NCT00711958|3156142|P1|Overall Study|Death|10
958864|NCT00711958|3156141|P2|Overall Study|Lost to Follow-up|2
958865|NCT00711958|3156142|P1|Overall Study|Lost to Follow-up|2
958866|NCT00711958|3156141|P2|Overall Study|Protocol Violation|0
958867|NCT00711958|3156142|P1|Overall Study|Protocol Violation|1
958868|NCT00711958|3156141|P2|Overall Study|Adverse Event|7
958869|NCT00711958|3156142|P1|Overall Study|Adverse Event|9
958870|NCT00711958|3156141|P2|Overall Study|Clinical deterioration|0
958871|NCT00711958|3156142|P1|Overall Study|Clinical deterioration|1
958872|NCT00711958|3156141|P2|Overall Study|Lack of Efficacy|1
958873|NCT00711958|3156142|P1|Overall Study|Lack of Efficacy|3
958874|NCT00711958|3156141|P2|Overall Study|Withdrawal by Subject|8
958875|NCT00711958|3156142|P1|Overall Study|Withdrawal by Subject|6
958876|NCT00711880|3156150|P2|Overall Study|Lack of Efficacy|5
958877|NCT00711880|3156151|P1|Overall Study|Lack of Efficacy|1
958878|NCT00711880|3156150|P2|Overall Study|Patient non-compliance|0
958879|NCT00711880|3156151|P1|Overall Study|Patient non-compliance|1
958880|NCT00711880|3156150|P2|Overall Study|Adverse Event|2
958881|NCT00711880|3156151|P1|Overall Study|Adverse Event|11
958882|NCT00711802|3156213|P8|Overall Study|Reason not reported|0
958883|NCT00711802|3156214|P7|Overall Study|Reason not reported|1
958884|NCT00711802|3156215|P6|Overall Study|Reason not reported|0
958885|NCT00711802|3156216|P5|Overall Study|Reason not reported|1
958886|NCT00711802|3156217|P4|Overall Study|Reason not reported|0
958887|NCT00711802|3156218|P3|Overall Study|Reason not reported|1
958888|NCT00711802|3156219|P2|Overall Study|Reason not reported|1
958889|NCT00711802|3156220|P1|Overall Study|Reason not reported|0
958890|NCT00711802|3156213|P8|Overall Study|Lost to Follow-up|2
958891|NCT00711802|3156214|P7|Overall Study|Lost to Follow-up|4
958892|NCT00711802|3156215|P6|Overall Study|Lost to Follow-up|6
958893|NCT00711802|3156216|P5|Overall Study|Lost to Follow-up|10
958894|NCT00711802|3156217|P4|Overall Study|Lost to Follow-up|1
958895|NCT00711802|3156218|P3|Overall Study|Lost to Follow-up|3
958896|NCT00711802|3156219|P2|Overall Study|Lost to Follow-up|0
958897|NCT00711802|3156220|P1|Overall Study|Lost to Follow-up|0
958898|NCT00711802|3156213|P8|Overall Study|Withdrawal by Subject|0
958899|NCT00711802|3156214|P7|Overall Study|Withdrawal by Subject|0
958900|NCT00711802|3156215|P6|Overall Study|Withdrawal by Subject|0
958901|NCT00711802|3156216|P5|Overall Study|Withdrawal by Subject|0
958902|NCT00711802|3156217|P4|Overall Study|Withdrawal by Subject|1
958903|NCT00711802|3156218|P3|Overall Study|Withdrawal by Subject|0
958904|NCT00711802|3156219|P2|Overall Study|Withdrawal by Subject|1
958905|NCT00711802|3156220|P1|Overall Study|Withdrawal by Subject|0
958906|NCT00711802|3156213|P8|Overall Study|Physician Decision|0
958907|NCT00711802|3156214|P7|Overall Study|Physician Decision|0
958908|NCT00711802|3156215|P6|Overall Study|Physician Decision|0
958909|NCT00711802|3156216|P5|Overall Study|Physician Decision|0
958910|NCT00711802|3156217|P4|Overall Study|Physician Decision|0
958911|NCT00711802|3156218|P3|Overall Study|Physician Decision|0
958912|NCT00711802|3156219|P2|Overall Study|Physician Decision|2
958913|NCT00711802|3156220|P1|Overall Study|Physician Decision|0
958914|NCT00711802|3156213|P8|Overall Study|Protocol Violation|0
958915|NCT00711802|3156214|P7|Overall Study|Protocol Violation|0
958916|NCT00711802|3156215|P6|Overall Study|Protocol Violation|0
958917|NCT00711802|3156216|P5|Overall Study|Protocol Violation|0
958918|NCT00711802|3156217|P4|Overall Study|Protocol Violation|1
958919|NCT00711802|3156218|P3|Overall Study|Protocol Violation|0
958920|NCT00711802|3156219|P2|Overall Study|Protocol Violation|0
958921|NCT00711802|3156220|P1|Overall Study|Protocol Violation|0
958922|NCT00711802|3156213|P8|Overall Study|Microbiological failure|0
958923|NCT00711802|3156214|P7|Overall Study|Microbiological failure|0
958924|NCT00711802|3156215|P6|Overall Study|Microbiological failure|1
958925|NCT00711802|3156216|P5|Overall Study|Microbiological failure|0
958926|NCT00711802|3156217|P4|Overall Study|Microbiological failure|0
958927|NCT00711802|3156218|P3|Overall Study|Microbiological failure|0
958928|NCT00711802|3156219|P2|Overall Study|Microbiological failure|1
958929|NCT00711802|3156220|P1|Overall Study|Microbiological failure|0
958930|NCT00711802|3156213|P8|Overall Study|Adverse Event|0
958931|NCT00711802|3156214|P7|Overall Study|Adverse Event|0
958932|NCT00711802|3156215|P6|Overall Study|Adverse Event|1
958933|NCT00711802|3156216|P5|Overall Study|Adverse Event|1
958934|NCT00711802|3156217|P4|Overall Study|Adverse Event|0
958935|NCT00711802|3156218|P3|Overall Study|Adverse Event|0
958936|NCT00711802|3156219|P2|Overall Study|Adverse Event|0
958937|NCT00711802|3156220|P1|Overall Study|Adverse Event|0
958938|NCT00711802|3156213|P8|Overall Study|Not treated (no further detail)|0
958939|NCT00711802|3156214|P7|Overall Study|Not treated (no further detail)|0
958940|NCT00711802|3156215|P6|Overall Study|Not treated (no further detail)|0
958941|NCT00711802|3156216|P5|Overall Study|Not treated (no further detail)|2
958942|NCT00711802|3156217|P4|Overall Study|Not treated (no further detail)|0
958943|NCT00711802|3156218|P3|Overall Study|Not treated (no further detail)|2
958944|NCT00711802|3156219|P2|Overall Study|Not treated (no further detail)|1
958945|NCT00711802|3156220|P1|Overall Study|Not treated (no further detail)|2
958946|NCT00711646|3156252|P2|Overall Study|patient non-compliance|0
958947|NCT00711646|3156253|P1|Overall Study|patient non-compliance|1
958948|NCT00711646|3156252|P2|Overall Study|administrative decision|1
958949|NCT00711646|3156253|P1|Overall Study|administrative decision|0
958950|NCT00711646|3156252|P2|Overall Study|Lost to Follow-up|0
958951|NCT00711646|3156253|P1|Overall Study|Lost to Follow-up|1
958952|NCT00711646|3156252|P2|Overall Study|Protocol Violation|1
958953|NCT00711646|3156253|P1|Overall Study|Protocol Violation|0
958954|NCT00711646|3156252|P2|Overall Study|Withdrawal by Subject|0
958955|NCT00711646|3156253|P1|Overall Study|Withdrawal by Subject|4
958956|NCT00711646|3156252|P2|Overall Study|Adverse Event|1
958957|NCT00711646|3156253|P1|Overall Study|Adverse Event|6
958958|NCT00711594|3156275|P4|Overall Study|Withdrawal by Subject|2
958959|NCT00711594|3156276|P3|Overall Study|Withdrawal by Subject|0
958960|NCT00711594|3156277|P2|Overall Study|Withdrawal by Subject|1
958961|NCT00711594|3156278|P1|Overall Study|Withdrawal by Subject|0
958962|NCT00711594|3156275|P4|Overall Study|Other Adverse Event|16
958963|NCT00711594|3156276|P3|Overall Study|Other Adverse Event|0
958964|NCT00711594|3156277|P2|Overall Study|Other Adverse Event|0
958965|NCT00711594|3156278|P1|Overall Study|Other Adverse Event|1
958966|NCT00711594|3156275|P4|Overall Study|Progressive disease|44
958967|NCT00711594|3156276|P3|Overall Study|Progressive disease|6
958968|NCT00711594|3156277|P2|Overall Study|Progressive disease|2
958969|NCT00711594|3156278|P1|Overall Study|Progressive disease|2
958970|NCT00711555|3156315|P1|Overall Study|Adverse Event|3
958971|NCT00711529|3156324|P2|Overall Study|Withdrawal by Subject|6
958972|NCT00711529|3156325|P1|Overall Study|Withdrawal by Subject|2
958973|NCT00711529|3156324|P2|Overall Study|Protocol Violation|0
958974|NCT00711529|3156325|P1|Overall Study|Protocol Violation|2
958975|NCT00711516|3156349|P2|Overall Study|Protocol Violation|1
958976|NCT00711516|3156350|P1|Overall Study|Protocol Violation|0
958977|NCT00711516|3156349|P2|Overall Study|Withdrawal by Subject|1
958978|NCT00711516|3156350|P1|Overall Study|Withdrawal by Subject|0
958979|NCT00711516|3156349|P2|Overall Study|Adverse Event|1
958980|NCT00711516|3156350|P1|Overall Study|Adverse Event|1
958981|NCT00711477|3156457|P2|Overall Study|Noncompliance|1
958982|NCT00711477|3156458|P1|Overall Study|Noncompliance|0
958983|NCT00711477|3156457|P2|Overall Study|Lost to Follow-up|1
958984|NCT00711477|3156458|P1|Overall Study|Lost to Follow-up|0
958985|NCT00711477|3156457|P2|Overall Study|Adverse Event|1
958986|NCT00711477|3156458|P1|Overall Study|Adverse Event|3
958987|NCT00711425|3156504|P1|Overall Study|Lost to Follow-up|1
958988|NCT00711425|3156504|P1|Overall Study|Death|2
958989|NCT00711425|3156504|P1|Overall Study|Protocol Violation|1
958990|NCT00711412|3156510|P1|Survival Follow up Until Death|Other|12
958991|NCT00711412|3156510|P1|Evaluation for Response and Surgery|Death|1
958992|NCT00711412|3156510|P1|Evaluation for Response and Surgery|Withdrawal by Subject|1
958993|NCT00711412|3156510|P1|Evaluation for Response and Surgery|Too high risk for surgery|2
958994|NCT00711412|3156510|P1|Evaluation for Response and Surgery|Progressive Disease|2
958995|NCT00711412|3156510|P1|Combination Treatment|Progressive Disease|1
958996|NCT00711412|3156510|P1|Evaluated for Combination Treatment|Progressive disease|2
958997|NCT00711412|3156510|P1|Evaluated for Combination Treatment|Withdrawal by Subject|1
958998|NCT00711412|3156510|P1|Evaluated for Combination Treatment|Death|1
958999|NCT00711412|3156510|P1|Evaluated for Combination Treatment|Adverse Event|2
959000|NCT00711412|3156510|P1|Induction Treatment|Other|1
959001|NCT00711412|3156510|P1|Induction Treatment|Adverse Event|1
959002|NCT00711412|3156510|P1|Induction Treatment|Death|2
959003|NCT00711243|3156588|P6|Follow up Every 3 Months Until Death|Lost to Follow-up|2
959004|NCT00711243|3156589|P5|Follow up Every 3 Months Until Death|Lost to Follow-up|0
959005|NCT00711243|3156590|P4|Follow up Every 3 Months Until Death|Lost to Follow-up|0
959006|NCT00711243|3156591|P3|Follow up Every 3 Months Until Death|Lost to Follow-up|0
959007|NCT00711243|3156592|P2|Follow up Every 3 Months Until Death|Lost to Follow-up|0
959008|NCT00711243|3156593|P1|Follow up Every 3 Months Until Death|Lost to Follow-up|0
959009|NCT00711243|3156588|P6|Treated Cycle 5 After First Response|Decline in performance status|1
959010|NCT00711243|3156589|P5|Treated Cycle 5 After First Response|Decline in performance status|0
959011|NCT00711243|3156590|P4|Treated Cycle 5 After First Response|Decline in performance status|0
959012|NCT00711243|3156591|P3|Treated Cycle 5 After First Response|Decline in performance status|0
959013|NCT00711243|3156592|P2|Treated Cycle 5 After First Response|Decline in performance status|0
959014|NCT00711243|3156593|P1|Treated Cycle 5 After First Response|Decline in performance status|0
959015|NCT00711243|3156588|P6|Treated Cycle 5 After First Response|Death|2
959016|NCT00711243|3156589|P5|Treated Cycle 5 After First Response|Death|0
959017|NCT00711243|3156590|P4|Treated Cycle 5 After First Response|Death|0
959018|NCT00711243|3156591|P3|Treated Cycle 5 After First Response|Death|0
959019|NCT00711243|3156592|P2|Treated Cycle 5 After First Response|Death|0
959020|NCT00711243|3156593|P1|Treated Cycle 5 After First Response|Death|0
959021|NCT00711243|3156588|P6|Treated Cycle 5 After First Response|Progressive disease|1
959022|NCT00711243|3156589|P5|Treated Cycle 5 After First Response|Progressive disease|1
959023|NCT00711243|3156590|P4|Treated Cycle 5 After First Response|Progressive disease|0
959024|NCT00711243|3156591|P3|Treated Cycle 5 After First Response|Progressive disease|0
959025|NCT00711243|3156592|P2|Treated Cycle 5 After First Response|Progressive disease|2
959026|NCT00711243|3156593|P1|Treated Cycle 5 After First Response|Progressive disease|1
959027|NCT00711243|3156588|P6|Reached First Response/4 Cycles|Progressive disease|0
959028|NCT00711243|3156589|P5|Reached First Response/4 Cycles|Progressive disease|0
959029|NCT00711243|3156590|P4|Reached First Response/4 Cycles|Progressive disease|1
959030|NCT00711243|3156591|P3|Reached First Response/4 Cycles|Progressive disease|0
959031|NCT00711243|3156592|P2|Reached First Response/4 Cycles|Progressive disease|0
959032|NCT00711243|3156593|P1|Reached First Response/4 Cycles|Progressive disease|0
959033|NCT00711243|3156588|P6|Reached First Response/4 Cycles|Death|2
959034|NCT00711243|3156589|P5|Reached First Response/4 Cycles|Death|0
959035|NCT00711243|3156590|P4|Reached First Response/4 Cycles|Death|0
959036|NCT00711243|3156591|P3|Reached First Response/4 Cycles|Death|0
959037|NCT00711243|3156592|P2|Reached First Response/4 Cycles|Death|0
959038|NCT00711243|3156593|P1|Reached First Response/4 Cycles|Death|0
959039|NCT00711243|3156588|P6|Registed and Started Treatment|Withdrawal by Subject|1
959040|NCT00711243|3156589|P5|Registed and Started Treatment|Withdrawal by Subject|0
959041|NCT00711243|3156590|P4|Registed and Started Treatment|Withdrawal by Subject|0
959042|NCT00711243|3156591|P3|Registed and Started Treatment|Withdrawal by Subject|0
959043|NCT00711243|3156592|P2|Registed and Started Treatment|Withdrawal by Subject|0
959044|NCT00711243|3156593|P1|Registed and Started Treatment|Withdrawal by Subject|0
959045|NCT00711191|3156616|P3|Overall Study|Withdrawal by Subject|3
959046|NCT00711191|3156617|P2|Overall Study|Withdrawal by Subject|1
959047|NCT00711191|3156618|P1|Overall Study|Withdrawal by Subject|0
959048|NCT00711191|3156616|P3|Overall Study|Objective progression or relapse|7
959049|NCT00711191|3156617|P2|Overall Study|Objective progression or relapse|3
959050|NCT00711191|3156618|P1|Overall Study|Objective progression or relapse|2
959051|NCT00711191|3156616|P3|Overall Study|Adverse Event|2
959052|NCT00711191|3156617|P2|Overall Study|Adverse Event|1
959053|NCT00711191|3156618|P1|Overall Study|Adverse Event|1
959054|NCT00711113|3156655|P1|Overall Study|Implant lost|2
959055|NCT00711113|3156655|P1|Overall Study|Lost to Follow-up|9
959056|NCT00711100|3156661|P1|Overall Study|Withdrawal by Subject|8
959057|NCT00711100|3156661|P1|Overall Study|Lack of Efficacy|5
959058|NCT00711087|3156679|P2|Overall Study|Lost to Follow-up|0
959059|NCT00711087|3156680|P1|Overall Study|Lost to Follow-up|1
959060|NCT00711009|3156692|P2|Overall Study|Dose adjustment|0
959061|NCT00711009|3156693|P1|Overall Study|Dose adjustment|1
959062|NCT00711009|3156692|P2|Overall Study|Site closing|1
959063|NCT00711009|3156693|P1|Overall Study|Site closing|0
959064|NCT00711009|3156692|P2|Overall Study|Pregnancy|0
959065|NCT00711009|3156693|P1|Overall Study|Pregnancy|1
959066|NCT00711009|3156692|P2|Overall Study|Virologic Failure|1
959067|NCT00711009|3156693|P1|Overall Study|Virologic Failure|2
959068|NCT00711009|3156692|P2|Overall Study|Participant Noncompliant|1
959069|NCT00711009|3156693|P1|Overall Study|Participant Noncompliant|0
959070|NCT00711009|3156692|P2|Overall Study|Lost to Follow-up|9
959071|NCT00711009|3156693|P1|Overall Study|Lost to Follow-up|3
959072|NCT00711009|3156692|P2|Overall Study|Withdrawal by Subject|2
959073|NCT00711009|3156693|P1|Overall Study|Withdrawal by Subject|4
959074|NCT00711009|3156692|P2|Overall Study|Adverse Event/HIV-Related Event|5
959075|NCT00711009|3156693|P1|Overall Study|Adverse Event/HIV-Related Event|4
959076|NCT00710970|3156874|P1|Overall Study|Never took drug|2
959077|NCT00710970|3156874|P1|Overall Study|Lost to Follow-up|8
959078|NCT00710879|3156901|P2|Overall Study|Protocol Violation|3
959079|NCT00710879|3156902|P1|Overall Study|Protocol Violation|0
959080|NCT00710879|3156901|P2|Overall Study|Lost to Follow-up|1
959081|NCT00710879|3156902|P1|Overall Study|Lost to Follow-up|2
959082|NCT00710866|3156914|P2|Overall Study|Failed to meet eligibility|1
959083|NCT00710866|3156915|P1|Overall Study|Failed to meet eligibility|1
959084|NCT00710866|3156914|P2|Overall Study|Lost to Follow-up|0
959085|NCT00710866|3156915|P1|Overall Study|Lost to Follow-up|1
959086|NCT00710866|3156914|P2|Overall Study|Withdrawal by Subject|1
959087|NCT00710866|3156915|P1|Overall Study|Withdrawal by Subject|2
959088|NCT00710866|3156914|P2|Overall Study|Protocol Violation|4
959089|NCT00710866|3156915|P1|Overall Study|Protocol Violation|5
959090|NCT00710762|3156961|P2|Overall Study|Reason other than listed above|2
959091|NCT00710762|3156962|P1|Overall Study|Reason other than listed above|2
959092|NCT00710762|3156961|P2|Overall Study|Lost to Follow-up|0
959093|NCT00710762|3156962|P1|Overall Study|Lost to Follow-up|1
959094|NCT00710762|3156961|P2|Overall Study|Other Adverse Event|7
959095|NCT00710762|3156962|P1|Overall Study|Other Adverse Event|7
959096|NCT00710762|3156961|P2|Overall Study|Adverse Event other disease worsening|1
959097|NCT00710762|3156962|P1|Overall Study|Adverse Event other disease worsening|2
959098|NCT00710762|3156961|P2|Overall Study|Progressive disease|30
959099|NCT00710762|3156962|P1|Overall Study|Progressive disease|27
959100|NCT00710749|3156978|P2|First Intervention|Withdrawal by Subject|0
959101|NCT00710749|3156979|P1|First Intervention|Withdrawal by Subject|1
959102|NCT00710684|3156990|P3|Overall Study|Did not continue after week 24|16
959103|NCT00710684|3156991|P2|Overall Study|Did not continue after week 24|21
959104|NCT00710684|3156992|P1|Overall Study|Did not continue after week 24|25
959105|NCT00710684|3156990|P3|Overall Study|Missing|0
959106|NCT00710684|3156991|P2|Overall Study|Missing|0
959107|NCT00710684|3156992|P1|Overall Study|Missing|1
959108|NCT00710684|3156990|P3|Overall Study|Withdrawal by Subject|11
959109|NCT00710684|3156991|P2|Overall Study|Withdrawal by Subject|18
959110|NCT00710684|3156992|P1|Overall Study|Withdrawal by Subject|24
959111|NCT00710684|3156990|P3|Overall Study|Physician Decision|4
959112|NCT00710684|3156991|P2|Overall Study|Physician Decision|2
959113|NCT00710684|3156992|P1|Overall Study|Physician Decision|0
959114|NCT00710684|3156990|P3|Overall Study|Lost to Follow-up|7
959115|NCT00710684|3156991|P2|Overall Study|Lost to Follow-up|6
959116|NCT00710684|3156992|P1|Overall Study|Lost to Follow-up|4
959117|NCT00710684|3156990|P3|Overall Study|Protocol Violation|5
959118|NCT00710684|3156991|P2|Overall Study|Protocol Violation|5
959119|NCT00710684|3156992|P1|Overall Study|Protocol Violation|5
959120|NCT00710684|3156990|P3|Overall Study|Lack of Efficacy|5
959121|NCT00710684|3156991|P2|Overall Study|Lack of Efficacy|3
959122|NCT00710684|3156992|P1|Overall Study|Lack of Efficacy|4
959123|NCT00710684|3156990|P3|Overall Study|Adverse Event|16
959124|NCT00710684|3156991|P2|Overall Study|Adverse Event|19
959125|NCT00710684|3156992|P1|Overall Study|Adverse Event|11
959126|NCT00710606|3157049|P2|Overall Study|Adverse Event|2
959127|NCT00710606|3157050|P1|Overall Study|Adverse Event|0
959128|NCT00710593|3157062|P2|Overall Study|Prem disc vaccine, completed all visits|2
959129|NCT00710593|3157063|P1|Overall Study|Prem disc vaccine, completed all visits|6
959130|NCT00710593|3157062|P2|Overall Study|Protocol Violation|1
959131|NCT00710593|3157063|P1|Overall Study|Protocol Violation|1
959132|NCT00710593|3157062|P2|Overall Study|Failure to adhere or complete study eval|1
959133|NCT00710593|3157063|P1|Overall Study|Failure to adhere or complete study eval|1
959134|NCT00710593|3157062|P2|Overall Study|Moved out of area|0
959135|NCT00710593|3157063|P1|Overall Study|Moved out of area|1
959136|NCT00710593|3157062|P2|Overall Study|Lost to Follow-up|1
959137|NCT00710593|3157063|P1|Overall Study|Lost to Follow-up|3
959138|NCT00710593|3157062|P2|Overall Study|Unable to complete Wk 48 within window|0
959139|NCT00710593|3157063|P1|Overall Study|Unable to complete Wk 48 within window|2
959140|NCT00710593|3157062|P2|Overall Study|Incarceration|0
959141|NCT00710593|3157063|P1|Overall Study|Incarceration|1
959142|NCT00710554|3157106|P2|Overall Study|Receiving radiotherapy - prostate cancer|1
959143|NCT00710554|3157107|P1|Overall Study|Receiving radiotherapy - prostate cancer|0
959144|NCT00710554|3157106|P2|Overall Study|Lack of Efficacy|12
959145|NCT00710554|3157107|P1|Overall Study|Lack of Efficacy|11
959146|NCT00710554|3157106|P2|Overall Study|Lost to Follow-up|1
959147|NCT00710554|3157107|P1|Overall Study|Lost to Follow-up|7
959148|NCT00710554|3157106|P2|Overall Study|Withdrawal by Subject|3
959149|NCT00710554|3157107|P1|Overall Study|Withdrawal by Subject|7
959150|NCT00710554|3157106|P2|Overall Study|Adverse Event|7
959151|NCT00710554|3157107|P1|Overall Study|Adverse Event|24
959152|NCT00710424|3157135|P2|Overall Study|Felt good so stopped treatment|1
959153|NCT00710424|3157136|P1|Overall Study|Felt good so stopped treatment|0
959154|NCT00710424|3157135|P2|Overall Study|Subject preferred paracetamol|1
959155|NCT00710424|3157136|P1|Overall Study|Subject preferred paracetamol|0
959156|NCT00710424|3157135|P2|Overall Study|Ceased treatment due to travel|0
959157|NCT00710424|3157136|P1|Overall Study|Ceased treatment due to travel|1
959158|NCT00710424|3157135|P2|Overall Study|Subject thought medication changed|0
959159|NCT00710424|3157136|P1|Overall Study|Subject thought medication changed|1
959160|NCT00710424|3157135|P2|Overall Study|Did not meet entry criteria at visit 1|0
959161|NCT00710424|3157136|P1|Overall Study|Did not meet entry criteria at visit 1|1
959162|NCT00710424|3157135|P2|Overall Study|Non-compliance with stable analgesia|0
959163|NCT00710424|3157136|P1|Overall Study|Non-compliance with stable analgesia|1
959164|NCT00710424|3157135|P2|Overall Study|Refused medication, no side effects|0
959165|NCT00710424|3157136|P1|Overall Study|Refused medication, no side effects|1
959166|NCT00710424|3157135|P2|Overall Study|Lost to Follow-up|1
959167|NCT00710424|3157136|P1|Overall Study|Lost to Follow-up|0
959168|NCT00710424|3157135|P2|Overall Study|Withdrawal by Subject|3
959169|NCT00710424|3157136|P1|Overall Study|Withdrawal by Subject|5
959170|NCT00710424|3157135|P2|Overall Study|Lack of Efficacy|5
959171|NCT00710424|3157136|P1|Overall Study|Lack of Efficacy|4
959172|NCT00710424|3157135|P2|Overall Study|Adverse Event|12
959173|NCT00710424|3157136|P1|Overall Study|Adverse Event|30
959174|NCT00710385|3157160|P1|Overall Study|Undisclosed excessive methadone use|1
959175|NCT00710385|3157160|P1|Overall Study|Physician Decision|1
959176|NCT00710385|3157160|P1|Overall Study|Undisclosed back pain|1
959177|NCT00710385|3157160|P1|Overall Study|Withdrawal by Subject|1
959178|NCT00710385|3157160|P1|Overall Study|Did not qualify|1
959179|NCT00710034|3157205|P2|Completed 12 Weeks of Treatment|Withdrawal by Subject|2
959180|NCT00710034|3157206|P1|Completed 12 Weeks of Treatment|Withdrawal by Subject|8
959181|NCT00710034|3157205|P2|Completed 12 Weeks of Treatment|Product Dissatisfaction|1
959182|NCT00710034|3157206|P1|Completed 12 Weeks of Treatment|Product Dissatisfaction|0
959183|NCT00710034|3157205|P2|Completed 12 Weeks of Treatment|Lost to Follow-up|5
959184|NCT00710034|3157206|P1|Completed 12 Weeks of Treatment|Lost to Follow-up|5
959185|NCT00710034|3157205|P2|Completed 12 Weeks of Treatment|Lack of Efficacy|2
959186|NCT00710034|3157206|P1|Completed 12 Weeks of Treatment|Lack of Efficacy|0
959187|NCT00710034|3157205|P2|Completed 12 Weeks of Treatment|Adverse Event|1
959188|NCT00710034|3157206|P1|Completed 12 Weeks of Treatment|Adverse Event|0
959189|NCT00710034|3157205|P2|Completed 6 Weeks of Treatment|Physician Decision|0
959190|NCT00710034|3157206|P1|Completed 6 Weeks of Treatment|Physician Decision|1
959191|NCT00710034|3157205|P2|Completed 6 Weeks of Treatment|Withdrawal by Subject|4
959192|NCT00710034|3157206|P1|Completed 6 Weeks of Treatment|Withdrawal by Subject|6
959193|NCT00710034|3157205|P2|Completed 6 Weeks of Treatment|Product dissatisfaction|6
959194|NCT00710034|3157206|P1|Completed 6 Weeks of Treatment|Product dissatisfaction|2
959195|NCT00710034|3157205|P2|Completed 6 Weeks of Treatment|Lost to Follow-up|17
959196|NCT00710034|3157206|P1|Completed 6 Weeks of Treatment|Lost to Follow-up|15
959197|NCT00710034|3157205|P2|Completed 6 Weeks of Treatment|Lack of Efficacy|8
959198|NCT00710034|3157206|P1|Completed 6 Weeks of Treatment|Lack of Efficacy|12
959199|NCT00710034|3157205|P2|Completed 6 Weeks of Treatment|Adverse Event|12
959200|NCT00710034|3157206|P1|Completed 6 Weeks of Treatment|Adverse Event|5
959201|NCT00710021|3157223|P3|Overall Study|Physician Decision|0
959202|NCT00710021|3157224|P2|Overall Study|Physician Decision|1
959203|NCT00710021|3157225|P1|Overall Study|Physician Decision|0
959204|NCT00710021|3157223|P3|Overall Study|Subject misrandomized|1
959205|NCT00710021|3157224|P2|Overall Study|Subject misrandomized|1
959206|NCT00710021|3157225|P1|Overall Study|Subject misrandomized|0
959207|NCT00710021|3157223|P3|Overall Study|Subject's Decision|0
959208|NCT00710021|3157224|P2|Overall Study|Subject's Decision|1
959209|NCT00710021|3157225|P1|Overall Study|Subject's Decision|0
959210|NCT00710021|3157223|P3|Overall Study|Lost to Follow-up|0
959211|NCT00710021|3157224|P2|Overall Study|Lost to Follow-up|0
959212|NCT00710021|3157225|P1|Overall Study|Lost to Follow-up|1
959213|NCT00709956|3157340|P2|Overall Study|Inclusion/exclusion criteria violation|3
959214|NCT00709956|3157341|P1|Overall Study|Inclusion/exclusion criteria violation|2
959215|NCT00709956|3157340|P2|Overall Study|Withdrawal by Subject|1
959216|NCT00709956|3157341|P1|Overall Study|Withdrawal by Subject|1
959217|NCT00709852|3157371|P2|Period 2|No 72-hour follow-up|0
959218|NCT00709852|3157372|P1|Period 2|No 72-hour follow-up|3
959219|NCT00709852|3157371|P2|Period 2|Lost to Follow-up|0
959220|NCT00709852|3157372|P1|Period 2|Lost to Follow-up|1
959221|NCT00709852|3157371|P2|Period 2|Adverse Event|1
959222|NCT00709852|3157372|P1|Period 2|Adverse Event|1
959223|NCT00709852|3157371|P2|Period 2|Protocol Violation|1
959224|NCT00709852|3157372|P1|Period 2|Protocol Violation|4
959225|NCT00709852|3157371|P2|Period 1|Lost to Follow-up|0
959226|NCT00709852|3157372|P1|Period 1|Lost to Follow-up|1
959227|NCT00709852|3157371|P2|Period 1|Defective scanner|1
959228|NCT00709852|3157372|P1|Period 1|Defective scanner|0
959229|NCT00709852|3157371|P2|Period 1|Protocol Violation|0
959230|NCT00709852|3157372|P1|Period 1|Protocol Violation|1
959231|NCT00709852|3157371|P2|Period 1|Withdrawal by Subject|2
959232|NCT00709852|3157372|P1|Period 1|Withdrawal by Subject|4
959233|NCT00709852|3157371|P2|Period 1|Adverse Event|0
959234|NCT00709852|3157372|P1|Period 1|Adverse Event|2
959235|NCT00709761|3157536|P1|Overall Study|Ongoing|40
959236|NCT00709761|3157536|P1|Overall Study|Withdrawal by Subject|7
959237|NCT00709735|3157547|P2|Overall Study|Did not meet PTSD Diagnostic Criteria|0
959238|NCT00709735|3157548|P1|Overall Study|Did not meet PTSD Diagnostic Criteria|2
959239|NCT00709735|3157547|P2|Overall Study|Relapse into Opioid Abuse|1
959240|NCT00709735|3157548|P1|Overall Study|Relapse into Opioid Abuse|0
959241|NCT00709735|3157547|P2|Overall Study|Lost to Follow-up|1
959242|NCT00709735|3157548|P1|Overall Study|Lost to Follow-up|1
959243|NCT00709722|3157556|P1|Overall Study|Adverse Event|1
959244|NCT00709618|3157571|P1|Overall Study|Study Closed/Terminated|25
959245|NCT00709618|3157571|P1|Overall Study|Lost to Follow-up|1
959246|NCT00709618|3157571|P1|Overall Study|Withdrawal by Subject|4
959247|NCT00709592|3157583|P2|Overall Study|Unable to proceed to transplant|1
959248|NCT00709592|3157584|P1|Overall Study|Unable to proceed to transplant|0
959249|NCT00709319|3157606|P1|Overall Study|Withdrawal by Subject|2
959250|NCT00709319|3157606|P1|Overall Study|Death|4
959251|NCT00709228|3157635|P1|Overall Study|Non-compliance|5
959252|NCT00709228|3157635|P1|Overall Study|Lost to Follow-up|6
959253|NCT00709228|3157635|P1|Overall Study|Disease progression|1
959254|NCT00709228|3157635|P1|Overall Study|Discontinued follow-up|5
959255|NCT00709228|3157635|P1|Overall Study|Did not enter follow-up|4
959256|NCT00709228|3157635|P1|Overall Study|Discontinued treatment|14
959257|NCT00709228|3157635|P1|Overall Study|Adverse events|2
959258|NCT00709228|3157635|P1|Overall Study|Eligibility criteria not met|281
959259|NCT00709228|3157635|P1|Overall Study|Not treated|14
959260|NCT00709124|3157641|P2|Overall Study|encephalopathy; can't do assessment|0
959261|NCT00709124|3157642|P1|Overall Study|encephalopathy; can't do assessment|1
959262|NCT00709124|3157641|P2|Overall Study|Death|1
959263|NCT00709124|3157642|P1|Overall Study|Death|3
959264|NCT00709111|3157676|P1|Overall Study|Unable to attend clinic visits|1
959265|NCT00709111|3157676|P1|Overall Study|Withdrawal by Subject|1
959266|NCT00709098|3157717|P3|Open-label Period|Lost to Follow-up|1
959267|NCT00709098|3157718|P2|Open-label Period|Lost to Follow-up|0
959268|NCT00709098|3157719|P1|Open-label Period|Lost to Follow-up|0
959269|NCT00709098|3157717|P3|Open-label Period|Death|1
959270|NCT00709098|3157718|P2|Open-label Period|Death|0
959271|NCT00709098|3157719|P1|Open-label Period|Death|0
959272|NCT00709098|3157717|P3|Open-label Period|Administrative reason|5
959273|NCT00709098|3157718|P2|Open-label Period|Administrative reason|0
959274|NCT00709098|3157719|P1|Open-label Period|Administrative reason|0
959275|NCT00709098|3157717|P3|Open-label Period|Withdrawal of consent|7
959276|NCT00709098|3157718|P2|Open-label Period|Withdrawal of consent|0
959277|NCT00709098|3157719|P1|Open-label Period|Withdrawal of consent|0
959278|NCT00709098|3157717|P3|Double-blind Period|Lost to Follow-up|0
959279|NCT00709098|3157718|P2|Double-blind Period|Lost to Follow-up|1
959280|NCT00709098|3157719|P1|Double-blind Period|Lost to Follow-up|1
959281|NCT00709098|3157717|P3|Double-blind Period|Death|0
959282|NCT00709098|3157718|P2|Double-blind Period|Death|1
959283|NCT00709098|3157719|P1|Double-blind Period|Death|1
959284|NCT00709098|3157717|P3|Double-blind Period|Administrative reason|0
959285|NCT00709098|3157718|P2|Double-blind Period|Administrative reason|3
959286|NCT00709098|3157719|P1|Double-blind Period|Administrative reason|1
959287|NCT00709098|3157717|P3|Double-blind Period|Withdrawal of consent|0
959288|NCT00709098|3157718|P2|Double-blind Period|Withdrawal of consent|3
959289|NCT00709098|3157719|P1|Double-blind Period|Withdrawal of consent|3
959290|NCT00709059|3157738|P1|Overall Study|Serious side effects|11
959291|NCT00709059|3157738|P1|Overall Study|Side effects|20
959292|NCT00709059|3157738|P1|Overall Study|Disease complication|3
959293|NCT00709059|3157738|P1|Overall Study|Physician Decision|7
959294|NCT00709059|3157738|P1|Overall Study|Withdrawal by Subject|19
959295|NCT00709059|3157738|P1|Overall Study|Lost to Follow-up|34
959296|NCT00708734|3157785|P1|Overall Study|leg fracture|1
959297|NCT00708734|3157785|P1|Overall Study|vertigo|1
959298|NCT00708734|3157785|P1|Overall Study|knee replacement|1
959299|NCT00708734|3157785|P1|Overall Study|leg injury|1
959300|NCT00708734|3157785|P1|Overall Study|moved|1
959301|NCT00708734|3157785|P1|Overall Study|scheduling conflict|2
959302|NCT00708708|3157805|P1|Overall Study|Missing values|392
959303|NCT00708708|3157805|P1|Overall Study|Adverse Event|3
959304|NCT00708708|3157805|P1|Overall Study|Pregnancy|3
959305|NCT00708708|3157805|P1|Overall Study|Lack of compliance|3
959306|NCT00708708|3157805|P1|Overall Study|Lack of effectiveness|4
959307|NCT00708708|3157805|P1|Overall Study|Administrative reasons|7
959308|NCT00708708|3157805|P1|Overall Study|Ineffectiveness (no systemic therapy)|9
959309|NCT00708708|3157805|P1|Overall Study|Good effectiveness|9
959310|NCT00708708|3157805|P1|Overall Study|Other unspecified|11
959311|NCT00708708|3157805|P1|Overall Study|Another therapy along with Enbrel|15
959312|NCT00708708|3157805|P1|Overall Study|Intolerance|42
959313|NCT00708708|3157805|P1|Overall Study|Withdrawal by Subject|51
959314|NCT00708708|3157805|P1|Overall Study|Lost to Follow-up|52
959315|NCT00708708|3157805|P1|Overall Study|Another therapy instead of Enbrel|141
959316|NCT00708682|3157853|P1|Toddler Dose|Failed to Return|4
959317|NCT00708682|3157853|P1|Toddler Dose|Lost to Follow-up|3
959318|NCT00708682|3157853|P1|Toddler Dose|Parent/Legal Guardian Request|1
959319|NCT00708682|3157853|P1|After Infant Series|Parent/Legal Guardian Request|1
959320|NCT00708682|3157853|P1|Infant Series|Not Specified|19
959321|NCT00708682|3157853|P1|Infant Series|Failed to return|2
959322|NCT00708682|3157853|P1|Infant Series|Parent/legal guardian request|6
959323|NCT00708682|3157853|P1|Infant Series|Protocol Violation|1
959324|NCT00708682|3157853|P1|Infant Series|Lost to Follow-up|4
959325|NCT00708682|3157853|P1|Infant Series|Adverse Event|1
959326|NCT00708643|3157874|P2|Overall Study|Adverse Event|1
959327|NCT00708643|3157875|P1|Overall Study|Adverse Event|0
959328|NCT00708552|3157895|P4|Overall Study|Withdrawal by Subject|10
959329|NCT00708552|3157896|P3|Overall Study|Withdrawal by Subject|8
959330|NCT00708552|3157897|P2|Overall Study|Withdrawal by Subject|7
959331|NCT00708552|3157898|P1|Overall Study|Withdrawal by Subject|12
959332|NCT00708552|3157895|P4|Overall Study|Physician Decision|0
959333|NCT00708552|3157896|P3|Overall Study|Physician Decision|0
959334|NCT00708552|3157897|P2|Overall Study|Physician Decision|2
959335|NCT00708552|3157898|P1|Overall Study|Physician Decision|1
959336|NCT00708552|3157895|P4|Overall Study|Lost to Follow-up|1
959337|NCT00708552|3157896|P3|Overall Study|Lost to Follow-up|0
959338|NCT00708552|3157897|P2|Overall Study|Lost to Follow-up|2
959339|NCT00708552|3157898|P1|Overall Study|Lost to Follow-up|4
959340|NCT00708552|3157895|P4|Overall Study|Protocol Violation|4
959341|NCT00708552|3157896|P3|Overall Study|Protocol Violation|2
959342|NCT00708552|3157897|P2|Overall Study|Protocol Violation|0
959343|NCT00708552|3157898|P1|Overall Study|Protocol Violation|0
959344|NCT00708552|3157895|P4|Overall Study|Lack of Efficacy|0
959345|NCT00708552|3157896|P3|Overall Study|Lack of Efficacy|1
959346|NCT00708552|3157897|P2|Overall Study|Lack of Efficacy|4
959347|NCT00708552|3157898|P1|Overall Study|Lack of Efficacy|0
959348|NCT00708552|3157895|P4|Overall Study|Adverse Event|6
959349|NCT00708552|3157896|P3|Overall Study|Adverse Event|4
959350|NCT00708552|3157897|P2|Overall Study|Adverse Event|3
959351|NCT00708552|3157898|P1|Overall Study|Adverse Event|10
959352|NCT00708500|3158060|P3|FOLLOWUP|Non-compliance with protocol|1
959353|NCT00708500|3158061|P2|FOLLOWUP|Non-compliance with protocol|0
959354|NCT00708500|3158062|P1|FOLLOWUP|Non-compliance with protocol|5
959355|NCT00708500|3158060|P3|FOLLOWUP|Subject withdrew consent|5
959356|NCT00708500|3158061|P2|FOLLOWUP|Subject withdrew consent|4
959357|NCT00708500|3158062|P1|FOLLOWUP|Subject withdrew consent|31
959358|NCT00708500|3158060|P3|FOLLOWUP|Subject withdrawal unrelated to Tx|5
959359|NCT00708500|3158061|P2|FOLLOWUP|Subject withdrawal unrelated to Tx|4
959360|NCT00708500|3158062|P1|FOLLOWUP|Subject withdrawal unrelated to Tx|3
959361|NCT00708500|3158060|P3|FOLLOWUP|Lost to Follow-up|4
959362|NCT00708500|3158061|P2|FOLLOWUP|Lost to Follow-up|6
959363|NCT00708500|3158062|P1|FOLLOWUP|Lost to Follow-up|1
959364|NCT00708500|3158060|P3|FOLLOWUP|Adverse Event|0
959365|NCT00708500|3158061|P2|FOLLOWUP|Adverse Event|1
959366|NCT00708500|3158062|P1|FOLLOWUP|Adverse Event|0
959367|NCT00708500|3158060|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
959368|NCT00708500|3158061|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1
959369|NCT00708500|3158062|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
959370|NCT00708500|3158060|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
959371|NCT00708500|3158061|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
959372|NCT00708500|3158062|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0
959373|NCT00708500|3158060|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1
959374|NCT00708500|3158061|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2
959375|NCT00708500|3158062|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0
959376|NCT00708500|3158060|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1
959377|NCT00708500|3158061|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0
959378|NCT00708500|3158062|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2
959379|NCT00708500|3158060|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4
959380|NCT00708500|3158061|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1
959381|NCT00708500|3158062|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3
959382|NCT00708500|3158060|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
959383|NCT00708500|3158061|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1
959384|NCT00708500|3158062|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
959385|NCT00708500|3158060|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29
959386|NCT00708500|3158061|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36
959387|NCT00708500|3158062|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49
959388|NCT00708500|3158060|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19
959389|NCT00708500|3158061|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10
959390|NCT00708500|3158062|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1
959391|NCT00708500|3158060|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1
959392|NCT00708500|3158061|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
959393|NCT00708500|3158062|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
959394|NCT00708500|3158060|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
959395|NCT00708500|3158061|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2
959396|NCT00708500|3158062|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
959397|NCT00708500|3158060|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
959398|NCT00708500|3158061|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1
959399|NCT00708500|3158062|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
959400|NCT00708500|3158060|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
959401|NCT00708500|3158061|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
959402|NCT00708500|3158062|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1
959403|NCT00708500|3158060|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
959404|NCT00708500|3158061|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3
959405|NCT00708500|3158062|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
959406|NCT00708461|3158081|P2|Overall Study|left workforce|180
959407|NCT00708461|3158082|P1|Overall Study|left workforce|115
959408|NCT00708461|3158081|P2|Overall Study|Withdrawal by Subject|9
959409|NCT00708461|3158082|P1|Overall Study|Withdrawal by Subject|8
959410|NCT00708461|3158081|P2|Overall Study|Lost to Follow-up|11
959411|NCT00708461|3158082|P1|Overall Study|Lost to Follow-up|18
959412|NCT00708435|3158090|P2|Overall Study|Refused hospitalization|0
959413|NCT00708435|3158091|P1|Overall Study|Refused hospitalization|1
959414|NCT00708435|3158090|P2|Overall Study|Intervention by primary care physician|0
959415|NCT00708435|3158091|P1|Overall Study|Intervention by primary care physician|1
959416|NCT00708435|3158090|P2|Overall Study|Protocol Violation|1
959417|NCT00708435|3158091|P1|Overall Study|Protocol Violation|0
959418|NCT00708435|3158090|P2|Overall Study|Adverse Event|0
959419|NCT00708435|3158091|P1|Overall Study|Adverse Event|1
959420|NCT00708435|3158090|P2|Overall Study|Withdrawal by Subject|7
959421|NCT00708435|3158091|P1|Overall Study|Withdrawal by Subject|3
959422|NCT00708435|3158090|P2|Overall Study|Lost to Follow-up|4
959423|NCT00708435|3158091|P1|Overall Study|Lost to Follow-up|9
959424|NCT00708435|3158090|P2|Overall Study|Death / Serious Adverse Event|5
959425|NCT00708435|3158091|P1|Overall Study|Death / Serious Adverse Event|10
959426|NCT00708422|3158118|P2|Overall Study|Withdrawal by Subject|0
959427|NCT00708422|3158119|P1|Overall Study|Withdrawal by Subject|1
959428|NCT00708422|3158118|P2|Overall Study|Adverse Event|1
959429|NCT00708422|3158119|P1|Overall Study|Adverse Event|3
959430|NCT00708305|3158127|P4|Period 3|Other Reason|0
959431|NCT00708305|3158128|P3|Period 3|Other Reason|0
959432|NCT00708305|3158129|P2|Period 3|Other Reason|0
959433|NCT00708305|3158130|P1|Period 3|Other Reason|1
959434|NCT00708305|3158127|P4|Period 3|Protocol Violation|0
959435|NCT00708305|3158128|P3|Period 3|Protocol Violation|0
959436|NCT00708305|3158129|P2|Period 3|Protocol Violation|2
959437|NCT00708305|3158130|P1|Period 3|Protocol Violation|0
959438|NCT00708305|3158127|P4|Period 2|Other Reason|1
959439|NCT00708305|3158128|P3|Period 2|Other Reason|0
959440|NCT00708305|3158129|P2|Period 2|Other Reason|0
959441|NCT00708305|3158130|P1|Period 2|Other Reason|1
959442|NCT00708305|3158127|P4|Period 2|Protocol Violation|0
959443|NCT00708305|3158128|P3|Period 2|Protocol Violation|0
959444|NCT00708305|3158129|P2|Period 2|Protocol Violation|1
959445|NCT00708305|3158130|P1|Period 2|Protocol Violation|0
959446|NCT00708305|3158127|P4|Period 2|Lost to Follow-up|0
959447|NCT00708305|3158128|P3|Period 2|Lost to Follow-up|0
959448|NCT00708305|3158129|P2|Period 2|Lost to Follow-up|1
959449|NCT00708305|3158130|P1|Period 2|Lost to Follow-up|0
959450|NCT00708305|3158127|P4|Period 1|Other Reason|2
959451|NCT00708305|3158128|P3|Period 1|Other Reason|0
959452|NCT00708305|3158129|P2|Period 1|Other Reason|0
959453|NCT00708305|3158130|P1|Period 1|Other Reason|0
959454|NCT00708305|3158127|P4|Period 1|Protocol Violation|0
959455|NCT00708305|3158128|P3|Period 1|Protocol Violation|1
959456|NCT00708305|3158129|P2|Period 1|Protocol Violation|0
959457|NCT00708305|3158130|P1|Period 1|Protocol Violation|1
959458|NCT00708227|3158166|P4|Overall Study|Withdrawal by Subject|1
959459|NCT00708227|3158167|P3|Overall Study|Withdrawal by Subject|0
959460|NCT00708227|3158168|P2|Overall Study|Withdrawal by Subject|2
959461|NCT00708227|3158169|P1|Overall Study|Withdrawal by Subject|1
959462|NCT00708227|3158166|P4|Overall Study|Physician Decision|2
959463|NCT00708227|3158167|P3|Overall Study|Physician Decision|1
959464|NCT00708227|3158168|P2|Overall Study|Physician Decision|3
959465|NCT00708227|3158169|P1|Overall Study|Physician Decision|0
959466|NCT00708214|3158202|P3|Overall Study|Progressive Disease|5
959467|NCT00708214|3158203|P2|Overall Study|Progressive Disease|6
959468|NCT00708214|3158204|P1|Overall Study|Progressive Disease|4
959469|NCT00708214|3158202|P3|Overall Study|Other|1
959470|NCT00708214|3158203|P2|Overall Study|Other|1
959471|NCT00708214|3158204|P1|Overall Study|Other|0
959472|NCT00708214|3158202|P3|Overall Study|Other Adverse Event|2
959473|NCT00708214|3158203|P2|Overall Study|Other Adverse Event|6
959474|NCT00708214|3158204|P1|Overall Study|Other Adverse Event|3
959475|NCT00708201|3158247|P2|Overall Study|Protocol Violation|1
959476|NCT00708201|3158248|P1|Overall Study|Protocol Violation|0
959477|NCT00708201|3158247|P2|Overall Study|Lost to Follow-up|0
959478|NCT00708201|3158248|P1|Overall Study|Lost to Follow-up|2
959479|NCT00708201|3158247|P2|Overall Study|Withdrawal by Subject|1
959480|NCT00708201|3158248|P1|Overall Study|Withdrawal by Subject|1
959481|NCT00708201|3158247|P2|Overall Study|Adverse Event|4
959482|NCT00708201|3158248|P1|Overall Study|Adverse Event|4
959483|NCT00708175|3158272|P2|Overall Study|BMD loss >7%|3
959484|NCT00708175|3158273|P1|Overall Study|BMD loss >7%|2
959485|NCT00708175|3158272|P2|Overall Study|Withdrawal by Subject|7
959486|NCT00708175|3158273|P1|Overall Study|Withdrawal by Subject|5
959487|NCT00708175|3158272|P2|Overall Study|Lost to Follow-up|3
959488|NCT00708175|3158273|P1|Overall Study|Lost to Follow-up|5
959489|NCT00708175|3158272|P2|Overall Study|Protocol Violation|3
959490|NCT00708175|3158273|P1|Overall Study|Protocol Violation|2
959491|NCT00708175|3158272|P2|Overall Study|Adverse Event|5
959492|NCT00708175|3158273|P1|Overall Study|Adverse Event|4
959493|NCT00708162|3158289|P2|Open-Label Phase|Other|0
959494|NCT00708162|3158290|P1|Open-Label Phase|Other|1
959495|NCT00708162|3158289|P2|Open-Label Phase|Adverse Event|2
959496|NCT00708162|3158290|P1|Open-Label Phase|Adverse Event|1
959497|NCT00708162|3158289|P2|Open-Label Phase|Death|1
959498|NCT00708162|3158290|P1|Open-Label Phase|Death|3
959499|NCT00708162|3158289|P2|Open-Label Phase|Investigator's Discretion|2
959500|NCT00708162|3158290|P1|Open-Label Phase|Investigator's Discretion|3
959501|NCT00708162|3158289|P2|Open-Label Phase|Lack of Efficacy|4
959502|NCT00708162|3158290|P1|Open-Label Phase|Lack of Efficacy|7
959503|NCT00708162|3158289|P2|Open-Label Phase|Participant Noncompliance|7
959504|NCT00708162|3158290|P1|Open-Label Phase|Participant Noncompliance|7
959505|NCT00708162|3158289|P2|Open-Label Phase|Withdrew Consent|6
959506|NCT00708162|3158290|P1|Open-Label Phase|Withdrew Consent|12
959507|NCT00708162|3158289|P2|Open-Label Phase|Lost to Follow-up|8
959508|NCT00708162|3158290|P1|Open-Label Phase|Lost to Follow-up|10
959509|NCT00708162|3158289|P2|Randomized Phase|Pregnancy|0
959510|NCT00708162|3158290|P1|Randomized Phase|Pregnancy|3
959511|NCT00708162|3158289|P2|Randomized Phase|Death|9
959512|NCT00708162|3158290|P1|Randomized Phase|Death|2
959513|NCT00708162|3158289|P2|Randomized Phase|Investigator’s Discretion|10
959514|NCT00708162|3158290|P1|Randomized Phase|Investigator’s Discretion|7
959515|NCT00708162|3158289|P2|Randomized Phase|Adverse Event|12
959516|NCT00708162|3158290|P1|Randomized Phase|Adverse Event|8
959517|NCT00708162|3158289|P2|Randomized Phase|Protocol Violation|11
959518|NCT00708162|3158290|P1|Randomized Phase|Protocol Violation|10
959519|NCT00708162|3158289|P2|Randomized Phase|Lack of Efficacy|19
959520|NCT00708162|3158290|P1|Randomized Phase|Lack of Efficacy|14
959521|NCT00708162|3158289|P2|Randomized Phase|Withdrew Consent|22
959522|NCT00708162|3158290|P1|Randomized Phase|Withdrew Consent|31
959523|NCT00708162|3158289|P2|Randomized Phase|Lost to Follow-up|34
959524|NCT00708162|3158290|P1|Randomized Phase|Lost to Follow-up|34
959525|NCT00708162|3158289|P2|Randomized Phase|Participant Noncompliance|32
959526|NCT00708162|3158290|P1|Randomized Phase|Participant Noncompliance|40
959527|NCT00708162|3158289|P2|Randomized Phase|Randomized but Not Treated|5
959528|NCT00708162|3158290|P1|Randomized Phase|Randomized but Not Treated|7
959529|NCT00708123|3158331|P5|Period 4|Protocol Violation|0
959530|NCT00708123|3158332|P4|Period 4|Protocol Violation|0
959531|NCT00708123|3158333|P3|Period 4|Protocol Violation|0
959532|NCT00708123|3158334|P2|Period 4|Protocol Violation|1
959533|NCT00708123|3158335|P1|Period 4|Protocol Violation|0
959534|NCT00708123|3158331|P5|Period 3|Lost to Follow-up|0
959535|NCT00708123|3158332|P4|Period 3|Lost to Follow-up|1
959536|NCT00708123|3158333|P3|Period 3|Lost to Follow-up|1
959537|NCT00708123|3158334|P2|Period 3|Lost to Follow-up|0
959538|NCT00708123|3158335|P1|Period 3|Lost to Follow-up|0
959539|NCT00708123|3158331|P5|Period 2|Other Reason|0
959540|NCT00708123|3158332|P4|Period 2|Other Reason|0
959541|NCT00708123|3158333|P3|Period 2|Other Reason|0
959542|NCT00708123|3158334|P2|Period 2|Other Reason|0
959543|NCT00708123|3158335|P1|Period 2|Other Reason|1
959544|NCT00708123|3158331|P5|Period 2|Protocol Violation|0
959545|NCT00708123|3158332|P4|Period 2|Protocol Violation|1
959546|NCT00708123|3158333|P3|Period 2|Protocol Violation|0
959547|NCT00708123|3158334|P2|Period 2|Protocol Violation|0
959548|NCT00708123|3158335|P1|Period 2|Protocol Violation|0
959549|NCT00708123|3158331|P5|Period 1|Adverse Event|0
959550|NCT00708123|3158332|P4|Period 1|Adverse Event|0
959551|NCT00708123|3158333|P3|Period 1|Adverse Event|1
959552|NCT00708123|3158334|P2|Period 1|Adverse Event|0
959553|NCT00708123|3158335|P1|Period 1|Adverse Event|0
959554|NCT00708123|3158331|P5|Period 1|Protocol Violation|0
959555|NCT00708123|3158332|P4|Period 1|Protocol Violation|1
959556|NCT00708123|3158333|P3|Period 1|Protocol Violation|0
959557|NCT00708123|3158334|P2|Period 1|Protocol Violation|1
959558|NCT00708123|3158335|P1|Period 1|Protocol Violation|0
959559|NCT00708097|3158468|P5|Period 2|Protocol Violation|0
959560|NCT00708097|3158469|P4|Period 2|Protocol Violation|1
959561|NCT00708097|3158470|P3|Period 2|Protocol Violation|1
959562|NCT00708097|3158471|P2|Period 2|Protocol Violation|1
959563|NCT00708097|3158472|P1|Period 2|Protocol Violation|0
959564|NCT00708097|3158468|P5|Period 1|Other Reason|1
959565|NCT00708097|3158469|P4|Period 1|Other Reason|0
959566|NCT00708097|3158470|P3|Period 1|Other Reason|0
959567|NCT00708097|3158471|P2|Period 1|Other Reason|0
959568|NCT00708097|3158472|P1|Period 1|Other Reason|0
959569|NCT00708097|3158468|P5|Period 1|Protocol Violation|0
959570|NCT00708097|3158469|P4|Period 1|Protocol Violation|2
959571|NCT00708097|3158470|P3|Period 1|Protocol Violation|0
959572|NCT00708097|3158471|P2|Period 1|Protocol Violation|1
959573|NCT00708097|3158472|P1|Period 1|Protocol Violation|0
959574|NCT00708032|3158582|P2|Overall Study|Withdrawal by Subject|1
959575|NCT00708032|3158583|P1|Overall Study|Withdrawal by Subject|0
959576|NCT00708032|3158582|P2|Overall Study|Protocol Violation|1
959577|NCT00708032|3158583|P1|Overall Study|Protocol Violation|4
959578|NCT00708032|3158582|P2|Overall Study|Did not meet protocol criteria|2
959579|NCT00708032|3158583|P1|Overall Study|Did not meet protocol criteria|1
959580|NCT00708032|3158582|P2|Overall Study|Visit out of range at month 12|1
959581|NCT00708032|3158583|P1|Overall Study|Visit out of range at month 12|4
959582|NCT00708032|3158582|P2|Overall Study|Poor vision|6
959583|NCT00708032|3158583|P1|Overall Study|Poor vision|0
959584|NCT00708032|3158582|P2|Overall Study|Pregnancy|1
959585|NCT00708032|3158583|P1|Overall Study|Pregnancy|0
959586|NCT00708032|3158582|P2|Overall Study|Lost to Follow-up|2
959587|NCT00708032|3158583|P1|Overall Study|Lost to Follow-up|1
959588|NCT00708032|3158582|P2|Overall Study|Adverse Event|2
959589|NCT00708032|3158583|P1|Overall Study|Adverse Event|0
959590|NCT00707993|3158610|P2|Overall Study|Other|0
959591|NCT00707993|3158611|P1|Overall Study|Other|2
959592|NCT00707993|3158610|P2|Overall Study|Hyperglycemic Rescue|47
959593|NCT00707993|3158611|P1|Overall Study|Hyperglycemic Rescue|55
959594|NCT00707993|3158610|P2|Overall Study|Withdrawal by Subject|16
959595|NCT00707993|3158611|P1|Overall Study|Withdrawal by Subject|12
959596|NCT00707993|3158610|P2|Overall Study|Lost to Follow-up|4
959597|NCT00707993|3158611|P1|Overall Study|Lost to Follow-up|0
959598|NCT00707993|3158610|P2|Overall Study|Protocol Violation|7
959599|NCT00707993|3158611|P1|Overall Study|Protocol Violation|4
959600|NCT00707993|3158610|P2|Overall Study|Adverse Event|20
959601|NCT00707993|3158611|P1|Overall Study|Adverse Event|16
959602|NCT00707980|3158653|P1|Overall Study|Other|39
959603|NCT00707980|3158653|P1|Overall Study|Lost to Follow-up|59
959604|NCT00707980|3158653|P1|Overall Study|Withdrawal of Consent|81
959605|NCT00707980|3158653|P1|Overall Study|Protocol Deviations|19
959606|NCT00707980|3158653|P1|Overall Study|Non-Compliance with Study Drug|28
959607|NCT00707980|3158653|P1|Overall Study|Lack of Efficacy|35
959608|NCT00707980|3158653|P1|Overall Study|Adverse Event|49
959609|NCT00707954|3158737|P5|Overall Study|Physician Decision|1
959610|NCT00707954|3158738|P4|Overall Study|Physician Decision|0
959611|NCT00707954|3158739|P3|Overall Study|Physician Decision|0
959612|NCT00707954|3158740|P2|Overall Study|Physician Decision|0
959613|NCT00707954|3158741|P1|Overall Study|Physician Decision|0
959614|NCT00707746|3158782|P2|Treatment Period|Ineligibility|1
959615|NCT00707746|3158783|P1|Treatment Period|Ineligibility|0
959616|NCT00707746|3158782|P2|Treatment Period|Adverse Event|4
959617|NCT00707746|3158783|P1|Treatment Period|Adverse Event|2
959618|NCT00707577|3158844|P2|Overall Study|Pregnancy|1
959619|NCT00707577|3158845|P1|Overall Study|Pregnancy|4
959620|NCT00707577|3158844|P2|Overall Study|Left employment|10
959621|NCT00707577|3158845|P1|Overall Study|Left employment|13
959622|NCT00707577|3158844|P2|Overall Study|Lost to Follow-up|25
959623|NCT00707577|3158845|P1|Overall Study|Lost to Follow-up|34
959624|NCT00707577|3158844|P2|Overall Study|Withdrawal by Subject|2
959625|NCT00707577|3158845|P1|Overall Study|Withdrawal by Subject|3
959626|NCT00707486|3158851|P1|Overall Study|Withdrawal by Subject|1
959627|NCT00707239|3158894|P3|Overall Study|Other|5
959628|NCT00707239|3158895|P2|Overall Study|Other|3
959629|NCT00707239|3158896|P1|Overall Study|Other|8
959630|NCT00707239|3158894|P3|Overall Study|Randomized, but not treated|1
959631|NCT00707239|3158895|P2|Overall Study|Randomized, but not treated|1
959632|NCT00707239|3158896|P1|Overall Study|Randomized, but not treated|1
959633|NCT00707239|3158894|P3|Overall Study|Lack of Efficacy|0
959634|NCT00707239|3158895|P2|Overall Study|Lack of Efficacy|2
959635|NCT00707239|3158896|P1|Overall Study|Lack of Efficacy|1
959636|NCT00707239|3158894|P3|Overall Study|Protocol Violation|1
959637|NCT00707239|3158895|P2|Overall Study|Protocol Violation|0
959638|NCT00707239|3158896|P1|Overall Study|Protocol Violation|0
959639|NCT00707239|3158894|P3|Overall Study|Physician Decision|2
959640|NCT00707239|3158895|P2|Overall Study|Physician Decision|1
959641|NCT00707239|3158896|P1|Overall Study|Physician Decision|1
959642|NCT00707239|3158894|P3|Overall Study|Death|3
959643|NCT00707239|3158895|P2|Overall Study|Death|1
959644|NCT00707239|3158896|P1|Overall Study|Death|3
959645|NCT00707239|3158894|P3|Overall Study|Adverse Event|2
959646|NCT00707239|3158895|P2|Overall Study|Adverse Event|3
959647|NCT00707239|3158896|P1|Overall Study|Adverse Event|5
959648|NCT00707174|3158944|P2|Overall Study|Withdrawal by Subject|1
959649|NCT00707174|3158945|P1|Overall Study|Withdrawal by Subject|4
959650|NCT00707174|3158944|P2|Overall Study|Adverse Event|6
959651|NCT00707174|3158945|P1|Overall Study|Adverse Event|1
959652|NCT00707161|3158951|P1|Overall Study|Physician Decision|6
959653|NCT00707057|3158957|P2|Overall Study|Dosed incorrectly|1
959654|NCT00707057|3158958|P1|Overall Study|Dosed incorrectly|0
959655|NCT00707057|3158957|P2|Overall Study|Withdrawal by Subject|3
959656|NCT00707057|3158958|P1|Overall Study|Withdrawal by Subject|8
959657|NCT00707031|3158992|P2|Overall Study|Sponsor Decision|8
959658|NCT00707031|3158993|P1|Overall Study|Sponsor Decision|9
959659|NCT00707031|3158992|P2|Overall Study|Serious Noncompliance|3
959660|NCT00707031|3158993|P1|Overall Study|Serious Noncompliance|2
959661|NCT00707031|3158992|P2|Overall Study|Familial or Personal Reasons|15
959662|NCT00707031|3158993|P1|Overall Study|Familial or Personal Reasons|12
959663|NCT00707031|3158992|P2|Overall Study|Poor Compliance to Protocol|13
959664|NCT00707031|3158993|P1|Overall Study|Poor Compliance to Protocol|7
959665|NCT00707031|3158992|P2|Overall Study|Withdrawal by Subject|8
959666|NCT00707031|3158993|P1|Overall Study|Withdrawal by Subject|7
959667|NCT00707031|3158992|P2|Overall Study|Protocol Violation|0
959668|NCT00707031|3158993|P1|Overall Study|Protocol Violation|1
959669|NCT00707031|3158992|P2|Overall Study|Lost to Follow-up|1
959670|NCT00707031|3158993|P1|Overall Study|Lost to Follow-up|2
959671|NCT00707031|3158992|P2|Overall Study|Lack of Efficacy|6
959672|NCT00707031|3158993|P1|Overall Study|Lack of Efficacy|19
959673|NCT00707031|3158992|P2|Overall Study|Adverse Event|45
959674|NCT00707031|3158993|P1|Overall Study|Adverse Event|45
959675|NCT00706992|3159022|P7|Overall Study|Disease progression before treatment|0
959676|NCT00706992|3159023|P6|Overall Study|Disease progression before treatment|0
959677|NCT00706992|3159024|P5|Overall Study|Disease progression before treatment|1
959678|NCT00706992|3159025|P4|Overall Study|Disease progression before treatment|0
959679|NCT00706992|3159026|P3|Overall Study|Disease progression before treatment|0
959680|NCT00706992|3159027|P2|Overall Study|Disease progression before treatment|0
959681|NCT00706992|3159028|P1|Overall Study|Disease progression before treatment|0
959682|NCT00706992|3159022|P7|Overall Study|Study termination|3
959683|NCT00706992|3159023|P6|Overall Study|Study termination|2
959684|NCT00706992|3159024|P5|Overall Study|Study termination|3
959685|NCT00706992|3159025|P4|Overall Study|Study termination|2
959686|NCT00706992|3159026|P3|Overall Study|Study termination|6
959687|NCT00706992|3159027|P2|Overall Study|Study termination|5
959688|NCT00706992|3159028|P1|Overall Study|Study termination|5
959689|NCT00706966|3159060|P1|Overall Study|Adverse Event|1
959690|NCT00706914|3159096|P3|Overall Study|Protocol Violation|1
959691|NCT00706914|3159097|P2|Overall Study|Protocol Violation|1
959692|NCT00706914|3159098|P1|Overall Study|Protocol Violation|3
959693|NCT00706914|3159096|P3|Overall Study|Adverse Event|0
959694|NCT00706914|3159097|P2|Overall Study|Adverse Event|2
959695|NCT00706914|3159098|P1|Overall Study|Adverse Event|2
959696|NCT00706914|3159096|P3|Overall Study|Lost to Follow-up|0
959697|NCT00706914|3159097|P2|Overall Study|Lost to Follow-up|0
959698|NCT00706914|3159098|P1|Overall Study|Lost to Follow-up|1
959699|NCT00706914|3159096|P3|Overall Study|Lack of Efficacy|0
959700|NCT00706914|3159097|P2|Overall Study|Lack of Efficacy|1
959701|NCT00706914|3159098|P1|Overall Study|Lack of Efficacy|0
959702|NCT00706901|3159121|P3|Overall Study|Death|0
959703|NCT00706901|3159122|P2|Overall Study|Death|0
959704|NCT00706901|3159123|P1|Overall Study|Death|1
959705|NCT00706901|3159121|P3|Overall Study|In Jail|1
959706|NCT00706901|3159122|P2|Overall Study|In Jail|0
959707|NCT00706901|3159123|P1|Overall Study|In Jail|1
959708|NCT00706901|3159121|P3|Overall Study|Withdrawal by Subject|5
959709|NCT00706901|3159122|P2|Overall Study|Withdrawal by Subject|2
959710|NCT00706901|3159123|P1|Overall Study|Withdrawal by Subject|4
959711|NCT00706901|3159121|P3|Overall Study|Lost to Follow-up|2
959712|NCT00706901|3159122|P2|Overall Study|Lost to Follow-up|3
959713|NCT00706901|3159123|P1|Overall Study|Lost to Follow-up|2
959714|NCT00706849|3159148|P2|Follow-up Period|Protocol non-compliance|1
959715|NCT00706849|3159149|P1|Follow-up Period|Protocol non-compliance|0
959716|NCT00706849|3159148|P2|Follow-up Period|Withdrawal by Subject|2
959717|NCT00706849|3159149|P1|Follow-up Period|Withdrawal by Subject|0
959718|NCT00706849|3159148|P2|Treatment Period|Other|1
959719|NCT00706849|3159149|P1|Treatment Period|Other|0
959720|NCT00706849|3159148|P2|Treatment Period|Adverse Event|9
959721|NCT00706849|3159149|P1|Treatment Period|Adverse Event|0
959722|NCT00706797|3159227|P2|Overall Study|Other|0
959723|NCT00706797|3159228|P1|Overall Study|Other|1
959724|NCT00706797|3159227|P2|Overall Study|Lost to Follow-up|2
959725|NCT00706797|3159228|P1|Overall Study|Lost to Follow-up|1
959726|NCT00706797|3159227|P2|Overall Study|Protocol Violation|2
959727|NCT00706797|3159228|P1|Overall Study|Protocol Violation|3
959728|NCT00706797|3159227|P2|Overall Study|Discontinuation of study by sponsor|63
959729|NCT00706797|3159228|P1|Overall Study|Discontinuation of study by sponsor|52
959730|NCT00706797|3159227|P2|Overall Study|Death|0
959731|NCT00706797|3159228|P1|Overall Study|Death|1
959732|NCT00706797|3159227|P2|Overall Study|Withdrawal by Subject|1
959733|NCT00706797|3159228|P1|Overall Study|Withdrawal by Subject|8
959734|NCT00706797|3159227|P2|Overall Study|Adverse Event|3
959735|NCT00706797|3159228|P1|Overall Study|Adverse Event|0
959736|NCT00706797|3159227|P2|Overall Study|Lack of Efficacy|0
959737|NCT00706797|3159228|P1|Overall Study|Lack of Efficacy|3
959738|NCT00706706|3159297|P1|Overall Study|Study endpoint had reached|45
959739|NCT00706706|3159297|P1|Overall Study|Lost to Follow-up|7
959740|NCT00706706|3159297|P1|Overall Study|Death|53
959741|NCT00706654|3159307|P4|Depot Maintenance Phase|Impending Relapse without Adverse Event|12
959742|NCT00706654|3159308|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
959743|NCT00706654|3159309|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
959744|NCT00706654|3159310|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
959745|NCT00706654|3159307|P4|Depot Maintenance Phase|Impending Relapse with Adverse Event|17
959746|NCT00706654|3159308|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|12
959747|NCT00706654|3159309|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
959748|NCT00706654|3159310|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
959749|NCT00706654|3159307|P4|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
959750|NCT00706654|3159308|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
959751|NCT00706654|3159309|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|8
959752|NCT00706654|3159310|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
959753|NCT00706654|3159307|P4|Depot Maintenance Phase|Protocol Deviation|1
959754|NCT00706654|3159308|P3|Depot Maintenance Phase|Protocol Deviation|3
959755|NCT00706654|3159309|P2|Depot Maintenance Phase|Protocol Deviation|2
959756|NCT00706654|3159310|P1|Depot Maintenance Phase|Protocol Deviation|0
959757|NCT00706654|3159307|P4|Depot Maintenance Phase|Withdrew Consent|14
959758|NCT00706654|3159308|P3|Depot Maintenance Phase|Withdrew Consent|29
959759|NCT00706654|3159309|P2|Depot Maintenance Phase|Withdrew Consent|21
959760|NCT00706654|3159310|P1|Depot Maintenance Phase|Withdrew Consent|0
959761|NCT00706654|3159307|P4|Depot Maintenance Phase|Withdrawn by Investigator|8
959762|NCT00706654|3159308|P3|Depot Maintenance Phase|Withdrawn by Investigator|12
959763|NCT00706654|3159309|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
959764|NCT00706654|3159310|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
959765|NCT00706654|3159307|P4|Depot Maintenance Phase|Met Withdrawal Criteria|5
959766|NCT00706654|3159308|P3|Depot Maintenance Phase|Met Withdrawal Criteria|6
959767|NCT00706654|3159309|P2|Depot Maintenance Phase|Met Withdrawal Criteria|4
959768|NCT00706654|3159310|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
959769|NCT00706654|3159307|P4|Depot Maintenance Phase|Lost to Follow-up|6
959770|NCT00706654|3159308|P3|Depot Maintenance Phase|Lost to Follow-up|10
959771|NCT00706654|3159309|P2|Depot Maintenance Phase|Lost to Follow-up|4
959772|NCT00706654|3159310|P1|Depot Maintenance Phase|Lost to Follow-up|0
959773|NCT00706654|3159307|P4|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
959774|NCT00706654|3159308|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
959775|NCT00706654|3159309|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
959776|NCT00706654|3159310|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10
959777|NCT00706654|3159307|P4|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
959778|NCT00706654|3159308|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
959779|NCT00706654|3159309|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
959780|NCT00706654|3159310|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20
959781|NCT00706654|3159307|P4|Oral Stabilization Phase|Adverse Event|0
959782|NCT00706654|3159308|P3|Oral Stabilization Phase|Adverse Event|0
959783|NCT00706654|3159309|P2|Oral Stabilization Phase|Adverse Event|0
959784|NCT00706654|3159310|P1|Oral Stabilization Phase|Adverse Event|21
959785|NCT00706654|3159307|P4|Oral Stabilization Phase|Protocol Deviation|0
959786|NCT00706654|3159308|P3|Oral Stabilization Phase|Protocol Deviation|0
959787|NCT00706654|3159309|P2|Oral Stabilization Phase|Protocol Deviation|0
959788|NCT00706654|3159310|P1|Oral Stabilization Phase|Protocol Deviation|2
959789|NCT00706654|3159307|P4|Oral Stabilization Phase|Withdrew consent|0
959790|NCT00706654|3159308|P3|Oral Stabilization Phase|Withdrew consent|0
959791|NCT00706654|3159309|P2|Oral Stabilization Phase|Withdrew consent|0
959792|NCT00706654|3159310|P1|Oral Stabilization Phase|Withdrew consent|55
959793|NCT00706654|3159307|P4|Oral Stabilization Phase|Withdrawn by Investigator|0
959794|NCT00706654|3159308|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
959795|NCT00706654|3159309|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
959796|NCT00706654|3159310|P1|Oral Stabilization Phase|Withdrawn by Investigator|21
959797|NCT00706654|3159307|P4|Oral Stabilization Phase|Met Withdrawal Criteria|0
959798|NCT00706654|3159308|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
959799|NCT00706654|3159309|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
959800|NCT00706654|3159310|P1|Oral Stabilization Phase|Met Withdrawal Criteria|15
959801|NCT00706654|3159307|P4|Oral Stabilization Phase|Sponsor Discontinue Trial|0
959802|NCT00706654|3159308|P3|Oral Stabilization Phase|Sponsor Discontinue Trial|0
959803|NCT00706654|3159309|P2|Oral Stabilization Phase|Sponsor Discontinue Trial|0
959804|NCT00706654|3159310|P1|Oral Stabilization Phase|Sponsor Discontinue Trial|19
959805|NCT00706654|3159307|P4|Oral Stabilization Phase|Lost to Follow-up|0
959806|NCT00706654|3159308|P3|Oral Stabilization Phase|Lost to Follow-up|0
959807|NCT00706654|3159309|P2|Oral Stabilization Phase|Lost to Follow-up|0
959808|NCT00706654|3159310|P1|Oral Stabilization Phase|Lost to Follow-up|17
959809|NCT00706654|3159307|P4|Conversion Phase|Lack of Efficacy without Adverse Event|0
959810|NCT00706654|3159308|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
959811|NCT00706654|3159309|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
959812|NCT00706654|3159310|P1|Conversion Phase|Lack of Efficacy without Adverse Event|2
959813|NCT00706654|3159307|P4|Conversion Phase|Lack of Efficacy with Adverse Event|0
959814|NCT00706654|3159308|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
959815|NCT00706654|3159309|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
959816|NCT00706654|3159310|P1|Conversion Phase|Lack of Efficacy with Adverse Event|9
959817|NCT00706654|3159307|P4|Conversion Phase|Adverse Event|0
959818|NCT00706654|3159308|P3|Conversion Phase|Adverse Event|0
959819|NCT00706654|3159309|P2|Conversion Phase|Adverse Event|0
959820|NCT00706654|3159310|P1|Conversion Phase|Adverse Event|18
959821|NCT00706654|3159307|P4|Conversion Phase|Withdrew Consent|0
959822|NCT00706654|3159308|P3|Conversion Phase|Withdrew Consent|0
959823|NCT00706654|3159309|P2|Conversion Phase|Withdrew Consent|0
959824|NCT00706654|3159310|P1|Conversion Phase|Withdrew Consent|38
959825|NCT00706654|3159307|P4|Conversion Phase|Withdrawn by Investigator|0
959826|NCT00706654|3159308|P3|Conversion Phase|Withdrawn by Investigator|0
959827|NCT00706654|3159309|P2|Conversion Phase|Withdrawn by Investigator|0
959828|NCT00706654|3159310|P1|Conversion Phase|Withdrawn by Investigator|14
959829|NCT00706654|3159307|P4|Conversion Phase|Met Withdrawal Criteria|0
959830|NCT00706654|3159308|P3|Conversion Phase|Met Withdrawal Criteria|0
959831|NCT00706654|3159309|P2|Conversion Phase|Met Withdrawal Criteria|0
959832|NCT00706654|3159310|P1|Conversion Phase|Met Withdrawal Criteria|2
959833|NCT00706654|3159307|P4|Conversion Phase|Sponsor Discontinued Trial|0
959834|NCT00706654|3159308|P3|Conversion Phase|Sponsor Discontinued Trial|0
959835|NCT00706654|3159309|P2|Conversion Phase|Sponsor Discontinued Trial|0
959836|NCT00706654|3159310|P1|Conversion Phase|Sponsor Discontinued Trial|8
959837|NCT00706654|3159307|P4|Conversion Phase|Lost to Follow-up|0
959838|NCT00706654|3159308|P3|Conversion Phase|Lost to Follow-up|0
959839|NCT00706654|3159309|P2|Conversion Phase|Lost to Follow-up|0
959840|NCT00706654|3159310|P1|Conversion Phase|Lost to Follow-up|4
959841|NCT00706641|3159329|P1|Radical Cystectomy|Deemed unresectable upon exploration|1
959842|NCT00706641|3159329|P1|Dasatinib Administration|Ineligible after start of therapy|1
959843|NCT00706641|3159329|P1|Dasatinib Administration|Withdrawal by Subject|1
959844|NCT00706628|3159343|P4|Overall Study|Not treated|0
959845|NCT00706628|3159344|P3|Overall Study|Not treated|0
959846|NCT00706628|3159345|P2|Overall Study|Not treated|1
959847|NCT00706628|3159346|P1|Overall Study|Not treated|1
959848|NCT00706628|3159343|P4|Overall Study|Other than those stated above|0
959849|NCT00706628|3159344|P3|Overall Study|Other than those stated above|0
959850|NCT00706628|3159345|P2|Overall Study|Other than those stated above|0
959851|NCT00706628|3159346|P1|Overall Study|Other than those stated above|4
959852|NCT00706628|3159343|P4|Overall Study|Progressive disease|1
959853|NCT00706628|3159344|P3|Overall Study|Progressive disease|8
959854|NCT00706628|3159345|P2|Overall Study|Progressive disease|13
959855|NCT00706628|3159346|P1|Overall Study|Progressive disease|20
959856|NCT00706628|3159343|P4|Overall Study|Consent withdrawn|0
959857|NCT00706628|3159344|P3|Overall Study|Consent withdrawn|3
959858|NCT00706628|3159345|P2|Overall Study|Consent withdrawn|1
959859|NCT00706628|3159346|P1|Overall Study|Consent withdrawn|6
959860|NCT00706628|3159343|P4|Overall Study|Non compliant with protocol|0
959861|NCT00706628|3159344|P3|Overall Study|Non compliant with protocol|0
959862|NCT00706628|3159345|P2|Overall Study|Non compliant with protocol|1
959863|NCT00706628|3159346|P1|Overall Study|Non compliant with protocol|0
959864|NCT00706628|3159343|P4|Overall Study|Other Adverse Event|2
959865|NCT00706628|3159344|P3|Overall Study|Other Adverse Event|5
959866|NCT00706628|3159345|P2|Overall Study|Other Adverse Event|5
959867|NCT00706628|3159346|P1|Overall Study|Other Adverse Event|16
959868|NCT00706433|3159506|P4|Overall Study|new job|1
959869|NCT00706433|3159507|P3|Overall Study|new job|0
959870|NCT00706433|3159508|P2|Overall Study|new job|0
959871|NCT00706433|3159509|P1|Overall Study|new job|0
959872|NCT00706433|3159506|P4|Overall Study|Protocol Violation|0
959873|NCT00706433|3159507|P3|Overall Study|Protocol Violation|0
959874|NCT00706433|3159508|P2|Overall Study|Protocol Violation|0
959875|NCT00706433|3159509|P1|Overall Study|Protocol Violation|1
959876|NCT00706433|3159506|P4|Overall Study|Adverse Event|0
959877|NCT00706433|3159507|P3|Overall Study|Adverse Event|1
959878|NCT00706433|3159508|P2|Overall Study|Adverse Event|0
959879|NCT00706433|3159509|P1|Overall Study|Adverse Event|0
959880|NCT00706433|3159506|P4|Overall Study|Withdrawal by Subject|1
959881|NCT00706433|3159507|P3|Overall Study|Withdrawal by Subject|3
959882|NCT00706433|3159508|P2|Overall Study|Withdrawal by Subject|2
959883|NCT00706433|3159509|P1|Overall Study|Withdrawal by Subject|1
959884|NCT00706433|3159506|P4|Overall Study|Lost to Follow-up|0
959885|NCT00706433|3159507|P3|Overall Study|Lost to Follow-up|6
959886|NCT00706433|3159508|P2|Overall Study|Lost to Follow-up|1
959887|NCT00706433|3159509|P1|Overall Study|Lost to Follow-up|3
959888|NCT00706355|3159836|P4|Period 4: PF-04217903 150 mg|Objective progression or relapse|2
959889|NCT00706355|3159837|P3|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
959890|NCT00706355|3159838|P2|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
959891|NCT00706355|3159839|P1|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
959892|NCT00706355|3159836|P4|Period 4: PF-04217903 150 mg|Adverse Event|2
959893|NCT00706355|3159837|P3|Period 4: PF-04217903 150 mg|Adverse Event|0
959894|NCT00706355|3159838|P2|Period 4: PF-04217903 150 mg|Adverse Event|0
959895|NCT00706355|3159839|P1|Period 4: PF-04217903 150 mg|Adverse Event|0
959896|NCT00706355|3159836|P4|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
959897|NCT00706355|3159837|P3|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1
959898|NCT00706355|3159838|P2|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
959899|NCT00706355|3159839|P1|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
959900|NCT00706355|3159836|P4|Period 3: PF-04217903 200 mg|Adverse Event|0
959901|NCT00706355|3159837|P3|Period 3: PF-04217903 200 mg|Adverse Event|1
959902|NCT00706355|3159838|P2|Period 3: PF-04217903 200 mg|Adverse Event|0
959903|NCT00706355|3159839|P1|Period 3: PF-04217903 200 mg|Adverse Event|0
959904|NCT00706355|3159836|P4|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
959905|NCT00706355|3159837|P3|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
959906|NCT00706355|3159838|P2|Period 2: PF-04217903 100 mg|Objective progression or relapse|5
959907|NCT00706355|3159839|P1|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
959908|NCT00706355|3159836|P4|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
959909|NCT00706355|3159837|P3|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
959910|NCT00706355|3159838|P2|Period 2: PF-04217903 100 mg|Global deterioration of health status|1
959911|NCT00706355|3159839|P1|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
959912|NCT00706355|3159836|P4|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
959913|NCT00706355|3159837|P3|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
959914|NCT00706355|3159838|P2|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1
959915|NCT00706355|3159839|P1|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
959916|NCT00706355|3159836|P4|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
959917|NCT00706355|3159837|P3|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
959918|NCT00706355|3159838|P2|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
959919|NCT00706355|3159839|P1|Period 1: PF-04217903 50 mg|Objective progression or relapse|2
959920|NCT00706355|3159836|P4|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
959921|NCT00706355|3159837|P3|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
959922|NCT00706355|3159838|P2|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
959923|NCT00706355|3159839|P1|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1
959924|NCT00706342|3159891|P1|Overall Study|WIthdrawal of consent|1
959925|NCT00706342|3159891|P1|Overall Study|Ongoing|6
959926|NCT00706342|3159891|P1|Overall Study|Non-responder Week 12|1
959927|NCT00706342|3159891|P1|Overall Study|Investigator discretion|2
959928|NCT00706342|3159891|P1|Overall Study|Withdrew from the study on his own.|1
959929|NCT00706342|3159891|P1|Overall Study|Death|1
959930|NCT00706342|3159891|P1|Overall Study|Withdrawn due to failure to respond|1
959931|NCT00706342|3159891|P1|Overall Study|Not responding to treatment|2
959932|NCT00706342|3159891|P1|Overall Study|Adverse Event|3
959933|NCT00706134|3159908|P4|Overall Study|Did not meet study criteria|0
959934|NCT00706134|3159909|P3|Overall Study|Did not meet study criteria|0
959935|NCT00706134|3159910|P2|Overall Study|Did not meet study criteria|0
959936|NCT00706134|3159911|P1|Overall Study|Did not meet study criteria|2
959937|NCT00706134|3159908|P4|Overall Study|Unsatisfactory therapeutic effect|5
959938|NCT00706134|3159909|P3|Overall Study|Unsatisfactory therapeutic effect|3
959939|NCT00706134|3159910|P2|Overall Study|Unsatisfactory therapeutic effect|3
959940|NCT00706134|3159911|P1|Overall Study|Unsatisfactory therapeutic effect|9
959941|NCT00706134|3159908|P4|Overall Study|Withdrawal by Subject|0
959942|NCT00706134|3159909|P3|Overall Study|Withdrawal by Subject|1
959943|NCT00706134|3159910|P2|Overall Study|Withdrawal by Subject|2
959944|NCT00706134|3159911|P1|Overall Study|Withdrawal by Subject|1
959945|NCT00706134|3159908|P4|Overall Study|Protocol Violation|3
959946|NCT00706134|3159909|P3|Overall Study|Protocol Violation|0
959947|NCT00706134|3159910|P2|Overall Study|Protocol Violation|6
959948|NCT00706134|3159911|P1|Overall Study|Protocol Violation|0
959949|NCT00706134|3159908|P4|Overall Study|Lost to Follow-up|0
959950|NCT00706134|3159909|P3|Overall Study|Lost to Follow-up|0
959951|NCT00706134|3159910|P2|Overall Study|Lost to Follow-up|1
959952|NCT00706134|3159911|P1|Overall Study|Lost to Follow-up|0
959953|NCT00706134|3159908|P4|Overall Study|Adverse Event|3
959954|NCT00706134|3159909|P3|Overall Study|Adverse Event|2
959955|NCT00706134|3159910|P2|Overall Study|Adverse Event|7
959956|NCT00706134|3159911|P1|Overall Study|Adverse Event|8
959957|NCT00706095|3159977|P3|Overall Study|Withdrawal by Subject|0
959958|NCT00706095|3159978|P2|Overall Study|Withdrawal by Subject|0
959959|NCT00706095|3159979|P1|Overall Study|Withdrawal by Subject|1
959960|NCT00706095|3159977|P3|Overall Study|Clinical Progression|2
959961|NCT00706095|3159978|P2|Overall Study|Clinical Progression|2
959962|NCT00706095|3159979|P1|Overall Study|Clinical Progression|1
959963|NCT00706095|3159977|P3|Overall Study|Progressive Disease|3
959964|NCT00706095|3159978|P2|Overall Study|Progressive Disease|5
959965|NCT00706095|3159979|P1|Overall Study|Progressive Disease|4
959966|NCT00706030|3159997|P4|Overall Study|Death|0
959967|NCT00706030|3159998|P3|Overall Study|Death|1
959968|NCT00706030|3159999|P2|Overall Study|Death|0
959969|NCT00706030|3160000|P1|Overall Study|Death|0
959970|NCT00706030|3159997|P4|Overall Study|No treatment received|1
959971|NCT00706030|3159998|P3|Overall Study|No treatment received|0
959972|NCT00706030|3159999|P2|Overall Study|No treatment received|0
959973|NCT00706030|3160000|P1|Overall Study|No treatment received|0
959974|NCT00706030|3159997|P4|Overall Study|Symptomatic Deterioration|0
959975|NCT00706030|3159998|P3|Overall Study|Symptomatic Deterioration|1
959976|NCT00706030|3159999|P2|Overall Study|Symptomatic Deterioration|0
959977|NCT00706030|3160000|P1|Overall Study|Symptomatic Deterioration|0
959978|NCT00706030|3159997|P4|Overall Study|Failed to return|0
959979|NCT00706030|3159998|P3|Overall Study|Failed to return|1
959980|NCT00706030|3159999|P2|Overall Study|Failed to return|0
959981|NCT00706030|3160000|P1|Overall Study|Failed to return|0
959982|NCT00706030|3159997|P4|Overall Study|Protocol Violation|1
959983|NCT00706030|3159998|P3|Overall Study|Protocol Violation|1
959984|NCT00706030|3159999|P2|Overall Study|Protocol Violation|0
959985|NCT00706030|3160000|P1|Overall Study|Protocol Violation|0
959986|NCT00706030|3159997|P4|Overall Study|Not recorded|0
959987|NCT00706030|3159998|P3|Overall Study|Not recorded|2
959988|NCT00706030|3159999|P2|Overall Study|Not recorded|0
959989|NCT00706030|3160000|P1|Overall Study|Not recorded|0
959990|NCT00706030|3159997|P4|Overall Study|Physician Decision|0
959991|NCT00706030|3159998|P3|Overall Study|Physician Decision|2
959992|NCT00706030|3159999|P2|Overall Study|Physician Decision|0
959993|NCT00706030|3160000|P1|Overall Study|Physician Decision|0
959994|NCT00706030|3159997|P4|Overall Study|Withdrawal by Subject|0
959995|NCT00706030|3159998|P3|Overall Study|Withdrawal by Subject|2
959996|NCT00706030|3159999|P2|Overall Study|Withdrawal by Subject|0
959997|NCT00706030|3160000|P1|Overall Study|Withdrawal by Subject|1
959998|NCT00706030|3159997|P4|Overall Study|Adverse Event|2
959999|NCT00706030|3159998|P3|Overall Study|Adverse Event|4
960000|NCT00706030|3159999|P2|Overall Study|Adverse Event|0
960001|NCT00706030|3160000|P1|Overall Study|Adverse Event|1
960002|NCT00706030|3159997|P4|Overall Study|Disease Progression|12
960003|NCT00706030|3159998|P3|Overall Study|Disease Progression|46
960004|NCT00706030|3159999|P2|Overall Study|Disease Progression|6
960005|NCT00706030|3160000|P1|Overall Study|Disease Progression|4
960006|NCT00706004|3160015|P1|Overall Study|Did not meet eligibility criteria|2
960007|NCT00705939|3160043|P3|Overall Study|Physician Decision|0
960008|NCT00705939|3160044|P2|Overall Study|Physician Decision|1
960009|NCT00705939|3160045|P1|Overall Study|Physician Decision|0
960010|NCT00705939|3160043|P3|Overall Study|Withdrawal by Subject|3
960011|NCT00705939|3160044|P2|Overall Study|Withdrawal by Subject|1
960012|NCT00705939|3160045|P1|Overall Study|Withdrawal by Subject|0
960013|NCT00705939|3160043|P3|Overall Study|Protocol Violation|1
960014|NCT00705939|3160044|P2|Overall Study|Protocol Violation|0
960015|NCT00705939|3160045|P1|Overall Study|Protocol Violation|0
960016|NCT00705783|3160099|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|40
960017|NCT00705783|3160100|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|16
960018|NCT00705783|3160101|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
960019|NCT00705783|3160099|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
960020|NCT00705783|3160100|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|11
960021|NCT00705783|3160101|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
960022|NCT00705783|3160099|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|5
960023|NCT00705783|3160100|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|9
960024|NCT00705783|3160101|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
960025|NCT00705783|3160099|P3|Depot Maintenance Phase|Protocol Deviation|0
960026|NCT00705783|3160100|P2|Depot Maintenance Phase|Protocol Deviation|2
960027|NCT00705783|3160101|P1|Depot Maintenance Phase|Protocol Deviation|0
960028|NCT00705783|3160099|P3|Depot Maintenance Phase|Withdrew Consent|4
960029|NCT00705783|3160100|P2|Depot Maintenance Phase|Withdrew Consent|14
960030|NCT00705783|3160101|P1|Depot Maintenance Phase|Withdrew Consent|0
960031|NCT00705783|3160099|P3|Depot Maintenance Phase|Withdrawn by Investigator|6
960032|NCT00705783|3160100|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
960033|NCT00705783|3160101|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
960034|NCT00705783|3160099|P3|Depot Maintenance Phase|Met Withdrawal Criteria|2
960035|NCT00705783|3160100|P2|Depot Maintenance Phase|Met Withdrawal Criteria|2
960036|NCT00705783|3160101|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
960037|NCT00705783|3160099|P3|Depot Maintenance Phase|Lost to Follow-up|3
960038|NCT00705783|3160100|P2|Depot Maintenance Phase|Lost to Follow-up|5
960039|NCT00705783|3160101|P1|Depot Maintenance Phase|Lost to Follow-up|0
960040|NCT00705783|3160099|P3|Depot Maintenance Phase|Sponsor Discontinued Study|58
960041|NCT00705783|3160100|P2|Depot Maintenance Phase|Sponsor Discontinued Study|179
960042|NCT00705783|3160101|P1|Depot Maintenance Phase|Sponsor Discontinued Study|0
960043|NCT00705783|3160099|P3|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
960044|NCT00705783|3160100|P2|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
960045|NCT00705783|3160101|P1|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1
960046|NCT00705783|3160099|P3|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
960047|NCT00705783|3160100|P2|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
960048|NCT00705783|3160101|P1|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12
960049|NCT00705783|3160099|P3|Depot Stabilization Phase|Adverse Event|0
960050|NCT00705783|3160100|P2|Depot Stabilization Phase|Adverse Event|0
960051|NCT00705783|3160101|P1|Depot Stabilization Phase|Adverse Event|17
960052|NCT00705783|3160099|P3|Depot Stabilization Phase|Withdrew Consent|0
960053|NCT00705783|3160100|P2|Depot Stabilization Phase|Withdrew Consent|0
960054|NCT00705783|3160101|P1|Depot Stabilization Phase|Withdrew Consent|29
960055|NCT00705783|3160099|P3|Depot Stabilization Phase|Withdrawn by Investigator|0
960056|NCT00705783|3160100|P2|Depot Stabilization Phase|Withdrawn by Investigator|0
960057|NCT00705783|3160101|P1|Depot Stabilization Phase|Withdrawn by Investigator|9
960058|NCT00705783|3160099|P3|Depot Stabilization Phase|Met Withdrawal Criteria|0
960059|NCT00705783|3160100|P2|Depot Stabilization Phase|Met Withdrawal Criteria|0
960060|NCT00705783|3160101|P1|Depot Stabilization Phase|Met Withdrawal Criteria|8
960061|NCT00705783|3160099|P3|Depot Stabilization Phase|Lost to Follow-up|0
960062|NCT00705783|3160100|P2|Depot Stabilization Phase|Lost to Follow-up|0
960063|NCT00705783|3160101|P1|Depot Stabilization Phase|Lost to Follow-up|11
960064|NCT00705783|3160099|P3|Depot Stabilization Phase|Sponsor Discontinued Study|0
960065|NCT00705783|3160100|P2|Depot Stabilization Phase|Sponsor Discontinued Study|0
960066|NCT00705783|3160101|P1|Depot Stabilization Phase|Sponsor Discontinued Study|86
960067|NCT00705783|3160099|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
960068|NCT00705783|3160100|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
960069|NCT00705783|3160101|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4
960070|NCT00705783|3160099|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
960071|NCT00705783|3160100|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
960072|NCT00705783|3160101|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7
960073|NCT00705783|3160099|P3|Oral Stabilization Phase|Adverse Event|0
960074|NCT00705783|3160100|P2|Oral Stabilization Phase|Adverse Event|0
960075|NCT00705783|3160101|P1|Oral Stabilization Phase|Adverse Event|14
960076|NCT00705783|3160099|P3|Oral Stabilization Phase|Withdrew Consent|0
960077|NCT00705783|3160100|P2|Oral Stabilization Phase|Withdrew Consent|0
960078|NCT00705783|3160101|P1|Oral Stabilization Phase|Withdrew Consent|29
960079|NCT00705783|3160099|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
960080|NCT00705783|3160100|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
960081|NCT00705783|3160101|P1|Oral Stabilization Phase|Withdrawn by Investigator|12
960082|NCT00705783|3160099|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
960083|NCT00705783|3160100|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
960084|NCT00705783|3160101|P1|Oral Stabilization Phase|Met Withdrawal Criteria|19
960085|NCT00705783|3160099|P3|Oral Stabilization Phase|Lost to Follow-up|0
960086|NCT00705783|3160100|P2|Oral Stabilization Phase|Lost to Follow-up|0
960087|NCT00705783|3160101|P1|Oral Stabilization Phase|Lost to Follow-up|7
960088|NCT00705783|3160099|P3|Oral Stabilization Phase|Sponsor Discontinue Study|0
960089|NCT00705783|3160100|P2|Oral Stabilization Phase|Sponsor Discontinue Study|0
960090|NCT00705783|3160101|P1|Oral Stabilization Phase|Sponsor Discontinue Study|42
960091|NCT00705783|3160099|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
960092|NCT00705783|3160100|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
960093|NCT00705783|3160101|P1|Conversion Phase|Lack of Efficacy without Adverse Event|8
960094|NCT00705783|3160099|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
960095|NCT00705783|3160100|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
960096|NCT00705783|3160101|P1|Conversion Phase|Lack of Efficacy with Adverse Event|13
960097|NCT00705783|3160099|P3|Conversion Phase|Adverse Event|0
960098|NCT00705783|3160100|P2|Conversion Phase|Adverse Event|0
960099|NCT00705783|3160101|P1|Conversion Phase|Adverse Event|11
960100|NCT00705783|3160099|P3|Conversion Phase|Protocol Deviation|0
960101|NCT00705783|3160100|P2|Conversion Phase|Protocol Deviation|0
960102|NCT00705783|3160101|P1|Conversion Phase|Protocol Deviation|2
960103|NCT00705783|3160099|P3|Conversion Phase|Withdrew Consent|0
960104|NCT00705783|3160100|P2|Conversion Phase|Withdrew Consent|0
960105|NCT00705783|3160101|P1|Conversion Phase|Withdrew Consent|24
960106|NCT00705783|3160099|P3|Conversion Phase|Withdrawn by Investigator|0
960107|NCT00705783|3160100|P2|Conversion Phase|Withdrawn by Investigator|0
960108|NCT00705783|3160101|P1|Conversion Phase|Withdrawn by Investigator|4
960109|NCT00705783|3160099|P3|Conversion Phase|Met Withdrawal Criteria|0
960110|NCT00705783|3160100|P2|Conversion Phase|Met Withdrawal Criteria|0
960111|NCT00705783|3160101|P1|Conversion Phase|Met Withdrawal Criteria|4
960112|NCT00705783|3160099|P3|Conversion Phase|Lost to Follow-up|0
960113|NCT00705783|3160100|P2|Conversion Phase|Lost to Follow-up|0
960114|NCT00705783|3160101|P1|Conversion Phase|Lost to Follow-up|13
960115|NCT00705783|3160099|P3|Conversion Phase|Sponsor Discontinued Study|0
960116|NCT00705783|3160100|P2|Conversion Phase|Sponsor Discontinued Study|0
960117|NCT00705783|3160101|P1|Conversion Phase|Sponsor Discontinued Study|54
960118|NCT00705757|3160131|P3|Overall Study|Withdrawal by Subject|2
960119|NCT00705757|3160132|P2|Overall Study|Withdrawal by Subject|1
960120|NCT00705757|3160133|P1|Overall Study|Withdrawal by Subject|1
960121|NCT00705757|3160131|P3|Overall Study|Lost to Follow-up|6
960122|NCT00705757|3160132|P2|Overall Study|Lost to Follow-up|6
960123|NCT00705757|3160133|P1|Overall Study|Lost to Follow-up|7
960124|NCT00705757|3160131|P3|Overall Study|Lack of Efficacy|3
960125|NCT00705757|3160132|P2|Overall Study|Lack of Efficacy|1
960126|NCT00705757|3160133|P1|Overall Study|Lack of Efficacy|5
960127|NCT00705718|3160143|P2|Overall Study|Follow up not done|4
960128|NCT00705718|3160144|P1|Overall Study|Follow up not done|1
960129|NCT00705718|3160143|P2|Overall Study|Not due for Visit|12
960130|NCT00705718|3160144|P1|Overall Study|Not due for Visit|0
960131|NCT00705718|3160143|P2|Overall Study|Death|6
960132|NCT00705718|3160144|P1|Overall Study|Death|6
960133|NCT00705679|3160165|P5|Overall Study|Withdrawal by Subject|33
960134|NCT00705679|3160166|P4|Overall Study|Withdrawal by Subject|47
960135|NCT00705679|3160167|P3|Overall Study|Withdrawal by Subject|68
960136|NCT00705679|3160168|P2|Overall Study|Withdrawal by Subject|77
960137|NCT00705679|3160169|P1|Overall Study|Withdrawal by Subject|32
960138|NCT00705679|3160165|P5|Overall Study|Physician Decision|0
960139|NCT00705679|3160166|P4|Overall Study|Physician Decision|1
960140|NCT00705679|3160167|P3|Overall Study|Physician Decision|0
960141|NCT00705679|3160168|P2|Overall Study|Physician Decision|1
960142|NCT00705679|3160169|P1|Overall Study|Physician Decision|0
960143|NCT00705679|3160165|P5|Overall Study|Lost to Follow-up|35
960144|NCT00705679|3160166|P4|Overall Study|Lost to Follow-up|30
960145|NCT00705679|3160167|P3|Overall Study|Lost to Follow-up|44
960146|NCT00705679|3160168|P2|Overall Study|Lost to Follow-up|60
960147|NCT00705679|3160169|P1|Overall Study|Lost to Follow-up|32
960148|NCT00705679|3160165|P5|Overall Study|Death|1
960149|NCT00705679|3160166|P4|Overall Study|Death|2
960150|NCT00705679|3160167|P3|Overall Study|Death|3
960151|NCT00705679|3160168|P2|Overall Study|Death|0
960152|NCT00705679|3160169|P1|Overall Study|Death|0
960153|NCT00705679|3160165|P5|Overall Study|Adverse Event|0
960154|NCT00705679|3160166|P4|Overall Study|Adverse Event|0
960155|NCT00705679|3160167|P3|Overall Study|Adverse Event|0
960156|NCT00705679|3160168|P2|Overall Study|Adverse Event|1
960157|NCT00705679|3160169|P1|Overall Study|Adverse Event|1
960158|NCT00705666|3160204|P1|Overall Study|Untreated|5
960159|NCT00705666|3160204|P1|Overall Study|Lack of data|3
960160|NCT00705666|3160204|P1|Overall Study|Other|2
960161|NCT00705666|3160204|P1|Overall Study|Not specified|12
960162|NCT00705666|3160204|P1|Overall Study|Adverse Event|4
960163|NCT00705666|3160204|P1|Overall Study|Death|1
960164|NCT00705666|3160204|P1|Overall Study|Lost to Follow-up|5
960165|NCT00705666|3160204|P1|Overall Study|Physician Decision|7
960166|NCT00705666|3160204|P1|Overall Study|Withdrawal by Subject|21
960167|NCT00705666|3160204|P1|Overall Study|No post-treatment questionnaire|279
960168|NCT00705614|3160215|P2|Switch to Remicade|Administrative Reason|9
960169|NCT00705614|3160216|P1|Switch to Remicade|Administrative Reason|0
960170|NCT00705614|3160215|P2|Switch to Remicade|Withdrawal by Subject|12
960171|NCT00705614|3160216|P1|Switch to Remicade|Withdrawal by Subject|0
960172|NCT00705614|3160215|P2|Switch to Remicade|Lost to Follow-up|23
960173|NCT00705614|3160216|P1|Switch to Remicade|Lost to Follow-up|0
960174|NCT00705614|3160215|P2|Switch to Remicade|Adverse Event|5
960175|NCT00705614|3160216|P1|Switch to Remicade|Adverse Event|0
960176|NCT00705614|3160215|P2|Initial Intervention|Status completion unknown|0
960177|NCT00705614|3160216|P1|Initial Intervention|Status completion unknown|3
960178|NCT00705614|3160215|P2|Initial Intervention|Administrative Reason|38
960179|NCT00705614|3160216|P1|Initial Intervention|Administrative Reason|51
960180|NCT00705614|3160215|P2|Initial Intervention|Withdrawal by Subject|71
960181|NCT00705614|3160216|P1|Initial Intervention|Withdrawal by Subject|114
960182|NCT00705614|3160215|P2|Initial Intervention|Lost to Follow-up|191
960183|NCT00705614|3160216|P1|Initial Intervention|Lost to Follow-up|310
960184|NCT00705614|3160215|P2|Initial Intervention|Adverse Event|21
960185|NCT00705614|3160216|P1|Initial Intervention|Adverse Event|40
960186|NCT00705575|3160265|P2|Overall Study|Withdrawal by Subject|10
960187|NCT00705575|3160266|P1|Overall Study|Withdrawal by Subject|5
960188|NCT00705575|3160265|P2|Overall Study|Protocol Violation|2
960189|NCT00705575|3160266|P1|Overall Study|Protocol Violation|2
960190|NCT00705575|3160265|P2|Overall Study|Lost to Follow-up|4
960191|NCT00705575|3160266|P1|Overall Study|Lost to Follow-up|3
960192|NCT00705575|3160265|P2|Overall Study|Adverse Event|15
960193|NCT00705575|3160266|P1|Overall Study|Adverse Event|11
960194|NCT00705575|3160265|P2|Overall Study|Abnormal test procedure result(s)|12
960195|NCT00705575|3160266|P1|Overall Study|Abnormal test procedure result(s)|2
960196|NCT00705575|3160265|P2|Overall Study|Abnormal laboratory value(s)|3
960197|NCT00705575|3160266|P1|Overall Study|Abnormal laboratory value(s)|0
960198|NCT00705536|3160280|P4|Start Period 1|Withdrawal by Subject|1
960199|NCT00705536|3160281|P3|Start Period 1|Withdrawal by Subject|0
960200|NCT00705536|3160282|P2|Start Period 1|Withdrawal by Subject|0
960201|NCT00705536|3160283|P1|Start Period 1|Withdrawal by Subject|0
960202|NCT00705523|3160344|P2|Overall Study|Lost to Follow-up|3
960203|NCT00705523|3160345|P1|Overall Study|Lost to Follow-up|2
960204|NCT00705484|3160355|P2|Overall Study|Administrative|59
960205|NCT00705484|3160356|P1|Overall Study|Administrative|89
960206|NCT00705484|3160355|P2|Overall Study|Withdrawal by Subject|72
960207|NCT00705484|3160356|P1|Overall Study|Withdrawal by Subject|96
960208|NCT00705484|3160355|P2|Overall Study|Lost to Follow-up|250
960209|NCT00705484|3160356|P1|Overall Study|Lost to Follow-up|169
960210|NCT00705484|3160355|P2|Overall Study|Adverse Event|27
960211|NCT00705484|3160356|P1|Overall Study|Adverse Event|28
960212|NCT00705432|3160370|P6|Follow-up Period (Upto Week 72)|Non medical reason|7
960213|NCT00705432|3160371|P5|Follow-up Period (Upto Week 72)|Non medical reason|6
960214|NCT00705432|3160372|P4|Follow-up Period (Upto Week 72)|Non medical reason|14
960215|NCT00705432|3160373|P3|Follow-up Period (Upto Week 72)|Non medical reason|24
960216|NCT00705432|3160374|P2|Follow-up Period (Upto Week 72)|Non medical reason|42
960217|NCT00705432|3160375|P1|Follow-up Period (Upto Week 72)|Non medical reason|69
960218|NCT00705432|3160370|P6|Follow-up Period (Upto Week 72)|Adverse Event|0
960219|NCT00705432|3160371|P5|Follow-up Period (Upto Week 72)|Adverse Event|0
960220|NCT00705432|3160372|P4|Follow-up Period (Upto Week 72)|Adverse Event|0
960221|NCT00705432|3160373|P3|Follow-up Period (Upto Week 72)|Adverse Event|1
960222|NCT00705432|3160374|P2|Follow-up Period (Upto Week 72)|Adverse Event|1
960223|NCT00705432|3160375|P1|Follow-up Period (Upto Week 72)|Adverse Event|2
960224|NCT00705432|3160370|P6|Treatment Period|Non medical reason|7
960225|NCT00705432|3160371|P5|Treatment Period|Non medical reason|7
960226|NCT00705432|3160372|P4|Treatment Period|Non medical reason|4
960227|NCT00705432|3160373|P3|Treatment Period|Non medical reason|37
960228|NCT00705432|3160374|P2|Treatment Period|Non medical reason|32
960229|NCT00705432|3160375|P1|Treatment Period|Non medical reason|26
960230|NCT00705432|3160370|P6|Treatment Period|Treatment failure|14
960231|NCT00705432|3160371|P5|Treatment Period|Treatment failure|13
960232|NCT00705432|3160372|P4|Treatment Period|Treatment failure|25
960233|NCT00705432|3160373|P3|Treatment Period|Treatment failure|33
960234|NCT00705432|3160374|P2|Treatment Period|Treatment failure|42
960235|NCT00705432|3160375|P1|Treatment Period|Treatment failure|92
960236|NCT00705432|3160370|P6|Treatment Period|Adverse Event|9
960237|NCT00705432|3160371|P5|Treatment Period|Adverse Event|8
960238|NCT00705432|3160372|P4|Treatment Period|Adverse Event|12
960239|NCT00705432|3160373|P3|Treatment Period|Adverse Event|51
960240|NCT00705432|3160374|P2|Treatment Period|Adverse Event|37
960241|NCT00705432|3160375|P1|Treatment Period|Adverse Event|45
960242|NCT00705406|3160412|P2|Overall Study|Did not receive study drug|2
960243|NCT00705406|3160413|P1|Overall Study|Did not receive study drug|1
960244|NCT00705406|3160412|P2|Overall Study|Lost to Follow-up|3
960245|NCT00705406|3160413|P1|Overall Study|Lost to Follow-up|3
960246|NCT00705367|3160437|P2|Long-term Extension Period|Administrative reason by sponsor|0
960247|NCT00705367|3160438|P1|Long-term Extension Period|Administrative reason by sponsor|3
960248|NCT00705367|3160437|P2|Long-term Extension Period|No longer met study criteria|0
960249|NCT00705367|3160438|P1|Long-term Extension Period|No longer met study criteria|1
960250|NCT00705367|3160437|P2|Long-term Extension Period|Lack of Efficacy|0
960251|NCT00705367|3160438|P1|Long-term Extension Period|Lack of Efficacy|1
960252|NCT00705367|3160437|P2|Long-term Extension Period|Withdrawal by Subject|0
960253|NCT00705367|3160438|P1|Long-term Extension Period|Withdrawal by Subject|2
960254|NCT00705367|3160437|P2|Long-term Extension Period|Adverse Event|0
960255|NCT00705367|3160438|P1|Long-term Extension Period|Adverse Event|2
960256|NCT00705341|3160465|P4|Phase 2: Trial|Did not meet post-diluent threshold|0
960257|NCT00705341|3160466|P3|Phase 2: Trial|Did not meet post-diluent threshold|1
960258|NCT00705341|3160467|P2|Phase 2: Trial|Did not meet post-diluent threshold|0
960259|NCT00705341|3160468|P1|Phase 2: Trial|Did not meet post-diluent threshold|0
960260|NCT00705341|3160465|P4|Phase 2: Trial|Withdrawal by Subject|4
960261|NCT00705341|3160466|P3|Phase 2: Trial|Withdrawal by Subject|6
960262|NCT00705341|3160467|P2|Phase 2: Trial|Withdrawal by Subject|0
960263|NCT00705341|3160468|P1|Phase 2: Trial|Withdrawal by Subject|0
960264|NCT00705289|3160476|P1|Overall Study|Subject or treating physician's choice|131
960265|NCT00705263|3160500|P1|Overall Study|Withdrawal by Subject|2
960266|NCT00705250|3160504|P1|Overall Study|Patient died in car accident|1
960267|NCT00705250|3160504|P1|Overall Study|Withdrawal by Subject|1
960268|NCT00705224|3160508|P1|Overall Study|Lost to Follow-up|5
960269|NCT00705224|3160508|P1|Overall Study|Withdrawal by Subject|3
960270|NCT00705224|3160508|P1|Overall Study|Lack of Efficacy|2
960271|NCT00705224|3160508|P1|Overall Study|Adverse Event|1
960272|NCT00705159|3160524|P4|Overall Study|Screen Failure|1
960273|NCT00705159|3160525|P3|Overall Study|Screen Failure|0
960274|NCT00705159|3160526|P2|Overall Study|Screen Failure|0
960275|NCT00705159|3160527|P1|Overall Study|Screen Failure|0
960276|NCT00705159|3160524|P4|Overall Study|Lost to Follow-up|2
960277|NCT00705159|3160525|P3|Overall Study|Lost to Follow-up|3
960278|NCT00705159|3160526|P2|Overall Study|Lost to Follow-up|0
960279|NCT00705159|3160527|P1|Overall Study|Lost to Follow-up|0
960280|NCT00705159|3160524|P4|Overall Study|Adverse Event|0
960281|NCT00705159|3160525|P3|Overall Study|Adverse Event|1
960282|NCT00705159|3160526|P2|Overall Study|Adverse Event|0
960283|NCT00705159|3160527|P1|Overall Study|Adverse Event|0
960284|NCT00705159|3160524|P4|Overall Study|Protocol Violation|0
960285|NCT00705159|3160525|P3|Overall Study|Protocol Violation|0
960286|NCT00705159|3160526|P2|Overall Study|Protocol Violation|1
960287|NCT00705159|3160527|P1|Overall Study|Protocol Violation|0
960288|NCT00705159|3160524|P4|Overall Study|Withdrawal by Subject|1
960289|NCT00705159|3160525|P3|Overall Study|Withdrawal by Subject|1
960290|NCT00705159|3160526|P2|Overall Study|Withdrawal by Subject|1
960291|NCT00705159|3160527|P1|Overall Study|Withdrawal by Subject|0
960292|NCT00705146|3160547|P2|Overall Study|Lost to Follow-up|1
960293|NCT00705146|3160548|P1|Overall Study|Lost to Follow-up|1
960294|NCT00705016|3160577|P3|Overall Study|Other|6
960295|NCT00705016|3160578|P2|Overall Study|Other|6
960296|NCT00705016|3160579|P1|Overall Study|Other|9
960297|NCT00705016|3160577|P3|Overall Study|Symptomatic Deterioration|1
960298|NCT00705016|3160578|P2|Overall Study|Symptomatic Deterioration|1
960299|NCT00705016|3160579|P1|Overall Study|Symptomatic Deterioration|3
960300|NCT00705016|3160577|P3|Overall Study|Progressive Disease|33
960301|NCT00705016|3160578|P2|Overall Study|Progressive Disease|29
960302|NCT00705016|3160579|P1|Overall Study|Progressive Disease|33
960303|NCT00705016|3160577|P3|Overall Study|Withdrawal by Subject|2
960304|NCT00705016|3160578|P2|Overall Study|Withdrawal by Subject|3
960305|NCT00705016|3160579|P1|Overall Study|Withdrawal by Subject|4
960306|NCT00705016|3160577|P3|Overall Study|Protocol Violation|1
960307|NCT00705016|3160578|P2|Overall Study|Protocol Violation|1
960308|NCT00705016|3160579|P1|Overall Study|Protocol Violation|0
960309|NCT00705016|3160577|P3|Overall Study|Death|5
960310|NCT00705016|3160578|P2|Overall Study|Death|7
960311|NCT00705016|3160579|P1|Overall Study|Death|5
960312|NCT00705016|3160577|P3|Overall Study|Adverse Event|10
960313|NCT00705016|3160578|P2|Overall Study|Adverse Event|11
960314|NCT00705016|3160579|P1|Overall Study|Adverse Event|6
960315|NCT00704964|3160630|P1|Overall Study|Not completed on time|328
960316|NCT00704808|3160679|P1|Overall Study|Treatment change|1
960317|NCT00704808|3160679|P1|Overall Study|Lost to Follow-up|1
960318|NCT00704808|3160679|P1|Overall Study|Adverse Event|1
960319|NCT00704808|3160679|P1|Overall Study|Early therapy discontinuation|16
960320|NCT00704808|3160679|P1|Overall Study|Patient's decision|11
960321|NCT00704808|3160679|P1|Overall Study|Tumor progression|80
960322|NCT00704808|3160679|P1|Overall Study|Death|7
960323|NCT00704808|3160679|P1|Overall Study|Discontinued prior to starting treatment|14
960324|NCT00704730|3160690|P2|Overall Study|Withdrawal by Subject|13
960325|NCT00704730|3160691|P1|Overall Study|Withdrawal by Subject|9
960326|NCT00704730|3160690|P2|Overall Study|data unavailable|0
960327|NCT00704730|3160691|P1|Overall Study|data unavailable|1
960328|NCT00704730|3160690|P2|Overall Study|Disease progression per PI|67
960329|NCT00704730|3160691|P1|Overall Study|Disease progression per PI|58
960330|NCT00704730|3160690|P2|Overall Study|Did not receive drug|2
960331|NCT00704730|3160691|P1|Overall Study|Did not receive drug|5
960332|NCT00704730|3160690|P2|Overall Study|Physician Decision|0
960333|NCT00704730|3160691|P1|Overall Study|Physician Decision|2
960334|NCT00704730|3160690|P2|Overall Study|Death|5
960335|NCT00704730|3160691|P1|Overall Study|Death|11
960336|NCT00704730|3160690|P2|Overall Study|Adverse Event|9
960337|NCT00704730|3160691|P1|Overall Study|Adverse Event|35
960338|NCT00704535|3160711|P1|Overall Study|Completed status not on Case Report Form|124
960339|NCT00704535|3160711|P1|Overall Study|Protocol Violation|10
960340|NCT00704535|3160711|P1|Overall Study|Lost to Follow-up|8
960341|NCT00704535|3160711|P1|Overall Study|Death|2
960342|NCT00704535|3160711|P1|Overall Study|Adverse Event|2
960343|NCT00704522|3160724|P2|Overall Study|No information on therapy end|2
960344|NCT00704522|3160725|P1|Overall Study|No information on therapy end|27
960345|NCT00704522|3160724|P2|Overall Study|Undefined causes|7
960346|NCT00704522|3160725|P1|Overall Study|Undefined causes|9
960347|NCT00704522|3160724|P2|Overall Study|Adverse Event|1
960348|NCT00704522|3160725|P1|Overall Study|Adverse Event|9
960349|NCT00704522|3160724|P2|Overall Study|Withdrawal by Subject|8
960350|NCT00704522|3160725|P1|Overall Study|Withdrawal by Subject|17
960351|NCT00704522|3160724|P2|Overall Study|Failure to appear again at hospital|10
960352|NCT00704522|3160725|P1|Overall Study|Failure to appear again at hospital|56
960353|NCT00704522|3160724|P2|Overall Study|Lack of Efficacy|17
960354|NCT00704522|3160725|P1|Overall Study|Lack of Efficacy|65
960355|NCT00704418|3160745|P2|Overall Study|Over-enrolled/surgery postponed|6
960356|NCT00704418|3160746|P1|Overall Study|Over-enrolled/surgery postponed|3
960357|NCT00704418|3160745|P2|Overall Study|Withdrawal by Subject|0
960358|NCT00704418|3160746|P1|Overall Study|Withdrawal by Subject|2
960359|NCT00704405|3160759|P5|Overall Study (C Population)|Lost to Follow-up|0
960360|NCT00704405|3160760|P4|Overall Study (C Population)|Lost to Follow-up|0
960361|NCT00704405|3160761|P3|Overall Study (C Population)|Lost to Follow-up|0
960362|NCT00704405|3160762|P2|Overall Study (C Population)|Lost to Follow-up|2
960363|NCT00704405|3160763|P1|Overall Study (C Population)|Lost to Follow-up|0
960364|NCT00704405|3160759|P5|Overall Study (C Population)|Withdrawal by Subject|0
960365|NCT00704405|3160760|P4|Overall Study (C Population)|Withdrawal by Subject|1
960366|NCT00704405|3160761|P3|Overall Study (C Population)|Withdrawal by Subject|1
960367|NCT00704405|3160762|P2|Overall Study (C Population)|Withdrawal by Subject|1
960368|NCT00704405|3160763|P1|Overall Study (C Population)|Withdrawal by Subject|1
960369|NCT00704405|3160759|P5|Overall Study (NC Population)|Other|1
960370|NCT00704405|3160760|P4|Overall Study (NC Population)|Other|0
960371|NCT00704405|3160761|P3|Overall Study (NC Population)|Other|0
960372|NCT00704405|3160762|P2|Overall Study (NC Population)|Other|0
960373|NCT00704405|3160763|P1|Overall Study (NC Population)|Other|0
960374|NCT00704405|3160759|P5|Overall Study (NC Population)|Withdrawal by Subject|2
960375|NCT00704405|3160760|P4|Overall Study (NC Population)|Withdrawal by Subject|2
960376|NCT00704405|3160761|P3|Overall Study (NC Population)|Withdrawal by Subject|2
960377|NCT00704405|3160762|P2|Overall Study (NC Population)|Withdrawal by Subject|3
960378|NCT00704405|3160763|P1|Overall Study (NC Population)|Withdrawal by Subject|2
960379|NCT00704405|3160759|P5|Overall Study (NC Population)|Lost to Follow-up|2
960380|NCT00704405|3160760|P4|Overall Study (NC Population)|Lost to Follow-up|2
960381|NCT00704405|3160761|P3|Overall Study (NC Population)|Lost to Follow-up|1
960382|NCT00704405|3160762|P2|Overall Study (NC Population)|Lost to Follow-up|1
960383|NCT00704405|3160763|P1|Overall Study (NC Population)|Lost to Follow-up|2
960384|NCT00704405|3160759|P5|Overall Study (NC Population)|Adverse Event|0
960385|NCT00704405|3160760|P4|Overall Study (NC Population)|Adverse Event|0
960386|NCT00704405|3160761|P3|Overall Study (NC Population)|Adverse Event|0
960387|NCT00704405|3160762|P2|Overall Study (NC Population)|Adverse Event|0
960388|NCT00704405|3160763|P1|Overall Study (NC Population)|Adverse Event|1
960389|NCT00704340|3160821|P2|Overall Study|Death|1
960390|NCT00704340|3160822|P1|Overall Study|Death|0
960391|NCT00704340|3160821|P2|Overall Study|Lost to Follow-up|1
960392|NCT00704340|3160822|P1|Overall Study|Lost to Follow-up|2
960393|NCT00704184|3160837|P5|Open-Label Treatment|Withdrawal by Subject|0
960394|NCT00704184|3160838|P4|Open-Label Treatment|Withdrawal by Subject|3
960395|NCT00704184|3160839|P3|Open-Label Treatment|Withdrawal by Subject|0
960396|NCT00704184|3160840|P2|Open-Label Treatment|Withdrawal by Subject|0
960397|NCT00704184|3160841|P1|Open-Label Treatment|Withdrawal by Subject|1
960398|NCT00704184|3160837|P5|Open-Label Treatment|Physician Decision|1
960399|NCT00704184|3160838|P4|Open-Label Treatment|Physician Decision|0
960400|NCT00704184|3160839|P3|Open-Label Treatment|Physician Decision|0
960401|NCT00704184|3160840|P2|Open-Label Treatment|Physician Decision|0
960402|NCT00704184|3160841|P1|Open-Label Treatment|Physician Decision|0
960403|NCT00704184|3160837|P5|Open-Label Treatment|Lack of Efficacy|1
960404|NCT00704184|3160838|P4|Open-Label Treatment|Lack of Efficacy|2
960405|NCT00704184|3160839|P3|Open-Label Treatment|Lack of Efficacy|2
960406|NCT00704184|3160840|P2|Open-Label Treatment|Lack of Efficacy|2
960407|NCT00704184|3160841|P1|Open-Label Treatment|Lack of Efficacy|0
960408|NCT00704184|3160837|P5|Open-Label Treatment|Adverse Event|1
960409|NCT00704184|3160838|P4|Open-Label Treatment|Adverse Event|0
960410|NCT00704184|3160839|P3|Open-Label Treatment|Adverse Event|2
960411|NCT00704184|3160840|P2|Open-Label Treatment|Adverse Event|0
960412|NCT00704184|3160841|P1|Open-Label Treatment|Adverse Event|0
960413|NCT00704184|3160837|P5|Double-Blind Treatment|Withdrawal by Subject|0
960414|NCT00704184|3160838|P4|Double-Blind Treatment|Withdrawal by Subject|0
960415|NCT00704184|3160839|P3|Double-Blind Treatment|Withdrawal by Subject|0
960416|NCT00704184|3160840|P2|Double-Blind Treatment|Withdrawal by Subject|0
960417|NCT00704184|3160841|P1|Double-Blind Treatment|Withdrawal by Subject|1
960418|NCT00704171|3160880|P2|Overall Study|Withdrawal by Subject|0
960419|NCT00704171|3160881|P1|Overall Study|Withdrawal by Subject|1
960420|NCT00704132|3160899|P2|Overall Study|Withdrawal by Subject|1
960421|NCT00704132|3160900|P1|Overall Study|Withdrawal by Subject|0
960422|NCT00704132|3160899|P2|Overall Study|Lack of Efficacy|1
960423|NCT00704132|3160900|P1|Overall Study|Lack of Efficacy|0
960424|NCT00704132|3160899|P2|Overall Study|Clinical Adverse Experience|0
960425|NCT00704132|3160900|P1|Overall Study|Clinical Adverse Experience|1
960426|NCT00703963|3160928|P2|Overall Study|Physician Decision|1
960427|NCT00703963|3160929|P1|Overall Study|Physician Decision|0
960428|NCT00703963|3160928|P2|Overall Study|Withdrawal by Subject|13
960429|NCT00703963|3160929|P1|Overall Study|Withdrawal by Subject|7
960430|NCT00703924|3160950|P2|Overall Study|Withdrawal by Subject|1
960431|NCT00703924|3160951|P1|Overall Study|Withdrawal by Subject|1
960432|NCT00703911|3160967|P1|Overall Study|Withdrawal by Subject|2
960433|NCT00703911|3160967|P1|Overall Study|Lost to Follow-up|1
960434|NCT00703911|3160967|P1|Overall Study|Physician Decision|6
960435|NCT00703911|3160967|P1|Overall Study|Death|1
960436|NCT00703846|3161000|P1|Overall Study|Did Not Receive Study Drug|2
960437|NCT00703846|3161000|P1|Overall Study|Other|14
960438|NCT00703846|3161000|P1|Overall Study|Death|1
960439|NCT00703846|3161000|P1|Overall Study|Withdrawal by Subject|40
960440|NCT00703846|3161000|P1|Overall Study|Noncompliance with Study Treatment|2
960441|NCT00703846|3161000|P1|Overall Study|Lack of Efficacy|15
960442|NCT00703846|3161000|P1|Overall Study|Lost to Follow-up|55
960443|NCT00703846|3161000|P1|Overall Study|Adverse Event|8
960444|NCT00703820|3161016|P2|Overall Study|Withdrawal by Subject|1
960445|NCT00703820|3161017|P1|Overall Study|Withdrawal by Subject|2
960446|NCT00703820|3161016|P2|Overall Study|Physician Decision|5
960447|NCT00703820|3161017|P1|Overall Study|Physician Decision|4
960448|NCT00703820|3161016|P2|Overall Study|Received non-protocol therapy|0
960449|NCT00703820|3161017|P1|Overall Study|Received non-protocol therapy|1
960450|NCT00703820|3161016|P2|Overall Study|Lack of Efficacy|11
960451|NCT00703820|3161017|P1|Overall Study|Lack of Efficacy|11
960452|NCT00703820|3161016|P2|Overall Study|Death|0
960453|NCT00703820|3161017|P1|Overall Study|Death|5
960454|NCT00703820|3161016|P2|Overall Study|Adverse Event|17
960455|NCT00703820|3161017|P1|Overall Study|Adverse Event|12
960456|NCT00703781|3161026|P2|Overall Study|Cancelled surgery|0
960457|NCT00703781|3161027|P1|Overall Study|Cancelled surgery|1
960458|NCT00703781|3161026|P2|Overall Study|Withdrawal by Subject|2
960459|NCT00703781|3161027|P1|Overall Study|Withdrawal by Subject|1
960460|NCT00703677|3161072|P1|Overall Study|Dropout-withdrawal not related to drug|3
960461|NCT00703534|3161112|P2|Overall Study|Severe Non Compliance|5
960462|NCT00703534|3161113|P1|Overall Study|Severe Non Compliance|1
960463|NCT00703534|3161112|P2|Overall Study|Lost to Follow-up|4
960464|NCT00703534|3161113|P1|Overall Study|Lost to Follow-up|1
960465|NCT00703534|3161112|P2|Overall Study|Incorrect Enrollment|6
960466|NCT00703534|3161113|P1|Overall Study|Incorrect Enrollment|6
960467|NCT00703534|3161112|P2|Overall Study|Withdrawal by Subject|7
960468|NCT00703534|3161113|P1|Overall Study|Withdrawal by Subject|8
960469|NCT00703534|3161112|P2|Overall Study|Adverse Event|3
960470|NCT00703534|3161113|P1|Overall Study|Adverse Event|14
960471|NCT00703326|3161185|P2|Overall Study|Withdrawal by Subject|20
960472|NCT00703326|3161186|P1|Overall Study|Withdrawal by Subject|42
960473|NCT00703326|3161185|P2|Overall Study|Lost to Follow-up|8
960474|NCT00703326|3161186|P1|Overall Study|Lost to Follow-up|25
960475|NCT00703326|3161185|P2|Overall Study|Still on study|197
960476|NCT00703326|3161186|P1|Overall Study|Still on study|380
960477|NCT00703157|3161218|P2|Overall Study|source data permanently lost/ other|1
960478|NCT00703157|3161219|P1|Overall Study|source data permanently lost/ other|4
960479|NCT00703157|3161218|P2|Overall Study|Lost to Follow-up|1
960480|NCT00703157|3161219|P1|Overall Study|Lost to Follow-up|0
960481|NCT00703118|3161253|P3|Overall Study|Not specified|1
960482|NCT00703118|3161254|P2|Overall Study|Not specified|0
960483|NCT00703118|3161255|P1|Overall Study|Not specified|0
960484|NCT00703118|3161253|P3|Overall Study|Withdrawal by Subject|13
960485|NCT00703118|3161254|P2|Overall Study|Withdrawal by Subject|7
960486|NCT00703118|3161255|P1|Overall Study|Withdrawal by Subject|8
960487|NCT00703118|3161253|P3|Overall Study|Lost to Follow-up|4
960488|NCT00703118|3161254|P2|Overall Study|Lost to Follow-up|4
960489|NCT00703118|3161255|P1|Overall Study|Lost to Follow-up|6
960490|NCT00703118|3161253|P3|Overall Study|Subject Ineligible To Continue The Trial|2
960491|NCT00703118|3161254|P2|Overall Study|Subject Ineligible To Continue The Trial|3
960492|NCT00703118|3161255|P1|Overall Study|Subject Ineligible To Continue The Trial|6
960493|NCT00703118|3161253|P3|Overall Study|Adverse Event|2
960494|NCT00703118|3161254|P2|Overall Study|Adverse Event|2
960495|NCT00703118|3161255|P1|Overall Study|Adverse Event|1
960496|NCT00703092|3161286|P1|Overall Study|Withdrawal by Subject|2
960497|NCT00703014|3161494|P4|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42
960498|NCT00703014|3161495|P3|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47
960499|NCT00703014|3161496|P2|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
960500|NCT00703014|3161497|P1|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
960501|NCT00703014|3161494|P4|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
960502|NCT00703014|3161495|P3|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
960503|NCT00703014|3161496|P2|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32
960504|NCT00703014|3161497|P1|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33
960505|NCT00702962|3161517|P2|Overall Study|Hospitalized for other health disorder|0
960506|NCT00702962|3161518|P1|Overall Study|Hospitalized for other health disorder|1
960507|NCT00702962|3161517|P2|Overall Study|Progressive disease|1
960508|NCT00702962|3161518|P1|Overall Study|Progressive disease|0
960509|NCT00702949|3161529|P3|Overall Study|Other Medical Reason/unknown|3
960510|NCT00702949|3161530|P2|Overall Study|Other Medical Reason/unknown|1
960511|NCT00702949|3161531|P1|Overall Study|Other Medical Reason/unknown|1
960512|NCT00702949|3161529|P3|Overall Study|Adverse Event|3
960513|NCT00702949|3161530|P2|Overall Study|Adverse Event|6
960514|NCT00702949|3161531|P1|Overall Study|Adverse Event|1
960515|NCT00702949|3161529|P3|Overall Study|Refusal|2
960516|NCT00702949|3161530|P2|Overall Study|Refusal|2
960517|NCT00702949|3161531|P1|Overall Study|Refusal|3
960518|NCT00702923|3161556|P1|Overall Study|Adverse Event|1
960519|NCT00702845|3161579|P2|Overall Study|Not randomized|1
960520|NCT00702845|3161580|P1|Overall Study|Not randomized|0
960521|NCT00702845|3161579|P2|Overall Study|Patient's decision|1
960522|NCT00702845|3161580|P1|Overall Study|Patient's decision|2
960523|NCT00702845|3161579|P2|Overall Study|No or abnormal fertilization|2
960524|NCT00702845|3161580|P1|Overall Study|No or abnormal fertilization|4
960525|NCT00702845|3161579|P2|Overall Study|No/too few/bad quality embryos retrieved|1
960526|NCT00702845|3161580|P1|Overall Study|No/too few/bad quality embryos retrieved|7
960527|NCT00702845|3161579|P2|Overall Study|Insufficient ovarian response|0
960528|NCT00702845|3161580|P1|Overall Study|Insufficient ovarian response|1
960529|NCT00702845|3161579|P2|Overall Study|Risk of ovarian hyperstimulation synd.|0
960530|NCT00702845|3161580|P1|Overall Study|Risk of ovarian hyperstimulation synd.|1
960531|NCT00702845|3161579|P2|Overall Study|Too high ovarian response|1
960532|NCT00702845|3161580|P1|Overall Study|Too high ovarian response|5
960533|NCT00702845|3161579|P2|Overall Study|No/too few/bad quality oocytes retrieved|2
960534|NCT00702845|3161580|P1|Overall Study|No/too few/bad quality oocytes retrieved|2
960535|NCT00702715|3161642|P2|Overall Study|Lost to Follow-up|0
960536|NCT00702715|3161643|P1|Overall Study|Lost to Follow-up|1
960537|NCT00702702|3161656|P1|Overall Study|Study prematurely terminated|56
960538|NCT00702689|3161664|P1|Overall Study|Adverse Event|1
960539|NCT00702689|3161664|P1|Overall Study|Recurrent malignancy|1
960540|NCT00702689|3161664|P1|Overall Study|Withdrawal by Subject|4
960541|NCT00702650|3161675|P1|Overall Study|Adverse Event|3
960542|NCT00702650|3161675|P1|Overall Study|Screening Testosterone Levels >300 ng/dL|1
960543|NCT00702650|3161675|P1|Overall Study|Sponsor Request|1
960544|NCT00702650|3161675|P1|Overall Study|Non-Compliance with Site Directives|1
960545|NCT00702650|3161675|P1|Overall Study|Lost to Follow-up|2
960546|NCT00702650|3161675|P1|Overall Study|Non-Compliance of Study Drug|3
960547|NCT00702650|3161675|P1|Overall Study|Withdrawal by Subject|9
960548|NCT00702520|3161737|P4|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
960549|NCT00702520|3161738|P3|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
960550|NCT00702520|3161739|P2|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10
960551|NCT00702520|3161740|P1|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15
960552|NCT00702520|3161737|P4|Base Study P05788 - Embryo Transfer|No embryo transfer|0
960553|NCT00702520|3161738|P3|Base Study P05788 - Embryo Transfer|No embryo transfer|0
960554|NCT00702520|3161739|P2|Base Study P05788 - Embryo Transfer|No embryo transfer|6
960555|NCT00702520|3161740|P1|Base Study P05788 - Embryo Transfer|No embryo transfer|3
960556|NCT00702520|3161737|P4|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
960557|NCT00702520|3161738|P3|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
960558|NCT00702520|3161739|P2|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1
960559|NCT00702520|3161740|P1|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
960560|NCT00702507|3161756|P1|Follow-up Phase|Late Enrollment|1
960561|NCT00702507|3161756|P1|Follow-up Phase|Lost to Follow-up|23
960562|NCT00702507|3161756|P1|Follow-up Phase|Protocol Violation|2
960563|NCT00702507|3161756|P1|Follow-up Phase|Participant's Caretaker Withdrew Consent|1
960564|NCT00702507|3161756|P1|Initial Treatment Phase|Negative Candida Culture|34
960565|NCT00702507|3161756|P1|Initial Treatment Phase|Lost to Follow-up|2
960566|NCT00702507|3161756|P1|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3
960567|NCT00702507|3161756|P1|Initial Treatment Phase|Adverse Event|2
960568|NCT00702403|3161793|P1|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5
960569|NCT00702403|3161793|P1|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1
960570|NCT00702403|3161793|P1|From Engraftment to Study Completion|Acute respiratory distress syndrome|1
960571|NCT00702403|3161793|P1|From Engraftment to Study Completion|Suicide|1
960572|NCT00702403|3161793|P1|From Engraftment to Study Completion|Liver GVHD|1
960573|NCT00702403|3161793|P1|From Engraftment to Study Completion|Adenocarcinoma|1
960574|NCT00702403|3161793|P1|From Engraftment to Study Completion|Non-compliance|2
960575|NCT00702403|3161793|P1|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4
960576|NCT00702403|3161793|P1|From Engraftment to Study Completion|Failed pre-1st dose criteria|11
960577|NCT00702403|3161793|P1|From Consent to Engraftment|Miscellaneous (unanticipated) other|2
960578|NCT00702403|3161793|P1|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4
960579|NCT00702403|3161793|P1|From Consent to Engraftment|Myocardial infarction|1
960580|NCT00702403|3161793|P1|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2
960581|NCT00702403|3161793|P1|From Consent to Engraftment|Critically ill|2
960582|NCT00702403|3161793|P1|From Consent to Engraftment|Progressive leukemia|6
960583|NCT00702325|3161847|P2|Overall Study|Incorrectly Discontinued|1
960584|NCT00702325|3161848|P1|Overall Study|Incorrectly Discontinued|0
960585|NCT00702325|3161847|P2|Overall Study|Withdrew consent|1
960586|NCT00702325|3161848|P1|Overall Study|Withdrew consent|0
960587|NCT00702325|3161847|P2|Overall Study|Didn't follow study medication dosage|2
960588|NCT00702325|3161848|P1|Overall Study|Didn't follow study medication dosage|0
960589|NCT00702325|3161847|P2|Overall Study|Termination due to lab results|0
960590|NCT00702325|3161848|P1|Overall Study|Termination due to lab results|1
960591|NCT00702325|3161847|P2|Overall Study|Severe noncompliance to protocol|3
960592|NCT00702325|3161848|P1|Overall Study|Severe noncompliance to protocol|3
960593|NCT00702325|3161847|P2|Overall Study|Developed study discontinuation criteria|28
960594|NCT00702325|3161848|P1|Overall Study|Developed study discontinuation criteria|18
960595|NCT00702325|3161847|P2|Overall Study|Incorrect enrollment|7
960596|NCT00702325|3161848|P1|Overall Study|Incorrect enrollment|5
960597|NCT00702325|3161847|P2|Overall Study|Lost to Follow-up|4
960598|NCT00702325|3161848|P1|Overall Study|Lost to Follow-up|3
960599|NCT00702325|3161847|P2|Overall Study|Withdrawal by Subject|7
960600|NCT00702325|3161848|P1|Overall Study|Withdrawal by Subject|7
960601|NCT00702325|3161847|P2|Overall Study|Adverse Event|0
960602|NCT00702325|3161848|P1|Overall Study|Adverse Event|1
960603|NCT00702221|3161944|P2|Overall Study|Adverse Event|3
960604|NCT00702221|3161945|P1|Overall Study|Adverse Event|4
960605|NCT00702208|3161951|P1|Overall Study|Unsatisfactory colposcopy|2
960606|NCT00702208|3161951|P1|Overall Study|Did not self-lavage|1
960607|NCT00702208|3161951|P1|Overall Study|Lost to Follow-up|28
960608|NCT00702143|3161960|P3|Overall Study|Lost to Follow-up|1
960609|NCT00702143|3161961|P2|Overall Study|Lost to Follow-up|0
960610|NCT00702143|3161962|P1|Overall Study|Lost to Follow-up|0
960611|NCT00701805|3162011|P4|Overall Study|Resumption criteria were not met|0
960612|NCT00701805|3162012|P3|Overall Study|Resumption criteria were not met|0
960613|NCT00701805|3162013|P2|Overall Study|Resumption criteria were not met|1
960614|NCT00701805|3162014|P1|Overall Study|Resumption criteria were not met|0
960615|NCT00701805|3162011|P4|Overall Study|Difficult to travel to dialysis site|0
960616|NCT00701805|3162012|P3|Overall Study|Difficult to travel to dialysis site|1
960617|NCT00701805|3162013|P2|Overall Study|Difficult to travel to dialysis site|0
960618|NCT00701805|3162014|P1|Overall Study|Difficult to travel to dialysis site|0
960619|NCT00701805|3162011|P4|Overall Study|Physician decision, change of therapy|1
960620|NCT00701805|3162012|P3|Overall Study|Physician decision, change of therapy|0
960621|NCT00701805|3162013|P2|Overall Study|Physician decision, change of therapy|0
960622|NCT00701805|3162014|P1|Overall Study|Physician decision, change of therapy|0
960623|NCT00701805|3162011|P4|Overall Study|Admitted to hospital for 2 weeks|0
960624|NCT00701805|3162012|P3|Overall Study|Admitted to hospital for 2 weeks|1
960625|NCT00701805|3162013|P2|Overall Study|Admitted to hospital for 2 weeks|0
960626|NCT00701805|3162014|P1|Overall Study|Admitted to hospital for 2 weeks|0
960627|NCT00701805|3162011|P4|Overall Study|Missed 7 consecutive doses|0
960628|NCT00701805|3162012|P3|Overall Study|Missed 7 consecutive doses|0
960629|NCT00701805|3162013|P2|Overall Study|Missed 7 consecutive doses|1
960630|NCT00701805|3162014|P1|Overall Study|Missed 7 consecutive doses|0
960631|NCT00701805|3162011|P4|Overall Study|Adverse Event|0
960632|NCT00701805|3162012|P3|Overall Study|Adverse Event|1
960633|NCT00701805|3162013|P2|Overall Study|Adverse Event|1
960634|NCT00701805|3162014|P1|Overall Study|Adverse Event|0
960635|NCT00701805|3162011|P4|Overall Study|Withdrawal by Subject|3
960636|NCT00701805|3162012|P3|Overall Study|Withdrawal by Subject|4
960637|NCT00701805|3162013|P2|Overall Study|Withdrawal by Subject|1
960638|NCT00701805|3162014|P1|Overall Study|Withdrawal by Subject|3
960639|NCT00701779|3162064|P1|Overall Study|Withdrawal by Subject|2
960640|NCT00701779|3162064|P1|Overall Study|Lost to Follow-up|1
960641|NCT00701779|3162064|P1|Overall Study|Adverse Event|6
960642|NCT00701727|3162076|P2|Second Treatment Period|Withdrawal by Subject|0
960643|NCT00701727|3162077|P1|Second Treatment Period|Withdrawal by Subject|2
960644|NCT00701727|3162076|P2|First Treatment Period|Lost to Follow-up|1
960645|NCT00701727|3162077|P1|First Treatment Period|Lost to Follow-up|0
960646|NCT00701727|3162076|P2|First Treatment Period|sponsor decision|1
960647|NCT00701727|3162077|P1|First Treatment Period|sponsor decision|0
960648|NCT00701727|3162076|P2|First Treatment Period|Withdrawal by Subject|0
960649|NCT00701727|3162077|P1|First Treatment Period|Withdrawal by Subject|1
960650|NCT00701727|3162076|P2|First Treatment Period|Adverse Event|0
960651|NCT00701727|3162077|P1|First Treatment Period|Adverse Event|0
960652|NCT00701662|3162123|P1|Overall Study|Lack of Efficacy|1
960653|NCT00701558|3162148|P1|Overall Study|Lost to Follow-up|8
960654|NCT00701558|3162148|P1|Overall Study|Death|7
960655|NCT00701441|3162156|P2|Overall Study|failure in cpap compliance|4
960656|NCT00701441|3162157|P1|Overall Study|failure in cpap compliance|0
960657|NCT00701415|3162169|P2|Overall Study|Social/family issues and needle phobia|0
960658|NCT00701415|3162170|P1|Overall Study|Social/family issues and needle phobia|1
960659|NCT00701415|3162169|P2|Overall Study|Adverse Event|1
960660|NCT00701415|3162170|P1|Overall Study|Adverse Event|0
960661|NCT00701363|3162205|P4|Treatment Phase 2|Withdrawal by Subject|0
960662|NCT00701363|3162206|P3|Treatment Phase 2|Withdrawal by Subject|1
960663|NCT00701363|3162207|P2|Treatment Phase 2|Withdrawal by Subject|0
960664|NCT00701363|3162208|P1|Treatment Phase 2|Withdrawal by Subject|0
960665|NCT00701363|3162205|P4|Treatment Phase 2|Adverse Event|0
960666|NCT00701363|3162206|P3|Treatment Phase 2|Adverse Event|1
960667|NCT00701363|3162207|P2|Treatment Phase 2|Adverse Event|0
960668|NCT00701363|3162208|P1|Treatment Phase 2|Adverse Event|0
960669|NCT00701363|3162205|P4|Treatment Phase 1|Lack of Efficacy|0
960670|NCT00701363|3162206|P3|Treatment Phase 1|Lack of Efficacy|0
960671|NCT00701363|3162207|P2|Treatment Phase 1|Lack of Efficacy|0
960672|NCT00701363|3162208|P1|Treatment Phase 1|Lack of Efficacy|1
960673|NCT00701363|3162205|P4|Treatment Phase 1|Withdrawal by Subject|0
960674|NCT00701363|3162206|P3|Treatment Phase 1|Withdrawal by Subject|0
960675|NCT00701363|3162207|P2|Treatment Phase 1|Withdrawal by Subject|0
960676|NCT00701363|3162208|P1|Treatment Phase 1|Withdrawal by Subject|5
960677|NCT00701363|3162205|P4|Treatment Phase 1|Protocol Violation|0
960678|NCT00701363|3162206|P3|Treatment Phase 1|Protocol Violation|0
960679|NCT00701363|3162207|P2|Treatment Phase 1|Protocol Violation|0
960680|NCT00701363|3162208|P1|Treatment Phase 1|Protocol Violation|1
960681|NCT00701363|3162205|P4|Treatment Phase 1|Adverse Event|0
960682|NCT00701363|3162206|P3|Treatment Phase 1|Adverse Event|0
960683|NCT00701363|3162207|P2|Treatment Phase 1|Adverse Event|0
960684|NCT00701363|3162208|P1|Treatment Phase 1|Adverse Event|7
960685|NCT00701363|3162205|P4|Treatment Phase 1|Does not meet entry Criteria|0
960686|NCT00701363|3162206|P3|Treatment Phase 1|Does not meet entry Criteria|0
960687|NCT00701363|3162207|P2|Treatment Phase 1|Does not meet entry Criteria|0
960688|NCT00701363|3162208|P1|Treatment Phase 1|Does not meet entry Criteria|1
960689|NCT00701363|3162205|P4|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
960690|NCT00701363|3162206|P3|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
960691|NCT00701363|3162207|P2|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
960692|NCT00701363|3162208|P1|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4
960693|NCT00701311|3162248|P1|Overall Study|Withdrawal by Subject|2
960694|NCT00701311|3162248|P1|Overall Study|Adverse Event|3
960695|NCT00701311|3162248|P1|Overall Study|Lack of Efficacy|3
960696|NCT00701129|3162252|P1|Overall Study|Death|2
960697|NCT00701103|3162274|P11|Overall Study|Other|0
960698|NCT00701103|3162275|P10|Overall Study|Other|1
960699|NCT00701103|3162276|P9|Overall Study|Other|1
960700|NCT00701103|3162277|P8|Overall Study|Other|0
960701|NCT00701103|3162278|P7|Overall Study|Other|0
960702|NCT00701103|3162279|P6|Overall Study|Other|0
960703|NCT00701103|3162280|P5|Overall Study|Other|0
960704|NCT00701103|3162281|P4|Overall Study|Other|0
960705|NCT00701103|3162282|P3|Overall Study|Other|0
960706|NCT00701103|3162283|P2|Overall Study|Other|0
960707|NCT00701103|3162284|P1|Overall Study|Other|0
960708|NCT00701103|3162274|P11|Overall Study|Withdrawal by Subject|0
960709|NCT00701103|3162275|P10|Overall Study|Withdrawal by Subject|0
960710|NCT00701103|3162276|P9|Overall Study|Withdrawal by Subject|0
960711|NCT00701103|3162277|P8|Overall Study|Withdrawal by Subject|0
960712|NCT00701103|3162278|P7|Overall Study|Withdrawal by Subject|0
960713|NCT00701103|3162279|P6|Overall Study|Withdrawal by Subject|0
960714|NCT00701103|3162280|P5|Overall Study|Withdrawal by Subject|0
960715|NCT00701103|3162281|P4|Overall Study|Withdrawal by Subject|0
960716|NCT00701103|3162282|P3|Overall Study|Withdrawal by Subject|1
960717|NCT00701103|3162283|P2|Overall Study|Withdrawal by Subject|1
960718|NCT00701103|3162284|P1|Overall Study|Withdrawal by Subject|0
960719|NCT00701103|3162274|P11|Overall Study|Progressive Disease|11
960720|NCT00701103|3162275|P10|Overall Study|Progressive Disease|8
960721|NCT00701103|3162276|P9|Overall Study|Progressive Disease|8
960722|NCT00701103|3162277|P8|Overall Study|Progressive Disease|7
960723|NCT00701103|3162278|P7|Overall Study|Progressive Disease|7
960724|NCT00701103|3162279|P6|Overall Study|Progressive Disease|5
960725|NCT00701103|3162280|P5|Overall Study|Progressive Disease|6
960726|NCT00701103|3162281|P4|Overall Study|Progressive Disease|5
960727|NCT00701103|3162282|P3|Overall Study|Progressive Disease|6
960728|NCT00701103|3162283|P2|Overall Study|Progressive Disease|2
960729|NCT00701103|3162284|P1|Overall Study|Progressive Disease|5
960730|NCT00701103|3162274|P11|Overall Study|Adverse Event|0
960731|NCT00701103|3162275|P10|Overall Study|Adverse Event|2
960732|NCT00701103|3162276|P9|Overall Study|Adverse Event|0
960733|NCT00701103|3162277|P8|Overall Study|Adverse Event|0
960734|NCT00701103|3162278|P7|Overall Study|Adverse Event|1
960735|NCT00701103|3162279|P6|Overall Study|Adverse Event|1
960736|NCT00701103|3162280|P5|Overall Study|Adverse Event|0
960737|NCT00701103|3162281|P4|Overall Study|Adverse Event|1
960738|NCT00701103|3162282|P3|Overall Study|Adverse Event|1
960739|NCT00701103|3162283|P2|Overall Study|Adverse Event|0
960740|NCT00701103|3162284|P1|Overall Study|Adverse Event|0
960741|NCT00701090|3162390|P2|Overall Study|Other|12
960742|NCT00701090|3162391|P1|Overall Study|Other|7
960743|NCT00701090|3162390|P2|Overall Study|Withdrawal by Subject|16
960744|NCT00701090|3162391|P1|Overall Study|Withdrawal by Subject|11
960745|NCT00701090|3162390|P2|Overall Study|Protocol Violation|3
960746|NCT00701090|3162391|P1|Overall Study|Protocol Violation|2
960747|NCT00701090|3162390|P2|Overall Study|Physician Decision|4
960748|NCT00701090|3162391|P1|Overall Study|Physician Decision|3
960749|NCT00701090|3162390|P2|Overall Study|Lost to Follow-up|9
960750|NCT00701090|3162391|P1|Overall Study|Lost to Follow-up|9
960751|NCT00701090|3162390|P2|Overall Study|Lack of Efficacy|4
960752|NCT00701090|3162391|P1|Overall Study|Lack of Efficacy|5
960753|NCT00701090|3162390|P2|Overall Study|Death|1
960754|NCT00701090|3162391|P1|Overall Study|Death|0
960755|NCT00701090|3162390|P2|Overall Study|Adverse Event|2
960756|NCT00701090|3162391|P1|Overall Study|Adverse Event|11
960757|NCT00701064|3162409|P2|Overall Study|initiated other PTSD treatment|2
960758|NCT00701064|3162410|P1|Overall Study|initiated other PTSD treatment|2
960759|NCT00701064|3162409|P2|Overall Study|Withdrawal by Subject|1
960760|NCT00701064|3162410|P1|Overall Study|Withdrawal by Subject|1
960761|NCT00701064|3162409|P2|Overall Study|Protocol Violation|1
960762|NCT00701064|3162410|P1|Overall Study|Protocol Violation|1
960763|NCT00701051|3162422|P3|Exercise Intervention|time conflict; non-study related illness|3
960764|NCT00701051|3162423|P2|Exercise Intervention|time conflict; non-study related illness|5
960765|NCT00701051|3162424|P1|Exercise Intervention|time conflict; non-study related illness|0
960766|NCT00701051|3162422|P3|Screening|Time conflicts|0
960767|NCT00701051|3162423|P2|Screening|Time conflicts|0
960768|NCT00701051|3162424|P1|Screening|Time conflicts|19
960769|NCT00701051|3162422|P3|Screening|Failed Screening|0
960770|NCT00701051|3162423|P2|Screening|Failed Screening|0
960771|NCT00701051|3162424|P1|Screening|Failed Screening|40
960772|NCT00701038|3162442|P2|Overall Study|study amended pilot group of patients|4
960773|NCT00701038|3162443|P1|Overall Study|study amended pilot group of patients|4
960774|NCT00700999|3162451|P2|Overall Study|Withdrawal by Subject|1
960775|NCT00700999|3162452|P1|Overall Study|Withdrawal by Subject|8
960776|NCT00700999|3162451|P2|Overall Study|Excluded - did not meet study criteria|1
960777|NCT00700999|3162452|P1|Overall Study|Excluded - did not meet study criteria|0
960778|NCT00700999|3162451|P2|Overall Study|Lost to Follow-up|7
960779|NCT00700999|3162452|P1|Overall Study|Lost to Follow-up|7
960780|NCT00700817|3162472|P5|Week 52-78 (Extension Period 2)|Unclassified|1
960781|NCT00700817|3162473|P4|Week 52-78 (Extension Period 2)|Unclassified|0
960782|NCT00700817|3162474|P3|Week 52-78 (Extension Period 2)|Unclassified|0
960783|NCT00700817|3162475|P2|Week 52-78 (Extension Period 2)|Unclassified|4
960784|NCT00700817|3162476|P1|Week 52-78 (Extension Period 2)|Unclassified|2
960785|NCT00700817|3162472|P5|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
960786|NCT00700817|3162473|P4|Week 52-78 (Extension Period 2)|Withdrawal criteria|1
960787|NCT00700817|3162474|P3|Week 52-78 (Extension Period 2)|Withdrawal criteria|0
960788|NCT00700817|3162475|P2|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
960789|NCT00700817|3162476|P1|Week 52-78 (Extension Period 2)|Withdrawal criteria|4
960790|NCT00700817|3162472|P5|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
960791|NCT00700817|3162473|P4|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
960792|NCT00700817|3162474|P3|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
960793|NCT00700817|3162475|P2|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
960794|NCT00700817|3162476|P1|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
960795|NCT00700817|3162472|P5|Week 52-78 (Extension Period 2)|Protocol Violation|1
960796|NCT00700817|3162473|P4|Week 52-78 (Extension Period 2)|Protocol Violation|1
960797|NCT00700817|3162474|P3|Week 52-78 (Extension Period 2)|Protocol Violation|0
960798|NCT00700817|3162475|P2|Week 52-78 (Extension Period 2)|Protocol Violation|2
960799|NCT00700817|3162476|P1|Week 52-78 (Extension Period 2)|Protocol Violation|1
960800|NCT00700817|3162472|P5|Week 52-78 (Extension Period 2)|Adverse Event|0
960801|NCT00700817|3162473|P4|Week 52-78 (Extension Period 2)|Adverse Event|6
960802|NCT00700817|3162474|P3|Week 52-78 (Extension Period 2)|Adverse Event|0
960803|NCT00700817|3162475|P2|Week 52-78 (Extension Period 2)|Adverse Event|3
960804|NCT00700817|3162476|P1|Week 52-78 (Extension Period 2)|Adverse Event|0
960805|NCT00700817|3162472|P5|Week 26-52 (Extension Period 1)|Unclassified|0
960806|NCT00700817|3162473|P4|Week 26-52 (Extension Period 1)|Unclassified|0
960807|NCT00700817|3162474|P3|Week 26-52 (Extension Period 1)|Unclassified|1
960808|NCT00700817|3162475|P2|Week 26-52 (Extension Period 1)|Unclassified|3
960809|NCT00700817|3162476|P1|Week 26-52 (Extension Period 1)|Unclassified|4
960810|NCT00700817|3162472|P5|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
960811|NCT00700817|3162473|P4|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
960812|NCT00700817|3162474|P3|Week 26-52 (Extension Period 1)|Withdrawal criteria|2
960813|NCT00700817|3162475|P2|Week 26-52 (Extension Period 1)|Withdrawal criteria|8
960814|NCT00700817|3162476|P1|Week 26-52 (Extension Period 1)|Withdrawal criteria|6
960815|NCT00700817|3162472|P5|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
960816|NCT00700817|3162473|P4|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
960817|NCT00700817|3162474|P3|Week 26-52 (Extension Period 1)|Lack of Efficacy|7
960818|NCT00700817|3162475|P2|Week 26-52 (Extension Period 1)|Lack of Efficacy|3
960819|NCT00700817|3162476|P1|Week 26-52 (Extension Period 1)|Lack of Efficacy|2
960820|NCT00700817|3162472|P5|Week 26-52 (Extension Period 1)|Protocol Violation|0
960821|NCT00700817|3162473|P4|Week 26-52 (Extension Period 1)|Protocol Violation|0
960822|NCT00700817|3162474|P3|Week 26-52 (Extension Period 1)|Protocol Violation|2
960823|NCT00700817|3162475|P2|Week 26-52 (Extension Period 1)|Protocol Violation|2
960824|NCT00700817|3162476|P1|Week 26-52 (Extension Period 1)|Protocol Violation|3
960825|NCT00700817|3162472|P5|Week 26-52 (Extension Period 1)|Adverse Event|0
960826|NCT00700817|3162473|P4|Week 26-52 (Extension Period 1)|Adverse Event|0
960827|NCT00700817|3162474|P3|Week 26-52 (Extension Period 1)|Adverse Event|3
960828|NCT00700817|3162475|P2|Week 26-52 (Extension Period 1)|Adverse Event|10
960829|NCT00700817|3162476|P1|Week 26-52 (Extension Period 1)|Adverse Event|5
960830|NCT00700817|3162472|P5|Week 0-26 (Main Period)|Unclassified|0
960831|NCT00700817|3162473|P4|Week 0-26 (Main Period)|Unclassified|0
960832|NCT00700817|3162474|P3|Week 0-26 (Main Period)|Unclassified|8
960833|NCT00700817|3162475|P2|Week 0-26 (Main Period)|Unclassified|4
960834|NCT00700817|3162476|P1|Week 0-26 (Main Period)|Unclassified|14
960835|NCT00700817|3162472|P5|Week 0-26 (Main Period)|Withdrawal criteria|0
960836|NCT00700817|3162473|P4|Week 0-26 (Main Period)|Withdrawal criteria|0
960837|NCT00700817|3162474|P3|Week 0-26 (Main Period)|Withdrawal criteria|5
960838|NCT00700817|3162475|P2|Week 0-26 (Main Period)|Withdrawal criteria|7
960839|NCT00700817|3162476|P1|Week 0-26 (Main Period)|Withdrawal criteria|10
960840|NCT00700817|3162472|P5|Week 0-26 (Main Period)|Protocol Violation|0
960841|NCT00700817|3162473|P4|Week 0-26 (Main Period)|Protocol Violation|0
960842|NCT00700817|3162474|P3|Week 0-26 (Main Period)|Protocol Violation|4
960843|NCT00700817|3162475|P2|Week 0-26 (Main Period)|Protocol Violation|4
960844|NCT00700817|3162476|P1|Week 0-26 (Main Period)|Protocol Violation|14
960845|NCT00700817|3162472|P5|Week 0-26 (Main Period)|Lack of Efficacy|0
960846|NCT00700817|3162473|P4|Week 0-26 (Main Period)|Lack of Efficacy|0
960847|NCT00700817|3162474|P3|Week 0-26 (Main Period)|Lack of Efficacy|4
960848|NCT00700817|3162475|P2|Week 0-26 (Main Period)|Lack of Efficacy|0
960849|NCT00700817|3162476|P1|Week 0-26 (Main Period)|Lack of Efficacy|4
960850|NCT00700817|3162472|P5|Week 0-26 (Main Period)|Adverse Event|0
960851|NCT00700817|3162473|P4|Week 0-26 (Main Period)|Adverse Event|0
960852|NCT00700817|3162474|P3|Week 0-26 (Main Period)|Adverse Event|4
960853|NCT00700817|3162475|P2|Week 0-26 (Main Period)|Adverse Event|15
960854|NCT00700817|3162476|P1|Week 0-26 (Main Period)|Adverse Event|14
960855|NCT00700804|3162858|P2|Overall Study|Loose Stools|1
960856|NCT00700804|3162859|P1|Overall Study|Loose Stools|1
960857|NCT00700804|3162858|P2|Overall Study|Protocol Violation|1
960858|NCT00700804|3162859|P1|Overall Study|Protocol Violation|1
960859|NCT00700804|3162858|P2|Overall Study|Withdrawal by Subject|2
960860|NCT00700804|3162859|P1|Overall Study|Withdrawal by Subject|1
960861|NCT00700752|3162867|P2|First Intervention|Withdrawal by Subject|2
960862|NCT00700752|3162868|P1|First Intervention|Withdrawal by Subject|0
960863|NCT00700739|3162876|P2|Overall Study|Lost to Follow-up|4
960864|NCT00700739|3162877|P1|Overall Study|Lost to Follow-up|4
960865|NCT00700713|3162916|P3|Overall Study|Withdrawal by Subject|1
960866|NCT00700713|3162917|P2|Overall Study|Withdrawal by Subject|0
960867|NCT00700713|3162918|P1|Overall Study|Withdrawal by Subject|0
960868|NCT00700713|3162916|P3|Overall Study|Protocol Violation|1
960869|NCT00700713|3162917|P2|Overall Study|Protocol Violation|0
960870|NCT00700713|3162918|P1|Overall Study|Protocol Violation|1
960871|NCT00700635|3162935|P3|Overall Study|Withdrawal by Subject|1
960872|NCT00700635|3162936|P2|Overall Study|Withdrawal by Subject|3
960873|NCT00700635|3162937|P1|Overall Study|Withdrawal by Subject|7
960874|NCT00700635|3162935|P3|Overall Study|Protocol Violation|0
960875|NCT00700635|3162936|P2|Overall Study|Protocol Violation|2
960876|NCT00700635|3162937|P1|Overall Study|Protocol Violation|2
960877|NCT00700635|3162935|P3|Overall Study|Lost to Follow-up|0
960878|NCT00700635|3162936|P2|Overall Study|Lost to Follow-up|3
960879|NCT00700635|3162937|P1|Overall Study|Lost to Follow-up|1
960880|NCT00700635|3162935|P3|Overall Study|Adverse Event|0
960881|NCT00700635|3162936|P2|Overall Study|Adverse Event|0
960882|NCT00700635|3162937|P1|Overall Study|Adverse Event|1
960883|NCT00700622|3162959|P2|Overall Study|Other|1
960884|NCT00700622|3162960|P1|Overall Study|Other|3
960885|NCT00700622|3162959|P2|Overall Study|Withdrawal by Subject|1
960886|NCT00700622|3162960|P1|Overall Study|Withdrawal by Subject|4
960887|NCT00700622|3162959|P2|Overall Study|Protocol Violation|1
960888|NCT00700622|3162960|P1|Overall Study|Protocol Violation|0
960889|NCT00700622|3162959|P2|Overall Study|Physician Decision|1
960890|NCT00700622|3162960|P1|Overall Study|Physician Decision|2
960891|NCT00700622|3162959|P2|Overall Study|Lost to Follow-up|1
960892|NCT00700622|3162960|P1|Overall Study|Lost to Follow-up|0
960893|NCT00700622|3162959|P2|Overall Study|Adverse Event|0
960894|NCT00700622|3162960|P1|Overall Study|Adverse Event|4
960895|NCT00700570|3162968|P2|Overall Study|Withdrawal by Subject|6
960896|NCT00700570|3162969|P1|Overall Study|Withdrawal by Subject|1
960897|NCT00700570|3162968|P2|Overall Study|Disease Progression|11
960898|NCT00700570|3162969|P1|Overall Study|Disease Progression|8
960899|NCT00700570|3162968|P2|Overall Study|Discretion of Investigator or Sponsor|3
960900|NCT00700570|3162969|P1|Overall Study|Discretion of Investigator or Sponsor|0
960901|NCT00700570|3162968|P2|Overall Study|Adverse Event|6
960902|NCT00700570|3162969|P1|Overall Study|Adverse Event|2
960903|NCT00700427|3162985|P5|Study Period 4 (Open-Label Extension)|Clinical Relapse|1
960904|NCT00700427|3162986|P4|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
960905|NCT00700427|3162987|P3|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
960906|NCT00700427|3162988|P2|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
960907|NCT00700427|3162989|P1|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
960908|NCT00700427|3162985|P5|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11
960909|NCT00700427|3162986|P4|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
960910|NCT00700427|3162987|P3|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
960911|NCT00700427|3162988|P2|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
960912|NCT00700427|3162989|P1|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
960913|NCT00700427|3162985|P5|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1
960914|NCT00700427|3162986|P4|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
960915|NCT00700427|3162987|P3|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
960916|NCT00700427|3162988|P2|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
960917|NCT00700427|3162989|P1|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
960918|NCT00700427|3162985|P5|Study Period 4 (Open-Label Extension)|Sponsor Decision|2
960919|NCT00700427|3162986|P4|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
960920|NCT00700427|3162987|P3|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
960921|NCT00700427|3162988|P2|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
960922|NCT00700427|3162989|P1|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
960923|NCT00700427|3162985|P5|Study Period 4 (Open-Label Extension)|Physician Decision|2
960924|NCT00700427|3162986|P4|Study Period 4 (Open-Label Extension)|Physician Decision|0
960925|NCT00700427|3162987|P3|Study Period 4 (Open-Label Extension)|Physician Decision|0
960926|NCT00700427|3162988|P2|Study Period 4 (Open-Label Extension)|Physician Decision|0
960927|NCT00700427|3162989|P1|Study Period 4 (Open-Label Extension)|Physician Decision|0
960928|NCT00700427|3162985|P5|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38
960929|NCT00700427|3162986|P4|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
960930|NCT00700427|3162987|P3|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
960931|NCT00700427|3162988|P2|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
960932|NCT00700427|3162989|P1|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
960933|NCT00700427|3162985|P5|Study Period 4 (Open-Label Extension)|Protocol Violation|12
960934|NCT00700427|3162986|P4|Study Period 4 (Open-Label Extension)|Protocol Violation|0
960935|NCT00700427|3162987|P3|Study Period 4 (Open-Label Extension)|Protocol Violation|0
960936|NCT00700427|3162988|P2|Study Period 4 (Open-Label Extension)|Protocol Violation|0
960937|NCT00700427|3162989|P1|Study Period 4 (Open-Label Extension)|Protocol Violation|0
960938|NCT00700427|3162985|P5|Study Period 4 (Open-Label Extension)|Death|1
960939|NCT00700427|3162986|P4|Study Period 4 (Open-Label Extension)|Death|0
960940|NCT00700427|3162987|P3|Study Period 4 (Open-Label Extension)|Death|0
960941|NCT00700427|3162988|P2|Study Period 4 (Open-Label Extension)|Death|0
960942|NCT00700427|3162989|P1|Study Period 4 (Open-Label Extension)|Death|0
960943|NCT00700427|3162985|P5|Study Period 4 (Open-Label Extension)|Adverse Event|16
960944|NCT00700427|3162986|P4|Study Period 4 (Open-Label Extension)|Adverse Event|0
960945|NCT00700427|3162987|P3|Study Period 4 (Open-Label Extension)|Adverse Event|0
960946|NCT00700427|3162988|P2|Study Period 4 (Open-Label Extension)|Adverse Event|0
960947|NCT00700427|3162989|P1|Study Period 4 (Open-Label Extension)|Adverse Event|0
960948|NCT00700427|3162985|P5|Study Period 3B (Randomized Withdrawal)|Death|0
960949|NCT00700427|3162986|P4|Study Period 3B (Randomized Withdrawal)|Death|0
960950|NCT00700427|3162987|P3|Study Period 3B (Randomized Withdrawal)|Death|1
960951|NCT00700427|3162988|P2|Study Period 3B (Randomized Withdrawal)|Death|0
960952|NCT00700427|3162989|P1|Study Period 3B (Randomized Withdrawal)|Death|0
960953|NCT00700427|3162985|P5|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
960954|NCT00700427|3162986|P4|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
960955|NCT00700427|3162987|P3|Study Period 3B (Randomized Withdrawal)|Physician Decision|2
960956|NCT00700427|3162988|P2|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
960957|NCT00700427|3162989|P1|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
960958|NCT00700427|3162985|P5|Study Period 3B (Randomized Withdrawal)|Missing|0
960959|NCT00700427|3162986|P4|Study Period 3B (Randomized Withdrawal)|Missing|1
960960|NCT00700427|3162987|P3|Study Period 3B (Randomized Withdrawal)|Missing|1
960961|NCT00700427|3162988|P2|Study Period 3B (Randomized Withdrawal)|Missing|0
960962|NCT00700427|3162989|P1|Study Period 3B (Randomized Withdrawal)|Missing|0
960963|NCT00700427|3162985|P5|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
960964|NCT00700427|3162986|P4|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3
960965|NCT00700427|3162987|P3|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
960966|NCT00700427|3162988|P2|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
960967|NCT00700427|3162989|P1|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
960968|NCT00700427|3162985|P5|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
960969|NCT00700427|3162986|P4|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5
960970|NCT00700427|3162987|P3|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
960971|NCT00700427|3162988|P2|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
960972|NCT00700427|3162989|P1|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
960973|NCT00700427|3162985|P5|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
960974|NCT00700427|3162986|P4|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11
960975|NCT00700427|3162987|P3|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3
960976|NCT00700427|3162988|P2|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
960977|NCT00700427|3162989|P1|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
960978|NCT00700427|3162985|P5|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
960979|NCT00700427|3162986|P4|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9
960980|NCT00700427|3162987|P3|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19
960981|NCT00700427|3162988|P2|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
960982|NCT00700427|3162989|P1|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
960983|NCT00700427|3162985|P5|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
960984|NCT00700427|3162986|P4|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25
960985|NCT00700427|3162987|P3|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23
960986|NCT00700427|3162988|P2|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
960987|NCT00700427|3162989|P1|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
960988|NCT00700427|3162985|P5|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
960989|NCT00700427|3162986|P4|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34
960990|NCT00700427|3162987|P3|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25
960991|NCT00700427|3162988|P2|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
960992|NCT00700427|3162989|P1|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
960993|NCT00700427|3162985|P5|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
960994|NCT00700427|3162986|P4|Study Period 3B (Randomized Withdrawal)|Adverse Event|5
960995|NCT00700427|3162987|P3|Study Period 3B (Randomized Withdrawal)|Adverse Event|8
960996|NCT00700427|3162988|P2|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
960997|NCT00700427|3162989|P1|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
960998|NCT00700427|3162985|P5|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
960999|NCT00700427|3162986|P4|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
961000|NCT00700427|3162987|P3|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
961001|NCT00700427|3162988|P2|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5
961002|NCT00700427|3162989|P1|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
961003|NCT00700427|3162985|P5|Study Period 3A (Blinded Maintenance)|Physician Decision|0
961004|NCT00700427|3162986|P4|Study Period 3A (Blinded Maintenance)|Physician Decision|0
961005|NCT00700427|3162987|P3|Study Period 3A (Blinded Maintenance)|Physician Decision|0
961006|NCT00700427|3162988|P2|Study Period 3A (Blinded Maintenance)|Physician Decision|2
961007|NCT00700427|3162989|P1|Study Period 3A (Blinded Maintenance)|Physician Decision|0
961008|NCT00700427|3162985|P5|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
961009|NCT00700427|3162986|P4|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
961010|NCT00700427|3162987|P3|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
961011|NCT00700427|3162988|P2|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3
961012|NCT00700427|3162989|P1|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
961013|NCT00700427|3162985|P5|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
961014|NCT00700427|3162986|P4|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
961015|NCT00700427|3162987|P3|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
961016|NCT00700427|3162988|P2|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32
961017|NCT00700427|3162989|P1|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
961018|NCT00700427|3162985|P5|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
961019|NCT00700427|3162986|P4|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
961020|NCT00700427|3162987|P3|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
961021|NCT00700427|3162988|P2|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41
961022|NCT00700427|3162989|P1|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
961023|NCT00700427|3162985|P5|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
961024|NCT00700427|3162986|P4|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
961025|NCT00700427|3162987|P3|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
961026|NCT00700427|3162988|P2|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49
961027|NCT00700427|3162989|P1|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
961098|NCT00700401|3163011|P1|Overall Study|Adverse Event|5
961028|NCT00700427|3162985|P5|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
961029|NCT00700427|3162986|P4|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
961030|NCT00700427|3162987|P3|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
961031|NCT00700427|3162988|P2|Study Period 3A (Blinded Maintenance)|Protocol Violation|56
961032|NCT00700427|3162989|P1|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
961033|NCT00700427|3162985|P5|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
961034|NCT00700427|3162986|P4|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
961035|NCT00700427|3162987|P3|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
961036|NCT00700427|3162988|P2|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81
961037|NCT00700427|3162989|P1|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
961038|NCT00700427|3162985|P5|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
961039|NCT00700427|3162986|P4|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
961040|NCT00700427|3162987|P3|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
961041|NCT00700427|3162988|P2|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162
961042|NCT00700427|3162989|P1|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
961043|NCT00700427|3162985|P5|Study Period 3A (Blinded Maintenance)|Adverse Event|0
961044|NCT00700427|3162986|P4|Study Period 3A (Blinded Maintenance)|Adverse Event|0
961045|NCT00700427|3162987|P3|Study Period 3A (Blinded Maintenance)|Adverse Event|0
961046|NCT00700427|3162988|P2|Study Period 3A (Blinded Maintenance)|Adverse Event|50
961047|NCT00700427|3162989|P1|Study Period 3A (Blinded Maintenance)|Adverse Event|0
961048|NCT00700427|3162985|P5|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
961049|NCT00700427|3162986|P4|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
961050|NCT00700427|3162987|P3|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
961051|NCT00700427|3162988|P2|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
961052|NCT00700427|3162989|P1|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2
961053|NCT00700427|3162985|P5|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
961054|NCT00700427|3162986|P4|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
961055|NCT00700427|3162987|P3|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
961056|NCT00700427|3162988|P2|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
961057|NCT00700427|3162989|P1|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7
961058|NCT00700427|3162985|P5|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
961059|NCT00700427|3162986|P4|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
961060|NCT00700427|3162987|P3|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
961061|NCT00700427|3162988|P2|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
961062|NCT00700427|3162989|P1|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8
961063|NCT00700427|3162985|P5|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
961064|NCT00700427|3162986|P4|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
961065|NCT00700427|3162987|P3|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
961066|NCT00700427|3162988|P2|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
961067|NCT00700427|3162989|P1|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90
961068|NCT00700427|3162985|P5|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
961069|NCT00700427|3162986|P4|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
961070|NCT00700427|3162987|P3|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
961071|NCT00700427|3162988|P2|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
961072|NCT00700427|3162989|P1|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108
961073|NCT00700427|3162985|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
961074|NCT00700427|3162986|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
961075|NCT00700427|3162987|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
961076|NCT00700427|3162988|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
961077|NCT00700427|3162989|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161
961078|NCT00700427|3162985|P5|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
961079|NCT00700427|3162986|P4|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
961080|NCT00700427|3162987|P3|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
961081|NCT00700427|3162988|P2|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
961082|NCT00700427|3162989|P1|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164
961083|NCT00700427|3162985|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
961084|NCT00700427|3162986|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
961085|NCT00700427|3162987|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
961086|NCT00700427|3162988|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
961087|NCT00700427|3162989|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173
961088|NCT00700427|3162985|P5|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
961089|NCT00700427|3162986|P4|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
961090|NCT00700427|3162987|P3|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
961091|NCT00700427|3162988|P2|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
961092|NCT00700427|3162989|P1|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298
961093|NCT00700401|3163011|P1|Overall Study|Withdrawal by Subject|2
961094|NCT00700401|3163011|P1|Overall Study|HCV RNA not detected at baseline and SAE|1
961095|NCT00700401|3163011|P1|Overall Study|Treatment never started|1
961096|NCT00700401|3163011|P1|Overall Study|Lost to Follow-up|1
961097|NCT00700401|3163011|P1|Overall Study|Refused Treatment|2
961099|NCT00700401|3163011|P1|Overall Study|Detectable HCV RNA after Week 4|82
961100|NCT00700310|3163035|P4|Overall Study|Randomized, Not Treated|2
961101|NCT00700310|3163036|P3|Overall Study|Randomized, Not Treated|2
961102|NCT00700310|3163037|P2|Overall Study|Randomized, Not Treated|0
961103|NCT00700310|3163038|P1|Overall Study|Randomized, Not Treated|2
961104|NCT00700310|3163035|P4|Overall Study|Administrative/Other|3
961105|NCT00700310|3163036|P3|Overall Study|Administrative/Other|1
961106|NCT00700310|3163037|P2|Overall Study|Administrative/Other|3
961107|NCT00700310|3163038|P1|Overall Study|Administrative/Other|1
961108|NCT00700310|3163035|P4|Overall Study|Lack of Efficacy|1
961109|NCT00700310|3163036|P3|Overall Study|Lack of Efficacy|0
961110|NCT00700310|3163037|P2|Overall Study|Lack of Efficacy|3
961111|NCT00700310|3163038|P1|Overall Study|Lack of Efficacy|0
961112|NCT00700310|3163035|P4|Overall Study|Withdrawal by Subject|8
961113|NCT00700310|3163036|P3|Overall Study|Withdrawal by Subject|8
961114|NCT00700310|3163037|P2|Overall Study|Withdrawal by Subject|9
961115|NCT00700310|3163038|P1|Overall Study|Withdrawal by Subject|8
961116|NCT00700310|3163035|P4|Overall Study|Lost to Follow-up|1
961117|NCT00700310|3163036|P3|Overall Study|Lost to Follow-up|0
961118|NCT00700310|3163037|P2|Overall Study|Lost to Follow-up|1
961119|NCT00700310|3163038|P1|Overall Study|Lost to Follow-up|4
961120|NCT00700310|3163035|P4|Overall Study|Adverse Event|11
961121|NCT00700310|3163036|P3|Overall Study|Adverse Event|5
961122|NCT00700310|3163037|P2|Overall Study|Adverse Event|10
961123|NCT00700310|3163038|P1|Overall Study|Adverse Event|6
961124|NCT00700271|3163058|P2|Overall Study|Lost to Follow-up|2
961125|NCT00700271|3163059|P1|Overall Study|Lost to Follow-up|2
961126|NCT00700271|3163058|P2|Overall Study|Withdrawal by Subject|4
961127|NCT00700271|3163059|P1|Overall Study|Withdrawal by Subject|6
961128|NCT00700271|3163058|P2|Overall Study|Administrative Reasons|0
961129|NCT00700271|3163059|P1|Overall Study|Administrative Reasons|1
961130|NCT00700271|3163058|P2|Overall Study|Protocol Violation|0
961131|NCT00700271|3163059|P1|Overall Study|Protocol Violation|1
961132|NCT00700271|3163058|P2|Overall Study|Adverse Event|6
961133|NCT00700271|3163059|P1|Overall Study|Adverse Event|4
961134|NCT00700180|3163087|P2|Overall Study|Lost to Follow-up|5
961135|NCT00700180|3163088|P1|Overall Study|Lost to Follow-up|4
961136|NCT00700180|3163087|P2|Overall Study|Alive in follow-up|27
961137|NCT00700180|3163088|P1|Overall Study|Alive in follow-up|46
961138|NCT00700180|3163087|P2|Overall Study|Alive on treatment|3
961139|NCT00700180|3163088|P1|Overall Study|Alive on treatment|5
961140|NCT00700180|3163087|P2|Overall Study|Death|114
961141|NCT00700180|3163088|P1|Overall Study|Death|99
961142|NCT00700115|3163117|P2|Overall Study|Lost to Follow-up|1
961143|NCT00700115|3163118|P1|Overall Study|Lost to Follow-up|0
961144|NCT00700115|3163117|P2|Overall Study|Withdrawal by Subject|0
961145|NCT00700115|3163118|P1|Overall Study|Withdrawal by Subject|1
961146|NCT00700102|3163128|P2|Overall Study|Lost to Follow-up|10
961147|NCT00700102|3163129|P1|Overall Study|Lost to Follow-up|8
961148|NCT00700102|3163128|P2|Overall Study|Died|385
961149|NCT00700102|3163129|P1|Overall Study|Died|394
961150|NCT00700011|3163268|P2|Overall Study|Death|1
961151|NCT00700011|3163269|P1|Overall Study|Death|0
961152|NCT00699998|3163285|P4|Overall Study|Lost to Follow-up|1
961153|NCT00699998|3163286|P3|Overall Study|Lost to Follow-up|3
961154|NCT00699998|3163287|P2|Overall Study|Lost to Follow-up|1
961155|NCT00699998|3163288|P1|Overall Study|Lost to Follow-up|2
961156|NCT00699998|3163285|P4|Overall Study|Physician Decision|1
961157|NCT00699998|3163286|P3|Overall Study|Physician Decision|1
961158|NCT00699998|3163287|P2|Overall Study|Physician Decision|2
961159|NCT00699998|3163288|P1|Overall Study|Physician Decision|3
961160|NCT00699998|3163285|P4|Overall Study|Withdrawal by Subject|80
961161|NCT00699998|3163286|P3|Overall Study|Withdrawal by Subject|202
961162|NCT00699998|3163287|P2|Overall Study|Withdrawal by Subject|83
961163|NCT00699998|3163288|P1|Overall Study|Withdrawal by Subject|194
961164|NCT00699972|3163333|P3|Overall Study|Randomized, Not Treated|1
961165|NCT00699972|3163334|P2|Overall Study|Randomized, Not Treated|0
961166|NCT00699972|3163335|P1|Overall Study|Randomized, Not Treated|1
961167|NCT00699972|3163333|P3|Overall Study|Administrative/Other|4
961168|NCT00699972|3163334|P2|Overall Study|Administrative/Other|1
961169|NCT00699972|3163335|P1|Overall Study|Administrative/Other|3
961170|NCT00699972|3163333|P3|Overall Study|Lack of Efficacy|2
961171|NCT00699972|3163334|P2|Overall Study|Lack of Efficacy|0
961172|NCT00699972|3163335|P1|Overall Study|Lack of Efficacy|2
961173|NCT00699972|3163333|P3|Overall Study|Withdrawal by Subject|4
961174|NCT00699972|3163334|P2|Overall Study|Withdrawal by Subject|7
961175|NCT00699972|3163335|P1|Overall Study|Withdrawal by Subject|3
961176|NCT00699972|3163333|P3|Overall Study|Lost to Follow-up|0
961177|NCT00699972|3163334|P2|Overall Study|Lost to Follow-up|2
961178|NCT00699972|3163335|P1|Overall Study|Lost to Follow-up|0
961179|NCT00699972|3163333|P3|Overall Study|Adverse Event|24
961180|NCT00699972|3163334|P2|Overall Study|Adverse Event|9
961181|NCT00699972|3163335|P1|Overall Study|Adverse Event|7
961182|NCT00699907|3163352|P3|Overall Study|No usable sample|8
961183|NCT00699907|3163353|P2|Overall Study|No usable sample|9
961184|NCT00699907|3163354|P1|Overall Study|No usable sample|0
961185|NCT00699907|3163352|P3|Overall Study|Withdrawal by Subject|0
961186|NCT00699907|3163353|P2|Overall Study|Withdrawal by Subject|1
961187|NCT00699907|3163354|P1|Overall Study|Withdrawal by Subject|2
961188|NCT00699842|3163389|P3|Overall Study|Death|0
961189|NCT00699842|3163390|P2|Overall Study|Death|1
961190|NCT00699842|3163391|P1|Overall Study|Death|0
961191|NCT00699816|3163404|P2|Overall Study|Protocol Violation|3
961192|NCT00699816|3163405|P1|Overall Study|Protocol Violation|1
961193|NCT00699751|3163423|P2|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4
961194|NCT00699751|3163424|P1|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0
961195|NCT00699751|3163423|P2|Period 2:Switched From Placebo to Xofigo|Investigator Request|1
961196|NCT00699751|3163424|P1|Period 2:Switched From Placebo to Xofigo|Investigator Request|0
961197|NCT00699751|3163423|P2|Period 2:Switched From Placebo to Xofigo|Adverse Event|4
961198|NCT00699751|3163424|P1|Period 2:Switched From Placebo to Xofigo|Adverse Event|0
961199|NCT00699751|3163423|P2|Period 1: Without/Before Drug Switch|Adverse Event|63
961200|NCT00699751|3163424|P1|Period 1: Without/Before Drug Switch|Adverse Event|97
961201|NCT00699751|3163423|P2|Period 1: Without/Before Drug Switch|Other|20
961202|NCT00699751|3163424|P1|Period 1: Without/Before Drug Switch|Other|30
961203|NCT00699751|3163423|P2|Period 1: Without/Before Drug Switch|Subject Request|23
961204|NCT00699751|3163424|P1|Period 1: Without/Before Drug Switch|Subject Request|43
961205|NCT00699751|3163423|P2|Period 1: Without/Before Drug Switch|Death|29
961206|NCT00699751|3163424|P1|Period 1: Without/Before Drug Switch|Death|28
961207|NCT00699751|3163423|P2|Period 1: Without/Before Drug Switch|Investigator Request|27
961208|NCT00699751|3163424|P1|Period 1: Without/Before Drug Switch|Investigator Request|27
961209|NCT00699699|3163509|P1|Overall Study|Individual different reasons|21
961210|NCT00699699|3163509|P1|Overall Study|Adverse Event|36
961211|NCT00699660|3163518|P2|Overall Study|missing reports and recording failures|6
961212|NCT00699660|3163519|P1|Overall Study|missing reports and recording failures|10
961213|NCT00699660|3163518|P2|Overall Study|Lost to Follow-up|2
961214|NCT00699660|3163519|P1|Overall Study|Lost to Follow-up|4
961215|NCT00699608|3163531|P6|Second Intervention|Withdrawal by Subject|0
961216|NCT00699608|3163532|P5|Second Intervention|Withdrawal by Subject|0
961217|NCT00699608|3163533|P4|Second Intervention|Withdrawal by Subject|1
961218|NCT00699608|3163534|P3|Second Intervention|Withdrawal by Subject|0
961219|NCT00699608|3163535|P2|Second Intervention|Withdrawal by Subject|0
961220|NCT00699608|3163536|P1|Second Intervention|Withdrawal by Subject|0
961221|NCT00699608|3163531|P6|Second Intervention|Adverse Event|0
961222|NCT00699608|3163532|P5|Second Intervention|Adverse Event|0
961223|NCT00699608|3163533|P4|Second Intervention|Adverse Event|0
961224|NCT00699608|3163534|P3|Second Intervention|Adverse Event|1
961225|NCT00699608|3163535|P2|Second Intervention|Adverse Event|0
961226|NCT00699608|3163536|P1|Second Intervention|Adverse Event|0
961227|NCT00699608|3163531|P6|First Intervention|Protocol Violation|0
961228|NCT00699608|3163532|P5|First Intervention|Protocol Violation|1
961229|NCT00699608|3163533|P4|First Intervention|Protocol Violation|0
961230|NCT00699608|3163534|P3|First Intervention|Protocol Violation|0
961231|NCT00699608|3163535|P2|First Intervention|Protocol Violation|0
961232|NCT00699608|3163536|P1|First Intervention|Protocol Violation|0
961233|NCT00699608|3163531|P6|First Intervention|Withdrawal by Subject|0
961234|NCT00699608|3163532|P5|First Intervention|Withdrawal by Subject|0
961235|NCT00699608|3163533|P4|First Intervention|Withdrawal by Subject|0
961236|NCT00699608|3163534|P3|First Intervention|Withdrawal by Subject|1
961237|NCT00699608|3163535|P2|First Intervention|Withdrawal by Subject|0
961238|NCT00699608|3163536|P1|First Intervention|Withdrawal by Subject|0
961239|NCT00699582|3163589|P3|Overall Study|Randomized, Not Treated|0
961240|NCT00699582|3163590|P2|Overall Study|Randomized, Not Treated|1
961241|NCT00699582|3163591|P1|Overall Study|Randomized, Not Treated|2
961242|NCT00699582|3163589|P3|Overall Study|Administrative/Other|0
961243|NCT00699582|3163590|P2|Overall Study|Administrative/Other|3
961244|NCT00699582|3163591|P1|Overall Study|Administrative/Other|4
961245|NCT00699582|3163589|P3|Overall Study|Progressive Disease|0
961246|NCT00699582|3163590|P2|Overall Study|Progressive Disease|0
961247|NCT00699582|3163591|P1|Overall Study|Progressive Disease|1
961248|NCT00699582|3163589|P3|Overall Study|Lack of Efficacy|1
961249|NCT00699582|3163590|P2|Overall Study|Lack of Efficacy|0
961250|NCT00699582|3163591|P1|Overall Study|Lack of Efficacy|1
961251|NCT00699582|3163589|P3|Overall Study|Withdrawal by Subject|4
961252|NCT00699582|3163590|P2|Overall Study|Withdrawal by Subject|7
961253|NCT00699582|3163591|P1|Overall Study|Withdrawal by Subject|6
961254|NCT00699582|3163589|P3|Overall Study|Adverse Event|23
961255|NCT00699582|3163590|P2|Overall Study|Adverse Event|11
961256|NCT00699582|3163591|P1|Overall Study|Adverse Event|4
961257|NCT00699374|3163695|P2|Overall Study|Died 28 days after last dose|9
961258|NCT00699374|3163696|P1|Overall Study|Died 28 days after last dose|5
961259|NCT00699374|3163695|P2|Overall Study|Randomized but not treated|2
961260|NCT00699374|3163696|P1|Overall Study|Randomized but not treated|4
961261|NCT00699374|3163695|P2|Overall Study|Study terminated by sponsor|28
961262|NCT00699374|3163696|P1|Overall Study|Study terminated by sponsor|13
961263|NCT00699374|3163695|P2|Overall Study|Protocol Violation|6
961264|NCT00699374|3163696|P1|Overall Study|Protocol Violation|2
961265|NCT00699374|3163695|P2|Overall Study|Other|15
961266|NCT00699374|3163696|P1|Overall Study|Other|18
961267|NCT00699374|3163695|P2|Overall Study|Objective progression or relapse|277
961268|NCT00699374|3163696|P1|Overall Study|Objective progression or relapse|281
961269|NCT00699374|3163695|P2|Overall Study|Withdrawal by Subject|44
961270|NCT00699374|3163696|P1|Overall Study|Withdrawal by Subject|34
961271|NCT00699374|3163695|P2|Overall Study|Lost to Follow-up|5
961272|NCT00699374|3163696|P1|Overall Study|Lost to Follow-up|3
961273|NCT00699374|3163695|P2|Overall Study|Global deterioration of health status|8
961274|NCT00699374|3163696|P1|Overall Study|Global deterioration of health status|7
961275|NCT00699374|3163695|P2|Overall Study|Adverse Event|67
961276|NCT00699374|3163696|P1|Overall Study|Adverse Event|70
961277|NCT00699374|3163695|P2|Overall Study|Death|83
961278|NCT00699374|3163696|P1|Overall Study|Death|93
961279|NCT00699348|3163708|P1|Overall Study|Other|5
961280|NCT00699348|3163708|P1|Overall Study|Renal transplantation|10
961281|NCT00699348|3163708|P1|Overall Study|Blood transfusion|24
961282|NCT00699348|3163708|P1|Overall Study|Failure to return|1
961283|NCT00699348|3163708|P1|Overall Study|Lack of Efficacy|8
961284|NCT00699348|3163708|P1|Overall Study|Protocol Violation|10
961285|NCT00699348|3163708|P1|Overall Study|Withdrawal by Subject|11
961286|NCT00699348|3163708|P1|Overall Study|Adverse Event|15
961287|NCT00699348|3163708|P1|Overall Study|Death|6
961288|NCT00699335|3163717|P1|Overall Study|Missing data|52
961289|NCT00699335|3163717|P1|Overall Study|Combination of multiple reasons|176
961290|NCT00699283|3163750|P2|Overall Study|AE of unknown type|0
961291|NCT00699283|3163751|P1|Overall Study|AE of unknown type|1
961292|NCT00699283|3163750|P2|Overall Study|AE, non-serious non-fatal|1
961293|NCT00699283|3163751|P1|Overall Study|AE, non-serious non-fatal|8
961294|NCT00699283|3163750|P2|Overall Study|SAE, non-fatal|1
961295|NCT00699283|3163751|P1|Overall Study|SAE, non-fatal|1
961296|NCT00699283|3163750|P2|Overall Study|Other Reason|1
961297|NCT00699283|3163751|P1|Overall Study|Other Reason|5
961298|NCT00699283|3163750|P2|Overall Study|Withdrawal by Subject|0
961299|NCT00699283|3163751|P1|Overall Study|Withdrawal by Subject|1
961300|NCT00699283|3163750|P2|Overall Study|Lost to Follow-up|0
961301|NCT00699283|3163751|P1|Overall Study|Lost to Follow-up|2
961302|NCT00699283|3163750|P2|Overall Study|Lack of Efficacy|5
961303|NCT00699283|3163751|P1|Overall Study|Lack of Efficacy|15
961304|NCT00699192|3163764|P3|Overall Study|Protocol Violation|0
961305|NCT00699192|3163765|P2|Overall Study|Protocol Violation|2
961306|NCT00699192|3163766|P1|Overall Study|Protocol Violation|2
961307|NCT00699192|3163764|P3|Overall Study|Administrative problems|1
961308|NCT00699192|3163765|P2|Overall Study|Administrative problems|3
961309|NCT00699192|3163766|P1|Overall Study|Administrative problems|1
961310|NCT00699192|3163764|P3|Overall Study|Withdrawal by Subject|4
961311|NCT00699192|3163765|P2|Overall Study|Withdrawal by Subject|2
961312|NCT00699192|3163766|P1|Overall Study|Withdrawal by Subject|3
961313|NCT00699192|3163764|P3|Overall Study|Lack of Efficacy|1
961314|NCT00699192|3163765|P2|Overall Study|Lack of Efficacy|0
961315|NCT00699192|3163766|P1|Overall Study|Lack of Efficacy|0
961316|NCT00699192|3163764|P3|Overall Study|Abnormal test procedure result(s)|1
961317|NCT00699192|3163765|P2|Overall Study|Abnormal test procedure result(s)|0
961318|NCT00699192|3163766|P1|Overall Study|Abnormal test procedure result(s)|0
961319|NCT00699192|3163764|P3|Overall Study|Adverse Event|3
961320|NCT00699192|3163765|P2|Overall Study|Adverse Event|4
961321|NCT00699192|3163766|P1|Overall Study|Adverse Event|9
961322|NCT00699192|3163764|P3|Overall Study|Missing|1
961323|NCT00699192|3163765|P2|Overall Study|Missing|1
961324|NCT00699192|3163766|P1|Overall Study|Missing|1
961325|NCT00699153|3163788|P2|Overall Study|Travel Problem|0
961326|NCT00699153|3163789|P1|Overall Study|Travel Problem|1
961327|NCT00699153|3163788|P2|Overall Study|Protocol Violation|0
961328|NCT00699153|3163789|P1|Overall Study|Protocol Violation|1
961329|NCT00699153|3163788|P2|Overall Study|Adverse Event|2
961330|NCT00699153|3163789|P1|Overall Study|Adverse Event|0
961331|NCT00699153|3163788|P2|Overall Study|Lost to Follow-up|0
961332|NCT00699153|3163789|P1|Overall Study|Lost to Follow-up|1
961333|NCT00698932|3163824|P2|Overall Study|Death|0
961334|NCT00698932|3163825|P1|Overall Study|Death|1
961335|NCT00698932|3163824|P2|Overall Study|Safety reasons|2
961336|NCT00698932|3163825|P1|Overall Study|Safety reasons|0
961337|NCT00698932|3163824|P2|Overall Study|Severe non-compliance to protocol|2
961338|NCT00698932|3163825|P1|Overall Study|Severe non-compliance to protocol|1
961339|NCT00698932|3163824|P2|Overall Study|Lost to Follow-up|1
961340|NCT00698932|3163825|P1|Overall Study|Lost to Follow-up|6
961341|NCT00698932|3163824|P2|Overall Study|Withdrawal by Subject|23
961342|NCT00698932|3163825|P1|Overall Study|Withdrawal by Subject|11
961343|NCT00698932|3163824|P2|Overall Study|Study specific discontinuation criteria|4
961344|NCT00698932|3163825|P1|Overall Study|Study specific discontinuation criteria|3
961345|NCT00698932|3163824|P2|Overall Study|Incorrect enrollment|2
961346|NCT00698932|3163825|P1|Overall Study|Incorrect enrollment|0
961347|NCT00698932|3163824|P2|Overall Study|Adverse Event|2
961348|NCT00698932|3163825|P1|Overall Study|Adverse Event|0
961349|NCT00698841|3163851|P1|Overall Study|Other|2
961350|NCT00698841|3163851|P1|Overall Study|Study drug toxicity|2
961351|NCT00698841|3163851|P1|Overall Study|Failure to meet eligibility criteria|2
961352|NCT00698841|3163851|P1|Overall Study|Disease progression|7
961353|NCT00698841|3163851|P1|Overall Study|Adverse Event|3
961354|NCT00698841|3163851|P1|Overall Study|Withdrawal by Subject|2
961355|NCT00698815|3163865|P3|Overall Study|Did not receive protocol treatment|2
961356|NCT00698815|3163866|P2|Overall Study|Did not receive protocol treatment|2
961357|NCT00698815|3163867|P1|Overall Study|Did not receive protocol treatment|1
961358|NCT00698815|3163865|P3|Overall Study|MD discretion|2
961359|NCT00698815|3163866|P2|Overall Study|MD discretion|7
961360|NCT00698815|3163867|P1|Overall Study|MD discretion|2
961361|NCT00698815|3163865|P3|Overall Study|Withdrawal by Subject|2
961362|NCT00698815|3163866|P2|Overall Study|Withdrawal by Subject|3
961363|NCT00698815|3163867|P1|Overall Study|Withdrawal by Subject|6
961364|NCT00698815|3163865|P3|Overall Study|Death|4
961365|NCT00698815|3163866|P2|Overall Study|Death|2
961366|NCT00698815|3163867|P1|Overall Study|Death|1
961367|NCT00698685|3163884|P1|Overall Study|Off study pre transplant by clinic MD|1
961368|NCT00698685|3163884|P1|Overall Study|Sister withdrew as donor|1
961369|NCT00698646|3163892|P3|Overall Study|Administrative problems|1
961370|NCT00698646|3163893|P2|Overall Study|Administrative problems|0
961371|NCT00698646|3163894|P1|Overall Study|Administrative problems|1
961372|NCT00698646|3163892|P3|Overall Study|Lost to Follow-up|2
961373|NCT00698646|3163893|P2|Overall Study|Lost to Follow-up|0
961374|NCT00698646|3163894|P1|Overall Study|Lost to Follow-up|0
961375|NCT00698646|3163892|P3|Overall Study|Withdrawal by Subject|8
961376|NCT00698646|3163893|P2|Overall Study|Withdrawal by Subject|11
961377|NCT00698646|3163894|P1|Overall Study|Withdrawal by Subject|10
961378|NCT00698646|3163892|P3|Overall Study|Protocol Deviation|3
961379|NCT00698646|3163893|P2|Overall Study|Protocol Deviation|2
961380|NCT00698646|3163894|P1|Overall Study|Protocol Deviation|6
961381|NCT00698646|3163892|P3|Overall Study|Unsatisfactory Therapeutic Effect|7
961382|NCT00698646|3163893|P2|Overall Study|Unsatisfactory Therapeutic Effect|11
961383|NCT00698646|3163894|P1|Overall Study|Unsatisfactory Therapeutic Effect|11
961384|NCT00698646|3163892|P3|Overall Study|Adverse Event|8
961385|NCT00698646|3163893|P2|Overall Study|Adverse Event|7
961386|NCT00698646|3163894|P1|Overall Study|Adverse Event|8
961387|NCT00698581|3163919|P2|Overall Study|AE of unknown type|0
961388|NCT00698581|3163920|P1|Overall Study|AE of unknown type|1
961389|NCT00698581|3163919|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
961390|NCT00698581|3163920|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
961391|NCT00698581|3163919|P2|Overall Study|AE, non-serious non-fatal|0
961392|NCT00698581|3163920|P1|Overall Study|AE, non-serious non-fatal|4
961393|NCT00698581|3163919|P2|Overall Study|SAE, non-fatal|0
961394|NCT00698581|3163920|P1|Overall Study|SAE, non-fatal|1
961395|NCT00698581|3163919|P2|Overall Study|Other reason|1
961396|NCT00698581|3163920|P1|Overall Study|Other reason|9
961397|NCT00698581|3163919|P2|Overall Study|Withdrawal by Subject|0
961398|NCT00698581|3163920|P1|Overall Study|Withdrawal by Subject|6
961399|NCT00698581|3163919|P2|Overall Study|Lack of Efficacy|11
961400|NCT00698581|3163920|P1|Overall Study|Lack of Efficacy|23
961401|NCT00698516|3163931|P1|Overall Study|Withdrawal by Subject|3
961402|NCT00698516|3163931|P1|Overall Study|Study Termination|2
961403|NCT00698451|3163949|P1|Overall Study|Disease progression|3
961404|NCT00698451|3163949|P1|Overall Study|Withdrawal by Subject|6
961405|NCT00698451|3163949|P1|Overall Study|Protocol Violation|6
961406|NCT00698451|3163949|P1|Overall Study|Physician Decision|2
961407|NCT00698451|3163949|P1|Overall Study|Adverse Event|22
961408|NCT00698204|3163956|P2|Overall Study|Withdrawal by Subject|0
961409|NCT00698204|3163957|P1|Overall Study|Withdrawal by Subject|1
961410|NCT00698009|3164017|P1|Overall Study|Withdrawal by Subject|1
961411|NCT00697827|3164023|P2|Overall Study|enrolled but not treated|1
961412|NCT00697827|3164024|P1|Overall Study|enrolled but not treated|2
961413|NCT00697788|3164051|P8|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
961414|NCT00697788|3164052|P7|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
961415|NCT00697788|3164053|P6|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
961416|NCT00697788|3164054|P5|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1
961417|NCT00697788|3164055|P4|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
961418|NCT00697788|3164056|P3|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
961419|NCT00697788|3164057|P2|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
961420|NCT00697788|3164058|P1|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
961421|NCT00697788|3164051|P8|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
961422|NCT00697788|3164052|P7|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
961423|NCT00697788|3164053|P6|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
961424|NCT00697788|3164054|P5|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
961425|NCT00697788|3164055|P4|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
961426|NCT00697788|3164056|P3|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
961427|NCT00697788|3164057|P2|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2
961428|NCT00697788|3164058|P1|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
961429|NCT00697619|3164113|P2|Overall Study|Adverse Event|6
961430|NCT00697619|3164114|P1|Overall Study|Adverse Event|4
961431|NCT00697619|3164113|P2|Overall Study|Lack of Efficacy|2
961432|NCT00697619|3164114|P1|Overall Study|Lack of Efficacy|2
961433|NCT00697593|3164120|P1|Overall Study|Suspension of the study by sponsor|12
961434|NCT00697593|3164120|P1|Overall Study|Lack of Efficacy|3
961435|NCT00697593|3164120|P1|Overall Study|Protocol Violation|1
961436|NCT00697593|3164120|P1|Overall Study|Adverse Event|3
961437|NCT00697515|3164164|P2|Second Intervention (Crossover Period)|Withdrawal by Subject|1
961438|NCT00697515|3164165|P1|Second Intervention (Crossover Period)|Withdrawal by Subject|1
961439|NCT00697515|3164164|P2|First Intervention (Crossover Period)|Withdrawal by Subject|1
961440|NCT00697515|3164165|P1|First Intervention (Crossover Period)|Withdrawal by Subject|2
961441|NCT00697515|3164164|P2|First Intervention (Crossover Period)|Adverse Event|2
961442|NCT00697515|3164165|P1|First Intervention (Crossover Period)|Adverse Event|0
961443|NCT00697515|3164164|P2|First Intervention (Crossover Period)|Natural disaster|9
961444|NCT00697515|3164165|P1|First Intervention (Crossover Period)|Natural disaster|8
961445|NCT00697515|3164164|P2|Dose Optimization Period|elevated QTc|0
961446|NCT00697515|3164165|P1|Dose Optimization Period|elevated QTc|1
961447|NCT00697515|3164164|P2|Dose Optimization Period|called to active duty|0
961448|NCT00697515|3164165|P1|Dose Optimization Period|called to active duty|1
961449|NCT00697515|3164164|P2|Dose Optimization Period|sponsor request|0
961450|NCT00697515|3164165|P1|Dose Optimization Period|sponsor request|2
961451|NCT00697515|3164164|P2|Dose Optimization Period|Lost to Follow-up|0
961452|NCT00697515|3164165|P1|Dose Optimization Period|Lost to Follow-up|2
961453|NCT00697515|3164164|P2|Dose Optimization Period|Withdrawal by Subject|0
961454|NCT00697515|3164165|P1|Dose Optimization Period|Withdrawal by Subject|5
961455|NCT00697515|3164164|P2|Dose Optimization Period|Adverse Event|0
961456|NCT00697515|3164165|P1|Dose Optimization Period|Adverse Event|4
961457|NCT00697463|3164193|P1|Overall Study|Withdrawal by Subject|1
961458|NCT00697255|3164199|P2|Stage 1b|Insufficient ovarian response|1
961459|NCT00697255|3164200|P1|Stage 1b|Insufficient ovarian response|0
961460|NCT00697255|3164199|P2|Stage 1b|Not growing of dominant follicle|1
961461|NCT00697255|3164200|P1|Stage 1b|Not growing of dominant follicle|0
961462|NCT00697255|3164199|P2|Stage 1a|Not growing of dominant follicle|0
961463|NCT00697255|3164200|P1|Stage 1a|Not growing of dominant follicle|1
961464|NCT00697255|3164199|P2|Stage 1a|Multifollicular growth|0
961465|NCT00697255|3164200|P1|Stage 1a|Multifollicular growth|1
961466|NCT00697255|3164199|P2|Stage 1a|Insufficient ovarian response|0
961467|NCT00697255|3164200|P1|Stage 1a|Insufficient ovarian response|1
961468|NCT00697112|3164251|P1|Overall Study|Did not meet inclusion criteria|1
961469|NCT00697112|3164251|P1|Overall Study|Lost to Follow-up|1
961470|NCT00697112|3164251|P1|Overall Study|Adverse Event|8
961471|NCT00697073|3164275|P1|Overall Study|non compliance and other|6
961472|NCT00697073|3164275|P1|Overall Study|Pregnancy|1
961473|NCT00697073|3164275|P1|Overall Study|Withdrawal by Subject|2
961474|NCT00696878|3164279|P1|Overall Study|Other reason (not specified)|55
961475|NCT00696878|3164279|P1|Overall Study|Trial stopped|32
961476|NCT00696878|3164279|P1|Overall Study|Pregnant prior to Treat Cycle 3|304
961477|NCT00696878|3164279|P1|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18
961478|NCT00696878|3164279|P1|Overall Study|Withdrawal by Subject|87
961479|NCT00696878|3164279|P1|Overall Study|Adverse Event|8
961480|NCT00696800|3164353|P2|Overall Study|Not treated|2
961481|NCT00696800|3164354|P1|Overall Study|Not treated|1
961482|NCT00696800|3164353|P2|Overall Study|Other Reasons|3
961483|NCT00696800|3164354|P1|Overall Study|Other Reasons|5
961484|NCT00696800|3164353|P2|Overall Study|No/too few/bad quality embryos|18
961485|NCT00696800|3164354|P1|Overall Study|No/too few/bad quality embryos|24
961486|NCT00696800|3164353|P2|Overall Study|No/abnormal fertilization|13
961487|NCT00696800|3164354|P1|Overall Study|No/abnormal fertilization|11
961488|NCT00696800|3164353|P2|Overall Study|No/too few/bad quality oocytes|3
961489|NCT00696800|3164354|P1|Overall Study|No/too few/bad quality oocytes|4
961490|NCT00696800|3164353|P2|Overall Study|Too high ovarian response|1
961491|NCT00696800|3164354|P1|Overall Study|Too high ovarian response|6
961492|NCT00696800|3164353|P2|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2
961493|NCT00696800|3164354|P1|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8
961494|NCT00696800|3164353|P2|Overall Study|Insufficient ovarian response|1
961495|NCT00696800|3164354|P1|Overall Study|Insufficient ovarian response|4
961496|NCT00696800|3164353|P2|Overall Study|Insufficient ovarian response on Day 8|1
961497|NCT00696800|3164354|P1|Overall Study|Insufficient ovarian response on Day 8|4
961498|NCT00696800|3164353|P2|Overall Study|Insufficient compliance with medication|1
961499|NCT00696800|3164354|P1|Overall Study|Insufficient compliance with medication|2
961500|NCT00696800|3164353|P2|Overall Study|Adverse Event|3
961501|NCT00696800|3164354|P1|Overall Study|Adverse Event|16
961502|NCT00696787|3164407|P3|Overall Study|Failed to return|1
961503|NCT00696787|3164408|P2|Overall Study|Failed to return|3
961504|NCT00696787|3164409|P1|Overall Study|Failed to return|1
961505|NCT00696787|3164407|P3|Overall Study|Withdrawal by Subject|2
961506|NCT00696787|3164408|P2|Overall Study|Withdrawal by Subject|3
961507|NCT00696787|3164409|P1|Overall Study|Withdrawal by Subject|0
961508|NCT00696787|3164407|P3|Overall Study|Lost to Follow-up|3
961509|NCT00696787|3164408|P2|Overall Study|Lost to Follow-up|0
961510|NCT00696787|3164409|P1|Overall Study|Lost to Follow-up|4
961511|NCT00696787|3164407|P3|Overall Study|Lack of Efficacy|0
961512|NCT00696787|3164408|P2|Overall Study|Lack of Efficacy|1
961513|NCT00696787|3164409|P1|Overall Study|Lack of Efficacy|0
961514|NCT00696787|3164407|P3|Overall Study|Discontinuation by Sponsor|14
961515|NCT00696787|3164408|P2|Overall Study|Discontinuation by Sponsor|13
961516|NCT00696787|3164409|P1|Overall Study|Discontinuation by Sponsor|9
961517|NCT00696787|3164407|P3|Overall Study|Adverse Event|6
961518|NCT00696787|3164408|P2|Overall Study|Adverse Event|0
961519|NCT00696787|3164409|P1|Overall Study|Adverse Event|1
961520|NCT00696774|3164423|P3|Period III|Lack of Efficacy|0
961521|NCT00696774|3164424|P2|Period III|Lack of Efficacy|2
961522|NCT00696774|3164425|P1|Period III|Lack of Efficacy|0
961523|NCT00696774|3164423|P3|Period III|Sponsor Decision|0
961524|NCT00696774|3164424|P2|Period III|Sponsor Decision|0
961525|NCT00696774|3164425|P1|Period III|Sponsor Decision|2
961526|NCT00696774|3164423|P3|Period III|Withdrawal by Subject|0
961527|NCT00696774|3164424|P2|Period III|Withdrawal by Subject|2
961528|NCT00696774|3164425|P1|Period III|Withdrawal by Subject|1
961529|NCT00696774|3164423|P3|Period III|Protocol Violation|0
961530|NCT00696774|3164424|P2|Period III|Protocol Violation|1
961531|NCT00696774|3164425|P1|Period III|Protocol Violation|1
961532|NCT00696774|3164423|P3|Period III|Lost to Follow-up|0
961533|NCT00696774|3164424|P2|Period III|Lost to Follow-up|1
961534|NCT00696774|3164425|P1|Period III|Lost to Follow-up|2
961535|NCT00696774|3164423|P3|Period III|Adverse Event|0
961536|NCT00696774|3164424|P2|Period III|Adverse Event|1
961537|NCT00696774|3164425|P1|Period III|Adverse Event|1
961538|NCT00696774|3164423|P3|Period II|Lack of Efficacy|2
961539|NCT00696774|3164424|P2|Period II|Lack of Efficacy|0
961540|NCT00696774|3164425|P1|Period II|Lack of Efficacy|0
961541|NCT00696774|3164423|P3|Period II|Sponsor Decision|0
961542|NCT00696774|3164424|P2|Period II|Sponsor Decision|0
961543|NCT00696774|3164425|P1|Period II|Sponsor Decision|0
961544|NCT00696774|3164423|P3|Period II|Withdrawal by Subject|4
961545|NCT00696774|3164424|P2|Period II|Withdrawal by Subject|0
961546|NCT00696774|3164425|P1|Period II|Withdrawal by Subject|0
961547|NCT00696774|3164423|P3|Period II|Protocol Violation|11
961548|NCT00696774|3164424|P2|Period II|Protocol Violation|0
961549|NCT00696774|3164425|P1|Period II|Protocol Violation|0
961550|NCT00696774|3164423|P3|Period II|Lost to Follow-up|4
961551|NCT00696774|3164424|P2|Period II|Lost to Follow-up|0
961552|NCT00696774|3164425|P1|Period II|Lost to Follow-up|0
961553|NCT00696774|3164423|P3|Period II|Adverse Event|15
961554|NCT00696774|3164424|P2|Period II|Adverse Event|0
961555|NCT00696774|3164425|P1|Period II|Adverse Event|0
961556|NCT00696696|3164480|P1|Overall Study|Death|3
961557|NCT00696696|3164480|P1|Overall Study|Physician Decision|2
961558|NCT00696696|3164480|P1|Overall Study|Withdrawal by Subject|8
961559|NCT00696696|3164480|P1|Overall Study|Adverse Event|5
961560|NCT00696657|3164495|P9|Overall Study|Adverse Event|5
961561|NCT00696657|3164496|P8|Overall Study|Adverse Event|2
961562|NCT00696657|3164497|P7|Overall Study|Adverse Event|14
961563|NCT00696657|3164498|P6|Overall Study|Adverse Event|9
961564|NCT00696657|3164499|P5|Overall Study|Adverse Event|6
961565|NCT00696657|3164500|P4|Overall Study|Adverse Event|7
961566|NCT00696657|3164501|P3|Overall Study|Adverse Event|3
961567|NCT00696657|3164502|P2|Overall Study|Adverse Event|0
961568|NCT00696657|3164503|P1|Overall Study|Adverse Event|0
961569|NCT00696657|3164495|P9|Overall Study|Unclassified|1
961570|NCT00696657|3164496|P8|Overall Study|Unclassified|0
961571|NCT00696657|3164497|P7|Overall Study|Unclassified|0
961572|NCT00696657|3164498|P6|Overall Study|Unclassified|2
961573|NCT00696657|3164499|P5|Overall Study|Unclassified|4
961574|NCT00696657|3164500|P4|Overall Study|Unclassified|2
961575|NCT00696657|3164501|P3|Overall Study|Unclassified|3
961576|NCT00696657|3164502|P2|Overall Study|Unclassified|1
961577|NCT00696657|3164503|P1|Overall Study|Unclassified|0
961578|NCT00696657|3164495|P9|Overall Study|Withdrawal criteria|2
961579|NCT00696657|3164496|P8|Overall Study|Withdrawal criteria|1
961580|NCT00696657|3164497|P7|Overall Study|Withdrawal criteria|1
961581|NCT00696657|3164498|P6|Overall Study|Withdrawal criteria|0
961582|NCT00696657|3164499|P5|Overall Study|Withdrawal criteria|0
961583|NCT00696657|3164500|P4|Overall Study|Withdrawal criteria|2
961584|NCT00696657|3164501|P3|Overall Study|Withdrawal criteria|2
961585|NCT00696657|3164502|P2|Overall Study|Withdrawal criteria|3
961586|NCT00696657|3164503|P1|Overall Study|Withdrawal criteria|1
961587|NCT00696657|3164495|P9|Overall Study|Lack of Efficacy|0
961588|NCT00696657|3164496|P8|Overall Study|Lack of Efficacy|0
961589|NCT00696657|3164497|P7|Overall Study|Lack of Efficacy|0
961590|NCT00696657|3164498|P6|Overall Study|Lack of Efficacy|0
961591|NCT00696657|3164499|P5|Overall Study|Lack of Efficacy|0
961592|NCT00696657|3164500|P4|Overall Study|Lack of Efficacy|0
961593|NCT00696657|3164501|P3|Overall Study|Lack of Efficacy|0
961594|NCT00696657|3164502|P2|Overall Study|Lack of Efficacy|1
961595|NCT00696657|3164503|P1|Overall Study|Lack of Efficacy|0
961596|NCT00696657|3164495|P9|Overall Study|Protocol Violation|1
961597|NCT00696657|3164496|P8|Overall Study|Protocol Violation|0
961598|NCT00696657|3164497|P7|Overall Study|Protocol Violation|0
961599|NCT00696657|3164498|P6|Overall Study|Protocol Violation|1
961600|NCT00696657|3164499|P5|Overall Study|Protocol Violation|0
961601|NCT00696657|3164500|P4|Overall Study|Protocol Violation|0
961602|NCT00696657|3164501|P3|Overall Study|Protocol Violation|0
961603|NCT00696657|3164502|P2|Overall Study|Protocol Violation|0
961604|NCT00696657|3164503|P1|Overall Study|Protocol Violation|0
961605|NCT00696436|3164872|P5|Overall Study|Missing|0
961606|NCT00696436|3164873|P4|Overall Study|Missing|0
961607|NCT00696436|3164874|P3|Overall Study|Missing|1
961608|NCT00696436|3164875|P2|Overall Study|Missing|1
961609|NCT00696436|3164876|P1|Overall Study|Missing|0
961610|NCT00696436|3164872|P5|Overall Study|Administrative Decision|0
961611|NCT00696436|3164873|P4|Overall Study|Administrative Decision|0
961612|NCT00696436|3164874|P3|Overall Study|Administrative Decision|0
961613|NCT00696436|3164875|P2|Overall Study|Administrative Decision|0
961614|NCT00696436|3164876|P1|Overall Study|Administrative Decision|1
961615|NCT00696436|3164872|P5|Overall Study|Participant Non-compliance|0
961616|NCT00696436|3164873|P4|Overall Study|Participant Non-compliance|2
961617|NCT00696436|3164874|P3|Overall Study|Participant Non-compliance|1
961618|NCT00696436|3164875|P2|Overall Study|Participant Non-compliance|0
961619|NCT00696436|3164876|P1|Overall Study|Participant Non-compliance|0
961620|NCT00696436|3164872|P5|Overall Study|Administrative Error|0
961621|NCT00696436|3164873|P4|Overall Study|Administrative Error|0
961622|NCT00696436|3164874|P3|Overall Study|Administrative Error|2
961623|NCT00696436|3164875|P2|Overall Study|Administrative Error|0
961624|NCT00696436|3164876|P1|Overall Study|Administrative Error|2
961625|NCT00696436|3164872|P5|Overall Study|Participant Unavailability|0
961626|NCT00696436|3164873|P4|Overall Study|Participant Unavailability|1
961627|NCT00696436|3164874|P3|Overall Study|Participant Unavailability|2
961628|NCT00696436|3164875|P2|Overall Study|Participant Unavailability|0
961629|NCT00696436|3164876|P1|Overall Study|Participant Unavailability|2
961630|NCT00696436|3164872|P5|Overall Study|Lack of Efficacy|4
961631|NCT00696436|3164873|P4|Overall Study|Lack of Efficacy|2
961632|NCT00696436|3164874|P3|Overall Study|Lack of Efficacy|5
961633|NCT00696436|3164875|P2|Overall Study|Lack of Efficacy|1
961634|NCT00696436|3164876|P1|Overall Study|Lack of Efficacy|3
961635|NCT00696436|3164872|P5|Overall Study|Withdrawal by Subject|1
961636|NCT00696436|3164873|P4|Overall Study|Withdrawal by Subject|7
961637|NCT00696436|3164874|P3|Overall Study|Withdrawal by Subject|5
961638|NCT00696436|3164875|P2|Overall Study|Withdrawal by Subject|11
961639|NCT00696436|3164876|P1|Overall Study|Withdrawal by Subject|4
961640|NCT00696436|3164872|P5|Overall Study|Lost to Follow-up|3
961641|NCT00696436|3164873|P4|Overall Study|Lost to Follow-up|4
961642|NCT00696436|3164874|P3|Overall Study|Lost to Follow-up|2
961643|NCT00696436|3164875|P2|Overall Study|Lost to Follow-up|6
961644|NCT00696436|3164876|P1|Overall Study|Lost to Follow-up|1
961645|NCT00696436|3164872|P5|Overall Study|Protocol Violation|1
961646|NCT00696436|3164873|P4|Overall Study|Protocol Violation|0
961647|NCT00696436|3164874|P3|Overall Study|Protocol Violation|2
961648|NCT00696436|3164875|P2|Overall Study|Protocol Violation|2
961649|NCT00696436|3164876|P1|Overall Study|Protocol Violation|3
961650|NCT00696436|3164872|P5|Overall Study|Adverse Event|4
961651|NCT00696436|3164873|P4|Overall Study|Adverse Event|6
961652|NCT00696436|3164874|P3|Overall Study|Adverse Event|8
961653|NCT00696436|3164875|P2|Overall Study|Adverse Event|9
961654|NCT00696436|3164876|P1|Overall Study|Adverse Event|7
961655|NCT00696423|3164960|P2|Overall Study|Lost to Follow-up|5
961656|NCT00696423|3164961|P1|Overall Study|Lost to Follow-up|0
961657|NCT00696410|3164993|P2|Overall Study|Physician Decision|0
961658|NCT00696410|3164994|P1|Overall Study|Physician Decision|3
961659|NCT00696410|3164993|P2|Overall Study|Withdrawal by Subject|0
961660|NCT00696410|3164994|P1|Overall Study|Withdrawal by Subject|8
961661|NCT00696410|3164993|P2|Overall Study|Lost to Follow-up|0
961662|NCT00696410|3164994|P1|Overall Study|Lost to Follow-up|2
961663|NCT00696384|3165008|P3|Double Blind Phase|Physician Decision|0
961664|NCT00696384|3165009|P2|Double Blind Phase|Physician Decision|2
961665|NCT00696384|3165010|P1|Double Blind Phase|Physician Decision|0
961666|NCT00696384|3165008|P3|Double Blind Phase|Lack of Efficacy|0
961667|NCT00696384|3165009|P2|Double Blind Phase|Lack of Efficacy|1
961668|NCT00696384|3165010|P1|Double Blind Phase|Lack of Efficacy|0
961669|NCT00696384|3165008|P3|Double Blind Phase|Withdrawal by Subject|3
961670|NCT00696384|3165009|P2|Double Blind Phase|Withdrawal by Subject|4
961671|NCT00696384|3165010|P1|Double Blind Phase|Withdrawal by Subject|0
961672|NCT00696384|3165008|P3|Double Blind Phase|Lost to Follow-up|1
961673|NCT00696384|3165009|P2|Double Blind Phase|Lost to Follow-up|2
961674|NCT00696384|3165010|P1|Double Blind Phase|Lost to Follow-up|0
961675|NCT00696384|3165008|P3|Double Blind Phase|Adverse Event|2
961676|NCT00696384|3165009|P2|Double Blind Phase|Adverse Event|2
961677|NCT00696384|3165010|P1|Double Blind Phase|Adverse Event|0
961678|NCT00696384|3165008|P3|Open Label Phase|Physician Decision|0
961679|NCT00696384|3165009|P2|Open Label Phase|Physician Decision|0
961680|NCT00696384|3165010|P1|Open Label Phase|Physician Decision|4
961681|NCT00696384|3165008|P3|Open Label Phase|Lack of Efficacy|0
961682|NCT00696384|3165009|P2|Open Label Phase|Lack of Efficacy|0
961683|NCT00696384|3165010|P1|Open Label Phase|Lack of Efficacy|3
961684|NCT00696384|3165008|P3|Open Label Phase|Other|0
961685|NCT00696384|3165009|P2|Open Label Phase|Other|0
961686|NCT00696384|3165010|P1|Open Label Phase|Other|6
961687|NCT00696384|3165008|P3|Open Label Phase|Withdrawal by Subject|0
961688|NCT00696384|3165009|P2|Open Label Phase|Withdrawal by Subject|0
961689|NCT00696384|3165010|P1|Open Label Phase|Withdrawal by Subject|37
961690|NCT00696384|3165008|P3|Open Label Phase|Lost to Follow-up|0
961691|NCT00696384|3165009|P2|Open Label Phase|Lost to Follow-up|0
961692|NCT00696384|3165010|P1|Open Label Phase|Lost to Follow-up|24
961693|NCT00696384|3165008|P3|Open Label Phase|Protocol Violation|0
961694|NCT00696384|3165009|P2|Open Label Phase|Protocol Violation|0
961695|NCT00696384|3165010|P1|Open Label Phase|Protocol Violation|18
961696|NCT00696384|3165008|P3|Open Label Phase|Adverse Event|0
961697|NCT00696384|3165009|P2|Open Label Phase|Adverse Event|0
961698|NCT00696384|3165010|P1|Open Label Phase|Adverse Event|27
961699|NCT00696241|3165034|P5|Overall Study|Other|1
961700|NCT00696241|3165035|P4|Overall Study|Other|2
961701|NCT00696241|3165036|P3|Overall Study|Other|5
961702|NCT00696241|3165037|P2|Overall Study|Other|1
961703|NCT00696241|3165038|P1|Overall Study|Other|6
961704|NCT00696241|3165034|P5|Overall Study|Lack of Efficacy|3
961705|NCT00696241|3165035|P4|Overall Study|Lack of Efficacy|5
961706|NCT00696241|3165036|P3|Overall Study|Lack of Efficacy|4
961707|NCT00696241|3165037|P2|Overall Study|Lack of Efficacy|5
961708|NCT00696241|3165038|P1|Overall Study|Lack of Efficacy|1
961709|NCT00696241|3165034|P5|Overall Study|Withdrawal by Subject|0
961710|NCT00696241|3165035|P4|Overall Study|Withdrawal by Subject|1
961711|NCT00696241|3165036|P3|Overall Study|Withdrawal by Subject|6
961712|NCT00696241|3165037|P2|Overall Study|Withdrawal by Subject|8
961713|NCT00696241|3165038|P1|Overall Study|Withdrawal by Subject|4
961714|NCT00696241|3165034|P5|Overall Study|Lost to Follow-up|0
961715|NCT00696241|3165035|P4|Overall Study|Lost to Follow-up|2
961716|NCT00696241|3165036|P3|Overall Study|Lost to Follow-up|1
961717|NCT00696241|3165037|P2|Overall Study|Lost to Follow-up|4
961718|NCT00696241|3165038|P1|Overall Study|Lost to Follow-up|1
961719|NCT00696241|3165034|P5|Overall Study|Protocol Violation|3
961720|NCT00696241|3165035|P4|Overall Study|Protocol Violation|0
961721|NCT00696241|3165036|P3|Overall Study|Protocol Violation|2
961722|NCT00696241|3165037|P2|Overall Study|Protocol Violation|1
961723|NCT00696241|3165038|P1|Overall Study|Protocol Violation|1
961724|NCT00696241|3165034|P5|Overall Study|Adverse Event|5
961725|NCT00696241|3165035|P4|Overall Study|Adverse Event|4
961726|NCT00696241|3165036|P3|Overall Study|Adverse Event|6
961727|NCT00696241|3165037|P2|Overall Study|Adverse Event|3
961728|NCT00696241|3165038|P1|Overall Study|Adverse Event|11
961729|NCT00696072|3165122|P2|Overall Study|Non-specified|2
961730|NCT00696072|3165123|P1|Overall Study|Non-specified|1
961731|NCT00696072|3165122|P2|Overall Study|Disease Progression|30
961732|NCT00696072|3165123|P1|Overall Study|Disease Progression|32
961733|NCT00696072|3165122|P2|Overall Study|Sponsor Request|1
961734|NCT00696072|3165123|P1|Overall Study|Sponsor Request|0
961735|NCT00696072|3165122|P2|Overall Study|Investigator Request|4
961736|NCT00696072|3165123|P1|Overall Study|Investigator Request|1
961737|NCT00696072|3165122|P2|Overall Study|Patient Request|7
961738|NCT00696072|3165123|P1|Overall Study|Patient Request|3
961739|NCT00696072|3165122|P2|Overall Study|Adverse Event|6
961740|NCT00696072|3165123|P1|Overall Study|Adverse Event|10
961741|NCT00696072|3165122|P2|Overall Study|continuing active treatment|13
961742|NCT00696072|3165123|P1|Overall Study|continuing active treatment|10
961743|NCT00696020|3165144|P4|Overall Study|Other not stated above|1
961744|NCT00696020|3165145|P3|Overall Study|Other not stated above|1
961745|NCT00696020|3165146|P2|Overall Study|Other not stated above|0
961746|NCT00696020|3165147|P1|Overall Study|Other not stated above|0
961747|NCT00696020|3165144|P4|Overall Study|Withdrawal by Subject|1
961748|NCT00696020|3165145|P3|Overall Study|Withdrawal by Subject|0
961749|NCT00696020|3165146|P2|Overall Study|Withdrawal by Subject|1
961750|NCT00696020|3165147|P1|Overall Study|Withdrawal by Subject|0
961751|NCT00696020|3165144|P4|Overall Study|Protocol Violation|1
961752|NCT00696020|3165145|P3|Overall Study|Protocol Violation|0
961753|NCT00696020|3165146|P2|Overall Study|Protocol Violation|0
961754|NCT00696020|3165147|P1|Overall Study|Protocol Violation|0
961755|NCT00696020|3165144|P4|Overall Study|Lack of Efficacy|0
961756|NCT00696020|3165145|P3|Overall Study|Lack of Efficacy|0
961757|NCT00696020|3165146|P2|Overall Study|Lack of Efficacy|0
961758|NCT00696020|3165147|P1|Overall Study|Lack of Efficacy|1
961759|NCT00696020|3165144|P4|Overall Study|Adverse Event|1
961760|NCT00696020|3165145|P3|Overall Study|Adverse Event|2
961761|NCT00696020|3165146|P2|Overall Study|Adverse Event|1
961762|NCT00696020|3165147|P1|Overall Study|Adverse Event|3
961763|NCT00695955|3165255|P1|Cohort 2|Other|5
961764|NCT00695955|3165255|P1|Cohort 2|Lack of Efficacy|4
961765|NCT00695955|3165255|P1|Cohort 2|Withdrawal by Subject|28
961766|NCT00695955|3165255|P1|Cohort 2|Lost to Follow-up|38
961767|NCT00695955|3165255|P1|Cohort 2|Protocol Violation|5
961768|NCT00695955|3165255|P1|Cohort 2|Adverse Event|24
961769|NCT00695955|3165255|P1|Cohort 1|Other|16
961770|NCT00695955|3165255|P1|Cohort 1|Lack of Efficacy|3
961771|NCT00695955|3165255|P1|Cohort 1|Withdrawal by Subject|25
961772|NCT00695955|3165255|P1|Cohort 1|Lost to Follow-up|30
961773|NCT00695955|3165255|P1|Cohort 1|Protocol Violation|2
961774|NCT00695955|3165255|P1|Cohort 1|Adverse Event|26
961775|NCT00695903|3165267|P2|Had Test of Cure (TOC) Assessment|Adverse Event|1
961776|NCT00695903|3165268|P1|Had Test of Cure (TOC) Assessment|Adverse Event|0
961777|NCT00695903|3165267|P2|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0
961778|NCT00695903|3165268|P1|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1
961779|NCT00695903|3165267|P2|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0
961780|NCT00695903|3165268|P1|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1
961781|NCT00695903|3165267|P2|Had End of Therapy (EOT) Assessment|Protocol Violation|2
961782|NCT00695903|3165268|P1|Had End of Therapy (EOT) Assessment|Protocol Violation|1
961783|NCT00695903|3165267|P2|Had End of Therapy (EOT) Assessment|Physician Decision|1
961784|NCT00695903|3165268|P1|Had End of Therapy (EOT) Assessment|Physician Decision|0
961785|NCT00695903|3165267|P2|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
961786|NCT00695903|3165268|P1|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
961787|NCT00695903|3165267|P2|Had End of Therapy (EOT) Assessment|Adverse Event|0
961788|NCT00695903|3165268|P1|Had End of Therapy (EOT) Assessment|Adverse Event|1
961789|NCT00695903|3165267|P2|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
961790|NCT00695903|3165268|P1|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
961791|NCT00695903|3165267|P2|Had End of Therapy (EOT) Assessment|Randomized not treated|2
961792|NCT00695903|3165268|P1|Had End of Therapy (EOT) Assessment|Randomized not treated|0
961793|NCT00695864|3165280|P1|Placebo|Physician Decision|4
961794|NCT00695864|3165280|P1|Placebo|Withdrawal by Subject|1
961795|NCT00695669|3165290|P4|Overall Study|Lost to Follow-up|4
961796|NCT00695669|3165291|P3|Overall Study|Lost to Follow-up|1
961797|NCT00695669|3165292|P2|Overall Study|Lost to Follow-up|4
961798|NCT00695669|3165293|P1|Overall Study|Lost to Follow-up|4
961799|NCT00695669|3165290|P4|Overall Study|Adverse Event|0
961800|NCT00695669|3165291|P3|Overall Study|Adverse Event|2
961801|NCT00695669|3165292|P2|Overall Study|Adverse Event|0
961802|NCT00695669|3165293|P1|Overall Study|Adverse Event|0
961803|NCT00695565|3165369|P2|Overall Study|Subject did not follow instructions|1
961804|NCT00695565|3165370|P1|Overall Study|Subject did not follow instructions|1
961805|NCT00695565|3165369|P2|Overall Study|Lack of Efficacy|1
961806|NCT00695565|3165370|P1|Overall Study|Lack of Efficacy|1
961807|NCT00695565|3165369|P2|Overall Study|Withdrawal by Subject|1
961808|NCT00695565|3165370|P1|Overall Study|Withdrawal by Subject|1
961809|NCT00695565|3165369|P2|Overall Study|Protocol Violation|1
961810|NCT00695565|3165370|P1|Overall Study|Protocol Violation|3
961811|NCT00695565|3165369|P2|Overall Study|Adverse Event|1
961812|NCT00695565|3165370|P1|Overall Study|Adverse Event|3
961813|NCT00695565|3165369|P2|Overall Study|Lost to Follow-up|4
961814|NCT00695565|3165370|P1|Overall Study|Lost to Follow-up|4
961815|NCT00695396|3165443|P3|Overall Study|Withdrawal by Subject|0
961816|NCT00695396|3165444|P2|Overall Study|Withdrawal by Subject|2
961817|NCT00695396|3165445|P1|Overall Study|Withdrawal by Subject|2
961818|NCT00695396|3165443|P3|Overall Study|Study Closed Prematurely|8
961819|NCT00695396|3165444|P2|Overall Study|Study Closed Prematurely|6
961820|NCT00695396|3165445|P1|Overall Study|Study Closed Prematurely|5
961821|NCT00695318|3165461|P2|Overall Study|Study Terminated|0
961822|NCT00695318|3165462|P1|Overall Study|Study Terminated|1
961823|NCT00695318|3165461|P2|Overall Study|Death|1
961824|NCT00695318|3165462|P1|Overall Study|Death|1
961825|NCT00695318|3165461|P2|Overall Study|Withdrawal by Subject|0
961826|NCT00695318|3165462|P1|Overall Study|Withdrawal by Subject|2
961827|NCT00695318|3165461|P2|Overall Study|Lost to Follow-up|0
961828|NCT00695318|3165462|P1|Overall Study|Lost to Follow-up|1
961829|NCT00695136|3165487|P1|Overall Study|unrelated adverse event|1
961830|NCT00695136|3165487|P1|Overall Study|Withdrawal by Subject|1
961831|NCT00695019|3165503|P3|Overall Study|Various|4
961832|NCT00695019|3165504|P2|Overall Study|Various|5
961833|NCT00695019|3165505|P1|Overall Study|Various|4
961834|NCT00695019|3165503|P3|Overall Study|Lack of Efficacy|1
961835|NCT00695019|3165504|P2|Overall Study|Lack of Efficacy|0
961836|NCT00695019|3165505|P1|Overall Study|Lack of Efficacy|0
961837|NCT00695019|3165503|P3|Overall Study|Protocol Violation|1
961838|NCT00695019|3165504|P2|Overall Study|Protocol Violation|3
961839|NCT00695019|3165505|P1|Overall Study|Protocol Violation|1
961840|NCT00695019|3165503|P3|Overall Study|Withdrawal by Subject|4
961841|NCT00695019|3165504|P2|Overall Study|Withdrawal by Subject|6
961842|NCT00695019|3165505|P1|Overall Study|Withdrawal by Subject|8
961843|NCT00694551|3165546|P3|Overall Study|Disease Progression|1
961844|NCT00694551|3165547|P2|Overall Study|Disease Progression|0
961845|NCT00694551|3165548|P1|Overall Study|Disease Progression|1
961846|NCT00694369|3165577|P5|Overall Study|Withdrawal by Subject|2
961847|NCT00694369|3165578|P4|Overall Study|Withdrawal by Subject|1
961848|NCT00694369|3165579|P3|Overall Study|Withdrawal by Subject|1
961849|NCT00694369|3165580|P2|Overall Study|Withdrawal by Subject|1
961850|NCT00694369|3165581|P1|Overall Study|Withdrawal by Subject|1
961851|NCT00694369|3165577|P5|Overall Study|Protocol Violation|0
961852|NCT00694369|3165578|P4|Overall Study|Protocol Violation|0
961853|NCT00694369|3165579|P3|Overall Study|Protocol Violation|0
961854|NCT00694369|3165580|P2|Overall Study|Protocol Violation|1
961855|NCT00694369|3165581|P1|Overall Study|Protocol Violation|0
961856|NCT00694369|3165577|P5|Overall Study|Physician Decision|1
961857|NCT00694369|3165578|P4|Overall Study|Physician Decision|0
961858|NCT00694369|3165579|P3|Overall Study|Physician Decision|0
961859|NCT00694369|3165580|P2|Overall Study|Physician Decision|0
961860|NCT00694369|3165581|P1|Overall Study|Physician Decision|0
961861|NCT00694369|3165577|P5|Overall Study|Lost to Follow-up|0
961862|NCT00694369|3165578|P4|Overall Study|Lost to Follow-up|1
961863|NCT00694369|3165579|P3|Overall Study|Lost to Follow-up|1
961864|NCT00694369|3165580|P2|Overall Study|Lost to Follow-up|0
961865|NCT00694369|3165581|P1|Overall Study|Lost to Follow-up|0
961866|NCT00694369|3165577|P5|Overall Study|Adverse Event|3
961867|NCT00694369|3165578|P4|Overall Study|Adverse Event|1
961868|NCT00694369|3165579|P3|Overall Study|Adverse Event|0
961869|NCT00694369|3165580|P2|Overall Study|Adverse Event|1
961870|NCT00694369|3165581|P1|Overall Study|Adverse Event|0
961871|NCT00694356|3165601|P3|Overall Study|Progressive Disease|6
961872|NCT00694356|3165602|P2|Overall Study|Progressive Disease|6
961873|NCT00694356|3165603|P1|Overall Study|Progressive Disease|2
961874|NCT00694356|3165601|P3|Overall Study|Adverse Event|0
961875|NCT00694356|3165602|P2|Overall Study|Adverse Event|0
961876|NCT00694356|3165603|P1|Overall Study|Adverse Event|1
961877|NCT00694304|3165638|P1|Overall Study|Administrative or Other Reasons|32
961878|NCT00694304|3165638|P1|Overall Study|Lost to Follow-up|15
961879|NCT00694304|3165638|P1|Overall Study|Withdrawal of Consent|61
961880|NCT00694304|3165638|P1|Overall Study|Protocol Violation|6
961881|NCT00694304|3165638|P1|Overall Study|Non-compliance With Study Product|16
961882|NCT00694304|3165638|P1|Overall Study|Lack of Efficacy|35
961883|NCT00694304|3165638|P1|Overall Study|Adverse Event|42
961884|NCT00694161|3165651|P1|Part 2 (After Week 6 up to Month 12)|Death|1
961885|NCT00694161|3165651|P1|Part 2 (After Week 6 up to Month 12)|Physician Decision|1
961886|NCT00694161|3165651|P1|Part 2 (After Week 6 up to Month 12)|Adverse Event|1
961887|NCT00694122|3165690|P2|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1
961888|NCT00694122|3165691|P1|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2
961889|NCT00694122|3165690|P2|First Intervention (3-4 Weeks)|Lost to Follow-up|1
961890|NCT00694122|3165691|P1|First Intervention (3-4 Weeks)|Lost to Follow-up|1
961891|NCT00694122|3165690|P2|First Intervention (3-4 Weeks)|Withdrawal by Subject|0
961892|NCT00694122|3165691|P1|First Intervention (3-4 Weeks)|Withdrawal by Subject|7
961893|NCT00694109|3165707|P1|Overall Study|Consented but no additional treatment|3
961894|NCT00694109|3165707|P1|Overall Study|Other|2
961895|NCT00694109|3165707|P1|Overall Study|Enrolled but not treated|1
961896|NCT00694109|3165707|P1|Overall Study|Pregnancy|1
961897|NCT00694109|3165707|P1|Overall Study|Withdrawal by Subject|13
961898|NCT00694109|3165707|P1|Overall Study|Lack of Efficacy|2
961899|NCT00694109|3165707|P1|Overall Study|Not consent of more 2 years of treatment|18
961900|NCT00694109|3165707|P1|Overall Study|Adverse Event|74
961901|NCT00694109|3165707|P1|Overall Study|Physician Decision|3
961902|NCT00694096|3165731|P1|Overall Study|Withdrawal by Subject|5
961903|NCT00693784|3165771|P1|Overall Study|Withdrawal by Subject|2
961904|NCT00693784|3165771|P1|Overall Study|Lost to Follow-up|2
961905|NCT00693706|3165784|P2|Overall Study|Protocol Violation|1
961906|NCT00693706|3165785|P1|Overall Study|Protocol Violation|0
961907|NCT00693693|3165812|P3|Overall Study|Lost to Follow-up|2
961908|NCT00693693|3165813|P2|Overall Study|Lost to Follow-up|1
961909|NCT00693693|3165814|P1|Overall Study|Lost to Follow-up|1
961910|NCT00693472|3165873|P4|Part 2|Withdrew - reason unrelated to treatment|2
961911|NCT00693472|3165874|P3|Part 2|Withdrew - reason unrelated to treatment|1
961912|NCT00693472|3165875|P2|Part 2|Withdrew - reason unrelated to treatment|0
961913|NCT00693472|3165876|P1|Part 2|Withdrew - reason unrelated to treatment|0
961914|NCT00693472|3165873|P4|Part 2|Adverse Event|0
961915|NCT00693472|3165874|P3|Part 2|Adverse Event|1
961916|NCT00693472|3165875|P2|Part 2|Adverse Event|0
961917|NCT00693472|3165876|P1|Part 2|Adverse Event|0
961918|NCT00693472|3165873|P4|Part 1|Withdrew - reason unrelated to treatment|0
961919|NCT00693472|3165874|P3|Part 1|Withdrew - reason unrelated to treatment|0
961920|NCT00693472|3165875|P2|Part 1|Withdrew - reason unrelated to treatment|2
961921|NCT00693472|3165876|P1|Part 1|Withdrew - reason unrelated to treatment|5
961922|NCT00693472|3165873|P4|Part 1|Lost to Follow-up|0
961923|NCT00693472|3165874|P3|Part 1|Lost to Follow-up|0
961924|NCT00693472|3165875|P2|Part 1|Lost to Follow-up|1
961925|NCT00693472|3165876|P1|Part 1|Lost to Follow-up|0
961926|NCT00693472|3165873|P4|Part 1|Adverse Event|0
961927|NCT00693472|3165874|P3|Part 1|Adverse Event|0
961928|NCT00693472|3165875|P2|Part 1|Adverse Event|1
961929|NCT00693472|3165876|P1|Part 1|Adverse Event|1
961930|NCT00693420|3165896|P2|Overall Study|Personal Reasons|4
961931|NCT00693420|3165897|P1|Overall Study|Personal Reasons|1
961932|NCT00693420|3165896|P2|Overall Study|Sponsor Request - Conflict of Interest|2
961933|NCT00693420|3165897|P1|Overall Study|Sponsor Request - Conflict of Interest|0
961934|NCT00693420|3165896|P2|Overall Study|Protocol Violation|2
961935|NCT00693420|3165897|P1|Overall Study|Protocol Violation|0
961936|NCT00693420|3165896|P2|Overall Study|Withdrawal by Subject|0
961937|NCT00693420|3165897|P1|Overall Study|Withdrawal by Subject|1
961938|NCT00693420|3165896|P2|Overall Study|Lost to Follow-up|3
961939|NCT00693420|3165897|P1|Overall Study|Lost to Follow-up|0
961940|NCT00693420|3165896|P2|Overall Study|Adverse Event|4
961941|NCT00693420|3165897|P1|Overall Study|Adverse Event|4
961942|NCT00693225|3165936|P2|Overall Study|Adverse Event|3
961943|NCT00693225|3165937|P1|Overall Study|Adverse Event|1
961944|NCT00693225|3165936|P2|Overall Study|Lost to Follow-up|2
961945|NCT00693225|3165937|P1|Overall Study|Lost to Follow-up|1
961946|NCT00693017|3165960|P2|Overall Study|Death|1
961947|NCT00693017|3165961|P1|Overall Study|Death|0
961948|NCT00693017|3165960|P2|Overall Study|Sponsor Decision|1
961949|NCT00693017|3165961|P1|Overall Study|Sponsor Decision|2
961950|NCT00692913|3165971|P2|Overall Study|Withdrawal by Subject|20
961951|NCT00692913|3165972|P1|Overall Study|Withdrawal by Subject|15
961952|NCT00692913|3165971|P2|Overall Study|Protocol Violation|1
961953|NCT00692913|3165972|P1|Overall Study|Protocol Violation|1
961954|NCT00692913|3165971|P2|Overall Study|Physician Decision|0
961955|NCT00692913|3165972|P1|Overall Study|Physician Decision|2
961956|NCT00692913|3165971|P2|Overall Study|Lost to Follow-up|5
961957|NCT00692913|3165972|P1|Overall Study|Lost to Follow-up|3
961958|NCT00692913|3165971|P2|Overall Study|Adverse Event|4
961959|NCT00692913|3165972|P1|Overall Study|Adverse Event|8
961960|NCT00692770|3165994|P2|Overall Study|Randomized but not treated|4
961961|NCT00692770|3165995|P1|Overall Study|Randomized but not treated|3
961962|NCT00692770|3165994|P2|Overall Study|Study terminated by sponsor|2
961963|NCT00692770|3165995|P1|Overall Study|Study terminated by sponsor|2
961964|NCT00692770|3165994|P2|Overall Study|Clinical endpoint reached|43
961965|NCT00692770|3165995|P1|Overall Study|Clinical endpoint reached|16
961966|NCT00692770|3165994|P2|Overall Study|Radiological and clinical progression|8
961967|NCT00692770|3165995|P1|Overall Study|Radiological and clinical progression|8
961968|NCT00692770|3165994|P2|Overall Study|Completed all planned assessments|101
961969|NCT00692770|3165995|P1|Overall Study|Completed all planned assessments|79
961970|NCT00692770|3165994|P2|Overall Study|Protocol driven decision point|7
961971|NCT00692770|3165995|P1|Overall Study|Protocol driven decision point|3
961972|NCT00692770|3165994|P2|Overall Study|Disease progression, recurrence/relapse|279
961973|NCT00692770|3165995|P1|Overall Study|Disease progression, recurrence/relapse|170
961974|NCT00692770|3165994|P2|Overall Study|Physician decision not protocol driven|14
961975|NCT00692770|3165995|P1|Overall Study|Physician decision not protocol driven|10
961976|NCT00692770|3165994|P2|Overall Study|Progression by clinical judgment|3
961977|NCT00692770|3165995|P1|Overall Study|Progression by clinical judgment|2
961978|NCT00692770|3165994|P2|Overall Study|Non-compliant with study medication|5
961979|NCT00692770|3165995|P1|Overall Study|Non-compliant with study medication|11
961980|NCT00692770|3165994|P2|Overall Study|Lost to Follow-up|3
961981|NCT00692770|3165995|P1|Overall Study|Lost to Follow-up|7
961982|NCT00692770|3165994|P2|Overall Study|Death|5
961983|NCT00692770|3165995|P1|Overall Study|Death|10
961984|NCT00692770|3165994|P2|Overall Study|Adverse Event|41
961985|NCT00692770|3165995|P1|Overall Study|Adverse Event|136
961986|NCT00692770|3165994|P2|Overall Study|Withdrawal by Subject|36
961987|NCT00692770|3165995|P1|Overall Study|Withdrawal by Subject|97
961988|NCT00692770|3165994|P2|Overall Study|Protocol Violation|7
961989|NCT00692770|3165995|P1|Overall Study|Protocol Violation|2
961990|NCT00692406|3166041|P1|Overall Study|PI dropped, bad data|57
961991|NCT00692237|3166103|P2|Overall Study|Adverse Event|1
961992|NCT00692237|3166104|P1|Overall Study|Adverse Event|0
961993|NCT00692237|3166103|P2|Overall Study|Withdrawal by Subject|3
961994|NCT00692237|3166104|P1|Overall Study|Withdrawal by Subject|1
961995|NCT00692003|3166168|P2|Overall Study|Sponsor Decision|1
961996|NCT00692003|3166169|P1|Overall Study|Sponsor Decision|5
961997|NCT00691938|3166184|P7|Overall Study|QTc prolongation|0
961998|NCT00691938|3166185|P6|Overall Study|QTc prolongation|0
961999|NCT00691938|3166186|P5|Overall Study|QTc prolongation|0
962000|NCT00691938|3166187|P4|Overall Study|QTc prolongation|0
962001|NCT00691938|3166188|P3|Overall Study|QTc prolongation|0
962002|NCT00691938|3166189|P2|Overall Study|QTc prolongation|0
962003|NCT00691938|3166190|P1|Overall Study|QTc prolongation|1
962004|NCT00691704|3166257|P1|Two Years of Maintenance Therapy|Withdrawal by Subject|1
962005|NCT00691704|3166257|P1|Two Years of Maintenance Therapy|Physician Decision|4
962006|NCT00691704|3166257|P1|Two Years of Maintenance Therapy|Disease Progression|8
962007|NCT00691704|3166257|P1|Induction Therapy|Active Hepatitis|1
962008|NCT00691704|3166257|P1|Induction Therapy|Disease Progression|1
962009|NCT00691483|3166286|P2|Overall Study|Randomized by not treated|1
962010|NCT00691483|3166287|P1|Overall Study|Randomized by not treated|7
962011|NCT00691483|3166286|P2|Overall Study|Other known cause|1
962012|NCT00691483|3166287|P1|Overall Study|Other known cause|6
962013|NCT00691483|3166286|P2|Overall Study|Withdrawal by Subject|7
962014|NCT00691483|3166287|P1|Overall Study|Withdrawal by Subject|24
962015|NCT00691483|3166286|P2|Overall Study|Lost to Follow-up|10
962016|NCT00691483|3166287|P1|Overall Study|Lost to Follow-up|17
962017|NCT00691483|3166286|P2|Overall Study|Adverse Event|6
962018|NCT00691483|3166287|P1|Overall Study|Adverse Event|14
962019|NCT00691301|3166314|P1|Overall Study|Did not initiate study treatment|1
962020|NCT00691301|3166314|P1|Overall Study|other reason|3
962021|NCT00691301|3166314|P1|Overall Study|Concurrent illness|2
962022|NCT00691301|3166314|P1|Overall Study|Withdrawal by Subject|4
962023|NCT00691301|3166314|P1|Overall Study|Lack of Efficacy|32
962024|NCT00691301|3166314|P1|Overall Study|Death|2
962025|NCT00691301|3166314|P1|Overall Study|Adverse Event|10
962026|NCT00691210|3166334|P8|Overall Study|Lack of Efficacy|0
962027|NCT00691210|3166335|P7|Overall Study|Lack of Efficacy|0
962028|NCT00691210|3166336|P6|Overall Study|Lack of Efficacy|1
962029|NCT00691210|3166337|P5|Overall Study|Lack of Efficacy|0
962030|NCT00691210|3166338|P4|Overall Study|Lack of Efficacy|1
962031|NCT00691210|3166339|P3|Overall Study|Lack of Efficacy|0
962032|NCT00691210|3166340|P2|Overall Study|Lack of Efficacy|0
962033|NCT00691210|3166341|P1|Overall Study|Lack of Efficacy|0
962034|NCT00691210|3166334|P8|Overall Study|Progression of Disease|0
962035|NCT00691210|3166335|P7|Overall Study|Progression of Disease|0
962036|NCT00691210|3166336|P6|Overall Study|Progression of Disease|0
962037|NCT00691210|3166337|P5|Overall Study|Progression of Disease|0
962038|NCT00691210|3166338|P4|Overall Study|Progression of Disease|2
962039|NCT00691210|3166339|P3|Overall Study|Progression of Disease|0
962040|NCT00691210|3166340|P2|Overall Study|Progression of Disease|0
962041|NCT00691210|3166341|P1|Overall Study|Progression of Disease|0
962042|NCT00691132|3166376|P2|Overall Study|Withdrawal by Subject|10
962043|NCT00691132|3166377|P1|Overall Study|Withdrawal by Subject|10
962044|NCT00691132|3166376|P2|Overall Study|Adverse Event|3
962045|NCT00691132|3166377|P1|Overall Study|Adverse Event|2
962046|NCT00691093|3166396|P1|Overall Study|Ongoing at Date of Cut-Off|4
962047|NCT00691093|3166396|P1|Overall Study|Lack of Efficacy|1
962048|NCT00691093|3166396|P1|Overall Study|Lost to Follow-up|1
962049|NCT00691093|3166396|P1|Overall Study|Adverse Event|1
962050|NCT00691054|3166430|P1|Overall Study|Withdrawal by Subject|1
962051|NCT00691028|3166442|P4|Double-blind Period|not come to a hospital.|0
962052|NCT00691028|3166443|P3|Double-blind Period|not come to a hospital.|0
962053|NCT00691028|3166444|P2|Double-blind Period|not come to a hospital.|1
962054|NCT00691028|3166445|P1|Double-blind Period|not come to a hospital.|0
962055|NCT00691028|3166442|P4|Double-blind Period|Withdrawal by Subject|0
962056|NCT00691028|3166443|P3|Double-blind Period|Withdrawal by Subject|1
962057|NCT00691028|3166444|P2|Double-blind Period|Withdrawal by Subject|0
962058|NCT00691028|3166445|P1|Double-blind Period|Withdrawal by Subject|1
962059|NCT00691028|3166442|P4|Double-blind Period|Lack of Efficacy|0
962060|NCT00691028|3166443|P3|Double-blind Period|Lack of Efficacy|2
962061|NCT00691028|3166444|P2|Double-blind Period|Lack of Efficacy|3
962062|NCT00691028|3166445|P1|Double-blind Period|Lack of Efficacy|4
962063|NCT00691028|3166442|P4|Double-blind Period|Adverse Event|0
962064|NCT00691028|3166443|P3|Double-blind Period|Adverse Event|6
962065|NCT00691028|3166444|P2|Double-blind Period|Adverse Event|9
962066|NCT00691028|3166445|P1|Double-blind Period|Adverse Event|8
962067|NCT00691028|3166442|P4|Open-label Period|not come to a hospital|1
962068|NCT00691028|3166443|P3|Open-label Period|not come to a hospital|0
962069|NCT00691028|3166444|P2|Open-label Period|not come to a hospital|0
962070|NCT00691028|3166445|P1|Open-label Period|not come to a hospital|0
962071|NCT00691028|3166442|P4|Open-label Period|Withdrawal by Subject|3
962072|NCT00691028|3166443|P3|Open-label Period|Withdrawal by Subject|0
962073|NCT00691028|3166444|P2|Open-label Period|Withdrawal by Subject|0
962074|NCT00691028|3166445|P1|Open-label Period|Withdrawal by Subject|0
962075|NCT00691028|3166442|P4|Open-label Period|Adverse Event|16
962076|NCT00691028|3166443|P3|Open-label Period|Adverse Event|0
962077|NCT00691028|3166444|P2|Open-label Period|Adverse Event|0
962078|NCT00691028|3166445|P1|Open-label Period|Adverse Event|0
962079|NCT00691015|3166478|P1|Overall Study|Refused further treatment|1
962080|NCT00690898|3166493|P1|TREATMENT|Other (not otherwise specified)|1
962081|NCT00690898|3166493|P1|TREATMENT|Withdrawal by Subject|4
962082|NCT00690898|3166493|P1|TREATMENT|Lack of Efficacy|18
962083|NCT00690898|3166493|P1|TREATMENT|Adverse Event|3
962084|NCT00690898|3166493|P1|SCREENING|Screen failure|18
962085|NCT00690820|3166513|P2|Period 1|Withdrawal by Subject|1
962086|NCT00690820|3166514|P1|Period 1|Withdrawal by Subject|0
962087|NCT00690794|3166536|P2|Overall Study|Other not specified|3
962088|NCT00690794|3166537|P1|Overall Study|Other not specified|1
962089|NCT00690794|3166536|P2|Overall Study|Noncompliance|2
962090|NCT00690794|3166537|P1|Overall Study|Noncompliance|1
962091|NCT00690794|3166536|P2|Overall Study|Protocol Violation|7
962092|NCT00690794|3166537|P1|Overall Study|Protocol Violation|6
962093|NCT00690794|3166536|P2|Overall Study|Withdrawal by Subject|9
962094|NCT00690794|3166537|P1|Overall Study|Withdrawal by Subject|0
962095|NCT00690794|3166536|P2|Overall Study|Lost to Follow-up|4
962096|NCT00690794|3166537|P1|Overall Study|Lost to Follow-up|1
962097|NCT00690794|3166536|P2|Overall Study|Adverse Event|10
962098|NCT00690794|3166537|P1|Overall Study|Adverse Event|12
962099|NCT00690755|3166552|P7|Overall Study|Physician Decision|0
962100|NCT00690755|3166553|P6|Overall Study|Physician Decision|4
962101|NCT00690755|3166554|P5|Overall Study|Physician Decision|0
962102|NCT00690755|3166555|P4|Overall Study|Physician Decision|5
962103|NCT00690755|3166556|P3|Overall Study|Physician Decision|46
962104|NCT00690755|3166557|P2|Overall Study|Physician Decision|0
962105|NCT00690755|3166558|P1|Overall Study|Physician Decision|2
962106|NCT00690612|3166574|P1|Overall Study|Withdrawal by Subject|2
962107|NCT00690612|3166574|P1|Overall Study|Adverse Event|1
962108|NCT00690573|3166579|P1|Overall Study|Withdrawal by Subject|1
962109|NCT00690573|3166579|P1|Overall Study|Lack of Efficacy|8
962110|NCT00690482|3166598|P2|Overall Study|withdrew consent at rand.day|1
962111|NCT00690482|3166599|P1|Overall Study|withdrew consent at rand.day|0
962112|NCT00690482|3166598|P2|Overall Study|Intake of prohibited medicine|0
962113|NCT00690482|3166599|P1|Overall Study|Intake of prohibited medicine|1
962114|NCT00690482|3166598|P2|Overall Study|Study-specific discontinuation criteria|0
962115|NCT00690482|3166599|P1|Overall Study|Study-specific discontinuation criteria|1
962116|NCT00690482|3166598|P2|Overall Study|Incorrect enrolment|1
962117|NCT00690482|3166599|P1|Overall Study|Incorrect enrolment|0
962118|NCT00690482|3166598|P2|Overall Study|Adverse Event|1
962119|NCT00690482|3166599|P1|Overall Study|Adverse Event|2
962120|NCT00690443|3166633|P2|Overall Study|Adverse Event|2
962121|NCT00690443|3166634|P1|Overall Study|Adverse Event|1
962122|NCT00690430|3166644|P3|Extension Phase|Early Termination|3
962123|NCT00690430|3166645|P2|Extension Phase|Early Termination|1
962124|NCT00690430|3166646|P1|Extension Phase|Early Termination|10
962125|NCT00690430|3166644|P3|Extension Phase|Withdrawal by Subject|2
962126|NCT00690430|3166645|P2|Extension Phase|Withdrawal by Subject|0
962127|NCT00690430|3166646|P1|Extension Phase|Withdrawal by Subject|0
962128|NCT00690430|3166644|P3|Extension Phase|Death|1
962129|NCT00690430|3166645|P2|Extension Phase|Death|1
962130|NCT00690430|3166646|P1|Extension Phase|Death|1
962131|NCT00690430|3166644|P3|Extension Phase|Adverse Event|2
962132|NCT00690430|3166645|P2|Extension Phase|Adverse Event|1
962133|NCT00690430|3166646|P1|Extension Phase|Adverse Event|2
962134|NCT00690430|3166644|P3|Extension Phase|Administrative Problems|1
962135|NCT00690430|3166645|P2|Extension Phase|Administrative Problems|1
962136|NCT00690430|3166646|P1|Extension Phase|Administrative Problems|0
962137|NCT00690430|3166644|P3|Extension Phase|Abnormal test procedure results|0
962138|NCT00690430|3166645|P2|Extension Phase|Abnormal test procedure results|0
962139|NCT00690430|3166646|P1|Extension Phase|Abnormal test procedure results|1
962140|NCT00690430|3166644|P3|Extension Phase|Abnormal Lab Values|0
962141|NCT00690430|3166645|P2|Extension Phase|Abnormal Lab Values|0
962142|NCT00690430|3166646|P1|Extension Phase|Abnormal Lab Values|1
962143|NCT00690430|3166644|P3|Extension Phase|Lack of Efficacy|4
962144|NCT00690430|3166645|P2|Extension Phase|Lack of Efficacy|1
962145|NCT00690430|3166646|P1|Extension Phase|Lack of Efficacy|3
962146|NCT00690430|3166644|P3|Core Phase|Early Termination|0
962147|NCT00690430|3166645|P2|Core Phase|Early Termination|5
962148|NCT00690430|3166646|P1|Core Phase|Early Termination|0
962149|NCT00690430|3166644|P3|Core Phase|Administrative Problems|0
962150|NCT00690430|3166645|P2|Core Phase|Administrative Problems|1
962151|NCT00690430|3166646|P1|Core Phase|Administrative Problems|0
962152|NCT00690430|3166644|P3|Core Phase|Lack of Efficacy|0
962153|NCT00690430|3166645|P2|Core Phase|Lack of Efficacy|10
962154|NCT00690430|3166646|P1|Core Phase|Lack of Efficacy|8
962155|NCT00690430|3166644|P3|Core Phase|Subject no longer requires study drug|0
962156|NCT00690430|3166645|P2|Core Phase|Subject no longer requires study drug|0
962157|NCT00690430|3166646|P1|Core Phase|Subject no longer requires study drug|1
962158|NCT00690430|3166644|P3|Core Phase|Withdrawal by Subject|0
962159|NCT00690430|3166645|P2|Core Phase|Withdrawal by Subject|3
962160|NCT00690430|3166646|P1|Core Phase|Withdrawal by Subject|3
962161|NCT00690430|3166644|P3|Core Phase|Protocol Violation|0
962162|NCT00690430|3166645|P2|Core Phase|Protocol Violation|0
962163|NCT00690430|3166646|P1|Core Phase|Protocol Violation|1
962164|NCT00690430|3166644|P3|Core Phase|Death|0
962165|NCT00690430|3166645|P2|Core Phase|Death|2
962166|NCT00690430|3166646|P1|Core Phase|Death|0
962167|NCT00690430|3166644|P3|Core Phase|Adverse Event|0
962168|NCT00690430|3166645|P2|Core Phase|Adverse Event|1
962169|NCT00690430|3166646|P1|Core Phase|Adverse Event|5
962170|NCT00690430|3166644|P3|Core Phase|Abnormal Laboratory value|0
962171|NCT00690430|3166645|P2|Core Phase|Abnormal Laboratory value|1
962172|NCT00690430|3166646|P1|Core Phase|Abnormal Laboratory value|0
962173|NCT00690378|3166675|P2|Overall Study|Social problem|0
962174|NCT00690378|3166676|P1|Overall Study|Social problem|1
962175|NCT00690378|3166675|P2|Overall Study|Did not meet inc/exc criteria|11
962176|NCT00690378|3166676|P1|Overall Study|Did not meet inc/exc criteria|13
962177|NCT00690378|3166675|P2|Overall Study|Lost to Follow-up|3
962178|NCT00690378|3166676|P1|Overall Study|Lost to Follow-up|2
962179|NCT00690378|3166675|P2|Overall Study|Protocol Violation|0
962180|NCT00690378|3166676|P1|Overall Study|Protocol Violation|1
962181|NCT00690378|3166675|P2|Overall Study|Withdrawal by Subject|0
962182|NCT00690378|3166676|P1|Overall Study|Withdrawal by Subject|2
962183|NCT00690378|3166675|P2|Overall Study|Adverse Event|0
962184|NCT00690378|3166676|P1|Overall Study|Adverse Event|1
962185|NCT00689936|3166762|P3|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144
962186|NCT00689936|3166763|P2|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188
962187|NCT00689936|3166764|P1|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127
962188|NCT00689936|3166762|P3|Active Treatment Phase|Miscellaneous|47
962189|NCT00689936|3166763|P2|Active Treatment Phase|Miscellaneous|34
962190|NCT00689936|3166764|P1|Active Treatment Phase|Miscellaneous|52
962191|NCT00689936|3166762|P3|Active Treatment Phase|Study Close Out|21
962192|NCT00689936|3166763|P2|Active Treatment Phase|Study Close Out|26
962193|NCT00689936|3166764|P1|Active Treatment Phase|Study Close Out|64
962194|NCT00689936|3166762|P3|Active Treatment Phase|Protocol Violation|4
962195|NCT00689936|3166763|P2|Active Treatment Phase|Protocol Violation|2
962196|NCT00689936|3166764|P1|Active Treatment Phase|Protocol Violation|2
962197|NCT00689936|3166762|P3|Active Treatment Phase|Lost to Follow-up|2
962198|NCT00689936|3166763|P2|Active Treatment Phase|Lost to Follow-up|2
962199|NCT00689936|3166764|P1|Active Treatment Phase|Lost to Follow-up|0
962200|NCT00689936|3166762|P3|Active Treatment Phase|Death|37
962201|NCT00689936|3166763|P2|Active Treatment Phase|Death|28
962202|NCT00689936|3166764|P1|Active Treatment Phase|Death|60
962203|NCT00689936|3166762|P3|Active Treatment Phase|Withdrawal by Subject|21
962204|NCT00689936|3166763|P2|Active Treatment Phase|Withdrawal by Subject|16
962205|NCT00689936|3166764|P1|Active Treatment Phase|Withdrawal by Subject|16
962206|NCT00689936|3166762|P3|Active Treatment Phase|Disease Progression|339
962207|NCT00689936|3166763|P2|Active Treatment Phase|Disease Progression|362
962208|NCT00689936|3166764|P1|Active Treatment Phase|Disease Progression|273
962209|NCT00689936|3166762|P3|Active Treatment Phase|Adverse Event|76
962210|NCT00689936|3166763|P2|Active Treatment Phase|Adverse Event|71
962211|NCT00689936|3166764|P1|Active Treatment Phase|Adverse Event|68
962212|NCT00689871|3166913|P4|Overall Study|Physician Decision|0
962213|NCT00689871|3166914|P3|Overall Study|Physician Decision|1
962214|NCT00689871|3166915|P2|Overall Study|Physician Decision|1
962215|NCT00689871|3166916|P1|Overall Study|Physician Decision|2
962216|NCT00689871|3166913|P4|Overall Study|Death|2
962217|NCT00689871|3166914|P3|Overall Study|Death|2
962218|NCT00689871|3166915|P2|Overall Study|Death|10
962219|NCT00689871|3166916|P1|Overall Study|Death|1
962220|NCT00689871|3166913|P4|Overall Study|Withdrawal by Subject|1
962221|NCT00689871|3166914|P3|Overall Study|Withdrawal by Subject|4
962222|NCT00689871|3166915|P2|Overall Study|Withdrawal by Subject|3
962223|NCT00689871|3166916|P1|Overall Study|Withdrawal by Subject|13
962224|NCT00689871|3166913|P4|Overall Study|Explanted of All Study Devices|3
962225|NCT00689871|3166914|P3|Overall Study|Explanted of All Study Devices|29
962226|NCT00689871|3166915|P2|Overall Study|Explanted of All Study Devices|25
962227|NCT00689871|3166916|P1|Overall Study|Explanted of All Study Devices|36
962228|NCT00689871|3166913|P4|Overall Study|Lost to Follow-up|1
962229|NCT00689871|3166914|P3|Overall Study|Lost to Follow-up|37
962230|NCT00689871|3166915|P2|Overall Study|Lost to Follow-up|13
962231|NCT00689871|3166916|P1|Overall Study|Lost to Follow-up|123
962232|NCT00689793|3166943|P2|Overall Study|Lost to Follow-up|5
962233|NCT00689793|3166944|P1|Overall Study|Lost to Follow-up|4
962234|NCT00689611|3166962|P2|Overall Study|Lost to Follow-up|28
962235|NCT00689611|3166963|P1|Overall Study|Lost to Follow-up|27
962236|NCT00689611|3166962|P2|Overall Study|Withdrawal by Subject|9
962237|NCT00689611|3166963|P1|Overall Study|Withdrawal by Subject|8
962238|NCT00689611|3166962|P2|Overall Study|Death|9
962239|NCT00689611|3166963|P1|Overall Study|Death|6
962240|NCT00689481|3166973|P2|Overall Study|Subject early term, left on vacation|1
962241|NCT00689481|3166974|P1|Overall Study|Subject early term, left on vacation|0
962242|NCT00689481|3166973|P2|Overall Study|Excluded medication started during study|1
962243|NCT00689481|3166974|P1|Overall Study|Excluded medication started during study|0
962244|NCT00689481|3166973|P2|Overall Study|Withdrawal by Subject|4
962245|NCT00689481|3166974|P1|Overall Study|Withdrawal by Subject|8
962246|NCT00689481|3166973|P2|Overall Study|Non-compliance with study treatment|1
962247|NCT00689481|3166974|P1|Overall Study|Non-compliance with study treatment|1
962248|NCT00689481|3166973|P2|Overall Study|Lack of Efficacy|3
962249|NCT00689481|3166974|P1|Overall Study|Lack of Efficacy|4
962250|NCT00689481|3166973|P2|Overall Study|Lost to Follow-up|3
962251|NCT00689481|3166974|P1|Overall Study|Lost to Follow-up|4
962252|NCT00689481|3166973|P2|Overall Study|Adverse Event|1
962253|NCT00689481|3166974|P1|Overall Study|Adverse Event|7
962254|NCT00689390|3166992|P2|Overall Study|Administrative|0
962255|NCT00689390|3166993|P1|Overall Study|Administrative|37
962256|NCT00689390|3166992|P2|Overall Study|Did Not Meet Protocol Eligibility|0
962257|NCT00689390|3166993|P1|Overall Study|Did Not Meet Protocol Eligibility|1
962258|NCT00689390|3166992|P2|Overall Study|Non-Compliance With Protocol|0
962259|NCT00689390|3166993|P1|Overall Study|Non-Compliance With Protocol|21
962260|NCT00689390|3166992|P2|Overall Study|Withdrew Consent-Retreatment Opportunity|0
962261|NCT00689390|3166993|P1|Overall Study|Withdrew Consent-Retreatment Opportunity|52
962262|NCT00689390|3166992|P2|Overall Study|Withdrawal by Subject|3
962263|NCT00689390|3166993|P1|Overall Study|Withdrawal by Subject|117
962264|NCT00689390|3166992|P2|Overall Study|Lost to Follow-up|7
962265|NCT00689390|3166993|P1|Overall Study|Lost to Follow-up|179
962266|NCT00689390|3166992|P2|Overall Study|Adverse Event|0
962267|NCT00689390|3166993|P1|Overall Study|Adverse Event|19
962268|NCT00689351|3167011|P2|After Infant Series|Parent/legal guardian request|0
962269|NCT00689351|3167012|P1|After Infant Series|Parent/legal guardian request|1
962270|NCT00689351|3167011|P2|Infant Series of Dosing|Lost to Follow-up|1
962271|NCT00689351|3167012|P1|Infant Series of Dosing|Lost to Follow-up|0
962272|NCT00689351|3167011|P2|Infant Series of Dosing|Adverse Event|0
962273|NCT00689351|3167012|P1|Infant Series of Dosing|Adverse Event|1
962274|NCT00689351|3167011|P2|Infant Series of Dosing|Parent/legal guardian request|0
962275|NCT00689351|3167012|P1|Infant Series of Dosing|Parent/legal guardian request|5
962276|NCT00689338|3167044|P1|Overall Study|Protocol Violation|15
962277|NCT00689338|3167044|P1|Overall Study|Withdrawal by Subject|3
962278|NCT00689338|3167044|P1|Overall Study|Lost to Follow-up|5
962279|NCT00689338|3167044|P1|Overall Study|Did not Meet Entrance Criteria|27
962280|NCT00689338|3167044|P1|Overall Study|Other|8
962281|NCT00689338|3167044|P1|Overall Study|Lack of Efficacy|6
962282|NCT00689338|3167044|P1|Overall Study|Insufficient Clinical Response|1
962283|NCT00689338|3167044|P1|Overall Study|Adverse Event|13
962284|NCT00689338|3167044|P1|Overall Study|Death|65
962285|NCT00689299|3167057|P3|Overall Study|Protocol Violation|0
962286|NCT00689299|3167058|P2|Overall Study|Protocol Violation|0
962287|NCT00689299|3167059|P1|Overall Study|Protocol Violation|1
962288|NCT00689299|3167057|P3|Overall Study|Withdrawal by Subject|3
962289|NCT00689299|3167058|P2|Overall Study|Withdrawal by Subject|1
962290|NCT00689299|3167059|P1|Overall Study|Withdrawal by Subject|4
962291|NCT00689299|3167057|P3|Overall Study|Lost to Follow-up|1
962292|NCT00689299|3167058|P2|Overall Study|Lost to Follow-up|1
962293|NCT00689299|3167059|P1|Overall Study|Lost to Follow-up|0
962294|NCT00689299|3167057|P3|Overall Study|Adverse Event|1
962295|NCT00689299|3167058|P2|Overall Study|Adverse Event|1
962296|NCT00689299|3167059|P1|Overall Study|Adverse Event|2
962297|NCT00689221|3167088|P2|Overall Study|Ongoing at cut-off date|36
962298|NCT00689221|3167089|P1|Overall Study|Ongoing at cut-off date|39
962299|NCT00689117|3167118|P4|Overall Study|Dispensing Error|0
962300|NCT00689117|3167119|P3|Overall Study|Dispensing Error|0
962301|NCT00689117|3167120|P2|Overall Study|Dispensing Error|1
962302|NCT00689117|3167121|P1|Overall Study|Dispensing Error|0
962303|NCT00689117|3167118|P4|Overall Study|Personal Reason|0
962304|NCT00689117|3167119|P3|Overall Study|Personal Reason|0
962305|NCT00689117|3167120|P2|Overall Study|Personal Reason|1
962306|NCT00689117|3167121|P1|Overall Study|Personal Reason|0
962307|NCT00689117|3167118|P4|Overall Study|Patient Withdrew from Study|1
962308|NCT00689117|3167119|P3|Overall Study|Patient Withdrew from Study|0
962309|NCT00689117|3167120|P2|Overall Study|Patient Withdrew from Study|0
962310|NCT00689117|3167121|P1|Overall Study|Patient Withdrew from Study|0
962311|NCT00689117|3167118|P4|Overall Study|Transportation|0
962312|NCT00689117|3167119|P3|Overall Study|Transportation|0
962313|NCT00689117|3167120|P2|Overall Study|Transportation|0
962314|NCT00689117|3167121|P1|Overall Study|Transportation|1
962315|NCT00689117|3167118|P4|Overall Study|Fear of Birth Defects|0
962316|NCT00689117|3167119|P3|Overall Study|Fear of Birth Defects|1
962317|NCT00689117|3167120|P2|Overall Study|Fear of Birth Defects|0
962318|NCT00689117|3167121|P1|Overall Study|Fear of Birth Defects|0
962319|NCT00689117|3167118|P4|Overall Study|Incarceration|0
962320|NCT00689117|3167119|P3|Overall Study|Incarceration|0
962321|NCT00689117|3167120|P2|Overall Study|Incarceration|0
962322|NCT00689117|3167121|P1|Overall Study|Incarceration|2
962323|NCT00689117|3167118|P4|Overall Study|Pregnancy|2
962324|NCT00689117|3167119|P3|Overall Study|Pregnancy|0
962325|NCT00689117|3167120|P2|Overall Study|Pregnancy|2
962326|NCT00689117|3167121|P1|Overall Study|Pregnancy|0
962327|NCT00689117|3167118|P4|Overall Study|Use of Prohibitive Medication|0
962328|NCT00689117|3167119|P3|Overall Study|Use of Prohibitive Medication|3
962329|NCT00689117|3167120|P2|Overall Study|Use of Prohibitive Medication|1
962330|NCT00689117|3167121|P1|Overall Study|Use of Prohibitive Medication|2
962331|NCT00689117|3167118|P4|Overall Study|Change/Discontinuation of Birth Control|0
962332|NCT00689117|3167119|P3|Overall Study|Change/Discontinuation of Birth Control|1
962333|NCT00689117|3167120|P2|Overall Study|Change/Discontinuation of Birth Control|1
962334|NCT00689117|3167121|P1|Overall Study|Change/Discontinuation of Birth Control|1
962335|NCT00689117|3167118|P4|Overall Study|Non-compliance with Treatment Regimen|0
962336|NCT00689117|3167119|P3|Overall Study|Non-compliance with Treatment Regimen|0
962337|NCT00689117|3167120|P2|Overall Study|Non-compliance with Treatment Regimen|1
962338|NCT00689117|3167121|P1|Overall Study|Non-compliance with Treatment Regimen|0
962339|NCT00689117|3167118|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
962340|NCT00689117|3167119|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
962341|NCT00689117|3167120|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
962342|NCT00689117|3167121|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
962343|NCT00689117|3167118|P4|Overall Study|Unable to Comply with Visit Schedule|1
962344|NCT00689117|3167119|P3|Overall Study|Unable to Comply with Visit Schedule|1
962345|NCT00689117|3167120|P2|Overall Study|Unable to Comply with Visit Schedule|0
962346|NCT00689117|3167121|P1|Overall Study|Unable to Comply with Visit Schedule|0
962347|NCT00689117|3167118|P4|Overall Study|Withdrawal by Subject|13
962348|NCT00689117|3167119|P3|Overall Study|Withdrawal by Subject|26
962349|NCT00689117|3167120|P2|Overall Study|Withdrawal by Subject|18
962350|NCT00689117|3167121|P1|Overall Study|Withdrawal by Subject|19
962351|NCT00689117|3167118|P4|Overall Study|Non-Compliance with Study Treatment|1
962352|NCT00689117|3167119|P3|Overall Study|Non-Compliance with Study Treatment|3
962353|NCT00689117|3167120|P2|Overall Study|Non-Compliance with Study Treatment|3
962354|NCT00689117|3167121|P1|Overall Study|Non-Compliance with Study Treatment|3
962355|NCT00689117|3167118|P4|Overall Study|Lack of Efficacy|2
962356|NCT00689117|3167119|P3|Overall Study|Lack of Efficacy|2
962357|NCT00689117|3167120|P2|Overall Study|Lack of Efficacy|2
962358|NCT00689117|3167121|P1|Overall Study|Lack of Efficacy|1
962359|NCT00689117|3167118|P4|Overall Study|Lost to Follow-up|11
962360|NCT00689117|3167119|P3|Overall Study|Lost to Follow-up|17
962361|NCT00689117|3167120|P2|Overall Study|Lost to Follow-up|19
962362|NCT00689117|3167121|P1|Overall Study|Lost to Follow-up|26
962363|NCT00689117|3167118|P4|Overall Study|Adverse Event|0
962364|NCT00689117|3167119|P3|Overall Study|Adverse Event|5
962365|NCT00689117|3167120|P2|Overall Study|Adverse Event|0
962366|NCT00689117|3167121|P1|Overall Study|Adverse Event|6
962367|NCT00689104|3167151|P4|Overall Study|Non-compliance with study procedures|0
962368|NCT00689104|3167152|P3|Overall Study|Non-compliance with study procedures|1
962369|NCT00689104|3167153|P2|Overall Study|Non-compliance with study procedures|0
962370|NCT00689104|3167154|P1|Overall Study|Non-compliance with study procedures|0
962371|NCT00689104|3167151|P4|Overall Study|Physician Decision|0
962372|NCT00689104|3167152|P3|Overall Study|Physician Decision|0
962373|NCT00689104|3167153|P2|Overall Study|Physician Decision|0
962374|NCT00689104|3167154|P1|Overall Study|Physician Decision|1
962375|NCT00689104|3167151|P4|Overall Study|Randomized but never received study drug|0
962376|NCT00689104|3167152|P3|Overall Study|Randomized but never received study drug|1
962377|NCT00689104|3167153|P2|Overall Study|Randomized but never received study drug|1
962378|NCT00689104|3167154|P1|Overall Study|Randomized but never received study drug|2
962379|NCT00689104|3167151|P4|Overall Study|Protocol Violation|3
962380|NCT00689104|3167152|P3|Overall Study|Protocol Violation|5
962381|NCT00689104|3167153|P2|Overall Study|Protocol Violation|3
962382|NCT00689104|3167154|P1|Overall Study|Protocol Violation|2
962383|NCT00689104|3167151|P4|Overall Study|Lost to Follow-up|5
962384|NCT00689104|3167152|P3|Overall Study|Lost to Follow-up|2
962385|NCT00689104|3167153|P2|Overall Study|Lost to Follow-up|3
962386|NCT00689104|3167154|P1|Overall Study|Lost to Follow-up|4
962387|NCT00689104|3167151|P4|Overall Study|Withdrawal by Subject|11
962388|NCT00689104|3167152|P3|Overall Study|Withdrawal by Subject|18
962389|NCT00689104|3167153|P2|Overall Study|Withdrawal by Subject|11
962390|NCT00689104|3167154|P1|Overall Study|Withdrawal by Subject|12
962391|NCT00689104|3167151|P4|Overall Study|Lack of Efficacy|3
962392|NCT00689104|3167152|P3|Overall Study|Lack of Efficacy|2
962393|NCT00689104|3167153|P2|Overall Study|Lack of Efficacy|6
962394|NCT00689104|3167154|P1|Overall Study|Lack of Efficacy|5
962395|NCT00689104|3167151|P4|Overall Study|Adverse Event|24
962396|NCT00689104|3167152|P3|Overall Study|Adverse Event|16
962397|NCT00689104|3167153|P2|Overall Study|Adverse Event|25
962398|NCT00689104|3167154|P1|Overall Study|Adverse Event|13
962399|NCT00689104|3167151|P4|Overall Study|Eligibility criterion not met|4
962400|NCT00689104|3167152|P3|Overall Study|Eligibility criterion not met|0
962401|NCT00689104|3167153|P2|Overall Study|Eligibility criterion not met|8
962402|NCT00689104|3167154|P1|Overall Study|Eligibility criterion not met|5
962403|NCT00689052|3167360|P2|Overall Study|Early termination of the trial|24
962404|NCT00689052|3167361|P1|Overall Study|Early termination of the trial|22
962405|NCT00689052|3167360|P2|Overall Study|Withdrawal by Subject|0
962406|NCT00689052|3167361|P1|Overall Study|Withdrawal by Subject|2
962407|NCT00689052|3167360|P2|Overall Study|Lost to Follow-up|0
962408|NCT00689052|3167361|P1|Overall Study|Lost to Follow-up|2
962409|NCT00689052|3167360|P2|Overall Study|Protocol Violation|0
962410|NCT00689052|3167361|P1|Overall Study|Protocol Violation|1
962411|NCT00689052|3167360|P2|Overall Study|Adverse Event|6
962412|NCT00689052|3167361|P1|Overall Study|Adverse Event|4
962413|NCT00689026|3167393|P2|Overall Study|Withdrawal by Subject|6
962414|NCT00689026|3167394|P1|Overall Study|Withdrawal by Subject|13
962415|NCT00688870|3167402|P2|Infant Series|Parent or legal guardian request|0
962416|NCT00688870|3167403|P1|Infant Series|Parent or legal guardian request|4
962417|NCT00688844|3167435|P1|Overall Study|Lost to Follow-up|10
962418|NCT00688753|3167445|P1|Overall Study|Lost to Follow-up|3
962419|NCT00688753|3167445|P1|Overall Study|Protocol Violation|1
962420|NCT00688753|3167445|P1|Overall Study|Adverse Event|20
962421|NCT00688753|3167445|P1|Overall Study|Withdrawal by Subject|3
962422|NCT00688753|3167445|P1|Overall Study|Death|9
962423|NCT00688753|3167445|P1|Overall Study|Missing|1
962424|NCT00688753|3167445|P1|Overall Study|Disease progression|55
962425|NCT00688740|3167456|P2|Overall Study|Violation of Inclusion Criteria|3
962426|NCT00688740|3167457|P1|Overall Study|Violation of Inclusion Criteria|1
962427|NCT00688740|3167456|P2|Overall Study|Breast Cancer Relapse|4
962428|NCT00688740|3167457|P1|Overall Study|Breast Cancer Relapse|1
962429|NCT00688740|3167456|P2|Overall Study|Consent Withdrawn|17
962430|NCT00688740|3167457|P1|Overall Study|Consent Withdrawn|17
962431|NCT00688740|3167456|P2|Overall Study|Lost to Follow-up|1
962432|NCT00688740|3167457|P1|Overall Study|Lost to Follow-up|0
962433|NCT00688740|3167456|P2|Overall Study|Death|2
962434|NCT00688740|3167457|P1|Overall Study|Death|2
962435|NCT00688740|3167456|P2|Overall Study|Adverse Event|8
962436|NCT00688740|3167457|P1|Overall Study|Adverse Event|45
962437|NCT00688701|3167470|P4|Overall Study|Poor compliance to protocol|0
962438|NCT00688701|3167471|P3|Overall Study|Poor compliance to protocol|1
962439|NCT00688701|3167472|P2|Overall Study|Poor compliance to protocol|1
962440|NCT00688701|3167473|P1|Overall Study|Poor compliance to protocol|0
962441|NCT00688701|3167470|P4|Overall Study|Withdrawal by Subject|8
962442|NCT00688701|3167471|P3|Overall Study|Withdrawal by Subject|4
962443|NCT00688701|3167472|P2|Overall Study|Withdrawal by Subject|3
962444|NCT00688701|3167473|P1|Overall Study|Withdrawal by Subject|3
962445|NCT00688701|3167470|P4|Overall Study|Lack of Efficacy|0
962446|NCT00688701|3167471|P3|Overall Study|Lack of Efficacy|0
962447|NCT00688701|3167472|P2|Overall Study|Lack of Efficacy|1
962448|NCT00688701|3167473|P1|Overall Study|Lack of Efficacy|0
962449|NCT00688701|3167470|P4|Overall Study|Adverse Event|3
962450|NCT00688701|3167471|P3|Overall Study|Adverse Event|5
962451|NCT00688701|3167472|P2|Overall Study|Adverse Event|0
962452|NCT00688701|3167473|P1|Overall Study|Adverse Event|1
962453|NCT00688688|3167514|P3|Overall Study|Violation of exclusion criterion|0
962454|NCT00688688|3167515|P2|Overall Study|Violation of exclusion criterion|1
962455|NCT00688688|3167516|P1|Overall Study|Violation of exclusion criterion|0
962456|NCT00688688|3167514|P3|Overall Study|Site closure|0
962457|NCT00688688|3167515|P2|Overall Study|Site closure|1
962458|NCT00688688|3167516|P1|Overall Study|Site closure|0
962459|NCT00688688|3167514|P3|Overall Study|Taking exclusionary medications|0
962460|NCT00688688|3167515|P2|Overall Study|Taking exclusionary medications|0
962461|NCT00688688|3167516|P1|Overall Study|Taking exclusionary medications|1
962462|NCT00688688|3167514|P3|Overall Study|Non-compliance with study procedures|4
962463|NCT00688688|3167515|P2|Overall Study|Non-compliance with study procedures|3
962464|NCT00688688|3167516|P1|Overall Study|Non-compliance with study procedures|5
962465|NCT00688688|3167514|P3|Overall Study|Randomized but never received study drug|0
962466|NCT00688688|3167515|P2|Overall Study|Randomized but never received study drug|0
962467|NCT00688688|3167516|P1|Overall Study|Randomized but never received study drug|1
962468|NCT00688688|3167514|P3|Overall Study|Protocol Violation|11
962469|NCT00688688|3167515|P2|Overall Study|Protocol Violation|9
962470|NCT00688688|3167516|P1|Overall Study|Protocol Violation|6
962471|NCT00688688|3167514|P3|Overall Study|Lost to Follow-up|7
962472|NCT00688688|3167515|P2|Overall Study|Lost to Follow-up|7
962473|NCT00688688|3167516|P1|Overall Study|Lost to Follow-up|14
962474|NCT00688688|3167514|P3|Overall Study|Withdrawal by Subject|65
962475|NCT00688688|3167515|P2|Overall Study|Withdrawal by Subject|75
962476|NCT00688688|3167516|P1|Overall Study|Withdrawal by Subject|66
962477|NCT00688688|3167514|P3|Overall Study|Lack of Efficacy|45
962478|NCT00688688|3167515|P2|Overall Study|Lack of Efficacy|25
962479|NCT00688688|3167516|P1|Overall Study|Lack of Efficacy|34
962480|NCT00688688|3167514|P3|Overall Study|Adverse Event|50
962481|NCT00688688|3167515|P2|Overall Study|Adverse Event|51
962482|NCT00688688|3167516|P1|Overall Study|Adverse Event|52
962483|NCT00688688|3167514|P3|Overall Study|Eligibility criterion not met|10
962484|NCT00688688|3167515|P2|Overall Study|Eligibility criterion not met|7
962485|NCT00688688|3167516|P1|Overall Study|Eligibility criterion not met|7
962486|NCT00688636|3167618|P2|Overall Study|Adverse Event|1
962487|NCT00688636|3167619|P1|Overall Study|Adverse Event|2
962488|NCT00688597|3167636|P3|Overall Study|Physician Decision|0
962489|NCT00688597|3167637|P2|Overall Study|Physician Decision|0
962490|NCT00688597|3167638|P1|Overall Study|Physician Decision|1
962491|NCT00688597|3167636|P3|Overall Study|Adverse Event|0
962492|NCT00688597|3167637|P2|Overall Study|Adverse Event|0
962493|NCT00688597|3167638|P1|Overall Study|Adverse Event|2
962494|NCT00688545|3167651|P2|Overall Study|Unspecified, unrelated to AE/Toxicity|7
962495|NCT00688545|3167652|P1|Overall Study|Unspecified, unrelated to AE/Toxicity|2
962496|NCT00688545|3167651|P2|Overall Study|Withdrawal by Subject|3
962497|NCT00688545|3167652|P1|Overall Study|Withdrawal by Subject|2
962498|NCT00688545|3167651|P2|Overall Study|Insurance/cost of drug|1
962499|NCT00688545|3167652|P1|Overall Study|Insurance/cost of drug|0
962500|NCT00688545|3167651|P2|Overall Study|Lost to Follow-up|4
962501|NCT00688545|3167652|P1|Overall Study|Lost to Follow-up|1
962502|NCT00688519|3167662|P2|Overall Study|Pregnancy|1
962503|NCT00688519|3167663|P1|Overall Study|Pregnancy|0
962504|NCT00688519|3167662|P2|Overall Study|Subject moved out of area|0
962505|NCT00688519|3167663|P1|Overall Study|Subject moved out of area|1
962506|NCT00688519|3167662|P2|Overall Study|Investigator decision|0
962507|NCT00688519|3167663|P1|Overall Study|Investigator decision|1
962508|NCT00688519|3167662|P2|Overall Study|Subject moved out of state|0
962509|NCT00688519|3167663|P1|Overall Study|Subject moved out of state|1
962510|NCT00688519|3167662|P2|Overall Study|Non-compliance|1
962511|NCT00688519|3167663|P1|Overall Study|Non-compliance|0
962512|NCT00688519|3167662|P2|Overall Study|Prohibited medication|0
962513|NCT00688519|3167663|P1|Overall Study|Prohibited medication|1
962514|NCT00688519|3167662|P2|Overall Study|Withdrawal by Subject|6
962515|NCT00688519|3167663|P1|Overall Study|Withdrawal by Subject|7
962516|NCT00688519|3167662|P2|Overall Study|Lack of Efficacy|1
962517|NCT00688519|3167663|P1|Overall Study|Lack of Efficacy|3
962518|NCT00688519|3167662|P2|Overall Study|Lost to Follow-up|3
962519|NCT00688519|3167663|P1|Overall Study|Lost to Follow-up|3
962520|NCT00688519|3167662|P2|Overall Study|Adverse Event|3
962521|NCT00688519|3167663|P1|Overall Study|Adverse Event|2
962522|NCT00688467|3167681|P2|Treatment Period 2|Adverse Event|1
962523|NCT00688467|3167682|P1|Treatment Period 2|Adverse Event|0
962524|NCT00688467|3167681|P2|Treatment Period 2|Protocol Violation|1
962525|NCT00688467|3167682|P1|Treatment Period 2|Protocol Violation|0
962526|NCT00688467|3167681|P2|Treatment Period 1|Did not meet protocol eligibility|1
962527|NCT00688467|3167682|P1|Treatment Period 1|Did not meet protocol eligibility|0
962528|NCT00688467|3167681|P2|Treatment Period 1|Adverse Event|1
962529|NCT00688467|3167682|P1|Treatment Period 1|Adverse Event|2
962530|NCT00688324|3167712|P1|Overall Study|Lost to Follow-up|1
962531|NCT00688324|3167712|P1|Overall Study|Physician Decision|5
962532|NCT00688324|3167712|P1|Overall Study|Withdrawal by Subject|2
962533|NCT00688259|3167757|P2|Overall Study|Hospitalized at Follow-up|1
962534|NCT00688259|3167758|P1|Overall Study|Hospitalized at Follow-up|0
962535|NCT00688259|3167757|P2|Overall Study|Declined Interview|3
962536|NCT00688259|3167758|P1|Overall Study|Declined Interview|2
962537|NCT00688259|3167757|P2|Overall Study|Withdrawal by Subject|0
962538|NCT00688259|3167758|P1|Overall Study|Withdrawal by Subject|2
962539|NCT00688259|3167757|P2|Overall Study|Physician Decision|0
962540|NCT00688259|3167758|P1|Overall Study|Physician Decision|1
962541|NCT00688259|3167757|P2|Overall Study|Lost to Follow-up|4
962542|NCT00688259|3167758|P1|Overall Study|Lost to Follow-up|2
962543|NCT00688155|3167778|P4|Overall Study|Withdrawal by Subject|1
962544|NCT00688155|3167779|P3|Overall Study|Withdrawal by Subject|1
962545|NCT00688155|3167780|P2|Overall Study|Withdrawal by Subject|2
962546|NCT00688155|3167781|P1|Overall Study|Withdrawal by Subject|2
962547|NCT00688103|3167801|P2|Overall Study|complex reasons|9
962548|NCT00688103|3167802|P1|Overall Study|complex reasons|11
962549|NCT00688103|3167801|P2|Overall Study|Withdrawal by Subject|2
962550|NCT00688103|3167802|P1|Overall Study|Withdrawal by Subject|4
962551|NCT00688103|3167801|P2|Overall Study|Lack of Efficacy|1
962552|NCT00688103|3167802|P1|Overall Study|Lack of Efficacy|11
962553|NCT00688103|3167801|P2|Overall Study|Adverse Event|1
962554|NCT00688103|3167802|P1|Overall Study|Adverse Event|4
962555|NCT00688064|3167814|P2|Overall Study|Any other reasons|3
962556|NCT00688064|3167815|P1|Overall Study|Any other reasons|1
962557|NCT00688064|3167814|P2|Overall Study|Pregnancy|0
962558|NCT00688064|3167815|P1|Overall Study|Pregnancy|1
962559|NCT00688064|3167814|P2|Overall Study|Lack of Efficacy|1
962560|NCT00688064|3167815|P1|Overall Study|Lack of Efficacy|0
962561|NCT00688064|3167814|P2|Overall Study|Lost to Follow-up|10
962562|NCT00688064|3167815|P1|Overall Study|Lost to Follow-up|10
962563|NCT00688064|3167814|P2|Overall Study|Withdrawal by Subject|7
962564|NCT00688064|3167815|P1|Overall Study|Withdrawal by Subject|7
962565|NCT00688064|3167814|P2|Overall Study|Adverse Event|4
962566|NCT00688064|3167815|P1|Overall Study|Adverse Event|2
962567|NCT00688064|3167814|P2|Overall Study|Protocol Violation|1
962568|NCT00688064|3167815|P1|Overall Study|Protocol Violation|0
962569|NCT00687973|3167831|P2|Overall Study|Withdrawal by Subject|3
962570|NCT00687973|3167832|P1|Overall Study|Withdrawal by Subject|3
962571|NCT00687973|3167831|P2|Overall Study|Administrative Reasons|2
962572|NCT00687973|3167832|P1|Overall Study|Administrative Reasons|0
962573|NCT00687973|3167831|P2|Overall Study|Protocol Violation|2
962574|NCT00687973|3167832|P1|Overall Study|Protocol Violation|1
962575|NCT00687973|3167831|P2|Overall Study|Lack of Efficacy|3
962576|NCT00687973|3167832|P1|Overall Study|Lack of Efficacy|2
962577|NCT00687973|3167831|P2|Overall Study|Adverse Event|28
962578|NCT00687973|3167832|P1|Overall Study|Adverse Event|18
962579|NCT00687804|3167894|P3|Open-Label Extension Study|Death|3
962580|NCT00687804|3167895|P2|Open-Label Extension Study|Death|3
962581|NCT00687804|3167896|P1|Open-Label Extension Study|Death|2
962582|NCT00687804|3167894|P3|Open-Label Extension Study|Administrative problems|0
962583|NCT00687804|3167895|P2|Open-Label Extension Study|Administrative problems|1
962584|NCT00687804|3167896|P1|Open-Label Extension Study|Administrative problems|1
962585|NCT00687804|3167894|P3|Open-Label Extension Study|Lost to Follow-up|2
962586|NCT00687804|3167895|P2|Open-Label Extension Study|Lost to Follow-up|1
962587|NCT00687804|3167896|P1|Open-Label Extension Study|Lost to Follow-up|2
962588|NCT00687804|3167894|P3|Open-Label Extension Study|Subject withdrew consent|4
962589|NCT00687804|3167895|P2|Open-Label Extension Study|Subject withdrew consent|4
962590|NCT00687804|3167896|P1|Open-Label Extension Study|Subject withdrew consent|3
962591|NCT00687804|3167894|P3|Open-Label Extension Study|Adverse Event|2
962592|NCT00687804|3167895|P2|Open-Label Extension Study|Adverse Event|2
962593|NCT00687804|3167896|P1|Open-Label Extension Study|Adverse Event|2
962594|NCT00687804|3167894|P3|Core Study|Protocol Violation|0
962595|NCT00687804|3167895|P2|Core Study|Protocol Violation|1
962596|NCT00687804|3167896|P1|Core Study|Protocol Violation|1
962597|NCT00687804|3167894|P3|Core Study|Death|2
962598|NCT00687804|3167895|P2|Core Study|Death|2
962599|NCT00687804|3167896|P1|Core Study|Death|2
962600|NCT00687804|3167894|P3|Core Study|Lost to Follow-up|0
962601|NCT00687804|3167895|P2|Core Study|Lost to Follow-up|1
962602|NCT00687804|3167896|P1|Core Study|Lost to Follow-up|0
962603|NCT00687804|3167894|P3|Core Study|Withdrawal by Subject|7
962604|NCT00687804|3167895|P2|Core Study|Withdrawal by Subject|7
962605|NCT00687804|3167896|P1|Core Study|Withdrawal by Subject|4
962606|NCT00687804|3167894|P3|Core Study|Lack of Efficacy|1
962607|NCT00687804|3167895|P2|Core Study|Lack of Efficacy|1
962608|NCT00687804|3167896|P1|Core Study|Lack of Efficacy|1
962609|NCT00687804|3167894|P3|Core Study|Abnormal laboratory value(s)|0
962610|NCT00687804|3167895|P2|Core Study|Abnormal laboratory value(s)|0
962611|NCT00687804|3167896|P1|Core Study|Abnormal laboratory value(s)|1
962612|NCT00687804|3167894|P3|Core Study|Adverse Event|3
962613|NCT00687804|3167895|P2|Core Study|Adverse Event|3
962614|NCT00687804|3167896|P1|Core Study|Adverse Event|5
962615|NCT00687609|3167957|P1|Overall Study|Withdrawal by Subject|2
962616|NCT00687609|3167957|P1|Overall Study|Physician Decision|1
962617|NCT00687531|3167980|P1|Overall Study|Lost to Follow-up|26
962618|NCT00687531|3167980|P1|Overall Study|Adverse Event|5
962619|NCT00687531|3167980|P1|Overall Study|Did not meet protocol eligibility|104
962620|NCT00687440|3168003|P1|Overall Study|Missing|1
962621|NCT00687440|3168003|P1|Overall Study|Not specified|1
962622|NCT00687440|3168003|P1|Overall Study|Death|2
962623|NCT00687440|3168003|P1|Overall Study|Lack of Efficacy|2
962624|NCT00687440|3168003|P1|Overall Study|Lost to Follow-up|3
962625|NCT00687440|3168003|P1|Overall Study|Adverse Event|3
962626|NCT00687401|3168007|P1|Overall Study|For reasons different from those above|4
962627|NCT00687401|3168007|P1|Overall Study|Did not return for visit|3
962628|NCT00687401|3168007|P1|Overall Study|Withdrawal by Subject|4
962629|NCT00687401|3168007|P1|Overall Study|Lack of Efficacy|6
962630|NCT00687401|3168007|P1|Overall Study|Adverse Event|6
962631|NCT00687401|3168007|P1|Overall Study|Protocol Violation|7
962632|NCT00687362|3168012|P1|Overall Study|Withdrawal by Subject|1
962633|NCT00687362|3168012|P1|Overall Study|Protocol Violation|2
962634|NCT00687323|3168016|P1|Overall Study|Screen failure|148
962635|NCT00687323|3168016|P1|Overall Study|Excluded from efficacy evaluations|6
962636|NCT00687323|3168016|P1|Overall Study|Withdrawal by Subject|1
962637|NCT00687323|3168016|P1|Overall Study|Death|25
962638|NCT00687297|3168032|P2|Induction|Other|1
962639|NCT00687297|3168033|P1|Induction|Other|0
962640|NCT00687297|3168032|P2|Induction|Physician Decision|2
962641|NCT00687297|3168033|P1|Induction|Physician Decision|0
962642|NCT00687297|3168032|P2|Induction|Patient Noncompliance|0
962643|NCT00687297|3168033|P1|Induction|Patient Noncompliance|1
962644|NCT00687297|3168032|P2|Induction|Ineligible|1
962645|NCT00687297|3168033|P1|Induction|Ineligible|0
962646|NCT00687297|3168032|P2|Induction|Lack of Efficacy|21
962647|NCT00687297|3168033|P1|Induction|Lack of Efficacy|17
962648|NCT00687297|3168032|P2|Induction|Death|11
962649|NCT00687297|3168033|P1|Induction|Death|7
962650|NCT00687297|3168032|P2|Induction|Adverse Event|15
962651|NCT00687297|3168033|P1|Induction|Adverse Event|16
962652|NCT00687297|3168032|P2|Induction|Withdrawal by Subject|4
962653|NCT00687297|3168033|P1|Induction|Withdrawal by Subject|4
962654|NCT00687297|3168032|P2|Randomization|Withdrew before treatment, ineligible|1
962655|NCT00687297|3168033|P1|Randomization|Withdrew before treatment, ineligible|1
962656|NCT00687297|3168032|P2|Randomization|Withdrawal by Subject|0
962657|NCT00687297|3168033|P1|Randomization|Withdrawal by Subject|2
962658|NCT00687271|3168047|P4|Overall Study|Withdrawal by Subject|0
962659|NCT00687271|3168048|P3|Overall Study|Withdrawal by Subject|3
962660|NCT00687271|3168049|P2|Overall Study|Withdrawal by Subject|1
962661|NCT00687271|3168050|P1|Overall Study|Withdrawal by Subject|0
962662|NCT00687271|3168047|P4|Overall Study|Protocol Violation|0
962663|NCT00687271|3168048|P3|Overall Study|Protocol Violation|1
962664|NCT00687271|3168049|P2|Overall Study|Protocol Violation|1
962665|NCT00687271|3168050|P1|Overall Study|Protocol Violation|2
962666|NCT00687271|3168047|P4|Overall Study|Lost to Follow-up|0
962667|NCT00687271|3168048|P3|Overall Study|Lost to Follow-up|0
962668|NCT00687271|3168049|P2|Overall Study|Lost to Follow-up|1
962669|NCT00687271|3168050|P1|Overall Study|Lost to Follow-up|0
962670|NCT00687271|3168047|P4|Overall Study|Adverse Event|0
962671|NCT00687271|3168048|P3|Overall Study|Adverse Event|1
962672|NCT00687271|3168049|P2|Overall Study|Adverse Event|3
962673|NCT00687271|3168050|P1|Overall Study|Adverse Event|1
962674|NCT00687219|3168088|P1|Overall Study|Lack of Efficacy|1
962675|NCT00687219|3168088|P1|Overall Study|Withdrawal by Subject|1
962676|NCT00687219|3168088|P1|Overall Study|HCV-RNA positive conversion|34
962677|NCT00687219|3168088|P1|Overall Study|Discontinuance criteria met|7
962678|NCT00687219|3168088|P1|Overall Study|Adverse Event|8
962679|NCT00687193|3168100|P6|Overall Study|Protocol Violation|0
962680|NCT00687193|3168101|P5|Overall Study|Protocol Violation|2
962681|NCT00687193|3168102|P4|Overall Study|Protocol Violation|1
962682|NCT00687193|3168103|P3|Overall Study|Protocol Violation|0
962683|NCT00687193|3168104|P2|Overall Study|Protocol Violation|2
962684|NCT00687193|3168105|P1|Overall Study|Protocol Violation|1
962685|NCT00687193|3168100|P6|Overall Study|Lack of Efficacy|2
962686|NCT00687193|3168101|P5|Overall Study|Lack of Efficacy|0
962687|NCT00687193|3168102|P4|Overall Study|Lack of Efficacy|0
962688|NCT00687193|3168103|P3|Overall Study|Lack of Efficacy|0
962689|NCT00687193|3168104|P2|Overall Study|Lack of Efficacy|1
962690|NCT00687193|3168105|P1|Overall Study|Lack of Efficacy|1
962691|NCT00687193|3168100|P6|Overall Study|Adverse Event|2
962692|NCT00687193|3168101|P5|Overall Study|Adverse Event|0
962693|NCT00687193|3168102|P4|Overall Study|Adverse Event|3
962694|NCT00687193|3168103|P3|Overall Study|Adverse Event|2
962695|NCT00687193|3168104|P2|Overall Study|Adverse Event|1
962696|NCT00687193|3168105|P1|Overall Study|Adverse Event|0
962697|NCT00686998|3168315|P3|Overall Study|Safety Reasons|0
962698|NCT00686998|3168316|P2|Overall Study|Safety Reasons|0
962699|NCT00686998|3168317|P1|Overall Study|Safety Reasons|1
962700|NCT00686998|3168315|P3|Overall Study|Not specified|1
962701|NCT00686998|3168316|P2|Overall Study|Not specified|0
962702|NCT00686998|3168317|P1|Overall Study|Not specified|0
962703|NCT00686998|3168315|P3|Overall Study|Lack of Efficacy|0
962704|NCT00686998|3168316|P2|Overall Study|Lack of Efficacy|5
962705|NCT00686998|3168317|P1|Overall Study|Lack of Efficacy|7
962706|NCT00686998|3168315|P3|Overall Study|Withdrawal by Subject|2
962707|NCT00686998|3168316|P2|Overall Study|Withdrawal by Subject|1
962708|NCT00686998|3168317|P1|Overall Study|Withdrawal by Subject|2
962709|NCT00686998|3168315|P3|Overall Study|Adverse Event|1
962710|NCT00686998|3168316|P2|Overall Study|Adverse Event|2
962711|NCT00686998|3168317|P1|Overall Study|Adverse Event|3
962712|NCT00686972|3168325|P1|Overall Study|P.I, Left institution. Study terminated|51
962713|NCT00686959|3168331|P2|Overall Study|Participants censored (no death events)|117
962714|NCT00686959|3168332|P1|Overall Study|Participants censored (no death events)|124
962715|NCT00686894|3168350|P1|Overall Study|Protocol Violation|4
962716|NCT00686894|3168350|P1|Overall Study|Relapse|2
962717|NCT00686881|3168356|P2|Overall Study|Never received study drug|6
962718|NCT00686881|3168357|P1|Overall Study|Never received study drug|2
962719|NCT00686881|3168356|P2|Overall Study|Study discontinuation|32
962720|NCT00686881|3168357|P1|Overall Study|Study discontinuation|35
962721|NCT00686881|3168356|P2|Overall Study|Irregular visits|0
962722|NCT00686881|3168357|P1|Overall Study|Irregular visits|1
962723|NCT00686881|3168356|P2|Overall Study|Did not meet protocol eligibility|0
962724|NCT00686881|3168357|P1|Overall Study|Did not meet protocol eligibility|1
962725|NCT00686881|3168356|P2|Overall Study|Circumstances of site|1
962726|NCT00686881|3168357|P1|Overall Study|Circumstances of site|1
962727|NCT00686881|3168356|P2|Overall Study|Physician Decision|0
962728|NCT00686881|3168357|P1|Overall Study|Physician Decision|1
962729|NCT00686881|3168356|P2|Overall Study|Lack of Efficacy|3
962730|NCT00686881|3168357|P1|Overall Study|Lack of Efficacy|4
962731|NCT00686881|3168356|P2|Overall Study|Onset of malignant tumor|11
962732|NCT00686881|3168357|P1|Overall Study|Onset of malignant tumor|11
962733|NCT00686881|3168356|P2|Overall Study|Met discontinuation criteria|0
962734|NCT00686881|3168357|P1|Overall Study|Met discontinuation criteria|5
962735|NCT00686881|3168356|P2|Overall Study|Treatment-related adverse event|9
962736|NCT00686881|3168357|P1|Overall Study|Treatment-related adverse event|10
962737|NCT00686881|3168356|P2|Overall Study|Lost to Follow-up|1
962738|NCT00686881|3168357|P1|Overall Study|Lost to Follow-up|0
962739|NCT00686881|3168356|P2|Overall Study|Withdrawal by Subject|18
962740|NCT00686881|3168357|P1|Overall Study|Withdrawal by Subject|11
962741|NCT00686855|3168369|P2|Overall Study|Progressive GVHD|1
962742|NCT00686855|3168370|P1|Overall Study|Progressive GVHD|0
962743|NCT00686855|3168369|P2|Overall Study|Lost to Follow-up|0
962744|NCT00686855|3168370|P1|Overall Study|Lost to Follow-up|1
962745|NCT00686790|3168396|P1|Overall Study|Lost to Follow-up|12
962746|NCT00686790|3168396|P1|Overall Study|Death|1
962747|NCT00686790|3168396|P1|Overall Study|Withdrawal by Subject|1
962748|NCT00686790|3168396|P1|Overall Study|Adverse Event|2
962749|NCT00686777|3168404|P1|Overall Study|No Visit|1
962750|NCT00686777|3168404|P1|Overall Study|Discontinuance Criteria (specified AEs)|4
962751|NCT00686777|3168404|P1|Overall Study|Withdrawal by Subject|2
962752|NCT00686777|3168404|P1|Overall Study|Pregnancy|1
962753|NCT00686777|3168404|P1|Overall Study|Adverse Event|2
962754|NCT00686725|3168412|P2|Overall Study|Not Specified|3
962755|NCT00686725|3168413|P1|Overall Study|Not Specified|1
962756|NCT00686725|3168412|P2|Overall Study|Protocol Violation|3
962757|NCT00686725|3168413|P1|Overall Study|Protocol Violation|1
962758|NCT00686725|3168412|P2|Overall Study|Withdrawal by Subject|4
962759|NCT00686725|3168413|P1|Overall Study|Withdrawal by Subject|13
962760|NCT00686725|3168412|P2|Overall Study|Death|3
962761|NCT00686725|3168413|P1|Overall Study|Death|6
962762|NCT00686725|3168412|P2|Overall Study|Lost to Follow-up|5
962763|NCT00686725|3168413|P1|Overall Study|Lost to Follow-up|7
962764|NCT00686725|3168412|P2|Overall Study|Progressive Disease|23
962765|NCT00686725|3168413|P1|Overall Study|Progressive Disease|17
962766|NCT00686725|3168412|P2|Overall Study|Adverse Event|1
962767|NCT00686725|3168413|P1|Overall Study|Adverse Event|1
962768|NCT00686712|3168438|P3|Overall Study|Adverse Event|0
962769|NCT00686712|3168439|P2|Overall Study|Adverse Event|1
962770|NCT00686712|3168440|P1|Overall Study|Adverse Event|1
962771|NCT00686712|3168438|P3|Overall Study|Lost to Follow-up|3
962772|NCT00686712|3168439|P2|Overall Study|Lost to Follow-up|2
962773|NCT00686712|3168440|P1|Overall Study|Lost to Follow-up|1
962774|NCT00686712|3168438|P3|Overall Study|Protocol Violation|10
962775|NCT00686712|3168439|P2|Overall Study|Protocol Violation|8
962776|NCT00686712|3168440|P1|Overall Study|Protocol Violation|8
962777|NCT00686699|3168468|P2|Treatment Period 1|Adverse Event|2
962778|NCT00686699|3168469|P1|Treatment Period 1|Adverse Event|0
962779|NCT00686686|3168493|P1|Overall Study|Lost to Follow-up|3
962780|NCT00686686|3168493|P1|Overall Study|Adverse Event|2
962781|NCT00686686|3168493|P1|Overall Study|Non-compliance|1
962782|NCT00686647|3168501|P1|Overall Study|Death|1
962783|NCT00686647|3168501|P1|Overall Study|Lost to Follow-up|1
962784|NCT00686634|3168507|P1|Overall Study|Protocol Violation|6
962785|NCT00686595|3168514|P1|Overall Study|Poor Compliance|1
962786|NCT00686595|3168514|P1|Overall Study|Lack of Efficacy|1
962787|NCT00686595|3168514|P1|Overall Study|Lost to Follow-up|1
962788|NCT00686595|3168514|P1|Overall Study|Protocol Violation|1
962789|NCT00686595|3168514|P1|Overall Study|Adverse Event|3
962790|NCT00686543|3168543|P4|Overall Study|Protocol Violation|1
962791|NCT00686543|3168544|P3|Overall Study|Protocol Violation|2
962792|NCT00686543|3168545|P2|Overall Study|Protocol Violation|0
962793|NCT00686543|3168546|P1|Overall Study|Protocol Violation|3
962794|NCT00686543|3168543|P4|Overall Study|Withdrawal by Subject|0
962795|NCT00686543|3168544|P3|Overall Study|Withdrawal by Subject|0
962796|NCT00686543|3168545|P2|Overall Study|Withdrawal by Subject|0
962797|NCT00686543|3168546|P1|Overall Study|Withdrawal by Subject|2
962798|NCT00686543|3168543|P4|Overall Study|Adverse Event|2
962799|NCT00686543|3168544|P3|Overall Study|Adverse Event|3
962800|NCT00686543|3168545|P2|Overall Study|Adverse Event|1
962801|NCT00686543|3168546|P1|Overall Study|Adverse Event|9
962802|NCT00686517|3168567|P3|Treatment|Protocol Violation|0
962803|NCT00686517|3168568|P2|Treatment|Protocol Violation|1
962804|NCT00686517|3168569|P1|Treatment|Protocol Violation|2
962805|NCT00686517|3168567|P3|Treatment|Poor Protocol Compliance|0
962806|NCT00686517|3168568|P2|Treatment|Poor Protocol Compliance|0
962807|NCT00686517|3168569|P1|Treatment|Poor Protocol Compliance|1
962808|NCT00686517|3168567|P3|Treatment|Adverse Event|0
962809|NCT00686517|3168568|P2|Treatment|Adverse Event|0
962810|NCT00686517|3168569|P1|Treatment|Adverse Event|2
962811|NCT00686517|3168567|P3|Treatment|Serious Adverse Event|1
962812|NCT00686517|3168568|P2|Treatment|Serious Adverse Event|2
962813|NCT00686517|3168569|P1|Treatment|Serious Adverse Event|1
962814|NCT00686374|3168592|P1|Overall Study|Other, not specified|4
962815|NCT00686374|3168592|P1|Overall Study|Missing reason|33
962816|NCT00686374|3168592|P1|Overall Study|Lost to Follow-up|1
962817|NCT00686374|3168592|P1|Overall Study|Withdrew consent|5
962818|NCT00686374|3168592|P1|Overall Study|Adverse Event|8
962819|NCT00686374|3168592|P1|Overall Study|Lack of Efficacy|10
962820|NCT00686335|3168603|P1|Run-in Period|violation of inclusion/exclusion criteri|3
962821|NCT00686335|3168603|P1|Run-in Period|asthma exacerbation|1
962822|NCT00686335|3168603|P1|Run-in Period|Adverse Event|1
962823|NCT00686205|3168647|P2|Overall Study|Specimens not confirmed HIV positive|981
962824|NCT00686205|3168648|P1|Overall Study|Specimens not confirmed HIV positive|0
962825|NCT00686205|3168647|P2|Overall Study|Specimen handling procedure altered|0
962826|NCT00686205|3168648|P1|Overall Study|Specimen handling procedure altered|5878
962827|NCT00686205|3168647|P2|Overall Study|Withdrawal by Subject|0
962828|NCT00686205|3168648|P1|Overall Study|Withdrawal by Subject|2
962829|NCT00686205|3168647|P2|Overall Study|Protocol Violation|0
962830|NCT00686205|3168648|P1|Overall Study|Protocol Violation|127
962831|NCT00686166|3168654|P1|Overall Study|Did not begin protocol therapy|4
962832|NCT00686166|3168654|P1|Overall Study|Ineligible|5
962833|NCT00686166|3168654|P1|Overall Study|Not Protocol Specified|1
962834|NCT00686166|3168654|P1|Overall Study|Death|1
962835|NCT00686166|3168654|P1|Overall Study|Progression/Relapse|1
962836|NCT00686166|3168654|P1|Overall Study|Withdrawal by Subject|1
962837|NCT00686166|3168654|P1|Overall Study|Adverse Event|7
962838|NCT00686127|3168666|P2|Overall Study|Withdrawal by Subject|6
962839|NCT00686127|3168667|P1|Overall Study|Withdrawal by Subject|14
962840|NCT00686075|3168683|P10|Overall Study|Other|1
962841|NCT00686075|3168684|P9|Overall Study|Other|0
962842|NCT00686075|3168685|P8|Overall Study|Other|0
962843|NCT00686075|3168686|P7|Overall Study|Other|0
962844|NCT00686075|3168687|P6|Overall Study|Other|0
962845|NCT00686075|3168688|P5|Overall Study|Other|0
962846|NCT00686075|3168689|P4|Overall Study|Other|0
962847|NCT00686075|3168690|P3|Overall Study|Other|0
962848|NCT00686075|3168691|P2|Overall Study|Other|1
962849|NCT00686075|3168692|P1|Overall Study|Other|1
962850|NCT00686075|3168683|P10|Overall Study|Lost to Follow-up|3
962851|NCT00686075|3168684|P9|Overall Study|Lost to Follow-up|2
962852|NCT00686075|3168685|P8|Overall Study|Lost to Follow-up|0
962853|NCT00686075|3168686|P7|Overall Study|Lost to Follow-up|0
962854|NCT00686075|3168687|P6|Overall Study|Lost to Follow-up|3
962855|NCT00686075|3168688|P5|Overall Study|Lost to Follow-up|3
962856|NCT00686075|3168689|P4|Overall Study|Lost to Follow-up|2
962857|NCT00686075|3168690|P3|Overall Study|Lost to Follow-up|3
962858|NCT00686075|3168691|P2|Overall Study|Lost to Follow-up|6
962859|NCT00686075|3168692|P1|Overall Study|Lost to Follow-up|3
962860|NCT00686075|3168683|P10|Overall Study|Withdrawal by Subject|6
962861|NCT00686075|3168684|P9|Overall Study|Withdrawal by Subject|4
962862|NCT00686075|3168685|P8|Overall Study|Withdrawal by Subject|2
962863|NCT00686075|3168686|P7|Overall Study|Withdrawal by Subject|0
962864|NCT00686075|3168687|P6|Overall Study|Withdrawal by Subject|0
962865|NCT00686075|3168688|P5|Overall Study|Withdrawal by Subject|1
962866|NCT00686075|3168689|P4|Overall Study|Withdrawal by Subject|7
962867|NCT00686075|3168690|P3|Overall Study|Withdrawal by Subject|3
962868|NCT00686075|3168691|P2|Overall Study|Withdrawal by Subject|3
962869|NCT00686075|3168692|P1|Overall Study|Withdrawal by Subject|4
962870|NCT00686036|3168886|P2|Overall Study|Other reasons not identified|4
962871|NCT00686036|3168887|P1|Overall Study|Other reasons not identified|0
962872|NCT00686036|3168886|P2|Overall Study|PSA ≥ 10ng/mL|0
962873|NCT00686036|3168887|P1|Overall Study|PSA ≥ 10ng/mL|1
962874|NCT00686036|3168886|P2|Overall Study|Study terminated by AstraZeneca|1
962875|NCT00686036|3168887|P1|Overall Study|Study terminated by AstraZeneca|2
962876|NCT00686036|3168886|P2|Overall Study|Withdrawal by Subject|1
962877|NCT00686036|3168887|P1|Overall Study|Withdrawal by Subject|3
962878|NCT00686036|3168886|P2|Overall Study|Adverse Event|0
962879|NCT00686036|3168887|P1|Overall Study|Adverse Event|3
962880|NCT00685945|3168899|P1|L-NMMA + Bradykinin|Physician Decision|1
962881|NCT00685802|3168934|P2|Washout Period of 7 Days|Withdrawal by Subject|1
962882|NCT00685802|3168935|P1|Washout Period of 7 Days|Withdrawal by Subject|0
962883|NCT00685802|3168934|P2|Washout Period of 7 Days|Protocol Violation|0
962884|NCT00685802|3168935|P1|Washout Period of 7 Days|Protocol Violation|2
962885|NCT00685763|3168945|P1|Overall Study|Protocol Violation|1
962886|NCT00685763|3168945|P1|Overall Study|Intercurrent death-incomplete treatment|1
962887|NCT00685698|3168949|P1|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1
962888|NCT00685698|3168949|P1|Overall Study|CULTURE RESULTS: GRAM-VE|1
962889|NCT00685698|3168949|P1|Overall Study|CULTURE GRAM NEG SPECIES|1
962890|NCT00685698|3168949|P1|Overall Study|Adverse Event|3
962891|NCT00685698|3168949|P1|Overall Study|Protocol Violation|6
962892|NCT00685698|3168949|P1|Overall Study|Withdrawal by Subject|1
962893|NCT00685685|3168984|P2|Washout Period of 7 Days|Withdrawal by Subject|1
962894|NCT00685685|3168985|P1|Washout Period of 7 Days|Withdrawal by Subject|0
962895|NCT00685685|3168984|P2|Washout Period of 7 Days|Adverse Event|0
962896|NCT00685685|3168985|P1|Washout Period of 7 Days|Adverse Event|2
962897|NCT00685399|3169138|P8|Extension|Adverse Event|0
962898|NCT00685399|3169139|P7|Extension|Adverse Event|0
962899|NCT00685399|3169140|P6|Extension|Adverse Event|0
962900|NCT00685399|3169141|P5|Extension|Adverse Event|0
962901|NCT00685399|3169142|P4|Extension|Adverse Event|2
962902|NCT00685399|3169143|P3|Extension|Adverse Event|0
962903|NCT00685399|3169144|P2|Extension|Adverse Event|0
962904|NCT00685399|3169145|P1|Extension|Adverse Event|0
962905|NCT00685399|3169138|P8|Extension|Lack of Efficacy|0
962906|NCT00685399|3169139|P7|Extension|Lack of Efficacy|0
962907|NCT00685399|3169140|P6|Extension|Lack of Efficacy|0
962908|NCT00685399|3169141|P5|Extension|Lack of Efficacy|0
962909|NCT00685399|3169142|P4|Extension|Lack of Efficacy|2
962910|NCT00685399|3169143|P3|Extension|Lack of Efficacy|0
962911|NCT00685399|3169144|P2|Extension|Lack of Efficacy|0
962912|NCT00685399|3169145|P1|Extension|Lack of Efficacy|0
962913|NCT00685399|3169138|P8|Extension|Protocol Violation|0
962914|NCT00685399|3169139|P7|Extension|Protocol Violation|0
962915|NCT00685399|3169140|P6|Extension|Protocol Violation|0
962916|NCT00685399|3169141|P5|Extension|Protocol Violation|0
962917|NCT00685399|3169142|P4|Extension|Protocol Violation|1
962918|NCT00685399|3169143|P3|Extension|Protocol Violation|0
962919|NCT00685399|3169144|P2|Extension|Protocol Violation|0
962920|NCT00685399|3169145|P1|Extension|Protocol Violation|0
962921|NCT00685399|3169138|P8|Extension|Withdrawal by Subject|0
962922|NCT00685399|3169139|P7|Extension|Withdrawal by Subject|0
962923|NCT00685399|3169140|P6|Extension|Withdrawal by Subject|0
962924|NCT00685399|3169141|P5|Extension|Withdrawal by Subject|0
962925|NCT00685399|3169142|P4|Extension|Withdrawal by Subject|1
962926|NCT00685399|3169143|P3|Extension|Withdrawal by Subject|0
962927|NCT00685399|3169144|P2|Extension|Withdrawal by Subject|0
962928|NCT00685399|3169145|P1|Extension|Withdrawal by Subject|0
962929|NCT00685399|3169138|P8|Extension|Administrative Issues|0
962930|NCT00685399|3169139|P7|Extension|Administrative Issues|0
962931|NCT00685399|3169140|P6|Extension|Administrative Issues|0
962932|NCT00685399|3169141|P5|Extension|Administrative Issues|0
962933|NCT00685399|3169142|P4|Extension|Administrative Issues|1
962934|NCT00685399|3169143|P3|Extension|Administrative Issues|0
962935|NCT00685399|3169144|P2|Extension|Administrative Issues|0
962936|NCT00685399|3169145|P1|Extension|Administrative Issues|0
962937|NCT00685399|3169138|P8|Treatment Period 2|Lack of Efficacy|0
962938|NCT00685399|3169139|P7|Treatment Period 2|Lack of Efficacy|0
962939|NCT00685399|3169140|P6|Treatment Period 2|Lack of Efficacy|1
962940|NCT00685399|3169141|P5|Treatment Period 2|Lack of Efficacy|0
962941|NCT00685399|3169142|P4|Treatment Period 2|Lack of Efficacy|0
962942|NCT00685399|3169143|P3|Treatment Period 2|Lack of Efficacy|2
962943|NCT00685399|3169144|P2|Treatment Period 2|Lack of Efficacy|10
962944|NCT00685399|3169145|P1|Treatment Period 2|Lack of Efficacy|0
962945|NCT00685399|3169138|P8|Treatment Period 2|Adverse Event|0
962946|NCT00685399|3169139|P7|Treatment Period 2|Adverse Event|0
962947|NCT00685399|3169140|P6|Treatment Period 2|Adverse Event|1
962948|NCT00685399|3169141|P5|Treatment Period 2|Adverse Event|0
962949|NCT00685399|3169142|P4|Treatment Period 2|Adverse Event|0
962950|NCT00685399|3169143|P3|Treatment Period 2|Adverse Event|0
962951|NCT00685399|3169144|P2|Treatment Period 2|Adverse Event|0
962952|NCT00685399|3169145|P1|Treatment Period 2|Adverse Event|0
962953|NCT00685399|3169138|P8|Treatment Period 2|Withdrawal by Subject|2
962954|NCT00685399|3169139|P7|Treatment Period 2|Withdrawal by Subject|0
962955|NCT00685399|3169140|P6|Treatment Period 2|Withdrawal by Subject|0
962956|NCT00685399|3169141|P5|Treatment Period 2|Withdrawal by Subject|0
962957|NCT00685399|3169142|P4|Treatment Period 2|Withdrawal by Subject|0
962958|NCT00685399|3169143|P3|Treatment Period 2|Withdrawal by Subject|0
962959|NCT00685399|3169144|P2|Treatment Period 2|Withdrawal by Subject|0
962960|NCT00685399|3169145|P1|Treatment Period 2|Withdrawal by Subject|0
962961|NCT00685399|3169138|P8|Treatment Period 2|Administrative Problems|0
962962|NCT00685399|3169139|P7|Treatment Period 2|Administrative Problems|0
962963|NCT00685399|3169140|P6|Treatment Period 2|Administrative Problems|0
962964|NCT00685399|3169141|P5|Treatment Period 2|Administrative Problems|0
962965|NCT00685399|3169142|P4|Treatment Period 2|Administrative Problems|0
962966|NCT00685399|3169143|P3|Treatment Period 2|Administrative Problems|1
962967|NCT00685399|3169144|P2|Treatment Period 2|Administrative Problems|2
962968|NCT00685399|3169145|P1|Treatment Period 2|Administrative Problems|0
962969|NCT00685399|3169138|P8|Treatment Period 1|Lack of Efficacy|0
962970|NCT00685399|3169139|P7|Treatment Period 1|Lack of Efficacy|0
962971|NCT00685399|3169140|P6|Treatment Period 1|Lack of Efficacy|0
962972|NCT00685399|3169141|P5|Treatment Period 1|Lack of Efficacy|0
962973|NCT00685399|3169142|P4|Treatment Period 1|Lack of Efficacy|0
962974|NCT00685399|3169143|P3|Treatment Period 1|Lack of Efficacy|0
962975|NCT00685399|3169144|P2|Treatment Period 1|Lack of Efficacy|0
962976|NCT00685399|3169145|P1|Treatment Period 1|Lack of Efficacy|1
962977|NCT00685399|3169138|P8|Treatment Period 1|Administrative|0
962978|NCT00685399|3169139|P7|Treatment Period 1|Administrative|0
962979|NCT00685399|3169140|P6|Treatment Period 1|Administrative|0
962980|NCT00685399|3169141|P5|Treatment Period 1|Administrative|0
962981|NCT00685399|3169142|P4|Treatment Period 1|Administrative|0
962982|NCT00685399|3169143|P3|Treatment Period 1|Administrative|0
962983|NCT00685399|3169144|P2|Treatment Period 1|Administrative|0
962984|NCT00685399|3169145|P1|Treatment Period 1|Administrative|2
962985|NCT00685399|3169138|P8|Treatment Period 1|Protocol Violation|0
962986|NCT00685399|3169139|P7|Treatment Period 1|Protocol Violation|0
962987|NCT00685399|3169140|P6|Treatment Period 1|Protocol Violation|0
962988|NCT00685399|3169141|P5|Treatment Period 1|Protocol Violation|0
962989|NCT00685399|3169142|P4|Treatment Period 1|Protocol Violation|0
962990|NCT00685399|3169143|P3|Treatment Period 1|Protocol Violation|0
962991|NCT00685399|3169144|P2|Treatment Period 1|Protocol Violation|0
962992|NCT00685399|3169145|P1|Treatment Period 1|Protocol Violation|1
962993|NCT00685399|3169138|P8|Treatment Period 1|Withdrawal by Subject|0
962994|NCT00685399|3169139|P7|Treatment Period 1|Withdrawal by Subject|0
962995|NCT00685399|3169140|P6|Treatment Period 1|Withdrawal by Subject|0
962996|NCT00685399|3169141|P5|Treatment Period 1|Withdrawal by Subject|0
962997|NCT00685399|3169142|P4|Treatment Period 1|Withdrawal by Subject|0
962998|NCT00685399|3169143|P3|Treatment Period 1|Withdrawal by Subject|0
962999|NCT00685399|3169144|P2|Treatment Period 1|Withdrawal by Subject|0
963000|NCT00685399|3169145|P1|Treatment Period 1|Withdrawal by Subject|2
963001|NCT00685373|3169178|P1|Overall Study|Protocol Violation|1
963002|NCT00685373|3169178|P1|Overall Study|Lost to Follow-up|2
963003|NCT00685373|3169178|P1|Overall Study|Condition no longer requires study drug|1
963004|NCT00685373|3169178|P1|Overall Study|Lack of Efficacy|3
963005|NCT00685373|3169178|P1|Overall Study|Withdrawal by Subject|5
963006|NCT00685373|3169178|P1|Overall Study|Adverse Event|3
963007|NCT00685334|3169187|P2|Overall Study|Chose to enter hospital|1
963008|NCT00685334|3169188|P1|Overall Study|Chose to enter hospital|1
963009|NCT00685334|3169187|P2|Overall Study|Lost to Follow-up|0
963010|NCT00685334|3169188|P1|Overall Study|Lost to Follow-up|4
963011|NCT00685334|3169187|P2|Overall Study|Withdrawal by Subject|6
963012|NCT00685334|3169188|P1|Overall Study|Withdrawal by Subject|5
963013|NCT00685178|3169213|P4|Overall Study|Pregnancy|1
963014|NCT00685178|3169214|P3|Overall Study|Pregnancy|0
963015|NCT00685178|3169215|P2|Overall Study|Pregnancy|0
963016|NCT00685178|3169216|P1|Overall Study|Pregnancy|0
963017|NCT00685178|3169213|P4|Overall Study|administrative (disciplinary) discharge|2
963018|NCT00685178|3169214|P3|Overall Study|administrative (disciplinary) discharge|0
963019|NCT00685178|3169215|P2|Overall Study|administrative (disciplinary) discharge|1
963020|NCT00685178|3169216|P1|Overall Study|administrative (disciplinary) discharge|0
963021|NCT00685178|3169213|P4|Overall Study|incarcerated|0
963022|NCT00685178|3169214|P3|Overall Study|incarcerated|7
963023|NCT00685178|3169215|P2|Overall Study|incarcerated|3
963024|NCT00685178|3169216|P1|Overall Study|incarcerated|1
963025|NCT00685178|3169213|P4|Overall Study|voluntary study discharge|1
963026|NCT00685178|3169214|P3|Overall Study|voluntary study discharge|1
963027|NCT00685178|3169215|P2|Overall Study|voluntary study discharge|5
963028|NCT00685178|3169216|P1|Overall Study|voluntary study discharge|4
963029|NCT00685178|3169213|P4|Overall Study|missed 3 consecutive methadone clin days|6
963030|NCT00685178|3169214|P3|Overall Study|missed 3 consecutive methadone clin days|2
963031|NCT00685178|3169215|P2|Overall Study|missed 3 consecutive methadone clin days|5
963032|NCT00685178|3169216|P1|Overall Study|missed 3 consecutive methadone clin days|7
963033|NCT00685178|3169213|P4|Overall Study|Adverse Event|4
963034|NCT00685178|3169214|P3|Overall Study|Adverse Event|2
963035|NCT00685178|3169215|P2|Overall Study|Adverse Event|5
963036|NCT00685178|3169216|P1|Overall Study|Adverse Event|1
963037|NCT00685165|3169230|P2|Washout Period of 14 Days|Adverse Event|0
963038|NCT00685165|3169231|P1|Washout Period of 14 Days|Adverse Event|1
963039|NCT00685035|3169250|P2|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0
963040|NCT00685035|3169251|P1|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1
963041|NCT00684996|3169275|P1|Overall Study|Other reasons not protocol specified|1
963042|NCT00684996|3169275|P1|Overall Study|Progression/relapse|2
963043|NCT00684996|3169275|P1|Overall Study|Refusal unrelated to adverse event|1
963044|NCT00684996|3169275|P1|Overall Study|Adverse Event|1
963045|NCT00684814|3169307|P2|Second Intervention|Adverse Event|0
963046|NCT00684814|3169308|P1|Second Intervention|Adverse Event|1
963047|NCT00684814|3169307|P2|Washout Period of 7 Days|Withdrawal by Subject|2
963048|NCT00684814|3169308|P1|Washout Period of 7 Days|Withdrawal by Subject|1
963049|NCT00684814|3169307|P2|Washout Period of 7 Days|Adverse Event|2
963050|NCT00684814|3169308|P1|Washout Period of 7 Days|Adverse Event|1
963051|NCT00684762|3169360|P2|Washout Period of 7 Days|Withdrawal by Subject|2
963052|NCT00684762|3169361|P1|Washout Period of 7 Days|Withdrawal by Subject|2
963053|NCT00684671|3169389|P3|Overall Study|Alcoholic dependance|0
963054|NCT00684671|3169390|P2|Overall Study|Alcoholic dependance|0
963055|NCT00684671|3169391|P1|Overall Study|Alcoholic dependance|1
963056|NCT00684671|3169389|P3|Overall Study|Lost to Follow-up|0
963057|NCT00684671|3169390|P2|Overall Study|Lost to Follow-up|0
963058|NCT00684671|3169391|P1|Overall Study|Lost to Follow-up|1
963059|NCT00684671|3169389|P3|Overall Study|Adverse Event|0
963060|NCT00684671|3169390|P2|Overall Study|Adverse Event|0
963061|NCT00684671|3169391|P1|Overall Study|Adverse Event|1
963062|NCT00684645|3169420|P1|Overall Study|Not specified|15
963063|NCT00684645|3169420|P1|Overall Study|Lost to Follow-up|3
963064|NCT00684645|3169420|P1|Overall Study|Adverse Event|27
963065|NCT00684645|3169420|P1|Overall Study|Progressive disease|67
963066|NCT00684645|3169420|P1|Overall Study|Death|2
963067|NCT00684593|3169440|P2|Overall Study|Adverse Event|2
963068|NCT00684593|3169441|P1|Overall Study|Adverse Event|0
963069|NCT00684567|3169453|P1|Monotherapy Period|Progression of primary disease|11
963070|NCT00684567|3169453|P1|Monotherapy Period|Death|1
963071|NCT00684567|3169453|P1|Monotherapy Period|Adverse Event|2
963072|NCT00684567|3169453|P1|Concomitant Radiotherapy Period|Adverse Event|2
963073|NCT00684515|3169486|P3|Overall Study|Protocol-Defined Clinical Event|0
963074|NCT00684515|3169487|P2|Overall Study|Protocol-Defined Clinical Event|0
963075|NCT00684515|3169488|P1|Overall Study|Protocol-Defined Clinical Event|1
963076|NCT00684515|3169486|P3|Overall Study|Adverse Event|1
963077|NCT00684515|3169487|P2|Overall Study|Adverse Event|3
963078|NCT00684515|3169488|P1|Overall Study|Adverse Event|3
963079|NCT00684424|3169511|P1|Overall Study|Not Specified|2
963080|NCT00684424|3169511|P1|Overall Study|Lost to Follow-up|2
963081|NCT00684424|3169511|P1|Overall Study|Adverse Event|1
963082|NCT00684411|3169526|P1|Overall Study|Adverse Event|1
963083|NCT00684411|3169526|P1|Overall Study|Disease Progression|10
963084|NCT00684411|3169526|P1|Overall Study|New Primary Cancer|1
963085|NCT00684307|3169548|P5|Overall Study|Criteria from the CSR|3
963086|NCT00684307|3169549|P4|Overall Study|Criteria from the CSR|3
963087|NCT00684307|3169550|P3|Overall Study|Criteria from the CSR|1
963088|NCT00684307|3169551|P2|Overall Study|Criteria from the CSR|0
963089|NCT00684307|3169552|P1|Overall Study|Criteria from the CSR|0
963090|NCT00684307|3169548|P5|Overall Study|Participant not willing to continue|8
963091|NCT00684307|3169549|P4|Overall Study|Participant not willing to continue|5
963092|NCT00684307|3169550|P3|Overall Study|Participant not willing to continue|11
963093|NCT00684307|3169551|P2|Overall Study|Participant not willing to continue|10
963094|NCT00684307|3169552|P1|Overall Study|Participant not willing to continue|7
963095|NCT00684307|3169548|P5|Overall Study|Severe non compliance to protocol|2
963096|NCT00684307|3169549|P4|Overall Study|Severe non compliance to protocol|1
963097|NCT00684307|3169550|P3|Overall Study|Severe non compliance to protocol|0
963098|NCT00684307|3169551|P2|Overall Study|Severe non compliance to protocol|0
963099|NCT00684307|3169552|P1|Overall Study|Severe non compliance to protocol|1
963100|NCT00684307|3169548|P5|Overall Study|Interupted IP for more than 7 days|3
963101|NCT00684307|3169549|P4|Overall Study|Interupted IP for more than 7 days|3
963102|NCT00684307|3169550|P3|Overall Study|Interupted IP for more than 7 days|1
963103|NCT00684307|3169551|P2|Overall Study|Interupted IP for more than 7 days|4
963104|NCT00684307|3169552|P1|Overall Study|Interupted IP for more than 7 days|0
963105|NCT00684307|3169548|P5|Overall Study|Incorrect enrolment or randomization|0
963106|NCT00684307|3169549|P4|Overall Study|Incorrect enrolment or randomization|0
963107|NCT00684307|3169550|P3|Overall Study|Incorrect enrolment or randomization|0
963108|NCT00684307|3169551|P2|Overall Study|Incorrect enrolment or randomization|0
963109|NCT00684307|3169552|P1|Overall Study|Incorrect enrolment or randomization|4
963110|NCT00684307|3169548|P5|Overall Study|Fullfillment of exclusion criteria|1
963111|NCT00684307|3169549|P4|Overall Study|Fullfillment of exclusion criteria|3
963112|NCT00684307|3169550|P3|Overall Study|Fullfillment of exclusion criteria|0
963113|NCT00684307|3169551|P2|Overall Study|Fullfillment of exclusion criteria|0
963114|NCT00684307|3169552|P1|Overall Study|Fullfillment of exclusion criteria|1
963115|NCT00684307|3169548|P5|Overall Study|Development of increasing Liver Function|0
963116|NCT00684307|3169549|P4|Overall Study|Development of increasing Liver Function|1
963117|NCT00684307|3169550|P3|Overall Study|Development of increasing Liver Function|0
963118|NCT00684307|3169551|P2|Overall Study|Development of increasing Liver Function|2
963119|NCT00684307|3169552|P1|Overall Study|Development of increasing Liver Function|0
963120|NCT00684307|3169548|P5|Overall Study|Adverse Event|8
963121|NCT00684307|3169549|P4|Overall Study|Adverse Event|16
963122|NCT00684307|3169550|P3|Overall Study|Adverse Event|15
963123|NCT00684307|3169551|P2|Overall Study|Adverse Event|6
963124|NCT00684307|3169552|P1|Overall Study|Adverse Event|11
963125|NCT00684203|3169634|P6|Overall Study|Did not meet protocol eligibility|0
963126|NCT00684203|3169635|P5|Overall Study|Did not meet protocol eligibility|0
963127|NCT00684203|3169636|P4|Overall Study|Did not meet protocol eligibility|0
963128|NCT00684203|3169637|P3|Overall Study|Did not meet protocol eligibility|0
963129|NCT00684203|3169638|P2|Overall Study|Did not meet protocol eligibility|1
963130|NCT00684203|3169639|P1|Overall Study|Did not meet protocol eligibility|0
963131|NCT00684203|3169634|P6|Overall Study|Withdrawal by Subject|0
963132|NCT00684203|3169635|P5|Overall Study|Withdrawal by Subject|0
963133|NCT00684203|3169636|P4|Overall Study|Withdrawal by Subject|0
963134|NCT00684203|3169637|P3|Overall Study|Withdrawal by Subject|1
963135|NCT00684203|3169638|P2|Overall Study|Withdrawal by Subject|2
963136|NCT00684203|3169639|P1|Overall Study|Withdrawal by Subject|0
963137|NCT00684203|3169634|P6|Overall Study|Protocol-defined clinical event|0
963138|NCT00684203|3169635|P5|Overall Study|Protocol-defined clinical event|0
963139|NCT00684203|3169636|P4|Overall Study|Protocol-defined clinical event|0
963140|NCT00684203|3169637|P3|Overall Study|Protocol-defined clinical event|0
963141|NCT00684203|3169638|P2|Overall Study|Protocol-defined clinical event|1
963142|NCT00684203|3169639|P1|Overall Study|Protocol-defined clinical event|3
963143|NCT00684203|3169634|P6|Overall Study|Adverse Event|0
963144|NCT00684203|3169635|P5|Overall Study|Adverse Event|0
963145|NCT00684203|3169636|P4|Overall Study|Adverse Event|0
963146|NCT00684203|3169637|P3|Overall Study|Adverse Event|8
963147|NCT00684203|3169638|P2|Overall Study|Adverse Event|4
963148|NCT00684203|3169639|P1|Overall Study|Adverse Event|6
963149|NCT00684177|3169700|P2|Overall Study|Other|2
963150|NCT00684177|3169701|P1|Overall Study|Other|1
963151|NCT00684177|3169700|P2|Overall Study|Withdrawal by Subject|2
963152|NCT00684177|3169701|P1|Overall Study|Withdrawal by Subject|1
963153|NCT00684177|3169700|P2|Overall Study|Physician Decision|0
963154|NCT00684177|3169701|P1|Overall Study|Physician Decision|2
963155|NCT00684177|3169700|P2|Overall Study|Lost to Follow-up|1
963156|NCT00684177|3169701|P1|Overall Study|Lost to Follow-up|2
963157|NCT00684177|3169700|P2|Overall Study|Protocol Violation|0
963158|NCT00684177|3169701|P1|Overall Study|Protocol Violation|1
963159|NCT00684177|3169700|P2|Overall Study|Lack of Efficacy|15
963160|NCT00684177|3169701|P1|Overall Study|Lack of Efficacy|10
963161|NCT00684177|3169700|P2|Overall Study|Adverse Event|3
963162|NCT00684177|3169701|P1|Overall Study|Adverse Event|4
963163|NCT00684073|3169736|P1|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1
963164|NCT00684073|3169736|P1|Selection|request of the sponsor|1
963165|NCT00684073|3169736|P1|Selection|Lost to Follow-up|1
963166|NCT00684073|3169736|P1|Selection|noncompliance|1
963167|NCT00684073|3169736|P1|Selection|Death|1
963168|NCT00684073|3169736|P1|Selection|Selection/non-selection criteria|3
963169|NCT00684060|3169746|P2|Overall Study|Death|1
963170|NCT00684060|3169747|P1|Overall Study|Death|0
963171|NCT00684060|3169746|P2|Overall Study|Unable to collect MRI|2
963172|NCT00684060|3169747|P1|Overall Study|Unable to collect MRI|1
963173|NCT00684060|3169746|P2|Overall Study|New stenosis identified|0
963174|NCT00684060|3169747|P1|Overall Study|New stenosis identified|1
963175|NCT00684060|3169746|P2|Overall Study|Lost to Follow-up|0
963176|NCT00684060|3169747|P1|Overall Study|Lost to Follow-up|1
963177|NCT00684021|3169786|P4|Overall Study|Death|0
963178|NCT00684021|3169787|P3|Overall Study|Death|0
963179|NCT00684021|3169788|P2|Overall Study|Death|0
963180|NCT00684021|3169789|P1|Overall Study|Death|1
963181|NCT00684021|3169786|P4|Overall Study|MRI not performed|2
963182|NCT00684021|3169787|P3|Overall Study|MRI not performed|1
963183|NCT00684021|3169788|P2|Overall Study|MRI not performed|1
963184|NCT00684021|3169789|P1|Overall Study|MRI not performed|0
963185|NCT00684021|3169786|P4|Overall Study|MRI Contraindicated|0
963186|NCT00684021|3169787|P3|Overall Study|MRI Contraindicated|1
963187|NCT00684021|3169788|P2|Overall Study|MRI Contraindicated|1
963188|NCT00684021|3169789|P1|Overall Study|MRI Contraindicated|1
963189|NCT00683917|3169850|P1|Overall Study|Study prematurely terminated|10
963190|NCT00683904|3169860|P2|Dose Level 2|Adverse Event|2
963191|NCT00683904|3169861|P1|Dose Level 2|Adverse Event|0
963192|NCT00683904|3169860|P2|Dose Level 1|Adverse Event|0
963193|NCT00683904|3169861|P1|Dose Level 1|Adverse Event|1
963194|NCT00683904|3169860|P2|Dose Level 1|Disease progression|0
963195|NCT00683904|3169861|P1|Dose Level 1|Disease progression|2
963196|NCT00683878|3169897|P3|Overall Study|Non-compliance, not met criteria etc.|0
963197|NCT00683878|3169898|P2|Overall Study|Non-compliance, not met criteria etc.|2
963198|NCT00683878|3169899|P1|Overall Study|Non-compliance, not met criteria etc.|3
963199|NCT00683878|3169897|P3|Overall Study|Lost to Follow-up|4
963200|NCT00683878|3169898|P2|Overall Study|Lost to Follow-up|2
963201|NCT00683878|3169899|P1|Overall Study|Lost to Follow-up|4
963202|NCT00683878|3169897|P3|Overall Study|Death|0
963203|NCT00683878|3169898|P2|Overall Study|Death|1
963204|NCT00683878|3169899|P1|Overall Study|Death|0
963205|NCT00683878|3169897|P3|Overall Study|Withdrawal by Subject|6
963206|NCT00683878|3169898|P2|Overall Study|Withdrawal by Subject|8
963207|NCT00683878|3169899|P1|Overall Study|Withdrawal by Subject|9
963208|NCT00683878|3169897|P3|Overall Study|Adverse Event|3
963209|NCT00683878|3169898|P2|Overall Study|Adverse Event|3
963210|NCT00683878|3169899|P1|Overall Study|Adverse Event|4
963211|NCT00683878|3169897|P3|Overall Study|Lack of Efficacy|1
963212|NCT00683878|3169898|P2|Overall Study|Lack of Efficacy|0
963213|NCT00683878|3169899|P1|Overall Study|Lack of Efficacy|3
963214|NCT00683800|3169973|P2|Overall Study|Randomized, not treated|33
963215|NCT00683800|3169974|P1|Overall Study|Randomized, not treated|35
963216|NCT00683800|3169973|P2|Overall Study|Lack of Efficacy|104
963217|NCT00683800|3169974|P1|Overall Study|Lack of Efficacy|61
963218|NCT00683800|3169973|P2|Overall Study|Withdrawal by Subject|64
963219|NCT00683800|3169974|P1|Overall Study|Withdrawal by Subject|66
963220|NCT00683800|3169973|P2|Overall Study|Protocol Violation|16
963221|NCT00683800|3169974|P1|Overall Study|Protocol Violation|13
963222|NCT00683800|3169973|P2|Overall Study|Other|2
963223|NCT00683800|3169974|P1|Overall Study|Other|5
963224|NCT00683800|3169973|P2|Overall Study|Lost to Follow-up|44
963225|NCT00683800|3169974|P1|Overall Study|Lost to Follow-up|57
963226|NCT00683800|3169973|P2|Overall Study|Death|1
963227|NCT00683800|3169974|P1|Overall Study|Death|0
963228|NCT00683800|3169973|P2|Overall Study|Adverse Event|102
963229|NCT00683800|3169974|P1|Overall Study|Adverse Event|195
963230|NCT00683787|3170041|P3|Overall Study|Adverse Event|2
963231|NCT00683787|3170042|P2|Overall Study|Adverse Event|0
963232|NCT00683787|3170043|P1|Overall Study|Adverse Event|0
963233|NCT00683787|3170041|P3|Overall Study|Progression|0
963234|NCT00683787|3170042|P2|Overall Study|Progression|3
963235|NCT00683787|3170043|P1|Overall Study|Progression|3
963236|NCT00683774|3170062|P2|Overall Study|Physician Decision|0
963237|NCT00683774|3170063|P1|Overall Study|Physician Decision|3
963238|NCT00683774|3170062|P2|Overall Study|Withdrawal by Subject|1
963239|NCT00683774|3170063|P1|Overall Study|Withdrawal by Subject|0
963240|NCT00683696|3170073|P2|Overall Study|Death|30
963241|NCT00683696|3170074|P1|Overall Study|Death|46
963242|NCT00683696|3170073|P2|Overall Study|Vital status follow-up only|3
963243|NCT00683696|3170074|P1|Overall Study|Vital status follow-up only|3
963244|NCT00683696|3170073|P2|Overall Study|Lost to Follow-up|6
963245|NCT00683696|3170074|P1|Overall Study|Lost to Follow-up|5
963246|NCT00683696|3170073|P2|Overall Study|Withdrawn prior to study closure|28
963247|NCT00683696|3170074|P1|Overall Study|Withdrawn prior to study closure|13
963248|NCT00683696|3170073|P2|Overall Study|Withdrawn due to study closure|338
963249|NCT00683696|3170074|P1|Overall Study|Withdrawn due to study closure|337
963250|NCT00683657|3170093|P2|Overall Study|Subject Withdrew Consent|0
963251|NCT00683657|3170094|P1|Overall Study|Subject Withdrew Consent|1
963252|NCT00683657|3170093|P2|Overall Study|Adverse Event|1
963253|NCT00683657|3170094|P1|Overall Study|Adverse Event|0
963254|NCT00683644|3170110|P2|Overall Study|Low copper, other health problems,|6
963255|NCT00683644|3170111|P1|Overall Study|Low copper, other health problems,|7
963256|NCT00683644|3170110|P2|Overall Study|Adverse Event|2
963257|NCT00683644|3170111|P1|Overall Study|Adverse Event|1
963258|NCT00683644|3170110|P2|Overall Study|Lost to Follow-up|4
963259|NCT00683644|3170111|P1|Overall Study|Lost to Follow-up|1
963260|NCT00683644|3170110|P2|Overall Study|Withdrawal by Subject|2
963261|NCT00683644|3170111|P1|Overall Study|Withdrawal by Subject|4
963262|NCT00683618|3170124|P3|Extension Treatment Period|Protocol Violation|0
963263|NCT00683618|3170125|P2|Extension Treatment Period|Protocol Violation|0
963264|NCT00683618|3170126|P1|Extension Treatment Period|Protocol Violation|1
963265|NCT00683618|3170124|P3|Extension Treatment Period|Adverse Event|0
963266|NCT00683618|3170125|P2|Extension Treatment Period|Adverse Event|0
963267|NCT00683618|3170126|P1|Extension Treatment Period|Adverse Event|1
963268|NCT00683618|3170124|P3|Extension Treatment Period|Withdrawal by Subject|0
963269|NCT00683618|3170125|P2|Extension Treatment Period|Withdrawal by Subject|0
963270|NCT00683618|3170126|P1|Extension Treatment Period|Withdrawal by Subject|1
963271|NCT00683618|3170124|P3|Randomised Treatment Period|Reason not provided|2
963272|NCT00683618|3170125|P2|Randomised Treatment Period|Reason not provided|0
963273|NCT00683618|3170126|P1|Randomised Treatment Period|Reason not provided|0
963274|NCT00683618|3170124|P3|Randomised Treatment Period|Adverse Event|2
963275|NCT00683618|3170125|P2|Randomised Treatment Period|Adverse Event|0
963276|NCT00683618|3170126|P1|Randomised Treatment Period|Adverse Event|2
963277|NCT00683618|3170124|P3|Randomised Treatment Period|Protocol Violation|0
963278|NCT00683618|3170125|P2|Randomised Treatment Period|Protocol Violation|1
963279|NCT00683618|3170126|P1|Randomised Treatment Period|Protocol Violation|0
963280|NCT00683618|3170124|P3|Randomised Treatment Period|Withdrawal by Subject|2
963281|NCT00683618|3170125|P2|Randomised Treatment Period|Withdrawal by Subject|1
963282|NCT00683618|3170126|P1|Randomised Treatment Period|Withdrawal by Subject|4
963283|NCT00683592|3170176|P2|Overall Study|Other|1
963284|NCT00683592|3170177|P1|Overall Study|Other|1
963285|NCT00683592|3170176|P2|Overall Study|Non-compliance|5
963286|NCT00683592|3170177|P1|Overall Study|Non-compliance|3
963287|NCT00683592|3170176|P2|Overall Study|Physician Decision|1
963288|NCT00683592|3170177|P1|Overall Study|Physician Decision|0
963289|NCT00683592|3170176|P2|Overall Study|Lack of Efficacy|7
963290|NCT00683592|3170177|P1|Overall Study|Lack of Efficacy|3
963291|NCT00683592|3170176|P2|Overall Study|Lost to Follow-up|17
963292|NCT00683592|3170177|P1|Overall Study|Lost to Follow-up|17
963293|NCT00683592|3170176|P2|Overall Study|Withdrawal by Subject|11
963294|NCT00683592|3170177|P1|Overall Study|Withdrawal by Subject|11
963295|NCT00683592|3170176|P2|Overall Study|Adverse Event|4
963296|NCT00683592|3170177|P1|Overall Study|Adverse Event|12
963297|NCT00683475|3170195|P2|Overall Study|Never Treated: Progressive Disease|0
963298|NCT00683475|3170196|P1|Overall Study|Never Treated: Progressive Disease|1
963299|NCT00683475|3170195|P2|Overall Study|Never Treated: Adverse Event|3
963300|NCT00683475|3170196|P1|Overall Study|Never Treated: Adverse Event|2
963301|NCT00683475|3170195|P2|Overall Study|Withdrawal by Subject|0
963302|NCT00683475|3170196|P1|Overall Study|Withdrawal by Subject|1
963303|NCT00683449|3170231|P5|Overall Study|Lost to Follow-up|0
963304|NCT00683449|3170232|P4|Overall Study|Lost to Follow-up|0
963305|NCT00683449|3170233|P3|Overall Study|Lost to Follow-up|0
963306|NCT00683449|3170234|P2|Overall Study|Lost to Follow-up|1
963307|NCT00683449|3170235|P1|Overall Study|Lost to Follow-up|0
963308|NCT00683384|3170261|P1|Overall Study|Adverse Event|1
963309|NCT00683384|3170261|P1|Overall Study|Death|1
963310|NCT00683293|3170271|P2|Overall Study|Withdrawal by Subject|3
963311|NCT00683293|3170272|P1|Overall Study|Withdrawal by Subject|2
963312|NCT00682929|3170335|P3|Overall Study|lag in DEA renewal|0
963313|NCT00682929|3170336|P2|Overall Study|lag in DEA renewal|0
963314|NCT00682929|3170337|P1|Overall Study|lag in DEA renewal|1
963315|NCT00682929|3170335|P3|Overall Study|dosing compliance < 80%|0
963316|NCT00682929|3170336|P2|Overall Study|dosing compliance < 80%|2
963317|NCT00682929|3170337|P1|Overall Study|dosing compliance < 80%|0
963318|NCT00682929|3170335|P3|Overall Study|Withdrawal by Subject|1
963319|NCT00682929|3170336|P2|Overall Study|Withdrawal by Subject|2
963320|NCT00682929|3170337|P1|Overall Study|Withdrawal by Subject|1
963321|NCT00682929|3170335|P3|Overall Study|Adverse Event|1
963322|NCT00682929|3170336|P2|Overall Study|Adverse Event|1
963323|NCT00682929|3170337|P1|Overall Study|Adverse Event|4
963324|NCT00682890|3170506|P2|Overall Study|heavy menstrual bleeding|0
963325|NCT00682890|3170507|P1|Overall Study|heavy menstrual bleeding|1
963326|NCT00682890|3170506|P2|Overall Study|subject moved away|1
963327|NCT00682890|3170507|P1|Overall Study|subject moved away|0
963328|NCT00682890|3170506|P2|Overall Study|Lost to Follow-up|1
963329|NCT00682890|3170507|P1|Overall Study|Lost to Follow-up|1
963330|NCT00682786|3170549|P2|Overall Study|Did not receive irinotecan|1
963331|NCT00682786|3170550|P1|Overall Study|Did not receive irinotecan|0
963332|NCT00682786|3170549|P2|Overall Study|Withdrawal by Subject|2
963333|NCT00682786|3170550|P1|Overall Study|Withdrawal by Subject|2
963334|NCT00682643|3170599|P2|Overall Study|Did Not Receive Study Drug|1
963335|NCT00682643|3170600|P1|Overall Study|Did Not Receive Study Drug|1
963336|NCT00682643|3170599|P2|Overall Study|Withdrawal by Subject|53
963337|NCT00682643|3170600|P1|Overall Study|Withdrawal by Subject|19
963338|NCT00682643|3170599|P2|Overall Study|Physician Decision|6
963339|NCT00682643|3170600|P1|Overall Study|Physician Decision|2
963340|NCT00682643|3170599|P2|Overall Study|Lost to Follow-up|6
963341|NCT00682643|3170600|P1|Overall Study|Lost to Follow-up|1
963342|NCT00682643|3170599|P2|Overall Study|Met Protocol-defined Stopping Criteria|4
963343|NCT00682643|3170600|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
963344|NCT00682643|3170599|P2|Overall Study|Protocol Violation|76
963345|NCT00682643|3170600|P1|Overall Study|Protocol Violation|38
963346|NCT00682643|3170599|P2|Overall Study|Lack of Efficacy|0
963347|NCT00682643|3170600|P1|Overall Study|Lack of Efficacy|2
963348|NCT00682643|3170599|P2|Overall Study|Adverse Event|23
963349|NCT00682643|3170600|P1|Overall Study|Adverse Event|12
963350|NCT00682539|3170661|P3|Ranibizumab vs Triamcinolone|Lost to Follow-up|8
963351|NCT00682539|3170662|P2|Ranibizumab vs Triamcinolone|Lost to Follow-up|3
963352|NCT00682539|3170663|P1|Ranibizumab vs Triamcinolone|Lost to Follow-up|0
963353|NCT00682539|3170661|P3|Bevacizumab vs Triamcinolone|Lost to Follow-up|0
963354|NCT00682539|3170662|P2|Bevacizumab vs Triamcinolone|Lost to Follow-up|1
963355|NCT00682539|3170663|P1|Bevacizumab vs Triamcinolone|Lost to Follow-up|3
963356|NCT00682461|3170676|P2|Overall Study|Withdrawal by Subject|19
963357|NCT00682461|3170677|P1|Overall Study|Withdrawal by Subject|12
963358|NCT00682461|3170676|P2|Overall Study|Lost to Follow-up|5
963359|NCT00682461|3170677|P1|Overall Study|Lost to Follow-up|8
963360|NCT00682461|3170676|P2|Overall Study|Adverse Event|7
963361|NCT00682461|3170677|P1|Overall Study|Adverse Event|5
963362|NCT00682435|3170691|P1|Overall Study|Erroneously enrolled twice|2
963363|NCT00682435|3170691|P1|Overall Study|Insufficient data|5
963364|NCT00681863|3170724|P1|Overall Study|not specified|18
963365|NCT00681863|3170724|P1|Overall Study|Lack of Efficacy|2
963366|NCT00681863|3170724|P1|Overall Study|Lost to Follow-up|2
963367|NCT00681863|3170724|P1|Overall Study|Adverse Event|1
963368|NCT00681824|3170772|P3|Overall Study|Death|0
963369|NCT00681824|3170773|P2|Overall Study|Death|1
963370|NCT00681824|3170774|P1|Overall Study|Death|0
963371|NCT00681824|3170772|P3|Overall Study|scheduling conflict|0
963372|NCT00681824|3170773|P2|Overall Study|scheduling conflict|0
963373|NCT00681824|3170774|P1|Overall Study|scheduling conflict|1
963374|NCT00681824|3170772|P3|Overall Study|withdrawn by investigator|1
963375|NCT00681824|3170773|P2|Overall Study|withdrawn by investigator|0
963376|NCT00681824|3170774|P1|Overall Study|withdrawn by investigator|0
963377|NCT00681811|3170792|P2|Overall Study|Non-compliance|1
963378|NCT00681811|3170793|P1|Overall Study|Non-compliance|0
963379|NCT00681811|3170792|P2|Overall Study|Withdrawal by Subject|2
963380|NCT00681811|3170793|P1|Overall Study|Withdrawal by Subject|2
963381|NCT00681811|3170792|P2|Overall Study|Adverse Event|1
963382|NCT00681811|3170793|P1|Overall Study|Adverse Event|1
963383|NCT00681668|3170821|P1|Overall Study|Withdrawal by Subject|1
963384|NCT00681668|3170821|P1|Overall Study|Protocol Violation|1
963385|NCT00681629|3170830|P2|Overall Study|Adverse Event|0
963386|NCT00681629|3170831|P1|Overall Study|Adverse Event|1
963387|NCT00681629|3170830|P2|Overall Study|Study termination|2
963388|NCT00681629|3170831|P1|Overall Study|Study termination|4
963389|NCT00681590|3170877|P2|Overall Study|Withdrawal by Subject|12
963390|NCT00681590|3170878|P1|Overall Study|Withdrawal by Subject|2
963391|NCT00681564|3170888|P2|Overall Study|Death|1
963392|NCT00681564|3170889|P1|Overall Study|Death|0
963393|NCT00681564|3170888|P2|Overall Study|Withdrawal by Subject|1
963394|NCT00681564|3170889|P1|Overall Study|Withdrawal by Subject|0
963395|NCT00681564|3170888|P2|Overall Study|Lost to Follow-up|6
963396|NCT00681564|3170889|P1|Overall Study|Lost to Follow-up|6
963397|NCT00681187|3170981|P2|Overall Study|Adverse Event|1
963398|NCT00681187|3170982|P1|Overall Study|Adverse Event|0
963399|NCT00681187|3170981|P2|Overall Study|Death|1
963400|NCT00681187|3170982|P1|Overall Study|Death|0
963401|NCT00681187|3170981|P2|Overall Study|Withdrawal by Subject|0
963402|NCT00681187|3170982|P1|Overall Study|Withdrawal by Subject|1
963403|NCT00681109|3171017|P3|Overall Study|Lost to Follow-up|0
963404|NCT00681109|3171018|P2|Overall Study|Lost to Follow-up|6
963405|NCT00681109|3171019|P1|Overall Study|Lost to Follow-up|2
963406|NCT00680914|3171069|P2|Overall Study|serious adverse event (SAE)|1
963407|NCT00680914|3171070|P1|Overall Study|serious adverse event (SAE)|0
963408|NCT00680914|3171069|P2|Overall Study|Lost to Follow-up|0
963409|NCT00680914|3171070|P1|Overall Study|Lost to Follow-up|4
963410|NCT00680914|3171069|P2|Overall Study|Consent withdrawal|3
963411|NCT00680914|3171070|P1|Overall Study|Consent withdrawal|6
963412|NCT00680901|3171104|P2|Overall Study|Ongoing: In Follow Up|41
963413|NCT00680901|3171105|P1|Overall Study|Ongoing: In Follow Up|45
963414|NCT00680901|3171104|P2|Overall Study|Ongoing: On Study Treatment|13
963415|NCT00680901|3171105|P1|Overall Study|Ongoing: On Study Treatment|16
963416|NCT00680901|3171104|P2|Overall Study|Physician Decision|1
963417|NCT00680901|3171105|P1|Overall Study|Physician Decision|0
963418|NCT00680901|3171104|P2|Overall Study|Withdrawal by Subject|13
963419|NCT00680901|3171105|P1|Overall Study|Withdrawal by Subject|4
963420|NCT00680901|3171104|P2|Overall Study|Lost to Follow-up|8
963421|NCT00680901|3171105|P1|Overall Study|Lost to Follow-up|8
963422|NCT00680836|3171143|P2|Overall Study|Physician Decision|1
963423|NCT00680836|3171144|P1|Overall Study|Physician Decision|2
963424|NCT00680836|3171143|P2|Overall Study|Lost to Follow-up|1
963425|NCT00680836|3171144|P1|Overall Study|Lost to Follow-up|3
963426|NCT00680836|3171143|P2|Overall Study|Withdrawal by Subject|0
963427|NCT00680836|3171144|P1|Overall Study|Withdrawal by Subject|3
963428|NCT00680771|3171198|P2|Overall Study|Prior Exposure to Hepatitus B Vaccine|2
963429|NCT00680771|3171199|P1|Overall Study|Prior Exposure to Hepatitus B Vaccine|4
963430|NCT00680771|3171198|P2|Overall Study|Sleep Apnea suspected after PSG|0
963431|NCT00680771|3171199|P1|Overall Study|Sleep Apnea suspected after PSG|1
963432|NCT00680771|3171198|P2|Overall Study|Withdrawal by Subject|0
963433|NCT00680771|3171199|P1|Overall Study|Withdrawal by Subject|1
963434|NCT00680745|3171209|P4|Overall Study|False Treatment|0
963435|NCT00680745|3171210|P3|Overall Study|False Treatment|3
963436|NCT00680745|3171211|P2|Overall Study|False Treatment|1
963437|NCT00680745|3171212|P1|Overall Study|False Treatment|0
963438|NCT00680745|3171209|P4|Overall Study|Subject No Longer Meets Study Criteria|2
963439|NCT00680745|3171210|P3|Overall Study|Subject No Longer Meets Study Criteria|0
963440|NCT00680745|3171211|P2|Overall Study|Subject No Longer Meets Study Criteria|2
963441|NCT00680745|3171212|P1|Overall Study|Subject No Longer Meets Study Criteria|0
963442|NCT00680745|3171209|P4|Overall Study|Poor/Non-compliance|0
963443|NCT00680745|3171210|P3|Overall Study|Poor/Non-compliance|0
963444|NCT00680745|3171211|P2|Overall Study|Poor/Non-compliance|3
963445|NCT00680745|3171212|P1|Overall Study|Poor/Non-compliance|0
963446|NCT00680745|3171209|P4|Overall Study|Adverse Event|3
963447|NCT00680745|3171210|P3|Overall Study|Adverse Event|3
963448|NCT00680745|3171211|P2|Overall Study|Adverse Event|3
963449|NCT00680745|3171212|P1|Overall Study|Adverse Event|5
963450|NCT00680745|3171209|P4|Overall Study|Death|0
963451|NCT00680745|3171210|P3|Overall Study|Death|1
963452|NCT00680745|3171211|P2|Overall Study|Death|0
963453|NCT00680745|3171212|P1|Overall Study|Death|1
963454|NCT00680745|3171209|P4|Overall Study|Lost to Follow-up|0
963455|NCT00680745|3171210|P3|Overall Study|Lost to Follow-up|1
963456|NCT00680745|3171211|P2|Overall Study|Lost to Follow-up|1
963457|NCT00680745|3171212|P1|Overall Study|Lost to Follow-up|0
963458|NCT00680745|3171209|P4|Overall Study|Withdrawal by Subject|8
963459|NCT00680745|3171210|P3|Overall Study|Withdrawal by Subject|2
963460|NCT00680745|3171211|P2|Overall Study|Withdrawal by Subject|3
963461|NCT00680745|3171212|P1|Overall Study|Withdrawal by Subject|8
963462|NCT00680407|3171286|P3|Overall Study|Withdrawal by Subject|2
963463|NCT00680407|3171287|P2|Overall Study|Withdrawal by Subject|2
963464|NCT00680407|3171288|P1|Overall Study|Withdrawal by Subject|5
963465|NCT00680407|3171286|P3|Overall Study|Lost to Follow-up|1
963466|NCT00680407|3171287|P2|Overall Study|Lost to Follow-up|3
963467|NCT00680407|3171288|P1|Overall Study|Lost to Follow-up|3
963468|NCT00680368|3171302|P1|Overall Study|not supervised, not eligible|15
963469|NCT00680186|3171330|P2|Overall Study|Other|1
963470|NCT00680186|3171331|P1|Overall Study|Other|4
963471|NCT00680186|3171330|P2|Overall Study|Withdrawal by Subject|39
963472|NCT00680186|3171331|P1|Overall Study|Withdrawal by Subject|32
963473|NCT00680186|3171330|P2|Overall Study|Lost to Follow-up|6
963474|NCT00680186|3171331|P1|Overall Study|Lost to Follow-up|11
963475|NCT00680186|3171330|P2|Overall Study|Protocol Violation|26
963476|NCT00680186|3171331|P1|Overall Study|Protocol Violation|31
963477|NCT00680186|3171330|P2|Overall Study|Adverse Event|44
963478|NCT00680186|3171331|P1|Overall Study|Adverse Event|47
963479|NCT00680121|3171357|P2|Overall Study|Lost to Follow-up|23
963480|NCT00680121|3171358|P1|Overall Study|Lost to Follow-up|27
963481|NCT00680056|3171372|P2|Second Intervention|Protocol Violation|1
963482|NCT00680056|3171373|P1|Second Intervention|Protocol Violation|3
963483|NCT00680056|3171372|P2|First Intervention|Mainly Exacerbation of COPD|2
963484|NCT00680056|3171373|P1|First Intervention|Mainly Exacerbation of COPD|1
963485|NCT00680043|3171384|P3|Overall Study|Renal Transplant|4
963486|NCT00680043|3171385|P2|Overall Study|Renal Transplant|0
963487|NCT00680043|3171386|P1|Overall Study|Renal Transplant|1
963488|NCT00680043|3171384|P3|Overall Study|Patient Not Compliant With Study Reqs.|0
963489|NCT00680043|3171385|P2|Overall Study|Patient Not Compliant With Study Reqs.|1
963490|NCT00680043|3171386|P1|Overall Study|Patient Not Compliant With Study Reqs.|0
963491|NCT00680043|3171384|P3|Overall Study|Withdrawal by Subject|0
963492|NCT00680043|3171385|P2|Overall Study|Withdrawal by Subject|0
963493|NCT00680043|3171386|P1|Overall Study|Withdrawal by Subject|1
963494|NCT00680017|3171402|P2|Overall Study|Lost to Follow-up|0
963495|NCT00680017|3171403|P1|Overall Study|Lost to Follow-up|2
963496|NCT00680017|3171402|P2|Overall Study|Withdrawal by Subject|5
963497|NCT00680017|3171403|P1|Overall Study|Withdrawal by Subject|2
963498|NCT00680017|3171402|P2|Overall Study|Adverse Event|7
963499|NCT00680017|3171403|P1|Overall Study|Adverse Event|13
963500|NCT00679939|3171422|P2|24-Week Open-Label (OL) Period|Withdrawal by Subject|1
963501|NCT00679939|3171423|P1|24-Week Open-Label (OL) Period|Withdrawal by Subject|2
963502|NCT00679939|3171422|P2|24-Week Open-Label (OL) Period|Physician Decision|0
963503|NCT00679939|3171423|P1|24-Week Open-Label (OL) Period|Physician Decision|1
963504|NCT00679939|3171422|P2|24-Week Open-Label (OL) Period|Met Stopping Criteria|1
963505|NCT00679939|3171423|P1|24-Week Open-Label (OL) Period|Met Stopping Criteria|3
963506|NCT00679939|3171422|P2|24-Week Open-Label (OL) Period|Protocol Violation|1
963507|NCT00679939|3171423|P1|24-Week Open-Label (OL) Period|Protocol Violation|1
963508|NCT00679939|3171422|P2|24-Week Open-Label (OL) Period|Adverse Event|1
963509|NCT00679939|3171423|P1|24-Week Open-Label (OL) Period|Adverse Event|0
963510|NCT00679939|3171422|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|2
963511|NCT00679939|3171423|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
963512|NCT00679939|3171422|P2|52-Week Double-Blind (DB) Period|Protocol Violation|0
963513|NCT00679939|3171423|P1|52-Week Double-Blind (DB) Period|Protocol Violation|1
963514|NCT00679939|3171422|P2|52-Week Double-Blind (DB) Period|Investigator Discretion|0
963515|NCT00679939|3171423|P1|52-Week Double-Blind (DB) Period|Investigator Discretion|5
963516|NCT00679939|3171422|P2|52-Week Double-Blind (DB) Period|Adverse Event|12
963517|NCT00679939|3171423|P1|52-Week Double-Blind (DB) Period|Adverse Event|14
963518|NCT00679939|3171422|P2|52-Week Double-Blind (DB) Period|Withdrew Consent|13
963519|NCT00679939|3171423|P1|52-Week Double-Blind (DB) Period|Withdrew Consent|17
963520|NCT00679913|3171574|P2|Overall Study|Protocol Violation|13
963521|NCT00679913|3171575|P1|Overall Study|Protocol Violation|18
963522|NCT00679783|3171590|P7|Overall Study|Ongoing at data cut-off|0
963523|NCT00679783|3171591|P6|Overall Study|Ongoing at data cut-off|0
963524|NCT00679783|3171592|P5|Overall Study|Ongoing at data cut-off|1
963525|NCT00679783|3171593|P4|Overall Study|Ongoing at data cut-off|9
963526|NCT00679783|3171594|P3|Overall Study|Ongoing at data cut-off|0
963527|NCT00679783|3171595|P2|Overall Study|Ongoing at data cut-off|2
963528|NCT00679783|3171596|P1|Overall Study|Ongoing at data cut-off|2
963529|NCT00679783|3171590|P7|Overall Study|Not Captured|0
963530|NCT00679783|3171591|P6|Overall Study|Not Captured|0
963531|NCT00679783|3171592|P5|Overall Study|Not Captured|0
963532|NCT00679783|3171593|P4|Overall Study|Not Captured|5
963533|NCT00679783|3171594|P3|Overall Study|Not Captured|0
963534|NCT00679783|3171595|P2|Overall Study|Not Captured|0
963535|NCT00679783|3171596|P1|Overall Study|Not Captured|0
963536|NCT00679783|3171590|P7|Overall Study|Withdrawal by Subject|0
963537|NCT00679783|3171591|P6|Overall Study|Withdrawal by Subject|0
963538|NCT00679783|3171592|P5|Overall Study|Withdrawal by Subject|0
963539|NCT00679783|3171593|P4|Overall Study|Withdrawal by Subject|1
963540|NCT00679783|3171594|P3|Overall Study|Withdrawal by Subject|1
963541|NCT00679783|3171595|P2|Overall Study|Withdrawal by Subject|0
963542|NCT00679783|3171596|P1|Overall Study|Withdrawal by Subject|0
963543|NCT00679783|3171590|P7|Overall Study|Lack of Efficacy|0
963544|NCT00679783|3171591|P6|Overall Study|Lack of Efficacy|0
963545|NCT00679783|3171592|P5|Overall Study|Lack of Efficacy|0
963546|NCT00679783|3171593|P4|Overall Study|Lack of Efficacy|2
963547|NCT00679783|3171594|P3|Overall Study|Lack of Efficacy|0
963548|NCT00679783|3171595|P2|Overall Study|Lack of Efficacy|1
963549|NCT00679783|3171596|P1|Overall Study|Lack of Efficacy|0
963550|NCT00679783|3171590|P7|Overall Study|Adverse Event|1
963551|NCT00679783|3171591|P6|Overall Study|Adverse Event|0
963552|NCT00679783|3171592|P5|Overall Study|Adverse Event|0
963553|NCT00679783|3171593|P4|Overall Study|Adverse Event|3
963554|NCT00679783|3171594|P3|Overall Study|Adverse Event|0
963555|NCT00679783|3171595|P2|Overall Study|Adverse Event|0
963556|NCT00679783|3171596|P1|Overall Study|Adverse Event|0
963557|NCT00679627|3171649|P2|Overall Study|Early Study Closure|405
963558|NCT00679627|3171650|P1|Overall Study|Early Study Closure|425
963559|NCT00679627|3171649|P2|Overall Study|Lost to Follow-up|26
963560|NCT00679627|3171650|P1|Overall Study|Lost to Follow-up|22
963561|NCT00679627|3171649|P2|Overall Study|Withdrawal by Subject|172
963562|NCT00679627|3171650|P1|Overall Study|Withdrawal by Subject|168
963563|NCT00679627|3171649|P2|Overall Study|Adverse Event|53
963564|NCT00679627|3171650|P1|Overall Study|Adverse Event|43
963565|NCT00679627|3171649|P2|Overall Study|Death|29
963566|NCT00679627|3171650|P1|Overall Study|Death|41
963567|NCT00679432|3171676|P4|Overall Study|Randomization error, return to prior Rx|0
963568|NCT00679432|3171677|P3|Overall Study|Randomization error, return to prior Rx|3
963569|NCT00679432|3171678|P2|Overall Study|Randomization error, return to prior Rx|0
963570|NCT00679432|3171679|P1|Overall Study|Randomization error, return to prior Rx|0
963571|NCT00679432|3171676|P4|Overall Study|Infectious colitis, normal histology|3
963572|NCT00679432|3171677|P3|Overall Study|Infectious colitis, normal histology|8
963573|NCT00679432|3171678|P2|Overall Study|Infectious colitis, normal histology|4
963574|NCT00679432|3171679|P1|Overall Study|Infectious colitis, normal histology|5
963575|NCT00679432|3171676|P4|Overall Study|Lack of Efficacy|8
963576|NCT00679432|3171677|P3|Overall Study|Lack of Efficacy|14
963577|NCT00679432|3171678|P2|Overall Study|Lack of Efficacy|9
963578|NCT00679432|3171679|P1|Overall Study|Lack of Efficacy|13
963579|NCT00679432|3171676|P4|Overall Study|Sponsor decision|0
963580|NCT00679432|3171677|P3|Overall Study|Sponsor decision|0
963581|NCT00679432|3171678|P2|Overall Study|Sponsor decision|0
963582|NCT00679432|3171679|P1|Overall Study|Sponsor decision|1
963583|NCT00679432|3171676|P4|Overall Study|Physician Decision|2
963584|NCT00679432|3171677|P3|Overall Study|Physician Decision|2
963585|NCT00679432|3171678|P2|Overall Study|Physician Decision|2
963586|NCT00679432|3171679|P1|Overall Study|Physician Decision|3
963587|NCT00679432|3171676|P4|Overall Study|Lost to Follow-up|2
963588|NCT00679432|3171677|P3|Overall Study|Lost to Follow-up|4
963589|NCT00679432|3171678|P2|Overall Study|Lost to Follow-up|5
963590|NCT00679432|3171679|P1|Overall Study|Lost to Follow-up|1
963591|NCT00679432|3171676|P4|Overall Study|Withdrawal by Subject|9
963592|NCT00679432|3171677|P3|Overall Study|Withdrawal by Subject|10
963593|NCT00679432|3171678|P2|Overall Study|Withdrawal by Subject|11
963594|NCT00679432|3171679|P1|Overall Study|Withdrawal by Subject|8
963595|NCT00679432|3171676|P4|Overall Study|Protocol Violation|1
963596|NCT00679432|3171677|P3|Overall Study|Protocol Violation|2
963597|NCT00679432|3171678|P2|Overall Study|Protocol Violation|1
963598|NCT00679432|3171679|P1|Overall Study|Protocol Violation|1
963599|NCT00679432|3171676|P4|Overall Study|Adverse Event|7
963600|NCT00679432|3171677|P3|Overall Study|Adverse Event|10
963601|NCT00679432|3171678|P2|Overall Study|Adverse Event|6
963602|NCT00679432|3171679|P1|Overall Study|Adverse Event|5
963603|NCT00679367|3171722|P1|Overall Study|Withdrawal by Subject|1
963604|NCT00679367|3171722|P1|Overall Study|Lack of Efficacy|3
963605|NCT00679367|3171722|P1|Overall Study|inability to swallow oral drugs|1
963606|NCT00679367|3171722|P1|Overall Study|Adverse Event|7
963607|NCT00679354|3171728|P1|Overall Study|Ineligible|1
963608|NCT00679354|3171728|P1|Overall Study|Physician Decision|4
963609|NCT00679354|3171728|P1|Overall Study|Lack of Efficacy|22
963610|NCT00679354|3171728|P1|Overall Study|Death|3
963611|NCT00679341|3171746|P2|Overall Study|Physician/patient decision to withdraw|6
963612|NCT00679341|3171747|P1|Overall Study|Physician/patient decision to withdraw|0
963613|NCT00679341|3171746|P2|Overall Study|Not treated|2
963614|NCT00679341|3171747|P1|Overall Study|Not treated|0
963615|NCT00679341|3171746|P2|Overall Study|Physician Decision|0
963616|NCT00679341|3171747|P1|Overall Study|Physician Decision|1
963617|NCT00679341|3171746|P2|Overall Study|Not specified|0
963618|NCT00679341|3171747|P1|Overall Study|Not specified|1
963619|NCT00679341|3171746|P2|Overall Study|Death|1
963620|NCT00679341|3171747|P1|Overall Study|Death|1
963621|NCT00679341|3171746|P2|Overall Study|Subject/guardian decision to discontinue|0
963622|NCT00679341|3171747|P1|Overall Study|Subject/guardian decision to discontinue|3
963623|NCT00679341|3171746|P2|Overall Study|Adverse Event|6
963624|NCT00679341|3171747|P1|Overall Study|Adverse Event|5
963625|NCT00679341|3171746|P2|Overall Study|Disease progression|36
963626|NCT00679341|3171747|P1|Overall Study|Disease progression|42
963627|NCT00679302|3171767|P2|Overall Study|Lost to Follow-up|4
963628|NCT00679302|3171768|P1|Overall Study|Lost to Follow-up|8
963629|NCT00679289|3171779|P3|Overall Study|Physician Decision|1
963630|NCT00679289|3171780|P2|Overall Study|Physician Decision|0
963631|NCT00679289|3171781|P1|Overall Study|Physician Decision|1
963632|NCT00679289|3171779|P3|Overall Study|Adverse Event|3
963633|NCT00679289|3171780|P2|Overall Study|Adverse Event|0
963634|NCT00679289|3171781|P1|Overall Study|Adverse Event|0
963635|NCT00679289|3171779|P3|Overall Study|Withdrawal by Subject|1
963636|NCT00679289|3171780|P2|Overall Study|Withdrawal by Subject|1
963637|NCT00679289|3171781|P1|Overall Study|Withdrawal by Subject|0
963638|NCT00679289|3171779|P3|Overall Study|Progressive disease|18
963639|NCT00679289|3171780|P2|Overall Study|Progressive disease|5
963640|NCT00679289|3171781|P1|Overall Study|Progressive disease|4
963641|NCT00679263|3171803|P3|Visit 2/Dose 1|subject not compliance|0
963642|NCT00679263|3171804|P2|Visit 2/Dose 1|subject not compliance|1
963643|NCT00679263|3171805|P1|Visit 2/Dose 1|subject not compliance|1
963644|NCT00679263|3171803|P3|Visit 2/Dose 1|Adverse Event|0
963645|NCT00679263|3171804|P2|Visit 2/Dose 1|Adverse Event|0
963646|NCT00679263|3171805|P1|Visit 2/Dose 1|Adverse Event|1
963647|NCT00679211|3171816|P1|Overall Study|Other|1
963648|NCT00679211|3171816|P1|Overall Study|Transferred to extension study TDM4529g|12
963649|NCT00679211|3171816|P1|Overall Study|Refused to undergo protocol procedures|1
963650|NCT00679211|3171816|P1|Overall Study|Physician Decision|5
963651|NCT00679211|3171816|P1|Overall Study|Withdrawal by Subject|2
963652|NCT00679211|3171816|P1|Overall Study|Adverse Event|7
963653|NCT00679211|3171816|P1|Overall Study|Progressive disease|82
963654|NCT00679172|3171833|P5|Overall Study|Other not specified|0
963655|NCT00679172|3171834|P4|Overall Study|Other not specified|0
963656|NCT00679172|3171835|P3|Overall Study|Other not specified|1
963657|NCT00679172|3171836|P2|Overall Study|Other not specified|0
963658|NCT00679172|3171837|P1|Overall Study|Other not specified|0
963659|NCT00679172|3171833|P5|Overall Study|Non-compliance|0
963660|NCT00679172|3171834|P4|Overall Study|Non-compliance|1
963661|NCT00679172|3171835|P3|Overall Study|Non-compliance|0
963662|NCT00679172|3171836|P2|Overall Study|Non-compliance|1
963663|NCT00679172|3171837|P1|Overall Study|Non-compliance|1
963664|NCT00679081|3171900|P1|Overall Study|Lost to Follow-up|1
963665|NCT00679055|3171910|P2|Overall Study|Study Terminated|1
963666|NCT00679055|3171911|P1|Overall Study|Study Terminated|2
963667|NCT00679055|3171910|P2|Overall Study|Other|3
963668|NCT00679055|3171911|P1|Overall Study|Other|0
963669|NCT00679055|3171910|P2|Overall Study|Adverse Event|1
963670|NCT00679055|3171911|P1|Overall Study|Adverse Event|0
963671|NCT00678899|3171921|P1|Overall Study|Adverse Event|1
963672|NCT00678886|3171930|P4|Overall Study|Other|0
963673|NCT00678886|3171931|P3|Overall Study|Other|1
963674|NCT00678886|3171932|P2|Overall Study|Other|0
963675|NCT00678886|3171933|P1|Overall Study|Other|0
963676|NCT00678886|3171930|P4|Overall Study|Lost to Follow-up|2
963677|NCT00678886|3171931|P3|Overall Study|Lost to Follow-up|3
963678|NCT00678886|3171932|P2|Overall Study|Lost to Follow-up|0
963679|NCT00678886|3171933|P1|Overall Study|Lost to Follow-up|0
963680|NCT00678886|3171930|P4|Overall Study|Physician Decision|1
963681|NCT00678886|3171931|P3|Overall Study|Physician Decision|1
963682|NCT00678886|3171932|P2|Overall Study|Physician Decision|0
963683|NCT00678886|3171933|P1|Overall Study|Physician Decision|0
963684|NCT00678886|3171930|P4|Overall Study|Withdrawal by Subject|6
963685|NCT00678886|3171931|P3|Overall Study|Withdrawal by Subject|4
963686|NCT00678886|3171932|P2|Overall Study|Withdrawal by Subject|0
963687|NCT00678886|3171933|P1|Overall Study|Withdrawal by Subject|0
963688|NCT00678795|3172002|P2|Overall Study|Lack of Efficacy|1
963689|NCT00678795|3172003|P1|Overall Study|Lack of Efficacy|1
963690|NCT00678795|3172002|P2|Overall Study|Lost to Follow-up|1
963691|NCT00678795|3172003|P1|Overall Study|Lost to Follow-up|0
963692|NCT00678795|3172002|P2|Overall Study|Protocol Violation|1
963693|NCT00678795|3172003|P1|Overall Study|Protocol Violation|0
963694|NCT00678795|3172002|P2|Overall Study|Withdrawal by Subject|0
963695|NCT00678795|3172003|P1|Overall Study|Withdrawal by Subject|3
963696|NCT00678795|3172002|P2|Overall Study|Adverse Event|3
963697|NCT00678795|3172003|P1|Overall Study|Adverse Event|7
963698|NCT00678691|3172025|P2|Overall Study|Adverse Event|4
963699|NCT00678691|3172026|P1|Overall Study|Adverse Event|6
963700|NCT00678652|3172036|P4|Overall Study|Relocation|0
963701|NCT00678652|3172037|P3|Overall Study|Relocation|0
963702|NCT00678652|3172038|P2|Overall Study|Relocation|0
963703|NCT00678652|3172039|P1|Overall Study|Relocation|1
963704|NCT00678652|3172036|P4|Overall Study|Pregnancy|0
963705|NCT00678652|3172037|P3|Overall Study|Pregnancy|1
963706|NCT00678652|3172038|P2|Overall Study|Pregnancy|0
963707|NCT00678652|3172039|P1|Overall Study|Pregnancy|0
963708|NCT00678652|3172036|P4|Overall Study|Protocol Violation|0
963709|NCT00678652|3172037|P3|Overall Study|Protocol Violation|0
963710|NCT00678652|3172038|P2|Overall Study|Protocol Violation|0
963711|NCT00678652|3172039|P1|Overall Study|Protocol Violation|2
963712|NCT00678639|3172063|P2|Overall Study|Lost to Follow-up at 30 days|0
963713|NCT00678639|3172064|P1|Overall Study|Lost to Follow-up at 30 days|2
963714|NCT00678587|3172079|P2|Overall Study|Withdrew Consent|3
963715|NCT00678587|3172080|P1|Overall Study|Withdrew Consent|8
963716|NCT00678587|3172079|P2|Overall Study|Investigator Discretion|6
963717|NCT00678587|3172080|P1|Overall Study|Investigator Discretion|2
963718|NCT00678587|3172079|P2|Overall Study|Lost to Follow-up|5
963719|NCT00678587|3172080|P1|Overall Study|Lost to Follow-up|3
963720|NCT00678587|3172079|P2|Overall Study|Study Closed/Terminated|0
963721|NCT00678587|3172080|P1|Overall Study|Study Closed/Terminated|1
963722|NCT00678587|3172079|P2|Overall Study|Protocol Violation|1
963723|NCT00678587|3172080|P1|Overall Study|Protocol Violation|2
963724|NCT00678587|3172079|P2|Overall Study|Lack of Efficacy|0
963725|NCT00678587|3172080|P1|Overall Study|Lack of Efficacy|1
963726|NCT00678587|3172079|P2|Overall Study|Adverse Event|3
963727|NCT00678587|3172080|P1|Overall Study|Adverse Event|3
963728|NCT00678392|3172174|P2|Overall Study|Other|53
963729|NCT00678392|3172175|P1|Overall Study|Other|56
963730|NCT00678392|3172174|P2|Overall Study|Randomized But Not Treated|7
963731|NCT00678392|3172175|P1|Overall Study|Randomized But Not Treated|2
963732|NCT00678392|3172174|P2|Overall Study|Withdrawal by Subject|4
963733|NCT00678392|3172175|P1|Overall Study|Withdrawal by Subject|4
963734|NCT00678392|3172174|P2|Overall Study|Sponsor's Decision|2
963735|NCT00678392|3172175|P1|Overall Study|Sponsor's Decision|1
963736|NCT00678392|3172174|P2|Overall Study|Objective Progression or Relapse|8
963737|NCT00678392|3172175|P1|Overall Study|Objective Progression or Relapse|3
963738|NCT00678392|3172174|P2|Overall Study|Lost to Follow-up|13
963739|NCT00678392|3172175|P1|Overall Study|Lost to Follow-up|15
963740|NCT00678392|3172174|P2|Overall Study|Death|269
963741|NCT00678392|3172175|P1|Overall Study|Death|280
963742|NCT00678392|3172174|P2|Overall Study|Adverse Event|6
963743|NCT00678392|3172175|P1|Overall Study|Adverse Event|0
963744|NCT00678379|3172210|P3|Overall Study|Incomplete Data|3
963745|NCT00678379|3172211|P2|Overall Study|Incomplete Data|3
963746|NCT00678379|3172212|P1|Overall Study|Incomplete Data|4
963747|NCT00678379|3172210|P3|Overall Study|Injection performed after tonsillectomy|1
963748|NCT00678379|3172211|P2|Overall Study|Injection performed after tonsillectomy|0
963749|NCT00678379|3172212|P1|Overall Study|Injection performed after tonsillectomy|2
963750|NCT00678301|3172240|P2|Overall Study|Lost to Follow-up|1
963751|NCT00678301|3172241|P1|Overall Study|Lost to Follow-up|3
963752|NCT00678301|3172240|P2|Overall Study|Withdrawal by Subject|0
963753|NCT00678301|3172241|P1|Overall Study|Withdrawal by Subject|4
963754|NCT00678301|3172240|P2|Overall Study|Adverse Event|0
963755|NCT00678301|3172241|P1|Overall Study|Adverse Event|1
963756|NCT00678301|3172240|P2|Overall Study|Non-compliance with study procedures|1
963757|NCT00678301|3172241|P1|Overall Study|Non-compliance with study procedures|0
963758|NCT00678288|3172299|P2|Overall Study|Disease progression/recurrence/relapse|1
963759|NCT00678288|3172300|P1|Overall Study|Disease progression/recurrence/relapse|6
963760|NCT00678288|3172299|P2|Overall Study|Reason not reported|0
963761|NCT00678288|3172300|P1|Overall Study|Reason not reported|1
963762|NCT00678288|3172299|P2|Overall Study|Switch to commercial drug|1
963763|NCT00678288|3172300|P1|Overall Study|Switch to commercial drug|0
963764|NCT00678288|3172299|P2|Overall Study|Not compliant with study medication|1
963765|NCT00678288|3172300|P1|Overall Study|Not compliant with study medication|0
963766|NCT00678288|3172299|P2|Overall Study|Study terminated by the sponsor|0
963767|NCT00678288|3172300|P1|Overall Study|Study terminated by the sponsor|2
963768|NCT00678288|3172299|P2|Overall Study|Withdrawal by Subject|1
963769|NCT00678288|3172300|P1|Overall Study|Withdrawal by Subject|1
963770|NCT00678288|3172299|P2|Overall Study|Adverse Event|2
963771|NCT00678288|3172300|P1|Overall Study|Adverse Event|0
963772|NCT00678210|3172355|P4|Overall Study|Other|0
963773|NCT00678210|3172356|P3|Overall Study|Other|1
963774|NCT00678210|3172357|P2|Overall Study|Other|0
963775|NCT00678210|3172358|P1|Overall Study|Other|1
963776|NCT00678210|3172355|P4|Overall Study|Withdrawal by Subject|7
963777|NCT00678210|3172356|P3|Overall Study|Withdrawal by Subject|1
963778|NCT00678210|3172357|P2|Overall Study|Withdrawal by Subject|4
963779|NCT00678210|3172358|P1|Overall Study|Withdrawal by Subject|3
963780|NCT00678210|3172355|P4|Overall Study|Lost to Follow-up|1
963781|NCT00678210|3172356|P3|Overall Study|Lost to Follow-up|0
963782|NCT00678210|3172357|P2|Overall Study|Lost to Follow-up|2
963783|NCT00678210|3172358|P1|Overall Study|Lost to Follow-up|4
963784|NCT00678210|3172355|P4|Overall Study|Lack of Efficacy|9
963785|NCT00678210|3172356|P3|Overall Study|Lack of Efficacy|1
963786|NCT00678210|3172357|P2|Overall Study|Lack of Efficacy|3
963787|NCT00678210|3172358|P1|Overall Study|Lack of Efficacy|2
963788|NCT00678210|3172355|P4|Overall Study|Adverse Event|3
963789|NCT00678210|3172356|P3|Overall Study|Adverse Event|3
963790|NCT00678210|3172357|P2|Overall Study|Adverse Event|2
963791|NCT00678210|3172358|P1|Overall Study|Adverse Event|1
963792|NCT00678080|3172394|P2|Overall Study|Withdrawal by Subject|1
963793|NCT00678080|3172395|P1|Overall Study|Withdrawal by Subject|0
963794|NCT00678080|3172394|P2|Overall Study|Lost to Follow-up|0
963795|NCT00678080|3172395|P1|Overall Study|Lost to Follow-up|1
963796|NCT00678080|3172394|P2|Overall Study|Physician Decision|0
963797|NCT00678080|3172395|P1|Overall Study|Physician Decision|2
963798|NCT00678041|3172421|P2|Overall Study|Physician Decision|5
963799|NCT00678041|3172422|P1|Overall Study|Physician Decision|5
963800|NCT00677833|3172475|P4|Overall Study|Lost to Follow-up|0
963801|NCT00677833|3172476|P3|Overall Study|Lost to Follow-up|1
963802|NCT00677833|3172477|P2|Overall Study|Lost to Follow-up|0
963803|NCT00677833|3172478|P1|Overall Study|Lost to Follow-up|0
963804|NCT00677833|3172475|P4|Overall Study|Withdrawal by Subject|3
963805|NCT00677833|3172476|P3|Overall Study|Withdrawal by Subject|1
963806|NCT00677833|3172477|P2|Overall Study|Withdrawal by Subject|0
963807|NCT00677833|3172478|P1|Overall Study|Withdrawal by Subject|4
963808|NCT00677820|3172528|P2|Overall Study|Lost to Follow-up|0
963809|NCT00677820|3172529|P1|Overall Study|Lost to Follow-up|1
963810|NCT00677807|3172550|P3|Overall Study|Protocol Deviation|0
963811|NCT00677807|3172551|P2|Overall Study|Protocol Deviation|3
963812|NCT00677807|3172552|P1|Overall Study|Protocol Deviation|1
963813|NCT00677807|3172550|P3|Overall Study|Death|1
963814|NCT00677807|3172551|P2|Overall Study|Death|1
963815|NCT00677807|3172552|P1|Overall Study|Death|0
963816|NCT00677807|3172550|P3|Overall Study|Administrative problems|2
963817|NCT00677807|3172551|P2|Overall Study|Administrative problems|1
963818|NCT00677807|3172552|P1|Overall Study|Administrative problems|1
963819|NCT00677807|3172550|P3|Overall Study|Lost to Follow-up|2
963820|NCT00677807|3172551|P2|Overall Study|Lost to Follow-up|2
963821|NCT00677807|3172552|P1|Overall Study|Lost to Follow-up|2
963822|NCT00677807|3172550|P3|Overall Study|Withdrawal by Subject|6
963823|NCT00677807|3172551|P2|Overall Study|Withdrawal by Subject|3
963824|NCT00677807|3172552|P1|Overall Study|Withdrawal by Subject|10
963825|NCT00677807|3172550|P3|Overall Study|Participant no longer needs study drug|1
963826|NCT00677807|3172551|P2|Overall Study|Participant no longer needs study drug|0
963827|NCT00677807|3172552|P1|Overall Study|Participant no longer needs study drug|0
963828|NCT00677807|3172550|P3|Overall Study|Lack of Efficacy|2
963829|NCT00677807|3172551|P2|Overall Study|Lack of Efficacy|0
963830|NCT00677807|3172552|P1|Overall Study|Lack of Efficacy|0
963831|NCT00677807|3172550|P3|Overall Study|Adverse Event|6
963832|NCT00677807|3172551|P2|Overall Study|Adverse Event|1
963833|NCT00677807|3172552|P1|Overall Study|Adverse Event|4
963834|NCT00677534|3172598|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
963835|NCT00677534|3172598|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
963836|NCT00677534|3172598|P1|Washout (Weeks 1-4)|did not qualify after signing consent|1
963837|NCT00677365|3172606|P4|Overall Study|Other reason|1
963838|NCT00677365|3172607|P3|Overall Study|Other reason|0
963839|NCT00677365|3172608|P2|Overall Study|Other reason|0
963840|NCT00677365|3172609|P1|Overall Study|Other reason|0
963841|NCT00677365|3172606|P4|Overall Study|Withdrawal by Subject|0
963842|NCT00677365|3172607|P3|Overall Study|Withdrawal by Subject|1
963843|NCT00677365|3172608|P2|Overall Study|Withdrawal by Subject|0
963844|NCT00677365|3172609|P1|Overall Study|Withdrawal by Subject|0
963845|NCT00677365|3172606|P4|Overall Study|Adverse Event|2
963846|NCT00677365|3172607|P3|Overall Study|Adverse Event|1
963847|NCT00677365|3172608|P2|Overall Study|Adverse Event|1
963848|NCT00677365|3172609|P1|Overall Study|Adverse Event|2
963849|NCT00677352|3172641|P2|Tapering Phase|Job transfer|1
963850|NCT00677352|3172642|P1|Tapering Phase|Job transfer|0
963851|NCT00677352|3172641|P2|Tapering Phase|Pregnancy|1
963852|NCT00677352|3172642|P1|Tapering Phase|Pregnancy|0
963853|NCT00677352|3172641|P2|Tapering Phase|Withdrawal by Subject|3
963854|NCT00677352|3172642|P1|Tapering Phase|Withdrawal by Subject|5
963855|NCT00677352|3172641|P2|Tapering Phase|Adverse Event|5
963856|NCT00677352|3172642|P1|Tapering Phase|Adverse Event|1
963857|NCT00677352|3172641|P2|Treatment Phase|Not treated|2
963858|NCT00677352|3172642|P1|Treatment Phase|Not treated|0
963859|NCT00677352|3172641|P2|Treatment Phase|Transference or work related matter|5
963860|NCT00677352|3172642|P1|Treatment Phase|Transference or work related matter|0
963861|NCT00677352|3172641|P2|Treatment Phase|Protocol Violation|1
963862|NCT00677352|3172642|P1|Treatment Phase|Protocol Violation|1
963863|NCT00677352|3172641|P2|Treatment Phase|Pregnancy|1
963864|NCT00677352|3172642|P1|Treatment Phase|Pregnancy|0
963865|NCT00677352|3172641|P2|Treatment Phase|Physician Decision|0
963866|NCT00677352|3172642|P1|Treatment Phase|Physician Decision|1
963867|NCT00677352|3172641|P2|Treatment Phase|Withdrawal by Subject|7
963868|NCT00677352|3172642|P1|Treatment Phase|Withdrawal by Subject|7
963869|NCT00677352|3172641|P2|Treatment Phase|Lost to Follow-up|1
963870|NCT00677352|3172642|P1|Treatment Phase|Lost to Follow-up|0
963871|NCT00677352|3172641|P2|Treatment Phase|Lack of Efficacy|3
963872|NCT00677352|3172642|P1|Treatment Phase|Lack of Efficacy|2
963873|NCT00677352|3172641|P2|Treatment Phase|Adverse Event|22
963874|NCT00677352|3172642|P1|Treatment Phase|Adverse Event|14
963875|NCT00677235|3172662|P2|Overall Study|Adverse Experience|0
963876|NCT00677235|3172663|P1|Overall Study|Adverse Experience|1
963877|NCT00677235|3172662|P2|Overall Study|Death|36
963878|NCT00677235|3172663|P1|Overall Study|Death|37
963879|NCT00677235|3172662|P2|Overall Study|Lost to Follow-up|1
963880|NCT00677235|3172663|P1|Overall Study|Lost to Follow-up|2
963881|NCT00677235|3172662|P2|Overall Study|Withdrawal by Subject|1
963882|NCT00677235|3172663|P1|Overall Study|Withdrawal by Subject|1
963883|NCT00677092|3172703|P1|Overall Study|Death Prior to Receiving Treatment|1
963884|NCT00677092|3172703|P1|Overall Study|Withdrawal by Subject|3
963885|NCT00677092|3172703|P1|Overall Study|Lost to Follow-up|1
963886|NCT00677092|3172703|P1|Overall Study|Adverse Event|1
963887|NCT00677014|3172720|P3|Overall Study|Unavailable or unreadable 6 month LVESV|18
963888|NCT00677014|3172721|P2|Overall Study|Unavailable or unreadable 6 month LVESV|14
963889|NCT00677014|3172722|P1|Overall Study|Unavailable or unreadable 6 month LVESV|18
963890|NCT00677014|3172720|P3|Overall Study|Death|7
963891|NCT00677014|3172721|P2|Overall Study|Death|15
963892|NCT00677014|3172722|P1|Overall Study|Death|6
963893|NCT00677014|3172720|P3|Overall Study|Lost to Follow-up|24
963894|NCT00677014|3172721|P2|Overall Study|Lost to Follow-up|12
963895|NCT00677014|3172722|P1|Overall Study|Lost to Follow-up|20
963896|NCT00676715|3172775|P4|Overall Study|Participants Ongoing|24
963897|NCT00676715|3172776|P3|Overall Study|Participants Ongoing|17
963898|NCT00676715|3172777|P2|Overall Study|Participants Ongoing|29
963899|NCT00676715|3172778|P1|Overall Study|Participants Ongoing|29
963900|NCT00676715|3172775|P4|Overall Study|Adverse Event|0
963901|NCT00676715|3172776|P3|Overall Study|Adverse Event|2
963902|NCT00676715|3172777|P2|Overall Study|Adverse Event|1
963903|NCT00676715|3172778|P1|Overall Study|Adverse Event|0
963904|NCT00676715|3172775|P4|Overall Study|Death|0
963905|NCT00676715|3172776|P3|Overall Study|Death|1
963906|NCT00676715|3172777|P2|Overall Study|Death|1
963907|NCT00676715|3172778|P1|Overall Study|Death|1
963908|NCT00676715|3172775|P4|Overall Study|Lost to Follow-up|3
963909|NCT00676715|3172776|P3|Overall Study|Lost to Follow-up|7
963910|NCT00676715|3172777|P2|Overall Study|Lost to Follow-up|1
963911|NCT00676715|3172778|P1|Overall Study|Lost to Follow-up|1
963912|NCT00676715|3172775|P4|Overall Study|Other|3
963913|NCT00676715|3172776|P3|Overall Study|Other|4
963914|NCT00676715|3172777|P2|Overall Study|Other|6
963915|NCT00676715|3172778|P1|Overall Study|Other|2
963916|NCT00676715|3172775|P4|Overall Study|Withdrawal by Subject|10
963917|NCT00676715|3172776|P3|Overall Study|Withdrawal by Subject|10
963918|NCT00676715|3172777|P2|Overall Study|Withdrawal by Subject|9
963919|NCT00676715|3172778|P1|Overall Study|Withdrawal by Subject|7
963920|NCT00676689|3172808|P1|Overall Study|Continuing FU|49
963921|NCT00676689|3172808|P1|Overall Study|Withdrawal by Subject|3
963922|NCT00676689|3172808|P1|Overall Study|Physician Decision|1
963923|NCT00676689|3172808|P1|Overall Study|Lost to Follow-up|4
963924|NCT00676689|3172808|P1|Overall Study|Death|2
963925|NCT00676689|3172808|P1|Overall Study|Screen Failure|2
963926|NCT00676650|3172820|P2|Overall Study|Randomized but not treated|4
963927|NCT00676650|3172821|P1|Overall Study|Randomized but not treated|3
963928|NCT00676650|3172820|P2|Overall Study|Withdrawal by Subject|24
963929|NCT00676650|3172821|P1|Overall Study|Withdrawal by Subject|48
963930|NCT00676650|3172820|P2|Overall Study|Study terminated by sponsor|43
963931|NCT00676650|3172821|P1|Overall Study|Study terminated by sponsor|57
963932|NCT00676650|3172820|P2|Overall Study|Protocol Violation|1
963933|NCT00676650|3172821|P1|Overall Study|Protocol Violation|3
963934|NCT00676650|3172820|P2|Overall Study|Other|10
963935|NCT00676650|3172821|P1|Overall Study|Other|14
963936|NCT00676650|3172820|P2|Overall Study|Objective progression or relapse|140
963937|NCT00676650|3172821|P1|Overall Study|Objective progression or relapse|189
963938|NCT00676650|3172820|P2|Overall Study|Lost to Follow-up|1
963939|NCT00676650|3172821|P1|Overall Study|Lost to Follow-up|0
963940|NCT00676650|3172820|P2|Overall Study|Global deterioration of health status|31
963941|NCT00676650|3172821|P1|Overall Study|Global deterioration of health status|66
963942|NCT00676650|3172820|P2|Overall Study|Adverse Event|21
963943|NCT00676650|3172821|P1|Overall Study|Adverse Event|159
963944|NCT00676650|3172820|P2|Overall Study|Death|14
963945|NCT00676650|3172821|P1|Overall Study|Death|45
963946|NCT00676520|3172852|P1|Overall Study|Other Reason|18
963947|NCT00676520|3172852|P1|Overall Study|Ineligible for Randomization to DAPT|209
963948|NCT00676520|3172852|P1|Overall Study|Physician Decision|20
963949|NCT00676520|3172852|P1|Overall Study|Death|159
963950|NCT00676520|3172852|P1|Overall Study|Lost to Follow-up|162
963951|NCT00676520|3172852|P1|Overall Study|Withdrawal by Subject|163
963952|NCT00676494|3172909|P1|Overall Study|Withdrawal by Subject|6
963953|NCT00676494|3172909|P1|Overall Study|Missed Visit|8
963954|NCT00676403|3172926|P6|Overall Study|Withdrawal by Subject|1
963955|NCT00676403|3172927|P5|Overall Study|Withdrawal by Subject|0
963956|NCT00676403|3172928|P4|Overall Study|Withdrawal by Subject|0
963957|NCT00676403|3172929|P3|Overall Study|Withdrawal by Subject|0
963958|NCT00676403|3172930|P2|Overall Study|Withdrawal by Subject|0
963959|NCT00676403|3172931|P1|Overall Study|Withdrawal by Subject|0
963960|NCT00676403|3172926|P6|Overall Study|Reason Unspecified|1
963961|NCT00676403|3172927|P5|Overall Study|Reason Unspecified|0
963962|NCT00676403|3172928|P4|Overall Study|Reason Unspecified|0
963963|NCT00676403|3172929|P3|Overall Study|Reason Unspecified|1
963964|NCT00676403|3172930|P2|Overall Study|Reason Unspecified|0
963965|NCT00676403|3172931|P1|Overall Study|Reason Unspecified|1
963966|NCT00676403|3172926|P6|Overall Study|Lost to Follow-up|1
963967|NCT00676403|3172927|P5|Overall Study|Lost to Follow-up|0
963968|NCT00676403|3172928|P4|Overall Study|Lost to Follow-up|0
963969|NCT00676403|3172929|P3|Overall Study|Lost to Follow-up|0
963970|NCT00676403|3172930|P2|Overall Study|Lost to Follow-up|0
963971|NCT00676403|3172931|P1|Overall Study|Lost to Follow-up|0
963972|NCT00676403|3172926|P6|Overall Study|Adverse Event|2
963973|NCT00676403|3172927|P5|Overall Study|Adverse Event|1
963974|NCT00676403|3172928|P4|Overall Study|Adverse Event|5
963975|NCT00676403|3172929|P3|Overall Study|Adverse Event|0
963976|NCT00676403|3172930|P2|Overall Study|Adverse Event|2
963977|NCT00676403|3172931|P1|Overall Study|Adverse Event|1
963978|NCT00676338|3173074|P4|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
963979|NCT00676338|3173075|P3|Overall Study|Lack of Efficacy-Loss of Glucose Control|5
963980|NCT00676338|3173076|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
963981|NCT00676338|3173077|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
963982|NCT00676338|3173074|P4|Overall Study|Entry Criteria Not Met|1
963983|NCT00676338|3173075|P3|Overall Study|Entry Criteria Not Met|1
963984|NCT00676338|3173076|P2|Overall Study|Entry Criteria Not Met|2
963985|NCT00676338|3173077|P1|Overall Study|Entry Criteria Not Met|0
963986|NCT00676338|3173074|P4|Overall Study|Withdrawal by Subject|6
963987|NCT00676338|3173075|P3|Overall Study|Withdrawal by Subject|12
963988|NCT00676338|3173076|P2|Overall Study|Withdrawal by Subject|9
963989|NCT00676338|3173077|P1|Overall Study|Withdrawal by Subject|17
963990|NCT00676338|3173074|P4|Overall Study|Protocol Violation|5
963991|NCT00676338|3173075|P3|Overall Study|Protocol Violation|2
963992|NCT00676338|3173076|P2|Overall Study|Protocol Violation|9
963993|NCT00676338|3173077|P1|Overall Study|Protocol Violation|5
963994|NCT00676338|3173074|P4|Overall Study|Physician Decision|3
963995|NCT00676338|3173075|P3|Overall Study|Physician Decision|2
963996|NCT00676338|3173076|P2|Overall Study|Physician Decision|3
963997|NCT00676338|3173077|P1|Overall Study|Physician Decision|3
963998|NCT00676338|3173074|P4|Overall Study|Lost to Follow-up|4
963999|NCT00676338|3173075|P3|Overall Study|Lost to Follow-up|3
964000|NCT00676338|3173076|P2|Overall Study|Lost to Follow-up|1
964001|NCT00676338|3173077|P1|Overall Study|Lost to Follow-up|4
964002|NCT00676338|3173074|P4|Overall Study|Adverse Event|1
964003|NCT00676338|3173075|P3|Overall Study|Adverse Event|5
964004|NCT00676338|3173076|P2|Overall Study|Adverse Event|6
964005|NCT00676338|3173077|P1|Overall Study|Adverse Event|6
964006|NCT00676208|3173129|P2|Overall Study|Incomplete data|4
964007|NCT00676208|3173130|P1|Overall Study|Incomplete data|2
964008|NCT00676208|3173129|P2|Overall Study|Lost to Follow-up|2
964009|NCT00676208|3173130|P1|Overall Study|Lost to Follow-up|0
964010|NCT00676195|3173138|P1|Overall Study|Physician Decision|1
964011|NCT00676195|3173138|P1|Overall Study|Adverse Event|1
964012|NCT00676195|3173138|P1|Overall Study|Lost to Follow-up|1
964013|NCT00676143|3173163|P2|Overall Study|Vasogenic edema recurrence|3
964014|NCT00676143|3173164|P1|Overall Study|Vasogenic edema recurrence|1
964015|NCT00676143|3173163|P2|Overall Study|Participant participation unknown|4
964016|NCT00676143|3173164|P1|Overall Study|Participant participation unknown|1
964017|NCT00676143|3173163|P2|Overall Study|Not specified|20
964018|NCT00676143|3173164|P1|Overall Study|Not specified|11
964019|NCT00676143|3173163|P2|Overall Study|Loss of caregiver|3
964020|NCT00676143|3173164|P1|Overall Study|Loss of caregiver|5
964021|NCT00676143|3173163|P2|Overall Study|Failed to return|1
964022|NCT00676143|3173164|P1|Overall Study|Failed to return|2
964023|NCT00676143|3173163|P2|Overall Study|Discontinuation of study by sponsor|88
964024|NCT00676143|3173164|P1|Overall Study|Discontinuation of study by sponsor|65
964025|NCT00676143|3173163|P2|Overall Study|Withdrawal by Subject|42
964026|NCT00676143|3173164|P1|Overall Study|Withdrawal by Subject|24
964027|NCT00676143|3173163|P2|Overall Study|Protocol Violation|8
964028|NCT00676143|3173164|P1|Overall Study|Protocol Violation|4
964029|NCT00676143|3173163|P2|Overall Study|Physician Decision|8
964030|NCT00676143|3173164|P1|Overall Study|Physician Decision|5
964031|NCT00676143|3173163|P2|Overall Study|Lost to Follow-up|13
964032|NCT00676143|3173164|P1|Overall Study|Lost to Follow-up|0
964033|NCT00676143|3173163|P2|Overall Study|Lack of Efficacy|6
964034|NCT00676143|3173164|P1|Overall Study|Lack of Efficacy|0
964035|NCT00676143|3173163|P2|Overall Study|Death|4
964036|NCT00676143|3173164|P1|Overall Study|Death|4
964037|NCT00676143|3173163|P2|Overall Study|Adverse Event|60
964038|NCT00676143|3173164|P1|Overall Study|Adverse Event|34
964039|NCT00676130|3173204|P2|Overall Study|Withdrawal by Subject|1
964040|NCT00676130|3173205|P1|Overall Study|Withdrawal by Subject|0
964041|NCT00676130|3173204|P2|Overall Study|Found ineligible|2
964042|NCT00676130|3173205|P1|Overall Study|Found ineligible|3
964043|NCT00676130|3173204|P2|Overall Study|Lost to Follow-up|1
964044|NCT00676130|3173205|P1|Overall Study|Lost to Follow-up|0
964045|NCT00676091|3173215|P2|Toddler Dose|Parent or legal guardian request|0
964046|NCT00676091|3173216|P1|Toddler Dose|Parent or legal guardian request|1
964047|NCT00676091|3173215|P2|Toddler Dose|Failed to return|0
964048|NCT00676091|3173216|P1|Toddler Dose|Failed to return|2
964049|NCT00676091|3173215|P2|After Infant Series|Failed to return|1
964050|NCT00676091|3173216|P1|After Infant Series|Failed to return|1
964051|NCT00676091|3173215|P2|After Infant Series|Protocol Violation|1
964052|NCT00676091|3173216|P1|After Infant Series|Protocol Violation|0
964053|NCT00676091|3173215|P2|After Infant Series|Adverse Event|1
964054|NCT00676091|3173216|P1|After Infant Series|Adverse Event|0
964055|NCT00676091|3173215|P2|Infant Series|Died prior to receiving 7vPnC|1
964056|NCT00676091|3173216|P1|Infant Series|Died prior to receiving 7vPnC|0
964057|NCT00676091|3173215|P2|Infant Series|Lost to Follow-up|0
964058|NCT00676091|3173216|P1|Infant Series|Lost to Follow-up|1
964059|NCT00676091|3173215|P2|Infant Series|Failed to return|3
964060|NCT00676091|3173216|P1|Infant Series|Failed to return|1
964061|NCT00676091|3173215|P2|Infant Series|Adverse Event|3
964062|NCT00676091|3173216|P1|Infant Series|Adverse Event|2
964063|NCT00676091|3173215|P2|Infant Series|Protocol Violation|3
964064|NCT00676091|3173216|P1|Infant Series|Protocol Violation|6
964065|NCT00676091|3173215|P2|Infant Series|Parent or legal guardian request|8
964066|NCT00676091|3173216|P1|Infant Series|Parent or legal guardian request|10
964067|NCT00676052|3173273|P6|Overall Study|Withdrawal by Subject|0
964068|NCT00676052|3173274|P5|Overall Study|Withdrawal by Subject|0
964069|NCT00676052|3173275|P4|Overall Study|Withdrawal by Subject|0
964070|NCT00676052|3173276|P3|Overall Study|Withdrawal by Subject|1
964071|NCT00676052|3173277|P2|Overall Study|Withdrawal by Subject|0
964072|NCT00676052|3173278|P1|Overall Study|Withdrawal by Subject|1
964073|NCT00676052|3173273|P6|Overall Study|Physician Decision|1
964074|NCT00676052|3173274|P5|Overall Study|Physician Decision|0
964075|NCT00676052|3173275|P4|Overall Study|Physician Decision|0
964076|NCT00676052|3173276|P3|Overall Study|Physician Decision|1
964077|NCT00676052|3173277|P2|Overall Study|Physician Decision|1
964078|NCT00676052|3173278|P1|Overall Study|Physician Decision|1
964079|NCT00676052|3173273|P6|Overall Study|Lost to Follow-up|0
964080|NCT00676052|3173274|P5|Overall Study|Lost to Follow-up|1
964081|NCT00676052|3173275|P4|Overall Study|Lost to Follow-up|0
964082|NCT00676052|3173276|P3|Overall Study|Lost to Follow-up|0
964083|NCT00676052|3173277|P2|Overall Study|Lost to Follow-up|0
964084|NCT00676052|3173278|P1|Overall Study|Lost to Follow-up|0
964085|NCT00676052|3173273|P6|Overall Study|Protocol Violation|2
964086|NCT00676052|3173274|P5|Overall Study|Protocol Violation|1
964087|NCT00676052|3173275|P4|Overall Study|Protocol Violation|2
964088|NCT00676052|3173276|P3|Overall Study|Protocol Violation|2
964089|NCT00676052|3173277|P2|Overall Study|Protocol Violation|3
964090|NCT00676052|3173278|P1|Overall Study|Protocol Violation|5
964091|NCT00676052|3173273|P6|Overall Study|Lack of Efficacy|1
964092|NCT00676052|3173274|P5|Overall Study|Lack of Efficacy|2
964093|NCT00676052|3173275|P4|Overall Study|Lack of Efficacy|1
964094|NCT00676052|3173276|P3|Overall Study|Lack of Efficacy|1
964095|NCT00676052|3173277|P2|Overall Study|Lack of Efficacy|2
964096|NCT00676052|3173278|P1|Overall Study|Lack of Efficacy|2
964097|NCT00676052|3173273|P6|Overall Study|Adverse Event|2
964098|NCT00676052|3173274|P5|Overall Study|Adverse Event|2
964099|NCT00676052|3173275|P4|Overall Study|Adverse Event|2
964100|NCT00676052|3173276|P3|Overall Study|Adverse Event|1
964101|NCT00676052|3173277|P2|Overall Study|Adverse Event|1
964102|NCT00676052|3173278|P1|Overall Study|Adverse Event|0
964103|NCT00675948|3173341|P2|Overall Study|Patient feels unable to take medication|1
964104|NCT00675948|3173342|P1|Overall Study|Patient feels unable to take medication|0
964105|NCT00675948|3173341|P2|Overall Study|Patient unable to comply with diaries|0
964106|NCT00675948|3173342|P1|Overall Study|Patient unable to comply with diaries|1
964107|NCT00675948|3173341|P2|Overall Study|Patient died|0
964108|NCT00675948|3173342|P1|Overall Study|Patient died|1
964109|NCT00675948|3173341|P2|Overall Study|Sponsor decision|1
964110|NCT00675948|3173342|P1|Overall Study|Sponsor decision|0
964111|NCT00675948|3173341|P2|Overall Study|Pain under control|0
964112|NCT00675948|3173342|P1|Overall Study|Pain under control|1
964113|NCT00675948|3173341|P2|Overall Study|Protocol Violation|0
964114|NCT00675948|3173342|P1|Overall Study|Protocol Violation|1
964115|NCT00675948|3173341|P2|Overall Study|Lost to Follow-up|0
964116|NCT00675948|3173342|P1|Overall Study|Lost to Follow-up|2
964117|NCT00675948|3173341|P2|Overall Study|Withdrawal by Subject|0
964118|NCT00675948|3173342|P1|Overall Study|Withdrawal by Subject|7
964119|NCT00675948|3173341|P2|Overall Study|Lack of Efficacy|0
964120|NCT00675948|3173342|P1|Overall Study|Lack of Efficacy|3
964121|NCT00675948|3173341|P2|Overall Study|Adverse Event|1
964122|NCT00675948|3173342|P1|Overall Study|Adverse Event|23
964123|NCT00675766|3173405|P4|Overall Study|Lost to Follow-up|26
964124|NCT00675766|3173406|P3|Overall Study|Lost to Follow-up|21
964125|NCT00675766|3173407|P2|Overall Study|Lost to Follow-up|5
964126|NCT00675766|3173408|P1|Overall Study|Lost to Follow-up|6
964127|NCT00675597|3173418|P1|Overall Study|Withdrawal by Subject|3
964128|NCT00675506|3173472|P2|Overall Study|Schedule conflict|1
964129|NCT00675506|3173473|P1|Overall Study|Schedule conflict|0
964130|NCT00675506|3173472|P2|Overall Study|Declined participation|0
964131|NCT00675506|3173473|P1|Overall Study|Declined participation|1
964132|NCT00675506|3173472|P2|Overall Study|Disclosed history of cancer|0
964133|NCT00675506|3173473|P1|Overall Study|Disclosed history of cancer|1
964134|NCT00675506|3173472|P2|Overall Study|Hypersensitivity Reaction|0
964135|NCT00675506|3173473|P1|Overall Study|Hypersensitivity Reaction|1
964136|NCT00675506|3173472|P2|Overall Study|Elevated IGF-1|0
964137|NCT00675506|3173473|P1|Overall Study|Elevated IGF-1|2
964138|NCT00675506|3173472|P2|Overall Study|Elevated IGF-1 prior to treatment|0
964139|NCT00675506|3173473|P1|Overall Study|Elevated IGF-1 prior to treatment|1
964140|NCT00675506|3173472|P2|Overall Study|Elevated fasting glucose|1
964141|NCT00675506|3173473|P1|Overall Study|Elevated fasting glucose|2
964142|NCT00675506|3173472|P2|Overall Study|Lost interest|5
964143|NCT00675506|3173473|P1|Overall Study|Lost interest|3
964144|NCT00675506|3173472|P2|Overall Study|Lost to Follow-up|5
964145|NCT00675506|3173473|P1|Overall Study|Lost to Follow-up|1
964146|NCT00675441|3173489|P1|Overall Study|Death|1
964147|NCT00675441|3173489|P1|Overall Study|Withdrawal by Subject|2
964148|NCT00675428|3173495|P2|Overall Study|Physician Decision|0
964149|NCT00675428|3173496|P1|Overall Study|Physician Decision|1
964150|NCT00675428|3173495|P2|Overall Study|No Disease Response After Cycle 6|1
964151|NCT00675428|3173496|P1|Overall Study|No Disease Response After Cycle 6|0
964152|NCT00675428|3173495|P2|Overall Study|Disease Progression|2
964153|NCT00675428|3173496|P1|Overall Study|Disease Progression|2
964154|NCT00675103|3173538|P1|Overall Study|Adverse Event|1
964155|NCT00675103|3173538|P1|Overall Study|Lack of Efficacy|2
964156|NCT00674986|3173545|P2|Overall Study|Other reasons|8
964157|NCT00674986|3173546|P1|Overall Study|Other reasons|4
964158|NCT00674986|3173545|P2|Overall Study|Lost to Follow-up|53
964159|NCT00674986|3173546|P1|Overall Study|Lost to Follow-up|25
964160|NCT00674986|3173545|P2|Overall Study|Subject withdrew consent|19
964161|NCT00674986|3173546|P1|Overall Study|Subject withdrew consent|12
964162|NCT00674986|3173545|P2|Overall Study|Adverse Event|1
964163|NCT00674986|3173546|P1|Overall Study|Adverse Event|2
964164|NCT00674973|3173567|P2|Overall Study|Protocol Violation|1
964165|NCT00674973|3173568|P1|Overall Study|Protocol Violation|0
964166|NCT00674973|3173567|P2|Overall Study|Death|15
964167|NCT00674973|3173568|P1|Overall Study|Death|19
964168|NCT00674973|3173567|P2|Overall Study|Adverse Event|9
964169|NCT00674973|3173568|P1|Overall Study|Adverse Event|2
964170|NCT00674973|3173567|P2|Overall Study|Failure to Return|0
964171|NCT00674973|3173568|P1|Overall Study|Failure to Return|1
964172|NCT00674973|3173567|P2|Overall Study|Refused Treatment|5
964173|NCT00674973|3173568|P1|Overall Study|Refused Treatment|1
964174|NCT00674973|3173567|P2|Overall Study|Insufficient Therapeutic Response|72
964175|NCT00674973|3173568|P1|Overall Study|Insufficient Therapeutic Response|77
964176|NCT00674817|3173582|P1|Period 4|Adverse Event|1
964177|NCT00674817|3173582|P1|Period 3|Protocol Violation|1
964178|NCT00674817|3173582|P1|Period 3|Adverse Event|1
964179|NCT00674817|3173582|P1|Period 1|Protocol Violation|1
964180|NCT00674817|3173582|P1|Period 1|Withdrawal by Subject|2
964181|NCT00674700|3173759|P3|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7
964182|NCT00674700|3173760|P2|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10
964183|NCT00674700|3173761|P1|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5
964184|NCT00674700|3173759|P3|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4
964185|NCT00674700|3173760|P2|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
964186|NCT00674700|3173761|P1|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
964187|NCT00674700|3173759|P3|Year 2 Follow-up Without Treatment|Adverse Event|1
964188|NCT00674700|3173760|P2|Year 2 Follow-up Without Treatment|Adverse Event|1
964189|NCT00674700|3173761|P1|Year 2 Follow-up Without Treatment|Adverse Event|0
964190|NCT00674700|3173759|P3|Year 1|Any other reason not above-mentioned|6
964191|NCT00674700|3173760|P2|Year 1|Any other reason not above-mentioned|7
964192|NCT00674700|3173761|P1|Year 1|Any other reason not above-mentioned|7
964193|NCT00674700|3173759|P3|Year 1|Withdrawal by Subject|6
964194|NCT00674700|3173760|P2|Year 1|Withdrawal by Subject|7
964195|NCT00674700|3173761|P1|Year 1|Withdrawal by Subject|7
964196|NCT00674700|3173759|P3|Year 1|Adverse Event|5
964197|NCT00674700|3173760|P2|Year 1|Adverse Event|20
964198|NCT00674700|3173761|P1|Year 1|Adverse Event|17
964199|NCT00674661|3173774|P2|Overall Study|Withdrawal by Subject|5
964200|NCT00674661|3173775|P1|Overall Study|Withdrawal by Subject|0
964201|NCT00674661|3173774|P2|Overall Study|Lost to Follow-up|3
964202|NCT00674661|3173775|P1|Overall Study|Lost to Follow-up|6
964203|NCT00674661|3173774|P2|Overall Study|not specified|7
964204|NCT00674661|3173775|P1|Overall Study|not specified|5
964205|NCT00674362|3173895|P2|Open Label|Other: Subject moved to extension study|0
964206|NCT00674362|3173896|P1|Open Label|Other: Subject moved to extension study|1
964207|NCT00674362|3173895|P2|Open Label|Adverse Event|0
964208|NCT00674362|3173896|P1|Open Label|Adverse Event|1
964209|NCT00674362|3173895|P2|Double Blind|Other: Surgery|1
964210|NCT00674362|3173896|P1|Double Blind|Other: Surgery|0
964211|NCT00674362|3173895|P2|Double Blind|Other: Loss of Patient Compliance|1
964212|NCT00674362|3173896|P1|Double Blind|Other: Loss of Patient Compliance|0
964213|NCT00674362|3173895|P2|Double Blind|Withdrawal by Subject|3
964214|NCT00674362|3173896|P1|Double Blind|Withdrawal by Subject|4
964215|NCT00674362|3173895|P2|Double Blind|Loss of efficacy|1
964216|NCT00674362|3173896|P1|Double Blind|Loss of efficacy|0
964217|NCT00674362|3173895|P2|Double Blind|Lack of Efficacy|6
964218|NCT00674362|3173896|P1|Double Blind|Lack of Efficacy|2
964219|NCT00674362|3173895|P2|Double Blind|Adverse Event|6
964220|NCT00674362|3173896|P1|Double Blind|Adverse Event|6
964221|NCT00674323|3173964|P3|Overall Study|Protocol Violation|0
964222|NCT00674323|3173965|P2|Overall Study|Protocol Violation|0
964223|NCT00674323|3173966|P1|Overall Study|Protocol Violation|1
964224|NCT00674323|3173964|P3|Overall Study|Adverse Event|0
964225|NCT00674323|3173965|P2|Overall Study|Adverse Event|1
964226|NCT00674323|3173966|P1|Overall Study|Adverse Event|0
964227|NCT00674154|3174008|P2|Overall Study|Did not want parathyroidectomy|2
964228|NCT00674154|3174009|P1|Overall Study|Did not want parathyroidectomy|0
964229|NCT00674154|3174008|P2|Overall Study|Withdrawal by Subject|1
964230|NCT00674154|3174009|P1|Overall Study|Withdrawal by Subject|3
964231|NCT00674128|3174017|P2|Overall Study|Withdrawal by Subject|23
964232|NCT00674128|3174018|P1|Overall Study|Withdrawal by Subject|25
964233|NCT00673933|3174043|P1|Overall Study|Lost to Follow-up|1
964234|NCT00673933|3174043|P1|Overall Study|Withdrawal by Subject|2
964235|NCT00673881|3174059|P1|Overall Study|Withdrawal by Subject|1
964236|NCT00673816|3174073|P1|Overall Study|Withdrawal by Subject|1
964237|NCT00673816|3174073|P1|Overall Study|Adverse Event|1
964238|NCT00673673|3174108|P1|Overall Study|Investigators' discretion|2
964239|NCT00673673|3174108|P1|Overall Study|Withdrawal by Subject|3
964240|NCT00673673|3174108|P1|Overall Study|Adverse Event|4
964241|NCT00673673|3174108|P1|Overall Study|Progressive disease|27
964242|NCT00673660|3174114|P1|Overall Study|Lost to Follow-up|107
964243|NCT00673465|3174136|P12|Part 1/Period 2 (United States)|Protocol Violation|0
964244|NCT00673465|3174137|P11|Part 1/Period 2 (United States)|Protocol Violation|0
964245|NCT00673465|3174138|P10|Part 1/Period 2 (United States)|Protocol Violation|0
964246|NCT00673465|3174139|P9|Part 1/Period 2 (United States)|Protocol Violation|0
964247|NCT00673465|3174140|P8|Part 1/Period 2 (United States)|Protocol Violation|0
964248|NCT00673465|3174141|P7|Part 1/Period 2 (United States)|Protocol Violation|0
964249|NCT00673465|3174142|P6|Part 1/Period 2 (United States)|Protocol Violation|0
964250|NCT00673465|3174143|P5|Part 1/Period 2 (United States)|Protocol Violation|1
964251|NCT00673465|3174144|P4|Part 1/Period 2 (United States)|Protocol Violation|0
964252|NCT00673465|3174145|P3|Part 1/Period 2 (United States)|Protocol Violation|0
964253|NCT00673465|3174146|P2|Part 1/Period 2 (United States)|Protocol Violation|0
964254|NCT00673465|3174147|P1|Part 1/Period 2 (United States)|Protocol Violation|0
964255|NCT00673465|3174136|P12|Part 1/Period 1 (United States)|Protocol Violation|0
964256|NCT00673465|3174137|P11|Part 1/Period 1 (United States)|Protocol Violation|0
964257|NCT00673465|3174138|P10|Part 1/Period 1 (United States)|Protocol Violation|0
964258|NCT00673465|3174139|P9|Part 1/Period 1 (United States)|Protocol Violation|0
964259|NCT00673465|3174140|P8|Part 1/Period 1 (United States)|Protocol Violation|0
964260|NCT00673465|3174141|P7|Part 1/Period 1 (United States)|Protocol Violation|0
964261|NCT00673465|3174142|P6|Part 1/Period 1 (United States)|Protocol Violation|1
964262|NCT00673465|3174143|P5|Part 1/Period 1 (United States)|Protocol Violation|1
964263|NCT00673465|3174144|P4|Part 1/Period 1 (United States)|Protocol Violation|0
964264|NCT00673465|3174145|P3|Part 1/Period 1 (United States)|Protocol Violation|0
964265|NCT00673465|3174146|P2|Part 1/Period 1 (United States)|Protocol Violation|0
964266|NCT00673465|3174147|P1|Part 1/Period 1 (United States)|Protocol Violation|0
964267|NCT00673452|3174196|P2|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0
964268|NCT00673452|3174197|P1|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1
964269|NCT00673452|3174196|P2|Continuation Double-Blind Phase|Physician Decision|0
964270|NCT00673452|3174197|P1|Continuation Double-Blind Phase|Physician Decision|2
964271|NCT00673452|3174196|P2|Continuation Double-Blind Phase|Sponsor Decision|3
964272|NCT00673452|3174197|P1|Continuation Double-Blind Phase|Sponsor Decision|0
964273|NCT00673452|3174196|P2|Continuation Double-Blind Phase|Protocol Violation|3
964274|NCT00673452|3174197|P1|Continuation Double-Blind Phase|Protocol Violation|2
964275|NCT00673452|3174196|P2|Continuation Double-Blind Phase|Lack of Efficacy|5
964276|NCT00673452|3174197|P1|Continuation Double-Blind Phase|Lack of Efficacy|2
964277|NCT00673452|3174196|P2|Continuation Double-Blind Phase|Lost to Follow-up|5
964278|NCT00673452|3174197|P1|Continuation Double-Blind Phase|Lost to Follow-up|4
964279|NCT00673452|3174196|P2|Continuation Double-Blind Phase|Withdrawal by Subject|5
964280|NCT00673452|3174197|P1|Continuation Double-Blind Phase|Withdrawal by Subject|9
964281|NCT00673452|3174196|P2|Continuation Double-Blind Phase|Adverse Event|13
964282|NCT00673452|3174197|P1|Continuation Double-Blind Phase|Adverse Event|5
964283|NCT00673452|3174196|P2|Acute Double-Blind Phase|Withdrawal by Subject|13
964284|NCT00673452|3174197|P1|Acute Double-Blind Phase|Withdrawal by Subject|16
964285|NCT00673452|3174196|P2|Acute Double-Blind Phase|Sponsor Decision|1
964286|NCT00673452|3174197|P1|Acute Double-Blind Phase|Sponsor Decision|0
964287|NCT00673452|3174196|P2|Acute Double-Blind Phase|Protocol Violation|3
964288|NCT00673452|3174197|P1|Acute Double-Blind Phase|Protocol Violation|5
964289|NCT00673452|3174196|P2|Acute Double-Blind Phase|Physician Decision|6
964290|NCT00673452|3174197|P1|Acute Double-Blind Phase|Physician Decision|0
964291|NCT00673452|3174196|P2|Acute Double-Blind Phase|Lost to Follow-up|19
964292|NCT00673452|3174197|P1|Acute Double-Blind Phase|Lost to Follow-up|16
964293|NCT00673452|3174196|P2|Acute Double-Blind Phase|Lack of Efficacy|14
964294|NCT00673452|3174197|P1|Acute Double-Blind Phase|Lack of Efficacy|9
964295|NCT00673452|3174196|P2|Acute Double-Blind Phase|Adverse Event|24
964296|NCT00673452|3174197|P1|Acute Double-Blind Phase|Adverse Event|41
964297|NCT00673387|3174260|P8|Overall Study|Lost to Follow-up|5
964298|NCT00673387|3174261|P7|Overall Study|Lost to Follow-up|8
964299|NCT00673387|3174262|P6|Overall Study|Lost to Follow-up|5
964300|NCT00673387|3174263|P5|Overall Study|Lost to Follow-up|6
964301|NCT00673387|3174264|P4|Overall Study|Lost to Follow-up|6
964302|NCT00673387|3174265|P3|Overall Study|Lost to Follow-up|5
964303|NCT00673387|3174266|P2|Overall Study|Lost to Follow-up|6
964304|NCT00673387|3174267|P1|Overall Study|Lost to Follow-up|8
964305|NCT00673387|3174260|P8|Overall Study|Protocol Violation|3
964306|NCT00673387|3174261|P7|Overall Study|Protocol Violation|1
964307|NCT00673387|3174262|P6|Overall Study|Protocol Violation|1
964308|NCT00673387|3174263|P5|Overall Study|Protocol Violation|0
964309|NCT00673387|3174264|P4|Overall Study|Protocol Violation|2
964310|NCT00673387|3174265|P3|Overall Study|Protocol Violation|1
964311|NCT00673387|3174266|P2|Overall Study|Protocol Violation|0
964312|NCT00673387|3174267|P1|Overall Study|Protocol Violation|3
964313|NCT00673387|3174260|P8|Overall Study|Physician Decision|1
964314|NCT00673387|3174261|P7|Overall Study|Physician Decision|1
964315|NCT00673387|3174262|P6|Overall Study|Physician Decision|5
964316|NCT00673387|3174263|P5|Overall Study|Physician Decision|0
964317|NCT00673387|3174264|P4|Overall Study|Physician Decision|0
964318|NCT00673387|3174265|P3|Overall Study|Physician Decision|0
964319|NCT00673387|3174266|P2|Overall Study|Physician Decision|0
964320|NCT00673387|3174267|P1|Overall Study|Physician Decision|0
964321|NCT00673387|3174260|P8|Overall Study|Adverse Event|5
964322|NCT00673387|3174261|P7|Overall Study|Adverse Event|5
964323|NCT00673387|3174262|P6|Overall Study|Adverse Event|2
964324|NCT00673387|3174263|P5|Overall Study|Adverse Event|6
964325|NCT00673387|3174264|P4|Overall Study|Adverse Event|2
964326|NCT00673387|3174265|P3|Overall Study|Adverse Event|5
964327|NCT00673387|3174266|P2|Overall Study|Adverse Event|1
964328|NCT00673387|3174267|P1|Overall Study|Adverse Event|3
964329|NCT00673387|3174260|P8|Overall Study|Withdrawal by Subject|21
964330|NCT00673387|3174261|P7|Overall Study|Withdrawal by Subject|15
964331|NCT00673387|3174262|P6|Overall Study|Withdrawal by Subject|21
964332|NCT00673387|3174263|P5|Overall Study|Withdrawal by Subject|18
964333|NCT00673387|3174264|P4|Overall Study|Withdrawal by Subject|16
964334|NCT00673387|3174265|P3|Overall Study|Withdrawal by Subject|20
964335|NCT00673387|3174266|P2|Overall Study|Withdrawal by Subject|16
964336|NCT00673387|3174267|P1|Overall Study|Withdrawal by Subject|15
964337|NCT00673361|3174483|P1|Overall Study|Screen Failure|2
964338|NCT00673257|3174487|P1|Overall Study|Unable to obtain specimen|1
964339|NCT00673257|3174487|P1|Overall Study|Withdrawal by Subject|4
964340|NCT00673231|3174496|P4|Overall Study|Study criteria,compliance,safety, other|4
964341|NCT00673231|3174497|P3|Overall Study|Study criteria,compliance,safety, other|7
964342|NCT00673231|3174498|P2|Overall Study|Study criteria,compliance,safety, other|5
964343|NCT00673231|3174499|P1|Overall Study|Study criteria,compliance,safety, other|8
964344|NCT00673231|3174496|P4|Overall Study|Death|0
964345|NCT00673231|3174497|P3|Overall Study|Death|1
964346|NCT00673231|3174498|P2|Overall Study|Death|0
964347|NCT00673231|3174499|P1|Overall Study|Death|0
964348|NCT00673231|3174496|P4|Overall Study|Lost to Follow-up|2
964349|NCT00673231|3174497|P3|Overall Study|Lost to Follow-up|1
964350|NCT00673231|3174498|P2|Overall Study|Lost to Follow-up|2
964351|NCT00673231|3174499|P1|Overall Study|Lost to Follow-up|1
964352|NCT00673231|3174496|P4|Overall Study|Adverse Event|6
964353|NCT00673231|3174497|P3|Overall Study|Adverse Event|9
964354|NCT00673231|3174498|P2|Overall Study|Adverse Event|5
964355|NCT00673231|3174499|P1|Overall Study|Adverse Event|6
964356|NCT00673231|3174496|P4|Overall Study|Withdrawal by Subject|6
964357|NCT00673231|3174497|P3|Overall Study|Withdrawal by Subject|8
964358|NCT00673231|3174498|P2|Overall Study|Withdrawal by Subject|10
964359|NCT00673231|3174499|P1|Overall Study|Withdrawal by Subject|14
964360|NCT00673179|3174531|P2|Overall Study|Toxicity/Complications|0
964361|NCT00673179|3174532|P1|Overall Study|Toxicity/Complications|3
964362|NCT00673049|3174581|P4|After Progression on Erlotinib|study terminated by sponsor|4
964363|NCT00673049|3174582|P3|After Progression on Erlotinib|study terminated by sponsor|0
964364|NCT00673049|3174583|P2|After Progression on Erlotinib|study terminated by sponsor|0
964365|NCT00673049|3174584|P1|After Progression on Erlotinib|study terminated by sponsor|0
964366|NCT00673049|3174581|P4|After Progression on Erlotinib|Withdrawal by Subject|5
964367|NCT00673049|3174582|P3|After Progression on Erlotinib|Withdrawal by Subject|0
964368|NCT00673049|3174583|P2|After Progression on Erlotinib|Withdrawal by Subject|0
964369|NCT00673049|3174584|P1|After Progression on Erlotinib|Withdrawal by Subject|0
964370|NCT00673049|3174581|P4|After Progression on Erlotinib|Lost to Follow-up|3
964371|NCT00673049|3174582|P3|After Progression on Erlotinib|Lost to Follow-up|0
964372|NCT00673049|3174583|P2|After Progression on Erlotinib|Lost to Follow-up|0
964373|NCT00673049|3174584|P1|After Progression on Erlotinib|Lost to Follow-up|0
964374|NCT00673049|3174581|P4|After Progression on Erlotinib|Death|71
964375|NCT00673049|3174582|P3|After Progression on Erlotinib|Death|0
964376|NCT00673049|3174583|P2|After Progression on Erlotinib|Death|0
964377|NCT00673049|3174584|P1|After Progression on Erlotinib|Death|0
964378|NCT00673049|3174581|P4|Before Progression on Erlotinib|Switched to figitumumab|0
964379|NCT00673049|3174582|P3|Before Progression on Erlotinib|Switched to figitumumab|0
964380|NCT00673049|3174583|P2|Before Progression on Erlotinib|Switched to figitumumab|83
964381|NCT00673049|3174584|P1|Before Progression on Erlotinib|Switched to figitumumab|0
964382|NCT00673049|3174581|P4|Before Progression on Erlotinib|study terminated by sponsor|0
964383|NCT00673049|3174582|P3|Before Progression on Erlotinib|study terminated by sponsor|0
964384|NCT00673049|3174583|P2|Before Progression on Erlotinib|study terminated by sponsor|14
964385|NCT00673049|3174584|P1|Before Progression on Erlotinib|study terminated by sponsor|18
964386|NCT00673049|3174581|P4|Before Progression on Erlotinib|Other|0
964387|NCT00673049|3174582|P3|Before Progression on Erlotinib|Other|0
964388|NCT00673049|3174583|P2|Before Progression on Erlotinib|Other|2
964389|NCT00673049|3174584|P1|Before Progression on Erlotinib|Other|1
964390|NCT00673049|3174581|P4|Before Progression on Erlotinib|Withdrawal by Subject|0
964391|NCT00673049|3174582|P3|Before Progression on Erlotinib|Withdrawal by Subject|0
964392|NCT00673049|3174583|P2|Before Progression on Erlotinib|Withdrawal by Subject|18
964393|NCT00673049|3174584|P1|Before Progression on Erlotinib|Withdrawal by Subject|26
964394|NCT00673049|3174581|P4|Before Progression on Erlotinib|Lost to Follow-up|0
964395|NCT00673049|3174582|P3|Before Progression on Erlotinib|Lost to Follow-up|0
964396|NCT00673049|3174583|P2|Before Progression on Erlotinib|Lost to Follow-up|5
964397|NCT00673049|3174584|P1|Before Progression on Erlotinib|Lost to Follow-up|9
964398|NCT00673049|3174581|P4|Before Progression on Erlotinib|Death|0
964399|NCT00673049|3174582|P3|Before Progression on Erlotinib|Death|1
964400|NCT00673049|3174583|P2|Before Progression on Erlotinib|Death|167
964401|NCT00673049|3174584|P1|Before Progression on Erlotinib|Death|235
964402|NCT00673049|3174581|P4|Before Progression on Erlotinib|Randomized but not treated|0
964403|NCT00673049|3174582|P3|Before Progression on Erlotinib|Randomized but not treated|0
964404|NCT00673049|3174583|P2|Before Progression on Erlotinib|Randomized but not treated|1
964405|NCT00673049|3174584|P1|Before Progression on Erlotinib|Randomized but not treated|3
964406|NCT00672984|3174608|P3|Third Intervention|Adverse Event|1
964407|NCT00672984|3174609|P2|Third Intervention|Adverse Event|0
964408|NCT00672984|3174610|P1|Third Intervention|Adverse Event|1
964409|NCT00672984|3174608|P3|Second Intervention|Protocol Violation|1
964410|NCT00672984|3174609|P2|Second Intervention|Protocol Violation|1
964411|NCT00672984|3174610|P1|Second Intervention|Protocol Violation|0
964412|NCT00672984|3174608|P3|Second Intervention|Withdrawal by Subject|0
964413|NCT00672984|3174609|P2|Second Intervention|Withdrawal by Subject|3
964414|NCT00672984|3174610|P1|Second Intervention|Withdrawal by Subject|0
964415|NCT00672984|3174608|P3|Second Intervention|Non-compliance with facility policies|0
964416|NCT00672984|3174609|P2|Second Intervention|Non-compliance with facility policies|2
964417|NCT00672984|3174610|P1|Second Intervention|Non-compliance with facility policies|0
964418|NCT00672984|3174608|P3|First Intervention|Sponsor decision|0
964419|NCT00672984|3174609|P2|First Intervention|Sponsor decision|0
964420|NCT00672984|3174610|P1|First Intervention|Sponsor decision|3
964421|NCT00672984|3174608|P3|First Intervention|Withdrawal by Subject|2
964422|NCT00672984|3174609|P2|First Intervention|Withdrawal by Subject|2
964423|NCT00672984|3174610|P1|First Intervention|Withdrawal by Subject|1
964424|NCT00672984|3174608|P3|First Intervention|Adverse Event|0
964425|NCT00672984|3174609|P2|First Intervention|Adverse Event|0
964426|NCT00672984|3174610|P1|First Intervention|Adverse Event|5
964427|NCT00672958|3174661|P2|Overall Study|Reason not specified|3
964428|NCT00672958|3174662|P1|Overall Study|Reason not specified|0
964429|NCT00672958|3174661|P2|Overall Study|Lost to Follow-up|17
964430|NCT00672958|3174662|P1|Overall Study|Lost to Follow-up|22
964431|NCT00672958|3174661|P2|Overall Study|Voluntary withdrawal|8
964432|NCT00672958|3174662|P1|Overall Study|Voluntary withdrawal|12
964433|NCT00672958|3174661|P2|Overall Study|Protocol deviations|5
964434|NCT00672958|3174662|P1|Overall Study|Protocol deviations|11
964435|NCT00672958|3174661|P2|Overall Study|Non-compliance with study drug|3
964436|NCT00672958|3174662|P1|Overall Study|Non-compliance with study drug|2
964437|NCT00672958|3174661|P2|Overall Study|Lack of Efficacy|11
964438|NCT00672958|3174662|P1|Overall Study|Lack of Efficacy|6
964439|NCT00672958|3174661|P2|Overall Study|Adverse Event|9
964440|NCT00672958|3174662|P1|Overall Study|Adverse Event|11
964441|NCT00672841|3174728|P2|Overall Study|Pregnancy|1
964442|NCT00672841|3174729|P1|Overall Study|Pregnancy|0
964443|NCT00672841|3174728|P2|Overall Study|Adverse Event|3
964444|NCT00672841|3174729|P1|Overall Study|Adverse Event|0
964445|NCT00672841|3174728|P2|Overall Study|Antifungal therapy, negative glucan|4
964446|NCT00672841|3174729|P1|Overall Study|Antifungal therapy, negative glucan|0
964447|NCT00672841|3174728|P2|Overall Study|icteric specimens|3
964448|NCT00672841|3174729|P1|Overall Study|icteric specimens|0
964449|NCT00672841|3174728|P2|Overall Study|Comfort care|4
964450|NCT00672841|3174729|P1|Overall Study|Comfort care|1
964451|NCT00672646|3174751|P3|Overall Study|Withdrawal by Subject|1
964452|NCT00672646|3174752|P2|Overall Study|Withdrawal by Subject|0
964453|NCT00672646|3174753|P1|Overall Study|Withdrawal by Subject|0
964454|NCT00672646|3174751|P3|Overall Study|Lost to Follow-up|2
964455|NCT00672646|3174752|P2|Overall Study|Lost to Follow-up|1
964456|NCT00672646|3174753|P1|Overall Study|Lost to Follow-up|0
964457|NCT00672633|3174778|P2|Overall Study|Withdrawal by Subject|1
964458|NCT00672633|3174779|P1|Overall Study|Withdrawal by Subject|0
964459|NCT00672620|3174793|P4|Overall Study|Reason not Specified|1
964460|NCT00672620|3174794|P3|Overall Study|Reason not Specified|2
964461|NCT00672620|3174795|P2|Overall Study|Reason not Specified|3
964462|NCT00672620|3174796|P1|Overall Study|Reason not Specified|3
964463|NCT00672620|3174793|P4|Overall Study|Lost to Follow-up|11
964464|NCT00672620|3174794|P3|Overall Study|Lost to Follow-up|8
964465|NCT00672620|3174795|P2|Overall Study|Lost to Follow-up|19
964466|NCT00672620|3174796|P1|Overall Study|Lost to Follow-up|8
964467|NCT00672620|3174793|P4|Overall Study|Withdrawal of Consent|6
964468|NCT00672620|3174794|P3|Overall Study|Withdrawal of Consent|5
964469|NCT00672620|3174795|P2|Overall Study|Withdrawal of Consent|12
964470|NCT00672620|3174796|P1|Overall Study|Withdrawal of Consent|6
964471|NCT00672620|3174793|P4|Overall Study|Protocol Deviations|5
964472|NCT00672620|3174794|P3|Overall Study|Protocol Deviations|2
964473|NCT00672620|3174795|P2|Overall Study|Protocol Deviations|7
964474|NCT00672620|3174796|P1|Overall Study|Protocol Deviations|5
964475|NCT00672620|3174793|P4|Overall Study|Noncompliance with Study Drug|2
964476|NCT00672620|3174794|P3|Overall Study|Noncompliance with Study Drug|0
964477|NCT00672620|3174795|P2|Overall Study|Noncompliance with Study Drug|4
964478|NCT00672620|3174796|P1|Overall Study|Noncompliance with Study Drug|3
964479|NCT00672620|3174793|P4|Overall Study|Lack of Efficacy|0
964480|NCT00672620|3174794|P3|Overall Study|Lack of Efficacy|2
964481|NCT00672620|3174795|P2|Overall Study|Lack of Efficacy|2
964482|NCT00672620|3174796|P1|Overall Study|Lack of Efficacy|1
964483|NCT00672620|3174793|P4|Overall Study|Adverse Event|17
964484|NCT00672620|3174794|P3|Overall Study|Adverse Event|12
964485|NCT00672620|3174795|P2|Overall Study|Adverse Event|7
964486|NCT00672620|3174796|P1|Overall Study|Adverse Event|7
964487|NCT00672555|3174861|P1|Overall Study|Did not want to answer questionnaire|2
964488|NCT00672555|3174861|P1|Overall Study|Lost to Follow-up|4
964489|NCT00672490|3174872|P2|Overall Study|No reason was provided|2
964490|NCT00672490|3174873|P1|Overall Study|No reason was provided|6
964491|NCT00672490|3174872|P2|Overall Study|Lost to Follow-up|5
964492|NCT00672490|3174873|P1|Overall Study|Lost to Follow-up|1
964493|NCT00672490|3174872|P2|Overall Study|Intolerance|2
964494|NCT00672490|3174873|P1|Overall Study|Intolerance|0
964495|NCT00672490|3174872|P2|Overall Study|Violation of Concomitant Medicine|0
964496|NCT00672490|3174873|P1|Overall Study|Violation of Concomitant Medicine|1
964497|NCT00672490|3174872|P2|Overall Study|Adverse Event|8
964498|NCT00672490|3174873|P1|Overall Study|Adverse Event|5
964499|NCT00672490|3174872|P2|Overall Study|Mismatch Include/Exclude Criteria|0
964500|NCT00672490|3174873|P1|Overall Study|Mismatch Include/Exclude Criteria|1
964501|NCT00672490|3174872|P2|Overall Study|Lack of Compliance|7
964502|NCT00672490|3174873|P1|Overall Study|Lack of Compliance|2
964503|NCT00672490|3174872|P2|Overall Study|Withdrawal by Subject|8
964504|NCT00672490|3174873|P1|Overall Study|Withdrawal by Subject|8
964505|NCT00672477|3174897|P2|Overall Study|no study drug for low GFR, health cond.|3
964506|NCT00672477|3174898|P1|Overall Study|no study drug for low GFR, health cond.|1
964507|NCT00672477|3174897|P2|Overall Study|Lack of Efficacy|1
964508|NCT00672477|3174898|P1|Overall Study|Lack of Efficacy|1
964509|NCT00672477|3174897|P2|Overall Study|Withdrawal by Subject|3
964510|NCT00672477|3174898|P1|Overall Study|Withdrawal by Subject|5
964511|NCT00672477|3174897|P2|Overall Study|Protocol Violation|1
964512|NCT00672477|3174898|P1|Overall Study|Protocol Violation|1
964513|NCT00672477|3174897|P2|Overall Study|Physician Decision|0
964514|NCT00672477|3174898|P1|Overall Study|Physician Decision|2
964515|NCT00672477|3174897|P2|Overall Study|Death|11
964516|NCT00672477|3174898|P1|Overall Study|Death|7
964517|NCT00672477|3174897|P2|Overall Study|Adverse Event|7
964518|NCT00672477|3174898|P1|Overall Study|Adverse Event|10
964519|NCT00672256|3174951|P1|Overall Study|PI dropped, bad data|44
964520|NCT00672139|3174976|P2|Overall Study|hospice discharge, caregiver requests|2
964521|NCT00672139|3174977|P1|Overall Study|hospice discharge, caregiver requests|3
964522|NCT00672139|3174976|P2|Overall Study|Protocol Violation|1
964523|NCT00672139|3174977|P1|Overall Study|Protocol Violation|1
964524|NCT00672139|3174976|P2|Overall Study|Lack of Efficacy|1
964525|NCT00672139|3174977|P1|Overall Study|Lack of Efficacy|4
964526|NCT00672139|3174976|P2|Overall Study|Physician Decision|0
964527|NCT00672139|3174977|P1|Overall Study|Physician Decision|2
964528|NCT00672139|3174976|P2|Overall Study|Adverse Event|7
964529|NCT00672139|3174977|P1|Overall Study|Adverse Event|4
964530|NCT00672139|3174976|P2|Overall Study|Withdrawal by Subject|11
964531|NCT00672139|3174977|P1|Overall Study|Withdrawal by Subject|2
964532|NCT00672139|3174976|P2|Overall Study|Death|23
964533|NCT00672139|3174977|P1|Overall Study|Death|14
964534|NCT00671931|3175034|P5|Overall Study|Physician Decision|1
964535|NCT00671931|3175035|P4|Overall Study|Physician Decision|2
964536|NCT00671931|3175036|P3|Overall Study|Physician Decision|0
964537|NCT00671931|3175037|P2|Overall Study|Physician Decision|0
964538|NCT00671931|3175038|P1|Overall Study|Physician Decision|1
964539|NCT00671879|3175058|P3|Overall Study|Withdrawal by Subject|6
964540|NCT00671879|3175059|P2|Overall Study|Withdrawal by Subject|4
964541|NCT00671879|3175060|P1|Overall Study|Withdrawal by Subject|0
964542|NCT00671853|3175073|P2|Overall Study|Non-adherence with study procedures|4
964543|NCT00671853|3175074|P1|Overall Study|Non-adherence with study procedures|1
964544|NCT00671853|3175073|P2|Overall Study|Physician Decision|2
964545|NCT00671853|3175074|P1|Overall Study|Physician Decision|0
964546|NCT00671853|3175073|P2|Overall Study|Lost to Follow-up|8
964547|NCT00671853|3175074|P1|Overall Study|Lost to Follow-up|8
964548|NCT00671853|3175073|P2|Overall Study|Withdrawal by Subject|5
964549|NCT00671853|3175074|P1|Overall Study|Withdrawal by Subject|1
964550|NCT00671853|3175073|P2|Overall Study|Adverse Event|1
964551|NCT00671853|3175074|P1|Overall Study|Adverse Event|7
964552|NCT00671853|3175073|P2|Overall Study|Lack of Efficacy|7
964553|NCT00671853|3175074|P1|Overall Study|Lack of Efficacy|3
964554|NCT00671788|3175090|P1|Overall Study|Other|1
964555|NCT00671788|3175090|P1|Overall Study|MD Decision|1
964556|NCT00671788|3175090|P1|Overall Study|Ineligible|1
964557|NCT00671788|3175090|P1|Overall Study|Refused further treatment|3
964558|NCT00671788|3175090|P1|Overall Study|Adverse Event|8
964559|NCT00671749|3175097|P1|Overall Study|Lost to Follow-up|1
964560|NCT00671749|3175097|P1|Overall Study|Protocol Violation|1
964561|NCT00671749|3175097|P1|Overall Study|Withdrawal by Subject|4
964562|NCT00671749|3175097|P1|Overall Study|Adverse Event|2
964563|NCT00671554|3175156|P1|Overall Study|Disease progression|3
964564|NCT00671437|3175195|P1|Overall Study|Ineligible post-hoc|1
964565|NCT00671437|3175195|P1|Overall Study|Adverse Event|3
964566|NCT00671437|3175195|P1|Overall Study|Cutaneous SCC of head and neck|3
964567|NCT00671437|3175195|P1|Overall Study|Progressive disease before C1 week 8|8
964568|NCT00671060|3175229|P2|Overall Study|Physician Decision|1
964569|NCT00671060|3175230|P1|Overall Study|Physician Decision|0
964570|NCT00671060|3175229|P2|Overall Study|Protocol Violation|0
964571|NCT00671060|3175230|P1|Overall Study|Protocol Violation|1
964572|NCT00671034|3175239|P3|Overall Study|includes Alternative therapy, etc.|7
964573|NCT00671034|3175240|P2|Overall Study|includes Alternative therapy, etc.|1
964574|NCT00671034|3175241|P1|Overall Study|includes Alternative therapy, etc.|6
964575|NCT00671034|3175239|P3|Overall Study|Refusal|5
964576|NCT00671034|3175240|P2|Overall Study|Refusal|3
964577|NCT00671034|3175241|P1|Overall Study|Refusal|5
964578|NCT00671034|3175239|P3|Overall Study|VHR ALL feature|5
964579|NCT00671034|3175240|P2|Overall Study|VHR ALL feature|3
964580|NCT00671034|3175241|P1|Overall Study|VHR ALL feature|8
964581|NCT00671034|3175239|P3|Overall Study|Physician Decision|5
964582|NCT00671034|3175240|P2|Overall Study|Physician Decision|4
964583|NCT00671034|3175241|P1|Overall Study|Physician Decision|12
964584|NCT00671034|3175239|P3|Overall Study|Death|1
964585|NCT00671034|3175240|P2|Overall Study|Death|2
964586|NCT00671034|3175241|P1|Overall Study|Death|3
964587|NCT00671034|3175239|P3|Overall Study|Adverse Event|1
964588|NCT00671034|3175240|P2|Overall Study|Adverse Event|7
964589|NCT00671034|3175241|P1|Overall Study|Adverse Event|5
964590|NCT00670930|3175296|P2|Overall Study|Lost to Follow-up|0
964591|NCT00670930|3175297|P1|Overall Study|Lost to Follow-up|1
964592|NCT00670930|3175296|P2|Overall Study|Adminstrative Problem|1
964593|NCT00670930|3175297|P1|Overall Study|Adminstrative Problem|0
964594|NCT00670800|3175313|P2|Overall Study|2 controls were insulin resistant|2
964595|NCT00670800|3175314|P1|Overall Study|2 controls were insulin resistant|0
964596|NCT00670748|3175345|P4|Overall Study|Not off study|1
964597|NCT00670748|3175346|P3|Overall Study|Not off study|1
964598|NCT00670748|3175347|P2|Overall Study|Not off study|1
964599|NCT00670748|3175348|P1|Overall Study|Not off study|2
964600|NCT00670748|3175345|P4|Overall Study|Death during treatment|0
964601|NCT00670748|3175346|P3|Overall Study|Death during treatment|1
964602|NCT00670748|3175347|P2|Overall Study|Death during treatment|1
964603|NCT00670748|3175348|P1|Overall Study|Death during treatment|1
964604|NCT00670540|3175383|P1|Overall Study|missing information inclusion criteria|1
964605|NCT00670540|3175383|P1|Overall Study|controls randomised for no follow up|2770
964606|NCT00670540|3175383|P1|Overall Study|refused to participate|189
964607|NCT00670540|3175383|P1|Overall Study|not living in France|348
964608|NCT00670540|3175383|P1|Overall Study|ineligible|17
964609|NCT00670449|3175428|P4|Overall Study|Abnormal Laboratory Value(s)|0
964610|NCT00670449|3175429|P3|Overall Study|Abnormal Laboratory Value(s)|0
964611|NCT00670449|3175430|P2|Overall Study|Abnormal Laboratory Value(s)|2
964612|NCT00670449|3175431|P1|Overall Study|Abnormal Laboratory Value(s)|0
964613|NCT00670449|3175428|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
964614|NCT00670449|3175429|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
964615|NCT00670449|3175430|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
964616|NCT00670449|3175431|P1|Overall Study|Unsatisfactory Therapeutic Effect|2
964617|NCT00670449|3175428|P4|Overall Study|Subject Withdrew Consent|1
964618|NCT00670449|3175429|P3|Overall Study|Subject Withdrew Consent|0
964619|NCT00670449|3175430|P2|Overall Study|Subject Withdrew Consent|2
964620|NCT00670449|3175431|P1|Overall Study|Subject Withdrew Consent|0
964621|NCT00670449|3175428|P4|Overall Study|Administrative Problems|1
964622|NCT00670449|3175429|P3|Overall Study|Administrative Problems|0
964623|NCT00670449|3175430|P2|Overall Study|Administrative Problems|2
964624|NCT00670449|3175431|P1|Overall Study|Administrative Problems|0
964625|NCT00670449|3175428|P4|Overall Study|Protocol Deviation|1
964626|NCT00670449|3175429|P3|Overall Study|Protocol Deviation|0
964627|NCT00670449|3175430|P2|Overall Study|Protocol Deviation|2
964628|NCT00670449|3175431|P1|Overall Study|Protocol Deviation|1
964629|NCT00670449|3175428|P4|Overall Study|Adverse Event|5
964630|NCT00670449|3175429|P3|Overall Study|Adverse Event|8
964631|NCT00670449|3175430|P2|Overall Study|Adverse Event|2
964632|NCT00670449|3175431|P1|Overall Study|Adverse Event|6
964633|NCT00670306|3175455|P1|Overall Study|incl/excl criterias did not meet|19
964634|NCT00670306|3175455|P1|Overall Study|Lost to Follow-up|8
964635|NCT00670306|3175455|P1|Overall Study|Physician Decision|1
964636|NCT00670306|3175455|P1|Overall Study|Withdrawal by Subject|9
964637|NCT00670306|3175455|P1|Overall Study|Lack of Efficacy|10
964638|NCT00670306|3175455|P1|Overall Study|Adverse Event|8
964639|NCT00670228|3175494|P2|Overall Study|Not meeting the selection criteria|0
964640|NCT00670228|3175495|P1|Overall Study|Not meeting the selection criteria|2
964641|NCT00670228|3175494|P2|Overall Study|Not treated|2
964642|NCT00670228|3175495|P1|Overall Study|Not treated|2
964643|NCT00670228|3175494|P2|Overall Study|Death or MACE|1
964644|NCT00670228|3175495|P1|Overall Study|Death or MACE|0
964645|NCT00670228|3175494|P2|Overall Study|Adverse Event|0
964646|NCT00670228|3175495|P1|Overall Study|Adverse Event|1
964647|NCT00670111|3175519|P3|Enrollment to One Month|Physician Decision|0
964648|NCT00670111|3175520|P2|Enrollment to One Month|Physician Decision|0
964649|NCT00670111|3175521|P1|Enrollment to One Month|Physician Decision|1
964650|NCT00670111|3175519|P3|Enrollment to One Month|Ebrolled Patients but not Implanted|6
964651|NCT00670111|3175520|P2|Enrollment to One Month|Ebrolled Patients but not Implanted|0
964652|NCT00670111|3175521|P1|Enrollment to One Month|Ebrolled Patients but not Implanted|0
964653|NCT00670111|3175519|P3|Enrollment to One Month|Testing Failure|13
964654|NCT00670111|3175520|P2|Enrollment to One Month|Testing Failure|0
964655|NCT00670111|3175521|P1|Enrollment to One Month|Testing Failure|0
964656|NCT00670046|3175531|P2|Overall Study|Withdrawal by Subject|1
964657|NCT00670046|3175532|P1|Overall Study|Withdrawal by Subject|0
964658|NCT00670046|3175531|P2|Overall Study|Lost to Follow-up|1
964659|NCT00670046|3175532|P1|Overall Study|Lost to Follow-up|1
964660|NCT00670007|3175546|P1|Overall Study|Withdrawal by Subject|4
964661|NCT00670007|3175546|P1|Overall Study|Adverse Event|1
964662|NCT00670007|3175546|P1|Overall Study|Adverse event, serious fatal|1
964663|NCT00670007|3175546|P1|Overall Study|Travel/Vacation|1
964664|NCT00670007|3175546|P1|Overall Study|Lung transplant|1
964665|NCT00670007|3175546|P1|Overall Study|Drug abuse|1
964666|NCT00669955|3175573|P2|Overall Study|not compliant with study drug/visit|3
964667|NCT00669955|3175574|P1|Overall Study|not compliant with study drug/visit|2
964668|NCT00669955|3175573|P2|Overall Study|Investigator Sponsor Judgement|1
964669|NCT00669955|3175574|P1|Overall Study|Investigator Sponsor Judgement|0
964670|NCT00669955|3175573|P2|Overall Study|Protocol Violation|7
964671|NCT00669955|3175574|P1|Overall Study|Protocol Violation|2
964672|NCT00669955|3175573|P2|Overall Study|Lost to Follow-up|7
964673|NCT00669955|3175574|P1|Overall Study|Lost to Follow-up|5
964674|NCT00669955|3175573|P2|Overall Study|Withdrawal by Subject|3
964675|NCT00669955|3175574|P1|Overall Study|Withdrawal by Subject|2
964676|NCT00669955|3175573|P2|Overall Study|Death|1
964677|NCT00669955|3175574|P1|Overall Study|Death|0
964678|NCT00669955|3175573|P2|Overall Study|Adverse Event|5
964679|NCT00669955|3175574|P1|Overall Study|Adverse Event|3
964680|NCT00669942|3175604|P12|Parts 2 and 3|Protocol Violation|0
964681|NCT00669942|3175605|P11|Parts 2 and 3|Protocol Violation|0
964682|NCT00669942|3175606|P10|Parts 2 and 3|Protocol Violation|0
964683|NCT00669942|3175607|P9|Parts 2 and 3|Protocol Violation|0
964684|NCT00669942|3175608|P8|Parts 2 and 3|Protocol Violation|0
964685|NCT00669942|3175609|P7|Parts 2 and 3|Protocol Violation|0
964686|NCT00669942|3175610|P6|Parts 2 and 3|Protocol Violation|1
964687|NCT00669942|3175611|P5|Parts 2 and 3|Protocol Violation|0
964688|NCT00669942|3175612|P4|Parts 2 and 3|Protocol Violation|0
964689|NCT00669942|3175613|P3|Parts 2 and 3|Protocol Violation|0
964690|NCT00669942|3175614|P2|Parts 2 and 3|Protocol Violation|0
964691|NCT00669942|3175615|P1|Parts 2 and 3|Protocol Violation|0
964692|NCT00669942|3175604|P12|Parts 2 and 3|Withdrawal by Subject|0
964693|NCT00669942|3175605|P11|Parts 2 and 3|Withdrawal by Subject|0
964694|NCT00669942|3175606|P10|Parts 2 and 3|Withdrawal by Subject|0
964695|NCT00669942|3175607|P9|Parts 2 and 3|Withdrawal by Subject|2
964696|NCT00669942|3175608|P8|Parts 2 and 3|Withdrawal by Subject|0
964697|NCT00669942|3175609|P7|Parts 2 and 3|Withdrawal by Subject|0
964698|NCT00669942|3175610|P6|Parts 2 and 3|Withdrawal by Subject|1
964699|NCT00669942|3175611|P5|Parts 2 and 3|Withdrawal by Subject|0
964700|NCT00669942|3175612|P4|Parts 2 and 3|Withdrawal by Subject|0
964701|NCT00669942|3175613|P3|Parts 2 and 3|Withdrawal by Subject|0
964702|NCT00669942|3175614|P2|Parts 2 and 3|Withdrawal by Subject|0
964703|NCT00669942|3175615|P1|Parts 2 and 3|Withdrawal by Subject|0
964704|NCT00669942|3175604|P12|Parts 2 and 3|Adverse Event|0
964705|NCT00669942|3175605|P11|Parts 2 and 3|Adverse Event|0
964706|NCT00669942|3175606|P10|Parts 2 and 3|Adverse Event|0
964707|NCT00669942|3175607|P9|Parts 2 and 3|Adverse Event|1
964708|NCT00669942|3175608|P8|Parts 2 and 3|Adverse Event|2
964709|NCT00669942|3175609|P7|Parts 2 and 3|Adverse Event|0
964710|NCT00669942|3175610|P6|Parts 2 and 3|Adverse Event|0
964711|NCT00669942|3175611|P5|Parts 2 and 3|Adverse Event|0
964712|NCT00669942|3175612|P4|Parts 2 and 3|Adverse Event|0
964713|NCT00669942|3175613|P3|Parts 2 and 3|Adverse Event|0
964714|NCT00669942|3175614|P2|Parts 2 and 3|Adverse Event|0
964715|NCT00669942|3175615|P1|Parts 2 and 3|Adverse Event|0
964716|NCT00669903|3175698|P4|Overall Study|Protocol Violation|0
964717|NCT00669903|3175699|P3|Overall Study|Protocol Violation|0
964718|NCT00669903|3175700|P2|Overall Study|Protocol Violation|1
964719|NCT00669903|3175701|P1|Overall Study|Protocol Violation|0
964720|NCT00669903|3175698|P4|Overall Study|Lost to Follow-up|1
964721|NCT00669903|3175699|P3|Overall Study|Lost to Follow-up|0
964722|NCT00669903|3175700|P2|Overall Study|Lost to Follow-up|1
964723|NCT00669903|3175701|P1|Overall Study|Lost to Follow-up|1
964724|NCT00669903|3175698|P4|Overall Study|Withdrawal by Subject|2
964725|NCT00669903|3175699|P3|Overall Study|Withdrawal by Subject|2
964726|NCT00669903|3175700|P2|Overall Study|Withdrawal by Subject|2
964727|NCT00669903|3175701|P1|Overall Study|Withdrawal by Subject|0
964728|NCT00669903|3175698|P4|Overall Study|Adverse Event|1
964729|NCT00669903|3175699|P3|Overall Study|Adverse Event|3
964730|NCT00669903|3175700|P2|Overall Study|Adverse Event|1
964731|NCT00669903|3175701|P1|Overall Study|Adverse Event|0
964732|NCT00669877|3175731|P1|Overall Study|Disease Progression/Death|4
964733|NCT00669864|3175736|P1|Overall Study|Other|2
964734|NCT00669864|3175736|P1|Overall Study|Withdrawal by Subject|3
964735|NCT00669864|3175736|P1|Overall Study|Protocol Violation|2
964736|NCT00669864|3175736|P1|Overall Study|Lost to Follow-up|2
964737|NCT00669617|3175750|P5|Period 3|Lost to Follow-up|0
964738|NCT00669617|3175751|P4|Period 3|Lost to Follow-up|0
964739|NCT00669617|3175752|P3|Period 3|Lost to Follow-up|0
964740|NCT00669617|3175753|P2|Period 3|Lost to Follow-up|0
964741|NCT00669617|3175754|P1|Period 3|Lost to Follow-up|1
964742|NCT00669617|3175750|P5|Period 1|Protocol Deviation|1
964743|NCT00669617|3175751|P4|Period 1|Protocol Deviation|0
964744|NCT00669617|3175752|P3|Period 1|Protocol Deviation|0
964745|NCT00669617|3175753|P2|Period 1|Protocol Deviation|0
964746|NCT00669617|3175754|P1|Period 1|Protocol Deviation|0
964747|NCT00669617|3175750|P5|Period 1|Withdrawal by Subject|0
964748|NCT00669617|3175751|P4|Period 1|Withdrawal by Subject|0
964749|NCT00669617|3175752|P3|Period 1|Withdrawal by Subject|1
964750|NCT00669617|3175753|P2|Period 1|Withdrawal by Subject|0
964751|NCT00669617|3175754|P1|Period 1|Withdrawal by Subject|0
964752|NCT00669396|3175802|P2|Overall Study|Lost to Follow-up|12
964753|NCT00669396|3175803|P1|Overall Study|Lost to Follow-up|10
964754|NCT00669331|3175817|P2|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
964755|NCT00669331|3175818|P1|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
964756|NCT00669331|3175817|P2|Blinded Treatment Period|Physician Decision|3
964757|NCT00669331|3175818|P1|Blinded Treatment Period|Physician Decision|3
964758|NCT00669331|3175817|P2|Blinded Treatment Period|Death|2
964759|NCT00669331|3175818|P1|Blinded Treatment Period|Death|0
964760|NCT00669331|3175817|P2|Blinded Treatment Period|Lost to Follow-up|2
964761|NCT00669331|3175818|P1|Blinded Treatment Period|Lost to Follow-up|3
964762|NCT00669331|3175817|P2|Blinded Treatment Period|Withdrawal by Subject|19
964763|NCT00669331|3175818|P1|Blinded Treatment Period|Withdrawal by Subject|17
964764|NCT00669331|3175817|P2|Blinded Treatment Period|Protocol Violation|1
964765|NCT00669331|3175818|P1|Blinded Treatment Period|Protocol Violation|1
964766|NCT00669331|3175817|P2|Blinded Treatment Period|Adverse Event|10
964767|NCT00669331|3175818|P1|Blinded Treatment Period|Adverse Event|16
964768|NCT00669331|3175817|P2|Randomisation to First Dose|Randomised in error|10
964769|NCT00669331|3175818|P1|Randomisation to First Dose|Randomised in error|3
964770|NCT00669331|3175817|P2|Randomisation to First Dose|Sponsor decision|1
964771|NCT00669331|3175818|P1|Randomisation to First Dose|Sponsor decision|0
964772|NCT00669331|3175817|P2|Randomisation to First Dose|Death|0
964773|NCT00669331|3175818|P1|Randomisation to First Dose|Death|1
964774|NCT00669331|3175817|P2|Randomisation to First Dose|Lost to Follow-up|0
964775|NCT00669331|3175818|P1|Randomisation to First Dose|Lost to Follow-up|2
964776|NCT00669331|3175817|P2|Randomisation to First Dose|Withdrawal by Subject|2
964777|NCT00669331|3175818|P1|Randomisation to First Dose|Withdrawal by Subject|3
964778|NCT00669331|3175817|P2|Randomisation to First Dose|Protocol Violation|0
964779|NCT00669331|3175818|P1|Randomisation to First Dose|Protocol Violation|1
964780|NCT00669331|3175817|P2|Randomisation to First Dose|Adverse Event|0
964781|NCT00669331|3175818|P1|Randomisation to First Dose|Adverse Event|1
964782|NCT00669318|3175860|P1|Overall Study|Withdrawal by Subject|2
964783|NCT00669240|3175877|P1|Overall Study|Enrolled but no dosing record|1
964784|NCT00669240|3175877|P1|Overall Study|Enrolled but not treated|15
964785|NCT00669240|3175877|P1|Overall Study|Other|19
964786|NCT00669240|3175877|P1|Overall Study|Adverse Event|21
964787|NCT00669240|3175877|P1|Overall Study|Lost to Follow-up|34
964788|NCT00669240|3175877|P1|Overall Study|Withdrawal by Subject|42
964789|NCT00669240|3175877|P1|Overall Study|Lack of Efficacy|33
964790|NCT00669110|3175928|P2|Overall Study|Withdrawal by Subject|2
964791|NCT00669110|3175929|P1|Overall Study|Withdrawal by Subject|0
964792|NCT00669110|3175928|P2|Overall Study|Protocol Violation|5
964793|NCT00669110|3175929|P1|Overall Study|Protocol Violation|0
964794|NCT00669110|3175928|P2|Overall Study|Lost to Follow-up|0
964795|NCT00669110|3175929|P1|Overall Study|Lost to Follow-up|1
964796|NCT00669110|3175928|P2|Overall Study|Physician Decision|1
964797|NCT00669110|3175929|P1|Overall Study|Physician Decision|0
964798|NCT00669110|3175928|P2|Overall Study|Caregiver request|2
964799|NCT00669110|3175929|P1|Overall Study|Caregiver request|3
964800|NCT00669110|3175928|P2|Overall Study|Adverse Event|3
964801|NCT00669110|3175929|P1|Overall Study|Adverse Event|4
964802|NCT00669071|3175965|P1|Overall Study|Final visit 40 days out of window|1
964803|NCT00669071|3175965|P1|Overall Study|Lost to Follow-up|3
964804|NCT00669032|3175986|P2|Overall Study|No fulfilment of the selection criteria|5
964805|NCT00669032|3175987|P1|Overall Study|No fulfilment of the selection criteria|5
964806|NCT00669032|3175986|P2|Overall Study|Physician Decision|1
964807|NCT00669032|3175987|P1|Overall Study|Physician Decision|1
964808|NCT00669032|3175986|P2|Overall Study|Adverse Event|16
964809|NCT00669032|3175987|P1|Overall Study|Adverse Event|12
964810|NCT00669032|3175986|P2|Overall Study|Withdrawal by Subject|13
964811|NCT00669032|3175987|P1|Overall Study|Withdrawal by Subject|12
964812|NCT00669032|3175986|P2|Overall Study|Lack of Efficacy|19
964813|NCT00669032|3175987|P1|Overall Study|Lack of Efficacy|8
964814|NCT00669032|3175986|P2|Overall Study|Lost to Follow-up|5
964815|NCT00669032|3175987|P1|Overall Study|Lost to Follow-up|6
964816|NCT00668863|3176033|P1|Overall Study|Physician Decision|1
964817|NCT00668863|3176033|P1|Overall Study|Subject’s work scheduling problem|1
964818|NCT00668863|3176033|P1|Overall Study|Surgery|1
964819|NCT00668863|3176033|P1|Overall Study|Withdrawal by Subject|1
964820|NCT00668863|3176033|P1|Overall Study|Global Deterioration of Health Status|4
964821|NCT00668863|3176033|P1|Overall Study|Study Terminated by Sponsor|8
964822|NCT00668863|3176033|P1|Overall Study|Adverse Event|13
964823|NCT00668863|3176033|P1|Overall Study|Objective Progression or Relapse|42
964824|NCT00668746|3176065|P2|Overall Study|Lost to Follow-up|1
964825|NCT00668746|3176066|P1|Overall Study|Lost to Follow-up|2
964826|NCT00668733|3176086|P2|Overall Study|Withdrawal by Subject|4
964827|NCT00668733|3176087|P1|Overall Study|Withdrawal by Subject|0
964828|NCT00668733|3176086|P2|Overall Study|Lost to Follow-up|3
964829|NCT00668733|3176087|P1|Overall Study|Lost to Follow-up|2
964830|NCT00668395|3176132|P3|Overall Study|Physician Decision|0
964831|NCT00668395|3176133|P2|Overall Study|Physician Decision|1
964832|NCT00668395|3176134|P1|Overall Study|Physician Decision|1
964833|NCT00668395|3176132|P3|Overall Study|Adverse Event|0
964834|NCT00668395|3176133|P2|Overall Study|Adverse Event|1
964835|NCT00668395|3176134|P1|Overall Study|Adverse Event|1
964836|NCT00668395|3176132|P3|Overall Study|Withdrawal by Subject|1
964837|NCT00668395|3176133|P2|Overall Study|Withdrawal by Subject|4
964838|NCT00668395|3176134|P1|Overall Study|Withdrawal by Subject|4
964839|NCT00668317|3176146|P1|Overall Study|Adverse Event|2
964840|NCT00668200|3176161|P1|Overall Study|Lost to Follow-up|1
964841|NCT00668200|3176161|P1|Overall Study|Withdrawal by Subject|2
964842|NCT00668148|3176167|P1|Overall Study|Withdrawal of Consent|2
964843|NCT00668148|3176167|P1|Overall Study|Progressive Disease Before Treatment|2
964844|NCT00668148|3176167|P1|Overall Study|Subject Non-compliance|1
964845|NCT00668148|3176167|P1|Overall Study|Adverse Event|5
964846|NCT00667992|3176206|P2|Third Intervention 100 Mcg Twice Daily|Adverse Event|1
964847|NCT00667992|3176207|P1|Third Intervention 100 Mcg Twice Daily|Adverse Event|0
964848|NCT00667992|3176206|P2|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
964849|NCT00667992|3176207|P1|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1
964850|NCT00667992|3176206|P2|Wash-out|Withdrawal by Subject|0
964851|NCT00667992|3176207|P1|Wash-out|Withdrawal by Subject|1
964852|NCT00667992|3176206|P2|Wash-out|Failure to wash-out|2
964853|NCT00667992|3176207|P1|Wash-out|Failure to wash-out|2
964854|NCT00667992|3176206|P2|Wash-out|Not within one doubling dilution|3
964855|NCT00667992|3176207|P1|Wash-out|Not within one doubling dilution|4
964856|NCT00667992|3176206|P2|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1
964857|NCT00667992|3176207|P1|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0
964858|NCT00667992|3176206|P2|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3
964859|NCT00667992|3176207|P1|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2
964860|NCT00667992|3176206|P2|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0
964861|NCT00667992|3176207|P1|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1
964862|NCT00667992|3176206|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
964863|NCT00667992|3176207|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
964864|NCT00667992|3176206|P2|First Intervention 100 Mcg Twice Daily|Pregnancy|0
964865|NCT00667992|3176207|P1|First Intervention 100 Mcg Twice Daily|Pregnancy|1
964866|NCT00667992|3176206|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
964867|NCT00667992|3176207|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
964868|NCT00667992|3176206|P2|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
964869|NCT00667992|3176207|P1|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2
964870|NCT00667992|3176206|P2|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3
964871|NCT00667992|3176207|P1|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2
964872|NCT00667875|3176264|P3|Overall Study|Withdrawal by Subject|7
964873|NCT00667875|3176265|P2|Overall Study|Withdrawal by Subject|9
964874|NCT00667875|3176266|P1|Overall Study|Withdrawal by Subject|10
964875|NCT00667875|3176264|P3|Overall Study|Adverse Event|6
964876|NCT00667875|3176265|P2|Overall Study|Adverse Event|2
964877|NCT00667875|3176266|P1|Overall Study|Adverse Event|0
964878|NCT00667810|3176300|P4|Overall Study|Not specified|0
964879|NCT00667810|3176301|P3|Overall Study|Not specified|5
964880|NCT00667810|3176302|P2|Overall Study|Not specified|6
964881|NCT00667810|3176303|P1|Overall Study|Not specified|6
964882|NCT00667810|3176300|P4|Overall Study|Vasogenic Edema Recurrence|0
964883|NCT00667810|3176301|P3|Overall Study|Vasogenic Edema Recurrence|0
964884|NCT00667810|3176302|P2|Overall Study|Vasogenic Edema Recurrence|3
964885|NCT00667810|3176303|P1|Overall Study|Vasogenic Edema Recurrence|0
964886|NCT00667810|3176300|P4|Overall Study|Loss of Caregiver|0
964887|NCT00667810|3176301|P3|Overall Study|Loss of Caregiver|3
964888|NCT00667810|3176302|P2|Overall Study|Loss of Caregiver|1
964889|NCT00667810|3176303|P1|Overall Study|Loss of Caregiver|0
964890|NCT00667810|3176300|P4|Overall Study|Failed to Return|0
964891|NCT00667810|3176301|P3|Overall Study|Failed to Return|2
964892|NCT00667810|3176302|P2|Overall Study|Failed to Return|0
964893|NCT00667810|3176303|P1|Overall Study|Failed to Return|0
964894|NCT00667810|3176300|P4|Overall Study|Discontinuation of Study by Sponsor|0
964895|NCT00667810|3176301|P3|Overall Study|Discontinuation of Study by Sponsor|155
964896|NCT00667810|3176302|P2|Overall Study|Discontinuation of Study by Sponsor|118
964897|NCT00667810|3176303|P1|Overall Study|Discontinuation of Study by Sponsor|130
964898|NCT00667810|3176300|P4|Overall Study|Withdrawal by Subject|1
964899|NCT00667810|3176301|P3|Overall Study|Withdrawal by Subject|29
964900|NCT00667810|3176302|P2|Overall Study|Withdrawal by Subject|20
964901|NCT00667810|3176303|P1|Overall Study|Withdrawal by Subject|14
964902|NCT00667810|3176300|P4|Overall Study|Protocol Violation|0
964903|NCT00667810|3176301|P3|Overall Study|Protocol Violation|0
964904|NCT00667810|3176302|P2|Overall Study|Protocol Violation|2
964905|NCT00667810|3176303|P1|Overall Study|Protocol Violation|0
964906|NCT00667810|3176300|P4|Overall Study|Physician Decision|0
964907|NCT00667810|3176301|P3|Overall Study|Physician Decision|2
964908|NCT00667810|3176302|P2|Overall Study|Physician Decision|1
964909|NCT00667810|3176303|P1|Overall Study|Physician Decision|1
964910|NCT00667810|3176300|P4|Overall Study|Lost to Follow-up|0
964911|NCT00667810|3176301|P3|Overall Study|Lost to Follow-up|2
964912|NCT00667810|3176302|P2|Overall Study|Lost to Follow-up|4
964913|NCT00667810|3176303|P1|Overall Study|Lost to Follow-up|1
964914|NCT00667810|3176300|P4|Overall Study|Lack of Efficacy|0
964915|NCT00667810|3176301|P3|Overall Study|Lack of Efficacy|2
964916|NCT00667810|3176302|P2|Overall Study|Lack of Efficacy|0
964917|NCT00667810|3176303|P1|Overall Study|Lack of Efficacy|1
964918|NCT00667810|3176300|P4|Overall Study|Death|0
964919|NCT00667810|3176301|P3|Overall Study|Death|3
964920|NCT00667810|3176302|P2|Overall Study|Death|1
964921|NCT00667810|3176303|P1|Overall Study|Death|1
964922|NCT00667810|3176300|P4|Overall Study|Adverse Event|1
964923|NCT00667810|3176301|P3|Overall Study|Adverse Event|19
964924|NCT00667810|3176302|P2|Overall Study|Adverse Event|14
964925|NCT00667810|3176303|P1|Overall Study|Adverse Event|13
964926|NCT00667732|3176379|P3|Randomization (24 Weeks)|Withdrawal by Subject|0
964927|NCT00667732|3176380|P2|Randomization (24 Weeks)|Withdrawal by Subject|1
964928|NCT00667732|3176381|P1|Randomization (24 Weeks)|Withdrawal by Subject|0
964929|NCT00667732|3176379|P3|Run -In (8 Weeks)|Withdrawal by Subject|0
964930|NCT00667732|3176380|P2|Run -In (8 Weeks)|Withdrawal by Subject|0
964931|NCT00667732|3176381|P1|Run -In (8 Weeks)|Withdrawal by Subject|3
964932|NCT00667732|3176379|P3|Run -In (8 Weeks)|Adverse Event|0
964933|NCT00667732|3176380|P2|Run -In (8 Weeks)|Adverse Event|0
964934|NCT00667732|3176381|P1|Run -In (8 Weeks)|Adverse Event|4
964935|NCT00667602|3176417|P3|Overall Study|Protocol Violation|0
964936|NCT00667602|3176418|P2|Overall Study|Protocol Violation|1
964937|NCT00667602|3176419|P1|Overall Study|Protocol Violation|0
964938|NCT00667602|3176417|P3|Overall Study|Administrative reason|2
964939|NCT00667602|3176418|P2|Overall Study|Administrative reason|0
964940|NCT00667602|3176419|P1|Overall Study|Administrative reason|0
964941|NCT00667602|3176417|P3|Overall Study|Lost to Follow-up|6
964942|NCT00667602|3176418|P2|Overall Study|Lost to Follow-up|5
964943|NCT00667602|3176419|P1|Overall Study|Lost to Follow-up|4
964944|NCT00667602|3176417|P3|Overall Study|Withdrawal by Subject|10
964945|NCT00667602|3176418|P2|Overall Study|Withdrawal by Subject|9
964946|NCT00667602|3176419|P1|Overall Study|Withdrawal by Subject|4
964947|NCT00667576|3176487|P5|Overall Study|Missed Visit|0
964948|NCT00667576|3176488|P4|Overall Study|Missed Visit|1
964949|NCT00667576|3176489|P3|Overall Study|Missed Visit|0
964950|NCT00667576|3176490|P2|Overall Study|Missed Visit|0
964951|NCT00667576|3176491|P1|Overall Study|Missed Visit|0
964952|NCT00667576|3176487|P5|Overall Study|Physician Decision|0
964953|NCT00667576|3176488|P4|Overall Study|Physician Decision|1
964954|NCT00667576|3176489|P3|Overall Study|Physician Decision|0
964955|NCT00667576|3176490|P2|Overall Study|Physician Decision|0
964956|NCT00667576|3176491|P1|Overall Study|Physician Decision|0
964957|NCT00667576|3176487|P5|Overall Study|Protocol Violation|0
964958|NCT00667576|3176488|P4|Overall Study|Protocol Violation|1
964959|NCT00667576|3176489|P3|Overall Study|Protocol Violation|0
964960|NCT00667576|3176490|P2|Overall Study|Protocol Violation|0
964961|NCT00667576|3176491|P1|Overall Study|Protocol Violation|0
964962|NCT00667576|3176487|P5|Overall Study|Lost to Follow-up|0
964963|NCT00667576|3176488|P4|Overall Study|Lost to Follow-up|0
964964|NCT00667576|3176489|P3|Overall Study|Lost to Follow-up|1
964965|NCT00667576|3176490|P2|Overall Study|Lost to Follow-up|0
964966|NCT00667576|3176491|P1|Overall Study|Lost to Follow-up|0
964967|NCT00667576|3176487|P5|Overall Study|Adverse Event|0
964968|NCT00667576|3176488|P4|Overall Study|Adverse Event|0
964969|NCT00667576|3176489|P3|Overall Study|Adverse Event|0
964970|NCT00667576|3176490|P2|Overall Study|Adverse Event|1
964971|NCT00667576|3176491|P1|Overall Study|Adverse Event|1
964972|NCT00667576|3176487|P5|Overall Study|Withdrawal by Subject|1
964973|NCT00667576|3176488|P4|Overall Study|Withdrawal by Subject|1
964974|NCT00667576|3176489|P3|Overall Study|Withdrawal by Subject|1
964975|NCT00667576|3176490|P2|Overall Study|Withdrawal by Subject|0
964976|NCT00667576|3176491|P1|Overall Study|Withdrawal by Subject|1
964977|NCT00667563|3176538|P1|Overall Study|Protocol Violation|24
964978|NCT00667459|3176558|P2|Overall Study|Lost to Follow-up|43
964979|NCT00667459|3176559|P1|Overall Study|Lost to Follow-up|8
964980|NCT00667459|3176558|P2|Overall Study|Death|2
964981|NCT00667459|3176559|P1|Overall Study|Death|0
964982|NCT00667446|3176601|P2|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1
964983|NCT00667446|3176602|P1|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0
964984|NCT00667446|3176601|P2|Treatment Period (36 Months)|Therapeutic Failure|1
964985|NCT00667446|3176602|P1|Treatment Period (36 Months)|Therapeutic Failure|1
964986|NCT00667446|3176601|P2|Treatment Period (36 Months)|Protocol Violation|1
964987|NCT00667446|3176602|P1|Treatment Period (36 Months)|Protocol Violation|1
964988|NCT00667446|3176601|P2|Treatment Period (36 Months)|Lost to Follow-up|0
964989|NCT00667446|3176602|P1|Treatment Period (36 Months)|Lost to Follow-up|1
964990|NCT00667446|3176601|P2|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0
964991|NCT00667446|3176602|P1|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3
964992|NCT00667446|3176601|P2|Treatment Period (36 Months)|Withdrawal by Subject|4
964993|NCT00667446|3176602|P1|Treatment Period (36 Months)|Withdrawal by Subject|0
964994|NCT00667446|3176601|P2|Treatment Period (36 Months)|Personal reasons|2
964995|NCT00667446|3176602|P1|Treatment Period (36 Months)|Personal reasons|2
964996|NCT00667446|3176601|P2|Treatment Period (36 Months)|Other|2
964997|NCT00667446|3176602|P1|Treatment Period (36 Months)|Other|2
964998|NCT00667446|3176601|P2|Treatment Period (36 Months)|Ready to enter puberty based on age|15
964999|NCT00667446|3176602|P1|Treatment Period (36 Months)|Ready to enter puberty based on age|13
965000|NCT00667420|3176624|P1|Overall Study|Withdrawal by Subject|2
965001|NCT00667420|3176624|P1|Overall Study|Physician Decision|1
965002|NCT00667420|3176624|P1|Overall Study|Lack of Efficacy|5
965003|NCT00667420|3176624|P1|Overall Study|Adverse Event|2
965004|NCT00667394|3176634|P2|Overall Study|Progressive disease|0
965005|NCT00667394|3176635|P1|Overall Study|Progressive disease|1
965006|NCT00667394|3176634|P2|Overall Study|Adverse Event|0
965007|NCT00667394|3176635|P1|Overall Study|Adverse Event|3
965008|NCT00667368|3176662|P2|Overall Study|Discontinued early|17
965009|NCT00667368|3176663|P1|Overall Study|Discontinued early|24
965010|NCT00667368|3176662|P2|Overall Study|Lost to Follow-up|155
965011|NCT00667368|3176663|P1|Overall Study|Lost to Follow-up|176
965012|NCT00667355|3176671|P1|Overall Study|Other reason was not specified|5
965013|NCT00667355|3176671|P1|Overall Study|Lost to Follow-up|1
965014|NCT00667355|3176671|P1|Overall Study|Adverse Event|5
965015|NCT00667342|3176696|P3|Overall Study|Ineligible|1
965016|NCT00667342|3176697|P2|Overall Study|Ineligible|0
965017|NCT00667342|3176698|P1|Overall Study|Ineligible|0
965018|NCT00667342|3176696|P3|Overall Study|Adverse Event|1
965019|NCT00667342|3176697|P2|Overall Study|Adverse Event|0
965020|NCT00667342|3176698|P1|Overall Study|Adverse Event|0
965021|NCT00667342|3176696|P3|Overall Study|Relapse or tumor progression|7
965022|NCT00667342|3176697|P2|Overall Study|Relapse or tumor progression|0
965023|NCT00667342|3176698|P1|Overall Study|Relapse or tumor progression|9
965024|NCT00667342|3176696|P3|Overall Study|Physician Decision|0
965025|NCT00667342|3176697|P2|Overall Study|Physician Decision|0
965026|NCT00667342|3176698|P1|Overall Study|Physician Decision|3
965027|NCT00667342|3176696|P3|Overall Study|Withdrawal by Subject|0
965028|NCT00667342|3176697|P2|Overall Study|Withdrawal by Subject|0
965029|NCT00667342|3176698|P1|Overall Study|Withdrawal by Subject|1
965030|NCT00667342|3176696|P3|Overall Study|Protocol Violation|0
965031|NCT00667342|3176697|P2|Overall Study|Protocol Violation|0
965032|NCT00667342|3176698|P1|Overall Study|Protocol Violation|1
965033|NCT00667277|3176736|P1|Overall Study|Withdrawal by Subject|2
965034|NCT00667251|3176743|P2|Overall Study|Symptomatic progression|2
965035|NCT00667251|3176744|P1|Overall Study|Symptomatic progression|1
965036|NCT00667251|3176743|P2|Overall Study|Intercurrent Illness|3
965037|NCT00667251|3176744|P1|Overall Study|Intercurrent Illness|4
965038|NCT00667251|3176743|P2|Overall Study|Other/missing|84
965039|NCT00667251|3176744|P1|Overall Study|Other/missing|46
965040|NCT00667251|3176743|P2|Overall Study|Withdrawal by Subject|2
965041|NCT00667251|3176744|P1|Overall Study|Withdrawal by Subject|6
965042|NCT00667251|3176743|P2|Overall Study|Adverse Event|4
965043|NCT00667251|3176744|P1|Overall Study|Adverse Event|13
965044|NCT00667225|3176770|P2|Overall Study|Lost to Follow-up|1
965045|NCT00667225|3176771|P1|Overall Study|Lost to Follow-up|0
965046|NCT00667225|3176770|P2|Overall Study|Subject had no more lesions to treat.|0
965047|NCT00667225|3176771|P1|Overall Study|Subject had no more lesions to treat.|1
965048|NCT00667095|3176792|P2|Overall Study|Withdrawal by Subject|1
965049|NCT00667095|3176793|P1|Overall Study|Withdrawal by Subject|0
965050|NCT00666965|3176825|P4|Overall Study|Withdrawal by Subject|2
965051|NCT00666965|3176826|P3|Overall Study|Withdrawal by Subject|0
965052|NCT00666965|3176827|P2|Overall Study|Withdrawal by Subject|0
965053|NCT00666965|3176828|P1|Overall Study|Withdrawal by Subject|0
965054|NCT00666965|3176825|P4|Overall Study|Discontinuation criteria|2
965055|NCT00666965|3176826|P3|Overall Study|Discontinuation criteria|1
965056|NCT00666965|3176827|P2|Overall Study|Discontinuation criteria|1
965057|NCT00666965|3176828|P1|Overall Study|Discontinuation criteria|2
965058|NCT00666965|3176825|P4|Overall Study|Protocol Violation|2
965059|NCT00666965|3176826|P3|Overall Study|Protocol Violation|0
965060|NCT00666965|3176827|P2|Overall Study|Protocol Violation|0
965061|NCT00666965|3176828|P1|Overall Study|Protocol Violation|0
965062|NCT00666965|3176825|P4|Overall Study|Lack of Efficacy|0
965063|NCT00666965|3176826|P3|Overall Study|Lack of Efficacy|0
965064|NCT00666965|3176827|P2|Overall Study|Lack of Efficacy|1
965065|NCT00666965|3176828|P1|Overall Study|Lack of Efficacy|1
965066|NCT00666965|3176825|P4|Overall Study|Adverse Event|9
965067|NCT00666965|3176826|P3|Overall Study|Adverse Event|1
965068|NCT00666965|3176827|P2|Overall Study|Adverse Event|2
965069|NCT00666965|3176828|P1|Overall Study|Adverse Event|0
965070|NCT00666926|3176858|P16|Overall Study|Death|0
965071|NCT00666926|3176859|P15|Overall Study|Death|0
965072|NCT00666926|3176860|P14|Overall Study|Death|0
965073|NCT00666926|3176861|P13|Overall Study|Death|0
965074|NCT00666926|3176862|P12|Overall Study|Death|1
965075|NCT00666926|3176863|P11|Overall Study|Death|0
965076|NCT00666926|3176864|P10|Overall Study|Death|0
965077|NCT00666926|3176865|P9|Overall Study|Death|0
965078|NCT00666926|3176866|P8|Overall Study|Death|0
965079|NCT00666926|3176867|P7|Overall Study|Death|0
965080|NCT00666926|3176868|P6|Overall Study|Death|0
965081|NCT00666926|3176869|P5|Overall Study|Death|0
965082|NCT00666926|3176870|P4|Overall Study|Death|0
965083|NCT00666926|3176871|P3|Overall Study|Death|0
965084|NCT00666926|3176872|P2|Overall Study|Death|0
965085|NCT00666926|3176873|P1|Overall Study|Death|0
965086|NCT00666926|3176858|P16|Overall Study|Withdrawal by Subject|3
965087|NCT00666926|3176859|P15|Overall Study|Withdrawal by Subject|3
965088|NCT00666926|3176860|P14|Overall Study|Withdrawal by Subject|1
965089|NCT00666926|3176861|P13|Overall Study|Withdrawal by Subject|0
965090|NCT00666926|3176862|P12|Overall Study|Withdrawal by Subject|3
965091|NCT00666926|3176863|P11|Overall Study|Withdrawal by Subject|0
965092|NCT00666926|3176864|P10|Overall Study|Withdrawal by Subject|3
965093|NCT00666926|3176865|P9|Overall Study|Withdrawal by Subject|0
965094|NCT00666926|3176866|P8|Overall Study|Withdrawal by Subject|1
965095|NCT00666926|3176867|P7|Overall Study|Withdrawal by Subject|0
965096|NCT00666926|3176868|P6|Overall Study|Withdrawal by Subject|0
965097|NCT00666926|3176869|P5|Overall Study|Withdrawal by Subject|0
965098|NCT00666926|3176870|P4|Overall Study|Withdrawal by Subject|0
965099|NCT00666926|3176871|P3|Overall Study|Withdrawal by Subject|0
965100|NCT00666926|3176872|P2|Overall Study|Withdrawal by Subject|0
965101|NCT00666926|3176873|P1|Overall Study|Withdrawal by Subject|0
965102|NCT00666926|3176858|P16|Overall Study|Other|4
965103|NCT00666926|3176859|P15|Overall Study|Other|4
965104|NCT00666926|3176860|P14|Overall Study|Other|2
965105|NCT00666926|3176861|P13|Overall Study|Other|3
965106|NCT00666926|3176862|P12|Overall Study|Other|26
965107|NCT00666926|3176863|P11|Overall Study|Other|3
965108|NCT00666926|3176864|P10|Overall Study|Other|5
965109|NCT00666926|3176865|P9|Overall Study|Other|3
965110|NCT00666926|3176866|P8|Overall Study|Other|0
965111|NCT00666926|3176867|P7|Overall Study|Other|4
965112|NCT00666926|3176868|P6|Overall Study|Other|3
965113|NCT00666926|3176869|P5|Overall Study|Other|3
965114|NCT00666926|3176870|P4|Overall Study|Other|3
965115|NCT00666926|3176871|P3|Overall Study|Other|3
965116|NCT00666926|3176872|P2|Overall Study|Other|4
965117|NCT00666926|3176873|P1|Overall Study|Other|2
965118|NCT00666926|3176858|P16|Overall Study|Lost to Follow-up|0
965119|NCT00666926|3176859|P15|Overall Study|Lost to Follow-up|0
965120|NCT00666926|3176860|P14|Overall Study|Lost to Follow-up|0
965121|NCT00666926|3176861|P13|Overall Study|Lost to Follow-up|0
965122|NCT00666926|3176862|P12|Overall Study|Lost to Follow-up|0
965123|NCT00666926|3176863|P11|Overall Study|Lost to Follow-up|0
965124|NCT00666926|3176864|P10|Overall Study|Lost to Follow-up|0
965125|NCT00666926|3176865|P9|Overall Study|Lost to Follow-up|0
965126|NCT00666926|3176866|P8|Overall Study|Lost to Follow-up|0
965127|NCT00666926|3176867|P7|Overall Study|Lost to Follow-up|0
965128|NCT00666926|3176868|P6|Overall Study|Lost to Follow-up|0
965129|NCT00666926|3176869|P5|Overall Study|Lost to Follow-up|0
965130|NCT00666926|3176870|P4|Overall Study|Lost to Follow-up|1
965131|NCT00666926|3176871|P3|Overall Study|Lost to Follow-up|0
965132|NCT00666926|3176872|P2|Overall Study|Lost to Follow-up|0
965133|NCT00666926|3176873|P1|Overall Study|Lost to Follow-up|0
965134|NCT00666926|3176858|P16|Overall Study|Lack of Efficacy|0
965135|NCT00666926|3176859|P15|Overall Study|Lack of Efficacy|0
965136|NCT00666926|3176860|P14|Overall Study|Lack of Efficacy|0
965137|NCT00666926|3176861|P13|Overall Study|Lack of Efficacy|0
965138|NCT00666926|3176862|P12|Overall Study|Lack of Efficacy|1
965139|NCT00666926|3176863|P11|Overall Study|Lack of Efficacy|0
965140|NCT00666926|3176864|P10|Overall Study|Lack of Efficacy|0
965141|NCT00666926|3176865|P9|Overall Study|Lack of Efficacy|0
965142|NCT00666926|3176866|P8|Overall Study|Lack of Efficacy|0
965143|NCT00666926|3176867|P7|Overall Study|Lack of Efficacy|0
965144|NCT00666926|3176868|P6|Overall Study|Lack of Efficacy|1
965145|NCT00666926|3176869|P5|Overall Study|Lack of Efficacy|0
965146|NCT00666926|3176870|P4|Overall Study|Lack of Efficacy|0
965147|NCT00666926|3176871|P3|Overall Study|Lack of Efficacy|0
965148|NCT00666926|3176872|P2|Overall Study|Lack of Efficacy|0
965149|NCT00666926|3176873|P1|Overall Study|Lack of Efficacy|0
965150|NCT00666926|3176858|P16|Overall Study|Laboratory abnormality|1
965151|NCT00666926|3176859|P15|Overall Study|Laboratory abnormality|0
965152|NCT00666926|3176860|P14|Overall Study|Laboratory abnormality|0
965153|NCT00666926|3176861|P13|Overall Study|Laboratory abnormality|0
965154|NCT00666926|3176862|P12|Overall Study|Laboratory abnormality|0
965155|NCT00666926|3176863|P11|Overall Study|Laboratory abnormality|1
965156|NCT00666926|3176864|P10|Overall Study|Laboratory abnormality|0
965157|NCT00666926|3176865|P9|Overall Study|Laboratory abnormality|0
965158|NCT00666926|3176866|P8|Overall Study|Laboratory abnormality|0
965159|NCT00666926|3176867|P7|Overall Study|Laboratory abnormality|0
965160|NCT00666926|3176868|P6|Overall Study|Laboratory abnormality|0
965161|NCT00666926|3176869|P5|Overall Study|Laboratory abnormality|0
965162|NCT00666926|3176870|P4|Overall Study|Laboratory abnormality|0
965163|NCT00666926|3176871|P3|Overall Study|Laboratory abnormality|0
965164|NCT00666926|3176872|P2|Overall Study|Laboratory abnormality|0
965165|NCT00666926|3176873|P1|Overall Study|Laboratory abnormality|0
965166|NCT00666926|3176858|P16|Overall Study|Adverse Event|0
965167|NCT00666926|3176859|P15|Overall Study|Adverse Event|0
965168|NCT00666926|3176860|P14|Overall Study|Adverse Event|1
965169|NCT00666926|3176861|P13|Overall Study|Adverse Event|0
965170|NCT00666926|3176862|P12|Overall Study|Adverse Event|2
965171|NCT00666926|3176863|P11|Overall Study|Adverse Event|2
965172|NCT00666926|3176864|P10|Overall Study|Adverse Event|2
965173|NCT00666926|3176865|P9|Overall Study|Adverse Event|0
965174|NCT00666926|3176866|P8|Overall Study|Adverse Event|0
965175|NCT00666926|3176867|P7|Overall Study|Adverse Event|0
965176|NCT00666926|3176868|P6|Overall Study|Adverse Event|0
965177|NCT00666926|3176869|P5|Overall Study|Adverse Event|0
965178|NCT00666926|3176870|P4|Overall Study|Adverse Event|0
965179|NCT00666926|3176871|P3|Overall Study|Adverse Event|0
965180|NCT00666926|3176872|P2|Overall Study|Adverse Event|0
965181|NCT00666926|3176873|P1|Overall Study|Adverse Event|0
965182|NCT00666835|3177182|P2|Overall Study|Physician Decision|2
965183|NCT00666835|3177183|P1|Overall Study|Physician Decision|1
965184|NCT00666835|3177182|P2|Overall Study|Planned operation|0
965185|NCT00666835|3177183|P1|Overall Study|Planned operation|2
965186|NCT00666835|3177182|P2|Overall Study|Hemoglobulin concentration|3
965187|NCT00666835|3177183|P1|Overall Study|Hemoglobulin concentration|4
965188|NCT00666835|3177182|P2|Overall Study|Kidney Transplantation (NTX)|2
965189|NCT00666835|3177183|P1|Overall Study|Kidney Transplantation (NTX)|10
965190|NCT00666835|3177182|P2|Overall Study|Death|4
965191|NCT00666835|3177183|P1|Overall Study|Death|15
965192|NCT00666835|3177182|P2|Overall Study|Protocol Violation|0
965193|NCT00666835|3177183|P1|Overall Study|Protocol Violation|2
965194|NCT00666835|3177182|P2|Overall Study|Adverse Event|6
965195|NCT00666835|3177183|P1|Overall Study|Adverse Event|7
965196|NCT00666835|3177182|P2|Overall Study|Incl./excl. not fulfilled|2
965197|NCT00666835|3177183|P1|Overall Study|Incl./excl. not fulfilled|7
965198|NCT00666835|3177182|P2|Overall Study|Lack of Efficacy|1
965199|NCT00666835|3177183|P1|Overall Study|Lack of Efficacy|0
965200|NCT00666835|3177182|P2|Overall Study|Withdrawal by Subject|2
965201|NCT00666835|3177183|P1|Overall Study|Withdrawal by Subject|5
965202|NCT00666757|3177193|P2|Overall Study|Sponsor decision|1
965203|NCT00666757|3177194|P1|Overall Study|Sponsor decision|0
965204|NCT00666757|3177193|P2|Overall Study|Physician Decision|2
965205|NCT00666757|3177194|P1|Overall Study|Physician Decision|0
965206|NCT00666757|3177193|P2|Overall Study|Lack of Efficacy|6
965207|NCT00666757|3177194|P1|Overall Study|Lack of Efficacy|3
965208|NCT00666757|3177193|P2|Overall Study|Withdrawal by Subject|17
965209|NCT00666757|3177194|P1|Overall Study|Withdrawal by Subject|13
965210|NCT00666757|3177193|P2|Overall Study|Adverse Event|12
965211|NCT00666757|3177194|P1|Overall Study|Adverse Event|22
965212|NCT00666757|3177193|P2|Overall Study|Protocol Violation|24
965213|NCT00666757|3177194|P1|Overall Study|Protocol Violation|23
965214|NCT00666757|3177193|P2|Overall Study|Lost to Follow-up|35
965215|NCT00666757|3177194|P1|Overall Study|Lost to Follow-up|39
965216|NCT00666718|3177253|P2|Overall Study|Physician Decision|2
965217|NCT00666718|3177254|P1|Overall Study|Physician Decision|0
965218|NCT00666718|3177253|P2|Overall Study|Withdrawal by Subject|12
965219|NCT00666718|3177254|P1|Overall Study|Withdrawal by Subject|7
965220|NCT00666718|3177253|P2|Overall Study|Protocol Violation|3
965221|NCT00666718|3177254|P1|Overall Study|Protocol Violation|1
965222|NCT00666718|3177253|P2|Overall Study|Entry Criteria Not Met|0
965223|NCT00666718|3177254|P1|Overall Study|Entry Criteria Not Met|2
965224|NCT00666718|3177253|P2|Overall Study|Lost to Follow-up|0
965225|NCT00666718|3177254|P1|Overall Study|Lost to Follow-up|1
965226|NCT00666718|3177253|P2|Overall Study|Death|0
965227|NCT00666718|3177254|P1|Overall Study|Death|1
965228|NCT00666718|3177253|P2|Overall Study|Adverse Event|1
965229|NCT00666718|3177254|P1|Overall Study|Adverse Event|0
965230|NCT00666705|3177280|P1|Overall Study|Withdrawal by Subject|1
965231|NCT00666679|3177299|P2|Second Intervention|Death|1
965232|NCT00666679|3177300|P1|Second Intervention|Death|0
965233|NCT00666679|3177299|P2|Second Intervention|Adverse Event|0
965234|NCT00666679|3177300|P1|Second Intervention|Adverse Event|1
965235|NCT00666679|3177299|P2|Washout Period of 1 Week|Protocol Violation|1
965236|NCT00666679|3177300|P1|Washout Period of 1 Week|Protocol Violation|0
965237|NCT00666679|3177299|P2|Washout Period of 1 Week|Lost to Follow-up|1
965238|NCT00666679|3177300|P1|Washout Period of 1 Week|Lost to Follow-up|0
965239|NCT00666679|3177299|P2|First Intervention|Randomized did not start treatment|1
965240|NCT00666679|3177300|P1|First Intervention|Randomized did not start treatment|1
965241|NCT00666679|3177299|P2|First Intervention|Withdrawal by Subject|0
965242|NCT00666679|3177300|P1|First Intervention|Withdrawal by Subject|1
965243|NCT00666679|3177299|P2|First Intervention|Protocol Violation|0
965244|NCT00666679|3177300|P1|First Intervention|Protocol Violation|1
965245|NCT00666679|3177299|P2|First Intervention|Lost to Follow-up|0
965246|NCT00666679|3177300|P1|First Intervention|Lost to Follow-up|1
965247|NCT00666588|3177330|P4|Overall Study|inevaluable|0
965248|NCT00666588|3177331|P3|Overall Study|inevaluable|0
965249|NCT00666588|3177332|P2|Overall Study|inevaluable|0
965250|NCT00666588|3177333|P1|Overall Study|inevaluable|2
965251|NCT00666588|3177330|P4|Overall Study|ineligible|2
965252|NCT00666588|3177331|P3|Overall Study|ineligible|0
965253|NCT00666588|3177332|P2|Overall Study|ineligible|0
965254|NCT00666588|3177333|P1|Overall Study|ineligible|2
965255|NCT00666562|3177366|P3|Overall Study|Concomitant Medication|0
965256|NCT00666562|3177367|P2|Overall Study|Concomitant Medication|1
965257|NCT00666562|3177368|P1|Overall Study|Concomitant Medication|0
965258|NCT00666562|3177366|P3|Overall Study|Withdrawal by Subject|0
965259|NCT00666562|3177367|P2|Overall Study|Withdrawal by Subject|1
965260|NCT00666562|3177368|P1|Overall Study|Withdrawal by Subject|0
965261|NCT00666536|3177415|P2|Overall Study|Lost to Follow-up|3
965262|NCT00666536|3177416|P1|Overall Study|Lost to Follow-up|4
965263|NCT00666536|3177415|P2|Overall Study|Withdrawal by Subject|9
965264|NCT00666536|3177416|P1|Overall Study|Withdrawal by Subject|10
965265|NCT00666536|3177415|P2|Overall Study|Protocol deviation(s)|6
965266|NCT00666536|3177416|P1|Overall Study|Protocol deviation(s)|8
965267|NCT00666536|3177415|P2|Overall Study|Unsatisfactory therapeutic effect|0
965268|NCT00666536|3177416|P1|Overall Study|Unsatisfactory therapeutic effect|2
965269|NCT00666536|3177415|P2|Overall Study|Adverse Event|19
965270|NCT00666536|3177416|P1|Overall Study|Adverse Event|9
965271|NCT00666458|3177434|P2|Overall Study|Medical history of anemia|0
965272|NCT00666458|3177435|P1|Overall Study|Medical history of anemia|1
965273|NCT00666458|3177434|P2|Overall Study|Safety reasons|0
965274|NCT00666458|3177435|P1|Overall Study|Safety reasons|1
965275|NCT00666458|3177434|P2|Overall Study|Severe non-compliance to the protocol|1
965276|NCT00666458|3177435|P1|Overall Study|Severe non-compliance to the protocol|1
965277|NCT00666458|3177434|P2|Overall Study|Study specific discontinuation criteria|7
965278|NCT00666458|3177435|P1|Overall Study|Study specific discontinuation criteria|14
965279|NCT00666458|3177434|P2|Overall Study|Incorrect enrollment|1
965280|NCT00666458|3177435|P1|Overall Study|Incorrect enrollment|7
965281|NCT00666458|3177434|P2|Overall Study|Administrative reason by sponsor|1
965282|NCT00666458|3177435|P1|Overall Study|Administrative reason by sponsor|1
965283|NCT00666458|3177434|P2|Overall Study|Lost to Follow-up|3
965284|NCT00666458|3177435|P1|Overall Study|Lost to Follow-up|0
965285|NCT00666458|3177434|P2|Overall Study|Withdrawal by Subject|4
965286|NCT00666458|3177435|P1|Overall Study|Withdrawal by Subject|5
965287|NCT00666458|3177434|P2|Overall Study|Adverse Event|7
965288|NCT00666458|3177435|P1|Overall Study|Adverse Event|8
965289|NCT00666328|3177523|P1|Overall Study|No longer met eligibility criteria|1
965290|NCT00666328|3177523|P1|Overall Study|Lost to Follow-up|2
965291|NCT00666328|3177523|P1|Overall Study|Death|2
965292|NCT00666276|3177536|P1|Overall Study|Protocol Violation|34
965293|NCT00666263|3177560|P2|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1
965294|NCT00666263|3177561|P1|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0
965295|NCT00666263|3177560|P2|Study Part 4 (Cross-over Period 2)|Adverse Event|0
965296|NCT00666263|3177561|P1|Study Part 4 (Cross-over Period 2)|Adverse Event|1
965297|NCT00666263|3177560|P2|Study Part 1 (Stabilization Phase 1)|Adverse Event|1
965298|NCT00666263|3177561|P1|Study Part 1 (Stabilization Phase 1)|Adverse Event|0
965299|NCT00666224|3177705|P2|Open-Label|Undefined/Unknown|1
965300|NCT00666224|3177706|P1|Open-Label|Undefined/Unknown|1
965301|NCT00666224|3177705|P2|Open-Label|Noncompliance|1
965302|NCT00666224|3177706|P1|Open-Label|Noncompliance|2
965303|NCT00666224|3177705|P2|Open-Label|Pregnancy|5
965304|NCT00666224|3177706|P1|Open-Label|Pregnancy|1
965305|NCT00666224|3177705|P2|Open-Label|Physician Decision|5
965306|NCT00666224|3177706|P1|Open-Label|Physician Decision|7
965307|NCT00666224|3177705|P2|Open-Label|Withdrawal by Subject|25
965308|NCT00666224|3177706|P1|Open-Label|Withdrawal by Subject|12
965309|NCT00666224|3177705|P2|Open-Label|Lost to Follow-up|5
965310|NCT00666224|3177706|P1|Open-Label|Lost to Follow-up|4
965311|NCT00666224|3177705|P2|Open-Label|Adverse Event|43
965312|NCT00666224|3177706|P1|Open-Label|Adverse Event|8
965313|NCT00666224|3177705|P2|Double-Blind|Undefined/Unknown|1
965314|NCT00666224|3177706|P1|Double-Blind|Undefined/Unknown|4
965315|NCT00666224|3177705|P2|Double-Blind|Death|0
965316|NCT00666224|3177706|P1|Double-Blind|Death|1
965317|NCT00666224|3177705|P2|Double-Blind|Noncompliance|0
965318|NCT00666224|3177706|P1|Double-Blind|Noncompliance|1
965319|NCT00666224|3177705|P2|Double-Blind|Pregnancy|2
965320|NCT00666224|3177706|P1|Double-Blind|Pregnancy|3
965321|NCT00666224|3177705|P2|Double-Blind|Sponsor decision|0
965322|NCT00666224|3177706|P1|Double-Blind|Sponsor decision|1
965323|NCT00666224|3177705|P2|Double-Blind|Physician Decision|3
965324|NCT00666224|3177706|P1|Double-Blind|Physician Decision|0
965325|NCT00666224|3177705|P2|Double-Blind|Withdrawal by Subject|14
965326|NCT00666224|3177706|P1|Double-Blind|Withdrawal by Subject|18
965327|NCT00666224|3177705|P2|Double-Blind|Lost to Follow-up|2
965328|NCT00666224|3177706|P1|Double-Blind|Lost to Follow-up|2
965329|NCT00666224|3177705|P2|Double-Blind|Adverse Event|5
965330|NCT00666224|3177706|P1|Double-Blind|Adverse Event|15
965331|NCT00666211|3177725|P2|Overall Study|Physician Decision|1
965332|NCT00666211|3177726|P1|Overall Study|Physician Decision|0
965333|NCT00666211|3177725|P2|Overall Study|off tx for other complicating disease|1
965334|NCT00666211|3177726|P1|Overall Study|off tx for other complicating disease|0
965335|NCT00666211|3177725|P2|Overall Study|Death|2
965336|NCT00666211|3177726|P1|Overall Study|Death|0
965337|NCT00666211|3177725|P2|Overall Study|hospital admission|5
965338|NCT00666211|3177726|P1|Overall Study|hospital admission|0
965339|NCT00666211|3177725|P2|Overall Study|toxicity|2
965340|NCT00666211|3177726|P1|Overall Study|toxicity|0
965341|NCT00666211|3177725|P2|Overall Study|Lost to Follow-up|0
965342|NCT00666211|3177726|P1|Overall Study|Lost to Follow-up|2
965343|NCT00666211|3177725|P2|Overall Study|disease progression|8
965344|NCT00666211|3177726|P1|Overall Study|disease progression|1
965345|NCT00666211|3177725|P2|Overall Study|patient non-compliant|6
965346|NCT00666211|3177726|P1|Overall Study|patient non-compliant|6
965347|NCT00666211|3177725|P2|Overall Study|went off medication, no more pain|0
965348|NCT00666211|3177726|P1|Overall Study|went off medication, no more pain|1
965349|NCT00666211|3177725|P2|Overall Study|Withdrawal by Subject|13
965350|NCT00666211|3177726|P1|Overall Study|Withdrawal by Subject|10
965351|NCT00666198|3177744|P1|Overall Study|No Drug Administration|4
965352|NCT00666198|3177744|P1|Overall Study|Safety Not Assessable|6
965353|NCT00666198|3177744|P1|Overall Study|No Visit After First Day of Treatment|13
965354|NCT00666198|3177744|P1|Overall Study|Protocol Violation|10
965355|NCT00665925|3177772|P4|Overall Study|Due to exclusion criteria|0
965356|NCT00665925|3177773|P3|Overall Study|Due to exclusion criteria|0
965357|NCT00665925|3177774|P2|Overall Study|Due to exclusion criteria|0
965358|NCT00665925|3177775|P1|Overall Study|Due to exclusion criteria|1
965359|NCT00665925|3177772|P4|Overall Study|Enrolled by mistake|1
965360|NCT00665925|3177773|P3|Overall Study|Enrolled by mistake|0
965361|NCT00665925|3177774|P2|Overall Study|Enrolled by mistake|0
965362|NCT00665925|3177775|P1|Overall Study|Enrolled by mistake|0
965363|NCT00665925|3177772|P4|Overall Study|Adverse Event|5
965364|NCT00665925|3177773|P3|Overall Study|Adverse Event|10
965365|NCT00665925|3177774|P2|Overall Study|Adverse Event|5
965366|NCT00665925|3177775|P1|Overall Study|Adverse Event|1
965367|NCT00665925|3177772|P4|Overall Study|Severe Non-Compliance to Protocol|1
965368|NCT00665925|3177773|P3|Overall Study|Severe Non-Compliance to Protocol|1
965369|NCT00665925|3177774|P2|Overall Study|Severe Non-Compliance to Protocol|0
965370|NCT00665925|3177775|P1|Overall Study|Severe Non-Compliance to Protocol|0
965371|NCT00665925|3177772|P4|Overall Study|Physician Decision|2
965372|NCT00665925|3177773|P3|Overall Study|Physician Decision|1
965373|NCT00665925|3177774|P2|Overall Study|Physician Decision|0
965374|NCT00665925|3177775|P1|Overall Study|Physician Decision|0
965375|NCT00665925|3177772|P4|Overall Study|Withdrawal by Subject|2
965376|NCT00665925|3177773|P3|Overall Study|Withdrawal by Subject|3
965377|NCT00665925|3177774|P2|Overall Study|Withdrawal by Subject|2
965378|NCT00665925|3177775|P1|Overall Study|Withdrawal by Subject|2
965379|NCT00665925|3177772|P4|Overall Study|Lost to Follow-up|2
965380|NCT00665925|3177773|P3|Overall Study|Lost to Follow-up|2
965381|NCT00665925|3177774|P2|Overall Study|Lost to Follow-up|2
965382|NCT00665925|3177775|P1|Overall Study|Lost to Follow-up|1
965383|NCT00665925|3177772|P4|Overall Study|Lack of Efficacy|8
965384|NCT00665925|3177773|P3|Overall Study|Lack of Efficacy|9
965385|NCT00665925|3177774|P2|Overall Study|Lack of Efficacy|8
965386|NCT00665925|3177775|P1|Overall Study|Lack of Efficacy|10
965387|NCT00665847|3178186|P1|Overall Study|Switch to Commercial Medication|1
965388|NCT00665847|3178186|P1|Overall Study|Subject ineligible to continue the trial|1
965389|NCT00665847|3178186|P1|Overall Study|Resistance to TMC125|1
965390|NCT00665847|3178186|P1|Overall Study|Subject reached a virologic endpoint|4
965391|NCT00665847|3178186|P1|Overall Study|Subject non-compliant|8
965392|NCT00665847|3178186|P1|Overall Study|Withdrawal by Subject|2
965393|NCT00665847|3178186|P1|Overall Study|Adverse Event|8
965394|NCT00665652|3178203|P1|Overall Study|No longer met inclusion criteria.|1
965395|NCT00665652|3178203|P1|Overall Study|Death|1
965396|NCT00665652|3178203|P1|Overall Study|Adverse Event|4
965397|NCT00665626|3178209|P2|Overall Study|Death|0
965398|NCT00665626|3178210|P1|Overall Study|Death|1
965399|NCT00665626|3178209|P2|Overall Study|Unably to comply with dosing regimen|1
965400|NCT00665626|3178210|P1|Overall Study|Unably to comply with dosing regimen|0
965401|NCT00665626|3178209|P2|Overall Study|Did not fulfil inclusion criteria|1
965402|NCT00665626|3178210|P1|Overall Study|Did not fulfil inclusion criteria|0
965403|NCT00665626|3178209|P2|Overall Study|Due to exclusion criteria|1
965404|NCT00665626|3178210|P1|Overall Study|Due to exclusion criteria|0
965405|NCT00665626|3178209|P2|Overall Study|Adverse Event|9
965406|NCT00665626|3178210|P1|Overall Study|Adverse Event|1
965407|NCT00665626|3178209|P2|Overall Study|Protocol Violation|2
965408|NCT00665626|3178210|P1|Overall Study|Protocol Violation|0
965409|NCT00665626|3178209|P2|Overall Study|Withdrawal by Subject|1
965410|NCT00665626|3178210|P1|Overall Study|Withdrawal by Subject|0
965411|NCT00665626|3178209|P2|Overall Study|Lost to Follow-up|2
965412|NCT00665626|3178210|P1|Overall Study|Lost to Follow-up|0
965413|NCT00665626|3178209|P2|Overall Study|Lack of Efficacy|5
965414|NCT00665626|3178210|P1|Overall Study|Lack of Efficacy|8
965415|NCT00665444|3178292|P1|Overall Study|Study Terminated by Study Sponsor|1
965416|NCT00665444|3178292|P1|Overall Study|Physician Decision|1
965417|NCT00665431|3178304|P3|Overall Study|Other|2
965418|NCT00665431|3178305|P2|Overall Study|Other|7
965419|NCT00665431|3178306|P1|Overall Study|Other|4
965420|NCT00665431|3178304|P3|Overall Study|Lost to Follow-up|1
965421|NCT00665431|3178305|P2|Overall Study|Lost to Follow-up|3
965422|NCT00665431|3178306|P1|Overall Study|Lost to Follow-up|3
965423|NCT00665431|3178304|P3|Overall Study|Withdrawal by Subject|15
965424|NCT00665431|3178305|P2|Overall Study|Withdrawal by Subject|25
965425|NCT00665431|3178306|P1|Overall Study|Withdrawal by Subject|17
965426|NCT00665431|3178304|P3|Overall Study|Adverse Event|6
965427|NCT00665431|3178305|P2|Overall Study|Adverse Event|22
965428|NCT00665431|3178306|P1|Overall Study|Adverse Event|16
965429|NCT00665366|3178349|P2|Overall Study|Other reasons|1
965430|NCT00665366|3178350|P1|Overall Study|Other reasons|4
965431|NCT00665366|3178349|P2|Overall Study|No longer meets study criteria|1
965432|NCT00665366|3178350|P1|Overall Study|No longer meets study criteria|0
965433|NCT00665366|3178349|P2|Overall Study|Pregnancy|0
965434|NCT00665366|3178350|P1|Overall Study|Pregnancy|1
965435|NCT00665366|3178349|P2|Overall Study|Poor compliance/noncompliance|5
965436|NCT00665366|3178350|P1|Overall Study|Poor compliance/noncompliance|3
965437|NCT00665366|3178349|P2|Overall Study|Lost to Follow-up|5
965438|NCT00665366|3178350|P1|Overall Study|Lost to Follow-up|3
965439|NCT00665366|3178349|P2|Overall Study|Withdrawal by Subject|14
965440|NCT00665366|3178350|P1|Overall Study|Withdrawal by Subject|11
965441|NCT00665366|3178349|P2|Overall Study|Adverse Event|23
965442|NCT00665366|3178350|P1|Overall Study|Adverse Event|25
965443|NCT00665366|3178349|P2|Overall Study|Lack of Efficacy|10
965444|NCT00665366|3178350|P1|Overall Study|Lack of Efficacy|11
965445|NCT00665353|3178378|P1|Study Step 2|Lack of Efficacy|12
965446|NCT00665353|3178378|P1|Study Step 2|Lost to Follow-up|2
965447|NCT00665353|3178378|P1|Study Step 1|Withdrawal by Subject|2
965448|NCT00665353|3178378|P1|Study Step 1|Adverse Event|1
965449|NCT00665002|3178395|P1|Overall Study|Cytogenetic resistance|1
965450|NCT00665002|3178395|P1|Overall Study|Progression/relapse during treatment|11
965451|NCT00664742|3178409|P1|Overall Study|Lost to Follow-up|92
965452|NCT00664742|3178409|P1|Overall Study|Withdrawal by Subject|31
965453|NCT00664742|3178409|P1|Overall Study|Withdrawn due to adverse events|3
965454|NCT00664560|3178417|P3|Overall Study|Other|5
965455|NCT00664560|3178418|P2|Overall Study|Other|4
965456|NCT00664560|3178419|P1|Overall Study|Other|11
965457|NCT00664560|3178417|P3|Overall Study|Lost to Follow-up|0
965458|NCT00664560|3178418|P2|Overall Study|Lost to Follow-up|2
965459|NCT00664560|3178419|P1|Overall Study|Lost to Follow-up|0
965460|NCT00664560|3178417|P3|Overall Study|Withdrawal by Subject|7
965461|NCT00664560|3178418|P2|Overall Study|Withdrawal by Subject|13
965462|NCT00664560|3178419|P1|Overall Study|Withdrawal by Subject|9
965463|NCT00664560|3178417|P3|Overall Study|Adverse Event|7
965464|NCT00664560|3178418|P2|Overall Study|Adverse Event|16
965465|NCT00664560|3178419|P1|Overall Study|Adverse Event|19
965466|NCT00664534|3178462|P2|Overall Study|Sponsor decision|6
965467|NCT00664534|3178463|P1|Overall Study|Sponsor decision|8
965468|NCT00664534|3178462|P2|Overall Study|Physician Decision|0
965469|NCT00664534|3178463|P1|Overall Study|Physician Decision|8
965470|NCT00664534|3178462|P2|Overall Study|Withdrawal by Subject|6
965471|NCT00664534|3178463|P1|Overall Study|Withdrawal by Subject|7
965472|NCT00664534|3178462|P2|Overall Study|Protocol Violation|8
965473|NCT00664534|3178463|P1|Overall Study|Protocol Violation|10
965474|NCT00664534|3178462|P2|Overall Study|Lost to Follow-up|10
965475|NCT00664534|3178463|P1|Overall Study|Lost to Follow-up|6
965476|NCT00664534|3178462|P2|Overall Study|Adverse Event|3
965477|NCT00664534|3178463|P1|Overall Study|Adverse Event|2
965478|NCT00664521|3178491|P2|Overall Study|Other|0
965479|NCT00664521|3178492|P1|Overall Study|Other|1
965480|NCT00664521|3178491|P2|Overall Study|Lost to Follow-up|0
965481|NCT00664521|3178492|P1|Overall Study|Lost to Follow-up|1
965482|NCT00664521|3178491|P2|Overall Study|Adverse Event|1
965483|NCT00664521|3178492|P1|Overall Study|Adverse Event|4
965484|NCT00664326|3178518|P1|Overall Study|ongoing with treatment|6
965485|NCT00664326|3178518|P1|Overall Study|Physician Decision|1
965486|NCT00664326|3178518|P1|Overall Study|Withdrawal by Subject|1
965487|NCT00664326|3178518|P1|Overall Study|Noncompliance with study medication|3
965488|NCT00664326|3178518|P1|Overall Study|Adverse Event|13
965489|NCT00664209|3178537|P1|Study Treatment Period|Withdrawal by Subject|2
965490|NCT00664209|3178537|P1|Study Treatment Period|Physician Decision|4
965491|NCT00664209|3178537|P1|Motor Fluctuations Screen|Negative for motor fluctuation|7
965492|NCT00664105|3178545|P1|Overall Study|Disease progression|7
965493|NCT00664105|3178545|P1|Overall Study|Adverse Event|9
965494|NCT00664105|3178545|P1|Overall Study|Withdrawal by Subject|5
965495|NCT00664105|3178545|P1|Overall Study|Death|3
965496|NCT00664066|3178552|P1|Overall Study|Study terminated|3
965497|NCT00663962|3178558|P2|Overall Study|somnolence|0
965498|NCT00663962|3178559|P1|Overall Study|somnolence|1
965499|NCT00663923|3178565|P1|Overall Study|Lost to Follow-up|2
965500|NCT00663858|3178582|P3|Overall Study|Other|4
965501|NCT00663858|3178583|P2|Overall Study|Other|2
965502|NCT00663858|3178584|P1|Overall Study|Other|8
965503|NCT00663858|3178582|P3|Overall Study|Protocol Violation|4
965504|NCT00663858|3178583|P2|Overall Study|Protocol Violation|3
965505|NCT00663858|3178584|P1|Overall Study|Protocol Violation|5
965506|NCT00663858|3178582|P3|Overall Study|Withdrawal by Subject|3
965507|NCT00663858|3178583|P2|Overall Study|Withdrawal by Subject|3
965508|NCT00663858|3178584|P1|Overall Study|Withdrawal by Subject|7
965509|NCT00663858|3178582|P3|Overall Study|Lack of Efficacy|3
965510|NCT00663858|3178583|P2|Overall Study|Lack of Efficacy|1
965511|NCT00663858|3178584|P1|Overall Study|Lack of Efficacy|5
965512|NCT00663858|3178582|P3|Overall Study|Adverse Event|6
965513|NCT00663858|3178583|P2|Overall Study|Adverse Event|1
965514|NCT00663858|3178584|P1|Overall Study|Adverse Event|9
965515|NCT00663702|3178622|P2|Overall Study|Lack of Efficacy|3
965516|NCT00663702|3178623|P1|Overall Study|Lack of Efficacy|3
965517|NCT00663702|3178622|P2|Overall Study|Death|1
965518|NCT00663702|3178623|P1|Overall Study|Death|1
965519|NCT00663702|3178622|P2|Overall Study|Lost to Follow-up|0
965520|NCT00663702|3178623|P1|Overall Study|Lost to Follow-up|3
965521|NCT00663702|3178622|P2|Overall Study|Pregnancy|1
965522|NCT00663702|3178623|P1|Overall Study|Pregnancy|0
965523|NCT00663702|3178622|P2|Overall Study|Withdrawal by Subject|1
965524|NCT00663702|3178623|P1|Overall Study|Withdrawal by Subject|3
965525|NCT00663702|3178622|P2|Overall Study|Adverse Event|4
965526|NCT00663702|3178623|P1|Overall Study|Adverse Event|8
965527|NCT00663260|3178659|P3|Overall Study|non-compliance, not met criteria, etc.|3
965528|NCT00663260|3178660|P2|Overall Study|non-compliance, not met criteria, etc.|2
965529|NCT00663260|3178661|P1|Overall Study|non-compliance, not met criteria, etc.|3
965530|NCT00663260|3178659|P3|Overall Study|Lost to Follow-up|0
965531|NCT00663260|3178660|P2|Overall Study|Lost to Follow-up|1
965532|NCT00663260|3178661|P1|Overall Study|Lost to Follow-up|0
965533|NCT00663260|3178659|P3|Overall Study|Death|1
965534|NCT00663260|3178660|P2|Overall Study|Death|0
965535|NCT00663260|3178661|P1|Overall Study|Death|1
965536|NCT00663260|3178659|P3|Overall Study|Withdrawal by Subject|6
965537|NCT00663260|3178660|P2|Overall Study|Withdrawal by Subject|1
965538|NCT00663260|3178661|P1|Overall Study|Withdrawal by Subject|3
965539|NCT00663260|3178659|P3|Overall Study|Adverse Event|6
965540|NCT00663260|3178660|P2|Overall Study|Adverse Event|7
965541|NCT00663260|3178661|P1|Overall Study|Adverse Event|12
965542|NCT00663260|3178659|P3|Overall Study|Lack of Efficacy|0
965543|NCT00663260|3178660|P2|Overall Study|Lack of Efficacy|0
965544|NCT00663260|3178661|P1|Overall Study|Lack of Efficacy|2
965545|NCT00663234|3178675|P1|Overall Study|Not willing to adhere to requirements|1
965546|NCT00663208|3178708|P7|Follow-up Period|Other reason|1
965547|NCT00663208|3178709|P6|Follow-up Period|Other reason|0
965548|NCT00663208|3178710|P5|Follow-up Period|Other reason|0
965549|NCT00663208|3178711|P4|Follow-up Period|Other reason|0
965550|NCT00663208|3178712|P3|Follow-up Period|Other reason|0
965551|NCT00663208|3178713|P2|Follow-up Period|Other reason|0
965552|NCT00663208|3178714|P1|Follow-up Period|Other reason|1
965553|NCT00663208|3178708|P7|Follow-up Period|Lost to Follow-up|0
965554|NCT00663208|3178709|P6|Follow-up Period|Lost to Follow-up|0
965555|NCT00663208|3178710|P5|Follow-up Period|Lost to Follow-up|0
965556|NCT00663208|3178711|P4|Follow-up Period|Lost to Follow-up|2
965557|NCT00663208|3178712|P3|Follow-up Period|Lost to Follow-up|3
965558|NCT00663208|3178713|P2|Follow-up Period|Lost to Follow-up|0
965559|NCT00663208|3178714|P1|Follow-up Period|Lost to Follow-up|2
965560|NCT00663208|3178708|P7|Treatment Period|Lost to Follow-up|0
965561|NCT00663208|3178709|P6|Treatment Period|Lost to Follow-up|0
965562|NCT00663208|3178710|P5|Treatment Period|Lost to Follow-up|0
965563|NCT00663208|3178711|P4|Treatment Period|Lost to Follow-up|0
965564|NCT00663208|3178712|P3|Treatment Period|Lost to Follow-up|0
965565|NCT00663208|3178713|P2|Treatment Period|Lost to Follow-up|1
965566|NCT00663208|3178714|P1|Treatment Period|Lost to Follow-up|0
965567|NCT00663117|3178892|P2|Overall Study|Lack of Efficacy|0
965568|NCT00663117|3178893|P1|Overall Study|Lack of Efficacy|1
965569|NCT00663052|3178907|P2|Overall Study|Other|1
965570|NCT00663052|3178908|P1|Overall Study|Other|0
965571|NCT00663052|3178907|P2|Overall Study|Unsatisfactory Response - Efficacy|1
965572|NCT00663052|3178908|P1|Overall Study|Unsatisfactory Response - Efficacy|1
965573|NCT00663052|3178907|P2|Overall Study|Withdrawal by Subject|5
965574|NCT00663052|3178908|P1|Overall Study|Withdrawal by Subject|2
965575|NCT00663052|3178907|P2|Overall Study|Protocol Violation|0
965576|NCT00663052|3178908|P1|Overall Study|Protocol Violation|1
965577|NCT00663052|3178907|P2|Overall Study|Discontinuation of Study by Sponsor|0
965578|NCT00663052|3178908|P1|Overall Study|Discontinuation of Study by Sponsor|2
965579|NCT00663052|3178907|P2|Overall Study|Adverse Event|3
965580|NCT00663052|3178908|P1|Overall Study|Adverse Event|6
965581|NCT00663026|3178991|P3|Overall Study|Withdrawal by Subject|1
965582|NCT00663026|3178992|P2|Overall Study|Withdrawal by Subject|0
965583|NCT00663026|3178993|P1|Overall Study|Withdrawal by Subject|0
965584|NCT00663026|3178991|P3|Overall Study|Caregiver Request|0
965585|NCT00663026|3178992|P2|Overall Study|Caregiver Request|2
965586|NCT00663026|3178993|P1|Overall Study|Caregiver Request|0
965587|NCT00663026|3178991|P3|Overall Study|Adverse Event|3
965588|NCT00663026|3178992|P2|Overall Study|Adverse Event|2
965589|NCT00663026|3178993|P1|Overall Study|Adverse Event|0
965590|NCT00663026|3178991|P3|Overall Study|Other|0
965591|NCT00663026|3178992|P2|Overall Study|Other|2
965592|NCT00663026|3178993|P1|Overall Study|Other|1
965593|NCT00663026|3178991|P3|Overall Study|Lost to Follow-up|0
965594|NCT00663026|3178992|P2|Overall Study|Lost to Follow-up|0
965595|NCT00663026|3178993|P1|Overall Study|Lost to Follow-up|1
965596|NCT00662909|3179016|P3|Overall Study|Eligibility criterion not met|1
965597|NCT00662909|3179017|P2|Overall Study|Eligibility criterion not met|1
965598|NCT00662909|3179018|P1|Overall Study|Eligibility criterion not met|0
965599|NCT00662909|3179016|P3|Overall Study|Physician Decision|2
965600|NCT00662909|3179017|P2|Overall Study|Physician Decision|1
965601|NCT00662909|3179018|P1|Overall Study|Physician Decision|1
965602|NCT00662909|3179016|P3|Overall Study|Non-compliance with study procedures|2
965603|NCT00662909|3179017|P2|Overall Study|Non-compliance with study procedures|3
965604|NCT00662909|3179018|P1|Overall Study|Non-compliance with study procedures|3
965605|NCT00662909|3179016|P3|Overall Study|Randomized- never received study drug|0
965606|NCT00662909|3179017|P2|Overall Study|Randomized- never received study drug|0
965607|NCT00662909|3179018|P1|Overall Study|Randomized- never received study drug|1
965608|NCT00662909|3179016|P3|Overall Study|Protocol Violation|5
965609|NCT00662909|3179017|P2|Overall Study|Protocol Violation|4
965610|NCT00662909|3179018|P1|Overall Study|Protocol Violation|7
965611|NCT00662909|3179016|P3|Overall Study|Lost to Follow-up|3
965612|NCT00662909|3179017|P2|Overall Study|Lost to Follow-up|9
965613|NCT00662909|3179018|P1|Overall Study|Lost to Follow-up|2
965614|NCT00662909|3179016|P3|Overall Study|Withdrawal by Subject|16
965615|NCT00662909|3179017|P2|Overall Study|Withdrawal by Subject|22
965616|NCT00662909|3179018|P1|Overall Study|Withdrawal by Subject|29
965617|NCT00662909|3179016|P3|Overall Study|Lack of Efficacy|5
965618|NCT00662909|3179017|P2|Overall Study|Lack of Efficacy|1
965619|NCT00662909|3179018|P1|Overall Study|Lack of Efficacy|9
965620|NCT00662909|3179016|P3|Overall Study|Adverse Event|19
965621|NCT00662909|3179017|P2|Overall Study|Adverse Event|18
965622|NCT00662909|3179018|P1|Overall Study|Adverse Event|17
965623|NCT00662857|3179116|P2|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0
965624|NCT00662857|3179117|P1|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1
965625|NCT00662857|3179116|P2|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1
965626|NCT00662857|3179117|P1|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0
965627|NCT00662857|3179116|P2|Washout 1 (3 - 14 Days)|Physician Decision|1
965628|NCT00662857|3179117|P1|Washout 1 (3 - 14 Days)|Physician Decision|0
965629|NCT00662831|3179132|P2|Overall Study|Adverse Event|16
965630|NCT00662831|3179133|P1|Overall Study|Adverse Event|23
965631|NCT00662831|3179132|P2|Overall Study|Protocol Violation|4
965632|NCT00662831|3179133|P1|Overall Study|Protocol Violation|8
965633|NCT00662831|3179132|P2|Overall Study|Other|31
965634|NCT00662831|3179133|P1|Overall Study|Other|62
965635|NCT00662831|3179132|P2|Overall Study|Withdrawal by Subject|1
965636|NCT00662831|3179133|P1|Overall Study|Withdrawal by Subject|2
965637|NCT00662831|3179132|P2|Overall Study|Lost to Follow-up|0
965638|NCT00662831|3179133|P1|Overall Study|Lost to Follow-up|1
965639|NCT00662831|3179132|P2|Overall Study|Lack of Efficacy|6
965640|NCT00662831|3179133|P1|Overall Study|Lack of Efficacy|6
965641|NCT00662831|3179132|P2|Overall Study|Death|1
965642|NCT00662831|3179133|P1|Overall Study|Death|4
965643|NCT00662649|3179213|P5|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
965644|NCT00662649|3179214|P4|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
965645|NCT00662649|3179215|P3|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0
965646|NCT00662649|3179216|P2|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
965647|NCT00662649|3179217|P1|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
965648|NCT00662649|3179213|P5|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
965649|NCT00662649|3179214|P4|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
965650|NCT00662649|3179215|P3|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
965651|NCT00662649|3179216|P2|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1
965652|NCT00662649|3179217|P1|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
965653|NCT00662649|3179213|P5|Extension Study (Month 24 to 60)|Subject withdrew consent|9
965654|NCT00662649|3179214|P4|Extension Study (Month 24 to 60)|Subject withdrew consent|15
965655|NCT00662649|3179215|P3|Extension Study (Month 24 to 60)|Subject withdrew consent|0
965656|NCT00662649|3179216|P2|Extension Study (Month 24 to 60)|Subject withdrew consent|23
965657|NCT00662649|3179217|P1|Extension Study (Month 24 to 60)|Subject withdrew consent|19
965658|NCT00662649|3179213|P5|Extension Study (Month 24 to 60)|Protocol Violation|0
965659|NCT00662649|3179214|P4|Extension Study (Month 24 to 60)|Protocol Violation|0
965660|NCT00662649|3179215|P3|Extension Study (Month 24 to 60)|Protocol Violation|0
965661|NCT00662649|3179216|P2|Extension Study (Month 24 to 60)|Protocol Violation|1
965662|NCT00662649|3179217|P1|Extension Study (Month 24 to 60)|Protocol Violation|1
965663|NCT00662649|3179213|P5|Extension Study (Month 24 to 60)|Lost to Follow-up|1
965664|NCT00662649|3179214|P4|Extension Study (Month 24 to 60)|Lost to Follow-up|1
965665|NCT00662649|3179215|P3|Extension Study (Month 24 to 60)|Lost to Follow-up|0
965666|NCT00662649|3179216|P2|Extension Study (Month 24 to 60)|Lost to Follow-up|0
965667|NCT00662649|3179217|P1|Extension Study (Month 24 to 60)|Lost to Follow-up|2
965668|NCT00662649|3179213|P5|Extension Study (Month 24 to 60)|Adverse Event|10
965669|NCT00662649|3179214|P4|Extension Study (Month 24 to 60)|Adverse Event|6
965670|NCT00662649|3179215|P3|Extension Study (Month 24 to 60)|Adverse Event|0
965671|NCT00662649|3179216|P2|Extension Study (Month 24 to 60)|Adverse Event|9
965672|NCT00662649|3179217|P1|Extension Study (Month 24 to 60)|Adverse Event|6
965673|NCT00662649|3179213|P5|Extension Study (Month 24 to 60)|Administrative problems|0
965674|NCT00662649|3179214|P4|Extension Study (Month 24 to 60)|Administrative problems|1
965675|NCT00662649|3179215|P3|Extension Study (Month 24 to 60)|Administrative problems|0
965676|NCT00662649|3179216|P2|Extension Study (Month 24 to 60)|Administrative problems|0
965677|NCT00662649|3179217|P1|Extension Study (Month 24 to 60)|Administrative problems|0
965678|NCT00662649|3179213|P5|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
965679|NCT00662649|3179214|P4|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
965680|NCT00662649|3179215|P3|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0
965681|NCT00662649|3179216|P2|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
965682|NCT00662649|3179217|P1|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
965683|NCT00662649|3179213|P5|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3
965684|NCT00662649|3179214|P4|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8
965685|NCT00662649|3179215|P3|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0
965686|NCT00662649|3179216|P2|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5
965687|NCT00662649|3179217|P1|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10
965688|NCT00662649|3179213|P5|Core Study (24 Months)|Death|0
965689|NCT00662649|3179214|P4|Core Study (24 Months)|Death|0
965690|NCT00662649|3179215|P3|Core Study (24 Months)|Death|2
965691|NCT00662649|3179216|P2|Core Study (24 Months)|Death|0
965692|NCT00662649|3179217|P1|Core Study (24 Months)|Death|1
965693|NCT00662649|3179213|P5|Core Study (24 Months)|Abnormal test procedure result(s)|0
965694|NCT00662649|3179214|P4|Core Study (24 Months)|Abnormal test procedure result(s)|0
965695|NCT00662649|3179215|P3|Core Study (24 Months)|Abnormal test procedure result(s)|1
965696|NCT00662649|3179216|P2|Core Study (24 Months)|Abnormal test procedure result(s)|1
965697|NCT00662649|3179217|P1|Core Study (24 Months)|Abnormal test procedure result(s)|2
965698|NCT00662649|3179213|P5|Core Study (24 Months)|Protocol Violation|0
965699|NCT00662649|3179214|P4|Core Study (24 Months)|Protocol Violation|0
965700|NCT00662649|3179215|P3|Core Study (24 Months)|Protocol Violation|4
965701|NCT00662649|3179216|P2|Core Study (24 Months)|Protocol Violation|5
965702|NCT00662649|3179217|P1|Core Study (24 Months)|Protocol Violation|5
965703|NCT00662649|3179213|P5|Core Study (24 Months)|Lost to Follow-up|0
965704|NCT00662649|3179214|P4|Core Study (24 Months)|Lost to Follow-up|0
965705|NCT00662649|3179215|P3|Core Study (24 Months)|Lost to Follow-up|7
965706|NCT00662649|3179216|P2|Core Study (24 Months)|Lost to Follow-up|5
965707|NCT00662649|3179217|P1|Core Study (24 Months)|Lost to Follow-up|3
965708|NCT00662649|3179213|P5|Core Study (24 Months)|Abnormal laboratory value(s)|0
965709|NCT00662649|3179214|P4|Core Study (24 Months)|Abnormal laboratory value(s)|0
965710|NCT00662649|3179215|P3|Core Study (24 Months)|Abnormal laboratory value(s)|1
965711|NCT00662649|3179216|P2|Core Study (24 Months)|Abnormal laboratory value(s)|9
965712|NCT00662649|3179217|P1|Core Study (24 Months)|Abnormal laboratory value(s)|20
965713|NCT00662649|3179213|P5|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
965714|NCT00662649|3179214|P4|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
965715|NCT00662649|3179215|P3|Core Study (24 Months)|Unsatisfactory therapeutic effect|25
965716|NCT00662649|3179216|P2|Core Study (24 Months)|Unsatisfactory therapeutic effect|6
965717|NCT00662649|3179217|P1|Core Study (24 Months)|Unsatisfactory therapeutic effect|13
965718|NCT00662649|3179213|P5|Core Study (24 Months)|Adverse Event|0
965719|NCT00662649|3179214|P4|Core Study (24 Months)|Adverse Event|0
965720|NCT00662649|3179215|P3|Core Study (24 Months)|Adverse Event|18
965721|NCT00662649|3179216|P2|Core Study (24 Months)|Adverse Event|13
965722|NCT00662649|3179217|P1|Core Study (24 Months)|Adverse Event|22
965723|NCT00662649|3179213|P5|Core Study (24 Months)|Withdrawal by Subject|0
965724|NCT00662649|3179214|P4|Core Study (24 Months)|Withdrawal by Subject|0
965725|NCT00662649|3179215|P3|Core Study (24 Months)|Withdrawal by Subject|28
965726|NCT00662649|3179216|P2|Core Study (24 Months)|Withdrawal by Subject|17
965727|NCT00662649|3179217|P1|Core Study (24 Months)|Withdrawal by Subject|31
965728|NCT00662558|3179257|P2|Overall Study|Randomized But Did Not Receive Treatment|8
965729|NCT00662558|3179258|P1|Overall Study|Randomized But Did Not Receive Treatment|2
965730|NCT00662558|3179257|P2|Overall Study|Withdrawal by Subject|12
965731|NCT00662558|3179258|P1|Overall Study|Withdrawal by Subject|7
965732|NCT00662558|3179257|P2|Overall Study|Other|14
965733|NCT00662558|3179258|P1|Overall Study|Other|9
965734|NCT00662558|3179257|P2|Overall Study|Lost to Follow-up|10
965735|NCT00662558|3179258|P1|Overall Study|Lost to Follow-up|13
965736|NCT00662558|3179257|P2|Overall Study|Lack of Efficacy|7
965737|NCT00662558|3179258|P1|Overall Study|Lack of Efficacy|4
965738|NCT00662558|3179257|P2|Overall Study|Adverse Event|59
965739|NCT00662558|3179258|P1|Overall Study|Adverse Event|21
965740|NCT00662532|3179309|P2|Overall Study|Lost to Follow-up|1
965741|NCT00662532|3179310|P1|Overall Study|Lost to Follow-up|0
965742|NCT00662532|3179309|P2|Overall Study|Adverse Event|1
965743|NCT00662532|3179310|P1|Overall Study|Adverse Event|0
965744|NCT00662363|3179325|P2|Overall Study|Protocol Violation|1
965745|NCT00662363|3179326|P1|Overall Study|Protocol Violation|1
965746|NCT00662363|3179325|P2|Overall Study|Discharged early from rehab|1
965747|NCT00662363|3179326|P1|Overall Study|Discharged early from rehab|4
965748|NCT00662363|3179325|P2|Overall Study|Adverse Event|3
965749|NCT00662363|3179326|P1|Overall Study|Adverse Event|0
965750|NCT00662363|3179325|P2|Overall Study|Withdrawal by Subject|5
965751|NCT00662363|3179326|P1|Overall Study|Withdrawal by Subject|6
965752|NCT00662311|3179337|P3|Overall Study|Respiratory Infection|0
965753|NCT00662311|3179338|P2|Overall Study|Respiratory Infection|0
965754|NCT00662311|3179339|P1|Overall Study|Respiratory Infection|1
965755|NCT00662129|3179390|P1|Overall Study|Ineligible|1
965756|NCT00662129|3179390|P1|Overall Study|Cancel prior to beginning treatment|1
965757|NCT00662129|3179390|P1|Overall Study|Protocol Violation|1
965758|NCT00662038|3179400|P1|Overall Study|Continued treatment|5
965759|NCT00662038|3179400|P1|Overall Study|Adverse Event|358
965760|NCT00662038|3179400|P1|Overall Study|Death|95
965761|NCT00662038|3179400|P1|Overall Study|Lost to Follow-up|1
965762|NCT00662038|3179400|P1|Overall Study|Lung transplantation|44
965763|NCT00662038|3179400|P1|Overall Study|Physician Decision|19
965764|NCT00662038|3179400|P1|Overall Study|Sponsor decision|1
965765|NCT00662038|3179400|P1|Overall Study|Withdrawal by Subject|83
965766|NCT00662038|3179400|P1|Overall Study|Withdrawn consent|22
965767|NCT00662038|3179400|P1|Overall Study|Reason not specified|3
965768|NCT00662025|3179404|P1|Overall Study|Domestic circumstances|1
965769|NCT00662025|3179404|P1|Overall Study|Target lesion cannot be evaluated|1
965770|NCT00662025|3179404|P1|Overall Study|Results of other clinical study|2
965771|NCT00662025|3179404|P1|Overall Study|Withdrawal by Subject|1
965772|NCT00662025|3179404|P1|Overall Study|Adverse Event|7
965773|NCT00662025|3179404|P1|Overall Study|Objective progression or relapse|51
965774|NCT00662012|3179424|P1|Overall Study|Withdrawal by Subject|1
965775|NCT00662012|3179424|P1|Overall Study|Death|1
965776|NCT00662012|3179424|P1|Overall Study|Lost to Follow-up|85
965777|NCT00661999|3179432|P3|Overall Study|Other Medical Problems|9
965778|NCT00661999|3179433|P2|Overall Study|Other Medical Problems|4
965779|NCT00661999|3179434|P1|Overall Study|Other Medical Problems|4
965780|NCT00661999|3179432|P3|Overall Study|Alternative Treatment|0
965781|NCT00661999|3179433|P2|Overall Study|Alternative Treatment|0
965782|NCT00661999|3179434|P1|Overall Study|Alternative Treatment|1
965783|NCT00661999|3179432|P3|Overall Study|Withdrawal by Subject|14
965784|NCT00661999|3179433|P2|Overall Study|Withdrawal by Subject|23
965785|NCT00661999|3179434|P1|Overall Study|Withdrawal by Subject|30
965786|NCT00661999|3179432|P3|Overall Study|Other Reasons|23
965787|NCT00661999|3179433|P2|Overall Study|Other Reasons|12
965788|NCT00661999|3179434|P1|Overall Study|Other Reasons|5
965789|NCT00661999|3179432|P3|Overall Study|Death|3
965790|NCT00661999|3179433|P2|Overall Study|Death|6
965791|NCT00661999|3179434|P1|Overall Study|Death|8
965792|NCT00661999|3179432|P3|Overall Study|Adverse Event|8
965793|NCT00661999|3179433|P2|Overall Study|Adverse Event|5
965794|NCT00661999|3179434|P1|Overall Study|Adverse Event|11
965795|NCT00661830|3179511|P2|Overall Study|Other reason|5
965796|NCT00661830|3179512|P1|Overall Study|Other reason|1
965797|NCT00661830|3179511|P2|Overall Study|Withdrawal by Subject|1
965798|NCT00661830|3179512|P1|Overall Study|Withdrawal by Subject|1
965799|NCT00661830|3179511|P2|Overall Study|Lost to Follow-up|3
965800|NCT00661830|3179512|P1|Overall Study|Lost to Follow-up|1
965801|NCT00661830|3179511|P2|Overall Study|Death|33
965802|NCT00661830|3179512|P1|Overall Study|Death|37
965803|NCT00661778|3179524|P1|Overall Study|Withdrawal of Consent|1
965804|NCT00661778|3179524|P1|Overall Study|Protocol Violation|2
965805|NCT00661778|3179524|P1|Overall Study|Reason not Specified|6
965806|NCT00661778|3179524|P1|Overall Study|Adverse Event|18
965807|NCT00661778|3179524|P1|Overall Study|Disease Progression|23
965808|NCT00661726|3179531|P1|Overall Study|Adverse Event|1
965809|NCT00661713|3179554|P8|Overall Study|Inappropriate Enrollment|0
965810|NCT00661713|3179555|P7|Overall Study|Inappropriate Enrollment|1
965811|NCT00661713|3179556|P6|Overall Study|Inappropriate Enrollment|0
965812|NCT00661713|3179557|P5|Overall Study|Inappropriate Enrollment|0
965813|NCT00661713|3179558|P4|Overall Study|Inappropriate Enrollment|0
965814|NCT00661713|3179559|P3|Overall Study|Inappropriate Enrollment|0
965815|NCT00661713|3179560|P2|Overall Study|Inappropriate Enrollment|0
965816|NCT00661713|3179561|P1|Overall Study|Inappropriate Enrollment|0
965817|NCT00661713|3179554|P8|Overall Study|Adverse Event|0
965818|NCT00661713|3179555|P7|Overall Study|Adverse Event|1
965819|NCT00661713|3179556|P6|Overall Study|Adverse Event|0
965820|NCT00661713|3179557|P5|Overall Study|Adverse Event|0
965821|NCT00661713|3179558|P4|Overall Study|Adverse Event|0
965822|NCT00661713|3179559|P3|Overall Study|Adverse Event|0
965823|NCT00661713|3179560|P2|Overall Study|Adverse Event|0
965824|NCT00661713|3179561|P1|Overall Study|Adverse Event|0
965825|NCT00661713|3179554|P8|Overall Study|Administrative Reason|0
965826|NCT00661713|3179555|P7|Overall Study|Administrative Reason|1
965827|NCT00661713|3179556|P6|Overall Study|Administrative Reason|2
965828|NCT00661713|3179557|P5|Overall Study|Administrative Reason|2
965829|NCT00661713|3179558|P4|Overall Study|Administrative Reason|2
965830|NCT00661713|3179559|P3|Overall Study|Administrative Reason|0
965831|NCT00661713|3179560|P2|Overall Study|Administrative Reason|1
965832|NCT00661713|3179561|P1|Overall Study|Administrative Reason|0
965833|NCT00661713|3179554|P8|Overall Study|Lost to Follow-up|1
965834|NCT00661713|3179555|P7|Overall Study|Lost to Follow-up|14
965835|NCT00661713|3179556|P6|Overall Study|Lost to Follow-up|7
965836|NCT00661713|3179557|P5|Overall Study|Lost to Follow-up|5
965837|NCT00661713|3179558|P4|Overall Study|Lost to Follow-up|2
965838|NCT00661713|3179559|P3|Overall Study|Lost to Follow-up|2
965839|NCT00661713|3179560|P2|Overall Study|Lost to Follow-up|7
965840|NCT00661713|3179561|P1|Overall Study|Lost to Follow-up|2
965841|NCT00661713|3179554|P8|Overall Study|Withdrawal by Subject|9
965842|NCT00661713|3179555|P7|Overall Study|Withdrawal by Subject|45
965843|NCT00661713|3179556|P6|Overall Study|Withdrawal by Subject|26
965844|NCT00661713|3179557|P5|Overall Study|Withdrawal by Subject|12
965845|NCT00661713|3179558|P4|Overall Study|Withdrawal by Subject|21
965846|NCT00661713|3179559|P3|Overall Study|Withdrawal by Subject|12
965847|NCT00661713|3179560|P2|Overall Study|Withdrawal by Subject|25
965848|NCT00661713|3179561|P1|Overall Study|Withdrawal by Subject|11
965849|NCT00661713|3179554|P8|Overall Study|Protocol Violation|1
965850|NCT00661713|3179555|P7|Overall Study|Protocol Violation|2
965851|NCT00661713|3179556|P6|Overall Study|Protocol Violation|2
965852|NCT00661713|3179557|P5|Overall Study|Protocol Violation|0
965853|NCT00661713|3179558|P4|Overall Study|Protocol Violation|3
965854|NCT00661713|3179559|P3|Overall Study|Protocol Violation|3
965855|NCT00661713|3179560|P2|Overall Study|Protocol Violation|6
965856|NCT00661713|3179561|P1|Overall Study|Protocol Violation|1
965857|NCT00661713|3179554|P8|Overall Study|Unable to Classify|0
965858|NCT00661713|3179555|P7|Overall Study|Unable to Classify|0
965859|NCT00661713|3179556|P6|Overall Study|Unable to Classify|0
965860|NCT00661713|3179557|P5|Overall Study|Unable to Classify|0
965861|NCT00661713|3179558|P4|Overall Study|Unable to Classify|0
965862|NCT00661713|3179559|P3|Overall Study|Unable to Classify|0
965863|NCT00661713|3179560|P2|Overall Study|Unable to Classify|0
965864|NCT00661713|3179561|P1|Overall Study|Unable to Classify|1
965865|NCT00661713|3179554|P8|Overall Study|Death|0
965866|NCT00661713|3179555|P7|Overall Study|Death|0
965867|NCT00661713|3179556|P6|Overall Study|Death|0
965868|NCT00661713|3179557|P5|Overall Study|Death|1
965869|NCT00661713|3179558|P4|Overall Study|Death|0
965870|NCT00661713|3179559|P3|Overall Study|Death|0
965871|NCT00661713|3179560|P2|Overall Study|Death|0
965872|NCT00661713|3179561|P1|Overall Study|Death|1
965873|NCT00661687|3179651|P1|Overall Study|Adverse Event|2
965874|NCT00661687|3179651|P1|Overall Study|Physician Decision|1
965875|NCT00661687|3179651|P1|Overall Study|Inability to maintain wearing schedule|3
965876|NCT00661687|3179651|P1|Overall Study|Positive slit lamp findings|4
965877|NCT00661687|3179651|P1|Overall Study|Study related symptoms and complaints|5
965878|NCT00661661|3179679|P2|Overall Study|Not assigned treatment|0
965879|NCT00661661|3179680|P1|Overall Study|Not assigned treatment|1
965880|NCT00661661|3179679|P2|Overall Study|Other|7
965881|NCT00661661|3179680|P1|Overall Study|Other|22
965882|NCT00661661|3179679|P2|Overall Study|Withdrawal by Subject|5
965883|NCT00661661|3179680|P1|Overall Study|Withdrawal by Subject|15
965884|NCT00661661|3179679|P2|Overall Study|Lost to Follow-up|1
965885|NCT00661661|3179680|P1|Overall Study|Lost to Follow-up|0
965886|NCT00661661|3179679|P2|Overall Study|Lack of Efficacy|2
965887|NCT00661661|3179680|P1|Overall Study|Lack of Efficacy|3
965888|NCT00661661|3179679|P2|Overall Study|Adverse Event|24
965889|NCT00661661|3179680|P1|Overall Study|Adverse Event|99
965890|NCT00661622|3179756|P2|Overall Study|Protocol Violation|0
965891|NCT00661622|3179757|P1|Overall Study|Protocol Violation|1
965892|NCT00661609|3179771|P1|Overall Study|Disease progression|3
965893|NCT00661609|3179771|P1|Overall Study|Survival follow up stage discontinued|11
965894|NCT00661609|3179771|P1|Overall Study|PI Decision|1
965895|NCT00661609|3179771|P1|Overall Study|Withdrawal by Subject|2
965896|NCT00661609|3179771|P1|Overall Study|Death|20
965897|NCT00661609|3179771|P1|Overall Study|Adverse Event|4
965898|NCT00661531|3179811|P1|Overall Study|Withdrawal by Subject|3
965899|NCT00661505|3179816|P1|Overall Study|Not Specified|2
965900|NCT00661505|3179816|P1|Overall Study|Lost to Follow-up|3
965901|NCT00661505|3179816|P1|Overall Study|Withdrawal by Subject|8
965902|NCT00661505|3179816|P1|Overall Study|Protocol Violation|14
965903|NCT00661505|3179816|P1|Overall Study|Adverse Event|3
965904|NCT00661492|3179844|P2|Overall Study|Other|0
965905|NCT00661492|3179845|P1|Overall Study|Other|1
965906|NCT00661492|3179844|P2|Overall Study|Lost to Follow-up|1
965907|NCT00661492|3179845|P1|Overall Study|Lost to Follow-up|0
965908|NCT00661492|3179844|P2|Overall Study|Investigator Request|0
965909|NCT00661492|3179845|P1|Overall Study|Investigator Request|1
965910|NCT00661492|3179844|P2|Overall Study|Patient Request|1
965911|NCT00661492|3179845|P1|Overall Study|Patient Request|6
965912|NCT00661492|3179844|P2|Overall Study|Disease Progression|14
965913|NCT00661492|3179845|P1|Overall Study|Disease Progression|44
965914|NCT00661492|3179844|P2|Overall Study|Adverse Event|13
965915|NCT00661492|3179845|P1|Overall Study|Adverse Event|16
965916|NCT00661427|3179891|P2|Overall Study|Patient not treated|2
965917|NCT00661427|3179892|P1|Overall Study|Patient not treated|0
965918|NCT00661427|3179891|P2|Overall Study|Adverse Event|5
965919|NCT00661427|3179892|P1|Overall Study|Adverse Event|5
965920|NCT00661388|3179900|P1|Overall Study|Administrative reasons|1
965921|NCT00661388|3179900|P1|Overall Study|Dialysis initiation|1
965922|NCT00661388|3179900|P1|Overall Study|Renal transplantation|1
965923|NCT00661388|3179900|P1|Overall Study|Protocol Violation|7
965924|NCT00661388|3179900|P1|Overall Study|Adverse Event|14
965925|NCT00661362|3179923|P2|Overall Study|Metformin dose haven't decreasd to 2.5 g|0
965926|NCT00661362|3179924|P1|Overall Study|Metformin dose haven't decreasd to 2.5 g|1
965927|NCT00661362|3179923|P2|Overall Study|Safety reasons|0
965928|NCT00661362|3179924|P1|Overall Study|Safety reasons|1
965929|NCT00661362|3179923|P2|Overall Study|Severe non-compliance to protocol|1
965930|NCT00661362|3179924|P1|Overall Study|Severe non-compliance to protocol|0
965931|NCT00661362|3179923|P2|Overall Study|Lost to Follow-up|1
965932|NCT00661362|3179924|P1|Overall Study|Lost to Follow-up|3
965933|NCT00661362|3179923|P2|Overall Study|Withdrawal by Subject|23
965934|NCT00661362|3179924|P1|Overall Study|Withdrawal by Subject|13
965935|NCT00661362|3179923|P2|Overall Study|Study specific discontinuation criteria|11
965936|NCT00661362|3179924|P1|Overall Study|Study specific discontinuation criteria|4
965937|NCT00661362|3179923|P2|Overall Study|Incorrect enrollment|0
965938|NCT00661362|3179924|P1|Overall Study|Incorrect enrollment|2
965939|NCT00661362|3179923|P2|Overall Study|Adverse Event|4
965940|NCT00661362|3179924|P1|Overall Study|Adverse Event|5
965941|NCT00661271|3179942|P2|Overall Study|Lost to Follow-up|25
965942|NCT00661271|3179943|P1|Overall Study|Lost to Follow-up|28
965943|NCT00661258|3179953|P2|Overall Study|caught by police and in detox center|1
965944|NCT00661258|3179954|P1|Overall Study|caught by police and in detox center|2
965945|NCT00661258|3179953|P2|Overall Study|Death|0
965946|NCT00661258|3179954|P1|Overall Study|Death|1
965947|NCT00661193|3179964|P2|Overall Study|Not protocol specified|0
965948|NCT00661193|3179965|P1|Overall Study|Not protocol specified|1
965949|NCT00661193|3179964|P2|Overall Study|Progression|24
965950|NCT00661193|3179965|P1|Overall Study|Progression|27
965951|NCT00661193|3179964|P2|Overall Study|Withdrawal by Subject|1
965952|NCT00661193|3179965|P1|Overall Study|Withdrawal by Subject|3
965953|NCT00661193|3179964|P2|Overall Study|Adverse Event|1
965954|NCT00661193|3179965|P1|Overall Study|Adverse Event|2
965955|NCT00661089|3180190|P2|Overall Study|death at 8 weeks due to new stroke|1
965956|NCT00661089|3180191|P1|Overall Study|death at 8 weeks due to new stroke|0
965957|NCT00661089|3180190|P2|Overall Study|1 subject withdrawal|1
965958|NCT00661089|3180191|P1|Overall Study|1 subject withdrawal|0
965959|NCT00660907|3180239|P2|Overall Study|Various|8
965960|NCT00660907|3180240|P1|Overall Study|Various|11
965961|NCT00660907|3180239|P2|Overall Study|Death|3
965962|NCT00660907|3180240|P1|Overall Study|Death|1
965963|NCT00660907|3180239|P2|Overall Study|Safety|0
965964|NCT00660907|3180240|P1|Overall Study|Safety|1
965965|NCT00660907|3180239|P2|Overall Study|Poor/Non-Compliance|1
965966|NCT00660907|3180240|P1|Overall Study|Poor/Non-Compliance|5
965967|NCT00660907|3180239|P2|Overall Study|Lost to Follow-up|3
965968|NCT00660907|3180240|P1|Overall Study|Lost to Follow-up|3
965969|NCT00660907|3180239|P2|Overall Study|Withdrawal by Subject|32
965970|NCT00660907|3180240|P1|Overall Study|Withdrawal by Subject|23
965971|NCT00660907|3180239|P2|Overall Study|Subject No Longer Meets Study Criteria|27
965972|NCT00660907|3180240|P1|Overall Study|Subject No Longer Meets Study Criteria|6
965973|NCT00660907|3180239|P2|Overall Study|Adverse Event|19
965974|NCT00660907|3180240|P1|Overall Study|Adverse Event|33
965975|NCT00660907|3180239|P2|Overall Study|Incorrect Enrollment|1
965976|NCT00660907|3180240|P1|Overall Study|Incorrect Enrollment|1
965977|NCT00660829|3180254|P2|Overall Study|Other|4
965978|NCT00660829|3180255|P1|Overall Study|Other|9
965979|NCT00660829|3180254|P2|Overall Study|Lost to Follow-up|2
965980|NCT00660829|3180255|P1|Overall Study|Lost to Follow-up|3
965981|NCT00660829|3180254|P2|Overall Study|Withdrawal by Subject|2
965982|NCT00660829|3180255|P1|Overall Study|Withdrawal by Subject|1
965983|NCT00660829|3180254|P2|Overall Study|Non-Compliance|4
965984|NCT00660829|3180255|P1|Overall Study|Non-Compliance|0
965985|NCT00660829|3180254|P2|Overall Study|Lack of Efficacy|3
965986|NCT00660829|3180255|P1|Overall Study|Lack of Efficacy|2
965987|NCT00660829|3180254|P2|Overall Study|Adverse Event|4
965988|NCT00660829|3180255|P1|Overall Study|Adverse Event|3
965989|NCT00660816|3180273|P2|Overall Study|Complicating Disease|1
965990|NCT00660816|3180274|P1|Overall Study|Complicating Disease|0
965991|NCT00660816|3180273|P2|Overall Study|Disease Progression|12
965992|NCT00660816|3180274|P1|Overall Study|Disease Progression|16
965993|NCT00660816|3180273|P2|Overall Study|Protocol Violation|0
965994|NCT00660816|3180274|P1|Overall Study|Protocol Violation|1
965995|NCT00660816|3180273|P2|Overall Study|Physician Decision|2
965996|NCT00660816|3180274|P1|Overall Study|Physician Decision|0
965997|NCT00660816|3180273|P2|Overall Study|Lack of Efficacy|0
965998|NCT00660816|3180274|P1|Overall Study|Lack of Efficacy|1
965999|NCT00660816|3180273|P2|Overall Study|Death|2
966000|NCT00660816|3180274|P1|Overall Study|Death|0
966001|NCT00660816|3180273|P2|Overall Study|Withdrawal by Subject|0
966002|NCT00660816|3180274|P1|Overall Study|Withdrawal by Subject|1
966003|NCT00660816|3180273|P2|Overall Study|Adverse Event|2
966004|NCT00660816|3180274|P1|Overall Study|Adverse Event|1
966005|NCT00660699|3180286|P1|Overall Study|Withdrawal by Subject|2
966006|NCT00660660|3180302|P2|Overall Study|New medication after randomization|0
966007|NCT00660660|3180303|P1|Overall Study|New medication after randomization|1
966008|NCT00660660|3180302|P2|Overall Study|Incorrect enrollment and other|1
966009|NCT00660660|3180303|P1|Overall Study|Incorrect enrollment and other|0
966010|NCT00660660|3180302|P2|Overall Study|Withdrawal by Subject|0
966011|NCT00660660|3180303|P1|Overall Study|Withdrawal by Subject|3
966012|NCT00660660|3180302|P2|Overall Study|Lack of Efficacy|2
966013|NCT00660660|3180303|P1|Overall Study|Lack of Efficacy|0
966014|NCT00660660|3180302|P2|Overall Study|Lost to Follow-up|6
966015|NCT00660660|3180303|P1|Overall Study|Lost to Follow-up|0
966016|NCT00660660|3180302|P2|Overall Study|Adverse Event|0
966017|NCT00660660|3180303|P1|Overall Study|Adverse Event|1
966018|NCT00660595|3180403|P2|Overall Study|Non Specified reasons|0
966019|NCT00660595|3180404|P1|Overall Study|Non Specified reasons|5
966020|NCT00660595|3180403|P2|Overall Study|Participant left hospital|0
966021|NCT00660595|3180404|P1|Overall Study|Participant left hospital|1
966022|NCT00660595|3180403|P2|Overall Study|Did not consent to participate in study|8
966023|NCT00660595|3180404|P1|Overall Study|Did not consent to participate in study|12
966024|NCT00660595|3180403|P2|Overall Study|Lost to Follow-up|1
966025|NCT00660595|3180404|P1|Overall Study|Lost to Follow-up|0
966026|NCT00660400|3180465|P1|Overall Study|Withdrawal by Subject|1
966027|NCT00660400|3180465|P1|Overall Study|Intracranial hemorrhage|1
966028|NCT00660400|3180465|P1|Overall Study|Suboptimal organ function|1
966029|NCT00660400|3180465|P1|Overall Study|Lack of insurance approval|1
966030|NCT00660387|3180474|P2|Overall Study|Protocol Violation|0
966031|NCT00660387|3180475|P1|Overall Study|Protocol Violation|1
966032|NCT00660387|3180474|P2|Overall Study|Lack of Efficacy|1
966033|NCT00660387|3180475|P1|Overall Study|Lack of Efficacy|0
966034|NCT00660387|3180474|P2|Overall Study|Adverse Event|2
966035|NCT00660387|3180475|P1|Overall Study|Adverse Event|1
966036|NCT00660348|3180529|P2|Overall Study|Withdrawal by Subject|0
966037|NCT00660348|3180530|P1|Overall Study|Withdrawal by Subject|1
966038|NCT00660309|3180538|P2|Overall Study|Withdrawal by Subject|3
966039|NCT00660309|3180539|P1|Overall Study|Withdrawal by Subject|0
966040|NCT00660309|3180538|P2|Overall Study|Adverse Event|0
966041|NCT00660309|3180539|P1|Overall Study|Adverse Event|2
966042|NCT00660192|3180580|P2|Overall Study|Lost to Follow-up|3
966043|NCT00660192|3180581|P1|Overall Study|Lost to Follow-up|2
966044|NCT00660179|3180592|P3|Overall Study|Incorrect randomization|0
966045|NCT00660179|3180593|P2|Overall Study|Incorrect randomization|0
966046|NCT00660179|3180594|P1|Overall Study|Incorrect randomization|1
966047|NCT00660179|3180592|P3|Overall Study|Administrative reason|1
966048|NCT00660179|3180593|P2|Overall Study|Administrative reason|0
966049|NCT00660179|3180594|P1|Overall Study|Administrative reason|0
966050|NCT00660179|3180592|P3|Overall Study|Lost to Follow-up|2
966051|NCT00660179|3180593|P2|Overall Study|Lost to Follow-up|5
966052|NCT00660179|3180594|P1|Overall Study|Lost to Follow-up|7
966053|NCT00660179|3180592|P3|Overall Study|Withdrawal of consent|4
966054|NCT00660179|3180593|P2|Overall Study|Withdrawal of consent|6
966055|NCT00660179|3180594|P1|Overall Study|Withdrawal of consent|4
966056|NCT00660179|3180592|P3|Overall Study|Death|34
966057|NCT00660179|3180593|P2|Overall Study|Death|47
966058|NCT00660179|3180594|P1|Overall Study|Death|44
966059|NCT00660023|3180639|P1|Overall Study|Other Screening Failure|9
966060|NCT00660023|3180639|P1|Overall Study|Missed Pregnancy Test|1
966061|NCT00660023|3180639|P1|Overall Study|Withdrawal by Subject|1
966062|NCT00660023|3180639|P1|Overall Study|Renal Transplantation|3
966063|NCT00660023|3180639|P1|Overall Study|Blood Transfusion|5
966064|NCT00660023|3180639|P1|Overall Study|Death|8
966065|NCT00660023|3180639|P1|Overall Study|Adverse Event|2
966066|NCT00660010|3180650|P1|Overall Study|Noncompliance with visit schedule|3
966067|NCT00660010|3180650|P1|Overall Study|Adverse Event|1
966068|NCT00660010|3180650|P1|Overall Study|Lost to Follow-up|3
966069|NCT00660010|3180650|P1|Overall Study|Withdrawal by Subject|2
966070|NCT00659984|3180664|P1|Overall Study|Adverse Event|1
966071|NCT00659880|3180684|P1|Overall Study|Lost to Follow-up|5
966072|NCT00659815|3180691|P2|Overall Study|Withdrawal by Subject|1
966073|NCT00659815|3180692|P1|Overall Study|Withdrawal by Subject|1
966074|NCT00659815|3180691|P2|Overall Study|Inability to maintain wearing schedule|2
966075|NCT00659815|3180692|P1|Overall Study|Inability to maintain wearing schedule|1
966076|NCT00659815|3180691|P2|Overall Study|Study related symptoms and complaints|1
966077|NCT00659815|3180692|P1|Overall Study|Study related symptoms and complaints|2
966078|NCT00659607|3180752|P1|Overall Study|Inconsistent BP measuring date|2
966079|NCT00659607|3180752|P1|Overall Study|No recorded efficacy data|15
966080|NCT00659607|3180752|P1|Overall Study|‘Unable to evaluate’ for the final asses|67
966081|NCT00659607|3180752|P1|Overall Study|Unknown measuring date of blood pressure|85
966082|NCT00659607|3180752|P1|Overall Study|No blood pressure recorded|147
966083|NCT00659581|3180770|P1|Overall Study|Other|6393
966084|NCT00659581|3180770|P1|Overall Study|Lack of Efficacy|1183
966085|NCT00659581|3180770|P1|Overall Study|Adverse Event|1006
966086|NCT00659529|3180782|P1|Overall Study|Screen failure|9
966087|NCT00659529|3180782|P1|Overall Study|Protocol Violation|3
966088|NCT00659529|3180782|P1|Overall Study|Withdrawal by Subject|4
966089|NCT00659490|3180789|P3|Overall Study|Lost to Follow-up|1
966090|NCT00659490|3180790|P2|Overall Study|Lost to Follow-up|0
966091|NCT00659490|3180791|P1|Overall Study|Lost to Follow-up|2
966092|NCT00659438|3180864|P2|Overall Study|Lost to Follow-up|0
966093|NCT00659438|3180865|P1|Overall Study|Lost to Follow-up|1
966094|NCT00659438|3180864|P2|Overall Study|Death|6
966095|NCT00659438|3180865|P1|Overall Study|Death|11
966096|NCT00659438|3180864|P2|Overall Study|Withdrawal by Subject|2
966097|NCT00659438|3180865|P1|Overall Study|Withdrawal by Subject|2
966098|NCT00659425|3180897|P10|Overall Study|Other|6
966099|NCT00659425|3180898|P9|Overall Study|Other|0
966100|NCT00659425|3180899|P8|Overall Study|Other|2
966101|NCT00659425|3180900|P7|Overall Study|Other|3
966102|NCT00659425|3180901|P6|Overall Study|Other|0
966103|NCT00659425|3180902|P5|Overall Study|Other|4
966104|NCT00659425|3180903|P4|Overall Study|Other|2
966105|NCT00659425|3180904|P3|Overall Study|Other|1
966106|NCT00659425|3180905|P2|Overall Study|Other|1
966107|NCT00659425|3180906|P1|Overall Study|Other|0
966108|NCT00659425|3180897|P10|Overall Study|Investigator Discretion|0
966109|NCT00659425|3180898|P9|Overall Study|Investigator Discretion|0
966110|NCT00659425|3180899|P8|Overall Study|Investigator Discretion|3
966111|NCT00659425|3180900|P7|Overall Study|Investigator Discretion|0
966112|NCT00659425|3180901|P6|Overall Study|Investigator Discretion|1
966113|NCT00659425|3180902|P5|Overall Study|Investigator Discretion|0
966114|NCT00659425|3180903|P4|Overall Study|Investigator Discretion|0
966115|NCT00659425|3180904|P3|Overall Study|Investigator Discretion|0
966116|NCT00659425|3180905|P2|Overall Study|Investigator Discretion|0
966117|NCT00659425|3180906|P1|Overall Study|Investigator Discretion|0
966118|NCT00659425|3180897|P10|Overall Study|Adverse Event|4
966119|NCT00659425|3180898|P9|Overall Study|Adverse Event|1
966120|NCT00659425|3180899|P8|Overall Study|Adverse Event|3
966121|NCT00659425|3180900|P7|Overall Study|Adverse Event|0
966122|NCT00659425|3180901|P6|Overall Study|Adverse Event|1
966123|NCT00659425|3180902|P5|Overall Study|Adverse Event|0
966124|NCT00659425|3180903|P4|Overall Study|Adverse Event|0
966125|NCT00659425|3180904|P3|Overall Study|Adverse Event|0
966126|NCT00659425|3180905|P2|Overall Study|Adverse Event|0
966127|NCT00659425|3180906|P1|Overall Study|Adverse Event|0
966128|NCT00659425|3180897|P10|Overall Study|Death|0
966129|NCT00659425|3180898|P9|Overall Study|Death|0
966130|NCT00659425|3180899|P8|Overall Study|Death|0
966131|NCT00659425|3180900|P7|Overall Study|Death|1
966132|NCT00659425|3180901|P6|Overall Study|Death|0
966133|NCT00659425|3180902|P5|Overall Study|Death|0
966134|NCT00659425|3180903|P4|Overall Study|Death|1
966135|NCT00659425|3180904|P3|Overall Study|Death|0
966136|NCT00659425|3180905|P2|Overall Study|Death|0
966137|NCT00659425|3180906|P1|Overall Study|Death|0
966138|NCT00659425|3180897|P10|Overall Study|Disease progression|3
966139|NCT00659425|3180898|P9|Overall Study|Disease progression|5
966140|NCT00659425|3180899|P8|Overall Study|Disease progression|3
966141|NCT00659425|3180900|P7|Overall Study|Disease progression|4
966142|NCT00659425|3180901|P6|Overall Study|Disease progression|2
966143|NCT00659425|3180902|P5|Overall Study|Disease progression|0
966144|NCT00659425|3180903|P4|Overall Study|Disease progression|1
966145|NCT00659425|3180904|P3|Overall Study|Disease progression|0
966146|NCT00659425|3180905|P2|Overall Study|Disease progression|0
966147|NCT00659425|3180906|P1|Overall Study|Disease progression|1
966148|NCT00659373|3181137|P2|Overall Study|Assessment Missed|2
966149|NCT00659373|3181138|P1|Overall Study|Assessment Missed|2
966150|NCT00659373|3181137|P2|Overall Study|Withdrawal by Subject|5
966151|NCT00659373|3181138|P1|Overall Study|Withdrawal by Subject|3
966152|NCT00659334|3181160|P7|Overall Study|Screen Failure|1
966153|NCT00659334|3181161|P6|Overall Study|Screen Failure|0
966154|NCT00659334|3181162|P5|Overall Study|Screen Failure|0
966155|NCT00659334|3181163|P4|Overall Study|Screen Failure|0
966156|NCT00659334|3181164|P3|Overall Study|Screen Failure|0
966157|NCT00659334|3181165|P2|Overall Study|Screen Failure|5
966158|NCT00659334|3181166|P1|Overall Study|Screen Failure|8
966159|NCT00659269|3181193|P2|Overall Study|Physician Decision|1
966160|NCT00659269|3181194|P1|Overall Study|Physician Decision|1
966161|NCT00659230|3181224|P2|Overall Study|Did not return post-randomization|3
966162|NCT00659230|3181225|P1|Overall Study|Did not return post-randomization|2
966163|NCT00659230|3181224|P2|Overall Study|Lost source documentation|4
966164|NCT00659230|3181225|P1|Overall Study|Lost source documentation|5
966165|NCT00659230|3181224|P2|Overall Study|Lost to Follow-up|5
966166|NCT00659230|3181225|P1|Overall Study|Lost to Follow-up|2
966167|NCT00659061|3181248|P2|Overall Study|Migration due to political unrest|15
966168|NCT00659061|3181249|P1|Overall Study|Migration due to political unrest|21
966169|NCT00658996|3181267|P2|Second Intervention|Positive slit lamp finding|1
966170|NCT00658996|3181268|P1|Second Intervention|Positive slit lamp finding|0
966171|NCT00658996|3181267|P2|Second Intervention|Developed a stye on upper lid|0
966172|NCT00658996|3181268|P1|Second Intervention|Developed a stye on upper lid|1
966173|NCT00658996|3181267|P2|Crossover Period|Ineligible|1
966174|NCT00658996|3181268|P1|Crossover Period|Ineligible|1
966175|NCT00658996|3181267|P2|Crossover Period|Physician Decision|0
966176|NCT00658996|3181268|P1|Crossover Period|Physician Decision|1
966177|NCT00658996|3181267|P2|First Intervention|Lack of lenses|1
966178|NCT00658996|3181268|P1|First Intervention|Lack of lenses|0
966179|NCT00658996|3181267|P2|First Intervention|Positive slit lamp finding|0
966180|NCT00658996|3181268|P1|First Intervention|Positive slit lamp finding|1
966181|NCT00658814|3181280|P2|Maintenance Therapy|Not eligible|0
966182|NCT00658814|3181281|P1|Maintenance Therapy|Not eligible|1
966183|NCT00658814|3181280|P2|Maintenance Therapy|Not protocol specified|0
966184|NCT00658814|3181281|P1|Maintenance Therapy|Not protocol specified|1
966185|NCT00658814|3181280|P2|Maintenance Therapy|Adverse Event|1
966186|NCT00658814|3181281|P1|Maintenance Therapy|Adverse Event|1
966187|NCT00658814|3181280|P2|Consolidation Therapy|Not eligible|2
966188|NCT00658814|3181281|P1|Consolidation Therapy|Not eligible|2
966189|NCT00658814|3181280|P2|Consolidation Therapy|Not protocol specified|1
966190|NCT00658814|3181281|P1|Consolidation Therapy|Not protocol specified|0
966191|NCT00658814|3181280|P2|Remission Induction Chemotherapy|Not eligible|2
966192|NCT00658814|3181281|P1|Remission Induction Chemotherapy|Not eligible|1
966193|NCT00658814|3181280|P2|Remission Induction Chemotherapy|Not protocol specified|4
966194|NCT00658814|3181281|P1|Remission Induction Chemotherapy|Not protocol specified|2
966195|NCT00658814|3181280|P2|Remission Induction Chemotherapy|Death|4
966196|NCT00658814|3181281|P1|Remission Induction Chemotherapy|Death|1
966197|NCT00658814|3181280|P2|Remission Induction Chemotherapy|Progression/Relapse|1
966198|NCT00658814|3181281|P1|Remission Induction Chemotherapy|Progression/Relapse|0
966199|NCT00658814|3181280|P2|Remission Induction Chemotherapy|Withdrawal by Subject|4
966200|NCT00658814|3181281|P1|Remission Induction Chemotherapy|Withdrawal by Subject|3
966201|NCT00658814|3181280|P2|Remission Induction Chemotherapy|Adverse Event|3
966202|NCT00658814|3181281|P1|Remission Induction Chemotherapy|Adverse Event|1
966203|NCT00658788|3181295|P1|Overall Study|Treatment Discontinuation|32
966204|NCT00658788|3181295|P1|Overall Study|Lost to Follow-up|18
966205|NCT00658788|3181295|P1|Overall Study|Withdrawal by Subject|13
966206|NCT00658788|3181295|P1|Overall Study|Adverse Event|11
966207|NCT00658775|3181350|P2|Overall Study|Not specified|8
966208|NCT00658775|3181351|P1|Overall Study|Not specified|7
966209|NCT00658775|3181350|P2|Overall Study|Withdrawal of consent|7
966210|NCT00658775|3181351|P1|Overall Study|Withdrawal of consent|8
966211|NCT00658775|3181350|P2|Overall Study|Withdrawal by Subject|4
966212|NCT00658775|3181351|P1|Overall Study|Withdrawal by Subject|6
966213|NCT00658775|3181350|P2|Overall Study|Lost to Follow-up|18
966214|NCT00658775|3181351|P1|Overall Study|Lost to Follow-up|17
966215|NCT00658775|3181350|P2|Overall Study|Adverse Event|6
966216|NCT00658775|3181351|P1|Overall Study|Adverse Event|4
966217|NCT00658723|3181374|P3|Overall Study|Withdrawal by Subject|1
966218|NCT00658723|3181375|P2|Overall Study|Withdrawal by Subject|0
966219|NCT00658723|3181376|P1|Overall Study|Withdrawal by Subject|1
966220|NCT00658723|3181374|P3|Overall Study|Scheduling Issue|0
966221|NCT00658723|3181375|P2|Overall Study|Scheduling Issue|1
966222|NCT00658723|3181376|P1|Overall Study|Scheduling Issue|1
966223|NCT00658723|3181374|P3|Overall Study|Death|4
966224|NCT00658723|3181375|P2|Overall Study|Death|1
966225|NCT00658723|3181376|P1|Overall Study|Death|2
966226|NCT00658723|3181374|P3|Overall Study|Lost to Follow-up|2
966227|NCT00658723|3181375|P2|Overall Study|Lost to Follow-up|2
966228|NCT00658723|3181376|P1|Overall Study|Lost to Follow-up|0
966229|NCT00658684|3181414|P4|Overall Study|Pregnancy|0
966230|NCT00658684|3181415|P3|Overall Study|Pregnancy|0
966231|NCT00658684|3181416|P2|Overall Study|Pregnancy|1
966232|NCT00658684|3181417|P1|Overall Study|Pregnancy|1
966233|NCT00658684|3181414|P4|Overall Study|Protocol Violation|0
966234|NCT00658684|3181415|P3|Overall Study|Protocol Violation|0
966235|NCT00658684|3181416|P2|Overall Study|Protocol Violation|1
966236|NCT00658684|3181417|P1|Overall Study|Protocol Violation|1
966237|NCT00658684|3181414|P4|Overall Study|Lack of Efficacy|0
966238|NCT00658684|3181415|P3|Overall Study|Lack of Efficacy|0
966239|NCT00658684|3181416|P2|Overall Study|Lack of Efficacy|1
966240|NCT00658684|3181417|P1|Overall Study|Lack of Efficacy|1
966241|NCT00658684|3181414|P4|Overall Study|Withdrawal by Subject|1
966242|NCT00658684|3181415|P3|Overall Study|Withdrawal by Subject|1
966243|NCT00658684|3181416|P2|Overall Study|Withdrawal by Subject|4
966244|NCT00658684|3181417|P1|Overall Study|Withdrawal by Subject|6
966245|NCT00658684|3181414|P4|Overall Study|Adverse Event|0
966246|NCT00658684|3181415|P3|Overall Study|Adverse Event|2
966247|NCT00658684|3181416|P2|Overall Study|Adverse Event|8
966248|NCT00658684|3181417|P1|Overall Study|Adverse Event|10
966249|NCT00658658|3181472|P5|Overall Study|Other|1
966250|NCT00658658|3181473|P4|Overall Study|Other|0
966251|NCT00658658|3181474|P3|Overall Study|Other|0
966252|NCT00658658|3181475|P2|Overall Study|Other|0
966253|NCT00658658|3181476|P1|Overall Study|Other|0
966254|NCT00658658|3181472|P5|Overall Study|Protocol-specified Criteria|0
966255|NCT00658658|3181473|P4|Overall Study|Protocol-specified Criteria|0
966256|NCT00658658|3181474|P3|Overall Study|Protocol-specified Criteria|0
966257|NCT00658658|3181475|P2|Overall Study|Protocol-specified Criteria|0
966258|NCT00658658|3181476|P1|Overall Study|Protocol-specified Criteria|1
966259|NCT00658658|3181472|P5|Overall Study|Disease Progression|3
966260|NCT00658658|3181473|P4|Overall Study|Disease Progression|1
966261|NCT00658658|3181474|P3|Overall Study|Disease Progression|0
966262|NCT00658658|3181475|P2|Overall Study|Disease Progression|1
966263|NCT00658658|3181476|P1|Overall Study|Disease Progression|0
966264|NCT00658658|3181472|P5|Overall Study|Death|1
966265|NCT00658658|3181473|P4|Overall Study|Death|1
966266|NCT00658658|3181474|P3|Overall Study|Death|0
966267|NCT00658658|3181475|P2|Overall Study|Death|0
966268|NCT00658658|3181476|P1|Overall Study|Death|4
966269|NCT00658658|3181472|P5|Overall Study|Withdrawal by Subject|0
966270|NCT00658658|3181473|P4|Overall Study|Withdrawal by Subject|0
966271|NCT00658658|3181474|P3|Overall Study|Withdrawal by Subject|0
966272|NCT00658658|3181475|P2|Overall Study|Withdrawal by Subject|1
966273|NCT00658658|3181476|P1|Overall Study|Withdrawal by Subject|0
966274|NCT00658632|3181535|P2|Overall Study|Not specified|8
966275|NCT00658632|3181536|P1|Overall Study|Not specified|7
966276|NCT00658632|3181535|P2|Overall Study|Pregnancy|1
966277|NCT00658632|3181536|P1|Overall Study|Pregnancy|1
966278|NCT00658632|3181535|P2|Overall Study|Withdrawal of consent|14
966279|NCT00658632|3181536|P1|Overall Study|Withdrawal of consent|8
966280|NCT00658632|3181535|P2|Overall Study|Lack of Efficacy|1
966281|NCT00658632|3181536|P1|Overall Study|Lack of Efficacy|0
966282|NCT00658632|3181535|P2|Overall Study|Withdrawal by Subject|7
966283|NCT00658632|3181536|P1|Overall Study|Withdrawal by Subject|10
966284|NCT00658632|3181535|P2|Overall Study|Lost to Follow-up|23
966285|NCT00658632|3181536|P1|Overall Study|Lost to Follow-up|25
966286|NCT00658632|3181535|P2|Overall Study|Adverse Event|11
966287|NCT00658632|3181536|P1|Overall Study|Adverse Event|13
966288|NCT00658606|3181577|P2|Overall Study|Lack of Compliance|3
966289|NCT00658606|3181578|P1|Overall Study|Lack of Compliance|0
966290|NCT00658606|3181577|P2|Overall Study|Withdrawal by Subject|16
966291|NCT00658606|3181578|P1|Overall Study|Withdrawal by Subject|7
966292|NCT00658606|3181577|P2|Overall Study|Lost to Follow-up|0
966293|NCT00658606|3181578|P1|Overall Study|Lost to Follow-up|1
966294|NCT00658606|3181577|P2|Overall Study|Lack of Efficacy|3
966295|NCT00658606|3181578|P1|Overall Study|Lack of Efficacy|6
966296|NCT00658606|3181577|P2|Overall Study|Adverse Event|1
966297|NCT00658606|3181578|P1|Overall Study|Adverse Event|2
966298|NCT00658567|3181607|P3|Overall Study|At Discretion of Sponsor|1
966299|NCT00658567|3181608|P2|Overall Study|At Discretion of Sponsor|1
966300|NCT00658567|3181609|P1|Overall Study|At Discretion of Sponsor|1
966301|NCT00658567|3181607|P3|Overall Study|Physician Decision|0
966302|NCT00658567|3181608|P2|Overall Study|Physician Decision|1
966303|NCT00658567|3181609|P1|Overall Study|Physician Decision|0
966304|NCT00658567|3181607|P3|Overall Study|Voluntary Withdrawal of Consent|2
966305|NCT00658567|3181608|P2|Overall Study|Voluntary Withdrawal of Consent|0
966306|NCT00658567|3181609|P1|Overall Study|Voluntary Withdrawal of Consent|2
966307|NCT00658567|3181607|P3|Overall Study|Adverse Event|3
966308|NCT00658567|3181608|P2|Overall Study|Adverse Event|2
966309|NCT00658567|3181609|P1|Overall Study|Adverse Event|5
966310|NCT00658541|3181620|P2|Washout Period of 7 Days|Withdrawal by Subject|1
966311|NCT00658541|3181621|P1|Washout Period of 7 Days|Withdrawal by Subject|0
966312|NCT00658541|3181620|P2|Washout Period of 7 Days|Withdrawal by Subject|1
966313|NCT00658541|3181621|P1|Washout Period of 7 Days|Withdrawal by Subject|1
966314|NCT00658528|3181633|P2|Overall Study|Not specified|4
966315|NCT00658528|3181634|P1|Overall Study|Not specified|8
966316|NCT00658528|3181633|P2|Overall Study|Withdrawal of consent|6
966317|NCT00658528|3181634|P1|Overall Study|Withdrawal of consent|5
966318|NCT00658528|3181633|P2|Overall Study|Withdrawal by Subject|6
966319|NCT00658528|3181634|P1|Overall Study|Withdrawal by Subject|8
966320|NCT00658528|3181633|P2|Overall Study|Lost to Follow-up|22
966321|NCT00658528|3181634|P1|Overall Study|Lost to Follow-up|14
966322|NCT00658528|3181633|P2|Overall Study|Adverse Event|7
966323|NCT00658528|3181634|P1|Overall Study|Adverse Event|5
966324|NCT00658359|3181659|P3|Overall Study|Lack of Efficacy|0
966325|NCT00658359|3181660|P2|Overall Study|Lack of Efficacy|1
966326|NCT00658359|3181661|P1|Overall Study|Lack of Efficacy|0
966327|NCT00658359|3181659|P3|Overall Study|Lost to Follow-up|4
966328|NCT00658359|3181660|P2|Overall Study|Lost to Follow-up|2
966329|NCT00658359|3181661|P1|Overall Study|Lost to Follow-up|2
966330|NCT00658359|3181659|P3|Overall Study|Withdrawal by Subject|2
966331|NCT00658359|3181660|P2|Overall Study|Withdrawal by Subject|4
966332|NCT00658359|3181661|P1|Overall Study|Withdrawal by Subject|7
966333|NCT00658359|3181659|P3|Overall Study|Includes protocol Amendments 3 and 4|29
966334|NCT00658359|3181660|P2|Overall Study|Includes protocol Amendments 3 and 4|31
966335|NCT00658359|3181661|P1|Overall Study|Includes protocol Amendments 3 and 4|2
966336|NCT00658359|3181659|P3|Overall Study|Protocol Violation|0
966337|NCT00658359|3181660|P2|Overall Study|Protocol Violation|0
966338|NCT00658359|3181661|P1|Overall Study|Protocol Violation|1
966339|NCT00658359|3181659|P3|Overall Study|Adverse Event|9
966340|NCT00658359|3181660|P2|Overall Study|Adverse Event|6
966341|NCT00658359|3181661|P1|Overall Study|Adverse Event|13
966342|NCT00658359|3181659|P3|Overall Study|Death|2
966343|NCT00658359|3181660|P2|Overall Study|Death|1
966344|NCT00658359|3181661|P1|Overall Study|Death|3
966345|NCT00658333|3181749|P2|Overall Study|Adverse Event|1
966346|NCT00658333|3181750|P1|Overall Study|Adverse Event|2
966347|NCT00658320|3181760|P2|Extension Study: After Month 24|Subject withdrew consent|0
966348|NCT00658320|3181761|P1|Extension Study: After Month 24|Subject withdrew consent|2
966349|NCT00658320|3181760|P2|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7
966350|NCT00658320|3181761|P1|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3
966351|NCT00658320|3181760|P2|Extension Study: Month 12 to Month 24|Subject withdrew consent|0
966352|NCT00658320|3181761|P1|Extension Study: Month 12 to Month 24|Subject withdrew consent|3
966353|NCT00658320|3181760|P2|Core Study: 12 Months|Subject withdrew consent|3
966354|NCT00658320|3181761|P1|Core Study: 12 Months|Subject withdrew consent|5
966355|NCT00657709|3181798|P5|Overall Study|Protocol Violation|2
966356|NCT00657709|3181799|P4|Overall Study|Protocol Violation|1
966357|NCT00657709|3181800|P3|Overall Study|Protocol Violation|0
966358|NCT00657709|3181801|P2|Overall Study|Protocol Violation|2
966359|NCT00657709|3181802|P1|Overall Study|Protocol Violation|0
966360|NCT00657709|3181798|P5|Overall Study|Lost to Follow-up|21
966361|NCT00657709|3181799|P4|Overall Study|Lost to Follow-up|1
966362|NCT00657709|3181800|P3|Overall Study|Lost to Follow-up|7
966363|NCT00657709|3181801|P2|Overall Study|Lost to Follow-up|9
966364|NCT00657709|3181802|P1|Overall Study|Lost to Follow-up|9
966365|NCT00657709|3181798|P5|Overall Study|Withdrawal by Subject|9
966366|NCT00657709|3181799|P4|Overall Study|Withdrawal by Subject|5
966367|NCT00657709|3181800|P3|Overall Study|Withdrawal by Subject|15
966368|NCT00657709|3181801|P2|Overall Study|Withdrawal by Subject|15
966369|NCT00657709|3181802|P1|Overall Study|Withdrawal by Subject|7
966370|NCT00657709|3181798|P5|Overall Study|AE or Death|1
966371|NCT00657709|3181799|P4|Overall Study|AE or Death|7
966372|NCT00657709|3181800|P3|Overall Study|AE or Death|6
966373|NCT00657709|3181801|P2|Overall Study|AE or Death|7
966374|NCT00657709|3181802|P1|Overall Study|AE or Death|7
966375|NCT00657618|3181851|P1|Overall Study|didn't start due to schedule conflicts|1
966376|NCT00657618|3181851|P1|Overall Study|negative for leishmaniasis|2
966377|NCT00657618|3181851|P1|Overall Study|Withdrawal by Subject|8
966378|NCT00657618|3181851|P1|Overall Study|Adverse Event|32
966379|NCT00657553|3181858|P2|Overall Study|low accrual, no analysis run|5
966380|NCT00657553|3181859|P1|Overall Study|low accrual, no analysis run|5
966381|NCT00657540|3181867|P2|Overall Study|Lost to Follow-up|4
966382|NCT00657540|3181868|P1|Overall Study|Lost to Follow-up|1
966383|NCT00657371|3181882|P1|Overall Study|Pre-existing medical condition|4
966384|NCT00657371|3181882|P1|Overall Study|Device- related reasons|13
966385|NCT00657371|3181882|P1|Overall Study|Protocol Violation|2
966386|NCT00657371|3181882|P1|Overall Study|Unable to intubate the cecum|5
966387|NCT00657371|3181882|P1|Overall Study|Poor bowel preparation|15
966388|NCT00657358|3181887|P1|Overall Study|Lack of Efficacy|6
966389|NCT00657267|3181899|P1|Overall Study|Adverse Event|9
966390|NCT00657267|3181899|P1|Overall Study|Progressive disease|45
966391|NCT00657150|3181909|P2|Treatment|Not Specified|15
966392|NCT00657150|3181910|P1|Treatment|Not Specified|13
966393|NCT00657150|3181909|P2|Treatment|Withdrawal by Subject|20
966394|NCT00657150|3181910|P1|Treatment|Withdrawal by Subject|23
966395|NCT00657150|3181909|P2|Treatment|Lost to Follow-up|0
966396|NCT00657150|3181910|P1|Treatment|Lost to Follow-up|1
966397|NCT00657150|3181909|P2|Treatment|Non-compliant with protocol|9
966398|NCT00657150|3181910|P1|Treatment|Non-compliant with protocol|10
966399|NCT00657150|3181909|P2|Treatment|Adverse Event|53
966400|NCT00657150|3181910|P1|Treatment|Adverse Event|60
966401|NCT00657150|3181909|P2|Overall Study|Not Specified|38
966402|NCT00657150|3181910|P1|Overall Study|Not Specified|38
966403|NCT00657150|3181909|P2|Overall Study|Withdrawal by Subject|36
966404|NCT00657150|3181910|P1|Overall Study|Withdrawal by Subject|51
966405|NCT00657150|3181909|P2|Overall Study|Lost to Follow-up|0
966406|NCT00657150|3181910|P1|Overall Study|Lost to Follow-up|2
966407|NCT00657150|3181909|P2|Overall Study|Non-compliant with protocol|9
966408|NCT00657150|3181910|P1|Overall Study|Non-compliant with protocol|5
966409|NCT00657150|3181909|P2|Overall Study|Adverse Event|10
966410|NCT00657150|3181910|P1|Overall Study|Adverse Event|19
966411|NCT00657046|3181941|P3|Overall Study|Surgery|1
966412|NCT00657046|3181942|P2|Overall Study|Surgery|0
966413|NCT00657046|3181943|P1|Overall Study|Surgery|0
966414|NCT00657046|3181941|P3|Overall Study|Death|1
966415|NCT00657046|3181942|P2|Overall Study|Death|0
966416|NCT00657046|3181943|P1|Overall Study|Death|0
966417|NCT00657046|3181941|P3|Overall Study|Withdrawal by Subject|0
966418|NCT00657046|3181942|P2|Overall Study|Withdrawal by Subject|0
966419|NCT00657046|3181943|P1|Overall Study|Withdrawal by Subject|1
966420|NCT00657046|3181941|P3|Overall Study|Protocol Violation|0
966421|NCT00657046|3181942|P2|Overall Study|Protocol Violation|2
966422|NCT00657046|3181943|P1|Overall Study|Protocol Violation|2
966423|NCT00657046|3181941|P3|Overall Study|Adverse Event|0
966424|NCT00657046|3181942|P2|Overall Study|Adverse Event|1
966425|NCT00657046|3181943|P1|Overall Study|Adverse Event|1
966426|NCT00657020|3181975|P2|PERIOD 1|Adverse Event|1
966427|NCT00657020|3181976|P1|PERIOD 1|Adverse Event|0
966428|NCT00656851|3182026|P2|Overall Study|Withdrawal by Subject|4
966429|NCT00656851|3182027|P1|Overall Study|Withdrawal by Subject|0
966430|NCT00656799|3182049|P1|Overall Study|Death|2
966431|NCT00656669|3182071|P1|AC (Cycles 6-9)|Did not start segment 3|1
966432|NCT00656669|3182071|P1|AC (Cycles 6-9)|Adverse Event|1
966433|NCT00656669|3182071|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2
966434|NCT00656669|3182071|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4
966435|NCT00656617|3182110|P1|Overall Study|Move to different clinical trial|2
966436|NCT00656617|3182110|P1|Overall Study|Insurance Issues|2
966437|NCT00656617|3182110|P1|Overall Study|Death|2
966438|NCT00656617|3182110|P1|Overall Study|Adverse Event|1
966439|NCT00656513|3182119|P3|Overall Study|Missing baseline form|5
966440|NCT00656513|3182120|P2|Overall Study|Missing baseline form|5
966441|NCT00656513|3182121|P1|Overall Study|Missing baseline form|0
966442|NCT00656513|3182119|P3|Overall Study|Treatment completed outside of timeframe|1
966443|NCT00656513|3182120|P2|Overall Study|Treatment completed outside of timeframe|3
966444|NCT00656513|3182121|P1|Overall Study|Treatment completed outside of timeframe|0
966445|NCT00656513|3182119|P3|Overall Study|Incomplete treatment|0
966446|NCT00656513|3182120|P2|Overall Study|Incomplete treatment|0
966447|NCT00656513|3182121|P1|Overall Study|Incomplete treatment|3
966448|NCT00656513|3182119|P3|Overall Study|Missing data|9
966449|NCT00656513|3182120|P2|Overall Study|Missing data|11
966450|NCT00656513|3182121|P1|Overall Study|Missing data|0
966451|NCT00656513|3182119|P3|Overall Study|Death|1
966452|NCT00656513|3182120|P2|Overall Study|Death|0
966453|NCT00656513|3182121|P1|Overall Study|Death|0
966454|NCT00656513|3182119|P3|Overall Study|Withdrawal by Subject|4
966455|NCT00656513|3182120|P2|Overall Study|Withdrawal by Subject|11
966456|NCT00656513|3182121|P1|Overall Study|Withdrawal by Subject|0
966457|NCT00656513|3182119|P3|Overall Study|Protocol Violation|2
966458|NCT00656513|3182120|P2|Overall Study|Protocol Violation|0
966459|NCT00656513|3182121|P1|Overall Study|Protocol Violation|1
966460|NCT00656474|3182168|P1|Overall Study|Other Reason|1
966461|NCT00656370|3182186|P1|Overall Study|Alternates|3
966462|NCT00656370|3182186|P1|Overall Study|Screen Failures|7
966463|NCT00656292|3182215|P2|Overall Study|Screen failure|2
966464|NCT00656292|3182216|P1|Overall Study|Screen failure|1
966465|NCT00656292|3182215|P2|Overall Study|Withdrawal by Subject|3
966466|NCT00656292|3182216|P1|Overall Study|Withdrawal by Subject|2
966467|NCT00656175|3182243|P2|Overall Study|Transportation issues|1
966468|NCT00656175|3182244|P1|Overall Study|Transportation issues|0
966469|NCT00656175|3182243|P2|Overall Study|Adverse Event|0
966470|NCT00656175|3182244|P1|Overall Study|Adverse Event|1
966471|NCT00656136|3182252|P2|Overall Study|Unknown and others|4
966472|NCT00656136|3182253|P1|Overall Study|Unknown and others|4
966473|NCT00656136|3182252|P2|Overall Study|Patient refused to take study medication|10
966474|NCT00656136|3182253|P1|Overall Study|Patient refused to take study medication|7
966475|NCT00656136|3182252|P2|Overall Study|Protocol Violation|3
966476|NCT00656136|3182253|P1|Overall Study|Protocol Violation|2
966477|NCT00656136|3182252|P2|Overall Study|Other Adverse Event|51
966478|NCT00656136|3182253|P1|Overall Study|Other Adverse Event|5
966479|NCT00656136|3182252|P2|Overall Study|Progressive disease|322
966480|NCT00656136|3182253|P1|Overall Study|Progressive disease|177
966481|NCT00656084|3182263|P1|Overall Study|Investigator Request|1
966482|NCT00656084|3182263|P1|Overall Study|Patient Request|1
966483|NCT00656084|3182263|P1|Overall Study|Withdrawal by Subject|1
966484|NCT00656084|3182263|P1|Overall Study|Adverse Event|4
966485|NCT00656058|3182270|P1|Overall Study|Withdrawal by Subject|4
966486|NCT00656058|3182270|P1|Overall Study|Withdrawal by Subject|2
966487|NCT00656019|3182283|P4|Overall Study|Lost to Follow-up|0
966488|NCT00656019|3182284|P3|Overall Study|Lost to Follow-up|0
966489|NCT00656019|3182285|P2|Overall Study|Lost to Follow-up|1
966490|NCT00656019|3182286|P1|Overall Study|Lost to Follow-up|2
966491|NCT00656019|3182283|P4|Overall Study|Withdrawal by Subject|0
966492|NCT00656019|3182284|P3|Overall Study|Withdrawal by Subject|0
966493|NCT00656019|3182285|P2|Overall Study|Withdrawal by Subject|0
966494|NCT00656019|3182286|P1|Overall Study|Withdrawal by Subject|2
966495|NCT00656019|3182283|P4|Overall Study|Not Eligible|0
966496|NCT00656019|3182284|P3|Overall Study|Not Eligible|0
966497|NCT00656019|3182285|P2|Overall Study|Not Eligible|0
966498|NCT00656019|3182286|P1|Overall Study|Not Eligible|10
966499|NCT00655889|3182296|P1|Overall Study|Protocol Violation|1
966500|NCT00655889|3182296|P1|Overall Study|Inadequate cell growth|1
966501|NCT00655876|3182303|P2|Overall Study|Protocol Violation|7
966502|NCT00655876|3182304|P1|Overall Study|Protocol Violation|9
966503|NCT00655863|3182323|P3|Overall Study|Lost to Follow-up|1
966504|NCT00655863|3182324|P2|Overall Study|Lost to Follow-up|0
966505|NCT00655863|3182325|P1|Overall Study|Lost to Follow-up|0
966506|NCT00655850|3182384|P1|Overall Study|Withdrawal by Subject|1
966507|NCT00655850|3182384|P1|Overall Study|Death|2
966508|NCT00655824|3182391|P1|Overall Study|Deterioration of Trial Disease|2
966509|NCT00655824|3182391|P1|Overall Study|Withdrawal by Subject|4
966510|NCT00655824|3182391|P1|Overall Study|Protocol Violation|1
966511|NCT00655824|3182391|P1|Overall Study|Early Termination of Study by Sponsor|74
966512|NCT00655824|3182391|P1|Overall Study|Adverse Event|3
966513|NCT00655746|3182439|P1|Overall Study|Withdrawal by Subject|1
966514|NCT00655733|3182458|P2|Overall Study|Physician Decision|1
966515|NCT00655733|3182459|P1|Overall Study|Physician Decision|0
966516|NCT00655733|3182458|P2|Overall Study|Withdrawal by Subject|3
966517|NCT00655733|3182459|P1|Overall Study|Withdrawal by Subject|3
966518|NCT00655733|3182458|P2|Overall Study|Adverse Event|2
966519|NCT00655733|3182459|P1|Overall Study|Adverse Event|2
966520|NCT00655733|3182458|P2|Overall Study|Lost to Follow-up|2
966521|NCT00655733|3182459|P1|Overall Study|Lost to Follow-up|2
966522|NCT00655668|3182465|P1|Overall Study|Withdrawal by Subject|2
966523|NCT00655668|3182465|P1|Overall Study|New Lymphoma Treatment Started|4
966524|NCT00655668|3182465|P1|Overall Study|Other|1
966525|NCT00655668|3182465|P1|Overall Study|Study Terminated|9
966526|NCT00655668|3182465|P1|Overall Study|Disease Progression|27
966527|NCT00655668|3182465|P1|Overall Study|Death|5
966528|NCT00655668|3182465|P1|Overall Study|Adverse Event|6
966529|NCT00655629|3182492|P2|Overall Study|consent withdrawn|4
966530|NCT00655629|3182493|P1|Overall Study|consent withdrawn|6
966531|NCT00655629|3182492|P2|Overall Study|Protocol Violation|3
966532|NCT00655629|3182493|P1|Overall Study|Protocol Violation|5
966533|NCT00655629|3182492|P2|Overall Study|Lost to Follow-up|3
966534|NCT00655629|3182493|P1|Overall Study|Lost to Follow-up|4
966535|NCT00655629|3182492|P2|Overall Study|Lack of Efficacy|12
966536|NCT00655629|3182493|P1|Overall Study|Lack of Efficacy|2
966537|NCT00655629|3182492|P2|Overall Study|Adverse Event|1
966538|NCT00655629|3182493|P1|Overall Study|Adverse Event|4
966539|NCT00655564|3182529|P1|Overall Study|Desired Alternate Therapy|1
966540|NCT00655564|3182529|P1|Overall Study|Lost to Follow-up|1
966541|NCT00655564|3182529|P1|Overall Study|Adverse Event|1
966542|NCT00655551|3182537|P3|Period 4 (up to 7 Days)|Adverse Event|0
966543|NCT00655551|3182538|P2|Period 4 (up to 7 Days)|Adverse Event|2
966544|NCT00655551|3182539|P1|Period 4 (up to 7 Days)|Adverse Event|0
966545|NCT00655551|3182537|P3|Period 3 (up to 7 Days)|Adverse Event|4
966546|NCT00655551|3182538|P2|Period 3 (up to 7 Days)|Adverse Event|0
966547|NCT00655551|3182539|P1|Period 3 (up to 7 Days)|Adverse Event|0
966548|NCT00655551|3182537|P3|Period 2 (up to 7 Days)|Adverse Event|0
966549|NCT00655551|3182538|P2|Period 2 (up to 7 Days)|Adverse Event|1
966550|NCT00655551|3182539|P1|Period 2 (up to 7 Days)|Adverse Event|0
966551|NCT00655551|3182537|P3|All Periods Combined|Adverse Event|4
966552|NCT00655551|3182538|P2|All Periods Combined|Adverse Event|3
966553|NCT00655551|3182539|P1|All Periods Combined|Adverse Event|0
966554|NCT00655486|3182553|P1|Overall Study|Other: Abnormal electrocardiogram (ECG)|1
966555|NCT00655486|3182553|P1|Overall Study|Other: Could not tolerate BID dosing|1
966556|NCT00655486|3182553|P1|Overall Study|Other: Pregnancy|1
966557|NCT00655486|3182553|P1|Overall Study|Unsatisfactory compliance|2
966558|NCT00655486|3182553|P1|Overall Study|Protocol Violation|1
966559|NCT00655486|3182553|P1|Overall Study|Withdrawal by Subject|4
966560|NCT00655486|3182553|P1|Overall Study|Lack of Efficacy|8
966561|NCT00655486|3182553|P1|Overall Study|Adverse Event|10
966562|NCT00655356|3182560|P2|Overall Study|Other Reason|0
966563|NCT00655356|3182561|P1|Overall Study|Other Reason|1
966564|NCT00655356|3182560|P2|Overall Study|Protocol Violation|1
966565|NCT00655356|3182561|P1|Overall Study|Protocol Violation|2
966566|NCT00655356|3182560|P2|Overall Study|Adverse Event|1
966567|NCT00655356|3182561|P1|Overall Study|Adverse Event|1
966568|NCT00655356|3182560|P2|Overall Study|Sponsor Request|4
966569|NCT00655356|3182561|P1|Overall Study|Sponsor Request|10
966570|NCT00655356|3182560|P2|Overall Study|Withdrawal by Subject|4
966571|NCT00655356|3182561|P1|Overall Study|Withdrawal by Subject|3
966572|NCT00654940|3182612|P2|Period 1|Intolerable Pain Level|0
966573|NCT00654940|3182613|P1|Period 1|Intolerable Pain Level|1
966574|NCT00654940|3182612|P2|Period 1|Adverse Event|1
966575|NCT00654940|3182613|P1|Period 1|Adverse Event|0
966576|NCT00654901|3182637|P4|Overall Study|Withdrawal by Subject|0
966577|NCT00654901|3182638|P3|Overall Study|Withdrawal by Subject|1
966578|NCT00654901|3182639|P2|Overall Study|Withdrawal by Subject|0
966579|NCT00654901|3182640|P1|Overall Study|Withdrawal by Subject|3
966580|NCT00654901|3182637|P4|Overall Study|Lost to Follow-up|0
966581|NCT00654901|3182638|P3|Overall Study|Lost to Follow-up|1
966582|NCT00654901|3182639|P2|Overall Study|Lost to Follow-up|0
966583|NCT00654901|3182640|P1|Overall Study|Lost to Follow-up|1
966584|NCT00654875|3182660|P2|Overall Study|Administrative Problems|0
966585|NCT00654875|3182661|P1|Overall Study|Administrative Problems|1
966586|NCT00654875|3182660|P2|Overall Study|Abnormal Test Procedure Result(s)|0
966587|NCT00654875|3182661|P1|Overall Study|Abnormal Test Procedure Result(s)|1
966588|NCT00654875|3182660|P2|Overall Study|Lost to Follow-up|3
966589|NCT00654875|3182661|P1|Overall Study|Lost to Follow-up|1
966590|NCT00654875|3182660|P2|Overall Study|Lack of Efficacy|2
966591|NCT00654875|3182661|P1|Overall Study|Lack of Efficacy|2
966592|NCT00654875|3182660|P2|Overall Study|Protocol Violation|3
966593|NCT00654875|3182661|P1|Overall Study|Protocol Violation|3
966594|NCT00654875|3182660|P2|Overall Study|Withdrawal by Subject|4
966595|NCT00654875|3182661|P1|Overall Study|Withdrawal by Subject|4
966596|NCT00654875|3182660|P2|Overall Study|Adverse Event|5
966597|NCT00654875|3182661|P1|Overall Study|Adverse Event|5
966598|NCT00654745|3182694|P1|Overall Study|poor ABPM, noncompliance, lab MAs|3
966599|NCT00654745|3182694|P1|Overall Study|Withdrawal by Subject|10
966600|NCT00654745|3182694|P1|Overall Study|Protocol Violation|11
966601|NCT00654745|3182694|P1|Overall Study|Lost to Follow-up|7
966602|NCT00654745|3182694|P1|Overall Study|Adverse Event|12
966603|NCT00654641|3182739|P2|Overall Study|Lost to Follow-up|3
966604|NCT00654641|3182740|P1|Overall Study|Lost to Follow-up|2
966605|NCT00654628|3182746|P1|6 –Week Extension Period (Single Site)|Lost to Follow-up|1
966606|NCT00654628|3182746|P1|6 –Week Extension Period (Single Site)|Adverse Event|4
966607|NCT00654628|3182746|P1|6-week Active Treatment Period|Out of window period|1
966608|NCT00654628|3182746|P1|6-week Active Treatment Period|Transferred to branch hospital|1
966609|NCT00654628|3182746|P1|6-week Active Treatment Period|Lost to Follow-up|10
966610|NCT00654628|3182746|P1|6-week Active Treatment Period|Adverse Event|9
966611|NCT00654498|3182795|P2|Overall Study|Other reason not defined above|5
966612|NCT00654498|3182796|P1|Overall Study|Other reason not defined above|4
966613|NCT00654498|3182795|P2|Overall Study|Withdrawal by Subject|0
966614|NCT00654498|3182796|P1|Overall Study|Withdrawal by Subject|1
966615|NCT00654498|3182795|P2|Overall Study|Lost to Follow-up|5
966616|NCT00654498|3182796|P1|Overall Study|Lost to Follow-up|1
966617|NCT00654498|3182795|P2|Overall Study|Protocol Violation|1
966618|NCT00654498|3182796|P1|Overall Study|Protocol Violation|1
966619|NCT00654498|3182795|P2|Overall Study|Adverse Event|1
966620|NCT00654498|3182796|P1|Overall Study|Adverse Event|6
966621|NCT00654498|3182795|P2|Overall Study|Not Treated|0
966622|NCT00654498|3182796|P1|Overall Study|Not Treated|1
966623|NCT00654420|3182828|P4|Phase II|Missing Disposition Record|0
966624|NCT00654420|3182829|P3|Phase II|Missing Disposition Record|1
966625|NCT00654420|3182830|P2|Phase II|Missing Disposition Record|0
966626|NCT00654420|3182831|P1|Phase II|Missing Disposition Record|0
966627|NCT00654420|3182828|P4|Phase II|Withdrawal by Subject|1
966628|NCT00654420|3182829|P3|Phase II|Withdrawal by Subject|4
966629|NCT00654420|3182830|P2|Phase II|Withdrawal by Subject|0
966630|NCT00654420|3182831|P1|Phase II|Withdrawal by Subject|0
966631|NCT00654420|3182828|P4|Phase II|Progressive Disease|29
966632|NCT00654420|3182829|P3|Phase II|Progressive Disease|29
966633|NCT00654420|3182830|P2|Phase II|Progressive Disease|0
966634|NCT00654420|3182831|P1|Phase II|Progressive Disease|0
966635|NCT00654420|3182828|P4|Phase II|Physician Decision|4
966636|NCT00654420|3182829|P3|Phase II|Physician Decision|0
966637|NCT00654420|3182830|P2|Phase II|Physician Decision|0
966638|NCT00654420|3182831|P1|Phase II|Physician Decision|0
966639|NCT00654420|3182828|P4|Phase II|Lost to Follow-up|1
966640|NCT00654420|3182829|P3|Phase II|Lost to Follow-up|0
966641|NCT00654420|3182830|P2|Phase II|Lost to Follow-up|0
966642|NCT00654420|3182831|P1|Phase II|Lost to Follow-up|0
966643|NCT00654420|3182828|P4|Phase II|Adverse Event|3
966644|NCT00654420|3182829|P3|Phase II|Adverse Event|3
966645|NCT00654420|3182830|P2|Phase II|Adverse Event|0
966646|NCT00654420|3182831|P1|Phase II|Adverse Event|0
966647|NCT00654420|3182828|P4|Phase I (Dose Escalation)|Progressive Disease|0
966648|NCT00654420|3182829|P3|Phase I (Dose Escalation)|Progressive Disease|0
966649|NCT00654420|3182830|P2|Phase I (Dose Escalation)|Progressive Disease|15
966650|NCT00654420|3182831|P1|Phase I (Dose Escalation)|Progressive Disease|4
966651|NCT00654420|3182828|P4|Phase I (Dose Escalation)|Adverse Event|0
966652|NCT00654420|3182829|P3|Phase I (Dose Escalation)|Adverse Event|0
966653|NCT00654420|3182830|P2|Phase I (Dose Escalation)|Adverse Event|1
966654|NCT00654420|3182831|P1|Phase I (Dose Escalation)|Adverse Event|0
966655|NCT00654381|3182857|P6|Extension Stage|Closure of the trial site|1
966656|NCT00654381|3182858|P5|Extension Stage|Closure of the trial site|1
966657|NCT00654381|3182859|P4|Extension Stage|Closure of the trial site|0
966658|NCT00654381|3182860|P3|Extension Stage|Closure of the trial site|0
966659|NCT00654381|3182861|P2|Extension Stage|Closure of the trial site|0
966660|NCT00654381|3182862|P1|Extension Stage|Closure of the trial site|0
966661|NCT00654381|3182857|P6|Extension Stage|Withdrawal by Subject|1
966662|NCT00654381|3182858|P5|Extension Stage|Withdrawal by Subject|1
966663|NCT00654381|3182859|P4|Extension Stage|Withdrawal by Subject|1
966664|NCT00654381|3182860|P3|Extension Stage|Withdrawal by Subject|1
966665|NCT00654381|3182861|P2|Extension Stage|Withdrawal by Subject|0
966666|NCT00654381|3182862|P1|Extension Stage|Withdrawal by Subject|0
966667|NCT00654381|3182857|P6|Extension Stage|Lack of Efficacy|0
966668|NCT00654381|3182858|P5|Extension Stage|Lack of Efficacy|0
966669|NCT00654381|3182859|P4|Extension Stage|Lack of Efficacy|0
966670|NCT00654381|3182860|P3|Extension Stage|Lack of Efficacy|1
966671|NCT00654381|3182861|P2|Extension Stage|Lack of Efficacy|0
966672|NCT00654381|3182862|P1|Extension Stage|Lack of Efficacy|0
966673|NCT00654381|3182857|P6|Extension Stage|Protocol Violation|0
966674|NCT00654381|3182858|P5|Extension Stage|Protocol Violation|0
966675|NCT00654381|3182859|P4|Extension Stage|Protocol Violation|1
966676|NCT00654381|3182860|P3|Extension Stage|Protocol Violation|0
966677|NCT00654381|3182861|P2|Extension Stage|Protocol Violation|0
966678|NCT00654381|3182862|P1|Extension Stage|Protocol Violation|0
966679|NCT00654381|3182857|P6|Extension Stage|Adverse Event|1
966680|NCT00654381|3182858|P5|Extension Stage|Adverse Event|1
966681|NCT00654381|3182859|P4|Extension Stage|Adverse Event|7
966682|NCT00654381|3182860|P3|Extension Stage|Adverse Event|9
966683|NCT00654381|3182861|P2|Extension Stage|Adverse Event|2
966684|NCT00654381|3182862|P1|Extension Stage|Adverse Event|1
966685|NCT00654381|3182857|P6|2nd Stage|Investigator's decision|0
966686|NCT00654381|3182858|P5|2nd Stage|Investigator's decision|0
966687|NCT00654381|3182859|P4|2nd Stage|Investigator's decision|1
966688|NCT00654381|3182860|P3|2nd Stage|Investigator's decision|1
966689|NCT00654381|3182861|P2|2nd Stage|Investigator's decision|0
966690|NCT00654381|3182862|P1|2nd Stage|Investigator's decision|0
966691|NCT00654381|3182857|P6|2nd Stage|Withdrawal by Subject|1
966692|NCT00654381|3182858|P5|2nd Stage|Withdrawal by Subject|1
966693|NCT00654381|3182859|P4|2nd Stage|Withdrawal by Subject|0
966694|NCT00654381|3182860|P3|2nd Stage|Withdrawal by Subject|0
966695|NCT00654381|3182861|P2|2nd Stage|Withdrawal by Subject|0
966696|NCT00654381|3182862|P1|2nd Stage|Withdrawal by Subject|0
966697|NCT00654381|3182857|P6|2nd Stage|Adverse Event|2
966698|NCT00654381|3182858|P5|2nd Stage|Adverse Event|7
966699|NCT00654381|3182859|P4|2nd Stage|Adverse Event|3
966700|NCT00654381|3182860|P3|2nd Stage|Adverse Event|2
966701|NCT00654381|3182861|P2|2nd Stage|Adverse Event|0
966702|NCT00654381|3182862|P1|2nd Stage|Adverse Event|2
966703|NCT00654381|3182857|P6|1st Stage|Investigator's decision|0
966704|NCT00654381|3182858|P5|1st Stage|Investigator's decision|0
966705|NCT00654381|3182859|P4|1st Stage|Investigator's decision|1
966706|NCT00654381|3182860|P3|1st Stage|Investigator's decision|0
966707|NCT00654381|3182861|P2|1st Stage|Investigator's decision|0
966708|NCT00654381|3182862|P1|1st Stage|Investigator's decision|0
966709|NCT00654381|3182857|P6|1st Stage|Withdrawal by Subject|1
966710|NCT00654381|3182858|P5|1st Stage|Withdrawal by Subject|0
966711|NCT00654381|3182859|P4|1st Stage|Withdrawal by Subject|1
966712|NCT00654381|3182860|P3|1st Stage|Withdrawal by Subject|0
966713|NCT00654381|3182861|P2|1st Stage|Withdrawal by Subject|0
966714|NCT00654381|3182862|P1|1st Stage|Withdrawal by Subject|0
966715|NCT00654381|3182857|P6|1st Stage|Adverse Event|1
966716|NCT00654381|3182858|P5|1st Stage|Adverse Event|2
966717|NCT00654381|3182859|P4|1st Stage|Adverse Event|3
966718|NCT00654381|3182860|P3|1st Stage|Adverse Event|3
966719|NCT00654381|3182861|P2|1st Stage|Adverse Event|3
966720|NCT00654381|3182862|P1|1st Stage|Adverse Event|3
966721|NCT00654368|3182899|P3|Overall Study|Adverse Event|6
966722|NCT00654368|3182900|P2|Overall Study|Adverse Event|9
966723|NCT00654368|3182901|P1|Overall Study|Adverse Event|14
966724|NCT00654368|3182899|P3|Overall Study|Other|3
966725|NCT00654368|3182900|P2|Overall Study|Other|2
966726|NCT00654368|3182901|P1|Overall Study|Other|0
966727|NCT00654368|3182899|P3|Overall Study|Pregnancy|2
966728|NCT00654368|3182900|P2|Overall Study|Pregnancy|0
966729|NCT00654368|3182901|P1|Overall Study|Pregnancy|0
966730|NCT00654368|3182899|P3|Overall Study|Death|0
966731|NCT00654368|3182900|P2|Overall Study|Death|0
966732|NCT00654368|3182901|P1|Overall Study|Death|1
966733|NCT00654368|3182899|P3|Overall Study|Physician Decision|2
966734|NCT00654368|3182900|P2|Overall Study|Physician Decision|0
966735|NCT00654368|3182901|P1|Overall Study|Physician Decision|0
966736|NCT00654368|3182899|P3|Overall Study|Requirement for alternative therapy|1
966737|NCT00654368|3182900|P2|Overall Study|Requirement for alternative therapy|1
966738|NCT00654368|3182901|P1|Overall Study|Requirement for alternative therapy|1
966739|NCT00654368|3182899|P3|Overall Study|Disease progression|13
966740|NCT00654368|3182900|P2|Overall Study|Disease progression|31
966741|NCT00654368|3182901|P1|Overall Study|Disease progression|21
966742|NCT00654368|3182899|P3|Overall Study|Withdrawal by Subject|2
966743|NCT00654368|3182900|P2|Overall Study|Withdrawal by Subject|2
966744|NCT00654368|3182901|P1|Overall Study|Withdrawal by Subject|5
966745|NCT00654368|3182899|P3|Overall Study|Non-compliance|2
966746|NCT00654368|3182900|P2|Overall Study|Non-compliance|1
966747|NCT00654368|3182901|P1|Overall Study|Non-compliance|2
966748|NCT00654368|3182899|P3|Overall Study|Protocol deviation|1
966749|NCT00654368|3182900|P2|Overall Study|Protocol deviation|2
966750|NCT00654368|3182901|P1|Overall Study|Protocol deviation|3
966751|NCT00654368|3182899|P3|Overall Study|Ineligibility determined|0
966752|NCT00654368|3182900|P2|Overall Study|Ineligibility determined|0
966753|NCT00654368|3182901|P1|Overall Study|Ineligibility determined|6
966754|NCT00654355|3182934|P2|Overall Study|Lost to Follow-up|2
966755|NCT00654355|3182935|P1|Overall Study|Lost to Follow-up|2
966756|NCT00654186|3182966|P1|Overall Study|Withdrawal by Subject|5
966757|NCT00654095|3182991|P1|Overall Study|Did not meet inclusion criteria|1
966758|NCT00654095|3182991|P1|Overall Study|Adverse reaction did not improve (5)|4
966759|NCT00654095|3182991|P1|Overall Study|Elevated alanine aminotransferase (4)|7
966760|NCT00654095|3182991|P1|Overall Study|Withdrawal by Subject|5
966761|NCT00654095|3182991|P1|Overall Study|Adverse Event|11
966762|NCT00654095|3182991|P1|Overall Study|Elevated alanine aminotransferase (3)|1
966763|NCT00654095|3182991|P1|Overall Study|Elevated triglyceride level (2)|1
966764|NCT00654095|3182991|P1|Overall Study|Drop in low density lipoprotein (1)|2
966765|NCT00654004|3183014|P2|Overall Study|Lost to Follow-up|0
966766|NCT00654004|3183015|P1|Overall Study|Lost to Follow-up|1
966767|NCT00653939|3183031|P2|Overall Study|Not Specified|6
966768|NCT00653939|3183032|P1|Overall Study|Not Specified|2
966769|NCT00653939|3183031|P2|Overall Study|Disease Progression|3
966770|NCT00653939|3183032|P1|Overall Study|Disease Progression|2
966771|NCT00653939|3183031|P2|Overall Study|Physician Decision|0
966772|NCT00653939|3183032|P1|Overall Study|Physician Decision|4
966773|NCT00653939|3183031|P2|Overall Study|Withdrawal by Subject|3
966774|NCT00653939|3183032|P1|Overall Study|Withdrawal by Subject|3
966775|NCT00653939|3183031|P2|Overall Study|Adverse Event|3
966776|NCT00653939|3183032|P1|Overall Study|Adverse Event|1
966777|NCT00653523|3183057|P1|Overall Study|Adverse reaction did not improve (4)|1
966778|NCT00653523|3183057|P1|Overall Study|Elevated alanine aminotransferase (3)|2
966779|NCT00653523|3183057|P1|Overall Study|Withdrawal by Subject|6
966780|NCT00653523|3183057|P1|Overall Study|Adverse Event|7
966781|NCT00653523|3183057|P1|Overall Study|Elevated creatine phosphokinase (2)|1
966782|NCT00653523|3183057|P1|Overall Study|Drop in low density lipoprotein (1)|2
966783|NCT00653328|3183061|P1|Overall Study|Drug manufacturer no longing making drug|2
966784|NCT00653328|3183061|P1|Overall Study|Disease progression|10
966785|NCT00653328|3183061|P1|Overall Study|Adverse Event|2
966786|NCT00653328|3183061|P1|Overall Study|Withdrawal by Subject|1
966787|NCT00653263|3183068|P1|Overall Study|Physician Decision|1
966788|NCT00653263|3183068|P1|Overall Study|Withdrawal by Subject|1
966789|NCT00653224|3183076|P2|Overall Study|Other|4
966790|NCT00653224|3183077|P1|Overall Study|Other|2
966791|NCT00653224|3183076|P2|Overall Study|Lost to Follow-up|0
966792|NCT00653224|3183077|P1|Overall Study|Lost to Follow-up|1
966793|NCT00653224|3183076|P2|Overall Study|Loss of efficacy|0
966794|NCT00653224|3183077|P1|Overall Study|Loss of efficacy|1
966795|NCT00653224|3183076|P2|Overall Study|Lack of Efficacy|2
966796|NCT00653224|3183077|P1|Overall Study|Lack of Efficacy|1
966797|NCT00653224|3183076|P2|Overall Study|Adverse Event|1
966798|NCT00653224|3183077|P1|Overall Study|Adverse Event|2
966799|NCT00653159|3183263|P2|Overall Study|Lost to Follow-up|2
966800|NCT00653159|3183264|P1|Overall Study|Lost to Follow-up|1
966801|NCT00653159|3183263|P2|Overall Study|Adverse Event|1
966802|NCT00653159|3183264|P1|Overall Study|Adverse Event|4
966803|NCT00653068|3183291|P1|Overall Study|Ineligible|2
966804|NCT00653068|3183291|P1|Overall Study|Withdrawal by Subject|1
966805|NCT00653068|3183291|P1|Overall Study|Physician Decision|4
966806|NCT00653068|3183291|P1|Overall Study|Lack of Efficacy|34
966807|NCT00653068|3183291|P1|Overall Study|Death|9
966808|NCT00652938|3183305|P3|Overall Study|fear of blood sampling|0
966809|NCT00652938|3183306|P2|Overall Study|fear of blood sampling|1
966810|NCT00652938|3183307|P1|Overall Study|fear of blood sampling|0
966811|NCT00652938|3183305|P3|Overall Study|Lost to Follow-up|2
966812|NCT00652938|3183306|P2|Overall Study|Lost to Follow-up|0
966813|NCT00652938|3183307|P1|Overall Study|Lost to Follow-up|0
966814|NCT00652938|3183305|P3|Overall Study|Withdrawal by Subject|1
966815|NCT00652938|3183306|P2|Overall Study|Withdrawal by Subject|6
966816|NCT00652938|3183307|P1|Overall Study|Withdrawal by Subject|0
966817|NCT00652938|3183305|P3|Overall Study|Adverse Event|2
966818|NCT00652938|3183306|P2|Overall Study|Adverse Event|0
966819|NCT00652938|3183307|P1|Overall Study|Adverse Event|1
966820|NCT00652899|3183372|P1|Overall Study|Treating physician decision|1
966821|NCT00652899|3183372|P1|Overall Study|Death|1
966822|NCT00652834|3183382|P1|Overall Study|Lost to Follow-up|2
966823|NCT00652834|3183382|P1|Overall Study|Withdrawal by Subject|3
966824|NCT00652743|3183389|P3|Months 36-42|Other|8
966825|NCT00652743|3183390|P2|Months 36-42|Other|2
966826|NCT00652743|3183391|P1|Months 36-42|Other|4
966827|NCT00652743|3183389|P3|Months 36-42|Migrated/moved from study area|0
966828|NCT00652743|3183390|P2|Months 36-42|Migrated/moved from study area|0
966829|NCT00652743|3183391|P1|Months 36-42|Migrated/moved from study area|1
966830|NCT00652743|3183389|P3|Months 36-42|Lost to Follow-up|0
966831|NCT00652743|3183390|P2|Months 36-42|Lost to Follow-up|1
966832|NCT00652743|3183391|P1|Months 36-42|Lost to Follow-up|0
966833|NCT00652743|3183389|P3|Months 36-42|Withdrawal by Subject|0
966834|NCT00652743|3183390|P2|Months 36-42|Withdrawal by Subject|1
966835|NCT00652743|3183391|P1|Months 36-42|Withdrawal by Subject|1
966836|NCT00652743|3183389|P3|Months 36-42|Serious Adverse Events|1
966837|NCT00652743|3183390|P2|Months 36-42|Serious Adverse Events|1
966838|NCT00652743|3183391|P1|Months 36-42|Serious Adverse Events|0
966839|NCT00652743|3183389|P3|Months 24-30|Other|11
966840|NCT00652743|3183390|P2|Months 24-30|Other|1
966841|NCT00652743|3183391|P1|Months 24-30|Other|5
966842|NCT00652743|3183389|P3|Months 12-18|Lost to Follow-up|7
966843|NCT00652743|3183390|P2|Months 12-18|Lost to Follow-up|2
966844|NCT00652743|3183391|P1|Months 12-18|Lost to Follow-up|1
966845|NCT00652626|3183473|P7|Extension Phase|Death|1
966846|NCT00652626|3183474|P6|Extension Phase|Death|1
966847|NCT00652626|3183475|P5|Extension Phase|Death|0
966848|NCT00652626|3183476|P4|Extension Phase|Death|0
966849|NCT00652626|3183477|P3|Extension Phase|Death|0
966850|NCT00652626|3183478|P2|Extension Phase|Death|0
966851|NCT00652626|3183479|P1|Extension Phase|Death|0
966852|NCT00652626|3183473|P7|Extension Phase|Physician Decision|1
966853|NCT00652626|3183474|P6|Extension Phase|Physician Decision|1
966854|NCT00652626|3183475|P5|Extension Phase|Physician Decision|0
966855|NCT00652626|3183476|P4|Extension Phase|Physician Decision|0
966856|NCT00652626|3183477|P3|Extension Phase|Physician Decision|0
966857|NCT00652626|3183478|P2|Extension Phase|Physician Decision|0
966858|NCT00652626|3183479|P1|Extension Phase|Physician Decision|0
966859|NCT00652626|3183473|P7|Extension Phase|No Longer Receiving Clinical Benefit|0
966860|NCT00652626|3183474|P6|Extension Phase|No Longer Receiving Clinical Benefit|6
966861|NCT00652626|3183475|P5|Extension Phase|No Longer Receiving Clinical Benefit|0
966862|NCT00652626|3183476|P4|Extension Phase|No Longer Receiving Clinical Benefit|0
966863|NCT00652626|3183477|P3|Extension Phase|No Longer Receiving Clinical Benefit|0
966864|NCT00652626|3183478|P2|Extension Phase|No Longer Receiving Clinical Benefit|0
966865|NCT00652626|3183479|P1|Extension Phase|No Longer Receiving Clinical Benefit|0
966866|NCT00652626|3183473|P7|Extension Phase|Adverse Event|1
966867|NCT00652626|3183474|P6|Extension Phase|Adverse Event|2
966868|NCT00652626|3183475|P5|Extension Phase|Adverse Event|0
966869|NCT00652626|3183476|P4|Extension Phase|Adverse Event|0
966870|NCT00652626|3183477|P3|Extension Phase|Adverse Event|0
966871|NCT00652626|3183478|P2|Extension Phase|Adverse Event|0
966872|NCT00652626|3183479|P1|Extension Phase|Adverse Event|0
966873|NCT00652626|3183473|P7|Extension Phase|Withdrawal by Subject|0
966874|NCT00652626|3183474|P6|Extension Phase|Withdrawal by Subject|2
966875|NCT00652626|3183475|P5|Extension Phase|Withdrawal by Subject|0
966876|NCT00652626|3183476|P4|Extension Phase|Withdrawal by Subject|0
966877|NCT00652626|3183477|P3|Extension Phase|Withdrawal by Subject|0
966878|NCT00652626|3183478|P2|Extension Phase|Withdrawal by Subject|0
966879|NCT00652626|3183479|P1|Extension Phase|Withdrawal by Subject|0
966880|NCT00652626|3183473|P7|Initial Treatment Phase|Lost to Follow-up|0
966881|NCT00652626|3183474|P6|Initial Treatment Phase|Lost to Follow-up|0
966882|NCT00652626|3183475|P5|Initial Treatment Phase|Lost to Follow-up|1
966883|NCT00652626|3183476|P4|Initial Treatment Phase|Lost to Follow-up|0
966884|NCT00652626|3183477|P3|Initial Treatment Phase|Lost to Follow-up|0
966885|NCT00652626|3183478|P2|Initial Treatment Phase|Lost to Follow-up|0
966886|NCT00652626|3183479|P1|Initial Treatment Phase|Lost to Follow-up|0
966887|NCT00652626|3183473|P7|Initial Treatment Phase|Sponsor Request|0
966888|NCT00652626|3183474|P6|Initial Treatment Phase|Sponsor Request|0
966889|NCT00652626|3183475|P5|Initial Treatment Phase|Sponsor Request|0
966890|NCT00652626|3183476|P4|Initial Treatment Phase|Sponsor Request|0
966891|NCT00652626|3183477|P3|Initial Treatment Phase|Sponsor Request|1
966892|NCT00652626|3183478|P2|Initial Treatment Phase|Sponsor Request|0
966893|NCT00652626|3183479|P1|Initial Treatment Phase|Sponsor Request|0
966894|NCT00652626|3183473|P7|Initial Treatment Phase|Physician Decision|0
966895|NCT00652626|3183474|P6|Initial Treatment Phase|Physician Decision|0
966896|NCT00652626|3183475|P5|Initial Treatment Phase|Physician Decision|1
966897|NCT00652626|3183476|P4|Initial Treatment Phase|Physician Decision|0
966898|NCT00652626|3183477|P3|Initial Treatment Phase|Physician Decision|0
966899|NCT00652626|3183478|P2|Initial Treatment Phase|Physician Decision|0
966900|NCT00652626|3183479|P1|Initial Treatment Phase|Physician Decision|0
966901|NCT00652626|3183473|P7|Initial Treatment Phase|Protocol Violation|0
966902|NCT00652626|3183474|P6|Initial Treatment Phase|Protocol Violation|0
966903|NCT00652626|3183475|P5|Initial Treatment Phase|Protocol Violation|0
966904|NCT00652626|3183476|P4|Initial Treatment Phase|Protocol Violation|1
966905|NCT00652626|3183477|P3|Initial Treatment Phase|Protocol Violation|0
966906|NCT00652626|3183478|P2|Initial Treatment Phase|Protocol Violation|0
966907|NCT00652626|3183479|P1|Initial Treatment Phase|Protocol Violation|0
966908|NCT00652626|3183473|P7|Initial Treatment Phase|Adverse Event|0
966909|NCT00652626|3183474|P6|Initial Treatment Phase|Adverse Event|0
966910|NCT00652626|3183475|P5|Initial Treatment Phase|Adverse Event|1
966911|NCT00652626|3183476|P4|Initial Treatment Phase|Adverse Event|0
966912|NCT00652626|3183477|P3|Initial Treatment Phase|Adverse Event|0
966913|NCT00652626|3183478|P2|Initial Treatment Phase|Adverse Event|0
966914|NCT00652626|3183479|P1|Initial Treatment Phase|Adverse Event|0
966915|NCT00652366|3183548|P5|Overall Study|Not specified|0
966916|NCT00652366|3183549|P4|Overall Study|Not specified|4
966917|NCT00652366|3183550|P3|Overall Study|Not specified|3
966918|NCT00652366|3183551|P2|Overall Study|Not specified|2
966919|NCT00652366|3183552|P1|Overall Study|Not specified|5
966920|NCT00652366|3183548|P5|Overall Study|Refused treatment|5
966921|NCT00652366|3183549|P4|Overall Study|Refused treatment|17
966922|NCT00652366|3183550|P3|Overall Study|Refused treatment|6
966923|NCT00652366|3183551|P2|Overall Study|Refused treatment|7
966924|NCT00652366|3183552|P1|Overall Study|Refused treatment|3
966925|NCT00652366|3183548|P5|Overall Study|Protocol Violation|0
966926|NCT00652366|3183549|P4|Overall Study|Protocol Violation|0
966927|NCT00652366|3183550|P3|Overall Study|Protocol Violation|0
966928|NCT00652366|3183551|P2|Overall Study|Protocol Violation|0
966929|NCT00652366|3183552|P1|Overall Study|Protocol Violation|1
966930|NCT00652366|3183548|P5|Overall Study|Violation of Selection Criteria|0
966931|NCT00652366|3183549|P4|Overall Study|Violation of Selection Criteria|0
966932|NCT00652366|3183550|P3|Overall Study|Violation of Selection Criteria|1
966933|NCT00652366|3183551|P2|Overall Study|Violation of Selection Criteria|0
966934|NCT00652366|3183552|P1|Overall Study|Violation of Selection Criteria|0
966935|NCT00652366|3183548|P5|Overall Study|Lack of Efficacy|13
966936|NCT00652366|3183549|P4|Overall Study|Lack of Efficacy|133
966937|NCT00652366|3183550|P3|Overall Study|Lack of Efficacy|53
966938|NCT00652366|3183551|P2|Overall Study|Lack of Efficacy|58
966939|NCT00652366|3183552|P1|Overall Study|Lack of Efficacy|84
966940|NCT00652366|3183548|P5|Overall Study|Death|5
966941|NCT00652366|3183549|P4|Overall Study|Death|8
966942|NCT00652366|3183550|P3|Overall Study|Death|1
966943|NCT00652366|3183551|P2|Overall Study|Death|4
966944|NCT00652366|3183552|P1|Overall Study|Death|5
966945|NCT00652366|3183548|P5|Overall Study|Adverse Event|13
966946|NCT00652366|3183549|P4|Overall Study|Adverse Event|17
966947|NCT00652366|3183550|P3|Overall Study|Adverse Event|7
966948|NCT00652366|3183551|P2|Overall Study|Adverse Event|4
966949|NCT00652366|3183552|P1|Overall Study|Adverse Event|8
966950|NCT00652340|3183587|P2|Overall Study|Had not progressed.|3
966951|NCT00652340|3183588|P1|Overall Study|Had not progressed.|4
966952|NCT00652327|3183598|P2|Overall Study|Lost to Follow-up|3
966953|NCT00652327|3183599|P1|Overall Study|Lost to Follow-up|0
966954|NCT00652327|3183598|P2|Overall Study|Adverse Event|2
966955|NCT00652327|3183599|P1|Overall Study|Adverse Event|0
966956|NCT00652093|3183641|P6|Overall Study|Physician Decision|0
966957|NCT00652093|3183642|P5|Overall Study|Physician Decision|1
966958|NCT00652093|3183643|P4|Overall Study|Physician Decision|0
966959|NCT00652093|3183644|P3|Overall Study|Physician Decision|0
966960|NCT00652093|3183645|P2|Overall Study|Physician Decision|0
966961|NCT00652093|3183646|P1|Overall Study|Physician Decision|0
966962|NCT00652093|3183641|P6|Overall Study|Withdrawal by Subject|0
966963|NCT00652093|3183642|P5|Overall Study|Withdrawal by Subject|1
966964|NCT00652093|3183643|P4|Overall Study|Withdrawal by Subject|0
966965|NCT00652093|3183644|P3|Overall Study|Withdrawal by Subject|1
966966|NCT00652093|3183645|P2|Overall Study|Withdrawal by Subject|0
966967|NCT00652093|3183646|P1|Overall Study|Withdrawal by Subject|0
966968|NCT00652028|3183730|P4|Overall Study|Physician Decision|0
966969|NCT00652028|3183731|P3|Overall Study|Physician Decision|1
966970|NCT00652028|3183732|P2|Overall Study|Physician Decision|0
966971|NCT00652028|3183733|P1|Overall Study|Physician Decision|0
966972|NCT00652028|3183730|P4|Overall Study|No Longer Meets Entry Criteria|0
966973|NCT00652028|3183731|P3|Overall Study|No Longer Meets Entry Criteria|0
966974|NCT00652028|3183732|P2|Overall Study|No Longer Meets Entry Criteria|1
966975|NCT00652028|3183733|P1|Overall Study|No Longer Meets Entry Criteria|0
966976|NCT00652028|3183730|P4|Overall Study|Adverse Event|0
966977|NCT00652028|3183731|P3|Overall Study|Adverse Event|0
966978|NCT00652028|3183732|P2|Overall Study|Adverse Event|0
966979|NCT00652028|3183733|P1|Overall Study|Adverse Event|1
966980|NCT00651924|3183777|P2|Overall Study|Withdrawal by Subject|5
966981|NCT00651924|3183778|P1|Overall Study|Withdrawal by Subject|0
966982|NCT00651924|3183777|P2|Overall Study|Withdrawal by PI|2
966983|NCT00651924|3183778|P1|Overall Study|Withdrawal by PI|0
966984|NCT00651820|3183784|P1|Overall Study|Lost to Follow-up|2
966985|NCT00651755|3183816|P2|Cycle 2 (Second 21 Days)|Not Evaluable|1
966986|NCT00651755|3183817|P1|Cycle 2 (Second 21 Days)|Not Evaluable|0
966987|NCT00651755|3183816|P2|Cycle 1 (First 21 Days)|Withdrawal by Subject|0
966988|NCT00651755|3183817|P1|Cycle 1 (First 21 Days)|Withdrawal by Subject|1
966989|NCT00651313|3183862|P2|Overall Study|Adminstrative Discontinuation|3
966990|NCT00651313|3183863|P1|Overall Study|Adminstrative Discontinuation|2
966991|NCT00651313|3183862|P2|Overall Study|Lost to Follow-up|1
966992|NCT00651313|3183863|P1|Overall Study|Lost to Follow-up|1
966993|NCT00651313|3183862|P2|Overall Study|Withdrawal by Subject|1
966994|NCT00651313|3183863|P1|Overall Study|Withdrawal by Subject|3
966995|NCT00651313|3183862|P2|Overall Study|Adverse Event|1
966996|NCT00651313|3183863|P1|Overall Study|Adverse Event|0
966997|NCT00651261|3183871|P2|Overall Study|Never treated|3
966998|NCT00651261|3183872|P1|Overall Study|Never treated|5
966999|NCT00651261|3183871|P2|Overall Study|Other disease or participant decisions|23
967000|NCT00651261|3183872|P1|Overall Study|Other disease or participant decisions|23
967001|NCT00651261|3183871|P2|Overall Study|Alternative therapy|107
967002|NCT00651261|3183872|P1|Overall Study|Alternative therapy|109
967003|NCT00651261|3183871|P2|Overall Study|Disease progression|58
967004|NCT00651261|3183872|P1|Overall Study|Disease progression|58
967005|NCT00651261|3183871|P2|Overall Study|Induction failure|35
967006|NCT00651261|3183872|P1|Overall Study|Induction failure|24
967007|NCT00651261|3183871|P2|Overall Study|Withdrawal by Subject|40
967008|NCT00651261|3183872|P1|Overall Study|Withdrawal by Subject|22
967009|NCT00651261|3183871|P2|Overall Study|Death|18
967010|NCT00651261|3183872|P1|Overall Study|Death|18
967011|NCT00651261|3183871|P2|Overall Study|Adverse Event|22
967012|NCT00651261|3183872|P1|Overall Study|Adverse Event|32
967013|NCT00651183|3183888|P2|Overall Study|missing|0
967014|NCT00651183|3183889|P1|Overall Study|missing|1
967015|NCT00651183|3183888|P2|Overall Study|Other reasons|2
967016|NCT00651183|3183889|P1|Overall Study|Other reasons|4
967017|NCT00651183|3183888|P2|Overall Study|Lost to Follow-up|1
967018|NCT00651183|3183889|P1|Overall Study|Lost to Follow-up|3
967019|NCT00651183|3183888|P2|Overall Study|Withdrawal by Subject|3
967020|NCT00651183|3183889|P1|Overall Study|Withdrawal by Subject|6
967021|NCT00651183|3183888|P2|Overall Study|Tolerability insufficient +Patients wish|1
967022|NCT00651183|3183889|P1|Overall Study|Tolerability insufficient +Patients wish|0
967023|NCT00651183|3183888|P2|Overall Study|Tolerability insufficient|2
967024|NCT00651183|3183889|P1|Overall Study|Tolerability insufficient|5
967025|NCT00651183|3183888|P2|Overall Study|Efficacy insufficient + patients wish|1
967026|NCT00651183|3183889|P1|Overall Study|Efficacy insufficient + patients wish|0
967027|NCT00651183|3183888|P2|Overall Study|Lack of Efficacy|0
967028|NCT00651183|3183889|P1|Overall Study|Lack of Efficacy|1
967029|NCT00651157|3183901|P1|Overall Study|Protocol Violation|1
967030|NCT00651157|3183901|P1|Overall Study|Death|1
967031|NCT00651118|3183911|P4|Overall Study|Withdrawal by Subject|1
967032|NCT00651118|3183912|P3|Overall Study|Withdrawal by Subject|1
967033|NCT00651118|3183913|P2|Overall Study|Withdrawal by Subject|1
967034|NCT00651118|3183914|P1|Overall Study|Withdrawal by Subject|0
967035|NCT00651118|3183911|P4|Overall Study|administrative|1
967036|NCT00651118|3183912|P3|Overall Study|administrative|2
967037|NCT00651118|3183913|P2|Overall Study|administrative|4
967038|NCT00651118|3183914|P1|Overall Study|administrative|1
967039|NCT00651118|3183911|P4|Overall Study|Lost to Follow-up|2
967040|NCT00651118|3183912|P3|Overall Study|Lost to Follow-up|1
967041|NCT00651118|3183913|P2|Overall Study|Lost to Follow-up|0
967042|NCT00651118|3183914|P1|Overall Study|Lost to Follow-up|2
967043|NCT00651118|3183911|P4|Overall Study|Protocol Violation|2
967044|NCT00651118|3183912|P3|Overall Study|Protocol Violation|6
967045|NCT00651118|3183913|P2|Overall Study|Protocol Violation|2
967046|NCT00651118|3183914|P1|Overall Study|Protocol Violation|2
967047|NCT00651118|3183911|P4|Overall Study|Adverse Event|1
967048|NCT00651118|3183912|P3|Overall Study|Adverse Event|1
967049|NCT00651118|3183913|P2|Overall Study|Adverse Event|0
967050|NCT00651118|3183914|P1|Overall Study|Adverse Event|4
967051|NCT00650845|3183977|P2|Overall Study|Protocol Violation|13
967052|NCT00650845|3183978|P1|Overall Study|Protocol Violation|0
967053|NCT00650845|3183977|P2|Overall Study|Withdrawal by Subject|0
967054|NCT00650845|3183978|P1|Overall Study|Withdrawal by Subject|5
967055|NCT00650806|3183998|P4|Overall Study|Not specified|0
967056|NCT00650806|3183999|P3|Overall Study|Not specified|2
967057|NCT00650806|3184000|P2|Overall Study|Not specified|1
967058|NCT00650806|3184001|P1|Overall Study|Not specified|1
967059|NCT00650806|3183998|P4|Overall Study|Study terminated by sponsor|4
967060|NCT00650806|3183999|P3|Overall Study|Study terminated by sponsor|5
967061|NCT00650806|3184000|P2|Overall Study|Study terminated by sponsor|3
967062|NCT00650806|3184001|P1|Overall Study|Study terminated by sponsor|2
967063|NCT00650806|3183998|P4|Overall Study|Noncompliance with study drug regimen|0
967064|NCT00650806|3183999|P3|Overall Study|Noncompliance with study drug regimen|0
967065|NCT00650806|3184000|P2|Overall Study|Noncompliance with study drug regimen|1
967066|NCT00650806|3184001|P1|Overall Study|Noncompliance with study drug regimen|1
967067|NCT00650806|3183998|P4|Overall Study|Withdrawal by Subject|6
967068|NCT00650806|3183999|P3|Overall Study|Withdrawal by Subject|8
967069|NCT00650806|3184000|P2|Overall Study|Withdrawal by Subject|5
967070|NCT00650806|3184001|P1|Overall Study|Withdrawal by Subject|7
967071|NCT00650806|3183998|P4|Overall Study|Pregnancy|1
967072|NCT00650806|3183999|P3|Overall Study|Pregnancy|0
967073|NCT00650806|3184000|P2|Overall Study|Pregnancy|0
967074|NCT00650806|3184001|P1|Overall Study|Pregnancy|0
967075|NCT00650806|3183998|P4|Overall Study|Protocol Violation|1
967076|NCT00650806|3183999|P3|Overall Study|Protocol Violation|0
967077|NCT00650806|3184000|P2|Overall Study|Protocol Violation|0
967078|NCT00650806|3184001|P1|Overall Study|Protocol Violation|0
967079|NCT00650806|3183998|P4|Overall Study|Lost to Follow-up|10
967080|NCT00650806|3183999|P3|Overall Study|Lost to Follow-up|11
967081|NCT00650806|3184000|P2|Overall Study|Lost to Follow-up|6
967082|NCT00650806|3184001|P1|Overall Study|Lost to Follow-up|7
967083|NCT00650806|3183998|P4|Overall Study|Adverse Event|4
967084|NCT00650806|3183999|P3|Overall Study|Adverse Event|3
967085|NCT00650806|3184000|P2|Overall Study|Adverse Event|5
967086|NCT00650806|3184001|P1|Overall Study|Adverse Event|0
967087|NCT00650767|3184043|P4|Overall Study|Other|0
967088|NCT00650767|3184044|P3|Overall Study|Other|0
967089|NCT00650767|3184045|P2|Overall Study|Other|1
967090|NCT00650767|3184046|P1|Overall Study|Other|1
967091|NCT00650767|3184043|P4|Overall Study|Lost to Follow-up|0
967092|NCT00650767|3184044|P3|Overall Study|Lost to Follow-up|1
967093|NCT00650767|3184045|P2|Overall Study|Lost to Follow-up|1
967094|NCT00650767|3184046|P1|Overall Study|Lost to Follow-up|1
967095|NCT00650767|3184043|P4|Overall Study|Withdrawal by Subject|3
967096|NCT00650767|3184044|P3|Overall Study|Withdrawal by Subject|3
967097|NCT00650767|3184045|P2|Overall Study|Withdrawal by Subject|4
967098|NCT00650767|3184046|P1|Overall Study|Withdrawal by Subject|2
967099|NCT00650767|3184043|P4|Overall Study|Death|0
967100|NCT00650767|3184044|P3|Overall Study|Death|0
967101|NCT00650767|3184045|P2|Overall Study|Death|0
967102|NCT00650767|3184046|P1|Overall Study|Death|1
967103|NCT00650767|3184043|P4|Overall Study|Adverse Event|8
967104|NCT00650767|3184044|P3|Overall Study|Adverse Event|10
967105|NCT00650767|3184045|P2|Overall Study|Adverse Event|3
967106|NCT00650767|3184046|P1|Overall Study|Adverse Event|0
967107|NCT00650585|3184550|P2|Overall Study|Excluded/ruled ineligible|129
967108|NCT00650585|3184551|P1|Overall Study|Excluded/ruled ineligible|357
967109|NCT00650585|3184550|P2|Overall Study|No parental consent|866
967110|NCT00650585|3184551|P1|Overall Study|No parental consent|935
967111|NCT00650585|3184550|P2|Overall Study|Lost to Follow-up|482
967112|NCT00650585|3184551|P1|Overall Study|Lost to Follow-up|505
967113|NCT00650104|3184595|P1|Overall Study|Sponsor Terminated Dosing|1
967114|NCT00650104|3184595|P1|Overall Study|Non-compliance|2
967115|NCT00650104|3184595|P1|Overall Study|Lost to Follow-up|1
967116|NCT00650104|3184595|P1|Overall Study|Physician Decision|7
967117|NCT00650104|3184595|P1|Overall Study|Withdrawal by Subject|11
967118|NCT00650104|3184595|P1|Overall Study|Death|2
967119|NCT00650104|3184595|P1|Overall Study|Adverse Event|17
967120|NCT00650091|3184610|P3|Amended Study Design|Not specified|0
967121|NCT00650091|3184611|P2|Amended Study Design|Not specified|3
967122|NCT00650091|3184612|P1|Amended Study Design|Not specified|1
967123|NCT00650091|3184610|P3|Amended Study Design|Lung transplantation|0
967124|NCT00650091|3184611|P2|Amended Study Design|Lung transplantation|2
967125|NCT00650091|3184612|P1|Amended Study Design|Lung transplantation|4
967126|NCT00650091|3184610|P3|Amended Study Design|Adverse Event|0
967127|NCT00650091|3184611|P2|Amended Study Design|Adverse Event|4
967128|NCT00650091|3184612|P1|Amended Study Design|Adverse Event|1
967129|NCT00650091|3184610|P3|Amended Study Design|Physician Decision|0
967130|NCT00650091|3184611|P2|Amended Study Design|Physician Decision|0
967131|NCT00650091|3184612|P1|Amended Study Design|Physician Decision|5
967132|NCT00650091|3184610|P3|Amended Study Design|Withdrawal by Subject|0
967133|NCT00650091|3184611|P2|Amended Study Design|Withdrawal by Subject|11
967134|NCT00650091|3184612|P1|Amended Study Design|Withdrawal by Subject|12
967135|NCT00649428|3184655|P2|Overall Study|Physician Decision|1
967136|NCT00649428|3184656|P1|Overall Study|Physician Decision|0
967137|NCT00649428|3184655|P2|Overall Study|Protocol Violation|2
967138|NCT00649428|3184656|P1|Overall Study|Protocol Violation|6
967139|NCT00649428|3184655|P2|Overall Study|Insufficient manufacturing yield|1
967140|NCT00649428|3184656|P1|Overall Study|Insufficient manufacturing yield|5
967141|NCT00649428|3184655|P2|Overall Study|Lost to Follow-up|3
967142|NCT00649428|3184656|P1|Overall Study|Lost to Follow-up|1
967143|NCT00649428|3184655|P2|Overall Study|Withdrawal by Subject|6
967144|NCT00649428|3184656|P1|Overall Study|Withdrawal by Subject|6
967145|NCT00649428|3184655|P2|Overall Study|Adverse Event|2
967146|NCT00649428|3184656|P1|Overall Study|Adverse Event|2
967147|NCT00649389|3184672|P4|Overall Study|Other|6
967148|NCT00649389|3184673|P3|Overall Study|Other|1
967149|NCT00649389|3184674|P2|Overall Study|Other|9
967150|NCT00649389|3184675|P1|Overall Study|Other|3
967151|NCT00649389|3184672|P4|Overall Study|Withdrawal by Subject|23
967152|NCT00649389|3184673|P3|Overall Study|Withdrawal by Subject|19
967153|NCT00649389|3184674|P2|Overall Study|Withdrawal by Subject|21
967154|NCT00649389|3184675|P1|Overall Study|Withdrawal by Subject|20
967155|NCT00649389|3184672|P4|Overall Study|Protocol Violation|8
967156|NCT00649389|3184673|P3|Overall Study|Protocol Violation|9
967157|NCT00649389|3184674|P2|Overall Study|Protocol Violation|13
967158|NCT00649389|3184675|P1|Overall Study|Protocol Violation|11
967159|NCT00649389|3184672|P4|Overall Study|Lost to Follow-up|26
967160|NCT00649389|3184673|P3|Overall Study|Lost to Follow-up|21
967161|NCT00649389|3184674|P2|Overall Study|Lost to Follow-up|17
967162|NCT00649389|3184675|P1|Overall Study|Lost to Follow-up|15
967163|NCT00649389|3184672|P4|Overall Study|Adverse Event|48
967164|NCT00649389|3184673|P3|Overall Study|Adverse Event|38
967165|NCT00649389|3184674|P2|Overall Study|Adverse Event|46
967166|NCT00649389|3184675|P1|Overall Study|Adverse Event|22
967167|NCT00649220|3184697|P1|Overall Study|Withdrawal by Subject|1
967168|NCT00649220|3184697|P1|Overall Study|Adverse Event|2
967169|NCT00648895|3184718|P2|Overall Study|Lack of Efficacy|1
967170|NCT00648895|3184719|P1|Overall Study|Lack of Efficacy|0
967171|NCT00648167|3184725|P1|Overall Study|unable to swallow tablets|1
967172|NCT00648167|3184725|P1|Overall Study|Adverse Event|6
967173|NCT00648037|3184745|P1|Overall Study|Other|1
967174|NCT00648037|3184745|P1|Overall Study|Relapse|2
967175|NCT00648037|3184745|P1|Overall Study|Adverse Event|11
967176|NCT00648037|3184745|P1|Overall Study|Withdrawal by Subject|1
967177|NCT00648037|3184745|P1|Overall Study|Not Treated|1
967178|NCT00647699|3184764|P2|Overall Study|Withdrawal by Subject|8
967179|NCT00647699|3184765|P1|Overall Study|Withdrawal by Subject|3
967180|NCT00647699|3184764|P2|Overall Study|Lost to Follow-up|4
967181|NCT00647699|3184765|P1|Overall Study|Lost to Follow-up|5
967182|NCT00647556|3184773|P2|Overall Study|Surgery for pre-existing neck pain|0
967183|NCT00647556|3184774|P1|Overall Study|Surgery for pre-existing neck pain|1
967184|NCT00647556|3184773|P2|Overall Study|Withdrawal by Subject|0
967185|NCT00647556|3184774|P1|Overall Study|Withdrawal by Subject|1
967186|NCT00647556|3184773|P2|Overall Study|Protocol Violation|1
967187|NCT00647556|3184774|P1|Overall Study|Protocol Violation|0
967188|NCT00647556|3184773|P2|Overall Study|Lost to Follow-up|0
967189|NCT00647556|3184774|P1|Overall Study|Lost to Follow-up|1
967190|NCT00647556|3184773|P2|Overall Study|Adverse Event|1
967191|NCT00647556|3184774|P1|Overall Study|Adverse Event|0
967192|NCT00647270|3184804|P3|Period 2, Placebo Switched to Adalimumab|Other|0
967193|NCT00647270|3184805|P2|Period 2, Placebo Switched to Adalimumab|Other|6
967194|NCT00647270|3184806|P1|Period 2, Placebo Switched to Adalimumab|Other|2
967195|NCT00647270|3184804|P3|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4
967196|NCT00647270|3184805|P2|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
967197|NCT00647270|3184806|P1|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
967198|NCT00647270|3184804|P3|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
967199|NCT00647270|3184805|P2|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
967200|NCT00647270|3184806|P1|Period 2, Placebo Switched to Adalimumab|Adverse Event|1
967201|NCT00647270|3184804|P3|Period 1, Placebo-control (12 Weeks)|Other|8
967202|NCT00647270|3184805|P2|Period 1, Placebo-control (12 Weeks)|Other|4
967203|NCT00647270|3184806|P1|Period 1, Placebo-control (12 Weeks)|Other|4
967204|NCT00647270|3184804|P3|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7
967205|NCT00647270|3184805|P2|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1
967206|NCT00647270|3184806|P1|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2
967207|NCT00647270|3184804|P3|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
967208|NCT00647270|3184805|P2|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
967209|NCT00647270|3184806|P1|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0
967210|NCT00647270|3184804|P3|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
967211|NCT00647270|3184805|P2|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
967212|NCT00647270|3184806|P1|Period 1, Placebo-control (12 Weeks)|Adverse Event|2
967213|NCT00646958|3184832|P3|Overall Study|Did not receive study drug|2
967214|NCT00646958|3184833|P2|Overall Study|Did not receive study drug|0
967215|NCT00646958|3184834|P1|Overall Study|Did not receive study drug|2
967216|NCT00646958|3184832|P3|Overall Study|Withdrawal by Subject|0
967217|NCT00646958|3184833|P2|Overall Study|Withdrawal by Subject|2
967218|NCT00646958|3184834|P1|Overall Study|Withdrawal by Subject|1
967219|NCT00646958|3184832|P3|Overall Study|Abnormal screening lab tests|0
967220|NCT00646958|3184833|P2|Overall Study|Abnormal screening lab tests|1
967221|NCT00646958|3184834|P1|Overall Study|Abnormal screening lab tests|1
967222|NCT00646958|3184832|P3|Overall Study|Protocol Violation|0
967223|NCT00646958|3184833|P2|Overall Study|Protocol Violation|1
967224|NCT00646958|3184834|P1|Overall Study|Protocol Violation|1
967225|NCT00646958|3184832|P3|Overall Study|Lost to Follow-up|7
967226|NCT00646958|3184833|P2|Overall Study|Lost to Follow-up|5
967227|NCT00646958|3184834|P1|Overall Study|Lost to Follow-up|1
967228|NCT00646958|3184832|P3|Overall Study|Adverse Event|0
967229|NCT00646958|3184833|P2|Overall Study|Adverse Event|0
967230|NCT00646958|3184834|P1|Overall Study|Adverse Event|4
967231|NCT00646958|3184832|P3|Overall Study|Lack of Efficacy|0
967232|NCT00646958|3184833|P2|Overall Study|Lack of Efficacy|0
967233|NCT00646958|3184834|P1|Overall Study|Lack of Efficacy|1
967234|NCT00646776|3184847|P2|Overall Study|Investigator discretion|4
967235|NCT00646776|3184848|P1|Overall Study|Investigator discretion|0
967236|NCT00646776|3184847|P2|Overall Study|Adverse Event|9
967237|NCT00646776|3184848|P1|Overall Study|Adverse Event|1
967238|NCT00646399|3184946|P2|Overall Study|Other Reason|11
967239|NCT00646399|3184947|P1|Overall Study|Other Reason|11
967240|NCT00646399|3184946|P2|Overall Study|Withdrawal by Subject|10
967241|NCT00646399|3184947|P1|Overall Study|Withdrawal by Subject|9
967242|NCT00646399|3184946|P2|Overall Study|Death|53
967243|NCT00646399|3184947|P1|Overall Study|Death|63
967244|NCT00646282|3184955|P2|Overall Study|Protocol terminated|4
967245|NCT00646282|3184956|P1|Overall Study|Protocol terminated|4
967246|NCT00645944|3184979|P2|Received Medication|Protocol Violation|1
967247|NCT00645944|3184980|P1|Received Medication|Protocol Violation|2
967248|NCT00645944|3184979|P2|Received Medication|Lost to Follow-up|0
967249|NCT00645944|3184980|P1|Received Medication|Lost to Follow-up|1
967250|NCT00645944|3184979|P2|Received Medication|Withdrawal by Subject|1
967251|NCT00645944|3184980|P1|Received Medication|Withdrawal by Subject|1
967252|NCT00645944|3184979|P2|Received Medication|Adverse Event|1
967253|NCT00645944|3184980|P1|Received Medication|Adverse Event|2
967254|NCT00645944|3184979|P2|Randomized|Withdrawal by Subject|2
967255|NCT00645944|3184980|P1|Randomized|Withdrawal by Subject|1
967256|NCT00645853|3184988|P2|Overall Study|recall of ICF, planned operation, death|4
967257|NCT00645853|3184989|P1|Overall Study|recall of ICF, planned operation, death|7
967258|NCT00645853|3184988|P2|Overall Study|Discontinuation criteria|2
967259|NCT00645853|3184989|P1|Overall Study|Discontinuation criteria|2
967260|NCT00645853|3184988|P2|Overall Study|Protocol Violation|2
967261|NCT00645853|3184989|P1|Overall Study|Protocol Violation|0
967262|NCT00645853|3184988|P2|Overall Study|Withdrawal by Subject|2
967263|NCT00645853|3184989|P1|Overall Study|Withdrawal by Subject|5
967264|NCT00645853|3184988|P2|Overall Study|AZ study closure in Hungary|40
967265|NCT00645853|3184989|P1|Overall Study|AZ study closure in Hungary|60
967266|NCT00645853|3184988|P2|Overall Study|Adverse Event|7
967267|NCT00645853|3184989|P1|Overall Study|Adverse Event|18
967268|NCT00645788|3185020|P4|Overall Study|Pulmonary exacerbation|9
967269|NCT00645788|3185021|P3|Overall Study|Pulmonary exacerbation|11
967270|NCT00645788|3185022|P2|Overall Study|Pulmonary exacerbation|16
967271|NCT00645788|3185023|P1|Overall Study|Pulmonary exacerbation|13
967272|NCT00645788|3185020|P4|Overall Study|Withdrawal by Subject|2
967273|NCT00645788|3185021|P3|Overall Study|Withdrawal by Subject|0
967274|NCT00645788|3185022|P2|Overall Study|Withdrawal by Subject|1
967275|NCT00645788|3185023|P1|Overall Study|Withdrawal by Subject|0
967276|NCT00645788|3185020|P4|Overall Study|Protocol Violation|0
967277|NCT00645788|3185021|P3|Overall Study|Protocol Violation|2
967278|NCT00645788|3185022|P2|Overall Study|Protocol Violation|0
967279|NCT00645788|3185023|P1|Overall Study|Protocol Violation|1
967280|NCT00645788|3185020|P4|Overall Study|Lost to Follow-up|0
967281|NCT00645788|3185021|P3|Overall Study|Lost to Follow-up|0
967282|NCT00645788|3185022|P2|Overall Study|Lost to Follow-up|0
967283|NCT00645788|3185023|P1|Overall Study|Lost to Follow-up|1
967284|NCT00645788|3185020|P4|Overall Study|Adverse Event|3
967285|NCT00645788|3185021|P3|Overall Study|Adverse Event|5
967286|NCT00645788|3185022|P2|Overall Study|Adverse Event|9
967287|NCT00645788|3185023|P1|Overall Study|Adverse Event|4
967288|NCT00645788|3185020|P4|Overall Study|Did not receive study drug|0
967289|NCT00645788|3185021|P3|Overall Study|Did not receive study drug|0
967290|NCT00645788|3185022|P2|Overall Study|Did not receive study drug|1
967291|NCT00645788|3185023|P1|Overall Study|Did not receive study drug|1
967292|NCT00645671|3185081|P2|Overall Study|Physician Decision|1
967293|NCT00645671|3185082|P1|Overall Study|Physician Decision|0
967294|NCT00645671|3185081|P2|Overall Study|Adverse Event|1
967295|NCT00645671|3185082|P1|Overall Study|Adverse Event|0
967296|NCT00645671|3185081|P2|Overall Study|Withdrawal by Subject|4
967297|NCT00645671|3185082|P1|Overall Study|Withdrawal by Subject|0
967298|NCT00645671|3185081|P2|Overall Study|Protocol Violation|0
967299|NCT00645671|3185082|P1|Overall Study|Protocol Violation|1
967300|NCT00645593|3185096|P2|Overall Study|Later found to be ineligible|0
967301|NCT00645593|3185097|P1|Overall Study|Later found to be ineligible|1
967302|NCT00645567|3185109|P1|Overall Study|Adverse Event|1
967303|NCT00645528|3185117|P1|Overall Study|Did not show up for Visit 2|7
967304|NCT00645411|3185130|P4|Overall Study|Unable to classify|4
967305|NCT00645411|3185131|P3|Overall Study|Unable to classify|3
967306|NCT00645411|3185132|P2|Overall Study|Unable to classify|0
967307|NCT00645411|3185133|P1|Overall Study|Unable to classify|0
967308|NCT00645411|3185130|P4|Overall Study|Inappropriate enrollment|1
967309|NCT00645411|3185131|P3|Overall Study|Inappropriate enrollment|4
967310|NCT00645411|3185132|P2|Overall Study|Inappropriate enrollment|0
967311|NCT00645411|3185133|P1|Overall Study|Inappropriate enrollment|0
967312|NCT00645411|3185130|P4|Overall Study|Protocol Violation|0
967313|NCT00645411|3185131|P3|Overall Study|Protocol Violation|1
967314|NCT00645411|3185132|P2|Overall Study|Protocol Violation|0
967315|NCT00645411|3185133|P1|Overall Study|Protocol Violation|1
967316|NCT00645411|3185130|P4|Overall Study|Lost to Follow-up|75
967317|NCT00645411|3185131|P3|Overall Study|Lost to Follow-up|124
967318|NCT00645411|3185132|P2|Overall Study|Lost to Follow-up|5
967319|NCT00645411|3185133|P1|Overall Study|Lost to Follow-up|10
967320|NCT00645411|3185130|P4|Overall Study|Withdrawal by Subject|21
967321|NCT00645411|3185131|P3|Overall Study|Withdrawal by Subject|19
967322|NCT00645411|3185132|P2|Overall Study|Withdrawal by Subject|1
967323|NCT00645411|3185133|P1|Overall Study|Withdrawal by Subject|2
967324|NCT00645411|3185130|P4|Overall Study|Adverse Event|2
967325|NCT00645411|3185131|P3|Overall Study|Adverse Event|0
967326|NCT00645411|3185132|P2|Overall Study|Adverse Event|0
967327|NCT00645411|3185133|P1|Overall Study|Adverse Event|0
967328|NCT00645164|3185175|P1|Overall Study|Protocol Violation|1
967329|NCT00645164|3185175|P1|Overall Study|Withdrawal by Subject|4
967330|NCT00645164|3185175|P1|Overall Study|Lost to Follow-up|2
967331|NCT00645099|3185181|P2|Overall Study|Other|5
967332|NCT00645099|3185182|P1|Overall Study|Other|9
967333|NCT00645099|3185181|P2|Overall Study|Adverse Event|5
967334|NCT00645099|3185182|P1|Overall Study|Adverse Event|11
967335|NCT00645099|3185181|P2|Overall Study|Lost to Follow-up|4
967336|NCT00645099|3185182|P1|Overall Study|Lost to Follow-up|6
967337|NCT00645099|3185181|P2|Overall Study|Withdrawal by Subject|22
967338|NCT00645099|3185182|P1|Overall Study|Withdrawal by Subject|30
967339|NCT00645099|3185181|P2|Overall Study|Lack of Efficacy|6
967340|NCT00645099|3185182|P1|Overall Study|Lack of Efficacy|15
967341|NCT00644995|3185251|P2|Overall Study|Refused|0
967342|NCT00644995|3185252|P1|Overall Study|Refused|1
967343|NCT00644995|3185251|P2|Overall Study|Lost to Follow-up|4
967344|NCT00644995|3185252|P1|Overall Study|Lost to Follow-up|1
967345|NCT00644969|3185272|P2|Post Treatment Phase|Other|0
967346|NCT00644969|3185273|P1|Post Treatment Phase|Other|1
967347|NCT00644969|3185272|P2|Post Treatment Phase|Lost to Follow-up|1
967348|NCT00644969|3185273|P1|Post Treatment Phase|Lost to Follow-up|4
967349|NCT00644969|3185272|P2|Post Treatment Phase|Withdrawal by Subject|2
967350|NCT00644969|3185273|P1|Post Treatment Phase|Withdrawal by Subject|4
967351|NCT00644969|3185272|P2|Post Treatment Phase|Death|0
967352|NCT00644969|3185273|P1|Post Treatment Phase|Death|1
967353|NCT00644969|3185272|P2|Treatment Phase|Other|1
967354|NCT00644969|3185273|P1|Treatment Phase|Other|4
967355|NCT00644969|3185272|P2|Treatment Phase|Lost to Follow-up|2
967356|NCT00644969|3185273|P1|Treatment Phase|Lost to Follow-up|2
967357|NCT00644969|3185272|P2|Treatment Phase|Withdrawal by Subject|0
967358|NCT00644969|3185273|P1|Treatment Phase|Withdrawal by Subject|4
967359|NCT00644969|3185272|P2|Treatment Phase|Adverse Event|0
967360|NCT00644969|3185273|P1|Treatment Phase|Adverse Event|3
967361|NCT00644969|3185272|P2|Treatment Phase|Randomized, not treated|0
967362|NCT00644969|3185273|P1|Treatment Phase|Randomized, not treated|1
967363|NCT00644917|3185319|P1|Overall Study|Withdrawal by Subject|2
967364|NCT00644787|3185327|P3|Period 2: Double Blind Phase|Worsening of symptoms|1
967365|NCT00644787|3185328|P2|Period 2: Double Blind Phase|Worsening of symptoms|0
967366|NCT00644787|3185329|P1|Period 2: Double Blind Phase|Worsening of symptoms|0
967367|NCT00644787|3185327|P3|Period 2: Double Blind Phase|Worsening of underlying disease|2
967368|NCT00644787|3185328|P2|Period 2: Double Blind Phase|Worsening of underlying disease|6
967369|NCT00644787|3185329|P1|Period 2: Double Blind Phase|Worsening of underlying disease|0
967370|NCT00644787|3185327|P3|Period 2: Double Blind Phase|Withdrawal by Subject|0
967371|NCT00644787|3185328|P2|Period 2: Double Blind Phase|Withdrawal by Subject|1
967372|NCT00644787|3185329|P1|Period 2: Double Blind Phase|Withdrawal by Subject|0
967373|NCT00644787|3185327|P3|Period 2: Double Blind Phase|Adverse Event|4
967374|NCT00644787|3185328|P2|Period 2: Double Blind Phase|Adverse Event|2
967375|NCT00644787|3185329|P1|Period 2: Double Blind Phase|Adverse Event|0
967376|NCT00644787|3185327|P3|Period 1: Titration Phase|Participant was judged as ineligible|0
967377|NCT00644787|3185328|P2|Period 1: Titration Phase|Participant was judged as ineligible|0
967378|NCT00644787|3185329|P1|Period 1: Titration Phase|Participant was judged as ineligible|3
967379|NCT00644787|3185327|P3|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
967380|NCT00644787|3185328|P2|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
967381|NCT00644787|3185329|P1|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3
967382|NCT00644787|3185327|P3|Period 1: Titration Phase|Worsening of symptoms|0
967383|NCT00644787|3185328|P2|Period 1: Titration Phase|Worsening of symptoms|0
967384|NCT00644787|3185329|P1|Period 1: Titration Phase|Worsening of symptoms|1
967385|NCT00644787|3185327|P3|Period 1: Titration Phase|Worsening of complications|0
967386|NCT00644787|3185328|P2|Period 1: Titration Phase|Worsening of complications|0
967387|NCT00644787|3185329|P1|Period 1: Titration Phase|Worsening of complications|1
967388|NCT00644787|3185327|P3|Period 1: Titration Phase|Worsening of underlying disease|0
967389|NCT00644787|3185328|P2|Period 1: Titration Phase|Worsening of underlying disease|0
967390|NCT00644787|3185329|P1|Period 1: Titration Phase|Worsening of underlying disease|5
967391|NCT00644787|3185327|P3|Period 1: Titration Phase|Physician Decision|0
967392|NCT00644787|3185328|P2|Period 1: Titration Phase|Physician Decision|0
967393|NCT00644787|3185329|P1|Period 1: Titration Phase|Physician Decision|1
967394|NCT00644787|3185327|P3|Period 1: Titration Phase|Withdrawal by Subject|0
967395|NCT00644787|3185328|P2|Period 1: Titration Phase|Withdrawal by Subject|0
967396|NCT00644787|3185329|P1|Period 1: Titration Phase|Withdrawal by Subject|2
967397|NCT00644787|3185327|P3|Period 1: Titration Phase|Adverse Event|0
967398|NCT00644787|3185328|P2|Period 1: Titration Phase|Adverse Event|0
967399|NCT00644787|3185329|P1|Period 1: Titration Phase|Adverse Event|11
967400|NCT00644358|3185371|P1|Overall Study|Other Unspecified|11
967401|NCT00644358|3185371|P1|Overall Study|Noncompliance|14
967402|NCT00644358|3185371|P1|Overall Study|Protocol Violation|5
967403|NCT00644358|3185371|P1|Overall Study|Lack of Effectiveness|39
967404|NCT00644358|3185371|P1|Overall Study|Consent Withdrawal|64
967405|NCT00644358|3185371|P1|Overall Study|Lost to Follow-up|105
967406|NCT00644358|3185371|P1|Overall Study|Adverse Event|124
967407|NCT00644332|3185378|P1|Overall Study|Could Not Attend Scheduled Visits|1
967408|NCT00644332|3185378|P1|Overall Study|Did Not Meet Eligibility Requirements|1
967409|NCT00644332|3185378|P1|Overall Study|Completion Status Unknown|2
967410|NCT00644332|3185378|P1|Overall Study|Withdrawal by Subject|6
967411|NCT00644332|3185378|P1|Overall Study|Adverse Event|11
967412|NCT00644228|3185404|P2|Maintenance|On Treatment|40
967413|NCT00644228|3185405|P1|Maintenance|On Treatment|26
967414|NCT00644228|3185404|P2|Maintenance|Not Protocol-Specified|15
967415|NCT00644228|3185405|P1|Maintenance|Not Protocol-Specified|14
967416|NCT00644228|3185404|P2|Maintenance|Death|3
967417|NCT00644228|3185405|P1|Maintenance|Death|3
967418|NCT00644228|3185404|P2|Maintenance|Progression/Relapse|42
967419|NCT00644228|3185405|P1|Maintenance|Progression/Relapse|67
967420|NCT00644228|3185404|P2|Maintenance|Withdrawal by Subject|4
967421|NCT00644228|3185405|P1|Maintenance|Withdrawal by Subject|6
967422|NCT00644228|3185404|P2|Maintenance|Adverse Event|31
967423|NCT00644228|3185405|P1|Maintenance|Adverse Event|27
967424|NCT00644228|3185404|P2|Induction Therapy|Not Protocol-Specified|28
967425|NCT00644228|3185405|P1|Induction Therapy|Not Protocol-Specified|24
967426|NCT00644228|3185404|P2|Induction Therapy|Death|7
967427|NCT00644228|3185405|P1|Induction Therapy|Death|3
967428|NCT00644228|3185404|P2|Induction Therapy|Progression/Relapse|12
967429|NCT00644228|3185405|P1|Induction Therapy|Progression/Relapse|24
967430|NCT00644228|3185404|P2|Induction Therapy|Withdrawal by Subject|3
967431|NCT00644228|3185405|P1|Induction Therapy|Withdrawal by Subject|10
967432|NCT00644228|3185404|P2|Induction Therapy|Adverse Event|55
967433|NCT00644228|3185405|P1|Induction Therapy|Adverse Event|22
967434|NCT00644228|3185404|P2|Randomization & Eligibility|Invalid Consent|1
967435|NCT00644228|3185405|P1|Randomization & Eligibility|Invalid Consent|0
967436|NCT00644228|3185404|P2|Randomization & Eligibility|Withdrew Consent prior to therapy start|0
967437|NCT00644228|3185405|P1|Randomization & Eligibility|Withdrew Consent prior to therapy start|1
967438|NCT00644228|3185404|P2|Randomization & Eligibility|Ineligible|21
967439|NCT00644228|3185405|P1|Randomization & Eligibility|Ineligible|31
967440|NCT00644059|3185434|P3|Overall Study|Unable to classify|3
967441|NCT00644059|3185435|P2|Overall Study|Unable to classify|2
967442|NCT00644059|3185436|P1|Overall Study|Unable to classify|6
967443|NCT00644059|3185434|P3|Overall Study|Protocol Deviation/violation|15
967444|NCT00644059|3185435|P2|Overall Study|Protocol Deviation/violation|19
967445|NCT00644059|3185436|P1|Overall Study|Protocol Deviation/violation|20
967446|NCT00644059|3185434|P3|Overall Study|Inappropriate Enrollment|0
967447|NCT00644059|3185435|P2|Overall Study|Inappropriate Enrollment|3
967448|NCT00644059|3185436|P1|Overall Study|Inappropriate Enrollment|1
967449|NCT00644059|3185434|P3|Overall Study|Adverse Event|1
967450|NCT00644059|3185435|P2|Overall Study|Adverse Event|5
967451|NCT00644059|3185436|P1|Overall Study|Adverse Event|8
967452|NCT00644059|3185434|P3|Overall Study|Withdrawal by Subject|30
967453|NCT00644059|3185435|P2|Overall Study|Withdrawal by Subject|60
967454|NCT00644059|3185436|P1|Overall Study|Withdrawal by Subject|52
967455|NCT00644059|3185434|P3|Overall Study|Lost to Follow-up|16
967456|NCT00644059|3185435|P2|Overall Study|Lost to Follow-up|34
967457|NCT00644059|3185436|P1|Overall Study|Lost to Follow-up|37
967458|NCT00643916|3185526|P6|Overall Study|Not Vaccinated|0
967459|NCT00643916|3185527|P5|Overall Study|Not Vaccinated|2
967460|NCT00643916|3185528|P4|Overall Study|Not Vaccinated|0
967461|NCT00643916|3185529|P3|Overall Study|Not Vaccinated|3
967462|NCT00643916|3185530|P2|Overall Study|Not Vaccinated|2
967463|NCT00643916|3185531|P1|Overall Study|Not Vaccinated|2
967464|NCT00643916|3185526|P6|Overall Study|Withdrawal by Subject|1
967465|NCT00643916|3185527|P5|Overall Study|Withdrawal by Subject|0
967466|NCT00643916|3185528|P4|Overall Study|Withdrawal by Subject|1
967467|NCT00643916|3185529|P3|Overall Study|Withdrawal by Subject|2
967468|NCT00643916|3185530|P2|Overall Study|Withdrawal by Subject|2
967469|NCT00643916|3185531|P1|Overall Study|Withdrawal by Subject|2
967470|NCT00643916|3185526|P6|Overall Study|Lost to Follow-up|0
967471|NCT00643916|3185527|P5|Overall Study|Lost to Follow-up|0
967472|NCT00643916|3185528|P4|Overall Study|Lost to Follow-up|0
967473|NCT00643916|3185529|P3|Overall Study|Lost to Follow-up|0
967474|NCT00643916|3185530|P2|Overall Study|Lost to Follow-up|1
967475|NCT00643916|3185531|P1|Overall Study|Lost to Follow-up|0
967476|NCT00643916|3185526|P6|Overall Study|Protocol Violation|0
967477|NCT00643916|3185527|P5|Overall Study|Protocol Violation|0
967478|NCT00643916|3185528|P4|Overall Study|Protocol Violation|1
967479|NCT00643916|3185529|P3|Overall Study|Protocol Violation|1
967480|NCT00643916|3185530|P2|Overall Study|Protocol Violation|1
967481|NCT00643916|3185531|P1|Overall Study|Protocol Violation|0
967482|NCT00643851|3185554|P3|Overall Study|Non-compl., not met criteria, etc.|6
967483|NCT00643851|3185555|P2|Overall Study|Non-compl., not met criteria, etc.|4
967484|NCT00643851|3185556|P1|Overall Study|Non-compl., not met criteria, etc.|3
967485|NCT00643851|3185554|P3|Overall Study|Withdrawal by Subject|9
967486|NCT00643851|3185555|P2|Overall Study|Withdrawal by Subject|15
967487|NCT00643851|3185556|P1|Overall Study|Withdrawal by Subject|8
967488|NCT00643851|3185554|P3|Overall Study|Lost to Follow-up|9
967489|NCT00643851|3185555|P2|Overall Study|Lost to Follow-up|6
967490|NCT00643851|3185556|P1|Overall Study|Lost to Follow-up|4
967491|NCT00643851|3185554|P3|Overall Study|Adverse Event|6
967492|NCT00643851|3185555|P2|Overall Study|Adverse Event|6
967493|NCT00643851|3185556|P1|Overall Study|Adverse Event|2
967494|NCT00643851|3185554|P3|Overall Study|Lack of Efficacy|0
967495|NCT00643851|3185555|P2|Overall Study|Lack of Efficacy|1
967496|NCT00643851|3185556|P1|Overall Study|Lack of Efficacy|0
967497|NCT00643851|3185554|P3|Overall Study|Death|0
967498|NCT00643851|3185555|P2|Overall Study|Death|1
967499|NCT00643851|3185556|P1|Overall Study|Death|0
967500|NCT00643760|3185584|P5|Overall Study|Withdrawal by Subject|1
967501|NCT00643760|3185585|P4|Overall Study|Withdrawal by Subject|4
967502|NCT00643760|3185586|P3|Overall Study|Withdrawal by Subject|2
967503|NCT00643760|3185587|P2|Overall Study|Withdrawal by Subject|1
967504|NCT00643760|3185588|P1|Overall Study|Withdrawal by Subject|3
967505|NCT00643760|3185584|P5|Overall Study|Investigator Discretion|0
967506|NCT00643760|3185585|P4|Overall Study|Investigator Discretion|2
967507|NCT00643760|3185586|P3|Overall Study|Investigator Discretion|0
967508|NCT00643760|3185587|P2|Overall Study|Investigator Discretion|0
967509|NCT00643760|3185588|P1|Overall Study|Investigator Discretion|0
967510|NCT00643760|3185584|P5|Overall Study|Lost to Follow-up|3
967511|NCT00643760|3185585|P4|Overall Study|Lost to Follow-up|3
967512|NCT00643760|3185586|P3|Overall Study|Lost to Follow-up|1
967513|NCT00643760|3185587|P2|Overall Study|Lost to Follow-up|2
967514|NCT00643760|3185588|P1|Overall Study|Lost to Follow-up|6
967515|NCT00643760|3185584|P5|Overall Study|Protocol Violation|6
967516|NCT00643760|3185585|P4|Overall Study|Protocol Violation|4
967517|NCT00643760|3185586|P3|Overall Study|Protocol Violation|4
967518|NCT00643760|3185587|P2|Overall Study|Protocol Violation|6
967519|NCT00643760|3185588|P1|Overall Study|Protocol Violation|7
967520|NCT00643760|3185584|P5|Overall Study|Lack of Efficacy|3
967521|NCT00643760|3185585|P4|Overall Study|Lack of Efficacy|4
967522|NCT00643760|3185586|P3|Overall Study|Lack of Efficacy|0
967523|NCT00643760|3185587|P2|Overall Study|Lack of Efficacy|1
967524|NCT00643760|3185588|P1|Overall Study|Lack of Efficacy|3
967525|NCT00643760|3185584|P5|Overall Study|Adverse Event|6
967526|NCT00643760|3185585|P4|Overall Study|Adverse Event|21
967527|NCT00643760|3185586|P3|Overall Study|Adverse Event|12
967528|NCT00643760|3185587|P2|Overall Study|Adverse Event|5
967529|NCT00643760|3185588|P1|Overall Study|Adverse Event|11
967530|NCT00643682|3185692|P2|Overall Study|did not keep appointment|509
967531|NCT00643682|3185693|P1|Overall Study|did not keep appointment|522
967532|NCT00643604|3185705|P1|Overall Study|Death|1
967533|NCT00643565|3185733|P2|Overall Study|Lost to Follow-up|0
967534|NCT00643565|3185734|P1|Overall Study|Lost to Follow-up|2
967535|NCT00643565|3185733|P2|Overall Study|Withdrawal by Subject|1
967536|NCT00643565|3185734|P1|Overall Study|Withdrawal by Subject|2
967537|NCT00643565|3185733|P2|Overall Study|Ongoing in Follow-up|39
967538|NCT00643565|3185734|P1|Overall Study|Ongoing in Follow-up|39
967539|NCT00643565|3185733|P2|Overall Study|Death|34
967540|NCT00643565|3185734|P1|Overall Study|Death|37
967541|NCT00643487|3185756|P1|Overall Study|Technical difficulty|3
967542|NCT00643448|3185763|P3|Overall Study|QTcF>550 ms|0
967543|NCT00643448|3185764|P2|Overall Study|QTcF>550 ms|3
967544|NCT00643448|3185765|P1|Overall Study|QTcF>550 ms|0
967545|NCT00643448|3185763|P3|Overall Study|Adverse Event|2
967546|NCT00643448|3185764|P2|Overall Study|Adverse Event|2
967547|NCT00643448|3185765|P1|Overall Study|Adverse Event|2
967548|NCT00643448|3185763|P3|Overall Study|Lack of Efficacy|4
967549|NCT00643448|3185764|P2|Overall Study|Lack of Efficacy|0
967550|NCT00643448|3185765|P1|Overall Study|Lack of Efficacy|2
967551|NCT00643201|3185782|P2|Completed Study Follow Up|non-specified|0
967552|NCT00643201|3185783|P1|Completed Study Follow Up|non-specified|1
967553|NCT00643201|3185782|P2|Completed Study Follow Up|Lost to Follow-up|16
967554|NCT00643201|3185783|P1|Completed Study Follow Up|Lost to Follow-up|18
967555|NCT00643201|3185782|P2|Completed Study Follow Up|Withdrawal by Subject|29
967556|NCT00643201|3185783|P1|Completed Study Follow Up|Withdrawal by Subject|23
967557|NCT00643201|3185782|P2|Completed Study Follow Up|Death|34
967558|NCT00643201|3185783|P1|Completed Study Follow Up|Death|28
967559|NCT00643201|3185782|P2|Randomized, Completed 6 Months of Study|not specified|107
967560|NCT00643201|3185783|P1|Randomized, Completed 6 Months of Study|not specified|107
967561|NCT00643201|3185782|P2|Randomized, Completed 6 Months of Study|Administrative reason|1
967562|NCT00643201|3185783|P1|Randomized, Completed 6 Months of Study|Administrative reason|1
967563|NCT00643201|3185782|P2|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9
967564|NCT00643201|3185783|P1|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13
967565|NCT00643201|3185782|P2|Randomized, Completed 6 Months of Study|Pregnancy|2
967566|NCT00643201|3185783|P1|Randomized, Completed 6 Months of Study|Pregnancy|3
967567|NCT00643201|3185782|P2|Randomized, Completed 6 Months of Study|Poor or non-compliance|23
967568|NCT00643201|3185783|P1|Randomized, Completed 6 Months of Study|Poor or non-compliance|20
967569|NCT00643201|3185782|P2|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
967570|NCT00643201|3185783|P1|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
967571|NCT00643201|3185782|P2|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
967572|NCT00643201|3185783|P1|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
967573|NCT00643201|3185782|P2|Randomized, Completed 6 Months of Study|Adverse Event|182
967574|NCT00643201|3185783|P1|Randomized, Completed 6 Months of Study|Adverse Event|150
967575|NCT00643201|3185782|P2|Randomized, Completed 6 Months of Study|Death|26
967576|NCT00643201|3185783|P1|Randomized, Completed 6 Months of Study|Death|20
967577|NCT00643123|3185831|P2|Overall Study|Withdrawal by Subject|1
967578|NCT00643123|3185832|P1|Overall Study|Withdrawal by Subject|1
967579|NCT00643123|3185831|P2|Overall Study|Lost to Follow-up|0
967580|NCT00643123|3185832|P1|Overall Study|Lost to Follow-up|4
967581|NCT00643006|3185862|P2|Overall Study|Lost to Follow-up|4
967582|NCT00643006|3185863|P1|Overall Study|Lost to Follow-up|5
967583|NCT00642993|3185873|P2|Overall Study|Administrative|0
967584|NCT00642993|3185874|P1|Overall Study|Administrative|1
967585|NCT00642993|3185873|P2|Overall Study|Did not meet protocol eligibility|1
967586|NCT00642993|3185874|P1|Overall Study|Did not meet protocol eligibility|0
967587|NCT00642993|3185873|P2|Overall Study|Protocol Violation|4
967588|NCT00642993|3185874|P1|Overall Study|Protocol Violation|1
967589|NCT00642993|3185873|P2|Overall Study|Withdrew - reason unrelated to treatment|3
967590|NCT00642993|3185874|P1|Overall Study|Withdrew - reason unrelated to treatment|11
967591|NCT00642993|3185873|P2|Overall Study|Lost to Follow-up|4
967592|NCT00642993|3185874|P1|Overall Study|Lost to Follow-up|8
967593|NCT00642993|3185873|P2|Overall Study|Adverse Event|4
967594|NCT00642993|3185874|P1|Overall Study|Adverse Event|85
967595|NCT00642902|3185892|P4|Overall Study|Other|4
967596|NCT00642902|3185893|P3|Overall Study|Other|1
967597|NCT00642902|3185894|P2|Overall Study|Other|5
967598|NCT00642902|3185895|P1|Overall Study|Other|1
967599|NCT00642902|3185892|P4|Overall Study|Randomized, but not treated|0
967600|NCT00642902|3185893|P3|Overall Study|Randomized, but not treated|1
967601|NCT00642902|3185894|P2|Overall Study|Randomized, but not treated|0
967602|NCT00642902|3185895|P1|Overall Study|Randomized, but not treated|0
967603|NCT00642902|3185892|P4|Overall Study|Premature termination of clinical trial|35
967604|NCT00642902|3185893|P3|Overall Study|Premature termination of clinical trial|35
967605|NCT00642902|3185894|P2|Overall Study|Premature termination of clinical trial|32
967606|NCT00642902|3185895|P1|Overall Study|Premature termination of clinical trial|37
967607|NCT00642902|3185892|P4|Overall Study|Death|0
967608|NCT00642902|3185893|P3|Overall Study|Death|0
967609|NCT00642902|3185894|P2|Overall Study|Death|0
967610|NCT00642902|3185895|P1|Overall Study|Death|1
967611|NCT00642902|3185892|P4|Overall Study|Lack of Efficacy|0
967612|NCT00642902|3185893|P3|Overall Study|Lack of Efficacy|3
967613|NCT00642902|3185894|P2|Overall Study|Lack of Efficacy|3
967614|NCT00642902|3185895|P1|Overall Study|Lack of Efficacy|0
967615|NCT00642902|3185892|P4|Overall Study|Lost to Follow-up|0
967616|NCT00642902|3185893|P3|Overall Study|Lost to Follow-up|0
967617|NCT00642902|3185894|P2|Overall Study|Lost to Follow-up|1
967618|NCT00642902|3185895|P1|Overall Study|Lost to Follow-up|1
967619|NCT00642902|3185892|P4|Overall Study|Adverse Event|1
967620|NCT00642902|3185893|P3|Overall Study|Adverse Event|3
967621|NCT00642902|3185894|P2|Overall Study|Adverse Event|1
967622|NCT00642902|3185895|P1|Overall Study|Adverse Event|0
967623|NCT00642850|3185917|P1|Overall Study|Other reasons|7
967624|NCT00642850|3185917|P1|Overall Study|Blood transfusion|6
967625|NCT00642850|3185917|P1|Overall Study|Kidney transplantation|8
967626|NCT00642850|3185917|P1|Overall Study|Protocol Violation|2
967627|NCT00642850|3185917|P1|Overall Study|Lack of Efficacy|1
967628|NCT00642850|3185917|P1|Overall Study|Adverse Event|2
967629|NCT00642850|3185917|P1|Overall Study|Death|7
967630|NCT00642811|3185933|P6|Overall Study|Other|0
967631|NCT00642811|3185934|P5|Overall Study|Other|0
967632|NCT00642811|3185935|P4|Overall Study|Other|1
967633|NCT00642811|3185936|P3|Overall Study|Other|0
967634|NCT00642811|3185937|P2|Overall Study|Other|1
967635|NCT00642811|3185938|P1|Overall Study|Other|0
967636|NCT00642811|3185933|P6|Overall Study|Severe Non-compliance to protocol|0
967637|NCT00642811|3185934|P5|Overall Study|Severe Non-compliance to protocol|0
967638|NCT00642811|3185935|P4|Overall Study|Severe Non-compliance to protocol|0
967639|NCT00642811|3185936|P3|Overall Study|Severe Non-compliance to protocol|0
967640|NCT00642811|3185937|P2|Overall Study|Severe Non-compliance to protocol|0
967641|NCT00642811|3185938|P1|Overall Study|Severe Non-compliance to protocol|1
967642|NCT00642811|3185933|P6|Overall Study|Developement of discontinuation criteria|0
967643|NCT00642811|3185934|P5|Overall Study|Developement of discontinuation criteria|1
967644|NCT00642811|3185935|P4|Overall Study|Developement of discontinuation criteria|0
967645|NCT00642811|3185936|P3|Overall Study|Developement of discontinuation criteria|0
967646|NCT00642811|3185937|P2|Overall Study|Developement of discontinuation criteria|0
967647|NCT00642811|3185938|P1|Overall Study|Developement of discontinuation criteria|0
967648|NCT00642811|3185933|P6|Overall Study|Adverse Event|1
967649|NCT00642811|3185934|P5|Overall Study|Adverse Event|0
967650|NCT00642811|3185935|P4|Overall Study|Adverse Event|0
967651|NCT00642811|3185936|P3|Overall Study|Adverse Event|0
967652|NCT00642811|3185937|P2|Overall Study|Adverse Event|3
967653|NCT00642811|3185938|P1|Overall Study|Adverse Event|2
967654|NCT00642772|3185960|P1|Overall Study|Withdrawal by Subject|7
967655|NCT00642772|3185960|P1|Overall Study|Lost to Follow-up|3
967656|NCT00642759|3185964|P1|Overall Study|Protocol Violation|1
967657|NCT00642746|3185973|P2|Overall Study|Patient unevaluable|0
967658|NCT00642746|3185974|P1|Overall Study|Patient unevaluable|1
967659|NCT00642707|3185988|P4|Overall Study|Withdrawal by Subject|0
967660|NCT00642707|3185989|P3|Overall Study|Withdrawal by Subject|0
967661|NCT00642707|3185990|P2|Overall Study|Withdrawal by Subject|0
967662|NCT00642707|3185991|P1|Overall Study|Withdrawal by Subject|1
967663|NCT00642707|3185988|P4|Overall Study|Adverse Event|2
967664|NCT00642707|3185989|P3|Overall Study|Adverse Event|0
967665|NCT00642707|3185990|P2|Overall Study|Adverse Event|0
967666|NCT00642707|3185991|P1|Overall Study|Adverse Event|0
967667|NCT00642668|3186012|P1|Overall Study|Blood Transfusion|2
967668|NCT00642668|3186012|P1|Overall Study|Dialysis Initiation|5
967669|NCT00642668|3186012|P1|Overall Study|Failure to Return|1
967670|NCT00642668|3186012|P1|Overall Study|Insufficient Therapeutic Response|1
967671|NCT00642668|3186012|P1|Overall Study|Death|2
967672|NCT00642668|3186012|P1|Overall Study|Adverse Event|2
967673|NCT00642668|3186012|P1|Overall Study|Lost to Follow-up|1
967674|NCT00642642|3186020|P1|Treatment & Follow Up|Lost to Follow-up|10
967675|NCT00642642|3186020|P1|Treatment & Follow Up|Withdrawal by Subject|5
967676|NCT00642642|3186020|P1|Treatment & Follow Up|Adverse Event|2
967677|NCT00642616|3186037|P4|Overall Study|Physician Decision|1
967678|NCT00642616|3186038|P3|Overall Study|Physician Decision|1
967679|NCT00642616|3186039|P2|Overall Study|Physician Decision|0
967680|NCT00642616|3186040|P1|Overall Study|Physician Decision|0
967681|NCT00642616|3186037|P4|Overall Study|Protocol Violation|0
967682|NCT00642616|3186038|P3|Overall Study|Protocol Violation|2
967683|NCT00642616|3186039|P2|Overall Study|Protocol Violation|0
967684|NCT00642616|3186040|P1|Overall Study|Protocol Violation|0
967685|NCT00642616|3186037|P4|Overall Study|Withdrawal by Subject|1
967686|NCT00642616|3186038|P3|Overall Study|Withdrawal by Subject|1
967687|NCT00642616|3186039|P2|Overall Study|Withdrawal by Subject|1
967688|NCT00642616|3186040|P1|Overall Study|Withdrawal by Subject|0
967689|NCT00642616|3186037|P4|Overall Study|Study Terminated by Sponsor|5
967690|NCT00642616|3186038|P3|Overall Study|Study Terminated by Sponsor|4
967691|NCT00642616|3186039|P2|Overall Study|Study Terminated by Sponsor|6
967692|NCT00642616|3186040|P1|Overall Study|Study Terminated by Sponsor|7
967693|NCT00642616|3186037|P4|Overall Study|Adverse Event|0
967694|NCT00642616|3186038|P3|Overall Study|Adverse Event|1
967695|NCT00642616|3186039|P2|Overall Study|Adverse Event|0
967696|NCT00642616|3186040|P1|Overall Study|Adverse Event|2
967697|NCT00642473|3186073|P2|Overall Study|Other|2
967698|NCT00642473|3186074|P1|Overall Study|Other|2
967699|NCT00642473|3186073|P2|Overall Study|Progression or death|4
967700|NCT00642473|3186074|P1|Overall Study|Progression or death|2
967701|NCT00642473|3186073|P2|Overall Study|Withdrawal by Subject|5
967702|NCT00642473|3186074|P1|Overall Study|Withdrawal by Subject|0
967703|NCT00642460|3186088|P6|Part III: Open-Label Up to Week 260|Refused treatment|3
967704|NCT00642460|3186089|P5|Part III: Open-Label Up to Week 260|Refused treatment|8
967705|NCT00642460|3186090|P4|Part III: Open-Label Up to Week 260|Refused treatment|0
967706|NCT00642460|3186091|P3|Part III: Open-Label Up to Week 260|Refused treatment|0
967707|NCT00642460|3186092|P2|Part III: Open-Label Up to Week 260|Refused treatment|0
967708|NCT00642460|3186093|P1|Part III: Open-Label Up to Week 260|Refused treatment|0
967709|NCT00642460|3186088|P6|Part III: Open-Label Up to Week 260|Administrative reason|1
967710|NCT00642460|3186089|P5|Part III: Open-Label Up to Week 260|Administrative reason|0
967711|NCT00642460|3186090|P4|Part III: Open-Label Up to Week 260|Administrative reason|0
967712|NCT00642460|3186091|P3|Part III: Open-Label Up to Week 260|Administrative reason|0
967713|NCT00642460|3186092|P2|Part III: Open-Label Up to Week 260|Administrative reason|0
967714|NCT00642460|3186093|P1|Part III: Open-Label Up to Week 260|Administrative reason|0
967715|NCT00642460|3186088|P6|Part III: Open-Label Up to Week 260|Death|3
967716|NCT00642460|3186089|P5|Part III: Open-Label Up to Week 260|Death|0
967717|NCT00642460|3186090|P4|Part III: Open-Label Up to Week 260|Death|0
967718|NCT00642460|3186091|P3|Part III: Open-Label Up to Week 260|Death|0
967719|NCT00642460|3186092|P2|Part III: Open-Label Up to Week 260|Death|0
967720|NCT00642460|3186093|P1|Part III: Open-Label Up to Week 260|Death|0
967721|NCT00642460|3186088|P6|Part III: Open-Label Up to Week 260|Other|2
967722|NCT00642460|3186089|P5|Part III: Open-Label Up to Week 260|Other|2
967723|NCT00642460|3186090|P4|Part III: Open-Label Up to Week 260|Other|0
967724|NCT00642460|3186091|P3|Part III: Open-Label Up to Week 260|Other|0
967725|NCT00642460|3186092|P2|Part III: Open-Label Up to Week 260|Other|0
967726|NCT00642460|3186093|P1|Part III: Open-Label Up to Week 260|Other|0
967727|NCT00642460|3186088|P6|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
967728|NCT00642460|3186089|P5|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
967729|NCT00642460|3186090|P4|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
967730|NCT00642460|3186091|P3|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
967731|NCT00642460|3186092|P2|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
967732|NCT00642460|3186093|P1|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
967733|NCT00642460|3186088|P6|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1
967734|NCT00642460|3186089|P5|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4
967735|NCT00642460|3186090|P4|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
967736|NCT00642460|3186091|P3|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
967737|NCT00642460|3186092|P2|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
967738|NCT00642460|3186093|P1|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
967739|NCT00642460|3186088|P6|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4
967740|NCT00642460|3186089|P5|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3
967741|NCT00642460|3186090|P4|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
967742|NCT00642460|3186091|P3|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
967743|NCT00642460|3186092|P2|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
967744|NCT00642460|3186093|P1|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
967745|NCT00642460|3186088|P6|Part III: Open-Label Up to Week 260|Adverse Event|6
967746|NCT00642460|3186089|P5|Part III: Open-Label Up to Week 260|Adverse Event|7
967747|NCT00642460|3186090|P4|Part III: Open-Label Up to Week 260|Adverse Event|0
967748|NCT00642460|3186091|P3|Part III: Open-Label Up to Week 260|Adverse Event|0
967749|NCT00642460|3186092|P2|Part III: Open-Label Up to Week 260|Adverse Event|0
967750|NCT00642460|3186093|P1|Part III: Open-Label Up to Week 260|Adverse Event|0
967751|NCT00642460|3186088|P6|Part II: Open-Label Up to Week 92|Administrative reasons|0
967752|NCT00642460|3186089|P5|Part II: Open-Label Up to Week 92|Administrative reasons|0
967753|NCT00642460|3186090|P4|Part II: Open-Label Up to Week 92|Administrative reasons|1
967754|NCT00642460|3186091|P3|Part II: Open-Label Up to Week 92|Administrative reasons|0
967755|NCT00642460|3186092|P2|Part II: Open-Label Up to Week 92|Administrative reasons|0
967756|NCT00642460|3186093|P1|Part II: Open-Label Up to Week 92|Administrative reasons|0
967757|NCT00642460|3186088|P6|Part II: Open-Label Up to Week 92|Failure to return|0
967758|NCT00642460|3186089|P5|Part II: Open-Label Up to Week 92|Failure to return|0
967759|NCT00642460|3186090|P4|Part II: Open-Label Up to Week 92|Failure to return|0
967760|NCT00642460|3186091|P3|Part II: Open-Label Up to Week 92|Failure to return|0
967761|NCT00642460|3186092|P2|Part II: Open-Label Up to Week 92|Failure to return|1
967762|NCT00642460|3186093|P1|Part II: Open-Label Up to Week 92|Failure to return|0
967763|NCT00642460|3186088|P6|Part II: Open-Label Up to Week 92|Refused treatment|0
967764|NCT00642460|3186089|P5|Part II: Open-Label Up to Week 92|Refused treatment|0
967765|NCT00642460|3186090|P4|Part II: Open-Label Up to Week 92|Refused treatment|0
967766|NCT00642460|3186091|P3|Part II: Open-Label Up to Week 92|Refused treatment|0
967767|NCT00642460|3186092|P2|Part II: Open-Label Up to Week 92|Refused treatment|1
967768|NCT00642460|3186093|P1|Part II: Open-Label Up to Week 92|Refused treatment|3
967769|NCT00642460|3186088|P6|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
967770|NCT00642460|3186089|P5|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
967771|NCT00642460|3186090|P4|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
967772|NCT00642460|3186091|P3|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
967773|NCT00642460|3186092|P2|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3
967774|NCT00642460|3186093|P1|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2
967775|NCT00642460|3186088|P6|Part II: Open-Label Up to Week 92|Death|0
967776|NCT00642460|3186089|P5|Part II: Open-Label Up to Week 92|Death|0
967777|NCT00642460|3186090|P4|Part II: Open-Label Up to Week 92|Death|2
967778|NCT00642460|3186091|P3|Part II: Open-Label Up to Week 92|Death|0
967779|NCT00642460|3186092|P2|Part II: Open-Label Up to Week 92|Death|1
967780|NCT00642460|3186093|P1|Part II: Open-Label Up to Week 92|Death|0
967781|NCT00642460|3186088|P6|Part II: Open-Label Up to Week 92|Adverse Event|0
967782|NCT00642460|3186089|P5|Part II: Open-Label Up to Week 92|Adverse Event|0
967783|NCT00642460|3186090|P4|Part II: Open-Label Up to Week 92|Adverse Event|0
967784|NCT00642460|3186091|P3|Part II: Open-Label Up to Week 92|Adverse Event|0
967785|NCT00642460|3186092|P2|Part II: Open-Label Up to Week 92|Adverse Event|2
967786|NCT00642460|3186093|P1|Part II: Open-Label Up to Week 92|Adverse Event|4
967787|NCT00642460|3186088|P6|Part I: 12 Week Double-Blind|Refused Treatment|0
967788|NCT00642460|3186089|P5|Part I: 12 Week Double-Blind|Refused Treatment|0
967789|NCT00642460|3186090|P4|Part I: 12 Week Double-Blind|Refused Treatment|0
967790|NCT00642460|3186091|P3|Part I: 12 Week Double-Blind|Refused Treatment|0
967791|NCT00642460|3186092|P2|Part I: 12 Week Double-Blind|Refused Treatment|0
967792|NCT00642460|3186093|P1|Part I: 12 Week Double-Blind|Refused Treatment|1
967793|NCT00642460|3186088|P6|Part I: 12 Week Double-Blind|Adverse Event|0
967794|NCT00642460|3186089|P5|Part I: 12 Week Double-Blind|Adverse Event|0
967795|NCT00642460|3186090|P4|Part I: 12 Week Double-Blind|Adverse Event|0
967796|NCT00642460|3186091|P3|Part I: 12 Week Double-Blind|Adverse Event|1
967797|NCT00642460|3186092|P2|Part I: 12 Week Double-Blind|Adverse Event|1
967798|NCT00642460|3186093|P1|Part I: 12 Week Double-Blind|Adverse Event|0
967799|NCT00642369|3186168|P2|Overall Study|Lack of Efficacy|2
967800|NCT00642369|3186169|P1|Overall Study|Lack of Efficacy|2
967801|NCT00642369|3186168|P2|Overall Study|misdiagnosis|1
967802|NCT00642369|3186169|P1|Overall Study|misdiagnosis|0
967803|NCT00642369|3186168|P2|Overall Study|Withdrawal by Subject|0
967804|NCT00642369|3186169|P1|Overall Study|Withdrawal by Subject|1
967805|NCT00642369|3186168|P2|Overall Study|Adverse Event|3
967806|NCT00642369|3186169|P1|Overall Study|Adverse Event|2
967807|NCT00642356|3186179|P2|Overall Study|Lack of Efficacy|0
967808|NCT00642356|3186180|P1|Overall Study|Lack of Efficacy|1
967809|NCT00642356|3186179|P2|Overall Study|Protocol Violation|3
967810|NCT00642356|3186180|P1|Overall Study|Protocol Violation|0
967811|NCT00642356|3186179|P2|Overall Study|Adverse Event|0
967812|NCT00642356|3186180|P1|Overall Study|Adverse Event|1
967813|NCT00642304|3186188|P1|Overall Study|Transplantation|1
967814|NCT00642304|3186188|P1|Overall Study|Erythropoiesis Stimulating Agent Use.|1
967815|NCT00642304|3186188|P1|Overall Study|Blood transfusion|2
967816|NCT00642304|3186188|P1|Overall Study|Death|1
967817|NCT00642304|3186188|P1|Overall Study|Adverse Event|1
967818|NCT00642278|3186204|P7|Overall Study|Not specified|0
967819|NCT00642278|3186205|P6|Overall Study|Not specified|1
967820|NCT00642278|3186206|P5|Overall Study|Not specified|0
967821|NCT00642278|3186207|P4|Overall Study|Not specified|1
967822|NCT00642278|3186208|P3|Overall Study|Not specified|0
967823|NCT00642278|3186209|P2|Overall Study|Not specified|1
967824|NCT00642278|3186210|P1|Overall Study|Not specified|2
967825|NCT00642278|3186204|P7|Overall Study|Noncompliance with study drug regimen|0
967826|NCT00642278|3186205|P6|Overall Study|Noncompliance with study drug regimen|0
967827|NCT00642278|3186206|P5|Overall Study|Noncompliance with study drug regimen|0
967828|NCT00642278|3186207|P4|Overall Study|Noncompliance with study drug regimen|1
967829|NCT00642278|3186208|P3|Overall Study|Noncompliance with study drug regimen|0
967830|NCT00642278|3186209|P2|Overall Study|Noncompliance with study drug regimen|0
967831|NCT00642278|3186210|P1|Overall Study|Noncompliance with study drug regimen|0
967832|NCT00642278|3186204|P7|Overall Study|Withdrawal by Subject|2
967833|NCT00642278|3186205|P6|Overall Study|Withdrawal by Subject|2
967834|NCT00642278|3186206|P5|Overall Study|Withdrawal by Subject|6
967835|NCT00642278|3186207|P4|Overall Study|Withdrawal by Subject|3
967836|NCT00642278|3186208|P3|Overall Study|Withdrawal by Subject|1
967837|NCT00642278|3186209|P2|Overall Study|Withdrawal by Subject|1
967838|NCT00642278|3186210|P1|Overall Study|Withdrawal by Subject|1
967839|NCT00642278|3186204|P7|Overall Study|Protocol Violation|2
967840|NCT00642278|3186205|P6|Overall Study|Protocol Violation|1
967841|NCT00642278|3186206|P5|Overall Study|Protocol Violation|0
967842|NCT00642278|3186207|P4|Overall Study|Protocol Violation|1
967843|NCT00642278|3186208|P3|Overall Study|Protocol Violation|1
967844|NCT00642278|3186209|P2|Overall Study|Protocol Violation|0
967845|NCT00642278|3186210|P1|Overall Study|Protocol Violation|0
967846|NCT00642278|3186204|P7|Overall Study|Physician Decision|0
967847|NCT00642278|3186205|P6|Overall Study|Physician Decision|0
967848|NCT00642278|3186206|P5|Overall Study|Physician Decision|0
967849|NCT00642278|3186207|P4|Overall Study|Physician Decision|1
967850|NCT00642278|3186208|P3|Overall Study|Physician Decision|0
967851|NCT00642278|3186209|P2|Overall Study|Physician Decision|0
967852|NCT00642278|3186210|P1|Overall Study|Physician Decision|0
967853|NCT00642278|3186204|P7|Overall Study|Lost to Follow-up|1
967854|NCT00642278|3186205|P6|Overall Study|Lost to Follow-up|1
967855|NCT00642278|3186206|P5|Overall Study|Lost to Follow-up|0
967856|NCT00642278|3186207|P4|Overall Study|Lost to Follow-up|1
967857|NCT00642278|3186208|P3|Overall Study|Lost to Follow-up|0
967858|NCT00642278|3186209|P2|Overall Study|Lost to Follow-up|1
967859|NCT00642278|3186210|P1|Overall Study|Lost to Follow-up|5
967860|NCT00642278|3186204|P7|Overall Study|Lack of Efficacy|0
967861|NCT00642278|3186205|P6|Overall Study|Lack of Efficacy|0
967862|NCT00642278|3186206|P5|Overall Study|Lack of Efficacy|0
967863|NCT00642278|3186207|P4|Overall Study|Lack of Efficacy|0
967864|NCT00642278|3186208|P3|Overall Study|Lack of Efficacy|0
967865|NCT00642278|3186209|P2|Overall Study|Lack of Efficacy|1
967866|NCT00642278|3186210|P1|Overall Study|Lack of Efficacy|0
967867|NCT00642278|3186204|P7|Overall Study|Adverse Event|0
967868|NCT00642278|3186205|P6|Overall Study|Adverse Event|2
967869|NCT00642278|3186206|P5|Overall Study|Adverse Event|2
967870|NCT00642278|3186207|P4|Overall Study|Adverse Event|1
967871|NCT00642278|3186208|P3|Overall Study|Adverse Event|3
967872|NCT00642278|3186209|P2|Overall Study|Adverse Event|1
967873|NCT00642278|3186210|P1|Overall Study|Adverse Event|2
967874|NCT00642174|3186263|P2|Period 1 - Initial Drug|Entry Criteria Not Met|1
967875|NCT00642174|3186264|P1|Period 1 - Initial Drug|Entry Criteria Not Met|0
967876|NCT00641719|3186307|P2|Overall Study|Reason Not Specified|2
967877|NCT00641719|3186308|P1|Overall Study|Reason Not Specified|1
967878|NCT00641719|3186307|P2|Overall Study|Withdrawal by Subject|4
967879|NCT00641719|3186308|P1|Overall Study|Withdrawal by Subject|4
967880|NCT00641719|3186307|P2|Overall Study|Adverse Event|29
967881|NCT00641719|3186308|P1|Overall Study|Adverse Event|24
967882|NCT00641719|3186307|P2|Overall Study|Lack of Efficacy|2
967883|NCT00641719|3186308|P1|Overall Study|Lack of Efficacy|1
967884|NCT00641706|3186332|P2|Overall Study|Lead Investigator Decision|1
967885|NCT00641706|3186333|P1|Overall Study|Lead Investigator Decision|0
967886|NCT00641706|3186332|P2|Overall Study|Clinical Decline|0
967887|NCT00641706|3186333|P1|Overall Study|Clinical Decline|1
967888|NCT00641706|3186332|P2|Overall Study|Withdrawal by Subject|1
967889|NCT00641706|3186333|P1|Overall Study|Withdrawal by Subject|6
967890|NCT00641706|3186332|P2|Overall Study|Adverse Event|1
967891|NCT00641706|3186333|P1|Overall Study|Adverse Event|2
967892|NCT00641667|3186345|P1|Overall Study|Worsening of underlying disease|3
967893|NCT00641667|3186345|P1|Overall Study|Physician Decision|1
967894|NCT00641667|3186345|P1|Overall Study|Adverse Event|1
967895|NCT00641667|3186345|P1|Overall Study|Withdrawal by Subject|1
967896|NCT00641537|3186373|P8|24-Week Supplemental Follow-up Period|Other|1
967897|NCT00641537|3186374|P7|24-Week Supplemental Follow-up Period|Other|1
967898|NCT00641537|3186375|P6|24-Week Supplemental Follow-up Period|Other|0
967899|NCT00641537|3186376|P5|24-Week Supplemental Follow-up Period|Other|3
967900|NCT00641537|3186377|P4|24-Week Supplemental Follow-up Period|Other|1
967901|NCT00641537|3186378|P3|24-Week Supplemental Follow-up Period|Other|2
967902|NCT00641537|3186379|P2|24-Week Supplemental Follow-up Period|Other|2
967903|NCT00641537|3186380|P1|24-Week Supplemental Follow-up Period|Other|0
967904|NCT00641537|3186373|P8|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
967905|NCT00641537|3186374|P7|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
967906|NCT00641537|3186375|P6|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
967907|NCT00641537|3186376|P5|24-Week Supplemental Follow-up Period|Lost to Follow-up|2
967908|NCT00641537|3186377|P4|24-Week Supplemental Follow-up Period|Lost to Follow-up|3
967909|NCT00641537|3186378|P3|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
967910|NCT00641537|3186379|P2|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
967911|NCT00641537|3186380|P1|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
967912|NCT00641537|3186373|P8|96-week Period|Other|6
967913|NCT00641537|3186374|P7|96-week Period|Other|4
967914|NCT00641537|3186375|P6|96-week Period|Other|6
967915|NCT00641537|3186376|P5|96-week Period|Other|12
967916|NCT00641537|3186377|P4|96-week Period|Other|9
967917|NCT00641537|3186378|P3|96-week Period|Other|14
967918|NCT00641537|3186379|P2|96-week Period|Other|7
967919|NCT00641537|3186380|P1|96-week Period|Other|4
967920|NCT00641537|3186373|P8|96-week Period|Death|0
967921|NCT00641537|3186374|P7|96-week Period|Death|0
967922|NCT00641537|3186375|P6|96-week Period|Death|0
967923|NCT00641537|3186376|P5|96-week Period|Death|0
967924|NCT00641537|3186377|P4|96-week Period|Death|0
967925|NCT00641537|3186378|P3|96-week Period|Death|1
967926|NCT00641537|3186379|P2|96-week Period|Death|0
967927|NCT00641537|3186380|P1|96-week Period|Death|2
967928|NCT00641537|3186373|P8|96-week Period|Protocol Violation|0
967929|NCT00641537|3186374|P7|96-week Period|Protocol Violation|0
967930|NCT00641537|3186375|P6|96-week Period|Protocol Violation|1
967931|NCT00641537|3186376|P5|96-week Period|Protocol Violation|0
967932|NCT00641537|3186377|P4|96-week Period|Protocol Violation|1
967933|NCT00641537|3186378|P3|96-week Period|Protocol Violation|0
967934|NCT00641537|3186379|P2|96-week Period|Protocol Violation|1
967935|NCT00641537|3186380|P1|96-week Period|Protocol Violation|0
967936|NCT00641537|3186373|P8|96-week Period|Lost to Follow-up|0
967937|NCT00641537|3186374|P7|96-week Period|Lost to Follow-up|1
967938|NCT00641537|3186375|P6|96-week Period|Lost to Follow-up|0
967939|NCT00641537|3186376|P5|96-week Period|Lost to Follow-up|4
967940|NCT00641537|3186377|P4|96-week Period|Lost to Follow-up|2
967941|NCT00641537|3186378|P3|96-week Period|Lost to Follow-up|2
967942|NCT00641537|3186379|P2|96-week Period|Lost to Follow-up|1
967943|NCT00641537|3186380|P1|96-week Period|Lost to Follow-up|3
967944|NCT00641537|3186373|P8|96-week Period|Adverse Event|0
967945|NCT00641537|3186374|P7|96-week Period|Adverse Event|0
967946|NCT00641537|3186375|P6|96-week Period|Adverse Event|0
967947|NCT00641537|3186376|P5|96-week Period|Adverse Event|2
967948|NCT00641537|3186377|P4|96-week Period|Adverse Event|0
967949|NCT00641537|3186378|P3|96-week Period|Adverse Event|3
967950|NCT00641537|3186379|P2|96-week Period|Adverse Event|1
967951|NCT00641537|3186380|P1|96-week Period|Adverse Event|0
967952|NCT00641147|3186435|P2|Completed 16 Months.|Lost to Follow-up|0
967953|NCT00641147|3186436|P1|Completed 16 Months.|Lost to Follow-up|1
967954|NCT00641147|3186435|P2|Completed 16 Months.|Physician Decision|0
967955|NCT00641147|3186436|P1|Completed 16 Months.|Physician Decision|1
967956|NCT00641147|3186435|P2|Completed 12 Months.|Withdrawal by Subject|1
967957|NCT00641147|3186436|P1|Completed 12 Months.|Withdrawal by Subject|0
967958|NCT00641147|3186435|P2|Completed 12 Months.|Physician Decision|1
967959|NCT00641147|3186436|P1|Completed 12 Months.|Physician Decision|1
967960|NCT00641147|3186435|P2|Completed 8 Months.|Withdrawal by Subject|1
967961|NCT00641147|3186436|P1|Completed 8 Months.|Withdrawal by Subject|0
967962|NCT00641147|3186435|P2|Completed 8 Months.|non compliance|0
967963|NCT00641147|3186436|P1|Completed 8 Months.|non compliance|1
967964|NCT00641147|3186435|P2|Completed 8 Months.|Physician Decision|1
967965|NCT00641147|3186436|P1|Completed 8 Months.|Physician Decision|2
967966|NCT00641147|3186435|P2|Completed 4 Months.|Adverse Event|0
967967|NCT00641147|3186436|P1|Completed 4 Months.|Adverse Event|1
967968|NCT00641147|3186435|P2|Completed 4 Months.|Physician Decision|0
967969|NCT00641147|3186436|P1|Completed 4 Months.|Physician Decision|1
967970|NCT00641056|3186480|P2|Overall Study|Sponsor Decision|2
967971|NCT00641056|3186481|P1|Overall Study|Sponsor Decision|1
967972|NCT00641056|3186480|P2|Overall Study|Subject Decision|19
967973|NCT00641056|3186481|P1|Overall Study|Subject Decision|6
967974|NCT00641056|3186480|P2|Overall Study|Entry Criteria Not Met|0
967975|NCT00641056|3186481|P1|Overall Study|Entry Criteria Not Met|3
967976|NCT00641056|3186480|P2|Overall Study|Protocol Violation|0
967977|NCT00641056|3186481|P1|Overall Study|Protocol Violation|2
967978|NCT00641056|3186480|P2|Overall Study|Physician Decision|1
967979|NCT00641056|3186481|P1|Overall Study|Physician Decision|3
967980|NCT00641056|3186480|P2|Overall Study|Lost to Follow-up|1
967981|NCT00641056|3186481|P1|Overall Study|Lost to Follow-up|2
967982|NCT00641056|3186480|P2|Overall Study|Adverse Event|2
967983|NCT00641056|3186481|P1|Overall Study|Adverse Event|12
967984|NCT00641043|3186509|P2|Overall Study|Other incl. lack of efficacy|2
967985|NCT00641043|3186510|P1|Overall Study|Other incl. lack of efficacy|4
967986|NCT00641043|3186509|P2|Overall Study|Withdrawal by Subject|4
967987|NCT00641043|3186510|P1|Overall Study|Withdrawal by Subject|4
967988|NCT00641043|3186509|P2|Overall Study|Lost to Follow-up|2
967989|NCT00641043|3186510|P1|Overall Study|Lost to Follow-up|3
967990|NCT00641043|3186509|P2|Overall Study|Protocol Violation|3
967991|NCT00641043|3186510|P1|Overall Study|Protocol Violation|2
967992|NCT00641043|3186509|P2|Overall Study|Adverse Event|4
967993|NCT00641043|3186510|P1|Overall Study|Adverse Event|6
967994|NCT00640926|3186547|P3|Overall Study|Withdrawal by Subject|1
967995|NCT00640926|3186548|P2|Overall Study|Withdrawal by Subject|0
967996|NCT00640926|3186549|P1|Overall Study|Withdrawal by Subject|1
967997|NCT00640926|3186547|P3|Overall Study|Lost to Follow-up|2
967998|NCT00640926|3186548|P2|Overall Study|Lost to Follow-up|1
967999|NCT00640926|3186549|P1|Overall Study|Lost to Follow-up|3
968000|NCT00640926|3186547|P3|Overall Study|Protocol Violation|2
968001|NCT00640926|3186548|P2|Overall Study|Protocol Violation|0
968002|NCT00640926|3186549|P1|Overall Study|Protocol Violation|2
968003|NCT00640926|3186547|P3|Overall Study|Lack of Efficacy|1
968004|NCT00640926|3186548|P2|Overall Study|Lack of Efficacy|2
968005|NCT00640926|3186549|P1|Overall Study|Lack of Efficacy|0
968006|NCT00640926|3186547|P3|Overall Study|Adverse Event|2
968007|NCT00640926|3186548|P2|Overall Study|Adverse Event|3
968008|NCT00640926|3186549|P1|Overall Study|Adverse Event|2
968009|NCT00640835|3186562|P2|Overall Study|Other Reason|4
968010|NCT00640835|3186563|P1|Overall Study|Other Reason|19
968011|NCT00640835|3186562|P2|Overall Study|Lost to Follow-up|13
968012|NCT00640835|3186563|P1|Overall Study|Lost to Follow-up|17
968013|NCT00640835|3186562|P2|Overall Study|Protocol Violation|2
968014|NCT00640835|3186563|P1|Overall Study|Protocol Violation|2
968015|NCT00640835|3186562|P2|Overall Study|Sponsor's Decision|7
968016|NCT00640835|3186563|P1|Overall Study|Sponsor's Decision|11
968017|NCT00640835|3186562|P2|Overall Study|Physician Decision|14
968018|NCT00640835|3186563|P1|Overall Study|Physician Decision|10
968019|NCT00640835|3186562|P2|Overall Study|Withdrawal by Subject|14
968020|NCT00640835|3186563|P1|Overall Study|Withdrawal by Subject|12
968021|NCT00640835|3186562|P2|Overall Study|Adverse Event|3
968022|NCT00640835|3186563|P1|Overall Study|Adverse Event|5
968023|NCT00640614|3186627|P2|Overall Study|Lost to Follow-up|0
968024|NCT00640614|3186628|P1|Overall Study|Lost to Follow-up|1
968025|NCT00640601|3186670|P1|Overall Study|treatment naive, combination therapy|10
968026|NCT00640601|3186670|P1|Overall Study|Physician Decision|8
968027|NCT00640601|3186670|P1|Overall Study|Lost to Follow-up|9
968028|NCT00640601|3186670|P1|Overall Study|Lack of Efficacy|16
968029|NCT00640601|3186670|P1|Overall Study|Protocol Violation|6
968030|NCT00640601|3186670|P1|Overall Study|Withdrawal by Subject|20
968031|NCT00640601|3186670|P1|Overall Study|Adverse Event|43
968032|NCT00640562|3186686|P2|Overall Study|Glycosylated Hemoglobin >8|0
968033|NCT00640562|3186687|P1|Overall Study|Glycosylated Hemoglobin >8|1
968034|NCT00640562|3186686|P2|Overall Study|Low study drug dose|1
968035|NCT00640562|3186687|P1|Overall Study|Low study drug dose|0
968036|NCT00640562|3186686|P2|Overall Study|Past use of Seroquel -stopped due to AE|1
968037|NCT00640562|3186687|P1|Overall Study|Past use of Seroquel -stopped due to AE|0
968038|NCT00640562|3186686|P2|Overall Study|Known risperidone intolerance|1
968039|NCT00640562|3186687|P1|Overall Study|Known risperidone intolerance|0
968040|NCT00640562|3186686|P2|Overall Study|Withdrawal by Subject|10
968041|NCT00640562|3186687|P1|Overall Study|Withdrawal by Subject|6
968042|NCT00640562|3186686|P2|Overall Study|Protocol Violation|4
968043|NCT00640562|3186687|P1|Overall Study|Protocol Violation|2
968044|NCT00640562|3186686|P2|Overall Study|Lack of Efficacy|4
968045|NCT00640562|3186687|P1|Overall Study|Lack of Efficacy|1
968046|NCT00640562|3186686|P2|Overall Study|Adverse Event|5
968047|NCT00640562|3186687|P1|Overall Study|Adverse Event|8
968048|NCT00640510|3186715|P2|Overall Study|Physician Decision|1
968049|NCT00640510|3186716|P1|Overall Study|Physician Decision|0
968050|NCT00640510|3186715|P2|Overall Study|Protocol Violation|0
968051|NCT00640510|3186716|P1|Overall Study|Protocol Violation|1
968052|NCT00640510|3186715|P2|Overall Study|Lack of Efficacy|1
968053|NCT00640510|3186716|P1|Overall Study|Lack of Efficacy|0
968054|NCT00640393|3186728|P3|Part 2|Adverse Event|0
968055|NCT00640393|3186729|P2|Part 2|Adverse Event|1
968056|NCT00640393|3186730|P1|Part 2|Adverse Event|0
968057|NCT00640393|3186728|P3|Part 2|Non-adherence|0
968058|NCT00640393|3186729|P2|Part 2|Non-adherence|1
968059|NCT00640393|3186730|P1|Part 2|Non-adherence|0
968060|NCT00640393|3186728|P3|Part 2|Withdrawal by Subject|1
968061|NCT00640393|3186729|P2|Part 2|Withdrawal by Subject|6
968062|NCT00640393|3186730|P1|Part 2|Withdrawal by Subject|0
968063|NCT00640393|3186728|P3|Part 2|Lost to Follow-up|2
968064|NCT00640393|3186729|P2|Part 2|Lost to Follow-up|2
968065|NCT00640393|3186730|P1|Part 2|Lost to Follow-up|0
968066|NCT00640393|3186728|P3|Randomization|Never randomized by site|0
968067|NCT00640393|3186729|P2|Randomization|Never randomized by site|0
968068|NCT00640393|3186730|P1|Randomization|Never randomized by site|2
968069|NCT00640393|3186728|P3|Randomization|Withdrawn per protocol|0
968070|NCT00640393|3186729|P2|Randomization|Withdrawn per protocol|0
968071|NCT00640393|3186730|P1|Randomization|Withdrawn per protocol|17
968072|NCT00640393|3186728|P3|Part 1|Withdrawal by Subject|0
968073|NCT00640393|3186729|P2|Part 1|Withdrawal by Subject|0
968074|NCT00640393|3186730|P1|Part 1|Withdrawal by Subject|3
968075|NCT00640393|3186728|P3|Part 1|Lost to Follow-up|0
968076|NCT00640393|3186729|P2|Part 1|Lost to Follow-up|0
968077|NCT00640393|3186730|P1|Part 1|Lost to Follow-up|2
968078|NCT00640341|3186795|P3|Overall Study|Adverse event and positive slit lamp|0
968079|NCT00640341|3186796|P2|Overall Study|Adverse event and positive slit lamp|0
968080|NCT00640341|3186797|P1|Overall Study|Adverse event and positive slit lamp|1
968081|NCT00640341|3186795|P3|Overall Study|Ineligable at Baseline|2
968082|NCT00640341|3186796|P2|Overall Study|Ineligable at Baseline|3
968083|NCT00640341|3186797|P1|Overall Study|Ineligable at Baseline|5
968084|NCT00640341|3186795|P3|Overall Study|Poor fit/Uncomfortable|0
968085|NCT00640341|3186796|P2|Overall Study|Poor fit/Uncomfortable|0
968086|NCT00640341|3186797|P1|Overall Study|Poor fit/Uncomfortable|4
968087|NCT00640341|3186795|P3|Overall Study|Unacceptable Lens Movement|0
968088|NCT00640341|3186796|P2|Overall Study|Unacceptable Lens Movement|0
968089|NCT00640341|3186797|P1|Overall Study|Unacceptable Lens Movement|1
968090|NCT00640341|3186795|P3|Overall Study|Withdrawal by Subject|1
968091|NCT00640341|3186796|P2|Overall Study|Withdrawal by Subject|0
968092|NCT00640341|3186797|P1|Overall Study|Withdrawal by Subject|4
968093|NCT00640341|3186795|P3|Overall Study|Lost to Follow-up|0
968094|NCT00640341|3186796|P2|Overall Study|Lost to Follow-up|0
968095|NCT00640341|3186797|P1|Overall Study|Lost to Follow-up|2
968096|NCT00640341|3186795|P3|Overall Study|Failure to Follow Subject Instructions|0
968097|NCT00640341|3186796|P2|Overall Study|Failure to Follow Subject Instructions|0
968098|NCT00640341|3186797|P1|Overall Study|Failure to Follow Subject Instructions|1
968099|NCT00640341|3186795|P3|Overall Study|Inability to Maintain Wearing Schedule|0
968100|NCT00640341|3186796|P2|Overall Study|Inability to Maintain Wearing Schedule|1
968101|NCT00640341|3186797|P1|Overall Study|Inability to Maintain Wearing Schedule|1
968102|NCT00640341|3186795|P3|Overall Study|Study Related Symptoms/Complaints|2
968103|NCT00640341|3186796|P2|Overall Study|Study Related Symptoms/Complaints|1
968104|NCT00640341|3186797|P1|Overall Study|Study Related Symptoms/Complaints|2
968105|NCT00640341|3186795|P3|Overall Study|Positive Slit Lamp Findings|1
968106|NCT00640341|3186796|P2|Overall Study|Positive Slit Lamp Findings|0
968107|NCT00640341|3186797|P1|Overall Study|Positive Slit Lamp Findings|0
968108|NCT00640341|3186795|P3|Overall Study|Adverse Event|1
968109|NCT00640341|3186796|P2|Overall Study|Adverse Event|0
968110|NCT00640341|3186797|P1|Overall Study|Adverse Event|0
968111|NCT00640328|3186817|P6|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
968112|NCT00640328|3186818|P5|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
968113|NCT00640328|3186819|P4|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
968114|NCT00640328|3186820|P3|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
968115|NCT00640328|3186821|P2|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
968116|NCT00640328|3186822|P1|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
968117|NCT00640328|3186817|P6|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
968118|NCT00640328|3186818|P5|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
968119|NCT00640328|3186819|P4|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
968120|NCT00640328|3186820|P3|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1
968121|NCT00640328|3186821|P2|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
968122|NCT00640328|3186822|P1|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
968123|NCT00640328|3186817|P6|Second Treatment Period (Weeks 24-48)|Adverse Event|0
968124|NCT00640328|3186818|P5|Second Treatment Period (Weeks 24-48)|Adverse Event|1
968125|NCT00640328|3186819|P4|Second Treatment Period (Weeks 24-48)|Adverse Event|0
968126|NCT00640328|3186820|P3|Second Treatment Period (Weeks 24-48)|Adverse Event|0
968127|NCT00640328|3186821|P2|Second Treatment Period (Weeks 24-48)|Adverse Event|0
968128|NCT00640328|3186822|P1|Second Treatment Period (Weeks 24-48)|Adverse Event|0
968129|NCT00640328|3186817|P6|First Treatment Period (Weeks 0-24)|Adverse Event|0
968130|NCT00640328|3186818|P5|First Treatment Period (Weeks 0-24)|Adverse Event|0
968131|NCT00640328|3186819|P4|First Treatment Period (Weeks 0-24)|Adverse Event|0
968132|NCT00640328|3186820|P3|First Treatment Period (Weeks 0-24)|Adverse Event|0
968133|NCT00640328|3186821|P2|First Treatment Period (Weeks 0-24)|Adverse Event|1
968134|NCT00640328|3186822|P1|First Treatment Period (Weeks 0-24)|Adverse Event|0
968135|NCT00640315|3186988|P2|Overall Study|Withdrawal by Subject|1
968136|NCT00640315|3186989|P1|Overall Study|Withdrawal by Subject|0
968137|NCT00640289|3187115|P1|Overall Study|Missing status|5
968138|NCT00640289|3187115|P1|Overall Study|Transferred to another center|1
968139|NCT00640289|3187115|P1|Overall Study|Data collected under different amendment|2
968140|NCT00640289|3187115|P1|Overall Study|Lost to Follow-up|1
968141|NCT00640289|3187115|P1|Overall Study|Withdrawal by Subject|1
968142|NCT00640289|3187115|P1|Overall Study|Death|3
968143|NCT00640224|3187227|P4|Overall Study|Headaches|0
968144|NCT00640224|3187228|P3|Overall Study|Headaches|0
968145|NCT00640224|3187229|P2|Overall Study|Headaches|1
968146|NCT00640224|3187230|P1|Overall Study|Headaches|0
968147|NCT00640224|3187227|P4|Overall Study|Withdrawal by Subject|0
968148|NCT00640224|3187228|P3|Overall Study|Withdrawal by Subject|0
968149|NCT00640224|3187229|P2|Overall Study|Withdrawal by Subject|0
968150|NCT00640224|3187230|P1|Overall Study|Withdrawal by Subject|1
968151|NCT00640224|3187227|P4|Overall Study|Lost to Follow-up|0
968152|NCT00640224|3187228|P3|Overall Study|Lost to Follow-up|0
968153|NCT00640224|3187229|P2|Overall Study|Lost to Follow-up|2
968154|NCT00640224|3187230|P1|Overall Study|Lost to Follow-up|5
968155|NCT00640042|3187328|P1|Enrollment|Did not receive study drug|83
968156|NCT00640016|3187344|P4|Overall Study|Adverse Event|1
968157|NCT00640016|3187345|P3|Overall Study|Adverse Event|0
968158|NCT00640016|3187346|P2|Overall Study|Adverse Event|0
968159|NCT00640016|3187347|P1|Overall Study|Adverse Event|0
968160|NCT00640016|3187344|P4|Overall Study|Study termination|2
968161|NCT00640016|3187345|P3|Overall Study|Study termination|3
968162|NCT00640016|3187346|P2|Overall Study|Study termination|1
968163|NCT00640016|3187347|P1|Overall Study|Study termination|2
968164|NCT00640016|3187344|P4|Overall Study|Withdrawal by Subject|0
968165|NCT00640016|3187345|P3|Overall Study|Withdrawal by Subject|0
968166|NCT00640016|3187346|P2|Overall Study|Withdrawal by Subject|1
968167|NCT00640016|3187347|P1|Overall Study|Withdrawal by Subject|0
968168|NCT00639769|3187399|P1|Overall Study|Withdrawal by Subject|4
968169|NCT00639769|3187399|P1|Overall Study|Disease progression|26
968170|NCT00639769|3187399|P1|Overall Study|Lack of Efficacy|1
968171|NCT00639769|3187399|P1|Overall Study|Adverse Event|7
968172|NCT00639769|3187399|P1|Overall Study|Death|2
968173|NCT00639678|3187416|P4|Overall Study|Lack of Compliance|0
968174|NCT00639678|3187417|P3|Overall Study|Lack of Compliance|1
968175|NCT00639678|3187418|P2|Overall Study|Lack of Compliance|0
968176|NCT00639678|3187419|P1|Overall Study|Lack of Compliance|0
968177|NCT00639678|3187416|P4|Overall Study|Adverse Event|0
968178|NCT00639678|3187417|P3|Overall Study|Adverse Event|0
968179|NCT00639678|3187418|P2|Overall Study|Adverse Event|1
968180|NCT00639678|3187419|P1|Overall Study|Adverse Event|0
968181|NCT00639678|3187416|P4|Overall Study|Lost to Follow-up|0
968182|NCT00639678|3187417|P3|Overall Study|Lost to Follow-up|6
968183|NCT00639678|3187418|P2|Overall Study|Lost to Follow-up|0
968184|NCT00639678|3187419|P1|Overall Study|Lost to Follow-up|1
968185|NCT00639678|3187416|P4|Overall Study|Withdrawal by Subject|0
968186|NCT00639678|3187417|P3|Overall Study|Withdrawal by Subject|4
968187|NCT00639678|3187418|P2|Overall Study|Withdrawal by Subject|0
968188|NCT00639678|3187419|P1|Overall Study|Withdrawal by Subject|3
968189|NCT00639509|3187484|P1|Overall Study|Death|1
968190|NCT00639457|3187492|P2|Overall Study|Withdrawal by Subject|3
968191|NCT00639457|3187493|P1|Overall Study|Withdrawal by Subject|2
968192|NCT00639379|3187552|P2|Period 1 - 2 Weeks|lens issue|0
968193|NCT00639379|3187553|P1|Period 1 - 2 Weeks|lens issue|3
968194|NCT00639379|3187552|P2|Period 1 - 2 Weeks|Lost to Follow-up|0
968195|NCT00639379|3187553|P1|Period 1 - 2 Weeks|Lost to Follow-up|2
968196|NCT00639223|3187569|P2|Overall Study|Lost to Follow-up|2
968197|NCT00639223|3187570|P1|Overall Study|Lost to Follow-up|0
968198|NCT00639002|3187610|P1|Overall Study|Lack of Efficacy|1
968199|NCT00639002|3187610|P1|Overall Study|Physician Decision|6
968200|NCT00639002|3187610|P1|Overall Study|Disease progression|3
968201|NCT00639002|3187610|P1|Overall Study|Protocol Violation|1
968202|NCT00639002|3187610|P1|Overall Study|Adverse Event|1
968203|NCT00639002|3187610|P1|Overall Study|Death|1
968204|NCT00638989|3187619|P3|Overall Study|Lost to Follow-up|1
968205|NCT00638989|3187620|P2|Overall Study|Lost to Follow-up|0
968206|NCT00638989|3187621|P1|Overall Study|Lost to Follow-up|0
968207|NCT00638963|3187661|P2|Overall Study|Withdrawal by Subject|0
968208|NCT00638963|3187662|P1|Overall Study|Withdrawal by Subject|1
968209|NCT00638846|3187703|P2|Overall Study|lens issue|3
968210|NCT00638846|3187704|P1|Overall Study|lens issue|1
968211|NCT00638846|3187703|P2|Overall Study|Lost to Follow-up|2
968212|NCT00638846|3187704|P1|Overall Study|Lost to Follow-up|3
968213|NCT00638846|3187703|P2|Overall Study|Adverse Event|1
968214|NCT00638846|3187704|P1|Overall Study|Adverse Event|0
968215|NCT00638690|3187748|P2|Overall Study|Lost to Follow-up|2
968216|NCT00638690|3187749|P1|Overall Study|Lost to Follow-up|4
968217|NCT00638690|3187748|P2|Overall Study|Withdrawal by Subject|5
968218|NCT00638690|3187749|P1|Overall Study|Withdrawal by Subject|22
968219|NCT00638690|3187748|P2|Overall Study|Death|335
968220|NCT00638690|3187749|P1|Overall Study|Death|655
968221|NCT00638508|3187769|P2|Overall Study|Physician Decision|2
968222|NCT00638508|3187770|P1|Overall Study|Physician Decision|5
968223|NCT00638443|3187814|P2|First Intervention|Adverse Event|1
968224|NCT00638443|3187815|P1|First Intervention|Adverse Event|2
968225|NCT00638404|3187845|P2|Overall Study|Physician Decision|0
968226|NCT00638404|3187846|P1|Overall Study|Physician Decision|8
968227|NCT00638378|3187858|P1|Overall Study|Physician Decision|4
968228|NCT00638378|3187858|P1|Overall Study|Disease progression|15
968229|NCT00638378|3187858|P1|Overall Study|Adverse Event|1
968230|NCT00638378|3187858|P1|Overall Study|Death|2
968231|NCT00638235|3187898|P9|Overall Study|Lost to Follow-up|18
968232|NCT00638235|3187899|P8|Overall Study|Lost to Follow-up|1
968233|NCT00638235|3187900|P7|Overall Study|Lost to Follow-up|0
968234|NCT00638235|3187901|P6|Overall Study|Lost to Follow-up|26
968235|NCT00638235|3187902|P5|Overall Study|Lost to Follow-up|13
968236|NCT00638235|3187903|P4|Overall Study|Lost to Follow-up|10
968237|NCT00638235|3187904|P3|Overall Study|Lost to Follow-up|18
968238|NCT00638235|3187905|P2|Overall Study|Lost to Follow-up|3
968239|NCT00638235|3187906|P1|Overall Study|Lost to Follow-up|31
968240|NCT00638183|3188316|P1|Overall Study|Other reason not defined above|27
968241|NCT00638183|3188316|P1|Overall Study|Lost to Follow-up|46
968242|NCT00638183|3188316|P1|Overall Study|Physician Decision|9
968243|NCT00638183|3188316|P1|Overall Study|Lack of Efficacy|14
968244|NCT00638183|3188316|P1|Overall Study|Adverse Event|23
968245|NCT00638157|3188325|P2|Overall Study|Randomized, not treated|0
968246|NCT00638157|3188326|P1|Overall Study|Randomized, not treated|2
968247|NCT00638157|3188325|P2|Overall Study|Not Specified|2
968248|NCT00638157|3188326|P1|Overall Study|Not Specified|1
968249|NCT00638157|3188325|P2|Overall Study|Physician Decision|0
968250|NCT00638157|3188326|P1|Overall Study|Physician Decision|1
968251|NCT00638157|3188325|P2|Overall Study|Lost to Follow-up|0
968252|NCT00638157|3188326|P1|Overall Study|Lost to Follow-up|1
968253|NCT00638157|3188325|P2|Overall Study|Microbiological failure|0
968254|NCT00638157|3188326|P1|Overall Study|Microbiological failure|1
968255|NCT00638157|3188325|P2|Overall Study|Clinical (symptomatic) failure|1
968256|NCT00638157|3188326|P1|Overall Study|Clinical (symptomatic) failure|1
968257|NCT00638157|3188325|P2|Overall Study|Adverse Event|1
968258|NCT00638157|3188326|P1|Overall Study|Adverse Event|0
968259|NCT00638027|3188336|P2|Overall Study|Adverse Event|2
968260|NCT00638027|3188337|P1|Overall Study|Adverse Event|0
968261|NCT00637806|3188384|P4|Extension Phase|Study Discontinued|1
968262|NCT00637806|3188385|P3|Extension Phase|Study Discontinued|0
968263|NCT00637806|3188386|P2|Extension Phase|Study Discontinued|0
968264|NCT00637806|3188387|P1|Extension Phase|Study Discontinued|0
968265|NCT00637806|3188384|P4|Double-blind Phase|Study Discontinued|0
968266|NCT00637806|3188385|P3|Double-blind Phase|Study Discontinued|1
968267|NCT00637806|3188386|P2|Double-blind Phase|Study Discontinued|0
968268|NCT00637806|3188387|P1|Double-blind Phase|Study Discontinued|2
968269|NCT00637728|3188422|P3|Double-blind Phase|Study Discontinued|0
968270|NCT00637728|3188423|P2|Double-blind Phase|Study Discontinued|1
968271|NCT00637728|3188424|P1|Double-blind Phase|Study Discontinued|1
968272|NCT00637728|3188422|P3|Double-blind Phase|Non-compliance|0
968273|NCT00637728|3188423|P2|Double-blind Phase|Non-compliance|0
968274|NCT00637728|3188424|P1|Double-blind Phase|Non-compliance|2
968275|NCT00637728|3188422|P3|Double-blind Phase|Adverse Event|0
968276|NCT00637728|3188423|P2|Double-blind Phase|Adverse Event|0
968277|NCT00637728|3188424|P1|Double-blind Phase|Adverse Event|1
968278|NCT00637572|3188439|P2|Overall Study|Illicit Drug Use|0
968279|NCT00637572|3188440|P1|Overall Study|Illicit Drug Use|1
968280|NCT00637572|3188439|P2|Overall Study|Withdrawal by Subject|2
968281|NCT00637572|3188440|P1|Overall Study|Withdrawal by Subject|0
968282|NCT00637572|3188439|P2|Overall Study|Physician Decision|1
968283|NCT00637572|3188440|P1|Overall Study|Physician Decision|1
968284|NCT00637572|3188439|P2|Overall Study|Lost to Follow-up|1
968285|NCT00637572|3188440|P1|Overall Study|Lost to Follow-up|0
968286|NCT00637572|3188439|P2|Overall Study|Death|1
968287|NCT00637572|3188440|P1|Overall Study|Death|0
968288|NCT00637572|3188439|P2|Overall Study|Adverse Event|2
968289|NCT00637572|3188440|P1|Overall Study|Adverse Event|1
968290|NCT00637416|3188479|P2|Overall Study|Unable to take study drug|1
968291|NCT00637416|3188480|P1|Overall Study|Unable to take study drug|0
968292|NCT00637416|3188479|P2|Overall Study|Lost to Follow-up|1
968293|NCT00637416|3188480|P1|Overall Study|Lost to Follow-up|1
968294|NCT00637377|3188490|P4|Overall Study|Other (no further information available)|5
968295|NCT00637377|3188491|P3|Overall Study|Other (no further information available)|10
968296|NCT00637377|3188492|P2|Overall Study|Other (no further information available)|6
968297|NCT00637377|3188493|P1|Overall Study|Other (no further information available)|7
968298|NCT00637377|3188490|P4|Overall Study|Withdrawal by Subject|11
968299|NCT00637377|3188491|P3|Overall Study|Withdrawal by Subject|13
968300|NCT00637377|3188492|P2|Overall Study|Withdrawal by Subject|15
968301|NCT00637377|3188493|P1|Overall Study|Withdrawal by Subject|11
968302|NCT00637377|3188490|P4|Overall Study|Protocol Violation|0
968303|NCT00637377|3188491|P3|Overall Study|Protocol Violation|1
968304|NCT00637377|3188492|P2|Overall Study|Protocol Violation|1
968305|NCT00637377|3188493|P1|Overall Study|Protocol Violation|2
968306|NCT00637377|3188490|P4|Overall Study|Lost to Follow-up|2
968307|NCT00637377|3188491|P3|Overall Study|Lost to Follow-up|2
968308|NCT00637377|3188492|P2|Overall Study|Lost to Follow-up|1
968309|NCT00637377|3188493|P1|Overall Study|Lost to Follow-up|4
968310|NCT00637377|3188490|P4|Overall Study|Lack of Efficacy|1
968311|NCT00637377|3188491|P3|Overall Study|Lack of Efficacy|1
968312|NCT00637377|3188492|P2|Overall Study|Lack of Efficacy|0
968313|NCT00637377|3188493|P1|Overall Study|Lack of Efficacy|0
968314|NCT00637377|3188490|P4|Overall Study|Death|1
968315|NCT00637377|3188491|P3|Overall Study|Death|2
968316|NCT00637377|3188492|P2|Overall Study|Death|3
968317|NCT00637377|3188493|P1|Overall Study|Death|1
968318|NCT00637377|3188490|P4|Overall Study|Adverse Event|9
968319|NCT00637377|3188491|P3|Overall Study|Adverse Event|8
968320|NCT00637377|3188492|P2|Overall Study|Adverse Event|6
968321|NCT00637377|3188493|P1|Overall Study|Adverse Event|2
968322|NCT00637273|3188542|P3|Overall Study|Loss of Glucose Control|1
968323|NCT00637273|3188543|P2|Overall Study|Loss of Glucose Control|1
968324|NCT00637273|3188544|P1|Overall Study|Loss of Glucose Control|1
968325|NCT00637273|3188542|P3|Overall Study|Administrative|0
968326|NCT00637273|3188543|P2|Overall Study|Administrative|0
968327|NCT00637273|3188544|P1|Overall Study|Administrative|2
968328|NCT00637273|3188542|P3|Overall Study|Investigator Decision|1
968329|NCT00637273|3188543|P2|Overall Study|Investigator Decision|3
968330|NCT00637273|3188544|P1|Overall Study|Investigator Decision|1
968331|NCT00637273|3188542|P3|Overall Study|Withdrawal of Consent|18
968332|NCT00637273|3188543|P2|Overall Study|Withdrawal of Consent|6
968333|NCT00637273|3188544|P1|Overall Study|Withdrawal of Consent|18
968334|NCT00637273|3188542|P3|Overall Study|Protocol Violation|1
968335|NCT00637273|3188543|P2|Overall Study|Protocol Violation|4
968336|NCT00637273|3188544|P1|Overall Study|Protocol Violation|2
968337|NCT00637273|3188542|P3|Overall Study|Lost to Follow-up|13
968338|NCT00637273|3188543|P2|Overall Study|Lost to Follow-up|9
968339|NCT00637273|3188544|P1|Overall Study|Lost to Follow-up|8
968340|NCT00637273|3188542|P3|Overall Study|Adverse Event|7
968341|NCT00637273|3188543|P2|Overall Study|Adverse Event|5
968342|NCT00637273|3188544|P1|Overall Study|Adverse Event|11
968343|NCT00637195|3188600|P2|Overall Study|Withdrawal by Subject|1
968344|NCT00637195|3188601|P1|Overall Study|Withdrawal by Subject|0
968345|NCT00637195|3188600|P2|Overall Study|Other|0
968346|NCT00637195|3188601|P1|Overall Study|Other|2
968347|NCT00637195|3188600|P2|Overall Study|Lost to Follow-up|0
968348|NCT00637195|3188601|P1|Overall Study|Lost to Follow-up|1
968349|NCT00637156|3188637|P2|Overall Study|Lost to Follow-up|16
968350|NCT00637156|3188638|P1|Overall Study|Lost to Follow-up|10
968351|NCT00637156|3188637|P2|Overall Study|Death|1
968352|NCT00637156|3188638|P1|Overall Study|Death|0
968353|NCT00637156|3188637|P2|Overall Study|Withdrawal by Subject|7
968354|NCT00637156|3188638|P1|Overall Study|Withdrawal by Subject|0
968355|NCT00637000|3188680|P2|Overall Study|Withdrawal by Subject|3
968356|NCT00637000|3188681|P1|Overall Study|Withdrawal by Subject|4
968357|NCT00636987|3188721|P1|Overall Study|5 year visit window not complete|69
968358|NCT00636987|3188721|P1|Overall Study|Lost to Follow-up|63
968359|NCT00636987|3188721|P1|Overall Study|Explanted|13
968360|NCT00636987|3188721|P1|Overall Study|Death|44
968361|NCT00636961|3188731|P2|Period 2|Adverse Event|0
968362|NCT00636961|3188732|P1|Period 2|Adverse Event|1
968363|NCT00636961|3188731|P2|Period 1|Administrative problems|1
968364|NCT00636961|3188732|P1|Period 1|Administrative problems|1
968365|NCT00636818|3188746|P1|Overall Study|Withdrawal by Subject|4
968366|NCT00636818|3188746|P1|Overall Study|Protocol Violation|1
968367|NCT00636818|3188746|P1|Overall Study|Entry Criteria Exclusion|3
968368|NCT00636818|3188746|P1|Overall Study|Lost to Follow-up|2
968369|NCT00636818|3188746|P1|Overall Study|Adverse Event|1
968370|NCT00636792|3188771|P1|Overall Study|Other|3
968371|NCT00636792|3188771|P1|Overall Study|Withdrawal by Subject|3
968372|NCT00636792|3188771|P1|Overall Study|Progressive Disease|4
968373|NCT00636792|3188771|P1|Overall Study|Physician Decision|7
968374|NCT00636792|3188771|P1|Overall Study|Adverse Event|16
968375|NCT00636636|3188818|P2|Overall Study|Withdrawal by Subject|9
968376|NCT00636636|3188819|P1|Overall Study|Withdrawal by Subject|4
968377|NCT00636636|3188818|P2|Overall Study|Death|1
968378|NCT00636636|3188819|P1|Overall Study|Death|0
968379|NCT00636636|3188818|P2|Overall Study|Lost to Follow-up|1
968380|NCT00636636|3188819|P1|Overall Study|Lost to Follow-up|0
968381|NCT00636636|3188818|P2|Overall Study|Protocol Violation|2
968382|NCT00636636|3188819|P1|Overall Study|Protocol Violation|2
968383|NCT00636636|3188818|P2|Overall Study|Lack of Efficacy|12
968384|NCT00636636|3188819|P1|Overall Study|Lack of Efficacy|7
968385|NCT00636636|3188818|P2|Overall Study|Adverse Event|8
968386|NCT00636636|3188819|P1|Overall Study|Adverse Event|19
968387|NCT00636636|3188818|P2|Overall Study|Other reason|6
968388|NCT00636636|3188819|P1|Overall Study|Other reason|4
968389|NCT00636610|3188835|P2|Overall Study|Reason for discontinuation not available|2
968390|NCT00636610|3188836|P1|Overall Study|Reason for discontinuation not available|3
968391|NCT00636610|3188835|P2|Overall Study|Disease progression - clinical|3
968392|NCT00636610|3188836|P1|Overall Study|Disease progression - clinical|8
968393|NCT00636610|3188835|P2|Overall Study|Disease progression - radiographic|51
968394|NCT00636610|3188836|P1|Overall Study|Disease progression - radiographic|41
968395|NCT00636610|3188835|P2|Overall Study|Subject decision to withdraw|11
968396|NCT00636610|3188836|P1|Overall Study|Subject decision to withdraw|15
968397|NCT00636610|3188835|P2|Overall Study|Physician decision to withdraw patient|9
968398|NCT00636610|3188836|P1|Overall Study|Physician decision to withdraw patient|15
968399|NCT00636610|3188835|P2|Overall Study|Death|3
968400|NCT00636610|3188836|P1|Overall Study|Death|6
968401|NCT00636610|3188835|P2|Overall Study|Adverse Event|4
968402|NCT00636610|3188836|P1|Overall Study|Adverse Event|4
968403|NCT00636441|3188853|P7|Overall Study|Screen Failure|17
968404|NCT00636441|3188854|P6|Overall Study|Screen Failure|0
968405|NCT00636441|3188855|P5|Overall Study|Screen Failure|0
968406|NCT00636441|3188856|P4|Overall Study|Screen Failure|0
968407|NCT00636441|3188857|P3|Overall Study|Screen Failure|0
968408|NCT00636441|3188858|P2|Overall Study|Screen Failure|0
968409|NCT00636441|3188859|P1|Overall Study|Screen Failure|0
968410|NCT00636441|3188853|P7|Overall Study|Late, ineligible|1
968411|NCT00636441|3188854|P6|Overall Study|Late, ineligible|0
968412|NCT00636441|3188855|P5|Overall Study|Late, ineligible|0
968413|NCT00636441|3188856|P4|Overall Study|Late, ineligible|0
968414|NCT00636441|3188857|P3|Overall Study|Late, ineligible|0
968415|NCT00636441|3188858|P2|Overall Study|Late, ineligible|0
968416|NCT00636441|3188859|P1|Overall Study|Late, ineligible|0
968417|NCT00636441|3188853|P7|Overall Study|Adverse Event|0
968418|NCT00636441|3188854|P6|Overall Study|Adverse Event|1
968419|NCT00636441|3188855|P5|Overall Study|Adverse Event|0
968420|NCT00636441|3188856|P4|Overall Study|Adverse Event|0
968421|NCT00636441|3188857|P3|Overall Study|Adverse Event|1
968422|NCT00636441|3188858|P2|Overall Study|Adverse Event|1
968423|NCT00636441|3188859|P1|Overall Study|Adverse Event|0
968424|NCT00636363|3188902|P3|Overall Study|Withdrawal by Subject|2
968425|NCT00636363|3188903|P2|Overall Study|Withdrawal by Subject|3
968426|NCT00636363|3188904|P1|Overall Study|Withdrawal by Subject|1
968427|NCT00636363|3188902|P3|Overall Study|Lost to Follow-up|2
968428|NCT00636363|3188903|P2|Overall Study|Lost to Follow-up|4
968429|NCT00636363|3188904|P1|Overall Study|Lost to Follow-up|3
968430|NCT00636363|3188902|P3|Overall Study|Protocol Violation|0
968431|NCT00636363|3188903|P2|Overall Study|Protocol Violation|3
968432|NCT00636363|3188904|P1|Overall Study|Protocol Violation|0
968433|NCT00636363|3188902|P3|Overall Study|Lack of motivation|1
968434|NCT00636363|3188903|P2|Overall Study|Lack of motivation|0
968435|NCT00636363|3188904|P1|Overall Study|Lack of motivation|1
968436|NCT00636363|3188902|P3|Overall Study|Missed > 1 visit|3
968437|NCT00636363|3188903|P2|Overall Study|Missed > 1 visit|1
968438|NCT00636363|3188904|P1|Overall Study|Missed > 1 visit|0
968439|NCT00636363|3188902|P3|Overall Study|Met ineligibility criteria|3
968440|NCT00636363|3188903|P2|Overall Study|Met ineligibility criteria|0
968441|NCT00636363|3188904|P1|Overall Study|Met ineligibility criteria|0
968442|NCT00636363|3188902|P3|Overall Study|Study related symptoms/complaints|4
968443|NCT00636363|3188903|P2|Overall Study|Study related symptoms/complaints|7
968444|NCT00636363|3188904|P1|Overall Study|Study related symptoms/complaints|8
968445|NCT00636363|3188902|P3|Overall Study|Positive slit lamp finding|1
968446|NCT00636363|3188903|P2|Overall Study|Positive slit lamp finding|2
968447|NCT00636363|3188904|P1|Overall Study|Positive slit lamp finding|0
968448|NCT00636363|3188902|P3|Overall Study|Adverse Event|1
968449|NCT00636363|3188903|P2|Overall Study|Adverse Event|0
968450|NCT00636363|3188904|P1|Overall Study|Adverse Event|0
968451|NCT00636363|3188902|P3|Overall Study|Conjunctivitis|1
968452|NCT00636363|3188903|P2|Overall Study|Conjunctivitis|0
968453|NCT00636363|3188904|P1|Overall Study|Conjunctivitis|0
968454|NCT00636207|3188925|P7|Overall Study|Withdrawal by Subject|0
968455|NCT00636207|3188926|P6|Overall Study|Withdrawal by Subject|0
968456|NCT00636207|3188927|P5|Overall Study|Withdrawal by Subject|1
968457|NCT00636207|3188928|P4|Overall Study|Withdrawal by Subject|0
968458|NCT00636207|3188929|P3|Overall Study|Withdrawal by Subject|0
968459|NCT00636207|3188930|P2|Overall Study|Withdrawal by Subject|1
968460|NCT00636207|3188931|P1|Overall Study|Withdrawal by Subject|0
968461|NCT00636207|3188925|P7|Overall Study|Adverse Event|0
968462|NCT00636207|3188926|P6|Overall Study|Adverse Event|0
968463|NCT00636207|3188927|P5|Overall Study|Adverse Event|0
968464|NCT00636207|3188928|P4|Overall Study|Adverse Event|0
968465|NCT00636207|3188929|P3|Overall Study|Adverse Event|0
968466|NCT00636207|3188930|P2|Overall Study|Adverse Event|0
968467|NCT00636207|3188931|P1|Overall Study|Adverse Event|1
968468|NCT00636194|3188995|P2|Overall Study|Protocol Violation|0
968469|NCT00636194|3188996|P1|Overall Study|Protocol Violation|2
968470|NCT00636194|3188995|P2|Overall Study|Study related symptoms and complaints|0
968471|NCT00636194|3188996|P1|Overall Study|Study related symptoms and complaints|1
968472|NCT00636168|3189008|P2|Treated With Study Drug|Still remains on treatment|94
968473|NCT00636168|3189009|P1|Treated With Study Drug|Still remains on treatment|48
968474|NCT00636168|3189008|P2|Treated With Study Drug|non-specified|1
968475|NCT00636168|3189009|P1|Treated With Study Drug|non-specified|1
968476|NCT00636168|3189008|P2|Treated With Study Drug|No longer meets criteria|0
968477|NCT00636168|3189009|P1|Treated With Study Drug|No longer meets criteria|1
968478|NCT00636168|3189008|P2|Treated With Study Drug|Pregnancy|0
968479|NCT00636168|3189009|P1|Treated With Study Drug|Pregnancy|1
968480|NCT00636168|3189008|P2|Treated With Study Drug|Death|0
968481|NCT00636168|3189009|P1|Treated With Study Drug|Death|3
968482|NCT00636168|3189008|P2|Treated With Study Drug|Poor or non-compliance|3
968483|NCT00636168|3189009|P1|Treated With Study Drug|Poor or non-compliance|1
968484|NCT00636168|3189008|P2|Treated With Study Drug|Withdrawal by Subject|20
968485|NCT00636168|3189009|P1|Treated With Study Drug|Withdrawal by Subject|16
968486|NCT00636168|3189008|P2|Treated With Study Drug|Adverse Event|20
968487|NCT00636168|3189009|P1|Treated With Study Drug|Adverse Event|244
968488|NCT00636168|3189008|P2|Treated With Study Drug|Recurrence of disease|273
968489|NCT00636168|3189009|P1|Treated With Study Drug|Recurrence of disease|132
968490|NCT00636168|3189008|P2|Randomized to Study Drug|No longer met study criteria|0
968491|NCT00636168|3189009|P1|Randomized to Study Drug|No longer met study criteria|1
968492|NCT00636168|3189008|P2|Randomized to Study Drug|Adverse Event|0
968493|NCT00636168|3189009|P1|Randomized to Study Drug|Adverse Event|1
968494|NCT00636168|3189008|P2|Randomized to Study Drug|Withdrawal by Subject|2
968495|NCT00636168|3189009|P1|Randomized to Study Drug|Withdrawal by Subject|2
968496|NCT00636155|3189029|P1|Overall Study|Physician Decision|5
968497|NCT00636155|3189029|P1|Overall Study|Stem cell transplant|1
968498|NCT00636155|3189029|P1|Overall Study|Withdrawal by Subject|3
968499|NCT00636155|3189029|P1|Overall Study|Lack of Efficacy|1
968500|NCT00636155|3189029|P1|Overall Study|Adverse Event|8
968501|NCT00635999|3189071|P3|Overall Study|Withdrawal by Subject|1
968502|NCT00635999|3189072|P2|Overall Study|Withdrawal by Subject|2
968503|NCT00635999|3189073|P1|Overall Study|Withdrawal by Subject|4
968504|NCT00635882|3189090|P6|Overall Study|Protocol Violation|0
968505|NCT00635882|3189091|P5|Overall Study|Protocol Violation|0
968506|NCT00635882|3189092|P4|Overall Study|Protocol Violation|0
968507|NCT00635882|3189093|P3|Overall Study|Protocol Violation|0
968508|NCT00635882|3189094|P2|Overall Study|Protocol Violation|0
968509|NCT00635882|3189095|P1|Overall Study|Protocol Violation|1
968510|NCT00635804|3189225|P8|Overall Study|Withdrawal by Subject|0
968511|NCT00635804|3189226|P7|Overall Study|Withdrawal by Subject|0
968512|NCT00635804|3189227|P6|Overall Study|Withdrawal by Subject|0
968513|NCT00635804|3189228|P5|Overall Study|Withdrawal by Subject|0
968514|NCT00635804|3189229|P4|Overall Study|Withdrawal by Subject|0
968515|NCT00635804|3189230|P3|Overall Study|Withdrawal by Subject|0
968516|NCT00635804|3189231|P2|Overall Study|Withdrawal by Subject|0
968517|NCT00635804|3189232|P1|Overall Study|Withdrawal by Subject|1
968518|NCT00635804|3189225|P8|Overall Study|Adverse Event|0
968519|NCT00635804|3189226|P7|Overall Study|Adverse Event|0
968520|NCT00635804|3189227|P6|Overall Study|Adverse Event|1
968521|NCT00635804|3189228|P5|Overall Study|Adverse Event|0
968522|NCT00635804|3189229|P4|Overall Study|Adverse Event|0
968523|NCT00635804|3189230|P3|Overall Study|Adverse Event|0
968524|NCT00635804|3189231|P2|Overall Study|Adverse Event|0
968525|NCT00635804|3189232|P1|Overall Study|Adverse Event|0
968526|NCT00635778|3189336|P7|Overall Study|Progressive disease|4
968527|NCT00635778|3189337|P6|Overall Study|Progressive disease|14
968528|NCT00635778|3189338|P5|Overall Study|Progressive disease|5
968529|NCT00635778|3189339|P4|Overall Study|Progressive disease|4
968530|NCT00635778|3189340|P3|Overall Study|Progressive disease|3
968531|NCT00635778|3189341|P2|Overall Study|Progressive disease|3
968532|NCT00635778|3189342|P1|Overall Study|Progressive disease|0
968533|NCT00635778|3189336|P7|Overall Study|Withdrawal by Subject|1
968534|NCT00635778|3189337|P6|Overall Study|Withdrawal by Subject|1
968535|NCT00635778|3189338|P5|Overall Study|Withdrawal by Subject|0
968536|NCT00635778|3189339|P4|Overall Study|Withdrawal by Subject|1
968537|NCT00635778|3189340|P3|Overall Study|Withdrawal by Subject|0
968538|NCT00635778|3189341|P2|Overall Study|Withdrawal by Subject|0
968539|NCT00635778|3189342|P1|Overall Study|Withdrawal by Subject|0
968540|NCT00635778|3189336|P7|Overall Study|Adverse Event|1
968541|NCT00635778|3189337|P6|Overall Study|Adverse Event|6
968542|NCT00635778|3189338|P5|Overall Study|Adverse Event|3
968543|NCT00635778|3189339|P4|Overall Study|Adverse Event|3
968544|NCT00635778|3189340|P3|Overall Study|Adverse Event|0
968545|NCT00635778|3189341|P2|Overall Study|Adverse Event|0
968546|NCT00635778|3189342|P1|Overall Study|Adverse Event|1
968547|NCT00635661|3189402|P1|Overall Study|Withdrawal by Subject|4
968548|NCT00635648|3189406|P1|Overall Study|Other reason|2
968549|NCT00635648|3189406|P1|Overall Study|Noncompliance with protocol|1
968550|NCT00635648|3189406|P1|Overall Study|No improvement after 7-10 days treatment|4
968551|NCT00635648|3189406|P1|Overall Study|Use of other antifungal agent needed|1
968552|NCT00635648|3189406|P1|Overall Study|Rapid progression of baseline disease|4
968553|NCT00635648|3189406|P1|Overall Study|Physician Decision|4
968554|NCT00635648|3189406|P1|Overall Study|Withdrawal by Subject|9
968555|NCT00635648|3189406|P1|Overall Study|Adverse Event|12
968556|NCT00635570|3189428|P2|Overall Study|Early termination(No sexual activity)|1
968557|NCT00635570|3189429|P1|Overall Study|Early termination(No sexual activity)|1
968558|NCT00635570|3189428|P2|Overall Study|Did not complete survey|1
968559|NCT00635570|3189429|P1|Overall Study|Did not complete survey|2
968560|NCT00635570|3189428|P2|Overall Study|Physician Decision|0
968561|NCT00635570|3189429|P1|Overall Study|Physician Decision|1
968562|NCT00635570|3189428|P2|Overall Study|Adverse Event|0
968563|NCT00635570|3189429|P1|Overall Study|Adverse Event|2
968564|NCT00635570|3189428|P2|Overall Study|Withdrawal by Subject|1
968565|NCT00635570|3189429|P1|Overall Study|Withdrawal by Subject|1
968566|NCT00635570|3189428|P2|Overall Study|Lost to Follow-up|8
968567|NCT00635570|3189429|P1|Overall Study|Lost to Follow-up|8
968568|NCT00635492|3189443|P2|Overall Study|Withdrawal by Subject|45
968569|NCT00635492|3189444|P1|Overall Study|Withdrawal by Subject|82
968570|NCT00635492|3189443|P2|Overall Study|Sponsor decision|3
968571|NCT00635492|3189444|P1|Overall Study|Sponsor decision|2
968572|NCT00635492|3189443|P2|Overall Study|Physician Decision|22
968573|NCT00635492|3189444|P1|Overall Study|Physician Decision|32
968574|NCT00635492|3189443|P2|Overall Study|Lost to Follow-up|172
968575|NCT00635492|3189444|P1|Overall Study|Lost to Follow-up|151
968576|NCT00635492|3189443|P2|Overall Study|Death|40
968577|NCT00635492|3189444|P1|Overall Study|Death|12
968578|NCT00635427|3189502|P5|Overall Study|Withdrawal Of Consent|2
968579|NCT00635427|3189503|P4|Overall Study|Withdrawal Of Consent|2
968580|NCT00635427|3189504|P3|Overall Study|Withdrawal Of Consent|0
968581|NCT00635427|3189505|P2|Overall Study|Withdrawal Of Consent|0
968582|NCT00635427|3189506|P1|Overall Study|Withdrawal Of Consent|0
968583|NCT00635427|3189502|P5|Overall Study|Termination Of Study By Sponsor|6
968584|NCT00635427|3189503|P4|Overall Study|Termination Of Study By Sponsor|6
968585|NCT00635427|3189504|P3|Overall Study|Termination Of Study By Sponsor|10
968586|NCT00635427|3189505|P2|Overall Study|Termination Of Study By Sponsor|6
968587|NCT00635427|3189506|P1|Overall Study|Termination Of Study By Sponsor|12
968588|NCT00635427|3189502|P5|Overall Study|Death|0
968589|NCT00635427|3189503|P4|Overall Study|Death|1
968590|NCT00635427|3189504|P3|Overall Study|Death|0
968591|NCT00635427|3189505|P2|Overall Study|Death|0
968592|NCT00635427|3189506|P1|Overall Study|Death|0
968593|NCT00635427|3189502|P5|Overall Study|Refusal Of Required DiagnosticEvaluation|0
968594|NCT00635427|3189503|P4|Overall Study|Refusal Of Required DiagnosticEvaluation|0
968595|NCT00635427|3189504|P3|Overall Study|Refusal Of Required DiagnosticEvaluation|1
968596|NCT00635427|3189505|P2|Overall Study|Refusal Of Required DiagnosticEvaluation|0
968597|NCT00635427|3189506|P1|Overall Study|Refusal Of Required DiagnosticEvaluation|0
968598|NCT00635349|3189545|P2|Overall Study|Adverse Event|9
968599|NCT00635349|3189546|P1|Overall Study|Adverse Event|11
968600|NCT00635349|3189545|P2|Overall Study|Lost to Follow-up|3
968601|NCT00635349|3189546|P1|Overall Study|Lost to Follow-up|4
968602|NCT00635349|3189545|P2|Overall Study|Withdrawal by Subject|8
968603|NCT00635349|3189546|P1|Overall Study|Withdrawal by Subject|3
968604|NCT00635349|3189545|P2|Overall Study|Protocol Violation|22
968605|NCT00635349|3189546|P1|Overall Study|Protocol Violation|18
968606|NCT00635349|3189545|P2|Overall Study|Other|6
968607|NCT00635349|3189546|P1|Overall Study|Other|8
968608|NCT00635219|3189600|P5|Overall Study|Administrative or Other Reasons|1
968609|NCT00635219|3189601|P4|Overall Study|Administrative or Other Reasons|0
968610|NCT00635219|3189602|P3|Overall Study|Administrative or Other Reasons|1
968611|NCT00635219|3189603|P2|Overall Study|Administrative or Other Reasons|1
968612|NCT00635219|3189604|P1|Overall Study|Administrative or Other Reasons|0
968613|NCT00635219|3189600|P5|Overall Study|Lost to Follow-up|3
968614|NCT00635219|3189601|P4|Overall Study|Lost to Follow-up|0
968615|NCT00635219|3189602|P3|Overall Study|Lost to Follow-up|2
968616|NCT00635219|3189603|P2|Overall Study|Lost to Follow-up|0
968617|NCT00635219|3189604|P1|Overall Study|Lost to Follow-up|0
968618|NCT00635219|3189600|P5|Overall Study|Withdrawal of Consent|8
968619|NCT00635219|3189601|P4|Overall Study|Withdrawal of Consent|11
968620|NCT00635219|3189602|P3|Overall Study|Withdrawal of Consent|8
968621|NCT00635219|3189603|P2|Overall Study|Withdrawal of Consent|6
968622|NCT00635219|3189604|P1|Overall Study|Withdrawal of Consent|8
968623|NCT00635219|3189600|P5|Overall Study|Protocol Violation|4
968624|NCT00635219|3189601|P4|Overall Study|Protocol Violation|2
968625|NCT00635219|3189602|P3|Overall Study|Protocol Violation|3
968626|NCT00635219|3189603|P2|Overall Study|Protocol Violation|2
968627|NCT00635219|3189604|P1|Overall Study|Protocol Violation|0
968628|NCT00635219|3189600|P5|Overall Study|Non-compliance With Study Product|1
968629|NCT00635219|3189601|P4|Overall Study|Non-compliance With Study Product|2
968630|NCT00635219|3189602|P3|Overall Study|Non-compliance With Study Product|0
968631|NCT00635219|3189603|P2|Overall Study|Non-compliance With Study Product|0
968632|NCT00635219|3189604|P1|Overall Study|Non-compliance With Study Product|0
968633|NCT00635219|3189600|P5|Overall Study|Lack of Efficacy|6
968634|NCT00635219|3189601|P4|Overall Study|Lack of Efficacy|4
968635|NCT00635219|3189602|P3|Overall Study|Lack of Efficacy|3
968636|NCT00635219|3189603|P2|Overall Study|Lack of Efficacy|6
968637|NCT00635219|3189604|P1|Overall Study|Lack of Efficacy|5
968638|NCT00635219|3189600|P5|Overall Study|Adverse Event|19
968639|NCT00635219|3189601|P4|Overall Study|Adverse Event|15
968640|NCT00635219|3189602|P3|Overall Study|Adverse Event|18
968641|NCT00635219|3189603|P2|Overall Study|Adverse Event|10
968642|NCT00635219|3189604|P1|Overall Study|Adverse Event|12
968643|NCT00635154|3189667|P1|Overall Study|Still on treatment|21
968644|NCT00635154|3189667|P1|Overall Study|Other|4
968645|NCT00635154|3189667|P1|Overall Study|Alternative Treatment|8
968646|NCT00635102|3189710|P2|Overall Study|Withdrawal by Subject|8
968647|NCT00635102|3189711|P1|Overall Study|Withdrawal by Subject|7
968648|NCT00635089|3189805|P1|Overall Study|Not Specified|31
968649|NCT00635089|3189805|P1|Overall Study|Lost to Follow-up|8
968650|NCT00635089|3189805|P1|Overall Study|Protocol Deviation|4
968651|NCT00635089|3189805|P1|Overall Study|Lack of Efficacy|28
968652|NCT00635089|3189805|P1|Overall Study|Adverse Event|7
968653|NCT00635050|3189832|P1|Overall Study|Withdrawal by Subject|1
968654|NCT00635024|3189839|P1|Overall Study|Adverse Event|1
968655|NCT00634933|3189850|P5|Part B: Week 24 to Week 52|Other|1
968656|NCT00634933|3189851|P4|Part B: Week 24 to Week 52|Other|0
968657|NCT00634933|3189852|P3|Part B: Week 24 to Week 52|Other|5
968658|NCT00634933|3189853|P2|Part B: Week 24 to Week 52|Other|0
968659|NCT00634933|3189854|P1|Part B: Week 24 to Week 52|Other|0
968660|NCT00634933|3189850|P5|Part B: Week 24 to Week 52|Lack of Efficacy|0
968661|NCT00634933|3189851|P4|Part B: Week 24 to Week 52|Lack of Efficacy|0
968662|NCT00634933|3189852|P3|Part B: Week 24 to Week 52|Lack of Efficacy|1
968663|NCT00634933|3189853|P2|Part B: Week 24 to Week 52|Lack of Efficacy|1
968664|NCT00634933|3189854|P1|Part B: Week 24 to Week 52|Lack of Efficacy|0
968665|NCT00634933|3189850|P5|Part B: Week 24 to Week 52|Withdrawal by Subject|1
968666|NCT00634933|3189851|P4|Part B: Week 24 to Week 52|Withdrawal by Subject|2
968667|NCT00634933|3189852|P3|Part B: Week 24 to Week 52|Withdrawal by Subject|0
968668|NCT00634933|3189853|P2|Part B: Week 24 to Week 52|Withdrawal by Subject|0
968669|NCT00634933|3189854|P1|Part B: Week 24 to Week 52|Withdrawal by Subject|0
968670|NCT00634933|3189850|P5|Part B: Week 24 to Week 52|Protocol Violation|1
968671|NCT00634933|3189851|P4|Part B: Week 24 to Week 52|Protocol Violation|0
968672|NCT00634933|3189852|P3|Part B: Week 24 to Week 52|Protocol Violation|0
968673|NCT00634933|3189853|P2|Part B: Week 24 to Week 52|Protocol Violation|0
968674|NCT00634933|3189854|P1|Part B: Week 24 to Week 52|Protocol Violation|0
968675|NCT00634933|3189850|P5|Part B: Week 24 to Week 52|Physician Decision|0
968676|NCT00634933|3189851|P4|Part B: Week 24 to Week 52|Physician Decision|0
968677|NCT00634933|3189852|P3|Part B: Week 24 to Week 52|Physician Decision|1
968678|NCT00634933|3189853|P2|Part B: Week 24 to Week 52|Physician Decision|1
968679|NCT00634933|3189854|P1|Part B: Week 24 to Week 52|Physician Decision|0
968680|NCT00634933|3189850|P5|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7
968681|NCT00634933|3189851|P4|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3
968682|NCT00634933|3189852|P3|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14
968683|NCT00634933|3189853|P2|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11
968684|NCT00634933|3189854|P1|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0
968685|NCT00634933|3189850|P5|Part B: Week 24 to Week 52|Adverse Event|0
968686|NCT00634933|3189851|P4|Part B: Week 24 to Week 52|Adverse Event|1
968687|NCT00634933|3189852|P3|Part B: Week 24 to Week 52|Adverse Event|1
968688|NCT00634933|3189853|P2|Part B: Week 24 to Week 52|Adverse Event|1
968689|NCT00634933|3189854|P1|Part B: Week 24 to Week 52|Adverse Event|0
968690|NCT00634933|3189850|P5|Between Part A and Part B|Physician Decision|0
968691|NCT00634933|3189851|P4|Between Part A and Part B|Physician Decision|0
968692|NCT00634933|3189852|P3|Between Part A and Part B|Physician Decision|0
968693|NCT00634933|3189853|P2|Between Part A and Part B|Physician Decision|1
968694|NCT00634933|3189854|P1|Between Part A and Part B|Physician Decision|0
968695|NCT00634933|3189850|P5|Part A: Baseline to Week 24|Other|0
968696|NCT00634933|3189851|P4|Part A: Baseline to Week 24|Other|0
968697|NCT00634933|3189852|P3|Part A: Baseline to Week 24|Other|5
968698|NCT00634933|3189853|P2|Part A: Baseline to Week 24|Other|8
968699|NCT00634933|3189854|P1|Part A: Baseline to Week 24|Other|1
968700|NCT00634933|3189850|P5|Part A: Baseline to Week 24|Lack of Efficacy|0
968701|NCT00634933|3189851|P4|Part A: Baseline to Week 24|Lack of Efficacy|0
968702|NCT00634933|3189852|P3|Part A: Baseline to Week 24|Lack of Efficacy|0
968703|NCT00634933|3189853|P2|Part A: Baseline to Week 24|Lack of Efficacy|1
968704|NCT00634933|3189854|P1|Part A: Baseline to Week 24|Lack of Efficacy|3
968705|NCT00634933|3189850|P5|Part A: Baseline to Week 24|Withdrawal by Subject|0
968706|NCT00634933|3189851|P4|Part A: Baseline to Week 24|Withdrawal by Subject|0
968707|NCT00634933|3189852|P3|Part A: Baseline to Week 24|Withdrawal by Subject|3
968708|NCT00634933|3189853|P2|Part A: Baseline to Week 24|Withdrawal by Subject|3
968709|NCT00634933|3189854|P1|Part A: Baseline to Week 24|Withdrawal by Subject|0
968710|NCT00634933|3189850|P5|Part A: Baseline to Week 24|Lost to Follow-up|0
968711|NCT00634933|3189851|P4|Part A: Baseline to Week 24|Lost to Follow-up|0
968712|NCT00634933|3189852|P3|Part A: Baseline to Week 24|Lost to Follow-up|1
968713|NCT00634933|3189853|P2|Part A: Baseline to Week 24|Lost to Follow-up|1
968714|NCT00634933|3189854|P1|Part A: Baseline to Week 24|Lost to Follow-up|0
968715|NCT00634933|3189850|P5|Part A: Baseline to Week 24|Investigator Request|0
968716|NCT00634933|3189851|P4|Part A: Baseline to Week 24|Investigator Request|0
968717|NCT00634933|3189852|P3|Part A: Baseline to Week 24|Investigator Request|1
968718|NCT00634933|3189853|P2|Part A: Baseline to Week 24|Investigator Request|1
968719|NCT00634933|3189854|P1|Part A: Baseline to Week 24|Investigator Request|1
968720|NCT00634933|3189850|P5|Part A: Baseline to Week 24|Failed to Return|0
968721|NCT00634933|3189851|P4|Part A: Baseline to Week 24|Failed to Return|0
968722|NCT00634933|3189852|P3|Part A: Baseline to Week 24|Failed to Return|0
968723|NCT00634933|3189853|P2|Part A: Baseline to Week 24|Failed to Return|0
968724|NCT00634933|3189854|P1|Part A: Baseline to Week 24|Failed to Return|1
968725|NCT00634933|3189850|P5|Part A: Baseline to Week 24|Death|0
968726|NCT00634933|3189851|P4|Part A: Baseline to Week 24|Death|0
968727|NCT00634933|3189852|P3|Part A: Baseline to Week 24|Death|0
968728|NCT00634933|3189853|P2|Part A: Baseline to Week 24|Death|0
968729|NCT00634933|3189854|P1|Part A: Baseline to Week 24|Death|1
968730|NCT00634933|3189850|P5|Part A: Baseline to Week 24|Adverse Event|0
968731|NCT00634933|3189851|P4|Part A: Baseline to Week 24|Adverse Event|0
968732|NCT00634933|3189852|P3|Part A: Baseline to Week 24|Adverse Event|8
968733|NCT00634933|3189853|P2|Part A: Baseline to Week 24|Adverse Event|4
968734|NCT00634933|3189854|P1|Part A: Baseline to Week 24|Adverse Event|4
968735|NCT00634920|3189923|P3|Period 2 - Post-Randomization|Patients did not receive study drug|0
968736|NCT00634920|3189924|P2|Period 2 - Post-Randomization|Patients did not receive study drug|0
968737|NCT00634920|3189925|P1|Period 2 - Post-Randomization|Patients did not receive study drug|2
968738|NCT00634920|3189923|P3|Period 2 - Post-Randomization|consent withdrawal, non compliance|0
968739|NCT00634920|3189924|P2|Period 2 - Post-Randomization|consent withdrawal, non compliance|13
968740|NCT00634920|3189925|P1|Period 2 - Post-Randomization|consent withdrawal, non compliance|9
968741|NCT00634920|3189923|P3|Period 2 - Post-Randomization|Death|0
968742|NCT00634920|3189924|P2|Period 2 - Post-Randomization|Death|5
968743|NCT00634920|3189925|P1|Period 2 - Post-Randomization|Death|2
968744|NCT00634920|3189923|P3|Period 2 - Post-Randomization|Rejection|0
968745|NCT00634920|3189924|P2|Period 2 - Post-Randomization|Rejection|5
968746|NCT00634920|3189925|P1|Period 2 - Post-Randomization|Rejection|11
968747|NCT00634920|3189923|P3|Period 2 - Post-Randomization|Adverse Event|0
968748|NCT00634920|3189924|P2|Period 2 - Post-Randomization|Adverse Event|9
968749|NCT00634920|3189925|P1|Period 2 - Post-Randomization|Adverse Event|37
968750|NCT00634920|3189923|P3|Period 1 - Pre-Randomization|Other issues|6
968751|NCT00634920|3189924|P2|Period 1 - Pre-Randomization|Other issues|0
968752|NCT00634920|3189925|P1|Period 1 - Pre-Randomization|Other issues|0
968753|NCT00634920|3189923|P3|Period 1 - Pre-Randomization|Non-Compliance|3
968754|NCT00634920|3189924|P2|Period 1 - Pre-Randomization|Non-Compliance|0
968755|NCT00634920|3189925|P1|Period 1 - Pre-Randomization|Non-Compliance|0
968756|NCT00634920|3189923|P3|Period 1 - Pre-Randomization|Withdrawal by Subject|21
968757|NCT00634920|3189924|P2|Period 1 - Pre-Randomization|Withdrawal by Subject|0
968758|NCT00634920|3189925|P1|Period 1 - Pre-Randomization|Withdrawal by Subject|0
968759|NCT00634920|3189923|P3|Period 1 - Pre-Randomization|Rejections|55
968760|NCT00634920|3189924|P2|Period 1 - Pre-Randomization|Rejections|0
968761|NCT00634920|3189925|P1|Period 1 - Pre-Randomization|Rejections|0
968762|NCT00634920|3189923|P3|Period 1 - Pre-Randomization|Wound healing problems|16
968763|NCT00634920|3189924|P2|Period 1 - Pre-Randomization|Wound healing problems|0
968764|NCT00634920|3189925|P1|Period 1 - Pre-Randomization|Wound healing problems|0
968765|NCT00634920|3189923|P3|Period 1 - Pre-Randomization|Adverse Event|36
968766|NCT00634920|3189924|P2|Period 1 - Pre-Randomization|Adverse Event|0
968767|NCT00634920|3189925|P1|Period 1 - Pre-Randomization|Adverse Event|0
968768|NCT00634907|3189969|P2|Overall Study|Withdrawal by Subject|8
968769|NCT00634907|3189970|P1|Overall Study|Withdrawal by Subject|11
968770|NCT00634907|3189969|P2|Overall Study|Physician Decision|9
968771|NCT00634907|3189970|P1|Overall Study|Physician Decision|3
968772|NCT00634907|3189969|P2|Overall Study|Withdrawal by Subject|0
968773|NCT00634907|3189970|P1|Overall Study|Withdrawal by Subject|3
968774|NCT00634842|3189994|P2|Overall Study|Subject off study drug for too long|1
968775|NCT00634842|3189995|P1|Overall Study|Subject off study drug for too long|0
968776|NCT00634842|3189994|P2|Overall Study|No wish to keep taking Avandia|1
968777|NCT00634842|3189995|P1|Overall Study|No wish to keep taking Avandia|0
968778|NCT00634842|3189994|P2|Overall Study|No need of study drug to treat diabetes|1
968779|NCT00634842|3189995|P1|Overall Study|No need of study drug to treat diabetes|0
968780|NCT00634842|3189994|P2|Overall Study|Discontinued due to injection|2
968781|NCT00634842|3189995|P1|Overall Study|Discontinued due to injection|0
968782|NCT00634842|3189994|P2|Overall Study|Lack of time and intolerance to drug|1
968783|NCT00634842|3189995|P1|Overall Study|Lack of time and intolerance to drug|0
968784|NCT00634842|3189994|P2|Overall Study|Withdrawal by Subject|3
968785|NCT00634842|3189995|P1|Overall Study|Withdrawal by Subject|1
968786|NCT00634842|3189994|P2|Overall Study|Physician Decision|0
968787|NCT00634842|3189995|P1|Overall Study|Physician Decision|1
968788|NCT00634842|3189994|P2|Overall Study|Lost to Follow-up|2
968789|NCT00634842|3189995|P1|Overall Study|Lost to Follow-up|1
968790|NCT00634842|3189994|P2|Overall Study|Inclusion criteria were not met|0
968791|NCT00634842|3189995|P1|Overall Study|Inclusion criteria were not met|1
968792|NCT00634842|3189994|P2|Overall Study|Move to another state|0
968793|NCT00634842|3189995|P1|Overall Study|Move to another state|1
968794|NCT00634842|3189994|P2|Overall Study|Protocol Violation|4
968795|NCT00634842|3189995|P1|Overall Study|Protocol Violation|8
968796|NCT00634842|3189994|P2|Overall Study|Adverse Event|3
968797|NCT00634842|3189995|P1|Overall Study|Adverse Event|2
968798|NCT00634751|3190011|P4|Pancreatic and Bilial Tract Cancer|Death|1
968799|NCT00634751|3190012|P3|Pancreatic and Bilial Tract Cancer|Death|1
968800|NCT00634751|3190013|P2|Pancreatic and Bilial Tract Cancer|Death|0
968801|NCT00634751|3190014|P1|Pancreatic and Bilial Tract Cancer|Death|0
968802|NCT00634751|3190011|P4|Phase I: 400mg Sorafenib BID+2DOC|Death|0
968803|NCT00634751|3190012|P3|Phase I: 400mg Sorafenib BID+2DOC|Death|0
968804|NCT00634751|3190013|P2|Phase I: 400mg Sorafenib BID+2DOC|Death|1
968805|NCT00634751|3190014|P1|Phase I: 400mg Sorafenib BID+2DOC|Death|0
968806|NCT00634751|3190011|P4|Phase I: 200mg Sorafenib+2DOC|Death|0
968807|NCT00634751|3190012|P3|Phase I: 200mg Sorafenib+2DOC|Death|0
968808|NCT00634751|3190013|P2|Phase I: 200mg Sorafenib+2DOC|Death|0
968809|NCT00634751|3190014|P1|Phase I: 200mg Sorafenib+2DOC|Death|1
968810|NCT00634647|3190032|P1|Overall Study|declined to participate before treatment|1
968811|NCT00634647|3190032|P1|Overall Study|refused further treatment|3
968812|NCT00634647|3190032|P1|Overall Study|death on study|3
968813|NCT00634569|3190052|P2|Overall Study|Physician Decision|1
968814|NCT00634569|3190053|P1|Overall Study|Physician Decision|0
968815|NCT00634569|3190052|P2|Overall Study|Withdrawal by Subject|4
968816|NCT00634569|3190053|P1|Overall Study|Withdrawal by Subject|0
968817|NCT00634543|3190067|P2|Overall Study|Lost to Follow-up|1
968818|NCT00634543|3190068|P1|Overall Study|Lost to Follow-up|0
968819|NCT00634543|3190067|P2|Overall Study|Withdrawal by Subject|4
968820|NCT00634543|3190068|P1|Overall Study|Withdrawal by Subject|4
968821|NCT00634543|3190067|P2|Overall Study|Adverse Event|11
968822|NCT00634543|3190068|P1|Overall Study|Adverse Event|11
968823|NCT00634543|3190067|P2|Overall Study|Protocol Violation|3
968824|NCT00634543|3190068|P1|Overall Study|Protocol Violation|3
968825|NCT00634543|3190067|P2|Overall Study|Other|2
968826|NCT00634543|3190068|P1|Overall Study|Other|1
968827|NCT00634504|3190086|P2|Overall Study|Protocol Violation|0
968828|NCT00634504|3190087|P1|Overall Study|Protocol Violation|1
968829|NCT00634244|3190138|P3|Overall Study|Other complicating disease|0
968830|NCT00634244|3190139|P2|Overall Study|Other complicating disease|1
968831|NCT00634244|3190140|P1|Overall Study|Other complicating disease|0
968832|NCT00634244|3190138|P3|Overall Study|Disease progression/relapse|0
968833|NCT00634244|3190139|P2|Overall Study|Disease progression/relapse|1
968834|NCT00634244|3190140|P1|Overall Study|Disease progression/relapse|0
968835|NCT00634244|3190138|P3|Overall Study|Physician Decision|0
968836|NCT00634244|3190139|P2|Overall Study|Physician Decision|1
968837|NCT00634244|3190140|P1|Overall Study|Physician Decision|0
968838|NCT00634244|3190138|P3|Overall Study|Withdrawal by Subject|0
968839|NCT00634244|3190139|P2|Overall Study|Withdrawal by Subject|1
968840|NCT00634244|3190140|P1|Overall Study|Withdrawal by Subject|0
968841|NCT00634244|3190138|P3|Overall Study|Adverse Event|0
968842|NCT00634244|3190139|P2|Overall Study|Adverse Event|2
968843|NCT00634244|3190140|P1|Overall Study|Adverse Event|0
968844|NCT00634244|3190138|P3|Overall Study|Death|0
968845|NCT00634244|3190139|P2|Overall Study|Death|6
968846|NCT00634244|3190140|P1|Overall Study|Death|1
968847|NCT00634244|3190138|P3|Overall Study|Never started treatment|0
968848|NCT00634244|3190139|P2|Overall Study|Never started treatment|1
968849|NCT00634244|3190140|P1|Overall Study|Never started treatment|0
968850|NCT00634179|3190151|P1|Phase II: Maintenance|Diagnosis changed after re-review|1
968851|NCT00634114|3190170|P3|Overall Study|Other reason|1
968852|NCT00634114|3190171|P2|Overall Study|Other reason|1
968853|NCT00634114|3190172|P1|Overall Study|Other reason|1
968854|NCT00634114|3190170|P3|Overall Study|Difficult to continue|1
968855|NCT00634114|3190171|P2|Overall Study|Difficult to continue|1
968856|NCT00634114|3190172|P1|Overall Study|Difficult to continue|3
968857|NCT00634114|3190170|P3|Overall Study|Recurrence of reflux esophagitis|21
968858|NCT00634114|3190171|P2|Overall Study|Recurrence of reflux esophagitis|15
968859|NCT00634114|3190172|P1|Overall Study|Recurrence of reflux esophagitis|5
968860|NCT00634114|3190170|P3|Overall Study|Incorrect enrolment|0
968861|NCT00634114|3190171|P2|Overall Study|Incorrect enrolment|1
968862|NCT00634114|3190172|P1|Overall Study|Incorrect enrolment|0
968863|NCT00634114|3190170|P3|Overall Study|Pregnancy|0
968864|NCT00634114|3190171|P2|Overall Study|Pregnancy|0
968865|NCT00634114|3190172|P1|Overall Study|Pregnancy|1
968866|NCT00634114|3190170|P3|Overall Study|Protocol Violation|1
968867|NCT00634114|3190171|P2|Overall Study|Protocol Violation|3
968868|NCT00634114|3190172|P1|Overall Study|Protocol Violation|3
968869|NCT00634114|3190170|P3|Overall Study|Lost to Follow-up|1
968870|NCT00634114|3190171|P2|Overall Study|Lost to Follow-up|0
968871|NCT00634114|3190172|P1|Overall Study|Lost to Follow-up|0
968872|NCT00634114|3190170|P3|Overall Study|Withdrawal by Subject|11
968873|NCT00634114|3190171|P2|Overall Study|Withdrawal by Subject|6
968874|NCT00634114|3190172|P1|Overall Study|Withdrawal by Subject|9
968875|NCT00634114|3190170|P3|Overall Study|Adverse Event|3
968876|NCT00634114|3190171|P2|Overall Study|Adverse Event|8
968877|NCT00634114|3190172|P1|Overall Study|Adverse Event|6
968878|NCT00634088|3190190|P4|Time Period 3: Dose Level 3|Progressive disease|0
968879|NCT00634088|3190191|P3|Time Period 3: Dose Level 3|Progressive disease|1
968880|NCT00634088|3190192|P2|Time Period 3: Dose Level 3|Progressive disease|0
968881|NCT00634088|3190193|P1|Time Period 3: Dose Level 3|Progressive disease|0
968882|NCT00634088|3190190|P4|Time Period 2: Dose Level 2|Progressive disease|0
968883|NCT00634088|3190191|P3|Time Period 2: Dose Level 2|Progressive disease|0
968884|NCT00634088|3190192|P2|Time Period 2: Dose Level 2|Progressive disease|1
968885|NCT00634088|3190193|P1|Time Period 2: Dose Level 2|Progressive disease|0
968886|NCT00634088|3190190|P4|Time Period 2: Dose Level 2|Adverse Event|0
968887|NCT00634088|3190191|P3|Time Period 2: Dose Level 2|Adverse Event|0
968888|NCT00634088|3190192|P2|Time Period 2: Dose Level 2|Adverse Event|2
968889|NCT00634088|3190193|P1|Time Period 2: Dose Level 2|Adverse Event|0
968890|NCT00634088|3190190|P4|Time Period 1: Dose Level 1|Adverse Event|0
968891|NCT00634088|3190191|P3|Time Period 1: Dose Level 1|Adverse Event|0
968892|NCT00634088|3190192|P2|Time Period 1: Dose Level 1|Adverse Event|0
968893|NCT00634088|3190193|P1|Time Period 1: Dose Level 1|Adverse Event|3
968894|NCT00634088|3190190|P4|Time Period 1: Dose Level 1|Physician Decision|0
968895|NCT00634088|3190191|P3|Time Period 1: Dose Level 1|Physician Decision|0
968896|NCT00634088|3190192|P2|Time Period 1: Dose Level 1|Physician Decision|0
968897|NCT00634088|3190193|P1|Time Period 1: Dose Level 1|Physician Decision|1
968898|NCT00634088|3190190|P4|Time Period 1: Dose Level 1|Disease progression|0
968899|NCT00634088|3190191|P3|Time Period 1: Dose Level 1|Disease progression|0
968900|NCT00634088|3190192|P2|Time Period 1: Dose Level 1|Disease progression|0
968901|NCT00634088|3190193|P1|Time Period 1: Dose Level 1|Disease progression|2
968902|NCT00634049|3190244|P1|Overall Study|Screening failure|1
968903|NCT00634049|3190244|P1|Overall Study|Died prior to receiving study drug|1
968904|NCT00634049|3190244|P1|Overall Study|Never received study drug|1
968905|NCT00634036|3190323|P2|Overall Study|Withdrawal by Subject|1
968906|NCT00634036|3190324|P1|Overall Study|Withdrawal by Subject|1
968907|NCT00634036|3190323|P2|Overall Study|Lost to Follow-up|1
968908|NCT00634036|3190324|P1|Overall Study|Lost to Follow-up|1
968909|NCT00634010|3190338|P2|Overall Study|Non-Compliant|1
968910|NCT00634010|3190339|P1|Overall Study|Non-Compliant|1
968911|NCT00634010|3190338|P2|Overall Study|Disease Progression|1
968912|NCT00634010|3190339|P1|Overall Study|Disease Progression|1
968913|NCT00634010|3190338|P2|Overall Study|Physician Decision|1
968914|NCT00634010|3190339|P1|Overall Study|Physician Decision|1
968915|NCT00634010|3190338|P2|Overall Study|Withdrawal by Subject|6
968916|NCT00634010|3190339|P1|Overall Study|Withdrawal by Subject|5
968917|NCT00634010|3190338|P2|Overall Study|Adverse Event|5
968918|NCT00634010|3190339|P1|Overall Study|Adverse Event|2
968919|NCT00633984|3190347|P2|Overall Study|Hospitalized|0
968920|NCT00633984|3190348|P1|Overall Study|Hospitalized|1
968921|NCT00633984|3190347|P2|Overall Study|Withdrawal by Subject|7
968922|NCT00633984|3190348|P1|Overall Study|Withdrawal by Subject|8
968923|NCT00633984|3190347|P2|Overall Study|Lost to Follow-up|6
968924|NCT00633984|3190348|P1|Overall Study|Lost to Follow-up|0
968925|NCT00633932|3190359|P3|Overall Study|Moved Away|0
968926|NCT00633932|3190360|P2|Overall Study|Moved Away|0
968927|NCT00633932|3190361|P1|Overall Study|Moved Away|1
968928|NCT00633932|3190359|P3|Overall Study|Doctor's judgement|0
968929|NCT00633932|3190360|P2|Overall Study|Doctor's judgement|0
968930|NCT00633932|3190361|P1|Overall Study|Doctor's judgement|1
968931|NCT00633932|3190359|P3|Overall Study|Physician Decision|1
968932|NCT00633932|3190360|P2|Overall Study|Physician Decision|0
968933|NCT00633932|3190361|P1|Overall Study|Physician Decision|0
968934|NCT00633932|3190359|P3|Overall Study|Protocol Violation|3
968935|NCT00633932|3190360|P2|Overall Study|Protocol Violation|2
968936|NCT00633932|3190361|P1|Overall Study|Protocol Violation|5
968937|NCT00633932|3190359|P3|Overall Study|Lost to Follow-up|2
968938|NCT00633932|3190360|P2|Overall Study|Lost to Follow-up|0
968939|NCT00633932|3190361|P1|Overall Study|Lost to Follow-up|1
968940|NCT00633932|3190359|P3|Overall Study|Withdrawal by Subject|1
968941|NCT00633932|3190360|P2|Overall Study|Withdrawal by Subject|9
968942|NCT00633932|3190361|P1|Overall Study|Withdrawal by Subject|3
968943|NCT00633932|3190359|P3|Overall Study|Adverse Event|4
968944|NCT00633932|3190360|P2|Overall Study|Adverse Event|3
968945|NCT00633932|3190361|P1|Overall Study|Adverse Event|1
968946|NCT00633893|3190392|P3|Overall Study|not specified|31
968947|NCT00633893|3190393|P2|Overall Study|not specified|33
968948|NCT00633893|3190394|P1|Overall Study|not specified|28
968949|NCT00633893|3190392|P3|Overall Study|Not meet/no longer meets criteria|4
968950|NCT00633893|3190393|P2|Overall Study|Not meet/no longer meets criteria|6
968951|NCT00633893|3190394|P1|Overall Study|Not meet/no longer meets criteria|4
968952|NCT00633893|3190392|P3|Overall Study|Pregnancy|1
968953|NCT00633893|3190393|P2|Overall Study|Pregnancy|1
968954|NCT00633893|3190394|P1|Overall Study|Pregnancy|2
968955|NCT00633893|3190392|P3|Overall Study|Poor/non-compliance|3
968956|NCT00633893|3190393|P2|Overall Study|Poor/non-compliance|12
968957|NCT00633893|3190394|P1|Overall Study|Poor/non-compliance|5
968958|NCT00633893|3190392|P3|Overall Study|Lost to Follow-up|8
968959|NCT00633893|3190393|P2|Overall Study|Lost to Follow-up|4
968960|NCT00633893|3190394|P1|Overall Study|Lost to Follow-up|2
968961|NCT00633893|3190392|P3|Overall Study|Withdrawal by Subject|6
968962|NCT00633893|3190393|P2|Overall Study|Withdrawal by Subject|12
968963|NCT00633893|3190394|P1|Overall Study|Withdrawal by Subject|7
968964|NCT00633893|3190392|P3|Overall Study|Adverse Event|126
968965|NCT00633893|3190393|P2|Overall Study|Adverse Event|58
968966|NCT00633893|3190394|P1|Overall Study|Adverse Event|65
968967|NCT00633893|3190392|P3|Overall Study|Death|9
968968|NCT00633893|3190393|P2|Overall Study|Death|3
968969|NCT00633893|3190394|P1|Overall Study|Death|1
968970|NCT00633880|3190468|P3|Open Label Titration|Withdrawal by Subject|0
968971|NCT00633880|3190469|P2|Open Label Titration|Withdrawal by Subject|0
968972|NCT00633880|3190470|P1|Open Label Titration|Withdrawal by Subject|4
968973|NCT00633880|3190468|P3|Open Label Titration|Physician Decision|0
968974|NCT00633880|3190469|P2|Open Label Titration|Physician Decision|0
968975|NCT00633880|3190470|P1|Open Label Titration|Physician Decision|1
968976|NCT00633880|3190468|P3|Open Label Titration|Protocol Violation|0
968977|NCT00633880|3190469|P2|Open Label Titration|Protocol Violation|0
968978|NCT00633880|3190470|P1|Open Label Titration|Protocol Violation|6
968979|NCT00633880|3190468|P3|Open Label Titration|Treatment Failure|0
968980|NCT00633880|3190469|P2|Open Label Titration|Treatment Failure|0
968981|NCT00633880|3190470|P1|Open Label Titration|Treatment Failure|55
968982|NCT00633880|3190468|P3|Open Label Titration|Adverse Event|0
968983|NCT00633880|3190469|P2|Open Label Titration|Adverse Event|0
968984|NCT00633880|3190470|P1|Open Label Titration|Adverse Event|13
968985|NCT00633880|3190468|P3|Open Label Titration|Lack of Efficacy|0
968986|NCT00633880|3190469|P2|Open Label Titration|Lack of Efficacy|0
968987|NCT00633880|3190470|P1|Open Label Titration|Lack of Efficacy|1
968988|NCT00633750|3190506|P1|Overall Study|Withdrawal by Subject|3
968989|NCT00633750|3190506|P1|Overall Study|Adverse Event|2
968990|NCT00633594|3190515|P3|Overall Study|Disease Progression|1
968991|NCT00633594|3190516|P2|Overall Study|Disease Progression|0
968992|NCT00633594|3190517|P1|Overall Study|Disease Progression|0
968993|NCT00633594|3190515|P3|Overall Study|Death|2
968994|NCT00633594|3190516|P2|Overall Study|Death|1
968995|NCT00633594|3190517|P1|Overall Study|Death|0
968996|NCT00633594|3190515|P3|Overall Study|Adverse Event|7
968997|NCT00633594|3190516|P2|Overall Study|Adverse Event|4
968998|NCT00633594|3190517|P1|Overall Study|Adverse Event|0
968999|NCT00633477|3190546|P2|Overall Study|Randomized but not treated|0
969000|NCT00633477|3190547|P1|Overall Study|Randomized but not treated|1
969001|NCT00633477|3190546|P2|Overall Study|Death|0
969002|NCT00633477|3190547|P1|Overall Study|Death|1
969003|NCT00633464|3190563|P2|Overall Study|Never Treated (Randomized in error)|1
969004|NCT00633464|3190564|P1|Overall Study|Never Treated (Randomized in error)|0
969005|NCT00633464|3190563|P2|Overall Study|Never Treated (Not met study criteria)|1
969006|NCT00633464|3190564|P1|Overall Study|Never Treated (Not met study criteria)|0
969007|NCT00633360|3190599|P2|Overall Study|Protocol Violation|1
969008|NCT00633360|3190600|P1|Overall Study|Protocol Violation|0
969009|NCT00633360|3190599|P2|Overall Study|Adverse Event|1
969010|NCT00633360|3190600|P1|Overall Study|Adverse Event|3
969011|NCT00633360|3190599|P2|Overall Study|Lost to Follow-up|1
969012|NCT00633360|3190600|P1|Overall Study|Lost to Follow-up|1
969013|NCT00633243|3190623|P2|Overall Study|Couldn't tolerate side-effects|1
969014|NCT00633243|3190624|P1|Overall Study|Couldn't tolerate side-effects|1
969015|NCT00633243|3190623|P2|Overall Study|Mental Health--Depression|1
969016|NCT00633243|3190624|P1|Overall Study|Mental Health--Depression|0
969017|NCT00633243|3190623|P2|Overall Study|Not comfortable with self-injecting|1
969018|NCT00633243|3190624|P1|Overall Study|Not comfortable with self-injecting|0
969019|NCT00633243|3190623|P2|Overall Study|Homeless--no refrigeration for meds|1
969020|NCT00633243|3190624|P1|Overall Study|Homeless--no refrigeration for meds|0
969021|NCT00633243|3190623|P2|Overall Study|incarceration|2
969022|NCT00633243|3190624|P1|Overall Study|incarceration|0
969023|NCT00633243|3190623|P2|Overall Study|Withdrawal by Subject|1
969024|NCT00633243|3190624|P1|Overall Study|Withdrawal by Subject|0
969025|NCT00633217|3190632|P2|Overall Study|Withdrew Consent|3
969026|NCT00633217|3190633|P1|Overall Study|Withdrew Consent|3
969027|NCT00633217|3190632|P2|Overall Study|Investigator Discretion|0
969028|NCT00633217|3190633|P1|Overall Study|Investigator Discretion|2
969029|NCT00633217|3190632|P2|Overall Study|Lost to Follow-up|2
969030|NCT00633217|3190633|P1|Overall Study|Lost to Follow-up|2
969031|NCT00633217|3190632|P2|Overall Study|Protocol Violation|7
969032|NCT00633217|3190633|P1|Overall Study|Protocol Violation|3
969033|NCT00633217|3190632|P2|Overall Study|Lack of Efficacy|2
969034|NCT00633217|3190633|P1|Overall Study|Lack of Efficacy|0
969035|NCT00633217|3190632|P2|Overall Study|Adverse Event|9
969036|NCT00633217|3190633|P1|Overall Study|Adverse Event|5
969037|NCT00633152|3190645|P2|Overall Study|Miscellaneous Other|2
969038|NCT00633152|3190646|P1|Overall Study|Miscellaneous Other|3
969039|NCT00633152|3190645|P2|Overall Study|Lost to Follow-up|1
969040|NCT00633152|3190646|P1|Overall Study|Lost to Follow-up|4
969041|NCT00633152|3190645|P2|Overall Study|Withdrawal by Subject|1
969042|NCT00633152|3190646|P1|Overall Study|Withdrawal by Subject|1
969043|NCT00633152|3190645|P2|Overall Study|Randomized, did not receive study drug|2
969044|NCT00633152|3190646|P1|Overall Study|Randomized, did not receive study drug|5
969045|NCT00633152|3190645|P2|Overall Study|Adverse Event|0
969046|NCT00633152|3190646|P1|Overall Study|Adverse Event|1
969047|NCT00633139|3190657|P3|Overall Study|Withdrawal by Subject|0
969048|NCT00633139|3190658|P2|Overall Study|Withdrawal by Subject|1
969049|NCT00633139|3190659|P1|Overall Study|Withdrawal by Subject|0
969050|NCT00633139|3190657|P3|Overall Study|Non compliance|1
969051|NCT00633139|3190658|P2|Overall Study|Non compliance|0
969052|NCT00633139|3190659|P1|Overall Study|Non compliance|0
969053|NCT00633126|3190673|P1|Overall Study|Did not receive full dose|1
969054|NCT00633074|3190687|P2|Overall Study|Adverse Event|0
969055|NCT00633074|3190688|P1|Overall Study|Adverse Event|1
969056|NCT00633022|3190719|P3|Overall Study|Physician Decision|0
969057|NCT00633022|3190720|P2|Overall Study|Physician Decision|1
969058|NCT00633022|3190721|P1|Overall Study|Physician Decision|0
969059|NCT00633022|3190719|P3|Overall Study|Adverse Event|5
969060|NCT00633022|3190720|P2|Overall Study|Adverse Event|0
969061|NCT00633022|3190721|P1|Overall Study|Adverse Event|1
969062|NCT00632931|3190783|P3|Part 2|Withdrawal by Subject|3
969063|NCT00632931|3190784|P2|Part 2|Withdrawal by Subject|0
969064|NCT00632931|3190785|P1|Part 2|Withdrawal by Subject|0
969065|NCT00632931|3190783|P3|Part 2|Lack of Efficacy|17
969066|NCT00632931|3190784|P2|Part 2|Lack of Efficacy|0
969067|NCT00632931|3190785|P1|Part 2|Lack of Efficacy|0
969068|NCT00632931|3190783|P3|Part 2|Death|1
969069|NCT00632931|3190784|P2|Part 2|Death|0
969070|NCT00632931|3190785|P1|Part 2|Death|0
969071|NCT00632931|3190783|P3|Part 2|Adverse Event|3
969072|NCT00632931|3190784|P2|Part 2|Adverse Event|0
969073|NCT00632931|3190785|P1|Part 2|Adverse Event|0
969074|NCT00632931|3190783|P3|Part 1, Period 1|Withdrawal by Subject|0
969075|NCT00632931|3190784|P2|Part 1, Period 1|Withdrawal by Subject|0
969076|NCT00632931|3190785|P1|Part 1, Period 1|Withdrawal by Subject|1
969077|NCT00632931|3190783|P3|Part 1, Period 1|Protocol Violation|0
969078|NCT00632931|3190784|P2|Part 1, Period 1|Protocol Violation|0
969079|NCT00632931|3190785|P1|Part 1, Period 1|Protocol Violation|1
969080|NCT00632749|3190855|P14|Overall Study|Reason other than those specified above|2
969081|NCT00632749|3190856|P13|Overall Study|Reason other than those specified above|0
969082|NCT00632749|3190857|P12|Overall Study|Reason other than those specified above|1
969083|NCT00632749|3190858|P11|Overall Study|Reason other than those specified above|2
969084|NCT00632749|3190859|P10|Overall Study|Reason other than those specified above|0
969085|NCT00632749|3190860|P9|Overall Study|Reason other than those specified above|0
969086|NCT00632749|3190861|P8|Overall Study|Reason other than those specified above|0
969087|NCT00632749|3190862|P7|Overall Study|Reason other than those specified above|1
969088|NCT00632749|3190863|P6|Overall Study|Reason other than those specified above|0
969089|NCT00632749|3190864|P5|Overall Study|Reason other than those specified above|1
969090|NCT00632749|3190865|P4|Overall Study|Reason other than those specified above|0
969091|NCT00632749|3190866|P3|Overall Study|Reason other than those specified above|0
969092|NCT00632749|3190867|P2|Overall Study|Reason other than those specified above|2
969093|NCT00632749|3190868|P1|Overall Study|Reason other than those specified above|0
969094|NCT00632749|3190855|P14|Overall Study|Refuse to continue medication|0
969095|NCT00632749|3190856|P13|Overall Study|Refuse to continue medication|0
969096|NCT00632749|3190857|P12|Overall Study|Refuse to continue medication|0
969097|NCT00632749|3190858|P11|Overall Study|Refuse to continue medication|0
969098|NCT00632749|3190859|P10|Overall Study|Refuse to continue medication|1
969099|NCT00632749|3190860|P9|Overall Study|Refuse to continue medication|0
969100|NCT00632749|3190861|P8|Overall Study|Refuse to continue medication|0
969101|NCT00632749|3190862|P7|Overall Study|Refuse to continue medication|0
969102|NCT00632749|3190863|P6|Overall Study|Refuse to continue medication|0
969103|NCT00632749|3190864|P5|Overall Study|Refuse to continue medication|0
969104|NCT00632749|3190865|P4|Overall Study|Refuse to continue medication|1
969105|NCT00632749|3190866|P3|Overall Study|Refuse to continue medication|0
969106|NCT00632749|3190867|P2|Overall Study|Refuse to continue medication|0
969107|NCT00632749|3190868|P1|Overall Study|Refuse to continue medication|0
969108|NCT00632749|3190855|P14|Overall Study|Other Adverse event|0
969109|NCT00632749|3190856|P13|Overall Study|Other Adverse event|1
969110|NCT00632749|3190857|P12|Overall Study|Other Adverse event|0
969111|NCT00632749|3190858|P11|Overall Study|Other Adverse event|1
969112|NCT00632749|3190859|P10|Overall Study|Other Adverse event|0
969113|NCT00632749|3190860|P9|Overall Study|Other Adverse event|2
969114|NCT00632749|3190861|P8|Overall Study|Other Adverse event|2
969115|NCT00632749|3190862|P7|Overall Study|Other Adverse event|1
969116|NCT00632749|3190863|P6|Overall Study|Other Adverse event|4
969117|NCT00632749|3190864|P5|Overall Study|Other Adverse event|2
969118|NCT00632749|3190865|P4|Overall Study|Other Adverse event|1
969119|NCT00632749|3190866|P3|Overall Study|Other Adverse event|1
969120|NCT00632749|3190867|P2|Overall Study|Other Adverse event|1
969121|NCT00632749|3190868|P1|Overall Study|Other Adverse event|1
969122|NCT00632749|3190855|P14|Overall Study|Progressive disease|4
969123|NCT00632749|3190856|P13|Overall Study|Progressive disease|2
969124|NCT00632749|3190857|P12|Overall Study|Progressive disease|3
969125|NCT00632749|3190858|P11|Overall Study|Progressive disease|4
969126|NCT00632749|3190859|P10|Overall Study|Progressive disease|2
969127|NCT00632749|3190860|P9|Overall Study|Progressive disease|3
969128|NCT00632749|3190861|P8|Overall Study|Progressive disease|2
969129|NCT00632749|3190862|P7|Overall Study|Progressive disease|3
969130|NCT00632749|3190863|P6|Overall Study|Progressive disease|4
969131|NCT00632749|3190864|P5|Overall Study|Progressive disease|4
969132|NCT00632749|3190865|P4|Overall Study|Progressive disease|2
969133|NCT00632749|3190866|P3|Overall Study|Progressive disease|2
969134|NCT00632749|3190867|P2|Overall Study|Progressive disease|2
969135|NCT00632749|3190868|P1|Overall Study|Progressive disease|3
969136|NCT00632736|3191162|P1|Overall Study|Other|16
969137|NCT00632736|3191162|P1|Overall Study|Non-compliance|10
969138|NCT00632736|3191162|P1|Overall Study|Sponsor terminated study|5
969139|NCT00632736|3191162|P1|Overall Study|Lack of Efficacy|5
969140|NCT00632736|3191162|P1|Overall Study|Withdrawal by Subject|99
969141|NCT00632736|3191162|P1|Overall Study|Protocol Violation|14
969142|NCT00632736|3191162|P1|Overall Study|Lost to Follow-up|15
969143|NCT00632736|3191162|P1|Overall Study|Adverse Event|104
969144|NCT00632541|3191197|P1|Overall Study|Adverse Event|7
969145|NCT00632502|3191206|P2|Overall Study|Randomized not treated|0
969146|NCT00632502|3191207|P1|Overall Study|Randomized not treated|3
969147|NCT00632502|3191206|P2|Overall Study|Adverse Event|1
969148|NCT00632502|3191207|P1|Overall Study|Adverse Event|0
969149|NCT00632463|3191251|P3|Overall Study|Adverse Event|0
969150|NCT00632463|3191252|P2|Overall Study|Adverse Event|1
969151|NCT00632463|3191253|P1|Overall Study|Adverse Event|0
969152|NCT00632424|3191270|P1|Overall Study|Study Drug Toxicity|1
969153|NCT00632424|3191270|P1|Overall Study|Disease Progression|17
969154|NCT00632229|3191308|P2|Overall Study|Undisclosed reasons within the first wee|1
969155|NCT00632229|3191309|P1|Overall Study|Undisclosed reasons within the first wee|0
969156|NCT00632229|3191308|P2|Overall Study|Lack of Efficacy|2
969157|NCT00632229|3191309|P1|Overall Study|Lack of Efficacy|0
969158|NCT00632229|3191308|P2|Overall Study|Lost to Follow-up|3
969159|NCT00632229|3191309|P1|Overall Study|Lost to Follow-up|0
969160|NCT00632229|3191308|P2|Overall Study|Adverse Event|0
969161|NCT00632229|3191309|P1|Overall Study|Adverse Event|6
969162|NCT00632203|3191319|P2|Overall Study|Did not start study treatment|0
969163|NCT00632203|3191320|P1|Overall Study|Did not start study treatment|1
969164|NCT00632125|3191338|P1|Overall Study|Moved to other dialysis unit, etc.|102
969165|NCT00632125|3191338|P1|Overall Study|Development of uncontrolled hypertension|5
969166|NCT00632125|3191338|P1|Overall Study|Non-compliance|8
969167|NCT00632125|3191338|P1|Overall Study|Need for systemic immunosuppressive medi|8
969168|NCT00632125|3191338|P1|Overall Study|Renal transplantation|17
969169|NCT00632125|3191338|P1|Overall Study|Adverse Event|36
969170|NCT00632125|3191338|P1|Overall Study|Withdrawal by Subject|44
969171|NCT00632125|3191338|P1|Overall Study|Death|82
969172|NCT00632099|3191344|P2|Overall Study|Lost to Follow-up|3
969173|NCT00632099|3191345|P1|Overall Study|Lost to Follow-up|3
969174|NCT00632021|3191353|P2|Overall Study|Withdrawal/death|7
969175|NCT00632021|3191354|P1|Overall Study|Withdrawal/death|4
969176|NCT00631969|3191364|P2|Overall Study|No Drug Exposure|2
969177|NCT00631969|3191365|P1|Overall Study|No Drug Exposure|2
969178|NCT00631969|3191364|P2|Overall Study|Noncompliant With Study Medication|1
969179|NCT00631969|3191365|P1|Overall Study|Noncompliant With Study Medication|0
969180|NCT00631969|3191364|P2|Overall Study|Consent Withdrawn|7
969181|NCT00631969|3191365|P1|Overall Study|Consent Withdrawn|5
969182|NCT00631969|3191364|P2|Overall Study|Protocol Violation|1
969183|NCT00631969|3191365|P1|Overall Study|Protocol Violation|1
969184|NCT00631969|3191364|P2|Overall Study|Lost to Follow-up|1
969185|NCT00631969|3191365|P1|Overall Study|Lost to Follow-up|2
969186|NCT00631969|3191364|P2|Overall Study|Lack of Efficacy|8
969187|NCT00631969|3191365|P1|Overall Study|Lack of Efficacy|2
969188|NCT00631969|3191364|P2|Overall Study|Adverse Event|1
969189|NCT00631969|3191365|P1|Overall Study|Adverse Event|3
969190|NCT00631917|3191411|P2|Overall Study|Death|0
969191|NCT00631917|3191412|P1|Overall Study|Death|1
969192|NCT00631917|3191411|P2|Overall Study|Administrative problems|0
969193|NCT00631917|3191412|P1|Overall Study|Administrative problems|2
969194|NCT00631917|3191411|P2|Overall Study|Lost to Follow-up|7
969195|NCT00631917|3191412|P1|Overall Study|Lost to Follow-up|7
969196|NCT00631917|3191411|P2|Overall Study|Subject withdrew consent|33
969197|NCT00631917|3191412|P1|Overall Study|Subject withdrew consent|25
969198|NCT00631917|3191411|P2|Overall Study|Protocol deviation|5
969199|NCT00631917|3191412|P1|Overall Study|Protocol deviation|6
969200|NCT00631917|3191411|P2|Overall Study|No longer required study drug|1
969201|NCT00631917|3191412|P1|Overall Study|No longer required study drug|0
969202|NCT00631917|3191411|P2|Overall Study|Unsatisfactory therapeutic effect|14
969203|NCT00631917|3191412|P1|Overall Study|Unsatisfactory therapeutic effect|8
969204|NCT00631917|3191411|P2|Overall Study|Abnormal test procedure result(s)|2
969205|NCT00631917|3191412|P1|Overall Study|Abnormal test procedure result(s)|3
969206|NCT00631917|3191411|P2|Overall Study|Abnormal laboratory value(s)|1
969207|NCT00631917|3191412|P1|Overall Study|Abnormal laboratory value(s)|2
969208|NCT00631917|3191411|P2|Overall Study|Adverse Event|45
969209|NCT00631917|3191412|P1|Overall Study|Adverse Event|34
969210|NCT00631696|3191439|P2|Overall Study|Adverse Event|0
969211|NCT00631696|3191440|P1|Overall Study|Adverse Event|5
969212|NCT00631696|3191439|P2|Overall Study|Study terminated by sponsor|3
969213|NCT00631696|3191440|P1|Overall Study|Study terminated by sponsor|3
969214|NCT00631696|3191439|P2|Overall Study|Protocol Violation|9
969215|NCT00631696|3191440|P1|Overall Study|Protocol Violation|9
969216|NCT00631696|3191439|P2|Overall Study|Other|8
969217|NCT00631696|3191440|P1|Overall Study|Other|8
969218|NCT00631696|3191439|P2|Overall Study|Withdrawal by Subject|9
969219|NCT00631696|3191440|P1|Overall Study|Withdrawal by Subject|2
969220|NCT00631696|3191439|P2|Overall Study|Lost to Follow-up|10
969221|NCT00631696|3191440|P1|Overall Study|Lost to Follow-up|7
969222|NCT00631696|3191439|P2|Overall Study|Follow up after database release date|0
969223|NCT00631696|3191440|P1|Overall Study|Follow up after database release date|1
969224|NCT00631696|3191439|P2|Overall Study|Discontinued after database release date|0
969225|NCT00631696|3191440|P1|Overall Study|Discontinued after database release date|1
969226|NCT00631696|3191439|P2|Overall Study|Entered, not randomized to treatment|1
969227|NCT00631696|3191440|P1|Overall Study|Entered, not randomized to treatment|1
969228|NCT00631657|3191483|P3|7-Day Discontinuation Period|Other|0
969229|NCT00631657|3191484|P2|7-Day Discontinuation Period|Other|0
969230|NCT00631657|3191485|P1|7-Day Discontinuation Period|Other|1
969231|NCT00631657|3191483|P3|7-Day Discontinuation Period|Not Treated|1
969232|NCT00631657|3191484|P2|7-Day Discontinuation Period|Not Treated|1
969233|NCT00631657|3191485|P1|7-Day Discontinuation Period|Not Treated|1
969234|NCT00631657|3191483|P3|6-Month Treatment Period|Not Treated|1
969235|NCT00631657|3191484|P2|6-Month Treatment Period|Not Treated|0
969236|NCT00631657|3191485|P1|6-Month Treatment Period|Not Treated|2
969237|NCT00631657|3191483|P3|6-Month Treatment Period|Other|4
969238|NCT00631657|3191484|P2|6-Month Treatment Period|Other|0
969239|NCT00631657|3191485|P1|6-Month Treatment Period|Other|16
969240|NCT00631657|3191483|P3|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6
969241|NCT00631657|3191484|P2|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0
969242|NCT00631657|3191485|P1|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21
969243|NCT00631657|3191483|P3|6-Month Treatment Period|Lost to Follow-up|2
969244|NCT00631657|3191484|P2|6-Month Treatment Period|Lost to Follow-up|0
969245|NCT00631657|3191485|P1|6-Month Treatment Period|Lost to Follow-up|7
969246|NCT00631657|3191483|P3|6-Month Treatment Period|Lack of Efficacy|25
969247|NCT00631657|3191484|P2|6-Month Treatment Period|Lack of Efficacy|0
969248|NCT00631657|3191485|P1|6-Month Treatment Period|Lack of Efficacy|34
969249|NCT00631657|3191483|P3|6-Month Treatment Period|Withdrawal by Subject|5
969250|NCT00631657|3191484|P2|6-Month Treatment Period|Withdrawal by Subject|0
969251|NCT00631657|3191485|P1|6-Month Treatment Period|Withdrawal by Subject|14
969252|NCT00631657|3191483|P3|6-Month Treatment Period|Adverse Event|7
969253|NCT00631657|3191484|P2|6-Month Treatment Period|Adverse Event|0
969254|NCT00631657|3191485|P1|6-Month Treatment Period|Adverse Event|47
969255|NCT00631540|3191534|P1|Overall Study|Core Lab Data Unavailable|3
969256|NCT00631540|3191534|P1|Overall Study|Lost to Follow-up|2
969257|NCT00631540|3191534|P1|Overall Study|Death|4
969258|NCT00631540|3191534|P1|Overall Study|Withdrawal by Subject|5
969259|NCT00631488|3191546|P3|Overall Study|Protocol Violation|1
969260|NCT00631488|3191547|P2|Overall Study|Protocol Violation|0
969261|NCT00631488|3191548|P1|Overall Study|Protocol Violation|0
969262|NCT00631488|3191546|P3|Overall Study|Physician Decision|1
969263|NCT00631488|3191547|P2|Overall Study|Physician Decision|0
969264|NCT00631488|3191548|P1|Overall Study|Physician Decision|1
969265|NCT00631488|3191546|P3|Overall Study|Lost to Follow-up|0
969266|NCT00631488|3191547|P2|Overall Study|Lost to Follow-up|2
969267|NCT00631488|3191548|P1|Overall Study|Lost to Follow-up|2
969268|NCT00631488|3191546|P3|Overall Study|Adverse Event|0
969269|NCT00631488|3191547|P2|Overall Study|Adverse Event|0
969270|NCT00631488|3191548|P1|Overall Study|Adverse Event|1
969271|NCT00631475|3191568|P1|Overall Study|Preparation for lung transplant|8
969272|NCT00631475|3191568|P1|Overall Study|Withdrew consent|5
969273|NCT00631475|3191568|P1|Overall Study|Adverse Event|14
969274|NCT00631475|3191568|P1|Overall Study|Death|18
969275|NCT00631410|3191587|P2|Overall Study|Surgery|0
969276|NCT00631410|3191588|P1|Overall Study|Surgery|1
969277|NCT00631410|3191587|P2|Overall Study|Objective Progression or Relapse|3
969278|NCT00631410|3191588|P1|Overall Study|Objective Progression or Relapse|4
969279|NCT00631410|3191587|P2|Overall Study|Adverse Event|3
969280|NCT00631410|3191588|P1|Overall Study|Adverse Event|1
969281|NCT00631371|3191607|P2|Overall Study|Death|239
969282|NCT00631371|3191608|P1|Overall Study|Death|263
969283|NCT00631371|3191607|P2|Overall Study|Discontinuation of study by Sponsor|76
969284|NCT00631371|3191608|P1|Overall Study|Discontinuation of study by Sponsor|70
969285|NCT00631371|3191607|P2|Overall Study|subject request|45
969286|NCT00631371|3191608|P1|Overall Study|subject request|38
969287|NCT00631371|3191607|P2|Overall Study|Other reason|12
969288|NCT00631371|3191608|P1|Overall Study|Other reason|5
969289|NCT00631371|3191607|P2|Overall Study|Lost to Follow-up|19
969290|NCT00631371|3191608|P1|Overall Study|Lost to Follow-up|24
969291|NCT00631189|3191641|P4|Treatment Phase|patient did not take pravastatin|0
969292|NCT00631189|3191642|P3|Treatment Phase|patient did not take pravastatin|1
969293|NCT00631189|3191643|P2|Treatment Phase|patient did not take pravastatin|0
969294|NCT00631189|3191644|P1|Treatment Phase|patient did not take pravastatin|0
969295|NCT00631189|3191641|P4|Treatment Phase|Pregnancy|0
969296|NCT00631189|3191642|P3|Treatment Phase|Pregnancy|1
969297|NCT00631189|3191643|P2|Treatment Phase|Pregnancy|0
969298|NCT00631189|3191644|P1|Treatment Phase|Pregnancy|0
969299|NCT00631189|3191641|P4|Treatment Phase|Lost to Follow-up|0
969300|NCT00631189|3191642|P3|Treatment Phase|Lost to Follow-up|0
969301|NCT00631189|3191643|P2|Treatment Phase|Lost to Follow-up|1
969302|NCT00631189|3191644|P1|Treatment Phase|Lost to Follow-up|0
969303|NCT00631189|3191641|P4|Treatment Phase|Adverse Event|4
969304|NCT00631189|3191642|P3|Treatment Phase|Adverse Event|2
969305|NCT00631189|3191643|P2|Treatment Phase|Adverse Event|3
969306|NCT00631189|3191644|P1|Treatment Phase|Adverse Event|0
969307|NCT00631189|3191641|P4|Treatment Phase|Protocol Violation|2
969308|NCT00631189|3191642|P3|Treatment Phase|Protocol Violation|6
969309|NCT00631189|3191643|P2|Treatment Phase|Protocol Violation|1
969310|NCT00631189|3191644|P1|Treatment Phase|Protocol Violation|0
969311|NCT00631189|3191641|P4|Treatment Phase|Withdrawal by Subject|1
969312|NCT00631189|3191642|P3|Treatment Phase|Withdrawal by Subject|1
969313|NCT00631189|3191643|P2|Treatment Phase|Withdrawal by Subject|2
969314|NCT00631189|3191644|P1|Treatment Phase|Withdrawal by Subject|0
969315|NCT00631189|3191641|P4|Initial Phase|Withdrawal by Subject|0
969316|NCT00631189|3191642|P3|Initial Phase|Withdrawal by Subject|0
969317|NCT00631189|3191643|P2|Initial Phase|Withdrawal by Subject|0
969318|NCT00631189|3191644|P1|Initial Phase|Withdrawal by Subject|4
969319|NCT00631189|3191641|P4|Initial Phase|Protocol Violation|0
969320|NCT00631189|3191642|P3|Initial Phase|Protocol Violation|0
969321|NCT00631189|3191643|P2|Initial Phase|Protocol Violation|0
969322|NCT00631189|3191644|P1|Initial Phase|Protocol Violation|347
969323|NCT00631137|3191688|P2|Overall Study|Withdrawal by Subject|0
969324|NCT00631137|3191689|P1|Overall Study|Withdrawal by Subject|1
969325|NCT00631020|3191707|P1|Overall Study|Incarcerated|1
969326|NCT00631020|3191707|P1|Overall Study|Lost to Follow-up|7
969327|NCT00631007|3191722|P6|Overall Study|Other|0
969328|NCT00631007|3191723|P5|Overall Study|Other|1
969329|NCT00631007|3191724|P4|Overall Study|Other|0
969330|NCT00631007|3191725|P3|Overall Study|Other|0
969331|NCT00631007|3191726|P2|Overall Study|Other|1
969332|NCT00631007|3191727|P1|Overall Study|Other|2
969333|NCT00631007|3191722|P6|Overall Study|Withdrawal by Subject|3
969334|NCT00631007|3191723|P5|Overall Study|Withdrawal by Subject|1
969335|NCT00631007|3191724|P4|Overall Study|Withdrawal by Subject|2
969336|NCT00631007|3191725|P3|Overall Study|Withdrawal by Subject|2
969337|NCT00631007|3191726|P2|Overall Study|Withdrawal by Subject|5
969338|NCT00631007|3191727|P1|Overall Study|Withdrawal by Subject|4
969339|NCT00631007|3191722|P6|Overall Study|Persistent Hyperglycemia|5
969340|NCT00631007|3191723|P5|Overall Study|Persistent Hyperglycemia|2
969341|NCT00631007|3191724|P4|Overall Study|Persistent Hyperglycemia|1
969342|NCT00631007|3191725|P3|Overall Study|Persistent Hyperglycemia|5
969343|NCT00631007|3191726|P2|Overall Study|Persistent Hyperglycemia|2
969344|NCT00631007|3191727|P1|Overall Study|Persistent Hyperglycemia|2
969345|NCT00631007|3191722|P6|Overall Study|Physician Decision|2
969346|NCT00631007|3191723|P5|Overall Study|Physician Decision|0
969347|NCT00631007|3191724|P4|Overall Study|Physician Decision|0
969348|NCT00631007|3191725|P3|Overall Study|Physician Decision|1
969349|NCT00631007|3191726|P2|Overall Study|Physician Decision|0
969350|NCT00631007|3191727|P1|Overall Study|Physician Decision|1
969351|NCT00631007|3191722|P6|Overall Study|Lost to Follow-up|3
969352|NCT00631007|3191723|P5|Overall Study|Lost to Follow-up|5
969353|NCT00631007|3191724|P4|Overall Study|Lost to Follow-up|4
969354|NCT00631007|3191725|P3|Overall Study|Lost to Follow-up|2
969355|NCT00631007|3191726|P2|Overall Study|Lost to Follow-up|1
969356|NCT00631007|3191727|P1|Overall Study|Lost to Follow-up|2
969357|NCT00631007|3191722|P6|Overall Study|Adverse Event|2
969358|NCT00631007|3191723|P5|Overall Study|Adverse Event|3
969359|NCT00631007|3191724|P4|Overall Study|Adverse Event|2
969360|NCT00631007|3191725|P3|Overall Study|Adverse Event|0
969361|NCT00631007|3191726|P2|Overall Study|Adverse Event|2
969362|NCT00631007|3191727|P1|Overall Study|Adverse Event|0
969363|NCT00630994|3191747|P1|Overall Study|Other|1
969364|NCT00630994|3191747|P1|Overall Study|Lack of Efficacy|1
969365|NCT00630994|3191747|P1|Overall Study|Disease Progression|1
969366|NCT00630994|3191747|P1|Overall Study|Adverse Event|1
969367|NCT00630916|3191777|P1|Overall Study|Lack of Efficacy|3
969368|NCT00630916|3191777|P1|Overall Study|Physician Decision|47
969369|NCT00630916|3191777|P1|Overall Study|Protocol Violation|7
969370|NCT00630916|3191777|P1|Overall Study|Withdrawal by Subject|30
969371|NCT00630916|3191777|P1|Overall Study|Lost to Follow-up|5
969372|NCT00630916|3191777|P1|Overall Study|Explant|8
969373|NCT00630916|3191777|P1|Overall Study|Death|110
969374|NCT00630877|3191787|P3|Overall Study|Personal reasons|1
969375|NCT00630877|3191788|P2|Overall Study|Personal reasons|0
969376|NCT00630877|3191789|P1|Overall Study|Personal reasons|0
969377|NCT00630877|3191787|P3|Overall Study|Protocol violation|1
969378|NCT00630877|3191788|P2|Overall Study|Protocol violation|0
969379|NCT00630877|3191789|P1|Overall Study|Protocol violation|1
969380|NCT00630877|3191787|P3|Overall Study|Noncompliance|1
969381|NCT00630877|3191788|P2|Overall Study|Noncompliance|3
969382|NCT00630877|3191789|P1|Overall Study|Noncompliance|2
969383|NCT00630877|3191787|P3|Overall Study|Lost to Follow-up|0
969384|NCT00630877|3191788|P2|Overall Study|Lost to Follow-up|0
969385|NCT00630877|3191789|P1|Overall Study|Lost to Follow-up|2
969386|NCT00630877|3191787|P3|Overall Study|Withdrawal by Subject|0
969387|NCT00630877|3191788|P2|Overall Study|Withdrawal by Subject|4
969388|NCT00630877|3191789|P1|Overall Study|Withdrawal by Subject|3
969389|NCT00630877|3191787|P3|Overall Study|Adverse Event|7
969390|NCT00630877|3191788|P2|Overall Study|Adverse Event|8
969391|NCT00630877|3191789|P1|Overall Study|Adverse Event|11
969392|NCT00630864|3191807|P1|Part 2 (After Week 6 up to Month 12)|Liver transplant|2
969393|NCT00630864|3191807|P1|Part 1 (up to Week 6)|Adverse Event|1
969394|NCT00630838|3191846|P2|Overall Study|Lost to Follow-up|1
969395|NCT00630838|3191847|P1|Overall Study|Lost to Follow-up|0
969396|NCT00630838|3191846|P2|Overall Study|Death|1
969397|NCT00630838|3191847|P1|Overall Study|Death|0
969398|NCT00630825|3191859|P4|Overall Study|Withdrawal by Subject|3
969399|NCT00630825|3191860|P3|Overall Study|Withdrawal by Subject|2
969400|NCT00630825|3191861|P2|Overall Study|Withdrawal by Subject|2
969401|NCT00630825|3191862|P1|Overall Study|Withdrawal by Subject|2
969402|NCT00630825|3191859|P4|Overall Study|Physician Decision|0
969403|NCT00630825|3191860|P3|Overall Study|Physician Decision|0
969404|NCT00630825|3191861|P2|Overall Study|Physician Decision|0
969405|NCT00630825|3191862|P1|Overall Study|Physician Decision|1
969406|NCT00630825|3191859|P4|Overall Study|Lost to Follow-up|1
969407|NCT00630825|3191860|P3|Overall Study|Lost to Follow-up|1
969408|NCT00630825|3191861|P2|Overall Study|Lost to Follow-up|1
969409|NCT00630825|3191862|P1|Overall Study|Lost to Follow-up|1
969410|NCT00630825|3191859|P4|Overall Study|Entry Criteria Not Met|1
969411|NCT00630825|3191860|P3|Overall Study|Entry Criteria Not Met|2
969412|NCT00630825|3191861|P2|Overall Study|Entry Criteria Not Met|0
969413|NCT00630825|3191862|P1|Overall Study|Entry Criteria Not Met|1
969414|NCT00630825|3191859|P4|Overall Study|Adverse Event|1
969415|NCT00630825|3191860|P3|Overall Study|Adverse Event|3
969416|NCT00630825|3191861|P2|Overall Study|Adverse Event|4
969417|NCT00630825|3191862|P1|Overall Study|Adverse Event|4
969418|NCT00630786|3191934|P3|Overall Study|Not specified|0
969419|NCT00630786|3191935|P2|Overall Study|Not specified|0
969420|NCT00630786|3191936|P1|Overall Study|Not specified|1
969421|NCT00630786|3191934|P3|Overall Study|Lost to Follow-up|0
969422|NCT00630786|3191935|P2|Overall Study|Lost to Follow-up|1
969423|NCT00630786|3191936|P1|Overall Study|Lost to Follow-up|0
969424|NCT00630786|3191934|P3|Overall Study|Withdrawal by Subject|1
969425|NCT00630786|3191935|P2|Overall Study|Withdrawal by Subject|1
969426|NCT00630786|3191936|P1|Overall Study|Withdrawal by Subject|0
969427|NCT00630786|3191934|P3|Overall Study|Physician Decision|1
969428|NCT00630786|3191935|P2|Overall Study|Physician Decision|0
969429|NCT00630786|3191936|P1|Overall Study|Physician Decision|0
969430|NCT00630747|3191955|P1|Overall Study|Returned to country of origin|1
969431|NCT00630747|3191955|P1|Overall Study|Transferred to Study TKT031NPU|7
969432|NCT00630747|3191955|P1|Overall Study|Death|1
969433|NCT00630539|3192008|P4|Overall Study|Withdrawal by Subject|1
969434|NCT00630539|3192009|P3|Overall Study|Withdrawal by Subject|0
969435|NCT00630539|3192010|P2|Overall Study|Withdrawal by Subject|1
969436|NCT00630539|3192011|P1|Overall Study|Withdrawal by Subject|0
969437|NCT00630539|3192008|P4|Overall Study|Adverse Event|2
969438|NCT00630539|3192009|P3|Overall Study|Adverse Event|1
969439|NCT00630539|3192010|P2|Overall Study|Adverse Event|3
969440|NCT00630539|3192011|P1|Overall Study|Adverse Event|1
969441|NCT00630396|3192107|P1|Overall Study|Lost to Follow-up|3
969442|NCT00630396|3192107|P1|Overall Study|Death|4
969443|NCT00630344|3192113|P1|Overall Study|Other|1
969444|NCT00630344|3192113|P1|Overall Study|Intercurrent Illness|1
969445|NCT00630344|3192113|P1|Overall Study|Withdrawal by Subject|1
969446|NCT00630344|3192113|P1|Overall Study|Physician Decision|9
969447|NCT00630344|3192113|P1|Overall Study|Progressive Disease|19
969448|NCT00630344|3192113|P1|Overall Study|Adverse Event|5
969449|NCT00630331|3192125|P3|Overall Study|Protocol Violation|6
969450|NCT00630331|3192126|P2|Overall Study|Protocol Violation|5
969451|NCT00630331|3192127|P1|Overall Study|Protocol Violation|4
969452|NCT00630331|3192125|P3|Overall Study|Unable to classify|3
969453|NCT00630331|3192126|P2|Overall Study|Unable to classify|4
969454|NCT00630331|3192127|P1|Overall Study|Unable to classify|9
969455|NCT00630331|3192125|P3|Overall Study|Inappropriate enrollment|3
969456|NCT00630331|3192126|P2|Overall Study|Inappropriate enrollment|6
969457|NCT00630331|3192127|P1|Overall Study|Inappropriate enrollment|3
969458|NCT00630331|3192125|P3|Overall Study|Lost to Follow-up|170
969459|NCT00630331|3192126|P2|Overall Study|Lost to Follow-up|143
969460|NCT00630331|3192127|P1|Overall Study|Lost to Follow-up|175
969461|NCT00630331|3192125|P3|Overall Study|Withdrawal by Subject|5
969462|NCT00630331|3192126|P2|Overall Study|Withdrawal by Subject|7
969463|NCT00630331|3192127|P1|Overall Study|Withdrawal by Subject|12
969464|NCT00630331|3192125|P3|Overall Study|Adverse Event|0
969465|NCT00630331|3192126|P2|Overall Study|Adverse Event|0
969466|NCT00630331|3192127|P1|Overall Study|Adverse Event|1
969467|NCT00630331|3192125|P3|Overall Study|Death|1
969468|NCT00630331|3192126|P2|Overall Study|Death|1
969469|NCT00630331|3192127|P1|Overall Study|Death|2
969470|NCT00630305|3192168|P1|Overall Study|Inability to insert contact lens|1
969471|NCT00630305|3192168|P1|Overall Study|Withdrawal by Subject|1
969472|NCT00630292|3192190|P1|Overall Study|Withdrawal by Subject|1
969473|NCT00630058|3192196|P2|Overall Study|stopping criteria|2
969474|NCT00630058|3192197|P1|Overall Study|stopping criteria|3
969475|NCT00630058|3192196|P2|Overall Study|Withdrawal by Subject|1
969476|NCT00630058|3192197|P1|Overall Study|Withdrawal by Subject|0
969477|NCT00630058|3192196|P2|Overall Study|Adverse Event|1
969478|NCT00630058|3192197|P1|Overall Study|Adverse Event|1
969479|NCT00629772|3192228|P2|Second Intervention Week 14 - Week 26|Lack of Efficacy|1
969480|NCT00629772|3192229|P1|Second Intervention Week 14 - Week 26|Lack of Efficacy|0
969481|NCT00629772|3192228|P2|Second Intervention Week 14 - Week 26|Adverse Event|1
969482|NCT00629772|3192229|P1|Second Intervention Week 14 - Week 26|Adverse Event|1
969483|NCT00629707|3192249|P2|Overall Study|Physician Decision|1
969484|NCT00629707|3192250|P1|Overall Study|Physician Decision|0
969485|NCT00629707|3192249|P2|Overall Study|Withdrawal by Subject|1
969486|NCT00629707|3192250|P1|Overall Study|Withdrawal by Subject|0
969487|NCT00629265|3192270|P2|Overall Study|Unknown Reason|2
969488|NCT00629265|3192271|P1|Overall Study|Unknown Reason|2
969489|NCT00629265|3192270|P2|Overall Study|Unrelated Medical Complications|1
969490|NCT00629265|3192271|P1|Overall Study|Unrelated Medical Complications|3
969491|NCT00629265|3192270|P2|Overall Study|Needed Esophageal Dilation|1
969492|NCT00629265|3192271|P1|Overall Study|Needed Esophageal Dilation|4
969493|NCT00629265|3192270|P2|Overall Study|Other CA Requiring Treatment|3
969494|NCT00629265|3192271|P1|Overall Study|Other CA Requiring Treatment|1
969495|NCT00629265|3192270|P2|Overall Study|HNC Recurrence|0
969496|NCT00629265|3192271|P1|Overall Study|HNC Recurrence|4
969497|NCT00629265|3192270|P2|Overall Study|Adverse Event|0
969498|NCT00629265|3192271|P1|Overall Study|Adverse Event|2
969499|NCT00629265|3192270|P2|Overall Study|Death|0
969500|NCT00629265|3192271|P1|Overall Study|Death|1
969501|NCT00629265|3192270|P2|Overall Study|Withdrawal by Subject|8
969502|NCT00629265|3192271|P1|Overall Study|Withdrawal by Subject|11
969503|NCT00629265|3192270|P2|Overall Study|Lost to Follow-up|5
969504|NCT00629265|3192271|P1|Overall Study|Lost to Follow-up|4
969505|NCT00629239|3192281|P2|Overall Study|Physician Decision|0
969506|NCT00629239|3192282|P1|Overall Study|Physician Decision|1
969507|NCT00629239|3192281|P2|Overall Study|Adverse Event|4
969508|NCT00629239|3192282|P1|Overall Study|Adverse Event|7
969509|NCT00628927|3192346|P2|Overall Study|Equipment failure|0
969510|NCT00628927|3192347|P1|Overall Study|Equipment failure|1
969511|NCT00628927|3192346|P2|Overall Study|Lost to Follow-up|0
969512|NCT00628927|3192347|P1|Overall Study|Lost to Follow-up|1
969513|NCT00628927|3192346|P2|Overall Study|Problems performing blood draw|0
969514|NCT00628927|3192347|P1|Overall Study|Problems performing blood draw|6
969515|NCT00628862|3192392|P3|Overall Study|COPD Exacerbation|0
969516|NCT00628862|3192393|P2|Overall Study|COPD Exacerbation|1
969517|NCT00628862|3192394|P1|Overall Study|COPD Exacerbation|0
969518|NCT00628862|3192392|P3|Overall Study|Protocol Violation|0
969519|NCT00628862|3192393|P2|Overall Study|Protocol Violation|0
969520|NCT00628862|3192394|P1|Overall Study|Protocol Violation|1
969521|NCT00628862|3192392|P3|Overall Study|Lost to Follow-up|1
969522|NCT00628862|3192393|P2|Overall Study|Lost to Follow-up|2
969523|NCT00628862|3192394|P1|Overall Study|Lost to Follow-up|0
969524|NCT00628862|3192392|P3|Overall Study|Withdrawal by Subject|11
969525|NCT00628862|3192393|P2|Overall Study|Withdrawal by Subject|6
969526|NCT00628862|3192394|P1|Overall Study|Withdrawal by Subject|4
969527|NCT00628862|3192392|P3|Overall Study|Adverse Event|10
969528|NCT00628862|3192393|P2|Overall Study|Adverse Event|8
969529|NCT00628862|3192394|P1|Overall Study|Adverse Event|6
969530|NCT00628758|3192440|P2|Overall Study|Treatment Failure|2
969531|NCT00628758|3192441|P1|Overall Study|Treatment Failure|0
969532|NCT00628758|3192440|P2|Overall Study|Investigator Moved|0
969533|NCT00628758|3192441|P1|Overall Study|Investigator Moved|3
969534|NCT00628758|3192440|P2|Overall Study|Pregnancy|2
969535|NCT00628758|3192441|P1|Overall Study|Pregnancy|2
969536|NCT00628758|3192440|P2|Overall Study|Lost to Follow-up|31
969537|NCT00628758|3192441|P1|Overall Study|Lost to Follow-up|25
969538|NCT00628758|3192440|P2|Overall Study|Protocol Violation|1
969539|NCT00628758|3192441|P1|Overall Study|Protocol Violation|5
969540|NCT00628758|3192440|P2|Overall Study|Death|0
969541|NCT00628758|3192441|P1|Overall Study|Death|1
969542|NCT00628758|3192440|P2|Overall Study|Withdrawal by Subject|3
969543|NCT00628758|3192441|P1|Overall Study|Withdrawal by Subject|6
969544|NCT00628758|3192440|P2|Overall Study|Adverse Event|3
969545|NCT00628758|3192441|P1|Overall Study|Adverse Event|2
969546|NCT00628446|3192485|P1|Overall Study|Protocol Violation|3
969547|NCT00628446|3192485|P1|Overall Study|Withdrawal by Subject|1
969548|NCT00628446|3192485|P1|Overall Study|Lost to Follow-up|3
969549|NCT00628355|3192496|P2|Overall Study|Withdrawal by Subject|1
969550|NCT00628355|3192497|P1|Overall Study|Withdrawal by Subject|1
969551|NCT00628251|3192508|P3|Cross-over/ Continuation of Olaparib|Other|0
969552|NCT00628251|3192509|P2|Cross-over/ Continuation of Olaparib|Other|1
969553|NCT00628251|3192510|P1|Cross-over/ Continuation of Olaparib|Other|1
969554|NCT00628251|3192508|P3|Cross-over/ Continuation of Olaparib|Withdrawal by Subject|4
969555|NCT00628251|3192509|P2|Cross-over/ Continuation of Olaparib|Withdrawal by Subject|2
969556|NCT00628251|3192510|P1|Cross-over/ Continuation of Olaparib|Withdrawal by Subject|1
969557|NCT00628251|3192508|P3|Cross-over/ Continuation of Olaparib|Condition under investigation worsened|13
969558|NCT00628251|3192509|P2|Cross-over/ Continuation of Olaparib|Condition under investigation worsened|21
969559|NCT00628251|3192510|P1|Cross-over/ Continuation of Olaparib|Condition under investigation worsened|24
969560|NCT00628251|3192508|P3|Cross-over/ Continuation of Olaparib|Adverse Event|0
969561|NCT00628251|3192509|P2|Cross-over/ Continuation of Olaparib|Adverse Event|2
969562|NCT00628251|3192510|P1|Cross-over/ Continuation of Olaparib|Adverse Event|1
969563|NCT00628251|3192508|P3|Randomised Part|Did not receive cross over treatment|8
969564|NCT00628251|3192509|P2|Randomised Part|Did not receive cross over treatment|0
969565|NCT00628251|3192510|P1|Randomised Part|Did not receive cross over treatment|0
969566|NCT00628212|3192553|P4|Overall Study|Physician Decision|3
969567|NCT00628212|3192554|P3|Overall Study|Physician Decision|2
969568|NCT00628212|3192555|P2|Overall Study|Physician Decision|1
969569|NCT00628212|3192556|P1|Overall Study|Physician Decision|1
969570|NCT00628212|3192553|P4|Overall Study|Adverse Event|2
969571|NCT00628212|3192554|P3|Overall Study|Adverse Event|1
969572|NCT00628212|3192555|P2|Overall Study|Adverse Event|0
969573|NCT00628212|3192556|P1|Overall Study|Adverse Event|2
969574|NCT00628108|3192604|P2|Overall Study|Withdrawal by Subject|0
969575|NCT00628108|3192605|P1|Overall Study|Withdrawal by Subject|1
969576|NCT00628108|3192604|P2|Overall Study|Adverse Event|3
969577|NCT00628108|3192605|P1|Overall Study|Adverse Event|0
969578|NCT00628030|3192637|P2|Post to 6 Month Follow-up|Lost to Follow-up|30
969579|NCT00628030|3192638|P1|Post to 6 Month Follow-up|Lost to Follow-up|32
969580|NCT00628030|3192637|P2|Baseline to Post-Assessment|Withdrawal by Subject|0
969581|NCT00628030|3192638|P1|Baseline to Post-Assessment|Withdrawal by Subject|5
969582|NCT00628030|3192637|P2|Baseline to Post-Assessment|Lost to Follow-up|29
969583|NCT00628030|3192638|P1|Baseline to Post-Assessment|Lost to Follow-up|28
969584|NCT00627926|3192664|P3|Overall Study|Noncompliance/unspecified|17
969585|NCT00627926|3192665|P2|Overall Study|Noncompliance/unspecified|23
969586|NCT00627926|3192666|P1|Overall Study|Noncompliance/unspecified|8
969587|NCT00627926|3192664|P3|Overall Study|Lack of Efficacy|38
969588|NCT00627926|3192665|P2|Overall Study|Lack of Efficacy|40
969589|NCT00627926|3192666|P1|Overall Study|Lack of Efficacy|118
969590|NCT00627926|3192664|P3|Overall Study|Withdrawal by Subject|0
969591|NCT00627926|3192665|P2|Overall Study|Withdrawal by Subject|1
969592|NCT00627926|3192666|P1|Overall Study|Withdrawal by Subject|2
969593|NCT00627926|3192664|P3|Overall Study|Lost to Follow-up|4
969594|NCT00627926|3192665|P2|Overall Study|Lost to Follow-up|3
969595|NCT00627926|3192666|P1|Overall Study|Lost to Follow-up|4
969596|NCT00627926|3192664|P3|Overall Study|Death|0
969597|NCT00627926|3192665|P2|Overall Study|Death|0
969598|NCT00627926|3192666|P1|Overall Study|Death|1
969599|NCT00627926|3192664|P3|Overall Study|Adverse Event|36
969600|NCT00627926|3192665|P2|Overall Study|Adverse Event|37
969601|NCT00627926|3192666|P1|Overall Study|Adverse Event|26
969602|NCT00627705|3192718|P2|Overall Study|Lost to Follow-up|1
969603|NCT00627705|3192719|P1|Overall Study|Lost to Follow-up|0
969604|NCT00627705|3192718|P2|Overall Study|Withdrawal by Subject|2
969605|NCT00627705|3192719|P1|Overall Study|Withdrawal by Subject|0
969606|NCT00627705|3192718|P2|Overall Study|Adverse Event|0
969607|NCT00627705|3192719|P1|Overall Study|Adverse Event|1
969608|NCT00627705|3192718|P2|Overall Study|Unwilling to take the compound (taste)|3
969609|NCT00627705|3192719|P1|Overall Study|Unwilling to take the compound (taste)|1
969610|NCT00627523|3192770|P2|Overall Study|Not specified|0
969611|NCT00627523|3192771|P1|Overall Study|Not specified|1
969612|NCT00627523|3192770|P2|Overall Study|Withdrawal by Subject|2
969613|NCT00627523|3192771|P1|Overall Study|Withdrawal by Subject|0
969614|NCT00627523|3192770|P2|Overall Study|Lack of Efficacy|0
969615|NCT00627523|3192771|P1|Overall Study|Lack of Efficacy|1
969616|NCT00627497|3192799|P4|Overall Study|Lost to Follow-up|0
969617|NCT00627497|3192800|P3|Overall Study|Lost to Follow-up|0
969618|NCT00627497|3192801|P2|Overall Study|Lost to Follow-up|1
969619|NCT00627497|3192802|P1|Overall Study|Lost to Follow-up|1
969620|NCT00627458|3192863|P3|Overall Study|Lost to Follow-up|0
969621|NCT00627458|3192864|P2|Overall Study|Lost to Follow-up|1
969622|NCT00627458|3192865|P1|Overall Study|Lost to Follow-up|1
969623|NCT00627458|3192863|P3|Overall Study|Withdrawal by Subject|5
969624|NCT00627458|3192864|P2|Overall Study|Withdrawal by Subject|6
969625|NCT00627458|3192865|P1|Overall Study|Withdrawal by Subject|2
969626|NCT00627458|3192863|P3|Overall Study|Migrated from study area|1
969627|NCT00627458|3192864|P2|Overall Study|Migrated from study area|0
969628|NCT00627458|3192865|P1|Overall Study|Migrated from study area|1
969629|NCT00627445|3192940|P2|Overall Study|Other|8
969630|NCT00627445|3192941|P1|Overall Study|Other|6
969631|NCT00627445|3192940|P2|Overall Study|Lack of Efficacy|1
969632|NCT00627445|3192941|P1|Overall Study|Lack of Efficacy|0
969633|NCT00627445|3192940|P2|Overall Study|Adverse Event|3
969634|NCT00627445|3192941|P1|Overall Study|Adverse Event|3
969635|NCT00627393|3192984|P2|Per-Protocol Analysis|Withdrawal by patient/family/physician|10
969636|NCT00627393|3192985|P1|Per-Protocol Analysis|Withdrawal by patient/family/physician|4
969637|NCT00627393|3192984|P2|Per-Protocol Analysis|Received unstimulated/no granulocytes|3
969638|NCT00627393|3192985|P1|Per-Protocol Analysis|Received unstimulated/no granulocytes|6
969639|NCT00627393|3192984|P2|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5
969640|NCT00627393|3192985|P1|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4
969641|NCT00627393|3192984|P2|Intention-To-Treat Analysis|Adjudication indeterminate|3
969642|NCT00627393|3192985|P1|Intention-To-Treat Analysis|Adjudication indeterminate|5
969643|NCT00627094|3193021|P2|Overall Study|Other reason|0
969644|NCT00627094|3193022|P1|Overall Study|Other reason|1
969645|NCT00627094|3193021|P2|Overall Study|ulcer healed|7
969646|NCT00627094|3193022|P1|Overall Study|ulcer healed|1
969647|NCT00627094|3193021|P2|Overall Study|Withdrawal by Subject|1
969648|NCT00627094|3193022|P1|Overall Study|Withdrawal by Subject|1
969649|NCT00627094|3193021|P2|Overall Study|Lost to Follow-up|0
969650|NCT00627094|3193022|P1|Overall Study|Lost to Follow-up|1
969651|NCT00627094|3193021|P2|Overall Study|Adverse Event|7
969652|NCT00627094|3193022|P1|Overall Study|Adverse Event|8
969653|NCT00627042|3193034|P1|Overall Study|Withdrawal by Subject|2
969654|NCT00627016|3193046|P2|Overall Study|Pregnancy|0
969655|NCT00627016|3193047|P1|Overall Study|Pregnancy|1
969656|NCT00627016|3193046|P2|Overall Study|Placed on Excluded Drugs|0
969657|NCT00627016|3193047|P1|Overall Study|Placed on Excluded Drugs|1
969658|NCT00627016|3193046|P2|Overall Study|Lack of Efficacy|0
969659|NCT00627016|3193047|P1|Overall Study|Lack of Efficacy|1
969660|NCT00627016|3193046|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
969661|NCT00627016|3193047|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
969662|NCT00627016|3193046|P2|Overall Study|Withdrawal by Subject|1
969663|NCT00627016|3193047|P1|Overall Study|Withdrawal by Subject|2
969664|NCT00627016|3193046|P2|Overall Study|Lost to Follow-up|1
969665|NCT00627016|3193047|P1|Overall Study|Lost to Follow-up|0
969666|NCT00627016|3193046|P2|Overall Study|Protocol Violation|2
969667|NCT00627016|3193047|P1|Overall Study|Protocol Violation|0
969668|NCT00627016|3193046|P2|Overall Study|Adverse Event|1
969669|NCT00627016|3193047|P1|Overall Study|Adverse Event|1
969670|NCT00626925|3193059|P2|Overall Study|Time constraints|1
969671|NCT00626925|3193060|P1|Overall Study|Time constraints|3
969672|NCT00626925|3193059|P2|Overall Study|Lack of Efficacy|4
969673|NCT00626925|3193060|P1|Overall Study|Lack of Efficacy|1
969674|NCT00626925|3193059|P2|Overall Study|Adverse effect|2
969675|NCT00626925|3193060|P1|Overall Study|Adverse effect|6
969676|NCT00626925|3193059|P2|Overall Study|relapse|0
969677|NCT00626925|3193060|P1|Overall Study|relapse|1
969678|NCT00626925|3193059|P2|Overall Study|Lost to Follow-up|2
969679|NCT00626925|3193060|P1|Overall Study|Lost to Follow-up|1
969680|NCT00626821|3193092|P1|Overall Study|other/unknown reason|104
969681|NCT00626821|3193092|P1|Overall Study|Product dysfunction|21
969682|NCT00626821|3193092|P1|Overall Study|Physician Decision|9
969683|NCT00626821|3193092|P1|Overall Study|Withdrawal by Subject|10
969684|NCT00626821|3193092|P1|Overall Study|Protocol Violation|33
969685|NCT00626821|3193092|P1|Overall Study|Adverse Event|44
969686|NCT00626795|3193172|P3|Blinded Treatment|Missing reason for withdrawal|5
969687|NCT00626795|3193173|P2|Blinded Treatment|Missing reason for withdrawal|3
969688|NCT00626795|3193174|P1|Blinded Treatment|Missing reason for withdrawal|5
969689|NCT00626795|3193172|P3|Blinded Treatment|Other reasons|2
969690|NCT00626795|3193173|P2|Blinded Treatment|Other reasons|0
969691|NCT00626795|3193174|P1|Blinded Treatment|Other reasons|2
969692|NCT00626795|3193172|P3|Blinded Treatment|Withdrawal by Subject|0
969693|NCT00626795|3193173|P2|Blinded Treatment|Withdrawal by Subject|1
969694|NCT00626795|3193174|P1|Blinded Treatment|Withdrawal by Subject|1
969695|NCT00626795|3193172|P3|Blinded Treatment|Protocol Violation|1
969696|NCT00626795|3193173|P2|Blinded Treatment|Protocol Violation|1
969697|NCT00626795|3193174|P1|Blinded Treatment|Protocol Violation|0
969698|NCT00626795|3193172|P3|Blinded Treatment|Unacceptable adverse event|1
969699|NCT00626795|3193173|P2|Blinded Treatment|Unacceptable adverse event|0
969700|NCT00626795|3193174|P1|Blinded Treatment|Unacceptable adverse event|0
969701|NCT00626795|3193172|P3|Blinded Treatment|Lack of Efficacy|0
969702|NCT00626795|3193173|P2|Blinded Treatment|Lack of Efficacy|0
969703|NCT00626795|3193174|P1|Blinded Treatment|Lack of Efficacy|2
969704|NCT00626795|3193172|P3|Open-label TD1414 Cream TID Treatment|Adverse Event|0
969705|NCT00626795|3193173|P2|Open-label TD1414 Cream TID Treatment|Adverse Event|1
969706|NCT00626795|3193174|P1|Open-label TD1414 Cream TID Treatment|Adverse Event|0
969707|NCT00626639|3193225|P2|Overall Study|Occurrence of grade 3 oral mucositis|2
969708|NCT00626639|3193226|P1|Overall Study|Occurrence of grade 3 oral mucositis|2
969709|NCT00626561|3193272|P1|Overall Study|Disease Progression|2
969710|NCT00626561|3193272|P1|Overall Study|Withdrawal by Subject|2
969711|NCT00626548|3193278|P2|Overall Study|Other termination reason|613
969712|NCT00626548|3193279|P1|Overall Study|Other termination reason|493
969713|NCT00626548|3193278|P2|Overall Study|Lost to Follow-up|2
969714|NCT00626548|3193279|P1|Overall Study|Lost to Follow-up|2
969715|NCT00626548|3193278|P2|Overall Study|Protocol Violation|11
969716|NCT00626548|3193279|P1|Overall Study|Protocol Violation|4
969717|NCT00626548|3193278|P2|Overall Study|Withdrawal by Subject|46
969718|NCT00626548|3193279|P1|Overall Study|Withdrawal by Subject|42
969719|NCT00626548|3193278|P2|Overall Study|Adverse Event|44
969720|NCT00626548|3193279|P1|Overall Study|Adverse Event|164
969721|NCT00626522|3193293|P6|Overall Study|Non-fulfilment of in/exclusion criteria|0
969722|NCT00626522|3193294|P5|Overall Study|Non-fulfilment of in/exclusion criteria|0
969723|NCT00626522|3193295|P4|Overall Study|Non-fulfilment of in/exclusion criteria|1
969724|NCT00626522|3193296|P3|Overall Study|Non-fulfilment of in/exclusion criteria|1
969725|NCT00626522|3193297|P2|Overall Study|Non-fulfilment of in/exclusion criteria|0
969726|NCT00626522|3193298|P1|Overall Study|Non-fulfilment of in/exclusion criteria|1
969727|NCT00626522|3193293|P6|Overall Study|Inconsistent reason reported|0
969728|NCT00626522|3193294|P5|Overall Study|Inconsistent reason reported|0
969729|NCT00626522|3193295|P4|Overall Study|Inconsistent reason reported|0
969730|NCT00626522|3193296|P3|Overall Study|Inconsistent reason reported|0
969731|NCT00626522|3193297|P2|Overall Study|Inconsistent reason reported|0
969732|NCT00626522|3193298|P1|Overall Study|Inconsistent reason reported|1
969733|NCT00626522|3193293|P6|Overall Study|Lost to Follow-up|0
969734|NCT00626522|3193294|P5|Overall Study|Lost to Follow-up|0
969735|NCT00626522|3193295|P4|Overall Study|Lost to Follow-up|0
969736|NCT00626522|3193296|P3|Overall Study|Lost to Follow-up|0
969737|NCT00626522|3193297|P2|Overall Study|Lost to Follow-up|1
969738|NCT00626522|3193298|P1|Overall Study|Lost to Follow-up|0
969739|NCT00626522|3193293|P6|Overall Study|COPD exacerbation|0
969740|NCT00626522|3193294|P5|Overall Study|COPD exacerbation|1
969741|NCT00626522|3193295|P4|Overall Study|COPD exacerbation|1
969742|NCT00626522|3193296|P3|Overall Study|COPD exacerbation|0
969743|NCT00626522|3193297|P2|Overall Study|COPD exacerbation|0
969744|NCT00626522|3193298|P1|Overall Study|COPD exacerbation|0
969745|NCT00626522|3193293|P6|Overall Study|Withdrawal by Subject|1
969746|NCT00626522|3193294|P5|Overall Study|Withdrawal by Subject|4
969747|NCT00626522|3193295|P4|Overall Study|Withdrawal by Subject|0
969748|NCT00626522|3193296|P3|Overall Study|Withdrawal by Subject|5
969749|NCT00626522|3193297|P2|Overall Study|Withdrawal by Subject|5
969750|NCT00626522|3193298|P1|Overall Study|Withdrawal by Subject|2
969751|NCT00626522|3193293|P6|Overall Study|Adverse Event|1
969752|NCT00626522|3193294|P5|Overall Study|Adverse Event|1
969753|NCT00626522|3193295|P4|Overall Study|Adverse Event|0
969754|NCT00626522|3193296|P3|Overall Study|Adverse Event|2
969755|NCT00626522|3193297|P2|Overall Study|Adverse Event|1
969756|NCT00626522|3193298|P1|Overall Study|Adverse Event|2
969757|NCT00626522|3193293|P6|Overall Study|Protocol Violation|0
969758|NCT00626522|3193294|P5|Overall Study|Protocol Violation|1
969759|NCT00626522|3193295|P4|Overall Study|Protocol Violation|0
969760|NCT00626522|3193296|P3|Overall Study|Protocol Violation|0
969761|NCT00626522|3193297|P2|Overall Study|Protocol Violation|0
969762|NCT00626522|3193298|P1|Overall Study|Protocol Violation|0
969763|NCT00626405|3193361|P2|Overall Study|Withdrawal by Subject|1
969764|NCT00626405|3193362|P1|Overall Study|Withdrawal by Subject|0
969765|NCT00626405|3193361|P2|Overall Study|Deemed Ineligible|0
969766|NCT00626405|3193362|P1|Overall Study|Deemed Ineligible|1
969767|NCT00626392|3193378|P6|Coadministration Period|Other|1
969768|NCT00626392|3193379|P5|Coadministration Period|Other|1
969769|NCT00626392|3193380|P4|Coadministration Period|Other|1
969770|NCT00626392|3193381|P3|Coadministration Period|Other|3
969771|NCT00626392|3193382|P2|Coadministration Period|Other|2
969772|NCT00626392|3193383|P1|Coadministration Period|Other|0
969773|NCT00626392|3193378|P6|Coadministration Period|Protocol Violation|0
969774|NCT00626392|3193379|P5|Coadministration Period|Protocol Violation|1
969775|NCT00626392|3193380|P4|Coadministration Period|Protocol Violation|1
969776|NCT00626392|3193381|P3|Coadministration Period|Protocol Violation|0
969777|NCT00626392|3193382|P2|Coadministration Period|Protocol Violation|1
969778|NCT00626392|3193383|P1|Coadministration Period|Protocol Violation|0
969779|NCT00626392|3193378|P6|Coadministration Period|Withdrawal by Subject|1
969780|NCT00626392|3193379|P5|Coadministration Period|Withdrawal by Subject|0
969781|NCT00626392|3193380|P4|Coadministration Period|Withdrawal by Subject|1
969782|NCT00626392|3193381|P3|Coadministration Period|Withdrawal by Subject|0
969783|NCT00626392|3193382|P2|Coadministration Period|Withdrawal by Subject|1
969784|NCT00626392|3193383|P1|Coadministration Period|Withdrawal by Subject|1
969785|NCT00626392|3193378|P6|Coadministration Period|Adverse Event|4
969786|NCT00626392|3193379|P5|Coadministration Period|Adverse Event|3
969787|NCT00626392|3193380|P4|Coadministration Period|Adverse Event|4
969788|NCT00626392|3193381|P3|Coadministration Period|Adverse Event|7
969789|NCT00626392|3193382|P2|Coadministration Period|Adverse Event|1
969790|NCT00626392|3193383|P1|Coadministration Period|Adverse Event|3
969791|NCT00626392|3193378|P6|Run-in Period|Noncompliance|0
969792|NCT00626392|3193379|P5|Run-in Period|Noncompliance|0
969793|NCT00626392|3193380|P4|Run-in Period|Noncompliance|0
969794|NCT00626392|3193381|P3|Run-in Period|Noncompliance|1
969795|NCT00626392|3193382|P2|Run-in Period|Noncompliance|0
969796|NCT00626392|3193383|P1|Run-in Period|Noncompliance|1
969797|NCT00626392|3193378|P6|Run-in Period|Withdrawal by Subject|1
969798|NCT00626392|3193379|P5|Run-in Period|Withdrawal by Subject|3
969799|NCT00626392|3193380|P4|Run-in Period|Withdrawal by Subject|1
969800|NCT00626392|3193381|P3|Run-in Period|Withdrawal by Subject|1
969801|NCT00626392|3193382|P2|Run-in Period|Withdrawal by Subject|1
969802|NCT00626392|3193383|P1|Run-in Period|Withdrawal by Subject|0
969803|NCT00626392|3193378|P6|Run-in Period|Adverse Event|0
969804|NCT00626392|3193379|P5|Run-in Period|Adverse Event|1
969805|NCT00626392|3193380|P4|Run-in Period|Adverse Event|0
969806|NCT00626392|3193381|P3|Run-in Period|Adverse Event|1
969807|NCT00626392|3193382|P2|Run-in Period|Adverse Event|0
969808|NCT00626392|3193383|P1|Run-in Period|Adverse Event|0
969809|NCT00626327|3193402|P3|Overall Study|Protocol Violation|26
969810|NCT00626327|3193403|P2|Overall Study|Protocol Violation|4
969811|NCT00626327|3193404|P1|Overall Study|Protocol Violation|26
969812|NCT00626327|3193402|P3|Overall Study|Administrative Reason|6
969813|NCT00626327|3193403|P2|Overall Study|Administrative Reason|0
969814|NCT00626327|3193404|P1|Overall Study|Administrative Reason|2
969815|NCT00626327|3193402|P3|Overall Study|Inappropriate enrollment|3
969816|NCT00626327|3193403|P2|Overall Study|Inappropriate enrollment|5
969817|NCT00626327|3193404|P1|Overall Study|Inappropriate enrollment|4
969818|NCT00626327|3193402|P3|Overall Study|Lost to Follow-up|23
969819|NCT00626327|3193403|P2|Overall Study|Lost to Follow-up|21
969820|NCT00626327|3193404|P1|Overall Study|Lost to Follow-up|24
969821|NCT00626327|3193402|P3|Overall Study|Adverse Event|0
969822|NCT00626327|3193403|P2|Overall Study|Adverse Event|0
969823|NCT00626327|3193404|P1|Overall Study|Adverse Event|1
969824|NCT00626327|3193402|P3|Overall Study|Withdrawal by Subject|30
969825|NCT00626327|3193403|P2|Overall Study|Withdrawal by Subject|29
969826|NCT00626327|3193404|P1|Overall Study|Withdrawal by Subject|21
969827|NCT00626275|3193430|P8|Part B|Withdrawal by Subject|1
969828|NCT00626275|3193431|P7|Part B|Withdrawal by Subject|0
969829|NCT00626275|3193432|P6|Part B|Withdrawal by Subject|0
969830|NCT00626275|3193433|P5|Part B|Withdrawal by Subject|0
969831|NCT00626275|3193434|P4|Part B|Withdrawal by Subject|0
969832|NCT00626275|3193435|P3|Part B|Withdrawal by Subject|0
969833|NCT00626275|3193436|P2|Part B|Withdrawal by Subject|0
969834|NCT00626275|3193437|P1|Part B|Withdrawal by Subject|0
969835|NCT00626275|3193430|P8|Part B|Lost to Follow-up|0
969836|NCT00626275|3193431|P7|Part B|Lost to Follow-up|1
969837|NCT00626275|3193432|P6|Part B|Lost to Follow-up|0
969838|NCT00626275|3193433|P5|Part B|Lost to Follow-up|0
969839|NCT00626275|3193434|P4|Part B|Lost to Follow-up|0
969840|NCT00626275|3193435|P3|Part B|Lost to Follow-up|0
969841|NCT00626275|3193436|P2|Part B|Lost to Follow-up|0
969842|NCT00626275|3193437|P1|Part B|Lost to Follow-up|0
969843|NCT00626275|3193430|P8|Part A - Treatment Period 1|Withdrawal by Subject|0
969844|NCT00626275|3193431|P7|Part A - Treatment Period 1|Withdrawal by Subject|0
969845|NCT00626275|3193432|P6|Part A - Treatment Period 1|Withdrawal by Subject|0
969846|NCT00626275|3193433|P5|Part A - Treatment Period 1|Withdrawal by Subject|0
969847|NCT00626275|3193434|P4|Part A - Treatment Period 1|Withdrawal by Subject|0
969848|NCT00626275|3193435|P3|Part A - Treatment Period 1|Withdrawal by Subject|1
969849|NCT00626275|3193436|P2|Part A - Treatment Period 1|Withdrawal by Subject|0
969850|NCT00626275|3193437|P1|Part A - Treatment Period 1|Withdrawal by Subject|0
969851|NCT00626275|3193430|P8|Part A - Treatment Period 1|Adverse Event|0
969852|NCT00626275|3193431|P7|Part A - Treatment Period 1|Adverse Event|0
969853|NCT00626275|3193432|P6|Part A - Treatment Period 1|Adverse Event|0
969854|NCT00626275|3193433|P5|Part A - Treatment Period 1|Adverse Event|0
969855|NCT00626275|3193434|P4|Part A - Treatment Period 1|Adverse Event|0
969856|NCT00626275|3193435|P3|Part A - Treatment Period 1|Adverse Event|0
969857|NCT00626275|3193436|P2|Part A - Treatment Period 1|Adverse Event|0
969858|NCT00626275|3193437|P1|Part A - Treatment Period 1|Adverse Event|1
969859|NCT00626093|3193481|P1|Overall Study|One of the required devices not implante|6
969860|NCT00626093|3193481|P1|Overall Study|Protocol Violation|1
969861|NCT00626093|3193481|P1|Overall Study|Withdrawal by Subject|6
969862|NCT00626093|3193481|P1|Overall Study|Physician Decision|4
969863|NCT00626093|3193481|P1|Overall Study|Death|1
969864|NCT00626093|3193481|P1|Overall Study|Lost to Follow-up|5
969865|NCT00626028|3193488|P2|Treatment 1 NO First, O2 Last|Inclusion/Exclusion Criteria|6
969866|NCT00626028|3193489|P1|Treatment 1 NO First, O2 Last|Inclusion/Exclusion Criteria|3
969867|NCT00626028|3193488|P2|Treatment 1 NO First, O2 Last|Physician Decision|1
969868|NCT00626028|3193489|P1|Treatment 1 NO First, O2 Last|Physician Decision|2
969869|NCT00626028|3193488|P2|Treatment 1 NO First, O2 Last|Device Failure|1
969870|NCT00626028|3193489|P1|Treatment 1 NO First, O2 Last|Device Failure|0
969871|NCT00626028|3193488|P2|Treatment 1 NO First, O2 Last|Adverse Event|1
969872|NCT00626028|3193489|P1|Treatment 1 NO First, O2 Last|Adverse Event|1
969873|NCT00625872|3193509|P2|Overall Study|Randomized but not treated|1
969874|NCT00625872|3193510|P1|Overall Study|Randomized but not treated|0
969875|NCT00625872|3193509|P2|Overall Study|Terminated by sponsor|5
969876|NCT00625872|3193510|P1|Overall Study|Terminated by sponsor|2
969877|NCT00625872|3193509|P2|Overall Study|Does not meet inclusion criteria|0
969878|NCT00625872|3193510|P1|Overall Study|Does not meet inclusion criteria|1
969879|NCT00625872|3193509|P2|Overall Study|Withdrawal by Subject|0
969880|NCT00625872|3193510|P1|Overall Study|Withdrawal by Subject|1
969881|NCT00625820|3193620|P1|Overall Study|Withdrawal by Subject|1
969882|NCT00625807|3193628|P2|Overall Study|schedule conflict|8
969883|NCT00625807|3193629|P1|Overall Study|schedule conflict|2
969884|NCT00625742|3193645|P1|Overall Study|Ineligible|1
969885|NCT00625742|3193645|P1|Overall Study|Lost to Follow-up|4
969886|NCT00625742|3193645|P1|Overall Study|Adverse Event|4
969887|NCT00625742|3193645|P1|Overall Study|Withdrawal by Subject|1
969888|NCT00625742|3193645|P1|Overall Study|Disease Progression|2
969889|NCT00625586|3193659|P1|Overall Study|Adverse Event|1
969890|NCT00625443|3193672|P3|Overall Study|Not specified|1
969891|NCT00625443|3193673|P2|Overall Study|Not specified|1
969892|NCT00625443|3193674|P1|Overall Study|Not specified|0
969893|NCT00625443|3193672|P3|Overall Study|Physician Decision|2
969894|NCT00625443|3193673|P2|Overall Study|Physician Decision|4
969895|NCT00625443|3193674|P1|Overall Study|Physician Decision|0
969896|NCT00625443|3193672|P3|Overall Study|Withdrawal by Subject|2
969897|NCT00625443|3193673|P2|Overall Study|Withdrawal by Subject|1
969898|NCT00625443|3193674|P1|Overall Study|Withdrawal by Subject|0
969899|NCT00625443|3193672|P3|Overall Study|Platelet count increase >=500,000/mm3|0
969900|NCT00625443|3193673|P2|Overall Study|Platelet count increase >=500,000/mm3|0
969901|NCT00625443|3193674|P1|Overall Study|Platelet count increase >=500,000/mm3|1
969902|NCT00625443|3193672|P3|Overall Study|Non-compliance with protocol|0
969903|NCT00625443|3193673|P2|Overall Study|Non-compliance with protocol|1
969904|NCT00625443|3193674|P1|Overall Study|Non-compliance with protocol|0
969905|NCT00625443|3193672|P3|Overall Study|Adverse Event|0
969906|NCT00625443|3193673|P2|Overall Study|Adverse Event|4
969907|NCT00625443|3193674|P1|Overall Study|Adverse Event|1
969908|NCT00625365|3193754|P1|Overall Study|VSD|1
969909|NCT00625365|3193754|P1|Overall Study|No IV access|5
969910|NCT00625365|3193754|P1|Overall Study|Withdrawal by Subject|1
969911|NCT00625183|3193760|P1|Overall Study|Disease Progression|1
969912|NCT00625131|3193771|P3|Overall Study|Withdrawal by Subject|5
969913|NCT00625131|3193772|P2|Overall Study|Withdrawal by Subject|0
969914|NCT00625131|3193773|P1|Overall Study|Withdrawal by Subject|1
969915|NCT00625131|3193771|P3|Overall Study|Lost to Follow-up|0
969916|NCT00625131|3193772|P2|Overall Study|Lost to Follow-up|2
969917|NCT00625131|3193773|P1|Overall Study|Lost to Follow-up|3
969918|NCT00624832|3193796|P4|Overall Study|Abnormal Laboratory Value|0
969919|NCT00624832|3193797|P3|Overall Study|Abnormal Laboratory Value|0
969920|NCT00624832|3193798|P2|Overall Study|Abnormal Laboratory Value|0
969921|NCT00624832|3193799|P1|Overall Study|Abnormal Laboratory Value|2
969922|NCT00624832|3193796|P4|Overall Study|Adverse Event|1
969923|NCT00624832|3193797|P3|Overall Study|Adverse Event|0
969924|NCT00624832|3193798|P2|Overall Study|Adverse Event|1
969925|NCT00624832|3193799|P1|Overall Study|Adverse Event|0
969926|NCT00624780|3193830|P6|Follow-up (Week 26)|Other|0
969927|NCT00624780|3193831|P5|Follow-up (Week 26)|Other|0
969928|NCT00624780|3193832|P4|Follow-up (Week 26)|Other|0
969929|NCT00624780|3193833|P3|Follow-up (Week 26)|Other|0
969930|NCT00624780|3193834|P2|Follow-up (Week 26)|Other|1
969931|NCT00624780|3193835|P1|Follow-up (Week 26)|Other|1
969932|NCT00624780|3193830|P6|Follow-up (Week 26)|Withdrawal by Subject|0
969933|NCT00624780|3193831|P5|Follow-up (Week 26)|Withdrawal by Subject|0
969934|NCT00624780|3193832|P4|Follow-up (Week 26)|Withdrawal by Subject|0
969935|NCT00624780|3193833|P3|Follow-up (Week 26)|Withdrawal by Subject|0
969936|NCT00624780|3193834|P2|Follow-up (Week 26)|Withdrawal by Subject|0
969937|NCT00624780|3193835|P1|Follow-up (Week 26)|Withdrawal by Subject|1
969938|NCT00624780|3193830|P6|Follow-up (Week 26)|Lost to Follow-up|0
969939|NCT00624780|3193831|P5|Follow-up (Week 26)|Lost to Follow-up|1
969940|NCT00624780|3193832|P4|Follow-up (Week 26)|Lost to Follow-up|0
969941|NCT00624780|3193833|P3|Follow-up (Week 26)|Lost to Follow-up|1
969942|NCT00624780|3193834|P2|Follow-up (Week 26)|Lost to Follow-up|0
969943|NCT00624780|3193835|P1|Follow-up (Week 26)|Lost to Follow-up|0
969944|NCT00624780|3193830|P6|Follow-up (Week 26)|Adverse Event|0
969945|NCT00624780|3193831|P5|Follow-up (Week 26)|Adverse Event|1
969946|NCT00624780|3193832|P4|Follow-up (Week 26)|Adverse Event|0
969947|NCT00624780|3193833|P3|Follow-up (Week 26)|Adverse Event|0
969948|NCT00624780|3193834|P2|Follow-up (Week 26)|Adverse Event|0
969949|NCT00624780|3193835|P1|Follow-up (Week 26)|Adverse Event|0
969950|NCT00624780|3193830|P6|Follow-up (Week 26)|Death|0
969951|NCT00624780|3193831|P5|Follow-up (Week 26)|Death|0
969952|NCT00624780|3193832|P4|Follow-up (Week 26)|Death|0
969953|NCT00624780|3193833|P3|Follow-up (Week 26)|Death|1
969954|NCT00624780|3193834|P2|Follow-up (Week 26)|Death|0
969955|NCT00624780|3193835|P1|Follow-up (Week 26)|Death|0
969956|NCT00624780|3193830|P6|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
969957|NCT00624780|3193831|P5|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
969958|NCT00624780|3193832|P4|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
969959|NCT00624780|3193833|P3|Treatment Discontinuation (Week 25)|Lost to Follow-up|1
969960|NCT00624780|3193834|P2|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
969961|NCT00624780|3193835|P1|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
969962|NCT00624780|3193830|P6|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
969963|NCT00624780|3193831|P5|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
969964|NCT00624780|3193832|P4|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
969965|NCT00624780|3193833|P3|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
969966|NCT00624780|3193834|P2|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
969967|NCT00624780|3193835|P1|Treatment Discontinuation (Week 25)|Lack of Efficacy|1
969968|NCT00624780|3193830|P6|Treatment Discontinuation (Week 25)|Adverse Event|1
969969|NCT00624780|3193831|P5|Treatment Discontinuation (Week 25)|Adverse Event|0
969970|NCT00624780|3193832|P4|Treatment Discontinuation (Week 25)|Adverse Event|1
969971|NCT00624780|3193833|P3|Treatment Discontinuation (Week 25)|Adverse Event|2
969972|NCT00624780|3193834|P2|Treatment Discontinuation (Week 25)|Adverse Event|0
969973|NCT00624780|3193835|P1|Treatment Discontinuation (Week 25)|Adverse Event|1
969974|NCT00624780|3193830|P6|Fixed Dosing (Week 13 to Week 24)|Other|3
969975|NCT00624780|3193831|P5|Fixed Dosing (Week 13 to Week 24)|Other|4
969976|NCT00624780|3193832|P4|Fixed Dosing (Week 13 to Week 24)|Other|1
969977|NCT00624780|3193833|P3|Fixed Dosing (Week 13 to Week 24)|Other|4
969978|NCT00624780|3193834|P2|Fixed Dosing (Week 13 to Week 24)|Other|3
969979|NCT00624780|3193835|P1|Fixed Dosing (Week 13 to Week 24)|Other|5
969980|NCT00624780|3193830|P6|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
969981|NCT00624780|3193831|P5|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
969982|NCT00624780|3193832|P4|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
969983|NCT00624780|3193833|P3|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
969984|NCT00624780|3193834|P2|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
969985|NCT00624780|3193835|P1|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
969986|NCT00624780|3193830|P6|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
969987|NCT00624780|3193831|P5|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
969988|NCT00624780|3193832|P4|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
969989|NCT00624780|3193833|P3|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
969990|NCT00624780|3193834|P2|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
969991|NCT00624780|3193835|P1|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
969992|NCT00624780|3193830|P6|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
969993|NCT00624780|3193831|P5|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
969994|NCT00624780|3193832|P4|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
969995|NCT00624780|3193833|P3|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
969996|NCT00624780|3193834|P2|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1
969997|NCT00624780|3193835|P1|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
969998|NCT00624780|3193830|P6|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1
969999|NCT00624780|3193831|P5|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3
970000|NCT00624780|3193832|P4|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2
970001|NCT00624780|3193833|P3|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
970002|NCT00624780|3193834|P2|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4
970003|NCT00624780|3193835|P1|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
970004|NCT00624780|3193830|P6|Treatment Optimization (Up to Week 12)|Other|0
970005|NCT00624780|3193831|P5|Treatment Optimization (Up to Week 12)|Other|9
970006|NCT00624780|3193832|P4|Treatment Optimization (Up to Week 12)|Other|2
970007|NCT00624780|3193833|P3|Treatment Optimization (Up to Week 12)|Other|8
970008|NCT00624780|3193834|P2|Treatment Optimization (Up to Week 12)|Other|4
970009|NCT00624780|3193835|P1|Treatment Optimization (Up to Week 12)|Other|10
970010|NCT00624780|3193830|P6|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
970011|NCT00624780|3193831|P5|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
970012|NCT00624780|3193832|P4|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
970013|NCT00624780|3193833|P3|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7
970014|NCT00624780|3193834|P2|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2
970015|NCT00624780|3193835|P1|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
970016|NCT00624780|3193830|P6|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
970017|NCT00624780|3193831|P5|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
970018|NCT00624780|3193832|P4|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
970019|NCT00624780|3193833|P3|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
970020|NCT00624780|3193834|P2|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
970021|NCT00624780|3193835|P1|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
970022|NCT00624780|3193830|P6|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1
970023|NCT00624780|3193831|P5|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9
970024|NCT00624780|3193832|P4|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
970025|NCT00624780|3193833|P3|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10
970026|NCT00624780|3193834|P2|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2
970027|NCT00624780|3193835|P1|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
970028|NCT00624780|3193830|P6|Treatment Optimization (Up to Week 12)|Adverse Event|5
970029|NCT00624780|3193831|P5|Treatment Optimization (Up to Week 12)|Adverse Event|9
970030|NCT00624780|3193832|P4|Treatment Optimization (Up to Week 12)|Adverse Event|3
970031|NCT00624780|3193833|P3|Treatment Optimization (Up to Week 12)|Adverse Event|15
970032|NCT00624780|3193834|P2|Treatment Optimization (Up to Week 12)|Adverse Event|5
970033|NCT00624780|3193835|P1|Treatment Optimization (Up to Week 12)|Adverse Event|7
970034|NCT00624585|3194017|P1|Overall Study|Adverse Event|3
970035|NCT00624585|3194017|P1|Overall Study|Disease Progression|6
970036|NCT00624585|3194017|P1|Overall Study|Death|3
970037|NCT00624520|3194047|P2|Overall Study|Death|1
970038|NCT00624520|3194048|P1|Overall Study|Death|0
970039|NCT00624520|3194047|P2|Overall Study|Withdrawal by Subject|7
970040|NCT00624520|3194048|P1|Overall Study|Withdrawal by Subject|12
970041|NCT00624468|3194075|P4|Safety Follow-up (SFU) Period|Other|1
970042|NCT00624468|3194076|P3|Safety Follow-up (SFU) Period|Other|1
970043|NCT00624468|3194077|P2|Safety Follow-up (SFU) Period|Other|0
970044|NCT00624468|3194078|P1|Safety Follow-up (SFU) Period|Other|0
970045|NCT00624468|3194075|P4|Safety Follow-up (SFU) Period|Lost to Follow-up|2
970046|NCT00624468|3194076|P3|Safety Follow-up (SFU) Period|Lost to Follow-up|1
970047|NCT00624468|3194077|P2|Safety Follow-up (SFU) Period|Lost to Follow-up|0
970048|NCT00624468|3194078|P1|Safety Follow-up (SFU) Period|Lost to Follow-up|0
970049|NCT00624468|3194075|P4|Double-blind Period|Withdrew Prematurely|0
970050|NCT00624468|3194076|P3|Double-blind Period|Withdrew Prematurely|0
970051|NCT00624468|3194077|P2|Double-blind Period|Withdrew Prematurely|1
970052|NCT00624468|3194078|P1|Double-blind Period|Withdrew Prematurely|1
970053|NCT00624468|3194075|P4|Double-blind Period|Early Termination Initiated by Sponsor|0
970054|NCT00624468|3194076|P3|Double-blind Period|Early Termination Initiated by Sponsor|0
970055|NCT00624468|3194077|P2|Double-blind Period|Early Termination Initiated by Sponsor|12
970056|NCT00624468|3194078|P1|Double-blind Period|Early Termination Initiated by Sponsor|13
970057|NCT00624377|3194145|P1|Overall Study|Non-evaluable population|84
970058|NCT00624377|3194145|P1|Overall Study|Other|91
970059|NCT00624377|3194145|P1|Overall Study|Adverse Event|14
970060|NCT00624377|3194145|P1|Overall Study|Withdrawal by Subject|100
970061|NCT00624377|3194145|P1|Overall Study|Lost to Follow-up|355
970062|NCT00624338|3194159|P3|Overall Study|Randomized but not treated|3
970063|NCT00624338|3194160|P2|Overall Study|Randomized but not treated|1
970064|NCT00624338|3194161|P1|Overall Study|Randomized but not treated|2
970065|NCT00624338|3194159|P3|Overall Study|Other|9
970066|NCT00624338|3194160|P2|Overall Study|Other|5
970067|NCT00624338|3194161|P1|Overall Study|Other|15
970068|NCT00624338|3194159|P3|Overall Study|Termination of 150 mg group by Sponsor|0
970069|NCT00624338|3194160|P2|Overall Study|Termination of 150 mg group by Sponsor|55
970070|NCT00624338|3194161|P1|Overall Study|Termination of 150 mg group by Sponsor|0
970071|NCT00624338|3194159|P3|Overall Study|Immunoglobulin less than 3gram per liter|0
970072|NCT00624338|3194160|P2|Overall Study|Immunoglobulin less than 3gram per liter|0
970073|NCT00624338|3194161|P1|Overall Study|Immunoglobulin less than 3gram per liter|1
970074|NCT00624338|3194159|P3|Overall Study|Death|0
970075|NCT00624338|3194160|P2|Overall Study|Death|2
970076|NCT00624338|3194161|P1|Overall Study|Death|0
970077|NCT00624338|3194159|P3|Overall Study|Protocol Violation|2
970078|NCT00624338|3194160|P2|Overall Study|Protocol Violation|3
970079|NCT00624338|3194161|P1|Overall Study|Protocol Violation|3
970080|NCT00624338|3194159|P3|Overall Study|Lack of Efficacy|14
970081|NCT00624338|3194160|P2|Overall Study|Lack of Efficacy|3
970082|NCT00624338|3194161|P1|Overall Study|Lack of Efficacy|11
970083|NCT00624338|3194159|P3|Overall Study|Lost to Follow-up|0
970084|NCT00624338|3194160|P2|Overall Study|Lost to Follow-up|0
970085|NCT00624338|3194161|P1|Overall Study|Lost to Follow-up|1
970086|NCT00624338|3194159|P3|Overall Study|Adverse Event|18
970087|NCT00624338|3194160|P2|Overall Study|Adverse Event|14
970088|NCT00624338|3194161|P1|Overall Study|Adverse Event|14
970089|NCT00624286|3194183|P2|Overall Study|Death|1
970090|NCT00624286|3194184|P1|Overall Study|Death|0
970091|NCT00624286|3194183|P2|Overall Study|Abnormal test procedure result(s)|1
970092|NCT00624286|3194184|P1|Overall Study|Abnormal test procedure result(s)|0
970093|NCT00624286|3194183|P2|Overall Study|Not stated|1
970094|NCT00624286|3194184|P1|Overall Study|Not stated|0
970095|NCT00624286|3194183|P2|Overall Study|Lack of Efficacy|6
970096|NCT00624286|3194184|P1|Overall Study|Lack of Efficacy|1
970097|NCT00624286|3194183|P2|Overall Study|Administrative problems|0
970098|NCT00624286|3194184|P1|Overall Study|Administrative problems|3
970099|NCT00624286|3194183|P2|Overall Study|Lost to Follow-up|2
970100|NCT00624286|3194184|P1|Overall Study|Lost to Follow-up|3
970101|NCT00624286|3194183|P2|Overall Study|Withdrawal by Subject|4
970102|NCT00624286|3194184|P1|Overall Study|Withdrawal by Subject|5
970103|NCT00624286|3194183|P2|Overall Study|Adverse Event|3
970104|NCT00624286|3194184|P1|Overall Study|Adverse Event|6
970105|NCT00624286|3194183|P2|Overall Study|Protocol Deviation|9
970106|NCT00624286|3194184|P1|Overall Study|Protocol Deviation|7
970107|NCT00624065|3194237|P2|Overall Study|Met protocol-defined stopping criteria|9
970108|NCT00624065|3194238|P1|Overall Study|Met protocol-defined stopping criteria|4
970109|NCT00624065|3194237|P2|Overall Study|Lack of Efficacy|3
970110|NCT00624065|3194238|P1|Overall Study|Lack of Efficacy|0
970111|NCT00624065|3194237|P2|Overall Study|Consent withdrawn|5
970112|NCT00624065|3194238|P1|Overall Study|Consent withdrawn|6
970113|NCT00624065|3194237|P2|Overall Study|Lost to Follow-up|1
970114|NCT00624065|3194238|P1|Overall Study|Lost to Follow-up|4
970115|NCT00624065|3194237|P2|Overall Study|Adverse Event|6
970116|NCT00624065|3194238|P1|Overall Study|Adverse Event|5
970117|NCT00624052|3194250|P4|Overall Study|Changed job/ran out if meds|0
970118|NCT00624052|3194251|P3|Overall Study|Changed job/ran out if meds|0
970119|NCT00624052|3194252|P2|Overall Study|Changed job/ran out if meds|2
970120|NCT00624052|3194253|P1|Overall Study|Changed job/ran out if meds|0
970121|NCT00624052|3194250|P4|Overall Study|Consent withdrawn|0
970122|NCT00624052|3194251|P3|Overall Study|Consent withdrawn|1
970123|NCT00624052|3194252|P2|Overall Study|Consent withdrawn|1
970124|NCT00624052|3194253|P1|Overall Study|Consent withdrawn|3
970125|NCT00624052|3194250|P4|Overall Study|Non compliant with the protocol|1
970126|NCT00624052|3194251|P3|Overall Study|Non compliant with the protocol|1
970127|NCT00624052|3194252|P2|Overall Study|Non compliant with the protocol|1
970128|NCT00624052|3194253|P1|Overall Study|Non compliant with the protocol|2
970129|NCT00624052|3194250|P4|Overall Study|Lost to Follow-up|0
970130|NCT00624052|3194251|P3|Overall Study|Lost to Follow-up|1
970131|NCT00624052|3194252|P2|Overall Study|Lost to Follow-up|3
970132|NCT00624052|3194253|P1|Overall Study|Lost to Follow-up|2
970133|NCT00624052|3194250|P4|Overall Study|Lack of Efficacy|0
970134|NCT00624052|3194251|P3|Overall Study|Lack of Efficacy|0
970135|NCT00624052|3194252|P2|Overall Study|Lack of Efficacy|1
970136|NCT00624052|3194253|P1|Overall Study|Lack of Efficacy|1
970137|NCT00624052|3194250|P4|Overall Study|Adverse Event|3
970138|NCT00624052|3194251|P3|Overall Study|Adverse Event|0
970139|NCT00624052|3194252|P2|Overall Study|Adverse Event|6
970140|NCT00624052|3194253|P1|Overall Study|Adverse Event|7
970141|NCT00623935|3194330|P1|Overall Study|Patient Declined Transplant|1
970142|NCT00623935|3194330|P1|Overall Study|Death|1
970143|NCT00623831|3194337|P2|Overall Study|Progressive Disease|1
970144|NCT00623831|3194338|P1|Overall Study|Progressive Disease|0
970145|NCT00623831|3194337|P2|Overall Study|Withdrawal by Subject|0
970146|NCT00623831|3194338|P1|Overall Study|Withdrawal by Subject|1
970147|NCT00623805|3194350|P2|Overall Study|Reason not Specified|6
970148|NCT00623805|3194351|P1|Overall Study|Reason not Specified|3
970149|NCT00623805|3194350|P2|Overall Study|Protocol Violation|1
970150|NCT00623805|3194351|P1|Overall Study|Protocol Violation|1
970151|NCT00623805|3194350|P2|Overall Study|Lost to Follow-up|2
970152|NCT00623805|3194351|P1|Overall Study|Lost to Follow-up|2
970153|NCT00623805|3194350|P2|Overall Study|Lack of Efficacy|7
970154|NCT00623805|3194351|P1|Overall Study|Lack of Efficacy|3
970155|NCT00623805|3194350|P2|Overall Study|Death|0
970156|NCT00623805|3194351|P1|Overall Study|Death|2
970157|NCT00623805|3194350|P2|Overall Study|Adverse Event|6
970158|NCT00623805|3194351|P1|Overall Study|Adverse Event|9
970159|NCT00623779|3194368|P3|Overall Study|Criteria from CSR|1
970160|NCT00623779|3194369|P2|Overall Study|Criteria from CSR|0
970161|NCT00623779|3194370|P1|Overall Study|Criteria from CSR|2
970162|NCT00623779|3194368|P3|Overall Study|Adverse Event|0
970163|NCT00623779|3194369|P2|Overall Study|Adverse Event|3
970164|NCT00623779|3194370|P1|Overall Study|Adverse Event|1
970165|NCT00623766|3194419|P2|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0
970166|NCT00623766|3194420|P1|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1
970167|NCT00623766|3194419|P2|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2
970168|NCT00623766|3194420|P1|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1
970169|NCT00623766|3194419|P2|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0
970170|NCT00623766|3194420|P1|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4
970171|NCT00623766|3194419|P2|Maintenance Phase (Week 24 to Year 2)|Disease progression|0
970172|NCT00623766|3194420|P1|Maintenance Phase (Week 24 to Year 2)|Disease progression|4
970173|NCT00623766|3194419|P2|Induction Phase (Day 1 to Week 24)|Off treatment|16
970174|NCT00623766|3194420|P1|Induction Phase (Day 1 to Week 24)|Off treatment|36
970175|NCT00623727|3194444|P2|Open Label Follow-up|Participant convenience|1
970176|NCT00623727|3194445|P1|Open Label Follow-up|Participant convenience|0
970177|NCT00623727|3194444|P2|Open Label Follow-up|Study termination|6
970178|NCT00623727|3194445|P1|Open Label Follow-up|Study termination|0
970179|NCT00623727|3194444|P2|Open Label Follow-up|Withdrawal by Subject|1
970180|NCT00623727|3194445|P1|Open Label Follow-up|Withdrawal by Subject|0
970181|NCT00623727|3194444|P2|Double Blind (DB)|Protocol Violation|2
970182|NCT00623727|3194445|P1|Double Blind (DB)|Protocol Violation|2
970183|NCT00623727|3194444|P2|Double Blind (DB)|Lost to Follow-up|1
970184|NCT00623727|3194445|P1|Double Blind (DB)|Lost to Follow-up|1
970185|NCT00623727|3194444|P2|Double Blind (DB)|Termination of the double-blind period|21
970186|NCT00623727|3194445|P1|Double Blind (DB)|Termination of the double-blind period|22
970187|NCT00623727|3194444|P2|Double Blind (DB)|Lack of Efficacy|2
970188|NCT00623727|3194445|P1|Double Blind (DB)|Lack of Efficacy|2
970189|NCT00623727|3194444|P2|Double Blind (DB)|Withdrawal by Subject|2
970190|NCT00623727|3194445|P1|Double Blind (DB)|Withdrawal by Subject|8
970191|NCT00623727|3194444|P2|Double Blind (DB)|Physician Decision|1
970192|NCT00623727|3194445|P1|Double Blind (DB)|Physician Decision|0
970193|NCT00623727|3194444|P2|Double Blind (DB)|Adverse Event|3
970194|NCT00623727|3194445|P1|Double Blind (DB)|Adverse Event|1
970195|NCT00623597|3194500|P2|Overall Study|Failed to return|0
970196|NCT00623597|3194501|P1|Overall Study|Failed to return|1
970197|NCT00623545|3194564|P1|Overall Study|Withdrawal by Subject|4
970198|NCT00623545|3194564|P1|Overall Study|Adverse Event|6
970199|NCT00623480|3194584|P2|Overall Study|Site closed by sponsor|1
970200|NCT00623480|3194585|P1|Overall Study|Site closed by sponsor|0
970201|NCT00623480|3194584|P2|Overall Study|Protocol Violation|1
970202|NCT00623480|3194585|P1|Overall Study|Protocol Violation|0
970203|NCT00623480|3194584|P2|Overall Study|Non-compliant with study medication|0
970204|NCT00623480|3194585|P1|Overall Study|Non-compliant with study medication|4
970205|NCT00623480|3194584|P2|Overall Study|Lack of Efficacy|0
970206|NCT00623480|3194585|P1|Overall Study|Lack of Efficacy|1
970207|NCT00623480|3194584|P2|Overall Study|Withdrawal by Subject|4
970208|NCT00623480|3194585|P1|Overall Study|Withdrawal by Subject|2
970209|NCT00623480|3194584|P2|Overall Study|Lost to Follow-up|1
970210|NCT00623480|3194585|P1|Overall Study|Lost to Follow-up|0
970211|NCT00623467|3194597|P1|Overall Study|Withdrawal by Subject|2
970212|NCT00623467|3194597|P1|Overall Study|Protocol Violation|4
970213|NCT00623467|3194597|P1|Overall Study|Lost to Follow-up|1
970214|NCT00623428|3194667|P2|Follow-up Period|Death|1
970215|NCT00623428|3194668|P1|Follow-up Period|Death|0
970216|NCT00623428|3194667|P2|Follow-up Period|Reason not specified|1
970217|NCT00623428|3194668|P1|Follow-up Period|Reason not specified|1
970218|NCT00623428|3194667|P2|Follow-up Period|Did not cooperate|3
970219|NCT00623428|3194668|P1|Follow-up Period|Did not cooperate|0
970220|NCT00623428|3194667|P2|Follow-up Period|HCV-RNA detectable at end of treatment|1
970221|NCT00623428|3194668|P1|Follow-up Period|HCV-RNA detectable at end of treatment|2
970222|NCT00623428|3194667|P2|Follow-up Period|Patient withdrew consent|4
970223|NCT00623428|3194668|P1|Follow-up Period|Patient withdrew consent|5
970224|NCT00623428|3194667|P2|Follow-up Period|Failure to return|2
970225|NCT00623428|3194668|P1|Follow-up Period|Failure to return|10
970226|NCT00623428|3194667|P2|Follow-up Period|Relapse post-treatment|3
970227|NCT00623428|3194668|P1|Follow-up Period|Relapse post-treatment|11
970228|NCT00623428|3194667|P2|Treatment Period|Withdrawal by Subject|1
970229|NCT00623428|3194668|P1|Treatment Period|Withdrawal by Subject|0
970230|NCT00623428|3194667|P2|Treatment Period|Other|1
970231|NCT00623428|3194668|P1|Treatment Period|Other|0
970232|NCT00623428|3194667|P2|Treatment Period|Insufficient therapeutic response|2
970233|NCT00623428|3194668|P1|Treatment Period|Insufficient therapeutic response|0
970234|NCT00623428|3194667|P2|Treatment Period|Did not cooperate / refused treatment|13
970235|NCT00623428|3194668|P1|Treatment Period|Did not cooperate / refused treatment|0
970236|NCT00623428|3194667|P2|Treatment Period|Death|1
970237|NCT00623428|3194668|P1|Treatment Period|Death|0
970238|NCT00623428|3194667|P2|Treatment Period|Adverse event/intercurrent illness|9
970239|NCT00623428|3194668|P1|Treatment Period|Adverse event/intercurrent illness|0
970240|NCT00623233|3194686|P1|Overall Study|Withdrawal by Subject|3
970241|NCT00623233|3194686|P1|Overall Study|Lost to Follow-up|1
970242|NCT00623233|3194686|P1|Overall Study|Physician Decision|10
970243|NCT00623233|3194686|P1|Overall Study|Adverse Event|10
970244|NCT00623194|3194693|P1|Overall Study|Unclassified|1
970245|NCT00623194|3194693|P1|Overall Study|Protocol Violation|3
970246|NCT00623194|3194693|P1|Overall Study|Lack of Efficacy|1
970247|NCT00623103|3194730|P2|Overall Study|Protocol deviation|1
970248|NCT00623103|3194731|P1|Overall Study|Protocol deviation|2
970249|NCT00623103|3194730|P2|Overall Study|Death|11
970250|NCT00623103|3194731|P1|Overall Study|Death|11
970251|NCT00623103|3194730|P2|Overall Study|Administrative problems|4
970252|NCT00623103|3194731|P1|Overall Study|Administrative problems|2
970253|NCT00623103|3194730|P2|Overall Study|Lost to Follow-up|1
970254|NCT00623103|3194731|P1|Overall Study|Lost to Follow-up|4
970255|NCT00623103|3194730|P2|Overall Study|Withdrawal by Subject|24
970256|NCT00623103|3194731|P1|Overall Study|Withdrawal by Subject|18
970257|NCT00623103|3194730|P2|Overall Study|Unsatisfactory therapeutic effect|12
970258|NCT00623103|3194731|P1|Overall Study|Unsatisfactory therapeutic effect|4
970259|NCT00623103|3194730|P2|Overall Study|Adverse Event|60
970260|NCT00623103|3194731|P1|Overall Study|Adverse Event|70
970261|NCT00622908|3194759|P2|Overall Study|Termination by study sponser|1
970262|NCT00622908|3194760|P1|Overall Study|Termination by study sponser|0
970263|NCT00622908|3194759|P2|Overall Study|Refusal|1
970264|NCT00622908|3194760|P1|Overall Study|Refusal|0
970265|NCT00622908|3194759|P2|Overall Study|Lost to Follow-up|0
970266|NCT00622908|3194760|P1|Overall Study|Lost to Follow-up|1
970267|NCT00622908|3194759|P2|Overall Study|Lack of Efficacy|7
970268|NCT00622908|3194760|P1|Overall Study|Lack of Efficacy|1
970269|NCT00622908|3194759|P2|Overall Study|Adverse Event|1
970270|NCT00622908|3194760|P1|Overall Study|Adverse Event|0
970271|NCT00622908|3194759|P2|Overall Study|Protocol Violation|0
970272|NCT00622908|3194760|P1|Overall Study|Protocol Violation|1
970273|NCT00622869|3194790|P3|Overall Study|Missing|1
970274|NCT00622869|3194791|P2|Overall Study|Missing|1
970275|NCT00622869|3194792|P1|Overall Study|Missing|0
970276|NCT00622869|3194790|P3|Overall Study|Graft Loss|2
970277|NCT00622869|3194791|P2|Overall Study|Graft Loss|3
970278|NCT00622869|3194792|P1|Overall Study|Graft Loss|5
970279|NCT00622869|3194790|P3|Overall Study|Lost to Follow-up|2
970280|NCT00622869|3194791|P2|Overall Study|Lost to Follow-up|4
970281|NCT00622869|3194792|P1|Overall Study|Lost to Follow-up|2
970282|NCT00622869|3194790|P3|Overall Study|Death|10
970283|NCT00622869|3194791|P2|Overall Study|Death|15
970284|NCT00622869|3194792|P1|Overall Study|Death|12
970285|NCT00622869|3194790|P3|Overall Study|Administrative Problems|13
970286|NCT00622869|3194791|P2|Overall Study|Administrative Problems|17
970287|NCT00622869|3194792|P1|Overall Study|Administrative Problems|11
970288|NCT00622869|3194790|P3|Overall Study|Subject Withdrew Consent|11
970289|NCT00622869|3194791|P2|Overall Study|Subject Withdrew Consent|17
970290|NCT00622869|3194792|P1|Overall Study|Subject Withdrew Consent|13
970291|NCT00622739|3194811|P2|Overall Study|Lost to Follow-up|1
970292|NCT00622739|3194812|P1|Overall Study|Lost to Follow-up|0
970293|NCT00622739|3194811|P2|Overall Study|Withdrawal by Subject|1
970294|NCT00622739|3194812|P1|Overall Study|Withdrawal by Subject|0
970295|NCT00622739|3194811|P2|Overall Study|Lack of Efficacy|2
970296|NCT00622739|3194812|P1|Overall Study|Lack of Efficacy|0
970297|NCT00622739|3194811|P2|Overall Study|Adverse Event|2
970298|NCT00622739|3194812|P1|Overall Study|Adverse Event|1
970299|NCT00622739|3194811|P2|Overall Study|Physician Decision|0
970300|NCT00622739|3194812|P1|Overall Study|Physician Decision|1
970301|NCT00622726|3194820|P2|August, 2010 to April, 2013|Death|5
970302|NCT00622726|3194821|P1|August, 2010 to April, 2013|Death|1
970303|NCT00622726|3194820|P2|March, 2008 to August, 2010|Death|2
970304|NCT00622726|3194821|P1|March, 2008 to August, 2010|Death|5
970305|NCT00622713|3194831|P1|Overall Study|Did not meet eligibility criteria|1
970306|NCT00622713|3194831|P1|Overall Study|Subject no longer required study drug|1
970307|NCT00622713|3194831|P1|Overall Study|Death|2
970308|NCT00622713|3194831|P1|Overall Study|Lost to Follow-up|5
970309|NCT00622713|3194831|P1|Overall Study|Withdrawal by Subject|11
970310|NCT00622713|3194831|P1|Overall Study|Administrative problems|4
970311|NCT00622713|3194831|P1|Overall Study|Adverse Event|35
970312|NCT00622700|3194842|P7|Extension Treatment Period|Other than specified above|1
970313|NCT00622700|3194843|P6|Extension Treatment Period|Other than specified above|1
970314|NCT00622700|3194844|P5|Extension Treatment Period|Other than specified above|0
970315|NCT00622700|3194845|P4|Extension Treatment Period|Other than specified above|0
970316|NCT00622700|3194846|P3|Extension Treatment Period|Other than specified above|0
970317|NCT00622700|3194847|P2|Extension Treatment Period|Other than specified above|0
970318|NCT00622700|3194848|P1|Extension Treatment Period|Other than specified above|0
970319|NCT00622700|3194842|P7|Extension Treatment Period|Missing|0
970320|NCT00622700|3194843|P6|Extension Treatment Period|Missing|1
970321|NCT00622700|3194844|P5|Extension Treatment Period|Missing|3
970322|NCT00622700|3194845|P4|Extension Treatment Period|Missing|2
970323|NCT00622700|3194846|P3|Extension Treatment Period|Missing|0
970324|NCT00622700|3194847|P2|Extension Treatment Period|Missing|0
970325|NCT00622700|3194848|P1|Extension Treatment Period|Missing|0
970326|NCT00622700|3194842|P7|Extension Treatment Period|Withdrawal by Subject|10
970327|NCT00622700|3194843|P6|Extension Treatment Period|Withdrawal by Subject|6
970328|NCT00622700|3194844|P5|Extension Treatment Period|Withdrawal by Subject|16
970329|NCT00622700|3194845|P4|Extension Treatment Period|Withdrawal by Subject|11
970330|NCT00622700|3194846|P3|Extension Treatment Period|Withdrawal by Subject|0
970331|NCT00622700|3194847|P2|Extension Treatment Period|Withdrawal by Subject|0
970332|NCT00622700|3194848|P1|Extension Treatment Period|Withdrawal by Subject|0
970333|NCT00622700|3194842|P7|Extension Treatment Period|Progressive Disease|2
970334|NCT00622700|3194843|P6|Extension Treatment Period|Progressive Disease|0
970335|NCT00622700|3194844|P5|Extension Treatment Period|Progressive Disease|2
970336|NCT00622700|3194845|P4|Extension Treatment Period|Progressive Disease|1
970337|NCT00622700|3194846|P3|Extension Treatment Period|Progressive Disease|0
970338|NCT00622700|3194847|P2|Extension Treatment Period|Progressive Disease|0
970339|NCT00622700|3194848|P1|Extension Treatment Period|Progressive Disease|0
970340|NCT00622700|3194842|P7|Extension Treatment Period|Lost to Follow-up|0
970341|NCT00622700|3194843|P6|Extension Treatment Period|Lost to Follow-up|0
970342|NCT00622700|3194844|P5|Extension Treatment Period|Lost to Follow-up|1
970343|NCT00622700|3194845|P4|Extension Treatment Period|Lost to Follow-up|0
970344|NCT00622700|3194846|P3|Extension Treatment Period|Lost to Follow-up|0
970345|NCT00622700|3194847|P2|Extension Treatment Period|Lost to Follow-up|0
970346|NCT00622700|3194848|P1|Extension Treatment Period|Lost to Follow-up|0
970347|NCT00622700|3194842|P7|Extension Treatment Period|Protocol Violation|0
970348|NCT00622700|3194843|P6|Extension Treatment Period|Protocol Violation|2
970349|NCT00622700|3194844|P5|Extension Treatment Period|Protocol Violation|0
970350|NCT00622700|3194845|P4|Extension Treatment Period|Protocol Violation|0
970351|NCT00622700|3194846|P3|Extension Treatment Period|Protocol Violation|0
970352|NCT00622700|3194847|P2|Extension Treatment Period|Protocol Violation|0
970353|NCT00622700|3194848|P1|Extension Treatment Period|Protocol Violation|0
970354|NCT00622700|3194842|P7|Extension Treatment Period|Lack of Efficacy|9
970355|NCT00622700|3194843|P6|Extension Treatment Period|Lack of Efficacy|1
970356|NCT00622700|3194844|P5|Extension Treatment Period|Lack of Efficacy|8
970357|NCT00622700|3194845|P4|Extension Treatment Period|Lack of Efficacy|2
970358|NCT00622700|3194846|P3|Extension Treatment Period|Lack of Efficacy|0
970359|NCT00622700|3194847|P2|Extension Treatment Period|Lack of Efficacy|0
970360|NCT00622700|3194848|P1|Extension Treatment Period|Lack of Efficacy|0
970361|NCT00622700|3194842|P7|Extension Treatment Period|Adverse Event|8
970362|NCT00622700|3194843|P6|Extension Treatment Period|Adverse Event|6
970363|NCT00622700|3194844|P5|Extension Treatment Period|Adverse Event|9
970364|NCT00622700|3194845|P4|Extension Treatment Period|Adverse Event|5
970365|NCT00622700|3194846|P3|Extension Treatment Period|Adverse Event|0
970366|NCT00622700|3194847|P2|Extension Treatment Period|Adverse Event|0
970367|NCT00622700|3194848|P1|Extension Treatment Period|Adverse Event|0
970368|NCT00622700|3194842|P7|Core Treatment Period|Other than specified above|0
970369|NCT00622700|3194843|P6|Core Treatment Period|Other than specified above|0
970370|NCT00622700|3194844|P5|Core Treatment Period|Other than specified above|0
970371|NCT00622700|3194845|P4|Core Treatment Period|Other than specified above|0
970372|NCT00622700|3194846|P3|Core Treatment Period|Other than specified above|5
970373|NCT00622700|3194847|P2|Core Treatment Period|Other than specified above|2
970374|NCT00622700|3194848|P1|Core Treatment Period|Other than specified above|2
970375|NCT00622700|3194842|P7|Core Treatment Period|Withdrawal by Subject|0
970376|NCT00622700|3194843|P6|Core Treatment Period|Withdrawal by Subject|0
970377|NCT00622700|3194844|P5|Core Treatment Period|Withdrawal by Subject|0
970378|NCT00622700|3194845|P4|Core Treatment Period|Withdrawal by Subject|0
970379|NCT00622700|3194846|P3|Core Treatment Period|Withdrawal by Subject|15
970380|NCT00622700|3194847|P2|Core Treatment Period|Withdrawal by Subject|18
970381|NCT00622700|3194848|P1|Core Treatment Period|Withdrawal by Subject|12
970382|NCT00622700|3194842|P7|Core Treatment Period|Progressive Disease|0
970383|NCT00622700|3194843|P6|Core Treatment Period|Progressive Disease|0
970384|NCT00622700|3194844|P5|Core Treatment Period|Progressive Disease|0
970385|NCT00622700|3194845|P4|Core Treatment Period|Progressive Disease|0
970386|NCT00622700|3194846|P3|Core Treatment Period|Progressive Disease|0
970387|NCT00622700|3194847|P2|Core Treatment Period|Progressive Disease|1
970388|NCT00622700|3194848|P1|Core Treatment Period|Progressive Disease|3
970389|NCT00622700|3194842|P7|Core Treatment Period|Death|0
970390|NCT00622700|3194843|P6|Core Treatment Period|Death|0
970391|NCT00622700|3194844|P5|Core Treatment Period|Death|0
970392|NCT00622700|3194845|P4|Core Treatment Period|Death|0
970393|NCT00622700|3194846|P3|Core Treatment Period|Death|0
970394|NCT00622700|3194847|P2|Core Treatment Period|Death|0
970395|NCT00622700|3194848|P1|Core Treatment Period|Death|1
970396|NCT00622700|3194842|P7|Core Treatment Period|Lost to Follow-up|0
970397|NCT00622700|3194843|P6|Core Treatment Period|Lost to Follow-up|0
970398|NCT00622700|3194844|P5|Core Treatment Period|Lost to Follow-up|0
970399|NCT00622700|3194845|P4|Core Treatment Period|Lost to Follow-up|0
970400|NCT00622700|3194846|P3|Core Treatment Period|Lost to Follow-up|1
970401|NCT00622700|3194847|P2|Core Treatment Period|Lost to Follow-up|1
970402|NCT00622700|3194848|P1|Core Treatment Period|Lost to Follow-up|1
970403|NCT00622700|3194842|P7|Core Treatment Period|Lack of Efficacy|0
970404|NCT00622700|3194843|P6|Core Treatment Period|Lack of Efficacy|0
970405|NCT00622700|3194844|P5|Core Treatment Period|Lack of Efficacy|0
970406|NCT00622700|3194845|P4|Core Treatment Period|Lack of Efficacy|0
970407|NCT00622700|3194846|P3|Core Treatment Period|Lack of Efficacy|12
970408|NCT00622700|3194847|P2|Core Treatment Period|Lack of Efficacy|6
970409|NCT00622700|3194848|P1|Core Treatment Period|Lack of Efficacy|19
970410|NCT00622700|3194842|P7|Core Treatment Period|Adverse Event|0
970411|NCT00622700|3194843|P6|Core Treatment Period|Adverse Event|0
970412|NCT00622700|3194844|P5|Core Treatment Period|Adverse Event|0
970413|NCT00622700|3194845|P4|Core Treatment Period|Adverse Event|0
970414|NCT00622700|3194846|P3|Core Treatment Period|Adverse Event|18
970415|NCT00622700|3194847|P2|Core Treatment Period|Adverse Event|25
970416|NCT00622700|3194848|P1|Core Treatment Period|Adverse Event|18
970417|NCT00622700|3194842|P7|Core Treatment Period|Randomized but Not Treated|0
970418|NCT00622700|3194843|P6|Core Treatment Period|Randomized but Not Treated|0
970419|NCT00622700|3194844|P5|Core Treatment Period|Randomized but Not Treated|0
970420|NCT00622700|3194845|P4|Core Treatment Period|Randomized but Not Treated|0
970421|NCT00622700|3194846|P3|Core Treatment Period|Randomized but Not Treated|2
970422|NCT00622700|3194847|P2|Core Treatment Period|Randomized but Not Treated|2
970423|NCT00622700|3194848|P1|Core Treatment Period|Randomized but Not Treated|0
970424|NCT00622635|3194907|P6|Treatment Period 3|Withdrawal by Subject|0
970425|NCT00622635|3194908|P5|Treatment Period 3|Withdrawal by Subject|0
970426|NCT00622635|3194909|P4|Treatment Period 3|Withdrawal by Subject|1
970427|NCT00622635|3194910|P3|Treatment Period 3|Withdrawal by Subject|0
970428|NCT00622635|3194911|P2|Treatment Period 3|Withdrawal by Subject|0
970429|NCT00622635|3194912|P1|Treatment Period 3|Withdrawal by Subject|0
970430|NCT00622635|3194907|P6|Treatment Period 3|Adverse Event|0
970431|NCT00622635|3194908|P5|Treatment Period 3|Adverse Event|0
970432|NCT00622635|3194909|P4|Treatment Period 3|Adverse Event|2
970433|NCT00622635|3194910|P3|Treatment Period 3|Adverse Event|0
970434|NCT00622635|3194911|P2|Treatment Period 3|Adverse Event|0
970435|NCT00622635|3194912|P1|Treatment Period 3|Adverse Event|0
970436|NCT00622635|3194907|P6|Treatment Period 2|Adverse Event|0
970437|NCT00622635|3194908|P5|Treatment Period 2|Adverse Event|0
970438|NCT00622635|3194909|P4|Treatment Period 2|Adverse Event|0
970439|NCT00622635|3194910|P3|Treatment Period 2|Adverse Event|0
970440|NCT00622635|3194911|P2|Treatment Period 2|Adverse Event|0
970441|NCT00622635|3194912|P1|Treatment Period 2|Adverse Event|1
970442|NCT00622635|3194907|P6|Treatment Period 1|Abnormal test procedure result(s)|0
970443|NCT00622635|3194908|P5|Treatment Period 1|Abnormal test procedure result(s)|1
970528|NCT00621855|3195176|P4|Overall Study|Withdrawal by Subject|13
970444|NCT00622635|3194909|P4|Treatment Period 1|Abnormal test procedure result(s)|0
970445|NCT00622635|3194910|P3|Treatment Period 1|Abnormal test procedure result(s)|0
970446|NCT00622635|3194911|P2|Treatment Period 1|Abnormal test procedure result(s)|0
970447|NCT00622635|3194912|P1|Treatment Period 1|Abnormal test procedure result(s)|0
970448|NCT00622635|3194907|P6|Treatment Period 1|Withdrawal by Subject|0
970449|NCT00622635|3194908|P5|Treatment Period 1|Withdrawal by Subject|0
970450|NCT00622635|3194909|P4|Treatment Period 1|Withdrawal by Subject|0
970451|NCT00622635|3194910|P3|Treatment Period 1|Withdrawal by Subject|0
970452|NCT00622635|3194911|P2|Treatment Period 1|Withdrawal by Subject|1
970453|NCT00622635|3194912|P1|Treatment Period 1|Withdrawal by Subject|0
970454|NCT00622635|3194907|P6|Treatment Period 1|Adverse Event|0
970455|NCT00622635|3194908|P5|Treatment Period 1|Adverse Event|0
970456|NCT00622635|3194909|P4|Treatment Period 1|Adverse Event|0
970457|NCT00622635|3194910|P3|Treatment Period 1|Adverse Event|1
970458|NCT00622635|3194911|P2|Treatment Period 1|Adverse Event|0
970459|NCT00622635|3194912|P1|Treatment Period 1|Adverse Event|0
970460|NCT00622440|3194995|P2|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1
970461|NCT00622440|3194996|P1|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0
970462|NCT00622440|3194995|P2|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1
970463|NCT00622440|3194996|P1|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0
970464|NCT00622440|3194995|P2|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5
970465|NCT00622440|3194996|P1|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3
970466|NCT00622440|3194995|P2|Baseline - Week 12 (Treatment)|Received cream but did not return|1
970467|NCT00622440|3194996|P1|Baseline - Week 12 (Treatment)|Received cream but did not return|4
970468|NCT00622401|3195022|P3|Overall Study|Disease progression prior to treatment|0
970469|NCT00622401|3195023|P2|Overall Study|Disease progression prior to treatment|2
970470|NCT00622401|3195024|P1|Overall Study|Disease progression prior to treatment|3
970471|NCT00622388|3195031|P1|Overall Study|Insurance Expired|1
970472|NCT00622388|3195031|P1|Overall Study|Withdrew Consent|1
970473|NCT00622388|3195031|P1|Overall Study|Took Prohibited Medication|2
970474|NCT00622388|3195031|P1|Overall Study|Received Alternate Anticancer Therapy|8
970475|NCT00622388|3195031|P1|Overall Study|Death|3
970476|NCT00622388|3195031|P1|Overall Study|Participant Refusal|1
970477|NCT00622388|3195031|P1|Overall Study|Protocol Violation|3
970478|NCT00622388|3195031|P1|Overall Study|Adverse Event|6
970479|NCT00622388|3195031|P1|Overall Study|Disease Progression|47
970480|NCT00622336|3195049|P1|Extension Phase|Other|9
970481|NCT00622336|3195049|P1|Extension Phase|Lost to Follow-up|1
970482|NCT00622336|3195049|P1|Extension Phase|Withdrawal by Subject|1
970483|NCT00622336|3195049|P1|Extension Phase|Lack of therapeutic effect|2
970484|NCT00622336|3195049|P1|Extension Phase|Progressive Disease|6
970485|NCT00622336|3195049|P1|Extension Phase|Adverse Event|2
970486|NCT00622336|3195049|P1|Treatment Phase|Lost to Follow-up|2
970487|NCT00622336|3195049|P1|Treatment Phase|Withdrawal by Subject|13
970488|NCT00622336|3195049|P1|Treatment Phase|Lack of therapeutic effect|13
970489|NCT00622336|3195049|P1|Treatment Phase|Death|14
970490|NCT00622336|3195049|P1|Treatment Phase|Other|40
970491|NCT00622336|3195049|P1|Treatment Phase|Adverse Event|46
970492|NCT00622336|3195049|P1|Treatment Phase|Progression of Disease|181
970493|NCT00622284|3195060|P2|Overall Study|Other reason (not specified)|24
970494|NCT00622284|3195061|P1|Overall Study|Other reason (not specified)|33
970495|NCT00622284|3195060|P2|Overall Study|Withdrawal by Subject|24
970496|NCT00622284|3195061|P1|Overall Study|Withdrawal by Subject|27
970497|NCT00622284|3195060|P2|Overall Study|Lost to Follow-up|13
970498|NCT00622284|3195061|P1|Overall Study|Lost to Follow-up|11
970499|NCT00622284|3195060|P2|Overall Study|Protocol Violation|5
970500|NCT00622284|3195061|P1|Overall Study|Protocol Violation|12
970501|NCT00622284|3195060|P2|Overall Study|Adverse Event|90
970502|NCT00622284|3195061|P1|Overall Study|Adverse Event|61
970503|NCT00622284|3195060|P2|Overall Study|Lack of Efficacy|15
970504|NCT00622284|3195061|P1|Overall Study|Lack of Efficacy|45
970505|NCT00622167|3195123|P1|Overall Study|Did not meet angiographic criteria|20
970506|NCT00621985|3195127|P1|Dexamethasone Admission|Adverse Event|1
970507|NCT00621959|3195135|P2|Overall Study|Other|3
970508|NCT00621959|3195136|P1|Overall Study|Other|1
970509|NCT00621959|3195135|P2|Overall Study|Withdrawal by Subject|1
970510|NCT00621959|3195136|P1|Overall Study|Withdrawal by Subject|1
970511|NCT00621959|3195135|P2|Overall Study|Lost to Follow-up|2
970512|NCT00621959|3195136|P1|Overall Study|Lost to Follow-up|0
970513|NCT00621959|3195135|P2|Overall Study|Lack of Efficacy|1
970514|NCT00621959|3195136|P1|Overall Study|Lack of Efficacy|1
970515|NCT00621959|3195135|P2|Overall Study|Adverse Event|2
970516|NCT00621959|3195136|P1|Overall Study|Adverse Event|4
970517|NCT00621855|3195175|P5|Overall Study|Patients did not receive study drug|2
970518|NCT00621855|3195176|P4|Overall Study|Patients did not receive study drug|4
970519|NCT00621855|3195177|P3|Overall Study|Patients did not receive study drug|5
970520|NCT00621855|3195178|P2|Overall Study|Patients did not receive study drug|3
970521|NCT00621855|3195179|P1|Overall Study|Patients did not receive study drug|3
970522|NCT00621855|3195175|P5|Overall Study|Other|4
970523|NCT00621855|3195176|P4|Overall Study|Other|5
970524|NCT00621855|3195177|P3|Overall Study|Other|6
970525|NCT00621855|3195178|P2|Overall Study|Other|7
970526|NCT00621855|3195179|P1|Overall Study|Other|9
970527|NCT00621855|3195175|P5|Overall Study|Withdrawal by Subject|9
970529|NCT00621855|3195177|P3|Overall Study|Withdrawal by Subject|13
970530|NCT00621855|3195178|P2|Overall Study|Withdrawal by Subject|11
970531|NCT00621855|3195179|P1|Overall Study|Withdrawal by Subject|16
970532|NCT00621855|3195175|P5|Overall Study|Protocol Violation|8
970533|NCT00621855|3195176|P4|Overall Study|Protocol Violation|7
970534|NCT00621855|3195177|P3|Overall Study|Protocol Violation|6
970535|NCT00621855|3195178|P2|Overall Study|Protocol Violation|8
970536|NCT00621855|3195179|P1|Overall Study|Protocol Violation|16
970537|NCT00621855|3195175|P5|Overall Study|Lost to Follow-up|1
970538|NCT00621855|3195176|P4|Overall Study|Lost to Follow-up|4
970539|NCT00621855|3195177|P3|Overall Study|Lost to Follow-up|3
970540|NCT00621855|3195178|P2|Overall Study|Lost to Follow-up|1
970541|NCT00621855|3195179|P1|Overall Study|Lost to Follow-up|0
970542|NCT00621855|3195175|P5|Overall Study|Adverse Event|31
970543|NCT00621855|3195176|P4|Overall Study|Adverse Event|34
970544|NCT00621855|3195177|P3|Overall Study|Adverse Event|48
970545|NCT00621855|3195178|P2|Overall Study|Adverse Event|31
970546|NCT00621855|3195179|P1|Overall Study|Adverse Event|32
970547|NCT00621842|3195221|P1|Overall Study|Lack of Efficacy|2
970548|NCT00621842|3195221|P1|Overall Study|Protocol Violation|4
970549|NCT00621842|3195221|P1|Overall Study|Withdrawal by Subject|7
970550|NCT00621842|3195221|P1|Overall Study|Adverse Event|6
970551|NCT00621777|3195238|P2|Randomized Phase|Death|1
970552|NCT00621777|3195239|P1|Randomized Phase|Death|0
970553|NCT00621777|3195238|P2|Randomized Phase|administrative|3
970554|NCT00621777|3195239|P1|Randomized Phase|administrative|0
970555|NCT00621777|3195238|P2|Randomized Phase|Withdrawal by Subject|9
970556|NCT00621777|3195239|P1|Randomized Phase|Withdrawal by Subject|1
970557|NCT00621777|3195238|P2|Randomized Phase|Lost to Follow-up|3
970558|NCT00621777|3195239|P1|Randomized Phase|Lost to Follow-up|3
970559|NCT00621777|3195238|P2|Randomized Phase|Adverse Event|3
970560|NCT00621777|3195239|P1|Randomized Phase|Adverse Event|3
970561|NCT00621777|3195238|P2|Open Phase|Lost to Follow-up|0
970562|NCT00621777|3195239|P1|Open Phase|Lost to Follow-up|10
970563|NCT00621777|3195238|P2|Open Phase|administrative|0
970564|NCT00621777|3195239|P1|Open Phase|administrative|13
970565|NCT00621777|3195238|P2|Open Phase|Withdrawal by Subject|0
970566|NCT00621777|3195239|P1|Open Phase|Withdrawal by Subject|17
970567|NCT00621777|3195238|P2|Open Phase|Did not abstain during open phase|0
970568|NCT00621777|3195239|P1|Open Phase|Did not abstain during open phase|56
970569|NCT00621777|3195238|P2|Open Phase|Adverse Event|0
970570|NCT00621777|3195239|P1|Open Phase|Adverse Event|20
970571|NCT00621764|3195254|P4|Overall Study|Protocol Violation|1
970572|NCT00621764|3195255|P3|Overall Study|Protocol Violation|0
970573|NCT00621764|3195256|P2|Overall Study|Protocol Violation|0
970574|NCT00621764|3195257|P1|Overall Study|Protocol Violation|0
970575|NCT00621621|3195303|P2|Overall Study|Subjects were exited at EP study|0
970576|NCT00621621|3195304|P1|Overall Study|Subjects were exited at EP study|30
970577|NCT00621582|3195312|P1|Overall Study|issues not identified by investigators|18
970578|NCT00621582|3195312|P1|Overall Study|Lost to Follow-up|24
970579|NCT00621582|3195312|P1|Overall Study|Protocol Violation|57
970580|NCT00621582|3195312|P1|Overall Study|Adverse Event|7
970581|NCT00621543|3195319|P1|Overall Study|Lost to Follow-up|23
970582|NCT00621517|3195343|P2|Overall Study|Adverse Event|0
970583|NCT00621517|3195344|P1|Overall Study|Adverse Event|1
970584|NCT00621517|3195343|P2|Overall Study|Withdrawal by Subject|4
970585|NCT00621517|3195344|P1|Overall Study|Withdrawal by Subject|3
970586|NCT00621517|3195343|P2|Overall Study|Lost to Follow-up|3
970587|NCT00621517|3195344|P1|Overall Study|Lost to Follow-up|3
970588|NCT00621504|3195352|P2|Overall Study|Death|6
970589|NCT00621504|3195353|P1|Overall Study|Death|6
970590|NCT00621504|3195352|P2|Overall Study|Other|0
970591|NCT00621504|3195353|P1|Overall Study|Other|1
970592|NCT00621504|3195352|P2|Overall Study|Lost to Follow-up|10
970593|NCT00621504|3195353|P1|Overall Study|Lost to Follow-up|8
970594|NCT00621504|3195352|P2|Overall Study|Withdrew consent|6
970595|NCT00621504|3195353|P1|Overall Study|Withdrew consent|9
970596|NCT00621504|3195352|P2|Overall Study|At the request of sponsor/investigator|0
970597|NCT00621504|3195353|P1|Overall Study|At the request of sponsor/investigator|1
970598|NCT00621504|3195352|P2|Overall Study|Adverse Event|3
970599|NCT00621504|3195353|P1|Overall Study|Adverse Event|1
970600|NCT00621322|3195387|P6|Overall Study|Migrated/moved from study area|2
970601|NCT00621322|3195388|P5|Overall Study|Migrated/moved from study area|0
970602|NCT00621322|3195389|P4|Overall Study|Migrated/moved from study area|1
970603|NCT00621322|3195390|P3|Overall Study|Migrated/moved from study area|1
970604|NCT00621322|3195391|P2|Overall Study|Migrated/moved from study area|0
970605|NCT00621322|3195392|P1|Overall Study|Migrated/moved from study area|1
970606|NCT00621322|3195387|P6|Overall Study|Withdrawal by Subject|2
970607|NCT00621322|3195388|P5|Overall Study|Withdrawal by Subject|0
970608|NCT00621322|3195389|P4|Overall Study|Withdrawal by Subject|1
970609|NCT00621322|3195390|P3|Overall Study|Withdrawal by Subject|0
970610|NCT00621322|3195391|P2|Overall Study|Withdrawal by Subject|0
970611|NCT00621322|3195392|P1|Overall Study|Withdrawal by Subject|0
970612|NCT00621322|3195387|P6|Overall Study|Physician Decision|0
970613|NCT00621322|3195388|P5|Overall Study|Physician Decision|0
970614|NCT00621322|3195389|P4|Overall Study|Physician Decision|1
970615|NCT00621322|3195390|P3|Overall Study|Physician Decision|1
970616|NCT00621322|3195391|P2|Overall Study|Physician Decision|0
970617|NCT00621322|3195392|P1|Overall Study|Physician Decision|0
970618|NCT00621322|3195387|P6|Overall Study|Lost to Follow-up|0
970619|NCT00621322|3195388|P5|Overall Study|Lost to Follow-up|1
970620|NCT00621322|3195389|P4|Overall Study|Lost to Follow-up|0
970621|NCT00621322|3195390|P3|Overall Study|Lost to Follow-up|0
970622|NCT00621322|3195391|P2|Overall Study|Lost to Follow-up|0
970623|NCT00621322|3195392|P1|Overall Study|Lost to Follow-up|0
970624|NCT00621296|3195472|P1|Overall Study|Stopping Criteria|3
970625|NCT00621296|3195472|P1|Overall Study|Unmatch Criteria|1
970626|NCT00621296|3195472|P1|Overall Study|Physician Decision|7
970627|NCT00621296|3195472|P1|Overall Study|Lack of Efficacy|1
970628|NCT00621296|3195472|P1|Overall Study|Adverse Event|2
970629|NCT00621257|3195481|P5|Overall Study|Withdrawal by Subject|1
970630|NCT00621257|3195482|P4|Overall Study|Withdrawal by Subject|1
970631|NCT00621257|3195483|P3|Overall Study|Withdrawal by Subject|0
970632|NCT00621257|3195484|P2|Overall Study|Withdrawal by Subject|0
970633|NCT00621257|3195485|P1|Overall Study|Withdrawal by Subject|0
970634|NCT00621257|3195481|P5|Overall Study|Physician Decision|1
970635|NCT00621257|3195482|P4|Overall Study|Physician Decision|1
970636|NCT00621257|3195483|P3|Overall Study|Physician Decision|0
970637|NCT00621257|3195484|P2|Overall Study|Physician Decision|2
970638|NCT00621257|3195485|P1|Overall Study|Physician Decision|0
970639|NCT00621257|3195481|P5|Overall Study|Adverse Event|0
970640|NCT00621257|3195482|P4|Overall Study|Adverse Event|0
970641|NCT00621257|3195483|P3|Overall Study|Adverse Event|1
970642|NCT00621257|3195484|P2|Overall Study|Adverse Event|1
970643|NCT00621257|3195485|P1|Overall Study|Adverse Event|0
970644|NCT00621257|3195481|P5|Overall Study|Lost to Follow-up|7
970645|NCT00621257|3195482|P4|Overall Study|Lost to Follow-up|4
970646|NCT00621257|3195483|P3|Overall Study|Lost to Follow-up|2
970647|NCT00621257|3195484|P2|Overall Study|Lost to Follow-up|0
970648|NCT00621257|3195485|P1|Overall Study|Lost to Follow-up|4
970649|NCT00621244|3195501|P4|Overall Study|Administrative problems|2
970650|NCT00621244|3195502|P3|Overall Study|Administrative problems|0
970651|NCT00621244|3195503|P2|Overall Study|Administrative problems|1
970652|NCT00621244|3195504|P1|Overall Study|Administrative problems|5
970653|NCT00621244|3195501|P4|Overall Study|Adverse Event|2
970654|NCT00621244|3195502|P3|Overall Study|Adverse Event|9
970655|NCT00621244|3195503|P2|Overall Study|Adverse Event|7
970656|NCT00621244|3195504|P1|Overall Study|Adverse Event|27
970657|NCT00621244|3195501|P4|Overall Study|Death|1
970658|NCT00621244|3195502|P3|Overall Study|Death|1
970659|NCT00621244|3195503|P2|Overall Study|Death|3
970660|NCT00621244|3195504|P1|Overall Study|Death|3
970661|NCT00621244|3195501|P4|Overall Study|Disease progression|15
970662|NCT00621244|3195502|P3|Overall Study|Disease progression|20
970663|NCT00621244|3195503|P2|Overall Study|Disease progression|20
970664|NCT00621244|3195504|P1|Overall Study|Disease progression|44
970665|NCT00621244|3195501|P4|Overall Study|Withdrawal by Subject|3
970666|NCT00621244|3195502|P3|Overall Study|Withdrawal by Subject|3
970667|NCT00621244|3195503|P2|Overall Study|Withdrawal by Subject|3
970668|NCT00621244|3195504|P1|Overall Study|Withdrawal by Subject|7
970669|NCT00621192|3195608|P4|Overall Study|Final Assessments not Completed|1
970670|NCT00621192|3195609|P3|Overall Study|Final Assessments not Completed|3
970671|NCT00621192|3195610|P2|Overall Study|Final Assessments not Completed|0
970672|NCT00621192|3195611|P1|Overall Study|Final Assessments not Completed|0
970673|NCT00621192|3195608|P4|Overall Study|Death|0
970674|NCT00621192|3195609|P3|Overall Study|Death|0
970675|NCT00621192|3195610|P2|Overall Study|Death|5
970676|NCT00621192|3195611|P1|Overall Study|Death|2
970677|NCT00621192|3195608|P4|Overall Study|Adverse Event|1
970678|NCT00621192|3195609|P3|Overall Study|Adverse Event|0
970679|NCT00621192|3195610|P2|Overall Study|Adverse Event|1
970680|NCT00621192|3195611|P1|Overall Study|Adverse Event|0
970681|NCT00621192|3195608|P4|Overall Study|Protocol Violation|1
970682|NCT00621192|3195609|P3|Overall Study|Protocol Violation|0
970683|NCT00621192|3195610|P2|Overall Study|Protocol Violation|0
970684|NCT00621192|3195611|P1|Overall Study|Protocol Violation|1
970685|NCT00621192|3195608|P4|Overall Study|Physician Decision|0
970686|NCT00621192|3195609|P3|Overall Study|Physician Decision|0
970687|NCT00621192|3195610|P2|Overall Study|Physician Decision|3
970688|NCT00621192|3195611|P1|Overall Study|Physician Decision|1
970689|NCT00621192|3195608|P4|Overall Study|Withdrawal by Subject|0
970690|NCT00621192|3195609|P3|Overall Study|Withdrawal by Subject|2
970691|NCT00621192|3195610|P2|Overall Study|Withdrawal by Subject|0
970692|NCT00621192|3195611|P1|Overall Study|Withdrawal by Subject|0
970693|NCT00621153|3195635|P2|Overall Study|Withdrawal by Subject|5
970694|NCT00621153|3195636|P1|Overall Study|Withdrawal by Subject|4
970695|NCT00621153|3195635|P2|Overall Study|Lost to Follow-up|1
970696|NCT00621153|3195636|P1|Overall Study|Lost to Follow-up|5
970697|NCT00621153|3195635|P2|Overall Study|Adverse Event|2
970698|NCT00621153|3195636|P1|Overall Study|Adverse Event|3
970699|NCT00621153|3195635|P2|Overall Study|Safety Reason|7
970700|NCT00621153|3195636|P1|Overall Study|Safety Reason|8
970701|NCT00621140|3195644|P2|Overall Study|Other incl. lack of efficacy|5
970702|NCT00621140|3195645|P1|Overall Study|Other incl. lack of efficacy|6
970703|NCT00621140|3195644|P2|Overall Study|Withdrawal by Subject|6
970704|NCT00621140|3195645|P1|Overall Study|Withdrawal by Subject|4
970705|NCT00621140|3195644|P2|Overall Study|Lost to Follow-up|2
970706|NCT00621140|3195645|P1|Overall Study|Lost to Follow-up|1
970707|NCT00621140|3195644|P2|Overall Study|Adverse Event|5
970708|NCT00621140|3195645|P1|Overall Study|Adverse Event|4
970709|NCT00621023|3195692|P1|Overall Study|Follow up discontinued|1
970710|NCT00621023|3195692|P1|Overall Study|Death|5
970711|NCT00620854|3195709|P6|Washout 1|Withdrawal by Subject|0
970712|NCT00620854|3195710|P5|Washout 1|Withdrawal by Subject|0
970713|NCT00620854|3195711|P4|Washout 1|Withdrawal by Subject|1
970714|NCT00620854|3195712|P3|Washout 1|Withdrawal by Subject|1
970715|NCT00620854|3195713|P2|Washout 1|Withdrawal by Subject|0
970716|NCT00620854|3195714|P1|Washout 1|Withdrawal by Subject|0
970717|NCT00620815|3195745|P3|Overall Study|Protocol Violation|1
970718|NCT00620815|3195746|P2|Overall Study|Protocol Violation|2
970719|NCT00620815|3195747|P1|Overall Study|Protocol Violation|1
970720|NCT00620815|3195745|P3|Overall Study|Inappropriate enrolment|1
970721|NCT00620815|3195746|P2|Overall Study|Inappropriate enrolment|0
970722|NCT00620815|3195747|P1|Overall Study|Inappropriate enrolment|0
970723|NCT00620815|3195745|P3|Overall Study|Lost to Follow-up|3
970724|NCT00620815|3195746|P2|Overall Study|Lost to Follow-up|6
970725|NCT00620815|3195747|P1|Overall Study|Lost to Follow-up|1
970726|NCT00620815|3195745|P3|Overall Study|Withdrawal by Subject|0
970727|NCT00620815|3195746|P2|Overall Study|Withdrawal by Subject|2
970728|NCT00620815|3195747|P1|Overall Study|Withdrawal by Subject|1
970729|NCT00620815|3195745|P3|Overall Study|Adverse Event|2
970730|NCT00620815|3195746|P2|Overall Study|Adverse Event|1
970731|NCT00620815|3195747|P1|Overall Study|Adverse Event|1
970732|NCT00620776|3195787|P2|Overall Study|Withdrawal by Subject|2
970733|NCT00620776|3195788|P1|Overall Study|Withdrawal by Subject|3
970734|NCT00620776|3195787|P2|Overall Study|Lost to Follow-up|5
970735|NCT00620776|3195788|P1|Overall Study|Lost to Follow-up|2
970736|NCT00620776|3195787|P2|Overall Study|Lack of Efficacy|1
970737|NCT00620776|3195788|P1|Overall Study|Lack of Efficacy|2
970738|NCT00620776|3195787|P2|Overall Study|Adverse Event|3
970739|NCT00620776|3195788|P1|Overall Study|Adverse Event|2
970740|NCT00620776|3195787|P2|Overall Study|Did not receive treatment|5
970741|NCT00620776|3195788|P1|Overall Study|Did not receive treatment|3
970742|NCT00620763|3195816|P2|Period: Second Intervention|Withdrawal by Subject|0
970743|NCT00620763|3195817|P1|Period: Second Intervention|Withdrawal by Subject|1
970744|NCT00620763|3195816|P2|Period: First Intervention|Protocol Violation|3
970745|NCT00620763|3195817|P1|Period: First Intervention|Protocol Violation|0
970746|NCT00620763|3195816|P2|Period: First Intervention|Withdrawal by Subject|2
970747|NCT00620763|3195817|P1|Period: First Intervention|Withdrawal by Subject|0
970748|NCT00620750|3195823|P1|Overall Study|Lost to Follow-up|25
970749|NCT00620659|3195838|P6|Treatment Period 3|Withdrawal by Subject|0
970750|NCT00620659|3195839|P5|Treatment Period 3|Withdrawal by Subject|0
970751|NCT00620659|3195840|P4|Treatment Period 3|Withdrawal by Subject|1
970752|NCT00620659|3195841|P3|Treatment Period 3|Withdrawal by Subject|0
970753|NCT00620659|3195842|P2|Treatment Period 3|Withdrawal by Subject|0
970754|NCT00620659|3195843|P1|Treatment Period 3|Withdrawal by Subject|0
970755|NCT00620659|3195838|P6|Treatment Period 3|Adverse Event|0
970756|NCT00620659|3195839|P5|Treatment Period 3|Adverse Event|0
970757|NCT00620659|3195840|P4|Treatment Period 3|Adverse Event|0
970758|NCT00620659|3195841|P3|Treatment Period 3|Adverse Event|0
970759|NCT00620659|3195842|P2|Treatment Period 3|Adverse Event|2
970760|NCT00620659|3195843|P1|Treatment Period 3|Adverse Event|0
970761|NCT00620659|3195838|P6|Placebo Washout Period 2|Adverse Event|0
970762|NCT00620659|3195839|P5|Placebo Washout Period 2|Adverse Event|0
970763|NCT00620659|3195840|P4|Placebo Washout Period 2|Adverse Event|0
970764|NCT00620659|3195841|P3|Placebo Washout Period 2|Adverse Event|0
970765|NCT00620659|3195842|P2|Placebo Washout Period 2|Adverse Event|0
970766|NCT00620659|3195843|P1|Placebo Washout Period 2|Adverse Event|2
970767|NCT00620659|3195838|P6|Treatment Period 2|Withdrawal by Subject|0
970768|NCT00620659|3195839|P5|Treatment Period 2|Withdrawal by Subject|3
970769|NCT00620659|3195840|P4|Treatment Period 2|Withdrawal by Subject|0
970770|NCT00620659|3195841|P3|Treatment Period 2|Withdrawal by Subject|1
970771|NCT00620659|3195842|P2|Treatment Period 2|Withdrawal by Subject|0
970772|NCT00620659|3195843|P1|Treatment Period 2|Withdrawal by Subject|0
970773|NCT00620659|3195838|P6|Treatment Period 2|Adverse Event|0
970774|NCT00620659|3195839|P5|Treatment Period 2|Adverse Event|2
970775|NCT00620659|3195840|P4|Treatment Period 2|Adverse Event|0
970776|NCT00620659|3195841|P3|Treatment Period 2|Adverse Event|0
970777|NCT00620659|3195842|P2|Treatment Period 2|Adverse Event|3
970778|NCT00620659|3195843|P1|Treatment Period 2|Adverse Event|0
970779|NCT00620659|3195838|P6|Placebo Washout Period 1|Withdrawal by Subject|0
970780|NCT00620659|3195839|P5|Placebo Washout Period 1|Withdrawal by Subject|0
970781|NCT00620659|3195840|P4|Placebo Washout Period 1|Withdrawal by Subject|1
970782|NCT00620659|3195841|P3|Placebo Washout Period 1|Withdrawal by Subject|0
970783|NCT00620659|3195842|P2|Placebo Washout Period 1|Withdrawal by Subject|0
970784|NCT00620659|3195843|P1|Placebo Washout Period 1|Withdrawal by Subject|0
970785|NCT00620659|3195838|P6|Treatment Period 1|Withdrawal by Subject|0
970786|NCT00620659|3195839|P5|Treatment Period 1|Withdrawal by Subject|1
970787|NCT00620659|3195840|P4|Treatment Period 1|Withdrawal by Subject|0
970788|NCT00620659|3195841|P3|Treatment Period 1|Withdrawal by Subject|1
970789|NCT00620659|3195842|P2|Treatment Period 1|Withdrawal by Subject|0
970790|NCT00620659|3195843|P1|Treatment Period 1|Withdrawal by Subject|1
970791|NCT00620659|3195838|P6|Treatment Period 1|Protocol Violation|0
970792|NCT00620659|3195839|P5|Treatment Period 1|Protocol Violation|0
970793|NCT00620659|3195840|P4|Treatment Period 1|Protocol Violation|0
970794|NCT00620659|3195841|P3|Treatment Period 1|Protocol Violation|0
970795|NCT00620659|3195842|P2|Treatment Period 1|Protocol Violation|0
970796|NCT00620659|3195843|P1|Treatment Period 1|Protocol Violation|1
970797|NCT00620659|3195838|P6|Treatment Period 1|Adverse Event|0
970798|NCT00620659|3195839|P5|Treatment Period 1|Adverse Event|0
970799|NCT00620659|3195840|P4|Treatment Period 1|Adverse Event|3
970800|NCT00620659|3195841|P3|Treatment Period 1|Adverse Event|0
970801|NCT00620659|3195842|P2|Treatment Period 1|Adverse Event|0
970802|NCT00620659|3195843|P1|Treatment Period 1|Adverse Event|1
970803|NCT00620555|3195861|P1|Overall Study|Visit failure against planned|1
970804|NCT00620555|3195861|P1|Overall Study|Choice of other treatment|1
970805|NCT00620555|3195861|P1|Overall Study|Withdrawal by Subject|1
970806|NCT00620555|3195861|P1|Overall Study|Lack of Efficacy|12
970807|NCT00620555|3195861|P1|Overall Study|Protocol Violation|2
970808|NCT00620555|3195861|P1|Overall Study|Adverse Event|4
970809|NCT00620542|3195870|P4|Part B (2 Year Core Study)|IVUS not available|2
970810|NCT00620542|3195871|P3|Part B (2 Year Core Study)|IVUS not available|3
970811|NCT00620542|3195872|P2|Part B (2 Year Core Study)|IVUS not available|0
970812|NCT00620542|3195873|P1|Part B (2 Year Core Study)|IVUS not available|0
970813|NCT00620542|3195870|P4|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
970814|NCT00620542|3195871|P3|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
970815|NCT00620542|3195872|P2|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
970816|NCT00620542|3195873|P1|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
970817|NCT00620542|3195870|P4|Part B (2 Year Core Study)|Safety reasons|3
970818|NCT00620542|3195871|P3|Part B (2 Year Core Study)|Safety reasons|2
970819|NCT00620542|3195872|P2|Part B (2 Year Core Study)|Safety reasons|0
970820|NCT00620542|3195873|P1|Part B (2 Year Core Study)|Safety reasons|0
970821|NCT00620542|3195870|P4|Part B (2 Year Core Study)|Protocol Violation|16
970822|NCT00620542|3195871|P3|Part B (2 Year Core Study)|Protocol Violation|13
970823|NCT00620542|3195872|P2|Part B (2 Year Core Study)|Protocol Violation|0
970824|NCT00620542|3195873|P1|Part B (2 Year Core Study)|Protocol Violation|0
970825|NCT00620542|3195870|P4|Part B (2 Year Core Study)|Lost to Follow-up|9
970826|NCT00620542|3195871|P3|Part B (2 Year Core Study)|Lost to Follow-up|20
970827|NCT00620542|3195872|P2|Part B (2 Year Core Study)|Lost to Follow-up|0
970828|NCT00620542|3195873|P1|Part B (2 Year Core Study)|Lost to Follow-up|0
970829|NCT00620542|3195870|P4|Part B (2 Year Core Study)|Withdrawal by Subject|54
970830|NCT00620542|3195871|P3|Part B (2 Year Core Study)|Withdrawal by Subject|55
970831|NCT00620542|3195872|P2|Part B (2 Year Core Study)|Withdrawal by Subject|0
970832|NCT00620542|3195873|P1|Part B (2 Year Core Study)|Withdrawal by Subject|0
970833|NCT00620542|3195870|P4|Part B (2 Year Core Study)|Protocol Violation|5
970834|NCT00620542|3195871|P3|Part B (2 Year Core Study)|Protocol Violation|3
970835|NCT00620542|3195872|P2|Part B (2 Year Core Study)|Protocol Violation|0
970836|NCT00620542|3195873|P1|Part B (2 Year Core Study)|Protocol Violation|0
970837|NCT00620542|3195870|P4|Part B (2 Year Core Study)|Adverse Event|49
970838|NCT00620542|3195871|P3|Part B (2 Year Core Study)|Adverse Event|46
970839|NCT00620542|3195872|P2|Part B (2 Year Core Study)|Adverse Event|0
970840|NCT00620542|3195873|P1|Part B (2 Year Core Study)|Adverse Event|0
970841|NCT00620542|3195870|P4|Part A (Run-in - 2 Weeks)|IVUS not available|0
970842|NCT00620542|3195871|P3|Part A (Run-in - 2 Weeks)|IVUS not available|0
970843|NCT00620542|3195872|P2|Part A (Run-in - 2 Weeks)|IVUS not available|4
970844|NCT00620542|3195873|P1|Part A (Run-in - 2 Weeks)|IVUS not available|4
970845|NCT00620542|3195870|P4|Part A (Run-in - 2 Weeks)|Safety reasons|0
970846|NCT00620542|3195871|P3|Part A (Run-in - 2 Weeks)|Safety reasons|0
970847|NCT00620542|3195872|P2|Part A (Run-in - 2 Weeks)|Safety reasons|1
970848|NCT00620542|3195873|P1|Part A (Run-in - 2 Weeks)|Safety reasons|0
970849|NCT00620542|3195870|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
970850|NCT00620542|3195871|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
970851|NCT00620542|3195872|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|1
970852|NCT00620542|3195873|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|0
970853|NCT00620542|3195870|P4|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
970854|NCT00620542|3195871|P3|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
970855|NCT00620542|3195872|P2|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6
970856|NCT00620542|3195873|P1|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7
970857|NCT00620542|3195870|P4|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
970858|NCT00620542|3195871|P3|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
970859|NCT00620542|3195872|P2|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40
970860|NCT00620542|3195873|P1|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43
970861|NCT00620542|3195870|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
970862|NCT00620542|3195871|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
970863|NCT00620542|3195872|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|409
970864|NCT00620542|3195873|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|406
970865|NCT00620542|3195870|P4|Part A (Run-in - 2 Weeks)|Adverse Event|0
970866|NCT00620542|3195871|P3|Part A (Run-in - 2 Weeks)|Adverse Event|0
970867|NCT00620542|3195872|P2|Part A (Run-in - 2 Weeks)|Adverse Event|15
970868|NCT00620542|3195873|P1|Part A (Run-in - 2 Weeks)|Adverse Event|12
970869|NCT00620464|3195913|P2|Overall Study|Used prohibited medication|0
970870|NCT00620464|3195914|P1|Overall Study|Used prohibited medication|1
970871|NCT00620464|3195913|P2|Overall Study|Personal|2
970872|NCT00620464|3195914|P1|Overall Study|Personal|2
970873|NCT00620464|3195913|P2|Overall Study|Planning Pregnancy|4
970874|NCT00620464|3195914|P1|Overall Study|Planning Pregnancy|1
970875|NCT00620464|3195913|P2|Overall Study|Lost to Follow-up|1
970876|NCT00620464|3195914|P1|Overall Study|Lost to Follow-up|1
970877|NCT00620464|3195913|P2|Overall Study|Adverse Event|17
970878|NCT00620464|3195914|P1|Overall Study|Adverse Event|15
970879|NCT00620373|3195933|P1|Overall Study|Unverified cancer status|33
970880|NCT00620282|3195952|P3|Overall Study|Withdrawal by Subject|0
970881|NCT00620282|3195953|P2|Overall Study|Withdrawal by Subject|1
970882|NCT00620282|3195954|P1|Overall Study|Withdrawal by Subject|0
970883|NCT00620282|3195952|P3|Overall Study|Arterial line unable to be placed|1
970884|NCT00620282|3195953|P2|Overall Study|Arterial line unable to be placed|0
970885|NCT00620282|3195954|P1|Overall Study|Arterial line unable to be placed|0
970886|NCT00620282|3195952|P3|Overall Study|Adverse Event|0
970887|NCT00620282|3195953|P2|Overall Study|Adverse Event|1
970888|NCT00620282|3195954|P1|Overall Study|Adverse Event|0
970889|NCT00620113|3196018|P4|Overall Study|Withdrawal by Subject|5
970890|NCT00620113|3196019|P3|Overall Study|Withdrawal by Subject|3
970891|NCT00620113|3196020|P2|Overall Study|Withdrawal by Subject|1
970892|NCT00620113|3196021|P1|Overall Study|Withdrawal by Subject|5
970893|NCT00620113|3196018|P4|Overall Study|Protocol Violation|0
970894|NCT00620113|3196019|P3|Overall Study|Protocol Violation|0
970895|NCT00620113|3196020|P2|Overall Study|Protocol Violation|1
970896|NCT00620113|3196021|P1|Overall Study|Protocol Violation|2
970897|NCT00620113|3196018|P4|Overall Study|Physician Decision|2
970898|NCT00620113|3196019|P3|Overall Study|Physician Decision|0
970899|NCT00620113|3196020|P2|Overall Study|Physician Decision|0
970900|NCT00620113|3196021|P1|Overall Study|Physician Decision|1
970901|NCT00620113|3196018|P4|Overall Study|Lack of Efficacy|2
970902|NCT00620113|3196019|P3|Overall Study|Lack of Efficacy|0
970903|NCT00620113|3196020|P2|Overall Study|Lack of Efficacy|3
970904|NCT00620113|3196021|P1|Overall Study|Lack of Efficacy|2
970905|NCT00620113|3196018|P4|Overall Study|Adverse Event|1
970906|NCT00620113|3196019|P3|Overall Study|Adverse Event|2
970907|NCT00620113|3196020|P2|Overall Study|Adverse Event|2
970908|NCT00620113|3196021|P1|Overall Study|Adverse Event|3
970909|NCT00620074|3196071|P1|Overall Study|Adverse Event|1
970910|NCT00620035|3196079|P1|Overall Study|Other Reason|38
970911|NCT00620035|3196079|P1|Overall Study|Withdrawal of Informed Consent|1
970912|NCT00620035|3196079|P1|Overall Study|Adverse Event|106
970913|NCT00620022|3196089|P2|Treatment Period 2|Adverse Event|2
970914|NCT00620022|3196090|P1|Treatment Period 2|Adverse Event|2
970915|NCT00620022|3196089|P2|Treatment Period 1|Subject withdrew consent|0
970916|NCT00620022|3196090|P1|Treatment Period 1|Subject withdrew consent|1
970917|NCT00620022|3196089|P2|Treatment Period 1|Adverse Event|6
970918|NCT00620022|3196090|P1|Treatment Period 1|Adverse Event|4
970919|NCT00619983|3196102|P4|Test Drug Alone|Failure of daily diary device|2
970920|NCT00619983|3196103|P3|Test Drug Alone|Failure of daily diary device|2
970921|NCT00619983|3196104|P2|Test Drug Alone|Failure of daily diary device|1
970922|NCT00619983|3196105|P1|Test Drug Alone|Failure of daily diary device|1
970923|NCT00619983|3196102|P4|Test Drug Alone|Withdrawal by Subject|1
970924|NCT00619983|3196103|P3|Test Drug Alone|Withdrawal by Subject|0
970925|NCT00619983|3196104|P2|Test Drug Alone|Withdrawal by Subject|0
970926|NCT00619983|3196105|P1|Test Drug Alone|Withdrawal by Subject|1
970927|NCT00619957|3196132|P2|Month 48 Open-Label|Withdrawal by Subject|9
970928|NCT00619957|3196133|P1|Month 48 Open-Label|Withdrawal by Subject|6
970929|NCT00619957|3196132|P2|Month 48 Open-Label|Lost to Follow-up|4
970930|NCT00619957|3196133|P1|Month 48 Open-Label|Lost to Follow-up|2
970931|NCT00619957|3196132|P2|Month 48 Open-Label|Adverse Event|4
970932|NCT00619957|3196133|P1|Month 48 Open-Label|Adverse Event|4
970933|NCT00619957|3196132|P2|Month 24 Double-Blind|Did not take any study medication|1
970934|NCT00619957|3196133|P1|Month 24 Double-Blind|Did not take any study medication|0
970935|NCT00619957|3196132|P2|Month 24 Double-Blind|Lost to Follow-up|0
970936|NCT00619957|3196133|P1|Month 24 Double-Blind|Lost to Follow-up|1
970937|NCT00619957|3196132|P2|Month 24 Double-Blind|Withdrawal by Subject|9
970938|NCT00619957|3196133|P1|Month 24 Double-Blind|Withdrawal by Subject|7
970939|NCT00619957|3196132|P2|Month 24 Double-Blind|Protocol Violation|0
970940|NCT00619957|3196133|P1|Month 24 Double-Blind|Protocol Violation|1
970941|NCT00619957|3196132|P2|Month 24 Double-Blind|Adverse Event|7
970942|NCT00619957|3196133|P1|Month 24 Double-Blind|Adverse Event|9
970943|NCT00619918|3196215|P2|Overall Study|Left before receiving first dose|8
970944|NCT00619918|3196216|P1|Overall Study|Left before receiving first dose|5
970945|NCT00619918|3196215|P2|Overall Study|Transfer to outside facility|3
970946|NCT00619918|3196216|P1|Overall Study|Transfer to outside facility|3
970947|NCT00619918|3196215|P2|Overall Study|Physician Decision|8
970948|NCT00619918|3196216|P1|Overall Study|Physician Decision|8
970949|NCT00619918|3196215|P2|Overall Study|Withdrawal by Subject|3
970950|NCT00619918|3196216|P1|Overall Study|Withdrawal by Subject|4
970951|NCT00619892|3196226|P2|Overall Study|Intercurrent illness|1
970952|NCT00619892|3196227|P1|Overall Study|Intercurrent illness|0
970953|NCT00619892|3196226|P2|Overall Study|Lost to Follow-up|1
970954|NCT00619892|3196227|P1|Overall Study|Lost to Follow-up|0
970955|NCT00619892|3196226|P2|Overall Study|Adverse Event|0
970956|NCT00619892|3196227|P1|Overall Study|Adverse Event|3
970957|NCT00619866|3196238|P5|Weeks 13 - 24|Lost to Follow-up|0
970958|NCT00619866|3196239|P4|Weeks 13 - 24|Lost to Follow-up|0
970959|NCT00619866|3196240|P3|Weeks 13 - 24|Lost to Follow-up|0
970960|NCT00619866|3196241|P2|Weeks 13 - 24|Lost to Follow-up|3
970961|NCT00619866|3196242|P1|Weeks 13 - 24|Lost to Follow-up|0
970962|NCT00619866|3196238|P5|Weeks 13 - 24|Non-compliance|0
970963|NCT00619866|3196239|P4|Weeks 13 - 24|Non-compliance|0
970964|NCT00619866|3196240|P3|Weeks 13 - 24|Non-compliance|1
970965|NCT00619866|3196241|P2|Weeks 13 - 24|Non-compliance|1
970966|NCT00619866|3196242|P1|Weeks 13 - 24|Non-compliance|0
970967|NCT00619866|3196238|P5|Weeks 13 - 24|Withdrawal by Subject|2
970968|NCT00619866|3196239|P4|Weeks 13 - 24|Withdrawal by Subject|2
970969|NCT00619866|3196240|P3|Weeks 13 - 24|Withdrawal by Subject|2
970970|NCT00619866|3196241|P2|Weeks 13 - 24|Withdrawal by Subject|3
970971|NCT00619866|3196242|P1|Weeks 13 - 24|Withdrawal by Subject|0
970972|NCT00619866|3196238|P5|Weeks 13 - 24|Protocol Deviation|0
970973|NCT00619866|3196239|P4|Weeks 13 - 24|Protocol Deviation|1
970974|NCT00619866|3196240|P3|Weeks 13 - 24|Protocol Deviation|0
970975|NCT00619866|3196241|P2|Weeks 13 - 24|Protocol Deviation|0
970976|NCT00619866|3196242|P1|Weeks 13 - 24|Protocol Deviation|0
970977|NCT00619866|3196238|P5|Weeks 13 - 24|Adverse Event|0
970978|NCT00619866|3196239|P4|Weeks 13 - 24|Adverse Event|1
970979|NCT00619866|3196240|P3|Weeks 13 - 24|Adverse Event|2
970980|NCT00619866|3196241|P2|Weeks 13 - 24|Adverse Event|0
970981|NCT00619866|3196242|P1|Weeks 13 - 24|Adverse Event|0
970982|NCT00619866|3196238|P5|Weeks 1 - 12|Sponsor Decision|0
970983|NCT00619866|3196239|P4|Weeks 1 - 12|Sponsor Decision|0
970984|NCT00619866|3196240|P3|Weeks 1 - 12|Sponsor Decision|0
970985|NCT00619866|3196241|P2|Weeks 1 - 12|Sponsor Decision|1
970986|NCT00619866|3196242|P1|Weeks 1 - 12|Sponsor Decision|0
970987|NCT00619866|3196238|P5|Weeks 1 - 12|Lost to Follow-up|0
970988|NCT00619866|3196239|P4|Weeks 1 - 12|Lost to Follow-up|0
970989|NCT00619866|3196240|P3|Weeks 1 - 12|Lost to Follow-up|2
970990|NCT00619866|3196241|P2|Weeks 1 - 12|Lost to Follow-up|0
970991|NCT00619866|3196242|P1|Weeks 1 - 12|Lost to Follow-up|4
970992|NCT00619866|3196238|P5|Weeks 1 - 12|Lack of Efficacy|0
970993|NCT00619866|3196239|P4|Weeks 1 - 12|Lack of Efficacy|0
970994|NCT00619866|3196240|P3|Weeks 1 - 12|Lack of Efficacy|1
970995|NCT00619866|3196241|P2|Weeks 1 - 12|Lack of Efficacy|2
970996|NCT00619866|3196242|P1|Weeks 1 - 12|Lack of Efficacy|3
970997|NCT00619866|3196238|P5|Weeks 1 - 12|Withdrawal by Subject|0
970998|NCT00619866|3196239|P4|Weeks 1 - 12|Withdrawal by Subject|0
970999|NCT00619866|3196240|P3|Weeks 1 - 12|Withdrawal by Subject|4
971000|NCT00619866|3196241|P2|Weeks 1 - 12|Withdrawal by Subject|2
971001|NCT00619866|3196242|P1|Weeks 1 - 12|Withdrawal by Subject|7
971002|NCT00619866|3196238|P5|Weeks 1 - 12|Non-compliance|0
971003|NCT00619866|3196239|P4|Weeks 1 - 12|Non-compliance|0
971004|NCT00619866|3196240|P3|Weeks 1 - 12|Non-compliance|1
971005|NCT00619866|3196241|P2|Weeks 1 - 12|Non-compliance|0
971006|NCT00619866|3196242|P1|Weeks 1 - 12|Non-compliance|0
971007|NCT00619866|3196238|P5|Weeks 1 - 12|Adverse Event|0
971008|NCT00619866|3196239|P4|Weeks 1 - 12|Adverse Event|0
971009|NCT00619866|3196240|P3|Weeks 1 - 12|Adverse Event|2
971010|NCT00619866|3196241|P2|Weeks 1 - 12|Adverse Event|1
971011|NCT00619866|3196242|P1|Weeks 1 - 12|Adverse Event|0
971012|NCT00619827|3196329|P2|Overall Study|Withdrawal by Subject|2
971013|NCT00619827|3196330|P1|Overall Study|Withdrawal by Subject|2
971014|NCT00619827|3196329|P2|Overall Study|Adverse Event|2
971015|NCT00619827|3196330|P1|Overall Study|Adverse Event|1
971016|NCT00619801|3196338|P2|Overall Study|Loss of efficacy|1
971017|NCT00619801|3196339|P1|Overall Study|Loss of efficacy|0
971018|NCT00619801|3196338|P2|Overall Study|Withdrawal by Subject|1
971019|NCT00619801|3196339|P1|Overall Study|Withdrawal by Subject|1
971020|NCT00619801|3196338|P2|Overall Study|Lack of Efficacy|1
971021|NCT00619801|3196339|P1|Overall Study|Lack of Efficacy|0
971022|NCT00619645|3196396|P1|Overall Study|Adverse Event|1
971023|NCT00619619|3196410|P8|Overall Study|Adverse Event|2
971024|NCT00619619|3196411|P7|Overall Study|Adverse Event|0
971025|NCT00619619|3196412|P6|Overall Study|Adverse Event|0
971026|NCT00619619|3196413|P5|Overall Study|Adverse Event|2
971027|NCT00619619|3196414|P4|Overall Study|Adverse Event|0
971028|NCT00619619|3196415|P3|Overall Study|Adverse Event|0
971029|NCT00619619|3196416|P2|Overall Study|Adverse Event|0
971030|NCT00619619|3196417|P1|Overall Study|Adverse Event|0
971031|NCT00619619|3196410|P8|Overall Study|Protocol Violation|1
971032|NCT00619619|3196411|P7|Overall Study|Protocol Violation|1
971033|NCT00619619|3196412|P6|Overall Study|Protocol Violation|0
971034|NCT00619619|3196413|P5|Overall Study|Protocol Violation|0
971035|NCT00619619|3196414|P4|Overall Study|Protocol Violation|1
971036|NCT00619619|3196415|P3|Overall Study|Protocol Violation|0
971037|NCT00619619|3196416|P2|Overall Study|Protocol Violation|0
971038|NCT00619619|3196417|P1|Overall Study|Protocol Violation|0
971039|NCT00619619|3196410|P8|Overall Study|Physician Decision|0
971040|NCT00619619|3196411|P7|Overall Study|Physician Decision|0
971041|NCT00619619|3196412|P6|Overall Study|Physician Decision|0
971042|NCT00619619|3196413|P5|Overall Study|Physician Decision|0
971043|NCT00619619|3196414|P4|Overall Study|Physician Decision|0
971044|NCT00619619|3196415|P3|Overall Study|Physician Decision|1
971045|NCT00619619|3196416|P2|Overall Study|Physician Decision|0
971046|NCT00619619|3196417|P1|Overall Study|Physician Decision|0
971047|NCT00619502|3196504|P2|Overall Study|Lost to Follow-up|10
971048|NCT00619502|3196505|P1|Overall Study|Lost to Follow-up|8
971049|NCT00619489|3196517|P2|Overall Study|Rolled over to Study C13008 (NCT00790933|15
971050|NCT00619489|3196518|P1|Overall Study|Rolled over to Study C13008 (NCT00790933|22
971051|NCT00619489|3196517|P2|Overall Study|Lack of Efficacy|11
971052|NCT00619489|3196518|P1|Overall Study|Lack of Efficacy|0
971053|NCT00619489|3196517|P2|Overall Study|Withdrawal by Subject|1
971054|NCT00619489|3196518|P1|Overall Study|Withdrawal by Subject|1
971055|NCT00619489|3196517|P2|Overall Study|Adverse Event|7
971056|NCT00619489|3196518|P1|Overall Study|Adverse Event|0
971057|NCT00619476|3196540|P4|Overall Study|Withdrawal by Subject|4
971058|NCT00619476|3196541|P3|Overall Study|Withdrawal by Subject|5
971059|NCT00619476|3196542|P2|Overall Study|Withdrawal by Subject|7
971060|NCT00619476|3196543|P1|Overall Study|Withdrawal by Subject|5
971061|NCT00619476|3196540|P4|Overall Study|Investigator Discretion|0
971062|NCT00619476|3196541|P3|Overall Study|Investigator Discretion|2
971063|NCT00619476|3196542|P2|Overall Study|Investigator Discretion|2
971064|NCT00619476|3196543|P1|Overall Study|Investigator Discretion|2
971065|NCT00619476|3196540|P4|Overall Study|Lost to Follow-up|1
971066|NCT00619476|3196541|P3|Overall Study|Lost to Follow-up|0
971067|NCT00619476|3196542|P2|Overall Study|Lost to Follow-up|2
971068|NCT00619476|3196543|P1|Overall Study|Lost to Follow-up|1
971069|NCT00619476|3196540|P4|Overall Study|Protocol Violation|9
971070|NCT00619476|3196541|P3|Overall Study|Protocol Violation|4
971071|NCT00619476|3196542|P2|Overall Study|Protocol Violation|4
971072|NCT00619476|3196543|P1|Overall Study|Protocol Violation|5
971073|NCT00619476|3196540|P4|Overall Study|Lack of Efficacy|4
971074|NCT00619476|3196541|P3|Overall Study|Lack of Efficacy|1
971075|NCT00619476|3196542|P2|Overall Study|Lack of Efficacy|1
971076|NCT00619476|3196543|P1|Overall Study|Lack of Efficacy|6
971077|NCT00619476|3196540|P4|Overall Study|Adverse Event|16
971078|NCT00619476|3196541|P3|Overall Study|Adverse Event|12
971079|NCT00619476|3196542|P2|Overall Study|Adverse Event|6
971080|NCT00619476|3196543|P1|Overall Study|Adverse Event|12
971081|NCT00619385|3196628|P3|Overall Study|Other|1
971082|NCT00619385|3196629|P2|Overall Study|Other|2
971083|NCT00619385|3196630|P1|Overall Study|Other|1
971084|NCT00619385|3196628|P3|Overall Study|Adverse Event|3
971085|NCT00619385|3196629|P2|Overall Study|Adverse Event|0
971086|NCT00619385|3196630|P1|Overall Study|Adverse Event|0
971087|NCT00619359|3196645|P2|Overall Study|Progressive Disease|1
971088|NCT00619359|3196646|P1|Overall Study|Progressive Disease|3
971089|NCT00619359|3196645|P2|Overall Study|Withdrawal by Subject|20
971090|NCT00619359|3196646|P1|Overall Study|Withdrawal by Subject|19
971091|NCT00619359|3196645|P2|Overall Study|Protocol Violation|1
971092|NCT00619359|3196646|P1|Overall Study|Protocol Violation|1
971093|NCT00619359|3196645|P2|Overall Study|Physician Decision|7
971094|NCT00619359|3196646|P1|Overall Study|Physician Decision|0
971095|NCT00619359|3196645|P2|Overall Study|Lost to Follow-up|16
971096|NCT00619359|3196646|P1|Overall Study|Lost to Follow-up|12
971097|NCT00619359|3196645|P2|Overall Study|Adverse Event|36
971098|NCT00619359|3196646|P1|Overall Study|Adverse Event|32
971099|NCT00619307|3196658|P2|Overall Study|MS attack plus steroids|1
971100|NCT00619307|3196659|P1|Overall Study|MS attack plus steroids|0
971101|NCT00619307|3196658|P2|Overall Study|Severe migraine|1
971102|NCT00619307|3196659|P1|Overall Study|Severe migraine|0
971103|NCT00619307|3196658|P2|Overall Study|Withdrew consent|0
971104|NCT00619307|3196659|P1|Overall Study|Withdrew consent|1
971105|NCT00619307|3196658|P2|Overall Study|Protocol Violation|0
971106|NCT00619307|3196659|P1|Overall Study|Protocol Violation|3
971107|NCT00619307|3196658|P2|Overall Study|Lost to Follow-up|1
971108|NCT00619307|3196659|P1|Overall Study|Lost to Follow-up|0
971109|NCT00619307|3196658|P2|Overall Study|Adverse Event|1
971110|NCT00619307|3196659|P1|Overall Study|Adverse Event|0
971111|NCT00619229|3196696|P2|Overall Study|Investigator planned Cataract Operation|0
971112|NCT00619229|3196697|P1|Overall Study|Investigator planned Cataract Operation|1
971113|NCT00619229|3196696|P2|Overall Study|Termination of the Study by the Sponsor|1
971114|NCT00619229|3196697|P1|Overall Study|Termination of the Study by the Sponsor|1
971115|NCT00619229|3196696|P2|Overall Study|Lost to Follow-up|0
971116|NCT00619229|3196697|P1|Overall Study|Lost to Follow-up|1
971117|NCT00619229|3196696|P2|Overall Study|Withdrawal by Subject|1
971118|NCT00619229|3196697|P1|Overall Study|Withdrawal by Subject|1
971119|NCT00619177|3196736|P1|Overall Study|Not specified reasons|6
971120|NCT00619177|3196736|P1|Overall Study|Missing termination information|481
971121|NCT00619177|3196736|P1|Overall Study|Lack of Efficacy|1
971122|NCT00619177|3196736|P1|Overall Study|Lost to Follow-up|2
971123|NCT00619177|3196736|P1|Overall Study|Adverse Event|18
971124|NCT00619151|3196746|P2|Overall Study|Study terminated prior to followup|0
971125|NCT00619151|3196747|P1|Overall Study|Study terminated prior to followup|1
971126|NCT00619112|3196757|P2|Overall Study|Adverse Event|2
971127|NCT00619112|3196758|P1|Overall Study|Adverse Event|1
971128|NCT00619099|3196779|P2|Overall Study|Physician Decision|6
971129|NCT00619099|3196780|P1|Overall Study|Physician Decision|9
971130|NCT00619099|3196779|P2|Overall Study|Withdrawal by Subject|2
971131|NCT00619099|3196780|P1|Overall Study|Withdrawal by Subject|10
971132|NCT00619099|3196779|P2|Overall Study|Emergence of Clinically Significant Lab|2
971133|NCT00619099|3196780|P1|Overall Study|Emergence of Clinically Significant Lab|1
971134|NCT00619099|3196779|P2|Overall Study|Adverse Event|3
971135|NCT00619099|3196780|P1|Overall Study|Adverse Event|4
971136|NCT00619099|3196779|P2|Overall Study|Allogeneic Bone Marrow Transplantation|1
971137|NCT00619099|3196780|P1|Overall Study|Allogeneic Bone Marrow Transplantation|2
971138|NCT00619099|3196779|P2|Overall Study|Progressive Disease|5
971139|NCT00619099|3196780|P1|Overall Study|Progressive Disease|7
971140|NCT00618995|3196802|P4|Period 4|Adverse Event|0
971141|NCT00618995|3196803|P3|Period 4|Adverse Event|0
971142|NCT00618995|3196804|P2|Period 4|Adverse Event|0
971143|NCT00618995|3196805|P1|Period 4|Adverse Event|1
971144|NCT00618995|3196802|P4|Period 2|Protocol Violation|0
971145|NCT00618995|3196803|P3|Period 2|Protocol Violation|1
971146|NCT00618995|3196804|P2|Period 2|Protocol Violation|0
971147|NCT00618995|3196805|P1|Period 2|Protocol Violation|0
971148|NCT00618995|3196802|P4|Period 1|Protocol Violation|0
971149|NCT00618995|3196803|P3|Period 1|Protocol Violation|1
971150|NCT00618995|3196804|P2|Period 1|Protocol Violation|1
971151|NCT00618995|3196805|P1|Period 1|Protocol Violation|0
971152|NCT00618995|3196802|P4|Period 1|Adverse Event|0
971153|NCT00618995|3196803|P3|Period 1|Adverse Event|1
971154|NCT00618995|3196804|P2|Period 1|Adverse Event|0
971155|NCT00618995|3196805|P1|Period 1|Adverse Event|0
971156|NCT00618982|3196819|P1|Overall Study|ongoing, still treated with study med.|25
971157|NCT00618982|3196819|P1|Overall Study|Protocol Violation|1
971158|NCT00618982|3196819|P1|Overall Study|Withdrawal by Subject|1
971159|NCT00618982|3196819|P1|Overall Study|Adverse Event|23
971160|NCT00618956|3196842|P2|Overall Study|did not meet criteria, non-compliance|1
971161|NCT00618956|3196843|P1|Overall Study|did not meet criteria, non-compliance|2
971162|NCT00618956|3196842|P2|Overall Study|Protocol Violation|2
971163|NCT00618956|3196843|P1|Overall Study|Protocol Violation|2
971164|NCT00618956|3196842|P2|Overall Study|Lost to Follow-up|5
971165|NCT00618956|3196843|P1|Overall Study|Lost to Follow-up|4
971166|NCT00618956|3196842|P2|Overall Study|Withdrawal by Subject|7
971167|NCT00618956|3196843|P1|Overall Study|Withdrawal by Subject|5
971168|NCT00618956|3196842|P2|Overall Study|Lack of Efficacy|1
971169|NCT00618956|3196843|P1|Overall Study|Lack of Efficacy|2
971170|NCT00618956|3196842|P2|Overall Study|Adverse Event|34
971171|NCT00618956|3196843|P1|Overall Study|Adverse Event|10
971172|NCT00618826|3196868|P1|Overall Study|Adverse Event|1
971173|NCT00618813|3196873|P1|Overall Study|Withdrawal by Subject|1
971174|NCT00618813|3196873|P1|Overall Study|Physician Decision|2
971175|NCT00618813|3196873|P1|Overall Study|Lack of Efficacy|1
971176|NCT00618787|3196883|P2|Overall Study|Lost to Follow-up|0
971177|NCT00618787|3196884|P1|Overall Study|Lost to Follow-up|1
971178|NCT00618787|3196883|P2|Overall Study|Withdrawal by Subject|1
971179|NCT00618787|3196884|P1|Overall Study|Withdrawal by Subject|2
971180|NCT00618787|3196883|P2|Overall Study|Adverse Event|1
971181|NCT00618787|3196884|P1|Overall Study|Adverse Event|0
971182|NCT00618774|3196892|P2|Overall Study|Withdrawal by Subject|0
971183|NCT00618774|3196893|P1|Overall Study|Withdrawal by Subject|1
971184|NCT00618774|3196892|P2|Overall Study|Adverse Event|3
971185|NCT00618774|3196893|P1|Overall Study|Adverse Event|5
971186|NCT00618748|3196926|P3|Overall Study|Withdrawal by Subject|5
971187|NCT00618748|3196927|P2|Overall Study|Withdrawal by Subject|1
971188|NCT00618748|3196928|P1|Overall Study|Withdrawal by Subject|4
971189|NCT00618748|3196926|P3|Overall Study|Physician Decision|1
971190|NCT00618748|3196927|P2|Overall Study|Physician Decision|1
971191|NCT00618748|3196928|P1|Overall Study|Physician Decision|3
971192|NCT00618748|3196926|P3|Overall Study|Adverse Event|8
971193|NCT00618748|3196927|P2|Overall Study|Adverse Event|3
971194|NCT00618748|3196928|P1|Overall Study|Adverse Event|4
971195|NCT00618722|3196973|P4|Overall Study|Miscellaneous Reasons|1
971196|NCT00618722|3196974|P3|Overall Study|Miscellaneous Reasons|1
971197|NCT00618722|3196975|P2|Overall Study|Miscellaneous Reasons|0
971198|NCT00618722|3196976|P1|Overall Study|Miscellaneous Reasons|0
971199|NCT00618722|3196973|P4|Overall Study|Lost to Follow-up|2
971200|NCT00618722|3196974|P3|Overall Study|Lost to Follow-up|0
971201|NCT00618722|3196975|P2|Overall Study|Lost to Follow-up|0
971202|NCT00618722|3196976|P1|Overall Study|Lost to Follow-up|2
971203|NCT00618722|3196973|P4|Overall Study|Inability to Complete Study Procedure|0
971204|NCT00618722|3196974|P3|Overall Study|Inability to Complete Study Procedure|0
971205|NCT00618722|3196975|P2|Overall Study|Inability to Complete Study Procedure|1
971206|NCT00618722|3196976|P1|Overall Study|Inability to Complete Study Procedure|0
971207|NCT00618722|3196973|P4|Overall Study|Patient Request|1
971208|NCT00618722|3196974|P3|Overall Study|Patient Request|1
971209|NCT00618722|3196975|P2|Overall Study|Patient Request|1
971210|NCT00618722|3196976|P1|Overall Study|Patient Request|1
971211|NCT00618722|3196973|P4|Overall Study|Refusal of Treatment|0
971212|NCT00618722|3196974|P3|Overall Study|Refusal of Treatment|1
971213|NCT00618722|3196975|P2|Overall Study|Refusal of Treatment|0
971214|NCT00618722|3196976|P1|Overall Study|Refusal of Treatment|0
971215|NCT00618618|3197014|P4|Overall Study|Death|0
971216|NCT00618618|3197015|P3|Overall Study|Death|0
971217|NCT00618618|3197016|P2|Overall Study|Death|1
971218|NCT00618618|3197017|P1|Overall Study|Death|0
971219|NCT00618618|3197014|P4|Overall Study|Did Not Meet Entry Criteria|0
971220|NCT00618618|3197015|P3|Overall Study|Did Not Meet Entry Criteria|1
971221|NCT00618618|3197016|P2|Overall Study|Did Not Meet Entry Criteria|0
971222|NCT00618618|3197017|P1|Overall Study|Did Not Meet Entry Criteria|0
971223|NCT00618618|3197014|P4|Overall Study|Non-compliance|0
971224|NCT00618618|3197015|P3|Overall Study|Non-compliance|0
971225|NCT00618618|3197016|P2|Overall Study|Non-compliance|1
971226|NCT00618618|3197017|P1|Overall Study|Non-compliance|1
971227|NCT00618618|3197014|P4|Overall Study|Lost to Follow-up|1
971228|NCT00618618|3197015|P3|Overall Study|Lost to Follow-up|0
971229|NCT00618618|3197016|P2|Overall Study|Lost to Follow-up|0
971230|NCT00618618|3197017|P1|Overall Study|Lost to Follow-up|3
971231|NCT00618618|3197014|P4|Overall Study|Inability to Complete Study Procedures|0
971232|NCT00618618|3197015|P3|Overall Study|Inability to Complete Study Procedures|0
971233|NCT00618618|3197016|P2|Overall Study|Inability to Complete Study Procedures|1
971234|NCT00618618|3197017|P1|Overall Study|Inability to Complete Study Procedures|0
971235|NCT00618618|3197014|P4|Overall Study|Patient Request|0
971236|NCT00618618|3197015|P3|Overall Study|Patient Request|2
971237|NCT00618618|3197016|P2|Overall Study|Patient Request|0
971238|NCT00618618|3197017|P1|Overall Study|Patient Request|0
971239|NCT00618514|3197076|P3|Overall Study|Lost to Follow-up|4
971240|NCT00618514|3197077|P2|Overall Study|Lost to Follow-up|12
971241|NCT00618514|3197078|P1|Overall Study|Lost to Follow-up|11
971242|NCT00618449|3197098|P2|Overall Study|Lost to Follow-up|110
971243|NCT00618449|3197099|P1|Overall Study|Lost to Follow-up|98
971244|NCT00618410|3197118|P2|Washout Period (2 Weeks)|Physician Decision|1
971245|NCT00618410|3197119|P1|Washout Period (2 Weeks)|Physician Decision|0
971246|NCT00618371|3197135|P1|Overall Study|Withdrawal by Subject|2
971247|NCT00618072|3197168|P3|Overall Study|Physician Decision|1
971248|NCT00618072|3197169|P2|Overall Study|Physician Decision|1
971249|NCT00618072|3197170|P1|Overall Study|Physician Decision|0
971250|NCT00618072|3197168|P3|Overall Study|Lost to Follow-up|3
971251|NCT00618072|3197169|P2|Overall Study|Lost to Follow-up|0
971252|NCT00618072|3197170|P1|Overall Study|Lost to Follow-up|2
971253|NCT00617929|3197226|P1|Overall Study|Physician Decision|1
971254|NCT00617903|3197238|P2|Overall Study|noncompliance|1
971255|NCT00617903|3197239|P1|Overall Study|noncompliance|0
971256|NCT00617903|3197238|P2|Overall Study|Adverse Event|1
971257|NCT00617903|3197239|P1|Overall Study|Adverse Event|0
971258|NCT00617903|3197238|P2|Overall Study|Lack of Efficacy|1
971259|NCT00617903|3197239|P1|Overall Study|Lack of Efficacy|0
971260|NCT00617903|3197238|P2|Overall Study|Lost to Follow-up|1
971261|NCT00617903|3197239|P1|Overall Study|Lost to Follow-up|1
971262|NCT00617903|3197238|P2|Overall Study|Withdrawal by Subject|3
971263|NCT00617903|3197239|P1|Overall Study|Withdrawal by Subject|2
971264|NCT00617890|3197285|P4|Overall Study|Not treated|1
971265|NCT00617890|3197286|P3|Overall Study|Not treated|1
971266|NCT00617890|3197287|P2|Overall Study|Not treated|0
971267|NCT00617890|3197288|P1|Overall Study|Not treated|1
971268|NCT00617890|3197285|P4|Overall Study|Adverse Event|8
971269|NCT00617890|3197286|P3|Overall Study|Adverse Event|3
971270|NCT00617890|3197287|P2|Overall Study|Adverse Event|0
971271|NCT00617890|3197288|P1|Overall Study|Adverse Event|1
971272|NCT00617890|3197285|P4|Overall Study|Protocol Violation|0
971273|NCT00617890|3197286|P3|Overall Study|Protocol Violation|0
971274|NCT00617890|3197287|P2|Overall Study|Protocol Violation|1
971275|NCT00617890|3197288|P1|Overall Study|Protocol Violation|2
971276|NCT00617890|3197285|P4|Overall Study|Withdrawal by Subject|2
971277|NCT00617890|3197286|P3|Overall Study|Withdrawal by Subject|0
971278|NCT00617890|3197287|P2|Overall Study|Withdrawal by Subject|1
971279|NCT00617890|3197288|P1|Overall Study|Withdrawal by Subject|4
971280|NCT00617890|3197285|P4|Overall Study|Lost to Follow-up|2
971281|NCT00617890|3197286|P3|Overall Study|Lost to Follow-up|1
971282|NCT00617890|3197287|P2|Overall Study|Lost to Follow-up|0
971283|NCT00617890|3197288|P1|Overall Study|Lost to Follow-up|0
971284|NCT00617890|3197285|P4|Overall Study|Lack of Efficacy|97
971285|NCT00617890|3197286|P3|Overall Study|Lack of Efficacy|30
971286|NCT00617890|3197287|P2|Overall Study|Lack of Efficacy|26
971287|NCT00617890|3197288|P1|Overall Study|Lack of Efficacy|23
971288|NCT00617890|3197285|P4|Overall Study|Treatment ongoing at data cut-off|5
971289|NCT00617890|3197286|P3|Overall Study|Treatment ongoing at data cut-off|0
971290|NCT00617890|3197287|P2|Overall Study|Treatment ongoing at data cut-off|0
971291|NCT00617890|3197288|P1|Overall Study|Treatment ongoing at data cut-off|0
971292|NCT00617851|3197324|P4|Overall Study|Unable to classify|0
971293|NCT00617851|3197325|P3|Overall Study|Unable to classify|1
971294|NCT00617851|3197326|P2|Overall Study|Unable to classify|0
971295|NCT00617851|3197327|P1|Overall Study|Unable to classify|1
971296|NCT00617851|3197324|P4|Overall Study|Inappropriate Enrollment|1
971297|NCT00617851|3197325|P3|Overall Study|Inappropriate Enrollment|1
971298|NCT00617851|3197326|P2|Overall Study|Inappropriate Enrollment|4
971299|NCT00617851|3197327|P1|Overall Study|Inappropriate Enrollment|5
971300|NCT00617851|3197324|P4|Overall Study|Lost to Follow-up|19
971301|NCT00617851|3197325|P3|Overall Study|Lost to Follow-up|31
971302|NCT00617851|3197326|P2|Overall Study|Lost to Follow-up|29
971303|NCT00617851|3197327|P1|Overall Study|Lost to Follow-up|27
971304|NCT00617851|3197324|P4|Overall Study|Withdrawal by Subject|4
971305|NCT00617851|3197325|P3|Overall Study|Withdrawal by Subject|12
971306|NCT00617851|3197326|P2|Overall Study|Withdrawal by Subject|7
971307|NCT00617851|3197327|P1|Overall Study|Withdrawal by Subject|14
971308|NCT00617851|3197324|P4|Overall Study|Death|1
971309|NCT00617851|3197325|P3|Overall Study|Death|0
971310|NCT00617851|3197326|P2|Overall Study|Death|0
971311|NCT00617851|3197327|P1|Overall Study|Death|0
971312|NCT00617773|3197365|P1|Overall Study|Protocol Violation|1
971313|NCT00617773|3197365|P1|Overall Study|Progressive disease|19
971314|NCT00617773|3197365|P1|Overall Study|Death|1
971315|NCT00617773|3197365|P1|Overall Study|Withdrawal by Subject|1
971316|NCT00617773|3197365|P1|Overall Study|Lack of compliance with the protocol|1
971317|NCT00617773|3197365|P1|Overall Study|Physician Decision|1
971318|NCT00617734|3197382|P2|Overall Study|Lost to Follow-up|1
971319|NCT00617734|3197383|P1|Overall Study|Lost to Follow-up|0
971320|NCT00617734|3197382|P2|Overall Study|Found Ineligible After Randomization|4
971321|NCT00617734|3197383|P1|Overall Study|Found Ineligible After Randomization|1
971322|NCT00617734|3197382|P2|Overall Study|Protocol Violation|0
971323|NCT00617734|3197383|P1|Overall Study|Protocol Violation|1
971324|NCT00617734|3197382|P2|Overall Study|Adverse Event|1
971325|NCT00617734|3197383|P1|Overall Study|Adverse Event|4
971326|NCT00617734|3197382|P2|Overall Study|Withdrew Consent|0
971327|NCT00617734|3197383|P1|Overall Study|Withdrew Consent|2
971328|NCT00617708|3197404|P3|Overall Study|Not eligible|5
971329|NCT00617708|3197405|P2|Overall Study|Not eligible|3
971330|NCT00617708|3197406|P1|Overall Study|Not eligible|1
971331|NCT00617708|3197404|P3|Overall Study|Not protocol specified|2
971332|NCT00617708|3197405|P2|Overall Study|Not protocol specified|4
971333|NCT00617708|3197406|P1|Overall Study|Not protocol specified|1
971334|NCT00617708|3197404|P3|Overall Study|Progression/Relapse|36
971335|NCT00617708|3197405|P2|Overall Study|Progression/Relapse|40
971336|NCT00617708|3197406|P1|Overall Study|Progression/Relapse|7
971337|NCT00617708|3197404|P3|Overall Study|Death|5
971338|NCT00617708|3197405|P2|Overall Study|Death|6
971339|NCT00617708|3197406|P1|Overall Study|Death|0
971340|NCT00617708|3197404|P3|Overall Study|Withdrawal by Subject|7
971341|NCT00617708|3197405|P2|Overall Study|Withdrawal by Subject|1
971342|NCT00617708|3197406|P1|Overall Study|Withdrawal by Subject|1
971343|NCT00617708|3197404|P3|Overall Study|Adverse Event|9
971344|NCT00617708|3197405|P2|Overall Study|Adverse Event|6
971345|NCT00617708|3197406|P1|Overall Study|Adverse Event|0
971346|NCT00617669|3197423|P2|Overall Study|Patients randomized but not treated|3
971347|NCT00617669|3197424|P1|Overall Study|Patients randomized but not treated|2
971348|NCT00617669|3197423|P2|Overall Study|Reason not otherwise captured, eg; death|290
971349|NCT00617669|3197424|P1|Overall Study|Reason not otherwise captured, eg; death|265
971350|NCT00617669|3197423|P2|Overall Study|Protocol Violation|3
971351|NCT00617669|3197424|P1|Overall Study|Protocol Violation|2
971352|NCT00617669|3197423|P2|Overall Study|Adverse Event|76
971353|NCT00617669|3197424|P1|Overall Study|Adverse Event|87
971354|NCT00617669|3197423|P2|Overall Study|Lost to Follow-up|2
971355|NCT00617669|3197424|P1|Overall Study|Lost to Follow-up|3
971356|NCT00617669|3197423|P2|Overall Study|Withdrawal by Subject|77
971357|NCT00617669|3197424|P1|Overall Study|Withdrawal by Subject|71
971358|NCT00617604|3197446|P2|Overall Study|Randomized but Never Received Study Drug|3
971359|NCT00617604|3197447|P1|Overall Study|Randomized but Never Received Study Drug|3
971360|NCT00617604|3197446|P2|Overall Study|Withdrawal by Subject|6
971361|NCT00617604|3197447|P1|Overall Study|Withdrawal by Subject|4
971362|NCT00617604|3197446|P2|Overall Study|Miscellaneous Reasons|10
971363|NCT00617604|3197447|P1|Overall Study|Miscellaneous Reasons|8
971364|NCT00617604|3197446|P2|Overall Study|Lost to Follow-up|0
971365|NCT00617604|3197447|P1|Overall Study|Lost to Follow-up|1
971366|NCT00617604|3197446|P2|Overall Study|Death|1
971367|NCT00617604|3197447|P1|Overall Study|Death|2
971368|NCT00617591|3197491|P1|Overall Study|Withdrew consent during Maintenance|6
971369|NCT00617591|3197491|P1|Overall Study|Withdrew consent during Induction|4
971370|NCT00617461|3197507|P2|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2
971371|NCT00617461|3197508|P1|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1
971372|NCT00617461|3197507|P2|6-Day Down-Titration Period|Withdrawal by Subject|0
971373|NCT00617461|3197508|P1|6-Day Down-Titration Period|Withdrawal by Subject|1
971374|NCT00617461|3197507|P2|Second Treatment Intervention Period|Lack of Efficacy|3
971375|NCT00617461|3197508|P1|Second Treatment Intervention Period|Lack of Efficacy|0
971376|NCT00617461|3197507|P2|Second Treatment Intervention Period|Adverse Event|1
971377|NCT00617461|3197508|P1|Second Treatment Intervention Period|Adverse Event|0
971378|NCT00617461|3197507|P2|4-Day Crossover Period|Withdrawal by Subject|0
971379|NCT00617461|3197508|P1|4-Day Crossover Period|Withdrawal by Subject|1
971380|NCT00617461|3197507|P2|First Treatment Intervention Period|Withdrawal by Subject|0
971381|NCT00617461|3197508|P1|First Treatment Intervention Period|Withdrawal by Subject|4
971382|NCT00617461|3197507|P2|First Treatment Intervention Period|Investigator Discretion|1
971383|NCT00617461|3197508|P1|First Treatment Intervention Period|Investigator Discretion|1
971384|NCT00617461|3197507|P2|First Treatment Intervention Period|Lost to Follow-up|1
971385|NCT00617461|3197508|P1|First Treatment Intervention Period|Lost to Follow-up|0
971386|NCT00617461|3197507|P2|First Treatment Intervention Period|Protocol Violation|1
971387|NCT00617461|3197508|P1|First Treatment Intervention Period|Protocol Violation|2
971388|NCT00617461|3197507|P2|First Treatment Intervention Period|Lack of Efficacy|0
971389|NCT00617461|3197508|P1|First Treatment Intervention Period|Lack of Efficacy|1
971390|NCT00617461|3197507|P2|First Treatment Intervention Period|Adverse Event|0
971391|NCT00617461|3197508|P1|First Treatment Intervention Period|Adverse Event|2
971392|NCT00617409|3197564|P3|Overall Study|Alternative Therapy|0
971393|NCT00617409|3197565|P2|Overall Study|Alternative Therapy|2
971394|NCT00617409|3197566|P1|Overall Study|Alternative Therapy|1
971395|NCT00617409|3197564|P3|Overall Study|Death|4
971396|NCT00617409|3197565|P2|Overall Study|Death|5
971397|NCT00617409|3197566|P1|Overall Study|Death|3
971398|NCT00617409|3197564|P3|Overall Study|Disease Progression|18
971399|NCT00617409|3197565|P2|Overall Study|Disease Progression|8
971400|NCT00617409|3197566|P1|Overall Study|Disease Progression|8
971401|NCT00617409|3197564|P3|Overall Study|Adverse Event|3
971402|NCT00617409|3197565|P2|Overall Study|Adverse Event|2
971403|NCT00617409|3197566|P1|Overall Study|Adverse Event|0
971404|NCT00617409|3197564|P3|Overall Study|Withdrawal by Subject|2
971405|NCT00617409|3197565|P2|Overall Study|Withdrawal by Subject|1
971406|NCT00617409|3197566|P1|Overall Study|Withdrawal by Subject|4
971407|NCT00617357|3197581|P1|Overall Study|Physician Decision|1
971408|NCT00617357|3197581|P1|Overall Study|Withdrawal by Subject|1
971409|NCT00617357|3197581|P1|Overall Study|insurance concerns|2
971410|NCT00617357|3197581|P1|Overall Study|Death|5
971411|NCT00617357|3197581|P1|Overall Study|Lost to Follow-up|7
971412|NCT00617305|3197594|P3|Overall Study|Withdrawal by Subject|0
971413|NCT00617305|3197595|P2|Overall Study|Withdrawal by Subject|0
971414|NCT00617305|3197596|P1|Overall Study|Withdrawal by Subject|1
971415|NCT00617305|3197594|P3|Overall Study|Protocol Violation|1
971416|NCT00617305|3197595|P2|Overall Study|Protocol Violation|0
971417|NCT00617305|3197596|P1|Overall Study|Protocol Violation|1
971418|NCT00617305|3197594|P3|Overall Study|Physician Decision|0
971419|NCT00617305|3197595|P2|Overall Study|Physician Decision|0
971420|NCT00617305|3197596|P1|Overall Study|Physician Decision|1
971421|NCT00617305|3197594|P3|Overall Study|Death|0
971422|NCT00617305|3197595|P2|Overall Study|Death|0
971423|NCT00617305|3197596|P1|Overall Study|Death|1
971424|NCT00617305|3197594|P3|Overall Study|Adverse Event|0
971425|NCT00617305|3197595|P2|Overall Study|Adverse Event|0
971426|NCT00617305|3197596|P1|Overall Study|Adverse Event|4
971427|NCT00617279|3197652|P2|Overall Study|Death|2
971428|NCT00617279|3197653|P1|Overall Study|Death|1
971429|NCT00617279|3197652|P2|Overall Study|Lost to Follow-up|0
971430|NCT00617279|3197653|P1|Overall Study|Lost to Follow-up|1
971431|NCT00617279|3197652|P2|Overall Study|Graft abandonment|0
971432|NCT00617279|3197653|P1|Overall Study|Graft abandonment|2
971433|NCT00617279|3197652|P2|Overall Study|Study terminated by Sponsor|15
971434|NCT00617279|3197653|P1|Overall Study|Study terminated by Sponsor|10
971435|NCT00617240|3197709|P2|Overall Study|Lack of Efficacy|0
971436|NCT00617240|3197710|P1|Overall Study|Lack of Efficacy|1
971437|NCT00617201|3197730|P2|Overall Study|Lost to Follow-up|13
971438|NCT00617201|3197731|P1|Overall Study|Lost to Follow-up|9
971439|NCT00617123|3197759|P2|Study Treatment Period|Noncompliance with Protocol|1
971440|NCT00617123|3197760|P1|Study Treatment Period|Noncompliance with Protocol|0
971441|NCT00617123|3197759|P2|Study Treatment Period|Did Not Meet Protocol Eligibility|0
971442|NCT00617123|3197760|P1|Study Treatment Period|Did Not Meet Protocol Eligibility|2
971443|NCT00617123|3197759|P2|Study Treatment Period|Adverse Event|3
971444|NCT00617123|3197760|P1|Study Treatment Period|Adverse Event|7
971445|NCT00617123|3197759|P2|Study Treatment Period|Withdrawal by Subject|12
971446|NCT00617123|3197760|P1|Study Treatment Period|Withdrawal by Subject|8
971447|NCT00617123|3197759|P2|Referral Screening Period|Adverse Event|1
971448|NCT00617123|3197760|P1|Referral Screening Period|Adverse Event|0
971449|NCT00617123|3197759|P2|Referral Screening Period|Did Not Wish To Continue|1
971450|NCT00617123|3197760|P1|Referral Screening Period|Did Not Wish To Continue|3
971451|NCT00617123|3197759|P2|Referral Screening Period|Did Not Meet Protocol Eligibility|24
971452|NCT00617123|3197760|P1|Referral Screening Period|Did Not Meet Protocol Eligibility|36
971453|NCT00617084|3197791|P2|Overall Study|Missed 12 Months visit|19
971454|NCT00617084|3197792|P1|Overall Study|Missed 12 Months visit|16
971455|NCT00617084|3197791|P2|Overall Study|Withdrawal by Subject|7
971456|NCT00617084|3197792|P1|Overall Study|Withdrawal by Subject|5
971457|NCT00616967|3197845|P3|Overall Study|Withdrawal by Subject|1
971458|NCT00616967|3197846|P2|Overall Study|Withdrawal by Subject|0
971459|NCT00616967|3197847|P1|Overall Study|Withdrawal by Subject|0
971460|NCT00616941|3197859|P3|Overall Study|Vaccination Suspended|3
971461|NCT00616941|3197860|P2|Overall Study|Vaccination Suspended|0
971462|NCT00616941|3197861|P1|Overall Study|Vaccination Suspended|0
971463|NCT00616941|3197859|P3|Overall Study|Unrelated Medical Illness/Complication|0
971464|NCT00616941|3197860|P2|Overall Study|Unrelated Medical Illness/Complication|2
971465|NCT00616941|3197861|P1|Overall Study|Unrelated Medical Illness/Complication|0
971466|NCT00616941|3197859|P3|Overall Study|Subject Non-compliance|1
971467|NCT00616941|3197860|P2|Overall Study|Subject Non-compliance|0
971468|NCT00616941|3197861|P1|Overall Study|Subject Non-compliance|0
971469|NCT00616941|3197859|P3|Overall Study|Adverse Event|1
971470|NCT00616941|3197860|P2|Overall Study|Adverse Event|1
971471|NCT00616941|3197861|P1|Overall Study|Adverse Event|0
971472|NCT00616941|3197859|P3|Overall Study|Progressive Disease|1
971473|NCT00616941|3197860|P2|Overall Study|Progressive Disease|2
971474|NCT00616941|3197861|P1|Overall Study|Progressive Disease|1
971475|NCT00616928|3197888|P4|Overall Study|Lost to Follow-up|0
971476|NCT00616928|3197889|P3|Overall Study|Lost to Follow-up|0
971477|NCT00616928|3197890|P2|Overall Study|Lost to Follow-up|7
971478|NCT00616928|3197891|P1|Overall Study|Lost to Follow-up|5
971479|NCT00616928|3197888|P4|Overall Study|Other|5
971480|NCT00616928|3197889|P3|Overall Study|Other|15
971481|NCT00616928|3197890|P2|Overall Study|Other|8
971482|NCT00616928|3197891|P1|Overall Study|Other|51
971483|NCT00616928|3197888|P4|Overall Study|Adverse Event|2
971484|NCT00616928|3197889|P3|Overall Study|Adverse Event|2
971485|NCT00616928|3197890|P2|Overall Study|Adverse Event|3
971486|NCT00616928|3197891|P1|Overall Study|Adverse Event|6
971487|NCT00616902|3197955|P2|Overall Study|Termination of study|6
971488|NCT00616902|3197956|P1|Overall Study|Termination of study|6
971489|NCT00616759|3197999|P2|Overall Study|Withdrawal by Subject|2
971490|NCT00616759|3198000|P1|Overall Study|Withdrawal by Subject|1
971491|NCT00616759|3197999|P2|Overall Study|Physician Decision|0
971492|NCT00616759|3198000|P1|Overall Study|Physician Decision|2
971493|NCT00616655|3198009|P3|Overall Study|Other|5
971494|NCT00616655|3198010|P2|Overall Study|Other|6
971495|NCT00616655|3198011|P1|Overall Study|Other|6
971496|NCT00616655|3198009|P3|Overall Study|Does not meet in/ex criteria|2
971497|NCT00616655|3198010|P2|Overall Study|Does not meet in/ex criteria|0
971498|NCT00616655|3198011|P1|Overall Study|Does not meet in/ex criteria|0
971499|NCT00616655|3198009|P3|Overall Study|Withdrawal by Subject|11
971500|NCT00616655|3198010|P2|Overall Study|Withdrawal by Subject|7
971501|NCT00616655|3198011|P1|Overall Study|Withdrawal by Subject|9
971502|NCT00616655|3198009|P3|Overall Study|Protocol Violation|3
971503|NCT00616655|3198010|P2|Overall Study|Protocol Violation|4
971504|NCT00616655|3198011|P1|Overall Study|Protocol Violation|2
971505|NCT00616655|3198009|P3|Overall Study|Lost to Follow-up|10
971506|NCT00616655|3198010|P2|Overall Study|Lost to Follow-up|12
971507|NCT00616655|3198011|P1|Overall Study|Lost to Follow-up|3
971508|NCT00616655|3198009|P3|Overall Study|Lack of Efficacy|5
971509|NCT00616655|3198010|P2|Overall Study|Lack of Efficacy|5
971510|NCT00616655|3198011|P1|Overall Study|Lack of Efficacy|5
971511|NCT00616655|3198009|P3|Overall Study|Adverse Event|12
971512|NCT00616655|3198010|P2|Overall Study|Adverse Event|7
971513|NCT00616655|3198011|P1|Overall Study|Adverse Event|10
971514|NCT00616642|3198051|P2|Overall Study|Withdrawal by Subject|1
971515|NCT00616642|3198052|P1|Overall Study|Withdrawal by Subject|0
971516|NCT00616629|3198063|P5|Overall Study|AV-block|0
971517|NCT00616629|3198064|P4|Overall Study|AV-block|0
971518|NCT00616629|3198065|P3|Overall Study|AV-block|0
971519|NCT00616629|3198066|P2|Overall Study|AV-block|0
971520|NCT00616629|3198067|P1|Overall Study|AV-block|1
971521|NCT00616629|3198063|P5|Overall Study|Protocol Violation|0
971522|NCT00616629|3198064|P4|Overall Study|Protocol Violation|0
971523|NCT00616629|3198065|P3|Overall Study|Protocol Violation|1
971524|NCT00616629|3198066|P2|Overall Study|Protocol Violation|2
971525|NCT00616629|3198067|P1|Overall Study|Protocol Violation|1
971526|NCT00616603|3198112|P3|Overall Study|Physician Decision|2
971527|NCT00616603|3198113|P2|Overall Study|Physician Decision|0
971528|NCT00616603|3198114|P1|Overall Study|Physician Decision|2
971529|NCT00616434|3198137|P2|Overall Study|Protocol deviation|1
971530|NCT00616434|3198138|P1|Overall Study|Protocol deviation|0
971531|NCT00616434|3198137|P2|Overall Study|Withdrawal by Subject|1
971532|NCT00616434|3198138|P1|Overall Study|Withdrawal by Subject|1
971533|NCT00616434|3198137|P2|Overall Study|Physician Decision|4
971534|NCT00616434|3198138|P1|Overall Study|Physician Decision|0
971535|NCT00616434|3198137|P2|Overall Study|Adverse Event|2
971536|NCT00616434|3198138|P1|Overall Study|Adverse Event|5
971537|NCT00616421|3198151|P3|Overall Study|Unable to classify|0
971538|NCT00616421|3198152|P2|Overall Study|Unable to classify|0
971539|NCT00616421|3198153|P1|Overall Study|Unable to classify|1
971540|NCT00616421|3198151|P3|Overall Study|Protocol Violation|2
971541|NCT00616421|3198152|P2|Overall Study|Protocol Violation|1
971542|NCT00616421|3198153|P1|Overall Study|Protocol Violation|0
971543|NCT00616421|3198151|P3|Overall Study|Administrative reason|0
971544|NCT00616421|3198152|P2|Overall Study|Administrative reason|0
971545|NCT00616421|3198153|P1|Overall Study|Administrative reason|1
971546|NCT00616421|3198151|P3|Overall Study|Inappropriate enrollment|1
971547|NCT00616421|3198152|P2|Overall Study|Inappropriate enrollment|0
971548|NCT00616421|3198153|P1|Overall Study|Inappropriate enrollment|3
971549|NCT00616421|3198151|P3|Overall Study|Lost to Follow-up|30
971550|NCT00616421|3198152|P2|Overall Study|Lost to Follow-up|26
971551|NCT00616421|3198153|P1|Overall Study|Lost to Follow-up|12
971552|NCT00616421|3198151|P3|Overall Study|Withdrawal by Subject|8
971553|NCT00616421|3198152|P2|Overall Study|Withdrawal by Subject|11
971554|NCT00616421|3198153|P1|Overall Study|Withdrawal by Subject|9
971555|NCT00616239|3198194|P1|Overall Study|Withdrawal by Subject|2
971556|NCT00616018|3198218|P1|Overall Study|Protocol Violation|3
971557|NCT00615992|3198223|P1|Overall Study|Protocol Violation|67
971558|NCT00615914|3198249|P1|Overall Study|Irregularly enrolled patients|10
971559|NCT00615914|3198249|P1|Overall Study|No treatment|2
971560|NCT00615914|3198249|P1|Overall Study|No data was collected.|65
971561|NCT00615914|3198249|P1|Overall Study|Physician Decision|4
971562|NCT00615914|3198249|P1|Overall Study|Withdrawal by Subject|16
971563|NCT00615914|3198249|P1|Overall Study|Lost to Follow-up|187
971564|NCT00615914|3198249|P1|Overall Study|Lack of Efficacy|59
971565|NCT00615914|3198249|P1|Overall Study|Death|20
971566|NCT00615914|3198249|P1|Overall Study|Adverse Event|274
971567|NCT00615901|3198256|P1|Overall Study|Adverse Event|7
971568|NCT00615901|3198256|P1|Overall Study|Withdrawal by Subject|2
971569|NCT00615836|3198264|P5|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
971570|NCT00615836|3198265|P4|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
971571|NCT00615836|3198266|P3|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
971572|NCT00615836|3198267|P2|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
971573|NCT00615836|3198268|P1|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65
971574|NCT00615836|3198264|P5|Extension Study (FE992026 CS31)|Not reported|0
971575|NCT00615836|3198265|P4|Extension Study (FE992026 CS31)|Not reported|4
971576|NCT00615836|3198266|P3|Extension Study (FE992026 CS31)|Not reported|1
971577|NCT00615836|3198267|P2|Extension Study (FE992026 CS31)|Not reported|4
971578|NCT00615836|3198268|P1|Extension Study (FE992026 CS31)|Not reported|6
971579|NCT00615836|3198264|P5|Extension Study (FE992026 CS31)|Not specified|0
971580|NCT00615836|3198265|P4|Extension Study (FE992026 CS31)|Not specified|8
971581|NCT00615836|3198266|P3|Extension Study (FE992026 CS31)|Not specified|8
971582|NCT00615836|3198267|P2|Extension Study (FE992026 CS31)|Not specified|7
971583|NCT00615836|3198268|P1|Extension Study (FE992026 CS31)|Not specified|10
971584|NCT00615836|3198264|P5|Extension Study (FE992026 CS31)|Lost to Follow-up|0
971585|NCT00615836|3198265|P4|Extension Study (FE992026 CS31)|Lost to Follow-up|10
971586|NCT00615836|3198266|P3|Extension Study (FE992026 CS31)|Lost to Follow-up|5
971587|NCT00615836|3198267|P2|Extension Study (FE992026 CS31)|Lost to Follow-up|14
971588|NCT00615836|3198268|P1|Extension Study (FE992026 CS31)|Lost to Follow-up|10
971589|NCT00615836|3198264|P5|Extension Study (FE992026 CS31)|Withdrawal by Subject|0
971590|NCT00615836|3198265|P4|Extension Study (FE992026 CS31)|Withdrawal by Subject|43
971591|NCT00615836|3198266|P3|Extension Study (FE992026 CS31)|Withdrawal by Subject|38
971592|NCT00615836|3198267|P2|Extension Study (FE992026 CS31)|Withdrawal by Subject|42
971593|NCT00615836|3198268|P1|Extension Study (FE992026 CS31)|Withdrawal by Subject|37
971594|NCT00615836|3198264|P5|Extension Study (FE992026 CS31)|Protocol Violation|0
971595|NCT00615836|3198265|P4|Extension Study (FE992026 CS31)|Protocol Violation|3
971596|NCT00615836|3198266|P3|Extension Study (FE992026 CS31)|Protocol Violation|2
971597|NCT00615836|3198267|P2|Extension Study (FE992026 CS31)|Protocol Violation|5
971598|NCT00615836|3198268|P1|Extension Study (FE992026 CS31)|Protocol Violation|4
971599|NCT00615836|3198264|P5|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
971600|NCT00615836|3198265|P4|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
971601|NCT00615836|3198266|P3|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
971602|NCT00615836|3198267|P2|Extension Study (FE992026 CS31)|Use of exclusionary medication|2
971603|NCT00615836|3198268|P1|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
971604|NCT00615836|3198264|P5|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
971605|NCT00615836|3198265|P4|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
971606|NCT00615836|3198266|P3|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
971607|NCT00615836|3198267|P2|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
971608|NCT00615836|3198268|P1|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1
971609|NCT00615836|3198264|P5|Extension Study (FE992026 CS31)|Adverse Event|0
971610|NCT00615836|3198265|P4|Extension Study (FE992026 CS31)|Adverse Event|13
971611|NCT00615836|3198266|P3|Extension Study (FE992026 CS31)|Adverse Event|15
971612|NCT00615836|3198267|P2|Extension Study (FE992026 CS31)|Adverse Event|12
971613|NCT00615836|3198268|P1|Extension Study (FE992026 CS31)|Adverse Event|7
971614|NCT00615719|3198328|P1|Overall Study|Physician Decision|5
971615|NCT00615550|3198342|P2|Overall Study|Lost to Follow-up|1
971616|NCT00615550|3198343|P1|Overall Study|Lost to Follow-up|6
971617|NCT00615459|3198366|P4|Period III|Unsatisfactory therapeutic effect|0
971618|NCT00615459|3198367|P3|Period III|Unsatisfactory therapeutic effect|0
971619|NCT00615459|3198368|P2|Period III|Unsatisfactory therapeutic effect|1
971620|NCT00615459|3198369|P1|Period III|Unsatisfactory therapeutic effect|0
971621|NCT00615459|3198366|P4|Period III|Administrative problems|0
971622|NCT00615459|3198367|P3|Period III|Administrative problems|1
971623|NCT00615459|3198368|P2|Period III|Administrative problems|1
971624|NCT00615459|3198369|P1|Period III|Administrative problems|0
971625|NCT00615459|3198366|P4|Period III|Adverse Event|0
971626|NCT00615459|3198367|P3|Period III|Adverse Event|0
971627|NCT00615459|3198368|P2|Period III|Adverse Event|1
971628|NCT00615459|3198369|P1|Period III|Adverse Event|0
971629|NCT00615459|3198366|P4|Period II|Lost to Follow-up|1
971630|NCT00615459|3198367|P3|Period II|Lost to Follow-up|0
971631|NCT00615459|3198368|P2|Period II|Lost to Follow-up|0
971632|NCT00615459|3198369|P1|Period II|Lost to Follow-up|0
971633|NCT00615459|3198366|P4|Period II|Adverse Event|0
971634|NCT00615459|3198367|P3|Period II|Adverse Event|0
971635|NCT00615459|3198368|P2|Period II|Adverse Event|0
971636|NCT00615459|3198369|P1|Period II|Adverse Event|1
971637|NCT00615459|3198366|P4|Period I|Abnormal test procedure results|0
971638|NCT00615459|3198367|P3|Period I|Abnormal test procedure results|1
971639|NCT00615459|3198368|P2|Period I|Abnormal test procedure results|1
971640|NCT00615459|3198369|P1|Period I|Abnormal test procedure results|1
971641|NCT00615459|3198366|P4|Period I|Subject withdrew consent|1
971642|NCT00615459|3198367|P3|Period I|Subject withdrew consent|0
971643|NCT00615459|3198368|P2|Period I|Subject withdrew consent|0
971644|NCT00615459|3198369|P1|Period I|Subject withdrew consent|1
971645|NCT00615459|3198366|P4|Period I|Adverse Event|0
971646|NCT00615459|3198367|P3|Period I|Adverse Event|1
971647|NCT00615459|3198368|P2|Period I|Adverse Event|0
971648|NCT00615459|3198369|P1|Period I|Adverse Event|2
971649|NCT00615290|3198404|P1|Overall Study|Other|2
971650|NCT00615290|3198404|P1|Overall Study|Withdrawal by Subject|1
971651|NCT00615290|3198404|P1|Overall Study|Lost to Follow-up|3
971652|NCT00615290|3198404|P1|Overall Study|Adverse Event|2
971653|NCT00615264|3198418|P2|Overall Study|Dermal Hypersensitivity|3
971654|NCT00615264|3198419|P1|Overall Study|Dermal Hypersensitivity|0
971655|NCT00615264|3198418|P2|Overall Study|Not defined|4
971656|NCT00615264|3198419|P1|Overall Study|Not defined|7
971657|NCT00615264|3198418|P2|Overall Study|Protocol Violation|7
971658|NCT00615264|3198419|P1|Overall Study|Protocol Violation|11
971659|NCT00615264|3198418|P2|Overall Study|Death|1
971660|NCT00615264|3198419|P1|Overall Study|Death|1
971661|NCT00615264|3198418|P2|Overall Study|Adverse Event|5
971662|NCT00615264|3198419|P1|Overall Study|Adverse Event|8
971663|NCT00615264|3198418|P2|Overall Study|Lost to Follow-up|13
971664|NCT00615264|3198419|P1|Overall Study|Lost to Follow-up|6
971665|NCT00615264|3198418|P2|Overall Study|Withdrawal by Subject|19
971666|NCT00615264|3198419|P1|Overall Study|Withdrawal by Subject|17
971667|NCT00615199|3198431|P4|Overall Study|Withdrawal by Subject|0
971668|NCT00615199|3198432|P3|Overall Study|Withdrawal by Subject|0
971669|NCT00615199|3198433|P2|Overall Study|Withdrawal by Subject|1
971670|NCT00615199|3198434|P1|Overall Study|Withdrawal by Subject|2
971671|NCT00615199|3198431|P4|Overall Study|Other|1
971672|NCT00615199|3198432|P3|Overall Study|Other|0
971673|NCT00615199|3198433|P2|Overall Study|Other|0
971674|NCT00615199|3198434|P1|Overall Study|Other|0
971675|NCT00615199|3198431|P4|Overall Study|Lost to Follow-up|0
971676|NCT00615199|3198432|P3|Overall Study|Lost to Follow-up|0
971677|NCT00615199|3198433|P2|Overall Study|Lost to Follow-up|0
971678|NCT00615199|3198434|P1|Overall Study|Lost to Follow-up|1
971679|NCT00615199|3198431|P4|Overall Study|Lack of Efficacy|1
971680|NCT00615199|3198432|P3|Overall Study|Lack of Efficacy|0
971681|NCT00615199|3198433|P2|Overall Study|Lack of Efficacy|0
971682|NCT00615199|3198434|P1|Overall Study|Lack of Efficacy|2
971683|NCT00615199|3198431|P4|Overall Study|Adverse Event|0
971684|NCT00615199|3198432|P3|Overall Study|Adverse Event|1
971685|NCT00615199|3198433|P2|Overall Study|Adverse Event|1
971686|NCT00615199|3198434|P1|Overall Study|Adverse Event|3
971687|NCT00615108|3198468|P1|Overall Study|Lost to Follow-up|15
971688|NCT00615108|3198468|P1|Overall Study|Other|370
971689|NCT00615108|3198468|P1|Overall Study|Adverse Event|122
971690|NCT00615069|3198483|P1|Overall Study|Withdrawal by Subject|4
971691|NCT00615069|3198483|P1|Overall Study|Physician Decision|2
971692|NCT00615069|3198483|P1|Overall Study|Death|10
971693|NCT00615056|3198492|P4|Overall Study|Randomized but not treated|0
971694|NCT00615056|3198493|P3|Overall Study|Randomized but not treated|0
971695|NCT00615056|3198494|P2|Overall Study|Randomized but not treated|0
971696|NCT00615056|3198495|P1|Overall Study|Randomized but not treated|3
971697|NCT00615056|3198492|P4|Overall Study|Discontinued by Sponsor|0
971698|NCT00615056|3198493|P3|Overall Study|Discontinued by Sponsor|0
971699|NCT00615056|3198494|P2|Overall Study|Discontinued by Sponsor|0
971700|NCT00615056|3198495|P1|Overall Study|Discontinued by Sponsor|1
971701|NCT00615056|3198492|P4|Overall Study|Withdrawal by Subject|0
971702|NCT00615056|3198493|P3|Overall Study|Withdrawal by Subject|1
971703|NCT00615056|3198494|P2|Overall Study|Withdrawal by Subject|1
971704|NCT00615056|3198495|P1|Overall Study|Withdrawal by Subject|0
971705|NCT00615056|3198492|P4|Overall Study|Objective progression or relapse|0
971706|NCT00615056|3198493|P3|Overall Study|Objective progression or relapse|0
971707|NCT00615056|3198494|P2|Overall Study|Objective progression or relapse|2
971708|NCT00615056|3198495|P1|Overall Study|Objective progression or relapse|0
971709|NCT00615056|3198492|P4|Overall Study|Other|7
971710|NCT00615056|3198493|P3|Overall Study|Other|10
971711|NCT00615056|3198494|P2|Overall Study|Other|15
971712|NCT00615056|3198495|P1|Overall Study|Other|13
971713|NCT00615056|3198492|P4|Overall Study|Lost to Follow-up|5
971714|NCT00615056|3198493|P3|Overall Study|Lost to Follow-up|4
971715|NCT00615056|3198494|P2|Overall Study|Lost to Follow-up|2
971716|NCT00615056|3198495|P1|Overall Study|Lost to Follow-up|1
971717|NCT00615056|3198492|P4|Overall Study|Death|23
971718|NCT00615056|3198493|P3|Overall Study|Death|21
971719|NCT00615056|3198494|P2|Overall Study|Death|31
971720|NCT00615056|3198495|P1|Overall Study|Death|31
971721|NCT00615030|3198525|P12|Period III|Administrative problems|0
971722|NCT00615030|3198526|P11|Period III|Administrative problems|0
971723|NCT00615030|3198527|P10|Period III|Administrative problems|0
971724|NCT00615030|3198528|P9|Period III|Administrative problems|0
971725|NCT00615030|3198529|P8|Period III|Administrative problems|0
971726|NCT00615030|3198530|P7|Period III|Administrative problems|0
971727|NCT00615030|3198531|P6|Period III|Administrative problems|0
971728|NCT00615030|3198532|P5|Period III|Administrative problems|0
971729|NCT00615030|3198533|P4|Period III|Administrative problems|1
971730|NCT00615030|3198534|P3|Period III|Administrative problems|0
971731|NCT00615030|3198535|P2|Period III|Administrative problems|0
971732|NCT00615030|3198536|P1|Period III|Administrative problems|1
971733|NCT00615030|3198525|P12|Period II|Subject withdrew consent|0
971734|NCT00615030|3198526|P11|Period II|Subject withdrew consent|0
971735|NCT00615030|3198527|P10|Period II|Subject withdrew consent|0
971736|NCT00615030|3198528|P9|Period II|Subject withdrew consent|0
971737|NCT00615030|3198529|P8|Period II|Subject withdrew consent|0
971738|NCT00615030|3198530|P7|Period II|Subject withdrew consent|1
971739|NCT00615030|3198531|P6|Period II|Subject withdrew consent|0
971740|NCT00615030|3198532|P5|Period II|Subject withdrew consent|0
971741|NCT00615030|3198533|P4|Period II|Subject withdrew consent|1
971742|NCT00615030|3198534|P3|Period II|Subject withdrew consent|0
971743|NCT00615030|3198535|P2|Period II|Subject withdrew consent|0
971744|NCT00615030|3198536|P1|Period II|Subject withdrew consent|0
971745|NCT00615030|3198525|P12|Period II|Adverse Event|0
971746|NCT00615030|3198526|P11|Period II|Adverse Event|0
971747|NCT00615030|3198527|P10|Period II|Adverse Event|0
971748|NCT00615030|3198528|P9|Period II|Adverse Event|1
971749|NCT00615030|3198529|P8|Period II|Adverse Event|0
971750|NCT00615030|3198530|P7|Period II|Adverse Event|0
971751|NCT00615030|3198531|P6|Period II|Adverse Event|0
971752|NCT00615030|3198532|P5|Period II|Adverse Event|0
971753|NCT00615030|3198533|P4|Period II|Adverse Event|0
971754|NCT00615030|3198534|P3|Period II|Adverse Event|1
971755|NCT00615030|3198535|P2|Period II|Adverse Event|0
971756|NCT00615030|3198536|P1|Period II|Adverse Event|0
971757|NCT00615030|3198525|P12|Period I|Abnormal laboratory value(s)|0
971758|NCT00615030|3198526|P11|Period I|Abnormal laboratory value(s)|0
971759|NCT00615030|3198527|P10|Period I|Abnormal laboratory value(s)|0
971760|NCT00615030|3198528|P9|Period I|Abnormal laboratory value(s)|0
971761|NCT00615030|3198529|P8|Period I|Abnormal laboratory value(s)|0
971762|NCT00615030|3198530|P7|Period I|Abnormal laboratory value(s)|0
971763|NCT00615030|3198531|P6|Period I|Abnormal laboratory value(s)|1
971764|NCT00615030|3198532|P5|Period I|Abnormal laboratory value(s)|0
971765|NCT00615030|3198533|P4|Period I|Abnormal laboratory value(s)|0
971766|NCT00615030|3198534|P3|Period I|Abnormal laboratory value(s)|0
971767|NCT00615030|3198535|P2|Period I|Abnormal laboratory value(s)|0
971768|NCT00615030|3198536|P1|Period I|Abnormal laboratory value(s)|0
971769|NCT00615030|3198525|P12|Period I|Subject withdrew consent|1
971770|NCT00615030|3198526|P11|Period I|Subject withdrew consent|1
971771|NCT00615030|3198527|P10|Period I|Subject withdrew consent|0
971772|NCT00615030|3198528|P9|Period I|Subject withdrew consent|1
971773|NCT00615030|3198529|P8|Period I|Subject withdrew consent|0
971774|NCT00615030|3198530|P7|Period I|Subject withdrew consent|0
971775|NCT00615030|3198531|P6|Period I|Subject withdrew consent|0
971776|NCT00615030|3198532|P5|Period I|Subject withdrew consent|0
971777|NCT00615030|3198533|P4|Period I|Subject withdrew consent|0
971778|NCT00615030|3198534|P3|Period I|Subject withdrew consent|0
971779|NCT00615030|3198535|P2|Period I|Subject withdrew consent|0
971780|NCT00615030|3198536|P1|Period I|Subject withdrew consent|0
971781|NCT00615030|3198525|P12|Period I|Protocol deviation|0
971782|NCT00615030|3198526|P11|Period I|Protocol deviation|0
971783|NCT00615030|3198527|P10|Period I|Protocol deviation|0
971784|NCT00615030|3198528|P9|Period I|Protocol deviation|0
971785|NCT00615030|3198529|P8|Period I|Protocol deviation|0
971786|NCT00615030|3198530|P7|Period I|Protocol deviation|0
971787|NCT00615030|3198531|P6|Period I|Protocol deviation|0
971788|NCT00615030|3198532|P5|Period I|Protocol deviation|0
971789|NCT00615030|3198533|P4|Period I|Protocol deviation|0
971790|NCT00615030|3198534|P3|Period I|Protocol deviation|0
971791|NCT00615030|3198535|P2|Period I|Protocol deviation|0
971792|NCT00615030|3198536|P1|Period I|Protocol deviation|1
971793|NCT00615030|3198525|P12|Period I|Administrative problem|0
971794|NCT00615030|3198526|P11|Period I|Administrative problem|0
971795|NCT00615030|3198527|P10|Period I|Administrative problem|0
971796|NCT00615030|3198528|P9|Period I|Administrative problem|0
971797|NCT00615030|3198529|P8|Period I|Administrative problem|0
971798|NCT00615030|3198530|P7|Period I|Administrative problem|0
971799|NCT00615030|3198531|P6|Period I|Administrative problem|0
971800|NCT00615030|3198532|P5|Period I|Administrative problem|1
971801|NCT00615030|3198533|P4|Period I|Administrative problem|0
971802|NCT00615030|3198534|P3|Period I|Administrative problem|0
971803|NCT00615030|3198535|P2|Period I|Administrative problem|0
971804|NCT00615030|3198536|P1|Period I|Administrative problem|0
971805|NCT00615017|3198556|P6|Overall Study|Physician discontinued drug|1
971806|NCT00615017|3198557|P5|Overall Study|Physician discontinued drug|0
971807|NCT00615017|3198558|P4|Overall Study|Physician discontinued drug|0
971808|NCT00615017|3198559|P3|Overall Study|Physician discontinued drug|0
971809|NCT00615017|3198560|P2|Overall Study|Physician discontinued drug|0
971810|NCT00615017|3198561|P1|Overall Study|Physician discontinued drug|0
971811|NCT00615017|3198556|P6|Overall Study|Transferred out of Intensive Care Unit|0
971812|NCT00615017|3198557|P5|Overall Study|Transferred out of Intensive Care Unit|0
971813|NCT00615017|3198558|P4|Overall Study|Transferred out of Intensive Care Unit|1
971814|NCT00615017|3198559|P3|Overall Study|Transferred out of Intensive Care Unit|0
971815|NCT00615017|3198560|P2|Overall Study|Transferred out of Intensive Care Unit|0
971816|NCT00615017|3198561|P1|Overall Study|Transferred out of Intensive Care Unit|0
971817|NCT00615017|3198556|P6|Overall Study|Sepsis resolved|0
971818|NCT00615017|3198557|P5|Overall Study|Sepsis resolved|0
971819|NCT00615017|3198558|P4|Overall Study|Sepsis resolved|0
971820|NCT00615017|3198559|P3|Overall Study|Sepsis resolved|1
971821|NCT00615017|3198560|P2|Overall Study|Sepsis resolved|0
971822|NCT00615017|3198561|P1|Overall Study|Sepsis resolved|0
971823|NCT00615017|3198556|P6|Overall Study|Death|1
971824|NCT00615017|3198557|P5|Overall Study|Death|1
971825|NCT00615017|3198558|P4|Overall Study|Death|0
971826|NCT00615017|3198559|P3|Overall Study|Death|2
971827|NCT00615017|3198560|P2|Overall Study|Death|0
971828|NCT00615017|3198561|P1|Overall Study|Death|0
971829|NCT00615017|3198556|P6|Overall Study|Adverse Event|1
971830|NCT00615017|3198557|P5|Overall Study|Adverse Event|0
971831|NCT00615017|3198558|P4|Overall Study|Adverse Event|0
971832|NCT00615017|3198559|P3|Overall Study|Adverse Event|2
971833|NCT00615017|3198560|P2|Overall Study|Adverse Event|1
971834|NCT00615017|3198561|P1|Overall Study|Adverse Event|0
971835|NCT00614991|3198719|P6|Overall Study|Adverse Event|0
971836|NCT00614991|3198720|P5|Overall Study|Adverse Event|1
971837|NCT00614991|3198721|P4|Overall Study|Adverse Event|0
971838|NCT00614991|3198722|P3|Overall Study|Adverse Event|0
971839|NCT00614991|3198723|P2|Overall Study|Adverse Event|3
971840|NCT00614991|3198724|P1|Overall Study|Adverse Event|3
971841|NCT00614939|3198758|P2|Overall Study|Hospitalized due to kidney transplant|0
971842|NCT00614939|3198759|P1|Overall Study|Hospitalized due to kidney transplant|1
971843|NCT00614939|3198758|P2|Overall Study|Poor/non-compliance|0
971844|NCT00614939|3198759|P1|Overall Study|Poor/non-compliance|4
971845|NCT00614939|3198758|P2|Overall Study|Death|3
971846|NCT00614939|3198759|P1|Overall Study|Death|4
971847|NCT00614939|3198758|P2|Overall Study|Incorrect enrollment|2
971848|NCT00614939|3198759|P1|Overall Study|Incorrect enrollment|1
971849|NCT00614939|3198758|P2|Overall Study|Adverse Event|5
971850|NCT00614939|3198759|P1|Overall Study|Adverse Event|2
971851|NCT00614939|3198758|P2|Overall Study|Study specific discontinuation criteris|16
971852|NCT00614939|3198759|P1|Overall Study|Study specific discontinuation criteris|13
971853|NCT00614939|3198758|P2|Overall Study|Withdrawal by Subject|17
971854|NCT00614939|3198759|P1|Overall Study|Withdrawal by Subject|10
971855|NCT00614926|3198793|P2|Overall Study|Adverse Event|0
971856|NCT00614926|3198794|P1|Overall Study|Adverse Event|3
971857|NCT00614926|3198793|P2|Overall Study|Burden of travel|0
971858|NCT00614926|3198794|P1|Overall Study|Burden of travel|1
971859|NCT00614874|3198807|P1|Overall Study|Withdrawal by Subject|1
971860|NCT00614874|3198807|P1|Overall Study|Protocol Violation|1
971861|NCT00614744|3198816|P2|Overall Study|Incomplete for Behavior Issues|2
971862|NCT00614744|3198817|P1|Overall Study|Incomplete for Behavior Issues|0
971863|NCT00614744|3198816|P2|Overall Study|Lost to Follow-up|4
971864|NCT00614744|3198817|P1|Overall Study|Lost to Follow-up|5
971865|NCT00614614|3198843|P5|Booster Vaccination Phase|Other|1
971866|NCT00614614|3198844|P4|Booster Vaccination Phase|Other|2
971867|NCT00614614|3198845|P3|Booster Vaccination Phase|Other|3
971868|NCT00614614|3198846|P2|Booster Vaccination Phase|Other|1
971869|NCT00614614|3198847|P1|Booster Vaccination Phase|Other|0
971870|NCT00614614|3198843|P5|Booster Vaccination Phase|Protocol Violation|0
971871|NCT00614614|3198844|P4|Booster Vaccination Phase|Protocol Violation|3
971872|NCT00614614|3198845|P3|Booster Vaccination Phase|Protocol Violation|2
971873|NCT00614614|3198846|P2|Booster Vaccination Phase|Protocol Violation|0
971874|NCT00614614|3198847|P1|Booster Vaccination Phase|Protocol Violation|0
971875|NCT00614614|3198843|P5|Booster Vaccination Phase|Lost to Follow-up|8
971876|NCT00614614|3198844|P4|Booster Vaccination Phase|Lost to Follow-up|10
971877|NCT00614614|3198845|P3|Booster Vaccination Phase|Lost to Follow-up|17
971878|NCT00614614|3198846|P2|Booster Vaccination Phase|Lost to Follow-up|5
971879|NCT00614614|3198847|P1|Booster Vaccination Phase|Lost to Follow-up|0
971880|NCT00614614|3198843|P5|Booster Vaccination Phase|Withdrawal by Subject|4
971881|NCT00614614|3198844|P4|Booster Vaccination Phase|Withdrawal by Subject|3
971882|NCT00614614|3198845|P3|Booster Vaccination Phase|Withdrawal by Subject|4
971883|NCT00614614|3198846|P2|Booster Vaccination Phase|Withdrawal by Subject|0
971884|NCT00614614|3198847|P1|Booster Vaccination Phase|Withdrawal by Subject|0
971885|NCT00614614|3198843|P5|Booster Vaccination Phase|Adverse Event|0
971886|NCT00614614|3198844|P4|Booster Vaccination Phase|Adverse Event|1
971887|NCT00614614|3198845|P3|Booster Vaccination Phase|Adverse Event|1
971888|NCT00614614|3198846|P2|Booster Vaccination Phase|Adverse Event|0
971889|NCT00614614|3198847|P1|Booster Vaccination Phase|Adverse Event|0
971890|NCT00614614|3198843|P5|Primary Vaccination Phase|Other|0
971891|NCT00614614|3198844|P4|Primary Vaccination Phase|Other|0
971892|NCT00614614|3198845|P3|Primary Vaccination Phase|Other|0
971893|NCT00614614|3198846|P2|Primary Vaccination Phase|Other|0
971894|NCT00614614|3198847|P1|Primary Vaccination Phase|Other|4
971895|NCT00614614|3198843|P5|Primary Vaccination Phase|Protocol Violation|0
971896|NCT00614614|3198844|P4|Primary Vaccination Phase|Protocol Violation|0
971897|NCT00614614|3198845|P3|Primary Vaccination Phase|Protocol Violation|0
971898|NCT00614614|3198846|P2|Primary Vaccination Phase|Protocol Violation|3
971899|NCT00614614|3198847|P1|Primary Vaccination Phase|Protocol Violation|9
971900|NCT00614614|3198843|P5|Primary Vaccination Phase|Lost to Follow-up|0
971901|NCT00614614|3198844|P4|Primary Vaccination Phase|Lost to Follow-up|0
971902|NCT00614614|3198845|P3|Primary Vaccination Phase|Lost to Follow-up|0
971903|NCT00614614|3198846|P2|Primary Vaccination Phase|Lost to Follow-up|8
971904|NCT00614614|3198847|P1|Primary Vaccination Phase|Lost to Follow-up|26
971905|NCT00614614|3198843|P5|Primary Vaccination Phase|Withdrawal by Subject|0
971906|NCT00614614|3198844|P4|Primary Vaccination Phase|Withdrawal by Subject|0
971907|NCT00614614|3198845|P3|Primary Vaccination Phase|Withdrawal by Subject|0
971908|NCT00614614|3198846|P2|Primary Vaccination Phase|Withdrawal by Subject|6
971909|NCT00614614|3198847|P1|Primary Vaccination Phase|Withdrawal by Subject|45
971910|NCT00614614|3198843|P5|Primary Vaccination Phase|Adverse Event|0
971911|NCT00614614|3198844|P4|Primary Vaccination Phase|Adverse Event|0
971912|NCT00614614|3198845|P3|Primary Vaccination Phase|Adverse Event|0
971913|NCT00614614|3198846|P2|Primary Vaccination Phase|Adverse Event|0
971914|NCT00614614|3198847|P1|Primary Vaccination Phase|Adverse Event|6
971915|NCT00614575|3198970|P1|Overall Study|No treatment|1
971916|NCT00614575|3198970|P1|Overall Study|Irregularly enrolled patients|23
971917|NCT00614575|3198970|P1|Overall Study|No data were collected.|18
971918|NCT00614575|3198970|P1|Overall Study|Physician Decision|2
971919|NCT00614575|3198970|P1|Overall Study|Death|3
971920|NCT00614575|3198970|P1|Overall Study|Withdrawal by Subject|6
971921|NCT00614575|3198970|P1|Overall Study|Lack of Efficacy|14
971922|NCT00614575|3198970|P1|Overall Study|Lost to Follow-up|55
971923|NCT00614575|3198970|P1|Overall Study|Adverse Event|106
971924|NCT00614523|3198981|P2|Overall Study|Administrative Decision|46
971925|NCT00614523|3198982|P1|Overall Study|Administrative Decision|23
971926|NCT00614523|3198981|P2|Overall Study|Disease Progression|8
971927|NCT00614523|3198982|P1|Overall Study|Disease Progression|0
971928|NCT00614523|3198981|P2|Overall Study|Ineligibility Determined|2
971929|NCT00614523|3198982|P1|Overall Study|Ineligibility Determined|1
971930|NCT00614523|3198981|P2|Overall Study|Other|11
971931|NCT00614523|3198982|P1|Overall Study|Other|6
971932|NCT00614523|3198981|P2|Overall Study|Withdrawal by Subject|22
971933|NCT00614523|3198982|P1|Overall Study|Withdrawal by Subject|12
971934|NCT00614523|3198981|P2|Overall Study|Protocol Violation|2
971935|NCT00614523|3198982|P1|Overall Study|Protocol Violation|3
971936|NCT00614523|3198981|P2|Overall Study|Lost to Follow-up|1
971937|NCT00614523|3198982|P1|Overall Study|Lost to Follow-up|0
971938|NCT00614523|3198981|P2|Overall Study|Lack of Efficacy|11
971939|NCT00614523|3198982|P1|Overall Study|Lack of Efficacy|9
971940|NCT00614523|3198981|P2|Overall Study|Death|8
971941|NCT00614523|3198982|P1|Overall Study|Death|5
971942|NCT00614523|3198981|P2|Overall Study|Adverse Event|20
971943|NCT00614523|3198982|P1|Overall Study|Adverse Event|4
971944|NCT00614393|3199038|P5|Overall Study|Not Treated|2
971945|NCT00614393|3199039|P4|Overall Study|Not Treated|0
971946|NCT00614393|3199040|P3|Overall Study|Not Treated|0
971947|NCT00614393|3199041|P2|Overall Study|Not Treated|0
971948|NCT00614393|3199042|P1|Overall Study|Not Treated|0
971949|NCT00614393|3199038|P5|Overall Study|Other|2
971950|NCT00614393|3199039|P4|Overall Study|Other|4
971951|NCT00614393|3199040|P3|Overall Study|Other|0
971952|NCT00614393|3199041|P2|Overall Study|Other|0
971953|NCT00614393|3199042|P1|Overall Study|Other|4
971954|NCT00614393|3199038|P5|Overall Study|Withdrawal by Subject|13
971955|NCT00614393|3199039|P4|Overall Study|Withdrawal by Subject|16
971956|NCT00614393|3199040|P3|Overall Study|Withdrawal by Subject|1
971957|NCT00614393|3199041|P2|Overall Study|Withdrawal by Subject|1
971958|NCT00614393|3199042|P1|Overall Study|Withdrawal by Subject|20
971959|NCT00614393|3199038|P5|Overall Study|Terminated by Sponsor|1
971960|NCT00614393|3199039|P4|Overall Study|Terminated by Sponsor|0
971961|NCT00614393|3199040|P3|Overall Study|Terminated by Sponsor|0
971962|NCT00614393|3199041|P2|Overall Study|Terminated by Sponsor|0
971963|NCT00614393|3199042|P1|Overall Study|Terminated by Sponsor|0
971964|NCT00614393|3199038|P5|Overall Study|Protocol Violation|0
971965|NCT00614393|3199039|P4|Overall Study|Protocol Violation|0
971966|NCT00614393|3199040|P3|Overall Study|Protocol Violation|0
971967|NCT00614393|3199041|P2|Overall Study|Protocol Violation|0
971968|NCT00614393|3199042|P1|Overall Study|Protocol Violation|1
971969|NCT00614393|3199038|P5|Overall Study|Progressive Disease|130
971970|NCT00614393|3199039|P4|Overall Study|Progressive Disease|138
971971|NCT00614393|3199040|P3|Overall Study|Progressive Disease|5
971972|NCT00614393|3199041|P2|Overall Study|Progressive Disease|5
971973|NCT00614393|3199042|P1|Overall Study|Progressive Disease|118
971974|NCT00614393|3199038|P5|Overall Study|Physician Decision|9
971975|NCT00614393|3199039|P4|Overall Study|Physician Decision|8
971976|NCT00614393|3199040|P3|Overall Study|Physician Decision|1
971977|NCT00614393|3199041|P2|Overall Study|Physician Decision|0
971978|NCT00614393|3199042|P1|Overall Study|Physician Decision|17
971979|NCT00614393|3199038|P5|Overall Study|Lost to Follow-up|2
971980|NCT00614393|3199039|P4|Overall Study|Lost to Follow-up|1
971981|NCT00614393|3199040|P3|Overall Study|Lost to Follow-up|0
971982|NCT00614393|3199041|P2|Overall Study|Lost to Follow-up|0
971983|NCT00614393|3199042|P1|Overall Study|Lost to Follow-up|0
971984|NCT00614393|3199038|P5|Overall Study|Adverse Event|21
971985|NCT00614393|3199039|P4|Overall Study|Adverse Event|13
971986|NCT00614393|3199040|P3|Overall Study|Adverse Event|3
971987|NCT00614393|3199041|P2|Overall Study|Adverse Event|2
971988|NCT00614393|3199042|P1|Overall Study|Adverse Event|20
971989|NCT00614380|3199088|P4|Overall Study|Consent withdrawn|0
971990|NCT00614380|3199089|P3|Overall Study|Consent withdrawn|0
971991|NCT00614380|3199090|P2|Overall Study|Consent withdrawn|1
971992|NCT00614380|3199091|P1|Overall Study|Consent withdrawn|3
971993|NCT00614380|3199088|P4|Overall Study|Non compliant with the protocol|2
971994|NCT00614380|3199089|P3|Overall Study|Non compliant with the protocol|1
971995|NCT00614380|3199090|P2|Overall Study|Non compliant with the protocol|2
971996|NCT00614380|3199091|P1|Overall Study|Non compliant with the protocol|12
971997|NCT00614380|3199088|P4|Overall Study|Lost to Follow-up|0
971998|NCT00614380|3199089|P3|Overall Study|Lost to Follow-up|0
971999|NCT00614380|3199090|P2|Overall Study|Lost to Follow-up|1
972000|NCT00614380|3199091|P1|Overall Study|Lost to Follow-up|6
972001|NCT00614380|3199088|P4|Overall Study|Adverse Event|0
972002|NCT00614380|3199089|P3|Overall Study|Adverse Event|0
972003|NCT00614380|3199090|P2|Overall Study|Adverse Event|4
972004|NCT00614380|3199091|P1|Overall Study|Adverse Event|14
972005|NCT00614120|3199158|P4|Overall Study|Lost to Follow-up|4
972006|NCT00614120|3199159|P3|Overall Study|Lost to Follow-up|3
972007|NCT00614120|3199160|P2|Overall Study|Lost to Follow-up|2
972008|NCT00614120|3199161|P1|Overall Study|Lost to Follow-up|1
972009|NCT00614120|3199158|P4|Overall Study|Taken inhibition medication eg Prandin|1
972010|NCT00614120|3199159|P3|Overall Study|Taken inhibition medication eg Prandin|1
972011|NCT00614120|3199160|P2|Overall Study|Taken inhibition medication eg Prandin|0
972012|NCT00614120|3199161|P1|Overall Study|Taken inhibition medication eg Prandin|0
972013|NCT00614120|3199158|P4|Overall Study|Late syphilis, latent|0
972014|NCT00614120|3199159|P3|Overall Study|Late syphilis, latent|0
972015|NCT00614120|3199160|P2|Overall Study|Late syphilis, latent|0
972016|NCT00614120|3199161|P1|Overall Study|Late syphilis, latent|1
972017|NCT00614120|3199158|P4|Overall Study|Lack of trial product|0
972018|NCT00614120|3199159|P3|Overall Study|Lack of trial product|2
972019|NCT00614120|3199160|P2|Overall Study|Lack of trial product|3
972020|NCT00614120|3199161|P1|Overall Study|Lack of trial product|3
972021|NCT00614120|3199158|P4|Overall Study|Hypoglycaemia|1
972022|NCT00614120|3199159|P3|Overall Study|Hypoglycaemia|0
972023|NCT00614120|3199160|P2|Overall Study|Hypoglycaemia|0
972024|NCT00614120|3199161|P1|Overall Study|Hypoglycaemia|0
972025|NCT00614120|3199158|P4|Overall Study|hCG positive (not pregnant)|0
972026|NCT00614120|3199159|P3|Overall Study|hCG positive (not pregnant)|1
972027|NCT00614120|3199160|P2|Overall Study|hCG positive (not pregnant)|0
972028|NCT00614120|3199161|P1|Overall Study|hCG positive (not pregnant)|0
972029|NCT00614120|3199158|P4|Overall Study|Did not meet trial criteria|1
972030|NCT00614120|3199159|P3|Overall Study|Did not meet trial criteria|1
972031|NCT00614120|3199160|P2|Overall Study|Did not meet trial criteria|1
972032|NCT00614120|3199161|P1|Overall Study|Did not meet trial criteria|0
972033|NCT00614120|3199158|P4|Overall Study|Withdrawal by Subject|3
972034|NCT00614120|3199159|P3|Overall Study|Withdrawal by Subject|16
972035|NCT00614120|3199160|P2|Overall Study|Withdrawal by Subject|10
972036|NCT00614120|3199161|P1|Overall Study|Withdrawal by Subject|9
972037|NCT00614120|3199158|P4|Overall Study|Withdrawal criteria|0
972038|NCT00614120|3199159|P3|Overall Study|Withdrawal criteria|0
972039|NCT00614120|3199160|P2|Overall Study|Withdrawal criteria|0
972040|NCT00614120|3199161|P1|Overall Study|Withdrawal criteria|1
972041|NCT00614120|3199158|P4|Overall Study|Protocol Violation|1
972042|NCT00614120|3199159|P3|Overall Study|Protocol Violation|3
972043|NCT00614120|3199160|P2|Overall Study|Protocol Violation|5
972044|NCT00614120|3199161|P1|Overall Study|Protocol Violation|2
972045|NCT00614120|3199158|P4|Overall Study|Lack of Efficacy|2
972046|NCT00614120|3199159|P3|Overall Study|Lack of Efficacy|2
972047|NCT00614120|3199160|P2|Overall Study|Lack of Efficacy|3
972048|NCT00614120|3199161|P1|Overall Study|Lack of Efficacy|3
972049|NCT00614120|3199158|P4|Overall Study|Adverse Event|3
972050|NCT00614120|3199159|P3|Overall Study|Adverse Event|30
972051|NCT00614120|3199160|P2|Overall Study|Adverse Event|22
972052|NCT00614120|3199161|P1|Overall Study|Adverse Event|9
972053|NCT00614055|3199202|P3|Overall Study|Unclassified|2
972054|NCT00614055|3199203|P2|Overall Study|Unclassified|4
972055|NCT00614055|3199204|P1|Overall Study|Unclassified|1
972056|NCT00614055|3199202|P3|Overall Study|Lack of Efficacy|2
972057|NCT00614055|3199203|P2|Overall Study|Lack of Efficacy|0
972058|NCT00614055|3199204|P1|Overall Study|Lack of Efficacy|0
972059|NCT00614055|3199202|P3|Overall Study|Protocol Violation|1
972060|NCT00614055|3199203|P2|Overall Study|Protocol Violation|2
972061|NCT00614055|3199204|P1|Overall Study|Protocol Violation|2
972062|NCT00614055|3199202|P3|Overall Study|Adverse Event|0
972063|NCT00614055|3199203|P2|Overall Study|Adverse Event|0
972064|NCT00614055|3199204|P1|Overall Study|Adverse Event|1
972065|NCT00613951|3199251|P3|Overall Study|Unclassified|2
972066|NCT00613951|3199252|P2|Overall Study|Unclassified|3
972067|NCT00613951|3199253|P1|Overall Study|Unclassified|5
972068|NCT00613951|3199251|P3|Overall Study|Protocol Violation|1
972069|NCT00613951|3199252|P2|Overall Study|Protocol Violation|1
972070|NCT00613951|3199253|P1|Overall Study|Protocol Violation|1
972071|NCT00613951|3199251|P3|Overall Study|Lack of Efficacy|1
972072|NCT00613951|3199252|P2|Overall Study|Lack of Efficacy|1
972073|NCT00613951|3199253|P1|Overall Study|Lack of Efficacy|0
972074|NCT00613951|3199251|P3|Overall Study|Adverse Event|1
972075|NCT00613951|3199252|P2|Overall Study|Adverse Event|0
972076|NCT00613951|3199253|P1|Overall Study|Adverse Event|1
972077|NCT00613938|3199298|P4|Overall Study|Other|3
972078|NCT00613938|3199299|P3|Overall Study|Other|1
972079|NCT00613938|3199300|P2|Overall Study|Other|2
972080|NCT00613938|3199301|P1|Overall Study|Other|1
972081|NCT00613938|3199298|P4|Overall Study|Lack of Efficacy|9
972082|NCT00613938|3199299|P3|Overall Study|Lack of Efficacy|5
972083|NCT00613938|3199300|P2|Overall Study|Lack of Efficacy|18
972084|NCT00613938|3199301|P1|Overall Study|Lack of Efficacy|16
972085|NCT00613938|3199298|P4|Overall Study|Adverse Event|5
972086|NCT00613938|3199299|P3|Overall Study|Adverse Event|8
972087|NCT00613938|3199300|P2|Overall Study|Adverse Event|4
972088|NCT00613938|3199301|P1|Overall Study|Adverse Event|1
972089|NCT00613938|3199298|P4|Overall Study|Withdrawal by Subject|9
972090|NCT00613938|3199299|P3|Overall Study|Withdrawal by Subject|9
972091|NCT00613938|3199300|P2|Overall Study|Withdrawal by Subject|4
972092|NCT00613938|3199301|P1|Overall Study|Withdrawal by Subject|2
972093|NCT00613925|3199333|P2|Overall Study|1 did not tolerate outpatient biopsy|1
972094|NCT00613925|3199334|P1|Overall Study|1 did not tolerate outpatient biopsy|0
972095|NCT00613821|3199344|P2|Overall Study|Physician Decision|1
972096|NCT00613821|3199345|P1|Overall Study|Physician Decision|1
972097|NCT00613821|3199344|P2|Overall Study|Withdrawal by Subject|0
972098|NCT00613821|3199345|P1|Overall Study|Withdrawal by Subject|1
972099|NCT00613730|3199351|P1|Overall Study|Administrative decision|1
972100|NCT00613730|3199351|P1|Overall Study|Disease progression|2
972101|NCT00613626|3199360|P3|Overall Study|Ineligible|0
972102|NCT00613626|3199361|P2|Overall Study|Ineligible|1
972103|NCT00613626|3199362|P1|Overall Study|Ineligible|0
972104|NCT00613574|3199378|P1|Overall Study|Other|1
972105|NCT00613574|3199378|P1|Overall Study|Lost to Follow-up|2
972106|NCT00613574|3199378|P1|Overall Study|Adverse Event|3
972107|NCT00613509|3199390|P2|Cycle 1|Other administrative reason|1
972108|NCT00613509|3199391|P1|Cycle 1|Other administrative reason|0
972109|NCT00613509|3199390|P2|Cycle 1|Unacceptable Toxicity|0
972110|NCT00613509|3199391|P1|Cycle 1|Unacceptable Toxicity|1
972111|NCT00613509|3199390|P2|Cycle 1|Disease Progression|6
972112|NCT00613509|3199391|P1|Cycle 1|Disease Progression|2
972113|NCT00613509|3199390|P2|Cycle 1|Adverse Event|1
972114|NCT00613509|3199391|P1|Cycle 1|Adverse Event|2
972115|NCT00613366|3199437|P2|Overall Study|Withdrawal by Subject|2
972116|NCT00613366|3199438|P1|Overall Study|Withdrawal by Subject|3
972117|NCT00613327|3199446|P1|Overall Study|Other|47
972118|NCT00613327|3199446|P1|Overall Study|Protocol Violation|2
972119|NCT00613327|3199446|P1|Overall Study|Withdrawal by Subject|6
972120|NCT00613327|3199446|P1|Overall Study|Lost to Follow-up|8
972121|NCT00613327|3199446|P1|Overall Study|Adverse Event|38
972122|NCT00613314|3199465|P1|Overall Study|Other reason not defined above|90
972123|NCT00613314|3199465|P1|Overall Study|Lost to Follow-up|46
972124|NCT00613314|3199465|P1|Overall Study|Protocol Violation|14
972125|NCT00613314|3199465|P1|Overall Study|Adverse Event|5
972126|NCT00613301|3199473|P1|Overall Study|Irregularly enrolled patients|12
972127|NCT00613301|3199473|P1|Overall Study|No data was collected|53
972128|NCT00613301|3199473|P1|Overall Study|Physician Decision|2
972129|NCT00613301|3199473|P1|Overall Study|Lack of Efficacy|13
972130|NCT00613301|3199473|P1|Overall Study|Death|6
972131|NCT00613301|3199473|P1|Overall Study|Withdrawal by Subject|5
972132|NCT00613301|3199473|P1|Overall Study|Lost to Follow-up|88
972133|NCT00613301|3199473|P1|Overall Study|Adverse Event|49
972134|NCT00613106|3199482|P2|Overall Study|misc|3
972135|NCT00613106|3199483|P1|Overall Study|misc|4
972136|NCT00613106|3199482|P2|Overall Study|Lost to Follow-up|2
972137|NCT00613106|3199483|P1|Overall Study|Lost to Follow-up|7
972138|NCT00613106|3199482|P2|Overall Study|Withdrawal by Subject|3
972139|NCT00613106|3199483|P1|Overall Study|Withdrawal by Subject|6
972140|NCT00613106|3199482|P2|Overall Study|Adverse Event|1
972141|NCT00613106|3199483|P1|Overall Study|Adverse Event|3
972142|NCT00613080|3199489|P1|Overall Study|Ineligible / no protocol treatment|11
972143|NCT00613015|3199524|P6|Overall Study|Lost to Follow-up|3
972144|NCT00613015|3199525|P5|Overall Study|Lost to Follow-up|2
972145|NCT00613015|3199526|P4|Overall Study|Lost to Follow-up|3
972146|NCT00613015|3199527|P3|Overall Study|Lost to Follow-up|3
972147|NCT00613015|3199528|P2|Overall Study|Lost to Follow-up|1
972148|NCT00613015|3199529|P1|Overall Study|Lost to Follow-up|0
972149|NCT00612807|3199565|P2|Overall Study|Withdrawal by Subject|0
972150|NCT00612807|3199566|P1|Overall Study|Withdrawal by Subject|2
972151|NCT00612690|3199601|P2|Overall Study|Withdrawal by Site|0
972152|NCT00612690|3199602|P1|Overall Study|Withdrawal by Site|11
972153|NCT00612690|3199601|P2|Overall Study|Withdrawal by Subject|20
972154|NCT00612690|3199602|P1|Overall Study|Withdrawal by Subject|32
972155|NCT00612690|3199601|P2|Overall Study|Lost to Follow-up|98
972156|NCT00612690|3199602|P1|Overall Study|Lost to Follow-up|72
972157|NCT00612677|3199610|P1|Overall Study|study closed before treatment started|1
972158|NCT00612534|3199678|P4|Overall Study|Other Reason|0
972159|NCT00612534|3199679|P3|Overall Study|Other Reason|0
972160|NCT00612534|3199680|P2|Overall Study|Other Reason|1
972161|NCT00612534|3199681|P1|Overall Study|Other Reason|0
972162|NCT00612534|3199678|P4|Overall Study|Lack of Efficacy|16
972163|NCT00612534|3199679|P3|Overall Study|Lack of Efficacy|5
972164|NCT00612534|3199680|P2|Overall Study|Lack of Efficacy|12
972165|NCT00612534|3199681|P1|Overall Study|Lack of Efficacy|13
972166|NCT00612534|3199678|P4|Overall Study|Adverse Event|1
972167|NCT00612534|3199679|P3|Overall Study|Adverse Event|2
972168|NCT00612534|3199680|P2|Overall Study|Adverse Event|4
972169|NCT00612534|3199681|P1|Overall Study|Adverse Event|0
972170|NCT00612508|3199693|P2|Overall Study|Withdrawal by Subject|4
972171|NCT00612508|3199694|P1|Overall Study|Withdrawal by Subject|3
972172|NCT00612456|3199705|P3|Overall Study|Withdrawal by Subject|0
972173|NCT00612456|3199706|P2|Overall Study|Withdrawal by Subject|1
972174|NCT00612456|3199707|P1|Overall Study|Withdrawal by Subject|0
972175|NCT00612456|3199705|P3|Overall Study|Lack of Efficacy|0
972176|NCT00612456|3199706|P2|Overall Study|Lack of Efficacy|1
972177|NCT00612456|3199707|P1|Overall Study|Lack of Efficacy|1
972178|NCT00612456|3199705|P3|Overall Study|Adverse Event|0
972179|NCT00612456|3199706|P2|Overall Study|Adverse Event|0
972180|NCT00612456|3199707|P1|Overall Study|Adverse Event|1
972181|NCT00612352|3199770|P2|Overall Study|didn't return calls/show up on test date|1
972182|NCT00612352|3199771|P1|Overall Study|didn't return calls/show up on test date|4
972183|NCT00612352|3199770|P2|Overall Study|moved out of state|0
972184|NCT00612352|3199771|P1|Overall Study|moved out of state|1
972185|NCT00612352|3199770|P2|Overall Study|Withdrawal by Subject|5
972186|NCT00612352|3199771|P1|Overall Study|Withdrawal by Subject|3
972187|NCT00612352|3199770|P2|Overall Study|Adverse Event|0
972188|NCT00612352|3199771|P1|Overall Study|Adverse Event|1
972189|NCT00612313|3199891|P2|Overall Study|Lost to Follow-up|4
972190|NCT00612313|3199892|P1|Overall Study|Lost to Follow-up|11
972191|NCT00612313|3199891|P2|Overall Study|Withdrawal by Subject|9
972192|NCT00612313|3199892|P1|Overall Study|Withdrawal by Subject|6
972193|NCT00612105|3199934|P2|Period Title 3: 3-Week Taper Phase|Other|0
972194|NCT00612105|3199935|P1|Period Title 3: 3-Week Taper Phase|Other|1
972195|NCT00612105|3199934|P2|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0
972196|NCT00612105|3199935|P1|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1
972197|NCT00612105|3199934|P2|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
972198|NCT00612105|3199935|P1|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
972199|NCT00612105|3199934|P2|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1
972200|NCT00612105|3199935|P1|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9
972201|NCT00612105|3199934|P2|Period Title 1: 6-Week Titration Phase|Other|1
972202|NCT00612105|3199935|P1|Period Title 1: 6-Week Titration Phase|Other|0
972203|NCT00612105|3199934|P2|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0
972204|NCT00612105|3199935|P1|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5
972205|NCT00612105|3199934|P2|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1
972206|NCT00612105|3199935|P1|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3
972207|NCT00612105|3199934|P2|Period Title 1: 6-Week Titration Phase|Protocol Violation|0
972208|NCT00612105|3199935|P1|Period Title 1: 6-Week Titration Phase|Protocol Violation|1
972209|NCT00612105|3199934|P2|Period Title 1: 6-Week Titration Phase|Physician Decision|1
972210|NCT00612105|3199935|P1|Period Title 1: 6-Week Titration Phase|Physician Decision|1
972211|NCT00612105|3199934|P2|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0
972212|NCT00612105|3199935|P1|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2
972213|NCT00612105|3199934|P2|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1
972214|NCT00612105|3199935|P1|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6
972215|NCT00612105|3199934|P2|Period Title 1: 6-Week Titration Phase|Adverse Event|1
972216|NCT00612105|3199935|P1|Period Title 1: 6-Week Titration Phase|Adverse Event|18
972217|NCT00612066|3199985|P1|Overall Study|Adverse Event|1
972218|NCT00612040|3199992|P3|Overall Study|Unclassified|5
972219|NCT00612040|3199993|P2|Overall Study|Unclassified|2
972220|NCT00612040|3199994|P1|Overall Study|Unclassified|2
972221|NCT00612040|3199992|P3|Overall Study|Lack of Efficacy|0
972222|NCT00612040|3199993|P2|Overall Study|Lack of Efficacy|1
972223|NCT00612040|3199994|P1|Overall Study|Lack of Efficacy|2
972224|NCT00612040|3199992|P3|Overall Study|Protocol Violation|1
972225|NCT00612040|3199993|P2|Overall Study|Protocol Violation|2
972226|NCT00612040|3199994|P1|Overall Study|Protocol Violation|1
972227|NCT00612040|3199992|P3|Overall Study|Adverse Event|1
972228|NCT00612040|3199993|P2|Overall Study|Adverse Event|2
972229|NCT00612040|3199994|P1|Overall Study|Adverse Event|0
972230|NCT00611884|3200067|P4|Overall Study|Unclassified|3
972231|NCT00611884|3200068|P3|Overall Study|Unclassified|2
972232|NCT00611884|3200069|P2|Overall Study|Unclassified|4
972233|NCT00611884|3200070|P1|Overall Study|Unclassified|7
972234|NCT00611884|3200067|P4|Overall Study|Lack of Efficacy|0
972235|NCT00611884|3200068|P3|Overall Study|Lack of Efficacy|0
972236|NCT00611884|3200069|P2|Overall Study|Lack of Efficacy|1
972237|NCT00611884|3200070|P1|Overall Study|Lack of Efficacy|0
972238|NCT00611884|3200067|P4|Overall Study|Non-Compliance|2
972239|NCT00611884|3200068|P3|Overall Study|Non-Compliance|2
972240|NCT00611884|3200069|P2|Overall Study|Non-Compliance|4
972241|NCT00611884|3200070|P1|Overall Study|Non-Compliance|1
972242|NCT00611884|3200067|P4|Overall Study|Adverse Event|1
972243|NCT00611884|3200068|P3|Overall Study|Adverse Event|0
972244|NCT00611884|3200069|P2|Overall Study|Adverse Event|0
972245|NCT00611884|3200070|P1|Overall Study|Adverse Event|1
972246|NCT00611858|3200124|P1|Overall Study|Withdrawal by Subject|2
972247|NCT00611858|3200124|P1|Overall Study|Adverse Event|2
972248|NCT00611806|3200136|P2|Overall Study|Lost to Follow-up|0
972249|NCT00611806|3200137|P1|Overall Study|Lost to Follow-up|6
972250|NCT00611806|3200136|P2|Overall Study|Adverse Event|1
972251|NCT00611806|3200137|P1|Overall Study|Adverse Event|2
972252|NCT00611806|3200136|P2|Overall Study|Withdrawal by Subject|2
972253|NCT00611806|3200137|P1|Overall Study|Withdrawal by Subject|8
972254|NCT00611767|3200151|P2|Overall Study|Physician Decision|0
972255|NCT00611767|3200152|P1|Overall Study|Physician Decision|1
972256|NCT00611767|3200151|P2|Overall Study|didn't like the medication|1
972257|NCT00611767|3200152|P1|Overall Study|didn't like the medication|1
972258|NCT00611767|3200151|P2|Overall Study|Thiopental not available|0
972259|NCT00611767|3200152|P1|Overall Study|Thiopental not available|3
972260|NCT00611767|3200151|P2|Overall Study|Withdrawal by Subject|1
972261|NCT00611767|3200152|P1|Overall Study|Withdrawal by Subject|4
972262|NCT00611715|3200314|P2|Overall Study|two patients are still on treatment|0
972263|NCT00611715|3200315|P1|Overall Study|two patients are still on treatment|2
972264|NCT00611715|3200314|P2|Overall Study|Death|0
972265|NCT00611715|3200315|P1|Overall Study|Death|1
972266|NCT00611715|3200314|P2|Overall Study|Adverse Event|1
972267|NCT00611715|3200315|P1|Overall Study|Adverse Event|9
972268|NCT00611715|3200314|P2|Overall Study|Withdrawal by Subject|1
972269|NCT00611715|3200315|P1|Overall Study|Withdrawal by Subject|5
972270|NCT00611715|3200314|P2|Overall Study|Disease Progression|4
972271|NCT00611715|3200315|P1|Overall Study|Disease Progression|24
972272|NCT00611559|3200335|P3|Overall Study|Protocol Violation|1
972273|NCT00611559|3200336|P2|Overall Study|Protocol Violation|0
972274|NCT00611559|3200337|P1|Overall Study|Protocol Violation|1
972275|NCT00611559|3200335|P3|Overall Study|Lost to Follow-up|0
972276|NCT00611559|3200336|P2|Overall Study|Lost to Follow-up|1
972277|NCT00611559|3200337|P1|Overall Study|Lost to Follow-up|0
972278|NCT00611533|3200396|P2|Second Intervention (6 Weeks)|Adverse Event|2
972279|NCT00611533|3200397|P1|Second Intervention (6 Weeks)|Adverse Event|0
972280|NCT00611533|3200396|P2|First Intervention (6 Weeks)|Adverse Event|1
972281|NCT00611533|3200397|P1|First Intervention (6 Weeks)|Adverse Event|0
972282|NCT00611533|3200396|P2|First Intervention (6 Weeks)|Never started study|1
972283|NCT00611533|3200397|P1|First Intervention (6 Weeks)|Never started study|0
972284|NCT00611455|3200431|P3|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49
972285|NCT00611455|3200432|P2|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
972286|NCT00611455|3200433|P1|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
972287|NCT00611455|3200431|P3|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13
972288|NCT00611455|3200432|P2|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
972289|NCT00611455|3200433|P1|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
972290|NCT00611455|3200431|P3|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80
972291|NCT00611455|3200432|P2|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
972292|NCT00611455|3200433|P1|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
972293|NCT00611455|3200431|P3|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23
972294|NCT00611455|3200432|P2|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
972295|NCT00611455|3200433|P1|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
972296|NCT00611455|3200431|P3|Follow-up Period (Approximately 2 Years)|Protocol Violation|4
972297|NCT00611455|3200432|P2|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
972298|NCT00611455|3200433|P1|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
972299|NCT00611455|3200431|P3|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12
972300|NCT00611455|3200432|P2|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
972301|NCT00611455|3200433|P1|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
972302|NCT00611455|3200431|P3|Follow-up Period (Approximately 2 Years)|Adverse Event|30
972303|NCT00611455|3200432|P2|Follow-up Period (Approximately 2 Years)|Adverse Event|0
972304|NCT00611455|3200433|P1|Follow-up Period (Approximately 2 Years)|Adverse Event|0
972305|NCT00611455|3200431|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
972306|NCT00611455|3200432|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18
972307|NCT00611455|3200433|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
972308|NCT00611455|3200431|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
972309|NCT00611455|3200432|P2|OL Treatment Period (120 Weeks)|Physician Decision|5
972310|NCT00611455|3200433|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
972311|NCT00611455|3200431|P3|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
972312|NCT00611455|3200432|P2|OL Treatment Period (120 Weeks)|Lost to Follow-up|5
972313|NCT00611455|3200433|P1|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
972314|NCT00611455|3200431|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
972315|NCT00611455|3200432|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110
972316|NCT00611455|3200433|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
972317|NCT00611455|3200431|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
972318|NCT00611455|3200432|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12
972319|NCT00611455|3200433|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
972320|NCT00611455|3200431|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
972321|NCT00611455|3200432|P2|OL Treatment Period (120 Weeks)|Protocol Violation|3
972322|NCT00611455|3200433|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
972323|NCT00611455|3200431|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
972324|NCT00611455|3200432|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|9
972325|NCT00611455|3200433|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
972326|NCT00611455|3200431|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
972327|NCT00611455|3200432|P2|OL Treatment Period (120 Weeks)|Adverse Event|17
972328|NCT00611455|3200433|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
972329|NCT00611455|3200431|P3|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
972330|NCT00611455|3200432|P2|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
972331|NCT00611455|3200433|P1|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1
972332|NCT00611455|3200431|P3|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0
972333|NCT00611455|3200432|P2|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
972334|NCT00611455|3200433|P1|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
972335|NCT00611455|3200431|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
972336|NCT00611455|3200432|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3
972337|NCT00611455|3200433|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2
972338|NCT00611455|3200431|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
972339|NCT00611455|3200432|P2|DB Treatment Period (24 Weeks)|Protocol Violation|1
972340|NCT00611455|3200433|P1|DB Treatment Period (24 Weeks)|Protocol Violation|4
972341|NCT00611455|3200431|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
972342|NCT00611455|3200432|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
972343|NCT00611455|3200433|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|2
972344|NCT00611455|3200431|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
972345|NCT00611455|3200432|P2|DB Treatment Period (24 Weeks)|Adverse Event|8
972346|NCT00611455|3200433|P1|DB Treatment Period (24 Weeks)|Adverse Event|2
972347|NCT00611247|3200613|P2|Overall Study|Lack of Efficacy|16
972348|NCT00611247|3200614|P1|Overall Study|Lack of Efficacy|1
972349|NCT00611247|3200613|P2|Overall Study|Death|5
972350|NCT00611247|3200614|P1|Overall Study|Death|1
972351|NCT00611130|3200626|P2|Overall Study|Death|0
972352|NCT00611130|3200627|P1|Overall Study|Death|1
972353|NCT00611130|3200626|P2|Overall Study|Adverse Event|0
972354|NCT00611130|3200627|P1|Overall Study|Adverse Event|1
972355|NCT00611130|3200626|P2|Overall Study|Administrative|1
972356|NCT00611130|3200627|P1|Overall Study|Administrative|1
972357|NCT00611130|3200626|P2|Overall Study|Incarceration|2
972358|NCT00611130|3200627|P1|Overall Study|Incarceration|3
972359|NCT00611130|3200626|P2|Overall Study|Other|4
972360|NCT00611130|3200627|P1|Overall Study|Other|5
972361|NCT00611130|3200626|P2|Overall Study|Withdrawal by Subject|5
972362|NCT00611130|3200627|P1|Overall Study|Withdrawal by Subject|6
972363|NCT00611130|3200626|P2|Overall Study|Protocol noncompliance|6
972364|NCT00611130|3200627|P1|Overall Study|Protocol noncompliance|7
972365|NCT00611130|3200626|P2|Overall Study|Lost to Follow-up|29
972366|NCT00611130|3200627|P1|Overall Study|Lost to Follow-up|25
972367|NCT00611026|3200637|P3|Double-blind Treatment Period|Other|18
972368|NCT00611026|3200638|P2|Double-blind Treatment Period|Other|20
972369|NCT00611026|3200639|P1|Double-blind Treatment Period|Other|13
972370|NCT00611026|3200637|P3|Double-blind Treatment Period|Withdrawal by Subject|16
972371|NCT00611026|3200638|P2|Double-blind Treatment Period|Withdrawal by Subject|19
972372|NCT00611026|3200639|P1|Double-blind Treatment Period|Withdrawal by Subject|7
972373|NCT00611026|3200637|P3|Double-blind Treatment Period|Lost to Follow-up|14
972374|NCT00611026|3200638|P2|Double-blind Treatment Period|Lost to Follow-up|11
972375|NCT00611026|3200639|P1|Double-blind Treatment Period|Lost to Follow-up|6
972376|NCT00611026|3200637|P3|Double-blind Treatment Period|Lack of Efficacy|4
972377|NCT00611026|3200638|P2|Double-blind Treatment Period|Lack of Efficacy|10
972378|NCT00611026|3200639|P1|Double-blind Treatment Period|Lack of Efficacy|11
972379|NCT00611026|3200637|P3|Double-blind Treatment Period|Adverse Event|46
972380|NCT00611026|3200638|P2|Double-blind Treatment Period|Adverse Event|28
972381|NCT00611026|3200639|P1|Double-blind Treatment Period|Adverse Event|9
972382|NCT00611026|3200637|P3|Double-blind Treatment Period|Death|0
972383|NCT00611026|3200638|P2|Double-blind Treatment Period|Death|0
972384|NCT00611026|3200639|P1|Double-blind Treatment Period|Death|1
972385|NCT00611026|3200637|P3|Randomized to Double-blind Treatment|Not treated|3
972386|NCT00611026|3200638|P2|Randomized to Double-blind Treatment|Not treated|1
972387|NCT00611026|3200639|P1|Randomized to Double-blind Treatment|Not treated|2
972388|NCT00610857|3200716|P1|Overall Study|Not evaluable for response|2
972389|NCT00610714|3200760|P2|Overall Study|Study completion at 120 PFS events|2
972390|NCT00610714|3200761|P1|Overall Study|Study completion at 120 PFS events|2
972391|NCT00610714|3200760|P2|Overall Study|Withdrawal by Subject|3
972392|NCT00610714|3200761|P1|Overall Study|Withdrawal by Subject|9
972393|NCT00610714|3200760|P2|Overall Study|Death|18
972394|NCT00610714|3200761|P1|Overall Study|Death|12
972395|NCT00610714|3200760|P2|Overall Study|Adverse Event|1
972396|NCT00610714|3200761|P1|Overall Study|Adverse Event|3
972397|NCT00610675|3200799|P1|Overall Study|Other reason (not specified)|25
972398|NCT00610675|3200799|P1|Overall Study|Lost to Follow-up|31
972399|NCT00610675|3200799|P1|Overall Study|Lack of Compliance|7
972400|NCT00610675|3200799|P1|Overall Study|Reasons unrelated to trial|27
972401|NCT00610675|3200799|P1|Overall Study|Withdrawal by Subject|28
972402|NCT00610675|3200799|P1|Overall Study|Insufficient Effect|31
972403|NCT00610675|3200799|P1|Overall Study|Adverse Event|67
972404|NCT00610675|3200799|P1|Overall Study|Untreated|4
972405|NCT00610649|3200821|P11|Overall Study|Withdrawal by Subject|0
972406|NCT00610649|3200822|P10|Overall Study|Withdrawal by Subject|1
972407|NCT00610649|3200823|P9|Overall Study|Withdrawal by Subject|0
972408|NCT00610649|3200824|P8|Overall Study|Withdrawal by Subject|0
972409|NCT00610649|3200825|P7|Overall Study|Withdrawal by Subject|0
972410|NCT00610649|3200826|P6|Overall Study|Withdrawal by Subject|0
972411|NCT00610649|3200827|P5|Overall Study|Withdrawal by Subject|0
972412|NCT00610649|3200828|P4|Overall Study|Withdrawal by Subject|0
972413|NCT00610649|3200829|P3|Overall Study|Withdrawal by Subject|0
972414|NCT00610649|3200830|P2|Overall Study|Withdrawal by Subject|0
972415|NCT00610649|3200831|P1|Overall Study|Withdrawal by Subject|0
972416|NCT00610649|3200821|P11|Overall Study|Family Emergency|0
972417|NCT00610649|3200822|P10|Overall Study|Family Emergency|0
972418|NCT00610649|3200823|P9|Overall Study|Family Emergency|0
972419|NCT00610649|3200824|P8|Overall Study|Family Emergency|0
972420|NCT00610649|3200825|P7|Overall Study|Family Emergency|0
972421|NCT00610649|3200826|P6|Overall Study|Family Emergency|0
972422|NCT00610649|3200827|P5|Overall Study|Family Emergency|0
972423|NCT00610649|3200828|P4|Overall Study|Family Emergency|0
972424|NCT00610649|3200829|P3|Overall Study|Family Emergency|0
972425|NCT00610649|3200830|P2|Overall Study|Family Emergency|1
972426|NCT00610649|3200831|P1|Overall Study|Family Emergency|0
972427|NCT00610649|3200821|P11|Overall Study|Adverse Event|1
972428|NCT00610649|3200822|P10|Overall Study|Adverse Event|0
972429|NCT00610649|3200823|P9|Overall Study|Adverse Event|0
972430|NCT00610649|3200824|P8|Overall Study|Adverse Event|0
972431|NCT00610649|3200825|P7|Overall Study|Adverse Event|0
972432|NCT00610649|3200826|P6|Overall Study|Adverse Event|0
972433|NCT00610649|3200827|P5|Overall Study|Adverse Event|0
972434|NCT00610649|3200828|P4|Overall Study|Adverse Event|0
972435|NCT00610649|3200829|P3|Overall Study|Adverse Event|0
972436|NCT00610649|3200830|P2|Overall Study|Adverse Event|0
972437|NCT00610649|3200831|P1|Overall Study|Adverse Event|1
972438|NCT00610441|3200895|P4|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
972439|NCT00610441|3200896|P3|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
972440|NCT00610441|3200897|P2|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
972441|NCT00610441|3200898|P1|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1
972442|NCT00610441|3200895|P4|Treatment Period 2 - 3 Weeks|Adverse Event|1
972443|NCT00610441|3200896|P3|Treatment Period 2 - 3 Weeks|Adverse Event|0
972444|NCT00610441|3200897|P2|Treatment Period 2 - 3 Weeks|Adverse Event|0
972445|NCT00610441|3200898|P1|Treatment Period 2 - 3 Weeks|Adverse Event|0
972446|NCT00610441|3200895|P4|Treatment Period 2 - 3 Weeks|Other|1
972447|NCT00610441|3200896|P3|Treatment Period 2 - 3 Weeks|Other|0
972448|NCT00610441|3200897|P2|Treatment Period 2 - 3 Weeks|Other|1
972449|NCT00610441|3200898|P1|Treatment Period 2 - 3 Weeks|Other|1
972450|NCT00610441|3200895|P4|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
972451|NCT00610441|3200896|P3|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
972452|NCT00610441|3200897|P2|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1
972453|NCT00610441|3200898|P1|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
972454|NCT00610441|3200895|P4|Placebo Washout Period - 2 Weeks|Adverse Event|0
972455|NCT00610441|3200896|P3|Placebo Washout Period - 2 Weeks|Adverse Event|2
972456|NCT00610441|3200897|P2|Placebo Washout Period - 2 Weeks|Adverse Event|0
972457|NCT00610441|3200898|P1|Placebo Washout Period - 2 Weeks|Adverse Event|0
972458|NCT00610441|3200895|P4|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
972459|NCT00610441|3200896|P3|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
972460|NCT00610441|3200897|P2|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0
972461|NCT00610441|3200898|P1|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
972462|NCT00610441|3200895|P4|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0
972463|NCT00610441|3200896|P3|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
972464|NCT00610441|3200897|P2|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
972465|NCT00610441|3200898|P1|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
972466|NCT00610441|3200895|P4|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
972467|NCT00610441|3200896|P3|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1
972468|NCT00610441|3200897|P2|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
972469|NCT00610441|3200898|P1|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
972470|NCT00610441|3200895|P4|Treatment Period 1 - 3 Weeks|Adverse Event|1
972471|NCT00610441|3200896|P3|Treatment Period 1 - 3 Weeks|Adverse Event|4
972472|NCT00610441|3200897|P2|Treatment Period 1 - 3 Weeks|Adverse Event|1
972473|NCT00610441|3200898|P1|Treatment Period 1 - 3 Weeks|Adverse Event|1
972474|NCT00610363|3201007|P2|Overall Study|Other than specified above|1
972475|NCT00610363|3201008|P1|Overall Study|Other than specified above|1
972476|NCT00610363|3201007|P2|Overall Study|Withdrawal by Subject|0
972477|NCT00610363|3201008|P1|Overall Study|Withdrawal by Subject|1
972478|NCT00610363|3201007|P2|Overall Study|Lost to Follow-up|0
972479|NCT00610363|3201008|P1|Overall Study|Lost to Follow-up|4
972480|NCT00610363|3201007|P2|Overall Study|Lack of Efficacy|0
972481|NCT00610363|3201008|P1|Overall Study|Lack of Efficacy|2
972482|NCT00610363|3201007|P2|Overall Study|Adverse Event|1
972483|NCT00610363|3201008|P1|Overall Study|Adverse Event|3
972484|NCT00610363|3201007|P2|Overall Study|Non-compliance with protocol|1
972485|NCT00610363|3201008|P1|Overall Study|Non-compliance with protocol|0
972486|NCT00610207|3201033|P1|Overall Study|Lost to Follow-up|3
972487|NCT00610168|3201040|P2|Overall Study|Withdrawal by Subject|0
972488|NCT00610168|3201041|P1|Overall Study|Withdrawal by Subject|2
972489|NCT00610155|3201060|P6|Period 3|Adverse Event|0
972490|NCT00610155|3201061|P5|Period 3|Adverse Event|0
972491|NCT00610155|3201062|P4|Period 3|Adverse Event|0
972492|NCT00610155|3201063|P3|Period 3|Adverse Event|0
972493|NCT00610155|3201064|P2|Period 3|Adverse Event|0
972494|NCT00610155|3201065|P1|Period 3|Adverse Event|1
972495|NCT00610155|3201060|P6|Period 1|Withdrawal by Subject|0
972496|NCT00610155|3201061|P5|Period 1|Withdrawal by Subject|0
972497|NCT00610155|3201062|P4|Period 1|Withdrawal by Subject|0
972498|NCT00610155|3201063|P3|Period 1|Withdrawal by Subject|1
972499|NCT00610155|3201064|P2|Period 1|Withdrawal by Subject|0
972500|NCT00610155|3201065|P1|Period 1|Withdrawal by Subject|0
972501|NCT00610129|3201112|P1|Overall Study|Not treated since patients ineligible|3
972502|NCT00609986|3201118|P2|Overall Study|Did not receive transplant or treatment|3
972503|NCT00609986|3201119|P1|Overall Study|Did not receive transplant or treatment|8
972504|NCT00609973|3201133|P2|Overall Study|Withdrawal by Subject|1
972505|NCT00609973|3201134|P1|Overall Study|Withdrawal by Subject|0
972506|NCT00609973|3201133|P2|Overall Study|Lost to Follow-up|1
972507|NCT00609973|3201134|P1|Overall Study|Lost to Follow-up|2
972508|NCT00609973|3201133|P2|Overall Study|Protocol Violation|3
972509|NCT00609973|3201134|P1|Overall Study|Protocol Violation|4
972510|NCT00609973|3201133|P2|Overall Study|Adverse Event|1
972511|NCT00609973|3201134|P1|Overall Study|Adverse Event|2
972512|NCT00609947|3201142|P1|Overall Study|Death|1
972513|NCT00609869|3201147|P1|Overall Study|Mantle cell: not evaluable|4
972514|NCT00609869|3201147|P1|Overall Study|Rituximab reaction prior to lenalidomide|1
972515|NCT00609869|3201147|P1|Overall Study|Hepatitis B infection|1
972516|NCT00609869|3201147|P1|Overall Study|Severe tumor flare reaction|1
972517|NCT00609869|3201147|P1|Overall Study|Seizures|1
972518|NCT00609869|3201147|P1|Overall Study|Withdrawal by Subject|1
972519|NCT00609869|3201147|P1|Overall Study|Severe hematologic toxicity|1
972520|NCT00609869|3201147|P1|Overall Study|Withdrawn, ischemic stroke|1
972521|NCT00609765|3201166|P1|Overall Study|Study ended prior to 12 months|1
972522|NCT00609674|3201180|P2|Overall Study|Withdrew consent|1
972523|NCT00609674|3201181|P1|Overall Study|Withdrew consent|2
972524|NCT00609674|3201180|P2|Overall Study|Lost to Follow-up|0
972525|NCT00609674|3201181|P1|Overall Study|Lost to Follow-up|1
972526|NCT00609674|3201180|P2|Overall Study|Protocol Violation|5
972527|NCT00609674|3201181|P1|Overall Study|Protocol Violation|3
972528|NCT00609674|3201180|P2|Overall Study|Adverse Event|1
972529|NCT00609674|3201181|P1|Overall Study|Adverse Event|1
972530|NCT00609622|3201217|P2|Overall Study|Global deterioration of health status|2
972531|NCT00609622|3201218|P1|Overall Study|Global deterioration of health status|6
972532|NCT00609622|3201217|P2|Overall Study|Other|14
972533|NCT00609622|3201218|P1|Overall Study|Other|7
972534|NCT00609622|3201217|P2|Overall Study|Study terminated by sponsor|3
972535|NCT00609622|3201218|P1|Overall Study|Study terminated by sponsor|16
972536|NCT00609622|3201217|P2|Overall Study|Objective progression or relapse|41
972537|NCT00609622|3201218|P1|Overall Study|Objective progression or relapse|47
972538|NCT00609622|3201217|P2|Overall Study|Protocol Violation|1
972539|NCT00609622|3201218|P1|Overall Study|Protocol Violation|1
972540|NCT00609622|3201217|P2|Overall Study|Death|4
972541|NCT00609622|3201218|P1|Overall Study|Death|1
972542|NCT00609622|3201217|P2|Overall Study|Withdrawal by Subject|20
972543|NCT00609622|3201218|P1|Overall Study|Withdrawal by Subject|4
972544|NCT00609622|3201217|P2|Overall Study|Adverse Event|10
972545|NCT00609622|3201218|P1|Overall Study|Adverse Event|14
972546|NCT00609609|3201240|P2|Overall Study|Progression|2
972547|NCT00609609|3201241|P1|Overall Study|Progression|4
972548|NCT00609609|3201240|P2|Overall Study|Withdrawal by Subject|0
972549|NCT00609609|3201241|P1|Overall Study|Withdrawal by Subject|2
972550|NCT00609518|3201253|P2|Overall Study|Death from Adverse Event|2
972551|NCT00609518|3201254|P1|Overall Study|Death from Adverse Event|2
972552|NCT00609518|3201253|P2|Overall Study|Physician Decision|3
972553|NCT00609518|3201254|P1|Overall Study|Physician Decision|1
972554|NCT00609518|3201253|P2|Overall Study|Lost to Follow-up|0
972555|NCT00609518|3201254|P1|Overall Study|Lost to Follow-up|3
972556|NCT00609518|3201253|P2|Overall Study|Withdrawal by Subject|3
972557|NCT00609518|3201254|P1|Overall Study|Withdrawal by Subject|5
972558|NCT00609518|3201253|P2|Overall Study|Death from Study Disease|32
972559|NCT00609518|3201254|P1|Overall Study|Death from Study Disease|32
972560|NCT00609492|3201269|P3|Overall Study|Lost to Follow-up|4
972561|NCT00609492|3201270|P2|Overall Study|Lost to Follow-up|1
972562|NCT00609492|3201271|P1|Overall Study|Lost to Follow-up|1
972563|NCT00609492|3201269|P3|Overall Study|Withdrawal by Subject|3
972564|NCT00609492|3201270|P2|Overall Study|Withdrawal by Subject|2
972565|NCT00609492|3201271|P1|Overall Study|Withdrawal by Subject|0
972566|NCT00609466|3201356|P3|Overall Study|Lack of Efficacy|2
972567|NCT00609466|3201357|P2|Overall Study|Lack of Efficacy|2
972568|NCT00609466|3201358|P1|Overall Study|Lack of Efficacy|0
972569|NCT00609466|3201356|P3|Overall Study|Adverse Event|1
972570|NCT00609466|3201357|P2|Overall Study|Adverse Event|3
972571|NCT00609466|3201358|P1|Overall Study|Adverse Event|2
972572|NCT00609466|3201356|P3|Overall Study|Withdrawal by Subject|1
972573|NCT00609466|3201357|P2|Overall Study|Withdrawal by Subject|1
972574|NCT00609466|3201358|P1|Overall Study|Withdrawal by Subject|0
972575|NCT00609362|3201386|P2|Overall Study|Adverse Event|0
972576|NCT00609362|3201387|P1|Overall Study|Adverse Event|1
972577|NCT00609362|3201386|P2|Overall Study|Withdrawal by Subject|1
972578|NCT00609362|3201387|P1|Overall Study|Withdrawal by Subject|2
972579|NCT00609336|3201397|P1|Overall Study|LA or Met at Surgery|9
972580|NCT00609336|3201397|P1|Overall Study|Death|1
972581|NCT00609336|3201397|P1|Overall Study|Protocol Violation|3
972582|NCT00609245|3201448|P1|Overall Study|Adverse Event|1
972583|NCT00609167|3201456|P2|Overall Study|Stem Cell Transplant|6
972584|NCT00609167|3201457|P1|Overall Study|Stem Cell Transplant|0
972585|NCT00609167|3201456|P2|Overall Study|Disease Progression|0
972586|NCT00609167|3201457|P1|Overall Study|Disease Progression|1
972587|NCT00609167|3201456|P2|Overall Study|Adverse Event|1
972588|NCT00609167|3201457|P1|Overall Study|Adverse Event|5
972589|NCT00609167|3201456|P2|Overall Study|Lack of Efficacy|0
972590|NCT00609167|3201457|P1|Overall Study|Lack of Efficacy|1
972591|NCT00609167|3201456|P2|Overall Study|Withdrawal by Subject|0
972592|NCT00609167|3201457|P1|Overall Study|Withdrawal by Subject|1
972593|NCT00608985|3201488|P4|Overall Study|Lost to Follow-up|0
972594|NCT00608985|3201489|P3|Overall Study|Lost to Follow-up|0
972595|NCT00608985|3201490|P2|Overall Study|Lost to Follow-up|1
972596|NCT00608985|3201491|P1|Overall Study|Lost to Follow-up|2
972597|NCT00608985|3201488|P4|Overall Study|Withdrawal of Consent|1
972598|NCT00608985|3201489|P3|Overall Study|Withdrawal of Consent|1
972599|NCT00608985|3201490|P2|Overall Study|Withdrawal of Consent|1
972600|NCT00608985|3201491|P1|Overall Study|Withdrawal of Consent|5
972601|NCT00608985|3201488|P4|Overall Study|Administrative/Other|2
972602|NCT00608985|3201489|P3|Overall Study|Administrative/Other|1
972603|NCT00608985|3201490|P2|Overall Study|Administrative/Other|4
972604|NCT00608985|3201491|P1|Overall Study|Administrative/Other|7
972605|NCT00608985|3201488|P4|Overall Study|Adverse Event|6
972606|NCT00608985|3201489|P3|Overall Study|Adverse Event|4
972607|NCT00608985|3201490|P2|Overall Study|Adverse Event|7
972608|NCT00608985|3201491|P1|Overall Study|Adverse Event|2
972609|NCT00608959|3201523|P1|Part 1|Did not meet eligibility criteria|1
972610|NCT00608907|3201536|P3|Overall Study|Progressive Disease|0
972611|NCT00608907|3201537|P2|Overall Study|Progressive Disease|0
972612|NCT00608907|3201538|P1|Overall Study|Progressive Disease|1
972613|NCT00608907|3201536|P3|Overall Study|Withdrawal by Subject|0
972614|NCT00608907|3201537|P2|Overall Study|Withdrawal by Subject|0
972615|NCT00608907|3201538|P1|Overall Study|Withdrawal by Subject|4
972616|NCT00608907|3201536|P3|Overall Study|Death|0
972617|NCT00608907|3201537|P2|Overall Study|Death|0
972618|NCT00608907|3201538|P1|Overall Study|Death|1
972619|NCT00608907|3201536|P3|Overall Study|Adverse Event|1
972620|NCT00608907|3201537|P2|Overall Study|Adverse Event|0
972621|NCT00608907|3201538|P1|Overall Study|Adverse Event|6
972622|NCT00608881|3201548|P2|Overall Study|Institutionalized|2
972623|NCT00608881|3201549|P1|Overall Study|Institutionalized|1
972624|NCT00608881|3201548|P2|Overall Study|Physician Decision|5
972625|NCT00608881|3201549|P1|Overall Study|Physician Decision|5
972626|NCT00608881|3201548|P2|Overall Study|Withdrawal by Subject|29
972627|NCT00608881|3201549|P1|Overall Study|Withdrawal by Subject|18
972628|NCT00608881|3201548|P2|Overall Study|Lost to Follow-up|14
972629|NCT00608881|3201549|P1|Overall Study|Lost to Follow-up|28
972630|NCT00608881|3201548|P2|Overall Study|Adverse Event|3
972631|NCT00608881|3201549|P1|Overall Study|Adverse Event|5
972632|NCT00608881|3201548|P2|Overall Study|Death|13
972633|NCT00608881|3201549|P1|Overall Study|Death|22
972634|NCT00608868|3201583|P1|Overall Study|Physician Decision|2
972635|NCT00608868|3201583|P1|Overall Study|Adverse Event|1
972636|NCT00608868|3201583|P1|Overall Study|Lost to Follow-up|2
972637|NCT00608868|3201583|P1|Overall Study|Protocol Violation|3
972638|NCT00608868|3201583|P1|Overall Study|Withdrawal by Subject|7
972639|NCT00608842|3201594|P4|Overall Study|Lost to Follow-up|0
972640|NCT00608842|3201595|P3|Overall Study|Lost to Follow-up|0
972641|NCT00608842|3201596|P2|Overall Study|Lost to Follow-up|0
972642|NCT00608842|3201597|P1|Overall Study|Lost to Follow-up|1
972643|NCT00608842|3201594|P4|Overall Study|Participant's Request|1
972644|NCT00608842|3201595|P3|Overall Study|Participant's Request|2
972645|NCT00608842|3201596|P2|Overall Study|Participant's Request|1
972646|NCT00608842|3201597|P1|Overall Study|Participant's Request|0
972647|NCT00608829|3201631|P1|Overall Study|Subject refuses to follow up or return.|5
972648|NCT00608829|3201631|P1|Overall Study|Withdrawal by Subject|4
972649|NCT00608829|3201631|P1|Overall Study|Death|6
972650|NCT00608582|3201657|P2|Overall Study|Early stage Design Change|3
972651|NCT00608582|3201658|P1|Overall Study|Early stage Design Change|0
972652|NCT00608582|3201657|P2|Overall Study|Illicit Drug Use|0
972653|NCT00608582|3201658|P1|Overall Study|Illicit Drug Use|1
972654|NCT00608582|3201657|P2|Overall Study|No Best Response in Phase 1 located|1
972655|NCT00608582|3201658|P1|Overall Study|No Best Response in Phase 1 located|1
972656|NCT00608582|3201657|P2|Overall Study|Lost to Follow-up|0
972657|NCT00608582|3201658|P1|Overall Study|Lost to Follow-up|2
972658|NCT00608569|3201668|P2|Overall Study|Unable to adhere with study requirements|1
972659|NCT00608569|3201669|P1|Overall Study|Unable to adhere with study requirements|0
972660|NCT00608569|3201668|P2|Overall Study|Adverse Event|0
972661|NCT00608569|3201669|P1|Overall Study|Adverse Event|1
972662|NCT00608569|3201668|P2|Overall Study|Withdrawal by Subject|0
972663|NCT00608569|3201669|P1|Overall Study|Withdrawal by Subject|1
972664|NCT00608569|3201668|P2|Overall Study|Lost to Follow-up|5
972665|NCT00608569|3201669|P1|Overall Study|Lost to Follow-up|4
972666|NCT00608569|3201668|P2|Overall Study|Death|3
972667|NCT00608569|3201669|P1|Overall Study|Death|4
972668|NCT00608543|3201689|P1|Overall Study|Adverse Event|4
972669|NCT00608530|3201702|P4|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
972670|NCT00608530|3201703|P3|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1
972671|NCT00608530|3201704|P2|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
972672|NCT00608530|3201705|P1|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
972673|NCT00608530|3201702|P4|Study 2 Nurse-delivered Treatments|Time demands of study|1
972674|NCT00608530|3201703|P3|Study 2 Nurse-delivered Treatments|Time demands of study|4
972675|NCT00608530|3201704|P2|Study 2 Nurse-delivered Treatments|Time demands of study|0
972676|NCT00608530|3201705|P1|Study 2 Nurse-delivered Treatments|Time demands of study|0
972677|NCT00608530|3201702|P4|Study 2 Nurse-delivered Treatments|Protocol Violation|0
972678|NCT00608530|3201703|P3|Study 2 Nurse-delivered Treatments|Protocol Violation|2
972679|NCT00608530|3201704|P2|Study 2 Nurse-delivered Treatments|Protocol Violation|0
972680|NCT00608530|3201705|P1|Study 2 Nurse-delivered Treatments|Protocol Violation|0
972681|NCT00608530|3201702|P4|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3
972682|NCT00608530|3201703|P3|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2
972683|NCT00608530|3201704|P2|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
972684|NCT00608530|3201705|P1|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
972685|NCT00608530|3201702|P4|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
972686|NCT00608530|3201703|P3|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
972687|NCT00608530|3201704|P2|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
972688|NCT00608530|3201705|P1|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
972689|NCT00608530|3201702|P4|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
972690|NCT00608530|3201703|P3|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
972691|NCT00608530|3201704|P2|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5
972692|NCT00608530|3201705|P1|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11
972693|NCT00608517|3201726|P3|Overall Study|Death|0
972694|NCT00608517|3201727|P2|Overall Study|Death|0
972695|NCT00608517|3201728|P1|Overall Study|Death|1
972696|NCT00608426|3201908|P2|Overall Study|refused, health issues, wrong address|348
972697|NCT00608426|3201909|P1|Overall Study|refused, health issues, wrong address|319
972698|NCT00608426|3201908|P2|Overall Study|Lost to Follow-up|521
972699|NCT00608426|3201909|P1|Overall Study|Lost to Follow-up|485
972700|NCT00608426|3201908|P2|Overall Study|Death|36
972701|NCT00608426|3201909|P1|Overall Study|Death|32
972702|NCT00608322|3201921|P2|Overall Study|Death|1
972703|NCT00608322|3201922|P1|Overall Study|Death|2
972704|NCT00608244|3201928|P1|Overall Study|Low trough levels|1
972705|NCT00608244|3201928|P1|Overall Study|Adverse Event|1
972706|NCT00608205|3201939|P2|Overall Study|Patient non-compliant|1
972707|NCT00608205|3201940|P1|Overall Study|Patient non-compliant|0
972708|NCT00608205|3201939|P2|Overall Study|Adverse Event|2
972709|NCT00608205|3201940|P1|Overall Study|Adverse Event|3
972710|NCT00608023|3202057|P3|Overall Study|Unknown reason|0
972711|NCT00608023|3202058|P2|Overall Study|Unknown reason|3
972712|NCT00608023|3202059|P1|Overall Study|Unknown reason|0
972713|NCT00608023|3202057|P3|Overall Study|Protocol Violation|1
972714|NCT00608023|3202058|P2|Overall Study|Protocol Violation|3
972715|NCT00608023|3202059|P1|Overall Study|Protocol Violation|1
972716|NCT00608023|3202057|P3|Overall Study|Lost to Follow-up|1
972717|NCT00608023|3202058|P2|Overall Study|Lost to Follow-up|2
972718|NCT00608023|3202059|P1|Overall Study|Lost to Follow-up|2
972719|NCT00608023|3202057|P3|Overall Study|Adverse Event|5
972720|NCT00608023|3202058|P2|Overall Study|Adverse Event|4
972721|NCT00608023|3202059|P1|Overall Study|Adverse Event|1
972722|NCT00608023|3202057|P3|Overall Study|Withdrawal by Subject|7
972723|NCT00608023|3202058|P2|Overall Study|Withdrawal by Subject|10
972724|NCT00608023|3202059|P1|Overall Study|Withdrawal by Subject|8
972725|NCT00607997|3202083|P4|Overall Study|Other without explanation|1
972726|NCT00607997|3202084|P3|Overall Study|Other without explanation|4
972727|NCT00607997|3202085|P2|Overall Study|Other without explanation|0
972728|NCT00607997|3202086|P1|Overall Study|Other without explanation|2
972729|NCT00607997|3202083|P4|Overall Study|Relapse, recurrent illness|0
972730|NCT00607997|3202084|P3|Overall Study|Relapse, recurrent illness|2
972731|NCT00607997|3202085|P2|Overall Study|Relapse, recurrent illness|0
972732|NCT00607997|3202086|P1|Overall Study|Relapse, recurrent illness|4
972733|NCT00607997|3202083|P4|Overall Study|Physician Decision|0
972734|NCT00607997|3202084|P3|Overall Study|Physician Decision|0
972735|NCT00607997|3202085|P2|Overall Study|Physician Decision|1
972736|NCT00607997|3202086|P1|Overall Study|Physician Decision|4
972737|NCT00607997|3202083|P4|Overall Study|Adverse Event|0
972738|NCT00607997|3202084|P3|Overall Study|Adverse Event|2
972739|NCT00607997|3202085|P2|Overall Study|Adverse Event|1
972740|NCT00607997|3202086|P1|Overall Study|Adverse Event|3
972741|NCT00607997|3202083|P4|Overall Study|Death|5
972742|NCT00607997|3202084|P3|Overall Study|Death|2
972743|NCT00607997|3202085|P2|Overall Study|Death|5
972744|NCT00607997|3202086|P1|Overall Study|Death|8
972745|NCT00607997|3202083|P4|Overall Study|Lack of Efficacy|10
972746|NCT00607997|3202084|P3|Overall Study|Lack of Efficacy|14
972747|NCT00607997|3202085|P2|Overall Study|Lack of Efficacy|20
972748|NCT00607997|3202086|P1|Overall Study|Lack of Efficacy|6
972749|NCT00607919|3202144|P2|Open-Label Phase|Parent/Caregiver Decision|2
972750|NCT00607919|3202145|P1|Open-Label Phase|Parent/Caregiver Decision|1
972751|NCT00607919|3202144|P2|Open-Label Phase|Withdrawal by Subject|2
972752|NCT00607919|3202145|P1|Open-Label Phase|Withdrawal by Subject|2
972753|NCT00607919|3202144|P2|Open-Label Phase|Protocol Violation|2
972754|NCT00607919|3202145|P1|Open-Label Phase|Protocol Violation|2
972755|NCT00607919|3202144|P2|Open-Label Phase|Lost to Follow-up|1
972756|NCT00607919|3202145|P1|Open-Label Phase|Lost to Follow-up|4
972757|NCT00607919|3202144|P2|Open-Label Phase|Adverse Event|5
972758|NCT00607919|3202145|P1|Open-Label Phase|Adverse Event|1
972759|NCT00607919|3202144|P2|Acute Phase|Withdrawal by Subject|3
972760|NCT00607919|3202145|P1|Acute Phase|Withdrawal by Subject|3
972761|NCT00607919|3202144|P2|Acute Phase|Protocol Violation|1
972762|NCT00607919|3202145|P1|Acute Phase|Protocol Violation|5
972763|NCT00607919|3202144|P2|Acute Phase|Parent/Caregiver Decision|4
972764|NCT00607919|3202145|P1|Acute Phase|Parent/Caregiver Decision|6
972765|NCT00607919|3202144|P2|Acute Phase|Lost to Follow-up|3
972766|NCT00607919|3202145|P1|Acute Phase|Lost to Follow-up|9
972767|NCT00607919|3202144|P2|Acute Phase|Lack of Efficacy|2
972768|NCT00607919|3202145|P1|Acute Phase|Lack of Efficacy|1
972769|NCT00607919|3202144|P2|Acute Phase|Entry Criteria Not Met|1
972770|NCT00607919|3202145|P1|Acute Phase|Entry Criteria Not Met|1
972771|NCT00607919|3202144|P2|Acute Phase|Adverse Event|2
972772|NCT00607919|3202145|P1|Acute Phase|Adverse Event|9
972773|NCT00607893|3202203|P2|Overall Study|Withdrew due to hypertensive urgency|1
972774|NCT00607893|3202204|P1|Overall Study|Withdrew due to hypertensive urgency|1
972775|NCT00607893|3202203|P2|Overall Study|Declined to be treated|0
972776|NCT00607893|3202204|P1|Overall Study|Declined to be treated|1
972777|NCT00607893|3202203|P2|Overall Study|withdrew could not tolerate CPAP|1
972778|NCT00607893|3202204|P1|Overall Study|withdrew could not tolerate CPAP|0
972779|NCT00607893|3202203|P2|Overall Study|Withdrew due to osteomyelitis surgery|1
972780|NCT00607893|3202204|P1|Overall Study|Withdrew due to osteomyelitis surgery|0
972781|NCT00607893|3202203|P2|Overall Study|withdrew due to loss of interest|1
972782|NCT00607893|3202204|P1|Overall Study|withdrew due to loss of interest|0
972783|NCT00607893|3202203|P2|Overall Study|Lost to Follow-up|0
972784|NCT00607893|3202204|P1|Overall Study|Lost to Follow-up|4
972785|NCT00607880|3202232|P2|Overall Study|Unable to place port due to occlusion|0
972786|NCT00607880|3202233|P1|Overall Study|Unable to place port due to occlusion|1
972787|NCT00607789|3202283|P2|Overall Study|Withdrawal by Subject|0
972788|NCT00607789|3202284|P1|Overall Study|Withdrawal by Subject|1
972789|NCT00607789|3202283|P2|Overall Study|Lost to Follow-up|5
972790|NCT00607789|3202284|P1|Overall Study|Lost to Follow-up|0
972791|NCT00607789|3202283|P2|Overall Study|Inadequate adherence|0
972792|NCT00607789|3202284|P1|Overall Study|Inadequate adherence|3
972793|NCT00607789|3202283|P2|Overall Study|Lack of Efficacy|1
972794|NCT00607789|3202284|P1|Overall Study|Lack of Efficacy|0
972795|NCT00607789|3202283|P2|Overall Study|Adverse Event|0
972796|NCT00607789|3202284|P1|Overall Study|Adverse Event|3
972797|NCT00607724|3202299|P7|Stage 2: Expanded Cohort|Withdrawal by Subject|0
972798|NCT00607724|3202300|P6|Stage 2: Expanded Cohort|Withdrawal by Subject|0
972799|NCT00607724|3202301|P5|Stage 2: Expanded Cohort|Withdrawal by Subject|0
972800|NCT00607724|3202302|P4|Stage 2: Expanded Cohort|Withdrawal by Subject|1
972801|NCT00607724|3202303|P3|Stage 2: Expanded Cohort|Withdrawal by Subject|0
972802|NCT00607724|3202304|P2|Stage 2: Expanded Cohort|Withdrawal by Subject|0
972803|NCT00607724|3202305|P1|Stage 2: Expanded Cohort|Withdrawal by Subject|0
972804|NCT00607724|3202299|P7|Stage 2: Expanded Cohort|Physician Decision|0
972805|NCT00607724|3202300|P6|Stage 2: Expanded Cohort|Physician Decision|1
972806|NCT00607724|3202301|P5|Stage 2: Expanded Cohort|Physician Decision|1
972807|NCT00607724|3202302|P4|Stage 2: Expanded Cohort|Physician Decision|0
972808|NCT00607724|3202303|P3|Stage 2: Expanded Cohort|Physician Decision|0
972809|NCT00607724|3202304|P2|Stage 2: Expanded Cohort|Physician Decision|0
972810|NCT00607724|3202305|P1|Stage 2: Expanded Cohort|Physician Decision|0
972811|NCT00607724|3202299|P7|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|10
972812|NCT00607724|3202300|P6|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|11
972813|NCT00607724|3202301|P5|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|8
972814|NCT00607724|3202302|P4|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|4
972815|NCT00607724|3202303|P3|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
972816|NCT00607724|3202304|P2|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
972817|NCT00607724|3202305|P1|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
972818|NCT00607724|3202299|P7|Stage 2: Expanded Cohort|Adverse Event|1
972819|NCT00607724|3202300|P6|Stage 2: Expanded Cohort|Adverse Event|0
972820|NCT00607724|3202301|P5|Stage 2: Expanded Cohort|Adverse Event|0
972821|NCT00607724|3202302|P4|Stage 2: Expanded Cohort|Adverse Event|0
972822|NCT00607724|3202303|P3|Stage 2: Expanded Cohort|Adverse Event|0
972823|NCT00607724|3202304|P2|Stage 2: Expanded Cohort|Adverse Event|0
972824|NCT00607724|3202305|P1|Stage 2: Expanded Cohort|Adverse Event|0
972825|NCT00607724|3202299|P7|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
972826|NCT00607724|3202300|P6|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
972827|NCT00607724|3202301|P5|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
972828|NCT00607724|3202302|P4|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
972829|NCT00607724|3202303|P3|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|4
972830|NCT00607724|3202304|P2|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|8
972831|NCT00607724|3202305|P1|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|7
972832|NCT00607386|3202468|P1|Overall Study|Physician Decision|1
972833|NCT00607373|3202483|P2|Follow-up Period|Withdrawal by Subject|3
972834|NCT00607373|3202484|P1|Follow-up Period|Withdrawal by Subject|1
972835|NCT00607373|3202483|P2|Follow-up Period|Protocol Violation|1
972836|NCT00607373|3202484|P1|Follow-up Period|Protocol Violation|0
972837|NCT00607373|3202483|P2|Follow-up Period|Not specified|1
972838|NCT00607373|3202484|P1|Follow-up Period|Not specified|0
972839|NCT00607373|3202483|P2|Treatment Period|Withdrawal by Subject|1
972840|NCT00607373|3202484|P1|Treatment Period|Withdrawal by Subject|0
972841|NCT00607373|3202483|P2|Treatment Period|Physician Decision|1
972842|NCT00607373|3202484|P1|Treatment Period|Physician Decision|0
972843|NCT00607373|3202483|P2|Treatment Period|Adverse Event|4
972844|NCT00607373|3202484|P1|Treatment Period|Adverse Event|0
972845|NCT00607087|3202586|P3|Period 3|Adverse Event|0
972846|NCT00607087|3202587|P2|Period 3|Adverse Event|1
972847|NCT00607087|3202588|P1|Period 3|Adverse Event|0
972848|NCT00607087|3202586|P3|Period 3|Withdrawal by Subject|0
972849|NCT00607087|3202587|P2|Period 3|Withdrawal by Subject|1
972850|NCT00607087|3202588|P1|Period 3|Withdrawal by Subject|2
972851|NCT00607087|3202586|P3|Period 2|Poor compliance to protocol|1
972852|NCT00607087|3202587|P2|Period 2|Poor compliance to protocol|0
972853|NCT00607087|3202588|P1|Period 2|Poor compliance to protocol|0
972854|NCT00607087|3202586|P3|Period 2|Adverse Event|3
972855|NCT00607087|3202587|P2|Period 2|Adverse Event|1
972856|NCT00607087|3202588|P1|Period 2|Adverse Event|0
972857|NCT00607087|3202586|P3|Period 2|Other reason|0
972858|NCT00607087|3202587|P2|Period 2|Other reason|1
972859|NCT00607087|3202588|P1|Period 2|Other reason|1
972860|NCT00607087|3202586|P3|Period 2|Withdrawal by Subject|1
972861|NCT00607087|3202587|P2|Period 2|Withdrawal by Subject|1
972862|NCT00607087|3202588|P1|Period 2|Withdrawal by Subject|0
972863|NCT00607087|3202586|P3|Period 1|Other reason|2
972864|NCT00607087|3202587|P2|Period 1|Other reason|4
972865|NCT00607087|3202588|P1|Period 1|Other reason|0
972866|NCT00607087|3202586|P3|Period 1|Lost to Follow-up|0
972867|NCT00607087|3202587|P2|Period 1|Lost to Follow-up|0
972868|NCT00607087|3202588|P1|Period 1|Lost to Follow-up|1
972869|NCT00607087|3202586|P3|Period 1|Poor compliance to protocol|0
972870|NCT00607087|3202587|P2|Period 1|Poor compliance to protocol|0
972871|NCT00607087|3202588|P1|Period 1|Poor compliance to protocol|1
972872|NCT00607087|3202586|P3|Period 1|Adverse Event|0
972873|NCT00607087|3202587|P2|Period 1|Adverse Event|0
972874|NCT00607087|3202588|P1|Period 1|Adverse Event|3
972875|NCT00607087|3202586|P3|Period 1|Withdrawal by Subject|3
972876|NCT00607087|3202587|P2|Period 1|Withdrawal by Subject|2
972877|NCT00607087|3202588|P1|Period 1|Withdrawal by Subject|7
972878|NCT00607087|3202586|P3|Overall Study|Lost to Follow-up|0
972879|NCT00607087|3202587|P2|Overall Study|Lost to Follow-up|0
972880|NCT00607087|3202588|P1|Overall Study|Lost to Follow-up|1
972881|NCT00607087|3202586|P3|Overall Study|Poor compliance to protocol|1
972882|NCT00607087|3202587|P2|Overall Study|Poor compliance to protocol|0
972883|NCT00607087|3202588|P1|Overall Study|Poor compliance to protocol|1
972884|NCT00607087|3202586|P3|Overall Study|Other reason|2
972885|NCT00607087|3202587|P2|Overall Study|Other reason|5
972886|NCT00607087|3202588|P1|Overall Study|Other reason|1
972887|NCT00607087|3202586|P3|Overall Study|Adverse Event|3
972888|NCT00607087|3202587|P2|Overall Study|Adverse Event|2
972889|NCT00607087|3202588|P1|Overall Study|Adverse Event|3
972890|NCT00607087|3202586|P3|Overall Study|Withdrawal by Subject|4
972891|NCT00607087|3202587|P2|Overall Study|Withdrawal by Subject|4
972892|NCT00607087|3202588|P1|Overall Study|Withdrawal by Subject|9
972893|NCT00607048|3202646|P6|Overall Study|Other|1
972894|NCT00607048|3202647|P5|Overall Study|Other|0
972895|NCT00607048|3202648|P4|Overall Study|Other|0
972896|NCT00607048|3202649|P3|Overall Study|Other|0
972897|NCT00607048|3202650|P2|Overall Study|Other|1
972898|NCT00607048|3202651|P1|Overall Study|Other|1
972899|NCT00607048|3202646|P6|Overall Study|Withdrawal by Subject|2
972900|NCT00607048|3202647|P5|Overall Study|Withdrawal by Subject|0
972901|NCT00607048|3202648|P4|Overall Study|Withdrawal by Subject|1
972902|NCT00607048|3202649|P3|Overall Study|Withdrawal by Subject|0
972903|NCT00607048|3202650|P2|Overall Study|Withdrawal by Subject|0
972904|NCT00607048|3202651|P1|Overall Study|Withdrawal by Subject|0
972905|NCT00607048|3202646|P6|Overall Study|Objective disease progression - relapse|2
972906|NCT00607048|3202647|P5|Overall Study|Objective disease progression - relapse|2
972907|NCT00607048|3202648|P4|Overall Study|Objective disease progression - relapse|2
972908|NCT00607048|3202649|P3|Overall Study|Objective disease progression - relapse|4
972909|NCT00607048|3202650|P2|Overall Study|Objective disease progression - relapse|2
972910|NCT00607048|3202651|P1|Overall Study|Objective disease progression - relapse|1
972911|NCT00607048|3202646|P6|Overall Study|Global deterioration of health|0
972912|NCT00607048|3202647|P5|Overall Study|Global deterioration of health|0
972913|NCT00607048|3202648|P4|Overall Study|Global deterioration of health|0
972914|NCT00607048|3202649|P3|Overall Study|Global deterioration of health|0
972915|NCT00607048|3202650|P2|Overall Study|Global deterioration of health|0
972916|NCT00607048|3202651|P1|Overall Study|Global deterioration of health|1
972917|NCT00607048|3202646|P6|Overall Study|Adverse Event|0
972918|NCT00607048|3202647|P5|Overall Study|Adverse Event|4
972919|NCT00607048|3202648|P4|Overall Study|Adverse Event|0
972920|NCT00607048|3202649|P3|Overall Study|Adverse Event|0
972921|NCT00607048|3202650|P2|Overall Study|Adverse Event|1
972922|NCT00607048|3202651|P1|Overall Study|Adverse Event|0
972923|NCT00607022|3202736|P3|Overall Study|Withdrawal by Subject|0
972924|NCT00607022|3202737|P2|Overall Study|Withdrawal by Subject|0
972925|NCT00607022|3202738|P1|Overall Study|Withdrawal by Subject|1
972926|NCT00606931|3202755|P1|Overall Study|Withdrawal by Subject|3
972927|NCT00606905|3202763|P2|Overall Study|Withdrew|5
972928|NCT00606905|3202764|P1|Overall Study|Withdrew|5
972929|NCT00606905|3202763|P2|Overall Study|Non-Index Pregnancy|4
972930|NCT00606905|3202764|P1|Overall Study|Non-Index Pregnancy|1
972931|NCT00606905|3202763|P2|Overall Study|No Pregnancy|6
972932|NCT00606905|3202764|P1|Overall Study|No Pregnancy|9
972933|NCT00606892|3202770|P2|First Intervention|Protocol Violation|4
972934|NCT00606892|3202771|P1|First Intervention|Protocol Violation|1
972935|NCT00606801|3202805|P2|Intervention|Protocol Violation|3
972936|NCT00606801|3202806|P1|Intervention|Protocol Violation|3
972937|NCT00606684|3202834|P7|Double-Blind Treatment Period|Withdrawal by Subject|0
972938|NCT00606684|3202835|P6|Double-Blind Treatment Period|Withdrawal by Subject|2
972939|NCT00606684|3202836|P5|Double-Blind Treatment Period|Withdrawal by Subject|1
972940|NCT00606684|3202837|P4|Double-Blind Treatment Period|Withdrawal by Subject|2
972941|NCT00606684|3202838|P3|Double-Blind Treatment Period|Withdrawal by Subject|1
972942|NCT00606684|3202839|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
972943|NCT00606684|3202840|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
972944|NCT00606684|3202834|P7|Double-Blind Treatment Period|Physician Decision|2
972945|NCT00606684|3202835|P6|Double-Blind Treatment Period|Physician Decision|1
972946|NCT00606684|3202836|P5|Double-Blind Treatment Period|Physician Decision|3
972947|NCT00606684|3202837|P4|Double-Blind Treatment Period|Physician Decision|0
972948|NCT00606684|3202838|P3|Double-Blind Treatment Period|Physician Decision|1
972949|NCT00606684|3202839|P2|Double-Blind Treatment Period|Physician Decision|5
972950|NCT00606684|3202840|P1|Double-Blind Treatment Period|Physician Decision|0
972951|NCT00606684|3202834|P7|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
972952|NCT00606684|3202835|P6|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3
972953|NCT00606684|3202836|P5|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
972954|NCT00606684|3202837|P4|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
972955|NCT00606684|3202838|P3|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
972956|NCT00606684|3202839|P2|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
972957|NCT00606684|3202840|P1|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0
972958|NCT00606684|3202834|P7|Double-Blind Treatment Period|Protocol Violation|4
972959|NCT00606684|3202835|P6|Double-Blind Treatment Period|Protocol Violation|3
972960|NCT00606684|3202836|P5|Double-Blind Treatment Period|Protocol Violation|0
972961|NCT00606684|3202837|P4|Double-Blind Treatment Period|Protocol Violation|3
972962|NCT00606684|3202838|P3|Double-Blind Treatment Period|Protocol Violation|5
972963|NCT00606684|3202839|P2|Double-Blind Treatment Period|Protocol Violation|5
972964|NCT00606684|3202840|P1|Double-Blind Treatment Period|Protocol Violation|0
972965|NCT00606684|3202834|P7|Double-Blind Treatment Period|Lack of Efficacy|0
972966|NCT00606684|3202835|P6|Double-Blind Treatment Period|Lack of Efficacy|0
972967|NCT00606684|3202836|P5|Double-Blind Treatment Period|Lack of Efficacy|1
972968|NCT00606684|3202837|P4|Double-Blind Treatment Period|Lack of Efficacy|0
972969|NCT00606684|3202838|P3|Double-Blind Treatment Period|Lack of Efficacy|0
972970|NCT00606684|3202839|P2|Double-Blind Treatment Period|Lack of Efficacy|1
972971|NCT00606684|3202840|P1|Double-Blind Treatment Period|Lack of Efficacy|0
972972|NCT00606684|3202834|P7|Double-Blind Treatment Period|Adverse Event|1
972973|NCT00606684|3202835|P6|Double-Blind Treatment Period|Adverse Event|0
972974|NCT00606684|3202836|P5|Double-Blind Treatment Period|Adverse Event|2
972975|NCT00606684|3202837|P4|Double-Blind Treatment Period|Adverse Event|4
972976|NCT00606684|3202838|P3|Double-Blind Treatment Period|Adverse Event|2
972977|NCT00606684|3202839|P2|Double-Blind Treatment Period|Adverse Event|3
972978|NCT00606684|3202840|P1|Double-Blind Treatment Period|Adverse Event|0
972979|NCT00606684|3202834|P7|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
972980|NCT00606684|3202835|P6|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
972981|NCT00606684|3202836|P5|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
972982|NCT00606684|3202837|P4|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
972983|NCT00606684|3202838|P3|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
972984|NCT00606684|3202839|P2|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
972985|NCT00606684|3202840|P1|2-week Single-Blind Run-in Period|Received Study Medication in Error|1
972986|NCT00606684|3202834|P7|2-week Single-Blind Run-in Period|Adverse Event|0
972987|NCT00606684|3202835|P6|2-week Single-Blind Run-in Period|Adverse Event|0
972988|NCT00606684|3202836|P5|2-week Single-Blind Run-in Period|Adverse Event|0
972989|NCT00606684|3202837|P4|2-week Single-Blind Run-in Period|Adverse Event|0
972990|NCT00606684|3202838|P3|2-week Single-Blind Run-in Period|Adverse Event|0
972991|NCT00606684|3202839|P2|2-week Single-Blind Run-in Period|Adverse Event|0
972992|NCT00606684|3202840|P1|2-week Single-Blind Run-in Period|Adverse Event|2
972993|NCT00606684|3202834|P7|2-week Single-Blind Run-in Period|Lost to Follow-up|0
972994|NCT00606684|3202835|P6|2-week Single-Blind Run-in Period|Lost to Follow-up|0
972995|NCT00606684|3202836|P5|2-week Single-Blind Run-in Period|Lost to Follow-up|0
972996|NCT00606684|3202837|P4|2-week Single-Blind Run-in Period|Lost to Follow-up|0
972997|NCT00606684|3202838|P3|2-week Single-Blind Run-in Period|Lost to Follow-up|0
972998|NCT00606684|3202839|P2|2-week Single-Blind Run-in Period|Lost to Follow-up|0
972999|NCT00606684|3202840|P1|2-week Single-Blind Run-in Period|Lost to Follow-up|5
973000|NCT00606684|3202834|P7|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
973001|NCT00606684|3202835|P6|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
973002|NCT00606684|3202836|P5|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
973003|NCT00606684|3202837|P4|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
973004|NCT00606684|3202838|P3|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
973005|NCT00606684|3202839|P2|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
973006|NCT00606684|3202840|P1|2-week Single-Blind Run-in Period|Withdrawal by Subject|15
973007|NCT00606684|3202834|P7|2-week Single-Blind Run-in Period|Physician Decision|0
973008|NCT00606684|3202835|P6|2-week Single-Blind Run-in Period|Physician Decision|0
973009|NCT00606684|3202836|P5|2-week Single-Blind Run-in Period|Physician Decision|0
973010|NCT00606684|3202837|P4|2-week Single-Blind Run-in Period|Physician Decision|0
973011|NCT00606684|3202838|P3|2-week Single-Blind Run-in Period|Physician Decision|0
973012|NCT00606684|3202839|P2|2-week Single-Blind Run-in Period|Physician Decision|0
973013|NCT00606684|3202840|P1|2-week Single-Blind Run-in Period|Physician Decision|18
973014|NCT00606684|3202834|P7|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
973015|NCT00606684|3202835|P6|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
973016|NCT00606684|3202836|P5|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
973017|NCT00606684|3202837|P4|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
973018|NCT00606684|3202838|P3|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
973019|NCT00606684|3202839|P2|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
973020|NCT00606684|3202840|P1|2-week Single-Blind Run-in Period|Study Closed/Terminated|32
973021|NCT00606684|3202834|P7|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
973022|NCT00606684|3202835|P6|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
973023|NCT00606684|3202836|P5|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
973024|NCT00606684|3202837|P4|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
973025|NCT00606684|3202838|P3|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
973026|NCT00606684|3202839|P2|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
973027|NCT00606684|3202840|P1|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173
973028|NCT00606632|3202872|P1|Overall Study|Miscellaneous reasons|9
973029|NCT00606632|3202872|P1|Overall Study|Withdrawal by Subject|13
973030|NCT00606593|3202885|P10|Overall Study|Administrative/Other|0
973031|NCT00606593|3202886|P9|Overall Study|Administrative/Other|0
973032|NCT00606593|3202887|P8|Overall Study|Administrative/Other|0
973033|NCT00606593|3202888|P7|Overall Study|Administrative/Other|0
973034|NCT00606593|3202889|P6|Overall Study|Administrative/Other|0
973035|NCT00606593|3202890|P5|Overall Study|Administrative/Other|0
973036|NCT00606593|3202891|P4|Overall Study|Administrative/Other|0
973037|NCT00606593|3202892|P3|Overall Study|Administrative/Other|1
973038|NCT00606593|3202893|P2|Overall Study|Administrative/Other|0
973039|NCT00606593|3202894|P1|Overall Study|Administrative/Other|0
973040|NCT00606593|3202885|P10|Overall Study|Withdrawal of consent|0
973041|NCT00606593|3202886|P9|Overall Study|Withdrawal of consent|0
973042|NCT00606593|3202887|P8|Overall Study|Withdrawal of consent|0
973043|NCT00606593|3202888|P7|Overall Study|Withdrawal of consent|0
973044|NCT00606593|3202889|P6|Overall Study|Withdrawal of consent|0
973045|NCT00606593|3202890|P5|Overall Study|Withdrawal of consent|0
973046|NCT00606593|3202891|P4|Overall Study|Withdrawal of consent|0
973047|NCT00606593|3202892|P3|Overall Study|Withdrawal of consent|1
973048|NCT00606593|3202893|P2|Overall Study|Withdrawal of consent|0
973049|NCT00606593|3202894|P1|Overall Study|Withdrawal of consent|1
973050|NCT00606593|3202885|P10|Overall Study|Adverse Event|0
973051|NCT00606593|3202886|P9|Overall Study|Adverse Event|1
973052|NCT00606593|3202887|P8|Overall Study|Adverse Event|2
973053|NCT00606593|3202888|P7|Overall Study|Adverse Event|1
973054|NCT00606593|3202889|P6|Overall Study|Adverse Event|0
973055|NCT00606593|3202890|P5|Overall Study|Adverse Event|1
973056|NCT00606593|3202891|P4|Overall Study|Adverse Event|1
973057|NCT00606593|3202892|P3|Overall Study|Adverse Event|0
973058|NCT00606593|3202893|P2|Overall Study|Adverse Event|0
973059|NCT00606593|3202894|P1|Overall Study|Adverse Event|0
973060|NCT00606580|3202915|P3|Overall Study|Withdrawal by Subject|0
973061|NCT00606580|3202916|P2|Overall Study|Withdrawal by Subject|1
973062|NCT00606580|3202917|P1|Overall Study|Withdrawal by Subject|0
973063|NCT00606580|3202915|P3|Overall Study|Withdrawal by investigator|6
973064|NCT00606580|3202916|P2|Overall Study|Withdrawal by investigator|1
973065|NCT00606580|3202917|P1|Overall Study|Withdrawal by investigator|0
973066|NCT00606580|3202915|P3|Overall Study|Clinical failures|12
973067|NCT00606580|3202916|P2|Overall Study|Clinical failures|0
973068|NCT00606580|3202917|P1|Overall Study|Clinical failures|1
973069|NCT00606580|3202915|P3|Overall Study|Lost to Follow-up|4
973070|NCT00606580|3202916|P2|Overall Study|Lost to Follow-up|1
973071|NCT00606580|3202917|P1|Overall Study|Lost to Follow-up|1
973072|NCT00606502|3202983|P2|Treatment|Treatment ongoing at time of data cutoff|3
973073|NCT00606502|3202984|P1|Treatment|Treatment ongoing at time of data cutoff|0
973074|NCT00606502|3202983|P2|Randomization|Randomized but not treated|0
973075|NCT00606502|3202984|P1|Randomization|Randomized but not treated|3
973076|NCT00606320|3203005|P1|Overall Study|Progression to depressive phase|4
973077|NCT00606320|3203005|P1|Overall Study|Withdrawal by Subject|10
973078|NCT00606320|3203005|P1|Overall Study|Protocol Violation|8
973079|NCT00606320|3203005|P1|Overall Study|Physician Decision|7
973080|NCT00606320|3203005|P1|Overall Study|Lack of Efficacy|5
973081|NCT00606320|3203005|P1|Overall Study|Adverse Event|3
973082|NCT00606281|3203012|P2|Overall Study|Change of residence or other commitments|1
973083|NCT00606281|3203013|P1|Overall Study|Change of residence or other commitments|1
973084|NCT00606281|3203012|P2|Overall Study|Progression to depressive phase|1
973085|NCT00606281|3203013|P1|Overall Study|Progression to depressive phase|1
973086|NCT00606281|3203012|P2|Overall Study|Withdrawal by Subject|13
973087|NCT00606281|3203013|P1|Overall Study|Withdrawal by Subject|11
973088|NCT00606281|3203012|P2|Overall Study|Protocol Violation|3
973089|NCT00606281|3203013|P1|Overall Study|Protocol Violation|3
973090|NCT00606281|3203012|P2|Overall Study|Physician Decision|1
973091|NCT00606281|3203013|P1|Overall Study|Physician Decision|0
973092|NCT00606281|3203012|P2|Overall Study|Lack of Efficacy|35
973093|NCT00606281|3203013|P1|Overall Study|Lack of Efficacy|28
973094|NCT00606281|3203012|P2|Overall Study|Death|0
973095|NCT00606281|3203013|P1|Overall Study|Death|1
973096|NCT00606281|3203012|P2|Overall Study|Adverse Event|12
973097|NCT00606281|3203013|P1|Overall Study|Adverse Event|11
973098|NCT00606229|3203021|P1|Overall Study|change of residence or other commitments|2
973099|NCT00606229|3203021|P1|Overall Study|does not meet inclusion criterion 1-3|4
973100|NCT00606229|3203021|P1|Overall Study|Withdrawal by Subject|4
973101|NCT00606229|3203021|P1|Overall Study|Lack of Efficacy|1
973102|NCT00606229|3203021|P1|Overall Study|Adverse Event|11
973103|NCT00606177|3203028|P2|Overall Study|Change of residence or other commitments|1
973104|NCT00606177|3203029|P1|Overall Study|Change of residence or other commitments|1
973105|NCT00606177|3203028|P2|Overall Study|Diabetic blood glucose level/ High HbA1c|1
973106|NCT00606177|3203029|P1|Overall Study|Diabetic blood glucose level/ High HbA1c|1
973107|NCT00606177|3203028|P2|Overall Study|Progression to depressive phase|1
973108|NCT00606177|3203029|P1|Overall Study|Progression to depressive phase|6
973109|NCT00606177|3203028|P2|Overall Study|Withdrawal by Subject|6
973110|NCT00606177|3203029|P1|Overall Study|Withdrawal by Subject|5
973111|NCT00606177|3203028|P2|Overall Study|Protocol Violation|4
973112|NCT00606177|3203029|P1|Overall Study|Protocol Violation|1
973113|NCT00606177|3203028|P2|Overall Study|Physician Decision|0
973114|NCT00606177|3203029|P1|Overall Study|Physician Decision|1
973115|NCT00606177|3203028|P2|Overall Study|Lack of Efficacy|7
973116|NCT00606177|3203029|P1|Overall Study|Lack of Efficacy|3
973117|NCT00606177|3203028|P2|Overall Study|Adverse Event|5
973118|NCT00606177|3203029|P1|Overall Study|Adverse Event|9
973119|NCT00606086|3203056|P2|Overall Study|Randomized, not treated|2
973120|NCT00606086|3203057|P1|Overall Study|Randomized, not treated|1
973121|NCT00606086|3203056|P2|Overall Study|Non-compliance|1
973122|NCT00606086|3203057|P1|Overall Study|Non-compliance|0
973123|NCT00606086|3203056|P2|Overall Study|Withdrawal by Subject|3
973124|NCT00606086|3203057|P1|Overall Study|Withdrawal by Subject|5
973125|NCT00606086|3203056|P2|Overall Study|Protocol Violation|0
973126|NCT00606086|3203057|P1|Overall Study|Protocol Violation|1
973127|NCT00606086|3203056|P2|Overall Study|Lost to Follow-up|8
973128|NCT00606086|3203057|P1|Overall Study|Lost to Follow-up|4
973129|NCT00606086|3203056|P2|Overall Study|Adverse Event|1
973130|NCT00606086|3203057|P1|Overall Study|Adverse Event|1
973131|NCT00606034|3203063|P1|Overall Study|incarceration|1
973132|NCT00606021|3203071|P3|Maintenance Phase|Lost to Follow-up|2
973133|NCT00606021|3203072|P2|Maintenance Phase|Lost to Follow-up|5
973134|NCT00606021|3203073|P1|Maintenance Phase|Lost to Follow-up|0
973135|NCT00606021|3203071|P3|Maintenance Phase|Physician Decision|0
973136|NCT00606021|3203072|P2|Maintenance Phase|Physician Decision|1
973137|NCT00606021|3203073|P1|Maintenance Phase|Physician Decision|0
973138|NCT00606021|3203071|P3|Maintenance Phase|Death|15
973139|NCT00606021|3203072|P2|Maintenance Phase|Death|17
973140|NCT00606021|3203073|P1|Maintenance Phase|Death|0
973141|NCT00606021|3203071|P3|Induction Phase|Lost to Follow-up|0
973142|NCT00606021|3203072|P2|Induction Phase|Lost to Follow-up|0
973143|NCT00606021|3203073|P1|Induction Phase|Lost to Follow-up|10
973144|NCT00606021|3203071|P3|Induction Phase|Withdrawal by Subject|0
973145|NCT00606021|3203072|P2|Induction Phase|Withdrawal by Subject|0
973146|NCT00606021|3203073|P1|Induction Phase|Withdrawal by Subject|2
973147|NCT00606021|3203071|P3|Induction Phase|Physician Decision|0
973148|NCT00606021|3203072|P2|Induction Phase|Physician Decision|0
973149|NCT00606021|3203073|P1|Induction Phase|Physician Decision|2
973150|NCT00606021|3203071|P3|Induction Phase|Death|0
973151|NCT00606021|3203072|P2|Induction Phase|Death|0
973152|NCT00606021|3203073|P1|Induction Phase|Death|73
973153|NCT00606008|3203091|P1|Overall Study|Withdrawal by Subject|4
973154|NCT00606008|3203091|P1|Overall Study|Adverse Event|1
973155|NCT00605917|3203105|P1|Overall Study|Protocol Violation|79
973156|NCT00605865|3203157|P1|Overall Study|Protocol Violation|115
973157|NCT00605839|3203199|P3|Overall Study|Protocol Violation|0
973158|NCT00605839|3203200|P2|Overall Study|Protocol Violation|0
973159|NCT00605839|3203201|P1|Overall Study|Protocol Violation|1
973160|NCT00605813|3203209|P1|Overall Study|Protocol Violation|25
973161|NCT00605722|3203222|P1|Overall Study|Failure to return|1
973162|NCT00605722|3203222|P1|Overall Study|Insufficient therapeutic response|44
973163|NCT00605722|3203222|P1|Overall Study|Adverse Event|6
973164|NCT00605657|3203243|P1|Overall Study|Protocol Violation|1
973165|NCT00605657|3203243|P1|Overall Study|Adverse Event|1
973166|NCT00605540|3203248|P1|Overall Study|Lost to Follow-up|23
973167|NCT00605540|3203248|P1|Overall Study|Death|15
973168|NCT00605475|3203266|P10|Overall Study|Withdrawal by Subject|1
973169|NCT00605475|3203267|P9|Overall Study|Withdrawal by Subject|0
973170|NCT00605475|3203268|P8|Overall Study|Withdrawal by Subject|0
973171|NCT00605475|3203269|P7|Overall Study|Withdrawal by Subject|0
973172|NCT00605475|3203270|P6|Overall Study|Withdrawal by Subject|2
973173|NCT00605475|3203271|P5|Overall Study|Withdrawal by Subject|0
973174|NCT00605475|3203272|P4|Overall Study|Withdrawal by Subject|0
973175|NCT00605475|3203273|P3|Overall Study|Withdrawal by Subject|0
973176|NCT00605475|3203274|P2|Overall Study|Withdrawal by Subject|0
973177|NCT00605475|3203275|P1|Overall Study|Withdrawal by Subject|0
973178|NCT00605475|3203266|P10|Overall Study|Protocol Violation|0
973179|NCT00605475|3203267|P9|Overall Study|Protocol Violation|0
973180|NCT00605475|3203268|P8|Overall Study|Protocol Violation|0
973181|NCT00605475|3203269|P7|Overall Study|Protocol Violation|0
973182|NCT00605475|3203270|P6|Overall Study|Protocol Violation|0
973183|NCT00605475|3203271|P5|Overall Study|Protocol Violation|1
973184|NCT00605475|3203272|P4|Overall Study|Protocol Violation|0
973185|NCT00605475|3203273|P3|Overall Study|Protocol Violation|0
973186|NCT00605475|3203274|P2|Overall Study|Protocol Violation|0
973187|NCT00605475|3203275|P1|Overall Study|Protocol Violation|0
973188|NCT00605475|3203266|P10|Overall Study|Lost to Follow-up|1
973189|NCT00605475|3203267|P9|Overall Study|Lost to Follow-up|1
973190|NCT00605475|3203268|P8|Overall Study|Lost to Follow-up|0
973191|NCT00605475|3203269|P7|Overall Study|Lost to Follow-up|0
973192|NCT00605475|3203270|P6|Overall Study|Lost to Follow-up|0
973193|NCT00605475|3203271|P5|Overall Study|Lost to Follow-up|0
973194|NCT00605475|3203272|P4|Overall Study|Lost to Follow-up|0
973195|NCT00605475|3203273|P3|Overall Study|Lost to Follow-up|0
973196|NCT00605475|3203274|P2|Overall Study|Lost to Follow-up|0
973197|NCT00605475|3203275|P1|Overall Study|Lost to Follow-up|0
973198|NCT00605475|3203266|P10|Overall Study|Administrative problems|0
973199|NCT00605475|3203267|P9|Overall Study|Administrative problems|0
973200|NCT00605475|3203268|P8|Overall Study|Administrative problems|0
973201|NCT00605475|3203269|P7|Overall Study|Administrative problems|1
973202|NCT00605475|3203270|P6|Overall Study|Administrative problems|0
973203|NCT00605475|3203271|P5|Overall Study|Administrative problems|0
973204|NCT00605475|3203272|P4|Overall Study|Administrative problems|0
973205|NCT00605475|3203273|P3|Overall Study|Administrative problems|0
973206|NCT00605475|3203274|P2|Overall Study|Administrative problems|0
973207|NCT00605475|3203275|P1|Overall Study|Administrative problems|0
973208|NCT00605475|3203266|P10|Overall Study|Abnormal Laboratory Values|0
973209|NCT00605475|3203267|P9|Overall Study|Abnormal Laboratory Values|1
973210|NCT00605475|3203268|P8|Overall Study|Abnormal Laboratory Values|0
973211|NCT00605475|3203269|P7|Overall Study|Abnormal Laboratory Values|0
973212|NCT00605475|3203270|P6|Overall Study|Abnormal Laboratory Values|0
973213|NCT00605475|3203271|P5|Overall Study|Abnormal Laboratory Values|0
973214|NCT00605475|3203272|P4|Overall Study|Abnormal Laboratory Values|0
973215|NCT00605475|3203273|P3|Overall Study|Abnormal Laboratory Values|0
973216|NCT00605475|3203274|P2|Overall Study|Abnormal Laboratory Values|0
973217|NCT00605475|3203275|P1|Overall Study|Abnormal Laboratory Values|0
973218|NCT00605345|3203452|P2|Overall Study|Protocol Violation|2
973219|NCT00605345|3203453|P1|Overall Study|Protocol Violation|0
973220|NCT00605345|3203452|P2|Overall Study|Adverse Event|1
973221|NCT00605345|3203453|P1|Overall Study|Adverse Event|0
973222|NCT00605345|3203452|P2|Overall Study|Withdrawal by Subject|0
973223|NCT00605345|3203453|P1|Overall Study|Withdrawal by Subject|1
973224|NCT00605319|3203469|P1|Overall Study|Adverse Event|6
973225|NCT00605306|3203481|P2|Overall Study|Adverse Event|1
973226|NCT00605306|3203482|P1|Overall Study|Adverse Event|0
973227|NCT00605293|3203496|P2|Overall Study|Principal Investigator Decision|1
973228|NCT00605293|3203497|P1|Overall Study|Principal Investigator Decision|0
973229|NCT00605293|3203496|P2|Overall Study|Dialysis Out of Centre for 3 Months|1
973230|NCT00605293|3203497|P1|Overall Study|Dialysis Out of Centre for 3 Months|0
973231|NCT00605293|3203496|P2|Overall Study|Incorrect Epoetin Beta Administration|0
973232|NCT00605293|3203497|P1|Overall Study|Incorrect Epoetin Beta Administration|1
973233|NCT00605293|3203496|P2|Overall Study|Renal Transplantation|1
973234|NCT00605293|3203497|P1|Overall Study|Renal Transplantation|3
973235|NCT00605293|3203496|P2|Overall Study|Blood Transfusion|1
973236|NCT00605293|3203497|P1|Overall Study|Blood Transfusion|7
973237|NCT00605293|3203496|P2|Overall Study|Holidays Dialysis Out|0
973238|NCT00605293|3203497|P1|Overall Study|Holidays Dialysis Out|1
973239|NCT00605293|3203496|P2|Overall Study|Adverse Event|0
973240|NCT00605293|3203497|P1|Overall Study|Adverse Event|1
973241|NCT00605293|3203496|P2|Overall Study|Insufficient Therapeutic Response|0
973242|NCT00605293|3203497|P1|Overall Study|Insufficient Therapeutic Response|2
973243|NCT00605293|3203496|P2|Overall Study|Death|1
973244|NCT00605293|3203497|P1|Overall Study|Death|2
973245|NCT00605280|3203517|P4|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
973246|NCT00605280|3203518|P3|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
973247|NCT00605280|3203519|P2|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
973248|NCT00605280|3203520|P1|Year 3 Extension|Lost to Follow-up or Patient non-comply|2
973249|NCT00605280|3203517|P4|Year 3 Extension|Other|0
973250|NCT00605280|3203518|P3|Year 3 Extension|Other|0
973251|NCT00605280|3203519|P2|Year 3 Extension|Other|0
973252|NCT00605280|3203520|P1|Year 3 Extension|Other|2
973253|NCT00605280|3203517|P4|Year 3 Extension|Withdrawal by Subject|5
973254|NCT00605280|3203518|P3|Year 3 Extension|Withdrawal by Subject|0
973255|NCT00605280|3203519|P2|Year 3 Extension|Withdrawal by Subject|0
973256|NCT00605280|3203520|P1|Year 3 Extension|Withdrawal by Subject|2
973257|NCT00605280|3203517|P4|Year 3 Extension|Physician Decision|2
973258|NCT00605280|3203518|P3|Year 3 Extension|Physician Decision|0
973259|NCT00605280|3203519|P2|Year 3 Extension|Physician Decision|0
973260|NCT00605280|3203520|P1|Year 3 Extension|Physician Decision|0
973261|NCT00605280|3203517|P4|Year 3 Extension|Adverse Event|2
973262|NCT00605280|3203518|P3|Year 3 Extension|Adverse Event|0
973263|NCT00605280|3203519|P2|Year 3 Extension|Adverse Event|0
973264|NCT00605280|3203520|P1|Year 3 Extension|Adverse Event|2
973265|NCT00605280|3203517|P4|Year 2|Lost to Follow-up or Patient non-comply|2
973266|NCT00605280|3203518|P3|Year 2|Lost to Follow-up or Patient non-comply|0
973267|NCT00605280|3203519|P2|Year 2|Lost to Follow-up or Patient non-comply|0
973268|NCT00605280|3203520|P1|Year 2|Lost to Follow-up or Patient non-comply|4
973269|NCT00605280|3203517|P4|Year 2|Other|1
973270|NCT00605280|3203518|P3|Year 2|Other|0
973271|NCT00605280|3203519|P2|Year 2|Other|0
973272|NCT00605280|3203520|P1|Year 2|Other|1
973273|NCT00605280|3203517|P4|Year 2|Withdrawal by Subject|4
973274|NCT00605280|3203518|P3|Year 2|Withdrawal by Subject|0
973275|NCT00605280|3203519|P2|Year 2|Withdrawal by Subject|0
973276|NCT00605280|3203520|P1|Year 2|Withdrawal by Subject|4
973277|NCT00605280|3203517|P4|Year 2|Physician Decision|11
973278|NCT00605280|3203518|P3|Year 2|Physician Decision|4
973279|NCT00605280|3203519|P2|Year 2|Physician Decision|6
973280|NCT00605280|3203520|P1|Year 2|Physician Decision|11
973281|NCT00605280|3203517|P4|Year 2|Adverse Event|4
973282|NCT00605280|3203518|P3|Year 2|Adverse Event|2
973283|NCT00605280|3203519|P2|Year 2|Adverse Event|0
973284|NCT00605280|3203520|P1|Year 2|Adverse Event|4
973285|NCT00605280|3203517|P4|Year 1|Lost to Follow-up or Patient non-comply|2
973286|NCT00605280|3203518|P3|Year 1|Lost to Follow-up or Patient non-comply|0
973287|NCT00605280|3203519|P2|Year 1|Lost to Follow-up or Patient non-comply|1
973288|NCT00605280|3203520|P1|Year 1|Lost to Follow-up or Patient non-comply|5
973289|NCT00605280|3203517|P4|Year 1|Other|1
973290|NCT00605280|3203518|P3|Year 1|Other|0
973291|NCT00605280|3203519|P2|Year 1|Other|1
973292|NCT00605280|3203520|P1|Year 1|Other|2
973293|NCT00605280|3203517|P4|Year 1|Withdrawal by Subject|4
973294|NCT00605280|3203518|P3|Year 1|Withdrawal by Subject|0
973295|NCT00605280|3203519|P2|Year 1|Withdrawal by Subject|4
973296|NCT00605280|3203520|P1|Year 1|Withdrawal by Subject|2
973297|NCT00605280|3203517|P4|Year 1|Physician Decision|6
973298|NCT00605280|3203518|P3|Year 1|Physician Decision|0
973299|NCT00605280|3203519|P2|Year 1|Physician Decision|4
973300|NCT00605280|3203520|P1|Year 1|Physician Decision|7
973301|NCT00605280|3203517|P4|Year 1|Adverse Event|5
973302|NCT00605280|3203518|P3|Year 1|Adverse Event|1
973303|NCT00605280|3203519|P2|Year 1|Adverse Event|1
973304|NCT00605280|3203520|P1|Year 1|Adverse Event|3
973305|NCT00605280|3203517|P4|Year 1|Protocol Violation|1
973306|NCT00605280|3203518|P3|Year 1|Protocol Violation|0
973307|NCT00605280|3203519|P2|Year 1|Protocol Violation|0
973308|NCT00605280|3203520|P1|Year 1|Protocol Violation|0
973309|NCT00605267|3203554|P2|Overall Study|Withdrawal by Subject|3
973310|NCT00605267|3203555|P1|Overall Study|Withdrawal by Subject|2
973311|NCT00605267|3203554|P2|Overall Study|Lack of Efficacy|5
973312|NCT00605267|3203555|P1|Overall Study|Lack of Efficacy|1
973313|NCT00605267|3203554|P2|Overall Study|Adverse Event|1
973314|NCT00605267|3203555|P1|Overall Study|Adverse Event|0
973315|NCT00605176|3203603|P3|Overall Study|Other (not due to AE)|0
973316|NCT00605176|3203604|P2|Overall Study|Other (not due to AE)|1
973317|NCT00605176|3203605|P1|Overall Study|Other (not due to AE)|1
973318|NCT00605176|3203603|P3|Overall Study|Use of concomitant therapy|1
973319|NCT00605176|3203604|P2|Overall Study|Use of concomitant therapy|0
973320|NCT00605176|3203605|P1|Overall Study|Use of concomitant therapy|1
973321|NCT00605176|3203603|P3|Overall Study|Non-complicance with study procedures|0
973322|NCT00605176|3203604|P2|Overall Study|Non-complicance with study procedures|0
973323|NCT00605176|3203605|P1|Overall Study|Non-complicance with study procedures|1
973324|NCT00605176|3203603|P3|Overall Study|Lost to Follow-up|1
973325|NCT00605176|3203604|P2|Overall Study|Lost to Follow-up|2
973326|NCT00605176|3203605|P1|Overall Study|Lost to Follow-up|2
973327|NCT00605176|3203603|P3|Overall Study|Withdrawal by Subject|4
973328|NCT00605176|3203604|P2|Overall Study|Withdrawal by Subject|2
973329|NCT00605176|3203605|P1|Overall Study|Withdrawal by Subject|4
973330|NCT00605176|3203603|P3|Overall Study|Adverse Event|3
973331|NCT00605176|3203604|P2|Overall Study|Adverse Event|1
973332|NCT00605176|3203605|P1|Overall Study|Adverse Event|2
973333|NCT00605085|3203628|P2|Overall Study|administrative reasons|8
973334|NCT00605085|3203629|P1|Overall Study|administrative reasons|18
973335|NCT00605085|3203628|P2|Overall Study|Lost to Follow-up|5
973336|NCT00605085|3203629|P1|Overall Study|Lost to Follow-up|10
973337|NCT00605085|3203628|P2|Overall Study|Protocol Violation|2
973338|NCT00605085|3203629|P1|Overall Study|Protocol Violation|3
973339|NCT00605085|3203628|P2|Overall Study|Pregnancy|0
973340|NCT00605085|3203629|P1|Overall Study|Pregnancy|2
973341|NCT00605085|3203628|P2|Overall Study|Adverse Event|5
973342|NCT00605085|3203629|P1|Overall Study|Adverse Event|9
973343|NCT00605085|3203628|P2|Overall Study|Withdrawal by Subject|5
973344|NCT00605085|3203629|P1|Overall Study|Withdrawal by Subject|8
973345|NCT00605033|3203662|P2|Overall Study|Protocol Violation|1
973346|NCT00605033|3203663|P1|Overall Study|Protocol Violation|1
973347|NCT00605033|3203662|P2|Overall Study|Withdrawal by Subject|4
973348|NCT00605033|3203663|P1|Overall Study|Withdrawal by Subject|3
973349|NCT00605033|3203662|P2|Overall Study|Lost to Follow-up|1
973350|NCT00605033|3203663|P1|Overall Study|Lost to Follow-up|1
973351|NCT00605033|3203662|P2|Overall Study|Adverse Event|2
973352|NCT00605033|3203663|P1|Overall Study|Adverse Event|2
973353|NCT00604825|3203686|P4|Overall Study|Exclusion criterion met|1
973354|NCT00604825|3203687|P3|Overall Study|Exclusion criterion met|0
973355|NCT00604825|3203688|P2|Overall Study|Exclusion criterion met|0
973356|NCT00604825|3203689|P1|Overall Study|Exclusion criterion met|0
973357|NCT00604825|3203686|P4|Overall Study|Physician Decision|1
973358|NCT00604825|3203687|P3|Overall Study|Physician Decision|0
973359|NCT00604825|3203688|P2|Overall Study|Physician Decision|0
973360|NCT00604825|3203689|P1|Overall Study|Physician Decision|0
973361|NCT00604825|3203686|P4|Overall Study|Did not meet eligibility criteria|0
973362|NCT00604825|3203687|P3|Overall Study|Did not meet eligibility criteria|2
973363|NCT00604825|3203688|P2|Overall Study|Did not meet eligibility criteria|0
973364|NCT00604825|3203689|P1|Overall Study|Did not meet eligibility criteria|0
973365|NCT00604825|3203686|P4|Overall Study|Lack of Efficacy|0
973366|NCT00604825|3203687|P3|Overall Study|Lack of Efficacy|1
973367|NCT00604825|3203688|P2|Overall Study|Lack of Efficacy|2
973368|NCT00604825|3203689|P1|Overall Study|Lack of Efficacy|3
973369|NCT00604825|3203686|P4|Overall Study|Withdrawal by Subject|5
973370|NCT00604825|3203687|P3|Overall Study|Withdrawal by Subject|5
973371|NCT00604825|3203688|P2|Overall Study|Withdrawal by Subject|3
973372|NCT00604825|3203689|P1|Overall Study|Withdrawal by Subject|4
973373|NCT00604825|3203686|P4|Overall Study|Protocol Violation|0
973374|NCT00604825|3203687|P3|Overall Study|Protocol Violation|0
973375|NCT00604825|3203688|P2|Overall Study|Protocol Violation|1
973376|NCT00604825|3203689|P1|Overall Study|Protocol Violation|0
973377|NCT00604825|3203686|P4|Overall Study|Lost to Follow-up|0
973378|NCT00604825|3203687|P3|Overall Study|Lost to Follow-up|1
973379|NCT00604825|3203688|P2|Overall Study|Lost to Follow-up|3
973380|NCT00604825|3203689|P1|Overall Study|Lost to Follow-up|0
973381|NCT00604825|3203686|P4|Overall Study|Adverse Event|4
973382|NCT00604825|3203687|P3|Overall Study|Adverse Event|7
973383|NCT00604825|3203688|P2|Overall Study|Adverse Event|6
973384|NCT00604825|3203689|P1|Overall Study|Adverse Event|2
973385|NCT00604786|3203917|P2|Overall Study|Lost to Follow-up|0
973386|NCT00604786|3203918|P1|Overall Study|Lost to Follow-up|2
973387|NCT00604721|3203924|P1|Overall Study|Withdrawal by Subject|1
973388|NCT00604721|3203924|P1|Overall Study|Physician Decision|1
973389|NCT00604708|3203932|P2|Overall Study|Adverse Event|6
973390|NCT00604708|3203933|P1|Overall Study|Adverse Event|6
973391|NCT00604708|3203932|P2|Overall Study|administrative reasons|11
973392|NCT00604708|3203933|P1|Overall Study|administrative reasons|9
973393|NCT00604708|3203932|P2|Overall Study|Lost to Follow-up|5
973394|NCT00604708|3203933|P1|Overall Study|Lost to Follow-up|5
973395|NCT00604708|3203932|P2|Overall Study|Protocol Violation|8
973396|NCT00604708|3203933|P1|Overall Study|Protocol Violation|2
973397|NCT00604708|3203932|P2|Overall Study|Withdrawal by Subject|10
973398|NCT00604708|3203933|P1|Overall Study|Withdrawal by Subject|9
973399|NCT00604695|3203943|P2|Overall Study|Did not receive first bolus.|4
973400|NCT00604695|3203944|P1|Overall Study|Did not receive first bolus.|0
973401|NCT00604669|3203966|P1|Overall Study|lack of information in chart|7
973402|NCT00604565|3203972|P2|Overall Study|Study terminated|3
973403|NCT00604565|3203973|P1|Overall Study|Study terminated|0
973404|NCT00604500|3203992|P1|Overall Study|Did not meet protocol eligibility|1
973405|NCT00604500|3203992|P1|Overall Study|Administrative|1
973406|NCT00604500|3203992|P1|Overall Study|Withdrawal by Subject|4
973407|NCT00604500|3203992|P1|Overall Study|Treatment Failure|1
973408|NCT00604500|3203992|P1|Overall Study|Protocol Violation|2
973409|NCT00604500|3203992|P1|Overall Study|Adverse Event|2
973410|NCT00604383|3204006|P2|Overall Study|Physician Decision|3
973411|NCT00604383|3204007|P1|Overall Study|Physician Decision|0
973412|NCT00604383|3204006|P2|Overall Study|Adverse Event|9
973413|NCT00604383|3204007|P1|Overall Study|Adverse Event|16
973414|NCT00604383|3204006|P2|Overall Study|Death|22
973415|NCT00604383|3204007|P1|Overall Study|Death|14
973416|NCT00604383|3204006|P2|Overall Study|Lost to Follow-up|19
973417|NCT00604383|3204007|P1|Overall Study|Lost to Follow-up|24
973418|NCT00604383|3204006|P2|Overall Study|Withdrawal by Subject|31
973419|NCT00604383|3204007|P1|Overall Study|Withdrawal by Subject|33
973420|NCT00604279|3204023|P2|Overall Study|Other|4
973421|NCT00604279|3204024|P1|Overall Study|Other|8
973422|NCT00604279|3204023|P2|Overall Study|Adverse Event|5
973423|NCT00604279|3204024|P1|Overall Study|Adverse Event|4
973424|NCT00604279|3204023|P2|Overall Study|Withdrawal by Subject|5
973425|NCT00604279|3204024|P1|Overall Study|Withdrawal by Subject|16
973426|NCT00604279|3204023|P2|Overall Study|Protocol Violation|1
973427|NCT00604279|3204024|P1|Overall Study|Protocol Violation|3
973428|NCT00604279|3204023|P2|Overall Study|Pregnancy|0
973429|NCT00604279|3204024|P1|Overall Study|Pregnancy|2
973430|NCT00604279|3204023|P2|Overall Study|Lost to Follow-up|14
973431|NCT00604279|3204024|P1|Overall Study|Lost to Follow-up|9
973432|NCT00604279|3204023|P2|Overall Study|Lack of Efficacy|9
973433|NCT00604279|3204024|P1|Overall Study|Lack of Efficacy|22
973434|NCT00604214|3204040|P2|Day 91 to Day 180|Withdrawal by Subject|1
973435|NCT00604214|3204041|P1|Day 91 to Day 180|Withdrawal by Subject|1
973436|NCT00604214|3204040|P2|Day 91 to Day 180|Lost to Follow-up|8
973437|NCT00604214|3204041|P1|Day 91 to Day 180|Lost to Follow-up|6
973438|NCT00604214|3204040|P2|Day 91 to Day 180|Death|23
973439|NCT00604214|3204041|P1|Day 91 to Day 180|Death|19
973440|NCT00604214|3204040|P2|Day 29 to Day 90|Withdrawal by Subject|6
973441|NCT00604214|3204041|P1|Day 29 to Day 90|Withdrawal by Subject|0
973442|NCT00604214|3204040|P2|Day 29 to Day 90|Lost to Follow-up|6
973443|NCT00604214|3204041|P1|Day 29 to Day 90|Lost to Follow-up|4
973444|NCT00604214|3204040|P2|Day 29 to Day 90|Death|67
973445|NCT00604214|3204041|P1|Day 29 to Day 90|Death|64
973446|NCT00604214|3204040|P2|Baseline to Day 28|Withdrawal by Subject|7
973447|NCT00604214|3204041|P1|Baseline to Day 28|Withdrawal by Subject|3
973448|NCT00604214|3204040|P2|Baseline to Day 28|Lost to Follow-up|4
973449|NCT00604214|3204041|P1|Baseline to Day 28|Lost to Follow-up|2
973450|NCT00604214|3204040|P2|Baseline to Day 28|Death|202
973451|NCT00604214|3204041|P1|Baseline to Day 28|Death|223
973452|NCT00604188|3204073|P2|Overall Study|Did not receive study drug|1
973453|NCT00604188|3204074|P1|Overall Study|Did not receive study drug|0
973454|NCT00604188|3204073|P2|Overall Study|Non-compliance with protocol|4
973455|NCT00604188|3204074|P1|Overall Study|Non-compliance with protocol|4
973456|NCT00604188|3204073|P2|Overall Study|Withdrawal by Subject|1
973457|NCT00604188|3204074|P1|Overall Study|Withdrawal by Subject|5
973458|NCT00604188|3204073|P2|Overall Study|Lost to Follow-up|15
973459|NCT00604188|3204074|P1|Overall Study|Lost to Follow-up|17
973460|NCT00604188|3204073|P2|Overall Study|Adverse Event|4
973461|NCT00604188|3204074|P1|Overall Study|Adverse Event|1
973462|NCT00604175|3204097|P3|Week 29 Through Week 72|Non-adherence to study requirements|1
973463|NCT00604175|3204098|P2|Week 29 Through Week 72|Non-adherence to study requirements|0
973464|NCT00604175|3204099|P1|Week 29 Through Week 72|Non-adherence to study requirements|0
973465|NCT00604175|3204097|P3|Week 29 Through Week 72|Site closure|0
973466|NCT00604175|3204098|P2|Week 29 Through Week 72|Site closure|1
973467|NCT00604175|3204099|P1|Week 29 Through Week 72|Site closure|0
973468|NCT00604175|3204097|P3|Week 29 Through Week 72|Lost to Follow-up|2
973469|NCT00604175|3204098|P2|Week 29 Through Week 72|Lost to Follow-up|6
973470|NCT00604175|3204099|P1|Week 29 Through Week 72|Lost to Follow-up|12
973471|NCT00604175|3204097|P3|Week 29 Through Week 72|Death|1
973472|NCT00604175|3204098|P2|Week 29 Through Week 72|Death|0
973473|NCT00604175|3204099|P1|Week 29 Through Week 72|Death|0
973474|NCT00604175|3204097|P3|Entry Through Week 28|Did not start intervention|1
973475|NCT00604175|3204098|P2|Entry Through Week 28|Did not start intervention|0
973476|NCT00604175|3204099|P1|Entry Through Week 28|Did not start intervention|2
973477|NCT00604175|3204097|P3|Entry Through Week 28|Ineligible|0
973478|NCT00604175|3204098|P2|Entry Through Week 28|Ineligible|0
973479|NCT00604175|3204099|P1|Entry Through Week 28|Ineligible|1
973480|NCT00604175|3204097|P3|Entry Through Week 28|Lost to Follow-up|0
973481|NCT00604175|3204098|P2|Entry Through Week 28|Lost to Follow-up|3
973482|NCT00604175|3204099|P1|Entry Through Week 28|Lost to Follow-up|4
973483|NCT00604175|3204097|P3|Entry Through Week 28|Withdrawal by Subject|0
973484|NCT00604175|3204098|P2|Entry Through Week 28|Withdrawal by Subject|0
973485|NCT00604175|3204099|P1|Entry Through Week 28|Withdrawal by Subject|1
973486|NCT00604175|3204097|P3|Entry Through Week 28|Death|0
973487|NCT00604175|3204098|P2|Entry Through Week 28|Death|0
973488|NCT00604175|3204099|P1|Entry Through Week 28|Death|2
973489|NCT00604162|3204152|P1|Overall Study|Withdrawal by Subject|1
973490|NCT00604162|3204152|P1|Overall Study|Physician Decision|3
973491|NCT00603915|3204194|P1|Overall Study|Physician Decision|1
973492|NCT00603837|3204224|P2|Overall Study|Physician Decision|0
973493|NCT00603837|3204225|P1|Overall Study|Physician Decision|3
973494|NCT00603798|3204234|P3|Overall Study|Not due to AE|4
973495|NCT00603798|3204235|P2|Overall Study|Not due to AE|1
973496|NCT00603798|3204236|P1|Overall Study|Not due to AE|1
973497|NCT00603798|3204234|P3|Overall Study|Non-compliance with study procedures|0
973498|NCT00603798|3204235|P2|Overall Study|Non-compliance with study procedures|1
973499|NCT00603798|3204236|P1|Overall Study|Non-compliance with study procedures|0
973500|NCT00603798|3204234|P3|Overall Study|Lost to Follow-up|1
973501|NCT00603798|3204235|P2|Overall Study|Lost to Follow-up|0
973502|NCT00603798|3204236|P1|Overall Study|Lost to Follow-up|1
973503|NCT00603798|3204234|P3|Overall Study|Withdrawal by Subject|4
973504|NCT00603798|3204235|P2|Overall Study|Withdrawal by Subject|3
973505|NCT00603798|3204236|P1|Overall Study|Withdrawal by Subject|4
973506|NCT00603798|3204234|P3|Overall Study|Adverse Event|1
973507|NCT00603798|3204235|P2|Overall Study|Adverse Event|2
973508|NCT00603798|3204236|P1|Overall Study|Adverse Event|4
973509|NCT00603746|3204259|P6|Overall Study|Withdrawal by Subject|1
973510|NCT00603746|3204260|P5|Overall Study|Withdrawal by Subject|3
973511|NCT00603746|3204261|P4|Overall Study|Withdrawal by Subject|1
973512|NCT00603746|3204262|P3|Overall Study|Withdrawal by Subject|0
973513|NCT00603746|3204263|P2|Overall Study|Withdrawal by Subject|0
973514|NCT00603746|3204264|P1|Overall Study|Withdrawal by Subject|1
973515|NCT00603746|3204259|P6|Overall Study|Physician Decision|0
973516|NCT00603746|3204260|P5|Overall Study|Physician Decision|1
973517|NCT00603746|3204261|P4|Overall Study|Physician Decision|0
973518|NCT00603746|3204262|P3|Overall Study|Physician Decision|0
973519|NCT00603746|3204263|P2|Overall Study|Physician Decision|0
973520|NCT00603746|3204264|P1|Overall Study|Physician Decision|1
973521|NCT00603746|3204259|P6|Overall Study|Lost to Follow-up|0
973522|NCT00603746|3204260|P5|Overall Study|Lost to Follow-up|0
973523|NCT00603746|3204261|P4|Overall Study|Lost to Follow-up|0
973524|NCT00603746|3204262|P3|Overall Study|Lost to Follow-up|1
973525|NCT00603746|3204263|P2|Overall Study|Lost to Follow-up|1
973526|NCT00603746|3204264|P1|Overall Study|Lost to Follow-up|0
973527|NCT00603746|3204259|P6|Overall Study|Protocol Violation|0
973528|NCT00603746|3204260|P5|Overall Study|Protocol Violation|1
973529|NCT00603746|3204261|P4|Overall Study|Protocol Violation|0
973530|NCT00603746|3204262|P3|Overall Study|Protocol Violation|1
973531|NCT00603746|3204263|P2|Overall Study|Protocol Violation|3
973532|NCT00603746|3204264|P1|Overall Study|Protocol Violation|0
973533|NCT00603746|3204259|P6|Overall Study|Lack of Efficacy|8
973534|NCT00603746|3204260|P5|Overall Study|Lack of Efficacy|12
973535|NCT00603746|3204261|P4|Overall Study|Lack of Efficacy|11
973536|NCT00603746|3204262|P3|Overall Study|Lack of Efficacy|6
973537|NCT00603746|3204263|P2|Overall Study|Lack of Efficacy|11
973538|NCT00603746|3204264|P1|Overall Study|Lack of Efficacy|34
973539|NCT00603746|3204259|P6|Overall Study|Adverse Event|4
973540|NCT00603746|3204260|P5|Overall Study|Adverse Event|0
973541|NCT00603746|3204261|P4|Overall Study|Adverse Event|1
973542|NCT00603746|3204262|P3|Overall Study|Adverse Event|0
973543|NCT00603746|3204263|P2|Overall Study|Adverse Event|3
973544|NCT00603746|3204264|P1|Overall Study|Adverse Event|2
973545|NCT00603733|3204412|P2|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5
973546|NCT00603733|3204413|P1|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3
973547|NCT00603733|3204412|P2|Maintenance Phase ITT|Physician Decision|1
973548|NCT00603733|3204413|P1|Maintenance Phase ITT|Physician Decision|0
973549|NCT00603733|3204412|P2|Maintenance Phase ITT|Lack of Efficacy|2
973550|NCT00603733|3204413|P1|Maintenance Phase ITT|Lack of Efficacy|2
973551|NCT00603733|3204412|P2|Maintenance Phase ITT|Lost to Follow-up|1
973552|NCT00603733|3204413|P1|Maintenance Phase ITT|Lost to Follow-up|0
973553|NCT00603733|3204412|P2|Maintenance Phase ITT|Protocol Violation|1
973554|NCT00603733|3204413|P1|Maintenance Phase ITT|Protocol Violation|1
973555|NCT00603733|3204412|P2|Maintenance Phase ITT|Withdrawal by Subject|0
973556|NCT00603733|3204413|P1|Maintenance Phase ITT|Withdrawal by Subject|1
973557|NCT00603733|3204412|P2|Maintenance Phase ITT|Adverse Event|6
973558|NCT00603733|3204413|P1|Maintenance Phase ITT|Adverse Event|3
973559|NCT00603733|3204412|P2|Run-In Phase - 4 Weeks|Lack of Efficacy|1
973560|NCT00603733|3204413|P1|Run-In Phase - 4 Weeks|Lack of Efficacy|2
973561|NCT00603733|3204412|P2|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10
973562|NCT00603733|3204413|P1|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5
973563|NCT00603733|3204412|P2|Run-In Phase - 4 Weeks|Lost to Follow-up|0
973564|NCT00603733|3204413|P1|Run-In Phase - 4 Weeks|Lost to Follow-up|1
973565|NCT00603733|3204412|P2|Run-In Phase - 4 Weeks|Withdrawal by Subject|1
973566|NCT00603733|3204413|P1|Run-In Phase - 4 Weeks|Withdrawal by Subject|4
973567|NCT00603733|3204412|P2|Run-In Phase - 4 Weeks|Adverse Event|1
973568|NCT00603733|3204413|P1|Run-In Phase - 4 Weeks|Adverse Event|2
973569|NCT00603733|3204412|P2|Active Phase ITT|Subject moved, site closed|1
973570|NCT00603733|3204413|P1|Active Phase ITT|Subject moved, site closed|1
973571|NCT00603733|3204412|P2|Active Phase ITT|Lack of Efficacy|2
973572|NCT00603733|3204413|P1|Active Phase ITT|Lack of Efficacy|1
973573|NCT00603733|3204412|P2|Active Phase ITT|Did not meet inclusion/exclusion|3
973574|NCT00603733|3204413|P1|Active Phase ITT|Did not meet inclusion/exclusion|1
973575|NCT00603733|3204412|P2|Active Phase ITT|Lost to Follow-up|1
973576|NCT00603733|3204413|P1|Active Phase ITT|Lost to Follow-up|0
973577|NCT00603733|3204412|P2|Active Phase ITT|Withdrawal by Subject|3
973578|NCT00603733|3204413|P1|Active Phase ITT|Withdrawal by Subject|0
973579|NCT00603733|3204412|P2|Active Phase ITT|Adverse Event|7
973580|NCT00603733|3204413|P1|Active Phase ITT|Adverse Event|8
973581|NCT00603590|3204463|P2|Overall Study|Cardiovascular event|1
973582|NCT00603590|3204464|P1|Overall Study|Cardiovascular event|0
973583|NCT00603590|3204463|P2|Overall Study|Lost to Follow-up|4
973584|NCT00603590|3204464|P1|Overall Study|Lost to Follow-up|8
973585|NCT00603590|3204463|P2|Overall Study|Adverse Event|0
973586|NCT00603590|3204464|P1|Overall Study|Adverse Event|2
973587|NCT00603590|3204463|P2|Overall Study|Patient discontinued study drug|15
973588|NCT00603590|3204464|P1|Overall Study|Patient discontinued study drug|22
973589|NCT00603590|3204463|P2|Overall Study|Refused blood test|1
973590|NCT00603590|3204464|P1|Overall Study|Refused blood test|5
973591|NCT00603590|3204463|P2|Overall Study|Did not attend study clinic|30
973592|NCT00603590|3204464|P1|Overall Study|Did not attend study clinic|39
973593|NCT00603538|3204488|P3|Overall Study|Objective progression or relapse|0
973594|NCT00603538|3204489|P2|Overall Study|Objective progression or relapse|0
973595|NCT00603538|3204490|P1|Overall Study|Objective progression or relapse|3
973596|NCT00603538|3204488|P3|Overall Study|Adverse Event|2
973597|NCT00603538|3204489|P2|Overall Study|Adverse Event|4
973598|NCT00603538|3204490|P1|Overall Study|Adverse Event|0
973599|NCT00603525|3204530|P3|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111
973600|NCT00603525|3204531|P2|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
973601|NCT00603525|3204532|P1|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
973602|NCT00603525|3204530|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
973603|NCT00603525|3204531|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8
973604|NCT00603525|3204532|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
973605|NCT00603525|3204530|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
973606|NCT00603525|3204531|P2|OL Treatment Period (120 Weeks)|Physician Decision|2
973607|NCT00603525|3204532|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
973608|NCT00603525|3204530|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
973609|NCT00603525|3204531|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71
973610|NCT00603525|3204532|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
973611|NCT00603525|3204530|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
973612|NCT00603525|3204531|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5
973613|NCT00603525|3204532|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
973614|NCT00603525|3204530|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
973615|NCT00603525|3204531|P2|OL Treatment Period (120 Weeks)|Protocol Violation|1
973616|NCT00603525|3204532|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
973617|NCT00603525|3204530|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
973618|NCT00603525|3204531|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|13
973619|NCT00603525|3204532|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
973620|NCT00603525|3204530|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
973621|NCT00603525|3204531|P2|OL Treatment Period (120 Weeks)|Adverse Event|12
973622|NCT00603525|3204532|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
973623|NCT00603525|3204530|P3|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
973624|NCT00603525|3204531|P2|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1
973625|NCT00603525|3204532|P1|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
973626|NCT00603525|3204530|P3|DB Treatment Period (24 Weeks)|Physician Decision|0
973627|NCT00603525|3204531|P2|DB Treatment Period (24 Weeks)|Physician Decision|1
973628|NCT00603525|3204532|P1|DB Treatment Period (24 Weeks)|Physician Decision|0
973629|NCT00603525|3204530|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
973630|NCT00603525|3204531|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6
973631|NCT00603525|3204532|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5
973632|NCT00603525|3204530|P3|DB Treatment Period (24 Weeks)|Lost to Follow-up|0
973633|NCT00603525|3204531|P2|DB Treatment Period (24 Weeks)|Lost to Follow-up|3
973634|NCT00603525|3204532|P1|DB Treatment Period (24 Weeks)|Lost to Follow-up|1
973635|NCT00603525|3204530|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
973636|NCT00603525|3204531|P2|DB Treatment Period (24 Weeks)|Protocol Violation|2
973637|NCT00603525|3204532|P1|DB Treatment Period (24 Weeks)|Protocol Violation|1
973638|NCT00603525|3204530|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
973639|NCT00603525|3204531|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
973640|NCT00603525|3204532|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|7
973641|NCT00603525|3204530|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
973642|NCT00603525|3204531|P2|DB Treatment Period (24 Weeks)|Adverse Event|9
973643|NCT00603525|3204532|P1|DB Treatment Period (24 Weeks)|Adverse Event|3
973644|NCT00603512|3204664|P5|Overall Study|Randomized but not treated|0
973645|NCT00603512|3204665|P4|Overall Study|Randomized but not treated|2
973646|NCT00603512|3204666|P3|Overall Study|Randomized but not treated|1
973647|NCT00603512|3204667|P2|Overall Study|Randomized but not treated|1
973648|NCT00603512|3204668|P1|Overall Study|Randomized but not treated|0
973649|NCT00603512|3204664|P5|Overall Study|Withdrawal by Subject|1
973650|NCT00603512|3204665|P4|Overall Study|Withdrawal by Subject|0
973651|NCT00603512|3204666|P3|Overall Study|Withdrawal by Subject|0
973652|NCT00603512|3204667|P2|Overall Study|Withdrawal by Subject|0
973653|NCT00603512|3204668|P1|Overall Study|Withdrawal by Subject|0
973654|NCT00603512|3204664|P5|Overall Study|Other|1
973655|NCT00603512|3204665|P4|Overall Study|Other|1
973656|NCT00603512|3204666|P3|Overall Study|Other|0
973657|NCT00603512|3204667|P2|Overall Study|Other|1
973658|NCT00603512|3204668|P1|Overall Study|Other|2
973659|NCT00603512|3204664|P5|Overall Study|Lack of Efficacy|1
973660|NCT00603512|3204665|P4|Overall Study|Lack of Efficacy|0
973661|NCT00603512|3204666|P3|Overall Study|Lack of Efficacy|0
973662|NCT00603512|3204667|P2|Overall Study|Lack of Efficacy|1
973663|NCT00603512|3204668|P1|Overall Study|Lack of Efficacy|0
973664|NCT00603512|3204664|P5|Overall Study|Adverse Event|2
973665|NCT00603512|3204665|P4|Overall Study|Adverse Event|4
973666|NCT00603512|3204666|P3|Overall Study|Adverse Event|4
973667|NCT00603512|3204667|P2|Overall Study|Adverse Event|2
973668|NCT00603512|3204668|P1|Overall Study|Adverse Event|0
973669|NCT00603473|3204810|P1|Overall Study|Protocol Violation|1
973670|NCT00603473|3204810|P1|Overall Study|Lack of Efficacy|4
973671|NCT00603473|3204810|P1|Overall Study|Adverse Event|4
973672|NCT00603447|3204823|P7|Overall Study|Withdrew Consent|1
973673|NCT00603447|3204824|P6|Overall Study|Withdrew Consent|0
973674|NCT00603447|3204825|P5|Overall Study|Withdrew Consent|1
973675|NCT00603447|3204826|P4|Overall Study|Withdrew Consent|0
973676|NCT00603447|3204827|P3|Overall Study|Withdrew Consent|0
973677|NCT00603447|3204828|P2|Overall Study|Withdrew Consent|2
973678|NCT00603447|3204829|P1|Overall Study|Withdrew Consent|0
973679|NCT00603447|3204823|P7|Overall Study|Other|13
973680|NCT00603447|3204824|P6|Overall Study|Other|0
973681|NCT00603447|3204825|P5|Overall Study|Other|3
973682|NCT00603447|3204826|P4|Overall Study|Other|0
973683|NCT00603447|3204827|P3|Overall Study|Other|1
973684|NCT00603447|3204828|P2|Overall Study|Other|0
973685|NCT00603447|3204829|P1|Overall Study|Other|0
973686|NCT00603447|3204823|P7|Overall Study|Adverse Event|10
973687|NCT00603447|3204824|P6|Overall Study|Adverse Event|2
973688|NCT00603447|3204825|P5|Overall Study|Adverse Event|1
973689|NCT00603447|3204826|P4|Overall Study|Adverse Event|2
973690|NCT00603447|3204827|P3|Overall Study|Adverse Event|1
973691|NCT00603447|3204828|P2|Overall Study|Adverse Event|1
973692|NCT00603447|3204829|P1|Overall Study|Adverse Event|0
973693|NCT00603382|3204868|P6|Overall Study|Withdrawal by Subject|1
973694|NCT00603382|3204869|P5|Overall Study|Withdrawal by Subject|0
973695|NCT00603382|3204870|P4|Overall Study|Withdrawal by Subject|1
973696|NCT00603382|3204871|P3|Overall Study|Withdrawal by Subject|1
973697|NCT00603382|3204872|P2|Overall Study|Withdrawal by Subject|3
973698|NCT00603382|3204873|P1|Overall Study|Withdrawal by Subject|3
973699|NCT00603382|3204868|P6|Overall Study|Physician Decision|3
973700|NCT00603382|3204869|P5|Overall Study|Physician Decision|1
973701|NCT00603382|3204870|P4|Overall Study|Physician Decision|0
973702|NCT00603382|3204871|P3|Overall Study|Physician Decision|2
973703|NCT00603382|3204872|P2|Overall Study|Physician Decision|0
973704|NCT00603382|3204873|P1|Overall Study|Physician Decision|0
973705|NCT00603382|3204868|P6|Overall Study|Lost to Follow-up|1
973706|NCT00603382|3204869|P5|Overall Study|Lost to Follow-up|0
973707|NCT00603382|3204870|P4|Overall Study|Lost to Follow-up|1
973708|NCT00603382|3204871|P3|Overall Study|Lost to Follow-up|1
973709|NCT00603382|3204872|P2|Overall Study|Lost to Follow-up|1
973710|NCT00603382|3204873|P1|Overall Study|Lost to Follow-up|0
973711|NCT00603382|3204868|P6|Overall Study|Protocol Violation|0
973712|NCT00603382|3204869|P5|Overall Study|Protocol Violation|1
973713|NCT00603382|3204870|P4|Overall Study|Protocol Violation|2
973714|NCT00603382|3204871|P3|Overall Study|Protocol Violation|1
973715|NCT00603382|3204872|P2|Overall Study|Protocol Violation|0
973716|NCT00603382|3204873|P1|Overall Study|Protocol Violation|1
973717|NCT00603382|3204868|P6|Overall Study|Lack of Efficacy|11
973718|NCT00603382|3204869|P5|Overall Study|Lack of Efficacy|6
973719|NCT00603382|3204870|P4|Overall Study|Lack of Efficacy|6
973720|NCT00603382|3204871|P3|Overall Study|Lack of Efficacy|3
973721|NCT00603382|3204872|P2|Overall Study|Lack of Efficacy|9
973722|NCT00603382|3204873|P1|Overall Study|Lack of Efficacy|14
973723|NCT00603382|3204868|P6|Overall Study|Adverse Event|2
973724|NCT00603382|3204869|P5|Overall Study|Adverse Event|1
973725|NCT00603382|3204870|P4|Overall Study|Adverse Event|2
973726|NCT00603382|3204871|P3|Overall Study|Adverse Event|1
973727|NCT00603382|3204872|P2|Overall Study|Adverse Event|1
973728|NCT00603382|3204873|P1|Overall Study|Adverse Event|0
973729|NCT00603304|3205021|P2|Overall Study|Patient Decision|0
973730|NCT00603304|3205022|P1|Overall Study|Patient Decision|2
973731|NCT00603304|3205021|P2|Overall Study|Not Specified|0
973732|NCT00603304|3205022|P1|Overall Study|Not Specified|2
973733|NCT00603304|3205021|P2|Overall Study|Moved Away|2
973734|NCT00603304|3205022|P1|Overall Study|Moved Away|0
973735|NCT00603304|3205021|P2|Overall Study|Non-Compliant|1
973736|NCT00603304|3205022|P1|Overall Study|Non-Compliant|0
973737|NCT00603304|3205021|P2|Overall Study|Exclusionary Medication|3
973738|NCT00603304|3205022|P1|Overall Study|Exclusionary Medication|2
973739|NCT00603304|3205021|P2|Overall Study|Crossed Over to Open Label Therapy|3
973740|NCT00603304|3205022|P1|Overall Study|Crossed Over to Open Label Therapy|3
973741|NCT00603304|3205021|P2|Overall Study|Unacceptable Treatment Toxicity|8
973742|NCT00603304|3205022|P1|Overall Study|Unacceptable Treatment Toxicity|5
973743|NCT00603304|3205021|P2|Overall Study|Adverse Event|2
973744|NCT00603304|3205022|P1|Overall Study|Adverse Event|4
973745|NCT00603304|3205021|P2|Overall Study|Protocol Violation|0
973746|NCT00603304|3205022|P1|Overall Study|Protocol Violation|1
973747|NCT00603304|3205021|P2|Overall Study|Withdrawal by Subject|5
973748|NCT00603304|3205022|P1|Overall Study|Withdrawal by Subject|8
973749|NCT00603304|3205021|P2|Overall Study|Lost to Follow-up|7
973750|NCT00603304|3205022|P1|Overall Study|Lost to Follow-up|5
973751|NCT00603278|3205078|P6|Overall Study|Lost to Follow-up|0
973752|NCT00603278|3205079|P5|Overall Study|Lost to Follow-up|1
973753|NCT00603278|3205080|P4|Overall Study|Lost to Follow-up|0
973754|NCT00603278|3205081|P3|Overall Study|Lost to Follow-up|0
973755|NCT00603278|3205082|P2|Overall Study|Lost to Follow-up|0
973756|NCT00603278|3205083|P1|Overall Study|Lost to Follow-up|1
973757|NCT00603278|3205078|P6|Overall Study|Physician Decision|1
973758|NCT00603278|3205079|P5|Overall Study|Physician Decision|2
973759|NCT00603278|3205080|P4|Overall Study|Physician Decision|0
973760|NCT00603278|3205081|P3|Overall Study|Physician Decision|0
973761|NCT00603278|3205082|P2|Overall Study|Physician Decision|1
973762|NCT00603278|3205083|P1|Overall Study|Physician Decision|0
973763|NCT00603278|3205078|P6|Overall Study|Protocol Violation|1
973764|NCT00603278|3205079|P5|Overall Study|Protocol Violation|0
973765|NCT00603278|3205080|P4|Overall Study|Protocol Violation|1
973766|NCT00603278|3205081|P3|Overall Study|Protocol Violation|1
973767|NCT00603278|3205082|P2|Overall Study|Protocol Violation|0
973768|NCT00603278|3205083|P1|Overall Study|Protocol Violation|3
973769|NCT00603278|3205078|P6|Overall Study|Withdrawal by Subject|2
973770|NCT00603278|3205079|P5|Overall Study|Withdrawal by Subject|1
973771|NCT00603278|3205080|P4|Overall Study|Withdrawal by Subject|2
973772|NCT00603278|3205081|P3|Overall Study|Withdrawal by Subject|1
973773|NCT00603278|3205082|P2|Overall Study|Withdrawal by Subject|3
973774|NCT00603278|3205083|P1|Overall Study|Withdrawal by Subject|2
973775|NCT00603278|3205078|P6|Overall Study|Adverse Event|1
973776|NCT00603278|3205079|P5|Overall Study|Adverse Event|2
973777|NCT00603278|3205080|P4|Overall Study|Adverse Event|0
973778|NCT00603278|3205081|P3|Overall Study|Adverse Event|1
973779|NCT00603278|3205082|P2|Overall Study|Adverse Event|3
973780|NCT00603278|3205083|P1|Overall Study|Adverse Event|0
973781|NCT00603278|3205078|P6|Overall Study|Lack of Efficacy|14
973782|NCT00603278|3205079|P5|Overall Study|Lack of Efficacy|7
973783|NCT00603278|3205080|P4|Overall Study|Lack of Efficacy|8
973784|NCT00603278|3205081|P3|Overall Study|Lack of Efficacy|11
973785|NCT00603278|3205082|P2|Overall Study|Lack of Efficacy|10
973786|NCT00603278|3205083|P1|Overall Study|Lack of Efficacy|35
973787|NCT00603265|3205232|P3|Overall Study|Protocol Violation|0
973788|NCT00603265|3205233|P2|Overall Study|Protocol Violation|0
973789|NCT00603265|3205234|P1|Overall Study|Protocol Violation|1
973790|NCT00603265|3205232|P3|Overall Study|Participant Left Country, No Responses|0
973791|NCT00603265|3205233|P2|Overall Study|Participant Left Country, No Responses|1
973792|NCT00603265|3205234|P1|Overall Study|Participant Left Country, No Responses|0
973793|NCT00603265|3205232|P3|Overall Study|Out of Town, Ran Out of Study Drug|0
973794|NCT00603265|3205233|P2|Overall Study|Out of Town, Ran Out of Study Drug|1
973795|NCT00603265|3205234|P1|Overall Study|Out of Town, Ran Out of Study Drug|0
973796|NCT00603265|3205232|P3|Overall Study|Lost to Follow-up|0
973797|NCT00603265|3205233|P2|Overall Study|Lost to Follow-up|1
973798|NCT00603265|3205234|P1|Overall Study|Lost to Follow-up|0
973799|NCT00603265|3205232|P3|Overall Study|Lack of Efficacy|3
973800|NCT00603265|3205233|P2|Overall Study|Lack of Efficacy|0
973801|NCT00603265|3205234|P1|Overall Study|Lack of Efficacy|3
973802|NCT00603265|3205232|P3|Overall Study|Withdrawal by Subject|1
973803|NCT00603265|3205233|P2|Overall Study|Withdrawal by Subject|2
973804|NCT00603265|3205234|P1|Overall Study|Withdrawal by Subject|1
973805|NCT00603265|3205232|P3|Overall Study|Adverse Event|1
973806|NCT00603265|3205233|P2|Overall Study|Adverse Event|11
973807|NCT00603265|3205234|P1|Overall Study|Adverse Event|2
973808|NCT00603239|3205262|P2|Overall Study|Subject decision|1
973809|NCT00603239|3205263|P1|Overall Study|Subject decision|2
973810|NCT00603239|3205262|P2|Overall Study|Protocol Violation|0
973811|NCT00603239|3205263|P1|Overall Study|Protocol Violation|2
973812|NCT00603239|3205262|P2|Overall Study|Physician Decision|0
973813|NCT00603239|3205263|P1|Overall Study|Physician Decision|2
973814|NCT00603239|3205262|P2|Overall Study|Lost to Follow-up|1
973815|NCT00603239|3205263|P1|Overall Study|Lost to Follow-up|2
973816|NCT00603239|3205262|P2|Overall Study|Loss of glucose control|0
973817|NCT00603239|3205263|P1|Overall Study|Loss of glucose control|3
973818|NCT00603239|3205262|P2|Overall Study|Entry criteria not met|1
973819|NCT00603239|3205263|P1|Overall Study|Entry criteria not met|0
973820|NCT00603239|3205262|P2|Overall Study|Adverse Event|1
973821|NCT00603239|3205263|P1|Overall Study|Adverse Event|4
973822|NCT00602979|3205324|P5|Overall Study|Failed Intubation|0
973823|NCT00602979|3205325|P4|Overall Study|Failed Intubation|1
973824|NCT00602979|3205326|P3|Overall Study|Failed Intubation|0
973825|NCT00602979|3205327|P2|Overall Study|Failed Intubation|1
973826|NCT00602979|3205328|P1|Overall Study|Failed Intubation|0
973827|NCT00602979|3205324|P5|Overall Study|Lost to Follow-up|3
973828|NCT00602979|3205325|P4|Overall Study|Lost to Follow-up|2
973829|NCT00602979|3205326|P3|Overall Study|Lost to Follow-up|3
973830|NCT00602979|3205327|P2|Overall Study|Lost to Follow-up|2
973831|NCT00602979|3205328|P1|Overall Study|Lost to Follow-up|3
973832|NCT00602927|3205378|P2|Period 3: 13 Days|MRI data quality|2
973833|NCT00602927|3205379|P1|Period 3: 13 Days|MRI data quality|2
973834|NCT00602927|3205378|P2|Period 3: 13 Days|Protocol Violation|1
973835|NCT00602927|3205379|P1|Period 3: 13 Days|Protocol Violation|0
973836|NCT00602927|3205378|P2|Period 2: 14 Days|Protocol Violation|2
973837|NCT00602927|3205379|P1|Period 2: 14 Days|Protocol Violation|0
973838|NCT00602927|3205378|P2|Period 1: 13 Days|Claustrophobia|1
973839|NCT00602927|3205379|P1|Period 1: 13 Days|Claustrophobia|0
973840|NCT00602927|3205378|P2|Period 1: 13 Days|Time|0
973841|NCT00602927|3205379|P1|Period 1: 13 Days|Time|1
973842|NCT00602927|3205378|P2|Period 1: 13 Days|MRI scanner technical issue|0
973843|NCT00602927|3205379|P1|Period 1: 13 Days|MRI scanner technical issue|1
973844|NCT00602927|3205378|P2|Period 1: 13 Days|Protocol Violation|4
973845|NCT00602927|3205379|P1|Period 1: 13 Days|Protocol Violation|2
973846|NCT00602797|3205391|P1|Overall Study|Adverse Event|1
973847|NCT00602641|3205408|P2|Overall Study|Other|1
973848|NCT00602641|3205409|P1|Overall Study|Other|3
973849|NCT00602641|3205408|P2|Overall Study|Administrative Closure|1
973850|NCT00602641|3205409|P1|Overall Study|Administrative Closure|1
973851|NCT00602641|3205408|P2|Overall Study|Physician Decision|4
973852|NCT00602641|3205409|P1|Overall Study|Physician Decision|5
973853|NCT00602641|3205408|P2|Overall Study|Other Complicating Disease|2
973854|NCT00602641|3205409|P1|Overall Study|Other Complicating Disease|5
973855|NCT00602641|3205408|P2|Overall Study|Alternative therapy|2
973856|NCT00602641|3205409|P1|Overall Study|Alternative therapy|5
973857|NCT00602641|3205408|P2|Overall Study|Withdrawal by Subject|12
973858|NCT00602641|3205409|P1|Overall Study|Withdrawal by Subject|15
973859|NCT00602641|3205408|P2|Overall Study|Death|5
973860|NCT00602641|3205409|P1|Overall Study|Death|6
973861|NCT00602641|3205408|P2|Overall Study|Disease progression|55
973862|NCT00602641|3205409|P1|Overall Study|Disease progression|38
973863|NCT00602641|3205408|P2|Overall Study|Adverse Event|53
973864|NCT00602641|3205409|P1|Overall Study|Adverse Event|62
973865|NCT00602641|3205408|P2|Overall Study|Still on treatment at time of analysis|15
973866|NCT00602641|3205409|P1|Overall Study|Still on treatment at time of analysis|8
973867|NCT00602641|3205408|P2|Overall Study|Never started protocol therapy|2
973868|NCT00602641|3205409|P1|Overall Study|Never started protocol therapy|6
973869|NCT00602537|3205423|P2|Follow Up Study Comparison|Withdrawal by Subject|2
973870|NCT00602537|3205424|P1|Follow Up Study Comparison|Withdrawal by Subject|2
973871|NCT00602537|3205423|P2|Follow Up Study Comparison|Lost to Follow-up|1
973872|NCT00602537|3205424|P1|Follow Up Study Comparison|Lost to Follow-up|8
973873|NCT00602537|3205423|P2|Follow Up Study Comparison|Adverse Event|0
973874|NCT00602537|3205424|P1|Follow Up Study Comparison|Adverse Event|1
973875|NCT00602537|3205423|P2|12 Week Double Blind Comparison|Withdrawal by Subject|13
973876|NCT00602537|3205424|P1|12 Week Double Blind Comparison|Withdrawal by Subject|3
973877|NCT00602537|3205423|P2|12 Week Double Blind Comparison|Lost to Follow-up|6
973878|NCT00602537|3205424|P1|12 Week Double Blind Comparison|Lost to Follow-up|5
973879|NCT00602537|3205423|P2|12 Week Double Blind Comparison|Lack of Efficacy|23
973880|NCT00602537|3205424|P1|12 Week Double Blind Comparison|Lack of Efficacy|13
973881|NCT00602537|3205423|P2|12 Week Double Blind Comparison|Adverse Event|5
973882|NCT00602537|3205424|P1|12 Week Double Blind Comparison|Adverse Event|2
973883|NCT00602472|3205434|P2|Overall Study|Other incl. lack of efficacy|2
973884|NCT00602472|3205435|P1|Overall Study|Other incl. lack of efficacy|4
973885|NCT00602472|3205434|P2|Overall Study|Withdrawal by Subject|14
973886|NCT00602472|3205435|P1|Overall Study|Withdrawal by Subject|8
973887|NCT00602472|3205434|P2|Overall Study|Protocol Violation|19
973888|NCT00602472|3205435|P1|Overall Study|Protocol Violation|4
973889|NCT00602472|3205434|P2|Overall Study|Adverse Event|23
973890|NCT00602472|3205435|P1|Overall Study|Adverse Event|5
973891|NCT00602420|3205500|P2|Overall Study|Adverse Event|0
973892|NCT00602420|3205501|P1|Overall Study|Adverse Event|1
973893|NCT00602420|3205500|P2|Overall Study|Withdrawal by Subject|17
973894|NCT00602420|3205501|P1|Overall Study|Withdrawal by Subject|18
973895|NCT00602420|3205500|P2|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3
973896|NCT00602420|3205501|P1|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5
973897|NCT00602420|3205500|P2|Overall Study|Death|4
973898|NCT00602420|3205501|P1|Overall Study|Death|1
973899|NCT00601900|3205609|P2|Overall Study|Withdrawal by Subject|3
973900|NCT00601900|3205610|P1|Overall Study|Withdrawal by Subject|0
973901|NCT00601835|3205626|P2|Overall Study|Relocate|2
973902|NCT00601835|3205627|P1|Overall Study|Relocate|12
973903|NCT00601835|3205626|P2|Overall Study|Adverse Event|1
973904|NCT00601835|3205627|P1|Overall Study|Adverse Event|1
973905|NCT00601835|3205626|P2|Overall Study|Lost to Follow-up|5
973906|NCT00601835|3205627|P1|Overall Study|Lost to Follow-up|37
973907|NCT00601835|3205626|P2|Overall Study|Physician Decision|0
973908|NCT00601835|3205627|P1|Overall Study|Physician Decision|1
973909|NCT00601835|3205626|P2|Overall Study|Withdrawal by Subject|6
973910|NCT00601835|3205627|P1|Overall Study|Withdrawal by Subject|9
973911|NCT00601640|3205719|P3|Overall Study|change in eligibility status|1
973912|NCT00601640|3205720|P2|Overall Study|change in eligibility status|1
973913|NCT00601640|3205721|P1|Overall Study|change in eligibility status|0
973914|NCT00601640|3205719|P3|Overall Study|intercurrent illness|0
973915|NCT00601640|3205720|P2|Overall Study|intercurrent illness|0
973916|NCT00601640|3205721|P1|Overall Study|intercurrent illness|1
973917|NCT00601640|3205719|P3|Overall Study|Adverse Event|2
973918|NCT00601640|3205720|P2|Overall Study|Adverse Event|4
973919|NCT00601640|3205721|P1|Overall Study|Adverse Event|0
973920|NCT00601640|3205719|P3|Overall Study|Death|0
973921|NCT00601640|3205720|P2|Overall Study|Death|0
973922|NCT00601640|3205721|P1|Overall Study|Death|1
973923|NCT00601640|3205719|P3|Overall Study|Withdrawal by Subject|7
973924|NCT00601640|3205720|P2|Overall Study|Withdrawal by Subject|0
973925|NCT00601640|3205721|P1|Overall Study|Withdrawal by Subject|3
973926|NCT00601523|3205746|P2|Overall Study|not specified|1
973927|NCT00601523|3205747|P1|Overall Study|not specified|9
973928|NCT00601523|3205746|P2|Overall Study|Withdrawal by Subject|9
973929|NCT00601523|3205747|P1|Overall Study|Withdrawal by Subject|18
973930|NCT00601523|3205746|P2|Overall Study|Lost to Follow-up|1
973931|NCT00601523|3205747|P1|Overall Study|Lost to Follow-up|0
973932|NCT00601523|3205746|P2|Overall Study|Protocol Violation|1
973933|NCT00601523|3205747|P1|Overall Study|Protocol Violation|5
973934|NCT00601523|3205746|P2|Overall Study|Lack of Efficacy|0
973935|NCT00601523|3205747|P1|Overall Study|Lack of Efficacy|3
973936|NCT00601523|3205746|P2|Overall Study|Adverse Event|14
973937|NCT00601523|3205747|P1|Overall Study|Adverse Event|42
973938|NCT00601458|3205782|P3|Overall Study|Early Termination|1
973939|NCT00601458|3205783|P2|Overall Study|Early Termination|1
973940|NCT00601458|3205784|P1|Overall Study|Early Termination|0
973941|NCT00601458|3205782|P3|Overall Study|Protocol Violation|1
973942|NCT00601458|3205783|P2|Overall Study|Protocol Violation|2
973943|NCT00601458|3205784|P1|Overall Study|Protocol Violation|3
973944|NCT00601458|3205782|P3|Overall Study|Incomplete Data|0
973945|NCT00601458|3205783|P2|Overall Study|Incomplete Data|2
973946|NCT00601458|3205784|P1|Overall Study|Incomplete Data|0
973947|NCT00601458|3205782|P3|Overall Study|Dosing Error|0
973948|NCT00601458|3205783|P2|Overall Study|Dosing Error|0
973949|NCT00601458|3205784|P1|Overall Study|Dosing Error|1
973950|NCT00601419|3205795|P1|Overall Study|Missed Visits|1
973951|NCT00601419|3205795|P1|Overall Study|Lost to Follow-up|3
973952|NCT00601354|3205825|P2|Overall Study|Lost to Follow-up|5
973953|NCT00601354|3205826|P1|Overall Study|Lost to Follow-up|4
973954|NCT00601250|3205838|P2|Overall Study|Other incl. lack of efficacy|9
973955|NCT00601250|3205839|P1|Overall Study|Other incl. lack of efficacy|2
973956|NCT00601250|3205838|P2|Overall Study|Withdrawal by Subject|13
973957|NCT00601250|3205839|P1|Overall Study|Withdrawal by Subject|4
973958|NCT00601250|3205838|P2|Overall Study|Lost to Follow-up|6
973959|NCT00601250|3205839|P1|Overall Study|Lost to Follow-up|2
973960|NCT00601250|3205838|P2|Overall Study|Protocol Violation|2
973961|NCT00601250|3205839|P1|Overall Study|Protocol Violation|3
973962|NCT00601250|3205838|P2|Overall Study|Adverse Event|9
973963|NCT00601250|3205839|P1|Overall Study|Adverse Event|3
973964|NCT00601172|3205875|P2|Overall Study|Did not meet continuation criteria|20
973965|NCT00601172|3205876|P1|Overall Study|Did not meet continuation criteria|19
973966|NCT00601172|3205875|P2|Overall Study|Withdrawal by Subject|27
973967|NCT00601172|3205876|P1|Overall Study|Withdrawal by Subject|35
973968|NCT00601172|3205875|P2|Overall Study|Physician Decision|28
973969|NCT00601172|3205876|P1|Overall Study|Physician Decision|27
973970|NCT00601172|3205875|P2|Overall Study|Lost to Follow-up|3
973971|NCT00601172|3205876|P1|Overall Study|Lost to Follow-up|4
973972|NCT00601172|3205875|P2|Overall Study|Protocol Violation|5
973973|NCT00601172|3205876|P1|Overall Study|Protocol Violation|2
973974|NCT00601172|3205875|P2|Overall Study|Lack of Efficacy|12
973975|NCT00601172|3205876|P1|Overall Study|Lack of Efficacy|11
973976|NCT00601172|3205875|P2|Overall Study|Adverse Event|32
973977|NCT00601172|3205876|P1|Overall Study|Adverse Event|43
973978|NCT00601107|3205933|P4|Overall Study|Undefined|0
973979|NCT00601107|3205934|P3|Overall Study|Undefined|1
973980|NCT00601107|3205935|P2|Overall Study|Undefined|0
973981|NCT00601107|3205936|P1|Overall Study|Undefined|1
973982|NCT00601107|3205933|P4|Overall Study|Worsening of Psoriasis|4
973983|NCT00601107|3205934|P3|Overall Study|Worsening of Psoriasis|1
973984|NCT00601107|3205935|P2|Overall Study|Worsening of Psoriasis|1
973985|NCT00601107|3205936|P1|Overall Study|Worsening of Psoriasis|4
973986|NCT00601107|3205933|P4|Overall Study|Serum Calcium >11.5 milligram/deciliter|1
973987|NCT00601107|3205934|P3|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
973988|NCT00601107|3205935|P2|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
973989|NCT00601107|3205936|P1|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
973990|NCT00601107|3205933|P4|Overall Study|Lost to Follow-up|3
973991|NCT00601107|3205934|P3|Overall Study|Lost to Follow-up|0
973992|NCT00601107|3205935|P2|Overall Study|Lost to Follow-up|3
973993|NCT00601107|3205936|P1|Overall Study|Lost to Follow-up|3
973994|NCT00601107|3205933|P4|Overall Study|Withdrawal by Subject|4
973995|NCT00601107|3205934|P3|Overall Study|Withdrawal by Subject|7
973996|NCT00601107|3205935|P2|Overall Study|Withdrawal by Subject|4
973997|NCT00601107|3205936|P1|Overall Study|Withdrawal by Subject|5
973998|NCT00601107|3205933|P4|Overall Study|Adverse Event|0
973999|NCT00601107|3205934|P3|Overall Study|Adverse Event|3
974000|NCT00601107|3205935|P2|Overall Study|Adverse Event|1
974001|NCT00601107|3205936|P1|Overall Study|Adverse Event|0
974002|NCT00600938|3205956|P4|Extension Study|Death|0
974003|NCT00600938|3205957|P3|Extension Study|Death|0
974004|NCT00600938|3205958|P2|Extension Study|Death|0
974005|NCT00600938|3205959|P1|Extension Study|Death|1
974006|NCT00600938|3205956|P4|Extension Study|Lost to Follow-up|0
974007|NCT00600938|3205957|P3|Extension Study|Lost to Follow-up|2
974008|NCT00600938|3205958|P2|Extension Study|Lost to Follow-up|1
974009|NCT00600938|3205959|P1|Extension Study|Lost to Follow-up|1
974010|NCT00600938|3205956|P4|Extension Study|Withdrawal by Subject|0
974011|NCT00600938|3205957|P3|Extension Study|Withdrawal by Subject|3
974012|NCT00600938|3205958|P2|Extension Study|Withdrawal by Subject|2
974013|NCT00600938|3205959|P1|Extension Study|Withdrawal by Subject|2
974014|NCT00600938|3205956|P4|Extension Study|Unsatisfactory therapeutic effect|0
974015|NCT00600938|3205957|P3|Extension Study|Unsatisfactory therapeutic effect|1
974016|NCT00600938|3205958|P2|Extension Study|Unsatisfactory therapeutic effect|1
974017|NCT00600938|3205959|P1|Extension Study|Unsatisfactory therapeutic effect|4
974018|NCT00600938|3205956|P4|Extension Study|Abnormal test procedure results|1
974019|NCT00600938|3205957|P3|Extension Study|Abnormal test procedure results|1
974020|NCT00600938|3205958|P2|Extension Study|Abnormal test procedure results|1
974021|NCT00600938|3205959|P1|Extension Study|Abnormal test procedure results|0
974022|NCT00600938|3205956|P4|Extension Study|Adverse Event|0
974023|NCT00600938|3205957|P3|Extension Study|Adverse Event|2
974024|NCT00600938|3205958|P2|Extension Study|Adverse Event|0
974025|NCT00600938|3205959|P1|Extension Study|Adverse Event|1
974026|NCT00600938|3205956|P4|Core Study|Protocol Violation|0
974027|NCT00600938|3205957|P3|Core Study|Protocol Violation|0
974028|NCT00600938|3205958|P2|Core Study|Protocol Violation|2
974029|NCT00600938|3205959|P1|Core Study|Protocol Violation|1
974030|NCT00600938|3205956|P4|Core Study|Death|0
974031|NCT00600938|3205957|P3|Core Study|Death|0
974032|NCT00600938|3205958|P2|Core Study|Death|1
974033|NCT00600938|3205959|P1|Core Study|Death|1
974034|NCT00600938|3205956|P4|Core Study|Lost to Follow-up|0
974035|NCT00600938|3205957|P3|Core Study|Lost to Follow-up|0
974036|NCT00600938|3205958|P2|Core Study|Lost to Follow-up|2
974037|NCT00600938|3205959|P1|Core Study|Lost to Follow-up|3
974038|NCT00600938|3205956|P4|Core Study|Patient withdrew consent|0
974039|NCT00600938|3205957|P3|Core Study|Patient withdrew consent|0
974040|NCT00600938|3205958|P2|Core Study|Patient withdrew consent|12
974041|NCT00600938|3205959|P1|Core Study|Patient withdrew consent|7
974042|NCT00600938|3205956|P4|Core Study|Unsatisfactory therapeutic effect|0
974043|NCT00600938|3205957|P3|Core Study|Unsatisfactory therapeutic effect|0
974044|NCT00600938|3205958|P2|Core Study|Unsatisfactory therapeutic effect|2
974045|NCT00600938|3205959|P1|Core Study|Unsatisfactory therapeutic effect|1
974046|NCT00600938|3205956|P4|Core Study|Abnormal test procedure result(s)|0
974047|NCT00600938|3205957|P3|Core Study|Abnormal test procedure result(s)|0
974048|NCT00600938|3205958|P2|Core Study|Abnormal test procedure result(s)|2
974049|NCT00600938|3205959|P1|Core Study|Abnormal test procedure result(s)|3
974050|NCT00600886|3206023|P2|Extension - After Crossover (CAS)|Death|0
974051|NCT00600886|3206024|P1|Extension - After Crossover (CAS)|Death|1
974052|NCT00600886|3206023|P2|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0
974053|NCT00600886|3206024|P1|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3
974054|NCT00600886|3206023|P2|Extension - After Crossover (CAS)|Subject no longer requires study drug|0
974055|NCT00600886|3206024|P1|Extension - After Crossover (CAS)|Subject no longer requires study drug|3
974056|NCT00600886|3206023|P2|Extension - After Crossover (CAS)|Administrative Problems|4
974057|NCT00600886|3206024|P1|Extension - After Crossover (CAS)|Administrative Problems|4
974058|NCT00600886|3206023|P2|Extension - After Crossover (CAS)|Lack of Efficacy|4
974059|NCT00600886|3206024|P1|Extension - After Crossover (CAS)|Lack of Efficacy|13
974060|NCT00600886|3206023|P2|Extension - After Crossover (CAS)|Withdrawal by Subject|4
974061|NCT00600886|3206024|P1|Extension - After Crossover (CAS)|Withdrawal by Subject|19
974062|NCT00600886|3206023|P2|Extension - After Crossover (CAS)|Adverse Event|1
974063|NCT00600886|3206024|P1|Extension - After Crossover (CAS)|Adverse Event|19
974064|NCT00600886|3206023|P2|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0
974065|NCT00600886|3206024|P1|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6
974066|NCT00600886|3206023|P2|Extension - Same Treatment (FAS)|Death|1
974067|NCT00600886|3206024|P1|Extension - Same Treatment (FAS)|Death|1
974068|NCT00600886|3206023|P2|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0
974069|NCT00600886|3206024|P1|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4
974070|NCT00600886|3206023|P2|Extension - Same Treatment (FAS)|Adverse Event|1
974071|NCT00600886|3206024|P1|Extension - Same Treatment (FAS)|Adverse Event|4
974072|NCT00600886|3206023|P2|Extension - Same Treatment (FAS)|Lost to Follow-up|1
974073|NCT00600886|3206024|P1|Extension - Same Treatment (FAS)|Lost to Follow-up|3
974074|NCT00600886|3206023|P2|Extension - Same Treatment (FAS)|Administrative Problems|3
974075|NCT00600886|3206024|P1|Extension - Same Treatment (FAS)|Administrative Problems|9
974076|NCT00600886|3206023|P2|Extension - Same Treatment (FAS)|Lack of Efficacy|3
974077|NCT00600886|3206024|P1|Extension - Same Treatment (FAS)|Lack of Efficacy|3
974078|NCT00600886|3206023|P2|Extension - Same Treatment (FAS)|Withdrawal by Subject|2
974079|NCT00600886|3206024|P1|Extension - Same Treatment (FAS)|Withdrawal by Subject|16
974080|NCT00600886|3206023|P2|Core Phase - Full Analysis Set (FAS)|Death|1
974081|NCT00600886|3206024|P1|Core Phase - Full Analysis Set (FAS)|Death|0
974082|NCT00600886|3206023|P2|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0
974083|NCT00600886|3206024|P1|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1
974084|NCT00600886|3206023|P2|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0
974085|NCT00600886|3206024|P1|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1
974086|NCT00600886|3206023|P2|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0
974087|NCT00600886|3206024|P1|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2
974088|NCT00600886|3206023|P2|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3
974089|NCT00600886|3206024|P1|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5
974090|NCT00600886|3206023|P2|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8
974091|NCT00600886|3206024|P1|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5
974092|NCT00600886|3206023|P2|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8
974093|NCT00600886|3206024|P1|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7
974094|NCT00600886|3206023|P2|Core Phase - Full Analysis Set (FAS)|Adverse Event|6
974095|NCT00600886|3206024|P1|Core Phase - Full Analysis Set (FAS)|Adverse Event|14
974096|NCT00600821|3206088|P2|Overall Study|Other|3
974097|NCT00600821|3206089|P1|Overall Study|Other|2
974098|NCT00600821|3206088|P2|Overall Study|Randomized but not treated|1
974099|NCT00600821|3206089|P1|Overall Study|Randomized but not treated|0
974100|NCT00600821|3206088|P2|Overall Study|Objective progression or relapse|1
974101|NCT00600821|3206089|P1|Overall Study|Objective progression or relapse|0
974102|NCT00600821|3206088|P2|Overall Study|Terminated by sponsor|6
974103|NCT00600821|3206089|P1|Overall Study|Terminated by sponsor|8
974104|NCT00600821|3206088|P2|Overall Study|Withdrawal by Subject|1
974105|NCT00600821|3206089|P1|Overall Study|Withdrawal by Subject|1
974106|NCT00600821|3206088|P2|Overall Study|Lost to Follow-up|2
974107|NCT00600821|3206089|P1|Overall Study|Lost to Follow-up|2
974108|NCT00600821|3206088|P2|Overall Study|Death|46
974109|NCT00600821|3206089|P1|Overall Study|Death|45
974110|NCT00600756|3206117|P2|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
974111|NCT00600756|3206118|P1|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
974112|NCT00600756|3206117|P2|Overall Study Analysis After 12 Months|Lost to Follow-up|13
974113|NCT00600756|3206118|P1|Overall Study Analysis After 12 Months|Lost to Follow-up|16
974114|NCT00600756|3206117|P2|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20
974115|NCT00600756|3206118|P1|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16
974116|NCT00600756|3206117|P2|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20
974117|NCT00600756|3206118|P1|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17
974118|NCT00600756|3206117|P2|Overall Study Analysis After 12 Months|Incorrect enrollment|29
974119|NCT00600756|3206118|P1|Overall Study Analysis After 12 Months|Incorrect enrollment|21
974120|NCT00600756|3206117|P2|Overall Study Analysis After 12 Months|Withdrawal by Subject|41
974121|NCT00600756|3206118|P1|Overall Study Analysis After 12 Months|Withdrawal by Subject|51
974122|NCT00600756|3206117|P2|Overall Study Analysis After 12 Months|Adverse Event|44
974123|NCT00600756|3206118|P1|Overall Study Analysis After 12 Months|Adverse Event|53
974124|NCT00600756|3206117|P2|Analysis After 6 Months|Study-specific discontinuation criteria|3
974125|NCT00600756|3206118|P1|Analysis After 6 Months|Study-specific discontinuation criteria|6
974126|NCT00600756|3206117|P2|Analysis After 6 Months|Lost to Follow-up|8
974127|NCT00600756|3206118|P1|Analysis After 6 Months|Lost to Follow-up|10
974128|NCT00600756|3206117|P2|Analysis After 6 Months|Severe non-compliance to protocol|11
974129|NCT00600756|3206118|P1|Analysis After 6 Months|Severe non-compliance to protocol|11
974130|NCT00600756|3206117|P2|Analysis After 6 Months|worsening symptom, lack of efficacy|14
974131|NCT00600756|3206118|P1|Analysis After 6 Months|worsening symptom, lack of efficacy|11
974132|NCT00600756|3206117|P2|Analysis After 6 Months|Incorrect Enrollment|21
974133|NCT00600756|3206118|P1|Analysis After 6 Months|Incorrect Enrollment|12
974134|NCT00600756|3206117|P2|Analysis After 6 Months|Withdrawal by Subject|30
974135|NCT00600756|3206118|P1|Analysis After 6 Months|Withdrawal by Subject|38
974136|NCT00600756|3206117|P2|Analysis After 6 Months|Adverse Event|33
974137|NCT00600756|3206118|P1|Analysis After 6 Months|Adverse Event|43
974138|NCT00600613|3206227|P1|Overall Study|Protocol Deviation|1
974139|NCT00600353|3206233|P2|Overall Study|History of prepartive regimen|1
974140|NCT00600353|3206234|P1|Overall Study|History of prepartive regimen|0
974141|NCT00600353|3206233|P2|Overall Study|history of malignancy within 5 years|0
974142|NCT00600353|3206234|P1|Overall Study|history of malignancy within 5 years|1
974143|NCT00600171|3206252|P6|Overall Study|Lost to Follow-up|0
974144|NCT00600171|3206253|P5|Overall Study|Lost to Follow-up|0
974145|NCT00600171|3206254|P4|Overall Study|Lost to Follow-up|1
974146|NCT00600171|3206255|P3|Overall Study|Lost to Follow-up|0
974147|NCT00600171|3206256|P2|Overall Study|Lost to Follow-up|0
974148|NCT00600171|3206257|P1|Overall Study|Lost to Follow-up|0
974149|NCT00600171|3206252|P6|Overall Study|Physician Decision|2
974150|NCT00600171|3206253|P5|Overall Study|Physician Decision|0
974151|NCT00600171|3206254|P4|Overall Study|Physician Decision|1
974152|NCT00600171|3206255|P3|Overall Study|Physician Decision|0
974153|NCT00600171|3206256|P2|Overall Study|Physician Decision|1
974154|NCT00600171|3206257|P1|Overall Study|Physician Decision|0
974155|NCT00600171|3206252|P6|Overall Study|Withdrawal by Subject|1
974156|NCT00600171|3206253|P5|Overall Study|Withdrawal by Subject|1
974157|NCT00600171|3206254|P4|Overall Study|Withdrawal by Subject|1
974158|NCT00600171|3206255|P3|Overall Study|Withdrawal by Subject|0
974159|NCT00600171|3206256|P2|Overall Study|Withdrawal by Subject|0
974160|NCT00600171|3206257|P1|Overall Study|Withdrawal by Subject|3
974161|NCT00600171|3206252|P6|Overall Study|Met Protocol-defined Stopping Criteria|2
974162|NCT00600171|3206253|P5|Overall Study|Met Protocol-defined Stopping Criteria|2
974163|NCT00600171|3206254|P4|Overall Study|Met Protocol-defined Stopping Criteria|3
974164|NCT00600171|3206255|P3|Overall Study|Met Protocol-defined Stopping Criteria|7
974165|NCT00600171|3206256|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
974166|NCT00600171|3206257|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
974167|NCT00600171|3206252|P6|Overall Study|Protocol Violation|0
974168|NCT00600171|3206253|P5|Overall Study|Protocol Violation|0
974169|NCT00600171|3206254|P4|Overall Study|Protocol Violation|1
974170|NCT00600171|3206255|P3|Overall Study|Protocol Violation|0
974171|NCT00600171|3206256|P2|Overall Study|Protocol Violation|2
974172|NCT00600171|3206257|P1|Overall Study|Protocol Violation|1
974173|NCT00600171|3206252|P6|Overall Study|Lack of Efficacy|0
974174|NCT00600171|3206253|P5|Overall Study|Lack of Efficacy|4
974175|NCT00600171|3206254|P4|Overall Study|Lack of Efficacy|5
974176|NCT00600171|3206255|P3|Overall Study|Lack of Efficacy|3
974177|NCT00600171|3206256|P2|Overall Study|Lack of Efficacy|12
974178|NCT00600171|3206257|P1|Overall Study|Lack of Efficacy|9
974179|NCT00600171|3206252|P6|Overall Study|Adverse Event|0
974180|NCT00600171|3206253|P5|Overall Study|Adverse Event|1
974181|NCT00600171|3206254|P4|Overall Study|Adverse Event|0
974182|NCT00600171|3206255|P3|Overall Study|Adverse Event|0
974183|NCT00600171|3206256|P2|Overall Study|Adverse Event|1
974184|NCT00600171|3206257|P1|Overall Study|Adverse Event|0
974185|NCT00600119|3206331|P6|Follow-up Period|Other|0
974186|NCT00600119|3206332|P5|Follow-up Period|Other|0
974187|NCT00600119|3206333|P4|Follow-up Period|Other|0
974188|NCT00600119|3206334|P3|Follow-up Period|Other|0
974189|NCT00600119|3206335|P2|Follow-up Period|Other|0
974190|NCT00600119|3206336|P1|Follow-up Period|Other|1
974191|NCT00600119|3206331|P6|Follow-up Period|Adverse Event|1
974192|NCT00600119|3206332|P5|Follow-up Period|Adverse Event|0
974193|NCT00600119|3206333|P4|Follow-up Period|Adverse Event|0
974194|NCT00600119|3206334|P3|Follow-up Period|Adverse Event|0
974195|NCT00600119|3206335|P2|Follow-up Period|Adverse Event|0
974196|NCT00600119|3206336|P1|Follow-up Period|Adverse Event|0
974197|NCT00600119|3206331|P6|Double-blind Treatment Period|Adverse Event|10
974198|NCT00600119|3206332|P5|Double-blind Treatment Period|Adverse Event|2
974199|NCT00600119|3206333|P4|Double-blind Treatment Period|Adverse Event|1
974200|NCT00600119|3206334|P3|Double-blind Treatment Period|Adverse Event|0
974201|NCT00600119|3206335|P2|Double-blind Treatment Period|Adverse Event|1
974202|NCT00600119|3206336|P1|Double-blind Treatment Period|Adverse Event|1
974203|NCT00600119|3206331|P6|Double-blind Treatment Period|Lost to Follow-up|0
974204|NCT00600119|3206332|P5|Double-blind Treatment Period|Lost to Follow-up|0
974205|NCT00600119|3206333|P4|Double-blind Treatment Period|Lost to Follow-up|0
974206|NCT00600119|3206334|P3|Double-blind Treatment Period|Lost to Follow-up|0
974207|NCT00600119|3206335|P2|Double-blind Treatment Period|Lost to Follow-up|1
974208|NCT00600119|3206336|P1|Double-blind Treatment Period|Lost to Follow-up|0
974209|NCT00600119|3206331|P6|Double-blind Treatment Period|Physician Decision|0
974210|NCT00600119|3206332|P5|Double-blind Treatment Period|Physician Decision|0
974211|NCT00600119|3206333|P4|Double-blind Treatment Period|Physician Decision|0
974212|NCT00600119|3206334|P3|Double-blind Treatment Period|Physician Decision|0
974213|NCT00600119|3206335|P2|Double-blind Treatment Period|Physician Decision|0
974214|NCT00600119|3206336|P1|Double-blind Treatment Period|Physician Decision|2
974215|NCT00600119|3206331|P6|Double-blind Treatment Period|Sponsor Decision|0
974216|NCT00600119|3206332|P5|Double-blind Treatment Period|Sponsor Decision|1
974217|NCT00600119|3206333|P4|Double-blind Treatment Period|Sponsor Decision|0
974218|NCT00600119|3206334|P3|Double-blind Treatment Period|Sponsor Decision|0
974219|NCT00600119|3206335|P2|Double-blind Treatment Period|Sponsor Decision|1
974220|NCT00600119|3206336|P1|Double-blind Treatment Period|Sponsor Decision|0
974221|NCT00600119|3206331|P6|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
974222|NCT00600119|3206332|P5|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
974223|NCT00600119|3206333|P4|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
974224|NCT00600119|3206334|P3|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
974225|NCT00600119|3206335|P2|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1
974226|NCT00600119|3206336|P1|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
974227|NCT00600119|3206331|P6|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
974228|NCT00600119|3206332|P5|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
974229|NCT00600119|3206333|P4|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
974230|NCT00600119|3206334|P3|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
974231|NCT00600119|3206335|P2|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
974232|NCT00600119|3206336|P1|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
974233|NCT00600119|3206331|P6|Double-blind Treatment Period|Other|1
974234|NCT00600119|3206332|P5|Double-blind Treatment Period|Other|2
974235|NCT00600119|3206333|P4|Double-blind Treatment Period|Other|0
974236|NCT00600119|3206334|P3|Double-blind Treatment Period|Other|0
974237|NCT00600119|3206335|P2|Double-blind Treatment Period|Other|0
974238|NCT00600119|3206336|P1|Double-blind Treatment Period|Other|0
974239|NCT00600119|3206331|P6|Double-blind Treatment Period|Withdrawal by Subject|3
974240|NCT00600119|3206332|P5|Double-blind Treatment Period|Withdrawal by Subject|0
974241|NCT00600119|3206333|P4|Double-blind Treatment Period|Withdrawal by Subject|1
974242|NCT00600119|3206334|P3|Double-blind Treatment Period|Withdrawal by Subject|0
974243|NCT00600119|3206335|P2|Double-blind Treatment Period|Withdrawal by Subject|0
974244|NCT00600119|3206336|P1|Double-blind Treatment Period|Withdrawal by Subject|2
974245|NCT00600119|3206331|P6|Single-blind Placebo run-in Period|Withdrawal by Subject|0
974246|NCT00600119|3206332|P5|Single-blind Placebo run-in Period|Withdrawal by Subject|0
974247|NCT00600119|3206333|P4|Single-blind Placebo run-in Period|Withdrawal by Subject|0
974248|NCT00600119|3206334|P3|Single-blind Placebo run-in Period|Withdrawal by Subject|0
974249|NCT00600119|3206335|P2|Single-blind Placebo run-in Period|Withdrawal by Subject|1
974250|NCT00600119|3206336|P1|Single-blind Placebo run-in Period|Withdrawal by Subject|2
974251|NCT00600119|3206331|P6|Single-blind Placebo run-in Period|Adverse Event|1
974252|NCT00600119|3206332|P5|Single-blind Placebo run-in Period|Adverse Event|0
974253|NCT00600119|3206333|P4|Single-blind Placebo run-in Period|Adverse Event|1
974254|NCT00600119|3206334|P3|Single-blind Placebo run-in Period|Adverse Event|0
974255|NCT00600119|3206335|P2|Single-blind Placebo run-in Period|Adverse Event|0
974256|NCT00600119|3206336|P1|Single-blind Placebo run-in Period|Adverse Event|0
974257|NCT00600119|3206331|P6|Single-blind Placebo run-in Period|Lost to Follow-up|0
974258|NCT00600119|3206332|P5|Single-blind Placebo run-in Period|Lost to Follow-up|0
974259|NCT00600119|3206333|P4|Single-blind Placebo run-in Period|Lost to Follow-up|0
974260|NCT00600119|3206334|P3|Single-blind Placebo run-in Period|Lost to Follow-up|0
974261|NCT00600119|3206335|P2|Single-blind Placebo run-in Period|Lost to Follow-up|0
974262|NCT00600119|3206336|P1|Single-blind Placebo run-in Period|Lost to Follow-up|1
974263|NCT00600119|3206331|P6|Single-blind Placebo run-in Period|Sponsor Decision|0
974264|NCT00600119|3206332|P5|Single-blind Placebo run-in Period|Sponsor Decision|1
974265|NCT00600119|3206333|P4|Single-blind Placebo run-in Period|Sponsor Decision|0
974266|NCT00600119|3206334|P3|Single-blind Placebo run-in Period|Sponsor Decision|1
974267|NCT00600119|3206335|P2|Single-blind Placebo run-in Period|Sponsor Decision|0
974268|NCT00600119|3206336|P1|Single-blind Placebo run-in Period|Sponsor Decision|0
974269|NCT00600119|3206331|P6|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
974270|NCT00600119|3206332|P5|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
974271|NCT00600119|3206333|P4|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
974272|NCT00600119|3206334|P3|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
974273|NCT00600119|3206335|P2|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
974274|NCT00600119|3206336|P1|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
974275|NCT00600119|3206331|P6|Single-blind Placebo run-in Period|Other - Not specified|1
974276|NCT00600119|3206332|P5|Single-blind Placebo run-in Period|Other - Not specified|1
974277|NCT00600119|3206333|P4|Single-blind Placebo run-in Period|Other - Not specified|0
974278|NCT00600119|3206334|P3|Single-blind Placebo run-in Period|Other - Not specified|0
974279|NCT00600119|3206335|P2|Single-blind Placebo run-in Period|Other - Not specified|0
974280|NCT00600119|3206336|P1|Single-blind Placebo run-in Period|Other - Not specified|1
974281|NCT00600106|3206370|P2|Overall Study|Withdrawal by Subject|1
974282|NCT00600106|3206371|P1|Overall Study|Withdrawal by Subject|1
974283|NCT00600067|3206418|P2|Overall Study|Lack of Efficacy|0
974284|NCT00600067|3206419|P1|Overall Study|Lack of Efficacy|1
974285|NCT00600067|3206418|P2|Overall Study|protocol non-compliance|3
974286|NCT00600067|3206419|P1|Overall Study|protocol non-compliance|0
974287|NCT00600067|3206418|P2|Overall Study|Lost to Follow-up|3
974288|NCT00600067|3206419|P1|Overall Study|Lost to Follow-up|2
974289|NCT00600067|3206418|P2|Overall Study|Adverse Event|1
974290|NCT00600067|3206419|P1|Overall Study|Adverse Event|0
974291|NCT00600028|3206429|P2|Second Intervention (12 Weeks)|Adverse Event|2
974292|NCT00600028|3206430|P1|Second Intervention (12 Weeks)|Adverse Event|0
974293|NCT00600028|3206429|P2|First Intervention (12 Weeks)|Adverse Event|1
974294|NCT00600028|3206430|P1|First Intervention (12 Weeks)|Adverse Event|0
974295|NCT00600028|3206429|P2|First Intervention (12 Weeks)|Withdrawal by Subject|0
974296|NCT00600028|3206430|P1|First Intervention (12 Weeks)|Withdrawal by Subject|1
974297|NCT00599924|3206460|P7|Overall Study|Other|2
974298|NCT00599924|3206461|P6|Overall Study|Other|0
974299|NCT00599924|3206462|P5|Overall Study|Other|2
974300|NCT00599924|3206463|P4|Overall Study|Other|1
974301|NCT00599924|3206464|P3|Overall Study|Other|0
974302|NCT00599924|3206465|P2|Overall Study|Other|0
974303|NCT00599924|3206466|P1|Overall Study|Other|0
974304|NCT00599924|3206460|P7|Overall Study|Withdrawal by Subject|0
974305|NCT00599924|3206461|P6|Overall Study|Withdrawal by Subject|0
974306|NCT00599924|3206462|P5|Overall Study|Withdrawal by Subject|1
974307|NCT00599924|3206463|P4|Overall Study|Withdrawal by Subject|0
974308|NCT00599924|3206464|P3|Overall Study|Withdrawal by Subject|1
974309|NCT00599924|3206465|P2|Overall Study|Withdrawal by Subject|0
974310|NCT00599924|3206466|P1|Overall Study|Withdrawal by Subject|0
974311|NCT00599924|3206460|P7|Overall Study|Protocol Violation|0
974312|NCT00599924|3206461|P6|Overall Study|Protocol Violation|0
974313|NCT00599924|3206462|P5|Overall Study|Protocol Violation|0
974314|NCT00599924|3206463|P4|Overall Study|Protocol Violation|1
974315|NCT00599924|3206464|P3|Overall Study|Protocol Violation|0
974316|NCT00599924|3206465|P2|Overall Study|Protocol Violation|0
974317|NCT00599924|3206466|P1|Overall Study|Protocol Violation|0
974318|NCT00599924|3206460|P7|Overall Study|Death|1
974319|NCT00599924|3206461|P6|Overall Study|Death|2
974320|NCT00599924|3206462|P5|Overall Study|Death|0
974321|NCT00599924|3206463|P4|Overall Study|Death|2
974322|NCT00599924|3206464|P3|Overall Study|Death|0
974323|NCT00599924|3206465|P2|Overall Study|Death|0
974324|NCT00599924|3206466|P1|Overall Study|Death|0
974325|NCT00599924|3206460|P7|Overall Study|Adverse Event|2
974326|NCT00599924|3206461|P6|Overall Study|Adverse Event|0
974327|NCT00599924|3206462|P5|Overall Study|Adverse Event|0
974328|NCT00599924|3206463|P4|Overall Study|Adverse Event|2
974329|NCT00599924|3206464|P3|Overall Study|Adverse Event|0
974330|NCT00599924|3206465|P2|Overall Study|Adverse Event|0
974331|NCT00599924|3206466|P1|Overall Study|Adverse Event|0
974332|NCT00599924|3206460|P7|Overall Study|Lack of Efficacy|0
974333|NCT00599924|3206461|P6|Overall Study|Lack of Efficacy|2
974334|NCT00599924|3206462|P5|Overall Study|Lack of Efficacy|3
974335|NCT00599924|3206463|P4|Overall Study|Lack of Efficacy|2
974336|NCT00599924|3206464|P3|Overall Study|Lack of Efficacy|1
974337|NCT00599924|3206465|P2|Overall Study|Lack of Efficacy|5
974338|NCT00599924|3206466|P1|Overall Study|Lack of Efficacy|3
974339|NCT00599755|3206570|P1|Overall Study|No data available|1
974340|NCT00599755|3206570|P1|Overall Study|Other Reason|2
974341|NCT00599755|3206570|P1|Overall Study|Progression of Disease|3
974342|NCT00599755|3206570|P1|Overall Study|Withdrawal by Subject|2
974343|NCT00599755|3206570|P1|Overall Study|Adverse Event|11
974344|NCT00599521|3206581|P2|Overall Study|Pregnancy|2
974345|NCT00599521|3206582|P1|Overall Study|Pregnancy|0
974346|NCT00599521|3206581|P2|Overall Study|Lost to Follow-up|23
974347|NCT00599521|3206582|P1|Overall Study|Lost to Follow-up|23
974348|NCT00599521|3206581|P2|Overall Study|Protocol Violation|1
974349|NCT00599521|3206582|P1|Overall Study|Protocol Violation|1
974350|NCT00599521|3206581|P2|Overall Study|Withdrawal by Subject|34
974351|NCT00599521|3206582|P1|Overall Study|Withdrawal by Subject|28
974352|NCT00599521|3206581|P2|Overall Study|Adverse Event|1
974353|NCT00599521|3206582|P1|Overall Study|Adverse Event|4
974354|NCT00599521|3206581|P2|Overall Study|Lack of Efficacy|8
974355|NCT00599521|3206582|P1|Overall Study|Lack of Efficacy|4
974356|NCT00599339|3206596|P1|Overall Study|Study Termination Status Unknown|12
974357|NCT00599339|3206596|P1|Overall Study|No valid data consent|36
974358|NCT00599339|3206596|P1|Overall Study|Lost to Follow-up|221
974359|NCT00599339|3206596|P1|Overall Study|Other Reason|179
974360|NCT00599339|3206596|P1|Overall Study|Withdrawal by Subject|137
974361|NCT00599339|3206596|P1|Overall Study|Adverse Event|79
974362|NCT00599326|3206698|P1|Overall Study|Noncompliant|1
974363|NCT00599326|3206698|P1|Overall Study|Lost to Follow-up|1
974364|NCT00599313|3206703|P1|Overall Study|Ineligible|1
974365|NCT00599313|3206703|P1|Overall Study|Patient Request|4
974366|NCT00599313|3206703|P1|Overall Study|Disease Progression|12
974367|NCT00599313|3206703|P1|Overall Study|Adverse Event|19
974368|NCT00599196|3206745|P1|Overall Study|Other: Inv Switched Dopamine Agonist|1
974369|NCT00599196|3206745|P1|Overall Study|Other: Patient Stopped Due To Moving|1
974370|NCT00599196|3206745|P1|Overall Study|Other: Pt Moved To Australia|1
974371|NCT00599196|3206745|P1|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1
974372|NCT00599196|3206745|P1|Overall Study|Other: Spouse Withdrew Consent|1
974373|NCT00599196|3206745|P1|Overall Study|Other: Patient Leaving For Israel|1
974374|NCT00599196|3206745|P1|Overall Study|Lost to Follow-up|17
974375|NCT00599196|3206745|P1|Overall Study|Study ended per sponsor|197
974376|NCT00599196|3206745|P1|Overall Study|Subject withdrew consent|43
974377|NCT00599196|3206745|P1|Overall Study|Unsatisfactory compliance of subject|3
974378|NCT00599196|3206745|P1|Overall Study|Adverse Event|93
974379|NCT00599196|3206745|P1|Overall Study|Lack of Efficacy|22
974380|NCT00599027|3206776|P2|Overall Study|Treatment Failure|1
974381|NCT00599027|3206777|P1|Overall Study|Treatment Failure|0
974382|NCT00599027|3206776|P2|Overall Study|Adverse Event|1
974383|NCT00599027|3206777|P1|Overall Study|Adverse Event|0
974384|NCT00599027|3206776|P2|Overall Study|Withdrawal by Subject|1
974385|NCT00599027|3206777|P1|Overall Study|Withdrawal by Subject|1
974386|NCT00598871|3206790|P2|Overall Study|Adverse Event|1
974387|NCT00598871|3206791|P1|Overall Study|Adverse Event|0
974388|NCT00598832|3206801|P2|Overall Study|Non compliance|0
974389|NCT00598832|3206802|P1|Overall Study|Non compliance|1
974390|NCT00598832|3206801|P2|Overall Study|Physician Decision|4
974391|NCT00598832|3206802|P1|Overall Study|Physician Decision|1
974392|NCT00598832|3206801|P2|Overall Study|Pregnancy|2
974393|NCT00598832|3206802|P1|Overall Study|Pregnancy|2
974394|NCT00598832|3206801|P2|Overall Study|Lost to Follow-up|29
974395|NCT00598832|3206802|P1|Overall Study|Lost to Follow-up|24
974396|NCT00598832|3206801|P2|Overall Study|Protocol Violation|2
974397|NCT00598832|3206802|P1|Overall Study|Protocol Violation|0
974398|NCT00598832|3206801|P2|Overall Study|Withdrawal by Subject|36
974399|NCT00598832|3206802|P1|Overall Study|Withdrawal by Subject|25
974400|NCT00598832|3206801|P2|Overall Study|Adverse Event|2
974401|NCT00598832|3206802|P1|Overall Study|Adverse Event|6
974402|NCT00598832|3206801|P2|Overall Study|Lack of Efficacy|7
974403|NCT00598832|3206802|P1|Overall Study|Lack of Efficacy|3
974404|NCT00598702|3206855|P8|Overall Study|Dose limiting toxicity|0
974405|NCT00598702|3206856|P7|Overall Study|Dose limiting toxicity|0
974406|NCT00598702|3206857|P6|Overall Study|Dose limiting toxicity|1
974407|NCT00598702|3206858|P5|Overall Study|Dose limiting toxicity|1
974408|NCT00598702|3206859|P4|Overall Study|Dose limiting toxicity|1
974409|NCT00598702|3206860|P3|Overall Study|Dose limiting toxicity|0
974410|NCT00598702|3206861|P2|Overall Study|Dose limiting toxicity|0
974411|NCT00598702|3206862|P1|Overall Study|Dose limiting toxicity|0
974412|NCT00598702|3206855|P8|Overall Study|Physician Decision|0
974413|NCT00598702|3206856|P7|Overall Study|Physician Decision|0
974414|NCT00598702|3206857|P6|Overall Study|Physician Decision|0
974415|NCT00598702|3206858|P5|Overall Study|Physician Decision|1
974416|NCT00598702|3206859|P4|Overall Study|Physician Decision|0
974417|NCT00598702|3206860|P3|Overall Study|Physician Decision|0
974418|NCT00598702|3206861|P2|Overall Study|Physician Decision|0
974419|NCT00598702|3206862|P1|Overall Study|Physician Decision|0
974420|NCT00598702|3206855|P8|Overall Study|Withdrawal by Subject|0
974421|NCT00598702|3206856|P7|Overall Study|Withdrawal by Subject|0
974422|NCT00598702|3206857|P6|Overall Study|Withdrawal by Subject|0
974423|NCT00598702|3206858|P5|Overall Study|Withdrawal by Subject|1
974424|NCT00598702|3206859|P4|Overall Study|Withdrawal by Subject|1
974425|NCT00598702|3206860|P3|Overall Study|Withdrawal by Subject|0
974426|NCT00598702|3206861|P2|Overall Study|Withdrawal by Subject|0
974427|NCT00598702|3206862|P1|Overall Study|Withdrawal by Subject|0
974428|NCT00598702|3206855|P8|Overall Study|Adverse Event|0
974429|NCT00598702|3206856|P7|Overall Study|Adverse Event|0
974430|NCT00598702|3206857|P6|Overall Study|Adverse Event|0
974431|NCT00598702|3206858|P5|Overall Study|Adverse Event|0
974432|NCT00598702|3206859|P4|Overall Study|Adverse Event|1
974433|NCT00598702|3206860|P3|Overall Study|Adverse Event|0
974434|NCT00598702|3206861|P2|Overall Study|Adverse Event|0
974435|NCT00598702|3206862|P1|Overall Study|Adverse Event|0
974436|NCT00598702|3206855|P8|Overall Study|Early discharge from hospital|0
974437|NCT00598702|3206856|P7|Overall Study|Early discharge from hospital|1
974438|NCT00598702|3206857|P6|Overall Study|Early discharge from hospital|10
974439|NCT00598702|3206858|P5|Overall Study|Early discharge from hospital|0
974440|NCT00598702|3206859|P4|Overall Study|Early discharge from hospital|5
974441|NCT00598702|3206860|P3|Overall Study|Early discharge from hospital|2
974442|NCT00598702|3206861|P2|Overall Study|Early discharge from hospital|0
974443|NCT00598702|3206862|P1|Overall Study|Early discharge from hospital|0
974444|NCT00598702|3206855|P8|Overall Study|Not specified|0
974445|NCT00598702|3206856|P7|Overall Study|Not specified|0
974446|NCT00598702|3206857|P6|Overall Study|Not specified|1
974447|NCT00598702|3206858|P5|Overall Study|Not specified|0
974448|NCT00598702|3206859|P4|Overall Study|Not specified|0
974449|NCT00598702|3206860|P3|Overall Study|Not specified|0
974450|NCT00598702|3206861|P2|Overall Study|Not specified|2
974451|NCT00598702|3206862|P1|Overall Study|Not specified|0
974452|NCT00598650|3206917|P1|Overall Study|Physician Decision|2
974453|NCT00598650|3206917|P1|Overall Study|Prohibited Concomitant Medication|2
974454|NCT00598650|3206917|P1|Overall Study|Not eligible|1
974455|NCT00598650|3206917|P1|Overall Study|No treatment for 3 weeks|1
974456|NCT00598650|3206917|P1|Overall Study|Adverse Event|18
974457|NCT00598650|3206917|P1|Overall Study|Withdrawal by Subject|3
974458|NCT00598585|3206926|P2|Overall Study|Lost to Follow-up|0
974459|NCT00598585|3206927|P1|Overall Study|Lost to Follow-up|1
974460|NCT00598559|3206936|P3|Overall Study|Subject unable/unwilling to attend visit|0
974461|NCT00598559|3206937|P2|Overall Study|Subject unable/unwilling to attend visit|7
974462|NCT00598559|3206938|P1|Overall Study|Subject unable/unwilling to attend visit|4
974463|NCT00598559|3206936|P3|Overall Study|Early discharge from hospital|3
974464|NCT00598559|3206937|P2|Overall Study|Early discharge from hospital|12
974465|NCT00598559|3206938|P1|Overall Study|Early discharge from hospital|9
974466|NCT00598559|3206936|P3|Overall Study|Protocol Non-compliance|0
974467|NCT00598559|3206937|P2|Overall Study|Protocol Non-compliance|0
974468|NCT00598559|3206938|P1|Overall Study|Protocol Non-compliance|1
974469|NCT00598559|3206936|P3|Overall Study|Withdrawal by Subject|0
974470|NCT00598559|3206937|P2|Overall Study|Withdrawal by Subject|2
974471|NCT00598559|3206938|P1|Overall Study|Withdrawal by Subject|2
974472|NCT00598559|3206936|P3|Overall Study|Adverse Event|0
974473|NCT00598559|3206937|P2|Overall Study|Adverse Event|7
974474|NCT00598559|3206938|P1|Overall Study|Adverse Event|11
974475|NCT00598442|3206965|P3|Overall Study|Started dialysis|0
974476|NCT00598442|3206966|P2|Overall Study|Started dialysis|0
974477|NCT00598442|3206967|P1|Overall Study|Started dialysis|1
974478|NCT00598442|3206965|P3|Overall Study|Site closed by sponsor|1
974479|NCT00598442|3206966|P2|Overall Study|Site closed by sponsor|2
974480|NCT00598442|3206967|P1|Overall Study|Site closed by sponsor|5
974481|NCT00598442|3206965|P3|Overall Study|Renal transplant|1
974482|NCT00598442|3206966|P2|Overall Study|Renal transplant|0
974483|NCT00598442|3206967|P1|Overall Study|Renal transplant|0
974484|NCT00598442|3206965|P3|Overall Study|Relocation|0
974485|NCT00598442|3206966|P2|Overall Study|Relocation|4
974486|NCT00598442|3206967|P1|Overall Study|Relocation|1
974487|NCT00598442|3206965|P3|Overall Study|Noncompliance|1
974488|NCT00598442|3206966|P2|Overall Study|Noncompliance|2
974489|NCT00598442|3206967|P1|Overall Study|Noncompliance|0
974490|NCT00598442|3206965|P3|Overall Study|Withdrawal by Subject|6
974491|NCT00598442|3206966|P2|Overall Study|Withdrawal by Subject|16
974492|NCT00598442|3206967|P1|Overall Study|Withdrawal by Subject|8
974493|NCT00598442|3206965|P3|Overall Study|Physician Decision|1
974494|NCT00598442|3206966|P2|Overall Study|Physician Decision|1
974495|NCT00598442|3206967|P1|Overall Study|Physician Decision|2
974496|NCT00598442|3206965|P3|Overall Study|Lost to Follow-up|3
974497|NCT00598442|3206966|P2|Overall Study|Lost to Follow-up|3
974498|NCT00598442|3206967|P1|Overall Study|Lost to Follow-up|4
974499|NCT00598442|3206965|P3|Overall Study|Death|11
974500|NCT00598442|3206966|P2|Overall Study|Death|11
974501|NCT00598442|3206967|P1|Overall Study|Death|19
974502|NCT00598442|3206965|P3|Overall Study|Adverse Event|0
974503|NCT00598442|3206966|P2|Overall Study|Adverse Event|0
974504|NCT00598442|3206967|P1|Overall Study|Adverse Event|3
974505|NCT00598273|3206984|P3|Overall Study|Started dialysis|5
974506|NCT00598273|3206985|P2|Overall Study|Started dialysis|4
974507|NCT00598273|3206986|P1|Overall Study|Started dialysis|6
974508|NCT00598273|3206984|P3|Overall Study|Site elected to close|0
974509|NCT00598273|3206985|P2|Overall Study|Site elected to close|0
974510|NCT00598273|3206986|P1|Overall Study|Site elected to close|1
974511|NCT00598273|3206984|P3|Overall Study|Renal transplant|1
974512|NCT00598273|3206985|P2|Overall Study|Renal transplant|0
974513|NCT00598273|3206986|P1|Overall Study|Renal transplant|1
974514|NCT00598273|3206984|P3|Overall Study|Relocation|4
974515|NCT00598273|3206985|P2|Overall Study|Relocation|2
974516|NCT00598273|3206986|P1|Overall Study|Relocation|0
974517|NCT00598273|3206984|P3|Overall Study|Noncompliance|3
974518|NCT00598273|3206985|P2|Overall Study|Noncompliance|2
974519|NCT00598273|3206986|P1|Overall Study|Noncompliance|3
974520|NCT00598273|3206984|P3|Overall Study|Withdrawal by Subject|10
974521|NCT00598273|3206985|P2|Overall Study|Withdrawal by Subject|10
974522|NCT00598273|3206986|P1|Overall Study|Withdrawal by Subject|12
974523|NCT00598273|3206984|P3|Overall Study|Physician Decision|1
974524|NCT00598273|3206985|P2|Overall Study|Physician Decision|0
974525|NCT00598273|3206986|P1|Overall Study|Physician Decision|0
974526|NCT00598273|3206984|P3|Overall Study|Lost to Follow-up|5
974527|NCT00598273|3206985|P2|Overall Study|Lost to Follow-up|3
974528|NCT00598273|3206986|P1|Overall Study|Lost to Follow-up|8
974529|NCT00598273|3206984|P3|Overall Study|Death|8
974530|NCT00598273|3206985|P2|Overall Study|Death|12
974531|NCT00598273|3206986|P1|Overall Study|Death|6
974532|NCT00598273|3206984|P3|Overall Study|Adverse Event|2
974533|NCT00598273|3206985|P2|Overall Study|Adverse Event|5
974534|NCT00598273|3206986|P1|Overall Study|Adverse Event|4
974535|NCT00598078|3207000|P2|Period 2 (Day 2)|Adverse Event|0
974536|NCT00598078|3207001|P1|Period 2 (Day 2)|Adverse Event|1
974537|NCT00597766|3207054|P3|Follow-up 2, Week 8|Lost to Follow-up|1
974538|NCT00597766|3207055|P2|Follow-up 2, Week 8|Lost to Follow-up|0
974539|NCT00597766|3207056|P1|Follow-up 2, Week 8|Lost to Follow-up|0
974540|NCT00597766|3207054|P3|Follow-up 1, Week 4|Withdrawal by Subject|0
974541|NCT00597766|3207055|P2|Follow-up 1, Week 4|Withdrawal by Subject|0
974542|NCT00597766|3207056|P1|Follow-up 1, Week 4|Withdrawal by Subject|1
974543|NCT00597753|3207075|P2|Overall Study|Site elected to close|4
974544|NCT00597753|3207076|P1|Overall Study|Site elected to close|2
974545|NCT00597753|3207075|P2|Overall Study|Site closed by sponsor|7
974546|NCT00597753|3207076|P1|Overall Study|Site closed by sponsor|19
974547|NCT00597753|3207075|P2|Overall Study|Renal transplant|3
974548|NCT00597753|3207076|P1|Overall Study|Renal transplant|10
974549|NCT00597753|3207075|P2|Overall Study|Relocation|6
974550|NCT00597753|3207076|P1|Overall Study|Relocation|17
974551|NCT00597753|3207075|P2|Overall Study|Noncompliance|1
974552|NCT00597753|3207076|P1|Overall Study|Noncompliance|2
974553|NCT00597753|3207075|P2|Overall Study|Never dosed|0
974554|NCT00597753|3207076|P1|Overall Study|Never dosed|2
974555|NCT00597753|3207075|P2|Overall Study|Discontinued Dialysis|1
974556|NCT00597753|3207076|P1|Overall Study|Discontinued Dialysis|0
974557|NCT00597753|3207075|P2|Overall Study|Withdrawal by Subject|12
974558|NCT00597753|3207076|P1|Overall Study|Withdrawal by Subject|35
974559|NCT00597753|3207075|P2|Overall Study|Pregnancy|0
974560|NCT00597753|3207076|P1|Overall Study|Pregnancy|1
974561|NCT00597753|3207075|P2|Overall Study|Physician Decision|1
974562|NCT00597753|3207076|P1|Overall Study|Physician Decision|5
974563|NCT00597753|3207075|P2|Overall Study|Lost to Follow-up|3
974564|NCT00597753|3207076|P1|Overall Study|Lost to Follow-up|10
974565|NCT00597753|3207075|P2|Overall Study|Lack of Efficacy|0
974566|NCT00597753|3207076|P1|Overall Study|Lack of Efficacy|2
974567|NCT00597753|3207075|P2|Overall Study|Death|29
974568|NCT00597753|3207076|P1|Overall Study|Death|55
974569|NCT00597753|3207075|P2|Overall Study|Adverse Event|2
974570|NCT00597753|3207076|P1|Overall Study|Adverse Event|6
974571|NCT00597714|3207110|P3|Overall Study|Recipient death|10
974572|NCT00597714|3207111|P2|Overall Study|Recipient death|0
974573|NCT00597714|3207112|P1|Overall Study|Recipient death|0
974574|NCT00597714|3207110|P3|Overall Study|Death|0
974575|NCT00597714|3207111|P2|Overall Study|Death|46
974576|NCT00597714|3207112|P1|Overall Study|Death|56
974577|NCT00597701|3207124|P2|Overall Study|Did not start intervention (pharmacy er)|2
974578|NCT00597701|3207125|P1|Overall Study|Did not start intervention (pharmacy er)|0
974579|NCT00597701|3207124|P2|Overall Study|Physician Decision|0
974580|NCT00597701|3207125|P1|Overall Study|Physician Decision|2
974581|NCT00597701|3207124|P2|Overall Study|Death|1
974582|NCT00597701|3207125|P1|Overall Study|Death|0
974583|NCT00597701|3207124|P2|Overall Study|Withdrawal by Subject|5
974584|NCT00597701|3207125|P1|Overall Study|Withdrawal by Subject|5
974585|NCT00597584|3207147|P2|Overall Study|Renal transplant|7
974586|NCT00597584|3207148|P1|Overall Study|Renal transplant|9
974587|NCT00597584|3207147|P2|Overall Study|Relocation|6
974588|NCT00597584|3207148|P1|Overall Study|Relocation|8
974589|NCT00597584|3207147|P2|Overall Study|Never dosed|0
974590|NCT00597584|3207148|P1|Overall Study|Never dosed|1
974591|NCT00597584|3207147|P2|Overall Study|Lost ability to consent|1
974592|NCT00597584|3207148|P1|Overall Study|Lost ability to consent|1
974593|NCT00597584|3207147|P2|Overall Study|Discontinued Dialysis|1
974594|NCT00597584|3207148|P1|Overall Study|Discontinued Dialysis|0
974595|NCT00597584|3207147|P2|Overall Study|Withdrawal by Subject|12
974596|NCT00597584|3207148|P1|Overall Study|Withdrawal by Subject|44
974597|NCT00597584|3207147|P2|Overall Study|Pregnancy|0
974598|NCT00597584|3207148|P1|Overall Study|Pregnancy|2
974599|NCT00597584|3207147|P2|Overall Study|Physician Decision|0
974600|NCT00597584|3207148|P1|Overall Study|Physician Decision|3
974601|NCT00597584|3207147|P2|Overall Study|Lost to Follow-up|4
974602|NCT00597584|3207148|P1|Overall Study|Lost to Follow-up|2
974603|NCT00597584|3207147|P2|Overall Study|Lack of Efficacy|0
974604|NCT00597584|3207148|P1|Overall Study|Lack of Efficacy|1
974605|NCT00597584|3207147|P2|Overall Study|Death|30
974606|NCT00597584|3207148|P1|Overall Study|Death|53
974607|NCT00597584|3207147|P2|Overall Study|Adverse Event|2
974608|NCT00597584|3207148|P1|Overall Study|Adverse Event|4
974609|NCT00597519|3207173|P1|Overall Study|Death|1
974610|NCT00597506|3207177|P1|Overall Study|Subject is being followed for survival|1
974611|NCT00597376|3207227|P2|Overall Study|Adverse Event|1
974612|NCT00597376|3207228|P1|Overall Study|Adverse Event|4
974613|NCT00597376|3207227|P2|Overall Study|Withdrawal by Subject|3
974614|NCT00597376|3207228|P1|Overall Study|Withdrawal by Subject|4
974615|NCT00597207|3207269|P2|Overall Study|Lost to Follow-up|7
974616|NCT00597207|3207270|P1|Overall Study|Lost to Follow-up|5
974617|NCT00597116|3207278|P2|Overall Study|Progressive disease|6
974618|NCT00597116|3207279|P1|Overall Study|Progressive disease|11
974619|NCT00597116|3207278|P2|Overall Study|Lost to Follow-up|0
974620|NCT00597116|3207279|P1|Overall Study|Lost to Follow-up|1
974621|NCT00597116|3207278|P2|Overall Study|Death|1
974622|NCT00597116|3207279|P1|Overall Study|Death|0
974623|NCT00597116|3207278|P2|Overall Study|Physician Decision|1
974624|NCT00597116|3207279|P1|Overall Study|Physician Decision|0
974625|NCT00597116|3207278|P2|Overall Study|Withdrawal by Subject|2
974626|NCT00597116|3207279|P1|Overall Study|Withdrawal by Subject|0
974627|NCT00597116|3207278|P2|Overall Study|Adverse Event|1
974628|NCT00597116|3207279|P1|Overall Study|Adverse Event|2
974629|NCT00597012|3207305|P2|Overall Study|Lost to Follow-up|2
974630|NCT00597012|3207306|P1|Overall Study|Lost to Follow-up|0
974631|NCT00597012|3207305|P2|Overall Study|Ineligible|0
974632|NCT00597012|3207306|P1|Overall Study|Ineligible|2
974633|NCT00597012|3207305|P2|Overall Study|Withdrawal by Subject|4
974634|NCT00597012|3207306|P1|Overall Study|Withdrawal by Subject|7
974635|NCT00597012|3207305|P2|Overall Study|Underwent Total Knee Replacement (TKR)|1
974636|NCT00597012|3207306|P1|Overall Study|Underwent Total Knee Replacement (TKR)|3
974637|NCT00597012|3207305|P2|Overall Study|Death|1
974638|NCT00597012|3207306|P1|Overall Study|Death|1
974639|NCT00596960|3207318|P2|Overall Study|No alcohol use data|1
974640|NCT00596960|3207319|P1|Overall Study|No alcohol use data|0
974641|NCT00596960|3207318|P2|Overall Study|Protocol Violation|1
974642|NCT00596960|3207319|P1|Overall Study|Protocol Violation|0
974643|NCT00596960|3207318|P2|Overall Study|Physician Decision|0
974644|NCT00596960|3207319|P1|Overall Study|Physician Decision|1
974645|NCT00596960|3207318|P2|Overall Study|Incarcerated|0
974646|NCT00596960|3207319|P1|Overall Study|Incarcerated|2
974647|NCT00596960|3207318|P2|Overall Study|Withdrawal by Subject|0
974648|NCT00596960|3207319|P1|Overall Study|Withdrawal by Subject|1
974649|NCT00596960|3207318|P2|Overall Study|Lost to Follow-up|5
974650|NCT00596960|3207319|P1|Overall Study|Lost to Follow-up|6
974651|NCT00596960|3207318|P2|Overall Study|Death|2
974652|NCT00596960|3207319|P1|Overall Study|Death|1
974653|NCT00596947|3207331|P2|Overall Study|Lost to Follow-up|0
974654|NCT00596947|3207332|P1|Overall Study|Lost to Follow-up|1
974655|NCT00596947|3207331|P2|Overall Study|study halted due to low enrollment|3
974656|NCT00596947|3207332|P1|Overall Study|study halted due to low enrollment|5
974657|NCT00596934|3207372|P1|Overall Study|Withdrawal by Subject|1
974658|NCT00596934|3207372|P1|Overall Study|Protocol Violation|1
974659|NCT00596830|3207385|P2|Overall Study|Randomized but not treated|7
974660|NCT00596830|3207386|P1|Overall Study|Randomized but not treated|3
974661|NCT00596830|3207385|P2|Overall Study|Follow-up was discontinued|0
974662|NCT00596830|3207386|P1|Overall Study|Follow-up was discontinued|1
974663|NCT00596830|3207385|P2|Overall Study|Study terminated by sponsor|62
974664|NCT00596830|3207386|P1|Overall Study|Study terminated by sponsor|51
974665|NCT00596830|3207385|P2|Overall Study|Withdrawal by Subject|12
974666|NCT00596830|3207386|P1|Overall Study|Withdrawal by Subject|22
974667|NCT00596830|3207385|P2|Overall Study|Lost to Follow-up|11
974668|NCT00596830|3207386|P1|Overall Study|Lost to Follow-up|7
974669|NCT00596830|3207385|P2|Overall Study|Death|247
974670|NCT00596830|3207386|P1|Overall Study|Death|258
974671|NCT00596817|3207412|P2|Double-blind Period|Other Reasons|18
974672|NCT00596817|3207413|P1|Double-blind Period|Other Reasons|10
974673|NCT00596817|3207412|P2|Double-blind Period|Lost to Follow-up|2
974674|NCT00596817|3207413|P1|Double-blind Period|Lost to Follow-up|0
974675|NCT00596817|3207412|P2|Double-blind Period|Withdrawal of Consent|3
974676|NCT00596817|3207413|P1|Double-blind Period|Withdrawal of Consent|7
974677|NCT00596817|3207412|P2|Double-blind Period|Protocol Violation|8
974678|NCT00596817|3207413|P1|Double-blind Period|Protocol Violation|11
974679|NCT00596817|3207412|P2|Double-blind Period|Non-compliance With Study Product|4
974680|NCT00596817|3207413|P1|Double-blind Period|Non-compliance With Study Product|3
974681|NCT00596817|3207412|P2|Double-blind Period|Lack of Efficacy|28
974682|NCT00596817|3207413|P1|Double-blind Period|Lack of Efficacy|52
974683|NCT00596817|3207412|P2|Double-blind Period|Adverse Event|16
974684|NCT00596817|3207413|P1|Double-blind Period|Adverse Event|5
974685|NCT00596817|3207412|P2|Open-label Period to Double-blind Period|Other Reasons|14
974686|NCT00596817|3207413|P1|Open-label Period to Double-blind Period|Other Reasons|0
974687|NCT00596817|3207412|P2|Open-label Period to Double-blind Period|Not Eligible|49
974688|NCT00596817|3207413|P1|Open-label Period to Double-blind Period|Not Eligible|0
974689|NCT00596817|3207412|P2|Open-label Period to Double-blind Period|Lack of Efficacy|24
974690|NCT00596817|3207413|P1|Open-label Period to Double-blind Period|Lack of Efficacy|0
974691|NCT00596817|3207412|P2|Open-label Period to Double-blind Period|Adverse Event|5
974692|NCT00596817|3207413|P1|Open-label Period to Double-blind Period|Adverse Event|0
974693|NCT00596817|3207412|P2|Open-label Period|Other Reasons|65
974694|NCT00596817|3207413|P1|Open-label Period|Other Reasons|0
974695|NCT00596817|3207412|P2|Open-label Period|Lack of Efficacy|33
974696|NCT00596817|3207413|P1|Open-label Period|Lack of Efficacy|0
974697|NCT00596817|3207412|P2|Open-label Period|Adverse Event|49
974698|NCT00596817|3207413|P1|Open-label Period|Adverse Event|0
974699|NCT00596752|3207438|P2|Overall Study|Protocol Violation|0
974700|NCT00596752|3207439|P1|Overall Study|Protocol Violation|1
974701|NCT00596752|3207438|P2|Overall Study|Lack of Efficacy|7
974702|NCT00596752|3207439|P1|Overall Study|Lack of Efficacy|4
974703|NCT00596752|3207438|P2|Overall Study|Unsatisfactory Compliance|6
974704|NCT00596752|3207439|P1|Overall Study|Unsatisfactory Compliance|9
974705|NCT00596752|3207438|P2|Overall Study|Withdrawal by Subject|9
974706|NCT00596752|3207439|P1|Overall Study|Withdrawal by Subject|12
974707|NCT00596752|3207438|P2|Overall Study|Lost to Follow-up|38
974708|NCT00596752|3207439|P1|Overall Study|Lost to Follow-up|22
974709|NCT00596752|3207438|P2|Overall Study|Adverse Event|34
974710|NCT00596752|3207439|P1|Overall Study|Adverse Event|34
974711|NCT00596752|3207438|P2|Overall Study|Other Reason|49
974712|NCT00596752|3207439|P1|Overall Study|Other Reason|44
974713|NCT00596687|3207469|P2|Overall Study|cancelled surgery|1
974714|NCT00596687|3207470|P1|Overall Study|cancelled surgery|1
974715|NCT00596687|3207469|P2|Overall Study|Withdrawal by Subject|1
974716|NCT00596687|3207470|P1|Overall Study|Withdrawal by Subject|3
974717|NCT00596687|3207469|P2|Overall Study|continuous insulin infusion during TPN|1
974718|NCT00596687|3207470|P1|Overall Study|continuous insulin infusion during TPN|2
974719|NCT00596687|3207469|P2|Overall Study|< 24 hours of insulin treatment|6
974720|NCT00596687|3207470|P1|Overall Study|< 24 hours of insulin treatment|8
974721|NCT00596635|3207481|P3|Overall Study|Could not provide urine specimen|2
974722|NCT00596635|3207482|P2|Overall Study|Could not provide urine specimen|2
974723|NCT00596635|3207483|P1|Overall Study|Could not provide urine specimen|1
974724|NCT00596635|3207481|P3|Overall Study|Hip fracture|3
974725|NCT00596635|3207482|P2|Overall Study|Hip fracture|3
974726|NCT00596635|3207483|P1|Overall Study|Hip fracture|2
974727|NCT00596635|3207481|P3|Overall Study|Treatment for symptomatic UTI|3
974728|NCT00596635|3207482|P2|Overall Study|Treatment for symptomatic UTI|6
974729|NCT00596635|3207483|P1|Overall Study|Treatment for symptomatic UTI|4
974730|NCT00596635|3207481|P3|Overall Study|Lost to Follow-up|0
974731|NCT00596635|3207482|P2|Overall Study|Lost to Follow-up|2
974732|NCT00596635|3207483|P1|Overall Study|Lost to Follow-up|0
974733|NCT00596466|3207509|P1|Overall Study|Enrolled, not treated|2
974734|NCT00596466|3207509|P1|Overall Study|Unpecified|2
974735|NCT00596466|3207509|P1|Overall Study|Protocol Violation|2
974736|NCT00596466|3207509|P1|Overall Study|Withdrawal by Subject|2
974737|NCT00596466|3207509|P1|Overall Study|Adverse Event|4
974738|NCT00596466|3207509|P1|Overall Study|Lack of Efficacy|5
974739|NCT00596427|3207539|P2|Overall Study|Protocol Violation|0
974740|NCT00596427|3207540|P1|Overall Study|Protocol Violation|1
974741|NCT00596427|3207539|P2|Overall Study|Increased Fasting Triacylglycerol level|0
974742|NCT00596427|3207540|P1|Overall Study|Increased Fasting Triacylglycerol level|1
974743|NCT00596427|3207539|P2|Overall Study|Withdrawal by Subject|2
974744|NCT00596427|3207540|P1|Overall Study|Withdrawal by Subject|2
974745|NCT00596362|3207568|P1|Overall Study|Progressive Disease|1
974746|NCT00596011|3207604|P2|Overall Study|Adverse Event|7
974747|NCT00596011|3207605|P1|Overall Study|Adverse Event|11
974748|NCT00596011|3207604|P2|Overall Study|Withdrawal by Subject|3
974749|NCT00596011|3207605|P1|Overall Study|Withdrawal by Subject|2
974750|NCT00595959|3207621|P1|Overall Study|Lost to Follow-up|1
974751|NCT00595959|3207621|P1|Overall Study|Withdrawal by Subject|1
974752|NCT00595920|3207655|P1|Overall Study|The OLTERMS study was discontinued by th|116
974753|NCT00595868|3207666|P2|Overall Study|Lost to Follow-up|50
974754|NCT00595868|3207667|P1|Overall Study|Lost to Follow-up|45
974755|NCT00595764|3207690|P2|Overall Study|Withdrawal by Subject|0
974756|NCT00595764|3207691|P1|Overall Study|Withdrawal by Subject|4
974757|NCT00595764|3207690|P2|Overall Study|Missed 3 PM visits|7
974758|NCT00595764|3207691|P1|Overall Study|Missed 3 PM visits|1
974759|NCT00595764|3207690|P2|Overall Study|Missed Medication >1 week|17
974760|NCT00595764|3207691|P1|Overall Study|Missed Medication >1 week|10
974761|NCT00595764|3207690|P2|Overall Study|Protocol Violation|19
974762|NCT00595764|3207691|P1|Overall Study|Protocol Violation|24
974763|NCT00595582|3207705|P1|Overall Study|Physician Decision|5
974764|NCT00595582|3207705|P1|Overall Study|Adverse Event|2
974765|NCT00595582|3207705|P1|Overall Study|Lost to Follow-up|1
974766|NCT00595582|3207705|P1|Overall Study|Pilot study that PI terminated|2
974767|NCT00595517|3207730|P1|Overall Study|No intention to attend regularly|1
974768|NCT00595517|3207730|P1|Overall Study|usage of prohibited treatment|1
974769|NCT00595517|3207730|P1|Overall Study|Recurrence of ulcer|5
974770|NCT00595517|3207730|P1|Overall Study|Protocol Violation|2
974771|NCT00595517|3207730|P1|Overall Study|Withdrawal by Subject|4
974772|NCT00595517|3207730|P1|Overall Study|Adverse Event|6
974773|NCT00595504|3207739|P2|Overall Study|Physician Decision|0
974774|NCT00595504|3207740|P1|Overall Study|Physician Decision|1
974775|NCT00595504|3207739|P2|Overall Study|Withdrawal by Subject|3
974776|NCT00595504|3207740|P1|Overall Study|Withdrawal by Subject|1
974777|NCT00595478|3207752|P2|36-week Follow-up Period|Withdrawal by Subject|4
974778|NCT00595478|3207753|P1|36-week Follow-up Period|Withdrawal by Subject|4
974779|NCT00595478|3207752|P2|36-week Follow-up Period|Lost to Follow-up|4
974780|NCT00595478|3207753|P1|36-week Follow-up Period|Lost to Follow-up|5
974781|NCT00595465|3207764|P3|Overall Study|administrative reason|1
974782|NCT00595465|3207765|P2|Overall Study|administrative reason|0
974783|NCT00595465|3207766|P1|Overall Study|administrative reason|0
974784|NCT00595465|3207764|P3|Overall Study|Lost to Follow-up|2
974785|NCT00595465|3207765|P2|Overall Study|Lost to Follow-up|0
974786|NCT00595465|3207766|P1|Overall Study|Lost to Follow-up|0
974787|NCT00595465|3207764|P3|Overall Study|Protocol Violation|0
974788|NCT00595465|3207765|P2|Overall Study|Protocol Violation|1
974789|NCT00595465|3207766|P1|Overall Study|Protocol Violation|2
974790|NCT00595465|3207764|P3|Overall Study|Pregnancy|1
974791|NCT00595465|3207765|P2|Overall Study|Pregnancy|0
974792|NCT00595465|3207766|P1|Overall Study|Pregnancy|0
974793|NCT00595465|3207764|P3|Overall Study|Adverse Event|3
974794|NCT00595465|3207765|P2|Overall Study|Adverse Event|3
974795|NCT00595465|3207766|P1|Overall Study|Adverse Event|4
974796|NCT00595413|3207778|P4|Overall Study|Other|0
974797|NCT00595413|3207779|P3|Overall Study|Other|5
974798|NCT00595413|3207780|P2|Overall Study|Other|1
974799|NCT00595413|3207781|P1|Overall Study|Other|5
974800|NCT00595413|3207778|P4|Overall Study|Death|0
974801|NCT00595413|3207779|P3|Overall Study|Death|1
974802|NCT00595413|3207780|P2|Overall Study|Death|0
974803|NCT00595413|3207781|P1|Overall Study|Death|0
974804|NCT00595413|3207778|P4|Overall Study|Lost to Follow-up|3
974805|NCT00595413|3207779|P3|Overall Study|Lost to Follow-up|1
974806|NCT00595413|3207780|P2|Overall Study|Lost to Follow-up|2
974807|NCT00595413|3207781|P1|Overall Study|Lost to Follow-up|2
974808|NCT00595413|3207778|P4|Overall Study|Adverse Event|1
974809|NCT00595413|3207779|P3|Overall Study|Adverse Event|1
974810|NCT00595413|3207780|P2|Overall Study|Adverse Event|2
974811|NCT00595413|3207781|P1|Overall Study|Adverse Event|0
974812|NCT00595335|3207822|P2|Six Months to Twelve Months|Disease Progression|0
974813|NCT00595335|3207823|P1|Six Months to Twelve Months|Disease Progression|1
974814|NCT00595335|3207822|P2|Six Months to Twelve Months|Withdrawal by Subject|1
974815|NCT00595335|3207823|P1|Six Months to Twelve Months|Withdrawal by Subject|0
974816|NCT00595335|3207822|P2|Baseline to Six Months|Adverse Event|0
974817|NCT00595335|3207823|P1|Baseline to Six Months|Adverse Event|1
974818|NCT00595335|3207822|P2|Baseline to Six Months|Disease Progression|1
974819|NCT00595335|3207823|P1|Baseline to Six Months|Disease Progression|1
974820|NCT00595335|3207822|P2|Baseline to Six Months|Withdrawal by Subject|1
974821|NCT00595335|3207823|P1|Baseline to Six Months|Withdrawal by Subject|0
974822|NCT00595309|3207843|P1|Overall Study|personal reason|1
974823|NCT00595309|3207843|P1|Overall Study|acute infection after V0|1
974824|NCT00595309|3207843|P1|Overall Study|planned vaccination against yellow fever|1
974825|NCT00595309|3207843|P1|Overall Study|Lost to Follow-up|1
974826|NCT00595127|3207873|P1|Overall Study|joined another trial|1
974827|NCT00595127|3207873|P1|Overall Study|Relapsed|3
974828|NCT00595127|3207873|P1|Overall Study|Death|6
974829|NCT00595075|3207895|P2|Overall Study|Withdrawal by Subject|0
974830|NCT00595075|3207896|P1|Overall Study|Withdrawal by Subject|1
974831|NCT00594958|3207917|P3|Overall Study|administrative|2
974832|NCT00594958|3207918|P2|Overall Study|administrative|0
974833|NCT00594958|3207919|P1|Overall Study|administrative|3
974834|NCT00594958|3207917|P3|Overall Study|Lost to Follow-up|3
974835|NCT00594958|3207918|P2|Overall Study|Lost to Follow-up|0
974836|NCT00594958|3207919|P1|Overall Study|Lost to Follow-up|5
974837|NCT00594958|3207917|P3|Overall Study|Protocol Violation|2
974838|NCT00594958|3207918|P2|Overall Study|Protocol Violation|0
974839|NCT00594958|3207919|P1|Overall Study|Protocol Violation|1
974840|NCT00594958|3207917|P3|Overall Study|Pregnancy|0
974841|NCT00594958|3207918|P2|Overall Study|Pregnancy|2
974842|NCT00594958|3207919|P1|Overall Study|Pregnancy|0
974843|NCT00594958|3207917|P3|Overall Study|Adverse Event|2
974844|NCT00594958|3207918|P2|Overall Study|Adverse Event|1
974845|NCT00594958|3207919|P1|Overall Study|Adverse Event|4
974846|NCT00594958|3207917|P3|Overall Study|Withdrawal by Subject|1
974847|NCT00594958|3207918|P2|Overall Study|Withdrawal by Subject|0
974848|NCT00594958|3207919|P1|Overall Study|Withdrawal by Subject|1
974849|NCT00594906|3207940|P2|Overall Study|Death|1
974850|NCT00594906|3207941|P1|Overall Study|Death|0
974851|NCT00594906|3207940|P2|Overall Study|Physician Decision|1
974852|NCT00594906|3207941|P1|Overall Study|Physician Decision|0
974853|NCT00594906|3207940|P2|Overall Study|Physician Decision|0
974854|NCT00594906|3207941|P1|Overall Study|Physician Decision|1
974855|NCT00594880|3207949|P2|Overall Study|Lost to Follow-up|0
974856|NCT00594880|3207950|P1|Overall Study|Lost to Follow-up|1
974857|NCT00594880|3207949|P2|Overall Study|Withdrawal by Subject|1
974858|NCT00594880|3207950|P1|Overall Study|Withdrawal by Subject|1
974859|NCT00594854|3207962|P2|Overall Study|Study terminated|10
974860|NCT00594854|3207963|P1|Overall Study|Study terminated|7
974861|NCT00594815|3207973|P1|Overall Study|Toxicity|4
974862|NCT00594815|3207973|P1|Overall Study|Withdrawal by Subject|2
974863|NCT00594815|3207973|P1|Overall Study|Never Treated|3
974864|NCT00594659|3207998|P3|Overall Study|Lost to Follow-up|7
974865|NCT00594659|3207999|P2|Overall Study|Lost to Follow-up|9
974866|NCT00594659|3208000|P1|Overall Study|Lost to Follow-up|13
974867|NCT00594646|3208011|P1|Overall Study|Lost to Follow-up|15
974868|NCT00594646|3208011|P1|Overall Study|Withdrawal by Subject|1
974869|NCT00594568|3208019|P3|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18
974870|NCT00594568|3208020|P2|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22
974871|NCT00594568|3208021|P1|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25
974872|NCT00594568|3208019|P3|Safety Follow Up (SFU)-Optional|Caregiver Decision|9
974873|NCT00594568|3208020|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|16
974874|NCT00594568|3208021|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|17
974875|NCT00594568|3208019|P3|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
974876|NCT00594568|3208020|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
974877|NCT00594568|3208021|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
974878|NCT00594568|3208019|P3|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13
974879|NCT00594568|3208020|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15
974880|NCT00594568|3208021|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12
974881|NCT00594568|3208019|P3|Safety Follow Up (SFU)-Optional|Adverse Event|0
974882|NCT00594568|3208020|P2|Safety Follow Up (SFU)-Optional|Adverse Event|0
974883|NCT00594568|3208021|P1|Safety Follow Up (SFU)-Optional|Adverse Event|5
974884|NCT00594568|3208019|P3|Safety Follow Up (SFU)-Optional|Death|0
974885|NCT00594568|3208020|P2|Safety Follow Up (SFU)-Optional|Death|1
974886|NCT00594568|3208021|P1|Safety Follow Up (SFU)-Optional|Death|0
974887|NCT00594568|3208019|P3|Delayed Start|Sponsor Decision|59
974888|NCT00594568|3208020|P2|Delayed Start|Sponsor Decision|66
974889|NCT00594568|3208021|P1|Delayed Start|Sponsor Decision|77
974890|NCT00594568|3208019|P3|Delayed Start|Caregiver Decision|2
974891|NCT00594568|3208020|P2|Delayed Start|Caregiver Decision|6
974892|NCT00594568|3208021|P1|Delayed Start|Caregiver Decision|5
974893|NCT00594568|3208019|P3|Delayed Start|Lost to Follow-up|1
974894|NCT00594568|3208020|P2|Delayed Start|Lost to Follow-up|0
974895|NCT00594568|3208021|P1|Delayed Start|Lost to Follow-up|0
974896|NCT00594568|3208019|P3|Delayed Start|Physician Decision|1
974897|NCT00594568|3208020|P2|Delayed Start|Physician Decision|0
974898|NCT00594568|3208021|P1|Delayed Start|Physician Decision|0
974899|NCT00594568|3208019|P3|Delayed Start|Withdrawal by Subject|0
974900|NCT00594568|3208020|P2|Delayed Start|Withdrawal by Subject|3
974901|NCT00594568|3208021|P1|Delayed Start|Withdrawal by Subject|4
974902|NCT00594568|3208019|P3|Delayed Start|Adverse Event|2
974903|NCT00594568|3208020|P2|Delayed Start|Adverse Event|2
974904|NCT00594568|3208021|P1|Delayed Start|Adverse Event|12
974905|NCT00594568|3208019|P3|Delayed Start|Death|1
974906|NCT00594568|3208020|P2|Delayed Start|Death|0
974907|NCT00594568|3208021|P1|Delayed Start|Death|0
974908|NCT00594568|3208019|P3|Initial Treatment|Entry criteria exclusion|1
974909|NCT00594568|3208020|P2|Initial Treatment|Entry criteria exclusion|1
974910|NCT00594568|3208021|P1|Initial Treatment|Entry criteria exclusion|0
974911|NCT00594568|3208019|P3|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6
974912|NCT00594568|3208020|P2|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
974913|NCT00594568|3208021|P1|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
974914|NCT00594568|3208019|P3|Initial Treatment|Caregiver decision|36
974915|NCT00594568|3208020|P2|Initial Treatment|Caregiver decision|36
974916|NCT00594568|3208021|P1|Initial Treatment|Caregiver decision|21
974917|NCT00594568|3208019|P3|Initial Treatment|Sponsor decision|147
974918|NCT00594568|3208020|P2|Initial Treatment|Sponsor decision|142
974919|NCT00594568|3208021|P1|Initial Treatment|Sponsor decision|193
974920|NCT00594568|3208019|P3|Initial Treatment|Withdrawal by Subject|46
974921|NCT00594568|3208020|P2|Initial Treatment|Withdrawal by Subject|31
974922|NCT00594568|3208021|P1|Initial Treatment|Withdrawal by Subject|25
974923|NCT00594568|3208019|P3|Initial Treatment|Protocol Violation|5
974924|NCT00594568|3208020|P2|Initial Treatment|Protocol Violation|2
974925|NCT00594568|3208021|P1|Initial Treatment|Protocol Violation|2
974926|NCT00594568|3208019|P3|Initial Treatment|Physician Decision|4
974927|NCT00594568|3208020|P2|Initial Treatment|Physician Decision|2
974928|NCT00594568|3208021|P1|Initial Treatment|Physician Decision|3
974929|NCT00594568|3208019|P3|Initial Treatment|Lost to Follow-up|4
974930|NCT00594568|3208020|P2|Initial Treatment|Lost to Follow-up|1
974931|NCT00594568|3208021|P1|Initial Treatment|Lost to Follow-up|4
974932|NCT00594568|3208019|P3|Initial Treatment|Death|15
974933|NCT00594568|3208020|P2|Initial Treatment|Death|11
974934|NCT00594568|3208021|P1|Initial Treatment|Death|6
974935|NCT00594568|3208019|P3|Initial Treatment|Adverse Event|144
974936|NCT00594568|3208020|P2|Initial Treatment|Adverse Event|121
974937|NCT00594568|3208021|P1|Initial Treatment|Adverse Event|51
974938|NCT00594516|3208109|P3|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2
974939|NCT00594516|3208110|P2|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
974940|NCT00594516|3208111|P1|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
974941|NCT00594516|3208109|P3|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
974942|NCT00594516|3208110|P2|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
974943|NCT00594516|3208111|P1|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0
974944|NCT00594516|3208109|P3|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2
974945|NCT00594516|3208110|P2|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3
974946|NCT00594516|3208111|P1|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0
974947|NCT00594516|3208109|P3|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
974948|NCT00594516|3208110|P2|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
974949|NCT00594516|3208111|P1|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0
974950|NCT00594516|3208109|P3|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
974951|NCT00594516|3208110|P2|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
974952|NCT00594516|3208111|P1|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6
974953|NCT00594516|3208109|P3|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
974954|NCT00594516|3208110|P2|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
974955|NCT00594516|3208111|P1|Open Label (OL): Tapentadol IR|Lack of Efficacy|1
974956|NCT00594516|3208109|P3|Open Label (OL): Tapentadol IR|Adverse Event|0
974957|NCT00594516|3208110|P2|Open Label (OL): Tapentadol IR|Adverse Event|0
974958|NCT00594516|3208111|P1|Open Label (OL): Tapentadol IR|Adverse Event|16
974959|NCT00594516|3208109|P3|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
974960|NCT00594516|3208110|P2|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
974961|NCT00594516|3208111|P1|Open Label (OL): Tapentadol IR|Lost to Follow-up|2
974962|NCT00594516|3208109|P3|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
974963|NCT00594516|3208110|P2|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
974964|NCT00594516|3208111|P1|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4
974965|NCT00594464|3208119|P1|Overall Study|Delay in operation|2
974966|NCT00594464|3208119|P1|Overall Study|Withdrawal by Subject|1
974967|NCT00594399|3208248|P3|Rerandomization Arm 1 Only|Withdrawal by Subject|0
974968|NCT00594399|3208249|P2|Rerandomization Arm 1 Only|Withdrawal by Subject|3
974969|NCT00594399|3208250|P1|Rerandomization Arm 1 Only|Withdrawal by Subject|0
974970|NCT00594399|3208248|P3|Rerandomization Arm 1 Only|Death|0
974971|NCT00594399|3208249|P2|Rerandomization Arm 1 Only|Death|1
974972|NCT00594399|3208250|P1|Rerandomization Arm 1 Only|Death|2
974973|NCT00594399|3208248|P3|Initial 3 Month Counseling|Family illness|0
974974|NCT00594399|3208249|P2|Initial 3 Month Counseling|Family illness|0
974975|NCT00594399|3208250|P1|Initial 3 Month Counseling|Family illness|1
974976|NCT00594399|3208248|P3|Initial 3 Month Counseling|Moved|0
974977|NCT00594399|3208249|P2|Initial 3 Month Counseling|Moved|0
974978|NCT00594399|3208250|P1|Initial 3 Month Counseling|Moved|1
974979|NCT00594399|3208248|P3|Initial 3 Month Counseling|Pain|0
974980|NCT00594399|3208249|P2|Initial 3 Month Counseling|Pain|0
974981|NCT00594399|3208250|P1|Initial 3 Month Counseling|Pain|2
974982|NCT00594399|3208248|P3|Initial 3 Month Counseling|Too busy|0
974983|NCT00594399|3208249|P2|Initial 3 Month Counseling|Too busy|1
974984|NCT00594399|3208250|P1|Initial 3 Month Counseling|Too busy|7
974985|NCT00594399|3208248|P3|Initial 3 Month Counseling|Personal issues|0
974986|NCT00594399|3208249|P2|Initial 3 Month Counseling|Personal issues|0
974987|NCT00594399|3208250|P1|Initial 3 Month Counseling|Personal issues|2
974988|NCT00594399|3208248|P3|Initial 3 Month Counseling|Lack of Interest|0
974989|NCT00594399|3208249|P2|Initial 3 Month Counseling|Lack of Interest|3
974990|NCT00594399|3208250|P1|Initial 3 Month Counseling|Lack of Interest|3
974991|NCT00594399|3208248|P3|Initial 3 Month Counseling|Not ready to exercise|0
974992|NCT00594399|3208249|P2|Initial 3 Month Counseling|Not ready to exercise|0
974993|NCT00594399|3208250|P1|Initial 3 Month Counseling|Not ready to exercise|1
974994|NCT00594386|3208272|P1|Overall Study|Other: Loss of drivers license|1
974995|NCT00594386|3208272|P1|Overall Study|Other: Patient wants prescription Neupro|1
974996|NCT00594386|3208272|P1|Overall Study|Other: Site terminated participation|1
974997|NCT00594386|3208272|P1|Overall Study|Other: Sponsor closure of study|1
974998|NCT00594386|3208272|P1|Overall Study|Other: Study terminated per investigator|2
974999|NCT00594386|3208272|P1|Overall Study|Other: Subject admitted to nursing home|1
975000|NCT00594386|3208272|P1|Overall Study|Other: Subject moved to Seattle|1
975001|NCT00594386|3208272|P1|Overall Study|Other: Patient went off patch (hospital)|1
975002|NCT00594386|3208272|P1|Overall Study|Lost to Follow-up|6
975003|NCT00594386|3208272|P1|Overall Study|Study ended per sponsor|115
975004|NCT00594386|3208272|P1|Overall Study|Subject withdrew consent|35
975005|NCT00594386|3208272|P1|Overall Study|Unsatisfactory compliance of subject|11
975006|NCT00594386|3208272|P1|Overall Study|Adverse Event|68
975007|NCT00594386|3208272|P1|Overall Study|Lack of Efficacy|12
975008|NCT00594386|3208272|P1|Overall Study|Major protocol violation|2
975009|NCT00594204|3208305|P2|Overall Study|Randomized but not treated|1
975010|NCT00594204|3208306|P1|Overall Study|Randomized but not treated|4
975011|NCT00594204|3208305|P2|Overall Study|Lack of Efficacy|4
975012|NCT00594204|3208306|P1|Overall Study|Lack of Efficacy|3
975013|NCT00594204|3208305|P2|Overall Study|Other|3
975014|NCT00594204|3208306|P1|Overall Study|Other|4
975015|NCT00594204|3208305|P2|Overall Study|Withdrawal by Subject|29
975016|NCT00594204|3208306|P1|Overall Study|Withdrawal by Subject|23
975017|NCT00594204|3208305|P2|Overall Study|Lost to Follow-up|5
975018|NCT00594204|3208306|P1|Overall Study|Lost to Follow-up|9
975019|NCT00594204|3208305|P2|Overall Study|Adverse Event|3
975020|NCT00594204|3208306|P1|Overall Study|Adverse Event|15
975021|NCT00594178|3208316|P1|Overall Study|Physician Decision|5
975022|NCT00594165|3208321|P1|Overall Study|Other: Site terminated participation|2
975023|NCT00594165|3208321|P1|Overall Study|Other: Subject enrolled in other trial|1
975024|NCT00594165|3208321|P1|Overall Study|Other: House bound; can't get to clinic|1
975025|NCT00594165|3208321|P1|Overall Study|Other: Brain surgery controlled symptoms|1
975026|NCT00594165|3208321|P1|Overall Study|Other: Subject moving|3
975027|NCT00594165|3208321|P1|Overall Study|Other: PI discretion|5
975028|NCT00594165|3208321|P1|Overall Study|Lost to Follow-up|4
975029|NCT00594165|3208321|P1|Overall Study|Study ended per sponsor|102
975030|NCT00594165|3208321|P1|Overall Study|Subject withdrew consent|27
975031|NCT00594165|3208321|P1|Overall Study|Unsatisfactory compliance of subject|6
975032|NCT00594165|3208321|P1|Overall Study|Adverse Event|52
975033|NCT00594165|3208321|P1|Overall Study|Lack of Efficacy|12
975034|NCT00594165|3208321|P1|Overall Study|Major protocol violation|1
975035|NCT00594100|3208327|P1|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4
975036|NCT00594100|3208327|P1|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6
975037|NCT00594100|3208327|P1|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2
975038|NCT00594100|3208327|P1|Procedure|Technical Failure|9
975039|NCT00594035|3208343|P2|Overall Study|Subject couldn't return due to job|1
975040|NCT00594035|3208344|P1|Overall Study|Subject couldn't return due to job|0
975041|NCT00594035|3208343|P2|Overall Study|Subject transferred to nursing home|1
975042|NCT00594035|3208344|P1|Overall Study|Subject transferred to nursing home|0
975043|NCT00594035|3208343|P2|Overall Study|Withdrawal by Subject|0
975044|NCT00594035|3208344|P1|Overall Study|Withdrawal by Subject|1
975045|NCT00594035|3208343|P2|Overall Study|Lost to Follow-up|1
975046|NCT00594035|3208344|P1|Overall Study|Lost to Follow-up|1
975047|NCT00593957|3208370|P3|Overall Study|Physician Decision|2
975048|NCT00593957|3208371|P2|Overall Study|Physician Decision|1
975049|NCT00593957|3208372|P1|Overall Study|Physician Decision|0
975050|NCT00593918|3208396|P2|Overall Study|Withdrawal by Subject|24
975051|NCT00593918|3208397|P1|Overall Study|Withdrawal by Subject|5
975052|NCT00593840|3208410|P1|Overall Study|Withdrawal by Subject|1
975053|NCT00593827|3208422|P2|Overall Study|On Active Treatment/Pending|2
975054|NCT00593827|3208423|P1|Overall Study|On Active Treatment/Pending|0
975055|NCT00593814|3208447|P2|Overall Study|Physician Decision|0
975056|NCT00593814|3208448|P1|Overall Study|Physician Decision|3
975057|NCT00593814|3208447|P2|Overall Study|Lost to Follow-up|0
975058|NCT00593814|3208448|P1|Overall Study|Lost to Follow-up|7
975059|NCT00593814|3208447|P2|Overall Study|Withdrawal by Subject|0
975060|NCT00593814|3208448|P1|Overall Study|Withdrawal by Subject|7
975061|NCT00593814|3208447|P2|Overall Study|Death|0
975062|NCT00593814|3208448|P1|Overall Study|Death|7
975063|NCT00593736|3208460|P4|Treatment Period and Placebo Run-out|Various|0
975064|NCT00593736|3208461|P3|Treatment Period and Placebo Run-out|Various|1
975065|NCT00593736|3208462|P2|Treatment Period and Placebo Run-out|Various|1
975066|NCT00593736|3208463|P1|Treatment Period and Placebo Run-out|Various|1
975067|NCT00593736|3208460|P4|Treatment Period and Placebo Run-out|Withdrawal by Subject|3
975068|NCT00593736|3208461|P3|Treatment Period and Placebo Run-out|Withdrawal by Subject|1
975069|NCT00593736|3208462|P2|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
975070|NCT00593736|3208463|P1|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
975071|NCT00593736|3208460|P4|Treatment Period and Placebo Run-out|Protocol Violation|1
975072|NCT00593736|3208461|P3|Treatment Period and Placebo Run-out|Protocol Violation|1
975073|NCT00593736|3208462|P2|Treatment Period and Placebo Run-out|Protocol Violation|0
975074|NCT00593736|3208463|P1|Treatment Period and Placebo Run-out|Protocol Violation|0
975075|NCT00593736|3208460|P4|Treatment Period and Placebo Run-out|Lost to Follow-up|0
975076|NCT00593736|3208461|P3|Treatment Period and Placebo Run-out|Lost to Follow-up|2
975077|NCT00593736|3208462|P2|Treatment Period and Placebo Run-out|Lost to Follow-up|1
975078|NCT00593736|3208463|P1|Treatment Period and Placebo Run-out|Lost to Follow-up|2
975079|NCT00593736|3208460|P4|Screening Period and Placebo Run-in|Various|25
975080|NCT00593736|3208461|P3|Screening Period and Placebo Run-in|Various|0
975081|NCT00593736|3208462|P2|Screening Period and Placebo Run-in|Various|0
975082|NCT00593736|3208463|P1|Screening Period and Placebo Run-in|Various|0
975083|NCT00593736|3208460|P4|Screening Period and Placebo Run-in|Did Not Meet Criteria|322
975084|NCT00593736|3208461|P3|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
975085|NCT00593736|3208462|P2|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
975086|NCT00593736|3208463|P1|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
975087|NCT00593736|3208460|P4|Screening Period and Placebo Run-in|Study Termination|15
975088|NCT00593736|3208461|P3|Screening Period and Placebo Run-in|Study Termination|0
975089|NCT00593736|3208462|P2|Screening Period and Placebo Run-in|Study Termination|0
975090|NCT00593736|3208463|P1|Screening Period and Placebo Run-in|Study Termination|0
975091|NCT00593736|3208460|P4|Screening Period and Placebo Run-in|Withdrawal by Subject|43
975092|NCT00593736|3208461|P3|Screening Period and Placebo Run-in|Withdrawal by Subject|0
975093|NCT00593736|3208462|P2|Screening Period and Placebo Run-in|Withdrawal by Subject|0
975094|NCT00593736|3208463|P1|Screening Period and Placebo Run-in|Withdrawal by Subject|0
975095|NCT00593736|3208460|P4|Screening Period and Placebo Run-in|Lost to Follow-up|9
975096|NCT00593736|3208461|P3|Screening Period and Placebo Run-in|Lost to Follow-up|0
975097|NCT00593736|3208462|P2|Screening Period and Placebo Run-in|Lost to Follow-up|0
975098|NCT00593736|3208463|P1|Screening Period and Placebo Run-in|Lost to Follow-up|0
975099|NCT00593736|3208460|P4|Screening Period and Placebo Run-in|Adverse Event|3
975100|NCT00593736|3208461|P3|Screening Period and Placebo Run-in|Adverse Event|0
975101|NCT00593736|3208462|P2|Screening Period and Placebo Run-in|Adverse Event|0
975102|NCT00593736|3208463|P1|Screening Period and Placebo Run-in|Adverse Event|0
975103|NCT00593684|3208711|P2|Overall Study|Death|1
975104|NCT00593684|3208712|P1|Overall Study|Death|2
975105|NCT00593606|3208738|P1|Overall Study|Screen Failure|3
975106|NCT00593606|3208738|P1|Overall Study|Run-In Failure|5
975107|NCT00593606|3208738|P1|Overall Study|Lost to Follow-up|2
975108|NCT00593606|3208738|P1|Overall Study|Protocol Violation|3
975109|NCT00593606|3208738|P1|Overall Study|Withdrawal by Subject|1
975110|NCT00593606|3208738|P1|Overall Study|Adverse Event|13
975111|NCT00593554|3208836|P2|Overall Study|Disease Progression|2
975112|NCT00593554|3208837|P1|Overall Study|Disease Progression|1
975113|NCT00593554|3208836|P2|Overall Study|Withdrawal by Subject|0
975114|NCT00593554|3208837|P1|Overall Study|Withdrawal by Subject|1
975115|NCT00593554|3208836|P2|Overall Study|Physician Decision|1
975116|NCT00593554|3208837|P1|Overall Study|Physician Decision|0
975117|NCT00593554|3208836|P2|Overall Study|Death|2
975118|NCT00593554|3208837|P1|Overall Study|Death|1
975119|NCT00593385|3208932|P1|Overall Study|Withdrawal by Subject|9
975120|NCT00593385|3208932|P1|Overall Study|Lost to Follow-up|17
975121|NCT00593385|3208932|P1|Overall Study|Death|14
975122|NCT00593333|3208993|P2|Overall Study|Lost to Follow-up|11
975123|NCT00593333|3208994|P1|Overall Study|Lost to Follow-up|10
975124|NCT00593112|3209017|P2|Overall Study|Withdrawal by Subject|0
975125|NCT00593112|3209018|P1|Overall Study|Withdrawal by Subject|5
975126|NCT00593112|3209017|P2|Overall Study|Unreadable Scan|0
975127|NCT00593112|3209018|P1|Overall Study|Unreadable Scan|1
975128|NCT00593112|3209017|P2|Overall Study|Abnormal Scan|0
975129|NCT00593112|3209018|P1|Overall Study|Abnormal Scan|1
975130|NCT00593112|3209017|P2|Overall Study|Scan Anxiety|0
975131|NCT00593112|3209018|P1|Overall Study|Scan Anxiety|3
975132|NCT00592904|3209045|P4|Overall Study|Not specified|0
975133|NCT00592904|3209046|P3|Overall Study|Not specified|0
975134|NCT00592904|3209047|P2|Overall Study|Not specified|3
975135|NCT00592904|3209048|P1|Overall Study|Not specified|3
975136|NCT00592904|3209045|P4|Overall Study|Physician Decision|0
975137|NCT00592904|3209046|P3|Overall Study|Physician Decision|1
975138|NCT00592904|3209047|P2|Overall Study|Physician Decision|3
975139|NCT00592904|3209048|P1|Overall Study|Physician Decision|0
975140|NCT00592904|3209045|P4|Overall Study|Lack of Efficacy|3
975141|NCT00592904|3209046|P3|Overall Study|Lack of Efficacy|2
975142|NCT00592904|3209047|P2|Overall Study|Lack of Efficacy|7
975143|NCT00592904|3209048|P1|Overall Study|Lack of Efficacy|2
975144|NCT00592904|3209045|P4|Overall Study|Withdrawal by Subject|2
975145|NCT00592904|3209046|P3|Overall Study|Withdrawal by Subject|1
975146|NCT00592904|3209047|P2|Overall Study|Withdrawal by Subject|16
975147|NCT00592904|3209048|P1|Overall Study|Withdrawal by Subject|4
975148|NCT00592904|3209045|P4|Overall Study|Protocol Violation|1
975149|NCT00592904|3209046|P3|Overall Study|Protocol Violation|0
975150|NCT00592904|3209047|P2|Overall Study|Protocol Violation|1
975151|NCT00592904|3209048|P1|Overall Study|Protocol Violation|1
975152|NCT00592904|3209045|P4|Overall Study|Adverse Event|5
975153|NCT00592904|3209046|P3|Overall Study|Adverse Event|13
975154|NCT00592904|3209047|P2|Overall Study|Adverse Event|25
975155|NCT00592904|3209048|P1|Overall Study|Adverse Event|15
975156|NCT00592852|3209074|P1|Overall Study|Withdrawal by Subject|1
975157|NCT00592852|3209074|P1|Overall Study|Found ineligible|1
975158|NCT00592852|3209074|P1|Overall Study|Adverse Event|3
975159|NCT00592852|3209074|P1|Overall Study|Non-compliance|1
975160|NCT00592839|3209082|P3|Overall Study|Lost to Follow-up|1
975161|NCT00592839|3209083|P2|Overall Study|Lost to Follow-up|1
975162|NCT00592839|3209084|P1|Overall Study|Lost to Follow-up|0
975163|NCT00592839|3209082|P3|Overall Study|Adverse Event|0
975164|NCT00592839|3209083|P2|Overall Study|Adverse Event|1
975165|NCT00592839|3209084|P1|Overall Study|Adverse Event|0
975166|NCT00592839|3209082|P3|Overall Study|Protocol Violation|2
975167|NCT00592839|3209083|P2|Overall Study|Protocol Violation|1
975168|NCT00592839|3209084|P1|Overall Study|Protocol Violation|1
975169|NCT00592839|3209082|P3|Overall Study|Withdrawal by Subject|3
975170|NCT00592839|3209083|P2|Overall Study|Withdrawal by Subject|1
975171|NCT00592839|3209084|P1|Overall Study|Withdrawal by Subject|1
975172|NCT00592774|3209112|P5|Overall Study|Not specified|2
975173|NCT00592774|3209113|P4|Overall Study|Not specified|0
975174|NCT00592774|3209114|P3|Overall Study|Not specified|1
975175|NCT00592774|3209115|P2|Overall Study|Not specified|1
975176|NCT00592774|3209116|P1|Overall Study|Not specified|0
975177|NCT00592774|3209112|P5|Overall Study|Physician Decision|1
975178|NCT00592774|3209113|P4|Overall Study|Physician Decision|0
975179|NCT00592774|3209114|P3|Overall Study|Physician Decision|1
975180|NCT00592774|3209115|P2|Overall Study|Physician Decision|1
975181|NCT00592774|3209116|P1|Overall Study|Physician Decision|0
975182|NCT00592774|3209112|P5|Overall Study|Lack of Efficacy|2
975183|NCT00592774|3209113|P4|Overall Study|Lack of Efficacy|0
975184|NCT00592774|3209114|P3|Overall Study|Lack of Efficacy|0
975185|NCT00592774|3209115|P2|Overall Study|Lack of Efficacy|3
975186|NCT00592774|3209116|P1|Overall Study|Lack of Efficacy|3
975187|NCT00592774|3209112|P5|Overall Study|Withdrawal by Subject|0
975188|NCT00592774|3209113|P4|Overall Study|Withdrawal by Subject|0
975189|NCT00592774|3209114|P3|Overall Study|Withdrawal by Subject|0
975190|NCT00592774|3209115|P2|Overall Study|Withdrawal by Subject|7
975191|NCT00592774|3209116|P1|Overall Study|Withdrawal by Subject|3
975192|NCT00592774|3209112|P5|Overall Study|Protocol Violation|1
975193|NCT00592774|3209113|P4|Overall Study|Protocol Violation|0
975194|NCT00592774|3209114|P3|Overall Study|Protocol Violation|0
975195|NCT00592774|3209115|P2|Overall Study|Protocol Violation|1
975196|NCT00592774|3209116|P1|Overall Study|Protocol Violation|0
975197|NCT00592774|3209112|P5|Overall Study|Adverse Event|8
975198|NCT00592774|3209113|P4|Overall Study|Adverse Event|14
975199|NCT00592774|3209114|P3|Overall Study|Adverse Event|2
975200|NCT00592774|3209115|P2|Overall Study|Adverse Event|19
975201|NCT00592774|3209116|P1|Overall Study|Adverse Event|5
975202|NCT00592683|3209188|P2|Overall Study|Lost to Follow-up|1
975203|NCT00592683|3209189|P1|Overall Study|Lost to Follow-up|0
975204|NCT00592683|3209188|P2|Overall Study|Other|0
975205|NCT00592683|3209189|P1|Overall Study|Other|1
975206|NCT00592683|3209188|P2|Overall Study|Study drug expired|0
975207|NCT00592683|3209189|P1|Overall Study|Study drug expired|1
975208|NCT00592683|3209188|P2|Overall Study|Protocol Violation|0
975209|NCT00592683|3209189|P1|Overall Study|Protocol Violation|1
975210|NCT00592683|3209188|P2|Overall Study|Adverse Event|2
975211|NCT00592683|3209189|P1|Overall Study|Adverse Event|0
975212|NCT00592683|3209188|P2|Overall Study|Withdrawal by Subject|0
975213|NCT00592683|3209189|P1|Overall Study|Withdrawal by Subject|1
975214|NCT00592683|3209188|P2|Overall Study|Found ineligible|1
975215|NCT00592683|3209189|P1|Overall Study|Found ineligible|0
975216|NCT00592631|3209199|P2|Overall Study|Lost to Follow-up|2
975217|NCT00592631|3209200|P1|Overall Study|Lost to Follow-up|0
975218|NCT00592384|3209249|P2|Overall Study|Withdrawal by Subject|6
975219|NCT00592384|3209250|P1|Overall Study|Withdrawal by Subject|5
975220|NCT00592358|3209258|P1|Overall Study|Inability to swallow pills|1
975221|NCT00592358|3209258|P1|Overall Study|Lack of Efficacy|2
975222|NCT00592358|3209258|P1|Overall Study|Adverse Event|1
975223|NCT00592358|3209258|P1|Overall Study|Withdrawal by Subject|2
975224|NCT00592319|3209265|P2|Overall Study|Lost to Follow-up|3
975225|NCT00592319|3209266|P1|Overall Study|Lost to Follow-up|0
975226|NCT00592072|3209341|P2|Wash Out Period|Lost to Follow-up|1
975227|NCT00592072|3209342|P1|Wash Out Period|Lost to Follow-up|1
975228|NCT00592007|3209364|P1|Overall Study|patient ineligible (out of lab range)|1
975229|NCT00592007|3209364|P1|Overall Study|Withdrawal by Subject|1
975230|NCT00591864|3209376|P1|Overall Study|Incomplete Imaging|5
975231|NCT00591851|3209382|P1|Overall Study|Progressive Disease|1
975232|NCT00591851|3209382|P1|Overall Study|Adverse Event|2
975233|NCT00591851|3209382|P1|Overall Study|Withdrawal by Subject|3
975234|NCT00591773|3209422|P3|Overall Study|Other|4
975235|NCT00591773|3209423|P2|Overall Study|Other|1
975236|NCT00591773|3209424|P1|Overall Study|Other|1
975237|NCT00591773|3209422|P3|Overall Study|Lack of Efficacy|2
975238|NCT00591773|3209423|P2|Overall Study|Lack of Efficacy|2
975239|NCT00591773|3209424|P1|Overall Study|Lack of Efficacy|1
975240|NCT00591773|3209422|P3|Overall Study|Withdrawal by Subject|3
975241|NCT00591773|3209423|P2|Overall Study|Withdrawal by Subject|5
975242|NCT00591773|3209424|P1|Overall Study|Withdrawal by Subject|2
975243|NCT00591773|3209422|P3|Overall Study|Lost to Follow-up|1
975244|NCT00591773|3209423|P2|Overall Study|Lost to Follow-up|4
975245|NCT00591773|3209424|P1|Overall Study|Lost to Follow-up|1
975246|NCT00591773|3209422|P3|Overall Study|Protocol Violation|0
975247|NCT00591773|3209423|P2|Overall Study|Protocol Violation|3
975248|NCT00591773|3209424|P1|Overall Study|Protocol Violation|2
975249|NCT00591773|3209422|P3|Overall Study|Adverse Event|6
975250|NCT00591773|3209423|P2|Overall Study|Adverse Event|9
975251|NCT00591773|3209424|P1|Overall Study|Adverse Event|9
975252|NCT00591734|3209483|P1|Overall Study|Intercurrent Illness|8
975253|NCT00591734|3209483|P1|Overall Study|Physician Decision|5
975254|NCT00591734|3209483|P1|Overall Study|Adverse Event|5
975255|NCT00591734|3209483|P1|Overall Study|Lack of Efficacy|35
975256|NCT00591721|3209489|P2|Overall Study|Intervention not received|8
975257|NCT00591721|3209490|P1|Overall Study|Intervention not received|10
975258|NCT00591721|3209489|P2|Overall Study|Lost to Follow-up|4
975259|NCT00591721|3209490|P1|Overall Study|Lost to Follow-up|1
975260|NCT00591721|3209489|P2|Overall Study|Withdrawal by Subject|10
975261|NCT00591721|3209490|P1|Overall Study|Withdrawal by Subject|10
975262|NCT00591591|3209498|P2|Overall Study|Lack of Efficacy|2
975263|NCT00591591|3209499|P1|Overall Study|Lack of Efficacy|10
975264|NCT00591591|3209498|P2|Overall Study|Withdrawal by Subject|37
975265|NCT00591591|3209499|P1|Overall Study|Withdrawal by Subject|1
975266|NCT00591578|3209516|P3|Open-Label Extension Phase|Other|0
975267|NCT00591578|3209517|P2|Open-Label Extension Phase|Other|0
975268|NCT00591578|3209518|P1|Open-Label Extension Phase|Other|1
975269|NCT00591578|3209516|P3|Open-Label Extension Phase|Withdrawal by Subject|0
975270|NCT00591578|3209517|P2|Open-Label Extension Phase|Withdrawal by Subject|1
975271|NCT00591578|3209518|P1|Open-Label Extension Phase|Withdrawal by Subject|1
975272|NCT00591578|3209516|P3|Open-Label Extension Phase|Lost to Follow-up|0
975273|NCT00591578|3209517|P2|Open-Label Extension Phase|Lost to Follow-up|4
975274|NCT00591578|3209518|P1|Open-Label Extension Phase|Lost to Follow-up|1
975275|NCT00591578|3209516|P3|Open-Label Extension Phase|Adverse Event|0
975276|NCT00591578|3209517|P2|Open-Label Extension Phase|Adverse Event|5
975277|NCT00591578|3209518|P1|Open-Label Extension Phase|Adverse Event|3
975278|NCT00591578|3209516|P3|Double-Blind Treatment Phase|Other|4
975279|NCT00591578|3209517|P2|Double-Blind Treatment Phase|Other|9
975280|NCT00591578|3209518|P1|Double-Blind Treatment Phase|Other|4
975281|NCT00591578|3209516|P3|Double-Blind Treatment Phase|Lack of Efficacy|25
975282|NCT00591578|3209517|P2|Double-Blind Treatment Phase|Lack of Efficacy|9
975283|NCT00591578|3209518|P1|Double-Blind Treatment Phase|Lack of Efficacy|16
975284|NCT00591578|3209516|P3|Double-Blind Treatment Phase|Pregnancy|0
975285|NCT00591578|3209517|P2|Double-Blind Treatment Phase|Pregnancy|0
975286|NCT00591578|3209518|P1|Double-Blind Treatment Phase|Pregnancy|1
975287|NCT00591578|3209516|P3|Double-Blind Treatment Phase|Withdrawal by Subject|22
975288|NCT00591578|3209517|P2|Double-Blind Treatment Phase|Withdrawal by Subject|22
975289|NCT00591578|3209518|P1|Double-Blind Treatment Phase|Withdrawal by Subject|22
975290|NCT00591578|3209516|P3|Double-Blind Treatment Phase|Lost to Follow-up|11
975291|NCT00591578|3209517|P2|Double-Blind Treatment Phase|Lost to Follow-up|12
975292|NCT00591578|3209518|P1|Double-Blind Treatment Phase|Lost to Follow-up|12
975293|NCT00591578|3209516|P3|Double-Blind Treatment Phase|Protocol Violation|3
975294|NCT00591578|3209517|P2|Double-Blind Treatment Phase|Protocol Violation|2
975295|NCT00591578|3209518|P1|Double-Blind Treatment Phase|Protocol Violation|3
975296|NCT00591578|3209516|P3|Double-Blind Treatment Phase|Adverse Event|19
975297|NCT00591578|3209517|P2|Double-Blind Treatment Phase|Adverse Event|26
975298|NCT00591578|3209518|P1|Double-Blind Treatment Phase|Adverse Event|20
975299|NCT00591565|3209569|P1|Overall Study|lost follow up, withdrawn|5
975300|NCT00591370|3209573|P1|Overall Study|Not Treated|2
975301|NCT00591344|3209581|P2|Overall Study|Did not want to come off medication|1
975302|NCT00591344|3209582|P1|Overall Study|Did not want to come off medication|0
975303|NCT00591344|3209581|P2|Overall Study|Lost to Follow-up|1
975304|NCT00591344|3209582|P1|Overall Study|Lost to Follow-up|0
975305|NCT00591344|3209581|P2|Overall Study|Death|1
975306|NCT00591344|3209582|P1|Overall Study|Death|0
975307|NCT00591344|3209581|P2|Overall Study|Underwent DBS|2
975308|NCT00591344|3209582|P1|Overall Study|Underwent DBS|2
975309|NCT00591344|3209581|P2|Overall Study|Medical complications|3
975310|NCT00591344|3209582|P1|Overall Study|Medical complications|1
975311|NCT00591344|3209581|P2|Overall Study|Moved out of state|0
975312|NCT00591344|3209582|P1|Overall Study|Moved out of state|1
975313|NCT00591344|3209581|P2|Overall Study|Transportation issues|0
975314|NCT00591344|3209582|P1|Overall Study|Transportation issues|1
975315|NCT00591266|3209608|P3|Overall Study|Other|5
975316|NCT00591266|3209609|P2|Overall Study|Other|4
975317|NCT00591266|3209610|P1|Overall Study|Other|1
975318|NCT00591266|3209608|P3|Overall Study|Lack of Efficacy|0
975319|NCT00591266|3209609|P2|Overall Study|Lack of Efficacy|2
975320|NCT00591266|3209610|P1|Overall Study|Lack of Efficacy|0
975321|NCT00591266|3209608|P3|Overall Study|Withdrawal by Subject|5
975322|NCT00591266|3209609|P2|Overall Study|Withdrawal by Subject|2
975323|NCT00591266|3209610|P1|Overall Study|Withdrawal by Subject|6
975324|NCT00591266|3209608|P3|Overall Study|Protocol Violation|1
975325|NCT00591266|3209609|P2|Overall Study|Protocol Violation|0
975326|NCT00591266|3209610|P1|Overall Study|Protocol Violation|0
975327|NCT00591266|3209608|P3|Overall Study|Lost to Follow-up|0
975328|NCT00591266|3209609|P2|Overall Study|Lost to Follow-up|1
975329|NCT00591266|3209610|P1|Overall Study|Lost to Follow-up|0
975330|NCT00591266|3209608|P3|Overall Study|Adverse Event|3
975331|NCT00591266|3209609|P2|Overall Study|Adverse Event|2
975332|NCT00591266|3209610|P1|Overall Study|Adverse Event|2
975333|NCT00591253|3209663|P3|Overall Study|Other|3
975334|NCT00591253|3209664|P2|Overall Study|Other|5
975335|NCT00591253|3209665|P1|Overall Study|Other|5
975336|NCT00591253|3209663|P3|Overall Study|Lack of Efficacy|3
975337|NCT00591253|3209664|P2|Overall Study|Lack of Efficacy|0
975338|NCT00591253|3209665|P1|Overall Study|Lack of Efficacy|1
975339|NCT00591253|3209663|P3|Overall Study|Withdrawal by Subject|6
975340|NCT00591253|3209664|P2|Overall Study|Withdrawal by Subject|7
975341|NCT00591253|3209665|P1|Overall Study|Withdrawal by Subject|1
975342|NCT00591253|3209663|P3|Overall Study|Lost to Follow-up|0
975343|NCT00591253|3209664|P2|Overall Study|Lost to Follow-up|4
975344|NCT00591253|3209665|P1|Overall Study|Lost to Follow-up|2
975345|NCT00591253|3209663|P3|Overall Study|Protocol Violation|2
975346|NCT00591253|3209664|P2|Overall Study|Protocol Violation|2
975347|NCT00591253|3209665|P1|Overall Study|Protocol Violation|2
975348|NCT00591253|3209663|P3|Overall Study|Adverse Event|1
975349|NCT00591253|3209664|P2|Overall Study|Adverse Event|3
975350|NCT00591253|3209665|P1|Overall Study|Adverse Event|3
975351|NCT00591214|3209733|P1|Overall Study|Withdrawal by Subject|1
975352|NCT00591214|3209733|P1|Overall Study|Physician Decision|7
975353|NCT00591149|3209742|P1|Overall Study|Withdrawal by Subject|1
975354|NCT00591149|3209742|P1|Overall Study|Adverse Event|4
975355|NCT00591006|3209758|P24|Overall Study|Adverse Event|0
975356|NCT00591006|3209759|P23|Overall Study|Adverse Event|1
975357|NCT00591006|3209760|P22|Overall Study|Adverse Event|0
975358|NCT00591006|3209761|P21|Overall Study|Adverse Event|0
975359|NCT00591006|3209762|P20|Overall Study|Adverse Event|0
975360|NCT00591006|3209763|P19|Overall Study|Adverse Event|0
975361|NCT00591006|3209764|P18|Overall Study|Adverse Event|0
975362|NCT00591006|3209765|P17|Overall Study|Adverse Event|0
975363|NCT00591006|3209766|P16|Overall Study|Adverse Event|0
975364|NCT00591006|3209767|P15|Overall Study|Adverse Event|0
975365|NCT00591006|3209768|P14|Overall Study|Adverse Event|0
975366|NCT00591006|3209769|P13|Overall Study|Adverse Event|0
975367|NCT00591006|3209770|P12|Overall Study|Adverse Event|0
975368|NCT00591006|3209771|P11|Overall Study|Adverse Event|0
975369|NCT00591006|3209772|P10|Overall Study|Adverse Event|0
975370|NCT00591006|3209773|P9|Overall Study|Adverse Event|0
975371|NCT00591006|3209774|P8|Overall Study|Adverse Event|0
975372|NCT00591006|3209775|P7|Overall Study|Adverse Event|0
975373|NCT00591006|3209776|P6|Overall Study|Adverse Event|0
975374|NCT00591006|3209777|P5|Overall Study|Adverse Event|0
975375|NCT00591006|3209778|P4|Overall Study|Adverse Event|0
975376|NCT00591006|3209779|P3|Overall Study|Adverse Event|0
975377|NCT00591006|3209780|P2|Overall Study|Adverse Event|0
975378|NCT00591006|3209781|P1|Overall Study|Adverse Event|0
975379|NCT00591006|3209758|P24|Overall Study|Withdrawal by Subject|1
975380|NCT00591006|3209759|P23|Overall Study|Withdrawal by Subject|0
975381|NCT00591006|3209760|P22|Overall Study|Withdrawal by Subject|0
975382|NCT00591006|3209761|P21|Overall Study|Withdrawal by Subject|0
975383|NCT00591006|3209762|P20|Overall Study|Withdrawal by Subject|0
975384|NCT00591006|3209763|P19|Overall Study|Withdrawal by Subject|0
975385|NCT00591006|3209764|P18|Overall Study|Withdrawal by Subject|0
975386|NCT00591006|3209765|P17|Overall Study|Withdrawal by Subject|0
975387|NCT00591006|3209766|P16|Overall Study|Withdrawal by Subject|1
975388|NCT00591006|3209767|P15|Overall Study|Withdrawal by Subject|0
975389|NCT00591006|3209768|P14|Overall Study|Withdrawal by Subject|0
975390|NCT00591006|3209769|P13|Overall Study|Withdrawal by Subject|0
975391|NCT00591006|3209770|P12|Overall Study|Withdrawal by Subject|0
975392|NCT00591006|3209771|P11|Overall Study|Withdrawal by Subject|0
975393|NCT00591006|3209772|P10|Overall Study|Withdrawal by Subject|0
975394|NCT00591006|3209773|P9|Overall Study|Withdrawal by Subject|0
975395|NCT00591006|3209774|P8|Overall Study|Withdrawal by Subject|0
975396|NCT00591006|3209775|P7|Overall Study|Withdrawal by Subject|0
975397|NCT00591006|3209776|P6|Overall Study|Withdrawal by Subject|0
975398|NCT00591006|3209777|P5|Overall Study|Withdrawal by Subject|0
975399|NCT00591006|3209778|P4|Overall Study|Withdrawal by Subject|0
975400|NCT00591006|3209779|P3|Overall Study|Withdrawal by Subject|0
975401|NCT00591006|3209780|P2|Overall Study|Withdrawal by Subject|0
975402|NCT00591006|3209781|P1|Overall Study|Withdrawal by Subject|0
975403|NCT00590980|3209799|P1|Overall Study|Did not meet all inclusion criteria|10
975404|NCT00590967|3209805|P2|Overall Study|Did not receive chemo per protocol|0
975405|NCT00590967|3209806|P1|Overall Study|Did not receive chemo per protocol|1
975406|NCT00590967|3209805|P2|Overall Study|Did not sign consent form|1
975407|NCT00590967|3209806|P1|Overall Study|Did not sign consent form|0
975408|NCT00590967|3209805|P2|Overall Study|Non-compliant|2
975409|NCT00590967|3209806|P1|Overall Study|Non-compliant|0
975410|NCT00590967|3209805|P2|Overall Study|Poor performance status|1
975411|NCT00590967|3209806|P1|Overall Study|Poor performance status|0
975412|NCT00590967|3209805|P2|Overall Study|Ineligible|0
975413|NCT00590967|3209806|P1|Overall Study|Ineligible|1
975414|NCT00590967|3209805|P2|Overall Study|Withdrawal by Subject|1
975415|NCT00590967|3209806|P1|Overall Study|Withdrawal by Subject|1
975416|NCT00590902|3209818|P1|Overall Study|Death|1
975417|NCT00590759|3209853|P1|Overall Study|Lost to Follow-up|28
975418|NCT00590759|3209853|P1|Overall Study|Death|52
975419|NCT00590720|3209860|P2|Overall Study|Withdrawal by Subject|1
975420|NCT00590720|3209861|P1|Overall Study|Withdrawal by Subject|0
975421|NCT00590720|3209860|P2|Overall Study|Lost to Follow-up|0
975422|NCT00590720|3209861|P1|Overall Study|Lost to Follow-up|1
975423|NCT00590590|3209923|P3|Overall Study|Did not complete study|0
975424|NCT00590590|3209924|P2|Overall Study|Did not complete study|1
975425|NCT00590590|3209925|P1|Overall Study|Did not complete study|0
975426|NCT00590590|3209923|P3|Overall Study|Did not complete due to study closure|1
975427|NCT00590590|3209924|P2|Overall Study|Did not complete due to study closure|1
975428|NCT00590590|3209925|P1|Overall Study|Did not complete due to study closure|1
975429|NCT00590590|3209923|P3|Overall Study|Withdrawal by Subject|1
975430|NCT00590590|3209924|P2|Overall Study|Withdrawal by Subject|1
975431|NCT00590590|3209925|P1|Overall Study|Withdrawal by Subject|0
975432|NCT00590590|3209923|P3|Overall Study|Lost to Follow-up|2
975433|NCT00590590|3209924|P2|Overall Study|Lost to Follow-up|1
975434|NCT00590590|3209925|P1|Overall Study|Lost to Follow-up|4
975435|NCT00590590|3209923|P3|Overall Study|Protocol Violation|2
975436|NCT00590590|3209924|P2|Overall Study|Protocol Violation|0
975437|NCT00590590|3209925|P1|Overall Study|Protocol Violation|0
975438|NCT00590590|3209923|P3|Overall Study|Adverse Event|0
975439|NCT00590590|3209924|P2|Overall Study|Adverse Event|0
975440|NCT00590590|3209925|P1|Overall Study|Adverse Event|1
975441|NCT00590590|3209923|P3|Overall Study|Lack of Efficacy|0
975442|NCT00590590|3209924|P2|Overall Study|Lack of Efficacy|2
975443|NCT00590590|3209925|P1|Overall Study|Lack of Efficacy|1
975444|NCT00590577|3209952|P4|Overall Study|Various reasons|2
975445|NCT00590577|3209953|P3|Overall Study|Various reasons|1
975446|NCT00590577|3209954|P2|Overall Study|Various reasons|3
975447|NCT00590577|3209955|P1|Overall Study|Various reasons|1
975448|NCT00590577|3209952|P4|Overall Study|Pregnancy|0
975449|NCT00590577|3209953|P3|Overall Study|Pregnancy|0
975450|NCT00590577|3209954|P2|Overall Study|Pregnancy|1
975451|NCT00590577|3209955|P1|Overall Study|Pregnancy|0
975452|NCT00590577|3209952|P4|Overall Study|Lost to Follow-up|9
975453|NCT00590577|3209953|P3|Overall Study|Lost to Follow-up|6
975454|NCT00590577|3209954|P2|Overall Study|Lost to Follow-up|6
975455|NCT00590577|3209955|P1|Overall Study|Lost to Follow-up|12
975456|NCT00590577|3209952|P4|Overall Study|Adverse Event|11
975457|NCT00590577|3209953|P3|Overall Study|Adverse Event|13
975458|NCT00590577|3209954|P2|Overall Study|Adverse Event|10
975459|NCT00590577|3209955|P1|Overall Study|Adverse Event|10
975460|NCT00590577|3209952|P4|Overall Study|Withdrawal by Subject|26
975461|NCT00590577|3209953|P3|Overall Study|Withdrawal by Subject|30
975462|NCT00590577|3209954|P2|Overall Study|Withdrawal by Subject|28
975463|NCT00590577|3209955|P1|Overall Study|Withdrawal by Subject|23
975464|NCT00590577|3209952|P4|Overall Study|Lack of Efficacy|45
975465|NCT00590577|3209953|P3|Overall Study|Lack of Efficacy|23
975466|NCT00590577|3209954|P2|Overall Study|Lack of Efficacy|28
975467|NCT00590577|3209955|P1|Overall Study|Lack of Efficacy|31
975468|NCT00590564|3209973|P1|Overall Study|Patient Non-compliance|6
975469|NCT00590564|3209973|P1|Overall Study|Patient Found to be Ineligible|1
975470|NCT00590564|3209973|P1|Overall Study|Protocol Violation|1
975471|NCT00590564|3209973|P1|Overall Study|Lost to Follow-up|6
975472|NCT00590564|3209973|P1|Overall Study|Withdrawal by Subject|4
975473|NCT00590538|3209977|P1|Overall Study|Study terminated before completed|2
975474|NCT00590317|3210019|P2|Overall Study|Lack of Efficacy|5
975475|NCT00590317|3210020|P1|Overall Study|Lack of Efficacy|1
975476|NCT00590135|3210050|P1|Overall Study|Primary endpoint measure not obtainable|59
975477|NCT00590044|3210060|P2|Overall Study|Protocol Violation|0
975478|NCT00590044|3210061|P1|Overall Study|Protocol Violation|1
975479|NCT00590044|3210060|P2|Overall Study|wrong insulin arm assigned|0
975480|NCT00590044|3210061|P1|Overall Study|wrong insulin arm assigned|1
975481|NCT00590044|3210060|P2|Overall Study|Withdrawal by Subject|2
975482|NCT00590044|3210061|P1|Overall Study|Withdrawal by Subject|2
975483|NCT00590031|3210073|P1|Overall Study|Admin Hold|1
975484|NCT00590031|3210073|P1|Overall Study|Metastatic Disease|1
975485|NCT00590031|3210073|P1|Overall Study|Withdrawal by Subject|1
975486|NCT00590031|3210073|P1|Overall Study|Adverse Event|3
975487|NCT00589979|3210100|P3|Double-Blind Treatment Period 3|Withdrawal by Subject|1
975488|NCT00589979|3210101|P2|Double-Blind Treatment Period 3|Withdrawal by Subject|0
975489|NCT00589979|3210102|P1|Double-Blind Treatment Period 3|Withdrawal by Subject|0
975490|NCT00589979|3210100|P3|Double-Blind Treatment Period 3|Protocol Violation|0
975491|NCT00589979|3210101|P2|Double-Blind Treatment Period 3|Protocol Violation|1
975492|NCT00589979|3210102|P1|Double-Blind Treatment Period 3|Protocol Violation|0
975493|NCT00589979|3210100|P3|Double-Blind Treatment Period 2|Other|1
975494|NCT00589979|3210101|P2|Double-Blind Treatment Period 2|Other|0
975495|NCT00589979|3210102|P1|Double-Blind Treatment Period 2|Other|0
975496|NCT00589979|3210100|P3|Double-Blind Treatment Period 2|Withdrawal by Subject|1
975497|NCT00589979|3210101|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|0
975498|NCT00589979|3210102|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
975499|NCT00589979|3210100|P3|Double-Blind Treatment Period 2|Adverse Event|0
975500|NCT00589979|3210101|P2|Double-Blind Treatment Period 2|Adverse Event|1
975501|NCT00589979|3210102|P1|Double-Blind Treatment Period 2|Adverse Event|0
975502|NCT00589979|3210100|P3|Double-Blind Treatment Period 1|Withdrawal by Subject|1
975503|NCT00589979|3210101|P2|Double-Blind Treatment Period 1|Withdrawal by Subject|0
975504|NCT00589979|3210102|P1|Double-Blind Treatment Period 1|Withdrawal by Subject|0
975505|NCT00589979|3210100|P3|Double-Blind Treatment Period 1|Protocol Violation|1
975506|NCT00589979|3210101|P2|Double-Blind Treatment Period 1|Protocol Violation|1
975507|NCT00589979|3210102|P1|Double-Blind Treatment Period 1|Protocol Violation|0
975508|NCT00589979|3210100|P3|Double-Blind Treatment Period 1|Adverse Event|0
975509|NCT00589979|3210101|P2|Double-Blind Treatment Period 1|Adverse Event|1
975510|NCT00589979|3210102|P1|Double-Blind Treatment Period 1|Adverse Event|0
975511|NCT00589979|3210100|P3|Run-In Period|Informed Consent Withdrawn|0
975512|NCT00589979|3210101|P2|Run-In Period|Informed Consent Withdrawn|0
975513|NCT00589979|3210102|P1|Run-In Period|Informed Consent Withdrawn|4
975514|NCT00589979|3210100|P3|Run-In Period|Withdrawal by Subject|0
975515|NCT00589979|3210101|P2|Run-In Period|Withdrawal by Subject|0
975516|NCT00589979|3210102|P1|Run-In Period|Withdrawal by Subject|10
975517|NCT00589979|3210100|P3|Run-In Period|Did not qualify for randomization|0
975518|NCT00589979|3210101|P2|Run-In Period|Did not qualify for randomization|0
975519|NCT00589979|3210102|P1|Run-In Period|Did not qualify for randomization|54
975520|NCT00589979|3210100|P3|Run-In Period|Protocol Violation|0
975521|NCT00589979|3210101|P2|Run-In Period|Protocol Violation|0
975522|NCT00589979|3210102|P1|Run-In Period|Protocol Violation|3
975523|NCT00589979|3210100|P3|Run-In Period|Adverse Event|0
975524|NCT00589979|3210101|P2|Run-In Period|Adverse Event|0
975525|NCT00589979|3210102|P1|Run-In Period|Adverse Event|5
975526|NCT00589914|3210141|P2|Overall Study|Other|17
975527|NCT00589914|3210142|P1|Overall Study|Other|22
975528|NCT00589914|3210141|P2|Overall Study|Withdrawal by Subject|49
975529|NCT00589914|3210142|P1|Overall Study|Withdrawal by Subject|55
975530|NCT00589914|3210141|P2|Overall Study|Pregnancy|0
975531|NCT00589914|3210142|P1|Overall Study|Pregnancy|1
975532|NCT00589914|3210141|P2|Overall Study|Lost to Follow-up|18
975533|NCT00589914|3210142|P1|Overall Study|Lost to Follow-up|11
975534|NCT00589914|3210141|P2|Overall Study|Lack of Efficacy|43
975535|NCT00589914|3210142|P1|Overall Study|Lack of Efficacy|40
975536|NCT00589914|3210141|P2|Overall Study|Death|0
975537|NCT00589914|3210142|P1|Overall Study|Death|2
975538|NCT00589914|3210141|P2|Overall Study|Adverse Event|10
975539|NCT00589914|3210142|P1|Overall Study|Adverse Event|19
975540|NCT00589784|3210198|P2|Overall Study|Adverse Event|4
975541|NCT00589784|3210199|P1|Overall Study|Adverse Event|0
975542|NCT00589784|3210198|P2|Overall Study|Patient inevaluable|0
975543|NCT00589784|3210199|P1|Overall Study|Patient inevaluable|1
975544|NCT00589784|3210198|P2|Overall Study|Withdrawal by Subject|6
975545|NCT00589784|3210199|P1|Overall Study|Withdrawal by Subject|0
975546|NCT00589693|3210206|P2|Overall Study|Protocol Violation|1
975547|NCT00589693|3210207|P1|Overall Study|Protocol Violation|1
975548|NCT00589693|3210206|P2|Overall Study|Physician Decision|1
975549|NCT00589693|3210207|P1|Overall Study|Physician Decision|0
975550|NCT00589693|3210206|P2|Overall Study|Lost to Follow-up|0
975551|NCT00589693|3210207|P1|Overall Study|Lost to Follow-up|1
975552|NCT00589693|3210206|P2|Overall Study|Lack of Efficacy|1
975553|NCT00589693|3210207|P1|Overall Study|Lack of Efficacy|0
975554|NCT00589693|3210206|P2|Overall Study|Death|16
975555|NCT00589693|3210207|P1|Overall Study|Death|26
975556|NCT00589693|3210206|P2|Overall Study|Adverse Event|4
975557|NCT00589693|3210207|P1|Overall Study|Adverse Event|4
975558|NCT00589693|3210206|P2|Overall Study|randomized in error|6
975559|NCT00589693|3210207|P1|Overall Study|randomized in error|12
975560|NCT00589667|3210221|P1|Overall Study|Withdrawal by Subject|1
975561|NCT00589667|3210221|P1|Overall Study|Adverse Event|2
975562|NCT00589628|3210228|P2|Overall Study|Lost to Follow-up|1
975563|NCT00589628|3210229|P1|Overall Study|Lost to Follow-up|0
975564|NCT00589602|3210235|P1|Overall Study|Did not collect enough CD34+ cells|1
975565|NCT00589472|3210270|P1|Overall Study|Adverse Event|1
975566|NCT00589303|3210282|P2|Overall Study|Withdrawal by Subject|1
975567|NCT00589303|3210283|P1|Overall Study|Withdrawal by Subject|2
975568|NCT00589290|3210289|P1|Overall Study|Withdrawal by Subject|1
975569|NCT00589121|3210312|P2|Overall Study|No protocol treatment received|1
975570|NCT00589121|3210313|P1|Overall Study|No protocol treatment received|0
975571|NCT00589121|3210312|P2|Overall Study|Protocol Violation|6
975572|NCT00589121|3210313|P1|Overall Study|Protocol Violation|2
975573|NCT00589108|3210333|P3|Overall Study|Death|4
975574|NCT00589108|3210334|P2|Overall Study|Death|3
975575|NCT00589108|3210335|P1|Overall Study|Death|3
975576|NCT00589108|3210333|P3|Overall Study|Lost to Follow-up|1
975577|NCT00589108|3210334|P2|Overall Study|Lost to Follow-up|1
975578|NCT00589108|3210335|P1|Overall Study|Lost to Follow-up|1
975579|NCT00588952|3210365|P2|Overall Study|Withdrawal by Subject|5
975580|NCT00588952|3210366|P1|Overall Study|Withdrawal by Subject|3
975581|NCT00588952|3210365|P2|Overall Study|Adverse Event|2
975582|NCT00588952|3210366|P1|Overall Study|Adverse Event|0
975583|NCT00588861|3210394|P2|10 Years|Incomplete due to study termination|114
975584|NCT00588861|3210395|P1|10 Years|Incomplete due to study termination|107
975585|NCT00588861|3210394|P2|8 Years|Patients did not return for follow-up|114
975586|NCT00588861|3210395|P1|8 Years|Patients did not return for follow-up|105
975587|NCT00588861|3210394|P2|6 Years|Patients did not return for follow-up|109
975588|NCT00588861|3210395|P1|6 Years|Patients did not return for follow-up|104
975589|NCT00588861|3210394|P2|4 Years|Patients did not return for follow-up|103
975590|NCT00588861|3210395|P1|4 Years|Patients did not return for follow-up|91
975591|NCT00588861|3210394|P2|2 Years|Patients did not return for follow-up|87
975923|NCT00584727|3211816|P3|First Intervention|Discontinuation|1
975592|NCT00588861|3210395|P1|2 Years|Patients did not return for follow-up|92
975593|NCT00588861|3210394|P2|1 Year|Patients did not return for follow-up|82
975594|NCT00588861|3210395|P1|1 Year|Patients did not return for follow-up|89
975595|NCT00588861|3210394|P2|6 Months|Patients did not return for follow-up|73
975596|NCT00588861|3210395|P1|6 Months|Patients did not return for follow-up|98
975597|NCT00588861|3210394|P2|Pre-Operative|Patients Did Not Complete Preop Data|86
975598|NCT00588861|3210395|P1|Pre-Operative|Patients Did Not Complete Preop Data|95
975599|NCT00588822|3210416|P1|Overall Study|progression of disease|8
975600|NCT00588731|3210436|P2|Overall Study|Withdrawal by Subject|2
975601|NCT00588731|3210437|P1|Overall Study|Withdrawal by Subject|3
975602|NCT00588692|3210447|P2|Overall Study|Death|0
975603|NCT00588692|3210448|P1|Overall Study|Death|1
975604|NCT00588692|3210447|P2|Overall Study|Cancer|0
975605|NCT00588692|3210448|P1|Overall Study|Cancer|1
975606|NCT00588692|3210447|P2|Overall Study|Severe Peptic Ulcer Disease|0
975607|NCT00588692|3210448|P1|Overall Study|Severe Peptic Ulcer Disease|1
975608|NCT00588692|3210447|P2|Overall Study|Hip Surgery|1
975609|NCT00588692|3210448|P1|Overall Study|Hip Surgery|0
975610|NCT00588692|3210447|P2|Overall Study|Withdrawal by Subject|2
975611|NCT00588692|3210448|P1|Overall Study|Withdrawal by Subject|4
975612|NCT00588666|3210484|P1|Overall Study|Adverse Event|4
975613|NCT00588640|3210489|P1|Overall Study|Ineligible Patient|1
975614|NCT00588640|3210489|P1|Overall Study|Physician Decision|1
975615|NCT00588445|3210508|P1|Overall Study|Not Treated|10
975616|NCT00588445|3210508|P1|Overall Study|Disease Progression|1
975617|NCT00588445|3210508|P1|Overall Study|Withdrawal by Subject|3
975618|NCT00588445|3210508|P1|Overall Study|Protocol Violation|1
975619|NCT00588354|3210532|P2|Baseline to 4 Weeks|Lost to Follow-up|1
975620|NCT00588354|3210533|P1|Baseline to 4 Weeks|Lost to Follow-up|0
975621|NCT00588354|3210532|P2|Baseline to 2 Weeks|Lack of Efficacy|0
975622|NCT00588354|3210533|P1|Baseline to 2 Weeks|Lack of Efficacy|1
975623|NCT00588354|3210532|P2|Baseline to 2 Weeks|Adverse Event|0
975624|NCT00588354|3210533|P1|Baseline to 2 Weeks|Adverse Event|1
975625|NCT00588341|3210553|P1|Overall Study|Patient ineligible|1
975626|NCT00588341|3210553|P1|Overall Study|Not treated due to metastatic disease|1
975627|NCT00588341|3210553|P1|Overall Study|Withdrawal by Subject|3
975628|NCT00588237|3210557|P1|Overall Study|Patien not treated|1
975629|NCT00588237|3210557|P1|Overall Study|Evaluable for toxicity only|3
975630|NCT00588146|3210580|P2|First Intervention (Baseline to 6 mo)|Adverse Event|3
975631|NCT00588146|3210581|P1|First Intervention (Baseline to 6 mo)|Adverse Event|4
975632|NCT00588094|3210587|P1|Overall Study|Progression of Disease|2
975633|NCT00588094|3210587|P1|Overall Study|Adverse Event|3
975634|NCT00587964|3210610|P1|Overall Study|Progression of Disease|4
975635|NCT00587964|3210610|P1|Overall Study|Patient did not receive intervention|5
975636|NCT00587964|3210610|P1|Overall Study|Patient found to be ineligible|1
975637|NCT00587964|3210610|P1|Overall Study|Lost to Follow-up|1
975638|NCT00587964|3210610|P1|Overall Study|Withdrawal by Subject|1
975639|NCT00587860|3210616|P2|Overall Study|Withdrawal by Subject|3
975640|NCT00587860|3210617|P1|Overall Study|Withdrawal by Subject|3
975641|NCT00587860|3210616|P2|Overall Study|Lost to Follow-up|2
975642|NCT00587860|3210617|P1|Overall Study|Lost to Follow-up|2
975643|NCT00587847|3210637|P1|Overall Study|Adverse Event|2
975644|NCT00587847|3210637|P1|Overall Study|Lack of Efficacy|5
975645|NCT00587795|3210660|P2|Overall Study|Withdrawal by Subject|0
975646|NCT00587795|3210661|P1|Overall Study|Withdrawal by Subject|1
975647|NCT00587639|3210715|P1|Overall Study|Withdrawal by Subject|1
975648|NCT00587587|3210722|P2|Overall Study|Lost to Follow-up|1
975649|NCT00587587|3210723|P1|Overall Study|Lost to Follow-up|6
975650|NCT00587457|3210777|P3|Overall Study|Development of neutralizing Abs|1
975651|NCT00587457|3210778|P2|Overall Study|Development of neutralizing Abs|0
975652|NCT00587457|3210779|P1|Overall Study|Development of neutralizing Abs|0
975653|NCT00587457|3210777|P3|Overall Study|Undefined|1
975654|NCT00587457|3210778|P2|Overall Study|Undefined|0
975655|NCT00587457|3210779|P1|Overall Study|Undefined|0
975656|NCT00587457|3210777|P3|Overall Study|Initiation of alternative therapy|0
975657|NCT00587457|3210778|P2|Overall Study|Initiation of alternative therapy|1
975658|NCT00587457|3210779|P1|Overall Study|Initiation of alternative therapy|0
975659|NCT00587457|3210777|P3|Overall Study|Disease progression|2
975660|NCT00587457|3210778|P2|Overall Study|Disease progression|0
975661|NCT00587457|3210779|P1|Overall Study|Disease progression|2
975662|NCT00587457|3210777|P3|Overall Study|Adverse Event|1
975663|NCT00587457|3210778|P2|Overall Study|Adverse Event|2
975664|NCT00587457|3210779|P1|Overall Study|Adverse Event|1
975665|NCT00587431|3210816|P2|Overall Study|Withdrawal by Subject|1
975666|NCT00587431|3210817|P1|Overall Study|Withdrawal by Subject|0
975667|NCT00587431|3210816|P2|Overall Study|Adverse Event|0
975668|NCT00587431|3210817|P1|Overall Study|Adverse Event|1
975669|NCT00587288|3210828|P2|Overall Study|Protocol Violation|0
975670|NCT00587288|3210829|P1|Overall Study|Protocol Violation|1
975671|NCT00587288|3210828|P2|Overall Study|Lack of Efficacy|8
975672|NCT00587288|3210829|P1|Overall Study|Lack of Efficacy|2
975673|NCT00587288|3210828|P2|Overall Study|Adverse Event|1
975674|NCT00587288|3210829|P1|Overall Study|Adverse Event|0
975675|NCT00587223|3210847|P1|Overall Study|Adverse Event|1
975676|NCT00587171|3210864|P2|Overall Study|Lost to Follow-up|1
975677|NCT00587171|3210865|P1|Overall Study|Lost to Follow-up|1
975678|NCT00587158|3210895|P2|Overall Study|Subject did not want to take study med|1
975679|NCT00587158|3210896|P1|Overall Study|Subject did not want to take study med|0
975680|NCT00587158|3210895|P2|Overall Study|Death|1
975681|NCT00587158|3210896|P1|Overall Study|Death|0
975682|NCT00587158|3210895|P2|Overall Study|Lost to Follow-up|2
975683|NCT00587158|3210896|P1|Overall Study|Lost to Follow-up|1
975684|NCT00587158|3210895|P2|Overall Study|Physician Decision|1
975685|NCT00587158|3210896|P1|Overall Study|Physician Decision|0
975686|NCT00587158|3210895|P2|Overall Study|Did not want to do 24 hr urine collect.|3
975687|NCT00587158|3210896|P1|Overall Study|Did not want to do 24 hr urine collect.|4
975688|NCT00587054|3210949|P1|Overall Study|Patient not treated|9
975689|NCT00586898|3210969|P1|Overall Study|Evaluable for Toxicity Only|5
975690|NCT00586898|3210969|P1|Overall Study|Patiemt Non-compliance|1
975691|NCT00586898|3210969|P1|Overall Study|Adverse Event|1
975692|NCT00586846|3210973|P1|Overall Study|Evaluable for Toxicity Only|4
975693|NCT00586846|3210973|P1|Overall Study|Death|1
975694|NCT00586846|3210973|P1|Overall Study|Physician Decision|1
975695|NCT00586820|3210979|P2|Overall Study|Unsuccessful PCI|0
975696|NCT00586820|3210980|P1|Overall Study|Unsuccessful PCI|1
975697|NCT00586703|3211011|P1|Overall Study|Death|12
975698|NCT00586690|3211018|P2|Overall Study|Lab can't accommodate|0
975699|NCT00586690|3211019|P1|Overall Study|Lab can't accommodate|1
975700|NCT00586690|3211018|P2|Overall Study|Lack of Efficacy|0
975701|NCT00586690|3211019|P1|Overall Study|Lack of Efficacy|2
975702|NCT00586690|3211018|P2|Overall Study|Adverse Event|0
975703|NCT00586690|3211019|P1|Overall Study|Adverse Event|1
975704|NCT00586690|3211018|P2|Overall Study|Disease Progression|0
975705|NCT00586690|3211019|P1|Overall Study|Disease Progression|10
975706|NCT00586690|3211018|P2|Overall Study|Death|0
975707|NCT00586690|3211019|P1|Overall Study|Death|2
975708|NCT00586664|3211029|P3|Overall Study|Exclusion criteria met|0
975709|NCT00586664|3211030|P2|Overall Study|Exclusion criteria met|0
975710|NCT00586664|3211031|P1|Overall Study|Exclusion criteria met|2
975711|NCT00586664|3211029|P3|Overall Study|Withdrawal by Subject|1
975712|NCT00586664|3211030|P2|Overall Study|Withdrawal by Subject|7
975713|NCT00586664|3211031|P1|Overall Study|Withdrawal by Subject|3
975714|NCT00586625|3211077|P2|Overall Study|Subject unable to return for visit|0
975715|NCT00586625|3211078|P1|Overall Study|Subject unable to return for visit|2
975716|NCT00586625|3211077|P2|Overall Study|Subject non-compliance|1
975717|NCT00586625|3211078|P1|Overall Study|Subject non-compliance|0
975718|NCT00586625|3211077|P2|Overall Study|Withdrawal by Subject|10
975719|NCT00586625|3211078|P1|Overall Study|Withdrawal by Subject|32
975720|NCT00586625|3211077|P2|Overall Study|Protocol Violation|0
975721|NCT00586625|3211078|P1|Overall Study|Protocol Violation|3
975722|NCT00586625|3211077|P2|Overall Study|Adverse Event|6
975723|NCT00586625|3211078|P1|Overall Study|Adverse Event|6
975724|NCT00586612|3211086|P2|Booster Phase|Lost to Follow-up|1
975725|NCT00586612|3211087|P1|Booster Phase|Lost to Follow-up|3
975726|NCT00586612|3211086|P2|Primary Phase|Withdrawal by Subject|2
975727|NCT00586612|3211087|P1|Primary Phase|Withdrawal by Subject|0
975728|NCT00586612|3211086|P2|Primary Phase|Lost to Follow-up|1
975729|NCT00586612|3211087|P1|Primary Phase|Lost to Follow-up|0
975730|NCT00586612|3211086|P2|Primary Phase|Protocol Violation|0
975731|NCT00586612|3211087|P1|Primary Phase|Protocol Violation|1
975732|NCT00586521|3211157|P1|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1
975733|NCT00586495|3211164|P1|Follow-up|Switch to commercial drug|10
975734|NCT00586495|3211164|P1|Follow-up|Protocol driven decision point|37
975735|NCT00586495|3211164|P1|Follow-up|Withdrawal by Subject|4
975736|NCT00586495|3211164|P1|Follow-up|Lost to Follow-up|1
975737|NCT00586495|3211164|P1|Follow-up|Death|40
975738|NCT00586495|3211164|P1|Treatment Period|Switch to commercial drug|10
975739|NCT00586495|3211164|P1|Treatment Period|Disease progression, recurrence/relapse|71
975740|NCT00586495|3211164|P1|Treatment Period|Withdrawal by Subject|1
975741|NCT00586495|3211164|P1|Treatment Period|Protocol Violation|1
975742|NCT00586495|3211164|P1|Treatment Period|Death|1
975743|NCT00586495|3211164|P1|Treatment Period|Adverse Event|11
975744|NCT00586469|3211193|P2|Overall Study|Adverse Event|1
975745|NCT00586469|3211194|P1|Overall Study|Adverse Event|0
975746|NCT00586339|3211221|P3|Overall Study|Withdrawal by Subject|1
975747|NCT00586339|3211222|P2|Overall Study|Withdrawal by Subject|3
975748|NCT00586339|3211223|P1|Overall Study|Withdrawal by Subject|1
975749|NCT00586339|3211221|P3|Overall Study|Lost to Follow-up|5
975750|NCT00586339|3211222|P2|Overall Study|Lost to Follow-up|4
975751|NCT00586339|3211223|P1|Overall Study|Lost to Follow-up|6
975752|NCT00586326|3211321|P1|Treated Through 5-yr Follow Up-Treated|Other|2
975753|NCT00586326|3211321|P1|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14
975754|NCT00586326|3211321|P1|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5
975755|NCT00586326|3211321|P1|Treated Through 5-yr Follow Up-Treated|Medical Reason|2
975756|NCT00586326|3211321|P1|Treated Through 5-yr Follow Up-Treated|Death|2
975757|NCT00586326|3211321|P1|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1
975758|NCT00586326|3211321|P1|Device Placed toTreatment-ITT|Physician Decision|1
975759|NCT00586326|3211321|P1|Device Placed toTreatment-ITT|Positive Margins|3
975760|NCT00586326|3211321|P1|Device Placed toTreatment-ITT|Microinvasion|1
975761|NCT00586326|3211321|P1|Device Placed toTreatment-ITT|Cavity Conformance|6
975762|NCT00586326|3211321|P1|Device Placed toTreatment-ITT|Skin Distance|7
975763|NCT00586326|3211321|P1|Enrollment to Device Placement-Enrolled|Other|1
975764|NCT00586326|3211321|P1|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1
975765|NCT00586326|3211321|P1|Enrollment to Device Placement-Enrolled|Physician Decision|1
975766|NCT00586326|3211321|P1|Enrollment to Device Placement-Enrolled|Microinvasion|2
975767|NCT00586326|3211321|P1|Enrollment to Device Placement-Enrolled|Cavity Conformance|4
975768|NCT00586326|3211321|P1|Enrollment to Device Placement-Enrolled|Skin Distance|6
975769|NCT00586313|3211332|P1|Overall Study|Lack of Efficacy|2
975770|NCT00586157|3211368|P2|Second Intervention|Adverse Event|1
975771|NCT00586157|3211369|P1|Second Intervention|Adverse Event|0
975772|NCT00586157|3211368|P2|Second Intervention|Worsening behavior|0
975773|NCT00586157|3211369|P1|Second Intervention|Worsening behavior|1
975774|NCT00586157|3211368|P2|Second Intervention|Withdrawal by Subject|0
975775|NCT00586157|3211369|P1|Second Intervention|Withdrawal by Subject|1
975776|NCT00586157|3211368|P2|First Intervention|Worsening behavior|0
975777|NCT00586157|3211369|P1|First Intervention|Worsening behavior|1
975778|NCT00586105|3211379|P1|Overall Study|Reason not reported|1
975779|NCT00586105|3211379|P1|Overall Study|Switched to commercial drug|9
975780|NCT00586105|3211379|P1|Overall Study|Disease progression|19
975781|NCT00586105|3211379|P1|Overall Study|Withdrawal by Subject|3
975782|NCT00586105|3211379|P1|Overall Study|Protocol Violation|1
975783|NCT00586105|3211379|P1|Overall Study|Death|2
975784|NCT00586105|3211379|P1|Overall Study|Adverse Event|4
975785|NCT00586066|3211394|P2|Overall Study|Withdrawal of consent|2
975786|NCT00586066|3211395|P1|Overall Study|Withdrawal of consent|4
975787|NCT00586066|3211394|P2|Overall Study|Physician Decision|0
975788|NCT00586066|3211395|P1|Overall Study|Physician Decision|1
975789|NCT00586066|3211394|P2|Overall Study|Adverse Event|2
975790|NCT00586066|3211395|P1|Overall Study|Adverse Event|2
975791|NCT00586066|3211394|P2|Overall Study|Lack of Efficacy|3
975792|NCT00586066|3211395|P1|Overall Study|Lack of Efficacy|5
975793|NCT00586066|3211394|P2|Overall Study|Lost to Follow-up|3
975794|NCT00586066|3211395|P1|Overall Study|Lost to Follow-up|6
975795|NCT00585975|3211407|P2|Overall Study|Enrollment met/over-enrolled|9
975796|NCT00585975|3211408|P1|Overall Study|Enrollment met/over-enrolled|10
975797|NCT00585975|3211407|P2|Overall Study|Lost to Follow-up|1
975798|NCT00585975|3211408|P1|Overall Study|Lost to Follow-up|2
975799|NCT00585975|3211407|P2|Overall Study|Withdrawal by Subject|3
975800|NCT00585975|3211408|P1|Overall Study|Withdrawal by Subject|3
975801|NCT00585923|3211418|P2|Overall Study|Physician decided not to continue|33
975802|NCT00585923|3211419|P1|Overall Study|Physician decided not to continue|31
975803|NCT00585689|3211450|P1|Overall Study|Death|1
975804|NCT00585689|3211450|P1|Overall Study|Patient had unresectable disease|1
975805|NCT00585689|3211450|P1|Overall Study|Patient Declined Surgery|1
975806|NCT00585689|3211450|P1|Overall Study|Adverse Event|1
975807|NCT00585689|3211450|P1|Overall Study|Received different ABI-007 schedule|3
975808|NCT00585585|3211496|P1|Overall Study|Adverse Event|1
975809|NCT00585546|3211500|P1|Clenbuterol Treatment - up to 12 Months|Adverse Event|3
975810|NCT00585546|3211500|P1|Clenbuterol Treatment - up to 12 Months|Death|1
975811|NCT00585533|3211514|P1|Overall Study|objective or symptomatic progression|9
975812|NCT00585468|3211523|P2|First Intervention|Withdrawal by Subject|1
975813|NCT00585468|3211524|P1|First Intervention|Withdrawal by Subject|1
975814|NCT00585351|3211556|P8|Enrollment Period (Intervention)|Unknown if alive or deceased|0
975815|NCT00585351|3211557|P7|Enrollment Period (Intervention)|Unknown if alive or deceased|0
975816|NCT00585351|3211558|P6|Enrollment Period (Intervention)|Unknown if alive or deceased|2
975817|NCT00585351|3211559|P5|Enrollment Period (Intervention)|Unknown if alive or deceased|1
975818|NCT00585351|3211560|P4|Enrollment Period (Intervention)|Unknown if alive or deceased|0
975819|NCT00585351|3211561|P3|Enrollment Period (Intervention)|Unknown if alive or deceased|0
975820|NCT00585351|3211562|P2|Enrollment Period (Intervention)|Unknown if alive or deceased|0
975821|NCT00585351|3211563|P1|Enrollment Period (Intervention)|Unknown if alive or deceased|0
975822|NCT00585351|3211556|P8|Enrollment Period (Intervention)|Death|0
975823|NCT00585351|3211557|P7|Enrollment Period (Intervention)|Death|1
975824|NCT00585351|3211558|P6|Enrollment Period (Intervention)|Death|0
975825|NCT00585351|3211559|P5|Enrollment Period (Intervention)|Death|1
975826|NCT00585351|3211560|P4|Enrollment Period (Intervention)|Death|0
975827|NCT00585351|3211561|P3|Enrollment Period (Intervention)|Death|0
975828|NCT00585351|3211562|P2|Enrollment Period (Intervention)|Death|0
975829|NCT00585351|3211563|P1|Enrollment Period (Intervention)|Death|0
975830|NCT00585351|3211556|P8|Enrollment Period (Intervention)|Lost to Follow-up|1
975831|NCT00585351|3211557|P7|Enrollment Period (Intervention)|Lost to Follow-up|1
975832|NCT00585351|3211558|P6|Enrollment Period (Intervention)|Lost to Follow-up|0
975833|NCT00585351|3211559|P5|Enrollment Period (Intervention)|Lost to Follow-up|0
975834|NCT00585351|3211560|P4|Enrollment Period (Intervention)|Lost to Follow-up|0
975835|NCT00585351|3211561|P3|Enrollment Period (Intervention)|Lost to Follow-up|0
975836|NCT00585351|3211562|P2|Enrollment Period (Intervention)|Lost to Follow-up|0
975837|NCT00585351|3211563|P1|Enrollment Period (Intervention)|Lost to Follow-up|0
975838|NCT00585351|3211556|P8|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
975839|NCT00585351|3211557|P7|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
975840|NCT00585351|3211558|P6|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
975841|NCT00585351|3211559|P5|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
975842|NCT00585351|3211560|P4|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
975924|NCT00584727|3211817|P2|First Intervention|Discontinuation|0
975843|NCT00585351|3211561|P3|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
975844|NCT00585351|3211562|P2|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
975845|NCT00585351|3211563|P1|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
975846|NCT00585351|3211556|P8|Notification Period (Informed Consent)|No study medication on flight|0
975847|NCT00585351|3211557|P7|Notification Period (Informed Consent)|No study medication on flight|0
975848|NCT00585351|3211558|P6|Notification Period (Informed Consent)|No study medication on flight|0
975849|NCT00585351|3211559|P5|Notification Period (Informed Consent)|No study medication on flight|0
975850|NCT00585351|3211560|P4|Notification Period (Informed Consent)|No study medication on flight|0
975851|NCT00585351|3211561|P3|Notification Period (Informed Consent)|No study medication on flight|0
975852|NCT00585351|3211562|P2|Notification Period (Informed Consent)|No study medication on flight|1
975853|NCT00585351|3211563|P1|Notification Period (Informed Consent)|No study medication on flight|0
975854|NCT00585351|3211556|P8|Notification Period (Informed Consent)|Flight aborted|0
975855|NCT00585351|3211557|P7|Notification Period (Informed Consent)|Flight aborted|0
975856|NCT00585351|3211558|P6|Notification Period (Informed Consent)|Flight aborted|0
975857|NCT00585351|3211559|P5|Notification Period (Informed Consent)|Flight aborted|0
975858|NCT00585351|3211560|P4|Notification Period (Informed Consent)|Flight aborted|0
975859|NCT00585351|3211561|P3|Notification Period (Informed Consent)|Flight aborted|0
975860|NCT00585351|3211562|P2|Notification Period (Informed Consent)|Flight aborted|1
975861|NCT00585351|3211563|P1|Notification Period (Informed Consent)|Flight aborted|2
975862|NCT00585351|3211556|P8|Notification Period (Informed Consent)|Physician Decision|0
975863|NCT00585351|3211557|P7|Notification Period (Informed Consent)|Physician Decision|0
975864|NCT00585351|3211558|P6|Notification Period (Informed Consent)|Physician Decision|0
975865|NCT00585351|3211559|P5|Notification Period (Informed Consent)|Physician Decision|0
975866|NCT00585351|3211560|P4|Notification Period (Informed Consent)|Physician Decision|0
975867|NCT00585351|3211561|P3|Notification Period (Informed Consent)|Physician Decision|0
975868|NCT00585351|3211562|P2|Notification Period (Informed Consent)|Physician Decision|2
975869|NCT00585351|3211563|P1|Notification Period (Informed Consent)|Physician Decision|0
975870|NCT00585325|3211579|P2|Overall Study|Withdrawal by Subject|1
975871|NCT00585325|3211580|P1|Overall Study|Withdrawal by Subject|1
975872|NCT00585312|3211588|P2|Overall Study|Study terminated by the sponsor|31
975873|NCT00585312|3211589|P1|Overall Study|Study terminated by the sponsor|34
975874|NCT00585312|3211588|P2|Overall Study|Withdrawal by Subject|1
975875|NCT00585312|3211589|P1|Overall Study|Withdrawal by Subject|5
975876|NCT00585312|3211588|P2|Overall Study|Reason not specified|0
975877|NCT00585312|3211589|P1|Overall Study|Reason not specified|2
975878|NCT00585312|3211588|P2|Overall Study|Lost to Follow-up|1
975879|NCT00585312|3211589|P1|Overall Study|Lost to Follow-up|1
975880|NCT00585312|3211588|P2|Overall Study|Lack of Efficacy|11
975881|NCT00585312|3211589|P1|Overall Study|Lack of Efficacy|6
975882|NCT00585312|3211588|P2|Overall Study|Adverse Event|0
975883|NCT00585312|3211589|P1|Overall Study|Adverse Event|3
975884|NCT00585286|3211601|P1|Overall Study|Lost to Follow-up|1
975885|NCT00585221|3211617|P1|Overall Study|Protocol Violation|8
975886|NCT00585169|3211627|P1|Overall Study|Withdrawal by Subject|1
975887|NCT00585078|3211637|P1|Overall Study|Death|1
975888|NCT00585078|3211637|P1|Overall Study|Adverse Event|10
975889|NCT00585078|3211637|P1|Overall Study|Disease Progression|24
975890|NCT00585078|3211637|P1|Overall Study|Poor performance status|1
975891|NCT00585078|3211637|P1|Overall Study|Withdrawal by Subject|4
975892|NCT00585052|3211644|P1|Overall Study|Withdrawal by Subject|1
975893|NCT00585039|3211651|P2|Overall Study|medication spilled|0
975894|NCT00585039|3211652|P1|Overall Study|medication spilled|2
975895|NCT00584987|3211681|P4|Overall Study|Adverse Event|1
975896|NCT00584987|3211682|P3|Overall Study|Adverse Event|0
975897|NCT00584987|3211683|P2|Overall Study|Adverse Event|0
975898|NCT00584987|3211684|P1|Overall Study|Adverse Event|0
975899|NCT00584987|3211681|P4|Overall Study|Protocol Violation|0
975900|NCT00584987|3211682|P3|Overall Study|Protocol Violation|1
975901|NCT00584987|3211683|P2|Overall Study|Protocol Violation|1
975902|NCT00584987|3211684|P1|Overall Study|Protocol Violation|1
975903|NCT00584909|3211732|P1|Overall Study|Adverse Event|4
975904|NCT00584844|3211742|P1|Overall Study|Screen Failure|20
975905|NCT00584844|3211742|P1|Overall Study|Withdrawal by Subject|59
975906|NCT00584740|3211794|P2|Overall Study|Lost to Follow-up|1
975907|NCT00584740|3211795|P1|Overall Study|Lost to Follow-up|0
975908|NCT00584740|3211794|P2|Overall Study|Withdrawal by Subject|2
975909|NCT00584740|3211795|P1|Overall Study|Withdrawal by Subject|3
975910|NCT00584740|3211794|P2|Overall Study|Lack of Efficacy|2
975911|NCT00584740|3211795|P1|Overall Study|Lack of Efficacy|8
975912|NCT00584740|3211794|P2|Overall Study|Adverse Event|1
975913|NCT00584740|3211795|P1|Overall Study|Adverse Event|1
975914|NCT00584727|3211813|P6|Third Intervention|Protocol Violation|2
975915|NCT00584727|3211814|P5|Third Intervention|Protocol Violation|4
975916|NCT00584727|3211815|P4|Third Intervention|Protocol Violation|0
975917|NCT00584727|3211816|P3|Third Intervention|Protocol Violation|1
975918|NCT00584727|3211817|P2|Third Intervention|Protocol Violation|0
975919|NCT00584727|3211818|P1|Third Intervention|Protocol Violation|0
975920|NCT00584727|3211813|P6|First Intervention|Discontinuation|0
975921|NCT00584727|3211814|P5|First Intervention|Discontinuation|0
975922|NCT00584727|3211815|P4|First Intervention|Discontinuation|0
975925|NCT00584727|3211818|P1|First Intervention|Discontinuation|0
975926|NCT00584454|3211856|P1|Overall Study|Clinical Hold|2
975927|NCT00584454|3211856|P1|Overall Study|Relocation|1
975928|NCT00584454|3211856|P1|Overall Study|Adverse Event|1
975929|NCT00584415|3211860|P1|Overall Study|Adverse Event|7
975930|NCT00584194|3211883|P1|Overall Study|Not specified|135
975931|NCT00584012|3211896|P1|Overall Study|Withdrawal by Subject|1
975932|NCT00583947|3211902|P2|Cross-over Period|not specified|1
975933|NCT00583947|3211903|P1|Cross-over Period|not specified|1
975934|NCT00583947|3211902|P2|Cross-over Period|Did not meet-no longer met entry criteri|1
975935|NCT00583947|3211903|P1|Cross-over Period|Did not meet-no longer met entry criteri|0
975936|NCT00583947|3211902|P2|Cross-over Period|Withdrawal by Subject|0
975937|NCT00583947|3211903|P1|Cross-over Period|Withdrawal by Subject|2
975938|NCT00583947|3211902|P2|Cross-over Period|Adverse Event|0
975939|NCT00583947|3211903|P1|Cross-over Period|Adverse Event|2
975940|NCT00583596|3212075|P1|Overall Study|Outside f-up window|26
975941|NCT00583596|3212075|P1|Overall Study|Not consented|15
975942|NCT00583596|3212075|P1|Overall Study|Data not complete|1
975943|NCT00583596|3212075|P1|Overall Study|Lost to Follow-up|94
975944|NCT00583596|3212075|P1|Overall Study|Withdrawal by Subject|6
975945|NCT00583596|3212075|P1|Overall Study|Death|2
975946|NCT00583596|3212075|P1|Overall Study|Excluded due to Hurricane Katrina|30
975947|NCT00583596|3212075|P1|Overall Study|Lost to Follow-up|110
975948|NCT00583557|3212080|P1|Overall Study|Did not receive belimumab in LBRA99|2
975949|NCT00583557|3212080|P1|Overall Study|Other|5
975950|NCT00583557|3212080|P1|Overall Study|Lack of Compliance|5
975951|NCT00583557|3212080|P1|Overall Study|Lack of Efficacy|31
975952|NCT00583557|3212080|P1|Overall Study|Adverse Event|9
975953|NCT00583557|3212080|P1|Overall Study|Withdrawal by Subject|18
975954|NCT00583453|3212111|P2|Overall Study|discontinued intervention|2
975955|NCT00583453|3212112|P1|Overall Study|discontinued intervention|0
975956|NCT00583362|3212145|P1|Overall Study|Withdrawal by Subject|57
975957|NCT00583362|3212145|P1|Overall Study|Protocol Violation|2
975958|NCT00583362|3212145|P1|Overall Study|Physician Decision|19
975959|NCT00583362|3212145|P1|Overall Study|Sponsor request due to missed doses|1
975960|NCT00583362|3212145|P1|Overall Study|Behavioral problems and non-compliance|1
975961|NCT00583362|3212145|P1|Overall Study|Misunderstanding of protocol|1
975962|NCT00583362|3212145|P1|Overall Study|Missed visits due to staff changes|1
975963|NCT00583362|3212145|P1|Overall Study|Subject moved out of the country/state|2
975964|NCT00583362|3212145|P1|Overall Study|Subject not dosed in LBSL99|1
975965|NCT00583362|3212145|P1|Overall Study|Current site closed|7
975966|NCT00583362|3212145|P1|Overall Study|Miscommunication of visit window|5
975967|NCT00583362|3212145|P1|Overall Study|Pregnancy|7
975968|NCT00583362|3212145|P1|Overall Study|Non-compliance with study drug|28
975969|NCT00583362|3212145|P1|Overall Study|Lost to Follow-up|4
975970|NCT00583362|3212145|P1|Overall Study|Lack of Efficacy|22
975971|NCT00583362|3212145|P1|Overall Study|Adverse Event|44
975972|NCT00583219|3212169|P1|Phase 2|Withdrawal by Subject|1
975973|NCT00583115|3212186|P1|Overall Study|Death|1
975974|NCT00583102|3212191|P1|Overall Study|Adverse Event|3
975975|NCT00582972|3212195|P1|Overall Study|Protocol Violation|2
975976|NCT00582933|3212204|P1|Overall Study|Physician Decision|3
975977|NCT00582907|3212208|P4|2nd Course|Lack of Efficacy|0
975978|NCT00582907|3212209|P3|2nd Course|Lack of Efficacy|0
975979|NCT00582907|3212210|P2|2nd Course|Lack of Efficacy|0
975980|NCT00582907|3212211|P1|2nd Course|Lack of Efficacy|1
975981|NCT00582907|3212208|P4|1st Course|Lost to Follow-up|1
975982|NCT00582907|3212209|P3|1st Course|Lost to Follow-up|0
975983|NCT00582907|3212210|P2|1st Course|Lost to Follow-up|0
975984|NCT00582907|3212211|P1|1st Course|Lost to Follow-up|0
975985|NCT00582907|3212208|P4|1st Course|Withdrawal by Subject|0
975986|NCT00582907|3212209|P3|1st Course|Withdrawal by Subject|0
975987|NCT00582907|3212210|P2|1st Course|Withdrawal by Subject|0
975988|NCT00582907|3212211|P1|1st Course|Withdrawal by Subject|1
975989|NCT00582816|3212250|P1|Overall Study|Engraftment Failure|3
975990|NCT00582790|3212260|P1|Overall Study|Rapid progression of disease|1
975991|NCT00582738|3212269|P2|Overall Study|Withdrawal by Subject|3
975992|NCT00582738|3212270|P1|Overall Study|Withdrawal by Subject|0
975993|NCT00582738|3212269|P2|Overall Study|Protocol Violation|1
975994|NCT00582738|3212270|P1|Overall Study|Protocol Violation|1
975995|NCT00582738|3212269|P2|Overall Study|Other|0
975996|NCT00582738|3212270|P1|Overall Study|Other|1
975997|NCT00582738|3212269|P2|Overall Study|Graft Lost|1
975998|NCT00582738|3212270|P1|Overall Study|Graft Lost|0
975999|NCT00582738|3212269|P2|Overall Study|Adverse Event|5
976000|NCT00582738|3212270|P1|Overall Study|Adverse Event|0
976001|NCT00582738|3212269|P2|Overall Study|Administrative Problems|8
976002|NCT00582738|3212270|P1|Overall Study|Administrative Problems|7
976003|NCT00582712|3212294|P1|Overall Study|Complicating disease requiring treatment|1
976004|NCT00582712|3212294|P1|Overall Study|Withdrawal by Subject|1
976005|NCT00582712|3212294|P1|Overall Study|Lack of Efficacy|1
976006|NCT00582712|3212294|P1|Overall Study|Adverse Event|1
976007|NCT00582608|3212309|P1|Overall Study|Lack of accrual|4
976008|NCT00582608|3212309|P1|Overall Study|Patient Ineligible|1
976009|NCT00582608|3212309|P1|Overall Study|Not Treated|7
976010|NCT00582556|3212316|P3|Overall Study|Physician Decision|1
976011|NCT00582556|3212317|P2|Overall Study|Physician Decision|0
976012|NCT00582556|3212318|P1|Overall Study|Physician Decision|0
976013|NCT00582556|3212316|P3|Overall Study|Withdrawal by Subject|1
976014|NCT00582556|3212317|P2|Overall Study|Withdrawal by Subject|1
976015|NCT00582556|3212318|P1|Overall Study|Withdrawal by Subject|0
976016|NCT00582491|3212346|P2|Overall Study|Withdrawal by Subject|0
976017|NCT00582491|3212347|P1|Overall Study|Withdrawal by Subject|1
976018|NCT00582426|3212371|P2|Overall Study|Use of illicit drugs|0
976019|NCT00582426|3212372|P1|Overall Study|Use of illicit drugs|1
976020|NCT00582426|3212371|P2|Overall Study|Disease Progression|2
976021|NCT00582426|3212372|P1|Overall Study|Disease Progression|2
976022|NCT00582426|3212371|P2|Overall Study|Withdrawal by Subject|2
976023|NCT00582426|3212372|P1|Overall Study|Withdrawal by Subject|3
976024|NCT00582426|3212371|P2|Overall Study|Death|3
976025|NCT00582426|3212372|P1|Overall Study|Death|4
976026|NCT00582426|3212371|P2|Overall Study|Protocol Violation|2
976027|NCT00582426|3212372|P1|Overall Study|Protocol Violation|6
976028|NCT00582426|3212371|P2|Overall Study|Adverse Event|2
976029|NCT00582426|3212372|P1|Overall Study|Adverse Event|4
976030|NCT00582426|3212371|P2|Overall Study|Lost to Follow-up|2
976031|NCT00582426|3212372|P1|Overall Study|Lost to Follow-up|0
976032|NCT00582309|3212419|P3|Overall Study|Protocol Violation|2
976033|NCT00582309|3212420|P2|Overall Study|Protocol Violation|0
976034|NCT00582309|3212421|P1|Overall Study|Protocol Violation|0
976035|NCT00582166|3212434|P1|Overall Study|Ineligible pathology|1
976036|NCT00582166|3212434|P1|Overall Study|Death|1
976037|NCT00582114|3212444|P2|Overall Study|Stopped by data safety monitoring board|20
976038|NCT00582114|3212445|P1|Overall Study|Stopped by data safety monitoring board|19
976039|NCT00582114|3212444|P2|Overall Study|Physician Decision|6
976040|NCT00582114|3212445|P1|Overall Study|Physician Decision|0
976041|NCT00582114|3212444|P2|Overall Study|Adverse Event|1
976042|NCT00582114|3212445|P1|Overall Study|Adverse Event|1
976043|NCT00582114|3212444|P2|Overall Study|Withdrawal by Subject|16
976044|NCT00582114|3212445|P1|Overall Study|Withdrawal by Subject|8
976045|NCT00582114|3212444|P2|Overall Study|Lost to Follow-up|6
976046|NCT00582114|3212445|P1|Overall Study|Lost to Follow-up|7
976047|NCT00582114|3212444|P2|Overall Study|Kidney Transplant|1
976048|NCT00582114|3212445|P1|Overall Study|Kidney Transplant|3
976049|NCT00582114|3212444|P2|Overall Study|Death|4
976050|NCT00582114|3212445|P1|Overall Study|Death|4
976051|NCT00582036|3212460|P2|Overall Study|Withdrawal by Subject|1
976052|NCT00582036|3212461|P1|Overall Study|Withdrawal by Subject|0
976053|NCT00582010|3212469|P2|Overall Study|Death|1
976054|NCT00582010|3212470|P1|Overall Study|Death|0
976055|NCT00581945|3212499|P2|Overall Study|Death|0
976056|NCT00581945|3212500|P1|Overall Study|Death|1
976057|NCT00581945|3212499|P2|Overall Study|Withdrawal by Subject|6
976058|NCT00581945|3212500|P1|Overall Study|Withdrawal by Subject|2
976059|NCT00581945|3212499|P2|Overall Study|Unsatisfactory therapeutic effect|0
976060|NCT00581945|3212500|P1|Overall Study|Unsatisfactory therapeutic effect|2
976061|NCT00581945|3212499|P2|Overall Study|Adverse Event|4
976062|NCT00581945|3212500|P1|Overall Study|Adverse Event|4
976063|NCT00581919|3212516|P1|Overall Study|Withdrawal by Subject|1
976064|NCT00581919|3212516|P1|Overall Study|Started Non-Protocol Therapy|2
976065|NCT00581919|3212516|P1|Overall Study|Other Complicating Disease|1
976066|NCT00581919|3212516|P1|Overall Study|Physician Decision|1
976067|NCT00581919|3212516|P1|Overall Study|Disease Progression|10
976068|NCT00581919|3212516|P1|Overall Study|Death|1
976069|NCT00581919|3212516|P1|Overall Study|Adverse Event|8
976070|NCT00581828|3212535|P1|Overall Study|Protocol Violation|1
976071|NCT00581776|3212539|P1|Overall Study|Disease progression or no response|3
976072|NCT00581555|3212557|P2|Overall Study|Other reasons|4
976073|NCT00581555|3212558|P1|Overall Study|Other reasons|16
976074|NCT00581555|3212557|P2|Overall Study|Lost to Follow-up|2
976075|NCT00581555|3212558|P1|Overall Study|Lost to Follow-up|2
976076|NCT00581555|3212557|P2|Overall Study|Withdrawal by Subject|9
976077|NCT00581555|3212558|P1|Overall Study|Withdrawal by Subject|18
976078|NCT00581555|3212557|P2|Overall Study|Physician Decision|2
976079|NCT00581555|3212558|P1|Overall Study|Physician Decision|3
976080|NCT00581555|3212557|P2|Overall Study|Adverse Event|3
976081|NCT00581555|3212558|P1|Overall Study|Adverse Event|4
976082|NCT00581542|3212582|P2|Overall Study|Lost to Follow-up|21
976083|NCT00581542|3212583|P1|Overall Study|Lost to Follow-up|9
976084|NCT00581542|3212582|P2|Overall Study|they met an exclusion criteria|2
976085|NCT00581542|3212583|P1|Overall Study|they met an exclusion criteria|2
976086|NCT00581360|3212637|P1|Overall Study|Withdrawal by Subject|1
976087|NCT00581308|3212656|P1|Month 12|Other|1
976088|NCT00581308|3212656|P1|Month 12|Device Removed|1
976089|NCT00581308|3212656|P1|Month 12|Withdrawal by Subject|3
976090|NCT00581308|3212656|P1|Month 12|Lost to Follow-up|14
976091|NCT00581308|3212656|P1|Month 12|Death|1
976092|NCT00581308|3212656|P1|Month 6|Withdrawal by Subject|2
976093|NCT00581308|3212656|P1|Month 6|Lost to Follow-up|1
976094|NCT00581308|3212656|P1|Month 1|Uknown|1
976095|NCT00581308|3212656|P1|Month 1|Device Removed|2
976096|NCT00581308|3212656|P1|Month 1|Withdrawal by Subject|2
976097|NCT00581308|3212656|P1|Month 1|Lost to Follow-up|3
976098|NCT00581308|3212656|P1|Pre Discharge|Device Removed|1
976099|NCT00581308|3212656|P1|Pre Discharge|Lost to Follow-up|1
976100|NCT00581113|3212687|P2|Overall Study|Withdrawal by Subject|1
976101|NCT00581113|3212688|P1|Overall Study|Withdrawal by Subject|0
976102|NCT00581100|3212698|P2|Overall Study|Other|0
976103|NCT00581100|3212699|P1|Overall Study|Other|3
976104|NCT00581100|3212698|P2|Overall Study|Withdrawal by Subject|4
976105|NCT00581100|3212699|P1|Overall Study|Withdrawal by Subject|1
976106|NCT00581100|3212698|P2|Overall Study|Adverse Event|1
976107|NCT00581100|3212699|P1|Overall Study|Adverse Event|2
976108|NCT00581100|3212698|P2|Overall Study|Death|0
976109|NCT00581100|3212699|P1|Overall Study|Death|1
976110|NCT00580983|3212752|P1|Overall Study|Did not complete 12 mon post RT studies|7
976111|NCT00580970|3212759|P1|Treatment (Lovastatin)|Death|1
976112|NCT00580970|3212759|P1|Treatment (Lovastatin)|Development of metastatic second primary|1
976113|NCT00580970|3212759|P1|Treatment (Lovastatin)|Physician Decision|4
976114|NCT00580970|3212759|P1|Treatment (Lovastatin)|Intolerance of Lovastatin|7
976115|NCT00580970|3212759|P1|Treatment (Lovastatin)|Non-compliance|6
976116|NCT00580970|3212759|P1|Pre-treatment|Non-compliance|1
976117|NCT00580866|3212774|P2|Overall Study|Lost to Follow-up|2
976118|NCT00580866|3212775|P1|Overall Study|Lost to Follow-up|2
976119|NCT00580840|3212799|P4|Double-Blind|Other: Forbidden Medication|0
976120|NCT00580840|3212800|P3|Double-Blind|Other: Forbidden Medication|1
976121|NCT00580840|3212801|P2|Double-Blind|Other: Forbidden Medication|0
976122|NCT00580840|3212802|P1|Double-Blind|Other: Forbidden Medication|0
976123|NCT00580840|3212799|P4|Double-Blind|Other: Discontinued Methotrexate|0
976124|NCT00580840|3212800|P3|Double-Blind|Other: Discontinued Methotrexate|0
976125|NCT00580840|3212801|P2|Double-Blind|Other: Discontinued Methotrexate|1
976126|NCT00580840|3212802|P1|Double-Blind|Other: Discontinued Methotrexate|0
976127|NCT00580840|3212799|P4|Double-Blind|Withdrawal by Subject|2
976128|NCT00580840|3212800|P3|Double-Blind|Withdrawal by Subject|2
976129|NCT00580840|3212801|P2|Double-Blind|Withdrawal by Subject|1
976130|NCT00580840|3212802|P1|Double-Blind|Withdrawal by Subject|0
976131|NCT00580840|3212799|P4|Double-Blind|Lost to Follow-up|2
976132|NCT00580840|3212800|P3|Double-Blind|Lost to Follow-up|0
976133|NCT00580840|3212801|P2|Double-Blind|Lost to Follow-up|1
976134|NCT00580840|3212802|P1|Double-Blind|Lost to Follow-up|0
976135|NCT00580840|3212799|P4|Double-Blind|Loss of Efficacy|10
976136|NCT00580840|3212800|P3|Double-Blind|Loss of Efficacy|2
976137|NCT00580840|3212801|P2|Double-Blind|Loss of Efficacy|1
976138|NCT00580840|3212802|P1|Double-Blind|Loss of Efficacy|0
976139|NCT00580840|3212799|P4|Double-Blind|Adverse Event|1
976140|NCT00580840|3212800|P3|Double-Blind|Adverse Event|4
976141|NCT00580840|3212801|P2|Double-Blind|Adverse Event|3
976142|NCT00580840|3212802|P1|Double-Blind|Adverse Event|0
976143|NCT00580840|3212799|P4|Run-in|Other: Exclusionary Lab Value|0
976144|NCT00580840|3212800|P3|Run-in|Other: Exclusionary Lab Value|0
976145|NCT00580840|3212801|P2|Run-in|Other: Exclusionary Lab Value|0
976146|NCT00580840|3212802|P1|Run-in|Other: Exclusionary Lab Value|1
976147|NCT00580840|3212799|P4|Run-in|Other: Did Not Meet Joint Count Criteria|0
976148|NCT00580840|3212800|P3|Run-in|Other: Did Not Meet Joint Count Criteria|0
976149|NCT00580840|3212801|P2|Run-in|Other: Did Not Meet Joint Count Criteria|0
976150|NCT00580840|3212802|P1|Run-in|Other: Did Not Meet Joint Count Criteria|1
976151|NCT00580840|3212799|P4|Run-in|Other: Per Sponsor Request|0
976152|NCT00580840|3212800|P3|Run-in|Other: Per Sponsor Request|0
976153|NCT00580840|3212801|P2|Run-in|Other: Per Sponsor Request|0
976154|NCT00580840|3212802|P1|Run-in|Other: Per Sponsor Request|2
976155|NCT00580840|3212799|P4|Run-in|Withdrawal by Subject|0
976156|NCT00580840|3212800|P3|Run-in|Withdrawal by Subject|0
976157|NCT00580840|3212801|P2|Run-in|Withdrawal by Subject|0
976158|NCT00580840|3212802|P1|Run-in|Withdrawal by Subject|5
976159|NCT00580840|3212799|P4|Run-in|Lost to Follow-up|0
976160|NCT00580840|3212800|P3|Run-in|Lost to Follow-up|0
976161|NCT00580840|3212801|P2|Run-in|Lost to Follow-up|0
976162|NCT00580840|3212802|P1|Run-in|Lost to Follow-up|4
976163|NCT00580840|3212799|P4|Run-in|Loss of Efficacy|0
976164|NCT00580840|3212800|P3|Run-in|Loss of Efficacy|0
976165|NCT00580840|3212801|P2|Run-in|Loss of Efficacy|0
976166|NCT00580840|3212802|P1|Run-in|Loss of Efficacy|1
976167|NCT00580840|3212799|P4|Run-in|Lack of Efficacy|0
976168|NCT00580840|3212800|P3|Run-in|Lack of Efficacy|0
976169|NCT00580840|3212801|P2|Run-in|Lack of Efficacy|0
976170|NCT00580840|3212802|P1|Run-in|Lack of Efficacy|93
976171|NCT00580840|3212799|P4|Run-in|Adverse Event|0
976172|NCT00580840|3212800|P3|Run-in|Adverse Event|0
976173|NCT00580840|3212801|P2|Run-in|Adverse Event|0
976174|NCT00580840|3212802|P1|Run-in|Adverse Event|17
976175|NCT00580801|3212910|P3|Overall Study|Travel|0
976176|NCT00580801|3212911|P2|Overall Study|Travel|0
976177|NCT00580801|3212912|P1|Overall Study|Travel|1
976178|NCT00580801|3212910|P3|Overall Study|Participant non-compliant|1
976179|NCT00580801|3212911|P2|Overall Study|Participant non-compliant|0
976180|NCT00580801|3212912|P1|Overall Study|Participant non-compliant|0
976181|NCT00580801|3212910|P3|Overall Study|Reached a virologic endpoint|2
976182|NCT00580801|3212911|P2|Overall Study|Reached a virologic endpoint|1
976183|NCT00580801|3212912|P1|Overall Study|Reached a virologic endpoint|0
976184|NCT00580801|3212910|P3|Overall Study|Lost to Follow-up|0
976185|NCT00580801|3212911|P2|Overall Study|Lost to Follow-up|0
976186|NCT00580801|3212912|P1|Overall Study|Lost to Follow-up|2
976187|NCT00580801|3212910|P3|Overall Study|Adverse Event|0
976188|NCT00580801|3212911|P2|Overall Study|Adverse Event|0
976189|NCT00580801|3212912|P1|Overall Study|Adverse Event|2
976190|NCT00580801|3212910|P3|Overall Study|Physician Decision|0
976191|NCT00580801|3212911|P2|Overall Study|Physician Decision|0
976192|NCT00580801|3212912|P1|Overall Study|Physician Decision|1
976193|NCT00580788|3212951|P4|Overall Study|Adverse Event|1
976194|NCT00580788|3212952|P3|Overall Study|Adverse Event|0
976195|NCT00580788|3212953|P2|Overall Study|Adverse Event|0
976196|NCT00580788|3212954|P1|Overall Study|Adverse Event|0
976197|NCT00580723|3213012|P1|Overall Study|Lost to Follow-up|5
976198|NCT00580723|3213012|P1|Overall Study|Did not want to participate in extension|3
976199|NCT00580606|3213055|P2|Open Label (OL)|Needed Prohibited Medication|1
976200|NCT00580606|3213056|P1|Open Label (OL)|Needed Prohibited Medication|0
976201|NCT00580606|3213055|P2|Open Label (OL)|Physician Decision|1
976202|NCT00580606|3213056|P1|Open Label (OL)|Physician Decision|1
976203|NCT00580606|3213055|P2|Open Label (OL)|Non-compliance|0
976204|NCT00580606|3213056|P1|Open Label (OL)|Non-compliance|2
976205|NCT00580606|3213055|P2|Open Label (OL)|Pregnancy|1
976206|NCT00580606|3213056|P1|Open Label (OL)|Pregnancy|0
976207|NCT00580606|3213055|P2|Open Label (OL)|Lost to Follow-up|1
976208|NCT00580606|3213056|P1|Open Label (OL)|Lost to Follow-up|0
976209|NCT00580606|3213055|P2|Open Label (OL)|Dosing Symptoms|1
976210|NCT00580606|3213056|P1|Open Label (OL)|Dosing Symptoms|0
976211|NCT00580606|3213055|P2|Open Label (OL)|Withdrawal by Subject|6
976212|NCT00580606|3213056|P1|Open Label (OL)|Withdrawal by Subject|4
976213|NCT00580606|3213055|P2|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1
976214|NCT00580606|3213056|P1|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2
976215|NCT00580047|3213137|P3|Overall Study|Withdrawal by Subject|0
976216|NCT00580047|3213138|P2|Overall Study|Withdrawal by Subject|0
976217|NCT00580047|3213139|P1|Overall Study|Withdrawal by Subject|1
976218|NCT00580047|3213137|P3|Overall Study|Withdrawal by Subject|2
976219|NCT00580047|3213138|P2|Overall Study|Withdrawal by Subject|1
976220|NCT00580047|3213139|P1|Overall Study|Withdrawal by Subject|1
976221|NCT00580047|3213137|P3|Overall Study|Lost to Follow-up|0
976222|NCT00580047|3213138|P2|Overall Study|Lost to Follow-up|1
976223|NCT00580047|3213139|P1|Overall Study|Lost to Follow-up|1
976224|NCT00580034|3213150|P2|Overall Study|Toxicity|0
976225|NCT00580034|3213151|P1|Overall Study|Toxicity|10
976226|NCT00579982|3213157|P1|Overall Study|Protocol Violation|4
976227|NCT00579982|3213157|P1|Overall Study|Adverse Event|4
976228|NCT00579826|3213178|P2|Overall Study|Withdrawal by Subject|3
976229|NCT00579826|3213179|P1|Overall Study|Withdrawal by Subject|5
976230|NCT00579670|3213213|P5|Overall Study|Withdrawal by Subject|0
976231|NCT00579670|3213214|P4|Overall Study|Withdrawal by Subject|0
976232|NCT00579670|3213215|P3|Overall Study|Withdrawal by Subject|1
976233|NCT00579670|3213216|P2|Overall Study|Withdrawal by Subject|0
976234|NCT00579670|3213217|P1|Overall Study|Withdrawal by Subject|0
976235|NCT00579670|3213213|P5|Overall Study|Other|0
976236|NCT00579670|3213214|P4|Overall Study|Other|2
976237|NCT00579670|3213215|P3|Overall Study|Other|1
976238|NCT00579670|3213216|P2|Overall Study|Other|0
976239|NCT00579670|3213217|P1|Overall Study|Other|0
976240|NCT00579670|3213213|P5|Overall Study|Lost to Follow-up|0
976241|NCT00579670|3213214|P4|Overall Study|Lost to Follow-up|4
976242|NCT00579670|3213215|P3|Overall Study|Lost to Follow-up|0
976243|NCT00579670|3213216|P2|Overall Study|Lost to Follow-up|1
976244|NCT00579670|3213217|P1|Overall Study|Lost to Follow-up|0
976245|NCT00579670|3213213|P5|Overall Study|Lack of Efficacy|0
976246|NCT00579670|3213214|P4|Overall Study|Lack of Efficacy|14
976247|NCT00579670|3213215|P3|Overall Study|Lack of Efficacy|1
976248|NCT00579670|3213216|P2|Overall Study|Lack of Efficacy|0
976249|NCT00579670|3213217|P1|Overall Study|Lack of Efficacy|0
976250|NCT00579670|3213213|P5|Overall Study|Adverse Event|0
976251|NCT00579670|3213214|P4|Overall Study|Adverse Event|2
976252|NCT00579670|3213215|P3|Overall Study|Adverse Event|1
976253|NCT00579670|3213216|P2|Overall Study|Adverse Event|0
976254|NCT00579670|3213217|P1|Overall Study|Adverse Event|1
976255|NCT00579670|3213213|P5|Overall Study|Death|0
976256|NCT00579670|3213214|P4|Overall Study|Death|0
976257|NCT00579670|3213215|P3|Overall Study|Death|0
976258|NCT00579670|3213216|P2|Overall Study|Death|0
976259|NCT00579670|3213217|P1|Overall Study|Death|1
976260|NCT00579501|3213429|P1|Overall Study|Radiation therapy before surgery|1
976261|NCT00579501|3213429|P1|Overall Study|Secondary lesion|1
976262|NCT00579501|3213429|P1|Overall Study|toxicity|1
976263|NCT00579501|3213429|P1|Overall Study|End of neoadjuvant therapy|25
976264|NCT00579501|3213429|P1|Overall Study|Death|1
976265|NCT00579345|3213457|P8|Overall Study|Death|0
976266|NCT00579345|3213458|P7|Overall Study|Death|0
976267|NCT00579345|3213459|P6|Overall Study|Death|0
976268|NCT00579345|3213460|P5|Overall Study|Death|0
976269|NCT00579345|3213461|P4|Overall Study|Death|1
976270|NCT00579345|3213462|P3|Overall Study|Death|1
976271|NCT00579345|3213463|P2|Overall Study|Death|1
976272|NCT00579345|3213464|P1|Overall Study|Death|1
976273|NCT00579345|3213457|P8|Overall Study|Protocol Violation|1
976274|NCT00579345|3213458|P7|Overall Study|Protocol Violation|0
976275|NCT00579345|3213459|P6|Overall Study|Protocol Violation|0
976276|NCT00579345|3213460|P5|Overall Study|Protocol Violation|0
976277|NCT00579345|3213461|P4|Overall Study|Protocol Violation|0
976278|NCT00579345|3213462|P3|Overall Study|Protocol Violation|0
976279|NCT00579345|3213463|P2|Overall Study|Protocol Violation|0
976280|NCT00579345|3213464|P1|Overall Study|Protocol Violation|1
976281|NCT00579345|3213457|P8|Overall Study|Adverse Event|0
976282|NCT00579345|3213458|P7|Overall Study|Adverse Event|0
976283|NCT00579345|3213459|P6|Overall Study|Adverse Event|0
976284|NCT00579345|3213460|P5|Overall Study|Adverse Event|0
976285|NCT00579345|3213461|P4|Overall Study|Adverse Event|0
976286|NCT00579345|3213462|P3|Overall Study|Adverse Event|1
976287|NCT00579345|3213463|P2|Overall Study|Adverse Event|0
976288|NCT00579345|3213464|P1|Overall Study|Adverse Event|0
976289|NCT00579345|3213457|P8|Overall Study|Lost to Follow-up|0
976290|NCT00579345|3213458|P7|Overall Study|Lost to Follow-up|0
976291|NCT00579345|3213459|P6|Overall Study|Lost to Follow-up|0
976292|NCT00579345|3213460|P5|Overall Study|Lost to Follow-up|0
976293|NCT00579345|3213461|P4|Overall Study|Lost to Follow-up|0
976294|NCT00579345|3213462|P3|Overall Study|Lost to Follow-up|0
976295|NCT00579345|3213463|P2|Overall Study|Lost to Follow-up|0
976296|NCT00579345|3213464|P1|Overall Study|Lost to Follow-up|1
976297|NCT00579345|3213457|P8|Overall Study|Withdrawal by Subject|1
976298|NCT00579345|3213458|P7|Overall Study|Withdrawal by Subject|0
976299|NCT00579345|3213459|P6|Overall Study|Withdrawal by Subject|0
976300|NCT00579345|3213460|P5|Overall Study|Withdrawal by Subject|0
976301|NCT00579345|3213461|P4|Overall Study|Withdrawal by Subject|0
976302|NCT00579345|3213462|P3|Overall Study|Withdrawal by Subject|0
976303|NCT00579345|3213463|P2|Overall Study|Withdrawal by Subject|0
976304|NCT00579345|3213464|P1|Overall Study|Withdrawal by Subject|2
976305|NCT00579254|3213496|P1|Overall Study|Discontinued when study terminated|73
976306|NCT00579254|3213496|P1|Overall Study|Lost to Follow-up|39
976307|NCT00579098|3213520|P2|Overall Study|AF returned after ablation|2
976308|NCT00579098|3213521|P1|Overall Study|AF returned after ablation|3
976309|NCT00579098|3213520|P2|Overall Study|Withdrawal by Subject|3
976310|NCT00579098|3213521|P1|Overall Study|Withdrawal by Subject|2
976311|NCT00579098|3213520|P2|Overall Study|Adverse Event|3
976312|NCT00579098|3213521|P1|Overall Study|Adverse Event|2
976313|NCT00579098|3213520|P2|Overall Study|Lost to Follow-up|0
976314|NCT00579098|3213521|P1|Overall Study|Lost to Follow-up|2
976315|NCT00579059|3213537|P2|Overall Study|Study Canceled at 1 Year|10
976316|NCT00579059|3213538|P1|Overall Study|Study Canceled at 1 Year|21
976317|NCT00578942|3213612|P1|Overall Study|Lost to Follow-up|1
976318|NCT00578877|3213651|P2|Overall Study|did not provide follow-up data|17
976319|NCT00578877|3213652|P1|Overall Study|did not provide follow-up data|12
976320|NCT00578877|3213651|P2|Overall Study|early discontinue|101
976321|NCT00578877|3213652|P1|Overall Study|early discontinue|61
976322|NCT00578877|3213651|P2|Overall Study|Lost to Follow-up|10
976323|NCT00578877|3213652|P1|Overall Study|Lost to Follow-up|8
976324|NCT00578864|3213660|P2|Overall Study|Death|0
976325|NCT00578864|3213661|P1|Overall Study|Death|1
976326|NCT00578812|3213677|P2|Overall Study|Not treated|7
976327|NCT00578812|3213678|P1|Overall Study|Not treated|6
976328|NCT00578786|3213717|P3|Overall Study|Qualified but Not Enrolled in Extension|0
976329|NCT00578786|3213718|P2|Overall Study|Qualified but Not Enrolled in Extension|3
976330|NCT00578786|3213719|P1|Overall Study|Qualified but Not Enrolled in Extension|0
976331|NCT00578786|3213717|P3|Overall Study|Not Otherwise Specified|1
976332|NCT00578786|3213718|P2|Overall Study|Not Otherwise Specified|4
976333|NCT00578786|3213719|P1|Overall Study|Not Otherwise Specified|0
976334|NCT00578786|3213717|P3|Overall Study|Pregnancy|0
976335|NCT00578786|3213718|P2|Overall Study|Pregnancy|1
976336|NCT00578786|3213719|P1|Overall Study|Pregnancy|0
976337|NCT00578786|3213717|P3|Overall Study|Lost to Follow-up|0
976338|NCT00578786|3213718|P2|Overall Study|Lost to Follow-up|4
976339|NCT00578786|3213719|P1|Overall Study|Lost to Follow-up|0
976340|NCT00578786|3213717|P3|Overall Study|Sponsor Decision|1
976341|NCT00578786|3213718|P2|Overall Study|Sponsor Decision|0
976342|NCT00578786|3213719|P1|Overall Study|Sponsor Decision|0
976343|NCT00578786|3213717|P3|Overall Study|Physician Decision|1
976344|NCT00578786|3213718|P2|Overall Study|Physician Decision|0
976345|NCT00578786|3213719|P1|Overall Study|Physician Decision|1
976346|NCT00578786|3213717|P3|Overall Study|Protocol Violation|1
976347|NCT00578786|3213718|P2|Overall Study|Protocol Violation|3
976348|NCT00578786|3213719|P1|Overall Study|Protocol Violation|0
976349|NCT00578786|3213717|P3|Overall Study|Withdrawal by Subject|5
976350|NCT00578786|3213718|P2|Overall Study|Withdrawal by Subject|8
976351|NCT00578786|3213719|P1|Overall Study|Withdrawal by Subject|7
976352|NCT00578786|3213717|P3|Overall Study|Early Escape from Prior Study|2
976353|NCT00578786|3213718|P2|Overall Study|Early Escape from Prior Study|1
976354|NCT00578786|3213719|P1|Overall Study|Early Escape from Prior Study|2
976355|NCT00578786|3213717|P3|Overall Study|Lack of Efficacy|2
976356|NCT00578786|3213718|P2|Overall Study|Lack of Efficacy|5
976357|NCT00578786|3213719|P1|Overall Study|Lack of Efficacy|2
976358|NCT00578786|3213717|P3|Overall Study|Adverse Event|17
976359|NCT00578786|3213718|P2|Overall Study|Adverse Event|37
976360|NCT00578786|3213719|P1|Overall Study|Adverse Event|27
976361|NCT00578643|3213820|P1|Overall Study|Lost to Follow-up|1
976362|NCT00578643|3213820|P1|Overall Study|Death|1
976363|NCT00578565|3213836|P1|Overall Study|Adverse Event|3
976364|NCT00578448|3213866|P1|1 Year Long Term Extension (LTE)|Adverse Event|1
976365|NCT00578448|3213866|P1|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1
976366|NCT00578448|3213866|P1|Day 1 up to 3 Years of Planned Study|Adverse Event|1
976367|NCT00578448|3213866|P1|Day 1 up to 3 Years of Planned Study|Death|1
976368|NCT00578318|3213930|P2|Overall Study|Physician Decision|0
976369|NCT00578318|3213931|P1|Overall Study|Physician Decision|1
976370|NCT00578318|3213930|P2|Overall Study|Lost to Follow-up|0
976371|NCT00578318|3213931|P1|Overall Study|Lost to Follow-up|2
976372|NCT00578227|3214013|P3|Overall Study|Withdrawal by Subject|3
976373|NCT00578227|3214014|P2|Overall Study|Withdrawal by Subject|1
976374|NCT00578227|3214015|P1|Overall Study|Withdrawal by Subject|5
976375|NCT00578227|3214013|P3|Overall Study|Lost to Follow-up|1
976376|NCT00578227|3214014|P2|Overall Study|Lost to Follow-up|1
976377|NCT00578227|3214015|P1|Overall Study|Lost to Follow-up|0
976378|NCT00578175|3214140|P3|Overall Study|Other reasons|23
976379|NCT00578175|3214141|P2|Overall Study|Other reasons|42
976380|NCT00578175|3214142|P1|Overall Study|Other reasons|70
976381|NCT00578175|3214140|P3|Overall Study|Adverse Event|1
976382|NCT00578175|3214141|P2|Overall Study|Adverse Event|1
976383|NCT00578175|3214142|P1|Overall Study|Adverse Event|0
976384|NCT00578136|3214221|P2|Overall Study|Not given intervention|1
976385|NCT00578136|3214222|P1|Overall Study|Not given intervention|1
976386|NCT00577889|3214240|P3|Overall Study|Withdrawal by Subject|0
976387|NCT00577889|3214241|P2|Overall Study|Withdrawal by Subject|0
976388|NCT00577889|3214242|P1|Overall Study|Withdrawal by Subject|1
976389|NCT00577863|3214261|P2|Overall Study|Did Not Receive at Least One Injection|1
976390|NCT00577863|3214262|P1|Overall Study|Did Not Receive at Least One Injection|0
976391|NCT00577863|3214261|P2|Overall Study|Sponsor Decision|7
976392|NCT00577863|3214262|P1|Overall Study|Sponsor Decision|2
976393|NCT00577863|3214261|P2|Overall Study|Withdrawal by Subject|2
976394|NCT00577863|3214262|P1|Overall Study|Withdrawal by Subject|0
976395|NCT00577863|3214261|P2|Overall Study|Entry Criteria Exclusion|0
976396|NCT00577863|3214262|P1|Overall Study|Entry Criteria Exclusion|1
976397|NCT00577863|3214261|P2|Overall Study|Lost to Follow-up|2
976398|NCT00577863|3214262|P1|Overall Study|Lost to Follow-up|2
976399|NCT00577863|3214261|P2|Overall Study|Death|0
976400|NCT00577863|3214262|P1|Overall Study|Death|1
976401|NCT00577863|3214261|P2|Overall Study|Adverse Event|2
976402|NCT00577863|3214262|P1|Overall Study|Adverse Event|4
976403|NCT00577824|3214304|P3|Overall Study|Protocol Violation|0
976404|NCT00577824|3214305|P2|Overall Study|Protocol Violation|1
976405|NCT00577824|3214306|P1|Overall Study|Protocol Violation|1
976406|NCT00577824|3214304|P3|Overall Study|Patient decision|1
976407|NCT00577824|3214305|P2|Overall Study|Patient decision|1
976408|NCT00577824|3214306|P1|Overall Study|Patient decision|0
976409|NCT00577824|3214304|P3|Overall Study|Adverse Event|1
976410|NCT00577824|3214305|P2|Overall Study|Adverse Event|18
976411|NCT00577824|3214306|P1|Overall Study|Adverse Event|6
976412|NCT00577772|3214364|P2|Overall Study|Lost to Follow-up|1
976413|NCT00577772|3214365|P1|Overall Study|Lost to Follow-up|0
976414|NCT00577720|3214375|P4|Overall Study|Withdrawal by Subject|2
976415|NCT00577720|3214376|P3|Overall Study|Withdrawal by Subject|0
976416|NCT00577720|3214377|P2|Overall Study|Withdrawal by Subject|0
976417|NCT00577720|3214378|P1|Overall Study|Withdrawal by Subject|2
976418|NCT00577720|3214375|P4|Overall Study|Protocol Violation|1
976419|NCT00577720|3214376|P3|Overall Study|Protocol Violation|0
976420|NCT00577720|3214377|P2|Overall Study|Protocol Violation|0
976421|NCT00577720|3214378|P1|Overall Study|Protocol Violation|0
976422|NCT00577720|3214375|P4|Overall Study|Lost to Follow-up|0
976423|NCT00577720|3214376|P3|Overall Study|Lost to Follow-up|1
976424|NCT00577720|3214377|P2|Overall Study|Lost to Follow-up|0
976425|NCT00577720|3214378|P1|Overall Study|Lost to Follow-up|0
976426|NCT00577720|3214375|P4|Overall Study|Adverse Event|4
976427|NCT00577720|3214376|P3|Overall Study|Adverse Event|0
976428|NCT00577720|3214377|P2|Overall Study|Adverse Event|1
976429|NCT00577720|3214378|P1|Overall Study|Adverse Event|2
976430|NCT00577707|3214396|P1|Overall Study|Withdrawal by Subject|3
976431|NCT00577655|3214404|P2|Overall Study|Lost to Follow-up|1
976432|NCT00577655|3214405|P1|Overall Study|Lost to Follow-up|1
976433|NCT00577655|3214404|P2|Overall Study|Protocol Violation|1
976434|NCT00577655|3214405|P1|Overall Study|Protocol Violation|0
976435|NCT00577655|3214404|P2|Overall Study|Patient Request|2
976436|NCT00577655|3214405|P1|Overall Study|Patient Request|0
976437|NCT00577642|3214443|P1|Overall Study|Clinical Disease Progression|1
976438|NCT00577629|3214447|P1|Long Term Follow-Up|Physician Decision|1
976439|NCT00577629|3214447|P1|Long Term Follow-Up|Withdrawal by Subject|4
976440|NCT00577629|3214447|P1|Long Term Follow-Up|Lost to Follow-up|5
976441|NCT00577629|3214447|P1|Long Term Follow-Up|Death|15
976442|NCT00577629|3214447|P1|Treatment Period|Death|1
976443|NCT00577473|3214474|P2|Overall Study|Lack of Efficacy|7
976444|NCT00577473|3214475|P1|Overall Study|Lack of Efficacy|8
976445|NCT00577473|3214474|P2|Overall Study|Physician Decision|2
976446|NCT00577473|3214475|P1|Overall Study|Physician Decision|2
976447|NCT00577473|3214474|P2|Overall Study|Withdrawal by Subject|6
976448|NCT00577473|3214475|P1|Overall Study|Withdrawal by Subject|2
976449|NCT00577473|3214474|P2|Overall Study|Adverse Event|5
976450|NCT00577473|3214475|P1|Overall Study|Adverse Event|8
976451|NCT00577473|3214474|P2|Overall Study|Protocol Violation|4
976452|NCT00577473|3214475|P1|Overall Study|Protocol Violation|1
976453|NCT00577460|3214506|P3|Overall Study|not specified|2
976454|NCT00577460|3214507|P2|Overall Study|not specified|3
976455|NCT00577460|3214508|P1|Overall Study|not specified|0
976456|NCT00577460|3214506|P3|Overall Study|Withdrawal by Subject|6
976457|NCT00577460|3214507|P2|Overall Study|Withdrawal by Subject|5
976458|NCT00577460|3214508|P1|Overall Study|Withdrawal by Subject|5
976459|NCT00577460|3214506|P3|Overall Study|Lost to Follow-up|4
976460|NCT00577460|3214507|P2|Overall Study|Lost to Follow-up|3
976461|NCT00577460|3214508|P1|Overall Study|Lost to Follow-up|0
976462|NCT00577460|3214506|P3|Overall Study|Protocol Violation|1
976463|NCT00577460|3214507|P2|Overall Study|Protocol Violation|1
976464|NCT00577460|3214508|P1|Overall Study|Protocol Violation|0
976465|NCT00577460|3214506|P3|Overall Study|Adverse Event|14
976466|NCT00577460|3214507|P2|Overall Study|Adverse Event|7
976467|NCT00577460|3214508|P1|Overall Study|Adverse Event|11
976468|NCT00577408|3214617|P2|Overall Study|Psychiatric hospitalization|1
976469|NCT00577408|3214618|P1|Overall Study|Psychiatric hospitalization|0
976470|NCT00577408|3214617|P2|Overall Study|Death|1
976471|NCT00577408|3214618|P1|Overall Study|Death|0
976472|NCT00577408|3214617|P2|Overall Study|Scheduling Issues|3
976473|NCT00577408|3214618|P1|Overall Study|Scheduling Issues|0
976474|NCT00577408|3214617|P2|Overall Study|Moved out of state|1
976475|NCT00577408|3214618|P1|Overall Study|Moved out of state|0
976476|NCT00577408|3214617|P2|Overall Study|Refused Oral Naltrexone|1
976477|NCT00577408|3214618|P1|Overall Study|Refused Oral Naltrexone|0
976478|NCT00577408|3214617|P2|Overall Study|Non-compliance with study meds|3
976479|NCT00577408|3214618|P1|Overall Study|Non-compliance with study meds|0
976480|NCT00577408|3214617|P2|Overall Study|Continued opioid use|2
976481|NCT00577408|3214618|P1|Overall Study|Continued opioid use|3
976482|NCT00577408|3214617|P2|Overall Study|Stopped attending study visits|11
976483|NCT00577408|3214618|P1|Overall Study|Stopped attending study visits|9
976484|NCT00577395|3214626|P2|Overall Study|Study was terminated early by Sponsor|6
976485|NCT00577395|3214627|P1|Overall Study|Study was terminated early by Sponsor|7
976486|NCT00577382|3214637|P2|Overall Study|Lost to Follow-up|2
976487|NCT00577382|3214638|P1|Overall Study|Lost to Follow-up|2
976488|NCT00577382|3214637|P2|Overall Study|Death|1
976489|NCT00577382|3214638|P1|Overall Study|Death|1
976490|NCT00577382|3214637|P2|Overall Study|Intercurrent Illness|2
976491|NCT00577382|3214638|P1|Overall Study|Intercurrent Illness|1
976492|NCT00577382|3214637|P2|Overall Study|Progressive Disease|19
976493|NCT00577382|3214638|P1|Overall Study|Progressive Disease|17
976494|NCT00577382|3214637|P2|Overall Study|Withdrawal by Subject|1
976495|NCT00577382|3214638|P1|Overall Study|Withdrawal by Subject|0
976496|NCT00577382|3214637|P2|Overall Study|Adverse Event|6
976497|NCT00577382|3214638|P1|Overall Study|Adverse Event|0
976498|NCT00577122|3214781|P2|Overall Study|Alternative Therapy|1
976499|NCT00577122|3214782|P1|Overall Study|Alternative Therapy|0
976500|NCT00577122|3214781|P2|Overall Study|Prog, refract disease during active trt|5
976501|NCT00577122|3214782|P1|Overall Study|Prog, refract disease during active trt|8
976502|NCT00577122|3214781|P2|Overall Study|Progression, relapse during active trt|8
976503|NCT00577122|3214782|P1|Overall Study|Progression, relapse during active trt|6
976504|NCT00577122|3214781|P2|Overall Study|Adverse Event|2
976505|NCT00577122|3214782|P1|Overall Study|Adverse Event|0
976506|NCT00577096|3214796|P2|Short Term Participation|Death|1
976507|NCT00577096|3214797|P1|Short Term Participation|Death|1
976508|NCT00577096|3214796|P2|Short Term Participation|Withdrawal by Subject|5
976509|NCT00577096|3214797|P1|Short Term Participation|Withdrawal by Subject|3
976510|NCT00577096|3214796|P2|Short Term Participation|withdrew from multiple myeloma treatment|2
976511|NCT00577096|3214797|P1|Short Term Participation|withdrew from multiple myeloma treatment|3
976512|NCT00577031|3214836|P1|Overall Study|Death|6
976513|NCT00577031|3214836|P1|Overall Study|Medical decision|14
976514|NCT00577031|3214836|P1|Overall Study|Need for surgery|17
976515|NCT00577031|3214836|P1|Overall Study|Participant non-compliance|5
976516|NCT00577031|3214836|P1|Overall Study|Participant withdrew consent|13
976517|NCT00577031|3214836|P1|Overall Study|Protocol Violation|5
976518|NCT00577031|3214836|P1|Overall Study|Progression of disease|93
976519|NCT00577031|3214836|P1|Overall Study|Adverse Event|52
976520|NCT00577005|3214857|P2|Overall Study|Withdrawal by Subject|1
976521|NCT00577005|3214858|P1|Overall Study|Withdrawal by Subject|2
976522|NCT00577005|3214857|P2|Overall Study|Lost to Follow-up|2
976523|NCT00577005|3214858|P1|Overall Study|Lost to Follow-up|3
976524|NCT00576927|3214872|P1|Sleep Hygiene With the Placebo|Withdrawal by Subject|1
976525|NCT00576927|3214872|P1|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1
976526|NCT00576927|3214872|P1|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1
976527|NCT00576927|3214872|P1|Sleep Hygiene Behavioral Intervention|Death|1
976528|NCT00576927|3214872|P1|Sleep Hygiene Behavioral Intervention|Responded to intervention|4
976529|NCT00576927|3214872|P1|Baseline|Withdrawal by Subject|3
976530|NCT00576927|3214872|P1|Baseline|Medication Change by PCP of subject|1
976531|NCT00576927|3214872|P1|Baseline|Physician Decision|9
976532|NCT00576927|3214872|P1|Clinical Assessment|Physician Decision|1
976533|NCT00576927|3214872|P1|Clinical Assessment|Withdrawal by Subject|10
976534|NCT00576927|3214872|P1|Clinical Assessment|Death|1
976535|NCT00576927|3214872|P1|Clinical Assessment|Lack of Efficacy|24
976536|NCT00576901|3214884|P1|Overall Study|Protocol Violation|1
976537|NCT00576901|3214884|P1|Overall Study|Disease course|1
976538|NCT00576901|3214884|P1|Overall Study|Withdrawal by Subject|1
976539|NCT00576823|3214895|P3|40-week Safety Extension Phase|Lack of Efficacy|0
976540|NCT00576823|3214896|P2|40-week Safety Extension Phase|Lack of Efficacy|0
976541|NCT00576823|3214897|P1|40-week Safety Extension Phase|Lack of Efficacy|1
976542|NCT00576823|3214895|P3|12-week Efficacy Phase|Parentʼs schedule issue|0
976543|NCT00576823|3214896|P2|12-week Efficacy Phase|Parentʼs schedule issue|0
976544|NCT00576823|3214897|P1|12-week Efficacy Phase|Parentʼs schedule issue|1
976545|NCT00576758|3214913|P2|Follow-up Period|Withdrew consent|1
976546|NCT00576758|3214914|P1|Follow-up Period|Withdrew consent|2
976547|NCT00576758|3214913|P2|Follow-up Period|Insufficient therapeutic response|5
976548|NCT00576758|3214914|P1|Follow-up Period|Insufficient therapeutic response|16
976549|NCT00576758|3214913|P2|Follow-up Period|Death|3
976550|NCT00576758|3214914|P1|Follow-up Period|Death|3
976551|NCT00576758|3214913|P2|Follow-up Period|Administrative/Other|8
976552|NCT00576758|3214914|P1|Follow-up Period|Administrative/Other|6
976553|NCT00576758|3214913|P2|Extension Treatment Period|Administrative/Other|1
976554|NCT00576758|3214914|P1|Extension Treatment Period|Administrative/Other|3
976555|NCT00576758|3214913|P2|Extension Treatment Period|Insufficient therapeutic response|33
976556|NCT00576758|3214914|P1|Extension Treatment Period|Insufficient therapeutic response|30
976557|NCT00576758|3214913|P2|Extension Treatment Period|Refused treatment/did not cooperate|1
976558|NCT00576758|3214914|P1|Extension Treatment Period|Refused treatment/did not cooperate|2
976559|NCT00576758|3214913|P2|Extension Treatment Period|Death|1
976560|NCT00576758|3214914|P1|Extension Treatment Period|Death|1
976561|NCT00576758|3214913|P2|Extension Treatment Period|Adverse event or Intercurrent illness|7
976562|NCT00576758|3214914|P1|Extension Treatment Period|Adverse event or Intercurrent illness|6
976563|NCT00576758|3214913|P2|Induction Treatment Period|Withdrew consent|0
976564|NCT00576758|3214914|P1|Induction Treatment Period|Withdrew consent|1
976565|NCT00576758|3214913|P2|Induction Treatment Period|Refused treatment/ Did not Cooperate|1
976566|NCT00576758|3214914|P1|Induction Treatment Period|Refused treatment/ Did not Cooperate|0
976567|NCT00576758|3214913|P2|Induction Treatment Period|Death|0
976568|NCT00576758|3214914|P1|Induction Treatment Period|Death|1
976569|NCT00576758|3214913|P2|Induction Treatment Period|Violation of selection criteria at entry|1
976570|NCT00576758|3214914|P1|Induction Treatment Period|Violation of selection criteria at entry|1
976571|NCT00576758|3214913|P2|Induction Treatment Period|Insufficient therapeutic response|0
976572|NCT00576758|3214914|P1|Induction Treatment Period|Insufficient therapeutic response|2
976573|NCT00576758|3214913|P2|Induction Treatment Period|Adverse event or Intercurrent illness|3
976574|NCT00576758|3214914|P1|Induction Treatment Period|Adverse event or Intercurrent illness|3
976575|NCT00576732|3214960|P6|OPEN LABEL|Protocol Violation|0
976576|NCT00576732|3214961|P5|OPEN LABEL|Protocol Violation|1
976577|NCT00576732|3214962|P4|OPEN LABEL|Protocol Violation|2
976578|NCT00576732|3214963|P3|OPEN LABEL|Protocol Violation|0
976579|NCT00576732|3214964|P2|OPEN LABEL|Protocol Violation|0
976580|NCT00576732|3214965|P1|OPEN LABEL|Protocol Violation|0
976581|NCT00576732|3214960|P6|OPEN LABEL|Lack of Efficacy|3
976582|NCT00576732|3214961|P5|OPEN LABEL|Lack of Efficacy|2
976583|NCT00576732|3214962|P4|OPEN LABEL|Lack of Efficacy|2
976584|NCT00576732|3214963|P3|OPEN LABEL|Lack of Efficacy|0
976585|NCT00576732|3214964|P2|OPEN LABEL|Lack of Efficacy|0
976586|NCT00576732|3214965|P1|OPEN LABEL|Lack of Efficacy|0
976587|NCT00576732|3214960|P6|OPEN LABEL|OTHER|2
976588|NCT00576732|3214961|P5|OPEN LABEL|OTHER|0
976589|NCT00576732|3214962|P4|OPEN LABEL|OTHER|0
976590|NCT00576732|3214963|P3|OPEN LABEL|OTHER|0
976591|NCT00576732|3214964|P2|OPEN LABEL|OTHER|0
976592|NCT00576732|3214965|P1|OPEN LABEL|OTHER|0
976593|NCT00576732|3214960|P6|OPEN LABEL|Withdrawal by Subject|1
976594|NCT00576732|3214961|P5|OPEN LABEL|Withdrawal by Subject|0
976595|NCT00576732|3214962|P4|OPEN LABEL|Withdrawal by Subject|1
976596|NCT00576732|3214963|P3|OPEN LABEL|Withdrawal by Subject|0
976597|NCT00576732|3214964|P2|OPEN LABEL|Withdrawal by Subject|0
976598|NCT00576732|3214965|P1|OPEN LABEL|Withdrawal by Subject|0
976599|NCT00576732|3214960|P6|OPEN LABEL|Lost to Follow-up|1
976600|NCT00576732|3214961|P5|OPEN LABEL|Lost to Follow-up|1
976601|NCT00576732|3214962|P4|OPEN LABEL|Lost to Follow-up|2
976602|NCT00576732|3214963|P3|OPEN LABEL|Lost to Follow-up|0
976603|NCT00576732|3214964|P2|OPEN LABEL|Lost to Follow-up|0
976604|NCT00576732|3214965|P1|OPEN LABEL|Lost to Follow-up|0
976605|NCT00576732|3214960|P6|OPEN LABEL|Adverse Event|1
976606|NCT00576732|3214961|P5|OPEN LABEL|Adverse Event|0
976607|NCT00576732|3214962|P4|OPEN LABEL|Adverse Event|4
976608|NCT00576732|3214963|P3|OPEN LABEL|Adverse Event|0
976609|NCT00576732|3214964|P2|OPEN LABEL|Adverse Event|0
976610|NCT00576732|3214965|P1|OPEN LABEL|Adverse Event|0
976611|NCT00576732|3214960|P6|DOUBLE BLIND|Protocol Violation|0
976612|NCT00576732|3214961|P5|DOUBLE BLIND|Protocol Violation|0
976613|NCT00576732|3214962|P4|DOUBLE BLIND|Protocol Violation|0
976614|NCT00576732|3214963|P3|DOUBLE BLIND|Protocol Violation|0
976615|NCT00576732|3214964|P2|DOUBLE BLIND|Protocol Violation|0
976616|NCT00576732|3214965|P1|DOUBLE BLIND|Protocol Violation|1
976617|NCT00576732|3214960|P6|DOUBLE BLIND|Lack of Efficacy|0
976618|NCT00576732|3214961|P5|DOUBLE BLIND|Lack of Efficacy|0
976619|NCT00576732|3214962|P4|DOUBLE BLIND|Lack of Efficacy|0
976620|NCT00576732|3214963|P3|DOUBLE BLIND|Lack of Efficacy|0
976621|NCT00576732|3214964|P2|DOUBLE BLIND|Lack of Efficacy|1
976622|NCT00576732|3214965|P1|DOUBLE BLIND|Lack of Efficacy|6
976623|NCT00576732|3214960|P6|DOUBLE BLIND|OTHER|0
976624|NCT00576732|3214961|P5|DOUBLE BLIND|OTHER|0
976625|NCT00576732|3214962|P4|DOUBLE BLIND|OTHER|0
976626|NCT00576732|3214963|P3|DOUBLE BLIND|OTHER|1
976627|NCT00576732|3214964|P2|DOUBLE BLIND|OTHER|2
976628|NCT00576732|3214965|P1|DOUBLE BLIND|OTHER|0
976629|NCT00576732|3214960|P6|DOUBLE BLIND|Withdrawal by Subject|0
976630|NCT00576732|3214961|P5|DOUBLE BLIND|Withdrawal by Subject|0
976631|NCT00576732|3214962|P4|DOUBLE BLIND|Withdrawal by Subject|0
976632|NCT00576732|3214963|P3|DOUBLE BLIND|Withdrawal by Subject|3
976633|NCT00576732|3214964|P2|DOUBLE BLIND|Withdrawal by Subject|1
976634|NCT00576732|3214965|P1|DOUBLE BLIND|Withdrawal by Subject|1
976635|NCT00576732|3214960|P6|DOUBLE BLIND|Lost to Follow-up|0
976636|NCT00576732|3214961|P5|DOUBLE BLIND|Lost to Follow-up|0
976637|NCT00576732|3214962|P4|DOUBLE BLIND|Lost to Follow-up|0
976638|NCT00576732|3214963|P3|DOUBLE BLIND|Lost to Follow-up|1
976639|NCT00576732|3214964|P2|DOUBLE BLIND|Lost to Follow-up|1
976640|NCT00576732|3214965|P1|DOUBLE BLIND|Lost to Follow-up|0
976641|NCT00576732|3214960|P6|DOUBLE BLIND|Adverse Event|0
976642|NCT00576732|3214961|P5|DOUBLE BLIND|Adverse Event|0
976643|NCT00576732|3214962|P4|DOUBLE BLIND|Adverse Event|0
976644|NCT00576732|3214963|P3|DOUBLE BLIND|Adverse Event|1
976645|NCT00576732|3214964|P2|DOUBLE BLIND|Adverse Event|0
976646|NCT00576732|3214965|P1|DOUBLE BLIND|Adverse Event|0
976647|NCT00576693|3214997|P2|Overall Study|Withdrawal by Subject|13
976648|NCT00576693|3214998|P1|Overall Study|Withdrawal by Subject|3
976649|NCT00576693|3214997|P2|Overall Study|Lost to Follow-up|11
976650|NCT00576693|3214998|P1|Overall Study|Lost to Follow-up|7
976651|NCT00576628|3215004|P1|Overall Study|Dialysis|15
976652|NCT00576628|3215004|P1|Overall Study|Transplantation|1
976653|NCT00576628|3215004|P1|Overall Study|The patient move into other town|1
976654|NCT00576628|3215004|P1|Overall Study|Progression of Renal Failure|1
976655|NCT00576628|3215004|P1|Overall Study|Progression of Kidney Disease|1
976656|NCT00576628|3215004|P1|Overall Study|RBC transfusion|1
976657|NCT00576628|3215004|P1|Overall Study|Pregnancy|1
976658|NCT00576628|3215004|P1|Overall Study|Refused Treatment|8
976659|NCT00576628|3215004|P1|Overall Study|Failure to return|1
976660|NCT00576628|3215004|P1|Overall Study|Death|2
976661|NCT00576628|3215004|P1|Overall Study|Adverse Event|11
976662|NCT00576576|3215024|P1|Overall Study|Protocol Violation|1
976663|NCT00576576|3215024|P1|Overall Study|Lost to Follow-up|6
976664|NCT00576472|3215058|P15|MPH Home Maintenance Phase|Lost to Follow-up|3
976665|NCT00576472|3215059|P14|MPH Home Maintenance Phase|Lost to Follow-up|0
976666|NCT00576472|3215060|P13|MPH Home Maintenance Phase|Lost to Follow-up|0
976667|NCT00576472|3215061|P12|MPH Home Maintenance Phase|Lost to Follow-up|0
976668|NCT00576472|3215062|P11|MPH Home Maintenance Phase|Lost to Follow-up|0
976669|NCT00576472|3215063|P10|MPH Home Maintenance Phase|Lost to Follow-up|0
976670|NCT00576472|3215064|P9|MPH Home Maintenance Phase|Lost to Follow-up|0
976671|NCT00576472|3215065|P8|MPH Home Maintenance Phase|Lost to Follow-up|0
976672|NCT00576472|3215066|P7|MPH Home Maintenance Phase|Lost to Follow-up|0
976673|NCT00576472|3215067|P6|MPH Home Maintenance Phase|Lost to Follow-up|0
976674|NCT00576472|3215068|P5|MPH Home Maintenance Phase|Lost to Follow-up|0
976675|NCT00576472|3215069|P4|MPH Home Maintenance Phase|Lost to Follow-up|0
976676|NCT00576472|3215070|P3|MPH Home Maintenance Phase|Lost to Follow-up|0
976677|NCT00576472|3215071|P2|MPH Home Maintenance Phase|Lost to Follow-up|0
976678|NCT00576472|3215072|P1|MPH Home Maintenance Phase|Lost to Follow-up|0
976679|NCT00576472|3215058|P15|MPH Home Maintenance Phase|Medical reasons|6
976680|NCT00576472|3215059|P14|MPH Home Maintenance Phase|Medical reasons|0
976681|NCT00576472|3215060|P13|MPH Home Maintenance Phase|Medical reasons|0
976682|NCT00576472|3215061|P12|MPH Home Maintenance Phase|Medical reasons|0
976683|NCT00576472|3215062|P11|MPH Home Maintenance Phase|Medical reasons|0
976684|NCT00576472|3215063|P10|MPH Home Maintenance Phase|Medical reasons|0
976685|NCT00576472|3215064|P9|MPH Home Maintenance Phase|Medical reasons|0
976686|NCT00576472|3215065|P8|MPH Home Maintenance Phase|Medical reasons|0
976687|NCT00576472|3215066|P7|MPH Home Maintenance Phase|Medical reasons|0
976688|NCT00576472|3215067|P6|MPH Home Maintenance Phase|Medical reasons|0
976689|NCT00576472|3215068|P5|MPH Home Maintenance Phase|Medical reasons|0
976690|NCT00576472|3215069|P4|MPH Home Maintenance Phase|Medical reasons|0
976691|NCT00576472|3215070|P3|MPH Home Maintenance Phase|Medical reasons|0
976692|NCT00576472|3215071|P2|MPH Home Maintenance Phase|Medical reasons|0
976693|NCT00576472|3215072|P1|MPH Home Maintenance Phase|Medical reasons|0
976694|NCT00576472|3215058|P15|MPH Home Maintenance Phase|Withdrawal by Subject|6
976695|NCT00576472|3215059|P14|MPH Home Maintenance Phase|Withdrawal by Subject|0
976696|NCT00576472|3215060|P13|MPH Home Maintenance Phase|Withdrawal by Subject|0
976697|NCT00576472|3215061|P12|MPH Home Maintenance Phase|Withdrawal by Subject|0
976698|NCT00576472|3215062|P11|MPH Home Maintenance Phase|Withdrawal by Subject|0
976699|NCT00576472|3215063|P10|MPH Home Maintenance Phase|Withdrawal by Subject|0
976700|NCT00576472|3215064|P9|MPH Home Maintenance Phase|Withdrawal by Subject|0
976701|NCT00576472|3215065|P8|MPH Home Maintenance Phase|Withdrawal by Subject|0
976702|NCT00576472|3215066|P7|MPH Home Maintenance Phase|Withdrawal by Subject|0
976703|NCT00576472|3215067|P6|MPH Home Maintenance Phase|Withdrawal by Subject|0
976704|NCT00576472|3215068|P5|MPH Home Maintenance Phase|Withdrawal by Subject|0
976705|NCT00576472|3215069|P4|MPH Home Maintenance Phase|Withdrawal by Subject|0
976706|NCT00576472|3215070|P3|MPH Home Maintenance Phase|Withdrawal by Subject|0
976707|NCT00576472|3215071|P2|MPH Home Maintenance Phase|Withdrawal by Subject|0
976708|NCT00576472|3215072|P1|MPH Home Maintenance Phase|Withdrawal by Subject|0
976709|NCT00576472|3215058|P15|MPH Home Maintenance Phase|Side effects|8
976710|NCT00576472|3215059|P14|MPH Home Maintenance Phase|Side effects|0
976711|NCT00576472|3215060|P13|MPH Home Maintenance Phase|Side effects|0
976712|NCT00576472|3215061|P12|MPH Home Maintenance Phase|Side effects|0
976713|NCT00576472|3215062|P11|MPH Home Maintenance Phase|Side effects|0
976714|NCT00576472|3215063|P10|MPH Home Maintenance Phase|Side effects|0
976715|NCT00576472|3215064|P9|MPH Home Maintenance Phase|Side effects|0
976716|NCT00576472|3215065|P8|MPH Home Maintenance Phase|Side effects|0
976717|NCT00576472|3215066|P7|MPH Home Maintenance Phase|Side effects|0
976718|NCT00576472|3215067|P6|MPH Home Maintenance Phase|Side effects|0
976719|NCT00576472|3215068|P5|MPH Home Maintenance Phase|Side effects|0
976720|NCT00576472|3215069|P4|MPH Home Maintenance Phase|Side effects|0
976721|NCT00576472|3215070|P3|MPH Home Maintenance Phase|Side effects|0
976722|NCT00576472|3215071|P2|MPH Home Maintenance Phase|Side effects|0
976723|NCT00576472|3215072|P1|MPH Home Maintenance Phase|Side effects|0
976724|NCT00576472|3215058|P15|MPH Home Maintenance Phase|Insufficient data|0
976725|NCT00576472|3215059|P14|MPH Home Maintenance Phase|Insufficient data|4
976726|NCT00576472|3215060|P13|MPH Home Maintenance Phase|Insufficient data|0
976727|NCT00576472|3215061|P12|MPH Home Maintenance Phase|Insufficient data|0
976728|NCT00576472|3215062|P11|MPH Home Maintenance Phase|Insufficient data|0
976729|NCT00576472|3215063|P10|MPH Home Maintenance Phase|Insufficient data|0
976730|NCT00576472|3215064|P9|MPH Home Maintenance Phase|Insufficient data|0
976731|NCT00576472|3215065|P8|MPH Home Maintenance Phase|Insufficient data|0
976732|NCT00576472|3215066|P7|MPH Home Maintenance Phase|Insufficient data|0
976733|NCT00576472|3215067|P6|MPH Home Maintenance Phase|Insufficient data|0
976734|NCT00576472|3215068|P5|MPH Home Maintenance Phase|Insufficient data|0
976735|NCT00576472|3215069|P4|MPH Home Maintenance Phase|Insufficient data|0
976736|NCT00576472|3215070|P3|MPH Home Maintenance Phase|Insufficient data|0
976737|NCT00576472|3215071|P2|MPH Home Maintenance Phase|Insufficient data|0
976738|NCT00576472|3215072|P1|MPH Home Maintenance Phase|Insufficient data|0
976739|NCT00576472|3215058|P15|MPH Home Maintenance Phase|Declined to participate|0
976740|NCT00576472|3215059|P14|MPH Home Maintenance Phase|Declined to participate|7
976741|NCT00576472|3215060|P13|MPH Home Maintenance Phase|Declined to participate|0
976742|NCT00576472|3215061|P12|MPH Home Maintenance Phase|Declined to participate|0
976743|NCT00576472|3215062|P11|MPH Home Maintenance Phase|Declined to participate|0
976744|NCT00576472|3215063|P10|MPH Home Maintenance Phase|Declined to participate|0
976745|NCT00576472|3215064|P9|MPH Home Maintenance Phase|Declined to participate|0
976746|NCT00576472|3215065|P8|MPH Home Maintenance Phase|Declined to participate|0
976747|NCT00576472|3215066|P7|MPH Home Maintenance Phase|Declined to participate|0
976748|NCT00576472|3215067|P6|MPH Home Maintenance Phase|Declined to participate|0
976749|NCT00576472|3215068|P5|MPH Home Maintenance Phase|Declined to participate|0
976750|NCT00576472|3215069|P4|MPH Home Maintenance Phase|Declined to participate|0
976751|NCT00576472|3215070|P3|MPH Home Maintenance Phase|Declined to participate|0
976752|NCT00576472|3215071|P2|MPH Home Maintenance Phase|Declined to participate|0
976753|NCT00576472|3215072|P1|MPH Home Maintenance Phase|Declined to participate|0
976754|NCT00576472|3215058|P15|MPH Home Maintenance Phase|Did not meet response criteria|0
976755|NCT00576472|3215059|P14|MPH Home Maintenance Phase|Did not meet response criteria|16
976756|NCT00576472|3215060|P13|MPH Home Maintenance Phase|Did not meet response criteria|0
976757|NCT00576472|3215061|P12|MPH Home Maintenance Phase|Did not meet response criteria|0
976758|NCT00576472|3215062|P11|MPH Home Maintenance Phase|Did not meet response criteria|0
976759|NCT00576472|3215063|P10|MPH Home Maintenance Phase|Did not meet response criteria|0
976760|NCT00576472|3215064|P9|MPH Home Maintenance Phase|Did not meet response criteria|0
976761|NCT00576472|3215065|P8|MPH Home Maintenance Phase|Did not meet response criteria|0
976762|NCT00576472|3215066|P7|MPH Home Maintenance Phase|Did not meet response criteria|0
976763|NCT00576472|3215067|P6|MPH Home Maintenance Phase|Did not meet response criteria|0
976764|NCT00576472|3215068|P5|MPH Home Maintenance Phase|Did not meet response criteria|0
976765|NCT00576472|3215069|P4|MPH Home Maintenance Phase|Did not meet response criteria|0
976766|NCT00576472|3215070|P3|MPH Home Maintenance Phase|Did not meet response criteria|0
976767|NCT00576472|3215071|P2|MPH Home Maintenance Phase|Did not meet response criteria|0
976768|NCT00576472|3215072|P1|MPH Home Maintenance Phase|Did not meet response criteria|0
976769|NCT00576472|3215058|P15|MPH Cross Over Phase|Did not complete cross over phase|0
976770|NCT00576472|3215059|P14|MPH Cross Over Phase|Did not complete cross over phase|0
976771|NCT00576472|3215060|P13|MPH Cross Over Phase|Did not complete cross over phase|0
976772|NCT00576472|3215061|P12|MPH Cross Over Phase|Did not complete cross over phase|1
976773|NCT00576472|3215062|P11|MPH Cross Over Phase|Did not complete cross over phase|1
976774|NCT00576472|3215063|P10|MPH Cross Over Phase|Did not complete cross over phase|0
976775|NCT00576472|3215064|P9|MPH Cross Over Phase|Did not complete cross over phase|2
976776|NCT00576472|3215065|P8|MPH Cross Over Phase|Did not complete cross over phase|0
976777|NCT00576472|3215066|P7|MPH Cross Over Phase|Did not complete cross over phase|0
976778|NCT00576472|3215067|P6|MPH Cross Over Phase|Did not complete cross over phase|0
976779|NCT00576472|3215068|P5|MPH Cross Over Phase|Did not complete cross over phase|0
976780|NCT00576472|3215069|P4|MPH Cross Over Phase|Did not complete cross over phase|0
976781|NCT00576472|3215070|P3|MPH Cross Over Phase|Did not complete cross over phase|0
976782|NCT00576472|3215071|P2|MPH Cross Over Phase|Did not complete cross over phase|0
976783|NCT00576472|3215072|P1|MPH Cross Over Phase|Did not complete cross over phase|0
976784|NCT00576472|3215058|P15|MPH Cross Over Phase|Physician Decision|0
976785|NCT00576472|3215059|P14|MPH Cross Over Phase|Physician Decision|0
976786|NCT00576472|3215060|P13|MPH Cross Over Phase|Physician Decision|0
976787|NCT00576472|3215061|P12|MPH Cross Over Phase|Physician Decision|0
976788|NCT00576472|3215062|P11|MPH Cross Over Phase|Physician Decision|0
976789|NCT00576472|3215063|P10|MPH Cross Over Phase|Physician Decision|0
976790|NCT00576472|3215064|P9|MPH Cross Over Phase|Physician Decision|0
976791|NCT00576472|3215065|P8|MPH Cross Over Phase|Physician Decision|0
976792|NCT00576472|3215066|P7|MPH Cross Over Phase|Physician Decision|4
976793|NCT00576472|3215067|P6|MPH Cross Over Phase|Physician Decision|0
976794|NCT00576472|3215068|P5|MPH Cross Over Phase|Physician Decision|0
976795|NCT00576472|3215069|P4|MPH Cross Over Phase|Physician Decision|0
976796|NCT00576472|3215070|P3|MPH Cross Over Phase|Physician Decision|0
976797|NCT00576472|3215071|P2|MPH Cross Over Phase|Physician Decision|0
976798|NCT00576472|3215072|P1|MPH Cross Over Phase|Physician Decision|0
976799|NCT00576472|3215058|P15|MPH Cross Over Phase|Ineligible due to disease|0
976800|NCT00576472|3215059|P14|MPH Cross Over Phase|Ineligible due to disease|0
976801|NCT00576472|3215060|P13|MPH Cross Over Phase|Ineligible due to disease|0
976802|NCT00576472|3215061|P12|MPH Cross Over Phase|Ineligible due to disease|0
976803|NCT00576472|3215062|P11|MPH Cross Over Phase|Ineligible due to disease|0
976804|NCT00576472|3215063|P10|MPH Cross Over Phase|Ineligible due to disease|0
976805|NCT00576472|3215064|P9|MPH Cross Over Phase|Ineligible due to disease|0
976806|NCT00576472|3215065|P8|MPH Cross Over Phase|Ineligible due to disease|0
976807|NCT00576472|3215066|P7|MPH Cross Over Phase|Ineligible due to disease|2
976808|NCT00576472|3215067|P6|MPH Cross Over Phase|Ineligible due to disease|0
976809|NCT00576472|3215068|P5|MPH Cross Over Phase|Ineligible due to disease|0
976810|NCT00576472|3215069|P4|MPH Cross Over Phase|Ineligible due to disease|0
976811|NCT00576472|3215070|P3|MPH Cross Over Phase|Ineligible due to disease|0
976812|NCT00576472|3215071|P2|MPH Cross Over Phase|Ineligible due to disease|0
976813|NCT00576472|3215072|P1|MPH Cross Over Phase|Ineligible due to disease|0
976814|NCT00576472|3215058|P15|MPH Cross Over Phase|Withdrawal by Subject|0
976815|NCT00576472|3215059|P14|MPH Cross Over Phase|Withdrawal by Subject|0
976816|NCT00576472|3215060|P13|MPH Cross Over Phase|Withdrawal by Subject|0
976817|NCT00576472|3215061|P12|MPH Cross Over Phase|Withdrawal by Subject|0
976818|NCT00576472|3215062|P11|MPH Cross Over Phase|Withdrawal by Subject|0
976819|NCT00576472|3215063|P10|MPH Cross Over Phase|Withdrawal by Subject|0
976820|NCT00576472|3215064|P9|MPH Cross Over Phase|Withdrawal by Subject|0
976821|NCT00576472|3215065|P8|MPH Cross Over Phase|Withdrawal by Subject|0
976822|NCT00576472|3215066|P7|MPH Cross Over Phase|Withdrawal by Subject|6
976823|NCT00576472|3215067|P6|MPH Cross Over Phase|Withdrawal by Subject|0
976824|NCT00576472|3215068|P5|MPH Cross Over Phase|Withdrawal by Subject|0
976825|NCT00576472|3215069|P4|MPH Cross Over Phase|Withdrawal by Subject|0
976826|NCT00576472|3215070|P3|MPH Cross Over Phase|Withdrawal by Subject|0
976827|NCT00576472|3215071|P2|MPH Cross Over Phase|Withdrawal by Subject|0
976828|NCT00576472|3215072|P1|MPH Cross Over Phase|Withdrawal by Subject|0
976829|NCT00576472|3215058|P15|MPH In-Lab Phase|Psychiatric exclusion|0
976830|NCT00576472|3215059|P14|MPH In-Lab Phase|Psychiatric exclusion|0
976831|NCT00576472|3215060|P13|MPH In-Lab Phase|Psychiatric exclusion|0
976832|NCT00576472|3215061|P12|MPH In-Lab Phase|Psychiatric exclusion|0
976833|NCT00576472|3215062|P11|MPH In-Lab Phase|Psychiatric exclusion|0
976834|NCT00576472|3215063|P10|MPH In-Lab Phase|Psychiatric exclusion|0
976835|NCT00576472|3215064|P9|MPH In-Lab Phase|Psychiatric exclusion|0
976836|NCT00576472|3215065|P8|MPH In-Lab Phase|Psychiatric exclusion|0
976837|NCT00576472|3215066|P7|MPH In-Lab Phase|Psychiatric exclusion|0
976838|NCT00576472|3215067|P6|MPH In-Lab Phase|Psychiatric exclusion|0
976839|NCT00576472|3215068|P5|MPH In-Lab Phase|Psychiatric exclusion|0
976840|NCT00576472|3215069|P4|MPH In-Lab Phase|Psychiatric exclusion|10
976841|NCT00576472|3215070|P3|MPH In-Lab Phase|Psychiatric exclusion|0
976842|NCT00576472|3215071|P2|MPH In-Lab Phase|Psychiatric exclusion|0
976843|NCT00576472|3215072|P1|MPH In-Lab Phase|Psychiatric exclusion|0
976844|NCT00576472|3215058|P15|MPH In-Lab Phase|No attention/academic problems|0
976845|NCT00576472|3215059|P14|MPH In-Lab Phase|No attention/academic problems|0
976846|NCT00576472|3215060|P13|MPH In-Lab Phase|No attention/academic problems|0
976847|NCT00576472|3215061|P12|MPH In-Lab Phase|No attention/academic problems|0
976848|NCT00576472|3215062|P11|MPH In-Lab Phase|No attention/academic problems|0
976849|NCT00576472|3215063|P10|MPH In-Lab Phase|No attention/academic problems|0
976850|NCT00576472|3215064|P9|MPH In-Lab Phase|No attention/academic problems|0
976851|NCT00576472|3215065|P8|MPH In-Lab Phase|No attention/academic problems|0
976852|NCT00576472|3215066|P7|MPH In-Lab Phase|No attention/academic problems|0
976853|NCT00576472|3215067|P6|MPH In-Lab Phase|No attention/academic problems|0
976854|NCT00576472|3215068|P5|MPH In-Lab Phase|No attention/academic problems|0
976855|NCT00576472|3215069|P4|MPH In-Lab Phase|No attention/academic problems|245
976856|NCT00576472|3215070|P3|MPH In-Lab Phase|No attention/academic problems|0
976857|NCT00576472|3215071|P2|MPH In-Lab Phase|No attention/academic problems|0
976858|NCT00576472|3215072|P1|MPH In-Lab Phase|No attention/academic problems|0
976859|NCT00576472|3215058|P15|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
976860|NCT00576472|3215059|P14|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
976861|NCT00576472|3215060|P13|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
976862|NCT00576472|3215061|P12|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
976863|NCT00576472|3215062|P11|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
976864|NCT00576472|3215063|P10|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
976865|NCT00576472|3215064|P9|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
976866|NCT00576472|3215065|P8|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
976867|NCT00576472|3215066|P7|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
976868|NCT00576472|3215067|P6|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
976869|NCT00576472|3215068|P5|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
976870|NCT00576472|3215069|P4|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4
976871|NCT00576472|3215070|P3|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
976872|NCT00576472|3215071|P2|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
976873|NCT00576472|3215072|P1|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
976874|NCT00576472|3215058|P15|MPH In-Lab Phase|Lost to Follow-up|0
976875|NCT00576472|3215059|P14|MPH In-Lab Phase|Lost to Follow-up|0
976876|NCT00576472|3215060|P13|MPH In-Lab Phase|Lost to Follow-up|0
976877|NCT00576472|3215061|P12|MPH In-Lab Phase|Lost to Follow-up|0
976878|NCT00576472|3215062|P11|MPH In-Lab Phase|Lost to Follow-up|0
976879|NCT00576472|3215063|P10|MPH In-Lab Phase|Lost to Follow-up|0
976880|NCT00576472|3215064|P9|MPH In-Lab Phase|Lost to Follow-up|0
976881|NCT00576472|3215065|P8|MPH In-Lab Phase|Lost to Follow-up|0
976882|NCT00576472|3215066|P7|MPH In-Lab Phase|Lost to Follow-up|0
976883|NCT00576472|3215067|P6|MPH In-Lab Phase|Lost to Follow-up|0
976884|NCT00576472|3215068|P5|MPH In-Lab Phase|Lost to Follow-up|0
976885|NCT00576472|3215069|P4|MPH In-Lab Phase|Lost to Follow-up|1
976886|NCT00576472|3215070|P3|MPH In-Lab Phase|Lost to Follow-up|0
976887|NCT00576472|3215071|P2|MPH In-Lab Phase|Lost to Follow-up|0
976888|NCT00576472|3215072|P1|MPH In-Lab Phase|Lost to Follow-up|0
976889|NCT00576472|3215058|P15|MPH In-Lab Phase|Declined participation in medication pha|0
976890|NCT00576472|3215059|P14|MPH In-Lab Phase|Declined participation in medication pha|0
976891|NCT00576472|3215060|P13|MPH In-Lab Phase|Declined participation in medication pha|0
976892|NCT00576472|3215061|P12|MPH In-Lab Phase|Declined participation in medication pha|0
976893|NCT00576472|3215062|P11|MPH In-Lab Phase|Declined participation in medication pha|0
976894|NCT00576472|3215063|P10|MPH In-Lab Phase|Declined participation in medication pha|0
976895|NCT00576472|3215064|P9|MPH In-Lab Phase|Declined participation in medication pha|0
976896|NCT00576472|3215065|P8|MPH In-Lab Phase|Declined participation in medication pha|0
976897|NCT00576472|3215066|P7|MPH In-Lab Phase|Declined participation in medication pha|0
976898|NCT00576472|3215067|P6|MPH In-Lab Phase|Declined participation in medication pha|0
976899|NCT00576472|3215068|P5|MPH In-Lab Phase|Declined participation in medication pha|0
976900|NCT00576472|3215069|P4|MPH In-Lab Phase|Declined participation in medication pha|75
976901|NCT00576472|3215070|P3|MPH In-Lab Phase|Declined participation in medication pha|0
976902|NCT00576472|3215071|P2|MPH In-Lab Phase|Declined participation in medication pha|0
976903|NCT00576472|3215072|P1|MPH In-Lab Phase|Declined participation in medication pha|0
976904|NCT00576420|3215165|P3|Overall Study|Death|1
976905|NCT00576420|3215166|P2|Overall Study|Death|0
976906|NCT00576420|3215167|P1|Overall Study|Death|0
976907|NCT00576381|3215332|P1|Overall Study|Adverse Event|4
976908|NCT00576381|3215332|P1|Overall Study|Reoperation|3
976909|NCT00576316|3215336|P1|Overall Study|Protocol Violation|9
976910|NCT00576316|3215336|P1|Overall Study|Withdrawal by Subject|2
976911|NCT00576316|3215336|P1|Overall Study|Adverse Event|9
976912|NCT00576303|3215341|P1|Long Term Safety Period|Early withdrawal|16
976913|NCT00576303|3215341|P1|Efficacy Evaluation Period|Early withdrawal|5
976914|NCT00576303|3215341|P1|Dose Titration Period|Early withdrawal|17
976915|NCT00576199|3215359|P1|Overall Study|Reason Unspecified|2
976916|NCT00576199|3215359|P1|Overall Study|Refused Treatment|2
976917|NCT00576199|3215359|P1|Overall Study|Insufficient Therapeutic Response|14
976918|NCT00576199|3215359|P1|Overall Study|Adverse Event|12
976919|NCT00576056|3215372|P1|Overall Study|Physician Decision|1
976920|NCT00576056|3215372|P1|Overall Study|did not meet eligibility criteria|8
976921|NCT00576056|3215372|P1|Overall Study|Withdrawal by Subject|2
976922|NCT00576056|3215372|P1|Overall Study|Lack of Efficacy|1
976923|NCT00576056|3215372|P1|Overall Study|Death|1
976924|NCT00576056|3215372|P1|Overall Study|Adverse Event|1
976925|NCT00575666|3215388|P2|Overall Study|Physician Decision|1
976926|NCT00575666|3215389|P1|Overall Study|Physician Decision|1
976927|NCT00575666|3215388|P2|Overall Study|Withdrawal by Subject|2
976928|NCT00575666|3215389|P1|Overall Study|Withdrawal by Subject|3
976929|NCT00575588|3215429|P2|Overall Study|Impossible to determine HbA1c|1
976930|NCT00575588|3215430|P1|Overall Study|Impossible to determine HbA1c|0
976931|NCT00575588|3215429|P2|Overall Study|Patient moved|3
976932|NCT00575588|3215430|P1|Overall Study|Patient moved|1
976933|NCT00575588|3215429|P2|Overall Study|Elevated triglyceride|0
976934|NCT00575588|3215430|P1|Overall Study|Elevated triglyceride|1
976935|NCT00575588|3215429|P2|Overall Study|Safety reasons|1
976936|NCT00575588|3215430|P1|Overall Study|Safety reasons|2
976937|NCT00575588|3215429|P2|Overall Study|Severe non-compliance to protocol|7
976938|NCT00575588|3215430|P1|Overall Study|Severe non-compliance to protocol|5
976939|NCT00575588|3215429|P2|Overall Study|Study specific discontinuation criteria|218
976940|NCT00575588|3215430|P1|Overall Study|Study specific discontinuation criteria|203
976941|NCT00575588|3215429|P2|Overall Study|Incorrect enrollment|4
976942|NCT00575588|3215430|P1|Overall Study|Incorrect enrollment|8
976943|NCT00575588|3215429|P2|Overall Study|Death|2
976944|NCT00575588|3215430|P1|Overall Study|Death|4
976945|NCT00575588|3215429|P2|Overall Study|Lost to Follow-up|3
976946|NCT00575588|3215430|P1|Overall Study|Lost to Follow-up|1
976947|NCT00575588|3215429|P2|Overall Study|Withdrawal by Subject|31
976948|NCT00575588|3215430|P1|Overall Study|Withdrawal by Subject|27
976949|NCT00575588|3215429|P2|Overall Study|Adverse Event|13
976950|NCT00575588|3215430|P1|Overall Study|Adverse Event|11
976951|NCT00575510|3215453|P3|Overall Study|Pregnancy|1
976952|NCT00575510|3215454|P2|Overall Study|Pregnancy|0
976953|NCT00575510|3215455|P1|Overall Study|Pregnancy|0
976954|NCT00575510|3215453|P3|Overall Study|Clinic Called Patient|7
976955|NCT00575510|3215454|P2|Overall Study|Clinic Called Patient|7
976956|NCT00575510|3215455|P1|Overall Study|Clinic Called Patient|7
976957|NCT00575510|3215453|P3|Overall Study|Withdrawal by Subject|0
976958|NCT00575510|3215454|P2|Overall Study|Withdrawal by Subject|0
976959|NCT00575510|3215455|P1|Overall Study|Withdrawal by Subject|1
976960|NCT00575510|3215453|P3|Overall Study|Lost to Follow-up|9
976961|NCT00575510|3215454|P2|Overall Study|Lost to Follow-up|6
976962|NCT00575510|3215455|P1|Overall Study|Lost to Follow-up|4
976963|NCT00575380|3215468|P2|Overall Study|Various|2
976964|NCT00575380|3215469|P1|Overall Study|Various|0
976965|NCT00575380|3215468|P2|Overall Study|Adverse Event|1
976966|NCT00575380|3215469|P1|Overall Study|Adverse Event|0
976967|NCT00575380|3215468|P2|Overall Study|Withdrawal by Subject|0
976968|NCT00575380|3215469|P1|Overall Study|Withdrawal by Subject|1
976969|NCT00575094|3215611|P1|Overall Study|Withdrawal by Subject|1
976970|NCT00575094|3215611|P1|Overall Study|Adverse Event|2
976971|NCT00575042|3215615|P1|Overall Study|Lost to Follow-up|1
976972|NCT00575042|3215615|P1|Overall Study|Adverse Event|2
976973|NCT00574951|3215666|P1|Overall Study|Ineligible - improper prior treatment|1
976974|NCT00574912|3215674|P1|Overall Study|Physician Decision|2
976975|NCT00574912|3215674|P1|Overall Study|scheduling conflicts|3
976976|NCT00574912|3215674|P1|Overall Study|Could not place IV lines.|3
976977|NCT00574873|3215688|P2|Overall Study|Extension Study|0
976978|NCT00574873|3215689|P1|Overall Study|Extension Study|126
976979|NCT00574873|3215688|P2|Overall Study|Blank, site closed per local regulations|2
976980|NCT00574873|3215689|P1|Overall Study|Blank, site closed per local regulations|2
976981|NCT00574873|3215688|P2|Overall Study|Discontinuation of study by sponsor|199
976982|NCT00574873|3215689|P1|Overall Study|Discontinuation of study by sponsor|5
976983|NCT00574873|3215688|P2|Overall Study|Other|4
976984|NCT00574873|3215689|P1|Overall Study|Other|40
976985|NCT00574873|3215688|P2|Overall Study|Lost to Follow-up|5
976986|NCT00574873|3215689|P1|Overall Study|Lost to Follow-up|14
976987|NCT00574873|3215688|P2|Overall Study|Death|14
976988|NCT00574873|3215689|P1|Overall Study|Death|15
976989|NCT00574873|3215688|P2|Overall Study|Investigator request|8
976990|NCT00574873|3215689|P1|Overall Study|Investigator request|18
976991|NCT00574873|3215688|P2|Overall Study|Withdrawal by Subject|19
976992|NCT00574873|3215689|P1|Overall Study|Withdrawal by Subject|18
976993|NCT00574847|3215707|P2|Overall Study|Did not receive medication (declined)|5
976994|NCT00574847|3215708|P1|Overall Study|Did not receive medication (declined)|2
976995|NCT00574847|3215707|P2|Overall Study|Physician Decision|0
976996|NCT00574847|3215708|P1|Overall Study|Physician Decision|1
976997|NCT00574847|3215707|P2|Overall Study|Withdrawal by Subject|2
976998|NCT00574847|3215708|P1|Overall Study|Withdrawal by Subject|2
976999|NCT00574847|3215707|P2|Overall Study|Death|0
977000|NCT00574847|3215708|P1|Overall Study|Death|1
977001|NCT00574847|3215707|P2|Overall Study|Adverse Event|0
977002|NCT00574847|3215708|P1|Overall Study|Adverse Event|2
977003|NCT00574795|3215753|P1|Toddler Dose|Withdrawal by Subject|1
977004|NCT00574795|3215753|P1|After Infant Series|Adverse Event|2
977005|NCT00574795|3215753|P1|After Infant Series|Withdrawal by Subject|1
977006|NCT00574795|3215753|P1|Infant Series|Adverse Event|1
977007|NCT00574795|3215753|P1|Infant Series|Protocol Violation|2
977008|NCT00574795|3215753|P1|Infant Series|Withdrawal by Subject|2
977009|NCT00574405|3215836|P2|Overall Study|Withdrawal by Subject|2
977010|NCT00574405|3215837|P1|Overall Study|Withdrawal by Subject|3
977011|NCT00574288|3215857|P7|Overall Study|Other|0
977012|NCT00574288|3215858|P6|Overall Study|Other|0
977013|NCT00574288|3215859|P5|Overall Study|Other|0
977014|NCT00574288|3215860|P4|Overall Study|Other|0
977015|NCT00574288|3215861|P3|Overall Study|Other|0
977016|NCT00574288|3215862|P2|Overall Study|Other|1
977017|NCT00574288|3215863|P1|Overall Study|Other|1
977018|NCT00574288|3215857|P7|Overall Study|Progressive Disease|0
977019|NCT00574288|3215858|P6|Overall Study|Progressive Disease|0
977020|NCT00574288|3215859|P5|Overall Study|Progressive Disease|1
977021|NCT00574288|3215860|P4|Overall Study|Progressive Disease|2
977022|NCT00574288|3215861|P3|Overall Study|Progressive Disease|3
977023|NCT00574288|3215862|P2|Overall Study|Progressive Disease|2
977024|NCT00574288|3215863|P1|Overall Study|Progressive Disease|17
977025|NCT00574288|3215857|P7|Overall Study|Study Terminated By Sponsor|5
977026|NCT00574288|3215858|P6|Overall Study|Study Terminated By Sponsor|0
977027|NCT00574288|3215859|P5|Overall Study|Study Terminated By Sponsor|0
977028|NCT00574288|3215860|P4|Overall Study|Study Terminated By Sponsor|0
977029|NCT00574288|3215861|P3|Overall Study|Study Terminated By Sponsor|0
977030|NCT00574288|3215862|P2|Overall Study|Study Terminated By Sponsor|0
977031|NCT00574288|3215863|P1|Overall Study|Study Terminated By Sponsor|0
977032|NCT00574288|3215857|P7|Overall Study|Lost to Follow-up|2
977033|NCT00574288|3215858|P6|Overall Study|Lost to Follow-up|1
977034|NCT00574288|3215859|P5|Overall Study|Lost to Follow-up|0
977035|NCT00574288|3215860|P4|Overall Study|Lost to Follow-up|0
977036|NCT00574288|3215861|P3|Overall Study|Lost to Follow-up|0
977037|NCT00574288|3215862|P2|Overall Study|Lost to Follow-up|0
977038|NCT00574288|3215863|P1|Overall Study|Lost to Follow-up|0
977039|NCT00574288|3215857|P7|Overall Study|Death|21
977040|NCT00574288|3215858|P6|Overall Study|Death|25
977041|NCT00574288|3215859|P5|Overall Study|Death|0
977042|NCT00574288|3215860|P4|Overall Study|Death|0
977043|NCT00574288|3215861|P3|Overall Study|Death|0
977044|NCT00574288|3215862|P2|Overall Study|Death|0
977045|NCT00574288|3215863|P1|Overall Study|Death|0
977046|NCT00574288|3215857|P7|Overall Study|Adverse Event|0
977047|NCT00574288|3215858|P6|Overall Study|Adverse Event|0
977048|NCT00574288|3215859|P5|Overall Study|Adverse Event|1
977049|NCT00574288|3215860|P4|Overall Study|Adverse Event|0
977050|NCT00574288|3215861|P3|Overall Study|Adverse Event|0
977051|NCT00574288|3215862|P2|Overall Study|Adverse Event|0
977052|NCT00574288|3215863|P1|Overall Study|Adverse Event|2
977053|NCT00574275|3215901|P2|Overall Study|Operation for curative intent|1
977054|NCT00574275|3215902|P1|Overall Study|Operation for curative intent|0
977055|NCT00574275|3215901|P2|Overall Study|Insurance change|1
977056|NCT00574275|3215902|P1|Overall Study|Insurance change|0
977057|NCT00574275|3215901|P2|Overall Study|Patient and Investigator decision|1
977058|NCT00574275|3215902|P1|Overall Study|Patient and Investigator decision|0
977059|NCT00574275|3215901|P2|Overall Study|Protocol Violation|1
977060|NCT00574275|3215902|P1|Overall Study|Protocol Violation|0
977061|NCT00574275|3215901|P2|Overall Study|Physician Decision|1
977062|NCT00574275|3215902|P1|Overall Study|Physician Decision|1
977063|NCT00574275|3215901|P2|Overall Study|Error calculating tumor measurement|0
977064|NCT00574275|3215902|P1|Overall Study|Error calculating tumor measurement|1
977065|NCT00574275|3215901|P2|Overall Study|Withdrawal by Subject|17
977066|NCT00574275|3215902|P1|Overall Study|Withdrawal by Subject|15
977067|NCT00574275|3215901|P2|Overall Study|Study stopped based on DMC decision|23
977068|NCT00574275|3215902|P1|Overall Study|Study stopped based on DMC decision|62
977069|NCT00574275|3215901|P2|Overall Study|Lost to Follow-up|1
977070|NCT00574275|3215902|P1|Overall Study|Lost to Follow-up|2
977071|NCT00574275|3215901|P2|Overall Study|Disease progression|146
977072|NCT00574275|3215902|P1|Overall Study|Disease progression|160
977073|NCT00574275|3215901|P2|Overall Study|Adverse Event|76
977074|NCT00574275|3215902|P1|Overall Study|Adverse Event|32
977075|NCT00574275|3215901|P2|Overall Study|Randomized but not treated|3
977076|NCT00574275|3215902|P1|Overall Study|Randomized but not treated|2
977077|NCT00574249|3215920|P2|Overall Study|PPD test taken twice|1
977078|NCT00574249|3215921|P1|Overall Study|PPD test taken twice|0
977079|NCT00574249|3215920|P2|Overall Study|Excluded by company|1
977080|NCT00574249|3215921|P1|Overall Study|Excluded by company|0
977081|NCT00574249|3215920|P2|Overall Study|Pregnancy|0
977082|NCT00574249|3215921|P1|Overall Study|Pregnancy|1
977083|NCT00574249|3215920|P2|Overall Study|Physician Decision|0
977084|NCT00574249|3215921|P1|Overall Study|Physician Decision|1
977085|NCT00574249|3215920|P2|Overall Study|Withdrawal by Subject|0
977086|NCT00574249|3215921|P1|Overall Study|Withdrawal by Subject|3
977087|NCT00574249|3215920|P2|Overall Study|History of carcinoma|0
977088|NCT00574249|3215921|P1|Overall Study|History of carcinoma|1
977089|NCT00574249|3215920|P2|Overall Study|Protocol Violation|2
977090|NCT00574249|3215921|P1|Overall Study|Protocol Violation|5
977091|NCT00574249|3215920|P2|Overall Study|Lost to Follow-up|3
977092|NCT00574249|3215921|P1|Overall Study|Lost to Follow-up|4
977093|NCT00574249|3215920|P2|Overall Study|Lack of Efficacy|3
977094|NCT00574249|3215921|P1|Overall Study|Lack of Efficacy|5
977095|NCT00574249|3215920|P2|Overall Study|Adverse Event|18
977096|NCT00574249|3215921|P1|Overall Study|Adverse Event|6
977097|NCT00574145|3215972|P2|Overall Study|Withdrawal by Subject|1
977098|NCT00574145|3215973|P1|Overall Study|Withdrawal by Subject|2
977099|NCT00574080|3215985|P2|Overall Study|Death|10
977100|NCT00574080|3215986|P1|Overall Study|Death|10
977101|NCT00573937|3216035|P2|Overall Study|Study Terminated|1
977102|NCT00573937|3216036|P1|Overall Study|Study Terminated|0
977103|NCT00573859|3216050|P1|Smoking Versus Abstinence|Scheduling conflicts|12
977104|NCT00573859|3216050|P1|Medication Versus Placebo|Scheduling conflicts|12
977105|NCT00573833|3216056|P1|Overall Study|Not Treated|2
977106|NCT00573794|3216063|P1|Overall Study|Not Specified|46
977107|NCT00573794|3216063|P1|Overall Study|Lack of Efficacy|94
977108|NCT00573794|3216063|P1|Overall Study|Protocol Violation|6
977109|NCT00573794|3216063|P1|Overall Study|Lost to Follow-up|13
977110|NCT00573794|3216063|P1|Overall Study|Withdrew Consent|90
977111|NCT00573794|3216063|P1|Overall Study|Adverse Event|81
977112|NCT00573768|3216094|P3|Overall Study|Lost to Follow-up|1
977113|NCT00573768|3216095|P2|Overall Study|Lost to Follow-up|0
977114|NCT00573768|3216096|P1|Overall Study|Lost to Follow-up|0
977115|NCT00573768|3216094|P3|Overall Study|Withdrawal by Subject|0
977116|NCT00573768|3216095|P2|Overall Study|Withdrawal by Subject|1
977117|NCT00573768|3216096|P1|Overall Study|Withdrawal by Subject|0
977118|NCT00573768|3216094|P3|Overall Study|Protocol Violation|1
977119|NCT00573768|3216095|P2|Overall Study|Protocol Violation|0
977120|NCT00573768|3216096|P1|Overall Study|Protocol Violation|1
977121|NCT00573768|3216094|P3|Overall Study|Adverse Event|2
977122|NCT00573768|3216095|P2|Overall Study|Adverse Event|1
977123|NCT00573768|3216096|P1|Overall Study|Adverse Event|1
977124|NCT00573755|3216106|P2|Overall Study|Still receiving treatment|0
977125|NCT00573755|3216107|P1|Overall Study|Still receiving treatment|1
977126|NCT00573534|3216123|P1|Overall Study|oppositional behavior|3
977127|NCT00573469|3216164|P3|Overall Study|Not Specified|3
977128|NCT00573469|3216165|P2|Overall Study|Not Specified|1
977129|NCT00573469|3216166|P1|Overall Study|Not Specified|5
977130|NCT00573469|3216164|P3|Overall Study|Withdrawal by Subject|0
977131|NCT00573469|3216165|P2|Overall Study|Withdrawal by Subject|2
977132|NCT00573469|3216166|P1|Overall Study|Withdrawal by Subject|0
977133|NCT00573469|3216164|P3|Overall Study|Adverse Event|1
977134|NCT00573469|3216165|P2|Overall Study|Adverse Event|1
977135|NCT00573469|3216166|P1|Overall Study|Adverse Event|1
977136|NCT00573443|3216189|P3|Open-Label Extension Phase|Not Specified|0
977137|NCT00573443|3216190|P2|Open-Label Extension Phase|Not Specified|0
977138|NCT00573443|3216191|P1|Open-Label Extension Phase|Not Specified|2
977139|NCT00573443|3216189|P3|Open-Label Extension Phase|Protocol Violation|0
977140|NCT00573443|3216190|P2|Open-Label Extension Phase|Protocol Violation|0
977141|NCT00573443|3216191|P1|Open-Label Extension Phase|Protocol Violation|2
977142|NCT00573443|3216189|P3|Open-Label Extension Phase|Withdrawal by Subject|0
977143|NCT00573443|3216190|P2|Open-Label Extension Phase|Withdrawal by Subject|0
977144|NCT00573443|3216191|P1|Open-Label Extension Phase|Withdrawal by Subject|3
977145|NCT00573443|3216189|P3|Open-Label Extension Phase|Serious Adverse Event|0
977146|NCT00573443|3216190|P2|Open-Label Extension Phase|Serious Adverse Event|0
977147|NCT00573443|3216191|P1|Open-Label Extension Phase|Serious Adverse Event|5
977148|NCT00573443|3216189|P3|Open-Label Extension Phase|Adverse Event|0
977149|NCT00573443|3216190|P2|Open-Label Extension Phase|Adverse Event|0
977150|NCT00573443|3216191|P1|Open-Label Extension Phase|Adverse Event|3
977151|NCT00573443|3216189|P3|Open-Label Extension Phase|Exacerbation of MS symptoms|0
977152|NCT00573443|3216190|P2|Open-Label Extension Phase|Exacerbation of MS symptoms|0
977153|NCT00573443|3216191|P1|Open-Label Extension Phase|Exacerbation of MS symptoms|2
977154|NCT00573443|3216189|P3|Open-Label Extension Phase|Lost to Follow-up|0
977155|NCT00573443|3216190|P2|Open-Label Extension Phase|Lost to Follow-up|0
977156|NCT00573443|3216191|P1|Open-Label Extension Phase|Lost to Follow-up|1
977157|NCT00573443|3216189|P3|Double-Blind Phase|Not specified|3
977158|NCT00573443|3216190|P2|Double-Blind Phase|Not specified|2
977159|NCT00573443|3216191|P1|Double-Blind Phase|Not specified|0
977160|NCT00573443|3216189|P3|Double-Blind Phase|Protocol Violation|1
977161|NCT00573443|3216190|P2|Double-Blind Phase|Protocol Violation|2
977162|NCT00573443|3216191|P1|Double-Blind Phase|Protocol Violation|0
977163|NCT00573443|3216189|P3|Double-Blind Phase|Withdrawal by Subject|7
977164|NCT00573443|3216190|P2|Double-Blind Phase|Withdrawal by Subject|2
977165|NCT00573443|3216191|P1|Double-Blind Phase|Withdrawal by Subject|2
977166|NCT00573443|3216189|P3|Double-Blind Phase|Medication refusal due to AE|0
977167|NCT00573443|3216190|P2|Double-Blind Phase|Medication refusal due to AE|2
977168|NCT00573443|3216191|P1|Double-Blind Phase|Medication refusal due to AE|2
977169|NCT00573443|3216189|P3|Double-Blind Phase|Serious Adverse Event (AE)|1
977170|NCT00573443|3216190|P2|Double-Blind Phase|Serious Adverse Event (AE)|3
977171|NCT00573443|3216191|P1|Double-Blind Phase|Serious Adverse Event (AE)|2
977172|NCT00573443|3216189|P3|Double-Blind Phase|Adverse Event|0
977173|NCT00573443|3216190|P2|Double-Blind Phase|Adverse Event|5
977174|NCT00573443|3216191|P1|Double-Blind Phase|Adverse Event|1
977175|NCT00573443|3216189|P3|Double-Blind Phase|Exacerbation of MS symptoms|1
977176|NCT00573443|3216190|P2|Double-Blind Phase|Exacerbation of MS symptoms|0
977177|NCT00573443|3216191|P1|Double-Blind Phase|Exacerbation of MS symptoms|1
977178|NCT00573443|3216189|P3|Double-Blind Phase|Lost to Follow-up|2
977179|NCT00573443|3216190|P2|Double-Blind Phase|Lost to Follow-up|3
977180|NCT00573443|3216191|P1|Double-Blind Phase|Lost to Follow-up|1
977181|NCT00573430|3216221|P3|Overall Study|Eligibility criteria not fulfilled|3
977182|NCT00573430|3216222|P2|Overall Study|Eligibility criteria not fulfilled|0
977183|NCT00573430|3216223|P1|Overall Study|Eligibility criteria not fulfilled|0
977184|NCT00573430|3216221|P3|Overall Study|Protocol Violation|1
977185|NCT00573430|3216222|P2|Overall Study|Protocol Violation|1
977186|NCT00573430|3216223|P1|Overall Study|Protocol Violation|0
977187|NCT00573430|3216221|P3|Overall Study|Withdrawal by Subject|1
977188|NCT00573430|3216222|P2|Overall Study|Withdrawal by Subject|0
977189|NCT00573430|3216223|P1|Overall Study|Withdrawal by Subject|1
977190|NCT00573430|3216221|P3|Overall Study|Adverse Event|2
977191|NCT00573430|3216222|P2|Overall Study|Adverse Event|0
977192|NCT00573430|3216223|P1|Overall Study|Adverse Event|0
977193|NCT00573430|3216221|P3|Overall Study|Incorrect enrollment of randomization|3
977194|NCT00573430|3216222|P2|Overall Study|Incorrect enrollment of randomization|4
977195|NCT00573430|3216223|P1|Overall Study|Incorrect enrollment of randomization|0
977196|NCT00573391|3216245|P2|Overall Study|Death|0
977197|NCT00573391|3216246|P1|Overall Study|Death|1
977198|NCT00573391|3216245|P2|Overall Study|study stopped|2
977199|NCT00573391|3216246|P1|Overall Study|study stopped|2
977200|NCT00573313|3216256|P4|Overall Study|Protocol Violation|0
977201|NCT00573313|3216257|P3|Overall Study|Protocol Violation|6
977202|NCT00573313|3216258|P2|Overall Study|Protocol Violation|0
977203|NCT00573313|3216259|P1|Overall Study|Protocol Violation|5
977204|NCT00573248|3216309|P2|Overall Study|scheduling conflicts|11
977205|NCT00573248|3216310|P1|Overall Study|scheduling conflicts|15
977206|NCT00573183|3216324|P2|Overall Study|Other|2
977207|NCT00573183|3216325|P1|Overall Study|Other|5
977208|NCT00573183|3216324|P2|Overall Study|Incarceration|8
977209|NCT00573183|3216325|P1|Overall Study|Incarceration|5
977210|NCT00573183|3216324|P2|Overall Study|Adverse Event|0
977211|NCT00573183|3216325|P1|Overall Study|Adverse Event|2
977212|NCT00573183|3216324|P2|Overall Study|Death|1
977213|NCT00573183|3216325|P1|Overall Study|Death|0
977214|NCT00573183|3216324|P2|Overall Study|Withdrawal by Subject|2
977215|NCT00573183|3216325|P1|Overall Study|Withdrawal by Subject|8
977216|NCT00573183|3216324|P2|Overall Study|Lost to Follow-up|50
977217|NCT00573183|3216325|P1|Overall Study|Lost to Follow-up|52
977218|NCT00573170|3216333|P6|Third Treatment Period|Lost to Follow-up|2
977219|NCT00573170|3216334|P5|Third Treatment Period|Lost to Follow-up|0
977220|NCT00573170|3216335|P4|Third Treatment Period|Lost to Follow-up|0
977221|NCT00573170|3216336|P3|Third Treatment Period|Lost to Follow-up|0
977222|NCT00573170|3216337|P2|Third Treatment Period|Lost to Follow-up|0
977223|NCT00573170|3216338|P1|Third Treatment Period|Lost to Follow-up|0
977224|NCT00573170|3216333|P6|Third Treatment Period|Withdrawal by Subject|0
977225|NCT00573170|3216334|P5|Third Treatment Period|Withdrawal by Subject|0
977226|NCT00573170|3216335|P4|Third Treatment Period|Withdrawal by Subject|0
977227|NCT00573170|3216336|P3|Third Treatment Period|Withdrawal by Subject|0
977228|NCT00573170|3216337|P2|Third Treatment Period|Withdrawal by Subject|0
977229|NCT00573170|3216338|P1|Third Treatment Period|Withdrawal by Subject|1
977230|NCT00573170|3216333|P6|Second Washout Period|Other|2
977231|NCT00573170|3216334|P5|Second Washout Period|Other|6
977232|NCT00573170|3216335|P4|Second Washout Period|Other|4
977233|NCT00573170|3216336|P3|Second Washout Period|Other|1
977234|NCT00573170|3216337|P2|Second Washout Period|Other|2
977235|NCT00573170|3216338|P1|Second Washout Period|Other|1
977236|NCT00573170|3216333|P6|Second Washout Period|Lost to Follow-up|0
977237|NCT00573170|3216334|P5|Second Washout Period|Lost to Follow-up|0
977238|NCT00573170|3216335|P4|Second Washout Period|Lost to Follow-up|1
977239|NCT00573170|3216336|P3|Second Washout Period|Lost to Follow-up|0
977240|NCT00573170|3216337|P2|Second Washout Period|Lost to Follow-up|0
977241|NCT00573170|3216338|P1|Second Washout Period|Lost to Follow-up|0
977242|NCT00573170|3216333|P6|Second Washout Period|Withdrawal by Subject|0
977243|NCT00573170|3216334|P5|Second Washout Period|Withdrawal by Subject|1
977244|NCT00573170|3216335|P4|Second Washout Period|Withdrawal by Subject|0
977245|NCT00573170|3216336|P3|Second Washout Period|Withdrawal by Subject|2
977246|NCT00573170|3216337|P2|Second Washout Period|Withdrawal by Subject|1
977247|NCT00573170|3216338|P1|Second Washout Period|Withdrawal by Subject|1
977248|NCT00573170|3216333|P6|Second Washout Period|Protocol Violation|0
977249|NCT00573170|3216334|P5|Second Washout Period|Protocol Violation|0
977250|NCT00573170|3216335|P4|Second Washout Period|Protocol Violation|0
977251|NCT00573170|3216336|P3|Second Washout Period|Protocol Violation|1
977252|NCT00573170|3216337|P2|Second Washout Period|Protocol Violation|1
977253|NCT00573170|3216338|P1|Second Washout Period|Protocol Violation|2
977254|NCT00573170|3216333|P6|Second Washout Period|Adverse Event|0
977255|NCT00573170|3216334|P5|Second Washout Period|Adverse Event|1
977256|NCT00573170|3216335|P4|Second Washout Period|Adverse Event|0
977257|NCT00573170|3216336|P3|Second Washout Period|Adverse Event|0
977258|NCT00573170|3216337|P2|Second Washout Period|Adverse Event|0
977259|NCT00573170|3216338|P1|Second Washout Period|Adverse Event|1
977260|NCT00573170|3216333|P6|First Washout Period|Other|0
977261|NCT00573170|3216334|P5|First Washout Period|Other|0
977262|NCT00573170|3216335|P4|First Washout Period|Other|1
977263|NCT00573170|3216336|P3|First Washout Period|Other|1
977264|NCT00573170|3216337|P2|First Washout Period|Other|0
977265|NCT00573170|3216338|P1|First Washout Period|Other|4
977266|NCT00573170|3216333|P6|First Washout Period|Withdrawal by Subject|3
977267|NCT00573170|3216334|P5|First Washout Period|Withdrawal by Subject|3
977268|NCT00573170|3216335|P4|First Washout Period|Withdrawal by Subject|2
977269|NCT00573170|3216336|P3|First Washout Period|Withdrawal by Subject|0
977270|NCT00573170|3216337|P2|First Washout Period|Withdrawal by Subject|0
977271|NCT00573170|3216338|P1|First Washout Period|Withdrawal by Subject|2
977272|NCT00573170|3216333|P6|First Washout Period|Lost to Follow-up|2
977273|NCT00573170|3216334|P5|First Washout Period|Lost to Follow-up|0
977274|NCT00573170|3216335|P4|First Washout Period|Lost to Follow-up|2
977275|NCT00573170|3216336|P3|First Washout Period|Lost to Follow-up|0
977276|NCT00573170|3216337|P2|First Washout Period|Lost to Follow-up|1
977277|NCT00573170|3216338|P1|First Washout Period|Lost to Follow-up|1
977278|NCT00573170|3216333|P6|First Washout Period|Lack of Efficacy|1
977279|NCT00573170|3216334|P5|First Washout Period|Lack of Efficacy|0
977280|NCT00573170|3216335|P4|First Washout Period|Lack of Efficacy|0
977281|NCT00573170|3216336|P3|First Washout Period|Lack of Efficacy|0
977282|NCT00573170|3216337|P2|First Washout Period|Lack of Efficacy|0
977283|NCT00573170|3216338|P1|First Washout Period|Lack of Efficacy|0
977284|NCT00573170|3216333|P6|First Washout Period|Adverse Event|1
977285|NCT00573170|3216334|P5|First Washout Period|Adverse Event|0
977286|NCT00573170|3216335|P4|First Washout Period|Adverse Event|0
977287|NCT00573170|3216336|P3|First Washout Period|Adverse Event|0
977288|NCT00573170|3216337|P2|First Washout Period|Adverse Event|1
977289|NCT00573170|3216338|P1|First Washout Period|Adverse Event|1
977290|NCT00573170|3216333|P6|First Treatment Period|Did Not Treat Attack 1|0
977291|NCT00573170|3216334|P5|First Treatment Period|Did Not Treat Attack 1|1
977292|NCT00573170|3216335|P4|First Treatment Period|Did Not Treat Attack 1|0
977293|NCT00573170|3216336|P3|First Treatment Period|Did Not Treat Attack 1|0
977294|NCT00573170|3216337|P2|First Treatment Period|Did Not Treat Attack 1|0
977295|NCT00573170|3216338|P1|First Treatment Period|Did Not Treat Attack 1|0
977296|NCT00573157|3216414|P2|Overall Study|Other|1
977297|NCT00573157|3216415|P1|Overall Study|Other|1
977298|NCT00573157|3216414|P2|Overall Study|Adverse Event|1
977299|NCT00573157|3216415|P1|Overall Study|Adverse Event|3
977300|NCT00573144|3216427|P2|Overall Study|Withdrawal by Subject|3
977301|NCT00573144|3216428|P1|Overall Study|Withdrawal by Subject|2
977302|NCT00573131|3216440|P2|Overall Study|Withdrawal by Subject|8
977303|NCT00573131|3216441|P1|Overall Study|Withdrawal by Subject|10
977304|NCT00573066|3216447|P1|Overall Study|Postoperative bleeding|1
977305|NCT00573066|3216447|P1|Overall Study|IV malfunction|1
977306|NCT00573066|3216447|P1|Overall Study|Exclusion criteria|18
977307|NCT00572910|3216491|P11|Overall Study|Withdrawal by Subject|1
977308|NCT00572910|3216492|P10|Overall Study|Withdrawal by Subject|2
977309|NCT00572910|3216493|P9|Overall Study|Withdrawal by Subject|2
977310|NCT00572910|3216494|P8|Overall Study|Withdrawal by Subject|2
977311|NCT00572910|3216495|P7|Overall Study|Withdrawal by Subject|0
977312|NCT00572910|3216496|P6|Overall Study|Withdrawal by Subject|3
977313|NCT00572910|3216497|P5|Overall Study|Withdrawal by Subject|1
977314|NCT00572910|3216498|P4|Overall Study|Withdrawal by Subject|0
977315|NCT00572910|3216499|P3|Overall Study|Withdrawal by Subject|1
977316|NCT00572910|3216500|P2|Overall Study|Withdrawal by Subject|0
977317|NCT00572910|3216501|P1|Overall Study|Withdrawal by Subject|3
977318|NCT00572910|3216491|P11|Overall Study|Lost to Follow-up|0
977319|NCT00572910|3216492|P10|Overall Study|Lost to Follow-up|1
977320|NCT00572910|3216493|P9|Overall Study|Lost to Follow-up|0
977321|NCT00572910|3216494|P8|Overall Study|Lost to Follow-up|0
977322|NCT00572910|3216495|P7|Overall Study|Lost to Follow-up|0
977323|NCT00572910|3216496|P6|Overall Study|Lost to Follow-up|0
977324|NCT00572910|3216497|P5|Overall Study|Lost to Follow-up|1
977325|NCT00572910|3216498|P4|Overall Study|Lost to Follow-up|2
977326|NCT00572910|3216499|P3|Overall Study|Lost to Follow-up|1
977327|NCT00572910|3216500|P2|Overall Study|Lost to Follow-up|1
977328|NCT00572910|3216501|P1|Overall Study|Lost to Follow-up|0
977329|NCT00572910|3216491|P11|Overall Study|Adverse Event|2
977330|NCT00572910|3216492|P10|Overall Study|Adverse Event|3
977331|NCT00572910|3216493|P9|Overall Study|Adverse Event|1
977332|NCT00572910|3216494|P8|Overall Study|Adverse Event|2
977333|NCT00572910|3216495|P7|Overall Study|Adverse Event|4
977334|NCT00572910|3216496|P6|Overall Study|Adverse Event|0
977335|NCT00572910|3216497|P5|Overall Study|Adverse Event|0
977336|NCT00572910|3216498|P4|Overall Study|Adverse Event|2
977337|NCT00572910|3216499|P3|Overall Study|Adverse Event|0
977338|NCT00572910|3216500|P2|Overall Study|Adverse Event|2
977339|NCT00572910|3216501|P1|Overall Study|Adverse Event|1
977340|NCT00572832|3216568|P2|Overall Study|Pregnancy|1
977341|NCT00572832|3216569|P1|Overall Study|Pregnancy|0
977342|NCT00572832|3216568|P2|Overall Study|Lost to Follow-up|11
977343|NCT00572832|3216569|P1|Overall Study|Lost to Follow-up|0
977344|NCT00572728|3216575|P1|Overall Study|Pathology missing|1
977345|NCT00572728|3216575|P1|Overall Study|FLT2 after second chemotherapy initiated|7
977346|NCT00572728|3216575|P1|Overall Study|Second chemotherapy not initiated|1
977347|NCT00572728|3216575|P1|Overall Study|FLT2 not completed|5
977348|NCT00572728|3216575|P1|Overall Study|First Chemotherapy not initiated|2
977349|NCT00572728|3216575|P1|Overall Study|FLT1 not completed|4
977350|NCT00572728|3216575|P1|Overall Study|Offstudy due to complicating disease|1
977351|NCT00572728|3216575|P1|Overall Study|Enrolled under Amendment 4|5
977352|NCT00572728|3216575|P1|Overall Study|Ineligible|3
977353|NCT00572728|3216575|P1|Overall Study|Withdrawal by Subject|10
977354|NCT00572624|3216589|P2|Overall Study|Health issues unrelated to the study|0
977355|NCT00572624|3216590|P1|Overall Study|Health issues unrelated to the study|1
977356|NCT00572624|3216589|P2|Overall Study|Problem with vascular access|0
977357|NCT00572624|3216590|P1|Overall Study|Problem with vascular access|1
977358|NCT00572624|3216589|P2|Overall Study|Refused to do the stress test|0
977359|NCT00572624|3216590|P1|Overall Study|Refused to do the stress test|1
977360|NCT00572624|3216589|P2|Overall Study|Admitted to being a smoker|0
977361|NCT00572624|3216590|P1|Overall Study|Admitted to being a smoker|1
977362|NCT00572624|3216589|P2|Overall Study|Started a new job-- no time for study|0
977363|NCT00572624|3216590|P1|Overall Study|Started a new job-- no time for study|1
977364|NCT00572624|3216589|P2|Overall Study|Medication change|0
977365|NCT00572624|3216590|P1|Overall Study|Medication change|1
977366|NCT00572624|3216589|P2|Overall Study|Wanted to do a different diet program|0
977367|NCT00572624|3216590|P1|Overall Study|Wanted to do a different diet program|1
977368|NCT00572624|3216589|P2|Overall Study|Lost to Follow-up|4
977369|NCT00572624|3216590|P1|Overall Study|Lost to Follow-up|10
977370|NCT00572572|3216618|P2|Overall Study|Withdrawal by Subject|6
977371|NCT00572572|3216619|P1|Overall Study|Withdrawal by Subject|3
977372|NCT00572533|3216637|P2|Overall Study|Transfer out of Facility|1
977373|NCT00572533|3216638|P1|Overall Study|Transfer out of Facility|0
977374|NCT00572533|3216637|P2|Overall Study|Social Issues|0
977375|NCT00572533|3216638|P1|Overall Study|Social Issues|1
977376|NCT00572533|3216637|P2|Overall Study|Received Kidney Transplant|1
977377|NCT00572533|3216638|P1|Overall Study|Received Kidney Transplant|2
977378|NCT00572533|3216637|P2|Overall Study|Death|1
977379|NCT00572533|3216638|P1|Overall Study|Death|4
977380|NCT00572156|3216677|P4|Overall Study|Sponsor Decision|19
977381|NCT00572156|3216678|P3|Overall Study|Sponsor Decision|17
977382|NCT00572156|3216679|P2|Overall Study|Sponsor Decision|16
977383|NCT00572156|3216680|P1|Overall Study|Sponsor Decision|20
977384|NCT00572156|3216677|P4|Overall Study|Patient/Parent Decision|3
977385|NCT00572156|3216678|P3|Overall Study|Patient/Parent Decision|4
977386|NCT00572156|3216679|P2|Overall Study|Patient/Parent Decision|6
977387|NCT00572156|3216680|P1|Overall Study|Patient/Parent Decision|1
977388|NCT00572156|3216677|P4|Overall Study|Protocol Violation|2
977389|NCT00572156|3216678|P3|Overall Study|Protocol Violation|0
977390|NCT00572156|3216679|P2|Overall Study|Protocol Violation|2
977391|NCT00572156|3216680|P1|Overall Study|Protocol Violation|1
977392|NCT00572156|3216677|P4|Overall Study|Lost to Follow-up|0
977393|NCT00572156|3216678|P3|Overall Study|Lost to Follow-up|1
977394|NCT00572156|3216679|P2|Overall Study|Lost to Follow-up|1
977395|NCT00572156|3216680|P1|Overall Study|Lost to Follow-up|1
977396|NCT00572156|3216677|P4|Overall Study|Adverse Event|1
977397|NCT00572156|3216678|P3|Overall Study|Adverse Event|5
977398|NCT00572156|3216679|P2|Overall Study|Adverse Event|1
977399|NCT00572156|3216680|P1|Overall Study|Adverse Event|3
977400|NCT00572039|3216751|P2|Overall Study|Ill|1
977401|NCT00572039|3216752|P1|Overall Study|Ill|5
977402|NCT00572039|3216751|P2|Overall Study|Death|3
977403|NCT00572039|3216752|P1|Overall Study|Death|2
977404|NCT00572039|3216751|P2|Overall Study|Withdrawal by Subject|6
977405|NCT00572039|3216752|P1|Overall Study|Withdrawal by Subject|9
977406|NCT00571948|3216784|P2|Overall Study|Parent were afraid of blood colection|5
977407|NCT00571948|3216785|P1|Overall Study|Parent were afraid of blood colection|2
977408|NCT00571948|3216784|P2|Overall Study|infant refused study meal|4
977409|NCT00571948|3216785|P1|Overall Study|infant refused study meal|3
977410|NCT00571948|3216784|P2|Overall Study|Protocol Violation|3
977411|NCT00571948|3216785|P1|Overall Study|Protocol Violation|3
977412|NCT00571948|3216784|P2|Overall Study|Withdrawal by Subject|2
977413|NCT00571948|3216785|P1|Overall Study|Withdrawal by Subject|1
977414|NCT00571948|3216784|P2|Overall Study|Lost to Follow-up|0
977415|NCT00571948|3216785|P1|Overall Study|Lost to Follow-up|2
977416|NCT00571922|3216793|P2|Overall Study|Completion unknown|36
977417|NCT00571922|3216794|P1|Overall Study|Completion unknown|36
977418|NCT00571701|3216804|P2|Second Intervention 12 Months|Withdrawal by Subject|0
977419|NCT00571701|3216805|P1|Second Intervention 12 Months|Withdrawal by Subject|3
977420|NCT00571701|3216804|P2|Second Intervention 12 Months|Adverse Event|1
977421|NCT00571701|3216805|P1|Second Intervention 12 Months|Adverse Event|0
977422|NCT00571701|3216804|P2|First Intervention 12 Months|Death|0
977423|NCT00571701|3216805|P1|First Intervention 12 Months|Death|1
977424|NCT00571701|3216804|P2|First Intervention 12 Months|Withdrawal by Subject|1
977425|NCT00571701|3216805|P1|First Intervention 12 Months|Withdrawal by Subject|2
977426|NCT00571688|3216831|P2|Overall Study|subject moved out of the area|0
977427|NCT00571688|3216832|P1|Overall Study|subject moved out of the area|1
977428|NCT00571688|3216831|P2|Overall Study|subject did not tolerate Consta|0
977429|NCT00571688|3216832|P1|Overall Study|subject did not tolerate Consta|1
977430|NCT00571688|3216831|P2|Overall Study|Lost to Follow-up|6
977431|NCT00571688|3216832|P1|Overall Study|Lost to Follow-up|3
977432|NCT00571662|3216838|P1|Overall Study|Adverse Event|5
977433|NCT00571662|3216838|P1|Overall Study|psychiatric instability|1
977434|NCT00571662|3216838|P1|Overall Study|Withdrawal by Subject|2
977435|NCT00571649|3216849|P2|Follow-up Period|Protocol Violation|12
977436|NCT00571649|3216850|P1|Follow-up Period|Protocol Violation|5
977437|NCT00571649|3216849|P2|Follow-up Period|Patient convenience|121
977438|NCT00571649|3216850|P1|Follow-up Period|Patient convenience|136
977439|NCT00571649|3216849|P2|Follow-up Period|Lost to Follow-up|92
977440|NCT00571649|3216850|P1|Follow-up Period|Lost to Follow-up|95
977441|NCT00571649|3216849|P2|Follow-up Period|Physician Decision|13
977442|NCT00571649|3216850|P1|Follow-up Period|Physician Decision|7
977443|NCT00571649|3216849|P2|Follow-up Period|Death|133
977444|NCT00571649|3216850|P1|Follow-up Period|Death|132
977445|NCT00571649|3216849|P2|Follow-up Period|Withdrawal by Subject|115
977446|NCT00571649|3216850|P1|Follow-up Period|Withdrawal by Subject|119
977447|NCT00571649|3216849|P2|Follow-up Period|Clinical endpoint reached|2
977448|NCT00571649|3216850|P1|Follow-up Period|Clinical endpoint reached|5
977449|NCT00571649|3216849|P2|Follow-up Period|Adverse Event|40
977450|NCT00571649|3216850|P1|Follow-up Period|Adverse Event|46
977451|NCT00571649|3216849|P2|Treatment Period|Technical problems|5
977452|NCT00571649|3216850|P1|Treatment Period|Technical problems|3
977453|NCT00571649|3216849|P2|Treatment Period|Protocol Violation|92
977454|NCT00571649|3216850|P1|Treatment Period|Protocol Violation|90
977455|NCT00571649|3216849|P2|Treatment Period|Patient convenience|13
977456|NCT00571649|3216850|P1|Treatment Period|Patient convenience|11
977457|NCT00571649|3216849|P2|Treatment Period|Non-compliant with study medication|89
977458|NCT00571649|3216850|P1|Treatment Period|Non-compliant with study medication|88
977459|NCT00571649|3216849|P2|Treatment Period|Lost to Follow-up|41
977460|NCT00571649|3216850|P1|Treatment Period|Lost to Follow-up|43
977461|NCT00571649|3216849|P2|Treatment Period|Physician Decision|9
977462|NCT00571649|3216850|P1|Treatment Period|Physician Decision|8
977463|NCT00571649|3216849|P2|Treatment Period|Death|59
977464|NCT00571649|3216850|P1|Treatment Period|Death|76
977465|NCT00571649|3216849|P2|Treatment Period|Withdrawal by Subject|255
977466|NCT00571649|3216850|P1|Treatment Period|Withdrawal by Subject|285
977467|NCT00571649|3216849|P2|Treatment Period|Clinical endpoint reached|56
977468|NCT00571649|3216850|P1|Treatment Period|Clinical endpoint reached|50
977469|NCT00571649|3216849|P2|Treatment Period|Adverse Event|385
977470|NCT00571649|3216850|P1|Treatment Period|Adverse Event|438
977471|NCT00571103|3216948|P1|Overall Study|Lost to Follow-up|1
977472|NCT00571103|3216948|P1|Overall Study|Withdrawal by Subject|1
977473|NCT00571064|3216953|P1|Overall Study|Not specified|2
977474|NCT00571064|3216953|P1|Overall Study|Withdrawal by Subject|2
977475|NCT00571064|3216953|P1|Overall Study|Protocol Violation|4
977476|NCT00571064|3216953|P1|Overall Study|Adverse Event|13
977477|NCT00571038|3216968|P2|Overall Study|Moved out of state|2
977478|NCT00571038|3216969|P1|Overall Study|Moved out of state|2
977479|NCT00571038|3216968|P2|Overall Study|Withdrawal by Subject|3
977480|NCT00571038|3216969|P1|Overall Study|Withdrawal by Subject|1
977481|NCT00571038|3216968|P2|Overall Study|Death|5
977482|NCT00571038|3216969|P1|Overall Study|Death|7
977483|NCT00571038|3216968|P2|Overall Study|Lost to Follow-up|4
977484|NCT00571038|3216969|P1|Overall Study|Lost to Follow-up|1
977485|NCT00570921|3217024|P1|Overall Study|Physician Decision|1
977486|NCT00570921|3217024|P1|Overall Study|Protocol Violation|1
977487|NCT00570908|3217030|P1|Overall Study|Withdrawal by Subject|2
977488|NCT00570908|3217030|P1|Overall Study|Adverse Event|5
977489|NCT00570778|3217034|P4|Overall Study|Subject no longer requires study drug|0
977490|NCT00570778|3217035|P3|Overall Study|Subject no longer requires study drug|0
977491|NCT00570778|3217036|P2|Overall Study|Subject no longer requires study drug|1
977492|NCT00570778|3217037|P1|Overall Study|Subject no longer requires study drug|0
977493|NCT00570778|3217034|P4|Overall Study|Lost to Follow-up|0
977494|NCT00570778|3217035|P3|Overall Study|Lost to Follow-up|1
977495|NCT00570778|3217036|P2|Overall Study|Lost to Follow-up|0
977496|NCT00570778|3217037|P1|Overall Study|Lost to Follow-up|0
977497|NCT00570778|3217034|P4|Overall Study|Unsatisfactory therapeutic effect|0
977498|NCT00570778|3217035|P3|Overall Study|Unsatisfactory therapeutic effect|0
977499|NCT00570778|3217036|P2|Overall Study|Unsatisfactory therapeutic effect|0
977500|NCT00570778|3217037|P1|Overall Study|Unsatisfactory therapeutic effect|1
977501|NCT00570778|3217034|P4|Overall Study|Abnormal test procedure|0
977502|NCT00570778|3217035|P3|Overall Study|Abnormal test procedure|0
977503|NCT00570778|3217036|P2|Overall Study|Abnormal test procedure|0
977504|NCT00570778|3217037|P1|Overall Study|Abnormal test procedure|1
977505|NCT00570778|3217034|P4|Overall Study|Subject withdrew consent|1
977506|NCT00570778|3217035|P3|Overall Study|Subject withdrew consent|0
977507|NCT00570778|3217036|P2|Overall Study|Subject withdrew consent|1
977508|NCT00570778|3217037|P1|Overall Study|Subject withdrew consent|0
977509|NCT00570778|3217034|P4|Overall Study|Adverse Event|1
977510|NCT00570778|3217035|P3|Overall Study|Adverse Event|4
977511|NCT00570778|3217036|P2|Overall Study|Adverse Event|1
977512|NCT00570778|3217037|P1|Overall Study|Adverse Event|0
977513|NCT00570778|3217034|P4|Overall Study|Protocol deviation|2
977514|NCT00570778|3217035|P3|Overall Study|Protocol deviation|2
977515|NCT00570778|3217036|P2|Overall Study|Protocol deviation|1
977516|NCT00570778|3217037|P1|Overall Study|Protocol deviation|2
977517|NCT00570739|3217078|P4|Overall Study|Not specified|3
977518|NCT00570739|3217079|P3|Overall Study|Not specified|5
977519|NCT00570739|3217080|P2|Overall Study|Not specified|2
977520|NCT00570739|3217081|P1|Overall Study|Not specified|0
977521|NCT00570739|3217078|P4|Overall Study|Met discontinuation criteria|1
977522|NCT00570739|3217079|P3|Overall Study|Met discontinuation criteria|1
977523|NCT00570739|3217080|P2|Overall Study|Met discontinuation criteria|0
977524|NCT00570739|3217081|P1|Overall Study|Met discontinuation criteria|1
977525|NCT00570739|3217078|P4|Overall Study|Required restricted medication|0
977526|NCT00570739|3217079|P3|Overall Study|Required restricted medication|1
977527|NCT00570739|3217080|P2|Overall Study|Required restricted medication|0
977528|NCT00570739|3217081|P1|Overall Study|Required restricted medication|0
977529|NCT00570739|3217078|P4|Overall Study|Withdrawal by Subject|5
977530|NCT00570739|3217079|P3|Overall Study|Withdrawal by Subject|3
977531|NCT00570739|3217080|P2|Overall Study|Withdrawal by Subject|7
977532|NCT00570739|3217081|P1|Overall Study|Withdrawal by Subject|7
977533|NCT00570739|3217078|P4|Overall Study|Physician Decision|0
977534|NCT00570739|3217079|P3|Overall Study|Physician Decision|0
977535|NCT00570739|3217080|P2|Overall Study|Physician Decision|1
977536|NCT00570739|3217081|P1|Overall Study|Physician Decision|1
977537|NCT00570739|3217078|P4|Overall Study|Lost to Follow-up|1
977538|NCT00570739|3217079|P3|Overall Study|Lost to Follow-up|4
977539|NCT00570739|3217080|P2|Overall Study|Lost to Follow-up|5
977540|NCT00570739|3217081|P1|Overall Study|Lost to Follow-up|4
977541|NCT00570739|3217078|P4|Overall Study|Adverse Event|2
977542|NCT00570739|3217079|P3|Overall Study|Adverse Event|2
977543|NCT00570739|3217080|P2|Overall Study|Adverse Event|6
977544|NCT00570739|3217081|P1|Overall Study|Adverse Event|8
977545|NCT00570713|3217233|P2|Overall Study|Discontinuation of Study by the Sponsor|7
977546|NCT00570713|3217234|P1|Overall Study|Discontinuation of Study by the Sponsor|10
977547|NCT00570713|3217233|P2|Overall Study|Withdrawal by Subject|3
977548|NCT00570713|3217234|P1|Overall Study|Withdrawal by Subject|3
977549|NCT00570713|3217233|P2|Overall Study|Physician Decision|2
977550|NCT00570713|3217234|P1|Overall Study|Physician Decision|2
977551|NCT00570713|3217233|P2|Overall Study|Lack of Efficacy|49
977552|NCT00570713|3217234|P1|Overall Study|Lack of Efficacy|40
977553|NCT00570713|3217233|P2|Overall Study|Death|7
977554|NCT00570713|3217234|P1|Overall Study|Death|7
977555|NCT00570713|3217233|P2|Overall Study|Adverse Event|9
977556|NCT00570713|3217234|P1|Overall Study|Adverse Event|16
977557|NCT00570687|3217252|P10|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
977558|NCT00570687|3217253|P9|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
977559|NCT00570687|3217254|P8|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
977560|NCT00570687|3217255|P7|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1
977561|NCT00570687|3217256|P6|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
977562|NCT00570687|3217257|P5|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
977563|NCT00570687|3217258|P4|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
977564|NCT00570687|3217259|P3|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
977565|NCT00570687|3217260|P2|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
977566|NCT00570687|3217261|P1|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
977567|NCT00570687|3217252|P10|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
977568|NCT00570687|3217253|P9|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1
977569|NCT00570687|3217254|P8|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
977570|NCT00570687|3217255|P7|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
977571|NCT00570687|3217256|P6|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
977572|NCT00570687|3217257|P5|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
977573|NCT00570687|3217258|P4|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
977574|NCT00570687|3217259|P3|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
977575|NCT00570687|3217260|P2|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
977576|NCT00570687|3217261|P1|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
977577|NCT00570687|3217252|P10|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
977578|NCT00570687|3217253|P9|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
977579|NCT00570687|3217254|P8|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
977580|NCT00570687|3217255|P7|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
977581|NCT00570687|3217256|P6|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
977582|NCT00570687|3217257|P5|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
977583|NCT00570687|3217258|P4|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
977584|NCT00570687|3217259|P3|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
977585|NCT00570687|3217260|P2|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
977586|NCT00570687|3217261|P1|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
977587|NCT00570674|3217287|P7|Overall Study|Withdrawal by Subject|0
977588|NCT00570674|3217288|P6|Overall Study|Withdrawal by Subject|0
977589|NCT00570674|3217289|P5|Overall Study|Withdrawal by Subject|0
977590|NCT00570674|3217290|P4|Overall Study|Withdrawal by Subject|0
977591|NCT00570674|3217291|P3|Overall Study|Withdrawal by Subject|1
977592|NCT00570674|3217292|P2|Overall Study|Withdrawal by Subject|0
977593|NCT00570674|3217293|P1|Overall Study|Withdrawal by Subject|0
977594|NCT00570505|3217316|P1|Overall Study|Other loss to follow-up|4
977595|NCT00570505|3217316|P1|Overall Study|Lost to Follow-up|23
977596|NCT00570505|3217316|P1|Overall Study|Withdrawal by Subject|7
977597|NCT00570505|3217316|P1|Overall Study|Adverse Event|7
977598|NCT00570492|3217329|P3|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
977599|NCT00570492|3217330|P2|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3
977600|NCT00570492|3217331|P1|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
977601|NCT00570492|3217329|P3|52-week Double-blind Treatment Period|Lack of Efficacy|0
977602|NCT00570492|3217330|P2|52-week Double-blind Treatment Period|Lack of Efficacy|3
977603|NCT00570492|3217331|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
977604|NCT00570492|3217329|P3|52-week Double-blind Treatment Period|Physician Decision|4
977605|NCT00570492|3217330|P2|52-week Double-blind Treatment Period|Physician Decision|2
977606|NCT00570492|3217331|P1|52-week Double-blind Treatment Period|Physician Decision|0
977607|NCT00570492|3217329|P3|52-week Double-blind Treatment Period|Adverse Event|5
977608|NCT00570492|3217330|P2|52-week Double-blind Treatment Period|Adverse Event|5
977609|NCT00570492|3217331|P1|52-week Double-blind Treatment Period|Adverse Event|0
977610|NCT00570492|3217329|P3|52-week Double-blind Treatment Period|Lost to Follow-up|7
977611|NCT00570492|3217330|P2|52-week Double-blind Treatment Period|Lost to Follow-up|5
977612|NCT00570492|3217331|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
977613|NCT00570492|3217329|P3|52-week Double-blind Treatment Period|Protocol Violation|15
977614|NCT00570492|3217330|P2|52-week Double-blind Treatment Period|Protocol Violation|12
977615|NCT00570492|3217331|P1|52-week Double-blind Treatment Period|Protocol Violation|0
977616|NCT00570492|3217329|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|20
977617|NCT00570492|3217330|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|20
977618|NCT00570492|3217331|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
977619|NCT00570492|3217329|P3|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
977620|NCT00570492|3217330|P2|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
977621|NCT00570492|3217331|P1|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1
977622|NCT00570492|3217329|P3|16-week Single-blind Baseline Period|Adverse Event|0
977623|NCT00570492|3217330|P2|16-week Single-blind Baseline Period|Adverse Event|0
977624|NCT00570492|3217331|P1|16-week Single-blind Baseline Period|Adverse Event|1
977625|NCT00570492|3217329|P3|16-week Single-blind Baseline Period|Lost to Follow-up|0
977626|NCT00570492|3217330|P2|16-week Single-blind Baseline Period|Lost to Follow-up|0
977627|NCT00570492|3217331|P1|16-week Single-blind Baseline Period|Lost to Follow-up|2
977628|NCT00570492|3217329|P3|16-week Single-blind Baseline Period|Protocol Violation|0
977629|NCT00570492|3217330|P2|16-week Single-blind Baseline Period|Protocol Violation|0
977630|NCT00570492|3217331|P1|16-week Single-blind Baseline Period|Protocol Violation|15
977631|NCT00570492|3217329|P3|16-week Single-blind Baseline Period|Withdrawal by Subject|0
977632|NCT00570492|3217330|P2|16-week Single-blind Baseline Period|Withdrawal by Subject|0
977633|NCT00570492|3217331|P1|16-week Single-blind Baseline Period|Withdrawal by Subject|56
977634|NCT00570492|3217329|P3|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
977635|NCT00570492|3217330|P2|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
977636|NCT00570492|3217331|P1|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263
977637|NCT00570492|3217329|P3|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
977638|NCT00570492|3217330|P2|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
977639|NCT00570492|3217331|P1|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98
977640|NCT00570401|3217369|P1|Overall Study|Adverse Event|2
977641|NCT00570310|3217403|P2|Overall Study|Lack of Efficacy|4
977642|NCT00570310|3217404|P1|Overall Study|Lack of Efficacy|1
977643|NCT00570310|3217403|P2|Overall Study|Adverse Event|2
977644|NCT00570310|3217404|P1|Overall Study|Adverse Event|1
977645|NCT00570232|3217412|P1|Overall Study|discontinued due to noncompliance|2
977646|NCT00570232|3217412|P1|Overall Study|discontinued due to recurrence|8
977647|NCT00570232|3217412|P1|Overall Study|discontinued due to medical condition|3
977648|NCT00570232|3217412|P1|Overall Study|Adverse Event|10
977649|NCT00570141|3217418|P1|Overall Study|Lost to Follow-up|1
977650|NCT00570141|3217418|P1|Overall Study|Missed visits|1
977651|NCT00570141|3217418|P1|Overall Study|Adverse Event|1
977652|NCT00570063|3217434|P2|Overall Study|Sponsor's Decision|3
977653|NCT00570063|3217435|P1|Overall Study|Sponsor's Decision|7
977654|NCT00570063|3217434|P2|Overall Study|Withdrawal by Subject|3
977655|NCT00570063|3217435|P1|Overall Study|Withdrawal by Subject|4
977656|NCT00570063|3217434|P2|Overall Study|Lack of Efficacy|1
977657|NCT00570063|3217435|P1|Overall Study|Lack of Efficacy|0
977658|NCT00570063|3217434|P2|Overall Study|Adverse Event|1
977659|NCT00570063|3217435|P1|Overall Study|Adverse Event|4
977660|NCT00570037|3217501|P2|Overall Study|Could not reach for 6-8 week contact|69
977661|NCT00570037|3217502|P1|Overall Study|Could not reach for 6-8 week contact|44
977662|NCT00569946|3217512|P1|Overall Study|Global Deterioration of Health Status|1
977663|NCT00569946|3217512|P1|Overall Study|Objective Progression or Relapse|42
977664|NCT00569946|3217512|P1|Overall Study|Adverse Event|16
977665|NCT00569803|3217544|P8|Overall Study|Withdrawal by Subject|1
977666|NCT00569803|3217545|P7|Overall Study|Withdrawal by Subject|0
977667|NCT00569803|3217546|P6|Overall Study|Withdrawal by Subject|0
977668|NCT00569803|3217547|P5|Overall Study|Withdrawal by Subject|0
977669|NCT00569803|3217548|P4|Overall Study|Withdrawal by Subject|0
977670|NCT00569803|3217549|P3|Overall Study|Withdrawal by Subject|0
977671|NCT00569803|3217550|P2|Overall Study|Withdrawal by Subject|0
977672|NCT00569803|3217551|P1|Overall Study|Withdrawal by Subject|0
977673|NCT00569803|3217544|P8|Overall Study|injection syringe leaked during dosing|0
977674|NCT00569803|3217545|P7|Overall Study|injection syringe leaked during dosing|0
977675|NCT00569803|3217546|P6|Overall Study|injection syringe leaked during dosing|0
977676|NCT00569803|3217547|P5|Overall Study|injection syringe leaked during dosing|0
977677|NCT00569803|3217548|P4|Overall Study|injection syringe leaked during dosing|1
977678|NCT00569803|3217549|P3|Overall Study|injection syringe leaked during dosing|0
977679|NCT00569803|3217550|P2|Overall Study|injection syringe leaked during dosing|0
977680|NCT00569803|3217551|P1|Overall Study|injection syringe leaked during dosing|0
977681|NCT00569803|3217544|P8|Overall Study|Lost to Follow-up|0
977682|NCT00569803|3217545|P7|Overall Study|Lost to Follow-up|0
977683|NCT00569803|3217546|P6|Overall Study|Lost to Follow-up|0
977684|NCT00569803|3217547|P5|Overall Study|Lost to Follow-up|0
977685|NCT00569803|3217548|P4|Overall Study|Lost to Follow-up|0
977686|NCT00569803|3217549|P3|Overall Study|Lost to Follow-up|0
977687|NCT00569803|3217550|P2|Overall Study|Lost to Follow-up|0
977688|NCT00569803|3217551|P1|Overall Study|Lost to Follow-up|1
977689|NCT00569777|3217678|P2|Overall Study|pregnant|0
977690|NCT00569777|3217679|P1|Overall Study|pregnant|1
977691|NCT00569777|3217678|P2|Overall Study|did not meet exclusion criteria|2
977692|NCT00569777|3217679|P1|Overall Study|did not meet exclusion criteria|1
977693|NCT00569777|3217678|P2|Overall Study|scheduled eye surgery|1
977694|NCT00569777|3217679|P1|Overall Study|scheduled eye surgery|0
977695|NCT00569777|3217678|P2|Overall Study|Lost to Follow-up|0
977696|NCT00569777|3217679|P1|Overall Study|Lost to Follow-up|1
977697|NCT00569777|3217678|P2|Overall Study|Adverse Event|0
977698|NCT00569777|3217679|P1|Overall Study|Adverse Event|3
977699|NCT00569777|3217678|P2|Overall Study|Withdrawal by Subject|0
977700|NCT00569777|3217679|P1|Overall Study|Withdrawal by Subject|4
977701|NCT00569582|3217730|P1|Overall Study|Subject was non-compliant.|1
977702|NCT00569582|3217730|P1|Overall Study|Subject was too ill to travel.|1
977703|NCT00569582|3217730|P1|Overall Study|Adverse Event|7
977704|NCT00569582|3217730|P1|Overall Study|Death|2
977705|NCT00569582|3217730|P1|Overall Study|Withdrawal by Subject|5
977706|NCT00569374|3217746|P1|Overall Study|Withdrawal by Subject|4
977707|NCT00569270|3217765|P2|Period: First Intervention|Protocol Violation|1
977708|NCT00569270|3217766|P1|Period: First Intervention|Protocol Violation|0
977709|NCT00569231|3217801|P1|Overall Study|Non-compliance|2
977710|NCT00569231|3217801|P1|Overall Study|Car accident injury|1
977711|NCT00569231|3217801|P1|Overall Study|Withdrawal by Subject|1
977712|NCT00569231|3217801|P1|Overall Study|Airfare expense|2
977713|NCT00569231|3217801|P1|Overall Study|Study unrelated surgery|1
977714|NCT00569166|3217839|P3|Overall Study|Lost to Follow-up|1
977715|NCT00569166|3217840|P2|Overall Study|Lost to Follow-up|1
977716|NCT00569166|3217841|P1|Overall Study|Lost to Follow-up|2
977717|NCT00569166|3217839|P3|Overall Study|Withdrawal by Subject|3
977718|NCT00569166|3217840|P2|Overall Study|Withdrawal by Subject|5
977719|NCT00569166|3217841|P1|Overall Study|Withdrawal by Subject|7
977720|NCT00569127|3217875|P2|Overall Study|Still on Treatment|3
977721|NCT00569127|3217876|P1|Overall Study|Still on Treatment|7
977722|NCT00569127|3217875|P2|Overall Study|Not Eligible|11
977723|NCT00569127|3217876|P1|Overall Study|Not Eligible|14
977724|NCT00569127|3217875|P2|Overall Study|Lost to Follow-up|3
977725|NCT00569127|3217876|P1|Overall Study|Lost to Follow-up|0
977726|NCT00569127|3217875|P2|Overall Study|Not Specified|19
977727|NCT00569127|3217876|P1|Overall Study|Not Specified|20
977728|NCT00569127|3217875|P2|Overall Study|Death|3
977729|NCT00569127|3217876|P1|Overall Study|Death|4
977730|NCT00569127|3217875|P2|Overall Study|Progression|100
977731|NCT00569127|3217876|P1|Overall Study|Progression|99
977732|NCT00569127|3217875|P2|Overall Study|Withdrawal by Subject|27
977733|NCT00569127|3217876|P1|Overall Study|Withdrawal by Subject|13
977734|NCT00569127|3217875|P2|Overall Study|Adverse Event|47
977735|NCT00569127|3217876|P1|Overall Study|Adverse Event|57
977736|NCT00568958|3217911|P2|Follow-Up|Adverse Event|0
977737|NCT00568958|3217912|P1|Follow-Up|Adverse Event|1
977738|NCT00568958|3217911|P2|Follow-Up|Family Emergency|0
977739|NCT00568958|3217912|P1|Follow-Up|Family Emergency|1
977740|NCT00568958|3217911|P2|Follow-Up|Physician Decision|1
977741|NCT00568958|3217912|P1|Follow-Up|Physician Decision|1
977742|NCT00568958|3217911|P2|Follow-Up|Withdrawal by Subject|6
977743|NCT00568958|3217912|P1|Follow-Up|Withdrawal by Subject|6
977744|NCT00568958|3217911|P2|Allocation|Physician Decision|0
977745|NCT00568958|3217912|P1|Allocation|Physician Decision|2
977746|NCT00568958|3217911|P2|Allocation|Withdrawal by Subject|3
977747|NCT00568958|3217912|P1|Allocation|Withdrawal by Subject|7
977748|NCT00568776|3217945|P4|Overall Study|Miscellaeneous|4
977749|NCT00568776|3217946|P3|Overall Study|Miscellaeneous|1
977750|NCT00568776|3217947|P2|Overall Study|Miscellaeneous|3
977751|NCT00568776|3217948|P1|Overall Study|Miscellaeneous|3
977752|NCT00568776|3217945|P4|Overall Study|Sponsor Decision|42
977753|NCT00568776|3217946|P3|Overall Study|Sponsor Decision|41
977754|NCT00568776|3217947|P2|Overall Study|Sponsor Decision|2
977755|NCT00568776|3217948|P1|Overall Study|Sponsor Decision|2
977756|NCT00568776|3217945|P4|Overall Study|Loss of Caregiver|2
977757|NCT00568776|3217946|P3|Overall Study|Loss of Caregiver|1
977758|NCT00568776|3217947|P2|Overall Study|Loss of Caregiver|2
977759|NCT00568776|3217948|P1|Overall Study|Loss of Caregiver|0
977760|NCT00568776|3217945|P4|Overall Study|Withdrawal by Subject|7
977761|NCT00568776|3217946|P3|Overall Study|Withdrawal by Subject|13
977762|NCT00568776|3217947|P2|Overall Study|Withdrawal by Subject|15
977763|NCT00568776|3217948|P1|Overall Study|Withdrawal by Subject|13
977764|NCT00568776|3217945|P4|Overall Study|Protocol Violation|1
977765|NCT00568776|3217946|P3|Overall Study|Protocol Violation|1
977766|NCT00568776|3217947|P2|Overall Study|Protocol Violation|0
977767|NCT00568776|3217948|P1|Overall Study|Protocol Violation|1
977768|NCT00568776|3217945|P4|Overall Study|Lost to Follow-up|1
977769|NCT00568776|3217946|P3|Overall Study|Lost to Follow-up|1
977770|NCT00568776|3217947|P2|Overall Study|Lost to Follow-up|1
977771|NCT00568776|3217948|P1|Overall Study|Lost to Follow-up|1
977772|NCT00568776|3217945|P4|Overall Study|Lack of Efficacy|4
977773|NCT00568776|3217946|P3|Overall Study|Lack of Efficacy|2
977774|NCT00568776|3217947|P2|Overall Study|Lack of Efficacy|2
977775|NCT00568776|3217948|P1|Overall Study|Lack of Efficacy|2
977776|NCT00568776|3217945|P4|Overall Study|Physician Decision|0
977777|NCT00568776|3217946|P3|Overall Study|Physician Decision|0
977778|NCT00568776|3217947|P2|Overall Study|Physician Decision|2
977779|NCT00568776|3217948|P1|Overall Study|Physician Decision|0
977780|NCT00568776|3217945|P4|Overall Study|Death|3
977781|NCT00568776|3217946|P3|Overall Study|Death|4
977782|NCT00568776|3217947|P2|Overall Study|Death|1
977783|NCT00568776|3217948|P1|Overall Study|Death|0
977784|NCT00568776|3217945|P4|Overall Study|Adverse Event|8
977785|NCT00568776|3217946|P3|Overall Study|Adverse Event|10
977786|NCT00568776|3217947|P2|Overall Study|Adverse Event|8
977787|NCT00568776|3217948|P1|Overall Study|Adverse Event|8
977788|NCT00568685|3217985|P3|Overall Study|Protocol Violation|0
977789|NCT00568685|3217986|P2|Overall Study|Protocol Violation|0
977790|NCT00568685|3217987|P1|Overall Study|Protocol Violation|1
977791|NCT00568685|3217985|P3|Overall Study|Withdrawal by Subject|2
977792|NCT00568685|3217986|P2|Overall Study|Withdrawal by Subject|2
977793|NCT00568685|3217987|P1|Overall Study|Withdrawal by Subject|7
977794|NCT00568685|3217985|P3|Overall Study|Adverse Event|3
977795|NCT00568685|3217986|P2|Overall Study|Adverse Event|3
977796|NCT00568685|3217987|P1|Overall Study|Adverse Event|2
977797|NCT00568555|3218021|P2|Overall Study|Withdrawal by Subject|1
977798|NCT00568555|3218022|P1|Overall Study|Withdrawal by Subject|1
977799|NCT00568451|3218040|P4|Overall Study|Disease Progression|7
977800|NCT00568451|3218041|P3|Overall Study|Disease Progression|2
977801|NCT00568451|3218042|P2|Overall Study|Disease Progression|0
977802|NCT00568451|3218043|P1|Overall Study|Disease Progression|0
977803|NCT00568399|3218059|P1|Overall Study|Withdrawal by Subject|8
977804|NCT00568399|3218059|P1|Overall Study|Adverse Event|5
977805|NCT00568399|3218059|P1|Overall Study|Death|2
977806|NCT00568334|3218074|P2|Overall Study|Lost to Follow-up|0
977807|NCT00568334|3218075|P1|Overall Study|Lost to Follow-up|1
977808|NCT00568334|3218074|P2|Overall Study|Withdrawal by Subject|1
977809|NCT00568334|3218075|P1|Overall Study|Withdrawal by Subject|0
977810|NCT00568178|3218101|P6|Open Label Extension|Withdrawal by Subject|4
977811|NCT00568178|3218102|P5|Open Label Extension|Withdrawal by Subject|4
977812|NCT00568178|3218103|P4|Open Label Extension|Withdrawal by Subject|0
977813|NCT00568178|3218104|P3|Open Label Extension|Withdrawal by Subject|0
977814|NCT00568178|3218105|P2|Open Label Extension|Withdrawal by Subject|0
977815|NCT00568178|3218106|P1|Open Label Extension|Withdrawal by Subject|0
977816|NCT00568178|3218101|P6|Open Label Extension|Termination of Trial|47
977817|NCT00568178|3218102|P5|Open Label Extension|Termination of Trial|45
977818|NCT00568178|3218103|P4|Open Label Extension|Termination of Trial|0
977819|NCT00568178|3218104|P3|Open Label Extension|Termination of Trial|0
977820|NCT00568178|3218105|P2|Open Label Extension|Termination of Trial|0
977821|NCT00568178|3218106|P1|Open Label Extension|Termination of Trial|0
977822|NCT00568178|3218101|P6|Open Label Extension|Progressive Disease|1
977823|NCT00568178|3218102|P5|Open Label Extension|Progressive Disease|3
977824|NCT00568178|3218103|P4|Open Label Extension|Progressive Disease|0
977825|NCT00568178|3218104|P3|Open Label Extension|Progressive Disease|0
977826|NCT00568178|3218105|P2|Open Label Extension|Progressive Disease|0
977827|NCT00568178|3218106|P1|Open Label Extension|Progressive Disease|0
977828|NCT00568178|3218101|P6|Open Label Extension|Pregnancy|1
977829|NCT00568178|3218102|P5|Open Label Extension|Pregnancy|0
977830|NCT00568178|3218103|P4|Open Label Extension|Pregnancy|0
977831|NCT00568178|3218104|P3|Open Label Extension|Pregnancy|0
977832|NCT00568178|3218105|P2|Open Label Extension|Pregnancy|0
977833|NCT00568178|3218106|P1|Open Label Extension|Pregnancy|0
977834|NCT00568178|3218101|P6|Open Label Extension|Physician Decision|8
977835|NCT00568178|3218102|P5|Open Label Extension|Physician Decision|9
977836|NCT00568178|3218103|P4|Open Label Extension|Physician Decision|0
977837|NCT00568178|3218104|P3|Open Label Extension|Physician Decision|0
977838|NCT00568178|3218105|P2|Open Label Extension|Physician Decision|0
977839|NCT00568178|3218106|P1|Open Label Extension|Physician Decision|0
977840|NCT00568178|3218101|P6|Open Label Extension|Lost to Follow-up|11
977841|NCT00568178|3218102|P5|Open Label Extension|Lost to Follow-up|6
977842|NCT00568178|3218103|P4|Open Label Extension|Lost to Follow-up|0
977843|NCT00568178|3218104|P3|Open Label Extension|Lost to Follow-up|0
977844|NCT00568178|3218105|P2|Open Label Extension|Lost to Follow-up|0
977845|NCT00568178|3218106|P1|Open Label Extension|Lost to Follow-up|0
977846|NCT00568178|3218101|P6|Open Label Extension|Protocol Violation|0
977847|NCT00568178|3218102|P5|Open Label Extension|Protocol Violation|1
977848|NCT00568178|3218103|P4|Open Label Extension|Protocol Violation|0
977849|NCT00568178|3218104|P3|Open Label Extension|Protocol Violation|0
977850|NCT00568178|3218105|P2|Open Label Extension|Protocol Violation|0
977851|NCT00568178|3218106|P1|Open Label Extension|Protocol Violation|0
977852|NCT00568178|3218101|P6|Open Label Extension|Adverse Event|8
977853|NCT00568178|3218102|P5|Open Label Extension|Adverse Event|11
977854|NCT00568178|3218103|P4|Open Label Extension|Adverse Event|0
977855|NCT00568178|3218104|P3|Open Label Extension|Adverse Event|0
977856|NCT00568178|3218105|P2|Open Label Extension|Adverse Event|0
977857|NCT00568178|3218106|P1|Open Label Extension|Adverse Event|0
977858|NCT00568178|3218101|P6|Double Blind Base Study|Progressive Disease|0
977859|NCT00568178|3218102|P5|Double Blind Base Study|Progressive Disease|0
977860|NCT00568178|3218103|P4|Double Blind Base Study|Progressive Disease|1
977861|NCT00568178|3218104|P3|Double Blind Base Study|Progressive Disease|0
977862|NCT00568178|3218105|P2|Double Blind Base Study|Progressive Disease|0
977863|NCT00568178|3218106|P1|Double Blind Base Study|Progressive Disease|0
977864|NCT00568178|3218101|P6|Double Blind Base Study|Withdrawal by Subject|0
977865|NCT00568178|3218102|P5|Double Blind Base Study|Withdrawal by Subject|0
977866|NCT00568178|3218103|P4|Double Blind Base Study|Withdrawal by Subject|0
977867|NCT00568178|3218104|P3|Double Blind Base Study|Withdrawal by Subject|0
977868|NCT00568178|3218105|P2|Double Blind Base Study|Withdrawal by Subject|1
977869|NCT00568178|3218106|P1|Double Blind Base Study|Withdrawal by Subject|1
977870|NCT00568178|3218101|P6|Double Blind Base Study|Protocol Violation|0
977871|NCT00568178|3218102|P5|Double Blind Base Study|Protocol Violation|0
977872|NCT00568178|3218103|P4|Double Blind Base Study|Protocol Violation|0
977873|NCT00568178|3218104|P3|Double Blind Base Study|Protocol Violation|0
977874|NCT00568178|3218105|P2|Double Blind Base Study|Protocol Violation|2
977875|NCT00568178|3218106|P1|Double Blind Base Study|Protocol Violation|3
977876|NCT00568178|3218101|P6|Double Blind Base Study|Physician Decision|0
977877|NCT00568178|3218102|P5|Double Blind Base Study|Physician Decision|0
977878|NCT00568178|3218103|P4|Double Blind Base Study|Physician Decision|1
977879|NCT00568178|3218104|P3|Double Blind Base Study|Physician Decision|0
977880|NCT00568178|3218105|P2|Double Blind Base Study|Physician Decision|1
977881|NCT00568178|3218106|P1|Double Blind Base Study|Physician Decision|1
977882|NCT00568178|3218101|P6|Double Blind Base Study|Lost to Follow-up|0
977883|NCT00568178|3218102|P5|Double Blind Base Study|Lost to Follow-up|0
977884|NCT00568178|3218103|P4|Double Blind Base Study|Lost to Follow-up|1
977885|NCT00568178|3218104|P3|Double Blind Base Study|Lost to Follow-up|0
977886|NCT00568178|3218105|P2|Double Blind Base Study|Lost to Follow-up|0
977887|NCT00568178|3218106|P1|Double Blind Base Study|Lost to Follow-up|1
977888|NCT00568178|3218101|P6|Double Blind Base Study|Adverse Event|0
977889|NCT00568178|3218102|P5|Double Blind Base Study|Adverse Event|0
977890|NCT00568178|3218103|P4|Double Blind Base Study|Adverse Event|2
977891|NCT00568178|3218104|P3|Double Blind Base Study|Adverse Event|1
977892|NCT00568178|3218105|P2|Double Blind Base Study|Adverse Event|2
977893|NCT00568178|3218106|P1|Double Blind Base Study|Adverse Event|0
977894|NCT00568061|3218137|P2|Overall Study|Adverse Event|1
977895|NCT00568061|3218138|P1|Overall Study|Adverse Event|0
977896|NCT00568061|3218137|P2|Overall Study|Inclusion / exclusion criteria|1
977897|NCT00568061|3218138|P1|Overall Study|Inclusion / exclusion criteria|5
977898|NCT00567996|3218182|P3|Overall Study|Patient's inability to use the device|0
977899|NCT00567996|3218183|P2|Overall Study|Patient's inability to use the device|1
977900|NCT00567996|3218184|P1|Overall Study|Patient's inability to use the device|0
977901|NCT00567996|3218182|P3|Overall Study|Death|2
977902|NCT00567996|3218183|P2|Overall Study|Death|0
977903|NCT00567996|3218184|P1|Overall Study|Death|1
977904|NCT00567996|3218182|P3|Overall Study|Administrative problems|0
977905|NCT00567996|3218183|P2|Overall Study|Administrative problems|1
977906|NCT00567996|3218184|P1|Overall Study|Administrative problems|1
977907|NCT00567996|3218182|P3|Overall Study|Unsatisfactory therapeutic effect|15
977908|NCT00567996|3218183|P2|Overall Study|Unsatisfactory therapeutic effect|2
977909|NCT00567996|3218184|P1|Overall Study|Unsatisfactory therapeutic effect|1
977910|NCT00567996|3218182|P3|Overall Study|Lost to Follow-up|2
977911|NCT00567996|3218183|P2|Overall Study|Lost to Follow-up|5
977912|NCT00567996|3218184|P1|Overall Study|Lost to Follow-up|2
977913|NCT00567996|3218182|P3|Overall Study|Abnormal test procedure result(s)|1
977914|NCT00567996|3218183|P2|Overall Study|Abnormal test procedure result(s)|1
977915|NCT00567996|3218184|P1|Overall Study|Abnormal test procedure result(s)|2
977916|NCT00567996|3218182|P3|Overall Study|Abnormal Lab value(s)|2
977917|NCT00567996|3218183|P2|Overall Study|Abnormal Lab value(s)|1
977918|NCT00567996|3218184|P1|Overall Study|Abnormal Lab value(s)|2
977919|NCT00567996|3218182|P3|Overall Study|Withdrawal by Subject|22
977920|NCT00567996|3218183|P2|Overall Study|Withdrawal by Subject|12
977921|NCT00567996|3218184|P1|Overall Study|Withdrawal by Subject|8
977922|NCT00567996|3218182|P3|Overall Study|Protocol Deviation|13
977923|NCT00567996|3218183|P2|Overall Study|Protocol Deviation|11
977924|NCT00567996|3218184|P1|Overall Study|Protocol Deviation|9
977925|NCT00567996|3218182|P3|Overall Study|Adverse Event|13
977926|NCT00567996|3218183|P2|Overall Study|Adverse Event|16
977927|NCT00567996|3218184|P1|Overall Study|Adverse Event|18
977928|NCT00567892|3218200|P4|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
977929|NCT00567892|3218201|P3|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
977930|NCT00567892|3218202|P2|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
977931|NCT00567892|3218203|P1|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
977932|NCT00567892|3218200|P4|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4
977933|NCT00567892|3218201|P3|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
977934|NCT00567892|3218202|P2|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
977935|NCT00567892|3218203|P1|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
977936|NCT00567879|3218221|P6|Overall Study|Disease progression|3
977937|NCT00567879|3218222|P5|Overall Study|Disease progression|11
977938|NCT00567879|3218223|P4|Overall Study|Disease progression|5
977939|NCT00567879|3218224|P3|Overall Study|Disease progression|15
977940|NCT00567879|3218225|P2|Overall Study|Disease progression|7
977941|NCT00567879|3218226|P1|Overall Study|Disease progression|5
977942|NCT00567879|3218221|P6|Overall Study|New cancer therapy|0
977943|NCT00567879|3218222|P5|Overall Study|New cancer therapy|0
977944|NCT00567879|3218223|P4|Overall Study|New cancer therapy|0
977945|NCT00567879|3218224|P3|Overall Study|New cancer therapy|1
977946|NCT00567879|3218225|P2|Overall Study|New cancer therapy|0
977947|NCT00567879|3218226|P1|Overall Study|New cancer therapy|0
977948|NCT00567879|3218221|P6|Overall Study|Withdrawal by Subject|0
977949|NCT00567879|3218222|P5|Overall Study|Withdrawal by Subject|0
977950|NCT00567879|3218223|P4|Overall Study|Withdrawal by Subject|1
977951|NCT00567879|3218224|P3|Overall Study|Withdrawal by Subject|3
977952|NCT00567879|3218225|P2|Overall Study|Withdrawal by Subject|0
977953|NCT00567879|3218226|P1|Overall Study|Withdrawal by Subject|0
977954|NCT00567879|3218221|P6|Overall Study|Abnormal test procedure(s)|0
977955|NCT00567879|3218222|P5|Overall Study|Abnormal test procedure(s)|0
977956|NCT00567879|3218223|P4|Overall Study|Abnormal test procedure(s)|0
977957|NCT00567879|3218224|P3|Overall Study|Abnormal test procedure(s)|1
977958|NCT00567879|3218225|P2|Overall Study|Abnormal test procedure(s)|0
977959|NCT00567879|3218226|P1|Overall Study|Abnormal test procedure(s)|0
977960|NCT00567879|3218221|P6|Overall Study|Adverse Event|0
977961|NCT00567879|3218222|P5|Overall Study|Adverse Event|1
977962|NCT00567879|3218223|P4|Overall Study|Adverse Event|0
977963|NCT00567879|3218224|P3|Overall Study|Adverse Event|1
977964|NCT00567879|3218225|P2|Overall Study|Adverse Event|0
977965|NCT00567879|3218226|P1|Overall Study|Adverse Event|2
977966|NCT00567593|3218293|P1|Overall Study|Physician Decision|1
977967|NCT00567593|3218293|P1|Overall Study|Adverse Event|1
977968|NCT00567567|3218300|P3|Overall Study|Unable adequate stem cell for transplant|2
977969|NCT00567567|3218301|P2|Overall Study|Unable adequate stem cell for transplant|0
977970|NCT00567567|3218302|P1|Overall Study|Unable adequate stem cell for transplant|0
977971|NCT00567567|3218300|P3|Overall Study|Enrolled another COG therapeutic study|0
977972|NCT00567567|3218301|P2|Overall Study|Enrolled another COG therapeutic study|80
977973|NCT00567567|3218302|P1|Overall Study|Enrolled another COG therapeutic study|99
977974|NCT00567567|3218300|P3|Overall Study|Refusal by patient/parent/guardian|122
977975|NCT00567567|3218301|P2|Overall Study|Refusal by patient/parent/guardian|16
977976|NCT00567567|3218302|P1|Overall Study|Refusal by patient/parent/guardian|9
977977|NCT00567567|3218300|P3|Overall Study|Ineligible|9
977978|NCT00567567|3218301|P2|Overall Study|Ineligible|0
977979|NCT00567567|3218302|P1|Overall Study|Ineligible|4
977980|NCT00567567|3218300|P3|Overall Study|Withdrawal by Subject|2
977981|NCT00567567|3218301|P2|Overall Study|Withdrawal by Subject|0
977982|NCT00567567|3218302|P1|Overall Study|Withdrawal by Subject|0
977983|NCT00567567|3218300|P3|Overall Study|Physician Decision|84
977984|NCT00567567|3218301|P2|Overall Study|Physician Decision|18
977985|NCT00567567|3218302|P1|Overall Study|Physician Decision|16
977986|NCT00567567|3218300|P3|Overall Study|Lost to Follow-up|1
977987|NCT00567567|3218301|P2|Overall Study|Lost to Follow-up|0
977988|NCT00567567|3218302|P1|Overall Study|Lost to Follow-up|0
977989|NCT00567567|3218300|P3|Overall Study|Lack of Efficacy|48
977990|NCT00567567|3218301|P2|Overall Study|Lack of Efficacy|17
977991|NCT00567567|3218302|P1|Overall Study|Lack of Efficacy|16
977992|NCT00567567|3218300|P3|Overall Study|Death|5
977993|NCT00567567|3218301|P2|Overall Study|Death|1
977994|NCT00567567|3218302|P1|Overall Study|Death|8
977995|NCT00567567|3218300|P3|Overall Study|Adverse Event|5
977996|NCT00567567|3218301|P2|Overall Study|Adverse Event|2
977997|NCT00567567|3218302|P1|Overall Study|Adverse Event|0
977998|NCT00567541|3218328|P2|Overall Study|Adverse Event|1
977999|NCT00567541|3218329|P1|Overall Study|Adverse Event|0
978000|NCT00567502|3218339|P4|Overall Study|Never Initiated Treatment|72
978001|NCT00567502|3218340|P3|Overall Study|Never Initiated Treatment|0
978002|NCT00567502|3218341|P2|Overall Study|Never Initiated Treatment|0
978003|NCT00567502|3218342|P1|Overall Study|Never Initiated Treatment|0
978004|NCT00567502|3218339|P4|Overall Study|Sponsor request|1
978005|NCT00567502|3218340|P3|Overall Study|Sponsor request|30
978006|NCT00567502|3218341|P2|Overall Study|Sponsor request|0
978007|NCT00567502|3218342|P1|Overall Study|Sponsor request|9
978008|NCT00567502|3218339|P4|Overall Study|Participant request|1
978009|NCT00567502|3218340|P3|Overall Study|Participant request|33
978010|NCT00567502|3218341|P2|Overall Study|Participant request|1
978011|NCT00567502|3218342|P1|Overall Study|Participant request|12
978012|NCT00567502|3218339|P4|Overall Study|Other|6
978013|NCT00567502|3218340|P3|Overall Study|Other|134
978014|NCT00567502|3218341|P2|Overall Study|Other|2
978015|NCT00567502|3218342|P1|Overall Study|Other|64
978016|NCT00567502|3218339|P4|Overall Study|Death|5
978017|NCT00567502|3218340|P3|Overall Study|Death|360
978018|NCT00567502|3218341|P2|Overall Study|Death|16
978019|NCT00567502|3218342|P1|Overall Study|Death|65
978020|NCT00567502|3218339|P4|Overall Study|Lost to Follow-up|2
978021|NCT00567502|3218340|P3|Overall Study|Lost to Follow-up|351
978022|NCT00567502|3218341|P2|Overall Study|Lost to Follow-up|14
978023|NCT00567502|3218342|P1|Overall Study|Lost to Follow-up|91
978024|NCT00567476|3218379|P2|Overall Study|Non-adherence to protocol|1
978025|NCT00567476|3218380|P1|Overall Study|Non-adherence to protocol|0
978026|NCT00567476|3218379|P2|Overall Study|Medical Decision|1
978027|NCT00567476|3218380|P1|Overall Study|Medical Decision|0
978028|NCT00567476|3218379|P2|Overall Study|Administrative issues|0
978029|NCT00567476|3218380|P1|Overall Study|Administrative issues|1
978030|NCT00567476|3218379|P2|Overall Study|Lost to Follow-up|1
978031|NCT00567476|3218380|P1|Overall Study|Lost to Follow-up|0
978032|NCT00567476|3218379|P2|Overall Study|Protocol Violation|1
978033|NCT00567476|3218380|P1|Overall Study|Protocol Violation|4
978034|NCT00567476|3218379|P2|Overall Study|Pregnancy|0
978035|NCT00567476|3218380|P1|Overall Study|Pregnancy|1
978036|NCT00567476|3218379|P2|Overall Study|Adverse Event|0
978037|NCT00567476|3218380|P1|Overall Study|Adverse Event|2
978038|NCT00567268|3218422|P1|Overall Study|"Safety Evaluation Not Assessable"|1
978039|NCT00567268|3218422|P1|Overall Study|No Drug Administration|4
978040|NCT00567268|3218422|P1|Overall Study|No Visit After First Day of Treatment|2
978041|NCT00567268|3218422|P1|Overall Study|Lost to Follow-up|36
978042|NCT00567268|3218422|P1|Overall Study|Protocol Violation|7
978043|NCT00567255|3218473|P2|Overall Study|Drug noncompliance,moved,other|15
978044|NCT00567255|3218474|P1|Overall Study|Drug noncompliance,moved,other|25
978045|NCT00567255|3218473|P2|Overall Study|Pregnancy|0
978046|NCT00567255|3218474|P1|Overall Study|Pregnancy|6
978047|NCT00567255|3218473|P2|Overall Study|Protocol Violation|8
978048|NCT00567255|3218474|P1|Overall Study|Protocol Violation|20
978049|NCT00567255|3218473|P2|Overall Study|Lack of Efficacy|33
978050|NCT00567255|3218474|P1|Overall Study|Lack of Efficacy|19
978051|NCT00567255|3218473|P2|Overall Study|Withdrawal by Subject|56
978052|NCT00567255|3218474|P1|Overall Study|Withdrawal by Subject|75
978053|NCT00567255|3218473|P2|Overall Study|Lost to Follow-up|48
978054|NCT00567255|3218474|P1|Overall Study|Lost to Follow-up|77
978055|NCT00567255|3218473|P2|Overall Study|Adverse Event|68
978056|NCT00567255|3218474|P1|Overall Study|Adverse Event|241
978057|NCT00567190|3218537|P2|Overall Study|Withdrew Consent or Lost to Follow-up|43
978058|NCT00567190|3218538|P1|Overall Study|Withdrew Consent or Lost to Follow-up|42
978059|NCT00567190|3218537|P2|Overall Study|Death|221
978060|NCT00567190|3218538|P1|Overall Study|Death|168
978061|NCT00567164|3218558|P3|Overall Study|Missing|0
978062|NCT00567164|3218559|P2|Overall Study|Missing|0
978063|NCT00567164|3218560|P1|Overall Study|Missing|1
978064|NCT00567164|3218558|P3|Overall Study|Primary Reason coded as 'Other'|16
978065|NCT00567164|3218559|P2|Overall Study|Primary Reason coded as 'Other'|8
978066|NCT00567164|3218560|P1|Overall Study|Primary Reason coded as 'Other'|37
978067|NCT00567164|3218558|P3|Overall Study|Pregnancy|6
978068|NCT00567164|3218559|P2|Overall Study|Pregnancy|4
978069|NCT00567164|3218560|P1|Overall Study|Pregnancy|20
978070|NCT00567164|3218558|P3|Overall Study|Lost to Follow-up|21
978071|NCT00567164|3218559|P2|Overall Study|Lost to Follow-up|23
978072|NCT00567164|3218560|P1|Overall Study|Lost to Follow-up|202
978073|NCT00567164|3218558|P3|Overall Study|Death|1
978074|NCT00567164|3218559|P2|Overall Study|Death|0
978075|NCT00567164|3218560|P1|Overall Study|Death|0
978076|NCT00567164|3218558|P3|Overall Study|Adverse Event|9
978077|NCT00567164|3218559|P2|Overall Study|Adverse Event|13
978078|NCT00567164|3218560|P1|Overall Study|Adverse Event|92
978079|NCT00567164|3218558|P3|Overall Study|Protocol Violation|2
978080|NCT00567164|3218559|P2|Overall Study|Protocol Violation|4
978081|NCT00567164|3218560|P1|Overall Study|Protocol Violation|23
978082|NCT00567164|3218558|P3|Overall Study|Withdrawal by Subject|17
978083|NCT00567164|3218559|P2|Overall Study|Withdrawal by Subject|21
978084|NCT00567164|3218560|P1|Overall Study|Withdrawal by Subject|171
978085|NCT00567112|3218632|P3|Washout Period 3 (3 Days)|Protocol Violation|0
978086|NCT00567112|3218633|P2|Washout Period 3 (3 Days)|Protocol Violation|0
978087|NCT00567112|3218634|P1|Washout Period 3 (3 Days)|Protocol Violation|1
978088|NCT00567112|3218632|P3|Washout Period 3 (3 Days)|Lost to Follow-up|0
978089|NCT00567112|3218633|P2|Washout Period 3 (3 Days)|Lost to Follow-up|0
978090|NCT00567112|3218634|P1|Washout Period 3 (3 Days)|Lost to Follow-up|2
978091|NCT00567112|3218632|P3|Treatment Period 2 (3 Days)|Protocol Violation|0
978092|NCT00567112|3218633|P2|Treatment Period 2 (3 Days)|Protocol Violation|1
978093|NCT00567112|3218634|P1|Treatment Period 2 (3 Days)|Protocol Violation|0
978094|NCT00566995|3218665|P1|Overall Study|Withdrew consent|3
978095|NCT00566995|3218665|P1|Overall Study|Toxicity|4
978096|NCT00566982|3218680|P2|Overall Study|Other-family problems & doctor's request|2
978097|NCT00566982|3218681|P1|Overall Study|Other-family problems & doctor's request|0
978098|NCT00566982|3218680|P2|Overall Study|Lost to Follow-up|1
978099|NCT00566982|3218681|P1|Overall Study|Lost to Follow-up|0
978100|NCT00566982|3218680|P2|Overall Study|Protocol Violation|4
978101|NCT00566982|3218681|P1|Overall Study|Protocol Violation|1
978102|NCT00566982|3218680|P2|Overall Study|Withdrawal by Subject|14
978103|NCT00566982|3218681|P1|Overall Study|Withdrawal by Subject|1
978104|NCT00566982|3218680|P2|Overall Study|Adverse Event|48
978105|NCT00566982|3218681|P1|Overall Study|Adverse Event|6
978106|NCT00566852|3218746|P2|Overall Study|Missing reason not reported|20
978107|NCT00566852|3218747|P1|Overall Study|Missing reason not reported|16
978108|NCT00566852|3218746|P2|Overall Study|Missing reason not specified|2
978109|NCT00566852|3218747|P1|Overall Study|Missing reason not specified|1
978110|NCT00566852|3218746|P2|Overall Study|Not tested due to disability|12
978111|NCT00566852|3218747|P1|Overall Study|Not tested due to disability|6
978112|NCT00566852|3218746|P2|Overall Study|Patient refusal|37
978113|NCT00566852|3218747|P1|Overall Study|Patient refusal|37
978114|NCT00566852|3218746|P2|Overall Study|Withdrawal by Subject|25
978115|NCT00566852|3218747|P1|Overall Study|Withdrawal by Subject|30
978116|NCT00566852|3218746|P2|Overall Study|Death|78
978117|NCT00566852|3218747|P1|Overall Study|Death|95
978118|NCT00566852|3218746|P2|Overall Study|Protocol Violation|24
978119|NCT00566852|3218747|P1|Overall Study|Protocol Violation|22
978120|NCT00566735|3218778|P2|Overall Study|Switched into a manic episode|1
978121|NCT00566735|3218779|P1|Overall Study|Switched into a manic episode|0
978122|NCT00566735|3218778|P2|Overall Study|Refused neuropsychological testing|5
978123|NCT00566735|3218779|P1|Overall Study|Refused neuropsychological testing|2
978124|NCT00566735|3218778|P2|Overall Study|Withdrawal by Subject|1
978125|NCT00566735|3218779|P1|Overall Study|Withdrawal by Subject|0
978126|NCT00566722|3218792|P3|Overall Study|Noncompliant with drug administration|1
978127|NCT00566722|3218793|P2|Overall Study|Noncompliant with drug administration|0
978128|NCT00566722|3218794|P1|Overall Study|Noncompliant with drug administration|0
978129|NCT00566722|3218792|P3|Overall Study|Serious adverse event|0
978130|NCT00566722|3218793|P2|Overall Study|Serious adverse event|1
978131|NCT00566722|3218794|P1|Overall Study|Serious adverse event|0
978132|NCT00566722|3218792|P3|Overall Study|Did not meet exclusion criteria|2
978133|NCT00566722|3218793|P2|Overall Study|Did not meet exclusion criteria|0
978134|NCT00566722|3218794|P1|Overall Study|Did not meet exclusion criteria|0
978135|NCT00566722|3218792|P3|Overall Study|Lack of Efficacy|4
978136|NCT00566722|3218793|P2|Overall Study|Lack of Efficacy|2
978137|NCT00566722|3218794|P1|Overall Study|Lack of Efficacy|1
978138|NCT00566722|3218792|P3|Overall Study|Lost to Follow-up|1
978139|NCT00566722|3218793|P2|Overall Study|Lost to Follow-up|1
978140|NCT00566722|3218794|P1|Overall Study|Lost to Follow-up|1
978141|NCT00566722|3218792|P3|Overall Study|Withdrawal by Subject|1
978142|NCT00566722|3218793|P2|Overall Study|Withdrawal by Subject|0
978143|NCT00566722|3218794|P1|Overall Study|Withdrawal by Subject|0
978144|NCT00566722|3218792|P3|Overall Study|Adverse Event|0
978145|NCT00566722|3218793|P2|Overall Study|Adverse Event|1
978146|NCT00566722|3218794|P1|Overall Study|Adverse Event|0
978147|NCT00566709|3218840|P2|Overall Study|Protocol Violation|0
978148|NCT00566709|3218841|P1|Overall Study|Protocol Violation|5
978149|NCT00566696|3218857|P1|Overall Study|Non-Patient Donors|37
978150|NCT00566696|3218857|P1|Overall Study|Physician Decision|1
978151|NCT00566696|3218857|P1|Overall Study|Health Status Change|1
978152|NCT00566696|3218857|P1|Overall Study|Muromonab not available|1
978153|NCT00566696|3218857|P1|Overall Study|Met Exclusion Criteria|2
978154|NCT00566631|3218865|P1|Part 2: Extension Phase|Other|5
978155|NCT00566631|3218865|P1|Part 2: Extension Phase|Death|1
978156|NCT00566631|3218865|P1|Part 2: Extension Phase|Lost to Follow-up|6
978157|NCT00566631|3218865|P1|Part 2: Extension Phase|Adverse Event|11
978158|NCT00566631|3218865|P1|Part 2: Extension Phase|Withdrawal by Subject|34
978159|NCT00566631|3218865|P1|Part 2: Extension Phase|Lack of Efficacy|25
978160|NCT00566631|3218865|P1|Between Treatment and Extension Phase|Participants not willing to participate|95
978161|NCT00566631|3218865|P1|Part 1: Core Treatment Phase|Met exclusion criteria|1
978162|NCT00566631|3218865|P1|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1
978163|NCT00566631|3218865|P1|Part 1: Core Treatment Phase|Withdrawal by Subject|26
978164|NCT00566631|3218865|P1|Part 1: Core Treatment Phase|Lost to Follow-up|4
978165|NCT00566631|3218865|P1|Part 1: Core Treatment Phase|Adverse Event|9
978166|NCT00566631|3218865|P1|Part 1: Core Treatment Phase|Physician Decision|1
978167|NCT00566631|3218865|P1|Part 1: Core Treatment Phase|Lack of Efficacy|18
978168|NCT00566527|3218892|P3|Overall Study|Withdrawal by Subject|43
978169|NCT00566527|3218893|P2|Overall Study|Withdrawal by Subject|43
978170|NCT00566527|3218894|P1|Overall Study|Withdrawal by Subject|6
978171|NCT00566527|3218892|P3|Overall Study|Lost to Follow-up|4
978172|NCT00566527|3218893|P2|Overall Study|Lost to Follow-up|4
978173|NCT00566527|3218894|P1|Overall Study|Lost to Follow-up|3
978174|NCT00566527|3218892|P3|Overall Study|Physician Decision|20
978175|NCT00566527|3218893|P2|Overall Study|Physician Decision|8
978176|NCT00566527|3218894|P1|Overall Study|Physician Decision|3
978177|NCT00566527|3218892|P3|Overall Study|Adverse Event|1
978178|NCT00566527|3218893|P2|Overall Study|Adverse Event|0
978179|NCT00566527|3218894|P1|Overall Study|Adverse Event|2
978180|NCT00566527|3218892|P3|Overall Study|Reason not provided|10
978181|NCT00566527|3218893|P2|Overall Study|Reason not provided|11
978182|NCT00566527|3218894|P1|Overall Study|Reason not provided|3
978183|NCT00566254|3218955|P2|Overall Study|Not Specified|2
978184|NCT00566254|3218956|P1|Overall Study|Not Specified|0
978185|NCT00566254|3218955|P2|Overall Study|Lack of Efficacy|6
978186|NCT00566254|3218956|P1|Overall Study|Lack of Efficacy|5
978187|NCT00566254|3218955|P2|Overall Study|Withdrawal by Subject|2
978188|NCT00566254|3218956|P1|Overall Study|Withdrawal by Subject|1
978189|NCT00566254|3218955|P2|Overall Study|Protocol Violation|3
978190|NCT00566254|3218956|P1|Overall Study|Protocol Violation|1
978191|NCT00566254|3218955|P2|Overall Study|Adverse Event|1
978192|NCT00566254|3218956|P1|Overall Study|Adverse Event|3
978193|NCT00566228|3218970|P2|Overall Study|progressed before infusion could occur|1
978194|NCT00566228|3218971|P1|Overall Study|progressed before infusion could occur|0
978195|NCT00566228|3218970|P2|Overall Study|Unable to collect sufficient CD34 cells|2
978196|NCT00566228|3218971|P1|Overall Study|Unable to collect sufficient CD34 cells|3
978197|NCT00566228|3218970|P2|Overall Study|Attempt to mobilize stem cells failed|2
978198|NCT00566228|3218971|P1|Overall Study|Attempt to mobilize stem cells failed|2
978199|NCT00566228|3218970|P2|Overall Study|Withdrawal by Subject|0
978200|NCT00566228|3218971|P1|Overall Study|Withdrawal by Subject|1
978201|NCT00566111|3219004|P2|Overall Study|Adverse Event|2
978202|NCT00566111|3219005|P1|Overall Study|Adverse Event|0
978203|NCT00566020|3219019|P2|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1
978204|NCT00566020|3219020|P1|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0
978205|NCT00566020|3219019|P2|46-week Long-term Administration Phase|Lost to Follow-up|2
978206|NCT00566020|3219020|P1|46-week Long-term Administration Phase|Lost to Follow-up|0
978207|NCT00566020|3219019|P2|46-week Long-term Administration Phase|Physician Decision|7
978208|NCT00566020|3219020|P1|46-week Long-term Administration Phase|Physician Decision|0
978209|NCT00566020|3219019|P2|46-week Long-term Administration Phase|Adverse Event|7
978210|NCT00566020|3219020|P1|46-week Long-term Administration Phase|Adverse Event|0
978211|NCT00566020|3219019|P2|6-week Dosage Adjustment Phase|Lack of Efficacy|0
978212|NCT00566020|3219020|P1|6-week Dosage Adjustment Phase|Lack of Efficacy|2
978213|NCT00566020|3219019|P2|6-week Dosage Adjustment Phase|Adverse Event|0
978214|NCT00566020|3219020|P1|6-week Dosage Adjustment Phase|Adverse Event|5
978215|NCT00565812|3219109|P3|Overall Study|Physician Decision|0
978216|NCT00565812|3219110|P2|Overall Study|Physician Decision|0
978217|NCT00565812|3219111|P1|Overall Study|Physician Decision|2
978218|NCT00565812|3219109|P3|Overall Study|Follow-up Visit Not Completed|1
978219|NCT00565812|3219110|P2|Overall Study|Follow-up Visit Not Completed|0
978220|NCT00565812|3219111|P1|Overall Study|Follow-up Visit Not Completed|2
978221|NCT00565812|3219109|P3|Overall Study|Low Compliance|1
978222|NCT00565812|3219110|P2|Overall Study|Low Compliance|0
978223|NCT00565812|3219111|P1|Overall Study|Low Compliance|1
978224|NCT00565812|3219109|P3|Overall Study|Surgical Intervention|2
978225|NCT00565812|3219110|P2|Overall Study|Surgical Intervention|1
978226|NCT00565812|3219111|P1|Overall Study|Surgical Intervention|0
978227|NCT00565812|3219109|P3|Overall Study|Research Site Closure|8
978228|NCT00565812|3219110|P2|Overall Study|Research Site Closure|1
978229|NCT00565812|3219111|P1|Overall Study|Research Site Closure|6
978230|NCT00565812|3219109|P3|Overall Study|Domestic Reasons|3
978231|NCT00565812|3219110|P2|Overall Study|Domestic Reasons|1
978232|NCT00565812|3219111|P1|Overall Study|Domestic Reasons|7
978233|NCT00565812|3219109|P3|Overall Study|Sponsor Decision|1
978234|NCT00565812|3219110|P2|Overall Study|Sponsor Decision|5
978235|NCT00565812|3219111|P1|Overall Study|Sponsor Decision|1
978236|NCT00565812|3219109|P3|Overall Study|Relocated Out of Area|9
978237|NCT00565812|3219110|P2|Overall Study|Relocated Out of Area|8
978238|NCT00565812|3219111|P1|Overall Study|Relocated Out of Area|5
978239|NCT00565812|3219109|P3|Overall Study|Jury Duty|0
978240|NCT00565812|3219110|P2|Overall Study|Jury Duty|0
978241|NCT00565812|3219111|P1|Overall Study|Jury Duty|1
978242|NCT00565812|3219109|P3|Overall Study|Adverse Event|40
978243|NCT00565812|3219110|P2|Overall Study|Adverse Event|54
978244|NCT00565812|3219111|P1|Overall Study|Adverse Event|41
978245|NCT00565812|3219109|P3|Overall Study|Protocol Violation|4
978246|NCT00565812|3219110|P2|Overall Study|Protocol Violation|6
978247|NCT00565812|3219111|P1|Overall Study|Protocol Violation|2
978248|NCT00565812|3219109|P3|Overall Study|Work Schedule|1
978249|NCT00565812|3219110|P2|Overall Study|Work Schedule|3
978250|NCT00565812|3219111|P1|Overall Study|Work Schedule|5
978251|NCT00565812|3219109|P3|Overall Study|Withdrawal by Subject|48
978252|NCT00565812|3219110|P2|Overall Study|Withdrawal by Subject|47
978253|NCT00565812|3219111|P1|Overall Study|Withdrawal by Subject|58
978254|NCT00565812|3219109|P3|Overall Study|Lost to Follow-up|8
978255|NCT00565812|3219110|P2|Overall Study|Lost to Follow-up|8
978256|NCT00565812|3219111|P1|Overall Study|Lost to Follow-up|10
978257|NCT00565812|3219109|P3|Overall Study|Did not Meet Entrance Criteria|1
978258|NCT00565812|3219110|P2|Overall Study|Did not Meet Entrance Criteria|0
978259|NCT00565812|3219111|P1|Overall Study|Did not Meet Entrance Criteria|1
978260|NCT00565812|3219109|P3|Overall Study|Death|3
978261|NCT00565812|3219110|P2|Overall Study|Death|1
978262|NCT00565812|3219111|P1|Overall Study|Death|2
978263|NCT00565747|3219250|P2|Overall Study|No embryo transfer|73
978264|NCT00565747|3219251|P1|Overall Study|No embryo transfer|67
978265|NCT00565721|3219261|P1|Overall Study|Other reasons|6
978266|NCT00565721|3219261|P1|Overall Study|Physician Decision|2
978267|NCT00565721|3219261|P1|Overall Study|Technical Problems|1
978268|NCT00565721|3219261|P1|Overall Study|Lost to Follow-up|6
978269|NCT00565721|3219261|P1|Overall Study|Screen Failure|2
978270|NCT00565617|3219310|P1|Overall Study|Withdrawal by Subject|1
978271|NCT00565604|3219314|P1|Overall Study|Lost to Follow-up|2
978272|NCT00565604|3219314|P1|Overall Study|Failure to treat|2
978273|NCT00565448|3219342|P2|Overall Study|Withdrawal by Subject|0
978274|NCT00565448|3219343|P1|Overall Study|Withdrawal by Subject|1
978275|NCT00565448|3219342|P2|Overall Study|Disease progression|0
978276|NCT00565448|3219343|P1|Overall Study|Disease progression|1
978277|NCT00565448|3219342|P2|Overall Study|Adverse Event|2
978278|NCT00565448|3219343|P1|Overall Study|Adverse Event|1
978279|NCT00565409|3219354|P4|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43
978280|NCT00565409|3219355|P3|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11
978281|NCT00565409|3219356|P2|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4
978282|NCT00565409|3219357|P1|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0
978283|NCT00565409|3219354|P4|Period 2 Double-Blind|Other|9
978284|NCT00565409|3219355|P3|Period 2 Double-Blind|Other|5
978285|NCT00565409|3219356|P2|Period 2 Double-Blind|Other|4
978286|NCT00565409|3219357|P1|Period 2 Double-Blind|Other|0
978287|NCT00565409|3219354|P4|Period 2 Double-Blind|Lost to Follow-up|0
978288|NCT00565409|3219355|P3|Period 2 Double-Blind|Lost to Follow-up|1
978289|NCT00565409|3219356|P2|Period 2 Double-Blind|Lost to Follow-up|0
978290|NCT00565409|3219357|P1|Period 2 Double-Blind|Lost to Follow-up|0
978291|NCT00565409|3219354|P4|Period 2 Double-Blind|Protocol Violation|2
978292|NCT00565409|3219355|P3|Period 2 Double-Blind|Protocol Violation|6
978293|NCT00565409|3219356|P2|Period 2 Double-Blind|Protocol Violation|4
978294|NCT00565409|3219357|P1|Period 2 Double-Blind|Protocol Violation|0
978295|NCT00565409|3219354|P4|Period 2 Double-Blind|Death|0
978296|NCT00565409|3219355|P3|Period 2 Double-Blind|Death|0
978297|NCT00565409|3219356|P2|Period 2 Double-Blind|Death|2
978298|NCT00565409|3219357|P1|Period 2 Double-Blind|Death|0
978299|NCT00565409|3219354|P4|Period 2 Double-Blind|Adverse Event|5
978300|NCT00565409|3219355|P3|Period 2 Double-Blind|Adverse Event|4
978301|NCT00565409|3219356|P2|Period 2 Double-Blind|Adverse Event|7
978302|NCT00565409|3219357|P1|Period 2 Double-Blind|Adverse Event|0
978303|NCT00565409|3219354|P4|After Period 1, Prior to Period 2|did not meet criteria|0
978304|NCT00565409|3219355|P3|After Period 1, Prior to Period 2|did not meet criteria|0
978305|NCT00565409|3219356|P2|After Period 1, Prior to Period 2|did not meet criteria|0
978306|NCT00565409|3219357|P1|After Period 1, Prior to Period 2|did not meet criteria|152
978307|NCT00565409|3219354|P4|Period 1 Open Label|no conclusion of participation record|0
978308|NCT00565409|3219355|P3|Period 1 Open Label|no conclusion of participation record|0
978309|NCT00565409|3219356|P2|Period 1 Open Label|no conclusion of participation record|0
978310|NCT00565409|3219357|P1|Period 1 Open Label|no conclusion of participation record|1
978311|NCT00565409|3219354|P4|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
978312|NCT00565409|3219355|P3|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
978313|NCT00565409|3219356|P2|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
978314|NCT00565409|3219357|P1|Period 1 Open Label|Unsatisfactory Response-Efficacy|22
978315|NCT00565409|3219354|P4|Period 1 Open Label|Protocol Violation|0
978316|NCT00565409|3219355|P3|Period 1 Open Label|Protocol Violation|0
978317|NCT00565409|3219356|P2|Period 1 Open Label|Protocol Violation|0
978318|NCT00565409|3219357|P1|Period 1 Open Label|Protocol Violation|14
978319|NCT00565409|3219354|P4|Period 1 Open Label|Other|0
978320|NCT00565409|3219355|P3|Period 1 Open Label|Other|0
978321|NCT00565409|3219356|P2|Period 1 Open Label|Other|0
978322|NCT00565409|3219357|P1|Period 1 Open Label|Other|21
978323|NCT00565409|3219354|P4|Period 1 Open Label|Lost to Follow-up|0
978324|NCT00565409|3219355|P3|Period 1 Open Label|Lost to Follow-up|0
978325|NCT00565409|3219356|P2|Period 1 Open Label|Lost to Follow-up|0
978326|NCT00565409|3219357|P1|Period 1 Open Label|Lost to Follow-up|1
978327|NCT00565409|3219354|P4|Period 1 Open Label|Death|0
978328|NCT00565409|3219355|P3|Period 1 Open Label|Death|0
978329|NCT00565409|3219356|P2|Period 1 Open Label|Death|0
978330|NCT00565409|3219357|P1|Period 1 Open Label|Death|2
978331|NCT00565409|3219354|P4|Period 1 Open Label|Adverse Event|0
978332|NCT00565409|3219355|P3|Period 1 Open Label|Adverse Event|0
978333|NCT00565409|3219356|P2|Period 1 Open Label|Adverse Event|0
978334|NCT00565409|3219357|P1|Period 1 Open Label|Adverse Event|17
978335|NCT00565136|3219493|P1|Overall Study|Protocol Violation|1
978336|NCT00565136|3219493|P1|Overall Study|Withdrawal by Subject|1
978337|NCT00565136|3219493|P1|Overall Study|Lost to Follow-up|1
978338|NCT00565058|3219534|P2|Overall Study|Adverse Event|0
978339|NCT00565058|3219535|P1|Overall Study|Adverse Event|1
978340|NCT00564902|3219582|P3|Overall Study|Death|0
978341|NCT00564902|3219583|P2|Overall Study|Death|1
978342|NCT00564902|3219584|P1|Overall Study|Death|1
978343|NCT00564902|3219582|P3|Overall Study|Withdrawal by Subject|4
978344|NCT00564902|3219583|P2|Overall Study|Withdrawal by Subject|3
978345|NCT00564902|3219584|P1|Overall Study|Withdrawal by Subject|0
978346|NCT00564889|3219616|P1|Overall Study|Other, not specified|4
978347|NCT00564889|3219616|P1|Overall Study|Disease progression|3
978348|NCT00564889|3219616|P1|Overall Study|Alternative treatment|3
978349|NCT00564889|3219616|P1|Overall Study|Adverse Event|12
978350|NCT00564889|3219616|P1|Overall Study|Death|7
978351|NCT00564850|3219631|P1|Overall Study|Protocol Violation|2
978352|NCT00564733|3219649|P1|Overall Study|Ineligible|5
978353|NCT00564733|3219649|P1|Overall Study|Withdrawal by Subject|4
978354|NCT00564629|3219683|P2|Overall Study|Vomited within 2 hours of receiving drug|9
978355|NCT00564629|3219684|P1|Overall Study|Vomited within 2 hours of receiving drug|15
978356|NCT00564486|3219709|P4|Overall Study|Lost to Follow-up|2
978357|NCT00564486|3219710|P3|Overall Study|Lost to Follow-up|2
978358|NCT00564486|3219711|P2|Overall Study|Lost to Follow-up|0
978359|NCT00564486|3219712|P1|Overall Study|Lost to Follow-up|3
978360|NCT00564486|3219709|P4|Overall Study|Subject refused to have blood drawn|0
978361|NCT00564486|3219710|P3|Overall Study|Subject refused to have blood drawn|1
978362|NCT00564486|3219711|P2|Overall Study|Subject refused to have blood drawn|0
978363|NCT00564486|3219712|P1|Overall Study|Subject refused to have blood drawn|0
978364|NCT00564486|3219709|P4|Overall Study|Withdrawal by Subject|5
978365|NCT00564486|3219710|P3|Overall Study|Withdrawal by Subject|0
978366|NCT00564486|3219711|P2|Overall Study|Withdrawal by Subject|0
978367|NCT00564486|3219712|P1|Overall Study|Withdrawal by Subject|4
978368|NCT00564486|3219709|P4|Overall Study|Adverse Event|0
978369|NCT00564486|3219710|P3|Overall Study|Adverse Event|0
978370|NCT00564486|3219711|P2|Overall Study|Adverse Event|1
978371|NCT00564486|3219712|P1|Overall Study|Adverse Event|0
978372|NCT00564395|3219761|P2|First Intervention (10 Days)|Trouble with the CGM tracing|2
978373|NCT00564395|3219762|P1|First Intervention (10 Days)|Trouble with the CGM tracing|1
978374|NCT00564395|3219761|P2|First Intervention (10 Days)|Withdrawal by Subject|0
978375|NCT00564395|3219762|P1|First Intervention (10 Days)|Withdrawal by Subject|1
978376|NCT00564278|3219770|P2|Overall Study|Withdrawal by Subject|7
978377|NCT00564278|3219771|P1|Overall Study|Withdrawal by Subject|11
978378|NCT00564278|3219770|P2|Overall Study|Physician Decision|2
978379|NCT00564278|3219771|P1|Overall Study|Physician Decision|1
978380|NCT00564278|3219770|P2|Overall Study|Lost to Follow-up|33
978381|NCT00564278|3219771|P1|Overall Study|Lost to Follow-up|35
978382|NCT00564070|3219793|P2|Overall Study|Worsening depression, referred to care|0
978383|NCT00564070|3219794|P1|Overall Study|Worsening depression, referred to care|3
978384|NCT00564070|3219793|P2|Overall Study|Lost to Follow-up|7
978385|NCT00564070|3219794|P1|Overall Study|Lost to Follow-up|9
978386|NCT00563797|3219820|P2|Overall Study|Lost to Follow-up|2
978387|NCT00563797|3219821|P1|Overall Study|Lost to Follow-up|7
978388|NCT00563706|3219842|P9|DB Treatment Period (Day 1 up to Day 28)|Other|2
978389|NCT00563706|3219843|P8|DB Treatment Period (Day 1 up to Day 28)|Other|1
978390|NCT00563706|3219844|P7|DB Treatment Period (Day 1 up to Day 28)|Other|0
978391|NCT00563706|3219845|P6|DB Treatment Period (Day 1 up to Day 28)|Other|0
978392|NCT00563706|3219846|P5|DB Treatment Period (Day 1 up to Day 28)|Other|0
978393|NCT00563706|3219847|P4|DB Treatment Period (Day 1 up to Day 28)|Other|0
978394|NCT00563706|3219848|P3|DB Treatment Period (Day 1 up to Day 28)|Other|0
978395|NCT00563706|3219849|P2|DB Treatment Period (Day 1 up to Day 28)|Other|0
978396|NCT00563706|3219850|P1|DB Treatment Period (Day 1 up to Day 28)|Other|0
978397|NCT00563706|3219842|P9|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
978398|NCT00563706|3219843|P8|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1
978399|NCT00563706|3219844|P7|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
978400|NCT00563706|3219845|P6|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
978401|NCT00563706|3219846|P5|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
978480|NCT00563368|3220040|P7|Overall Study|Adverse Event|17
978402|NCT00563706|3219847|P4|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
978403|NCT00563706|3219848|P3|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
978404|NCT00563706|3219849|P2|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
978405|NCT00563706|3219850|P1|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2
978406|NCT00563706|3219842|P9|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
978407|NCT00563706|3219843|P8|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6
978408|NCT00563706|3219844|P7|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1
978409|NCT00563706|3219845|P6|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
978410|NCT00563706|3219846|P5|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4
978411|NCT00563706|3219847|P4|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5
978412|NCT00563706|3219848|P3|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2
978413|NCT00563706|3219849|P2|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
978414|NCT00563706|3219850|P1|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9
978415|NCT00563706|3219842|P9|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
978416|NCT00563706|3219843|P8|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5
978417|NCT00563706|3219844|P7|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
978418|NCT00563706|3219845|P6|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
978419|NCT00563706|3219846|P5|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
978420|NCT00563706|3219847|P4|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4
978421|NCT00563706|3219848|P3|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
978422|NCT00563706|3219849|P2|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
978423|NCT00563706|3219850|P1|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
978424|NCT00563706|3219842|P9|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5
978425|NCT00563706|3219843|P8|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
978426|NCT00563706|3219844|P7|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
978427|NCT00563706|3219845|P6|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
978428|NCT00563706|3219846|P5|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
978429|NCT00563706|3219847|P4|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
978430|NCT00563706|3219848|P3|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
978431|NCT00563706|3219849|P2|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
978432|NCT00563706|3219850|P1|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4
978433|NCT00563381|3219966|P2|Overall Study|Individual different reasons|34
978434|NCT00563381|3219967|P1|Overall Study|Individual different reasons|24
978435|NCT00563381|3219966|P2|Overall Study|Lack of Efficacy|24
978436|NCT00563381|3219967|P1|Overall Study|Lack of Efficacy|32
978437|NCT00563381|3219966|P2|Overall Study|Withdrawal by Subject|209
978438|NCT00563381|3219967|P1|Overall Study|Withdrawal by Subject|192
978439|NCT00563381|3219966|P2|Overall Study|Lost to Follow-up|15
978440|NCT00563381|3219967|P1|Overall Study|Lost to Follow-up|7
978441|NCT00563381|3219966|P2|Overall Study|Protocol Violation|74
978442|NCT00563381|3219967|P1|Overall Study|Protocol Violation|66
978443|NCT00563381|3219966|P2|Overall Study|Adverse Event|292
978444|NCT00563381|3219967|P1|Overall Study|Adverse Event|264
978445|NCT00563368|3220040|P7|Overall Study|not specified|0
978446|NCT00563368|3220041|P6|Overall Study|not specified|4
978447|NCT00563368|3220042|P5|Overall Study|not specified|4
978448|NCT00563368|3220043|P4|Overall Study|not specified|4
978449|NCT00563368|3220044|P3|Overall Study|not specified|3
978450|NCT00563368|3220045|P2|Overall Study|not specified|5
978451|NCT00563368|3220046|P1|Overall Study|not specified|5
978452|NCT00563368|3220040|P7|Overall Study|requirement for restricted medication|0
978453|NCT00563368|3220041|P6|Overall Study|requirement for restricted medication|0
978454|NCT00563368|3220042|P5|Overall Study|requirement for restricted medication|0
978455|NCT00563368|3220043|P4|Overall Study|requirement for restricted medication|0
978456|NCT00563368|3220044|P3|Overall Study|requirement for restricted medication|2
978457|NCT00563368|3220045|P2|Overall Study|requirement for restricted medication|0
978458|NCT00563368|3220046|P1|Overall Study|requirement for restricted medication|0
978459|NCT00563368|3220040|P7|Overall Study|Pregnancy|0
978460|NCT00563368|3220041|P6|Overall Study|Pregnancy|2
978461|NCT00563368|3220042|P5|Overall Study|Pregnancy|1
978462|NCT00563368|3220043|P4|Overall Study|Pregnancy|2
978463|NCT00563368|3220044|P3|Overall Study|Pregnancy|1
978464|NCT00563368|3220045|P2|Overall Study|Pregnancy|0
978465|NCT00563368|3220046|P1|Overall Study|Pregnancy|1
978466|NCT00563368|3220040|P7|Overall Study|protocol non-compliance|3
978467|NCT00563368|3220041|P6|Overall Study|protocol non-compliance|1
978468|NCT00563368|3220042|P5|Overall Study|protocol non-compliance|0
978469|NCT00563368|3220043|P4|Overall Study|protocol non-compliance|1
978470|NCT00563368|3220044|P3|Overall Study|protocol non-compliance|2
978471|NCT00563368|3220045|P2|Overall Study|protocol non-compliance|1
978472|NCT00563368|3220046|P1|Overall Study|protocol non-compliance|1
978473|NCT00563368|3220040|P7|Overall Study|Withdrawal by Subject|4
978474|NCT00563368|3220041|P6|Overall Study|Withdrawal by Subject|5
978475|NCT00563368|3220042|P5|Overall Study|Withdrawal by Subject|8
978476|NCT00563368|3220043|P4|Overall Study|Withdrawal by Subject|7
978477|NCT00563368|3220044|P3|Overall Study|Withdrawal by Subject|5
978478|NCT00563368|3220045|P2|Overall Study|Withdrawal by Subject|6
978479|NCT00563368|3220046|P1|Overall Study|Withdrawal by Subject|11
978481|NCT00563368|3220041|P6|Overall Study|Adverse Event|10
978482|NCT00563368|3220042|P5|Overall Study|Adverse Event|6
978483|NCT00563368|3220043|P4|Overall Study|Adverse Event|9
978484|NCT00563368|3220044|P3|Overall Study|Adverse Event|5
978485|NCT00563368|3220045|P2|Overall Study|Adverse Event|4
978486|NCT00563368|3220046|P1|Overall Study|Adverse Event|3
978487|NCT00563368|3220040|P7|Overall Study|Lost to Follow-up|9
978488|NCT00563368|3220041|P6|Overall Study|Lost to Follow-up|8
978489|NCT00563368|3220042|P5|Overall Study|Lost to Follow-up|9
978490|NCT00563368|3220043|P4|Overall Study|Lost to Follow-up|6
978491|NCT00563368|3220044|P3|Overall Study|Lost to Follow-up|12
978492|NCT00563368|3220045|P2|Overall Study|Lost to Follow-up|14
978493|NCT00563368|3220046|P1|Overall Study|Lost to Follow-up|14
978494|NCT00563316|3220069|P1|Overall Study|Other|1
978495|NCT00563316|3220069|P1|Overall Study|On-going in study as of 16 July 2009.|5
978496|NCT00563316|3220069|P1|Overall Study|Death|1
978497|NCT00563316|3220069|P1|Overall Study|Lost to Follow-up|2
978498|NCT00563316|3220069|P1|Overall Study|Physician Decision|1
978499|NCT00563316|3220069|P1|Overall Study|Adverse Event|2
978500|NCT00563186|3220094|P2|Overall Study|Incomplete data|1
978501|NCT00563186|3220095|P1|Overall Study|Incomplete data|1
978502|NCT00563186|3220094|P2|Overall Study|LOS<48 hours|74
978503|NCT00563186|3220095|P1|Overall Study|LOS<48 hours|97
978504|NCT00562965|3220106|P2|Overall Study|Other|1
978505|NCT00562965|3220107|P1|Overall Study|Other|0
978506|NCT00562965|3220106|P2|Overall Study|Lost to Follow-up|0
978507|NCT00562965|3220107|P1|Overall Study|Lost to Follow-up|1
978508|NCT00562965|3220106|P2|Overall Study|Death|4
978509|NCT00562965|3220107|P1|Overall Study|Death|2
978510|NCT00562965|3220106|P2|Overall Study|Withdrawal by Subject|1
978511|NCT00562965|3220107|P1|Overall Study|Withdrawal by Subject|0
978512|NCT00562861|3220128|P2|Overall Study|Lost to Follow-up|3
978513|NCT00562861|3220129|P1|Overall Study|Lost to Follow-up|7
978514|NCT00562861|3220128|P2|Overall Study|noncompliance, moved|2
978515|NCT00562861|3220129|P1|Overall Study|noncompliance, moved|7
978516|NCT00562861|3220128|P2|Overall Study|Lack of Efficacy|5
978517|NCT00562861|3220129|P1|Overall Study|Lack of Efficacy|5
978518|NCT00562861|3220128|P2|Overall Study|Adverse Event|1
978519|NCT00562861|3220129|P1|Overall Study|Adverse Event|1
978520|NCT00562627|3220138|P3|Overall Study|Protocol Violation|1
978521|NCT00562627|3220139|P2|Overall Study|Protocol Violation|1
978522|NCT00562627|3220140|P1|Overall Study|Protocol Violation|1
978523|NCT00562588|3220156|P2|Overall Study|Other|2
978524|NCT00562588|3220157|P1|Overall Study|Other|0
978525|NCT00562588|3220156|P2|Overall Study|Withdrawal by Subject|9
978526|NCT00562588|3220157|P1|Overall Study|Withdrawal by Subject|10
978527|NCT00562588|3220156|P2|Overall Study|Lost to Follow-up|4
978528|NCT00562588|3220157|P1|Overall Study|Lost to Follow-up|12
978529|NCT00562588|3220156|P2|Overall Study|Protocol Violation|26
978530|NCT00562588|3220157|P1|Overall Study|Protocol Violation|30
978531|NCT00562588|3220156|P2|Overall Study|Adverse Event|58
978532|NCT00562588|3220157|P1|Overall Study|Adverse Event|40
978533|NCT00562484|3220187|P2|Overall Study|Reason not provided or not specified|12
978534|NCT00562484|3220188|P1|Overall Study|Reason not provided or not specified|25
978535|NCT00562484|3220187|P2|Overall Study|Lost to Follow-up|71
978536|NCT00562484|3220188|P1|Overall Study|Lost to Follow-up|132
978537|NCT00562484|3220187|P2|Overall Study|Moved away from the study area|9
978538|NCT00562484|3220188|P1|Overall Study|Moved away from the study area|20
978539|NCT00562484|3220187|P2|Overall Study|Withdrawal by Subject|9
978540|NCT00562484|3220188|P1|Overall Study|Withdrawal by Subject|12
978541|NCT00562484|3220187|P2|Overall Study|Protocol Violation|2
978542|NCT00562484|3220188|P1|Overall Study|Protocol Violation|11
978543|NCT00562484|3220187|P2|Overall Study|Adverse Event|1
978544|NCT00562484|3220188|P1|Overall Study|Adverse Event|6
978545|NCT00562354|3220220|P2|Overall Study|Lost to Follow-up|1
978546|NCT00562354|3220221|P1|Overall Study|Lost to Follow-up|0
978547|NCT00562354|3220220|P2|Overall Study|Physician Decision|1
978548|NCT00562354|3220221|P1|Overall Study|Physician Decision|0
978549|NCT00562302|3220283|P2|Overall Study|Not stated|4
978550|NCT00562302|3220284|P1|Overall Study|Not stated|1
978551|NCT00562302|3220283|P2|Overall Study|Lung resection prior to study completion|7
978552|NCT00562302|3220284|P1|Overall Study|Lung resection prior to study completion|7
978553|NCT00562302|3220283|P2|Overall Study|Death|2
978554|NCT00562302|3220284|P1|Overall Study|Death|1
978555|NCT00562302|3220283|P2|Overall Study|Withdrawal by Subject|8
978556|NCT00562302|3220284|P1|Overall Study|Withdrawal by Subject|7
978557|NCT00562302|3220283|P2|Overall Study|Non-compliance|2
978558|NCT00562302|3220284|P1|Overall Study|Non-compliance|1
978559|NCT00562302|3220283|P2|Overall Study|Adverse Event|6
978560|NCT00562302|3220284|P1|Overall Study|Adverse Event|0
978561|NCT00562302|3220283|P2|Overall Study|Lost to Follow-up|3
978562|NCT00562302|3220284|P1|Overall Study|Lost to Follow-up|3
978563|NCT00562159|3220306|P2|Overall Study|Did not meet protocol eligibility|1
978564|NCT00562159|3220307|P1|Overall Study|Did not meet protocol eligibility|1
978565|NCT00562159|3220306|P2|Overall Study|Protocol Violation|12
978566|NCT00562159|3220307|P1|Overall Study|Protocol Violation|12
978567|NCT00562159|3220306|P2|Overall Study|Withdrawal by Subject|8
978568|NCT00562159|3220307|P1|Overall Study|Withdrawal by Subject|9
978569|NCT00562159|3220306|P2|Overall Study|Lost to Follow-up|4
978570|NCT00562159|3220307|P1|Overall Study|Lost to Follow-up|5
978571|NCT00562159|3220306|P2|Overall Study|Adverse Event|8
978572|NCT00562159|3220307|P1|Overall Study|Adverse Event|11
978573|NCT00562120|3220319|P4|First Intervention Period|Randomized but not Treated|0
978574|NCT00562120|3220320|P3|First Intervention Period|Randomized but not Treated|0
978575|NCT00562120|3220321|P2|First Intervention Period|Randomized but not Treated|0
978576|NCT00562120|3220322|P1|First Intervention Period|Randomized but not Treated|1
978577|NCT00562120|3220319|P4|First Intervention Period|Adverse Event|0
978578|NCT00562120|3220320|P3|First Intervention Period|Adverse Event|0
978579|NCT00562120|3220321|P2|First Intervention Period|Adverse Event|0
978580|NCT00562120|3220322|P1|First Intervention Period|Adverse Event|1
978581|NCT00562094|3220354|P1|Overall Study|Lost to Follow-up|62
978582|NCT00561977|3220369|P3|Overall Study|Pregnancy|1
978583|NCT00561977|3220370|P2|Overall Study|Pregnancy|1
978584|NCT00561977|3220371|P1|Overall Study|Pregnancy|0
978585|NCT00561977|3220369|P3|Overall Study|Withdrawal by Subject|1
978586|NCT00561977|3220370|P2|Overall Study|Withdrawal by Subject|2
978587|NCT00561977|3220371|P1|Overall Study|Withdrawal by Subject|0
978588|NCT00561951|3220397|P3|Overall Study|Adverse Event Occured Before Treatment|1
978589|NCT00561951|3220398|P2|Overall Study|Adverse Event Occured Before Treatment|2
978590|NCT00561951|3220399|P1|Overall Study|Adverse Event Occured Before Treatment|1
978591|NCT00561951|3220397|P3|Overall Study|Meet Withdrawal Criterion|1
978592|NCT00561951|3220398|P2|Overall Study|Meet Withdrawal Criterion|1
978593|NCT00561951|3220399|P1|Overall Study|Meet Withdrawal Criterion|0
978594|NCT00561951|3220397|P3|Overall Study|Pregnancy|0
978595|NCT00561951|3220398|P2|Overall Study|Pregnancy|1
978596|NCT00561951|3220399|P1|Overall Study|Pregnancy|0
978597|NCT00561951|3220397|P3|Overall Study|Physician Decision|0
978598|NCT00561951|3220398|P2|Overall Study|Physician Decision|0
978599|NCT00561951|3220399|P1|Overall Study|Physician Decision|1
978600|NCT00561951|3220397|P3|Overall Study|Protocol Violation|4
978601|NCT00561951|3220398|P2|Overall Study|Protocol Violation|3
978602|NCT00561951|3220399|P1|Overall Study|Protocol Violation|4
978603|NCT00561951|3220397|P3|Overall Study|Withdrawal by Subject|10
978604|NCT00561951|3220398|P2|Overall Study|Withdrawal by Subject|9
978605|NCT00561951|3220399|P1|Overall Study|Withdrawal by Subject|10
978606|NCT00561951|3220397|P3|Overall Study|Lost to Follow-up|0
978607|NCT00561951|3220398|P2|Overall Study|Lost to Follow-up|1
978608|NCT00561951|3220399|P1|Overall Study|Lost to Follow-up|1
978609|NCT00561951|3220397|P3|Overall Study|Lack of Efficacy|2
978610|NCT00561951|3220398|P2|Overall Study|Lack of Efficacy|3
978611|NCT00561951|3220399|P1|Overall Study|Lack of Efficacy|5
978612|NCT00561951|3220397|P3|Overall Study|Adverse Event|14
978613|NCT00561951|3220398|P2|Overall Study|Adverse Event|14
978614|NCT00561951|3220399|P1|Overall Study|Adverse Event|11
978615|NCT00561925|3220455|P5|Open-Label Extension Period|Declined entry into extension period|50
978616|NCT00561925|3220456|P4|Open-Label Extension Period|Declined entry into extension period|43
978617|NCT00561925|3220457|P3|Open-Label Extension Period|Declined entry into extension period|0
978618|NCT00561925|3220458|P2|Open-Label Extension Period|Declined entry into extension period|0
978619|NCT00561925|3220459|P1|Open-Label Extension Period|Declined entry into extension period|0
978620|NCT00561925|3220455|P5|144-week Double-blind, Double-dummy|Other|0
978621|NCT00561925|3220456|P4|144-week Double-blind, Double-dummy|Other|0
978622|NCT00561925|3220457|P3|144-week Double-blind, Double-dummy|Other|11
978623|NCT00561925|3220458|P2|144-week Double-blind, Double-dummy|Other|8
978624|NCT00561925|3220459|P1|144-week Double-blind, Double-dummy|Other|0
978625|NCT00561925|3220455|P5|144-week Double-blind, Double-dummy|Not treated with study drug|0
978626|NCT00561925|3220456|P4|144-week Double-blind, Double-dummy|Not treated with study drug|0
978627|NCT00561925|3220457|P3|144-week Double-blind, Double-dummy|Not treated with study drug|0
978628|NCT00561925|3220458|P2|144-week Double-blind, Double-dummy|Not treated with study drug|2
978629|NCT00561925|3220459|P1|144-week Double-blind, Double-dummy|Not treated with study drug|0
978630|NCT00561925|3220455|P5|144-week Double-blind, Double-dummy|Death|0
978631|NCT00561925|3220456|P4|144-week Double-blind, Double-dummy|Death|0
978632|NCT00561925|3220457|P3|144-week Double-blind, Double-dummy|Death|3
978633|NCT00561925|3220458|P2|144-week Double-blind, Double-dummy|Death|6
978634|NCT00561925|3220459|P1|144-week Double-blind, Double-dummy|Death|0
978635|NCT00561925|3220455|P5|144-week Double-blind, Double-dummy|Pregnancy|0
978636|NCT00561925|3220456|P4|144-week Double-blind, Double-dummy|Pregnancy|0
978637|NCT00561925|3220457|P3|144-week Double-blind, Double-dummy|Pregnancy|9
978638|NCT00561925|3220458|P2|144-week Double-blind, Double-dummy|Pregnancy|1
978639|NCT00561925|3220459|P1|144-week Double-blind, Double-dummy|Pregnancy|0
978640|NCT00561925|3220455|P5|144-week Double-blind, Double-dummy|Lack of Efficacy|0
978641|NCT00561925|3220456|P4|144-week Double-blind, Double-dummy|Lack of Efficacy|0
978642|NCT00561925|3220457|P3|144-week Double-blind, Double-dummy|Lack of Efficacy|33
978643|NCT00561925|3220458|P2|144-week Double-blind, Double-dummy|Lack of Efficacy|36
978644|NCT00561925|3220459|P1|144-week Double-blind, Double-dummy|Lack of Efficacy|0
978645|NCT00561925|3220455|P5|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
978646|NCT00561925|3220456|P4|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
978647|NCT00561925|3220457|P3|144-week Double-blind, Double-dummy|Withdrawal by Subject|7
978648|NCT00561925|3220458|P2|144-week Double-blind, Double-dummy|Withdrawal by Subject|19
978649|NCT00561925|3220459|P1|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
978650|NCT00561925|3220455|P5|144-week Double-blind, Double-dummy|Lost to Follow-up|0
978651|NCT00561925|3220456|P4|144-week Double-blind, Double-dummy|Lost to Follow-up|0
978652|NCT00561925|3220457|P3|144-week Double-blind, Double-dummy|Lost to Follow-up|12
978653|NCT00561925|3220458|P2|144-week Double-blind, Double-dummy|Lost to Follow-up|15
978654|NCT00561925|3220459|P1|144-week Double-blind, Double-dummy|Lost to Follow-up|0
978655|NCT00561925|3220455|P5|144-week Double-blind, Double-dummy|Protocol Violation|0
978656|NCT00561925|3220456|P4|144-week Double-blind, Double-dummy|Protocol Violation|0
978657|NCT00561925|3220457|P3|144-week Double-blind, Double-dummy|Protocol Violation|9
978658|NCT00561925|3220458|P2|144-week Double-blind, Double-dummy|Protocol Violation|15
978659|NCT00561925|3220459|P1|144-week Double-blind, Double-dummy|Protocol Violation|0
978660|NCT00561925|3220455|P5|144-week Double-blind, Double-dummy|Adverse Event|0
978661|NCT00561925|3220456|P4|144-week Double-blind, Double-dummy|Adverse Event|0
978662|NCT00561925|3220457|P3|144-week Double-blind, Double-dummy|Adverse Event|43
978663|NCT00561925|3220458|P2|144-week Double-blind, Double-dummy|Adverse Event|48
978664|NCT00561925|3220459|P1|144-week Double-blind, Double-dummy|Adverse Event|0
978665|NCT00561925|3220455|P5|14 Day Lead-In Period|Other|0
978666|NCT00561925|3220456|P4|14 Day Lead-In Period|Other|0
978667|NCT00561925|3220457|P3|14 Day Lead-In Period|Other|0
978668|NCT00561925|3220458|P2|14 Day Lead-In Period|Other|0
978669|NCT00561925|3220459|P1|14 Day Lead-In Period|Other|5
978670|NCT00561925|3220455|P5|14 Day Lead-In Period|Withdrawal by Subject|0
978671|NCT00561925|3220456|P4|14 Day Lead-In Period|Withdrawal by Subject|0
978672|NCT00561925|3220457|P3|14 Day Lead-In Period|Withdrawal by Subject|0
978673|NCT00561925|3220458|P2|14 Day Lead-In Period|Withdrawal by Subject|0
978674|NCT00561925|3220459|P1|14 Day Lead-In Period|Withdrawal by Subject|4
978675|NCT00561925|3220455|P5|14 Day Lead-In Period|Lost to Follow-up|0
978676|NCT00561925|3220456|P4|14 Day Lead-In Period|Lost to Follow-up|0
978677|NCT00561925|3220457|P3|14 Day Lead-In Period|Lost to Follow-up|0
978678|NCT00561925|3220458|P2|14 Day Lead-In Period|Lost to Follow-up|0
978679|NCT00561925|3220459|P1|14 Day Lead-In Period|Lost to Follow-up|4
978680|NCT00561925|3220455|P5|14 Day Lead-In Period|In/Exclusion criteria|0
978681|NCT00561925|3220456|P4|14 Day Lead-In Period|In/Exclusion criteria|0
978682|NCT00561925|3220457|P3|14 Day Lead-In Period|In/Exclusion criteria|0
978683|NCT00561925|3220458|P2|14 Day Lead-In Period|In/Exclusion criteria|0
978684|NCT00561925|3220459|P1|14 Day Lead-In Period|In/Exclusion criteria|4
978685|NCT00561925|3220455|P5|14 Day Lead-In Period|Adverse Event|0
978686|NCT00561925|3220456|P4|14 Day Lead-In Period|Adverse Event|0
978687|NCT00561925|3220457|P3|14 Day Lead-In Period|Adverse Event|0
978688|NCT00561925|3220458|P2|14 Day Lead-In Period|Adverse Event|0
978689|NCT00561925|3220459|P1|14 Day Lead-In Period|Adverse Event|38
978690|NCT00561912|3220508|P1|Overall Study|ineligible|1
978691|NCT00561821|3220520|P4|Overall Study|Adverse Event|1
978692|NCT00561821|3220521|P3|Overall Study|Adverse Event|1
978693|NCT00561821|3220522|P2|Overall Study|Adverse Event|3
978694|NCT00561821|3220523|P1|Overall Study|Adverse Event|2
978695|NCT00561821|3220520|P4|Overall Study|Other (reason not specified)|0
978696|NCT00561821|3220521|P3|Overall Study|Other (reason not specified)|0
978697|NCT00561821|3220522|P2|Overall Study|Other (reason not specified)|1
978698|NCT00561821|3220523|P1|Overall Study|Other (reason not specified)|1
978699|NCT00561821|3220520|P4|Overall Study|Reasons not related to trial|0
978700|NCT00561821|3220521|P3|Overall Study|Reasons not related to trial|0
978701|NCT00561821|3220522|P2|Overall Study|Reasons not related to trial|1
978702|NCT00561821|3220523|P1|Overall Study|Reasons not related to trial|2
978703|NCT00561821|3220520|P4|Overall Study|Withdrawal by Subject|2
978704|NCT00561821|3220521|P3|Overall Study|Withdrawal by Subject|0
978705|NCT00561821|3220522|P2|Overall Study|Withdrawal by Subject|1
978706|NCT00561821|3220523|P1|Overall Study|Withdrawal by Subject|0
978707|NCT00561821|3220520|P4|Overall Study|Not treated|0
978708|NCT00561821|3220521|P3|Overall Study|Not treated|1
978709|NCT00561821|3220522|P2|Overall Study|Not treated|0
978710|NCT00561821|3220523|P1|Overall Study|Not treated|0
978711|NCT00561795|3220599|P4|Overall Study|Physician Decision|0
978712|NCT00561795|3220600|P3|Overall Study|Physician Decision|0
978713|NCT00561795|3220601|P2|Overall Study|Physician Decision|0
978714|NCT00561795|3220602|P1|Overall Study|Physician Decision|1
978715|NCT00561795|3220599|P4|Overall Study|Study Closed/Terminated|0
978716|NCT00561795|3220600|P3|Overall Study|Study Closed/Terminated|0
978717|NCT00561795|3220601|P2|Overall Study|Study Closed/Terminated|3
978718|NCT00561795|3220602|P1|Overall Study|Study Closed/Terminated|0
978719|NCT00561795|3220599|P4|Overall Study|Adverse Event|0
978720|NCT00561795|3220600|P3|Overall Study|Adverse Event|0
978721|NCT00561795|3220601|P2|Overall Study|Adverse Event|3
978722|NCT00561795|3220602|P1|Overall Study|Adverse Event|3
978723|NCT00561730|3220622|P1|Overall Study|Not specified reasons|1
978724|NCT00561730|3220622|P1|Overall Study|Lost to Follow-up|5
978725|NCT00561730|3220622|P1|Overall Study|Handling of the drug|1
978726|NCT00561730|3220622|P1|Overall Study|Adverse Event|2
978727|NCT00561678|3220638|P2|Overall Study|anesthesia provider refusal|0
978728|NCT00561678|3220639|P1|Overall Study|anesthesia provider refusal|1
978729|NCT00561678|3220638|P2|Overall Study|surgery rescheduled to different site|2
978730|NCT00561678|3220639|P1|Overall Study|surgery rescheduled to different site|2
978731|NCT00561678|3220638|P2|Overall Study|surgery cancelled|1
978732|NCT00561678|3220639|P1|Overall Study|surgery cancelled|1
978733|NCT00561678|3220638|P2|Overall Study|Withdrawal by Subject|3
978734|NCT00561678|3220639|P1|Overall Study|Withdrawal by Subject|4
978735|NCT00561652|3220657|P2|Overall Study|Withdrawal by Subject|1
978736|NCT00561652|3220658|P1|Overall Study|Withdrawal by Subject|0
978737|NCT00561574|3220741|P2|Overall Study|Other|7
978738|NCT00561574|3220742|P1|Overall Study|Other|5
978739|NCT00561574|3220741|P2|Overall Study|Lost to Follow-up|0
978740|NCT00561574|3220742|P1|Overall Study|Lost to Follow-up|1
978741|NCT00561574|3220741|P2|Overall Study|Reason Unrelated to Trial|2
978742|NCT00561574|3220742|P1|Overall Study|Reason Unrelated to Trial|6
978743|NCT00561574|3220741|P2|Overall Study|Withdrawal by Subject|4
978744|NCT00561574|3220742|P1|Overall Study|Withdrawal by Subject|4
978745|NCT00561574|3220741|P2|Overall Study|Lack of Efficacy|21
978746|NCT00561574|3220742|P1|Overall Study|Lack of Efficacy|11
978747|NCT00561574|3220741|P2|Overall Study|Adverse Event|24
978748|NCT00561574|3220742|P1|Overall Study|Adverse Event|21
978749|NCT00561470|3220768|P2|Overall Study|Ongoing Treatment|14
978750|NCT00561470|3220769|P1|Overall Study|Ongoing Treatment|11
978751|NCT00561470|3220768|P2|Overall Study|Planning surgery|1
978752|NCT00561470|3220769|P1|Overall Study|Planning surgery|1
978753|NCT00561470|3220768|P2|Overall Study|Missed visit window|4
978754|NCT00561470|3220769|P1|Overall Study|Missed visit window|1
978755|NCT00561470|3220768|P2|Overall Study|Randomized but not treated|5
978756|NCT00561470|3220769|P1|Overall Study|Randomized but not treated|5
978757|NCT00561470|3220768|P2|Overall Study|Unauthorized procedure|1
978758|NCT00561470|3220769|P1|Overall Study|Unauthorized procedure|3
978759|NCT00561470|3220768|P2|Overall Study|Metastatic surgery|12
978760|NCT00561470|3220769|P1|Overall Study|Metastatic surgery|10
978761|NCT00561470|3220768|P2|Overall Study|Subject request|77
978762|NCT00561470|3220769|P1|Overall Study|Subject request|43
978763|NCT00561470|3220768|P2|Overall Study|Consent Withdrawn|6
978764|NCT00561470|3220769|P1|Overall Study|Consent Withdrawn|2
978765|NCT00561470|3220768|P2|Overall Study|Physician Decision|20
978766|NCT00561470|3220769|P1|Overall Study|Physician Decision|21
978767|NCT00561470|3220768|P2|Overall Study|Lost to Follow-up|0
978768|NCT00561470|3220769|P1|Overall Study|Lost to Follow-up|2
978769|NCT00561470|3220768|P2|Overall Study|poor compliance to protocol|4
978770|NCT00561470|3220769|P1|Overall Study|poor compliance to protocol|4
978771|NCT00561470|3220768|P2|Overall Study|Disease progression|305
978772|NCT00561470|3220769|P1|Overall Study|Disease progression|437
978773|NCT00561470|3220768|P2|Overall Study|Adverse Event|163
978774|NCT00561470|3220769|P1|Overall Study|Adverse Event|74
978775|NCT00561392|3220805|P1|Overall Study|Administrative problems|4
978776|NCT00561392|3220805|P1|Overall Study|Withdrawal by Subject|8
978777|NCT00561392|3220805|P1|Overall Study|Protocol Violation|1
978778|NCT00561392|3220805|P1|Overall Study|Lack of Efficacy|2
978779|NCT00561392|3220805|P1|Overall Study|Adverse Event|38
978780|NCT00561353|3220827|P10|Overall Study|Withdrawal by Subject|0
978781|NCT00561353|3220828|P9|Overall Study|Withdrawal by Subject|0
978782|NCT00561353|3220829|P8|Overall Study|Withdrawal by Subject|0
978783|NCT00561353|3220830|P7|Overall Study|Withdrawal by Subject|0
978784|NCT00561353|3220831|P6|Overall Study|Withdrawal by Subject|0
978785|NCT00561353|3220832|P5|Overall Study|Withdrawal by Subject|0
978786|NCT00561353|3220833|P4|Overall Study|Withdrawal by Subject|0
978787|NCT00561353|3220834|P3|Overall Study|Withdrawal by Subject|0
978788|NCT00561353|3220835|P2|Overall Study|Withdrawal by Subject|2
978789|NCT00561353|3220836|P1|Overall Study|Withdrawal by Subject|0
978790|NCT00561353|3220827|P10|Overall Study|Lost to Follow-up|0
978791|NCT00561353|3220828|P9|Overall Study|Lost to Follow-up|0
978792|NCT00561353|3220829|P8|Overall Study|Lost to Follow-up|0
978793|NCT00561353|3220830|P7|Overall Study|Lost to Follow-up|0
978794|NCT00561353|3220831|P6|Overall Study|Lost to Follow-up|0
978795|NCT00561353|3220832|P5|Overall Study|Lost to Follow-up|0
978796|NCT00561353|3220833|P4|Overall Study|Lost to Follow-up|0
978797|NCT00561353|3220834|P3|Overall Study|Lost to Follow-up|1
978798|NCT00561353|3220835|P2|Overall Study|Lost to Follow-up|0
978799|NCT00561353|3220836|P1|Overall Study|Lost to Follow-up|2
978800|NCT00561353|3220827|P10|Overall Study|Adverse Event|1
978801|NCT00561353|3220828|P9|Overall Study|Adverse Event|0
978802|NCT00561353|3220829|P8|Overall Study|Adverse Event|0
978803|NCT00561353|3220830|P7|Overall Study|Adverse Event|1
978804|NCT00561353|3220831|P6|Overall Study|Adverse Event|0
978805|NCT00561353|3220832|P5|Overall Study|Adverse Event|0
978806|NCT00561353|3220833|P4|Overall Study|Adverse Event|2
978807|NCT00561353|3220834|P3|Overall Study|Adverse Event|0
978808|NCT00561353|3220835|P2|Overall Study|Adverse Event|0
978809|NCT00561353|3220836|P1|Overall Study|Adverse Event|0
978810|NCT00561353|3220827|P10|Overall Study|Not specified|0
978811|NCT00561353|3220828|P9|Overall Study|Not specified|0
978812|NCT00561353|3220829|P8|Overall Study|Not specified|0
978813|NCT00561353|3220830|P7|Overall Study|Not specified|0
978814|NCT00561353|3220831|P6|Overall Study|Not specified|2
978815|NCT00561353|3220832|P5|Overall Study|Not specified|0
978816|NCT00561353|3220833|P4|Overall Study|Not specified|0
978817|NCT00561353|3220834|P3|Overall Study|Not specified|1
978818|NCT00561353|3220835|P2|Overall Study|Not specified|0
978819|NCT00561353|3220836|P1|Overall Study|Not specified|1
978820|NCT00561353|3220827|P10|Overall Study|Subject ineligible to continue the trial|1
978821|NCT00561353|3220828|P9|Overall Study|Subject ineligible to continue the trial|2
978822|NCT00561353|3220829|P8|Overall Study|Subject ineligible to continue the trial|0
978823|NCT00561353|3220830|P7|Overall Study|Subject ineligible to continue the trial|1
978824|NCT00561353|3220831|P6|Overall Study|Subject ineligible to continue the trial|1
978825|NCT00561353|3220832|P5|Overall Study|Subject ineligible to continue the trial|0
978826|NCT00561353|3220833|P4|Overall Study|Subject ineligible to continue the trial|0
978827|NCT00561353|3220834|P3|Overall Study|Subject ineligible to continue the trial|0
978828|NCT00561353|3220835|P2|Overall Study|Subject ineligible to continue the trial|0
978829|NCT00561353|3220836|P1|Overall Study|Subject ineligible to continue the trial|0
978830|NCT00561353|3220827|P10|Overall Study|Subject reached a virologic endpoint|0
978831|NCT00561353|3220828|P9|Overall Study|Subject reached a virologic endpoint|5
978832|NCT00561353|3220829|P8|Overall Study|Subject reached a virologic endpoint|4
978833|NCT00561353|3220830|P7|Overall Study|Subject reached a virologic endpoint|4
978834|NCT00561353|3220831|P6|Overall Study|Subject reached a virologic endpoint|3
978835|NCT00561353|3220832|P5|Overall Study|Subject reached a virologic endpoint|1
978836|NCT00561353|3220833|P4|Overall Study|Subject reached a virologic endpoint|4
978837|NCT00561353|3220834|P3|Overall Study|Subject reached a virologic endpoint|1
978838|NCT00561353|3220835|P2|Overall Study|Subject reached a virologic endpoint|1
978839|NCT00561353|3220836|P1|Overall Study|Subject reached a virologic endpoint|2
978840|NCT00561340|3220991|P2|Overall Study|refused to drink pediasure|0
978841|NCT00561340|3220992|P1|Overall Study|refused to drink pediasure|6
978842|NCT00561080|3221012|P3|12-month Post Last Dose Follow-up|Lost to Follow-up|0
978843|NCT00561080|3221013|P2|12-month Post Last Dose Follow-up|Lost to Follow-up|0
978844|NCT00561080|3221014|P1|12-month Post Last Dose Follow-up|Lost to Follow-up|2
978845|NCT00561080|3221012|P3|12-month Post Last Dose Follow-up|Withdrawal by Subject|5
978846|NCT00561080|3221013|P2|12-month Post Last Dose Follow-up|Withdrawal by Subject|6
978847|NCT00561080|3221014|P1|12-month Post Last Dose Follow-up|Withdrawal by Subject|2
978848|NCT00561080|3221012|P3|12-month Post Last Dose Follow-up|Protocol Violation|4
978849|NCT00561080|3221013|P2|12-month Post Last Dose Follow-up|Protocol Violation|0
978850|NCT00561080|3221014|P1|12-month Post Last Dose Follow-up|Protocol Violation|0
978851|NCT00561080|3221012|P3|12-month Post Last Dose Follow-up|Adverse Event|1
978852|NCT00561080|3221013|P2|12-month Post Last Dose Follow-up|Adverse Event|3
978853|NCT00561080|3221014|P1|12-month Post Last Dose Follow-up|Adverse Event|3
978854|NCT00561080|3221012|P3|Vaccination Period (up to Month 4)|Other|1
978855|NCT00561080|3221013|P2|Vaccination Period (up to Month 4)|Other|2
978856|NCT00561080|3221014|P1|Vaccination Period (up to Month 4)|Other|0
978857|NCT00561080|3221012|P3|Vaccination Period (up to Month 4)|Lost to Follow-up|0
978858|NCT00561080|3221013|P2|Vaccination Period (up to Month 4)|Lost to Follow-up|1
978859|NCT00561080|3221014|P1|Vaccination Period (up to Month 4)|Lost to Follow-up|0
978860|NCT00561080|3221012|P3|Vaccination Period (up to Month 4)|Withdrawal by Subject|13
978861|NCT00561080|3221013|P2|Vaccination Period (up to Month 4)|Withdrawal by Subject|16
978862|NCT00561080|3221014|P1|Vaccination Period (up to Month 4)|Withdrawal by Subject|3
978863|NCT00561080|3221012|P3|Vaccination Period (up to Month 4)|Protocol Violation|3
978864|NCT00561080|3221013|P2|Vaccination Period (up to Month 4)|Protocol Violation|1
978865|NCT00561080|3221014|P1|Vaccination Period (up to Month 4)|Protocol Violation|0
978866|NCT00561080|3221012|P3|Vaccination Period (up to Month 4)|Definitive Contra-indication|3
978867|NCT00561080|3221013|P2|Vaccination Period (up to Month 4)|Definitive Contra-indication|2
978868|NCT00561080|3221014|P1|Vaccination Period (up to Month 4)|Definitive Contra-indication|0
978869|NCT00561080|3221012|P3|Vaccination Period (up to Month 4)|Adverse Event|6
978870|NCT00561080|3221013|P2|Vaccination Period (up to Month 4)|Adverse Event|4
978871|NCT00561080|3221014|P1|Vaccination Period (up to Month 4)|Adverse Event|0
978872|NCT00561015|3221091|P6|Overall Study|Participant non-compliance|0
978873|NCT00561015|3221092|P5|Overall Study|Participant non-compliance|0
978874|NCT00561015|3221093|P4|Overall Study|Participant non-compliance|0
978875|NCT00561015|3221094|P3|Overall Study|Participant non-compliance|0
978876|NCT00561015|3221095|P2|Overall Study|Participant non-compliance|0
978877|NCT00561015|3221096|P1|Overall Study|Participant non-compliance|2
978878|NCT00561015|3221091|P6|Overall Study|Lost to Follow-up|3
978879|NCT00561015|3221092|P5|Overall Study|Lost to Follow-up|0
978880|NCT00561015|3221093|P4|Overall Study|Lost to Follow-up|1
978881|NCT00561015|3221094|P3|Overall Study|Lost to Follow-up|0
978882|NCT00561015|3221095|P2|Overall Study|Lost to Follow-up|0
978883|NCT00561015|3221096|P1|Overall Study|Lost to Follow-up|2
978884|NCT00561015|3221091|P6|Overall Study|Adverse Event|0
978885|NCT00561015|3221092|P5|Overall Study|Adverse Event|1
978886|NCT00561015|3221093|P4|Overall Study|Adverse Event|0
978887|NCT00561015|3221094|P3|Overall Study|Adverse Event|0
978888|NCT00561015|3221095|P2|Overall Study|Adverse Event|0
978889|NCT00561015|3221096|P1|Overall Study|Adverse Event|0
978890|NCT00560950|3221187|P2|Overall Study|Lost to Follow-up|0
978891|NCT00560950|3221188|P1|Overall Study|Lost to Follow-up|1
978892|NCT00560937|3221226|P2|Overall Study|Physician Decision|1
978893|NCT00560937|3221227|P1|Overall Study|Physician Decision|1
978894|NCT00560937|3221226|P2|Overall Study|Withdrawal by Subject|1
978895|NCT00560937|3221227|P1|Overall Study|Withdrawal by Subject|0
978896|NCT00560885|3221243|P1|Overall Study|Withdrawal by Subject|1
978897|NCT00560885|3221243|P1|Overall Study|Death|7
978898|NCT00560833|3221268|P5|Overall Study|Never received drug|1
978899|NCT00560833|3221269|P4|Overall Study|Never received drug|0
978900|NCT00560833|3221270|P3|Overall Study|Never received drug|0
978901|NCT00560833|3221271|P2|Overall Study|Never received drug|1
978902|NCT00560833|3221272|P1|Overall Study|Never received drug|0
978903|NCT00560833|3221268|P5|Overall Study|Other|0
978904|NCT00560833|3221269|P4|Overall Study|Other|0
978905|NCT00560833|3221270|P3|Overall Study|Other|3
978906|NCT00560833|3221271|P2|Overall Study|Other|1
978907|NCT00560833|3221272|P1|Overall Study|Other|1
978908|NCT00560833|3221268|P5|Overall Study|Participant uncooperative|2
978909|NCT00560833|3221269|P4|Overall Study|Participant uncooperative|4
978910|NCT00560833|3221270|P3|Overall Study|Participant uncooperative|4
978911|NCT00560833|3221271|P2|Overall Study|Participant uncooperative|5
978912|NCT00560833|3221272|P1|Overall Study|Participant uncooperative|5
978913|NCT00560833|3221268|P5|Overall Study|Lack of Efficacy|4
978914|NCT00560833|3221269|P4|Overall Study|Lack of Efficacy|4
978915|NCT00560833|3221270|P3|Overall Study|Lack of Efficacy|6
978916|NCT00560833|3221271|P2|Overall Study|Lack of Efficacy|9
978917|NCT00560833|3221272|P1|Overall Study|Lack of Efficacy|22
978918|NCT00560833|3221268|P5|Overall Study|Lost to Follow-up|0
978919|NCT00560833|3221269|P4|Overall Study|Lost to Follow-up|0
978920|NCT00560833|3221270|P3|Overall Study|Lost to Follow-up|1
978921|NCT00560833|3221271|P2|Overall Study|Lost to Follow-up|0
978922|NCT00560833|3221272|P1|Overall Study|Lost to Follow-up|0
978923|NCT00560833|3221268|P5|Overall Study|Adverse Event|35
978924|NCT00560833|3221269|P4|Overall Study|Adverse Event|23
978925|NCT00560833|3221270|P3|Overall Study|Adverse Event|25
978926|NCT00560833|3221271|P2|Overall Study|Adverse Event|10
978927|NCT00560833|3221272|P1|Overall Study|Adverse Event|16
978928|NCT00560794|3221304|P1|Overall Study|Received Bone Marrow Transplant|6
978929|NCT00560794|3221304|P1|Overall Study|Hematological Relapse|1
978930|NCT00560794|3221304|P1|Overall Study|Minimal Residual Disease Relapse|1
978931|NCT00560794|3221304|P1|Overall Study|Patient was not Compliant|1
978932|NCT00560794|3221304|P1|Overall Study|Adverse Event|2
978933|NCT00560755|3221321|P1|Overall Study|Physician Decision|2
978934|NCT00560755|3221321|P1|Overall Study|Adverse Event|8
978935|NCT00560755|3221321|P1|Overall Study|Lost to Follow-up|9
978936|NCT00560755|3221321|P1|Overall Study|Withdrawal by Subject|26
978937|NCT00560755|3221321|P1|Overall Study|Protocol Violation|15
978938|NCT00560703|3221342|P2|Overall Study|non-compliance|1
978939|NCT00560703|3221343|P1|Overall Study|non-compliance|0
978940|NCT00560703|3221342|P2|Overall Study|Withdrawal by Subject|1
978941|NCT00560703|3221343|P1|Overall Study|Withdrawal by Subject|0
978942|NCT00560703|3221342|P2|Overall Study|Protocol Violation|2
978943|NCT00560703|3221343|P1|Overall Study|Protocol Violation|0
978944|NCT00560703|3221342|P2|Overall Study|Adverse Event|2
978945|NCT00560703|3221343|P1|Overall Study|Adverse Event|0
978946|NCT00560573|3221360|P6|Overall Study|Enrolled, not treated|0
978947|NCT00560573|3221361|P5|Overall Study|Enrolled, not treated|1
978948|NCT00560573|3221362|P4|Overall Study|Enrolled, not treated|0
978949|NCT00560573|3221363|P3|Overall Study|Enrolled, not treated|0
978950|NCT00560573|3221364|P2|Overall Study|Enrolled, not treated|0
978951|NCT00560573|3221365|P1|Overall Study|Enrolled, not treated|0
978952|NCT00560573|3221360|P6|Overall Study|Other|3
978953|NCT00560573|3221361|P5|Overall Study|Other|3
978954|NCT00560573|3221362|P4|Overall Study|Other|3
978955|NCT00560573|3221363|P3|Overall Study|Other|2
978956|NCT00560573|3221364|P2|Overall Study|Other|2
978957|NCT00560573|3221365|P1|Overall Study|Other|2
978958|NCT00560573|3221360|P6|Overall Study|Withdrawal by Subject|0
978959|NCT00560573|3221361|P5|Overall Study|Withdrawal by Subject|1
978960|NCT00560573|3221362|P4|Overall Study|Withdrawal by Subject|1
978961|NCT00560573|3221363|P3|Overall Study|Withdrawal by Subject|0
978962|NCT00560573|3221364|P2|Overall Study|Withdrawal by Subject|0
978963|NCT00560573|3221365|P1|Overall Study|Withdrawal by Subject|0
978964|NCT00560573|3221360|P6|Overall Study|Lost to Follow-up|0
978965|NCT00560573|3221361|P5|Overall Study|Lost to Follow-up|1
978966|NCT00560573|3221362|P4|Overall Study|Lost to Follow-up|1
978967|NCT00560573|3221363|P3|Overall Study|Lost to Follow-up|0
978968|NCT00560573|3221364|P2|Overall Study|Lost to Follow-up|0
978969|NCT00560573|3221365|P1|Overall Study|Lost to Follow-up|0
978970|NCT00560573|3221360|P6|Overall Study|Death|10
978971|NCT00560573|3221361|P5|Overall Study|Death|1
978972|NCT00560573|3221362|P4|Overall Study|Death|5
978973|NCT00560573|3221363|P3|Overall Study|Death|4
978974|NCT00560573|3221364|P2|Overall Study|Death|1
978975|NCT00560573|3221365|P1|Overall Study|Death|4
978976|NCT00560508|3221442|P2|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
978977|NCT00560508|3221443|P1|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
978978|NCT00560508|3221442|P2|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3
978979|NCT00560508|3221443|P1|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0
978980|NCT00560508|3221442|P2|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
978981|NCT00560508|3221443|P1|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
978982|NCT00560508|3221442|P2|52-week Open-label Period Pramipexole ER|Adverse Event|6
978983|NCT00560508|3221443|P1|52-week Open-label Period Pramipexole ER|Adverse Event|6
978984|NCT00560508|3221442|P2|12 Week Double-blind Period|Withdrawal by Subject|1
978985|NCT00560508|3221443|P1|12 Week Double-blind Period|Withdrawal by Subject|1
978986|NCT00560508|3221442|P2|12 Week Double-blind Period|Protocol Violation|0
978987|NCT00560508|3221443|P1|12 Week Double-blind Period|Protocol Violation|1
978988|NCT00560508|3221442|P2|12 Week Double-blind Period|Adverse Event|2
978989|NCT00560508|3221443|P1|12 Week Double-blind Period|Adverse Event|3
978990|NCT00560417|3221502|P2|Overall Study|Withdrawal by Subject|3
978991|NCT00560417|3221503|P1|Overall Study|Withdrawal by Subject|3
978992|NCT00560417|3221502|P2|Overall Study|Sponsor Decision|0
978993|NCT00560417|3221503|P1|Overall Study|Sponsor Decision|2
978994|NCT00560417|3221502|P2|Overall Study|Protocol Violation|5
978995|NCT00560417|3221503|P1|Overall Study|Protocol Violation|6
978996|NCT00560417|3221502|P2|Overall Study|Physician Decision|6
978997|NCT00560417|3221503|P1|Overall Study|Physician Decision|2
978998|NCT00560417|3221502|P2|Overall Study|Lost to Follow-up|1
978999|NCT00560417|3221503|P1|Overall Study|Lost to Follow-up|0
979000|NCT00560417|3221502|P2|Overall Study|Entry Criteria Not Met|0
979001|NCT00560417|3221503|P1|Overall Study|Entry Criteria Not Met|1
979002|NCT00560417|3221502|P2|Overall Study|Adverse Event|2
979003|NCT00560417|3221503|P1|Overall Study|Adverse Event|3
979004|NCT00560404|3221531|P2|Overall Study|Other withdrawal reason|5
979005|NCT00560404|3221532|P1|Overall Study|Other withdrawal reason|13
979006|NCT00560404|3221531|P2|Overall Study|Failure to return|2
979007|NCT00560404|3221532|P1|Overall Study|Failure to return|1
979008|NCT00560404|3221531|P2|Overall Study|Withdrew Consent|0
979009|NCT00560404|3221532|P1|Overall Study|Withdrew Consent|4
979010|NCT00560404|3221531|P2|Overall Study|Administrative Reasons|1
979011|NCT00560404|3221532|P1|Overall Study|Administrative Reasons|1
979012|NCT00560404|3221531|P2|Overall Study|Protocol Violation|7
979013|NCT00560404|3221532|P1|Overall Study|Protocol Violation|12
979014|NCT00560404|3221531|P2|Overall Study|Death|3
979015|NCT00560404|3221532|P1|Overall Study|Death|3
979016|NCT00560404|3221531|P2|Overall Study|Adverse Event|3
979017|NCT00560404|3221532|P1|Overall Study|Adverse Event|2
979018|NCT00560391|3221579|P5|Overall Study|Still on treatment|2
979019|NCT00560391|3221580|P4|Overall Study|Still on treatment|1
979020|NCT00560391|3221581|P3|Overall Study|Still on treatment|0
979021|NCT00560391|3221582|P2|Overall Study|Still on treatment|0
979022|NCT00560391|3221583|P1|Overall Study|Still on treatment|0
979023|NCT00560352|3221639|P3|Overall Study|Maximum clinical benefit|0
979024|NCT00560352|3221640|P2|Overall Study|Maximum clinical benefit|0
979025|NCT00560352|3221641|P1|Overall Study|Maximum clinical benefit|1
979026|NCT00560352|3221639|P3|Overall Study|Withdrawal by Subject|1
979027|NCT00560352|3221640|P2|Overall Study|Withdrawal by Subject|1
979028|NCT00560352|3221641|P1|Overall Study|Withdrawal by Subject|1
979029|NCT00560352|3221639|P3|Overall Study|Disease progression|1
979030|NCT00560352|3221640|P2|Overall Study|Disease progression|1
979031|NCT00560352|3221641|P1|Overall Study|Disease progression|0
979032|NCT00560352|3221639|P3|Overall Study|Study drug toxicity|1
979033|NCT00560352|3221640|P2|Overall Study|Study drug toxicity|0
979034|NCT00560352|3221641|P1|Overall Study|Study drug toxicity|3
979035|NCT00560352|3221639|P3|Overall Study|Adverse event unrelated to study drug|1
979036|NCT00560352|3221640|P2|Overall Study|Adverse event unrelated to study drug|1
979037|NCT00560352|3221641|P1|Overall Study|Adverse event unrelated to study drug|2
979038|NCT00560313|3221658|P1|Overall Study|Protocol Violation|1
979039|NCT00560313|3221658|P1|Overall Study|Lost to Follow-up|1
979040|NCT00560313|3221658|P1|Overall Study|Withdrawal by Subject|2
979041|NCT00560313|3221658|P1|Overall Study|Adverse Events or Death|2
979042|NCT00560235|3221685|P3|Phase 2|Ongoing at Date of Cut-Off|1
979043|NCT00560235|3221686|P2|Phase 2|Ongoing at Date of Cut-Off|0
979044|NCT00560235|3221687|P1|Phase 2|Ongoing at Date of Cut-Off|0
979045|NCT00560235|3221685|P3|Phase 2|Discontinued|96
979046|NCT00560235|3221686|P2|Phase 2|Discontinued|0
979047|NCT00560235|3221687|P1|Phase 2|Discontinued|0
979048|NCT00560235|3221685|P3|Phase 1B|Discontinued|0
979049|NCT00560235|3221686|P2|Phase 1B|Discontinued|19
979050|NCT00560235|3221687|P1|Phase 1B|Discontinued|0
979051|NCT00560235|3221685|P3|Phase 1|Discontinued|0
979052|NCT00560235|3221686|P2|Phase 1|Discontinued|0
979053|NCT00560235|3221687|P1|Phase 1|Discontinued|8
979054|NCT00560105|3221718|P2|Overall Study|musculoskeletal chest discomfort with us|2
979055|NCT00560105|3221719|P1|Overall Study|musculoskeletal chest discomfort with us|1
979056|NCT00560066|3221733|P2|Overall Study|Missing primary reason|2
979057|NCT00560066|3221734|P1|Overall Study|Missing primary reason|0
979058|NCT00560066|3221733|P2|Overall Study|Administrative reason|5
979059|NCT00560066|3221734|P1|Overall Study|Administrative reason|0
979060|NCT00560066|3221733|P2|Overall Study|Protocol Violation|1
979061|NCT00560066|3221734|P1|Overall Study|Protocol Violation|0
979062|NCT00560066|3221733|P2|Overall Study|Lost to Follow-up|10
979063|NCT00560066|3221734|P1|Overall Study|Lost to Follow-up|4
979064|NCT00560066|3221733|P2|Overall Study|Withdrawal by Subject|3
979065|NCT00560066|3221734|P1|Overall Study|Withdrawal by Subject|0
979066|NCT00560066|3221733|P2|Overall Study|Death|1
979067|NCT00560066|3221734|P1|Overall Study|Death|2
979068|NCT00559988|3221766|P2|Overall Study|ICD device explanted|17
979069|NCT00559988|3221767|P1|Overall Study|ICD device explanted|10
979070|NCT00559988|3221766|P2|Overall Study|Lost to Follow-up|56
979071|NCT00559988|3221767|P1|Overall Study|Lost to Follow-up|42
979072|NCT00559988|3221766|P2|Overall Study|Withdrawal by Subject|139
979073|NCT00559988|3221767|P1|Overall Study|Withdrawal by Subject|152
979074|NCT00559988|3221766|P2|Overall Study|Death|140
979075|NCT00559988|3221767|P1|Overall Study|Death|147
979076|NCT00559962|3221797|P8|Overall Study|Inclusion/exclusion criteria not met|0
979077|NCT00559962|3221798|P7|Overall Study|Inclusion/exclusion criteria not met|1
979078|NCT00559962|3221799|P6|Overall Study|Inclusion/exclusion criteria not met|0
979079|NCT00559962|3221800|P5|Overall Study|Inclusion/exclusion criteria not met|0
979080|NCT00559962|3221801|P4|Overall Study|Inclusion/exclusion criteria not met|0
979081|NCT00559962|3221802|P3|Overall Study|Inclusion/exclusion criteria not met|0
979082|NCT00559962|3221803|P2|Overall Study|Inclusion/exclusion criteria not met|0
979083|NCT00559962|3221804|P1|Overall Study|Inclusion/exclusion criteria not met|0
979084|NCT00559962|3221797|P8|Overall Study|Withdrawal by Subject|2
979085|NCT00559962|3221798|P7|Overall Study|Withdrawal by Subject|0
979086|NCT00559962|3221799|P6|Overall Study|Withdrawal by Subject|1
979087|NCT00559962|3221800|P5|Overall Study|Withdrawal by Subject|3
979088|NCT00559962|3221801|P4|Overall Study|Withdrawal by Subject|0
979089|NCT00559962|3221802|P3|Overall Study|Withdrawal by Subject|2
979090|NCT00559962|3221803|P2|Overall Study|Withdrawal by Subject|1
979091|NCT00559962|3221804|P1|Overall Study|Withdrawal by Subject|1
979092|NCT00559962|3221797|P8|Overall Study|Lost to Follow-up|0
979093|NCT00559962|3221798|P7|Overall Study|Lost to Follow-up|0
979094|NCT00559962|3221799|P6|Overall Study|Lost to Follow-up|0
979095|NCT00559962|3221800|P5|Overall Study|Lost to Follow-up|0
979096|NCT00559962|3221801|P4|Overall Study|Lost to Follow-up|0
979097|NCT00559962|3221802|P3|Overall Study|Lost to Follow-up|0
979098|NCT00559962|3221803|P2|Overall Study|Lost to Follow-up|1
979099|NCT00559962|3221804|P1|Overall Study|Lost to Follow-up|0
979100|NCT00559962|3221797|P8|Overall Study|Adverse Event|2
979101|NCT00559962|3221798|P7|Overall Study|Adverse Event|4
979102|NCT00559962|3221799|P6|Overall Study|Adverse Event|4
979103|NCT00559962|3221800|P5|Overall Study|Adverse Event|11
979104|NCT00559962|3221801|P4|Overall Study|Adverse Event|5
979105|NCT00559962|3221802|P3|Overall Study|Adverse Event|8
979106|NCT00559962|3221803|P2|Overall Study|Adverse Event|7
979107|NCT00559962|3221804|P1|Overall Study|Adverse Event|1
979108|NCT00559949|3221824|P1|Overall Study|No disease evaluation per protocol|1
979109|NCT00559949|3221824|P1|Overall Study|Withdrawal by Subject|4
979110|NCT00559949|3221824|P1|Overall Study|Adverse Event|1
979111|NCT00559949|3221824|P1|Overall Study|Progressive Disease during cycle 1|1
979112|NCT00559845|3221840|P1|Overall Study|Premature Surgery-Investigator Decision|1
979113|NCT00559845|3221840|P1|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1
979114|NCT00559845|3221840|P1|Overall Study|Adverse Event|3
979115|NCT00559845|3221840|P1|Overall Study|Disease Progression|1
979116|NCT00559845|3221840|P1|Overall Study|Withdrew Consent|1
979117|NCT00559754|3221849|P1|Overall Study|Withdrawal by Subject|2
979118|NCT00559754|3221849|P1|Overall Study|Investigator criteria|2
979119|NCT00559754|3221849|P1|Overall Study|Protocol Violation|1
979120|NCT00559754|3221849|P1|Overall Study|Adverse Event|5
979121|NCT00559754|3221849|P1|Overall Study|Disease progression|1
979122|NCT00559637|3221873|P1|Overall Study|Inclusion or exclusion criteria violated|2
979123|NCT00559637|3221873|P1|Overall Study|Change of home|1
979124|NCT00559637|3221873|P1|Overall Study|Change of center|1
979125|NCT00559637|3221873|P1|Overall Study|Delayed administration of C.E.R.A|1
979126|NCT00559637|3221873|P1|Overall Study|Participation in another study|1
979127|NCT00559637|3221873|P1|Overall Study|Suspected lung cancer|1
979128|NCT00559637|3221873|P1|Overall Study|Started requiring dialysis after month 7|2
979129|NCT00559637|3221873|P1|Overall Study|Insufficient response|3
979130|NCT00559637|3221873|P1|Overall Study|Failure to return|6
979131|NCT00559637|3221873|P1|Overall Study|Withdrawal criteria fulfilled|4
979132|NCT00559637|3221873|P1|Overall Study|Protocol Violation|6
979133|NCT00559637|3221873|P1|Overall Study|Withdrawal by Subject|4
979134|NCT00559637|3221873|P1|Overall Study|Adverse Event|22
979135|NCT00559585|3221886|P2|Open Label LT Period Main + Sub-Study|no end of study status page|0
979136|NCT00559585|3221887|P1|Open Label LT Period Main + Sub-Study|no end of study status page|1
979137|NCT00559585|3221886|P2|Open Label LT Period Main + Sub-Study|non-specified|0
979138|NCT00559585|3221887|P1|Open Label LT Period Main + Sub-Study|non-specified|71
979139|NCT00559585|3221886|P2|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0
979140|NCT00559585|3221887|P1|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8
979141|NCT00559585|3221886|P2|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0
979142|NCT00559585|3221887|P1|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89
979143|NCT00559585|3221886|P2|Open Label LT Period Main + Sub-Study|No longer met criteria|0
979144|NCT00559585|3221887|P1|Open Label LT Period Main + Sub-Study|No longer met criteria|1
979145|NCT00559585|3221886|P2|Open Label LT Period Main + Sub-Study|Death|0
979146|NCT00559585|3221887|P1|Open Label LT Period Main + Sub-Study|Death|20
979147|NCT00559585|3221886|P2|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0
979148|NCT00559585|3221887|P1|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9
979149|NCT00559585|3221886|P2|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0
979150|NCT00559585|3221887|P1|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32
979151|NCT00559585|3221886|P2|Open Label LT Period Main + Sub-Study|Pregnancy|0
979152|NCT00559585|3221887|P1|Open Label LT Period Main + Sub-Study|Pregnancy|16
979153|NCT00559585|3221886|P2|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0
979154|NCT00559585|3221887|P1|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81
979155|NCT00559585|3221886|P2|Open Label LT Period Main + Sub-Study|Adverse Event|0
979156|NCT00559585|3221887|P1|Open Label LT Period Main + Sub-Study|Adverse Event|100
979157|NCT00559585|3221886|P2|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
979158|NCT00559585|3221887|P1|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
979159|NCT00559585|3221886|P2|Double Blind ST Period Main Study|Ongoing Infection Risk|0
979160|NCT00559585|3221887|P1|Double Blind ST Period Main Study|Ongoing Infection Risk|1
979161|NCT00559585|3221886|P2|Double Blind ST Period Main Study|Investigator Decision|1
979162|NCT00559585|3221887|P1|Double Blind ST Period Main Study|Investigator Decision|0
979163|NCT00559585|3221886|P2|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1
979164|NCT00559585|3221887|P1|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0
979165|NCT00559585|3221886|P2|Double Blind ST Period Main Study|Participant Weight Gain|0
979166|NCT00559585|3221887|P1|Double Blind ST Period Main Study|Participant Weight Gain|1
979167|NCT00559585|3221886|P2|Double Blind ST Period Main Study|Early Discontinuation|1
979168|NCT00559585|3221887|P1|Double Blind ST Period Main Study|Early Discontinuation|0
979169|NCT00559585|3221886|P2|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1
979170|NCT00559585|3221887|P1|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0
979171|NCT00559585|3221886|P2|Double Blind ST Period Main Study|Incomplete Breast Exam|1
979172|NCT00559585|3221887|P1|Double Blind ST Period Main Study|Incomplete Breast Exam|0
979173|NCT00559585|3221886|P2|Double Blind ST Period Main Study|Missed Doses|1
979174|NCT00559585|3221887|P1|Double Blind ST Period Main Study|Missed Doses|0
979175|NCT00559585|3221886|P2|Double Blind ST Period Main Study|Poor/Non-Compliance|0
979176|NCT00559585|3221887|P1|Double Blind ST Period Main Study|Poor/Non-Compliance|3
979177|NCT00559585|3221886|P2|Double Blind ST Period Main Study|Lack of Efficacy|1
979178|NCT00559585|3221887|P1|Double Blind ST Period Main Study|Lack of Efficacy|6
979179|NCT00559585|3221886|P2|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1
979180|NCT00559585|3221887|P1|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2
979181|NCT00559585|3221886|P2|Double Blind ST Period Main Study|Death|1
979182|NCT00559585|3221887|P1|Double Blind ST Period Main Study|Death|1
979183|NCT00559585|3221886|P2|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0
979184|NCT00559585|3221887|P1|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1
979185|NCT00559585|3221886|P2|Double Blind ST Period Main Study|Lost to Follow-up|6
979186|NCT00559585|3221887|P1|Double Blind ST Period Main Study|Lost to Follow-up|0
979187|NCT00559585|3221886|P2|Double Blind ST Period Main Study|Withdrawal by Subject|5
979188|NCT00559585|3221887|P1|Double Blind ST Period Main Study|Withdrawal by Subject|11
979189|NCT00559585|3221886|P2|Double Blind ST Period Main Study|Adverse Event|25
979190|NCT00559585|3221887|P1|Double Blind ST Period Main Study|Adverse Event|17
979191|NCT00559507|3221947|P1|Overall Study|Not treated, patient ineligible|3
979192|NCT00559377|3221953|P1|Overall Study|Withdrawal by Subject|9
979193|NCT00559364|3221963|P2|Overall Study|Inclusion/exclusion criteria failure|0
979194|NCT00559364|3221964|P1|Overall Study|Inclusion/exclusion criteria failure|1
979195|NCT00559273|3221976|P2|Evaluation Period (8 Weeks)|Physician Decision|1
979196|NCT00559273|3221977|P1|Evaluation Period (8 Weeks)|Physician Decision|0
979197|NCT00559273|3221976|P2|Evaluation Period (8 Weeks)|Withdrawal by Subject|0
979198|NCT00559273|3221977|P1|Evaluation Period (8 Weeks)|Withdrawal by Subject|2
979199|NCT00559273|3221976|P2|Evaluation Period (8 Weeks)|Adverse Event|1
979200|NCT00559273|3221977|P1|Evaluation Period (8 Weeks)|Adverse Event|0
979201|NCT00559273|3221976|P2|Evaluation Period (8 Weeks)|Death|3
979202|NCT00559273|3221977|P1|Evaluation Period (8 Weeks)|Death|1
979203|NCT00559273|3221976|P2|Correction Period (20 Weeks)|Did not received study treatment|0
979204|NCT00559273|3221977|P1|Correction Period (20 Weeks)|Did not received study treatment|2
979205|NCT00559273|3221976|P2|Correction Period (20 Weeks)|Participant treated by another center|1
979206|NCT00559273|3221977|P1|Correction Period (20 Weeks)|Participant treated by another center|0
979207|NCT00559273|3221976|P2|Correction Period (20 Weeks)|Withdrawal by Subject|6
979208|NCT00559273|3221977|P1|Correction Period (20 Weeks)|Withdrawal by Subject|2
979209|NCT00559273|3221976|P2|Correction Period (20 Weeks)|Adverse Event|1
979210|NCT00559273|3221977|P1|Correction Period (20 Weeks)|Adverse Event|2
979211|NCT00559273|3221976|P2|Correction Period (20 Weeks)|Death|4
979212|NCT00559273|3221977|P1|Correction Period (20 Weeks)|Death|3
979213|NCT00559104|3221999|P2|Overall Study|Lack of Efficacy|0
979214|NCT00559104|3222000|P1|Overall Study|Lack of Efficacy|9
979215|NCT00558896|3222021|P7|Overall Study|Continues on treatment|6
979216|NCT00558896|3222022|P6|Overall Study|Continues on treatment|25
979217|NCT00558896|3222023|P5|Overall Study|Continues on treatment|9
979218|NCT00558896|3222024|P4|Overall Study|Continues on treatment|1
979219|NCT00558896|3222025|P3|Overall Study|Continues on treatment|0
979220|NCT00558896|3222026|P2|Overall Study|Continues on treatment|1
979221|NCT00558896|3222027|P1|Overall Study|Continues on treatment|10
979222|NCT00558896|3222021|P7|Overall Study|Physician discretion|3
979223|NCT00558896|3222022|P6|Overall Study|Physician discretion|3
979224|NCT00558896|3222023|P5|Overall Study|Physician discretion|1
979225|NCT00558896|3222024|P4|Overall Study|Physician discretion|2
979226|NCT00558896|3222025|P3|Overall Study|Physician discretion|1
979227|NCT00558896|3222026|P2|Overall Study|Physician discretion|2
979228|NCT00558896|3222027|P1|Overall Study|Physician discretion|3
979229|NCT00558896|3222021|P7|Overall Study|Alternative Treatment|1
979230|NCT00558896|3222022|P6|Overall Study|Alternative Treatment|7
979231|NCT00558896|3222023|P5|Overall Study|Alternative Treatment|6
979232|NCT00558896|3222024|P4|Overall Study|Alternative Treatment|2
979233|NCT00558896|3222025|P3|Overall Study|Alternative Treatment|0
979234|NCT00558896|3222026|P2|Overall Study|Alternative Treatment|2
979235|NCT00558896|3222027|P1|Overall Study|Alternative Treatment|2
979236|NCT00558896|3222021|P7|Overall Study|Withdrawal by Subject|5
979237|NCT00558896|3222022|P6|Overall Study|Withdrawal by Subject|5
979238|NCT00558896|3222023|P5|Overall Study|Withdrawal by Subject|1
979239|NCT00558896|3222024|P4|Overall Study|Withdrawal by Subject|1
979240|NCT00558896|3222025|P3|Overall Study|Withdrawal by Subject|1
979241|NCT00558896|3222026|P2|Overall Study|Withdrawal by Subject|1
979242|NCT00558896|3222027|P1|Overall Study|Withdrawal by Subject|2
979243|NCT00558896|3222021|P7|Overall Study|Death|6
979244|NCT00558896|3222022|P6|Overall Study|Death|2
979245|NCT00558896|3222023|P5|Overall Study|Death|2
979246|NCT00558896|3222024|P4|Overall Study|Death|3
979247|NCT00558896|3222025|P3|Overall Study|Death|2
979248|NCT00558896|3222026|P2|Overall Study|Death|0
979249|NCT00558896|3222027|P1|Overall Study|Death|3
979250|NCT00558896|3222021|P7|Overall Study|Adverse Event|3
979251|NCT00558896|3222022|P6|Overall Study|Adverse Event|10
979252|NCT00558896|3222023|P5|Overall Study|Adverse Event|4
979253|NCT00558896|3222024|P4|Overall Study|Adverse Event|3
979254|NCT00558896|3222025|P3|Overall Study|Adverse Event|1
979255|NCT00558896|3222026|P2|Overall Study|Adverse Event|1
979256|NCT00558896|3222027|P1|Overall Study|Adverse Event|1
979257|NCT00558831|3222068|P1|Overall Study|Lost to Follow-up|1
979258|NCT00558753|3222125|P2|Overall Study|Lost to Follow-up|7
979259|NCT00558753|3222126|P1|Overall Study|Lost to Follow-up|5
979260|NCT00558701|3222138|P2|Overall Study|Protocol Deviations|4
979261|NCT00558701|3222139|P1|Overall Study|Protocol Deviations|1
979262|NCT00558636|3222147|P2|Follow-up|Premature termination of the study|7
979263|NCT00558636|3222148|P1|Follow-up|Premature termination of the study|12
979264|NCT00558636|3222147|P2|Treatment|Disease progression|5
979265|NCT00558636|3222148|P1|Treatment|Disease progression|1
979266|NCT00558636|3222147|P2|Treatment|Premature termination of the study|37
979267|NCT00558636|3222148|P1|Treatment|Premature termination of the study|35
979268|NCT00558636|3222147|P2|Treatment|Withdrawal by Subject|0
979269|NCT00558636|3222148|P1|Treatment|Withdrawal by Subject|2
979270|NCT00558636|3222147|P2|Treatment|Adverse Event|2
979271|NCT00558636|3222148|P1|Treatment|Adverse Event|9
979272|NCT00558558|3222248|P1|Overall Study|Lack of Efficacy|4
979273|NCT00558558|3222248|P1|Overall Study|Withdrawal by Subject|1
979274|NCT00558558|3222248|P1|Overall Study|Unable to swallow|1
979275|NCT00558467|3222254|P2|Overall Study|Patient moving out of state|1
979276|NCT00558467|3222255|P1|Overall Study|Patient moving out of state|0
979277|NCT00558467|3222254|P2|Overall Study|Lack of Efficacy|1
979278|NCT00558467|3222255|P1|Overall Study|Lack of Efficacy|0
979279|NCT00558467|3222254|P2|Overall Study|Adverse Event|2
979280|NCT00558467|3222255|P1|Overall Study|Adverse Event|1
979281|NCT00558428|3222315|P4|Overall Study|Other|1
979282|NCT00558428|3222316|P3|Overall Study|Other|0
979283|NCT00558428|3222317|P2|Overall Study|Other|0
979284|NCT00558428|3222318|P1|Overall Study|Other|3
979285|NCT00558428|3222315|P4|Overall Study|Consent withdrawn|1
979286|NCT00558428|3222316|P3|Overall Study|Consent withdrawn|0
979287|NCT00558428|3222317|P2|Overall Study|Consent withdrawn|1
979288|NCT00558428|3222318|P1|Overall Study|Consent withdrawn|2
979289|NCT00558428|3222315|P4|Overall Study|Non compliant with protocol|3
979290|NCT00558428|3222316|P3|Overall Study|Non compliant with protocol|0
979291|NCT00558428|3222317|P2|Overall Study|Non compliant with protocol|0
979292|NCT00558428|3222318|P1|Overall Study|Non compliant with protocol|1
979293|NCT00558428|3222315|P4|Overall Study|Lack of Efficacy|2
979294|NCT00558428|3222316|P3|Overall Study|Lack of Efficacy|1
979295|NCT00558428|3222317|P2|Overall Study|Lack of Efficacy|0
979296|NCT00558428|3222318|P1|Overall Study|Lack of Efficacy|0
979297|NCT00558428|3222315|P4|Overall Study|Lost to Follow-up|0
979298|NCT00558428|3222316|P3|Overall Study|Lost to Follow-up|0
979299|NCT00558428|3222317|P2|Overall Study|Lost to Follow-up|1
979300|NCT00558428|3222318|P1|Overall Study|Lost to Follow-up|0
979301|NCT00558428|3222315|P4|Overall Study|Adverse Event|4
979302|NCT00558428|3222316|P3|Overall Study|Adverse Event|3
979303|NCT00558428|3222317|P2|Overall Study|Adverse Event|22
979304|NCT00558428|3222318|P1|Overall Study|Adverse Event|6
979305|NCT00558363|3222358|P2|Overall Study|Hospitalized; Unable to Continue|1
979306|NCT00558363|3222359|P1|Overall Study|Hospitalized; Unable to Continue|0
979307|NCT00558363|3222358|P2|Overall Study|Randomized in Error|2
979308|NCT00558363|3222359|P1|Overall Study|Randomized in Error|1
979309|NCT00558363|3222358|P2|Overall Study|Met Protocol-defined Stopping Criteria|16
979310|NCT00558363|3222359|P1|Overall Study|Met Protocol-defined Stopping Criteria|32
979311|NCT00558363|3222358|P2|Overall Study|Lost to Follow-up|1
979312|NCT00558363|3222359|P1|Overall Study|Lost to Follow-up|0
979313|NCT00558363|3222358|P2|Overall Study|Protocol Violation|1
979314|NCT00558363|3222359|P1|Overall Study|Protocol Violation|2
979315|NCT00558363|3222358|P2|Overall Study|Lack of Efficacy|2
979316|NCT00558363|3222359|P1|Overall Study|Lack of Efficacy|2
979317|NCT00558363|3222358|P2|Overall Study|Adverse Event|5
979318|NCT00558363|3222359|P1|Overall Study|Adverse Event|5
979319|NCT00558363|3222358|P2|Overall Study|Withdrawal by Subject|4
979320|NCT00558363|3222359|P1|Overall Study|Withdrawal by Subject|11
979321|NCT00558363|3222358|P2|Overall Study|Physician Decision|4
979322|NCT00558363|3222359|P1|Overall Study|Physician Decision|18
979323|NCT00558285|3222414|P5|Overall Study|Protocol deviation|0
979324|NCT00558285|3222415|P4|Overall Study|Protocol deviation|1
979325|NCT00558285|3222416|P3|Overall Study|Protocol deviation|0
979326|NCT00558285|3222417|P2|Overall Study|Protocol deviation|1
979327|NCT00558285|3222418|P1|Overall Study|Protocol deviation|1
979328|NCT00558285|3222414|P5|Overall Study|Administrative problems|1
979329|NCT00558285|3222415|P4|Overall Study|Administrative problems|1
979330|NCT00558285|3222416|P3|Overall Study|Administrative problems|0
979331|NCT00558285|3222417|P2|Overall Study|Administrative problems|0
979332|NCT00558285|3222418|P1|Overall Study|Administrative problems|0
979333|NCT00558285|3222414|P5|Overall Study|Lost to Follow-up|0
979334|NCT00558285|3222415|P4|Overall Study|Lost to Follow-up|0
979335|NCT00558285|3222416|P3|Overall Study|Lost to Follow-up|0
979336|NCT00558285|3222417|P2|Overall Study|Lost to Follow-up|1
979337|NCT00558285|3222418|P1|Overall Study|Lost to Follow-up|1
979338|NCT00558285|3222414|P5|Overall Study|Subject withdrew consent|1
979339|NCT00558285|3222415|P4|Overall Study|Subject withdrew consent|1
979340|NCT00558285|3222416|P3|Overall Study|Subject withdrew consent|1
979341|NCT00558285|3222417|P2|Overall Study|Subject withdrew consent|0
979342|NCT00558285|3222418|P1|Overall Study|Subject withdrew consent|2
979343|NCT00558285|3222414|P5|Overall Study|Abnormal test procedure result(s)|0
979344|NCT00558285|3222415|P4|Overall Study|Abnormal test procedure result(s)|0
979345|NCT00558285|3222416|P3|Overall Study|Abnormal test procedure result(s)|0
979346|NCT00558285|3222417|P2|Overall Study|Abnormal test procedure result(s)|0
979347|NCT00558285|3222418|P1|Overall Study|Abnormal test procedure result(s)|1
979348|NCT00558285|3222414|P5|Overall Study|Adverse Event|2
979349|NCT00558285|3222415|P4|Overall Study|Adverse Event|1
979350|NCT00558285|3222416|P3|Overall Study|Adverse Event|4
979351|NCT00558285|3222417|P2|Overall Study|Adverse Event|1
979352|NCT00558285|3222418|P1|Overall Study|Adverse Event|1
979353|NCT00558272|3222462|P2|Overall Study|Withdrawal by Subject|1
979354|NCT00558272|3222463|P1|Overall Study|Withdrawal by Subject|0
979355|NCT00558272|3222462|P2|Overall Study|Incorrectly enrolled|0
979356|NCT00558272|3222463|P1|Overall Study|Incorrectly enrolled|1
979357|NCT00558272|3222462|P2|Overall Study|AZ study team decision|1
979358|NCT00558272|3222463|P1|Overall Study|AZ study team decision|0
979359|NCT00558272|3222462|P2|Overall Study|Dev. of study specific discon. criteria|0
979360|NCT00558272|3222463|P1|Overall Study|Dev. of study specific discon. criteria|1
979361|NCT00558272|3222462|P2|Overall Study|Death|0
979362|NCT00558272|3222463|P1|Overall Study|Death|1
979363|NCT00558272|3222462|P2|Overall Study|Adverse Event|0
979364|NCT00558272|3222463|P1|Overall Study|Adverse Event|10
979365|NCT00558259|3222503|P2|Overall Study|Withdrawal by Subject|13
979366|NCT00558259|3222504|P1|Overall Study|Withdrawal by Subject|12
979367|NCT00558259|3222503|P2|Overall Study|Protocol Violation|5
979368|NCT00558259|3222504|P1|Overall Study|Protocol Violation|9
979369|NCT00558259|3222503|P2|Overall Study|Adverse Event|81
979370|NCT00558259|3222504|P1|Overall Study|Adverse Event|50
979371|NCT00558103|3222544|P6|Monotherapy Extension Phase|Disease Progression|8
979372|NCT00558103|3222545|P5|Monotherapy Extension Phase|Disease Progression|0
979373|NCT00558103|3222546|P4|Monotherapy Extension Phase|Disease Progression|0
979374|NCT00558103|3222547|P3|Monotherapy Extension Phase|Disease Progression|0
979375|NCT00558103|3222548|P2|Monotherapy Extension Phase|Disease Progression|0
979376|NCT00558103|3222549|P1|Monotherapy Extension Phase|Disease Progression|0
979377|NCT00558103|3222544|P6|Monotherapy Extension Phase|Protocol Violation|1
979378|NCT00558103|3222545|P5|Monotherapy Extension Phase|Protocol Violation|0
979379|NCT00558103|3222546|P4|Monotherapy Extension Phase|Protocol Violation|0
979380|NCT00558103|3222547|P3|Monotherapy Extension Phase|Protocol Violation|0
979381|NCT00558103|3222548|P2|Monotherapy Extension Phase|Protocol Violation|0
979382|NCT00558103|3222549|P1|Monotherapy Extension Phase|Protocol Violation|0
979383|NCT00558103|3222544|P6|Randomized Treatment Phase|Adverse Event|0
979384|NCT00558103|3222545|P5|Randomized Treatment Phase|Adverse Event|1
979385|NCT00558103|3222546|P4|Randomized Treatment Phase|Adverse Event|1
979386|NCT00558103|3222547|P3|Randomized Treatment Phase|Adverse Event|0
979387|NCT00558103|3222548|P2|Randomized Treatment Phase|Adverse Event|0
979388|NCT00558103|3222549|P1|Randomized Treatment Phase|Adverse Event|0
979389|NCT00558103|3222544|P6|Randomized Treatment Phase|Disease Progression|0
979390|NCT00558103|3222545|P5|Randomized Treatment Phase|Disease Progression|0
979391|NCT00558103|3222546|P4|Randomized Treatment Phase|Disease Progression|0
979392|NCT00558103|3222547|P3|Randomized Treatment Phase|Disease Progression|1
979393|NCT00558103|3222548|P2|Randomized Treatment Phase|Disease Progression|0
979394|NCT00558103|3222549|P1|Randomized Treatment Phase|Disease Progression|1
979395|NCT00558103|3222544|P6|Randomized Treatment Phase|Withdrawal by Subject|0
979396|NCT00558103|3222545|P5|Randomized Treatment Phase|Withdrawal by Subject|1
979397|NCT00558103|3222546|P4|Randomized Treatment Phase|Withdrawal by Subject|0
979398|NCT00558103|3222547|P3|Randomized Treatment Phase|Withdrawal by Subject|0
979399|NCT00558103|3222548|P2|Randomized Treatment Phase|Withdrawal by Subject|2
979400|NCT00558103|3222549|P1|Randomized Treatment Phase|Withdrawal by Subject|2
979401|NCT00558103|3222544|P6|Randomized Treatment Phase|Lost to Follow-up|0
979402|NCT00558103|3222545|P5|Randomized Treatment Phase|Lost to Follow-up|3
979403|NCT00558103|3222546|P4|Randomized Treatment Phase|Lost to Follow-up|1
979404|NCT00558103|3222547|P3|Randomized Treatment Phase|Lost to Follow-up|2
979405|NCT00558103|3222548|P2|Randomized Treatment Phase|Lost to Follow-up|2
979406|NCT00558103|3222549|P1|Randomized Treatment Phase|Lost to Follow-up|2
979407|NCT00558064|3222579|P2|Overall Study|No visit within allowance period|0
979408|NCT00558064|3222580|P1|Overall Study|No visit within allowance period|1
979409|NCT00558064|3222579|P2|Overall Study|Withdrawal by Subject|1
979410|NCT00558064|3222580|P1|Overall Study|Withdrawal by Subject|0
979411|NCT00558064|3222579|P2|Overall Study|Lost to Follow-up|1
979412|NCT00558064|3222580|P1|Overall Study|Lost to Follow-up|0
979413|NCT00558064|3222579|P2|Overall Study|Protocol Violation|0
979414|NCT00558064|3222580|P1|Overall Study|Protocol Violation|1
979415|NCT00558064|3222579|P2|Overall Study|Lack of Efficacy|1
979416|NCT00558064|3222580|P1|Overall Study|Lack of Efficacy|0
979417|NCT00558064|3222579|P2|Overall Study|Adverse Event|2
979418|NCT00558064|3222580|P1|Overall Study|Adverse Event|3
979419|NCT00558025|3222602|P2|Overall Study|Protocol Violation|0
979420|NCT00558025|3222603|P1|Overall Study|Protocol Violation|1
979421|NCT00558025|3222602|P2|Overall Study|Withdrawal by Subject|2
979422|NCT00558025|3222603|P1|Overall Study|Withdrawal by Subject|2
979423|NCT00558025|3222602|P2|Overall Study|Adverse Event|1
979424|NCT00558025|3222603|P1|Overall Study|Adverse Event|1
979425|NCT00557856|3222650|P9|Part 2: Exploratory Phase|global deterioration of health status|1
979426|NCT00557856|3222651|P8|Part 2: Exploratory Phase|global deterioration of health status|0
979427|NCT00557856|3222652|P7|Part 2: Exploratory Phase|global deterioration of health status|0
979428|NCT00557856|3222653|P6|Part 2: Exploratory Phase|global deterioration of health status|0
979429|NCT00557856|3222654|P5|Part 2: Exploratory Phase|global deterioration of health status|0
979430|NCT00557856|3222655|P4|Part 2: Exploratory Phase|global deterioration of health status|0
979431|NCT00557856|3222656|P3|Part 2: Exploratory Phase|global deterioration of health status|0
979432|NCT00557856|3222657|P2|Part 2: Exploratory Phase|global deterioration of health status|0
979433|NCT00557856|3222658|P1|Part 2: Exploratory Phase|global deterioration of health status|0
979434|NCT00557856|3222650|P9|Part 2: Exploratory Phase|Death|2
979435|NCT00557856|3222651|P8|Part 2: Exploratory Phase|Death|0
979436|NCT00557856|3222652|P7|Part 2: Exploratory Phase|Death|0
979437|NCT00557856|3222653|P6|Part 2: Exploratory Phase|Death|0
979438|NCT00557856|3222654|P5|Part 2: Exploratory Phase|Death|0
979439|NCT00557856|3222655|P4|Part 2: Exploratory Phase|Death|0
979440|NCT00557856|3222656|P3|Part 2: Exploratory Phase|Death|0
979441|NCT00557856|3222657|P2|Part 2: Exploratory Phase|Death|0
979442|NCT00557856|3222658|P1|Part 2: Exploratory Phase|Death|0
979443|NCT00557856|3222650|P9|Part 2: Exploratory Phase|Other|1
979444|NCT00557856|3222651|P8|Part 2: Exploratory Phase|Other|0
979445|NCT00557856|3222652|P7|Part 2: Exploratory Phase|Other|0
979446|NCT00557856|3222653|P6|Part 2: Exploratory Phase|Other|0
979447|NCT00557856|3222654|P5|Part 2: Exploratory Phase|Other|0
979448|NCT00557856|3222655|P4|Part 2: Exploratory Phase|Other|0
979449|NCT00557856|3222656|P3|Part 2: Exploratory Phase|Other|0
979450|NCT00557856|3222657|P2|Part 2: Exploratory Phase|Other|0
979451|NCT00557856|3222658|P1|Part 2: Exploratory Phase|Other|0
979452|NCT00557856|3222650|P9|Part 2: Exploratory Phase|Adverse Event|4
979453|NCT00557856|3222651|P8|Part 2: Exploratory Phase|Adverse Event|0
979454|NCT00557856|3222652|P7|Part 2: Exploratory Phase|Adverse Event|0
979455|NCT00557856|3222653|P6|Part 2: Exploratory Phase|Adverse Event|0
979456|NCT00557856|3222654|P5|Part 2: Exploratory Phase|Adverse Event|0
979457|NCT00557856|3222655|P4|Part 2: Exploratory Phase|Adverse Event|0
979458|NCT00557856|3222656|P3|Part 2: Exploratory Phase|Adverse Event|0
979459|NCT00557856|3222657|P2|Part 2: Exploratory Phase|Adverse Event|0
979460|NCT00557856|3222658|P1|Part 2: Exploratory Phase|Adverse Event|0
979461|NCT00557856|3222650|P9|Part 2: Exploratory Phase|Withdrawal by Subject|1
979462|NCT00557856|3222651|P8|Part 2: Exploratory Phase|Withdrawal by Subject|0
979463|NCT00557856|3222652|P7|Part 2: Exploratory Phase|Withdrawal by Subject|0
979464|NCT00557856|3222653|P6|Part 2: Exploratory Phase|Withdrawal by Subject|0
979465|NCT00557856|3222654|P5|Part 2: Exploratory Phase|Withdrawal by Subject|0
979466|NCT00557856|3222655|P4|Part 2: Exploratory Phase|Withdrawal by Subject|0
979467|NCT00557856|3222656|P3|Part 2: Exploratory Phase|Withdrawal by Subject|0
979468|NCT00557856|3222657|P2|Part 2: Exploratory Phase|Withdrawal by Subject|0
979469|NCT00557856|3222658|P1|Part 2: Exploratory Phase|Withdrawal by Subject|0
979470|NCT00557856|3222650|P9|Part 2: Exploratory Phase|objective progression or relapse|15
979471|NCT00557856|3222651|P8|Part 2: Exploratory Phase|objective progression or relapse|0
979472|NCT00557856|3222652|P7|Part 2: Exploratory Phase|objective progression or relapse|0
979473|NCT00557856|3222653|P6|Part 2: Exploratory Phase|objective progression or relapse|0
979474|NCT00557856|3222654|P5|Part 2: Exploratory Phase|objective progression or relapse|0
979475|NCT00557856|3222655|P4|Part 2: Exploratory Phase|objective progression or relapse|0
979476|NCT00557856|3222656|P3|Part 2: Exploratory Phase|objective progression or relapse|0
979477|NCT00557856|3222657|P2|Part 2: Exploratory Phase|objective progression or relapse|0
979478|NCT00557856|3222658|P1|Part 2: Exploratory Phase|objective progression or relapse|0
979479|NCT00557856|3222650|P9|Part 1: Dose Escalation Phase|randomized but not treated|0
979480|NCT00557856|3222651|P8|Part 1: Dose Escalation Phase|randomized but not treated|0
979481|NCT00557856|3222652|P7|Part 1: Dose Escalation Phase|randomized but not treated|0
979482|NCT00557856|3222653|P6|Part 1: Dose Escalation Phase|randomized but not treated|0
979483|NCT00557856|3222654|P5|Part 1: Dose Escalation Phase|randomized but not treated|0
979484|NCT00557856|3222655|P4|Part 1: Dose Escalation Phase|randomized but not treated|0
979485|NCT00557856|3222656|P3|Part 1: Dose Escalation Phase|randomized but not treated|0
979486|NCT00557856|3222657|P2|Part 1: Dose Escalation Phase|randomized but not treated|0
979487|NCT00557856|3222658|P1|Part 1: Dose Escalation Phase|randomized but not treated|2
979488|NCT00557856|3222650|P9|Part 1: Dose Escalation Phase|global deterioration of health status|0
979489|NCT00557856|3222651|P8|Part 1: Dose Escalation Phase|global deterioration of health status|0
979490|NCT00557856|3222652|P7|Part 1: Dose Escalation Phase|global deterioration of health status|1
979491|NCT00557856|3222653|P6|Part 1: Dose Escalation Phase|global deterioration of health status|2
979492|NCT00557856|3222654|P5|Part 1: Dose Escalation Phase|global deterioration of health status|0
979493|NCT00557856|3222655|P4|Part 1: Dose Escalation Phase|global deterioration of health status|0
979494|NCT00557856|3222656|P3|Part 1: Dose Escalation Phase|global deterioration of health status|0
979495|NCT00557856|3222657|P2|Part 1: Dose Escalation Phase|global deterioration of health status|0
979496|NCT00557856|3222658|P1|Part 1: Dose Escalation Phase|global deterioration of health status|0
979497|NCT00557856|3222650|P9|Part 1: Dose Escalation Phase|Death|0
979498|NCT00557856|3222651|P8|Part 1: Dose Escalation Phase|Death|0
979499|NCT00557856|3222652|P7|Part 1: Dose Escalation Phase|Death|0
979500|NCT00557856|3222653|P6|Part 1: Dose Escalation Phase|Death|1
979501|NCT00557856|3222654|P5|Part 1: Dose Escalation Phase|Death|0
979502|NCT00557856|3222655|P4|Part 1: Dose Escalation Phase|Death|0
979503|NCT00557856|3222656|P3|Part 1: Dose Escalation Phase|Death|0
979504|NCT00557856|3222657|P2|Part 1: Dose Escalation Phase|Death|0
979505|NCT00557856|3222658|P1|Part 1: Dose Escalation Phase|Death|0
979506|NCT00557856|3222650|P9|Part 1: Dose Escalation Phase|Other|0
979507|NCT00557856|3222651|P8|Part 1: Dose Escalation Phase|Other|1
979508|NCT00557856|3222652|P7|Part 1: Dose Escalation Phase|Other|0
979509|NCT00557856|3222653|P6|Part 1: Dose Escalation Phase|Other|0
979510|NCT00557856|3222654|P5|Part 1: Dose Escalation Phase|Other|0
979511|NCT00557856|3222655|P4|Part 1: Dose Escalation Phase|Other|1
979512|NCT00557856|3222656|P3|Part 1: Dose Escalation Phase|Other|1
979513|NCT00557856|3222657|P2|Part 1: Dose Escalation Phase|Other|0
979514|NCT00557856|3222658|P1|Part 1: Dose Escalation Phase|Other|0
979515|NCT00557856|3222650|P9|Part 1: Dose Escalation Phase|Adverse Event|0
979516|NCT00557856|3222651|P8|Part 1: Dose Escalation Phase|Adverse Event|2
979517|NCT00557856|3222652|P7|Part 1: Dose Escalation Phase|Adverse Event|1
979518|NCT00557856|3222653|P6|Part 1: Dose Escalation Phase|Adverse Event|3
979519|NCT00557856|3222654|P5|Part 1: Dose Escalation Phase|Adverse Event|1
979520|NCT00557856|3222655|P4|Part 1: Dose Escalation Phase|Adverse Event|1
979521|NCT00557856|3222656|P3|Part 1: Dose Escalation Phase|Adverse Event|1
979522|NCT00557856|3222657|P2|Part 1: Dose Escalation Phase|Adverse Event|0
979523|NCT00557856|3222658|P1|Part 1: Dose Escalation Phase|Adverse Event|1
979524|NCT00557856|3222650|P9|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
979525|NCT00557856|3222651|P8|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
979526|NCT00557856|3222652|P7|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
979527|NCT00557856|3222653|P6|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
979528|NCT00557856|3222654|P5|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
979529|NCT00557856|3222655|P4|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
979530|NCT00557856|3222656|P3|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
979531|NCT00557856|3222657|P2|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
979532|NCT00557856|3222658|P1|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
979533|NCT00557856|3222650|P9|Part 1: Dose Escalation Phase|objective progression or relapse|0
979534|NCT00557856|3222651|P8|Part 1: Dose Escalation Phase|objective progression or relapse|3
979535|NCT00557856|3222652|P7|Part 1: Dose Escalation Phase|objective progression or relapse|5
979536|NCT00557856|3222653|P6|Part 1: Dose Escalation Phase|objective progression or relapse|2
979537|NCT00557856|3222654|P5|Part 1: Dose Escalation Phase|objective progression or relapse|3
979538|NCT00557856|3222655|P4|Part 1: Dose Escalation Phase|objective progression or relapse|1
979539|NCT00557856|3222656|P3|Part 1: Dose Escalation Phase|objective progression or relapse|3
979540|NCT00557856|3222657|P2|Part 1: Dose Escalation Phase|objective progression or relapse|5
979541|NCT00557856|3222658|P1|Part 1: Dose Escalation Phase|objective progression or relapse|3
979542|NCT00557830|3222857|P3|Screening Treatment Phase|Unable to tolerate standard dose|0
979543|NCT00557830|3222858|P2|Screening Treatment Phase|Unable to tolerate standard dose|0
979544|NCT00557830|3222859|P1|Screening Treatment Phase|Unable to tolerate standard dose|3
979545|NCT00557830|3222857|P3|Screening Treatment Phase|Adverse Event|0
979546|NCT00557830|3222858|P2|Screening Treatment Phase|Adverse Event|0
979547|NCT00557830|3222859|P1|Screening Treatment Phase|Adverse Event|2
979548|NCT00557830|3222857|P3|Screening Treatment Phase|Withdrawal by Subject|0
979549|NCT00557830|3222858|P2|Screening Treatment Phase|Withdrawal by Subject|0
979550|NCT00557830|3222859|P1|Screening Treatment Phase|Withdrawal by Subject|1
979551|NCT00557622|3222881|P2|12-Week Treatment Phase|Lost to Follow-up|1
979552|NCT00557622|3222882|P1|12-Week Treatment Phase|Lost to Follow-up|0
979553|NCT00557622|3222881|P2|4-Week Run-in Phase|Protocol-defined stopping criteria|0
979554|NCT00557622|3222882|P1|4-Week Run-in Phase|Protocol-defined stopping criteria|1
979555|NCT00557622|3222881|P2|4-Week Run-in Phase|Withdrawal by Subject|0
979556|NCT00557622|3222882|P1|4-Week Run-in Phase|Withdrawal by Subject|1
979557|NCT00557505|3222911|P9|Overall Study|Withdrawal by Subject|1
979558|NCT00557505|3222912|P8|Overall Study|Withdrawal by Subject|0
979559|NCT00557505|3222913|P7|Overall Study|Withdrawal by Subject|0
979560|NCT00557505|3222914|P6|Overall Study|Withdrawal by Subject|0
979561|NCT00557505|3222915|P5|Overall Study|Withdrawal by Subject|0
979562|NCT00557505|3222916|P4|Overall Study|Withdrawal by Subject|1
979563|NCT00557505|3222917|P3|Overall Study|Withdrawal by Subject|0
979564|NCT00557505|3222918|P2|Overall Study|Withdrawal by Subject|0
979565|NCT00557505|3222919|P1|Overall Study|Withdrawal by Subject|0
979566|NCT00557505|3222911|P9|Overall Study|Objective progression or relapse|15
979567|NCT00557505|3222912|P8|Overall Study|Objective progression or relapse|5
979568|NCT00557505|3222913|P7|Overall Study|Objective progression or relapse|2
979569|NCT00557505|3222914|P6|Overall Study|Objective progression or relapse|3
979570|NCT00557505|3222915|P5|Overall Study|Objective progression or relapse|2
979571|NCT00557505|3222916|P4|Overall Study|Objective progression or relapse|2
979572|NCT00557505|3222917|P3|Overall Study|Objective progression or relapse|3
979573|NCT00557505|3222918|P2|Overall Study|Objective progression or relapse|3
979574|NCT00557505|3222919|P1|Overall Study|Objective progression or relapse|2
979575|NCT00557505|3222911|P9|Overall Study|Global deterioration of health|0
979576|NCT00557505|3222912|P8|Overall Study|Global deterioration of health|0
979577|NCT00557505|3222913|P7|Overall Study|Global deterioration of health|0
979578|NCT00557505|3222914|P6|Overall Study|Global deterioration of health|0
979579|NCT00557505|3222915|P5|Overall Study|Global deterioration of health|0
979580|NCT00557505|3222916|P4|Overall Study|Global deterioration of health|0
979581|NCT00557505|3222917|P3|Overall Study|Global deterioration of health|0
979582|NCT00557505|3222918|P2|Overall Study|Global deterioration of health|0
979583|NCT00557505|3222919|P1|Overall Study|Global deterioration of health|1
979584|NCT00557505|3222911|P9|Overall Study|Adverse Event|0
979585|NCT00557505|3222912|P8|Overall Study|Adverse Event|0
979586|NCT00557505|3222913|P7|Overall Study|Adverse Event|1
979587|NCT00557505|3222914|P6|Overall Study|Adverse Event|0
979588|NCT00557505|3222915|P5|Overall Study|Adverse Event|0
979589|NCT00557505|3222916|P4|Overall Study|Adverse Event|0
979590|NCT00557505|3222917|P3|Overall Study|Adverse Event|1
979591|NCT00557505|3222918|P2|Overall Study|Adverse Event|0
979592|NCT00557505|3222919|P1|Overall Study|Adverse Event|0
979593|NCT00557505|3222911|P9|Overall Study|Death|1
979594|NCT00557505|3222912|P8|Overall Study|Death|0
979595|NCT00557505|3222913|P7|Overall Study|Death|0
979596|NCT00557505|3222914|P6|Overall Study|Death|0
979597|NCT00557505|3222915|P5|Overall Study|Death|0
979598|NCT00557505|3222916|P4|Overall Study|Death|0
979599|NCT00557505|3222917|P3|Overall Study|Death|0
979600|NCT00557505|3222918|P2|Overall Study|Death|0
979601|NCT00557505|3222919|P1|Overall Study|Death|0
979602|NCT00557492|3223083|P1|Overall Study|Change in health insurance|1
979603|NCT00557466|3223101|P6|Overall Study|Lost to Follow-up|0
979604|NCT00557466|3223102|P5|Overall Study|Lost to Follow-up|0
979605|NCT00557466|3223103|P4|Overall Study|Lost to Follow-up|1
979606|NCT00557466|3223104|P3|Overall Study|Lost to Follow-up|0
979607|NCT00557466|3223105|P2|Overall Study|Lost to Follow-up|0
979608|NCT00557466|3223106|P1|Overall Study|Lost to Follow-up|0
979609|NCT00557466|3223101|P6|Overall Study|Abnormal test procedure results|0
979610|NCT00557466|3223102|P5|Overall Study|Abnormal test procedure results|0
979611|NCT00557466|3223103|P4|Overall Study|Abnormal test procedure results|0
979612|NCT00557466|3223104|P3|Overall Study|Abnormal test procedure results|1
979613|NCT00557466|3223105|P2|Overall Study|Abnormal test procedure results|0
979614|NCT00557466|3223106|P1|Overall Study|Abnormal test procedure results|0
979615|NCT00557466|3223101|P6|Overall Study|Administrative problems|0
979616|NCT00557466|3223102|P5|Overall Study|Administrative problems|0
979617|NCT00557466|3223103|P4|Overall Study|Administrative problems|0
979618|NCT00557466|3223104|P3|Overall Study|Administrative problems|1
979619|NCT00557466|3223105|P2|Overall Study|Administrative problems|1
979620|NCT00557466|3223106|P1|Overall Study|Administrative problems|0
979621|NCT00557466|3223101|P6|Overall Study|Subject withdrew consent|2
979622|NCT00557466|3223102|P5|Overall Study|Subject withdrew consent|1
979623|NCT00557466|3223103|P4|Overall Study|Subject withdrew consent|0
979624|NCT00557466|3223104|P3|Overall Study|Subject withdrew consent|0
979625|NCT00557466|3223105|P2|Overall Study|Subject withdrew consent|0
979626|NCT00557466|3223106|P1|Overall Study|Subject withdrew consent|0
979627|NCT00557466|3223101|P6|Overall Study|Protocol deviation|0
979628|NCT00557466|3223102|P5|Overall Study|Protocol deviation|0
979629|NCT00557466|3223103|P4|Overall Study|Protocol deviation|2
979630|NCT00557466|3223104|P3|Overall Study|Protocol deviation|0
979631|NCT00557466|3223105|P2|Overall Study|Protocol deviation|1
979632|NCT00557466|3223106|P1|Overall Study|Protocol deviation|0
979633|NCT00557466|3223101|P6|Overall Study|Abnormal laboratory value(s)|0
979634|NCT00557466|3223102|P5|Overall Study|Abnormal laboratory value(s)|0
979635|NCT00557466|3223103|P4|Overall Study|Abnormal laboratory value(s)|0
979636|NCT00557466|3223104|P3|Overall Study|Abnormal laboratory value(s)|0
979637|NCT00557466|3223105|P2|Overall Study|Abnormal laboratory value(s)|2
979638|NCT00557466|3223106|P1|Overall Study|Abnormal laboratory value(s)|1
979639|NCT00557466|3223101|P6|Overall Study|Adverse Event|4
979640|NCT00557466|3223102|P5|Overall Study|Adverse Event|2
979641|NCT00557466|3223103|P4|Overall Study|Adverse Event|1
979642|NCT00557466|3223104|P3|Overall Study|Adverse Event|4
979643|NCT00557466|3223105|P2|Overall Study|Adverse Event|1
979644|NCT00557466|3223106|P1|Overall Study|Adverse Event|3
979645|NCT00557440|3223159|P3|Treatment Period 1|Adverse Event|1
979646|NCT00557440|3223160|P2|Treatment Period 1|Adverse Event|0
979647|NCT00557440|3223161|P1|Treatment Period 1|Adverse Event|0
979648|NCT00557323|3223215|P1|Overall Study|Administrative change|2
979649|NCT00557323|3223215|P1|Overall Study|Withdrawal by Subject|2
979650|NCT00557323|3223215|P1|Overall Study|Death|3
979651|NCT00557310|3223220|P1|Extension Phase (18 - 24 Months)|Protocol Violation|1
979652|NCT00557310|3223220|P1|Extension Phase (18 - 24 Months)|Physician Decision|2
979653|NCT00557310|3223220|P1|Extension Phase (18 - 24 Months)|Lost to Follow-up|1
979654|NCT00557310|3223220|P1|Extension Phase (18 - 24 Months)|Adverse Event|1
979655|NCT00557310|3223220|P1|Main Study (0 - 18 Months)|Withdrawal by Subject|1
979656|NCT00557310|3223220|P1|Main Study (0 - 18 Months)|Adverse Event|4
979657|NCT00557245|3223266|P3|Overall Study|Ineligible|2
979658|NCT00557245|3223267|P2|Overall Study|Ineligible|4
979659|NCT00557245|3223268|P1|Overall Study|Ineligible|5
979660|NCT00557245|3223266|P3|Overall Study|Lost to Follow-up|10
979661|NCT00557245|3223267|P2|Overall Study|Lost to Follow-up|8
979662|NCT00557245|3223268|P1|Overall Study|Lost to Follow-up|7
979663|NCT00557076|3223308|P2|Overall Study|Unblinding|1
979664|NCT00557076|3223309|P1|Overall Study|Unblinding|0
979665|NCT00556998|3223317|P1|Voriconazole Oral|Intolerant of oral treatment|1
979666|NCT00556998|3223317|P1|Voriconazole Oral|Adverse Event|1
979667|NCT00556998|3223317|P1|Voriconazole Intravenous (IV)|Other|4
979668|NCT00556998|3223317|P1|Voriconazole Intravenous (IV)|Adverse Event|1
979669|NCT00556933|3223352|P4|CNI Withdrawal vs. Minimization|Death|1
979670|NCT00556933|3223353|P3|CNI Withdrawal vs. Minimization|Death|0
979671|NCT00556933|3223354|P2|CNI Withdrawal vs. Minimization|Death|0
979672|NCT00556933|3223355|P1|CNI Withdrawal vs. Minimization|Death|0
979673|NCT00556933|3223352|P4|CNI Withdrawal vs. Minimization|Graft loss|0
979674|NCT00556933|3223353|P3|CNI Withdrawal vs. Minimization|Graft loss|2
979675|NCT00556933|3223354|P2|CNI Withdrawal vs. Minimization|Graft loss|1
979676|NCT00556933|3223355|P1|CNI Withdrawal vs. Minimization|Graft loss|0
979677|NCT00556933|3223352|P4|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
979678|NCT00556933|3223353|P3|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
979679|NCT00556933|3223354|P2|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
979680|NCT00556933|3223355|P1|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
979681|NCT00556933|3223352|P4|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
979682|NCT00556933|3223353|P3|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
979683|NCT00556933|3223354|P2|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
979684|NCT00556933|3223355|P1|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
979685|NCT00556933|3223352|P4|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
979686|NCT00556933|3223353|P3|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
979687|NCT00556933|3223354|P2|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
979688|NCT00556933|3223355|P1|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
979689|NCT00556933|3223352|P4|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
979690|NCT00556933|3223353|P3|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
979691|NCT00556933|3223354|P2|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1
979692|NCT00556933|3223355|P1|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
979693|NCT00556933|3223352|P4|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
979694|NCT00556933|3223353|P3|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
979695|NCT00556933|3223354|P2|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1
979696|NCT00556933|3223355|P1|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
979697|NCT00556933|3223352|P4|Single vs. Divided-dose rATG Induction|Death|0
979698|NCT00556933|3223353|P3|Single vs. Divided-dose rATG Induction|Death|0
979699|NCT00556933|3223354|P2|Single vs. Divided-dose rATG Induction|Death|1
979700|NCT00556933|3223355|P1|Single vs. Divided-dose rATG Induction|Death|0
979701|NCT00556933|3223352|P4|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
979702|NCT00556933|3223353|P3|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
979703|NCT00556933|3223354|P2|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
979704|NCT00556933|3223355|P1|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0
979705|NCT00556933|3223352|P4|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
979706|NCT00556933|3223353|P3|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1
979707|NCT00556933|3223354|P2|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
979708|NCT00556933|3223355|P1|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
979709|NCT00556933|3223352|P4|Single vs. Divided-dose rATG Induction|Protocol Violation|0
979710|NCT00556933|3223353|P3|Single vs. Divided-dose rATG Induction|Protocol Violation|3
979711|NCT00556933|3223354|P2|Single vs. Divided-dose rATG Induction|Protocol Violation|3
979712|NCT00556933|3223355|P1|Single vs. Divided-dose rATG Induction|Protocol Violation|2
979713|NCT00556894|3223412|P3|Overall Study|Withdrawal by Subject|1
979714|NCT00556894|3223413|P2|Overall Study|Withdrawal by Subject|1
979715|NCT00556894|3223414|P1|Overall Study|Withdrawal by Subject|1
979716|NCT00556894|3223412|P3|Overall Study|Change in therapy|2
979717|NCT00556894|3223413|P2|Overall Study|Change in therapy|1
979718|NCT00556894|3223414|P1|Overall Study|Change in therapy|2
979719|NCT00556894|3223412|P3|Overall Study|regulatory decision in Bulgaria|13
979720|NCT00556894|3223413|P2|Overall Study|regulatory decision in Bulgaria|14
979721|NCT00556894|3223414|P1|Overall Study|regulatory decision in Bulgaria|10
979722|NCT00556894|3223412|P3|Overall Study|Death|0
979723|NCT00556894|3223413|P2|Overall Study|Death|0
979724|NCT00556894|3223414|P1|Overall Study|Death|1
979725|NCT00556894|3223412|P3|Overall Study|Adverse Event|3
979726|NCT00556894|3223413|P2|Overall Study|Adverse Event|3
979727|NCT00556894|3223414|P1|Overall Study|Adverse Event|2
979728|NCT00556712|3223424|P2|Overall Study|Ongoing at Data Cutoff|66
979729|NCT00556712|3223425|P1|Overall Study|Ongoing at Data Cutoff|32
979730|NCT00556712|3223424|P2|Overall Study|Not Specified|2
979731|NCT00556712|3223425|P1|Overall Study|Not Specified|2
979732|NCT00556712|3223424|P2|Overall Study|Failure to Return|3
979733|NCT00556712|3223425|P1|Overall Study|Failure to Return|2
979734|NCT00556712|3223424|P2|Overall Study|Refused Treatment|16
979735|NCT00556712|3223425|P1|Overall Study|Refused Treatment|17
979736|NCT00556712|3223424|P2|Overall Study|Protocol Violation|2
979737|NCT00556712|3223425|P1|Overall Study|Protocol Violation|3
979738|NCT00556712|3223424|P2|Overall Study|Progressive Disease|320
979739|NCT00556712|3223425|P1|Overall Study|Progressive Disease|383
979740|NCT00556712|3223424|P2|Overall Study|Death|10
979741|NCT00556712|3223425|P1|Overall Study|Death|5
979742|NCT00556712|3223424|P2|Overall Study|Adverse Event|19
979743|NCT00556712|3223425|P1|Overall Study|Adverse Event|7
979744|NCT00556673|3223503|P2|Overall Study|Protocol deviation|2
979745|NCT00556673|3223504|P1|Overall Study|Protocol deviation|3
979746|NCT00556439|3223640|P4|After Week 12 (Randomized Study Period)|Severe infection|0
979747|NCT00556439|3223641|P3|After Week 12 (Randomized Study Period)|Severe infection|0
979748|NCT00556439|3223642|P2|After Week 12 (Randomized Study Period)|Severe infection|0
979749|NCT00556439|3223643|P1|After Week 12 (Randomized Study Period)|Severe infection|1
979750|NCT00556439|3223640|P4|After Week 12 (Randomized Study Period)|Malignancy|1
979751|NCT00556439|3223641|P3|After Week 12 (Randomized Study Period)|Malignancy|0
979752|NCT00556439|3223642|P2|After Week 12 (Randomized Study Period)|Malignancy|1
979753|NCT00556439|3223643|P1|After Week 12 (Randomized Study Period)|Malignancy|0
979754|NCT00556439|3223640|P4|After Week 12 (Randomized Study Period)|Physician Decision|0
979755|NCT00556439|3223641|P3|After Week 12 (Randomized Study Period)|Physician Decision|0
979756|NCT00556439|3223642|P2|After Week 12 (Randomized Study Period)|Physician Decision|0
979757|NCT00556439|3223643|P1|After Week 12 (Randomized Study Period)|Physician Decision|1
979758|NCT00556439|3223640|P4|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
979759|NCT00556439|3223641|P3|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
979760|NCT00556439|3223642|P2|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3
979761|NCT00556439|3223643|P1|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1
979762|NCT00556439|3223640|P4|Study Entry to Week 12|Malignancy|0
979763|NCT00556439|3223641|P3|Study Entry to Week 12|Malignancy|1
979764|NCT00556439|3223642|P2|Study Entry to Week 12|Malignancy|0
979765|NCT00556439|3223643|P1|Study Entry to Week 12|Malignancy|0
979766|NCT00556439|3223640|P4|Study Entry to Week 12|Recurrent infection|0
979767|NCT00556439|3223641|P3|Study Entry to Week 12|Recurrent infection|0
979768|NCT00556439|3223642|P2|Study Entry to Week 12|Recurrent infection|0
979769|NCT00556439|3223643|P1|Study Entry to Week 12|Recurrent infection|1
979770|NCT00556439|3223640|P4|Study Entry to Week 12|Withdrawal by Subject|0
979771|NCT00556439|3223641|P3|Study Entry to Week 12|Withdrawal by Subject|1
979772|NCT00556439|3223642|P2|Study Entry to Week 12|Withdrawal by Subject|0
979773|NCT00556439|3223643|P1|Study Entry to Week 12|Withdrawal by Subject|1
979774|NCT00556439|3223640|P4|Study Entry to Week 12|Physician Decision|0
979775|NCT00556439|3223641|P3|Study Entry to Week 12|Physician Decision|0
979776|NCT00556439|3223642|P2|Study Entry to Week 12|Physician Decision|0
979777|NCT00556439|3223643|P1|Study Entry to Week 12|Physician Decision|1
979778|NCT00556439|3223640|P4|Study Entry to Week 12|Lack of Efficacy|0
979779|NCT00556439|3223641|P3|Study Entry to Week 12|Lack of Efficacy|6
979780|NCT00556439|3223642|P2|Study Entry to Week 12|Lack of Efficacy|0
979781|NCT00556439|3223643|P1|Study Entry to Week 12|Lack of Efficacy|5
979782|NCT00556426|3223653|P1|Overall Study|Death|6
979783|NCT00556426|3223653|P1|Overall Study|Withdrawal by Subject|3
979784|NCT00556374|3223675|P2|Overall Study|Lost to Follow-up|5
979785|NCT00556374|3223676|P1|Overall Study|Lost to Follow-up|7
979786|NCT00556374|3223675|P2|Overall Study|Death|43
979787|NCT00556374|3223676|P1|Overall Study|Death|50
979788|NCT00556374|3223675|P2|Overall Study|Withdrawal by Subject|172
979789|NCT00556374|3223676|P1|Overall Study|Withdrawal by Subject|190
979790|NCT00556322|3223694|P2|Overall Study|Death|14
979791|NCT00556322|3223695|P1|Overall Study|Death|20
979792|NCT00556322|3223694|P2|Overall Study|Ongoing at data cutoff|5
979793|NCT00556322|3223695|P1|Overall Study|Ongoing at data cutoff|3
979794|NCT00556322|3223694|P2|Overall Study|Protocol Violation|1
979795|NCT00556322|3223695|P1|Overall Study|Protocol Violation|5
979796|NCT00556322|3223694|P2|Overall Study|Withdrawal by Subject|7
979797|NCT00556322|3223695|P1|Overall Study|Withdrawal by Subject|19
979798|NCT00556322|3223694|P2|Overall Study|Lost to Follow-up|3
979799|NCT00556322|3223695|P1|Overall Study|Lost to Follow-up|5
979800|NCT00556322|3223694|P2|Overall Study|Other|1
979801|NCT00556322|3223695|P1|Overall Study|Other|4
979802|NCT00556322|3223694|P2|Overall Study|Adverse Event|4
979803|NCT00556322|3223695|P1|Overall Study|Adverse Event|7
979804|NCT00556322|3223694|P2|Overall Study|Insufficient therapeutic response|168
979805|NCT00556322|3223695|P1|Overall Study|Insufficient therapeutic response|158
979806|NCT00556166|3223743|P1|Overall Study|Withdrawal by Subject|1
979807|NCT00556075|3223756|P3|Overall Study|Endometrial stripe not viewed on 2 tvu|0
979808|NCT00556075|3223757|P2|Overall Study|Endometrial stripe not viewed on 2 tvu|1
979809|NCT00556075|3223758|P1|Overall Study|Endometrial stripe not viewed on 2 tvu|0
979810|NCT00556075|3223756|P3|Overall Study|Personal issues|0
979811|NCT00556075|3223757|P2|Overall Study|Personal issues|1
979812|NCT00556075|3223758|P1|Overall Study|Personal issues|4
979813|NCT00556075|3223756|P3|Overall Study|Adverse Event|0
979814|NCT00556075|3223757|P2|Overall Study|Adverse Event|2
979815|NCT00556075|3223758|P1|Overall Study|Adverse Event|1
979816|NCT00556075|3223756|P3|Overall Study|Not eligible|2
979817|NCT00556075|3223757|P2|Overall Study|Not eligible|1
979818|NCT00556075|3223758|P1|Overall Study|Not eligible|1
979819|NCT00556075|3223756|P3|Overall Study|Protocol Violation|3
979820|NCT00556075|3223757|P2|Overall Study|Protocol Violation|1
979821|NCT00556075|3223758|P1|Overall Study|Protocol Violation|1
979822|NCT00556075|3223756|P3|Overall Study|Withdrawal by Subject|0
979823|NCT00556075|3223757|P2|Overall Study|Withdrawal by Subject|3
979824|NCT00556075|3223758|P1|Overall Study|Withdrawal by Subject|3
979825|NCT00556075|3223756|P3|Overall Study|Lost to Follow-up|3
979826|NCT00556075|3223757|P2|Overall Study|Lost to Follow-up|0
979827|NCT00556075|3223758|P1|Overall Study|Lost to Follow-up|3
979828|NCT00555906|3223810|P5|Phase 2|Randomized but not Treated|2
979829|NCT00555906|3223811|P4|Phase 2|Randomized but not Treated|0
979830|NCT00555906|3223812|P3|Phase 2|Randomized but not Treated|0
979831|NCT00555906|3223813|P2|Phase 2|Randomized but not Treated|0
979832|NCT00555906|3223814|P1|Phase 2|Randomized but not Treated|0
979833|NCT00555906|3223810|P5|Phase 2|Other|6
979834|NCT00555906|3223811|P4|Phase 2|Other|0
979835|NCT00555906|3223812|P3|Phase 2|Other|0
979836|NCT00555906|3223813|P2|Phase 2|Other|0
979837|NCT00555906|3223814|P1|Phase 2|Other|0
979838|NCT00555906|3223810|P5|Phase 2|Withdrawal by Subject|2
979839|NCT00555906|3223811|P4|Phase 2|Withdrawal by Subject|0
979840|NCT00555906|3223812|P3|Phase 2|Withdrawal by Subject|0
979841|NCT00555906|3223813|P2|Phase 2|Withdrawal by Subject|0
979842|NCT00555906|3223814|P1|Phase 2|Withdrawal by Subject|0
979843|NCT00555906|3223810|P5|Phase 2|Objective Progression or Relapse|16
979844|NCT00555906|3223811|P4|Phase 2|Objective Progression or Relapse|0
979845|NCT00555906|3223812|P3|Phase 2|Objective Progression or Relapse|0
979846|NCT00555906|3223813|P2|Phase 2|Objective Progression or Relapse|0
979847|NCT00555906|3223814|P1|Phase 2|Objective Progression or Relapse|0
979848|NCT00555906|3223810|P5|Phase 2|Global Deterioration of Health Status|2
979849|NCT00555906|3223811|P4|Phase 2|Global Deterioration of Health Status|0
979850|NCT00555906|3223812|P3|Phase 2|Global Deterioration of Health Status|0
979851|NCT00555906|3223813|P2|Phase 2|Global Deterioration of Health Status|0
979852|NCT00555906|3223814|P1|Phase 2|Global Deterioration of Health Status|0
979853|NCT00555906|3223810|P5|Phase 2|Adverse Event|4
979854|NCT00555906|3223811|P4|Phase 2|Adverse Event|0
979855|NCT00555906|3223812|P3|Phase 2|Adverse Event|0
979856|NCT00555906|3223813|P2|Phase 2|Adverse Event|0
979857|NCT00555906|3223814|P1|Phase 2|Adverse Event|0
979858|NCT00555906|3223810|P5|Phase 1|Withdrawal by Subject|0
979859|NCT00555906|3223811|P4|Phase 1|Withdrawal by Subject|1
979860|NCT00555906|3223812|P3|Phase 1|Withdrawal by Subject|0
979861|NCT00555906|3223813|P2|Phase 1|Withdrawal by Subject|0
979862|NCT00555906|3223814|P1|Phase 1|Withdrawal by Subject|0
979863|NCT00555906|3223810|P5|Phase 1|Adverse Event|0
979864|NCT00555906|3223811|P4|Phase 1|Adverse Event|2
979865|NCT00555906|3223812|P3|Phase 1|Adverse Event|3
979866|NCT00555906|3223813|P2|Phase 1|Adverse Event|0
979867|NCT00555906|3223814|P1|Phase 1|Adverse Event|0
979868|NCT00555906|3223810|P5|Phase 1|Global Deterioration of Health Status|0
979869|NCT00555906|3223811|P4|Phase 1|Global Deterioration of Health Status|1
979870|NCT00555906|3223812|P3|Phase 1|Global Deterioration of Health Status|1
979871|NCT00555906|3223813|P2|Phase 1|Global Deterioration of Health Status|1
979872|NCT00555906|3223814|P1|Phase 1|Global Deterioration of Health Status|0
979873|NCT00555906|3223810|P5|Phase 1|Objective Progression or Relapse|0
979874|NCT00555906|3223811|P4|Phase 1|Objective Progression or Relapse|1
979875|NCT00555906|3223812|P3|Phase 1|Objective Progression or Relapse|3
979876|NCT00555906|3223813|P2|Phase 1|Objective Progression or Relapse|5
979877|NCT00555906|3223814|P1|Phase 1|Objective Progression or Relapse|3
979878|NCT00555672|3223936|P2|Overall Study|Participant refused|0
979879|NCT00555672|3223937|P1|Overall Study|Participant refused|2
979880|NCT00555672|3223936|P2|Overall Study|Other|1
979881|NCT00555672|3223937|P1|Overall Study|Other|3
979882|NCT00555672|3223936|P2|Overall Study|Objective progression or relapse|5
979883|NCT00555672|3223937|P1|Overall Study|Objective progression or relapse|11
979884|NCT00555672|3223936|P2|Overall Study|Adverse Event|2
979885|NCT00555672|3223937|P1|Overall Study|Adverse Event|8
979886|NCT00555672|3223936|P2|Overall Study|Death|2
979887|NCT00555672|3223937|P1|Overall Study|Death|0
979888|NCT00555620|3223962|P6|Overall Study|Not specified|3
979889|NCT00555620|3223963|P5|Overall Study|Not specified|0
979890|NCT00555620|3223964|P4|Overall Study|Not specified|1
979891|NCT00555620|3223965|P3|Overall Study|Not specified|0
979892|NCT00555620|3223966|P2|Overall Study|Not specified|0
979893|NCT00555620|3223967|P1|Overall Study|Not specified|0
979894|NCT00555620|3223962|P6|Overall Study|Participant refused treatment|1
979895|NCT00555620|3223963|P5|Overall Study|Participant refused treatment|0
979896|NCT00555620|3223964|P4|Overall Study|Participant refused treatment|0
979897|NCT00555620|3223965|P3|Overall Study|Participant refused treatment|1
979898|NCT00555620|3223966|P2|Overall Study|Participant refused treatment|1
979899|NCT00555620|3223967|P1|Overall Study|Participant refused treatment|0
979900|NCT00555620|3223962|P6|Overall Study|Objective progression or relapse|16
979901|NCT00555620|3223963|P5|Overall Study|Objective progression or relapse|3
979902|NCT00555620|3223964|P4|Overall Study|Objective progression or relapse|17
979903|NCT00555620|3223965|P3|Overall Study|Objective progression or relapse|12
979904|NCT00555620|3223966|P2|Overall Study|Objective progression or relapse|5
979905|NCT00555620|3223967|P1|Overall Study|Objective progression or relapse|6
979906|NCT00555620|3223962|P6|Overall Study|Adverse Event|1
979907|NCT00555620|3223963|P5|Overall Study|Adverse Event|0
979908|NCT00555620|3223964|P4|Overall Study|Adverse Event|5
979909|NCT00555620|3223965|P3|Overall Study|Adverse Event|1
979910|NCT00555620|3223966|P2|Overall Study|Adverse Event|0
979911|NCT00555620|3223967|P1|Overall Study|Adverse Event|0
979912|NCT00555620|3223962|P6|Overall Study|Study terminated by sponsor|0
979913|NCT00555620|3223963|P5|Overall Study|Study terminated by sponsor|0
979914|NCT00555620|3223964|P4|Overall Study|Study terminated by sponsor|0
979915|NCT00555620|3223965|P3|Overall Study|Study terminated by sponsor|1
979916|NCT00555620|3223966|P2|Overall Study|Study terminated by sponsor|0
979917|NCT00555620|3223967|P1|Overall Study|Study terminated by sponsor|0
979918|NCT00555620|3223962|P6|Overall Study|Death|1
979919|NCT00555620|3223963|P5|Overall Study|Death|0
979920|NCT00555620|3223964|P4|Overall Study|Death|0
979921|NCT00555620|3223965|P3|Overall Study|Death|0
979922|NCT00555620|3223966|P2|Overall Study|Death|1
979923|NCT00555620|3223967|P1|Overall Study|Death|0
979924|NCT00555568|3224091|P3|Overall Study|Lost to Follow-up|16
979925|NCT00555568|3224092|P2|Overall Study|Lost to Follow-up|16
979926|NCT00555568|3224093|P1|Overall Study|Lost to Follow-up|26
979927|NCT00555477|3224115|P2|Overall Study|Physician Decision|2
979928|NCT00555477|3224116|P1|Overall Study|Physician Decision|1
979929|NCT00555477|3224115|P2|Overall Study|Withdrawal by Subject|2
979930|NCT00555477|3224116|P1|Overall Study|Withdrawal by Subject|1
979931|NCT00555477|3224115|P2|Overall Study|Adverse Event|9
979932|NCT00555477|3224116|P1|Overall Study|Adverse Event|0
979933|NCT00555438|3224132|P1|Between 10 Days and 30 Days Postoperativ|Death|5
979934|NCT00555438|3224132|P1|10 Days Post-operative|Death|4
979935|NCT00555425|3224142|P2|Overall Study|Became pregnant and transferred care|1
979936|NCT00555425|3224143|P1|Overall Study|Became pregnant and transferred care|0
979937|NCT00555425|3224142|P2|Overall Study|Met criteria for protective transfer|3
979938|NCT00555425|3224143|P1|Overall Study|Met criteria for protective transfer|16
979939|NCT00555425|3224142|P2|Overall Study|Missed 3 physician management visits|0
979940|NCT00555425|3224143|P1|Overall Study|Missed 3 physician management visits|1
979941|NCT00555425|3224142|P2|Overall Study|Missed Medication > 1 wk|15
979942|NCT00555425|3224143|P1|Overall Study|Missed Medication > 1 wk|34
979943|NCT00555321|3224179|P5|Long-term Extension Phase|Other Reason|0
979944|NCT00555321|3224180|P4|Long-term Extension Phase|Other Reason|0
979945|NCT00555321|3224181|P3|Long-term Extension Phase|Other Reason|2
979946|NCT00555321|3224182|P2|Long-term Extension Phase|Other Reason|0
979947|NCT00555321|3224183|P1|Long-term Extension Phase|Other Reason|1
979948|NCT00555321|3224179|P5|Long-term Extension Phase|Participant did not meet study criteria|1
979949|NCT00555321|3224180|P4|Long-term Extension Phase|Participant did not meet study criteria|0
979950|NCT00555321|3224181|P3|Long-term Extension Phase|Participant did not meet study criteria|0
979951|NCT00555321|3224182|P2|Long-term Extension Phase|Participant did not meet study criteria|0
979952|NCT00555321|3224183|P1|Long-term Extension Phase|Participant did not meet study criteria|0
979953|NCT00555321|3224179|P5|Long-term Extension Phase|Death|0
979954|NCT00555321|3224180|P4|Long-term Extension Phase|Death|3
979955|NCT00555321|3224181|P3|Long-term Extension Phase|Death|0
979956|NCT00555321|3224182|P2|Long-term Extension Phase|Death|0
979957|NCT00555321|3224183|P1|Long-term Extension Phase|Death|2
979958|NCT00555321|3224179|P5|Long-term Extension Phase|Administrative reason by sponsor|23
979959|NCT00555321|3224180|P4|Long-term Extension Phase|Administrative reason by sponsor|31
979960|NCT00555321|3224181|P3|Long-term Extension Phase|Administrative reason by sponsor|18
979961|NCT00555321|3224182|P2|Long-term Extension Phase|Administrative reason by sponsor|21
979962|NCT00555321|3224183|P1|Long-term Extension Phase|Administrative reason by sponsor|23
979963|NCT00555321|3224179|P5|Long-term Extension Phase|Withdrawal by Subject|2
979964|NCT00555321|3224180|P4|Long-term Extension Phase|Withdrawal by Subject|3
979965|NCT00555321|3224181|P3|Long-term Extension Phase|Withdrawal by Subject|2
979966|NCT00555321|3224182|P2|Long-term Extension Phase|Withdrawal by Subject|1
979967|NCT00555321|3224183|P1|Long-term Extension Phase|Withdrawal by Subject|2
979968|NCT00555321|3224179|P5|Long-term Extension Phase|Adverse Event|0
979969|NCT00555321|3224180|P4|Long-term Extension Phase|Adverse Event|1
979970|NCT00555321|3224181|P3|Long-term Extension Phase|Adverse Event|2
979971|NCT00555321|3224182|P2|Long-term Extension Phase|Adverse Event|5
979972|NCT00555321|3224183|P1|Long-term Extension Phase|Adverse Event|2
979973|NCT00555321|3224179|P5|Treatment Phase up to 12-months|Never treated|4
979974|NCT00555321|3224180|P4|Treatment Phase up to 12-months|Never treated|0
979975|NCT00555321|3224181|P3|Treatment Phase up to 12-months|Never treated|1
979976|NCT00555321|3224182|P2|Treatment Phase up to 12-months|Never treated|3
979977|NCT00555321|3224183|P1|Treatment Phase up to 12-months|Never treated|2
979978|NCT00555321|3224179|P5|Treatment Phase up to 12-months|Other Reason|0
979979|NCT00555321|3224180|P4|Treatment Phase up to 12-months|Other Reason|0
979980|NCT00555321|3224181|P3|Treatment Phase up to 12-months|Other Reason|2
979981|NCT00555321|3224182|P2|Treatment Phase up to 12-months|Other Reason|3
979982|NCT00555321|3224183|P1|Treatment Phase up to 12-months|Other Reason|1
979983|NCT00555321|3224179|P5|Treatment Phase up to 12-months|Lack of Efficacy|0
979984|NCT00555321|3224180|P4|Treatment Phase up to 12-months|Lack of Efficacy|0
979985|NCT00555321|3224181|P3|Treatment Phase up to 12-months|Lack of Efficacy|5
979986|NCT00555321|3224182|P2|Treatment Phase up to 12-months|Lack of Efficacy|8
979987|NCT00555321|3224183|P1|Treatment Phase up to 12-months|Lack of Efficacy|9
979988|NCT00555321|3224179|P5|Treatment Phase up to 12-months|Death|0
979989|NCT00555321|3224180|P4|Treatment Phase up to 12-months|Death|0
979990|NCT00555321|3224181|P3|Treatment Phase up to 12-months|Death|4
979991|NCT00555321|3224182|P2|Treatment Phase up to 12-months|Death|1
979992|NCT00555321|3224183|P1|Treatment Phase up to 12-months|Death|2
979993|NCT00555321|3224179|P5|Treatment Phase up to 12-months|Withdrawal by Subject|0
979994|NCT00555321|3224180|P4|Treatment Phase up to 12-months|Withdrawal by Subject|0
979995|NCT00555321|3224181|P3|Treatment Phase up to 12-months|Withdrawal by Subject|1
979996|NCT00555321|3224182|P2|Treatment Phase up to 12-months|Withdrawal by Subject|0
979997|NCT00555321|3224183|P1|Treatment Phase up to 12-months|Withdrawal by Subject|1
979998|NCT00555321|3224179|P5|Treatment Phase up to 12-months|Adverse Event|18
979999|NCT00555321|3224180|P4|Treatment Phase up to 12-months|Adverse Event|7
980000|NCT00555321|3224181|P3|Treatment Phase up to 12-months|Adverse Event|11
980001|NCT00555321|3224182|P2|Treatment Phase up to 12-months|Adverse Event|7
980002|NCT00555321|3224183|P1|Treatment Phase up to 12-months|Adverse Event|6
980003|NCT00555217|3224487|P2|Overall Study|close out sites|17
980004|NCT00555217|3224488|P1|Overall Study|close out sites|21
980005|NCT00555217|3224487|P2|Overall Study|Lost to Follow-up|20
980006|NCT00555217|3224488|P1|Overall Study|Lost to Follow-up|19
980007|NCT00555217|3224487|P2|Overall Study|Withdrawal by Subject|31
980008|NCT00555217|3224488|P1|Overall Study|Withdrawal by Subject|35
980009|NCT00555061|3224525|P1|Overall Study|Participant enrolled, but never treated|1
980010|NCT00555061|3224525|P1|Overall Study|Withdrawal by Subject|2
980011|NCT00555061|3224525|P1|Overall Study|Lost to Follow-up|2
980012|NCT00555061|3224525|P1|Overall Study|Protocol Violation|1
980013|NCT00555061|3224525|P1|Overall Study|Adverse Event|3
980014|NCT00555009|3224544|P2|Overall Study|Terminated by Sponsor|5
980015|NCT00555009|3224545|P1|Overall Study|Terminated by Sponsor|2
980016|NCT00555009|3224544|P2|Overall Study|Withdrawal by Subject|1
980017|NCT00555009|3224545|P1|Overall Study|Withdrawal by Subject|0
980018|NCT00554840|3224625|P2|Overall Study|Physician Decision|1
980019|NCT00554840|3224626|P1|Overall Study|Physician Decision|0
980020|NCT00554801|3224644|P2|Overall Study|Withdrawal by Subject|0
980021|NCT00554801|3224645|P1|Overall Study|Withdrawal by Subject|14
980022|NCT00554801|3224644|P2|Overall Study|left area before completion|0
980023|NCT00554801|3224645|P1|Overall Study|left area before completion|5
980024|NCT00554619|3224673|P1|Overall Study|Liver Function Test Abnormality|1
980025|NCT00554619|3224673|P1|Overall Study|Physician Decision|1
980026|NCT00554619|3224673|P1|Overall Study|Adverse Event|1
980027|NCT00554515|3224685|P1|Overall Study|Misc|15
980028|NCT00554515|3224685|P1|Overall Study|Other|1
980029|NCT00554515|3224685|P1|Overall Study|Achieved Stable Disease|7
980030|NCT00554515|3224685|P1|Overall Study|Death|2
980031|NCT00554515|3224685|P1|Overall Study|Adverse Event|9
980032|NCT00554515|3224685|P1|Overall Study|Withdrawal by Subject|11
980033|NCT00554515|3224685|P1|Overall Study|Physician Decision|18
980034|NCT00554515|3224685|P1|Overall Study|Disease progression|52
980035|NCT00554515|3224685|P1|Overall Study|Withdrawal by Subject|3
980036|NCT00554229|3224742|P2|Overall Study|Randomised but no treatment received|0
980037|NCT00554229|3224743|P1|Overall Study|Randomised but no treatment received|1
980038|NCT00554229|3224742|P2|Overall Study|Reason not otherwise captured, eg; death|140
980039|NCT00554229|3224743|P1|Overall Study|Reason not otherwise captured, eg; death|119
980040|NCT00554229|3224742|P2|Overall Study|Protocol Violation|3
980041|NCT00554229|3224743|P1|Overall Study|Protocol Violation|3
980042|NCT00554229|3224742|P2|Overall Study|Adverse Event|39
980043|NCT00554229|3224743|P1|Overall Study|Adverse Event|71
980044|NCT00554229|3224742|P2|Overall Study|Withdrawal by Subject|37
980045|NCT00554229|3224743|P1|Overall Study|Withdrawal by Subject|29
980046|NCT00554229|3224742|P2|Overall Study|Lost to Follow-up|6
980047|NCT00554229|3224743|P1|Overall Study|Lost to Follow-up|3
980048|NCT00554216|3224768|P3|Overall Study|Lack of Efficacy|0
980049|NCT00554216|3224769|P2|Overall Study|Lack of Efficacy|3
980050|NCT00554216|3224770|P1|Overall Study|Lack of Efficacy|15
980051|NCT00554216|3224768|P3|Overall Study|not specified|10
980052|NCT00554216|3224769|P2|Overall Study|not specified|7
980053|NCT00554216|3224770|P1|Overall Study|not specified|12
980054|NCT00554216|3224768|P3|Overall Study|Restricted med|1
980055|NCT00554216|3224769|P2|Overall Study|Restricted med|1
980056|NCT00554216|3224770|P1|Overall Study|Restricted med|3
980057|NCT00554216|3224768|P3|Overall Study|Pregnancy|14
980058|NCT00554216|3224769|P2|Overall Study|Pregnancy|1
980059|NCT00554216|3224770|P1|Overall Study|Pregnancy|2
980060|NCT00554216|3224768|P3|Overall Study|Non compliance|5
980061|NCT00554216|3224769|P2|Overall Study|Non compliance|4
980062|NCT00554216|3224770|P1|Overall Study|Non compliance|10
980063|NCT00554216|3224768|P3|Overall Study|Withdrawal by Subject|43
980064|NCT00554216|3224769|P2|Overall Study|Withdrawal by Subject|31
980065|NCT00554216|3224770|P1|Overall Study|Withdrawal by Subject|92
980066|NCT00554216|3224768|P3|Overall Study|Adverse Event|36
980067|NCT00554216|3224769|P2|Overall Study|Adverse Event|16
980068|NCT00554216|3224770|P1|Overall Study|Adverse Event|16
980069|NCT00554216|3224768|P3|Overall Study|Lost to Follow-up|63
980070|NCT00554216|3224769|P2|Overall Study|Lost to Follow-up|31
980071|NCT00554216|3224770|P1|Overall Study|Lost to Follow-up|92
980072|NCT00554190|3224781|P1|Overall Study|Termination forms not completed|10
980073|NCT00554099|3224790|P3|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
980074|NCT00554099|3224791|P2|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
980075|NCT00554099|3224792|P1|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4
980076|NCT00554099|3224790|P3|Non-Treatment Phase (9 Months)|Relapse|1
980077|NCT00554099|3224791|P2|Non-Treatment Phase (9 Months)|Relapse|1
980078|NCT00554099|3224792|P1|Non-Treatment Phase (9 Months)|Relapse|2
980079|NCT00554099|3224790|P3|Non-Treatment Phase (9 Months)|Lost to Follow-up|0
980080|NCT00554099|3224791|P2|Non-Treatment Phase (9 Months)|Lost to Follow-up|2
980081|NCT00554099|3224792|P1|Non-Treatment Phase (9 Months)|Lost to Follow-up|1
980082|NCT00554099|3224790|P3|Treatment Period (12 Weeks)|Withdrawal by Subject|4
980083|NCT00554099|3224791|P2|Treatment Period (12 Weeks)|Withdrawal by Subject|1
980084|NCT00554099|3224792|P1|Treatment Period (12 Weeks)|Withdrawal by Subject|4
980085|NCT00554099|3224790|P3|Treatment Period (12 Weeks)|Protocol Violation|2
980086|NCT00554099|3224791|P2|Treatment Period (12 Weeks)|Protocol Violation|0
980087|NCT00554099|3224792|P1|Treatment Period (12 Weeks)|Protocol Violation|0
980088|NCT00554099|3224790|P3|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0
980089|NCT00554099|3224791|P2|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2
980090|NCT00554099|3224792|P1|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1
980091|NCT00554099|3224790|P3|Treatment Period (12 Weeks)|Lost to Follow-up|2
980092|NCT00554099|3224791|P2|Treatment Period (12 Weeks)|Lost to Follow-up|0
980093|NCT00554099|3224792|P1|Treatment Period (12 Weeks)|Lost to Follow-up|1
980094|NCT00554099|3224790|P3|Treatment Period (12 Weeks)|Physician Decision|0
980095|NCT00554099|3224791|P2|Treatment Period (12 Weeks)|Physician Decision|0
980096|NCT00554099|3224792|P1|Treatment Period (12 Weeks)|Physician Decision|3
980097|NCT00554099|3224790|P3|Treatment Period (12 Weeks)|Adverse Event|1
980098|NCT00554099|3224791|P2|Treatment Period (12 Weeks)|Adverse Event|5
980099|NCT00554099|3224792|P1|Treatment Period (12 Weeks)|Adverse Event|3
980100|NCT00553787|3224847|P3|Overall Study|not specified|13
980101|NCT00553787|3224848|P2|Overall Study|not specified|10
980102|NCT00553787|3224849|P1|Overall Study|not specified|18
980103|NCT00553787|3224847|P3|Overall Study|Requirement for restricted medication|5
980104|NCT00553787|3224848|P2|Overall Study|Requirement for restricted medication|7
980105|NCT00553787|3224849|P1|Overall Study|Requirement for restricted medication|8
980106|NCT00553787|3224847|P3|Overall Study|non compliance|11
980107|NCT00553787|3224848|P2|Overall Study|non compliance|0
980108|NCT00553787|3224849|P1|Overall Study|non compliance|4
980109|NCT00553787|3224847|P3|Overall Study|Pregnancy|2
980110|NCT00553787|3224848|P2|Overall Study|Pregnancy|1
980111|NCT00553787|3224849|P1|Overall Study|Pregnancy|0
980112|NCT00553787|3224847|P3|Overall Study|Lack of Efficacy|3
980113|NCT00553787|3224848|P2|Overall Study|Lack of Efficacy|1
980114|NCT00553787|3224849|P1|Overall Study|Lack of Efficacy|31
980115|NCT00553787|3224847|P3|Overall Study|Withdrawal by Subject|83
980116|NCT00553787|3224848|P2|Overall Study|Withdrawal by Subject|40
980117|NCT00553787|3224849|P1|Overall Study|Withdrawal by Subject|151
980118|NCT00553787|3224847|P3|Overall Study|Lost to Follow-up|78
980119|NCT00553787|3224848|P2|Overall Study|Lost to Follow-up|44
980120|NCT00553787|3224849|P1|Overall Study|Lost to Follow-up|132
980121|NCT00553787|3224847|P3|Overall Study|Adverse Event|67
980122|NCT00553787|3224848|P2|Overall Study|Adverse Event|21
980123|NCT00553787|3224849|P1|Overall Study|Adverse Event|34
980124|NCT00553696|3224881|P4|Overall Study|Withdrawal by Subject|0
980125|NCT00553696|3224882|P3|Overall Study|Withdrawal by Subject|0
980126|NCT00553696|3224883|P2|Overall Study|Withdrawal by Subject|1
980127|NCT00553696|3224884|P1|Overall Study|Withdrawal by Subject|0
980128|NCT00553696|3224881|P4|Overall Study|Objective progression or relapse|0
980129|NCT00553696|3224882|P3|Overall Study|Objective progression or relapse|6
980130|NCT00553696|3224883|P2|Overall Study|Objective progression or relapse|9
980131|NCT00553696|3224884|P1|Overall Study|Objective progression or relapse|2
980132|NCT00553696|3224881|P4|Overall Study|Global deterioration of health status|0
980133|NCT00553696|3224882|P3|Overall Study|Global deterioration of health status|0
980134|NCT00553696|3224883|P2|Overall Study|Global deterioration of health status|2
980135|NCT00553696|3224884|P1|Overall Study|Global deterioration of health status|0
980136|NCT00553696|3224881|P4|Overall Study|Adverse Event|1
980137|NCT00553696|3224882|P3|Overall Study|Adverse Event|0
980138|NCT00553696|3224883|P2|Overall Study|Adverse Event|4
980139|NCT00553696|3224884|P1|Overall Study|Adverse Event|2
980140|NCT00553644|3224922|P1|Overall Study|Alternative therapy|6
980141|NCT00553644|3224922|P1|Overall Study|Physician Decision|1
980142|NCT00553644|3224922|P1|Overall Study|Withdrawal by Subject|4
980143|NCT00553644|3224922|P1|Overall Study|Adverse Event|17
980144|NCT00553631|3224931|P2|Overall Study|Lost to Follow-up|0
980145|NCT00553631|3224932|P1|Overall Study|Lost to Follow-up|1
980146|NCT00553631|3224931|P2|Overall Study|Withdrawal by Subject|1
980147|NCT00553631|3224932|P1|Overall Study|Withdrawal by Subject|0
980148|NCT00553605|3224954|P2|Overall Study|Randomized but not treated|0
980149|NCT00553605|3224955|P1|Overall Study|Randomized but not treated|2
980150|NCT00553605|3224954|P2|Overall Study|Did not receive full dose|0
980151|NCT00553605|3224955|P1|Overall Study|Did not receive full dose|1
980152|NCT00553605|3224954|P2|Overall Study|Did not meet entrance criteria|3
980153|NCT00553605|3224955|P1|Overall Study|Did not meet entrance criteria|1
980154|NCT00553514|3224984|P5|Overall Study|Other|1
980155|NCT00553514|3224985|P4|Overall Study|Other|0
980156|NCT00553514|3224986|P3|Overall Study|Other|0
980157|NCT00553514|3224987|P2|Overall Study|Other|1
980158|NCT00553514|3224988|P1|Overall Study|Other|1
980159|NCT00553514|3224984|P5|Overall Study|Risk of multiple pregnancy|0
980160|NCT00553514|3224985|P4|Overall Study|Risk of multiple pregnancy|1
980161|NCT00553514|3224986|P3|Overall Study|Risk of multiple pregnancy|0
980162|NCT00553514|3224987|P2|Overall Study|Risk of multiple pregnancy|2
980163|NCT00553514|3224988|P1|Overall Study|Risk of multiple pregnancy|0
980164|NCT00553514|3224984|P5|Overall Study|Ovarian hyperstimulation syndrome risk|0
980165|NCT00553514|3224985|P4|Overall Study|Ovarian hyperstimulation syndrome risk|0
980166|NCT00553514|3224986|P3|Overall Study|Ovarian hyperstimulation syndrome risk|1
980167|NCT00553514|3224987|P2|Overall Study|Ovarian hyperstimulation syndrome risk|0
980168|NCT00553514|3224988|P1|Overall Study|Ovarian hyperstimulation syndrome risk|3
980169|NCT00553514|3224984|P5|Overall Study|Lack of ovarian response|6
980170|NCT00553514|3224985|P4|Overall Study|Lack of ovarian response|5
980171|NCT00553514|3224986|P3|Overall Study|Lack of ovarian response|5
980172|NCT00553514|3224987|P2|Overall Study|Lack of ovarian response|5
980173|NCT00553514|3224988|P1|Overall Study|Lack of ovarian response|4
980174|NCT00553514|3224984|P5|Overall Study|Protocol deviation|0
980175|NCT00553514|3224985|P4|Overall Study|Protocol deviation|1
980176|NCT00553514|3224986|P3|Overall Study|Protocol deviation|0
980177|NCT00553514|3224987|P2|Overall Study|Protocol deviation|0
980178|NCT00553514|3224988|P1|Overall Study|Protocol deviation|0
980179|NCT00553501|3225025|P1|Overall Study|Progression|1
980180|NCT00553501|3225025|P1|Overall Study|Death|1
980181|NCT00553501|3225025|P1|Overall Study|Adverse Event|2
980182|NCT00553475|3225034|P3|Overall Study|Due to moving|0
980183|NCT00553475|3225035|P2|Overall Study|Due to moving|1
980184|NCT00553475|3225036|P1|Overall Study|Due to moving|0
980185|NCT00553475|3225034|P3|Overall Study|Physician Decision|0
980186|NCT00553475|3225035|P2|Overall Study|Physician Decision|0
980187|NCT00553475|3225036|P1|Overall Study|Physician Decision|1
980188|NCT00553475|3225034|P3|Overall Study|Withdrawal by Subject|0
980189|NCT00553475|3225035|P2|Overall Study|Withdrawal by Subject|1
980190|NCT00553475|3225036|P1|Overall Study|Withdrawal by Subject|1
980191|NCT00553475|3225034|P3|Overall Study|Lack of Efficacy|0
980192|NCT00553475|3225035|P2|Overall Study|Lack of Efficacy|1
980193|NCT00553475|3225036|P1|Overall Study|Lack of Efficacy|7
980194|NCT00553475|3225034|P3|Overall Study|Adverse Event|13
980195|NCT00553475|3225035|P2|Overall Study|Adverse Event|17
980196|NCT00553475|3225036|P1|Overall Study|Adverse Event|7
980197|NCT00553462|3225158|P1|Overall Study|Physician Decision|1
980198|NCT00553462|3225158|P1|Overall Study|Withdrawal by Subject|5
980199|NCT00553462|3225158|P1|Overall Study|Progression|4
980200|NCT00553462|3225158|P1|Overall Study|Adverse Event|4
980201|NCT00553436|3225164|P1|Overall Study|Conversion to another procedure|1
980202|NCT00553358|3225173|P3|Overall Study|Other: Reason Not Specified|20
980203|NCT00553358|3225174|P2|Overall Study|Other: Reason Not Specified|4
980204|NCT00553358|3225175|P1|Overall Study|Other: Reason Not Specified|15
980205|NCT00553358|3225173|P3|Overall Study|Missing|1
980206|NCT00553358|3225174|P2|Overall Study|Missing|1
980207|NCT00553358|3225175|P1|Overall Study|Missing|1
980208|NCT00553358|3225173|P3|Overall Study|Participant Withdrawal from Drug|3
980209|NCT00553358|3225174|P2|Overall Study|Participant Withdrawal from Drug|0
980210|NCT00553358|3225175|P1|Overall Study|Participant Withdrawal from Drug|0
980211|NCT00553358|3225173|P3|Overall Study|Recurrence of Disease|1
980212|NCT00553358|3225174|P2|Overall Study|Recurrence of Disease|4
980213|NCT00553358|3225175|P1|Overall Study|Recurrence of Disease|3
980214|NCT00553358|3225173|P3|Overall Study|Withdrawal by Subject|1
980215|NCT00553358|3225174|P2|Overall Study|Withdrawal by Subject|0
980216|NCT00553358|3225175|P1|Overall Study|Withdrawal by Subject|5
980217|NCT00553358|3225173|P3|Overall Study|Protocol Violation|1
980218|NCT00553358|3225174|P2|Overall Study|Protocol Violation|1
980219|NCT00553358|3225175|P1|Overall Study|Protocol Violation|0
980220|NCT00553358|3225173|P3|Overall Study|Lost to Follow-up|1
980221|NCT00553358|3225174|P2|Overall Study|Lost to Follow-up|0
980222|NCT00553358|3225175|P1|Overall Study|Lost to Follow-up|0
980223|NCT00553358|3225173|P3|Overall Study|Adverse Event|32
980224|NCT00553358|3225174|P2|Overall Study|Adverse Event|2
980225|NCT00553358|3225175|P1|Overall Study|Adverse Event|29
980226|NCT00553332|3225201|P1|Overall Study|ineligible, incorrect diagnosis|1
980227|NCT00553319|3225213|P3|Overall Study|moved|1
980228|NCT00553319|3225214|P2|Overall Study|moved|0
980229|NCT00553319|3225215|P1|Overall Study|moved|1
980230|NCT00553319|3225213|P3|Overall Study|incarceration|0
980231|NCT00553319|3225214|P2|Overall Study|incarceration|0
980232|NCT00553319|3225215|P1|Overall Study|incarceration|1
980233|NCT00553319|3225213|P3|Overall Study|non-compliance|2
980234|NCT00553319|3225214|P2|Overall Study|non-compliance|0
980235|NCT00553319|3225215|P1|Overall Study|non-compliance|0
980236|NCT00553319|3225213|P3|Overall Study|wanted treatment elsewhere|1
980237|NCT00553319|3225214|P2|Overall Study|wanted treatment elsewhere|1
980238|NCT00553319|3225215|P1|Overall Study|wanted treatment elsewhere|2
980239|NCT00553319|3225213|P3|Overall Study|Lost to Follow-up|5
980240|NCT00553319|3225214|P2|Overall Study|Lost to Follow-up|9
980241|NCT00553319|3225215|P1|Overall Study|Lost to Follow-up|10
980242|NCT00553280|3225226|P1|Overall Study|Physician Decision|1
980243|NCT00553280|3225226|P1|Overall Study|Withdrawal by Subject|3
980244|NCT00553280|3225226|P1|Overall Study|Lack of Efficacy|3
980245|NCT00553280|3225226|P1|Overall Study|Adverse Event|19
980246|NCT00553267|3225238|P3|Overall Study|Specified category|1
980247|NCT00553267|3225239|P2|Overall Study|Specified category|2
980248|NCT00553267|3225240|P1|Overall Study|Specified category|1
980249|NCT00553267|3225238|P3|Overall Study|Consent withdrawn|1
980250|NCT00553267|3225239|P2|Overall Study|Consent withdrawn|3
980251|NCT00553267|3225240|P1|Overall Study|Consent withdrawn|2
980252|NCT00553267|3225238|P3|Overall Study|Lost to Follow-up|1
980253|NCT00553267|3225239|P2|Overall Study|Lost to Follow-up|0
980254|NCT00553267|3225240|P1|Overall Study|Lost to Follow-up|0
980255|NCT00553267|3225238|P3|Overall Study|Non compliant with protocol|2
980256|NCT00553267|3225239|P2|Overall Study|Non compliant with protocol|3
980257|NCT00553267|3225240|P1|Overall Study|Non compliant with protocol|3
980258|NCT00553267|3225238|P3|Overall Study|Adverse Event|5
980259|NCT00553267|3225239|P2|Overall Study|Adverse Event|10
980260|NCT00553267|3225240|P1|Overall Study|Adverse Event|8
980261|NCT00553202|3225275|P1|Overall Study|Fails to meet organ function|6
980262|NCT00553202|3225275|P1|Overall Study|No donor identified|16
980263|NCT00553202|3225275|P1|Overall Study|Withdrawal by Subject|1
980264|NCT00553202|3225275|P1|Overall Study|Physician Decision|28
980265|NCT00553202|3225275|P1|Overall Study|Lost to Follow-up|1
980266|NCT00553202|3225275|P1|Overall Study|Death|16
980267|NCT00553150|3225285|P4|Overall Study|Ineligible|1
980268|NCT00553150|3225286|P3|Overall Study|Ineligible|0
980269|NCT00553150|3225287|P2|Overall Study|Ineligible|0
980270|NCT00553150|3225288|P1|Overall Study|Ineligible|0
980271|NCT00553150|3225285|P4|Overall Study|Protocol Violation|1
980272|NCT00553150|3225286|P3|Overall Study|Protocol Violation|0
980273|NCT00553150|3225287|P2|Overall Study|Protocol Violation|0
980274|NCT00553150|3225288|P1|Overall Study|Protocol Violation|0
980275|NCT00553150|3225285|P4|Overall Study|Withdrawal by Subject|2
980276|NCT00553150|3225286|P3|Overall Study|Withdrawal by Subject|0
980277|NCT00553150|3225287|P2|Overall Study|Withdrawal by Subject|0
980278|NCT00553150|3225288|P1|Overall Study|Withdrawal by Subject|0
980279|NCT00552760|3225333|P2|Overall Study|Medication Change|0
980280|NCT00552760|3225334|P1|Overall Study|Medication Change|1
980281|NCT00552760|3225333|P2|Overall Study|Withdrawal by Subject|0
980282|NCT00552760|3225334|P1|Overall Study|Withdrawal by Subject|3
980283|NCT00552760|3225333|P2|Overall Study|Medical Condition|1
980284|NCT00552760|3225334|P1|Overall Study|Medical Condition|1
980285|NCT00552760|3225333|P2|Overall Study|Non-compliance|1
980286|NCT00552760|3225334|P1|Overall Study|Non-compliance|1
980287|NCT00552760|3225333|P2|Overall Study|Lost to Follow-up|1
980288|NCT00552760|3225334|P1|Overall Study|Lost to Follow-up|1
980289|NCT00552760|3225333|P2|Overall Study|Protocol Violation|1
980290|NCT00552760|3225334|P1|Overall Study|Protocol Violation|0
980291|NCT00552760|3225333|P2|Overall Study|Relapsed- Mixed Event|5
980292|NCT00552760|3225334|P1|Overall Study|Relapsed- Mixed Event|3
980293|NCT00552760|3225333|P2|Overall Study|Relapse- Manic Event|3
980294|NCT00552760|3225334|P1|Overall Study|Relapse- Manic Event|3
980295|NCT00552760|3225333|P2|Overall Study|Relapsed- Depressed Event|16
980296|NCT00552760|3225334|P1|Overall Study|Relapsed- Depressed Event|10
980297|NCT00552760|3225333|P2|Overall Study|Adverse Event|5
980298|NCT00552760|3225334|P1|Overall Study|Adverse Event|3
980299|NCT00552669|3225361|P2|Overall Study|Death|7
980300|NCT00552669|3225362|P1|Overall Study|Death|3
980301|NCT00552578|3225374|P2|Overall Study|Lost to Follow-up|1
980302|NCT00552578|3225375|P1|Overall Study|Lost to Follow-up|1
980303|NCT00552513|3225387|P2|Overall Study|Lost to Follow-up|1
980304|NCT00552513|3225388|P1|Overall Study|Lost to Follow-up|5
980305|NCT00552396|3225433|P7|Overall Study|protocol withdrawal criteria|9
980306|NCT00552396|3225434|P6|Overall Study|protocol withdrawal criteria|3
980307|NCT00552396|3225435|P5|Overall Study|protocol withdrawal criteria|3
980308|NCT00552396|3225436|P4|Overall Study|protocol withdrawal criteria|6
980309|NCT00552396|3225437|P3|Overall Study|protocol withdrawal criteria|3
980310|NCT00552396|3225438|P2|Overall Study|protocol withdrawal criteria|3
980311|NCT00552396|3225439|P1|Overall Study|protocol withdrawal criteria|3
980312|NCT00552344|3225476|P1|Overall Study|Other Reason|22
980313|NCT00552344|3225476|P1|Overall Study|SAE, fatal + AE, non-serious non-fatal|1
980314|NCT00552344|3225476|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62
980315|NCT00552344|3225476|P1|Overall Study|AE, non-serious non-fatal|38
980316|NCT00552344|3225476|P1|Overall Study|SAE, non-fatal|6
980317|NCT00552344|3225476|P1|Overall Study|Withdrawal by Subject|48
980318|NCT00552344|3225476|P1|Overall Study|Lost to Follow-up|8
980319|NCT00552344|3225476|P1|Overall Study|Loss of efficacy|75
980320|NCT00552344|3225476|P1|Overall Study|Lack of Efficacy|55
980321|NCT00552305|3225485|P1|Overall Study|Other: Subject went to rehab|1
980322|NCT00552305|3225485|P1|Overall Study|Other: Subject incarcerated|1
980323|NCT00552305|3225485|P1|Overall Study|Other: Subject moved from area|2
980324|NCT00552305|3225485|P1|Overall Study|Other: Health problems, not drug related|1
980325|NCT00552305|3225485|P1|Overall Study|Other: Subject became pregnant|1
980326|NCT00552305|3225485|P1|Overall Study|Other: Subject underwent surgery|4
980327|NCT00552305|3225485|P1|Overall Study|Other: Unable to attend visits|1
980328|NCT00552305|3225485|P1|Overall Study|Other: Personal problems|1
980329|NCT00552305|3225485|P1|Overall Study|Other: Site closed|4
980330|NCT00552305|3225485|P1|Overall Study|LoE/WD consent/Other: cannot make visits|1
980331|NCT00552305|3225485|P1|Overall Study|AE/Other: prohibited drug required|1
980332|NCT00552305|3225485|P1|Overall Study|Poor compliance/lost to follow-up|1
980333|NCT00552305|3225485|P1|Overall Study|Unsatisfactory compliance|11
980334|NCT00552305|3225485|P1|Overall Study|Adverse event (AE)/withdrew (WD) consent|2
980335|NCT00552305|3225485|P1|Overall Study|Lack of efficacy (LoE)/adverse event|3
980336|NCT00552305|3225485|P1|Overall Study|Lack of efficacy/withdrew consent|1
980337|NCT00552305|3225485|P1|Overall Study|Withdrawal by Subject|44
980338|NCT00552305|3225485|P1|Overall Study|Protocol Violation|3
980339|NCT00552305|3225485|P1|Overall Study|Lost to Follow-up|4
980340|NCT00552305|3225485|P1|Overall Study|Lack of Efficacy|120
980341|NCT00552305|3225485|P1|Overall Study|Adverse Event|43
980342|NCT00552279|3225495|P2|Overall Study|Other|1
980343|NCT00552279|3225496|P1|Overall Study|Other|1
980344|NCT00552279|3225495|P2|Overall Study|Lost to Follow-up|0
980345|NCT00552279|3225496|P1|Overall Study|Lost to Follow-up|1
980346|NCT00552279|3225495|P2|Overall Study|Withdrawal by Subject|1
980347|NCT00552279|3225496|P1|Overall Study|Withdrawal by Subject|12
980348|NCT00552279|3225495|P2|Overall Study|Adverse Event|1
980349|NCT00552279|3225496|P1|Overall Study|Adverse Event|0
980350|NCT00552240|3225522|P2|Overall Study|not specified|0
980351|NCT00552240|3225523|P1|Overall Study|not specified|1
980352|NCT00552240|3225522|P2|Overall Study|Lack of Efficacy|0
980353|NCT00552240|3225523|P1|Overall Study|Lack of Efficacy|6
980354|NCT00552240|3225522|P2|Overall Study|Withdrawal by Subject|2
980355|NCT00552240|3225523|P1|Overall Study|Withdrawal by Subject|2
980356|NCT00552240|3225522|P2|Overall Study|Lost to Follow-up|6
980357|NCT00552240|3225523|P1|Overall Study|Lost to Follow-up|5
980358|NCT00552240|3225522|P2|Overall Study|Protocol Violation|1
980359|NCT00552240|3225523|P1|Overall Study|Protocol Violation|1
980360|NCT00552240|3225522|P2|Overall Study|Adverse Event|9
980361|NCT00552240|3225523|P1|Overall Study|Adverse Event|9
980362|NCT00552188|3225625|P2|Overall Study|Subject returned to home country|1
980363|NCT00552188|3225626|P1|Overall Study|Subject returned to home country|0
980364|NCT00552188|3225625|P2|Overall Study|Withdrawal of consent|1
980365|NCT00552188|3225626|P1|Overall Study|Withdrawal of consent|0
980366|NCT00552188|3225625|P2|Overall Study|Lost to Follow-up|1
980367|NCT00552188|3225626|P1|Overall Study|Lost to Follow-up|2
980368|NCT00552188|3225625|P2|Overall Study|Adverse Event|2
980369|NCT00552188|3225626|P1|Overall Study|Adverse Event|0
980370|NCT00552175|3225637|P3|Overall Study|Reason Not Specified|1
980371|NCT00552175|3225638|P2|Overall Study|Reason Not Specified|1
980372|NCT00552175|3225639|P1|Overall Study|Reason Not Specified|3
980373|NCT00552175|3225637|P3|Overall Study|Entry Criteria Not Met|0
980374|NCT00552175|3225638|P2|Overall Study|Entry Criteria Not Met|1
980375|NCT00552175|3225639|P1|Overall Study|Entry Criteria Not Met|1
980376|NCT00552175|3225637|P3|Overall Study|Lost to Follow-up|1
980377|NCT00552175|3225638|P2|Overall Study|Lost to Follow-up|0
980378|NCT00552175|3225639|P1|Overall Study|Lost to Follow-up|0
980379|NCT00552175|3225637|P3|Overall Study|Withdrawal by Subject|1
980380|NCT00552175|3225638|P2|Overall Study|Withdrawal by Subject|2
980381|NCT00552175|3225639|P1|Overall Study|Withdrawal by Subject|2
980382|NCT00552175|3225637|P3|Overall Study|Adverse Event|10
980383|NCT00552175|3225638|P2|Overall Study|Adverse Event|9
980384|NCT00552175|3225639|P1|Overall Study|Adverse Event|9
980385|NCT00552175|3225637|P3|Overall Study|Lack of Efficacy|1
980386|NCT00552175|3225638|P2|Overall Study|Lack of Efficacy|0
980387|NCT00552175|3225639|P1|Overall Study|Lack of Efficacy|2
980388|NCT00552110|3225679|P5|Overall Study|Nonserious Adverse Event (AE)|0
980389|NCT00552110|3225680|P4|Overall Study|Nonserious Adverse Event (AE)|1
980390|NCT00552110|3225681|P3|Overall Study|Nonserious Adverse Event (AE)|0
980391|NCT00552110|3225682|P2|Overall Study|Nonserious Adverse Event (AE)|0
980392|NCT00552110|3225683|P1|Overall Study|Nonserious Adverse Event (AE)|1
980393|NCT00552110|3225679|P5|Overall Study|Increased Blood Pressure at Visit 2|0
980394|NCT00552110|3225680|P4|Overall Study|Increased Blood Pressure at Visit 2|1
980395|NCT00552110|3225681|P3|Overall Study|Increased Blood Pressure at Visit 2|0
980396|NCT00552110|3225682|P2|Overall Study|Increased Blood Pressure at Visit 2|0
980397|NCT00552110|3225683|P1|Overall Study|Increased Blood Pressure at Visit 2|0
980398|NCT00552110|3225679|P5|Overall Study|Delay of Study due to Relabeling|0
980399|NCT00552110|3225680|P4|Overall Study|Delay of Study due to Relabeling|1
980400|NCT00552110|3225681|P3|Overall Study|Delay of Study due to Relabeling|0
980401|NCT00552110|3225682|P2|Overall Study|Delay of Study due to Relabeling|0
980402|NCT00552110|3225683|P1|Overall Study|Delay of Study due to Relabeling|0
980403|NCT00552110|3225679|P5|Overall Study|Use of Prohibited Medication|0
980404|NCT00552110|3225680|P4|Overall Study|Use of Prohibited Medication|0
980405|NCT00552110|3225681|P3|Overall Study|Use of Prohibited Medication|0
980406|NCT00552110|3225682|P2|Overall Study|Use of Prohibited Medication|1
980407|NCT00552110|3225683|P1|Overall Study|Use of Prohibited Medication|1
980408|NCT00552110|3225679|P5|Overall Study|Withdrawn per Sponsor|1
980409|NCT00552110|3225680|P4|Overall Study|Withdrawn per Sponsor|0
980410|NCT00552110|3225681|P3|Overall Study|Withdrawn per Sponsor|0
980411|NCT00552110|3225682|P2|Overall Study|Withdrawn per Sponsor|1
980412|NCT00552110|3225683|P1|Overall Study|Withdrawn per Sponsor|0
980413|NCT00552110|3225679|P5|Overall Study|Failed to Comply With Study Requirements|1
980414|NCT00552110|3225680|P4|Overall Study|Failed to Comply With Study Requirements|0
980415|NCT00552110|3225681|P3|Overall Study|Failed to Comply With Study Requirements|1
980416|NCT00552110|3225682|P2|Overall Study|Failed to Comply With Study Requirements|1
980417|NCT00552110|3225683|P1|Overall Study|Failed to Comply With Study Requirements|1
980418|NCT00552110|3225679|P5|Overall Study|Lost to Follow-up|1
980419|NCT00552110|3225680|P4|Overall Study|Lost to Follow-up|1
980420|NCT00552110|3225681|P3|Overall Study|Lost to Follow-up|0
980421|NCT00552110|3225682|P2|Overall Study|Lost to Follow-up|0
980422|NCT00552110|3225683|P1|Overall Study|Lost to Follow-up|0
980423|NCT00552110|3225679|P5|Overall Study|Withdrawal by Subject|2
980424|NCT00552110|3225680|P4|Overall Study|Withdrawal by Subject|3
980425|NCT00552110|3225681|P3|Overall Study|Withdrawal by Subject|0
980426|NCT00552110|3225682|P2|Overall Study|Withdrawal by Subject|2
980427|NCT00552110|3225683|P1|Overall Study|Withdrawal by Subject|0
980428|NCT00552110|3225679|P5|Overall Study|Lack of Efficacy|4
980429|NCT00552110|3225680|P4|Overall Study|Lack of Efficacy|1
980430|NCT00552110|3225681|P3|Overall Study|Lack of Efficacy|0
980431|NCT00552110|3225682|P2|Overall Study|Lack of Efficacy|0
980432|NCT00552110|3225683|P1|Overall Study|Lack of Efficacy|1
980433|NCT00552110|3225679|P5|Overall Study|Serious or Life-Threatening AE|0
980434|NCT00552110|3225680|P4|Overall Study|Serious or Life-Threatening AE|0
980435|NCT00552110|3225681|P3|Overall Study|Serious or Life-Threatening AE|1
980436|NCT00552110|3225682|P2|Overall Study|Serious or Life-Threatening AE|0
980437|NCT00552110|3225683|P1|Overall Study|Serious or Life-Threatening AE|0
980438|NCT00552084|3225702|P2|Overall Study|change in anti-arrythmic drug|1
980439|NCT00552084|3225703|P1|Overall Study|change in anti-arrythmic drug|1
980440|NCT00552084|3225702|P2|Overall Study|Protocol Violation|0
980441|NCT00552084|3225703|P1|Overall Study|Protocol Violation|1
980442|NCT00552084|3225702|P2|Overall Study|Withdrawal by Subject|5
980443|NCT00552084|3225703|P1|Overall Study|Withdrawal by Subject|4
980444|NCT00552084|3225702|P2|Overall Study|Adverse Event|3
980445|NCT00552084|3225703|P1|Overall Study|Adverse Event|2
980446|NCT00552071|3225711|P2|Overall Study|Withdrawal by Subject|1
980447|NCT00552071|3225712|P1|Overall Study|Withdrawal by Subject|0
980448|NCT00552071|3225711|P2|Overall Study|Death|1
980449|NCT00552071|3225712|P1|Overall Study|Death|0
980450|NCT00552071|3225711|P2|Overall Study|Pregnancy|0
980451|NCT00552071|3225712|P1|Overall Study|Pregnancy|1
980452|NCT00552071|3225711|P2|Overall Study|Physician Decision|0
980453|NCT00552071|3225712|P1|Overall Study|Physician Decision|1
980454|NCT00552071|3225711|P2|Overall Study|Lack of Efficacy|0
980455|NCT00552071|3225712|P1|Overall Study|Lack of Efficacy|1
980456|NCT00552071|3225711|P2|Overall Study|Adverse Event|0
980457|NCT00552071|3225712|P1|Overall Study|Adverse Event|1
980458|NCT00552058|3225722|P2|Overall Study|Other: Early Roll Over|0
980459|NCT00552058|3225723|P1|Overall Study|Other: Early Roll Over|1
980460|NCT00552058|3225722|P2|Overall Study|Other: Sponsors Decision|1
980461|NCT00552058|3225723|P1|Overall Study|Other: Sponsors Decision|0
980462|NCT00552058|3225722|P2|Overall Study|Other: Randomized in error|1
980463|NCT00552058|3225723|P1|Overall Study|Other: Randomized in error|0
980464|NCT00552058|3225722|P2|Overall Study|Other: Positive Stool Result|1
980465|NCT00552058|3225723|P1|Overall Study|Other: Positive Stool Result|0
980466|NCT00552058|3225722|P2|Overall Study|Other: Low CDAI score, entry violation|1
980467|NCT00552058|3225723|P1|Overall Study|Other: Low CDAI score, entry violation|0
980468|NCT00552058|3225722|P2|Overall Study|Other: Crossed Over to a Follow-up Study|1
980469|NCT00552058|3225723|P1|Overall Study|Other: Crossed Over to a Follow-up Study|0
980470|NCT00552058|3225722|P2|Overall Study|Other: Non Compliance|2
980471|NCT00552058|3225723|P1|Overall Study|Other: Non Compliance|1
980472|NCT00552058|3225722|P2|Overall Study|Other: Protocol Violation|1
980473|NCT00552058|3225723|P1|Overall Study|Other: Protocol Violation|0
980474|NCT00552058|3225722|P2|Overall Study|Withdrawal by Subject|4
980475|NCT00552058|3225723|P1|Overall Study|Withdrawal by Subject|4
980476|NCT00552058|3225722|P2|Overall Study|Lost to Follow-up|0
980477|NCT00552058|3225723|P1|Overall Study|Lost to Follow-up|1
980478|NCT00552058|3225722|P2|Overall Study|Lack of Efficacy|5
980479|NCT00552058|3225723|P1|Overall Study|Lack of Efficacy|1
980480|NCT00552058|3225722|P2|Overall Study|Adverse Event|7
980481|NCT00552058|3225723|P1|Overall Study|Adverse Event|8
980482|NCT00552032|3225763|P2|Overall Study|Lost to Follow-up|5
980483|NCT00552032|3225764|P1|Overall Study|Lost to Follow-up|8
980484|NCT00552032|3225763|P2|Overall Study|Protocol Violation|12
980485|NCT00552032|3225764|P1|Overall Study|Protocol Violation|7
980486|NCT00552032|3225763|P2|Overall Study|Withdrawal by Subject|2
980487|NCT00552032|3225764|P1|Overall Study|Withdrawal by Subject|2
980488|NCT00551759|3225808|P1|Overall Study|Ineligible|1
980489|NCT00551759|3225808|P1|Overall Study|Death|5
980490|NCT00551759|3225808|P1|Overall Study|Adverse Event|7
980491|NCT00551642|3225849|P2|Overall Study|Inclusion/Exclusion criteria|4
980492|NCT00551642|3225850|P1|Overall Study|Inclusion/Exclusion criteria|4
980493|NCT00551642|3225849|P2|Overall Study|Delivery device failure|3
980494|NCT00551642|3225850|P1|Overall Study|Delivery device failure|1
980495|NCT00551642|3225849|P2|Overall Study|Physician Decision|1
980496|NCT00551642|3225850|P1|Overall Study|Physician Decision|0
980497|NCT00551642|3225849|P2|Overall Study|Protocol Violation|11
980498|NCT00551642|3225850|P1|Overall Study|Protocol Violation|6
980499|NCT00551642|3225849|P2|Overall Study|Death|31
980500|NCT00551642|3225850|P1|Overall Study|Death|33
980501|NCT00551642|3225849|P2|Overall Study|Adverse Event|12
980502|NCT00551642|3225850|P1|Overall Study|Adverse Event|15
980503|NCT00551642|3225849|P2|Overall Study|Withdrawal by Subject|1
980504|NCT00551642|3225850|P1|Overall Study|Withdrawal by Subject|2
980505|NCT00551525|3225856|P1|Overall Study|Protocol Violation|5
980506|NCT00551460|3225865|P1|Overall Study|Not analyzable (did not start treatment)|4
980507|NCT00551460|3225865|P1|Overall Study|Ineligible|4
980508|NCT00551460|3225865|P1|Overall Study|Death|7
980509|NCT00551460|3225865|P1|Overall Study|Physician Decision|1
980510|NCT00551460|3225865|P1|Overall Study|Withdrawal by Subject|1
980511|NCT00551460|3225865|P1|Overall Study|Adverse Event|1
980512|NCT00551421|3225871|P1|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1
980513|NCT00551369|3225878|P1|Overall Study|Not treated per protocol and re|1
980514|NCT00551369|3225878|P1|Overall Study|Withdrawal by Subject|1
980515|NCT00551369|3225878|P1|Overall Study|Protocol Violation|5
980516|NCT00551291|3225886|P1|Overall Study|Physician Decision|1
980517|NCT00551213|3225894|P2|Overall Study|Not Treated|2
980518|NCT00551213|3225895|P1|Overall Study|Not Treated|1
980519|NCT00551213|3225894|P2|Overall Study|Withdrawal by Subject|0
980520|NCT00551213|3225895|P1|Overall Study|Withdrawal by Subject|2
980521|NCT00551213|3225894|P2|Overall Study|Progressive Disease|12
980522|NCT00551213|3225895|P1|Overall Study|Progressive Disease|41
980523|NCT00551213|3225894|P2|Overall Study|Adverse Event|3
980524|NCT00551213|3225895|P1|Overall Study|Adverse Event|6
980525|NCT00551161|3225939|P1|Overall Study|Withdrawal by Subject|1
980526|NCT00551135|3225947|P4|Overall Study|Withdrawal by Subject|1
980527|NCT00551135|3225948|P3|Overall Study|Withdrawal by Subject|3
980528|NCT00551135|3225949|P2|Overall Study|Withdrawal by Subject|0
980529|NCT00551135|3225950|P1|Overall Study|Withdrawal by Subject|1
980530|NCT00551135|3225947|P4|Overall Study|Other|2
980531|NCT00551135|3225948|P3|Overall Study|Other|1
980532|NCT00551135|3225949|P2|Overall Study|Other|2
980533|NCT00551135|3225950|P1|Overall Study|Other|3
980534|NCT00551135|3225947|P4|Overall Study|Lost to Follow-up|1
980535|NCT00551135|3225948|P3|Overall Study|Lost to Follow-up|0
980536|NCT00551135|3225949|P2|Overall Study|Lost to Follow-up|0
980537|NCT00551135|3225950|P1|Overall Study|Lost to Follow-up|0
980538|NCT00551135|3225947|P4|Overall Study|Adverse Event|1
980539|NCT00551135|3225948|P3|Overall Study|Adverse Event|1
980540|NCT00551135|3225949|P2|Overall Study|Adverse Event|0
980541|NCT00551135|3225950|P1|Overall Study|Adverse Event|1
980542|NCT00551031|3226079|P5|Overall Study|Did not receive vaccine|0
980543|NCT00551031|3226080|P4|Overall Study|Did not receive vaccine|0
980544|NCT00551031|3226081|P3|Overall Study|Did not receive vaccine|0
980545|NCT00551031|3226082|P2|Overall Study|Did not receive vaccine|2
980546|NCT00551031|3226083|P1|Overall Study|Did not receive vaccine|1
980547|NCT00551031|3226079|P5|Overall Study|Serious Adverse Event|0
980548|NCT00551031|3226080|P4|Overall Study|Serious Adverse Event|0
980549|NCT00551031|3226081|P3|Overall Study|Serious Adverse Event|1
980550|NCT00551031|3226082|P2|Overall Study|Serious Adverse Event|2
980551|NCT00551031|3226083|P1|Overall Study|Serious Adverse Event|0
980552|NCT00551031|3226079|P5|Overall Study|Withdrawal by Subject|0
980553|NCT00551031|3226080|P4|Overall Study|Withdrawal by Subject|2
980554|NCT00551031|3226081|P3|Overall Study|Withdrawal by Subject|1
980555|NCT00551031|3226082|P2|Overall Study|Withdrawal by Subject|4
980556|NCT00551031|3226083|P1|Overall Study|Withdrawal by Subject|0
980557|NCT00551031|3226079|P5|Overall Study|Lost to Follow-up|1
980558|NCT00551031|3226080|P4|Overall Study|Lost to Follow-up|1
980559|NCT00551031|3226081|P3|Overall Study|Lost to Follow-up|0
980560|NCT00551031|3226082|P2|Overall Study|Lost to Follow-up|1
980561|NCT00551031|3226083|P1|Overall Study|Lost to Follow-up|0
980562|NCT00551031|3226079|P5|Overall Study|Protocol Violation|0
980563|NCT00551031|3226080|P4|Overall Study|Protocol Violation|0
980564|NCT00551031|3226081|P3|Overall Study|Protocol Violation|0
980565|NCT00551031|3226082|P2|Overall Study|Protocol Violation|1
980566|NCT00551031|3226083|P1|Overall Study|Protocol Violation|1
980567|NCT00551031|3226079|P5|Overall Study|Adverse Event|0
980568|NCT00551031|3226080|P4|Overall Study|Adverse Event|0
980569|NCT00551031|3226081|P3|Overall Study|Adverse Event|0
980570|NCT00551031|3226082|P2|Overall Study|Adverse Event|1
980571|NCT00551031|3226083|P1|Overall Study|Adverse Event|0
980572|NCT00550953|3226112|P2|Overall Study|Not able to visit the site|3
980573|NCT00550953|3226113|P1|Overall Study|Not able to visit the site|2
980574|NCT00550953|3226112|P2|Overall Study|Adverse Event|3
980575|NCT00550953|3226113|P1|Overall Study|Adverse Event|4
980576|NCT00550836|3226160|P2|Overall Study|Withdrawal by Subject|9
980577|NCT00550836|3226161|P1|Overall Study|Withdrawal by Subject|3
980578|NCT00550771|3226177|P2|Overall Study|Protocol Violation|5
980579|NCT00550771|3226178|P1|Overall Study|Protocol Violation|4
980580|NCT00550771|3226177|P2|Overall Study|Withdrawal by Subject|1
980581|NCT00550771|3226178|P1|Overall Study|Withdrawal by Subject|0
980582|NCT00550771|3226177|P2|Overall Study|Physician Decision|0
980583|NCT00550771|3226178|P1|Overall Study|Physician Decision|2
980584|NCT00550771|3226177|P2|Overall Study|Discontinued for study-related reasons|1
980585|NCT00550771|3226178|P1|Overall Study|Discontinued for study-related reasons|0
980586|NCT00550771|3226177|P2|Overall Study|Adverse Event|3
980587|NCT00550771|3226178|P1|Overall Study|Adverse Event|11
980588|NCT00550745|3226192|P2|Overall Study|Screen failure|0
980589|NCT00550745|3226193|P1|Overall Study|Screen failure|1
980590|NCT00550745|3226192|P2|Overall Study|Withdrawal by Subject|10
980591|NCT00550745|3226193|P1|Overall Study|Withdrawal by Subject|17
980592|NCT00550745|3226192|P2|Overall Study|Protocol Violation|2
980593|NCT00550745|3226193|P1|Overall Study|Protocol Violation|4
980594|NCT00550745|3226192|P2|Overall Study|Physician Decision|2
980595|NCT00550745|3226193|P1|Overall Study|Physician Decision|0
980596|NCT00550745|3226192|P2|Overall Study|Lost to Follow-up|30
980597|NCT00550745|3226193|P1|Overall Study|Lost to Follow-up|45
980598|NCT00550745|3226192|P2|Overall Study|Death|16
980599|NCT00550745|3226193|P1|Overall Study|Death|20
980600|NCT00550732|3226201|P1|Overall Study|Adverse Event|1
980601|NCT00550732|3226201|P1|Overall Study|Palliative care|1
980602|NCT00550732|3226201|P1|Overall Study|Lost to Follow-up|1
980603|NCT00550732|3226201|P1|Overall Study|Physician Decision|2
980604|NCT00550732|3226201|P1|Overall Study|Withdrawal by Subject|2
980605|NCT00550732|3226201|P1|Overall Study|Death|4
980606|NCT00550680|3226212|P1|Overall Study|Screen Failure|6
980607|NCT00550680|3226212|P1|Overall Study|Refused Treatment|19
980608|NCT00550680|3226212|P1|Overall Study|Protocol Violation|7
980609|NCT00550680|3226212|P1|Overall Study|Not Specified|10
980610|NCT00550680|3226212|P1|Overall Study|Lack of Efficacy|1
980611|NCT00550680|3226212|P1|Overall Study|Lost to Follow-up|3
980612|NCT00550680|3226212|P1|Overall Study|Early Improvement|1
980613|NCT00550680|3226212|P1|Overall Study|Death|3
980614|NCT00550680|3226212|P1|Overall Study|Adverse Event|5
980615|NCT00550680|3226212|P1|Overall Study|Administrative Reasons|1
980616|NCT00550550|3226244|P2|Overall Study|Randomized But Not Treated|0
980617|NCT00550550|3226245|P1|Overall Study|Randomized But Not Treated|1
980618|NCT00550550|3226244|P2|Overall Study|Did Not Meet Protocol Eligibility|1
980619|NCT00550550|3226245|P1|Overall Study|Did Not Meet Protocol Eligibility|1
980620|NCT00550550|3226244|P2|Overall Study|Protocol Violation|14
980621|NCT00550550|3226245|P1|Overall Study|Protocol Violation|5
980622|NCT00550550|3226244|P2|Overall Study|Withdrawal by Subject|8
980623|NCT00550550|3226245|P1|Overall Study|Withdrawal by Subject|10
980624|NCT00550550|3226244|P2|Overall Study|Lost to Follow-up|0
980625|NCT00550550|3226245|P1|Overall Study|Lost to Follow-up|4
980626|NCT00550550|3226244|P2|Overall Study|Treatment Failure|1
980627|NCT00550550|3226245|P1|Overall Study|Treatment Failure|0
980628|NCT00550550|3226244|P2|Overall Study|Adverse Event|5
980629|NCT00550550|3226245|P1|Overall Study|Adverse Event|13
980630|NCT00550537|3226257|P1|Overall Study|Treated closer to home|4
980631|NCT00550537|3226257|P1|Overall Study|Declining performance status|2
980632|NCT00550537|3226257|P1|Overall Study|Other complicating ilness|3
980633|NCT00550537|3226257|P1|Overall Study|Change in treatment plan|4
980634|NCT00550537|3226257|P1|Overall Study|Withdrawal by Subject|7
980635|NCT00550537|3226257|P1|Overall Study|Disease progression before|46
980636|NCT00550537|3226257|P1|Overall Study|Adverse Event|20
980637|NCT00550537|3226257|P1|Overall Study|Death|18
980638|NCT00550459|3226274|P2|Overall Study|Withdrawal by Subject|1
980639|NCT00550459|3226275|P1|Overall Study|Withdrawal by Subject|1
980640|NCT00550459|3226274|P2|Overall Study|Adverse Event|2
980641|NCT00550459|3226275|P1|Overall Study|Adverse Event|0
980642|NCT00550446|3226344|P11|Post Week 12|Other|0
980643|NCT00550446|3226345|P10|Post Week 12|Other|1
980644|NCT00550446|3226346|P9|Post Week 12|Other|1
980645|NCT00550446|3226347|P8|Post Week 12|Other|0
980646|NCT00550446|3226348|P7|Post Week 12|Other|1
980647|NCT00550446|3226349|P6|Post Week 12|Other|0
980648|NCT00550446|3226350|P5|Post Week 12|Other|0
980649|NCT00550446|3226351|P4|Post Week 12|Other|1
980650|NCT00550446|3226352|P3|Post Week 12|Other|0
980651|NCT00550446|3226353|P2|Post Week 12|Other|1
980652|NCT00550446|3226354|P1|Post Week 12|Other|1
980653|NCT00550446|3226344|P11|Post Week 12|Withdrawal by Subject|0
980654|NCT00550446|3226345|P10|Post Week 12|Withdrawal by Subject|0
980655|NCT00550446|3226346|P9|Post Week 12|Withdrawal by Subject|0
980656|NCT00550446|3226347|P8|Post Week 12|Withdrawal by Subject|0
980657|NCT00550446|3226348|P7|Post Week 12|Withdrawal by Subject|0
980658|NCT00550446|3226349|P6|Post Week 12|Withdrawal by Subject|0
980659|NCT00550446|3226350|P5|Post Week 12|Withdrawal by Subject|1
980660|NCT00550446|3226351|P4|Post Week 12|Withdrawal by Subject|0
980661|NCT00550446|3226352|P3|Post Week 12|Withdrawal by Subject|0
980662|NCT00550446|3226353|P2|Post Week 12|Withdrawal by Subject|0
980663|NCT00550446|3226354|P1|Post Week 12|Withdrawal by Subject|0
980664|NCT00550446|3226344|P11|Post Week 12|Lost to Follow-up|0
980665|NCT00550446|3226345|P10|Post Week 12|Lost to Follow-up|0
980666|NCT00550446|3226346|P9|Post Week 12|Lost to Follow-up|0
980667|NCT00550446|3226347|P8|Post Week 12|Lost to Follow-up|0
980668|NCT00550446|3226348|P7|Post Week 12|Lost to Follow-up|1
980669|NCT00550446|3226349|P6|Post Week 12|Lost to Follow-up|0
980670|NCT00550446|3226350|P5|Post Week 12|Lost to Follow-up|0
980671|NCT00550446|3226351|P4|Post Week 12|Lost to Follow-up|1
980672|NCT00550446|3226352|P3|Post Week 12|Lost to Follow-up|1
980673|NCT00550446|3226353|P2|Post Week 12|Lost to Follow-up|0
980674|NCT00550446|3226354|P1|Post Week 12|Lost to Follow-up|0
980675|NCT00550446|3226344|P11|Post Week 12|Lack of Efficacy|1
980676|NCT00550446|3226345|P10|Post Week 12|Lack of Efficacy|2
980677|NCT00550446|3226346|P9|Post Week 12|Lack of Efficacy|1
980678|NCT00550446|3226347|P8|Post Week 12|Lack of Efficacy|1
980679|NCT00550446|3226348|P7|Post Week 12|Lack of Efficacy|0
980680|NCT00550446|3226349|P6|Post Week 12|Lack of Efficacy|0
980681|NCT00550446|3226350|P5|Post Week 12|Lack of Efficacy|0
980682|NCT00550446|3226351|P4|Post Week 12|Lack of Efficacy|0
980683|NCT00550446|3226352|P3|Post Week 12|Lack of Efficacy|1
980684|NCT00550446|3226353|P2|Post Week 12|Lack of Efficacy|0
980685|NCT00550446|3226354|P1|Post Week 12|Lack of Efficacy|0
980686|NCT00550446|3226344|P11|Post Week 12|Adverse Event|0
980687|NCT00550446|3226345|P10|Post Week 12|Adverse Event|4
980688|NCT00550446|3226346|P9|Post Week 12|Adverse Event|0
980689|NCT00550446|3226347|P8|Post Week 12|Adverse Event|0
980690|NCT00550446|3226348|P7|Post Week 12|Adverse Event|0
980691|NCT00550446|3226349|P6|Post Week 12|Adverse Event|1
980692|NCT00550446|3226350|P5|Post Week 12|Adverse Event|1
980693|NCT00550446|3226351|P4|Post Week 12|Adverse Event|1
980694|NCT00550446|3226352|P3|Post Week 12|Adverse Event|1
980695|NCT00550446|3226353|P2|Post Week 12|Adverse Event|1
980696|NCT00550446|3226354|P1|Post Week 12|Adverse Event|2
980697|NCT00550446|3226344|P11|Up To Week 12|Randomized not treated|0
980698|NCT00550446|3226345|P10|Up To Week 12|Randomized not treated|0
980699|NCT00550446|3226346|P9|Up To Week 12|Randomized not treated|0
980700|NCT00550446|3226347|P8|Up To Week 12|Randomized not treated|0
980701|NCT00550446|3226348|P7|Up To Week 12|Randomized not treated|0
980702|NCT00550446|3226349|P6|Up To Week 12|Randomized not treated|0
980703|NCT00550446|3226350|P5|Up To Week 12|Randomized not treated|0
980704|NCT00550446|3226351|P4|Up To Week 12|Randomized not treated|0
980705|NCT00550446|3226352|P3|Up To Week 12|Randomized not treated|1
980706|NCT00550446|3226353|P2|Up To Week 12|Randomized not treated|1
980707|NCT00550446|3226354|P1|Up To Week 12|Randomized not treated|0
980708|NCT00550446|3226344|P11|Up To Week 12|Other|0
980709|NCT00550446|3226345|P10|Up To Week 12|Other|0
980710|NCT00550446|3226346|P9|Up To Week 12|Other|0
980711|NCT00550446|3226347|P8|Up To Week 12|Other|0
980712|NCT00550446|3226348|P7|Up To Week 12|Other|4
980713|NCT00550446|3226349|P6|Up To Week 12|Other|1
980714|NCT00550446|3226350|P5|Up To Week 12|Other|0
980715|NCT00550446|3226351|P4|Up To Week 12|Other|0
980716|NCT00550446|3226352|P3|Up To Week 12|Other|0
980717|NCT00550446|3226353|P2|Up To Week 12|Other|0
980718|NCT00550446|3226354|P1|Up To Week 12|Other|3
980719|NCT00550446|3226344|P11|Up To Week 12|Withdrawal by Subject|0
980720|NCT00550446|3226345|P10|Up To Week 12|Withdrawal by Subject|0
980721|NCT00550446|3226346|P9|Up To Week 12|Withdrawal by Subject|0
980722|NCT00550446|3226347|P8|Up To Week 12|Withdrawal by Subject|0
980723|NCT00550446|3226348|P7|Up To Week 12|Withdrawal by Subject|3
980724|NCT00550446|3226349|P6|Up To Week 12|Withdrawal by Subject|1
980725|NCT00550446|3226350|P5|Up To Week 12|Withdrawal by Subject|0
980726|NCT00550446|3226351|P4|Up To Week 12|Withdrawal by Subject|2
980727|NCT00550446|3226352|P3|Up To Week 12|Withdrawal by Subject|3
980728|NCT00550446|3226353|P2|Up To Week 12|Withdrawal by Subject|0
980729|NCT00550446|3226354|P1|Up To Week 12|Withdrawal by Subject|2
980730|NCT00550446|3226344|P11|Up To Week 12|Lost to Follow-up|0
980731|NCT00550446|3226345|P10|Up To Week 12|Lost to Follow-up|0
980732|NCT00550446|3226346|P9|Up To Week 12|Lost to Follow-up|0
980733|NCT00550446|3226347|P8|Up To Week 12|Lost to Follow-up|0
980734|NCT00550446|3226348|P7|Up To Week 12|Lost to Follow-up|2
980735|NCT00550446|3226349|P6|Up To Week 12|Lost to Follow-up|1
980736|NCT00550446|3226350|P5|Up To Week 12|Lost to Follow-up|1
980737|NCT00550446|3226351|P4|Up To Week 12|Lost to Follow-up|0
980738|NCT00550446|3226352|P3|Up To Week 12|Lost to Follow-up|0
980739|NCT00550446|3226353|P2|Up To Week 12|Lost to Follow-up|1
980740|NCT00550446|3226354|P1|Up To Week 12|Lost to Follow-up|0
980741|NCT00550446|3226344|P11|Up To Week 12|Lack of Efficacy|0
980742|NCT00550446|3226345|P10|Up To Week 12|Lack of Efficacy|0
980743|NCT00550446|3226346|P9|Up To Week 12|Lack of Efficacy|0
980744|NCT00550446|3226347|P8|Up To Week 12|Lack of Efficacy|0
980745|NCT00550446|3226348|P7|Up To Week 12|Lack of Efficacy|3
980746|NCT00550446|3226349|P6|Up To Week 12|Lack of Efficacy|3
980747|NCT00550446|3226350|P5|Up To Week 12|Lack of Efficacy|0
980748|NCT00550446|3226351|P4|Up To Week 12|Lack of Efficacy|1
980749|NCT00550446|3226352|P3|Up To Week 12|Lack of Efficacy|0
980750|NCT00550446|3226353|P2|Up To Week 12|Lack of Efficacy|1
980751|NCT00550446|3226354|P1|Up To Week 12|Lack of Efficacy|3
980752|NCT00550446|3226344|P11|Up To Week 12|Adverse Event|0
980753|NCT00550446|3226345|P10|Up To Week 12|Adverse Event|0
980754|NCT00550446|3226346|P9|Up To Week 12|Adverse Event|0
980755|NCT00550446|3226347|P8|Up To Week 12|Adverse Event|0
980756|NCT00550446|3226348|P7|Up To Week 12|Adverse Event|1
980757|NCT00550446|3226349|P6|Up To Week 12|Adverse Event|2
980758|NCT00550446|3226350|P5|Up To Week 12|Adverse Event|2
980759|NCT00550446|3226351|P4|Up To Week 12|Adverse Event|0
980760|NCT00550446|3226352|P3|Up To Week 12|Adverse Event|0
980761|NCT00550446|3226353|P2|Up To Week 12|Adverse Event|2
980762|NCT00550446|3226354|P1|Up To Week 12|Adverse Event|2
980763|NCT00550420|3226786|P1|Overall Study|Prohibited medicine|1
980764|NCT00550420|3226786|P1|Overall Study|Exclusion criteria|1
980765|NCT00550420|3226786|P1|Overall Study|Out of Electrocardiogram criteria|1
980766|NCT00550420|3226786|P1|Overall Study|Caregiver's decision to withdraw|1
980767|NCT00550420|3226786|P1|Overall Study|Unethical stop of enrollment|2
980768|NCT00550420|3226786|P1|Overall Study|Lack of curative effect|1
980769|NCT00550420|3226786|P1|Overall Study|Investigators opinion|1
980770|NCT00550420|3226786|P1|Overall Study|Prolonged QT Interval Electrocardiogram|12
980771|NCT00550420|3226786|P1|Overall Study|Missing|2
980772|NCT00550420|3226786|P1|Overall Study|Still in study at termination|206
980773|NCT00550420|3226786|P1|Overall Study|Withdrawal by Subject|30
980774|NCT00550420|3226786|P1|Overall Study|Protocol Violation|11
980775|NCT00550420|3226786|P1|Overall Study|Lost to Follow-up|8
980776|NCT00550420|3226786|P1|Overall Study|Adverse Event|28
980777|NCT00550407|3226809|P3|26-Week Randomized Phase|Withdrawal by Subject|3
980778|NCT00550407|3226810|P2|26-Week Randomized Phase|Withdrawal by Subject|1
980779|NCT00550407|3226811|P1|26-Week Randomized Phase|Withdrawal by Subject|0
980780|NCT00550407|3226809|P3|26-Week Randomized Phase|Investigator Discretion|0
980781|NCT00550407|3226810|P2|26-Week Randomized Phase|Investigator Discretion|1
980782|NCT00550407|3226811|P1|26-Week Randomized Phase|Investigator Discretion|0
980783|NCT00550407|3226809|P3|26-Week Randomized Phase|Lack of Efficacy|19
980784|NCT00550407|3226810|P2|26-Week Randomized Phase|Lack of Efficacy|36
980785|NCT00550407|3226811|P1|26-Week Randomized Phase|Lack of Efficacy|0
980786|NCT00550407|3226809|P3|26-Week Randomized Phase|Adverse Event|2
980787|NCT00550407|3226810|P2|26-Week Randomized Phase|Adverse Event|5
980788|NCT00550407|3226811|P1|26-Week Randomized Phase|Adverse Event|0
980789|NCT00550407|3226809|P3|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
980790|NCT00550407|3226810|P2|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
980791|NCT00550407|3226811|P1|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1
980792|NCT00550407|3226809|P3|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
980793|NCT00550407|3226810|P2|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
980794|NCT00550407|3226811|P1|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6
980795|NCT00550407|3226809|P3|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
980796|NCT00550407|3226810|P2|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
980797|NCT00550407|3226811|P1|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8
980798|NCT00550407|3226809|P3|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
980799|NCT00550407|3226810|P2|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
980800|NCT00550407|3226811|P1|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1
980801|NCT00550407|3226809|P3|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
980802|NCT00550407|3226810|P2|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
980803|NCT00550407|3226811|P1|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1
980804|NCT00550407|3226809|P3|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
980805|NCT00550407|3226810|P2|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
980806|NCT00550407|3226811|P1|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1
980807|NCT00550407|3226809|P3|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
980808|NCT00550407|3226810|P2|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
980809|NCT00550407|3226811|P1|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39
980810|NCT00550407|3226809|P3|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
980811|NCT00550407|3226810|P2|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
980812|NCT00550407|3226811|P1|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55
980813|NCT00550173|3226886|P3|Overall Study|Lost to Follow-up|3
980814|NCT00550173|3226887|P2|Overall Study|Lost to Follow-up|4
980815|NCT00550173|3226888|P1|Overall Study|Lost to Follow-up|4
980816|NCT00550173|3226886|P3|Overall Study|Sponsor Decision|1
980817|NCT00550173|3226887|P2|Overall Study|Sponsor Decision|7
980818|NCT00550173|3226888|P1|Overall Study|Sponsor Decision|13
980819|NCT00550173|3226886|P3|Overall Study|Withdrawal by Subject|17
980820|NCT00550173|3226887|P2|Overall Study|Withdrawal by Subject|12
980821|NCT00550173|3226888|P1|Overall Study|Withdrawal by Subject|9
980822|NCT00550173|3226886|P3|Overall Study|Physician Decision|2
980823|NCT00550173|3226887|P2|Overall Study|Physician Decision|2
980824|NCT00550173|3226888|P1|Overall Study|Physician Decision|1
980825|NCT00550173|3226886|P3|Overall Study|Death|50
980826|NCT00550173|3226887|P2|Overall Study|Death|38
980827|NCT00550173|3226888|P1|Overall Study|Death|45
980828|NCT00550147|3226917|P1|Quetiapine Addition Treatment Period|Moved out of state|1
980829|NCT00550147|3226917|P1|Quetiapine Addition Treatment Period|Noncompliance|2
980830|NCT00550147|3226917|P1|Quetiapine Addition Treatment Period|Adverse Event|3
980831|NCT00550147|3226917|P1|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2
980832|NCT00550147|3226917|P1|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4
980833|NCT00550043|3226940|P5|Overall Study|Other Reasons- Unspecified|0
980834|NCT00550043|3226941|P4|Overall Study|Other Reasons- Unspecified|1
980835|NCT00550043|3226942|P3|Overall Study|Other Reasons- Unspecified|0
980836|NCT00550043|3226943|P2|Overall Study|Other Reasons- Unspecified|1
980837|NCT00550043|3226944|P1|Overall Study|Other Reasons- Unspecified|0
980838|NCT00550043|3226940|P5|Overall Study|Subject Withdrew Consent|0
980839|NCT00550043|3226941|P4|Overall Study|Subject Withdrew Consent|0
980840|NCT00550043|3226942|P3|Overall Study|Subject Withdrew Consent|1
980841|NCT00550043|3226943|P2|Overall Study|Subject Withdrew Consent|2
980842|NCT00550043|3226944|P1|Overall Study|Subject Withdrew Consent|0
980843|NCT00550043|3226940|P5|Overall Study|Adverse Event|1
980844|NCT00550043|3226941|P4|Overall Study|Adverse Event|1
980845|NCT00550043|3226942|P3|Overall Study|Adverse Event|0
980846|NCT00550043|3226943|P2|Overall Study|Adverse Event|0
980847|NCT00550043|3226944|P1|Overall Study|Adverse Event|0
980848|NCT00549939|3226999|P3|40-week Open Label Treatment Period|Other|4
980849|NCT00549939|3227000|P2|40-week Open Label Treatment Period|Other|1
980850|NCT00549939|3227001|P1|40-week Open Label Treatment Period|Other|0
980851|NCT00549939|3226999|P3|40-week Open Label Treatment Period|Protocol Violation|0
980852|NCT00549939|3227000|P2|40-week Open Label Treatment Period|Protocol Violation|1
980853|NCT00549939|3227001|P1|40-week Open Label Treatment Period|Protocol Violation|0
980854|NCT00549939|3226999|P3|40-week Open Label Treatment Period|Lack of Efficacy|0
980855|NCT00549939|3227000|P2|40-week Open Label Treatment Period|Lack of Efficacy|1
980856|NCT00549939|3227001|P1|40-week Open Label Treatment Period|Lack of Efficacy|0
980857|NCT00549939|3226999|P3|40-week Open Label Treatment Period|Adverse Event|1
980858|NCT00549939|3227000|P2|40-week Open Label Treatment Period|Adverse Event|2
980859|NCT00549939|3227001|P1|40-week Open Label Treatment Period|Adverse Event|0
980860|NCT00549939|3226999|P3|12-week Double Blind Treatment Period|Too many blood draws|0
980861|NCT00549939|3227000|P2|12-week Double Blind Treatment Period|Too many blood draws|1
980862|NCT00549939|3227001|P1|12-week Double Blind Treatment Period|Too many blood draws|0
980863|NCT00549939|3226999|P3|12-week Double Blind Treatment Period|Adverse Event|2
980864|NCT00549939|3227000|P2|12-week Double Blind Treatment Period|Adverse Event|1
980865|NCT00549939|3227001|P1|12-week Double Blind Treatment Period|Adverse Event|1
980866|NCT00549900|3227028|P1|Overall Study|Adverse Event|1
980867|NCT00549770|3227084|P8|Overall Study|Adverse Event|4
980868|NCT00549770|3227085|P7|Overall Study|Adverse Event|5
980869|NCT00549770|3227086|P6|Overall Study|Adverse Event|0
980870|NCT00549770|3227087|P5|Overall Study|Adverse Event|1
980871|NCT00549770|3227088|P4|Overall Study|Adverse Event|2
980872|NCT00549770|3227089|P3|Overall Study|Adverse Event|1
980873|NCT00549770|3227090|P2|Overall Study|Adverse Event|3
980874|NCT00549770|3227091|P1|Overall Study|Adverse Event|1
980875|NCT00549770|3227084|P8|Overall Study|Abnormal laboratory values|0
980876|NCT00549770|3227085|P7|Overall Study|Abnormal laboratory values|0
980877|NCT00549770|3227086|P6|Overall Study|Abnormal laboratory values|1
980878|NCT00549770|3227087|P5|Overall Study|Abnormal laboratory values|0
980879|NCT00549770|3227088|P4|Overall Study|Abnormal laboratory values|0
980880|NCT00549770|3227089|P3|Overall Study|Abnormal laboratory values|0
980881|NCT00549770|3227090|P2|Overall Study|Abnormal laboratory values|0
980882|NCT00549770|3227091|P1|Overall Study|Abnormal laboratory values|0
980883|NCT00549770|3227084|P8|Overall Study|Abnormal test procedure results|1
980884|NCT00549770|3227085|P7|Overall Study|Abnormal test procedure results|1
980885|NCT00549770|3227086|P6|Overall Study|Abnormal test procedure results|1
980886|NCT00549770|3227087|P5|Overall Study|Abnormal test procedure results|0
980887|NCT00549770|3227088|P4|Overall Study|Abnormal test procedure results|2
980888|NCT00549770|3227089|P3|Overall Study|Abnormal test procedure results|0
980889|NCT00549770|3227090|P2|Overall Study|Abnormal test procedure results|0
980890|NCT00549770|3227091|P1|Overall Study|Abnormal test procedure results|0
980891|NCT00549770|3227084|P8|Overall Study|Lack of Efficacy|8
980892|NCT00549770|3227085|P7|Overall Study|Lack of Efficacy|3
980893|NCT00549770|3227086|P6|Overall Study|Lack of Efficacy|1
980894|NCT00549770|3227087|P5|Overall Study|Lack of Efficacy|5
980895|NCT00549770|3227088|P4|Overall Study|Lack of Efficacy|3
980896|NCT00549770|3227089|P3|Overall Study|Lack of Efficacy|2
980897|NCT00549770|3227090|P2|Overall Study|Lack of Efficacy|0
980898|NCT00549770|3227091|P1|Overall Study|Lack of Efficacy|1
980899|NCT00549770|3227084|P8|Overall Study|Withdrawal by Subject|9
980900|NCT00549770|3227085|P7|Overall Study|Withdrawal by Subject|4
980901|NCT00549770|3227086|P6|Overall Study|Withdrawal by Subject|6
980902|NCT00549770|3227087|P5|Overall Study|Withdrawal by Subject|6
980903|NCT00549770|3227088|P4|Overall Study|Withdrawal by Subject|5
980904|NCT00549770|3227089|P3|Overall Study|Withdrawal by Subject|4
980905|NCT00549770|3227090|P2|Overall Study|Withdrawal by Subject|6
980906|NCT00549770|3227091|P1|Overall Study|Withdrawal by Subject|4
980907|NCT00549770|3227084|P8|Overall Study|Lost to Follow-up|0
980908|NCT00549770|3227085|P7|Overall Study|Lost to Follow-up|0
980909|NCT00549770|3227086|P6|Overall Study|Lost to Follow-up|2
980910|NCT00549770|3227087|P5|Overall Study|Lost to Follow-up|3
980911|NCT00549770|3227088|P4|Overall Study|Lost to Follow-up|2
980912|NCT00549770|3227089|P3|Overall Study|Lost to Follow-up|2
980913|NCT00549770|3227090|P2|Overall Study|Lost to Follow-up|0
980914|NCT00549770|3227091|P1|Overall Study|Lost to Follow-up|0
980915|NCT00549770|3227084|P8|Overall Study|Administrative problems|1
980916|NCT00549770|3227085|P7|Overall Study|Administrative problems|0
980917|NCT00549770|3227086|P6|Overall Study|Administrative problems|0
980918|NCT00549770|3227087|P5|Overall Study|Administrative problems|0
980919|NCT00549770|3227088|P4|Overall Study|Administrative problems|0
980920|NCT00549770|3227089|P3|Overall Study|Administrative problems|0
980921|NCT00549770|3227090|P2|Overall Study|Administrative problems|1
980922|NCT00549770|3227091|P1|Overall Study|Administrative problems|0
980923|NCT00549770|3227084|P8|Overall Study|Protocol deviation|2
980924|NCT00549770|3227085|P7|Overall Study|Protocol deviation|1
980925|NCT00549770|3227086|P6|Overall Study|Protocol deviation|2
980926|NCT00549770|3227087|P5|Overall Study|Protocol deviation|2
980927|NCT00549770|3227088|P4|Overall Study|Protocol deviation|2
980928|NCT00549770|3227089|P3|Overall Study|Protocol deviation|1
980929|NCT00549770|3227090|P2|Overall Study|Protocol deviation|1
980930|NCT00549770|3227091|P1|Overall Study|Protocol deviation|1
980931|NCT00549757|3227175|P2|Extension Period (in Average 9 Months)|Patient's request|436
980932|NCT00549757|3227176|P1|Extension Period (in Average 9 Months)|Patient's request|421
980933|NCT00549757|3227175|P2|Extension Period (in Average 9 Months)|Withdrawal by Subject|16
980934|NCT00549757|3227176|P1|Extension Period (in Average 9 Months)|Withdrawal by Subject|9
980935|NCT00549757|3227175|P2|Extension Period (in Average 9 Months)|Lost to Follow-up|47
980936|NCT00549757|3227176|P1|Extension Period (in Average 9 Months)|Lost to Follow-up|52
980937|NCT00549757|3227175|P2|Extension Period (in Average 9 Months)|Death|136
980938|NCT00549757|3227176|P1|Extension Period (in Average 9 Months)|Death|143
980939|NCT00549757|3227175|P2|Active Treatment Phase: Max. 50 Months|Missing data|9
980940|NCT00549757|3227176|P1|Active Treatment Phase: Max. 50 Months|Missing data|8
980941|NCT00549757|3227175|P2|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55
980942|NCT00549757|3227176|P1|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69
980943|NCT00549757|3227175|P2|Active Treatment Phase: Max. 50 Months|Patient's request|380
980944|NCT00549757|3227176|P1|Active Treatment Phase: Max. 50 Months|Patient's request|353
980945|NCT00549757|3227175|P2|Active Treatment Phase: Max. 50 Months|Death|200
980946|NCT00549757|3227176|P1|Active Treatment Phase: Max. 50 Months|Death|188
980947|NCT00549757|3227175|P2|Active Treatment Phase: Max. 50 Months|Administrative problems|3019
980948|NCT00549757|3227176|P1|Active Treatment Phase: Max. 50 Months|Administrative problems|2857
980949|NCT00549757|3227175|P2|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29
980950|NCT00549757|3227176|P1|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41
980951|NCT00549757|3227175|P2|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
980952|NCT00549757|3227176|P1|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
980953|NCT00549757|3227175|P2|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53
980954|NCT00549757|3227176|P1|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47
980955|NCT00549757|3227175|P2|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
980956|NCT00549757|3227176|P1|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
980957|NCT00549757|3227175|P2|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58
980958|NCT00549757|3227176|P1|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98
980959|NCT00549757|3227175|P2|Active Treatment Phase: Max. 50 Months|Adverse Event|462
980960|NCT00549757|3227176|P1|Active Treatment Phase: Max. 50 Months|Adverse Event|590
980961|NCT00549718|3227238|P4|Overall Study|Administrative|1
980962|NCT00549718|3227239|P3|Overall Study|Administrative|2
980963|NCT00549718|3227240|P2|Overall Study|Administrative|2
980964|NCT00549718|3227241|P1|Overall Study|Administrative|2
980965|NCT00549718|3227238|P4|Overall Study|Withdrawal by Subject|13
980966|NCT00549718|3227239|P3|Overall Study|Withdrawal by Subject|12
980967|NCT00549718|3227240|P2|Overall Study|Withdrawal by Subject|18
980968|NCT00549718|3227241|P1|Overall Study|Withdrawal by Subject|9
980969|NCT00549718|3227238|P4|Overall Study|Lost to Follow-up|6
980970|NCT00549718|3227239|P3|Overall Study|Lost to Follow-up|0
980971|NCT00549718|3227240|P2|Overall Study|Lost to Follow-up|2
980972|NCT00549718|3227241|P1|Overall Study|Lost to Follow-up|4
980973|NCT00549718|3227238|P4|Overall Study|Adverse Event|3
980974|NCT00549718|3227239|P3|Overall Study|Adverse Event|7
980975|NCT00549718|3227240|P2|Overall Study|Adverse Event|8
980976|NCT00549718|3227241|P1|Overall Study|Adverse Event|6
980977|NCT00549718|3227238|P4|Overall Study|Insufficient clinical response|32
980978|NCT00549718|3227239|P3|Overall Study|Insufficient clinical response|18
980979|NCT00549718|3227240|P2|Overall Study|Insufficient clinical response|7
980980|NCT00549718|3227241|P1|Overall Study|Insufficient clinical response|20
980981|NCT00549640|3227257|P2|Overall Study|Lost to Follow-up|4
980982|NCT00549640|3227258|P1|Overall Study|Lost to Follow-up|7
980983|NCT00549640|3227257|P2|Overall Study|Adverse Event|0
980984|NCT00549640|3227258|P1|Overall Study|Adverse Event|5
980985|NCT00549640|3227257|P2|Overall Study|Withdrawal by Subject|12
980986|NCT00549640|3227258|P1|Overall Study|Withdrawal by Subject|6
980987|NCT00549601|3227271|P3|Received Study Drug|Withdrawal by Subject|1
980988|NCT00549601|3227272|P2|Received Study Drug|Withdrawal by Subject|0
980989|NCT00549601|3227273|P1|Received Study Drug|Withdrawal by Subject|2
980990|NCT00549601|3227271|P3|Received Study Drug|Protocol Violation|1
980991|NCT00549601|3227272|P2|Received Study Drug|Protocol Violation|4
980992|NCT00549601|3227273|P1|Received Study Drug|Protocol Violation|3
980993|NCT00549601|3227271|P3|Received Study Drug|Lost to Follow-up|1
980994|NCT00549601|3227272|P2|Received Study Drug|Lost to Follow-up|1
980995|NCT00549601|3227273|P1|Received Study Drug|Lost to Follow-up|0
980996|NCT00549601|3227271|P3|Received Study Drug|Death|0
980997|NCT00549601|3227272|P2|Received Study Drug|Death|1
980998|NCT00549601|3227273|P1|Received Study Drug|Death|0
980999|NCT00549601|3227271|P3|Received Study Drug|Adverse Event|1
981000|NCT00549601|3227272|P2|Received Study Drug|Adverse Event|5
981001|NCT00549601|3227273|P1|Received Study Drug|Adverse Event|2
981002|NCT00549601|3227271|P3|Randomized|Withdrawal by Subject|1
981003|NCT00549601|3227272|P2|Randomized|Withdrawal by Subject|1
981004|NCT00549601|3227273|P1|Randomized|Withdrawal by Subject|0
981005|NCT00549601|3227271|P3|Randomized|Protocol Violation|1
981006|NCT00549601|3227272|P2|Randomized|Protocol Violation|0
981007|NCT00549601|3227273|P1|Randomized|Protocol Violation|0
981008|NCT00549562|3227295|P1|Overall Study|Lack of Efficacy|1
981009|NCT00549562|3227295|P1|Overall Study|Adverse Event|1
981010|NCT00549549|3227307|P4|Overall Study|Randomized but not treated|1
981011|NCT00549549|3227308|P3|Overall Study|Randomized but not treated|1
981012|NCT00549549|3227309|P2|Overall Study|Randomized but not treated|0
981013|NCT00549549|3227310|P1|Overall Study|Randomized but not treated|0
981014|NCT00549549|3227307|P4|Overall Study|Other|11
981015|NCT00549549|3227308|P3|Overall Study|Other|9
981016|NCT00549549|3227309|P2|Overall Study|Other|9
981017|NCT00549549|3227310|P1|Overall Study|Other|9
981018|NCT00549549|3227307|P4|Overall Study|Withdrawal by Subject|0
981019|NCT00549549|3227308|P3|Overall Study|Withdrawal by Subject|1
981020|NCT00549549|3227309|P2|Overall Study|Withdrawal by Subject|4
981021|NCT00549549|3227310|P1|Overall Study|Withdrawal by Subject|0
981022|NCT00549549|3227307|P4|Overall Study|Lost to Follow-up|2
981023|NCT00549549|3227308|P3|Overall Study|Lost to Follow-up|1
981024|NCT00549549|3227309|P2|Overall Study|Lost to Follow-up|0
981025|NCT00549549|3227310|P1|Overall Study|Lost to Follow-up|1
981026|NCT00549549|3227307|P4|Overall Study|Lack of Efficacy|2
981027|NCT00549549|3227308|P3|Overall Study|Lack of Efficacy|4
981028|NCT00549549|3227309|P2|Overall Study|Lack of Efficacy|6
981029|NCT00549549|3227310|P1|Overall Study|Lack of Efficacy|9
981030|NCT00549549|3227307|P4|Overall Study|Adverse Event|9
981031|NCT00549549|3227308|P3|Overall Study|Adverse Event|1
981032|NCT00549549|3227309|P2|Overall Study|Adverse Event|3
981033|NCT00549549|3227310|P1|Overall Study|Adverse Event|5
981034|NCT00549445|3227378|P2|Overall Study|Sputum & Blood Samples Not Available|17
981035|NCT00549445|3227379|P1|Overall Study|Sputum & Blood Samples Not Available|15
981036|NCT00549328|3227398|P1|Overall Study|Use of Prohibited Medication|1
981037|NCT00549328|3227398|P1|Overall Study|Death|1
981038|NCT00549328|3227398|P1|Overall Study|Disease Progression|10
981039|NCT00549328|3227398|P1|Overall Study|Adverse Event|2
981040|NCT00549302|3227409|P3|Open-Label|Withdrawal by Subject|6
981041|NCT00549302|3227410|P2|Open-Label|Withdrawal by Subject|0
981042|NCT00549302|3227411|P1|Open-Label|Withdrawal by Subject|0
981043|NCT00549302|3227409|P3|Open-Label|New drug pulmonary atrial hypertension|2
981044|NCT00549302|3227410|P2|Open-Label|New drug pulmonary atrial hypertension|0
981045|NCT00549302|3227411|P1|Open-Label|New drug pulmonary atrial hypertension|0
981046|NCT00549302|3227409|P3|Open-Label|Other|3
981047|NCT00549302|3227410|P2|Open-Label|Other|0
981048|NCT00549302|3227411|P1|Open-Label|Other|0
981049|NCT00549302|3227409|P3|Open-Label|Lost to Follow-up|2
981050|NCT00549302|3227410|P2|Open-Label|Lost to Follow-up|0
981051|NCT00549302|3227411|P1|Open-Label|Lost to Follow-up|0
981052|NCT00549302|3227409|P3|Open-Label|Investigator Decision|5
981053|NCT00549302|3227410|P2|Open-Label|Investigator Decision|0
981054|NCT00549302|3227411|P1|Open-Label|Investigator Decision|0
981055|NCT00549302|3227409|P3|Open-Label|Death|40
981056|NCT00549302|3227410|P2|Open-Label|Death|0
981057|NCT00549302|3227411|P1|Open-Label|Death|0
981058|NCT00549302|3227409|P3|Open-Label|Adverse Event|11
981059|NCT00549302|3227410|P2|Open-Label|Adverse Event|0
981060|NCT00549302|3227411|P1|Open-Label|Adverse Event|0
981061|NCT00549302|3227409|P3|Double-Blind|New condition or starts new therapy|0
981062|NCT00549302|3227410|P2|Double-Blind|New condition or starts new therapy|2
981063|NCT00549302|3227411|P1|Double-Blind|New condition or starts new therapy|0
981064|NCT00549302|3227409|P3|Double-Blind|New Drug Pulmonary Atrial Hypertension|0
981065|NCT00549302|3227410|P2|Double-Blind|New Drug Pulmonary Atrial Hypertension|10
981066|NCT00549302|3227411|P1|Double-Blind|New Drug Pulmonary Atrial Hypertension|1
981067|NCT00549302|3227409|P3|Double-Blind|Lost to Follow-up|0
981068|NCT00549302|3227410|P2|Double-Blind|Lost to Follow-up|2
981069|NCT00549302|3227411|P1|Double-Blind|Lost to Follow-up|1
981070|NCT00549302|3227409|P3|Double-Blind|Sponsor Decision|0
981071|NCT00549302|3227410|P2|Double-Blind|Sponsor Decision|1
981072|NCT00549302|3227411|P1|Double-Blind|Sponsor Decision|0
981073|NCT00549302|3227409|P3|Double-Blind|Investigator Decision|0
981074|NCT00549302|3227410|P2|Double-Blind|Investigator Decision|5
981075|NCT00549302|3227411|P1|Double-Blind|Investigator Decision|1
981076|NCT00549302|3227409|P3|Double-Blind|Withdrawal by Subject|0
981077|NCT00549302|3227410|P2|Double-Blind|Withdrawal by Subject|8
981078|NCT00549302|3227411|P1|Double-Blind|Withdrawal by Subject|3
981079|NCT00549302|3227409|P3|Double-Blind|Adverse Event|0
981080|NCT00549302|3227410|P2|Double-Blind|Adverse Event|16
981081|NCT00549302|3227411|P1|Double-Blind|Adverse Event|3
981082|NCT00549302|3227409|P3|Double-Blind|Death|0
981083|NCT00549302|3227410|P2|Double-Blind|Death|9
981084|NCT00549302|3227411|P1|Double-Blind|Death|2
981085|NCT00549198|3227423|P2|Overall Study|Not Exposed to Study Drug|4
981086|NCT00549198|3227424|P1|Overall Study|Not Exposed to Study Drug|3
981087|NCT00549198|3227423|P2|Overall Study|Pregnancy|3
981088|NCT00549198|3227424|P1|Overall Study|Pregnancy|0
981089|NCT00549198|3227423|P2|Overall Study|No scan facilities|2
981090|NCT00549198|3227424|P1|Overall Study|No scan facilities|0
981091|NCT00549198|3227423|P2|Overall Study|Participant overweight, no scan possible|0
981092|NCT00549198|3227424|P1|Overall Study|Participant overweight, no scan possible|1
981093|NCT00549198|3227423|P2|Overall Study|Participant planning pregnancy|0
981094|NCT00549198|3227424|P1|Overall Study|Participant planning pregnancy|1
981095|NCT00549198|3227423|P2|Overall Study|Prohibited Medication|2
981096|NCT00549198|3227424|P1|Overall Study|Prohibited Medication|1
981097|NCT00549198|3227423|P2|Overall Study|Participant moved.Week 96 visit, no scan|0
981186|NCT00548405|3227690|P3|Overall Study|Lack of Efficacy|0
981098|NCT00549198|3227424|P1|Overall Study|Participant moved.Week 96 visit, no scan|1
981099|NCT00549198|3227423|P2|Overall Study|Participant not able to perform Week 96|0
981100|NCT00549198|3227424|P1|Overall Study|Participant not able to perform Week 96|1
981101|NCT00549198|3227423|P2|Overall Study|Participant Moved|0
981102|NCT00549198|3227424|P1|Overall Study|Participant Moved|2
981103|NCT00549198|3227423|P2|Overall Study|Disease Progression|0
981104|NCT00549198|3227424|P1|Overall Study|Disease Progression|1
981105|NCT00549198|3227423|P2|Overall Study|Withdrawal by Subject|7
981106|NCT00549198|3227424|P1|Overall Study|Withdrawal by Subject|7
981107|NCT00549198|3227423|P2|Overall Study|Investigator Decision|3
981108|NCT00549198|3227424|P1|Overall Study|Investigator Decision|4
981109|NCT00549198|3227423|P2|Overall Study|Protocol Violation|2
981110|NCT00549198|3227424|P1|Overall Study|Protocol Violation|7
981111|NCT00549198|3227423|P2|Overall Study|Treatment Eligibility Criteria Not Met|0
981112|NCT00549198|3227424|P1|Overall Study|Treatment Eligibility Criteria Not Met|3
981113|NCT00549198|3227423|P2|Overall Study|Lost to Follow-up|8
981114|NCT00549198|3227424|P1|Overall Study|Lost to Follow-up|7
981115|NCT00549198|3227423|P2|Overall Study|Non-compliance|4
981116|NCT00549198|3227424|P1|Overall Study|Non-compliance|2
981117|NCT00549198|3227423|P2|Overall Study|Protocol-defined Virological Failure|0
981118|NCT00549198|3227424|P1|Overall Study|Protocol-defined Virological Failure|7
981119|NCT00549198|3227423|P2|Overall Study|Insufficient Viral Load Response|2
981120|NCT00549198|3227424|P1|Overall Study|Insufficient Viral Load Response|4
981121|NCT00549198|3227423|P2|Overall Study|Adverse Event|26
981122|NCT00549198|3227424|P1|Overall Study|Adverse Event|28
981123|NCT00549055|3227561|P1|Overall Study|Very low visual acuity (VA)|1
981124|NCT00549055|3227561|P1|Overall Study|Choroidal neovascularization|1
981125|NCT00549055|3227561|P1|Overall Study|Growth choroidal neovascularisation|1
981126|NCT00549055|3227561|P1|Overall Study|Vitreous hemorrhage|1
981127|NCT00549055|3227561|P1|Overall Study|Active choroidal neovascula increased|1
981128|NCT00549055|3227561|P1|Overall Study|Decrease of size|1
981129|NCT00549055|3227561|P1|Overall Study|Progression to fibrosis|2
981130|NCT00549055|3227561|P1|Overall Study|Stabilization|5
981131|NCT00549055|3227561|P1|Overall Study|Lack of efficacy|18
981132|NCT00549055|3227561|P1|Overall Study|Adverse Event|4
981133|NCT00548847|3227585|P1|Overall Study|Disease progression|7
981134|NCT00548808|3227592|P2|Overall Study|Sponsor Decision|1
981135|NCT00548808|3227593|P1|Overall Study|Sponsor Decision|1
981136|NCT00548808|3227592|P2|Overall Study|Lack of Efficacy|0
981137|NCT00548808|3227593|P1|Overall Study|Lack of Efficacy|2
981138|NCT00548808|3227592|P2|Overall Study|Entry Criteria Not Met|2
981139|NCT00548808|3227593|P1|Overall Study|Entry Criteria Not Met|2
981140|NCT00548808|3227592|P2|Overall Study|Death|0
981141|NCT00548808|3227593|P1|Overall Study|Death|2
981142|NCT00548808|3227592|P2|Overall Study|Adverse Event|5
981143|NCT00548808|3227593|P1|Overall Study|Adverse Event|4
981144|NCT00548808|3227592|P2|Overall Study|Physician Decision|3
981145|NCT00548808|3227593|P1|Overall Study|Physician Decision|6
981146|NCT00548808|3227592|P2|Overall Study|Withdrawal by Subject|4
981147|NCT00548808|3227593|P1|Overall Study|Withdrawal by Subject|8
981148|NCT00548808|3227592|P2|Overall Study|Protocol Violation|8
981149|NCT00548808|3227593|P1|Overall Study|Protocol Violation|8
981150|NCT00548808|3227592|P2|Overall Study|Lost to Follow-up|3
981151|NCT00548808|3227593|P1|Overall Study|Lost to Follow-up|9
981152|NCT00548717|3227617|P2|Overall Study|Alternative treatment for GVHD|0
981153|NCT00548717|3227618|P1|Overall Study|Alternative treatment for GVHD|1
981154|NCT00548717|3227617|P2|Overall Study|Relapse|0
981155|NCT00548717|3227618|P1|Overall Study|Relapse|3
981156|NCT00548717|3227617|P2|Overall Study|Death|2
981157|NCT00548717|3227618|P1|Overall Study|Death|5
981158|NCT00548548|3227646|P2|Overall Study|Lost to Follow-up|18
981159|NCT00548548|3227647|P1|Overall Study|Lost to Follow-up|17
981160|NCT00548548|3227646|P2|Overall Study|Death|348
981161|NCT00548548|3227647|P1|Overall Study|Death|345
981162|NCT00548405|3227690|P3|Overall Study|Randomized but not treated|0
981163|NCT00548405|3227691|P2|Overall Study|Randomized but not treated|0
981164|NCT00548405|3227692|P1|Overall Study|Randomized but not treated|1
981165|NCT00548405|3227690|P3|Overall Study|Sponsor decision|0
981166|NCT00548405|3227691|P2|Overall Study|Sponsor decision|0
981167|NCT00548405|3227692|P1|Overall Study|Sponsor decision|1
981168|NCT00548405|3227690|P3|Overall Study|Death|1
981169|NCT00548405|3227691|P2|Overall Study|Death|1
981170|NCT00548405|3227692|P1|Overall Study|Death|0
981171|NCT00548405|3227690|P3|Overall Study|Lost to Follow-up|2
981172|NCT00548405|3227691|P2|Overall Study|Lost to Follow-up|1
981173|NCT00548405|3227692|P1|Overall Study|Lost to Follow-up|1
981174|NCT00548405|3227690|P3|Overall Study|Withdrawal by Subject|5
981175|NCT00548405|3227691|P2|Overall Study|Withdrawal by Subject|12
981176|NCT00548405|3227692|P1|Overall Study|Withdrawal by Subject|36
981177|NCT00548405|3227690|P3|Overall Study|Protocol Violation|0
981178|NCT00548405|3227691|P2|Overall Study|Protocol Violation|0
981179|NCT00548405|3227692|P1|Overall Study|Protocol Violation|1
981180|NCT00548405|3227690|P3|Overall Study|Pregnancy|0
981181|NCT00548405|3227691|P2|Overall Study|Pregnancy|0
981182|NCT00548405|3227692|P1|Overall Study|Pregnancy|1
981183|NCT00548405|3227690|P3|Overall Study|Physician Decision|1
981184|NCT00548405|3227691|P2|Overall Study|Physician Decision|4
981185|NCT00548405|3227692|P1|Overall Study|Physician Decision|3
981187|NCT00548405|3227691|P2|Overall Study|Lack of Efficacy|0
981188|NCT00548405|3227692|P1|Overall Study|Lack of Efficacy|6
981189|NCT00548405|3227690|P3|Overall Study|Adverse Event|0
981190|NCT00548405|3227691|P2|Overall Study|Adverse Event|2
981191|NCT00548405|3227692|P1|Overall Study|Adverse Event|6
981192|NCT00548340|3227713|P3|Overall Study|Other|1
981193|NCT00548340|3227714|P2|Overall Study|Other|1
981194|NCT00548340|3227715|P1|Overall Study|Other|1
981195|NCT00548340|3227713|P3|Overall Study|Withdrawal by Subject|3
981196|NCT00548340|3227714|P2|Overall Study|Withdrawal by Subject|4
981197|NCT00548340|3227715|P1|Overall Study|Withdrawal by Subject|2
981198|NCT00548340|3227713|P3|Overall Study|Lost to Follow-up|0
981199|NCT00548340|3227714|P2|Overall Study|Lost to Follow-up|1
981200|NCT00548340|3227715|P1|Overall Study|Lost to Follow-up|1
981201|NCT00548340|3227713|P3|Overall Study|Adverse Event|2
981202|NCT00548340|3227714|P2|Overall Study|Adverse Event|2
981203|NCT00548340|3227715|P1|Overall Study|Adverse Event|2
981204|NCT00548340|3227713|P3|Overall Study|Protocol Violation|3
981205|NCT00548340|3227714|P2|Overall Study|Protocol Violation|3
981206|NCT00548340|3227715|P1|Overall Study|Protocol Violation|2
981207|NCT00548327|3227734|P2|Overall Study|Adverse Event|1
981208|NCT00548327|3227735|P1|Overall Study|Adverse Event|0
981209|NCT00548262|3227753|P1|Overall Study|Withdrawal by Subject|1
981210|NCT00548262|3227753|P1|Overall Study|Other|3
981211|NCT00548262|3227753|P1|Overall Study|Lost to Follow-up|1
981212|NCT00548262|3227753|P1|Overall Study|Lack of Efficacy|4
981213|NCT00548262|3227753|P1|Overall Study|Adverse Event|2
981214|NCT00548262|3227753|P1|Overall Study|Death|21
981215|NCT00548249|3227783|P5|Overall Study|Sponsor's request|0
981216|NCT00548249|3227784|P4|Overall Study|Sponsor's request|1
981217|NCT00548249|3227785|P3|Overall Study|Sponsor's request|0
981218|NCT00548249|3227786|P2|Overall Study|Sponsor's request|0
981219|NCT00548249|3227787|P1|Overall Study|Sponsor's request|0
981220|NCT00548249|3227783|P5|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
981221|NCT00548249|3227784|P4|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
981222|NCT00548249|3227785|P3|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
981223|NCT00548249|3227786|P2|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
981224|NCT00548249|3227787|P1|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
981225|NCT00548249|3227783|P5|Overall Study|Withdrawal by Subject|0
981226|NCT00548249|3227784|P4|Overall Study|Withdrawal by Subject|0
981227|NCT00548249|3227785|P3|Overall Study|Withdrawal by Subject|0
981228|NCT00548249|3227786|P2|Overall Study|Withdrawal by Subject|0
981229|NCT00548249|3227787|P1|Overall Study|Withdrawal by Subject|2
981230|NCT00548249|3227783|P5|Overall Study|Prolonged hospitalization|0
981231|NCT00548249|3227784|P4|Overall Study|Prolonged hospitalization|1
981232|NCT00548249|3227785|P3|Overall Study|Prolonged hospitalization|2
981233|NCT00548249|3227786|P2|Overall Study|Prolonged hospitalization|0
981234|NCT00548249|3227787|P1|Overall Study|Prolonged hospitalization|0
981235|NCT00548249|3227783|P5|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0
981236|NCT00548249|3227784|P4|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
981237|NCT00548249|3227785|P3|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
981238|NCT00548249|3227786|P2|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
981239|NCT00548249|3227787|P1|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
981240|NCT00548249|3227783|P5|Overall Study|Erythropoietin (ESA)Dose Change Required|2
981241|NCT00548249|3227784|P4|Overall Study|Erythropoietin (ESA)Dose Change Required|2
981242|NCT00548249|3227785|P3|Overall Study|Erythropoietin (ESA)Dose Change Required|1
981243|NCT00548249|3227786|P2|Overall Study|Erythropoietin (ESA)Dose Change Required|0
981244|NCT00548249|3227787|P1|Overall Study|Erythropoietin (ESA)Dose Change Required|0
981245|NCT00548249|3227783|P5|Overall Study|Post-dialysis high TSAT or low UIBC|2
981246|NCT00548249|3227784|P4|Overall Study|Post-dialysis high TSAT or low UIBC|3
981247|NCT00548249|3227785|P3|Overall Study|Post-dialysis high TSAT or low UIBC|1
981248|NCT00548249|3227786|P2|Overall Study|Post-dialysis high TSAT or low UIBC|0
981249|NCT00548249|3227787|P1|Overall Study|Post-dialysis high TSAT or low UIBC|0
981250|NCT00548249|3227783|P5|Overall Study|Adverse Event|1
981251|NCT00548249|3227784|P4|Overall Study|Adverse Event|1
981252|NCT00548249|3227785|P3|Overall Study|Adverse Event|0
981253|NCT00548249|3227786|P2|Overall Study|Adverse Event|2
981254|NCT00548249|3227787|P1|Overall Study|Adverse Event|2
981255|NCT00548249|3227783|P5|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4
981256|NCT00548249|3227784|P4|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1
981257|NCT00548249|3227785|P3|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2
981258|NCT00548249|3227786|P2|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
981259|NCT00548249|3227787|P1|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
981260|NCT00548249|3227783|P5|Overall Study|Miscellaneous|2
981261|NCT00548249|3227784|P4|Overall Study|Miscellaneous|0
981262|NCT00548249|3227785|P3|Overall Study|Miscellaneous|2
981263|NCT00548249|3227786|P2|Overall Study|Miscellaneous|3
981264|NCT00548249|3227787|P1|Overall Study|Miscellaneous|2
981265|NCT00548249|3227783|P5|Overall Study|Protocol Violation|3
981266|NCT00548249|3227784|P4|Overall Study|Protocol Violation|0
981267|NCT00548249|3227785|P3|Overall Study|Protocol Violation|4
981268|NCT00548249|3227786|P2|Overall Study|Protocol Violation|1
981269|NCT00548249|3227787|P1|Overall Study|Protocol Violation|1
981270|NCT00548249|3227783|P5|Overall Study|Transferrin Saturation (TSAT) <20%|2
981271|NCT00548249|3227784|P4|Overall Study|Transferrin Saturation (TSAT) <20%|1
981272|NCT00548249|3227785|P3|Overall Study|Transferrin Saturation (TSAT) <20%|3
981273|NCT00548249|3227786|P2|Overall Study|Transferrin Saturation (TSAT) <20%|1
981274|NCT00548249|3227787|P1|Overall Study|Transferrin Saturation (TSAT) <20%|5
981275|NCT00548249|3227783|P5|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
981276|NCT00548249|3227784|P4|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2
981277|NCT00548249|3227785|P3|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
981278|NCT00548249|3227786|P2|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
981279|NCT00548249|3227787|P1|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3
981280|NCT00548184|3227835|P1|Overall Study|Found Her2 negative|1
981281|NCT00548184|3227835|P1|Overall Study|took other drug|1
981282|NCT00548184|3227835|P1|Overall Study|Adverse Event|3
981283|NCT00548145|3227841|P2|Overall Study|Physician Decision|1
981284|NCT00548145|3227842|P1|Overall Study|Physician Decision|1
981285|NCT00548145|3227841|P2|Overall Study|Withdrawal by Subject|2
981286|NCT00548145|3227842|P1|Overall Study|Withdrawal by Subject|0
981287|NCT00548145|3227841|P2|Overall Study|Death|1
981288|NCT00548145|3227842|P1|Overall Study|Death|0
981289|NCT00547911|3227867|P6|Overall Study|Adverse Event|0
981290|NCT00547911|3227868|P5|Overall Study|Adverse Event|0
981291|NCT00547911|3227869|P4|Overall Study|Adverse Event|1
981292|NCT00547911|3227870|P3|Overall Study|Adverse Event|0
981293|NCT00547911|3227871|P2|Overall Study|Adverse Event|0
981294|NCT00547911|3227872|P1|Overall Study|Adverse Event|0
981295|NCT00547703|3227903|P2|Overall Study|Lost to Follow-up|0
981296|NCT00547703|3227904|P1|Overall Study|Lost to Follow-up|1
981297|NCT00547534|3227929|P1|Overall Study|Disease Progression|4
981298|NCT00547534|3227929|P1|Overall Study|Adverse Event|7
981299|NCT00547521|3227937|P2|Long Term Extension (LTE) Study|Poor/Non-Compliance|1
981300|NCT00547521|3227938|P1|Long Term Extension (LTE) Study|Poor/Non-Compliance|0
981301|NCT00547521|3227937|P2|Long Term Extension (LTE) Study|Not Specified|2
981302|NCT00547521|3227938|P1|Long Term Extension (LTE) Study|Not Specified|0
981303|NCT00547521|3227937|P2|Long Term Extension (LTE) Study|Withdrawal by Subject|2
981304|NCT00547521|3227938|P1|Long Term Extension (LTE) Study|Withdrawal by Subject|0
981305|NCT00547521|3227937|P2|Long Term Extension (LTE) Study|Lost to Follow-up|3
981306|NCT00547521|3227938|P1|Long Term Extension (LTE) Study|Lost to Follow-up|0
981307|NCT00547521|3227937|P2|Long Term Extension (LTE) Study|Adverse Event|9
981308|NCT00547521|3227938|P1|Long Term Extension (LTE) Study|Adverse Event|0
981309|NCT00547521|3227937|P2|Long Term Extension (LTE) Study|Lack of Efficacy|14
981310|NCT00547521|3227938|P1|Long Term Extension (LTE) Study|Lack of Efficacy|0
981311|NCT00547521|3227937|P2|Short Term Study (4 Months)|primary endpoint evaluation not complete|1
981312|NCT00547521|3227938|P1|Short Term Study (4 Months)|primary endpoint evaluation not complete|0
981313|NCT00547521|3227937|P2|Short Term Study (4 Months)|Withdrawal of consent|1
981314|NCT00547521|3227938|P1|Short Term Study (4 Months)|Withdrawal of consent|0
981315|NCT00547521|3227937|P2|Short Term Study (4 Months)|Lack of Efficacy|2
981316|NCT00547521|3227938|P1|Short Term Study (4 Months)|Lack of Efficacy|0
981317|NCT00547521|3227937|P2|Short Term Study (4 Months)|Adverse Event|0
981318|NCT00547521|3227938|P1|Short Term Study (4 Months)|Adverse Event|1
981319|NCT00547378|3228015|P3|All Implanted Cohort|Other reasons|1
981320|NCT00547378|3228016|P2|All Implanted Cohort|Other reasons|0
981321|NCT00547378|3228017|P1|All Implanted Cohort|Other reasons|1
981322|NCT00547378|3228015|P3|All Implanted Cohort|Site closure|1
981323|NCT00547378|3228016|P2|All Implanted Cohort|Site closure|0
981324|NCT00547378|3228017|P1|All Implanted Cohort|Site closure|2
981325|NCT00547378|3228015|P3|All Implanted Cohort|Physician Decision|6
981326|NCT00547378|3228016|P2|All Implanted Cohort|Physician Decision|2
981327|NCT00547378|3228017|P1|All Implanted Cohort|Physician Decision|0
981328|NCT00547378|3228015|P3|All Implanted Cohort|Death|4
981329|NCT00547378|3228016|P2|All Implanted Cohort|Death|1
981330|NCT00547378|3228017|P1|All Implanted Cohort|Death|3
981331|NCT00547378|3228015|P3|All Implanted Cohort|Lost to Follow-up|14
981332|NCT00547378|3228016|P2|All Implanted Cohort|Lost to Follow-up|1
981333|NCT00547378|3228017|P1|All Implanted Cohort|Lost to Follow-up|0
981334|NCT00547378|3228015|P3|All Implanted Cohort|Adverse Event|17
981335|NCT00547378|3228016|P2|All Implanted Cohort|Adverse Event|10
981336|NCT00547378|3228017|P1|All Implanted Cohort|Adverse Event|4
981337|NCT00547378|3228015|P3|All Implanted Cohort|Withdrawal by Subject|27
981338|NCT00547378|3228016|P2|All Implanted Cohort|Withdrawal by Subject|4
981339|NCT00547378|3228017|P1|All Implanted Cohort|Withdrawal by Subject|5
981340|NCT00547378|3228015|P3|Randomized Cohort|Other reasons|0
981341|NCT00547378|3228016|P2|Randomized Cohort|Other reasons|0
981342|NCT00547378|3228017|P1|Randomized Cohort|Other reasons|2
981343|NCT00547378|3228015|P3|Randomized Cohort|Adverse Event|0
981344|NCT00547378|3228016|P2|Randomized Cohort|Adverse Event|0
981345|NCT00547378|3228017|P1|Randomized Cohort|Adverse Event|1
981346|NCT00547378|3228015|P3|Randomized Cohort|Lost to Follow-up|0
981347|NCT00547378|3228016|P2|Randomized Cohort|Lost to Follow-up|0
981348|NCT00547378|3228017|P1|Randomized Cohort|Lost to Follow-up|1
981349|NCT00547378|3228015|P3|Randomized Cohort|Death|0
981350|NCT00547378|3228016|P2|Randomized Cohort|Death|1
981351|NCT00547378|3228017|P1|Randomized Cohort|Death|0
981352|NCT00547378|3228015|P3|Randomized Cohort|Withdrawal by Subject|0
981353|NCT00547378|3228016|P2|Randomized Cohort|Withdrawal by Subject|5
981354|NCT00547378|3228017|P1|Randomized Cohort|Withdrawal by Subject|7
981355|NCT00547365|3228027|P1|Overall Study|death (not related to study)|4
981356|NCT00547365|3228027|P1|Overall Study|Protocol Violation|2
981357|NCT00547365|3228027|P1|Overall Study|Lost to Follow-up|1
981358|NCT00547365|3228027|P1|Overall Study|Physician Decision|1
981359|NCT00547157|3228034|P2|Overall Study|Lost to Follow-up|2
981360|NCT00547157|3228035|P1|Overall Study|Lost to Follow-up|4
981361|NCT00547157|3228034|P2|Overall Study|Administrative decision|2
981362|NCT00547157|3228035|P1|Overall Study|Administrative decision|3
981363|NCT00547157|3228034|P2|Overall Study|Withdrawal by Subject|1
981364|NCT00547157|3228035|P1|Overall Study|Withdrawal by Subject|3
981365|NCT00547157|3228034|P2|Overall Study|Death|18
981366|NCT00547157|3228035|P1|Overall Study|Death|38
981367|NCT00547157|3228034|P2|Overall Study|Other|0
981368|NCT00547157|3228035|P1|Overall Study|Other|1
981369|NCT00547118|3228053|P2|Overall Study|Study suspended|8
981370|NCT00547118|3228054|P1|Overall Study|Study suspended|7
981371|NCT00547118|3228053|P2|Overall Study|Did not qualify prior to starting drug|1
981372|NCT00547118|3228054|P1|Overall Study|Did not qualify prior to starting drug|1
981373|NCT00546910|3228098|P2|Overall Study|Withdrawal by Subject|0
981374|NCT00546910|3228099|P1|Overall Study|Withdrawal by Subject|2
981375|NCT00546910|3228098|P2|Overall Study|Physician Decision|1
981376|NCT00546910|3228099|P1|Overall Study|Physician Decision|0
981377|NCT00546910|3228098|P2|Overall Study|Lack of Efficacy|7
981378|NCT00546910|3228099|P1|Overall Study|Lack of Efficacy|5
981379|NCT00546910|3228098|P2|Overall Study|Adverse Event|3
981380|NCT00546910|3228099|P1|Overall Study|Adverse Event|2
981381|NCT00546871|3228165|P2|Study Extension Period|Withdrawal by Subject|1
981382|NCT00546871|3228166|P1|Study Extension Period|Withdrawal by Subject|0
981383|NCT00546871|3228165|P2|Study Extension Period|Protocol Violation|0
981384|NCT00546871|3228166|P1|Study Extension Period|Protocol Violation|1
981385|NCT00546871|3228165|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1
981386|NCT00546871|3228166|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0
981387|NCT00546871|3228165|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2
981388|NCT00546871|3228166|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1
981389|NCT00546871|3228165|P2|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0
981390|NCT00546871|3228166|P1|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1
981391|NCT00546819|3228271|P2|Overall Study|Withdrawal by Subject|2
981392|NCT00546819|3228272|P1|Overall Study|Withdrawal by Subject|4
981393|NCT00546819|3228271|P2|Overall Study|Lost to Follow-up|1
981394|NCT00546819|3228272|P1|Overall Study|Lost to Follow-up|2
981395|NCT00546819|3228271|P2|Overall Study|Adverse Event|3
981396|NCT00546819|3228272|P1|Overall Study|Adverse Event|2
981397|NCT00546754|3228284|P2|Overall Study|Missing|7
981398|NCT00546754|3228285|P1|Overall Study|Missing|14
981399|NCT00546754|3228284|P2|Overall Study|Patient's Decision|1
981400|NCT00546754|3228285|P1|Overall Study|Patient's Decision|0
981401|NCT00546754|3228284|P2|Overall Study|Elevated Creatinine and Potassium levels|1
981402|NCT00546754|3228285|P1|Overall Study|Elevated Creatinine and Potassium levels|0
981403|NCT00546754|3228284|P2|Overall Study|Missing Cooperation|0
981404|NCT00546754|3228285|P1|Overall Study|Missing Cooperation|1
981405|NCT00546754|3228284|P2|Overall Study|Suicide|0
981406|NCT00546754|3228285|P1|Overall Study|Suicide|1
981407|NCT00546754|3228284|P2|Overall Study|Hip Replacement|0
981408|NCT00546754|3228285|P1|Overall Study|Hip Replacement|1
981409|NCT00546754|3228284|P2|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0
981410|NCT00546754|3228285|P1|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1
981411|NCT00546754|3228284|P2|Overall Study|Dyspnea|0
981412|NCT00546754|3228285|P1|Overall Study|Dyspnea|1
981413|NCT00546754|3228284|P2|Overall Study|Withdrawal by Subject|7
981414|NCT00546754|3228285|P1|Overall Study|Withdrawal by Subject|6
981415|NCT00546754|3228284|P2|Overall Study|Protocol Violation|0
981416|NCT00546754|3228285|P1|Overall Study|Protocol Violation|3
981417|NCT00546754|3228284|P2|Overall Study|Lost to Follow-up|15
981418|NCT00546754|3228285|P1|Overall Study|Lost to Follow-up|9
981419|NCT00546754|3228284|P2|Overall Study|Lack of Efficacy|1
981420|NCT00546754|3228285|P1|Overall Study|Lack of Efficacy|1
981421|NCT00546754|3228284|P2|Overall Study|Adverse Event|16
981422|NCT00546754|3228285|P1|Overall Study|Adverse Event|11
981423|NCT00546754|3228284|P2|Overall Study|Serious Adverse Event|1
981424|NCT00546754|3228285|P1|Overall Study|Serious Adverse Event|1
981425|NCT00546715|3228328|P4|Overall Study|Withdrawal by Subject|0
981426|NCT00546715|3228329|P3|Overall Study|Withdrawal by Subject|0
981427|NCT00546715|3228330|P2|Overall Study|Withdrawal by Subject|1
981428|NCT00546715|3228331|P1|Overall Study|Withdrawal by Subject|0
981429|NCT00546637|3228386|P2|Overall Study|Randomized, but not treated|1
981430|NCT00546637|3228387|P1|Overall Study|Randomized, but not treated|3
981431|NCT00546637|3228386|P2|Overall Study|Withdrawal by Subject|9
981432|NCT00546637|3228387|P1|Overall Study|Withdrawal by Subject|7
981433|NCT00546637|3228386|P2|Overall Study|Other|12
981434|NCT00546637|3228387|P1|Overall Study|Other|10
981435|NCT00546637|3228386|P2|Overall Study|Lost to Follow-up|2
981436|NCT00546637|3228387|P1|Overall Study|Lost to Follow-up|2
981437|NCT00546637|3228386|P2|Overall Study|Lack of Efficacy|5
981438|NCT00546637|3228387|P1|Overall Study|Lack of Efficacy|5
981439|NCT00546637|3228386|P2|Overall Study|Adverse Event|20
981440|NCT00546637|3228387|P1|Overall Study|Adverse Event|46
981441|NCT00546572|3228461|P2|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1
981442|NCT00546572|3228462|P1|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2
981443|NCT00546572|3228461|P2|Vax 2 / Year 1|Adverse Event|0
981444|NCT00546572|3228462|P1|Vax 2 / Year 1|Adverse Event|1
981445|NCT00546572|3228461|P2|Vax 2 / Year 1|Other|1
981446|NCT00546572|3228462|P1|Vax 2 / Year 1|Other|1
981447|NCT00546572|3228461|P2|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59
981448|NCT00546572|3228462|P1|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64
981449|NCT00546572|3228461|P2|Vax 1 / Year 0|Lost to Follow-up|1
981450|NCT00546572|3228462|P1|Vax 1 / Year 0|Lost to Follow-up|0
981451|NCT00546572|3228461|P2|Vax 1 / Year 0|Adverse Event|1
981452|NCT00546572|3228462|P1|Vax 1 / Year 0|Adverse Event|0
981453|NCT00546572|3228461|P2|Vax 1 / Year 0|Death|2
981454|NCT00546572|3228462|P1|Vax 1 / Year 0|Death|2
981455|NCT00546572|3228461|P2|Vax 1 / Year 0|Protocol Violation|4
981456|NCT00546572|3228462|P1|Vax 1 / Year 0|Protocol Violation|3
981457|NCT00546572|3228461|P2|Vax 1 / Year 0|Withdrawal by Subject|2
981458|NCT00546572|3228462|P1|Vax 1 / Year 0|Withdrawal by Subject|3
981459|NCT00546572|3228461|P2|Vax 1 / Year 0|Randomized, not treated|1
981460|NCT00546572|3228462|P1|Vax 1 / Year 0|Randomized, not treated|1
981461|NCT00546481|3228506|P3|Maintenance Phase (CERA)|Other Reason|1
981462|NCT00546481|3228507|P2|Maintenance Phase (CERA)|Other Reason|0
981463|NCT00546481|3228508|P1|Maintenance Phase (CERA)|Other Reason|0
981464|NCT00546481|3228506|P3|Maintenance Phase (CERA)|Kidney transplantation|1
981465|NCT00546481|3228507|P2|Maintenance Phase (CERA)|Kidney transplantation|0
981466|NCT00546481|3228508|P1|Maintenance Phase (CERA)|Kidney transplantation|0
981467|NCT00546481|3228506|P3|Maintenance Phase (CERA)|Withdrawal by Subject|2
981468|NCT00546481|3228507|P2|Maintenance Phase (CERA)|Withdrawal by Subject|0
981469|NCT00546481|3228508|P1|Maintenance Phase (CERA)|Withdrawal by Subject|0
981470|NCT00546481|3228506|P3|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
981471|NCT00546481|3228507|P2|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1
981472|NCT00546481|3228508|P1|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
981473|NCT00546481|3228506|P3|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0
981474|NCT00546481|3228507|P2|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
981475|NCT00546481|3228508|P1|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
981476|NCT00546481|3228506|P3|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
981477|NCT00546481|3228507|P2|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
981478|NCT00546481|3228508|P1|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2
981479|NCT00546481|3228506|P3|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
981480|NCT00546481|3228507|P2|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
981481|NCT00546481|3228508|P1|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1
981482|NCT00546481|3228506|P3|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0
981483|NCT00546481|3228507|P2|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3
981484|NCT00546481|3228508|P1|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1
981485|NCT00546481|3228506|P3|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
981486|NCT00546481|3228507|P2|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
981487|NCT00546481|3228508|P1|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1
981488|NCT00546377|3228535|P1|Overall Study|Adverse Event|6
981489|NCT00546377|3228535|P1|Overall Study|Deemed ineligible|1
981490|NCT00546364|3228543|P3|Overall Study|Sponsor decision|1
981491|NCT00546364|3228544|P2|Overall Study|Sponsor decision|0
981492|NCT00546364|3228545|P1|Overall Study|Sponsor decision|0
981493|NCT00546364|3228543|P3|Overall Study|Physician Decision|1
981494|NCT00546364|3228544|P2|Overall Study|Physician Decision|0
981495|NCT00546364|3228545|P1|Overall Study|Physician Decision|0
981496|NCT00546364|3228543|P3|Overall Study|Target lesions resected|0
981497|NCT00546364|3228544|P2|Overall Study|Target lesions resected|0
981498|NCT00546364|3228545|P1|Overall Study|Target lesions resected|1
981499|NCT00546364|3228543|P3|Overall Study|Palliative treatment|1
981500|NCT00546364|3228544|P2|Overall Study|Palliative treatment|0
981501|NCT00546364|3228545|P1|Overall Study|Palliative treatment|1
981502|NCT00546364|3228543|P3|Overall Study|Mixed response|0
981503|NCT00546364|3228544|P2|Overall Study|Mixed response|0
981504|NCT00546364|3228545|P1|Overall Study|Mixed response|1
981505|NCT00546364|3228543|P3|Overall Study|Prior taxotere|0
981506|NCT00546364|3228544|P2|Overall Study|Prior taxotere|0
981507|NCT00546364|3228545|P1|Overall Study|Prior taxotere|1
981508|NCT00546364|3228543|P3|Overall Study|Withdrawal by Subject|3
981509|NCT00546364|3228544|P2|Overall Study|Withdrawal by Subject|6
981510|NCT00546364|3228545|P1|Overall Study|Withdrawal by Subject|5
981511|NCT00546364|3228543|P3|Overall Study|No longer meets study criteria|0
981512|NCT00546364|3228544|P2|Overall Study|No longer meets study criteria|1
981513|NCT00546364|3228545|P1|Overall Study|No longer meets study criteria|1
981514|NCT00546364|3228543|P3|Overall Study|Poor compliance/noncompliance|1
981515|NCT00546364|3228544|P2|Overall Study|Poor compliance/noncompliance|0
981516|NCT00546364|3228545|P1|Overall Study|Poor compliance/noncompliance|0
981517|NCT00546364|3228543|P3|Overall Study|Administrative reason by sponsor|0
981518|NCT00546364|3228544|P2|Overall Study|Administrative reason by sponsor|0
981519|NCT00546364|3228545|P1|Overall Study|Administrative reason by sponsor|1
981520|NCT00546364|3228543|P3|Overall Study|Completed and off treatment|2
981521|NCT00546364|3228544|P2|Overall Study|Completed and off treatment|0
981522|NCT00546364|3228545|P1|Overall Study|Completed and off treatment|1
981523|NCT00546364|3228543|P3|Overall Study|Disease progression|8
981524|NCT00546364|3228544|P2|Overall Study|Disease progression|11
981525|NCT00546364|3228545|P1|Overall Study|Disease progression|5
981526|NCT00546351|3228580|P1|Overall Study|Other reasons for premature termination|17
981527|NCT00546351|3228580|P1|Overall Study|Unsatisfactory compliance|9
981528|NCT00546351|3228580|P1|Overall Study|Protocol Deviation|1
981529|NCT00546351|3228580|P1|Overall Study|Lost to Follow-up|9
981530|NCT00546351|3228580|P1|Overall Study|Withdrawal by Subject|109
981531|NCT00546351|3228580|P1|Overall Study|Lack of Efficacy|15
981532|NCT00546351|3228580|P1|Overall Study|Adverse Event|76
981533|NCT00546260|3228626|P2|Overall Study|Drug not given pre diagnostic angiogr|2
981534|NCT00546260|3228627|P1|Overall Study|Drug not given pre diagnostic angiogr|8
981535|NCT00546117|3228649|P2|Overall Study|Inability to schedule follow-up visit|0
981536|NCT00546117|3228650|P1|Overall Study|Inability to schedule follow-up visit|1
981537|NCT00546117|3228649|P2|Overall Study|Withdrawal by Subject|0
981538|NCT00546117|3228650|P1|Overall Study|Withdrawal by Subject|3
981539|NCT00546078|3228675|P2|Overall Study|Other reason|1
981540|NCT00546078|3228676|P1|Overall Study|Other reason|1
981541|NCT00546078|3228675|P2|Overall Study|Withdrawal by Subject|3
981542|NCT00546078|3228676|P1|Overall Study|Withdrawal by Subject|2
981543|NCT00546078|3228675|P2|Overall Study|Lost to Follow-up|3
981544|NCT00546078|3228676|P1|Overall Study|Lost to Follow-up|1
981545|NCT00546052|3228714|P1|Overall Study|Non Compliance|7
981546|NCT00546052|3228714|P1|Overall Study|Withdrawal by Subject|20
981547|NCT00546052|3228714|P1|Overall Study|Protocol Violation|9
981548|NCT00546052|3228714|P1|Overall Study|Lost to Follow-up|144
981549|NCT00546052|3228714|P1|Overall Study|Adverse Event|47
981550|NCT00546000|3228732|P1|Overall Study|Baseline HPA Axis Supression|2
981551|NCT00546000|3228732|P1|Overall Study|Lost to Follow-up|1
981552|NCT00546000|3228732|P1|Overall Study|Adverse Event|1
981553|NCT00545948|3228751|P3|Overall Study|Not Treated|7
981554|NCT00545948|3228752|P2|Overall Study|Not Treated|1
981555|NCT00545948|3228753|P1|Overall Study|Not Treated|1
981556|NCT00545844|3228763|P1|Overall Study|Withdrawal by Subject|2
981557|NCT00545844|3228763|P1|Overall Study|Protocol Violation|1
981558|NCT00545844|3228763|P1|Overall Study|Lost to Follow-up|9
981559|NCT00545792|3228777|P1|Overall Study|Withdrawal by Subject|1
981560|NCT00545779|3228782|P1|Overall Study|Failure to return|3
981561|NCT00545779|3228782|P1|Overall Study|Adverse Event/intercurrent illness|5
981562|NCT00545779|3228782|P1|Overall Study|Withdrawal by Subject|20
981563|NCT00545779|3228782|P1|Overall Study|Did not cooperate|7
981564|NCT00545779|3228782|P1|Overall Study|Other protocol violation|1
981565|NCT00545779|3228782|P1|Overall Study|Violation of selection criteria at entry|8
981566|NCT00545753|3228802|P3|Overall Study|Protocol Violation|4
981567|NCT00545753|3228803|P2|Overall Study|Protocol Violation|1
981568|NCT00545753|3228804|P1|Overall Study|Protocol Violation|3
981569|NCT00545753|3228802|P3|Overall Study|Lost to Follow-up|12
981570|NCT00545753|3228803|P2|Overall Study|Lost to Follow-up|3
981571|NCT00545753|3228804|P1|Overall Study|Lost to Follow-up|13
981572|NCT00545753|3228802|P3|Overall Study|Withdrawal by Subject|10
981573|NCT00545753|3228803|P2|Overall Study|Withdrawal by Subject|1
981574|NCT00545753|3228804|P1|Overall Study|Withdrawal by Subject|0
981575|NCT00545740|3228817|P4|Overall Study|Husband against study|0
981576|NCT00545740|3228818|P3|Overall Study|Husband against study|1
981577|NCT00545740|3228819|P2|Overall Study|Husband against study|0
981578|NCT00545740|3228820|P1|Overall Study|Husband against study|0
981579|NCT00545740|3228817|P4|Overall Study|Patient difficulties|0
981580|NCT00545740|3228818|P3|Overall Study|Patient difficulties|0
981581|NCT00545740|3228819|P2|Overall Study|Patient difficulties|1
981582|NCT00545740|3228820|P1|Overall Study|Patient difficulties|0
981583|NCT00545740|3228817|P4|Overall Study|Non-adherence to visits|0
981584|NCT00545740|3228818|P3|Overall Study|Non-adherence to visits|0
981585|NCT00545740|3228819|P2|Overall Study|Non-adherence to visits|1
981586|NCT00545740|3228820|P1|Overall Study|Non-adherence to visits|0
981587|NCT00545740|3228817|P4|Overall Study|Lack of time|0
981588|NCT00545740|3228818|P3|Overall Study|Lack of time|0
981589|NCT00545740|3228819|P2|Overall Study|Lack of time|1
981590|NCT00545740|3228820|P1|Overall Study|Lack of time|0
981591|NCT00545740|3228817|P4|Overall Study|Sponsor decision|0
981592|NCT00545740|3228818|P3|Overall Study|Sponsor decision|0
981593|NCT00545740|3228819|P2|Overall Study|Sponsor decision|1
981594|NCT00545740|3228820|P1|Overall Study|Sponsor decision|0
981595|NCT00545740|3228817|P4|Overall Study|Accepted only monthly telephone calls|0
981596|NCT00545740|3228818|P3|Overall Study|Accepted only monthly telephone calls|0
981597|NCT00545740|3228819|P2|Overall Study|Accepted only monthly telephone calls|0
981598|NCT00545740|3228820|P1|Overall Study|Accepted only monthly telephone calls|1
981599|NCT00545740|3228817|P4|Overall Study|Physician Decision|0
981600|NCT00545740|3228818|P3|Overall Study|Physician Decision|3
981601|NCT00545740|3228819|P2|Overall Study|Physician Decision|0
981602|NCT00545740|3228820|P1|Overall Study|Physician Decision|0
981603|NCT00545740|3228817|P4|Overall Study|Missed visit|0
981604|NCT00545740|3228818|P3|Overall Study|Missed visit|0
981605|NCT00545740|3228819|P2|Overall Study|Missed visit|0
981606|NCT00545740|3228820|P1|Overall Study|Missed visit|1
981607|NCT00545740|3228817|P4|Overall Study|Site closure|0
981608|NCT00545740|3228818|P3|Overall Study|Site closure|0
981609|NCT00545740|3228819|P2|Overall Study|Site closure|0
981610|NCT00545740|3228820|P1|Overall Study|Site closure|1
981611|NCT00545740|3228817|P4|Overall Study|Suspected Diverticulitis Recurrence|1
981612|NCT00545740|3228818|P3|Overall Study|Suspected Diverticulitis Recurrence|1
981613|NCT00545740|3228819|P2|Overall Study|Suspected Diverticulitis Recurrence|1
981614|NCT00545740|3228820|P1|Overall Study|Suspected Diverticulitis Recurrence|1
981615|NCT00545740|3228817|P4|Overall Study|Diverticulitis attack|1
981616|NCT00545740|3228818|P3|Overall Study|Diverticulitis attack|1
981617|NCT00545740|3228819|P2|Overall Study|Diverticulitis attack|0
981618|NCT00545740|3228820|P1|Overall Study|Diverticulitis attack|0
981619|NCT00545740|3228817|P4|Overall Study|Moved|0
981620|NCT00545740|3228818|P3|Overall Study|Moved|1
981621|NCT00545740|3228819|P2|Overall Study|Moved|0
981622|NCT00545740|3228820|P1|Overall Study|Moved|2
981623|NCT00545740|3228817|P4|Overall Study|Non-compliance|0
981624|NCT00545740|3228818|P3|Overall Study|Non-compliance|1
981625|NCT00545740|3228819|P2|Overall Study|Non-compliance|2
981626|NCT00545740|3228820|P1|Overall Study|Non-compliance|0
981627|NCT00545740|3228817|P4|Overall Study|Protocol Violation|0
981628|NCT00545740|3228818|P3|Overall Study|Protocol Violation|1
981629|NCT00545740|3228819|P2|Overall Study|Protocol Violation|3
981630|NCT00545740|3228820|P1|Overall Study|Protocol Violation|1
981631|NCT00545740|3228817|P4|Overall Study|Lost to Follow-up|6
981632|NCT00545740|3228818|P3|Overall Study|Lost to Follow-up|5
981633|NCT00545740|3228819|P2|Overall Study|Lost to Follow-up|5
981634|NCT00545740|3228820|P1|Overall Study|Lost to Follow-up|7
981635|NCT00545740|3228817|P4|Overall Study|Adverse Event|9
981636|NCT00545740|3228818|P3|Overall Study|Adverse Event|19
981637|NCT00545740|3228819|P2|Overall Study|Adverse Event|18
981638|NCT00545740|3228820|P1|Overall Study|Adverse Event|10
981639|NCT00545740|3228817|P4|Overall Study|Withdrawal by Subject|18
981640|NCT00545740|3228818|P3|Overall Study|Withdrawal by Subject|16
981641|NCT00545740|3228819|P2|Overall Study|Withdrawal by Subject|15
981642|NCT00545740|3228820|P1|Overall Study|Withdrawal by Subject|17
981643|NCT00545740|3228817|P4|Overall Study|Lack of Efficacy|36
981644|NCT00545740|3228818|P3|Overall Study|Lack of Efficacy|47
981645|NCT00545740|3228819|P2|Overall Study|Lack of Efficacy|35
981646|NCT00545740|3228820|P1|Overall Study|Lack of Efficacy|34
981647|NCT00545688|3228858|P4|Follow-Up Period|Violation of Selection Criteria at Entry|1
981648|NCT00545688|3228859|P3|Follow-Up Period|Violation of Selection Criteria at Entry|0
981649|NCT00545688|3228860|P2|Follow-Up Period|Violation of Selection Criteria at Entry|2
981650|NCT00545688|3228861|P1|Follow-Up Period|Violation of Selection Criteria at Entry|0
981651|NCT00545688|3228858|P4|Follow-Up Period|Unspecified Reason|8
981652|NCT00545688|3228859|P3|Follow-Up Period|Unspecified Reason|6
981653|NCT00545688|3228860|P2|Follow-Up Period|Unspecified Reason|5
981654|NCT00545688|3228861|P1|Follow-Up Period|Unspecified Reason|2
981655|NCT00545688|3228858|P4|Follow-Up Period|Lost to Follow-up|1
981656|NCT00545688|3228859|P3|Follow-Up Period|Lost to Follow-up|3
981657|NCT00545688|3228860|P2|Follow-Up Period|Lost to Follow-up|3
981658|NCT00545688|3228861|P1|Follow-Up Period|Lost to Follow-up|3
981659|NCT00545688|3228858|P4|Follow-Up Period|Refused Treatment|2
981660|NCT00545688|3228859|P3|Follow-Up Period|Refused Treatment|0
981661|NCT00545688|3228860|P2|Follow-Up Period|Refused Treatment|2
981662|NCT00545688|3228861|P1|Follow-Up Period|Refused Treatment|6
981663|NCT00545688|3228858|P4|Follow-Up Period|Disease Progression|9
981664|NCT00545688|3228859|P3|Follow-Up Period|Disease Progression|9
981665|NCT00545688|3228860|P2|Follow-Up Period|Disease Progression|5
981666|NCT00545688|3228861|P1|Follow-Up Period|Disease Progression|6
981667|NCT00545688|3228858|P4|Follow-Up Period|Death|6
981668|NCT00545688|3228859|P3|Follow-Up Period|Death|2
981669|NCT00545688|3228860|P2|Follow-Up Period|Death|2
981670|NCT00545688|3228861|P1|Follow-Up Period|Death|4
981671|NCT00545688|3228858|P4|Adjuvant Treatment Period|Unknown Reason|0
981672|NCT00545688|3228859|P3|Adjuvant Treatment Period|Unknown Reason|0
981673|NCT00545688|3228860|P2|Adjuvant Treatment Period|Unknown Reason|1
981674|NCT00545688|3228861|P1|Adjuvant Treatment Period|Unknown Reason|0
981675|NCT00545688|3228858|P4|Adjuvant Treatment Period|Adverse Event|2
981676|NCT00545688|3228859|P3|Adjuvant Treatment Period|Adverse Event|2
981677|NCT00545688|3228860|P2|Adjuvant Treatment Period|Adverse Event|3
981678|NCT00545688|3228861|P1|Adjuvant Treatment Period|Adverse Event|0
981679|NCT00545688|3228858|P4|Adjuvant Treatment Period|Lost to Follow-up|0
981680|NCT00545688|3228859|P3|Adjuvant Treatment Period|Lost to Follow-up|1
981681|NCT00545688|3228860|P2|Adjuvant Treatment Period|Lost to Follow-up|0
981682|NCT00545688|3228861|P1|Adjuvant Treatment Period|Lost to Follow-up|1
981683|NCT00545688|3228858|P4|Adjuvant Treatment Period|Refused Treatment|5
981684|NCT00545688|3228859|P3|Adjuvant Treatment Period|Refused Treatment|1
981685|NCT00545688|3228860|P2|Adjuvant Treatment Period|Refused Treatment|1
981686|NCT00545688|3228861|P1|Adjuvant Treatment Period|Refused Treatment|1
981687|NCT00545688|3228858|P4|Adjuvant Treatment Period|Disease Progression|7
981688|NCT00545688|3228859|P3|Adjuvant Treatment Period|Disease Progression|0
981689|NCT00545688|3228860|P2|Adjuvant Treatment Period|Disease Progression|3
981690|NCT00545688|3228861|P1|Adjuvant Treatment Period|Disease Progression|3
981691|NCT00545688|3228858|P4|Neo-Adjuvant Treatment Period|Adverse Event|2
981692|NCT00545688|3228859|P3|Neo-Adjuvant Treatment Period|Adverse Event|2
981693|NCT00545688|3228860|P2|Neo-Adjuvant Treatment Period|Adverse Event|0
981694|NCT00545688|3228861|P1|Neo-Adjuvant Treatment Period|Adverse Event|0
981695|NCT00545688|3228858|P4|Neo-Adjuvant Treatment Period|Unknown Reason|0
981696|NCT00545688|3228859|P3|Neo-Adjuvant Treatment Period|Unknown Reason|0
981697|NCT00545688|3228860|P2|Neo-Adjuvant Treatment Period|Unknown Reason|0
981698|NCT00545688|3228861|P1|Neo-Adjuvant Treatment Period|Unknown Reason|1
981699|NCT00545688|3228858|P4|Neo-Adjuvant Treatment Period|Disease Progression|2
981700|NCT00545688|3228859|P3|Neo-Adjuvant Treatment Period|Disease Progression|7
981701|NCT00545688|3228860|P2|Neo-Adjuvant Treatment Period|Disease Progression|1
981702|NCT00545688|3228861|P1|Neo-Adjuvant Treatment Period|Disease Progression|0
981703|NCT00545688|3228858|P4|Neo-Adjuvant Treatment Period|Death|0
981704|NCT00545688|3228859|P3|Neo-Adjuvant Treatment Period|Death|0
981705|NCT00545688|3228860|P2|Neo-Adjuvant Treatment Period|Death|1
981706|NCT00545688|3228861|P1|Neo-Adjuvant Treatment Period|Death|0
981707|NCT00545688|3228858|P4|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
981708|NCT00545688|3228859|P3|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
981709|NCT00545688|3228860|P2|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
981710|NCT00545688|3228861|P1|Neo-Adjuvant Treatment Period|Lost to Follow-up|1
981711|NCT00545688|3228858|P4|Neo-Adjuvant Treatment Period|Refused Treatment|1
981712|NCT00545688|3228859|P3|Neo-Adjuvant Treatment Period|Refused Treatment|4
981713|NCT00545688|3228860|P2|Neo-Adjuvant Treatment Period|Refused Treatment|1
981714|NCT00545688|3228861|P1|Neo-Adjuvant Treatment Period|Refused Treatment|1
981715|NCT00545688|3228858|P4|Neo-Adjuvant Treatment Period|Protocol Violation|1
981716|NCT00545688|3228859|P3|Neo-Adjuvant Treatment Period|Protocol Violation|1
981717|NCT00545688|3228860|P2|Neo-Adjuvant Treatment Period|Protocol Violation|2
981718|NCT00545688|3228861|P1|Neo-Adjuvant Treatment Period|Protocol Violation|1
981719|NCT00545584|3228960|P3|Overall Study|Two or more reasons for discontinuation|8
981720|NCT00545584|3228961|P2|Overall Study|Two or more reasons for discontinuation|19
981721|NCT00545584|3228962|P1|Overall Study|Two or more reasons for discontinuation|17
981722|NCT00545584|3228960|P3|Overall Study|Only one reason for discontinuation|48
981723|NCT00545584|3228961|P2|Overall Study|Only one reason for discontinuation|61
981724|NCT00545584|3228962|P1|Overall Study|Only one reason for discontinuation|62
981725|NCT00545571|3228973|P1|Overall Study|Kidney Transplantation|3
981726|NCT00545571|3228973|P1|Overall Study|Early Termination of Study|24
981727|NCT00545571|3228973|P1|Overall Study|Transfusion|12
981728|NCT00545571|3228973|P1|Overall Study|Screen Failure|16
981729|NCT00545571|3228973|P1|Overall Study|Refused Treatment|1
981730|NCT00545571|3228973|P1|Overall Study|Protocol Violation|2
981731|NCT00545571|3228973|P1|Overall Study|Lack of Efficacy|1
981732|NCT00545571|3228973|P1|Overall Study|Death|5
981733|NCT00545571|3228973|P1|Overall Study|Adverse Event|2
981734|NCT00545571|3228973|P1|Overall Study|Administrative Reasons|1
981735|NCT00545532|3228988|P2|Overall Study|Death|1
981736|NCT00545532|3228989|P1|Overall Study|Death|0
981737|NCT00545532|3228988|P2|Overall Study|Lost to Follow-up|6
981738|NCT00545532|3228989|P1|Overall Study|Lost to Follow-up|5
981739|NCT00545532|3228988|P2|Overall Study|Withdrawal by Subject|3
981740|NCT00545532|3228989|P1|Overall Study|Withdrawal by Subject|1
981741|NCT00545441|3229080|P2|Overall Study|Patients were not treated|3
981742|NCT00545441|3229081|P1|Overall Study|Patients were not treated|1
981743|NCT00545441|3229080|P2|Overall Study|Persistence or recurrence of fistula|2
981744|NCT00545441|3229081|P1|Overall Study|Persistence or recurrence of fistula|5
981745|NCT00545441|3229080|P2|Overall Study|Withdrawal by Subject|1
981746|NCT00545441|3229081|P1|Overall Study|Withdrawal by Subject|1
981747|NCT00545441|3229080|P2|Overall Study|Technical failure|1
981748|NCT00545441|3229081|P1|Overall Study|Technical failure|0
981749|NCT00545441|3229080|P2|Overall Study|Lost to Follow-up|5
981750|NCT00545441|3229081|P1|Overall Study|Lost to Follow-up|9
981751|NCT00545441|3229080|P2|Overall Study|Fistula draining at 6 months|4
981752|NCT00545441|3229081|P1|Overall Study|Fistula draining at 6 months|2
981753|NCT00545402|3229089|P2|Overall Study|Reason not specified|1
981754|NCT00545402|3229090|P1|Overall Study|Reason not specified|1
981755|NCT00545402|3229089|P2|Overall Study|Protocol Violation|0
981756|NCT00545402|3229090|P1|Overall Study|Protocol Violation|1
981757|NCT00545402|3229089|P2|Overall Study|Withdrawal by Subject|1
981758|NCT00545402|3229090|P1|Overall Study|Withdrawal by Subject|0
981759|NCT00545402|3229089|P2|Overall Study|Graft loss|4
981760|NCT00545402|3229090|P1|Overall Study|Graft loss|2
981761|NCT00545402|3229089|P2|Overall Study|Death|7
981762|NCT00545402|3229090|P1|Overall Study|Death|5
981763|NCT00545402|3229089|P2|Overall Study|Use of unauthorized immunosuppressant|7
981764|NCT00545402|3229090|P1|Overall Study|Use of unauthorized immunosuppressant|8
981765|NCT00545402|3229089|P2|Overall Study|Discontinuation of treatment|9
981766|NCT00545402|3229090|P1|Overall Study|Discontinuation of treatment|17
981767|NCT00545363|3229108|P2|Overall Study|Other|1
981768|NCT00545363|3229109|P1|Overall Study|Other|1
981769|NCT00545363|3229108|P2|Overall Study|Lost to Follow-up|0
981770|NCT00545363|3229109|P1|Overall Study|Lost to Follow-up|2
981771|NCT00545363|3229108|P2|Overall Study|Did not meet entry criteria|1
981772|NCT00545363|3229109|P1|Overall Study|Did not meet entry criteria|1
981773|NCT00545363|3229108|P2|Overall Study|Non-compliance|1
981774|NCT00545363|3229109|P1|Overall Study|Non-compliance|3
981775|NCT00545363|3229108|P2|Overall Study|Withdrawal by Subject|5
981776|NCT00545363|3229109|P1|Overall Study|Withdrawal by Subject|6
981777|NCT00545363|3229108|P2|Overall Study|Adverse Event|7
981778|NCT00545363|3229109|P1|Overall Study|Adverse Event|6
981779|NCT00545298|3229124|P3|Overall Study|Issues with Standard of Care|1
981780|NCT00545298|3229125|P2|Overall Study|Issues with Standard of Care|0
981781|NCT00545298|3229126|P1|Overall Study|Issues with Standard of Care|2
981782|NCT00545272|3229143|P6|Overall Study|Lost to Follow-up|0
981783|NCT00545272|3229144|P5|Overall Study|Lost to Follow-up|1
981784|NCT00545272|3229145|P4|Overall Study|Lost to Follow-up|0
981785|NCT00545272|3229146|P3|Overall Study|Lost to Follow-up|0
981786|NCT00545272|3229147|P2|Overall Study|Lost to Follow-up|0
981787|NCT00545272|3229148|P1|Overall Study|Lost to Follow-up|0
981788|NCT00545272|3229143|P6|Overall Study|Abnormal test procedure result(s)|0
981789|NCT00545272|3229144|P5|Overall Study|Abnormal test procedure result(s)|1
981790|NCT00545272|3229145|P4|Overall Study|Abnormal test procedure result(s)|0
981791|NCT00545272|3229146|P3|Overall Study|Abnormal test procedure result(s)|0
981792|NCT00545272|3229147|P2|Overall Study|Abnormal test procedure result(s)|0
981793|NCT00545272|3229148|P1|Overall Study|Abnormal test procedure result(s)|0
981794|NCT00545272|3229143|P6|Overall Study|Abnormal laboratory value(s)|1
981795|NCT00545272|3229144|P5|Overall Study|Abnormal laboratory value(s)|0
981796|NCT00545272|3229145|P4|Overall Study|Abnormal laboratory value(s)|0
981797|NCT00545272|3229146|P3|Overall Study|Abnormal laboratory value(s)|0
981798|NCT00545272|3229147|P2|Overall Study|Abnormal laboratory value(s)|0
981799|NCT00545272|3229148|P1|Overall Study|Abnormal laboratory value(s)|0
981800|NCT00545272|3229143|P6|Overall Study|Adverse Event|1
981801|NCT00545272|3229144|P5|Overall Study|Adverse Event|0
981802|NCT00545272|3229145|P4|Overall Study|Adverse Event|0
981803|NCT00545272|3229146|P3|Overall Study|Adverse Event|1
981804|NCT00545272|3229147|P2|Overall Study|Adverse Event|0
981805|NCT00545272|3229148|P1|Overall Study|Adverse Event|0
981806|NCT00545272|3229143|P6|Overall Study|Protocol deviation|1
981807|NCT00545272|3229144|P5|Overall Study|Protocol deviation|0
981808|NCT00545272|3229145|P4|Overall Study|Protocol deviation|1
981809|NCT00545272|3229146|P3|Overall Study|Protocol deviation|0
981810|NCT00545272|3229147|P2|Overall Study|Protocol deviation|1
981811|NCT00545272|3229148|P1|Overall Study|Protocol deviation|0
981812|NCT00545233|3229200|P2|Overall Study|Physician Decision|1
981813|NCT00545233|3229201|P1|Overall Study|Physician Decision|2
981814|NCT00545233|3229200|P2|Overall Study|Insufficient response|15
981815|NCT00545233|3229201|P1|Overall Study|Insufficient response|14
981816|NCT00545233|3229200|P2|Overall Study|Failure to Return|6
981817|NCT00545233|3229201|P1|Overall Study|Failure to Return|4
981818|NCT00545233|3229200|P2|Overall Study|Refused Treatment|7
981819|NCT00545233|3229201|P1|Overall Study|Refused Treatment|9
981820|NCT00545233|3229200|P2|Overall Study|Protocol Violation|0
981821|NCT00545233|3229201|P1|Overall Study|Protocol Violation|2
981822|NCT00545233|3229200|P2|Overall Study|Violation of Selection Criteria at Entry|1
981823|NCT00545233|3229201|P1|Overall Study|Violation of Selection Criteria at Entry|5
981824|NCT00545233|3229200|P2|Overall Study|Adverse Event|5
981825|NCT00545233|3229201|P1|Overall Study|Adverse Event|10
981826|NCT00545168|3229260|P3|Overall Study|Visit for Day 21 was not done in error|2
981827|NCT00545168|3229261|P2|Overall Study|Visit for Day 21 was not done in error|0
981828|NCT00545168|3229262|P1|Overall Study|Visit for Day 21 was not done in error|1
981829|NCT00545168|3229260|P3|Overall Study|Protocol Violation|1
981830|NCT00545168|3229261|P2|Overall Study|Protocol Violation|0
981831|NCT00545168|3229262|P1|Overall Study|Protocol Violation|1
981832|NCT00545168|3229260|P3|Overall Study|Withdrawal by Subject|13
981833|NCT00545168|3229261|P2|Overall Study|Withdrawal by Subject|0
981834|NCT00545168|3229262|P1|Overall Study|Withdrawal by Subject|9
981835|NCT00545168|3229260|P3|Overall Study|Lost to Follow-up|5
981836|NCT00545168|3229261|P2|Overall Study|Lost to Follow-up|5
981837|NCT00545168|3229262|P1|Overall Study|Lost to Follow-up|5
981838|NCT00545103|3229288|P4|Overall Study|Death|0
981839|NCT00545103|3229289|P3|Overall Study|Death|0
981840|NCT00545103|3229290|P2|Overall Study|Death|1
981841|NCT00545103|3229291|P1|Overall Study|Death|0
981842|NCT00545103|3229288|P4|Overall Study|Subject met endpoint under protocol v. 1|0
981843|NCT00545103|3229289|P3|Overall Study|Subject met endpoint under protocol v. 1|1
981844|NCT00545103|3229290|P2|Overall Study|Subject met endpoint under protocol v. 1|0
981845|NCT00545103|3229291|P1|Overall Study|Subject met endpoint under protocol v. 1|0
981846|NCT00545103|3229288|P4|Overall Study|Does not want to take study drug anymore|0
981847|NCT00545103|3229289|P3|Overall Study|Does not want to take study drug anymore|1
981848|NCT00545103|3229290|P2|Overall Study|Does not want to take study drug anymore|0
981849|NCT00545103|3229291|P1|Overall Study|Does not want to take study drug anymore|1
981850|NCT00545103|3229288|P4|Overall Study|Use of prohibited medication|0
981851|NCT00545103|3229289|P3|Overall Study|Use of prohibited medication|1
981852|NCT00545103|3229290|P2|Overall Study|Use of prohibited medication|0
981853|NCT00545103|3229291|P1|Overall Study|Use of prohibited medication|0
981854|NCT00545103|3229288|P4|Overall Study|Subject moved|0
981855|NCT00545103|3229289|P3|Overall Study|Subject moved|0
981856|NCT00545103|3229290|P2|Overall Study|Subject moved|1
981857|NCT00545103|3229291|P1|Overall Study|Subject moved|0
981858|NCT00545103|3229288|P4|Overall Study|Investigator decision|0
981859|NCT00545103|3229289|P3|Overall Study|Investigator decision|1
981860|NCT00545103|3229290|P2|Overall Study|Investigator decision|0
981861|NCT00545103|3229291|P1|Overall Study|Investigator decision|0
981862|NCT00545103|3229288|P4|Overall Study|Noncompliance|0
981863|NCT00545103|3229289|P3|Overall Study|Noncompliance|0
981864|NCT00545103|3229290|P2|Overall Study|Noncompliance|1
981865|NCT00545103|3229291|P1|Overall Study|Noncompliance|0
981866|NCT00545103|3229288|P4|Overall Study|Subject's decision|0
981867|NCT00545103|3229289|P3|Overall Study|Subject's decision|0
981868|NCT00545103|3229290|P2|Overall Study|Subject's decision|0
981869|NCT00545103|3229291|P1|Overall Study|Subject's decision|1
981870|NCT00545103|3229288|P4|Overall Study|Personal reasons|0
981871|NCT00545103|3229289|P3|Overall Study|Personal reasons|0
981872|NCT00545103|3229290|P2|Overall Study|Personal reasons|0
981873|NCT00545103|3229291|P1|Overall Study|Personal reasons|1
981874|NCT00545103|3229288|P4|Overall Study|Diverticulitis crisis|1
981875|NCT00545103|3229289|P3|Overall Study|Diverticulitis crisis|0
981876|NCT00545103|3229290|P2|Overall Study|Diverticulitis crisis|0
981877|NCT00545103|3229291|P1|Overall Study|Diverticulitis crisis|0
981878|NCT00545103|3229288|P4|Overall Study|Wish to start a family|1
981879|NCT00545103|3229289|P3|Overall Study|Wish to start a family|0
981880|NCT00545103|3229290|P2|Overall Study|Wish to start a family|0
981881|NCT00545103|3229291|P1|Overall Study|Wish to start a family|0
981882|NCT00545103|3229288|P4|Overall Study|Investigational product not taken|1
981883|NCT00545103|3229289|P3|Overall Study|Investigational product not taken|0
981884|NCT00545103|3229290|P2|Overall Study|Investigational product not taken|0
981885|NCT00545103|3229291|P1|Overall Study|Investigational product not taken|1
981886|NCT00545103|3229288|P4|Overall Study|Difficult to open package|1
981887|NCT00545103|3229289|P3|Overall Study|Difficult to open package|0
981888|NCT00545103|3229290|P2|Overall Study|Difficult to open package|0
981889|NCT00545103|3229291|P1|Overall Study|Difficult to open package|0
981890|NCT00545103|3229288|P4|Overall Study|Suspected recurrence of diverticulitis|3
981891|NCT00545103|3229289|P3|Overall Study|Suspected recurrence of diverticulitis|0
981892|NCT00545103|3229290|P2|Overall Study|Suspected recurrence of diverticulitis|0
981893|NCT00545103|3229291|P1|Overall Study|Suspected recurrence of diverticulitis|1
981894|NCT00545103|3229288|P4|Overall Study|Protocol Violation|0
981895|NCT00545103|3229289|P3|Overall Study|Protocol Violation|3
981896|NCT00545103|3229290|P2|Overall Study|Protocol Violation|2
981897|NCT00545103|3229291|P1|Overall Study|Protocol Violation|1
981898|NCT00545103|3229288|P4|Overall Study|Lost to Follow-up|4
981899|NCT00545103|3229289|P3|Overall Study|Lost to Follow-up|3
981900|NCT00545103|3229290|P2|Overall Study|Lost to Follow-up|6
981901|NCT00545103|3229291|P1|Overall Study|Lost to Follow-up|4
981902|NCT00545103|3229288|P4|Overall Study|Adverse Event|10
981903|NCT00545103|3229289|P3|Overall Study|Adverse Event|17
981904|NCT00545103|3229290|P2|Overall Study|Adverse Event|12
981905|NCT00545103|3229291|P1|Overall Study|Adverse Event|11
981906|NCT00545103|3229288|P4|Overall Study|Withdrawal by Subject|22
981907|NCT00545103|3229289|P3|Overall Study|Withdrawal by Subject|18
981908|NCT00545103|3229290|P2|Overall Study|Withdrawal by Subject|10
981909|NCT00545103|3229291|P1|Overall Study|Withdrawal by Subject|6
981910|NCT00545103|3229288|P4|Overall Study|Lack of Efficacy|27
981911|NCT00545103|3229289|P3|Overall Study|Lack of Efficacy|31
981912|NCT00545103|3229290|P2|Overall Study|Lack of Efficacy|45
981913|NCT00545103|3229291|P1|Overall Study|Lack of Efficacy|48
981914|NCT00545064|3229325|P1|Overall Study|inclement weather|1
981915|NCT00545064|3229325|P1|Overall Study|cancel all appointments, no rebooking|1
981916|NCT00545064|3229325|P1|Overall Study|did not complete course of treatment|1
981917|NCT00545064|3229325|P1|Overall Study|Withdrawal by Subject|2
981918|NCT00545064|3229325|P1|Overall Study|Lost to Follow-up|3
981919|NCT00545051|3229336|P2|Overall Study|Administrative reasons|1
981920|NCT00545051|3229337|P1|Overall Study|Administrative reasons|0
981921|NCT00545051|3229336|P2|Overall Study|Withdrawal by Subject|1
981922|NCT00545051|3229337|P1|Overall Study|Withdrawal by Subject|0
981923|NCT00545051|3229336|P2|Overall Study|Protocol Violation|0
981924|NCT00545051|3229337|P1|Overall Study|Protocol Violation|1
981925|NCT00545051|3229336|P2|Overall Study|Violation of inclusion/exclusion|2
981926|NCT00545051|3229337|P1|Overall Study|Violation of inclusion/exclusion|0
981927|NCT00545051|3229336|P2|Overall Study|Death|0
981928|NCT00545051|3229337|P1|Overall Study|Death|1
981929|NCT00545051|3229336|P2|Overall Study|Adverse Event|3
981930|NCT00545051|3229337|P1|Overall Study|Adverse Event|7
981931|NCT00544882|3229381|P3|Cycle 3: Follow-up|Pregnancy|0
981932|NCT00544882|3229382|P2|Cycle 3: Follow-up|Pregnancy|1
981933|NCT00544882|3229383|P1|Cycle 3: Follow-up|Pregnancy|0
981934|NCT00544882|3229381|P3|Cycle 3: Follow-up|Noncompliance|0
981935|NCT00544882|3229382|P2|Cycle 3: Follow-up|Noncompliance|1
981936|NCT00544882|3229383|P1|Cycle 3: Follow-up|Noncompliance|0
981937|NCT00544882|3229381|P3|Cycle 2: Randomized Treatment Cycle|Noncompliance|1
981938|NCT00544882|3229382|P2|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
981939|NCT00544882|3229383|P1|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
981940|NCT00544882|3229381|P3|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
981941|NCT00544882|3229382|P2|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1
981942|NCT00544882|3229383|P1|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
981943|NCT00544882|3229381|P3|Cycle 1: Run-in Cycle|Adverse Event|0
981944|NCT00544882|3229382|P2|Cycle 1: Run-in Cycle|Adverse Event|0
981945|NCT00544882|3229383|P1|Cycle 1: Run-in Cycle|Adverse Event|1
981946|NCT00544882|3229381|P3|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
981947|NCT00544882|3229382|P2|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
981948|NCT00544882|3229383|P1|Cycle 1: Run-in Cycle|Withdrawal by Subject|2
981949|NCT00544869|3229408|P3|Overall Study|Physician Decision|0
981950|NCT00544869|3229409|P2|Overall Study|Physician Decision|0
981951|NCT00544869|3229410|P1|Overall Study|Physician Decision|2
981952|NCT00544869|3229408|P3|Overall Study|Lack of Efficacy|0
981953|NCT00544869|3229409|P2|Overall Study|Lack of Efficacy|1
981954|NCT00544869|3229410|P1|Overall Study|Lack of Efficacy|1
981955|NCT00544869|3229408|P3|Overall Study|Adverse Event|0
981956|NCT00544869|3229409|P2|Overall Study|Adverse Event|1
981957|NCT00544869|3229410|P1|Overall Study|Adverse Event|6
981958|NCT00544869|3229408|P3|Overall Study|Rsolution of congenitive symptoms|0
981959|NCT00544869|3229409|P2|Overall Study|Rsolution of congenitive symptoms|0
981960|NCT00544869|3229410|P1|Overall Study|Rsolution of congenitive symptoms|3
981961|NCT00544817|3229418|P1|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1
981962|NCT00544817|3229418|P1|Follow-up Systemic Therapy|Physician Decision|3
981963|NCT00544817|3229418|P1|Follow-up Systemic Therapy|Lack of Efficacy|15
981964|NCT00544817|3229418|P1|No Treatment Interval|Adverse Event|1
981965|NCT00544817|3229418|P1|No Treatment Interval|Physician Decision|3
981966|NCT00544817|3229418|P1|No Treatment Interval|Lack of Efficacy|8
981967|NCT00544817|3229418|P1|Combined Modality|Intercurrent Illness - Pneumonia|1
981968|NCT00544817|3229418|P1|Combined Modality|Adverse Event|2
981969|NCT00544817|3229418|P1|Combined Modality|Worsening Neurologic Symptoms|2
981970|NCT00544817|3229418|P1|Combined Modality|Lack of Efficacy|2
981971|NCT00544648|3229467|P2|Overall Study|progression of disease|0
981972|NCT00544648|3229468|P1|Overall Study|progression of disease|1
981973|NCT00544648|3229467|P2|Overall Study|Adverse Event|1
981974|NCT00544648|3229468|P1|Overall Study|Adverse Event|1
981975|NCT00544648|3229467|P2|Overall Study|Withdrawal by Subject|0
981976|NCT00544648|3229468|P1|Overall Study|Withdrawal by Subject|1
981977|NCT00544557|3229482|P1|Overall Study|Other|98
981978|NCT00544557|3229482|P1|Overall Study|Lack of Efficacy|196
981979|NCT00544557|3229482|P1|Overall Study|Adverse Event|140
981980|NCT00544544|3229513|P1|Overall Study|Lost to Follow-up|1
981981|NCT00544544|3229513|P1|Overall Study|Adverse Event|1
981982|NCT00544544|3229513|P1|Overall Study|Withdrawal by Subject|1
981983|NCT00544440|3229520|P1|Overall Study|Other|5
981984|NCT00544440|3229520|P1|Overall Study|Progressive Disease|47
981985|NCT00544440|3229520|P1|Overall Study|Subject Non-compliance|1
981986|NCT00544440|3229520|P1|Overall Study|Withdrawal by Subject|2
981987|NCT00544440|3229520|P1|Overall Study|Adverse Event|1
981988|NCT00544440|3229520|P1|Overall Study|Other|1
981989|NCT00544167|3229527|P1|Overall Study|Physician Decision|8
981990|NCT00544167|3229527|P1|Overall Study|Adverse Event|21
981991|NCT00543985|3229531|P1|Overall Study|Withdrawal by Subject|4
981992|NCT00543855|3229542|P4|Overall Study|Protocol Violation|0
981993|NCT00543855|3229543|P3|Overall Study|Protocol Violation|0
981994|NCT00543855|3229544|P2|Overall Study|Protocol Violation|0
981995|NCT00543855|3229545|P1|Overall Study|Protocol Violation|1
981996|NCT00543855|3229542|P4|Overall Study|Withdrawal by Subject|0
981997|NCT00543855|3229543|P3|Overall Study|Withdrawal by Subject|2
981998|NCT00543855|3229544|P2|Overall Study|Withdrawal by Subject|1
981999|NCT00543855|3229545|P1|Overall Study|Withdrawal by Subject|0
982000|NCT00543855|3229542|P4|Overall Study|Lost to Follow-up|0
982001|NCT00543855|3229543|P3|Overall Study|Lost to Follow-up|1
982002|NCT00543855|3229544|P2|Overall Study|Lost to Follow-up|0
982003|NCT00543855|3229545|P1|Overall Study|Lost to Follow-up|0
982004|NCT00543855|3229542|P4|Overall Study|Adverse Event|4
982005|NCT00543855|3229543|P3|Overall Study|Adverse Event|3
982006|NCT00543855|3229544|P2|Overall Study|Adverse Event|1
982007|NCT00543855|3229545|P1|Overall Study|Adverse Event|3
982008|NCT00543803|3229567|P1|Overall Study|not specified|86
982009|NCT00543803|3229567|P1|Overall Study|Lost to Follow-up|20
982010|NCT00543803|3229567|P1|Overall Study|Lack of Efficacy|22
982011|NCT00543803|3229567|P1|Overall Study|Adverse Event|14
982012|NCT00543725|3229595|P2|Overall Study|Not specified|3
982013|NCT00543725|3229596|P1|Overall Study|Not specified|3
982014|NCT00543725|3229595|P2|Overall Study|Lost to Follow-up|11
982015|NCT00543725|3229596|P1|Overall Study|Lost to Follow-up|15
982016|NCT00543725|3229595|P2|Overall Study|Withdrawal by Subject|13
982017|NCT00543725|3229596|P1|Overall Study|Withdrawal by Subject|4
982018|NCT00543725|3229595|P2|Overall Study|Protocol Violation|1
982019|NCT00543725|3229596|P1|Overall Study|Protocol Violation|0
982020|NCT00543725|3229595|P2|Overall Study|Subject Reached A Virologic Endpoint|14
982021|NCT00543725|3229596|P1|Overall Study|Subject Reached A Virologic Endpoint|22
982022|NCT00543725|3229595|P2|Overall Study|Subject Ineligible To Continue The Trial|0
982023|NCT00543725|3229596|P1|Overall Study|Subject Ineligible To Continue The Trial|2
982024|NCT00543725|3229595|P2|Overall Study|Subject Non-Compliant|4
982025|NCT00543725|3229596|P1|Overall Study|Subject Non-Compliant|4
982026|NCT00543725|3229595|P2|Overall Study|Sponsor's Decision|1
982027|NCT00543725|3229596|P1|Overall Study|Sponsor's Decision|0
982028|NCT00543725|3229595|P2|Overall Study|Adverse Event|27
982029|NCT00543725|3229596|P1|Overall Study|Adverse Event|18
982030|NCT00543569|3229622|P4|Overall Study|Randomized but never received study drug|3
982031|NCT00543569|3229623|P3|Overall Study|Randomized but never received study drug|5
982032|NCT00543569|3229624|P2|Overall Study|Randomized but never received study drug|3
982033|NCT00543569|3229625|P1|Overall Study|Randomized but never received study drug|3
982034|NCT00543569|3229622|P4|Overall Study|Miscellaneous Reasons|4
982035|NCT00543569|3229623|P3|Overall Study|Miscellaneous Reasons|11
982036|NCT00543569|3229624|P2|Overall Study|Miscellaneous Reasons|3
982037|NCT00543569|3229625|P1|Overall Study|Miscellaneous Reasons|7
982038|NCT00543569|3229622|P4|Overall Study|Lost to Follow-up|1
982039|NCT00543569|3229623|P3|Overall Study|Lost to Follow-up|1
982040|NCT00543569|3229624|P2|Overall Study|Lost to Follow-up|0
982041|NCT00543569|3229625|P1|Overall Study|Lost to Follow-up|0
982042|NCT00543569|3229622|P4|Overall Study|Death|1
982043|NCT00543569|3229623|P3|Overall Study|Death|3
982044|NCT00543569|3229624|P2|Overall Study|Death|2
982045|NCT00543569|3229625|P1|Overall Study|Death|2
982046|NCT00543543|3229731|P4|Extension Study|Withdrawal by Subject|120
982047|NCT00543543|3229732|P3|Extension Study|Withdrawal by Subject|0
982048|NCT00543543|3229733|P2|Extension Study|Withdrawal by Subject|0
982049|NCT00543543|3229734|P1|Extension Study|Withdrawal by Subject|0
982050|NCT00543543|3229731|P4|Extension Study|Protocol Violation|11
982051|NCT00543543|3229732|P3|Extension Study|Protocol Violation|0
982052|NCT00543543|3229733|P2|Extension Study|Protocol Violation|0
982053|NCT00543543|3229734|P1|Extension Study|Protocol Violation|0
982054|NCT00543543|3229731|P4|Extension Study|Pregnancy|6
982055|NCT00543543|3229732|P3|Extension Study|Pregnancy|0
982056|NCT00543543|3229733|P2|Extension Study|Pregnancy|0
982057|NCT00543543|3229734|P1|Extension Study|Pregnancy|0
982058|NCT00543543|3229731|P4|Extension Study|Physician Decision|7
982059|NCT00543543|3229732|P3|Extension Study|Physician Decision|0
982060|NCT00543543|3229733|P2|Extension Study|Physician Decision|0
982061|NCT00543543|3229734|P1|Extension Study|Physician Decision|0
982062|NCT00543543|3229731|P4|Extension Study|Lost to Follow-up|77
982063|NCT00543543|3229732|P3|Extension Study|Lost to Follow-up|0
982064|NCT00543543|3229733|P2|Extension Study|Lost to Follow-up|0
982065|NCT00543543|3229734|P1|Extension Study|Lost to Follow-up|0
982066|NCT00543543|3229731|P4|Extension Study|Adverse Event|5
982067|NCT00543543|3229732|P3|Extension Study|Adverse Event|0
982068|NCT00543543|3229733|P2|Extension Study|Adverse Event|0
982069|NCT00543543|3229734|P1|Extension Study|Adverse Event|0
982070|NCT00543543|3229731|P4|Base Study|Withdrawal by Subject|503
982071|NCT00543543|3229732|P3|Base Study|Withdrawal by Subject|5
982072|NCT00543543|3229733|P2|Base Study|Withdrawal by Subject|482
982073|NCT00543543|3229734|P1|Base Study|Withdrawal by Subject|7
982074|NCT00543543|3229731|P4|Base Study|Protocol Violation|6
982075|NCT00543543|3229732|P3|Base Study|Protocol Violation|0
982076|NCT00543543|3229733|P2|Base Study|Protocol Violation|6
982077|NCT00543543|3229734|P1|Base Study|Protocol Violation|0
982078|NCT00543543|3229731|P4|Base Study|Physician Decision|7
982079|NCT00543543|3229732|P3|Base Study|Physician Decision|0
982080|NCT00543543|3229733|P2|Base Study|Physician Decision|4
982081|NCT00543543|3229734|P1|Base Study|Physician Decision|0
982082|NCT00543543|3229731|P4|Base Study|Lost to Follow-up|701
982083|NCT00543543|3229732|P3|Base Study|Lost to Follow-up|9
982084|NCT00543543|3229733|P2|Base Study|Lost to Follow-up|749
982085|NCT00543543|3229734|P1|Base Study|Lost to Follow-up|12
982086|NCT00543543|3229731|P4|Base Study|Adverse Event|5
982087|NCT00543543|3229732|P3|Base Study|Adverse Event|0
982088|NCT00543543|3229733|P2|Base Study|Adverse Event|11
982089|NCT00543543|3229734|P1|Base Study|Adverse Event|1
982090|NCT00543387|3229801|P11|Crossover Participants|Study Terminated by Sponsor|1
982091|NCT00543387|3229802|P10|Crossover Participants|Study Terminated by Sponsor|0
982092|NCT00543387|3229803|P9|Crossover Participants|Study Terminated by Sponsor|0
982093|NCT00543387|3229804|P8|Crossover Participants|Study Terminated by Sponsor|0
982094|NCT00543387|3229805|P7|Crossover Participants|Study Terminated by Sponsor|0
982095|NCT00543387|3229806|P6|Crossover Participants|Study Terminated by Sponsor|0
982096|NCT00543387|3229807|P5|Crossover Participants|Study Terminated by Sponsor|0
982097|NCT00543387|3229808|P4|Crossover Participants|Study Terminated by Sponsor|0
982098|NCT00543387|3229809|P3|Crossover Participants|Study Terminated by Sponsor|0
982099|NCT00543387|3229810|P2|Crossover Participants|Study Terminated by Sponsor|0
982100|NCT00543387|3229811|P1|Crossover Participants|Study Terminated by Sponsor|0
982101|NCT00543387|3229801|P11|Crossover Participants|Progressive Disease|2
982102|NCT00543387|3229802|P10|Crossover Participants|Progressive Disease|1
982103|NCT00543387|3229803|P9|Crossover Participants|Progressive Disease|0
982104|NCT00543387|3229804|P8|Crossover Participants|Progressive Disease|0
982105|NCT00543387|3229805|P7|Crossover Participants|Progressive Disease|0
982106|NCT00543387|3229806|P6|Crossover Participants|Progressive Disease|0
982107|NCT00543387|3229807|P5|Crossover Participants|Progressive Disease|0
982108|NCT00543387|3229808|P4|Crossover Participants|Progressive Disease|0
982109|NCT00543387|3229809|P3|Crossover Participants|Progressive Disease|0
982110|NCT00543387|3229810|P2|Crossover Participants|Progressive Disease|0
982111|NCT00543387|3229811|P1|Crossover Participants|Progressive Disease|0
982112|NCT00543387|3229801|P11|Panel 1 + Panel 2|Withdrawal by Subject|0
982113|NCT00543387|3229802|P10|Panel 1 + Panel 2|Withdrawal by Subject|0
982114|NCT00543387|3229803|P9|Panel 1 + Panel 2|Withdrawal by Subject|0
982115|NCT00543387|3229804|P8|Panel 1 + Panel 2|Withdrawal by Subject|0
982116|NCT00543387|3229805|P7|Panel 1 + Panel 2|Withdrawal by Subject|1
982117|NCT00543387|3229806|P6|Panel 1 + Panel 2|Withdrawal by Subject|0
982118|NCT00543387|3229807|P5|Panel 1 + Panel 2|Withdrawal by Subject|0
982119|NCT00543387|3229808|P4|Panel 1 + Panel 2|Withdrawal by Subject|0
982120|NCT00543387|3229809|P3|Panel 1 + Panel 2|Withdrawal by Subject|0
982121|NCT00543387|3229810|P2|Panel 1 + Panel 2|Withdrawal by Subject|0
982122|NCT00543387|3229811|P1|Panel 1 + Panel 2|Withdrawal by Subject|0
982123|NCT00543387|3229801|P11|Panel 1 + Panel 2|Progressive Disease (PD)|0
982124|NCT00543387|3229802|P10|Panel 1 + Panel 2|Progressive Disease (PD)|0
982125|NCT00543387|3229803|P9|Panel 1 + Panel 2|Progressive Disease (PD)|4
982126|NCT00543387|3229804|P8|Panel 1 + Panel 2|Progressive Disease (PD)|4
982127|NCT00543387|3229805|P7|Panel 1 + Panel 2|Progressive Disease (PD)|5
982128|NCT00543387|3229806|P6|Panel 1 + Panel 2|Progressive Disease (PD)|3
982129|NCT00543387|3229807|P5|Panel 1 + Panel 2|Progressive Disease (PD)|3
982130|NCT00543387|3229808|P4|Panel 1 + Panel 2|Progressive Disease (PD)|3
982131|NCT00543387|3229809|P3|Panel 1 + Panel 2|Progressive Disease (PD)|2
982132|NCT00543387|3229810|P2|Panel 1 + Panel 2|Progressive Disease (PD)|2
982133|NCT00543387|3229811|P1|Panel 1 + Panel 2|Progressive Disease (PD)|3
982134|NCT00543387|3229801|P11|Panel 1 + Panel 2|Physician Decision|0
982135|NCT00543387|3229802|P10|Panel 1 + Panel 2|Physician Decision|0
982136|NCT00543387|3229803|P9|Panel 1 + Panel 2|Physician Decision|0
982137|NCT00543387|3229804|P8|Panel 1 + Panel 2|Physician Decision|1
982138|NCT00543387|3229805|P7|Panel 1 + Panel 2|Physician Decision|0
982139|NCT00543387|3229806|P6|Panel 1 + Panel 2|Physician Decision|0
982140|NCT00543387|3229807|P5|Panel 1 + Panel 2|Physician Decision|0
982141|NCT00543387|3229808|P4|Panel 1 + Panel 2|Physician Decision|0
982142|NCT00543387|3229809|P3|Panel 1 + Panel 2|Physician Decision|1
982143|NCT00543387|3229810|P2|Panel 1 + Panel 2|Physician Decision|0
982144|NCT00543387|3229811|P1|Panel 1 + Panel 2|Physician Decision|0
982145|NCT00543387|3229801|P11|Panel 1 + Panel 2|Adverse Event|0
982146|NCT00543387|3229802|P10|Panel 1 + Panel 2|Adverse Event|0
982147|NCT00543387|3229803|P9|Panel 1 + Panel 2|Adverse Event|1
982148|NCT00543387|3229804|P8|Panel 1 + Panel 2|Adverse Event|1
982149|NCT00543387|3229805|P7|Panel 1 + Panel 2|Adverse Event|0
982150|NCT00543387|3229806|P6|Panel 1 + Panel 2|Adverse Event|0
982151|NCT00543387|3229807|P5|Panel 1 + Panel 2|Adverse Event|0
982152|NCT00543387|3229808|P4|Panel 1 + Panel 2|Adverse Event|0
982153|NCT00543387|3229809|P3|Panel 1 + Panel 2|Adverse Event|0
982154|NCT00543387|3229810|P2|Panel 1 + Panel 2|Adverse Event|1
982155|NCT00543387|3229811|P1|Panel 1 + Panel 2|Adverse Event|0
982156|NCT00543309|3229849|P3|Overall Study|Physician Decision|0
982157|NCT00543309|3229850|P2|Overall Study|Physician Decision|1
982158|NCT00543309|3229851|P1|Overall Study|Physician Decision|0
982159|NCT00543296|3229901|P1|Overall Study|Physician Decision|7
982160|NCT00543140|3229908|P1|Overall Study|Conversion to different procedure|1
982161|NCT00543140|3229908|P1|Overall Study|Subject moved|1
982162|NCT00543140|3229908|P1|Overall Study|Death|1
982163|NCT00543140|3229908|P1|Overall Study|SAE leading to explant of SAGB|3
982164|NCT00543140|3229908|P1|Overall Study|Insufficient weight loss|10
982165|NCT00543140|3229908|P1|Overall Study|Protocol Violation|10
982166|NCT00543140|3229908|P1|Overall Study|Withdrawal by Subject|13
982167|NCT00543140|3229908|P1|Overall Study|Lost to Follow-up|33
982168|NCT00542997|3229931|P1|Efficacy Period|Adverse Event|3
982169|NCT00542997|3229931|P1|Wash in / Wash Out Period|Adverse Event|3
982170|NCT00542997|3229931|P1|Wash in / Wash Out Period|Withdrawal by Subject|2
982171|NCT00542880|3229953|P2|Period 3|Adverse Event|2
982172|NCT00542880|3229954|P1|Period 3|Adverse Event|0
982173|NCT00542880|3229953|P2|Period 2|Not specified|1
982174|NCT00542880|3229954|P1|Period 2|Not specified|0
982175|NCT00542880|3229953|P2|Period 2|Severe non-compliance|1
982176|NCT00542880|3229954|P1|Period 2|Severe non-compliance|0
982177|NCT00542880|3229953|P2|Period 2|Discontinuation criteria|0
982178|NCT00542880|3229954|P1|Period 2|Discontinuation criteria|2
982179|NCT00542880|3229953|P2|Period 2|Eligibility not fulfilled|1
982180|NCT00542880|3229954|P1|Period 2|Eligibility not fulfilled|0
982181|NCT00542880|3229953|P2|Period 2|Adverse Event|7
982182|NCT00542880|3229954|P1|Period 2|Adverse Event|5
982183|NCT00542880|3229953|P2|Period 1|Protocol Violation|1
982184|NCT00542880|3229954|P1|Period 1|Protocol Violation|0
982185|NCT00542880|3229953|P2|Period 1|Withdrawal by Subject|1
982186|NCT00542880|3229954|P1|Period 1|Withdrawal by Subject|1
982187|NCT00542880|3229953|P2|Period 1|Development of study-specific criteria|2
982188|NCT00542880|3229954|P1|Period 1|Development of study-specific criteria|1
982189|NCT00542880|3229953|P2|Period 1|Adverse Event|2
982190|NCT00542880|3229954|P1|Period 1|Adverse Event|2
982191|NCT00542880|3229953|P2|Period 1|Eligibility criteria not fulfilled|6
982192|NCT00542880|3229954|P1|Period 1|Eligibility criteria not fulfilled|2
982193|NCT00542828|3229990|P1|Overall Study|Did Not Receive Thymoglobulin Treatment|2
982194|NCT00542828|3229990|P1|Overall Study|Study Prematurely Discontinued|7
982195|NCT00542828|3229990|P1|Overall Study|Need for Prohibited Treatment|3
982196|NCT00542828|3229990|P1|Overall Study|Physician Decision|1
982197|NCT00542815|3230008|P3|Overall Study|Other reasons|10
982198|NCT00542815|3230009|P2|Overall Study|Other reasons|10
982199|NCT00542815|3230010|P1|Overall Study|Other reasons|24
982200|NCT00542815|3230008|P3|Overall Study|Withdrawal by Subject|8
982201|NCT00542815|3230009|P2|Overall Study|Withdrawal by Subject|5
982202|NCT00542815|3230010|P1|Overall Study|Withdrawal by Subject|41
982203|NCT00542815|3230008|P3|Overall Study|Protocol Violation|2
982204|NCT00542815|3230009|P2|Overall Study|Protocol Violation|1
982205|NCT00542815|3230010|P1|Overall Study|Protocol Violation|1
982206|NCT00542815|3230008|P3|Overall Study|Physician Decision|0
982207|NCT00542815|3230009|P2|Overall Study|Physician Decision|1
982208|NCT00542815|3230010|P1|Overall Study|Physician Decision|2
982209|NCT00542815|3230008|P3|Overall Study|Lack of Efficacy|0
982210|NCT00542815|3230009|P2|Overall Study|Lack of Efficacy|2
982211|NCT00542815|3230010|P1|Overall Study|Lack of Efficacy|9
982212|NCT00542815|3230008|P3|Overall Study|Death|3
982213|NCT00542815|3230009|P2|Overall Study|Death|7
982214|NCT00542815|3230010|P1|Overall Study|Death|10
982215|NCT00542815|3230008|P3|Overall Study|Adverse Event|9
982216|NCT00542815|3230009|P2|Overall Study|Adverse Event|6
982217|NCT00542815|3230010|P1|Overall Study|Adverse Event|19
982218|NCT00542789|3230023|P2|Overall Study|Recurrence of Gastric Ulcer|57
982219|NCT00542789|3230024|P1|Overall Study|Recurrence of Gastric Ulcer|8
982220|NCT00542789|3230023|P2|Overall Study|Protocol Violation|1
982221|NCT00542789|3230024|P1|Overall Study|Protocol Violation|8
982222|NCT00542789|3230023|P2|Overall Study|Withdrawal by Subject|3
982223|NCT00542789|3230024|P1|Overall Study|Withdrawal by Subject|7
982224|NCT00542789|3230023|P2|Overall Study|Adverse Event|17
982225|NCT00542789|3230024|P1|Overall Study|Adverse Event|18
982226|NCT00542425|3230124|P5|Extended 24 Weeks of Treatment|Other|1
982227|NCT00542425|3230125|P4|Extended 24 Weeks of Treatment|Other|0
982228|NCT00542425|3230126|P3|Extended 24 Weeks of Treatment|Other|0
982229|NCT00542425|3230127|P2|Extended 24 Weeks of Treatment|Other|1
982230|NCT00542425|3230128|P1|Extended 24 Weeks of Treatment|Other|1
982231|NCT00542425|3230124|P5|Extended 24 Weeks of Treatment|Refusal of treatment|0
982232|NCT00542425|3230125|P4|Extended 24 Weeks of Treatment|Refusal of treatment|0
982233|NCT00542425|3230126|P3|Extended 24 Weeks of Treatment|Refusal of treatment|0
982234|NCT00542425|3230127|P2|Extended 24 Weeks of Treatment|Refusal of treatment|1
982235|NCT00542425|3230128|P1|Extended 24 Weeks of Treatment|Refusal of treatment|0
982236|NCT00542425|3230124|P5|Extended 24 Weeks of Treatment|Protocol Violation|0
982237|NCT00542425|3230125|P4|Extended 24 Weeks of Treatment|Protocol Violation|0
982238|NCT00542425|3230126|P3|Extended 24 Weeks of Treatment|Protocol Violation|1
982239|NCT00542425|3230127|P2|Extended 24 Weeks of Treatment|Protocol Violation|0
982240|NCT00542425|3230128|P1|Extended 24 Weeks of Treatment|Protocol Violation|0
982241|NCT00542425|3230124|P5|Extended 24 Weeks of Treatment|Adverse Event|0
982242|NCT00542425|3230125|P4|Extended 24 Weeks of Treatment|Adverse Event|1
982243|NCT00542425|3230126|P3|Extended 24 Weeks of Treatment|Adverse Event|1
982244|NCT00542425|3230127|P2|Extended 24 Weeks of Treatment|Adverse Event|0
982245|NCT00542425|3230128|P1|Extended 24 Weeks of Treatment|Adverse Event|0
982246|NCT00542425|3230124|P5|Initial 24 Weeks|Other|0
982247|NCT00542425|3230125|P4|Initial 24 Weeks|Other|0
982248|NCT00542425|3230126|P3|Initial 24 Weeks|Other|1
982249|NCT00542425|3230127|P2|Initial 24 Weeks|Other|2
982250|NCT00542425|3230128|P1|Initial 24 Weeks|Other|0
982251|NCT00542425|3230124|P5|Initial 24 Weeks|Refusal of treatment|1
982252|NCT00542425|3230125|P4|Initial 24 Weeks|Refusal of treatment|4
982253|NCT00542425|3230126|P3|Initial 24 Weeks|Refusal of treatment|1
982254|NCT00542425|3230127|P2|Initial 24 Weeks|Refusal of treatment|2
982255|NCT00542425|3230128|P1|Initial 24 Weeks|Refusal of treatment|2
982256|NCT00542425|3230124|P5|Initial 24 Weeks|Protocol Violation|0
982257|NCT00542425|3230125|P4|Initial 24 Weeks|Protocol Violation|1
982258|NCT00542425|3230126|P3|Initial 24 Weeks|Protocol Violation|0
982259|NCT00542425|3230127|P2|Initial 24 Weeks|Protocol Violation|0
982260|NCT00542425|3230128|P1|Initial 24 Weeks|Protocol Violation|0
982261|NCT00542425|3230124|P5|Initial 24 Weeks|Non-compliance|1
982262|NCT00542425|3230125|P4|Initial 24 Weeks|Non-compliance|1
982263|NCT00542425|3230126|P3|Initial 24 Weeks|Non-compliance|0
982264|NCT00542425|3230127|P2|Initial 24 Weeks|Non-compliance|0
982265|NCT00542425|3230128|P1|Initial 24 Weeks|Non-compliance|0
982266|NCT00542425|3230124|P5|Initial 24 Weeks|Lost to Follow-up|0
982267|NCT00542425|3230125|P4|Initial 24 Weeks|Lost to Follow-up|0
982268|NCT00542425|3230126|P3|Initial 24 Weeks|Lost to Follow-up|1
982269|NCT00542425|3230127|P2|Initial 24 Weeks|Lost to Follow-up|2
982270|NCT00542425|3230128|P1|Initial 24 Weeks|Lost to Follow-up|2
982271|NCT00542425|3230124|P5|Initial 24 Weeks|Inability to complete procedures|2
982272|NCT00542425|3230125|P4|Initial 24 Weeks|Inability to complete procedures|1
982273|NCT00542425|3230126|P3|Initial 24 Weeks|Inability to complete procedures|2
982274|NCT00542425|3230127|P2|Initial 24 Weeks|Inability to complete procedures|3
982275|NCT00542425|3230128|P1|Initial 24 Weeks|Inability to complete procedures|0
982276|NCT00542425|3230124|P5|Initial 24 Weeks|Adverse Event|2
982277|NCT00542425|3230125|P4|Initial 24 Weeks|Adverse Event|3
982278|NCT00542425|3230126|P3|Initial 24 Weeks|Adverse Event|1
982279|NCT00542425|3230127|P2|Initial 24 Weeks|Adverse Event|1
982280|NCT00542425|3230128|P1|Initial 24 Weeks|Adverse Event|0
982281|NCT00542425|3230124|P5|Initial 24 Weeks|Administrative reasons|0
982282|NCT00542425|3230125|P4|Initial 24 Weeks|Administrative reasons|1
982283|NCT00542425|3230126|P3|Initial 24 Weeks|Administrative reasons|1
982284|NCT00542425|3230127|P2|Initial 24 Weeks|Administrative reasons|0
982285|NCT00542425|3230128|P1|Initial 24 Weeks|Administrative reasons|0
982286|NCT00542386|3230166|P6|Overall Study|Other Reasons|2
982287|NCT00542386|3230167|P5|Overall Study|Other Reasons|4
982288|NCT00542386|3230168|P4|Overall Study|Other Reasons|3
982289|NCT00542386|3230169|P3|Overall Study|Other Reasons|4
982290|NCT00542386|3230170|P2|Overall Study|Other Reasons|1
982291|NCT00542386|3230171|P1|Overall Study|Other Reasons|4
982292|NCT00542386|3230166|P6|Overall Study|Withdrawal by Subject|7
982293|NCT00542386|3230167|P5|Overall Study|Withdrawal by Subject|15
982294|NCT00542386|3230168|P4|Overall Study|Withdrawal by Subject|11
982295|NCT00542386|3230169|P3|Overall Study|Withdrawal by Subject|10
982296|NCT00542386|3230170|P2|Overall Study|Withdrawal by Subject|8
982297|NCT00542386|3230171|P1|Overall Study|Withdrawal by Subject|5
982298|NCT00542386|3230166|P6|Overall Study|Protocol Violation|4
982299|NCT00542386|3230167|P5|Overall Study|Protocol Violation|0
982300|NCT00542386|3230168|P4|Overall Study|Protocol Violation|0
982301|NCT00542386|3230169|P3|Overall Study|Protocol Violation|1
982302|NCT00542386|3230170|P2|Overall Study|Protocol Violation|0
982303|NCT00542386|3230171|P1|Overall Study|Protocol Violation|0
982304|NCT00542386|3230166|P6|Overall Study|Physician Decision|0
982305|NCT00542386|3230167|P5|Overall Study|Physician Decision|0
982306|NCT00542386|3230168|P4|Overall Study|Physician Decision|1
982307|NCT00542386|3230169|P3|Overall Study|Physician Decision|0
982308|NCT00542386|3230170|P2|Overall Study|Physician Decision|0
982309|NCT00542386|3230171|P1|Overall Study|Physician Decision|1
982310|NCT00542386|3230166|P6|Overall Study|Lack of Efficacy|31
982311|NCT00542386|3230167|P5|Overall Study|Lack of Efficacy|7
982312|NCT00542386|3230168|P4|Overall Study|Lack of Efficacy|13
982313|NCT00542386|3230169|P3|Overall Study|Lack of Efficacy|10
982314|NCT00542386|3230170|P2|Overall Study|Lack of Efficacy|12
982315|NCT00542386|3230171|P1|Overall Study|Lack of Efficacy|32
982316|NCT00542386|3230166|P6|Overall Study|Death|2
982317|NCT00542386|3230167|P5|Overall Study|Death|1
982318|NCT00542386|3230168|P4|Overall Study|Death|2
982319|NCT00542386|3230169|P3|Overall Study|Death|1
982320|NCT00542386|3230170|P2|Overall Study|Death|0
982321|NCT00542386|3230171|P1|Overall Study|Death|0
982322|NCT00542386|3230166|P6|Overall Study|Adverse Event|4
982323|NCT00542386|3230167|P5|Overall Study|Adverse Event|13
982324|NCT00542386|3230168|P4|Overall Study|Adverse Event|8
982325|NCT00542386|3230169|P3|Overall Study|Adverse Event|7
982326|NCT00542386|3230170|P2|Overall Study|Adverse Event|7
982327|NCT00542386|3230171|P1|Overall Study|Adverse Event|1
982328|NCT00542321|3230193|P2|Overall Study|Death|1
982329|NCT00542321|3230194|P1|Overall Study|Death|0
982330|NCT00542269|3230216|P3|Overall Study|Administrative problems|1
982331|NCT00542269|3230217|P2|Overall Study|Administrative problems|1
982332|NCT00542269|3230218|P1|Overall Study|Administrative problems|1
982333|NCT00542269|3230216|P3|Overall Study|Withdrawal by Subject|0
982334|NCT00542269|3230217|P2|Overall Study|Withdrawal by Subject|0
982335|NCT00542269|3230218|P1|Overall Study|Withdrawal by Subject|1
982336|NCT00542269|3230216|P3|Overall Study|Protocol Violation|0
982337|NCT00542269|3230217|P2|Overall Study|Protocol Violation|1
982338|NCT00542269|3230218|P1|Overall Study|Protocol Violation|1
982339|NCT00542269|3230216|P3|Overall Study|Adverse Event|5
982340|NCT00542269|3230217|P2|Overall Study|Adverse Event|4
982341|NCT00542269|3230218|P1|Overall Study|Adverse Event|10
982342|NCT00542178|3230253|P8|Overall Study|did not complete year 4 follow-up|85
982343|NCT00542178|3230254|P7|Overall Study|did not complete year 4 follow-up|87
982344|NCT00542178|3230255|P6|Overall Study|did not complete year 4 follow-up|89
982345|NCT00542178|3230256|P5|Overall Study|did not complete year 4 follow-up|64
982346|NCT00542178|3230257|P4|Overall Study|did not complete year 4 follow-up|62
982347|NCT00542178|3230258|P3|Overall Study|did not complete year 4 follow-up|74
982348|NCT00542178|3230259|P2|Overall Study|did not complete year 4 follow-up|80
982349|NCT00542178|3230260|P1|Overall Study|did not complete year 4 follow-up|75
982350|NCT00541970|3230296|P4|Month 60|Protocol Violation|72
982351|NCT00541970|3230297|P3|Month 60|Protocol Violation|82
982352|NCT00541970|3230298|P2|Month 60|Protocol Violation|77
982353|NCT00541970|3230299|P1|Month 60|Protocol Violation|78
982354|NCT00541970|3230296|P4|Month 48|Lost to Follow-up|73
982355|NCT00541970|3230297|P3|Month 48|Lost to Follow-up|68
982356|NCT00541970|3230298|P2|Month 48|Lost to Follow-up|68
982357|NCT00541970|3230299|P1|Month 48|Lost to Follow-up|66
982358|NCT00541970|3230296|P4|Month 48|Other|0
982359|NCT00541970|3230297|P3|Month 48|Other|1
982360|NCT00541970|3230298|P2|Month 48|Other|1
982361|NCT00541970|3230299|P1|Month 48|Other|3
982362|NCT00541970|3230296|P4|Month 48|Withdrawal by Subject|2
982363|NCT00541970|3230297|P3|Month 48|Withdrawal by Subject|4
982364|NCT00541970|3230298|P2|Month 48|Withdrawal by Subject|4
982365|NCT00541970|3230299|P1|Month 48|Withdrawal by Subject|2
982366|NCT00541970|3230296|P4|Month 36|Protocol Violation|60
982367|NCT00541970|3230297|P3|Month 36|Protocol Violation|66
982368|NCT00541970|3230298|P2|Month 36|Protocol Violation|66
982369|NCT00541970|3230299|P1|Month 36|Protocol Violation|61
982370|NCT00541970|3230296|P4|Month 24|Protocol Violation|21
982371|NCT00541970|3230297|P3|Month 24|Protocol Violation|31
982372|NCT00541970|3230298|P2|Month 24|Protocol Violation|31
982373|NCT00541970|3230299|P1|Month 24|Protocol Violation|29
982374|NCT00541970|3230296|P4|Month 24|Adverse Event|1
982375|NCT00541970|3230297|P3|Month 24|Adverse Event|1
982376|NCT00541970|3230298|P2|Month 24|Adverse Event|1
982377|NCT00541970|3230299|P1|Month 24|Adverse Event|0
982378|NCT00541970|3230296|P4|Month 18|Protocol Violation|16
982379|NCT00541970|3230297|P3|Month 18|Protocol Violation|24
982380|NCT00541970|3230298|P2|Month 18|Protocol Violation|23
982381|NCT00541970|3230299|P1|Month 18|Protocol Violation|14
982382|NCT00541970|3230296|P4|Month 18|Adverse Event|1
982383|NCT00541970|3230297|P3|Month 18|Adverse Event|1
982384|NCT00541970|3230298|P2|Month 18|Adverse Event|1
982385|NCT00541970|3230299|P1|Month 18|Adverse Event|0
982386|NCT00541970|3230296|P4|Month 12|Protocol Violation|15
982387|NCT00541970|3230297|P3|Month 12|Protocol Violation|20
982388|NCT00541970|3230298|P2|Month 12|Protocol Violation|21
982389|NCT00541970|3230299|P1|Month 12|Protocol Violation|12
982390|NCT00541970|3230296|P4|Month 12|Adverse Event|1
982391|NCT00541970|3230297|P3|Month 12|Adverse Event|1
982392|NCT00541970|3230298|P2|Month 12|Adverse Event|1
982393|NCT00541970|3230299|P1|Month 12|Adverse Event|0
982394|NCT00541970|3230296|P4|Month 7|Protocol Violation|5
982395|NCT00541970|3230297|P3|Month 7|Protocol Violation|11
982396|NCT00541970|3230298|P2|Month 7|Protocol Violation|13
982397|NCT00541970|3230299|P1|Month 7|Protocol Violation|9
982398|NCT00541931|3230450|P2|Overall Study|Transportation Issue|1
982399|NCT00541931|3230451|P1|Overall Study|Transportation Issue|0
982400|NCT00541931|3230450|P2|Overall Study|Withdrawal by Subject|0
982401|NCT00541931|3230451|P1|Overall Study|Withdrawal by Subject|1
982402|NCT00541931|3230450|P2|Overall Study|Lost to Follow-up|3
982403|NCT00541931|3230451|P1|Overall Study|Lost to Follow-up|3
982404|NCT00541931|3230450|P2|Overall Study|Adverse Event|0
982405|NCT00541931|3230451|P1|Overall Study|Adverse Event|1
982406|NCT00541866|3230464|P5|Overall Study|Physician Decision|0
982407|NCT00541866|3230465|P4|Overall Study|Physician Decision|1
982408|NCT00541866|3230466|P3|Overall Study|Physician Decision|2
982409|NCT00541866|3230467|P2|Overall Study|Physician Decision|0
982410|NCT00541866|3230468|P1|Overall Study|Physician Decision|0
982411|NCT00541866|3230464|P5|Overall Study|Not Reported or Other|1
982412|NCT00541866|3230465|P4|Overall Study|Not Reported or Other|3
982413|NCT00541866|3230466|P3|Overall Study|Not Reported or Other|3
982414|NCT00541866|3230467|P2|Overall Study|Not Reported or Other|3
982415|NCT00541866|3230468|P1|Overall Study|Not Reported or Other|11
982416|NCT00541866|3230464|P5|Overall Study|Lack of Efficacy|14
982417|NCT00541866|3230465|P4|Overall Study|Lack of Efficacy|12
982418|NCT00541866|3230466|P3|Overall Study|Lack of Efficacy|10
982419|NCT00541866|3230467|P2|Overall Study|Lack of Efficacy|15
982420|NCT00541866|3230468|P1|Overall Study|Lack of Efficacy|19
982421|NCT00541866|3230464|P5|Overall Study|Death|0
982422|NCT00541866|3230465|P4|Overall Study|Death|0
982423|NCT00541866|3230466|P3|Overall Study|Death|0
982424|NCT00541866|3230467|P2|Overall Study|Death|0
982425|NCT00541866|3230468|P1|Overall Study|Death|1
982426|NCT00541866|3230464|P5|Overall Study|Adverse Event|0
982427|NCT00541866|3230465|P4|Overall Study|Adverse Event|0
982428|NCT00541866|3230466|P3|Overall Study|Adverse Event|0
982429|NCT00541866|3230467|P2|Overall Study|Adverse Event|0
982430|NCT00541866|3230468|P1|Overall Study|Adverse Event|3
982431|NCT00541775|3230509|P3|Overall Study|Withdrawal by Subject and Other|2
982432|NCT00541775|3230510|P2|Overall Study|Withdrawal by Subject and Other|0
982433|NCT00541775|3230511|P1|Overall Study|Withdrawal by Subject and Other|5
982434|NCT00541775|3230509|P3|Overall Study|Protocol Violation|0
982435|NCT00541775|3230510|P2|Overall Study|Protocol Violation|0
982436|NCT00541775|3230511|P1|Overall Study|Protocol Violation|1
982437|NCT00541775|3230509|P3|Overall Study|Lost to Follow-up|2
982438|NCT00541775|3230510|P2|Overall Study|Lost to Follow-up|0
982439|NCT00541775|3230511|P1|Overall Study|Lost to Follow-up|0
982440|NCT00541775|3230509|P3|Overall Study|Lack of Efficacy|3
982441|NCT00541775|3230510|P2|Overall Study|Lack of Efficacy|0
982442|NCT00541775|3230511|P1|Overall Study|Lack of Efficacy|0
982443|NCT00541775|3230509|P3|Overall Study|Adverse Event|1
982444|NCT00541775|3230510|P2|Overall Study|Adverse Event|2
982445|NCT00541775|3230511|P1|Overall Study|Adverse Event|3
982446|NCT00541658|3230537|P3|Overall Study|Took No Study Drug|0
982447|NCT00541658|3230538|P2|Overall Study|Took No Study Drug|0
982448|NCT00541658|3230539|P1|Overall Study|Took No Study Drug|1
982449|NCT00541658|3230537|P3|Overall Study|Withdrawal by Subject|32
982450|NCT00541658|3230538|P2|Overall Study|Withdrawal by Subject|32
982451|NCT00541658|3230539|P1|Overall Study|Withdrawal by Subject|28
982452|NCT00541658|3230537|P3|Overall Study|Protocol Violation|1
982453|NCT00541658|3230538|P2|Overall Study|Protocol Violation|1
982454|NCT00541658|3230539|P1|Overall Study|Protocol Violation|0
982455|NCT00541658|3230537|P3|Overall Study|Lost to Follow-up|6
982456|NCT00541658|3230538|P2|Overall Study|Lost to Follow-up|3
982457|NCT00541658|3230539|P1|Overall Study|Lost to Follow-up|3
982458|NCT00541658|3230537|P3|Overall Study|Physician Decision|4
982459|NCT00541658|3230538|P2|Overall Study|Physician Decision|0
982460|NCT00541658|3230539|P1|Overall Study|Physician Decision|0
982461|NCT00541658|3230537|P3|Overall Study|Adverse Event|25
982462|NCT00541658|3230538|P2|Overall Study|Adverse Event|37
982463|NCT00541658|3230539|P1|Overall Study|Adverse Event|28
982464|NCT00541450|3230702|P2|Phase B|Withdrawal by Subject|6
982465|NCT00541450|3230703|P1|Phase B|Withdrawal by Subject|8
982466|NCT00541450|3230702|P2|Phase B|Protocol Violation|3
982467|NCT00541450|3230703|P1|Phase B|Protocol Violation|3
982468|NCT00541450|3230702|P2|Phase B|Pregnancy|1
982469|NCT00541450|3230703|P1|Phase B|Pregnancy|0
982470|NCT00541450|3230702|P2|Phase B|Physician Decision|2
982471|NCT00541450|3230703|P1|Phase B|Physician Decision|4
982472|NCT00541450|3230702|P2|Phase B|Lost to Follow-up|4
982473|NCT00541450|3230703|P1|Phase B|Lost to Follow-up|6
982474|NCT00541450|3230702|P2|Phase B|Hyperglycemia|9
982475|NCT00541450|3230703|P1|Phase B|Hyperglycemia|10
982476|NCT00541450|3230702|P2|Phase B|Adverse Event|6
982477|NCT00541450|3230703|P1|Phase B|Adverse Event|6
982478|NCT00541450|3230702|P2|Phase A|Withdrawal by Subject|7
982479|NCT00541450|3230703|P1|Phase A|Withdrawal by Subject|7
982480|NCT00541450|3230702|P2|Phase A|Protocol Violation|3
982481|NCT00541450|3230703|P1|Phase A|Protocol Violation|2
982482|NCT00541450|3230702|P2|Phase A|Physician Decision|0
982483|NCT00541450|3230703|P1|Phase A|Physician Decision|2
982484|NCT00541450|3230702|P2|Phase A|Lost to Follow-up|4
982485|NCT00541450|3230703|P1|Phase A|Lost to Follow-up|6
982486|NCT00541450|3230702|P2|Phase A|Hyperglycemia|1
982487|NCT00541450|3230703|P1|Phase A|Hyperglycemia|0
982488|NCT00541450|3230702|P2|Phase A|Creatinine/CrCl -Increase in creatinine|2
982489|NCT00541450|3230703|P1|Phase A|Creatinine/CrCl -Increase in creatinine|0
982490|NCT00541450|3230702|P2|Phase A|Adverse Event|0
982491|NCT00541450|3230703|P1|Phase A|Adverse Event|3
982492|NCT00541346|3230721|P1|Follow-up|Adverse Event|1
982493|NCT00541307|3230735|P1|Overall Study|Surgical Bypass|5
982494|NCT00541307|3230735|P1|Overall Study|Subject returned early (outside window)|1
982495|NCT00541307|3230735|P1|Overall Study|Lost to Follow-up|4
982496|NCT00541307|3230735|P1|Overall Study|Withdrawal by Subject|6
982497|NCT00541307|3230735|P1|Overall Study|Physician Decision|3
982498|NCT00541307|3230735|P1|Overall Study|Death|5
982499|NCT00541229|3230760|P6|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
982500|NCT00541229|3230761|P5|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
982501|NCT00541229|3230762|P4|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
982502|NCT00541229|3230763|P3|Treatment Period III (Week 11)|Study Terminated by Sponsor|1
982503|NCT00541229|3230764|P2|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
982504|NCT00541229|3230765|P1|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
982505|NCT00541229|3230760|P6|Treatment Period III (Week 11)|Protocol Specified Criteria|1
982506|NCT00541229|3230761|P5|Treatment Period III (Week 11)|Protocol Specified Criteria|0
982507|NCT00541229|3230762|P4|Treatment Period III (Week 11)|Protocol Specified Criteria|0
982508|NCT00541229|3230763|P3|Treatment Period III (Week 11)|Protocol Specified Criteria|0
982509|NCT00541229|3230764|P2|Treatment Period III (Week 11)|Protocol Specified Criteria|0
982510|NCT00541229|3230765|P1|Treatment Period III (Week 11)|Protocol Specified Criteria|0
982511|NCT00541229|3230760|P6|Treatment Period III (Week 11)|Adverse Event|0
982512|NCT00541229|3230761|P5|Treatment Period III (Week 11)|Adverse Event|1
982513|NCT00541229|3230762|P4|Treatment Period III (Week 11)|Adverse Event|0
982514|NCT00541229|3230763|P3|Treatment Period III (Week 11)|Adverse Event|0
982515|NCT00541229|3230764|P2|Treatment Period III (Week 11)|Adverse Event|0
982516|NCT00541229|3230765|P1|Treatment Period III (Week 11)|Adverse Event|0
982517|NCT00541229|3230760|P6|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
982518|NCT00541229|3230761|P5|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
982519|NCT00541229|3230762|P4|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
982520|NCT00541229|3230763|P3|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2
982521|NCT00541229|3230764|P2|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
982522|NCT00541229|3230765|P1|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
982523|NCT00541229|3230760|P6|Washout Period II (Week 7-10)|Withdrawal by Subject|0
982524|NCT00541229|3230761|P5|Washout Period II (Week 7-10)|Withdrawal by Subject|1
982525|NCT00541229|3230762|P4|Washout Period II (Week 7-10)|Withdrawal by Subject|0
982526|NCT00541229|3230763|P3|Washout Period II (Week 7-10)|Withdrawal by Subject|0
982527|NCT00541229|3230764|P2|Washout Period II (Week 7-10)|Withdrawal by Subject|0
982528|NCT00541229|3230765|P1|Washout Period II (Week 7-10)|Withdrawal by Subject|0
982529|NCT00541229|3230760|P6|Washout Period II (Week 7-10)|Protocol Violation|0
982530|NCT00541229|3230761|P5|Washout Period II (Week 7-10)|Protocol Violation|0
982531|NCT00541229|3230762|P4|Washout Period II (Week 7-10)|Protocol Violation|0
982532|NCT00541229|3230763|P3|Washout Period II (Week 7-10)|Protocol Violation|0
982533|NCT00541229|3230764|P2|Washout Period II (Week 7-10)|Protocol Violation|0
982534|NCT00541229|3230765|P1|Washout Period II (Week 7-10)|Protocol Violation|1
982535|NCT00541229|3230760|P6|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
982536|NCT00541229|3230761|P5|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
982537|NCT00541229|3230762|P4|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
982538|NCT00541229|3230763|P3|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
982539|NCT00541229|3230764|P2|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
982540|NCT00541229|3230765|P1|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
982541|NCT00541229|3230760|P6|Treatment Period II (Week 6)|Protocol Violation|1
982542|NCT00541229|3230761|P5|Treatment Period II (Week 6)|Protocol Violation|1
982543|NCT00541229|3230762|P4|Treatment Period II (Week 6)|Protocol Violation|0
982544|NCT00541229|3230763|P3|Treatment Period II (Week 6)|Protocol Violation|0
982545|NCT00541229|3230764|P2|Treatment Period II (Week 6)|Protocol Violation|0
982546|NCT00541229|3230765|P1|Treatment Period II (Week 6)|Protocol Violation|0
982547|NCT00541229|3230760|P6|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4
982548|NCT00541229|3230761|P5|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1
982549|NCT00541229|3230762|P4|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
982550|NCT00541229|3230763|P3|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
982551|NCT00541229|3230764|P2|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2
982552|NCT00541229|3230765|P1|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
982553|NCT00541229|3230760|P6|Washout Period I (Week 2-5)|Protocol Violation|1
982554|NCT00541229|3230761|P5|Washout Period I (Week 2-5)|Protocol Violation|0
982555|NCT00541229|3230762|P4|Washout Period I (Week 2-5)|Protocol Violation|0
982556|NCT00541229|3230763|P3|Washout Period I (Week 2-5)|Protocol Violation|0
982557|NCT00541229|3230764|P2|Washout Period I (Week 2-5)|Protocol Violation|0
982558|NCT00541229|3230765|P1|Washout Period I (Week 2-5)|Protocol Violation|0
982559|NCT00541229|3230760|P6|Washout Period I (Week 2-5)|Physician Decision|0
982560|NCT00541229|3230761|P5|Washout Period I (Week 2-5)|Physician Decision|0
982561|NCT00541229|3230762|P4|Washout Period I (Week 2-5)|Physician Decision|1
982562|NCT00541229|3230763|P3|Washout Period I (Week 2-5)|Physician Decision|0
982563|NCT00541229|3230764|P2|Washout Period I (Week 2-5)|Physician Decision|0
982564|NCT00541229|3230765|P1|Washout Period I (Week 2-5)|Physician Decision|0
982565|NCT00541229|3230760|P6|Washout Period I (Week 2-5)|Adverse Event|0
982566|NCT00541229|3230761|P5|Washout Period I (Week 2-5)|Adverse Event|0
982567|NCT00541229|3230762|P4|Washout Period I (Week 2-5)|Adverse Event|0
982568|NCT00541229|3230763|P3|Washout Period I (Week 2-5)|Adverse Event|1
982569|NCT00541229|3230764|P2|Washout Period I (Week 2-5)|Adverse Event|0
982570|NCT00541229|3230765|P1|Washout Period I (Week 2-5)|Adverse Event|1
982571|NCT00541229|3230760|P6|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
982572|NCT00541229|3230761|P5|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
982573|NCT00541229|3230762|P4|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
982574|NCT00541229|3230763|P3|Treatment Period I (Week 1)|Study Terminated by Sponsor|2
982575|NCT00541229|3230764|P2|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
982576|NCT00541229|3230765|P1|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
982577|NCT00541229|3230760|P6|Treatment Period I (Week 1)|Protocol Specified Criteria|1
982578|NCT00541229|3230761|P5|Treatment Period I (Week 1)|Protocol Specified Criteria|0
982579|NCT00541229|3230762|P4|Treatment Period I (Week 1)|Protocol Specified Criteria|0
982580|NCT00541229|3230763|P3|Treatment Period I (Week 1)|Protocol Specified Criteria|0
982581|NCT00541229|3230764|P2|Treatment Period I (Week 1)|Protocol Specified Criteria|0
982582|NCT00541229|3230765|P1|Treatment Period I (Week 1)|Protocol Specified Criteria|0
982583|NCT00541229|3230760|P6|Treatment Period I (Week 1)|Withdrawal by Subject|1
982584|NCT00541229|3230761|P5|Treatment Period I (Week 1)|Withdrawal by Subject|0
982585|NCT00541229|3230762|P4|Treatment Period I (Week 1)|Withdrawal by Subject|0
982586|NCT00541229|3230763|P3|Treatment Period I (Week 1)|Withdrawal by Subject|0
982587|NCT00541229|3230764|P2|Treatment Period I (Week 1)|Withdrawal by Subject|0
982588|NCT00541229|3230765|P1|Treatment Period I (Week 1)|Withdrawal by Subject|0
982589|NCT00541229|3230760|P6|Treatment Period I (Week 1)|Physician Decision|0
982590|NCT00541229|3230761|P5|Treatment Period I (Week 1)|Physician Decision|0
982591|NCT00541229|3230762|P4|Treatment Period I (Week 1)|Physician Decision|0
982592|NCT00541229|3230763|P3|Treatment Period I (Week 1)|Physician Decision|1
982593|NCT00541229|3230764|P2|Treatment Period I (Week 1)|Physician Decision|0
982594|NCT00541229|3230765|P1|Treatment Period I (Week 1)|Physician Decision|0
982595|NCT00541099|3230784|P1|Overall Study|Ineligible|3
982596|NCT00541034|3230790|P1|Overall Study|Non-Compliance|3
982597|NCT00540644|3230817|P2|Overall Study|Noncomplilance|0
982598|NCT00540644|3230818|P1|Overall Study|Noncomplilance|1
982599|NCT00540644|3230817|P2|Overall Study|Withdrawal by Subject|2
982600|NCT00540644|3230818|P1|Overall Study|Withdrawal by Subject|2
982601|NCT00540644|3230817|P2|Overall Study|Physician Decision|5
982602|NCT00540644|3230818|P1|Overall Study|Physician Decision|0
982603|NCT00540644|3230817|P2|Overall Study|Disease Progression|1
982604|NCT00540644|3230818|P1|Overall Study|Disease Progression|3
982605|NCT00540644|3230817|P2|Overall Study|Adverse Event|1
982606|NCT00540644|3230818|P1|Overall Study|Adverse Event|3
982607|NCT00540592|3230838|P10|Overall Study|Withdrawal by Subject|0
982608|NCT00540592|3230839|P9|Overall Study|Withdrawal by Subject|0
982609|NCT00540592|3230840|P8|Overall Study|Withdrawal by Subject|0
982610|NCT00540592|3230841|P7|Overall Study|Withdrawal by Subject|0
982611|NCT00540592|3230842|P6|Overall Study|Withdrawal by Subject|0
982612|NCT00540592|3230843|P5|Overall Study|Withdrawal by Subject|0
982613|NCT00540592|3230844|P4|Overall Study|Withdrawal by Subject|1
982614|NCT00540592|3230845|P3|Overall Study|Withdrawal by Subject|1
982615|NCT00540592|3230846|P2|Overall Study|Withdrawal by Subject|0
982616|NCT00540592|3230847|P1|Overall Study|Withdrawal by Subject|0
982617|NCT00540592|3230838|P10|Overall Study|Lost to Follow-up|0
982618|NCT00540592|3230839|P9|Overall Study|Lost to Follow-up|0
982619|NCT00540592|3230840|P8|Overall Study|Lost to Follow-up|0
982620|NCT00540592|3230841|P7|Overall Study|Lost to Follow-up|0
982621|NCT00540592|3230842|P6|Overall Study|Lost to Follow-up|0
982622|NCT00540592|3230843|P5|Overall Study|Lost to Follow-up|0
982623|NCT00540592|3230844|P4|Overall Study|Lost to Follow-up|0
982624|NCT00540592|3230845|P3|Overall Study|Lost to Follow-up|0
982625|NCT00540592|3230846|P2|Overall Study|Lost to Follow-up|0
982626|NCT00540592|3230847|P1|Overall Study|Lost to Follow-up|2
982627|NCT00540592|3230838|P10|Overall Study|Adverse Event|2
982628|NCT00540592|3230839|P9|Overall Study|Adverse Event|1
982629|NCT00540592|3230840|P8|Overall Study|Adverse Event|1
982630|NCT00540592|3230841|P7|Overall Study|Adverse Event|0
982631|NCT00540592|3230842|P6|Overall Study|Adverse Event|0
982632|NCT00540592|3230843|P5|Overall Study|Adverse Event|1
982633|NCT00540592|3230844|P4|Overall Study|Adverse Event|0
982634|NCT00540592|3230845|P3|Overall Study|Adverse Event|0
982635|NCT00540592|3230846|P2|Overall Study|Adverse Event|1
982636|NCT00540592|3230847|P1|Overall Study|Adverse Event|0
982637|NCT00540514|3231086|P2|Overall Study|Paclitaxel not available|2
982638|NCT00540514|3231087|P1|Overall Study|Paclitaxel not available|0
982639|NCT00540514|3231086|P2|Overall Study|Excluded prior to treatment|7
982640|NCT00540514|3231087|P1|Overall Study|Excluded prior to treatment|7
982641|NCT00540514|3231086|P2|Overall Study|Withdrawal by Subject|67
982642|NCT00540514|3231087|P1|Overall Study|Withdrawal by Subject|65
982643|NCT00540514|3231086|P2|Overall Study|Lost to Follow-up|1
982644|NCT00540514|3231087|P1|Overall Study|Lost to Follow-up|1
982645|NCT00540514|3231086|P2|Overall Study|Protocol Deviation|4
982646|NCT00540514|3231087|P1|Overall Study|Protocol Deviation|3
982647|NCT00540514|3231086|P2|Overall Study|Physician Decision|99
982648|NCT00540514|3231087|P1|Overall Study|Physician Decision|86
982649|NCT00540514|3231086|P2|Overall Study|Adverse Event|24
982650|NCT00540514|3231087|P1|Overall Study|Adverse Event|20
982651|NCT00540514|3231086|P2|Overall Study|Unacceptable Toxicity|62
982652|NCT00540514|3231087|P1|Overall Study|Unacceptable Toxicity|61
982653|NCT00540514|3231086|P2|Overall Study|Still on treatment|0
982654|NCT00540514|3231087|P1|Overall Study|Still on treatment|3
982655|NCT00540449|3231119|P2|Overall Study|Not specified|4
982656|NCT00540449|3231120|P1|Overall Study|Not specified|1
982657|NCT00540449|3231119|P2|Overall Study|Withdrawal by Subject|10
982658|NCT00540449|3231120|P1|Overall Study|Withdrawal by Subject|10
982659|NCT00540449|3231119|P2|Overall Study|Subject Reached A Virologic Endpoint|8
982660|NCT00540449|3231120|P1|Overall Study|Subject Reached A Virologic Endpoint|32
982661|NCT00540449|3231119|P2|Overall Study|Subject Non-Compliant|5
982662|NCT00540449|3231120|P1|Overall Study|Subject Non-Compliant|7
982663|NCT00540449|3231119|P2|Overall Study|Lost to Follow-up|17
982664|NCT00540449|3231120|P1|Overall Study|Lost to Follow-up|19
982665|NCT00540449|3231119|P2|Overall Study|Subject Ineligible To Continue The Trial|1
982666|NCT00540449|3231120|P1|Overall Study|Subject Ineligible To Continue The Trial|2
982667|NCT00540449|3231119|P2|Overall Study|Sponsor's Decision|1
982668|NCT00540449|3231120|P1|Overall Study|Sponsor's Decision|1
982669|NCT00540449|3231119|P2|Overall Study|Adverse Event|32
982670|NCT00540449|3231120|P1|Overall Study|Adverse Event|12
982671|NCT00540436|3231142|P1|Second 12-Week Treatment Period|Adverse Event|1
982672|NCT00540436|3231142|P1|First 12-Week Treatment Period|Initiation of prohibited medication|1
982673|NCT00540436|3231142|P1|First 12-Week Treatment Period|Withdrawal by Subject|1
982674|NCT00540436|3231142|P1|First 12-Week Treatment Period|Adverse Event|1
982675|NCT00540423|3231157|P3|Open-Label Treatment Period|Lack of Efficacy|2
982676|NCT00540423|3231158|P2|Open-Label Treatment Period|Lack of Efficacy|0
982677|NCT00540423|3231159|P1|Open-Label Treatment Period|Lack of Efficacy|0
982678|NCT00540423|3231157|P3|Double-Blind Treatment Period|Adverse Event|0
982679|NCT00540423|3231158|P2|Double-Blind Treatment Period|Adverse Event|1
982680|NCT00540423|3231159|P1|Double-Blind Treatment Period|Adverse Event|0
982681|NCT00540293|3231209|P1|Overall Study|Protocol violation, & subject schedule|12
982682|NCT00540293|3231209|P1|Overall Study|Withdrawal by Subject|6
982683|NCT00540293|3231209|P1|Overall Study|Adverse event not related to study drug|7
982684|NCT00540293|3231209|P1|Overall Study|Adverse event related to study drug|10
982685|NCT00540228|3231257|P5|Overall Study|Lost to Follow-up|0
982686|NCT00540228|3231258|P4|Overall Study|Lost to Follow-up|0
982687|NCT00540228|3231259|P3|Overall Study|Lost to Follow-up|0
982688|NCT00540228|3231260|P2|Overall Study|Lost to Follow-up|1
982689|NCT00540228|3231261|P1|Overall Study|Lost to Follow-up|1
982690|NCT00540228|3231257|P5|Overall Study|Adverse Event|0
982691|NCT00540228|3231258|P4|Overall Study|Adverse Event|0
982692|NCT00540228|3231259|P3|Overall Study|Adverse Event|0
982693|NCT00540228|3231260|P2|Overall Study|Adverse Event|0
982694|NCT00540228|3231261|P1|Overall Study|Adverse Event|2
982695|NCT00540124|3231331|P3|Overall Study|Withdrawal by Subject|0
982696|NCT00540124|3231332|P2|Overall Study|Withdrawal by Subject|1
982697|NCT00540124|3231333|P1|Overall Study|Withdrawal by Subject|1
982698|NCT00540124|3231331|P3|Overall Study|Lack of Efficacy|0
982699|NCT00540124|3231332|P2|Overall Study|Lack of Efficacy|0
982700|NCT00540124|3231333|P1|Overall Study|Lack of Efficacy|1
982701|NCT00540124|3231331|P3|Overall Study|Entry Criteria Not Met|0
982702|NCT00540124|3231332|P2|Overall Study|Entry Criteria Not Met|0
982703|NCT00540124|3231333|P1|Overall Study|Entry Criteria Not Met|2
982704|NCT00540124|3231331|P3|Overall Study|Adverse Event|1
982705|NCT00540124|3231332|P2|Overall Study|Adverse Event|2
982706|NCT00540124|3231333|P1|Overall Study|Adverse Event|0
982707|NCT00540046|3231379|P2|Overall Study|Lost to Follow-up|23
982708|NCT00540046|3231380|P1|Overall Study|Lost to Follow-up|33
982709|NCT00539994|3231416|P3|Overall Study|Physician Decision|1
982710|NCT00539994|3231417|P2|Overall Study|Physician Decision|0
982711|NCT00539994|3231418|P1|Overall Study|Physician Decision|0
982712|NCT00539994|3231416|P3|Overall Study|Withdrawal by Subject|1
982713|NCT00539994|3231417|P2|Overall Study|Withdrawal by Subject|0
982714|NCT00539994|3231418|P1|Overall Study|Withdrawal by Subject|1
982715|NCT00539994|3231416|P3|Overall Study|Lost to Follow-up|0
982716|NCT00539994|3231417|P2|Overall Study|Lost to Follow-up|1
982717|NCT00539994|3231418|P1|Overall Study|Lost to Follow-up|2
982718|NCT00539864|3231468|P2|Overall Study|Withdrawal by Subject|1
982719|NCT00539864|3231469|P1|Overall Study|Withdrawal by Subject|1
982720|NCT00539864|3231468|P2|Overall Study|Lost to Follow-up|1
982721|NCT00539864|3231469|P1|Overall Study|Lost to Follow-up|0
982722|NCT00539734|3231481|P1|Overall Study|Protocol Violation|1
982723|NCT00539591|3231500|P3|Overall Study|Disease progression|3
982724|NCT00539591|3231501|P2|Overall Study|Disease progression|2
982725|NCT00539591|3231502|P1|Overall Study|Disease progression|2
982726|NCT00539591|3231500|P3|Overall Study|Toxicity|0
982727|NCT00539591|3231501|P2|Overall Study|Toxicity|0
982728|NCT00539591|3231502|P1|Overall Study|Toxicity|3
982729|NCT00539513|3231654|P2|Overall Study|Lost to Follow-up|1
982730|NCT00539513|3231655|P1|Overall Study|Lost to Follow-up|0
982731|NCT00539513|3231654|P2|Overall Study|Withdrawal by Subject|1
982732|NCT00539513|3231655|P1|Overall Study|Withdrawal by Subject|2
982733|NCT00539305|3231669|P2|Overall Study|Withdrawal by Subject|1
982734|NCT00539305|3231670|P1|Overall Study|Withdrawal by Subject|0
982735|NCT00539305|3231669|P2|Overall Study|Substance Use|1
982736|NCT00539305|3231670|P1|Overall Study|Substance Use|0
982737|NCT00539305|3231669|P2|Overall Study|Adverse Event|0
982738|NCT00539305|3231670|P1|Overall Study|Adverse Event|1
982739|NCT00539279|3231684|P2|6-Month Follow-Up Assessment|Lost to Follow-up|7
982740|NCT00539279|3231685|P1|6-Month Follow-Up Assessment|Lost to Follow-up|1
982741|NCT00539279|3231684|P2|Post-Treatment Assessment|Lost to Follow-up|9
982742|NCT00539279|3231685|P1|Post-Treatment Assessment|Lost to Follow-up|12
982743|NCT00539279|3231684|P2|Treatment|Death|0
982744|NCT00539279|3231685|P1|Treatment|Death|1
982745|NCT00539279|3231684|P2|Treatment|Withdrawal by Subject|8
982746|NCT00539279|3231685|P1|Treatment|Withdrawal by Subject|10
982747|NCT00539240|3231711|P3|Overall Study|Adverse Event|10
982748|NCT00539240|3231712|P2|Overall Study|Adverse Event|1
982749|NCT00539240|3231713|P1|Overall Study|Adverse Event|3
982750|NCT00539240|3231711|P3|Overall Study|Lost to Follow-up|1
982751|NCT00539240|3231712|P2|Overall Study|Lost to Follow-up|3
982752|NCT00539240|3231713|P1|Overall Study|Lost to Follow-up|2
982753|NCT00539240|3231711|P3|Overall Study|Protocol Violation|4
982754|NCT00539240|3231712|P2|Overall Study|Protocol Violation|1
982755|NCT00539240|3231713|P1|Overall Study|Protocol Violation|1
982756|NCT00539240|3231711|P3|Overall Study|Withdrawal by Subject|0
982757|NCT00539240|3231712|P2|Overall Study|Withdrawal by Subject|2
982758|NCT00539240|3231713|P1|Overall Study|Withdrawal by Subject|0
982759|NCT00539188|3231732|P2|Overall Study|Lost to Follow-up|1
982760|NCT00539188|3231733|P1|Overall Study|Lost to Follow-up|2
982761|NCT00539188|3231732|P2|Overall Study|Withdrawal by Subject|0
982762|NCT00539188|3231733|P1|Overall Study|Withdrawal by Subject|1
982763|NCT00539032|3231756|P2|Overall Study|Withdrawal by Subject|1
982764|NCT00539032|3231757|P1|Overall Study|Withdrawal by Subject|2
982765|NCT00539006|3231771|P4|Treatment Period 2|Other|0
982766|NCT00539006|3231772|P3|Treatment Period 2|Other|0
982767|NCT00539006|3231773|P2|Treatment Period 2|Other|1
982768|NCT00539006|3231774|P1|Treatment Period 2|Other|0
982769|NCT00539006|3231771|P4|Treatment Period 2|Protocol Violation|0
982770|NCT00539006|3231772|P3|Treatment Period 2|Protocol Violation|0
982771|NCT00539006|3231773|P2|Treatment Period 2|Protocol Violation|0
982772|NCT00539006|3231774|P1|Treatment Period 2|Protocol Violation|1
982773|NCT00539006|3231771|P4|Washout|Other|3
982774|NCT00539006|3231772|P3|Washout|Other|2
982775|NCT00539006|3231773|P2|Washout|Other|1
982776|NCT00539006|3231774|P1|Washout|Other|1
982777|NCT00539006|3231771|P4|Washout|Failed to meet continuation criteria|6
982778|NCT00539006|3231772|P3|Washout|Failed to meet continuation criteria|14
982779|NCT00539006|3231773|P2|Washout|Failed to meet continuation criteria|5
982780|NCT00539006|3231774|P1|Washout|Failed to meet continuation criteria|16
982781|NCT00539006|3231771|P4|Washout|Withdrawal by Subject|0
982782|NCT00539006|3231772|P3|Washout|Withdrawal by Subject|0
982783|NCT00539006|3231773|P2|Washout|Withdrawal by Subject|2
982784|NCT00539006|3231774|P1|Washout|Withdrawal by Subject|0
982785|NCT00539006|3231771|P4|Washout|Protocol Violation|0
982786|NCT00539006|3231772|P3|Washout|Protocol Violation|0
982787|NCT00539006|3231773|P2|Washout|Protocol Violation|1
982788|NCT00539006|3231774|P1|Washout|Protocol Violation|1
982789|NCT00539006|3231771|P4|Washout|Adverse Event|0
982790|NCT00539006|3231772|P3|Washout|Adverse Event|0
982791|NCT00539006|3231773|P2|Washout|Adverse Event|1
982792|NCT00539006|3231774|P1|Washout|Adverse Event|2
982793|NCT00539006|3231771|P4|Treatment Period 1|Lack of Efficacy|1
982794|NCT00539006|3231772|P3|Treatment Period 1|Lack of Efficacy|0
982795|NCT00539006|3231773|P2|Treatment Period 1|Lack of Efficacy|0
982796|NCT00539006|3231774|P1|Treatment Period 1|Lack of Efficacy|0
982797|NCT00539006|3231771|P4|Treatment Period 1|Protocol Violation|0
982798|NCT00539006|3231772|P3|Treatment Period 1|Protocol Violation|1
982799|NCT00539006|3231773|P2|Treatment Period 1|Protocol Violation|0
982800|NCT00539006|3231774|P1|Treatment Period 1|Protocol Violation|0
982801|NCT00539006|3231771|P4|Treatment Period 1|Lost to Follow-up|0
982802|NCT00539006|3231772|P3|Treatment Period 1|Lost to Follow-up|1
982803|NCT00539006|3231773|P2|Treatment Period 1|Lost to Follow-up|0
982804|NCT00539006|3231774|P1|Treatment Period 1|Lost to Follow-up|0
982805|NCT00539006|3231771|P4|Pre-treatment|Other|0
982806|NCT00539006|3231772|P3|Pre-treatment|Other|0
982807|NCT00539006|3231773|P2|Pre-treatment|Other|1
982808|NCT00539006|3231774|P1|Pre-treatment|Other|0
982809|NCT00538902|3231819|P3|OL Wk 24 to End (Primary D/C Reasons)|Various|22
982810|NCT00538902|3231820|P2|OL Wk 24 to End (Primary D/C Reasons)|Various|25
982811|NCT00538902|3231821|P1|OL Wk 24 to End (Primary D/C Reasons)|Various|18
982812|NCT00538902|3231819|P3|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6
982813|NCT00538902|3231820|P2|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10
982814|NCT00538902|3231821|P1|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1
982815|NCT00538902|3231819|P3|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25
982816|NCT00538902|3231820|P2|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19
982817|NCT00538902|3231821|P1|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15
982818|NCT00538902|3231819|P3|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11
982819|NCT00538902|3231820|P2|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10
982820|NCT00538902|3231821|P1|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2
982821|NCT00538902|3231819|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
982822|NCT00538902|3231820|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
982823|NCT00538902|3231821|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
982824|NCT00538902|3231819|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1
982825|NCT00538902|3231820|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
982826|NCT00538902|3231821|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
982827|NCT00538902|3231819|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1
982828|NCT00538902|3231820|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
982829|NCT00538902|3231821|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
982830|NCT00538902|3231819|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3
982831|NCT00538902|3231820|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2
982832|NCT00538902|3231821|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1
982833|NCT00538785|3231882|P2|Overall Study|Lost to Follow-up|0
982834|NCT00538785|3231883|P1|Overall Study|Lost to Follow-up|1
982835|NCT00538785|3231882|P2|Overall Study|Withdrawal of consent|7
982836|NCT00538785|3231883|P1|Overall Study|Withdrawal of consent|9
982837|NCT00538785|3231882|P2|Overall Study|Death|10
982838|NCT00538785|3231883|P1|Overall Study|Death|9
982839|NCT00538733|3231904|P1|Overall Study|still on therapy|1
982840|NCT00538733|3231904|P1|Overall Study|declined to participate|2
982841|NCT00538733|3231904|P1|Overall Study|Death|1
982842|NCT00538733|3231904|P1|Overall Study|Adverse Event|8
982843|NCT00538629|3231954|P1|Overall Study|Subject's untimely distrust of medicine|1
982844|NCT00538629|3231954|P1|Overall Study|Lost to Follow-up|6
982845|NCT00538629|3231954|P1|Overall Study|Lack of Efficacy|12
982846|NCT00538629|3231954|P1|Overall Study|Adverse Event|2
982847|NCT00538629|3231954|P1|Overall Study|At subject's request|1
982848|NCT00538590|3232010|P2|Overall Study|Death|0
982849|NCT00538590|3232011|P1|Overall Study|Death|1
982850|NCT00538473|3232049|P2|Overall Study|Adverse Event|0
982851|NCT00538473|3232050|P1|Overall Study|Adverse Event|1
982852|NCT00538291|3232130|P1|Overall Study|Withdrawal by Subject|1
982853|NCT00538291|3232130|P1|Overall Study|Adverse Event|2
982854|NCT00537979|3232188|P2|Overall Study|Heart failure|1
982855|NCT00537979|3232189|P1|Overall Study|Heart failure|0
982856|NCT00537979|3232188|P2|Overall Study|Kidney transplant|3
982857|NCT00537979|3232189|P1|Overall Study|Kidney transplant|0
982858|NCT00537979|3232188|P2|Overall Study|Death|3
982859|NCT00537979|3232189|P1|Overall Study|Death|0
982860|NCT00537979|3232188|P2|Overall Study|Non-compliance with treatment/procedure|2
982861|NCT00537979|3232189|P1|Overall Study|Non-compliance with treatment/procedure|2
982862|NCT00537979|3232188|P2|Overall Study|Lack of Efficacy|1
982863|NCT00537979|3232189|P1|Overall Study|Lack of Efficacy|0
982864|NCT00537979|3232188|P2|Overall Study|Lost to Follow-up|4
982865|NCT00537979|3232189|P1|Overall Study|Lost to Follow-up|1
982866|NCT00537979|3232188|P2|Overall Study|Withdrawal by Subject|4
982867|NCT00537979|3232189|P1|Overall Study|Withdrawal by Subject|1
982868|NCT00537979|3232188|P2|Overall Study|Adverse Event|2
982869|NCT00537979|3232189|P1|Overall Study|Adverse Event|2
982870|NCT00537940|3232205|P2|Overall Study|Other|12
982871|NCT00537940|3232206|P1|Overall Study|Other|10
982872|NCT00537940|3232205|P2|Overall Study|Study terminated by sponsor|3
982873|NCT00537940|3232206|P1|Overall Study|Study terminated by sponsor|2
982874|NCT00537940|3232205|P2|Overall Study|Pregnancy|1
982875|NCT00537940|3232206|P1|Overall Study|Pregnancy|1
982876|NCT00537940|3232205|P2|Overall Study|Protocol Violation|4
982877|NCT00537940|3232206|P1|Overall Study|Protocol Violation|6
982878|NCT00537940|3232205|P2|Overall Study|Withdrawal by Subject|95
982879|NCT00537940|3232206|P1|Overall Study|Withdrawal by Subject|113
982880|NCT00537940|3232205|P2|Overall Study|Lost to Follow-up|29
982881|NCT00537940|3232206|P1|Overall Study|Lost to Follow-up|23
982882|NCT00537940|3232205|P2|Overall Study|Lack of Efficacy|16
982883|NCT00537940|3232206|P1|Overall Study|Lack of Efficacy|8
982884|NCT00537940|3232205|P2|Overall Study|Adverse Event|19
982885|NCT00537940|3232206|P1|Overall Study|Adverse Event|20
982886|NCT00537823|3232230|P2|Overall Study|Adverse Event|0
982887|NCT00537823|3232231|P1|Overall Study|Adverse Event|2
982888|NCT00537810|3232257|P4|Overall Study|Medically withdrawn|1
982889|NCT00537810|3232258|P3|Overall Study|Medically withdrawn|0
982890|NCT00537810|3232259|P2|Overall Study|Medically withdrawn|2
982891|NCT00537810|3232260|P1|Overall Study|Medically withdrawn|2
982892|NCT00537810|3232257|P4|Overall Study|Withdrawal by Subject|3
982893|NCT00537810|3232258|P3|Overall Study|Withdrawal by Subject|4
982894|NCT00537810|3232259|P2|Overall Study|Withdrawal by Subject|11
982895|NCT00537810|3232260|P1|Overall Study|Withdrawal by Subject|4
982896|NCT00537771|3232276|P2|Overall Study|Severe Non-Compliance to Protocol|2
982897|NCT00537771|3232277|P1|Overall Study|Severe Non-Compliance to Protocol|4
982898|NCT00537771|3232276|P2|Overall Study|Protocol Violation|6
982899|NCT00537771|3232277|P1|Overall Study|Protocol Violation|2
982900|NCT00537771|3232276|P2|Overall Study|Lost to Follow-up|15
982901|NCT00537771|3232277|P1|Overall Study|Lost to Follow-up|9
982902|NCT00537771|3232276|P2|Overall Study|Adverse Event|15
982903|NCT00537771|3232277|P1|Overall Study|Adverse Event|8
982904|NCT00537771|3232276|P2|Overall Study|Withdrawal by Subject|23
982905|NCT00537771|3232277|P1|Overall Study|Withdrawal by Subject|6
982906|NCT00537745|3232287|P1|Overall Study|Subject unable to provide Interlock info|1
982907|NCT00537745|3232287|P1|Overall Study|Withdrawal by Subject|2
982908|NCT00537745|3232287|P1|Overall Study|Did not meet eligibility criteria|2
982909|NCT00537485|3232332|P2|Overall Study|Physician Decision|0
982910|NCT00537485|3232333|P1|Overall Study|Physician Decision|1
982911|NCT00537485|3232332|P2|Overall Study|Withdrawal by Subject|3
982912|NCT00537485|3232333|P1|Overall Study|Withdrawal by Subject|1
982913|NCT00537485|3232332|P2|Overall Study|Withdrawal by Subject|2
982914|NCT00537485|3232333|P1|Overall Study|Withdrawal by Subject|3
982915|NCT00537485|3232332|P2|Overall Study|Adverse Event|5
982916|NCT00537485|3232333|P1|Overall Study|Adverse Event|10
982917|NCT00537394|3232406|P3|2nd Year of Follow-up|Clinic site closure|0
982918|NCT00537394|3232407|P2|2nd Year of Follow-up|Clinic site closure|0
982919|NCT00537394|3232408|P1|2nd Year of Follow-up|Clinic site closure|1
982920|NCT00537394|3232406|P3|2nd Year of Follow-up|Lost to Follow-up|2
982921|NCT00537394|3232407|P2|2nd Year of Follow-up|Lost to Follow-up|7
982922|NCT00537394|3232408|P1|2nd Year of Follow-up|Lost to Follow-up|6
982923|NCT00537394|3232406|P3|2nd Year of Follow-up|Withdrawal by Subject|2
982924|NCT00537394|3232407|P2|2nd Year of Follow-up|Withdrawal by Subject|1
982925|NCT00537394|3232408|P1|2nd Year of Follow-up|Withdrawal by Subject|0
982926|NCT00537394|3232406|P3|2nd Year of Follow-up|Death|2
982927|NCT00537394|3232407|P2|2nd Year of Follow-up|Death|1
982928|NCT00537394|3232408|P1|2nd Year of Follow-up|Death|4
982929|NCT00537394|3232406|P3|First Year of Follow-up|Lost to Follow-up|1
982930|NCT00537394|3232407|P2|First Year of Follow-up|Lost to Follow-up|5
982931|NCT00537394|3232408|P1|First Year of Follow-up|Lost to Follow-up|1
982932|NCT00537394|3232406|P3|First Year of Follow-up|Withdrawal by Subject|1
982933|NCT00537394|3232407|P2|First Year of Follow-up|Withdrawal by Subject|6
982934|NCT00537394|3232408|P1|First Year of Follow-up|Withdrawal by Subject|3
982935|NCT00537394|3232406|P3|First Year of Follow-up|Severe debilitation|1
982936|NCT00537394|3232407|P2|First Year of Follow-up|Severe debilitation|0
982937|NCT00537394|3232408|P1|First Year of Follow-up|Severe debilitation|1
982938|NCT00537394|3232406|P3|First Year of Follow-up|Death|0
982939|NCT00537394|3232407|P2|First Year of Follow-up|Death|0
982940|NCT00537394|3232408|P1|First Year of Follow-up|Death|7
982941|NCT00537381|3232444|P2|Overall Study|Other|3
982942|NCT00537381|3232445|P1|Overall Study|Other|5
982943|NCT00537381|3232444|P2|Overall Study|Sponsor decision|9
982944|NCT00537381|3232445|P1|Overall Study|Sponsor decision|14
982945|NCT00537381|3232444|P2|Overall Study|Disease Progression|18
982946|NCT00537381|3232445|P1|Overall Study|Disease Progression|9
982947|NCT00537381|3232444|P2|Overall Study|Physician Decision|6
982948|NCT00537381|3232445|P1|Overall Study|Physician Decision|7
982949|NCT00537381|3232444|P2|Overall Study|Withdrawal by Subject|14
982950|NCT00537381|3232445|P1|Overall Study|Withdrawal by Subject|5
982951|NCT00537381|3232444|P2|Overall Study|Death|3
982952|NCT00537381|3232445|P1|Overall Study|Death|3
982953|NCT00537381|3232444|P2|Overall Study|Adverse Event|9
982954|NCT00537381|3232445|P1|Overall Study|Adverse Event|13
982955|NCT00537329|3232465|P1|Overall Study|Other|1
982956|NCT00537329|3232465|P1|Overall Study|Withdrawal by Subject|4
982957|NCT00537329|3232465|P1|Overall Study|Lost to Follow-up|6
982958|NCT00537329|3232465|P1|Overall Study|Lack of Efficacy|2
982959|NCT00537329|3232465|P1|Overall Study|Adverse Event|3
982960|NCT00537329|3232465|P1|Overall Study|Death|10
982961|NCT00537316|3232485|P7|Part 2|Administrative|1
982962|NCT00537316|3232486|P6|Part 2|Administrative|4
982963|NCT00537316|3232487|P5|Part 2|Administrative|1
982964|NCT00537316|3232488|P4|Part 2|Administrative|3
982965|NCT00537316|3232489|P3|Part 2|Administrative|24
982966|NCT00537316|3232490|P2|Part 2|Administrative|8
982967|NCT00537316|3232491|P1|Part 2|Administrative|16
982968|NCT00537316|3232485|P7|Part 2|Withdrawal by Subject|0
982969|NCT00537316|3232486|P6|Part 2|Withdrawal by Subject|0
982970|NCT00537316|3232487|P5|Part 2|Withdrawal by Subject|0
982971|NCT00537316|3232488|P4|Part 2|Withdrawal by Subject|0
982972|NCT00537316|3232489|P3|Part 2|Withdrawal by Subject|4
982973|NCT00537316|3232490|P2|Part 2|Withdrawal by Subject|1
982974|NCT00537316|3232491|P1|Part 2|Withdrawal by Subject|5
982975|NCT00537316|3232485|P7|Part 2|Lost to Follow-up|0
982976|NCT00537316|3232486|P6|Part 2|Lost to Follow-up|0
982977|NCT00537316|3232487|P5|Part 2|Lost to Follow-up|0
982978|NCT00537316|3232488|P4|Part 2|Lost to Follow-up|0
982979|NCT00537316|3232489|P3|Part 2|Lost to Follow-up|2
982980|NCT00537316|3232490|P2|Part 2|Lost to Follow-up|0
982981|NCT00537316|3232491|P1|Part 2|Lost to Follow-up|1
982982|NCT00537316|3232485|P7|Part 2|Adverse Event|0
982983|NCT00537316|3232486|P6|Part 2|Adverse Event|0
982984|NCT00537316|3232487|P5|Part 2|Adverse Event|0
982985|NCT00537316|3232488|P4|Part 2|Adverse Event|0
982986|NCT00537316|3232489|P3|Part 2|Adverse Event|2
982987|NCT00537316|3232490|P2|Part 2|Adverse Event|0
982988|NCT00537316|3232491|P1|Part 2|Adverse Event|4
982989|NCT00537316|3232485|P7|Part 2|Never entered follow-up|1
982990|NCT00537316|3232486|P6|Part 2|Never entered follow-up|0
982991|NCT00537316|3232487|P5|Part 2|Never entered follow-up|0
982992|NCT00537316|3232488|P4|Part 2|Never entered follow-up|0
982993|NCT00537316|3232489|P3|Part 2|Never entered follow-up|0
982994|NCT00537316|3232490|P2|Part 2|Never entered follow-up|0
982995|NCT00537316|3232491|P1|Part 2|Never entered follow-up|0
982996|NCT00537316|3232485|P7|Part 1|Administrative|0
982997|NCT00537316|3232486|P6|Part 1|Administrative|0
982998|NCT00537316|3232487|P5|Part 1|Administrative|0
982999|NCT00537316|3232488|P4|Part 1|Administrative|0
983000|NCT00537316|3232489|P3|Part 1|Administrative|2
983001|NCT00537316|3232490|P2|Part 1|Administrative|0
983002|NCT00537316|3232491|P1|Part 1|Administrative|0
983003|NCT00537316|3232485|P7|Part 1|Did not meet protocol eligibility|0
983004|NCT00537316|3232486|P6|Part 1|Did not meet protocol eligibility|0
983005|NCT00537316|3232487|P5|Part 1|Did not meet protocol eligibility|0
983006|NCT00537316|3232488|P4|Part 1|Did not meet protocol eligibility|0
983007|NCT00537316|3232489|P3|Part 1|Did not meet protocol eligibility|2
983008|NCT00537316|3232490|P2|Part 1|Did not meet protocol eligibility|3
983009|NCT00537316|3232491|P1|Part 1|Did not meet protocol eligibility|1
983010|NCT00537316|3232485|P7|Part 1|Protocol Violation|0
983011|NCT00537316|3232486|P6|Part 1|Protocol Violation|0
983012|NCT00537316|3232487|P5|Part 1|Protocol Violation|0
983013|NCT00537316|3232488|P4|Part 1|Protocol Violation|0
983014|NCT00537316|3232489|P3|Part 1|Protocol Violation|1
983015|NCT00537316|3232490|P2|Part 1|Protocol Violation|5
983016|NCT00537316|3232491|P1|Part 1|Protocol Violation|1
983017|NCT00537316|3232485|P7|Part 1|Withdrawal by Subject|0
983018|NCT00537316|3232486|P6|Part 1|Withdrawal by Subject|0
983019|NCT00537316|3232487|P5|Part 1|Withdrawal by Subject|0
983020|NCT00537316|3232488|P4|Part 1|Withdrawal by Subject|0
983021|NCT00537316|3232489|P3|Part 1|Withdrawal by Subject|4
983022|NCT00537316|3232490|P2|Part 1|Withdrawal by Subject|8
983023|NCT00537316|3232491|P1|Part 1|Withdrawal by Subject|3
983024|NCT00537316|3232485|P7|Part 1|Lost to Follow-up|0
983025|NCT00537316|3232486|P6|Part 1|Lost to Follow-up|0
983026|NCT00537316|3232487|P5|Part 1|Lost to Follow-up|0
983027|NCT00537316|3232488|P4|Part 1|Lost to Follow-up|0
983028|NCT00537316|3232489|P3|Part 1|Lost to Follow-up|0
983029|NCT00537316|3232490|P2|Part 1|Lost to Follow-up|0
983030|NCT00537316|3232491|P1|Part 1|Lost to Follow-up|1
983031|NCT00537316|3232485|P7|Part 1|Protocol defined clinical event|0
983032|NCT00537316|3232486|P6|Part 1|Protocol defined clinical event|0
983033|NCT00537316|3232487|P5|Part 1|Protocol defined clinical event|0
983034|NCT00537316|3232488|P4|Part 1|Protocol defined clinical event|0
983035|NCT00537316|3232489|P3|Part 1|Protocol defined clinical event|0
983036|NCT00537316|3232490|P2|Part 1|Protocol defined clinical event|0
983037|NCT00537316|3232491|P1|Part 1|Protocol defined clinical event|1
983038|NCT00537316|3232485|P7|Part 1|Adverse Event|0
983039|NCT00537316|3232486|P6|Part 1|Adverse Event|0
983040|NCT00537316|3232487|P5|Part 1|Adverse Event|0
983041|NCT00537316|3232488|P4|Part 1|Adverse Event|0
983042|NCT00537316|3232489|P3|Part 1|Adverse Event|8
983043|NCT00537316|3232490|P2|Part 1|Adverse Event|11
983044|NCT00537316|3232491|P1|Part 1|Adverse Event|7
983045|NCT00537303|3232518|P2|Overall Study|Unclassified|7
983046|NCT00537303|3232519|P1|Overall Study|Unclassified|8
983047|NCT00537303|3232518|P2|Overall Study|Withdrawal criteria|3
983048|NCT00537303|3232519|P1|Overall Study|Withdrawal criteria|3
983049|NCT00537303|3232518|P2|Overall Study|Protocol Violation|4
983050|NCT00537303|3232519|P1|Overall Study|Protocol Violation|8
983051|NCT00537303|3232518|P2|Overall Study|Lack of Efficacy|7
983052|NCT00537303|3232519|P1|Overall Study|Lack of Efficacy|6
983053|NCT00537303|3232518|P2|Overall Study|Adverse Event|4
983054|NCT00537303|3232519|P1|Overall Study|Adverse Event|1
983055|NCT00537277|3232540|P1|Overall Study|Non-compliance with trial procedures|15
983056|NCT00537277|3232540|P1|Overall Study|Inability to tolerate trial medication|4
983057|NCT00537277|3232540|P1|Overall Study|Unclassified|4
983058|NCT00537277|3232540|P1|Overall Study|Protocol Violation|11
983059|NCT00537277|3232540|P1|Overall Study|Lost to Follow-up|12
983060|NCT00537277|3232540|P1|Overall Study|Lack of Efficacy|2
983061|NCT00537277|3232540|P1|Overall Study|Adverse Event|1
983062|NCT00537238|3232551|P2|Overall Study|Other|52
983063|NCT00537238|3232552|P1|Overall Study|Other|44
983064|NCT00537238|3232551|P2|Overall Study|Does not meet entrance criteria|2
983065|NCT00537238|3232552|P1|Overall Study|Does not meet entrance criteria|0
983066|NCT00537238|3232551|P2|Overall Study|Protocol Violation|19
983067|NCT00537238|3232552|P1|Overall Study|Protocol Violation|15
983068|NCT00537238|3232551|P2|Overall Study|Withdrawal by Subject|47
983069|NCT00537238|3232552|P1|Overall Study|Withdrawal by Subject|51
983070|NCT00537238|3232551|P2|Overall Study|Lost to Follow-up|8
983071|NCT00537238|3232552|P1|Overall Study|Lost to Follow-up|12
983072|NCT00537238|3232551|P2|Overall Study|Lack of Efficacy|21
983073|NCT00537238|3232552|P1|Overall Study|Lack of Efficacy|20
983074|NCT00537238|3232551|P2|Overall Study|Adverse Event|22
983075|NCT00537238|3232552|P1|Overall Study|Adverse Event|31
983076|NCT00537238|3232551|P2|Overall Study|Death|2
983077|NCT00537238|3232552|P1|Overall Study|Death|1
983078|NCT00537199|3232572|P1|Overall Study|Study Terminated|1
983079|NCT00537095|3232578|P2|Overall Study|Incorrect enrolment|1
983080|NCT00537095|3232579|P1|Overall Study|Incorrect enrolment|0
983081|NCT00537095|3232578|P2|Overall Study|subjective disease progression|1
983082|NCT00537095|3232579|P1|Overall Study|subjective disease progression|0
983083|NCT00537095|3232578|P2|Overall Study|Withdrawal by Subject|2
983084|NCT00537095|3232579|P1|Overall Study|Withdrawal by Subject|2
983085|NCT00537095|3232578|P2|Overall Study|Death|1
983086|NCT00537095|3232579|P1|Overall Study|Death|3
983087|NCT00537095|3232578|P2|Overall Study|disease progression|48
983088|NCT00537095|3232579|P1|Overall Study|disease progression|21
983089|NCT00537095|3232578|P2|Overall Study|Adverse Event|4
983090|NCT00537095|3232579|P1|Overall Study|Adverse Event|24
983091|NCT00537095|3232578|P2|Overall Study|surgery|0
983092|NCT00537095|3232579|P1|Overall Study|surgery|1
983093|NCT00537082|3232594|P3|Overall Study|Discontinued before initiating treatment|0
983094|NCT00537082|3232595|P2|Overall Study|Discontinued before initiating treatment|0
983095|NCT00537082|3232596|P1|Overall Study|Discontinued before initiating treatment|3
983096|NCT00537082|3232594|P3|Overall Study|Withdrawal by Subject|0
983097|NCT00537082|3232595|P2|Overall Study|Withdrawal by Subject|1
983098|NCT00537082|3232596|P1|Overall Study|Withdrawal by Subject|0
983099|NCT00537082|3232594|P3|Overall Study|Lack of Efficacy|2
983100|NCT00537082|3232595|P2|Overall Study|Lack of Efficacy|0
983101|NCT00537082|3232596|P1|Overall Study|Lack of Efficacy|0
983102|NCT00537082|3232594|P3|Overall Study|Protocol Violation|1
983103|NCT00537082|3232595|P2|Overall Study|Protocol Violation|2
983104|NCT00537082|3232596|P1|Overall Study|Protocol Violation|0
983105|NCT00537082|3232594|P3|Overall Study|Adverse Event|3
983106|NCT00537082|3232595|P2|Overall Study|Adverse Event|6
983107|NCT00537082|3232596|P1|Overall Study|Adverse Event|6
983108|NCT00537056|3232613|P1|Interim PET/CT|scheduling conflicts and/or exposure|5
983109|NCT00537030|3232625|P1|Overall Study|Inevaluable|3
983110|NCT00537030|3232625|P1|Overall Study|Confirm patient ineligibility|1
983111|NCT00537030|3232625|P1|Overall Study|Disease progression or relapse during ac|1
983112|NCT00537030|3232625|P1|Overall Study|Greater then or equal to a Grade 2 aller|7
983113|NCT00537030|3232625|P1|Overall Study|Withdrawal by Subject|2
983114|NCT00537030|3232625|P1|Overall Study|Physician Decision|2
983115|NCT00537017|3232629|P1|Follow-up Phase|Withdrawal by Subject|9
983116|NCT00537017|3232629|P1|Treatment Phase|Protocol Violation|2
983117|NCT00537017|3232629|P1|Treatment Phase|Withdrawal by Subject|13
983118|NCT00537017|3232629|P1|Treatment Phase|Adverse Event|19
983119|NCT00536991|3232640|P1|Overall Study|patient ineligible|2
983120|NCT00536991|3232640|P1|Overall Study|Physician Decision|1
983121|NCT00536991|3232640|P1|Overall Study|Withdrawal by Subject|10
983122|NCT00536978|3232647|P1|Overall Study|Not eligible for Adback Infusion|22
983123|NCT00536874|3232676|P1|Overall Study|Withdrawal by Subject|1
983124|NCT00536874|3232676|P1|Overall Study|Death|2
983125|NCT00536874|3232676|P1|Overall Study|Adverse Event|1
983126|NCT00536809|3232686|P1|Phase II|Referred for surgical resection|1
983127|NCT00536809|3232686|P1|Phase II|Adverse Event|1
983128|NCT00536744|3232709|P2|Overall Study|PI tried alternative treatment|3
983129|NCT00536744|3232710|P1|Overall Study|PI tried alternative treatment|1
983130|NCT00536744|3232709|P2|Overall Study|Withdrawal by Subject|8
983131|NCT00536744|3232710|P1|Overall Study|Withdrawal by Subject|7
983132|NCT00536744|3232709|P2|Overall Study|Lost to Follow-up|5
983133|NCT00536744|3232710|P1|Overall Study|Lost to Follow-up|3
983134|NCT00536744|3232709|P2|Overall Study|Physician Decision|1
983135|NCT00536744|3232710|P1|Overall Study|Physician Decision|3
983136|NCT00536744|3232709|P2|Overall Study|Death|1
983137|NCT00536744|3232710|P1|Overall Study|Death|2
983138|NCT00536744|3232709|P2|Overall Study|Adverse Event|10
983139|NCT00536744|3232710|P1|Overall Study|Adverse Event|13
983140|NCT00536731|3232719|P3|Overall Study|Other|0
983141|NCT00536731|3232720|P2|Overall Study|Other|1
983142|NCT00536731|3232721|P1|Overall Study|Other|1
983143|NCT00536731|3232719|P3|Overall Study|Safety reasons|1
983144|NCT00536731|3232720|P2|Overall Study|Safety reasons|0
983145|NCT00536731|3232721|P1|Overall Study|Safety reasons|0
983146|NCT00536731|3232719|P3|Overall Study|Intake of prohibited conc. medication|1
983147|NCT00536731|3232720|P2|Overall Study|Intake of prohibited conc. medication|0
983148|NCT00536731|3232721|P1|Overall Study|Intake of prohibited conc. medication|0
983149|NCT00536731|3232719|P3|Overall Study|Withdrawal by Subject|0
983150|NCT00536731|3232720|P2|Overall Study|Withdrawal by Subject|2
983151|NCT00536731|3232721|P1|Overall Study|Withdrawal by Subject|0
983152|NCT00536731|3232719|P3|Overall Study|Adverse Event|3
983153|NCT00536731|3232720|P2|Overall Study|Adverse Event|2
983154|NCT00536731|3232721|P1|Overall Study|Adverse Event|3
983155|NCT00536575|3232765|P1|Overall Study|Death|1
983156|NCT00536575|3232765|P1|Overall Study|Withdrawal by Subject|1
983157|NCT00536510|3232771|P2|Overall Study|Patient Discontinued for Other Reasons|2
983158|NCT00536510|3232772|P1|Overall Study|Patient Discontinued for Other Reasons|2
983159|NCT00536510|3232771|P2|Overall Study|Laboratory Adverse Event|1
983160|NCT00536510|3232772|P1|Overall Study|Laboratory Adverse Event|2
983161|NCT00536510|3232771|P2|Overall Study|Flushing with Product|0
983162|NCT00536510|3232772|P1|Overall Study|Flushing with Product|20
983163|NCT00536510|3232771|P2|Overall Study|Withdrawal by Subject|9
983164|NCT00536510|3232772|P1|Overall Study|Withdrawal by Subject|16
983165|NCT00536510|3232771|P2|Overall Study|Protocol Violation|5
983166|NCT00536510|3232772|P1|Overall Study|Protocol Violation|4
983167|NCT00536510|3232771|P2|Overall Study|Lost to Follow-up|8
983168|NCT00536510|3232772|P1|Overall Study|Lost to Follow-up|11
983169|NCT00536510|3232771|P2|Overall Study|Adverse Event|4
983170|NCT00536510|3232772|P1|Overall Study|Adverse Event|27
983171|NCT00536484|3232782|P2|Overall Study|Other|0
983172|NCT00536484|3232783|P1|Overall Study|Other|4
983173|NCT00536484|3232782|P2|Overall Study|Lack of Efficacy|5
983174|NCT00536484|3232783|P1|Overall Study|Lack of Efficacy|16
983175|NCT00536484|3232782|P2|Overall Study|Lost to Follow-up|6
983176|NCT00536484|3232783|P1|Overall Study|Lost to Follow-up|8
983177|NCT00536484|3232782|P2|Overall Study|Withdrawal by Subject|11
983178|NCT00536484|3232783|P1|Overall Study|Withdrawal by Subject|11
983179|NCT00536484|3232782|P2|Overall Study|Adverse Event|34
983180|NCT00536484|3232783|P1|Overall Study|Adverse Event|21
983181|NCT00536471|3232817|P4|Overall Study|Sponsor Decision|2
983182|NCT00536471|3232818|P3|Overall Study|Sponsor Decision|3
983183|NCT00536471|3232819|P2|Overall Study|Sponsor Decision|1
983184|NCT00536471|3232820|P1|Overall Study|Sponsor Decision|0
983185|NCT00536471|3232817|P4|Overall Study|Death|2
983186|NCT00536471|3232818|P3|Overall Study|Death|1
983187|NCT00536471|3232819|P2|Overall Study|Death|0
983188|NCT00536471|3232820|P1|Overall Study|Death|0
983189|NCT00536471|3232817|P4|Overall Study|Physician Decision|2
983190|NCT00536471|3232818|P3|Overall Study|Physician Decision|3
983191|NCT00536471|3232819|P2|Overall Study|Physician Decision|1
983192|NCT00536471|3232820|P1|Overall Study|Physician Decision|11
983193|NCT00536471|3232817|P4|Overall Study|Protocol Violation|3
983194|NCT00536471|3232818|P3|Overall Study|Protocol Violation|2
983195|NCT00536471|3232819|P2|Overall Study|Protocol Violation|1
983196|NCT00536471|3232820|P1|Overall Study|Protocol Violation|8
983197|NCT00536471|3232817|P4|Overall Study|Lack of Efficacy|9
983198|NCT00536471|3232818|P3|Overall Study|Lack of Efficacy|11
983199|NCT00536471|3232819|P2|Overall Study|Lack of Efficacy|18
983200|NCT00536471|3232820|P1|Overall Study|Lack of Efficacy|17
983201|NCT00536471|3232817|P4|Overall Study|Withdrawal by Subject|21
983202|NCT00536471|3232818|P3|Overall Study|Withdrawal by Subject|43
983203|NCT00536471|3232819|P2|Overall Study|Withdrawal by Subject|24
983204|NCT00536471|3232820|P1|Overall Study|Withdrawal by Subject|40
983205|NCT00536471|3232817|P4|Overall Study|Adverse Event|13
983206|NCT00536471|3232818|P3|Overall Study|Adverse Event|28
983207|NCT00536471|3232819|P2|Overall Study|Adverse Event|16
983208|NCT00536471|3232820|P1|Overall Study|Adverse Event|32
983209|NCT00536471|3232817|P4|Overall Study|Lost to Follow-up|22
983210|NCT00536471|3232818|P3|Overall Study|Lost to Follow-up|48
983211|NCT00536471|3232819|P2|Overall Study|Lost to Follow-up|23
983212|NCT00536471|3232820|P1|Overall Study|Lost to Follow-up|48
983213|NCT00536380|3233065|P3|Overall Study|Administrative|1
983214|NCT00536380|3233066|P2|Overall Study|Administrative|0
983215|NCT00536380|3233067|P1|Overall Study|Administrative|0
983216|NCT00536380|3233065|P3|Overall Study|Did not meet protocol eligibility|1
983217|NCT00536380|3233066|P2|Overall Study|Did not meet protocol eligibility|0
983218|NCT00536380|3233067|P1|Overall Study|Did not meet protocol eligibility|0
983219|NCT00536380|3233065|P3|Overall Study|Noncompliance with protocol|2
983220|NCT00536380|3233066|P2|Overall Study|Noncompliance with protocol|2
983221|NCT00536380|3233067|P1|Overall Study|Noncompliance with protocol|3
983222|NCT00536380|3233065|P3|Overall Study|Withdrawal related to study drug|2
983223|NCT00536380|3233066|P2|Overall Study|Withdrawal related to study drug|5
983224|NCT00536380|3233067|P1|Overall Study|Withdrawal related to study drug|7
983225|NCT00536380|3233065|P3|Overall Study|Withdrawal unrelated to study drug|1
983226|NCT00536380|3233066|P2|Overall Study|Withdrawal unrelated to study drug|0
983227|NCT00536380|3233067|P1|Overall Study|Withdrawal unrelated to study drug|2
983228|NCT00536380|3233065|P3|Overall Study|Lost to Follow-up|1
983229|NCT00536380|3233066|P2|Overall Study|Lost to Follow-up|0
983230|NCT00536380|3233067|P1|Overall Study|Lost to Follow-up|0
983231|NCT00536380|3233065|P3|Overall Study|Adverse Event|2
983232|NCT00536380|3233066|P2|Overall Study|Adverse Event|2
983233|NCT00536380|3233067|P1|Overall Study|Adverse Event|0
983234|NCT00536263|3233091|P3|Overall Study|Did not meet protocol eligibility|2
983235|NCT00536263|3233092|P2|Overall Study|Did not meet protocol eligibility|2
983236|NCT00536263|3233093|P1|Overall Study|Did not meet protocol eligibility|1
983237|NCT00536263|3233091|P3|Overall Study|Noncompliance with protocol|1
983238|NCT00536263|3233092|P2|Overall Study|Noncompliance with protocol|0
983239|NCT00536263|3233093|P1|Overall Study|Noncompliance with protocol|0
983240|NCT00536263|3233091|P3|Overall Study|Subject withdrew - treatment related|2
983241|NCT00536263|3233092|P2|Overall Study|Subject withdrew - treatment related|3
983242|NCT00536263|3233093|P1|Overall Study|Subject withdrew - treatment related|0
983243|NCT00536263|3233091|P3|Overall Study|Subject withdrew - not treatment related|5
983244|NCT00536263|3233092|P2|Overall Study|Subject withdrew - not treatment related|0
983245|NCT00536263|3233093|P1|Overall Study|Subject withdrew - not treatment related|2
983246|NCT00536263|3233091|P3|Overall Study|Lost to Follow-up|4
983247|NCT00536263|3233092|P2|Overall Study|Lost to Follow-up|4
983248|NCT00536263|3233093|P1|Overall Study|Lost to Follow-up|3
983249|NCT00536263|3233091|P3|Overall Study|Adverse Event|7
983250|NCT00536263|3233092|P2|Overall Study|Adverse Event|5
983251|NCT00536263|3233093|P1|Overall Study|Adverse Event|5
983252|NCT00536198|3233133|P2|Overall Study|Protocol Violation|1
983253|NCT00536198|3233134|P1|Overall Study|Protocol Violation|0
983254|NCT00536198|3233133|P2|Overall Study|Pregnancy|1
983255|NCT00536198|3233134|P1|Overall Study|Pregnancy|1
983256|NCT00536198|3233133|P2|Overall Study|Rescue|9
983257|NCT00536198|3233134|P1|Overall Study|Rescue|3
983258|NCT00536198|3233133|P2|Overall Study|Adverse Event|2
983259|NCT00536198|3233134|P1|Overall Study|Adverse Event|2
983260|NCT00536198|3233133|P2|Overall Study|Withdrawal by Subject|12
983261|NCT00536198|3233134|P1|Overall Study|Withdrawal by Subject|16
983262|NCT00536198|3233133|P2|Overall Study|Lost to Follow-up|14
983263|NCT00536198|3233134|P1|Overall Study|Lost to Follow-up|15
983264|NCT00536120|3233173|P2|Overall Study|Missed Study Visit|1
983265|NCT00536120|3233174|P1|Overall Study|Missed Study Visit|0
983266|NCT00536120|3233173|P2|Overall Study|Steroid Use|2
983267|NCT00536120|3233174|P1|Overall Study|Steroid Use|0
983268|NCT00536120|3233173|P2|Overall Study|Sponsor Decision Due to Lab Values|0
983269|NCT00536120|3233174|P1|Overall Study|Sponsor Decision Due to Lab Values|1
983270|NCT00536120|3233173|P2|Overall Study|Non-compliance|0
983271|NCT00536120|3233174|P1|Overall Study|Non-compliance|1
983272|NCT00536120|3233173|P2|Overall Study|Positive for Anti-natalizumab Antibodies|0
983273|NCT00536120|3233174|P1|Overall Study|Positive for Anti-natalizumab Antibodies|3
983274|NCT00536120|3233173|P2|Overall Study|Lost to Follow-up|0
983275|NCT00536120|3233174|P1|Overall Study|Lost to Follow-up|1
983276|NCT00536107|3233188|P2|Overall Study|Study Termination|4
983277|NCT00536107|3233189|P1|Overall Study|Study Termination|2
983278|NCT00536107|3233188|P2|Overall Study|Withdrawal by Subject|1
983279|NCT00536107|3233189|P1|Overall Study|Withdrawal by Subject|0
983280|NCT00536107|3233188|P2|Overall Study|Incorrect enrolment|0
983281|NCT00536107|3233189|P1|Overall Study|Incorrect enrolment|1
983282|NCT00536107|3233188|P2|Overall Study|Death|1
983283|NCT00536107|3233189|P1|Overall Study|Death|5
983284|NCT00535847|3233243|P3|Overall Study|Protocol-defined Virologic Stopping Rule|0
983285|NCT00535847|3233244|P2|Overall Study|Protocol-defined Virologic Stopping Rule|10
983286|NCT00535847|3233245|P1|Overall Study|Protocol-defined Virologic Stopping Rule|16
983287|NCT00535847|3233243|P3|Overall Study|Non compliance|0
983288|NCT00535847|3233244|P2|Overall Study|Non compliance|1
983289|NCT00535847|3233245|P1|Overall Study|Non compliance|1
983290|NCT00535847|3233243|P3|Overall Study|Adverse Event|2
983291|NCT00535847|3233244|P2|Overall Study|Adverse Event|3
983292|NCT00535847|3233245|P1|Overall Study|Adverse Event|5
983293|NCT00535730|3233311|P2|Overall Study|Withdrawal by Subject|4
983294|NCT00535730|3233312|P1|Overall Study|Withdrawal by Subject|0
983295|NCT00535730|3233311|P2|Overall Study|Protocol Violation|0
983296|NCT00535730|3233312|P1|Overall Study|Protocol Violation|1
983297|NCT00535730|3233311|P2|Overall Study|Physician Decision|1
983298|NCT00535730|3233312|P1|Overall Study|Physician Decision|0
983299|NCT00535730|3233311|P2|Overall Study|Lost to Follow-up|1
983300|NCT00535730|3233312|P1|Overall Study|Lost to Follow-up|0
983301|NCT00535730|3233311|P2|Overall Study|Adverse Event|1
983302|NCT00535730|3233312|P1|Overall Study|Adverse Event|1
983303|NCT00535626|3233333|P1|Overall Study|Unable to return|2
983304|NCT00535626|3233333|P1|Overall Study|Subject terminated|31
983305|NCT00535626|3233333|P1|Overall Study|Removal/revision of study component|8
983306|NCT00535626|3233333|P1|Overall Study|Withdrawal by Subject|20
983307|NCT00535626|3233333|P1|Overall Study|Lost to Follow-up|29
983308|NCT00535626|3233333|P1|Overall Study|Death|15
983309|NCT00535496|3233360|P4|Overall Study|Not treated with sugammadex|0
983310|NCT00535496|3233361|P3|Overall Study|Not treated with sugammadex|0
983311|NCT00535496|3233362|P2|Overall Study|Not treated with sugammadex|1
983312|NCT00535496|3233363|P1|Overall Study|Not treated with sugammadex|0
983313|NCT00535496|3233360|P4|Overall Study|Lost to Follow-up|0
983314|NCT00535496|3233361|P3|Overall Study|Lost to Follow-up|0
983315|NCT00535496|3233362|P2|Overall Study|Lost to Follow-up|1
983316|NCT00535496|3233363|P1|Overall Study|Lost to Follow-up|0
983317|NCT00535405|3233383|P5|Overall Study|Withdrawal by Subject|8
983318|NCT00535405|3233384|P4|Overall Study|Withdrawal by Subject|10
983319|NCT00535405|3233385|P3|Overall Study|Withdrawal by Subject|10
983320|NCT00535405|3233386|P2|Overall Study|Withdrawal by Subject|11
983321|NCT00535405|3233387|P1|Overall Study|Withdrawal by Subject|5
983322|NCT00535405|3233383|P5|Overall Study|Protocol Violation|0
983323|NCT00535405|3233384|P4|Overall Study|Protocol Violation|1
983324|NCT00535405|3233385|P3|Overall Study|Protocol Violation|2
983325|NCT00535405|3233386|P2|Overall Study|Protocol Violation|2
983326|NCT00535405|3233387|P1|Overall Study|Protocol Violation|2
983327|NCT00535405|3233383|P5|Overall Study|Physician Decision|1
983328|NCT00535405|3233384|P4|Overall Study|Physician Decision|1
983329|NCT00535405|3233385|P3|Overall Study|Physician Decision|0
983330|NCT00535405|3233386|P2|Overall Study|Physician Decision|2
983331|NCT00535405|3233387|P1|Overall Study|Physician Decision|3
983332|NCT00535405|3233383|P5|Overall Study|Lost to Follow-up|1
983333|NCT00535405|3233384|P4|Overall Study|Lost to Follow-up|2
983334|NCT00535405|3233385|P3|Overall Study|Lost to Follow-up|3
983335|NCT00535405|3233386|P2|Overall Study|Lost to Follow-up|3
983336|NCT00535405|3233387|P1|Overall Study|Lost to Follow-up|1
983337|NCT00535405|3233383|P5|Overall Study|Adverse Event|6
983338|NCT00535405|3233384|P4|Overall Study|Adverse Event|8
983339|NCT00535405|3233385|P3|Overall Study|Adverse Event|3
983340|NCT00535405|3233386|P2|Overall Study|Adverse Event|8
983341|NCT00535405|3233387|P1|Overall Study|Adverse Event|6
983342|NCT00535288|3233448|P5|Overall Study|Not specified|1
983343|NCT00535288|3233449|P4|Overall Study|Not specified|2
983344|NCT00535288|3233450|P3|Overall Study|Not specified|1
983345|NCT00535288|3233451|P2|Overall Study|Not specified|1
983346|NCT00535288|3233452|P1|Overall Study|Not specified|2
983347|NCT00535288|3233448|P5|Overall Study|Unwilling to cooperate|4
983348|NCT00535288|3233449|P4|Overall Study|Unwilling to cooperate|3
983349|NCT00535288|3233450|P3|Overall Study|Unwilling to cooperate|3
983350|NCT00535288|3233451|P2|Overall Study|Unwilling to cooperate|6
983351|NCT00535288|3233452|P1|Overall Study|Unwilling to cooperate|6
983352|NCT00535288|3233448|P5|Overall Study|Lack of Efficacy|7
983353|NCT00535288|3233449|P4|Overall Study|Lack of Efficacy|4
983354|NCT00535288|3233450|P3|Overall Study|Lack of Efficacy|4
983355|NCT00535288|3233451|P2|Overall Study|Lack of Efficacy|3
983356|NCT00535288|3233452|P1|Overall Study|Lack of Efficacy|26
983357|NCT00535288|3233448|P5|Overall Study|Lost to Follow-up|0
983358|NCT00535288|3233449|P4|Overall Study|Lost to Follow-up|0
983359|NCT00535288|3233450|P3|Overall Study|Lost to Follow-up|0
983360|NCT00535288|3233451|P2|Overall Study|Lost to Follow-up|3
983361|NCT00535288|3233452|P1|Overall Study|Lost to Follow-up|0
983362|NCT00535288|3233448|P5|Overall Study|Adverse Event|30
983363|NCT00535288|3233449|P4|Overall Study|Adverse Event|20
983364|NCT00535288|3233450|P3|Overall Study|Adverse Event|25
983365|NCT00535288|3233451|P2|Overall Study|Adverse Event|19
983366|NCT00535288|3233452|P1|Overall Study|Adverse Event|20
983367|NCT00535262|3233529|P1|Overall Study|No funding|3
983368|NCT00535223|3233535|P2|Overall Study|Withdrawal by Subject|1
983369|NCT00535223|3233536|P1|Overall Study|Withdrawal by Subject|4
983370|NCT00535145|3233544|P1|Phase II|Subject non-compliance|2
983371|NCT00535145|3233544|P1|Phase II|Withdrawal by Subject|5
983372|NCT00535145|3233544|P1|Phase II|Lost to Follow-up|5
983373|NCT00535145|3233544|P1|Phase II|Lack of Efficacy|1
983374|NCT00535145|3233544|P1|Phase II|Adverse Event|2
983375|NCT00535145|3233544|P1|Phase I|(diagnosis)|3
983376|NCT00535145|3233544|P1|Phase I|(PI decision)|1
983377|NCT00535145|3233544|P1|Phase I|(protocol violation)|1
983378|NCT00535145|3233544|P1|Phase I|(eligibility)|8
983379|NCT00535145|3233544|P1|Phase I|Withdrawal by Subject|6
983380|NCT00535145|3233544|P1|Phase I|Lost to Follow-up|7
983381|NCT00535145|3233544|P1|Phase I|Adverse Event|3
983382|NCT00535132|3233556|P2|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
983383|NCT00535132|3233557|P1|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
983384|NCT00535132|3233556|P2|Safety Analysis Set|Did Not Receive Study Medication|2
983385|NCT00535132|3233557|P1|Safety Analysis Set|Did Not Receive Study Medication|2
983386|NCT00534976|3233638|P2|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0
983387|NCT00534976|3233639|P1|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1
983388|NCT00534976|3233638|P2|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0
983389|NCT00534976|3233639|P1|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1
983390|NCT00534976|3233638|P2|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1
983391|NCT00534976|3233639|P1|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0
983392|NCT00534638|3233700|P2|Overall Study|Refused participation to study|883
983393|NCT00534638|3233701|P1|Overall Study|Refused participation to study|1665
983394|NCT00534638|3233700|P2|Overall Study|Rejected origin of signature|2
983395|NCT00534638|3233701|P1|Overall Study|Rejected origin of signature|0
983396|NCT00534638|3233700|P2|Overall Study|Received without ICF|1
983397|NCT00534638|3233701|P1|Overall Study|Received without ICF|0
983398|NCT00534638|3233700|P2|Overall Study|Subject unable to read|1
983399|NCT00534638|3233701|P1|Overall Study|Subject unable to read|0
983400|NCT00534638|3233700|P2|Overall Study|ICF not returned|1
983401|NCT00534638|3233701|P1|Overall Study|ICF not returned|0
983402|NCT00534638|3233700|P2|Overall Study|Mentally disabled|0
983403|NCT00534638|3233701|P1|Overall Study|Mentally disabled|1
983404|NCT00534638|3233700|P2|Overall Study|Death|5
983405|NCT00534638|3233701|P1|Overall Study|Death|5
983406|NCT00534638|3233700|P2|Overall Study|Pregnancy|4
983407|NCT00534638|3233701|P1|Overall Study|Pregnancy|6
983408|NCT00534638|3233700|P2|Overall Study|Blinded treatment broken|0
983409|NCT00534638|3233701|P1|Overall Study|Blinded treatment broken|2
983410|NCT00534638|3233700|P2|Overall Study|Urticaria|0
983411|NCT00534638|3233701|P1|Overall Study|Urticaria|1
983412|NCT00534638|3233700|P2|Overall Study|Already received HPV vaccine|1
983413|NCT00534638|3233701|P1|Overall Study|Already received HPV vaccine|0
983414|NCT00534638|3233700|P2|Overall Study|Lost to Follow-up|10875
983415|NCT00534638|3233701|P1|Overall Study|Lost to Follow-up|4793
983416|NCT00534638|3233700|P2|Overall Study|Migrated/moved from study area|13
983417|NCT00534638|3233701|P1|Overall Study|Migrated/moved from study area|14
983418|NCT00534638|3233700|P2|Overall Study|Withdrawal by Subject|5
983419|NCT00534638|3233701|P1|Overall Study|Withdrawal by Subject|4
983420|NCT00534599|3233736|P2|Overall Study|Other|0
983421|NCT00534599|3233737|P1|Overall Study|Other|7
983422|NCT00534599|3233736|P2|Overall Study|Withdrawal by Subject|6
983423|NCT00534599|3233737|P1|Overall Study|Withdrawal by Subject|4
983424|NCT00534599|3233736|P2|Overall Study|Lost to Follow-up|14
983425|NCT00534599|3233737|P1|Overall Study|Lost to Follow-up|11
983426|NCT00534599|3233736|P2|Overall Study|Protocol Violation|3
983427|NCT00534599|3233737|P1|Overall Study|Protocol Violation|1
983428|NCT00534599|3233736|P2|Overall Study|Generalized anxiety disorder worsened|1
983429|NCT00534599|3233737|P1|Overall Study|Generalized anxiety disorder worsened|0
983430|NCT00534599|3233736|P2|Overall Study|Lack of Efficacy|1
983431|NCT00534599|3233737|P1|Overall Study|Lack of Efficacy|0
983432|NCT00534599|3233736|P2|Overall Study|Developed study-specific d/c criteria|0
983433|NCT00534599|3233737|P1|Overall Study|Developed study-specific d/c criteria|5
983434|NCT00534599|3233736|P2|Overall Study|Mis-randomization|2
983435|NCT00534599|3233737|P1|Overall Study|Mis-randomization|2
983436|NCT00534599|3233736|P2|Overall Study|Incorrect enrollment|1
983437|NCT00534599|3233737|P1|Overall Study|Incorrect enrollment|2
983438|NCT00534599|3233736|P2|Overall Study|Adverse Event|4
983439|NCT00534599|3233737|P1|Overall Study|Adverse Event|25
983440|NCT00534495|3233773|P3|Long Term Ext. Phase Week 24-month 21|non compliance|2
983441|NCT00534495|3233774|P2|Long Term Ext. Phase Week 24-month 21|non compliance|0
983442|NCT00534495|3233775|P1|Long Term Ext. Phase Week 24-month 21|non compliance|0
983443|NCT00534495|3233773|P3|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3
983444|NCT00534495|3233774|P2|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
983445|NCT00534495|3233775|P1|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
983446|NCT00534495|3233773|P3|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5
983447|NCT00534495|3233774|P2|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
983448|NCT00534495|3233775|P1|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
983449|NCT00534495|3233773|P3|Long Term Ext. Phase Week 24-month 21|Adverse Event|1
983450|NCT00534495|3233774|P2|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
983451|NCT00534495|3233775|P1|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
983452|NCT00534495|3233773|P3|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0
983453|NCT00534495|3233774|P2|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
983454|NCT00534495|3233775|P1|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
983455|NCT00534495|3233773|P3|All Active Treatment Phase Week 4-24|Lost to Follow-up|0
983456|NCT00534495|3233774|P2|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
983457|NCT00534495|3233775|P1|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
983458|NCT00534495|3233773|P3|All Active Treatment Phase Week 4-24|Lack of Efficacy|0
983459|NCT00534495|3233774|P2|All Active Treatment Phase Week 4-24|Lack of Efficacy|7
983460|NCT00534495|3233775|P1|All Active Treatment Phase Week 4-24|Lack of Efficacy|1
983461|NCT00534495|3233773|P3|All Active Treatment Phase Week 4-24|Adverse Event|0
983462|NCT00534495|3233774|P2|All Active Treatment Phase Week 4-24|Adverse Event|0
983463|NCT00534495|3233775|P1|All Active Treatment Phase Week 4-24|Adverse Event|1
983464|NCT00534495|3233773|P3|Double Blind Placebo Phase Week 0-4|randomized in error|0
983465|NCT00534495|3233774|P2|Double Blind Placebo Phase Week 0-4|randomized in error|1
983466|NCT00534495|3233775|P1|Double Blind Placebo Phase Week 0-4|randomized in error|0
983467|NCT00534404|3233813|P3|Overall Study|Lost to Follow-up|201
983468|NCT00534404|3233814|P2|Overall Study|Lost to Follow-up|138
983469|NCT00534404|3233815|P1|Overall Study|Lost to Follow-up|170
983470|NCT00534404|3233813|P3|Overall Study|Removed by study staff|1
983471|NCT00534404|3233814|P2|Overall Study|Removed by study staff|3
983472|NCT00534404|3233815|P1|Overall Study|Removed by study staff|2
983473|NCT00534404|3233813|P3|Overall Study|Withdrawal by Subject|38
983474|NCT00534404|3233814|P2|Overall Study|Withdrawal by Subject|2
983475|NCT00534404|3233815|P1|Overall Study|Withdrawal by Subject|8
983476|NCT00534404|3233813|P3|Overall Study|Death|2
983477|NCT00534404|3233814|P2|Overall Study|Death|0
983478|NCT00534404|3233815|P1|Overall Study|Death|0
983479|NCT00534352|3233846|P1|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1
983480|NCT00534352|3233846|P1|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2
983481|NCT00534352|3233846|P1|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1
983482|NCT00534352|3233846|P1|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1
983483|NCT00534352|3233846|P1|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1
983484|NCT00534352|3233846|P1|Treatment A: TMC125 + TDF/FTC|Physician Decision|1
983485|NCT00534313|3233890|P4|Long-term Period|Not specified|2
983486|NCT00534313|3233891|P3|Long-term Period|Not specified|2
983487|NCT00534313|3233892|P2|Long-term Period|Not specified|2
983488|NCT00534313|3233893|P1|Long-term Period|Not specified|1
983489|NCT00534313|3233890|P4|Long-term Period|Administrative reason by sponsor|18
983490|NCT00534313|3233891|P3|Long-term Period|Administrative reason by sponsor|26
983491|NCT00534313|3233892|P2|Long-term Period|Administrative reason by sponsor|15
983492|NCT00534313|3233893|P1|Long-term Period|Administrative reason by sponsor|17
983493|NCT00534313|3233890|P4|Long-term Period|Poor compliance/noncompliance|0
983494|NCT00534313|3233891|P3|Long-term Period|Poor compliance/noncompliance|1
983495|NCT00534313|3233892|P2|Long-term Period|Poor compliance/noncompliance|1
983496|NCT00534313|3233893|P1|Long-term Period|Poor compliance/noncompliance|0
983497|NCT00534313|3233890|P4|Long-term Period|No longer meets study criteria|0
983498|NCT00534313|3233891|P3|Long-term Period|No longer meets study criteria|0
983499|NCT00534313|3233892|P2|Long-term Period|No longer meets study criteria|1
983500|NCT00534313|3233893|P1|Long-term Period|No longer meets study criteria|0
983501|NCT00534313|3233890|P4|Long-term Period|Withdrawal by Subject|0
983502|NCT00534313|3233891|P3|Long-term Period|Withdrawal by Subject|0
983503|NCT00534313|3233892|P2|Long-term Period|Withdrawal by Subject|2
983504|NCT00534313|3233893|P1|Long-term Period|Withdrawal by Subject|2
983505|NCT00534313|3233890|P4|Long-term Period|Lost to Follow-up|0
983506|NCT00534313|3233891|P3|Long-term Period|Lost to Follow-up|0
983507|NCT00534313|3233892|P2|Long-term Period|Lost to Follow-up|2
983508|NCT00534313|3233893|P1|Long-term Period|Lost to Follow-up|1
983509|NCT00534313|3233890|P4|Long-term Period|Lack of Efficacy|12
983510|NCT00534313|3233891|P3|Long-term Period|Lack of Efficacy|14
983511|NCT00534313|3233892|P2|Long-term Period|Lack of Efficacy|10
983512|NCT00534313|3233893|P1|Long-term Period|Lack of Efficacy|14
983513|NCT00534313|3233890|P4|Long-term Period|Adverse Event|1
983514|NCT00534313|3233891|P3|Long-term Period|Adverse Event|0
983515|NCT00534313|3233892|P2|Long-term Period|Adverse Event|1
983516|NCT00534313|3233893|P1|Long-term Period|Adverse Event|2
983517|NCT00534313|3233890|P4|Short-term Period|Pregnancy|0
983518|NCT00534313|3233891|P3|Short-term Period|Pregnancy|1
983519|NCT00534313|3233892|P2|Short-term Period|Pregnancy|0
983520|NCT00534313|3233893|P1|Short-term Period|Pregnancy|0
983521|NCT00534313|3233890|P4|Short-term Period|Participant withdrew consent|2
983522|NCT00534313|3233891|P3|Short-term Period|Participant withdrew consent|0
983523|NCT00534313|3233892|P2|Short-term Period|Participant withdrew consent|0
983524|NCT00534313|3233893|P1|Short-term Period|Participant withdrew consent|2
983525|NCT00534313|3233890|P4|Short-term Period|Participant not meeting study criteria|1
983526|NCT00534313|3233891|P3|Short-term Period|Participant not meeting study criteria|0
983527|NCT00534313|3233892|P2|Short-term Period|Participant not meeting study criteria|0
983528|NCT00534313|3233893|P1|Short-term Period|Participant not meeting study criteria|0
983529|NCT00534313|3233890|P4|Short-term Period|Lack of Efficacy|3
983530|NCT00534313|3233891|P3|Short-term Period|Lack of Efficacy|0
983531|NCT00534313|3233892|P2|Short-term Period|Lack of Efficacy|4
983532|NCT00534313|3233893|P1|Short-term Period|Lack of Efficacy|3
983533|NCT00534313|3233890|P4|Short-term Period|Adverse Event|3
983534|NCT00534313|3233891|P3|Short-term Period|Adverse Event|1
983535|NCT00534313|3233892|P2|Short-term Period|Adverse Event|2
983536|NCT00534313|3233893|P1|Short-term Period|Adverse Event|1
983537|NCT00534248|3233988|P2|Overall Study|Withdrawal by Subject|255
983538|NCT00534248|3233989|P1|Overall Study|Withdrawal by Subject|263
983539|NCT00534248|3233988|P2|Overall Study|Protocol Violation|4
983540|NCT00534248|3233989|P1|Overall Study|Protocol Violation|3
983541|NCT00534248|3233988|P2|Overall Study|Physician Decision|7
983542|NCT00534248|3233989|P1|Overall Study|Physician Decision|10
983543|NCT00534248|3233988|P2|Overall Study|Other protocol specified criteria|3
983544|NCT00534248|3233989|P1|Overall Study|Other protocol specified criteria|13
983545|NCT00534248|3233988|P2|Overall Study|Lost to Follow-up|375
983546|NCT00534248|3233989|P1|Overall Study|Lost to Follow-up|353
983547|NCT00534248|3233988|P2|Overall Study|Adverse Event|29
983548|NCT00534248|3233989|P1|Overall Study|Adverse Event|19
983549|NCT00534105|3234019|P2|Overall Study|Lost to Follow-up|39
983550|NCT00534105|3234020|P1|Overall Study|Lost to Follow-up|23
983551|NCT00534092|3234034|P2|Overall Study|personal reasons/family concerns|0
983552|NCT00534092|3234035|P1|Overall Study|personal reasons/family concerns|1
983553|NCT00534092|3234034|P2|Overall Study|Lost to Follow-up|0
983554|NCT00534092|3234035|P1|Overall Study|Lost to Follow-up|1
983555|NCT00533949|3234073|P4|Overall Study|Withdrawal by Subject|1
983556|NCT00533949|3234074|P3|Overall Study|Withdrawal by Subject|1
983557|NCT00533949|3234075|P2|Overall Study|Withdrawal by Subject|2
983558|NCT00533949|3234076|P1|Overall Study|Withdrawal by Subject|3
983559|NCT00533949|3234073|P4|Overall Study|Protocol Violation|9
983560|NCT00533949|3234074|P3|Overall Study|Protocol Violation|9
983561|NCT00533949|3234075|P2|Overall Study|Protocol Violation|12
983562|NCT00533949|3234076|P1|Overall Study|Protocol Violation|12
983563|NCT00533897|3234107|P8|Long Term Extension (LTE)|not specified|6
983564|NCT00533897|3234108|P7|Long Term Extension (LTE)|not specified|1
983565|NCT00533897|3234109|P6|Long Term Extension (LTE)|not specified|0
983566|NCT00533897|3234110|P5|Long Term Extension (LTE)|not specified|0
983567|NCT00533897|3234111|P4|Long Term Extension (LTE)|not specified|0
983568|NCT00533897|3234112|P3|Long Term Extension (LTE)|not specified|0
983569|NCT00533897|3234113|P2|Long Term Extension (LTE)|not specified|0
983570|NCT00533897|3234114|P1|Long Term Extension (LTE)|not specified|0
983571|NCT00533897|3234107|P8|Long Term Extension (LTE)|Lost to Follow-up|1
983572|NCT00533897|3234108|P7|Long Term Extension (LTE)|Lost to Follow-up|1
983573|NCT00533897|3234109|P6|Long Term Extension (LTE)|Lost to Follow-up|0
983574|NCT00533897|3234110|P5|Long Term Extension (LTE)|Lost to Follow-up|0
983575|NCT00533897|3234111|P4|Long Term Extension (LTE)|Lost to Follow-up|0
983576|NCT00533897|3234112|P3|Long Term Extension (LTE)|Lost to Follow-up|0
983577|NCT00533897|3234113|P2|Long Term Extension (LTE)|Lost to Follow-up|0
983578|NCT00533897|3234114|P1|Long Term Extension (LTE)|Lost to Follow-up|0
983579|NCT00533897|3234107|P8|Long Term Extension (LTE)|Pregnancy|2
983580|NCT00533897|3234108|P7|Long Term Extension (LTE)|Pregnancy|0
983581|NCT00533897|3234109|P6|Long Term Extension (LTE)|Pregnancy|0
983582|NCT00533897|3234110|P5|Long Term Extension (LTE)|Pregnancy|0
983583|NCT00533897|3234111|P4|Long Term Extension (LTE)|Pregnancy|0
983584|NCT00533897|3234112|P3|Long Term Extension (LTE)|Pregnancy|0
983585|NCT00533897|3234113|P2|Long Term Extension (LTE)|Pregnancy|0
983586|NCT00533897|3234114|P1|Long Term Extension (LTE)|Pregnancy|0
983587|NCT00533897|3234107|P8|Long Term Extension (LTE)|Adverse Event|5
983588|NCT00533897|3234108|P7|Long Term Extension (LTE)|Adverse Event|2
983589|NCT00533897|3234109|P6|Long Term Extension (LTE)|Adverse Event|0
983590|NCT00533897|3234110|P5|Long Term Extension (LTE)|Adverse Event|0
983591|NCT00533897|3234111|P4|Long Term Extension (LTE)|Adverse Event|0
983592|NCT00533897|3234112|P3|Long Term Extension (LTE)|Adverse Event|0
983593|NCT00533897|3234113|P2|Long Term Extension (LTE)|Adverse Event|0
983594|NCT00533897|3234114|P1|Long Term Extension (LTE)|Adverse Event|0
983595|NCT00533897|3234107|P8|Long Term Extension (LTE)|Poor/Non-compliance|0
983596|NCT00533897|3234108|P7|Long Term Extension (LTE)|Poor/Non-compliance|1
983597|NCT00533897|3234109|P6|Long Term Extension (LTE)|Poor/Non-compliance|0
983598|NCT00533897|3234110|P5|Long Term Extension (LTE)|Poor/Non-compliance|0
983599|NCT00533897|3234111|P4|Long Term Extension (LTE)|Poor/Non-compliance|0
983600|NCT00533897|3234112|P3|Long Term Extension (LTE)|Poor/Non-compliance|0
983601|NCT00533897|3234113|P2|Long Term Extension (LTE)|Poor/Non-compliance|0
983602|NCT00533897|3234114|P1|Long Term Extension (LTE)|Poor/Non-compliance|0
983603|NCT00533897|3234107|P8|Long Term Extension (LTE)|Lack of Efficacy|3
983604|NCT00533897|3234108|P7|Long Term Extension (LTE)|Lack of Efficacy|5
983605|NCT00533897|3234109|P6|Long Term Extension (LTE)|Lack of Efficacy|0
983606|NCT00533897|3234110|P5|Long Term Extension (LTE)|Lack of Efficacy|0
983607|NCT00533897|3234111|P4|Long Term Extension (LTE)|Lack of Efficacy|0
983608|NCT00533897|3234112|P3|Long Term Extension (LTE)|Lack of Efficacy|0
983609|NCT00533897|3234113|P2|Long Term Extension (LTE)|Lack of Efficacy|0
983610|NCT00533897|3234114|P1|Long Term Extension (LTE)|Lack of Efficacy|0
983611|NCT00533897|3234107|P8|Long Term Extension (LTE)|Death|3
983612|NCT00533897|3234108|P7|Long Term Extension (LTE)|Death|1
983613|NCT00533897|3234109|P6|Long Term Extension (LTE)|Death|0
983614|NCT00533897|3234110|P5|Long Term Extension (LTE)|Death|0
983615|NCT00533897|3234111|P4|Long Term Extension (LTE)|Death|0
983616|NCT00533897|3234112|P3|Long Term Extension (LTE)|Death|0
983617|NCT00533897|3234113|P2|Long Term Extension (LTE)|Death|0
983618|NCT00533897|3234114|P1|Long Term Extension (LTE)|Death|0
983619|NCT00533897|3234107|P8|Long Term Extension (LTE)|Participant Withdrew Consent|5
983620|NCT00533897|3234108|P7|Long Term Extension (LTE)|Participant Withdrew Consent|2
983621|NCT00533897|3234109|P6|Long Term Extension (LTE)|Participant Withdrew Consent|0
983622|NCT00533897|3234110|P5|Long Term Extension (LTE)|Participant Withdrew Consent|0
983623|NCT00533897|3234111|P4|Long Term Extension (LTE)|Participant Withdrew Consent|0
983624|NCT00533897|3234112|P3|Long Term Extension (LTE)|Participant Withdrew Consent|0
983625|NCT00533897|3234113|P2|Long Term Extension (LTE)|Participant Withdrew Consent|0
983626|NCT00533897|3234114|P1|Long Term Extension (LTE)|Participant Withdrew Consent|0
983627|NCT00533897|3234107|P8|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
983628|NCT00533897|3234108|P7|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
983629|NCT00533897|3234109|P6|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1
983630|NCT00533897|3234110|P5|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
983631|NCT00533897|3234111|P4|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
983632|NCT00533897|3234112|P3|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
983633|NCT00533897|3234113|P2|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
983634|NCT00533897|3234114|P1|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
983635|NCT00533897|3234107|P8|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
983636|NCT00533897|3234108|P7|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
983637|NCT00533897|3234109|P6|Re-introduction (RI) Period 3|Participant Withdrew Consent|1
983638|NCT00533897|3234110|P5|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
983639|NCT00533897|3234111|P4|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
983640|NCT00533897|3234112|P3|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
983641|NCT00533897|3234113|P2|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
983642|NCT00533897|3234114|P1|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
983643|NCT00533897|3234107|P8|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
983644|NCT00533897|3234108|P7|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
983645|NCT00533897|3234109|P6|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
983646|NCT00533897|3234110|P5|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
983647|NCT00533897|3234111|P4|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
983648|NCT00533897|3234112|P3|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1
983649|NCT00533897|3234113|P2|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
983650|NCT00533897|3234114|P1|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
983651|NCT00533897|3234107|P8|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
983652|NCT00533897|3234108|P7|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
983653|NCT00533897|3234109|P6|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
983654|NCT00533897|3234110|P5|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
983655|NCT00533897|3234111|P4|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
983656|NCT00533897|3234112|P3|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2
983657|NCT00533897|3234113|P2|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1
983658|NCT00533897|3234114|P1|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
983659|NCT00533897|3234107|P8|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
983660|NCT00533897|3234108|P7|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
983661|NCT00533897|3234109|P6|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
983662|NCT00533897|3234110|P5|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
983663|NCT00533897|3234111|P4|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
983664|NCT00533897|3234112|P3|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
983665|NCT00533897|3234113|P2|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
983666|NCT00533897|3234114|P1|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1
983667|NCT00533897|3234107|P8|Lead-in (LI) Period 1|Lack of Efficacy|0
983668|NCT00533897|3234108|P7|Lead-in (LI) Period 1|Lack of Efficacy|0
983669|NCT00533897|3234109|P6|Lead-in (LI) Period 1|Lack of Efficacy|0
983670|NCT00533897|3234110|P5|Lead-in (LI) Period 1|Lack of Efficacy|0
983671|NCT00533897|3234111|P4|Lead-in (LI) Period 1|Lack of Efficacy|0
983672|NCT00533897|3234112|P3|Lead-in (LI) Period 1|Lack of Efficacy|0
983673|NCT00533897|3234113|P2|Lead-in (LI) Period 1|Lack of Efficacy|0
983674|NCT00533897|3234114|P1|Lead-in (LI) Period 1|Lack of Efficacy|3
983675|NCT00533897|3234107|P8|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
983676|NCT00533897|3234108|P7|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
983677|NCT00533897|3234109|P6|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
983678|NCT00533897|3234110|P5|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
983679|NCT00533897|3234111|P4|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
983680|NCT00533897|3234112|P3|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
983681|NCT00533897|3234113|P2|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
983682|NCT00533897|3234114|P1|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2
983683|NCT00533897|3234107|P8|Lead-in (LI) Period 1|Lost to Follow-up|0
983684|NCT00533897|3234108|P7|Lead-in (LI) Period 1|Lost to Follow-up|0
983685|NCT00533897|3234109|P6|Lead-in (LI) Period 1|Lost to Follow-up|0
983686|NCT00533897|3234110|P5|Lead-in (LI) Period 1|Lost to Follow-up|0
983687|NCT00533897|3234111|P4|Lead-in (LI) Period 1|Lost to Follow-up|0
983688|NCT00533897|3234112|P3|Lead-in (LI) Period 1|Lost to Follow-up|0
983689|NCT00533897|3234113|P2|Lead-in (LI) Period 1|Lost to Follow-up|0
983690|NCT00533897|3234114|P1|Lead-in (LI) Period 1|Lost to Follow-up|1
983691|NCT00533897|3234107|P8|Lead-in (LI) Period 1|Participant Withdrew Consent|0
983692|NCT00533897|3234108|P7|Lead-in (LI) Period 1|Participant Withdrew Consent|0
983693|NCT00533897|3234109|P6|Lead-in (LI) Period 1|Participant Withdrew Consent|0
983694|NCT00533897|3234110|P5|Lead-in (LI) Period 1|Participant Withdrew Consent|0
983695|NCT00533897|3234111|P4|Lead-in (LI) Period 1|Participant Withdrew Consent|0
983696|NCT00533897|3234112|P3|Lead-in (LI) Period 1|Participant Withdrew Consent|0
983697|NCT00533897|3234113|P2|Lead-in (LI) Period 1|Participant Withdrew Consent|0
983698|NCT00533897|3234114|P1|Lead-in (LI) Period 1|Participant Withdrew Consent|2
983699|NCT00533897|3234107|P8|Lead-in (LI) Period 1|Adverse Event|0
983700|NCT00533897|3234108|P7|Lead-in (LI) Period 1|Adverse Event|0
983701|NCT00533897|3234109|P6|Lead-in (LI) Period 1|Adverse Event|0
983702|NCT00533897|3234110|P5|Lead-in (LI) Period 1|Adverse Event|0
983703|NCT00533897|3234111|P4|Lead-in (LI) Period 1|Adverse Event|0
983704|NCT00533897|3234112|P3|Lead-in (LI) Period 1|Adverse Event|0
983705|NCT00533897|3234113|P2|Lead-in (LI) Period 1|Adverse Event|0
983706|NCT00533897|3234114|P1|Lead-in (LI) Period 1|Adverse Event|1
983707|NCT00533702|3234254|P2|Overall Study|Found ineligible after randomization|1
983708|NCT00533702|3234255|P1|Overall Study|Found ineligible after randomization|2
983709|NCT00533702|3234254|P2|Overall Study|Withdrawal by Subject|1
983710|NCT00533702|3234255|P1|Overall Study|Withdrawal by Subject|3
983711|NCT00533507|3234286|P1|Overall Study|Withdrawal by Subject|1
983712|NCT00533273|3234331|P2|Open-label|Withdrawal by Subject|0
983713|NCT00533273|3234332|P1|Open-label|Withdrawal by Subject|6
983714|NCT00533273|3234331|P2|Double-blind|Withdrew consent|2
983715|NCT00533273|3234332|P1|Double-blind|Withdrew consent|0
983716|NCT00532948|3234381|P3|Overall Study|Failure to return|0
983717|NCT00532948|3234382|P2|Overall Study|Failure to return|1
983718|NCT00532948|3234383|P1|Overall Study|Failure to return|0
983719|NCT00532948|3234381|P3|Overall Study|Violation of selection criteria at entry|0
983720|NCT00532948|3234382|P2|Overall Study|Violation of selection criteria at entry|1
983721|NCT00532948|3234383|P1|Overall Study|Violation of selection criteria at entry|0
983722|NCT00532948|3234381|P3|Overall Study|Death|4
983723|NCT00532948|3234382|P2|Overall Study|Death|3
983724|NCT00532948|3234383|P1|Overall Study|Death|3
983725|NCT00532948|3234381|P3|Overall Study|Protocol Violation|0
983726|NCT00532948|3234382|P2|Overall Study|Protocol Violation|0
983727|NCT00532948|3234383|P1|Overall Study|Protocol Violation|1
983728|NCT00532935|3234415|P2|Overall Study|Protocol Specific Criteria|15
983729|NCT00532935|3234416|P1|Overall Study|Protocol Specific Criteria|11
983730|NCT00532935|3234415|P2|Overall Study|Withdrawal by Subject|9
983731|NCT00532935|3234416|P1|Overall Study|Withdrawal by Subject|10
983732|NCT00532935|3234415|P2|Overall Study|Protocol Violation|2
983733|NCT00532935|3234416|P1|Overall Study|Protocol Violation|4
983734|NCT00532935|3234415|P2|Overall Study|Pregnancy|0
983735|NCT00532935|3234416|P1|Overall Study|Pregnancy|1
983736|NCT00532935|3234415|P2|Overall Study|Physician Decision|5
983737|NCT00532935|3234416|P1|Overall Study|Physician Decision|4
983738|NCT00532935|3234415|P2|Overall Study|Lost to Follow-up|6
983739|NCT00532935|3234416|P1|Overall Study|Lost to Follow-up|10
983740|NCT00532935|3234415|P2|Overall Study|Lack of Efficacy|3
983741|NCT00532935|3234416|P1|Overall Study|Lack of Efficacy|0
983742|NCT00532935|3234415|P2|Overall Study|Adverse Event|12
983743|NCT00532935|3234416|P1|Overall Study|Adverse Event|11
983744|NCT00532883|3234434|P4|Overall Study|Early Study Termination|4
983745|NCT00532883|3234435|P3|Overall Study|Early Study Termination|1
983746|NCT00532883|3234436|P2|Overall Study|Early Study Termination|4
983747|NCT00532883|3234437|P1|Overall Study|Early Study Termination|4
983748|NCT00532883|3234434|P4|Overall Study|Subject was Nonadherent|0
983749|NCT00532883|3234435|P3|Overall Study|Subject was Nonadherent|1
983750|NCT00532883|3234436|P2|Overall Study|Subject was Nonadherent|1
983751|NCT00532883|3234437|P1|Overall Study|Subject was Nonadherent|0
983752|NCT00532883|3234434|P4|Overall Study|Withdrawal by Subject|0
983753|NCT00532883|3234435|P3|Overall Study|Withdrawal by Subject|1
983754|NCT00532883|3234436|P2|Overall Study|Withdrawal by Subject|1
983755|NCT00532883|3234437|P1|Overall Study|Withdrawal by Subject|0
983756|NCT00532883|3234434|P4|Overall Study|Lost to Follow-up|0
983757|NCT00532883|3234435|P3|Overall Study|Lost to Follow-up|1
983758|NCT00532883|3234436|P2|Overall Study|Lost to Follow-up|1
983759|NCT00532883|3234437|P1|Overall Study|Lost to Follow-up|1
983760|NCT00532883|3234434|P4|Overall Study|Adverse Event|1
983761|NCT00532883|3234435|P3|Overall Study|Adverse Event|0
983762|NCT00532883|3234436|P2|Overall Study|Adverse Event|0
983763|NCT00532883|3234437|P1|Overall Study|Adverse Event|1
983764|NCT00532779|3234450|P3|Overall Study|Drug noncompliance, moved, other|29
983765|NCT00532779|3234451|P2|Overall Study|Drug noncompliance, moved, other|23
983766|NCT00532779|3234452|P1|Overall Study|Drug noncompliance, moved, other|14
983767|NCT00532779|3234450|P3|Overall Study|Death|0
983768|NCT00532779|3234451|P2|Overall Study|Death|1
983769|NCT00532779|3234452|P1|Overall Study|Death|0
983770|NCT00532779|3234450|P3|Overall Study|Pregnancy|3
983771|NCT00532779|3234451|P2|Overall Study|Pregnancy|5
983772|NCT00532779|3234452|P1|Overall Study|Pregnancy|2
983773|NCT00532779|3234450|P3|Overall Study|Protocol Violation|7
983774|NCT00532779|3234451|P2|Overall Study|Protocol Violation|9
983775|NCT00532779|3234452|P1|Overall Study|Protocol Violation|5
983776|NCT00532779|3234450|P3|Overall Study|Lack of Efficacy|40
983777|NCT00532779|3234451|P2|Overall Study|Lack of Efficacy|12
983778|NCT00532779|3234452|P1|Overall Study|Lack of Efficacy|12
983779|NCT00532779|3234450|P3|Overall Study|Withdrawal by Subject|90
983780|NCT00532779|3234451|P2|Overall Study|Withdrawal by Subject|60
983781|NCT00532779|3234452|P1|Overall Study|Withdrawal by Subject|63
983782|NCT00532779|3234450|P3|Overall Study|Lost to Follow-up|66
983783|NCT00532779|3234451|P2|Overall Study|Lost to Follow-up|65
983784|NCT00532779|3234452|P1|Overall Study|Lost to Follow-up|76
983785|NCT00532779|3234450|P3|Overall Study|Adverse Event|56
983786|NCT00532779|3234451|P2|Overall Study|Adverse Event|112
983787|NCT00532779|3234452|P1|Overall Study|Adverse Event|122
983788|NCT00532493|3234513|P2|Overall Study|Contraindicative Medication|0
983789|NCT00532493|3234514|P1|Overall Study|Contraindicative Medication|1
983790|NCT00532493|3234513|P2|Overall Study|Subject Moved Away|1
983791|NCT00532493|3234514|P1|Overall Study|Subject Moved Away|3
983792|NCT00532493|3234513|P2|Overall Study|Protocol Deviation|0
983793|NCT00532493|3234514|P1|Overall Study|Protocol Deviation|1
983794|NCT00532493|3234513|P2|Overall Study|Adverse Event|5
983795|NCT00532493|3234514|P1|Overall Study|Adverse Event|6
983796|NCT00532493|3234513|P2|Overall Study|Physician Decision|6
983797|NCT00532493|3234514|P1|Overall Study|Physician Decision|1
983798|NCT00532493|3234513|P2|Overall Study|Withdrawal by Subject|9
983799|NCT00532493|3234514|P1|Overall Study|Withdrawal by Subject|7
983800|NCT00532493|3234513|P2|Overall Study|Lost to Follow-up|7
983801|NCT00532493|3234514|P1|Overall Study|Lost to Follow-up|10
983802|NCT00532493|3234513|P2|Overall Study|Death|1
983803|NCT00532493|3234514|P1|Overall Study|Death|1
983804|NCT00532441|3234548|P2|Overall Study|Death|0
983805|NCT00532441|3234549|P1|Overall Study|Death|1
983806|NCT00532298|3234564|P6|Overall Study|Lost to Follow-up|1
983807|NCT00532298|3234565|P5|Overall Study|Lost to Follow-up|0
983808|NCT00532298|3234566|P4|Overall Study|Lost to Follow-up|0
983809|NCT00532298|3234567|P3|Overall Study|Lost to Follow-up|1
983810|NCT00532298|3234568|P2|Overall Study|Lost to Follow-up|1
983811|NCT00532298|3234569|P1|Overall Study|Lost to Follow-up|1
983812|NCT00532298|3234564|P6|Overall Study|Adverse Event|1
983813|NCT00532298|3234565|P5|Overall Study|Adverse Event|1
983814|NCT00532298|3234566|P4|Overall Study|Adverse Event|0
983815|NCT00532298|3234567|P3|Overall Study|Adverse Event|0
983816|NCT00532298|3234568|P2|Overall Study|Adverse Event|0
983817|NCT00532298|3234569|P1|Overall Study|Adverse Event|1
983818|NCT00532259|3234649|P1|Overall Study|Protocol Violation|1
983819|NCT00532259|3234649|P1|Overall Study|Physician Decision|3
983820|NCT00532259|3234649|P1|Overall Study|Lost to Follow-up|3
983821|NCT00532259|3234649|P1|Overall Study|Lack of Efficacy|21
983822|NCT00532259|3234649|P1|Overall Study|Death|1
983823|NCT00532259|3234649|P1|Overall Study|Adverse Event|1
983824|NCT00532259|3234649|P1|Overall Study|Withdrawal by Subject|2
983825|NCT00532155|3234656|P2|Overall Study|Did not receive study medication|6
983826|NCT00532155|3234657|P1|Overall Study|Did not receive study medication|2
983827|NCT00532155|3234656|P2|Overall Study|Study termination stop further treatment|0
983828|NCT00532155|3234657|P1|Overall Study|Study termination stop further treatment|4
983829|NCT00532155|3234656|P2|Overall Study|Study terminated by sponsor|0
983830|NCT00532155|3234657|P1|Overall Study|Study terminated by sponsor|1
983831|NCT00532155|3234656|P2|Overall Study|Study stopped|0
983832|NCT00532155|3234657|P1|Overall Study|Study stopped|1
983833|NCT00532155|3234656|P2|Overall Study|Had brain metastasis, was mis-randomized|0
983834|NCT00532155|3234657|P1|Overall Study|Had brain metastasis, was mis-randomized|1
983835|NCT00532155|3234656|P2|Overall Study|Progressive disease (by incorrect scan)|1
983836|NCT00532155|3234657|P1|Overall Study|Progressive disease (by incorrect scan)|0
983837|NCT00532155|3234656|P2|Overall Study|Promotor ended study|0
983838|NCT00532155|3234657|P1|Overall Study|Promotor ended study|1
983839|NCT00532155|3234656|P2|Overall Study|Occurence of a secondary cancer|1
983840|NCT00532155|3234657|P1|Overall Study|Occurence of a secondary cancer|0
983841|NCT00532155|3234656|P2|Overall Study|Occurence of a second cancer|1
983842|NCT00532155|3234657|P1|Overall Study|Occurence of a second cancer|0
983843|NCT00532155|3234656|P2|Overall Study|Pre-existing brain metastasis (by MRI)|0
983844|NCT00532155|3234657|P1|Overall Study|Pre-existing brain metastasis (by MRI)|1
983845|NCT00532155|3234656|P2|Overall Study|Moved|0
983846|NCT00532155|3234657|P1|Overall Study|Moved|1
983847|NCT00532155|3234656|P2|Overall Study|Consent withdrawn|7
983848|NCT00532155|3234657|P1|Overall Study|Consent withdrawn|5
983849|NCT00532155|3234656|P2|Overall Study|Withdrawal by Subject|44
983850|NCT00532155|3234657|P1|Overall Study|Withdrawal by Subject|23
983851|NCT00532155|3234656|P2|Overall Study|Physician Decision|15
983852|NCT00532155|3234657|P1|Overall Study|Physician Decision|16
983853|NCT00532155|3234656|P2|Overall Study|Lost to Follow-up|0
983854|NCT00532155|3234657|P1|Overall Study|Lost to Follow-up|2
983855|NCT00532155|3234656|P2|Overall Study|Protocol Violation|3
983856|NCT00532155|3234657|P1|Overall Study|Protocol Violation|1
983857|NCT00532155|3234656|P2|Overall Study|Lack of Efficacy|255
983858|NCT00532155|3234657|P1|Overall Study|Lack of Efficacy|332
983859|NCT00532155|3234656|P2|Overall Study|Adverse Event|123
983860|NCT00532155|3234657|P1|Overall Study|Adverse Event|66
983861|NCT00532129|3234671|P1|Follow-up Period|Other|6
983862|NCT00532129|3234671|P1|Follow-up Period|Lost to Follow-up|1
983863|NCT00532129|3234671|P1|Follow-up Period|Disease progression|57
983864|NCT00532129|3234671|P1|Follow-up Period|Adverse event/Serious adverse event|1
983865|NCT00532129|3234671|P1|Treatment Period|Other|5
983866|NCT00532129|3234671|P1|Treatment Period|Protocol Violation|1
983867|NCT00532129|3234671|P1|Treatment Period|Disease progression|3
983868|NCT00532129|3234671|P1|Treatment Period|Physician Decision|15
983869|NCT00532129|3234671|P1|Treatment Period|Adverse event/Serious adverse event|25
983870|NCT00531960|3234691|P2|Overall Study|Not Specified|10
983871|NCT00531960|3234692|P1|Overall Study|Not Specified|4
983872|NCT00531960|3234691|P2|Overall Study|Refused Treatment|6
983873|NCT00531960|3234692|P1|Overall Study|Refused Treatment|5
983874|NCT00531960|3234691|P2|Overall Study|Violation of Selection Criteria|0
983875|NCT00531960|3234692|P1|Overall Study|Violation of Selection Criteria|2
983876|NCT00531960|3234691|P2|Overall Study|Lack of Efficacy|41
983877|NCT00531960|3234692|P1|Overall Study|Lack of Efficacy|42
983878|NCT00531960|3234691|P2|Overall Study|Death|2
983879|NCT00531960|3234692|P1|Overall Study|Death|3
983880|NCT00531960|3234691|P2|Overall Study|Adverse Event|4
983881|NCT00531960|3234692|P1|Overall Study|Adverse Event|5
983882|NCT00531947|3234710|P2|Overall Study|Other (e.g., Lack of Efficacy)|5
983883|NCT00531947|3234711|P1|Overall Study|Other (e.g., Lack of Efficacy)|5
983884|NCT00531947|3234710|P2|Overall Study|Non-Compliance|7
983885|NCT00531947|3234711|P1|Overall Study|Non-Compliance|4
983886|NCT00531947|3234710|P2|Overall Study|Protocol Violation|1
983887|NCT00531947|3234711|P1|Overall Study|Protocol Violation|2
983888|NCT00531947|3234710|P2|Overall Study|Withdrawal by Subject|19
983889|NCT00531947|3234711|P1|Overall Study|Withdrawal by Subject|14
983890|NCT00531947|3234710|P2|Overall Study|Lost to Follow-up|9
983891|NCT00531947|3234711|P1|Overall Study|Lost to Follow-up|12
983892|NCT00531947|3234710|P2|Overall Study|Adverse Event|10
983893|NCT00531947|3234711|P1|Overall Study|Adverse Event|5
983894|NCT00531934|3234755|P2|Overall Study|Not specified|2
983895|NCT00531934|3234756|P1|Overall Study|Not specified|2
983896|NCT00531934|3234755|P2|Overall Study|Withdrawal by Subject|1
983897|NCT00531934|3234756|P1|Overall Study|Withdrawal by Subject|1
983898|NCT00531934|3234755|P2|Overall Study|Death|10
983899|NCT00531934|3234756|P1|Overall Study|Death|7
983900|NCT00531934|3234755|P2|Overall Study|Progression|42
983901|NCT00531934|3234756|P1|Overall Study|Progression|52
983902|NCT00531934|3234755|P2|Overall Study|Adverse Event|8
983903|NCT00531934|3234756|P1|Overall Study|Adverse Event|4
983904|NCT00531752|3234884|P4|Second Double-blind Intervention Period|Lost to Follow-up|1
983905|NCT00531752|3234885|P3|Second Double-blind Intervention Period|Lost to Follow-up|0
983906|NCT00531752|3234886|P2|Second Double-blind Intervention Period|Lost to Follow-up|0
983907|NCT00531752|3234887|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
983908|NCT00531752|3234884|P4|Second Double-blind Intervention Period|Withdrawal by Subject|1
983909|NCT00531752|3234885|P3|Second Double-blind Intervention Period|Withdrawal by Subject|0
983910|NCT00531752|3234886|P2|Second Double-blind Intervention Period|Withdrawal by Subject|0
983911|NCT00531752|3234887|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
983912|NCT00531752|3234884|P4|Second Double-blind Intervention Period|Other|0
983913|NCT00531752|3234885|P3|Second Double-blind Intervention Period|Other|0
983914|NCT00531752|3234886|P2|Second Double-blind Intervention Period|Other|1
983915|NCT00531752|3234887|P1|Second Double-blind Intervention Period|Other|1
983916|NCT00531752|3234884|P4|Second Double-blind Intervention Period|Adverse Event|0
983917|NCT00531752|3234885|P3|Second Double-blind Intervention Period|Adverse Event|0
983918|NCT00531752|3234886|P2|Second Double-blind Intervention Period|Adverse Event|1
983919|NCT00531752|3234887|P1|Second Double-blind Intervention Period|Adverse Event|1
983920|NCT00531752|3234884|P4|First Double-blind Intervention Period|Randomized but not treated|0
983921|NCT00531752|3234885|P3|First Double-blind Intervention Period|Randomized but not treated|0
983922|NCT00531752|3234886|P2|First Double-blind Intervention Period|Randomized but not treated|0
983923|NCT00531752|3234887|P1|First Double-blind Intervention Period|Randomized but not treated|1
983924|NCT00531752|3234884|P4|First Double-blind Intervention Period|Lost to Follow-up|1
983925|NCT00531752|3234885|P3|First Double-blind Intervention Period|Lost to Follow-up|1
983926|NCT00531752|3234886|P2|First Double-blind Intervention Period|Lost to Follow-up|0
983927|NCT00531752|3234887|P1|First Double-blind Intervention Period|Lost to Follow-up|0
983928|NCT00531752|3234884|P4|First Double-blind Intervention Period|Withdrawal by Subject|1
983929|NCT00531752|3234885|P3|First Double-blind Intervention Period|Withdrawal by Subject|1
983930|NCT00531752|3234886|P2|First Double-blind Intervention Period|Withdrawal by Subject|0
983931|NCT00531752|3234887|P1|First Double-blind Intervention Period|Withdrawal by Subject|2
983932|NCT00531752|3234884|P4|First Double-blind Intervention Period|Other|0
983933|NCT00531752|3234885|P3|First Double-blind Intervention Period|Other|4
983934|NCT00531752|3234886|P2|First Double-blind Intervention Period|Other|4
983935|NCT00531752|3234887|P1|First Double-blind Intervention Period|Other|1
983936|NCT00531752|3234884|P4|First Double-blind Intervention Period|Adverse Event|1
983937|NCT00531752|3234885|P3|First Double-blind Intervention Period|Adverse Event|1
983938|NCT00531752|3234886|P2|First Double-blind Intervention Period|Adverse Event|0
983939|NCT00531752|3234887|P1|First Double-blind Intervention Period|Adverse Event|2
983940|NCT00531479|3234998|P2|Overall Study|Did not receive treatment|3
983941|NCT00531479|3234999|P1|Overall Study|Did not receive treatment|2
983942|NCT00531479|3234998|P2|Overall Study|Withdrawal by Subject|6
983943|NCT00531479|3234999|P1|Overall Study|Withdrawal by Subject|6
983944|NCT00531479|3234998|P2|Overall Study|Other|1
983945|NCT00531479|3234999|P1|Overall Study|Other|0
983946|NCT00531479|3234998|P2|Overall Study|Lost to Follow-up|2
983947|NCT00531479|3234999|P1|Overall Study|Lost to Follow-up|0
983948|NCT00531479|3234998|P2|Overall Study|Death|71
983949|NCT00531479|3234999|P1|Overall Study|Death|68
983950|NCT00531427|3235030|P2|Overall Study|Administrative|9
983951|NCT00531427|3235031|P1|Overall Study|Administrative|4
983952|NCT00531427|3235030|P2|Overall Study|Lack of Efficacy|39
983953|NCT00531427|3235031|P1|Overall Study|Lack of Efficacy|14
983954|NCT00531427|3235030|P2|Overall Study|Lost to Follow-up|3
983955|NCT00531427|3235031|P1|Overall Study|Lost to Follow-up|4
983956|NCT00531427|3235030|P2|Overall Study|Adverse Event|30
983957|NCT00531427|3235031|P1|Overall Study|Adverse Event|44
983958|NCT00531427|3235030|P2|Overall Study|Withdrawal by Subject|13
983959|NCT00531427|3235031|P1|Overall Study|Withdrawal by Subject|7
983960|NCT00531284|3235059|P17|Overall Study|Other|0
983961|NCT00531284|3235060|P16|Overall Study|Other|0
983962|NCT00531284|3235061|P15|Overall Study|Other|1
983963|NCT00531284|3235062|P14|Overall Study|Other|0
983964|NCT00531284|3235063|P13|Overall Study|Other|0
983965|NCT00531284|3235064|P12|Overall Study|Other|2
983966|NCT00531284|3235065|P11|Overall Study|Other|0
983967|NCT00531284|3235066|P10|Overall Study|Other|1
983968|NCT00531284|3235067|P9|Overall Study|Other|2
983969|NCT00531284|3235068|P8|Overall Study|Other|0
983970|NCT00531284|3235069|P7|Overall Study|Other|0
983971|NCT00531284|3235070|P6|Overall Study|Other|1
983972|NCT00531284|3235071|P5|Overall Study|Other|2
983973|NCT00531284|3235072|P4|Overall Study|Other|10
983974|NCT00531284|3235073|P3|Overall Study|Other|0
983975|NCT00531284|3235074|P2|Overall Study|Other|0
983976|NCT00531284|3235075|P1|Overall Study|Other|1
983977|NCT00531284|3235059|P17|Overall Study|Withdrawal by Subject|1
983978|NCT00531284|3235060|P16|Overall Study|Withdrawal by Subject|1
983979|NCT00531284|3235061|P15|Overall Study|Withdrawal by Subject|0
983980|NCT00531284|3235062|P14|Overall Study|Withdrawal by Subject|1
983981|NCT00531284|3235063|P13|Overall Study|Withdrawal by Subject|0
983982|NCT00531284|3235064|P12|Overall Study|Withdrawal by Subject|3
983983|NCT00531284|3235065|P11|Overall Study|Withdrawal by Subject|0
983984|NCT00531284|3235066|P10|Overall Study|Withdrawal by Subject|0
983985|NCT00531284|3235067|P9|Overall Study|Withdrawal by Subject|0
983986|NCT00531284|3235068|P8|Overall Study|Withdrawal by Subject|0
983987|NCT00531284|3235069|P7|Overall Study|Withdrawal by Subject|0
983988|NCT00531284|3235070|P6|Overall Study|Withdrawal by Subject|0
983989|NCT00531284|3235071|P5|Overall Study|Withdrawal by Subject|0
983990|NCT00531284|3235072|P4|Overall Study|Withdrawal by Subject|4
983991|NCT00531284|3235073|P3|Overall Study|Withdrawal by Subject|0
983992|NCT00531284|3235074|P2|Overall Study|Withdrawal by Subject|0
983993|NCT00531284|3235075|P1|Overall Study|Withdrawal by Subject|1
983994|NCT00531284|3235059|P17|Overall Study|Adverse Event|2
983995|NCT00531284|3235060|P16|Overall Study|Adverse Event|0
983996|NCT00531284|3235061|P15|Overall Study|Adverse Event|1
983997|NCT00531284|3235062|P14|Overall Study|Adverse Event|1
983998|NCT00531284|3235063|P13|Overall Study|Adverse Event|0
983999|NCT00531284|3235064|P12|Overall Study|Adverse Event|5
984000|NCT00531284|3235065|P11|Overall Study|Adverse Event|0
984001|NCT00531284|3235066|P10|Overall Study|Adverse Event|0
984002|NCT00531284|3235067|P9|Overall Study|Adverse Event|3
984003|NCT00531284|3235068|P8|Overall Study|Adverse Event|2
984004|NCT00531284|3235069|P7|Overall Study|Adverse Event|3
984005|NCT00531284|3235070|P6|Overall Study|Adverse Event|2
984006|NCT00531284|3235071|P5|Overall Study|Adverse Event|0
984007|NCT00531284|3235072|P4|Overall Study|Adverse Event|7
984008|NCT00531284|3235073|P3|Overall Study|Adverse Event|1
984009|NCT00531284|3235074|P2|Overall Study|Adverse Event|1
984010|NCT00531284|3235075|P1|Overall Study|Adverse Event|0
984011|NCT00531284|3235059|P17|Overall Study|Progressive Disease|5
984012|NCT00531284|3235060|P16|Overall Study|Progressive Disease|11
984013|NCT00531284|3235061|P15|Overall Study|Progressive Disease|2
984014|NCT00531284|3235062|P14|Overall Study|Progressive Disease|1
984015|NCT00531284|3235063|P13|Overall Study|Progressive Disease|2
984016|NCT00531284|3235064|P12|Overall Study|Progressive Disease|14
984017|NCT00531284|3235065|P11|Overall Study|Progressive Disease|3
984018|NCT00531284|3235066|P10|Overall Study|Progressive Disease|3
984019|NCT00531284|3235067|P9|Overall Study|Progressive Disease|6
984020|NCT00531284|3235068|P8|Overall Study|Progressive Disease|8
984021|NCT00531284|3235069|P7|Overall Study|Progressive Disease|3
984022|NCT00531284|3235070|P6|Overall Study|Progressive Disease|4
984023|NCT00531284|3235071|P5|Overall Study|Progressive Disease|4
984024|NCT00531284|3235072|P4|Overall Study|Progressive Disease|42
984025|NCT00531284|3235073|P3|Overall Study|Progressive Disease|5
984026|NCT00531284|3235074|P2|Overall Study|Progressive Disease|3
984027|NCT00531284|3235075|P1|Overall Study|Progressive Disease|1
984028|NCT00531206|3235225|P1|Overall Study|including non-related adverse events|8
984029|NCT00531206|3235225|P1|Overall Study|Lost to Follow-up|5
984030|NCT00531206|3235225|P1|Overall Study|Lack of Efficacy|2
984031|NCT00531206|3235225|P1|Overall Study|Adverse Event related|5
984032|NCT00531050|3235255|P6|Part 2: Period 3|Abnormal test procedure|1
984033|NCT00531050|3235256|P5|Part 2: Period 3|Abnormal test procedure|0
984034|NCT00531050|3235257|P4|Part 2: Period 3|Abnormal test procedure|0
984035|NCT00531050|3235258|P3|Part 2: Period 3|Abnormal test procedure|0
984036|NCT00531050|3235259|P2|Part 2: Period 3|Abnormal test procedure|0
984037|NCT00531050|3235260|P1|Part 2: Period 3|Abnormal test procedure|1
984038|NCT00531050|3235255|P6|Part 2: Period 1|Adverse Event|1
984039|NCT00531050|3235256|P5|Part 2: Period 1|Adverse Event|0
984040|NCT00531050|3235257|P4|Part 2: Period 1|Adverse Event|0
984041|NCT00531050|3235258|P3|Part 2: Period 1|Adverse Event|0
984042|NCT00531050|3235259|P2|Part 2: Period 1|Adverse Event|0
984043|NCT00531050|3235260|P1|Part 2: Period 1|Adverse Event|0
984044|NCT00531050|3235255|P6|Part 1: Period 3|Adverse Event|0
984045|NCT00531050|3235256|P5|Part 1: Period 3|Adverse Event|0
984046|NCT00531050|3235257|P4|Part 1: Period 3|Adverse Event|0
984047|NCT00531050|3235258|P3|Part 1: Period 3|Adverse Event|0
984048|NCT00531050|3235259|P2|Part 1: Period 3|Adverse Event|0
984049|NCT00531050|3235260|P1|Part 1: Period 3|Adverse Event|1
984050|NCT00531050|3235255|P6|Part 1: Period 1|Protocol Deviation|0
984051|NCT00531050|3235256|P5|Part 1: Period 1|Protocol Deviation|0
984052|NCT00531050|3235257|P4|Part 1: Period 1|Protocol Deviation|1
984053|NCT00531050|3235258|P3|Part 1: Period 1|Protocol Deviation|0
984054|NCT00531050|3235259|P2|Part 1: Period 1|Protocol Deviation|0
984055|NCT00531050|3235260|P1|Part 1: Period 1|Protocol Deviation|0
984056|NCT00531050|3235255|P6|Part 1: Period 1|Adverse Event|0
984057|NCT00531050|3235256|P5|Part 1: Period 1|Adverse Event|0
984058|NCT00531050|3235257|P4|Part 1: Period 1|Adverse Event|0
984059|NCT00531050|3235258|P3|Part 1: Period 1|Adverse Event|0
984060|NCT00531050|3235259|P2|Part 1: Period 1|Adverse Event|1
984061|NCT00531050|3235260|P1|Part 1: Period 1|Adverse Event|0
984062|NCT00531011|3235289|P2|Overall Study|Physician Decision|3
984063|NCT00531011|3235290|P1|Overall Study|Physician Decision|0
984064|NCT00531011|3235289|P2|Overall Study|Lost to Follow-up|0
984065|NCT00531011|3235290|P1|Overall Study|Lost to Follow-up|1
984066|NCT00531011|3235289|P2|Overall Study|Death|0
984067|NCT00531011|3235290|P1|Overall Study|Death|1
984068|NCT00531011|3235289|P2|Overall Study|Withdrawal by Subject|4
984069|NCT00531011|3235290|P1|Overall Study|Withdrawal by Subject|2
984070|NCT00530946|3235336|P4|Overall Study|Noncompliance|0
984071|NCT00530946|3235337|P3|Overall Study|Noncompliance|0
984072|NCT00530946|3235338|P2|Overall Study|Noncompliance|0
984073|NCT00530946|3235339|P1|Overall Study|Noncompliance|1
984074|NCT00530946|3235336|P4|Overall Study|Protocol Violation|1
984075|NCT00530946|3235337|P3|Overall Study|Protocol Violation|0
984076|NCT00530946|3235338|P2|Overall Study|Protocol Violation|0
984077|NCT00530946|3235339|P1|Overall Study|Protocol Violation|0
984078|NCT00530946|3235336|P4|Overall Study|Adverse Event|1
984079|NCT00530946|3235337|P3|Overall Study|Adverse Event|1
984080|NCT00530946|3235338|P2|Overall Study|Adverse Event|2
984081|NCT00530946|3235339|P1|Overall Study|Adverse Event|1
984082|NCT00530920|3235392|P3|Overall Study|Withdrawal by Subject|1
984083|NCT00530920|3235393|P2|Overall Study|Withdrawal by Subject|0
984084|NCT00530920|3235394|P1|Overall Study|Withdrawal by Subject|0
984085|NCT00530920|3235392|P3|Overall Study|Adverse Event|3
984086|NCT00530920|3235393|P2|Overall Study|Adverse Event|0
984087|NCT00530920|3235394|P1|Overall Study|Adverse Event|0
984088|NCT00530920|3235392|P3|Overall Study|Randomized but not treated|0
984089|NCT00530920|3235393|P2|Overall Study|Randomized but not treated|2
984090|NCT00530920|3235394|P1|Overall Study|Randomized but not treated|0
984091|NCT00530894|3235454|P4|Overall Study|Alive and censored prior to 1 year|0
984092|NCT00530894|3235455|P3|Overall Study|Alive and censored prior to 1 year|0
984093|NCT00530894|3235456|P2|Overall Study|Alive and censored prior to 1 year|0
984094|NCT00530894|3235457|P1|Overall Study|Alive and censored prior to 1 year|2
984095|NCT00530894|3235454|P4|Overall Study|Withdrawal by Subject|5
984096|NCT00530894|3235455|P3|Overall Study|Withdrawal by Subject|0
984097|NCT00530894|3235456|P2|Overall Study|Withdrawal by Subject|23
984098|NCT00530894|3235457|P1|Overall Study|Withdrawal by Subject|1
984099|NCT00530894|3235454|P4|Overall Study|Lost to Follow-up|0
984100|NCT00530894|3235455|P3|Overall Study|Lost to Follow-up|0
984101|NCT00530894|3235456|P2|Overall Study|Lost to Follow-up|3
984102|NCT00530894|3235457|P1|Overall Study|Lost to Follow-up|1
984103|NCT00530894|3235454|P4|Overall Study|Death|89
984104|NCT00530894|3235455|P3|Overall Study|Death|55
984105|NCT00530894|3235456|P2|Overall Study|Death|89
984106|NCT00530894|3235457|P1|Overall Study|Death|84
984107|NCT00530855|3235485|P1|Overall Study|Other reason for premature termination|17
984108|NCT00530855|3235485|P1|Overall Study|Lost to Follow-up|9
984109|NCT00530855|3235485|P1|Overall Study|Unsatisfactory compliance of subject|11
984110|NCT00530855|3235485|P1|Overall Study|Protocol Violation|3
984111|NCT00530855|3235485|P1|Overall Study|Non Fatal Non Serious AE|12
984112|NCT00530855|3235485|P1|Overall Study|Non Fatal Serious AE|7
984113|NCT00530855|3235485|P1|Overall Study|Fatal Serious AE|3
984114|NCT00530855|3235485|P1|Overall Study|Withdrawal by Subject|30
984115|NCT00530855|3235485|P1|Overall Study|Lack of Efficacy|20
984116|NCT00530842|3235494|P2|Period 2|Individual different reasons|0
984117|NCT00530842|3235495|P1|Period 2|Individual different reasons|2
984118|NCT00530842|3235494|P2|Period 2|Withdrawal by Subject|2
984119|NCT00530842|3235495|P1|Period 2|Withdrawal by Subject|1
984120|NCT00530842|3235494|P2|Period 2|Protocol Violation|0
984121|NCT00530842|3235495|P1|Period 2|Protocol Violation|1
984122|NCT00530842|3235494|P2|Period 2|Lost to Follow-up|4
984123|NCT00530842|3235495|P1|Period 2|Lost to Follow-up|0
984124|NCT00530842|3235494|P2|Period 2|Lack of Efficacy|0
984125|NCT00530842|3235495|P1|Period 2|Lack of Efficacy|1
984126|NCT00530842|3235494|P2|Period 2|Adverse Event|3
984127|NCT00530842|3235495|P1|Period 2|Adverse Event|3
984128|NCT00530842|3235494|P2|Period 1|Individual different reasons|3
984129|NCT00530842|3235495|P1|Period 1|Individual different reasons|2
984130|NCT00530842|3235494|P2|Period 1|Withdrawal by Subject|3
984131|NCT00530842|3235495|P1|Period 1|Withdrawal by Subject|2
984132|NCT00530842|3235494|P2|Period 1|Protocol Violation|1
984133|NCT00530842|3235495|P1|Period 1|Protocol Violation|2
984134|NCT00530842|3235494|P2|Period 1|Lack of Efficacy|1
984135|NCT00530842|3235495|P1|Period 1|Lack of Efficacy|1
984136|NCT00530842|3235494|P2|Period 1|Adverse Event|3
984137|NCT00530842|3235495|P1|Period 1|Adverse Event|7
984138|NCT00530842|3235494|P2|Overall Study|Individual different reasons|3
984139|NCT00530842|3235495|P1|Overall Study|Individual different reasons|4
984140|NCT00530842|3235494|P2|Overall Study|Withdrawal by Subject|5
984141|NCT00530842|3235495|P1|Overall Study|Withdrawal by Subject|4
984142|NCT00530842|3235494|P2|Overall Study|Protocol Violation|2
984143|NCT00530842|3235495|P1|Overall Study|Protocol Violation|3
984144|NCT00530842|3235494|P2|Overall Study|Lost to Follow-up|4
984145|NCT00530842|3235495|P1|Overall Study|Lost to Follow-up|0
984146|NCT00530842|3235494|P2|Overall Study|Lack of Efficacy|1
984147|NCT00530842|3235495|P1|Overall Study|Lack of Efficacy|2
984148|NCT00530842|3235494|P2|Overall Study|Adverse Event|6
984149|NCT00530842|3235495|P1|Overall Study|Adverse Event|10
984150|NCT00530816|3235622|P3|Overall Study|Withdrawal by Subject|6
984151|NCT00530816|3235623|P2|Overall Study|Withdrawal by Subject|2
984152|NCT00530816|3235624|P1|Overall Study|Withdrawal by Subject|1
984153|NCT00530816|3235622|P3|Overall Study|Other|4
984154|NCT00530816|3235623|P2|Overall Study|Other|3
984155|NCT00530816|3235624|P1|Overall Study|Other|3
984156|NCT00530816|3235622|P3|Overall Study|Adverse Event|7
984157|NCT00530816|3235623|P2|Overall Study|Adverse Event|13
984158|NCT00530816|3235624|P1|Overall Study|Adverse Event|6
984159|NCT00530816|3235622|P3|Overall Study|Progressive Disease|24
984160|NCT00530816|3235623|P2|Overall Study|Progressive Disease|24
984161|NCT00530816|3235624|P1|Overall Study|Progressive Disease|16
984162|NCT00530790|3235667|P1|Overall Study|Physician Decision|1
984163|NCT00530790|3235667|P1|Overall Study|Withdrawal by Subject|2
984164|NCT00530790|3235667|P1|Overall Study|Adverse Event|2
984165|NCT00530777|3235689|P2|Overall Study|Unable to adhere to visit schedule|1
984166|NCT00530777|3235690|P1|Overall Study|Unable to adhere to visit schedule|5
984167|NCT00530777|3235689|P2|Overall Study|Withdrawal by Subject|1
984168|NCT00530777|3235690|P1|Overall Study|Withdrawal by Subject|0
984169|NCT00530777|3235689|P2|Overall Study|Physician Decision|0
984170|NCT00530777|3235690|P1|Overall Study|Physician Decision|1
984171|NCT00530777|3235689|P2|Overall Study|Death|2
984172|NCT00530777|3235690|P1|Overall Study|Death|1
984173|NCT00530777|3235689|P2|Overall Study|Lost to Follow-up|1
984174|NCT00530777|3235690|P1|Overall Study|Lost to Follow-up|0
984175|NCT00530712|3235747|P1|12 Month Follow-up Visit|Death|9
984176|NCT00530712|3235747|P1|12 Month Follow-up Visit|Lost to Follow-up|7
984177|NCT00530712|3235747|P1|12 Month Follow-up Visit|Missed Visit|3
984178|NCT00530712|3235747|P1|12 Month Follow-up Visit|Withdrawal by Subject|5
984179|NCT00530712|3235747|P1|6 Month Follow-up Visit|Death|2
984180|NCT00530712|3235747|P1|6 Month Follow-up Visit|Lost to Follow-up|3
984181|NCT00530712|3235747|P1|6 Month Follow-up Visit|Missed Visit|3
984182|NCT00530712|3235747|P1|6 Month Follow-up Visit|Withdrawal by Subject|4
984183|NCT00530712|3235747|P1|30 Day Follow-up Visit|Missed Visit|5
984184|NCT00530712|3235747|P1|30 Day Follow-up Visit|Withdrawal by Subject|2
984185|NCT00530504|3235766|P1|Overall Study|Exited study due to other reasons|33
984186|NCT00530504|3235766|P1|Overall Study|Withdrawal by Subject|39
984187|NCT00530504|3235766|P1|Overall Study|Lost to Follow-up|26
984188|NCT00530504|3235766|P1|Overall Study|Death|54
984189|NCT00530439|3235772|P2|Overall Study|Severe malformation/abortion|3
984190|NCT00530439|3235773|P1|Overall Study|Severe malformation/abortion|0
984191|NCT00530439|3235772|P2|Overall Study|Twin pregnancy|2
984192|NCT00530439|3235773|P1|Overall Study|Twin pregnancy|0
984193|NCT00530439|3235772|P2|Overall Study|Misclassification|0
984194|NCT00530439|3235773|P1|Overall Study|Misclassification|2
984195|NCT00530439|3235772|P2|Overall Study|Missed abortion|4
984196|NCT00530439|3235773|P1|Overall Study|Missed abortion|1
984197|NCT00530439|3235772|P2|Overall Study|Withdraw|14
984198|NCT00530439|3235773|P1|Overall Study|Withdraw|18
984199|NCT00530439|3235772|P2|Overall Study|GDM|3
984200|NCT00530439|3235773|P1|Overall Study|GDM|9
984201|NCT00530348|3235781|P2|Overall Study|Noncompliance with inclusion criterion 3|1
984202|NCT00530348|3235782|P1|Overall Study|Noncompliance with inclusion criterion 3|0
984203|NCT00530348|3235781|P2|Overall Study|Randomised in error|0
984204|NCT00530348|3235782|P1|Overall Study|Randomised in error|1
984205|NCT00530348|3235781|P2|Overall Study|Withdrawal by Subject|12
984206|NCT00530348|3235782|P1|Overall Study|Withdrawal by Subject|12
984207|NCT00530348|3235781|P2|Overall Study|Pregnancy|0
984208|NCT00530348|3235782|P1|Overall Study|Pregnancy|1
984209|NCT00530348|3235781|P2|Overall Study|Physician Decision|2
984210|NCT00530348|3235782|P1|Overall Study|Physician Decision|1
984211|NCT00530348|3235781|P2|Overall Study|Lost to Follow-up|2
984212|NCT00530348|3235782|P1|Overall Study|Lost to Follow-up|0
984213|NCT00530348|3235781|P2|Overall Study|Lack of Efficacy|0
984214|NCT00530348|3235782|P1|Overall Study|Lack of Efficacy|2
984215|NCT00530348|3235781|P2|Overall Study|Death|1
984216|NCT00530348|3235782|P1|Overall Study|Death|0
984217|NCT00530348|3235781|P2|Overall Study|Adverse Event|1
984218|NCT00530348|3235782|P1|Overall Study|Adverse Event|5
984219|NCT00530335|3235798|P1|Overall Study|Physician Decision|1
984220|NCT00530335|3235798|P1|Overall Study|Withdrawal by Subject|1
984221|NCT00530335|3235798|P1|Overall Study|Protocol Violation|1
984222|NCT00530335|3235798|P1|Overall Study|Adverse Event|3
984223|NCT00530270|3235815|P2|Overall Study|Protocol Violation|0
984224|NCT00530270|3235816|P1|Overall Study|Protocol Violation|1
984225|NCT00530257|3235830|P1|Overall Study|Lost to Follow-up|1
984226|NCT00530218|3235858|P1|Overall Study|Death|12
984227|NCT00530218|3235858|P1|Overall Study|CMV Not Detected|13
984228|NCT00530088|3235865|P1|Overall Study|Other Not Specified|2
984229|NCT00530088|3235865|P1|Overall Study|Physician Decision|4
984230|NCT00530088|3235865|P1|Overall Study|Disease Progression|4
984231|NCT00530075|3235870|P1|Overall Study|Withdrawal by Subject|1
984232|NCT00530075|3235870|P1|Overall Study|Protocol Violation|1
984233|NCT00530075|3235870|P1|Overall Study|Lack of Efficacy|3
984234|NCT00530075|3235870|P1|Overall Study|Death|1
984235|NCT00530075|3235870|P1|Overall Study|Adverse Event|1
984236|NCT00530023|3235883|P2|Overall Study|Withdrawal by Subject|1
984237|NCT00530023|3235884|P1|Overall Study|Withdrawal by Subject|0
984238|NCT00529802|3235898|P1|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2
984239|NCT00529802|3235898|P1|Evaluable for Primary Endpoint|Lost to Follow-up|1
984240|NCT00529802|3235898|P1|Evaluable for Primary Endpoint|Lack of Efficacy|1
984241|NCT00529802|3235898|P1|Evaluable for Primary Endpoint|Death|1
984242|NCT00529802|3235898|P1|Evaluable for Primary Endpoint|Adverse Event|2
984243|NCT00529802|3235898|P1|Evaluable for Primary Endpoint|Worsening performance status|2
984244|NCT00529802|3235898|P1|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3
984245|NCT00529789|3235904|P1|Study Period IV|Lost to Follow-up|3
984246|NCT00529789|3235904|P1|Study Period IV|Lack of Efficacy|1
984247|NCT00529789|3235904|P1|Study Period IV|Adverse Event|1
984248|NCT00529789|3235904|P1|Study Period IV|Parent/Caregiver Decision|1
984249|NCT00529789|3235904|P1|Study Period II/III|Lost to Follow-up|3
984250|NCT00529789|3235904|P1|Study Period II/III|Physician Decision|3
984251|NCT00529789|3235904|P1|Study Period II/III|Protocol Violation|3
984252|NCT00529789|3235904|P1|Study Period II/III|Withdrawal by Subject|1
984253|NCT00529789|3235904|P1|Study Period II/III|Lack of Efficacy|2
984254|NCT00529789|3235904|P1|Study Period II/III|Adverse Event|3
984255|NCT00529789|3235904|P1|Study Period II/III|Parent/Caregiver Decision|9
984256|NCT00529763|3235929|P3|Overall Study|Patient Withdrew Consent|2
984257|NCT00529763|3235930|P2|Overall Study|Patient Withdrew Consent|3
984258|NCT00529763|3235931|P1|Overall Study|Patient Withdrew Consent|2
984259|NCT00529763|3235929|P3|Overall Study|Study Drug Toxicity|1
984260|NCT00529763|3235930|P2|Overall Study|Study Drug Toxicity|6
984261|NCT00529763|3235931|P1|Overall Study|Study Drug Toxicity|1
984262|NCT00529763|3235929|P3|Overall Study|Stem Cell Transplant|0
984263|NCT00529763|3235930|P2|Overall Study|Stem Cell Transplant|3
984264|NCT00529763|3235931|P1|Overall Study|Stem Cell Transplant|0
984265|NCT00529763|3235929|P3|Overall Study|Lost to Follow-up|1
984266|NCT00529763|3235930|P2|Overall Study|Lost to Follow-up|1
984267|NCT00529763|3235931|P1|Overall Study|Lost to Follow-up|0
984268|NCT00529763|3235929|P3|Overall Study|Disease Progression|1
984269|NCT00529763|3235930|P2|Overall Study|Disease Progression|16
984270|NCT00529763|3235931|P1|Overall Study|Disease Progression|6
984271|NCT00529763|3235929|P3|Overall Study|Death|1
984272|NCT00529763|3235930|P2|Overall Study|Death|1
984273|NCT00529763|3235931|P1|Overall Study|Death|0
984274|NCT00529763|3235929|P3|Overall Study|Adverse Event Unrelated to Study Drug|1
984275|NCT00529763|3235930|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
984276|NCT00529763|3235931|P1|Overall Study|Adverse Event Unrelated to Study Drug|1
984277|NCT00529659|3235969|P2|Overall Study|Withdrawal by Subject|6
984278|NCT00529659|3235970|P1|Overall Study|Withdrawal by Subject|1
984279|NCT00529659|3235969|P2|Overall Study|Protocol Violation|6
984280|NCT00529659|3235970|P1|Overall Study|Protocol Violation|2
984281|NCT00529659|3235969|P2|Overall Study|Physician Decision|2
984282|NCT00529659|3235970|P1|Overall Study|Physician Decision|0
984283|NCT00529659|3235969|P2|Overall Study|Lost to Follow-up|2
984284|NCT00529659|3235970|P1|Overall Study|Lost to Follow-up|0
984285|NCT00529659|3235969|P2|Overall Study|Adverse Event|7
984286|NCT00529659|3235970|P1|Overall Study|Adverse Event|8
984287|NCT00529633|3235988|P2|Overall Study|Withdrawal by Subject|1
984288|NCT00529633|3235989|P1|Overall Study|Withdrawal by Subject|1
984289|NCT00529568|3236001|P3|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19
984290|NCT00529568|3236002|P2|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17
984291|NCT00529568|3236003|P1|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0
984292|NCT00529568|3236001|P3|Double-bilnd Antiviral Treatment Phase|Physician Decision|8
984293|NCT00529568|3236002|P2|Double-bilnd Antiviral Treatment Phase|Physician Decision|5
984294|NCT00529568|3236003|P1|Double-bilnd Antiviral Treatment Phase|Physician Decision|0
984295|NCT00529568|3236001|P3|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48
984296|NCT00529568|3236002|P2|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15
984297|NCT00529568|3236003|P1|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0
984298|NCT00529568|3236001|P3|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
984299|NCT00529568|3236002|P2|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1
984300|NCT00529568|3236003|P1|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
984301|NCT00529568|3236001|P3|Double-bilnd Antiviral Treatment Phase|Adverse Event|27
984302|NCT00529568|3236002|P2|Double-bilnd Antiviral Treatment Phase|Adverse Event|10
984303|NCT00529568|3236003|P1|Double-bilnd Antiviral Treatment Phase|Adverse Event|0
984304|NCT00529568|3236001|P3|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
984305|NCT00529568|3236002|P2|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
984306|NCT00529568|3236003|P1|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3
984307|NCT00529568|3236001|P3|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
984308|NCT00529568|3236002|P2|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
984309|NCT00529568|3236003|P1|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13
984310|NCT00529568|3236001|P3|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
984311|NCT00529568|3236002|P2|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
984312|NCT00529568|3236003|P1|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8
984313|NCT00529568|3236001|P3|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
984314|NCT00529568|3236002|P2|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
984315|NCT00529568|3236003|P1|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5
984316|NCT00529568|3236001|P3|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
984317|NCT00529568|3236002|P2|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
984318|NCT00529568|3236003|P1|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12
984319|NCT00529568|3236001|P3|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
984320|NCT00529568|3236002|P2|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
984321|NCT00529568|3236003|P1|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5
984322|NCT00529542|3236066|P2|Overall Study|Lost to Follow-up|1
984323|NCT00529542|3236067|P1|Overall Study|Lost to Follow-up|0
984324|NCT00529542|3236066|P2|Overall Study|Withdrawal by Subject|0
984325|NCT00529542|3236067|P1|Overall Study|Withdrawal by Subject|1
984326|NCT00529529|3236110|P3|Overall Study|Administrative problems|3
984327|NCT00529529|3236111|P2|Overall Study|Administrative problems|0
984328|NCT00529529|3236112|P1|Overall Study|Administrative problems|1
984329|NCT00529529|3236110|P3|Overall Study|Abnormal test procedure result(s)|0
984330|NCT00529529|3236111|P2|Overall Study|Abnormal test procedure result(s)|0
984331|NCT00529529|3236112|P1|Overall Study|Abnormal test procedure result(s)|1
984332|NCT00529529|3236110|P3|Overall Study|Death|0
984333|NCT00529529|3236111|P2|Overall Study|Death|0
984334|NCT00529529|3236112|P1|Overall Study|Death|2
984335|NCT00529529|3236110|P3|Overall Study|Unsatisfactory therapeutic effect|2
984336|NCT00529529|3236111|P2|Overall Study|Unsatisfactory therapeutic effect|2
984337|NCT00529529|3236112|P1|Overall Study|Unsatisfactory therapeutic effect|2
984338|NCT00529529|3236110|P3|Overall Study|Lost to Follow-up|1
984339|NCT00529529|3236111|P2|Overall Study|Lost to Follow-up|3
984340|NCT00529529|3236112|P1|Overall Study|Lost to Follow-up|5
984341|NCT00529529|3236110|P3|Overall Study|Protocol deviation|5
984342|NCT00529529|3236111|P2|Overall Study|Protocol deviation|12
984343|NCT00529529|3236112|P1|Overall Study|Protocol deviation|8
984344|NCT00529529|3236110|P3|Overall Study|Subject withdrew consent|12
984345|NCT00529529|3236111|P2|Overall Study|Subject withdrew consent|9
984346|NCT00529529|3236112|P1|Overall Study|Subject withdrew consent|12
984347|NCT00529529|3236110|P3|Overall Study|Adverse Event|8
984348|NCT00529529|3236111|P2|Overall Study|Adverse Event|17
984349|NCT00529529|3236112|P1|Overall Study|Adverse Event|12
984350|NCT00529516|3236171|P3|Overall Study|Lost to Follow-up|1
984351|NCT00529516|3236172|P2|Overall Study|Lost to Follow-up|0
984352|NCT00529516|3236173|P1|Overall Study|Lost to Follow-up|0
984353|NCT00529516|3236171|P3|Overall Study|Withdrawal by Subject|0
984354|NCT00529516|3236172|P2|Overall Study|Withdrawal by Subject|1
984355|NCT00529516|3236173|P1|Overall Study|Withdrawal by Subject|1
984356|NCT00529516|3236171|P3|Overall Study|Adverse Event|0
984357|NCT00529516|3236172|P2|Overall Study|Adverse Event|1
984358|NCT00529516|3236173|P1|Overall Study|Adverse Event|2
984359|NCT00529451|3236258|P4|Overall Study|Administrative problems|2
984360|NCT00529451|3236259|P3|Overall Study|Administrative problems|0
984361|NCT00529451|3236260|P2|Overall Study|Administrative problems|1
984362|NCT00529451|3236261|P1|Overall Study|Administrative problems|1
984363|NCT00529451|3236258|P4|Overall Study|Protocol deviation|1
984364|NCT00529451|3236259|P3|Overall Study|Protocol deviation|4
984365|NCT00529451|3236260|P2|Overall Study|Protocol deviation|1
984366|NCT00529451|3236261|P1|Overall Study|Protocol deviation|1
984367|NCT00529451|3236258|P4|Overall Study|Lost to Follow-up|4
984368|NCT00529451|3236259|P3|Overall Study|Lost to Follow-up|4
984369|NCT00529451|3236260|P2|Overall Study|Lost to Follow-up|7
984370|NCT00529451|3236261|P1|Overall Study|Lost to Follow-up|4
984371|NCT00529451|3236258|P4|Overall Study|Unsatisfactory therapeutic response|4
984372|NCT00529451|3236259|P3|Overall Study|Unsatisfactory therapeutic response|5
984373|NCT00529451|3236260|P2|Overall Study|Unsatisfactory therapeutic response|2
984374|NCT00529451|3236261|P1|Overall Study|Unsatisfactory therapeutic response|6
984375|NCT00529451|3236258|P4|Overall Study|Adverse Event|8
984376|NCT00529451|3236259|P3|Overall Study|Adverse Event|14
984377|NCT00529451|3236260|P2|Overall Study|Adverse Event|16
984378|NCT00529451|3236261|P1|Overall Study|Adverse Event|9
984379|NCT00529451|3236258|P4|Overall Study|Subject withdrew consent|12
984380|NCT00529451|3236259|P3|Overall Study|Subject withdrew consent|13
984381|NCT00529451|3236260|P2|Overall Study|Subject withdrew consent|21
984382|NCT00529451|3236261|P1|Overall Study|Subject withdrew consent|16
984383|NCT00529399|3236288|P3|Overall Study|Non-compliant|0
984384|NCT00529399|3236289|P2|Overall Study|Non-compliant|1
984385|NCT00529399|3236290|P1|Overall Study|Non-compliant|0
984386|NCT00529399|3236288|P3|Overall Study|Withdrawal by Subject|1
984387|NCT00529399|3236289|P2|Overall Study|Withdrawal by Subject|0
984388|NCT00529399|3236290|P1|Overall Study|Withdrawal by Subject|1
984389|NCT00529399|3236288|P3|Overall Study|Lost to Follow-up|1
984390|NCT00529399|3236289|P2|Overall Study|Lost to Follow-up|0
984391|NCT00529399|3236290|P1|Overall Study|Lost to Follow-up|1
984392|NCT00529308|3236300|P2|Overall Study|Withdrawal by Subject|1
984393|NCT00529308|3236301|P1|Overall Study|Withdrawal by Subject|1
984394|NCT00529243|3236330|P1|Overall Study|Relocated|1
984395|NCT00529243|3236330|P1|Overall Study|Death|1
984396|NCT00529243|3236330|P1|Overall Study|Adverse Event|1
984397|NCT00529217|3236335|P1|Overall Study|Unable to adhere to study schedule|2
984398|NCT00529217|3236335|P1|Overall Study|Lack of Efficacy|2
984399|NCT00529152|3236371|P1|Overall Study|Lost to Follow-up|1
984400|NCT00529152|3236371|P1|Overall Study|Withdrawal by Subject|2
984401|NCT00529152|3236371|P1|Overall Study|Adverse Event|2
984402|NCT00529100|3236395|P2|Overall Study|Participant Ineligibility|1
984403|NCT00529100|3236396|P1|Overall Study|Participant Ineligibility|0
984404|NCT00529100|3236395|P2|Overall Study|Withdrawal by Subject|1
984405|NCT00529100|3236396|P1|Overall Study|Withdrawal by Subject|0
984406|NCT00529100|3236395|P2|Overall Study|Progressive Disease|1
984407|NCT00529100|3236396|P1|Overall Study|Progressive Disease|0
984408|NCT00529100|3236395|P2|Overall Study|Protocol Violation|1
984409|NCT00529100|3236396|P1|Overall Study|Protocol Violation|0
984410|NCT00529100|3236395|P2|Overall Study|Adverse Event|5
984411|NCT00529100|3236396|P1|Overall Study|Adverse Event|0
984412|NCT00529087|3236413|P3|Overall Study|Protocol deviation|2
984413|NCT00529087|3236414|P2|Overall Study|Protocol deviation|1
984414|NCT00529087|3236415|P1|Overall Study|Protocol deviation|1
984415|NCT00529087|3236413|P3|Overall Study|Withdrawal by Subject|3
984416|NCT00529087|3236414|P2|Overall Study|Withdrawal by Subject|3
984417|NCT00529087|3236415|P1|Overall Study|Withdrawal by Subject|3
984418|NCT00529087|3236413|P3|Overall Study|Protocol Violation|6
984419|NCT00529087|3236414|P2|Overall Study|Protocol Violation|7
984420|NCT00529087|3236415|P1|Overall Study|Protocol Violation|8
984421|NCT00529087|3236413|P3|Overall Study|Lost to Follow-up|1
984422|NCT00529087|3236414|P2|Overall Study|Lost to Follow-up|4
984423|NCT00529087|3236415|P1|Overall Study|Lost to Follow-up|6
984424|NCT00529087|3236413|P3|Overall Study|Adverse Event|4
984425|NCT00529087|3236414|P2|Overall Study|Adverse Event|13
984426|NCT00529087|3236415|P1|Overall Study|Adverse Event|10
984427|NCT00529035|3236479|P1|Overall Study|Withdrawal by Subject|1
984428|NCT00528957|3236492|P2|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
984429|NCT00528957|3236493|P1|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
984430|NCT00528957|3236492|P2|Long-Term Extension (Week 336 and On)|Withdrew Consent|1
984431|NCT00528957|3236493|P1|Long-Term Extension (Week 336 and On)|Withdrew Consent|2
984432|NCT00528957|3236492|P2|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5
984433|NCT00528957|3236493|P1|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3
984434|NCT00528957|3236492|P2|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10
984435|NCT00528957|3236493|P1|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4
984436|NCT00528957|3236492|P2|Third Extension (Week 240 to Week 336)|Withdrew Consent|1
984437|NCT00528957|3236493|P1|Third Extension (Week 240 to Week 336)|Withdrew Consent|0
984438|NCT00528957|3236492|P2|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1
984439|NCT00528957|3236493|P1|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0
984440|NCT00528957|3236492|P2|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
984441|NCT00528957|3236493|P1|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
984442|NCT00528957|3236492|P2|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3
984443|NCT00528957|3236493|P1|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0
984444|NCT00528957|3236492|P2|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4
984445|NCT00528957|3236493|P1|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5
984446|NCT00528957|3236492|P2|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0
984447|NCT00528957|3236493|P1|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3
984448|NCT00528957|3236492|P2|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3
984449|NCT00528957|3236493|P1|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4
984450|NCT00528957|3236492|P2|First Extension (Week 48 to Week 144)|Withdrew Consent|1
984451|NCT00528957|3236493|P1|First Extension (Week 48 to Week 144)|Withdrew Consent|0
984452|NCT00528957|3236492|P2|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0
984453|NCT00528957|3236493|P1|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1
984454|NCT00528957|3236492|P2|First Extension (Week 48 to Week 144)|Investigator's Discretion|0
984455|NCT00528957|3236493|P1|First Extension (Week 48 to Week 144)|Investigator's Discretion|2
984456|NCT00528957|3236492|P2|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0
984457|NCT00528957|3236493|P1|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2
984458|NCT00528957|3236492|P2|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1
984459|NCT00528957|3236493|P1|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2
984460|NCT00528931|3236634|P1|Overall Study|Lost to Follow-up|1
984461|NCT00528879|3236646|P4|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0
984462|NCT00528879|3236647|P3|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
984463|NCT00528879|3236648|P2|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
984464|NCT00528879|3236649|P1|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
984465|NCT00528879|3236646|P4|Long-term Period (Weeks 24 to 102)|Pregnancy|0
984466|NCT00528879|3236647|P3|Long-term Period (Weeks 24 to 102)|Pregnancy|0
984467|NCT00528879|3236648|P2|Long-term Period (Weeks 24 to 102)|Pregnancy|0
984468|NCT00528879|3236649|P1|Long-term Period (Weeks 24 to 102)|Pregnancy|1
984469|NCT00528879|3236646|P4|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2
984470|NCT00528879|3236647|P3|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1
984471|NCT00528879|3236648|P2|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5
984472|NCT00528879|3236649|P1|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0
984473|NCT00528879|3236646|P4|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7
984474|NCT00528879|3236647|P3|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3
984475|NCT00528879|3236648|P2|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5
984476|NCT00528879|3236649|P1|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4
984477|NCT00528879|3236646|P4|Long-term Period (Weeks 24 to 102)|Death|0
984478|NCT00528879|3236647|P3|Long-term Period (Weeks 24 to 102)|Death|0
984479|NCT00528879|3236648|P2|Long-term Period (Weeks 24 to 102)|Death|1
984480|NCT00528879|3236649|P1|Long-term Period (Weeks 24 to 102)|Death|0
984481|NCT00528879|3236646|P4|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
984482|NCT00528879|3236647|P3|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8
984483|NCT00528879|3236648|P2|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6
984484|NCT00528879|3236649|P1|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
984485|NCT00528879|3236646|P4|Long-term Period (Weeks 24 to 102)|Adverse Event|2
984486|NCT00528879|3236647|P3|Long-term Period (Weeks 24 to 102)|Adverse Event|3
984487|NCT00528879|3236648|P2|Long-term Period (Weeks 24 to 102)|Adverse Event|4
984488|NCT00528879|3236649|P1|Long-term Period (Weeks 24 to 102)|Adverse Event|5
984489|NCT00528879|3236646|P4|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9
984490|NCT00528879|3236647|P3|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17
984491|NCT00528879|3236648|P2|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16
984492|NCT00528879|3236649|P1|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27
984493|NCT00528879|3236646|P4|Short-term Period (Day 1 to Week 24)|Not specified|1
984494|NCT00528879|3236647|P3|Short-term Period (Day 1 to Week 24)|Not specified|1
984495|NCT00528879|3236648|P2|Short-term Period (Day 1 to Week 24)|Not specified|0
984496|NCT00528879|3236649|P1|Short-term Period (Day 1 to Week 24)|Not specified|0
984497|NCT00528879|3236646|P4|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
984498|NCT00528879|3236647|P3|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0
984499|NCT00528879|3236648|P2|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
984500|NCT00528879|3236649|P1|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
984501|NCT00528879|3236646|P4|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
984502|NCT00528879|3236647|P3|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
984503|NCT00528879|3236648|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3
984504|NCT00528879|3236649|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
984505|NCT00528879|3236646|P4|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
984506|NCT00528879|3236647|P3|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2
984507|NCT00528879|3236648|P2|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
984508|NCT00528879|3236649|P1|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
984509|NCT00528879|3236646|P4|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
984510|NCT00528879|3236647|P3|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
984511|NCT00528879|3236648|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
984512|NCT00528879|3236649|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
984513|NCT00528879|3236646|P4|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3
984514|NCT00528879|3236647|P3|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
984515|NCT00528879|3236648|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
984516|NCT00528879|3236649|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7
984517|NCT00528879|3236646|P4|Short-term Period (Day 1 to Week 24)|Adverse Event|4
984518|NCT00528879|3236647|P3|Short-term Period (Day 1 to Week 24)|Adverse Event|2
984519|NCT00528879|3236648|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|4
984520|NCT00528879|3236649|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|4
984521|NCT00528879|3236646|P4|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
984522|NCT00528879|3236647|P3|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1
984523|NCT00528879|3236648|P2|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
984524|NCT00528879|3236649|P1|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3
984525|NCT00528866|3236715|P1|Overall Study|Protocol Violation|6
984526|NCT00528840|3236727|P1|Overall Study|Not Specified|2
984527|NCT00528840|3236727|P1|Overall Study|Administrative Reasons|1
984528|NCT00528840|3236727|P1|Overall Study|Death|2
984529|NCT00528840|3236727|P1|Overall Study|Withdrawal by Subject|17
984530|NCT00528840|3236727|P1|Overall Study|Adverse Event|1
984531|NCT00528840|3236727|P1|Overall Study|Lost to Follow-up|10
984532|NCT00528801|3236741|P2|Overall Study|Administrative Reasons|1
984533|NCT00528801|3236742|P1|Overall Study|Administrative Reasons|0
984534|NCT00528801|3236741|P2|Overall Study|Lost to Follow-up|4
984535|NCT00528801|3236742|P1|Overall Study|Lost to Follow-up|15
984536|NCT00528801|3236741|P2|Overall Study|Protocol Violation|5
984537|NCT00528801|3236742|P1|Overall Study|Protocol Violation|11
984538|NCT00528801|3236741|P2|Overall Study|Withdrawal by Subject|1
984539|NCT00528801|3236742|P1|Overall Study|Withdrawal by Subject|1
984540|NCT00528775|3236756|P1|Overall Study|Other not specified|1
984541|NCT00528645|3236764|P1|Overall Study|Adverse Event|3
984542|NCT00528606|3236773|P2|Overall Study|Not specified|0
984543|NCT00528606|3236774|P1|Overall Study|Not specified|2
984544|NCT00528606|3236773|P2|Overall Study|Adverse Event|0
984545|NCT00528606|3236774|P1|Overall Study|Adverse Event|3
984546|NCT00528606|3236773|P2|Overall Study|Lost to Follow-up|1
984547|NCT00528606|3236774|P1|Overall Study|Lost to Follow-up|4
984548|NCT00528606|3236773|P2|Overall Study|Withdrew consent|3
984549|NCT00528606|3236774|P1|Overall Study|Withdrew consent|4
984550|NCT00528567|3236807|P2|Overall Study|Administrative/Other|75
984551|NCT00528567|3236808|P1|Overall Study|Administrative/Other|22
984552|NCT00528567|3236807|P2|Overall Study|Other Protocol Violation|21
984553|NCT00528567|3236808|P1|Overall Study|Other Protocol Violation|5
984554|NCT00528567|3236807|P2|Overall Study|Failure to Return|4
984555|NCT00528567|3236808|P1|Overall Study|Failure to Return|1
984556|NCT00528567|3236807|P2|Overall Study|Refused Treatment/Did Not Cooperate|42
984557|NCT00528567|3236808|P1|Overall Study|Refused Treatment/Did Not Cooperate|52
984558|NCT00528567|3236807|P2|Overall Study|Withdrew Consent|55
984559|NCT00528567|3236808|P1|Overall Study|Withdrew Consent|59
984560|NCT00528567|3236807|P2|Overall Study|Violation Criteria at Entry|17
984561|NCT00528567|3236808|P1|Overall Study|Violation Criteria at Entry|3
984562|NCT00528567|3236807|P2|Overall Study|Adverse Event/Intermittent Illness|29
984563|NCT00528567|3236808|P1|Overall Study|Adverse Event/Intermittent Illness|255
984564|NCT00528567|3236807|P2|Overall Study|Breast Cancer Recurrence/2nd Primary|60
984565|NCT00528567|3236808|P1|Overall Study|Breast Cancer Recurrence/2nd Primary|30
984566|NCT00528567|3236807|P2|Overall Study|Death|5
984567|NCT00528567|3236808|P1|Overall Study|Death|4
984568|NCT00528528|3236875|P4|Overall Study|Ongoing participant|0
984569|NCT00528528|3236876|P3|Overall Study|Ongoing participant|1
984570|NCT00528528|3236877|P2|Overall Study|Ongoing participant|0
984571|NCT00528528|3236878|P1|Overall Study|Ongoing participant|0
984572|NCT00528528|3236875|P4|Overall Study|Withdrawal by Subject|1
984573|NCT00528528|3236876|P3|Overall Study|Withdrawal by Subject|1
984574|NCT00528528|3236877|P2|Overall Study|Withdrawal by Subject|2
984575|NCT00528528|3236878|P1|Overall Study|Withdrawal by Subject|3
984576|NCT00528528|3236875|P4|Overall Study|Other|0
984577|NCT00528528|3236876|P3|Overall Study|Other|0
984578|NCT00528528|3236877|P2|Overall Study|Other|1
984579|NCT00528528|3236878|P1|Overall Study|Other|0
984580|NCT00528528|3236875|P4|Overall Study|Ineligible to continue the trial|1
984581|NCT00528528|3236876|P3|Overall Study|Ineligible to continue the trial|0
984582|NCT00528528|3236877|P2|Overall Study|Ineligible to continue the trial|0
984583|NCT00528528|3236878|P1|Overall Study|Ineligible to continue the trial|0
984584|NCT00528528|3236875|P4|Overall Study|Lost to Follow-up|1
984585|NCT00528528|3236876|P3|Overall Study|Lost to Follow-up|1
984586|NCT00528528|3236877|P2|Overall Study|Lost to Follow-up|0
984587|NCT00528528|3236878|P1|Overall Study|Lost to Follow-up|0
984588|NCT00528424|3236916|P1|Overall Study|Not specified|12
984589|NCT00528424|3236916|P1|Overall Study|Administrative reason|2
984590|NCT00528424|3236916|P1|Overall Study|Withdrew consent|2
984591|NCT00528424|3236916|P1|Overall Study|Lost to Follow-up|13
984592|NCT00528411|3236931|P3|Overall Study|Prior commitment medication|0
984593|NCT00528411|3236932|P2|Overall Study|Prior commitment medication|1
984594|NCT00528411|3236933|P1|Overall Study|Prior commitment medication|0
984595|NCT00528411|3236931|P3|Overall Study|Severe non-compliance to protocol|0
984822|NCT00527735|3237427|P1|Overall Study|Adverse Event|10
984596|NCT00528411|3236932|P2|Overall Study|Severe non-compliance to protocol|1
984597|NCT00528411|3236933|P1|Overall Study|Severe non-compliance to protocol|0
984598|NCT00528411|3236931|P3|Overall Study|Incorrect Enrolment|0
984599|NCT00528411|3236932|P2|Overall Study|Incorrect Enrolment|1
984600|NCT00528411|3236933|P1|Overall Study|Incorrect Enrolment|1
984601|NCT00528411|3236931|P3|Overall Study|Adverse Event|1
984602|NCT00528411|3236932|P2|Overall Study|Adverse Event|0
984603|NCT00528411|3236933|P1|Overall Study|Adverse Event|4
984604|NCT00528372|3237070|P9|Long-term (LT) Period (Weeks 24-102)|Not specified|0
984605|NCT00528372|3237071|P8|Long-term (LT) Period (Weeks 24-102)|Not specified|1
984606|NCT00528372|3237072|P7|Long-term (LT) Period (Weeks 24-102)|Not specified|3
984607|NCT00528372|3237073|P6|Long-term (LT) Period (Weeks 24-102)|Not specified|0
984608|NCT00528372|3237074|P5|Long-term (LT) Period (Weeks 24-102)|Not specified|3
984609|NCT00528372|3237075|P4|Long-term (LT) Period (Weeks 24-102)|Not specified|2
984610|NCT00528372|3237076|P3|Long-term (LT) Period (Weeks 24-102)|Not specified|1
984611|NCT00528372|3237077|P2|Long-term (LT) Period (Weeks 24-102)|Not specified|2
984612|NCT00528372|3237078|P1|Long-term (LT) Period (Weeks 24-102)|Not specified|2
984613|NCT00528372|3237070|P9|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
984614|NCT00528372|3237071|P8|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
984615|NCT00528372|3237072|P7|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
984616|NCT00528372|3237073|P6|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
984617|NCT00528372|3237074|P5|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
984618|NCT00528372|3237075|P4|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
984619|NCT00528372|3237076|P3|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
984620|NCT00528372|3237077|P2|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
984621|NCT00528372|3237078|P1|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
984622|NCT00528372|3237070|P9|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
984623|NCT00528372|3237071|P8|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
984624|NCT00528372|3237072|P7|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
984625|NCT00528372|3237073|P6|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1
984626|NCT00528372|3237074|P5|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2
984627|NCT00528372|3237075|P4|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
984628|NCT00528372|3237076|P3|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
984629|NCT00528372|3237077|P2|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
984630|NCT00528372|3237078|P1|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
984631|NCT00528372|3237070|P9|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
984632|NCT00528372|3237071|P8|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
984633|NCT00528372|3237072|P7|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
984634|NCT00528372|3237073|P6|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
984635|NCT00528372|3237074|P5|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
984636|NCT00528372|3237075|P4|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
984637|NCT00528372|3237076|P3|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
984638|NCT00528372|3237077|P2|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
984639|NCT00528372|3237078|P1|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
984640|NCT00528372|3237070|P9|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
984641|NCT00528372|3237071|P8|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
984642|NCT00528372|3237072|P7|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
984643|NCT00528372|3237073|P6|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4
984644|NCT00528372|3237074|P5|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0
984645|NCT00528372|3237075|P4|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
984646|NCT00528372|3237076|P3|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
984647|NCT00528372|3237077|P2|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
984648|NCT00528372|3237078|P1|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
984649|NCT00528372|3237070|P9|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
984650|NCT00528372|3237071|P8|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2
984651|NCT00528372|3237072|P7|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
984652|NCT00528372|3237073|P6|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0
984653|NCT00528372|3237074|P5|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7
984654|NCT00528372|3237075|P4|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
984655|NCT00528372|3237076|P3|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
984656|NCT00528372|3237077|P2|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
984657|NCT00528372|3237078|P1|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
984658|NCT00528372|3237070|P9|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
984659|NCT00528372|3237071|P8|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
984660|NCT00528372|3237072|P7|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4
984661|NCT00528372|3237073|P6|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
984662|NCT00528372|3237074|P5|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2
984663|NCT00528372|3237075|P4|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
984664|NCT00528372|3237076|P3|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
984665|NCT00528372|3237077|P2|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
984666|NCT00528372|3237078|P1|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
984667|NCT00528372|3237070|P9|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
984668|NCT00528372|3237071|P8|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
984669|NCT00528372|3237072|P7|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2
984670|NCT00528372|3237073|P6|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
984671|NCT00528372|3237074|P5|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
984672|NCT00528372|3237075|P4|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
984673|NCT00528372|3237076|P3|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1
984674|NCT00528372|3237077|P2|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
984675|NCT00528372|3237078|P1|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
984676|NCT00528372|3237070|P9|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
984677|NCT00528372|3237071|P8|Short-term (ST) Period (Day 1-Week 24)|Not specified|1
984678|NCT00528372|3237072|P7|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
984679|NCT00528372|3237073|P6|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
984680|NCT00528372|3237074|P5|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
984681|NCT00528372|3237075|P4|Short-term (ST) Period (Day 1-Week 24)|Not specified|1
984682|NCT00528372|3237076|P3|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
984683|NCT00528372|3237077|P2|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
984684|NCT00528372|3237078|P1|Short-term (ST) Period (Day 1-Week 24)|Not specified|3
984685|NCT00528372|3237070|P9|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
984686|NCT00528372|3237071|P8|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
984687|NCT00528372|3237072|P7|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
984688|NCT00528372|3237073|P6|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
984689|NCT00528372|3237074|P5|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
984690|NCT00528372|3237075|P4|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
984691|NCT00528372|3237076|P3|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
984692|NCT00528372|3237077|P2|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
984693|NCT00528372|3237078|P1|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
984694|NCT00528372|3237070|P9|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
984695|NCT00528372|3237071|P8|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
984696|NCT00528372|3237072|P7|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
984697|NCT00528372|3237073|P6|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1
984698|NCT00528372|3237074|P5|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
984699|NCT00528372|3237075|P4|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2
984700|NCT00528372|3237076|P3|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
984701|NCT00528372|3237077|P2|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
984702|NCT00528372|3237078|P1|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
984703|NCT00528372|3237070|P9|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
984704|NCT00528372|3237071|P8|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
984705|NCT00528372|3237072|P7|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
984706|NCT00528372|3237073|P6|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
984707|NCT00528372|3237074|P5|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
984708|NCT00528372|3237075|P4|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
984709|NCT00528372|3237076|P3|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
984710|NCT00528372|3237077|P2|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
984711|NCT00528372|3237078|P1|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5
984712|NCT00528372|3237070|P9|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
984713|NCT00528372|3237071|P8|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
984714|NCT00528372|3237072|P7|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
984715|NCT00528372|3237073|P6|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
984716|NCT00528372|3237074|P5|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
984717|NCT00528372|3237075|P4|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
984718|NCT00528372|3237076|P3|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7
984719|NCT00528372|3237077|P2|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
984720|NCT00528372|3237078|P1|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
984721|NCT00528372|3237070|P9|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
984722|NCT00528372|3237071|P8|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
984723|NCT00528372|3237072|P7|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
984724|NCT00528372|3237073|P6|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
984725|NCT00528372|3237074|P5|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
984726|NCT00528372|3237075|P4|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6
984727|NCT00528372|3237076|P3|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
984728|NCT00528372|3237077|P2|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
984729|NCT00528372|3237078|P1|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
984730|NCT00528372|3237070|P9|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
984731|NCT00528372|3237071|P8|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
984732|NCT00528372|3237072|P7|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
984733|NCT00528372|3237073|P6|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
984734|NCT00528372|3237074|P5|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
984735|NCT00528372|3237075|P4|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
984736|NCT00528372|3237076|P3|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
984737|NCT00528372|3237077|P2|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
984738|NCT00528372|3237078|P1|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2
984739|NCT00528112|3237210|P2|Extension Phase|Protocol Violation|2
984740|NCT00528112|3237211|P1|Extension Phase|Protocol Violation|0
984741|NCT00528112|3237210|P2|Extension Phase|Adverse Event|36
984742|NCT00528112|3237211|P1|Extension Phase|Adverse Event|0
984743|NCT00528112|3237210|P2|Extension Phase|Death|1
984744|NCT00528112|3237211|P1|Extension Phase|Death|0
984745|NCT00528112|3237210|P2|Extension Phase|Lost to Follow-up|12
984746|NCT00528112|3237211|P1|Extension Phase|Lost to Follow-up|0
984747|NCT00528112|3237210|P2|Extension Phase|Pregnancy|3
984748|NCT00528112|3237211|P1|Extension Phase|Pregnancy|0
984749|NCT00528112|3237210|P2|Extension Phase|Other reasons|100
984750|NCT00528112|3237211|P1|Extension Phase|Other reasons|0
984751|NCT00528112|3237210|P2|Extension Phase|Withdrawal by Subject|3
984752|NCT00528112|3237211|P1|Extension Phase|Withdrawal by Subject|0
984753|NCT00528112|3237210|P2|Treatment up to 3 Years|Other reasons|186
984754|NCT00528112|3237211|P1|Treatment up to 3 Years|Other reasons|186
984755|NCT00528112|3237210|P2|Treatment up to 3 Years|Pregnancy|10
984756|NCT00528112|3237211|P1|Treatment up to 3 Years|Pregnancy|9
984757|NCT00528112|3237210|P2|Treatment up to 3 Years|Lost to Follow-up|61
984758|NCT00528112|3237211|P1|Treatment up to 3 Years|Lost to Follow-up|63
984759|NCT00528112|3237210|P2|Treatment up to 3 Years|Death|1
984760|NCT00528112|3237211|P1|Treatment up to 3 Years|Death|0
984761|NCT00528112|3237210|P2|Treatment up to 3 Years|Protocol Violation|16
984762|NCT00528112|3237211|P1|Treatment up to 3 Years|Protocol Violation|16
984763|NCT00528112|3237210|P2|Treatment up to 3 Years|Withdrawal by Subject|31
984764|NCT00528112|3237211|P1|Treatment up to 3 Years|Withdrawal by Subject|26
984765|NCT00528112|3237210|P2|Treatment up to 3 Years|Adverse Event|278
984766|NCT00528112|3237211|P1|Treatment up to 3 Years|Adverse Event|313
984767|NCT00528021|3237269|P4|Overall Study|Lack of Efficacy|9
984768|NCT00528021|3237270|P3|Overall Study|Lack of Efficacy|7
984769|NCT00528021|3237271|P2|Overall Study|Lack of Efficacy|13
984770|NCT00528021|3237272|P1|Overall Study|Lack of Efficacy|17
984771|NCT00527982|3237284|P2|Overall Study|Physician Decision|0
984772|NCT00527982|3237285|P1|Overall Study|Physician Decision|1
984773|NCT00527904|3237326|P1|Overall Study|misc|22
984774|NCT00527904|3237326|P1|Overall Study|Lost to Follow-up|8
984775|NCT00527904|3237326|P1|Overall Study|Withdrawal by Subject|21
984776|NCT00527904|3237326|P1|Overall Study|Adverse Event|45
984777|NCT00527826|3237345|P2|Overall Study|Participant moved away|1
984778|NCT00527826|3237346|P1|Overall Study|Participant moved away|0
984779|NCT00527826|3237345|P2|Overall Study|Additional Intake of Viani forte|1
984780|NCT00527826|3237346|P1|Overall Study|Additional Intake of Viani forte|0
984781|NCT00527826|3237345|P2|Overall Study|Alpha-1 Antitrypsin Deficiency|1
984782|NCT00527826|3237346|P1|Overall Study|Alpha-1 Antitrypsin Deficiency|0
984783|NCT00527826|3237345|P2|Overall Study|Inclusion Criteria Not Met|3
984784|NCT00527826|3237346|P1|Overall Study|Inclusion Criteria Not Met|3
984785|NCT00527826|3237345|P2|Overall Study|Withdrawal by Subject|8
984786|NCT00527826|3237346|P1|Overall Study|Withdrawal by Subject|5
984787|NCT00527826|3237345|P2|Overall Study|Lost to Follow-up|2
984788|NCT00527826|3237346|P1|Overall Study|Lost to Follow-up|3
984789|NCT00527826|3237345|P2|Overall Study|Adverse Event|10
984790|NCT00527826|3237346|P1|Overall Study|Adverse Event|10
984791|NCT00527787|3237395|P2|Overall Study|misc|2
984792|NCT00527787|3237396|P1|Overall Study|misc|5
984793|NCT00527787|3237395|P2|Overall Study|Duodenal Ulcer|10
984794|NCT00527787|3237396|P1|Overall Study|Duodenal Ulcer|1
984795|NCT00527787|3237395|P2|Overall Study|Lost to Follow-up|2
984796|NCT00527787|3237396|P1|Overall Study|Lost to Follow-up|5
984797|NCT00527787|3237395|P2|Overall Study|Withdrawal by Subject|25
984798|NCT00527787|3237396|P1|Overall Study|Withdrawal by Subject|13
984799|NCT00527787|3237395|P2|Overall Study|Adverse Event|24
984800|NCT00527787|3237396|P1|Overall Study|Adverse Event|14
984801|NCT00527748|3237418|P1|Overall Study|Other|3
984802|NCT00527735|3237425|P3|Overall Study|Completed treatment during maintenance|1
984803|NCT00527735|3237426|P2|Overall Study|Completed treatment during maintenance|2
984804|NCT00527735|3237427|P1|Overall Study|Completed treatment during maintenance|2
984805|NCT00527735|3237425|P3|Overall Study|Poor compliance or noncompliance|1
984806|NCT00527735|3237426|P2|Overall Study|Poor compliance or noncompliance|1
984807|NCT00527735|3237427|P1|Overall Study|Poor compliance or noncompliance|0
984808|NCT00527735|3237425|P3|Overall Study|Lost to Follow-up|3
984809|NCT00527735|3237426|P2|Overall Study|Lost to Follow-up|0
984810|NCT00527735|3237427|P1|Overall Study|Lost to Follow-up|0
984811|NCT00527735|3237425|P3|Overall Study|No longer met study criteria|1
984812|NCT00527735|3237426|P2|Overall Study|No longer met study criteria|2
984813|NCT00527735|3237427|P1|Overall Study|No longer met study criteria|2
984814|NCT00527735|3237425|P3|Overall Study|Withdrawal by Subject|3
984815|NCT00527735|3237426|P2|Overall Study|Withdrawal by Subject|4
984816|NCT00527735|3237427|P1|Overall Study|Withdrawal by Subject|5
984817|NCT00527735|3237425|P3|Overall Study|Not identified|5
984818|NCT00527735|3237426|P2|Overall Study|Not identified|5
984819|NCT00527735|3237427|P1|Overall Study|Not identified|5
984820|NCT00527735|3237425|P3|Overall Study|Adverse Event|7
984821|NCT00527735|3237426|P2|Overall Study|Adverse Event|6
984823|NCT00527735|3237425|P3|Overall Study|Completed treatment in treatment phase|18
984824|NCT00527735|3237426|P2|Overall Study|Completed treatment in treatment phase|13
984825|NCT00527735|3237427|P1|Overall Study|Completed treatment in treatment phase|14
984826|NCT00527735|3237425|P3|Overall Study|Death|15
984827|NCT00527735|3237426|P2|Overall Study|Death|13
984828|NCT00527735|3237427|P1|Overall Study|Death|23
984829|NCT00527735|3237425|P3|Overall Study|Disease progression|53
984830|NCT00527735|3237426|P2|Overall Study|Disease progression|61
984831|NCT00527735|3237427|P1|Overall Study|Disease progression|47
984832|NCT00527618|3237513|P2|Week 15-18 (Second Intervention)|Withdrawal by Subject|1
984833|NCT00527618|3237514|P1|Week 15-18 (Second Intervention)|Withdrawal by Subject|0
984834|NCT00527618|3237513|P2|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1
984835|NCT00527618|3237514|P1|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0
984836|NCT00527618|3237513|P2|Week 15-18 (Second Intervention)|Lost to Follow-up|1
984837|NCT00527618|3237514|P1|Week 15-18 (Second Intervention)|Lost to Follow-up|0
984838|NCT00527618|3237513|P2|Week 13-14 (Washout)|Lost to Follow-up|0
984839|NCT00527618|3237514|P1|Week 13-14 (Washout)|Lost to Follow-up|1
984840|NCT00527618|3237513|P2|Week 1-12 (First Intervention)|Adverse Event|1
984841|NCT00527618|3237514|P1|Week 1-12 (First Intervention)|Adverse Event|0
984842|NCT00527618|3237513|P2|Week 1-12 (First Intervention)|Lost to Follow-up|1
984843|NCT00527618|3237514|P1|Week 1-12 (First Intervention)|Lost to Follow-up|3
984844|NCT00527605|3237529|P2|Overall Study|Protocol Violation|2
984845|NCT00527605|3237530|P1|Overall Study|Protocol Violation|1
984846|NCT00527605|3237529|P2|Overall Study|Lost to Follow-up|2
984847|NCT00527605|3237530|P1|Overall Study|Lost to Follow-up|6
984848|NCT00527605|3237529|P2|Overall Study|Withdrawal by Subject|7
984849|NCT00527605|3237530|P1|Overall Study|Withdrawal by Subject|3
984850|NCT00527605|3237529|P2|Overall Study|Adverse Event|0
984851|NCT00527605|3237530|P1|Overall Study|Adverse Event|3
984852|NCT00527514|3237581|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1
984853|NCT00527514|3237581|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1
984854|NCT00527514|3237581|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1
984855|NCT00527514|3237581|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1
984856|NCT00527514|3237581|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1
984857|NCT00527514|3237581|P1|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2
984858|NCT00527514|3237581|P1|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1
984859|NCT00527488|3237597|P4|Overall Study|Withdrawn prior to dosing|0
984860|NCT00527488|3237598|P3|Overall Study|Withdrawn prior to dosing|1
984861|NCT00527488|3237599|P2|Overall Study|Withdrawn prior to dosing|1
984862|NCT00527488|3237600|P1|Overall Study|Withdrawn prior to dosing|0
984863|NCT00527423|3237683|P1|Overall Study|Death|9
984864|NCT00527423|3237683|P1|Overall Study|OTHER|4
984865|NCT00527423|3237683|P1|Overall Study|Lost to Follow-up|4
984866|NCT00527423|3237683|P1|Overall Study|Withdrawal by Subject|10
984867|NCT00527423|3237683|P1|Overall Study|Physician Decision|4
984868|NCT00527423|3237683|P1|Overall Study|Adverse Event|5
984869|NCT00527423|3237683|P1|Overall Study|Protocol Violation|1
984870|NCT00527397|3237689|P1|Overall Study|Study terminated by sponsor|13
984871|NCT00527397|3237689|P1|Overall Study|Withdrawal by Subject|6
984872|NCT00527397|3237689|P1|Overall Study|Protocol Violation|1
984873|NCT00527397|3237689|P1|Overall Study|Lack of Efficacy|1
984874|NCT00527397|3237689|P1|Overall Study|Adverse Event|3
984875|NCT00527332|3237715|P2|Overall Study|Withdrew consent|1
984876|NCT00527332|3237716|P1|Overall Study|Withdrew consent|5
984877|NCT00527332|3237715|P2|Overall Study|Protocol Violation|8
984878|NCT00527332|3237716|P1|Overall Study|Protocol Violation|4
984879|NCT00527319|3237725|P3|Overall Study|Adverse Event|1
984880|NCT00527319|3237726|P2|Overall Study|Adverse Event|0
984881|NCT00527319|3237727|P1|Overall Study|Adverse Event|0
984882|NCT00527319|3237725|P3|Overall Study|Intercurrent Medical Illness|3
984883|NCT00527319|3237726|P2|Overall Study|Intercurrent Medical Illness|1
984884|NCT00527319|3237727|P1|Overall Study|Intercurrent Medical Illness|0
984885|NCT00527319|3237725|P3|Overall Study|Death|1
984886|NCT00527319|3237726|P2|Overall Study|Death|3
984887|NCT00527319|3237727|P1|Overall Study|Death|0
984888|NCT00527319|3237725|P3|Overall Study|Lost to Follow-up|0
984889|NCT00527319|3237726|P2|Overall Study|Lost to Follow-up|0
984890|NCT00527319|3237727|P1|Overall Study|Lost to Follow-up|1
984891|NCT00527319|3237725|P3|Overall Study|Withdrawal by Subject|1
984892|NCT00527319|3237726|P2|Overall Study|Withdrawal by Subject|0
984893|NCT00527319|3237727|P1|Overall Study|Withdrawal by Subject|5
984894|NCT00527111|3237757|P2|Overall Study|Other|2
984895|NCT00527111|3237758|P1|Overall Study|Other|2
984896|NCT00527111|3237757|P2|Overall Study|Patient Request|5
984897|NCT00527111|3237758|P1|Overall Study|Patient Request|2
984898|NCT00527111|3237757|P2|Overall Study|Investigator Request|1
984899|NCT00527111|3237758|P1|Overall Study|Investigator Request|2
984900|NCT00527111|3237757|P2|Overall Study|Death|1
984901|NCT00527111|3237758|P1|Overall Study|Death|0
984902|NCT00527111|3237757|P2|Overall Study|Adverse Event|13
984903|NCT00527111|3237758|P1|Overall Study|Adverse Event|14
984904|NCT00527072|3237780|P1|Overall Study|Withdrawal by Subject|7
984905|NCT00527072|3237780|P1|Overall Study|Protocol Violation|2
984906|NCT00527072|3237780|P1|Overall Study|Lost to Follow-up|3
984907|NCT00527072|3237780|P1|Overall Study|Lack of Efficacy|11
984908|NCT00527072|3237780|P1|Overall Study|Adverse Event|13
984909|NCT00526994|3237789|P3|Overall Study|incarcerated, impaired, incomplete|3
984910|NCT00526994|3237790|P2|Overall Study|incarcerated, impaired, incomplete|3
984911|NCT00526994|3237791|P1|Overall Study|incarcerated, impaired, incomplete|4
984912|NCT00526994|3237789|P3|Overall Study|Withdrawal by Subject|5
984913|NCT00526994|3237790|P2|Overall Study|Withdrawal by Subject|7
984914|NCT00526994|3237791|P1|Overall Study|Withdrawal by Subject|2
984915|NCT00526994|3237789|P3|Overall Study|Death|3
984916|NCT00526994|3237790|P2|Overall Study|Death|3
984917|NCT00526994|3237791|P1|Overall Study|Death|4
984918|NCT00526994|3237789|P3|Overall Study|Lost to Follow-up|96
984919|NCT00526994|3237790|P2|Overall Study|Lost to Follow-up|108
984920|NCT00526994|3237791|P1|Overall Study|Lost to Follow-up|98
984921|NCT00526890|3237808|P1|Overall Study|Adverse Event|2
984922|NCT00526799|3237820|P2|Overall Study|Intercurrent Complicating Disease|1
984923|NCT00526799|3237821|P1|Overall Study|Intercurrent Complicating Disease|0
984924|NCT00526799|3237820|P2|Overall Study|Withdrawal by Subject|0
984925|NCT00526799|3237821|P1|Overall Study|Withdrawal by Subject|1
984926|NCT00526669|3237829|P2|Combined Treatment Phase|Death|2
984927|NCT00526669|3237830|P1|Combined Treatment Phase|Death|0
984928|NCT00526669|3237829|P2|Combined Treatment Phase|Sponsor Terminated Study|2
984929|NCT00526669|3237830|P1|Combined Treatment Phase|Sponsor Terminated Study|0
984930|NCT00526669|3237829|P2|Combined Treatment Phase|Withdrawal by Subject|2
984931|NCT00526669|3237830|P1|Combined Treatment Phase|Withdrawal by Subject|0
984932|NCT00526669|3237829|P2|Combined Treatment Phase|Lost to Follow-up|2
984933|NCT00526669|3237830|P1|Combined Treatment Phase|Lost to Follow-up|0
984934|NCT00526630|3237859|P2|Second Intervention Period - 12 Weeks|Withdrawn|1
984935|NCT00526630|3237860|P1|Second Intervention Period - 12 Weeks|Withdrawn|2
984936|NCT00526630|3237859|P2|First Intervention Period - 12 Weeks|Withdrawn|3
984937|NCT00526630|3237860|P1|First Intervention Period - 12 Weeks|Withdrawn|0
984938|NCT00526331|3237959|P1|Overall Study|Sponsor Termination|55
984939|NCT00526227|3237967|P1|Overall Study|Death|1
984940|NCT00526227|3237967|P1|Overall Study|Device not implanted|1
984941|NCT00526162|3237978|P1|Overall Study|Device not implanted|3
984942|NCT00526110|3238008|P2|Overall Study|Poor Tolerance|5
984943|NCT00526110|3238009|P1|Overall Study|Poor Tolerance|0
984944|NCT00526110|3238008|P2|Overall Study|Withdrawal by Subject|2
984945|NCT00526110|3238009|P1|Overall Study|Withdrawal by Subject|0
984946|NCT00526110|3238008|P2|Overall Study|Maximal Response|6
984947|NCT00526110|3238009|P1|Overall Study|Maximal Response|0
984948|NCT00526110|3238008|P2|Overall Study|Disease Progression|19
984949|NCT00526110|3238009|P1|Overall Study|Disease Progression|0
984950|NCT00526110|3238008|P2|Overall Study|Adverse Event|9
984951|NCT00526110|3238009|P1|Overall Study|Adverse Event|2
984952|NCT00526097|3238018|P2|Overall Study|Other|1
984953|NCT00526097|3238019|P1|Overall Study|Other|2
984954|NCT00526097|3238018|P2|Overall Study|Withdrawal by Subject|1
984955|NCT00526097|3238019|P1|Overall Study|Withdrawal by Subject|3
984956|NCT00526097|3238018|P2|Overall Study|Protocol Violation|10
984957|NCT00526097|3238019|P1|Overall Study|Protocol Violation|4
984958|NCT00526097|3238018|P2|Overall Study|Adverse Event|44
984959|NCT00526097|3238019|P1|Overall Study|Adverse Event|6
984960|NCT00526071|3238195|P1|Overall Study|Lack of Response to Study Drug|4
984961|NCT00526071|3238195|P1|Overall Study|Withdrawal by Subject|1
984962|NCT00526071|3238195|P1|Overall Study|Adverse Event|1
984963|NCT00525915|3238221|P2|Overall Study|Unrelated illness|0
984964|NCT00525915|3238222|P1|Overall Study|Unrelated illness|1
984965|NCT00525915|3238221|P2|Overall Study|Refused Surgery|2
984966|NCT00525915|3238222|P1|Overall Study|Refused Surgery|1
984967|NCT00525915|3238221|P2|Overall Study|Withdrawal by Subject|0
984968|NCT00525915|3238222|P1|Overall Study|Withdrawal by Subject|1
984969|NCT00525915|3238221|P2|Overall Study|Disease Progression|6
984970|NCT00525915|3238222|P1|Overall Study|Disease Progression|5
984971|NCT00525915|3238221|P2|Overall Study|Non-Compliance|1
984972|NCT00525915|3238222|P1|Overall Study|Non-Compliance|0
984973|NCT00525902|3238228|P1|Overall Study|Lack of Efficacy|1
984974|NCT00525824|3238252|P4|Overall Study|Other|1
984975|NCT00525824|3238253|P3|Overall Study|Other|3
984976|NCT00525824|3238254|P2|Overall Study|Other|3
984977|NCT00525824|3238255|P1|Overall Study|Other|1
984978|NCT00525824|3238252|P4|Overall Study|Safety reasons|0
984979|NCT00525824|3238253|P3|Overall Study|Safety reasons|1
984980|NCT00525824|3238254|P2|Overall Study|Safety reasons|0
984981|NCT00525824|3238255|P1|Overall Study|Safety reasons|1
984982|NCT00525824|3238252|P4|Overall Study|Severe non-compliance|1
984983|NCT00525824|3238253|P3|Overall Study|Severe non-compliance|1
984984|NCT00525824|3238254|P2|Overall Study|Severe non-compliance|1
984985|NCT00525824|3238255|P1|Overall Study|Severe non-compliance|0
984986|NCT00525824|3238252|P4|Overall Study|Incorrect enrolment/mis-randomisation|2
984987|NCT00525824|3238253|P3|Overall Study|Incorrect enrolment/mis-randomisation|1
984988|NCT00525824|3238254|P2|Overall Study|Incorrect enrolment/mis-randomisation|2
984989|NCT00525824|3238255|P1|Overall Study|Incorrect enrolment/mis-randomisation|1
984990|NCT00525824|3238252|P4|Overall Study|Lost to Follow-up|0
984991|NCT00525824|3238253|P3|Overall Study|Lost to Follow-up|4
984992|NCT00525824|3238254|P2|Overall Study|Lost to Follow-up|2
984993|NCT00525824|3238255|P1|Overall Study|Lost to Follow-up|4
984994|NCT00525824|3238252|P4|Overall Study|Withdrawal by Subject|4
984995|NCT00525824|3238253|P3|Overall Study|Withdrawal by Subject|3
984996|NCT00525824|3238254|P2|Overall Study|Withdrawal by Subject|9
984997|NCT00525824|3238255|P1|Overall Study|Withdrawal by Subject|5
984998|NCT00525824|3238252|P4|Overall Study|Adverse Event|7
984999|NCT00525824|3238253|P3|Overall Study|Adverse Event|6
985000|NCT00525824|3238254|P2|Overall Study|Adverse Event|11
985001|NCT00525824|3238255|P1|Overall Study|Adverse Event|7
985002|NCT00525512|3238360|P4|Open-Label Phase|Other reason (not specified)|5
985003|NCT00525512|3238361|P3|Open-Label Phase|Other reason (not specified)|4
985004|NCT00525512|3238362|P2|Open-Label Phase|Other reason (not specified)|0
985005|NCT00525512|3238363|P1|Open-Label Phase|Other reason (not specified)|0
985006|NCT00525512|3238360|P4|Open-Label Phase|Lost to Follow-up|0
985007|NCT00525512|3238361|P3|Open-Label Phase|Lost to Follow-up|1
985008|NCT00525512|3238362|P2|Open-Label Phase|Lost to Follow-up|0
985009|NCT00525512|3238363|P1|Open-Label Phase|Lost to Follow-up|0
985010|NCT00525512|3238360|P4|Open-Label Phase|Adverse Event|0
985011|NCT00525512|3238361|P3|Open-Label Phase|Adverse Event|1
985012|NCT00525512|3238362|P2|Open-Label Phase|Adverse Event|0
985013|NCT00525512|3238363|P1|Open-Label Phase|Adverse Event|0
985014|NCT00525512|3238360|P4|Double-Blind Phase|Other reason (not specified)|0
985015|NCT00525512|3238361|P3|Double-Blind Phase|Other reason (not specified)|0
985016|NCT00525512|3238362|P2|Double-Blind Phase|Other reason (not specified)|13
985017|NCT00525512|3238363|P1|Double-Blind Phase|Other reason (not specified)|12
985018|NCT00525512|3238360|P4|Double-Blind Phase|Lack of Efficacy|0
985019|NCT00525512|3238361|P3|Double-Blind Phase|Lack of Efficacy|0
985020|NCT00525512|3238362|P2|Double-Blind Phase|Lack of Efficacy|5
985021|NCT00525512|3238363|P1|Double-Blind Phase|Lack of Efficacy|13
985022|NCT00525512|3238360|P4|Double-Blind Phase|Withdrawal by Subject|0
985023|NCT00525512|3238361|P3|Double-Blind Phase|Withdrawal by Subject|0
985024|NCT00525512|3238362|P2|Double-Blind Phase|Withdrawal by Subject|12
985025|NCT00525512|3238363|P1|Double-Blind Phase|Withdrawal by Subject|17
985026|NCT00525512|3238360|P4|Double-Blind Phase|Lost to Follow-up|0
985027|NCT00525512|3238361|P3|Double-Blind Phase|Lost to Follow-up|0
985028|NCT00525512|3238362|P2|Double-Blind Phase|Lost to Follow-up|7
985029|NCT00525512|3238363|P1|Double-Blind Phase|Lost to Follow-up|3
985030|NCT00525512|3238360|P4|Double-Blind Phase|Protocol Violation|0
985031|NCT00525512|3238361|P3|Double-Blind Phase|Protocol Violation|0
985032|NCT00525512|3238362|P2|Double-Blind Phase|Protocol Violation|1
985033|NCT00525512|3238363|P1|Double-Blind Phase|Protocol Violation|3
985034|NCT00525512|3238360|P4|Double-Blind Phase|Adverse Event|0
985035|NCT00525512|3238361|P3|Double-Blind Phase|Adverse Event|0
985036|NCT00525512|3238362|P2|Double-Blind Phase|Adverse Event|28
985037|NCT00525512|3238363|P1|Double-Blind Phase|Adverse Event|48
985038|NCT00525499|3238505|P4|Overall Study|Protocol Violation|0
985039|NCT00525499|3238506|P3|Overall Study|Protocol Violation|1
985040|NCT00525499|3238507|P2|Overall Study|Protocol Violation|1
985041|NCT00525499|3238508|P1|Overall Study|Protocol Violation|0
985042|NCT00525499|3238505|P4|Overall Study|Withdrawal by Subject|2
985043|NCT00525499|3238506|P3|Overall Study|Withdrawal by Subject|5
985044|NCT00525499|3238507|P2|Overall Study|Withdrawal by Subject|1
985045|NCT00525499|3238508|P1|Overall Study|Withdrawal by Subject|5
985046|NCT00525499|3238505|P4|Overall Study|Adverse Event|1
985047|NCT00525499|3238506|P3|Overall Study|Adverse Event|0
985048|NCT00525499|3238507|P2|Overall Study|Adverse Event|1
985049|NCT00525499|3238508|P1|Overall Study|Adverse Event|0
985050|NCT00525499|3238505|P4|Overall Study|Lost to Follow-up|4
985051|NCT00525499|3238506|P3|Overall Study|Lost to Follow-up|1
985052|NCT00525499|3238507|P2|Overall Study|Lost to Follow-up|4
985053|NCT00525499|3238508|P1|Overall Study|Lost to Follow-up|2
985054|NCT00525265|3238535|P2|Overall Study|Protocol Violation|0
985055|NCT00525265|3238536|P1|Overall Study|Protocol Violation|1
985056|NCT00525161|3238593|P1|Overall Study|Adverse Event|1
985057|NCT00525148|3238603|P4|Overall Study|Other than stated|3
985058|NCT00525148|3238604|P3|Overall Study|Other than stated|0
985059|NCT00525148|3238605|P2|Overall Study|Other than stated|1
985060|NCT00525148|3238606|P1|Overall Study|Other than stated|2
985061|NCT00525148|3238603|P4|Overall Study|Refused continuation of study medication|1
985062|NCT00525148|3238604|P3|Overall Study|Refused continuation of study medication|0
985063|NCT00525148|3238605|P2|Overall Study|Refused continuation of study medication|2
985064|NCT00525148|3238606|P1|Overall Study|Refused continuation of study medication|0
985065|NCT00525148|3238603|P4|Overall Study|Progressive disease|49
985066|NCT00525148|3238604|P3|Overall Study|Progressive disease|6
985067|NCT00525148|3238605|P2|Overall Study|Progressive disease|30
985068|NCT00525148|3238606|P1|Overall Study|Progressive disease|18
985069|NCT00525148|3238603|P4|Overall Study|Other Adverse Event|8
985070|NCT00525148|3238604|P3|Overall Study|Other Adverse Event|1
985071|NCT00525148|3238605|P2|Overall Study|Other Adverse Event|5
985072|NCT00525148|3238606|P1|Overall Study|Other Adverse Event|3
985073|NCT00525031|3238634|P2|Overall Study|Disease Progression|1
985074|NCT00525031|3238635|P1|Overall Study|Disease Progression|1
985075|NCT00524771|3238649|P2|Overall Study|Protocol Violation|585
985076|NCT00524771|3238650|P1|Overall Study|Protocol Violation|220
985077|NCT00524745|3238664|P4|Overall Study|subject withdrawal or lost to follow up|22
985078|NCT00524745|3238665|P3|Overall Study|subject withdrawal or lost to follow up|29
985079|NCT00524745|3238666|P2|Overall Study|subject withdrawal or lost to follow up|13
985080|NCT00524745|3238667|P1|Overall Study|subject withdrawal or lost to follow up|34
985081|NCT00524680|3238693|P4|Overall Study|Withdrawal by Subject|1
985082|NCT00524680|3238694|P3|Overall Study|Withdrawal by Subject|1
985083|NCT00524680|3238695|P2|Overall Study|Withdrawal by Subject|0
985084|NCT00524680|3238696|P1|Overall Study|Withdrawal by Subject|1
985085|NCT00524680|3238693|P4|Overall Study|not specified|3
985086|NCT00524680|3238694|P3|Overall Study|not specified|2
985087|NCT00524680|3238695|P2|Overall Study|not specified|1
985088|NCT00524680|3238696|P1|Overall Study|not specified|0
985089|NCT00524680|3238693|P4|Overall Study|Adverse Event|1
985090|NCT00524680|3238694|P3|Overall Study|Adverse Event|0
985091|NCT00524680|3238695|P2|Overall Study|Adverse Event|0
985092|NCT00524680|3238696|P1|Overall Study|Adverse Event|2
985093|NCT00524680|3238693|P4|Overall Study|progression|1
985094|NCT00524680|3238694|P3|Overall Study|progression|0
985095|NCT00524680|3238695|P2|Overall Study|progression|0
985096|NCT00524680|3238696|P1|Overall Study|progression|0
985097|NCT00524589|3238718|P1|Overall Study|Disease Progression|16
985098|NCT00524589|3238718|P1|Overall Study|Withdrawal by Subject|2
985099|NCT00524485|3238769|P1|Overall Study|Withdrawal by Subject|5
985100|NCT00524459|3238798|P1|Overall Study|Other|1
985101|NCT00524459|3238798|P1|Overall Study|Withdrawal by Subject|1
985102|NCT00524420|3238808|P2|Overall Study|Lack of Efficacy|0
985103|NCT00524420|3238809|P1|Overall Study|Lack of Efficacy|1
985104|NCT00524368|3238827|P2|Overall Study|Other|2
985105|NCT00524368|3238828|P1|Overall Study|Other|3
985106|NCT00524368|3238827|P2|Overall Study|Ineligible to Continue the study|5
985107|NCT00524368|3238828|P1|Overall Study|Ineligible to Continue the study|2
985108|NCT00524368|3238827|P2|Overall Study|Sponsor's Decision|0
985109|NCT00524368|3238828|P1|Overall Study|Sponsor's Decision|2
985110|NCT00524368|3238827|P2|Overall Study|Reached a Virologic Endpoint|2
985111|NCT00524368|3238828|P1|Overall Study|Reached a Virologic Endpoint|3
985112|NCT00524368|3238827|P2|Overall Study|Non-compliant|9
985113|NCT00524368|3238828|P1|Overall Study|Non-compliant|8
985114|NCT00524368|3238827|P2|Overall Study|Withdrawal by Subject|5
985115|NCT00524368|3238828|P1|Overall Study|Withdrawal by Subject|4
985116|NCT00524368|3238827|P2|Overall Study|Lost to Follow-up|13
985117|NCT00524368|3238828|P1|Overall Study|Lost to Follow-up|9
985118|NCT00524368|3238827|P2|Overall Study|Adverse Event|12
985119|NCT00524368|3238828|P1|Overall Study|Adverse Event|10
985120|NCT00524316|3238862|P1|Overall Study|Disease Progression|7
985121|NCT00524316|3238862|P1|Overall Study|Adverse Event|7
985122|NCT00524316|3238862|P1|Overall Study|Withdrawal by Subject|2
985123|NCT00524303|3238874|P3|Overall Study|Completed 5 years|1
985124|NCT00524303|3238875|P2|Overall Study|Completed 5 years|0
985125|NCT00524303|3238876|P1|Overall Study|Completed 5 years|0
985126|NCT00524303|3238874|P3|Overall Study|Physician Decision|1
985127|NCT00524303|3238875|P2|Overall Study|Physician Decision|0
985128|NCT00524303|3238876|P1|Overall Study|Physician Decision|0
985129|NCT00524303|3238874|P3|Overall Study|Sponsor Request|1
985130|NCT00524303|3238875|P2|Overall Study|Sponsor Request|0
985131|NCT00524303|3238876|P1|Overall Study|Sponsor Request|0
985132|NCT00524303|3238874|P3|Overall Study|Disease Recurrence|0
985133|NCT00524303|3238875|P2|Overall Study|Disease Recurrence|1
985134|NCT00524303|3238876|P1|Overall Study|Disease Recurrence|0
985135|NCT00524303|3238874|P3|Overall Study|Disease Progression|1
985136|NCT00524303|3238875|P2|Overall Study|Disease Progression|4
985137|NCT00524303|3238876|P1|Overall Study|Disease Progression|0
985138|NCT00524303|3238874|P3|Overall Study|Worsening Peripheral Neuropathy|0
985139|NCT00524303|3238875|P2|Overall Study|Worsening Peripheral Neuropathy|0
985140|NCT00524303|3238876|P1|Overall Study|Worsening Peripheral Neuropathy|1
985141|NCT00524303|3238874|P3|Overall Study|Did not Complete Study Dosing|0
985142|NCT00524303|3238875|P2|Overall Study|Did not Complete Study Dosing|0
985143|NCT00524303|3238876|P1|Overall Study|Did not Complete Study Dosing|1
985144|NCT00524303|3238874|P3|Overall Study|Adverse Event|3
985145|NCT00524303|3238875|P2|Overall Study|Adverse Event|2
985146|NCT00524303|3238876|P1|Overall Study|Adverse Event|1
985147|NCT00524303|3238874|P3|Overall Study|Death|3
985148|NCT00524303|3238875|P2|Overall Study|Death|2
985149|NCT00524303|3238876|P1|Overall Study|Death|0
985150|NCT00524303|3238874|P3|Overall Study|Withdrawal by Subject|4
985151|NCT00524303|3238875|P2|Overall Study|Withdrawal by Subject|0
985152|NCT00524303|3238876|P1|Overall Study|Withdrawal by Subject|3
985153|NCT00524303|3238874|P3|Overall Study|Protocol Violation|1
985154|NCT00524303|3238875|P2|Overall Study|Protocol Violation|1
985155|NCT00524303|3238876|P1|Overall Study|Protocol Violation|0
985156|NCT00524303|3238874|P3|Overall Study|Lost to Follow-up|3
985157|NCT00524303|3238875|P2|Overall Study|Lost to Follow-up|0
985158|NCT00524303|3238876|P1|Overall Study|Lost to Follow-up|6
985159|NCT00524173|3238928|P2|Overall Study|Had not reached endpoint at study close|1
985160|NCT00524173|3238929|P1|Overall Study|Had not reached endpoint at study close|4
985161|NCT00524173|3238928|P2|Overall Study|Death|0
985162|NCT00524173|3238929|P1|Overall Study|Death|1
985163|NCT00524173|3238928|P2|Overall Study|Lost to Follow-up|1
985164|NCT00524173|3238929|P1|Overall Study|Lost to Follow-up|0
985165|NCT00524134|3238941|P1|Overall Study|Physician Decision|1
985166|NCT00524134|3238941|P1|Overall Study|Withdrawal by Subject|1
985167|NCT00524121|3238948|P1|Overall Study|Not treated (changed mind)|1
985168|NCT00524121|3238948|P1|Overall Study|Not treated (became ineligible)|4
985169|NCT00524121|3238948|P1|Overall Study|Death|1
985170|NCT00524121|3238948|P1|Overall Study|Other|1
985171|NCT00524121|3238948|P1|Overall Study|Patient refused|2
985172|NCT00524121|3238948|P1|Overall Study|Adverse Event|4
985173|NCT00524121|3238948|P1|Overall Study|Disease progression|6
985174|NCT00524043|3238968|P3|Overall Study|Various (eg, incarceration)|0
985175|NCT00524043|3238969|P2|Overall Study|Various (eg, incarceration)|1
985176|NCT00524043|3238970|P1|Overall Study|Various (eg, incarceration)|2
985177|NCT00524043|3238968|P3|Overall Study|Lost to Follow-up|3
985178|NCT00524043|3238969|P2|Overall Study|Lost to Follow-up|5
985179|NCT00524043|3238970|P1|Overall Study|Lost to Follow-up|3
985180|NCT00524043|3238968|P3|Overall Study|Adverse Event|7
985181|NCT00524043|3238969|P2|Overall Study|Adverse Event|2
985182|NCT00524043|3238970|P1|Overall Study|Adverse Event|5
985183|NCT00524043|3238968|P3|Overall Study|Withdrawal by Subject|7
985184|NCT00524043|3238969|P2|Overall Study|Withdrawal by Subject|7
985185|NCT00524043|3238970|P1|Overall Study|Withdrawal by Subject|5
985186|NCT00524043|3238968|P3|Overall Study|Lack of Efficacy|14
985187|NCT00524043|3238969|P2|Overall Study|Lack of Efficacy|13
985188|NCT00524043|3238970|P1|Overall Study|Lack of Efficacy|15
985189|NCT00524030|3238992|P2|Overall Study|Death|1
985190|NCT00524030|3238993|P1|Overall Study|Death|0
985191|NCT00524030|3238992|P2|Overall Study|Adverse Event|21
985192|NCT00524030|3238993|P1|Overall Study|Adverse Event|3
985193|NCT00524030|3238992|P2|Overall Study|Pregnancy|0
985194|NCT00524030|3238993|P1|Overall Study|Pregnancy|1
985195|NCT00524030|3238992|P2|Overall Study|Protocol Violation|1
985196|NCT00524030|3238993|P1|Overall Study|Protocol Violation|0
985197|NCT00524030|3238992|P2|Overall Study|Noncompliance/Investigator discretion|2
985198|NCT00524030|3238993|P1|Overall Study|Noncompliance/Investigator discretion|0
985199|NCT00524030|3238992|P2|Overall Study|Withdrawal by Subject|8
985200|NCT00524030|3238993|P1|Overall Study|Withdrawal by Subject|3
985201|NCT00524030|3238992|P2|Overall Study|Lost to Follow-up|2
985202|NCT00524030|3238993|P1|Overall Study|Lost to Follow-up|0
985203|NCT00524030|3238992|P2|Overall Study|Lack of Efficacy|24
985204|NCT00524030|3238993|P1|Overall Study|Lack of Efficacy|10
985205|NCT00523991|3239011|P2|Overall Study|Other reason (not specified)|0
985206|NCT00523991|3239012|P1|Overall Study|Other reason (not specified)|3
985207|NCT00523991|3239011|P2|Overall Study|Withdrawal by Subject|17
985208|NCT00523991|3239012|P1|Overall Study|Withdrawal by Subject|7
985209|NCT00523991|3239011|P2|Overall Study|Lost to Follow-up|1
985210|NCT00523991|3239012|P1|Overall Study|Lost to Follow-up|4
985211|NCT00523991|3239011|P2|Overall Study|Protocol Violation|4
985212|NCT00523991|3239012|P1|Overall Study|Protocol Violation|1
985213|NCT00523991|3239011|P2|Overall Study|Adverse Event|5
985214|NCT00523991|3239012|P1|Overall Study|Adverse Event|6
985215|NCT00523978|3239292|P2|Overall Study|Death|0
985216|NCT00523978|3239293|P1|Overall Study|Death|1
985217|NCT00523978|3239292|P2|Overall Study|Screen Failures|1
985218|NCT00523978|3239293|P1|Overall Study|Screen Failures|5
985219|NCT00523978|3239292|P2|Overall Study|Withdrawal by Subject|7
985220|NCT00523978|3239293|P1|Overall Study|Withdrawal by Subject|3
985221|NCT00523848|3239315|P1|Overall Study|Other, unspecified|4
985222|NCT00523848|3239315|P1|Overall Study|Disease Progression|5
985223|NCT00523848|3239315|P1|Overall Study|NOT TREATED (Became ineligible)|2
985224|NCT00523848|3239315|P1|Overall Study|Withdrawal by Subject|2
985225|NCT00523848|3239315|P1|Overall Study|Adverse Event|11
985226|NCT00523744|3239325|P1|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1
985227|NCT00523744|3239325|P1|Phase 2 - Amlodipine+Valsartan|Adverse Event|2
985228|NCT00523744|3239325|P1|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1
985229|NCT00523744|3239325|P1|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2
985230|NCT00523744|3239325|P1|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1
985231|NCT00523744|3239325|P1|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2
985232|NCT00523718|3239344|P2|Overall Study|Protocol Violation|0
985233|NCT00523718|3239345|P1|Overall Study|Protocol Violation|2
985234|NCT00523718|3239344|P2|Overall Study|Withdrawal by Subject|0
985235|NCT00523718|3239345|P1|Overall Study|Withdrawal by Subject|1
985236|NCT00523705|3239359|P2|Overall Study|No time for study.|1
985237|NCT00523705|3239360|P1|Overall Study|No time for study.|0
985238|NCT00523640|3239372|P1|Overall Study|Death|1
985239|NCT00523549|3239389|P2|Overall Study|Lost to Follow-up|5
985240|NCT00523549|3239390|P1|Overall Study|Lost to Follow-up|3
985241|NCT00523549|3239389|P2|Overall Study|Patient withdrew consent|6
985242|NCT00523549|3239390|P1|Overall Study|Patient withdrew consent|7
985243|NCT00523549|3239389|P2|Overall Study|Protocol Deviation|1
985244|NCT00523549|3239390|P1|Overall Study|Protocol Deviation|3
985245|NCT00523549|3239389|P2|Overall Study|Unsatisfactory therapeutic effect|1
985246|NCT00523549|3239390|P1|Overall Study|Unsatisfactory therapeutic effect|0
985247|NCT00523549|3239389|P2|Overall Study|Adverse Event|3
985248|NCT00523549|3239390|P1|Overall Study|Adverse Event|6
985249|NCT00523419|3239408|P1|Overall Study|Death due to Adverse Event|2
985250|NCT00523419|3239408|P1|Overall Study|Death due to Study Disease|4
985251|NCT00523419|3239408|P1|Overall Study|Progressive Disease|22
985252|NCT00523419|3239408|P1|Overall Study|Physician Decision|2
985253|NCT00523419|3239408|P1|Overall Study|Withdrawal by Subject|1
985254|NCT00523419|3239408|P1|Overall Study|Adverse Event|1
985255|NCT00523367|3239418|P1|Overall Study|4 Withdrawn by PI|4
985256|NCT00523367|3239418|P1|Overall Study|19 screen failures|19
985257|NCT00523341|3239424|P2|Overall Study|Disease Progression|0
985258|NCT00523341|3239425|P1|Overall Study|Disease Progression|1
985259|NCT00523341|3239424|P2|Overall Study|Ineligibility Determined|4
985260|NCT00523341|3239425|P1|Overall Study|Ineligibility Determined|3
985261|NCT00523341|3239424|P2|Overall Study|Protocol Deviation|5
985262|NCT00523341|3239425|P1|Overall Study|Protocol Deviation|6
985263|NCT00523341|3239424|P2|Overall Study|Requirement for Alternative Therapy|14
985264|NCT00523341|3239425|P1|Overall Study|Requirement for Alternative Therapy|4
985265|NCT00523341|3239424|P2|Overall Study|Physician Decision|13
985266|NCT00523341|3239425|P1|Overall Study|Physician Decision|14
985267|NCT00523341|3239424|P2|Overall Study|Non-compliance|13
985268|NCT00523341|3239425|P1|Overall Study|Non-compliance|20
985269|NCT00523341|3239424|P2|Overall Study|Lost to Follow-up|61
985270|NCT00523341|3239425|P1|Overall Study|Lost to Follow-up|73
985271|NCT00523341|3239424|P2|Overall Study|Death|110
985272|NCT00523341|3239425|P1|Overall Study|Death|101
985273|NCT00523341|3239424|P2|Overall Study|Adverse Event|155
985274|NCT00523341|3239425|P1|Overall Study|Adverse Event|122
985275|NCT00523341|3239424|P2|Overall Study|Other|198
985276|NCT00523341|3239425|P1|Overall Study|Other|181
985277|NCT00523341|3239424|P2|Overall Study|Withdrawal by Subject|427
985278|NCT00523341|3239425|P1|Overall Study|Withdrawal by Subject|399
985279|NCT00522951|3239542|P2|Period 2|residual contrast medium|1
985280|NCT00522951|3239543|P1|Period 2|residual contrast medium|1
985281|NCT00522951|3239542|P2|Period 2|Withdrawal by Subject|0
985282|NCT00522951|3239543|P1|Period 2|Withdrawal by Subject|1
985283|NCT00522951|3239542|P2|Washout Period|Death|1
985284|NCT00522951|3239543|P1|Washout Period|Death|0
985285|NCT00522951|3239542|P2|Washout Period|Adverse Event|1
985286|NCT00522951|3239543|P1|Washout Period|Adverse Event|0
985287|NCT00522951|3239542|P2|Period 1|body motion|1
985288|NCT00522951|3239543|P1|Period 1|body motion|0
985289|NCT00522873|3239598|P2|Overall Study|Never Received Medication|0
985290|NCT00522873|3239599|P1|Overall Study|Never Received Medication|1
985291|NCT00522873|3239598|P2|Overall Study|Medication Errors|1
985292|NCT00522873|3239599|P1|Overall Study|Medication Errors|1
985293|NCT00522873|3239598|P2|Overall Study|Personal Reasons|1
985294|NCT00522873|3239599|P1|Overall Study|Personal Reasons|8
985295|NCT00522873|3239598|P2|Overall Study|Lost to Follow-up|3
985296|NCT00522873|3239599|P1|Overall Study|Lost to Follow-up|11
985297|NCT00522873|3239598|P2|Overall Study|Protocol Violation|4
985298|NCT00522873|3239599|P1|Overall Study|Protocol Violation|14
985299|NCT00522873|3239598|P2|Overall Study|Withdrawal by Subject|9
985300|NCT00522873|3239599|P1|Overall Study|Withdrawal by Subject|20
985301|NCT00522873|3239598|P2|Overall Study|Adverse Event|26
985302|NCT00522873|3239599|P1|Overall Study|Adverse Event|41
985303|NCT00522626|3239612|P1|Overall Study|Lost to Follow-up|7
985304|NCT00522548|3239618|P2|Overall Study|Withdrawal by Subject|2
985305|NCT00522548|3239619|P1|Overall Study|Withdrawal by Subject|0
985306|NCT00522548|3239618|P2|Overall Study|Adverse Event|2
985307|NCT00522548|3239619|P1|Overall Study|Adverse Event|2
985308|NCT00522457|3239647|P1|Overall Study|Adverse Event|2
985309|NCT00522457|3239647|P1|Overall Study|Due to disease progression|16
985310|NCT00522431|3239653|P1|Overall Study|Other/unknown|1
985311|NCT00522431|3239653|P1|Overall Study|Subject non-compliance|1
985312|NCT00522431|3239653|P1|Overall Study|Withdrawal by Subject|2
985313|NCT00522431|3239653|P1|Overall Study|Protocol Violation|2
985314|NCT00522431|3239653|P1|Overall Study|Adverse Event|5
985315|NCT00522418|3239660|P2|Overall Study|Lack of Efficacy|1
985316|NCT00522418|3239661|P1|Overall Study|Lack of Efficacy|0
985317|NCT00522418|3239660|P2|Overall Study|Consent Withdraw|2
985318|NCT00522418|3239661|P1|Overall Study|Consent Withdraw|1
985319|NCT00522418|3239660|P2|Overall Study|Reason Not Specified|1
985320|NCT00522418|3239661|P1|Overall Study|Reason Not Specified|3
985321|NCT00522418|3239660|P2|Overall Study|Noncompliance|2
985322|NCT00522418|3239661|P1|Overall Study|Noncompliance|2
985323|NCT00522418|3239660|P2|Overall Study|Early Study Termination|47
985324|NCT00522418|3239661|P1|Overall Study|Early Study Termination|46
985325|NCT00522418|3239660|P2|Overall Study|Local IRB Consent Violation|5
985326|NCT00522418|3239661|P1|Overall Study|Local IRB Consent Violation|5
985327|NCT00522392|3239709|P2|Overall Study|Non-compliance|1
985328|NCT00522392|3239710|P1|Overall Study|Non-compliance|0
985329|NCT00522392|3239709|P2|Overall Study|Physician Decision|1
985330|NCT00522392|3239710|P1|Overall Study|Physician Decision|0
985331|NCT00522392|3239709|P2|Overall Study|Withdrawal by Subject|1
985332|NCT00522392|3239710|P1|Overall Study|Withdrawal by Subject|1
985333|NCT00522392|3239709|P2|Overall Study|Adverse Event|7
985334|NCT00522392|3239710|P1|Overall Study|Adverse Event|7
985335|NCT00522392|3239709|P2|Overall Study|Disease progression|3
985336|NCT00522392|3239710|P1|Overall Study|Disease progression|0
985337|NCT00522379|3239727|P5|Overall Study|Subject Withdrawal|0
985338|NCT00522379|3239728|P4|Overall Study|Subject Withdrawal|1
985339|NCT00522379|3239729|P3|Overall Study|Subject Withdrawal|0
985340|NCT00522379|3239730|P2|Overall Study|Subject Withdrawal|0
985341|NCT00522379|3239731|P1|Overall Study|Subject Withdrawal|0
985342|NCT00522379|3239727|P5|Overall Study|Site Closed|0
985343|NCT00522379|3239728|P4|Overall Study|Site Closed|1
985344|NCT00522379|3239729|P3|Overall Study|Site Closed|0
985345|NCT00522379|3239730|P2|Overall Study|Site Closed|0
985346|NCT00522379|3239731|P1|Overall Study|Site Closed|0
985347|NCT00522379|3239727|P5|Overall Study|Family Problem|0
985348|NCT00522379|3239728|P4|Overall Study|Family Problem|0
985349|NCT00522379|3239729|P3|Overall Study|Family Problem|1
985350|NCT00522379|3239730|P2|Overall Study|Family Problem|0
985351|NCT00522379|3239731|P1|Overall Study|Family Problem|0
985352|NCT00522379|3239727|P5|Overall Study|Sponsor Request|0
985353|NCT00522379|3239728|P4|Overall Study|Sponsor Request|0
985354|NCT00522379|3239729|P3|Overall Study|Sponsor Request|0
985355|NCT00522379|3239730|P2|Overall Study|Sponsor Request|1
985356|NCT00522379|3239731|P1|Overall Study|Sponsor Request|0
985357|NCT00522379|3239727|P5|Overall Study|Subject Moved|0
985358|NCT00522379|3239728|P4|Overall Study|Subject Moved|0
985359|NCT00522379|3239729|P3|Overall Study|Subject Moved|0
985360|NCT00522379|3239730|P2|Overall Study|Subject Moved|1
985361|NCT00522379|3239731|P1|Overall Study|Subject Moved|1
985362|NCT00522379|3239727|P5|Overall Study|Dispensing error|0
985363|NCT00522379|3239728|P4|Overall Study|Dispensing error|1
985364|NCT00522379|3239729|P3|Overall Study|Dispensing error|0
985365|NCT00522379|3239730|P2|Overall Study|Dispensing error|0
985366|NCT00522379|3239731|P1|Overall Study|Dispensing error|1
985367|NCT00522379|3239727|P5|Overall Study|Randomization error|1
985368|NCT00522379|3239728|P4|Overall Study|Randomization error|0
985369|NCT00522379|3239729|P3|Overall Study|Randomization error|0
985370|NCT00522379|3239730|P2|Overall Study|Randomization error|0
985371|NCT00522379|3239731|P1|Overall Study|Randomization error|0
985372|NCT00522379|3239727|P5|Overall Study|Lost to Follow-up|2
985373|NCT00522379|3239728|P4|Overall Study|Lost to Follow-up|2
985374|NCT00522379|3239729|P3|Overall Study|Lost to Follow-up|4
985375|NCT00522379|3239730|P2|Overall Study|Lost to Follow-up|0
985376|NCT00522379|3239731|P1|Overall Study|Lost to Follow-up|1
985377|NCT00522379|3239727|P5|Overall Study|Unsatisfactory Subject Compliance|0
985378|NCT00522379|3239728|P4|Overall Study|Unsatisfactory Subject Compliance|0
985379|NCT00522379|3239729|P3|Overall Study|Unsatisfactory Subject Compliance|0
985380|NCT00522379|3239730|P2|Overall Study|Unsatisfactory Subject Compliance|2
985381|NCT00522379|3239731|P1|Overall Study|Unsatisfactory Subject Compliance|1
985382|NCT00522379|3239727|P5|Overall Study|Protocol Violation|0
985383|NCT00522379|3239728|P4|Overall Study|Protocol Violation|0
985384|NCT00522379|3239729|P3|Overall Study|Protocol Violation|2
985385|NCT00522379|3239730|P2|Overall Study|Protocol Violation|1
985386|NCT00522379|3239731|P1|Overall Study|Protocol Violation|1
985387|NCT00522379|3239727|P5|Overall Study|Withdrawal by Subject|0
985388|NCT00522379|3239728|P4|Overall Study|Withdrawal by Subject|2
985389|NCT00522379|3239729|P3|Overall Study|Withdrawal by Subject|1
985390|NCT00522379|3239730|P2|Overall Study|Withdrawal by Subject|3
985391|NCT00522379|3239731|P1|Overall Study|Withdrawal by Subject|2
985392|NCT00522379|3239727|P5|Overall Study|Lack of Efficacy|7
985393|NCT00522379|3239728|P4|Overall Study|Lack of Efficacy|2
985394|NCT00522379|3239729|P3|Overall Study|Lack of Efficacy|2
985395|NCT00522379|3239730|P2|Overall Study|Lack of Efficacy|0
985396|NCT00522379|3239731|P1|Overall Study|Lack of Efficacy|3
985397|NCT00522379|3239727|P5|Overall Study|Adverse Event|17
985398|NCT00522379|3239728|P4|Overall Study|Adverse Event|5
985399|NCT00522379|3239729|P3|Overall Study|Adverse Event|12
985400|NCT00522379|3239730|P2|Overall Study|Adverse Event|15
985401|NCT00522379|3239731|P1|Overall Study|Adverse Event|12
985402|NCT00522301|3239833|P1|Overall Study|Adverse Event|5
985403|NCT00522301|3239833|P1|Overall Study|Withdrawal by Subject|1
985404|NCT00522275|3239837|P1|Overall Study|Other: Subject had surgery for epilepsy|2
985405|NCT00522275|3239837|P1|Overall Study|Other: Subject ran out of medication|1
985406|NCT00522275|3239837|P1|Overall Study|Other: Sponsor request|2
985407|NCT00522275|3239837|P1|Overall Study|Other: Travel to / from site difficulty|3
985408|NCT00522275|3239837|P1|Overall Study|Other: Site / clinic closed|4
985409|NCT00522275|3239837|P1|Overall Study|Other: Subject arrested|1
985410|NCT00522275|3239837|P1|Overall Study|Other: Subject relocated|2
985411|NCT00522275|3239837|P1|Overall Study|Other: Subject is pregnant|2
985412|NCT00522275|3239837|P1|Overall Study|Other: Subject wants to become pregnant|2
985413|NCT00522275|3239837|P1|Overall Study|Lost to Follow-up|8
985414|NCT00522275|3239837|P1|Overall Study|Unsatisfactory compliance|11
985415|NCT00522275|3239837|P1|Overall Study|Protocol deviation|1
985416|NCT00522275|3239837|P1|Overall Study|Subject withdrew consent|16
985417|NCT00522275|3239837|P1|Overall Study|Lack of Efficacy|80
985418|NCT00522275|3239837|P1|Overall Study|Adverse Event|35
985419|NCT00522041|3239858|P2|Overall Study|Did not receive treatment|1
985420|NCT00522041|3239859|P1|Overall Study|Did not receive treatment|0
985421|NCT00522041|3239858|P2|Overall Study|Voluntary withdrawal|4
985422|NCT00522041|3239859|P1|Overall Study|Voluntary withdrawal|5
985423|NCT00522041|3239858|P2|Overall Study|Lost to Follow-up|4
985424|NCT00522041|3239859|P1|Overall Study|Lost to Follow-up|1
985425|NCT00522041|3239858|P2|Overall Study|Protocol Violation|0
985426|NCT00522041|3239859|P1|Overall Study|Protocol Violation|2
985427|NCT00522041|3239858|P2|Overall Study|Adverse Event|3
985428|NCT00522041|3239859|P1|Overall Study|Adverse Event|9
985429|NCT00521599|3239918|P3|Overall Study|Did not meet protocol eligibility|1
985430|NCT00521599|3239919|P2|Overall Study|Did not meet protocol eligibility|2
985431|NCT00521599|3239920|P1|Overall Study|Did not meet protocol eligibility|2
985432|NCT00521599|3239918|P3|Overall Study|Protocol Violation|2
985433|NCT00521599|3239919|P2|Overall Study|Protocol Violation|4
985434|NCT00521599|3239920|P1|Overall Study|Protocol Violation|2
985435|NCT00521599|3239918|P3|Overall Study|Withdrawal by subject treatment related|2
985436|NCT00521599|3239919|P2|Overall Study|Withdrawal by subject treatment related|1
985437|NCT00521599|3239920|P1|Overall Study|Withdrawal by subject treatment related|3
985438|NCT00521599|3239918|P3|Overall Study|Withdrawal by Subject|1
985439|NCT00521599|3239919|P2|Overall Study|Withdrawal by Subject|5
985440|NCT00521599|3239920|P1|Overall Study|Withdrawal by Subject|3
985441|NCT00521599|3239918|P3|Overall Study|Lost to Follow-up|2
985442|NCT00521599|3239919|P2|Overall Study|Lost to Follow-up|1
985443|NCT00521599|3239920|P1|Overall Study|Lost to Follow-up|2
985444|NCT00521599|3239918|P3|Overall Study|Treatment Failure|22
985445|NCT00521599|3239919|P2|Overall Study|Treatment Failure|9
985446|NCT00521599|3239920|P1|Overall Study|Treatment Failure|8
985447|NCT00521599|3239918|P3|Overall Study|Adverse Event|6
985448|NCT00521599|3239919|P2|Overall Study|Adverse Event|7
985449|NCT00521599|3239920|P1|Overall Study|Adverse Event|5
985450|NCT00521586|3239931|P2|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7
985451|NCT00521586|3239932|P1|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2
985452|NCT00521586|3239931|P2|Revaccination With 13vPnC (Year 5)|Failed to return|4
985453|NCT00521586|3239932|P1|Revaccination With 13vPnC (Year 5)|Failed to return|1
985454|NCT00521586|3239931|P2|Revaccination With 13vPnC (Year 5)|Subject request|1
985455|NCT00521586|3239932|P1|Revaccination With 13vPnC (Year 5)|Subject request|0
985456|NCT00521586|3239931|P2|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57
985457|NCT00521586|3239932|P1|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54
985458|NCT00521586|3239931|P2|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22
985459|NCT00521586|3239932|P1|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18
985460|NCT00521586|3239931|P2|Follow-up (From 6-month[Year 0]-Year 5)|Other|26
985461|NCT00521586|3239932|P1|Follow-up (From 6-month[Year 0]-Year 5)|Other|22
985462|NCT00521586|3239931|P2|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56
985463|NCT00521586|3239932|P1|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55
985464|NCT00521586|3239931|P2|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
985465|NCT00521586|3239932|P1|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
985466|NCT00521586|3239931|P2|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3
985467|NCT00521586|3239932|P1|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7
985468|NCT00521586|3239931|P2|Follow-up (From 6-month[Year 0]-Year 5)|Death|2
985469|NCT00521586|3239932|P1|Follow-up (From 6-month[Year 0]-Year 5)|Death|5
985470|NCT00521586|3239931|P2|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1
985471|NCT00521586|3239932|P1|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5
985472|NCT00521586|3239931|P2|Initial Vaccination (Year 0)|Failed to return|1
985473|NCT00521586|3239932|P1|Initial Vaccination (Year 0)|Failed to return|0
985474|NCT00521586|3239931|P2|Initial Vaccination (Year 0)|Death|0
985475|NCT00521586|3239932|P1|Initial Vaccination (Year 0)|Death|1
985476|NCT00521586|3239931|P2|Initial Vaccination (Year 0)|Adverse Event|1
985477|NCT00521586|3239932|P1|Initial Vaccination (Year 0)|Adverse Event|0
985478|NCT00521586|3239931|P2|Initial Vaccination (Year 0)|Investigator request|0
985479|NCT00521586|3239932|P1|Initial Vaccination (Year 0)|Investigator request|2
985480|NCT00521586|3239931|P2|Initial Vaccination (Year 0)|Other, unspecified|1
985481|NCT00521586|3239932|P1|Initial Vaccination (Year 0)|Other, unspecified|3
985482|NCT00521586|3239931|P2|Initial Vaccination (Year 0)|Protocol Violation|5
985483|NCT00521586|3239932|P1|Initial Vaccination (Year 0)|Protocol Violation|2
985484|NCT00521586|3239931|P2|Initial Vaccination (Year 0)|Lost to Follow-up|10
985485|NCT00521586|3239932|P1|Initial Vaccination (Year 0)|Lost to Follow-up|5
985486|NCT00521586|3239931|P2|Initial Vaccination (Year 0)|Subject request|11
985487|NCT00521586|3239932|P1|Initial Vaccination (Year 0)|Subject request|8
985488|NCT00521365|3240005|P1|Overall Study|Usage of not allowed drugs|6
985489|NCT00521365|3240005|P1|Overall Study|Drug compliance|3
985490|NCT00521365|3240005|P1|Overall Study|Protocol deviation|2
985491|NCT00521365|3240005|P1|Overall Study|Lost to Follow-up|6
985492|NCT00521365|3240005|P1|Overall Study|Adverse Event|3
985493|NCT00521339|3240035|P3|Treatment Extension Phase|Death|1
985494|NCT00521339|3240036|P2|Treatment Extension Phase|Death|0
985495|NCT00521339|3240037|P1|Treatment Extension Phase|Death|0
985496|NCT00521339|3240035|P3|Treatment Extension Phase|Withdrawal by Subject|2
985497|NCT00521339|3240036|P2|Treatment Extension Phase|Withdrawal by Subject|0
985498|NCT00521339|3240037|P1|Treatment Extension Phase|Withdrawal by Subject|0
985499|NCT00521339|3240035|P3|Treatment Phase|Protocol Violation|0
985500|NCT00521339|3240036|P2|Treatment Phase|Protocol Violation|0
985501|NCT00521339|3240037|P1|Treatment Phase|Protocol Violation|1
985502|NCT00521339|3240035|P3|Treatment Phase|Lost to Follow-up|0
985503|NCT00521339|3240036|P2|Treatment Phase|Lost to Follow-up|0
985504|NCT00521339|3240037|P1|Treatment Phase|Lost to Follow-up|1
985505|NCT00521339|3240035|P3|Treatment Phase|Withdrawal by Subject|0
985506|NCT00521339|3240036|P2|Treatment Phase|Withdrawal by Subject|0
985507|NCT00521339|3240037|P1|Treatment Phase|Withdrawal by Subject|3
985508|NCT00521339|3240035|P3|Treatment Phase|Lack of Efficacy|0
985509|NCT00521339|3240036|P2|Treatment Phase|Lack of Efficacy|0
985510|NCT00521339|3240037|P1|Treatment Phase|Lack of Efficacy|3
985511|NCT00521339|3240035|P3|Treatment Phase|Intolerability to study drug|0
985512|NCT00521339|3240036|P2|Treatment Phase|Intolerability to study drug|0
985513|NCT00521339|3240037|P1|Treatment Phase|Intolerability to study drug|2
985514|NCT00521339|3240035|P3|Treatment Phase|Adverse Event|0
985515|NCT00521339|3240036|P2|Treatment Phase|Adverse Event|0
985516|NCT00521339|3240037|P1|Treatment Phase|Adverse Event|2
985517|NCT00521144|3240105|P5|Overall Study|Progressive Disease|6
985518|NCT00521144|3240106|P4|Overall Study|Progressive Disease|0
985519|NCT00521144|3240107|P3|Overall Study|Progressive Disease|2
985520|NCT00521144|3240108|P2|Overall Study|Progressive Disease|2
985521|NCT00521144|3240109|P1|Overall Study|Progressive Disease|4
985522|NCT00521144|3240105|P5|Overall Study|Adverse Event|1
985523|NCT00521144|3240106|P4|Overall Study|Adverse Event|0
985524|NCT00521144|3240107|P3|Overall Study|Adverse Event|0
985525|NCT00521144|3240108|P2|Overall Study|Adverse Event|1
985526|NCT00521144|3240109|P1|Overall Study|Adverse Event|0
985527|NCT00521144|3240105|P5|Overall Study|Not Treated|0
985528|NCT00521144|3240106|P4|Overall Study|Not Treated|1
985529|NCT00521144|3240107|P3|Overall Study|Not Treated|0
985530|NCT00521144|3240108|P2|Overall Study|Not Treated|0
985531|NCT00521144|3240109|P1|Overall Study|Not Treated|0
985532|NCT00521079|3240123|P2|Overall Study|Withdrawal by Subject|3
985533|NCT00521079|3240124|P1|Overall Study|Withdrawal by Subject|5
985534|NCT00521079|3240123|P2|Overall Study|Lost to Follow-up|1
985535|NCT00521079|3240124|P1|Overall Study|Lost to Follow-up|2
985536|NCT00521079|3240123|P2|Overall Study|Adverse Event|1
985537|NCT00521079|3240124|P1|Overall Study|Adverse Event|7
985538|NCT00521053|3240134|P1|Observation Phase|Physician Decision|1
985539|NCT00521053|3240134|P1|Observation Phase|Other non-study melanoma treatment|1
985540|NCT00521053|3240134|P1|Observation Phase|Adverse Event|1
985541|NCT00521053|3240134|P1|Observation Phase|Death|2
985542|NCT00521053|3240134|P1|Observation Phase|Additional PV-10 via alternate protocol|8
985543|NCT00521053|3240134|P1|Observation Phase|Disease Progression|55
985544|NCT00521014|3240144|P1|Overall Study|Inevaluable, not treated|1
985545|NCT00521001|3240148|P1|Overall Study|Ineligible|1
985546|NCT00520975|3240157|P2|Overall Study|Not start protocol therapy|2
985547|NCT00520975|3240158|P1|Overall Study|Not start protocol therapy|1
985548|NCT00520975|3240157|P2|Overall Study|Other reasons|2
985549|NCT00520975|3240158|P1|Overall Study|Other reasons|4
985550|NCT00520975|3240157|P2|Overall Study|Other therapy|4
985551|NCT00520975|3240158|P1|Overall Study|Other therapy|2
985552|NCT00520975|3240157|P2|Overall Study|Withdrawal by Subject|5
985553|NCT00520975|3240158|P1|Overall Study|Withdrawal by Subject|3
985554|NCT00520975|3240157|P2|Overall Study|Death|2
985555|NCT00520975|3240158|P1|Overall Study|Death|0
985556|NCT00520975|3240157|P2|Overall Study|Adverse Event|10
985557|NCT00520975|3240158|P1|Overall Study|Adverse Event|7
985558|NCT00520975|3240157|P2|Overall Study|Disease progression|23
985559|NCT00520975|3240158|P1|Overall Study|Disease progression|31
985560|NCT00520936|3240190|P8|Overall Study|Protocol Violation|0
985561|NCT00520936|3240191|P7|Overall Study|Protocol Violation|1
985562|NCT00520936|3240192|P6|Overall Study|Protocol Violation|0
985563|NCT00520936|3240193|P5|Overall Study|Protocol Violation|1
985564|NCT00520936|3240194|P4|Overall Study|Protocol Violation|0
985565|NCT00520936|3240195|P3|Overall Study|Protocol Violation|1
985566|NCT00520936|3240196|P2|Overall Study|Protocol Violation|1
985567|NCT00520936|3240197|P1|Overall Study|Protocol Violation|0
985568|NCT00520936|3240190|P8|Overall Study|Death|0
985569|NCT00520936|3240191|P7|Overall Study|Death|1
985570|NCT00520936|3240192|P6|Overall Study|Death|0
985571|NCT00520936|3240193|P5|Overall Study|Death|0
985572|NCT00520936|3240194|P4|Overall Study|Death|0
985573|NCT00520936|3240195|P3|Overall Study|Death|0
985574|NCT00520936|3240196|P2|Overall Study|Death|0
985575|NCT00520936|3240197|P1|Overall Study|Death|0
985576|NCT00520936|3240190|P8|Overall Study|Toxicity Requiring Removal from Study|0
985577|NCT00520936|3240191|P7|Overall Study|Toxicity Requiring Removal from Study|2
985578|NCT00520936|3240192|P6|Overall Study|Toxicity Requiring Removal from Study|0
985579|NCT00520936|3240193|P5|Overall Study|Toxicity Requiring Removal from Study|0
985580|NCT00520936|3240194|P4|Overall Study|Toxicity Requiring Removal from Study|0
985581|NCT00520936|3240195|P3|Overall Study|Toxicity Requiring Removal from Study|0
985582|NCT00520936|3240196|P2|Overall Study|Toxicity Requiring Removal from Study|1
985583|NCT00520936|3240197|P1|Overall Study|Toxicity Requiring Removal from Study|0
985584|NCT00520936|3240190|P8|Overall Study|Withdrawal by Subject|1
985585|NCT00520936|3240191|P7|Overall Study|Withdrawal by Subject|0
985586|NCT00520936|3240192|P6|Overall Study|Withdrawal by Subject|0
985587|NCT00520936|3240193|P5|Overall Study|Withdrawal by Subject|0
985588|NCT00520936|3240194|P4|Overall Study|Withdrawal by Subject|0
985589|NCT00520936|3240195|P3|Overall Study|Withdrawal by Subject|0
985590|NCT00520936|3240196|P2|Overall Study|Withdrawal by Subject|0
985591|NCT00520936|3240197|P1|Overall Study|Withdrawal by Subject|0
985592|NCT00520936|3240190|P8|Overall Study|Physician Decision|0
985593|NCT00520936|3240191|P7|Overall Study|Physician Decision|0
985594|NCT00520936|3240192|P6|Overall Study|Physician Decision|0
985595|NCT00520936|3240193|P5|Overall Study|Physician Decision|0
985596|NCT00520936|3240194|P4|Overall Study|Physician Decision|0
985597|NCT00520936|3240195|P3|Overall Study|Physician Decision|1
985598|NCT00520936|3240196|P2|Overall Study|Physician Decision|2
985599|NCT00520936|3240197|P1|Overall Study|Physician Decision|0
985600|NCT00520845|3240224|P1|Overall Study|Alternative Therapy|1
985601|NCT00520845|3240224|P1|Overall Study|Withdrawal by Subject|1
985602|NCT00520845|3240224|P1|Overall Study|Disease Progression, relapse|13
985603|NCT00520845|3240224|P1|Overall Study|Adverse Event|4
985604|NCT00520845|3240224|P1|Overall Study|Death|3
985605|NCT00520767|3240232|P1|Overall Study|Death|2
985606|NCT00520741|3240238|P2|Overall Study|Other reasons for premature termination|6
985607|NCT00520741|3240239|P1|Overall Study|Other reasons for premature termination|0
985608|NCT00520741|3240238|P2|Overall Study|Lost to Follow-up|4
985609|NCT00520741|3240239|P1|Overall Study|Lost to Follow-up|4
985610|NCT00520741|3240238|P2|Overall Study|Unsatisfactory compliance of subject|3
985611|NCT00520741|3240239|P1|Overall Study|Unsatisfactory compliance of subject|4
985612|NCT00520741|3240238|P2|Overall Study|Protocol Violation|15
985613|NCT00520741|3240239|P1|Overall Study|Protocol Violation|2
985614|NCT00520741|3240238|P2|Overall Study|Withdrawal by Subject|11
985615|NCT00520741|3240239|P1|Overall Study|Withdrawal by Subject|0
985616|NCT00520741|3240238|P2|Overall Study|Lack of Efficacy|30
985617|NCT00520741|3240239|P1|Overall Study|Lack of Efficacy|11
985618|NCT00520741|3240238|P2|Overall Study|Adverse Event|56
985619|NCT00520741|3240239|P1|Overall Study|Adverse Event|16
985620|NCT00520676|3240257|P2|Overall Study|Withdrawal by Subject|11
985621|NCT00520676|3240258|P1|Overall Study|Withdrawal by Subject|7
985622|NCT00520676|3240257|P2|Overall Study|Physician Decision|1
985623|NCT00520676|3240258|P1|Overall Study|Physician Decision|4
985624|NCT00520676|3240257|P2|Overall Study|Lost to Follow-up|10
985625|NCT00520676|3240258|P1|Overall Study|Lost to Follow-up|6
985626|NCT00520676|3240257|P2|Overall Study|Death|81
985627|NCT00520676|3240258|P1|Overall Study|Death|84
985628|NCT00520572|3240284|P6|Overall Study|Did not receive Treatment|0
985629|NCT00520572|3240285|P5|Overall Study|Did not receive Treatment|0
985630|NCT00520572|3240286|P4|Overall Study|Did not receive Treatment|0
985631|NCT00520572|3240287|P3|Overall Study|Did not receive Treatment|1
985632|NCT00520572|3240288|P2|Overall Study|Did not receive Treatment|0
985633|NCT00520572|3240289|P1|Overall Study|Did not receive Treatment|1
985634|NCT00520572|3240284|P6|Overall Study|Long break in taking Medication|0
985635|NCT00520572|3240285|P5|Overall Study|Long break in taking Medication|0
985636|NCT00520572|3240286|P4|Overall Study|Long break in taking Medication|1
985637|NCT00520572|3240287|P3|Overall Study|Long break in taking Medication|0
985638|NCT00520572|3240288|P2|Overall Study|Long break in taking Medication|0
985639|NCT00520572|3240289|P1|Overall Study|Long break in taking Medication|0
985640|NCT00520572|3240284|P6|Overall Study|Oral corticotherapy for acute urticaria|0
985641|NCT00520572|3240285|P5|Overall Study|Oral corticotherapy for acute urticaria|0
985642|NCT00520572|3240286|P4|Overall Study|Oral corticotherapy for acute urticaria|0
985643|NCT00520572|3240287|P3|Overall Study|Oral corticotherapy for acute urticaria|0
985644|NCT00520572|3240288|P2|Overall Study|Oral corticotherapy for acute urticaria|1
985645|NCT00520572|3240289|P1|Overall Study|Oral corticotherapy for acute urticaria|0
985646|NCT00520572|3240284|P6|Overall Study|Incorrect enrollment|0
985647|NCT00520572|3240285|P5|Overall Study|Incorrect enrollment|1
985648|NCT00520572|3240286|P4|Overall Study|Incorrect enrollment|0
985649|NCT00520572|3240287|P3|Overall Study|Incorrect enrollment|1
985650|NCT00520572|3240288|P2|Overall Study|Incorrect enrollment|0
985651|NCT00520572|3240289|P1|Overall Study|Incorrect enrollment|1
985652|NCT00520572|3240284|P6|Overall Study|Lost to Follow-up|0
985653|NCT00520572|3240285|P5|Overall Study|Lost to Follow-up|1
985654|NCT00520572|3240286|P4|Overall Study|Lost to Follow-up|0
985655|NCT00520572|3240287|P3|Overall Study|Lost to Follow-up|0
985656|NCT00520572|3240288|P2|Overall Study|Lost to Follow-up|0
985657|NCT00520572|3240289|P1|Overall Study|Lost to Follow-up|0
985658|NCT00520572|3240284|P6|Overall Study|Lack of Efficacy|0
985659|NCT00520572|3240285|P5|Overall Study|Lack of Efficacy|1
985660|NCT00520572|3240286|P4|Overall Study|Lack of Efficacy|2
985661|NCT00520572|3240287|P3|Overall Study|Lack of Efficacy|1
985662|NCT00520572|3240288|P2|Overall Study|Lack of Efficacy|1
985663|NCT00520572|3240289|P1|Overall Study|Lack of Efficacy|1
985664|NCT00520572|3240284|P6|Overall Study|Protocol Violation|0
985665|NCT00520572|3240285|P5|Overall Study|Protocol Violation|0
985666|NCT00520572|3240286|P4|Overall Study|Protocol Violation|0
985667|NCT00520572|3240287|P3|Overall Study|Protocol Violation|1
985668|NCT00520572|3240288|P2|Overall Study|Protocol Violation|0
985669|NCT00520572|3240289|P1|Overall Study|Protocol Violation|0
985670|NCT00520572|3240284|P6|Overall Study|Withdrawal by Subject|0
985671|NCT00520572|3240285|P5|Overall Study|Withdrawal by Subject|2
985672|NCT00520572|3240286|P4|Overall Study|Withdrawal by Subject|2
985673|NCT00520572|3240287|P3|Overall Study|Withdrawal by Subject|5
985674|NCT00520572|3240288|P2|Overall Study|Withdrawal by Subject|9
985675|NCT00520572|3240289|P1|Overall Study|Withdrawal by Subject|0
985676|NCT00520572|3240284|P6|Overall Study|Adverse Event|2
985677|NCT00520572|3240285|P5|Overall Study|Adverse Event|7
985678|NCT00520572|3240286|P4|Overall Study|Adverse Event|9
985679|NCT00520572|3240287|P3|Overall Study|Adverse Event|6
985680|NCT00520572|3240288|P2|Overall Study|Adverse Event|3
985681|NCT00520572|3240289|P1|Overall Study|Adverse Event|9
985682|NCT00520546|3240327|P1|Overall Study|failed radiopharmaceut. synthesis of FEC|5
985683|NCT00520546|3240327|P1|Overall Study|Withdrawal by Subject|1
985684|NCT00520494|3240342|P1|Overall Study|Withdrawal by Subject|1
985685|NCT00520481|3240367|P2|Overall Study|Withdrawal by Subject|0
985686|NCT00520481|3240368|P1|Overall Study|Withdrawal by Subject|3
985687|NCT00520481|3240367|P2|Overall Study|Adverse Event|1
985688|NCT00520481|3240368|P1|Overall Study|Adverse Event|4
985689|NCT00520403|3240392|P1|Bevacizumab Monotherapy|Symptomatic progression of cancer|1
985690|NCT00520403|3240392|P1|Bevacizumab Monotherapy|Radiological progression of cancer|1
985691|NCT00520403|3240392|P1|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1
985692|NCT00520403|3240392|P1|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1
985693|NCT00520403|3240392|P1|Bevacizumab + IFN/Vinblastine|Death|2
985694|NCT00520403|3240392|P1|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4
985695|NCT00520403|3240392|P1|Bevacizumab + IFN/Vinblastine|Adverse Event|4
985696|NCT00520403|3240392|P1|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6
985697|NCT00520351|3240401|P2|First Intervention|Withdrawal by Subject|1
985698|NCT00520351|3240402|P1|First Intervention|Withdrawal by Subject|1
985699|NCT00520299|3240417|P3|Overall Study|Progressive disease|4
985700|NCT00520299|3240418|P2|Overall Study|Progressive disease|3
985701|NCT00520299|3240419|P1|Overall Study|Progressive disease|0
985702|NCT00520299|3240417|P3|Overall Study|Withdrawal by Subject|2
985703|NCT00520299|3240418|P2|Overall Study|Withdrawal by Subject|0
985704|NCT00520299|3240419|P1|Overall Study|Withdrawal by Subject|0
985705|NCT00520130|3240474|P2|Overall Study|Physician Decision|1
985706|NCT00520130|3240475|P1|Overall Study|Physician Decision|1
985707|NCT00520130|3240474|P2|Overall Study|Disease progression on study|0
985708|NCT00520130|3240475|P1|Overall Study|Disease progression on study|4
985709|NCT00520039|3240517|P2|Overall Study|Exclusion criteria met at first visit|5
985710|NCT00520039|3240518|P1|Overall Study|Exclusion criteria met at first visit|7
985711|NCT00520013|3240531|P3|Overall Study|Physician Decision|3
985712|NCT00520013|3240532|P2|Overall Study|Physician Decision|0
985713|NCT00520013|3240533|P1|Overall Study|Physician Decision|0
985714|NCT00520013|3240531|P3|Overall Study|Death|0
985715|NCT00520013|3240532|P2|Overall Study|Death|1
985716|NCT00520013|3240533|P1|Overall Study|Death|0
985717|NCT00520013|3240531|P3|Overall Study|Clinical Progression|0
985718|NCT00520013|3240532|P2|Overall Study|Clinical Progression|1
985719|NCT00520013|3240533|P1|Overall Study|Clinical Progression|3
985720|NCT00520013|3240531|P3|Overall Study|Progressive Disease|0
985721|NCT00520013|3240532|P2|Overall Study|Progressive Disease|3
985722|NCT00520013|3240533|P1|Overall Study|Progressive Disease|7
985723|NCT00520013|3240531|P3|Overall Study|Adverse Event|7
985724|NCT00520013|3240532|P2|Overall Study|Adverse Event|10
985725|NCT00520013|3240533|P1|Overall Study|Adverse Event|2
985726|NCT00520013|3240531|P3|Overall Study|Withdrawal by Subject|1
985727|NCT00520013|3240532|P2|Overall Study|Withdrawal by Subject|0
985728|NCT00520013|3240533|P1|Overall Study|Withdrawal by Subject|0
985729|NCT00519896|3240543|P1|Overall Study|Adverse Event|1
985730|NCT00519896|3240543|P1|Overall Study|Protocol Violation|1
985731|NCT00519831|3240549|P1|Overall Study|Adverse Event|3
985732|NCT00519779|3240566|P2|Overall Study|Withdrawal by Subject|1
985733|NCT00519779|3240567|P1|Overall Study|Withdrawal by Subject|0
985734|NCT00519649|3240583|P1|Overall Study|Withdrawal by Subject|1
985735|NCT00519636|3240596|P4|Post Study Period|Subject randomized in error|1
985736|NCT00519636|3240597|P3|Post Study Period|Subject randomized in error|0
985737|NCT00519636|3240598|P2|Post Study Period|Subject randomized in error|0
985738|NCT00519636|3240599|P1|Post Study Period|Subject randomized in error|0
985739|NCT00519636|3240596|P4|Treatment Period 2|Subject misrandomized|1
985740|NCT00519636|3240597|P3|Treatment Period 2|Subject misrandomized|0
985741|NCT00519636|3240598|P2|Treatment Period 2|Subject misrandomized|0
985742|NCT00519636|3240599|P1|Treatment Period 2|Subject misrandomized|0
985743|NCT00519636|3240596|P4|Treatment Period 2|Per doctors request|0
985744|NCT00519636|3240597|P3|Treatment Period 2|Per doctors request|1
985745|NCT00519636|3240598|P2|Treatment Period 2|Per doctors request|0
985746|NCT00519636|3240599|P1|Treatment Period 2|Per doctors request|0
985747|NCT00519636|3240596|P4|Treatment Period 2|Subject randomized in error|0
985748|NCT00519636|3240597|P3|Treatment Period 2|Subject randomized in error|0
985749|NCT00519636|3240598|P2|Treatment Period 2|Subject randomized in error|1
985750|NCT00519636|3240599|P1|Treatment Period 2|Subject randomized in error|0
985751|NCT00519636|3240596|P4|Treatment Period 2|Failed To Meet Continuation Criteria|1
985752|NCT00519636|3240597|P3|Treatment Period 2|Failed To Meet Continuation Criteria|0
985753|NCT00519636|3240598|P2|Treatment Period 2|Failed To Meet Continuation Criteria|0
985754|NCT00519636|3240599|P1|Treatment Period 2|Failed To Meet Continuation Criteria|0
985755|NCT00519636|3240596|P4|Washout Period|Prohibited medications|0
985756|NCT00519636|3240597|P3|Washout Period|Prohibited medications|1
985757|NCT00519636|3240598|P2|Washout Period|Prohibited medications|0
985758|NCT00519636|3240599|P1|Washout Period|Prohibited medications|0
985759|NCT00519636|3240596|P4|Washout Period|Subject randomized in error|0
985760|NCT00519636|3240597|P3|Washout Period|Subject randomized in error|1
985761|NCT00519636|3240598|P2|Washout Period|Subject randomized in error|0
985762|NCT00519636|3240599|P1|Washout Period|Subject randomized in error|0
985763|NCT00519636|3240596|P4|Washout Period|Per doctors request|0
985764|NCT00519636|3240597|P3|Washout Period|Per doctors request|0
985765|NCT00519636|3240598|P2|Washout Period|Per doctors request|1
985766|NCT00519636|3240599|P1|Washout Period|Per doctors request|0
985767|NCT00519636|3240596|P4|Washout Period|Non-compliant|0
985768|NCT00519636|3240597|P3|Washout Period|Non-compliant|0
985769|NCT00519636|3240598|P2|Washout Period|Non-compliant|1
985770|NCT00519636|3240599|P1|Washout Period|Non-compliant|0
985771|NCT00519636|3240596|P4|Washout Period|Participating in study at another site|0
985772|NCT00519636|3240597|P3|Washout Period|Participating in study at another site|0
985773|NCT00519636|3240598|P2|Washout Period|Participating in study at another site|0
985774|NCT00519636|3240599|P1|Washout Period|Participating in study at another site|1
985775|NCT00519636|3240596|P4|Washout Period|Out of pollen area > 48 hours|0
985776|NCT00519636|3240597|P3|Washout Period|Out of pollen area > 48 hours|0
985777|NCT00519636|3240598|P2|Washout Period|Out of pollen area > 48 hours|0
985778|NCT00519636|3240599|P1|Washout Period|Out of pollen area > 48 hours|1
985779|NCT00519636|3240596|P4|Washout Period|Failed to meet continuation criteria|3
985780|NCT00519636|3240597|P3|Washout Period|Failed to meet continuation criteria|9
985781|NCT00519636|3240598|P2|Washout Period|Failed to meet continuation criteria|11
985782|NCT00519636|3240599|P1|Washout Period|Failed to meet continuation criteria|14
985783|NCT00519636|3240596|P4|Washout Period|Withdrawal by Subject|0
985784|NCT00519636|3240597|P3|Washout Period|Withdrawal by Subject|1
985785|NCT00519636|3240598|P2|Washout Period|Withdrawal by Subject|0
985786|NCT00519636|3240599|P1|Washout Period|Withdrawal by Subject|1
985787|NCT00519636|3240596|P4|Washout Period|Protocol Violation|2
985788|NCT00519636|3240597|P3|Washout Period|Protocol Violation|1
985789|NCT00519636|3240598|P2|Washout Period|Protocol Violation|0
985790|NCT00519636|3240599|P1|Washout Period|Protocol Violation|0
985791|NCT00519636|3240596|P4|Washout Period|Lost to Follow-up|0
985792|NCT00519636|3240597|P3|Washout Period|Lost to Follow-up|0
985793|NCT00519636|3240598|P2|Washout Period|Lost to Follow-up|0
985794|NCT00519636|3240599|P1|Washout Period|Lost to Follow-up|1
985795|NCT00519636|3240596|P4|Washout Period|Adverse Event|0
985796|NCT00519636|3240597|P3|Washout Period|Adverse Event|1
985797|NCT00519636|3240598|P2|Washout Period|Adverse Event|1
985798|NCT00519636|3240599|P1|Washout Period|Adverse Event|2
985799|NCT00519636|3240596|P4|Treatment Period 1|Sponsor request due to missed visit|0
985800|NCT00519636|3240597|P3|Treatment Period 1|Sponsor request due to missed visit|0
985801|NCT00519636|3240598|P2|Treatment Period 1|Sponsor request due to missed visit|0
985802|NCT00519636|3240599|P1|Treatment Period 1|Sponsor request due to missed visit|1
985803|NCT00519636|3240596|P4|Treatment Period 1|Adverse Event|0
985804|NCT00519636|3240597|P3|Treatment Period 1|Adverse Event|1
985805|NCT00519636|3240598|P2|Treatment Period 1|Adverse Event|0
985806|NCT00519636|3240599|P1|Treatment Period 1|Adverse Event|1
985807|NCT00519623|3240629|P1|Overall Study|Adverse Event|1
985808|NCT00519532|3240663|P1|Overall Study|Lost to Follow-up|2
985809|NCT00519532|3240663|P1|Overall Study|Withdrawal by Subject|5
985810|NCT00519532|3240663|P1|Overall Study|Adverse Event|11
985811|NCT00519428|3240673|P3|Overall Study|unstated|2
985812|NCT00519428|3240674|P2|Overall Study|unstated|3
985813|NCT00519428|3240675|P1|Overall Study|unstated|1
985814|NCT00519428|3240673|P3|Overall Study|Withdrawal by Subject|7
985815|NCT00519428|3240674|P2|Overall Study|Withdrawal by Subject|3
985816|NCT00519428|3240675|P1|Overall Study|Withdrawal by Subject|8
985817|NCT00519428|3240673|P3|Overall Study|Lost to Follow-up|6
985818|NCT00519428|3240674|P2|Overall Study|Lost to Follow-up|7
985819|NCT00519428|3240675|P1|Overall Study|Lost to Follow-up|7
985820|NCT00519428|3240673|P3|Overall Study|Adverse Event|10
985821|NCT00519428|3240674|P2|Overall Study|Adverse Event|2
985822|NCT00519428|3240675|P1|Overall Study|Adverse Event|5
985823|NCT00519376|3240695|P16|Treatment Period 4|Lost to Follow-up|0
985824|NCT00519376|3240696|P15|Treatment Period 4|Lost to Follow-up|0
985825|NCT00519376|3240697|P14|Treatment Period 4|Lost to Follow-up|0
985826|NCT00519376|3240698|P13|Treatment Period 4|Lost to Follow-up|0
985827|NCT00519376|3240699|P12|Treatment Period 4|Lost to Follow-up|0
985828|NCT00519376|3240700|P11|Treatment Period 4|Lost to Follow-up|0
985829|NCT00519376|3240701|P10|Treatment Period 4|Lost to Follow-up|0
985830|NCT00519376|3240702|P9|Treatment Period 4|Lost to Follow-up|0
985831|NCT00519376|3240703|P8|Treatment Period 4|Lost to Follow-up|0
985832|NCT00519376|3240704|P7|Treatment Period 4|Lost to Follow-up|0
985833|NCT00519376|3240705|P6|Treatment Period 4|Lost to Follow-up|0
985834|NCT00519376|3240706|P5|Treatment Period 4|Lost to Follow-up|0
985835|NCT00519376|3240707|P4|Treatment Period 4|Lost to Follow-up|0
985836|NCT00519376|3240708|P3|Treatment Period 4|Lost to Follow-up|1
985837|NCT00519376|3240709|P2|Treatment Period 4|Lost to Follow-up|0
985838|NCT00519376|3240710|P1|Treatment Period 4|Lost to Follow-up|0
985839|NCT00519376|3240695|P16|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
985840|NCT00519376|3240696|P15|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
985841|NCT00519376|3240697|P14|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
985842|NCT00519376|3240698|P13|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1
985843|NCT00519376|3240699|P12|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
985844|NCT00519376|3240700|P11|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
985845|NCT00519376|3240701|P10|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
985846|NCT00519376|3240702|P9|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
985847|NCT00519376|3240703|P8|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
985848|NCT00519376|3240704|P7|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
985849|NCT00519376|3240705|P6|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
985850|NCT00519376|3240706|P5|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
985851|NCT00519376|3240707|P4|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
985852|NCT00519376|3240708|P3|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
985853|NCT00519376|3240709|P2|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
985854|NCT00519376|3240710|P1|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
985855|NCT00519285|3240834|P2|Overall Study|Treatment ongoing|2
985856|NCT00519285|3240835|P1|Overall Study|Treatment ongoing|1
985857|NCT00519285|3240834|P2|Overall Study|Not treated|7
985858|NCT00519285|3240835|P1|Overall Study|Not treated|8
985859|NCT00519285|3240834|P2|Overall Study|Reason unspecified|8
985860|NCT00519285|3240835|P1|Overall Study|Reason unspecified|5
985861|NCT00519285|3240834|P2|Overall Study|Poor compliance to protocol|7
985862|NCT00519285|3240835|P1|Overall Study|Poor compliance to protocol|5
985863|NCT00519285|3240834|P2|Overall Study|Consent withdrawn|5
985864|NCT00519285|3240835|P1|Overall Study|Consent withdrawn|4
985865|NCT00519285|3240834|P2|Overall Study|Participant's request|84
985866|NCT00519285|3240835|P1|Overall Study|Participant's request|53
985867|NCT00519285|3240834|P2|Overall Study|Physician Decision|47
985868|NCT00519285|3240835|P1|Overall Study|Physician Decision|75
985869|NCT00519285|3240834|P2|Overall Study|Disease progression|186
985870|NCT00519285|3240835|P1|Overall Study|Disease progression|334
985871|NCT00519285|3240834|P2|Overall Study|Adverse Event|266
985872|NCT00519285|3240835|P1|Overall Study|Adverse Event|127
985873|NCT00519194|3240861|P1|Overall Study|Lost to Follow-up|3
985874|NCT00519194|3240861|P1|Overall Study|Death|9
985875|NCT00519194|3240861|P1|Overall Study|Withdrawal by Subject|9
985876|NCT00519077|3240876|P1|Overall Study|Other|2
985877|NCT00519077|3240876|P1|Overall Study|Death|6
985878|NCT00518986|3240883|P2|Overall Study|Non-Specific|1
985879|NCT00518986|3240884|P1|Overall Study|Non-Specific|2
985880|NCT00518986|3240883|P2|Overall Study|Withdrawal by Subject|4
985881|NCT00518986|3240884|P1|Overall Study|Withdrawal by Subject|4
985882|NCT00518986|3240883|P2|Overall Study|Protocol Violation|7
985883|NCT00518986|3240884|P1|Overall Study|Protocol Violation|5
985884|NCT00518986|3240883|P2|Overall Study|Physician Decision|3
985885|NCT00518986|3240884|P1|Overall Study|Physician Decision|0
985886|NCT00518986|3240883|P2|Overall Study|Lost to Follow-up|2
985887|NCT00518986|3240884|P1|Overall Study|Lost to Follow-up|3
985888|NCT00518986|3240883|P2|Overall Study|Lack of Efficacy|2
985889|NCT00518986|3240884|P1|Overall Study|Lack of Efficacy|0
985890|NCT00518986|3240883|P2|Overall Study|Adverse Event|7
985891|NCT00518986|3240884|P1|Overall Study|Adverse Event|12
985892|NCT00518882|3241010|P2|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25
985893|NCT00518882|3241011|P1|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18
985894|NCT00518882|3241010|P2|Open-Label Extension, Week 26-78|Subject decision|0
985895|NCT00518882|3241011|P1|Open-Label Extension, Week 26-78|Subject decision|2
985896|NCT00518882|3241010|P2|Open-Label Extension, Week 26-78|Exclusion criteria|0
985897|NCT00518882|3241011|P1|Open-Label Extension, Week 26-78|Exclusion criteria|2
985898|NCT00518882|3241010|P2|Open-Label Extension, Week 26-78|Decreased kidney function|0
985899|NCT00518882|3241011|P1|Open-Label Extension, Week 26-78|Decreased kidney function|1
985900|NCT00518882|3241010|P2|Open-Label Extension, Week 26-78|Creatine increased|0
985901|NCT00518882|3241011|P1|Open-Label Extension, Week 26-78|Creatine increased|1
985902|NCT00518882|3241010|P2|Open-Label Extension, Week 26-78|Change in treatment|1
985903|NCT00518882|3241011|P1|Open-Label Extension, Week 26-78|Change in treatment|1
985904|NCT00518882|3241010|P2|Open-Label Extension, Week 26-78|Consent withdrawn|1
985905|NCT00518882|3241011|P1|Open-Label Extension, Week 26-78|Consent withdrawn|2
985906|NCT00518882|3241010|P2|Open-Label Extension, Week 26-78|Lost to follow up|1
985907|NCT00518882|3241011|P1|Open-Label Extension, Week 26-78|Lost to follow up|1
985908|NCT00518882|3241010|P2|Open-Label Extension, Week 26-78|Hypoglycaemia|1
985909|NCT00518882|3241011|P1|Open-Label Extension, Week 26-78|Hypoglycaemia|0
985910|NCT00518882|3241010|P2|Open-Label Extension, Week 26-78|Withdrawel criteria|2
985911|NCT00518882|3241011|P1|Open-Label Extension, Week 26-78|Withdrawel criteria|1
985912|NCT00518882|3241010|P2|Open-Label Extension, Week 26-78|Protocol Violation|4
985913|NCT00518882|3241011|P1|Open-Label Extension, Week 26-78|Protocol Violation|3
985914|NCT00518882|3241010|P2|Open-Label Extension, Week 26-78|Lack of Efficacy|5
985915|NCT00518882|3241011|P1|Open-Label Extension, Week 26-78|Lack of Efficacy|6
985916|NCT00518882|3241010|P2|Open-Label Extension, Week 26-78|Adverse Event|9
985917|NCT00518882|3241011|P1|Open-Label Extension, Week 26-78|Adverse Event|3
985918|NCT00518882|3241010|P2|Double-Blind, Week 0-26|Mutual consent|1
985919|NCT00518882|3241011|P1|Double-Blind, Week 0-26|Mutual consent|0
985920|NCT00518882|3241010|P2|Double-Blind, Week 0-26|Hypoglycaemia|2
985921|NCT00518882|3241011|P1|Double-Blind, Week 0-26|Hypoglycaemia|0
985922|NCT00518882|3241010|P2|Double-Blind, Week 0-26|Fear of hypoglycaemia|1
985923|NCT00518882|3241011|P1|Double-Blind, Week 0-26|Fear of hypoglycaemia|0
985924|NCT00518882|3241010|P2|Double-Blind, Week 0-26|Loss of trust|1
985925|NCT00518882|3241011|P1|Double-Blind, Week 0-26|Loss of trust|0
985926|NCT00518882|3241010|P2|Double-Blind, Week 0-26|Withdrawal of consent|3
985927|NCT00518882|3241011|P1|Double-Blind, Week 0-26|Withdrawal of consent|1
985928|NCT00518882|3241010|P2|Double-Blind, Week 0-26|Subject decision|1
985929|NCT00518882|3241011|P1|Double-Blind, Week 0-26|Subject decision|1
985930|NCT00518882|3241010|P2|Double-Blind, Week 0-26|Lost to follow up|1
985931|NCT00518882|3241011|P1|Double-Blind, Week 0-26|Lost to follow up|2
985932|NCT00518882|3241010|P2|Double-Blind, Week 0-26|Withdrawal criteria|1
985933|NCT00518882|3241011|P1|Double-Blind, Week 0-26|Withdrawal criteria|1
985934|NCT00518882|3241010|P2|Double-Blind, Week 0-26|Protocol Violation|3
985935|NCT00518882|3241011|P1|Double-Blind, Week 0-26|Protocol Violation|4
985936|NCT00518882|3241010|P2|Double-Blind, Week 0-26|Lack of Efficacy|0
985937|NCT00518882|3241011|P1|Double-Blind, Week 0-26|Lack of Efficacy|1
985938|NCT00518882|3241010|P2|Double-Blind, Week 0-26|Adverse Event|31
985939|NCT00518882|3241011|P1|Double-Blind, Week 0-26|Adverse Event|23
985940|NCT00518687|3241192|P2|Overall Study|Withdrawal by Subject|110
985941|NCT00518687|3241193|P1|Overall Study|Withdrawal by Subject|110
985942|NCT00518687|3241192|P2|Overall Study|Study terminated by sponsor|918
985943|NCT00518687|3241193|P1|Overall Study|Study terminated by sponsor|930
985944|NCT00518687|3241192|P2|Overall Study|Protocol Violation|10
985945|NCT00518687|3241193|P1|Overall Study|Protocol Violation|8
985946|NCT00518687|3241192|P2|Overall Study|Progressive disease|2
985947|NCT00518687|3241193|P1|Overall Study|Progressive disease|2
985948|NCT00518687|3241192|P2|Overall Study|Physician Decision|48
985949|NCT00518687|3241193|P1|Overall Study|Physician Decision|42
985950|NCT00518687|3241192|P2|Overall Study|Lost to Follow-up|155
985951|NCT00518687|3241193|P1|Overall Study|Lost to Follow-up|144
985952|NCT00518687|3241192|P2|Overall Study|Adverse Event|177
985953|NCT00518687|3241193|P1|Overall Study|Adverse Event|201
985954|NCT00518622|3241213|P8|Overall Study|Study medication taken incorrectly|0
985955|NCT00518622|3241214|P7|Overall Study|Study medication taken incorrectly|0
985956|NCT00518622|3241215|P6|Overall Study|Study medication taken incorrectly|0
985957|NCT00518622|3241216|P5|Overall Study|Study medication taken incorrectly|0
985958|NCT00518622|3241217|P4|Overall Study|Study medication taken incorrectly|0
985959|NCT00518622|3241218|P3|Overall Study|Study medication taken incorrectly|0
985960|NCT00518622|3241219|P2|Overall Study|Study medication taken incorrectly|1
985961|NCT00518622|3241220|P1|Overall Study|Study medication taken incorrectly|0
985962|NCT00518622|3241213|P8|Overall Study|Lost to Follow-up|0
985963|NCT00518622|3241214|P7|Overall Study|Lost to Follow-up|0
985964|NCT00518622|3241215|P6|Overall Study|Lost to Follow-up|0
985965|NCT00518622|3241216|P5|Overall Study|Lost to Follow-up|0
985966|NCT00518622|3241217|P4|Overall Study|Lost to Follow-up|0
985967|NCT00518622|3241218|P3|Overall Study|Lost to Follow-up|1
985968|NCT00518622|3241219|P2|Overall Study|Lost to Follow-up|0
985969|NCT00518622|3241220|P1|Overall Study|Lost to Follow-up|0
985970|NCT00518531|3241248|P2|Treatment Period 2|Non-compliance|2
985971|NCT00518531|3241249|P1|Treatment Period 2|Non-compliance|1
985972|NCT00518531|3241248|P2|Treatment Period 2|Protocol-specified criteria|1
985973|NCT00518531|3241249|P1|Treatment Period 2|Protocol-specified criteria|0
985974|NCT00518531|3241248|P2|Treatment Period 2|Adverse Event|7
985975|NCT00518531|3241249|P1|Treatment Period 2|Adverse Event|1
985976|NCT00518531|3241248|P2|Treatment Period 2|Complete out of scheduled visit window|2
985977|NCT00518531|3241249|P1|Treatment Period 2|Complete out of scheduled visit window|1
985978|NCT00518531|3241248|P2|Treatment Period 2|Withdrawal by Subject|8
985979|NCT00518531|3241249|P1|Treatment Period 2|Withdrawal by Subject|0
985980|NCT00518531|3241248|P2|Treatment Period 1|Early crossover|3
985981|NCT00518531|3241249|P1|Treatment Period 1|Early crossover|1
985982|NCT00518531|3241248|P2|Treatment Period 1|Withdrawal by Subject|6
985983|NCT00518531|3241249|P1|Treatment Period 1|Withdrawal by Subject|4
985984|NCT00518531|3241248|P2|Treatment Period 1|Protocol Violation|0
985985|NCT00518531|3241249|P1|Treatment Period 1|Protocol Violation|2
985986|NCT00518531|3241248|P2|Treatment Period 1|Physician Decision|0
985987|NCT00518531|3241249|P1|Treatment Period 1|Physician Decision|1
985988|NCT00518531|3241248|P2|Treatment Period 1|Lost to Follow-up|3
985989|NCT00518531|3241249|P1|Treatment Period 1|Lost to Follow-up|5
985990|NCT00518531|3241248|P2|Treatment Period 1|Adverse Event|0
985991|NCT00518531|3241249|P1|Treatment Period 1|Adverse Event|5
985992|NCT00518336|3241294|P2|Year 9|Personal reasons|0
985993|NCT00518336|3241295|P1|Year 9|Personal reasons|1
985994|NCT00518336|3241294|P2|Year 9|Lost to Follow-up|0
985995|NCT00518336|3241295|P1|Year 9|Lost to Follow-up|3
985996|NCT00518336|3241294|P2|Year 9|Migrated/moved from study area|1
985997|NCT00518336|3241295|P1|Year 9|Migrated/moved from study area|1
985998|NCT00518336|3241294|P2|Year 8|Could not attend in time|1
985999|NCT00518336|3241295|P1|Year 8|Could not attend in time|0
986000|NCT00518336|3241294|P2|Year 8|Lost to Follow-up|1
986001|NCT00518336|3241295|P1|Year 8|Lost to Follow-up|1
986002|NCT00518336|3241294|P2|Year 7|Could not attend in time|3
986003|NCT00518336|3241295|P1|Year 7|Could not attend in time|0
986004|NCT00518336|3241294|P2|Year 7|Lost to Follow-up|0
986005|NCT00518336|3241295|P1|Year 7|Lost to Follow-up|2
986006|NCT00518323|3241461|P4|Overall Study|Prohibited medication and others|0
986007|NCT00518323|3241462|P3|Overall Study|Prohibited medication and others|1
986008|NCT00518323|3241463|P2|Overall Study|Prohibited medication and others|1
986009|NCT00518323|3241464|P1|Overall Study|Prohibited medication and others|3
986010|NCT00518323|3241461|P4|Overall Study|Adverse Event|0
986011|NCT00518323|3241462|P3|Overall Study|Adverse Event|1
986012|NCT00518323|3241463|P2|Overall Study|Adverse Event|1
986013|NCT00518323|3241464|P1|Overall Study|Adverse Event|1
986014|NCT00518323|3241461|P4|Overall Study|Lost to Follow-up|3
986015|NCT00518323|3241462|P3|Overall Study|Lost to Follow-up|1
986016|NCT00518323|3241463|P2|Overall Study|Lost to Follow-up|2
986017|NCT00518323|3241464|P1|Overall Study|Lost to Follow-up|0
986018|NCT00518323|3241461|P4|Overall Study|Withdrawal by Subject|2
986019|NCT00518323|3241462|P3|Overall Study|Withdrawal by Subject|4
986020|NCT00518323|3241463|P2|Overall Study|Withdrawal by Subject|2
986021|NCT00518323|3241464|P1|Overall Study|Withdrawal by Subject|1
986022|NCT00518323|3241461|P4|Overall Study|Lack of Efficacy|20
986023|NCT00518323|3241462|P3|Overall Study|Lack of Efficacy|4
986024|NCT00518323|3241463|P2|Overall Study|Lack of Efficacy|2
986025|NCT00518323|3241464|P1|Overall Study|Lack of Efficacy|14
986026|NCT00518284|3241494|P4|Overall Study|Study Termination|2
986027|NCT00518284|3241495|P3|Overall Study|Study Termination|1
986028|NCT00518284|3241496|P2|Overall Study|Study Termination|2
986029|NCT00518284|3241497|P1|Overall Study|Study Termination|0
986030|NCT00518284|3241494|P4|Overall Study|Adverse Event|0
986031|NCT00518284|3241495|P3|Overall Study|Adverse Event|0
986032|NCT00518284|3241496|P2|Overall Study|Adverse Event|1
986033|NCT00518284|3241497|P1|Overall Study|Adverse Event|0
986034|NCT00518206|3241553|P2|Overall Study|Completion Status Unknown|0
986035|NCT00518206|3241554|P1|Overall Study|Completion Status Unknown|1
986036|NCT00518206|3241553|P2|Overall Study|Reason Unknown|0
986037|NCT00518206|3241554|P1|Overall Study|Reason Unknown|1
986038|NCT00518206|3241553|P2|Overall Study|Drug Supply Issue|0
986039|NCT00518206|3241554|P1|Overall Study|Drug Supply Issue|1
986040|NCT00518206|3241553|P2|Overall Study|Withdrawal by Subject|0
986041|NCT00518206|3241554|P1|Overall Study|Withdrawal by Subject|2
986042|NCT00518206|3241553|P2|Overall Study|Disease Progression Requiring Therapy|6
986043|NCT00518206|3241554|P1|Overall Study|Disease Progression Requiring Therapy|6
986044|NCT00518180|3241571|P3|Overall Study|Adverse Event|0
986045|NCT00518180|3241572|P2|Overall Study|Adverse Event|0
986046|NCT00518180|3241573|P1|Overall Study|Adverse Event|1
986047|NCT00518180|3241571|P3|Overall Study|Unable to classify|0
986048|NCT00518180|3241572|P2|Overall Study|Unable to classify|2
986049|NCT00518180|3241573|P1|Overall Study|Unable to classify|0
986050|NCT00518180|3241571|P3|Overall Study|Protocol Violation|4
986051|NCT00518180|3241572|P2|Overall Study|Protocol Violation|7
986052|NCT00518180|3241573|P1|Overall Study|Protocol Violation|5
986053|NCT00518180|3241571|P3|Overall Study|Administrative reason|2
986054|NCT00518180|3241572|P2|Overall Study|Administrative reason|2
986055|NCT00518180|3241573|P1|Overall Study|Administrative reason|0
986056|NCT00518180|3241571|P3|Overall Study|Lost to Follow-up|34
986057|NCT00518180|3241572|P2|Overall Study|Lost to Follow-up|28
986058|NCT00518180|3241573|P1|Overall Study|Lost to Follow-up|30
986059|NCT00518180|3241571|P3|Overall Study|Withdrawal by Subject|42
986060|NCT00518180|3241572|P2|Overall Study|Withdrawal by Subject|30
986061|NCT00518180|3241573|P1|Overall Study|Withdrawal by Subject|29
986062|NCT00518115|3241625|P10|Overall Study|Moved Out of State|1
986063|NCT00518115|3241626|P9|Overall Study|Moved Out of State|0
986064|NCT00518115|3241627|P8|Overall Study|Moved Out of State|0
986065|NCT00518115|3241628|P7|Overall Study|Moved Out of State|0
986066|NCT00518115|3241629|P6|Overall Study|Moved Out of State|0
986067|NCT00518115|3241630|P5|Overall Study|Moved Out of State|0
986068|NCT00518115|3241631|P4|Overall Study|Moved Out of State|0
986069|NCT00518115|3241632|P3|Overall Study|Moved Out of State|0
986070|NCT00518115|3241633|P2|Overall Study|Moved Out of State|0
986071|NCT00518115|3241634|P1|Overall Study|Moved Out of State|0
986072|NCT00518115|3241625|P10|Overall Study|Withdrew Consent|0
986073|NCT00518115|3241626|P9|Overall Study|Withdrew Consent|0
986074|NCT00518115|3241627|P8|Overall Study|Withdrew Consent|0
986075|NCT00518115|3241628|P7|Overall Study|Withdrew Consent|0
986076|NCT00518115|3241629|P6|Overall Study|Withdrew Consent|1
986077|NCT00518115|3241630|P5|Overall Study|Withdrew Consent|0
986078|NCT00518115|3241631|P4|Overall Study|Withdrew Consent|0
986079|NCT00518115|3241632|P3|Overall Study|Withdrew Consent|0
986080|NCT00518115|3241633|P2|Overall Study|Withdrew Consent|0
986081|NCT00518115|3241634|P1|Overall Study|Withdrew Consent|0
986082|NCT00518115|3241625|P10|Overall Study|Family Emergency; Had to Go to England|0
986083|NCT00518115|3241626|P9|Overall Study|Family Emergency; Had to Go to England|0
986084|NCT00518115|3241627|P8|Overall Study|Family Emergency; Had to Go to England|0
986085|NCT00518115|3241628|P7|Overall Study|Family Emergency; Had to Go to England|0
986086|NCT00518115|3241629|P6|Overall Study|Family Emergency; Had to Go to England|0
986087|NCT00518115|3241630|P5|Overall Study|Family Emergency; Had to Go to England|1
986088|NCT00518115|3241631|P4|Overall Study|Family Emergency; Had to Go to England|0
986089|NCT00518115|3241632|P3|Overall Study|Family Emergency; Had to Go to England|0
986090|NCT00518115|3241633|P2|Overall Study|Family Emergency; Had to Go to England|0
986091|NCT00518115|3241634|P1|Overall Study|Family Emergency; Had to Go to England|0
986092|NCT00518115|3241625|P10|Overall Study|Violation of Exclusion Criteria|0
986093|NCT00518115|3241626|P9|Overall Study|Violation of Exclusion Criteria|0
986094|NCT00518115|3241627|P8|Overall Study|Violation of Exclusion Criteria|0
986095|NCT00518115|3241628|P7|Overall Study|Violation of Exclusion Criteria|1
986096|NCT00518115|3241629|P6|Overall Study|Violation of Exclusion Criteria|0
986097|NCT00518115|3241630|P5|Overall Study|Violation of Exclusion Criteria|0
986098|NCT00518115|3241631|P4|Overall Study|Violation of Exclusion Criteria|1
986099|NCT00518115|3241632|P3|Overall Study|Violation of Exclusion Criteria|0
986100|NCT00518115|3241633|P2|Overall Study|Violation of Exclusion Criteria|0
986101|NCT00518115|3241634|P1|Overall Study|Violation of Exclusion Criteria|0
986102|NCT00518115|3241625|P10|Overall Study|Wrong Monotherapy Administered|0
986103|NCT00518115|3241626|P9|Overall Study|Wrong Monotherapy Administered|0
986104|NCT00518115|3241627|P8|Overall Study|Wrong Monotherapy Administered|0
986105|NCT00518115|3241628|P7|Overall Study|Wrong Monotherapy Administered|1
986106|NCT00518115|3241629|P6|Overall Study|Wrong Monotherapy Administered|0
986107|NCT00518115|3241630|P5|Overall Study|Wrong Monotherapy Administered|0
986108|NCT00518115|3241631|P4|Overall Study|Wrong Monotherapy Administered|0
986109|NCT00518115|3241632|P3|Overall Study|Wrong Monotherapy Administered|1
986110|NCT00518115|3241633|P2|Overall Study|Wrong Monotherapy Administered|0
986111|NCT00518115|3241634|P1|Overall Study|Wrong Monotherapy Administered|0
986112|NCT00518115|3241625|P10|Overall Study|Different Monotherapy Diabetic Drug|0
986113|NCT00518115|3241626|P9|Overall Study|Different Monotherapy Diabetic Drug|1
986114|NCT00518115|3241627|P8|Overall Study|Different Monotherapy Diabetic Drug|0
986115|NCT00518115|3241628|P7|Overall Study|Different Monotherapy Diabetic Drug|0
986116|NCT00518115|3241629|P6|Overall Study|Different Monotherapy Diabetic Drug|0
986117|NCT00518115|3241630|P5|Overall Study|Different Monotherapy Diabetic Drug|0
986118|NCT00518115|3241631|P4|Overall Study|Different Monotherapy Diabetic Drug|0
986119|NCT00518115|3241632|P3|Overall Study|Different Monotherapy Diabetic Drug|1
986120|NCT00518115|3241633|P2|Overall Study|Different Monotherapy Diabetic Drug|0
986121|NCT00518115|3241634|P1|Overall Study|Different Monotherapy Diabetic Drug|0
986122|NCT00518115|3241625|P10|Overall Study|Physician Prescribed Antidiabetic Drug|0
986123|NCT00518115|3241626|P9|Overall Study|Physician Prescribed Antidiabetic Drug|0
986124|NCT00518115|3241627|P8|Overall Study|Physician Prescribed Antidiabetic Drug|0
986125|NCT00518115|3241628|P7|Overall Study|Physician Prescribed Antidiabetic Drug|0
986126|NCT00518115|3241629|P6|Overall Study|Physician Prescribed Antidiabetic Drug|0
986127|NCT00518115|3241630|P5|Overall Study|Physician Prescribed Antidiabetic Drug|0
986128|NCT00518115|3241631|P4|Overall Study|Physician Prescribed Antidiabetic Drug|0
986129|NCT00518115|3241632|P3|Overall Study|Physician Prescribed Antidiabetic Drug|0
986130|NCT00518115|3241633|P2|Overall Study|Physician Prescribed Antidiabetic Drug|0
986131|NCT00518115|3241634|P1|Overall Study|Physician Prescribed Antidiabetic Drug|1
986132|NCT00518115|3241625|P10|Overall Study|Treatment Eligibility Criteria Not Met|0
986133|NCT00518115|3241626|P9|Overall Study|Treatment Eligibility Criteria Not Met|0
986134|NCT00518115|3241627|P8|Overall Study|Treatment Eligibility Criteria Not Met|0
986135|NCT00518115|3241628|P7|Overall Study|Treatment Eligibility Criteria Not Met|0
986136|NCT00518115|3241629|P6|Overall Study|Treatment Eligibility Criteria Not Met|4
986137|NCT00518115|3241630|P5|Overall Study|Treatment Eligibility Criteria Not Met|0
986138|NCT00518115|3241631|P4|Overall Study|Treatment Eligibility Criteria Not Met|0
986139|NCT00518115|3241632|P3|Overall Study|Treatment Eligibility Criteria Not Met|0
986140|NCT00518115|3241633|P2|Overall Study|Treatment Eligibility Criteria Not Met|1
986141|NCT00518115|3241634|P1|Overall Study|Treatment Eligibility Criteria Not Met|1
986142|NCT00518115|3241625|P10|Overall Study|Non-Compliance|1
986143|NCT00518115|3241626|P9|Overall Study|Non-Compliance|0
986144|NCT00518115|3241627|P8|Overall Study|Non-Compliance|1
986145|NCT00518115|3241628|P7|Overall Study|Non-Compliance|1
986146|NCT00518115|3241629|P6|Overall Study|Non-Compliance|1
986147|NCT00518115|3241630|P5|Overall Study|Non-Compliance|1
986148|NCT00518115|3241631|P4|Overall Study|Non-Compliance|0
986149|NCT00518115|3241632|P3|Overall Study|Non-Compliance|1
986150|NCT00518115|3241633|P2|Overall Study|Non-Compliance|0
986151|NCT00518115|3241634|P1|Overall Study|Non-Compliance|1
986152|NCT00518115|3241625|P10|Overall Study|Lack of Efficacy|0
986153|NCT00518115|3241626|P9|Overall Study|Lack of Efficacy|0
986154|NCT00518115|3241627|P8|Overall Study|Lack of Efficacy|1
986155|NCT00518115|3241628|P7|Overall Study|Lack of Efficacy|0
986156|NCT00518115|3241629|P6|Overall Study|Lack of Efficacy|0
986157|NCT00518115|3241630|P5|Overall Study|Lack of Efficacy|0
986158|NCT00518115|3241631|P4|Overall Study|Lack of Efficacy|1
986159|NCT00518115|3241632|P3|Overall Study|Lack of Efficacy|1
986160|NCT00518115|3241633|P2|Overall Study|Lack of Efficacy|0
986161|NCT00518115|3241634|P1|Overall Study|Lack of Efficacy|1
986162|NCT00518115|3241625|P10|Overall Study|Withdrawal by Subject|3
986163|NCT00518115|3241626|P9|Overall Study|Withdrawal by Subject|1
986164|NCT00518115|3241627|P8|Overall Study|Withdrawal by Subject|2
986165|NCT00518115|3241628|P7|Overall Study|Withdrawal by Subject|0
986166|NCT00518115|3241629|P6|Overall Study|Withdrawal by Subject|1
986167|NCT00518115|3241630|P5|Overall Study|Withdrawal by Subject|2
986168|NCT00518115|3241631|P4|Overall Study|Withdrawal by Subject|0
986169|NCT00518115|3241632|P3|Overall Study|Withdrawal by Subject|5
986170|NCT00518115|3241633|P2|Overall Study|Withdrawal by Subject|1
986171|NCT00518115|3241634|P1|Overall Study|Withdrawal by Subject|1
986172|NCT00518115|3241625|P10|Overall Study|Protocol Violation|0
986173|NCT00518115|3241626|P9|Overall Study|Protocol Violation|0
986174|NCT00518115|3241627|P8|Overall Study|Protocol Violation|0
986175|NCT00518115|3241628|P7|Overall Study|Protocol Violation|0
986176|NCT00518115|3241629|P6|Overall Study|Protocol Violation|0
986177|NCT00518115|3241630|P5|Overall Study|Protocol Violation|0
986178|NCT00518115|3241631|P4|Overall Study|Protocol Violation|0
986179|NCT00518115|3241632|P3|Overall Study|Protocol Violation|1
986180|NCT00518115|3241633|P2|Overall Study|Protocol Violation|3
986181|NCT00518115|3241634|P1|Overall Study|Protocol Violation|1
986182|NCT00518115|3241625|P10|Overall Study|Lost to Follow-up|1
986183|NCT00518115|3241626|P9|Overall Study|Lost to Follow-up|1
986184|NCT00518115|3241627|P8|Overall Study|Lost to Follow-up|1
986185|NCT00518115|3241628|P7|Overall Study|Lost to Follow-up|0
986186|NCT00518115|3241629|P6|Overall Study|Lost to Follow-up|3
986187|NCT00518115|3241630|P5|Overall Study|Lost to Follow-up|1
986188|NCT00518115|3241631|P4|Overall Study|Lost to Follow-up|3
986189|NCT00518115|3241632|P3|Overall Study|Lost to Follow-up|2
986190|NCT00518115|3241633|P2|Overall Study|Lost to Follow-up|0
986191|NCT00518115|3241634|P1|Overall Study|Lost to Follow-up|0
986192|NCT00518115|3241625|P10|Overall Study|Adverse Event|9
986193|NCT00518115|3241626|P9|Overall Study|Adverse Event|2
986194|NCT00518115|3241627|P8|Overall Study|Adverse Event|10
986195|NCT00518115|3241628|P7|Overall Study|Adverse Event|5
986196|NCT00518115|3241629|P6|Overall Study|Adverse Event|5
986197|NCT00518115|3241630|P5|Overall Study|Adverse Event|5
986198|NCT00518115|3241631|P4|Overall Study|Adverse Event|6
986199|NCT00518115|3241632|P3|Overall Study|Adverse Event|5
986200|NCT00518115|3241633|P2|Overall Study|Adverse Event|1
986201|NCT00518115|3241634|P1|Overall Study|Adverse Event|6
986202|NCT00518011|3241809|P2|Overall Study|Withdrawal by Subject|0
986203|NCT00518011|3241810|P1|Overall Study|Withdrawal by Subject|1
986204|NCT00518011|3241809|P2|Overall Study|Other Reasons|2
986205|NCT00518011|3241810|P1|Overall Study|Other Reasons|3
986206|NCT00518011|3241809|P2|Overall Study|Disease Progression|2
986207|NCT00518011|3241810|P1|Overall Study|Disease Progression|2
986208|NCT00518011|3241809|P2|Overall Study|Adverse Event|3
986209|NCT00518011|3241810|P1|Overall Study|Adverse Event|2
986210|NCT00518011|3241809|P2|Overall Study|Death|1
986211|NCT00518011|3241810|P1|Overall Study|Death|1
986212|NCT00517933|3241832|P2|Period 2|Underwent lung transplant|2
986213|NCT00517933|3241833|P1|Period 2|Underwent lung transplant|0
986214|NCT00517933|3241832|P2|Period 2|Withdrawal by Subject|3
986215|NCT00517933|3241833|P1|Period 2|Withdrawal by Subject|1
986216|NCT00517933|3241832|P2|Period 2|Physician Decision|0
986217|NCT00517933|3241833|P1|Period 2|Physician Decision|1
986218|NCT00517933|3241832|P2|Period 2|Adverse Event|4
986219|NCT00517933|3241833|P1|Period 2|Adverse Event|2
986220|NCT00517933|3241832|P2|Period 2|Death|4
986221|NCT00517933|3241833|P1|Period 2|Death|2
986222|NCT00517933|3241832|P2|Period 1|Underwent lung transplant|1
986223|NCT00517933|3241833|P1|Period 1|Underwent lung transplant|0
986224|NCT00517933|3241832|P2|Period 1|Lost to Follow-up|0
986225|NCT00517933|3241833|P1|Period 1|Lost to Follow-up|2
986226|NCT00517933|3241832|P2|Period 1|Adverse Event|4
986227|NCT00517933|3241833|P1|Period 1|Adverse Event|4
986228|NCT00517933|3241832|P2|Period 1|Death|1
986229|NCT00517933|3241833|P1|Period 1|Death|2
986230|NCT00517881|3241897|P1|Overall Study|Renal transplantation|2
986231|NCT00517881|3241897|P1|Overall Study|Adverse Event|1
986232|NCT00517881|3241897|P1|Overall Study|Protocol Violation|2
986233|NCT00517829|3241909|P2|Overall Study|Other|1
986234|NCT00517829|3241910|P1|Overall Study|Other|3
986235|NCT00517829|3241909|P2|Overall Study|Investigator Request|3
986236|NCT00517829|3241910|P1|Overall Study|Investigator Request|5
986237|NCT00517829|3241909|P2|Overall Study|Patient Request|5
986238|NCT00517829|3241910|P1|Overall Study|Patient Request|6
986239|NCT00517829|3241909|P2|Overall Study|Disease Progression|32
986240|NCT00517829|3241910|P1|Overall Study|Disease Progression|39
986241|NCT00517829|3241909|P2|Overall Study|Adverse Event|34
986242|NCT00517829|3241910|P1|Overall Study|Adverse Event|22
986243|NCT00517751|3241924|P1|Overall Study|Missing|3
986244|NCT00517751|3241924|P1|Overall Study|Patient not due for visit|76
986245|NCT00517751|3241924|P1|Overall Study|patient not over due|6
986246|NCT00517751|3241924|P1|Overall Study|Lost to Follow-up|4
986247|NCT00517751|3241924|P1|Overall Study|Withdrawal by Subject|37
986248|NCT00517751|3241924|P1|Overall Study|Death|3
986249|NCT00517699|3241947|P1|Overall Study|Study terminated by Sponsor|2
986250|NCT00517699|3241947|P1|Overall Study|Administrative error|1
986251|NCT00517699|3241947|P1|Overall Study|Lack of Efficacy|1
986252|NCT00517699|3241947|P1|Overall Study|Withdrawal by Subject|1
986253|NCT00517634|3241955|P6|Second Treatment Period|Withdrawal by Subject|0
986254|NCT00517634|3241956|P5|Second Treatment Period|Withdrawal by Subject|1
986255|NCT00517634|3241957|P4|Second Treatment Period|Withdrawal by Subject|0
986256|NCT00517634|3241958|P3|Second Treatment Period|Withdrawal by Subject|0
986257|NCT00517634|3241959|P2|Second Treatment Period|Withdrawal by Subject|0
986258|NCT00517634|3241960|P1|Second Treatment Period|Withdrawal by Subject|0
986259|NCT00517413|3242062|P1|Overall Study|Other-Reasons|23
986260|NCT00517413|3242062|P1|Overall Study|Failure to return|1
986261|NCT00517413|3242062|P1|Overall Study|Withdrawal by Subject|2
986262|NCT00517413|3242062|P1|Overall Study|Protocol Violation|15
986263|NCT00517413|3242062|P1|Overall Study|Death|13
986264|NCT00517413|3242062|P1|Overall Study|Adverse Event|7
986265|NCT00517361|3242083|P1|Overall Study|The study was terminated|5
986266|NCT00517361|3242083|P1|Overall Study|Death|6
986267|NCT00517296|3242092|P2|Overall Study|Withdrawal by Subject|0
986268|NCT00517296|3242093|P1|Overall Study|Withdrawal by Subject|1
986269|NCT00517192|3242105|P2|Overall Study|Early termination of the trial|18
986270|NCT00517192|3242106|P1|Overall Study|Early termination of the trial|16
986271|NCT00517192|3242105|P2|Overall Study|Withdrawal by Subject|0
986272|NCT00517192|3242106|P1|Overall Study|Withdrawal by Subject|1
986273|NCT00517192|3242105|P2|Overall Study|Lost to Follow-up|1
986274|NCT00517192|3242106|P1|Overall Study|Lost to Follow-up|1
986275|NCT00517192|3242105|P2|Overall Study|Adverse Event|1
986276|NCT00517192|3242106|P1|Overall Study|Adverse Event|1
986277|NCT00516906|3242213|P2|Overall Study|Final Dressing Removal Data not captured|2
986278|NCT00516906|3242214|P1|Overall Study|Final Dressing Removal Data not captured|6
986279|NCT00516893|3242224|P1|Overall Study|Received Medication From Another Study|1
986280|NCT00516893|3242224|P1|Overall Study|Pregnancy|1
986281|NCT00516893|3242224|P1|Overall Study|Relocated|1
986282|NCT00516893|3242224|P1|Overall Study|Persistent Antibodies per Protocol|6
986283|NCT00516893|3242224|P1|Overall Study|Death|1
986284|NCT00516893|3242224|P1|Overall Study|Noncompliance|2
986285|NCT00516893|3242224|P1|Overall Study|Withdrawal by Subject|2
986286|NCT00516893|3242224|P1|Overall Study|Adverse Event|3
986287|NCT00516893|3242224|P1|Overall Study|Lost to Follow-up|4
986288|NCT00516737|3242233|P2|Overall Study|Lack of Qualifying Event|6
986289|NCT00516737|3242234|P1|Overall Study|Lack of Qualifying Event|9
986290|NCT00516737|3242233|P2|Overall Study|Withdrawal by Subject|1
986291|NCT00516737|3242234|P1|Overall Study|Withdrawal by Subject|0
986292|NCT00516737|3242233|P2|Overall Study|Physician Decision|1
986293|NCT00516737|3242234|P1|Overall Study|Physician Decision|0
986294|NCT00516737|3242233|P2|Overall Study|Lost to Follow-up|0
986295|NCT00516737|3242234|P1|Overall Study|Lost to Follow-up|2
986296|NCT00516386|3242273|P1|Overall Study|Lost to Follow-up|2
986297|NCT00516386|3242273|P1|Overall Study|not interested in the study|4
986298|NCT00516321|3242280|P3|Double-blind (DB) Antiviral Treatment|Physician Decision|0
986299|NCT00516321|3242281|P2|Double-blind (DB) Antiviral Treatment|Physician Decision|2
986300|NCT00516321|3242282|P1|Double-blind (DB) Antiviral Treatment|Physician Decision|0
986301|NCT00516321|3242280|P3|Double-blind (DB) Antiviral Treatment|Protocol Violation|1
986302|NCT00516321|3242281|P2|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
986303|NCT00516321|3242282|P1|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
986304|NCT00516321|3242280|P3|Double-blind (DB) Antiviral Treatment|Adverse Event|13
986305|NCT00516321|3242281|P2|Double-blind (DB) Antiviral Treatment|Adverse Event|8
986306|NCT00516321|3242282|P1|Double-blind (DB) Antiviral Treatment|Adverse Event|0
986307|NCT00516321|3242280|P3|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18
986308|NCT00516321|3242281|P2|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13
986309|NCT00516321|3242282|P1|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0
986310|NCT00516321|3242280|P3|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22
986311|NCT00516321|3242281|P2|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12
986312|NCT00516321|3242282|P1|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0
986313|NCT00516321|3242280|P3|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
986314|NCT00516321|3242281|P2|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
986315|NCT00516321|3242282|P1|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3
986316|NCT00516321|3242280|P3|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
986317|NCT00516321|3242281|P2|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
986318|NCT00516321|3242282|P1|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7
986319|NCT00516321|3242280|P3|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
986320|NCT00516321|3242281|P2|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
986321|NCT00516321|3242282|P1|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2
986322|NCT00516321|3242280|P3|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
986323|NCT00516321|3242281|P2|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
986324|NCT00516321|3242282|P1|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1
986325|NCT00516321|3242280|P3|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
986326|NCT00516321|3242281|P2|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
986327|NCT00516321|3242282|P1|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9
986328|NCT00516321|3242280|P3|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
986329|NCT00516321|3242281|P2|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
986330|NCT00516321|3242282|P1|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11
986331|NCT00516295|3242333|P3|Overall Study|Ineligible|0
986332|NCT00516295|3242334|P2|Overall Study|Ineligible|0
986333|NCT00516295|3242335|P1|Overall Study|Ineligible|1
986334|NCT00516295|3242333|P3|Overall Study|Lack of Efficacy|0
986335|NCT00516295|3242334|P2|Overall Study|Lack of Efficacy|0
986336|NCT00516295|3242335|P1|Overall Study|Lack of Efficacy|2
986337|NCT00516269|3242348|P2|Overall Study|Protocol Violation|1
986338|NCT00516269|3242349|P1|Overall Study|Protocol Violation|0
986339|NCT00516269|3242348|P2|Overall Study|Lost to Follow-up|1
986340|NCT00516269|3242349|P1|Overall Study|Lost to Follow-up|0
986341|NCT00516269|3242348|P2|Overall Study|Adverse Event|1
986342|NCT00516269|3242349|P1|Overall Study|Adverse Event|2
986343|NCT00516139|3242370|P1|Overall Study|Lack of Efficacy|1
986344|NCT00516139|3242370|P1|Overall Study|Withdrawal by Subject|8
986345|NCT00516139|3242370|P1|Overall Study|Protocol Violation|1
986346|NCT00516139|3242370|P1|Overall Study|Lost to Follow-up|1
986347|NCT00516139|3242370|P1|Overall Study|Adverse Event|27
986348|NCT00516074|3242401|P2|Overall Study|Loss of Glucose Control|0
986349|NCT00516074|3242402|P1|Overall Study|Loss of Glucose Control|2
986350|NCT00516074|3242401|P2|Overall Study|Subject Decision|2
986351|NCT00516074|3242402|P1|Overall Study|Subject Decision|4
986352|NCT00516074|3242401|P2|Overall Study|Adverse Event|1
986353|NCT00516074|3242402|P1|Overall Study|Adverse Event|0
986354|NCT00516048|3242420|P3|Overall Study|Subject Decision|0
986355|NCT00516048|3242421|P2|Overall Study|Subject Decision|2
986356|NCT00516048|3242422|P1|Overall Study|Subject Decision|0
986357|NCT00516048|3242420|P3|Overall Study|Death|1
986358|NCT00516048|3242421|P2|Overall Study|Death|0
986359|NCT00516048|3242422|P1|Overall Study|Death|0
986360|NCT00515827|3242449|P2|Second Intervention (12 Weeks)|Consent withdraw|0
986361|NCT00515827|3242450|P1|Second Intervention (12 Weeks)|Consent withdraw|1
986362|NCT00515827|3242449|P2|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
986363|NCT00515827|3242450|P1|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
986364|NCT00515671|3242485|P2|Overall Study|incarcerated|2
986365|NCT00515671|3242486|P1|Overall Study|incarcerated|1
986366|NCT00515671|3242485|P2|Overall Study|Withdrawal by Subject|5
986367|NCT00515671|3242486|P1|Overall Study|Withdrawal by Subject|3
986368|NCT00515671|3242485|P2|Overall Study|Lost to Follow-up|10
986369|NCT00515671|3242486|P1|Overall Study|Lost to Follow-up|13
986370|NCT00515619|3242494|P1|Overall Study|Other: Subject interested in other AED|1
986371|NCT00515619|3242494|P1|Overall Study|Other: Drug available on license|1
986372|NCT00515619|3242494|P1|Overall Study|Other: Request from sponsor|1
986373|NCT00515619|3242494|P1|Overall Study|Other: Subject became pregnant|1
986374|NCT00515619|3242494|P1|Overall Study|Other: Investigator decision|1
986375|NCT00515619|3242494|P1|Overall Study|Other: Subject moved to another country|1
986376|NCT00515619|3242494|P1|Overall Study|Other: Subject required surgery|1
986377|NCT00515619|3242494|P1|Overall Study|Other: Subject cannot attend visits|2
986378|NCT00515619|3242494|P1|Overall Study|Other: Site discontinuing trials|2
986379|NCT00515619|3242494|P1|Overall Study|Unsatisfactory compliance|6
986380|NCT00515619|3242494|P1|Overall Study|Lost to Follow-up|4
986381|NCT00515619|3242494|P1|Overall Study|Protocol Violation|3
986382|NCT00515619|3242494|P1|Overall Study|Withdrawal by Subject|66
986383|NCT00515619|3242494|P1|Overall Study|Lack of Efficacy|92
986384|NCT00515619|3242494|P1|Overall Study|Adverse Event|34
986385|NCT00515541|3242506|P4|Overall Study|Withdrawal by Subject|2
986386|NCT00515541|3242507|P3|Overall Study|Withdrawal by Subject|0
986387|NCT00515541|3242508|P2|Overall Study|Withdrawal by Subject|2
986388|NCT00515541|3242509|P1|Overall Study|Withdrawal by Subject|0
986389|NCT00515541|3242506|P4|Overall Study|No show for appointments|2
986390|NCT00515541|3242507|P3|Overall Study|No show for appointments|0
986391|NCT00515541|3242508|P2|Overall Study|No show for appointments|1
986392|NCT00515541|3242509|P1|Overall Study|No show for appointments|0
986393|NCT00515541|3242506|P4|Overall Study|Physician Decision|1
986394|NCT00515541|3242507|P3|Overall Study|Physician Decision|0
986395|NCT00515541|3242508|P2|Overall Study|Physician Decision|2
986396|NCT00515541|3242509|P1|Overall Study|Physician Decision|0
986397|NCT00515502|3242531|P12|Treatment Period 2|Adverse Event|0
986398|NCT00515502|3242532|P11|Treatment Period 2|Adverse Event|0
986399|NCT00515502|3242533|P10|Treatment Period 2|Adverse Event|0
986400|NCT00515502|3242534|P9|Treatment Period 2|Adverse Event|0
986401|NCT00515502|3242535|P8|Treatment Period 2|Adverse Event|0
986402|NCT00515502|3242536|P7|Treatment Period 2|Adverse Event|0
986403|NCT00515502|3242537|P6|Treatment Period 2|Adverse Event|0
986404|NCT00515502|3242538|P5|Treatment Period 2|Adverse Event|0
986405|NCT00515502|3242539|P4|Treatment Period 2|Adverse Event|0
986406|NCT00515502|3242540|P3|Treatment Period 2|Adverse Event|0
986407|NCT00515502|3242541|P2|Treatment Period 2|Adverse Event|1
986408|NCT00515502|3242542|P1|Treatment Period 2|Adverse Event|0
986409|NCT00515502|3242531|P12|Treatment Period 1|Adverse Event|1
986410|NCT00515502|3242532|P11|Treatment Period 1|Adverse Event|0
986411|NCT00515502|3242533|P10|Treatment Period 1|Adverse Event|0
986412|NCT00515502|3242534|P9|Treatment Period 1|Adverse Event|1
986413|NCT00515502|3242535|P8|Treatment Period 1|Adverse Event|0
986414|NCT00515502|3242536|P7|Treatment Period 1|Adverse Event|1
986415|NCT00515502|3242537|P6|Treatment Period 1|Adverse Event|0
986416|NCT00515502|3242538|P5|Treatment Period 1|Adverse Event|0
986417|NCT00515502|3242539|P4|Treatment Period 1|Adverse Event|0
986418|NCT00515502|3242540|P3|Treatment Period 1|Adverse Event|0
986419|NCT00515502|3242541|P2|Treatment Period 1|Adverse Event|0
986420|NCT00515502|3242542|P1|Treatment Period 1|Adverse Event|0
986421|NCT00515463|3242702|P2|Overall Study|Other|1
986422|NCT00515463|3242703|P1|Overall Study|Other|0
986423|NCT00515463|3242702|P2|Overall Study|Lost to Follow-up|5
986424|NCT00515463|3242703|P1|Overall Study|Lost to Follow-up|6
986425|NCT00515463|3242702|P2|Overall Study|Withdrawal by Subject|4
986426|NCT00515463|3242703|P1|Overall Study|Withdrawal by Subject|3
986427|NCT00515463|3242702|P2|Overall Study|Adverse Event|2
986428|NCT00515463|3242703|P1|Overall Study|Adverse Event|1
986429|NCT00515463|3242702|P2|Overall Study|Physician Decision|2
986430|NCT00515463|3242703|P1|Overall Study|Physician Decision|4
986431|NCT00515294|3242886|P4|Overall Study|Caffeine amount inaccurate|0
986432|NCT00515294|3242887|P3|Overall Study|Caffeine amount inaccurate|7
986433|NCT00515294|3242888|P2|Overall Study|Caffeine amount inaccurate|0
986434|NCT00515294|3242889|P1|Overall Study|Caffeine amount inaccurate|5
986435|NCT00515294|3242886|P4|Overall Study|Driver simulator problems|3
986436|NCT00515294|3242887|P3|Overall Study|Driver simulator problems|1
986437|NCT00515294|3242888|P2|Overall Study|Driver simulator problems|1
986438|NCT00515294|3242889|P1|Overall Study|Driver simulator problems|1
986439|NCT00515294|3242886|P4|Overall Study|Lost to Follow-up|1
986440|NCT00515294|3242887|P3|Overall Study|Lost to Follow-up|3
986441|NCT00515294|3242888|P2|Overall Study|Lost to Follow-up|2
986442|NCT00515294|3242889|P1|Overall Study|Lost to Follow-up|3
986443|NCT00515216|3242903|P1|Overall Study|Withdrawal by Subject|1
986444|NCT00515112|3242965|P2|Overall Study|The study was terminated|2
986445|NCT00515112|3242966|P1|Overall Study|The study was terminated|3
986446|NCT00515112|3242965|P2|Overall Study|Death|1
986447|NCT00515112|3242966|P1|Overall Study|Death|0
986448|NCT00515099|3242976|P2|Overall Study|IRB Recommendation|0
986449|NCT00515099|3242977|P1|Overall Study|IRB Recommendation|1
986450|NCT00515099|3242976|P2|Overall Study|Withdrawal by Subject|0
986451|NCT00515099|3242977|P1|Overall Study|Withdrawal by Subject|2
986452|NCT00515099|3242976|P2|Overall Study|Lost to Follow-up|4
986453|NCT00515099|3242977|P1|Overall Study|Lost to Follow-up|0
986454|NCT00515086|3242999|P4|Overall Study|Death|0
986455|NCT00515086|3243000|P3|Overall Study|Death|0
986456|NCT00515086|3243001|P2|Overall Study|Death|0
986457|NCT00515086|3243002|P1|Overall Study|Death|2
986458|NCT00515086|3242999|P4|Overall Study|Study drug no longer required|0
986459|NCT00515086|3243000|P3|Overall Study|Study drug no longer required|0
986460|NCT00515086|3243001|P2|Overall Study|Study drug no longer required|1
986461|NCT00515086|3243002|P1|Overall Study|Study drug no longer required|0
986462|NCT00515086|3242999|P4|Overall Study|Lost to Follow-up|0
986463|NCT00515086|3243000|P3|Overall Study|Lost to Follow-up|0
986464|NCT00515086|3243001|P2|Overall Study|Lost to Follow-up|0
986465|NCT00515086|3243002|P1|Overall Study|Lost to Follow-up|1
986466|NCT00515086|3242999|P4|Overall Study|Unsatisfactory therapeutic effect|2
986467|NCT00515086|3243000|P3|Overall Study|Unsatisfactory therapeutic effect|3
986468|NCT00515086|3243001|P2|Overall Study|Unsatisfactory therapeutic effect|3
986469|NCT00515086|3243002|P1|Overall Study|Unsatisfactory therapeutic effect|18
986470|NCT00515086|3242999|P4|Overall Study|Withdrawal by Subject|1
986471|NCT00515086|3243000|P3|Overall Study|Withdrawal by Subject|0
986472|NCT00515086|3243001|P2|Overall Study|Withdrawal by Subject|0
986473|NCT00515086|3243002|P1|Overall Study|Withdrawal by Subject|1
986474|NCT00515086|3242999|P4|Overall Study|Administrative|0
986475|NCT00515086|3243000|P3|Overall Study|Administrative|0
986476|NCT00515086|3243001|P2|Overall Study|Administrative|1
986477|NCT00515086|3243002|P1|Overall Study|Administrative|1
986478|NCT00515086|3242999|P4|Overall Study|Adverse Event|3
986479|NCT00515086|3243000|P3|Overall Study|Adverse Event|2
986480|NCT00515086|3243001|P2|Overall Study|Adverse Event|1
986481|NCT00515086|3243002|P1|Overall Study|Adverse Event|1
986482|NCT00515073|3243029|P1|Overall Study|Physician Decision|1
986483|NCT00515073|3243029|P1|Overall Study|Withdrawal by Subject|1
986484|NCT00515034|3243037|P4|Overall Study|Other|1
986485|NCT00515034|3243038|P3|Overall Study|Other|2
986486|NCT00515034|3243039|P2|Overall Study|Other|0
986487|NCT00515034|3243040|P1|Overall Study|Other|1
986488|NCT00515034|3243037|P4|Overall Study|Physician Decision|1
986489|NCT00515034|3243038|P3|Overall Study|Physician Decision|1
986490|NCT00515034|3243039|P2|Overall Study|Physician Decision|0
986491|NCT00515034|3243040|P1|Overall Study|Physician Decision|0
986492|NCT00515034|3243037|P4|Overall Study|Withdrawal by Subject|0
986493|NCT00515034|3243038|P3|Overall Study|Withdrawal by Subject|3
986494|NCT00515034|3243039|P2|Overall Study|Withdrawal by Subject|0
986495|NCT00515034|3243040|P1|Overall Study|Withdrawal by Subject|1
986496|NCT00515034|3243037|P4|Overall Study|Death|3
986497|NCT00515034|3243038|P3|Overall Study|Death|1
986498|NCT00515034|3243039|P2|Overall Study|Death|2
986499|NCT00515034|3243040|P1|Overall Study|Death|4
986500|NCT00515034|3243037|P4|Overall Study|Adverse Event|0
986501|NCT00515034|3243038|P3|Overall Study|Adverse Event|1
986502|NCT00515034|3243039|P2|Overall Study|Adverse Event|0
986503|NCT00515034|3243040|P1|Overall Study|Adverse Event|2
986504|NCT00515008|3243060|P2|Overall Study|Scheduling conflict|0
986505|NCT00515008|3243061|P1|Overall Study|Scheduling conflict|1
986506|NCT00515008|3243060|P2|Overall Study|Left the Boston Area|1
986507|NCT00515008|3243061|P1|Overall Study|Left the Boston Area|1
986508|NCT00515008|3243060|P2|Overall Study|Declined|3
986509|NCT00515008|3243061|P1|Overall Study|Declined|0
986510|NCT00515008|3243060|P2|Overall Study|Lost to Follow-up|0
986511|NCT00515008|3243061|P1|Overall Study|Lost to Follow-up|1
986512|NCT00514943|3243085|P2|Stage 2|Other than stated above|2
986513|NCT00514943|3243086|P1|Stage 2|Other than stated above|0
986514|NCT00514943|3243085|P2|Stage 2|Patient refused to continue study meds|0
986515|NCT00514943|3243086|P1|Stage 2|Patient refused to continue study meds|2
986516|NCT00514943|3243085|P2|Stage 2|Other Adverse Event|10
986517|NCT00514943|3243086|P1|Stage 2|Other Adverse Event|3
986518|NCT00514943|3243085|P2|Stage 2|Progressive disease|24
986519|NCT00514943|3243086|P1|Stage 2|Progressive disease|27
986520|NCT00514943|3243085|P2|Stage 1|Other than stated above|7
986521|NCT00514943|3243086|P1|Stage 1|Other than stated above|1
986522|NCT00514943|3243085|P2|Stage 1|Patient refused to continue study meds|3
986523|NCT00514943|3243086|P1|Stage 1|Patient refused to continue study meds|8
986524|NCT00514943|3243085|P2|Stage 1|Not treated|2
986525|NCT00514943|3243086|P1|Stage 1|Not treated|1
986526|NCT00514943|3243085|P2|Stage 1|Other Adverse Event|6
986527|NCT00514943|3243086|P1|Stage 1|Other Adverse Event|16
986528|NCT00514943|3243085|P2|Stage 1|Progressive disease|8
986529|NCT00514943|3243086|P1|Stage 1|Progressive disease|4
986530|NCT00514917|3243144|P2|Overall Study|Undefined|5
986531|NCT00514917|3243145|P1|Overall Study|Undefined|11
986532|NCT00514917|3243144|P2|Overall Study|Discontinued due to study closure|81
986533|NCT00514917|3243145|P1|Overall Study|Discontinued due to study closure|88
986534|NCT00514917|3243144|P2|Overall Study|Withdrawal by Subject|16
986535|NCT00514917|3243145|P1|Overall Study|Withdrawal by Subject|18
986536|NCT00514917|3243144|P2|Overall Study|Lost to Follow-up|3
986537|NCT00514917|3243145|P1|Overall Study|Lost to Follow-up|4
986538|NCT00514917|3243144|P2|Overall Study|Protocol Violation|0
986539|NCT00514917|3243145|P1|Overall Study|Protocol Violation|1
986540|NCT00514917|3243144|P2|Overall Study|Death|10
986541|NCT00514917|3243145|P1|Overall Study|Death|4
986542|NCT00514904|3243173|P2|Overall Study|Lost to Follow-up|3
986543|NCT00514904|3243174|P1|Overall Study|Lost to Follow-up|21
986544|NCT00514904|3243173|P2|Overall Study|Withdrawal by Subject|2
986545|NCT00514904|3243174|P1|Overall Study|Withdrawal by Subject|3
986546|NCT00514813|3243239|P4|Overall Study|Death|2
986547|NCT00514813|3243240|P3|Overall Study|Death|3
986548|NCT00514813|3243241|P2|Overall Study|Death|2
986549|NCT00514813|3243242|P1|Overall Study|Death|0
986550|NCT00514813|3243239|P4|Overall Study|Kidney transplant|0
986551|NCT00514813|3243240|P3|Overall Study|Kidney transplant|2
986552|NCT00514813|3243241|P2|Overall Study|Kidney transplant|6
986553|NCT00514813|3243242|P1|Overall Study|Kidney transplant|0
986554|NCT00514813|3243239|P4|Overall Study|Lack of Efficacy|0
986555|NCT00514813|3243240|P3|Overall Study|Lack of Efficacy|0
986556|NCT00514813|3243241|P2|Overall Study|Lack of Efficacy|1
986557|NCT00514813|3243242|P1|Overall Study|Lack of Efficacy|0
986558|NCT00514813|3243239|P4|Overall Study|Withdrawal by Subject|0
986559|NCT00514813|3243240|P3|Overall Study|Withdrawal by Subject|0
986560|NCT00514813|3243241|P2|Overall Study|Withdrawal by Subject|1
986561|NCT00514813|3243242|P1|Overall Study|Withdrawal by Subject|0
986562|NCT00514813|3243239|P4|Overall Study|Protocol Violation|0
986563|NCT00514813|3243240|P3|Overall Study|Protocol Violation|0
986564|NCT00514813|3243241|P2|Overall Study|Protocol Violation|0
986565|NCT00514813|3243242|P1|Overall Study|Protocol Violation|1
986566|NCT00514813|3243239|P4|Overall Study|Adverse Event|0
986567|NCT00514813|3243240|P3|Overall Study|Adverse Event|2
986568|NCT00514813|3243241|P2|Overall Study|Adverse Event|2
986569|NCT00514813|3243242|P1|Overall Study|Adverse Event|0
986570|NCT00514813|3243239|P4|Overall Study|Study terminated|2
986571|NCT00514813|3243240|P3|Overall Study|Study terminated|40
986572|NCT00514813|3243241|P2|Overall Study|Study terminated|74
986573|NCT00514813|3243242|P1|Overall Study|Study terminated|14
986574|NCT00514735|3243262|P2|Overall Study|Lost to Follow-up|1
986575|NCT00514735|3243263|P1|Overall Study|Lost to Follow-up|0
986576|NCT00514735|3243262|P2|Overall Study|Death|0
986577|NCT00514735|3243263|P1|Overall Study|Death|1
986578|NCT00514735|3243262|P2|Overall Study|Withdrawal by Subject|5
986579|NCT00514735|3243263|P1|Overall Study|Withdrawal by Subject|13
986580|NCT00514683|3243299|P5|Overall Study|Reason other than listed above|1
986581|NCT00514683|3243300|P4|Overall Study|Reason other than listed above|0
986582|NCT00514683|3243301|P3|Overall Study|Reason other than listed above|2
986583|NCT00514683|3243302|P2|Overall Study|Reason other than listed above|1
986584|NCT00514683|3243303|P1|Overall Study|Reason other than listed above|0
986585|NCT00514683|3243299|P5|Overall Study|Withdrawal by Subject|4
986586|NCT00514683|3243300|P4|Overall Study|Withdrawal by Subject|0
986587|NCT00514683|3243301|P3|Overall Study|Withdrawal by Subject|1
986588|NCT00514683|3243302|P2|Overall Study|Withdrawal by Subject|2
986589|NCT00514683|3243303|P1|Overall Study|Withdrawal by Subject|2
986590|NCT00514683|3243299|P5|Overall Study|Protocol Violation|0
986591|NCT00514683|3243300|P4|Overall Study|Protocol Violation|1
986592|NCT00514683|3243301|P3|Overall Study|Protocol Violation|0
986593|NCT00514683|3243302|P2|Overall Study|Protocol Violation|1
986594|NCT00514683|3243303|P1|Overall Study|Protocol Violation|1
986595|NCT00514683|3243299|P5|Overall Study|Adverse Event|27
986596|NCT00514683|3243300|P4|Overall Study|Adverse Event|13
986597|NCT00514683|3243301|P3|Overall Study|Adverse Event|15
986598|NCT00514683|3243302|P2|Overall Study|Adverse Event|20
986599|NCT00514683|3243303|P1|Overall Study|Adverse Event|21
986600|NCT00514683|3243299|P5|Overall Study|Not treated|1
986601|NCT00514683|3243300|P4|Overall Study|Not treated|0
986602|NCT00514683|3243301|P3|Overall Study|Not treated|0
986603|NCT00514683|3243302|P2|Overall Study|Not treated|1
986604|NCT00514683|3243303|P1|Overall Study|Not treated|2
986605|NCT00514514|3243502|P3|Extension - 4 Years|Adverse Event|3
986606|NCT00514514|3243503|P2|Extension - 4 Years|Adverse Event|6
986607|NCT00514514|3243504|P1|Extension - 4 Years|Adverse Event|9
986608|NCT00514514|3243502|P3|Extension - 4 Years|Death|6
986609|NCT00514514|3243503|P2|Extension - 4 Years|Death|3
986610|NCT00514514|3243504|P1|Extension - 4 Years|Death|8
986611|NCT00514514|3243502|P3|Extension - 4 Years|Administrative problems|1
986612|NCT00514514|3243503|P2|Extension - 4 Years|Administrative problems|1
986613|NCT00514514|3243504|P1|Extension - 4 Years|Administrative problems|3
986614|NCT00514514|3243502|P3|Extension - 4 Years|Lost to Follow-up|9
986615|NCT00514514|3243503|P2|Extension - 4 Years|Lost to Follow-up|10
986616|NCT00514514|3243504|P1|Extension - 4 Years|Lost to Follow-up|12
986617|NCT00514514|3243502|P3|Extension - 4 Years|Withdrawal by Subject|2
986618|NCT00514514|3243503|P2|Extension - 4 Years|Withdrawal by Subject|2
986619|NCT00514514|3243504|P1|Extension - 4 Years|Withdrawal by Subject|5
986620|NCT00514514|3243502|P3|Randomized - 9 Month|Adverse Event|27
986621|NCT00514514|3243503|P2|Randomized - 9 Month|Adverse Event|44
986622|NCT00514514|3243504|P1|Randomized - 9 Month|Adverse Event|25
986623|NCT00514514|3243502|P3|Randomized - 9 Month|Abnormal laboratory values|1
986624|NCT00514514|3243503|P2|Randomized - 9 Month|Abnormal laboratory values|3
986625|NCT00514514|3243504|P1|Randomized - 9 Month|Abnormal laboratory values|0
986626|NCT00514514|3243502|P3|Randomized - 9 Month|Lack of Efficacy|1
986627|NCT00514514|3243503|P2|Randomized - 9 Month|Lack of Efficacy|3
986628|NCT00514514|3243504|P1|Randomized - 9 Month|Lack of Efficacy|2
986629|NCT00514514|3243502|P3|Randomized - 9 Month|Protocol Violation|0
986630|NCT00514514|3243503|P2|Randomized - 9 Month|Protocol Violation|1
986631|NCT00514514|3243504|P1|Randomized - 9 Month|Protocol Violation|1
986632|NCT00514514|3243502|P3|Randomized - 9 Month|Withdrawal by Subject|5
986633|NCT00514514|3243503|P2|Randomized - 9 Month|Withdrawal by Subject|7
986634|NCT00514514|3243504|P1|Randomized - 9 Month|Withdrawal by Subject|7
986635|NCT00514514|3243502|P3|Randomized - 9 Month|Administrative problems|2
986636|NCT00514514|3243503|P2|Randomized - 9 Month|Administrative problems|1
986637|NCT00514514|3243504|P1|Randomized - 9 Month|Administrative problems|1
986638|NCT00514514|3243502|P3|Randomized - 9 Month|Death|2
986639|NCT00514514|3243503|P2|Randomized - 9 Month|Death|2
986640|NCT00514514|3243504|P1|Randomized - 9 Month|Death|3
986641|NCT00514514|3243502|P3|Pre-phase|Withdrawal by Subject|0
986642|NCT00514514|3243503|P2|Pre-phase|Withdrawal by Subject|0
986643|NCT00514514|3243504|P1|Pre-phase|Withdrawal by Subject|66
986644|NCT00514514|3243502|P3|Pre-phase|Adverse Event|0
986645|NCT00514514|3243503|P2|Pre-phase|Adverse Event|0
986646|NCT00514514|3243504|P1|Pre-phase|Adverse Event|137
986647|NCT00514514|3243502|P3|Pre-phase|Lack of Efficacy|0
986648|NCT00514514|3243503|P2|Pre-phase|Lack of Efficacy|0
986649|NCT00514514|3243504|P1|Pre-phase|Lack of Efficacy|35
986650|NCT00514514|3243502|P3|Pre-phase|abnormal lab values|0
986651|NCT00514514|3243503|P2|Pre-phase|abnormal lab values|0
986652|NCT00514514|3243504|P1|Pre-phase|abnormal lab values|23
986653|NCT00514514|3243502|P3|Pre-phase|Lost to Follow-up|0
986654|NCT00514514|3243503|P2|Pre-phase|Lost to Follow-up|0
986655|NCT00514514|3243504|P1|Pre-phase|Lost to Follow-up|2
986656|NCT00514514|3243502|P3|Pre-phase|abnormal test procedure results|0
986657|NCT00514514|3243503|P2|Pre-phase|abnormal test procedure results|0
986658|NCT00514514|3243504|P1|Pre-phase|abnormal test procedure results|15
986659|NCT00514514|3243502|P3|Pre-phase|condition no longer requires study drug|0
986660|NCT00514514|3243503|P2|Pre-phase|condition no longer requires study drug|0
986661|NCT00514514|3243504|P1|Pre-phase|condition no longer requires study drug|7
986662|NCT00514514|3243502|P3|Pre-phase|Protocol Violation|0
986663|NCT00514514|3243503|P2|Pre-phase|Protocol Violation|0
986664|NCT00514514|3243504|P1|Pre-phase|Protocol Violation|6
986665|NCT00514514|3243502|P3|Pre-phase|administrative problems|0
986666|NCT00514514|3243503|P2|Pre-phase|administrative problems|0
986667|NCT00514514|3243504|P1|Pre-phase|administrative problems|2
986668|NCT00514514|3243502|P3|Pre-phase|Death|0
986669|NCT00514514|3243503|P2|Pre-phase|Death|0
986670|NCT00514514|3243504|P1|Pre-phase|Death|10
986671|NCT00514449|3243556|P2|Overall Study|Lost to Follow-up|0
986672|NCT00514449|3243557|P1|Overall Study|Lost to Follow-up|1
986673|NCT00514449|3243556|P2|Overall Study|Protocol Violation|2
986674|NCT00514449|3243557|P1|Overall Study|Protocol Violation|1
986675|NCT00514449|3243556|P2|Overall Study|Withdrawal by Subject|2
986676|NCT00514449|3243557|P1|Overall Study|Withdrawal by Subject|1
986677|NCT00514020|3243578|P1|Overall Study|"patients moved to the no tx group"|6
986678|NCT00514020|3243578|P1|Overall Study|patient went to radiation treatment|1
986679|NCT00514020|3243578|P1|Overall Study|other complicating disease|2
986680|NCT00514020|3243578|P1|Overall Study|disease progression|9
986681|NCT00514020|3243578|P1|Overall Study|Physician Decision|1
986682|NCT00514020|3243578|P1|Overall Study|Withdrawal by Subject|3
986683|NCT00514020|3243578|P1|Overall Study|Adverse Event|6
986684|NCT00513708|3243610|P3|Overall Study|Lost to Follow-up|4
986685|NCT00513708|3243611|P2|Overall Study|Lost to Follow-up|4
986686|NCT00513708|3243612|P1|Overall Study|Lost to Follow-up|4
986687|NCT00513695|3243626|P1|Overall Study|Progression prior to surgery|3
986688|NCT00513695|3243626|P1|Overall Study|Discontinued therapy|2
986689|NCT00513682|3243635|P1|Washout Phase|Adverse Event|2
986690|NCT00513604|3243665|P5|Overall Study|Death during treatment|0
986691|NCT00513604|3243666|P4|Overall Study|Death during treatment|0
986692|NCT00513604|3243667|P3|Overall Study|Death during treatment|2
986693|NCT00513604|3243668|P2|Overall Study|Death during treatment|3
986694|NCT00513604|3243669|P1|Overall Study|Death during treatment|0
986695|NCT00513604|3243665|P5|Overall Study|Not treated|0
986696|NCT00513604|3243666|P4|Overall Study|Not treated|0
986697|NCT00513604|3243667|P3|Overall Study|Not treated|1
986698|NCT00513604|3243668|P2|Overall Study|Not treated|0
986699|NCT00513604|3243669|P1|Overall Study|Not treated|2
986700|NCT00513500|3243703|P2|Overall Study|Hospitalized|14
986701|NCT00513500|3243704|P1|Overall Study|Hospitalized|4
986702|NCT00513500|3243703|P2|Overall Study|Death|1
986703|NCT00513500|3243704|P1|Overall Study|Death|2
986704|NCT00513500|3243703|P2|Overall Study|Lost to Follow-up|39
986705|NCT00513500|3243704|P1|Overall Study|Lost to Follow-up|35
986706|NCT00513474|3243716|P2|Overall Study|Participant Withdrew Consent|0
986707|NCT00513474|3243717|P1|Overall Study|Participant Withdrew Consent|1
986708|NCT00513474|3243716|P2|Overall Study|Death|9
986709|NCT00513474|3243717|P1|Overall Study|Death|6
986710|NCT00513409|3243773|P2|Overall Study|Visit 3 not done|2
986711|NCT00513409|3243774|P1|Overall Study|Visit 3 not done|1
986712|NCT00513409|3243773|P2|Overall Study|Physician Decision|0
986713|NCT00513409|3243774|P1|Overall Study|Physician Decision|1
986714|NCT00513409|3243773|P2|Overall Study|Lost to Follow-up|1
986715|NCT00513409|3243774|P1|Overall Study|Lost to Follow-up|0
986716|NCT00513409|3243773|P2|Overall Study|Withdrawal by Subject|2
986717|NCT00513409|3243774|P1|Overall Study|Withdrawal by Subject|0
986718|NCT00513409|3243773|P2|Overall Study|Adverse Event|1
986719|NCT00513409|3243774|P1|Overall Study|Adverse Event|0
986720|NCT00513357|3243830|P2|Overall Study|Disease Progression|1
986721|NCT00513357|3243831|P1|Overall Study|Disease Progression|2
986722|NCT00513357|3243830|P2|Overall Study|Withdrawal by Subject|4
986723|NCT00513357|3243831|P1|Overall Study|Withdrawal by Subject|5
986724|NCT00513357|3243830|P2|Overall Study|Death|0
986725|NCT00513357|3243831|P1|Overall Study|Death|2
986726|NCT00513357|3243830|P2|Overall Study|Adverse Event|2
986727|NCT00513357|3243831|P1|Overall Study|Adverse Event|4
986728|NCT00513357|3243830|P2|Overall Study|did not receive allocated placebo|3
986729|NCT00513357|3243831|P1|Overall Study|did not receive allocated placebo|2
986730|NCT00513305|3243850|P2|Overall Study|Sponsor Decision|2
986731|NCT00513305|3243851|P1|Overall Study|Sponsor Decision|0
986732|NCT00513305|3243850|P2|Overall Study|Persistent hypocellularity|1
986733|NCT00513305|3243851|P1|Overall Study|Persistent hypocellularity|0
986734|NCT00513305|3243850|P2|Overall Study|Physician Decision|0
986735|NCT00513305|3243851|P1|Overall Study|Physician Decision|1
986736|NCT00513305|3243850|P2|Overall Study|Hematologic counts did not recover|0
986737|NCT00513305|3243851|P1|Overall Study|Hematologic counts did not recover|1
986738|NCT00513305|3243850|P2|Overall Study|Eligible for stem cell transplant|0
986739|NCT00513305|3243851|P1|Overall Study|Eligible for stem cell transplant|1
986740|NCT00513305|3243850|P2|Overall Study|Disease progression|5
986741|NCT00513305|3243851|P1|Overall Study|Disease progression|8
986742|NCT00513305|3243850|P2|Overall Study|Withdrawal by Subject|2
986743|NCT00513305|3243851|P1|Overall Study|Withdrawal by Subject|1
986744|NCT00513305|3243850|P2|Overall Study|Lack of Efficacy|13
986745|NCT00513305|3243851|P1|Overall Study|Lack of Efficacy|8
986746|NCT00513305|3243850|P2|Overall Study|Death (through Consolidation Treatment)|2
986747|NCT00513305|3243851|P1|Overall Study|Death (through Consolidation Treatment)|2
986748|NCT00513305|3243850|P2|Overall Study|Adverse Event|2
986749|NCT00513305|3243851|P1|Overall Study|Adverse Event|6
986750|NCT00513240|3243888|P2|Overall Study|Withdrawal by Subject|4
986751|NCT00513240|3243889|P1|Overall Study|Withdrawal by Subject|7
986752|NCT00513240|3243888|P2|Overall Study|Death|3
986753|NCT00513240|3243889|P1|Overall Study|Death|3
986754|NCT00513240|3243888|P2|Overall Study|Did not have intended surgery|0
986755|NCT00513240|3243889|P1|Overall Study|Did not have intended surgery|3
986756|NCT00513071|3243896|P1|Overall Study|Physician Decision|3
986757|NCT00513071|3243896|P1|Overall Study|Withdrawal by Subject|1
986758|NCT00513071|3243896|P1|Overall Study|Adverse Event|1
986759|NCT00513019|3243908|P2|Overall Study|Withdrawal by Subject|5
986760|NCT00513019|3243909|P1|Overall Study|Withdrawal by Subject|4
986761|NCT00513019|3243908|P2|Overall Study|Adverse Event|0
986762|NCT00513019|3243909|P1|Overall Study|Adverse Event|1
986763|NCT00512902|3243915|P1|Overall Study|Lost to Follow-up|1
986764|NCT00512902|3243915|P1|Overall Study|Adverse Event|7
986765|NCT00512798|3243930|P2|Overall Study|Withdrawal by Subject|0
986766|NCT00512798|3243931|P1|Overall Study|Withdrawal by Subject|3
986767|NCT00512798|3243930|P2|Overall Study|Progression of disease|20
986768|NCT00512798|3243931|P1|Overall Study|Progression of disease|14
986769|NCT00512798|3243930|P2|Overall Study|Adverse Event|4
986770|NCT00512798|3243931|P1|Overall Study|Adverse Event|2
986771|NCT00512798|3243930|P2|Overall Study|Death|3
986772|NCT00512798|3243931|P1|Overall Study|Death|0
986773|NCT00512707|3243942|P2|Overall Study|Unable to tolerate the smell of the gel|0
986774|NCT00512707|3243943|P1|Overall Study|Unable to tolerate the smell of the gel|1
986775|NCT00512707|3243942|P2|Overall Study|Developed a hematocrit exceeding 0.54|0
986776|NCT00512707|3243943|P1|Overall Study|Developed a hematocrit exceeding 0.54|2
986777|NCT00512707|3243942|P2|Overall Study|Developed skin irritation|1
986778|NCT00512707|3243943|P1|Overall Study|Developed skin irritation|2
986779|NCT00512707|3243942|P2|Overall Study|Lost to Follow-up|11
986780|NCT00512707|3243943|P1|Overall Study|Lost to Follow-up|5
986781|NCT00512252|3243993|P3|Overall Study|Death|1
986782|NCT00512252|3243994|P2|Overall Study|Death|0
986783|NCT00512252|3243995|P1|Overall Study|Death|0
986784|NCT00512252|3243993|P3|Overall Study|Protocol Violation|1
986785|NCT00512252|3243994|P2|Overall Study|Protocol Violation|0
986786|NCT00512252|3243995|P1|Overall Study|Protocol Violation|0
986787|NCT00512252|3243993|P3|Overall Study|Lost to Follow-up|1
986788|NCT00512252|3243994|P2|Overall Study|Lost to Follow-up|0
986789|NCT00512252|3243995|P1|Overall Study|Lost to Follow-up|0
986790|NCT00512148|3244023|P1|Primay Study Period|Withdrawal by Subject|1
986791|NCT00512096|3244029|P1|Overall Study|Lack of Efficacy|3
986792|NCT00512096|3244029|P1|Overall Study|Withdrawal by Subject|2
986793|NCT00512096|3244029|P1|Overall Study|Adverse Event|2
986794|NCT00511901|3244057|P2|Overall Study|Withdrawal by Subject|3
986795|NCT00511901|3244058|P1|Overall Study|Withdrawal by Subject|1
986796|NCT00511875|3244080|P2|Overall Study|Missing variables|0
986797|NCT00511875|3244081|P1|Overall Study|Missing variables|1
986798|NCT00511875|3244080|P2|Overall Study|Lost to Follow-up|0
986799|NCT00511875|3244081|P1|Overall Study|Lost to Follow-up|4
986800|NCT00511836|3244121|P2|Double-blind Period|Lost to Follow-up|0
986801|NCT00511836|3244122|P1|Double-blind Period|Lost to Follow-up|1
986802|NCT00511810|3244139|P2|Overall Study|Refused second scn|1
986803|NCT00511810|3244140|P1|Overall Study|Refused second scn|0
986804|NCT00511810|3244139|P2|Overall Study|Lack of Efficacy|2
986805|NCT00511810|3244140|P1|Overall Study|Lack of Efficacy|0
986806|NCT00511810|3244139|P2|Overall Study|Lost to Follow-up|2
986807|NCT00511810|3244140|P1|Overall Study|Lost to Follow-up|1
986808|NCT00511797|3244150|P4|Overall Study|Other (moving etc)|2
986809|NCT00511797|3244151|P3|Overall Study|Other (moving etc)|1
986810|NCT00511797|3244152|P2|Overall Study|Other (moving etc)|0
986811|NCT00511797|3244153|P1|Overall Study|Other (moving etc)|1
986812|NCT00511797|3244150|P4|Overall Study|Partially missing diary|0
986813|NCT00511797|3244151|P3|Overall Study|Partially missing diary|1
986814|NCT00511797|3244152|P2|Overall Study|Partially missing diary|0
986815|NCT00511797|3244153|P1|Overall Study|Partially missing diary|0
986816|NCT00511797|3244150|P4|Overall Study|Study drug not taken|1
986817|NCT00511797|3244151|P3|Overall Study|Study drug not taken|0
986818|NCT00511797|3244152|P2|Overall Study|Study drug not taken|1
986819|NCT00511797|3244153|P1|Overall Study|Study drug not taken|0
986820|NCT00511797|3244150|P4|Overall Study|Never dispensed|3
986821|NCT00511797|3244151|P3|Overall Study|Never dispensed|1
986822|NCT00511797|3244152|P2|Overall Study|Never dispensed|0
986823|NCT00511797|3244153|P1|Overall Study|Never dispensed|1
986824|NCT00511797|3244150|P4|Overall Study|Withdrawal by Subject|2
986825|NCT00511797|3244151|P3|Overall Study|Withdrawal by Subject|4
986826|NCT00511797|3244152|P2|Overall Study|Withdrawal by Subject|3
986827|NCT00511797|3244153|P1|Overall Study|Withdrawal by Subject|3
986828|NCT00511797|3244150|P4|Overall Study|Protocol Violation|3
986829|NCT00511797|3244151|P3|Overall Study|Protocol Violation|2
986830|NCT00511797|3244152|P2|Overall Study|Protocol Violation|2
986831|NCT00511797|3244153|P1|Overall Study|Protocol Violation|0
986832|NCT00511797|3244150|P4|Overall Study|Pregnancy|1
986833|NCT00511797|3244151|P3|Overall Study|Pregnancy|0
986834|NCT00511797|3244152|P2|Overall Study|Pregnancy|0
986835|NCT00511797|3244153|P1|Overall Study|Pregnancy|0
986836|NCT00511797|3244150|P4|Overall Study|Lost to Follow-up|1
986837|NCT00511797|3244151|P3|Overall Study|Lost to Follow-up|0
986838|NCT00511797|3244152|P2|Overall Study|Lost to Follow-up|0
986839|NCT00511797|3244153|P1|Overall Study|Lost to Follow-up|1
986840|NCT00511797|3244150|P4|Overall Study|Adverse Event|2
986841|NCT00511797|3244151|P3|Overall Study|Adverse Event|2
986842|NCT00511797|3244152|P2|Overall Study|Adverse Event|2
986843|NCT00511797|3244153|P1|Overall Study|Adverse Event|1
986844|NCT00511667|3244272|P2|Overall Study|Other|1
986845|NCT00511667|3244273|P1|Overall Study|Other|2
986846|NCT00511667|3244272|P2|Overall Study|Site terminated|1
986847|NCT00511667|3244273|P1|Overall Study|Site terminated|6
986848|NCT00511667|3244272|P2|Overall Study|Withdrawal by Subject|0
986849|NCT00511667|3244273|P1|Overall Study|Withdrawal by Subject|2
986850|NCT00511667|3244272|P2|Overall Study|Protocol Violation|1
986851|NCT00511667|3244273|P1|Overall Study|Protocol Violation|1
986852|NCT00511667|3244272|P2|Overall Study|Adverse Event|0
986853|NCT00511667|3244273|P1|Overall Study|Adverse Event|1
986854|NCT00511472|3244308|P2|Overall Study|Not reported|2
986855|NCT00511472|3244309|P1|Overall Study|Not reported|2
986856|NCT00511472|3244308|P2|Overall Study|Laboratory Adverse Event|2
986857|NCT00511472|3244309|P1|Overall Study|Laboratory Adverse Event|0
986858|NCT00511472|3244308|P2|Overall Study|Clinical Adverse Event|2
986859|NCT00511472|3244309|P1|Overall Study|Clinical Adverse Event|1
986860|NCT00511433|3244328|P2|Overall Study|Other Reason|1
986861|NCT00511433|3244329|P1|Overall Study|Other Reason|1
986862|NCT00511433|3244328|P2|Overall Study|Adverse Event|0
986863|NCT00511433|3244329|P1|Overall Study|Adverse Event|5
986864|NCT00511355|3244369|P2|Overall Study|Other reason pre-treatment|1
986865|NCT00511355|3244370|P1|Overall Study|Other reason pre-treatment|0
986866|NCT00511355|3244369|P2|Overall Study|Withdrawal of informed consent|1
986867|NCT00511355|3244370|P1|Overall Study|Withdrawal of informed consent|0
986868|NCT00511355|3244369|P2|Overall Study|Pre-treatment (serious) adverse event|1
986869|NCT00511355|3244370|P1|Overall Study|Pre-treatment (serious) adverse event|0
986870|NCT00511355|3244369|P2|Overall Study|Other Reason|1
986871|NCT00511355|3244370|P1|Overall Study|Other Reason|0
986872|NCT00511355|3244369|P2|Overall Study|Lost to Follow-up|1
986873|NCT00511355|3244370|P1|Overall Study|Lost to Follow-up|2
986874|NCT00511355|3244369|P2|Overall Study|Pregnancy Wish|0
986875|NCT00511355|3244370|P1|Overall Study|Pregnancy Wish|1
986876|NCT00511355|3244369|P2|Overall Study|Adverse Event|4
986877|NCT00511355|3244370|P1|Overall Study|Adverse Event|4
986878|NCT00511342|3244470|P2|Overall Study|Other Reason|2
986879|NCT00511342|3244471|P1|Overall Study|Other Reason|2
986880|NCT00511342|3244470|P2|Overall Study|Lost to Follow-up|5
986881|NCT00511342|3244471|P1|Overall Study|Lost to Follow-up|1
986882|NCT00511342|3244470|P2|Overall Study|Pregnancy wish|1
986883|NCT00511342|3244471|P1|Overall Study|Pregnancy wish|0
986884|NCT00511342|3244470|P2|Overall Study|Pregnancy|1
986885|NCT00511342|3244471|P1|Overall Study|Pregnancy|0
986886|NCT00511342|3244470|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|12
986887|NCT00511342|3244471|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|8
986888|NCT00511342|3244470|P2|Overall Study|Unacceptable vaginal bleeding|1
986889|NCT00511342|3244471|P1|Overall Study|Unacceptable vaginal bleeding|2
986890|NCT00511238|3244502|P2|Overall Study|various reasons|14
986891|NCT00511238|3244503|P1|Overall Study|various reasons|4
986892|NCT00511238|3244502|P2|Overall Study|Progressive Disease|157
986893|NCT00511238|3244503|P1|Overall Study|Progressive Disease|23
986894|NCT00511238|3244502|P2|Overall Study|Withdrawal by Subject|22
986895|NCT00511238|3244503|P1|Overall Study|Withdrawal by Subject|2
986896|NCT00511238|3244502|P2|Overall Study|Adverse Event|33
986897|NCT00511238|3244503|P1|Overall Study|Adverse Event|13
986898|NCT00511199|3244522|P2|Overall Study|Other Reason|37
986899|NCT00511199|3244523|P1|Overall Study|Other Reason|78
986900|NCT00511199|3244522|P2|Overall Study|Lost to Follow-up|17
986901|NCT00511199|3244523|P1|Overall Study|Lost to Follow-up|40
986902|NCT00511199|3244522|P2|Overall Study|Pregnancy Wish|8
986903|NCT00511199|3244523|P1|Overall Study|Pregnancy Wish|16
986904|NCT00511199|3244522|P2|Overall Study|Pregnancy|3
986905|NCT00511199|3244523|P1|Overall Study|Pregnancy|6
986906|NCT00511199|3244522|P2|Overall Study|Withdrawal of Informed Consent|4
986907|NCT00511199|3244523|P1|Overall Study|Withdrawal of Informed Consent|19
986908|NCT00511199|3244522|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|52
986909|NCT00511199|3244523|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|227
986910|NCT00511199|3244522|P2|Overall Study|Unacceptable Vaginal Bleeding|4
986911|NCT00511199|3244523|P1|Overall Study|Unacceptable Vaginal Bleeding|63
986912|NCT00511147|3244552|P1|Overall Study|Required platelet transfusion|1
986913|NCT00511147|3244552|P1|Overall Study|Disease progression|5
986914|NCT00511147|3244552|P1|Overall Study|Withdrawal by Subject|1
986915|NCT00511134|3244561|P2|Overall Study|Withdrawal by Subject|2
986916|NCT00511134|3244562|P1|Overall Study|Withdrawal by Subject|0
986917|NCT00511108|3244574|P4|Overall Study|Withdrawal by Subject|2
986918|NCT00511108|3244575|P3|Overall Study|Withdrawal by Subject|3
986919|NCT00511108|3244576|P2|Overall Study|Withdrawal by Subject|0
986920|NCT00511108|3244577|P1|Overall Study|Withdrawal by Subject|4
986921|NCT00511108|3244574|P4|Overall Study|Physician Decision|1
986922|NCT00511108|3244575|P3|Overall Study|Physician Decision|0
986923|NCT00511108|3244576|P2|Overall Study|Physician Decision|0
986924|NCT00511108|3244577|P1|Overall Study|Physician Decision|0
986925|NCT00511108|3244574|P4|Overall Study|Lost to Follow-up|0
986926|NCT00511108|3244575|P3|Overall Study|Lost to Follow-up|1
986927|NCT00511108|3244576|P2|Overall Study|Lost to Follow-up|2
986928|NCT00511108|3244577|P1|Overall Study|Lost to Follow-up|0
986929|NCT00511108|3244574|P4|Overall Study|Adverse Event|2
986930|NCT00511108|3244575|P3|Overall Study|Adverse Event|1
986931|NCT00511108|3244576|P2|Overall Study|Adverse Event|0
986932|NCT00511108|3244577|P1|Overall Study|Adverse Event|2
986933|NCT00511004|3244608|P3|Overall Study|Lost to Follow-up|4
986934|NCT00511004|3244609|P2|Overall Study|Lost to Follow-up|0
986935|NCT00511004|3244610|P1|Overall Study|Lost to Follow-up|0
986936|NCT00510952|3244629|P2|Overall Study|Did Not Receive Study Drug|0
986937|NCT00510952|3244630|P1|Overall Study|Did Not Receive Study Drug|2
986938|NCT00510952|3244629|P2|Overall Study|Withdrawal by Subject|7
986939|NCT00510952|3244630|P1|Overall Study|Withdrawal by Subject|6
986940|NCT00510952|3244629|P2|Overall Study|Sponsor Decision|0
986941|NCT00510952|3244630|P1|Overall Study|Sponsor Decision|1
986942|NCT00510952|3244629|P2|Overall Study|Protocol Violation|4
986943|NCT00510952|3244630|P1|Overall Study|Protocol Violation|7
986944|NCT00510952|3244629|P2|Overall Study|Physician Decision|1
986945|NCT00510952|3244630|P1|Overall Study|Physician Decision|1
986946|NCT00510952|3244629|P2|Overall Study|Lost to Follow-up|3
986947|NCT00510952|3244630|P1|Overall Study|Lost to Follow-up|5
986948|NCT00510952|3244629|P2|Overall Study|Entry Criteria Not Met|1
986949|NCT00510952|3244630|P1|Overall Study|Entry Criteria Not Met|3
986950|NCT00510952|3244629|P2|Overall Study|Adverse Event|0
986951|NCT00510952|3244630|P1|Overall Study|Adverse Event|1
986952|NCT00510887|3244656|P1|Overall Study|Lost to Follow-up|1
986953|NCT00510874|3244672|P7|Overall Study|Lost to Follow-up|1
986954|NCT00510874|3244673|P6|Overall Study|Lost to Follow-up|0
986955|NCT00510874|3244674|P5|Overall Study|Lost to Follow-up|4
986956|NCT00510874|3244675|P4|Overall Study|Lost to Follow-up|3
986957|NCT00510874|3244676|P3|Overall Study|Lost to Follow-up|1
986958|NCT00510874|3244677|P2|Overall Study|Lost to Follow-up|3
986959|NCT00510874|3244678|P1|Overall Study|Lost to Follow-up|2
986960|NCT00510874|3244672|P7|Overall Study|Withdrawal by Subject|0
986961|NCT00510874|3244673|P6|Overall Study|Withdrawal by Subject|0
986962|NCT00510874|3244674|P5|Overall Study|Withdrawal by Subject|3
986963|NCT00510874|3244675|P4|Overall Study|Withdrawal by Subject|0
986964|NCT00510874|3244676|P3|Overall Study|Withdrawal by Subject|0
986965|NCT00510874|3244677|P2|Overall Study|Withdrawal by Subject|1
986966|NCT00510874|3244678|P1|Overall Study|Withdrawal by Subject|1
986967|NCT00510835|3244781|P3|Overall Study|Withdrawal by Subject|2
986968|NCT00510835|3244782|P2|Overall Study|Withdrawal by Subject|2
986969|NCT00510835|3244783|P1|Overall Study|Withdrawal by Subject|6
986970|NCT00510783|3244809|P2|Overall Study|Protocol Violation|1
986971|NCT00510783|3244810|P1|Overall Study|Protocol Violation|0
986972|NCT00510783|3244809|P2|Overall Study|Withdrawal by Subject|3
986973|NCT00510783|3244810|P1|Overall Study|Withdrawal by Subject|2
986974|NCT00510783|3244809|P2|Overall Study|Lost to Follow-up|25
986975|NCT00510783|3244810|P1|Overall Study|Lost to Follow-up|29
986976|NCT00510692|3244822|P2|Overall Study|Withdrawal by Subject|0
986977|NCT00510692|3244823|P1|Overall Study|Withdrawal by Subject|1
986978|NCT00510692|3244822|P2|Overall Study|Adverse Event|3
986979|NCT00510692|3244823|P1|Overall Study|Adverse Event|1
986980|NCT00510653|3244837|P1|Overall Study|Monetary|3
986981|NCT00510653|3244837|P1|Overall Study|Withdrawal by Subject|8
986982|NCT00510510|3244844|P3|Overall Study|Protocol Violation|4
986983|NCT00510510|3244845|P2|Overall Study|Protocol Violation|3
986984|NCT00510510|3244846|P1|Overall Study|Protocol Violation|0
986985|NCT00510510|3244844|P3|Overall Study|Lost to Follow-up|1
986986|NCT00510510|3244845|P2|Overall Study|Lost to Follow-up|0
986987|NCT00510510|3244846|P1|Overall Study|Lost to Follow-up|0
986988|NCT00510510|3244844|P3|Overall Study|Withdrawal by Subject|3
986989|NCT00510510|3244845|P2|Overall Study|Withdrawal by Subject|2
986990|NCT00510510|3244846|P1|Overall Study|Withdrawal by Subject|1
986991|NCT00510510|3244844|P3|Overall Study|Subjects no longer requires study drug|2
986992|NCT00510510|3244845|P2|Overall Study|Subjects no longer requires study drug|0
986993|NCT00510510|3244846|P1|Overall Study|Subjects no longer requires study drug|0
986994|NCT00510510|3244844|P3|Overall Study|Lack of Efficacy|1
986995|NCT00510510|3244845|P2|Overall Study|Lack of Efficacy|1
986996|NCT00510510|3244846|P1|Overall Study|Lack of Efficacy|0
986997|NCT00510510|3244844|P3|Overall Study|Adverse Event|6
986998|NCT00510510|3244845|P2|Overall Study|Adverse Event|3
986999|NCT00510510|3244846|P1|Overall Study|Adverse Event|4
987000|NCT00510484|3244864|P2|Wash-out Period|Adverse Event|1
987001|NCT00510484|3244865|P1|Wash-out Period|Adverse Event|0
987002|NCT00510458|3244885|P1|Overall Study|Revision|2
987003|NCT00510458|3244885|P1|Overall Study|Withdrawal by Subject|3
987004|NCT00510458|3244885|P1|Overall Study|Lost to Follow-up|6
987005|NCT00510458|3244885|P1|Overall Study|Terminated|14
987006|NCT00510458|3244885|P1|Overall Study|Death|1
987007|NCT00510458|3244885|P1|Overall Study|5 year not evaluable/missed|21
987008|NCT00510289|3244898|P1|Overall Study|Progressed prior to starting drug|2
987009|NCT00510289|3244898|P1|Overall Study|Lost to Follow-up|1
987010|NCT00510289|3244898|P1|Overall Study|Refused bone marrow biopsy|2
987011|NCT00510289|3244898|P1|Overall Study|Withdrawal by Subject|7
987012|NCT00510276|3244908|P2|Extension Open-Label Phase|Subject Decision|9
987013|NCT00510276|3244909|P1|Extension Open-Label Phase|Subject Decision|7
987014|NCT00510276|3244908|P2|Extension Open-Label Phase|Sponsor Decision|0
987015|NCT00510276|3244909|P1|Extension Open-Label Phase|Sponsor Decision|1
987016|NCT00510276|3244908|P2|Extension Open-Label Phase|Protocol Violation|1
987017|NCT00510276|3244909|P1|Extension Open-Label Phase|Protocol Violation|0
987018|NCT00510276|3244908|P2|Extension Open-Label Phase|Physician Decision|3
987019|NCT00510276|3244909|P1|Extension Open-Label Phase|Physician Decision|2
987020|NCT00510276|3244908|P2|Extension Open-Label Phase|Lost to Follow-up|10
987021|NCT00510276|3244909|P1|Extension Open-Label Phase|Lost to Follow-up|12
987022|NCT00510276|3244908|P2|Extension Open-Label Phase|Lack of Efficacy|7
987023|NCT00510276|3244909|P1|Extension Open-Label Phase|Lack of Efficacy|2
987024|NCT00510276|3244908|P2|Extension Open-Label Phase|Adverse Event|18
987025|NCT00510276|3244909|P1|Extension Open-Label Phase|Adverse Event|9
987026|NCT00510276|3244908|P2|Acute Double-Blind Phase|Subject Decision|28
987027|NCT00510276|3244909|P1|Acute Double-Blind Phase|Subject Decision|26
987028|NCT00510276|3244908|P2|Acute Double-Blind Phase|Sponsor Decision|1
987029|NCT00510276|3244909|P1|Acute Double-Blind Phase|Sponsor Decision|2
987030|NCT00510276|3244908|P2|Acute Double-Blind Phase|Protocol Violation|3
987031|NCT00510276|3244909|P1|Acute Double-Blind Phase|Protocol Violation|4
987032|NCT00510276|3244908|P2|Acute Double-Blind Phase|Physician Decision|3
987033|NCT00510276|3244909|P1|Acute Double-Blind Phase|Physician Decision|0
987034|NCT00510276|3244908|P2|Acute Double-Blind Phase|Lost to Follow-up|49
987035|NCT00510276|3244909|P1|Acute Double-Blind Phase|Lost to Follow-up|48
987036|NCT00510276|3244908|P2|Acute Double-Blind Phase|Lack of Efficacy|4
987037|NCT00510276|3244909|P1|Acute Double-Blind Phase|Lack of Efficacy|3
987038|NCT00510276|3244908|P2|Acute Double-Blind Phase|Entry Criteria Not Met|1
987039|NCT00510276|3244909|P1|Acute Double-Blind Phase|Entry Criteria Not Met|1
987040|NCT00510276|3244908|P2|Acute Double-Blind Phase|Adverse Event|6
987041|NCT00510276|3244909|P1|Acute Double-Blind Phase|Adverse Event|21
987042|NCT00510146|3245003|P2|Open-Label Treatment|Sponsor Decision|0
987043|NCT00510146|3245004|P1|Open-Label Treatment|Sponsor Decision|2
987044|NCT00510146|3245003|P2|Open-Label Treatment|Clinical Relapse|1
987045|NCT00510146|3245004|P1|Open-Label Treatment|Clinical Relapse|1
987046|NCT00510146|3245003|P2|Open-Label Treatment|Withdrawal by Subject|12
987047|NCT00510146|3245004|P1|Open-Label Treatment|Withdrawal by Subject|24
987048|NCT00510146|3245003|P2|Open-Label Treatment|Protocol Violation|2
987049|NCT00510146|3245004|P1|Open-Label Treatment|Protocol Violation|4
987050|NCT00510146|3245003|P2|Open-Label Treatment|Physician Decision|1
987051|NCT00510146|3245004|P1|Open-Label Treatment|Physician Decision|3
987052|NCT00510146|3245003|P2|Open-Label Treatment|Lost to Follow-up|1
987053|NCT00510146|3245004|P1|Open-Label Treatment|Lost to Follow-up|10
987054|NCT00510146|3245003|P2|Open-Label Treatment|Lack of Efficacy|0
987055|NCT00510146|3245004|P1|Open-Label Treatment|Lack of Efficacy|4
987056|NCT00510146|3245003|P2|Open-Label Treatment|Death|1
987057|NCT00510146|3245004|P1|Open-Label Treatment|Death|1
987058|NCT00510146|3245003|P2|Open-Label Treatment|Adverse Event|8
987059|NCT00510146|3245004|P1|Open-Label Treatment|Adverse Event|22
987060|NCT00510146|3245003|P2|Double-Blind Treatment|Entry Criteria Not Met|0
987061|NCT00510146|3245004|P1|Double-Blind Treatment|Entry Criteria Not Met|3
987062|NCT00510146|3245003|P2|Double-Blind Treatment|Clinical Relapse|1
987063|NCT00510146|3245004|P1|Double-Blind Treatment|Clinical Relapse|0
987064|NCT00510146|3245003|P2|Double-Blind Treatment|Withdrawal by Subject|13
987065|NCT00510146|3245004|P1|Double-Blind Treatment|Withdrawal by Subject|27
987066|NCT00510146|3245003|P2|Double-Blind Treatment|Protocol Violation|2
987067|NCT00510146|3245004|P1|Double-Blind Treatment|Protocol Violation|1
987068|NCT00510146|3245003|P2|Double-Blind Treatment|Physician Decision|0
987069|NCT00510146|3245004|P1|Double-Blind Treatment|Physician Decision|6
987070|NCT00510146|3245003|P2|Double-Blind Treatment|Lost to Follow-up|7
987071|NCT00510146|3245004|P1|Double-Blind Treatment|Lost to Follow-up|3
987072|NCT00510146|3245003|P2|Double-Blind Treatment|Lack of Efficacy|13
987073|NCT00510146|3245004|P1|Double-Blind Treatment|Lack of Efficacy|6
987074|NCT00510146|3245003|P2|Double-Blind Treatment|Adverse Event|13
987075|NCT00510146|3245004|P1|Double-Blind Treatment|Adverse Event|30
987076|NCT00510068|3245093|P2|Open-label Period|Abnormal laboratory value (s)|0
987077|NCT00510068|3245094|P1|Open-label Period|Abnormal laboratory value (s)|1
987078|NCT00510068|3245093|P2|Open-label Period|Protocol Violation|0
987079|NCT00510068|3245094|P1|Open-label Period|Protocol Violation|2
987080|NCT00510068|3245093|P2|Open-label Period|New cancer therapy|0
987081|NCT00510068|3245094|P1|Open-label Period|New cancer therapy|7
987082|NCT00510068|3245093|P2|Open-label Period|Death|0
987083|NCT00510068|3245094|P1|Open-label Period|Death|7
987084|NCT00510068|3245093|P2|Open-label Period|Administrative problems|0
987085|NCT00510068|3245094|P1|Open-label Period|Administrative problems|17
987086|NCT00510068|3245093|P2|Open-label Period|Withdrawal by Subject|0
987087|NCT00510068|3245094|P1|Open-label Period|Withdrawal by Subject|21
987088|NCT00510068|3245093|P2|Open-label Period|Adverse Event|0
987089|NCT00510068|3245094|P1|Open-label Period|Adverse Event|46
987090|NCT00510068|3245093|P2|Open-label Period|Disease Progression|0
987091|NCT00510068|3245094|P1|Open-label Period|Disease Progression|124
987092|NCT00510068|3245093|P2|Double-blind Period|Protocol Violation|0
987093|NCT00510068|3245094|P1|Double-blind Period|Protocol Violation|6
987094|NCT00510068|3245093|P2|Double-blind Period|Lost to Follow-up|0
987095|NCT00510068|3245094|P1|Double-blind Period|Lost to Follow-up|1
987096|NCT00510068|3245093|P2|Double-blind Period|Abnormal test result (s)|0
987097|NCT00510068|3245094|P1|Double-blind Period|Abnormal test result (s)|1
987098|NCT00510068|3245093|P2|Double-blind Period|Death|3
987099|NCT00510068|3245094|P1|Double-blind Period|Death|4
987100|NCT00510068|3245093|P2|Double-blind Period|Withdrawal by Subject|6
987101|NCT00510068|3245094|P1|Double-blind Period|Withdrawal by Subject|8
987102|NCT00510068|3245093|P2|Double-blind Period|Adverse Event|7
987103|NCT00510068|3245094|P1|Double-blind Period|Adverse Event|37
987104|NCT00510068|3245093|P2|Double-blind Period|Final primary analysis|18
987105|NCT00510068|3245094|P1|Double-blind Period|Final primary analysis|52
987106|NCT00510068|3245093|P2|Double-blind Period|Disease progression|169
987107|NCT00510068|3245094|P1|Double-blind Period|Disease progression|98
987108|NCT00509925|3245135|P2|Overall Study|Personal reasons|1
987109|NCT00509925|3245136|P1|Overall Study|Personal reasons|0
987110|NCT00509899|3245184|P8|Overall Study|Lack of Efficacy|0
987111|NCT00509899|3245185|P7|Overall Study|Lack of Efficacy|0
987112|NCT00509899|3245186|P6|Overall Study|Lack of Efficacy|1
987113|NCT00509899|3245187|P5|Overall Study|Lack of Efficacy|0
987114|NCT00509899|3245188|P4|Overall Study|Lack of Efficacy|0
987115|NCT00509899|3245189|P3|Overall Study|Lack of Efficacy|2
987116|NCT00509899|3245190|P2|Overall Study|Lack of Efficacy|0
987117|NCT00509899|3245191|P1|Overall Study|Lack of Efficacy|1
987118|NCT00509899|3245184|P8|Overall Study|Death|1
987119|NCT00509899|3245185|P7|Overall Study|Death|1
987120|NCT00509899|3245186|P6|Overall Study|Death|1
987121|NCT00509899|3245187|P5|Overall Study|Death|1
987122|NCT00509899|3245188|P4|Overall Study|Death|0
987123|NCT00509899|3245189|P3|Overall Study|Death|3
987124|NCT00509899|3245190|P2|Overall Study|Death|2
987125|NCT00509899|3245191|P1|Overall Study|Death|2
987126|NCT00509899|3245184|P8|Overall Study|Intercurrent Illness|0
987127|NCT00509899|3245185|P7|Overall Study|Intercurrent Illness|0
987128|NCT00509899|3245186|P6|Overall Study|Intercurrent Illness|1
987129|NCT00509899|3245187|P5|Overall Study|Intercurrent Illness|0
987130|NCT00509899|3245188|P4|Overall Study|Intercurrent Illness|1
987131|NCT00509899|3245189|P3|Overall Study|Intercurrent Illness|0
987132|NCT00509899|3245190|P2|Overall Study|Intercurrent Illness|0
987133|NCT00509899|3245191|P1|Overall Study|Intercurrent Illness|1
987134|NCT00509899|3245184|P8|Overall Study|Physician Decision|0
987135|NCT00509899|3245185|P7|Overall Study|Physician Decision|0
987136|NCT00509899|3245186|P6|Overall Study|Physician Decision|4
987137|NCT00509899|3245187|P5|Overall Study|Physician Decision|1
987138|NCT00509899|3245188|P4|Overall Study|Physician Decision|0
987139|NCT00509899|3245189|P3|Overall Study|Physician Decision|7
987140|NCT00509899|3245190|P2|Overall Study|Physician Decision|2
987141|NCT00509899|3245191|P1|Overall Study|Physician Decision|4
987142|NCT00509899|3245184|P8|Overall Study|Withdrawal by Subject|0
987143|NCT00509899|3245185|P7|Overall Study|Withdrawal by Subject|0
987144|NCT00509899|3245186|P6|Overall Study|Withdrawal by Subject|2
987145|NCT00509899|3245187|P5|Overall Study|Withdrawal by Subject|3
987146|NCT00509899|3245188|P4|Overall Study|Withdrawal by Subject|0
987147|NCT00509899|3245189|P3|Overall Study|Withdrawal by Subject|3
987148|NCT00509899|3245190|P2|Overall Study|Withdrawal by Subject|2
987149|NCT00509899|3245191|P1|Overall Study|Withdrawal by Subject|6
987150|NCT00509899|3245184|P8|Overall Study|Unacceptable Toxicity|0
987151|NCT00509899|3245185|P7|Overall Study|Unacceptable Toxicity|0
987152|NCT00509899|3245186|P6|Overall Study|Unacceptable Toxicity|0
987153|NCT00509899|3245187|P5|Overall Study|Unacceptable Toxicity|0
987154|NCT00509899|3245188|P4|Overall Study|Unacceptable Toxicity|2
987155|NCT00509899|3245189|P3|Overall Study|Unacceptable Toxicity|0
987156|NCT00509899|3245190|P2|Overall Study|Unacceptable Toxicity|0
987157|NCT00509899|3245191|P1|Overall Study|Unacceptable Toxicity|1
987158|NCT00509899|3245184|P8|Overall Study|Progressive disease|0
987159|NCT00509899|3245185|P7|Overall Study|Progressive disease|0
987160|NCT00509899|3245186|P6|Overall Study|Progressive disease|1
987161|NCT00509899|3245187|P5|Overall Study|Progressive disease|0
987162|NCT00509899|3245188|P4|Overall Study|Progressive disease|1
987163|NCT00509899|3245189|P3|Overall Study|Progressive disease|5
987164|NCT00509899|3245190|P2|Overall Study|Progressive disease|3
987165|NCT00509899|3245191|P1|Overall Study|Progressive disease|1
987166|NCT00509795|3245250|P4|Overall Study|Withdrawal by Subject|8
987167|NCT00509795|3245251|P3|Overall Study|Withdrawal by Subject|7
987168|NCT00509795|3245252|P2|Overall Study|Withdrawal by Subject|5
987169|NCT00509795|3245253|P1|Overall Study|Withdrawal by Subject|10
987170|NCT00509795|3245250|P4|Overall Study|Protocol Violation|1
987171|NCT00509795|3245251|P3|Overall Study|Protocol Violation|3
987172|NCT00509795|3245252|P2|Overall Study|Protocol Violation|0
987173|NCT00509795|3245253|P1|Overall Study|Protocol Violation|3
987174|NCT00509795|3245250|P4|Overall Study|OTHER|1
987175|NCT00509795|3245251|P3|Overall Study|OTHER|4
987176|NCT00509795|3245252|P2|Overall Study|OTHER|0
987177|NCT00509795|3245253|P1|Overall Study|OTHER|1
987178|NCT00509795|3245250|P4|Overall Study|Lost to Follow-up|4
987179|NCT00509795|3245251|P3|Overall Study|Lost to Follow-up|4
987180|NCT00509795|3245252|P2|Overall Study|Lost to Follow-up|2
987181|NCT00509795|3245253|P1|Overall Study|Lost to Follow-up|1
987182|NCT00509795|3245250|P4|Overall Study|Lack of Efficacy|2
987183|NCT00509795|3245251|P3|Overall Study|Lack of Efficacy|2
987184|NCT00509795|3245252|P2|Overall Study|Lack of Efficacy|0
987185|NCT00509795|3245253|P1|Overall Study|Lack of Efficacy|0
987186|NCT00509795|3245250|P4|Overall Study|Death|7
987187|NCT00509795|3245251|P3|Overall Study|Death|2
987188|NCT00509795|3245252|P2|Overall Study|Death|1
987189|NCT00509795|3245253|P1|Overall Study|Death|3
987190|NCT00509795|3245250|P4|Overall Study|Adverse Event|4
987191|NCT00509795|3245251|P3|Overall Study|Adverse Event|5
987192|NCT00509795|3245252|P2|Overall Study|Adverse Event|3
987193|NCT00509795|3245253|P1|Overall Study|Adverse Event|4
987194|NCT00509769|3245284|P1|Overall Study|Use of prohibited therapies during study|1
987195|NCT00509769|3245284|P1|Overall Study|Physician Decision|8
987196|NCT00509769|3245284|P1|Overall Study|Patient’s decision|1
987197|NCT00509769|3245284|P1|Overall Study|Adverse Event|4
987198|NCT00509769|3245284|P1|Overall Study|Progressive disease|77
987199|NCT00509600|3245303|P1|Overall Study|Adverse Event|1
987200|NCT00509366|3245382|P5|Overall Study|Not Treated (Screen Failure)|0
987201|NCT00509366|3245383|P4|Overall Study|Not Treated (Screen Failure)|0
987202|NCT00509366|3245384|P3|Overall Study|Not Treated (Screen Failure)|1
987203|NCT00509366|3245385|P2|Overall Study|Not Treated (Screen Failure)|1
987204|NCT00509366|3245386|P1|Overall Study|Not Treated (Screen Failure)|1
987205|NCT00509262|3245410|P2|Overall Study|Withdrawal by Subject|11
987206|NCT00509262|3245411|P1|Overall Study|Withdrawal by Subject|24
987207|NCT00509262|3245410|P2|Overall Study|Protocol Violation|2
987208|NCT00509262|3245411|P1|Overall Study|Protocol Violation|2
987209|NCT00509262|3245410|P2|Overall Study|Physician Decision|3
987210|NCT00509262|3245411|P1|Overall Study|Physician Decision|1
987211|NCT00509262|3245410|P2|Overall Study|Lost to Follow-up|6
987212|NCT00509262|3245411|P1|Overall Study|Lost to Follow-up|1
987213|NCT00509262|3245410|P2|Overall Study|Lack of Efficacy|0
987214|NCT00509262|3245411|P1|Overall Study|Lack of Efficacy|1
987215|NCT00509262|3245410|P2|Overall Study|Not specified|2
987216|NCT00509262|3245411|P1|Overall Study|Not specified|2
987217|NCT00509262|3245410|P2|Overall Study|Adverse Event|18
987218|NCT00509262|3245411|P1|Overall Study|Adverse Event|16
987219|NCT00509236|3245429|P2|Overall Study|Scheduled Kidney Transplant|0
987220|NCT00509236|3245430|P1|Overall Study|Scheduled Kidney Transplant|1
987221|NCT00509236|3245429|P2|Overall Study|Excluded Medication|1
987222|NCT00509236|3245430|P1|Overall Study|Excluded Medication|1
987223|NCT00509236|3245429|P2|Overall Study|Protocol Violation|0
987224|NCT00509236|3245430|P1|Overall Study|Protocol Violation|3
987225|NCT00509236|3245429|P2|Overall Study|Withdrawal by Subject|10
987226|NCT00509236|3245430|P1|Overall Study|Withdrawal by Subject|5
987227|NCT00509236|3245429|P2|Overall Study|Adverse Event|9
987228|NCT00509236|3245430|P1|Overall Study|Adverse Event|7
987229|NCT00509223|3245445|P2|Overall Study|Did not meet revised inclusion criteria|62
987230|NCT00509223|3245446|P1|Overall Study|Did not meet revised inclusion criteria|56
987231|NCT00509223|3245445|P2|Overall Study|Including: subject change of address|2
987232|NCT00509223|3245446|P1|Overall Study|Including: subject change of address|5
987233|NCT00509223|3245445|P2|Overall Study|Withdrawal by Subject|6
987234|NCT00509223|3245446|P1|Overall Study|Withdrawal by Subject|25
987235|NCT00509223|3245445|P2|Overall Study|Adverse Event|1
987236|NCT00509223|3245446|P1|Overall Study|Adverse Event|1
987237|NCT00509223|3245445|P2|Overall Study|Lost to Follow-up|1
987238|NCT00509223|3245446|P1|Overall Study|Lost to Follow-up|1
987239|NCT00509106|3245469|P2|Overall Study|Death|6
987240|NCT00509106|3245470|P1|Overall Study|Death|6
987241|NCT00509106|3245469|P2|Overall Study|Other|0
987242|NCT00509106|3245470|P1|Overall Study|Other|1
987243|NCT00509106|3245469|P2|Overall Study|Lost to Follow-up|10
987244|NCT00509106|3245470|P1|Overall Study|Lost to Follow-up|16
987245|NCT00509106|3245469|P2|Overall Study|Withdrew consent|8
987246|NCT00509106|3245470|P1|Overall Study|Withdrew consent|4
987247|NCT00509106|3245469|P2|Overall Study|At the request of sponsor/investigator|2
987248|NCT00509106|3245470|P1|Overall Study|At the request of sponsor/investigator|1
987249|NCT00509106|3245469|P2|Overall Study|Noncompliance|1
987250|NCT00509106|3245470|P1|Overall Study|Noncompliance|0
987251|NCT00509106|3245469|P2|Overall Study|Adverse Event|2
987252|NCT00509106|3245470|P1|Overall Study|Adverse Event|3
987253|NCT00509067|3245478|P2|Overall Study|Protocol Violation|3
987254|NCT00509067|3245479|P1|Overall Study|Protocol Violation|0
987255|NCT00509067|3245478|P2|Overall Study|Adverse Event|1
987256|NCT00509067|3245479|P1|Overall Study|Adverse Event|3
987257|NCT00509067|3245478|P2|Overall Study|Lost to Follow-up|1
987258|NCT00509067|3245479|P1|Overall Study|Lost to Follow-up|1
987259|NCT00509028|3245498|P2|Overall Study|Non-compliance|1
987260|NCT00509028|3245499|P1|Overall Study|Non-compliance|2
987261|NCT00509028|3245498|P2|Overall Study|Protocol Violation|2
987262|NCT00509028|3245499|P1|Overall Study|Protocol Violation|4
987263|NCT00509028|3245498|P2|Overall Study|Lost to Follow-up|1
987264|NCT00509028|3245499|P1|Overall Study|Lost to Follow-up|0
987265|NCT00509028|3245498|P2|Overall Study|Withdrawal by Subject|3
987266|NCT00509028|3245499|P1|Overall Study|Withdrawal by Subject|4
987267|NCT00509028|3245498|P2|Overall Study|Adverse Event|0
987268|NCT00509028|3245499|P1|Overall Study|Adverse Event|2
987269|NCT00508924|3245539|P4|Overall Study|Protocol Violation|1
987270|NCT00508924|3245540|P3|Overall Study|Protocol Violation|1
987271|NCT00508924|3245541|P2|Overall Study|Protocol Violation|0
987272|NCT00508924|3245542|P1|Overall Study|Protocol Violation|0
987273|NCT00508872|3245556|P1|Overall Study|Physician Decision|1
987274|NCT00508872|3245556|P1|Overall Study|Lost to Follow-up|1
987275|NCT00508820|3245562|P2|Overall Study|Protocol-specified Criteria|12
987276|NCT00508820|3245563|P1|Overall Study|Protocol-specified Criteria|3
987277|NCT00508820|3245562|P2|Overall Study|Requirement for alternative therapy|15
987278|NCT00508820|3245563|P1|Overall Study|Requirement for alternative therapy|7
987279|NCT00508820|3245562|P2|Overall Study|Noncompliance|0
987280|NCT00508820|3245563|P1|Overall Study|Noncompliance|1
987281|NCT00508820|3245562|P2|Overall Study|Other|2
987282|NCT00508820|3245563|P1|Overall Study|Other|11
987283|NCT00508820|3245562|P2|Overall Study|Withdrawal by Subject|12
987284|NCT00508820|3245563|P1|Overall Study|Withdrawal by Subject|10
987285|NCT00508820|3245562|P2|Overall Study|Protocol Violation|0
987286|NCT00508820|3245563|P1|Overall Study|Protocol Violation|2
987287|NCT00508820|3245562|P2|Overall Study|Pregnancy|2
987288|NCT00508820|3245563|P1|Overall Study|Pregnancy|0
987289|NCT00508820|3245562|P2|Overall Study|Physician Decision|2
987290|NCT00508820|3245563|P1|Overall Study|Physician Decision|8
987291|NCT00508820|3245562|P2|Overall Study|Lost to Follow-up|1
987292|NCT00508820|3245563|P1|Overall Study|Lost to Follow-up|1
987293|NCT00508820|3245562|P2|Overall Study|Death|8
987294|NCT00508820|3245563|P1|Overall Study|Death|6
987295|NCT00508820|3245562|P2|Overall Study|Adverse Event|10
987296|NCT00508820|3245563|P1|Overall Study|Adverse Event|6
987297|NCT00508755|3245573|P1|Overall Study|Withdrawal by Subject|1
987298|NCT00508742|3245581|P2|Period 3: Toddler Dose|Other|4
987299|NCT00508742|3245582|P1|Period 3: Toddler Dose|Other|5
987300|NCT00508742|3245581|P2|Period 3: Toddler Dose|Parent/Legal Guardian Request|8
987301|NCT00508742|3245582|P1|Period 3: Toddler Dose|Parent/Legal Guardian Request|17
987302|NCT00508742|3245581|P2|Period 3: Toddler Dose|Lost to Follow-up|3
987303|NCT00508742|3245582|P1|Period 3: Toddler Dose|Lost to Follow-up|2
987304|NCT00508742|3245581|P2|Period 3: Toddler Dose|Adverse Event|0
987305|NCT00508742|3245582|P1|Period 3: Toddler Dose|Adverse Event|1
987306|NCT00508742|3245581|P2|Period 2: After Infant Series|Other|1
987307|NCT00508742|3245582|P1|Period 2: After Infant Series|Other|2
987308|NCT00508742|3245581|P2|Period 2: After Infant Series|Failed to Return|0
987309|NCT00508742|3245582|P1|Period 2: After Infant Series|Failed to Return|1
987310|NCT00508742|3245581|P2|Period 2: After Infant Series|Parent/Legal Guardian Request|3
987311|NCT00508742|3245582|P1|Period 2: After Infant Series|Parent/Legal Guardian Request|0
987312|NCT00508742|3245581|P2|Period 2: After Infant Series|Protocol Violation|0
987313|NCT00508742|3245582|P1|Period 2: After Infant Series|Protocol Violation|1
987314|NCT00508742|3245581|P2|Period 2: After Infant Series|Lost to Follow-up|1
987315|NCT00508742|3245582|P1|Period 2: After Infant Series|Lost to Follow-up|1
987316|NCT00508742|3245581|P2|Period 2: After Infant Series|Adverse Event|6
987317|NCT00508742|3245582|P1|Period 2: After Infant Series|Adverse Event|2
987318|NCT00508742|3245581|P2|Period 1: Infant Series|Other|1
987319|NCT00508742|3245582|P1|Period 1: Infant Series|Other|4
987320|NCT00508742|3245581|P2|Period 1: Infant Series|Physician Decision|0
987321|NCT00508742|3245582|P1|Period 1: Infant Series|Physician Decision|1
987322|NCT00508742|3245581|P2|Period 1: Infant Series|Parent/Legal Guardian Request|40
987323|NCT00508742|3245582|P1|Period 1: Infant Series|Parent/Legal Guardian Request|31
987324|NCT00508742|3245581|P2|Period 1: Infant Series|Protocol Violation|0
987325|NCT00508742|3245582|P1|Period 1: Infant Series|Protocol Violation|1
987326|NCT00508742|3245581|P2|Period 1: Infant Series|Adverse Event|4
987327|NCT00508742|3245582|P1|Period 1: Infant Series|Adverse Event|5
987328|NCT00508651|3245607|P2|Overall Study|Withdrawal by Subject|1
987329|NCT00508651|3245608|P1|Overall Study|Withdrawal by Subject|1
987330|NCT00508651|3245607|P2|Overall Study|Lost to Follow-up|1
987331|NCT00508651|3245608|P1|Overall Study|Lost to Follow-up|3
987332|NCT00508482|3245689|P3|at the 4th Week of Follow-up|Lost to Follow-up|1
987333|NCT00508482|3245690|P2|at the 4th Week of Follow-up|Lost to Follow-up|6
987334|NCT00508482|3245691|P1|at the 4th Week of Follow-up|Lost to Follow-up|20
987335|NCT00508482|3245689|P3|Over 4 Weeks of Treatment|Lost to Follow-up|16
987336|NCT00508482|3245690|P2|Over 4 Weeks of Treatment|Lost to Follow-up|10
987337|NCT00508482|3245691|P1|Over 4 Weeks of Treatment|Lost to Follow-up|12
987338|NCT00508482|3245689|P3|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|4
987339|NCT00508482|3245690|P2|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|7
987340|NCT00508482|3245691|P1|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|9
987341|NCT00508404|3245735|P1|Overall Study|Other - Not Specified|3
987342|NCT00508404|3245735|P1|Overall Study|Lost to Follow-up|2
987343|NCT00508404|3245735|P1|Overall Study|Protocol-specified Criteria|2
987344|NCT00508404|3245735|P1|Overall Study|Withdrawal by Subject|3
987345|NCT00508404|3245735|P1|Overall Study|Physician Decision|2
987346|NCT00508404|3245735|P1|Overall Study|Death|16
987347|NCT00508404|3245735|P1|Overall Study|Adverse Event|2
987348|NCT00508404|3245735|P1|Overall Study|Ongoing at Data Cut-off|12
987349|NCT00508391|3245762|P2|Second Treatment|Withdrawal by Subject|0
987350|NCT00508391|3245763|P1|Second Treatment|Withdrawal by Subject|2
987351|NCT00508391|3245762|P2|First Treatment|Withdrawal by Subject|3
987352|NCT00508391|3245763|P1|First Treatment|Withdrawal by Subject|6
987353|NCT00508274|3245774|P1|Overall Study|Withdrawal by Subject|1
987354|NCT00508274|3245774|P1|Overall Study|Adverse Event|1
987355|NCT00508157|3245802|P2|Overall Study|Other known cause|1
987356|NCT00508157|3245803|P1|Overall Study|Other known cause|0
987357|NCT00508157|3245802|P2|Overall Study|Subject no longer met study criteria|1
987358|NCT00508157|3245803|P1|Overall Study|Subject no longer met study criteria|0
987359|NCT00508157|3245802|P2|Overall Study|Lost to Follow-up|0
987360|NCT00508157|3245803|P1|Overall Study|Lost to Follow-up|1
987361|NCT00508157|3245802|P2|Overall Study|Subject Withdrew Consent|0
987362|NCT00508157|3245803|P1|Overall Study|Subject Withdrew Consent|1
987363|NCT00508157|3245802|P2|Overall Study|Adverse Event|1
987364|NCT00508157|3245803|P1|Overall Study|Adverse Event|0
987365|NCT00508144|3245825|P1|Overall Study|Death|5
987366|NCT00508144|3245825|P1|Overall Study|Not eligible|6
987367|NCT00508027|3245851|P1|Dose Level 2|Withdrawal by Subject|2
987368|NCT00508027|3245851|P1|Dose Level 2|Lost to Follow-up|2
987369|NCT00508027|3245851|P1|Dose Level 1|Physician Decision|2
987370|NCT00508027|3245851|P1|Dose Level 1|Withdrawal by Subject|2
987371|NCT00508027|3245851|P1|Dose Level 1|Lost to Follow-up|4
987372|NCT00508001|3245892|P3|Overall Study|Withdrawal by Subject|1
987373|NCT00508001|3245893|P2|Overall Study|Withdrawal by Subject|4
987374|NCT00508001|3245894|P1|Overall Study|Withdrawal by Subject|4
987375|NCT00508001|3245892|P3|Overall Study|Death|1
987376|NCT00508001|3245893|P2|Overall Study|Death|1
987377|NCT00508001|3245894|P1|Overall Study|Death|0
987378|NCT00508001|3245892|P3|Overall Study|condition under investigation worsened|1
987379|NCT00508001|3245893|P2|Overall Study|condition under investigation worsened|7
987380|NCT00508001|3245894|P1|Overall Study|condition under investigation worsened|13
987381|NCT00508001|3245892|P3|Overall Study|Adverse Event|4
987382|NCT00508001|3245893|P2|Overall Study|Adverse Event|0
987383|NCT00508001|3245894|P1|Overall Study|Adverse Event|2
987384|NCT00507819|3245911|P2|Washout (6 Weeks)|Withdrawal by Subject|0
987385|NCT00507819|3245912|P1|Washout (6 Weeks)|Withdrawal by Subject|1
987386|NCT00507689|3245931|P2|Randomized Period|Withdrawal by Subject|1
987387|NCT00507689|3245932|P1|Randomized Period|Withdrawal by Subject|0
987388|NCT00507689|3245931|P2|Randomized Period|Adverse Event|1
987389|NCT00507689|3245932|P1|Randomized Period|Adverse Event|1
987390|NCT00507689|3245931|P2|Pre-Randomization Period|Withdrawal by Subject|0
987391|NCT00507689|3245932|P1|Pre-Randomization Period|Withdrawal by Subject|1
987392|NCT00507689|3245931|P2|Pre-Randomization Period|Physician Decision|0
987393|NCT00507689|3245932|P1|Pre-Randomization Period|Physician Decision|1
987394|NCT00507689|3245931|P2|Pre-Randomization Period|Adverse Event|0
987395|NCT00507689|3245932|P1|Pre-Randomization Period|Adverse Event|1
987396|NCT00507546|3245964|P2|Overall Study|Physician Decision|1
987397|NCT00507546|3245965|P1|Overall Study|Physician Decision|0
987398|NCT00507546|3245964|P2|Overall Study|Protocol Violation|0
987399|NCT00507546|3245965|P1|Overall Study|Protocol Violation|1
987400|NCT00507546|3245964|P2|Overall Study|Withdrawal by Subject|0
987401|NCT00507546|3245965|P1|Overall Study|Withdrawal by Subject|1
987402|NCT00507507|3245975|P2|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16
987403|NCT00507507|3245976|P1|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9
987404|NCT00507507|3245975|P2|24-week Treatment-free Follow-up Period|Adverse Event|1
987405|NCT00507507|3245976|P1|24-week Treatment-free Follow-up Period|Adverse Event|0
987406|NCT00507507|3245975|P2|24-week Treatment-free Follow-up Period|Physician Decision|0
987407|NCT00507507|3245976|P1|24-week Treatment-free Follow-up Period|Physician Decision|1
987408|NCT00507507|3245975|P2|Treatment Period|Withdrawal by Subject|47
987409|NCT00507507|3245976|P1|Treatment Period|Withdrawal by Subject|46
987410|NCT00507507|3245975|P2|Treatment Period|Adverse Event|1
987411|NCT00507507|3245976|P1|Treatment Period|Adverse Event|1
987412|NCT00507507|3245975|P2|Treatment Period|Protocol Violation|2
987413|NCT00507507|3245976|P1|Treatment Period|Protocol Violation|1
987414|NCT00507507|3245975|P2|Treatment Period|Physician Decision|1
987415|NCT00507507|3245976|P1|Treatment Period|Physician Decision|4
987416|NCT00507507|3245975|P2|Treatment Period|Lost to Follow-up|2
987417|NCT00507507|3245976|P1|Treatment Period|Lost to Follow-up|0
987418|NCT00507455|3246011|P3|Overall Study|Other - miscellaneous reason|1
987419|NCT00507455|3246012|P2|Overall Study|Other - miscellaneous reason|0
987420|NCT00507455|3246013|P1|Overall Study|Other - miscellaneous reason|1
987421|NCT00507455|3246011|P3|Overall Study|Lack of Efficacy|0
987422|NCT00507455|3246012|P2|Overall Study|Lack of Efficacy|1
987423|NCT00507455|3246013|P1|Overall Study|Lack of Efficacy|0
987424|NCT00507455|3246011|P3|Overall Study|Lost to Follow-up|2
987425|NCT00507455|3246012|P2|Overall Study|Lost to Follow-up|0
987426|NCT00507455|3246013|P1|Overall Study|Lost to Follow-up|2
987427|NCT00507455|3246011|P3|Overall Study|Protocol Violation|1
987428|NCT00507455|3246012|P2|Overall Study|Protocol Violation|1
987429|NCT00507455|3246013|P1|Overall Study|Protocol Violation|4
987430|NCT00507455|3246011|P3|Overall Study|Withdrawal by Subject|2
987431|NCT00507455|3246012|P2|Overall Study|Withdrawal by Subject|1
987432|NCT00507455|3246013|P1|Overall Study|Withdrawal by Subject|2
987433|NCT00507455|3246011|P3|Overall Study|Adverse Event|6
987434|NCT00507455|3246012|P2|Overall Study|Adverse Event|3
987435|NCT00507455|3246013|P1|Overall Study|Adverse Event|3
987436|NCT00507442|3246076|P4|Overall Study|Not Specified|2
987437|NCT00507442|3246077|P3|Overall Study|Not Specified|2
987438|NCT00507442|3246078|P2|Overall Study|Not Specified|5
987439|NCT00507442|3246079|P1|Overall Study|Not Specified|2
987440|NCT00507442|3246076|P4|Overall Study|Withdrawal by Subject|1
987441|NCT00507442|3246077|P3|Overall Study|Withdrawal by Subject|2
987442|NCT00507442|3246078|P2|Overall Study|Withdrawal by Subject|4
987443|NCT00507442|3246079|P1|Overall Study|Withdrawal by Subject|4
987444|NCT00507442|3246076|P4|Overall Study|Progressive Disease|0
987445|NCT00507442|3246077|P3|Overall Study|Progressive Disease|2
987446|NCT00507442|3246078|P2|Overall Study|Progressive Disease|4
987447|NCT00507442|3246079|P1|Overall Study|Progressive Disease|2
987448|NCT00507442|3246076|P4|Overall Study|Physician Decision|1
987449|NCT00507442|3246077|P3|Overall Study|Physician Decision|4
987450|NCT00507442|3246078|P2|Overall Study|Physician Decision|2
987451|NCT00507442|3246079|P1|Overall Study|Physician Decision|0
987452|NCT00507442|3246076|P4|Overall Study|Lost to Follow-up|0
987453|NCT00507442|3246077|P3|Overall Study|Lost to Follow-up|1
987454|NCT00507442|3246078|P2|Overall Study|Lost to Follow-up|0
987455|NCT00507442|3246079|P1|Overall Study|Lost to Follow-up|0
987456|NCT00507442|3246076|P4|Overall Study|Protocol Violation|0
987457|NCT00507442|3246077|P3|Overall Study|Protocol Violation|0
987458|NCT00507442|3246078|P2|Overall Study|Protocol Violation|1
987459|NCT00507442|3246079|P1|Overall Study|Protocol Violation|0
987460|NCT00507442|3246076|P4|Overall Study|Adverse Event|1
987461|NCT00507442|3246077|P3|Overall Study|Adverse Event|4
987462|NCT00507442|3246078|P2|Overall Study|Adverse Event|11
987463|NCT00507442|3246079|P1|Overall Study|Adverse Event|8
987464|NCT00507429|3246131|P2|Maintenance Phase|Progressive Disease|0
987465|NCT00507429|3246132|P1|Maintenance Phase|Progressive Disease|14
987466|NCT00507429|3246131|P2|Treatment Phase|Other|3
987467|NCT00507429|3246132|P1|Treatment Phase|Other|6
987468|NCT00507429|3246131|P2|Treatment Phase|Physician Decision|2
987469|NCT00507429|3246132|P1|Treatment Phase|Physician Decision|4
987470|NCT00507429|3246131|P2|Treatment Phase|Withdrawal by Subject|3
987471|NCT00507429|3246132|P1|Treatment Phase|Withdrawal by Subject|3
987472|NCT00507429|3246131|P2|Treatment Phase|Adverse Event|5
987473|NCT00507429|3246132|P1|Treatment Phase|Adverse Event|12
987474|NCT00507429|3246131|P2|Treatment Phase|Disease Progression|5
987475|NCT00507429|3246132|P1|Treatment Phase|Disease Progression|12
987476|NCT00507416|3246143|P3|Overall Study|Did not Receive Study Treatment|4
987477|NCT00507416|3246144|P2|Overall Study|Did not Receive Study Treatment|9
987478|NCT00507416|3246145|P1|Overall Study|Did not Receive Study Treatment|3
987479|NCT00507416|3246143|P3|Overall Study|Other|13
987480|NCT00507416|3246144|P2|Overall Study|Other|16
987481|NCT00507416|3246145|P1|Overall Study|Other|11
987482|NCT00507416|3246143|P3|Overall Study|Patient declined further treatment|11
987483|NCT00507416|3246144|P2|Overall Study|Patient declined further treatment|14
987484|NCT00507416|3246145|P1|Overall Study|Patient declined further treatment|18
987485|NCT00507416|3246143|P3|Overall Study|Progressive Disease|13
987486|NCT00507416|3246144|P2|Overall Study|Progressive Disease|10
987487|NCT00507416|3246145|P1|Overall Study|Progressive Disease|20
987488|NCT00507416|3246143|P3|Overall Study|Lack ofEfficacy / Physician Decision|8
987489|NCT00507416|3246144|P2|Overall Study|Lack ofEfficacy / Physician Decision|7
987490|NCT00507416|3246145|P1|Overall Study|Lack ofEfficacy / Physician Decision|7
987491|NCT00507416|3246143|P3|Overall Study|Protocol Violation|0
987492|NCT00507416|3246144|P2|Overall Study|Protocol Violation|2
987493|NCT00507416|3246145|P1|Overall Study|Protocol Violation|1
987494|NCT00507416|3246143|P3|Overall Study|Adverse Event|65
987495|NCT00507416|3246144|P2|Overall Study|Adverse Event|67
987496|NCT00507416|3246145|P1|Overall Study|Adverse Event|58
987497|NCT00507130|3246187|P4|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
987498|NCT00507130|3246188|P3|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
987499|NCT00507130|3246189|P2|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
987500|NCT00507130|3246190|P1|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1
987501|NCT00507130|3246187|P4|Overall Study|Lost to Follow-up|1
987502|NCT00507130|3246188|P3|Overall Study|Lost to Follow-up|1
987503|NCT00507130|3246189|P2|Overall Study|Lost to Follow-up|0
987504|NCT00507130|3246190|P1|Overall Study|Lost to Follow-up|0
987505|NCT00506948|3246232|P1|Overall Study|Physician Decision|1
987506|NCT00506948|3246232|P1|Overall Study|Adverse Event|5
987507|NCT00506948|3246232|P1|Overall Study|Death|4
987508|NCT00506922|3246241|P5|Overall Study|Withdrawal by Subject|1
987509|NCT00506922|3246242|P4|Overall Study|Withdrawal by Subject|0
987510|NCT00506922|3246243|P3|Overall Study|Withdrawal by Subject|0
987511|NCT00506922|3246244|P2|Overall Study|Withdrawal by Subject|0
987512|NCT00506922|3246245|P1|Overall Study|Withdrawal by Subject|0
987513|NCT00506922|3246241|P5|Overall Study|Physician Decision|0
987514|NCT00506922|3246242|P4|Overall Study|Physician Decision|2
987515|NCT00506922|3246243|P3|Overall Study|Physician Decision|0
987516|NCT00506922|3246244|P2|Overall Study|Physician Decision|0
987517|NCT00506922|3246245|P1|Overall Study|Physician Decision|0
987518|NCT00506883|3246256|P3|Overall Study|Other|1
987519|NCT00506883|3246257|P2|Overall Study|Other|1
987520|NCT00506883|3246258|P1|Overall Study|Other|5
987521|NCT00506883|3246256|P3|Overall Study|Lack of Efficacy|1
987522|NCT00506883|3246257|P2|Overall Study|Lack of Efficacy|1
987523|NCT00506883|3246258|P1|Overall Study|Lack of Efficacy|0
987524|NCT00506883|3246256|P3|Overall Study|Withdrawal by Subject|1
987525|NCT00506883|3246257|P2|Overall Study|Withdrawal by Subject|0
987526|NCT00506883|3246258|P1|Overall Study|Withdrawal by Subject|1
987527|NCT00506883|3246256|P3|Overall Study|Lost to Follow-up|1
987528|NCT00506883|3246257|P2|Overall Study|Lost to Follow-up|1
987529|NCT00506883|3246258|P1|Overall Study|Lost to Follow-up|1
987530|NCT00506831|3246271|P1|Overall Study|Withdrawal by Subject|1
987531|NCT00506831|3246271|P1|Overall Study|Death|1
987532|NCT00506662|3246310|P2|Overall Study|Not recorded|6
987533|NCT00506662|3246311|P1|Overall Study|Not recorded|4
987534|NCT00506662|3246310|P2|Overall Study|Trial terminated|16
987535|NCT00506662|3246311|P1|Overall Study|Trial terminated|10
987536|NCT00506662|3246310|P2|Overall Study|Protocol Violation|4
987537|NCT00506662|3246311|P1|Overall Study|Protocol Violation|2
987538|NCT00506662|3246310|P2|Overall Study|Lack of Efficacy|0
987539|NCT00506662|3246311|P1|Overall Study|Lack of Efficacy|1
987540|NCT00506662|3246310|P2|Overall Study|Adverse Event|2
987541|NCT00506662|3246311|P1|Overall Study|Adverse Event|0
987542|NCT00506493|3246345|P1|Overall Study|Withdrawal by Subject|5
987543|NCT00506493|3246345|P1|Overall Study|Death|6
987544|NCT00506454|3246354|P2|Overall Study|Withdrawal by Subject|1
987545|NCT00506454|3246355|P1|Overall Study|Withdrawal by Subject|1
987546|NCT00506441|3246361|P2|Period 2; Double-blind Period|Other Reason|1
987547|NCT00506441|3246362|P1|Period 2; Double-blind Period|Other Reason|1
987548|NCT00506441|3246361|P2|Period 2; Double-blind Period|Withdrawal by Subject|0
987549|NCT00506441|3246362|P1|Period 2; Double-blind Period|Withdrawal by Subject|1
987550|NCT00506441|3246361|P2|Period 2; Double-blind Period|Physician Decision|1
987551|NCT00506441|3246362|P1|Period 2; Double-blind Period|Physician Decision|1
987552|NCT00506441|3246361|P2|Period 2; Double-blind Period|Lack of Efficacy|2
987553|NCT00506441|3246362|P1|Period 2; Double-blind Period|Lack of Efficacy|0
987554|NCT00506441|3246361|P2|Period 2; Double-blind Period|Adverse Event|1
987555|NCT00506441|3246362|P1|Period 2; Double-blind Period|Adverse Event|0
987556|NCT00506441|3246361|P2|Period 1; Open-label Period|Other Reasons|0
987557|NCT00506441|3246362|P1|Period 1; Open-label Period|Other Reasons|13
987558|NCT00506441|3246361|P2|Period 1; Open-label Period|Withdrawal by Subject|0
987559|NCT00506441|3246362|P1|Period 1; Open-label Period|Withdrawal by Subject|13
987560|NCT00506441|3246361|P2|Period 1; Open-label Period|Protocol Violation|0
987561|NCT00506441|3246362|P1|Period 1; Open-label Period|Protocol Violation|9
987562|NCT00506441|3246361|P2|Period 1; Open-label Period|Physician Decision|0
987563|NCT00506441|3246362|P1|Period 1; Open-label Period|Physician Decision|5
987564|NCT00506441|3246361|P2|Period 1; Open-label Period|Lost to Follow-up|0
987565|NCT00506441|3246362|P1|Period 1; Open-label Period|Lost to Follow-up|2
987566|NCT00506441|3246361|P2|Period 1; Open-label Period|Lack of Efficacy|0
987567|NCT00506441|3246362|P1|Period 1; Open-label Period|Lack of Efficacy|13
987568|NCT00506441|3246361|P2|Period 1; Open-label Period|Adverse Event|0
987569|NCT00506441|3246362|P1|Period 1; Open-label Period|Adverse Event|21
987570|NCT00506415|3246370|P4|Extended Open Label (Maximum 48 Weeks)|Death|7
987571|NCT00506415|3246371|P3|Extended Open Label (Maximum 48 Weeks)|Death|0
987572|NCT00506415|3246372|P2|Extended Open Label (Maximum 48 Weeks)|Death|0
987573|NCT00506415|3246373|P1|Extended Open Label (Maximum 48 Weeks)|Death|0
987574|NCT00506415|3246370|P4|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6
987575|NCT00506415|3246371|P3|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
987576|NCT00506415|3246372|P2|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
987577|NCT00506415|3246373|P1|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
987578|NCT00506415|3246370|P4|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5
987579|NCT00506415|3246371|P3|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
987580|NCT00506415|3246372|P2|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
987581|NCT00506415|3246373|P1|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
987582|NCT00506415|3246370|P4|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14
987583|NCT00506415|3246371|P3|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
987584|NCT00506415|3246372|P2|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
987585|NCT00506415|3246373|P1|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
987586|NCT00506415|3246370|P4|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8
987587|NCT00506415|3246371|P3|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
987745|NCT00506350|3246427|P8|Overall Study|Serious Adverse Event|0
987588|NCT00506415|3246372|P2|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
987589|NCT00506415|3246373|P1|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
987590|NCT00506415|3246370|P4|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18
987591|NCT00506415|3246371|P3|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
987592|NCT00506415|3246372|P2|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
987593|NCT00506415|3246373|P1|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
987594|NCT00506415|3246370|P4|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4
987595|NCT00506415|3246371|P3|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
987596|NCT00506415|3246372|P2|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
987597|NCT00506415|3246373|P1|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
987598|NCT00506415|3246370|P4|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
987599|NCT00506415|3246371|P3|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1
987600|NCT00506415|3246372|P2|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
987601|NCT00506415|3246373|P1|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
987602|NCT00506415|3246370|P4|Double Blind (Maximum 48 Weeks )|Administrative problems|0
987603|NCT00506415|3246371|P3|Double Blind (Maximum 48 Weeks )|Administrative problems|2
987604|NCT00506415|3246372|P2|Double Blind (Maximum 48 Weeks )|Administrative problems|3
987605|NCT00506415|3246373|P1|Double Blind (Maximum 48 Weeks )|Administrative problems|0
987606|NCT00506415|3246370|P4|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
987607|NCT00506415|3246371|P3|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17
987608|NCT00506415|3246372|P2|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20
987609|NCT00506415|3246373|P1|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
987610|NCT00506415|3246370|P4|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
987611|NCT00506415|3246371|P3|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6
987612|NCT00506415|3246372|P2|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4
987613|NCT00506415|3246373|P1|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
987614|NCT00506415|3246370|P4|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
987615|NCT00506415|3246371|P3|Double Blind (Maximum 48 Weeks )|Protocol Violation|3
987616|NCT00506415|3246372|P2|Double Blind (Maximum 48 Weeks )|Protocol Violation|5
987617|NCT00506415|3246373|P1|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
987618|NCT00506415|3246370|P4|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
987619|NCT00506415|3246371|P3|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
987620|NCT00506415|3246372|P2|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
987621|NCT00506415|3246373|P1|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
987622|NCT00506415|3246370|P4|Double Blind (Maximum 48 Weeks )|Death|0
987623|NCT00506415|3246371|P3|Double Blind (Maximum 48 Weeks )|Death|3
987624|NCT00506415|3246372|P2|Double Blind (Maximum 48 Weeks )|Death|5
987625|NCT00506415|3246373|P1|Double Blind (Maximum 48 Weeks )|Death|0
987626|NCT00506415|3246370|P4|Double Blind (Maximum 48 Weeks )|Adverse Event|0
987627|NCT00506415|3246371|P3|Double Blind (Maximum 48 Weeks )|Adverse Event|28
987628|NCT00506415|3246372|P2|Double Blind (Maximum 48 Weeks )|Adverse Event|33
987629|NCT00506415|3246373|P1|Double Blind (Maximum 48 Weeks )|Adverse Event|0
987630|NCT00506415|3246370|P4|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
987631|NCT00506415|3246371|P3|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
987632|NCT00506415|3246372|P2|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
987633|NCT00506415|3246373|P1|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28
987634|NCT00506415|3246370|P4|Initial Open Label (Maximum 48 Weeks)|Death|0
987635|NCT00506415|3246371|P3|Initial Open Label (Maximum 48 Weeks)|Death|0
987636|NCT00506415|3246372|P2|Initial Open Label (Maximum 48 Weeks)|Death|0
987637|NCT00506415|3246373|P1|Initial Open Label (Maximum 48 Weeks)|Death|22
987638|NCT00506415|3246370|P4|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
987639|NCT00506415|3246371|P3|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
987640|NCT00506415|3246372|P2|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
987641|NCT00506415|3246373|P1|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7
987642|NCT00506415|3246370|P4|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
987643|NCT00506415|3246371|P3|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
987644|NCT00506415|3246372|P2|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
987645|NCT00506415|3246373|P1|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22
987646|NCT00506415|3246370|P4|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
987647|NCT00506415|3246371|P3|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
987648|NCT00506415|3246372|P2|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
987649|NCT00506415|3246373|P1|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88
987650|NCT00506415|3246370|P4|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
987651|NCT00506415|3246371|P3|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
987652|NCT00506415|3246372|P2|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
987653|NCT00506415|3246373|P1|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58
987654|NCT00506415|3246370|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
987655|NCT00506415|3246371|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
987656|NCT00506415|3246372|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
987657|NCT00506415|3246373|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1
987658|NCT00506415|3246370|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
987659|NCT00506415|3246371|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
987660|NCT00506415|3246372|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
987661|NCT00506415|3246373|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1
987662|NCT00506415|3246370|P4|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
987663|NCT00506415|3246371|P3|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
987664|NCT00506415|3246372|P2|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
987665|NCT00506415|3246373|P1|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272
987666|NCT00506389|3246398|P3|In-treatment Period|Randomized but not treated|1
987667|NCT00506389|3246399|P2|In-treatment Period|Randomized but not treated|1
987668|NCT00506389|3246400|P1|In-treatment Period|Randomized but not treated|4
987669|NCT00506389|3246398|P3|In-treatment Period|Adverse Event|2
987670|NCT00506389|3246399|P2|In-treatment Period|Adverse Event|5
987671|NCT00506389|3246400|P1|In-treatment Period|Adverse Event|11
987672|NCT00506389|3246398|P3|In-treatment Period|Lack of Efficacy|0
987673|NCT00506389|3246399|P2|In-treatment Period|Lack of Efficacy|2
987674|NCT00506389|3246400|P1|In-treatment Period|Lack of Efficacy|0
987675|NCT00506389|3246398|P3|In-treatment Period|Withdrawal by Subject|4
987676|NCT00506389|3246399|P2|In-treatment Period|Withdrawal by Subject|3
987677|NCT00506389|3246400|P1|In-treatment Period|Withdrawal by Subject|3
987678|NCT00506389|3246398|P3|In-treatment Period|Reasons not related to trial|0
987679|NCT00506389|3246399|P2|In-treatment Period|Reasons not related to trial|1
987680|NCT00506389|3246400|P1|In-treatment Period|Reasons not related to trial|4
987681|NCT00506389|3246398|P3|In-treatment Period|Lack of compliance|0
987682|NCT00506389|3246399|P2|In-treatment Period|Lack of compliance|0
987683|NCT00506389|3246400|P1|In-treatment Period|Lack of compliance|1
987684|NCT00506389|3246398|P3|In-treatment Period|Lost to Follow-up|1
987685|NCT00506389|3246399|P2|In-treatment Period|Lost to Follow-up|0
987686|NCT00506389|3246400|P1|In-treatment Period|Lost to Follow-up|0
987687|NCT00506389|3246398|P3|In-treatment Period|Not specified|4
987688|NCT00506389|3246399|P2|In-treatment Period|Not specified|3
987689|NCT00506389|3246400|P1|In-treatment Period|Not specified|3
987690|NCT00506350|3246426|P9|Overall Study|Not specified|2
987691|NCT00506350|3246427|P8|Overall Study|Not specified|2
987692|NCT00506350|3246428|P7|Overall Study|Not specified|0
987693|NCT00506350|3246429|P6|Overall Study|Not specified|0
987694|NCT00506350|3246430|P5|Overall Study|Not specified|3
987695|NCT00506350|3246431|P4|Overall Study|Not specified|0
987696|NCT00506350|3246432|P3|Overall Study|Not specified|3
987697|NCT00506350|3246433|P2|Overall Study|Not specified|1
987698|NCT00506350|3246434|P1|Overall Study|Not specified|1
987699|NCT00506350|3246426|P9|Overall Study|Medical Reason|0
987700|NCT00506350|3246427|P8|Overall Study|Medical Reason|0
987701|NCT00506350|3246428|P7|Overall Study|Medical Reason|0
987702|NCT00506350|3246429|P6|Overall Study|Medical Reason|0
987703|NCT00506350|3246430|P5|Overall Study|Medical Reason|1
987704|NCT00506350|3246431|P4|Overall Study|Medical Reason|0
987705|NCT00506350|3246432|P3|Overall Study|Medical Reason|0
987706|NCT00506350|3246433|P2|Overall Study|Medical Reason|0
987707|NCT00506350|3246434|P1|Overall Study|Medical Reason|0
987708|NCT00506350|3246426|P9|Overall Study|Lost to Follow-up|2
987709|NCT00506350|3246427|P8|Overall Study|Lost to Follow-up|0
987710|NCT00506350|3246428|P7|Overall Study|Lost to Follow-up|0
987711|NCT00506350|3246429|P6|Overall Study|Lost to Follow-up|1
987712|NCT00506350|3246430|P5|Overall Study|Lost to Follow-up|2
987713|NCT00506350|3246431|P4|Overall Study|Lost to Follow-up|1
987714|NCT00506350|3246432|P3|Overall Study|Lost to Follow-up|1
987715|NCT00506350|3246433|P2|Overall Study|Lost to Follow-up|1
987716|NCT00506350|3246434|P1|Overall Study|Lost to Follow-up|1
987717|NCT00506350|3246426|P9|Overall Study|Withdrawal by Subject|0
987718|NCT00506350|3246427|P8|Overall Study|Withdrawal by Subject|2
987719|NCT00506350|3246428|P7|Overall Study|Withdrawal by Subject|1
987720|NCT00506350|3246429|P6|Overall Study|Withdrawal by Subject|1
987721|NCT00506350|3246430|P5|Overall Study|Withdrawal by Subject|4
987722|NCT00506350|3246431|P4|Overall Study|Withdrawal by Subject|1
987723|NCT00506350|3246432|P3|Overall Study|Withdrawal by Subject|1
987724|NCT00506350|3246433|P2|Overall Study|Withdrawal by Subject|1
987725|NCT00506350|3246434|P1|Overall Study|Withdrawal by Subject|0
987726|NCT00506350|3246426|P9|Overall Study|Protocol Violation|0
987727|NCT00506350|3246427|P8|Overall Study|Protocol Violation|0
987728|NCT00506350|3246428|P7|Overall Study|Protocol Violation|1
987729|NCT00506350|3246429|P6|Overall Study|Protocol Violation|0
987730|NCT00506350|3246430|P5|Overall Study|Protocol Violation|0
987731|NCT00506350|3246431|P4|Overall Study|Protocol Violation|0
987732|NCT00506350|3246432|P3|Overall Study|Protocol Violation|1
987733|NCT00506350|3246433|P2|Overall Study|Protocol Violation|0
987734|NCT00506350|3246434|P1|Overall Study|Protocol Violation|0
987735|NCT00506350|3246426|P9|Overall Study|Adverse Event|1
987736|NCT00506350|3246427|P8|Overall Study|Adverse Event|1
987737|NCT00506350|3246428|P7|Overall Study|Adverse Event|0
987738|NCT00506350|3246429|P6|Overall Study|Adverse Event|0
987739|NCT00506350|3246430|P5|Overall Study|Adverse Event|0
987740|NCT00506350|3246431|P4|Overall Study|Adverse Event|0
987741|NCT00506350|3246432|P3|Overall Study|Adverse Event|0
987742|NCT00506350|3246433|P2|Overall Study|Adverse Event|0
987743|NCT00506350|3246434|P1|Overall Study|Adverse Event|0
987744|NCT00506350|3246426|P9|Overall Study|Serious Adverse Event|0
987746|NCT00506350|3246428|P7|Overall Study|Serious Adverse Event|0
987747|NCT00506350|3246429|P6|Overall Study|Serious Adverse Event|0
987748|NCT00506350|3246430|P5|Overall Study|Serious Adverse Event|0
987749|NCT00506350|3246431|P4|Overall Study|Serious Adverse Event|0
987750|NCT00506350|3246432|P3|Overall Study|Serious Adverse Event|0
987751|NCT00506350|3246433|P2|Overall Study|Serious Adverse Event|0
987752|NCT00506350|3246434|P1|Overall Study|Serious Adverse Event|1
987753|NCT00506285|3246581|P2|6-month Open Label Phase|Withdrawal by Subject|5
987754|NCT00506285|3246582|P1|6-month Open Label Phase|Withdrawal by Subject|9
987755|NCT00506285|3246581|P2|6-month Open Label Phase|Lost to Follow-up|7
987756|NCT00506285|3246582|P1|6-month Open Label Phase|Lost to Follow-up|1
987757|NCT00506285|3246581|P2|Double Blind Cross-Over Phase|Lost to Follow-up|2
987758|NCT00506285|3246582|P1|Double Blind Cross-Over Phase|Lost to Follow-up|5
987759|NCT00506285|3246581|P2|Double Blind Cross-Over Phase|Withdrawal by Subject|3
987760|NCT00506285|3246582|P1|Double Blind Cross-Over Phase|Withdrawal by Subject|4
987761|NCT00506285|3246581|P2|3 Week Screening Phase|Withdrawal by Subject|10
987762|NCT00506285|3246582|P1|3 Week Screening Phase|Withdrawal by Subject|17
987763|NCT00506077|3246597|P2|Treatment Period 2|Withdrawal by Subject|0
987764|NCT00506077|3246598|P1|Treatment Period 2|Withdrawal by Subject|1
987765|NCT00506077|3246597|P2|Treatment Period 2|Adverse Event|1
987766|NCT00506077|3246598|P1|Treatment Period 2|Adverse Event|0
987767|NCT00506077|3246597|P2|Treatment Period 1|Withdrawal by Subject|0
987768|NCT00506077|3246598|P1|Treatment Period 1|Withdrawal by Subject|2
987769|NCT00506077|3246597|P2|Treatment Period 1|Lost to Follow-up|2
987770|NCT00506077|3246598|P1|Treatment Period 1|Lost to Follow-up|0
987771|NCT00506077|3246597|P2|Treatment Period 1|Adverse Event|1
987772|NCT00506077|3246598|P1|Treatment Period 1|Adverse Event|2
987773|NCT00505934|3246640|P1|Overall Study|Other: IV dose needed to be changed|1
987774|NCT00505934|3246640|P1|Overall Study|Other: Unable to obtain IV & PK samples|1
987775|NCT00505934|3246640|P1|Overall Study|Adverse Event|1
987776|NCT00505921|3246646|P1|Overall Study|Failed to Mobilize|8
987777|NCT00505921|3246646|P1|Overall Study|Ineligible|1
987778|NCT00505778|3246663|P2|Overall Study|Took No Study Drug|2
987779|NCT00505778|3246664|P1|Overall Study|Took No Study Drug|2
987780|NCT00505778|3246663|P2|Overall Study|Relapse|65
987781|NCT00505778|3246664|P1|Overall Study|Relapse|65
987782|NCT00505778|3246663|P2|Overall Study|Withdrawal by Subject|14
987783|NCT00505778|3246664|P1|Overall Study|Withdrawal by Subject|29
987784|NCT00505778|3246663|P2|Overall Study|Protocol Violation|9
987785|NCT00505778|3246664|P1|Overall Study|Protocol Violation|7
987786|NCT00505778|3246663|P2|Overall Study|Unable to Meet Protocol Criteria|1
987787|NCT00505778|3246664|P1|Overall Study|Unable to Meet Protocol Criteria|4
987788|NCT00505778|3246663|P2|Overall Study|Lost to Follow-up|23
987789|NCT00505778|3246664|P1|Overall Study|Lost to Follow-up|17
987790|NCT00505778|3246663|P2|Overall Study|Physician Decision|14
987791|NCT00505778|3246664|P1|Overall Study|Physician Decision|8
987792|NCT00505778|3246663|P2|Overall Study|Adverse Event|7
987793|NCT00505778|3246664|P1|Overall Study|Adverse Event|2
987794|NCT00505765|3246683|P3|Overall Study|Noncompliance|3
987795|NCT00505765|3246684|P2|Overall Study|Noncompliance|1
987796|NCT00505765|3246685|P1|Overall Study|Noncompliance|0
987797|NCT00505765|3246683|P3|Overall Study|Adverse Event|0
987798|NCT00505765|3246684|P2|Overall Study|Adverse Event|2
987799|NCT00505765|3246685|P1|Overall Study|Adverse Event|1
987800|NCT00505765|3246683|P3|Overall Study|Withdrawal by Subject|0
987801|NCT00505765|3246684|P2|Overall Study|Withdrawal by Subject|0
987802|NCT00505765|3246685|P1|Overall Study|Withdrawal by Subject|1
987803|NCT00505752|3246712|P4|Overall Study|Other|2
987804|NCT00505752|3246713|P3|Overall Study|Other|1
987805|NCT00505752|3246714|P2|Overall Study|Other|2
987806|NCT00505752|3246715|P1|Overall Study|Other|1
987807|NCT00505752|3246712|P4|Overall Study|All embryos/blastocysts discarded|1
987808|NCT00505752|3246713|P3|Overall Study|All embryos/blastocysts discarded|1
987809|NCT00505752|3246714|P2|Overall Study|All embryos/blastocysts discarded|0
987810|NCT00505752|3246715|P1|Overall Study|All embryos/blastocysts discarded|0
987811|NCT00505752|3246712|P4|Overall Study|No Fertilization|1
987812|NCT00505752|3246713|P3|Overall Study|No Fertilization|2
987813|NCT00505752|3246714|P2|Overall Study|No Fertilization|1
987814|NCT00505752|3246715|P1|Overall Study|No Fertilization|1
987815|NCT00505752|3246712|P4|Overall Study|No oocytes retrieved|1
987816|NCT00505752|3246713|P3|Overall Study|No oocytes retrieved|0
987817|NCT00505752|3246714|P2|Overall Study|No oocytes retrieved|2
987818|NCT00505752|3246715|P1|Overall Study|No oocytes retrieved|0
987819|NCT00505752|3246712|P4|Overall Study|Ovarian hyperstimulation syndrome risk|1
987820|NCT00505752|3246713|P3|Overall Study|Ovarian hyperstimulation syndrome risk|3
987821|NCT00505752|3246714|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
987822|NCT00505752|3246715|P1|Overall Study|Ovarian hyperstimulation syndrome risk|1
987823|NCT00505752|3246712|P4|Overall Study|Lack of ovarian response|0
987824|NCT00505752|3246713|P3|Overall Study|Lack of ovarian response|0
987825|NCT00505752|3246714|P2|Overall Study|Lack of ovarian response|3
987826|NCT00505752|3246715|P1|Overall Study|Lack of ovarian response|1
987827|NCT00505752|3246712|P4|Overall Study|Lost to Follow-up|0
987828|NCT00505752|3246713|P3|Overall Study|Lost to Follow-up|0
987829|NCT00505752|3246714|P2|Overall Study|Lost to Follow-up|0
987830|NCT00505752|3246715|P1|Overall Study|Lost to Follow-up|1
987831|NCT00505752|3246712|P4|Overall Study|Adverse Event|0
987832|NCT00505752|3246713|P3|Overall Study|Adverse Event|1
987833|NCT00505752|3246714|P2|Overall Study|Adverse Event|0
987834|NCT00505752|3246715|P1|Overall Study|Adverse Event|1
987835|NCT00505687|3246729|P1|Overall Study|Other: As Per Sponsor|8
987836|NCT00505687|3246729|P1|Overall Study|Other: Disease Progression|1
987837|NCT00505687|3246729|P1|Overall Study|Other: Neupro Given In Hospital|1
987838|NCT00505687|3246729|P1|Overall Study|Other: Patches Would Not Stick D/T Sweat|1
987839|NCT00505687|3246729|P1|Overall Study|Other: Prolonged Hospitalization|1
987840|NCT00505687|3246729|P1|Overall Study|Other: Scheduled DBS Surgery|1
987841|NCT00505687|3246729|P1|Overall Study|Other: Underwent Implantation Of DBS|1
987842|NCT00505687|3246729|P1|Overall Study|Lost to Follow-up|1
987843|NCT00505687|3246729|P1|Overall Study|Subject withdrew consent|15
987844|NCT00505687|3246729|P1|Overall Study|Adverse Event|48
987845|NCT00505687|3246729|P1|Overall Study|Lack of Efficacy|15
987846|NCT00505687|3246729|P1|Overall Study|Important protocol violation|2
987847|NCT00505661|3246735|P1|Overall Study|Not Eligible|4
987848|NCT00505622|3246746|P3|Overall Study|Study termination by sponsor|90
987849|NCT00505622|3246747|P2|Overall Study|Study termination by sponsor|98
987850|NCT00505622|3246748|P1|Overall Study|Study termination by sponsor|115
987851|NCT00505622|3246746|P3|Overall Study|Withdrawal by Subject|2
987852|NCT00505622|3246747|P2|Overall Study|Withdrawal by Subject|3
987853|NCT00505622|3246748|P1|Overall Study|Withdrawal by Subject|0
987854|NCT00505622|3246746|P3|Overall Study|Protocol Violation|0
987855|NCT00505622|3246747|P2|Overall Study|Protocol Violation|1
987856|NCT00505622|3246748|P1|Overall Study|Protocol Violation|1
987857|NCT00505622|3246746|P3|Overall Study|Adverse Event|4
987858|NCT00505622|3246747|P2|Overall Study|Adverse Event|6
987859|NCT00505622|3246748|P1|Overall Study|Adverse Event|5
987860|NCT00505414|3246773|P5|Maintenance Phase|underlying disease and therapy required|0
987861|NCT00505414|3246774|P4|Maintenance Phase|underlying disease and therapy required|0
987862|NCT00505414|3246775|P3|Maintenance Phase|underlying disease and therapy required|2
987863|NCT00505414|3246776|P2|Maintenance Phase|underlying disease and therapy required|2
987864|NCT00505414|3246777|P1|Maintenance Phase|underlying disease and therapy required|0
987865|NCT00505414|3246773|P5|Maintenance Phase|Withdrawal by Subject|0
987866|NCT00505414|3246774|P4|Maintenance Phase|Withdrawal by Subject|0
987867|NCT00505414|3246775|P3|Maintenance Phase|Withdrawal by Subject|1
987868|NCT00505414|3246776|P2|Maintenance Phase|Withdrawal by Subject|0
987869|NCT00505414|3246777|P1|Maintenance Phase|Withdrawal by Subject|0
987870|NCT00505414|3246773|P5|Maintenance Phase|Lack of Efficacy|0
987871|NCT00505414|3246774|P4|Maintenance Phase|Lack of Efficacy|0
987872|NCT00505414|3246775|P3|Maintenance Phase|Lack of Efficacy|1
987873|NCT00505414|3246776|P2|Maintenance Phase|Lack of Efficacy|1
987874|NCT00505414|3246777|P1|Maintenance Phase|Lack of Efficacy|2
987875|NCT00505414|3246773|P5|Maintenance Phase|Death|0
987876|NCT00505414|3246774|P4|Maintenance Phase|Death|0
987877|NCT00505414|3246775|P3|Maintenance Phase|Death|1
987878|NCT00505414|3246776|P2|Maintenance Phase|Death|0
987879|NCT00505414|3246777|P1|Maintenance Phase|Death|2
987880|NCT00505414|3246773|P5|Maintenance Phase|Adverse Event|0
987881|NCT00505414|3246774|P4|Maintenance Phase|Adverse Event|0
987882|NCT00505414|3246775|P3|Maintenance Phase|Adverse Event|3
987883|NCT00505414|3246776|P2|Maintenance Phase|Adverse Event|2
987884|NCT00505414|3246777|P1|Maintenance Phase|Adverse Event|2
987885|NCT00505414|3246773|P5|Titration Phase|Underlying disease and therapy required|3
987886|NCT00505414|3246774|P4|Titration Phase|Underlying disease and therapy required|7
987887|NCT00505414|3246775|P3|Titration Phase|Underlying disease and therapy required|0
987888|NCT00505414|3246776|P2|Titration Phase|Underlying disease and therapy required|0
987889|NCT00505414|3246777|P1|Titration Phase|Underlying disease and therapy required|0
987890|NCT00505414|3246773|P5|Titration Phase|Withdrawal by Subject|4
987891|NCT00505414|3246774|P4|Titration Phase|Withdrawal by Subject|3
987892|NCT00505414|3246775|P3|Titration Phase|Withdrawal by Subject|0
987893|NCT00505414|3246776|P2|Titration Phase|Withdrawal by Subject|0
987894|NCT00505414|3246777|P1|Titration Phase|Withdrawal by Subject|0
987895|NCT00505414|3246773|P5|Titration Phase|Protocol Violation|1
987896|NCT00505414|3246774|P4|Titration Phase|Protocol Violation|0
987897|NCT00505414|3246775|P3|Titration Phase|Protocol Violation|0
987898|NCT00505414|3246776|P2|Titration Phase|Protocol Violation|0
987899|NCT00505414|3246777|P1|Titration Phase|Protocol Violation|0
987900|NCT00505414|3246773|P5|Titration Phase|Lack of Efficacy|1
987901|NCT00505414|3246774|P4|Titration Phase|Lack of Efficacy|10
987902|NCT00505414|3246775|P3|Titration Phase|Lack of Efficacy|0
987903|NCT00505414|3246776|P2|Titration Phase|Lack of Efficacy|0
987904|NCT00505414|3246777|P1|Titration Phase|Lack of Efficacy|0
987905|NCT00505414|3246773|P5|Titration Phase|Death|0
987906|NCT00505414|3246774|P4|Titration Phase|Death|2
987907|NCT00505414|3246775|P3|Titration Phase|Death|0
987908|NCT00505414|3246776|P2|Titration Phase|Death|0
987909|NCT00505414|3246777|P1|Titration Phase|Death|0
987910|NCT00505414|3246773|P5|Titration Phase|Adverse Event|3
987911|NCT00505414|3246774|P4|Titration Phase|Adverse Event|8
987912|NCT00505414|3246775|P3|Titration Phase|Adverse Event|0
987913|NCT00505414|3246776|P2|Titration Phase|Adverse Event|0
987914|NCT00505414|3246777|P1|Titration Phase|Adverse Event|0
987915|NCT00505375|3246794|P2|Overall Study|Travel issues|1
987916|NCT00505375|3246795|P1|Overall Study|Travel issues|0
987917|NCT00505375|3246794|P2|Overall Study|Pregnancy|0
987918|NCT00505375|3246795|P1|Overall Study|Pregnancy|1
987919|NCT00505375|3246794|P2|Overall Study|Lost to Follow-up|2
987920|NCT00505375|3246795|P1|Overall Study|Lost to Follow-up|0
987921|NCT00505375|3246794|P2|Overall Study|Withdrawal by Subject|2
987922|NCT00505375|3246795|P1|Overall Study|Withdrawal by Subject|2
987923|NCT00505375|3246794|P2|Overall Study|Death|0
987924|NCT00505375|3246795|P1|Overall Study|Death|1
987925|NCT00505284|3246817|P5|Overall Study|Not specified|4
987926|NCT00505284|3246818|P4|Overall Study|Not specified|4
987927|NCT00505284|3246819|P3|Overall Study|Not specified|0
987928|NCT00505284|3246820|P2|Overall Study|Not specified|0
987929|NCT00505284|3246821|P1|Overall Study|Not specified|5
987930|NCT00505284|3246817|P5|Overall Study|Physician Decision|0
987931|NCT00505284|3246818|P4|Overall Study|Physician Decision|0
987932|NCT00505284|3246819|P3|Overall Study|Physician Decision|0
987933|NCT00505284|3246820|P2|Overall Study|Physician Decision|1
987934|NCT00505284|3246821|P1|Overall Study|Physician Decision|0
987935|NCT00505284|3246817|P5|Overall Study|Lack of Efficacy|1
987936|NCT00505284|3246818|P4|Overall Study|Lack of Efficacy|1
987937|NCT00505284|3246819|P3|Overall Study|Lack of Efficacy|1
987938|NCT00505284|3246820|P2|Overall Study|Lack of Efficacy|1
987939|NCT00505284|3246821|P1|Overall Study|Lack of Efficacy|0
987940|NCT00505284|3246817|P5|Overall Study|Withdrawal by Subject|6
987941|NCT00505284|3246818|P4|Overall Study|Withdrawal by Subject|0
987942|NCT00505284|3246819|P3|Overall Study|Withdrawal by Subject|1
987943|NCT00505284|3246820|P2|Overall Study|Withdrawal by Subject|6
987944|NCT00505284|3246821|P1|Overall Study|Withdrawal by Subject|2
987945|NCT00505284|3246817|P5|Overall Study|Protocol Violation|0
987946|NCT00505284|3246818|P4|Overall Study|Protocol Violation|0
987947|NCT00505284|3246819|P3|Overall Study|Protocol Violation|1
987948|NCT00505284|3246820|P2|Overall Study|Protocol Violation|1
987949|NCT00505284|3246821|P1|Overall Study|Protocol Violation|0
987950|NCT00505284|3246817|P5|Overall Study|Adverse Event|22
987951|NCT00505284|3246818|P4|Overall Study|Adverse Event|14
987952|NCT00505284|3246819|P3|Overall Study|Adverse Event|9
987953|NCT00505284|3246820|P2|Overall Study|Adverse Event|7
987954|NCT00505284|3246821|P1|Overall Study|Adverse Event|3
987955|NCT00505076|3246891|P3|Overall Study|Withdrawal by Subject|2
987956|NCT00505076|3246892|P2|Overall Study|Withdrawal by Subject|1
987957|NCT00505076|3246893|P1|Overall Study|Withdrawal by Subject|0
987958|NCT00505076|3246891|P3|Overall Study|Protocol Violation|2
987959|NCT00505076|3246892|P2|Overall Study|Protocol Violation|1
987960|NCT00505076|3246893|P1|Overall Study|Protocol Violation|2
987961|NCT00505076|3246891|P3|Overall Study|Adverse Event|1
987962|NCT00505076|3246892|P2|Overall Study|Adverse Event|0
987963|NCT00505076|3246893|P1|Overall Study|Adverse Event|1
987964|NCT00504881|3246922|P2|Overall Study|AE of unknown type|0
987965|NCT00504881|3246923|P1|Overall Study|AE of unknown type|1
987966|NCT00504881|3246922|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2
987967|NCT00504881|3246923|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
987968|NCT00504881|3246922|P2|Overall Study|AE, non-serious non-fatal|14
987969|NCT00504881|3246923|P1|Overall Study|AE, non-serious non-fatal|4
987970|NCT00504881|3246922|P2|Overall Study|SAE, non-fatal|6
987971|NCT00504881|3246923|P1|Overall Study|SAE, non-fatal|2
987972|NCT00504881|3246922|P2|Overall Study|AE, serious fatal|1
987973|NCT00504881|3246923|P1|Overall Study|AE, serious fatal|0
987974|NCT00504881|3246922|P2|Overall Study|Safety Visit not performed|1
987975|NCT00504881|3246923|P1|Overall Study|Safety Visit not performed|0
987976|NCT00504881|3246922|P2|Overall Study|No Birth Control|1
987977|NCT00504881|3246923|P1|Overall Study|No Birth Control|0
987978|NCT00504881|3246922|P2|Overall Study|Non-Compliance|0
987979|NCT00504881|3246923|P1|Overall Study|Non-Compliance|1
987980|NCT00504881|3246922|P2|Overall Study|Withdrawal by Subject|4
987981|NCT00504881|3246923|P1|Overall Study|Withdrawal by Subject|1
987982|NCT00504881|3246922|P2|Overall Study|Lost to Follow-up|2
987983|NCT00504881|3246923|P1|Overall Study|Lost to Follow-up|0
987984|NCT00504881|3246922|P2|Overall Study|Lack of Efficacy|5
987985|NCT00504881|3246923|P1|Overall Study|Lack of Efficacy|1
987986|NCT00504777|3246973|P1|Overall Study|Adverse Event|1
987987|NCT00504725|3246986|P2|Overall Study|Protocol Violation|0
987988|NCT00504725|3246987|P1|Overall Study|Protocol Violation|1
987989|NCT00504595|3247010|P4|Overall Study|Not specified|0
987990|NCT00504595|3247011|P3|Overall Study|Not specified|2
987991|NCT00504595|3247012|P2|Overall Study|Not specified|0
987992|NCT00504595|3247013|P1|Overall Study|Not specified|0
987993|NCT00504595|3247010|P4|Overall Study|Lack of Efficacy|0
987994|NCT00504595|3247011|P3|Overall Study|Lack of Efficacy|0
987995|NCT00504595|3247012|P2|Overall Study|Lack of Efficacy|0
987996|NCT00504595|3247013|P1|Overall Study|Lack of Efficacy|1
987997|NCT00504556|3247030|P5|Overall Study|not in safety analysis set|1
987998|NCT00504556|3247031|P4|Overall Study|not in safety analysis set|0
987999|NCT00504556|3247032|P3|Overall Study|not in safety analysis set|1
988000|NCT00504556|3247033|P2|Overall Study|not in safety analysis set|1
988001|NCT00504556|3247034|P1|Overall Study|not in safety analysis set|0
988002|NCT00504556|3247030|P5|Overall Study|not specified|0
988003|NCT00504556|3247031|P4|Overall Study|not specified|3
988004|NCT00504556|3247032|P3|Overall Study|not specified|2
988005|NCT00504556|3247033|P2|Overall Study|not specified|2
988006|NCT00504556|3247034|P1|Overall Study|not specified|2
988007|NCT00504556|3247030|P5|Overall Study|data monitor committee decision|0
988008|NCT00504556|3247031|P4|Overall Study|data monitor committee decision|100
988009|NCT00504556|3247032|P3|Overall Study|data monitor committee decision|0
988010|NCT00504556|3247033|P2|Overall Study|data monitor committee decision|0
988011|NCT00504556|3247034|P1|Overall Study|data monitor committee decision|0
988012|NCT00504556|3247030|P5|Overall Study|did not meet entry criteria|0
988013|NCT00504556|3247031|P4|Overall Study|did not meet entry criteria|1
988014|NCT00504556|3247032|P3|Overall Study|did not meet entry criteria|1
988015|NCT00504556|3247033|P2|Overall Study|did not meet entry criteria|0
988016|NCT00504556|3247034|P1|Overall Study|did not meet entry criteria|2
988017|NCT00504556|3247030|P5|Overall Study|administrative reasons|2
988018|NCT00504556|3247031|P4|Overall Study|administrative reasons|1
988019|NCT00504556|3247032|P3|Overall Study|administrative reasons|2
988020|NCT00504556|3247033|P2|Overall Study|administrative reasons|2
988021|NCT00504556|3247034|P1|Overall Study|administrative reasons|0
988022|NCT00504556|3247030|P5|Overall Study|Withdrawal by Subject|12
988023|NCT00504556|3247031|P4|Overall Study|Withdrawal by Subject|8
988024|NCT00504556|3247032|P3|Overall Study|Withdrawal by Subject|7
988025|NCT00504556|3247033|P2|Overall Study|Withdrawal by Subject|16
988026|NCT00504556|3247034|P1|Overall Study|Withdrawal by Subject|16
988027|NCT00504556|3247030|P5|Overall Study|Lost to Follow-up|1
988028|NCT00504556|3247031|P4|Overall Study|Lost to Follow-up|1
988029|NCT00504556|3247032|P3|Overall Study|Lost to Follow-up|1
988030|NCT00504556|3247033|P2|Overall Study|Lost to Follow-up|0
988031|NCT00504556|3247034|P1|Overall Study|Lost to Follow-up|0
988032|NCT00504556|3247030|P5|Overall Study|Protocol Violation|2
988033|NCT00504556|3247031|P4|Overall Study|Protocol Violation|1
988034|NCT00504556|3247032|P3|Overall Study|Protocol Violation|2
988035|NCT00504556|3247033|P2|Overall Study|Protocol Violation|3
988036|NCT00504556|3247034|P1|Overall Study|Protocol Violation|1
988037|NCT00504556|3247030|P5|Overall Study|Death|2
988038|NCT00504556|3247031|P4|Overall Study|Death|0
988039|NCT00504556|3247032|P3|Overall Study|Death|1
988040|NCT00504556|3247033|P2|Overall Study|Death|3
988041|NCT00504556|3247034|P1|Overall Study|Death|3
988042|NCT00504556|3247030|P5|Overall Study|Adverse Event|5
988043|NCT00504556|3247031|P4|Overall Study|Adverse Event|13
988044|NCT00504556|3247032|P3|Overall Study|Adverse Event|14
988045|NCT00504556|3247033|P2|Overall Study|Adverse Event|11
988046|NCT00504556|3247034|P1|Overall Study|Adverse Event|11
988047|NCT00504426|3247102|P4|Overall Study|Withdrawal by Subject|0
988048|NCT00504426|3247103|P3|Overall Study|Withdrawal by Subject|0
988049|NCT00504426|3247104|P2|Overall Study|Withdrawal by Subject|0
988050|NCT00504426|3247105|P1|Overall Study|Withdrawal by Subject|2
988051|NCT00504426|3247102|P4|Overall Study|Protocol Violation|0
988052|NCT00504426|3247103|P3|Overall Study|Protocol Violation|2
988053|NCT00504426|3247104|P2|Overall Study|Protocol Violation|1
988054|NCT00504426|3247105|P1|Overall Study|Protocol Violation|1
988055|NCT00504426|3247102|P4|Overall Study|Adverse Event|0
988056|NCT00504426|3247103|P3|Overall Study|Adverse Event|2
988057|NCT00504426|3247104|P2|Overall Study|Adverse Event|0
988058|NCT00504426|3247105|P1|Overall Study|Adverse Event|0
988059|NCT00504309|3247125|P6|Overall Study|Withdrawal by Subject|0
988060|NCT00504309|3247126|P5|Overall Study|Withdrawal by Subject|0
988061|NCT00504309|3247127|P4|Overall Study|Withdrawal by Subject|0
988062|NCT00504309|3247128|P3|Overall Study|Withdrawal by Subject|1
988063|NCT00504309|3247129|P2|Overall Study|Withdrawal by Subject|0
988064|NCT00504309|3247130|P1|Overall Study|Withdrawal by Subject|0
988065|NCT00504309|3247125|P6|Overall Study|Death|0
988066|NCT00504309|3247126|P5|Overall Study|Death|1
988067|NCT00504309|3247127|P4|Overall Study|Death|0
988068|NCT00504309|3247128|P3|Overall Study|Death|0
988069|NCT00504309|3247129|P2|Overall Study|Death|0
988070|NCT00504309|3247130|P1|Overall Study|Death|0
988071|NCT00504257|3247168|P1|Overall Study|ineligible histology|2
988072|NCT00504257|3247168|P1|Overall Study|Withdrawal by Subject|2
988073|NCT00504231|3247180|P4|Overall Study|Discrepant chart documentation re route|0
988074|NCT00504231|3247181|P3|Overall Study|Discrepant chart documentation re route|1
988075|NCT00504231|3247182|P2|Overall Study|Discrepant chart documentation re route|0
988076|NCT00504231|3247183|P1|Overall Study|Discrepant chart documentation re route|0
988077|NCT00504166|3247203|P2|Overall Study|Lost to Follow-up|3
988078|NCT00504166|3247204|P1|Overall Study|Lost to Follow-up|1
988079|NCT00504166|3247203|P2|Overall Study|Physician Decision|1
988080|NCT00504166|3247204|P1|Overall Study|Physician Decision|1
988081|NCT00504166|3247203|P2|Overall Study|Withdrawal by Subject|6
988082|NCT00504166|3247204|P1|Overall Study|Withdrawal by Subject|3
988083|NCT00504166|3247203|P2|Overall Study|Adverse Event|4
988084|NCT00504166|3247204|P1|Overall Study|Adverse Event|1
988085|NCT00504153|3247210|P1|Overall Study|Death|1
988086|NCT00504153|3247210|P1|Overall Study|Adverse Event|4
988087|NCT00504153|3247210|P1|Overall Study|Withdrawal by Subject|1
988088|NCT00504075|3247218|P1|Overall Study|Required other therapeutic intervention|1
988089|NCT00504075|3247218|P1|Overall Study|Withdrawal by Subject|1
988090|NCT00504075|3247218|P1|Overall Study|Lost to Follow-up|5
988091|NCT00504075|3247218|P1|Overall Study|Adverse Event|1
988092|NCT00503997|3247228|P1|Overall Study|Withdrawal by Subject|1
988093|NCT00503997|3247228|P1|Overall Study|Death|1
988094|NCT00503997|3247228|P1|Overall Study|Adverse Event|5
988095|NCT00503997|3247228|P1|Overall Study|disease progression|1
988096|NCT00503984|3247234|P6|Overall Study|Death|0
988097|NCT00503984|3247235|P5|Overall Study|Death|1
988098|NCT00503984|3247236|P4|Overall Study|Death|0
988099|NCT00503984|3247237|P3|Overall Study|Death|0
988100|NCT00503984|3247238|P2|Overall Study|Death|0
988101|NCT00503984|3247239|P1|Overall Study|Death|0
988102|NCT00503984|3247234|P6|Overall Study|Adverse Event|0
988103|NCT00503984|3247235|P5|Overall Study|Adverse Event|0
988104|NCT00503984|3247236|P4|Overall Study|Adverse Event|0
988105|NCT00503984|3247237|P3|Overall Study|Adverse Event|0
988106|NCT00503984|3247238|P2|Overall Study|Adverse Event|1
988107|NCT00503984|3247239|P1|Overall Study|Adverse Event|0
988108|NCT00503984|3247234|P6|Overall Study|Protocol Violation|0
988109|NCT00503984|3247235|P5|Overall Study|Protocol Violation|0
988110|NCT00503984|3247236|P4|Overall Study|Protocol Violation|0
988111|NCT00503984|3247237|P3|Overall Study|Protocol Violation|0
988112|NCT00503984|3247238|P2|Overall Study|Protocol Violation|1
988113|NCT00503984|3247239|P1|Overall Study|Protocol Violation|0
988114|NCT00503906|3247265|P1|Overall Study|Withdrawal by Subject|1
988115|NCT00503841|3247287|P1|Overall Study|All screen failures|44
988116|NCT00503776|3247295|P4|Overall Study|Physician Decision|1
988117|NCT00503776|3247296|P3|Overall Study|Physician Decision|1
988118|NCT00503776|3247297|P2|Overall Study|Physician Decision|0
988119|NCT00503776|3247298|P1|Overall Study|Physician Decision|0
988120|NCT00503776|3247295|P4|Overall Study|Withdrawal by Subject|1
988121|NCT00503776|3247296|P3|Overall Study|Withdrawal by Subject|1
988122|NCT00503776|3247297|P2|Overall Study|Withdrawal by Subject|0
988123|NCT00503776|3247298|P1|Overall Study|Withdrawal by Subject|1
988124|NCT00503698|3247331|P2|Overall Study|Not exposed to trial drug|6
988125|NCT00503698|3247332|P1|Overall Study|Not exposed to trial drug|11
988126|NCT00503698|3247331|P2|Overall Study|Unclassified|32
988127|NCT00503698|3247332|P1|Overall Study|Unclassified|48
988128|NCT00503698|3247331|P2|Overall Study|Critically ill|0
988129|NCT00503698|3247332|P1|Overall Study|Critically ill|2
988130|NCT00503698|3247331|P2|Overall Study|Move to nonparticipating dialysis center|1
988131|NCT00503698|3247332|P1|Overall Study|Move to nonparticipating dialysis center|2
988132|NCT00503698|3247331|P2|Overall Study|Switch to peritoneal or home dialysis|2
988133|NCT00503698|3247332|P1|Overall Study|Switch to peritoneal or home dialysis|2
988134|NCT00503698|3247331|P2|Overall Study|Any condition in exclusion criteria|6
988135|NCT00503698|3247332|P1|Overall Study|Any condition in exclusion criteria|4
988136|NCT00503698|3247331|P2|Overall Study|Pregnancy/intention to become pregnant|0
988137|NCT00503698|3247332|P1|Overall Study|Pregnancy/intention to become pregnant|1
988138|NCT00503698|3247331|P2|Overall Study|End hemodialysis due to renal transplant|4
988139|NCT00503698|3247332|P1|Overall Study|End hemodialysis due to renal transplant|10
988140|NCT00503698|3247331|P2|Overall Study|Trial terminated|253
988141|NCT00503698|3247332|P1|Overall Study|Trial terminated|216
988142|NCT00503698|3247331|P2|Overall Study|Lack of Efficacy|4
988143|NCT00503698|3247332|P1|Overall Study|Lack of Efficacy|3
988144|NCT00503698|3247331|P2|Overall Study|Death|0
988145|NCT00503698|3247332|P1|Overall Study|Death|1
988146|NCT00503698|3247331|P2|Overall Study|Adverse Event|41
988147|NCT00503698|3247332|P1|Overall Study|Adverse Event|52
988148|NCT00503698|3247331|P2|Overall Study|Protocol Violation|6
988149|NCT00503698|3247332|P1|Overall Study|Protocol Violation|5
988150|NCT00503685|3247349|P3|Overall Study|Eligibility Criteria Not Met|0
988151|NCT00503685|3247350|P2|Overall Study|Eligibility Criteria Not Met|1
988152|NCT00503685|3247351|P1|Overall Study|Eligibility Criteria Not Met|0
988153|NCT00503685|3247349|P3|Overall Study|Protocol Violation|0
988154|NCT00503685|3247350|P2|Overall Study|Protocol Violation|1
988155|NCT00503685|3247351|P1|Overall Study|Protocol Violation|0
988156|NCT00503685|3247349|P3|Overall Study|Withdrawal by Subject|0
988157|NCT00503685|3247350|P2|Overall Study|Withdrawal by Subject|1
988158|NCT00503685|3247351|P1|Overall Study|Withdrawal by Subject|0
988159|NCT00503685|3247349|P3|Overall Study|Adverse Event|2
988160|NCT00503685|3247350|P2|Overall Study|Adverse Event|0
988161|NCT00503685|3247351|P1|Overall Study|Adverse Event|0
988162|NCT00503425|3247393|P1|Overall Study|Missing Data/Unknown|4
988163|NCT00503425|3247393|P1|Overall Study|Death|3
988164|NCT00503425|3247393|P1|Overall Study|Lost to Follow-up|3
988165|NCT00503425|3247393|P1|Overall Study|Withdrawal by Subject|8
988166|NCT00503425|3247393|P1|Overall Study|Lack of Efficacy|25
988167|NCT00503425|3247393|P1|Overall Study|Adverse Event|5
988168|NCT00503425|3247393|P1|Overall Study|Participant files lost|6
988169|NCT00503399|3247403|P2|Overall Study|Lost to Follow-up|2
988170|NCT00503399|3247404|P1|Overall Study|Lost to Follow-up|0
988171|NCT00503399|3247403|P2|Overall Study|Adverse Event|3
988172|NCT00503399|3247404|P1|Overall Study|Adverse Event|0
988173|NCT00503399|3247403|P2|Overall Study|Withdrawal by Subject|2
988174|NCT00503399|3247404|P1|Overall Study|Withdrawal by Subject|4
988175|NCT00503399|3247403|P2|Overall Study|Protocol Violation|0
988176|NCT00503399|3247404|P1|Overall Study|Protocol Violation|1
988177|NCT00503399|3247403|P2|Overall Study|Death|1
988178|NCT00503399|3247404|P1|Overall Study|Death|2
988179|NCT00503308|3247428|P2|Overall Study|Protocol Violation|1
988180|NCT00503308|3247429|P1|Overall Study|Protocol Violation|2
988181|NCT00503139|3247435|P1|Overall Study|Protocol Violation|4
988182|NCT00503139|3247435|P1|Overall Study|Case Report Forms were not collected|4
988183|NCT00503009|3247483|P3|Overall Study|Physician Decision|1
988184|NCT00503009|3247484|P2|Overall Study|Physician Decision|1
988185|NCT00503009|3247485|P1|Overall Study|Physician Decision|0
988186|NCT00503009|3247483|P3|Overall Study|Withdrawal by Subject|1
988187|NCT00503009|3247484|P2|Overall Study|Withdrawal by Subject|1
988188|NCT00503009|3247485|P1|Overall Study|Withdrawal by Subject|0
988189|NCT00503009|3247483|P3|Overall Study|Protocol Violation|1
988190|NCT00503009|3247484|P2|Overall Study|Protocol Violation|0
988191|NCT00503009|3247485|P1|Overall Study|Protocol Violation|1
988192|NCT00502996|3247502|P1|Overall Study|Adverse Event|2
988193|NCT00502996|3247502|P1|Overall Study|Withdrawal Informed Consent|6
988194|NCT00502996|3247502|P1|Overall Study|Treatment failure|25
988195|NCT00502996|3247502|P1|Overall Study|Protocol Violation|2
988196|NCT00502996|3247502|P1|Overall Study|Lost to Follow-up|9
988197|NCT00502840|3247570|P1|Overall Study|Not specified|20
988198|NCT00502840|3247570|P1|Overall Study|Administrative problems|1
988199|NCT00502840|3247570|P1|Overall Study|Lost to Follow-up|6
988200|NCT00502840|3247570|P1|Overall Study|Withdrawal by Subject|5
988201|NCT00502840|3247570|P1|Overall Study|Protocol Violation|4
988202|NCT00502840|3247570|P1|Overall Study|Lack of Efficacy|11
988203|NCT00502840|3247570|P1|Overall Study|Additional or changed therapy|48
988204|NCT00502840|3247570|P1|Overall Study|Adverse Event|5
988205|NCT00502801|3247598|P1|End of Therapy to Test of Cure|OTHER|2
988206|NCT00502801|3247598|P1|End of Therapy to Test of Cure|Death|3
988207|NCT00502801|3247598|P1|End of Therapy to Test of Cure|Lost to Follow-up|2
988208|NCT00502801|3247598|P1|End of Therapy to Test of Cure|Withdrawal by Subject|1
988209|NCT00502801|3247598|P1|Treatment Period|OTHER|30
988210|NCT00502801|3247598|P1|Treatment Period|Death|14
988211|NCT00502801|3247598|P1|Treatment Period|Adverse Event|7
988212|NCT00502801|3247598|P1|Treatment Period|Withdrawal by Subject|3
988213|NCT00502775|3247606|P3|Overall Study|Subject took disallowed drug|1
988214|NCT00502775|3247607|P2|Overall Study|Subject took disallowed drug|0
988215|NCT00502775|3247608|P1|Overall Study|Subject took disallowed drug|0
988216|NCT00502775|3247606|P3|Overall Study|Subject in jail|0
988217|NCT00502775|3247607|P2|Overall Study|Subject in jail|1
988218|NCT00502775|3247608|P1|Overall Study|Subject in jail|0
988219|NCT00502775|3247606|P3|Overall Study|Declining pollen counts|1
988220|NCT00502775|3247607|P2|Overall Study|Declining pollen counts|1
988221|NCT00502775|3247608|P1|Overall Study|Declining pollen counts|0
988222|NCT00502775|3247606|P3|Overall Study|Outside pollen area more than 48 hours|0
988223|NCT00502775|3247607|P2|Overall Study|Outside pollen area more than 48 hours|1
988224|NCT00502775|3247608|P1|Overall Study|Outside pollen area more than 48 hours|0
988225|NCT00502775|3247606|P3|Overall Study|Non-compliance|2
988226|NCT00502775|3247607|P2|Overall Study|Non-compliance|2
988227|NCT00502775|3247608|P1|Overall Study|Non-compliance|0
988228|NCT00502775|3247606|P3|Overall Study|Randomized in error|1
988229|NCT00502775|3247607|P2|Overall Study|Randomized in error|1
988230|NCT00502775|3247608|P1|Overall Study|Randomized in error|0
988231|NCT00502775|3247606|P3|Overall Study|Logpad compliance <80%|0
988232|NCT00502775|3247607|P2|Overall Study|Logpad compliance <80%|0
988233|NCT00502775|3247608|P1|Overall Study|Logpad compliance <80%|1
988234|NCT00502775|3247606|P3|Overall Study|Subject unable to swallow capsule|1
988235|NCT00502775|3247607|P2|Overall Study|Subject unable to swallow capsule|0
988236|NCT00502775|3247608|P1|Overall Study|Subject unable to swallow capsule|1
988237|NCT00502775|3247606|P3|Overall Study|Non-compliance with eDiary|1
988238|NCT00502775|3247607|P2|Overall Study|Non-compliance with eDiary|1
988239|NCT00502775|3247608|P1|Overall Study|Non-compliance with eDiary|4
988240|NCT00502775|3247606|P3|Overall Study|Sponsor Terminated Study|1
988241|NCT00502775|3247607|P2|Overall Study|Sponsor Terminated Study|0
988242|NCT00502775|3247608|P1|Overall Study|Sponsor Terminated Study|1
988243|NCT00502775|3247606|P3|Overall Study|Withdrawal by Subject|2
988244|NCT00502775|3247607|P2|Overall Study|Withdrawal by Subject|1
988245|NCT00502775|3247608|P1|Overall Study|Withdrawal by Subject|1
988246|NCT00502775|3247606|P3|Overall Study|Protocol Violation|2
988247|NCT00502775|3247607|P2|Overall Study|Protocol Violation|5
988248|NCT00502775|3247608|P1|Overall Study|Protocol Violation|1
988249|NCT00502775|3247606|P3|Overall Study|Adverse Event|1
988250|NCT00502775|3247607|P2|Overall Study|Adverse Event|2
988251|NCT00502775|3247608|P1|Overall Study|Adverse Event|1
988252|NCT00502697|3247651|P2|Overall Study|did not meet assignment criteria|2
988253|NCT00502697|3247652|P1|Overall Study|did not meet assignment criteria|4
988254|NCT00502697|3247651|P2|Overall Study|found not to meet eligibility criteria|4
988255|NCT00502697|3247652|P1|Overall Study|found not to meet eligibility criteria|3
988256|NCT00502697|3247651|P2|Overall Study|disenrolled due to pregnancy loss|5
988257|NCT00502697|3247652|P1|Overall Study|disenrolled due to pregnancy loss|3
988258|NCT00502697|3247651|P2|Overall Study|Withdrawal by Subject|1
988259|NCT00502697|3247652|P1|Overall Study|Withdrawal by Subject|3
988260|NCT00502671|3247660|P1|Overall Study|Adverse Event|19
988261|NCT00502671|3247660|P1|Overall Study|Protocol Violation|16
988262|NCT00502671|3247660|P1|Overall Study|Lost to Follow-up|7
988263|NCT00502671|3247660|P1|Overall Study|Personal Reasons|22
988264|NCT00502671|3247660|P1|Overall Study|Disease Progression|13
988265|NCT00502593|3247677|P12|Overall Study|Lost to Follow-up|0
988266|NCT00502593|3247678|P11|Overall Study|Lost to Follow-up|1
988267|NCT00502593|3247679|P10|Overall Study|Lost to Follow-up|0
988268|NCT00502593|3247680|P9|Overall Study|Lost to Follow-up|3
988269|NCT00502593|3247681|P8|Overall Study|Lost to Follow-up|0
988270|NCT00502593|3247682|P7|Overall Study|Lost to Follow-up|0
988271|NCT00502593|3247683|P6|Overall Study|Lost to Follow-up|0
988272|NCT00502593|3247684|P5|Overall Study|Lost to Follow-up|0
988273|NCT00502593|3247685|P4|Overall Study|Lost to Follow-up|1
988274|NCT00502593|3247686|P3|Overall Study|Lost to Follow-up|1
988275|NCT00502593|3247687|P2|Overall Study|Lost to Follow-up|1
988276|NCT00502593|3247688|P1|Overall Study|Lost to Follow-up|2
988277|NCT00502593|3247677|P12|Overall Study|Withdrawal by Subject|0
988278|NCT00502593|3247678|P11|Overall Study|Withdrawal by Subject|1
988279|NCT00502593|3247679|P10|Overall Study|Withdrawal by Subject|0
988280|NCT00502593|3247680|P9|Overall Study|Withdrawal by Subject|3
988281|NCT00502593|3247681|P8|Overall Study|Withdrawal by Subject|0
988282|NCT00502593|3247682|P7|Overall Study|Withdrawal by Subject|3
988283|NCT00502593|3247683|P6|Overall Study|Withdrawal by Subject|0
988284|NCT00502593|3247684|P5|Overall Study|Withdrawal by Subject|2
988285|NCT00502593|3247685|P4|Overall Study|Withdrawal by Subject|2
988286|NCT00502593|3247686|P3|Overall Study|Withdrawal by Subject|6
988287|NCT00502593|3247687|P2|Overall Study|Withdrawal by Subject|0
988288|NCT00502593|3247688|P1|Overall Study|Withdrawal by Subject|0
988289|NCT00502593|3247677|P12|Overall Study|Withdrawn unspecified reason|0
988290|NCT00502593|3247678|P11|Overall Study|Withdrawn unspecified reason|0
988291|NCT00502593|3247679|P10|Overall Study|Withdrawn unspecified reason|0
988292|NCT00502593|3247680|P9|Overall Study|Withdrawn unspecified reason|0
988293|NCT00502593|3247681|P8|Overall Study|Withdrawn unspecified reason|0
988294|NCT00502593|3247682|P7|Overall Study|Withdrawn unspecified reason|2
988295|NCT00502593|3247683|P6|Overall Study|Withdrawn unspecified reason|0
988296|NCT00502593|3247684|P5|Overall Study|Withdrawn unspecified reason|2
988297|NCT00502593|3247685|P4|Overall Study|Withdrawn unspecified reason|1
988298|NCT00502593|3247686|P3|Overall Study|Withdrawn unspecified reason|3
988299|NCT00502593|3247687|P2|Overall Study|Withdrawn unspecified reason|1
988300|NCT00502593|3247688|P1|Overall Study|Withdrawn unspecified reason|1
988301|NCT00502320|3248204|P2|Overall Study|Adverse Event|5
988302|NCT00502320|3248205|P1|Overall Study|Adverse Event|3
988303|NCT00502320|3248204|P2|Overall Study|Screen Failure|1
988304|NCT00502320|3248205|P1|Overall Study|Screen Failure|0
988305|NCT00502320|3248204|P2|Overall Study|No longer met criteria|0
988306|NCT00502320|3248205|P1|Overall Study|No longer met criteria|1
988307|NCT00502320|3248204|P2|Overall Study|Withdrew Consent|0
988308|NCT00502320|3248205|P1|Overall Study|Withdrew Consent|1
988309|NCT00502320|3248204|P2|Overall Study|Lost to Follow-up|1
988310|NCT00502320|3248205|P1|Overall Study|Lost to Follow-up|1
988311|NCT00502242|3248217|P2|Overall Study|Withdrawal by Subject|7
988312|NCT00502242|3248218|P1|Overall Study|Withdrawal by Subject|6
988313|NCT00502242|3248217|P2|Overall Study|Protocol Violation|1
988314|NCT00502242|3248218|P1|Overall Study|Protocol Violation|3
988315|NCT00502242|3248217|P2|Overall Study|Other - Unspecified|14
988316|NCT00502242|3248218|P1|Overall Study|Other - Unspecified|8
988317|NCT00502242|3248217|P2|Overall Study|Physician Decision|3
988318|NCT00502242|3248218|P1|Overall Study|Physician Decision|2
988319|NCT00502242|3248217|P2|Overall Study|Adverse Event|20
988320|NCT00502242|3248218|P1|Overall Study|Adverse Event|31
988321|NCT00502242|3248217|P2|Overall Study|Lack of Efficacy|11
988322|NCT00502242|3248218|P1|Overall Study|Lack of Efficacy|1
988323|NCT00502203|3248282|P1|Overall Study|Inevaluable|1
988324|NCT00501969|3248291|P1|Overall Study|Other: Sponsor Termination/Commercial RX|1
988325|NCT00501969|3248291|P1|Overall Study|Other: Admin Request from the Sponsor|3
988326|NCT00501969|3248291|P1|Overall Study|Other: As Required by Local EC|2
988327|NCT00501969|3248291|P1|Overall Study|Other: DX Changed - Parkinsons to PSNP|1
988328|NCT00501969|3248291|P1|Overall Study|Other: Pat Pending Surgery for PD|1
988329|NCT00501969|3248291|P1|Overall Study|Other: Patient is Going to Have DBS|1
988330|NCT00501969|3248291|P1|Overall Study|Other: Patients + Investigator Agreement|1
988331|NCT00501969|3248291|P1|Overall Study|Other: Severe Dementia Unable Sign PIC|1
988332|NCT00501969|3248291|P1|Overall Study|Other: Sponsor Stopped Study|12
988333|NCT00501969|3248291|P1|Overall Study|Other: Sponsor Termination at Site|1
988334|NCT00501969|3248291|P1|Overall Study|Other: Sponsors Request|10
988335|NCT00501969|3248291|P1|Overall Study|Other: Tired Of Clinical Trial Process|1
988336|NCT00501969|3248291|P1|Overall Study|Lost to Follow-up|4
988337|NCT00501969|3248291|P1|Overall Study|Subject withdrew consent|51
988338|NCT00501969|3248291|P1|Overall Study|Unsatisfactory compliance of subject|7
988339|NCT00501969|3248291|P1|Overall Study|Adverse Event|76
988340|NCT00501969|3248291|P1|Overall Study|Lack of Efficacy|29
988341|NCT00501969|3248291|P1|Overall Study|Major Protocol Violation|4
988342|NCT00501852|3248323|P1|Overall Study|Withdrawal by Subject|2
988343|NCT00501852|3248323|P1|Overall Study|Adverse Event|3
988344|NCT00501644|3248343|P1|Overall Study|Withdrawal by Subject|1
988345|NCT00501644|3248343|P1|Overall Study|Adverse Event|4
988346|NCT00501540|3248372|P1|Overall Study|Death|5
988347|NCT00501293|3248384|P2|Maintenance Period|Application site reaction|0
988348|NCT00501293|3248385|P1|Maintenance Period|Application site reaction|1
988349|NCT00501293|3248384|P2|Maintenance Period|Would not wear patch|0
988350|NCT00501293|3248385|P1|Maintenance Period|Would not wear patch|1
988351|NCT00501293|3248384|P2|Maintenance Period|Went into rehabilitation|0
988352|NCT00501293|3248385|P1|Maintenance Period|Went into rehabilitation|1
988353|NCT00501293|3248384|P2|Maintenance Period|Noncompliant with study medication|0
988354|NCT00501293|3248385|P1|Maintenance Period|Noncompliant with study medication|5
988355|NCT00501293|3248384|P2|Maintenance Period|Lack of Efficacy|1
988356|NCT00501293|3248385|P1|Maintenance Period|Lack of Efficacy|4
988357|NCT00501293|3248384|P2|Maintenance Period|Protocol Violation|1
988358|NCT00501293|3248385|P1|Maintenance Period|Protocol Violation|2
988359|NCT00501293|3248384|P2|Maintenance Period|Adverse Event|6
988360|NCT00501293|3248385|P1|Maintenance Period|Adverse Event|6
988361|NCT00501293|3248384|P2|Maintenance Period|Lost to Follow-up|7
988362|NCT00501293|3248385|P1|Maintenance Period|Lost to Follow-up|12
988363|NCT00501293|3248384|P2|Maintenance Period|Withdrawal by Subject|13
988364|NCT00501293|3248385|P1|Maintenance Period|Withdrawal by Subject|14
988365|NCT00501293|3248384|P2|Optimization Period|Enrolled in error|0
988366|NCT00501293|3248385|P1|Optimization Period|Enrolled in error|1
988367|NCT00501228|3248412|P1|Overall Study|Withdrawal by Subject|1
988368|NCT00501085|3248416|P1|Overall Study|Other loss to follow-up|32
988369|NCT00501085|3248416|P1|Overall Study|Study closed by sponsor|109
988370|NCT00501085|3248416|P1|Overall Study|Non-Compliance|24
988371|NCT00501085|3248416|P1|Overall Study|Adverse Event|4
988372|NCT00501085|3248416|P1|Overall Study|Explantation Surgery|26
988373|NCT00501085|3248416|P1|Overall Study|Revision Surgery|7
988374|NCT00501085|3248416|P1|Overall Study|Subject Decision|1
988375|NCT00501085|3248416|P1|Overall Study|Withdrawal by Subject|34
988376|NCT00501085|3248416|P1|Overall Study|Lost to Follow-up|195
988377|NCT00501059|3248426|P2|Overall Study|Not treated|17
988378|NCT00501059|3248427|P1|Overall Study|Not treated|25
988379|NCT00501059|3248426|P2|Overall Study|Lost to Follow-up|198
988380|NCT00501059|3248427|P1|Overall Study|Lost to Follow-up|210
988381|NCT00501059|3248426|P2|Overall Study|Adverse Event|122
988382|NCT00501059|3248427|P1|Overall Study|Adverse Event|129
988383|NCT00501059|3248426|P2|Overall Study|Reason not given|1
988384|NCT00501059|3248427|P1|Overall Study|Reason not given|3
988385|NCT00501059|3248426|P2|Overall Study|Non-compliant with study treatment|16
988386|NCT00501059|3248427|P1|Overall Study|Non-compliant with study treatment|23
988387|NCT00501059|3248426|P2|Overall Study|Consent withdrawn by subject|873
988388|NCT00501059|3248427|P1|Overall Study|Consent withdrawn by subject|817
988389|NCT00501059|3248426|P2|Overall Study|Insufficient therapeutic effect|5
988390|NCT00501059|3248427|P1|Overall Study|Insufficient therapeutic effect|4
988391|NCT00501059|3248426|P2|Overall Study|Clinical endpoint reached|123
988392|NCT00501059|3248427|P1|Overall Study|Clinical endpoint reached|110
988393|NCT00501059|3248426|P2|Overall Study|Missing end-of-study page|92
988394|NCT00501059|3248427|P1|Overall Study|Missing end-of-study page|91
988395|NCT00501059|3248426|P2|Overall Study|Other|239
988396|NCT00501059|3248427|P1|Overall Study|Other|236
988397|NCT00501059|3248426|P2|Overall Study|Death|137
988398|NCT00501059|3248427|P1|Overall Study|Death|140
988399|NCT00501059|3248426|P2|Overall Study|Protocol Violation|69
988400|NCT00501059|3248427|P1|Overall Study|Protocol Violation|80
988401|NCT00501046|3248451|P2|Overall Study|Reaching endpoints,Noncompliance,etc|137
988402|NCT00501046|3248452|P1|Overall Study|Reaching endpoints,Noncompliance,etc|119
988403|NCT00501046|3248451|P2|Overall Study|Withdrawal by Subject|83
988404|NCT00501046|3248452|P1|Overall Study|Withdrawal by Subject|84
988405|NCT00501046|3248451|P2|Overall Study|Protocol Violation|1
988406|NCT00501046|3248452|P1|Overall Study|Protocol Violation|2
988407|NCT00501046|3248451|P2|Overall Study|Pregnancy|3
988408|NCT00501046|3248452|P1|Overall Study|Pregnancy|0
988409|NCT00501046|3248451|P2|Overall Study|Physician Decision|2
988410|NCT00501046|3248452|P1|Overall Study|Physician Decision|7
988411|NCT00501046|3248451|P2|Overall Study|Lost to Follow-up|13
988412|NCT00501046|3248452|P1|Overall Study|Lost to Follow-up|14
988413|NCT00501046|3248451|P2|Overall Study|Death|30
988414|NCT00501046|3248452|P1|Overall Study|Death|23
988415|NCT00501046|3248451|P2|Overall Study|Adverse Event|25
988416|NCT00501046|3248452|P1|Overall Study|Adverse Event|21
988417|NCT00501007|3248458|P2|Overall Study|Inclusion criteria not met.|25
988418|NCT00501007|3248459|P1|Overall Study|Inclusion criteria not met.|29
988419|NCT00500760|3248467|P2|Overall Study|Other|2
988420|NCT00500760|3248468|P1|Overall Study|Other|1
988421|NCT00500760|3248467|P2|Overall Study|Lost to Follow-up|0
988422|NCT00500760|3248468|P1|Overall Study|Lost to Follow-up|3
988423|NCT00500760|3248467|P2|Overall Study|Administrative decision|0
988424|NCT00500760|3248468|P1|Overall Study|Administrative decision|2
988425|NCT00500760|3248467|P2|Overall Study|Withdrawal by Subject|7
988426|NCT00500760|3248468|P1|Overall Study|Withdrawal by Subject|5
988427|NCT00500760|3248467|P2|Overall Study|Death|15
988428|NCT00500760|3248468|P1|Overall Study|Death|32
988429|NCT00500682|3248488|P2|Overall Study|Reaching endpoints, Noncompliance, etc|144
988430|NCT00500682|3248489|P1|Overall Study|Reaching endpoints, Noncompliance, etc|144
988431|NCT00500682|3248488|P2|Overall Study|Withdrawal by Subject|74
988432|NCT00500682|3248489|P1|Overall Study|Withdrawal by Subject|80
988433|NCT00500682|3248488|P2|Overall Study|Protocol Violation|3
988434|NCT00500682|3248489|P1|Overall Study|Protocol Violation|1
988435|NCT00500682|3248488|P2|Overall Study|Pregnancy|0
988436|NCT00500682|3248489|P1|Overall Study|Pregnancy|2
988437|NCT00500682|3248488|P2|Overall Study|Physician Decision|10
988438|NCT00500682|3248489|P1|Overall Study|Physician Decision|6
988439|NCT00500682|3248488|P2|Overall Study|Lost to Follow-up|11
988440|NCT00500682|3248489|P1|Overall Study|Lost to Follow-up|11
988441|NCT00500682|3248488|P2|Overall Study|Death|16
988442|NCT00500682|3248489|P1|Overall Study|Death|25
988443|NCT00500682|3248488|P2|Overall Study|Adverse Event|29
988444|NCT00500682|3248489|P1|Overall Study|Adverse Event|37
988445|NCT00500539|3248523|P1|Follow-up Period (16 Weeks)|Missing|3
988446|NCT00500539|3248523|P1|Follow-up Period (16 Weeks)|Protocol Deviation|1
988447|NCT00500539|3248523|P1|Follow-up Period (16 Weeks)|Death|1
988448|NCT00500539|3248523|P1|Follow-up Period (16 Weeks)|Administrative problems|1
988449|NCT00500539|3248523|P1|Follow-up Period (16 Weeks)|Lost to Follow-up|3
988450|NCT00500539|3248523|P1|Follow-up Period (16 Weeks)|Subject withdrew consent|2
988451|NCT00500539|3248523|P1|Follow-up Period (16 Weeks)|Adverse Event|1
988452|NCT00500539|3248523|P1|Treatment Period (24 Weeks)|Protocol Deviation|5
988453|NCT00500539|3248523|P1|Treatment Period (24 Weeks)|Administrative problems|2
988454|NCT00500539|3248523|P1|Treatment Period (24 Weeks)|Lost to Follow-up|2
988455|NCT00500539|3248523|P1|Treatment Period (24 Weeks)|Subject withdrew consent|1
988456|NCT00500539|3248523|P1|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1
988457|NCT00500539|3248523|P1|Treatment Period (24 Weeks)|Adverse Event|4
988458|NCT00500370|3248549|P2|Overall Study|Subject Decision|17
988459|NCT00500370|3248550|P1|Overall Study|Subject Decision|10
988460|NCT00500370|3248549|P2|Overall Study|Sponsor Decision|0
988461|NCT00500370|3248550|P1|Overall Study|Sponsor Decision|2
988462|NCT00500370|3248549|P2|Overall Study|Protocol Violation|4
988463|NCT00500370|3248550|P1|Overall Study|Protocol Violation|2
988464|NCT00500370|3248549|P2|Overall Study|Lost to Follow-up|10
988465|NCT00500370|3248550|P1|Overall Study|Lost to Follow-up|10
988466|NCT00500370|3248549|P2|Overall Study|Adverse Event|3
988467|NCT00500370|3248550|P1|Overall Study|Adverse Event|9
988468|NCT00500357|3248586|P1|Overall Study|Death|1
988469|NCT00500331|3248612|P7|Overall Study|Protocol violated|0
988470|NCT00500331|3248613|P6|Overall Study|Protocol violated|0
988471|NCT00500331|3248614|P5|Overall Study|Protocol violated|0
988472|NCT00500331|3248615|P4|Overall Study|Protocol violated|1
988473|NCT00500331|3248616|P3|Overall Study|Protocol violated|0
988474|NCT00500331|3248617|P2|Overall Study|Protocol violated|0
988475|NCT00500331|3248618|P1|Overall Study|Protocol violated|0
988476|NCT00500331|3248612|P7|Overall Study|State ban of biological samples export|0
988477|NCT00500331|3248613|P6|Overall Study|State ban of biological samples export|0
988478|NCT00500331|3248614|P5|Overall Study|State ban of biological samples export|0
988479|NCT00500331|3248615|P4|Overall Study|State ban of biological samples export|1
988480|NCT00500331|3248616|P3|Overall Study|State ban of biological samples export|0
988481|NCT00500331|3248617|P2|Overall Study|State ban of biological samples export|0
988482|NCT00500331|3248618|P1|Overall Study|State ban of biological samples export|0
988483|NCT00500331|3248612|P7|Overall Study|Diabetologist nurse in the study|0
988484|NCT00500331|3248613|P6|Overall Study|Diabetologist nurse in the study|0
988485|NCT00500331|3248614|P5|Overall Study|Diabetologist nurse in the study|0
988486|NCT00500331|3248615|P4|Overall Study|Diabetologist nurse in the study|0
988487|NCT00500331|3248616|P3|Overall Study|Diabetologist nurse in the study|1
988488|NCT00500331|3248617|P2|Overall Study|Diabetologist nurse in the study|0
988489|NCT00500331|3248618|P1|Overall Study|Diabetologist nurse in the study|0
988490|NCT00500331|3248612|P7|Overall Study|Participant was randomized by mistake|0
988491|NCT00500331|3248613|P6|Overall Study|Participant was randomized by mistake|0
988492|NCT00500331|3248614|P5|Overall Study|Participant was randomized by mistake|0
988493|NCT00500331|3248615|P4|Overall Study|Participant was randomized by mistake|0
988494|NCT00500331|3248616|P3|Overall Study|Participant was randomized by mistake|0
988495|NCT00500331|3248617|P2|Overall Study|Participant was randomized by mistake|0
988496|NCT00500331|3248618|P1|Overall Study|Participant was randomized by mistake|1
988497|NCT00500331|3248612|P7|Overall Study|Sponsor decided to withdraw participant|0
988498|NCT00500331|3248613|P6|Overall Study|Sponsor decided to withdraw participant|0
988499|NCT00500331|3248614|P5|Overall Study|Sponsor decided to withdraw participant|0
988500|NCT00500331|3248615|P4|Overall Study|Sponsor decided to withdraw participant|0
988501|NCT00500331|3248616|P3|Overall Study|Sponsor decided to withdraw participant|0
988502|NCT00500331|3248617|P2|Overall Study|Sponsor decided to withdraw participant|0
988503|NCT00500331|3248618|P1|Overall Study|Sponsor decided to withdraw participant|1
988504|NCT00500331|3248612|P7|Overall Study|Exclusion citeria not met on Visit 4|0
988505|NCT00500331|3248613|P6|Overall Study|Exclusion citeria not met on Visit 4|0
988506|NCT00500331|3248614|P5|Overall Study|Exclusion citeria not met on Visit 4|0
988507|NCT00500331|3248615|P4|Overall Study|Exclusion citeria not met on Visit 4|0
988508|NCT00500331|3248616|P3|Overall Study|Exclusion citeria not met on Visit 4|0
988509|NCT00500331|3248617|P2|Overall Study|Exclusion citeria not met on Visit 4|0
988510|NCT00500331|3248618|P1|Overall Study|Exclusion citeria not met on Visit 4|1
988511|NCT00500331|3248612|P7|Overall Study|Didn't return for continuation of study|0
988512|NCT00500331|3248613|P6|Overall Study|Didn't return for continuation of study|0
988513|NCT00500331|3248614|P5|Overall Study|Didn't return for continuation of study|0
988514|NCT00500331|3248615|P4|Overall Study|Didn't return for continuation of study|0
988515|NCT00500331|3248616|P3|Overall Study|Didn't return for continuation of study|0
988516|NCT00500331|3248617|P2|Overall Study|Didn't return for continuation of study|0
988517|NCT00500331|3248618|P1|Overall Study|Didn't return for continuation of study|1
988518|NCT00500331|3248612|P7|Overall Study|Increased serum creatinine from Baseline|0
988519|NCT00500331|3248613|P6|Overall Study|Increased serum creatinine from Baseline|1
988520|NCT00500331|3248614|P5|Overall Study|Increased serum creatinine from Baseline|0
988521|NCT00500331|3248615|P4|Overall Study|Increased serum creatinine from Baseline|0
988522|NCT00500331|3248616|P3|Overall Study|Increased serum creatinine from Baseline|0
988523|NCT00500331|3248617|P2|Overall Study|Increased serum creatinine from Baseline|0
988524|NCT00500331|3248618|P1|Overall Study|Increased serum creatinine from Baseline|0
988525|NCT00500331|3248612|P7|Overall Study|Liver function test abnormality|0
988526|NCT00500331|3248613|P6|Overall Study|Liver function test abnormality|0
988527|NCT00500331|3248614|P5|Overall Study|Liver function test abnormality|0
988528|NCT00500331|3248615|P4|Overall Study|Liver function test abnormality|0
988529|NCT00500331|3248616|P3|Overall Study|Liver function test abnormality|1
988530|NCT00500331|3248617|P2|Overall Study|Liver function test abnormality|0
988531|NCT00500331|3248618|P1|Overall Study|Liver function test abnormality|0
988532|NCT00500331|3248612|P7|Overall Study|Lack of Efficacy|0
988533|NCT00500331|3248613|P6|Overall Study|Lack of Efficacy|0
988534|NCT00500331|3248614|P5|Overall Study|Lack of Efficacy|0
988535|NCT00500331|3248615|P4|Overall Study|Lack of Efficacy|0
988536|NCT00500331|3248616|P3|Overall Study|Lack of Efficacy|0
988537|NCT00500331|3248617|P2|Overall Study|Lack of Efficacy|1
988538|NCT00500331|3248618|P1|Overall Study|Lack of Efficacy|3
988539|NCT00500331|3248612|P7|Overall Study|Withdrawal by Subject|1
988540|NCT00500331|3248613|P6|Overall Study|Withdrawal by Subject|1
988541|NCT00500331|3248614|P5|Overall Study|Withdrawal by Subject|0
988542|NCT00500331|3248615|P4|Overall Study|Withdrawal by Subject|5
988543|NCT00500331|3248616|P3|Overall Study|Withdrawal by Subject|1
988544|NCT00500331|3248617|P2|Overall Study|Withdrawal by Subject|0
988545|NCT00500331|3248618|P1|Overall Study|Withdrawal by Subject|4
988546|NCT00500331|3248612|P7|Overall Study|Protocol Violation|1
988547|NCT00500331|3248613|P6|Overall Study|Protocol Violation|1
988548|NCT00500331|3248614|P5|Overall Study|Protocol Violation|1
988549|NCT00500331|3248615|P4|Overall Study|Protocol Violation|0
988550|NCT00500331|3248616|P3|Overall Study|Protocol Violation|1
988551|NCT00500331|3248617|P2|Overall Study|Protocol Violation|1
988552|NCT00500331|3248618|P1|Overall Study|Protocol Violation|3
988553|NCT00500331|3248612|P7|Overall Study|Lost to Follow-up|0
988554|NCT00500331|3248613|P6|Overall Study|Lost to Follow-up|0
988555|NCT00500331|3248614|P5|Overall Study|Lost to Follow-up|1
988556|NCT00500331|3248615|P4|Overall Study|Lost to Follow-up|2
988557|NCT00500331|3248616|P3|Overall Study|Lost to Follow-up|1
988558|NCT00500331|3248617|P2|Overall Study|Lost to Follow-up|1
988559|NCT00500331|3248618|P1|Overall Study|Lost to Follow-up|1
988560|NCT00500331|3248612|P7|Overall Study|Adverse Event|0
988561|NCT00500331|3248613|P6|Overall Study|Adverse Event|2
988562|NCT00500331|3248614|P5|Overall Study|Adverse Event|2
988563|NCT00500331|3248615|P4|Overall Study|Adverse Event|1
988564|NCT00500331|3248616|P3|Overall Study|Adverse Event|0
988565|NCT00500331|3248617|P2|Overall Study|Adverse Event|2
988566|NCT00500331|3248618|P1|Overall Study|Adverse Event|0
988567|NCT00500318|3248755|P2|Overall Study|Other Reason|1
988568|NCT00500318|3248756|P1|Overall Study|Other Reason|0
988569|NCT00500318|3248755|P2|Overall Study|Lack of Efficacy|3
988570|NCT00500318|3248756|P1|Overall Study|Lack of Efficacy|0
988571|NCT00500318|3248755|P2|Overall Study|Withdrawal by Subject|2
988572|NCT00500318|3248756|P1|Overall Study|Withdrawal by Subject|1
988573|NCT00500318|3248755|P2|Overall Study|Protocol Violation|3
988574|NCT00500318|3248756|P1|Overall Study|Protocol Violation|1
988575|NCT00500318|3248755|P2|Overall Study|Adverse Event|8
988576|NCT00500318|3248756|P1|Overall Study|Adverse Event|3
988577|NCT00500292|3248773|P3|Overall Study|Other|4
988578|NCT00500292|3248774|P2|Overall Study|Other|1
988579|NCT00500292|3248775|P1|Overall Study|Other|1
988580|NCT00500292|3248773|P3|Overall Study|Withdrawal by Subject|0
988581|NCT00500292|3248774|P2|Overall Study|Withdrawal by Subject|1
988582|NCT00500292|3248775|P1|Overall Study|Withdrawal by Subject|0
988583|NCT00500292|3248773|P3|Overall Study|Condition under investigation worsened|19
988584|NCT00500292|3248774|P2|Overall Study|Condition under investigation worsened|23
988585|NCT00500292|3248775|P1|Overall Study|Condition under investigation worsened|21
988586|NCT00500292|3248773|P3|Overall Study|Adverse Event|4
988587|NCT00500292|3248774|P2|Overall Study|Adverse Event|6
988588|NCT00500292|3248775|P1|Overall Study|Adverse Event|3
988589|NCT00500149|3248796|P2|Second Intervention (Cross-over Phase)|Lost to Follow-up|0
988590|NCT00500149|3248797|P1|Second Intervention (Cross-over Phase)|Lost to Follow-up|2
988591|NCT00500149|3248796|P2|First Intervention (Cross-over Phase)|Protocol Violation|0
988592|NCT00500149|3248797|P1|First Intervention (Cross-over Phase)|Protocol Violation|1
988593|NCT00500149|3248796|P2|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
988594|NCT00500149|3248797|P1|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
988595|NCT00500149|3248796|P2|First Intervention (Cross-over Phase)|Adverse Event|1
988596|NCT00500149|3248797|P1|First Intervention (Cross-over Phase)|Adverse Event|0
988597|NCT00500149|3248796|P2|Enrolled (Dose-optimization Phase)|Protocol Violation|0
988598|NCT00500149|3248797|P1|Enrolled (Dose-optimization Phase)|Protocol Violation|1
988599|NCT00500149|3248796|P2|Enrolled (Dose-optimization Phase)|Adverse Event|0
988600|NCT00500149|3248797|P1|Enrolled (Dose-optimization Phase)|Adverse Event|8
988601|NCT00500149|3248796|P2|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0
988602|NCT00500149|3248797|P1|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3
988603|NCT00500110|3248805|P1|Overall Study|Withdrawal by Subject|3
988604|NCT00500071|3248809|P1|30-day Safety Follow-up|Lost to Follow-up|17
988605|NCT00500071|3248809|P1|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4
988606|NCT00500071|3248809|P1|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1
988607|NCT00500071|3248809|P1|Dose-optimization and Maintenance Phase|Lack of Efficacy|2
988608|NCT00500071|3248809|P1|Dose-optimization and Maintenance Phase|Protocol Violation|2
988609|NCT00500071|3248809|P1|Dose-optimization and Maintenance Phase|Adverse Event|13
988610|NCT00500071|3248809|P1|Screening and Washout Phase|Protocol Violation|1
988611|NCT00499889|3248827|P1|Overall Study|Infection prior to treatment|1
988612|NCT00499863|3248835|P2|Overall Study|Lost to Follow-up|1
988613|NCT00499863|3248836|P1|Overall Study|Lost to Follow-up|1
988614|NCT00499863|3248835|P2|Overall Study|Sponsor decision|2
988615|NCT00499863|3248836|P1|Overall Study|Sponsor decision|2
988616|NCT00499863|3248835|P2|Overall Study|Adverse Event|2
988617|NCT00499863|3248836|P1|Overall Study|Adverse Event|8
988618|NCT00499863|3248835|P2|Overall Study|Withdrawal by Subject|4
988619|NCT00499863|3248836|P1|Overall Study|Withdrawal by Subject|6
988620|NCT00499863|3248835|P2|Overall Study|Protocol Violation|7
988621|NCT00499863|3248836|P1|Overall Study|Protocol Violation|12
988622|NCT00499863|3248835|P2|Overall Study|Lack of Efficacy|27
988623|NCT00499863|3248836|P1|Overall Study|Lack of Efficacy|21
988624|NCT00500266|3248864|P1|Overall Study|Assigned, not treated|4
988625|NCT00500266|3248864|P1|Overall Study|Withdrawal by Subject|3
988626|NCT00500266|3248864|P1|Overall Study|Lost to Follow-up|3
988627|NCT00500266|3248864|P1|Overall Study|Death|3
988628|NCT00499746|3248871|P1|Phase 1(6-9 One Day Sessions)|Unable to determine|1
988629|NCT00499746|3248871|P1|Phase 1(6-9 One Day Sessions)|Investigator decision|1
988630|NCT00499746|3248871|P1|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3
988631|NCT00499746|3248871|P1|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7
988632|NCT00499694|3248940|P1|Overall Study|Patient never received treatment.|1
988633|NCT00499681|3248949|P2|Overall Study|disease progression|1
988634|NCT00499681|3248950|P1|Overall Study|disease progression|0
988635|NCT00499681|3248949|P2|Overall Study|toxicity|1
988636|NCT00499681|3248950|P1|Overall Study|toxicity|0
988637|NCT00499616|3248977|P4|Overall Study|Patient/Parent Refusal|0
988638|NCT00499616|3248978|P3|Overall Study|Patient/Parent Refusal|3
988639|NCT00499616|3248979|P2|Overall Study|Patient/Parent Refusal|5
988640|NCT00499616|3248980|P1|Overall Study|Patient/Parent Refusal|1
988641|NCT00499616|3248977|P4|Overall Study|Not evaluable|41
988642|NCT00499616|3248978|P3|Overall Study|Not evaluable|0
988643|NCT00499616|3248979|P2|Overall Study|Not evaluable|0
988644|NCT00499616|3248980|P1|Overall Study|Not evaluable|0
988645|NCT00499616|3248977|P4|Overall Study|Ineligible|15
988646|NCT00499616|3248978|P3|Overall Study|Ineligible|0
988647|NCT00499616|3248979|P2|Overall Study|Ineligible|2
988648|NCT00499616|3248980|P1|Overall Study|Ineligible|1
988649|NCT00499616|3248977|P4|Overall Study|Withdrawal by Subject|0
988650|NCT00499616|3248978|P3|Overall Study|Withdrawal by Subject|1
988651|NCT00499616|3248979|P2|Overall Study|Withdrawal by Subject|0
988652|NCT00499616|3248980|P1|Overall Study|Withdrawal by Subject|1
988653|NCT00499616|3248977|P4|Overall Study|Physician Decision|0
988654|NCT00499616|3248978|P3|Overall Study|Physician Decision|9
988655|NCT00499616|3248979|P2|Overall Study|Physician Decision|16
988656|NCT00499616|3248980|P1|Overall Study|Physician Decision|6
988657|NCT00499616|3248977|P4|Overall Study|Lost to Follow-up|0
988658|NCT00499616|3248978|P3|Overall Study|Lost to Follow-up|1
988659|NCT00499616|3248979|P2|Overall Study|Lost to Follow-up|0
988660|NCT00499616|3248980|P1|Overall Study|Lost to Follow-up|0
988661|NCT00499616|3248977|P4|Overall Study|Lack of Efficacy|0
988662|NCT00499616|3248978|P3|Overall Study|Lack of Efficacy|19
988663|NCT00499616|3248979|P2|Overall Study|Lack of Efficacy|0
988664|NCT00499616|3248980|P1|Overall Study|Lack of Efficacy|5
988665|NCT00499616|3248977|P4|Overall Study|Death|1
988666|NCT00499616|3248978|P3|Overall Study|Death|3
988667|NCT00499616|3248979|P2|Overall Study|Death|5
988668|NCT00499616|3248980|P1|Overall Study|Death|1
988669|NCT00499603|3249017|P2|Overall Study|Adverse Event|1
988670|NCT00499603|3249018|P1|Overall Study|Adverse Event|0
988671|NCT00499590|3249031|P3|Overall Study|Not treated|1
988672|NCT00499590|3249032|P2|Overall Study|Not treated|0
988673|NCT00499590|3249033|P1|Overall Study|Not treated|1
988674|NCT00499590|3249031|P3|Overall Study|Study Terminated|112
988675|NCT00499590|3249032|P2|Overall Study|Study Terminated|112
988676|NCT00499590|3249033|P1|Overall Study|Study Terminated|112
988677|NCT00499486|3249044|P1|Overall Study|Withdrawal by Subject|16
988678|NCT00499460|3249071|P2|Intervention 2 (30 Days)|Withdrawal by Subject|1
988679|NCT00499460|3249072|P1|Intervention 2 (30 Days)|Withdrawal by Subject|0
988680|NCT00499460|3249071|P2|Intervention 1 (30 Days)|Fainting upon Blood Draw|0
988681|NCT00499460|3249072|P1|Intervention 1 (30 Days)|Fainting upon Blood Draw|1
988682|NCT00499460|3249071|P2|Intervention 1 (30 Days)|Withdrawal by Subject|0
988683|NCT00499460|3249072|P1|Intervention 1 (30 Days)|Withdrawal by Subject|1
988684|NCT00499369|3249105|P5|Overall Study|Ineligible|0
988685|NCT00499369|3249106|P4|Overall Study|Ineligible|1
988686|NCT00499369|3249107|P3|Overall Study|Ineligible|1
988687|NCT00499369|3249108|P2|Overall Study|Ineligible|2
988688|NCT00499369|3249109|P1|Overall Study|Ineligible|2
988689|NCT00499369|3249105|P5|Overall Study|Not protocol specified|0
988690|NCT00499369|3249106|P4|Overall Study|Not protocol specified|1
988691|NCT00499369|3249107|P3|Overall Study|Not protocol specified|3
988692|NCT00499369|3249108|P2|Overall Study|Not protocol specified|0
988693|NCT00499369|3249109|P1|Overall Study|Not protocol specified|2
988694|NCT00499369|3249105|P5|Overall Study|Death|0
988695|NCT00499369|3249106|P4|Overall Study|Death|0
988696|NCT00499369|3249107|P3|Overall Study|Death|0
988697|NCT00499369|3249108|P2|Overall Study|Death|1
988698|NCT00499369|3249109|P1|Overall Study|Death|0
988699|NCT00499369|3249105|P5|Overall Study|Progression|10
988700|NCT00499369|3249106|P4|Overall Study|Progression|6
988701|NCT00499369|3249107|P3|Overall Study|Progression|9
988702|NCT00499369|3249108|P2|Overall Study|Progression|12
988703|NCT00499369|3249109|P1|Overall Study|Progression|10
988704|NCT00499369|3249105|P5|Overall Study|Withdrawal by Subject|0
988705|NCT00499369|3249106|P4|Overall Study|Withdrawal by Subject|0
988706|NCT00499369|3249107|P3|Overall Study|Withdrawal by Subject|1
988707|NCT00499369|3249108|P2|Overall Study|Withdrawal by Subject|1
988708|NCT00499369|3249109|P1|Overall Study|Withdrawal by Subject|0
988709|NCT00499369|3249105|P5|Overall Study|Adverse Event|2
988710|NCT00499369|3249106|P4|Overall Study|Adverse Event|1
988711|NCT00499369|3249107|P3|Overall Study|Adverse Event|3
988712|NCT00499369|3249108|P2|Overall Study|Adverse Event|2
988713|NCT00499369|3249109|P1|Overall Study|Adverse Event|2
988714|NCT00499252|3249145|P1|Overall Study|<no further label>|3
988715|NCT00499252|3249145|P1|Overall Study|Ineligible|4
988716|NCT00499252|3249145|P1|Overall Study|Refused further treatment|2
988717|NCT00499252|3249145|P1|Overall Study|Adverse Event|3
988718|NCT00499122|3249155|P1|Overall Study|Withdrawal by Subject|2
988719|NCT00499083|3249198|P1|Overall Study|Not evaluable|3
988720|NCT00499031|3249205|P1|Overall Study|Never treated|1
988721|NCT00499031|3249205|P1|Overall Study|Required test not done|1
988722|NCT00499031|3249205|P1|Overall Study|Improper pre-protocol treatment|1
988723|NCT00498797|3249228|P2|Overall Study|Other|1
988724|NCT00498797|3249229|P1|Overall Study|Other|3
988725|NCT00498797|3249228|P2|Overall Study|Condition under investigation worsened|21
988726|NCT00498797|3249229|P1|Overall Study|Condition under investigation worsened|19
988727|NCT00498797|3249228|P2|Overall Study|Adverse Event|5
988728|NCT00498797|3249229|P1|Overall Study|Adverse Event|12
988729|NCT00498797|3249228|P2|Overall Study|Withdrawal by Subject|2
988730|NCT00498797|3249229|P1|Overall Study|Withdrawal by Subject|4
988731|NCT00498602|3249287|P7|Overall Study|Not specified|0
988732|NCT00498602|3249288|P6|Overall Study|Not specified|3
988733|NCT00498602|3249289|P5|Overall Study|Not specified|0
988734|NCT00498602|3249290|P4|Overall Study|Not specified|0
988735|NCT00498602|3249291|P3|Overall Study|Not specified|1
988736|NCT00498602|3249292|P2|Overall Study|Not specified|3
988737|NCT00498602|3249293|P1|Overall Study|Not specified|2
988738|NCT00498602|3249287|P7|Overall Study|Subject Request|1
988739|NCT00498602|3249288|P6|Overall Study|Subject Request|4
988740|NCT00498602|3249289|P5|Overall Study|Subject Request|1
988741|NCT00498602|3249290|P4|Overall Study|Subject Request|1
988742|NCT00498602|3249291|P3|Overall Study|Subject Request|1
988743|NCT00498602|3249292|P2|Overall Study|Subject Request|0
988744|NCT00498602|3249293|P1|Overall Study|Subject Request|3
988745|NCT00498602|3249287|P7|Overall Study|Investigator Request|0
988746|NCT00498602|3249288|P6|Overall Study|Investigator Request|0
988747|NCT00498602|3249289|P5|Overall Study|Investigator Request|0
988748|NCT00498602|3249290|P4|Overall Study|Investigator Request|0
988749|NCT00498602|3249291|P3|Overall Study|Investigator Request|1
988750|NCT00498602|3249292|P2|Overall Study|Investigator Request|0
988751|NCT00498602|3249293|P1|Overall Study|Investigator Request|0
988752|NCT00498602|3249287|P7|Overall Study|Caregiver Request|0
988753|NCT00498602|3249288|P6|Overall Study|Caregiver Request|2
988754|NCT00498602|3249289|P5|Overall Study|Caregiver Request|1
988755|NCT00498602|3249290|P4|Overall Study|Caregiver Request|0
988756|NCT00498602|3249291|P3|Overall Study|Caregiver Request|2
988757|NCT00498602|3249292|P2|Overall Study|Caregiver Request|2
988758|NCT00498602|3249293|P1|Overall Study|Caregiver Request|2
988759|NCT00498602|3249287|P7|Overall Study|AE not related to Study Drug|1
988760|NCT00498602|3249288|P6|Overall Study|AE not related to Study Drug|2
988761|NCT00498602|3249289|P5|Overall Study|AE not related to Study Drug|2
988762|NCT00498602|3249290|P4|Overall Study|AE not related to Study Drug|0
988763|NCT00498602|3249291|P3|Overall Study|AE not related to Study Drug|0
988764|NCT00498602|3249292|P2|Overall Study|AE not related to Study Drug|3
988765|NCT00498602|3249293|P1|Overall Study|AE not related to Study Drug|1
988766|NCT00498602|3249287|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
988767|NCT00498602|3249288|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
988768|NCT00498602|3249289|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
988769|NCT00498602|3249290|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
988770|NCT00498602|3249291|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
988771|NCT00498602|3249292|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
988772|NCT00498602|3249293|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
988773|NCT00498602|3249287|P7|Overall Study|Lost to Follow-up|0
988774|NCT00498602|3249288|P6|Overall Study|Lost to Follow-up|0
988775|NCT00498602|3249289|P5|Overall Study|Lost to Follow-up|0
988776|NCT00498602|3249290|P4|Overall Study|Lost to Follow-up|2
988777|NCT00498602|3249291|P3|Overall Study|Lost to Follow-up|0
988778|NCT00498602|3249292|P2|Overall Study|Lost to Follow-up|2
988779|NCT00498602|3249293|P1|Overall Study|Lost to Follow-up|0
988780|NCT00498602|3249287|P7|Overall Study|Lack of Efficacy|0
988781|NCT00498602|3249288|P6|Overall Study|Lack of Efficacy|0
988782|NCT00498602|3249289|P5|Overall Study|Lack of Efficacy|0
988783|NCT00498602|3249290|P4|Overall Study|Lack of Efficacy|0
988784|NCT00498602|3249291|P3|Overall Study|Lack of Efficacy|0
988785|NCT00498602|3249292|P2|Overall Study|Lack of Efficacy|0
988786|NCT00498602|3249293|P1|Overall Study|Lack of Efficacy|1
988787|NCT00498602|3249287|P7|Overall Study|Death|0
988788|NCT00498602|3249288|P6|Overall Study|Death|1
988789|NCT00498602|3249289|P5|Overall Study|Death|0
988790|NCT00498602|3249290|P4|Overall Study|Death|0
988791|NCT00498602|3249291|P3|Overall Study|Death|0
988792|NCT00498602|3249292|P2|Overall Study|Death|0
988793|NCT00498602|3249293|P1|Overall Study|Death|0
988794|NCT00498485|3249341|P2|Overall Study|Adverse Event|5
988795|NCT00498485|3249342|P1|Overall Study|Adverse Event|1
988796|NCT00498433|3249353|P3|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
988797|NCT00498433|3249354|P2|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
988798|NCT00498433|3249355|P1|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1
988799|NCT00498433|3249353|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
988800|NCT00498433|3249354|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
988801|NCT00498433|3249355|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15
988802|NCT00498433|3249353|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
988803|NCT00498433|3249354|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
988804|NCT00498433|3249355|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2
988805|NCT00498433|3249353|P3|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
988806|NCT00498433|3249354|P2|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
988807|NCT00498433|3249355|P1|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2
988808|NCT00498368|3249400|P2|Overall Study|Withdrawal by Subject|2
988809|NCT00498368|3249401|P1|Overall Study|Withdrawal by Subject|3
988810|NCT00498355|3249413|P1|Overall Study|Lost to Follow-up|1
988811|NCT00498186|3249421|P1|Overall Study|Other|10
988812|NCT00498186|3249421|P1|Overall Study|Lost to Follow-up|3
988813|NCT00498186|3249421|P1|Overall Study|Withdrawal by Subject|18
988814|NCT00498186|3249421|P1|Overall Study|Unsatisfactory compliance of subject|12
988815|NCT00498186|3249421|P1|Overall Study|Adverse Event|89
988816|NCT00498186|3249421|P1|Overall Study|Lack of Efficacy|31
988817|NCT00498186|3249421|P1|Overall Study|Protocol Violation|10
988818|NCT00498173|3249428|P3|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0
988819|NCT00498173|3249429|P2|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1
988820|NCT00498173|3249430|P1|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2
988821|NCT00497874|3249460|P2|Overall Study|Unable to schedule|24
988822|NCT00497874|3249461|P1|Overall Study|Unable to schedule|37
988823|NCT00497874|3249460|P2|Overall Study|Unable to contact|67
988824|NCT00497874|3249461|P1|Overall Study|Unable to contact|52
988825|NCT00497874|3249460|P2|Overall Study|Death|4
988826|NCT00497874|3249461|P1|Overall Study|Death|2
988827|NCT00497874|3249460|P2|Overall Study|Illness|4
988828|NCT00497874|3249461|P1|Overall Study|Illness|8
988829|NCT00497874|3249460|P2|Overall Study|Withdrawal by Subject|17
988830|NCT00497874|3249461|P1|Overall Study|Withdrawal by Subject|48
988831|NCT00497796|3249479|P2|Overall Study|Not applicable (randomized not treated)|4
988832|NCT00497796|3249480|P1|Overall Study|Not applicable (randomized not treated)|0
988833|NCT00497796|3249479|P2|Overall Study|Lost to Follow-up|1
988834|NCT00497796|3249480|P1|Overall Study|Lost to Follow-up|0
988835|NCT00497796|3249479|P2|Overall Study|Investigator/sponsor discretion|34
988836|NCT00497796|3249480|P1|Overall Study|Investigator/sponsor discretion|31
988837|NCT00497796|3249479|P2|Overall Study|Consent withdrawn|3
988838|NCT00497796|3249480|P1|Overall Study|Consent withdrawn|10
988839|NCT00497796|3249479|P2|Overall Study|CMV infection or disease treatment|4
988840|NCT00497796|3249480|P1|Overall Study|CMV infection or disease treatment|30
988841|NCT00497796|3249479|P2|Overall Study|Adverse event (related)|4
988842|NCT00497796|3249480|P1|Overall Study|Adverse event (related)|5
988843|NCT00497796|3249479|P2|Overall Study|Adverse event (not related)|9
988844|NCT00497796|3249480|P1|Overall Study|Adverse event (not related)|9
988845|NCT00497198|3249567|P2|Overall Study|Withdrawal by Subject|1
988846|NCT00497198|3249568|P1|Overall Study|Withdrawal by Subject|0
988847|NCT00497198|3249567|P2|Overall Study|Physician Decision|2
988848|NCT00497198|3249568|P1|Overall Study|Physician Decision|1
988849|NCT00497198|3249567|P2|Overall Study|Adverse Event|2
988850|NCT00497198|3249568|P1|Overall Study|Adverse Event|4
988851|NCT00497146|3249584|P2|Long-term Follow-up Period|Other|1
988852|NCT00497146|3249585|P1|Long-term Follow-up Period|Other|0
988853|NCT00497146|3249584|P2|Long-term Follow-up Period|Lost to Follow-up|1
988854|NCT00497146|3249585|P1|Long-term Follow-up Period|Lost to Follow-up|5
988855|NCT00497146|3249584|P2|Long-term Follow-up Period|Withdrawal by Subject|2
988856|NCT00497146|3249585|P1|Long-term Follow-up Period|Withdrawal by Subject|8
988857|NCT00497146|3249584|P2|Long-term Follow-up Period|Adverse Event|2
988858|NCT00497146|3249585|P1|Long-term Follow-up Period|Adverse Event|2
988859|NCT00497146|3249584|P2|Treatment Period|Other Reason|3
988860|NCT00497146|3249585|P1|Treatment Period|Other Reason|2
988861|NCT00497146|3249584|P2|Treatment Period|Unable to dose reduce per protocol|1
988862|NCT00497146|3249585|P1|Treatment Period|Unable to dose reduce per protocol|4
988863|NCT00497146|3249584|P2|Treatment Period|Change in RAAS inhibitor therapy|2
988864|NCT00497146|3249585|P1|Treatment Period|Change in RAAS inhibitor therapy|5
988865|NCT00497146|3249584|P2|Treatment Period|Required dialysis|1
988866|NCT00497146|3249585|P1|Treatment Period|Required dialysis|4
988867|NCT00497146|3249584|P2|Treatment Period|Lost to Follow-up|3
988868|NCT00497146|3249585|P1|Treatment Period|Lost to Follow-up|1
988869|NCT00497146|3249584|P2|Treatment Period|Withdrawal by Subject|9
988870|NCT00497146|3249585|P1|Treatment Period|Withdrawal by Subject|5
988871|NCT00497146|3249584|P2|Treatment Period|Adverse Event|2
988872|NCT00497146|3249585|P1|Treatment Period|Adverse Event|6
988873|NCT00496964|3249653|P2|Overall Study|Withdrawal by Subject|1
988874|NCT00496964|3249654|P1|Overall Study|Withdrawal by Subject|0
988875|NCT00496873|3249672|P1|Overall Study|Withdrawal by Subject|3
988876|NCT00496873|3249672|P1|Overall Study|Death|2
988877|NCT00496873|3249672|P1|Overall Study|Ineligible|2
988878|NCT00496834|3249705|P2|Overall Study|Blood Pressure control failure|1
988879|NCT00496834|3249706|P1|Overall Study|Blood Pressure control failure|2
988880|NCT00496834|3249705|P2|Overall Study|Lost to Follow-up|0
988881|NCT00496834|3249706|P1|Overall Study|Lost to Follow-up|2
988882|NCT00496834|3249705|P2|Overall Study|IP administration violation|0
988883|NCT00496834|3249706|P1|Overall Study|IP administration violation|2
988884|NCT00496834|3249705|P2|Overall Study|Adverse Event|3
988885|NCT00496834|3249706|P1|Overall Study|Adverse Event|5
988886|NCT00496834|3249705|P2|Overall Study|Inclusion/exclusion criteria not met|2
988887|NCT00496834|3249706|P1|Overall Study|Inclusion/exclusion criteria not met|3
988888|NCT00496834|3249705|P2|Overall Study|Contraindicated medication administered|1
988889|NCT00496834|3249706|P1|Overall Study|Contraindicated medication administered|0
988890|NCT00496834|3249705|P2|Overall Study|Withdrawal by Subject|6
988891|NCT00496834|3249706|P1|Overall Study|Withdrawal by Subject|4
988892|NCT00496782|3249725|P2|Overall Study|Protocol Violation|2
988893|NCT00496782|3249726|P1|Overall Study|Protocol Violation|1
988894|NCT00496769|3249760|P3|Open Label|>=1 reason assigned per patient|1011
988895|NCT00496769|3249761|P2|Open Label|>=1 reason assigned per patient|0
988896|NCT00496769|3249762|P1|Open Label|>=1 reason assigned per patient|0
988897|NCT00496769|3249760|P3|Double Blind|>=1 reason assigned per patient|0
988898|NCT00496769|3249761|P2|Double Blind|>=1 reason assigned per patient|649
988899|NCT00496769|3249762|P1|Double Blind|>=1 reason assigned per patient|558
988900|NCT00496730|3249787|P2|Overall Study|Withdrawal by Subject|2
988901|NCT00496730|3249788|P1|Overall Study|Withdrawal by Subject|2
988902|NCT00496730|3249787|P2|Overall Study|Lost to Follow-up|3
988903|NCT00496730|3249788|P1|Overall Study|Lost to Follow-up|4
988904|NCT00496626|3249800|P2|Overall Study|Relocated|1
988905|NCT00496626|3249801|P1|Overall Study|Relocated|0
988906|NCT00496626|3249800|P2|Overall Study|Withdrawal by Subject|4
988907|NCT00496626|3249801|P1|Overall Study|Withdrawal by Subject|5
988908|NCT00496626|3249800|P2|Overall Study|Protocol Violation|0
988909|NCT00496626|3249801|P1|Overall Study|Protocol Violation|1
988910|NCT00496626|3249800|P2|Overall Study|Lost to Follow-up|1
988911|NCT00496626|3249801|P1|Overall Study|Lost to Follow-up|0
988912|NCT00496587|3249813|P1|Overall Study|Complications unrelated|2
988913|NCT00496587|3249813|P1|Overall Study|Death|1
988914|NCT00496587|3249813|P1|Overall Study|Withdrawal by Subject|2
988915|NCT00496587|3249813|P1|Overall Study|Progressive Disease|24
988916|NCT00496587|3249813|P1|Overall Study|Adverse Event|2
988917|NCT00496483|3249819|P1|Overall Study|Lack of Efficacy|1
988918|NCT00496483|3249819|P1|Overall Study|Adverse Event|2
988919|NCT00496483|3249819|P1|Overall Study|Not dosed|9
988920|NCT00496470|3249836|P2|Overall Study|Other reason|2
988921|NCT00496470|3249837|P1|Overall Study|Other reason|0
988922|NCT00496470|3249836|P2|Overall Study|Incorrectly enrolled|5
988923|NCT00496470|3249837|P1|Overall Study|Incorrectly enrolled|13
988924|NCT00496470|3249836|P2|Overall Study|Withdrawal by Subject|12
988925|NCT00496470|3249837|P1|Overall Study|Withdrawal by Subject|5
988926|NCT00496470|3249836|P2|Overall Study|Adverse Event|10
988927|NCT00496470|3249837|P1|Overall Study|Adverse Event|8
988928|NCT00496366|3249923|P1|Overall Study|Death|1
988929|NCT00496197|3249954|P1|Overall Study|Protocol Violation|8
988930|NCT00496197|3249954|P1|Overall Study|Other|14
988931|NCT00496197|3249954|P1|Overall Study|Pathogen not isolated baseline specimen|4
988932|NCT00496197|3249954|P1|Overall Study|Withdrawal by Subject|11
988933|NCT00496197|3249954|P1|Overall Study|Lost to Follow-up|11
988934|NCT00496197|3249954|P1|Overall Study|Insufficient bacteriological response|10
988935|NCT00496197|3249954|P1|Overall Study|Insufficient clinical response|3
988936|NCT00496197|3249954|P1|Overall Study|Does not meet entrance criteria|5
988937|NCT00496197|3249954|P1|Overall Study|Adverse Event|13
988938|NCT00496197|3249954|P1|Overall Study|Discontinued study due to death|43
988939|NCT00496080|3249981|P1|Overall Study|Physician Decision|6
988940|NCT00496080|3249981|P1|Overall Study|Withdrawal by Subject|5
988941|NCT00496080|3249981|P1|Overall Study|Surgical re-intervention|7
988942|NCT00496080|3249981|P1|Overall Study|Lost to Follow-up|9
988943|NCT00496054|3249991|P1|Overall Study|Lost to Follow-up|7
988944|NCT00496054|3249991|P1|Overall Study|Adverse Event|1
988945|NCT00495820|3250020|P2|Overall Study|Adverse Event|1
988946|NCT00495820|3250021|P1|Overall Study|Adverse Event|1
988947|NCT00495794|3250033|P2|Overall Study|Pharmacist did not activate patient|0
988948|NCT00495794|3250034|P1|Overall Study|Pharmacist did not activate patient|522
988949|NCT00495755|3250044|P1|Overall Study|Adverse Event|3
988950|NCT00495677|3250056|P7|Stage 1 (25 Days)|Adverse Event|0
988951|NCT00495677|3250057|P6|Stage 1 (25 Days)|Adverse Event|0
988952|NCT00495677|3250058|P5|Stage 1 (25 Days)|Adverse Event|0
988953|NCT00495677|3250059|P4|Stage 1 (25 Days)|Adverse Event|0
988954|NCT00495677|3250060|P3|Stage 1 (25 Days)|Adverse Event|1
988955|NCT00495677|3250061|P2|Stage 1 (25 Days)|Adverse Event|0
988956|NCT00495677|3250062|P1|Stage 1 (25 Days)|Adverse Event|0
988957|NCT00495625|3250117|P1|Overall Study|Did not complete at least 1 42 day cycle|10
988958|NCT00495612|3250128|P2|Overall Study|Subject's Decision to Withdraw|0
988959|NCT00495612|3250129|P1|Overall Study|Subject's Decision to Withdraw|3
988960|NCT00495612|3250128|P2|Overall Study|Lost to Follow-up|0
988961|NCT00495612|3250129|P1|Overall Study|Lost to Follow-up|1
988962|NCT00495586|3250147|P2|Overall Study|Withdrawal by Subject|4
988963|NCT00495586|3250148|P1|Overall Study|Withdrawal by Subject|4
988964|NCT00495521|3250158|P2|Overall Study|Physician Decision|1
988965|NCT00495521|3250159|P1|Overall Study|Physician Decision|0
988966|NCT00495495|3250189|P1|Overall Study|Protocol Violation|99
988967|NCT00495469|3250209|P7|Overall Study|ST depression at randomisation in ECG|0
988968|NCT00495469|3250210|P6|Overall Study|ST depression at randomisation in ECG|0
988969|NCT00495469|3250211|P5|Overall Study|ST depression at randomisation in ECG|0
988970|NCT00495469|3250212|P4|Overall Study|ST depression at randomisation in ECG|0
988971|NCT00495469|3250213|P3|Overall Study|ST depression at randomisation in ECG|0
988972|NCT00495469|3250214|P2|Overall Study|ST depression at randomisation in ECG|1
988973|NCT00495469|3250215|P1|Overall Study|ST depression at randomisation in ECG|0
988974|NCT00495469|3250209|P7|Overall Study|Liver function test abnormality|0
988975|NCT00495469|3250210|P6|Overall Study|Liver function test abnormality|0
988976|NCT00495469|3250211|P5|Overall Study|Liver function test abnormality|0
988977|NCT00495469|3250212|P4|Overall Study|Liver function test abnormality|0
988978|NCT00495469|3250213|P3|Overall Study|Liver function test abnormality|0
988979|NCT00495469|3250214|P2|Overall Study|Liver function test abnormality|1
988980|NCT00495469|3250215|P1|Overall Study|Liver function test abnormality|0
988981|NCT00495469|3250209|P7|Overall Study|Lack of Efficacy|1
988982|NCT00495469|3250210|P6|Overall Study|Lack of Efficacy|0
988983|NCT00495469|3250211|P5|Overall Study|Lack of Efficacy|0
988984|NCT00495469|3250212|P4|Overall Study|Lack of Efficacy|0
988985|NCT00495469|3250213|P3|Overall Study|Lack of Efficacy|0
988986|NCT00495469|3250214|P2|Overall Study|Lack of Efficacy|0
988987|NCT00495469|3250215|P1|Overall Study|Lack of Efficacy|0
988988|NCT00495469|3250209|P7|Overall Study|Withdrawal by Subject|3
988989|NCT00495469|3250210|P6|Overall Study|Withdrawal by Subject|2
988990|NCT00495469|3250211|P5|Overall Study|Withdrawal by Subject|3
988991|NCT00495469|3250212|P4|Overall Study|Withdrawal by Subject|3
988992|NCT00495469|3250213|P3|Overall Study|Withdrawal by Subject|1
988993|NCT00495469|3250214|P2|Overall Study|Withdrawal by Subject|3
988994|NCT00495469|3250215|P1|Overall Study|Withdrawal by Subject|5
988995|NCT00495469|3250209|P7|Overall Study|Protocol Violation|0
988996|NCT00495469|3250210|P6|Overall Study|Protocol Violation|2
988997|NCT00495469|3250211|P5|Overall Study|Protocol Violation|1
988998|NCT00495469|3250212|P4|Overall Study|Protocol Violation|0
988999|NCT00495469|3250213|P3|Overall Study|Protocol Violation|0
989000|NCT00495469|3250214|P2|Overall Study|Protocol Violation|0
989001|NCT00495469|3250215|P1|Overall Study|Protocol Violation|0
989002|NCT00495469|3250209|P7|Overall Study|Lost to Follow-up|0
989003|NCT00495469|3250210|P6|Overall Study|Lost to Follow-up|0
989004|NCT00495469|3250211|P5|Overall Study|Lost to Follow-up|0
989005|NCT00495469|3250212|P4|Overall Study|Lost to Follow-up|1
989006|NCT00495469|3250213|P3|Overall Study|Lost to Follow-up|3
989007|NCT00495469|3250214|P2|Overall Study|Lost to Follow-up|1
989008|NCT00495469|3250215|P1|Overall Study|Lost to Follow-up|1
989009|NCT00495469|3250209|P7|Overall Study|Adverse Event|1
989010|NCT00495469|3250210|P6|Overall Study|Adverse Event|1
989011|NCT00495469|3250211|P5|Overall Study|Adverse Event|1
989012|NCT00495469|3250212|P4|Overall Study|Adverse Event|0
989013|NCT00495469|3250213|P3|Overall Study|Adverse Event|3
989014|NCT00495469|3250214|P2|Overall Study|Adverse Event|1
989015|NCT00495469|3250215|P1|Overall Study|Adverse Event|0
989016|NCT00495391|3250359|P2|Overall Study|Withdrawal by Subject|3
989017|NCT00495391|3250360|P1|Overall Study|Withdrawal by Subject|2
989018|NCT00495391|3250359|P2|Overall Study|Lack of Efficacy|18
989019|NCT00495391|3250360|P1|Overall Study|Lack of Efficacy|34
989020|NCT00495131|3250398|P2|Overall Study|Withdrawal by Subject|0
989021|NCT00495131|3250399|P1|Overall Study|Withdrawal by Subject|1
989022|NCT00495131|3250398|P2|Overall Study|Lost to Follow-up|2
989023|NCT00495131|3250399|P1|Overall Study|Lost to Follow-up|0
989024|NCT00495131|3250398|P2|Overall Study|Lack of Efficacy|2
989025|NCT00495131|3250399|P1|Overall Study|Lack of Efficacy|0
989026|NCT00495131|3250398|P2|Overall Study|Adverse Event|2
989027|NCT00495131|3250399|P1|Overall Study|Adverse Event|6
989028|NCT00494871|3250427|P2|Follow-up (FU) Period|Clinical Endpoint Reached|2
989029|NCT00494871|3250428|P1|Follow-up (FU) Period|Clinical Endpoint Reached|3
989030|NCT00494871|3250427|P2|Follow-up (FU) Period|Withdrawal by Subject|5
989031|NCT00494871|3250428|P1|Follow-up (FU) Period|Withdrawal by Subject|5
989032|NCT00494871|3250427|P2|Follow-up (FU) Period|Protocol Violation|0
989033|NCT00494871|3250428|P1|Follow-up (FU) Period|Protocol Violation|1
989034|NCT00494871|3250427|P2|Follow-up (FU) Period|Physician Decision|1
989035|NCT00494871|3250428|P1|Follow-up (FU) Period|Physician Decision|0
989036|NCT00494871|3250427|P2|Follow-up (FU) Period|Lost to Follow-up|2
989037|NCT00494871|3250428|P1|Follow-up (FU) Period|Lost to Follow-up|6
989038|NCT00494871|3250427|P2|Follow-up (FU) Period|Death|12
989039|NCT00494871|3250428|P1|Follow-up (FU) Period|Death|13
989040|NCT00494871|3250427|P2|Follow-up (FU) Period|Adverse Event|1
989041|NCT00494871|3250428|P1|Follow-up (FU) Period|Adverse Event|1
989042|NCT00494871|3250427|P2|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
989043|NCT00494871|3250428|P1|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
989044|NCT00494871|3250427|P2|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
989045|NCT00494871|3250428|P1|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
989046|NCT00494871|3250427|P2|Double-blind (DB) Treatment Period|Site Closed by Investigator|2
989047|NCT00494871|3250428|P1|Double-blind (DB) Treatment Period|Site Closed by Investigator|1
989048|NCT00494871|3250427|P2|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8
989049|NCT00494871|3250428|P1|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12
989050|NCT00494871|3250427|P2|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1
989051|NCT00494871|3250428|P1|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3
989052|NCT00494871|3250427|P2|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28
989053|NCT00494871|3250428|P1|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18
989054|NCT00494871|3250427|P2|Double-blind (DB) Treatment Period|Protocol Violation|9
989055|NCT00494871|3250428|P1|Double-blind (DB) Treatment Period|Protocol Violation|9
989056|NCT00494871|3250427|P2|Double-blind (DB) Treatment Period|Lost to Follow-up|1
989057|NCT00494871|3250428|P1|Double-blind (DB) Treatment Period|Lost to Follow-up|4
989058|NCT00494871|3250427|P2|Double-blind (DB) Treatment Period|Physician Decision|13
989059|NCT00494871|3250428|P1|Double-blind (DB) Treatment Period|Physician Decision|4
989060|NCT00494871|3250427|P2|Double-blind (DB) Treatment Period|Death|3
989061|NCT00494871|3250428|P1|Double-blind (DB) Treatment Period|Death|8
989062|NCT00494871|3250427|P2|Double-blind (DB) Treatment Period|Withdrawal by Subject|35
989063|NCT00494871|3250428|P1|Double-blind (DB) Treatment Period|Withdrawal by Subject|26
989064|NCT00494871|3250427|P2|Double-blind (DB) Treatment Period|Adverse Event|70
989065|NCT00494871|3250428|P1|Double-blind (DB) Treatment Period|Adverse Event|73
989066|NCT00494780|3250469|P2|Overall Study|Insurance Issues|1
989067|NCT00494780|3250470|P1|Overall Study|Insurance Issues|0
989068|NCT00494780|3250469|P2|Overall Study|Residual Tumour Mass|1
989069|NCT00494780|3250470|P1|Overall Study|Residual Tumour Mass|0
989070|NCT00494780|3250469|P2|Overall Study|Non-compliance|0
989071|NCT00494780|3250470|P1|Overall Study|Non-compliance|1
989072|NCT00494780|3250469|P2|Overall Study|New Treatment|2
989073|NCT00494780|3250470|P1|Overall Study|New Treatment|2
989074|NCT00494780|3250469|P2|Overall Study|Progression of Study Disease|8
989075|NCT00494780|3250470|P1|Overall Study|Progression of Study Disease|7
989076|NCT00494780|3250469|P2|Overall Study|Withdrew before Dosed|1
989077|NCT00494780|3250470|P1|Overall Study|Withdrew before Dosed|0
989078|NCT00494780|3250469|P2|Overall Study|Adverse Event|0
989079|NCT00494780|3250470|P1|Overall Study|Adverse Event|1
989080|NCT00494676|3250508|P2|Second Intervention|Withdrawal by Subject|1
989081|NCT00494676|3250509|P1|Second Intervention|Withdrawal by Subject|1
989082|NCT00494676|3250508|P2|First Intervention|Withdrawal by Subject|3
989083|NCT00494676|3250509|P1|First Intervention|Withdrawal by Subject|1
989084|NCT00494676|3250508|P2|Allocation|Withdrawal by Subject|4
989085|NCT00494676|3250509|P1|Allocation|Withdrawal by Subject|2
989086|NCT00494507|3250524|P4|Open-Label Phase|Worsening Disease|2
989087|NCT00494507|3250525|P3|Open-Label Phase|Worsening Disease|0
989088|NCT00494507|3250526|P2|Open-Label Phase|Worsening Disease|0
989089|NCT00494507|3250527|P1|Open-Label Phase|Worsening Disease|0
989090|NCT00494507|3250524|P4|Open-Label Phase|Adverse Event|3
989091|NCT00494507|3250525|P3|Open-Label Phase|Adverse Event|5
989092|NCT00494507|3250526|P2|Open-Label Phase|Adverse Event|1
989093|NCT00494507|3250527|P1|Open-Label Phase|Adverse Event|0
989094|NCT00494507|3250524|P4|Double-Blind Phase|Negative DNA test|1
989095|NCT00494507|3250525|P3|Double-Blind Phase|Negative DNA test|0
989096|NCT00494507|3250526|P2|Double-Blind Phase|Negative DNA test|0
989097|NCT00494507|3250527|P1|Double-Blind Phase|Negative DNA test|0
989098|NCT00494507|3250524|P4|Double-Blind Phase|Subject Non-compliance|0
989099|NCT00494507|3250525|P3|Double-Blind Phase|Subject Non-compliance|1
989100|NCT00494507|3250526|P2|Double-Blind Phase|Subject Non-compliance|0
989101|NCT00494507|3250527|P1|Double-Blind Phase|Subject Non-compliance|0
989102|NCT00494507|3250524|P4|Double-Blind Phase|Withdrawal by Subject|0
989103|NCT00494507|3250525|P3|Double-Blind Phase|Withdrawal by Subject|0
989104|NCT00494507|3250526|P2|Double-Blind Phase|Withdrawal by Subject|0
989105|NCT00494507|3250527|P1|Double-Blind Phase|Withdrawal by Subject|1
989106|NCT00494507|3250524|P4|Double-Blind Phase|Adverse Event|0
989107|NCT00494507|3250525|P3|Double-Blind Phase|Adverse Event|1
989108|NCT00494507|3250526|P2|Double-Blind Phase|Adverse Event|0
989109|NCT00494507|3250527|P1|Double-Blind Phase|Adverse Event|2
989110|NCT00494481|3250594|P2|Overall Study|Never received IP|0
989111|NCT00494481|3250595|P1|Overall Study|Never received IP|2
989112|NCT00494481|3250594|P2|Overall Study|Other|0
989113|NCT00494481|3250595|P1|Overall Study|Other|1
989114|NCT00494481|3250594|P2|Overall Study|Adverse Event|11
989115|NCT00494481|3250595|P1|Overall Study|Adverse Event|15
989116|NCT00494481|3250594|P2|Overall Study|Condition under investigation worsened|13
989117|NCT00494481|3250595|P1|Overall Study|Condition under investigation worsened|11
989118|NCT00494442|3250603|P2|Overall Study|Intercurrent illness|1
989119|NCT00494442|3250604|P1|Overall Study|Intercurrent illness|0
989120|NCT00494442|3250603|P2|Overall Study|Non-compliance|1
989121|NCT00494442|3250604|P1|Overall Study|Non-compliance|0
989122|NCT00494442|3250603|P2|Overall Study|Physician Decision|1
989123|NCT00494442|3250604|P1|Overall Study|Physician Decision|0
989124|NCT00494442|3250603|P2|Overall Study|Adverse Event|2
989125|NCT00494442|3250604|P1|Overall Study|Adverse Event|0
989126|NCT00494442|3250603|P2|Overall Study|Lack of Efficacy|10
989127|NCT00494442|3250604|P1|Overall Study|Lack of Efficacy|16
989128|NCT00494442|3250603|P2|Overall Study|Death|1
989129|NCT00494442|3250604|P1|Overall Study|Death|1
989130|NCT00494299|3250620|P2|Overall Study|Protocol Driven Decision Point|22
989131|NCT00494299|3250621|P1|Overall Study|Protocol Driven Decision Point|11
989132|NCT00494299|3250620|P2|Overall Study|Site Closed by Sponsor|0
989133|NCT00494299|3250621|P1|Overall Study|Site Closed by Sponsor|6
989134|NCT00494299|3250620|P2|Overall Study|Participant Did Not Take Study Drug|2
989135|NCT00494299|3250621|P1|Overall Study|Participant Did Not Take Study Drug|0
989136|NCT00494299|3250620|P2|Overall Study|Disease Progression, Recurrence/Relapse|185
989137|NCT00494299|3250621|P1|Overall Study|Disease Progression, Recurrence/Relapse|109
989138|NCT00494299|3250620|P2|Overall Study|Withdrawal by Subject|3
989139|NCT00494299|3250621|P1|Overall Study|Withdrawal by Subject|8
989140|NCT00494299|3250620|P2|Overall Study|Protocol Violation|2
989141|NCT00494299|3250621|P1|Overall Study|Protocol Violation|1
989142|NCT00494299|3250620|P2|Overall Study|Physician Decision|2
989143|NCT00494299|3250621|P1|Overall Study|Physician Decision|0
989144|NCT00494299|3250620|P2|Overall Study|Lost to Follow-up|0
989145|NCT00494299|3250621|P1|Overall Study|Lost to Follow-up|1
989146|NCT00494299|3250620|P2|Overall Study|Adverse Event|13
989147|NCT00494299|3250621|P1|Overall Study|Adverse Event|93
989148|NCT00494234|3250633|P2|Overall Study|Death|1
989149|NCT00494234|3250634|P1|Overall Study|Death|2
989150|NCT00494234|3250633|P2|Overall Study|Withdrawal by Subject|0
989151|NCT00494234|3250634|P1|Overall Study|Withdrawal by Subject|1
989152|NCT00494234|3250633|P2|Overall Study|Lack of Efficacy|9
989153|NCT00494234|3250634|P1|Overall Study|Lack of Efficacy|12
989154|NCT00494221|3250653|P3|Overall Study|Withdrawal by Subject|0
989155|NCT00494221|3250654|P2|Overall Study|Withdrawal by Subject|2
989156|NCT00494221|3250655|P1|Overall Study|Withdrawal by Subject|1
989157|NCT00494221|3250653|P3|Overall Study|Death|14
989158|NCT00494221|3250654|P2|Overall Study|Death|9
989159|NCT00494221|3250655|P1|Overall Study|Death|15
989160|NCT00494091|3250696|P2|Overall Study|Withdrawal by Subject|7
989161|NCT00494091|3250697|P1|Overall Study|Withdrawal by Subject|0
989162|NCT00494091|3250696|P2|Overall Study|Not Specified|11
989163|NCT00494091|3250697|P1|Overall Study|Not Specified|1
989164|NCT00494091|3250696|P2|Overall Study|Lost to Follow-up|4
989165|NCT00494091|3250697|P1|Overall Study|Lost to Follow-up|0
989166|NCT00494091|3250696|P2|Overall Study|Death|54
989167|NCT00494091|3250697|P1|Overall Study|Death|5
989168|NCT00494026|3250719|P1|Overall Study|Sponsor Decision|4
989169|NCT00494013|3250729|P2|Overall Study|Sponsor Decision|1
989170|NCT00494013|3250730|P1|Overall Study|Sponsor Decision|0
989171|NCT00494013|3250729|P2|Overall Study|Withdrawal by Subject|14
989172|NCT00494013|3250730|P1|Overall Study|Withdrawal by Subject|13
989173|NCT00494013|3250729|P2|Overall Study|Protocol Violation|5
989174|NCT00494013|3250730|P1|Overall Study|Protocol Violation|8
989175|NCT00494013|3250729|P2|Overall Study|Physician Decision|5
989176|NCT00494013|3250730|P1|Overall Study|Physician Decision|3
989177|NCT00494013|3250729|P2|Overall Study|Lost to Follow-up|6
989178|NCT00494013|3250730|P1|Overall Study|Lost to Follow-up|5
989179|NCT00494013|3250729|P2|Overall Study|Entry Criteria Not Met|4
989180|NCT00494013|3250730|P1|Overall Study|Entry Criteria Not Met|1
989181|NCT00494013|3250729|P2|Overall Study|Adverse Event|1
989182|NCT00494013|3250730|P1|Overall Study|Adverse Event|0
989183|NCT00493974|3250760|P2|Overall Study|Lost to Follow-up|6
989184|NCT00493974|3250761|P1|Overall Study|Lost to Follow-up|4
989185|NCT00493974|3250760|P2|Overall Study|Withdrawal by Subject|6
989186|NCT00493974|3250761|P1|Overall Study|Withdrawal by Subject|8
989187|NCT00493974|3250760|P2|Overall Study|Death|2
989188|NCT00493974|3250761|P1|Overall Study|Death|1
989189|NCT00493779|3250788|P1|Overall Study|Logistical issue at site|1
989190|NCT00493649|3250795|P1|Overall Study|Other|13
989191|NCT00493649|3250795|P1|Overall Study|Lost to Follow-up|1
989192|NCT00493649|3250795|P1|Overall Study|Disease Progression|1
989193|NCT00493649|3250795|P1|Overall Study|Investigator Request|2
989194|NCT00493649|3250795|P1|Overall Study|Patient Request|21
989195|NCT00493649|3250795|P1|Overall Study|Adverse Event|44
989196|NCT00493636|3250808|P2|Overall Study|Mis-randomization|1
989197|NCT00493636|3250809|P1|Overall Study|Mis-randomization|1
989198|NCT00493636|3250808|P2|Overall Study|Disease progression/recurrence/relapse|1
989199|NCT00493636|3250809|P1|Overall Study|Disease progression/recurrence/relapse|0
989200|NCT00493636|3250808|P2|Overall Study|Withdrawal by Subject|0
989201|NCT00493636|3250809|P1|Overall Study|Withdrawal by Subject|1
989202|NCT00493454|3250823|P1|Overall Study|Withdrawal by Subject|1
989203|NCT00493311|3250829|P2|Overall Study|Need for rescue medication|2
989204|NCT00493311|3250830|P1|Overall Study|Need for rescue medication|2
989205|NCT00493285|3250850|P6|Overall Study|Lost to Follow-up|0
989206|NCT00493285|3250851|P5|Overall Study|Lost to Follow-up|1
989207|NCT00493285|3250852|P4|Overall Study|Lost to Follow-up|0
989208|NCT00493285|3250853|P3|Overall Study|Lost to Follow-up|0
989209|NCT00493285|3250854|P2|Overall Study|Lost to Follow-up|0
989210|NCT00493285|3250855|P1|Overall Study|Lost to Follow-up|0
989211|NCT00493246|3251087|P8|Overall Study|Lost to Follow-up|0
989212|NCT00493246|3251088|P7|Overall Study|Lost to Follow-up|1
989213|NCT00493246|3251089|P6|Overall Study|Lost to Follow-up|0
989214|NCT00493246|3251090|P5|Overall Study|Lost to Follow-up|0
989215|NCT00493246|3251091|P4|Overall Study|Lost to Follow-up|0
989216|NCT00493246|3251092|P3|Overall Study|Lost to Follow-up|0
989217|NCT00493246|3251093|P2|Overall Study|Lost to Follow-up|0
989218|NCT00493246|3251094|P1|Overall Study|Lost to Follow-up|0
989219|NCT00493246|3251087|P8|Overall Study|No access to draw blood|0
989220|NCT00493246|3251088|P7|Overall Study|No access to draw blood|0
989221|NCT00493246|3251089|P6|Overall Study|No access to draw blood|1
989222|NCT00493246|3251090|P5|Overall Study|No access to draw blood|0
989223|NCT00493246|3251091|P4|Overall Study|No access to draw blood|0
989224|NCT00493246|3251092|P3|Overall Study|No access to draw blood|0
989225|NCT00493246|3251093|P2|Overall Study|No access to draw blood|0
989226|NCT00493246|3251094|P1|Overall Study|No access to draw blood|0
989227|NCT00493246|3251087|P8|Overall Study|Withdrawal by Subject|0
989228|NCT00493246|3251088|P7|Overall Study|Withdrawal by Subject|0
989229|NCT00493246|3251089|P6|Overall Study|Withdrawal by Subject|0
989230|NCT00493246|3251090|P5|Overall Study|Withdrawal by Subject|1
989231|NCT00493246|3251091|P4|Overall Study|Withdrawal by Subject|0
989232|NCT00493246|3251092|P3|Overall Study|Withdrawal by Subject|0
989233|NCT00493246|3251093|P2|Overall Study|Withdrawal by Subject|0
989234|NCT00493246|3251094|P1|Overall Study|Withdrawal by Subject|0
989235|NCT00493220|3251158|P6|Third Intervention|Withdrawal by Subject|0
989236|NCT00493220|3251159|P5|Third Intervention|Withdrawal by Subject|0
989237|NCT00493220|3251160|P4|Third Intervention|Withdrawal by Subject|0
989238|NCT00493220|3251161|P3|Third Intervention|Withdrawal by Subject|0
989239|NCT00493220|3251162|P2|Third Intervention|Withdrawal by Subject|0
989240|NCT00493220|3251163|P1|Third Intervention|Withdrawal by Subject|1
989241|NCT00493038|3251186|P2|Follow-up|Lost to Follow-up|0
989242|NCT00493038|3251187|P1|Follow-up|Lost to Follow-up|1
989243|NCT00493038|3251186|P2|Treatment|Other|1
989244|NCT00493038|3251187|P1|Treatment|Other|0
989245|NCT00493038|3251186|P2|Treatment|Withdrawal by Subject|12
989246|NCT00493038|3251187|P1|Treatment|Withdrawal by Subject|11
989247|NCT00493038|3251186|P2|Treatment|Lost to Follow-up|3
989248|NCT00493038|3251187|P1|Treatment|Lost to Follow-up|5
989249|NCT00493038|3251186|P2|Treatment|Adverse Event|4
989250|NCT00493038|3251187|P1|Treatment|Adverse Event|8
989251|NCT00493012|3251203|P2|Overall Study|Lost to Follow-up|17
989252|NCT00493012|3251204|P1|Overall Study|Lost to Follow-up|18
989253|NCT00492921|3251247|P3|Overall Study|Death|1
989254|NCT00492921|3251248|P2|Overall Study|Death|0
989255|NCT00492921|3251249|P1|Overall Study|Death|1
989256|NCT00492856|3251260|P4|Post-consolidation|Observation Arm|0
989257|NCT00492856|3251261|P3|Post-consolidation|Observation Arm|27
989258|NCT00492856|3251262|P2|Post-consolidation|Observation Arm|0
989259|NCT00492856|3251263|P1|Post-consolidation|Observation Arm|0
989260|NCT00492856|3251260|P4|Post-consolidation|Lost to Follow-up|0
989261|NCT00492856|3251261|P3|Post-consolidation|Lost to Follow-up|0
989262|NCT00492856|3251262|P2|Post-consolidation|Lost to Follow-up|2
989263|NCT00492856|3251263|P1|Post-consolidation|Lost to Follow-up|0
989264|NCT00492856|3251260|P4|Post-consolidation|Not protocol specified|0
989265|NCT00492856|3251261|P3|Post-consolidation|Not protocol specified|0
989266|NCT00492856|3251262|P2|Post-consolidation|Not protocol specified|1
989267|NCT00492856|3251263|P1|Post-consolidation|Not protocol specified|0
989268|NCT00492856|3251260|P4|Post-consolidation|Death|0
989269|NCT00492856|3251261|P3|Post-consolidation|Death|0
989270|NCT00492856|3251262|P2|Post-consolidation|Death|1
989271|NCT00492856|3251263|P1|Post-consolidation|Death|0
989272|NCT00492856|3251260|P4|Post-consolidation|Withdrawal by Subject|0
989273|NCT00492856|3251261|P3|Post-consolidation|Withdrawal by Subject|0
989274|NCT00492856|3251262|P2|Post-consolidation|Withdrawal by Subject|4
989275|NCT00492856|3251263|P1|Post-consolidation|Withdrawal by Subject|0
989276|NCT00492856|3251260|P4|Post-consolidation|Adverse Event|1
989277|NCT00492856|3251261|P3|Post-consolidation|Adverse Event|0
989278|NCT00492856|3251262|P2|Post-consolidation|Adverse Event|4
989279|NCT00492856|3251263|P1|Post-consolidation|Adverse Event|0
989280|NCT00492856|3251260|P4|Consolidation|Lost to Follow-up|0
989281|NCT00492856|3251261|P3|Consolidation|Lost to Follow-up|0
989282|NCT00492856|3251262|P2|Consolidation|Lost to Follow-up|0
989283|NCT00492856|3251263|P1|Consolidation|Lost to Follow-up|1
989284|NCT00492856|3251260|P4|Consolidation|Not protocol specified|0
989285|NCT00492856|3251261|P3|Consolidation|Not protocol specified|0
989286|NCT00492856|3251262|P2|Consolidation|Not protocol specified|0
989287|NCT00492856|3251263|P1|Consolidation|Not protocol specified|2
989288|NCT00492856|3251260|P4|Consolidation|Adverse Event|0
989289|NCT00492856|3251261|P3|Consolidation|Adverse Event|0
989290|NCT00492856|3251262|P2|Consolidation|Adverse Event|0
989291|NCT00492856|3251263|P1|Consolidation|Adverse Event|6
989292|NCT00492856|3251260|P4|Induction|Death|0
989293|NCT00492856|3251261|P3|Induction|Death|0
989294|NCT00492856|3251262|P2|Induction|Death|0
989295|NCT00492856|3251263|P1|Induction|Death|3
989296|NCT00492856|3251260|P4|Induction|Withdrawal by Subject|0
989297|NCT00492856|3251261|P3|Induction|Withdrawal by Subject|0
989298|NCT00492856|3251262|P2|Induction|Withdrawal by Subject|0
989299|NCT00492856|3251263|P1|Induction|Withdrawal by Subject|1
989300|NCT00492856|3251260|P4|Induction|Adverse Event|0
989301|NCT00492856|3251261|P3|Induction|Adverse Event|0
989302|NCT00492856|3251262|P2|Induction|Adverse Event|0
989303|NCT00492856|3251263|P1|Induction|Adverse Event|2
989304|NCT00492752|3251277|P4|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
989305|NCT00492752|3251278|P3|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
989306|NCT00492752|3251279|P2|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
989307|NCT00492752|3251280|P1|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1
989308|NCT00492752|3251277|P4|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
989309|NCT00492752|3251278|P3|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
989310|NCT00492752|3251279|P2|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6
989311|NCT00492752|3251280|P1|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
989312|NCT00492752|3251277|P4|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1
989313|NCT00492752|3251278|P3|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
989314|NCT00492752|3251279|P2|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
989315|NCT00492752|3251280|P1|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
989316|NCT00492752|3251277|P4|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2
989317|NCT00492752|3251278|P3|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
989318|NCT00492752|3251279|P2|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1
989319|NCT00492752|3251280|P1|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
989320|NCT00492752|3251277|P4|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
989321|NCT00492752|3251278|P3|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
989322|NCT00492752|3251279|P2|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1
989323|NCT00492752|3251280|P1|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2
989324|NCT00492752|3251277|P4|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0
989325|NCT00492752|3251278|P3|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2
989326|NCT00492752|3251279|P2|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1
989327|NCT00492752|3251280|P1|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8
989328|NCT00492752|3251277|P4|Follow-up and/or Open Label Sorafenib|Death|1
989329|NCT00492752|3251278|P3|Follow-up and/or Open Label Sorafenib|Death|45
989330|NCT00492752|3251279|P2|Follow-up and/or Open Label Sorafenib|Death|5
989331|NCT00492752|3251280|P1|Follow-up and/or Open Label Sorafenib|Death|75
989332|NCT00492752|3251277|P4|Follow-up and/or Open Label Sorafenib|Adverse Event|2
989333|NCT00492752|3251278|P3|Follow-up and/or Open Label Sorafenib|Adverse Event|0
989334|NCT00492752|3251279|P2|Follow-up and/or Open Label Sorafenib|Adverse Event|2
989335|NCT00492752|3251280|P1|Follow-up and/or Open Label Sorafenib|Adverse Event|0
989336|NCT00492752|3251277|P4|Double Blind Treatment|Protocol Violation|0
989337|NCT00492752|3251278|P3|Double Blind Treatment|Protocol Violation|1
989338|NCT00492752|3251279|P2|Double Blind Treatment|Protocol Violation|0
989339|NCT00492752|3251280|P1|Double Blind Treatment|Protocol Violation|0
989340|NCT00492752|3251277|P4|Double Blind Treatment|Adverse Event|0
989341|NCT00492752|3251278|P3|Double Blind Treatment|Adverse Event|0
989342|NCT00492752|3251279|P2|Double Blind Treatment|Adverse Event|0
989343|NCT00492752|3251280|P1|Double Blind Treatment|Adverse Event|1
989344|NCT00492752|3251277|P4|Double Blind Treatment|Death|0
989345|NCT00492752|3251278|P3|Double Blind Treatment|Death|2
989346|NCT00492752|3251279|P2|Double Blind Treatment|Death|0
989347|NCT00492752|3251280|P1|Double Blind Treatment|Death|13
989348|NCT00492726|3251315|P2|Overall Study|Non compliant with study medication|3
989349|NCT00492726|3251316|P1|Overall Study|Non compliant with study medication|0
989350|NCT00492726|3251315|P2|Overall Study|Withdrawal by Subject|3
989351|NCT00492726|3251316|P1|Overall Study|Withdrawal by Subject|6
989352|NCT00492726|3251315|P2|Overall Study|Physician Decision|1
989353|NCT00492726|3251316|P1|Overall Study|Physician Decision|0
989354|NCT00492726|3251315|P2|Overall Study|Lost to Follow-up|19
989355|NCT00492726|3251316|P1|Overall Study|Lost to Follow-up|27
989356|NCT00492726|3251315|P2|Overall Study|Lack of Efficacy|2
989357|NCT00492726|3251316|P1|Overall Study|Lack of Efficacy|0
989358|NCT00492726|3251315|P2|Overall Study|Death|2
989359|NCT00492726|3251316|P1|Overall Study|Death|7
989360|NCT00492726|3251315|P2|Overall Study|Adverse Event|6
989361|NCT00492726|3251316|P1|Overall Study|Adverse Event|10
989362|NCT00492557|3251361|P2|Overall Study|Lost to Follow-up|1
989363|NCT00492557|3251362|P1|Overall Study|Lost to Follow-up|0
989364|NCT00492557|3251361|P2|Overall Study|Failed to return|0
989365|NCT00492557|3251362|P1|Overall Study|Failed to return|1
989366|NCT00492557|3251361|P2|Overall Study|Adverse Event|0
989367|NCT00492557|3251362|P1|Overall Study|Adverse Event|1
989368|NCT00492557|3251361|P2|Overall Study|Death|1
989369|NCT00492557|3251362|P1|Overall Study|Death|1
989370|NCT00492557|3251361|P2|Overall Study|Other|2
989371|NCT00492557|3251362|P1|Overall Study|Other|2
989372|NCT00492557|3251361|P2|Overall Study|Protocol Violation|8
989373|NCT00492557|3251362|P1|Overall Study|Protocol Violation|7
989374|NCT00492557|3251361|P2|Overall Study|Subject request|11
989375|NCT00492557|3251362|P1|Overall Study|Subject request|12
989376|NCT00492531|3251392|P2|Overall Study|Withdrawn(More than one reason selected)|23
989377|NCT00492531|3251393|P1|Overall Study|Withdrawn(More than one reason selected)|22
989378|NCT00492297|3251466|P1|Survival Only Follow-up|Study terminated by sponsor|12
989379|NCT00492297|3251466|P1|Survival Only Follow-up|Lack of Efficacy|1
989380|NCT00492297|3251466|P1|Survival Only Follow-up|Death|46
989381|NCT00492297|3251466|P1|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2
989382|NCT00492297|3251466|P1|Active Follow-up 30(+4) Days Duration|Death|17
989383|NCT00492297|3251466|P1|Treatment|Study terminated by sponsor|3
989384|NCT00492297|3251466|P1|Treatment|Death|2
989385|NCT00492284|3251484|P4|Overall Study|Withdrawal by Subject|2
989386|NCT00492284|3251485|P3|Overall Study|Withdrawal by Subject|0
989387|NCT00492284|3251486|P2|Overall Study|Withdrawal by Subject|0
989388|NCT00492284|3251487|P1|Overall Study|Withdrawal by Subject|1
989389|NCT00492284|3251484|P4|Overall Study|Death|5
989390|NCT00492284|3251485|P3|Overall Study|Death|2
989391|NCT00492284|3251486|P2|Overall Study|Death|3
989392|NCT00492284|3251487|P1|Overall Study|Death|0
989393|NCT00492284|3251484|P4|Overall Study|Lost to Follow-up|1
989394|NCT00492284|3251485|P3|Overall Study|Lost to Follow-up|3
989395|NCT00492284|3251486|P2|Overall Study|Lost to Follow-up|0
989396|NCT00492284|3251487|P1|Overall Study|Lost to Follow-up|0
989397|NCT00492284|3251484|P4|Overall Study|Adverse Event|2
989398|NCT00492284|3251485|P3|Overall Study|Adverse Event|1
989399|NCT00492284|3251486|P2|Overall Study|Adverse Event|1
989400|NCT00492284|3251487|P1|Overall Study|Adverse Event|0
989401|NCT00492232|3251531|P2|Open-Label Treatment|Withdrawal by Subject|0
989402|NCT00492232|3251532|P1|Open-Label Treatment|Withdrawal by Subject|1
989403|NCT00492232|3251531|P2|Double-Blind Treatment|Randomized not treated|0
989404|NCT00492232|3251532|P1|Double-Blind Treatment|Randomized not treated|1
989405|NCT00492232|3251531|P2|Double-Blind Treatment|Other|5
989406|NCT00492232|3251532|P1|Double-Blind Treatment|Other|6
989407|NCT00492232|3251531|P2|Double-Blind Treatment|Lack of Efficacy|0
989408|NCT00492232|3251532|P1|Double-Blind Treatment|Lack of Efficacy|1
989409|NCT00492232|3251531|P2|Double-Blind Treatment|Withdrawal by Subject|8
989410|NCT00492232|3251532|P1|Double-Blind Treatment|Withdrawal by Subject|4
989411|NCT00492232|3251531|P2|Double-Blind Treatment|Lost to Follow-up|3
989412|NCT00492232|3251532|P1|Double-Blind Treatment|Lost to Follow-up|2
989413|NCT00492232|3251531|P2|Double-Blind Treatment|Protocol Violation|7
989414|NCT00492232|3251532|P1|Double-Blind Treatment|Protocol Violation|3
989415|NCT00492232|3251531|P2|Double-Blind Treatment|Adverse Event|2
989416|NCT00492232|3251532|P1|Double-Blind Treatment|Adverse Event|1
989417|NCT00492232|3251531|P2|Placebo Run-in|Missing|2
989418|NCT00492232|3251532|P1|Placebo Run-in|Missing|0
989419|NCT00492232|3251531|P2|Placebo Run-in|Other|6
989420|NCT00492232|3251532|P1|Placebo Run-in|Other|0
989421|NCT00492232|3251531|P2|Placebo Run-in|Entrance criteria not met|45
989422|NCT00492232|3251532|P1|Placebo Run-in|Entrance criteria not met|0
989423|NCT00492232|3251531|P2|Placebo Run-in|Pregnancy|1
989424|NCT00492232|3251532|P1|Placebo Run-in|Pregnancy|0
989425|NCT00492232|3251531|P2|Placebo Run-in|Withdrawal by Subject|8
989426|NCT00492232|3251532|P1|Placebo Run-in|Withdrawal by Subject|0
989427|NCT00492232|3251531|P2|Placebo Run-in|Lost to Follow-up|3
989428|NCT00492232|3251532|P1|Placebo Run-in|Lost to Follow-up|0
989429|NCT00492232|3251531|P2|Placebo Run-in|Protocol Violation|3
989430|NCT00492232|3251532|P1|Placebo Run-in|Protocol Violation|0
989431|NCT00492232|3251531|P2|Placebo Run-in|Adverse Event|2
989432|NCT00492232|3251532|P1|Placebo Run-in|Adverse Event|0
989433|NCT00492115|3251573|P2|Overall Study|Withdrawal by Subject|4
989434|NCT00492115|3251574|P1|Overall Study|Withdrawal by Subject|3
989435|NCT00492063|3251595|P4|Overall Study|Protocol Violation|1
989436|NCT00492063|3251596|P3|Overall Study|Protocol Violation|0
989437|NCT00492063|3251597|P2|Overall Study|Protocol Violation|0
989438|NCT00492063|3251598|P1|Overall Study|Protocol Violation|0
989439|NCT00492063|3251595|P4|Overall Study|Lost to Follow-up|3
989440|NCT00492063|3251596|P3|Overall Study|Lost to Follow-up|5
989441|NCT00492063|3251597|P2|Overall Study|Lost to Follow-up|11
989442|NCT00492063|3251598|P1|Overall Study|Lost to Follow-up|6
989443|NCT00492063|3251595|P4|Overall Study|Withdrawal by Subject|4
989444|NCT00492063|3251596|P3|Overall Study|Withdrawal by Subject|5
989445|NCT00492063|3251597|P2|Overall Study|Withdrawal by Subject|3
989446|NCT00492063|3251598|P1|Overall Study|Withdrawal by Subject|4
989447|NCT00492063|3251595|P4|Overall Study|Death|2
989448|NCT00492063|3251596|P3|Overall Study|Death|1
989449|NCT00492063|3251597|P2|Overall Study|Death|0
989450|NCT00492063|3251598|P1|Overall Study|Death|0
989451|NCT00492024|3251622|P2|Follow up|Lost to Follow-up|1
989452|NCT00492024|3251623|P1|Follow up|Lost to Follow-up|1
989453|NCT00492024|3251622|P2|Follow up|Lack of Efficacy|1
989454|NCT00492024|3251623|P1|Follow up|Lack of Efficacy|0
989455|NCT00492024|3251622|P2|Treatment|Withdrawal by Subject|0
989456|NCT00492024|3251623|P1|Treatment|Withdrawal by Subject|2
989457|NCT00492024|3251622|P2|Treatment|Lost to Follow-up|1
989458|NCT00492024|3251623|P1|Treatment|Lost to Follow-up|3
989459|NCT00492024|3251622|P2|Treatment|Lack of Efficacy|20
989460|NCT00492024|3251623|P1|Treatment|Lack of Efficacy|21
989461|NCT00492024|3251622|P2|Treatment|Adverse Event|1
989462|NCT00492024|3251623|P1|Treatment|Adverse Event|3
989463|NCT00491894|3251639|P1|Overall Study|Other-Intake of prohibited medication|1
989464|NCT00491894|3251639|P1|Overall Study|Protocol Violation|2
989465|NCT00491894|3251639|P1|Overall Study|Physician Decision|2
989466|NCT00491894|3251639|P1|Overall Study|Other-Failed to meet any criteria|2
989467|NCT00491894|3251639|P1|Overall Study|Lack of Efficacy|2
989468|NCT00491894|3251639|P1|Overall Study|Lost to Follow-up|3
989469|NCT00491894|3251639|P1|Overall Study|Death|3
989470|NCT00491894|3251639|P1|Overall Study|Withdrawal by Subject|5
989471|NCT00491894|3251639|P1|Overall Study|Adverse Event|14
989472|NCT00491764|3251666|P6|Overall Study|Administrative|0
989473|NCT00491764|3251667|P5|Overall Study|Administrative|0
989474|NCT00491764|3251668|P4|Overall Study|Administrative|1
989475|NCT00491764|3251669|P3|Overall Study|Administrative|2
989476|NCT00491764|3251670|P2|Overall Study|Administrative|0
989477|NCT00491764|3251671|P1|Overall Study|Administrative|1
989478|NCT00491764|3251666|P6|Overall Study|Did not Meet Protocol Eligibility|1
989479|NCT00491764|3251667|P5|Overall Study|Did not Meet Protocol Eligibility|1
989480|NCT00491764|3251668|P4|Overall Study|Did not Meet Protocol Eligibility|0
989481|NCT00491764|3251669|P3|Overall Study|Did not Meet Protocol Eligibility|1
989482|NCT00491764|3251670|P2|Overall Study|Did not Meet Protocol Eligibility|1
989483|NCT00491764|3251671|P1|Overall Study|Did not Meet Protocol Eligibility|0
989484|NCT00491764|3251666|P6|Overall Study|Non Compliance with the Protocol|0
989485|NCT00491764|3251667|P5|Overall Study|Non Compliance with the Protocol|0
989486|NCT00491764|3251668|P4|Overall Study|Non Compliance with the Protocol|0
989487|NCT00491764|3251669|P3|Overall Study|Non Compliance with the Protocol|0
989488|NCT00491764|3251670|P2|Overall Study|Non Compliance with the Protocol|0
989489|NCT00491764|3251671|P1|Overall Study|Non Compliance with the Protocol|1
989490|NCT00491764|3251666|P6|Overall Study|Withdrawal by Subject|4
989491|NCT00491764|3251667|P5|Overall Study|Withdrawal by Subject|2
989492|NCT00491764|3251668|P4|Overall Study|Withdrawal by Subject|2
989493|NCT00491764|3251669|P3|Overall Study|Withdrawal by Subject|1
989494|NCT00491764|3251670|P2|Overall Study|Withdrawal by Subject|3
989495|NCT00491764|3251671|P1|Overall Study|Withdrawal by Subject|2
989496|NCT00491764|3251666|P6|Overall Study|Lost to Follow-up|3
989497|NCT00491764|3251667|P5|Overall Study|Lost to Follow-up|0
989498|NCT00491764|3251668|P4|Overall Study|Lost to Follow-up|1
989499|NCT00491764|3251669|P3|Overall Study|Lost to Follow-up|0
989500|NCT00491764|3251670|P2|Overall Study|Lost to Follow-up|1
989501|NCT00491764|3251671|P1|Overall Study|Lost to Follow-up|0
989502|NCT00491764|3251666|P6|Overall Study|Adverse Event|1
989503|NCT00491764|3251667|P5|Overall Study|Adverse Event|0
989504|NCT00491764|3251668|P4|Overall Study|Adverse Event|4
989505|NCT00491764|3251669|P3|Overall Study|Adverse Event|4
989506|NCT00491764|3251670|P2|Overall Study|Adverse Event|2
989507|NCT00491764|3251671|P1|Overall Study|Adverse Event|1
989508|NCT00491608|3251719|P1|Overall Study|Withdrawal by Subject|1
989509|NCT00491608|3251719|P1|Overall Study|Death|2
989510|NCT00491556|3251730|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1
989511|NCT00491556|3251731|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0
989512|NCT00491556|3251730|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1
989513|NCT00491556|3251731|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0
989514|NCT00491556|3251730|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Not Specified|0
989515|NCT00491556|3251731|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Not Specified|2
989516|NCT00491556|3251730|P2|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0
989517|NCT00491556|3251731|P1|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2
989518|NCT00491556|3251730|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0
989519|NCT00491556|3251731|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2
989520|NCT00491556|3251730|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0
989521|NCT00491556|3251731|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5
989522|NCT00491556|3251730|P2|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0
989523|NCT00491556|3251731|P1|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2
989524|NCT00491556|3251730|P2|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0
989525|NCT00491556|3251731|P1|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5
989526|NCT00491556|3251730|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1
989527|NCT00491556|3251731|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2
989528|NCT00491556|3251730|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0
989529|NCT00491556|3251731|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2
989530|NCT00491556|3251730|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
989531|NCT00491556|3251731|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
989532|NCT00491556|3251730|P2|Entry-Week (WK) 48: EXP/Standard Care|Not Specified|0
989533|NCT00491556|3251731|P1|Entry-Week (WK) 48: EXP/Standard Care|Not Specified|3
989534|NCT00491556|3251730|P2|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0
989535|NCT00491556|3251731|P1|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3
989536|NCT00491556|3251730|P2|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0
989537|NCT00491556|3251731|P1|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2
989538|NCT00491556|3251730|P2|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0
989539|NCT00491556|3251731|P1|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2
989540|NCT00491556|3251730|P2|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0
989541|NCT00491556|3251731|P1|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11
989542|NCT00491556|3251730|P2|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0
989543|NCT00491556|3251731|P1|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2
989544|NCT00491556|3251730|P2|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0
989545|NCT00491556|3251731|P1|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1
989546|NCT00491556|3251730|P2|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0
989547|NCT00491556|3251731|P1|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1
989548|NCT00491556|3251730|P2|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0
989549|NCT00491556|3251731|P1|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1
989550|NCT00491530|3251790|P3|Overall Study|Use of Prohibited Medication|1
989551|NCT00491530|3251791|P2|Overall Study|Use of Prohibited Medication|0
989552|NCT00491530|3251792|P1|Overall Study|Use of Prohibited Medication|0
989553|NCT00491530|3251790|P3|Overall Study|Patient Request|0
989554|NCT00491530|3251791|P2|Overall Study|Patient Request|1
989555|NCT00491530|3251792|P1|Overall Study|Patient Request|0
989556|NCT00491530|3251790|P3|Overall Study|Investigator Discretion|0
989557|NCT00491530|3251791|P2|Overall Study|Investigator Discretion|1
989558|NCT00491530|3251792|P1|Overall Study|Investigator Discretion|0
989559|NCT00491530|3251790|P3|Overall Study|Lack of Efficacy|0
989560|NCT00491530|3251791|P2|Overall Study|Lack of Efficacy|1
989561|NCT00491530|3251792|P1|Overall Study|Lack of Efficacy|0
989562|NCT00491530|3251790|P3|Overall Study|Lost to Follow-up|2
989563|NCT00491530|3251791|P2|Overall Study|Lost to Follow-up|2
989564|NCT00491530|3251792|P1|Overall Study|Lost to Follow-up|3
989565|NCT00491530|3251790|P3|Overall Study|Withdrawal by Subject|0
989566|NCT00491530|3251791|P2|Overall Study|Withdrawal by Subject|0
989567|NCT00491530|3251792|P1|Overall Study|Withdrawal by Subject|3
989568|NCT00491530|3251790|P3|Overall Study|Adverse Event|2
989569|NCT00491530|3251791|P2|Overall Study|Adverse Event|1
989570|NCT00491530|3251792|P1|Overall Study|Adverse Event|6
989571|NCT00491504|3251822|P4|Overall Study|Protocol Violation|2
989572|NCT00491504|3251823|P3|Overall Study|Protocol Violation|3
989573|NCT00491504|3251824|P2|Overall Study|Protocol Violation|0
989574|NCT00491504|3251825|P1|Overall Study|Protocol Violation|0
989575|NCT00491504|3251822|P4|Overall Study|Withdrawal by Subject|2
989576|NCT00491504|3251823|P3|Overall Study|Withdrawal by Subject|1
989577|NCT00491504|3251824|P2|Overall Study|Withdrawal by Subject|0
989578|NCT00491504|3251825|P1|Overall Study|Withdrawal by Subject|0
989579|NCT00491504|3251822|P4|Overall Study|Adverse Event|0
989580|NCT00491504|3251823|P3|Overall Study|Adverse Event|0
989581|NCT00491504|3251824|P2|Overall Study|Adverse Event|1
989582|NCT00491504|3251825|P1|Overall Study|Adverse Event|0
989583|NCT00491400|3251835|P2|Overall Study|Withdrawal by Subject|4
989584|NCT00491400|3251836|P1|Overall Study|Withdrawal by Subject|5
989585|NCT00491387|3251844|P1|Overall Study|study terminated|20
989586|NCT00491322|3251859|P2|Overall Study|Pregnancy|1
989587|NCT00491322|3251860|P1|Overall Study|Pregnancy|0
989588|NCT00491322|3251859|P2|Overall Study|Protocol Violation|0
989589|NCT00491322|3251860|P1|Overall Study|Protocol Violation|1
989590|NCT00491179|3251879|P2|Overall Study|Withdrawal by Subject|1
989591|NCT00491179|3251880|P1|Overall Study|Withdrawal by Subject|2
989592|NCT00491179|3251879|P2|Overall Study|Adverse Event|1
989593|NCT00491179|3251880|P1|Overall Study|Adverse Event|5
989594|NCT00491075|3251888|P1|Overall Study|Physician Decision|1
989595|NCT00491075|3251888|P1|Overall Study|Withdrawal by Subject|1
989596|NCT00490971|3251894|P5|Maintenance|Not specified|3
989597|NCT00490971|3251895|P4|Maintenance|Not specified|9
989598|NCT00490971|3251896|P3|Maintenance|Not specified|11
989599|NCT00490971|3251897|P2|Maintenance|Not specified|0
989600|NCT00490971|3251898|P1|Maintenance|Not specified|0
989601|NCT00490971|3251894|P5|Maintenance|Withdrawal by Subject|18
989602|NCT00490971|3251895|P4|Maintenance|Withdrawal by Subject|28
989603|NCT00490971|3251896|P3|Maintenance|Withdrawal by Subject|26
989604|NCT00490971|3251897|P2|Maintenance|Withdrawal by Subject|0
989605|NCT00490971|3251898|P1|Maintenance|Withdrawal by Subject|0
989606|NCT00490971|3251894|P5|Maintenance|Protocol Violation|1
989607|NCT00490971|3251895|P4|Maintenance|Protocol Violation|1
989608|NCT00490971|3251896|P3|Maintenance|Protocol Violation|4
989609|NCT00490971|3251897|P2|Maintenance|Protocol Violation|0
989610|NCT00490971|3251898|P1|Maintenance|Protocol Violation|0
989611|NCT00490971|3251894|P5|Maintenance|Pregnancy|0
989612|NCT00490971|3251895|P4|Maintenance|Pregnancy|0
989613|NCT00490971|3251896|P3|Maintenance|Pregnancy|1
989614|NCT00490971|3251897|P2|Maintenance|Pregnancy|0
989615|NCT00490971|3251898|P1|Maintenance|Pregnancy|0
989616|NCT00490971|3251894|P5|Maintenance|Lost to Follow-up|10
989617|NCT00490971|3251895|P4|Maintenance|Lost to Follow-up|8
989618|NCT00490971|3251896|P3|Maintenance|Lost to Follow-up|5
989619|NCT00490971|3251897|P2|Maintenance|Lost to Follow-up|0
989620|NCT00490971|3251898|P1|Maintenance|Lost to Follow-up|0
989621|NCT00490971|3251894|P5|Maintenance|Death|0
989622|NCT00490971|3251895|P4|Maintenance|Death|2
989623|NCT00490971|3251896|P3|Maintenance|Death|0
989624|NCT00490971|3251897|P2|Maintenance|Death|0
989625|NCT00490971|3251898|P1|Maintenance|Death|0
989626|NCT00490971|3251894|P5|Maintenance|Adverse Event|7
989627|NCT00490971|3251895|P4|Maintenance|Adverse Event|5
989628|NCT00490971|3251896|P3|Maintenance|Adverse Event|4
989629|NCT00490971|3251897|P2|Maintenance|Adverse Event|0
989630|NCT00490971|3251898|P1|Maintenance|Adverse Event|0
989631|NCT00490971|3251894|P5|Acute/Continuation|Not specified|0
989632|NCT00490971|3251895|P4|Acute/Continuation|Not specified|0
989633|NCT00490971|3251896|P3|Acute/Continuation|Not specified|0
989634|NCT00490971|3251897|P2|Acute/Continuation|Not specified|4
989635|NCT00490971|3251898|P1|Acute/Continuation|Not specified|11
989636|NCT00490971|3251894|P5|Acute/Continuation|Withdrawal by Subject|0
989637|NCT00490971|3251895|P4|Acute/Continuation|Withdrawal by Subject|0
989638|NCT00490971|3251896|P3|Acute/Continuation|Withdrawal by Subject|0
989639|NCT00490971|3251897|P2|Acute/Continuation|Withdrawal by Subject|24
989640|NCT00490971|3251898|P1|Acute/Continuation|Withdrawal by Subject|92
989641|NCT00490971|3251894|P5|Acute/Continuation|Protocol Violation|0
989642|NCT00490971|3251895|P4|Acute/Continuation|Protocol Violation|0
989643|NCT00490971|3251896|P3|Acute/Continuation|Protocol Violation|0
989644|NCT00490971|3251897|P2|Acute/Continuation|Protocol Violation|2
989645|NCT00490971|3251898|P1|Acute/Continuation|Protocol Violation|10
989646|NCT00490971|3251894|P5|Acute/Continuation|Lost to Follow-up|0
989647|NCT00490971|3251895|P4|Acute/Continuation|Lost to Follow-up|0
989648|NCT00490971|3251896|P3|Acute/Continuation|Lost to Follow-up|0
989649|NCT00490971|3251897|P2|Acute/Continuation|Lost to Follow-up|7
989650|NCT00490971|3251898|P1|Acute/Continuation|Lost to Follow-up|23
989651|NCT00490971|3251894|P5|Acute/Continuation|Lack of Efficacy|0
989652|NCT00490971|3251895|P4|Acute/Continuation|Lack of Efficacy|0
989653|NCT00490971|3251896|P3|Acute/Continuation|Lack of Efficacy|0
989654|NCT00490971|3251897|P2|Acute/Continuation|Lack of Efficacy|12
989655|NCT00490971|3251898|P1|Acute/Continuation|Lack of Efficacy|106
989656|NCT00490971|3251894|P5|Acute/Continuation|Death|0
989657|NCT00490971|3251895|P4|Acute/Continuation|Death|0
989658|NCT00490971|3251896|P3|Acute/Continuation|Death|0
989659|NCT00490971|3251897|P2|Acute/Continuation|Death|0
989660|NCT00490971|3251898|P1|Acute/Continuation|Death|2
989661|NCT00490971|3251894|P5|Acute/Continuation|Adverse Event|0
989662|NCT00490971|3251895|P4|Acute/Continuation|Adverse Event|0
989663|NCT00490971|3251896|P3|Acute/Continuation|Adverse Event|0
989664|NCT00490971|3251897|P2|Acute/Continuation|Adverse Event|13
989665|NCT00490971|3251898|P1|Acute/Continuation|Adverse Event|62
989666|NCT00490945|3251945|P5|Overall Study|Adverse Event|0
989667|NCT00490945|3251946|P4|Overall Study|Adverse Event|0
989668|NCT00490945|3251947|P3|Overall Study|Adverse Event|0
989669|NCT00490945|3251948|P2|Overall Study|Adverse Event|1
989670|NCT00490945|3251949|P1|Overall Study|Adverse Event|0
989671|NCT00490919|3251985|P3|Double-blind Phase|Administrative|6
989672|NCT00490919|3251986|P2|Double-blind Phase|Administrative|6
989673|NCT00490919|3251987|P1|Double-blind Phase|Administrative|0
989674|NCT00490919|3251985|P3|Double-blind Phase|Lack of Efficacy|36
989675|NCT00490919|3251986|P2|Double-blind Phase|Lack of Efficacy|22
989676|NCT00490919|3251987|P1|Double-blind Phase|Lack of Efficacy|0
989677|NCT00490919|3251985|P3|Double-blind Phase|Lost to Follow-up|11
989678|NCT00490919|3251986|P2|Double-blind Phase|Lost to Follow-up|8
989679|NCT00490919|3251987|P1|Double-blind Phase|Lost to Follow-up|0
989680|NCT00490919|3251985|P3|Double-blind Phase|Withdrawal by Subject|11
989681|NCT00490919|3251986|P2|Double-blind Phase|Withdrawal by Subject|10
989682|NCT00490919|3251987|P1|Double-blind Phase|Withdrawal by Subject|0
989683|NCT00490919|3251985|P3|Double-blind Phase|Adverse Event|20
989684|NCT00490919|3251986|P2|Double-blind Phase|Adverse Event|40
989685|NCT00490919|3251987|P1|Double-blind Phase|Adverse Event|0
989686|NCT00490919|3251985|P3|Open-label Run-in Period|Confirmed or suspected diversion|0
989687|NCT00490919|3251986|P2|Open-label Run-in Period|Confirmed or suspected diversion|0
989688|NCT00490919|3251987|P1|Open-label Run-in Period|Confirmed or suspected diversion|3
989689|NCT00490919|3251985|P3|Open-label Run-in Period|Administrative|0
989690|NCT00490919|3251986|P2|Open-label Run-in Period|Administrative|0
989691|NCT00490919|3251987|P1|Open-label Run-in Period|Administrative|40
989692|NCT00490919|3251985|P3|Open-label Run-in Period|Lack of Efficacy|0
989693|NCT00490919|3251986|P2|Open-label Run-in Period|Lack of Efficacy|0
989694|NCT00490919|3251987|P1|Open-label Run-in Period|Lack of Efficacy|143
989695|NCT00490919|3251985|P3|Open-label Run-in Period|Lost to Follow-up|0
989696|NCT00490919|3251986|P2|Open-label Run-in Period|Lost to Follow-up|0
989697|NCT00490919|3251987|P1|Open-label Run-in Period|Lost to Follow-up|21
989698|NCT00490919|3251985|P3|Open-label Run-in Period|Withdrawal by Subject|0
989699|NCT00490919|3251986|P2|Open-label Run-in Period|Withdrawal by Subject|0
989700|NCT00490919|3251987|P1|Open-label Run-in Period|Withdrawal by Subject|37
989701|NCT00490919|3251985|P3|Open-label Run-in Period|Adverse Event|0
989702|NCT00490919|3251986|P2|Open-label Run-in Period|Adverse Event|0
989703|NCT00490919|3251987|P1|Open-label Run-in Period|Adverse Event|239
989704|NCT00490841|3251998|P1|Overall Study|30 day f/u, only non-study stent used|3
989705|NCT00490841|3251998|P1|Overall Study|Lost to Follow-up|1
989706|NCT00490841|3251998|P1|Overall Study|Withdrawal by Subject|4
989707|NCT00490841|3251998|P1|Overall Study|Death|5
989708|NCT00490815|3252020|P2|Overall Study|Death|3
989709|NCT00490815|3252021|P1|Overall Study|Death|1
989710|NCT00490815|3252020|P2|Overall Study|Lost to Follow-up|3
989711|NCT00490815|3252021|P1|Overall Study|Lost to Follow-up|1
989712|NCT00490815|3252020|P2|Overall Study|Withdrawal by Subject|0
989713|NCT00490815|3252021|P1|Overall Study|Withdrawal by Subject|4
989714|NCT00490815|3252020|P2|Overall Study|Adverse Event|3
989715|NCT00490815|3252021|P1|Overall Study|Adverse Event|2
989716|NCT00490724|3252049|P3|Period II|Treatment Discontinuation|3
989717|NCT00490724|3252050|P2|Period II|Treatment Discontinuation|1
989718|NCT00490724|3252051|P1|Period II|Treatment Discontinuation|3
989719|NCT00490724|3252049|P3|Period I|Physician Decision|1
989720|NCT00490724|3252050|P2|Period I|Physician Decision|0
989721|NCT00490724|3252051|P1|Period I|Physician Decision|0
989722|NCT00490698|3252116|P1|Overall Study|Physician Decision|2
989723|NCT00490698|3252116|P1|Overall Study|Disease Progression|7
989724|NCT00490698|3252116|P1|Overall Study|Withdrawal by Subject|1
989725|NCT00490646|3252122|P2|Overall Study|Never Treated (withdrew consent)|1
989726|NCT00490646|3252123|P1|Overall Study|Never Treated (withdrew consent)|0
989727|NCT00490646|3252122|P2|Overall Study|Never Treated (had an adverse event)|0
989728|NCT00490646|3252123|P1|Overall Study|Never Treated (had an adverse event)|1
989729|NCT00490646|3252122|P2|Overall Study|Still on trastuzumab monotherapy|1
989730|NCT00490646|3252123|P1|Overall Study|Still on trastuzumab monotherapy|1
989731|NCT00490568|3252143|P1|Overall Study|Participant withdrawal due to surgery|1
989732|NCT00490568|3252143|P1|Overall Study|Participant died|1
989733|NCT00490568|3252143|P1|Overall Study|Efficacy related|3
989734|NCT00490568|3252143|P1|Overall Study|Non-Compliance|7
989735|NCT00490568|3252143|P1|Overall Study|Investigator decision|3
989736|NCT00490568|3252143|P1|Overall Study|Unmet inclusion-exclusion criteria|5
989737|NCT00490568|3252143|P1|Overall Study|Disease progression|4
989738|NCT00490568|3252143|P1|Overall Study|Legal representative withdrew consent|1
989739|NCT00490568|3252143|P1|Overall Study|Participant refused follow-up|9
989740|NCT00490568|3252143|P1|Overall Study|Abnormal ECG|25
989741|NCT00490568|3252143|P1|Overall Study|Caregiver related|20
989742|NCT00490568|3252143|P1|Overall Study|Exclusion criteria met|1
989743|NCT00490568|3252143|P1|Overall Study|Other|1
989744|NCT00490568|3252143|P1|Overall Study|Still in the study at termination|974
989745|NCT00490568|3252143|P1|Overall Study|Withdrawal by Subject|135
989746|NCT00490568|3252143|P1|Overall Study|Protocol Violation|45
989747|NCT00490568|3252143|P1|Overall Study|Lost to Follow-up|13
989748|NCT00490568|3252143|P1|Overall Study|Adverse Event|116
989749|NCT00490555|3252167|P4|Overall Study|noncompliant with drug administration|0
989750|NCT00490555|3252168|P3|Overall Study|noncompliant with drug administration|2
989751|NCT00490555|3252169|P2|Overall Study|noncompliant with drug administration|0
989752|NCT00490555|3252170|P1|Overall Study|noncompliant with drug administration|0
989753|NCT00490542|3252198|P2|Overall Study|Lack of Efficacy|1
989754|NCT00490542|3252199|P1|Overall Study|Lack of Efficacy|1
989755|NCT00490542|3252198|P2|Overall Study|Adverse Event|3
989756|NCT00490542|3252199|P1|Overall Study|Adverse Event|3
989757|NCT00490542|3252198|P2|Overall Study|Lost to Follow-up|0
989758|NCT00490542|3252199|P1|Overall Study|Lost to Follow-up|3
989759|NCT00490490|3252205|P1|Completed Assessment for TTP|Lost to Follow-up|2
989760|NCT00490490|3252205|P1|Completed Assessment for TTP|Withdrawal by Subject|1
989761|NCT00490451|3252222|P2|Overall Study|Progressive Disease|34
989762|NCT00490451|3252223|P1|Overall Study|Progressive Disease|53
989763|NCT00490451|3252222|P2|Overall Study|Protocol Violation|0
989764|NCT00490451|3252223|P1|Overall Study|Protocol Violation|1
989765|NCT00490451|3252222|P2|Overall Study|Investigator Decision|0
989766|NCT00490451|3252223|P1|Overall Study|Investigator Decision|1
989767|NCT00490451|3252222|P2|Overall Study|Withdrawal by Subject|0
989768|NCT00490451|3252223|P1|Overall Study|Withdrawal by Subject|2
989769|NCT00490451|3252222|P2|Overall Study|Death|1
989770|NCT00490451|3252223|P1|Overall Study|Death|3
989771|NCT00490451|3252222|P2|Overall Study|Adverse Event|3
989772|NCT00490451|3252223|P1|Overall Study|Adverse Event|3
989773|NCT00490139|3252265|P4|Overall Study|Participant Withdrew Consent|116
989774|NCT00490139|3252266|P3|Overall Study|Participant Withdrew Consent|208
989775|NCT00490139|3252267|P2|Overall Study|Participant Withdrew Consent|110
989776|NCT00490139|3252268|P1|Overall Study|Participant Withdrew Consent|146
989777|NCT00490139|3252265|P4|Overall Study|Lost to Follow-up|56
989778|NCT00490139|3252266|P3|Overall Study|Lost to Follow-up|58
989779|NCT00490139|3252267|P2|Overall Study|Lost to Follow-up|46
989780|NCT00490139|3252268|P1|Overall Study|Lost to Follow-up|56
989781|NCT00490139|3252265|P4|Overall Study|Death|135
989782|NCT00490139|3252266|P3|Overall Study|Death|168
989783|NCT00490139|3252267|P2|Overall Study|Death|119
989784|NCT00490139|3252268|P1|Overall Study|Death|106
989785|NCT00490061|3252303|P1|Overall Study|Physician Decision|1
989786|NCT00490035|3252312|P4|Overall Study|AE of unknown type|0
989787|NCT00490035|3252313|P3|Overall Study|AE of unknown type|2
989788|NCT00490035|3252314|P2|Overall Study|AE of unknown type|0
989789|NCT00490035|3252315|P1|Overall Study|AE of unknown type|0
989790|NCT00490035|3252312|P4|Overall Study|Serious adverse event (SAE), non-fatal|0
989791|NCT00490035|3252313|P3|Overall Study|Serious adverse event (SAE), non-fatal|1
989792|NCT00490035|3252314|P2|Overall Study|Serious adverse event (SAE), non-fatal|0
989793|NCT00490035|3252315|P1|Overall Study|Serious adverse event (SAE), non-fatal|0
989794|NCT00490035|3252312|P4|Overall Study|AE, serious fatal|0
989795|NCT00490035|3252313|P3|Overall Study|AE, serious fatal|0
989796|NCT00490035|3252314|P2|Overall Study|AE, serious fatal|0
989797|NCT00490035|3252315|P1|Overall Study|AE, serious fatal|1
989798|NCT00490035|3252312|P4|Overall Study|Other reason|1
989799|NCT00490035|3252313|P3|Overall Study|Other reason|3
989800|NCT00490035|3252314|P2|Overall Study|Other reason|1
989801|NCT00490035|3252315|P1|Overall Study|Other reason|0
989802|NCT00490035|3252312|P4|Overall Study|Withdrawal by Subject|0
989803|NCT00490035|3252313|P3|Overall Study|Withdrawal by Subject|1
989804|NCT00490035|3252314|P2|Overall Study|Withdrawal by Subject|1
989805|NCT00490035|3252315|P1|Overall Study|Withdrawal by Subject|2
989806|NCT00490035|3252312|P4|Overall Study|Lost to Follow-up|0
989807|NCT00490035|3252313|P3|Overall Study|Lost to Follow-up|1
989808|NCT00490035|3252314|P2|Overall Study|Lost to Follow-up|0
989809|NCT00490035|3252315|P1|Overall Study|Lost to Follow-up|2
989810|NCT00490035|3252312|P4|Overall Study|AE, non-serious non-fatal|5
989811|NCT00490035|3252313|P3|Overall Study|AE, non-serious non-fatal|4
989812|NCT00490035|3252314|P2|Overall Study|AE, non-serious non-fatal|4
989813|NCT00490035|3252315|P1|Overall Study|AE, non-serious non-fatal|3
989814|NCT00490022|3252415|P2|Overall Study|Subject failed to disclose concommitant|1
989815|NCT00490022|3252416|P1|Overall Study|Subject failed to disclose concommitant|0
989816|NCT00490022|3252415|P2|Overall Study|Withdrawal by Subject|0
989817|NCT00490022|3252416|P1|Overall Study|Withdrawal by Subject|1
989818|NCT00490022|3252415|P2|Overall Study|Adverse Event|2
989819|NCT00490022|3252416|P1|Overall Study|Adverse Event|0
989820|NCT00489918|3252462|P5|Overall Study|Physician Decision|0
989821|NCT00489918|3252463|P4|Overall Study|Physician Decision|0
989822|NCT00489918|3252464|P3|Overall Study|Physician Decision|1
989823|NCT00489918|3252465|P2|Overall Study|Physician Decision|0
989824|NCT00489918|3252466|P1|Overall Study|Physician Decision|0
989825|NCT00489918|3252462|P5|Overall Study|Lost to Follow-up|0
989826|NCT00489918|3252463|P4|Overall Study|Lost to Follow-up|1
989827|NCT00489918|3252464|P3|Overall Study|Lost to Follow-up|1
989828|NCT00489918|3252465|P2|Overall Study|Lost to Follow-up|0
989829|NCT00489918|3252466|P1|Overall Study|Lost to Follow-up|0
989830|NCT00489918|3252462|P5|Overall Study|Adverse Event|0
989831|NCT00489918|3252463|P4|Overall Study|Adverse Event|0
989832|NCT00489918|3252464|P3|Overall Study|Adverse Event|1
989833|NCT00489918|3252465|P2|Overall Study|Adverse Event|1
989834|NCT00489918|3252466|P1|Overall Study|Adverse Event|0
989835|NCT00489918|3252462|P5|Overall Study|Withdrawal by Subject|1
989836|NCT00489918|3252463|P4|Overall Study|Withdrawal by Subject|0
989837|NCT00489918|3252464|P3|Overall Study|Withdrawal by Subject|1
989838|NCT00489918|3252465|P2|Overall Study|Withdrawal by Subject|1
989839|NCT00489918|3252466|P1|Overall Study|Withdrawal by Subject|2
989840|NCT00489853|3252515|P3|Treatment Period 3|Study specific discontinuation criteria|0
989841|NCT00489853|3252516|P2|Treatment Period 3|Study specific discontinuation criteria|1
989842|NCT00489853|3252517|P1|Treatment Period 3|Study specific discontinuation criteria|0
989843|NCT00489853|3252515|P3|Wash-out Period 2|Study specific discontinuation criteria|2
989844|NCT00489853|3252516|P2|Wash-out Period 2|Study specific discontinuation criteria|2
989845|NCT00489853|3252517|P1|Wash-out Period 2|Study specific discontinuation criteria|3
989846|NCT00489853|3252515|P3|Wash-out Period 2|Adverse Event|0
989847|NCT00489853|3252516|P2|Wash-out Period 2|Adverse Event|1
989848|NCT00489853|3252517|P1|Wash-out Period 2|Adverse Event|1
989849|NCT00489853|3252515|P3|Wash-out Period 1|Study-specific discontinuation criteria|4
989850|NCT00489853|3252516|P2|Wash-out Period 1|Study-specific discontinuation criteria|1
989851|NCT00489853|3252517|P1|Wash-out Period 1|Study-specific discontinuation criteria|0
989852|NCT00489853|3252515|P3|Wash-out Period 1|Protocol Violation|1
989853|NCT00489853|3252516|P2|Wash-out Period 1|Protocol Violation|1
989854|NCT00489853|3252517|P1|Wash-out Period 1|Protocol Violation|0
989855|NCT00489853|3252515|P3|Wash-out Period 1|Adverse Event|1
989856|NCT00489853|3252516|P2|Wash-out Period 1|Adverse Event|1
989857|NCT00489853|3252517|P1|Wash-out Period 1|Adverse Event|0
989858|NCT00489853|3252515|P3|Wash-out Period 1|Withdrawal by Subject|0
989859|NCT00489853|3252516|P2|Wash-out Period 1|Withdrawal by Subject|0
989860|NCT00489853|3252517|P1|Wash-out Period 1|Withdrawal by Subject|1
989861|NCT00489736|3252614|P2|Overall Study|Not coded/ Not pre-specified|8
989862|NCT00489736|3252615|P1|Overall Study|Not coded/ Not pre-specified|5
989863|NCT00489736|3252614|P2|Overall Study|Poor compliance|2
989864|NCT00489736|3252615|P1|Overall Study|Poor compliance|6
989865|NCT00489736|3252614|P2|Overall Study|Adverse Event|45
989866|NCT00489736|3252615|P1|Overall Study|Adverse Event|32
989867|NCT00489736|3252614|P2|Overall Study|Lack of Efficacy|14
989868|NCT00489736|3252615|P1|Overall Study|Lack of Efficacy|53
989869|NCT00489554|3252625|P1|Overall Study|Lost to Follow-up|1
989870|NCT00489554|3252625|P1|Overall Study|Withdrawal by Subject|1
989871|NCT00489554|3252625|P1|Overall Study|Adverse Event|2
989872|NCT00489541|3252645|P2|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5
989873|NCT00489541|3252646|P1|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4
989874|NCT00489541|3252645|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12
989875|NCT00489541|3252646|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23
989876|NCT00489541|3252645|P2|12-Month Clinical Follow-up|Death|2
989877|NCT00489541|3252646|P1|12-Month Clinical Follow-up|Death|3
989878|NCT00489541|3252645|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|0
989879|NCT00489541|3252646|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|2
989880|NCT00489541|3252645|P2|12-Month Clinical Follow-up|Lost to Follow-up|0
989881|NCT00489541|3252646|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
989882|NCT00489541|3252645|P2|12-Month Clinical Follow-up|Withdrawal by Subject|3
989883|NCT00489541|3252646|P1|12-Month Clinical Follow-up|Withdrawal by Subject|2
989884|NCT00489489|3252657|P3|Overall Study|Other than above|0
989885|NCT00489489|3252658|P2|Overall Study|Other than above|1
989886|NCT00489489|3252659|P1|Overall Study|Other than above|0
989887|NCT00489489|3252657|P3|Overall Study|Participant did not wish to continue|0
989888|NCT00489489|3252658|P2|Overall Study|Participant did not wish to continue|1
989889|NCT00489489|3252659|P1|Overall Study|Participant did not wish to continue|1
989890|NCT00489489|3252657|P3|Overall Study|Progressive disease|0
989891|NCT00489489|3252658|P2|Overall Study|Progressive disease|1
989892|NCT00489489|3252659|P1|Overall Study|Progressive disease|0
989893|NCT00489489|3252657|P3|Overall Study|Protocol Violation|1
989894|NCT00489489|3252658|P2|Overall Study|Protocol Violation|0
989895|NCT00489489|3252659|P1|Overall Study|Protocol Violation|1
989896|NCT00489489|3252657|P3|Overall Study|Adverse Event|1
989897|NCT00489489|3252658|P2|Overall Study|Adverse Event|1
989898|NCT00489489|3252659|P1|Overall Study|Adverse Event|1
989899|NCT00489489|3252657|P3|Overall Study|Not treated due to protocol violation|1
989900|NCT00489489|3252658|P2|Overall Study|Not treated due to protocol violation|1
989901|NCT00489489|3252659|P1|Overall Study|Not treated due to protocol violation|0
989902|NCT00489476|3252691|P4|Overall Study|Lost to Follow-up|0
989903|NCT00489476|3252692|P3|Overall Study|Lost to Follow-up|0
989904|NCT00489476|3252693|P2|Overall Study|Lost to Follow-up|1
989905|NCT00489476|3252694|P1|Overall Study|Lost to Follow-up|0
989906|NCT00489424|3252715|P3|Overall Study|Administrative problems|1
989907|NCT00489424|3252716|P2|Overall Study|Administrative problems|2
989908|NCT00489424|3252717|P1|Overall Study|Administrative problems|0
989909|NCT00489424|3252715|P3|Overall Study|Lack of Efficacy|0
989910|NCT00489424|3252716|P2|Overall Study|Lack of Efficacy|0
989911|NCT00489424|3252717|P1|Overall Study|Lack of Efficacy|1
989912|NCT00489424|3252715|P3|Overall Study|Adverse Event|4
989913|NCT00489424|3252716|P2|Overall Study|Adverse Event|3
989914|NCT00489424|3252717|P1|Overall Study|Adverse Event|3
989915|NCT00489411|3252748|P2|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
989916|NCT00489411|3252749|P1|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
989917|NCT00489411|3252748|P2|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12
989918|NCT00489411|3252749|P1|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11
989919|NCT00489411|3252748|P2|Initial Treatment Period (Weeks 1-5)|Incomplete data|5
989920|NCT00489411|3252749|P1|Initial Treatment Period (Weeks 1-5)|Incomplete data|1
989921|NCT00489411|3252748|P2|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12
989922|NCT00489411|3252749|P1|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21
989923|NCT00489411|3252748|P2|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5
989924|NCT00489411|3252749|P1|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6
989925|NCT00489359|3252763|P2|Overall Study|Adverse Event|16
989926|NCT00489359|3252764|P1|Overall Study|Adverse Event|0
989927|NCT00489359|3252763|P2|Overall Study|Withdrawal by Subject|5
989928|NCT00489359|3252764|P1|Overall Study|Withdrawal by Subject|1
989929|NCT00489359|3252763|P2|Overall Study|Lost to Follow-up|0
989930|NCT00489359|3252764|P1|Overall Study|Lost to Follow-up|1
989931|NCT00489359|3252763|P2|Overall Study|Progressive Disease|6
989932|NCT00489359|3252764|P1|Overall Study|Progressive Disease|5
989933|NCT00489359|3252763|P2|Overall Study|Death|2
989934|NCT00489359|3252764|P1|Overall Study|Death|0
989935|NCT00489255|3252825|P2|Period 3: Days 57 to 84|Lost to Follow-up|1
989936|NCT00489255|3252826|P1|Period 3: Days 57 to 84|Lost to Follow-up|0
989937|NCT00489255|3252825|P2|Period 3: Days 57 to 84|Withdrawal by Subject|0
989938|NCT00489255|3252826|P1|Period 3: Days 57 to 84|Withdrawal by Subject|1
989939|NCT00489255|3252825|P2|Period 3: Days 57 to 84|Adverse Event|3
989940|NCT00489255|3252826|P1|Period 3: Days 57 to 84|Adverse Event|3
989941|NCT00489255|3252825|P2|Period 2: Days 29 to 56|Withdrawal by Subject|3
989942|NCT00489255|3252826|P1|Period 2: Days 29 to 56|Withdrawal by Subject|0
989943|NCT00489255|3252825|P2|Period 2: Days 29 to 56|Adverse Event|1
989944|NCT00489255|3252826|P1|Period 2: Days 29 to 56|Adverse Event|3
989945|NCT00489255|3252825|P2|Period 1: Days 1 to 28|Noncompliance|0
989946|NCT00489255|3252826|P1|Period 1: Days 1 to 28|Noncompliance|2
989947|NCT00489255|3252825|P2|Period 1: Days 1 to 28|Physician Decision|4
989948|NCT00489255|3252826|P1|Period 1: Days 1 to 28|Physician Decision|1
989949|NCT00489255|3252825|P2|Period 1: Days 1 to 28|Withdrawal by Subject|0
989950|NCT00489255|3252826|P1|Period 1: Days 1 to 28|Withdrawal by Subject|5
989951|NCT00489255|3252825|P2|Period 1: Days 1 to 28|Adverse Event|8
989952|NCT00489255|3252826|P1|Period 1: Days 1 to 28|Adverse Event|21
989953|NCT00489255|3252825|P2|Screening and Initial Randomization|Discontinued prior to taking study drug|3
989954|NCT00489255|3252826|P1|Screening and Initial Randomization|Discontinued prior to taking study drug|9
989955|NCT00489216|3252874|P1|Overall Study|Adverse Event|1
989956|NCT00488826|3252896|P3|Overall Study|Protocol Deviations|1
989957|NCT00488826|3252897|P2|Overall Study|Protocol Deviations|1
989958|NCT00488826|3252898|P1|Overall Study|Protocol Deviations|2
989959|NCT00488826|3252896|P3|Overall Study|Lost to Follow-up|0
989960|NCT00488826|3252897|P2|Overall Study|Lost to Follow-up|1
989961|NCT00488826|3252898|P1|Overall Study|Lost to Follow-up|5
989962|NCT00488826|3252896|P3|Overall Study|Adverse Event|4
989963|NCT00488826|3252897|P2|Overall Study|Adverse Event|15
989964|NCT00488826|3252898|P1|Overall Study|Adverse Event|9
989965|NCT00488826|3252896|P3|Overall Study|Protocol Violation|2
989966|NCT00488826|3252897|P2|Overall Study|Protocol Violation|0
989967|NCT00488826|3252898|P1|Overall Study|Protocol Violation|0
989968|NCT00488826|3252896|P3|Overall Study|Withdrawal by Subject|19
989969|NCT00488826|3252897|P2|Overall Study|Withdrawal by Subject|35
989970|NCT00488826|3252898|P1|Overall Study|Withdrawal by Subject|40
989971|NCT00488774|3252913|P4|Overall Study|Lost to Follow-up|1
989972|NCT00488774|3252914|P3|Overall Study|Lost to Follow-up|1
989973|NCT00488774|3252915|P2|Overall Study|Lost to Follow-up|0
989974|NCT00488774|3252916|P1|Overall Study|Lost to Follow-up|0
989975|NCT00488774|3252913|P4|Overall Study|Other|2
989976|NCT00488774|3252914|P3|Overall Study|Other|2
989977|NCT00488774|3252915|P2|Overall Study|Other|3
989978|NCT00488774|3252916|P1|Overall Study|Other|6
989979|NCT00488774|3252913|P4|Overall Study|Withdrawal of consent|0
989980|NCT00488774|3252914|P3|Overall Study|Withdrawal of consent|2
989981|NCT00488774|3252915|P2|Overall Study|Withdrawal of consent|2
989982|NCT00488774|3252916|P1|Overall Study|Withdrawal of consent|2
989983|NCT00488683|3252933|P3|Overall Study|Unable to Classify|0
989984|NCT00488683|3252934|P2|Overall Study|Unable to Classify|0
989985|NCT00488683|3252935|P1|Overall Study|Unable to Classify|1
989986|NCT00488683|3252933|P3|Overall Study|Protocol Violation|0
989987|NCT00488683|3252934|P2|Overall Study|Protocol Violation|1
989988|NCT00488683|3252935|P1|Overall Study|Protocol Violation|5
989989|NCT00488683|3252933|P3|Overall Study|Lost to Follow-up|0
989990|NCT00488683|3252934|P2|Overall Study|Lost to Follow-up|3
989991|NCT00488683|3252935|P1|Overall Study|Lost to Follow-up|5
989992|NCT00488683|3252933|P3|Overall Study|Withdrawal by Subject|2
989993|NCT00488683|3252934|P2|Overall Study|Withdrawal by Subject|2
989994|NCT00488683|3252935|P1|Overall Study|Withdrawal by Subject|1
989995|NCT00488644|3252994|P1|Overall Study|Not Evaluable|1
989996|NCT00488644|3252994|P1|Overall Study|Not Eligible|1
989997|NCT00488631|3253004|P10|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
989998|NCT00488631|3253005|P9|Open Label Study Extension (Week 54-228)|Unspecified reasons|87
989999|NCT00488631|3253006|P8|Open Label Study Extension (Week 54-228)|Unspecified reasons|14
990000|NCT00488631|3253007|P7|Open Label Study Extension (Week 54-228)|Unspecified reasons|63
990001|NCT00488631|3253008|P6|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
990002|NCT00488631|3253009|P5|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
990003|NCT00488631|3253010|P4|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
990004|NCT00488631|3253011|P3|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
990005|NCT00488631|3253012|P2|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
990006|NCT00488631|3253013|P1|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
990007|NCT00488631|3253004|P10|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
990008|NCT00488631|3253005|P9|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6
990009|NCT00488631|3253006|P8|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
990010|NCT00488631|3253007|P7|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2
990011|NCT00488631|3253008|P6|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
990012|NCT00488631|3253009|P5|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
990013|NCT00488631|3253010|P4|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
990014|NCT00488631|3253011|P3|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
990015|NCT00488631|3253012|P2|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
990016|NCT00488631|3253013|P1|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
990017|NCT00488631|3253004|P10|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3
990018|NCT00488631|3253005|P9|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34
990019|NCT00488631|3253006|P8|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
990020|NCT00488631|3253007|P7|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
990021|NCT00488631|3253008|P6|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
990022|NCT00488631|3253009|P5|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
990023|NCT00488631|3253010|P4|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
990024|NCT00488631|3253011|P3|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
990025|NCT00488631|3253012|P2|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
990026|NCT00488631|3253013|P1|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
990027|NCT00488631|3253004|P10|Open Label Study Extension (Week 54-228)|Death|0
990028|NCT00488631|3253005|P9|Open Label Study Extension (Week 54-228)|Death|1
990029|NCT00488631|3253006|P8|Open Label Study Extension (Week 54-228)|Death|0
990030|NCT00488631|3253007|P7|Open Label Study Extension (Week 54-228)|Death|0
990031|NCT00488631|3253008|P6|Open Label Study Extension (Week 54-228)|Death|0
990032|NCT00488631|3253009|P5|Open Label Study Extension (Week 54-228)|Death|0
990033|NCT00488631|3253010|P4|Open Label Study Extension (Week 54-228)|Death|0
990034|NCT00488631|3253011|P3|Open Label Study Extension (Week 54-228)|Death|0
990035|NCT00488631|3253012|P2|Open Label Study Extension (Week 54-228)|Death|0
990036|NCT00488631|3253013|P1|Open Label Study Extension (Week 54-228)|Death|0
990037|NCT00488631|3253004|P10|Open Label Study Extension (Week 54-228)|Adverse Event|0
990038|NCT00488631|3253005|P9|Open Label Study Extension (Week 54-228)|Adverse Event|54
990039|NCT00488631|3253006|P8|Open Label Study Extension (Week 54-228)|Adverse Event|8
990040|NCT00488631|3253007|P7|Open Label Study Extension (Week 54-228)|Adverse Event|10
990041|NCT00488631|3253008|P6|Open Label Study Extension (Week 54-228)|Adverse Event|0
990042|NCT00488631|3253009|P5|Open Label Study Extension (Week 54-228)|Adverse Event|0
990043|NCT00488631|3253010|P4|Open Label Study Extension (Week 54-228)|Adverse Event|0
990044|NCT00488631|3253011|P3|Open Label Study Extension (Week 54-228)|Adverse Event|0
990045|NCT00488631|3253012|P2|Open Label Study Extension (Week 54-228)|Adverse Event|0
990046|NCT00488631|3253013|P1|Open Label Study Extension (Week 54-228)|Adverse Event|0
990047|NCT00488631|3253004|P10|Double Blind Period (Week 0-54)|Other|0
990048|NCT00488631|3253005|P9|Double Blind Period (Week 0-54)|Other|0
990049|NCT00488631|3253006|P8|Double Blind Period (Week 0-54)|Other|0
990050|NCT00488631|3253007|P7|Double Blind Period (Week 0-54)|Other|0
990051|NCT00488631|3253008|P6|Double Blind Period (Week 0-54)|Other|34
990052|NCT00488631|3253009|P5|Double Blind Period (Week 0-54)|Other|14
990053|NCT00488631|3253010|P4|Double Blind Period (Week 0-54)|Other|11
990054|NCT00488631|3253011|P3|Double Blind Period (Week 0-54)|Other|10
990055|NCT00488631|3253012|P2|Double Blind Period (Week 0-54)|Other|12
990056|NCT00488631|3253013|P1|Double Blind Period (Week 0-54)|Other|6
990057|NCT00488631|3253004|P10|Double Blind Period (Week 0-54)|Lost to Follow-up|0
990058|NCT00488631|3253005|P9|Double Blind Period (Week 0-54)|Lost to Follow-up|0
990059|NCT00488631|3253006|P8|Double Blind Period (Week 0-54)|Lost to Follow-up|0
990060|NCT00488631|3253007|P7|Double Blind Period (Week 0-54)|Lost to Follow-up|0
990061|NCT00488631|3253008|P6|Double Blind Period (Week 0-54)|Lost to Follow-up|7
990062|NCT00488631|3253009|P5|Double Blind Period (Week 0-54)|Lost to Follow-up|3
990063|NCT00488631|3253010|P4|Double Blind Period (Week 0-54)|Lost to Follow-up|0
990064|NCT00488631|3253011|P3|Double Blind Period (Week 0-54)|Lost to Follow-up|1
990065|NCT00488631|3253012|P2|Double Blind Period (Week 0-54)|Lost to Follow-up|2
990066|NCT00488631|3253013|P1|Double Blind Period (Week 0-54)|Lost to Follow-up|1
990067|NCT00488631|3253004|P10|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
990068|NCT00488631|3253005|P9|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
990069|NCT00488631|3253006|P8|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
990070|NCT00488631|3253007|P7|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
990071|NCT00488631|3253008|P6|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124
990072|NCT00488631|3253009|P5|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56
990073|NCT00488631|3253010|P4|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18
990074|NCT00488631|3253011|P3|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22
990075|NCT00488631|3253012|P2|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17
990076|NCT00488631|3253013|P1|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19
990077|NCT00488631|3253004|P10|Double Blind Period (Week 0-54)|Death|0
990078|NCT00488631|3253005|P9|Double Blind Period (Week 0-54)|Death|0
990079|NCT00488631|3253006|P8|Double Blind Period (Week 0-54)|Death|0
990080|NCT00488631|3253007|P7|Double Blind Period (Week 0-54)|Death|0
990081|NCT00488631|3253008|P6|Double Blind Period (Week 0-54)|Death|1
990082|NCT00488631|3253009|P5|Double Blind Period (Week 0-54)|Death|0
990083|NCT00488631|3253010|P4|Double Blind Period (Week 0-54)|Death|0
990084|NCT00488631|3253011|P3|Double Blind Period (Week 0-54)|Death|0
990085|NCT00488631|3253012|P2|Double Blind Period (Week 0-54)|Death|0
990086|NCT00488631|3253013|P1|Double Blind Period (Week 0-54)|Death|0
990087|NCT00488631|3253004|P10|Double Blind Period (Week 0-54)|Adverse Event|0
990088|NCT00488631|3253005|P9|Double Blind Period (Week 0-54)|Adverse Event|0
990089|NCT00488631|3253006|P8|Double Blind Period (Week 0-54)|Adverse Event|0
990090|NCT00488631|3253007|P7|Double Blind Period (Week 0-54)|Adverse Event|0
990091|NCT00488631|3253008|P6|Double Blind Period (Week 0-54)|Adverse Event|50
990092|NCT00488631|3253009|P5|Double Blind Period (Week 0-54)|Adverse Event|30
990093|NCT00488631|3253010|P4|Double Blind Period (Week 0-54)|Adverse Event|12
990094|NCT00488631|3253011|P3|Double Blind Period (Week 0-54)|Adverse Event|12
990095|NCT00488631|3253012|P2|Double Blind Period (Week 0-54)|Adverse Event|12
990096|NCT00488631|3253013|P1|Double Blind Period (Week 0-54)|Adverse Event|17
990097|NCT00488618|3253050|P2|Overall Study|Lost to Follow-up|0
990098|NCT00488618|3253051|P1|Overall Study|Lost to Follow-up|1
990099|NCT00488618|3253050|P2|Overall Study|Withdrawal of Consent|13
990100|NCT00488618|3253051|P1|Overall Study|Withdrawal of Consent|15
990101|NCT00488618|3253050|P2|Overall Study|Protocol Violation|2
990102|NCT00488618|3253051|P1|Overall Study|Protocol Violation|0
990103|NCT00488618|3253050|P2|Overall Study|Insufficient Therapeutic Response|11
990104|NCT00488618|3253051|P1|Overall Study|Insufficient Therapeutic Response|18
990105|NCT00488618|3253050|P2|Overall Study|Adverse Event|17
990106|NCT00488618|3253051|P1|Overall Study|Adverse Event|13
990107|NCT00488592|3253059|P1|Overall Study|Enrolled but not treated|1
990108|NCT00488592|3253059|P1|Overall Study|Disease progression|1
990109|NCT00488592|3253059|P1|Overall Study|Withdrawal by Subject|1
990110|NCT00488514|3253063|P1|Overall Study|Increased use of concomitant medication|1
990111|NCT00488514|3253063|P1|Overall Study|Increase in number of migraines|2
990112|NCT00488514|3253063|P1|Overall Study|Participant had too few migraines|5
990113|NCT00488514|3253063|P1|Overall Study|Investigator decision|1
990114|NCT00488514|3253063|P1|Overall Study|Withdrawn per medical monitor decision|2
990115|NCT00488514|3253063|P1|Overall Study|Postive drug screen|1
990116|NCT00488514|3253063|P1|Overall Study|Did not meet criteria for treatment|30
990117|NCT00488514|3253063|P1|Overall Study|Lack of Efficacy|28
990118|NCT00488514|3253063|P1|Overall Study|Withdrawal by Subject|106
990119|NCT00488514|3253063|P1|Overall Study|Protocol Violation|32
990120|NCT00488514|3253063|P1|Overall Study|Lost to Follow-up|44
990121|NCT00488514|3253063|P1|Overall Study|Adverse Event|41
990122|NCT00488475|3253151|P1|Overall Study|Other|1754
990123|NCT00488345|3253180|P3|Overall Study|Parent/legal guardian request|1
990124|NCT00488345|3253181|P2|Overall Study|Parent/legal guardian request|1
990125|NCT00488345|3253182|P1|Overall Study|Parent/legal guardian request|0
990126|NCT00488345|3253180|P3|Overall Study|Surgical team recommendation|0
990127|NCT00488345|3253181|P2|Overall Study|Surgical team recommendation|1
990128|NCT00488345|3253182|P1|Overall Study|Surgical team recommendation|0
990129|NCT00488345|3253180|P3|Overall Study|Institutional Review Board review|1
990130|NCT00488345|3253181|P2|Overall Study|Institutional Review Board review|0
990131|NCT00488345|3253182|P1|Overall Study|Institutional Review Board review|0
990132|NCT00488345|3253180|P3|Overall Study|Unable to administer antibiotics at home|0
990133|NCT00488345|3253181|P2|Overall Study|Unable to administer antibiotics at home|1
990134|NCT00488345|3253182|P1|Overall Study|Unable to administer antibiotics at home|0
990135|NCT00488345|3253180|P3|Overall Study|Adverse Event|1
990136|NCT00488345|3253181|P2|Overall Study|Adverse Event|1
990137|NCT00488345|3253182|P1|Overall Study|Adverse Event|0
990138|NCT00488319|3253208|P3|Overall Study|Other reasons for withdrawal|12
990139|NCT00488319|3253209|P2|Overall Study|Other reasons for withdrawal|4
990140|NCT00488319|3253210|P1|Overall Study|Other reasons for withdrawal|0
990141|NCT00488319|3253208|P3|Overall Study|Withdrawal by Subject|44
990142|NCT00488319|3253209|P2|Overall Study|Withdrawal by Subject|20
990143|NCT00488319|3253210|P1|Overall Study|Withdrawal by Subject|5
990144|NCT00488319|3253208|P3|Overall Study|Lost to Follow-up|16
990145|NCT00488319|3253209|P2|Overall Study|Lost to Follow-up|5
990146|NCT00488319|3253210|P1|Overall Study|Lost to Follow-up|3
990147|NCT00488319|3253208|P3|Overall Study|Lack of Efficacy|27
990148|NCT00488319|3253209|P2|Overall Study|Lack of Efficacy|12
990149|NCT00488319|3253210|P1|Overall Study|Lack of Efficacy|6
990150|NCT00488319|3253208|P3|Overall Study|Adverse Event|23
990151|NCT00488319|3253209|P2|Overall Study|Adverse Event|2
990152|NCT00488319|3253210|P1|Overall Study|Adverse Event|1
990153|NCT00488293|3253297|P2|Overall Study|Misrandomization/Other Unspecified|1
990154|NCT00488293|3253298|P1|Overall Study|Misrandomization/Other Unspecified|1
990155|NCT00488293|3253297|P2|Overall Study|Death|1
990156|NCT00488293|3253298|P1|Overall Study|Death|2
990157|NCT00488293|3253297|P2|Overall Study|Withdrawal by Subject|3
990158|NCT00488293|3253298|P1|Overall Study|Withdrawal by Subject|5
990159|NCT00488293|3253297|P2|Overall Study|Lost to Follow-up|25
990160|NCT00488293|3253298|P1|Overall Study|Lost to Follow-up|28
990161|NCT00488033|3253343|P2|Overall Study|Withdrawal by Subject|0
990162|NCT00488033|3253344|P1|Overall Study|Withdrawal by Subject|1
990163|NCT00487981|3253360|P1|Overall Study|Hypothyroidism diagnosis|1
990164|NCT00487942|3253368|P4|Overall Study|Withdrawal by Subject|0
990165|NCT00487942|3253369|P3|Overall Study|Withdrawal by Subject|2
990166|NCT00487942|3253370|P2|Overall Study|Withdrawal by Subject|1
990167|NCT00487942|3253371|P1|Overall Study|Withdrawal by Subject|0
990168|NCT00487942|3253368|P4|Overall Study|Protocol Violation|0
990169|NCT00487942|3253369|P3|Overall Study|Protocol Violation|0
990170|NCT00487942|3253370|P2|Overall Study|Protocol Violation|1
990171|NCT00487942|3253371|P1|Overall Study|Protocol Violation|1
990172|NCT00487942|3253368|P4|Overall Study|Lost to Follow-up|1
990173|NCT00487942|3253369|P3|Overall Study|Lost to Follow-up|0
990174|NCT00487942|3253370|P2|Overall Study|Lost to Follow-up|0
990175|NCT00487942|3253371|P1|Overall Study|Lost to Follow-up|1
990176|NCT00487942|3253368|P4|Overall Study|Adverse Event|1
990177|NCT00487942|3253369|P3|Overall Study|Adverse Event|1
990178|NCT00487942|3253370|P2|Overall Study|Adverse Event|1
990179|NCT00487942|3253371|P1|Overall Study|Adverse Event|1
990180|NCT00487825|3253755|P2|Overall Study|not specified|2
990181|NCT00487825|3253756|P1|Overall Study|not specified|3
990182|NCT00487825|3253755|P2|Overall Study|Lack of Efficacy|1
990183|NCT00487825|3253756|P1|Overall Study|Lack of Efficacy|1
990184|NCT00487825|3253755|P2|Overall Study|Adverse Event|2
990185|NCT00487825|3253756|P1|Overall Study|Adverse Event|2
990186|NCT00487747|3253768|P1|Overall Study|Lack of Efficacy|1
990187|NCT00487747|3253768|P1|Overall Study|Lost to Follow-up|9
990188|NCT00487747|3253768|P1|Overall Study|Adverse Event|1
990189|NCT00487695|3253785|P2|Second Procedure|Withdrawal by Subject|2
990190|NCT00487695|3253786|P1|Second Procedure|Withdrawal by Subject|1
990191|NCT00487695|3253785|P2|Second Procedure|active wheezing|1
990192|NCT00487695|3253786|P1|Second Procedure|active wheezing|0
990193|NCT00487695|3253785|P2|First Procedure|esophageal stricture found (excl crit)|0
990194|NCT00487695|3253786|P1|First Procedure|esophageal stricture found (excl crit)|1
990195|NCT00487695|3253785|P2|First Procedure|active wheezing (did not have procedure)|0
990196|NCT00487695|3253786|P1|First Procedure|active wheezing (did not have procedure)|1
990197|NCT00487695|3253785|P2|First Procedure|invasive cancer on EGD (excl criteria)|0
990198|NCT00487695|3253786|P1|First Procedure|invasive cancer on EGD (excl criteria)|1
990199|NCT00487578|3253814|P2|Overall Study|Lost to Follow-up|1
990200|NCT00487578|3253815|P1|Overall Study|Lost to Follow-up|0
990201|NCT00487578|3253814|P2|Overall Study|Lack of Efficacy|1
990202|NCT00487578|3253815|P1|Overall Study|Lack of Efficacy|0
990203|NCT00487578|3253814|P2|Overall Study|Adverse Event|2
990204|NCT00487578|3253815|P1|Overall Study|Adverse Event|1
990205|NCT00487552|3253835|P1|Overall Study|Stent not placed|1
990206|NCT00487552|3253835|P1|Overall Study|Death due to progressive malignancy|2
990207|NCT00487552|3253835|P1|Overall Study|Unsuccessful magnet placements|3
990208|NCT00487539|3253844|P4|Overall Study|Other|2
990209|NCT00487539|3253845|P3|Overall Study|Other|2
990210|NCT00487539|3253846|P2|Overall Study|Other|1
990211|NCT00487539|3253847|P1|Overall Study|Other|3
990212|NCT00487539|3253844|P4|Overall Study|Unsatisfactory therapeutic effect|1
990213|NCT00487539|3253845|P3|Overall Study|Unsatisfactory therapeutic effect|0
990214|NCT00487539|3253846|P2|Overall Study|Unsatisfactory therapeutic effect|0
990215|NCT00487539|3253847|P1|Overall Study|Unsatisfactory therapeutic effect|1
990216|NCT00487539|3253844|P4|Overall Study|Adverse Event|1
990217|NCT00487539|3253845|P3|Overall Study|Adverse Event|1
990218|NCT00487539|3253846|P2|Overall Study|Adverse Event|2
990219|NCT00487539|3253847|P1|Overall Study|Adverse Event|3
990220|NCT00487435|3253881|P1|Overall Study|Other|83
990221|NCT00487435|3253881|P1|Overall Study|Study Medication Non-Compliant|32
990222|NCT00487435|3253881|P1|Overall Study|Resolution Of Pain|1
990223|NCT00487435|3253881|P1|Overall Study|Withdrawal by Subject|132
990224|NCT00487435|3253881|P1|Overall Study|Pregnancy|2
990225|NCT00487435|3253881|P1|Overall Study|Lost to Follow-up|54
990226|NCT00487435|3253881|P1|Overall Study|Lack of Efficacy|33
990227|NCT00487435|3253881|P1|Overall Study|Death|2
990228|NCT00487435|3253881|P1|Overall Study|Adverse Event|146
990229|NCT00487279|3253894|P2|Overall Study|Withdrawal by Subject|2
990230|NCT00487279|3253895|P1|Overall Study|Withdrawal by Subject|0
990231|NCT00487279|3253894|P2|Overall Study|Death|0
990232|NCT00487279|3253895|P1|Overall Study|Death|1
990233|NCT00487240|3253905|P2|Overall Study|Physician Decision|0
990234|NCT00487240|3253906|P1|Overall Study|Physician Decision|2
990235|NCT00487240|3253905|P2|Overall Study|Sponsor Decision|1
990236|NCT00487240|3253906|P1|Overall Study|Sponsor Decision|2
990237|NCT00487240|3253905|P2|Overall Study|Entry Criteria Not Met|4
990238|NCT00487240|3253906|P1|Overall Study|Entry Criteria Not Met|3
990239|NCT00487240|3253905|P2|Overall Study|Protocol Violation|5
990240|NCT00487240|3253906|P1|Overall Study|Protocol Violation|5
990241|NCT00487240|3253905|P2|Overall Study|Adverse Event|4
990242|NCT00487240|3253906|P1|Overall Study|Adverse Event|0
990243|NCT00487240|3253905|P2|Overall Study|Lost to Follow-up|6
990244|NCT00487240|3253906|P1|Overall Study|Lost to Follow-up|7
990245|NCT00487240|3253905|P2|Overall Study|Withdrawal by Subject|6
990246|NCT00487240|3253906|P1|Overall Study|Withdrawal by Subject|12
990247|NCT00487188|3253934|P3|Maintenance Phase|Administrative|1
990248|NCT00487188|3253935|P2|Maintenance Phase|Administrative|0
990249|NCT00487188|3253936|P1|Maintenance Phase|Administrative|0
990250|NCT00487188|3253934|P3|Maintenance Phase|Lost to Follow-up|0
990251|NCT00487188|3253935|P2|Maintenance Phase|Lost to Follow-up|0
990252|NCT00487188|3253936|P1|Maintenance Phase|Lost to Follow-up|1
990253|NCT00487188|3253934|P3|Maintenance Phase|Death|0
990254|NCT00487188|3253935|P2|Maintenance Phase|Death|0
990255|NCT00487188|3253936|P1|Maintenance Phase|Death|1
990256|NCT00487188|3253934|P3|Maintenance Phase|Adverse Event|0
990257|NCT00487188|3253935|P2|Maintenance Phase|Adverse Event|0
990258|NCT00487188|3253936|P1|Maintenance Phase|Adverse Event|1
990259|NCT00487188|3253934|P3|Induction Phase|Administrative|0
990260|NCT00487188|3253935|P2|Induction Phase|Administrative|1
990261|NCT00487188|3253936|P1|Induction Phase|Administrative|0
990262|NCT00487188|3253934|P3|Induction Phase|Lost to Follow-up|0
990263|NCT00487188|3253935|P2|Induction Phase|Lost to Follow-up|2
990264|NCT00487188|3253936|P1|Induction Phase|Lost to Follow-up|2
990265|NCT00487188|3253934|P3|Induction Phase|Refused Treatment|0
990266|NCT00487188|3253935|P2|Induction Phase|Refused Treatment|2
990267|NCT00487188|3253936|P1|Induction Phase|Refused Treatment|1
990268|NCT00487188|3253934|P3|Induction Phase|Protocol Violation|0
990269|NCT00487188|3253935|P2|Induction Phase|Protocol Violation|0
990270|NCT00487188|3253936|P1|Induction Phase|Protocol Violation|1
990271|NCT00487188|3253934|P3|Induction Phase|Lack of Efficacy|0
990272|NCT00487188|3253935|P2|Induction Phase|Lack of Efficacy|1
990273|NCT00487188|3253936|P1|Induction Phase|Lack of Efficacy|0
990274|NCT00487188|3253934|P3|Induction Phase|Adverse Event|0
990275|NCT00487188|3253935|P2|Induction Phase|Adverse Event|0
990276|NCT00487188|3253936|P1|Induction Phase|Adverse Event|5
990277|NCT00487188|3253934|P3|Induction Phase|Abnormality of Laboratory Test|0
990278|NCT00487188|3253935|P2|Induction Phase|Abnormality of Laboratory Test|1
990279|NCT00487188|3253936|P1|Induction Phase|Abnormality of Laboratory Test|0
990280|NCT00487162|3253975|P2|Overall Study|Withdrawal by Subject|3
990281|NCT00487162|3253976|P1|Overall Study|Withdrawal by Subject|2
990282|NCT00487162|3253975|P2|Overall Study|Physician Decision|1
990283|NCT00487162|3253976|P1|Overall Study|Physician Decision|0
990284|NCT00487162|3253975|P2|Overall Study|Adverse Event|1
990285|NCT00487162|3253976|P1|Overall Study|Adverse Event|0
990286|NCT00487084|3253987|P3|Overall Study|Did not receive intervention|5
990287|NCT00487084|3253988|P2|Overall Study|Did not receive intervention|3
990288|NCT00487084|3253989|P1|Overall Study|Did not receive intervention|4
990289|NCT00486954|3254010|P5|Randomized Part|Sponsor Terminated Study|13
990290|NCT00486954|3254011|P4|Randomized Part|Sponsor Terminated Study|19
990291|NCT00486954|3254012|P3|Randomized Part|Sponsor Terminated Study|0
990292|NCT00486954|3254013|P2|Randomized Part|Sponsor Terminated Study|0
990293|NCT00486954|3254014|P1|Randomized Part|Sponsor Terminated Study|0
990294|NCT00486954|3254010|P5|Randomized Part|Withdrawal by Subject|0
990295|NCT00486954|3254011|P4|Randomized Part|Withdrawal by Subject|1
990296|NCT00486954|3254012|P3|Randomized Part|Withdrawal by Subject|0
990297|NCT00486954|3254013|P2|Randomized Part|Withdrawal by Subject|0
990298|NCT00486954|3254014|P1|Randomized Part|Withdrawal by Subject|0
990299|NCT00486954|3254010|P5|Randomized Part|Lost to Follow-up|1
990300|NCT00486954|3254011|P4|Randomized Part|Lost to Follow-up|0
990301|NCT00486954|3254012|P3|Randomized Part|Lost to Follow-up|0
990302|NCT00486954|3254013|P2|Randomized Part|Lost to Follow-up|0
990303|NCT00486954|3254014|P1|Randomized Part|Lost to Follow-up|0
990304|NCT00486954|3254010|P5|Pilot Part|Disease Progression|0
990305|NCT00486954|3254011|P4|Pilot Part|Disease Progression|0
990306|NCT00486954|3254012|P3|Pilot Part|Disease Progression|1
990307|NCT00486954|3254013|P2|Pilot Part|Disease Progression|0
990308|NCT00486954|3254014|P1|Pilot Part|Disease Progression|2
990309|NCT00486954|3254010|P5|Pilot Part|Adverse Event|0
990310|NCT00486954|3254011|P4|Pilot Part|Adverse Event|0
990311|NCT00486954|3254012|P3|Pilot Part|Adverse Event|5
990312|NCT00486954|3254013|P2|Pilot Part|Adverse Event|0
990313|NCT00486954|3254014|P1|Pilot Part|Adverse Event|4
990314|NCT00486902|3254112|P2|Overall Study|No toradol due to hemmorhage or allergy|1
990315|NCT00486902|3254113|P1|Overall Study|No toradol due to hemmorhage or allergy|3
990316|NCT00486902|3254112|P2|Overall Study|Did not meet inclusion criteria|0
990317|NCT00486902|3254113|P1|Overall Study|Did not meet inclusion criteria|1
990318|NCT00486902|3254112|P2|Overall Study|spinal anesthetic protocal violation|1
990319|NCT00486902|3254113|P1|Overall Study|spinal anesthetic protocal violation|1
990320|NCT00486902|3254112|P2|Overall Study|decision for postpartum tubal ligation|1
990321|NCT00486902|3254113|P1|Overall Study|decision for postpartum tubal ligation|3
990322|NCT00486902|3254112|P2|Overall Study|Withdrawal by Subject|2
990323|NCT00486902|3254113|P1|Overall Study|Withdrawal by Subject|1
990324|NCT00486837|3254180|P2|Overall Study|No sputum, devise issues, exacerbation|4
990325|NCT00486837|3254181|P1|Overall Study|No sputum, devise issues, exacerbation|3
990326|NCT00486837|3254180|P2|Overall Study|Protocol Violation|2
990327|NCT00486837|3254181|P1|Overall Study|Protocol Violation|4
990328|NCT00486837|3254180|P2|Overall Study|Adverse Event|1
990329|NCT00486837|3254181|P1|Overall Study|Adverse Event|1
990330|NCT00486837|3254180|P2|Overall Study|Withdrawal by Subject|0
990331|NCT00486837|3254181|P1|Overall Study|Withdrawal by Subject|1
990332|NCT00486811|3254221|P3|Overall Study|All other|7
990333|NCT00486811|3254222|P2|Overall Study|All other|11
990334|NCT00486811|3254223|P1|Overall Study|All other|18
990335|NCT00486811|3254221|P3|Overall Study|Study drug non-compliant|3
990336|NCT00486811|3254222|P2|Overall Study|Study drug non-compliant|6
990337|NCT00486811|3254223|P1|Overall Study|Study drug non-compliant|5
990338|NCT00486811|3254221|P3|Overall Study|Withdrawal by Subject|58
990339|NCT00486811|3254222|P2|Overall Study|Withdrawal by Subject|44
990340|NCT00486811|3254223|P1|Overall Study|Withdrawal by Subject|33
990341|NCT00486811|3254221|P3|Overall Study|Lost to Follow-up|4
990342|NCT00486811|3254222|P2|Overall Study|Lost to Follow-up|6
990343|NCT00486811|3254223|P1|Overall Study|Lost to Follow-up|4
990344|NCT00486811|3254221|P3|Overall Study|Lack of Efficacy|7
990345|NCT00486811|3254222|P2|Overall Study|Lack of Efficacy|14
990346|NCT00486811|3254223|P1|Overall Study|Lack of Efficacy|34
990347|NCT00486811|3254221|P3|Overall Study|Adverse Event|135
990348|NCT00486811|3254222|P2|Overall Study|Adverse Event|60
990349|NCT00486811|3254223|P1|Overall Study|Adverse Event|28
990350|NCT00486759|3254266|P2|Safety Follow-up|Adverse event/intercurrent illness|0
990351|NCT00486759|3254267|P1|Safety Follow-up|Adverse event/intercurrent illness|4
990352|NCT00486759|3254266|P2|Safety Follow-up|Refused treatment/did not cooperate|4
990353|NCT00486759|3254267|P1|Safety Follow-up|Refused treatment/did not cooperate|6
990354|NCT00486759|3254266|P2|Safety Follow-up|Administrative/not specified|6
990355|NCT00486759|3254267|P1|Safety Follow-up|Administrative/not specified|8
990356|NCT00486759|3254266|P2|Safety Follow-up|Failure to return|6
990357|NCT00486759|3254267|P1|Safety Follow-up|Failure to return|9
990358|NCT00486759|3254266|P2|Safety Follow-up|Withdrew consent|23
990359|NCT00486759|3254267|P1|Safety Follow-up|Withdrew consent|32
990360|NCT00486759|3254266|P2|Safety Follow-up|Death|29
990361|NCT00486759|3254267|P1|Safety Follow-up|Death|40
990362|NCT00486759|3254266|P2|Safety Follow-up|Insufficient therapeutic response|50
990363|NCT00486759|3254267|P1|Safety Follow-up|Insufficient therapeutic response|40
990364|NCT00486759|3254266|P2|Treatment|Failure to return|1
990365|NCT00486759|3254267|P1|Treatment|Failure to return|1
990366|NCT00486759|3254266|P2|Treatment|Other protocol violation|5
990367|NCT00486759|3254267|P1|Treatment|Other protocol violation|1
990368|NCT00486759|3254266|P2|Treatment|Violation of selection criteria at entry|3
990369|NCT00486759|3254267|P1|Treatment|Violation of selection criteria at entry|3
990370|NCT00486759|3254266|P2|Treatment|Refused treatment|7
990371|NCT00486759|3254267|P1|Treatment|Refused treatment|10
990372|NCT00486759|3254266|P2|Treatment|Administrative/reason not specified|21
990373|NCT00486759|3254267|P1|Treatment|Administrative/reason not specified|17
990374|NCT00486759|3254266|P2|Treatment|Withdrew consent|12
990375|NCT00486759|3254267|P1|Treatment|Withdrew consent|15
990376|NCT00486759|3254266|P2|Treatment|Death|10
990377|NCT00486759|3254267|P1|Treatment|Death|17
990378|NCT00486759|3254266|P2|Treatment|Insufficient therapeutic response|39
990379|NCT00486759|3254267|P1|Treatment|Insufficient therapeutic response|37
990380|NCT00486759|3254266|P2|Treatment|Adverse event/intercurrent illness|39
990381|NCT00486759|3254267|P1|Treatment|Adverse event/intercurrent illness|86
990382|NCT00486720|3254279|P2|Overall Study|Progressive Disease|1
990383|NCT00486720|3254280|P1|Overall Study|Progressive Disease|0
990384|NCT00486720|3254279|P2|Overall Study|Withdrawal by Subject|1
990385|NCT00486720|3254280|P1|Overall Study|Withdrawal by Subject|3
990386|NCT00486720|3254279|P2|Overall Study|Protocol Violation|0
990387|NCT00486720|3254280|P1|Overall Study|Protocol Violation|1
990388|NCT00486720|3254279|P2|Overall Study|Physician Decision|2
990389|NCT00486720|3254280|P1|Overall Study|Physician Decision|1
990390|NCT00486720|3254279|P2|Overall Study|Lack of Efficacy|6
990391|NCT00486720|3254280|P1|Overall Study|Lack of Efficacy|4
990392|NCT00486720|3254279|P2|Overall Study|Adverse Event|2
990393|NCT00486720|3254280|P1|Overall Study|Adverse Event|1
990394|NCT00486434|3254339|P2|Overall Study|Personal reasons|6
990395|NCT00486434|3254340|P1|Overall Study|Personal reasons|5
990396|NCT00486434|3254339|P2|Overall Study|Death|2
990397|NCT00486434|3254340|P1|Overall Study|Death|1
990398|NCT00486434|3254339|P2|Overall Study|Lost to Follow-up|3
990399|NCT00486434|3254340|P1|Overall Study|Lost to Follow-up|2
990400|NCT00486434|3254339|P2|Overall Study|Lack of Efficacy|19
990401|NCT00486434|3254340|P1|Overall Study|Lack of Efficacy|12
990402|NCT00486434|3254339|P2|Overall Study|Protocol Violation|21
990403|NCT00486434|3254340|P1|Overall Study|Protocol Violation|22
990404|NCT00486434|3254339|P2|Overall Study|Adverse Event|44
990405|NCT00486434|3254340|P1|Overall Study|Adverse Event|118
990406|NCT00486434|3254339|P2|Overall Study|Withdrawal by Subject|39
990407|NCT00486434|3254340|P1|Overall Study|Withdrawal by Subject|34
990408|NCT00486330|3254350|P1|Overall Study|Adverse Event|2
990409|NCT00486291|3254356|P2|Overall Study|requirement for restricted medication|3
990410|NCT00486291|3254357|P1|Overall Study|requirement for restricted medication|0
990411|NCT00486291|3254356|P2|Overall Study|protocol non-compliance|15
990412|NCT00486291|3254357|P1|Overall Study|protocol non-compliance|10
990413|NCT00486291|3254356|P2|Overall Study|Lost to Follow-up|7
990414|NCT00486291|3254357|P1|Overall Study|Lost to Follow-up|3
990415|NCT00486291|3254356|P2|Overall Study|Adverse Event|4
990416|NCT00486291|3254357|P1|Overall Study|Adverse Event|3
990417|NCT00486278|3254365|P1|Overall Study|Physician Decision|2
990418|NCT00486278|3254365|P1|Overall Study|Withdrawal by Subject|2
990419|NCT00486278|3254365|P1|Overall Study|Adverse Event|5
990420|NCT00486265|3254499|P1|Overall Study|Lack of Efficacy|8
990421|NCT00486265|3254499|P1|Overall Study|Adverse Event|1
990422|NCT00486252|3254503|P1|Overall Study|Other|18
990423|NCT00486252|3254503|P1|Overall Study|Lost to Follow-up|24
990424|NCT00486252|3254503|P1|Overall Study|Lack of Efficacy|9
990425|NCT00486252|3254503|P1|Overall Study|Adverse Event|7
990426|NCT00486226|3254518|P1|Overall Study|Lost to Follow-up|8
990427|NCT00486226|3254518|P1|Overall Study|Withdrawal by Subject|1
990428|NCT00486226|3254518|P1|Overall Study|Adverse Event|1
990429|NCT00486226|3254518|P1|Overall Study|Death|3
990430|NCT00486044|3254528|P2|Overall Study|Lost to Follow-up|1
990431|NCT00486044|3254529|P1|Overall Study|Lost to Follow-up|0
990432|NCT00486044|3254528|P2|Overall Study|Adverse Event|1
990433|NCT00486044|3254529|P1|Overall Study|Adverse Event|0
990434|NCT00486044|3254528|P2|Overall Study|Withdrawal by Subject|1
990435|NCT00486044|3254529|P1|Overall Study|Withdrawal by Subject|2
990436|NCT00485758|3254622|P2|Overall Study|Study Terminated by Sponsor|0
990437|NCT00485758|3254623|P1|Overall Study|Study Terminated by Sponsor|3
990438|NCT00485758|3254622|P2|Overall Study|Withdrawal by Subject|27
990439|NCT00485758|3254623|P1|Overall Study|Withdrawal by Subject|32
990440|NCT00485758|3254622|P2|Overall Study|Protocol Violation|2
990441|NCT00485758|3254623|P1|Overall Study|Protocol Violation|11
990442|NCT00485758|3254622|P2|Overall Study|Physician Decision|3
990443|NCT00485758|3254623|P1|Overall Study|Physician Decision|3
990444|NCT00485758|3254622|P2|Overall Study|Lost to Follow-up|1
990445|NCT00485758|3254623|P1|Overall Study|Lost to Follow-up|5
990446|NCT00485758|3254622|P2|Overall Study|Death|1
990447|NCT00485758|3254623|P1|Overall Study|Death|0
990448|NCT00485758|3254622|P2|Overall Study|Adverse Event|31
990449|NCT00485758|3254623|P1|Overall Study|Adverse Event|102
990450|NCT00485732|3254635|P2|Overall Study|Lost to Follow-up|2
990451|NCT00485732|3254636|P1|Overall Study|Lost to Follow-up|2
990452|NCT00485732|3254635|P2|Overall Study|Withdrawal by Subject|4
990453|NCT00485732|3254636|P1|Overall Study|Withdrawal by Subject|5
990454|NCT00485732|3254635|P2|Overall Study|Protocol Violation|3
990455|NCT00485732|3254636|P1|Overall Study|Protocol Violation|1
990456|NCT00485472|3254674|P2|Overall Study|Lost to Follow-up|1
990457|NCT00485472|3254675|P1|Overall Study|Lost to Follow-up|0
990458|NCT00485472|3254674|P2|Overall Study|Other|1
990459|NCT00485472|3254675|P1|Overall Study|Other|2
990460|NCT00485472|3254674|P2|Overall Study|Protocol Violation|1
990461|NCT00485472|3254675|P1|Overall Study|Protocol Violation|0
990462|NCT00485472|3254674|P2|Overall Study|Withdrawal by Subject|0
990463|NCT00485472|3254675|P1|Overall Study|Withdrawal by Subject|1
990464|NCT00485472|3254674|P2|Overall Study|Lack of Efficacy|4
990465|NCT00485472|3254675|P1|Overall Study|Lack of Efficacy|5
990466|NCT00485472|3254674|P2|Overall Study|Adverse Event|5
990467|NCT00485472|3254675|P1|Overall Study|Adverse Event|8
990468|NCT00485303|3254712|P1|Overall Study|Treatment ongoing at cutoff date|2
990469|NCT00485303|3254712|P1|Overall Study|Initiation of new anti-cancer treatment|2
990470|NCT00485303|3254712|P1|Overall Study|Other|3
990471|NCT00485303|3254712|P1|Overall Study|Progressive Disease|44
990472|NCT00485303|3254712|P1|Overall Study|Adverse Event|5
990473|NCT00485264|3254730|P6|Overall Study|Other Reason|0
990474|NCT00485264|3254731|P5|Overall Study|Other Reason|0
990475|NCT00485264|3254732|P4|Overall Study|Other Reason|0
990476|NCT00485264|3254733|P3|Overall Study|Other Reason|0
990477|NCT00485264|3254734|P2|Overall Study|Other Reason|0
990478|NCT00485264|3254735|P1|Overall Study|Other Reason|3
990479|NCT00485264|3254730|P6|Overall Study|Lost to Follow-up|1
990480|NCT00485264|3254731|P5|Overall Study|Lost to Follow-up|0
990481|NCT00485264|3254732|P4|Overall Study|Lost to Follow-up|0
990482|NCT00485264|3254733|P3|Overall Study|Lost to Follow-up|1
990483|NCT00485264|3254734|P2|Overall Study|Lost to Follow-up|1
990484|NCT00485264|3254735|P1|Overall Study|Lost to Follow-up|2
990485|NCT00485264|3254730|P6|Overall Study|Non-Compliant|0
990486|NCT00485264|3254731|P5|Overall Study|Non-Compliant|1
990487|NCT00485264|3254732|P4|Overall Study|Non-Compliant|0
990488|NCT00485264|3254733|P3|Overall Study|Non-Compliant|1
990489|NCT00485264|3254734|P2|Overall Study|Non-Compliant|2
990490|NCT00485264|3254735|P1|Overall Study|Non-Compliant|17
990491|NCT00485264|3254730|P6|Overall Study|Not Able to Attend Clinic|2
990492|NCT00485264|3254731|P5|Overall Study|Not Able to Attend Clinic|1
990493|NCT00485264|3254732|P4|Overall Study|Not Able to Attend Clinic|1
990494|NCT00485264|3254733|P3|Overall Study|Not Able to Attend Clinic|0
990495|NCT00485264|3254734|P2|Overall Study|Not Able to Attend Clinic|0
990496|NCT00485264|3254735|P1|Overall Study|Not Able to Attend Clinic|5
990497|NCT00485264|3254730|P6|Overall Study|Intolerance/Unable to Tolerate Dose|0
990498|NCT00485264|3254731|P5|Overall Study|Intolerance/Unable to Tolerate Dose|0
990499|NCT00485264|3254732|P4|Overall Study|Intolerance/Unable to Tolerate Dose|0
990500|NCT00485264|3254733|P3|Overall Study|Intolerance/Unable to Tolerate Dose|1
990501|NCT00485264|3254734|P2|Overall Study|Intolerance/Unable to Tolerate Dose|0
990502|NCT00485264|3254735|P1|Overall Study|Intolerance/Unable to Tolerate Dose|0
990503|NCT00485264|3254730|P6|Overall Study|Physician Decision|0
990504|NCT00485264|3254731|P5|Overall Study|Physician Decision|0
990505|NCT00485264|3254732|P4|Overall Study|Physician Decision|0
990506|NCT00485264|3254733|P3|Overall Study|Physician Decision|0
990507|NCT00485264|3254734|P2|Overall Study|Physician Decision|2
990508|NCT00485264|3254735|P1|Overall Study|Physician Decision|0
990509|NCT00485264|3254730|P6|Overall Study|Guardian Consent Withdrawn|0
990510|NCT00485264|3254731|P5|Overall Study|Guardian Consent Withdrawn|1
990511|NCT00485264|3254732|P4|Overall Study|Guardian Consent Withdrawn|0
990512|NCT00485264|3254733|P3|Overall Study|Guardian Consent Withdrawn|0
990513|NCT00485264|3254734|P2|Overall Study|Guardian Consent Withdrawn|0
990514|NCT00485264|3254735|P1|Overall Study|Guardian Consent Withdrawn|1
990515|NCT00485264|3254730|P6|Overall Study|Lack of Efficacy|0
990516|NCT00485264|3254731|P5|Overall Study|Lack of Efficacy|0
990517|NCT00485264|3254732|P4|Overall Study|Lack of Efficacy|0
990518|NCT00485264|3254733|P3|Overall Study|Lack of Efficacy|0
990519|NCT00485264|3254734|P2|Overall Study|Lack of Efficacy|1
990520|NCT00485264|3254735|P1|Overall Study|Lack of Efficacy|0
990521|NCT00485264|3254730|P6|Overall Study|Number/Volume/Timing of Study Meds|0
990522|NCT00485264|3254731|P5|Overall Study|Number/Volume/Timing of Study Meds|0
990523|NCT00485264|3254732|P4|Overall Study|Number/Volume/Timing of Study Meds|0
990524|NCT00485264|3254733|P3|Overall Study|Number/Volume/Timing of Study Meds|1
990525|NCT00485264|3254734|P2|Overall Study|Number/Volume/Timing of Study Meds|1
990526|NCT00485264|3254735|P1|Overall Study|Number/Volume/Timing of Study Meds|2
990527|NCT00485264|3254730|P6|Overall Study|Disallowed Medication|1
990528|NCT00485264|3254731|P5|Overall Study|Disallowed Medication|0
990529|NCT00485264|3254732|P4|Overall Study|Disallowed Medication|0
990530|NCT00485264|3254733|P3|Overall Study|Disallowed Medication|0
990531|NCT00485264|3254734|P2|Overall Study|Disallowed Medication|0
990532|NCT00485264|3254735|P1|Overall Study|Disallowed Medication|0
990533|NCT00485264|3254730|P6|Overall Study|Pregnancy|0
990534|NCT00485264|3254731|P5|Overall Study|Pregnancy|0
990535|NCT00485264|3254732|P4|Overall Study|Pregnancy|0
990536|NCT00485264|3254733|P3|Overall Study|Pregnancy|0
990537|NCT00485264|3254734|P2|Overall Study|Pregnancy|0
990538|NCT00485264|3254735|P1|Overall Study|Pregnancy|4
990539|NCT00485264|3254730|P6|Overall Study|Adverse Event|3
990540|NCT00485264|3254731|P5|Overall Study|Adverse Event|1
990541|NCT00485264|3254732|P4|Overall Study|Adverse Event|3
990542|NCT00485264|3254733|P3|Overall Study|Adverse Event|2
990543|NCT00485264|3254734|P2|Overall Study|Adverse Event|0
990544|NCT00485264|3254735|P1|Overall Study|Adverse Event|1
990545|NCT00485264|3254730|P6|Overall Study|Death|0
990546|NCT00485264|3254731|P5|Overall Study|Death|1
990547|NCT00485264|3254732|P4|Overall Study|Death|0
990548|NCT00485264|3254733|P3|Overall Study|Death|0
990549|NCT00485264|3254734|P2|Overall Study|Death|0
990550|NCT00485264|3254735|P1|Overall Study|Death|1
990551|NCT00485264|3254730|P6|Overall Study|Enrolled But Not Given Treatment|0
990552|NCT00485264|3254731|P5|Overall Study|Enrolled But Not Given Treatment|1
990553|NCT00485264|3254732|P4|Overall Study|Enrolled But Not Given Treatment|0
990554|NCT00485264|3254733|P3|Overall Study|Enrolled But Not Given Treatment|0
990555|NCT00485264|3254734|P2|Overall Study|Enrolled But Not Given Treatment|0
990556|NCT00485264|3254735|P1|Overall Study|Enrolled But Not Given Treatment|0
990557|NCT00485173|3254823|P2|Overall Study|Lost to Follow-up|61
990558|NCT00485173|3254824|P1|Overall Study|Lost to Follow-up|32
990559|NCT00485173|3254823|P2|Overall Study|Death|3
990560|NCT00485173|3254824|P1|Overall Study|Death|4
990561|NCT00485134|3254872|P8|Overall Study|Pregnancy|0
990562|NCT00485134|3254873|P7|Overall Study|Pregnancy|1
990563|NCT00485134|3254874|P6|Overall Study|Pregnancy|0
990564|NCT00485134|3254875|P5|Overall Study|Pregnancy|0
990565|NCT00485134|3254876|P4|Overall Study|Pregnancy|0
990566|NCT00485134|3254877|P3|Overall Study|Pregnancy|0
990567|NCT00485134|3254878|P2|Overall Study|Pregnancy|0
990568|NCT00485134|3254879|P1|Overall Study|Pregnancy|0
990569|NCT00485134|3254872|P8|Overall Study|Unable to comply with study schedule|1
990570|NCT00485134|3254873|P7|Overall Study|Unable to comply with study schedule|0
990571|NCT00485134|3254874|P6|Overall Study|Unable to comply with study schedule|0
990572|NCT00485134|3254875|P5|Overall Study|Unable to comply with study schedule|0
990573|NCT00485134|3254876|P4|Overall Study|Unable to comply with study schedule|0
990574|NCT00485134|3254877|P3|Overall Study|Unable to comply with study schedule|0
990575|NCT00485134|3254878|P2|Overall Study|Unable to comply with study schedule|0
990576|NCT00485134|3254879|P1|Overall Study|Unable to comply with study schedule|0
990577|NCT00485134|3254872|P8|Overall Study|Non-compliance|0
990578|NCT00485134|3254873|P7|Overall Study|Non-compliance|2
990579|NCT00485134|3254874|P6|Overall Study|Non-compliance|2
990580|NCT00485134|3254875|P5|Overall Study|Non-compliance|1
990581|NCT00485134|3254876|P4|Overall Study|Non-compliance|0
990582|NCT00485134|3254877|P3|Overall Study|Non-compliance|0
990583|NCT00485134|3254878|P2|Overall Study|Non-compliance|0
990584|NCT00485134|3254879|P1|Overall Study|Non-compliance|0
990585|NCT00485134|3254872|P8|Overall Study|Positive drug test|0
990586|NCT00485134|3254873|P7|Overall Study|Positive drug test|0
990587|NCT00485134|3254874|P6|Overall Study|Positive drug test|1
990588|NCT00485134|3254875|P5|Overall Study|Positive drug test|2
990589|NCT00485134|3254876|P4|Overall Study|Positive drug test|0
990590|NCT00485134|3254877|P3|Overall Study|Positive drug test|0
990591|NCT00485134|3254878|P2|Overall Study|Positive drug test|0
990592|NCT00485134|3254879|P1|Overall Study|Positive drug test|0
990593|NCT00485134|3254872|P8|Overall Study|Withdrew for adverse event|0
990594|NCT00485134|3254873|P7|Overall Study|Withdrew for adverse event|0
990595|NCT00485134|3254874|P6|Overall Study|Withdrew for adverse event|0
990596|NCT00485134|3254875|P5|Overall Study|Withdrew for adverse event|0
990597|NCT00485134|3254876|P4|Overall Study|Withdrew for adverse event|0
990598|NCT00485134|3254877|P3|Overall Study|Withdrew for adverse event|1
990599|NCT00485134|3254878|P2|Overall Study|Withdrew for adverse event|0
990600|NCT00485134|3254879|P1|Overall Study|Withdrew for adverse event|0
990601|NCT00485134|3254872|P8|Overall Study|Change in health status|0
990602|NCT00485134|3254873|P7|Overall Study|Change in health status|0
990603|NCT00485134|3254874|P6|Overall Study|Change in health status|1
990604|NCT00485134|3254875|P5|Overall Study|Change in health status|0
990605|NCT00485134|3254876|P4|Overall Study|Change in health status|1
990606|NCT00485134|3254877|P3|Overall Study|Change in health status|2
990607|NCT00485134|3254878|P2|Overall Study|Change in health status|1
990608|NCT00485134|3254879|P1|Overall Study|Change in health status|0
990609|NCT00485134|3254872|P8|Overall Study|Withdrawal by Subject|0
990610|NCT00485134|3254873|P7|Overall Study|Withdrawal by Subject|0
990611|NCT00485134|3254874|P6|Overall Study|Withdrawal by Subject|0
990612|NCT00485134|3254875|P5|Overall Study|Withdrawal by Subject|0
990613|NCT00485134|3254876|P4|Overall Study|Withdrawal by Subject|0
990614|NCT00485134|3254877|P3|Overall Study|Withdrawal by Subject|0
990615|NCT00485134|3254878|P2|Overall Study|Withdrawal by Subject|1
990616|NCT00485134|3254879|P1|Overall Study|Withdrawal by Subject|0
990617|NCT00485134|3254872|P8|Overall Study|Lost to Follow-up|0
990618|NCT00485134|3254873|P7|Overall Study|Lost to Follow-up|0
990619|NCT00485134|3254874|P6|Overall Study|Lost to Follow-up|0
990620|NCT00485134|3254875|P5|Overall Study|Lost to Follow-up|0
990621|NCT00485134|3254876|P4|Overall Study|Lost to Follow-up|0
990622|NCT00485134|3254877|P3|Overall Study|Lost to Follow-up|0
990623|NCT00485134|3254878|P2|Overall Study|Lost to Follow-up|0
990624|NCT00485134|3254879|P1|Overall Study|Lost to Follow-up|1
990625|NCT00485069|3254901|P2|Overall Study|Withdrawal by Subject|6
990626|NCT00485069|3254902|P1|Overall Study|Withdrawal by Subject|6
990627|NCT00485069|3254901|P2|Overall Study|Protocol Violation|1
990628|NCT00485069|3254902|P1|Overall Study|Protocol Violation|0
990629|NCT00485069|3254901|P2|Overall Study|Lack of Efficacy|1
990630|NCT00485069|3254902|P1|Overall Study|Lack of Efficacy|2
990631|NCT00485069|3254901|P2|Overall Study|Adverse Event|4
990632|NCT00485069|3254902|P1|Overall Study|Adverse Event|10
990633|NCT00484939|3254947|P2|Overall Study|Reason Not Specified|6
990634|NCT00484939|3254948|P1|Overall Study|Reason Not Specified|11
990635|NCT00484939|3254947|P2|Overall Study|Screen Failure|2
990636|NCT00484939|3254948|P1|Overall Study|Screen Failure|2
990637|NCT00484939|3254947|P2|Overall Study|Disease progression|88
990638|NCT00484939|3254948|P1|Overall Study|Disease progression|67
990639|NCT00484939|3254947|P2|Overall Study|Discretion of Investigator or Sponsor|3
990640|NCT00484939|3254948|P1|Overall Study|Discretion of Investigator or Sponsor|7
990641|NCT00484939|3254947|P2|Overall Study|Lost to Follow-up|3
990642|NCT00484939|3254948|P1|Overall Study|Lost to Follow-up|0
990643|NCT00484939|3254947|P2|Overall Study|Protocol Violation|3
990644|NCT00484939|3254948|P1|Overall Study|Protocol Violation|3
990645|NCT00484939|3254947|P2|Overall Study|Patient Withdrew Consent|10
990646|NCT00484939|3254948|P1|Overall Study|Patient Withdrew Consent|19
990647|NCT00484939|3254947|P2|Overall Study|Adverse Event|12
990648|NCT00484939|3254948|P1|Overall Study|Adverse Event|22
990649|NCT00484939|3254947|P2|Overall Study|Death|13
990650|NCT00484939|3254948|P1|Overall Study|Death|9
990651|NCT00484679|3254975|P1|Overall Study|Withdrawal by Subject|3
990652|NCT00484419|3254982|P3|Overall Study|sponsor decision, randomized in error|2
990653|NCT00484419|3254983|P2|Overall Study|sponsor decision, randomized in error|0
990654|NCT00484419|3254984|P1|Overall Study|sponsor decision, randomized in error|0
990655|NCT00484419|3254982|P3|Overall Study|subject relocated|0
990656|NCT00484419|3254983|P2|Overall Study|subject relocated|1
990657|NCT00484419|3254984|P1|Overall Study|subject relocated|0
990658|NCT00484419|3254982|P3|Overall Study|subject unable to receive medication|0
990659|NCT00484419|3254983|P2|Overall Study|subject unable to receive medication|0
990660|NCT00484419|3254984|P1|Overall Study|subject unable to receive medication|1
990661|NCT00484419|3254982|P3|Overall Study|Physician Decision|1
990662|NCT00484419|3254983|P2|Overall Study|Physician Decision|1
990663|NCT00484419|3254984|P1|Overall Study|Physician Decision|1
990664|NCT00484419|3254982|P3|Overall Study|required restricted medication|1
990665|NCT00484419|3254983|P2|Overall Study|required restricted medication|0
990666|NCT00484419|3254984|P1|Overall Study|required restricted medication|1
990667|NCT00484419|3254982|P3|Overall Study|subject met discontinuation criteria|4
990668|NCT00484419|3254983|P2|Overall Study|subject met discontinuation criteria|2
990669|NCT00484419|3254984|P1|Overall Study|subject met discontinuation criteria|2
990670|NCT00484419|3254982|P3|Overall Study|Withdrawal by Subject|1
990671|NCT00484419|3254983|P2|Overall Study|Withdrawal by Subject|1
990672|NCT00484419|3254984|P1|Overall Study|Withdrawal by Subject|3
990673|NCT00484419|3254982|P3|Overall Study|Lost to Follow-up|2
990674|NCT00484419|3254983|P2|Overall Study|Lost to Follow-up|0
990675|NCT00484419|3254984|P1|Overall Study|Lost to Follow-up|1
990676|NCT00484419|3254982|P3|Overall Study|Adverse Event|0
990677|NCT00484419|3254983|P2|Overall Study|Adverse Event|0
990678|NCT00484419|3254984|P1|Overall Study|Adverse Event|3
990679|NCT00484315|3255068|P2|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2
990680|NCT00484315|3255069|P1|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3
990681|NCT00484315|3255068|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11
990682|NCT00484315|3255069|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25
990683|NCT00484315|3255068|P2|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2
990684|NCT00484315|3255069|P1|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3
990685|NCT00484315|3255068|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|4
990686|NCT00484315|3255069|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|13
990687|NCT00484315|3255068|P2|12-Month Clinical Follow-up|Lost to Follow-up|1
990688|NCT00484315|3255069|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
990689|NCT00484315|3255068|P2|12-Month Clinical Follow-up|Withdrawal by Subject|0
990690|NCT00484315|3255069|P1|12-Month Clinical Follow-up|Withdrawal by Subject|4
990691|NCT00484315|3255068|P2|12-Month Clinical Follow-up|Death|2
990692|NCT00484315|3255069|P1|12-Month Clinical Follow-up|Death|6
990693|NCT00484289|3255080|P3|Post Marketing Phase|Adverse Event|0
990694|NCT00484289|3255081|P2|Post Marketing Phase|Adverse Event|1
990695|NCT00484289|3255082|P1|Post Marketing Phase|Adverse Event|0
990696|NCT00484289|3255080|P3|Long Term Phase|Other Reason|1
990697|NCT00484289|3255081|P2|Long Term Phase|Other Reason|5
990698|NCT00484289|3255082|P1|Long Term Phase|Other Reason|0
990699|NCT00484289|3255080|P3|Long Term Phase|Inadequate response|4
990700|NCT00484289|3255081|P2|Long Term Phase|Inadequate response|7
990701|NCT00484289|3255082|P1|Long Term Phase|Inadequate response|2
990702|NCT00484289|3255080|P3|Long Term Phase|Withdrawal by Subject|6
990703|NCT00484289|3255081|P2|Long Term Phase|Withdrawal by Subject|7
990704|NCT00484289|3255082|P1|Long Term Phase|Withdrawal by Subject|0
990705|NCT00484289|3255080|P3|Long Term Phase|Adverse Event|5
990706|NCT00484289|3255081|P2|Long Term Phase|Adverse Event|17
990707|NCT00484289|3255082|P1|Long Term Phase|Adverse Event|1
990708|NCT00484185|3255154|P1|Overall Study|Death|2
990709|NCT00484185|3255154|P1|Overall Study|Randomized but not treated|5
990710|NCT00484185|3255154|P1|Overall Study|Other|20
990711|NCT00484185|3255154|P1|Overall Study|Lost to Follow-up|44
990712|NCT00484159|3255176|P3|Overall Study|Lost to Follow-up|0
990713|NCT00484159|3255177|P2|Overall Study|Lost to Follow-up|1
990714|NCT00484159|3255178|P1|Overall Study|Lost to Follow-up|1
990715|NCT00484094|3255189|P1|Overall Study|Other|3
990716|NCT00484094|3255189|P1|Overall Study|Discontinued|39
990717|NCT00483938|3255205|P7|Overall Study|Other|32
990718|NCT00483938|3255206|P6|Overall Study|Other|4
990719|NCT00483938|3255207|P5|Overall Study|Other|0
990720|NCT00483938|3255208|P4|Overall Study|Other|4
990721|NCT00483938|3255209|P3|Overall Study|Other|0
990722|NCT00483938|3255210|P2|Overall Study|Other|9
990723|NCT00483938|3255211|P1|Overall Study|Other|3
990724|NCT00483938|3255205|P7|Overall Study|Death|0
990725|NCT00483938|3255206|P6|Overall Study|Death|0
990726|NCT00483938|3255207|P5|Overall Study|Death|0
990727|NCT00483938|3255208|P4|Overall Study|Death|0
990728|NCT00483938|3255209|P3|Overall Study|Death|0
990729|NCT00483938|3255210|P2|Overall Study|Death|2
990730|NCT00483938|3255211|P1|Overall Study|Death|0
990731|NCT00483938|3255205|P7|Overall Study|Lost to Follow-up|3
990732|NCT00483938|3255206|P6|Overall Study|Lost to Follow-up|1
990733|NCT00483938|3255207|P5|Overall Study|Lost to Follow-up|1
990734|NCT00483938|3255208|P4|Overall Study|Lost to Follow-up|2
990735|NCT00483938|3255209|P3|Overall Study|Lost to Follow-up|0
990736|NCT00483938|3255210|P2|Overall Study|Lost to Follow-up|2
990737|NCT00483938|3255211|P1|Overall Study|Lost to Follow-up|1
990738|NCT00483938|3255205|P7|Overall Study|Withdrawal by Subject|2
990739|NCT00483938|3255206|P6|Overall Study|Withdrawal by Subject|3
990740|NCT00483938|3255207|P5|Overall Study|Withdrawal by Subject|1
990741|NCT00483938|3255208|P4|Overall Study|Withdrawal by Subject|0
990742|NCT00483938|3255209|P3|Overall Study|Withdrawal by Subject|0
990743|NCT00483938|3255210|P2|Overall Study|Withdrawal by Subject|6
990744|NCT00483938|3255211|P1|Overall Study|Withdrawal by Subject|1
990745|NCT00483938|3255205|P7|Overall Study|Protocol Violation|3
990746|NCT00483938|3255206|P6|Overall Study|Protocol Violation|0
990747|NCT00483938|3255207|P5|Overall Study|Protocol Violation|0
990748|NCT00483938|3255208|P4|Overall Study|Protocol Violation|0
990749|NCT00483938|3255209|P3|Overall Study|Protocol Violation|0
990750|NCT00483938|3255210|P2|Overall Study|Protocol Violation|0
990751|NCT00483938|3255211|P1|Overall Study|Protocol Violation|0
990752|NCT00483756|3255235|P3|Overall Study|Randomized, Not Treated|4
990753|NCT00483756|3255236|P2|Overall Study|Randomized, Not Treated|4
990754|NCT00483756|3255237|P1|Overall Study|Randomized, Not Treated|1
990755|NCT00483756|3255235|P3|Overall Study|Other|3
990756|NCT00483756|3255236|P2|Overall Study|Other|4
990757|NCT00483756|3255237|P1|Overall Study|Other|2
990758|NCT00483756|3255235|P3|Overall Study|Withdrawal by Subject|4
990759|NCT00483756|3255236|P2|Overall Study|Withdrawal by Subject|3
990760|NCT00483756|3255237|P1|Overall Study|Withdrawal by Subject|5
990761|NCT00483756|3255235|P3|Overall Study|Lost to Follow-up|0
990762|NCT00483756|3255236|P2|Overall Study|Lost to Follow-up|1
990763|NCT00483756|3255237|P1|Overall Study|Lost to Follow-up|3
990764|NCT00483756|3255235|P3|Overall Study|Lack of Efficacy|0
990765|NCT00483756|3255236|P2|Overall Study|Lack of Efficacy|0
990766|NCT00483756|3255237|P1|Overall Study|Lack of Efficacy|1
990767|NCT00483756|3255235|P3|Overall Study|Adverse Event|40
990768|NCT00483756|3255236|P2|Overall Study|Adverse Event|38
990769|NCT00483756|3255237|P1|Overall Study|Adverse Event|19
990770|NCT00483756|3255235|P3|Overall Study|Death|1
990771|NCT00483756|3255236|P2|Overall Study|Death|0
990772|NCT00483756|3255237|P1|Overall Study|Death|2
990773|NCT00483717|3255301|P2|Overall Study|Withdrawal by Subject|0
990774|NCT00483717|3255302|P1|Overall Study|Withdrawal by Subject|1
990775|NCT00483717|3255301|P2|Overall Study|Lost to Follow-up|0
990776|NCT00483717|3255302|P1|Overall Study|Lost to Follow-up|1
990777|NCT00483717|3255301|P2|Overall Study|No treatment for migraine|13
990778|NCT00483717|3255302|P1|Overall Study|No treatment for migraine|16
990779|NCT00483717|3255301|P2|Overall Study|Time of dosing missing|1
990780|NCT00483717|3255302|P1|Overall Study|Time of dosing missing|1
990781|NCT00483717|3255301|P2|Overall Study|Protocol Violation|7
990782|NCT00483717|3255302|P1|Overall Study|Protocol Violation|5
990783|NCT00483704|3255325|P3|Treatment|Physician Decision|4
990784|NCT00483704|3255326|P2|Treatment|Physician Decision|1
990785|NCT00483704|3255327|P1|Treatment|Physician Decision|0
990786|NCT00483704|3255325|P3|Treatment|Pregnancy|0
990787|NCT00483704|3255326|P2|Treatment|Pregnancy|1
990788|NCT00483704|3255327|P1|Treatment|Pregnancy|0
990789|NCT00483704|3255325|P3|Treatment|Lack of Efficacy|1
990790|NCT00483704|3255326|P2|Treatment|Lack of Efficacy|1
990791|NCT00483704|3255327|P1|Treatment|Lack of Efficacy|1
990792|NCT00483704|3255325|P3|Treatment|Lost to Follow-up|5
990793|NCT00483704|3255326|P2|Treatment|Lost to Follow-up|7
990794|NCT00483704|3255327|P1|Treatment|Lost to Follow-up|2
990795|NCT00483704|3255325|P3|Treatment|Protocol Violation|5
990796|NCT00483704|3255326|P2|Treatment|Protocol Violation|3
990797|NCT00483704|3255327|P1|Treatment|Protocol Violation|6
990798|NCT00483704|3255325|P3|Treatment|Withdrawal by Subject|21
990799|NCT00483704|3255326|P2|Treatment|Withdrawal by Subject|12
990800|NCT00483704|3255327|P1|Treatment|Withdrawal by Subject|16
990801|NCT00483704|3255325|P3|Treatment|Adverse Event|4
990802|NCT00483704|3255326|P2|Treatment|Adverse Event|5
990803|NCT00483704|3255327|P1|Treatment|Adverse Event|3
990804|NCT00483704|3255325|P3|Treatment|Lack of qualifying migraines|116
990805|NCT00483704|3255326|P2|Treatment|Lack of qualifying migraines|99
990806|NCT00483704|3255327|P1|Treatment|Lack of qualifying migraines|101
990807|NCT00483704|3255325|P3|Randomization|Lack of qualifying migraines|31
990808|NCT00483704|3255326|P2|Randomization|Lack of qualifying migraines|25
990809|NCT00483704|3255327|P1|Randomization|Lack of qualifying migraines|21
990810|NCT00483704|3255325|P3|Randomization|Progressive disease|1
990811|NCT00483704|3255326|P2|Randomization|Progressive disease|0
990812|NCT00483704|3255327|P1|Randomization|Progressive disease|0
990813|NCT00483704|3255325|P3|Randomization|Physician Decision|0
990814|NCT00483704|3255326|P2|Randomization|Physician Decision|4
990815|NCT00483704|3255327|P1|Randomization|Physician Decision|2
990816|NCT00483704|3255325|P3|Randomization|Pregnancy|0
990817|NCT00483704|3255326|P2|Randomization|Pregnancy|0
990818|NCT00483704|3255327|P1|Randomization|Pregnancy|1
990819|NCT00483704|3255325|P3|Randomization|Lost to Follow-up|19
990820|NCT00483704|3255326|P2|Randomization|Lost to Follow-up|14
990821|NCT00483704|3255327|P1|Randomization|Lost to Follow-up|14
990822|NCT00483704|3255325|P3|Randomization|Protocol Violation|22
990823|NCT00483704|3255326|P2|Randomization|Protocol Violation|25
990824|NCT00483704|3255327|P1|Randomization|Protocol Violation|14
990825|NCT00483704|3255325|P3|Randomization|Withdrawal by Subject|18
990826|NCT00483704|3255326|P2|Randomization|Withdrawal by Subject|28
990827|NCT00483704|3255327|P1|Randomization|Withdrawal by Subject|19
990828|NCT00483652|3255373|P2|Double-blind Treatment Period|Withdrawal due to AE before study began|0
990829|NCT00483652|3255374|P1|Double-blind Treatment Period|Withdrawal due to AE before study began|1
990830|NCT00483652|3255373|P2|Double-blind Treatment Period|Protocol inclusion deviation|0
990831|NCT00483652|3255374|P1|Double-blind Treatment Period|Protocol inclusion deviation|1
990832|NCT00483652|3255373|P2|Double-blind Treatment Period|Adverse Event|4
990833|NCT00483652|3255374|P1|Double-blind Treatment Period|Adverse Event|3
990834|NCT00483652|3255373|P2|Double-blind Treatment Period|Protocol Violation|1
990835|NCT00483652|3255374|P1|Double-blind Treatment Period|Protocol Violation|2
990836|NCT00483574|3255384|P2|Overall Study|Withdrawal by Subject|0
990837|NCT00483574|3255385|P1|Overall Study|Withdrawal by Subject|52
990838|NCT00483574|3255384|P2|Overall Study|Lost to Follow-up|4
990839|NCT00483574|3255385|P1|Overall Study|Lost to Follow-up|16
990840|NCT00483574|3255384|P2|Overall Study|Protocol Violation|9
990841|NCT00483574|3255385|P1|Overall Study|Protocol Violation|28
990842|NCT00483574|3255384|P2|Overall Study|Adverse Event|0
990843|NCT00483574|3255385|P1|Overall Study|Adverse Event|6
990844|NCT00483548|3255400|P2|Overall Study|Withdrawal by Subject|2
990845|NCT00483548|3255401|P1|Overall Study|Withdrawal by Subject|5
990846|NCT00483548|3255400|P2|Overall Study|Lost to Follow-up|4
990847|NCT00483548|3255401|P1|Overall Study|Lost to Follow-up|3
990848|NCT00483548|3255400|P2|Overall Study|Non-compliance with medication|0
990849|NCT00483548|3255401|P1|Overall Study|Non-compliance with medication|2
990850|NCT00483548|3255400|P2|Overall Study|Unable to comply with protocol schedule|0
990851|NCT00483548|3255401|P1|Overall Study|Unable to comply with protocol schedule|1
990852|NCT00483548|3255400|P2|Overall Study|Protocol required discontinuation|6
990853|NCT00483548|3255401|P1|Overall Study|Protocol required discontinuation|6
990854|NCT00483548|3255400|P2|Overall Study|Pregnancy|0
990855|NCT00483548|3255401|P1|Overall Study|Pregnancy|1
990856|NCT00483548|3255400|P2|Overall Study|Protocol Violation|7
990857|NCT00483548|3255401|P1|Overall Study|Protocol Violation|11
990858|NCT00483548|3255400|P2|Overall Study|Lack of Efficacy|8
990859|NCT00483548|3255401|P1|Overall Study|Lack of Efficacy|4
990860|NCT00483548|3255400|P2|Overall Study|Laboratory abnormality|2
990861|NCT00483548|3255401|P1|Overall Study|Laboratory abnormality|1
990862|NCT00483548|3255400|P2|Overall Study|Adverse Event|14
990863|NCT00483548|3255401|P1|Overall Study|Adverse Event|25
990864|NCT00483548|3255400|P2|Overall Study|Randomized; not treated with study drug|3
990865|NCT00483548|3255401|P1|Overall Study|Randomized; not treated with study drug|1
990866|NCT00483405|3255451|P1|Overall Study|Other complicating disease|1
990867|NCT00483405|3255451|P1|Overall Study|Withdrawal by Subject|2
990868|NCT00483405|3255451|P1|Overall Study|Death|3
990869|NCT00483405|3255451|P1|Overall Study|Lack of Efficacy|14
990870|NCT00483405|3255451|P1|Overall Study|Adverse Event|8
990871|NCT00483379|3255460|P2|Treatment Period|Withdrawal by Subject|0
990872|NCT00483379|3255461|P1|Treatment Period|Withdrawal by Subject|1
990873|NCT00483379|3255460|P2|Treatment Period|Adverse Event|0
990874|NCT00483379|3255461|P1|Treatment Period|Adverse Event|1
990875|NCT00483327|3255497|P1|Overall Study|Patient Non Compliance|2
990876|NCT00483327|3255497|P1|Overall Study|Lost to Follow-up|4
990877|NCT00483327|3255497|P1|Overall Study|Withdrawal by Subject|3
990878|NCT00483327|3255497|P1|Overall Study|Adverse Event|1
990879|NCT00483184|3255529|P3|Overall Study|Protocol Violation|1
990880|NCT00483184|3255530|P2|Overall Study|Protocol Violation|0
990881|NCT00483184|3255531|P1|Overall Study|Protocol Violation|1
990882|NCT00483184|3255529|P3|Overall Study|Adverse Event|2
990883|NCT00483184|3255530|P2|Overall Study|Adverse Event|2
990884|NCT00483184|3255531|P1|Overall Study|Adverse Event|1
990885|NCT00483184|3255529|P3|Overall Study|Lost to Follow-up|0
990886|NCT00483184|3255530|P2|Overall Study|Lost to Follow-up|0
990887|NCT00483184|3255531|P1|Overall Study|Lost to Follow-up|1
990888|NCT00483184|3255529|P3|Overall Study|Withdrawal by Subject|0
990889|NCT00483184|3255530|P2|Overall Study|Withdrawal by Subject|2
990890|NCT00483184|3255531|P1|Overall Study|Withdrawal by Subject|2
990891|NCT00483119|3255541|P2|Overall Study|Physician Decision|0
990892|NCT00483119|3255542|P1|Overall Study|Physician Decision|1
990893|NCT00483119|3255541|P2|Overall Study|Adverse Event|1
990894|NCT00483119|3255542|P1|Overall Study|Adverse Event|0
990895|NCT00483041|3255556|P2|Overall Study|ABNORMAL LAB DATA AT SCREENING|1
990896|NCT00483041|3255557|P1|Overall Study|ABNORMAL LAB DATA AT SCREENING|0
990897|NCT00483002|3255587|P1|Overall Study|Other|967
990898|NCT00483002|3255587|P1|Overall Study|Other|2
990899|NCT00483002|3255587|P1|Overall Study|Lost to Follow-up|962
990900|NCT00483002|3255587|P1|Overall Study|Lack of Efficacy|555
990901|NCT00483002|3255587|P1|Overall Study|Adverse Event|68
990902|NCT00482729|3255612|P2|Overall Study|Withdrawal by Subject|69
990903|NCT00482729|3255613|P1|Overall Study|Withdrawal by Subject|67
990904|NCT00482729|3255612|P2|Overall Study|Protocol Violation|18
990905|NCT00482729|3255613|P1|Overall Study|Protocol Violation|10
990906|NCT00482729|3255612|P2|Overall Study|Pregnancy|2
990907|NCT00482729|3255613|P1|Overall Study|Pregnancy|4
990908|NCT00482729|3255612|P2|Overall Study|Physician Decision|7
990909|NCT00482729|3255613|P1|Overall Study|Physician Decision|10
990910|NCT00482729|3255612|P2|Overall Study|Lost to Follow-up|66
990911|NCT00482729|3255613|P1|Overall Study|Lost to Follow-up|86
990912|NCT00482729|3255612|P2|Overall Study|Lack of Efficacy|16
990913|NCT00482729|3255613|P1|Overall Study|Lack of Efficacy|4
990914|NCT00482729|3255612|P2|Overall Study|Hyperglycemia Criteria|5
990915|NCT00482729|3255613|P1|Overall Study|Hyperglycemia Criteria|7
990916|NCT00482729|3255612|P2|Overall Study|Creatinine/Creatinine Clearance Criteria|2
990917|NCT00482729|3255613|P1|Overall Study|Creatinine/Creatinine Clearance Criteria|0
990918|NCT00482729|3255612|P2|Overall Study|Adverse Event|33
990919|NCT00482729|3255613|P1|Overall Study|Adverse Event|29
990920|NCT00482703|3255629|P2|Overall Study|Poor compliance|0
990921|NCT00482703|3255630|P1|Overall Study|Poor compliance|1
990922|NCT00482612|3255701|P4|Follow-up Period|Reasons not related to trial|3
990923|NCT00482612|3255702|P3|Follow-up Period|Reasons not related to trial|1
990924|NCT00482612|3255703|P2|Follow-up Period|Reasons not related to trial|0
990925|NCT00482612|3255704|P1|Follow-up Period|Reasons not related to trial|1
990926|NCT00482612|3255701|P4|Follow-up Period|Withdrawal by Subject|2
990927|NCT00482612|3255702|P3|Follow-up Period|Withdrawal by Subject|7
990928|NCT00482612|3255703|P2|Follow-up Period|Withdrawal by Subject|5
990929|NCT00482612|3255704|P1|Follow-up Period|Withdrawal by Subject|3
990930|NCT00482612|3255701|P4|Follow-up Period|Lack of Efficacy|0
990931|NCT00482612|3255702|P3|Follow-up Period|Lack of Efficacy|1
990932|NCT00482612|3255703|P2|Follow-up Period|Lack of Efficacy|0
990933|NCT00482612|3255704|P1|Follow-up Period|Lack of Efficacy|2
990934|NCT00482612|3255701|P4|Follow-up Period|Adverse Event|0
990935|NCT00482612|3255702|P3|Follow-up Period|Adverse Event|9
990936|NCT00482612|3255703|P2|Follow-up Period|Adverse Event|7
990937|NCT00482612|3255704|P1|Follow-up Period|Adverse Event|4
990938|NCT00482612|3255701|P4|Follow-up Period|Lost to Follow-up|1
990939|NCT00482612|3255702|P3|Follow-up Period|Lost to Follow-up|2
990940|NCT00482612|3255703|P2|Follow-up Period|Lost to Follow-up|4
990941|NCT00482612|3255704|P1|Follow-up Period|Lost to Follow-up|0
990942|NCT00482612|3255701|P4|Follow-up Period|Lack of compliance|0
990943|NCT00482612|3255702|P3|Follow-up Period|Lack of compliance|1
990944|NCT00482612|3255703|P2|Follow-up Period|Lack of compliance|0
990945|NCT00482612|3255704|P1|Follow-up Period|Lack of compliance|0
990946|NCT00482612|3255701|P4|Follow-up Period|Other|2
990947|NCT00482612|3255702|P3|Follow-up Period|Other|1
990948|NCT00482612|3255703|P2|Follow-up Period|Other|2
990949|NCT00482612|3255704|P1|Follow-up Period|Other|4
990950|NCT00482612|3255701|P4|In-treatment Period|No study medication administered|0
990951|NCT00482612|3255702|P3|In-treatment Period|No study medication administered|1
990952|NCT00482612|3255703|P2|In-treatment Period|No study medication administered|0
990953|NCT00482612|3255704|P1|In-treatment Period|No study medication administered|0
990954|NCT00482391|3255753|P1|Overall Study|Death|1
990955|NCT00482391|3255753|P1|Overall Study|Adverse Event|1
990956|NCT00482391|3255753|P1|Overall Study|Withdrawal by Subject|1
990957|NCT00482274|3255758|P1|Overall Study|Adverse Event|1
990958|NCT00482170|3255768|P2|Overall Study|Unspecified reason|2
990959|NCT00482170|3255769|P1|Overall Study|Unspecified reason|0
990960|NCT00482170|3255768|P2|Overall Study|Lost to Follow-up|0
990961|NCT00482170|3255769|P1|Overall Study|Lost to Follow-up|2
990962|NCT00482170|3255768|P2|Overall Study|Protocol Violation|3
990963|NCT00482170|3255769|P1|Overall Study|Protocol Violation|2
990964|NCT00482170|3255768|P2|Overall Study|Withdrawal by Subject|1
990965|NCT00482170|3255769|P1|Overall Study|Withdrawal by Subject|6
990966|NCT00482170|3255768|P2|Overall Study|Adverse Event|14
990967|NCT00482170|3255769|P1|Overall Study|Adverse Event|5
990968|NCT00482053|3255887|P1|Inter-treatment Period|Disease progression|1
990969|NCT00482014|3255901|P4|Overall Study|Sponsor Decision|1
990970|NCT00482014|3255902|P3|Overall Study|Sponsor Decision|1
990971|NCT00482014|3255903|P2|Overall Study|Sponsor Decision|2
990972|NCT00482014|3255904|P1|Overall Study|Sponsor Decision|1
990973|NCT00482014|3255901|P4|Overall Study|Lack of Efficacy|6
990974|NCT00482014|3255902|P3|Overall Study|Lack of Efficacy|4
990975|NCT00482014|3255903|P2|Overall Study|Lack of Efficacy|0
990976|NCT00482014|3255904|P1|Overall Study|Lack of Efficacy|1
990977|NCT00482014|3255901|P4|Overall Study|Death|4
990978|NCT00482014|3255902|P3|Overall Study|Death|1
990979|NCT00482014|3255903|P2|Overall Study|Death|2
990980|NCT00482014|3255904|P1|Overall Study|Death|1
990981|NCT00482014|3255901|P4|Overall Study|Adverse Event|8
990982|NCT00482014|3255902|P3|Overall Study|Adverse Event|2
990983|NCT00482014|3255903|P2|Overall Study|Adverse Event|0
990984|NCT00482014|3255904|P1|Overall Study|Adverse Event|3
990985|NCT00482014|3255901|P4|Overall Study|Withdrawal by Subject|4
990986|NCT00482014|3255902|P3|Overall Study|Withdrawal by Subject|3
990987|NCT00482014|3255903|P2|Overall Study|Withdrawal by Subject|2
990988|NCT00482014|3255904|P1|Overall Study|Withdrawal by Subject|1
990989|NCT00481988|3255928|P2|Overall Study|Withdrawal by Subject|1
990990|NCT00481988|3255929|P1|Overall Study|Withdrawal by Subject|1
990991|NCT00481871|3255942|P5|Overall Study|Progressive Disease - pt withdrew|0
990992|NCT00481871|3255943|P4|Overall Study|Progressive Disease - pt withdrew|0
990993|NCT00481871|3255944|P3|Overall Study|Progressive Disease - pt withdrew|1
990994|NCT00481871|3255945|P2|Overall Study|Progressive Disease - pt withdrew|0
990995|NCT00481871|3255946|P1|Overall Study|Progressive Disease - pt withdrew|0
990996|NCT00481832|3255971|P1|Inter-transplant Period|Lack of allogeneic donor|5
990997|NCT00481832|3255971|P1|Inter-transplant Period|Disease relapse|11
990998|NCT00481832|3255971|P1|Inter-transplant Period|Physician Decision|4
990999|NCT00481832|3255971|P1|Inter-transplant Period|Death|3
991000|NCT00481832|3255971|P1|Inter-transplant Period|Adverse Event|4
991001|NCT00481832|3255971|P1|Enrollment|Unable to collect enough stem cells|2
991002|NCT00481832|3255971|P1|Enrollment|Physician Decision|8
991003|NCT00481767|3255986|P2|Overall Study|Lost to Follow-up|10
991004|NCT00481767|3255987|P1|Overall Study|Lost to Follow-up|16
991005|NCT00481767|3255986|P2|Overall Study|Withdrawal by Subject|11
991006|NCT00481767|3255987|P1|Overall Study|Withdrawal by Subject|16
991007|NCT00481676|3256021|P2|Overall Study|Administrative problem|0
991008|NCT00481676|3256022|P1|Overall Study|Administrative problem|1
991009|NCT00481676|3256021|P2|Overall Study|Unsatisfactory therapeutic effect|4
991010|NCT00481676|3256022|P1|Overall Study|Unsatisfactory therapeutic effect|1
991011|NCT00481676|3256021|P2|Overall Study|Adverse Event|1
991012|NCT00481676|3256022|P1|Overall Study|Adverse Event|0
991013|NCT00481247|3256072|P2|Overall Study|Did not receive treatment|2
991014|NCT00481247|3256073|P1|Overall Study|Did not receive treatment|1
991015|NCT00481247|3256072|P2|Overall Study|Varied|15
991016|NCT00481247|3256073|P1|Overall Study|Varied|6
991017|NCT00481247|3256072|P2|Overall Study|Administrative reason by sponsor|162
991018|NCT00481247|3256073|P1|Overall Study|Administrative reason by sponsor|157
991019|NCT00481247|3256072|P2|Overall Study|Poor compliance/noncompliance|7
991020|NCT00481247|3256073|P1|Overall Study|Poor compliance/noncompliance|1
991021|NCT00481247|3256072|P2|Overall Study|Lost to Follow-up|2
991022|NCT00481247|3256073|P1|Overall Study|Lost to Follow-up|1
991023|NCT00481247|3256072|P2|Overall Study|Pregnancy|1
991024|NCT00481247|3256073|P1|Overall Study|Pregnancy|2
991025|NCT00481247|3256072|P2|Overall Study|Withdrawal by Subject|13
991026|NCT00481247|3256073|P1|Overall Study|Withdrawal by Subject|8
991027|NCT00481247|3256072|P2|Overall Study|AE unrelated to study drug|4
991028|NCT00481247|3256073|P1|Overall Study|AE unrelated to study drug|13
991029|NCT00481247|3256072|P2|Overall Study|Treatment failure|14
991030|NCT00481247|3256073|P1|Overall Study|Treatment failure|10
991031|NCT00481247|3256072|P2|Overall Study|Intolerance|17
991032|NCT00481247|3256073|P1|Overall Study|Intolerance|42
991033|NCT00481247|3256072|P2|Overall Study|Disease progression|22
991034|NCT00481247|3256073|P1|Overall Study|Disease progression|18
991035|NCT00481247|3256072|P2|Overall Study|Death|1
991036|NCT00481247|3256073|P1|Overall Study|Death|0
991037|NCT00481195|3256097|P2|Overall Study|Miscellaneous|2
991038|NCT00481195|3256098|P1|Overall Study|Miscellaneous|2
991039|NCT00481195|3256097|P2|Overall Study|Withdrawal by Subject|9
991040|NCT00481195|3256098|P1|Overall Study|Withdrawal by Subject|3
991041|NCT00481195|3256097|P2|Overall Study|Protocol Violation|7
991042|NCT00481195|3256098|P1|Overall Study|Protocol Violation|10
991043|NCT00481195|3256097|P2|Overall Study|Physician Decision|1
991044|NCT00481195|3256098|P1|Overall Study|Physician Decision|3
991045|NCT00481195|3256097|P2|Overall Study|Lost to Follow-up|6
991046|NCT00481195|3256098|P1|Overall Study|Lost to Follow-up|4
991047|NCT00481195|3256097|P2|Overall Study|Lack of Efficacy|3
991048|NCT00481195|3256098|P1|Overall Study|Lack of Efficacy|1
991049|NCT00481195|3256097|P2|Overall Study|Adverse Event|11
991050|NCT00481195|3256098|P1|Overall Study|Adverse Event|16
991051|NCT00481078|3256184|P2|Overall Study|Brain metastasis|1
991052|NCT00481078|3256185|P1|Overall Study|Brain metastasis|0
991053|NCT00481078|3256184|P2|Overall Study|Received other treatment|1
991054|NCT00481078|3256185|P1|Overall Study|Received other treatment|2
991055|NCT00481078|3256184|P2|Overall Study|Information not available|0
991056|NCT00481078|3256185|P1|Overall Study|Information not available|1
991057|NCT00481078|3256184|P2|Overall Study|Withdrawal by Subject|1
991058|NCT00481078|3256185|P1|Overall Study|Withdrawal by Subject|7
991059|NCT00481078|3256184|P2|Overall Study|Intercurrent illness|0
991060|NCT00481078|3256185|P1|Overall Study|Intercurrent illness|1
991061|NCT00481078|3256184|P2|Overall Study|Death|3
991062|NCT00481078|3256185|P1|Overall Study|Death|5
991063|NCT00481078|3256184|P2|Overall Study|Adverse Event|3
991064|NCT00481078|3256185|P1|Overall Study|Adverse Event|15
991065|NCT00481078|3256184|P2|Overall Study|Progression of disease|11
991066|NCT00481078|3256185|P1|Overall Study|Progression of disease|11
991067|NCT00481065|3256203|P8|Overall Study|Unable to classify|0
991068|NCT00481065|3256204|P7|Overall Study|Unable to classify|0
991069|NCT00481065|3256205|P6|Overall Study|Unable to classify|0
991070|NCT00481065|3256206|P5|Overall Study|Unable to classify|1
991071|NCT00481065|3256207|P4|Overall Study|Unable to classify|0
991072|NCT00481065|3256208|P3|Overall Study|Unable to classify|2
991073|NCT00481065|3256209|P2|Overall Study|Unable to classify|1
991074|NCT00481065|3256210|P1|Overall Study|Unable to classify|0
991075|NCT00481065|3256203|P8|Overall Study|Protocol Violation|2
991076|NCT00481065|3256204|P7|Overall Study|Protocol Violation|3
991077|NCT00481065|3256205|P6|Overall Study|Protocol Violation|6
991078|NCT00481065|3256206|P5|Overall Study|Protocol Violation|2
991079|NCT00481065|3256207|P4|Overall Study|Protocol Violation|1
991080|NCT00481065|3256208|P3|Overall Study|Protocol Violation|1
991081|NCT00481065|3256209|P2|Overall Study|Protocol Violation|1
991082|NCT00481065|3256210|P1|Overall Study|Protocol Violation|2
991083|NCT00481065|3256203|P8|Overall Study|Administrative reason|0
991084|NCT00481065|3256204|P7|Overall Study|Administrative reason|1
991085|NCT00481065|3256205|P6|Overall Study|Administrative reason|2
991086|NCT00481065|3256206|P5|Overall Study|Administrative reason|0
991087|NCT00481065|3256207|P4|Overall Study|Administrative reason|0
991088|NCT00481065|3256208|P3|Overall Study|Administrative reason|0
991089|NCT00481065|3256209|P2|Overall Study|Administrative reason|0
991090|NCT00481065|3256210|P1|Overall Study|Administrative reason|0
991091|NCT00481065|3256203|P8|Overall Study|Inappropriate enrollment|1
991092|NCT00481065|3256204|P7|Overall Study|Inappropriate enrollment|0
991093|NCT00481065|3256205|P6|Overall Study|Inappropriate enrollment|1
991094|NCT00481065|3256206|P5|Overall Study|Inappropriate enrollment|2
991095|NCT00481065|3256207|P4|Overall Study|Inappropriate enrollment|0
991096|NCT00481065|3256208|P3|Overall Study|Inappropriate enrollment|2
991097|NCT00481065|3256209|P2|Overall Study|Inappropriate enrollment|0
991098|NCT00481065|3256210|P1|Overall Study|Inappropriate enrollment|4
991099|NCT00481065|3256203|P8|Overall Study|Lost to Follow-up|5
991100|NCT00481065|3256204|P7|Overall Study|Lost to Follow-up|2
991101|NCT00481065|3256205|P6|Overall Study|Lost to Follow-up|3
991102|NCT00481065|3256206|P5|Overall Study|Lost to Follow-up|3
991103|NCT00481065|3256207|P4|Overall Study|Lost to Follow-up|3
991104|NCT00481065|3256208|P3|Overall Study|Lost to Follow-up|4
991105|NCT00481065|3256209|P2|Overall Study|Lost to Follow-up|2
991106|NCT00481065|3256210|P1|Overall Study|Lost to Follow-up|4
991107|NCT00481065|3256203|P8|Overall Study|Withdrawal by Subject|10
991108|NCT00481065|3256204|P7|Overall Study|Withdrawal by Subject|9
991109|NCT00481065|3256205|P6|Overall Study|Withdrawal by Subject|12
991110|NCT00481065|3256206|P5|Overall Study|Withdrawal by Subject|13
991111|NCT00481065|3256207|P4|Overall Study|Withdrawal by Subject|11
991112|NCT00481065|3256208|P3|Overall Study|Withdrawal by Subject|7
991113|NCT00481065|3256209|P2|Overall Study|Withdrawal by Subject|12
991114|NCT00481065|3256210|P1|Overall Study|Withdrawal by Subject|11
991115|NCT00481065|3256203|P8|Overall Study|Adverse event or death|1
991116|NCT00481065|3256204|P7|Overall Study|Adverse event or death|1
991117|NCT00481065|3256205|P6|Overall Study|Adverse event or death|0
991118|NCT00481065|3256206|P5|Overall Study|Adverse event or death|2
991119|NCT00481065|3256207|P4|Overall Study|Adverse event or death|0
991120|NCT00481065|3256208|P3|Overall Study|Adverse event or death|3
991121|NCT00481065|3256209|P2|Overall Study|Adverse event or death|1
991122|NCT00481065|3256210|P1|Overall Study|Adverse event or death|1
991123|NCT00480857|3256300|P1|Overall Study|Lack of Efficacy|2
991124|NCT00480779|3256310|P2|Overall Study|Job and Health-related|3
991125|NCT00480779|3256311|P1|Overall Study|Job and Health-related|0
991126|NCT00480779|3256310|P2|Overall Study|Other|0
991127|NCT00480779|3256311|P1|Overall Study|Other|2
991128|NCT00480636|3256348|P1|Overall Study|Lost to follow-up; subsequently died|1
991129|NCT00480636|3256348|P1|Overall Study|Other|2
991130|NCT00480636|3256348|P1|Overall Study|Lost to Follow-up|4
991131|NCT00480636|3256348|P1|Overall Study|Death|12
991132|NCT00480532|3256360|P4|Overall Study|Protocol Violation|0
991133|NCT00480532|3256361|P3|Overall Study|Protocol Violation|1
991134|NCT00480532|3256362|P2|Overall Study|Protocol Violation|0
991135|NCT00480532|3256363|P1|Overall Study|Protocol Violation|0
991136|NCT00480532|3256360|P4|Overall Study|Withdrawal by Subject|1
991137|NCT00480532|3256361|P3|Overall Study|Withdrawal by Subject|3
991138|NCT00480532|3256362|P2|Overall Study|Withdrawal by Subject|4
991139|NCT00480532|3256363|P1|Overall Study|Withdrawal by Subject|2
991140|NCT00480493|3256383|P2|Overall Study|moved|7
991141|NCT00480493|3256384|P1|Overall Study|moved|2
991142|NCT00480324|3256396|P2|Overall Study|Subject’s mother pregnant|1
991143|NCT00480324|3256397|P1|Overall Study|Subject’s mother pregnant|0
991144|NCT00480324|3256396|P2|Overall Study|Lost to Follow-up|8
991145|NCT00480324|3256397|P1|Overall Study|Lost to Follow-up|17
991146|NCT00480324|3256396|P2|Overall Study|Withdrawal by Subject|5
991147|NCT00480324|3256397|P1|Overall Study|Withdrawal by Subject|14
991148|NCT00480324|3256396|P2|Overall Study|Protocol Violation|1
991149|NCT00480324|3256397|P1|Overall Study|Protocol Violation|0
991150|NCT00480324|3256396|P2|Overall Study|Adverse Event|1
991151|NCT00480324|3256397|P1|Overall Study|Adverse Event|1
991152|NCT00479882|3256427|P4|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
991153|NCT00479882|3256428|P3|Crossover: Period III (Weeks 13-20)|Protocol Violation|1
991154|NCT00479882|3256429|P2|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
991155|NCT00479882|3256430|P1|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
991156|NCT00479882|3256427|P4|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
991157|NCT00479882|3256428|P3|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1
991158|NCT00479882|3256429|P2|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
991159|NCT00479882|3256430|P1|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
991160|NCT00479882|3256427|P4|Crossover: Period III (Weeks 13-20)|Participant moved|0
991161|NCT00479882|3256428|P3|Crossover: Period III (Weeks 13-20)|Participant moved|1
991162|NCT00479882|3256429|P2|Crossover: Period III (Weeks 13-20)|Participant moved|2
991163|NCT00479882|3256430|P1|Crossover: Period III (Weeks 13-20)|Participant moved|1
991164|NCT00479882|3256427|P4|Crossover: Period III (Weeks 13-20)|Other|2
991165|NCT00479882|3256428|P3|Crossover: Period III (Weeks 13-20)|Other|2
991166|NCT00479882|3256429|P2|Crossover: Period III (Weeks 13-20)|Other|0
991167|NCT00479882|3256430|P1|Crossover: Period III (Weeks 13-20)|Other|5
991168|NCT00479882|3256427|P4|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
991169|NCT00479882|3256428|P3|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
991170|NCT00479882|3256429|P2|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2
991171|NCT00479882|3256430|P1|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
991172|NCT00479882|3256427|P4|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
991173|NCT00479882|3256428|P3|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
991174|NCT00479882|3256429|P2|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1
991175|NCT00479882|3256430|P1|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3
991176|NCT00479882|3256427|P4|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10
991177|NCT00479882|3256428|P3|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
991178|NCT00479882|3256429|P2|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13
991179|NCT00479882|3256430|P1|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
991180|NCT00479882|3256427|P4|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
991181|NCT00479882|3256428|P3|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5
991182|NCT00479882|3256429|P2|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
991183|NCT00479882|3256430|P1|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2
991184|NCT00479882|3256427|P4|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25
991185|NCT00479882|3256428|P3|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30
991186|NCT00479882|3256429|P2|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33
991187|NCT00479882|3256430|P1|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24
991188|NCT00479882|3256427|P4|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1
991189|NCT00479882|3256428|P3|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2
991190|NCT00479882|3256429|P2|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4
991191|NCT00479882|3256430|P1|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0
991192|NCT00479882|3256427|P4|Precrossover: Periods I/II (Weeks 1-12)|Other|5
991193|NCT00479882|3256428|P3|Precrossover: Periods I/II (Weeks 1-12)|Other|9
991194|NCT00479882|3256429|P2|Precrossover: Periods I/II (Weeks 1-12)|Other|6
991195|NCT00479882|3256430|P1|Precrossover: Periods I/II (Weeks 1-12)|Other|4
991196|NCT00479882|3256427|P4|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11
991197|NCT00479882|3256428|P3|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
991198|NCT00479882|3256429|P2|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
991199|NCT00479882|3256430|P1|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12
991200|NCT00479882|3256427|P4|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
991201|NCT00479882|3256428|P3|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
991202|NCT00479882|3256429|P2|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
991203|NCT00479882|3256430|P1|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0
991204|NCT00479882|3256427|P4|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87
991205|NCT00479882|3256428|P3|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98
991206|NCT00479882|3256429|P2|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99
991207|NCT00479882|3256430|P1|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96
991208|NCT00479856|3256560|P1|Overall Study|Physician Decision|1
991209|NCT00479856|3256560|P1|Overall Study|Withdrawal by Subject|1
991210|NCT00479856|3256560|P1|Overall Study|Adverse Event|1
991211|NCT00479765|3256569|P1|Overall Study|study terminated|4
991212|NCT00479713|3256575|P2|Overall Study|Withdrawal by Subject|1
991213|NCT00479713|3256576|P1|Overall Study|Withdrawal by Subject|4
991214|NCT00479713|3256575|P2|Overall Study|Protocol Violation|1
991215|NCT00479713|3256576|P1|Overall Study|Protocol Violation|0
991216|NCT00479713|3256575|P2|Overall Study|Lost to Follow-up|1
991217|NCT00479713|3256576|P1|Overall Study|Lost to Follow-up|0
991218|NCT00479713|3256575|P2|Overall Study|Death|0
991219|NCT00479713|3256576|P1|Overall Study|Death|1
991220|NCT00479713|3256575|P2|Overall Study|Adverse Event|6
991221|NCT00479713|3256576|P1|Overall Study|Adverse Event|8
991222|NCT00479674|3256600|P1|Overall Study|none provided|3
991223|NCT00479674|3256600|P1|Overall Study|Physician Decision|14
991224|NCT00479674|3256600|P1|Overall Study|Withdrawal by Subject|6
991225|NCT00479674|3256600|P1|Overall Study|Adverse Event|18
991226|NCT00479557|3256615|P7|Overall Study|Not specified|0
991227|NCT00479557|3256616|P6|Overall Study|Not specified|3
991228|NCT00479557|3256617|P5|Overall Study|Not specified|0
991229|NCT00479557|3256618|P4|Overall Study|Not specified|0
991230|NCT00479557|3256619|P3|Overall Study|Not specified|1
991231|NCT00479557|3256620|P2|Overall Study|Not specified|3
991232|NCT00479557|3256621|P1|Overall Study|Not specified|2
991233|NCT00479557|3256615|P7|Overall Study|Subject Request|1
991234|NCT00479557|3256616|P6|Overall Study|Subject Request|4
991235|NCT00479557|3256617|P5|Overall Study|Subject Request|1
991236|NCT00479557|3256618|P4|Overall Study|Subject Request|1
991237|NCT00479557|3256619|P3|Overall Study|Subject Request|1
991238|NCT00479557|3256620|P2|Overall Study|Subject Request|0
991239|NCT00479557|3256621|P1|Overall Study|Subject Request|3
991240|NCT00479557|3256615|P7|Overall Study|Investigator Request|0
991241|NCT00479557|3256616|P6|Overall Study|Investigator Request|0
991242|NCT00479557|3256617|P5|Overall Study|Investigator Request|0
991243|NCT00479557|3256618|P4|Overall Study|Investigator Request|0
991244|NCT00479557|3256619|P3|Overall Study|Investigator Request|1
991245|NCT00479557|3256620|P2|Overall Study|Investigator Request|0
991246|NCT00479557|3256621|P1|Overall Study|Investigator Request|0
991247|NCT00479557|3256615|P7|Overall Study|Caregiver Request|0
991248|NCT00479557|3256616|P6|Overall Study|Caregiver Request|2
991249|NCT00479557|3256617|P5|Overall Study|Caregiver Request|1
991250|NCT00479557|3256618|P4|Overall Study|Caregiver Request|0
991251|NCT00479557|3256619|P3|Overall Study|Caregiver Request|2
991252|NCT00479557|3256620|P2|Overall Study|Caregiver Request|2
991253|NCT00479557|3256621|P1|Overall Study|Caregiver Request|2
991254|NCT00479557|3256615|P7|Overall Study|AE not related to Study Drug|1
991255|NCT00479557|3256616|P6|Overall Study|AE not related to Study Drug|2
991256|NCT00479557|3256617|P5|Overall Study|AE not related to Study Drug|2
991257|NCT00479557|3256618|P4|Overall Study|AE not related to Study Drug|0
991258|NCT00479557|3256619|P3|Overall Study|AE not related to Study Drug|0
991259|NCT00479557|3256620|P2|Overall Study|AE not related to Study Drug|3
991260|NCT00479557|3256621|P1|Overall Study|AE not related to Study Drug|1
991261|NCT00479557|3256615|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
991262|NCT00479557|3256616|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
991263|NCT00479557|3256617|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
991264|NCT00479557|3256618|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
991265|NCT00479557|3256619|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
991266|NCT00479557|3256620|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
991267|NCT00479557|3256621|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
991268|NCT00479557|3256615|P7|Overall Study|Lost to Follow-up|0
991269|NCT00479557|3256616|P6|Overall Study|Lost to Follow-up|0
991270|NCT00479557|3256617|P5|Overall Study|Lost to Follow-up|0
991271|NCT00479557|3256618|P4|Overall Study|Lost to Follow-up|2
991272|NCT00479557|3256619|P3|Overall Study|Lost to Follow-up|0
991273|NCT00479557|3256620|P2|Overall Study|Lost to Follow-up|2
991274|NCT00479557|3256621|P1|Overall Study|Lost to Follow-up|0
991275|NCT00479557|3256615|P7|Overall Study|Lack of Efficacy|0
991276|NCT00479557|3256616|P6|Overall Study|Lack of Efficacy|0
991277|NCT00479557|3256617|P5|Overall Study|Lack of Efficacy|0
991278|NCT00479557|3256618|P4|Overall Study|Lack of Efficacy|0
991279|NCT00479557|3256619|P3|Overall Study|Lack of Efficacy|0
991280|NCT00479557|3256620|P2|Overall Study|Lack of Efficacy|0
991281|NCT00479557|3256621|P1|Overall Study|Lack of Efficacy|1
991282|NCT00479557|3256615|P7|Overall Study|Death|0
991283|NCT00479557|3256616|P6|Overall Study|Death|1
991284|NCT00479557|3256617|P5|Overall Study|Death|0
991285|NCT00479557|3256618|P4|Overall Study|Death|0
991286|NCT00479557|3256619|P3|Overall Study|Death|0
991287|NCT00479557|3256620|P2|Overall Study|Death|0
991288|NCT00479557|3256621|P1|Overall Study|Death|0
991289|NCT00479466|3256664|P6|Overall Study|Withdrawal by Subject|1
991290|NCT00479466|3256665|P5|Overall Study|Withdrawal by Subject|3
991291|NCT00479466|3256666|P4|Overall Study|Withdrawal by Subject|2
991292|NCT00479466|3256667|P3|Overall Study|Withdrawal by Subject|0
991293|NCT00479466|3256668|P2|Overall Study|Withdrawal by Subject|5
991294|NCT00479466|3256669|P1|Overall Study|Withdrawal by Subject|3
991295|NCT00479466|3256664|P6|Overall Study|Protocol Violation|0
991296|NCT00479466|3256665|P5|Overall Study|Protocol Violation|0
991297|NCT00479466|3256666|P4|Overall Study|Protocol Violation|0
991298|NCT00479466|3256667|P3|Overall Study|Protocol Violation|0
991299|NCT00479466|3256668|P2|Overall Study|Protocol Violation|0
991300|NCT00479466|3256669|P1|Overall Study|Protocol Violation|1
991301|NCT00479466|3256664|P6|Overall Study|Pregnancy|0
991302|NCT00479466|3256665|P5|Overall Study|Pregnancy|1
991303|NCT00479466|3256666|P4|Overall Study|Pregnancy|0
991304|NCT00479466|3256667|P3|Overall Study|Pregnancy|0
991305|NCT00479466|3256668|P2|Overall Study|Pregnancy|0
991306|NCT00479466|3256669|P1|Overall Study|Pregnancy|0
991307|NCT00479466|3256664|P6|Overall Study|Physician Decision|0
991308|NCT00479466|3256665|P5|Overall Study|Physician Decision|0
991309|NCT00479466|3256666|P4|Overall Study|Physician Decision|0
991310|NCT00479466|3256667|P3|Overall Study|Physician Decision|1
991311|NCT00479466|3256668|P2|Overall Study|Physician Decision|1
991312|NCT00479466|3256669|P1|Overall Study|Physician Decision|2
991313|NCT00479466|3256664|P6|Overall Study|Lost to Follow-up|2
991314|NCT00479466|3256665|P5|Overall Study|Lost to Follow-up|2
991315|NCT00479466|3256666|P4|Overall Study|Lost to Follow-up|0
991316|NCT00479466|3256667|P3|Overall Study|Lost to Follow-up|1
991317|NCT00479466|3256668|P2|Overall Study|Lost to Follow-up|1
991318|NCT00479466|3256669|P1|Overall Study|Lost to Follow-up|0
991319|NCT00479466|3256664|P6|Overall Study|Lack of Efficacy|0
991320|NCT00479466|3256665|P5|Overall Study|Lack of Efficacy|0
991321|NCT00479466|3256666|P4|Overall Study|Lack of Efficacy|0
991322|NCT00479466|3256667|P3|Overall Study|Lack of Efficacy|1
991323|NCT00479466|3256668|P2|Overall Study|Lack of Efficacy|0
991324|NCT00479466|3256669|P1|Overall Study|Lack of Efficacy|2
991325|NCT00479466|3256664|P6|Overall Study|Hyperglycemia|1
991326|NCT00479466|3256665|P5|Overall Study|Hyperglycemia|0
991327|NCT00479466|3256666|P4|Overall Study|Hyperglycemia|0
991328|NCT00479466|3256667|P3|Overall Study|Hyperglycemia|0
991329|NCT00479466|3256668|P2|Overall Study|Hyperglycemia|0
991330|NCT00479466|3256669|P1|Overall Study|Hyperglycemia|0
991331|NCT00479466|3256664|P6|Overall Study|Adverse Event|0
991332|NCT00479466|3256665|P5|Overall Study|Adverse Event|2
991333|NCT00479466|3256666|P4|Overall Study|Adverse Event|1
991334|NCT00479466|3256667|P3|Overall Study|Adverse Event|0
991335|NCT00479466|3256668|P2|Overall Study|Adverse Event|1
991336|NCT00479466|3256669|P1|Overall Study|Adverse Event|5
991337|NCT00479401|3256698|P3|Overall Study|Exclusion criteria, relocation|0
991338|NCT00479401|3256699|P2|Overall Study|Exclusion criteria, relocation|3
991339|NCT00479401|3256700|P1|Overall Study|Exclusion criteria, relocation|4
991340|NCT00479401|3256698|P3|Overall Study|Withdrawal by Subject|2
991341|NCT00479401|3256699|P2|Overall Study|Withdrawal by Subject|10
991342|NCT00479401|3256700|P1|Overall Study|Withdrawal by Subject|16
991343|NCT00479401|3256698|P3|Overall Study|Lost to Follow-up|1
991344|NCT00479401|3256699|P2|Overall Study|Lost to Follow-up|1
991345|NCT00479401|3256700|P1|Overall Study|Lost to Follow-up|1
991346|NCT00479401|3256698|P3|Overall Study|Protocol Violation|1
991347|NCT00479401|3256699|P2|Overall Study|Protocol Violation|1
991348|NCT00479401|3256700|P1|Overall Study|Protocol Violation|2
991349|NCT00479401|3256698|P3|Overall Study|Lack of Efficacy|4
991350|NCT00479401|3256699|P2|Overall Study|Lack of Efficacy|2
991351|NCT00479401|3256700|P1|Overall Study|Lack of Efficacy|2
991352|NCT00479401|3256698|P3|Overall Study|Adverse Event|4
991353|NCT00479401|3256699|P2|Overall Study|Adverse Event|20
991354|NCT00479401|3256700|P1|Overall Study|Adverse Event|24
991355|NCT00479388|3256755|P2|Overall Study|Withdrawal by Subject|17
991356|NCT00479388|3256756|P1|Overall Study|Withdrawal by Subject|32
991357|NCT00479388|3256755|P2|Overall Study|Protocol Violation|9
991358|NCT00479388|3256756|P1|Overall Study|Protocol Violation|10
991359|NCT00479388|3256755|P2|Overall Study|Lost to Follow-up|2
991360|NCT00479388|3256756|P1|Overall Study|Lost to Follow-up|0
991361|NCT00479388|3256755|P2|Overall Study|Adverse Event|45
991362|NCT00479388|3256756|P1|Overall Study|Adverse Event|90
991363|NCT00479336|3256770|P4|Overall Study|Resolution of all hepatic edema findings|0
991364|NCT00479336|3256771|P3|Overall Study|Resolution of all hepatic edema findings|0
991365|NCT00479336|3256772|P2|Overall Study|Resolution of all hepatic edema findings|1
991366|NCT00479336|3256773|P1|Overall Study|Resolution of all hepatic edema findings|1
991367|NCT00479336|3256770|P4|Overall Study|Physician Decision|2
991368|NCT00479336|3256771|P3|Overall Study|Physician Decision|0
991369|NCT00479336|3256772|P2|Overall Study|Physician Decision|1
991370|NCT00479336|3256773|P1|Overall Study|Physician Decision|0
991371|NCT00479336|3256770|P4|Overall Study|Withdrawal by Subject|0
991372|NCT00479336|3256771|P3|Overall Study|Withdrawal by Subject|0
991373|NCT00479336|3256772|P2|Overall Study|Withdrawal by Subject|2
991374|NCT00479336|3256773|P1|Overall Study|Withdrawal by Subject|1
991375|NCT00479336|3256770|P4|Overall Study|Protocol Violation|0
991376|NCT00479336|3256771|P3|Overall Study|Protocol Violation|0
991377|NCT00479336|3256772|P2|Overall Study|Protocol Violation|1
991378|NCT00479336|3256773|P1|Overall Study|Protocol Violation|0
991379|NCT00479336|3256770|P4|Overall Study|Lack of Efficacy|0
991380|NCT00479336|3256771|P3|Overall Study|Lack of Efficacy|0
991381|NCT00479336|3256772|P2|Overall Study|Lack of Efficacy|0
991382|NCT00479336|3256773|P1|Overall Study|Lack of Efficacy|1
991383|NCT00479336|3256770|P4|Overall Study|Adverse Event|3
991384|NCT00479336|3256771|P3|Overall Study|Adverse Event|1
991385|NCT00479336|3256772|P2|Overall Study|Adverse Event|1
991386|NCT00479336|3256773|P1|Overall Study|Adverse Event|1
991387|NCT00479232|3256796|P6|Overall Study|Withdrew Consent|3
991388|NCT00479232|3256797|P5|Overall Study|Withdrew Consent|1
991389|NCT00479232|3256798|P4|Overall Study|Withdrew Consent|0
991390|NCT00479232|3256799|P3|Overall Study|Withdrew Consent|6
991391|NCT00479232|3256800|P2|Overall Study|Withdrew Consent|2
991392|NCT00479232|3256801|P1|Overall Study|Withdrew Consent|0
991393|NCT00479232|3256796|P6|Overall Study|Progressive Disease|12
991394|NCT00479232|3256797|P5|Overall Study|Progressive Disease|3
991395|NCT00479232|3256798|P4|Overall Study|Progressive Disease|3
991396|NCT00479232|3256799|P3|Overall Study|Progressive Disease|12
991397|NCT00479232|3256800|P2|Overall Study|Progressive Disease|1
991398|NCT00479232|3256801|P1|Overall Study|Progressive Disease|3
991399|NCT00479232|3256796|P6|Overall Study|Physician Decision|1
991400|NCT00479232|3256797|P5|Overall Study|Physician Decision|0
991401|NCT00479232|3256798|P4|Overall Study|Physician Decision|0
991402|NCT00479232|3256799|P3|Overall Study|Physician Decision|2
991403|NCT00479232|3256800|P2|Overall Study|Physician Decision|0
991404|NCT00479232|3256801|P1|Overall Study|Physician Decision|0
991405|NCT00479232|3256796|P6|Overall Study|Lack of Efficacy|4
991406|NCT00479232|3256797|P5|Overall Study|Lack of Efficacy|0
991407|NCT00479232|3256798|P4|Overall Study|Lack of Efficacy|0
991408|NCT00479232|3256799|P3|Overall Study|Lack of Efficacy|2
991409|NCT00479232|3256800|P2|Overall Study|Lack of Efficacy|0
991410|NCT00479232|3256801|P1|Overall Study|Lack of Efficacy|0
991411|NCT00479232|3256796|P6|Overall Study|Deviation from Protocol|0
991412|NCT00479232|3256797|P5|Overall Study|Deviation from Protocol|0
991413|NCT00479232|3256798|P4|Overall Study|Deviation from Protocol|0
991414|NCT00479232|3256799|P3|Overall Study|Deviation from Protocol|1
991415|NCT00479232|3256800|P2|Overall Study|Deviation from Protocol|0
991416|NCT00479232|3256801|P1|Overall Study|Deviation from Protocol|0
991417|NCT00479232|3256796|P6|Overall Study|Adverse Event|10
991418|NCT00479232|3256797|P5|Overall Study|Adverse Event|0
991419|NCT00479232|3256798|P4|Overall Study|Adverse Event|0
991420|NCT00479232|3256799|P3|Overall Study|Adverse Event|5
991421|NCT00479232|3256800|P2|Overall Study|Adverse Event|0
991422|NCT00479232|3256801|P1|Overall Study|Adverse Event|0
991423|NCT00478933|3256854|P1|Overall Study|Inadequate data available|53
991424|NCT00478933|3256854|P1|Overall Study|Informed consent not verified|3
991425|NCT00478933|3256854|P1|Overall Study|Protocol Violation|22
991426|NCT00478881|3256880|P2|Overall Study|Non-Compliance with Study Medication|2
991427|NCT00478881|3256881|P1|Overall Study|Non-Compliance with Study Medication|0
991428|NCT00478881|3256880|P2|Overall Study|Withdrawal by Subject|2
991429|NCT00478881|3256881|P1|Overall Study|Withdrawal by Subject|6
991430|NCT00478881|3256880|P2|Overall Study|Protocol Violation|2
991431|NCT00478881|3256881|P1|Overall Study|Protocol Violation|2
991432|NCT00478881|3256880|P2|Overall Study|Lost to Follow-up|1
991433|NCT00478881|3256881|P1|Overall Study|Lost to Follow-up|0
991434|NCT00478881|3256880|P2|Overall Study|Lack of Efficacy|3
991435|NCT00478881|3256881|P1|Overall Study|Lack of Efficacy|0
991436|NCT00478881|3256880|P2|Overall Study|Adverse Event|12
991437|NCT00478881|3256881|P1|Overall Study|Adverse Event|31
991438|NCT00478777|3256905|P1|Overall Study|Not treated with lenalidomide|6
991439|NCT00478777|3256905|P1|Overall Study|End of therapy|2
991440|NCT00478777|3256905|P1|Overall Study|Lymphocytes infusion|1
991441|NCT00478777|3256905|P1|Overall Study|Lack of compliance|1
991442|NCT00478777|3256905|P1|Overall Study|Intolerance of therapy|1
991443|NCT00478777|3256905|P1|Overall Study|Physician Decision|1
991444|NCT00478777|3256905|P1|Overall Study|Lost to Follow-up|3
991445|NCT00478777|3256905|P1|Overall Study|Protocol Violation|3
991446|NCT00478777|3256905|P1|Overall Study|Death|3
991447|NCT00478777|3256905|P1|Overall Study|Withdrawal by Subject|4
991448|NCT00478777|3256905|P1|Overall Study|Lack of Efficacy|23
991449|NCT00478777|3256905|P1|Overall Study|Adverse Event|29
991450|NCT00478673|3256912|P1|12-Months Post-Procedure|Visit Not Required by Protocol|6
991451|NCT00478673|3256912|P1|12-Months Post-Procedure|Missed Visit|25
991452|NCT00478673|3256912|P1|12-Months Post-Procedure|Withdrawal by Subject|6
991453|NCT00478673|3256912|P1|12-Months Post-Procedure|Lost to Follow-up|4
991454|NCT00478673|3256912|P1|12-Months Post-Procedure|Death|23
991455|NCT00478673|3256912|P1|30-Days Post-Procedure|Missed Visit|7
991456|NCT00478673|3256912|P1|30-Days Post-Procedure|Withdrawal by Subject|1
991457|NCT00478673|3256912|P1|30-Days Post-Procedure|Death|2
991458|NCT00478647|3256917|P1|Overall Study|Withdrawal by Subject|1
991459|NCT00478647|3256917|P1|Overall Study|Adverse Event|1
991460|NCT00478608|3256925|P1|Overall Study|Protocol Violation|3
991461|NCT00478608|3256925|P1|Overall Study|Withdrawal by Subject|2
991462|NCT00478608|3256925|P1|Overall Study|Serious Adverse Event|14
991463|NCT00478608|3256925|P1|Overall Study|Adverse Event|1
991464|NCT00478257|3256969|P2|Overall Study|Withdrawal by Subject|3
991465|NCT00478257|3256970|P1|Overall Study|Withdrawal by Subject|8
991466|NCT00478244|3256976|P1|Overall Study|Did not receive transplant|1
991467|NCT00478231|3256989|P1|Overall Study|Randomized, not treated|3
991468|NCT00478231|3256989|P1|Overall Study|Adverse Event|5
991469|NCT00478231|3256989|P1|Overall Study|Other|9
991470|NCT00478231|3256989|P1|Overall Study|Withdrawal by Subject|6
991471|NCT00478231|3256989|P1|Overall Study|Lost to Follow-up|7
991472|NCT00478231|3256989|P1|Overall Study|Lack of Efficacy|47
991473|NCT00478231|3256989|P1|Overall Study|Death|7
991474|NCT00478205|3257025|P2|Overall Study|Not specified|12
991475|NCT00478205|3257026|P1|Overall Study|Not specified|24
991476|NCT00478205|3257025|P2|Overall Study|Lack of Efficacy|0
991477|NCT00478205|3257026|P1|Overall Study|Lack of Efficacy|1
991478|NCT00478205|3257025|P2|Overall Study|Withdrawal by Subject|22
991479|NCT00478205|3257026|P1|Overall Study|Withdrawal by Subject|61
991480|NCT00478205|3257025|P2|Overall Study|Request of Investigator or Sponsor|5
991481|NCT00478205|3257026|P1|Overall Study|Request of Investigator or Sponsor|4
991482|NCT00478205|3257025|P2|Overall Study|Protocol Violation|5
991483|NCT00478205|3257026|P1|Overall Study|Protocol Violation|15
991484|NCT00478205|3257025|P2|Overall Study|Medication Non-compliance|4
991485|NCT00478205|3257026|P1|Overall Study|Medication Non-compliance|9
991486|NCT00478205|3257025|P2|Overall Study|Adverse Event|39
991487|NCT00478205|3257026|P1|Overall Study|Adverse Event|182
991488|NCT00478140|3257070|P1|Overall Study|Disease Progression|3
991489|NCT00478023|3257099|P5|Overall Study|Lack of pain, Technical difficulties|3
991490|NCT00478023|3257100|P4|Overall Study|Lack of pain, Technical difficulties|6
991491|NCT00478023|3257101|P3|Overall Study|Lack of pain, Technical difficulties|5
991492|NCT00478023|3257102|P2|Overall Study|Lack of pain, Technical difficulties|3
991493|NCT00478023|3257103|P1|Overall Study|Lack of pain, Technical difficulties|7
991494|NCT00478023|3257099|P5|Overall Study|Withdrawal by Subject|5
991495|NCT00478023|3257100|P4|Overall Study|Withdrawal by Subject|4
991496|NCT00478023|3257101|P3|Overall Study|Withdrawal by Subject|2
991497|NCT00478023|3257102|P2|Overall Study|Withdrawal by Subject|3
991498|NCT00478023|3257103|P1|Overall Study|Withdrawal by Subject|2
991499|NCT00478023|3257099|P5|Overall Study|Lost to Follow-up|0
991500|NCT00478023|3257100|P4|Overall Study|Lost to Follow-up|1
991501|NCT00478023|3257101|P3|Overall Study|Lost to Follow-up|1
991502|NCT00478023|3257102|P2|Overall Study|Lost to Follow-up|1
991503|NCT00478023|3257103|P1|Overall Study|Lost to Follow-up|3
991504|NCT00478023|3257099|P5|Overall Study|Lack of Efficacy|41
991505|NCT00478023|3257100|P4|Overall Study|Lack of Efficacy|5
991506|NCT00478023|3257101|P3|Overall Study|Lack of Efficacy|4
991507|NCT00478023|3257102|P2|Overall Study|Lack of Efficacy|10
991508|NCT00478023|3257103|P1|Overall Study|Lack of Efficacy|11
991509|NCT00478023|3257099|P5|Overall Study|Death|0
991510|NCT00478023|3257100|P4|Overall Study|Death|0
991511|NCT00478023|3257101|P3|Overall Study|Death|0
991512|NCT00478023|3257102|P2|Overall Study|Death|0
991513|NCT00478023|3257103|P1|Overall Study|Death|1
991514|NCT00478023|3257099|P5|Overall Study|Adverse Event|6
991515|NCT00478023|3257100|P4|Overall Study|Adverse Event|14
991516|NCT00478023|3257101|P3|Overall Study|Adverse Event|8
991517|NCT00478023|3257102|P2|Overall Study|Adverse Event|7
991518|NCT00478023|3257103|P1|Overall Study|Adverse Event|11
991519|NCT00477971|3257122|P2|Overall Study|Alternative treatment|1
991520|NCT00477971|3257123|P1|Overall Study|Alternative treatment|3
991521|NCT00477971|3257122|P2|Overall Study|Death|4
991522|NCT00477971|3257123|P1|Overall Study|Death|2
991523|NCT00477971|3257122|P2|Overall Study|Adverse Event|0
991524|NCT00477971|3257123|P1|Overall Study|Adverse Event|3
991525|NCT00477971|3257122|P2|Overall Study|Withdrawal by Subject|1
991526|NCT00477971|3257123|P1|Overall Study|Withdrawal by Subject|3
991527|NCT00477971|3257122|P2|Overall Study|Disease progression|0
991528|NCT00477971|3257123|P1|Overall Study|Disease progression|6
991529|NCT00477750|3257135|P1|Overall Study|Currently Receiving Treatment|11
991530|NCT00477672|3257147|P3|Overall Study|Discretion of Sponsor|0
991531|NCT00477672|3257148|P2|Overall Study|Discretion of Sponsor|2
991532|NCT00477672|3257149|P1|Overall Study|Discretion of Sponsor|1
991533|NCT00477672|3257147|P3|Overall Study|Consent withdrawn|10
991534|NCT00477672|3257148|P2|Overall Study|Consent withdrawn|5
991535|NCT00477672|3257149|P1|Overall Study|Consent withdrawn|2
991536|NCT00477672|3257147|P3|Overall Study|Protocol noncompliance|0
991537|NCT00477672|3257148|P2|Overall Study|Protocol noncompliance|2
991538|NCT00477672|3257149|P1|Overall Study|Protocol noncompliance|0
991539|NCT00477672|3257147|P3|Overall Study|Physician Decision|0
991540|NCT00477672|3257148|P2|Overall Study|Physician Decision|0
991541|NCT00477672|3257149|P1|Overall Study|Physician Decision|1
991542|NCT00477672|3257147|P3|Overall Study|Disease progression|0
991543|NCT00477672|3257148|P2|Overall Study|Disease progression|1
991544|NCT00477672|3257149|P1|Overall Study|Disease progression|0
991545|NCT00477672|3257147|P3|Overall Study|Death|0
991546|NCT00477672|3257148|P2|Overall Study|Death|1
991547|NCT00477672|3257149|P1|Overall Study|Death|0
991548|NCT00477672|3257147|P3|Overall Study|Adverse Event|6
991549|NCT00477672|3257148|P2|Overall Study|Adverse Event|5
991550|NCT00477672|3257149|P1|Overall Study|Adverse Event|3
991551|NCT00477633|3257160|P1|Overall Study|Various (Moving, Enrollment closed)|75
991552|NCT00477633|3257160|P1|Overall Study|Protocol Violation|25
991553|NCT00477633|3257160|P1|Overall Study|Withdrawal by Subject|149
991554|NCT00477633|3257160|P1|Overall Study|Lost to Follow-up|271
991555|NCT00477633|3257160|P1|Overall Study|Pregnancy|23
991556|NCT00477633|3257160|P1|Overall Study|Adverse Event|143
991557|NCT00477633|3257160|P1|Overall Study|Did not receive treatment|23
991558|NCT00477607|3257168|P2|Overall Study|Lost to Follow-up|7
991559|NCT00477607|3257169|P1|Overall Study|Lost to Follow-up|7
991560|NCT00477594|3257181|P2|Follow-up Period|Other|0
991561|NCT00477594|3257182|P1|Follow-up Period|Other|1
991562|NCT00477594|3257181|P2|Follow-up Period|Withdrawal by Subject|1
991563|NCT00477594|3257182|P1|Follow-up Period|Withdrawal by Subject|2
991564|NCT00477594|3257181|P2|Year 3|Withdrawal by Subject|0
991565|NCT00477594|3257182|P1|Year 3|Withdrawal by Subject|1
991566|NCT00477594|3257181|P2|Year 3|Adverse Event|0
991567|NCT00477594|3257182|P1|Year 3|Adverse Event|1
991568|NCT00477594|3257181|P2|Year 1 and Year 2|Other|0
991569|NCT00477594|3257182|P1|Year 1 and Year 2|Other|1
991570|NCT00477594|3257181|P2|Year 1 and Year 2|Withdrawal by Subject|1
991571|NCT00477594|3257182|P1|Year 1 and Year 2|Withdrawal by Subject|2
991572|NCT00477594|3257181|P2|Year 1 and Year 2|Physician Decision|1
991573|NCT00477594|3257182|P1|Year 1 and Year 2|Physician Decision|2
991574|NCT00477594|3257181|P2|Year 1 and Year 2|Adverse Event|2
991575|NCT00477594|3257182|P1|Year 1 and Year 2|Adverse Event|4
991576|NCT00477490|3257243|P9|Part II: Extension Week 5 up to Day 169|Not reported|0
991577|NCT00477490|3257244|P8|Part II: Extension Week 5 up to Day 169|Not reported|0
991578|NCT00477490|3257245|P7|Part II: Extension Week 5 up to Day 169|Not reported|0
991579|NCT00477490|3257246|P6|Part II: Extension Week 5 up to Day 169|Not reported|0
991580|NCT00477490|3257247|P5|Part II: Extension Week 5 up to Day 169|Not reported|1
991581|NCT00477490|3257248|P4|Part II: Extension Week 5 up to Day 169|Not reported|0
991582|NCT00477490|3257249|P3|Part II: Extension Week 5 up to Day 169|Not reported|1
991583|NCT00477490|3257250|P2|Part II: Extension Week 5 up to Day 169|Not reported|3
991584|NCT00477490|3257251|P1|Part II: Extension Week 5 up to Day 169|Not reported|0
991585|NCT00477490|3257243|P9|Part II: Extension Week 5 up to Day 169|Other, not specified|1
991586|NCT00477490|3257244|P8|Part II: Extension Week 5 up to Day 169|Other, not specified|0
991587|NCT00477490|3257245|P7|Part II: Extension Week 5 up to Day 169|Other, not specified|1
991588|NCT00477490|3257246|P6|Part II: Extension Week 5 up to Day 169|Other, not specified|1
991589|NCT00477490|3257247|P5|Part II: Extension Week 5 up to Day 169|Other, not specified|2
991590|NCT00477490|3257248|P4|Part II: Extension Week 5 up to Day 169|Other, not specified|4
991591|NCT00477490|3257249|P3|Part II: Extension Week 5 up to Day 169|Other, not specified|2
991592|NCT00477490|3257250|P2|Part II: Extension Week 5 up to Day 169|Other, not specified|4
991593|NCT00477490|3257251|P1|Part II: Extension Week 5 up to Day 169|Other, not specified|0
991594|NCT00477490|3257243|P9|Part II: Extension Week 5 up to Day 169|Excluded medication|0
991595|NCT00477490|3257244|P8|Part II: Extension Week 5 up to Day 169|Excluded medication|0
991596|NCT00477490|3257245|P7|Part II: Extension Week 5 up to Day 169|Excluded medication|0
991597|NCT00477490|3257246|P6|Part II: Extension Week 5 up to Day 169|Excluded medication|0
991598|NCT00477490|3257247|P5|Part II: Extension Week 5 up to Day 169|Excluded medication|0
991599|NCT00477490|3257248|P4|Part II: Extension Week 5 up to Day 169|Excluded medication|0
991600|NCT00477490|3257249|P3|Part II: Extension Week 5 up to Day 169|Excluded medication|0
991601|NCT00477490|3257250|P2|Part II: Extension Week 5 up to Day 169|Excluded medication|1
991602|NCT00477490|3257251|P1|Part II: Extension Week 5 up to Day 169|Excluded medication|0
991603|NCT00477490|3257243|P9|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
991604|NCT00477490|3257244|P8|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
991605|NCT00477490|3257245|P7|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
991606|NCT00477490|3257246|P6|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
991607|NCT00477490|3257247|P5|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
991608|NCT00477490|3257248|P4|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
991609|NCT00477490|3257249|P3|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
991610|NCT00477490|3257250|P2|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
991611|NCT00477490|3257251|P1|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
991612|NCT00477490|3257243|P9|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
991613|NCT00477490|3257244|P8|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
991614|NCT00477490|3257245|P7|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1
991615|NCT00477490|3257246|P6|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
991616|NCT00477490|3257247|P5|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5
991617|NCT00477490|3257248|P4|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
991618|NCT00477490|3257249|P3|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2
991619|NCT00477490|3257250|P2|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3
991620|NCT00477490|3257251|P1|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
991621|NCT00477490|3257243|P9|Part II: Extension Week 5 up to Day 169|Adverse Event|4
991622|NCT00477490|3257244|P8|Part II: Extension Week 5 up to Day 169|Adverse Event|1
991623|NCT00477490|3257245|P7|Part II: Extension Week 5 up to Day 169|Adverse Event|1
991624|NCT00477490|3257246|P6|Part II: Extension Week 5 up to Day 169|Adverse Event|1
991625|NCT00477490|3257247|P5|Part II: Extension Week 5 up to Day 169|Adverse Event|1
991626|NCT00477490|3257248|P4|Part II: Extension Week 5 up to Day 169|Adverse Event|1
991627|NCT00477490|3257249|P3|Part II: Extension Week 5 up to Day 169|Adverse Event|3
991628|NCT00477490|3257250|P2|Part II: Extension Week 5 up to Day 169|Adverse Event|2
991629|NCT00477490|3257251|P1|Part II: Extension Week 5 up to Day 169|Adverse Event|0
991630|NCT00477490|3257243|P9|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
991631|NCT00477490|3257244|P8|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3
991632|NCT00477490|3257245|P7|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
991633|NCT00477490|3257246|P6|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4
991634|NCT00477490|3257247|P5|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10
991635|NCT00477490|3257248|P4|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
991636|NCT00477490|3257249|P3|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
991637|NCT00477490|3257250|P2|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15
991638|NCT00477490|3257251|P1|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0
991639|NCT00477490|3257243|P9|Part I: 4 Week Efficacy|Not Reported|0
991640|NCT00477490|3257244|P8|Part I: 4 Week Efficacy|Not Reported|0
991641|NCT00477490|3257245|P7|Part I: 4 Week Efficacy|Not Reported|0
991642|NCT00477490|3257246|P6|Part I: 4 Week Efficacy|Not Reported|0
991643|NCT00477490|3257247|P5|Part I: 4 Week Efficacy|Not Reported|1
991644|NCT00477490|3257248|P4|Part I: 4 Week Efficacy|Not Reported|0
991645|NCT00477490|3257249|P3|Part I: 4 Week Efficacy|Not Reported|3
991646|NCT00477490|3257250|P2|Part I: 4 Week Efficacy|Not Reported|2
991647|NCT00477490|3257251|P1|Part I: 4 Week Efficacy|Not Reported|1
991648|NCT00477490|3257243|P9|Part I: 4 Week Efficacy|Other, not specified|0
991649|NCT00477490|3257244|P8|Part I: 4 Week Efficacy|Other, not specified|0
991650|NCT00477490|3257245|P7|Part I: 4 Week Efficacy|Other, not specified|0
991651|NCT00477490|3257246|P6|Part I: 4 Week Efficacy|Other, not specified|0
991652|NCT00477490|3257247|P5|Part I: 4 Week Efficacy|Other, not specified|1
991653|NCT00477490|3257248|P4|Part I: 4 Week Efficacy|Other, not specified|1
991654|NCT00477490|3257249|P3|Part I: 4 Week Efficacy|Other, not specified|0
991655|NCT00477490|3257250|P2|Part I: 4 Week Efficacy|Other, not specified|4
991656|NCT00477490|3257251|P1|Part I: 4 Week Efficacy|Other, not specified|2
991657|NCT00477490|3257243|P9|Part I: 4 Week Efficacy|Lost to Follow-up|0
991658|NCT00477490|3257244|P8|Part I: 4 Week Efficacy|Lost to Follow-up|0
991659|NCT00477490|3257245|P7|Part I: 4 Week Efficacy|Lost to Follow-up|0
991660|NCT00477490|3257246|P6|Part I: 4 Week Efficacy|Lost to Follow-up|0
991661|NCT00477490|3257247|P5|Part I: 4 Week Efficacy|Lost to Follow-up|3
991662|NCT00477490|3257248|P4|Part I: 4 Week Efficacy|Lost to Follow-up|5
991663|NCT00477490|3257249|P3|Part I: 4 Week Efficacy|Lost to Follow-up|1
991664|NCT00477490|3257250|P2|Part I: 4 Week Efficacy|Lost to Follow-up|4
991665|NCT00477490|3257251|P1|Part I: 4 Week Efficacy|Lost to Follow-up|2
991666|NCT00477490|3257243|P9|Part I: 4 Week Efficacy|Withdrawal by Subject|0
991667|NCT00477490|3257244|P8|Part I: 4 Week Efficacy|Withdrawal by Subject|0
991668|NCT00477490|3257245|P7|Part I: 4 Week Efficacy|Withdrawal by Subject|0
991669|NCT00477490|3257246|P6|Part I: 4 Week Efficacy|Withdrawal by Subject|0
991670|NCT00477490|3257247|P5|Part I: 4 Week Efficacy|Withdrawal by Subject|9
991671|NCT00477490|3257248|P4|Part I: 4 Week Efficacy|Withdrawal by Subject|4
991672|NCT00477490|3257249|P3|Part I: 4 Week Efficacy|Withdrawal by Subject|6
991673|NCT00477490|3257250|P2|Part I: 4 Week Efficacy|Withdrawal by Subject|5
991674|NCT00477490|3257251|P1|Part I: 4 Week Efficacy|Withdrawal by Subject|6
991675|NCT00477490|3257243|P9|Part I: 4 Week Efficacy|Protocol Violation|0
991676|NCT00477490|3257244|P8|Part I: 4 Week Efficacy|Protocol Violation|0
991677|NCT00477490|3257245|P7|Part I: 4 Week Efficacy|Protocol Violation|0
991678|NCT00477490|3257246|P6|Part I: 4 Week Efficacy|Protocol Violation|0
991679|NCT00477490|3257247|P5|Part I: 4 Week Efficacy|Protocol Violation|1
991680|NCT00477490|3257248|P4|Part I: 4 Week Efficacy|Protocol Violation|0
991681|NCT00477490|3257249|P3|Part I: 4 Week Efficacy|Protocol Violation|0
991682|NCT00477490|3257250|P2|Part I: 4 Week Efficacy|Protocol Violation|0
991683|NCT00477490|3257251|P1|Part I: 4 Week Efficacy|Protocol Violation|2
991684|NCT00477490|3257243|P9|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
991685|NCT00477490|3257244|P8|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
991686|NCT00477490|3257245|P7|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
991687|NCT00477490|3257246|P6|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
991688|NCT00477490|3257247|P5|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4
991689|NCT00477490|3257248|P4|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5
991690|NCT00477490|3257249|P3|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
991691|NCT00477490|3257250|P2|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
991692|NCT00477490|3257251|P1|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1
991693|NCT00477490|3257243|P9|Part I: 4 Week Efficacy|Adverse Event|0
991694|NCT00477490|3257244|P8|Part I: 4 Week Efficacy|Adverse Event|0
991695|NCT00477490|3257245|P7|Part I: 4 Week Efficacy|Adverse Event|0
991696|NCT00477490|3257246|P6|Part I: 4 Week Efficacy|Adverse Event|0
991697|NCT00477490|3257247|P5|Part I: 4 Week Efficacy|Adverse Event|6
991698|NCT00477490|3257248|P4|Part I: 4 Week Efficacy|Adverse Event|5
991699|NCT00477490|3257249|P3|Part I: 4 Week Efficacy|Adverse Event|0
991700|NCT00477490|3257250|P2|Part I: 4 Week Efficacy|Adverse Event|4
991701|NCT00477490|3257251|P1|Part I: 4 Week Efficacy|Adverse Event|1
991702|NCT00477464|3257335|P1|Overall Study|Completion of protocol-defined follow-up|14
991703|NCT00477464|3257335|P1|Overall Study|Death|36
991704|NCT00477464|3257335|P1|Overall Study|Lost to Follow-up|1
991705|NCT00477386|3257379|P2|Overall Study|Withdrawal by Subject|0
991706|NCT00477386|3257380|P1|Overall Study|Withdrawal by Subject|1
991707|NCT00477386|3257379|P2|Overall Study|Physician Decision|0
991708|NCT00477386|3257380|P1|Overall Study|Physician Decision|1
991709|NCT00477386|3257379|P2|Overall Study|Other|2
991710|NCT00477386|3257380|P1|Overall Study|Other|1
991711|NCT00477386|3257379|P2|Overall Study|Disease progression, refractory|3
991712|NCT00477386|3257380|P1|Overall Study|Disease progression, refractory|1
991713|NCT00477386|3257379|P2|Overall Study|Disease progression, relapse|4
991714|NCT00477386|3257380|P1|Overall Study|Disease progression, relapse|3
991715|NCT00477386|3257379|P2|Overall Study|Adverse Event|8
991716|NCT00477386|3257380|P1|Overall Study|Adverse Event|4
991717|NCT00477334|3257390|P2|Overall Study|Protocol Violation|1
991718|NCT00477334|3257391|P1|Overall Study|Protocol Violation|7
991719|NCT00477334|3257390|P2|Overall Study|Administrative Problems|15
991720|NCT00477334|3257391|P1|Overall Study|Administrative Problems|39
991721|NCT00477334|3257390|P2|Overall Study|Lost to Follow-up|4
991722|NCT00477334|3257391|P1|Overall Study|Lost to Follow-up|15
991723|NCT00477334|3257390|P2|Overall Study|Withdrawal by Subject|1
991724|NCT00477334|3257391|P1|Overall Study|Withdrawal by Subject|2
991725|NCT00477334|3257390|P2|Overall Study|Adverse Event|2
991726|NCT00477334|3257391|P1|Overall Study|Adverse Event|1
991727|NCT00477334|3257390|P2|Overall Study|Discontinued prior to taking study drug|53
991728|NCT00477334|3257391|P1|Overall Study|Discontinued prior to taking study drug|106
991729|NCT00477295|3257417|P2|Overall Study|Not specified|3
991730|NCT00477295|3257418|P1|Overall Study|Not specified|4
991731|NCT00477295|3257417|P2|Overall Study|Lost to Follow-up|11
991732|NCT00477295|3257418|P1|Overall Study|Lost to Follow-up|21
991733|NCT00477295|3257417|P2|Overall Study|Physician Decision|5
991734|NCT00477295|3257418|P1|Overall Study|Physician Decision|4
991735|NCT00477295|3257417|P2|Overall Study|Protocol Violation|8
991736|NCT00477295|3257418|P1|Overall Study|Protocol Violation|3
991737|NCT00477295|3257417|P2|Overall Study|Lack of Efficacy|23
991738|NCT00477295|3257418|P1|Overall Study|Lack of Efficacy|23
991739|NCT00477295|3257417|P2|Overall Study|Withdrawal by Subject|24
991740|NCT00477295|3257418|P1|Overall Study|Withdrawal by Subject|35
991741|NCT00477295|3257417|P2|Overall Study|Adverse Event|35
991742|NCT00477295|3257418|P1|Overall Study|Adverse Event|31
991743|NCT00477269|3257446|P3|Open Label Extension|Death|4
991744|NCT00477269|3257447|P2|Open Label Extension|Death|0
991745|NCT00477269|3257448|P1|Open Label Extension|Death|0
991746|NCT00477269|3257446|P3|Open Label Extension|Adminiatrative problems|2
991747|NCT00477269|3257447|P2|Open Label Extension|Adminiatrative problems|0
991748|NCT00477269|3257448|P1|Open Label Extension|Adminiatrative problems|0
991749|NCT00477269|3257446|P3|Open Label Extension|unsatisfactory therapeutic effects|2
991750|NCT00477269|3257447|P2|Open Label Extension|unsatisfactory therapeutic effects|0
991751|NCT00477269|3257448|P1|Open Label Extension|unsatisfactory therapeutic effects|0
991752|NCT00477269|3257446|P3|Open Label Extension|Abnormal laboratory values|1
991753|NCT00477269|3257447|P2|Open Label Extension|Abnormal laboratory values|0
991754|NCT00477269|3257448|P1|Open Label Extension|Abnormal laboratory values|0
991755|NCT00477269|3257446|P3|Open Label Extension|Adverse Event|4
991756|NCT00477269|3257447|P2|Open Label Extension|Adverse Event|0
991757|NCT00477269|3257448|P1|Open Label Extension|Adverse Event|0
991758|NCT00477269|3257446|P3|Core Study|Withdrawn Consent|0
991759|NCT00477269|3257447|P2|Core Study|Withdrawn Consent|1
991760|NCT00477269|3257448|P1|Core Study|Withdrawn Consent|0
991761|NCT00477269|3257446|P3|Core Study|Death|0
991762|NCT00477269|3257447|P2|Core Study|Death|3
991763|NCT00477269|3257448|P1|Core Study|Death|3
991764|NCT00477269|3257446|P3|Core Study|Adverse Event|0
991765|NCT00477269|3257447|P2|Core Study|Adverse Event|4
991766|NCT00477269|3257448|P1|Core Study|Adverse Event|6
991767|NCT00477165|3257527|P2|Overall Study|Adverse Event|2
991768|NCT00477165|3257528|P1|Overall Study|Adverse Event|7
991769|NCT00477152|3257540|P1|Overall Study|Adverse Event|1
991770|NCT00477152|3257540|P1|Overall Study|Parent withdrew consent|2
991771|NCT00476957|3257555|P2|Overall Study|Lost to Follow-up|193
991772|NCT00476957|3257556|P1|Overall Study|Lost to Follow-up|176
991773|NCT00476593|3257620|P4|Overall Study|Lost to Follow-up|22
991774|NCT00476593|3257621|P3|Overall Study|Lost to Follow-up|8
991775|NCT00476593|3257622|P2|Overall Study|Lost to Follow-up|2
991776|NCT00476593|3257623|P1|Overall Study|Lost to Follow-up|10
991777|NCT00476476|3257635|P2|Overall Study|Progressive Disease|17
991778|NCT00476476|3257636|P1|Overall Study|Progressive Disease|0
991779|NCT00476476|3257635|P2|Overall Study|Adverse Event|7
991780|NCT00476476|3257636|P1|Overall Study|Adverse Event|2
991781|NCT00476229|3257654|P1|Overall Study|Progressive shortness of breath|1
991782|NCT00476151|3257660|P2|Overall Study|Physician Decision|2
991783|NCT00476151|3257661|P1|Overall Study|Physician Decision|0
991784|NCT00476151|3257660|P2|Overall Study|Withdrawal by Subject|0
991785|NCT00476151|3257661|P1|Overall Study|Withdrawal by Subject|2
991786|NCT00476151|3257660|P2|Overall Study|Protocol Violation|3
991787|NCT00476151|3257661|P1|Overall Study|Protocol Violation|1
991788|NCT00476151|3257660|P2|Overall Study|Adverse Event|2
991789|NCT00476151|3257661|P1|Overall Study|Adverse Event|0
991790|NCT00476086|3257667|P1|Overall Study|Progressive Disease|4
991791|NCT00476086|3257667|P1|Overall Study|Alternative therapy|1
991792|NCT00476047|3257673|P1|Overall Study|Lost to Follow-up|1
991793|NCT00476008|3257699|P2|Overall Study|Death|0
991794|NCT00476008|3257700|P1|Overall Study|Death|1
991795|NCT00476008|3257699|P2|Overall Study|Withdrawal by Subject|1
991796|NCT00476008|3257700|P1|Overall Study|Withdrawal by Subject|0
991797|NCT00476008|3257699|P2|Overall Study|Physician Decision: Medication Noncompli|1
991798|NCT00476008|3257700|P1|Overall Study|Physician Decision: Medication Noncompli|2
991799|NCT00476008|3257699|P2|Overall Study|Placebo concerns|2
991800|NCT00476008|3257700|P1|Overall Study|Placebo concerns|2
991801|NCT00476008|3257699|P2|Overall Study|Adverse Event|4
991802|NCT00476008|3257700|P1|Overall Study|Adverse Event|4
991803|NCT00475865|3257754|P3|Overall Study|Other than above|0
991804|NCT00475865|3257755|P2|Overall Study|Other than above|1
991805|NCT00475865|3257756|P1|Overall Study|Other than above|0
991806|NCT00475865|3257754|P3|Overall Study|Participant did not wish to continue|0
991807|NCT00475865|3257755|P2|Overall Study|Participant did not wish to continue|0
991808|NCT00475865|3257756|P1|Overall Study|Participant did not wish to continue|1
991809|NCT00475865|3257754|P3|Overall Study|Progressive disease|2
991810|NCT00475865|3257755|P2|Overall Study|Progressive disease|1
991811|NCT00475865|3257756|P1|Overall Study|Progressive disease|0
991812|NCT00475865|3257754|P3|Overall Study|Lack of Efficacy|0
991813|NCT00475865|3257755|P2|Overall Study|Lack of Efficacy|0
991814|NCT00475865|3257756|P1|Overall Study|Lack of Efficacy|1
991815|NCT00475865|3257754|P3|Overall Study|Adverse Event|4
991816|NCT00475865|3257755|P2|Overall Study|Adverse Event|3
991817|NCT00475865|3257756|P1|Overall Study|Adverse Event|0
991818|NCT00475852|3257786|P2|Overall Study|Lost to Follow-up|68
991819|NCT00475852|3257787|P1|Overall Study|Lost to Follow-up|54
991820|NCT00475852|3257786|P2|Overall Study|Withdrawal by Subject|24
991821|NCT00475852|3257787|P1|Overall Study|Withdrawal by Subject|19
991822|NCT00475852|3257786|P2|Overall Study|Death|456
991823|NCT00475852|3257787|P1|Overall Study|Death|444
991824|NCT00475735|3257838|P6|Treatment Period 2|Withdrawal by Subject|0
991825|NCT00475735|3257839|P5|Treatment Period 2|Withdrawal by Subject|1
991826|NCT00475735|3257840|P4|Treatment Period 2|Withdrawal by Subject|0
991827|NCT00475735|3257841|P3|Treatment Period 2|Withdrawal by Subject|0
991828|NCT00475735|3257842|P2|Treatment Period 2|Withdrawal by Subject|0
991829|NCT00475735|3257843|P1|Treatment Period 2|Withdrawal by Subject|0
991830|NCT00475735|3257838|P6|Treatment Period 2|Lack of Efficacy|1
991831|NCT00475735|3257839|P5|Treatment Period 2|Lack of Efficacy|0
991832|NCT00475735|3257840|P4|Treatment Period 2|Lack of Efficacy|0
991833|NCT00475735|3257841|P3|Treatment Period 2|Lack of Efficacy|0
991834|NCT00475735|3257842|P2|Treatment Period 2|Lack of Efficacy|0
991835|NCT00475735|3257843|P1|Treatment Period 2|Lack of Efficacy|0
991836|NCT00475735|3257838|P6|Treatment Period 2|Adverse Event|0
991837|NCT00475735|3257839|P5|Treatment Period 2|Adverse Event|0
991838|NCT00475735|3257840|P4|Treatment Period 2|Adverse Event|2
991839|NCT00475735|3257841|P3|Treatment Period 2|Adverse Event|0
991840|NCT00475735|3257842|P2|Treatment Period 2|Adverse Event|1
991841|NCT00475735|3257843|P1|Treatment Period 2|Adverse Event|0
991842|NCT00475735|3257838|P6|Treatment Washout|Protocol Violation|0
991843|NCT00475735|3257839|P5|Treatment Washout|Protocol Violation|0
991844|NCT00475735|3257840|P4|Treatment Washout|Protocol Violation|0
991845|NCT00475735|3257841|P3|Treatment Washout|Protocol Violation|0
991846|NCT00475735|3257842|P2|Treatment Washout|Protocol Violation|1
991847|NCT00475735|3257843|P1|Treatment Washout|Protocol Violation|0
991848|NCT00475735|3257838|P6|Treatment Washout|Lost to Follow-up|0
991849|NCT00475735|3257839|P5|Treatment Washout|Lost to Follow-up|0
991850|NCT00475735|3257840|P4|Treatment Washout|Lost to Follow-up|0
991851|NCT00475735|3257841|P3|Treatment Washout|Lost to Follow-up|0
991852|NCT00475735|3257842|P2|Treatment Washout|Lost to Follow-up|1
991853|NCT00475735|3257843|P1|Treatment Washout|Lost to Follow-up|0
991854|NCT00475735|3257838|P6|Treatment Period 1|DC due to no efficacy but Continuing|0
991855|NCT00475735|3257839|P5|Treatment Period 1|DC due to no efficacy but Continuing|0
991856|NCT00475735|3257840|P4|Treatment Period 1|DC due to no efficacy but Continuing|0
991857|NCT00475735|3257841|P3|Treatment Period 1|DC due to no efficacy but Continuing|0
991858|NCT00475735|3257842|P2|Treatment Period 1|DC due to no efficacy but Continuing|1
991859|NCT00475735|3257843|P1|Treatment Period 1|DC due to no efficacy but Continuing|0
991860|NCT00475735|3257838|P6|Treatment Period 1|DC due to AE but continuing|2
991861|NCT00475735|3257839|P5|Treatment Period 1|DC due to AE but continuing|2
991862|NCT00475735|3257840|P4|Treatment Period 1|DC due to AE but continuing|1
991863|NCT00475735|3257841|P3|Treatment Period 1|DC due to AE but continuing|0
991864|NCT00475735|3257842|P2|Treatment Period 1|DC due to AE but continuing|0
991865|NCT00475735|3257843|P1|Treatment Period 1|DC due to AE but continuing|0
991866|NCT00475735|3257838|P6|Treatment Period 1|Withdrawal by Subject|0
991867|NCT00475735|3257839|P5|Treatment Period 1|Withdrawal by Subject|0
991868|NCT00475735|3257840|P4|Treatment Period 1|Withdrawal by Subject|0
991869|NCT00475735|3257841|P3|Treatment Period 1|Withdrawal by Subject|0
991870|NCT00475735|3257842|P2|Treatment Period 1|Withdrawal by Subject|1
991871|NCT00475735|3257843|P1|Treatment Period 1|Withdrawal by Subject|1
991872|NCT00475735|3257838|P6|Treatment Period 1|Protocol Violation|0
991873|NCT00475735|3257839|P5|Treatment Period 1|Protocol Violation|0
991874|NCT00475735|3257840|P4|Treatment Period 1|Protocol Violation|1
991875|NCT00475735|3257841|P3|Treatment Period 1|Protocol Violation|0
991876|NCT00475735|3257842|P2|Treatment Period 1|Protocol Violation|0
991877|NCT00475735|3257843|P1|Treatment Period 1|Protocol Violation|0
991878|NCT00475735|3257838|P6|Treatment Period 1|Lost to Follow-up|1
991879|NCT00475735|3257839|P5|Treatment Period 1|Lost to Follow-up|0
991880|NCT00475735|3257840|P4|Treatment Period 1|Lost to Follow-up|0
991881|NCT00475735|3257841|P3|Treatment Period 1|Lost to Follow-up|0
991882|NCT00475735|3257842|P2|Treatment Period 1|Lost to Follow-up|0
991883|NCT00475735|3257843|P1|Treatment Period 1|Lost to Follow-up|0
991884|NCT00475735|3257838|P6|Treatment Period 1|Lack of Efficacy|0
991885|NCT00475735|3257839|P5|Treatment Period 1|Lack of Efficacy|0
991886|NCT00475735|3257840|P4|Treatment Period 1|Lack of Efficacy|0
991887|NCT00475735|3257841|P3|Treatment Period 1|Lack of Efficacy|0
991888|NCT00475735|3257842|P2|Treatment Period 1|Lack of Efficacy|0
991889|NCT00475735|3257843|P1|Treatment Period 1|Lack of Efficacy|1
991890|NCT00475735|3257838|P6|Treatment Period 1|Adverse Event|0
991891|NCT00475735|3257839|P5|Treatment Period 1|Adverse Event|0
991892|NCT00475735|3257840|P4|Treatment Period 1|Adverse Event|0
991893|NCT00475735|3257841|P3|Treatment Period 1|Adverse Event|0
991894|NCT00475735|3257842|P2|Treatment Period 1|Adverse Event|0
991895|NCT00475735|3257843|P1|Treatment Period 1|Adverse Event|2
991896|NCT00475722|3257856|P2|Overall Study|Protocol Violation|0
991897|NCT00475722|3257857|P1|Overall Study|Protocol Violation|3
991898|NCT00475722|3257856|P2|Overall Study|Withdrawal by Subject|12
991899|NCT00475722|3257857|P1|Overall Study|Withdrawal by Subject|12
991900|NCT00475709|3257863|P1|Overall Study|Lost to Follow-up|21
991901|NCT00475709|3257863|P1|Overall Study|Device Explant|6
991902|NCT00475709|3257863|P1|Overall Study|Death|41
991903|NCT00475709|3257863|P1|Overall Study|Did not meet eligibility criteria|8
991904|NCT00475670|3257871|P2|Overall Study|Not Specified|3
991905|NCT00475670|3257872|P1|Overall Study|Not Specified|0
991906|NCT00475670|3257871|P2|Overall Study|Failure to Return|1
991907|NCT00475670|3257872|P1|Overall Study|Failure to Return|0
991908|NCT00475670|3257871|P2|Overall Study|Refused treatment|2
991909|NCT00475670|3257872|P1|Overall Study|Refused treatment|0
991910|NCT00475670|3257871|P2|Overall Study|Lack of Efficacy|34
991911|NCT00475670|3257872|P1|Overall Study|Lack of Efficacy|3
991912|NCT00475670|3257871|P2|Overall Study|Death|1
991913|NCT00475670|3257872|P1|Overall Study|Death|0
991914|NCT00475657|3257896|P1|Overall Study|Sponsor's Decision|3
991915|NCT00475657|3257896|P1|Overall Study|Death|1
991916|NCT00475644|3257904|P1|Overall Study|Protocol Violation|13
991917|NCT00475423|3257969|P1|Overall Study|Lost to Follow-up|7
991918|NCT00475423|3257969|P1|Overall Study|Reason not specified|1
991919|NCT00475423|3257969|P1|Overall Study|Death|1
991920|NCT00475423|3257969|P1|Overall Study|Lack of Efficacy|8
991921|NCT00475423|3257969|P1|Overall Study|Withdrawal by Subject|6
991922|NCT00475423|3257969|P1|Overall Study|Adverse Event|4
991923|NCT00475423|3257969|P1|Overall Study|Protocol Violation|5
991924|NCT00475306|3258015|P4|Overall Study|Protocol Violation|1
991925|NCT00475306|3258016|P3|Overall Study|Protocol Violation|0
991926|NCT00475306|3258017|P2|Overall Study|Protocol Violation|1
991927|NCT00475306|3258018|P1|Overall Study|Protocol Violation|1
991928|NCT00475228|3258043|P2|Overall Study|Lost to Follow-up|17
991929|NCT00475228|3258044|P1|Overall Study|Lost to Follow-up|17
991930|NCT00475176|3258054|P1|Overall Study|Protocol Violation|1
991931|NCT00475176|3258054|P1|Overall Study|Withdrawal by Subject|1
991932|NCT00475176|3258054|P1|Overall Study|Adverse Event|2
991933|NCT00475033|3258094|P2|Toddler Dose|Lost to Follow-up|0
991934|NCT00475033|3258095|P1|Toddler Dose|Lost to Follow-up|1
991935|NCT00475033|3258094|P2|Toddler Dose|Failed to return|0
991936|NCT00475033|3258095|P1|Toddler Dose|Failed to return|1
991937|NCT00475033|3258094|P2|Toddler Dose|Parent or legal guardian request|0
991938|NCT00475033|3258095|P1|Toddler Dose|Parent or legal guardian request|2
991939|NCT00475033|3258094|P2|After the Infant Series|Other|1
991940|NCT00475033|3258095|P1|After the Infant Series|Other|0
991941|NCT00475033|3258094|P2|After the Infant Series|Lost to Follow-up|0
991942|NCT00475033|3258095|P1|After the Infant Series|Lost to Follow-up|1
991943|NCT00475033|3258094|P2|After the Infant Series|Protocol Violation|0
991944|NCT00475033|3258095|P1|After the Infant Series|Protocol Violation|1
991945|NCT00475033|3258094|P2|After the Infant Series|Failed to return|1
991946|NCT00475033|3258095|P1|After the Infant Series|Failed to return|2
991947|NCT00475033|3258094|P2|After the Infant Series|Parent or legal guardian request|2
991948|NCT00475033|3258095|P1|After the Infant Series|Parent or legal guardian request|2
991949|NCT00475033|3258094|P2|After the Infant Series|Adverse Event|4
991950|NCT00475033|3258095|P1|After the Infant Series|Adverse Event|0
991951|NCT00475033|3258094|P2|Infant Series|Adverse Event|2
991952|NCT00475033|3258095|P1|Infant Series|Adverse Event|0
991953|NCT00475033|3258094|P2|Infant Series|Lost to Follow-up|0
991954|NCT00475033|3258095|P1|Infant Series|Lost to Follow-up|2
991955|NCT00475033|3258094|P2|Infant Series|Protocol Violation|2
991956|NCT00475033|3258095|P1|Infant Series|Protocol Violation|1
991957|NCT00475033|3258094|P2|Infant Series|Parent or legal guardian request|5
991958|NCT00475033|3258095|P1|Infant Series|Parent or legal guardian request|1
991959|NCT00475033|3258094|P2|Infant Series|Failed to return|4
991960|NCT00475033|3258095|P1|Infant Series|Failed to return|3
991961|NCT00474994|3258143|P1|Overall Study|Patient found to be ineligible|1
991962|NCT00474994|3258143|P1|Overall Study|Patient evaluable for toxicity only|3
991963|NCT00474994|3258143|P1|Overall Study|Patient Not treated|1
991964|NCT00474968|3258149|P2|Overall Study|Sample not collected|1
991965|NCT00474968|3258150|P1|Overall Study|Sample not collected|1
991966|NCT00474968|3258149|P2|Overall Study|Protocol Violation|8
991967|NCT00474968|3258150|P1|Overall Study|Protocol Violation|9
991968|NCT00474968|3258149|P2|Overall Study|Withdrawal by Subject|7
991969|NCT00474968|3258150|P1|Overall Study|Withdrawal by Subject|8
991970|NCT00474955|3258160|P1|Overall Study|Personal reasons|5
991971|NCT00474955|3258160|P1|Overall Study|Drug unavailability|1
991972|NCT00474955|3258160|P1|Overall Study|Adverse Event|2
991973|NCT00474929|3258176|P5|Overall Study|Physician Decision|0
991974|NCT00474929|3258177|P4|Overall Study|Physician Decision|2
991975|NCT00474929|3258178|P3|Overall Study|Physician Decision|1
991976|NCT00474929|3258179|P2|Overall Study|Physician Decision|0
991977|NCT00474929|3258180|P1|Overall Study|Physician Decision|0
991978|NCT00474929|3258176|P5|Overall Study|Unrelated medical condition|0
991979|NCT00474929|3258177|P4|Overall Study|Unrelated medical condition|0
991980|NCT00474929|3258178|P3|Overall Study|Unrelated medical condition|1
991981|NCT00474929|3258179|P2|Overall Study|Unrelated medical condition|0
991982|NCT00474929|3258180|P1|Overall Study|Unrelated medical condition|0
991983|NCT00474929|3258176|P5|Overall Study|Withdrawal by Subject|0
991984|NCT00474929|3258177|P4|Overall Study|Withdrawal by Subject|0
991985|NCT00474929|3258178|P3|Overall Study|Withdrawal by Subject|0
991986|NCT00474929|3258179|P2|Overall Study|Withdrawal by Subject|1
991987|NCT00474929|3258180|P1|Overall Study|Withdrawal by Subject|0
991988|NCT00474903|3258197|P3|Overall Study|Protocol Violation|2
991989|NCT00474903|3258198|P2|Overall Study|Protocol Violation|5
991990|NCT00474903|3258199|P1|Overall Study|Protocol Violation|1
991991|NCT00474812|3258221|P1|Overall Study|No Initiation of treatment|2
991992|NCT00474812|3258221|P1|Overall Study|Withdrawal by Subject|5
991993|NCT00474786|3258231|P2|Overall Study|Not specified|0
991994|NCT00474786|3258232|P1|Overall Study|Not specified|5
991995|NCT00474786|3258231|P2|Overall Study|Withdrawal by Subject|15
991996|NCT00474786|3258232|P1|Overall Study|Withdrawal by Subject|15
991997|NCT00474786|3258231|P2|Overall Study|Protocol Violation|0
991998|NCT00474786|3258232|P1|Overall Study|Protocol Violation|2
991999|NCT00474786|3258231|P2|Overall Study|Lost to Follow-up|7
992000|NCT00474786|3258232|P1|Overall Study|Lost to Follow-up|4
992001|NCT00474786|3258231|P2|Overall Study|Discontinuation of Study by Sponsor|59
992002|NCT00474786|3258232|P1|Overall Study|Discontinuation of Study by Sponsor|42
992003|NCT00474786|3258231|P2|Overall Study|Death|170
992004|NCT00474786|3258232|P1|Overall Study|Death|189
992005|NCT00474786|3258231|P2|Overall Study|Investigator Request|1
992006|NCT00474786|3258232|P1|Overall Study|Investigator Request|2
992007|NCT00474786|3258231|P2|Overall Study|Not Meeting Study Criteria|1
992008|NCT00474786|3258232|P1|Overall Study|Not Meeting Study Criteria|0
992009|NCT00474760|3258257|P7|Overall Study|Terminated by sponsor|2
992010|NCT00474760|3258258|P6|Overall Study|Terminated by sponsor|0
992011|NCT00474760|3258259|P5|Overall Study|Terminated by sponsor|0
992012|NCT00474760|3258260|P4|Overall Study|Terminated by sponsor|0
992013|NCT00474760|3258261|P3|Overall Study|Terminated by sponsor|0
992014|NCT00474760|3258262|P2|Overall Study|Terminated by sponsor|0
992015|NCT00474760|3258263|P1|Overall Study|Terminated by sponsor|0
992016|NCT00474760|3258257|P7|Overall Study|Progressive disease|7
992017|NCT00474760|3258258|P6|Overall Study|Progressive disease|20
992018|NCT00474760|3258259|P5|Overall Study|Progressive disease|8
992019|NCT00474760|3258260|P4|Overall Study|Progressive disease|2
992020|NCT00474760|3258261|P3|Overall Study|Progressive disease|3
992021|NCT00474760|3258262|P2|Overall Study|Progressive disease|2
992022|NCT00474760|3258263|P1|Overall Study|Progressive disease|3
992023|NCT00474760|3258257|P7|Overall Study|Other|0
992024|NCT00474760|3258258|P6|Overall Study|Other|0
992025|NCT00474760|3258259|P5|Overall Study|Other|1
992026|NCT00474760|3258260|P4|Overall Study|Other|0
992027|NCT00474760|3258261|P3|Overall Study|Other|0
992028|NCT00474760|3258262|P2|Overall Study|Other|1
992029|NCT00474760|3258263|P1|Overall Study|Other|0
992030|NCT00474760|3258257|P7|Overall Study|Withdrawal by Subject|1
992031|NCT00474760|3258258|P6|Overall Study|Withdrawal by Subject|1
992032|NCT00474760|3258259|P5|Overall Study|Withdrawal by Subject|0
992033|NCT00474760|3258260|P4|Overall Study|Withdrawal by Subject|1
992034|NCT00474760|3258261|P3|Overall Study|Withdrawal by Subject|0
992035|NCT00474760|3258262|P2|Overall Study|Withdrawal by Subject|0
992036|NCT00474760|3258263|P1|Overall Study|Withdrawal by Subject|0
992037|NCT00474760|3258257|P7|Overall Study|Laboratory abnormality|0
992038|NCT00474760|3258258|P6|Overall Study|Laboratory abnormality|1
992039|NCT00474760|3258259|P5|Overall Study|Laboratory abnormality|0
992040|NCT00474760|3258260|P4|Overall Study|Laboratory abnormality|0
992041|NCT00474760|3258261|P3|Overall Study|Laboratory abnormality|0
992042|NCT00474760|3258262|P2|Overall Study|Laboratory abnormality|0
992043|NCT00474760|3258263|P1|Overall Study|Laboratory abnormality|0
992044|NCT00474760|3258257|P7|Overall Study|Adverse Event|0
992045|NCT00474760|3258258|P6|Overall Study|Adverse Event|7
992046|NCT00474760|3258259|P5|Overall Study|Adverse Event|1
992047|NCT00474760|3258260|P4|Overall Study|Adverse Event|0
992048|NCT00474760|3258261|P3|Overall Study|Adverse Event|0
992049|NCT00474760|3258262|P2|Overall Study|Adverse Event|0
992050|NCT00474760|3258263|P1|Overall Study|Adverse Event|0
992051|NCT00474760|3258257|P7|Overall Study|Death|0
992052|NCT00474760|3258258|P6|Overall Study|Death|0
992053|NCT00474760|3258259|P5|Overall Study|Death|2
992054|NCT00474760|3258260|P4|Overall Study|Death|0
992055|NCT00474760|3258261|P3|Overall Study|Death|0
992056|NCT00474760|3258262|P2|Overall Study|Death|0
992057|NCT00474760|3258263|P1|Overall Study|Death|0
992058|NCT00474708|3258370|P2|Overall Study|Physician Decision|6
992059|NCT00474708|3258371|P1|Overall Study|Physician Decision|9
992060|NCT00474708|3258370|P2|Overall Study|Lost to Follow-up|9
992061|NCT00474708|3258371|P1|Overall Study|Lost to Follow-up|18
992062|NCT00474708|3258370|P2|Overall Study|Lack of compliance|4
992063|NCT00474708|3258371|P1|Overall Study|Lack of compliance|12
992064|NCT00474708|3258370|P2|Overall Study|Withdrawal by Subject|0
992065|NCT00474708|3258371|P1|Overall Study|Withdrawal by Subject|7
992066|NCT00474708|3258370|P2|Overall Study|Suicide ideation/behavior|1
992067|NCT00474708|3258371|P1|Overall Study|Suicide ideation/behavior|0
992068|NCT00474708|3258370|P2|Overall Study|Lack of Efficacy|5
992069|NCT00474708|3258371|P1|Overall Study|Lack of Efficacy|11
992070|NCT00474630|3258381|P2|Overall Study|Drug noncompliance, other|4
992071|NCT00474630|3258382|P1|Overall Study|Drug noncompliance, other|11
992072|NCT00474630|3258381|P2|Overall Study|Lack of Efficacy|6
992073|NCT00474630|3258382|P1|Overall Study|Lack of Efficacy|5
992074|NCT00474630|3258381|P2|Overall Study|Protocol Violation|4
992075|NCT00474630|3258382|P1|Overall Study|Protocol Violation|3
992076|NCT00474630|3258381|P2|Overall Study|Withdrawal by Subject|15
992077|NCT00474630|3258382|P1|Overall Study|Withdrawal by Subject|21
992078|NCT00474630|3258381|P2|Overall Study|Lost to Follow-up|15
992079|NCT00474630|3258382|P1|Overall Study|Lost to Follow-up|22
992080|NCT00474630|3258381|P2|Overall Study|Adverse Event|26
992081|NCT00474630|3258382|P1|Overall Study|Adverse Event|98
992082|NCT00474539|3258438|P2|Toddler Dose|Protocol Violation|0
992083|NCT00474539|3258439|P1|Toddler Dose|Protocol Violation|1
992084|NCT00474539|3258438|P2|After Infant Series|Withdrawal by Subject|0
992085|NCT00474539|3258439|P1|After Infant Series|Withdrawal by Subject|1
992086|NCT00474539|3258438|P2|After Infant Series|Lost to Follow-up|0
992087|NCT00474539|3258439|P1|After Infant Series|Lost to Follow-up|3
992088|NCT00474539|3258438|P2|Infant Series|Protocol Violation|1
992089|NCT00474539|3258439|P1|Infant Series|Protocol Violation|0
992090|NCT00474539|3258438|P2|Infant Series|Lost to Follow-up|1
992091|NCT00474539|3258439|P1|Infant Series|Lost to Follow-up|2
992092|NCT00474539|3258438|P2|Infant Series|Randomization error|0
992093|NCT00474539|3258439|P1|Infant Series|Randomization error|5
992094|NCT00474539|3258438|P2|Infant Series|Withdrawal by Subject|4
992095|NCT00474539|3258439|P1|Infant Series|Withdrawal by Subject|3
992096|NCT00474526|3258504|P17|Overall Study|Withdrawal by Subject|1
992097|NCT00474526|3258505|P16|Overall Study|Withdrawal by Subject|1
992098|NCT00474526|3258506|P15|Overall Study|Withdrawal by Subject|22
992099|NCT00474526|3258507|P14|Overall Study|Withdrawal by Subject|37
992100|NCT00474526|3258508|P13|Overall Study|Withdrawal by Subject|4
992101|NCT00474526|3258509|P12|Overall Study|Withdrawal by Subject|4
992102|NCT00474526|3258510|P11|Overall Study|Withdrawal by Subject|5
992103|NCT00474526|3258511|P10|Overall Study|Withdrawal by Subject|13
992104|NCT00474526|3258512|P9|Overall Study|Withdrawal by Subject|4
992105|NCT00474526|3258513|P8|Overall Study|Withdrawal by Subject|4
992106|NCT00474526|3258514|P7|Overall Study|Withdrawal by Subject|12
992107|NCT00474526|3258515|P6|Overall Study|Withdrawal by Subject|6
992108|NCT00474526|3258516|P5|Overall Study|Withdrawal by Subject|38
992109|NCT00474526|3258517|P4|Overall Study|Withdrawal by Subject|52
992110|NCT00474526|3258518|P3|Overall Study|Withdrawal by Subject|21
992111|NCT00474526|3258519|P2|Overall Study|Withdrawal by Subject|24
992112|NCT00474526|3258520|P1|Overall Study|Withdrawal by Subject|9
992113|NCT00474526|3258504|P17|Overall Study|UNABLE TO CLASSIFY|1
992114|NCT00474526|3258505|P16|Overall Study|UNABLE TO CLASSIFY|6
992115|NCT00474526|3258506|P15|Overall Study|UNABLE TO CLASSIFY|12
992116|NCT00474526|3258507|P14|Overall Study|UNABLE TO CLASSIFY|20
992117|NCT00474526|3258508|P13|Overall Study|UNABLE TO CLASSIFY|0
992118|NCT00474526|3258509|P12|Overall Study|UNABLE TO CLASSIFY|0
992119|NCT00474526|3258510|P11|Overall Study|UNABLE TO CLASSIFY|0
992120|NCT00474526|3258511|P10|Overall Study|UNABLE TO CLASSIFY|3
992121|NCT00474526|3258512|P9|Overall Study|UNABLE TO CLASSIFY|0
992122|NCT00474526|3258513|P8|Overall Study|UNABLE TO CLASSIFY|1
992123|NCT00474526|3258514|P7|Overall Study|UNABLE TO CLASSIFY|0
992124|NCT00474526|3258515|P6|Overall Study|UNABLE TO CLASSIFY|2
992125|NCT00474526|3258516|P5|Overall Study|UNABLE TO CLASSIFY|3
992126|NCT00474526|3258517|P4|Overall Study|UNABLE TO CLASSIFY|1
992127|NCT00474526|3258518|P3|Overall Study|UNABLE TO CLASSIFY|0
992128|NCT00474526|3258519|P2|Overall Study|UNABLE TO CLASSIFY|0
992129|NCT00474526|3258520|P1|Overall Study|UNABLE TO CLASSIFY|1
992130|NCT00474526|3258504|P17|Overall Study|Protocol Violation|2
992131|NCT00474526|3258505|P16|Overall Study|Protocol Violation|6
992132|NCT00474526|3258506|P15|Overall Study|Protocol Violation|9
992133|NCT00474526|3258507|P14|Overall Study|Protocol Violation|19
992134|NCT00474526|3258508|P13|Overall Study|Protocol Violation|4
992135|NCT00474526|3258509|P12|Overall Study|Protocol Violation|2
992136|NCT00474526|3258510|P11|Overall Study|Protocol Violation|2
992137|NCT00474526|3258511|P10|Overall Study|Protocol Violation|4
992138|NCT00474526|3258512|P9|Overall Study|Protocol Violation|0
992139|NCT00474526|3258513|P8|Overall Study|Protocol Violation|0
992140|NCT00474526|3258514|P7|Overall Study|Protocol Violation|3
992141|NCT00474526|3258515|P6|Overall Study|Protocol Violation|1
992142|NCT00474526|3258516|P5|Overall Study|Protocol Violation|3
992143|NCT00474526|3258517|P4|Overall Study|Protocol Violation|12
992144|NCT00474526|3258518|P3|Overall Study|Protocol Violation|4
992145|NCT00474526|3258519|P2|Overall Study|Protocol Violation|6
992146|NCT00474526|3258520|P1|Overall Study|Protocol Violation|2
992147|NCT00474526|3258504|P17|Overall Study|Lost to Follow-up|5
992148|NCT00474526|3258505|P16|Overall Study|Lost to Follow-up|4
992149|NCT00474526|3258506|P15|Overall Study|Lost to Follow-up|29
992150|NCT00474526|3258507|P14|Overall Study|Lost to Follow-up|74
992151|NCT00474526|3258508|P13|Overall Study|Lost to Follow-up|6
992152|NCT00474526|3258509|P12|Overall Study|Lost to Follow-up|4
992153|NCT00474526|3258510|P11|Overall Study|Lost to Follow-up|2
992154|NCT00474526|3258511|P10|Overall Study|Lost to Follow-up|6
992155|NCT00474526|3258512|P9|Overall Study|Lost to Follow-up|0
992156|NCT00474526|3258513|P8|Overall Study|Lost to Follow-up|1
992157|NCT00474526|3258514|P7|Overall Study|Lost to Follow-up|8
992158|NCT00474526|3258515|P6|Overall Study|Lost to Follow-up|5
992159|NCT00474526|3258516|P5|Overall Study|Lost to Follow-up|11
992160|NCT00474526|3258517|P4|Overall Study|Lost to Follow-up|29
992161|NCT00474526|3258518|P3|Overall Study|Lost to Follow-up|13
992162|NCT00474526|3258519|P2|Overall Study|Lost to Follow-up|6
992163|NCT00474526|3258520|P1|Overall Study|Lost to Follow-up|8
992164|NCT00474526|3258504|P17|Overall Study|INAPPROPRIATE ENROLLMENT|0
992165|NCT00474526|3258505|P16|Overall Study|INAPPROPRIATE ENROLLMENT|0
992166|NCT00474526|3258506|P15|Overall Study|INAPPROPRIATE ENROLLMENT|2
992167|NCT00474526|3258507|P14|Overall Study|INAPPROPRIATE ENROLLMENT|2
992168|NCT00474526|3258508|P13|Overall Study|INAPPROPRIATE ENROLLMENT|0
992169|NCT00474526|3258509|P12|Overall Study|INAPPROPRIATE ENROLLMENT|0
992170|NCT00474526|3258510|P11|Overall Study|INAPPROPRIATE ENROLLMENT|0
992171|NCT00474526|3258511|P10|Overall Study|INAPPROPRIATE ENROLLMENT|0
992172|NCT00474526|3258512|P9|Overall Study|INAPPROPRIATE ENROLLMENT|0
992173|NCT00474526|3258513|P8|Overall Study|INAPPROPRIATE ENROLLMENT|0
992174|NCT00474526|3258514|P7|Overall Study|INAPPROPRIATE ENROLLMENT|0
992175|NCT00474526|3258515|P6|Overall Study|INAPPROPRIATE ENROLLMENT|0
992176|NCT00474526|3258516|P5|Overall Study|INAPPROPRIATE ENROLLMENT|2
992177|NCT00474526|3258517|P4|Overall Study|INAPPROPRIATE ENROLLMENT|1
992178|NCT00474526|3258518|P3|Overall Study|INAPPROPRIATE ENROLLMENT|0
992179|NCT00474526|3258519|P2|Overall Study|INAPPROPRIATE ENROLLMENT|1
992180|NCT00474526|3258520|P1|Overall Study|INAPPROPRIATE ENROLLMENT|0
992181|NCT00474526|3258504|P17|Overall Study|Death|0
992182|NCT00474526|3258505|P16|Overall Study|Death|0
992183|NCT00474526|3258506|P15|Overall Study|Death|0
992184|NCT00474526|3258507|P14|Overall Study|Death|3
992185|NCT00474526|3258508|P13|Overall Study|Death|0
992186|NCT00474526|3258509|P12|Overall Study|Death|0
992187|NCT00474526|3258510|P11|Overall Study|Death|0
992188|NCT00474526|3258511|P10|Overall Study|Death|0
992189|NCT00474526|3258512|P9|Overall Study|Death|0
992190|NCT00474526|3258513|P8|Overall Study|Death|0
992191|NCT00474526|3258514|P7|Overall Study|Death|0
992192|NCT00474526|3258515|P6|Overall Study|Death|0
992193|NCT00474526|3258516|P5|Overall Study|Death|0
992194|NCT00474526|3258517|P4|Overall Study|Death|0
992195|NCT00474526|3258518|P3|Overall Study|Death|0
992196|NCT00474526|3258519|P2|Overall Study|Death|0
992197|NCT00474526|3258520|P1|Overall Study|Death|0
992198|NCT00474526|3258504|P17|Overall Study|Adverse Event|0
992199|NCT00474526|3258505|P16|Overall Study|Adverse Event|1
992200|NCT00474526|3258506|P15|Overall Study|Adverse Event|1
992201|NCT00474526|3258507|P14|Overall Study|Adverse Event|0
992202|NCT00474526|3258508|P13|Overall Study|Adverse Event|0
992203|NCT00474526|3258509|P12|Overall Study|Adverse Event|0
992204|NCT00474526|3258510|P11|Overall Study|Adverse Event|0
992205|NCT00474526|3258511|P10|Overall Study|Adverse Event|0
992206|NCT00474526|3258512|P9|Overall Study|Adverse Event|0
992207|NCT00474526|3258513|P8|Overall Study|Adverse Event|0
992208|NCT00474526|3258514|P7|Overall Study|Adverse Event|1
992209|NCT00474526|3258515|P6|Overall Study|Adverse Event|1
992210|NCT00474526|3258516|P5|Overall Study|Adverse Event|2
992211|NCT00474526|3258517|P4|Overall Study|Adverse Event|4
992212|NCT00474526|3258518|P3|Overall Study|Adverse Event|2
992213|NCT00474526|3258519|P2|Overall Study|Adverse Event|0
992214|NCT00474526|3258520|P1|Overall Study|Adverse Event|2
992215|NCT00474526|3258504|P17|Overall Study|ADMINISTRATIVE REASON|0
992216|NCT00474526|3258505|P16|Overall Study|ADMINISTRATIVE REASON|0
992217|NCT00474526|3258506|P15|Overall Study|ADMINISTRATIVE REASON|2
992218|NCT00474526|3258507|P14|Overall Study|ADMINISTRATIVE REASON|1
992219|NCT00474526|3258508|P13|Overall Study|ADMINISTRATIVE REASON|1
992220|NCT00474526|3258509|P12|Overall Study|ADMINISTRATIVE REASON|1
992221|NCT00474526|3258510|P11|Overall Study|ADMINISTRATIVE REASON|1
992222|NCT00474526|3258511|P10|Overall Study|ADMINISTRATIVE REASON|1
992223|NCT00474526|3258512|P9|Overall Study|ADMINISTRATIVE REASON|2
992224|NCT00474526|3258513|P8|Overall Study|ADMINISTRATIVE REASON|0
992225|NCT00474526|3258514|P7|Overall Study|ADMINISTRATIVE REASON|1
992226|NCT00474526|3258515|P6|Overall Study|ADMINISTRATIVE REASON|1
992227|NCT00474526|3258516|P5|Overall Study|ADMINISTRATIVE REASON|9
992228|NCT00474526|3258517|P4|Overall Study|ADMINISTRATIVE REASON|20
992229|NCT00474526|3258518|P3|Overall Study|ADMINISTRATIVE REASON|9
992230|NCT00474526|3258519|P2|Overall Study|ADMINISTRATIVE REASON|9
992231|NCT00474526|3258520|P1|Overall Study|ADMINISTRATIVE REASON|11
992232|NCT00474487|3258685|P4|Overall Study|Death|0
992233|NCT00474487|3258686|P3|Overall Study|Death|0
992234|NCT00474487|3258687|P2|Overall Study|Death|1
992235|NCT00474487|3258688|P1|Overall Study|Death|0
992236|NCT00474487|3258685|P4|Overall Study|Inappropriate enrollment|0
992237|NCT00474487|3258686|P3|Overall Study|Inappropriate enrollment|7
992238|NCT00474487|3258687|P2|Overall Study|Inappropriate enrollment|0
992239|NCT00474487|3258688|P1|Overall Study|Inappropriate enrollment|4
992240|NCT00474487|3258685|P4|Overall Study|Lost to Follow-up|0
992241|NCT00474487|3258686|P3|Overall Study|Lost to Follow-up|7
992242|NCT00474487|3258687|P2|Overall Study|Lost to Follow-up|1
992243|NCT00474487|3258688|P1|Overall Study|Lost to Follow-up|20
992244|NCT00474487|3258685|P4|Overall Study|Withdrawal by Subject|0
992245|NCT00474487|3258686|P3|Overall Study|Withdrawal by Subject|0
992246|NCT00474487|3258687|P2|Overall Study|Withdrawal by Subject|0
992247|NCT00474487|3258688|P1|Overall Study|Withdrawal by Subject|6
992248|NCT00474383|3258708|P2|Extension|Progressive Disease|5
992249|NCT00474383|3258709|P1|Extension|Progressive Disease|0
992250|NCT00474383|3258708|P2|Between Main Study and Extension|Did Not Enter Extension Phase|0
992251|NCT00474383|3258709|P1|Between Main Study and Extension|Did Not Enter Extension Phase|6
992252|NCT00474383|3258708|P2|Main Study|Other|0
992253|NCT00474383|3258709|P1|Main Study|Other|1
992254|NCT00474383|3258708|P2|Main Study|Progressive Disease|0
992255|NCT00474383|3258709|P1|Main Study|Progressive Disease|23
992256|NCT00474383|3258708|P2|Main Study|Symptomatic Deterioration|0
992257|NCT00474383|3258709|P1|Main Study|Symptomatic Deterioration|1
992258|NCT00474383|3258708|P2|Main Study|Adverse Event|0
992259|NCT00474383|3258709|P1|Main Study|Adverse Event|11
992260|NCT00474266|3258724|P4|Overall Study|Withdrawal by Subject|7
992261|NCT00474266|3258725|P3|Overall Study|Withdrawal by Subject|4
992262|NCT00474266|3258726|P2|Overall Study|Withdrawal by Subject|20
992263|NCT00474266|3258727|P1|Overall Study|Withdrawal by Subject|7
992264|NCT00474240|3258835|P6|Overall Study|Removed due to lab value|1
992265|NCT00474240|3258836|P5|Overall Study|Removed due to lab value|0
992266|NCT00474240|3258837|P4|Overall Study|Removed due to lab value|0
992267|NCT00474240|3258838|P3|Overall Study|Removed due to lab value|0
992268|NCT00474240|3258839|P2|Overall Study|Removed due to lab value|0
992269|NCT00474240|3258840|P1|Overall Study|Removed due to lab value|0
992270|NCT00474240|3258835|P6|Overall Study|Adverse Event|16
992271|NCT00474240|3258836|P5|Overall Study|Adverse Event|5
992272|NCT00474240|3258837|P4|Overall Study|Adverse Event|14
992273|NCT00474240|3258838|P3|Overall Study|Adverse Event|9
992274|NCT00474240|3258839|P2|Overall Study|Adverse Event|0
992275|NCT00474240|3258840|P1|Overall Study|Adverse Event|0
992276|NCT00474240|3258835|P6|Overall Study|Withdrawal by Subject|1
992277|NCT00474240|3258836|P5|Overall Study|Withdrawal by Subject|3
992278|NCT00474240|3258837|P4|Overall Study|Withdrawal by Subject|2
992279|NCT00474240|3258838|P3|Overall Study|Withdrawal by Subject|0
992280|NCT00474240|3258839|P2|Overall Study|Withdrawal by Subject|1
992281|NCT00474240|3258840|P1|Overall Study|Withdrawal by Subject|1
992282|NCT00474188|3258865|P1|Overall Study|Study discontinued by sponsor|5
992283|NCT00474188|3258865|P1|Overall Study|Withdrawal by Subject|1
992284|NCT00474175|3258875|P3|Overall Study|Administrative|0
992285|NCT00474175|3258876|P2|Overall Study|Administrative|1
992286|NCT00474175|3258877|P1|Overall Study|Administrative|0
992287|NCT00474175|3258875|P3|Overall Study|Protocol Violation|1
992288|NCT00474175|3258876|P2|Overall Study|Protocol Violation|2
992289|NCT00474175|3258877|P1|Overall Study|Protocol Violation|0
992290|NCT00474175|3258875|P3|Overall Study|Ineligible|1
992291|NCT00474175|3258876|P2|Overall Study|Ineligible|3
992292|NCT00474175|3258877|P1|Overall Study|Ineligible|1
992293|NCT00474175|3258875|P3|Overall Study|Withdrawal by Subject|1
992294|NCT00474175|3258876|P2|Overall Study|Withdrawal by Subject|1
992295|NCT00474175|3258877|P1|Overall Study|Withdrawal by Subject|0
992296|NCT00474175|3258875|P3|Overall Study|Lack of Efficacy|1
992297|NCT00474175|3258876|P2|Overall Study|Lack of Efficacy|0
992298|NCT00474175|3258877|P1|Overall Study|Lack of Efficacy|0
992299|NCT00474058|3258941|P2|Overall Study|Other|0
992300|NCT00474058|3258942|P1|Overall Study|Other|2
992301|NCT00474058|3258941|P2|Overall Study|Withdrawal by Subject|7
992302|NCT00474058|3258942|P1|Overall Study|Withdrawal by Subject|11
992303|NCT00474058|3258941|P2|Overall Study|Lack of Efficacy|4
992304|NCT00474058|3258942|P1|Overall Study|Lack of Efficacy|0
992305|NCT00474058|3258941|P2|Overall Study|Adverse Event|6
992306|NCT00474058|3258942|P1|Overall Study|Adverse Event|11
992307|NCT00474045|3258956|P2|Overall Study|Withdrawal criteria|50
992308|NCT00474045|3258957|P1|Overall Study|Withdrawal criteria|60
992309|NCT00474045|3258956|P2|Overall Study|Withdrawal by Subject|18
992310|NCT00474045|3258957|P1|Overall Study|Withdrawal by Subject|16
992311|NCT00474045|3258956|P2|Overall Study|Protocol Violation|12
992312|NCT00474045|3258957|P1|Overall Study|Protocol Violation|10
992313|NCT00474045|3258956|P2|Overall Study|Lost to Follow-up|1
992314|NCT00474045|3258957|P1|Overall Study|Lost to Follow-up|1
992315|NCT00474045|3258956|P2|Overall Study|Lack of Efficacy|9
992316|NCT00474045|3258957|P1|Overall Study|Lack of Efficacy|0
992317|NCT00474045|3258956|P2|Overall Study|Unclassified|3
992318|NCT00474045|3258957|P1|Overall Study|Unclassified|1
992319|NCT00474045|3258956|P2|Overall Study|Adverse Event|8
992320|NCT00474045|3258957|P1|Overall Study|Adverse Event|18
992321|NCT00473889|3259057|P2|Overall Study|Withdrawal by Subject|0
992322|NCT00473889|3259058|P1|Overall Study|Withdrawal by Subject|5
992323|NCT00473889|3259057|P2|Overall Study|Trial Terminated|6
992324|NCT00473889|3259058|P1|Overall Study|Trial Terminated|3
992325|NCT00473889|3259057|P2|Overall Study|Physician Decision|5
992326|NCT00473889|3259058|P1|Overall Study|Physician Decision|10
992327|NCT00473889|3259057|P2|Overall Study|Lost to Follow-up|1
992328|NCT00473889|3259058|P1|Overall Study|Lost to Follow-up|2
992329|NCT00473889|3259057|P2|Overall Study|Lack of Efficacy|29
992330|NCT00473889|3259058|P1|Overall Study|Lack of Efficacy|28
992331|NCT00473889|3259057|P2|Overall Study|Protocol Violation|2
992332|NCT00473889|3259058|P1|Overall Study|Protocol Violation|4
992333|NCT00473889|3259057|P2|Overall Study|Adverse Event|17
992334|NCT00473889|3259058|P1|Overall Study|Adverse Event|30
992335|NCT00473889|3259057|P2|Overall Study|Did not receive study medication|4
992336|NCT00473889|3259058|P1|Overall Study|Did not receive study medication|1
992337|NCT00473876|3259070|P2|Overall Study|Lost to Follow-up|1
992338|NCT00473876|3259071|P1|Overall Study|Lost to Follow-up|3
992339|NCT00473824|3259090|P2|Overall Study|Withdrawal by physician|0
992340|NCT00473824|3259091|P1|Overall Study|Withdrawal by physician|1
992341|NCT00473824|3259090|P2|Overall Study|Lost to Follow-up|0
992342|NCT00473824|3259091|P1|Overall Study|Lost to Follow-up|1
992343|NCT00473824|3259090|P2|Overall Study|Death|0
992344|NCT00473824|3259091|P1|Overall Study|Death|1
992345|NCT00473824|3259090|P2|Overall Study|Adverse Event|0
992346|NCT00473824|3259091|P1|Overall Study|Adverse Event|1
992347|NCT00473824|3259090|P2|Overall Study|Virologic Breakthrough|0
992348|NCT00473824|3259091|P1|Overall Study|Virologic Breakthrough|1
992349|NCT00473746|3259102|P5|Period 2 (Phase 2)|Reason not specified|3
992350|NCT00473746|3259103|P4|Period 2 (Phase 2)|Reason not specified|0
992351|NCT00473746|3259104|P3|Period 2 (Phase 2)|Reason not specified|0
992352|NCT00473746|3259105|P2|Period 2 (Phase 2)|Reason not specified|0
992353|NCT00473746|3259106|P1|Period 2 (Phase 2)|Reason not specified|0
992354|NCT00473746|3259102|P5|Period 2 (Phase 2)|Progressive Disease|20
992355|NCT00473746|3259103|P4|Period 2 (Phase 2)|Progressive Disease|0
992356|NCT00473746|3259104|P3|Period 2 (Phase 2)|Progressive Disease|0
992357|NCT00473746|3259105|P2|Period 2 (Phase 2)|Progressive Disease|0
992358|NCT00473746|3259106|P1|Period 2 (Phase 2)|Progressive Disease|0
992359|NCT00473746|3259102|P5|Period 2 (Phase 2)|Death|1
992360|NCT00473746|3259103|P4|Period 2 (Phase 2)|Death|0
992361|NCT00473746|3259104|P3|Period 2 (Phase 2)|Death|0
992362|NCT00473746|3259105|P2|Period 2 (Phase 2)|Death|0
992363|NCT00473746|3259106|P1|Period 2 (Phase 2)|Death|0
992364|NCT00473746|3259102|P5|Period 2 (Phase 2)|Adverse Event|3
992365|NCT00473746|3259103|P4|Period 2 (Phase 2)|Adverse Event|0
992366|NCT00473746|3259104|P3|Period 2 (Phase 2)|Adverse Event|0
992367|NCT00473746|3259105|P2|Period 2 (Phase 2)|Adverse Event|0
992368|NCT00473746|3259106|P1|Period 2 (Phase 2)|Adverse Event|0
992369|NCT00473746|3259102|P5|Period 1 (Phase 1)|Reason not specified|0
992370|NCT00473746|3259103|P4|Period 1 (Phase 1)|Reason not specified|0
992371|NCT00473746|3259104|P3|Period 1 (Phase 1)|Reason not specified|0
992372|NCT00473746|3259105|P2|Period 1 (Phase 1)|Reason not specified|1
992373|NCT00473746|3259106|P1|Period 1 (Phase 1)|Reason not specified|0
992374|NCT00473746|3259102|P5|Period 1 (Phase 1)|Symptomatic Deterioration|0
992375|NCT00473746|3259103|P4|Period 1 (Phase 1)|Symptomatic Deterioration|0
992376|NCT00473746|3259104|P3|Period 1 (Phase 1)|Symptomatic Deterioration|0
992377|NCT00473746|3259105|P2|Period 1 (Phase 1)|Symptomatic Deterioration|1
992378|NCT00473746|3259106|P1|Period 1 (Phase 1)|Symptomatic Deterioration|0
992379|NCT00473746|3259102|P5|Period 1 (Phase 1)|Progressive Disease|0
992380|NCT00473746|3259103|P4|Period 1 (Phase 1)|Progressive Disease|10
992381|NCT00473746|3259104|P3|Period 1 (Phase 1)|Progressive Disease|6
992382|NCT00473746|3259105|P2|Period 1 (Phase 1)|Progressive Disease|6
992383|NCT00473746|3259106|P1|Period 1 (Phase 1)|Progressive Disease|5
992384|NCT00473746|3259102|P5|Period 1 (Phase 1)|Withdrawal by Subject|0
992385|NCT00473746|3259103|P4|Period 1 (Phase 1)|Withdrawal by Subject|0
992386|NCT00473746|3259104|P3|Period 1 (Phase 1)|Withdrawal by Subject|0
992387|NCT00473746|3259105|P2|Period 1 (Phase 1)|Withdrawal by Subject|1
992388|NCT00473746|3259106|P1|Period 1 (Phase 1)|Withdrawal by Subject|0
992389|NCT00473746|3259102|P5|Period 1 (Phase 1)|Adverse Event|0
992390|NCT00473746|3259103|P4|Period 1 (Phase 1)|Adverse Event|0
992391|NCT00473746|3259104|P3|Period 1 (Phase 1)|Adverse Event|0
992392|NCT00473746|3259105|P2|Period 1 (Phase 1)|Adverse Event|0
992393|NCT00473746|3259106|P1|Period 1 (Phase 1)|Adverse Event|1
992394|NCT00473668|3259154|P3|Overall Study|Other|4
992395|NCT00473668|3259155|P2|Overall Study|Other|3
992396|NCT00473668|3259156|P1|Overall Study|Other|2
992397|NCT00473668|3259154|P3|Overall Study|Lost to Follow-up|6
992398|NCT00473668|3259155|P2|Overall Study|Lost to Follow-up|4
992399|NCT00473668|3259156|P1|Overall Study|Lost to Follow-up|0
992400|NCT00473668|3259154|P3|Overall Study|Migrated/moved from study area|0
992401|NCT00473668|3259155|P2|Overall Study|Migrated/moved from study area|2
992402|NCT00473668|3259156|P1|Overall Study|Migrated/moved from study area|3
992403|NCT00473668|3259154|P3|Overall Study|Withdrawal by Subject|0
992404|NCT00473668|3259155|P2|Overall Study|Withdrawal by Subject|2
992405|NCT00473668|3259156|P1|Overall Study|Withdrawal by Subject|0
992406|NCT00473655|3259209|P3|Overall Study|Lost to Follow-up|8
992407|NCT00473655|3259210|P2|Overall Study|Lost to Follow-up|5
992408|NCT00473655|3259211|P1|Overall Study|Lost to Follow-up|9
992409|NCT00473590|3259258|P2|Overall Study|Other|1
992410|NCT00473590|3259259|P1|Overall Study|Other|0
992411|NCT00473590|3259258|P2|Overall Study|Withdrawal by Subject|3
992412|NCT00473590|3259259|P1|Overall Study|Withdrawal by Subject|5
992413|NCT00473590|3259258|P2|Overall Study|Physician Decision|4
992414|NCT00473590|3259259|P1|Overall Study|Physician Decision|2
992415|NCT00473590|3259258|P2|Overall Study|Non–protocol-specified therapy|5
992416|NCT00473590|3259259|P1|Overall Study|Non–protocol-specified therapy|7
992417|NCT00473590|3259258|P2|Overall Study|Progression not resulting in death|20
992418|NCT00473590|3259259|P1|Overall Study|Progression not resulting in death|24
992419|NCT00473590|3259258|P2|Overall Study|Death|2
992420|NCT00473590|3259259|P1|Overall Study|Death|4
992421|NCT00473590|3259258|P2|Overall Study|Adverse Event|3
992422|NCT00473590|3259259|P1|Overall Study|Adverse Event|3
992423|NCT00473564|3259275|P1|Overall Study|robot surgery aborted in OR|23
992424|NCT00473512|3259285|P5|Period 2 (Phase 2)|Other|0
992425|NCT00473512|3259286|P4|Period 2 (Phase 2)|Other|3
992426|NCT00473512|3259287|P3|Period 2 (Phase 2)|Other|0
992427|NCT00473512|3259288|P2|Period 2 (Phase 2)|Other|0
992428|NCT00473512|3259289|P1|Period 2 (Phase 2)|Other|1
992429|NCT00473512|3259285|P5|Period 2 (Phase 2)|Symptomatic Deterioration|0
992430|NCT00473512|3259286|P4|Period 2 (Phase 2)|Symptomatic Deterioration|1
992431|NCT00473512|3259287|P3|Period 2 (Phase 2)|Symptomatic Deterioration|0
992432|NCT00473512|3259288|P2|Period 2 (Phase 2)|Symptomatic Deterioration|0
992433|NCT00473512|3259289|P1|Period 2 (Phase 2)|Symptomatic Deterioration|0
992434|NCT00473512|3259285|P5|Period 2 (Phase 2)|Disease Progression|1
992435|NCT00473512|3259286|P4|Period 2 (Phase 2)|Disease Progression|17
992436|NCT00473512|3259287|P3|Period 2 (Phase 2)|Disease Progression|2
992437|NCT00473512|3259288|P2|Period 2 (Phase 2)|Disease Progression|2
992438|NCT00473512|3259289|P1|Period 2 (Phase 2)|Disease Progression|0
992439|NCT00473512|3259285|P5|Period 2 (Phase 2)|Death|1
992440|NCT00473512|3259286|P4|Period 2 (Phase 2)|Death|1
992441|NCT00473512|3259287|P3|Period 2 (Phase 2)|Death|0
992442|NCT00473512|3259288|P2|Period 2 (Phase 2)|Death|0
992443|NCT00473512|3259289|P1|Period 2 (Phase 2)|Death|0
992444|NCT00473512|3259285|P5|Period 2 (Phase 2)|Adverse Event|0
992445|NCT00473512|3259286|P4|Period 2 (Phase 2)|Adverse Event|1
992446|NCT00473512|3259287|P3|Period 2 (Phase 2)|Adverse Event|0
992447|NCT00473512|3259288|P2|Period 2 (Phase 2)|Adverse Event|0
992448|NCT00473512|3259289|P1|Period 2 (Phase 2)|Adverse Event|0
992449|NCT00473512|3259285|P5|Period 1 (Phase 1)|Other|0
992450|NCT00473512|3259286|P4|Period 1 (Phase 1)|Other|1
992451|NCT00473512|3259287|P3|Period 1 (Phase 1)|Other|0
992452|NCT00473512|3259288|P2|Period 1 (Phase 1)|Other|0
992453|NCT00473512|3259289|P1|Period 1 (Phase 1)|Other|0
992454|NCT00473512|3259285|P5|Period 1 (Phase 1)|Disease Progression|1
992455|NCT00473512|3259286|P4|Period 1 (Phase 1)|Disease Progression|10
992456|NCT00473512|3259287|P3|Period 1 (Phase 1)|Disease Progression|0
992457|NCT00473512|3259288|P2|Period 1 (Phase 1)|Disease Progression|1
992458|NCT00473512|3259289|P1|Period 1 (Phase 1)|Disease Progression|1
992459|NCT00473512|3259285|P5|Period 1 (Phase 1)|Death|0
992460|NCT00473512|3259286|P4|Period 1 (Phase 1)|Death|1
992461|NCT00473512|3259287|P3|Period 1 (Phase 1)|Death|0
992462|NCT00473512|3259288|P2|Period 1 (Phase 1)|Death|0
992463|NCT00473512|3259289|P1|Period 1 (Phase 1)|Death|0
992464|NCT00473512|3259285|P5|Period 1 (Phase 1)|Adverse Event|0
992465|NCT00473512|3259286|P4|Period 1 (Phase 1)|Adverse Event|5
992466|NCT00473512|3259287|P3|Period 1 (Phase 1)|Adverse Event|0
992467|NCT00473512|3259288|P2|Period 1 (Phase 1)|Adverse Event|0
992468|NCT00473512|3259289|P1|Period 1 (Phase 1)|Adverse Event|0
992469|NCT00473434|3259347|P1|Overall Study|No longer required|1
992470|NCT00473434|3259347|P1|Overall Study|Switching to trial medication|1
992471|NCT00473434|3259347|P1|Overall Study|Ceased in favor of Paliperidone|1
992472|NCT00473434|3259347|P1|Overall Study|Reason not specified|6
992473|NCT00473434|3259347|P1|Overall Study|Safety evaluation|1
992474|NCT00473434|3259347|P1|Overall Study|Patient was selling medication to others|1
992475|NCT00473434|3259347|P1|Overall Study|Adverse Event|3
992476|NCT00473434|3259347|P1|Overall Study|Lack of Efficacy|3
992477|NCT00473434|3259347|P1|Overall Study|Compliance|3
992478|NCT00473434|3259347|P1|Overall Study|Withdrawal by Subject|9
992479|NCT00473434|3259347|P1|Overall Study|Physician Decision|3
992480|NCT00473382|3259412|P3|Open-label Extension Through Month 60|Subject Required Other Intervention|0
992481|NCT00473382|3259413|P2|Open-label Extension Through Month 60|Subject Required Other Intervention|1
992482|NCT00473382|3259414|P1|Open-label Extension Through Month 60|Subject Required Other Intervention|2
992483|NCT00473382|3259412|P3|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|69
992484|NCT00473382|3259413|P2|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|70
992485|NCT00473382|3259414|P1|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|75
992486|NCT00473382|3259412|P3|Open-label Extension Through Month 60|Subject's Decision|6
992487|NCT00473382|3259413|P2|Open-label Extension Through Month 60|Subject's Decision|1
992488|NCT00473382|3259414|P1|Open-label Extension Through Month 60|Subject's Decision|7
992489|NCT00473382|3259412|P3|Open-label Extension Through Month 60|Lost to Follow-up|1
992490|NCT00473382|3259413|P2|Open-label Extension Through Month 60|Lost to Follow-up|3
992491|NCT00473382|3259414|P1|Open-label Extension Through Month 60|Lost to Follow-up|1
992492|NCT00473382|3259412|P3|Open-label Extension Through Month 60|Death|4
992493|NCT00473382|3259413|P2|Open-label Extension Through Month 60|Death|7
992494|NCT00473382|3259414|P1|Open-label Extension Through Month 60|Death|1
992495|NCT00473382|3259412|P3|Open-label Extension Through Month 60|Adverse Event|2
992496|NCT00473382|3259413|P2|Open-label Extension Through Month 60|Adverse Event|0
992497|NCT00473382|3259414|P1|Open-label Extension Through Month 60|Adverse Event|0
992498|NCT00473382|3259412|P3|Open-label Extension Through Month 48|Subject Required Other Intervention|0
992499|NCT00473382|3259413|P2|Open-label Extension Through Month 48|Subject Required Other Intervention|1
992500|NCT00473382|3259414|P1|Open-label Extension Through Month 48|Subject Required Other Intervention|2
992501|NCT00473382|3259412|P3|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|36
992502|NCT00473382|3259413|P2|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|34
992503|NCT00473382|3259414|P1|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|41
992504|NCT00473382|3259412|P3|Open-label Extension Through Month 48|Subject's Decision|6
992505|NCT00473382|3259413|P2|Open-label Extension Through Month 48|Subject's Decision|1
992506|NCT00473382|3259414|P1|Open-label Extension Through Month 48|Subject's Decision|5
992507|NCT00473382|3259412|P3|Open-label Extension Through Month 48|Lost to Follow-up|1
992508|NCT00473382|3259413|P2|Open-label Extension Through Month 48|Lost to Follow-up|2
992509|NCT00473382|3259414|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
992510|NCT00473382|3259412|P3|Open-label Extension Through Month 48|Death|3
992511|NCT00473382|3259413|P2|Open-label Extension Through Month 48|Death|3
992512|NCT00473382|3259414|P1|Open-label Extension Through Month 48|Death|1
992513|NCT00473382|3259412|P3|Open-label Extension Through Month 48|Adverse Event|1
992514|NCT00473382|3259413|P2|Open-label Extension Through Month 48|Adverse Event|0
992515|NCT00473382|3259414|P1|Open-label Extension Through Month 48|Adverse Event|0
992516|NCT00473382|3259412|P3|Core Study|Subject's decision|10
992517|NCT00473382|3259413|P2|Core Study|Subject's decision|11
992518|NCT00473382|3259414|P1|Core Study|Subject's decision|12
992519|NCT00473382|3259412|P3|Core Study|Subject needed other treatment|2
992520|NCT00473382|3259413|P2|Core Study|Subject needed other treatment|3
992521|NCT00473382|3259414|P1|Core Study|Subject needed other treatment|1
992522|NCT00473382|3259412|P3|Core Study|Subject non-compliance|1
992523|NCT00473382|3259413|P2|Core Study|Subject non-compliance|2
992524|NCT00473382|3259414|P1|Core Study|Subject non-compliance|5
992525|NCT00473382|3259412|P3|Core Study|Physician Decision|2
992526|NCT00473382|3259413|P2|Core Study|Physician Decision|2
992527|NCT00473382|3259414|P1|Core Study|Physician Decision|1
992528|NCT00473382|3259412|P3|Core Study|Lost to Follow-up|3
992529|NCT00473382|3259413|P2|Core Study|Lost to Follow-up|3
992530|NCT00473382|3259414|P1|Core Study|Lost to Follow-up|3
992531|NCT00473382|3259412|P3|Core Study|Death|10
992532|NCT00473382|3259413|P2|Core Study|Death|5
992533|NCT00473382|3259414|P1|Core Study|Death|3
992534|NCT00473382|3259412|P3|Core Study|Adverse Event|1
992535|NCT00473382|3259413|P2|Core Study|Adverse Event|1
992536|NCT00473382|3259414|P1|Core Study|Adverse Event|3
992537|NCT00473330|3259472|P3|Open-label Extension Through Month 60|Subject Required Other Therapy|1
992538|NCT00473330|3259473|P2|Open-label Extension Through Month 60|Subject Required Other Therapy|0
992539|NCT00473330|3259474|P1|Open-label Extension Through Month 60|Subject Required Other Therapy|1
992540|NCT00473330|3259472|P3|Open-label Extension Through Month 60|Subject Non-compliance|0
992541|NCT00473330|3259473|P2|Open-label Extension Through Month 60|Subject Non-compliance|1
992542|NCT00473330|3259474|P1|Open-label Extension Through Month 60|Subject Non-compliance|2
992543|NCT00473330|3259472|P3|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|62
992544|NCT00473330|3259473|P2|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|71
992545|NCT00473330|3259474|P1|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|77
992546|NCT00473330|3259472|P3|Open-label Extension Through Month 60|Subject's Decision|4
992547|NCT00473330|3259473|P2|Open-label Extension Through Month 60|Subject's Decision|3
992548|NCT00473330|3259474|P1|Open-label Extension Through Month 60|Subject's Decision|1
992549|NCT00473330|3259472|P3|Open-label Extension Through Month 60|Physician's Decision|3
992550|NCT00473330|3259473|P2|Open-label Extension Through Month 60|Physician's Decision|1
992551|NCT00473330|3259474|P1|Open-label Extension Through Month 60|Physician's Decision|2
992552|NCT00473330|3259472|P3|Open-label Extension Through Month 60|Lost to Follow-up|4
992553|NCT00473330|3259473|P2|Open-label Extension Through Month 60|Lost to Follow-up|0
992554|NCT00473330|3259474|P1|Open-label Extension Through Month 60|Lost to Follow-up|3
992555|NCT00473330|3259472|P3|Open-label Extension Through Month 60|Death|1
992556|NCT00473330|3259473|P2|Open-label Extension Through Month 60|Death|2
992557|NCT00473330|3259474|P1|Open-label Extension Through Month 60|Death|2
992558|NCT00473330|3259472|P3|Open-label Extension Through Month 60|Adverse Event|2
992559|NCT00473330|3259473|P2|Open-label Extension Through Month 60|Adverse Event|0
992560|NCT00473330|3259474|P1|Open-label Extension Through Month 60|Adverse Event|0
992561|NCT00473330|3259472|P3|Open-label Extension Through Month 48|Subject Required Other Therapy|1
992562|NCT00473330|3259473|P2|Open-label Extension Through Month 48|Subject Required Other Therapy|0
992563|NCT00473330|3259474|P1|Open-label Extension Through Month 48|Subject Required Other Therapy|0
992564|NCT00473330|3259472|P3|Open-label Extension Through Month 48|Subject Non-compliance|0
992565|NCT00473330|3259473|P2|Open-label Extension Through Month 48|Subject Non-compliance|1
992566|NCT00473330|3259474|P1|Open-label Extension Through Month 48|Subject Non-compliance|2
992567|NCT00473330|3259472|P3|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|16
992568|NCT00473330|3259473|P2|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|15
992569|NCT00473330|3259474|P1|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|18
992570|NCT00473330|3259472|P3|Open-label Extension Through Month 48|Subject's Decision|3
992571|NCT00473330|3259473|P2|Open-label Extension Through Month 48|Subject's Decision|3
992572|NCT00473330|3259474|P1|Open-label Extension Through Month 48|Subject's Decision|1
992573|NCT00473330|3259472|P3|Open-label Extension Through Month 48|Physician's Decision|3
992574|NCT00473330|3259473|P2|Open-label Extension Through Month 48|Physician's Decision|1
992575|NCT00473330|3259474|P1|Open-label Extension Through Month 48|Physician's Decision|2
992576|NCT00473330|3259472|P3|Open-label Extension Through Month 48|Lost to Follow-up|2
992577|NCT00473330|3259473|P2|Open-label Extension Through Month 48|Lost to Follow-up|0
992578|NCT00473330|3259474|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
992579|NCT00473330|3259472|P3|Open-label Extension Through Month 48|Death|0
992580|NCT00473330|3259473|P2|Open-label Extension Through Month 48|Death|0
992581|NCT00473330|3259474|P1|Open-label Extension Through Month 48|Death|2
992582|NCT00473330|3259472|P3|Open-label Extension Through Month 48|Adverse Event|2
992583|NCT00473330|3259473|P2|Open-label Extension Through Month 48|Adverse Event|0
992584|NCT00473330|3259474|P1|Open-label Extension Through Month 48|Adverse Event|0
992585|NCT00473330|3259472|P3|Core Study|Subject's Decision|19
992586|NCT00473330|3259473|P2|Core Study|Subject's Decision|8
992587|NCT00473330|3259474|P1|Core Study|Subject's Decision|9
992588|NCT00473330|3259472|P3|Core Study|Subject Required Other Therapy|3
992589|NCT00473330|3259473|P2|Core Study|Subject Required Other Therapy|1
992590|NCT00473330|3259474|P1|Core Study|Subject Required Other Therapy|0
992591|NCT00473330|3259472|P3|Core Study|Subject Non-compliance|1
992592|NCT00473330|3259473|P2|Core Study|Subject Non-compliance|2
992593|NCT00473330|3259474|P1|Core Study|Subject Non-compliance|1
992594|NCT00473330|3259472|P3|Core Study|Physician Decision|3
992595|NCT00473330|3259473|P2|Core Study|Physician Decision|1
992596|NCT00473330|3259474|P1|Core Study|Physician Decision|2
992597|NCT00473330|3259472|P3|Core Study|Lost to Follow-up|10
992598|NCT00473330|3259473|P2|Core Study|Lost to Follow-up|5
992599|NCT00473330|3259474|P1|Core Study|Lost to Follow-up|5
992600|NCT00473330|3259472|P3|Core Study|Death|4
992601|NCT00473330|3259473|P2|Core Study|Death|4
992602|NCT00473330|3259474|P1|Core Study|Death|6
992603|NCT00473330|3259472|P3|Core Study|Adverse Event|1
992604|NCT00473330|3259473|P2|Core Study|Adverse Event|4
992605|NCT00473330|3259474|P1|Core Study|Adverse Event|4
992606|NCT00473265|3259529|P1|Overall Study|Off treatment early|15
992607|NCT00473265|3259529|P1|Overall Study|Unrelated adverse event|5
992608|NCT00473083|3259541|P3|Overall Study|Adverse Event|0
992609|NCT00473083|3259542|P2|Overall Study|Adverse Event|0
992610|NCT00473083|3259543|P1|Overall Study|Adverse Event|1
992611|NCT00472641|3259618|P1|Overall Study|Lost to Follow-up|1
992612|NCT00472641|3259618|P1|Overall Study|Adverse Event|3
992613|NCT00472641|3259618|P1|Overall Study|Lack of Efficacy|3
992614|NCT00472446|3259638|P4|Overall Study|Questionnaires not returned|4
992615|NCT00472446|3259639|P3|Overall Study|Questionnaires not returned|6
992616|NCT00472446|3259640|P2|Overall Study|Questionnaires not returned|6
992617|NCT00472446|3259641|P1|Overall Study|Questionnaires not returned|5
992618|NCT00472446|3259638|P4|Overall Study|Reintervention|1
992619|NCT00472446|3259639|P3|Overall Study|Reintervention|1
992620|NCT00472446|3259640|P2|Overall Study|Reintervention|0
992621|NCT00472446|3259641|P1|Overall Study|Reintervention|0
992622|NCT00472446|3259638|P4|Overall Study|Protocol Violation|1
992623|NCT00472446|3259639|P3|Overall Study|Protocol Violation|0
992624|NCT00472446|3259640|P2|Overall Study|Protocol Violation|0
992625|NCT00472446|3259641|P1|Overall Study|Protocol Violation|0
992626|NCT00472420|3259671|P1|Follow-up Period|Protocol Violation|1
992627|NCT00472420|3259671|P1|Follow-up Period|Lost to Follow-up|2
992628|NCT00472420|3259671|P1|Follow-up Period|Physician Decision|9
992629|NCT00472420|3259671|P1|Follow-up Period|Death|5
992630|NCT00472420|3259671|P1|Induction Treatment Period|Death|3
992631|NCT00472420|3259671|P1|Induction Treatment Period|Non-compliance|1
992632|NCT00472420|3259671|P1|Induction Treatment Period|Adverse Event|3
992633|NCT00472420|3259671|P1|Induction Treatment Period|Physician Decision|9
992634|NCT00472303|3259679|P3|Maintenance Phase|not specified|0
992635|NCT00472303|3259680|P2|Maintenance Phase|not specified|1
992636|NCT00472303|3259681|P1|Maintenance Phase|not specified|1
992637|NCT00472303|3259679|P3|Maintenance Phase|Resolution of pain|1
992638|NCT00472303|3259680|P2|Maintenance Phase|Resolution of pain|0
992639|NCT00472303|3259681|P1|Maintenance Phase|Resolution of pain|0
992640|NCT00472303|3259679|P3|Maintenance Phase|Trial medication non-compliant|1
992641|NCT00472303|3259680|P2|Maintenance Phase|Trial medication non-compliant|0
992642|NCT00472303|3259681|P1|Maintenance Phase|Trial medication non-compliant|0
992643|NCT00472303|3259679|P3|Maintenance Phase|Withdrawal by Subject|3
992644|NCT00472303|3259680|P2|Maintenance Phase|Withdrawal by Subject|7
992645|NCT00472303|3259681|P1|Maintenance Phase|Withdrawal by Subject|6
992646|NCT00472303|3259679|P3|Maintenance Phase|Lack of Efficacy|4
992647|NCT00472303|3259680|P2|Maintenance Phase|Lack of Efficacy|2
992648|NCT00472303|3259681|P1|Maintenance Phase|Lack of Efficacy|2
992649|NCT00472303|3259679|P3|Maintenance Phase|Death|2
992650|NCT00472303|3259680|P2|Maintenance Phase|Death|0
992651|NCT00472303|3259681|P1|Maintenance Phase|Death|3
992652|NCT00472303|3259679|P3|Maintenance Phase|Adverse Event|6
992653|NCT00472303|3259680|P2|Maintenance Phase|Adverse Event|6
992654|NCT00472303|3259681|P1|Maintenance Phase|Adverse Event|5
992655|NCT00472303|3259679|P3|Discontinuations After Titration Phase|not specified|0
992656|NCT00472303|3259680|P2|Discontinuations After Titration Phase|not specified|0
992657|NCT00472303|3259681|P1|Discontinuations After Titration Phase|not specified|5
992658|NCT00472303|3259679|P3|Discontinuations After Titration Phase|Trial Medication non-compliant|0
992659|NCT00472303|3259680|P2|Discontinuations After Titration Phase|Trial Medication non-compliant|1
992660|NCT00472303|3259681|P1|Discontinuations After Titration Phase|Trial Medication non-compliant|0
992661|NCT00472303|3259679|P3|Discontinuations After Titration Phase|Withdrawal by Subject|0
992662|NCT00472303|3259680|P2|Discontinuations After Titration Phase|Withdrawal by Subject|2
992663|NCT00472303|3259681|P1|Discontinuations After Titration Phase|Withdrawal by Subject|2
992664|NCT00472303|3259679|P3|Discontinuations After Titration Phase|Lack of Efficacy|0
992665|NCT00472303|3259680|P2|Discontinuations After Titration Phase|Lack of Efficacy|17
992666|NCT00472303|3259681|P1|Discontinuations After Titration Phase|Lack of Efficacy|48
992667|NCT00472303|3259679|P3|Discontinuations After Titration Phase|Adverse Event|0
992668|NCT00472303|3259680|P2|Discontinuations After Titration Phase|Adverse Event|0
992669|NCT00472303|3259681|P1|Discontinuations After Titration Phase|Adverse Event|6
992670|NCT00472303|3259679|P3|Titration Phase|not specified|0
992671|NCT00472303|3259680|P2|Titration Phase|not specified|1
992672|NCT00472303|3259681|P1|Titration Phase|not specified|3
992673|NCT00472303|3259679|P3|Titration Phase|Trial Medication non-compliant|0
992674|NCT00472303|3259680|P2|Titration Phase|Trial Medication non-compliant|1
992675|NCT00472303|3259681|P1|Titration Phase|Trial Medication non-compliant|4
992676|NCT00472303|3259679|P3|Titration Phase|Withdrawal by Subject|0
992677|NCT00472303|3259680|P2|Titration Phase|Withdrawal by Subject|13
992678|NCT00472303|3259681|P1|Titration Phase|Withdrawal by Subject|16
992679|NCT00472303|3259679|P3|Titration Phase|Lack of Efficacy|0
992680|NCT00472303|3259680|P2|Titration Phase|Lack of Efficacy|0
992681|NCT00472303|3259681|P1|Titration Phase|Lack of Efficacy|10
992682|NCT00472303|3259679|P3|Titration Phase|Death|0
992683|NCT00472303|3259680|P2|Titration Phase|Death|2
992684|NCT00472303|3259681|P1|Titration Phase|Death|4
992685|NCT00472303|3259679|P3|Titration Phase|Adverse Event|0
992686|NCT00472303|3259680|P2|Titration Phase|Adverse Event|12
992687|NCT00472303|3259681|P1|Titration Phase|Adverse Event|22
992688|NCT00472290|3259744|P1|Overall Study|Requirement for alternative therapy|7
992689|NCT00472290|3259744|P1|Overall Study|Adverse Event|6
992690|NCT00472290|3259744|P1|Overall Study|Withdrawal by Subject|5
992691|NCT00472290|3259744|P1|Overall Study|Disease Progression|4
992692|NCT00472290|3259744|P1|Overall Study|Lack of Efficacy|1
992693|NCT00472290|3259744|P1|Overall Study|Lost to Follow-up|1
992694|NCT00472290|3259744|P1|Overall Study|Death|3
992695|NCT00472290|3259744|P1|Overall Study|Administrative Decision|37
992696|NCT00472290|3259744|P1|Overall Study|Protocol Specified Criteria|7
992697|NCT00472290|3259744|P1|Overall Study|Progression of Therapy-Related MDS|1
992698|NCT00472199|3259756|P2|Overall Study|patient was asymptomatic|0
992699|NCT00472199|3259757|P1|Overall Study|patient was asymptomatic|1
992700|NCT00472199|3259756|P2|Overall Study|personal reason|1
992701|NCT00472199|3259757|P1|Overall Study|personal reason|0
992702|NCT00472199|3259756|P2|Overall Study|Withdrawal by Subject|5
992703|NCT00472199|3259757|P1|Overall Study|Withdrawal by Subject|6
992704|NCT00472199|3259756|P2|Overall Study|Protocol Violation|2
992705|NCT00472199|3259757|P1|Overall Study|Protocol Violation|3
992706|NCT00472199|3259756|P2|Overall Study|Lost to Follow-up|4
992707|NCT00472199|3259757|P1|Overall Study|Lost to Follow-up|2
992708|NCT00472199|3259756|P2|Overall Study|Lack of Efficacy|25
992709|NCT00472199|3259757|P1|Overall Study|Lack of Efficacy|4
992710|NCT00472199|3259756|P2|Overall Study|Adverse Event|23
992711|NCT00472199|3259757|P1|Overall Study|Adverse Event|19
992712|NCT00472082|3259823|P1|Overall Study|Study prematurely terminated|5
992713|NCT00472030|3259845|P2|Overall Study|Physician Decision|0
992714|NCT00472030|3259846|P1|Overall Study|Physician Decision|1
992715|NCT00471822|3259862|P1|Overall Study|Protocol Violation|2
992716|NCT00471718|3259870|P1|Overall Study|Withdrawal by Subject|1
992717|NCT00471718|3259870|P1|Overall Study|disease progression|22
992718|NCT00471718|3259870|P1|Overall Study|other complicating disease|1
992719|NCT00471718|3259870|P1|Overall Study|Adverse Event|3
992720|NCT00471536|3259898|P1|Overall Study|Withdrawal by Subject|1
992721|NCT00471497|3259910|P3|Overall Study|Sub optimal response or treat. failure|0
992722|NCT00471497|3259911|P2|Overall Study|Sub optimal response or treat. failure|3
992723|NCT00471497|3259912|P1|Overall Study|Sub optimal response or treat. failure|8
992724|NCT00471497|3259910|P3|Overall Study|Protocol Violation|5
992725|NCT00471497|3259911|P2|Overall Study|Protocol Violation|3
992726|NCT00471497|3259912|P1|Overall Study|Protocol Violation|3
992727|NCT00471497|3259910|P3|Overall Study|Disease Progression|2
992728|NCT00471497|3259911|P2|Overall Study|Disease Progression|2
992729|NCT00471497|3259912|P1|Overall Study|Disease Progression|8
992730|NCT00471497|3259910|P3|Overall Study|Death|0
992731|NCT00471497|3259911|P2|Overall Study|Death|2
992732|NCT00471497|3259912|P1|Overall Study|Death|0
992733|NCT00471497|3259910|P3|Overall Study|Lost to Follow-up|1
992734|NCT00471497|3259911|P2|Overall Study|Lost to Follow-up|2
992735|NCT00471497|3259912|P1|Overall Study|Lost to Follow-up|1
992736|NCT00471497|3259910|P3|Overall Study|Withdrawal by Subject|5
992737|NCT00471497|3259911|P2|Overall Study|Withdrawal by Subject|5
992738|NCT00471497|3259912|P1|Overall Study|Withdrawal by Subject|3
992739|NCT00471497|3259910|P3|Overall Study|Condition no longer requires study drug|0
992740|NCT00471497|3259911|P2|Overall Study|Condition no longer requires study drug|1
992741|NCT00471497|3259912|P1|Overall Study|Condition no longer requires study drug|0
992742|NCT00471497|3259910|P3|Overall Study|Abnormal Test Procedure|1
992743|NCT00471497|3259911|P2|Overall Study|Abnormal Test Procedure|0
992744|NCT00471497|3259912|P1|Overall Study|Abnormal Test Procedure|1
992745|NCT00471497|3259910|P3|Overall Study|Abnormal Laboratory Value|4
992746|NCT00471497|3259911|P2|Overall Study|Abnormal Laboratory Value|6
992747|NCT00471497|3259912|P1|Overall Study|Abnormal Laboratory Value|3
992748|NCT00471497|3259910|P3|Overall Study|Adverse Event|22
992749|NCT00471497|3259911|P2|Overall Study|Adverse Event|11
992750|NCT00471497|3259912|P1|Overall Study|Adverse Event|19
992751|NCT00471445|3259922|P2|Overall Study|Protocol Violation|1
992752|NCT00471445|3259923|P1|Overall Study|Protocol Violation|0
992753|NCT00471445|3259922|P2|Overall Study|Ineligible|0
992754|NCT00471445|3259923|P1|Overall Study|Ineligible|1
992755|NCT00471445|3259922|P2|Overall Study|Withdrawal by Subject|1
992756|NCT00471445|3259923|P1|Overall Study|Withdrawal by Subject|1
992757|NCT00471354|3259936|P1|Overall Study|Patient/Caregiver Decision|12
992758|NCT00471354|3259936|P1|Overall Study|Lack of Efficacy|5
992759|NCT00471354|3259936|P1|Overall Study|Lost to Follow-up|3
992760|NCT00471354|3259936|P1|Overall Study|Sponsor Decision|1
992761|NCT00471354|3259936|P1|Overall Study|Physician Decision|4
992762|NCT00471354|3259936|P1|Overall Study|Withdrawal by Subject|1
992763|NCT00471354|3259936|P1|Overall Study|Protocol Violation|12
992764|NCT00471354|3259936|P1|Overall Study|Adverse Event|13
992765|NCT00471354|3259936|P1|Overall Study|Protocol Entry Criteria Not Met|1
992766|NCT00471328|3259948|P2|Extension Phase|Administrative Problem|0
992767|NCT00471328|3259949|P1|Extension Phase|Administrative Problem|1
992768|NCT00471328|3259948|P2|Extension Phase|New cancer Therapy|0
992769|NCT00471328|3259949|P1|Extension Phase|New cancer Therapy|1
992770|NCT00471328|3259948|P2|Extension Phase|Disease Progression|44
992771|NCT00471328|3259949|P1|Extension Phase|Disease Progression|32
992772|NCT00471328|3259948|P2|Extension Phase|Treatment duration as per protocol|1
992773|NCT00471328|3259949|P1|Extension Phase|Treatment duration as per protocol|0
992774|NCT00471328|3259948|P2|Extension Phase|Protocol Deviation|1
992775|NCT00471328|3259949|P1|Extension Phase|Protocol Deviation|3
992776|NCT00471328|3259948|P2|Extension Phase|Death|7
992777|NCT00471328|3259949|P1|Extension Phase|Death|1
992778|NCT00471328|3259948|P2|Extension Phase|Withdrawal by Subject|2
992779|NCT00471328|3259949|P1|Extension Phase|Withdrawal by Subject|0
992780|NCT00471328|3259948|P2|Extension Phase|Adverse Event|12
992781|NCT00471328|3259949|P1|Extension Phase|Adverse Event|3
992782|NCT00471328|3259948|P2|Core Phase|Protocol Deviation|1
992783|NCT00471328|3259949|P1|Core Phase|Protocol Deviation|0
992784|NCT00471328|3259948|P2|Core Phase|Administrative Problem|1
992785|NCT00471328|3259949|P1|Core Phase|Administrative Problem|0
992786|NCT00471328|3259948|P2|Core Phase|Disease Progression|53
992787|NCT00471328|3259949|P1|Core Phase|Disease Progression|78
992788|NCT00471328|3259948|P2|Core Phase|Abnormal laboratory value|0
992789|NCT00471328|3259949|P1|Core Phase|Abnormal laboratory value|1
992790|NCT00471328|3259948|P2|Core Phase|Withdrawal by Subject|2
992791|NCT00471328|3259949|P1|Core Phase|Withdrawal by Subject|2
992792|NCT00471328|3259948|P2|Core Phase|Death|4
992793|NCT00471328|3259949|P1|Core Phase|Death|8
992794|NCT00471328|3259948|P2|Core Phase|Adverse Event|6
992795|NCT00471328|3259949|P1|Core Phase|Adverse Event|18
992796|NCT00471315|3259968|P1|Overall Study|Withdrawal by Subject|1
992797|NCT00471315|3259968|P1|Overall Study|Adverse Event|7
992798|NCT00471276|3259973|P1|Overall Study|Refused treatment|6
992799|NCT00471276|3259973|P1|Overall Study|Other|3
992800|NCT00471276|3259973|P1|Overall Study|Global deterioration of health status|1
992801|NCT00471276|3259973|P1|Overall Study|Objective progression or relapse|54
992802|NCT00471276|3259973|P1|Overall Study|Protocol Violation|1
992803|NCT00471276|3259973|P1|Overall Study|Adverse Event|16
992804|NCT00471276|3259973|P1|Overall Study|Death|2
992805|NCT00471237|3260003|P7|Overall Study|Participant's decision|0
992806|NCT00471237|3260004|P6|Overall Study|Participant's decision|1
992807|NCT00471237|3260005|P5|Overall Study|Participant's decision|0
992808|NCT00471237|3260006|P4|Overall Study|Participant's decision|0
992809|NCT00471237|3260007|P3|Overall Study|Participant's decision|0
992810|NCT00471237|3260008|P2|Overall Study|Participant's decision|0
992811|NCT00471237|3260009|P1|Overall Study|Participant's decision|0
992812|NCT00471237|3260003|P7|Overall Study|Participant shifted residence|0
992813|NCT00471237|3260004|P6|Overall Study|Participant shifted residence|0
992814|NCT00471237|3260005|P5|Overall Study|Participant shifted residence|1
992815|NCT00471237|3260006|P4|Overall Study|Participant shifted residence|0
992816|NCT00471237|3260007|P3|Overall Study|Participant shifted residence|0
992817|NCT00471237|3260008|P2|Overall Study|Participant shifted residence|0
992818|NCT00471237|3260009|P1|Overall Study|Participant shifted residence|0
992819|NCT00471237|3260003|P7|Overall Study|Administration of prohibited medicine|0
992820|NCT00471237|3260004|P6|Overall Study|Administration of prohibited medicine|0
992821|NCT00471237|3260005|P5|Overall Study|Administration of prohibited medicine|1
992822|NCT00471237|3260006|P4|Overall Study|Administration of prohibited medicine|0
992823|NCT00471237|3260007|P3|Overall Study|Administration of prohibited medicine|0
992824|NCT00471237|3260008|P2|Overall Study|Administration of prohibited medicine|0
992825|NCT00471237|3260009|P1|Overall Study|Administration of prohibited medicine|0
992826|NCT00471237|3260003|P7|Overall Study|Participant lost medication|0
992827|NCT00471237|3260004|P6|Overall Study|Participant lost medication|0
992828|NCT00471237|3260005|P5|Overall Study|Participant lost medication|1
992829|NCT00471237|3260006|P4|Overall Study|Participant lost medication|0
992830|NCT00471237|3260007|P3|Overall Study|Participant lost medication|0
992831|NCT00471237|3260008|P2|Overall Study|Participant lost medication|0
992832|NCT00471237|3260009|P1|Overall Study|Participant lost medication|0
992833|NCT00471237|3260003|P7|Overall Study|High parathyroid hormone|0
992834|NCT00471237|3260004|P6|Overall Study|High parathyroid hormone|0
992835|NCT00471237|3260005|P5|Overall Study|High parathyroid hormone|0
992836|NCT00471237|3260006|P4|Overall Study|High parathyroid hormone|0
992837|NCT00471237|3260007|P3|Overall Study|High parathyroid hormone|1
992838|NCT00471237|3260008|P2|Overall Study|High parathyroid hormone|0
992839|NCT00471237|3260009|P1|Overall Study|High parathyroid hormone|0
992840|NCT00471237|3260003|P7|Overall Study|Participant planned to travel to abraod|0
992841|NCT00471237|3260004|P6|Overall Study|Participant planned to travel to abraod|1
992842|NCT00471237|3260005|P5|Overall Study|Participant planned to travel to abraod|0
992843|NCT00471237|3260006|P4|Overall Study|Participant planned to travel to abraod|0
992844|NCT00471237|3260007|P3|Overall Study|Participant planned to travel to abraod|0
992845|NCT00471237|3260008|P2|Overall Study|Participant planned to travel to abraod|0
992846|NCT00471237|3260009|P1|Overall Study|Participant planned to travel to abraod|1
992847|NCT00471237|3260003|P7|Overall Study|Early stopping due to non-efficacy|0
992848|NCT00471237|3260004|P6|Overall Study|Early stopping due to non-efficacy|0
992849|NCT00471237|3260005|P5|Overall Study|Early stopping due to non-efficacy|1
992850|NCT00471237|3260006|P4|Overall Study|Early stopping due to non-efficacy|0
992851|NCT00471237|3260007|P3|Overall Study|Early stopping due to non-efficacy|0
992852|NCT00471237|3260008|P2|Overall Study|Early stopping due to non-efficacy|0
992853|NCT00471237|3260009|P1|Overall Study|Early stopping due to non-efficacy|1
992854|NCT00471237|3260003|P7|Overall Study|Met serum creatinine withdrawal criteria|0
992855|NCT00471237|3260004|P6|Overall Study|Met serum creatinine withdrawal criteria|0
992856|NCT00471237|3260005|P5|Overall Study|Met serum creatinine withdrawal criteria|0
992857|NCT00471237|3260006|P4|Overall Study|Met serum creatinine withdrawal criteria|2
992858|NCT00471237|3260007|P3|Overall Study|Met serum creatinine withdrawal criteria|2
992859|NCT00471237|3260008|P2|Overall Study|Met serum creatinine withdrawal criteria|0
992860|NCT00471237|3260009|P1|Overall Study|Met serum creatinine withdrawal criteria|1
992861|NCT00471237|3260003|P7|Overall Study|Non-compliance|0
992862|NCT00471237|3260004|P6|Overall Study|Non-compliance|0
992863|NCT00471237|3260005|P5|Overall Study|Non-compliance|0
992864|NCT00471237|3260006|P4|Overall Study|Non-compliance|1
992865|NCT00471237|3260007|P3|Overall Study|Non-compliance|0
992866|NCT00471237|3260008|P2|Overall Study|Non-compliance|1
992867|NCT00471237|3260009|P1|Overall Study|Non-compliance|0
992868|NCT00471237|3260003|P7|Overall Study|Sponsor terminated study|0
992869|NCT00471237|3260004|P6|Overall Study|Sponsor terminated study|24
992870|NCT00471237|3260005|P5|Overall Study|Sponsor terminated study|18
992871|NCT00471237|3260006|P4|Overall Study|Sponsor terminated study|22
992872|NCT00471237|3260007|P3|Overall Study|Sponsor terminated study|19
992873|NCT00471237|3260008|P2|Overall Study|Sponsor terminated study|23
992874|NCT00471237|3260009|P1|Overall Study|Sponsor terminated study|20
992875|NCT00471237|3260003|P7|Overall Study|Withdrawal by Subject|2
992876|NCT00471237|3260004|P6|Overall Study|Withdrawal by Subject|4
992877|NCT00471237|3260005|P5|Overall Study|Withdrawal by Subject|7
992878|NCT00471237|3260006|P4|Overall Study|Withdrawal by Subject|8
992879|NCT00471237|3260007|P3|Overall Study|Withdrawal by Subject|5
992880|NCT00471237|3260008|P2|Overall Study|Withdrawal by Subject|6
992881|NCT00471237|3260009|P1|Overall Study|Withdrawal by Subject|8
992882|NCT00471237|3260003|P7|Overall Study|Protocol Violation|1
992883|NCT00471237|3260004|P6|Overall Study|Protocol Violation|4
992884|NCT00471237|3260005|P5|Overall Study|Protocol Violation|2
992885|NCT00471237|3260006|P4|Overall Study|Protocol Violation|2
992886|NCT00471237|3260007|P3|Overall Study|Protocol Violation|3
992887|NCT00471237|3260008|P2|Overall Study|Protocol Violation|6
992888|NCT00471237|3260009|P1|Overall Study|Protocol Violation|3
992889|NCT00471237|3260003|P7|Overall Study|Lost to Follow-up|0
992890|NCT00471237|3260004|P6|Overall Study|Lost to Follow-up|0
992891|NCT00471237|3260005|P5|Overall Study|Lost to Follow-up|3
992892|NCT00471237|3260006|P4|Overall Study|Lost to Follow-up|2
992893|NCT00471237|3260007|P3|Overall Study|Lost to Follow-up|0
992894|NCT00471237|3260008|P2|Overall Study|Lost to Follow-up|1
992895|NCT00471237|3260009|P1|Overall Study|Lost to Follow-up|1
992896|NCT00471237|3260003|P7|Overall Study|Adverse Event|0
992897|NCT00471237|3260004|P6|Overall Study|Adverse Event|5
992898|NCT00471237|3260005|P5|Overall Study|Adverse Event|7
992899|NCT00471237|3260006|P4|Overall Study|Adverse Event|8
992900|NCT00471237|3260007|P3|Overall Study|Adverse Event|4
992901|NCT00471237|3260008|P2|Overall Study|Adverse Event|5
992902|NCT00471237|3260009|P1|Overall Study|Adverse Event|6
992903|NCT00471146|3260159|P2|Overall Study|Other|5
992904|NCT00471146|3260160|P1|Overall Study|Other|4
992905|NCT00471146|3260159|P2|Overall Study|Randomized but not treated|8
992906|NCT00471146|3260160|P1|Overall Study|Randomized but not treated|9
992907|NCT00471146|3260159|P2|Overall Study|Global deterioration of health status|14
992908|NCT00471146|3260160|P1|Overall Study|Global deterioration of health status|12
992909|NCT00471146|3260159|P2|Overall Study|Objective progression or relapse|87
992910|NCT00471146|3260160|P1|Overall Study|Objective progression or relapse|84
992911|NCT00471146|3260159|P2|Overall Study|Protocol Violation|2
992912|NCT00471146|3260160|P1|Overall Study|Protocol Violation|2
992913|NCT00471146|3260159|P2|Overall Study|Lost to Follow-up|2
992914|NCT00471146|3260160|P1|Overall Study|Lost to Follow-up|4
992915|NCT00471146|3260159|P2|Overall Study|Death|12
992916|NCT00471146|3260160|P1|Overall Study|Death|11
992917|NCT00471146|3260159|P2|Overall Study|Withdrawal by Subject|11
992918|NCT00471146|3260160|P1|Overall Study|Withdrawal by Subject|14
992919|NCT00471146|3260159|P2|Overall Study|Adverse Event|33
992920|NCT00471146|3260160|P1|Overall Study|Adverse Event|32
992921|NCT00471107|3260185|P3|Overall Study|Technical problems/data loss|3
992922|NCT00471107|3260186|P2|Overall Study|Technical problems/data loss|1
992923|NCT00471107|3260187|P1|Overall Study|Technical problems/data loss|3
992924|NCT00471081|3260197|P2|Extended Safety Follow-Up|Missing confirmed|1
992925|NCT00471081|3260198|P1|Extended Safety Follow-Up|Missing confirmed|0
992926|NCT00471081|3260197|P2|Extended Safety Follow-Up|Lost to Follow-up|8
992927|NCT00471081|3260198|P1|Extended Safety Follow-Up|Lost to Follow-up|1
992928|NCT00471081|3260197|P2|Extended Safety Follow-Up|Withdrawal by Subject|4
992929|NCT00471081|3260198|P1|Extended Safety Follow-Up|Withdrawal by Subject|1
992930|NCT00471081|3260197|P2|Active Phase|Lost health plan/insurance|8
992931|NCT00471081|3260198|P1|Active Phase|Lost health plan/insurance|1
992932|NCT00471081|3260197|P2|Active Phase|Lost to Follow-up|1
992933|NCT00471081|3260198|P1|Active Phase|Lost to Follow-up|0
992934|NCT00471081|3260197|P2|Active Phase|Withdrawal by Subject|3
992935|NCT00471081|3260198|P1|Active Phase|Withdrawal by Subject|0
992936|NCT00471081|3260197|P2|Active Phase|Protocol Violation|1
992937|NCT00471081|3260198|P1|Active Phase|Protocol Violation|1
992938|NCT00470847|3260244|P1|Overall Study|Pt still receiving treatment|1
992939|NCT00470834|3260257|P2|Extension Period (24 Months)|Disease Progression|1
992940|NCT00470834|3260258|P1|Extension Period (24 Months)|Disease Progression|0
992941|NCT00470834|3260257|P2|Extension Period (24 Months)|Non-compliance|1
992942|NCT00470834|3260258|P1|Extension Period (24 Months)|Non-compliance|0
992943|NCT00470834|3260257|P2|Extension Period (24 Months)|Lost to Follow-up|1
992944|NCT00470834|3260258|P1|Extension Period (24 Months)|Lost to Follow-up|0
992945|NCT00470834|3260257|P2|Extension Period (24 Months)|Sponsor Terminated Study|1
992946|NCT00470834|3260258|P1|Extension Period (24 Months)|Sponsor Terminated Study|0
992947|NCT00470834|3260257|P2|Extension Period (24 Months)|Physician Decision|3
992948|NCT00470834|3260258|P1|Extension Period (24 Months)|Physician Decision|4
992949|NCT00470834|3260257|P2|Extension Period (24 Months)|Withdrawal by Subject|5
992950|NCT00470834|3260258|P1|Extension Period (24 Months)|Withdrawal by Subject|2
992951|NCT00470834|3260257|P2|Extension Period (24 Months)|Adverse Event|4
992952|NCT00470834|3260258|P1|Extension Period (24 Months)|Adverse Event|3
992953|NCT00470834|3260257|P2|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7
992954|NCT00470834|3260258|P1|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6
992955|NCT00470834|3260257|P2|Treatment Period (18 Months)|Lack of Efficacy|0
992956|NCT00470834|3260258|P1|Treatment Period (18 Months)|Lack of Efficacy|1
992957|NCT00470834|3260257|P2|Treatment Period (18 Months)|Non-compliance|0
992958|NCT00470834|3260258|P1|Treatment Period (18 Months)|Non-compliance|1
992959|NCT00470834|3260257|P2|Treatment Period (18 Months)|Lost to Follow-up|0
992960|NCT00470834|3260258|P1|Treatment Period (18 Months)|Lost to Follow-up|1
992961|NCT00470834|3260257|P2|Treatment Period (18 Months)|Sponsor Terminated Study|1
992962|NCT00470834|3260258|P1|Treatment Period (18 Months)|Sponsor Terminated Study|1
992963|NCT00470834|3260257|P2|Treatment Period (18 Months)|Protocol Violation|1
992964|NCT00470834|3260258|P1|Treatment Period (18 Months)|Protocol Violation|3
992965|NCT00470834|3260257|P2|Treatment Period (18 Months)|Physician Decision|4
992966|NCT00470834|3260258|P1|Treatment Period (18 Months)|Physician Decision|4
992967|NCT00470834|3260257|P2|Treatment Period (18 Months)|Withdrawal by Subject|5
992968|NCT00470834|3260258|P1|Treatment Period (18 Months)|Withdrawal by Subject|4
992969|NCT00470834|3260257|P2|Treatment Period (18 Months)|Adverse Event|6
992970|NCT00470834|3260258|P1|Treatment Period (18 Months)|Adverse Event|7
992971|NCT00470834|3260257|P2|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14
992972|NCT00470834|3260258|P1|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16
992973|NCT00470626|3260272|P1|Overall Study|Withdrawal by Subject|7
992974|NCT00470626|3260272|P1|Overall Study|Lost to Follow-up|10
992975|NCT00470535|3260314|P1|Overall Study|Other|2
992976|NCT00470535|3260314|P1|Overall Study|Death|1
992977|NCT00470535|3260314|P1|Overall Study|Adverse Event|1
992978|NCT00470535|3260314|P1|Overall Study|Withdrawal by Subject|1
992979|NCT00470535|3260314|P1|Overall Study|Disease Progression|13
992980|NCT00470470|3260323|P1|Overall Study|Not treated|1
992981|NCT00470470|3260323|P1|Overall Study|Death|2
992982|NCT00470470|3260323|P1|Overall Study|Adverse Event|2
992983|NCT00470418|3260330|P2|Overall Study|Withdrawal by Subject|0
992984|NCT00470418|3260331|P1|Overall Study|Withdrawal by Subject|1
992985|NCT00470366|3260352|P1|Overall Study|Poor compliance|1
992986|NCT00470366|3260352|P1|Overall Study|Adverse Event|3
992987|NCT00470275|3260363|P1|Overall Study|Withdrawal by Subject|2
992988|NCT00470275|3260363|P1|Overall Study|Lack of Efficacy|7
992989|NCT00470275|3260363|P1|Overall Study|Death|1
992990|NCT00470262|3260369|P2|Overall Study|Withdrawal by Subject|0
992991|NCT00470262|3260370|P1|Overall Study|Withdrawal by Subject|2
992992|NCT00470184|3260378|P1|Overall Study|recurrence|1
992993|NCT00470184|3260378|P1|Overall Study|other|5
992994|NCT00470184|3260378|P1|Overall Study|Withdrawal by Subject|4
992995|NCT00470184|3260378|P1|Overall Study|Adverse Event|3
992996|NCT00470184|3260378|P1|Overall Study|disease Progression|4
992997|NCT00470184|3260378|P1|Overall Study|Not treated (other)|1
992998|NCT00470184|3260378|P1|Overall Study|Not Treated(became ineligible)|4
992999|NCT00470158|3260390|P5|Overall Study|Protocol Violation|0
993000|NCT00470158|3260391|P4|Overall Study|Protocol Violation|0
993001|NCT00470158|3260392|P3|Overall Study|Protocol Violation|0
993002|NCT00470158|3260393|P2|Overall Study|Protocol Violation|0
993003|NCT00470158|3260394|P1|Overall Study|Protocol Violation|1
993004|NCT00470158|3260390|P5|Overall Study|Lost to Follow-up|4
993005|NCT00470158|3260391|P4|Overall Study|Lost to Follow-up|5
993006|NCT00470158|3260392|P3|Overall Study|Lost to Follow-up|8
993007|NCT00470158|3260393|P2|Overall Study|Lost to Follow-up|8
993008|NCT00470158|3260394|P1|Overall Study|Lost to Follow-up|7
993009|NCT00470158|3260390|P5|Overall Study|Death|2
993010|NCT00470158|3260391|P4|Overall Study|Death|0
993011|NCT00470158|3260392|P3|Overall Study|Death|0
993012|NCT00470158|3260393|P2|Overall Study|Death|0
993013|NCT00470158|3260394|P1|Overall Study|Death|0
993014|NCT00470093|3260427|P1|Overall Study|Adverse Event|2
993015|NCT00470067|3260434|P1|Overall Study|Disease Progression|6
993016|NCT00470067|3260434|P1|Overall Study|Death|1
993017|NCT00470054|3260438|P1|Overall Study|Ineligible|1
993018|NCT00469898|3260454|P1|Overall Study|Decreased performance status|1
993019|NCT00469898|3260454|P1|Overall Study|Disease progression|9
993020|NCT00469898|3260454|P1|Overall Study|Death|4
993021|NCT00469898|3260454|P1|Overall Study|Withdrawal by Subject|4
993022|NCT00469898|3260454|P1|Overall Study|Adverse Event|7
993023|NCT00469859|3260463|P2|Overall Study|Inevaluable|2
993024|NCT00469859|3260464|P1|Overall Study|Inevaluable|0
993025|NCT00469833|3260472|P1|Overall Study|No IV access|2
993026|NCT00469612|3260484|P2|Overall Study|Study terminated before data collected|0
993027|NCT00469612|3260485|P1|Overall Study|Study terminated before data collected|2
993028|NCT00469456|3260512|P2|Overall Study|Withdrawal by Subject|1
993029|NCT00469456|3260513|P1|Overall Study|Withdrawal by Subject|4
993030|NCT00469456|3260512|P2|Overall Study|Protocol Violation|0
993031|NCT00469456|3260513|P1|Overall Study|Protocol Violation|1
993032|NCT00469456|3260512|P2|Overall Study|Adverse Event|3
993033|NCT00469456|3260513|P1|Overall Study|Adverse Event|4
993034|NCT00469209|3260542|P3|Overall Study|Adverse Event|1
993035|NCT00469209|3260543|P2|Overall Study|Adverse Event|0
993036|NCT00469209|3260544|P1|Overall Study|Adverse Event|1
993037|NCT00469092|3260554|P2|Overall Study|Use of Corticosteroid|0
993038|NCT00469092|3260555|P1|Overall Study|Use of Corticosteroid|1
993039|NCT00469092|3260554|P2|Overall Study|Abnormal lab value|0
993040|NCT00469092|3260555|P1|Overall Study|Abnormal lab value|1
993041|NCT00469092|3260554|P2|Overall Study|Hypoglycaemic Episodes|1
993042|NCT00469092|3260555|P1|Overall Study|Hypoglycaemic Episodes|1
993043|NCT00469092|3260554|P2|Overall Study|Use of lipid lowering drug|0
993044|NCT00469092|3260555|P1|Overall Study|Use of lipid lowering drug|1
993045|NCT00469092|3260554|P2|Overall Study|Contraindication metformin/glimepiride|0
993046|NCT00469092|3260555|P1|Overall Study|Contraindication metformin/glimepiride|1
993047|NCT00469092|3260554|P2|Overall Study|Incorrectly Randomised|3
993048|NCT00469092|3260555|P1|Overall Study|Incorrectly Randomised|4
993049|NCT00469092|3260554|P2|Overall Study|Withdrawal Criteria|4
993050|NCT00469092|3260555|P1|Overall Study|Withdrawal Criteria|3
993051|NCT00469092|3260554|P2|Overall Study|Withdrawal by Subject|4
993052|NCT00469092|3260555|P1|Overall Study|Withdrawal by Subject|4
993053|NCT00469092|3260554|P2|Overall Study|Protocol Violation|3
993054|NCT00469092|3260555|P1|Overall Study|Protocol Violation|3
993055|NCT00469092|3260554|P2|Overall Study|Lost to Follow-up|2
993056|NCT00469092|3260555|P1|Overall Study|Lost to Follow-up|1
993057|NCT00469092|3260554|P2|Overall Study|Lack of Efficacy|0
993058|NCT00469092|3260555|P1|Overall Study|Lack of Efficacy|1
993059|NCT00469092|3260554|P2|Overall Study|Adverse Event|4
993060|NCT00469092|3260555|P1|Overall Study|Adverse Event|5
993061|NCT00469079|3260574|P3|Overall Study|Ineligible|0
993062|NCT00469079|3260575|P2|Overall Study|Ineligible|1
993063|NCT00469079|3260576|P1|Overall Study|Ineligible|0
993064|NCT00469079|3260574|P3|Overall Study|Withdrawal by Subject|2
993065|NCT00469079|3260575|P2|Overall Study|Withdrawal by Subject|2
993066|NCT00469079|3260576|P1|Overall Study|Withdrawal by Subject|1
993067|NCT00469079|3260574|P3|Overall Study|Lost to Follow-up|10
993068|NCT00469079|3260575|P2|Overall Study|Lost to Follow-up|8
993069|NCT00469079|3260576|P1|Overall Study|Lost to Follow-up|4
993070|NCT00469079|3260574|P3|Overall Study|Adverse Event|2
993071|NCT00469079|3260575|P2|Overall Study|Adverse Event|3
993072|NCT00469079|3260576|P1|Overall Study|Adverse Event|1
993073|NCT00469079|3260574|P3|Overall Study|Lack of Efficacy|5
993074|NCT00469079|3260575|P2|Overall Study|Lack of Efficacy|8
993075|NCT00469079|3260576|P1|Overall Study|Lack of Efficacy|3
993076|NCT00468910|3260595|P2|Overall Study|Medical Contraindication|1
993077|NCT00468910|3260596|P1|Overall Study|Medical Contraindication|0
993078|NCT00468910|3260595|P2|Overall Study|Withdrawal by Subject|1
993079|NCT00468910|3260596|P1|Overall Study|Withdrawal by Subject|2
993080|NCT00468910|3260595|P2|Overall Study|Lost to Follow-up|1
993081|NCT00468910|3260596|P1|Overall Study|Lost to Follow-up|2
993082|NCT00468858|3260615|P3|Overall Study|Other|1
993083|NCT00468858|3260616|P2|Overall Study|Other|0
993084|NCT00468858|3260617|P1|Overall Study|Other|0
993085|NCT00468858|3260615|P3|Overall Study|Lost to Follow-up|5
993086|NCT00468858|3260616|P2|Overall Study|Lost to Follow-up|2
993087|NCT00468858|3260617|P1|Overall Study|Lost to Follow-up|1
993088|NCT00468858|3260615|P3|Overall Study|Relocation|3
993089|NCT00468858|3260616|P2|Overall Study|Relocation|3
993090|NCT00468858|3260617|P1|Overall Study|Relocation|1
993091|NCT00468858|3260615|P3|Overall Study|Withdrawal by Subject|5
993092|NCT00468858|3260616|P2|Overall Study|Withdrawal by Subject|4
993093|NCT00468858|3260617|P1|Overall Study|Withdrawal by Subject|7
993094|NCT00468858|3260615|P3|Overall Study|Adverse Event|0
993095|NCT00468858|3260616|P2|Overall Study|Adverse Event|1
993096|NCT00468858|3260617|P1|Overall Study|Adverse Event|0
993097|NCT00468845|3260738|P3|Overall Study|Randomized, not treated|2
993098|NCT00468845|3260739|P2|Overall Study|Randomized, not treated|4
993099|NCT00468845|3260740|P1|Overall Study|Randomized, not treated|1
993100|NCT00468845|3260738|P3|Overall Study|No longer willing to participate|10
993101|NCT00468845|3260739|P2|Overall Study|No longer willing to participate|6
993102|NCT00468845|3260740|P1|Overall Study|No longer willing to participate|5
993103|NCT00468845|3260738|P3|Overall Study|Other|5
993104|NCT00468845|3260739|P2|Overall Study|Other|9
993105|NCT00468845|3260740|P1|Overall Study|Other|4
993106|NCT00468845|3260738|P3|Overall Study|Lost to Follow-up|2
993107|NCT00468845|3260739|P2|Overall Study|Lost to Follow-up|1
993108|NCT00468845|3260740|P1|Overall Study|Lost to Follow-up|2
993109|NCT00468845|3260738|P3|Overall Study|Adverse Event|11
993110|NCT00468845|3260739|P2|Overall Study|Adverse Event|14
993111|NCT00468845|3260740|P1|Overall Study|Adverse Event|9
993112|NCT00468819|3260877|P3|Overall Study|Drop-outs (Treatment never received)|0
993113|NCT00468819|3260878|P2|Overall Study|Drop-outs (Treatment never received)|0
993114|NCT00468819|3260879|P1|Overall Study|Drop-outs (Treatment never received)|2
993115|NCT00468819|3260877|P3|Overall Study|Lost to Follow-up|1
993116|NCT00468819|3260878|P2|Overall Study|Lost to Follow-up|0
993117|NCT00468819|3260879|P1|Overall Study|Lost to Follow-up|0
993118|NCT00468819|3260877|P3|Overall Study|Withdrawal by Subject|1
993119|NCT00468819|3260878|P2|Overall Study|Withdrawal by Subject|0
993120|NCT00468819|3260879|P1|Overall Study|Withdrawal by Subject|4
993121|NCT00468728|3260959|P2|Follow-up|mITT failure|31
993122|NCT00468728|3260960|P1|Follow-up|mITT failure|34
993123|NCT00468728|3260959|P2|Treatment|criteria for mITT population|11
993124|NCT00468728|3260960|P1|Treatment|criteria for mITT population|4
993125|NCT00468676|3260972|P2|Overall Study|Death|1
993126|NCT00468676|3260973|P1|Overall Study|Death|2
993127|NCT00468676|3260972|P2|Overall Study|Lost to Follow-up|11
993128|NCT00468676|3260973|P1|Overall Study|Lost to Follow-up|14
993129|NCT00468650|3260990|P1|Overall Study|Protocol Violation|1
993130|NCT00468650|3260990|P1|Overall Study|Withdrawal by Subject|2
993131|NCT00468650|3260990|P1|Overall Study|Lost to Follow-up|4
993132|NCT00468585|3261038|P4|Overall Study|Withdrawal by Subject|1
993133|NCT00468585|3261039|P3|Overall Study|Withdrawal by Subject|2
993134|NCT00468585|3261040|P2|Overall Study|Withdrawal by Subject|0
993135|NCT00468585|3261041|P1|Overall Study|Withdrawal by Subject|0
993136|NCT00468585|3261038|P4|Overall Study|Adverse Event|0
993137|NCT00468585|3261039|P3|Overall Study|Adverse Event|1
993138|NCT00468585|3261040|P2|Overall Study|Adverse Event|0
993139|NCT00468585|3261041|P1|Overall Study|Adverse Event|0
993140|NCT00468585|3261038|P4|Overall Study|Patient found to be ineligible|0
993141|NCT00468585|3261039|P3|Overall Study|Patient found to be ineligible|1
993142|NCT00468585|3261040|P2|Overall Study|Patient found to be ineligible|0
993143|NCT00468585|3261041|P1|Overall Study|Patient found to be ineligible|0
993144|NCT00468585|3261038|P4|Overall Study|Patient not treated|0
993145|NCT00468585|3261039|P3|Overall Study|Patient not treated|1
993146|NCT00468585|3261040|P2|Overall Study|Patient not treated|0
993147|NCT00468585|3261041|P1|Overall Study|Patient not treated|1
993148|NCT00468559|3261053|P3|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
993149|NCT00468559|3261054|P2|Double-blind, Treatment-withdrawal Phase|Adverse Event|2
993150|NCT00468559|3261055|P1|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
993151|NCT00468559|3261053|P3|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17
993152|NCT00468559|3261054|P2|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8
993153|NCT00468559|3261055|P1|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0
993154|NCT00468559|3261053|P3|Open-label Treatment Phase|Withdrawal by Subject|0
993155|NCT00468559|3261054|P2|Open-label Treatment Phase|Withdrawal by Subject|0
993156|NCT00468559|3261055|P1|Open-label Treatment Phase|Withdrawal by Subject|4
993157|NCT00468559|3261053|P3|Open-label Treatment Phase|Lack of Efficacy|0
993158|NCT00468559|3261054|P2|Open-label Treatment Phase|Lack of Efficacy|0
993159|NCT00468559|3261055|P1|Open-label Treatment Phase|Lack of Efficacy|9
993160|NCT00468559|3261053|P3|Open-label Treatment Phase|Adverse Event|0
993161|NCT00468559|3261054|P2|Open-label Treatment Phase|Adverse Event|0
993162|NCT00468559|3261055|P1|Open-label Treatment Phase|Adverse Event|5
993163|NCT00468546|3261083|P2|Week 24 to Week 104 Analysis|Other|14
993164|NCT00468546|3261084|P1|Week 24 to Week 104 Analysis|Other|17
993165|NCT00468546|3261083|P2|Week 24 to Week 104 Analysis|Movement into re-treatment study|183
993166|NCT00468546|3261084|P1|Week 24 to Week 104 Analysis|Movement into re-treatment study|77
993167|NCT00468546|3261083|P2|Week 24 to Week 104 Analysis|Failure to return|2
993168|NCT00468546|3261084|P1|Week 24 to Week 104 Analysis|Failure to return|1
993169|NCT00468546|3261083|P2|Week 24 to Week 104 Analysis|Refused treatment|7
993170|NCT00468546|3261084|P1|Week 24 to Week 104 Analysis|Refused treatment|4
993171|NCT00468546|3261083|P2|Week 24 to Week 104 Analysis|Protocol Violation|2
993172|NCT00468546|3261084|P1|Week 24 to Week 104 Analysis|Protocol Violation|0
993173|NCT00468546|3261083|P2|Week 24 to Week 104 Analysis|Lack of Efficacy|12
993174|NCT00468546|3261084|P1|Week 24 to Week 104 Analysis|Lack of Efficacy|3
993175|NCT00468546|3261083|P2|Week 24 to Week 104 Analysis|Death|0
993176|NCT00468546|3261084|P1|Week 24 to Week 104 Analysis|Death|1
993177|NCT00468546|3261083|P2|Week 24 to Week 104 Analysis|Adverse Event|5
993178|NCT00468546|3261084|P1|Week 24 to Week 104 Analysis|Adverse Event|2
993179|NCT00468546|3261083|P2|Week 24 Analysis|Participant unblinded (clinical hold)|0
993180|NCT00468546|3261084|P1|Week 24 Analysis|Participant unblinded (clinical hold)|1
993181|NCT00468546|3261083|P2|Week 24 Analysis|Went onto rescue therapy|0
993182|NCT00468546|3261084|P1|Week 24 Analysis|Went onto rescue therapy|1
993183|NCT00468546|3261083|P2|Week 24 Analysis|Due to clinical hold|0
993184|NCT00468546|3261084|P1|Week 24 Analysis|Due to clinical hold|1
993185|NCT00468546|3261083|P2|Week 24 Analysis|Incorrect diagnosis and treatment|1
993186|NCT00468546|3261084|P1|Week 24 Analysis|Incorrect diagnosis and treatment|0
993187|NCT00468546|3261083|P2|Week 24 Analysis|Rescue therapy|0
993188|NCT00468546|3261084|P1|Week 24 Analysis|Rescue therapy|2
993189|NCT00468546|3261083|P2|Week 24 Analysis|Failure to return|4
993190|NCT00468546|3261084|P1|Week 24 Analysis|Failure to return|3
993191|NCT00468546|3261083|P2|Week 24 Analysis|Adverse Event|8
993192|NCT00468546|3261084|P1|Week 24 Analysis|Adverse Event|1
993193|NCT00468546|3261083|P2|Week 24 Analysis|Refused treatment|5
993194|NCT00468546|3261084|P1|Week 24 Analysis|Refused treatment|5
993195|NCT00468546|3261083|P2|Week 24 Analysis|Lack of Efficacy|37
993196|NCT00468546|3261084|P1|Week 24 Analysis|Lack of Efficacy|83
993197|NCT00468481|3261114|P2|Overall Study|Other|0
993198|NCT00468481|3261115|P1|Overall Study|Other|6
993199|NCT00468481|3261114|P2|Overall Study|Non-Compliance|0
993200|NCT00468481|3261115|P1|Overall Study|Non-Compliance|5
993201|NCT00468481|3261114|P2|Overall Study|Moved out of area|1
993202|NCT00468481|3261115|P1|Overall Study|Moved out of area|4
993203|NCT00468481|3261114|P2|Overall Study|Egg Donor|0
993204|NCT00468481|3261115|P1|Overall Study|Egg Donor|1
993205|NCT00468481|3261114|P2|Overall Study|Prohibited Medication|1
993206|NCT00468481|3261115|P1|Overall Study|Prohibited Medication|1
993207|NCT00468481|3261114|P2|Overall Study|susp/diag malignant/premalignant disease|0
993208|NCT00468481|3261115|P1|Overall Study|susp/diag malignant/premalignant disease|1
993209|NCT00468481|3261114|P2|Overall Study|Withdrawal by Subject|3
993210|NCT00468481|3261115|P1|Overall Study|Withdrawal by Subject|12
993211|NCT00468481|3261114|P2|Overall Study|Protocol Violation|8
993212|NCT00468481|3261115|P1|Overall Study|Protocol Violation|18
993213|NCT00468481|3261114|P2|Overall Study|Pregnancy|0
993214|NCT00468481|3261115|P1|Overall Study|Pregnancy|2
993215|NCT00468481|3261114|P2|Overall Study|Lost to Follow-up|8
993216|NCT00468481|3261115|P1|Overall Study|Lost to Follow-up|25
993217|NCT00468481|3261114|P2|Overall Study|Adverse Event|3
993218|NCT00468481|3261115|P1|Overall Study|Adverse Event|13
993219|NCT00468312|3261215|P2|Overall Study|Did not meet protocol eligibility|1
993220|NCT00468312|3261216|P1|Overall Study|Did not meet protocol eligibility|0
993221|NCT00468312|3261215|P2|Overall Study|Protocol Violation|1
993222|NCT00468312|3261216|P1|Overall Study|Protocol Violation|2
993223|NCT00468312|3261215|P2|Overall Study|Withdrawal by Subject|1
993224|NCT00468312|3261216|P1|Overall Study|Withdrawal by Subject|0
993225|NCT00468312|3261215|P2|Overall Study|Lack of Efficacy|1
993226|NCT00468312|3261216|P1|Overall Study|Lack of Efficacy|0
993227|NCT00468312|3261215|P2|Overall Study|Adverse Event|1
993228|NCT00468312|3261216|P1|Overall Study|Adverse Event|2
993229|NCT00468299|3261232|P2|Overall Study|Withdrawal by Subject|1
993230|NCT00468299|3261233|P1|Overall Study|Withdrawal by Subject|0
993231|NCT00468286|3261243|P2|Overall Study|Physician Decision|1
993232|NCT00468286|3261244|P1|Overall Study|Physician Decision|0
993233|NCT00468286|3261243|P2|Overall Study|Withdrawal by Subject|3
993234|NCT00468286|3261244|P1|Overall Study|Withdrawal by Subject|4
993235|NCT00468286|3261243|P2|Overall Study|Protocol Violation|2
993236|NCT00468286|3261244|P1|Overall Study|Protocol Violation|2
993237|NCT00468286|3261243|P2|Overall Study|Adverse Event|6
993238|NCT00468286|3261244|P1|Overall Study|Adverse Event|1
993239|NCT00468143|3261274|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|3
993240|NCT00468143|3261275|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|3
993241|NCT00468143|3261274|P2|First Intervention (3 Weeks)|Withdrawal by Subject|4
993242|NCT00468143|3261275|P1|First Intervention (3 Weeks)|Withdrawal by Subject|3
993243|NCT00468104|3261289|P2|Second Intervention|discarded for malposition of chest tube|2
993244|NCT00468104|3261290|P1|Second Intervention|discarded for malposition of chest tube|0
993245|NCT00468104|3261289|P2|Second Intervention|Withdrawal by Subject|2
993246|NCT00468104|3261290|P1|Second Intervention|Withdrawal by Subject|5
993247|NCT00468104|3261289|P2|First Intervention|trapped lung|0
993248|NCT00468104|3261290|P1|First Intervention|trapped lung|1
993249|NCT00468104|3261289|P2|First Intervention|associated prolonged pneumothorax|0
993250|NCT00468104|3261290|P1|First Intervention|associated prolonged pneumothorax|1
993251|NCT00468104|3261289|P2|First Intervention|large lung mass with minimal effusion|0
993252|NCT00468104|3261290|P1|First Intervention|large lung mass with minimal effusion|1
993253|NCT00468104|3261289|P2|First Intervention|malposition/blocked chest tube tube|0
993254|NCT00468104|3261290|P1|First Intervention|malposition/blocked chest tube tube|2
993255|NCT00468104|3261289|P2|First Intervention|died within 3 weeks|0
993256|NCT00468104|3261290|P1|First Intervention|died within 3 weeks|1
993257|NCT00468104|3261289|P2|First Intervention|bleeding at chest tube site--first dose|0
993258|NCT00468104|3261290|P1|First Intervention|bleeding at chest tube site--first dose|1
993259|NCT00468104|3261289|P2|First Intervention|Protocol Violation|1
993260|NCT00468104|3261290|P1|First Intervention|Protocol Violation|2
993261|NCT00468052|3261307|P2|Overall Study|Protocol Violation|8
993262|NCT00468052|3261308|P1|Overall Study|Protocol Violation|7
993263|NCT00467961|3261326|P1|Overall Study|Disease Progression|2
993264|NCT00467961|3261326|P1|Overall Study|Technical Failures|5
993265|NCT00467896|3261330|P1|Overall Study|Patient had no improvement|1
993266|NCT00467896|3261330|P1|Overall Study|Started inhaled Remodulin|1
993267|NCT00467896|3261330|P1|Overall Study|Started intravenous prostacyclin|1
993268|NCT00467896|3261330|P1|Overall Study|Mainly used Prodose not I-neb® device|1
993269|NCT00467896|3261330|P1|Overall Study|Patient weaned off iloprost|1
993270|NCT00467896|3261330|P1|Overall Study|Patient had atrial septostomy|1
993271|NCT00467896|3261330|P1|Overall Study|Patient received transplant|2
993272|NCT00467896|3261330|P1|Overall Study|Changed therapy|2
993273|NCT00467896|3261330|P1|Overall Study|Non-compliance|3
993274|NCT00467896|3261330|P1|Overall Study|Serious Adverse Event|13
993275|NCT00467896|3261330|P1|Overall Study|Adverse Event|7
993276|NCT00467896|3261330|P1|Overall Study|Consent Withdrawal|18
993277|NCT00467870|3261356|P6|Overall Study|Other/Unknown|0
993278|NCT00467870|3261357|P5|Overall Study|Other/Unknown|4
993279|NCT00467870|3261358|P4|Overall Study|Other/Unknown|5
993280|NCT00467870|3261359|P3|Overall Study|Other/Unknown|1
993281|NCT00467870|3261360|P2|Overall Study|Other/Unknown|5
993282|NCT00467870|3261361|P1|Overall Study|Other/Unknown|8
993283|NCT00467870|3261356|P6|Overall Study|Subject Non-compliance|0
993284|NCT00467870|3261357|P5|Overall Study|Subject Non-compliance|5
993285|NCT00467870|3261358|P4|Overall Study|Subject Non-compliance|1
993286|NCT00467870|3261359|P3|Overall Study|Subject Non-compliance|0
993287|NCT00467870|3261360|P2|Overall Study|Subject Non-compliance|4
993288|NCT00467870|3261361|P1|Overall Study|Subject Non-compliance|3
993289|NCT00467870|3261356|P6|Overall Study|Lost to Follow-up|0
993290|NCT00467870|3261357|P5|Overall Study|Lost to Follow-up|3
993291|NCT00467870|3261358|P4|Overall Study|Lost to Follow-up|1
993292|NCT00467870|3261359|P3|Overall Study|Lost to Follow-up|1
993293|NCT00467870|3261360|P2|Overall Study|Lost to Follow-up|3
993294|NCT00467870|3261361|P1|Overall Study|Lost to Follow-up|5
993295|NCT00467870|3261356|P6|Overall Study|Withdrawal by Subject|1
993296|NCT00467870|3261357|P5|Overall Study|Withdrawal by Subject|10
993297|NCT00467870|3261358|P4|Overall Study|Withdrawal by Subject|9
993298|NCT00467870|3261359|P3|Overall Study|Withdrawal by Subject|0
993299|NCT00467870|3261360|P2|Overall Study|Withdrawal by Subject|21
993300|NCT00467870|3261361|P1|Overall Study|Withdrawal by Subject|14
993301|NCT00467870|3261356|P6|Overall Study|Protocol Violation|0
993302|NCT00467870|3261357|P5|Overall Study|Protocol Violation|0
993303|NCT00467870|3261358|P4|Overall Study|Protocol Violation|2
993304|NCT00467870|3261359|P3|Overall Study|Protocol Violation|1
993305|NCT00467870|3261360|P2|Overall Study|Protocol Violation|1
993306|NCT00467870|3261361|P1|Overall Study|Protocol Violation|2
993307|NCT00467870|3261356|P6|Overall Study|Adverse Event|1
993308|NCT00467870|3261357|P5|Overall Study|Adverse Event|15
993309|NCT00467870|3261358|P4|Overall Study|Adverse Event|15
993310|NCT00467870|3261359|P3|Overall Study|Adverse Event|1
993311|NCT00467870|3261360|P2|Overall Study|Adverse Event|9
993312|NCT00467870|3261361|P1|Overall Study|Adverse Event|13
993313|NCT00467857|3261404|P2|Overall Study|Discontinuation reason missing|3
993314|NCT00467857|3261405|P1|Overall Study|Discontinuation reason missing|0
993315|NCT00467857|3261404|P2|Overall Study|Did not meet inclusion/exclusion criteri|2
993316|NCT00467857|3261405|P1|Overall Study|Did not meet inclusion/exclusion criteri|0
993317|NCT00467857|3261404|P2|Overall Study|Emergency care required|1
993318|NCT00467857|3261405|P1|Overall Study|Emergency care required|0
993319|NCT00467857|3261404|P2|Overall Study|Discharged from court service|1
993320|NCT00467857|3261405|P1|Overall Study|Discharged from court service|0
993321|NCT00467857|3261404|P2|Overall Study|Death|1
993322|NCT00467857|3261405|P1|Overall Study|Death|0
993323|NCT00467857|3261404|P2|Overall Study|Withdrew consent|0
993324|NCT00467857|3261405|P1|Overall Study|Withdrew consent|2
993325|NCT00467857|3261404|P2|Overall Study|Adverse Event|0
993326|NCT00467857|3261405|P1|Overall Study|Adverse Event|1
993327|NCT00467831|3261453|P1|Overall Study|Withdrawal by Subject|1
993328|NCT00467831|3261453|P1|Overall Study|Death|2
993329|NCT00467779|3261472|P15|Stage 3|Unspecified Reason|5
993330|NCT00467779|3261473|P14|Stage 3|Unspecified Reason|0
993331|NCT00467779|3261474|P13|Stage 3|Unspecified Reason|0
993332|NCT00467779|3261475|P12|Stage 3|Unspecified Reason|0
993333|NCT00467779|3261476|P11|Stage 3|Unspecified Reason|0
993334|NCT00467779|3261477|P10|Stage 3|Unspecified Reason|0
993335|NCT00467779|3261478|P9|Stage 3|Unspecified Reason|0
993336|NCT00467779|3261479|P8|Stage 3|Unspecified Reason|0
993337|NCT00467779|3261480|P7|Stage 3|Unspecified Reason|0
993338|NCT00467779|3261481|P6|Stage 3|Unspecified Reason|0
993339|NCT00467779|3261482|P5|Stage 3|Unspecified Reason|0
993340|NCT00467779|3261483|P4|Stage 3|Unspecified Reason|0
993341|NCT00467779|3261484|P3|Stage 3|Unspecified Reason|0
993342|NCT00467779|3261485|P2|Stage 3|Unspecified Reason|0
993343|NCT00467779|3261486|P1|Stage 3|Unspecified Reason|0
993344|NCT00467779|3261472|P15|Stage 3|Disease Progression|9
993345|NCT00467779|3261473|P14|Stage 3|Disease Progression|0
993346|NCT00467779|3261474|P13|Stage 3|Disease Progression|0
993347|NCT00467779|3261475|P12|Stage 3|Disease Progression|0
993348|NCT00467779|3261476|P11|Stage 3|Disease Progression|0
993349|NCT00467779|3261477|P10|Stage 3|Disease Progression|0
993350|NCT00467779|3261478|P9|Stage 3|Disease Progression|0
993351|NCT00467779|3261479|P8|Stage 3|Disease Progression|0
993352|NCT00467779|3261480|P7|Stage 3|Disease Progression|0
993353|NCT00467779|3261481|P6|Stage 3|Disease Progression|0
993354|NCT00467779|3261482|P5|Stage 3|Disease Progression|0
993355|NCT00467779|3261483|P4|Stage 3|Disease Progression|0
993356|NCT00467779|3261484|P3|Stage 3|Disease Progression|0
993357|NCT00467779|3261485|P2|Stage 3|Disease Progression|0
993358|NCT00467779|3261486|P1|Stage 3|Disease Progression|0
993359|NCT00467779|3261472|P15|Stage 3|Death|1
993360|NCT00467779|3261473|P14|Stage 3|Death|0
993361|NCT00467779|3261474|P13|Stage 3|Death|0
993362|NCT00467779|3261475|P12|Stage 3|Death|0
993363|NCT00467779|3261476|P11|Stage 3|Death|0
993364|NCT00467779|3261477|P10|Stage 3|Death|0
993365|NCT00467779|3261478|P9|Stage 3|Death|0
993366|NCT00467779|3261479|P8|Stage 3|Death|0
993367|NCT00467779|3261480|P7|Stage 3|Death|0
993368|NCT00467779|3261481|P6|Stage 3|Death|0
993369|NCT00467779|3261482|P5|Stage 3|Death|0
993370|NCT00467779|3261483|P4|Stage 3|Death|0
993371|NCT00467779|3261484|P3|Stage 3|Death|0
993372|NCT00467779|3261485|P2|Stage 3|Death|0
993373|NCT00467779|3261486|P1|Stage 3|Death|0
993374|NCT00467779|3261472|P15|Stage 3|Adverse Event|2
993375|NCT00467779|3261473|P14|Stage 3|Adverse Event|0
993376|NCT00467779|3261474|P13|Stage 3|Adverse Event|0
993377|NCT00467779|3261475|P12|Stage 3|Adverse Event|0
993378|NCT00467779|3261476|P11|Stage 3|Adverse Event|0
993379|NCT00467779|3261477|P10|Stage 3|Adverse Event|0
993380|NCT00467779|3261478|P9|Stage 3|Adverse Event|0
993381|NCT00467779|3261479|P8|Stage 3|Adverse Event|0
993382|NCT00467779|3261480|P7|Stage 3|Adverse Event|0
993383|NCT00467779|3261481|P6|Stage 3|Adverse Event|0
993384|NCT00467779|3261482|P5|Stage 3|Adverse Event|0
993385|NCT00467779|3261483|P4|Stage 3|Adverse Event|0
993386|NCT00467779|3261484|P3|Stage 3|Adverse Event|0
993387|NCT00467779|3261485|P2|Stage 3|Adverse Event|0
993388|NCT00467779|3261486|P1|Stage 3|Adverse Event|0
993389|NCT00467779|3261472|P15|Stage 2A|Withdrawal by Subject|0
993390|NCT00467779|3261473|P14|Stage 2A|Withdrawal by Subject|1
993391|NCT00467779|3261474|P13|Stage 2A|Withdrawal by Subject|0
993392|NCT00467779|3261475|P12|Stage 2A|Withdrawal by Subject|0
993393|NCT00467779|3261476|P11|Stage 2A|Withdrawal by Subject|0
993394|NCT00467779|3261477|P10|Stage 2A|Withdrawal by Subject|0
993395|NCT00467779|3261478|P9|Stage 2A|Withdrawal by Subject|0
993396|NCT00467779|3261479|P8|Stage 2A|Withdrawal by Subject|0
993397|NCT00467779|3261480|P7|Stage 2A|Withdrawal by Subject|0
993398|NCT00467779|3261481|P6|Stage 2A|Withdrawal by Subject|0
993399|NCT00467779|3261482|P5|Stage 2A|Withdrawal by Subject|0
993400|NCT00467779|3261483|P4|Stage 2A|Withdrawal by Subject|0
993401|NCT00467779|3261484|P3|Stage 2A|Withdrawal by Subject|0
993402|NCT00467779|3261485|P2|Stage 2A|Withdrawal by Subject|0
993403|NCT00467779|3261486|P1|Stage 2A|Withdrawal by Subject|0
993404|NCT00467779|3261472|P15|Stage 2A|Unspecified Reason|0
993405|NCT00467779|3261473|P14|Stage 2A|Unspecified Reason|7
993406|NCT00467779|3261474|P13|Stage 2A|Unspecified Reason|0
993407|NCT00467779|3261475|P12|Stage 2A|Unspecified Reason|0
993408|NCT00467779|3261476|P11|Stage 2A|Unspecified Reason|0
993409|NCT00467779|3261477|P10|Stage 2A|Unspecified Reason|0
993410|NCT00467779|3261478|P9|Stage 2A|Unspecified Reason|0
993411|NCT00467779|3261479|P8|Stage 2A|Unspecified Reason|0
993412|NCT00467779|3261480|P7|Stage 2A|Unspecified Reason|0
993413|NCT00467779|3261481|P6|Stage 2A|Unspecified Reason|0
993414|NCT00467779|3261482|P5|Stage 2A|Unspecified Reason|0
993415|NCT00467779|3261483|P4|Stage 2A|Unspecified Reason|0
993416|NCT00467779|3261484|P3|Stage 2A|Unspecified Reason|0
993417|NCT00467779|3261485|P2|Stage 2A|Unspecified Reason|0
993418|NCT00467779|3261486|P1|Stage 2A|Unspecified Reason|0
993419|NCT00467779|3261472|P15|Stage 2A|Disease Progression|0
993420|NCT00467779|3261473|P14|Stage 2A|Disease Progression|10
993421|NCT00467779|3261474|P13|Stage 2A|Disease Progression|0
993422|NCT00467779|3261475|P12|Stage 2A|Disease Progression|0
993423|NCT00467779|3261476|P11|Stage 2A|Disease Progression|0
993424|NCT00467779|3261477|P10|Stage 2A|Disease Progression|0
993425|NCT00467779|3261478|P9|Stage 2A|Disease Progression|0
993426|NCT00467779|3261479|P8|Stage 2A|Disease Progression|0
993427|NCT00467779|3261480|P7|Stage 2A|Disease Progression|0
993428|NCT00467779|3261481|P6|Stage 2A|Disease Progression|0
993429|NCT00467779|3261482|P5|Stage 2A|Disease Progression|0
993430|NCT00467779|3261483|P4|Stage 2A|Disease Progression|0
993431|NCT00467779|3261484|P3|Stage 2A|Disease Progression|0
993432|NCT00467779|3261485|P2|Stage 2A|Disease Progression|0
993433|NCT00467779|3261486|P1|Stage 2A|Disease Progression|0
993434|NCT00467779|3261472|P15|Stage 2A|Death|0
993435|NCT00467779|3261473|P14|Stage 2A|Death|1
993436|NCT00467779|3261474|P13|Stage 2A|Death|0
993437|NCT00467779|3261475|P12|Stage 2A|Death|0
993438|NCT00467779|3261476|P11|Stage 2A|Death|0
993439|NCT00467779|3261477|P10|Stage 2A|Death|0
993440|NCT00467779|3261478|P9|Stage 2A|Death|0
993441|NCT00467779|3261479|P8|Stage 2A|Death|0
993442|NCT00467779|3261480|P7|Stage 2A|Death|0
993443|NCT00467779|3261481|P6|Stage 2A|Death|0
993444|NCT00467779|3261482|P5|Stage 2A|Death|0
993445|NCT00467779|3261483|P4|Stage 2A|Death|0
993446|NCT00467779|3261484|P3|Stage 2A|Death|0
993447|NCT00467779|3261485|P2|Stage 2A|Death|0
993448|NCT00467779|3261486|P1|Stage 2A|Death|0
993449|NCT00467779|3261472|P15|Stage 2A|Adverse Event|0
993450|NCT00467779|3261473|P14|Stage 2A|Adverse Event|2
993451|NCT00467779|3261474|P13|Stage 2A|Adverse Event|0
993452|NCT00467779|3261475|P12|Stage 2A|Adverse Event|0
993453|NCT00467779|3261476|P11|Stage 2A|Adverse Event|0
993454|NCT00467779|3261477|P10|Stage 2A|Adverse Event|0
993455|NCT00467779|3261478|P9|Stage 2A|Adverse Event|0
993456|NCT00467779|3261479|P8|Stage 2A|Adverse Event|0
993457|NCT00467779|3261480|P7|Stage 2A|Adverse Event|0
993458|NCT00467779|3261481|P6|Stage 2A|Adverse Event|0
993459|NCT00467779|3261482|P5|Stage 2A|Adverse Event|0
993460|NCT00467779|3261483|P4|Stage 2A|Adverse Event|0
993461|NCT00467779|3261484|P3|Stage 2A|Adverse Event|0
993462|NCT00467779|3261485|P2|Stage 2A|Adverse Event|0
993463|NCT00467779|3261486|P1|Stage 2A|Adverse Event|0
993464|NCT00467779|3261472|P15|Stage 2|Unspecified Reason|0
993465|NCT00467779|3261473|P14|Stage 2|Unspecified Reason|0
993466|NCT00467779|3261474|P13|Stage 2|Unspecified Reason|0
993467|NCT00467779|3261475|P12|Stage 2|Unspecified Reason|0
993468|NCT00467779|3261476|P11|Stage 2|Unspecified Reason|0
993469|NCT00467779|3261477|P10|Stage 2|Unspecified Reason|0
993470|NCT00467779|3261478|P9|Stage 2|Unspecified Reason|3
993471|NCT00467779|3261479|P8|Stage 2|Unspecified Reason|0
993472|NCT00467779|3261480|P7|Stage 2|Unspecified Reason|0
993473|NCT00467779|3261481|P6|Stage 2|Unspecified Reason|0
993474|NCT00467779|3261482|P5|Stage 2|Unspecified Reason|0
993475|NCT00467779|3261483|P4|Stage 2|Unspecified Reason|0
993476|NCT00467779|3261484|P3|Stage 2|Unspecified Reason|0
993477|NCT00467779|3261485|P2|Stage 2|Unspecified Reason|0
993478|NCT00467779|3261486|P1|Stage 2|Unspecified Reason|0
993479|NCT00467779|3261472|P15|Stage 2|Disease Progression|0
993480|NCT00467779|3261473|P14|Stage 2|Disease Progression|0
993481|NCT00467779|3261474|P13|Stage 2|Disease Progression|0
993482|NCT00467779|3261475|P12|Stage 2|Disease Progression|0
993483|NCT00467779|3261476|P11|Stage 2|Disease Progression|0
993484|NCT00467779|3261477|P10|Stage 2|Disease Progression|0
993485|NCT00467779|3261478|P9|Stage 2|Disease Progression|16
993486|NCT00467779|3261479|P8|Stage 2|Disease Progression|0
993487|NCT00467779|3261480|P7|Stage 2|Disease Progression|0
993488|NCT00467779|3261481|P6|Stage 2|Disease Progression|0
993489|NCT00467779|3261482|P5|Stage 2|Disease Progression|0
993490|NCT00467779|3261483|P4|Stage 2|Disease Progression|0
993491|NCT00467779|3261484|P3|Stage 2|Disease Progression|0
993492|NCT00467779|3261485|P2|Stage 2|Disease Progression|0
993493|NCT00467779|3261486|P1|Stage 2|Disease Progression|0
993494|NCT00467779|3261472|P15|Stage 2|Death|0
993495|NCT00467779|3261473|P14|Stage 2|Death|0
993496|NCT00467779|3261474|P13|Stage 2|Death|0
993497|NCT00467779|3261475|P12|Stage 2|Death|0
993498|NCT00467779|3261476|P11|Stage 2|Death|0
993499|NCT00467779|3261477|P10|Stage 2|Death|0
993500|NCT00467779|3261478|P9|Stage 2|Death|1
993501|NCT00467779|3261479|P8|Stage 2|Death|0
993502|NCT00467779|3261480|P7|Stage 2|Death|0
993503|NCT00467779|3261481|P6|Stage 2|Death|0
993504|NCT00467779|3261482|P5|Stage 2|Death|0
993505|NCT00467779|3261483|P4|Stage 2|Death|0
993506|NCT00467779|3261484|P3|Stage 2|Death|0
993507|NCT00467779|3261485|P2|Stage 2|Death|0
993508|NCT00467779|3261486|P1|Stage 2|Death|0
993509|NCT00467779|3261472|P15|Stage 2|Adverse Event|0
993510|NCT00467779|3261473|P14|Stage 2|Adverse Event|0
993511|NCT00467779|3261474|P13|Stage 2|Adverse Event|0
993512|NCT00467779|3261475|P12|Stage 2|Adverse Event|0
993513|NCT00467779|3261476|P11|Stage 2|Adverse Event|0
993514|NCT00467779|3261477|P10|Stage 2|Adverse Event|0
993515|NCT00467779|3261478|P9|Stage 2|Adverse Event|1
993516|NCT00467779|3261479|P8|Stage 2|Adverse Event|0
993517|NCT00467779|3261480|P7|Stage 2|Adverse Event|0
993518|NCT00467779|3261481|P6|Stage 2|Adverse Event|0
993519|NCT00467779|3261482|P5|Stage 2|Adverse Event|0
993520|NCT00467779|3261483|P4|Stage 2|Adverse Event|0
993521|NCT00467779|3261484|P3|Stage 2|Adverse Event|0
993522|NCT00467779|3261485|P2|Stage 2|Adverse Event|0
993523|NCT00467779|3261486|P1|Stage 2|Adverse Event|0
993524|NCT00467779|3261472|P15|Stage 1A|Unspecified Reason|0
993525|NCT00467779|3261473|P14|Stage 1A|Unspecified Reason|0
993526|NCT00467779|3261474|P13|Stage 1A|Unspecified Reason|1
993527|NCT00467779|3261475|P12|Stage 1A|Unspecified Reason|1
993528|NCT00467779|3261476|P11|Stage 1A|Unspecified Reason|0
993529|NCT00467779|3261477|P10|Stage 1A|Unspecified Reason|0
993530|NCT00467779|3261478|P9|Stage 1A|Unspecified Reason|0
993531|NCT00467779|3261479|P8|Stage 1A|Unspecified Reason|0
993532|NCT00467779|3261480|P7|Stage 1A|Unspecified Reason|0
993533|NCT00467779|3261481|P6|Stage 1A|Unspecified Reason|0
993534|NCT00467779|3261482|P5|Stage 1A|Unspecified Reason|0
993535|NCT00467779|3261483|P4|Stage 1A|Unspecified Reason|0
993536|NCT00467779|3261484|P3|Stage 1A|Unspecified Reason|0
993537|NCT00467779|3261485|P2|Stage 1A|Unspecified Reason|0
993538|NCT00467779|3261486|P1|Stage 1A|Unspecified Reason|0
993539|NCT00467779|3261472|P15|Stage 1A|Withdrawal by Subject|0
993540|NCT00467779|3261473|P14|Stage 1A|Withdrawal by Subject|0
993541|NCT00467779|3261474|P13|Stage 1A|Withdrawal by Subject|1
993542|NCT00467779|3261475|P12|Stage 1A|Withdrawal by Subject|1
993543|NCT00467779|3261476|P11|Stage 1A|Withdrawal by Subject|1
993544|NCT00467779|3261477|P10|Stage 1A|Withdrawal by Subject|0
993545|NCT00467779|3261478|P9|Stage 1A|Withdrawal by Subject|0
993546|NCT00467779|3261479|P8|Stage 1A|Withdrawal by Subject|0
993547|NCT00467779|3261480|P7|Stage 1A|Withdrawal by Subject|0
993548|NCT00467779|3261481|P6|Stage 1A|Withdrawal by Subject|0
993549|NCT00467779|3261482|P5|Stage 1A|Withdrawal by Subject|0
993550|NCT00467779|3261483|P4|Stage 1A|Withdrawal by Subject|0
993551|NCT00467779|3261484|P3|Stage 1A|Withdrawal by Subject|0
993552|NCT00467779|3261485|P2|Stage 1A|Withdrawal by Subject|0
993553|NCT00467779|3261486|P1|Stage 1A|Withdrawal by Subject|0
993554|NCT00467779|3261472|P15|Stage 1A|Physician Decision|0
993555|NCT00467779|3261473|P14|Stage 1A|Physician Decision|0
993556|NCT00467779|3261474|P13|Stage 1A|Physician Decision|0
993557|NCT00467779|3261475|P12|Stage 1A|Physician Decision|0
993558|NCT00467779|3261476|P11|Stage 1A|Physician Decision|0
993559|NCT00467779|3261477|P10|Stage 1A|Physician Decision|1
993560|NCT00467779|3261478|P9|Stage 1A|Physician Decision|0
993561|NCT00467779|3261479|P8|Stage 1A|Physician Decision|0
993562|NCT00467779|3261480|P7|Stage 1A|Physician Decision|0
993563|NCT00467779|3261481|P6|Stage 1A|Physician Decision|0
993564|NCT00467779|3261482|P5|Stage 1A|Physician Decision|0
993565|NCT00467779|3261483|P4|Stage 1A|Physician Decision|0
993566|NCT00467779|3261484|P3|Stage 1A|Physician Decision|0
993567|NCT00467779|3261485|P2|Stage 1A|Physician Decision|0
993568|NCT00467779|3261486|P1|Stage 1A|Physician Decision|0
993569|NCT00467779|3261472|P15|Stage 1A|Disease Progression|0
993570|NCT00467779|3261473|P14|Stage 1A|Disease Progression|0
993571|NCT00467779|3261474|P13|Stage 1A|Disease Progression|2
993572|NCT00467779|3261475|P12|Stage 1A|Disease Progression|5
993573|NCT00467779|3261476|P11|Stage 1A|Disease Progression|2
993574|NCT00467779|3261477|P10|Stage 1A|Disease Progression|2
993575|NCT00467779|3261478|P9|Stage 1A|Disease Progression|0
993576|NCT00467779|3261479|P8|Stage 1A|Disease Progression|0
993577|NCT00467779|3261480|P7|Stage 1A|Disease Progression|0
993578|NCT00467779|3261481|P6|Stage 1A|Disease Progression|0
993579|NCT00467779|3261482|P5|Stage 1A|Disease Progression|0
993580|NCT00467779|3261483|P4|Stage 1A|Disease Progression|0
993581|NCT00467779|3261484|P3|Stage 1A|Disease Progression|0
993582|NCT00467779|3261485|P2|Stage 1A|Disease Progression|0
993583|NCT00467779|3261486|P1|Stage 1A|Disease Progression|0
993584|NCT00467779|3261472|P15|Stage 1A|Death|0
993585|NCT00467779|3261473|P14|Stage 1A|Death|0
993586|NCT00467779|3261474|P13|Stage 1A|Death|1
993587|NCT00467779|3261475|P12|Stage 1A|Death|1
993588|NCT00467779|3261476|P11|Stage 1A|Death|0
993589|NCT00467779|3261477|P10|Stage 1A|Death|0
993590|NCT00467779|3261478|P9|Stage 1A|Death|0
993591|NCT00467779|3261479|P8|Stage 1A|Death|0
993592|NCT00467779|3261480|P7|Stage 1A|Death|0
993593|NCT00467779|3261481|P6|Stage 1A|Death|0
993594|NCT00467779|3261482|P5|Stage 1A|Death|0
993595|NCT00467779|3261483|P4|Stage 1A|Death|0
993596|NCT00467779|3261484|P3|Stage 1A|Death|0
993597|NCT00467779|3261485|P2|Stage 1A|Death|0
993598|NCT00467779|3261486|P1|Stage 1A|Death|0
993599|NCT00467779|3261472|P15|Stage 1A|Adverse Event|0
993600|NCT00467779|3261473|P14|Stage 1A|Adverse Event|0
993601|NCT00467779|3261474|P13|Stage 1A|Adverse Event|1
993602|NCT00467779|3261475|P12|Stage 1A|Adverse Event|0
993603|NCT00467779|3261476|P11|Stage 1A|Adverse Event|0
993604|NCT00467779|3261477|P10|Stage 1A|Adverse Event|0
993605|NCT00467779|3261478|P9|Stage 1A|Adverse Event|0
993606|NCT00467779|3261479|P8|Stage 1A|Adverse Event|0
993607|NCT00467779|3261480|P7|Stage 1A|Adverse Event|0
993608|NCT00467779|3261481|P6|Stage 1A|Adverse Event|0
993609|NCT00467779|3261482|P5|Stage 1A|Adverse Event|0
993610|NCT00467779|3261483|P4|Stage 1A|Adverse Event|0
993611|NCT00467779|3261484|P3|Stage 1A|Adverse Event|0
993612|NCT00467779|3261485|P2|Stage 1A|Adverse Event|0
993613|NCT00467779|3261486|P1|Stage 1A|Adverse Event|0
993614|NCT00467779|3261472|P15|Stage 1|Withdrawal by Subject|0
993615|NCT00467779|3261473|P14|Stage 1|Withdrawal by Subject|0
993616|NCT00467779|3261474|P13|Stage 1|Withdrawal by Subject|0
993617|NCT00467779|3261475|P12|Stage 1|Withdrawal by Subject|0
993618|NCT00467779|3261476|P11|Stage 1|Withdrawal by Subject|0
993619|NCT00467779|3261477|P10|Stage 1|Withdrawal by Subject|0
993620|NCT00467779|3261478|P9|Stage 1|Withdrawal by Subject|0
993621|NCT00467779|3261479|P8|Stage 1|Withdrawal by Subject|1
993622|NCT00467779|3261480|P7|Stage 1|Withdrawal by Subject|1
993623|NCT00467779|3261481|P6|Stage 1|Withdrawal by Subject|0
993624|NCT00467779|3261482|P5|Stage 1|Withdrawal by Subject|0
993625|NCT00467779|3261483|P4|Stage 1|Withdrawal by Subject|0
993626|NCT00467779|3261484|P3|Stage 1|Withdrawal by Subject|0
993627|NCT00467779|3261485|P2|Stage 1|Withdrawal by Subject|0
993628|NCT00467779|3261486|P1|Stage 1|Withdrawal by Subject|0
993629|NCT00467779|3261472|P15|Stage 1|Physician Decision|0
993630|NCT00467779|3261473|P14|Stage 1|Physician Decision|0
993631|NCT00467779|3261474|P13|Stage 1|Physician Decision|0
993632|NCT00467779|3261475|P12|Stage 1|Physician Decision|0
993633|NCT00467779|3261476|P11|Stage 1|Physician Decision|0
993634|NCT00467779|3261477|P10|Stage 1|Physician Decision|0
993635|NCT00467779|3261478|P9|Stage 1|Physician Decision|0
993636|NCT00467779|3261479|P8|Stage 1|Physician Decision|0
993637|NCT00467779|3261480|P7|Stage 1|Physician Decision|0
993638|NCT00467779|3261481|P6|Stage 1|Physician Decision|0
993639|NCT00467779|3261482|P5|Stage 1|Physician Decision|0
993640|NCT00467779|3261483|P4|Stage 1|Physician Decision|0
993641|NCT00467779|3261484|P3|Stage 1|Physician Decision|0
993642|NCT00467779|3261485|P2|Stage 1|Physician Decision|1
993643|NCT00467779|3261486|P1|Stage 1|Physician Decision|0
993644|NCT00467779|3261472|P15|Stage 1|Unspecified Reason|0
993645|NCT00467779|3261473|P14|Stage 1|Unspecified Reason|0
993646|NCT00467779|3261474|P13|Stage 1|Unspecified Reason|0
993647|NCT00467779|3261475|P12|Stage 1|Unspecified Reason|0
993648|NCT00467779|3261476|P11|Stage 1|Unspecified Reason|0
993649|NCT00467779|3261477|P10|Stage 1|Unspecified Reason|0
993650|NCT00467779|3261478|P9|Stage 1|Unspecified Reason|0
993651|NCT00467779|3261479|P8|Stage 1|Unspecified Reason|0
993652|NCT00467779|3261480|P7|Stage 1|Unspecified Reason|0
993653|NCT00467779|3261481|P6|Stage 1|Unspecified Reason|2
993654|NCT00467779|3261482|P5|Stage 1|Unspecified Reason|1
993655|NCT00467779|3261483|P4|Stage 1|Unspecified Reason|0
993656|NCT00467779|3261484|P3|Stage 1|Unspecified Reason|1
993657|NCT00467779|3261485|P2|Stage 1|Unspecified Reason|0
993658|NCT00467779|3261486|P1|Stage 1|Unspecified Reason|1
993659|NCT00467779|3261472|P15|Stage 1|Disease Progression|0
993660|NCT00467779|3261473|P14|Stage 1|Disease Progression|0
993661|NCT00467779|3261474|P13|Stage 1|Disease Progression|0
993662|NCT00467779|3261475|P12|Stage 1|Disease Progression|0
993663|NCT00467779|3261476|P11|Stage 1|Disease Progression|0
993664|NCT00467779|3261477|P10|Stage 1|Disease Progression|0
993665|NCT00467779|3261478|P9|Stage 1|Disease Progression|0
993666|NCT00467779|3261479|P8|Stage 1|Disease Progression|5
993667|NCT00467779|3261480|P7|Stage 1|Disease Progression|4
993668|NCT00467779|3261481|P6|Stage 1|Disease Progression|2
993669|NCT00467779|3261482|P5|Stage 1|Disease Progression|2
993670|NCT00467779|3261483|P4|Stage 1|Disease Progression|3
993671|NCT00467779|3261484|P3|Stage 1|Disease Progression|2
993672|NCT00467779|3261485|P2|Stage 1|Disease Progression|2
993673|NCT00467779|3261486|P1|Stage 1|Disease Progression|2
993674|NCT00467779|3261472|P15|Stage 1|Adverse Event|0
993675|NCT00467779|3261473|P14|Stage 1|Adverse Event|0
993676|NCT00467779|3261474|P13|Stage 1|Adverse Event|0
993677|NCT00467779|3261475|P12|Stage 1|Adverse Event|0
993678|NCT00467779|3261476|P11|Stage 1|Adverse Event|0
993679|NCT00467779|3261477|P10|Stage 1|Adverse Event|0
993680|NCT00467779|3261478|P9|Stage 1|Adverse Event|0
993681|NCT00467779|3261479|P8|Stage 1|Adverse Event|1
993682|NCT00467779|3261480|P7|Stage 1|Adverse Event|2
993683|NCT00467779|3261481|P6|Stage 1|Adverse Event|1
993684|NCT00467779|3261482|P5|Stage 1|Adverse Event|0
993685|NCT00467779|3261483|P4|Stage 1|Adverse Event|0
993686|NCT00467779|3261484|P3|Stage 1|Adverse Event|0
993687|NCT00467779|3261485|P2|Stage 1|Adverse Event|0
993688|NCT00467779|3261486|P1|Stage 1|Adverse Event|1
993689|NCT00467753|3261660|P2|Overall Study|Adverse Event|0
993690|NCT00467753|3261661|P1|Overall Study|Adverse Event|2
993691|NCT00467753|3261660|P2|Overall Study|Lost to Follow-up|2
993692|NCT00467753|3261661|P1|Overall Study|Lost to Follow-up|1
993693|NCT00467740|3261672|P5|Overall Study|Lack of Efficacy|0
993694|NCT00467740|3261673|P4|Overall Study|Lack of Efficacy|0
993695|NCT00467740|3261674|P3|Overall Study|Lack of Efficacy|0
993696|NCT00467740|3261675|P2|Overall Study|Lack of Efficacy|1
993697|NCT00467740|3261676|P1|Overall Study|Lack of Efficacy|0
993698|NCT00467740|3261672|P5|Overall Study|Withdrawal by Subject|0
993699|NCT00467740|3261673|P4|Overall Study|Withdrawal by Subject|1
993700|NCT00467740|3261674|P3|Overall Study|Withdrawal by Subject|0
993701|NCT00467740|3261675|P2|Overall Study|Withdrawal by Subject|1
993702|NCT00467740|3261676|P1|Overall Study|Withdrawal by Subject|1
993703|NCT00467740|3261672|P5|Overall Study|Lost to Follow-up|0
993704|NCT00467740|3261673|P4|Overall Study|Lost to Follow-up|0
993705|NCT00467740|3261674|P3|Overall Study|Lost to Follow-up|0
993706|NCT00467740|3261675|P2|Overall Study|Lost to Follow-up|1
993707|NCT00467740|3261676|P1|Overall Study|Lost to Follow-up|0
993708|NCT00467740|3261672|P5|Overall Study|Protocol Violation|0
993709|NCT00467740|3261673|P4|Overall Study|Protocol Violation|0
993710|NCT00467740|3261674|P3|Overall Study|Protocol Violation|1
993711|NCT00467740|3261675|P2|Overall Study|Protocol Violation|0
993712|NCT00467740|3261676|P1|Overall Study|Protocol Violation|0
993713|NCT00467740|3261672|P5|Overall Study|Adverse Event|0
993714|NCT00467740|3261673|P4|Overall Study|Adverse Event|0
993715|NCT00467740|3261674|P3|Overall Study|Adverse Event|1
993716|NCT00467740|3261675|P2|Overall Study|Adverse Event|0
993717|NCT00467740|3261676|P1|Overall Study|Adverse Event|0
993718|NCT00467649|3261865|P6|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1
993719|NCT00467649|3261866|P5|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
993720|NCT00467649|3261867|P4|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
993721|NCT00467649|3261868|P3|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
993722|NCT00467649|3261869|P2|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
993723|NCT00467649|3261870|P1|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
993724|NCT00467649|3261865|P6|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
993725|NCT00467649|3261866|P5|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
993726|NCT00467649|3261867|P4|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1
993727|NCT00467649|3261868|P3|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
993728|NCT00467649|3261869|P2|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
993729|NCT00467649|3261870|P1|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
993730|NCT00467649|3261865|P6|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
993731|NCT00467649|3261866|P5|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
993732|NCT00467649|3261867|P4|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1
993733|NCT00467649|3261868|P3|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
993734|NCT00467649|3261869|P2|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
993735|NCT00467649|3261870|P1|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
993736|NCT00467649|3261865|P6|Phase 1 (Randomized Population)|Withdrawal of Consent|0
993737|NCT00467649|3261866|P5|Phase 1 (Randomized Population)|Withdrawal of Consent|0
993738|NCT00467649|3261867|P4|Phase 1 (Randomized Population)|Withdrawal of Consent|0
993739|NCT00467649|3261868|P3|Phase 1 (Randomized Population)|Withdrawal of Consent|0
993740|NCT00467649|3261869|P2|Phase 1 (Randomized Population)|Withdrawal of Consent|2
993741|NCT00467649|3261870|P1|Phase 1 (Randomized Population)|Withdrawal of Consent|4
993742|NCT00467649|3261865|P6|Phase 1 (Randomized Population)|Lost to Follow-up|0
993743|NCT00467649|3261866|P5|Phase 1 (Randomized Population)|Lost to Follow-up|0
993744|NCT00467649|3261867|P4|Phase 1 (Randomized Population)|Lost to Follow-up|0
993745|NCT00467649|3261868|P3|Phase 1 (Randomized Population)|Lost to Follow-up|0
993746|NCT00467649|3261869|P2|Phase 1 (Randomized Population)|Lost to Follow-up|4
993747|NCT00467649|3261870|P1|Phase 1 (Randomized Population)|Lost to Follow-up|2
993748|NCT00467649|3261865|P6|Phase 1 (Randomized Population)|Investigator Decision|0
993749|NCT00467649|3261866|P5|Phase 1 (Randomized Population)|Investigator Decision|0
993750|NCT00467649|3261867|P4|Phase 1 (Randomized Population)|Investigator Decision|0
993751|NCT00467649|3261868|P3|Phase 1 (Randomized Population)|Investigator Decision|0
993752|NCT00467649|3261869|P2|Phase 1 (Randomized Population)|Investigator Decision|0
993753|NCT00467649|3261870|P1|Phase 1 (Randomized Population)|Investigator Decision|1
993754|NCT00467649|3261865|P6|Phase 1 (Randomized Population)|Adverse Event|0
993755|NCT00467649|3261866|P5|Phase 1 (Randomized Population)|Adverse Event|0
993756|NCT00467649|3261867|P4|Phase 1 (Randomized Population)|Adverse Event|0
993757|NCT00467649|3261868|P3|Phase 1 (Randomized Population)|Adverse Event|0
993758|NCT00467649|3261869|P2|Phase 1 (Randomized Population)|Adverse Event|0
993759|NCT00467649|3261870|P1|Phase 1 (Randomized Population)|Adverse Event|2
993760|NCT00467610|3261910|P1|Overall Study|Withdrawal by Subject|1
993761|NCT00467597|3261921|P2|Overall Study|Withdrawal by Subject|0
993762|NCT00467597|3261922|P1|Overall Study|Withdrawal by Subject|2
993763|NCT00467584|3261935|P3|Overall Study|Withdrawal by Subject|1
993764|NCT00467584|3261936|P2|Overall Study|Withdrawal by Subject|5
993765|NCT00467584|3261937|P1|Overall Study|Withdrawal by Subject|4
993766|NCT00467558|3261947|P2|Overall Study|Lost to Follow-up|0
993767|NCT00467558|3261948|P1|Overall Study|Lost to Follow-up|2
993768|NCT00467519|3261958|P2|Overall Study|Withdrawal by Subject|10
993769|NCT00467519|3261959|P1|Overall Study|Withdrawal by Subject|4
993770|NCT00467519|3261958|P2|Overall Study|Lost to Follow-up|9
993771|NCT00467519|3261959|P1|Overall Study|Lost to Follow-up|2
993772|NCT00467519|3261958|P2|Overall Study|Protocol Violation|4
993773|NCT00467519|3261959|P1|Overall Study|Protocol Violation|8
993774|NCT00467363|3261988|P2|Overall Study|Lost to Follow-up|70
993775|NCT00467363|3261989|P1|Overall Study|Lost to Follow-up|80
993776|NCT00467285|3262036|P2|Overall Study|Lost to Follow-up|4
993777|NCT00467285|3262037|P1|Overall Study|Lost to Follow-up|4
993778|NCT00467259|3262057|P2|Overall Study|Site Closed|1
993779|NCT00467259|3262058|P1|Overall Study|Site Closed|2
993780|NCT00467259|3262057|P2|Overall Study|Lost to Follow-up|34
993781|NCT00467259|3262058|P1|Overall Study|Lost to Follow-up|14
993782|NCT00467259|3262057|P2|Overall Study|Physician Decision|2
993783|NCT00467259|3262058|P1|Overall Study|Physician Decision|0
993784|NCT00467259|3262057|P2|Overall Study|Withdrawal by Subject|108
993785|NCT00467259|3262058|P1|Overall Study|Withdrawal by Subject|34
993786|NCT00467259|3262057|P2|Overall Study|Protocol Violation|7
993787|NCT00467259|3262058|P1|Overall Study|Protocol Violation|1
993788|NCT00467259|3262057|P2|Overall Study|Adverse Event|90
993789|NCT00467259|3262058|P1|Overall Study|Adverse Event|24
993790|NCT00467051|3262075|P1|Overall Study|Adverse Event|2
993791|NCT00466947|3262102|P2|Study End Analysis Period|Other – Unconformity in team’s treatment|1
993792|NCT00466947|3262103|P1|Study End Analysis Period|Other – Unconformity in team’s treatment|0
993793|NCT00466947|3262102|P2|Study End Analysis Period|Other – Subject without a legal guardian|0
993794|NCT00466947|3262103|P1|Study End Analysis Period|Other – Subject without a legal guardian|1
993795|NCT00466947|3262102|P2|Study End Analysis Period|Other – Forbidden vaccination|10
993796|NCT00466947|3262103|P1|Study End Analysis Period|Other – Forbidden vaccination|21
993797|NCT00466947|3262102|P2|Study End Analysis Period|Withdrawal by Subject|1267
993798|NCT00466947|3262103|P1|Study End Analysis Period|Withdrawal by Subject|1264
993799|NCT00466947|3262102|P2|Study End Analysis Period|Protocol Violation|17
993800|NCT00466947|3262103|P1|Study End Analysis Period|Protocol Violation|9
993801|NCT00466947|3262102|P2|Study End Analysis Period|Physician Decision|29
993802|NCT00466947|3262103|P1|Study End Analysis Period|Physician Decision|29
993803|NCT00466947|3262102|P2|Study End Analysis Period|Lost to Follow-up|1167
993804|NCT00466947|3262103|P1|Study End Analysis Period|Lost to Follow-up|1137
993805|NCT00466947|3262102|P2|Study End Analysis Period|Adverse Event|43
993806|NCT00466947|3262103|P1|Study End Analysis Period|Adverse Event|35
993807|NCT00466947|3262102|P2|Primary Outcome Analysis Period|Other: study still ongoing|11863
993808|NCT00466947|3262103|P1|Primary Outcome Analysis Period|Other: study still ongoing|11875
993809|NCT00466726|3262294|P1|Overall Study|Not evaluable for response|14
993810|NCT00466687|3262300|P1|Overall Study|Disease progression|29
993811|NCT00466687|3262300|P1|Overall Study|Withdrawal by Subject|1
993812|NCT00466687|3262300|P1|Overall Study|Other complicating illness|3
993813|NCT00466687|3262300|P1|Overall Study|Adverse Event|1
993814|NCT00466505|3262307|P1|Overall Study|Adverse Event|4
993815|NCT00466505|3262307|P1|Overall Study|disease progression|13
993816|NCT00466193|3262357|P2|Overall Study|Patient refused Visit 4 procedures|0
993817|NCT00466193|3262358|P1|Overall Study|Patient refused Visit 4 procedures|1
993818|NCT00466193|3262357|P2|Overall Study|Withdrawal by Subject|2
993819|NCT00466193|3262358|P1|Overall Study|Withdrawal by Subject|7
993820|NCT00466193|3262357|P2|Overall Study|Protocol Violation|1
993821|NCT00466193|3262358|P1|Overall Study|Protocol Violation|1
993822|NCT00466193|3262357|P2|Overall Study|Physician Decision|0
993823|NCT00466193|3262358|P1|Overall Study|Physician Decision|1
993824|NCT00466193|3262357|P2|Overall Study|Lost to Follow-up|4
993825|NCT00466193|3262358|P1|Overall Study|Lost to Follow-up|2
993826|NCT00466193|3262357|P2|Overall Study|Adverse Event|1
993827|NCT00466193|3262358|P1|Overall Study|Adverse Event|0
993828|NCT00466167|3262385|P3|Overall Study|Not treated|0
993829|NCT00466167|3262386|P2|Overall Study|Not treated|0
993830|NCT00466167|3262387|P1|Overall Study|Not treated|1
993831|NCT00466167|3262385|P3|Overall Study|patient did not meet inclusion criteria|1
993832|NCT00466167|3262386|P2|Overall Study|patient did not meet inclusion criteria|0
993833|NCT00466167|3262387|P1|Overall Study|patient did not meet inclusion criteria|1
993834|NCT00466167|3262385|P3|Overall Study|Withdrawal by Subject|6
993835|NCT00466167|3262386|P2|Overall Study|Withdrawal by Subject|1
993836|NCT00466167|3262387|P1|Overall Study|Withdrawal by Subject|4
993837|NCT00466167|3262385|P3|Overall Study|Lost to Follow-up|2
993838|NCT00466167|3262386|P2|Overall Study|Lost to Follow-up|2
993839|NCT00466167|3262387|P1|Overall Study|Lost to Follow-up|3
993840|NCT00466167|3262385|P3|Overall Study|Protocol Violation|2
993841|NCT00466167|3262386|P2|Overall Study|Protocol Violation|1
993842|NCT00466167|3262387|P1|Overall Study|Protocol Violation|1
993843|NCT00466167|3262385|P3|Overall Study|Lack of Efficacy|3
993844|NCT00466167|3262386|P2|Overall Study|Lack of Efficacy|0
993845|NCT00466167|3262387|P1|Overall Study|Lack of Efficacy|2
993846|NCT00466167|3262385|P3|Overall Study|Adverse Event|7
993847|NCT00466167|3262386|P2|Overall Study|Adverse Event|8
993848|NCT00466167|3262387|P1|Overall Study|Adverse Event|8
993849|NCT00465985|3262448|P2|Part III - Open-label Treatment Period|Adverse Event|0
993850|NCT00465985|3262449|P1|Part III - Open-label Treatment Period|Adverse Event|1
993851|NCT00465985|3262448|P2|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
993852|NCT00465985|3262449|P1|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1
993853|NCT00465985|3262448|P2|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12
993854|NCT00465985|3262449|P1|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0
993855|NCT00465985|3262448|P2|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
993856|NCT00465985|3262449|P1|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4
993857|NCT00465972|3262472|P2|Overall Study|Withdrawal by Subject|1
993858|NCT00465972|3262473|P1|Overall Study|Withdrawal by Subject|2
993859|NCT00465894|3262483|P2|Treatment For 12 Weeks|Withdrawal by Subject|1
993860|NCT00465894|3262484|P1|Treatment For 12 Weeks|Withdrawal by Subject|0
993861|NCT00465894|3262483|P2|Treatment For 12 Weeks|Family Issues|1
993862|NCT00465894|3262484|P1|Treatment For 12 Weeks|Family Issues|1
993863|NCT00465894|3262483|P2|Treatment For 12 Weeks|Lost to Follow-up|1
993864|NCT00465894|3262484|P1|Treatment For 12 Weeks|Lost to Follow-up|4
993865|NCT00465816|3262517|P3|Overall Study|Lost to Follow-up|2
993866|NCT00465816|3262518|P2|Overall Study|Lost to Follow-up|0
993867|NCT00465816|3262519|P1|Overall Study|Lost to Follow-up|0
993868|NCT00465738|3262582|P2|Overall Study|Other|5
993869|NCT00465738|3262583|P1|Overall Study|Other|2
993870|NCT00465738|3262582|P2|Overall Study|Withdrawal by Subject|0
993871|NCT00465738|3262583|P1|Overall Study|Withdrawal by Subject|2
993872|NCT00465738|3262582|P2|Overall Study|Adverse Event|1
993873|NCT00465738|3262583|P1|Overall Study|Adverse Event|0
993874|NCT00465738|3262582|P2|Overall Study|Lost to Follow-up|0
993875|NCT00465738|3262583|P1|Overall Study|Lost to Follow-up|2
993876|NCT00465647|3262677|P4|Overall Study|"The other reasons included loss of IV"|2
993877|NCT00465647|3262678|P3|Overall Study|"The other reasons included loss of IV"|3
993878|NCT00465647|3262679|P2|Overall Study|"The other reasons included loss of IV"|4
993879|NCT00465647|3262680|P1|Overall Study|"The other reasons included loss of IV"|8
993880|NCT00465647|3262677|P4|Overall Study|Withdrawal by Subject|7
993881|NCT00465647|3262678|P3|Overall Study|Withdrawal by Subject|2
993882|NCT00465647|3262679|P2|Overall Study|Withdrawal by Subject|2
993883|NCT00465647|3262680|P1|Overall Study|Withdrawal by Subject|1
993884|NCT00465647|3262677|P4|Overall Study|Adverse Event|2
993885|NCT00465647|3262678|P3|Overall Study|Adverse Event|3
993886|NCT00465647|3262679|P2|Overall Study|Adverse Event|0
993887|NCT00465647|3262680|P1|Overall Study|Adverse Event|2
993888|NCT00465647|3262677|P4|Overall Study|Administrative|2
993889|NCT00465647|3262678|P3|Overall Study|Administrative|3
993890|NCT00465647|3262679|P2|Overall Study|Administrative|2
993891|NCT00465647|3262680|P1|Overall Study|Administrative|2
993892|NCT00465569|3262728|P2|Overall Study|persistent eczema during dose escalation|0
993893|NCT00465569|3262729|P1|Overall Study|persistent eczema during dose escalation|1
993894|NCT00465361|3262752|P1|Baseline Assessment|Personal Issues/Scheduling|4
993895|NCT00465270|3262758|P2|Overall Study|Investigator request|4
993896|NCT00465270|3262759|P1|Overall Study|Investigator request|3
993897|NCT00465270|3262758|P2|Overall Study|Lost to Follow-up|67
993898|NCT00465270|3262759|P1|Overall Study|Lost to Follow-up|60
993899|NCT00465270|3262758|P2|Overall Study|Withdrawal by Subject|78
993900|NCT00465270|3262759|P1|Overall Study|Withdrawal by Subject|34
993901|NCT00465270|3262758|P2|Overall Study|Death|11
993902|NCT00465270|3262759|P1|Overall Study|Death|7
993903|NCT00465179|3262768|P1|Overall Study|Progression of Disease|47
993904|NCT00465179|3262768|P1|Overall Study|Withdrawal by Subject|2
993905|NCT00465179|3262768|P1|Overall Study|Adverse Event|4
993906|NCT00465101|3262774|P1|Overall Study|Withdrew consent prior to procedure|3
993907|NCT00465101|3262774|P1|Overall Study|Physician Decision|1
993908|NCT00465101|3262774|P1|Overall Study|Withdrawal by Subject|25
993909|NCT00465101|3262774|P1|Overall Study|Death|3
993910|NCT00465101|3262774|P1|Overall Study|Unable to obtain IRB approval|1
993911|NCT00465101|3262774|P1|Overall Study|Site closed due to IRB expiration|1
993912|NCT00465101|3262774|P1|Overall Study|Patient postponed procedure|1
993913|NCT00465101|3262774|P1|Overall Study|Pt. Insurance not accepted at center|2
993914|NCT00465101|3262774|P1|Overall Study|Other|6
993915|NCT00465101|3262774|P1|Overall Study|Lost to Follow-up|5
993916|NCT00465101|3262774|P1|Overall Study|Did not meet study criteria|4
993917|NCT00465101|3262774|P1|Overall Study|Change in health precluded follow up|4
993918|NCT00465101|3262774|P1|Overall Study|Aborted Proc./Treatment Not Attempted|3
993919|NCT00464945|3262844|P2|Toddler Dose|Lost to Follow-up|1
993920|NCT00464945|3262845|P1|Toddler Dose|Lost to Follow-up|0
993921|NCT00464945|3262844|P2|After Infant Series|Withdrawal by Subject|2
993922|NCT00464945|3262845|P1|After Infant Series|Withdrawal by Subject|0
993923|NCT00464945|3262844|P2|Infant Series|Lost to Follow-up|0
993924|NCT00464945|3262845|P1|Infant Series|Lost to Follow-up|1
993925|NCT00464945|3262844|P2|Infant Series|Protocol Violation|0
993926|NCT00464945|3262845|P1|Infant Series|Protocol Violation|1
993927|NCT00464945|3262844|P2|Infant Series|Withdrawal by parent/guardian request|1
993928|NCT00464945|3262845|P1|Infant Series|Withdrawal by parent/guardian request|2
993929|NCT00464815|3262875|P2|Overall Study|Withdrawal by Subject|3
993930|NCT00464815|3262876|P1|Overall Study|Withdrawal by Subject|6
993931|NCT00464737|3262909|P3|Overall Study|Other: Subject's disability per sponsor|1
993932|NCT00464737|3262910|P2|Overall Study|Other: Subject's disability per sponsor|0
993933|NCT00464737|3262911|P1|Overall Study|Other: Subject's disability per sponsor|0
993934|NCT00464737|3262909|P3|Overall Study|Other: Personal family reasons|1
993935|NCT00464737|3262910|P2|Overall Study|Other: Personal family reasons|0
993936|NCT00464737|3262911|P1|Overall Study|Other: Personal family reasons|0
993937|NCT00464737|3262909|P3|Overall Study|Other: Study demands too great|0
993938|NCT00464737|3262910|P2|Overall Study|Other: Study demands too great|1
993939|NCT00464737|3262911|P1|Overall Study|Other: Study demands too great|0
993940|NCT00464737|3262909|P3|Overall Study|Other: Subject left town; family illness|0
993941|NCT00464737|3262910|P2|Overall Study|Other: Subject left town; family illness|0
993942|NCT00464737|3262911|P1|Overall Study|Other: Subject left town; family illness|1
993943|NCT00464737|3262909|P3|Overall Study|Other: Subject's schedule doesn't permit|0
993944|NCT00464737|3262910|P2|Overall Study|Other: Subject's schedule doesn't permit|0
993945|NCT00464737|3262911|P1|Overall Study|Other: Subject's schedule doesn't permit|1
993946|NCT00464737|3262909|P3|Overall Study|Lost to Follow-up|5
993947|NCT00464737|3262910|P2|Overall Study|Lost to Follow-up|2
993948|NCT00464737|3262911|P1|Overall Study|Lost to Follow-up|5
993949|NCT00464737|3262909|P3|Overall Study|Non-compliance|1
993950|NCT00464737|3262910|P2|Overall Study|Non-compliance|1
993951|NCT00464737|3262911|P1|Overall Study|Non-compliance|0
993952|NCT00464737|3262909|P3|Overall Study|Protocol Violation|5
993953|NCT00464737|3262910|P2|Overall Study|Protocol Violation|1
993954|NCT00464737|3262911|P1|Overall Study|Protocol Violation|1
993955|NCT00464737|3262909|P3|Overall Study|Withdrawal by Subject|5
993956|NCT00464737|3262910|P2|Overall Study|Withdrawal by Subject|3
993957|NCT00464737|3262911|P1|Overall Study|Withdrawal by Subject|5
993958|NCT00464737|3262909|P3|Overall Study|Lack of Efficacy|4
993959|NCT00464737|3262910|P2|Overall Study|Lack of Efficacy|7
993960|NCT00464737|3262911|P1|Overall Study|Lack of Efficacy|7
993961|NCT00464737|3262909|P3|Overall Study|Adverse Event|33
993962|NCT00464737|3262910|P2|Overall Study|Adverse Event|17
993963|NCT00464737|3262911|P1|Overall Study|Adverse Event|12
993964|NCT00464672|3262991|P6|Overall Study|Lost to Follow-up|0
993965|NCT00464672|3262992|P5|Overall Study|Lost to Follow-up|1
993966|NCT00464672|3262993|P4|Overall Study|Lost to Follow-up|0
993967|NCT00464672|3262994|P3|Overall Study|Lost to Follow-up|0
993968|NCT00464672|3262995|P2|Overall Study|Lost to Follow-up|10
993969|NCT00464672|3262996|P1|Overall Study|Lost to Follow-up|25
993970|NCT00464672|3262991|P6|Overall Study|withdrawal of consent|4
993971|NCT00464672|3262992|P5|Overall Study|withdrawal of consent|9
993972|NCT00464672|3262993|P4|Overall Study|withdrawal of consent|1
993973|NCT00464672|3262994|P3|Overall Study|withdrawal of consent|0
993974|NCT00464672|3262995|P2|Overall Study|withdrawal of consent|0
993975|NCT00464672|3262996|P1|Overall Study|withdrawal of consent|0
993976|NCT00464620|3263075|P3|Overall Study|Use of prohibited concomitant medication|2
993977|NCT00464620|3263076|P2|Overall Study|Use of prohibited concomitant medication|0
993978|NCT00464620|3263077|P1|Overall Study|Use of prohibited concomitant medication|0
993979|NCT00464620|3263075|P3|Overall Study|Ineligible sarcoma subtype|2
993980|NCT00464620|3263076|P2|Overall Study|Ineligible sarcoma subtype|2
993981|NCT00464620|3263077|P1|Overall Study|Ineligible sarcoma subtype|0
993982|NCT00464620|3263075|P3|Overall Study|Withdrawal by Subject|3
993983|NCT00464620|3263076|P2|Overall Study|Withdrawal by Subject|0
993984|NCT00464620|3263077|P1|Overall Study|Withdrawal by Subject|1
993985|NCT00464620|3263075|P3|Overall Study|Physician Decision|0
993986|NCT00464620|3263076|P2|Overall Study|Physician Decision|0
993987|NCT00464620|3263077|P1|Overall Study|Physician Decision|1
993988|NCT00464568|3263104|P1|Overall Study|Adverse Event|2
993989|NCT00464542|3263177|P1|Pre-treatment|Withdrawal by Subject|2
993990|NCT00464490|3263184|P2|Overall Study|Physician Decision|11
993991|NCT00464490|3263185|P1|Overall Study|Physician Decision|11
993992|NCT00464334|3263232|P11|Overall Study|Withdrawal by Subject|0
993993|NCT00464334|3263233|P10|Overall Study|Withdrawal by Subject|0
993994|NCT00464334|3263234|P9|Overall Study|Withdrawal by Subject|3
993995|NCT00464334|3263235|P8|Overall Study|Withdrawal by Subject|1
993996|NCT00464334|3263236|P7|Overall Study|Withdrawal by Subject|2
993997|NCT00464334|3263237|P6|Overall Study|Withdrawal by Subject|2
993998|NCT00464334|3263238|P5|Overall Study|Withdrawal by Subject|2
993999|NCT00464334|3263239|P4|Overall Study|Withdrawal by Subject|2
994000|NCT00464334|3263240|P3|Overall Study|Withdrawal by Subject|4
994001|NCT00464334|3263241|P2|Overall Study|Withdrawal by Subject|7
994002|NCT00464334|3263242|P1|Overall Study|Withdrawal by Subject|1
994003|NCT00464334|3263232|P11|Overall Study|Study Terminated by Sponsor|0
994004|NCT00464334|3263233|P10|Overall Study|Study Terminated by Sponsor|0
994005|NCT00464334|3263234|P9|Overall Study|Study Terminated by Sponsor|0
994006|NCT00464334|3263235|P8|Overall Study|Study Terminated by Sponsor|0
994007|NCT00464334|3263236|P7|Overall Study|Study Terminated by Sponsor|0
994008|NCT00464334|3263237|P6|Overall Study|Study Terminated by Sponsor|0
994009|NCT00464334|3263238|P5|Overall Study|Study Terminated by Sponsor|0
994010|NCT00464334|3263239|P4|Overall Study|Study Terminated by Sponsor|1
994011|NCT00464334|3263240|P3|Overall Study|Study Terminated by Sponsor|0
994012|NCT00464334|3263241|P2|Overall Study|Study Terminated by Sponsor|0
994013|NCT00464334|3263242|P1|Overall Study|Study Terminated by Sponsor|0
994014|NCT00464334|3263232|P11|Overall Study|Progressive Disease|0
994015|NCT00464334|3263233|P10|Overall Study|Progressive Disease|0
994016|NCT00464334|3263234|P9|Overall Study|Progressive Disease|1
994017|NCT00464334|3263235|P8|Overall Study|Progressive Disease|0
994018|NCT00464334|3263236|P7|Overall Study|Progressive Disease|0
994019|NCT00464334|3263237|P6|Overall Study|Progressive Disease|1
994020|NCT00464334|3263238|P5|Overall Study|Progressive Disease|0
994021|NCT00464334|3263239|P4|Overall Study|Progressive Disease|0
994022|NCT00464334|3263240|P3|Overall Study|Progressive Disease|0
994023|NCT00464334|3263241|P2|Overall Study|Progressive Disease|0
994024|NCT00464334|3263242|P1|Overall Study|Progressive Disease|0
994025|NCT00464334|3263232|P11|Overall Study|Lost to Follow-up|2
994026|NCT00464334|3263233|P10|Overall Study|Lost to Follow-up|0
994027|NCT00464334|3263234|P9|Overall Study|Lost to Follow-up|0
994028|NCT00464334|3263235|P8|Overall Study|Lost to Follow-up|0
994029|NCT00464334|3263236|P7|Overall Study|Lost to Follow-up|1
994030|NCT00464334|3263237|P6|Overall Study|Lost to Follow-up|0
994031|NCT00464334|3263238|P5|Overall Study|Lost to Follow-up|1
994032|NCT00464334|3263239|P4|Overall Study|Lost to Follow-up|0
994033|NCT00464334|3263240|P3|Overall Study|Lost to Follow-up|1
994034|NCT00464334|3263241|P2|Overall Study|Lost to Follow-up|0
994035|NCT00464334|3263242|P1|Overall Study|Lost to Follow-up|0
994036|NCT00464334|3263232|P11|Overall Study|Lack of Efficacy|0
994037|NCT00464334|3263233|P10|Overall Study|Lack of Efficacy|0
994038|NCT00464334|3263234|P9|Overall Study|Lack of Efficacy|0
994039|NCT00464334|3263235|P8|Overall Study|Lack of Efficacy|0
994040|NCT00464334|3263236|P7|Overall Study|Lack of Efficacy|0
994041|NCT00464334|3263237|P6|Overall Study|Lack of Efficacy|0
994042|NCT00464334|3263238|P5|Overall Study|Lack of Efficacy|0
994043|NCT00464334|3263239|P4|Overall Study|Lack of Efficacy|0
994044|NCT00464334|3263240|P3|Overall Study|Lack of Efficacy|0
994045|NCT00464334|3263241|P2|Overall Study|Lack of Efficacy|1
994046|NCT00464334|3263242|P1|Overall Study|Lack of Efficacy|0
994047|NCT00464334|3263232|P11|Overall Study|Adverse Event|2
994048|NCT00464334|3263233|P10|Overall Study|Adverse Event|1
994049|NCT00464334|3263234|P9|Overall Study|Adverse Event|2
994050|NCT00464334|3263235|P8|Overall Study|Adverse Event|0
994051|NCT00464334|3263236|P7|Overall Study|Adverse Event|0
994052|NCT00464334|3263237|P6|Overall Study|Adverse Event|1
994053|NCT00464334|3263238|P5|Overall Study|Adverse Event|1
994054|NCT00464334|3263239|P4|Overall Study|Adverse Event|1
994055|NCT00464334|3263240|P3|Overall Study|Adverse Event|0
994056|NCT00464334|3263241|P2|Overall Study|Adverse Event|0
994057|NCT00464334|3263242|P1|Overall Study|Adverse Event|0
994058|NCT00464308|3263302|P3|Overall Study|Physician Decision|0
994059|NCT00464308|3263303|P2|Overall Study|Physician Decision|0
994060|NCT00464308|3263304|P1|Overall Study|Physician Decision|1
994061|NCT00464308|3263302|P3|Overall Study|Patient discontinued and other reasons|23
994062|NCT00464308|3263303|P2|Overall Study|Patient discontinued and other reasons|17
994063|NCT00464308|3263304|P1|Overall Study|Patient discontinued and other reasons|17
994064|NCT00464308|3263302|P3|Overall Study|Lost to Follow-up|20
994065|NCT00464308|3263303|P2|Overall Study|Lost to Follow-up|19
994066|NCT00464308|3263304|P1|Overall Study|Lost to Follow-up|29
994067|NCT00464308|3263302|P3|Overall Study|Adverse Event|16
994068|NCT00464308|3263303|P2|Overall Study|Adverse Event|27
994069|NCT00464308|3263304|P1|Overall Study|Adverse Event|22
994070|NCT00464269|3263334|P4|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
994071|NCT00464269|3263335|P3|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
994072|NCT00464269|3263336|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
994073|NCT00464269|3263337|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
994074|NCT00464269|3263334|P4|Overall Study|AE, non-serious non-fatal|4
994075|NCT00464269|3263335|P3|Overall Study|AE, non-serious non-fatal|3
994076|NCT00464269|3263336|P2|Overall Study|AE, non-serious non-fatal|8
994077|NCT00464269|3263337|P1|Overall Study|AE, non-serious non-fatal|2
994078|NCT00464269|3263334|P4|Overall Study|SAE, non-fatal|1
994079|NCT00464269|3263335|P3|Overall Study|SAE, non-fatal|0
994080|NCT00464269|3263336|P2|Overall Study|SAE, non-fatal|0
994081|NCT00464269|3263337|P1|Overall Study|SAE, non-fatal|0
994082|NCT00464269|3263334|P4|Overall Study|AE, serious fatal|1
994083|NCT00464269|3263335|P3|Overall Study|AE, serious fatal|1
994084|NCT00464269|3263336|P2|Overall Study|AE, serious fatal|0
994085|NCT00464269|3263337|P1|Overall Study|AE, serious fatal|0
994086|NCT00464269|3263334|P4|Overall Study|Other reason|1
994087|NCT00464269|3263335|P3|Overall Study|Other reason|1
994088|NCT00464269|3263336|P2|Overall Study|Other reason|3
994089|NCT00464269|3263337|P1|Overall Study|Other reason|3
994090|NCT00464269|3263334|P4|Overall Study|Withdrawal by Subject|1
994091|NCT00464269|3263335|P3|Overall Study|Withdrawal by Subject|1
994092|NCT00464269|3263336|P2|Overall Study|Withdrawal by Subject|2
994093|NCT00464269|3263337|P1|Overall Study|Withdrawal by Subject|0
994094|NCT00464269|3263334|P4|Overall Study|Lost to Follow-up|1
994095|NCT00464269|3263335|P3|Overall Study|Lost to Follow-up|0
994096|NCT00464269|3263336|P2|Overall Study|Lost to Follow-up|4
994097|NCT00464269|3263337|P1|Overall Study|Lost to Follow-up|0
994098|NCT00464269|3263334|P4|Overall Study|Lack of Efficacy|0
994099|NCT00464269|3263335|P3|Overall Study|Lack of Efficacy|0
994100|NCT00464269|3263336|P2|Overall Study|Lack of Efficacy|0
994101|NCT00464269|3263337|P1|Overall Study|Lack of Efficacy|1
994102|NCT00464087|3263475|P3|Overall Study|No PCI per inclusion criteria|29
994103|NCT00464087|3263476|P2|Overall Study|No PCI per inclusion criteria|0
994104|NCT00464087|3263477|P1|Overall Study|No PCI per inclusion criteria|0
994105|NCT00463866|3263495|P2|Overall Study|Other|22
994106|NCT00463866|3263496|P1|Overall Study|Other|22
994107|NCT00463866|3263495|P2|Overall Study|Mis-Randomization of subject|1
994108|NCT00463866|3263496|P1|Overall Study|Mis-Randomization of subject|0
994109|NCT00463866|3263495|P2|Overall Study|Safety Reason|3
994110|NCT00463866|3263496|P1|Overall Study|Safety Reason|1
994111|NCT00463866|3263495|P2|Overall Study|Severe Non-Compliance to Protocol|21
994112|NCT00463866|3263496|P1|Overall Study|Severe Non-Compliance to Protocol|25
994113|NCT00463866|3263495|P2|Overall Study|Incorrect Enrolment|66
994114|NCT00463866|3263496|P1|Overall Study|Incorrect Enrolment|64
994115|NCT00463866|3263495|P2|Overall Study|Lost to Follow-up|55
994116|NCT00463866|3263496|P1|Overall Study|Lost to Follow-up|46
994117|NCT00463866|3263495|P2|Overall Study|Withdrawal by Subject|79
994118|NCT00463866|3263496|P1|Overall Study|Withdrawal by Subject|81
994119|NCT00463866|3263495|P2|Overall Study|Adverse Event|93
994120|NCT00463866|3263496|P1|Overall Study|Adverse Event|70
994121|NCT00463840|3263516|P1|Overall Study|Adverse Event|3
994122|NCT00463840|3263516|P1|Overall Study|Withdrawal by Subject|2
994123|NCT00463840|3263516|P1|Overall Study|Disease progression|7
994124|NCT00463801|3263521|P1|Overall Study|No longer require therapy|1
994125|NCT00463801|3263521|P1|Overall Study|Lost to Follow-up|5
994126|NCT00463801|3263521|P1|Overall Study|Adverse Event|4
994127|NCT00463801|3263521|P1|Overall Study|Lack of Efficacy|2
994128|NCT00463801|3263521|P1|Overall Study|Protocol Violation|1
994129|NCT00463788|3263527|P2|Overall Study|Randomized but not treated|1
994130|NCT00463788|3263528|P1|Overall Study|Randomized but not treated|1
994131|NCT00463788|3263527|P2|Overall Study|Other|0
994132|NCT00463788|3263528|P1|Overall Study|Other|3
994133|NCT00463788|3263527|P2|Overall Study|Protocol Violation|1
994134|NCT00463788|3263528|P1|Overall Study|Protocol Violation|0
994135|NCT00463788|3263527|P2|Overall Study|Lost to Follow-up|0
994136|NCT00463788|3263528|P1|Overall Study|Lost to Follow-up|1
994137|NCT00463788|3263527|P2|Overall Study|Symptomatic Deterioration|3
994138|NCT00463788|3263528|P1|Overall Study|Symptomatic Deterioration|2
994139|NCT00463788|3263527|P2|Overall Study|Death|3
994140|NCT00463788|3263528|P1|Overall Study|Death|4
994141|NCT00463788|3263527|P2|Overall Study|Withdrawal by Subject|2
994142|NCT00463788|3263528|P1|Overall Study|Withdrawal by Subject|6
994143|NCT00463788|3263527|P2|Overall Study|Adverse Event|2
994144|NCT00463788|3263528|P1|Overall Study|Adverse Event|6
994145|NCT00463788|3263527|P2|Overall Study|Progressive Disease|42
994146|NCT00463788|3263528|P1|Overall Study|Progressive Disease|86
994147|NCT00463606|3263546|P3|Overall Study|Protocol Violation|1
994148|NCT00463606|3263547|P2|Overall Study|Protocol Violation|0
994149|NCT00463606|3263548|P1|Overall Study|Protocol Violation|0
994150|NCT00463606|3263546|P3|Overall Study|Participation in another ABT-335 trial|0
994151|NCT00463606|3263547|P2|Overall Study|Participation in another ABT-335 trial|0
994152|NCT00463606|3263548|P1|Overall Study|Participation in another ABT-335 trial|1
994153|NCT00463606|3263546|P3|Overall Study|Patient randomized in error|0
994154|NCT00463606|3263547|P2|Overall Study|Patient randomized in error|0
994155|NCT00463606|3263548|P1|Overall Study|Patient randomized in error|1
994156|NCT00463606|3263546|P3|Overall Study|Coordinator error|0
994157|NCT00463606|3263547|P2|Overall Study|Coordinator error|0
994158|NCT00463606|3263548|P1|Overall Study|Coordinator error|1
994159|NCT00463606|3263546|P3|Overall Study|Exclusion criteria violation|0
994160|NCT00463606|3263547|P2|Overall Study|Exclusion criteria violation|0
994161|NCT00463606|3263548|P1|Overall Study|Exclusion criteria violation|2
994162|NCT00463606|3263546|P3|Overall Study|Sponsor request|0
994163|NCT00463606|3263547|P2|Overall Study|Sponsor request|1
994164|NCT00463606|3263548|P1|Overall Study|Sponsor request|0
994165|NCT00463606|3263546|P3|Overall Study|Physician Decision|0
994166|NCT00463606|3263547|P2|Overall Study|Physician Decision|1
994167|NCT00463606|3263548|P1|Overall Study|Physician Decision|0
994168|NCT00463606|3263546|P3|Overall Study|Subject moved out of town|0
994169|NCT00463606|3263547|P2|Overall Study|Subject moved out of town|0
994170|NCT00463606|3263548|P1|Overall Study|Subject moved out of town|1
994171|NCT00463606|3263546|P3|Overall Study|Subject noncompliance|0
994172|NCT00463606|3263547|P2|Overall Study|Subject noncompliance|1
994173|NCT00463606|3263548|P1|Overall Study|Subject noncompliance|1
994174|NCT00463606|3263546|P3|Overall Study|Lost to Follow-up|3
994175|NCT00463606|3263547|P2|Overall Study|Lost to Follow-up|2
994176|NCT00463606|3263548|P1|Overall Study|Lost to Follow-up|2
994177|NCT00463606|3263546|P3|Overall Study|Withdrawal by Subject|5
994178|NCT00463606|3263547|P2|Overall Study|Withdrawal by Subject|11
994179|NCT00463606|3263548|P1|Overall Study|Withdrawal by Subject|11
994180|NCT00463606|3263546|P3|Overall Study|Adverse Event|11
994181|NCT00463606|3263547|P2|Overall Study|Adverse Event|18
994182|NCT00463606|3263548|P1|Overall Study|Adverse Event|21
994183|NCT00463580|3263573|P2|Overall Study|Medical/psychiatric complications|2
994184|NCT00463580|3263574|P1|Overall Study|Medical/psychiatric complications|0
994185|NCT00463580|3263573|P2|Overall Study|schedule conflict|0
994186|NCT00463580|3263574|P1|Overall Study|schedule conflict|2
994187|NCT00463580|3263573|P2|Overall Study|Lost to Follow-up|0
994188|NCT00463580|3263574|P1|Overall Study|Lost to Follow-up|1
994189|NCT00463567|3263589|P7|Overall Study|Death|0
994190|NCT00463567|3263590|P6|Overall Study|Death|0
994191|NCT00463567|3263591|P5|Overall Study|Death|0
994192|NCT00463567|3263592|P4|Overall Study|Death|0
994193|NCT00463567|3263593|P3|Overall Study|Death|2
994194|NCT00463567|3263594|P2|Overall Study|Death|0
994195|NCT00463567|3263595|P1|Overall Study|Death|1
994196|NCT00463567|3263589|P7|Overall Study|Abnormal test procedure result(s)|0
994197|NCT00463567|3263590|P6|Overall Study|Abnormal test procedure result(s)|2
994198|NCT00463567|3263591|P5|Overall Study|Abnormal test procedure result(s)|0
994199|NCT00463567|3263592|P4|Overall Study|Abnormal test procedure result(s)|2
994200|NCT00463567|3263593|P3|Overall Study|Abnormal test procedure result(s)|6
994201|NCT00463567|3263594|P2|Overall Study|Abnormal test procedure result(s)|1
994202|NCT00463567|3263595|P1|Overall Study|Abnormal test procedure result(s)|1
994203|NCT00463567|3263589|P7|Overall Study|Abnormal lab value(s)|0
994204|NCT00463567|3263590|P6|Overall Study|Abnormal lab value(s)|0
994205|NCT00463567|3263591|P5|Overall Study|Abnormal lab value(s)|1
994206|NCT00463567|3263592|P4|Overall Study|Abnormal lab value(s)|1
994207|NCT00463567|3263593|P3|Overall Study|Abnormal lab value(s)|2
994208|NCT00463567|3263594|P2|Overall Study|Abnormal lab value(s)|1
994209|NCT00463567|3263595|P1|Overall Study|Abnormal lab value(s)|1
994210|NCT00463567|3263589|P7|Overall Study|Lack of Efficacy|1
994211|NCT00463567|3263590|P6|Overall Study|Lack of Efficacy|0
994212|NCT00463567|3263591|P5|Overall Study|Lack of Efficacy|1
994213|NCT00463567|3263592|P4|Overall Study|Lack of Efficacy|17
994214|NCT00463567|3263593|P3|Overall Study|Lack of Efficacy|9
994215|NCT00463567|3263594|P2|Overall Study|Lack of Efficacy|9
994216|NCT00463567|3263595|P1|Overall Study|Lack of Efficacy|4
994217|NCT00463567|3263589|P7|Overall Study|Administrative problems|2
994218|NCT00463567|3263590|P6|Overall Study|Administrative problems|2
994219|NCT00463567|3263591|P5|Overall Study|Administrative problems|3
994220|NCT00463567|3263592|P4|Overall Study|Administrative problems|9
994221|NCT00463567|3263593|P3|Overall Study|Administrative problems|6
994222|NCT00463567|3263594|P2|Overall Study|Administrative problems|3
994223|NCT00463567|3263595|P1|Overall Study|Administrative problems|5
994224|NCT00463567|3263589|P7|Overall Study|Lost to Follow-up|1
994225|NCT00463567|3263590|P6|Overall Study|Lost to Follow-up|1
994226|NCT00463567|3263591|P5|Overall Study|Lost to Follow-up|1
994227|NCT00463567|3263592|P4|Overall Study|Lost to Follow-up|8
994228|NCT00463567|3263593|P3|Overall Study|Lost to Follow-up|13
994229|NCT00463567|3263594|P2|Overall Study|Lost to Follow-up|6
994230|NCT00463567|3263595|P1|Overall Study|Lost to Follow-up|12
994231|NCT00463567|3263589|P7|Overall Study|Protocol Deviation|2
994232|NCT00463567|3263590|P6|Overall Study|Protocol Deviation|1
994233|NCT00463567|3263591|P5|Overall Study|Protocol Deviation|1
994234|NCT00463567|3263592|P4|Overall Study|Protocol Deviation|11
994235|NCT00463567|3263593|P3|Overall Study|Protocol Deviation|14
994236|NCT00463567|3263594|P2|Overall Study|Protocol Deviation|9
994237|NCT00463567|3263595|P1|Overall Study|Protocol Deviation|13
994238|NCT00463567|3263589|P7|Overall Study|Withdrawal by Subject|1
994239|NCT00463567|3263590|P6|Overall Study|Withdrawal by Subject|5
994240|NCT00463567|3263591|P5|Overall Study|Withdrawal by Subject|6
994241|NCT00463567|3263592|P4|Overall Study|Withdrawal by Subject|37
994242|NCT00463567|3263593|P3|Overall Study|Withdrawal by Subject|20
994243|NCT00463567|3263594|P2|Overall Study|Withdrawal by Subject|22
994244|NCT00463567|3263595|P1|Overall Study|Withdrawal by Subject|29
994245|NCT00463567|3263589|P7|Overall Study|Adverse Event|4
994246|NCT00463567|3263590|P6|Overall Study|Adverse Event|10
994247|NCT00463567|3263591|P5|Overall Study|Adverse Event|10
994248|NCT00463567|3263592|P4|Overall Study|Adverse Event|46
994249|NCT00463567|3263593|P3|Overall Study|Adverse Event|17
994250|NCT00463567|3263594|P2|Overall Study|Adverse Event|26
994251|NCT00463567|3263595|P1|Overall Study|Adverse Event|29
994252|NCT00463385|3263699|P4|Overall Study|1 participant received commercial drug|0
994253|NCT00463385|3263700|P3|Overall Study|1 participant received commercial drug|0
994254|NCT00463385|3263701|P2|Overall Study|1 participant received commercial drug|1
994255|NCT00463385|3263702|P1|Overall Study|1 participant received commercial drug|0
994256|NCT00463385|3263699|P4|Overall Study|Missing|2
994257|NCT00463385|3263700|P3|Overall Study|Missing|0
994258|NCT00463385|3263701|P2|Overall Study|Missing|0
994259|NCT00463385|3263702|P1|Overall Study|Missing|2
994260|NCT00463385|3263699|P4|Overall Study|Death|0
994261|NCT00463385|3263700|P3|Overall Study|Death|2
994262|NCT00463385|3263701|P2|Overall Study|Death|1
994263|NCT00463385|3263702|P1|Overall Study|Death|2
994264|NCT00463385|3263699|P4|Overall Study|Lost to Follow-up|1
994265|NCT00463385|3263700|P3|Overall Study|Lost to Follow-up|0
994266|NCT00463385|3263701|P2|Overall Study|Lost to Follow-up|0
994267|NCT00463385|3263702|P1|Overall Study|Lost to Follow-up|0
994268|NCT00463385|3263699|P4|Overall Study|Withdrawal by Subject|4
994269|NCT00463385|3263700|P3|Overall Study|Withdrawal by Subject|3
994270|NCT00463385|3263701|P2|Overall Study|Withdrawal by Subject|3
994271|NCT00463385|3263702|P1|Overall Study|Withdrawal by Subject|3
994272|NCT00463385|3263699|P4|Overall Study|Lack of Efficacy|9
994273|NCT00463385|3263700|P3|Overall Study|Lack of Efficacy|7
994274|NCT00463385|3263701|P2|Overall Study|Lack of Efficacy|6
994275|NCT00463385|3263702|P1|Overall Study|Lack of Efficacy|6
994276|NCT00463385|3263699|P4|Overall Study|Adverse Event|2
994277|NCT00463385|3263700|P3|Overall Study|Adverse Event|4
994278|NCT00463385|3263701|P2|Overall Study|Adverse Event|8
994279|NCT00463385|3263702|P1|Overall Study|Adverse Event|5
994280|NCT00463385|3263699|P4|Overall Study|Other|4
994281|NCT00463385|3263700|P3|Overall Study|Other|6
994282|NCT00463385|3263701|P2|Overall Study|Other|3
994283|NCT00463385|3263702|P1|Overall Study|Other|4
994284|NCT00463346|3263754|P2|Overall Study|Withdrawal by Subject|3
994285|NCT00463346|3263755|P1|Overall Study|Withdrawal by Subject|3
994286|NCT00463229|3263765|P2|Overall Study|Death|3
994287|NCT00463229|3263766|P1|Overall Study|Death|4
994288|NCT00463229|3263765|P2|Overall Study|Lost to Follow-up|7
994289|NCT00463229|3263766|P1|Overall Study|Lost to Follow-up|5
994290|NCT00463060|3263786|P1|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1
994291|NCT00463060|3263786|P1|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5
994292|NCT00463047|3263800|P2|Double-Blind Treatment Period 2|Non-compliance with procedures|0
994293|NCT00463047|3263801|P1|Double-Blind Treatment Period 2|Non-compliance with procedures|1
994294|NCT00463047|3263800|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|1
994295|NCT00463047|3263801|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
994296|NCT00463047|3263800|P2|Double-Blind Treatment Period 2|Adverse Event|1
994297|NCT00463047|3263801|P1|Double-Blind Treatment Period 2|Adverse Event|0
994298|NCT00463047|3263800|P2|Double-Blind Treatment Period 1|Not specified|0
994299|NCT00463047|3263801|P1|Double-Blind Treatment Period 1|Not specified|1
994300|NCT00463047|3263800|P2|Double-Blind Treatment Period 1|Non-compliance with procedures|0
994301|NCT00463047|3263801|P1|Double-Blind Treatment Period 1|Non-compliance with procedures|1
994302|NCT00463047|3263800|P2|Double-Blind Treatment Period 1|Protocol Violation|2
994303|NCT00463047|3263801|P1|Double-Blind Treatment Period 1|Protocol Violation|1
994304|NCT00463047|3263800|P2|Double-Blind Treatment Period 1|Adverse Event|2
994305|NCT00463047|3263801|P1|Double-Blind Treatment Period 1|Adverse Event|0
994306|NCT00463047|3263800|P2|Titration Period 2|Not specified|2
994307|NCT00463047|3263801|P1|Titration Period 2|Not specified|3
994308|NCT00463047|3263800|P2|Titration Period 2|Non-compliance procedures|1
994309|NCT00463047|3263801|P1|Titration Period 2|Non-compliance procedures|4
994310|NCT00463047|3263800|P2|Titration Period 2|Non-compliance study medication|2
994311|NCT00463047|3263801|P1|Titration Period 2|Non-compliance study medication|4
994312|NCT00463047|3263800|P2|Titration Period 2|Lost to Follow-up|2
994313|NCT00463047|3263801|P1|Titration Period 2|Lost to Follow-up|1
994314|NCT00463047|3263800|P2|Titration Period 2|Protocol Violation|3
994315|NCT00463047|3263801|P1|Titration Period 2|Protocol Violation|2
994316|NCT00463047|3263800|P2|Titration Period 2|Withdrawal by Subject|0
994317|NCT00463047|3263801|P1|Titration Period 2|Withdrawal by Subject|1
994318|NCT00463047|3263800|P2|Titration Period 2|Lack of Efficacy|4
994319|NCT00463047|3263801|P1|Titration Period 2|Lack of Efficacy|6
994320|NCT00463047|3263800|P2|Titration Period 2|Adverse Event|9
994321|NCT00463047|3263801|P1|Titration Period 2|Adverse Event|9
994322|NCT00463047|3263800|P2|Titration Period 1|Not specified|2
994323|NCT00463047|3263801|P1|Titration Period 1|Not specified|0
994324|NCT00463047|3263800|P2|Titration Period 1|Non-compliance procedures|10
994325|NCT00463047|3263801|P1|Titration Period 1|Non-compliance procedures|4
994326|NCT00463047|3263800|P2|Titration Period 1|Withdrawal by Subject|5
994327|NCT00463047|3263801|P1|Titration Period 1|Withdrawal by Subject|3
994328|NCT00463047|3263800|P2|Titration Period 1|Protocol Violation|5
994329|NCT00463047|3263801|P1|Titration Period 1|Protocol Violation|5
994330|NCT00463047|3263800|P2|Titration Period 1|Non-compliance with study medication|5
994331|NCT00463047|3263801|P1|Titration Period 1|Non-compliance with study medication|3
994332|NCT00463047|3263800|P2|Titration Period 1|Lost to Follow-up|0
994333|NCT00463047|3263801|P1|Titration Period 1|Lost to Follow-up|2
994334|NCT00463047|3263800|P2|Titration Period 1|Lack of Efficacy|4
994335|NCT00463047|3263801|P1|Titration Period 1|Lack of Efficacy|10
994336|NCT00463047|3263800|P2|Titration Period 1|Adverse Event|8
994337|NCT00463047|3263801|P1|Titration Period 1|Adverse Event|10
994338|NCT00462982|3263886|P1|Overall Study|Patient Not Treated|2
994339|NCT00462982|3263886|P1|Overall Study|Adverse Event|1
994340|NCT00462943|3263893|P3|Overall Study|Withdrawal by Subject|0
994341|NCT00462943|3263894|P2|Overall Study|Withdrawal by Subject|1
994342|NCT00462943|3263895|P1|Overall Study|Withdrawal by Subject|0
994343|NCT00462943|3263893|P3|Overall Study|Physician Decision|0
994344|NCT00462943|3263894|P2|Overall Study|Physician Decision|0
994345|NCT00462943|3263895|P1|Overall Study|Physician Decision|1
994346|NCT00462943|3263893|P3|Overall Study|Transplant - not specified|1
994347|NCT00462943|3263894|P2|Overall Study|Transplant - not specified|0
994348|NCT00462943|3263895|P1|Overall Study|Transplant - not specified|1
994349|NCT00462943|3263893|P3|Overall Study|Required Lymphocyte Infusion|0
994350|NCT00462943|3263894|P2|Overall Study|Required Lymphocyte Infusion|0
994351|NCT00462943|3263895|P1|Overall Study|Required Lymphocyte Infusion|1
994352|NCT00462943|3263893|P3|Overall Study|Bone Marrow Transplant|0
994353|NCT00462943|3263894|P2|Overall Study|Bone Marrow Transplant|0
994354|NCT00462943|3263895|P1|Overall Study|Bone Marrow Transplant|1
994355|NCT00462943|3263893|P3|Overall Study|Stem Cell Transplant|0
994356|NCT00462943|3263894|P2|Overall Study|Stem Cell Transplant|1
994357|NCT00462943|3263895|P1|Overall Study|Stem Cell Transplant|1
994358|NCT00462943|3263893|P3|Overall Study|Death|7
994359|NCT00462943|3263894|P2|Overall Study|Death|2
994360|NCT00462943|3263895|P1|Overall Study|Death|5
994361|NCT00462943|3263893|P3|Overall Study|Disease Progression|9
994362|NCT00462943|3263894|P2|Overall Study|Disease Progression|15
994363|NCT00462943|3263895|P1|Overall Study|Disease Progression|15
994364|NCT00462943|3263893|P3|Overall Study|Request of Patient, PI, Sponsor or RA|4
994365|NCT00462943|3263894|P2|Overall Study|Request of Patient, PI, Sponsor or RA|2
994366|NCT00462943|3263895|P1|Overall Study|Request of Patient, PI, Sponsor or RA|8
994367|NCT00462943|3263893|P3|Overall Study|Protocol Violation|0
994368|NCT00462943|3263894|P2|Overall Study|Protocol Violation|0
994369|NCT00462943|3263895|P1|Overall Study|Protocol Violation|1
994370|NCT00462943|3263893|P3|Overall Study|Adverse Event|1
994371|NCT00462943|3263894|P2|Overall Study|Adverse Event|4
994372|NCT00462943|3263895|P1|Overall Study|Adverse Event|6
994373|NCT00462943|3263893|P3|Overall Study|Failure to achieve a response|1
994374|NCT00462943|3263894|P2|Overall Study|Failure to achieve a response|5
994375|NCT00462943|3263895|P1|Overall Study|Failure to achieve a response|5
994376|NCT00462865|3263987|P1|Overall Study|Adverse Event|1
994377|NCT00462826|3264006|P1|Overall Study|Never treated|1
994378|NCT00462826|3264006|P1|Overall Study|Ineligible - wrong primary|2
994379|NCT00462826|3264006|P1|Overall Study|Ineligible - wrong cell type|1
994380|NCT00462826|3264006|P1|Overall Study|Ineligible - second primary|1
994381|NCT00462748|3264022|P3|Overall Study|Discontinued after 41 days Rx|0
994382|NCT00462748|3264023|P2|Overall Study|Discontinued after 41 days Rx|0
994383|NCT00462748|3264024|P1|Overall Study|Discontinued after 41 days Rx|1
994384|NCT00462748|3264022|P3|Overall Study|Lost to Follow-up|1
994385|NCT00462748|3264023|P2|Overall Study|Lost to Follow-up|1
994386|NCT00462748|3264024|P1|Overall Study|Lost to Follow-up|1
994387|NCT00462748|3264022|P3|Overall Study|Withdrew consent|0
994388|NCT00462748|3264023|P2|Overall Study|Withdrew consent|3
994389|NCT00462748|3264024|P1|Overall Study|Withdrew consent|3
994390|NCT00462748|3264022|P3|Overall Study|Protocol Violation|1
994391|NCT00462748|3264023|P2|Overall Study|Protocol Violation|2
994392|NCT00462748|3264024|P1|Overall Study|Protocol Violation|0
994393|NCT00462748|3264022|P3|Overall Study|Adverse Event|9
994394|NCT00462748|3264023|P2|Overall Study|Adverse Event|5
994395|NCT00462748|3264024|P1|Overall Study|Adverse Event|7
994396|NCT00462709|3264077|P1|Overall Study|Withdrew to start treatment with Cetor|1
994397|NCT00462709|3264077|P1|Overall Study|Physician Decision|1
994398|NCT00462709|3264077|P1|Overall Study|Logistical reasons|2
994399|NCT00462709|3264077|P1|Overall Study|Death|2
994400|NCT00462709|3264077|P1|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3
994401|NCT00462709|3264077|P1|Overall Study|Withdrawal by Subject|8
994402|NCT00462709|3264077|P1|Overall Study|Lost to Follow-up|10
994403|NCT00462709|3264077|P1|Overall Study|Transitioned to commercial C1INH-nf|40
994404|NCT00462670|3264086|P2|Overall Study|Resolution of signs and symptoms|2
994405|NCT00462670|3264087|P1|Overall Study|Resolution of signs and symptoms|0
994406|NCT00462670|3264086|P2|Overall Study|Protocol Violation|0
994407|NCT00462670|3264087|P1|Overall Study|Protocol Violation|1
994408|NCT00462670|3264086|P2|Overall Study|Lack of Efficacy|0
994409|NCT00462670|3264087|P1|Overall Study|Lack of Efficacy|1
994410|NCT00462670|3264086|P2|Overall Study|Adverse Event|5
994411|NCT00462670|3264087|P1|Overall Study|Adverse Event|3
994412|NCT00462501|3264124|P1|Overall Study|Adverse Event|2
994413|NCT00462501|3264124|P1|Overall Study|Not treated|3
994414|NCT00462462|3264130|P2|Overall Study|Physician Decision|1
994415|NCT00462462|3264131|P1|Overall Study|Physician Decision|0
994416|NCT00462384|3264159|P1|Overall Study|Other|4
994417|NCT00462384|3264159|P1|Overall Study|Withdrawal by Subject|1
994418|NCT00462384|3264159|P1|Overall Study|Death|2
994419|NCT00462384|3264159|P1|Overall Study|Adverse Event|2
994420|NCT00462345|3264167|P1|Overall Study|Did not complete second course|1
994421|NCT00462345|3264167|P1|Overall Study|Withdrawal by Subject|2
994422|NCT00462306|3264202|P2|Overall Study|insufficient data|13
994423|NCT00462306|3264203|P1|Overall Study|insufficient data|0
994424|NCT00461981|3264329|P2|Overall Study|Withdrawal by Subject|3
994425|NCT00461981|3264330|P1|Overall Study|Withdrawal by Subject|2
994426|NCT00461981|3264329|P2|Overall Study|Lost to Follow-up|6
994427|NCT00461981|3264330|P1|Overall Study|Lost to Follow-up|9
994428|NCT00461812|3264446|P1|Overall Study|study terminated|10
994429|NCT00461786|3264451|P1|Overall Study|Inevaluable (Never Treated)|1
994430|NCT00461786|3264451|P1|Overall Study|Entry Criteria Not Met|2
994431|NCT00461708|3264496|P2|Overall Study|Death|1
994432|NCT00461708|3264497|P1|Overall Study|Death|8
994433|NCT00461708|3264496|P2|Overall Study|Not specified|4
994434|NCT00461708|3264497|P1|Overall Study|Not specified|4
994435|NCT00461708|3264496|P2|Overall Study|Withdrawal by Subject|2
994436|NCT00461708|3264497|P1|Overall Study|Withdrawal by Subject|8
994437|NCT00461708|3264496|P2|Overall Study|Physician Decision|4
994438|NCT00461708|3264497|P1|Overall Study|Physician Decision|10
994439|NCT00461708|3264496|P2|Overall Study|Lack of Efficacy|20
994440|NCT00461708|3264497|P1|Overall Study|Lack of Efficacy|68
994441|NCT00461708|3264496|P2|Overall Study|Adverse Event|7
994442|NCT00461708|3264497|P1|Overall Study|Adverse Event|17
994443|NCT00461682|3264523|P1|Overall Study|Protocol Violation|1
994444|NCT00461630|3264551|P2|Overall Study|Lost to Follow-up|95
994445|NCT00461630|3264552|P1|Overall Study|Lost to Follow-up|108
994446|NCT00461630|3264551|P2|Overall Study|Death|732
994447|NCT00461630|3264552|P1|Overall Study|Death|798
994448|NCT00461500|3264604|P2|Overall Study|Lost to Follow-up|2
994449|NCT00461500|3264605|P1|Overall Study|Lost to Follow-up|2
994450|NCT00461500|3264604|P2|Overall Study|No Longer Willing to Take Part in Study|0
994451|NCT00461500|3264605|P1|Overall Study|No Longer Willing to Take Part in Study|1
994452|NCT00461500|3264604|P2|Overall Study|Drug Treatment Misuse|0
994453|NCT00461500|3264605|P1|Overall Study|Drug Treatment Misuse|1
994454|NCT00461500|3264604|P2|Overall Study|Study Stopped|2
994455|NCT00461500|3264605|P1|Overall Study|Study Stopped|1
994456|NCT00461500|3264604|P2|Overall Study|Expired Drug Treatment|1
994457|NCT00461500|3264605|P1|Overall Study|Expired Drug Treatment|1
994458|NCT00461500|3264604|P2|Overall Study|Lack of Efficacy|1
994459|NCT00461500|3264605|P1|Overall Study|Lack of Efficacy|0
994460|NCT00461500|3264604|P2|Overall Study|Adverse Event|0
994461|NCT00461500|3264605|P1|Overall Study|Adverse Event|1
994462|NCT00461305|3264648|P2|Continued Treatment|Other (missing drug etc)|0
994463|NCT00461305|3264649|P1|Continued Treatment|Other (missing drug etc)|2
994464|NCT00461305|3264648|P2|Continued Treatment|Partially missing diary|0
994465|NCT00461305|3264649|P1|Continued Treatment|Partially missing diary|2
994466|NCT00461305|3264648|P2|Continued Treatment|Withdrawal by Subject|0
994467|NCT00461305|3264649|P1|Continued Treatment|Withdrawal by Subject|48
994468|NCT00461305|3264648|P2|Continued Treatment|Protocol Violation|0
994469|NCT00461305|3264649|P1|Continued Treatment|Protocol Violation|13
994470|NCT00461305|3264648|P2|Continued Treatment|Lost to Follow-up|0
994471|NCT00461305|3264649|P1|Continued Treatment|Lost to Follow-up|4
994472|NCT00461305|3264648|P2|Continued Treatment|Adverse Event|0
994473|NCT00461305|3264649|P1|Continued Treatment|Adverse Event|26
994474|NCT00461305|3264648|P2|Treatment|Other (missing drug etc)|0
994475|NCT00461305|3264649|P1|Treatment|Other (missing drug etc)|2
994476|NCT00461305|3264648|P2|Treatment|Partially missing diary|0
994477|NCT00461305|3264649|P1|Treatment|Partially missing diary|2
994478|NCT00461305|3264648|P2|Treatment|Study drug not taken|0
994479|NCT00461305|3264649|P1|Treatment|Study drug not taken|1
994480|NCT00461305|3264648|P2|Treatment|Never dispensed|0
994481|NCT00461305|3264649|P1|Treatment|Never dispensed|5
994482|NCT00461305|3264648|P2|Treatment|Withdrawal by Subject|2
994483|NCT00461305|3264649|P1|Treatment|Withdrawal by Subject|48
994484|NCT00461305|3264648|P2|Treatment|Protocol Violation|2
994485|NCT00461305|3264649|P1|Treatment|Protocol Violation|13
994486|NCT00461305|3264648|P2|Treatment|Lost to Follow-up|2
994487|NCT00461305|3264649|P1|Treatment|Lost to Follow-up|4
994488|NCT00461305|3264648|P2|Treatment|Adverse Event|3
994489|NCT00461305|3264649|P1|Treatment|Adverse Event|26
994490|NCT00461253|3264733|P2|Overall Study|administrative|7773
994491|NCT00461253|3264734|P1|Overall Study|administrative|773
994492|NCT00461253|3264733|P2|Overall Study|no response|11789
994493|NCT00461253|3264734|P1|Overall Study|no response|2609
994494|NCT00461253|3264733|P2|Overall Study|Protocol Violation|236
994495|NCT00461253|3264734|P1|Overall Study|Protocol Violation|613
994496|NCT00461253|3264733|P2|Overall Study|Death|0
994497|NCT00461253|3264734|P1|Overall Study|Death|985
994498|NCT00461175|3264742|P2|Overall Study|Protocol Violation|365
994499|NCT00461175|3264743|P1|Overall Study|Protocol Violation|522
994500|NCT00461123|3264753|P2|Overall Study|Withdrawal by Subject|3
994501|NCT00461123|3264754|P1|Overall Study|Withdrawal by Subject|1
994502|NCT00461123|3264753|P2|Overall Study|Protocol Violation|2
994503|NCT00461123|3264754|P1|Overall Study|Protocol Violation|3
994504|NCT00461123|3264753|P2|Overall Study|Lost to Follow-up|1
994505|NCT00461123|3264754|P1|Overall Study|Lost to Follow-up|1
994506|NCT00461123|3264753|P2|Overall Study|Adverse Event|0
994507|NCT00461123|3264754|P1|Overall Study|Adverse Event|1
994508|NCT00461032|3264799|P2|Overall Study|Not Specified|5
994509|NCT00461032|3264800|P1|Overall Study|Not Specified|7
994510|NCT00461032|3264799|P2|Overall Study|Patient Moved or Relocated|1
994511|NCT00461032|3264800|P1|Overall Study|Patient Moved or Relocated|2
994512|NCT00461032|3264799|P2|Overall Study|Withdrawal by Subject|15
994513|NCT00461032|3264800|P1|Overall Study|Withdrawal by Subject|7
994514|NCT00461032|3264799|P2|Overall Study|Protocol Violation|4
994515|NCT00461032|3264800|P1|Overall Study|Protocol Violation|4
994516|NCT00461032|3264799|P2|Overall Study|Lost to Follow-up|12
994517|NCT00461032|3264800|P1|Overall Study|Lost to Follow-up|7
994518|NCT00461032|3264799|P2|Overall Study|Lack of Efficacy|1
994519|NCT00461032|3264800|P1|Overall Study|Lack of Efficacy|5
994520|NCT00461032|3264799|P2|Overall Study|Adverse Event|6
994521|NCT00461032|3264800|P1|Overall Study|Adverse Event|5
994522|NCT00460811|3264826|P5|Overall Study|Lost to Follow-up|6
994523|NCT00460811|3264827|P4|Overall Study|Lost to Follow-up|3
994524|NCT00460811|3264828|P3|Overall Study|Lost to Follow-up|5
994525|NCT00460811|3264829|P2|Overall Study|Lost to Follow-up|2
994526|NCT00460811|3264830|P1|Overall Study|Lost to Follow-up|3
994527|NCT00460811|3264826|P5|Overall Study|Physician Decision|0
994528|NCT00460811|3264827|P4|Overall Study|Physician Decision|0
994529|NCT00460811|3264828|P3|Overall Study|Physician Decision|0
994530|NCT00460811|3264829|P2|Overall Study|Physician Decision|0
994531|NCT00460811|3264830|P1|Overall Study|Physician Decision|1
994532|NCT00460811|3264826|P5|Overall Study|Withdrawal by Subject|11
994533|NCT00460811|3264827|P4|Overall Study|Withdrawal by Subject|3
994534|NCT00460811|3264828|P3|Overall Study|Withdrawal by Subject|6
994535|NCT00460811|3264829|P2|Overall Study|Withdrawal by Subject|7
994536|NCT00460811|3264830|P1|Overall Study|Withdrawal by Subject|7
994537|NCT00460811|3264826|P5|Overall Study|Noncompliance|1
994538|NCT00460811|3264827|P4|Overall Study|Noncompliance|2
994539|NCT00460811|3264828|P3|Overall Study|Noncompliance|0
994540|NCT00460811|3264829|P2|Overall Study|Noncompliance|0
994541|NCT00460811|3264830|P1|Overall Study|Noncompliance|1
994542|NCT00460811|3264826|P5|Overall Study|Adverse Event|2
994543|NCT00460811|3264827|P4|Overall Study|Adverse Event|10
994544|NCT00460811|3264828|P3|Overall Study|Adverse Event|3
994545|NCT00460811|3264829|P2|Overall Study|Adverse Event|6
994546|NCT00460811|3264830|P1|Overall Study|Adverse Event|4
994547|NCT00460798|3264872|P1|Overall Study|Missing/Incomplete Dosing Information|27
994548|NCT00460798|3264872|P1|Overall Study|Ongoing at Date of Cut-Off|82
994549|NCT00460798|3264872|P1|Overall Study|Other|27
994550|NCT00460798|3264872|P1|Overall Study|Progressive Disease|99
994551|NCT00460798|3264872|P1|Overall Study|Lost to Follow-up|19
994552|NCT00460798|3264872|P1|Overall Study|Adverse Event|27
994553|NCT00460798|3264872|P1|Overall Study|Death|59
994554|NCT00460746|3264880|P1|Overall Study|Lost to Follow-up|1
994555|NCT00460746|3264880|P1|Overall Study|Adverse Event|1
994556|NCT00460655|3264895|P4|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1
994557|NCT00460655|3264896|P3|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
994558|NCT00460655|3264897|P2|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
994559|NCT00460655|3264898|P1|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
994560|NCT00460655|3264895|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2
994561|NCT00460655|3264896|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6
994562|NCT00460655|3264897|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
994563|NCT00460655|3264898|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
994564|NCT00460655|3264895|P4|Open-Label Phase (36 Weeks)|Adverse Event|6
994565|NCT00460655|3264896|P3|Open-Label Phase (36 Weeks)|Adverse Event|1
994566|NCT00460655|3264897|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
994567|NCT00460655|3264898|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
994568|NCT00460655|3264895|P4|Double-Blind Phase (12 Weeks)|Protocol Violation|0
994569|NCT00460655|3264896|P3|Double-Blind Phase (12 Weeks)|Protocol Violation|0
994570|NCT00460655|3264897|P2|Double-Blind Phase (12 Weeks)|Protocol Violation|1
994571|NCT00460655|3264898|P1|Double-Blind Phase (12 Weeks)|Protocol Violation|0
994572|NCT00460655|3264895|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
994573|NCT00460655|3264896|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
994574|NCT00460655|3264897|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
994575|NCT00460655|3264898|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3
994576|NCT00460655|3264895|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
994577|NCT00460655|3264896|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
994578|NCT00460655|3264897|P2|Double-Blind Phase (12 Weeks)|Adverse Event|0
994579|NCT00460655|3264898|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
994580|NCT00460603|3264942|P12|Phase 2|Randomized, but not treated|0
994581|NCT00460603|3264943|P11|Phase 2|Randomized, but not treated|0
994582|NCT00460603|3264944|P10|Phase 2|Randomized, but not treated|3
994583|NCT00460603|3264945|P9|Phase 2|Randomized, but not treated|0
994584|NCT00460603|3264946|P8|Phase 2|Randomized, but not treated|0
994585|NCT00460603|3264947|P7|Phase 2|Randomized, but not treated|0
994586|NCT00460603|3264948|P6|Phase 2|Randomized, but not treated|0
994587|NCT00460603|3264949|P5|Phase 2|Randomized, but not treated|0
994588|NCT00460603|3264950|P4|Phase 2|Randomized, but not treated|0
994589|NCT00460603|3264951|P3|Phase 2|Randomized, but not treated|0
994590|NCT00460603|3264952|P2|Phase 2|Randomized, but not treated|0
994591|NCT00460603|3264953|P1|Phase 2|Randomized, but not treated|0
994592|NCT00460603|3264942|P12|Phase 2|Withdrawal by Subject|5
994593|NCT00460603|3264943|P11|Phase 2|Withdrawal by Subject|4
994594|NCT00460603|3264944|P10|Phase 2|Withdrawal by Subject|5
994595|NCT00460603|3264945|P9|Phase 2|Withdrawal by Subject|0
994596|NCT00460603|3264946|P8|Phase 2|Withdrawal by Subject|0
994597|NCT00460603|3264947|P7|Phase 2|Withdrawal by Subject|0
994598|NCT00460603|3264948|P6|Phase 2|Withdrawal by Subject|0
994599|NCT00460603|3264949|P5|Phase 2|Withdrawal by Subject|0
994600|NCT00460603|3264950|P4|Phase 2|Withdrawal by Subject|0
994601|NCT00460603|3264951|P3|Phase 2|Withdrawal by Subject|0
994602|NCT00460603|3264952|P2|Phase 2|Withdrawal by Subject|0
994603|NCT00460603|3264953|P1|Phase 2|Withdrawal by Subject|0
994604|NCT00460603|3264942|P12|Phase 2|Global Deterioration of Health Status|0
994605|NCT00460603|3264943|P11|Phase 2|Global Deterioration of Health Status|1
994606|NCT00460603|3264944|P10|Phase 2|Global Deterioration of Health Status|0
994607|NCT00460603|3264945|P9|Phase 2|Global Deterioration of Health Status|0
994608|NCT00460603|3264946|P8|Phase 2|Global Deterioration of Health Status|0
994609|NCT00460603|3264947|P7|Phase 2|Global Deterioration of Health Status|0
994610|NCT00460603|3264948|P6|Phase 2|Global Deterioration of Health Status|0
994611|NCT00460603|3264949|P5|Phase 2|Global Deterioration of Health Status|0
994612|NCT00460603|3264950|P4|Phase 2|Global Deterioration of Health Status|0
994613|NCT00460603|3264951|P3|Phase 2|Global Deterioration of Health Status|0
994614|NCT00460603|3264952|P2|Phase 2|Global Deterioration of Health Status|0
994615|NCT00460603|3264953|P1|Phase 2|Global Deterioration of Health Status|0
994616|NCT00460603|3264942|P12|Phase 2|Objective Progression or Relapse|17
994617|NCT00460603|3264943|P11|Phase 2|Objective Progression or Relapse|10
994618|NCT00460603|3264944|P10|Phase 2|Objective Progression or Relapse|9
994619|NCT00460603|3264945|P9|Phase 2|Objective Progression or Relapse|0
994620|NCT00460603|3264946|P8|Phase 2|Objective Progression or Relapse|0
994621|NCT00460603|3264947|P7|Phase 2|Objective Progression or Relapse|0
994622|NCT00460603|3264948|P6|Phase 2|Objective Progression or Relapse|0
994623|NCT00460603|3264949|P5|Phase 2|Objective Progression or Relapse|0
994624|NCT00460603|3264950|P4|Phase 2|Objective Progression or Relapse|0
994625|NCT00460603|3264951|P3|Phase 2|Objective Progression or Relapse|0
994626|NCT00460603|3264952|P2|Phase 2|Objective Progression or Relapse|0
994627|NCT00460603|3264953|P1|Phase 2|Objective Progression or Relapse|0
994628|NCT00460603|3264942|P12|Phase 2|Other|7
994629|NCT00460603|3264943|P11|Phase 2|Other|16
994630|NCT00460603|3264944|P10|Phase 2|Other|6
994631|NCT00460603|3264945|P9|Phase 2|Other|0
994632|NCT00460603|3264946|P8|Phase 2|Other|0
994633|NCT00460603|3264947|P7|Phase 2|Other|0
994634|NCT00460603|3264948|P6|Phase 2|Other|0
994635|NCT00460603|3264949|P5|Phase 2|Other|0
994636|NCT00460603|3264950|P4|Phase 2|Other|0
994637|NCT00460603|3264951|P3|Phase 2|Other|0
994638|NCT00460603|3264952|P2|Phase 2|Other|0
994639|NCT00460603|3264953|P1|Phase 2|Other|0
994640|NCT00460603|3264942|P12|Phase 2|Lost to Follow-up|0
994641|NCT00460603|3264943|P11|Phase 2|Lost to Follow-up|0
994642|NCT00460603|3264944|P10|Phase 2|Lost to Follow-up|1
994643|NCT00460603|3264945|P9|Phase 2|Lost to Follow-up|0
994644|NCT00460603|3264946|P8|Phase 2|Lost to Follow-up|0
994645|NCT00460603|3264947|P7|Phase 2|Lost to Follow-up|0
994646|NCT00460603|3264948|P6|Phase 2|Lost to Follow-up|0
994647|NCT00460603|3264949|P5|Phase 2|Lost to Follow-up|0
994648|NCT00460603|3264950|P4|Phase 2|Lost to Follow-up|0
994649|NCT00460603|3264951|P3|Phase 2|Lost to Follow-up|0
994650|NCT00460603|3264952|P2|Phase 2|Lost to Follow-up|0
994651|NCT00460603|3264953|P1|Phase 2|Lost to Follow-up|0
994652|NCT00460603|3264942|P12|Phase 2|Protocol Violation|0
994653|NCT00460603|3264943|P11|Phase 2|Protocol Violation|1
994654|NCT00460603|3264944|P10|Phase 2|Protocol Violation|1
994655|NCT00460603|3264945|P9|Phase 2|Protocol Violation|0
994656|NCT00460603|3264946|P8|Phase 2|Protocol Violation|0
994657|NCT00460603|3264947|P7|Phase 2|Protocol Violation|0
994658|NCT00460603|3264948|P6|Phase 2|Protocol Violation|0
994659|NCT00460603|3264949|P5|Phase 2|Protocol Violation|0
994660|NCT00460603|3264950|P4|Phase 2|Protocol Violation|0
994661|NCT00460603|3264951|P3|Phase 2|Protocol Violation|0
994662|NCT00460603|3264952|P2|Phase 2|Protocol Violation|0
994663|NCT00460603|3264953|P1|Phase 2|Protocol Violation|0
994664|NCT00460603|3264942|P12|Phase 2|Death|2
994665|NCT00460603|3264943|P11|Phase 2|Death|2
994666|NCT00460603|3264944|P10|Phase 2|Death|4
994667|NCT00460603|3264945|P9|Phase 2|Death|0
994668|NCT00460603|3264946|P8|Phase 2|Death|0
994669|NCT00460603|3264947|P7|Phase 2|Death|0
994670|NCT00460603|3264948|P6|Phase 2|Death|0
994671|NCT00460603|3264949|P5|Phase 2|Death|0
994672|NCT00460603|3264950|P4|Phase 2|Death|0
994673|NCT00460603|3264951|P3|Phase 2|Death|0
994674|NCT00460603|3264952|P2|Phase 2|Death|0
994675|NCT00460603|3264953|P1|Phase 2|Death|0
994676|NCT00460603|3264942|P12|Phase 2|Adverse Event|10
994677|NCT00460603|3264943|P11|Phase 2|Adverse Event|9
994678|NCT00460603|3264944|P10|Phase 2|Adverse Event|12
994679|NCT00460603|3264945|P9|Phase 2|Adverse Event|0
994680|NCT00460603|3264946|P8|Phase 2|Adverse Event|0
994681|NCT00460603|3264947|P7|Phase 2|Adverse Event|0
994682|NCT00460603|3264948|P6|Phase 2|Adverse Event|0
994683|NCT00460603|3264949|P5|Phase 2|Adverse Event|0
994684|NCT00460603|3264950|P4|Phase 2|Adverse Event|0
994685|NCT00460603|3264951|P3|Phase 2|Adverse Event|0
994686|NCT00460603|3264952|P2|Phase 2|Adverse Event|0
994687|NCT00460603|3264953|P1|Phase 2|Adverse Event|0
994688|NCT00460603|3264942|P12|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
994689|NCT00460603|3264943|P11|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
994690|NCT00460603|3264944|P10|Phase 2|Ongoing in study A4061008 (NCT00828919)|1
994691|NCT00460603|3264945|P9|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
994692|NCT00460603|3264946|P8|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
994693|NCT00460603|3264947|P7|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
994694|NCT00460603|3264948|P6|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
994695|NCT00460603|3264949|P5|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
994696|NCT00460603|3264950|P4|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
994697|NCT00460603|3264951|P3|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
994698|NCT00460603|3264952|P2|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
994699|NCT00460603|3264953|P1|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
994700|NCT00460603|3264942|P12|Phase 1|Other|0
994701|NCT00460603|3264943|P11|Phase 1|Other|0
994702|NCT00460603|3264944|P10|Phase 1|Other|0
994703|NCT00460603|3264945|P9|Phase 1|Other|0
994704|NCT00460603|3264946|P8|Phase 1|Other|1
994705|NCT00460603|3264947|P7|Phase 1|Other|0
994706|NCT00460603|3264948|P6|Phase 1|Other|2
994707|NCT00460603|3264949|P5|Phase 1|Other|1
994708|NCT00460603|3264950|P4|Phase 1|Other|1
994709|NCT00460603|3264951|P3|Phase 1|Other|1
994710|NCT00460603|3264952|P2|Phase 1|Other|3
994711|NCT00460603|3264953|P1|Phase 1|Other|0
994712|NCT00460603|3264942|P12|Phase 1|Withdrawal by Subject|0
994713|NCT00460603|3264943|P11|Phase 1|Withdrawal by Subject|0
994714|NCT00460603|3264944|P10|Phase 1|Withdrawal by Subject|0
994715|NCT00460603|3264945|P9|Phase 1|Withdrawal by Subject|2
994716|NCT00460603|3264946|P8|Phase 1|Withdrawal by Subject|0
994717|NCT00460603|3264947|P7|Phase 1|Withdrawal by Subject|1
994718|NCT00460603|3264948|P6|Phase 1|Withdrawal by Subject|0
994719|NCT00460603|3264949|P5|Phase 1|Withdrawal by Subject|3
994720|NCT00460603|3264950|P4|Phase 1|Withdrawal by Subject|1
994721|NCT00460603|3264951|P3|Phase 1|Withdrawal by Subject|1
994722|NCT00460603|3264952|P2|Phase 1|Withdrawal by Subject|2
994723|NCT00460603|3264953|P1|Phase 1|Withdrawal by Subject|1
994724|NCT00460603|3264942|P12|Phase 1|Lack of Efficacy|0
994725|NCT00460603|3264943|P11|Phase 1|Lack of Efficacy|0
994726|NCT00460603|3264944|P10|Phase 1|Lack of Efficacy|0
994727|NCT00460603|3264945|P9|Phase 1|Lack of Efficacy|11
994728|NCT00460603|3264946|P8|Phase 1|Lack of Efficacy|2
994729|NCT00460603|3264947|P7|Phase 1|Lack of Efficacy|2
994730|NCT00460603|3264948|P6|Phase 1|Lack of Efficacy|2
994731|NCT00460603|3264949|P5|Phase 1|Lack of Efficacy|2
994732|NCT00460603|3264950|P4|Phase 1|Lack of Efficacy|2
994733|NCT00460603|3264951|P3|Phase 1|Lack of Efficacy|1
994734|NCT00460603|3264952|P2|Phase 1|Lack of Efficacy|0
994735|NCT00460603|3264953|P1|Phase 1|Lack of Efficacy|1
994736|NCT00460603|3264942|P12|Phase 1|Adverse Event|0
994737|NCT00460603|3264943|P11|Phase 1|Adverse Event|0
994738|NCT00460603|3264944|P10|Phase 1|Adverse Event|0
994739|NCT00460603|3264945|P9|Phase 1|Adverse Event|4
994740|NCT00460603|3264946|P8|Phase 1|Adverse Event|0
994741|NCT00460603|3264947|P7|Phase 1|Adverse Event|3
994742|NCT00460603|3264948|P6|Phase 1|Adverse Event|0
994743|NCT00460603|3264949|P5|Phase 1|Adverse Event|0
994744|NCT00460603|3264950|P4|Phase 1|Adverse Event|2
994745|NCT00460603|3264951|P3|Phase 1|Adverse Event|1
994746|NCT00460603|3264952|P2|Phase 1|Adverse Event|1
994747|NCT00460603|3264953|P1|Phase 1|Adverse Event|3
994748|NCT00460603|3264942|P12|Phase 1|Death|0
994749|NCT00460603|3264943|P11|Phase 1|Death|0
994750|NCT00460603|3264944|P10|Phase 1|Death|0
994751|NCT00460603|3264945|P9|Phase 1|Death|1
994752|NCT00460603|3264946|P8|Phase 1|Death|0
994753|NCT00460603|3264947|P7|Phase 1|Death|0
994754|NCT00460603|3264948|P6|Phase 1|Death|0
994755|NCT00460603|3264949|P5|Phase 1|Death|0
994756|NCT00460603|3264950|P4|Phase 1|Death|2
994757|NCT00460603|3264951|P3|Phase 1|Death|0
994758|NCT00460603|3264952|P2|Phase 1|Death|0
994759|NCT00460603|3264953|P1|Phase 1|Death|1
994760|NCT00460577|3265047|P2|Overall Study|Protocol Violation|6
994761|NCT00460577|3265048|P1|Overall Study|Protocol Violation|2
994762|NCT00460564|3265066|P8|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
994763|NCT00460564|3265067|P7|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
994764|NCT00460564|3265068|P6|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
994765|NCT00460564|3265069|P5|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1
994766|NCT00460564|3265070|P4|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
994767|NCT00460564|3265071|P3|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
994768|NCT00460564|3265072|P2|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
994769|NCT00460564|3265073|P1|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
994770|NCT00460564|3265066|P8|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
994771|NCT00460564|3265067|P7|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
994772|NCT00460564|3265068|P6|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1
994773|NCT00460564|3265069|P5|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5
994774|NCT00460564|3265070|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
994775|NCT00460564|3265071|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
994776|NCT00460564|3265072|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
994777|NCT00460564|3265073|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
994778|NCT00460564|3265066|P8|Open-Label Phase (36 Weeks)|Adverse Event|0
994779|NCT00460564|3265067|P7|Open-Label Phase (36 Weeks)|Adverse Event|2
994780|NCT00460564|3265068|P6|Open-Label Phase (36 Weeks)|Adverse Event|5
994781|NCT00460564|3265069|P5|Open-Label Phase (36 Weeks)|Adverse Event|3
994782|NCT00460564|3265070|P4|Open-Label Phase (36 Weeks)|Adverse Event|0
994783|NCT00460564|3265071|P3|Open-Label Phase (36 Weeks)|Adverse Event|0
994784|NCT00460564|3265072|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
994785|NCT00460564|3265073|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
994786|NCT00460564|3265066|P8|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
994787|NCT00460564|3265067|P7|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
994788|NCT00460564|3265068|P6|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
994789|NCT00460564|3265069|P5|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
994790|NCT00460564|3265070|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
994791|NCT00460564|3265071|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
994792|NCT00460564|3265072|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
994793|NCT00460564|3265073|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1
994794|NCT00460564|3265066|P8|Double-Blind Phase (12 Weeks)|Adverse Event|0
994795|NCT00460564|3265067|P7|Double-Blind Phase (12 Weeks)|Adverse Event|0
994796|NCT00460564|3265068|P6|Double-Blind Phase (12 Weeks)|Adverse Event|0
994797|NCT00460564|3265069|P5|Double-Blind Phase (12 Weeks)|Adverse Event|0
994798|NCT00460564|3265070|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
994799|NCT00460564|3265071|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
994800|NCT00460564|3265072|P2|Double-Blind Phase (12 Weeks)|Adverse Event|1
994801|NCT00460564|3265073|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
994802|NCT00460434|3265217|P2|Overall Study|Lost to Follow-up|7
994803|NCT00460434|3265218|P1|Overall Study|Lost to Follow-up|3
994804|NCT00460408|3265297|P4|Overall Study|Other|0
994805|NCT00460408|3265298|P3|Overall Study|Other|0
994806|NCT00460408|3265299|P2|Overall Study|Other|2
994807|NCT00460408|3265300|P1|Overall Study|Other|12
994808|NCT00460408|3265297|P4|Overall Study|Insufficient clinical response|0
994809|NCT00460408|3265298|P3|Overall Study|Insufficient clinical response|5
994810|NCT00460408|3265299|P2|Overall Study|Insufficient clinical response|1
994811|NCT00460408|3265300|P1|Overall Study|Insufficient clinical response|5
994812|NCT00460408|3265297|P4|Overall Study|Withdrawal by Subject|0
994813|NCT00460408|3265298|P3|Overall Study|Withdrawal by Subject|0
994814|NCT00460408|3265299|P2|Overall Study|Withdrawal by Subject|0
994815|NCT00460408|3265300|P1|Overall Study|Withdrawal by Subject|31
994816|NCT00460408|3265297|P4|Overall Study|Lost to Follow-up|0
994817|NCT00460408|3265298|P3|Overall Study|Lost to Follow-up|1
994818|NCT00460408|3265299|P2|Overall Study|Lost to Follow-up|0
994819|NCT00460408|3265300|P1|Overall Study|Lost to Follow-up|11
994820|NCT00460408|3265297|P4|Overall Study|Death|0
994821|NCT00460408|3265298|P3|Overall Study|Death|0
994822|NCT00460408|3265299|P2|Overall Study|Death|0
994823|NCT00460408|3265300|P1|Overall Study|Death|7
994824|NCT00460408|3265297|P4|Overall Study|Adverse Event|0
994825|NCT00460408|3265298|P3|Overall Study|Adverse Event|0
994826|NCT00460408|3265299|P2|Overall Study|Adverse Event|0
994827|NCT00460408|3265300|P1|Overall Study|Adverse Event|1
994828|NCT00460265|3265337|P2|Overall Study|Ongoing|47
994829|NCT00460265|3265338|P1|Overall Study|Ongoing|60
994830|NCT00460265|3265337|P2|Overall Study|Withdrawal by Subject|25
994831|NCT00460265|3265338|P1|Overall Study|Withdrawal by Subject|10
994832|NCT00460265|3265337|P2|Overall Study|Physician Decision|2
994833|NCT00460265|3265338|P1|Overall Study|Physician Decision|1
994834|NCT00460265|3265337|P2|Overall Study|Lost to Follow-up|15
994835|NCT00460265|3265338|P1|Overall Study|Lost to Follow-up|14
994836|NCT00460239|3265354|P9|Overall Study|Withdrawal by Subject|0
994837|NCT00460239|3265355|P8|Overall Study|Withdrawal by Subject|0
994838|NCT00460239|3265356|P7|Overall Study|Withdrawal by Subject|0
994839|NCT00460239|3265357|P6|Overall Study|Withdrawal by Subject|1
994840|NCT00460239|3265358|P5|Overall Study|Withdrawal by Subject|0
994841|NCT00460239|3265359|P4|Overall Study|Withdrawal by Subject|0
994842|NCT00460239|3265360|P3|Overall Study|Withdrawal by Subject|0
994843|NCT00460239|3265361|P2|Overall Study|Withdrawal by Subject|0
994844|NCT00460239|3265362|P1|Overall Study|Withdrawal by Subject|0
994845|NCT00460239|3265354|P9|Overall Study|Physician Decision|0
994846|NCT00460239|3265355|P8|Overall Study|Physician Decision|0
994847|NCT00460239|3265356|P7|Overall Study|Physician Decision|0
994848|NCT00460239|3265357|P6|Overall Study|Physician Decision|2
994849|NCT00460239|3265358|P5|Overall Study|Physician Decision|0
994850|NCT00460239|3265359|P4|Overall Study|Physician Decision|0
994851|NCT00460239|3265360|P3|Overall Study|Physician Decision|0
994852|NCT00460239|3265361|P2|Overall Study|Physician Decision|1
994853|NCT00460239|3265362|P1|Overall Study|Physician Decision|0
994854|NCT00460109|3265431|P1|Overall Study|Death|1
994855|NCT00460031|3265439|P1|Overall Study|Death|1
994856|NCT00460031|3265439|P1|Overall Study|Withdrawal by Subject|5
994857|NCT00460031|3265439|P1|Overall Study|Adverse Event|5
994858|NCT00459979|3265447|P1|Overall Study|Protocol Violation|1
994859|NCT00459979|3265447|P1|Overall Study|Withdrawal by Subject|1
994860|NCT00459953|3265459|P2|Overall Study|not analyzed-household member in study|1
994861|NCT00459953|3265460|P1|Overall Study|not analyzed-household member in study|1
994862|NCT00459875|3265466|P1|Overall Study|Adverse Event|2
994863|NCT00459875|3265466|P1|Overall Study|Ineligible participant|1
994864|NCT00459706|3265502|P2|Overall Study|Other|1
994865|NCT00459706|3265503|P1|Overall Study|Other|0
994866|NCT00459706|3265502|P2|Overall Study|Failed to Return|0
994867|NCT00459706|3265503|P1|Overall Study|Failed to Return|1
994868|NCT00459706|3265502|P2|Overall Study|Protocol Violation|1
994869|NCT00459706|3265503|P1|Overall Study|Protocol Violation|2
994870|NCT00459706|3265502|P2|Overall Study|Discontinuation of Study by Sponsor|0
994871|NCT00459706|3265503|P1|Overall Study|Discontinuation of Study by Sponsor|1
994872|NCT00459706|3265502|P2|Overall Study|Physician Decision|0
994873|NCT00459706|3265503|P1|Overall Study|Physician Decision|2
994874|NCT00459706|3265502|P2|Overall Study|Withdrawal by Subject|6
994875|NCT00459706|3265503|P1|Overall Study|Withdrawal by Subject|1
994876|NCT00459706|3265502|P2|Overall Study|Adverse Event|13
994877|NCT00459706|3265503|P1|Overall Study|Adverse Event|19
994878|NCT00459667|3265646|P3|Overall Study|No treatment administered|1
994879|NCT00459667|3265647|P2|Overall Study|No treatment administered|3
994880|NCT00459667|3265648|P1|Overall Study|No treatment administered|6
994881|NCT00459667|3265646|P3|Overall Study|Other reason (incl. 2 missing subjects)|1
994882|NCT00459667|3265647|P2|Overall Study|Other reason (incl. 2 missing subjects)|15
994883|NCT00459667|3265648|P1|Overall Study|Other reason (incl. 2 missing subjects)|12
994884|NCT00459667|3265646|P3|Overall Study|Other disease modifying treatment|1
994885|NCT00459667|3265647|P2|Overall Study|Other disease modifying treatment|2
994886|NCT00459667|3265648|P1|Overall Study|Other disease modifying treatment|1
994887|NCT00459667|3265646|P3|Overall Study|Withdrawal by Subject|5
994888|NCT00459667|3265647|P2|Overall Study|Withdrawal by Subject|5
994889|NCT00459667|3265648|P1|Overall Study|Withdrawal by Subject|3
994890|NCT00459667|3265646|P3|Overall Study|Protocol Violation|0
994891|NCT00459667|3265647|P2|Overall Study|Protocol Violation|0
994892|NCT00459667|3265648|P1|Overall Study|Protocol Violation|1
994893|NCT00459667|3265646|P3|Overall Study|Pregnancy|1
994894|NCT00459667|3265647|P2|Overall Study|Pregnancy|1
994895|NCT00459667|3265648|P1|Overall Study|Pregnancy|1
994896|NCT00459667|3265646|P3|Overall Study|Lost to Follow-up|3
994897|NCT00459667|3265647|P2|Overall Study|Lost to Follow-up|9
994898|NCT00459667|3265648|P1|Overall Study|Lost to Follow-up|5
994899|NCT00459667|3265646|P3|Overall Study|Adverse Event|8
994900|NCT00459667|3265647|P2|Overall Study|Adverse Event|12
994901|NCT00459667|3265648|P1|Overall Study|Adverse Event|9
994902|NCT00459537|3265670|P2|Overall Study|Missing|0
994903|NCT00459537|3265671|P1|Overall Study|Missing|1
994904|NCT00459537|3265670|P2|Overall Study|Protocol Violation|3
994905|NCT00459537|3265671|P1|Overall Study|Protocol Violation|4
994906|NCT00459537|3265670|P2|Overall Study|Administrative problems|0
994907|NCT00459537|3265671|P1|Overall Study|Administrative problems|3
994908|NCT00459537|3265670|P2|Overall Study|Lost to Follow-up|30
994909|NCT00459537|3265671|P1|Overall Study|Lost to Follow-up|27
994910|NCT00459537|3265670|P2|Overall Study|Withdrawal by Subject|26
994911|NCT00459537|3265671|P1|Overall Study|Withdrawal by Subject|20
994912|NCT00459537|3265670|P2|Overall Study|Lack of Efficacy|11
994913|NCT00459537|3265671|P1|Overall Study|Lack of Efficacy|10
994914|NCT00459537|3265670|P2|Overall Study|Adverse Event|6
994915|NCT00459537|3265671|P1|Overall Study|Adverse Event|1
994916|NCT00459355|3265706|P2|Overall Study|Subject no longer met inc criteria|18
994917|NCT00459355|3265707|P1|Overall Study|Subject no longer met inc criteria|20
994918|NCT00459342|3265719|P1|Overall Study|Not eligible|1
994919|NCT00459316|3265728|P3|Step 3|Withdrawal by Subject|1
994920|NCT00459316|3265729|P2|Step 3|Withdrawal by Subject|0
994921|NCT00459316|3265730|P1|Step 3|Withdrawal by Subject|3
994922|NCT00459316|3265728|P3|Steps 1 & 2|Lost to Follow-up|2
994923|NCT00459316|3265729|P2|Steps 1 & 2|Lost to Follow-up|0
994924|NCT00459316|3265730|P1|Steps 1 & 2|Lost to Follow-up|5
994925|NCT00459316|3265728|P3|Steps 1 & 2|Not willing to adhere to regulations|0
994926|NCT00459316|3265729|P2|Steps 1 & 2|Not willing to adhere to regulations|0
994927|NCT00459316|3265730|P1|Steps 1 & 2|Not willing to adhere to regulations|1
994928|NCT00459316|3265728|P3|Steps 1 & 2|Withdrawal by Subject|0
994929|NCT00459316|3265729|P2|Steps 1 & 2|Withdrawal by Subject|1
994930|NCT00459316|3265730|P1|Steps 1 & 2|Withdrawal by Subject|6
994931|NCT00459316|3265728|P3|Steps 1 & 2|Not able to get to clinic|0
994932|NCT00459316|3265729|P2|Steps 1 & 2|Not able to get to clinic|4
994933|NCT00459316|3265730|P1|Steps 1 & 2|Not able to get to clinic|7
994934|NCT00459316|3265728|P3|Steps 1 & 2|Death|0
994935|NCT00459316|3265729|P2|Steps 1 & 2|Death|1
994936|NCT00459316|3265730|P1|Steps 1 & 2|Death|1
994937|NCT00459316|3265728|P3|Steps 1 & 2|Other eligibility failure|0
994938|NCT00459316|3265729|P2|Steps 1 & 2|Other eligibility failure|1
994939|NCT00459316|3265730|P1|Steps 1 & 2|Other eligibility failure|1
994940|NCT00459290|3265795|P1|Overall Study|Ineligible|2
994941|NCT00459290|3265795|P1|Overall Study|Adverse Event|3
994942|NCT00459186|3265810|P1|PET Imaging and Assessment|Adverse Event|3
994943|NCT00459186|3265810|P1|Single Agent RAD001|Withdrawal by Subject|1
994944|NCT00459134|3265817|P2|Overall Study|Multiple Reasons|3
994945|NCT00459134|3265818|P1|Overall Study|Multiple Reasons|2
994946|NCT00459134|3265817|P2|Overall Study|Progression|0
994947|NCT00459134|3265818|P1|Overall Study|Progression|1
994948|NCT00459134|3265817|P2|Overall Study|Toxicity|5
994949|NCT00459134|3265818|P1|Overall Study|Toxicity|4
994950|NCT00459134|3265817|P2|Overall Study|Surgery|2
994951|NCT00459134|3265818|P1|Overall Study|Surgery|1
994952|NCT00459134|3265817|P2|Overall Study|Lost to Follow-up|7
994953|NCT00459134|3265818|P1|Overall Study|Lost to Follow-up|6
994954|NCT00459134|3265817|P2|Overall Study|Withdrawal by Subject|7
994955|NCT00459134|3265818|P1|Overall Study|Withdrawal by Subject|8
994956|NCT00459134|3265817|P2|Overall Study|Physician Decision|1
994957|NCT00459134|3265818|P1|Overall Study|Physician Decision|1
994958|NCT00459108|3265830|P1|Overall Study|Progression|1
994959|NCT00459108|3265830|P1|Overall Study|Death|2
994960|NCT00459108|3265830|P1|Overall Study|Adverse Event|3
994961|NCT00459108|3265830|P1|Overall Study|Withdrawal by Subject|5
994962|NCT00459056|3265840|P2|First Intervention (First Three Months)|Lost to Follow-up|1
994963|NCT00459056|3265841|P1|First Intervention (First Three Months)|Lost to Follow-up|1
994964|NCT00459043|3265849|P2|Overall Study|Withdrawal by Subject|0
994965|NCT00459043|3265850|P1|Overall Study|Withdrawal by Subject|1
994966|NCT00458705|3265871|P1|Overall Study|Not Treated|1
994967|NCT00458705|3265871|P1|Overall Study|Adverse Event|4
994968|NCT00458536|3265875|P1|Overall Study|Progressive disease during treatment|2
994969|NCT00458536|3265875|P1|Overall Study|Withdrawal by Subject|1
994970|NCT00458536|3265875|P1|Overall Study|Ineligible due to toxicity|1
994971|NCT00458536|3265875|P1|Overall Study|Patient did not have surgery|1
994972|NCT00458536|3265875|P1|Overall Study|Did not have renal cell carcinoma|2
994973|NCT00458536|3265875|P1|Overall Study|No measurable disease after surgery|2
994974|NCT00458536|3265875|P1|Overall Study|Unable to make vaccine|3
994975|NCT00458536|3265875|P1|Overall Study|Disease progression prior to treatment|7
994976|NCT00458393|3265902|P2|Overall Study|Sites marked other on the form.|20
994977|NCT00458393|3265903|P1|Overall Study|Sites marked other on the form.|19
994978|NCT00458393|3265902|P2|Overall Study|Lost to Follow-up|92
994979|NCT00458393|3265903|P1|Overall Study|Lost to Follow-up|115
994980|NCT00458393|3265902|P2|Overall Study|Relocated|81
994981|NCT00458393|3265903|P1|Overall Study|Relocated|77
994982|NCT00458393|3265902|P2|Overall Study|Physician Decision|22
994983|NCT00458393|3265903|P1|Overall Study|Physician Decision|31
994984|NCT00458393|3265902|P2|Overall Study|Withdrawal by Subject|80
994985|NCT00458393|3265903|P1|Overall Study|Withdrawal by Subject|67
994986|NCT00458302|3265951|P2|Overall Study|Other|2
994987|NCT00458302|3265952|P1|Overall Study|Other|4
994988|NCT00458302|3265951|P2|Overall Study|Lost to Follow-up|0
994989|NCT00458302|3265952|P1|Overall Study|Lost to Follow-up|2
994990|NCT00458302|3265951|P2|Overall Study|Study Termination By Sponsor|0
994991|NCT00458302|3265952|P1|Overall Study|Study Termination By Sponsor|1
994992|NCT00458302|3265951|P2|Overall Study|Inc/Exc Criteria Not Met|1
994993|NCT00458302|3265952|P1|Overall Study|Inc/Exc Criteria Not Met|1
994994|NCT00458302|3265951|P2|Overall Study|Withdrawal by Subject|4
994995|NCT00458302|3265952|P1|Overall Study|Withdrawal by Subject|6
994996|NCT00458302|3265951|P2|Overall Study|Protocol Violation|2
994997|NCT00458302|3265952|P1|Overall Study|Protocol Violation|0
994998|NCT00458302|3265951|P2|Overall Study|Pregnancy|1
994999|NCT00458302|3265952|P1|Overall Study|Pregnancy|2
995000|NCT00458302|3265951|P2|Overall Study|Adverse Event|14
995001|NCT00458302|3265952|P1|Overall Study|Adverse Event|4
995002|NCT00458211|3265997|P1|Overall Study|Protocol Violation|2
995003|NCT00458211|3265997|P1|Overall Study|Withdrawal by Subject|2
995004|NCT00458211|3265997|P1|Overall Study|Lack of Efficacy|12
995005|NCT00457821|3266039|P8|Part 2|Withdrawal by Subject|1
995006|NCT00457821|3266040|P7|Part 2|Withdrawal by Subject|0
995007|NCT00457821|3266041|P6|Part 2|Withdrawal by Subject|0
995008|NCT00457821|3266042|P5|Part 2|Withdrawal by Subject|0
995009|NCT00457821|3266043|P4|Part 2|Withdrawal by Subject|0
995010|NCT00457821|3266044|P3|Part 2|Withdrawal by Subject|0
995011|NCT00457821|3266045|P2|Part 2|Withdrawal by Subject|0
995012|NCT00457821|3266046|P1|Part 2|Withdrawal by Subject|0
995013|NCT00457743|3266085|P3|Overall Study|Lack of Efficacy|3
995014|NCT00457743|3266086|P2|Overall Study|Lack of Efficacy|23
995015|NCT00457743|3266087|P1|Overall Study|Lack of Efficacy|3
995016|NCT00457743|3266085|P3|Overall Study|Adverse Event|0
995017|NCT00457743|3266086|P2|Overall Study|Adverse Event|4
995018|NCT00457743|3266087|P1|Overall Study|Adverse Event|0
995019|NCT00457691|3266144|P2|Overall Study|Disease progression, study terminated|196
995020|NCT00457691|3266145|P1|Overall Study|Disease progression, study terminated|180
995021|NCT00457691|3266144|P2|Overall Study|Subject refused (reason other than AE)|19
995022|NCT00457691|3266145|P1|Overall Study|Subject refused (reason other than AE)|14
995023|NCT00457691|3266144|P2|Overall Study|Study terminated by Sponsor|1
995024|NCT00457691|3266145|P1|Overall Study|Study terminated by Sponsor|1
995025|NCT00457691|3266144|P2|Overall Study|Lost to Follow-up|14
995026|NCT00457691|3266145|P1|Overall Study|Lost to Follow-up|23
995027|NCT00457691|3266144|P2|Overall Study|Protocol Violation|3
995028|NCT00457691|3266145|P1|Overall Study|Protocol Violation|1
995029|NCT00457691|3266144|P2|Overall Study|Death|148
995030|NCT00457691|3266145|P1|Overall Study|Death|163
995031|NCT00457691|3266144|P2|Overall Study|Adverse Event|1
995032|NCT00457691|3266145|P1|Overall Study|Adverse Event|4
995033|NCT00457418|3266165|P1|Post PK Maintenance|Lost to Follow-up|1
995034|NCT00457418|3266165|P1|Post PK Maintenance|Withdrawal by Subject|11
995035|NCT00457418|3266165|P1|Post PK Maintenance|Progression of Disease|6
995036|NCT00457418|3266165|P1|Post PK Maintenance|Adverse Event|10
995037|NCT00457418|3266165|P1|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2
995038|NCT00457418|3266165|P1|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1
995039|NCT00457418|3266165|P1|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2
995040|NCT00457392|3266177|P2|Overall Study|Randomized, Not Treated|3
995041|NCT00457392|3266178|P1|Overall Study|Randomized, Not Treated|7
995042|NCT00457392|3266177|P2|Overall Study|Study Terminated by Sponsor|4
995043|NCT00457392|3266178|P1|Overall Study|Study Terminated by Sponsor|1
995044|NCT00457392|3266177|P2|Overall Study|Other|4
995045|NCT00457392|3266178|P1|Overall Study|Other|7
995046|NCT00457392|3266177|P2|Overall Study|Protocol Violation|3
995047|NCT00457392|3266178|P1|Overall Study|Protocol Violation|4
995048|NCT00457392|3266177|P2|Overall Study|Lost to Follow-up|7
995049|NCT00457392|3266178|P1|Overall Study|Lost to Follow-up|6
995050|NCT00457392|3266177|P2|Overall Study|Withdrawal by Subject|8
995051|NCT00457392|3266178|P1|Overall Study|Withdrawal by Subject|14
995052|NCT00457392|3266177|P2|Overall Study|Global Deterioration of Health Status|8
995053|NCT00457392|3266178|P1|Overall Study|Global Deterioration of Health Status|22
995054|NCT00457392|3266177|P2|Overall Study|Adverse Event|41
995055|NCT00457392|3266178|P1|Overall Study|Adverse Event|84
995056|NCT00457392|3266177|P2|Overall Study|Death|106
995057|NCT00457392|3266178|P1|Overall Study|Death|106
995058|NCT00457392|3266177|P2|Overall Study|Objective Progression or Relapse|296
995059|NCT00457392|3266178|P1|Overall Study|Objective Progression or Relapse|229
995060|NCT00457301|3266196|P2|Overall Study|Death|7
995061|NCT00457301|3266197|P1|Overall Study|Death|5
995062|NCT00457301|3266196|P2|Overall Study|Censored out of the study|14
995063|NCT00457301|3266197|P1|Overall Study|Censored out of the study|15
995064|NCT00457301|3266196|P2|Overall Study|Withdrawal by Subject|3
995065|NCT00457301|3266197|P1|Overall Study|Withdrawal by Subject|3
995066|NCT00457249|3266211|P2|Overall Study|Serious Adverse Events|0
995067|NCT00457249|3266212|P1|Overall Study|Serious Adverse Events|2
995068|NCT00457249|3266211|P2|Overall Study|Withdrawal by Subject|1
995069|NCT00457249|3266212|P1|Overall Study|Withdrawal by Subject|3
995070|NCT00457249|3266211|P2|Overall Study|Protocol Violation|1
995071|NCT00457249|3266212|P1|Overall Study|Protocol Violation|4
995072|NCT00457249|3266211|P2|Overall Study|Lost to Follow-up|0
995073|NCT00457249|3266212|P1|Overall Study|Lost to Follow-up|3
995074|NCT00457015|3266251|P2|Overall Study|Left study site against medical advice|1
995075|NCT00457015|3266252|P1|Overall Study|Left study site against medical advice|0
995076|NCT00457002|3266268|P2|Overall Study|treated for 1 day; missing status/reason|0
995077|NCT00457002|3266269|P1|Overall Study|treated for 1 day; missing status/reason|1
995078|NCT00457002|3266268|P2|Overall Study|non-specified|38
995079|NCT00457002|3266269|P1|Overall Study|non-specified|29
995080|NCT00457002|3266268|P2|Overall Study|Administrative reason by Sponsor|0
995081|NCT00457002|3266269|P1|Overall Study|Administrative reason by Sponsor|1
995082|NCT00457002|3266268|P2|Overall Study|No longer met criteria|37
995083|NCT00457002|3266269|P1|Overall Study|No longer met criteria|41
995084|NCT00457002|3266268|P2|Overall Study|Poor/Non-compliance|33
995085|NCT00457002|3266269|P1|Overall Study|Poor/Non-compliance|46
995086|NCT00457002|3266268|P2|Overall Study|Lost to Follow-up|71
995087|NCT00457002|3266269|P1|Overall Study|Lost to Follow-up|72
995088|NCT00457002|3266268|P2|Overall Study|Withdrawal by Subject|271
995089|NCT00457002|3266269|P1|Overall Study|Withdrawal by Subject|299
995090|NCT00457002|3266268|P2|Overall Study|Adverse Event|260
995091|NCT00457002|3266269|P1|Overall Study|Adverse Event|284
995092|NCT00457002|3266268|P2|Overall Study|Death|47
995093|NCT00457002|3266269|P1|Overall Study|Death|40
995094|NCT00456846|3266373|P2|Overall Study|Other|2
995095|NCT00456846|3266374|P1|Overall Study|Other|0
995096|NCT00456846|3266373|P2|Overall Study|Participant Discretion|5
995097|NCT00456846|3266374|P1|Overall Study|Participant Discretion|1
995098|NCT00456846|3266373|P2|Overall Study|Protocol Deviation|0
995099|NCT00456846|3266374|P1|Overall Study|Protocol Deviation|2
995100|NCT00456846|3266373|P2|Overall Study|Physician Decision|6
995101|NCT00456846|3266374|P1|Overall Study|Physician Decision|11
995102|NCT00456846|3266373|P2|Overall Study|Adverse Event|15
995103|NCT00456846|3266374|P1|Overall Study|Adverse Event|2
995104|NCT00456755|3266415|P2|Overall Study|Lost to Follow-up|1
995105|NCT00456755|3266416|P1|Overall Study|Lost to Follow-up|2
995106|NCT00456612|3266430|P1|Overall Study|Withdrawal by Subject|3
995107|NCT00456599|3266435|P1|Overall Study|Withdrawal by Subject|2
995108|NCT00456599|3266435|P1|Overall Study|Non-compliance|1
995109|NCT00456521|3266458|P2|Overall Study|Drug non-compliance, moved, other|11
995110|NCT00456521|3266459|P1|Overall Study|Drug non-compliance, moved, other|26
995111|NCT00456521|3266458|P2|Overall Study|Pregnancy|1
995112|NCT00456521|3266459|P1|Overall Study|Pregnancy|1
995113|NCT00456521|3266458|P2|Overall Study|Protocol Violation|0
995114|NCT00456521|3266459|P1|Overall Study|Protocol Violation|4
995115|NCT00456521|3266458|P2|Overall Study|Lack of Efficacy|6
995116|NCT00456521|3266459|P1|Overall Study|Lack of Efficacy|3
995117|NCT00456521|3266458|P2|Overall Study|Lost to Follow-up|17
995118|NCT00456521|3266459|P1|Overall Study|Lost to Follow-up|22
995119|NCT00456521|3266458|P2|Overall Study|Withdrawal by Subject|24
995120|NCT00456521|3266459|P1|Overall Study|Withdrawal by Subject|43
995121|NCT00456521|3266458|P2|Overall Study|Adverse Event|25
995122|NCT00456521|3266459|P1|Overall Study|Adverse Event|150
995123|NCT00456495|3266505|P1|Overall Study|Physician Decision|2
995124|NCT00456365|3266512|P2|Overall Study|oncologic diagnosis|1
995125|NCT00456365|3266513|P1|Overall Study|oncologic diagnosis|1
995126|NCT00456365|3266512|P2|Overall Study|Pregnancy|1
995127|NCT00456365|3266513|P1|Overall Study|Pregnancy|1
995128|NCT00456365|3266512|P2|Overall Study|Withdrawal by Subject|7
995129|NCT00456365|3266513|P1|Overall Study|Withdrawal by Subject|4
995130|NCT00456365|3266512|P2|Overall Study|Lost to Follow-up|3
995131|NCT00456365|3266513|P1|Overall Study|Lost to Follow-up|1
995132|NCT00455923|3266570|P2|Overall Study|Other|1
995133|NCT00455923|3266571|P1|Overall Study|Other|3
995134|NCT00455923|3266570|P2|Overall Study|Pregnancy|2
995135|NCT00455923|3266571|P1|Overall Study|Pregnancy|0
995136|NCT00455858|3266587|P1|Overall Study|Withdrawal|1
995137|NCT00455858|3266587|P1|Overall Study|Well controlled FPG without insulin|1
995138|NCT00455858|3266587|P1|Overall Study|Lack of Efficacy|1
995139|NCT00455858|3266587|P1|Overall Study|Protocol Violation|1
995140|NCT00455858|3266587|P1|Overall Study|Lost to Follow-up|2
995141|NCT00455741|3266597|P2|Overall Study|Physician Decision|1
995142|NCT00455741|3266598|P1|Overall Study|Physician Decision|0
995143|NCT00455533|3266694|P3|Period Two: Randomized Period|Subject Withdrew Consent|1
995144|NCT00455533|3266695|P2|Period Two: Randomized Period|Subject Withdrew Consent|2
995145|NCT00455533|3266696|P1|Period Two: Randomized Period|Subject Withdrew Consent|0
995146|NCT00455533|3266694|P3|Period Two: Randomized Period|Study Drug Toxicity|0
995147|NCT00455533|3266695|P2|Period Two: Randomized Period|Study Drug Toxicity|2
995148|NCT00455533|3266696|P1|Period Two: Randomized Period|Study Drug Toxicity|0
995149|NCT00455533|3266694|P3|Period Two: Randomized Period|Other - need reasons|0
995150|NCT00455533|3266695|P2|Period Two: Randomized Period|Other - need reasons|1
995151|NCT00455533|3266696|P1|Period Two: Randomized Period|Other - need reasons|0
995152|NCT00455533|3266694|P3|Period Two: Randomized Period|Lost to Follow-up|1
995153|NCT00455533|3266695|P2|Period Two: Randomized Period|Lost to Follow-up|0
995154|NCT00455533|3266696|P1|Period Two: Randomized Period|Lost to Follow-up|0
995155|NCT00455533|3266694|P3|Period Two: Randomized Period|Disease Progression|1
995156|NCT00455533|3266695|P2|Period Two: Randomized Period|Disease Progression|1
995157|NCT00455533|3266696|P1|Period Two: Randomized Period|Disease Progression|0
995158|NCT00455533|3266694|P3|Period Two: Randomized Period|Death|3
995159|NCT00455533|3266695|P2|Period Two: Randomized Period|Death|0
995160|NCT00455533|3266696|P1|Period Two: Randomized Period|Death|0
995161|NCT00455533|3266694|P3|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
995162|NCT00455533|3266695|P2|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
995163|NCT00455533|3266696|P1|Period One: Initial Chemotherapy|Subject Withdrew Consent|2
995164|NCT00455533|3266694|P3|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
995165|NCT00455533|3266695|P2|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
995166|NCT00455533|3266696|P1|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2
995167|NCT00455533|3266694|P3|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
995168|NCT00455533|3266695|P2|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
995169|NCT00455533|3266696|P1|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1
995170|NCT00455533|3266694|P3|Period One: Initial Chemotherapy|Study Drug Toxicity|0
995171|NCT00455533|3266695|P2|Period One: Initial Chemotherapy|Study Drug Toxicity|0
995172|NCT00455533|3266696|P1|Period One: Initial Chemotherapy|Study Drug Toxicity|2
995173|NCT00455533|3266694|P3|Period One: Initial Chemotherapy|Other--Need Reasons|0
995174|NCT00455533|3266695|P2|Period One: Initial Chemotherapy|Other--Need Reasons|0
995175|NCT00455533|3266696|P1|Period One: Initial Chemotherapy|Other--Need Reasons|2
995176|NCT00455533|3266694|P3|Period One: Initial Chemotherapy|Not Reported|0
995177|NCT00455533|3266695|P2|Period One: Initial Chemotherapy|Not Reported|0
995178|NCT00455533|3266696|P1|Period One: Initial Chemotherapy|Not Reported|1
995179|NCT00455533|3266694|P3|Period One: Initial Chemotherapy|Lost to Follow-up|0
995180|NCT00455533|3266695|P2|Period One: Initial Chemotherapy|Lost to Follow-up|0
995181|NCT00455533|3266696|P1|Period One: Initial Chemotherapy|Lost to Follow-up|2
995182|NCT00455533|3266694|P3|Period One: Initial Chemotherapy|Disease Progression|0
995183|NCT00455533|3266695|P2|Period One: Initial Chemotherapy|Disease Progression|0
995184|NCT00455533|3266696|P1|Period One: Initial Chemotherapy|Disease Progression|5
995185|NCT00455533|3266694|P3|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
995186|NCT00455533|3266695|P2|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
995187|NCT00455533|3266696|P1|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1
995188|NCT00455520|3266745|P2|Double Blind Tapentadol ER vs Placebo|All other|6
995189|NCT00455520|3266746|P1|Double Blind Tapentadol ER vs Placebo|All other|4
995190|NCT00455520|3266745|P2|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2
995191|NCT00455520|3266746|P1|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4
995192|NCT00455520|3266745|P2|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
995193|NCT00455520|3266746|P1|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
995194|NCT00455520|3266745|P2|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7
995195|NCT00455520|3266746|P1|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15
995196|NCT00455520|3266745|P2|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29
995197|NCT00455520|3266746|P1|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8
995198|NCT00455520|3266745|P2|Double Blind Tapentadol ER vs Placebo|Adverse Event|15
995199|NCT00455520|3266746|P1|Double Blind Tapentadol ER vs Placebo|Adverse Event|29
995200|NCT00455520|3266745|P2|Open Label Tapentadol Extended Release|All other|0
995201|NCT00455520|3266746|P1|Open Label Tapentadol Extended Release|All other|33
995202|NCT00455520|3266745|P2|Open Label Tapentadol Extended Release|Study drug non-compliant|0
995203|NCT00455520|3266746|P1|Open Label Tapentadol Extended Release|Study drug non-compliant|13
995204|NCT00455520|3266745|P2|Open Label Tapentadol Extended Release|Lack of Efficacy|0
995205|NCT00455520|3266746|P1|Open Label Tapentadol Extended Release|Lack of Efficacy|23
995206|NCT00455520|3266745|P2|Open Label Tapentadol Extended Release|Adverse Event|0
995207|NCT00455520|3266746|P1|Open Label Tapentadol Extended Release|Adverse Event|100
995208|NCT00455520|3266745|P2|Open Label Tapentadol Extended Release|Lost to Follow-up|0
995209|NCT00455520|3266746|P1|Open Label Tapentadol Extended Release|Lost to Follow-up|3
995210|NCT00455520|3266745|P2|Open Label Tapentadol Extended Release|Withdrawal by Subject|0
995211|NCT00455520|3266746|P1|Open Label Tapentadol Extended Release|Withdrawal by Subject|24
995212|NCT00455455|3266762|P2|Washout|Withdrawal by Subject|0
995213|NCT00455455|3266763|P1|Washout|Withdrawal by Subject|1
995214|NCT00455455|3266762|P2|Washout|Withdrawal by Subject|1
995215|NCT00455455|3266763|P1|Washout|Withdrawal by Subject|0
995216|NCT00455429|3266783|P4|Overall Study|Other|1
995217|NCT00455429|3266784|P3|Overall Study|Other|0
995218|NCT00455429|3266785|P2|Overall Study|Other|2
995219|NCT00455429|3266786|P1|Overall Study|Other|0
995220|NCT00455429|3266783|P4|Overall Study|Non-compliance|1
995221|NCT00455429|3266784|P3|Overall Study|Non-compliance|0
995222|NCT00455429|3266785|P2|Overall Study|Non-compliance|0
995223|NCT00455429|3266786|P1|Overall Study|Non-compliance|0
995224|NCT00455429|3266783|P4|Overall Study|Personal Reason|0
995225|NCT00455429|3266784|P3|Overall Study|Personal Reason|0
995226|NCT00455429|3266785|P2|Overall Study|Personal Reason|0
995227|NCT00455429|3266786|P1|Overall Study|Personal Reason|1
995228|NCT00455429|3266783|P4|Overall Study|Randomly assigned but not treated|2
995229|NCT00455429|3266784|P3|Overall Study|Randomly assigned but not treated|0
995230|NCT00455429|3266785|P2|Overall Study|Randomly assigned but not treated|0
995231|NCT00455429|3266786|P1|Overall Study|Randomly assigned but not treated|0
995232|NCT00455429|3266783|P4|Overall Study|Adverse Event|3
995233|NCT00455429|3266784|P3|Overall Study|Adverse Event|0
995234|NCT00455429|3266785|P2|Overall Study|Adverse Event|1
995235|NCT00455429|3266786|P1|Overall Study|Adverse Event|0
995236|NCT00455429|3266783|P4|Overall Study|Lack of Efficacy|1
995237|NCT00455429|3266784|P3|Overall Study|Lack of Efficacy|0
995238|NCT00455429|3266785|P2|Overall Study|Lack of Efficacy|1
995239|NCT00455429|3266786|P1|Overall Study|Lack of Efficacy|0
995240|NCT00455429|3266783|P4|Overall Study|Withdrawal by Subject|0
995241|NCT00455429|3266784|P3|Overall Study|Withdrawal by Subject|1
995242|NCT00455429|3266785|P2|Overall Study|Withdrawal by Subject|1
995243|NCT00455429|3266786|P1|Overall Study|Withdrawal by Subject|0
995244|NCT00455429|3266783|P4|Overall Study|Lost to Follow-up|3
995245|NCT00455429|3266784|P3|Overall Study|Lost to Follow-up|0
995246|NCT00455429|3266785|P2|Overall Study|Lost to Follow-up|0
995247|NCT00455429|3266786|P1|Overall Study|Lost to Follow-up|1
995248|NCT00455429|3266783|P4|Overall Study|Study Terminated by Sponsor|3
995249|NCT00455429|3266784|P3|Overall Study|Study Terminated by Sponsor|0
995250|NCT00455429|3266785|P2|Overall Study|Study Terminated by Sponsor|0
995251|NCT00455429|3266786|P1|Overall Study|Study Terminated by Sponsor|0
995252|NCT00455312|3266845|P2|Overall Study|Death|1
995253|NCT00455312|3266846|P1|Overall Study|Death|0
995254|NCT00455195|3266872|P2|Double-blind Study AGLU02704|Unable to commit time to study|1
995255|NCT00455195|3266873|P1|Double-blind Study AGLU02704|Unable to commit time to study|0
995256|NCT00455195|3266872|P2|Double-blind Study AGLU02704|Withdrawal by Subject|2
995257|NCT00455195|3266873|P1|Double-blind Study AGLU02704|Withdrawal by Subject|2
995258|NCT00455195|3266872|P2|Double-blind Study AGLU02704|Death|0
995259|NCT00455195|3266873|P1|Double-blind Study AGLU02704|Death|1
995260|NCT00455195|3266872|P2|Double-blind Study AGLU02704|Adverse Event|1
995261|NCT00455195|3266873|P1|Double-blind Study AGLU02704|Adverse Event|2
995262|NCT00455013|3266890|P3|Long Term Extension (LTE)|non-specified|1
995263|NCT00455013|3266891|P2|Long Term Extension (LTE)|non-specified|0
995264|NCT00455013|3266892|P1|Long Term Extension (LTE)|non-specified|0
995265|NCT00455013|3266890|P3|Long Term Extension (LTE)|Poor non-compliance|0
995266|NCT00455013|3266891|P2|Long Term Extension (LTE)|Poor non-compliance|1
995267|NCT00455013|3266892|P1|Long Term Extension (LTE)|Poor non-compliance|0
995268|NCT00455013|3266890|P3|Long Term Extension (LTE)|Subject Request or refused|3
995269|NCT00455013|3266891|P2|Long Term Extension (LTE)|Subject Request or refused|0
995270|NCT00455013|3266892|P1|Long Term Extension (LTE)|Subject Request or refused|0
995271|NCT00455013|3266890|P3|Long Term Extension (LTE)|No longer met criteria|1
995272|NCT00455013|3266891|P2|Long Term Extension (LTE)|No longer met criteria|0
995273|NCT00455013|3266892|P1|Long Term Extension (LTE)|No longer met criteria|0
995274|NCT00455013|3266890|P3|Long Term Extension (LTE)|Death|0
995275|NCT00455013|3266891|P2|Long Term Extension (LTE)|Death|1
995276|NCT00455013|3266892|P1|Long Term Extension (LTE)|Death|1
995277|NCT00455013|3266890|P3|Long Term Extension (LTE)|Withdrawal by Subject|1
995278|NCT00455013|3266891|P2|Long Term Extension (LTE)|Withdrawal by Subject|0
995279|NCT00455013|3266892|P1|Long Term Extension (LTE)|Withdrawal by Subject|1
995280|NCT00455013|3266890|P3|Long Term Extension (LTE)|Adverse Event|1
995281|NCT00455013|3266891|P2|Long Term Extension (LTE)|Adverse Event|1
995282|NCT00455013|3266892|P1|Long Term Extension (LTE)|Adverse Event|0
995283|NCT00455013|3266890|P3|Short Term Period|Other|1
995284|NCT00455013|3266891|P2|Short Term Period|Other|0
995285|NCT00455013|3266892|P1|Short Term Period|Other|0
995286|NCT00455013|3266890|P3|Short Term Period|Lack of Efficacy|0
995287|NCT00455013|3266891|P2|Short Term Period|Lack of Efficacy|0
995288|NCT00455013|3266892|P1|Short Term Period|Lack of Efficacy|4
995289|NCT00455013|3266890|P3|Short Term Period|Withdrawal by Subject|1
995290|NCT00455013|3266891|P2|Short Term Period|Withdrawal by Subject|0
995291|NCT00455013|3266892|P1|Short Term Period|Withdrawal by Subject|0
995292|NCT00455013|3266890|P3|Short Term Period|Adverse Event|0
995293|NCT00455013|3266891|P2|Short Term Period|Adverse Event|5
995294|NCT00455013|3266892|P1|Short Term Period|Adverse Event|2
995295|NCT00454987|3266960|P3|Booster Period|Lost to Follow-up|0
995296|NCT00454987|3266961|P2|Booster Period|Lost to Follow-up|0
995297|NCT00454987|3266962|P1|Booster Period|Lost to Follow-up|1
995298|NCT00454987|3266960|P3|Booster Period|Withdrawal by Subject|0
995299|NCT00454987|3266961|P2|Booster Period|Withdrawal by Subject|1
995300|NCT00454987|3266962|P1|Booster Period|Withdrawal by Subject|0
995301|NCT00454987|3266960|P3|Booster Period|Adverse Event|0
995302|NCT00454987|3266961|P2|Booster Period|Adverse Event|0
995303|NCT00454987|3266962|P1|Booster Period|Adverse Event|1
995304|NCT00454909|3267036|P3|Overall Study|Others|0
995305|NCT00454909|3267037|P2|Overall Study|Others|0
995306|NCT00454909|3267038|P1|Overall Study|Others|1
995307|NCT00454909|3267036|P3|Overall Study|Lost to follow-up (complete vaccination)|1
995308|NCT00454909|3267037|P2|Overall Study|Lost to follow-up (complete vaccination)|3
995309|NCT00454909|3267038|P1|Overall Study|Lost to follow-up (complete vaccination)|5
995310|NCT00454909|3267036|P3|Overall Study|Migrated/moved from study area|1
995311|NCT00454909|3267037|P2|Overall Study|Migrated/moved from study area|0
995312|NCT00454909|3267038|P1|Overall Study|Migrated/moved from study area|0
995313|NCT00454909|3267036|P3|Overall Study|Withdrawal by Subject|0
995314|NCT00454909|3267037|P2|Overall Study|Withdrawal by Subject|0
995315|NCT00454909|3267038|P1|Overall Study|Withdrawal by Subject|1
995316|NCT00454857|3267076|P1|Overall Study|Reason unknown|1
995317|NCT00454857|3267076|P1|Overall Study|Other|11
995318|NCT00454857|3267076|P1|Overall Study|Death|5
995319|NCT00454857|3267076|P1|Overall Study|Noncompliance|6
995320|NCT00454857|3267076|P1|Overall Study|Lost to Follow-up|16
995321|NCT00454857|3267076|P1|Overall Study|Withdrawal by Subject|15
995322|NCT00454818|3267101|P5|Phase 2: Randomized Double-blind|Received left ventricular assist device|2
995323|NCT00454818|3267102|P4|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
995324|NCT00454818|3267103|P3|Phase 2: Randomized Double-blind|Received left ventricular assist device|1
995325|NCT00454818|3267104|P2|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
995326|NCT00454818|3267105|P1|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
995327|NCT00454818|3267101|P5|Phase 2: Randomized Double-blind|Received a heart transplant|1
995328|NCT00454818|3267102|P4|Phase 2: Randomized Double-blind|Received a heart transplant|0
995329|NCT00454818|3267103|P3|Phase 2: Randomized Double-blind|Received a heart transplant|2
995330|NCT00454818|3267104|P2|Phase 2: Randomized Double-blind|Received a heart transplant|0
995331|NCT00454818|3267105|P1|Phase 2: Randomized Double-blind|Received a heart transplant|0
995332|NCT00454818|3267101|P5|Phase 2: Randomized Double-blind|Death|1
995333|NCT00454818|3267102|P4|Phase 2: Randomized Double-blind|Death|0
995334|NCT00454818|3267103|P3|Phase 2: Randomized Double-blind|Death|0
995335|NCT00454818|3267104|P2|Phase 2: Randomized Double-blind|Death|1
995336|NCT00454818|3267105|P1|Phase 2: Randomized Double-blind|Death|0
995337|NCT00454818|3267101|P5|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
995338|NCT00454818|3267102|P4|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
995339|NCT00454818|3267103|P3|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
995340|NCT00454818|3267104|P2|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
995341|NCT00454818|3267105|P1|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
995342|NCT00454818|3267101|P5|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
995343|NCT00454818|3267102|P4|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
995344|NCT00454818|3267103|P3|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
995345|NCT00454818|3267104|P2|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
995346|NCT00454818|3267105|P1|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
995347|NCT00454818|3267101|P5|Phase I: Open-label Dose-escalation|Death|0
995348|NCT00454818|3267102|P4|Phase I: Open-label Dose-escalation|Death|0
995349|NCT00454818|3267103|P3|Phase I: Open-label Dose-escalation|Death|0
995350|NCT00454818|3267104|P2|Phase I: Open-label Dose-escalation|Death|1
995351|NCT00454818|3267105|P1|Phase I: Open-label Dose-escalation|Death|0
995352|NCT00454818|3267101|P5|Phase I: Open-label Dose-escalation|Received heart transplant|0
995353|NCT00454818|3267102|P4|Phase I: Open-label Dose-escalation|Received heart transplant|0
995354|NCT00454818|3267103|P3|Phase I: Open-label Dose-escalation|Received heart transplant|0
995355|NCT00454818|3267104|P2|Phase I: Open-label Dose-escalation|Received heart transplant|0
995356|NCT00454818|3267105|P1|Phase I: Open-label Dose-escalation|Received heart transplant|1
995357|NCT00454805|3267184|P2|Overall Study|In order to begin radiotherapy|0
995358|NCT00454805|3267185|P1|Overall Study|In order to begin radiotherapy|1
995359|NCT00454805|3267184|P2|Overall Study|Disease progression|19
995360|NCT00454805|3267185|P1|Overall Study|Disease progression|16
995361|NCT00454805|3267184|P2|Overall Study|Death|2
995362|NCT00454805|3267185|P1|Overall Study|Death|0
995363|NCT00454805|3267184|P2|Overall Study|Withdrawal by Subject|2
995364|NCT00454805|3267185|P1|Overall Study|Withdrawal by Subject|9
995365|NCT00454779|3267201|P2|Second-line Treatment Phase|Ongoing|1
995366|NCT00454779|3267202|P1|Second-line Treatment Phase|Ongoing|0
995367|NCT00454779|3267201|P2|Second-line Treatment Phase|Ended follow-up prior to analysis|1
995368|NCT00454779|3267202|P1|Second-line Treatment Phase|Ended follow-up prior to analysis|0
995369|NCT00454779|3267201|P2|Second-line Treatment Phase|Withdrawal by Subject|1
995370|NCT00454779|3267202|P1|Second-line Treatment Phase|Withdrawal by Subject|0
995371|NCT00454779|3267201|P2|First-line Treatment Phase|Ongoing|0
995372|NCT00454779|3267202|P1|First-line Treatment Phase|Ongoing|1
995373|NCT00454779|3267201|P2|First-line Treatment Phase|Ended follow-up prior to analysis|1
995374|NCT00454779|3267202|P1|First-line Treatment Phase|Ended follow-up prior to analysis|1
995375|NCT00454779|3267201|P2|First-line Treatment Phase|Protocol Violation|1
995376|NCT00454779|3267202|P1|First-line Treatment Phase|Protocol Violation|0
995377|NCT00454779|3267201|P2|First-line Treatment Phase|Lost to Follow-up|0
995378|NCT00454779|3267202|P1|First-line Treatment Phase|Lost to Follow-up|1
995379|NCT00454779|3267201|P2|First-line Treatment Phase|Withdrawal by Subject|4
995380|NCT00454779|3267202|P1|First-line Treatment Phase|Withdrawal by Subject|2
995381|NCT00454779|3267201|P2|First-line Treatment Phase|Lack of Efficacy|2
995382|NCT00454779|3267202|P1|First-line Treatment Phase|Lack of Efficacy|0
995383|NCT00454649|3267240|P10|Overall Study|Withdrawal by Subject|0
995384|NCT00454649|3267241|P9|Overall Study|Withdrawal by Subject|1
995385|NCT00454649|3267242|P8|Overall Study|Withdrawal by Subject|2
995386|NCT00454649|3267243|P7|Overall Study|Withdrawal by Subject|0
995387|NCT00454649|3267244|P6|Overall Study|Withdrawal by Subject|1
995388|NCT00454649|3267245|P5|Overall Study|Withdrawal by Subject|0
995389|NCT00454649|3267246|P4|Overall Study|Withdrawal by Subject|0
995390|NCT00454649|3267247|P3|Overall Study|Withdrawal by Subject|0
995391|NCT00454649|3267248|P2|Overall Study|Withdrawal by Subject|0
995392|NCT00454649|3267249|P1|Overall Study|Withdrawal by Subject|0
995393|NCT00454649|3267240|P10|Overall Study|Other|1
995394|NCT00454649|3267241|P9|Overall Study|Other|3
995395|NCT00454649|3267242|P8|Overall Study|Other|0
995396|NCT00454649|3267243|P7|Overall Study|Other|0
995397|NCT00454649|3267244|P6|Overall Study|Other|0
995398|NCT00454649|3267245|P5|Overall Study|Other|0
995399|NCT00454649|3267246|P4|Overall Study|Other|3
995400|NCT00454649|3267247|P3|Overall Study|Other|5
995401|NCT00454649|3267248|P2|Overall Study|Other|1
995402|NCT00454649|3267249|P1|Overall Study|Other|1
995403|NCT00454649|3267240|P10|Overall Study|Lost to Follow-up|0
995404|NCT00454649|3267241|P9|Overall Study|Lost to Follow-up|0
995405|NCT00454649|3267242|P8|Overall Study|Lost to Follow-up|0
995406|NCT00454649|3267243|P7|Overall Study|Lost to Follow-up|1
995407|NCT00454649|3267244|P6|Overall Study|Lost to Follow-up|0
995408|NCT00454649|3267245|P5|Overall Study|Lost to Follow-up|0
995409|NCT00454649|3267246|P4|Overall Study|Lost to Follow-up|0
995410|NCT00454649|3267247|P3|Overall Study|Lost to Follow-up|1
995411|NCT00454649|3267248|P2|Overall Study|Lost to Follow-up|0
995412|NCT00454649|3267249|P1|Overall Study|Lost to Follow-up|0
995413|NCT00454649|3267240|P10|Overall Study|Adverse Event|2
995414|NCT00454649|3267241|P9|Overall Study|Adverse Event|6
995415|NCT00454649|3267242|P8|Overall Study|Adverse Event|4
995416|NCT00454649|3267243|P7|Overall Study|Adverse Event|3
995417|NCT00454649|3267244|P6|Overall Study|Adverse Event|2
995418|NCT00454649|3267245|P5|Overall Study|Adverse Event|1
995419|NCT00454649|3267246|P4|Overall Study|Adverse Event|0
995420|NCT00454649|3267247|P3|Overall Study|Adverse Event|3
995421|NCT00454649|3267248|P2|Overall Study|Adverse Event|1
995422|NCT00454649|3267249|P1|Overall Study|Adverse Event|0
995423|NCT00454649|3267240|P10|Overall Study|Lack of Efficacy|2
995424|NCT00454649|3267241|P9|Overall Study|Lack of Efficacy|10
995425|NCT00454649|3267242|P8|Overall Study|Lack of Efficacy|13
995426|NCT00454649|3267243|P7|Overall Study|Lack of Efficacy|5
995427|NCT00454649|3267244|P6|Overall Study|Lack of Efficacy|4
995428|NCT00454649|3267245|P5|Overall Study|Lack of Efficacy|0
995429|NCT00454649|3267246|P4|Overall Study|Lack of Efficacy|3
995430|NCT00454649|3267247|P3|Overall Study|Lack of Efficacy|10
995431|NCT00454649|3267248|P2|Overall Study|Lack of Efficacy|2
995432|NCT00454649|3267249|P1|Overall Study|Lack of Efficacy|2
995433|NCT00454636|3267378|P4|Overall Study|Lost to Follow-up|0
995434|NCT00454636|3267379|P3|Overall Study|Lost to Follow-up|0
995435|NCT00454636|3267380|P2|Overall Study|Lost to Follow-up|1
995436|NCT00454636|3267381|P1|Overall Study|Lost to Follow-up|0
995437|NCT00454636|3267378|P4|Overall Study|Patient refusal|2
995438|NCT00454636|3267379|P3|Overall Study|Patient refusal|3
995439|NCT00454636|3267380|P2|Overall Study|Patient refusal|1
995440|NCT00454636|3267381|P1|Overall Study|Patient refusal|1
995441|NCT00454636|3267378|P4|Overall Study|Death|1
995442|NCT00454636|3267379|P3|Overall Study|Death|1
995443|NCT00454636|3267380|P2|Overall Study|Death|1
995444|NCT00454636|3267381|P1|Overall Study|Death|6
995445|NCT00454636|3267378|P4|Overall Study|Protocol Violation|3
995446|NCT00454636|3267379|P3|Overall Study|Protocol Violation|3
995447|NCT00454636|3267380|P2|Overall Study|Protocol Violation|2
995448|NCT00454636|3267381|P1|Overall Study|Protocol Violation|3
995449|NCT00454636|3267378|P4|Overall Study|Disease Progression|11
995450|NCT00454636|3267379|P3|Overall Study|Disease Progression|4
995451|NCT00454636|3267380|P2|Overall Study|Disease Progression|12
995452|NCT00454636|3267381|P1|Overall Study|Disease Progression|11
995453|NCT00454636|3267378|P4|Overall Study|Adverse Event|15
995454|NCT00454636|3267379|P3|Overall Study|Adverse Event|9
995455|NCT00454636|3267380|P2|Overall Study|Adverse Event|6
995456|NCT00454636|3267381|P1|Overall Study|Adverse Event|10
995457|NCT00454584|3267414|P6|After Controlled Period|Other|17
995458|NCT00454584|3267415|P5|After Controlled Period|Other|5
995459|NCT00454584|3267416|P4|After Controlled Period|Other|13
995460|NCT00454584|3267417|P3|After Controlled Period|Other|0
995461|NCT00454584|3267418|P2|After Controlled Period|Other|0
995462|NCT00454584|3267419|P1|After Controlled Period|Other|0
995463|NCT00454584|3267414|P6|After Controlled Period|Other|0
995464|NCT00454584|3267415|P5|After Controlled Period|Other|0
995465|NCT00454584|3267416|P4|After Controlled Period|Other|1
995466|NCT00454584|3267417|P3|After Controlled Period|Other|0
995467|NCT00454584|3267418|P2|After Controlled Period|Other|0
995468|NCT00454584|3267419|P1|After Controlled Period|Other|0
995469|NCT00454584|3267414|P6|After Controlled Period|Lost to Follow-up|6
995470|NCT00454584|3267415|P5|After Controlled Period|Lost to Follow-up|4
995471|NCT00454584|3267416|P4|After Controlled Period|Lost to Follow-up|2
995472|NCT00454584|3267417|P3|After Controlled Period|Lost to Follow-up|0
995473|NCT00454584|3267418|P2|After Controlled Period|Lost to Follow-up|0
995474|NCT00454584|3267419|P1|After Controlled Period|Lost to Follow-up|0
995475|NCT00454584|3267414|P6|After Controlled Period|Lack of Efficacy|0
995476|NCT00454584|3267415|P5|After Controlled Period|Lack of Efficacy|0
995477|NCT00454584|3267416|P4|After Controlled Period|Lack of Efficacy|1
995478|NCT00454584|3267417|P3|After Controlled Period|Lack of Efficacy|0
995479|NCT00454584|3267418|P2|After Controlled Period|Lack of Efficacy|0
995480|NCT00454584|3267419|P1|After Controlled Period|Lack of Efficacy|0
995481|NCT00454584|3267414|P6|After Controlled Period|Adverse Event|9
995482|NCT00454584|3267415|P5|After Controlled Period|Adverse Event|3
995483|NCT00454584|3267416|P4|After Controlled Period|Adverse Event|9
995484|NCT00454584|3267417|P3|After Controlled Period|Adverse Event|0
995485|NCT00454584|3267418|P2|After Controlled Period|Adverse Event|0
995486|NCT00454584|3267419|P1|After Controlled Period|Adverse Event|0
995487|NCT00454584|3267414|P6|Controlled Period|Other|0
995488|NCT00454584|3267415|P5|Controlled Period|Other|0
995489|NCT00454584|3267416|P4|Controlled Period|Other|0
995490|NCT00454584|3267417|P3|Controlled Period|Other|2
995491|NCT00454584|3267418|P2|Controlled Period|Other|4
995492|NCT00454584|3267419|P1|Controlled Period|Other|5
995493|NCT00454584|3267414|P6|Controlled Period|Lost to Follow-up|0
995494|NCT00454584|3267415|P5|Controlled Period|Lost to Follow-up|0
995495|NCT00454584|3267416|P4|Controlled Period|Lost to Follow-up|0
995496|NCT00454584|3267417|P3|Controlled Period|Lost to Follow-up|2
995497|NCT00454584|3267418|P2|Controlled Period|Lost to Follow-up|2
995498|NCT00454584|3267419|P1|Controlled Period|Lost to Follow-up|1
995499|NCT00454584|3267414|P6|Controlled Period|Adverse Event|0
995500|NCT00454584|3267415|P5|Controlled Period|Adverse Event|0
995501|NCT00454584|3267416|P4|Controlled Period|Adverse Event|0
995502|NCT00454584|3267417|P3|Controlled Period|Adverse Event|1
995503|NCT00454584|3267418|P2|Controlled Period|Adverse Event|2
995504|NCT00454584|3267419|P1|Controlled Period|Adverse Event|5
995505|NCT00454571|3267441|P2|Overall Study|Withdrawal by Subject|5
995506|NCT00454571|3267442|P1|Overall Study|Withdrawal by Subject|10
995507|NCT00454571|3267441|P2|Overall Study|Protocol Violation|0
995508|NCT00454571|3267442|P1|Overall Study|Protocol Violation|1
995509|NCT00454571|3267441|P2|Overall Study|Physician Decision|1
995510|NCT00454571|3267442|P1|Overall Study|Physician Decision|0
995511|NCT00454571|3267441|P2|Overall Study|Adverse Event|0
995512|NCT00454571|3267442|P1|Overall Study|Adverse Event|2
995513|NCT00454363|3267477|P2|Overall Study|Withdrawal prior to 12 weeks treatment|0
995514|NCT00454363|3267478|P1|Overall Study|Withdrawal prior to 12 weeks treatment|4
995515|NCT00454363|3267477|P2|Overall Study|Adverse Event|2
995516|NCT00454363|3267478|P1|Overall Study|Adverse Event|1
995517|NCT00454246|3267503|P3|Overall Study|Early termination of study|9
995518|NCT00454246|3267504|P2|Overall Study|Early termination of study|26
995519|NCT00454246|3267505|P1|Overall Study|Early termination of study|62
995520|NCT00454246|3267503|P3|Overall Study|Failure to return|0
995521|NCT00454246|3267504|P2|Overall Study|Failure to return|0
995522|NCT00454246|3267505|P1|Overall Study|Failure to return|1
995523|NCT00454246|3267503|P3|Overall Study|Refused Treatment|0
995524|NCT00454246|3267504|P2|Overall Study|Refused Treatment|1
995525|NCT00454246|3267505|P1|Overall Study|Refused Treatment|1
995526|NCT00454246|3267503|P3|Overall Study|Protocol Violation|0
995527|NCT00454246|3267504|P2|Overall Study|Protocol Violation|0
995528|NCT00454246|3267505|P1|Overall Study|Protocol Violation|1
995529|NCT00454246|3267503|P3|Overall Study|Violation of selection criteria at entry|0
995530|NCT00454246|3267504|P2|Overall Study|Violation of selection criteria at entry|0
995531|NCT00454246|3267505|P1|Overall Study|Violation of selection criteria at entry|6
995532|NCT00454246|3267503|P3|Overall Study|Adverse Event|0
995533|NCT00454246|3267504|P2|Overall Study|Adverse Event|2
995534|NCT00454246|3267505|P1|Overall Study|Adverse Event|2
995535|NCT00454207|3267521|P2|Overall Study|Protocol Violation|1
995536|NCT00454207|3267522|P1|Overall Study|Protocol Violation|0
995537|NCT00454207|3267521|P2|Overall Study|Lack of Efficacy|0
995538|NCT00454207|3267522|P1|Overall Study|Lack of Efficacy|1
995539|NCT00454207|3267521|P2|Overall Study|Adverse Event|1
995540|NCT00454207|3267522|P1|Overall Study|Adverse Event|3
995541|NCT00454194|3267567|P2|Overall Study|Other Unspecified Reason|2
995542|NCT00454194|3267568|P1|Overall Study|Other Unspecified Reason|2
995543|NCT00454194|3267567|P2|Overall Study|Other Medical Problems|2
995544|NCT00454194|3267568|P1|Overall Study|Other Medical Problems|1
995545|NCT00454194|3267567|P2|Overall Study|Withdrawal by Subject|8
995546|NCT00454194|3267568|P1|Overall Study|Withdrawal by Subject|12
995547|NCT00454194|3267567|P2|Overall Study|Adverse Event|2
995548|NCT00454194|3267568|P1|Overall Study|Adverse Event|7
995549|NCT00454181|3267586|P2|Overall Study|Withdrawal by Subject|0
995550|NCT00454181|3267587|P1|Overall Study|Withdrawal by Subject|2
995551|NCT00454181|3267586|P2|Overall Study|Protocol Violation|1
995552|NCT00454181|3267587|P1|Overall Study|Protocol Violation|1
995553|NCT00454181|3267586|P2|Overall Study|Lost to Follow-up|1
995554|NCT00454181|3267587|P1|Overall Study|Lost to Follow-up|11
995555|NCT00454181|3267586|P2|Overall Study|Adverse Event|1
995556|NCT00454181|3267587|P1|Overall Study|Adverse Event|1
995557|NCT00454142|3267603|P1|Overall Study|Withdrawal by Subject|1
995558|NCT00454116|3267621|P3|Overall Study|Other|0
995559|NCT00454116|3267622|P2|Overall Study|Other|2
995560|NCT00454116|3267623|P1|Overall Study|Other|2
995561|NCT00454116|3267621|P3|Overall Study|Withdrawal by Subject|1
995562|NCT00454116|3267622|P2|Overall Study|Withdrawal by Subject|3
995563|NCT00454116|3267623|P1|Overall Study|Withdrawal by Subject|3
995564|NCT00454116|3267621|P3|Overall Study|Condition under investigation worsened|18
995565|NCT00454116|3267622|P2|Overall Study|Condition under investigation worsened|13
995566|NCT00454116|3267623|P1|Overall Study|Condition under investigation worsened|17
995567|NCT00454116|3267621|P3|Overall Study|Adverse Event|9
995568|NCT00454116|3267622|P2|Overall Study|Adverse Event|11
995569|NCT00454116|3267623|P1|Overall Study|Adverse Event|5
995570|NCT00454051|3267633|P2|Overall Study|Protocol Violation|1
995571|NCT00454051|3267634|P1|Overall Study|Protocol Violation|1
995572|NCT00454051|3267633|P2|Overall Study|Withdrawal by Subject|0
995573|NCT00454051|3267634|P1|Overall Study|Withdrawal by Subject|1
995574|NCT00454051|3267633|P2|Overall Study|Adverse Event|2
995575|NCT00454051|3267634|P1|Overall Study|Adverse Event|1
995576|NCT00453999|3267667|P3|Overall Study|Subject Request|0
995577|NCT00453999|3267668|P2|Overall Study|Subject Request|1
995578|NCT00453999|3267669|P1|Overall Study|Subject Request|2
995579|NCT00453999|3267667|P3|Overall Study|Withdrawal by Subject|1
995580|NCT00453999|3267668|P2|Overall Study|Withdrawal by Subject|1
995581|NCT00453999|3267669|P1|Overall Study|Withdrawal by Subject|2
995582|NCT00453999|3267667|P3|Overall Study|Lost to Follow-up|1
995583|NCT00453999|3267668|P2|Overall Study|Lost to Follow-up|1
995584|NCT00453999|3267669|P1|Overall Study|Lost to Follow-up|0
995585|NCT00453999|3267667|P3|Overall Study|Adverse Event|1
995586|NCT00453999|3267668|P2|Overall Study|Adverse Event|2
995587|NCT00453999|3267669|P1|Overall Study|Adverse Event|1
995588|NCT00453986|3267697|P5|Overall Study|Lost to Follow-up|0
995589|NCT00453986|3267698|P4|Overall Study|Lost to Follow-up|2
995590|NCT00453986|3267699|P3|Overall Study|Lost to Follow-up|6
995591|NCT00453986|3267700|P2|Overall Study|Lost to Follow-up|5
995592|NCT00453986|3267701|P1|Overall Study|Lost to Follow-up|6
995593|NCT00453973|3267794|P2|Overall Study|Sponsor Decision to Terminate Study|30
995594|NCT00453973|3267795|P1|Overall Study|Sponsor Decision to Terminate Study|35
995595|NCT00453973|3267794|P2|Overall Study|Site closed by sponsor|0
995596|NCT00453973|3267795|P1|Overall Study|Site closed by sponsor|3
995597|NCT00453973|3267794|P2|Overall Study|Renal transplant|1
995598|NCT00453973|3267795|P1|Overall Study|Renal transplant|1
995599|NCT00453973|3267794|P2|Overall Study|Relocation|0
995600|NCT00453973|3267795|P1|Overall Study|Relocation|1
995601|NCT00453973|3267794|P2|Overall Study|PI Decision|2
995602|NCT00453973|3267795|P1|Overall Study|PI Decision|0
995603|NCT00453973|3267794|P2|Overall Study|Withdrawal by Subject|6
995604|NCT00453973|3267795|P1|Overall Study|Withdrawal by Subject|7
995605|NCT00453973|3267794|P2|Overall Study|Adverse Event|9
995606|NCT00453973|3267795|P1|Overall Study|Adverse Event|4
995607|NCT00453921|3267805|P4|Overall Study|Lost to Follow-up|0
995608|NCT00453921|3267806|P3|Overall Study|Lost to Follow-up|1
995609|NCT00453921|3267807|P2|Overall Study|Lost to Follow-up|0
995610|NCT00453921|3267808|P1|Overall Study|Lost to Follow-up|0
995611|NCT00453921|3267805|P4|Overall Study|Withdrawal by Subject|1
995612|NCT00453921|3267806|P3|Overall Study|Withdrawal by Subject|1
995613|NCT00453921|3267807|P2|Overall Study|Withdrawal by Subject|1
995614|NCT00453921|3267808|P1|Overall Study|Withdrawal by Subject|1
995615|NCT00453362|3267947|P1|Overall Study|Screening Failure|14
995616|NCT00453362|3267947|P1|Overall Study|Progression of disease|56
995617|NCT00453362|3267947|P1|Overall Study|Withdrawal by Subject|3
995618|NCT00453362|3267947|P1|Overall Study|Physician Decision|2
995619|NCT00453362|3267947|P1|Overall Study|Death|7
995620|NCT00453362|3267947|P1|Overall Study|Adverse Event|5
995621|NCT00453349|3267973|P2|Completed Study|Lost to follow up after study treatment|11
995622|NCT00453349|3267974|P1|Completed Study|Lost to follow up after study treatment|2
995623|NCT00453349|3267973|P2|Completed Study|Withdrawal by Subject|5
995624|NCT00453349|3267974|P1|Completed Study|Withdrawal by Subject|3
995625|NCT00453349|3267973|P2|Completed Study|Protocol Violation|1
995626|NCT00453349|3267974|P1|Completed Study|Protocol Violation|1
995627|NCT00453349|3267973|P2|Completed Study|Lost to Follow-up|5
995628|NCT00453349|3267974|P1|Completed Study|Lost to Follow-up|7
995629|NCT00453349|3267973|P2|Completed Study|Lack of Efficacy|1
995630|NCT00453349|3267974|P1|Completed Study|Lack of Efficacy|2
995631|NCT00453349|3267973|P2|Completed Study|Adverse Event|11
995632|NCT00453349|3267974|P1|Completed Study|Adverse Event|12
995633|NCT00453349|3267973|P2|Reaching of Primary Endpoint (TOC)|Missing information|11
995634|NCT00453349|3267974|P1|Reaching of Primary Endpoint (TOC)|Missing information|10
995635|NCT00453349|3267973|P2|Randomized|Withdrawal by Subject|5
995636|NCT00453349|3267974|P1|Randomized|Withdrawal by Subject|3
995637|NCT00453349|3267973|P2|Randomized|Protocol Violation|1
995638|NCT00453349|3267974|P1|Randomized|Protocol Violation|1
995639|NCT00453349|3267973|P2|Randomized|Lost to Follow-up|5
995640|NCT00453349|3267974|P1|Randomized|Lost to Follow-up|7
995641|NCT00453349|3267973|P2|Randomized|Lack of Efficacy|1
995642|NCT00453349|3267974|P1|Randomized|Lack of Efficacy|2
995643|NCT00453349|3267973|P2|Randomized|Adverse Event|11
995644|NCT00453349|3267974|P1|Randomized|Adverse Event|12
995645|NCT00453310|3268005|P1|Overall Study|Progression of Disease|10
995646|NCT00453206|3268009|P1|Overall Study|Death|1
995647|NCT00453180|3268019|P2|Overall Study|Adverse Event|2
995648|NCT00453180|3268020|P1|Overall Study|Adverse Event|1
995649|NCT00453180|3268019|P2|Overall Study|Lost to Follow-up|1
995650|NCT00453180|3268020|P1|Overall Study|Lost to Follow-up|2
995651|NCT00453154|3268039|P4|Double BIind Maintenance|Randomized, did not receive therapy|5
995652|NCT00453154|3268040|P3|Double BIind Maintenance|Randomized, did not receive therapy|5
995653|NCT00453154|3268041|P2|Double BIind Maintenance|Randomized, did not receive therapy|0
995654|NCT00453154|3268042|P1|Double BIind Maintenance|Randomized, did not receive therapy|0
995655|NCT00453154|3268039|P4|Double BIind Maintenance|Medical Issues|1
995656|NCT00453154|3268040|P3|Double BIind Maintenance|Medical Issues|3
995657|NCT00453154|3268041|P2|Double BIind Maintenance|Medical Issues|0
995658|NCT00453154|3268042|P1|Double BIind Maintenance|Medical Issues|0
995659|NCT00453154|3268039|P4|Double BIind Maintenance|Progression|26
995660|NCT00453154|3268040|P3|Double BIind Maintenance|Progression|29
995661|NCT00453154|3268041|P2|Double BIind Maintenance|Progression|0
995662|NCT00453154|3268042|P1|Double BIind Maintenance|Progression|0
995663|NCT00453154|3268039|P4|Double BIind Maintenance|Withdrawal by Subject|4
995664|NCT00453154|3268040|P3|Double BIind Maintenance|Withdrawal by Subject|4
995665|NCT00453154|3268041|P2|Double BIind Maintenance|Withdrawal by Subject|0
995666|NCT00453154|3268042|P1|Double BIind Maintenance|Withdrawal by Subject|0
995667|NCT00453154|3268039|P4|Double BIind Maintenance|Death|1
995668|NCT00453154|3268040|P3|Double BIind Maintenance|Death|2
995669|NCT00453154|3268041|P2|Double BIind Maintenance|Death|0
995670|NCT00453154|3268042|P1|Double BIind Maintenance|Death|0
995671|NCT00453154|3268039|P4|Double BIind Maintenance|Adverse Event|12
995672|NCT00453154|3268040|P3|Double BIind Maintenance|Adverse Event|3
995673|NCT00453154|3268041|P2|Double BIind Maintenance|Adverse Event|0
995674|NCT00453154|3268042|P1|Double BIind Maintenance|Adverse Event|0
995675|NCT00453102|3268055|P1|Overall Study|Withdrawal by Subject|2
995676|NCT00453063|3268066|P2|Overall Study|Protocol Violation|0
995677|NCT00453063|3268067|P1|Overall Study|Protocol Violation|1
995678|NCT00453063|3268066|P2|Overall Study|Withdrawal by Subject|1
995679|NCT00453063|3268067|P1|Overall Study|Withdrawal by Subject|1
995680|NCT00453063|3268066|P2|Overall Study|Adverse Event|2
995681|NCT00453063|3268067|P1|Overall Study|Adverse Event|1
995682|NCT00452790|3268087|P2|Toddler Dose|Parent/legal guardian request|1
995683|NCT00452790|3268088|P1|Toddler Dose|Parent/legal guardian request|0
995684|NCT00452790|3268087|P2|Toddler Dose|Failed to return|1
995685|NCT00452790|3268088|P1|Toddler Dose|Failed to return|0
995686|NCT00452790|3268087|P2|After Infant Series|Other reasons|0
995687|NCT00452790|3268088|P1|After Infant Series|Other reasons|1
995688|NCT00452790|3268087|P2|After Infant Series|Failed to return|0
995689|NCT00452790|3268088|P1|After Infant Series|Failed to return|1
995690|NCT00452790|3268087|P2|After Infant Series|Lost to Follow-up|0
995691|NCT00452790|3268088|P1|After Infant Series|Lost to Follow-up|4
995692|NCT00452790|3268087|P2|After Infant Series|Parent/legal guardian request|3
995693|NCT00452790|3268088|P1|After Infant Series|Parent/legal guardian request|1
995694|NCT00452790|3268087|P2|After Infant Series|Adverse Event|1
995695|NCT00452790|3268088|P1|After Infant Series|Adverse Event|4
995696|NCT00452790|3268087|P2|After Infant Series|Investigator request|10
995697|NCT00452790|3268088|P1|After Infant Series|Investigator request|10
995698|NCT00452790|3268087|P2|Infant Series|Death|1
995699|NCT00452790|3268088|P1|Infant Series|Death|0
995700|NCT00452790|3268087|P2|Infant Series|Investigator request|1
995701|NCT00452790|3268088|P1|Infant Series|Investigator request|0
995702|NCT00452790|3268087|P2|Infant Series|Other reasons|2
995703|NCT00452790|3268088|P1|Infant Series|Other reasons|1
995704|NCT00452790|3268087|P2|Infant Series|Adverse Event|2
995705|NCT00452790|3268088|P1|Infant Series|Adverse Event|1
995706|NCT00452790|3268087|P2|Infant Series|Lost to Follow-up|2
995707|NCT00452790|3268088|P1|Infant Series|Lost to Follow-up|2
995708|NCT00452790|3268087|P2|Infant Series|Protocol Violation|3
995709|NCT00452790|3268088|P1|Infant Series|Protocol Violation|1
995710|NCT00452790|3268087|P2|Infant Series|Failed to return|1
995711|NCT00452790|3268088|P1|Infant Series|Failed to return|4
995712|NCT00452790|3268087|P2|Infant Series|Parent/legal guardian request|6
995713|NCT00452790|3268088|P1|Infant Series|Parent/legal guardian request|8
995714|NCT00452790|3268087|P2|Infant Series|Clinical hold - consent withdrawn|123
995715|NCT00452790|3268088|P1|Infant Series|Clinical hold - consent withdrawn|118
995716|NCT00452699|3268124|P2|Overall Study|Other|7
995717|NCT00452699|3268125|P1|Overall Study|Other|12
995718|NCT00452699|3268124|P2|Overall Study|Withdrawal by Subject|25
995719|NCT00452699|3268125|P1|Overall Study|Withdrawal by Subject|26
995720|NCT00452699|3268124|P2|Overall Study|Protocol Violation|25
995721|NCT00452699|3268125|P1|Overall Study|Protocol Violation|21
995722|NCT00452699|3268124|P2|Overall Study|Lost to Follow-up|9
995723|NCT00452699|3268125|P1|Overall Study|Lost to Follow-up|6
995724|NCT00452699|3268124|P2|Overall Study|Lack of Efficacy|4
995725|NCT00452699|3268125|P1|Overall Study|Lack of Efficacy|6
995726|NCT00452699|3268124|P2|Overall Study|Adverse Event|3
995727|NCT00452699|3268125|P1|Overall Study|Adverse Event|10
995728|NCT00452673|3268141|P5|Dose Expansion Period|not specified|2
995729|NCT00452673|3268142|P4|Dose Expansion Period|not specified|0
995730|NCT00452673|3268143|P3|Dose Expansion Period|not specified|0
995731|NCT00452673|3268144|P2|Dose Expansion Period|not specified|0
995732|NCT00452673|3268145|P1|Dose Expansion Period|not specified|0
995733|NCT00452673|3268141|P5|Dose Expansion Period|Disease Progression|19
995734|NCT00452673|3268142|P4|Dose Expansion Period|Disease Progression|0
995735|NCT00452673|3268143|P3|Dose Expansion Period|Disease Progression|0
995736|NCT00452673|3268144|P2|Dose Expansion Period|Disease Progression|0
995737|NCT00452673|3268145|P1|Dose Expansion Period|Disease Progression|0
995738|NCT00452673|3268141|P5|Dose Escalation Period|Withdrawal by Subject|0
995739|NCT00452673|3268142|P4|Dose Escalation Period|Withdrawal by Subject|1
995740|NCT00452673|3268143|P3|Dose Escalation Period|Withdrawal by Subject|0
995741|NCT00452673|3268144|P2|Dose Escalation Period|Withdrawal by Subject|0
995742|NCT00452673|3268145|P1|Dose Escalation Period|Withdrawal by Subject|0
995743|NCT00452673|3268141|P5|Dose Escalation Period|Adverse Event|0
995744|NCT00452673|3268142|P4|Dose Escalation Period|Adverse Event|1
995745|NCT00452673|3268143|P3|Dose Escalation Period|Adverse Event|0
995746|NCT00452673|3268144|P2|Dose Escalation Period|Adverse Event|0
995747|NCT00452673|3268145|P1|Dose Escalation Period|Adverse Event|0
995748|NCT00452673|3268141|P5|Dose Escalation Period|not specified|0
995749|NCT00452673|3268142|P4|Dose Escalation Period|not specified|0
995750|NCT00452673|3268143|P3|Dose Escalation Period|not specified|1
995751|NCT00452673|3268144|P2|Dose Escalation Period|not specified|0
995752|NCT00452673|3268145|P1|Dose Escalation Period|not specified|0
995753|NCT00452673|3268141|P5|Dose Escalation Period|study drug toxicity|0
995754|NCT00452673|3268142|P4|Dose Escalation Period|study drug toxicity|1
995755|NCT00452673|3268143|P3|Dose Escalation Period|study drug toxicity|3
995756|NCT00452673|3268144|P2|Dose Escalation Period|study drug toxicity|3
995757|NCT00452673|3268145|P1|Dose Escalation Period|study drug toxicity|1
995758|NCT00452673|3268141|P5|Dose Escalation Period|Disease Progression|0
995759|NCT00452673|3268142|P4|Dose Escalation Period|Disease Progression|6
995760|NCT00452673|3268143|P3|Dose Escalation Period|Disease Progression|2
995761|NCT00452673|3268144|P2|Dose Escalation Period|Disease Progression|6
995762|NCT00452673|3268145|P1|Dose Escalation Period|Disease Progression|6
995763|NCT00452530|3268192|P2|Overall Study|Not specified|11
995764|NCT00452530|3268193|P1|Overall Study|Not specified|7
995765|NCT00452530|3268192|P2|Overall Study|No longer met study criteria|22
995766|NCT00452530|3268193|P1|Overall Study|No longer met study criteria|18
995767|NCT00452530|3268192|P2|Overall Study|Poor compliance/noncompliance|2
995768|NCT00452530|3268193|P1|Overall Study|Poor compliance/noncompliance|1
995769|NCT00452530|3268192|P2|Overall Study|Lost to Follow-up|0
995770|NCT00452530|3268193|P1|Overall Study|Lost to Follow-up|1
995771|NCT00452530|3268192|P2|Overall Study|Withdrawal by Subject|57
995772|NCT00452530|3268193|P1|Overall Study|Withdrawal by Subject|68
995773|NCT00452530|3268192|P2|Overall Study|Adverse Event|44
995774|NCT00452530|3268193|P1|Overall Study|Adverse Event|40
995775|NCT00452530|3268192|P2|Overall Study|Death|0
995776|NCT00452530|3268193|P1|Overall Study|Death|1
995777|NCT00452452|3268214|P3|Overall Study|Lost to Follow-up|0
995778|NCT00452452|3268215|P2|Overall Study|Lost to Follow-up|0
995779|NCT00452452|3268216|P1|Overall Study|Lost to Follow-up|1
995780|NCT00452452|3268214|P3|Overall Study|Withdrawal by Subject|0
995781|NCT00452452|3268215|P2|Overall Study|Withdrawal by Subject|0
995782|NCT00452452|3268216|P1|Overall Study|Withdrawal by Subject|1
995783|NCT00452452|3268214|P3|Overall Study|Protocol Violation|1
995784|NCT00452452|3268215|P2|Overall Study|Protocol Violation|0
995785|NCT00452452|3268216|P1|Overall Study|Protocol Violation|0
995786|NCT00452400|3268261|P5|Overall Study|Other reasons not listed above|1
995787|NCT00452400|3268262|P4|Overall Study|Other reasons not listed above|1
995788|NCT00452400|3268263|P3|Overall Study|Other reasons not listed above|0
995789|NCT00452400|3268264|P2|Overall Study|Other reasons not listed above|0
995790|NCT00452400|3268265|P1|Overall Study|Other reasons not listed above|0
995791|NCT00452400|3268261|P5|Overall Study|Lack of Efficacy|0
995792|NCT00452400|3268262|P4|Overall Study|Lack of Efficacy|0
995793|NCT00452400|3268263|P3|Overall Study|Lack of Efficacy|0
995794|NCT00452400|3268264|P2|Overall Study|Lack of Efficacy|0
995795|NCT00452400|3268265|P1|Overall Study|Lack of Efficacy|2
995796|NCT00452400|3268261|P5|Overall Study|Withdrawal by Subject|0
995797|NCT00452400|3268262|P4|Overall Study|Withdrawal by Subject|0
995798|NCT00452400|3268263|P3|Overall Study|Withdrawal by Subject|1
995799|NCT00452400|3268264|P2|Overall Study|Withdrawal by Subject|0
995800|NCT00452400|3268265|P1|Overall Study|Withdrawal by Subject|1
995801|NCT00452400|3268261|P5|Overall Study|Lost to Follow-up|0
995802|NCT00452400|3268262|P4|Overall Study|Lost to Follow-up|0
995803|NCT00452400|3268263|P3|Overall Study|Lost to Follow-up|0
995804|NCT00452400|3268264|P2|Overall Study|Lost to Follow-up|0
995805|NCT00452400|3268265|P1|Overall Study|Lost to Follow-up|1
995806|NCT00452400|3268261|P5|Overall Study|Protocol Violation|0
995807|NCT00452400|3268262|P4|Overall Study|Protocol Violation|0
995808|NCT00452400|3268263|P3|Overall Study|Protocol Violation|1
995809|NCT00452400|3268264|P2|Overall Study|Protocol Violation|0
995810|NCT00452400|3268265|P1|Overall Study|Protocol Violation|0
995811|NCT00452400|3268261|P5|Overall Study|Adverse Event|2
995812|NCT00452400|3268262|P4|Overall Study|Adverse Event|0
995813|NCT00452400|3268263|P3|Overall Study|Adverse Event|5
995814|NCT00452400|3268264|P2|Overall Study|Adverse Event|1
995815|NCT00452400|3268265|P1|Overall Study|Adverse Event|1
995816|NCT00452361|3268452|P2|Overall Study|Premature termination|9
995817|NCT00452361|3268453|P1|Overall Study|Premature termination|13
995818|NCT00452361|3268452|P2|Overall Study|Withdrawal by Subject|1
995819|NCT00452361|3268453|P1|Overall Study|Withdrawal by Subject|0
995820|NCT00452361|3268452|P2|Overall Study|Adverse Event|0
995821|NCT00452361|3268453|P1|Overall Study|Adverse Event|8
995822|NCT00452348|3268497|P2|Overall Study|Other|9
995823|NCT00452348|3268498|P1|Overall Study|Other|9
995824|NCT00452348|3268497|P2|Overall Study|Withdrawal by Subject|21
995825|NCT00452348|3268498|P1|Overall Study|Withdrawal by Subject|18
995826|NCT00452348|3268497|P2|Overall Study|Protocol Violation|28
995827|NCT00452348|3268498|P1|Overall Study|Protocol Violation|22
995828|NCT00452348|3268497|P2|Overall Study|Lost to Follow-up|8
995829|NCT00452348|3268498|P1|Overall Study|Lost to Follow-up|14
995830|NCT00452348|3268497|P2|Overall Study|Lack of Efficacy|9
995831|NCT00452348|3268498|P1|Overall Study|Lack of Efficacy|10
995832|NCT00452348|3268497|P2|Overall Study|Adverse Event|9
995833|NCT00452348|3268498|P1|Overall Study|Adverse Event|6
995834|NCT00452114|3268552|P2|Overall Study|Physician Decision|3
995835|NCT00452114|3268553|P1|Overall Study|Physician Decision|3
995836|NCT00451958|3268569|P5|CS21A (NCT00451958)|Miscellaneous reasons|0
995837|NCT00451958|3268570|P4|CS21A (NCT00451958)|Miscellaneous reasons|14
995838|NCT00451958|3268571|P3|CS21A (NCT00451958)|Miscellaneous reasons|17
995839|NCT00451958|3268572|P2|CS21A (NCT00451958)|Miscellaneous reasons|27
995840|NCT00451958|3268573|P1|CS21A (NCT00451958)|Miscellaneous reasons|28
995841|NCT00451958|3268569|P5|CS21A (NCT00451958)|Withdrawal by Subject|0
995842|NCT00451958|3268570|P4|CS21A (NCT00451958)|Withdrawal by Subject|3
995843|NCT00451958|3268571|P3|CS21A (NCT00451958)|Withdrawal by Subject|4
995844|NCT00451958|3268572|P2|CS21A (NCT00451958)|Withdrawal by Subject|4
995845|NCT00451958|3268573|P1|CS21A (NCT00451958)|Withdrawal by Subject|7
995846|NCT00451958|3268569|P5|CS21A (NCT00451958)|Physician Decision|0
995847|NCT00451958|3268570|P4|CS21A (NCT00451958)|Physician Decision|4
995848|NCT00451958|3268571|P3|CS21A (NCT00451958)|Physician Decision|4
995849|NCT00451958|3268572|P2|CS21A (NCT00451958)|Physician Decision|4
995850|NCT00451958|3268573|P1|CS21A (NCT00451958)|Physician Decision|2
995851|NCT00451958|3268569|P5|CS21A (NCT00451958)|Protocol Violation|0
995852|NCT00451958|3268570|P4|CS21A (NCT00451958)|Protocol Violation|0
995853|NCT00451958|3268571|P3|CS21A (NCT00451958)|Protocol Violation|2
995854|NCT00451958|3268572|P2|CS21A (NCT00451958)|Protocol Violation|3
995855|NCT00451958|3268573|P1|CS21A (NCT00451958)|Protocol Violation|1
995856|NCT00451958|3268569|P5|CS21A (NCT00451958)|Lost to Follow-up|0
995857|NCT00451958|3268570|P4|CS21A (NCT00451958)|Lost to Follow-up|1
995858|NCT00451958|3268571|P3|CS21A (NCT00451958)|Lost to Follow-up|1
995859|NCT00451958|3268572|P2|CS21A (NCT00451958)|Lost to Follow-up|5
995860|NCT00451958|3268573|P1|CS21A (NCT00451958)|Lost to Follow-up|6
995861|NCT00451958|3268569|P5|CS21A (NCT00451958)|Adverse Event|0
995862|NCT00451958|3268570|P4|CS21A (NCT00451958)|Adverse Event|17
995863|NCT00451958|3268571|P3|CS21A (NCT00451958)|Adverse Event|14
995864|NCT00451958|3268572|P2|CS21A (NCT00451958)|Adverse Event|34
995865|NCT00451958|3268573|P1|CS21A (NCT00451958)|Adverse Event|21
995866|NCT00451906|3268603|P1|Overall Study|Did not complete final visit|4
995867|NCT00451906|3268603|P1|Overall Study|Other Reasons|121
995868|NCT00451906|3268603|P1|Overall Study|Termination of the study|108
995869|NCT00451906|3268603|P1|Overall Study|Progressive disease|1328
995870|NCT00451906|3268603|P1|Overall Study|Protocol Violation|21
995871|NCT00451906|3268603|P1|Overall Study|Withdrawal by Subject|111
995872|NCT00451906|3268603|P1|Overall Study|Lost to Follow-up|31
995873|NCT00451906|3268603|P1|Overall Study|Adverse Event|515
995874|NCT00451451|3268632|P4|Overall Study|Other Reasons for Not Completing Study|14
995875|NCT00451451|3268633|P3|Overall Study|Other Reasons for Not Completing Study|17
995876|NCT00451451|3268634|P2|Overall Study|Other Reasons for Not Completing Study|30
995877|NCT00451451|3268635|P1|Overall Study|Other Reasons for Not Completing Study|34
995878|NCT00451451|3268632|P4|Overall Study|Death|1
995879|NCT00451451|3268633|P3|Overall Study|Death|0
995880|NCT00451451|3268634|P2|Overall Study|Death|0
995881|NCT00451451|3268635|P1|Overall Study|Death|1
995882|NCT00451451|3268632|P4|Overall Study|Subject Non-Compliance|3
995883|NCT00451451|3268633|P3|Overall Study|Subject Non-Compliance|3
995884|NCT00451451|3268634|P2|Overall Study|Subject Non-Compliance|4
995885|NCT00451451|3268635|P1|Overall Study|Subject Non-Compliance|8
995886|NCT00451451|3268632|P4|Overall Study|Investigator Decision|2
995887|NCT00451451|3268633|P3|Overall Study|Investigator Decision|1
995888|NCT00451451|3268634|P2|Overall Study|Investigator Decision|2
995889|NCT00451451|3268635|P1|Overall Study|Investigator Decision|6
995890|NCT00451451|3268632|P4|Overall Study|Consent Withdrawn|17
995891|NCT00451451|3268633|P3|Overall Study|Consent Withdrawn|17
995892|NCT00451451|3268634|P2|Overall Study|Consent Withdrawn|9
995893|NCT00451451|3268635|P1|Overall Study|Consent Withdrawn|14
995894|NCT00451451|3268632|P4|Overall Study|Lost to Follow-up|11
995895|NCT00451451|3268633|P3|Overall Study|Lost to Follow-up|8
995896|NCT00451451|3268634|P2|Overall Study|Lost to Follow-up|9
995897|NCT00451451|3268635|P1|Overall Study|Lost to Follow-up|11
995898|NCT00451451|3268632|P4|Overall Study|Adverse Event|10
995899|NCT00451451|3268633|P3|Overall Study|Adverse Event|26
995900|NCT00451451|3268634|P2|Overall Study|Adverse Event|21
995901|NCT00451451|3268635|P1|Overall Study|Adverse Event|11
995902|NCT00451321|3268670|P8|Overall Study|Sponsor decision to amend protocol|3
995903|NCT00451321|3268671|P7|Overall Study|Sponsor decision to amend protocol|1
995904|NCT00451321|3268672|P6|Overall Study|Sponsor decision to amend protocol|1
995905|NCT00451321|3268673|P5|Overall Study|Sponsor decision to amend protocol|0
995906|NCT00451321|3268674|P4|Overall Study|Sponsor decision to amend protocol|0
995907|NCT00451321|3268675|P3|Overall Study|Sponsor decision to amend protocol|0
995908|NCT00451321|3268676|P2|Overall Study|Sponsor decision to amend protocol|0
995909|NCT00451321|3268677|P1|Overall Study|Sponsor decision to amend protocol|0
995910|NCT00451321|3268670|P8|Overall Study|Study closed/terminated|3
995911|NCT00451321|3268671|P7|Overall Study|Study closed/terminated|5
995912|NCT00451321|3268672|P6|Overall Study|Study closed/terminated|7
995913|NCT00451321|3268673|P5|Overall Study|Study closed/terminated|7
995914|NCT00451321|3268674|P4|Overall Study|Study closed/terminated|5
995915|NCT00451321|3268675|P3|Overall Study|Study closed/terminated|17
995916|NCT00451321|3268676|P2|Overall Study|Study closed/terminated|1
995917|NCT00451321|3268677|P1|Overall Study|Study closed/terminated|1
995918|NCT00451321|3268670|P8|Overall Study|Withdrawal by Subject|0
995919|NCT00451321|3268671|P7|Overall Study|Withdrawal by Subject|0
995920|NCT00451321|3268672|P6|Overall Study|Withdrawal by Subject|0
995921|NCT00451321|3268673|P5|Overall Study|Withdrawal by Subject|0
995922|NCT00451321|3268674|P4|Overall Study|Withdrawal by Subject|4
995923|NCT00451321|3268675|P3|Overall Study|Withdrawal by Subject|0
995924|NCT00451321|3268676|P2|Overall Study|Withdrawal by Subject|1
995925|NCT00451321|3268677|P1|Overall Study|Withdrawal by Subject|3
995926|NCT00451321|3268670|P8|Overall Study|Lost to Follow-up|0
995927|NCT00451321|3268671|P7|Overall Study|Lost to Follow-up|0
995928|NCT00451321|3268672|P6|Overall Study|Lost to Follow-up|1
995929|NCT00451321|3268673|P5|Overall Study|Lost to Follow-up|0
995930|NCT00451321|3268674|P4|Overall Study|Lost to Follow-up|3
995931|NCT00451321|3268675|P3|Overall Study|Lost to Follow-up|1
995932|NCT00451321|3268676|P2|Overall Study|Lost to Follow-up|3
995933|NCT00451321|3268677|P1|Overall Study|Lost to Follow-up|3
995934|NCT00451282|3268849|P2|Overall Study|Lost to Follow-up|5
995935|NCT00451282|3268850|P1|Overall Study|Lost to Follow-up|6
995936|NCT00451204|3268864|P2|Overall Study|Other|2
995937|NCT00451204|3268865|P1|Overall Study|Other|1
995938|NCT00451204|3268864|P2|Overall Study|Patient refusal|4
995939|NCT00451204|3268865|P1|Overall Study|Patient refusal|8
995940|NCT00451204|3268864|P2|Overall Study|Protocol Violation|0
995941|NCT00451204|3268865|P1|Overall Study|Protocol Violation|1
995942|NCT00451204|3268864|P2|Overall Study|Lost to Follow-up|4
995943|NCT00451204|3268865|P1|Overall Study|Lost to Follow-up|4
995944|NCT00451204|3268864|P2|Overall Study|Lack of Efficacy|4
995945|NCT00451204|3268865|P1|Overall Study|Lack of Efficacy|4
995946|NCT00451204|3268864|P2|Overall Study|Adverse Event|6
995947|NCT00451204|3268865|P1|Overall Study|Adverse Event|4
995948|NCT00451191|3268883|P2|Overall Study|withdrawal or received alternate tx|11
995949|NCT00451191|3268884|P1|Overall Study|withdrawal or received alternate tx|15
995950|NCT00450866|3268911|P2|Overall Study|Physician Decision|0
995951|NCT00450866|3268912|P1|Overall Study|Physician Decision|1
995952|NCT00450866|3268911|P2|Overall Study|Death|0
995953|NCT00450866|3268912|P1|Overall Study|Death|1
995954|NCT00450866|3268911|P2|Overall Study|Withdrawal by Subject|2
995955|NCT00450866|3268912|P1|Overall Study|Withdrawal by Subject|5
995956|NCT00450866|3268911|P2|Overall Study|Adverse Event|1
995957|NCT00450866|3268912|P1|Overall Study|Adverse Event|0
995958|NCT00450801|3268922|P1|Overall Study|Death|1
995959|NCT00450749|3268936|P3|Overall Study|Noncompliant|0
995960|NCT00450749|3268937|P2|Overall Study|Noncompliant|1
995961|NCT00450749|3268938|P1|Overall Study|Noncompliant|0
995962|NCT00450749|3268936|P3|Overall Study|Withdrawal by Subject|2
995963|NCT00450749|3268937|P2|Overall Study|Withdrawal by Subject|0
995964|NCT00450749|3268938|P1|Overall Study|Withdrawal by Subject|0
995965|NCT00450723|3268946|P1|Overall Study|Physician Decision|5
995966|NCT00450658|3268954|P2|Overall Study|misc|10
995967|NCT00450658|3268955|P1|Overall Study|misc|21
995968|NCT00450658|3268954|P2|Overall Study|UGI ulcer|34
995969|NCT00450658|3268955|P1|Overall Study|UGI ulcer|33
995970|NCT00450658|3268954|P2|Overall Study|Lost to Follow-up|5
995971|NCT00450658|3268955|P1|Overall Study|Lost to Follow-up|22
995972|NCT00450658|3268954|P2|Overall Study|Withdrawal by Subject|26
995973|NCT00450658|3268955|P1|Overall Study|Withdrawal by Subject|43
995974|NCT00450658|3268954|P2|Overall Study|Adverse Event|15
995975|NCT00450658|3268955|P1|Overall Study|Adverse Event|24
995976|NCT00450619|3268969|P2|Overall Study|Adverse Event|0
995977|NCT00450619|3268970|P1|Overall Study|Adverse Event|1
995978|NCT00450619|3268969|P2|Overall Study|did not progress; refused further trmt|1
995979|NCT00450619|3268970|P1|Overall Study|did not progress; refused further trmt|1
995980|NCT00450619|3268969|P2|Overall Study|refused treatment after randomization|0
995981|NCT00450619|3268970|P1|Overall Study|refused treatment after randomization|2
995982|NCT00450580|3268996|P2|Overall Study|Withdrawal due to pregnancy|1
995983|NCT00450580|3268997|P1|Overall Study|Withdrawal due to pregnancy|0
995984|NCT00450580|3268996|P2|Overall Study|Patient could not swallow Norvir|0
995985|NCT00450580|3268997|P1|Overall Study|Patient could not swallow Norvir|1
995986|NCT00450580|3268996|P2|Overall Study|Patient went to Brazil|0
995987|NCT00450580|3268997|P1|Overall Study|Patient went to Brazil|1
995988|NCT00450580|3268996|P2|Overall Study|Could not comply with scheduled visits|0
995989|NCT00450580|3268997|P1|Overall Study|Could not comply with scheduled visits|1
995990|NCT00450580|3268996|P2|Overall Study|Protocol-defined virologic failure|0
995991|NCT00450580|3268997|P1|Overall Study|Protocol-defined virologic failure|1
995992|NCT00450580|3268996|P2|Overall Study|Protocol Violation|1
995993|NCT00450580|3268997|P1|Overall Study|Protocol Violation|1
995994|NCT00450580|3268996|P2|Overall Study|Withdrawal by Subject|2
995995|NCT00450580|3268997|P1|Overall Study|Withdrawal by Subject|2
995996|NCT00450580|3268996|P2|Overall Study|Lost to Follow-up|5
995997|NCT00450580|3268997|P1|Overall Study|Lost to Follow-up|4
995998|NCT00450580|3268996|P2|Overall Study|Adverse Event|7
995999|NCT00450580|3268997|P1|Overall Study|Adverse Event|5
996000|NCT00450450|3269034|P2|Overall Study|Missing Data|0
996001|NCT00450450|3269035|P1|Overall Study|Missing Data|2
996002|NCT00450450|3269034|P2|Overall Study|Relapse|0
996003|NCT00450450|3269035|P1|Overall Study|Relapse|2
996004|NCT00450450|3269034|P2|Overall Study|Death|3
996005|NCT00450450|3269035|P1|Overall Study|Death|1
996006|NCT00450437|3269059|P4|Overall Study|Unable to Classify|0
996007|NCT00450437|3269060|P3|Overall Study|Unable to Classify|1
996008|NCT00450437|3269061|P2|Overall Study|Unable to Classify|0
996009|NCT00450437|3269062|P1|Overall Study|Unable to Classify|1
996010|NCT00450437|3269059|P4|Overall Study|Administrative reason|0
996011|NCT00450437|3269060|P3|Overall Study|Administrative reason|1
996012|NCT00450437|3269061|P2|Overall Study|Administrative reason|0
996013|NCT00450437|3269062|P1|Overall Study|Administrative reason|0
996014|NCT00450437|3269059|P4|Overall Study|Inappropriate enrollment|0
996015|NCT00450437|3269060|P3|Overall Study|Inappropriate enrollment|3
996016|NCT00450437|3269061|P2|Overall Study|Inappropriate enrollment|1
996017|NCT00450437|3269062|P1|Overall Study|Inappropriate enrollment|4
996018|NCT00450437|3269059|P4|Overall Study|Protocol Violation|1
996019|NCT00450437|3269060|P3|Overall Study|Protocol Violation|0
996020|NCT00450437|3269061|P2|Overall Study|Protocol Violation|1
996021|NCT00450437|3269062|P1|Overall Study|Protocol Violation|0
996022|NCT00450437|3269059|P4|Overall Study|Lost to Follow-up|9
996023|NCT00450437|3269060|P3|Overall Study|Lost to Follow-up|19
996024|NCT00450437|3269061|P2|Overall Study|Lost to Follow-up|12
996025|NCT00450437|3269062|P1|Overall Study|Lost to Follow-up|31
996026|NCT00450437|3269059|P4|Overall Study|Withdrawal by Subject|1
996027|NCT00450437|3269060|P3|Overall Study|Withdrawal by Subject|0
996028|NCT00450437|3269061|P2|Overall Study|Withdrawal by Subject|2
996029|NCT00450437|3269062|P1|Overall Study|Withdrawal by Subject|10
996030|NCT00450411|3269093|P1|Overall Study|No protocol treatment|2
996031|NCT00450411|3269093|P1|Overall Study|Protocol Violation|6
996032|NCT00450385|3269098|P1|Overall Study|Other|3
996033|NCT00450385|3269098|P1|Overall Study|Physician Decision|1
996034|NCT00450385|3269098|P1|Overall Study|Adverse Event|1
996035|NCT00450385|3269098|P1|Overall Study|Lack of Efficacy|2
996036|NCT00450385|3269098|P1|Overall Study|Withdrawal by Subject|2
996037|NCT00450385|3269098|P1|Overall Study|Protocol Violation|1
996038|NCT00450385|3269098|P1|Overall Study|Death|3
996039|NCT00450372|3269107|P1|Overall Study|Physician Decision|1
996040|NCT00450333|3269120|P4|Overall Study|Death|2
996041|NCT00450333|3269121|P3|Overall Study|Death|2
996042|NCT00450333|3269122|P2|Overall Study|Death|2
996043|NCT00450333|3269123|P1|Overall Study|Death|3
996044|NCT00450333|3269120|P4|Overall Study|Kidney transplant|3
996045|NCT00450333|3269121|P3|Overall Study|Kidney transplant|1
996046|NCT00450333|3269122|P2|Overall Study|Kidney transplant|0
996047|NCT00450333|3269123|P1|Overall Study|Kidney transplant|1
996048|NCT00450333|3269120|P4|Overall Study|Withdrawal by Subject|0
996049|NCT00450333|3269121|P3|Overall Study|Withdrawal by Subject|3
996050|NCT00450333|3269122|P2|Overall Study|Withdrawal by Subject|0
996051|NCT00450333|3269123|P1|Overall Study|Withdrawal by Subject|1
996052|NCT00450333|3269120|P4|Overall Study|Protocol Violation|0
996053|NCT00450333|3269121|P3|Overall Study|Protocol Violation|1
996054|NCT00450333|3269122|P2|Overall Study|Protocol Violation|0
996055|NCT00450333|3269123|P1|Overall Study|Protocol Violation|1
996056|NCT00450333|3269120|P4|Overall Study|Adverse Event|2
996057|NCT00450333|3269121|P3|Overall Study|Adverse Event|2
996058|NCT00450333|3269122|P2|Overall Study|Adverse Event|7
996059|NCT00450333|3269123|P1|Overall Study|Adverse Event|1
996060|NCT00450333|3269120|P4|Overall Study|Study terminated|21
996061|NCT00450333|3269121|P3|Overall Study|Study terminated|16
996062|NCT00450333|3269122|P2|Overall Study|Study terminated|54
996063|NCT00450333|3269123|P1|Overall Study|Study terminated|47
996064|NCT00450255|3269146|P1|Overall Study|Prior RFA ablation of liver|1
996065|NCT00450216|3269171|P2|Overall Study|misc|20
996066|NCT00450216|3269172|P1|Overall Study|misc|21
996067|NCT00450216|3269171|P2|Overall Study|upper gastrointestinal (UGI) ulcer|51
996068|NCT00450216|3269172|P1|Overall Study|upper gastrointestinal (UGI) ulcer|51
996069|NCT00450216|3269171|P2|Overall Study|Lost to Follow-up|9
996070|NCT00450216|3269172|P1|Overall Study|Lost to Follow-up|16
996071|NCT00450216|3269171|P2|Overall Study|Withdrawal by Subject|26
996072|NCT00450216|3269172|P1|Overall Study|Withdrawal by Subject|48
996073|NCT00450216|3269171|P2|Overall Study|Adverse Event|23
996074|NCT00450216|3269172|P1|Overall Study|Adverse Event|38
996075|NCT00450190|3269184|P1|Overall Study|Withdrawal by Subject|2
996076|NCT00450112|3269194|P2|Overall Study|Others|3
996077|NCT00450112|3269195|P1|Overall Study|Others|2
996078|NCT00450112|3269194|P2|Overall Study|Lost to Follow-up|1
996079|NCT00450112|3269195|P1|Overall Study|Lost to Follow-up|2
996080|NCT00450112|3269194|P2|Overall Study|Withdrawal by Subject|1
996081|NCT00450112|3269195|P1|Overall Study|Withdrawal by Subject|4
996082|NCT00450112|3269194|P2|Overall Study|Other Treatment Required|1
996083|NCT00450112|3269195|P1|Overall Study|Other Treatment Required|5
996084|NCT00449956|3269233|P3|Overall Study|Physician Decision|1
996085|NCT00449956|3269234|P2|Overall Study|Physician Decision|1
996086|NCT00449956|3269235|P1|Overall Study|Physician Decision|2
996087|NCT00449956|3269233|P3|Overall Study|Withdrawal by Subject|0
996088|NCT00449956|3269234|P2|Overall Study|Withdrawal by Subject|1
996089|NCT00449956|3269235|P1|Overall Study|Withdrawal by Subject|0
996090|NCT00449956|3269233|P3|Overall Study|Protocol Violation|1
996091|NCT00449956|3269234|P2|Overall Study|Protocol Violation|1
996092|NCT00449956|3269235|P1|Overall Study|Protocol Violation|1
996093|NCT00449956|3269233|P3|Overall Study|Lack of Efficacy|1
996094|NCT00449956|3269234|P2|Overall Study|Lack of Efficacy|0
996095|NCT00449956|3269235|P1|Overall Study|Lack of Efficacy|0
996096|NCT00449956|3269233|P3|Overall Study|Adverse Event|6
996097|NCT00449956|3269234|P2|Overall Study|Adverse Event|1
996098|NCT00449956|3269235|P1|Overall Study|Adverse Event|7
996099|NCT00449930|3269251|P2|Overall Study|Glycemic discontinuation criteria|1
996100|NCT00449930|3269252|P1|Overall Study|Glycemic discontinuation criteria|1
996101|NCT00449930|3269251|P2|Overall Study|Withdrawal by Subject|23
996102|NCT00449930|3269252|P1|Overall Study|Withdrawal by Subject|16
996103|NCT00449930|3269251|P2|Overall Study|Protocol Violation|15
996104|NCT00449930|3269252|P1|Overall Study|Protocol Violation|14
996105|NCT00449930|3269251|P2|Overall Study|Physician Decision|2
996106|NCT00449930|3269252|P1|Overall Study|Physician Decision|1
996107|NCT00449930|3269251|P2|Overall Study|Lost to Follow-up|14
996108|NCT00449930|3269252|P1|Overall Study|Lost to Follow-up|9
996109|NCT00449930|3269251|P2|Overall Study|Lack of Efficacy|1
996110|NCT00449930|3269252|P1|Overall Study|Lack of Efficacy|10
996111|NCT00449930|3269251|P2|Overall Study|Trial Terminated ( Site Closed)|0
996112|NCT00449930|3269252|P1|Overall Study|Trial Terminated ( Site Closed)|1
996113|NCT00449930|3269251|P2|Overall Study|Adverse Event|19
996114|NCT00449930|3269252|P1|Overall Study|Adverse Event|9
996115|NCT00449865|3269268|P2|Overall Study|Study was stopped|328
996116|NCT00449865|3269269|P1|Overall Study|Study was stopped|324
996117|NCT00449865|3269268|P2|Overall Study|Protocol Violation|7
996118|NCT00449865|3269269|P1|Overall Study|Protocol Violation|8
996119|NCT00449865|3269268|P2|Overall Study|Death|40
996120|NCT00449865|3269269|P1|Overall Study|Death|31
996121|NCT00449865|3269268|P2|Overall Study|Physician Decision|12
996122|NCT00449865|3269269|P1|Overall Study|Physician Decision|13
996123|NCT00449865|3269268|P2|Overall Study|Lost to Follow-up|37
996124|NCT00449865|3269269|P1|Overall Study|Lost to Follow-up|36
996125|NCT00449865|3269268|P2|Overall Study|Withdrawal by Subject|110
996126|NCT00449865|3269269|P1|Overall Study|Withdrawal by Subject|110
996127|NCT00449787|3269277|P2|Overall Study|Did not require medication|92
996128|NCT00449787|3269278|P1|Overall Study|Did not require medication|95
996129|NCT00449787|3269277|P2|Overall Study|Lost to Follow-up|8
996130|NCT00449787|3269278|P1|Overall Study|Lost to Follow-up|10
996131|NCT00449696|3269294|P2|Overall Study|Others|0
996132|NCT00449696|3269295|P1|Overall Study|Others|7
996133|NCT00449696|3269294|P2|Overall Study|Lost to Follow-up|3
996134|NCT00449696|3269295|P1|Overall Study|Lost to Follow-up|2
996135|NCT00449696|3269294|P2|Overall Study|Withdrawal by Subject|5
996136|NCT00449696|3269295|P1|Overall Study|Withdrawal by Subject|5
996137|NCT00449696|3269294|P2|Overall Study|Other Treatment Required|1
996138|NCT00449696|3269295|P1|Overall Study|Other Treatment Required|6
996139|NCT00449644|3269321|P4|Overall Study|Rolled-over to treatment with TMC207|1
996140|NCT00449644|3269322|P3|Overall Study|Rolled-over to treatment with TMC207|0
996141|NCT00449644|3269323|P2|Overall Study|Rolled-over to treatment with TMC207|0
996142|NCT00449644|3269324|P1|Overall Study|Rolled-over to treatment with TMC207|0
996143|NCT00449644|3269321|P4|Overall Study|Not specified|0
996144|NCT00449644|3269322|P3|Overall Study|Not specified|1
996145|NCT00449644|3269323|P2|Overall Study|Not specified|4
996146|NCT00449644|3269324|P1|Overall Study|Not specified|1
996147|NCT00449644|3269321|P4|Overall Study|Inclusion/exclusion criteria not met|6
996148|NCT00449644|3269322|P3|Overall Study|Inclusion/exclusion criteria not met|2
996149|NCT00449644|3269323|P2|Overall Study|Inclusion/exclusion criteria not met|0
996150|NCT00449644|3269324|P1|Overall Study|Inclusion/exclusion criteria not met|0
996151|NCT00449644|3269321|P4|Overall Study|Withdrawal by Subject|7
996152|NCT00449644|3269322|P3|Overall Study|Withdrawal by Subject|6
996153|NCT00449644|3269323|P2|Overall Study|Withdrawal by Subject|4
996154|NCT00449644|3269324|P1|Overall Study|Withdrawal by Subject|3
996155|NCT00449644|3269321|P4|Overall Study|Protocol Violation|7
996156|NCT00449644|3269322|P3|Overall Study|Protocol Violation|3
996157|NCT00449644|3269323|P2|Overall Study|Protocol Violation|4
996158|NCT00449644|3269324|P1|Overall Study|Protocol Violation|4
996159|NCT00449644|3269321|P4|Overall Study|Pregnancy|2
996160|NCT00449644|3269322|P3|Overall Study|Pregnancy|3
996161|NCT00449644|3269323|P2|Overall Study|Pregnancy|0
996162|NCT00449644|3269324|P1|Overall Study|Pregnancy|0
996163|NCT00449644|3269321|P4|Overall Study|Lost to Follow-up|3
996164|NCT00449644|3269322|P3|Overall Study|Lost to Follow-up|5
996165|NCT00449644|3269323|P2|Overall Study|Lost to Follow-up|1
996166|NCT00449644|3269324|P1|Overall Study|Lost to Follow-up|1
996167|NCT00449644|3269321|P4|Overall Study|Death|1
996168|NCT00449644|3269322|P3|Overall Study|Death|6
996169|NCT00449644|3269323|P2|Overall Study|Death|0
996170|NCT00449644|3269324|P1|Overall Study|Death|1
996171|NCT00449644|3269321|P4|Overall Study|Adverse Event|5
996172|NCT00449644|3269322|P3|Overall Study|Adverse Event|3
996173|NCT00449644|3269323|P2|Overall Study|Adverse Event|0
996174|NCT00449644|3269324|P1|Overall Study|Adverse Event|0
996175|NCT00449540|3269344|P3|Treatment Phase|did not experience or treat migraine|17
996176|NCT00449540|3269345|P2|Treatment Phase|did not experience or treat migraine|20
996177|NCT00449540|3269346|P1|Treatment Phase|did not experience or treat migraine|0
996178|NCT00449540|3269344|P3|Pretreatment Phase|No migraine experienced|0
996179|NCT00449540|3269345|P2|Pretreatment Phase|No migraine experienced|0
996180|NCT00449540|3269346|P1|Pretreatment Phase|No migraine experienced|66
996181|NCT00449176|3269363|P3|Overall Study|all other|20
996182|NCT00449176|3269364|P2|Overall Study|all other|19
996183|NCT00449176|3269365|P1|Overall Study|all other|22
996184|NCT00449176|3269363|P3|Overall Study|Study drug non-compliant|11
996185|NCT00449176|3269364|P2|Overall Study|Study drug non-compliant|11
996186|NCT00449176|3269365|P1|Overall Study|Study drug non-compliant|14
996187|NCT00449176|3269363|P3|Overall Study|Lack of Efficacy|50
996188|NCT00449176|3269364|P2|Overall Study|Lack of Efficacy|7
996189|NCT00449176|3269365|P1|Overall Study|Lack of Efficacy|13
996190|NCT00449176|3269363|P3|Overall Study|Adverse Event|15
996191|NCT00449176|3269364|P2|Overall Study|Adverse Event|107
996192|NCT00449176|3269365|P1|Overall Study|Adverse Event|51
996193|NCT00449176|3269363|P3|Overall Study|Lost to Follow-up|12
996194|NCT00449176|3269364|P2|Overall Study|Lost to Follow-up|8
996195|NCT00449176|3269365|P1|Overall Study|Lost to Follow-up|13
996196|NCT00449176|3269363|P3|Overall Study|Withdrawal by Subject|59
996197|NCT00449176|3269364|P2|Overall Study|Withdrawal by Subject|43
996198|NCT00449176|3269365|P1|Overall Study|Withdrawal by Subject|39
996199|NCT00449163|3269391|P1|Overall Study|Physician Decision|3
996200|NCT00449150|3269401|P3|Overall Study|Protocol Violation|1
996201|NCT00449150|3269402|P2|Overall Study|Protocol Violation|2
996202|NCT00449150|3269403|P1|Overall Study|Protocol Violation|1
996203|NCT00449150|3269401|P3|Overall Study|Withdrawal by Subject|21
996204|NCT00449150|3269402|P2|Overall Study|Withdrawal by Subject|18
996205|NCT00449150|3269403|P1|Overall Study|Withdrawal by Subject|17
996206|NCT00449150|3269401|P3|Overall Study|Not specified|14
996207|NCT00449150|3269402|P2|Overall Study|Not specified|13
996208|NCT00449150|3269403|P1|Overall Study|Not specified|16
996209|NCT00449150|3269401|P3|Overall Study|Lack of Efficacy|2
996210|NCT00449150|3269402|P2|Overall Study|Lack of Efficacy|2
996211|NCT00449150|3269403|P1|Overall Study|Lack of Efficacy|1
996212|NCT00449150|3269401|P3|Overall Study|Adverse Event|9
996213|NCT00449150|3269402|P2|Overall Study|Adverse Event|18
996214|NCT00449150|3269403|P1|Overall Study|Adverse Event|11
996215|NCT00449072|3269416|P2|Overall Study|Relocation|2
996216|NCT00449072|3269417|P1|Overall Study|Relocation|3
996217|NCT00449072|3269416|P2|Overall Study|Sponsor decision|3
996218|NCT00449072|3269417|P1|Overall Study|Sponsor decision|1
996219|NCT00449072|3269416|P2|Overall Study|Non-compliance|5
996220|NCT00449072|3269417|P1|Overall Study|Non-compliance|2
996221|NCT00449072|3269416|P2|Overall Study|Excluded medication|2
996222|NCT00449072|3269417|P1|Overall Study|Excluded medication|0
996223|NCT00449072|3269416|P2|Overall Study|Not treated|1
996224|NCT00449072|3269417|P1|Overall Study|Not treated|0
996225|NCT00449072|3269416|P2|Overall Study|Physician Decision|0
996226|NCT00449072|3269417|P1|Overall Study|Physician Decision|1
996227|NCT00449072|3269416|P2|Overall Study|Lack of Efficacy|1
996228|NCT00449072|3269417|P1|Overall Study|Lack of Efficacy|1
996229|NCT00449072|3269416|P2|Overall Study|Withdrawal by Subject|8
996230|NCT00449072|3269417|P1|Overall Study|Withdrawal by Subject|11
996231|NCT00449072|3269416|P2|Overall Study|Lost to Follow-up|7
996232|NCT00449072|3269417|P1|Overall Study|Lost to Follow-up|5
996233|NCT00449072|3269416|P2|Overall Study|Protocol Violation|12
996234|NCT00449072|3269417|P1|Overall Study|Protocol Violation|14
996235|NCT00449072|3269416|P2|Overall Study|Adverse Event|1
996236|NCT00449072|3269417|P1|Overall Study|Adverse Event|3
996237|NCT00449033|3269454|P2|Follow-up Period|Reason Missing|113
996238|NCT00449033|3269455|P1|Follow-up Period|Reason Missing|120
996239|NCT00449033|3269454|P2|Follow-up Period|Lost to Follow-up|10
996240|NCT00449033|3269455|P1|Follow-up Period|Lost to Follow-up|6
996241|NCT00449033|3269454|P2|Follow-up Period|Death|311
996242|NCT00449033|3269455|P1|Follow-up Period|Death|299
996243|NCT00449033|3269454|P2|Treatment Period|Treatment Ongoing|4
996244|NCT00449033|3269455|P1|Treatment Period|Treatment Ongoing|6
996245|NCT00449033|3269454|P2|Treatment Period|Reason Missing|4
996246|NCT00449033|3269455|P1|Treatment Period|Reason Missing|0
996247|NCT00449033|3269454|P2|Treatment Period|Second Malignancy|1
996248|NCT00449033|3269455|P1|Treatment Period|Second Malignancy|0
996249|NCT00449033|3269454|P2|Treatment Period|Non-compliance|8
996250|NCT00449033|3269455|P1|Treatment Period|Non-compliance|7
996251|NCT00449033|3269454|P2|Treatment Period|Amended Protocol Criteria|18
996252|NCT00449033|3269455|P1|Treatment Period|Amended Protocol Criteria|22
996253|NCT00449033|3269454|P2|Treatment Period|Consent Withdrawn|20
996254|NCT00449033|3269455|P1|Treatment Period|Consent Withdrawn|36
996255|NCT00449033|3269454|P2|Treatment Period|Disease Progression|288
996256|NCT00449033|3269455|P1|Treatment Period|Disease Progression|231
996257|NCT00449033|3269454|P2|Treatment Period|Protocol Violation|7
996258|NCT00449033|3269455|P1|Treatment Period|Protocol Violation|8
996259|NCT00449033|3269454|P2|Treatment Period|Physician Decision|5
996260|NCT00449033|3269455|P1|Treatment Period|Physician Decision|4
996261|NCT00449033|3269454|P2|Treatment Period|Lost to Follow-up|2
996262|NCT00449033|3269455|P1|Treatment Period|Lost to Follow-up|0
996263|NCT00449033|3269454|P2|Treatment Period|Death|12
996264|NCT00449033|3269455|P1|Treatment Period|Death|21
996265|NCT00449033|3269454|P2|Treatment Period|Adverse Event|83
996266|NCT00449033|3269455|P1|Treatment Period|Adverse Event|117
996267|NCT00448916|3269493|P4|Overall Study|Protocol Violation|1
996268|NCT00448916|3269494|P3|Overall Study|Protocol Violation|0
996269|NCT00448916|3269495|P2|Overall Study|Protocol Violation|0
996270|NCT00448916|3269496|P1|Overall Study|Protocol Violation|0
996271|NCT00448916|3269493|P4|Overall Study|Lost to Follow-up|1
996272|NCT00448916|3269494|P3|Overall Study|Lost to Follow-up|0
996273|NCT00448916|3269495|P2|Overall Study|Lost to Follow-up|1
996274|NCT00448916|3269496|P1|Overall Study|Lost to Follow-up|0
996275|NCT00448916|3269493|P4|Overall Study|Not specified|0
996276|NCT00448916|3269494|P3|Overall Study|Not specified|0
996277|NCT00448916|3269495|P2|Overall Study|Not specified|0
996278|NCT00448916|3269496|P1|Overall Study|Not specified|1
996279|NCT00448916|3269493|P4|Overall Study|Withdrawal by Subject|1
996280|NCT00448916|3269494|P3|Overall Study|Withdrawal by Subject|1
996281|NCT00448916|3269495|P2|Overall Study|Withdrawal by Subject|3
996282|NCT00448916|3269496|P1|Overall Study|Withdrawal by Subject|3
996283|NCT00448916|3269493|P4|Overall Study|Lack of Efficacy|1
996284|NCT00448916|3269494|P3|Overall Study|Lack of Efficacy|2
996285|NCT00448916|3269495|P2|Overall Study|Lack of Efficacy|0
996286|NCT00448916|3269496|P1|Overall Study|Lack of Efficacy|1
996287|NCT00448916|3269493|P4|Overall Study|Adverse Event|2
996288|NCT00448916|3269494|P3|Overall Study|Adverse Event|3
996289|NCT00448916|3269495|P2|Overall Study|Adverse Event|2
996290|NCT00448916|3269496|P1|Overall Study|Adverse Event|2
996291|NCT00448864|3269570|P3|Overall Study|Protocol Violation|0
996292|NCT00448864|3269571|P2|Overall Study|Protocol Violation|2
996293|NCT00448864|3269572|P1|Overall Study|Protocol Violation|0
996294|NCT00448864|3269570|P3|Overall Study|Withdrawal by Subject|0
996295|NCT00448864|3269571|P2|Overall Study|Withdrawal by Subject|2
996296|NCT00448864|3269572|P1|Overall Study|Withdrawal by Subject|0
996297|NCT00448864|3269570|P3|Overall Study|Physician Decision|1
996298|NCT00448864|3269571|P2|Overall Study|Physician Decision|0
996299|NCT00448864|3269572|P1|Overall Study|Physician Decision|1
996300|NCT00448864|3269570|P3|Overall Study|Lost to Follow-up|0
996301|NCT00448864|3269571|P2|Overall Study|Lost to Follow-up|1
996302|NCT00448864|3269572|P1|Overall Study|Lost to Follow-up|3
996303|NCT00448864|3269570|P3|Overall Study|Death|0
996304|NCT00448864|3269571|P2|Overall Study|Death|0
996305|NCT00448864|3269572|P1|Overall Study|Death|1
996306|NCT00448760|3269588|P1|Overall Study|Death|3
996307|NCT00448708|3269597|P2|Overall Study|not listed|2
996308|NCT00448708|3269598|P1|Overall Study|not listed|0
996309|NCT00448708|3269597|P2|Overall Study|Lost to Follow-up|8
996310|NCT00448708|3269598|P1|Overall Study|Lost to Follow-up|6
996311|NCT00448708|3269597|P2|Overall Study|Withdrawal by Subject|4
996312|NCT00448708|3269598|P1|Overall Study|Withdrawal by Subject|8
996313|NCT00448708|3269597|P2|Overall Study|Death|17
996314|NCT00448708|3269598|P1|Overall Study|Death|21
996315|NCT00448591|3269657|P1|Overall Study|Termination of Study|70
996316|NCT00448591|3269657|P1|Overall Study|Not specified|154
996317|NCT00448591|3269657|P1|Overall Study|Treatment Regimen Completed|70
996318|NCT00448591|3269657|P1|Overall Study|Lost to Follow-up|19
996319|NCT00448591|3269657|P1|Overall Study|Protocol Violation|41
996320|NCT00448591|3269657|P1|Overall Study|Adverse Event|382
996321|NCT00448591|3269657|P1|Overall Study|Progressive Disease|1382
996322|NCT00448591|3269657|P1|Overall Study|Withdrawal by Subject|178
996323|NCT00448539|3269668|P2|Overall Study|Lost to Follow-up|3
996324|NCT00448539|3269669|P1|Overall Study|Lost to Follow-up|1
996325|NCT00448539|3269668|P2|Overall Study|Change of meds|3
996326|NCT00448539|3269669|P1|Overall Study|Change of meds|2
996327|NCT00448539|3269668|P2|Overall Study|Miscellaneous|1
996328|NCT00448539|3269669|P1|Overall Study|Miscellaneous|2
996329|NCT00448539|3269668|P2|Overall Study|Lack of Efficacy|40
996330|NCT00448539|3269669|P1|Overall Study|Lack of Efficacy|27
996331|NCT00448539|3269668|P2|Overall Study|Adverse Event|26
996332|NCT00448539|3269669|P1|Overall Study|Adverse Event|9
996333|NCT00448539|3269668|P2|Overall Study|Diary non-compliance|0
996334|NCT00448539|3269669|P1|Overall Study|Diary non-compliance|1
996335|NCT00448539|3269668|P2|Overall Study|Withdrawal by Subject|24
996336|NCT00448539|3269669|P1|Overall Study|Withdrawal by Subject|20
996337|NCT00448539|3269668|P2|Overall Study|Request of the investigator or sponsor|54
996338|NCT00448539|3269669|P1|Overall Study|Request of the investigator or sponsor|67
996339|NCT00448539|3269668|P2|Overall Study|Protocol Violation|0
996340|NCT00448539|3269669|P1|Overall Study|Protocol Violation|1
996341|NCT00448539|3269668|P2|Overall Study|Medication non-compliance|1
996342|NCT00448539|3269669|P1|Overall Study|Medication non-compliance|4
996343|NCT00448448|3269677|P2|Overall Study|Signed consent lost|1
996344|NCT00448448|3269678|P1|Overall Study|Signed consent lost|0
996345|NCT00448448|3269677|P2|Overall Study|Wrong diagnosis (n=3) or other|1
996346|NCT00448448|3269678|P1|Overall Study|Wrong diagnosis (n=3) or other|2
996347|NCT00448448|3269677|P2|Overall Study|Lost to Follow-up|1
996348|NCT00448448|3269678|P1|Overall Study|Lost to Follow-up|2
996349|NCT00448448|3269677|P2|Overall Study|On protocol when study ended|36
996350|NCT00448448|3269678|P1|Overall Study|On protocol when study ended|83
996351|NCT00448448|3269677|P2|Overall Study|Withdrawal by Subject|2
996352|NCT00448448|3269678|P1|Overall Study|Withdrawal by Subject|13
996353|NCT00448435|3269684|P2|Washout Period - 2 Weeks|Withdrawal by Subject|0
996354|NCT00448435|3269685|P1|Washout Period - 2 Weeks|Withdrawal by Subject|1
996355|NCT00448344|3269736|P2|Overall Study|Physician Decision|2
996356|NCT00448344|3269737|P1|Overall Study|Physician Decision|1
996357|NCT00448344|3269736|P2|Overall Study|Death|4
996358|NCT00448344|3269737|P1|Overall Study|Death|3
996359|NCT00448344|3269736|P2|Overall Study|Withdrawal by Subject|8
996360|NCT00448344|3269737|P1|Overall Study|Withdrawal by Subject|6
996361|NCT00448344|3269736|P2|Overall Study|Lost to Follow-up|22
996362|NCT00448344|3269737|P1|Overall Study|Lost to Follow-up|20
996363|NCT00448279|3269747|P2|Overall Study|Protocol Violation|1
996364|NCT00448279|3269748|P1|Overall Study|Protocol Violation|0
996365|NCT00448279|3269747|P2|Overall Study|Not specified|4
996366|NCT00448279|3269748|P1|Overall Study|Not specified|6
996367|NCT00448279|3269747|P2|Overall Study|Withdrawal by Subject|3
996368|NCT00448279|3269748|P1|Overall Study|Withdrawal by Subject|4
996369|NCT00448279|3269747|P2|Overall Study|Disease progression|18
996370|NCT00448279|3269748|P1|Overall Study|Disease progression|16
996371|NCT00448279|3269747|P2|Overall Study|Adverse Event|1
996372|NCT00448279|3269748|P1|Overall Study|Adverse Event|1
996373|NCT00448279|3269747|P2|Overall Study|Lost to Follow-up|2
996374|NCT00448279|3269748|P1|Overall Study|Lost to Follow-up|2
996375|NCT00448136|3269811|P2|Overall Study|Investigator's decision (progression)|0
996376|NCT00448136|3269812|P1|Overall Study|Investigator's decision (progression)|1
996377|NCT00448136|3269811|P2|Overall Study|Death|8
996378|NCT00448136|3269812|P1|Overall Study|Death|3
996379|NCT00448123|3269850|P2|Overall Study|Physician Decision|6
996380|NCT00448123|3269851|P1|Overall Study|Physician Decision|6
996381|NCT00448123|3269850|P2|Overall Study|Lost to Follow-up|6
996382|NCT00448123|3269851|P1|Overall Study|Lost to Follow-up|9
996383|NCT00448019|3269861|P1|Overall Study|Insurance Issues|1
996384|NCT00448019|3269861|P1|Overall Study|Death|2
996385|NCT00448019|3269861|P1|Overall Study|Disease progression|1
996386|NCT00448019|3269861|P1|Overall Study|Withdrawal by Subject|3
996387|NCT00447902|3269869|P2|Overall Study|Lack of Efficacy|1
996388|NCT00447902|3269870|P1|Overall Study|Lack of Efficacy|2
996389|NCT00447902|3269869|P2|Overall Study|included patients who discontinued|1
996390|NCT00447902|3269870|P1|Overall Study|included patients who discontinued|1
996391|NCT00447902|3269869|P2|Overall Study|Withdrawal by Subject|1
996392|NCT00447902|3269870|P1|Overall Study|Withdrawal by Subject|0
996393|NCT00447902|3269869|P2|Overall Study|Protocol Violation|0
996394|NCT00447902|3269870|P1|Overall Study|Protocol Violation|1
996395|NCT00447902|3269869|P2|Overall Study|Adverse Event|3
996396|NCT00447902|3269870|P1|Overall Study|Adverse Event|0
996397|NCT00447876|3269912|P2|Overall Study|Deterioration of symptomology|0
996398|NCT00447876|3269913|P1|Overall Study|Deterioration of symptomology|1
996399|NCT00447876|3269912|P2|Overall Study|Lost to Follow-up|0
996400|NCT00447876|3269913|P1|Overall Study|Lost to Follow-up|1
996401|NCT00447876|3269912|P2|Overall Study|Withdrawal by Subject|4
996402|NCT00447876|3269913|P1|Overall Study|Withdrawal by Subject|1
996403|NCT00447772|3269943|P1|Overall Study|Premature re-injection required|1
996404|NCT00447772|3269943|P1|Overall Study|Chemotherapy for lung cancer|1
996405|NCT00447772|3269943|P1|Overall Study|Incomplete documentation at visit 1|1
996406|NCT00447772|3269943|P1|Overall Study|Patient relocated|1
996407|NCT00447772|3269943|P1|Overall Study|Adverse Event|1
996408|NCT00447772|3269943|P1|Overall Study|Unable to attend all study visits|2
996409|NCT00447772|3269943|P1|Overall Study|Withdrawal by Subject|1
996410|NCT00447772|3269943|P1|Overall Study|Lost to Follow-up|9
996411|NCT00447772|3269943|P1|Overall Study|Discontinuation of drug therapy|1
996412|NCT00447772|3269943|P1|Overall Study|Insufficient compliance|6
996413|NCT00447772|3269943|P1|Overall Study|Lack of Efficacy|3
996414|NCT00447603|3269963|P3|Filter Period|Study terminated by Sponsor|10
996415|NCT00447603|3269964|P2|Filter Period|Study terminated by Sponsor|1
996416|NCT00447603|3269965|P1|Filter Period|Study terminated by Sponsor|0
996417|NCT00447603|3269963|P3|Filter Period|Screen Failure|4
996418|NCT00447603|3269964|P2|Filter Period|Screen Failure|3
996419|NCT00447603|3269965|P1|Filter Period|Screen Failure|0
996420|NCT00447603|3269963|P3|Filter Period|Adverse Event|1
996421|NCT00447603|3269964|P2|Filter Period|Adverse Event|0
996422|NCT00447603|3269965|P1|Filter Period|Adverse Event|0
996423|NCT00447603|3269963|P3|Screening|Study Terminated by Sponsor|0
996424|NCT00447603|3269964|P2|Screening|Study Terminated by Sponsor|0
996425|NCT00447603|3269965|P1|Screening|Study Terminated by Sponsor|15
996426|NCT00447603|3269963|P3|Screening|Screen Failure|0
996427|NCT00447603|3269964|P2|Screening|Screen Failure|0
996428|NCT00447603|3269965|P1|Screening|Screen Failure|4
996429|NCT00447603|3269963|P3|Screening|Protocol Violation|0
996430|NCT00447603|3269964|P2|Screening|Protocol Violation|0
996431|NCT00447603|3269965|P1|Screening|Protocol Violation|1
996432|NCT00447603|3269963|P3|Screening|Withdrawal by Subject|0
996433|NCT00447603|3269964|P2|Screening|Withdrawal by Subject|0
996434|NCT00447603|3269965|P1|Screening|Withdrawal by Subject|1
996435|NCT00447590|3269985|P1|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10
996436|NCT00447590|3269985|P1|Overall Study|Lost to Follow-up|24
996437|NCT00447590|3269985|P1|Overall Study|Withdrawal by Subject|26
996438|NCT00447499|3269994|P1|Overall Study|Physician Decision|1
996439|NCT00447499|3269994|P1|Overall Study|Sponsor Decision|1
996440|NCT00447499|3269994|P1|Overall Study|Patient Decision|4
996441|NCT00447499|3269994|P1|Overall Study|Adverse Event|1
996442|NCT00447421|3270004|P1|Overall Study|Sponsor Decision|2
996443|NCT00447421|3270004|P1|Overall Study|Adverse Event|3
996444|NCT00447421|3270004|P1|Overall Study|Lack of Efficacy|1
996445|NCT00447382|3270016|P2|Overall Study|Unclassified|5
996446|NCT00447382|3270017|P1|Overall Study|Unclassified|2
996447|NCT00447382|3270016|P2|Overall Study|Protocol Violation|0
996448|NCT00447382|3270017|P1|Overall Study|Protocol Violation|2
996449|NCT00447382|3270016|P2|Overall Study|Lack of Efficacy|0
996450|NCT00447382|3270017|P1|Overall Study|Lack of Efficacy|1
996451|NCT00447382|3270016|P2|Overall Study|Adverse Event|1
996452|NCT00447382|3270017|P1|Overall Study|Adverse Event|1
996453|NCT00447278|3270078|P2|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8
996454|NCT00447278|3270079|P1|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11
996455|NCT00447278|3270078|P2|Period III (Optional 6 Month Extension)|Lack of Efficacy|0
996456|NCT00447278|3270079|P1|Period III (Optional 6 Month Extension)|Lack of Efficacy|4
996457|NCT00447278|3270078|P2|Period III (Optional 6 Month Extension)|Physician Decision|1
996458|NCT00447278|3270079|P1|Period III (Optional 6 Month Extension)|Physician Decision|1
996459|NCT00447278|3270078|P2|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1
996460|NCT00447278|3270079|P1|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4
996461|NCT00447278|3270078|P2|Period III (Optional 6 Month Extension)|Protocol Violation|1
996462|NCT00447278|3270079|P1|Period III (Optional 6 Month Extension)|Protocol Violation|6
996463|NCT00447278|3270078|P2|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
996464|NCT00447278|3270079|P1|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
996465|NCT00447278|3270078|P2|Period III (Optional 6 Month Extension)|Adverse Event|2
996466|NCT00447278|3270079|P1|Period III (Optional 6 Month Extension)|Adverse Event|2
996467|NCT00447278|3270078|P2|Period II (6 Month Open-Label)|Parent/Guardian Decision|10
996468|NCT00447278|3270079|P1|Period II (6 Month Open-Label)|Parent/Guardian Decision|9
996469|NCT00447278|3270078|P2|Period II (6 Month Open-Label)|Lack of Efficacy|1
996470|NCT00447278|3270079|P1|Period II (6 Month Open-Label)|Lack of Efficacy|11
996471|NCT00447278|3270078|P2|Period II (6 Month Open-Label)|Physician Decision|1
996472|NCT00447278|3270079|P1|Period II (6 Month Open-Label)|Physician Decision|4
996473|NCT00447278|3270078|P2|Period II (6 Month Open-Label)|Withdrawal by Subject|3
996474|NCT00447278|3270079|P1|Period II (6 Month Open-Label)|Withdrawal by Subject|1
996475|NCT00447278|3270078|P2|Period II (6 Month Open-Label)|Protocol Violation|7
996476|NCT00447278|3270079|P1|Period II (6 Month Open-Label)|Protocol Violation|10
996477|NCT00447278|3270078|P2|Period II (6 Month Open-Label)|Lost to Follow-up|4
996478|NCT00447278|3270079|P1|Period II (6 Month Open-Label)|Lost to Follow-up|0
996479|NCT00447278|3270078|P2|Period II (6 Month Open-Label)|Adverse Event|3
996480|NCT00447278|3270079|P1|Period II (6 Month Open-Label)|Adverse Event|7
996481|NCT00447265|3270100|P2|Overall Study|Physician Decision|0
996482|NCT00447265|3270101|P1|Overall Study|Physician Decision|1
996483|NCT00447226|3270114|P2|Double-blind Phase|Disease Progression|3
996484|NCT00447226|3270115|P1|Double-blind Phase|Disease Progression|4
996485|NCT00447226|3270114|P2|12-Week Open-label Phase|Physician Decision|1
996486|NCT00447226|3270115|P1|12-Week Open-label Phase|Physician Decision|0
996487|NCT00447226|3270114|P2|12-Week Open-label Phase|Disease Progression|20
996488|NCT00447226|3270115|P1|12-Week Open-label Phase|Disease Progression|0
996489|NCT00447226|3270114|P2|12-Week Open-label Phase|Protocol Violation|1
996490|NCT00447226|3270115|P1|12-Week Open-label Phase|Protocol Violation|0
996491|NCT00447226|3270114|P2|12-Week Open-label Phase|Adverse Event|3
996492|NCT00447226|3270115|P1|12-Week Open-label Phase|Adverse Event|0
996493|NCT00447057|3270158|P4|Overall Study|Death, study drug related|0
996494|NCT00447057|3270159|P3|Overall Study|Death, study drug related|0
996495|NCT00447057|3270160|P2|Overall Study|Death, study drug related|1
996496|NCT00447057|3270161|P1|Overall Study|Death, study drug related|0
996497|NCT00447057|3270158|P4|Overall Study|Death due to adverse event|2
996498|NCT00447057|3270159|P3|Overall Study|Death due to adverse event|1
996499|NCT00447057|3270160|P2|Overall Study|Death due to adverse event|0
996500|NCT00447057|3270161|P1|Overall Study|Death due to adverse event|0
996501|NCT00447057|3270158|P4|Overall Study|Progressive disease|18
996502|NCT00447057|3270159|P3|Overall Study|Progressive disease|13
996503|NCT00447057|3270160|P2|Overall Study|Progressive disease|43
996504|NCT00447057|3270161|P1|Overall Study|Progressive disease|58
996505|NCT00447057|3270158|P4|Overall Study|Sponsor decision|0
996506|NCT00447057|3270159|P3|Overall Study|Sponsor decision|0
996507|NCT00447057|3270160|P2|Overall Study|Sponsor decision|1
996508|NCT00447057|3270161|P1|Overall Study|Sponsor decision|1
996509|NCT00447057|3270158|P4|Overall Study|Physician Decision|1
996510|NCT00447057|3270159|P3|Overall Study|Physician Decision|3
996511|NCT00447057|3270160|P2|Overall Study|Physician Decision|6
996512|NCT00447057|3270161|P1|Overall Study|Physician Decision|9
996513|NCT00447057|3270158|P4|Overall Study|Withdrawal by Subject|1
996514|NCT00447057|3270159|P3|Overall Study|Withdrawal by Subject|1
996515|NCT00447057|3270160|P2|Overall Study|Withdrawal by Subject|5
996516|NCT00447057|3270161|P1|Overall Study|Withdrawal by Subject|4
996517|NCT00447057|3270158|P4|Overall Study|Protocol Violation|0
996518|NCT00447057|3270159|P3|Overall Study|Protocol Violation|0
996519|NCT00447057|3270160|P2|Overall Study|Protocol Violation|1
996520|NCT00447057|3270161|P1|Overall Study|Protocol Violation|0
996521|NCT00447057|3270158|P4|Overall Study|Entry criteria not met|0
996522|NCT00447057|3270159|P3|Overall Study|Entry criteria not met|0
996523|NCT00447057|3270160|P2|Overall Study|Entry criteria not met|1
996524|NCT00447057|3270161|P1|Overall Study|Entry criteria not met|1
996525|NCT00447057|3270158|P4|Overall Study|Lost to Follow-up|0
996526|NCT00447057|3270159|P3|Overall Study|Lost to Follow-up|0
996527|NCT00447057|3270160|P2|Overall Study|Lost to Follow-up|1
996528|NCT00447057|3270161|P1|Overall Study|Lost to Follow-up|0
996529|NCT00447057|3270158|P4|Overall Study|Death due to study disease|1
996530|NCT00447057|3270159|P3|Overall Study|Death due to study disease|1
996531|NCT00447057|3270160|P2|Overall Study|Death due to study disease|4
996532|NCT00447057|3270161|P1|Overall Study|Death due to study disease|6
996533|NCT00447057|3270158|P4|Overall Study|Adverse Event|3
996534|NCT00447057|3270159|P3|Overall Study|Adverse Event|0
996535|NCT00447057|3270160|P2|Overall Study|Adverse Event|10
996536|NCT00447057|3270161|P1|Overall Study|Adverse Event|4
996537|NCT00447005|3270179|P1|Overall Study|Lack of Efficacy|11
996538|NCT00447005|3270179|P1|Overall Study|Adverse Event|1
996539|NCT00446992|3270193|P1|Overall Study|Lost to Follow-up|5
996540|NCT00446992|3270193|P1|Overall Study|Adverse Event|11
996541|NCT00446966|3270207|P2|Overall Study|Lost to Follow-up|7
996542|NCT00446966|3270208|P1|Overall Study|Lost to Follow-up|10
996543|NCT00446849|3270214|P1|Maintenance Phase|concomitant medication use|1
996544|NCT00446849|3270214|P1|Maintenance Phase|hydrocodone use|1
996545|NCT00446849|3270214|P1|Maintenance Phase|study closure|1
996546|NCT00446849|3270214|P1|Maintenance Phase|antibiotic use|1
996547|NCT00446849|3270214|P1|Maintenance Phase|prohibited medication use|2
996548|NCT00446849|3270214|P1|Maintenance Phase|noncompliance|2
996549|NCT00446849|3270214|P1|Maintenance Phase|Pregnancy|1
996550|NCT00446849|3270214|P1|Maintenance Phase|Lost to Follow-up|3
996551|NCT00446849|3270214|P1|Maintenance Phase|Consent withdrawn|5
996552|NCT00446849|3270214|P1|Maintenance Phase|Adverse Event|6
996553|NCT00446849|3270214|P1|Maintenance Phase|Protocol Violation|7
996554|NCT00446849|3270214|P1|Maintenance Phase|Lack of Efficacy|40
996555|NCT00446849|3270214|P1|Acute Phase|noncompliance|1
996556|NCT00446849|3270214|P1|Acute Phase|Physician Decision|1
996557|NCT00446849|3270214|P1|Acute Phase|Lost to Follow-up|2
996558|NCT00446849|3270214|P1|Acute Phase|Consent withdrawn|4
996559|NCT00446849|3270214|P1|Acute Phase|Protocol Violation|10
996560|NCT00446849|3270214|P1|Acute Phase|Lack of Efficacy|64
996561|NCT00446797|3270226|P2|Overall Study|did not meet entrance criteria|1
996562|NCT00446797|3270227|P1|Overall Study|did not meet entrance criteria|0
996563|NCT00446797|3270226|P2|Overall Study|subject entered at another site|1
996564|NCT00446797|3270227|P1|Overall Study|subject entered at another site|0
996565|NCT00446797|3270226|P2|Overall Study|Protocol Violation|3
996566|NCT00446797|3270227|P1|Overall Study|Protocol Violation|1
996567|NCT00446797|3270226|P2|Overall Study|Withdrawal by Subject|2
996568|NCT00446797|3270227|P1|Overall Study|Withdrawal by Subject|2
996569|NCT00446797|3270226|P2|Overall Study|Lost to Follow-up|3
996570|NCT00446797|3270227|P1|Overall Study|Lost to Follow-up|5
996571|NCT00446797|3270226|P2|Overall Study|Lack of Efficacy|2
996572|NCT00446797|3270227|P1|Overall Study|Lack of Efficacy|0
996573|NCT00446654|3270273|P2|Overall Study|Adverse Event|0
996574|NCT00446654|3270274|P1|Overall Study|Adverse Event|1
996575|NCT00446654|3270273|P2|Overall Study|Withdrawal by Subject|0
996576|NCT00446654|3270274|P1|Overall Study|Withdrawal by Subject|1
996577|NCT00446641|3270282|P2|Overall Study|Lost to Follow-up|1
996578|NCT00446641|3270283|P1|Overall Study|Lost to Follow-up|1
996579|NCT00446641|3270282|P2|Overall Study|poor compliance|6
996580|NCT00446641|3270283|P1|Overall Study|poor compliance|8
996581|NCT00446641|3270282|P2|Overall Study|Withdrawal by Subject|3
996582|NCT00446641|3270283|P1|Overall Study|Withdrawal by Subject|8
996583|NCT00446563|3270303|P2|Overall Study|Administrative problems|1
996584|NCT00446563|3270304|P1|Overall Study|Administrative problems|0
996585|NCT00446563|3270303|P2|Overall Study|Withdrawal by Subject|1
996586|NCT00446563|3270304|P1|Overall Study|Withdrawal by Subject|2
996587|NCT00446563|3270303|P2|Overall Study|Unsatisfactory therapeutic effect|3
996588|NCT00446563|3270304|P1|Overall Study|Unsatisfactory therapeutic effect|0
996589|NCT00446563|3270303|P2|Overall Study|Abnormal test procedure result(s)|0
996590|NCT00446563|3270304|P1|Overall Study|Abnormal test procedure result(s)|1
996591|NCT00446563|3270303|P2|Overall Study|Abnormal laboratory value(s)|1
996592|NCT00446563|3270304|P1|Overall Study|Abnormal laboratory value(s)|0
996593|NCT00446563|3270303|P2|Overall Study|Adverse Event|3
996594|NCT00446563|3270304|P1|Overall Study|Adverse Event|4
996595|NCT00446550|3270340|P2|Overall Study|Adverse Event|0
996596|NCT00446550|3270341|P1|Overall Study|Adverse Event|1
996597|NCT00446511|3270353|P4|Overall Study|Administrative Problems|1
996598|NCT00446511|3270354|P3|Overall Study|Administrative Problems|4
996599|NCT00446511|3270355|P2|Overall Study|Administrative Problems|0
996600|NCT00446511|3270356|P1|Overall Study|Administrative Problems|3
996601|NCT00446511|3270353|P4|Overall Study|Withdrawal by Subject|3
996602|NCT00446511|3270354|P3|Overall Study|Withdrawal by Subject|0
996603|NCT00446511|3270355|P2|Overall Study|Withdrawal by Subject|0
996604|NCT00446511|3270356|P1|Overall Study|Withdrawal by Subject|0
996605|NCT00446511|3270353|P4|Overall Study|Protocol Violation|1
996606|NCT00446511|3270354|P3|Overall Study|Protocol Violation|0
996607|NCT00446511|3270355|P2|Overall Study|Protocol Violation|0
996608|NCT00446511|3270356|P1|Overall Study|Protocol Violation|0
996609|NCT00446511|3270353|P4|Overall Study|Adverse Event|1
996610|NCT00446511|3270354|P3|Overall Study|Adverse Event|3
996611|NCT00446511|3270355|P2|Overall Study|Adverse Event|2
996612|NCT00446511|3270356|P1|Overall Study|Adverse Event|7
996613|NCT00446459|3270380|P1|12 Months|14 subjects to MMF + Rituximab Study|14
996614|NCT00446459|3270380|P1|12 Months|Protocol Violation|4
996615|NCT00446459|3270380|P1|8 Months|Protocol Violation|12
996616|NCT00446446|3270388|P1|Overall Study|On Treatment at Time of Data Cut-off|1
996617|NCT00446446|3270388|P1|Overall Study|Adverse Event|1
996618|NCT00446446|3270388|P1|Overall Study|Disease Progession|2
996619|NCT00446446|3270388|P1|Overall Study|Other|4
996620|NCT00446446|3270388|P1|Overall Study|Withdrawal by Subject|6
996621|NCT00446446|3270388|P1|Overall Study|Death|10
996622|NCT00446251|3270412|P1|Overall Study|Lost to Follow-up|1
996623|NCT00446251|3270412|P1|Overall Study|Rituximab Infusion Reaction|2
996624|NCT00446251|3270412|P1|Overall Study|On-study Transplants|2
996625|NCT00446199|3270422|P4|Overall Study|Move|0
996626|NCT00446199|3270423|P3|Overall Study|Move|0
996627|NCT00446199|3270424|P2|Overall Study|Move|1
996628|NCT00446199|3270425|P1|Overall Study|Move|0
996629|NCT00446199|3270422|P4|Overall Study|In-/Exclusion criterion violated|1
996630|NCT00446199|3270423|P3|Overall Study|In-/Exclusion criterion violated|2
996631|NCT00446199|3270424|P2|Overall Study|In-/Exclusion criterion violated|1
996632|NCT00446199|3270425|P1|Overall Study|In-/Exclusion criterion violated|2
996633|NCT00446199|3270422|P4|Overall Study|Lost interest in study participation|0
996634|NCT00446199|3270423|P3|Overall Study|Lost interest in study participation|0
996635|NCT00446199|3270424|P2|Overall Study|Lost interest in study participation|1
996636|NCT00446199|3270425|P1|Overall Study|Lost interest in study participation|0
996637|NCT00446199|3270422|P4|Overall Study|Hormone fear|1
996638|NCT00446199|3270423|P3|Overall Study|Hormone fear|0
996639|NCT00446199|3270424|P2|Overall Study|Hormone fear|0
996640|NCT00446199|3270425|P1|Overall Study|Hormone fear|0
996641|NCT00446199|3270422|P4|Overall Study|Non-compliant with visit schedule|2
996642|NCT00446199|3270423|P3|Overall Study|Non-compliant with visit schedule|1
996643|NCT00446199|3270424|P2|Overall Study|Non-compliant with visit schedule|1
996644|NCT00446199|3270425|P1|Overall Study|Non-compliant with visit schedule|1
996645|NCT00446199|3270422|P4|Overall Study|Non-compliant with study drug|0
996646|NCT00446199|3270423|P3|Overall Study|Non-compliant with study drug|5
996647|NCT00446199|3270424|P2|Overall Study|Non-compliant with study drug|0
996648|NCT00446199|3270425|P1|Overall Study|Non-compliant with study drug|1
996649|NCT00446199|3270422|P4|Overall Study|Lack of Efficacy|1
996650|NCT00446199|3270423|P3|Overall Study|Lack of Efficacy|0
996651|NCT00446199|3270424|P2|Overall Study|Lack of Efficacy|0
996652|NCT00446199|3270425|P1|Overall Study|Lack of Efficacy|1
996653|NCT00446199|3270422|P4|Overall Study|Randomization in Error|1
996654|NCT00446199|3270423|P3|Overall Study|Randomization in Error|1
996655|NCT00446199|3270424|P2|Overall Study|Randomization in Error|0
996656|NCT00446199|3270425|P1|Overall Study|Randomization in Error|2
996657|NCT00446199|3270422|P4|Overall Study|Site termination|1
996658|NCT00446199|3270423|P3|Overall Study|Site termination|0
996659|NCT00446199|3270424|P2|Overall Study|Site termination|0
996660|NCT00446199|3270425|P1|Overall Study|Site termination|2
996661|NCT00446199|3270422|P4|Overall Study|Withdrawal by Subject|10
996662|NCT00446199|3270423|P3|Overall Study|Withdrawal by Subject|9
996663|NCT00446199|3270424|P2|Overall Study|Withdrawal by Subject|5
996664|NCT00446199|3270425|P1|Overall Study|Withdrawal by Subject|2
996665|NCT00446199|3270422|P4|Overall Study|Protocol Violation|3
996666|NCT00446199|3270423|P3|Overall Study|Protocol Violation|1
996667|NCT00446199|3270424|P2|Overall Study|Protocol Violation|2
996668|NCT00446199|3270425|P1|Overall Study|Protocol Violation|1
996669|NCT00446199|3270422|P4|Overall Study|Lost to Follow-up|6
996670|NCT00446199|3270423|P3|Overall Study|Lost to Follow-up|2
996671|NCT00446199|3270424|P2|Overall Study|Lost to Follow-up|5
996672|NCT00446199|3270425|P1|Overall Study|Lost to Follow-up|4
996673|NCT00446199|3270422|P4|Overall Study|Adverse Event|4
996674|NCT00446199|3270423|P3|Overall Study|Adverse Event|6
996675|NCT00446199|3270424|P2|Overall Study|Adverse Event|4
996676|NCT00446199|3270425|P1|Overall Study|Adverse Event|7
996677|NCT00446134|3270518|P4|Overall Study|Reason Not Completed|2
996678|NCT00446134|3270519|P3|Overall Study|Reason Not Completed|1
996679|NCT00446134|3270520|P2|Overall Study|Reason Not Completed|0
996680|NCT00446134|3270521|P1|Overall Study|Reason Not Completed|3
996681|NCT00446134|3270518|P4|Overall Study|Adverse Event-Diarrhea|0
996682|NCT00446134|3270519|P3|Overall Study|Adverse Event-Diarrhea|2
996683|NCT00446134|3270520|P2|Overall Study|Adverse Event-Diarrhea|1
996684|NCT00446134|3270521|P1|Overall Study|Adverse Event-Diarrhea|1
996685|NCT00446134|3270518|P4|Overall Study|Physician Decision|2
996686|NCT00446134|3270519|P3|Overall Study|Physician Decision|0
996687|NCT00446134|3270520|P2|Overall Study|Physician Decision|0
996688|NCT00446134|3270521|P1|Overall Study|Physician Decision|0
996689|NCT00446134|3270518|P4|Overall Study|Withdrawal by Subject|3
996690|NCT00446134|3270519|P3|Overall Study|Withdrawal by Subject|1
996691|NCT00446134|3270520|P2|Overall Study|Withdrawal by Subject|3
996692|NCT00446134|3270521|P1|Overall Study|Withdrawal by Subject|3
996693|NCT00446134|3270518|P4|Overall Study|Lost to Follow-up|1
996694|NCT00446134|3270519|P3|Overall Study|Lost to Follow-up|1
996695|NCT00446134|3270520|P2|Overall Study|Lost to Follow-up|3
996696|NCT00446134|3270521|P1|Overall Study|Lost to Follow-up|1
996697|NCT00446134|3270518|P4|Overall Study|Protocol Violation|0
996698|NCT00446134|3270519|P3|Overall Study|Protocol Violation|1
996699|NCT00446134|3270520|P2|Overall Study|Protocol Violation|2
996700|NCT00446134|3270521|P1|Overall Study|Protocol Violation|0
996701|NCT00446134|3270518|P4|Overall Study|Lack of Efficacy|19
996702|NCT00446134|3270519|P3|Overall Study|Lack of Efficacy|24
996703|NCT00446134|3270520|P2|Overall Study|Lack of Efficacy|19
996704|NCT00446134|3270521|P1|Overall Study|Lack of Efficacy|19
996705|NCT00446134|3270518|P4|Overall Study|Adverse Event|18
996706|NCT00446134|3270519|P3|Overall Study|Adverse Event|13
996707|NCT00446134|3270520|P2|Overall Study|Adverse Event|17
996708|NCT00446134|3270521|P1|Overall Study|Adverse Event|7
996709|NCT00446095|3270548|P5|Phase I (28 Days)|Lack of Efficacy|3
996710|NCT00446095|3270549|P4|Phase I (28 Days)|Lack of Efficacy|0
996711|NCT00446095|3270550|P3|Phase I (28 Days)|Lack of Efficacy|0
996712|NCT00446095|3270551|P2|Phase I (28 Days)|Lack of Efficacy|0
996713|NCT00446095|3270552|P1|Phase I (28 Days)|Lack of Efficacy|0
996714|NCT00446095|3270548|P5|Phase I (28 Days)|Adverse Event|0
996715|NCT00446095|3270549|P4|Phase I (28 Days)|Adverse Event|1
996716|NCT00446095|3270550|P3|Phase I (28 Days)|Adverse Event|0
996717|NCT00446095|3270551|P2|Phase I (28 Days)|Adverse Event|0
996718|NCT00446095|3270552|P1|Phase I (28 Days)|Adverse Event|0
996719|NCT00446095|3270548|P5|Phase II (8 Weeks)|Ongoing|0
996720|NCT00446095|3270549|P4|Phase II (8 Weeks)|Ongoing|0
996721|NCT00446095|3270550|P3|Phase II (8 Weeks)|Ongoing|1
996722|NCT00446095|3270551|P2|Phase II (8 Weeks)|Ongoing|0
996723|NCT00446095|3270552|P1|Phase II (8 Weeks)|Ongoing|0
996724|NCT00446095|3270548|P5|Phase II (8 Weeks)|Lack of Efficacy|0
996725|NCT00446095|3270549|P4|Phase II (8 Weeks)|Lack of Efficacy|0
996726|NCT00446095|3270550|P3|Phase II (8 Weeks)|Lack of Efficacy|1
996727|NCT00446095|3270551|P2|Phase II (8 Weeks)|Lack of Efficacy|2
996728|NCT00446095|3270552|P1|Phase II (8 Weeks)|Lack of Efficacy|9
996729|NCT00446095|3270548|P5|Phase II (8 Weeks)|Physician Decision|0
996730|NCT00446095|3270549|P4|Phase II (8 Weeks)|Physician Decision|0
996731|NCT00446095|3270550|P3|Phase II (8 Weeks)|Physician Decision|0
996732|NCT00446095|3270551|P2|Phase II (8 Weeks)|Physician Decision|0
996733|NCT00446095|3270552|P1|Phase II (8 Weeks)|Physician Decision|1
996734|NCT00446095|3270548|P5|Phase II (8 Weeks)|Withdrawal by Subject|0
996735|NCT00446095|3270549|P4|Phase II (8 Weeks)|Withdrawal by Subject|0
996736|NCT00446095|3270550|P3|Phase II (8 Weeks)|Withdrawal by Subject|0
996737|NCT00446095|3270551|P2|Phase II (8 Weeks)|Withdrawal by Subject|0
996738|NCT00446095|3270552|P1|Phase II (8 Weeks)|Withdrawal by Subject|1
996739|NCT00446095|3270548|P5|Phase II (8 Weeks)|Adverse Event|0
996740|NCT00446095|3270549|P4|Phase II (8 Weeks)|Adverse Event|0
996741|NCT00446095|3270550|P3|Phase II (8 Weeks)|Adverse Event|1
996742|NCT00446095|3270551|P2|Phase II (8 Weeks)|Adverse Event|1
996743|NCT00446095|3270552|P1|Phase II (8 Weeks)|Adverse Event|0
996744|NCT00446095|3270548|P5|Phase II (8 Weeks)|Lost to Follow-up|0
996745|NCT00446095|3270549|P4|Phase II (8 Weeks)|Lost to Follow-up|0
996746|NCT00446095|3270550|P3|Phase II (8 Weeks)|Lost to Follow-up|0
996747|NCT00446095|3270551|P2|Phase II (8 Weeks)|Lost to Follow-up|0
996748|NCT00446095|3270552|P1|Phase II (8 Weeks)|Lost to Follow-up|1
996749|NCT00446030|3270575|P2|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1
996750|NCT00446030|3270576|P1|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0
996751|NCT00446030|3270575|P2|FOLLOW-UP (up to 2-years)|Right axilla wound|0
996752|NCT00446030|3270576|P1|FOLLOW-UP (up to 2-years)|Right axilla wound|1
996753|NCT00446030|3270575|P2|FOLLOW-UP (up to 2-years)|Patient concern|0
996754|NCT00446030|3270576|P1|FOLLOW-UP (up to 2-years)|Patient concern|1
996755|NCT00446030|3270575|P2|FOLLOW-UP (up to 2-years)|Protocol Violation|0
996756|NCT00446030|3270576|P1|FOLLOW-UP (up to 2-years)|Protocol Violation|1
996757|NCT00446030|3270575|P2|FOLLOW-UP (up to 2-years)|Per physician discretion|0
996758|NCT00446030|3270576|P1|FOLLOW-UP (up to 2-years)|Per physician discretion|2
996759|NCT00446030|3270575|P2|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0
996760|NCT00446030|3270576|P1|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2
996761|NCT00446030|3270575|P2|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2
996762|NCT00446030|3270576|P1|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3
996763|NCT00446030|3270575|P2|FOLLOW-UP (up to 2-years)|Death|2
996764|NCT00446030|3270576|P1|FOLLOW-UP (up to 2-years)|Death|2
996765|NCT00446030|3270575|P2|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0
996766|NCT00446030|3270576|P1|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4
996767|NCT00446030|3270575|P2|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0
996768|NCT00446030|3270576|P1|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5
996769|NCT00446030|3270575|P2|FOLLOW-UP (up to 2-years)|Subject's request|4
996770|NCT00446030|3270576|P1|FOLLOW-UP (up to 2-years)|Subject's request|9
996771|NCT00446030|3270575|P2|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0
996772|NCT00446030|3270576|P1|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1
996773|NCT00446030|3270575|P2|TREATMENT (up to 52 Weeks)|Patient concern|0
996774|NCT00446030|3270576|P1|TREATMENT (up to 52 Weeks)|Patient concern|1
996775|NCT00446030|3270575|P2|TREATMENT (up to 52 Weeks)|Physician Decision|0
996776|NCT00446030|3270576|P1|TREATMENT (up to 52 Weeks)|Physician Decision|1
996777|NCT00446030|3270575|P2|TREATMENT (up to 52 Weeks)|Protocol Violation|0
996778|NCT00446030|3270576|P1|TREATMENT (up to 52 Weeks)|Protocol Violation|1
996779|NCT00446030|3270575|P2|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0
996780|NCT00446030|3270576|P1|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1
996781|NCT00446030|3270575|P2|TREATMENT (up to 52 Weeks)|Poor compliance|0
996782|NCT00446030|3270576|P1|TREATMENT (up to 52 Weeks)|Poor compliance|1
996783|NCT00446030|3270575|P2|TREATMENT (up to 52 Weeks)|Subject Request|1
996784|NCT00446030|3270576|P1|TREATMENT (up to 52 Weeks)|Subject Request|9
996785|NCT00446030|3270575|P2|TREATMENT (up to 52 Weeks)|Adverse Event|8
996786|NCT00446030|3270576|P1|TREATMENT (up to 52 Weeks)|Adverse Event|29
996787|NCT00445939|3270587|P4|Period B - Week 4 - Week 8|Adverse Event|1
996788|NCT00445939|3270588|P3|Period B - Week 4 - Week 8|Adverse Event|0
996789|NCT00445939|3270589|P2|Period B - Week 4 - Week 8|Adverse Event|0
996790|NCT00445939|3270590|P1|Period B - Week 4 - Week 8|Adverse Event|2
996791|NCT00445939|3270587|P4|Period A - Week 0 - Week 4|Adverse Event|0
996792|NCT00445939|3270588|P3|Period A - Week 0 - Week 4|Adverse Event|0
996793|NCT00445939|3270589|P2|Period A - Week 0 - Week 4|Adverse Event|2
996794|NCT00445939|3270590|P1|Period A - Week 0 - Week 4|Adverse Event|1
996795|NCT00445848|3270638|P1|Overall Study|Other-Not protocol specified|5
996796|NCT00445848|3270638|P1|Overall Study|Progression|62
996797|NCT00445848|3270638|P1|Overall Study|Withdrawal by Subject|4
996798|NCT00445848|3270638|P1|Overall Study|Adverse Event|14
996799|NCT00445770|3270648|P3|Overall Study|Not specified|6
996800|NCT00445770|3270649|P2|Overall Study|Not specified|5
996801|NCT00445770|3270650|P1|Overall Study|Not specified|6
996802|NCT00445770|3270648|P3|Overall Study|Lost to Follow-up|0
996803|NCT00445770|3270649|P2|Overall Study|Lost to Follow-up|2
996804|NCT00445770|3270650|P1|Overall Study|Lost to Follow-up|0
996805|NCT00445770|3270648|P3|Overall Study|Lack of Efficacy|6
996806|NCT00445770|3270649|P2|Overall Study|Lack of Efficacy|13
996807|NCT00445770|3270650|P1|Overall Study|Lack of Efficacy|38
996808|NCT00445770|3270648|P3|Overall Study|Adverse Event|19
996809|NCT00445770|3270649|P2|Overall Study|Adverse Event|15
996810|NCT00445770|3270650|P1|Overall Study|Adverse Event|9
996811|NCT00445692|3270751|P1|Overall Study|Lack of Efficacy|5
996812|NCT00445692|3270751|P1|Overall Study|Adverse Event|11
996813|NCT00445679|3270761|P4|Overall Study|Lack of Efficacy|0
996814|NCT00445679|3270762|P3|Overall Study|Lack of Efficacy|2
996815|NCT00445679|3270763|P2|Overall Study|Lack of Efficacy|6
996816|NCT00445679|3270764|P1|Overall Study|Lack of Efficacy|2
996817|NCT00445679|3270761|P4|Overall Study|Withdrawal by Subject|18
996818|NCT00445679|3270762|P3|Overall Study|Withdrawal by Subject|20
996819|NCT00445679|3270763|P2|Overall Study|Withdrawal by Subject|14
996820|NCT00445679|3270764|P1|Overall Study|Withdrawal by Subject|8
996821|NCT00445679|3270761|P4|Overall Study|Protocol Violation|1
996822|NCT00445679|3270762|P3|Overall Study|Protocol Violation|3
996823|NCT00445679|3270763|P2|Overall Study|Protocol Violation|3
996824|NCT00445679|3270764|P1|Overall Study|Protocol Violation|2
996825|NCT00445679|3270761|P4|Overall Study|Withdrawal of Informed Consent|0
996826|NCT00445679|3270762|P3|Overall Study|Withdrawal of Informed Consent|1
996827|NCT00445679|3270763|P2|Overall Study|Withdrawal of Informed Consent|0
996828|NCT00445679|3270764|P1|Overall Study|Withdrawal of Informed Consent|0
996829|NCT00445679|3270761|P4|Overall Study|Compliance|2
996830|NCT00445679|3270762|P3|Overall Study|Compliance|1
996831|NCT00445679|3270763|P2|Overall Study|Compliance|2
996832|NCT00445679|3270764|P1|Overall Study|Compliance|3
996833|NCT00445679|3270761|P4|Overall Study|Lost to Follow-up|5
996834|NCT00445679|3270762|P3|Overall Study|Lost to Follow-up|6
996835|NCT00445679|3270763|P2|Overall Study|Lost to Follow-up|6
996836|NCT00445679|3270764|P1|Overall Study|Lost to Follow-up|10
996837|NCT00445679|3270761|P4|Overall Study|Physician Decision|0
996838|NCT00445679|3270762|P3|Overall Study|Physician Decision|1
996839|NCT00445679|3270763|P2|Overall Study|Physician Decision|0
996840|NCT00445679|3270764|P1|Overall Study|Physician Decision|0
996841|NCT00445679|3270761|P4|Overall Study|Failed to return|2
996842|NCT00445679|3270762|P3|Overall Study|Failed to return|2
996843|NCT00445679|3270763|P2|Overall Study|Failed to return|3
996844|NCT00445679|3270764|P1|Overall Study|Failed to return|1
996845|NCT00445679|3270761|P4|Overall Study|Adverse Event|19
996846|NCT00445679|3270762|P3|Overall Study|Adverse Event|30
996847|NCT00445679|3270763|P2|Overall Study|Adverse Event|12
996848|NCT00445679|3270764|P1|Overall Study|Adverse Event|22
996849|NCT00445601|3270800|P2|Overall Study|Death prior to TURBT|1
996850|NCT00445601|3270801|P1|Overall Study|Death prior to TURBT|0
996851|NCT00445601|3270800|P2|Overall Study|Adverse Event|0
996852|NCT00445601|3270801|P1|Overall Study|Adverse Event|2
996853|NCT00445601|3270800|P2|Overall Study|Drug Delivery Issue|2
996854|NCT00445601|3270801|P1|Overall Study|Drug Delivery Issue|2
996855|NCT00445601|3270800|P2|Overall Study|Incorrect Disease Status|6
996856|NCT00445601|3270801|P1|Overall Study|Incorrect Disease Status|6
996857|NCT00445601|3270800|P2|Overall Study|TURBT Complication|8
996858|NCT00445601|3270801|P1|Overall Study|TURBT Complication|12
996859|NCT00445601|3270800|P2|Overall Study|Withdrawal by Subject|11
996860|NCT00445601|3270801|P1|Overall Study|Withdrawal by Subject|11
996861|NCT00445549|3270818|P1|Overall Study|progressive disease|12
996862|NCT00445458|3270842|P4|Overall Study|Surgery|0
996863|NCT00445458|3270843|P3|Overall Study|Surgery|1
996864|NCT00445458|3270844|P2|Overall Study|Surgery|0
996865|NCT00445458|3270845|P1|Overall Study|Surgery|0
996866|NCT00445458|3270842|P4|Overall Study|Physician Decision|1
996867|NCT00445458|3270843|P3|Overall Study|Physician Decision|1
996868|NCT00445458|3270844|P2|Overall Study|Physician Decision|0
996869|NCT00445458|3270845|P1|Overall Study|Physician Decision|0
996870|NCT00445458|3270842|P4|Overall Study|Death|0
996871|NCT00445458|3270843|P3|Overall Study|Death|2
996872|NCT00445458|3270844|P2|Overall Study|Death|1
996873|NCT00445458|3270845|P1|Overall Study|Death|0
996874|NCT00445458|3270842|P4|Overall Study|Adverse Event|0
996875|NCT00445458|3270843|P3|Overall Study|Adverse Event|3
996876|NCT00445458|3270844|P2|Overall Study|Adverse Event|0
996877|NCT00445458|3270845|P1|Overall Study|Adverse Event|0
996878|NCT00445458|3270842|P4|Overall Study|Withdrawal by Subject|0
996879|NCT00445458|3270843|P3|Overall Study|Withdrawal by Subject|7
996880|NCT00445458|3270844|P2|Overall Study|Withdrawal by Subject|0
996881|NCT00445458|3270845|P1|Overall Study|Withdrawal by Subject|0
996882|NCT00445458|3270842|P4|Overall Study|Disease Progression|27
996883|NCT00445458|3270843|P3|Overall Study|Disease Progression|54
996884|NCT00445458|3270844|P2|Overall Study|Disease Progression|4
996885|NCT00445458|3270845|P1|Overall Study|Disease Progression|3
996886|NCT00445432|3270863|P4|148 Weeks of Adalimumab Treatment|Not specified|9
996887|NCT00445432|3270864|P3|148 Weeks of Adalimumab Treatment|Not specified|0
996888|NCT00445432|3270865|P2|148 Weeks of Adalimumab Treatment|Not specified|0
996889|NCT00445432|3270866|P1|148 Weeks of Adalimumab Treatment|Not specified|0
996890|NCT00445432|3270863|P4|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3
996891|NCT00445432|3270864|P3|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
996892|NCT00445432|3270865|P2|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
996893|NCT00445432|3270866|P1|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
996894|NCT00445432|3270863|P4|148 Weeks of Adalimumab Treatment|Adverse Event|32
996895|NCT00445432|3270864|P3|148 Weeks of Adalimumab Treatment|Adverse Event|0
996896|NCT00445432|3270865|P2|148 Weeks of Adalimumab Treatment|Adverse Event|0
996897|NCT00445432|3270866|P1|148 Weeks of Adalimumab Treatment|Adverse Event|0
996898|NCT00445432|3270863|P4|Through Week 52 of NCT00445432 (M06-837)|Not specified|0
996899|NCT00445432|3270864|P3|Through Week 52 of NCT00445432 (M06-837)|Not specified|2
996900|NCT00445432|3270865|P2|Through Week 52 of NCT00445432 (M06-837)|Not specified|1
996901|NCT00445432|3270866|P1|Through Week 52 of NCT00445432 (M06-837)|Not specified|0
996902|NCT00445432|3270863|P4|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
996903|NCT00445432|3270864|P3|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
996904|NCT00445432|3270865|P2|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20
996905|NCT00445432|3270866|P1|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14
996906|NCT00445432|3270863|P4|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
996907|NCT00445432|3270864|P3|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2
996908|NCT00445432|3270865|P2|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
996909|NCT00445432|3270866|P1|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
996910|NCT00445432|3270863|P4|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0
996911|NCT00445432|3270864|P3|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7
996912|NCT00445432|3270865|P2|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2
996913|NCT00445432|3270866|P1|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1
996914|NCT00445341|3270899|P1|Overall Study|taken off treatment too early|1
996915|NCT00445341|3270899|P1|Overall Study|refused further treatment|1
996916|NCT00445328|3270906|P2|Overall Study|Protocol Violation|0
996917|NCT00445328|3270907|P1|Overall Study|Protocol Violation|1
996918|NCT00445328|3270906|P2|Overall Study|Withdrawal by Subject|0
996919|NCT00445328|3270907|P1|Overall Study|Withdrawal by Subject|2
996920|NCT00445328|3270906|P2|Overall Study|Other|2
996921|NCT00445328|3270907|P1|Overall Study|Other|0
996922|NCT00445328|3270906|P2|Overall Study|Adverse Event|3
996923|NCT00445328|3270907|P1|Overall Study|Adverse Event|0
996924|NCT00445328|3270906|P2|Overall Study|Death|1
996925|NCT00445328|3270907|P1|Overall Study|Death|0
996926|NCT00445224|3271068|P2|Specific Exercises|Withdrawal by Subject|0
996927|NCT00445224|3271069|P1|Specific Exercises|Withdrawal by Subject|1
996928|NCT00445224|3271068|P2|Specific Exercises|Withdrawal by Subject|3
996929|NCT00445224|3271069|P1|Specific Exercises|Withdrawal by Subject|3
996930|NCT00445146|3271096|P1|Overall Study|Pregnancy|1
996931|NCT00445146|3271096|P1|Overall Study|Protocol Violation|4
996932|NCT00445146|3271096|P1|Overall Study|Death|9
996933|NCT00445146|3271096|P1|Overall Study|Lost to Follow-up|13
996934|NCT00445146|3271096|P1|Overall Study|Adverse Event|13
996935|NCT00445146|3271096|P1|Overall Study|Investigator’s Discretion|22
996936|NCT00445146|3271096|P1|Overall Study|Lack of Efficacy|28
996937|NCT00445146|3271096|P1|Overall Study|Withdrew Consent|29
996938|NCT00445003|3271118|P3|Overall Study|Dropped|2
996939|NCT00445003|3271119|P2|Overall Study|Dropped|3
996940|NCT00445003|3271120|P1|Overall Study|Dropped|1
996941|NCT00445003|3271118|P3|Overall Study|Missed Visit|1
996942|NCT00445003|3271119|P2|Overall Study|Missed Visit|5
996943|NCT00445003|3271120|P1|Overall Study|Missed Visit|3
996944|NCT00445003|3271118|P3|Overall Study|Death|1
996945|NCT00445003|3271119|P2|Overall Study|Death|2
996946|NCT00445003|3271120|P1|Overall Study|Death|1
996947|NCT00444951|3271152|P3|Overall Study|Withdrawal by Subject|3
996948|NCT00444951|3271153|P2|Overall Study|Withdrawal by Subject|5
996949|NCT00444951|3271154|P1|Overall Study|Withdrawal by Subject|4
996950|NCT00444951|3271152|P3|Overall Study|Lost to Follow-up|0
996951|NCT00444951|3271153|P2|Overall Study|Lost to Follow-up|1
996952|NCT00444951|3271154|P1|Overall Study|Lost to Follow-up|1
996953|NCT00444925|3271171|P3|Double-blind Treatment Period|Other|12
996954|NCT00444925|3271172|P2|Double-blind Treatment Period|Other|7
996955|NCT00444925|3271173|P1|Double-blind Treatment Period|Other|7
996956|NCT00444925|3271171|P3|Double-blind Treatment Period|Withdrawal by Subject|7
996957|NCT00444925|3271172|P2|Double-blind Treatment Period|Withdrawal by Subject|8
996958|NCT00444925|3271173|P1|Double-blind Treatment Period|Withdrawal by Subject|6
996959|NCT00444925|3271171|P3|Double-blind Treatment Period|Lost to Follow-up|5
996960|NCT00444925|3271172|P2|Double-blind Treatment Period|Lost to Follow-up|8
996961|NCT00444925|3271173|P1|Double-blind Treatment Period|Lost to Follow-up|4
996962|NCT00444925|3271171|P3|Double-blind Treatment Period|Lack of Efficacy|13
996963|NCT00444925|3271172|P2|Double-blind Treatment Period|Lack of Efficacy|5
996964|NCT00444925|3271173|P1|Double-blind Treatment Period|Lack of Efficacy|5
996965|NCT00444925|3271171|P3|Double-blind Treatment Period|Adverse Event|44
996966|NCT00444925|3271172|P2|Double-blind Treatment Period|Adverse Event|28
996967|NCT00444925|3271173|P1|Double-blind Treatment Period|Adverse Event|6
996968|NCT00444925|3271171|P3|Double-blind Treatment Period|Death|0
996969|NCT00444925|3271172|P2|Double-blind Treatment Period|Death|0
996970|NCT00444925|3271173|P1|Double-blind Treatment Period|Death|2
996971|NCT00444925|3271171|P3|Randomized to Double-blind Treatment|Never returned after randomization|6
997059|NCT00444457|3271444|P2|After Infant Series|Other|1
996972|NCT00444925|3271172|P2|Randomized to Double-blind Treatment|Never returned after randomization|6
996973|NCT00444925|3271173|P1|Randomized to Double-blind Treatment|Never returned after randomization|3
996974|NCT00444912|3271237|P2|Overall Study|Participant Failed Mobilization|0
996975|NCT00444912|3271238|P1|Overall Study|Participant Failed Mobilization|1
996976|NCT00444912|3271237|P2|Overall Study|Lost to Follow-up|0
996977|NCT00444912|3271238|P1|Overall Study|Lost to Follow-up|1
996978|NCT00444912|3271237|P2|Overall Study|Death|2
996979|NCT00444912|3271238|P1|Overall Study|Death|1
996980|NCT00444795|3271279|P1|Overall Study|Treated Prior to the Contract Date|2
996981|NCT00444795|3271279|P1|Overall Study|Not Treated|1
996982|NCT00444626|3271284|P1|Initial Treatment Period|Lost to Follow-up|9
996983|NCT00444626|3271284|P1|Initial Treatment Period|Adverse Event|1
996984|NCT00444626|3271284|P1|Initial Treatment Period|Withdrawal by Subject|2
996985|NCT00444600|3271314|P4|Overall Study|Missed visit|1
996986|NCT00444600|3271315|P3|Overall Study|Missed visit|0
996987|NCT00444600|3271316|P2|Overall Study|Missed visit|0
996988|NCT00444600|3271317|P1|Overall Study|Missed visit|1
996989|NCT00444600|3271314|P4|Overall Study|Dropped|7
996990|NCT00444600|3271315|P3|Overall Study|Dropped|7
996991|NCT00444600|3271316|P2|Overall Study|Dropped|11
996992|NCT00444600|3271317|P1|Overall Study|Dropped|11
996993|NCT00444600|3271314|P4|Overall Study|Death|2
996994|NCT00444600|3271315|P3|Overall Study|Death|3
996995|NCT00444600|3271316|P2|Overall Study|Death|5
996996|NCT00444600|3271317|P1|Overall Study|Death|7
996997|NCT00444587|3271409|P2|Overall Study|Missing|5
996998|NCT00444587|3271410|P1|Overall Study|Missing|0
996999|NCT00444587|3271409|P2|Overall Study|Protocol Violation|0
997000|NCT00444587|3271410|P1|Overall Study|Protocol Violation|1
997001|NCT00444587|3271409|P2|Overall Study|Investigator decision|0
997002|NCT00444587|3271410|P1|Overall Study|Investigator decision|3
997003|NCT00444587|3271409|P2|Overall Study|Refused treatment/did not cooperate|1
997004|NCT00444587|3271410|P1|Overall Study|Refused treatment/did not cooperate|4
997005|NCT00444587|3271409|P2|Overall Study|Progression of the disease|8
997006|NCT00444587|3271410|P1|Overall Study|Progression of the disease|73
997007|NCT00444587|3271409|P2|Overall Study|Death|1
997008|NCT00444587|3271410|P1|Overall Study|Death|2
997009|NCT00444535|3271431|P1|Overall Study|Adverse Event|3
997010|NCT00444535|3271431|P1|Overall Study|Investigator decision|2
997011|NCT00444535|3271431|P1|Overall Study|Withdrawal by Subject|3
997012|NCT00444535|3271431|P1|Overall Study|Treatment is ongoing|16
997013|NCT00444457|3271442|P4|Toddler Dose|Protocol Violation|1
997014|NCT00444457|3271443|P3|Toddler Dose|Protocol Violation|0
997015|NCT00444457|3271444|P2|Toddler Dose|Protocol Violation|0
997016|NCT00444457|3271445|P1|Toddler Dose|Protocol Violation|1
997017|NCT00444457|3271442|P4|Toddler Dose|Parent or legal guardian request|1
997018|NCT00444457|3271443|P3|Toddler Dose|Parent or legal guardian request|2
997019|NCT00444457|3271444|P2|Toddler Dose|Parent or legal guardian request|3
997020|NCT00444457|3271445|P1|Toddler Dose|Parent or legal guardian request|0
997021|NCT00444457|3271442|P4|Toddler Dose|Failed to return|3
997022|NCT00444457|3271443|P3|Toddler Dose|Failed to return|1
997023|NCT00444457|3271444|P2|Toddler Dose|Failed to return|2
997024|NCT00444457|3271445|P1|Toddler Dose|Failed to return|2
997025|NCT00444457|3271442|P4|Toddler Dose|Lost to Follow-up|3
997026|NCT00444457|3271443|P3|Toddler Dose|Lost to Follow-up|1
997027|NCT00444457|3271444|P2|Toddler Dose|Lost to Follow-up|1
997028|NCT00444457|3271445|P1|Toddler Dose|Lost to Follow-up|4
997029|NCT00444457|3271442|P4|After Infant Series|Other|0
997030|NCT00444457|3271443|P3|After Infant Series|Other|0
997031|NCT00444457|3271444|P2|After Infant Series|Other|1
997032|NCT00444457|3271445|P1|After Infant Series|Other|0
997033|NCT00444457|3271442|P4|After Infant Series|Investigator request|1
997034|NCT00444457|3271443|P3|After Infant Series|Investigator request|0
997035|NCT00444457|3271444|P2|After Infant Series|Investigator request|0
997036|NCT00444457|3271445|P1|After Infant Series|Investigator request|0
997037|NCT00444457|3271442|P4|After Infant Series|Adverse Event|0
997038|NCT00444457|3271443|P3|After Infant Series|Adverse Event|0
997039|NCT00444457|3271444|P2|After Infant Series|Adverse Event|2
997040|NCT00444457|3271445|P1|After Infant Series|Adverse Event|2
997041|NCT00444457|3271442|P4|After Infant Series|Protocol Violation|2
997042|NCT00444457|3271443|P3|After Infant Series|Protocol Violation|2
997043|NCT00444457|3271444|P2|After Infant Series|Protocol Violation|4
997044|NCT00444457|3271445|P1|After Infant Series|Protocol Violation|2
997045|NCT00444457|3271442|P4|After Infant Series|Lost to Follow-up|2
997046|NCT00444457|3271443|P3|After Infant Series|Lost to Follow-up|5
997047|NCT00444457|3271444|P2|After Infant Series|Lost to Follow-up|5
997048|NCT00444457|3271445|P1|After Infant Series|Lost to Follow-up|5
997049|NCT00444457|3271442|P4|After Infant Series|Failed to return|1
997050|NCT00444457|3271443|P3|After Infant Series|Failed to return|5
997051|NCT00444457|3271444|P2|After Infant Series|Failed to return|6
997052|NCT00444457|3271445|P1|After Infant Series|Failed to return|7
997053|NCT00444457|3271442|P4|After Infant Series|Parent or legal guardian request|3
997054|NCT00444457|3271443|P3|After Infant Series|Parent or legal guardian request|6
997055|NCT00444457|3271444|P2|After Infant Series|Parent or legal guardian request|11
997056|NCT00444457|3271445|P1|After Infant Series|Parent or legal guardian request|4
997057|NCT00444457|3271442|P4|After Infant Series|Other|1
997058|NCT00444457|3271443|P3|After Infant Series|Other|1
997060|NCT00444457|3271445|P1|After Infant Series|Other|0
997061|NCT00444457|3271442|P4|Infant Series|Death|1
997062|NCT00444457|3271443|P3|Infant Series|Death|1
997063|NCT00444457|3271444|P2|Infant Series|Death|1
997064|NCT00444457|3271445|P1|Infant Series|Death|0
997065|NCT00444457|3271442|P4|Infant Series|Adverse Event|0
997066|NCT00444457|3271443|P3|Infant Series|Adverse Event|2
997067|NCT00444457|3271444|P2|Infant Series|Adverse Event|2
997068|NCT00444457|3271445|P1|Infant Series|Adverse Event|1
997069|NCT00444457|3271442|P4|Infant Series|Other|0
997070|NCT00444457|3271443|P3|Infant Series|Other|4
997071|NCT00444457|3271444|P2|Infant Series|Other|2
997072|NCT00444457|3271445|P1|Infant Series|Other|0
997073|NCT00444457|3271442|P4|Infant Series|Investigator request|2
997074|NCT00444457|3271443|P3|Infant Series|Investigator request|3
997075|NCT00444457|3271444|P2|Infant Series|Investigator request|3
997076|NCT00444457|3271445|P1|Infant Series|Investigator request|4
997077|NCT00444457|3271442|P4|Infant Series|Failed to return|2
997078|NCT00444457|3271443|P3|Infant Series|Failed to return|4
997079|NCT00444457|3271444|P2|Infant Series|Failed to return|4
997080|NCT00444457|3271445|P1|Infant Series|Failed to return|5
997081|NCT00444457|3271442|P4|Infant Series|Protocol Violation|3
997082|NCT00444457|3271443|P3|Infant Series|Protocol Violation|6
997083|NCT00444457|3271444|P2|Infant Series|Protocol Violation|8
997084|NCT00444457|3271445|P1|Infant Series|Protocol Violation|16
997085|NCT00444457|3271442|P4|Infant Series|Lost to Follow-up|6
997086|NCT00444457|3271443|P3|Infant Series|Lost to Follow-up|7
997087|NCT00444457|3271444|P2|Infant Series|Lost to Follow-up|11
997088|NCT00444457|3271445|P1|Infant Series|Lost to Follow-up|10
997089|NCT00444457|3271442|P4|Infant Series|Parent or legal guardian request|14
997090|NCT00444457|3271443|P3|Infant Series|Parent or legal guardian request|34
997091|NCT00444457|3271444|P2|Infant Series|Parent or legal guardian request|29
997092|NCT00444457|3271445|P1|Infant Series|Parent or legal guardian request|18
997093|NCT00444457|3271442|P4|Infant Series|Other|0
997094|NCT00444457|3271443|P3|Infant Series|Other|0
997095|NCT00444457|3271444|P2|Infant Series|Other|1
997096|NCT00444457|3271445|P1|Infant Series|Other|0
997097|NCT00444275|3271510|P5|Maintenance Treatment Phase|Ineffectiveness|14
997098|NCT00444275|3271511|P4|Maintenance Treatment Phase|Ineffectiveness|3
997099|NCT00444275|3271512|P3|Maintenance Treatment Phase|Ineffectiveness|5
997100|NCT00444275|3271513|P2|Maintenance Treatment Phase|Ineffectiveness|0
997101|NCT00444275|3271514|P1|Maintenance Treatment Phase|Ineffectiveness|0
997102|NCT00444275|3271510|P5|Maintenance Treatment Phase|Protocol Violation|87
997103|NCT00444275|3271511|P4|Maintenance Treatment Phase|Protocol Violation|88
997104|NCT00444275|3271512|P3|Maintenance Treatment Phase|Protocol Violation|103
997105|NCT00444275|3271513|P2|Maintenance Treatment Phase|Protocol Violation|0
997106|NCT00444275|3271514|P1|Maintenance Treatment Phase|Protocol Violation|0
997107|NCT00444275|3271510|P5|Maintenance Treatment Phase|Patient's wish|20
997108|NCT00444275|3271511|P4|Maintenance Treatment Phase|Patient's wish|9
997109|NCT00444275|3271512|P3|Maintenance Treatment Phase|Patient's wish|19
997110|NCT00444275|3271513|P2|Maintenance Treatment Phase|Patient's wish|0
997111|NCT00444275|3271514|P1|Maintenance Treatment Phase|Patient's wish|0
997112|NCT00444275|3271510|P5|Maintenance Treatment Phase|Protocol specific criteria's development|6
997113|NCT00444275|3271511|P4|Maintenance Treatment Phase|Protocol specific criteria's development|0
997114|NCT00444275|3271512|P3|Maintenance Treatment Phase|Protocol specific criteria's development|1
997115|NCT00444275|3271513|P2|Maintenance Treatment Phase|Protocol specific criteria's development|0
997116|NCT00444275|3271514|P1|Maintenance Treatment Phase|Protocol specific criteria's development|0
997117|NCT00444275|3271510|P5|Maintenance Treatment Phase|Adverse Event|13
997118|NCT00444275|3271511|P4|Maintenance Treatment Phase|Adverse Event|2
997119|NCT00444275|3271512|P3|Maintenance Treatment Phase|Adverse Event|3
997120|NCT00444275|3271513|P2|Maintenance Treatment Phase|Adverse Event|0
997121|NCT00444275|3271514|P1|Maintenance Treatment Phase|Adverse Event|0
997122|NCT00444275|3271510|P5|Maintenance Treatment Phase|Lost to Follow-up|10
997123|NCT00444275|3271511|P4|Maintenance Treatment Phase|Lost to Follow-up|14
997124|NCT00444275|3271512|P3|Maintenance Treatment Phase|Lost to Follow-up|8
997125|NCT00444275|3271513|P2|Maintenance Treatment Phase|Lost to Follow-up|0
997126|NCT00444275|3271514|P1|Maintenance Treatment Phase|Lost to Follow-up|0
997127|NCT00444275|3271510|P5|Maintenance Treatment Phase|Didn'r receive the treatment|29
997128|NCT00444275|3271511|P4|Maintenance Treatment Phase|Didn'r receive the treatment|17
997129|NCT00444275|3271512|P3|Maintenance Treatment Phase|Didn'r receive the treatment|22
997130|NCT00444275|3271513|P2|Maintenance Treatment Phase|Didn'r receive the treatment|0
997131|NCT00444275|3271514|P1|Maintenance Treatment Phase|Didn'r receive the treatment|0
997132|NCT00444145|3271564|P1|Overall Study|Screen Failures|5
997133|NCT00444145|3271564|P1|Overall Study|non-compliant|11
997134|NCT00444145|3271564|P1|Overall Study|Lost to Follow-up|1
997135|NCT00444145|3271564|P1|Overall Study|Withdrawal by Subject|2
997136|NCT00444106|3271571|P3|Overall Study|Abnormal Test Procedure Results|1
997137|NCT00444106|3271572|P2|Overall Study|Abnormal Test Procedure Results|0
997138|NCT00444106|3271573|P1|Overall Study|Abnormal Test Procedure Results|0
997139|NCT00444106|3271571|P3|Overall Study|Lost to Follow-up|0
997140|NCT00444106|3271572|P2|Overall Study|Lost to Follow-up|1
997141|NCT00444106|3271573|P1|Overall Study|Lost to Follow-up|2
997142|NCT00444067|3271590|P2|Overall Study|Lost to Follow-up|1
997143|NCT00444067|3271591|P1|Overall Study|Lost to Follow-up|0
997144|NCT00443898|3271654|P4|Overall Study|Death|0
997145|NCT00443898|3271655|P3|Overall Study|Death|0
997146|NCT00443898|3271656|P2|Overall Study|Death|1
997147|NCT00443898|3271657|P1|Overall Study|Death|0
997148|NCT00443898|3271654|P4|Overall Study|Lost to Follow-up|10
997149|NCT00443898|3271655|P3|Overall Study|Lost to Follow-up|14
997150|NCT00443898|3271656|P2|Overall Study|Lost to Follow-up|10
997151|NCT00443898|3271657|P1|Overall Study|Lost to Follow-up|10
997152|NCT00443898|3271654|P4|Overall Study|Withdrawal by Subject|6
997153|NCT00443898|3271655|P3|Overall Study|Withdrawal by Subject|10
997154|NCT00443898|3271656|P2|Overall Study|Withdrawal by Subject|10
997155|NCT00443898|3271657|P1|Overall Study|Withdrawal by Subject|11
997156|NCT00443898|3271654|P4|Overall Study|Protocol Violation|0
997157|NCT00443898|3271655|P3|Overall Study|Protocol Violation|1
997158|NCT00443898|3271656|P2|Overall Study|Protocol Violation|1
997159|NCT00443898|3271657|P1|Overall Study|Protocol Violation|1
997160|NCT00443898|3271654|P4|Overall Study|Lack of Efficacy|1
997161|NCT00443898|3271655|P3|Overall Study|Lack of Efficacy|3
997162|NCT00443898|3271656|P2|Overall Study|Lack of Efficacy|3
997163|NCT00443898|3271657|P1|Overall Study|Lack of Efficacy|2
997164|NCT00443898|3271654|P4|Overall Study|Adverse Event|1
997165|NCT00443898|3271655|P3|Overall Study|Adverse Event|1
997166|NCT00443898|3271656|P2|Overall Study|Adverse Event|0
997167|NCT00443898|3271657|P1|Overall Study|Adverse Event|0
997168|NCT00443872|3271679|P1|Overall Study|Adverse Event|8
997169|NCT00443872|3271679|P1|Overall Study|Lost to Follow-up|2
997170|NCT00443872|3271679|P1|Overall Study|Protocol Violation|7
997171|NCT00443846|3271694|P2|Overall Study|Lost to Follow-up|2
997172|NCT00443846|3271695|P1|Overall Study|Lost to Follow-up|1
997173|NCT00443846|3271694|P2|Overall Study|Personal reason|3
997174|NCT00443846|3271695|P1|Overall Study|Personal reason|8
997175|NCT00443846|3271694|P2|Overall Study|Adverse Event|1
997176|NCT00443846|3271695|P1|Overall Study|Adverse Event|0
997177|NCT00443846|3271694|P2|Overall Study|Not vaccinated, no blood sample drawn|0
997178|NCT00443846|3271695|P1|Overall Study|Not vaccinated, no blood sample drawn|1
997179|NCT00443846|3271694|P2|Overall Study|Withdrawn due to intercurrent disease|0
997180|NCT00443846|3271695|P1|Overall Study|Withdrawn due to intercurrent disease|1
997181|NCT00443820|3271705|P4|Overall Study|Death|0
997182|NCT00443820|3271706|P3|Overall Study|Death|1
997183|NCT00443820|3271707|P2|Overall Study|Death|0
997184|NCT00443820|3271708|P1|Overall Study|Death|0
997185|NCT00443820|3271705|P4|Overall Study|Administrative problems|1
997186|NCT00443820|3271706|P3|Overall Study|Administrative problems|0
997187|NCT00443820|3271707|P2|Overall Study|Administrative problems|0
997188|NCT00443820|3271708|P1|Overall Study|Administrative problems|0
997189|NCT00443820|3271705|P4|Overall Study|Lost to Follow-up|5
997190|NCT00443820|3271706|P3|Overall Study|Lost to Follow-up|6
997191|NCT00443820|3271707|P2|Overall Study|Lost to Follow-up|8
997192|NCT00443820|3271708|P1|Overall Study|Lost to Follow-up|9
997193|NCT00443820|3271705|P4|Overall Study|Withdrawal by Subject|9
997194|NCT00443820|3271706|P3|Overall Study|Withdrawal by Subject|8
997195|NCT00443820|3271707|P2|Overall Study|Withdrawal by Subject|7
997196|NCT00443820|3271708|P1|Overall Study|Withdrawal by Subject|6
997197|NCT00443820|3271705|P4|Overall Study|Protocol Violation|1
997198|NCT00443820|3271706|P3|Overall Study|Protocol Violation|2
997199|NCT00443820|3271707|P2|Overall Study|Protocol Violation|1
997200|NCT00443820|3271708|P1|Overall Study|Protocol Violation|2
997201|NCT00443820|3271705|P4|Overall Study|Lack of Efficacy|1
997202|NCT00443820|3271706|P3|Overall Study|Lack of Efficacy|1
997203|NCT00443820|3271707|P2|Overall Study|Lack of Efficacy|2
997204|NCT00443820|3271708|P1|Overall Study|Lack of Efficacy|3
997205|NCT00443820|3271705|P4|Overall Study|Adverse Event|0
997206|NCT00443820|3271706|P3|Overall Study|Adverse Event|0
997207|NCT00443820|3271707|P2|Overall Study|Adverse Event|1
997208|NCT00443820|3271708|P1|Overall Study|Adverse Event|1
997209|NCT00443781|3271730|P1|Overall Study|PD/FAD not done|1
997210|NCT00443781|3271730|P1|Overall Study|Insurance not covered|2
997211|NCT00443781|3271730|P1|Overall Study|Investigator terminated participation|1
997212|NCT00443781|3271730|P1|Overall Study|Unable to comply with study follow up|2
997213|NCT00443781|3271730|P1|Overall Study|Withdrawal by Subject|6
997214|NCT00443781|3271730|P1|Overall Study|Protocol Violation|1
997215|NCT00443781|3271730|P1|Overall Study|Physician Decision|2
997216|NCT00443781|3271730|P1|Overall Study|Lost to Follow-up|10
997217|NCT00443755|3271736|P2|Overall Study|Withdrawal by Subject|1
997218|NCT00443755|3271737|P1|Overall Study|Withdrawal by Subject|2
997219|NCT00443729|3271771|P2|Overall Study|Withdrawal by Subject|1
997220|NCT00443729|3271772|P1|Overall Study|Withdrawal by Subject|3
997221|NCT00443729|3271771|P2|Overall Study|Protocol Violation|1
997222|NCT00443729|3271772|P1|Overall Study|Protocol Violation|1
997223|NCT00443729|3271771|P2|Overall Study|Physician Decision|1
997224|NCT00443729|3271772|P1|Overall Study|Physician Decision|2
997225|NCT00443729|3271771|P2|Overall Study|Lost to Follow-up|1
997226|NCT00443729|3271772|P1|Overall Study|Lost to Follow-up|0
997227|NCT00443729|3271771|P2|Overall Study|Lack of Efficacy|2
997228|NCT00443729|3271772|P1|Overall Study|Lack of Efficacy|4
997229|NCT00443729|3271771|P2|Overall Study|Never Treated|1
997230|NCT00443729|3271772|P1|Overall Study|Never Treated|0
997231|NCT00443703|3271820|P2|Overall Study|Progressive Disease|0
997232|NCT00443703|3271821|P1|Overall Study|Progressive Disease|1
997233|NCT00443703|3271820|P2|Overall Study|Withdrawal by Subject|6
997234|NCT00443703|3271821|P1|Overall Study|Withdrawal by Subject|9
997235|NCT00443703|3271820|P2|Overall Study|Protocol Violation|1
997236|NCT00443703|3271821|P1|Overall Study|Protocol Violation|1
997237|NCT00443703|3271820|P2|Overall Study|Physician Decision|2
997238|NCT00443703|3271821|P1|Overall Study|Physician Decision|4
997239|NCT00443703|3271820|P2|Overall Study|Lost to Follow-up|4
997240|NCT00443703|3271821|P1|Overall Study|Lost to Follow-up|0
997241|NCT00443703|3271820|P2|Overall Study|Lack of Efficacy|1
997242|NCT00443703|3271821|P1|Overall Study|Lack of Efficacy|3
997243|NCT00443703|3271820|P2|Overall Study|Adverse Event|3
997244|NCT00443703|3271821|P1|Overall Study|Adverse Event|7
997245|NCT00443703|3271820|P2|Overall Study|Never Treated|1
997246|NCT00443703|3271821|P1|Overall Study|Never Treated|3
997247|NCT00443651|3271873|P2|Overall Study|Pregnancy|1
997248|NCT00443651|3271874|P1|Overall Study|Pregnancy|0
997249|NCT00443651|3271873|P2|Overall Study|Physician Decision|4
997250|NCT00443651|3271874|P1|Overall Study|Physician Decision|13
997251|NCT00443651|3271873|P2|Overall Study|Patient's/Guardian's Decision|30
997252|NCT00443651|3271874|P1|Overall Study|Patient's/Guardian's Decision|58
997253|NCT00443651|3271873|P2|Overall Study|Lost to Follow-up|12
997254|NCT00443651|3271874|P1|Overall Study|Lost to Follow-up|18
997255|NCT00443651|3271873|P2|Overall Study|Adverse Event|6
997256|NCT00443651|3271874|P1|Overall Study|Adverse Event|5
997257|NCT00443651|3271873|P2|Overall Study|Death|5
997258|NCT00443651|3271874|P1|Overall Study|Death|1
997259|NCT00443599|3271894|P2|Overall Study|Cardiopulmonary bypass canceled|1
997260|NCT00443599|3271895|P1|Overall Study|Cardiopulmonary bypass canceled|3
997261|NCT00443599|3271894|P2|Overall Study|Death|1
997262|NCT00443599|3271895|P1|Overall Study|Death|1
997263|NCT00443599|3271894|P2|Overall Study|Physician Decision|1
997264|NCT00443599|3271895|P1|Overall Study|Physician Decision|2
997265|NCT00443560|3271929|P2|Overall Study|Multiple pregnancies or fetal demise|4
997266|NCT00443560|3271930|P1|Overall Study|Multiple pregnancies or fetal demise|2
997267|NCT00443560|3271929|P2|Overall Study|No intrathecal dose|26
997268|NCT00443560|3271930|P1|Overall Study|No intrathecal dose|58
997269|NCT00443534|3271940|P1|Overall Study|Enrolled, Not Treated|1
997270|NCT00443534|3271940|P1|Overall Study|Other|10
997271|NCT00443534|3271940|P1|Overall Study|Study Terminated by Sponsor|12
997272|NCT00443534|3271940|P1|Overall Study|Withdrawal by Subject|8
997273|NCT00443534|3271940|P1|Overall Study|Death|9
997274|NCT00443534|3271940|P1|Overall Study|Adverse Event|16
997275|NCT00443534|3271940|P1|Overall Study|Lack of Efficacy|67
997276|NCT00443456|3271947|P1|Overall Study|Withdrawal by Subject|1
997277|NCT00443456|3271947|P1|Overall Study|Move|1
997278|NCT00443456|3271947|P1|Overall Study|Adverse Event|16
997279|NCT00443430|3271982|P2|Overall Study|Adverse Event|1
997280|NCT00443430|3271983|P1|Overall Study|Adverse Event|1
997281|NCT00443430|3271982|P2|Overall Study|Lack of Efficacy|3
997282|NCT00443430|3271983|P1|Overall Study|Lack of Efficacy|3
997283|NCT00443261|3271997|P1|Overall Study|Death|1
997284|NCT00443209|3272003|P2|Months 13 to 18 Treatment Period|Withdrawal by Subject|2
997285|NCT00443209|3272004|P1|Months 13 to 18 Treatment Period|Withdrawal by Subject|7
997286|NCT00443209|3272003|P2|Months 13 to 18 Treatment Period|Trial Terminated|43
997287|NCT00443209|3272004|P1|Months 13 to 18 Treatment Period|Trial Terminated|87
997288|NCT00443209|3272003|P2|Months 13 to 18 Treatment Period|Lost to Follow-up|2
997289|NCT00443209|3272004|P1|Months 13 to 18 Treatment Period|Lost to Follow-up|2
997290|NCT00443209|3272003|P2|Months 13 to 18 Treatment Period|Lack of Efficacy|0
997291|NCT00443209|3272004|P1|Months 13 to 18 Treatment Period|Lack of Efficacy|1
997292|NCT00443209|3272003|P2|Months 13 to 18 Treatment Period|Protocol Violation|0
997293|NCT00443209|3272004|P1|Months 13 to 18 Treatment Period|Protocol Violation|1
997294|NCT00443209|3272003|P2|Months 13 to 18 Treatment Period|Adverse Event|0
997295|NCT00443209|3272004|P1|Months 13 to 18 Treatment Period|Adverse Event|1
997296|NCT00443209|3272003|P2|Months 1 to 12 Treatment Period|Not Treated|43
997297|NCT00443209|3272004|P1|Months 1 to 12 Treatment Period|Not Treated|71
997298|NCT00443209|3272003|P2|Months 1 to 12 Treatment Period|Missing|1
997299|NCT00443209|3272004|P1|Months 1 to 12 Treatment Period|Missing|2
997300|NCT00443209|3272003|P2|Months 1 to 12 Treatment Period|Withdrawal by Subject|34
997301|NCT00443209|3272004|P1|Months 1 to 12 Treatment Period|Withdrawal by Subject|95
997302|NCT00443209|3272003|P2|Months 1 to 12 Treatment Period|Trial Terminated|23
997303|NCT00443209|3272004|P1|Months 1 to 12 Treatment Period|Trial Terminated|43
997304|NCT00443209|3272003|P2|Months 1 to 12 Treatment Period|Pregnancy|4
997305|NCT00443209|3272004|P1|Months 1 to 12 Treatment Period|Pregnancy|3
997306|NCT00443209|3272003|P2|Months 1 to 12 Treatment Period|Physician Decision|4
997307|NCT00443209|3272004|P1|Months 1 to 12 Treatment Period|Physician Decision|8
997308|NCT00443209|3272003|P2|Months 1 to 12 Treatment Period|Lost to Follow-up|15
997309|NCT00443209|3272004|P1|Months 1 to 12 Treatment Period|Lost to Follow-up|36
997310|NCT00443209|3272003|P2|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
997311|NCT00443209|3272004|P1|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
997312|NCT00443209|3272003|P2|Months 1 to 12 Treatment Period|Lack of Efficacy|11
997313|NCT00443209|3272004|P1|Months 1 to 12 Treatment Period|Lack of Efficacy|50
997314|NCT00443209|3272003|P2|Months 1 to 12 Treatment Period|Protocol Violation|7
997315|NCT00443209|3272004|P1|Months 1 to 12 Treatment Period|Protocol Violation|14
997316|NCT00443209|3272003|P2|Months 1 to 12 Treatment Period|Adverse Event|11
997317|NCT00443209|3272004|P1|Months 1 to 12 Treatment Period|Adverse Event|22
997318|NCT00443118|3272021|P3|Overall Study|Withdrawal by Subject|0
997319|NCT00443118|3272022|P2|Overall Study|Withdrawal by Subject|0
997320|NCT00443118|3272023|P1|Overall Study|Withdrawal by Subject|1
997321|NCT00443118|3272021|P3|Overall Study|unknown primary outcome|0
997322|NCT00443118|3272022|P2|Overall Study|unknown primary outcome|1
997323|NCT00443118|3272023|P1|Overall Study|unknown primary outcome|3
997324|NCT00443053|3272072|P2|Overall Study|Physician Decision|4
997325|NCT00443053|3272073|P1|Overall Study|Physician Decision|0
997326|NCT00443053|3272072|P2|Overall Study|Other|4
997327|NCT00443053|3272073|P1|Overall Study|Other|3
997328|NCT00443053|3272072|P2|Overall Study|Noncompliance|1
997329|NCT00443053|3272073|P1|Overall Study|Noncompliance|2
997330|NCT00443053|3272072|P2|Overall Study|Did Not Meet Eligibility Criteria|0
997331|NCT00443053|3272073|P1|Overall Study|Did Not Meet Eligibility Criteria|1
997332|NCT00443053|3272072|P2|Overall Study|Lost to Follow-up|5
997333|NCT00443053|3272073|P1|Overall Study|Lost to Follow-up|4
997334|NCT00443053|3272072|P2|Overall Study|Withdrawal by Subject|18
997335|NCT00443053|3272073|P1|Overall Study|Withdrawal by Subject|9
997336|NCT00443053|3272072|P2|Overall Study|Adverse Event|1
997337|NCT00443053|3272073|P1|Overall Study|Adverse Event|2
997338|NCT00443040|3272094|P3|Overall Study|Converted to an open laparotomy|1
997339|NCT00443040|3272095|P2|Overall Study|Converted to an open laparotomy|0
997340|NCT00443040|3272096|P1|Overall Study|Converted to an open laparotomy|3
997341|NCT00443040|3272094|P3|Overall Study|Withdrawal by Subject|0
997342|NCT00443040|3272095|P2|Overall Study|Withdrawal by Subject|0
997343|NCT00443040|3272096|P1|Overall Study|Withdrawal by Subject|1
997344|NCT00442962|3272104|P1|Overall Study|Lost to Follow-up|7
997345|NCT00442962|3272104|P1|Overall Study|Pregnancy|1
997346|NCT00442936|3272122|P4|Overall Study|Protocol Violation|1
997347|NCT00442936|3272123|P3|Overall Study|Protocol Violation|1
997348|NCT00442936|3272124|P2|Overall Study|Protocol Violation|0
997349|NCT00442936|3272125|P1|Overall Study|Protocol Violation|1
997350|NCT00442897|3272173|P2|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3
997351|NCT00442897|3272174|P1|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1
997352|NCT00442897|3272173|P2|24 Weeks Follow-up (3 Centers)|Protocol Violation|1
997353|NCT00442897|3272174|P1|24 Weeks Follow-up (3 Centers)|Protocol Violation|2
997354|NCT00442897|3272173|P2|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
997355|NCT00442897|3272174|P1|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
997356|NCT00442897|3272173|P2|24 Weeks Follow-up (3 Centers)|Adverse Event|0
997357|NCT00442897|3272174|P1|24 Weeks Follow-up (3 Centers)|Adverse Event|1
997358|NCT00442897|3272173|P2|Base Study (12 Week Follow-up)|Withdrawal by Subject|8
997359|NCT00442897|3272174|P1|Base Study (12 Week Follow-up)|Withdrawal by Subject|9
997360|NCT00442897|3272173|P2|Base Study (12 Week Follow-up)|Protocol Violation|3
997361|NCT00442897|3272174|P1|Base Study (12 Week Follow-up)|Protocol Violation|7
997362|NCT00442897|3272173|P2|Base Study (12 Week Follow-up)|Death|1
997363|NCT00442897|3272174|P1|Base Study (12 Week Follow-up)|Death|0
997364|NCT00442897|3272173|P2|Base Study (12 Week Follow-up)|Adverse Event|0
997365|NCT00442897|3272174|P1|Base Study (12 Week Follow-up)|Adverse Event|1
997366|NCT00442702|3272192|P2|Evaluation Period|Site closure|1
997367|NCT00442702|3272193|P1|Evaluation Period|Site closure|0
997368|NCT00442702|3272192|P2|Evaluation Period|Failure to return|0
997369|NCT00442702|3272193|P1|Evaluation Period|Failure to return|1
997370|NCT00442702|3272192|P2|Evaluation Period|Renal transplant|1
997371|NCT00442702|3272193|P1|Evaluation Period|Renal transplant|0
997372|NCT00442702|3272192|P2|Evaluation Period|Refused treatment|1
997373|NCT00442702|3272193|P1|Evaluation Period|Refused treatment|1
997374|NCT00442702|3272192|P2|Evaluation Period|Insufficient Therapeutic Response|0
997375|NCT00442702|3272193|P1|Evaluation Period|Insufficient Therapeutic Response|1
997376|NCT00442702|3272192|P2|Evaluation Period|Death|1
997377|NCT00442702|3272193|P1|Evaluation Period|Death|1
997378|NCT00442702|3272192|P2|Evaluation Period|Adverse Event|0
997379|NCT00442702|3272193|P1|Evaluation Period|Adverse Event|1
997380|NCT00442702|3272192|P2|Titration Period|Hospitalized in another hospital|0
997381|NCT00442702|3272193|P1|Titration Period|Hospitalized in another hospital|1
997382|NCT00442702|3272192|P2|Titration Period|Failure to return|0
997383|NCT00442702|3272193|P1|Titration Period|Failure to return|1
997384|NCT00442702|3272192|P2|Titration Period|Refused Treatment|1
997385|NCT00442702|3272193|P1|Titration Period|Refused Treatment|4
997386|NCT00442702|3272192|P2|Titration Period|Insufficient Therapeutic Response|0
997387|NCT00442702|3272193|P1|Titration Period|Insufficient Therapeutic Response|1
997388|NCT00442702|3272192|P2|Titration Period|Death|2
997389|NCT00442702|3272193|P1|Titration Period|Death|3
997390|NCT00442702|3272192|P2|Titration Period|Adverse Event|0
997391|NCT00442702|3272193|P1|Titration Period|Adverse Event|2
997392|NCT00442598|3272258|P3|Overall Study|Death|0
997393|NCT00442598|3272259|P2|Overall Study|Death|1
997394|NCT00442598|3272260|P1|Overall Study|Death|0
997395|NCT00442598|3272258|P3|Overall Study|Reduced creatinine clearance|0
997396|NCT00442598|3272259|P2|Overall Study|Reduced creatinine clearance|0
997397|NCT00442598|3272260|P1|Overall Study|Reduced creatinine clearance|1
997398|NCT00442598|3272258|P3|Overall Study|CA125 progression|0
997399|NCT00442598|3272259|P2|Overall Study|CA125 progression|1
997400|NCT00442598|3272260|P1|Overall Study|CA125 progression|0
997401|NCT00442598|3272258|P3|Overall Study|Clinical deterioration|0
997402|NCT00442598|3272259|P2|Overall Study|Clinical deterioration|2
997403|NCT00442598|3272260|P1|Overall Study|Clinical deterioration|1
997404|NCT00442598|3272258|P3|Overall Study|Tumor progression|0
997405|NCT00442598|3272259|P2|Overall Study|Tumor progression|4
997406|NCT00442598|3272260|P1|Overall Study|Tumor progression|3
997407|NCT00442598|3272258|P3|Overall Study|Adverse Event|0
997408|NCT00442598|3272259|P2|Overall Study|Adverse Event|0
997409|NCT00442598|3272260|P1|Overall Study|Adverse Event|1
997410|NCT00442572|3272278|P2|Overall Study|Withdrawal by Subject|1
997411|NCT00442572|3272279|P1|Overall Study|Withdrawal by Subject|0
997412|NCT00442572|3272278|P2|Overall Study|Lost to Follow-up|1
997413|NCT00442572|3272279|P1|Overall Study|Lost to Follow-up|0
997414|NCT00442572|3272278|P2|Overall Study|Relapse|1
997415|NCT00442572|3272279|P1|Overall Study|Relapse|8
997416|NCT00442559|3272319|P2|Overall Study|Withdrawal by Subject|0
997417|NCT00442559|3272320|P1|Overall Study|Withdrawal by Subject|1
997418|NCT00442559|3272319|P2|Overall Study|Protocol Violation|1
997419|NCT00442559|3272320|P1|Overall Study|Protocol Violation|1
997420|NCT00442559|3272319|P2|Overall Study|Lost to Follow-up|34
997421|NCT00442559|3272320|P1|Overall Study|Lost to Follow-up|32
997422|NCT00442546|3272335|P3|Overall Study|Randomized But Not Treated|6
997423|NCT00442546|3272336|P2|Overall Study|Randomized But Not Treated|4
997424|NCT00442546|3272337|P1|Overall Study|Randomized But Not Treated|5
997425|NCT00442546|3272335|P3|Overall Study|Withdrawal by Subject|7
997426|NCT00442546|3272336|P2|Overall Study|Withdrawal by Subject|5
997427|NCT00442546|3272337|P1|Overall Study|Withdrawal by Subject|5
997428|NCT00442546|3272335|P3|Overall Study|Other|6
997429|NCT00442546|3272336|P2|Overall Study|Other|9
997430|NCT00442546|3272337|P1|Overall Study|Other|4
997431|NCT00442546|3272335|P3|Overall Study|Lost to Follow-up|1
997432|NCT00442546|3272336|P2|Overall Study|Lost to Follow-up|2
997433|NCT00442546|3272337|P1|Overall Study|Lost to Follow-up|1
997434|NCT00442546|3272335|P3|Overall Study|Adverse Event|13
997435|NCT00442546|3272336|P2|Overall Study|Adverse Event|17
997436|NCT00442546|3272337|P1|Overall Study|Adverse Event|11
997437|NCT00442468|3272466|P1|Overall Study|Did not complete all study procedures|88
997438|NCT00442468|3272466|P1|Overall Study|Withdrawal by Subject|91
997439|NCT00442468|3272466|P1|Overall Study|Adverse Event|4
997440|NCT00442416|3272496|P2|Overall Study|Administrative/Other|33
997441|NCT00442416|3272497|P1|Overall Study|Administrative/Other|27
997442|NCT00442416|3272496|P2|Overall Study|Withdrew consent|2
997443|NCT00442416|3272497|P1|Overall Study|Withdrew consent|1
997444|NCT00442416|3272496|P2|Overall Study|Protocol Violation|3
997445|NCT00442416|3272497|P1|Overall Study|Protocol Violation|2
997446|NCT00442416|3272496|P2|Overall Study|Lack of Efficacy|0
997447|NCT00442416|3272497|P1|Overall Study|Lack of Efficacy|2
997448|NCT00442416|3272496|P2|Overall Study|Death|0
997449|NCT00442416|3272497|P1|Overall Study|Death|1
997450|NCT00442416|3272496|P2|Overall Study|Adverse Event|1
997451|NCT00442416|3272497|P1|Overall Study|Adverse Event|4
997452|NCT00442351|3272536|P2|Overall Study|Not specified|1
997453|NCT00442351|3272537|P1|Overall Study|Not specified|0
997454|NCT00442351|3272536|P2|Overall Study|Did not meet protocol eligibility|0
997455|NCT00442351|3272537|P1|Overall Study|Did not meet protocol eligibility|1
997456|NCT00442351|3272536|P2|Overall Study|Administrative|5
997457|NCT00442351|3272537|P1|Overall Study|Administrative|6
997458|NCT00442286|3272559|P2|Overall Study|Patient Injury|0
997459|NCT00442286|3272560|P1|Overall Study|Patient Injury|1
997460|NCT00442286|3272559|P2|Overall Study|System explanted|0
997461|NCT00442286|3272560|P1|Overall Study|System explanted|1
997462|NCT00442286|3272559|P2|Overall Study|Withdrawal by Subject|0
997463|NCT00442286|3272560|P1|Overall Study|Withdrawal by Subject|2
997464|NCT00442286|3272559|P2|Overall Study|Lost to Follow-up|0
997465|NCT00442286|3272560|P1|Overall Study|Lost to Follow-up|1
997466|NCT00442286|3272559|P2|Overall Study|Death|2
997467|NCT00442286|3272560|P1|Overall Study|Death|2
997468|NCT00442117|3272622|P2|Overall Study|Met Withdrawal Criteria|1
997469|NCT00442117|3272623|P1|Overall Study|Met Withdrawal Criteria|2
997470|NCT00442117|3272622|P2|Overall Study|Non compliance with protocol|5
997471|NCT00442117|3272623|P1|Overall Study|Non compliance with protocol|3
997472|NCT00442117|3272622|P2|Overall Study|Major Deviation|20
997473|NCT00442117|3272623|P1|Overall Study|Major Deviation|25
997474|NCT00442117|3272622|P2|Overall Study|Withdrawal by Subject|2
997475|NCT00442117|3272623|P1|Overall Study|Withdrawal by Subject|2
997476|NCT00442117|3272622|P2|Overall Study|Lost to Follow-up|2
997477|NCT00442117|3272623|P1|Overall Study|Lost to Follow-up|1
997478|NCT00442117|3272622|P2|Overall Study|Lack of Efficacy|6
997479|NCT00442117|3272623|P1|Overall Study|Lack of Efficacy|2
997480|NCT00442117|3272622|P2|Overall Study|Adverse Event|2
997481|NCT00442117|3272623|P1|Overall Study|Adverse Event|3
997482|NCT00441974|3272654|P1|Overall Study|Protocol Violation|7
997483|NCT00441974|3272654|P1|Overall Study|Lost to Follow-up|80
997484|NCT00441974|3272654|P1|Overall Study|Consent Withdrawn|35
997485|NCT00441974|3272654|P1|Overall Study|Adverse Event|6
997486|NCT00441792|3272670|P2|Overall Study|Lost to Follow-up|2
997487|NCT00441792|3272671|P1|Overall Study|Lost to Follow-up|0
997488|NCT00441727|3272711|P3|Overall Study|Various reason specified|5
997489|NCT00441727|3272712|P2|Overall Study|Various reason specified|8
997490|NCT00441727|3272713|P1|Overall Study|Various reason specified|6
997491|NCT00441727|3272711|P3|Overall Study|Safety Reasons|3
997492|NCT00441727|3272712|P2|Overall Study|Safety Reasons|1
997493|NCT00441727|3272713|P1|Overall Study|Safety Reasons|3
997494|NCT00441727|3272711|P3|Overall Study|Lost to Follow-up|5
997495|NCT00441727|3272712|P2|Overall Study|Lost to Follow-up|6
997496|NCT00441727|3272713|P1|Overall Study|Lost to Follow-up|5
997497|NCT00441727|3272711|P3|Overall Study|Withdrawal by Subject|47
997498|NCT00441727|3272712|P2|Overall Study|Withdrawal by Subject|34
997499|NCT00441727|3272713|P1|Overall Study|Withdrawal by Subject|40
997500|NCT00441727|3272711|P3|Overall Study|Lack of Efficacy|48
997501|NCT00441727|3272712|P2|Overall Study|Lack of Efficacy|8
997502|NCT00441727|3272713|P1|Overall Study|Lack of Efficacy|7
997503|NCT00441727|3272711|P3|Overall Study|Adverse Event|28
997504|NCT00441727|3272712|P2|Overall Study|Adverse Event|33
997505|NCT00441727|3272713|P1|Overall Study|Adverse Event|26
997506|NCT00441727|3272711|P3|Overall Study|Protocol Violation|32
997507|NCT00441727|3272712|P2|Overall Study|Protocol Violation|28
997508|NCT00441727|3272713|P1|Overall Study|Protocol Violation|19
997509|NCT00441701|3272746|P10|Overall Study|Withdrawal by Subject|0
997510|NCT00441701|3272747|P9|Overall Study|Withdrawal by Subject|0
997511|NCT00441701|3272748|P8|Overall Study|Withdrawal by Subject|0
997512|NCT00441701|3272749|P7|Overall Study|Withdrawal by Subject|0
997513|NCT00441701|3272750|P6|Overall Study|Withdrawal by Subject|0
997514|NCT00441701|3272751|P5|Overall Study|Withdrawal by Subject|0
997515|NCT00441701|3272752|P4|Overall Study|Withdrawal by Subject|1
997516|NCT00441701|3272753|P3|Overall Study|Withdrawal by Subject|1
997517|NCT00441701|3272754|P2|Overall Study|Withdrawal by Subject|2
997518|NCT00441701|3272755|P1|Overall Study|Withdrawal by Subject|0
997519|NCT00441701|3272746|P10|Overall Study|Lack of Efficacy|0
997520|NCT00441701|3272747|P9|Overall Study|Lack of Efficacy|0
997521|NCT00441701|3272748|P8|Overall Study|Lack of Efficacy|0
997522|NCT00441701|3272749|P7|Overall Study|Lack of Efficacy|0
997523|NCT00441701|3272750|P6|Overall Study|Lack of Efficacy|1
997524|NCT00441701|3272751|P5|Overall Study|Lack of Efficacy|0
997525|NCT00441701|3272752|P4|Overall Study|Lack of Efficacy|2
997526|NCT00441701|3272753|P3|Overall Study|Lack of Efficacy|2
997527|NCT00441701|3272754|P2|Overall Study|Lack of Efficacy|0
997528|NCT00441701|3272755|P1|Overall Study|Lack of Efficacy|2
997529|NCT00441701|3272746|P10|Overall Study|Adverse Event|0
997530|NCT00441701|3272747|P9|Overall Study|Adverse Event|0
997531|NCT00441701|3272748|P8|Overall Study|Adverse Event|0
997532|NCT00441701|3272749|P7|Overall Study|Adverse Event|0
997533|NCT00441701|3272750|P6|Overall Study|Adverse Event|2
997534|NCT00441701|3272751|P5|Overall Study|Adverse Event|2
997535|NCT00441701|3272752|P4|Overall Study|Adverse Event|0
997536|NCT00441701|3272753|P3|Overall Study|Adverse Event|1
997537|NCT00441701|3272754|P2|Overall Study|Adverse Event|2
997538|NCT00441701|3272755|P1|Overall Study|Adverse Event|3
997539|NCT00441584|3272837|P1|Overall Study|Failure to meet eligibility criteria|3
997540|NCT00441584|3272837|P1|Overall Study|Lost to Follow-up|4
997541|NCT00441584|3272837|P1|Overall Study|Protocol Violation|5
997542|NCT00441584|3272837|P1|Overall Study|Adverse Event|6
997543|NCT00441584|3272837|P1|Overall Study|Withdrawal by Subject|8
997544|NCT00441584|3272837|P1|Overall Study|Lack of Efficacy|79
997545|NCT00441545|3272845|P2|Second Intervention|Subject moved|1
997546|NCT00441545|3272846|P1|Second Intervention|Subject moved|0
997547|NCT00441545|3272845|P2|Second Intervention|Subject exceeded safety criteria|0
997548|NCT00441545|3272846|P1|Second Intervention|Subject exceeded safety criteria|1
997549|NCT00441545|3272845|P2|Second Intervention|Lack of Efficacy|1
997550|NCT00441545|3272846|P1|Second Intervention|Lack of Efficacy|0
997551|NCT00441545|3272845|P2|Second Intervention|Kidney Transplant|1
997552|NCT00441545|3272846|P1|Second Intervention|Kidney Transplant|1
997553|NCT00441545|3272845|P2|Second Intervention|Withdrawal by Subject|1
997554|NCT00441545|3272846|P1|Second Intervention|Withdrawal by Subject|1
997555|NCT00441545|3272845|P2|Second Intervention|Protocol Violation|1
997556|NCT00441545|3272846|P1|Second Intervention|Protocol Violation|4
997557|NCT00441545|3272845|P2|Second Intervention|Adverse Event|2
997558|NCT00441545|3272846|P1|Second Intervention|Adverse Event|5
997559|NCT00441545|3272845|P2|First Intervention|Sponsor's request|0
997560|NCT00441545|3272846|P1|First Intervention|Sponsor's request|1
997561|NCT00441545|3272845|P2|First Intervention|Site error|0
997562|NCT00441545|3272846|P1|First Intervention|Site error|1
997563|NCT00441545|3272845|P2|First Intervention|Extended hospitalization|0
997564|NCT00441545|3272846|P1|First Intervention|Extended hospitalization|1
997565|NCT00441545|3272845|P2|First Intervention|Subject met an exclusionary criteria|0
997566|NCT00441545|3272846|P1|First Intervention|Subject met an exclusionary criteria|1
997567|NCT00441545|3272845|P2|First Intervention|Subject exceeded safety criteria|1
997568|NCT00441545|3272846|P1|First Intervention|Subject exceeded safety criteria|0
997569|NCT00441545|3272845|P2|First Intervention|Lack of Efficacy|0
997570|NCT00441545|3272846|P1|First Intervention|Lack of Efficacy|2
997571|NCT00441545|3272845|P2|First Intervention|Kidney transplant|1
997572|NCT00441545|3272846|P1|First Intervention|Kidney transplant|1
997573|NCT00441545|3272845|P2|First Intervention|Withdrawal by Subject|3
997574|NCT00441545|3272846|P1|First Intervention|Withdrawal by Subject|3
997575|NCT00441545|3272845|P2|First Intervention|Protocol Violation|2
997576|NCT00441545|3272846|P1|First Intervention|Protocol Violation|2
997577|NCT00441545|3272845|P2|First Intervention|Adverse Event|5
997578|NCT00441545|3272846|P1|First Intervention|Adverse Event|6
997579|NCT00441480|3272860|P2|Overall Study|Withdrawal by Subject|3
997580|NCT00441480|3272861|P1|Overall Study|Withdrawal by Subject|2
997581|NCT00441480|3272860|P2|Overall Study|Protocol Violation|1
997582|NCT00441480|3272861|P1|Overall Study|Protocol Violation|1
997583|NCT00441467|3272893|P1|Overall Study|Progressive disease|9
997584|NCT00441467|3272893|P1|Overall Study|Withdrawal by Subject|3
997585|NCT00441467|3272893|P1|Overall Study|Adverse Event|6
997586|NCT00441441|3272901|P2|Overall Study|Not specified|3
997587|NCT00441441|3272902|P1|Overall Study|Not specified|3
997588|NCT00441441|3272901|P2|Overall Study|Withdrawal by Subject|2
997589|NCT00441441|3272902|P1|Overall Study|Withdrawal by Subject|1
997590|NCT00441441|3272901|P2|Overall Study|Exacerbation of asthma|2
997591|NCT00441441|3272902|P1|Overall Study|Exacerbation of asthma|1
997592|NCT00441441|3272901|P2|Overall Study|Protocol Violation|6
997593|NCT00441441|3272902|P1|Overall Study|Protocol Violation|4
997594|NCT00441441|3272901|P2|Overall Study|Adverse Event|1
997595|NCT00441441|3272902|P1|Overall Study|Adverse Event|2
997596|NCT00441363|3272962|P2|Overall Study|not specified|0
997597|NCT00441363|3272963|P1|Overall Study|not specified|2
997598|NCT00441363|3272962|P2|Overall Study|Lost to Follow-up|2
997599|NCT00441363|3272963|P1|Overall Study|Lost to Follow-up|2
997600|NCT00441363|3272962|P2|Overall Study|Physician Decision|7
997601|NCT00441363|3272963|P1|Overall Study|Physician Decision|6
997602|NCT00441363|3272962|P2|Overall Study|Withdrawal by Subject|4
997603|NCT00441363|3272963|P1|Overall Study|Withdrawal by Subject|3
997604|NCT00441363|3272962|P2|Overall Study|Adverse Event|2
997605|NCT00441363|3272963|P1|Overall Study|Adverse Event|4
997606|NCT00441337|3272975|P4|Overall Study|Did not meet inclusion criteria|0
997607|NCT00441337|3272976|P3|Overall Study|Did not meet inclusion criteria|1
997608|NCT00441337|3272977|P2|Overall Study|Did not meet inclusion criteria|0
997609|NCT00441337|3272978|P1|Overall Study|Did not meet inclusion criteria|0
997610|NCT00441337|3272975|P4|Overall Study|Sponsor Decision|2
997611|NCT00441337|3272976|P3|Overall Study|Sponsor Decision|1
997612|NCT00441337|3272977|P2|Overall Study|Sponsor Decision|0
997613|NCT00441337|3272978|P1|Overall Study|Sponsor Decision|0
997614|NCT00441337|3272975|P4|Overall Study|Lost to Follow-up|1
997615|NCT00441337|3272976|P3|Overall Study|Lost to Follow-up|0
997616|NCT00441337|3272977|P2|Overall Study|Lost to Follow-up|0
997617|NCT00441337|3272978|P1|Overall Study|Lost to Follow-up|0
997618|NCT00441337|3272975|P4|Overall Study|Disease Progression|18
997619|NCT00441337|3272976|P3|Overall Study|Disease Progression|4
997620|NCT00441337|3272977|P2|Overall Study|Disease Progression|6
997621|NCT00441337|3272978|P1|Overall Study|Disease Progression|6
997622|NCT00441272|3273091|P2|Overall Study|Study terminated prior to enrollment|25
997623|NCT00441272|3273092|P1|Overall Study|Study terminated prior to enrollment|25
997624|NCT00441168|3273119|P2|Follow-up Period|Other|3
997625|NCT00441168|3273120|P1|Follow-up Period|Other|1
997626|NCT00441168|3273119|P2|Follow-up Period|Withdrawal by Subject|0
997627|NCT00441168|3273120|P1|Follow-up Period|Withdrawal by Subject|3
997628|NCT00441168|3273119|P2|Follow-up Period|Lost to Follow-up|6
997629|NCT00441168|3273120|P1|Follow-up Period|Lost to Follow-up|5
997630|NCT00441168|3273119|P2|Follow-up Period|Death|0
997631|NCT00441168|3273120|P1|Follow-up Period|Death|3
997632|NCT00441168|3273119|P2|Treatment Period|refractory disease|0
997633|NCT00441168|3273120|P1|Treatment Period|refractory disease|1
997634|NCT00441168|3273119|P2|Treatment Period|qualified for stem-cell transplantation|0
997635|NCT00441168|3273120|P1|Treatment Period|qualified for stem-cell transplantation|3
997636|NCT00441168|3273119|P2|Treatment Period|Withdrawal by Subject|0
997637|NCT00441168|3273120|P1|Treatment Period|Withdrawal by Subject|3
997638|NCT00441168|3273119|P2|Treatment Period|Lost to Follow-up|1
997639|NCT00441168|3273120|P1|Treatment Period|Lost to Follow-up|0
997640|NCT00441168|3273119|P2|Treatment Period|Protocol Violation|1
997641|NCT00441168|3273120|P1|Treatment Period|Protocol Violation|0
997642|NCT00441168|3273119|P2|Treatment Period|Progressive Disease|2
997643|NCT00441168|3273120|P1|Treatment Period|Progressive Disease|0
997644|NCT00441168|3273119|P2|Treatment Period|Adverse Event|2
997645|NCT00441168|3273120|P1|Treatment Period|Adverse Event|1
997646|NCT00441168|3273119|P2|Treatment Period|Death|0
997647|NCT00441168|3273120|P1|Treatment Period|Death|3
997648|NCT00441142|3273134|P4|Overall Study|Death|1
997649|NCT00441142|3273135|P3|Overall Study|Death|0
997650|NCT00441142|3273136|P2|Overall Study|Death|0
997651|NCT00441142|3273137|P1|Overall Study|Death|0
997652|NCT00441142|3273134|P4|Overall Study|Physician Decision|1
997653|NCT00441142|3273135|P3|Overall Study|Physician Decision|0
997654|NCT00441142|3273136|P2|Overall Study|Physician Decision|1
997655|NCT00441142|3273137|P1|Overall Study|Physician Decision|0
997656|NCT00441142|3273134|P4|Overall Study|Patient still receiving active study tx|2
997657|NCT00441142|3273135|P3|Overall Study|Patient still receiving active study tx|0
997658|NCT00441142|3273136|P2|Overall Study|Patient still receiving active study tx|0
997659|NCT00441142|3273137|P1|Overall Study|Patient still receiving active study tx|1
997660|NCT00441142|3273134|P4|Overall Study|Withdrawal by Subject|10
997661|NCT00441142|3273135|P3|Overall Study|Withdrawal by Subject|2
997662|NCT00441142|3273136|P2|Overall Study|Withdrawal by Subject|0
997663|NCT00441142|3273137|P1|Overall Study|Withdrawal by Subject|0
997664|NCT00441142|3273134|P4|Overall Study|Lack of Efficacy|32
997665|NCT00441142|3273135|P3|Overall Study|Lack of Efficacy|17
997666|NCT00441142|3273136|P2|Overall Study|Lack of Efficacy|3
997667|NCT00441142|3273137|P1|Overall Study|Lack of Efficacy|3
997668|NCT00441142|3273134|P4|Overall Study|Adverse Event|22
997669|NCT00441142|3273135|P3|Overall Study|Adverse Event|3
997670|NCT00441142|3273136|P2|Overall Study|Adverse Event|3
997671|NCT00441142|3273137|P1|Overall Study|Adverse Event|2
997672|NCT00441116|3273155|P2|Overall Study|Did not meet Eligibility Criteria|1
997673|NCT00441116|3273156|P1|Overall Study|Did not meet Eligibility Criteria|1
997674|NCT00441116|3273155|P2|Overall Study|Withdrawal by Subject|0
997675|NCT00441116|3273156|P1|Overall Study|Withdrawal by Subject|1
997676|NCT00441116|3273155|P2|Overall Study|Adverse Event|1
997677|NCT00441116|3273156|P1|Overall Study|Adverse Event|1
997678|NCT00441103|3273224|P2|Overall Study|Participant decided to stop|1
997679|NCT00441103|3273225|P1|Overall Study|Participant decided to stop|0
997680|NCT00441103|3273224|P2|Overall Study|Participant's reason|1
997681|NCT00441103|3273225|P1|Overall Study|Participant's reason|0
997682|NCT00441103|3273224|P2|Overall Study|Participant decided to withdraw|0
997683|NCT00441103|3273225|P1|Overall Study|Participant decided to withdraw|1
997684|NCT00441103|3273224|P2|Overall Study|Non-compliant|1
997685|NCT00441103|3273225|P1|Overall Study|Non-compliant|0
997686|NCT00441103|3273224|P2|Overall Study|Inclusion criteria absent|0
997687|NCT00441103|3273225|P1|Overall Study|Inclusion criteria absent|1
997688|NCT00441103|3273224|P2|Overall Study|Participant refused MRI|0
997689|NCT00441103|3273225|P1|Overall Study|Participant refused MRI|1
997690|NCT00441103|3273224|P2|Overall Study|Participant unable to use Rebiject II|0
997691|NCT00441103|3273225|P1|Overall Study|Participant unable to use Rebiject II|1
997692|NCT00441103|3273224|P2|Overall Study|Protocol Violation|0
997693|NCT00441103|3273225|P1|Overall Study|Protocol Violation|1
997694|NCT00441103|3273224|P2|Overall Study|Lost to Follow-up|0
997695|NCT00441103|3273225|P1|Overall Study|Lost to Follow-up|1
997696|NCT00441103|3273224|P2|Overall Study|Disease Progression|0
997697|NCT00441103|3273225|P1|Overall Study|Disease Progression|2
997698|NCT00441103|3273224|P2|Overall Study|Death|0
997699|NCT00441103|3273225|P1|Overall Study|Death|1
997700|NCT00441103|3273224|P2|Overall Study|Adverse Event|1
997701|NCT00441103|3273225|P1|Overall Study|Adverse Event|2
997702|NCT00441090|3273241|P5|Overall Study|Lack of Efficacy|0
997703|NCT00441090|3273242|P4|Overall Study|Lack of Efficacy|0
997704|NCT00441090|3273243|P3|Overall Study|Lack of Efficacy|0
997705|NCT00441090|3273244|P2|Overall Study|Lack of Efficacy|0
997706|NCT00441090|3273245|P1|Overall Study|Lack of Efficacy|1
997707|NCT00441090|3273241|P5|Overall Study|Withdrawal by Subject|0
997708|NCT00441090|3273242|P4|Overall Study|Withdrawal by Subject|0
997709|NCT00441090|3273243|P3|Overall Study|Withdrawal by Subject|1
997710|NCT00441090|3273244|P2|Overall Study|Withdrawal by Subject|0
997711|NCT00441090|3273245|P1|Overall Study|Withdrawal by Subject|1
997712|NCT00441090|3273241|P5|Overall Study|Platelet increase;more than 500,000 mm^3|0
997713|NCT00441090|3273242|P4|Overall Study|Platelet increase;more than 500,000 mm^3|2
997714|NCT00441090|3273243|P3|Overall Study|Platelet increase;more than 500,000 mm^3|0
997715|NCT00441090|3273244|P2|Overall Study|Platelet increase;more than 500,000 mm^3|0
997716|NCT00441090|3273245|P1|Overall Study|Platelet increase;more than 500,000 mm^3|0
997717|NCT00441090|3273241|P5|Overall Study|Adverse Event|0
997718|NCT00441090|3273242|P4|Overall Study|Adverse Event|0
997719|NCT00441090|3273243|P3|Overall Study|Adverse Event|1
997720|NCT00441090|3273244|P2|Overall Study|Adverse Event|1
997721|NCT00441090|3273245|P1|Overall Study|Adverse Event|0
997722|NCT00441064|3273289|P2|Overall Study|Patient withdrew consent|2
997723|NCT00441064|3273290|P1|Overall Study|Patient withdrew consent|5
997724|NCT00441064|3273289|P2|Overall Study|Protocol Deviation|2
997725|NCT00441064|3273290|P1|Overall Study|Protocol Deviation|3
997726|NCT00441064|3273289|P2|Overall Study|Unsatisfactory therapeutic effect|0
997727|NCT00441064|3273290|P1|Overall Study|Unsatisfactory therapeutic effect|1
997728|NCT00441064|3273289|P2|Overall Study|Abnormal test procedure results|1
997729|NCT00441064|3273290|P1|Overall Study|Abnormal test procedure results|0
997730|NCT00441064|3273289|P2|Overall Study|Abnormal laboratory values|2
997731|NCT00441064|3273290|P1|Overall Study|Abnormal laboratory values|0
997732|NCT00441064|3273289|P2|Overall Study|Adverse Event|0
997733|NCT00441064|3273290|P1|Overall Study|Adverse Event|1
997734|NCT00441012|3273302|P2|Overall Study|Subject Randomized but Not Vaccinated|0
997735|NCT00441012|3273303|P1|Overall Study|Subject Randomized but Not Vaccinated|1
997736|NCT00441012|3273302|P2|Overall Study|Withdrawal by Subject|0
997737|NCT00441012|3273303|P1|Overall Study|Withdrawal by Subject|4
997738|NCT00441012|3273302|P2|Overall Study|Protocol Violation|9
997739|NCT00441012|3273303|P1|Overall Study|Protocol Violation|10
997740|NCT00441012|3273302|P2|Overall Study|Lost to Follow-up|3
997741|NCT00441012|3273303|P1|Overall Study|Lost to Follow-up|3
997742|NCT00441012|3273302|P2|Overall Study|Adverse Event|1
997743|NCT00441012|3273303|P1|Overall Study|Adverse Event|0
997744|NCT00440947|3273317|P5|Optional 60-Week Extension Phase|Participant Remained in Cuba|1
997745|NCT00440947|3273318|P4|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
997746|NCT00440947|3273319|P3|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
997747|NCT00440947|3273320|P2|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
997748|NCT00440947|3273321|P1|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
997749|NCT00440947|3273317|P5|Optional 60-Week Extension Phase|Physician Decision|1
997750|NCT00440947|3273318|P4|Optional 60-Week Extension Phase|Physician Decision|0
997751|NCT00440947|3273319|P3|Optional 60-Week Extension Phase|Physician Decision|0
997752|NCT00440947|3273320|P2|Optional 60-Week Extension Phase|Physician Decision|0
997753|NCT00440947|3273321|P1|Optional 60-Week Extension Phase|Physician Decision|0
997754|NCT00440947|3273317|P5|Optional 60-Week Extension Phase|Other|0
997755|NCT00440947|3273318|P4|Optional 60-Week Extension Phase|Other|1
997756|NCT00440947|3273319|P3|Optional 60-Week Extension Phase|Other|0
997757|NCT00440947|3273320|P2|Optional 60-Week Extension Phase|Other|0
997758|NCT00440947|3273321|P1|Optional 60-Week Extension Phase|Other|0
997759|NCT00440947|3273317|P5|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
997760|NCT00440947|3273318|P4|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
997761|NCT00440947|3273319|P3|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
997762|NCT00440947|3273320|P2|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
997763|NCT00440947|3273321|P1|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
997764|NCT00440947|3273317|P5|Optional 60-Week Extension Phase|Sponsor Request|1
997765|NCT00440947|3273318|P4|Optional 60-Week Extension Phase|Sponsor Request|1
997766|NCT00440947|3273319|P3|Optional 60-Week Extension Phase|Sponsor Request|0
997767|NCT00440947|3273320|P2|Optional 60-Week Extension Phase|Sponsor Request|0
997768|NCT00440947|3273321|P1|Optional 60-Week Extension Phase|Sponsor Request|0
997769|NCT00440947|3273317|P5|Optional 60-Week Extension Phase|Participant Moved|1
997770|NCT00440947|3273318|P4|Optional 60-Week Extension Phase|Participant Moved|1
997771|NCT00440947|3273319|P3|Optional 60-Week Extension Phase|Participant Moved|0
997772|NCT00440947|3273320|P2|Optional 60-Week Extension Phase|Participant Moved|0
997773|NCT00440947|3273321|P1|Optional 60-Week Extension Phase|Participant Moved|0
997774|NCT00440947|3273317|P5|Optional 60-Week Extension Phase|Pregnancy|0
997775|NCT00440947|3273318|P4|Optional 60-Week Extension Phase|Pregnancy|3
997776|NCT00440947|3273319|P3|Optional 60-Week Extension Phase|Pregnancy|0
997777|NCT00440947|3273320|P2|Optional 60-Week Extension Phase|Pregnancy|0
997778|NCT00440947|3273321|P1|Optional 60-Week Extension Phase|Pregnancy|0
997779|NCT00440947|3273317|P5|Optional 60-Week Extension Phase|Withdrawal by Subject|3
997780|NCT00440947|3273318|P4|Optional 60-Week Extension Phase|Withdrawal by Subject|4
997781|NCT00440947|3273319|P3|Optional 60-Week Extension Phase|Withdrawal by Subject|0
997782|NCT00440947|3273320|P2|Optional 60-Week Extension Phase|Withdrawal by Subject|0
997783|NCT00440947|3273321|P1|Optional 60-Week Extension Phase|Withdrawal by Subject|0
997784|NCT00440947|3273317|P5|Optional 60-Week Extension Phase|Protocol Violation|0
997785|NCT00440947|3273318|P4|Optional 60-Week Extension Phase|Protocol Violation|1
997786|NCT00440947|3273319|P3|Optional 60-Week Extension Phase|Protocol Violation|0
997787|NCT00440947|3273320|P2|Optional 60-Week Extension Phase|Protocol Violation|0
997788|NCT00440947|3273321|P1|Optional 60-Week Extension Phase|Protocol Violation|0
997789|NCT00440947|3273317|P5|Optional 60-Week Extension Phase|Lost to Follow-up|9
997790|NCT00440947|3273318|P4|Optional 60-Week Extension Phase|Lost to Follow-up|9
997791|NCT00440947|3273319|P3|Optional 60-Week Extension Phase|Lost to Follow-up|0
997792|NCT00440947|3273320|P2|Optional 60-Week Extension Phase|Lost to Follow-up|0
997793|NCT00440947|3273321|P1|Optional 60-Week Extension Phase|Lost to Follow-up|0
997794|NCT00440947|3273317|P5|Optional 60-Week Extension Phase|Non-compliance|1
997795|NCT00440947|3273318|P4|Optional 60-Week Extension Phase|Non-compliance|1
997796|NCT00440947|3273319|P3|Optional 60-Week Extension Phase|Non-compliance|0
997797|NCT00440947|3273320|P2|Optional 60-Week Extension Phase|Non-compliance|0
997798|NCT00440947|3273321|P1|Optional 60-Week Extension Phase|Non-compliance|0
997799|NCT00440947|3273317|P5|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2
997800|NCT00440947|3273318|P4|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3
997801|NCT00440947|3273319|P3|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
997802|NCT00440947|3273320|P2|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
997803|NCT00440947|3273321|P1|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
997804|NCT00440947|3273317|P5|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
997805|NCT00440947|3273318|P4|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
997806|NCT00440947|3273319|P3|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
997807|NCT00440947|3273320|P2|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
997808|NCT00440947|3273321|P1|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
997809|NCT00440947|3273317|P5|Optional 60-Week Extension Phase|Adverse Event|3
997810|NCT00440947|3273318|P4|Optional 60-Week Extension Phase|Adverse Event|1
997811|NCT00440947|3273319|P3|Optional 60-Week Extension Phase|Adverse Event|0
997812|NCT00440947|3273320|P2|Optional 60-Week Extension Phase|Adverse Event|0
997813|NCT00440947|3273321|P1|Optional 60-Week Extension Phase|Adverse Event|0
997814|NCT00440947|3273317|P5|48-Week Randomization Phase|Physician Decision|0
997815|NCT00440947|3273318|P4|48-Week Randomization Phase|Physician Decision|0
997816|NCT00440947|3273319|P3|48-Week Randomization Phase|Physician Decision|0
997817|NCT00440947|3273320|P2|48-Week Randomization Phase|Physician Decision|2
997818|NCT00440947|3273321|P1|48-Week Randomization Phase|Physician Decision|0
997819|NCT00440947|3273317|P5|48-Week Randomization Phase|Trying to Get Pregnant|0
997820|NCT00440947|3273318|P4|48-Week Randomization Phase|Trying to Get Pregnant|0
997821|NCT00440947|3273319|P3|48-Week Randomization Phase|Trying to Get Pregnant|0
997822|NCT00440947|3273320|P2|48-Week Randomization Phase|Trying to Get Pregnant|1
997823|NCT00440947|3273321|P1|48-Week Randomization Phase|Trying to Get Pregnant|0
997824|NCT00440947|3273317|P5|48-Week Randomization Phase|Incarceration|0
997825|NCT00440947|3273318|P4|48-Week Randomization Phase|Incarceration|0
997826|NCT00440947|3273319|P3|48-Week Randomization Phase|Incarceration|0
997827|NCT00440947|3273320|P2|48-Week Randomization Phase|Incarceration|3
997828|NCT00440947|3273321|P1|48-Week Randomization Phase|Incarceration|0
997829|NCT00440947|3273317|P5|48-Week Randomization Phase|Pregnancy|0
997830|NCT00440947|3273318|P4|48-Week Randomization Phase|Pregnancy|0
997831|NCT00440947|3273319|P3|48-Week Randomization Phase|Pregnancy|1
997832|NCT00440947|3273320|P2|48-Week Randomization Phase|Pregnancy|0
997833|NCT00440947|3273321|P1|48-Week Randomization Phase|Pregnancy|0
997834|NCT00440947|3273317|P5|48-Week Randomization Phase|Withdrawal by Subject|0
997835|NCT00440947|3273318|P4|48-Week Randomization Phase|Withdrawal by Subject|0
997836|NCT00440947|3273319|P3|48-Week Randomization Phase|Withdrawal by Subject|4
997837|NCT00440947|3273320|P2|48-Week Randomization Phase|Withdrawal by Subject|2
997838|NCT00440947|3273321|P1|48-Week Randomization Phase|Withdrawal by Subject|0
997839|NCT00440947|3273317|P5|48-Week Randomization Phase|Protocol Violation|0
997840|NCT00440947|3273318|P4|48-Week Randomization Phase|Protocol Violation|0
997841|NCT00440947|3273319|P3|48-Week Randomization Phase|Protocol Violation|1
997842|NCT00440947|3273320|P2|48-Week Randomization Phase|Protocol Violation|0
997843|NCT00440947|3273321|P1|48-Week Randomization Phase|Protocol Violation|0
997844|NCT00440947|3273317|P5|48-Week Randomization Phase|Lost to Follow-up|0
997845|NCT00440947|3273318|P4|48-Week Randomization Phase|Lost to Follow-up|0
997846|NCT00440947|3273319|P3|48-Week Randomization Phase|Lost to Follow-up|8
997847|NCT00440947|3273320|P2|48-Week Randomization Phase|Lost to Follow-up|2
997848|NCT00440947|3273321|P1|48-Week Randomization Phase|Lost to Follow-up|0
997849|NCT00440947|3273317|P5|48-Week Randomization Phase|Non-compliance|0
997850|NCT00440947|3273318|P4|48-Week Randomization Phase|Non-compliance|0
997851|NCT00440947|3273319|P3|48-Week Randomization Phase|Non-compliance|4
997852|NCT00440947|3273320|P2|48-Week Randomization Phase|Non-compliance|3
997853|NCT00440947|3273321|P1|48-Week Randomization Phase|Non-compliance|0
997854|NCT00440947|3273317|P5|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
997855|NCT00440947|3273318|P4|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
997856|NCT00440947|3273319|P3|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
997857|NCT00440947|3273320|P2|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
997858|NCT00440947|3273321|P1|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
997859|NCT00440947|3273317|P5|48-Week Randomization Phase|Adverse Event|0
997860|NCT00440947|3273318|P4|48-Week Randomization Phase|Adverse Event|0
997861|NCT00440947|3273319|P3|48-Week Randomization Phase|Adverse Event|5
997862|NCT00440947|3273320|P2|48-Week Randomization Phase|Adverse Event|2
997863|NCT00440947|3273321|P1|48-Week Randomization Phase|Adverse Event|0
997864|NCT00440947|3273317|P5|36-Week Induction Phase|Pregnancy|0
997865|NCT00440947|3273318|P4|36-Week Induction Phase|Pregnancy|0
997866|NCT00440947|3273319|P3|36-Week Induction Phase|Pregnancy|0
997867|NCT00440947|3273320|P2|36-Week Induction Phase|Pregnancy|0
997868|NCT00440947|3273321|P1|36-Week Induction Phase|Pregnancy|1
997869|NCT00440947|3273317|P5|36-Week Induction Phase|Incarceration|0
997870|NCT00440947|3273318|P4|36-Week Induction Phase|Incarceration|0
997871|NCT00440947|3273319|P3|36-Week Induction Phase|Incarceration|0
997872|NCT00440947|3273320|P2|36-Week Induction Phase|Incarceration|0
997873|NCT00440947|3273321|P1|36-Week Induction Phase|Incarceration|3
997874|NCT00440947|3273317|P5|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
997875|NCT00440947|3273318|P4|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
997876|NCT00440947|3273319|P3|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
997877|NCT00440947|3273320|P2|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
997878|NCT00440947|3273321|P1|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1
997879|NCT00440947|3273317|P5|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
997880|NCT00440947|3273318|P4|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
997881|NCT00440947|3273319|P3|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
997882|NCT00440947|3273320|P2|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
997883|NCT00440947|3273321|P1|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1
997884|NCT00440947|3273317|P5|36-Week Induction Phase|Took Exclusionary Medications|0
997885|NCT00440947|3273318|P4|36-Week Induction Phase|Took Exclusionary Medications|0
997886|NCT00440947|3273319|P3|36-Week Induction Phase|Took Exclusionary Medications|0
997887|NCT00440947|3273320|P2|36-Week Induction Phase|Took Exclusionary Medications|0
997888|NCT00440947|3273321|P1|36-Week Induction Phase|Took Exclusionary Medications|1
997889|NCT00440947|3273317|P5|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
997890|NCT00440947|3273318|P4|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
997891|NCT00440947|3273319|P3|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
997892|NCT00440947|3273320|P2|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
997893|NCT00440947|3273321|P1|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1
997894|NCT00440947|3273317|P5|36-Week Induction Phase|Withdrawal by Subject|0
997895|NCT00440947|3273318|P4|36-Week Induction Phase|Withdrawal by Subject|0
997896|NCT00440947|3273319|P3|36-Week Induction Phase|Withdrawal by Subject|0
997897|NCT00440947|3273320|P2|36-Week Induction Phase|Withdrawal by Subject|0
997898|NCT00440947|3273321|P1|36-Week Induction Phase|Withdrawal by Subject|7
997899|NCT00440947|3273317|P5|36-Week Induction Phase|Lost to Follow-up|0
997900|NCT00440947|3273318|P4|36-Week Induction Phase|Lost to Follow-up|0
997901|NCT00440947|3273319|P3|36-Week Induction Phase|Lost to Follow-up|0
997902|NCT00440947|3273320|P2|36-Week Induction Phase|Lost to Follow-up|0
997903|NCT00440947|3273321|P1|36-Week Induction Phase|Lost to Follow-up|16
997904|NCT00440947|3273317|P5|36-Week Induction Phase|Non-compliance|0
997905|NCT00440947|3273318|P4|36-Week Induction Phase|Non-compliance|0
997906|NCT00440947|3273319|P3|36-Week Induction Phase|Non-compliance|0
997907|NCT00440947|3273320|P2|36-Week Induction Phase|Non-compliance|0
997908|NCT00440947|3273321|P1|36-Week Induction Phase|Non-compliance|10
997909|NCT00440947|3273317|P5|36-Week Induction Phase|Protocol-defined Virologic Failure|0
997910|NCT00440947|3273318|P4|36-Week Induction Phase|Protocol-defined Virologic Failure|0
997911|NCT00440947|3273319|P3|36-Week Induction Phase|Protocol-defined Virologic Failure|0
997912|NCT00440947|3273320|P2|36-Week Induction Phase|Protocol-defined Virologic Failure|0
997913|NCT00440947|3273321|P1|36-Week Induction Phase|Protocol-defined Virologic Failure|5
997914|NCT00440947|3273317|P5|36-Week Induction Phase|Insufficient Viral Load Response|0
997915|NCT00440947|3273318|P4|36-Week Induction Phase|Insufficient Viral Load Response|0
997916|NCT00440947|3273319|P3|36-Week Induction Phase|Insufficient Viral Load Response|0
997917|NCT00440947|3273320|P2|36-Week Induction Phase|Insufficient Viral Load Response|0
997918|NCT00440947|3273321|P1|36-Week Induction Phase|Insufficient Viral Load Response|11
997919|NCT00440947|3273317|P5|36-Week Induction Phase|Adverse Event|0
997920|NCT00440947|3273318|P4|36-Week Induction Phase|Adverse Event|0
997921|NCT00440947|3273319|P3|36-Week Induction Phase|Adverse Event|0
997922|NCT00440947|3273320|P2|36-Week Induction Phase|Adverse Event|0
997923|NCT00440947|3273321|P1|36-Week Induction Phase|Adverse Event|16
997924|NCT00440700|3273396|P3|Overall Study|Withdrawal by Subject|4
997925|NCT00440700|3273397|P2|Overall Study|Withdrawal by Subject|8
997926|NCT00440700|3273398|P1|Overall Study|Withdrawal by Subject|8
997927|NCT00440557|3273421|P3|Overall Study|Patient had surgery|0
997928|NCT00440557|3273422|P2|Overall Study|Patient had surgery|0
997929|NCT00440557|3273423|P1|Overall Study|Patient had surgery|1
997930|NCT00440557|3273421|P3|Overall Study|Patient transferred to nursing home|0
997931|NCT00440557|3273422|P2|Overall Study|Patient transferred to nursing home|1
997932|NCT00440557|3273423|P1|Overall Study|Patient transferred to nursing home|0
997933|NCT00440557|3273421|P3|Overall Study|Principal Investigator's office closed|4
997934|NCT00440557|3273422|P2|Overall Study|Principal Investigator's office closed|6
997935|NCT00440557|3273423|P1|Overall Study|Principal Investigator's office closed|3
997936|NCT00440557|3273421|P3|Overall Study|Patient moved|1
997937|NCT00440557|3273422|P2|Overall Study|Patient moved|2
997938|NCT00440557|3273423|P1|Overall Study|Patient moved|1
997939|NCT00440557|3273421|P3|Overall Study|Principal Investigator decision|1
997940|NCT00440557|3273422|P2|Overall Study|Principal Investigator decision|3
997941|NCT00440557|3273423|P1|Overall Study|Principal Investigator decision|0
997942|NCT00440557|3273421|P3|Overall Study|Began Dialysis|4
997943|NCT00440557|3273422|P2|Overall Study|Began Dialysis|1
997944|NCT00440557|3273423|P1|Overall Study|Began Dialysis|4
997945|NCT00440557|3273421|P3|Overall Study|Death|3
997946|NCT00440557|3273422|P2|Overall Study|Death|6
997947|NCT00440557|3273423|P1|Overall Study|Death|2
997948|NCT00440557|3273421|P3|Overall Study|Adverse Event|5
997949|NCT00440557|3273422|P2|Overall Study|Adverse Event|3
997950|NCT00440557|3273423|P1|Overall Study|Adverse Event|3
997951|NCT00440557|3273421|P3|Overall Study|Lost to Follow-up|6
997952|NCT00440557|3273422|P2|Overall Study|Lost to Follow-up|2
997953|NCT00440557|3273423|P1|Overall Study|Lost to Follow-up|1
997954|NCT00440557|3273421|P3|Overall Study|Withdrawal by Subject|11
997955|NCT00440557|3273422|P2|Overall Study|Withdrawal by Subject|5
997956|NCT00440557|3273423|P1|Overall Study|Withdrawal by Subject|10
997957|NCT00440531|3273455|P3|Overall Study|see pre-assignment details|0
997958|NCT00440531|3273456|P2|Overall Study|see pre-assignment details|0
997959|NCT00440531|3273457|P1|Overall Study|see pre-assignment details|2
997960|NCT00440531|3273455|P3|Overall Study|Lost to Follow-up|5
997961|NCT00440531|3273456|P2|Overall Study|Lost to Follow-up|3
997962|NCT00440531|3273457|P1|Overall Study|Lost to Follow-up|4
997963|NCT00440531|3273455|P3|Overall Study|Protocol Violation|0
997964|NCT00440531|3273456|P2|Overall Study|Protocol Violation|2
997965|NCT00440531|3273457|P1|Overall Study|Protocol Violation|1
997966|NCT00440531|3273455|P3|Overall Study|Withdrawal by Subject|0
997967|NCT00440531|3273456|P2|Overall Study|Withdrawal by Subject|0
997968|NCT00440531|3273457|P1|Overall Study|Withdrawal by Subject|2
997969|NCT00440531|3273455|P3|Overall Study|Adverse Event|2
997970|NCT00440531|3273456|P2|Overall Study|Adverse Event|0
997971|NCT00440531|3273457|P1|Overall Study|Adverse Event|1
997972|NCT00440518|3273474|P3|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0
997973|NCT00440518|3273475|P2|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2
997974|NCT00440518|3273476|P1|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1
997975|NCT00440518|3273474|P3|Maintenance and Safety Follow-up Periods|Other|2
997976|NCT00440518|3273475|P2|Maintenance and Safety Follow-up Periods|Other|0
997977|NCT00440518|3273476|P1|Maintenance and Safety Follow-up Periods|Other|0
997978|NCT00440518|3273474|P3|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6
997979|NCT00440518|3273475|P2|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3
997980|NCT00440518|3273476|P1|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0
997981|NCT00440518|3273474|P3|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4
997982|NCT00440518|3273475|P2|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2
997983|NCT00440518|3273476|P1|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3
997984|NCT00440518|3273474|P3|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
997985|NCT00440518|3273475|P2|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
997986|NCT00440518|3273476|P1|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0
997987|NCT00440518|3273474|P3|Maintenance and Safety Follow-up Periods|Adverse Event|2
997988|NCT00440518|3273475|P2|Maintenance and Safety Follow-up Periods|Adverse Event|4
997989|NCT00440518|3273476|P1|Maintenance and Safety Follow-up Periods|Adverse Event|3
997990|NCT00440518|3273474|P3|Randomized /Titration Period|Adverse Event|0
997991|NCT00440518|3273475|P2|Randomized /Titration Period|Adverse Event|3
997992|NCT00440518|3273476|P1|Randomized /Titration Period|Adverse Event|2
997993|NCT00440518|3273474|P3|Randomized /Titration Period|Lost to Follow-up|1
997994|NCT00440518|3273475|P2|Randomized /Titration Period|Lost to Follow-up|2
997995|NCT00440518|3273476|P1|Randomized /Titration Period|Lost to Follow-up|2
997996|NCT00440518|3273474|P3|Randomized /Titration Period|Other|0
997997|NCT00440518|3273475|P2|Randomized /Titration Period|Other|0
997998|NCT00440518|3273476|P1|Randomized /Titration Period|Other|1
997999|NCT00440518|3273474|P3|Randomized /Titration Period|Unsatisfactory Compliance|2
998000|NCT00440518|3273475|P2|Randomized /Titration Period|Unsatisfactory Compliance|3
998001|NCT00440518|3273476|P1|Randomized /Titration Period|Unsatisfactory Compliance|2
998002|NCT00440518|3273474|P3|Randomized /Titration Period|Protocol Deviation|0
998003|NCT00440518|3273475|P2|Randomized /Titration Period|Protocol Deviation|0
998004|NCT00440518|3273476|P1|Randomized /Titration Period|Protocol Deviation|1
998005|NCT00440518|3273474|P3|Randomized /Titration Period|Subject Withdrew Consent|0
998006|NCT00440518|3273475|P2|Randomized /Titration Period|Subject Withdrew Consent|1
998007|NCT00440518|3273476|P1|Randomized /Titration Period|Subject Withdrew Consent|4
998008|NCT00440518|3273474|P3|Randomized /Titration Period|Lack of Efficacy|1
998009|NCT00440518|3273475|P2|Randomized /Titration Period|Lack of Efficacy|0
998010|NCT00440518|3273476|P1|Randomized /Titration Period|Lack of Efficacy|1
998011|NCT00440466|3273521|P3|Overall Study|Met Hemoglobin Withdrawal Criteria|4
998012|NCT00440466|3273522|P2|Overall Study|Met Hemoglobin Withdrawal Criteria|4
998013|NCT00440466|3273523|P1|Overall Study|Met Hemoglobin Withdrawal Criteria|0
998014|NCT00440466|3273521|P3|Overall Study|Began Dialysis|1
998015|NCT00440466|3273522|P2|Overall Study|Began Dialysis|0
998016|NCT00440466|3273523|P1|Overall Study|Began Dialysis|0
998017|NCT00440466|3273521|P3|Overall Study|Withdrawal by Subject|9
998018|NCT00440466|3273522|P2|Overall Study|Withdrawal by Subject|5
998019|NCT00440466|3273523|P1|Overall Study|Withdrawal by Subject|2
998020|NCT00440466|3273521|P3|Overall Study|Protocol Violation|4
998021|NCT00440466|3273522|P2|Overall Study|Protocol Violation|0
998022|NCT00440466|3273523|P1|Overall Study|Protocol Violation|2
998023|NCT00440466|3273521|P3|Overall Study|Physician Decision|1
998024|NCT00440466|3273522|P2|Overall Study|Physician Decision|0
998025|NCT00440466|3273523|P1|Overall Study|Physician Decision|2
998026|NCT00440466|3273521|P3|Overall Study|Lost to Follow-up|2
998027|NCT00440466|3273522|P2|Overall Study|Lost to Follow-up|0
998028|NCT00440466|3273523|P1|Overall Study|Lost to Follow-up|1
998029|NCT00440466|3273521|P3|Overall Study|Adverse Event|11
998030|NCT00440466|3273522|P2|Overall Study|Adverse Event|4
998031|NCT00440466|3273523|P1|Overall Study|Adverse Event|3
998032|NCT00440466|3273521|P3|Overall Study|Death|9
998033|NCT00440466|3273522|P2|Overall Study|Death|2
998034|NCT00440466|3273523|P1|Overall Study|Death|3
998035|NCT00440401|3273557|P2|Overall Study|Not specified|5
998036|NCT00440401|3273558|P1|Overall Study|Not specified|2
998037|NCT00440401|3273557|P2|Overall Study|Adverse Event|1
998038|NCT00440401|3273558|P1|Overall Study|Adverse Event|2
998039|NCT00440310|3273568|P2|Overall Study|Status Unknown|3
998040|NCT00440310|3273569|P1|Overall Study|Status Unknown|1
998041|NCT00440310|3273568|P2|Overall Study|Other|0
998042|NCT00440310|3273569|P1|Overall Study|Other|1
998043|NCT00440310|3273568|P2|Overall Study|No Reply at EOS|7
998044|NCT00440310|3273569|P1|Overall Study|No Reply at EOS|7
998045|NCT00440310|3273568|P2|Overall Study|Withdrawal by Subject|14
998046|NCT00440310|3273569|P1|Overall Study|Withdrawal by Subject|15
998047|NCT00440310|3273568|P2|Overall Study|Protocol Violation|1
998048|NCT00440310|3273569|P1|Overall Study|Protocol Violation|0
998049|NCT00440310|3273568|P2|Overall Study|Lost to Follow-up|5
998050|NCT00440310|3273569|P1|Overall Study|Lost to Follow-up|4
998051|NCT00440297|3273577|P2|Overall Study|Randomized by mistake|0
998052|NCT00440297|3273578|P1|Overall Study|Randomized by mistake|1
998053|NCT00440297|3273577|P2|Overall Study|Withdrawal by Subject|6
998054|NCT00440297|3273578|P1|Overall Study|Withdrawal by Subject|1
998055|NCT00440297|3273577|P2|Overall Study|Protocol Violation|7
998056|NCT00440297|3273578|P1|Overall Study|Protocol Violation|11
998057|NCT00440297|3273577|P2|Overall Study|Physician Decision|0
998058|NCT00440297|3273578|P1|Overall Study|Physician Decision|1
998059|NCT00440297|3273577|P2|Overall Study|Lost to Follow-up|0
998060|NCT00440297|3273578|P1|Overall Study|Lost to Follow-up|1
998061|NCT00440297|3273577|P2|Overall Study|Adverse Event|5
998062|NCT00440297|3273578|P1|Overall Study|Adverse Event|8
998063|NCT00440271|3273594|P2|Overall Study|Other|0
998064|NCT00440271|3273595|P1|Overall Study|Other|2
998065|NCT00440271|3273594|P2|Overall Study|Due to closure of trial|10
998066|NCT00440271|3273595|P1|Overall Study|Due to closure of trial|8
998067|NCT00440271|3273594|P2|Overall Study|Lack of Efficacy|1
998068|NCT00440271|3273595|P1|Overall Study|Lack of Efficacy|0
998069|NCT00440271|3273594|P2|Overall Study|Withdrawal by Subject|2
998070|NCT00440271|3273595|P1|Overall Study|Withdrawal by Subject|0
998071|NCT00440271|3273594|P2|Overall Study|Lost to Follow-up|0
998072|NCT00440271|3273595|P1|Overall Study|Lost to Follow-up|1
998073|NCT00440271|3273594|P2|Overall Study|Adverse Event|1
998074|NCT00440271|3273595|P1|Overall Study|Adverse Event|0
998075|NCT00440271|3273594|P2|Overall Study|Protocol Violation|1
998076|NCT00440271|3273595|P1|Overall Study|Protocol Violation|1
998077|NCT00440232|3273629|P2|Overall Study|Onset of headache within 4 hours of fast|2
998078|NCT00440232|3273630|P1|Overall Study|Onset of headache within 4 hours of fast|2
998079|NCT00440232|3273629|P2|Overall Study|Unable to treat within allowed time|1
998080|NCT00440232|3273630|P1|Overall Study|Unable to treat within allowed time|0
998081|NCT00440232|3273629|P2|Overall Study|Lost to Follow-up|1
998082|NCT00440232|3273630|P1|Overall Study|Lost to Follow-up|1
998083|NCT00440193|3273640|P2|Observational Period|Participant convenience|0
998084|NCT00440193|3273641|P1|Observational Period|Participant convenience|2
998085|NCT00440193|3273640|P2|Observational Period|Clinical endpoint reached|0
998086|NCT00440193|3273641|P1|Observational Period|Clinical endpoint reached|1
998087|NCT00440193|3273640|P2|Observational Period|Physician Decision|0
998088|NCT00440193|3273641|P1|Observational Period|Physician Decision|1
998089|NCT00440193|3273640|P2|Observational Period|Withdrawal by Subject|8
998090|NCT00440193|3273641|P1|Observational Period|Withdrawal by Subject|11
998091|NCT00440193|3273640|P2|Observational Period|Protocol Violation|0
998092|NCT00440193|3273641|P1|Observational Period|Protocol Violation|1
998093|NCT00440193|3273640|P2|Observational Period|Lost to Follow-up|8
998094|NCT00440193|3273641|P1|Observational Period|Lost to Follow-up|12
998095|NCT00440193|3273640|P2|Observational Period|Death|20
998096|NCT00440193|3273641|P1|Observational Period|Death|15
998097|NCT00440193|3273640|P2|Observational Period|Adverse Event|2
998098|NCT00440193|3273641|P1|Observational Period|Adverse Event|2
998099|NCT00440193|3273640|P2|Treatment Period|Site closed by investigator|2
998100|NCT00440193|3273641|P1|Treatment Period|Site closed by investigator|0
998101|NCT00440193|3273640|P2|Treatment Period|Participant did not receive treatment|13
998102|NCT00440193|3273641|P1|Treatment Period|Participant did not receive treatment|7
998103|NCT00440193|3273640|P2|Treatment Period|Participant convenience|2
998104|NCT00440193|3273641|P1|Treatment Period|Participant convenience|5
998105|NCT00440193|3273640|P2|Treatment Period|Technical problems|1
998106|NCT00440193|3273641|P1|Treatment Period|Technical problems|1
998107|NCT00440193|3273640|P2|Treatment Period|Switch to commercial drug|2
998108|NCT00440193|3273641|P1|Treatment Period|Switch to commercial drug|0
998109|NCT00440193|3273640|P2|Treatment Period|Protocol driven decision point|2
998110|NCT00440193|3273641|P1|Treatment Period|Protocol driven decision point|2
998111|NCT00440193|3273640|P2|Treatment Period|Study terminated by sponsor|94
998112|NCT00440193|3273641|P1|Treatment Period|Study terminated by sponsor|102
998113|NCT00440193|3273640|P2|Treatment Period|Clinical endpoint reached|25
998114|NCT00440193|3273641|P1|Treatment Period|Clinical endpoint reached|28
998115|NCT00440193|3273640|P2|Treatment Period|Withdrawal by Subject|77
998116|NCT00440193|3273641|P1|Treatment Period|Withdrawal by Subject|36
998117|NCT00440193|3273640|P2|Treatment Period|Protocol Violation|19
998118|NCT00440193|3273641|P1|Treatment Period|Protocol Violation|16
998119|NCT00440193|3273640|P2|Treatment Period|Physician Decision|6
998120|NCT00440193|3273641|P1|Treatment Period|Physician Decision|3
998121|NCT00440193|3273640|P2|Treatment Period|Lost to Follow-up|18
998122|NCT00440193|3273641|P1|Treatment Period|Lost to Follow-up|12
998123|NCT00440193|3273640|P2|Treatment Period|Lack of Efficacy|1
998124|NCT00440193|3273641|P1|Treatment Period|Lack of Efficacy|0
998125|NCT00440193|3273640|P2|Treatment Period|Death|22
998126|NCT00440193|3273641|P1|Treatment Period|Death|19
998127|NCT00440193|3273640|P2|Treatment Period|Adverse Event|67
998128|NCT00440193|3273641|P1|Treatment Period|Adverse Event|74
998129|NCT00440115|3273687|P3|Overall Study|Incarceration|1
998130|NCT00440115|3273688|P2|Overall Study|Incarceration|2
998131|NCT00440115|3273689|P1|Overall Study|Incarceration|0
998132|NCT00440115|3273687|P3|Overall Study|Death|5
998133|NCT00440115|3273688|P2|Overall Study|Death|9
998134|NCT00440115|3273689|P1|Overall Study|Death|7
998135|NCT00440011|3273720|P2|Overall Study|Withdrawal by Subject|0
998136|NCT00440011|3273721|P1|Overall Study|Withdrawal by Subject|1
998137|NCT00440011|3273720|P2|Overall Study|Protocol Violation|1
998138|NCT00440011|3273721|P1|Overall Study|Protocol Violation|1
998139|NCT00440011|3273720|P2|Overall Study|Lost to Follow-up|2
998140|NCT00440011|3273721|P1|Overall Study|Lost to Follow-up|0
998141|NCT00440011|3273720|P2|Overall Study|Adverse Event|0
998142|NCT00440011|3273721|P1|Overall Study|Adverse Event|2
998143|NCT00439777|3273748|P2|Observational Period|Technical problems|1
998144|NCT00439777|3273749|P1|Observational Period|Technical problems|0
998145|NCT00439777|3273748|P2|Observational Period|Lack of Efficacy|0
998146|NCT00439777|3273749|P1|Observational Period|Lack of Efficacy|1
998147|NCT00439777|3273748|P2|Observational Period|Protocol driven decision point|1
998148|NCT00439777|3273749|P1|Observational Period|Protocol driven decision point|0
998149|NCT00439777|3273748|P2|Observational Period|Study terminated by sponsor|1
998150|NCT00439777|3273749|P1|Observational Period|Study terminated by sponsor|3
998151|NCT00439777|3273748|P2|Observational Period|Death|20
998152|NCT00439777|3273749|P1|Observational Period|Death|27
998153|NCT00439777|3273748|P2|Observational Period|Lost to Follow-up|11
998154|NCT00439777|3273749|P1|Observational Period|Lost to Follow-up|1
998155|NCT00439777|3273748|P2|Observational Period|Withdrawal by Subject|5
998156|NCT00439777|3273749|P1|Observational Period|Withdrawal by Subject|9
998157|NCT00439777|3273748|P2|Observational Period|Protocol Violation|2
998158|NCT00439777|3273749|P1|Observational Period|Protocol Violation|0
998159|NCT00439777|3273748|P2|Treatment Period|Participant convenience|8
998160|NCT00439777|3273749|P1|Treatment Period|Participant convenience|12
998161|NCT00439777|3273748|P2|Treatment Period|Technical problems|1
998162|NCT00439777|3273749|P1|Treatment Period|Technical problems|3
998163|NCT00439777|3273748|P2|Treatment Period|Clinical endpoint reached|13
998164|NCT00439777|3273749|P1|Treatment Period|Clinical endpoint reached|26
998165|NCT00439777|3273748|P2|Treatment Period|Physician Decision|18
998166|NCT00439777|3273749|P1|Treatment Period|Physician Decision|7
998167|NCT00439777|3273748|P2|Treatment Period|Protocol driven decision point|3
998168|NCT00439777|3273749|P1|Treatment Period|Protocol driven decision point|1
998169|NCT00439777|3273748|P2|Treatment Period|Lost to Follow-up|10
998170|NCT00439777|3273749|P1|Treatment Period|Lost to Follow-up|8
998171|NCT00439777|3273748|P2|Treatment Period|Lack of Efficacy|4
998172|NCT00439777|3273749|P1|Treatment Period|Lack of Efficacy|1
998173|NCT00439777|3273748|P2|Treatment Period|Withdrawal by Subject|118
998174|NCT00439777|3273749|P1|Treatment Period|Withdrawal by Subject|66
998175|NCT00439777|3273748|P2|Treatment Period|Protocol Violation|30
998176|NCT00439777|3273749|P1|Treatment Period|Protocol Violation|23
998177|NCT00439777|3273748|P2|Treatment Period|Adverse Event|92
998178|NCT00439777|3273749|P1|Treatment Period|Adverse Event|111
998179|NCT00439777|3273748|P2|Treatment Period|Did not take study treatment|8
998180|NCT00439777|3273749|P1|Treatment Period|Did not take study treatment|7
998181|NCT00439777|3273748|P2|Treatment Period|Site closed by investigator|1
998182|NCT00439777|3273749|P1|Treatment Period|Site closed by investigator|0
998183|NCT00439777|3273748|P2|Treatment Period|Study terminated by sponsor|132
998184|NCT00439777|3273749|P1|Treatment Period|Study terminated by sponsor|125
998185|NCT00439777|3273748|P2|Treatment Period|Death|21
998186|NCT00439777|3273749|P1|Treatment Period|Death|29
998187|NCT00439738|3273787|P2|Overall Study|Abnormal Lab Values|0
998188|NCT00439738|3273788|P1|Overall Study|Abnormal Lab Values|1
998189|NCT00439738|3273787|P2|Overall Study|Lack of Efficacy|2
998190|NCT00439738|3273788|P1|Overall Study|Lack of Efficacy|2
998191|NCT00439738|3273787|P2|Overall Study|Protocol Violation|3
998192|NCT00439738|3273788|P1|Overall Study|Protocol Violation|6
998193|NCT00439738|3273787|P2|Overall Study|Lost to Follow-up|6
998194|NCT00439738|3273788|P1|Overall Study|Lost to Follow-up|5
998195|NCT00439738|3273787|P2|Overall Study|Adverse Event|4
998196|NCT00439738|3273788|P1|Overall Study|Adverse Event|6
998197|NCT00439738|3273787|P2|Overall Study|Withdrawal by Subject|13
998198|NCT00439738|3273788|P1|Overall Study|Withdrawal by Subject|16
998199|NCT00439725|3273806|P2|Observational Period|Participant convenience|0
998200|NCT00439725|3273807|P1|Observational Period|Participant convenience|1
998201|NCT00439725|3273806|P2|Observational Period|Technical problems|0
998202|NCT00439725|3273807|P1|Observational Period|Technical problems|1
998203|NCT00439725|3273806|P2|Observational Period|Clinical endpoint reached|1
998204|NCT00439725|3273807|P1|Observational Period|Clinical endpoint reached|3
998205|NCT00439725|3273806|P2|Observational Period|Study termination by sponsor|1
998206|NCT00439725|3273807|P1|Observational Period|Study termination by sponsor|1
998207|NCT00439725|3273806|P2|Observational Period|Death|2
998208|NCT00439725|3273807|P1|Observational Period|Death|0
998209|NCT00439725|3273806|P2|Observational Period|Lost to Follow-up|1
998210|NCT00439725|3273807|P1|Observational Period|Lost to Follow-up|0
998211|NCT00439725|3273806|P2|Observational Period|Withdrawal by Subject|2
998212|NCT00439725|3273807|P1|Observational Period|Withdrawal by Subject|2
998213|NCT00439725|3273806|P2|Treatment Period|Participant did not receive treatment|4
998214|NCT00439725|3273807|P1|Treatment Period|Participant did not receive treatment|4
998215|NCT00439725|3273806|P2|Treatment Period|Death|1
998216|NCT00439725|3273807|P1|Treatment Period|Death|1
998217|NCT00439725|3273806|P2|Treatment Period|Protocol driven decision point|1
998218|NCT00439725|3273807|P1|Treatment Period|Protocol driven decision point|1
998219|NCT00439725|3273806|P2|Treatment Period|Participant convenience|0
998220|NCT00439725|3273807|P1|Treatment Period|Participant convenience|1
998221|NCT00439725|3273806|P2|Treatment Period|Lost to Follow-up|1
998222|NCT00439725|3273807|P1|Treatment Period|Lost to Follow-up|1
998223|NCT00439725|3273806|P2|Treatment Period|Technical problems|0
998224|NCT00439725|3273807|P1|Treatment Period|Technical problems|1
998225|NCT00439725|3273806|P2|Treatment Period|Clinical endpoint reached|50
998226|NCT00439725|3273807|P1|Treatment Period|Clinical endpoint reached|6
998227|NCT00439725|3273806|P2|Treatment Period|Protocol Violation|1
998228|NCT00439725|3273807|P1|Treatment Period|Protocol Violation|2
998229|NCT00439725|3273806|P2|Treatment Period|Physician Decision|1
998230|NCT00439725|3273807|P1|Treatment Period|Physician Decision|1
998231|NCT00439725|3273806|P2|Treatment Period|Adverse Event|18
998232|NCT00439725|3273807|P1|Treatment Period|Adverse Event|39
998233|NCT00439725|3273806|P2|Treatment Period|Site closed by investigator|2
998234|NCT00439725|3273807|P1|Treatment Period|Site closed by investigator|1
998235|NCT00439725|3273806|P2|Treatment Period|Study terminated by sponsor|148
998236|NCT00439725|3273807|P1|Treatment Period|Study terminated by sponsor|156
998237|NCT00439725|3273806|P2|Treatment Period|Withdrawal by Subject|19
998238|NCT00439725|3273807|P1|Treatment Period|Withdrawal by Subject|22
998239|NCT00439647|3273858|P2|Overall Study|Lack of Efficacy|4
998240|NCT00439647|3273859|P1|Overall Study|Lack of Efficacy|0
998241|NCT00439647|3273858|P2|Overall Study|Protocol Violation|4
998242|NCT00439647|3273859|P1|Overall Study|Protocol Violation|3
998243|NCT00439647|3273858|P2|Overall Study|Lost to Follow-up|12
998244|NCT00439647|3273859|P1|Overall Study|Lost to Follow-up|4
998245|NCT00439647|3273858|P2|Overall Study|Adverse Event|11
998246|NCT00439647|3273859|P1|Overall Study|Adverse Event|11
998247|NCT00439647|3273858|P2|Overall Study|Death|18
998248|NCT00439647|3273859|P1|Overall Study|Death|15
998249|NCT00439647|3273858|P2|Overall Study|Withdrawal by Subject|22
998250|NCT00439647|3273859|P1|Overall Study|Withdrawal by Subject|25
998251|NCT00439569|3273896|P1|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1
998252|NCT00439569|3273896|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3
998253|NCT00439569|3273896|P1|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1
998254|NCT00439517|3273909|P2|Overall Study|Subject in survival follow-up|0
998255|NCT00439517|3273910|P1|Overall Study|Subject in survival follow-up|1
998256|NCT00439517|3273909|P2|Overall Study|Subject on treatment|0
998257|NCT00439517|3273910|P1|Overall Study|Subject on treatment|1
998258|NCT00439309|3273978|P2|Follow-Up|Late response by subject|1
998259|NCT00439309|3273979|P1|Follow-Up|Late response by subject|0
998260|NCT00439309|3273978|P2|Follow-Up|Withdrawal by Subject|1
998261|NCT00439309|3273979|P1|Follow-Up|Withdrawal by Subject|0
998262|NCT00439309|3273978|P2|Follow-Up|Lost to Follow-up|0
998263|NCT00439309|3273979|P1|Follow-Up|Lost to Follow-up|2
998264|NCT00439309|3273978|P2|Follow-Up|Death|0
998265|NCT00439309|3273979|P1|Follow-Up|Death|1
998266|NCT00439270|3273998|P5|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
998267|NCT00439270|3273999|P4|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1
998268|NCT00439270|3274000|P3|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
998269|NCT00439270|3274001|P2|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
998270|NCT00439270|3274002|P1|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
998271|NCT00439270|3273998|P5|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
998272|NCT00439270|3273999|P4|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2
998273|NCT00439270|3274000|P3|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
998274|NCT00439270|3274001|P2|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
998275|NCT00439270|3274002|P1|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
998276|NCT00439270|3273998|P5|Phase 2 (51.6 Months)|Withdrawal by Subject|0
998277|NCT00439270|3273999|P4|Phase 2 (51.6 Months)|Withdrawal by Subject|2
998278|NCT00439270|3274000|P3|Phase 2 (51.6 Months)|Withdrawal by Subject|0
998279|NCT00439270|3274001|P2|Phase 2 (51.6 Months)|Withdrawal by Subject|0
998280|NCT00439270|3274002|P1|Phase 2 (51.6 Months)|Withdrawal by Subject|0
998281|NCT00439270|3273998|P5|Phase 2 (51.6 Months)|No longer meets study criteria|0
998282|NCT00439270|3273999|P4|Phase 2 (51.6 Months)|No longer meets study criteria|1
998283|NCT00439270|3274000|P3|Phase 2 (51.6 Months)|No longer meets study criteria|0
998284|NCT00439270|3274001|P2|Phase 2 (51.6 Months)|No longer meets study criteria|0
998285|NCT00439270|3274002|P1|Phase 2 (51.6 Months)|No longer meets study criteria|0
998286|NCT00439270|3273998|P5|Phase 2 (51.6 Months)|Maximum clinical benefit|0
998287|NCT00439270|3273999|P4|Phase 2 (51.6 Months)|Maximum clinical benefit|3
998288|NCT00439270|3274000|P3|Phase 2 (51.6 Months)|Maximum clinical benefit|0
998289|NCT00439270|3274001|P2|Phase 2 (51.6 Months)|Maximum clinical benefit|0
998290|NCT00439270|3274002|P1|Phase 2 (51.6 Months)|Maximum clinical benefit|0
998291|NCT00439270|3273998|P5|Phase 2 (51.6 Months)|Study drug toxicity|0
998292|NCT00439270|3273999|P4|Phase 2 (51.6 Months)|Study drug toxicity|6
998293|NCT00439270|3274000|P3|Phase 2 (51.6 Months)|Study drug toxicity|0
998294|NCT00439270|3274001|P2|Phase 2 (51.6 Months)|Study drug toxicity|0
998295|NCT00439270|3274002|P1|Phase 2 (51.6 Months)|Study drug toxicity|0
998296|NCT00439270|3273998|P5|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
998297|NCT00439270|3273999|P4|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1
998298|NCT00439270|3274000|P3|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
998299|NCT00439270|3274001|P2|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
998300|NCT00439270|3274002|P1|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
998301|NCT00439270|3273998|P5|Phase 2 (51.6 Months)|Disease progression|0
998302|NCT00439270|3273999|P4|Phase 2 (51.6 Months)|Disease progression|18
998303|NCT00439270|3274000|P3|Phase 2 (51.6 Months)|Disease progression|0
998304|NCT00439270|3274001|P2|Phase 2 (51.6 Months)|Disease progression|0
998305|NCT00439270|3274002|P1|Phase 2 (51.6 Months)|Disease progression|0
998306|NCT00439270|3273998|P5|Phase 1 (18.1 Months)|Study drug toxicity|0
998307|NCT00439270|3273999|P4|Phase 1 (18.1 Months)|Study drug toxicity|0
998308|NCT00439270|3274000|P3|Phase 1 (18.1 Months)|Study drug toxicity|0
998309|NCT00439270|3274001|P2|Phase 1 (18.1 Months)|Study drug toxicity|1
998310|NCT00439270|3274002|P1|Phase 1 (18.1 Months)|Study drug toxicity|0
998311|NCT00439270|3273998|P5|Phase 1 (18.1 Months)|Disease progression|3
998312|NCT00439270|3273999|P4|Phase 1 (18.1 Months)|Disease progression|0
998313|NCT00439270|3274000|P3|Phase 1 (18.1 Months)|Disease progression|3
998314|NCT00439270|3274001|P2|Phase 1 (18.1 Months)|Disease progression|2
998315|NCT00439270|3274002|P1|Phase 1 (18.1 Months)|Disease progression|3
998316|NCT00439244|3274044|P3|Overall Study|Administrative problems|0
998317|NCT00439244|3274045|P2|Overall Study|Administrative problems|0
998318|NCT00439244|3274046|P1|Overall Study|Administrative problems|1
998319|NCT00439244|3274044|P3|Overall Study|Protocol Violation|0
998320|NCT00439244|3274045|P2|Overall Study|Protocol Violation|1
998321|NCT00439244|3274046|P1|Overall Study|Protocol Violation|0
998322|NCT00439244|3274044|P3|Overall Study|Death|0
998323|NCT00439244|3274045|P2|Overall Study|Death|1
998324|NCT00439244|3274046|P1|Overall Study|Death|0
998325|NCT00439244|3274044|P3|Overall Study|Lost to Follow-up|2
998326|NCT00439244|3274045|P2|Overall Study|Lost to Follow-up|1
998327|NCT00439244|3274046|P1|Overall Study|Lost to Follow-up|2
998328|NCT00439244|3274044|P3|Overall Study|Withdrawal by Subject|2
998329|NCT00439244|3274045|P2|Overall Study|Withdrawal by Subject|1
998330|NCT00439244|3274046|P1|Overall Study|Withdrawal by Subject|3
998331|NCT00439244|3274044|P3|Overall Study|Adverse Event|3
998332|NCT00439244|3274045|P2|Overall Study|Adverse Event|2
998333|NCT00439244|3274046|P1|Overall Study|Adverse Event|5
998334|NCT00439231|3274066|P1|Overall Study|Lack of Efficacy|28
998335|NCT00439218|3274070|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1
998336|NCT00439179|3274085|P4|Overall Study|* 1 pt inelig, 1 pt numb not used|0
998337|NCT00439179|3274086|P3|Overall Study|* 1 pt inelig, 1 pt numb not used|0
998338|NCT00439179|3274087|P2|Overall Study|* 1 pt inelig, 1 pt numb not used|2
998339|NCT00439179|3274088|P1|Overall Study|* 1 pt inelig, 1 pt numb not used|0
998340|NCT00439140|3274105|P3|Treatment Cycle 2|Lost to Follow-up|0
998341|NCT00439140|3274106|P2|Treatment Cycle 2|Lost to Follow-up|1
998342|NCT00439140|3274107|P1|Treatment Cycle 2|Lost to Follow-up|1
998343|NCT00439140|3274105|P3|Treatment Cycle 2|Withdrawal by Subject|0
998344|NCT00439140|3274106|P2|Treatment Cycle 2|Withdrawal by Subject|0
998345|NCT00439140|3274107|P1|Treatment Cycle 2|Withdrawal by Subject|1
998346|NCT00439140|3274105|P3|Treatment Cycle 1|Withdrawal by Subject|0
998347|NCT00439140|3274106|P2|Treatment Cycle 1|Withdrawal by Subject|1
998348|NCT00439140|3274107|P1|Treatment Cycle 1|Withdrawal by Subject|0
998349|NCT00439140|3274105|P3|Treatment Cycle 1|Personal reasons|0
998350|NCT00439140|3274106|P2|Treatment Cycle 1|Personal reasons|2
998351|NCT00439140|3274107|P1|Treatment Cycle 1|Personal reasons|0
998352|NCT00439140|3274105|P3|Treatment Cycle 1|Lost to Follow-up|1
998353|NCT00439140|3274106|P2|Treatment Cycle 1|Lost to Follow-up|1
998354|NCT00439140|3274107|P1|Treatment Cycle 1|Lost to Follow-up|1
998355|NCT00438815|3274190|P1|Overall Study|Death|1
998356|NCT00438815|3274190|P1|Overall Study|Withdrawal by Subject|6
998357|NCT00438815|3274190|P1|Overall Study|Lost to Follow-up|6
998358|NCT00438815|3274190|P1|Overall Study|Transitioned to commercial C1INH-nf|6
998359|NCT00438815|3274190|P1|Overall Study|Noncompliance with protocol requirements|9
998360|NCT00438815|3274190|P1|Overall Study|3-month follow-up no longer required|12
998361|NCT00438815|3274190|P1|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30
998362|NCT00438672|3274240|P2|Overall Study|Lost to Follow-up|9
998363|NCT00438672|3274241|P1|Overall Study|Lost to Follow-up|7
998364|NCT00438659|3274251|P2|Overall Study|Cancel|2
998365|NCT00438659|3274252|P1|Overall Study|Cancel|5
998366|NCT00438659|3274251|P2|Overall Study|Discontinued Mometasone/Placebo|2
998367|NCT00438659|3274252|P1|Overall Study|Discontinued Mometasone/Placebo|1
998368|NCT00438464|3274291|P2|Overall Study|Incomplete data submission|2
998369|NCT00438464|3274292|P1|Overall Study|Incomplete data submission|0
998370|NCT00438464|3274291|P2|Overall Study|Terminated Early|5
998371|NCT00438464|3274292|P1|Overall Study|Terminated Early|14
998372|NCT00438399|3274393|P6|Overall Study|Patien stopped study at visit 4 by error|0
998373|NCT00438399|3274394|P5|Overall Study|Patien stopped study at visit 4 by error|0
998374|NCT00438399|3274395|P4|Overall Study|Patien stopped study at visit 4 by error|0
998375|NCT00438399|3274396|P3|Overall Study|Patien stopped study at visit 4 by error|0
998376|NCT00438399|3274397|P2|Overall Study|Patien stopped study at visit 4 by error|0
998377|NCT00438399|3274398|P1|Overall Study|Patien stopped study at visit 4 by error|1
998378|NCT00438399|3274393|P6|Overall Study|Pregnancy|1
998379|NCT00438399|3274394|P5|Overall Study|Pregnancy|0
998380|NCT00438399|3274395|P4|Overall Study|Pregnancy|0
998381|NCT00438399|3274396|P3|Overall Study|Pregnancy|0
998382|NCT00438399|3274397|P2|Overall Study|Pregnancy|0
998383|NCT00438399|3274398|P1|Overall Study|Pregnancy|0
998384|NCT00438399|3274393|P6|Overall Study|Subje stopped study|0
998385|NCT00438399|3274394|P5|Overall Study|Subje stopped study|0
998386|NCT00438399|3274395|P4|Overall Study|Subje stopped study|0
998387|NCT00438399|3274396|P3|Overall Study|Subje stopped study|1
998388|NCT00438399|3274397|P2|Overall Study|Subje stopped study|0
998389|NCT00438399|3274398|P1|Overall Study|Subje stopped study|0
998390|NCT00438399|3274393|P6|Overall Study|Protocol Violation|1
998391|NCT00438399|3274394|P5|Overall Study|Protocol Violation|0
998392|NCT00438399|3274395|P4|Overall Study|Protocol Violation|0
998393|NCT00438399|3274396|P3|Overall Study|Protocol Violation|1
998394|NCT00438399|3274397|P2|Overall Study|Protocol Violation|0
998395|NCT00438399|3274398|P1|Overall Study|Protocol Violation|0
998396|NCT00438399|3274393|P6|Overall Study|Withdrawal by Subject|2
998397|NCT00438399|3274394|P5|Overall Study|Withdrawal by Subject|2
998398|NCT00438399|3274395|P4|Overall Study|Withdrawal by Subject|2
998399|NCT00438399|3274396|P3|Overall Study|Withdrawal by Subject|3
998400|NCT00438399|3274397|P2|Overall Study|Withdrawal by Subject|6
998401|NCT00438399|3274398|P1|Overall Study|Withdrawal by Subject|5
998402|NCT00438399|3274393|P6|Overall Study|Adverse Event|1
998403|NCT00438399|3274394|P5|Overall Study|Adverse Event|0
998404|NCT00438399|3274395|P4|Overall Study|Adverse Event|1
998405|NCT00438399|3274396|P3|Overall Study|Adverse Event|1
998406|NCT00438399|3274397|P2|Overall Study|Adverse Event|0
998407|NCT00438399|3274398|P1|Overall Study|Adverse Event|0
998408|NCT00438399|3274393|P6|Overall Study|Lost to Follow-up|1
998409|NCT00438399|3274394|P5|Overall Study|Lost to Follow-up|1
998410|NCT00438399|3274395|P4|Overall Study|Lost to Follow-up|1
998411|NCT00438399|3274396|P3|Overall Study|Lost to Follow-up|1
998412|NCT00438399|3274397|P2|Overall Study|Lost to Follow-up|2
998413|NCT00438399|3274398|P1|Overall Study|Lost to Follow-up|2
998414|NCT00438360|3274409|P2|Overall Study|not specified|15
998415|NCT00438360|3274410|P1|Overall Study|not specified|24
998416|NCT00438360|3274409|P2|Overall Study|Lack of Efficacy|27
998417|NCT00438360|3274410|P1|Overall Study|Lack of Efficacy|42
998418|NCT00438360|3274409|P2|Overall Study|Adverse Event|1
998419|NCT00438360|3274410|P1|Overall Study|Adverse Event|6
998420|NCT00437983|3274458|P2|Overall Study|Withdrawal by Subject|6
998421|NCT00437983|3274459|P1|Overall Study|Withdrawal by Subject|5
998422|NCT00437983|3274458|P2|Overall Study|Protocol Violation|1
998423|NCT00437983|3274459|P1|Overall Study|Protocol Violation|2
998424|NCT00437983|3274458|P2|Overall Study|Adverse Event|6
998425|NCT00437983|3274459|P1|Overall Study|Adverse Event|6
998426|NCT00437658|3274472|P3|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
998427|NCT00437658|3274473|P2|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
998428|NCT00437658|3274474|P1|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3
998429|NCT00437658|3274472|P3|Post-treatment Period (24 Weeks)|Lost to Follow-up|1
998430|NCT00437658|3274473|P2|Post-treatment Period (24 Weeks)|Lost to Follow-up|0
998431|NCT00437658|3274474|P1|Post-treatment Period (24 Weeks)|Lost to Follow-up|5
998432|NCT00437658|3274472|P3|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
998433|NCT00437658|3274473|P2|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
998434|NCT00437658|3274474|P1|Post-treatment Period (24 Weeks)|Lack of Efficacy|0
998435|NCT00437658|3274472|P3|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8
998436|NCT00437658|3274473|P2|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6
998437|NCT00437658|3274474|P1|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12
998438|NCT00437658|3274472|P3|Post-treatment Period (24 Weeks)|Non-compliance|1
998439|NCT00437658|3274473|P2|Post-treatment Period (24 Weeks)|Non-compliance|0
998440|NCT00437658|3274474|P1|Post-treatment Period (24 Weeks)|Non-compliance|3
998441|NCT00437658|3274472|P3|Post-treatment Period (24 Weeks)|Adverse Event|1
998442|NCT00437658|3274473|P2|Post-treatment Period (24 Weeks)|Adverse Event|0
998443|NCT00437658|3274474|P1|Post-treatment Period (24 Weeks)|Adverse Event|1
998444|NCT00437658|3274472|P3|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
998445|NCT00437658|3274473|P2|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
998446|NCT00437658|3274474|P1|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5
998447|NCT00437658|3274472|P3|Treatment Period (24 Weeks)|Lost to Follow-up|5
998448|NCT00437658|3274473|P2|Treatment Period (24 Weeks)|Lost to Follow-up|4
998449|NCT00437658|3274474|P1|Treatment Period (24 Weeks)|Lost to Follow-up|5
998450|NCT00437658|3274472|P3|Treatment Period (24 Weeks)|Lack of Efficacy|3
998451|NCT00437658|3274473|P2|Treatment Period (24 Weeks)|Lack of Efficacy|2
998452|NCT00437658|3274474|P1|Treatment Period (24 Weeks)|Lack of Efficacy|4
998453|NCT00437658|3274472|P3|Treatment Period (24 Weeks)|Withdrawal by Subject|7
998454|NCT00437658|3274473|P2|Treatment Period (24 Weeks)|Withdrawal by Subject|7
998455|NCT00437658|3274474|P1|Treatment Period (24 Weeks)|Withdrawal by Subject|9
998456|NCT00437658|3274472|P3|Treatment Period (24 Weeks)|Non-compliance|4
998457|NCT00437658|3274473|P2|Treatment Period (24 Weeks)|Non-compliance|1
998458|NCT00437658|3274474|P1|Treatment Period (24 Weeks)|Non-compliance|1
998459|NCT00437658|3274472|P3|Treatment Period (24 Weeks)|Adverse Event|14
998460|NCT00437658|3274473|P2|Treatment Period (24 Weeks)|Adverse Event|7
998461|NCT00437658|3274474|P1|Treatment Period (24 Weeks)|Adverse Event|4
998462|NCT00437645|3274568|P2|Overall Study|Condition no longer requires study drug|1
998463|NCT00437645|3274569|P1|Overall Study|Condition no longer requires study drug|1
998464|NCT00437645|3274568|P2|Overall Study|Lack of Efficacy|1
998465|NCT00437645|3274569|P1|Overall Study|Lack of Efficacy|2
998466|NCT00437645|3274568|P2|Overall Study|Administrative problems|1
998467|NCT00437645|3274569|P1|Overall Study|Administrative problems|2
998468|NCT00437645|3274568|P2|Overall Study|Lost to Follow-up|3
998469|NCT00437645|3274569|P1|Overall Study|Lost to Follow-up|2
998470|NCT00437645|3274568|P2|Overall Study|Protocol Violation|3
998471|NCT00437645|3274569|P1|Overall Study|Protocol Violation|3
998472|NCT00437645|3274568|P2|Overall Study|Withdrawal by Subject|22
998473|NCT00437645|3274569|P1|Overall Study|Withdrawal by Subject|10
998474|NCT00437645|3274568|P2|Overall Study|Adverse Event|84
998475|NCT00437645|3274569|P1|Overall Study|Adverse Event|15
998476|NCT00437489|3274585|P2|Overall Study|Lost to Follow-up|1
998477|NCT00437489|3274586|P1|Overall Study|Lost to Follow-up|0
998478|NCT00437489|3274585|P2|Overall Study|Study terminated by sponsor|21
998479|NCT00437489|3274586|P1|Overall Study|Study terminated by sponsor|23
998480|NCT00437281|3274623|P20|Overall Study|Lost to Follow-up|1
998481|NCT00437281|3274624|P19|Overall Study|Lost to Follow-up|0
998482|NCT00437281|3274625|P18|Overall Study|Lost to Follow-up|0
998483|NCT00437281|3274626|P17|Overall Study|Lost to Follow-up|0
998484|NCT00437281|3274627|P16|Overall Study|Lost to Follow-up|0
998485|NCT00437281|3274628|P15|Overall Study|Lost to Follow-up|0
998486|NCT00437281|3274629|P14|Overall Study|Lost to Follow-up|0
998487|NCT00437281|3274630|P13|Overall Study|Lost to Follow-up|0
998488|NCT00437281|3274631|P12|Overall Study|Lost to Follow-up|0
998489|NCT00437281|3274632|P11|Overall Study|Lost to Follow-up|0
998490|NCT00437281|3274633|P10|Overall Study|Lost to Follow-up|0
998491|NCT00437281|3274634|P9|Overall Study|Lost to Follow-up|0
998492|NCT00437281|3274635|P8|Overall Study|Lost to Follow-up|0
998493|NCT00437281|3274636|P7|Overall Study|Lost to Follow-up|0
998494|NCT00437281|3274637|P6|Overall Study|Lost to Follow-up|0
998495|NCT00437281|3274638|P5|Overall Study|Lost to Follow-up|0
998496|NCT00437281|3274639|P4|Overall Study|Lost to Follow-up|0
998497|NCT00437281|3274640|P3|Overall Study|Lost to Follow-up|0
998498|NCT00437281|3274641|P2|Overall Study|Lost to Follow-up|0
998499|NCT00437281|3274642|P1|Overall Study|Lost to Follow-up|0
998500|NCT00437281|3274623|P20|Overall Study|Adverse Event|0
998501|NCT00437281|3274624|P19|Overall Study|Adverse Event|1
998502|NCT00437281|3274625|P18|Overall Study|Adverse Event|0
998503|NCT00437281|3274626|P17|Overall Study|Adverse Event|0
998504|NCT00437281|3274627|P16|Overall Study|Adverse Event|0
998505|NCT00437281|3274628|P15|Overall Study|Adverse Event|1
998506|NCT00437281|3274629|P14|Overall Study|Adverse Event|1
998507|NCT00437281|3274630|P13|Overall Study|Adverse Event|0
998508|NCT00437281|3274631|P12|Overall Study|Adverse Event|0
998509|NCT00437281|3274632|P11|Overall Study|Adverse Event|0
998510|NCT00437281|3274633|P10|Overall Study|Adverse Event|1
998511|NCT00437281|3274634|P9|Overall Study|Adverse Event|0
998512|NCT00437281|3274635|P8|Overall Study|Adverse Event|0
998513|NCT00437281|3274636|P7|Overall Study|Adverse Event|0
998514|NCT00437281|3274637|P6|Overall Study|Adverse Event|1
998515|NCT00437281|3274638|P5|Overall Study|Adverse Event|0
998516|NCT00437281|3274639|P4|Overall Study|Adverse Event|1
998517|NCT00437281|3274640|P3|Overall Study|Adverse Event|0
998518|NCT00437281|3274641|P2|Overall Study|Adverse Event|0
998519|NCT00437281|3274642|P1|Overall Study|Adverse Event|0
998520|NCT00437203|3274946|P10|Overall Study|Other|0
998521|NCT00437203|3274947|P9|Overall Study|Other|0
998522|NCT00437203|3274948|P8|Overall Study|Other|0
998523|NCT00437203|3274949|P7|Overall Study|Other|1
998524|NCT00437203|3274950|P6|Overall Study|Other|0
998525|NCT00437203|3274951|P5|Overall Study|Other|0
998526|NCT00437203|3274952|P4|Overall Study|Other|0
998527|NCT00437203|3274953|P3|Overall Study|Other|0
998528|NCT00437203|3274954|P2|Overall Study|Other|1
998529|NCT00437203|3274955|P1|Overall Study|Other|0
998530|NCT00437203|3274946|P10|Overall Study|Objective progression or relapse|2
998531|NCT00437203|3274947|P9|Overall Study|Objective progression or relapse|2
998532|NCT00437203|3274948|P8|Overall Study|Objective progression or relapse|1
998533|NCT00437203|3274949|P7|Overall Study|Objective progression or relapse|6
998534|NCT00437203|3274950|P6|Overall Study|Objective progression or relapse|3
998535|NCT00437203|3274951|P5|Overall Study|Objective progression or relapse|3
998536|NCT00437203|3274952|P4|Overall Study|Objective progression or relapse|3
998537|NCT00437203|3274953|P3|Overall Study|Objective progression or relapse|2
998538|NCT00437203|3274954|P2|Overall Study|Objective progression or relapse|6
998539|NCT00437203|3274955|P1|Overall Study|Objective progression or relapse|5
998540|NCT00437203|3274946|P10|Overall Study|Study terminated by sponsor|0
998541|NCT00437203|3274947|P9|Overall Study|Study terminated by sponsor|1
998542|NCT00437203|3274948|P8|Overall Study|Study terminated by sponsor|0
998543|NCT00437203|3274949|P7|Overall Study|Study terminated by sponsor|0
998544|NCT00437203|3274950|P6|Overall Study|Study terminated by sponsor|0
998545|NCT00437203|3274951|P5|Overall Study|Study terminated by sponsor|0
998546|NCT00437203|3274952|P4|Overall Study|Study terminated by sponsor|0
998547|NCT00437203|3274953|P3|Overall Study|Study terminated by sponsor|0
998548|NCT00437203|3274954|P2|Overall Study|Study terminated by sponsor|0
998549|NCT00437203|3274955|P1|Overall Study|Study terminated by sponsor|0
998550|NCT00437203|3274946|P10|Overall Study|Adverse Event|1
998551|NCT00437203|3274947|P9|Overall Study|Adverse Event|0
998552|NCT00437203|3274948|P8|Overall Study|Adverse Event|1
998553|NCT00437203|3274949|P7|Overall Study|Adverse Event|0
998554|NCT00437203|3274950|P6|Overall Study|Adverse Event|0
998555|NCT00437203|3274951|P5|Overall Study|Adverse Event|0
998556|NCT00437203|3274952|P4|Overall Study|Adverse Event|0
998557|NCT00437203|3274953|P3|Overall Study|Adverse Event|0
998558|NCT00437203|3274954|P2|Overall Study|Adverse Event|1
998559|NCT00437203|3274955|P1|Overall Study|Adverse Event|1
998560|NCT00437203|3274946|P10|Overall Study|Death|1
998561|NCT00437203|3274947|P9|Overall Study|Death|0
998562|NCT00437203|3274948|P8|Overall Study|Death|1
998563|NCT00437203|3274949|P7|Overall Study|Death|0
998564|NCT00437203|3274950|P6|Overall Study|Death|0
998565|NCT00437203|3274951|P5|Overall Study|Death|0
998566|NCT00437203|3274952|P4|Overall Study|Death|0
998567|NCT00437203|3274953|P3|Overall Study|Death|1
998568|NCT00437203|3274954|P2|Overall Study|Death|0
998569|NCT00437203|3274955|P1|Overall Study|Death|0
998570|NCT00437125|3275059|P1|Overall Study|Physician Decision|1
998571|NCT00437125|3275059|P1|Overall Study|Withdrawal by Caregiver|2
998572|NCT00437125|3275059|P1|Overall Study|Withdrawal by Subject|13
998573|NCT00437125|3275059|P1|Overall Study|Lost to Follow-up|1
998574|NCT00437125|3275059|P1|Overall Study|Lack of Efficacy|1
998575|NCT00437125|3275059|P1|Overall Study|Clinical Relapse|1
998576|NCT00437125|3275059|P1|Overall Study|Death|1
998577|NCT00437125|3275059|P1|Overall Study|Adverse Event|12
998578|NCT00437073|3275080|P2|Overall Study|Physician Decision|1
998579|NCT00437073|3275081|P1|Overall Study|Physician Decision|0
998580|NCT00437073|3275080|P2|Overall Study|Sponsor Terminated Study|0
998581|NCT00437073|3275081|P1|Overall Study|Sponsor Terminated Study|1
998582|NCT00437034|3275109|P1|Overall Study|Disease progression during treatment|5
998583|NCT00437034|3275109|P1|Overall Study|Adverse Event|1
998584|NCT00436982|3275115|P2|Overall Study|no RSA data|2
998585|NCT00436982|3275116|P1|Overall Study|no RSA data|1
998586|NCT00436982|3275115|P2|Overall Study|Did not receive allocated intervention|1
998587|NCT00436982|3275116|P1|Overall Study|Did not receive allocated intervention|0
998588|NCT00436982|3275115|P2|Overall Study|Withdrawal by Subject|1
998589|NCT00436982|3275116|P1|Overall Study|Withdrawal by Subject|3
998590|NCT00436956|3275187|P2|Overall Study|Not evaluable|0
998591|NCT00436956|3275188|P1|Overall Study|Not evaluable|1
998592|NCT00436917|3275202|P1|Overall Study|Still on treatment|47
998593|NCT00436917|3275202|P1|Overall Study|Adverse Event|1
998594|NCT00436917|3275202|P1|Overall Study|Withdrawal by Subject|6
998595|NCT00436852|3275217|P2|Overall Study|Ineligible|0
998596|NCT00436852|3275218|P1|Overall Study|Ineligible|1
998597|NCT00436852|3275217|P2|Overall Study|Withdrawal by Subject|4
998598|NCT00436852|3275218|P1|Overall Study|Withdrawal by Subject|2
998599|NCT00436852|3275217|P2|Overall Study|Lack of Efficacy|7
998600|NCT00436852|3275218|P1|Overall Study|Lack of Efficacy|9
998601|NCT00436852|3275217|P2|Overall Study|Death|34
998602|NCT00436852|3275218|P1|Overall Study|Death|23
998603|NCT00436826|3275228|P6|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7
998604|NCT00436826|3275229|P5|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51
998605|NCT00436826|3275230|P4|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
998606|NCT00436826|3275231|P3|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
998607|NCT00436826|3275232|P2|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
998608|NCT00436826|3275233|P1|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
998609|NCT00436826|3275228|P6|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
998610|NCT00436826|3275229|P5|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
998611|NCT00436826|3275230|P4|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|24
998612|NCT00436826|3275231|P3|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|44
998613|NCT00436826|3275232|P2|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
998614|NCT00436826|3275233|P1|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
998615|NCT00436826|3275228|P6|Double Blind Period|Other|0
998616|NCT00436826|3275229|P5|Double Blind Period|Other|0
998617|NCT00436826|3275230|P4|Double Blind Period|Other|0
998618|NCT00436826|3275231|P3|Double Blind Period|Other|0
998619|NCT00436826|3275232|P2|Double Blind Period|Other|11
998620|NCT00436826|3275233|P1|Double Blind Period|Other|10
998621|NCT00436826|3275228|P6|Double Blind Period|Protocol Violation|0
998622|NCT00436826|3275229|P5|Double Blind Period|Protocol Violation|0
998623|NCT00436826|3275230|P4|Double Blind Period|Protocol Violation|0
998624|NCT00436826|3275231|P3|Double Blind Period|Protocol Violation|0
998625|NCT00436826|3275232|P2|Double Blind Period|Protocol Violation|0
998626|NCT00436826|3275233|P1|Double Blind Period|Protocol Violation|1
998627|NCT00436826|3275228|P6|Double Blind Period|Adverse Event|0
998628|NCT00436826|3275229|P5|Double Blind Period|Adverse Event|0
998629|NCT00436826|3275230|P4|Double Blind Period|Adverse Event|0
998630|NCT00436826|3275231|P3|Double Blind Period|Adverse Event|0
998631|NCT00436826|3275232|P2|Double Blind Period|Adverse Event|0
998632|NCT00436826|3275233|P1|Double Blind Period|Adverse Event|2
998633|NCT00436748|3275255|P2|Overall Study|Other|0
998634|NCT00436748|3275256|P1|Overall Study|Other|3
998635|NCT00436748|3275255|P2|Overall Study|Protocol-specified Criteria|4
998636|NCT00436748|3275256|P1|Overall Study|Protocol-specified Criteria|5
998637|NCT00436748|3275255|P2|Overall Study|Lost to Follow-up|1
998638|NCT00436748|3275256|P1|Overall Study|Lost to Follow-up|0
998639|NCT00436748|3275255|P2|Overall Study|Administrative Decision|0
998640|NCT00436748|3275256|P1|Overall Study|Administrative Decision|1
998641|NCT00436748|3275255|P2|Overall Study|Consent Withdrawn|4
998642|NCT00436748|3275256|P1|Overall Study|Consent Withdrawn|1
998643|NCT00436748|3275255|P2|Overall Study|Adverse Event|2
998644|NCT00436748|3275256|P1|Overall Study|Adverse Event|0
998645|NCT00436748|3275255|P2|Overall Study|Ineligibility Determined|1
998646|NCT00436748|3275256|P1|Overall Study|Ineligibility Determined|1
998647|NCT00436644|3275290|P1|Overall Study|Death|1
998648|NCT00436644|3275290|P1|Overall Study|Adverse Event|2
998649|NCT00436618|3275300|P3|Overall Study|Still on treatment|7
998650|NCT00436618|3275301|P2|Overall Study|Still on treatment|2
998651|NCT00436618|3275302|P1|Overall Study|Still on treatment|1
998652|NCT00436618|3275300|P3|Overall Study|New Primary or Other Reasons|12
998653|NCT00436618|3275301|P2|Overall Study|New Primary or Other Reasons|2
998654|NCT00436618|3275302|P1|Overall Study|New Primary or Other Reasons|6
998655|NCT00436618|3275300|P3|Overall Study|Death|3
998656|NCT00436618|3275301|P2|Overall Study|Death|2
998657|NCT00436618|3275302|P1|Overall Study|Death|4
998658|NCT00436618|3275300|P3|Overall Study|Other Medical Problems|7
998659|NCT00436618|3275301|P2|Overall Study|Other Medical Problems|1
998660|NCT00436618|3275302|P1|Overall Study|Other Medical Problems|3
998661|NCT00436618|3275300|P3|Overall Study|Alternate Treatment|12
998662|NCT00436618|3275301|P2|Overall Study|Alternate Treatment|4
998663|NCT00436618|3275302|P1|Overall Study|Alternate Treatment|3
998664|NCT00436618|3275300|P3|Overall Study|Adverse Event|9
998665|NCT00436618|3275301|P2|Overall Study|Adverse Event|8
998666|NCT00436618|3275302|P1|Overall Study|Adverse Event|8
998667|NCT00436618|3275300|P3|Overall Study|Withdrawal by Subject|11
998668|NCT00436618|3275301|P2|Overall Study|Withdrawal by Subject|8
998669|NCT00436618|3275302|P1|Overall Study|Withdrawal by Subject|5
998670|NCT00436605|3275319|P1|Overall Study|Protocol Violation|3
998671|NCT00436566|3275324|P1|Overall Study|Protocol Violation|1
998672|NCT00436566|3275324|P1|Overall Study|Withdrawal by Subject|2
998673|NCT00436553|3275331|P3|Overall Study|Withdrawal by Subject|3
998674|NCT00436553|3275332|P2|Overall Study|Withdrawal by Subject|6
998675|NCT00436553|3275333|P1|Overall Study|Withdrawal by Subject|5
998676|NCT00436553|3275331|P3|Overall Study|Protocol Violation|0
998677|NCT00436553|3275332|P2|Overall Study|Protocol Violation|0
998678|NCT00436553|3275333|P1|Overall Study|Protocol Violation|1
998679|NCT00436553|3275331|P3|Overall Study|Lost to Follow-up|0
998680|NCT00436553|3275332|P2|Overall Study|Lost to Follow-up|2
998681|NCT00436553|3275333|P1|Overall Study|Lost to Follow-up|0
998682|NCT00436553|3275331|P3|Overall Study|Death|3
998683|NCT00436553|3275332|P2|Overall Study|Death|1
998684|NCT00436553|3275333|P1|Overall Study|Death|3
998685|NCT00436553|3275331|P3|Overall Study|Adverse Event|4
998686|NCT00436553|3275332|P2|Overall Study|Adverse Event|3
998687|NCT00436553|3275333|P1|Overall Study|Adverse Event|4
998688|NCT00436501|3275354|P2|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1
998689|NCT00436501|3275355|P1|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0
998690|NCT00436501|3275354|P2|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2
998691|NCT00436501|3275355|P1|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0
998692|NCT00436436|3275366|P1|Overall Study|Death|6
998693|NCT00436436|3275366|P1|Overall Study|Adverse Event|2
998694|NCT00436436|3275366|P1|Overall Study|Progression|4
998695|NCT00436345|3275377|P2|Overall Study|ICU resident beyond follow-up period|0
998696|NCT00436345|3275378|P1|Overall Study|ICU resident beyond follow-up period|3
998697|NCT00436332|3275431|P1|Overall Study|Never Received Treatment|3
998698|NCT00436332|3275431|P1|Overall Study|Ineligible|2
998699|NCT00436332|3275431|P1|Overall Study|Not Protocol Specified|6
998700|NCT00436332|3275431|P1|Overall Study|Death|2
998701|NCT00436332|3275431|P1|Overall Study|Progression|59
998702|NCT00436332|3275431|P1|Overall Study|Withdrawal by Subject|2
998703|NCT00436332|3275431|P1|Overall Study|Adverse Event|9
998704|NCT00436215|3275438|P1|Overall Study|Small bowel obstruction|1
998705|NCT00436215|3275438|P1|Overall Study|Refused further treatment|3
998706|NCT00436163|3275444|P1|Overall Study|Adverse Event|1
998707|NCT00436163|3275444|P1|Overall Study|Lost to Follow-up|2
998708|NCT00436007|3275492|P3|Overall Study|Other|1
998709|NCT00436007|3275493|P2|Overall Study|Other|0
998710|NCT00436007|3275494|P1|Overall Study|Other|0
998711|NCT00436007|3275492|P3|Overall Study|Death|3
998712|NCT00436007|3275493|P2|Overall Study|Death|1
998713|NCT00436007|3275494|P1|Overall Study|Death|0
998714|NCT00436007|3275492|P3|Overall Study|Physician Decision|2
998715|NCT00436007|3275493|P2|Overall Study|Physician Decision|0
998716|NCT00436007|3275494|P1|Overall Study|Physician Decision|0
998717|NCT00436007|3275492|P3|Overall Study|Lost to Follow-up|13
998718|NCT00436007|3275493|P2|Overall Study|Lost to Follow-up|10
998719|NCT00436007|3275494|P1|Overall Study|Lost to Follow-up|14
998720|NCT00436007|3275492|P3|Overall Study|Withdrawal by Subject|4
998721|NCT00436007|3275493|P2|Overall Study|Withdrawal by Subject|3
998722|NCT00436007|3275494|P1|Overall Study|Withdrawal by Subject|5
998723|NCT00435994|3275542|P3|Overall Study|Lost to Follow-up|0
998724|NCT00435994|3275543|P2|Overall Study|Lost to Follow-up|0
998725|NCT00435994|3275544|P1|Overall Study|Lost to Follow-up|7
998726|NCT00435942|3275555|P2|Overall Study|Other|1
998727|NCT00435942|3275556|P1|Overall Study|Other|0
998728|NCT00435942|3275555|P2|Overall Study|Technical Failure|0
998729|NCT00435942|3275556|P1|Overall Study|Technical Failure|3
998730|NCT00435942|3275555|P2|Overall Study|Conversion to Open Repair|0
998731|NCT00435942|3275556|P1|Overall Study|Conversion to Open Repair|1
998732|NCT00435942|3275555|P2|Overall Study|Lost to Follow-up|16
998733|NCT00435942|3275556|P1|Overall Study|Lost to Follow-up|0
998734|NCT00435942|3275555|P2|Overall Study|Withdrawal by Subject|0
998735|NCT00435942|3275556|P1|Overall Study|Withdrawal by Subject|2
998736|NCT00435942|3275555|P2|Overall Study|Death|10
998737|NCT00435942|3275556|P1|Overall Study|Death|17
998738|NCT00435825|3275596|P4|Overall Study|Did not complete full follow-up period|5
998739|NCT00435825|3275597|P3|Overall Study|Did not complete full follow-up period|4
998740|NCT00435825|3275598|P2|Overall Study|Did not complete full follow-up period|6
998741|NCT00435825|3275599|P1|Overall Study|Did not complete full follow-up period|6
998742|NCT00435825|3275596|P4|Overall Study|Did not enter follow-up|3
998743|NCT00435825|3275597|P3|Overall Study|Did not enter follow-up|1
998744|NCT00435825|3275598|P2|Overall Study|Did not enter follow-up|4
998745|NCT00435825|3275599|P1|Overall Study|Did not enter follow-up|0
998746|NCT00435825|3275596|P4|Overall Study|Did not receive study drug|0
998747|NCT00435825|3275597|P3|Overall Study|Did not receive study drug|2
998748|NCT00435825|3275598|P2|Overall Study|Did not receive study drug|0
998749|NCT00435825|3275599|P1|Overall Study|Did not receive study drug|1
998750|NCT00435825|3275596|P4|Overall Study|Failure to return|0
998751|NCT00435825|3275597|P3|Overall Study|Failure to return|4
998752|NCT00435825|3275598|P2|Overall Study|Failure to return|0
998753|NCT00435825|3275599|P1|Overall Study|Failure to return|5
998754|NCT00435825|3275596|P4|Overall Study|Refused treatment|5
998755|NCT00435825|3275597|P3|Overall Study|Refused treatment|0
998756|NCT00435825|3275598|P2|Overall Study|Refused treatment|0
998757|NCT00435825|3275599|P1|Overall Study|Refused treatment|2
998758|NCT00435825|3275596|P4|Overall Study|Other Protocol Violation|0
998759|NCT00435825|3275597|P3|Overall Study|Other Protocol Violation|0
998760|NCT00435825|3275598|P2|Overall Study|Other Protocol Violation|0
998761|NCT00435825|3275599|P1|Overall Study|Other Protocol Violation|1
998762|NCT00435825|3275596|P4|Overall Study|Insufficient Therapeutic Response|3
998763|NCT00435825|3275597|P3|Overall Study|Insufficient Therapeutic Response|0
998764|NCT00435825|3275598|P2|Overall Study|Insufficient Therapeutic Response|1
998765|NCT00435825|3275599|P1|Overall Study|Insufficient Therapeutic Response|3
998766|NCT00435825|3275596|P4|Overall Study|Abnormality of Laboratory Test|0
998767|NCT00435825|3275597|P3|Overall Study|Abnormality of Laboratory Test|0
998768|NCT00435825|3275598|P2|Overall Study|Abnormality of Laboratory Test|1
998769|NCT00435825|3275599|P1|Overall Study|Abnormality of Laboratory Test|0
998770|NCT00435487|3275722|P2|Overall Study|Received Drug in Other Treatment Group|1
998771|NCT00435487|3275723|P1|Overall Study|Received Drug in Other Treatment Group|0
998772|NCT00435487|3275722|P2|Overall Study|Withdrawal by Subject Prior to Treatment|2
998773|NCT00435487|3275723|P1|Overall Study|Withdrawal by Subject Prior to Treatment|0
998774|NCT00435487|3275722|P2|Overall Study|Withdrawal by Subject|1
998775|NCT00435487|3275723|P1|Overall Study|Withdrawal by Subject|2
998776|NCT00435487|3275722|P2|Overall Study|Other|2
998777|NCT00435487|3275723|P1|Overall Study|Other|5
998778|NCT00435487|3275722|P2|Overall Study|Lost to Follow-up|2
998779|NCT00435487|3275723|P1|Overall Study|Lost to Follow-up|2
998780|NCT00435487|3275722|P2|Overall Study|Adverse Event|3
998781|NCT00435487|3275723|P1|Overall Study|Adverse Event|0
998782|NCT00435487|3275722|P2|Overall Study|Death|4
998783|NCT00435487|3275723|P1|Overall Study|Death|3
998784|NCT00435461|3275742|P3|Overall Study|Lost to Follow-up|2
998785|NCT00435461|3275743|P2|Overall Study|Lost to Follow-up|1
998786|NCT00435461|3275744|P1|Overall Study|Lost to Follow-up|1
998787|NCT00435461|3275742|P3|Overall Study|Non-Compliance of diary|1
998788|NCT00435461|3275743|P2|Overall Study|Non-Compliance of diary|0
998789|NCT00435461|3275744|P1|Overall Study|Non-Compliance of diary|2
998790|NCT00435461|3275742|P3|Overall Study|Adverse Event|6
998791|NCT00435461|3275743|P2|Overall Study|Adverse Event|2
998792|NCT00435461|3275744|P1|Overall Study|Adverse Event|1
998793|NCT00435461|3275742|P3|Overall Study|Noncompliance with study requirements|1
998794|NCT00435461|3275743|P2|Overall Study|Noncompliance with study requirements|1
998795|NCT00435461|3275744|P1|Overall Study|Noncompliance with study requirements|1
998796|NCT00435461|3275742|P3|Overall Study|Participant ended study one day early|0
998797|NCT00435461|3275743|P2|Overall Study|Participant ended study one day early|0
998798|NCT00435461|3275744|P1|Overall Study|Participant ended study one day early|1
998799|NCT00435461|3275742|P3|Overall Study|Participant moved eDiary,studymedication|0
998800|NCT00435461|3275743|P2|Overall Study|Participant moved eDiary,studymedication|0
998801|NCT00435461|3275744|P1|Overall Study|Participant moved eDiary,studymedication|1
998802|NCT00435461|3275742|P3|Overall Study|Pregnancy|0
998803|NCT00435461|3275743|P2|Overall Study|Pregnancy|0
998804|NCT00435461|3275744|P1|Overall Study|Pregnancy|2
998805|NCT00435461|3275742|P3|Overall Study|Participant could not swallow capsule|1
998806|NCT00435461|3275743|P2|Overall Study|Participant could not swallow capsule|0
998807|NCT00435461|3275744|P1|Overall Study|Participant could not swallow capsule|0
998808|NCT00435461|3275742|P3|Overall Study|Participant could not tolerate symptoms|1
998809|NCT00435461|3275743|P2|Overall Study|Participant could not tolerate symptoms|0
998810|NCT00435461|3275744|P1|Overall Study|Participant could not tolerate symptoms|0
998811|NCT00435461|3275742|P3|Overall Study|Randomized in error|0
998812|NCT00435461|3275743|P2|Overall Study|Randomized in error|0
998813|NCT00435461|3275744|P1|Overall Study|Randomized in error|1
998814|NCT00435461|3275742|P3|Overall Study|Withdrawal by Subject|2
998815|NCT00435461|3275743|P2|Overall Study|Withdrawal by Subject|0
998816|NCT00435461|3275744|P1|Overall Study|Withdrawal by Subject|1
998817|NCT00435461|3275742|P3|Overall Study|Lack of Efficacy|0
998818|NCT00435461|3275743|P2|Overall Study|Lack of Efficacy|1
998819|NCT00435461|3275744|P1|Overall Study|Lack of Efficacy|2
998820|NCT00435461|3275742|P3|Overall Study|In error, two study medications switched|0
998821|NCT00435461|3275743|P2|Overall Study|In error, two study medications switched|0
998822|NCT00435461|3275744|P1|Overall Study|In error, two study medications switched|1
998823|NCT00435461|3275742|P3|Overall Study|Compliance less than 80 percent|0
998824|NCT00435461|3275743|P2|Overall Study|Compliance less than 80 percent|0
998825|NCT00435461|3275744|P1|Overall Study|Compliance less than 80 percent|1
998826|NCT00435461|3275742|P3|Overall Study|Participant randomized(inadequate score)|0
998827|NCT00435461|3275743|P2|Overall Study|Participant randomized(inadequate score)|0
998828|NCT00435461|3275744|P1|Overall Study|Participant randomized(inadequate score)|1
998829|NCT00435461|3275742|P3|Overall Study|Protocol Violation|10
998830|NCT00435461|3275743|P2|Overall Study|Protocol Violation|9
998831|NCT00435461|3275744|P1|Overall Study|Protocol Violation|6
998832|NCT00435461|3275742|P3|Overall Study|Visit changed to EarlyWithdrawn Visit|0
998833|NCT00435461|3275743|P2|Overall Study|Visit changed to EarlyWithdrawn Visit|0
998834|NCT00435461|3275744|P1|Overall Study|Visit changed to EarlyWithdrawn Visit|1
998835|NCT00435409|3275781|P3|Overall Study|Sponsor decision|0
998836|NCT00435409|3275782|P2|Overall Study|Sponsor decision|3
998837|NCT00435409|3275783|P1|Overall Study|Sponsor decision|0
998838|NCT00435409|3275781|P3|Overall Study|Adverse Event|8
998839|NCT00435409|3275782|P2|Overall Study|Adverse Event|0
998840|NCT00435409|3275783|P1|Overall Study|Adverse Event|0
998841|NCT00435409|3275781|P3|Overall Study|Not specified|1
998842|NCT00435409|3275782|P2|Overall Study|Not specified|30
998843|NCT00435409|3275783|P1|Overall Study|Not specified|45
998844|NCT00435409|3275781|P3|Overall Study|Withdrawal by Subject|1
998845|NCT00435409|3275782|P2|Overall Study|Withdrawal by Subject|7
998846|NCT00435409|3275783|P1|Overall Study|Withdrawal by Subject|8
998847|NCT00435409|3275781|P3|Overall Study|Global deterioration of health status|4
998848|NCT00435409|3275782|P2|Overall Study|Global deterioration of health status|0
998849|NCT00435409|3275783|P1|Overall Study|Global deterioration of health status|0
998850|NCT00435409|3275781|P3|Overall Study|Objective progression or relapse|58
998851|NCT00435409|3275782|P2|Overall Study|Objective progression or relapse|93
998852|NCT00435409|3275783|P1|Overall Study|Objective progression or relapse|158
998853|NCT00435409|3275781|P3|Overall Study|Death|6
998854|NCT00435409|3275782|P2|Overall Study|Death|6
998855|NCT00435409|3275783|P1|Overall Study|Death|8
998856|NCT00435409|3275781|P3|Overall Study|Lost to Follow-up|0
998857|NCT00435409|3275782|P2|Overall Study|Lost to Follow-up|2
998858|NCT00435409|3275783|P1|Overall Study|Lost to Follow-up|1
998859|NCT00435409|3275781|P3|Overall Study|Protocol Violation|0
998860|NCT00435409|3275782|P2|Overall Study|Protocol Violation|2
998861|NCT00435409|3275783|P1|Overall Study|Protocol Violation|1
998862|NCT00435370|3275805|P2|Overall Study|Antipsychotic medication changed|2
998863|NCT00435370|3275806|P1|Overall Study|Antipsychotic medication changed|4
998864|NCT00435370|3275805|P2|Overall Study|Withdrawal by Subject|10
998865|NCT00435370|3275806|P1|Overall Study|Withdrawal by Subject|10
998866|NCT00435370|3275805|P2|Overall Study|Adverse Event|8
998867|NCT00435370|3275806|P1|Overall Study|Adverse Event|8
998868|NCT00435188|3275814|P2|Overall Study|Lost to Follow-up|6
998869|NCT00435188|3275815|P1|Overall Study|Lost to Follow-up|5
998870|NCT00435188|3275814|P2|Overall Study|Withdrawal by Subject|11
998871|NCT00435188|3275815|P1|Overall Study|Withdrawal by Subject|16
998872|NCT00435188|3275814|P2|Overall Study|Death|6
998873|NCT00435188|3275815|P1|Overall Study|Death|1
998874|NCT00435162|3275858|P6|Period 2 (2 Weeks)|Adverse Event|0
998875|NCT00435162|3275859|P5|Period 2 (2 Weeks)|Adverse Event|0
998876|NCT00435162|3275860|P4|Period 2 (2 Weeks)|Adverse Event|0
998877|NCT00435162|3275861|P3|Period 2 (2 Weeks)|Adverse Event|0
998878|NCT00435162|3275862|P2|Period 2 (2 Weeks)|Adverse Event|1
998879|NCT00435162|3275863|P1|Period 2 (2 Weeks)|Adverse Event|0
998880|NCT00435045|3275883|P2|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0
998881|NCT00435045|3275884|P1|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1
998882|NCT00435045|3275883|P2|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0
998883|NCT00435045|3275884|P1|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1
998884|NCT00435045|3275883|P2|Weeks 13-16 / 40mg Dose Level|Adverse Event|2
998885|NCT00435045|3275884|P1|Weeks 13-16 / 40mg Dose Level|Adverse Event|3
998886|NCT00435045|3275883|P2|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1
998887|NCT00435045|3275884|P1|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0
998888|NCT00435045|3275883|P2|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
998889|NCT00435045|3275884|P1|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
998890|NCT00435045|3275883|P2|Weeks 9-12 / 20mg Dose Level|Adverse Event|3
998891|NCT00435045|3275884|P1|Weeks 9-12 / 20mg Dose Level|Adverse Event|4
998892|NCT00435045|3275883|P2|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1
998893|NCT00435045|3275884|P1|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0
998894|NCT00435045|3275883|P2|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0
998895|NCT00435045|3275884|P1|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1
998896|NCT00435045|3275883|P2|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1
998897|NCT00435045|3275884|P1|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2
998898|NCT00435045|3275883|P2|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
998899|NCT00435045|3275884|P1|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
998900|NCT00435045|3275883|P2|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
998901|NCT00435045|3275884|P1|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
998902|NCT00435019|3275940|P2|Overall Study|Personal reasons for withdrawal|7
998903|NCT00435019|3275941|P1|Overall Study|Personal reasons for withdrawal|8
998904|NCT00435019|3275940|P2|Overall Study|Protocol Violation|1
998905|NCT00435019|3275941|P1|Overall Study|Protocol Violation|3
998906|NCT00435019|3275940|P2|Overall Study|Lack of Efficacy|2
998907|NCT00435019|3275941|P1|Overall Study|Lack of Efficacy|1
998908|NCT00435019|3275940|P2|Overall Study|Adverse Event|0
998909|NCT00435019|3275941|P1|Overall Study|Adverse Event|1
998910|NCT00434967|3275982|P4|Overall Study|Patient Disposition Challenges|3
998911|NCT00434967|3275983|P3|Overall Study|Patient Disposition Challenges|0
998912|NCT00434967|3275984|P2|Overall Study|Patient Disposition Challenges|0
998913|NCT00434967|3275985|P1|Overall Study|Patient Disposition Challenges|2
998914|NCT00434967|3275982|P4|Overall Study|Physician Decision|0
998915|NCT00434967|3275983|P3|Overall Study|Physician Decision|1
998916|NCT00434967|3275984|P2|Overall Study|Physician Decision|1
998917|NCT00434967|3275985|P1|Overall Study|Physician Decision|1
998918|NCT00434967|3275982|P4|Overall Study|Protocol Violation|1
998919|NCT00434967|3275983|P3|Overall Study|Protocol Violation|0
998920|NCT00434967|3275984|P2|Overall Study|Protocol Violation|1
998921|NCT00434967|3275985|P1|Overall Study|Protocol Violation|0
998922|NCT00434967|3275982|P4|Overall Study|Randomized in error|1
998923|NCT00434967|3275983|P3|Overall Study|Randomized in error|0
998924|NCT00434967|3275984|P2|Overall Study|Randomized in error|0
998925|NCT00434967|3275985|P1|Overall Study|Randomized in error|0
998926|NCT00434967|3275982|P4|Overall Study|Withdrawal by Subject|6
998927|NCT00434967|3275983|P3|Overall Study|Withdrawal by Subject|4
998928|NCT00434967|3275984|P2|Overall Study|Withdrawal by Subject|2
998929|NCT00434967|3275985|P1|Overall Study|Withdrawal by Subject|2
998930|NCT00434967|3275982|P4|Overall Study|Lost to Follow-up|0
998931|NCT00434967|3275983|P3|Overall Study|Lost to Follow-up|1
998932|NCT00434967|3275984|P2|Overall Study|Lost to Follow-up|0
998933|NCT00434967|3275985|P1|Overall Study|Lost to Follow-up|0
998934|NCT00434967|3275982|P4|Overall Study|Adverse Event|3
998935|NCT00434967|3275983|P3|Overall Study|Adverse Event|3
998936|NCT00434967|3275984|P2|Overall Study|Adverse Event|4
998937|NCT00434967|3275985|P1|Overall Study|Adverse Event|2
998938|NCT00434954|3276005|P2|Overall Study|Subject decision|22
998939|NCT00434954|3276006|P1|Overall Study|Subject decision|8
998940|NCT00434954|3276005|P2|Overall Study|Sponsor decision|0
998941|NCT00434954|3276006|P1|Overall Study|Sponsor decision|1
998942|NCT00434954|3276005|P2|Overall Study|Protocol Violation|27
998943|NCT00434954|3276006|P1|Overall Study|Protocol Violation|36
998944|NCT00434954|3276005|P2|Overall Study|Physician Decision|3
998945|NCT00434954|3276006|P1|Overall Study|Physician Decision|6
998946|NCT00434954|3276005|P2|Overall Study|Lost to Follow-up|1
998947|NCT00434954|3276006|P1|Overall Study|Lost to Follow-up|0
998948|NCT00434954|3276005|P2|Overall Study|Entry criteria not met|16
998949|NCT00434954|3276006|P1|Overall Study|Entry criteria not met|14
998950|NCT00434954|3276005|P2|Overall Study|Adverse Event|2
998951|NCT00434954|3276006|P1|Overall Study|Adverse Event|17
998952|NCT00434876|3276036|P2|Overall Study|Lost to Follow-up|1
998953|NCT00434876|3276037|P1|Overall Study|Lost to Follow-up|1
998954|NCT00434759|3276051|P2|Overall Study|family affairs|0
998955|NCT00434759|3276052|P1|Overall Study|family affairs|2
998956|NCT00434759|3276051|P2|Overall Study|Withdrawal by Subject|1
998957|NCT00434759|3276052|P1|Overall Study|Withdrawal by Subject|17
998958|NCT00434759|3276051|P2|Overall Study|Lack of Efficacy|4
998959|NCT00434759|3276052|P1|Overall Study|Lack of Efficacy|5
998960|NCT00434642|3276068|P2|Open-label Treatment Phase|Disease Progression Per RECIST|6
998961|NCT00434642|3276069|P1|Open-label Treatment Phase|Disease Progression Per RECIST|0
998962|NCT00434642|3276068|P2|Open-label Treatment Phase|Adverse Event|5
998963|NCT00434642|3276069|P1|Open-label Treatment Phase|Adverse Event|0
998964|NCT00434642|3276068|P2|Blinded Treatment Phase|Did not Receive Treatment|1
998965|NCT00434642|3276069|P1|Blinded Treatment Phase|Did not Receive Treatment|4
998966|NCT00434642|3276068|P2|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29
998967|NCT00434642|3276069|P1|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32
998968|NCT00434642|3276068|P2|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0
998969|NCT00434642|3276069|P1|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3
998970|NCT00434642|3276068|P2|Blinded Treatment Phase|Physician Decision|27
998971|NCT00434642|3276069|P1|Blinded Treatment Phase|Physician Decision|19
998972|NCT00434642|3276068|P2|Blinded Treatment Phase|Disease Progression Per RECIST|109
998973|NCT00434642|3276069|P1|Blinded Treatment Phase|Disease Progression Per RECIST|168
998974|NCT00434642|3276068|P2|Blinded Treatment Phase|Clinical Disease Progression|5
998975|NCT00434642|3276069|P1|Blinded Treatment Phase|Clinical Disease Progression|4
998976|NCT00434642|3276068|P2|Blinded Treatment Phase|Adverse Event|58
998977|NCT00434642|3276069|P1|Blinded Treatment Phase|Adverse Event|12
998978|NCT00434590|3276087|P2|Overall Study|Administrative problems|5
998979|NCT00434590|3276088|P1|Overall Study|Administrative problems|5
998980|NCT00434421|3276110|P1|Overall Study|Non-compliance with study treatment|1
998981|NCT00434421|3276110|P1|Overall Study|Withdrawal by Subject|1
998982|NCT00434330|3276138|P6|Overall Study|Subject Not Compliant With Study|0
998983|NCT00434330|3276139|P5|Overall Study|Subject Not Compliant With Study|0
998984|NCT00434330|3276140|P4|Overall Study|Subject Not Compliant With Study|0
998985|NCT00434330|3276141|P3|Overall Study|Subject Not Compliant With Study|1
998986|NCT00434330|3276142|P2|Overall Study|Subject Not Compliant With Study|0
998987|NCT00434330|3276143|P1|Overall Study|Subject Not Compliant With Study|0
998988|NCT00434330|3276138|P6|Overall Study|Renal transplant|0
998989|NCT00434330|3276139|P5|Overall Study|Renal transplant|0
998990|NCT00434330|3276140|P4|Overall Study|Renal transplant|1
998991|NCT00434330|3276141|P3|Overall Study|Renal transplant|0
998992|NCT00434330|3276142|P2|Overall Study|Renal transplant|0
998993|NCT00434330|3276143|P1|Overall Study|Renal transplant|0
998994|NCT00434330|3276138|P6|Overall Study|Withdrawal by Subject|0
998995|NCT00434330|3276139|P5|Overall Study|Withdrawal by Subject|0
998996|NCT00434330|3276140|P4|Overall Study|Withdrawal by Subject|1
998997|NCT00434330|3276141|P3|Overall Study|Withdrawal by Subject|1
998998|NCT00434330|3276142|P2|Overall Study|Withdrawal by Subject|0
998999|NCT00434330|3276143|P1|Overall Study|Withdrawal by Subject|0
999000|NCT00434330|3276138|P6|Overall Study|Death|1
999001|NCT00434330|3276139|P5|Overall Study|Death|1
999002|NCT00434330|3276140|P4|Overall Study|Death|0
999003|NCT00434330|3276141|P3|Overall Study|Death|0
999004|NCT00434330|3276142|P2|Overall Study|Death|0
999005|NCT00434330|3276143|P1|Overall Study|Death|1
999006|NCT00434330|3276138|P6|Overall Study|Adverse Event|0
999007|NCT00434330|3276139|P5|Overall Study|Adverse Event|0
999008|NCT00434330|3276140|P4|Overall Study|Adverse Event|0
999009|NCT00434330|3276141|P3|Overall Study|Adverse Event|1
999010|NCT00434330|3276142|P2|Overall Study|Adverse Event|0
999011|NCT00434330|3276143|P1|Overall Study|Adverse Event|0
999012|NCT00434304|3276175|P1|Overall Study|Withdrawal by Subject|4
999013|NCT00434304|3276175|P1|Overall Study|Lack of Efficacy|2
999014|NCT00434304|3276175|P1|Overall Study|Adverse Event|14
999015|NCT00434252|3276224|P2|Overall Study|Withdrawal by Subject|7
999016|NCT00434252|3276225|P1|Overall Study|Withdrawal by Subject|3
999017|NCT00434252|3276224|P2|Overall Study|Physician Decision|8
999018|NCT00434252|3276225|P1|Overall Study|Physician Decision|4
999019|NCT00434252|3276224|P2|Overall Study|Lost to Follow-up|1
999020|NCT00434252|3276225|P1|Overall Study|Lost to Follow-up|0
999021|NCT00434252|3276224|P2|Overall Study|Death|2
999022|NCT00434252|3276225|P1|Overall Study|Death|1
999023|NCT00434252|3276224|P2|Overall Study|Adverse Event|13
999024|NCT00434252|3276225|P1|Overall Study|Adverse Event|6
999025|NCT00434252|3276224|P2|Overall Study|Lack of Efficacy|100
999026|NCT00434252|3276225|P1|Overall Study|Lack of Efficacy|50
999027|NCT00434213|3276259|P1|Overall Study|Non-compliant to study schedule|1
999028|NCT00434213|3276259|P1|Overall Study|Application site reaction|1
999029|NCT00434213|3276259|P1|Overall Study|Unable to comply with study visit window|2
999030|NCT00434213|3276259|P1|Overall Study|Protocol Violation|3
999031|NCT00434213|3276259|P1|Overall Study|Withdrawal by Subject|7
999032|NCT00434213|3276259|P1|Overall Study|Lost to Follow-up|14
999033|NCT00434213|3276259|P1|Overall Study|Lack of Efficacy|9
999034|NCT00434213|3276259|P1|Overall Study|Adverse Event|12
999035|NCT00434161|3276267|P3|Overall Study|Logistical error study assessments|3
999036|NCT00434161|3276268|P2|Overall Study|Logistical error study assessments|0
999037|NCT00434161|3276269|P1|Overall Study|Logistical error study assessments|1
999038|NCT00434161|3276267|P3|Overall Study|Withdrawal by Subject|3
999039|NCT00434161|3276268|P2|Overall Study|Withdrawal by Subject|0
999040|NCT00434161|3276269|P1|Overall Study|Withdrawal by Subject|2
999041|NCT00434161|3276267|P3|Overall Study|Non-Compliance|0
999042|NCT00434161|3276268|P2|Overall Study|Non-Compliance|1
999043|NCT00434161|3276269|P1|Overall Study|Non-Compliance|1
999044|NCT00434161|3276267|P3|Overall Study|Death|1
999045|NCT00434161|3276268|P2|Overall Study|Death|0
999046|NCT00434161|3276269|P1|Overall Study|Death|1
999047|NCT00434161|3276267|P3|Overall Study|Lost to Follow-up|0
999048|NCT00434161|3276268|P2|Overall Study|Lost to Follow-up|1
999049|NCT00434161|3276269|P1|Overall Study|Lost to Follow-up|0
999050|NCT00434161|3276267|P3|Overall Study|Adverse Event|4
999051|NCT00434161|3276268|P2|Overall Study|Adverse Event|1
999052|NCT00434161|3276269|P1|Overall Study|Adverse Event|5
999053|NCT00434148|3276313|P2|Overall Study|Abnormal test procedure result|1
999054|NCT00434148|3276314|P1|Overall Study|Abnormal test procedure result|0
999055|NCT00434148|3276313|P2|Overall Study|Condition no longer requires study drug|0
999056|NCT00434148|3276314|P1|Overall Study|Condition no longer requires study drug|1
999057|NCT00434148|3276313|P2|Overall Study|Lost to Follow-up|1
999058|NCT00434148|3276314|P1|Overall Study|Lost to Follow-up|0
999059|NCT00434148|3276313|P2|Overall Study|Administrative problems|10
999060|NCT00434148|3276314|P1|Overall Study|Administrative problems|6
999061|NCT00434148|3276313|P2|Overall Study|Protocol Violation|0
999062|NCT00434148|3276314|P1|Overall Study|Protocol Violation|4
999063|NCT00434148|3276313|P2|Overall Study|Withdrawal by Subject|15
999064|NCT00434148|3276314|P1|Overall Study|Withdrawal by Subject|15
999065|NCT00434148|3276313|P2|Overall Study|Lack of Efficacy|28
999066|NCT00434148|3276314|P1|Overall Study|Lack of Efficacy|25
999067|NCT00434148|3276313|P2|Overall Study|Adverse Event|18
999068|NCT00434148|3276314|P1|Overall Study|Adverse Event|18
999069|NCT00434122|3276350|P2|Overall Study|Travelling of subject.|0
999070|NCT00434122|3276351|P1|Overall Study|Travelling of subject.|1
999071|NCT00434122|3276350|P2|Overall Study|Low follicular response.|2
999072|NCT00434122|3276351|P1|Overall Study|Low follicular response.|1
999073|NCT00434122|3276350|P2|Overall Study|Large follicle size|2
999074|NCT00434122|3276351|P1|Overall Study|Large follicle size|2
999075|NCT00434122|3276350|P2|Overall Study|Personal reasons|1
999076|NCT00434122|3276351|P1|Overall Study|Personal reasons|1
999077|NCT00434122|3276350|P2|Overall Study|loss of subject contact|1
999078|NCT00434122|3276351|P1|Overall Study|loss of subject contact|1
999079|NCT00434122|3276350|P2|Overall Study|Non-compliance with protocol|1
999080|NCT00434122|3276351|P1|Overall Study|Non-compliance with protocol|0
999081|NCT00434109|3276360|P1|Overall Study|had embolism, did not receive sunitinib|3
999082|NCT00434109|3276360|P1|Overall Study|Protocol Violation|1
999083|NCT00434109|3276360|P1|Overall Study|Adverse Event|5
999084|NCT00434109|3276360|P1|Overall Study|Physician Decision|9
999085|NCT00434057|3276369|P1|Overall Study|Withdrawal by Subject|1
999086|NCT00433966|3276407|P4|Stent Intervention/Randomization|Lost to Follow-up|47
999087|NCT00433966|3276408|P3|Stent Intervention/Randomization|Lost to Follow-up|113
999088|NCT00433966|3276409|P2|Stent Intervention/Randomization|Lost to Follow-up|0
999089|NCT00433966|3276410|P1|Stent Intervention/Randomization|Lost to Follow-up|0
999090|NCT00433966|3276407|P4|Stent Intervention/Randomization|Withdrawal by Subject|15
999091|NCT00433966|3276408|P3|Stent Intervention/Randomization|Withdrawal by Subject|41
999092|NCT00433966|3276409|P2|Stent Intervention/Randomization|Withdrawal by Subject|0
999093|NCT00433966|3276410|P1|Stent Intervention/Randomization|Withdrawal by Subject|0
999094|NCT00433966|3276407|P4|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
999095|NCT00433966|3276408|P3|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
999096|NCT00433966|3276409|P2|Pharmacology Intervention/Randomization|Not true myocardial infarction|28
999097|NCT00433966|3276410|P1|Pharmacology Intervention/Randomization|Not true myocardial infarction|29
999098|NCT00433966|3276407|P4|Pharmacology Intervention/Randomization|Lost to Follow-up|0
999099|NCT00433966|3276408|P3|Pharmacology Intervention/Randomization|Lost to Follow-up|0
999100|NCT00433966|3276409|P2|Pharmacology Intervention/Randomization|Lost to Follow-up|103
999101|NCT00433966|3276410|P1|Pharmacology Intervention/Randomization|Lost to Follow-up|97
999102|NCT00433966|3276407|P4|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
999103|NCT00433966|3276408|P3|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
999104|NCT00433966|3276409|P2|Pharmacology Intervention/Randomization|Withdrawal by Subject|43
999105|NCT00433966|3276410|P1|Pharmacology Intervention/Randomization|Withdrawal by Subject|40
999106|NCT00433914|3276432|P2|Overall Study|Lost to Follow-up|1
999107|NCT00433914|3276433|P1|Overall Study|Lost to Follow-up|0
999108|NCT00433914|3276432|P2|Overall Study|Withdrawal by Subject|2
999109|NCT00433914|3276433|P1|Overall Study|Withdrawal by Subject|0
999110|NCT00433836|3276453|P2|Overall Study|Abnormal laboratory values|1
999111|NCT00433836|3276454|P1|Overall Study|Abnormal laboratory values|0
999112|NCT00433836|3276453|P2|Overall Study|Condition no longer requires study drug|1
999113|NCT00433836|3276454|P1|Overall Study|Condition no longer requires study drug|0
999114|NCT00433836|3276453|P2|Overall Study|Protocol Violation|2
999115|NCT00433836|3276454|P1|Overall Study|Protocol Violation|0
999116|NCT00433836|3276453|P2|Overall Study|Unsatisfactory therapeutic effect|1
999117|NCT00433836|3276454|P1|Overall Study|Unsatisfactory therapeutic effect|1
999118|NCT00433836|3276453|P2|Overall Study|Withdrawal by Subject|1
999119|NCT00433836|3276454|P1|Overall Study|Withdrawal by Subject|2
999120|NCT00433836|3276453|P2|Overall Study|Lost to Follow-up|0
999121|NCT00433836|3276454|P1|Overall Study|Lost to Follow-up|3
999122|NCT00433836|3276453|P2|Overall Study|Adverse Event|0
999123|NCT00433836|3276454|P1|Overall Study|Adverse Event|7
999124|NCT00433771|3276466|P1|Overall Study|Failure to deploy stent|1
999125|NCT00433771|3276466|P1|Overall Study|Death|2
999126|NCT00433771|3276466|P1|Overall Study|Treated and later found to be ineligible|2
999127|NCT00433771|3276466|P1|Overall Study|screen fail|14
999128|NCT00433654|3276489|P2|Overall Study|Withdrawal by Subject|2
999129|NCT00433654|3276490|P1|Overall Study|Withdrawal by Subject|1
999130|NCT00433654|3276489|P2|Overall Study|Subject not yet due for visit|0
999131|NCT00433654|3276490|P1|Overall Study|Subject not yet due for visit|4
999132|NCT00433654|3276489|P2|Overall Study|Missed visit|3
999133|NCT00433654|3276490|P1|Overall Study|Missed visit|6
999134|NCT00433654|3276489|P2|Overall Study|Death|0
999135|NCT00433654|3276490|P1|Overall Study|Death|4
999136|NCT00433537|3276536|P3|Step 2 - Maintenance Rituximab or ASCT|Other|0
999137|NCT00433537|3276537|P2|Step 2 - Maintenance Rituximab or ASCT|Other|0
999138|NCT00433537|3276538|P1|Step 2 - Maintenance Rituximab or ASCT|Other|1
999139|NCT00433537|3276536|P3|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
999140|NCT00433537|3276537|P2|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
999141|NCT00433537|3276538|P1|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4
999142|NCT00433537|3276536|P3|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
999143|NCT00433537|3276537|P2|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
999144|NCT00433537|3276538|P1|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2
999145|NCT00433537|3276536|P3|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
999146|NCT00433537|3276537|P2|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
999147|NCT00433537|3276538|P1|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8
999148|NCT00433537|3276536|P3|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
999149|NCT00433537|3276537|P2|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
999150|NCT00433537|3276538|P1|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1
999151|NCT00433537|3276536|P3|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2
999152|NCT00433537|3276537|P2|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
999153|NCT00433537|3276538|P1|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
999154|NCT00433537|3276536|P3|Step 1 - VcR-CVAD Induction|Adverse Event|4
999155|NCT00433537|3276537|P2|Step 1 - VcR-CVAD Induction|Adverse Event|0
999156|NCT00433537|3276538|P1|Step 1 - VcR-CVAD Induction|Adverse Event|0
999157|NCT00433537|3276536|P3|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2
999158|NCT00433537|3276537|P2|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
999159|NCT00433537|3276538|P1|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
999160|NCT00433537|3276536|P3|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
999161|NCT00433537|3276537|P2|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0
999162|NCT00433537|3276538|P1|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
999163|NCT00433446|3276547|P1|Overall Study|Ineligible|9
999164|NCT00433446|3276547|P1|Overall Study|Other - Not Protocol specified|3
999165|NCT00433446|3276547|P1|Overall Study|Progression|44
999166|NCT00433446|3276547|P1|Overall Study|Refusal Unrelated to Adverse Event|1
999167|NCT00433446|3276547|P1|Overall Study|Adverse Event|4
999168|NCT00433381|3276557|P2|Overall Study|Ineligible / no protocol treatment|3
999169|NCT00433381|3276558|P1|Overall Study|Ineligible / no protocol treatment|3
999170|NCT00433329|3276577|P1|Overall Study|Physician Decision|1
999171|NCT00433329|3276577|P1|Overall Study|Lost to Follow-up|1
999172|NCT00433329|3276577|P1|Overall Study|Moved out of state|1
999173|NCT00433329|3276577|P1|Overall Study|Discontinued sildenafil|2
999174|NCT00433329|3276577|P1|Overall Study|Withdrew consent|3
999175|NCT00433329|3276577|P1|Overall Study|Death|4
999176|NCT00433329|3276577|P1|Overall Study|Adverse Event|9
999177|NCT00433290|3276583|P2|Overall Study|Lost to Follow-up|0
999178|NCT00433290|3276584|P1|Overall Study|Lost to Follow-up|1
999179|NCT00433290|3276583|P2|Overall Study|Entry Criteria Not Met|1
999180|NCT00433290|3276584|P1|Overall Study|Entry Criteria Not Met|0
999181|NCT00433290|3276583|P2|Overall Study|Physician Decision|0
999182|NCT00433290|3276584|P1|Overall Study|Physician Decision|2
999183|NCT00433290|3276583|P2|Overall Study|Protocol Violation|2
999184|NCT00433290|3276584|P1|Overall Study|Protocol Violation|3
999185|NCT00433290|3276583|P2|Overall Study|Withdrawal by Subject|2
999186|NCT00433290|3276584|P1|Overall Study|Withdrawal by Subject|4
999187|NCT00433290|3276583|P2|Overall Study|Lack of Efficacy|5
999188|NCT00433290|3276584|P1|Overall Study|Lack of Efficacy|1
999189|NCT00433290|3276583|P2|Overall Study|Adverse Event|7
999190|NCT00433290|3276584|P1|Overall Study|Adverse Event|24
999191|NCT00433199|3276653|P2|Open-Label Period|Administrative|1
999192|NCT00433199|3276654|P1|Open-Label Period|Administrative|0
999193|NCT00433199|3276653|P2|Open-Label Period|Protocol Violation|2
999194|NCT00433199|3276654|P1|Open-Label Period|Protocol Violation|0
999195|NCT00433199|3276653|P2|Open-Label Period|Withdrawal by Subject|7
999196|NCT00433199|3276654|P1|Open-Label Period|Withdrawal by Subject|0
999197|NCT00433199|3276653|P2|Open-Label Period|Lost to Follow-up|3
999198|NCT00433199|3276654|P1|Open-Label Period|Lost to Follow-up|0
999199|NCT00433199|3276653|P2|Open-Label Period|Lack of Efficacy|2
999200|NCT00433199|3276654|P1|Open-Label Period|Lack of Efficacy|0
999201|NCT00433199|3276653|P2|Open-Label Period|Adverse Event|19
999202|NCT00433199|3276654|P1|Open-Label Period|Adverse Event|0
999203|NCT00433199|3276653|P2|Double-Blind Period|Administrative|5
999204|NCT00433199|3276654|P1|Double-Blind Period|Administrative|1
999205|NCT00433199|3276653|P2|Double-Blind Period|Protocol Violation|10
999206|NCT00433199|3276654|P1|Double-Blind Period|Protocol Violation|1
999207|NCT00433199|3276653|P2|Double-Blind Period|Withdrawal by Subject|19
999208|NCT00433199|3276654|P1|Double-Blind Period|Withdrawal by Subject|8
999209|NCT00433199|3276653|P2|Double-Blind Period|Lost to Follow-up|5
999210|NCT00433199|3276654|P1|Double-Blind Period|Lost to Follow-up|2
999211|NCT00433199|3276653|P2|Double-Blind Period|Lack of Efficacy|2
999212|NCT00433199|3276654|P1|Double-Blind Period|Lack of Efficacy|0
999213|NCT00433199|3276653|P2|Double-Blind Period|Adverse Event|25
999214|NCT00433199|3276654|P1|Double-Blind Period|Adverse Event|0
999215|NCT00433160|3276674|P2|104 Weeks, 28-Week OL Period|Physician Decision|1
999216|NCT00433160|3276675|P1|104 Weeks, 28-Week OL Period|Physician Decision|0
999217|NCT00433160|3276674|P2|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2
999218|NCT00433160|3276675|P1|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8
999219|NCT00433160|3276674|P2|104 Weeks, 28-Week OL Period|Adverse Event|0
999220|NCT00433160|3276675|P1|104 Weeks, 28-Week OL Period|Adverse Event|2
999221|NCT00433160|3276674|P2|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1
999222|NCT00433160|3276675|P1|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0
999223|NCT00433160|3276674|P2|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0
999224|NCT00433160|3276675|P1|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2
999225|NCT00433160|3276674|P2|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2
999226|NCT00433160|3276675|P1|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1
999227|NCT00433160|3276674|P2|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1
999228|NCT00433160|3276675|P1|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3
999229|NCT00433160|3276674|P2|52-Week Double-Blind (DB) Period|Lack of Efficacy|2
999230|NCT00433160|3276675|P1|52-Week Double-Blind (DB) Period|Lack of Efficacy|1
999231|NCT00433160|3276674|P2|52-Week Double-Blind (DB) Period|Sponsor Decision|0
999232|NCT00433160|3276675|P1|52-Week Double-Blind (DB) Period|Sponsor Decision|0
999233|NCT00433160|3276674|P2|52-Week Double-Blind (DB) Period|Physician Decision|2
999234|NCT00433160|3276675|P1|52-Week Double-Blind (DB) Period|Physician Decision|4
999235|NCT00433160|3276674|P2|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1
999236|NCT00433160|3276675|P1|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6
999237|NCT00433160|3276674|P2|52-Week Double-Blind (DB) Period|Protocol Violation|2
999238|NCT00433160|3276675|P1|52-Week Double-Blind (DB) Period|Protocol Violation|0
999239|NCT00433160|3276674|P2|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1
999240|NCT00433160|3276675|P1|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0
999241|NCT00433160|3276674|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
999242|NCT00433160|3276675|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
999243|NCT00433160|3276674|P2|52-Week Double-Blind (DB) Period|Death|0
999244|NCT00433160|3276675|P1|52-Week Double-Blind (DB) Period|Death|0
999245|NCT00433160|3276674|P2|52-Week Double-Blind (DB) Period|Adverse Event|2
999246|NCT00433160|3276675|P1|52-Week Double-Blind (DB) Period|Adverse Event|6
999247|NCT00433147|3276727|P4|Overall Study|Adverse Event|0
999248|NCT00433147|3276728|P3|Overall Study|Adverse Event|0
999249|NCT00433147|3276729|P2|Overall Study|Adverse Event|1
999250|NCT00433147|3276730|P1|Overall Study|Adverse Event|0
999251|NCT00433017|3276746|P2|Overall Study|Subject no longer requires study drug|1
999252|NCT00433017|3276747|P1|Overall Study|Subject no longer requires study drug|1
999253|NCT00433017|3276746|P2|Overall Study|Death|2
999254|NCT00433017|3276747|P1|Overall Study|Death|2
999255|NCT00433017|3276746|P2|Overall Study|Protocol Violation|0
999256|NCT00433017|3276747|P1|Overall Study|Protocol Violation|1
999257|NCT00433017|3276746|P2|Overall Study|Administrative problems|86
999258|NCT00433017|3276747|P1|Overall Study|Administrative problems|80
999259|NCT00433017|3276746|P2|Overall Study|Lost to Follow-up|4
999260|NCT00433017|3276747|P1|Overall Study|Lost to Follow-up|3
999261|NCT00433017|3276746|P2|Overall Study|Withdrawal by Subject|5
999262|NCT00433017|3276747|P1|Overall Study|Withdrawal by Subject|4
999263|NCT00433017|3276746|P2|Overall Study|Adverse Event|3
999264|NCT00433017|3276747|P1|Overall Study|Adverse Event|5
999265|NCT00433004|3276763|P2|Overall Study|Lost to Follow-up|7
999266|NCT00433004|3276764|P1|Overall Study|Lost to Follow-up|5
999267|NCT00432991|3276776|P2|Overall Study|Protocol Violation|12
999268|NCT00432991|3276777|P1|Overall Study|Protocol Violation|7
999269|NCT00432965|3276789|P2|Overall Study|Incomplete Data|3
999270|NCT00432965|3276790|P1|Overall Study|Incomplete Data|4
999271|NCT00432965|3276789|P2|Overall Study|Exclusionary Methods|2
999272|NCT00432965|3276790|P1|Overall Study|Exclusionary Methods|1
999273|NCT00432965|3276789|P2|Overall Study|Death|4
999274|NCT00432965|3276790|P1|Overall Study|Death|3
999275|NCT00432965|3276789|P2|Overall Study|Adverse Event|19
999276|NCT00432965|3276790|P1|Overall Study|Adverse Event|22
999277|NCT00432965|3276789|P2|Overall Study|Non-compliance|0
999278|NCT00432965|3276790|P1|Overall Study|Non-compliance|7
999279|NCT00432965|3276789|P2|Overall Study|Lack of Efficacy|13
999280|NCT00432965|3276790|P1|Overall Study|Lack of Efficacy|8
999281|NCT00432965|3276789|P2|Overall Study|Physician Decision|13
999282|NCT00432965|3276790|P1|Overall Study|Physician Decision|14
999283|NCT00432965|3276789|P2|Overall Study|Withdrawal by Subject|13
999284|NCT00432965|3276790|P1|Overall Study|Withdrawal by Subject|13
999285|NCT00432965|3276789|P2|Overall Study|Lost to Follow-up|19
999286|NCT00432965|3276790|P1|Overall Study|Lost to Follow-up|22
999287|NCT00432835|3276798|P2|Overall Study|Adverse event: lead dislodgement.|7
999288|NCT00432835|3276799|P1|Overall Study|Adverse event: lead dislodgement.|6
999289|NCT00432809|3276812|P3|1 Year Follow-up|Withdrawal by Subject|1
999290|NCT00432809|3276813|P2|1 Year Follow-up|Withdrawal by Subject|0
999291|NCT00432809|3276814|P1|1 Year Follow-up|Withdrawal by Subject|7
999292|NCT00432809|3276812|P3|1 Year Follow-up|Misses 9 and 12 month visit|0
999293|NCT00432809|3276813|P2|1 Year Follow-up|Misses 9 and 12 month visit|0
999294|NCT00432809|3276814|P1|1 Year Follow-up|Misses 9 and 12 month visit|2
999295|NCT00432744|3276887|P2|Months 7 - 12|Too disabled to score|1
999296|NCT00432744|3276888|P1|Months 7 - 12|Too disabled to score|0
999297|NCT00432744|3276887|P2|Months 7 - 12|Withdrawal by Subject|0
999298|NCT00432744|3276888|P1|Months 7 - 12|Withdrawal by Subject|1
999299|NCT00432744|3276887|P2|Months 0-6|Too disabled to score|0
999300|NCT00432744|3276888|P1|Months 0-6|Too disabled to score|1
999301|NCT00432744|3276887|P2|Months 0-6|Withdrawal by Subject|4
999302|NCT00432744|3276888|P1|Months 0-6|Withdrawal by Subject|4
999303|NCT00432666|3276900|P2|Open-Label Extension Period|Physician Decision|0
999304|NCT00432666|3276901|P1|Open-Label Extension Period|Physician Decision|3
999305|NCT00432666|3276900|P2|Open-Label Extension Period|Consent withdrawn|0
999306|NCT00432666|3276901|P1|Open-Label Extension Period|Consent withdrawn|10
999307|NCT00432666|3276900|P2|Open-Label Extension Period|Adverse Event|0
999308|NCT00432666|3276901|P1|Open-Label Extension Period|Adverse Event|5
999309|NCT00432666|3276900|P2|Open-Label Extension Period|Lack of Efficacy|0
999310|NCT00432666|3276901|P1|Open-Label Extension Period|Lack of Efficacy|6
999311|NCT00432666|3276900|P2|Open-Label Extension Period|Withdrawal Criteria Occurred|0
999312|NCT00432666|3276901|P1|Open-Label Extension Period|Withdrawal Criteria Occurred|1
999313|NCT00432666|3276900|P2|Main Period|Consent Withdrawn|0
999314|NCT00432666|3276901|P1|Main Period|Consent Withdrawn|1
999315|NCT00432666|3276900|P2|Main Period|Adverse Event|1
999316|NCT00432666|3276901|P1|Main Period|Adverse Event|1
999317|NCT00432562|3277074|P2|Overall Study|Death|0
999318|NCT00432562|3277075|P1|Overall Study|Death|3
999319|NCT00432380|3277127|P3|Overall Study|Adverse Event|0
999320|NCT00432380|3277128|P2|Overall Study|Adverse Event|0
999321|NCT00432380|3277129|P1|Overall Study|Adverse Event|1
999322|NCT00432380|3277127|P3|Overall Study|Migrated/moved from study area|1
999323|NCT00432380|3277128|P2|Overall Study|Migrated/moved from study area|4
999324|NCT00432380|3277129|P1|Overall Study|Migrated/moved from study area|3
999325|NCT00432276|3277182|P2|Overall Study|Other|3
999326|NCT00432276|3277183|P1|Overall Study|Other|2
999327|NCT00432276|3277182|P2|Overall Study|Physician Decision|8
999328|NCT00432276|3277183|P1|Overall Study|Physician Decision|6
999329|NCT00432276|3277182|P2|Overall Study|Withdrawal by Subject|20
999330|NCT00432276|3277183|P1|Overall Study|Withdrawal by Subject|25
999331|NCT00432276|3277182|P2|Overall Study|Lost to Follow-up|2
999332|NCT00432276|3277183|P1|Overall Study|Lost to Follow-up|6
999333|NCT00432276|3277182|P2|Overall Study|Protocol Violation|20
999334|NCT00432276|3277183|P1|Overall Study|Protocol Violation|25
999335|NCT00432276|3277182|P2|Overall Study|Adverse Event|16
999336|NCT00432276|3277183|P1|Overall Study|Adverse Event|13
999337|NCT00432276|3277182|P2|Overall Study|Hyperglycemic Rescue|87
999338|NCT00432276|3277183|P1|Overall Study|Hyperglycemic Rescue|44
999339|NCT00432237|3277273|P4|Overall Study|Lack of Qualifying Event|84
999340|NCT00432237|3277274|P3|Overall Study|Lack of Qualifying Event|69
999341|NCT00432237|3277275|P2|Overall Study|Lack of Qualifying Event|71
999342|NCT00432237|3277276|P1|Overall Study|Lack of Qualifying Event|38
999343|NCT00432237|3277273|P4|Overall Study|Withdrawal by Subject|11
999344|NCT00432237|3277274|P3|Overall Study|Withdrawal by Subject|9
999345|NCT00432237|3277275|P2|Overall Study|Withdrawal by Subject|6
999346|NCT00432237|3277276|P1|Overall Study|Withdrawal by Subject|5
999347|NCT00432237|3277273|P4|Overall Study|Protocol Violation|8
999348|NCT00432237|3277274|P3|Overall Study|Protocol Violation|11
999349|NCT00432237|3277275|P2|Overall Study|Protocol Violation|10
999350|NCT00432237|3277276|P1|Overall Study|Protocol Violation|13
999351|NCT00432237|3277273|P4|Overall Study|Pregnancy|0
999352|NCT00432237|3277274|P3|Overall Study|Pregnancy|0
999353|NCT00432237|3277275|P2|Overall Study|Pregnancy|1
999354|NCT00432237|3277276|P1|Overall Study|Pregnancy|0
999355|NCT00432237|3277273|P4|Overall Study|Physician Decision|1
999356|NCT00432237|3277274|P3|Overall Study|Physician Decision|2
999357|NCT00432237|3277275|P2|Overall Study|Physician Decision|3
999358|NCT00432237|3277276|P1|Overall Study|Physician Decision|1
999359|NCT00432237|3277273|P4|Overall Study|Lost to Follow-up|18
999360|NCT00432237|3277274|P3|Overall Study|Lost to Follow-up|18
999361|NCT00432237|3277275|P2|Overall Study|Lost to Follow-up|10
999362|NCT00432237|3277276|P1|Overall Study|Lost to Follow-up|10
999363|NCT00432237|3277273|P4|Overall Study|Lack of Efficacy|1
999364|NCT00432237|3277274|P3|Overall Study|Lack of Efficacy|0
999365|NCT00432237|3277275|P2|Overall Study|Lack of Efficacy|0
999366|NCT00432237|3277276|P1|Overall Study|Lack of Efficacy|0
999367|NCT00432237|3277273|P4|Overall Study|Adverse Event|1
999368|NCT00432237|3277274|P3|Overall Study|Adverse Event|0
999369|NCT00432237|3277275|P2|Overall Study|Adverse Event|0
999370|NCT00432237|3277276|P1|Overall Study|Adverse Event|0
999371|NCT00432159|3277319|P5|Overall Study|Missing NDI and/or neuro. assessment|7
999372|NCT00432159|3277320|P4|Overall Study|Missing NDI and/or neuro. assessment|3
999373|NCT00432159|3277321|P3|Overall Study|Missing NDI and/or neuro. assessment|1
999374|NCT00432159|3277322|P2|Overall Study|Missing NDI and/or neuro. assessment|24
999375|NCT00432159|3277323|P1|Overall Study|Missing NDI and/or neuro. assessment|13
999376|NCT00432159|3277319|P5|Overall Study|Failure|3
999377|NCT00432159|3277320|P4|Overall Study|Failure|2
999378|NCT00432159|3277321|P3|Overall Study|Failure|3
999379|NCT00432159|3277322|P2|Overall Study|Failure|5
999380|NCT00432159|3277323|P1|Overall Study|Failure|9
999381|NCT00432159|3277319|P5|Overall Study|Death|0
999382|NCT00432159|3277320|P4|Overall Study|Death|0
999383|NCT00432159|3277321|P3|Overall Study|Death|0
999384|NCT00432159|3277322|P2|Overall Study|Death|1
999385|NCT00432159|3277323|P1|Overall Study|Death|0
999386|NCT00432042|3277430|P3|Overall Study|Lost to Follow-up|0
999387|NCT00432042|3277431|P2|Overall Study|Lost to Follow-up|1
999388|NCT00432042|3277432|P1|Overall Study|Lost to Follow-up|5
999389|NCT00432042|3277430|P3|Overall Study|Withdrawal by Subject|2
999390|NCT00432042|3277431|P2|Overall Study|Withdrawal by Subject|0
999391|NCT00432042|3277432|P1|Overall Study|Withdrawal by Subject|0
999392|NCT00432042|3277430|P3|Overall Study|Protocol Violation|0
999393|NCT00432042|3277431|P2|Overall Study|Protocol Violation|0
999394|NCT00432042|3277432|P1|Overall Study|Protocol Violation|2
999395|NCT00431964|3277445|P2|Overall Study|Due to Unstable Health|1
999396|NCT00431964|3277446|P1|Overall Study|Due to Unstable Health|0
999397|NCT00431964|3277445|P2|Overall Study|Parental Consent Withdrawn|2
999398|NCT00431964|3277446|P1|Overall Study|Parental Consent Withdrawn|0
999399|NCT00431964|3277445|P2|Overall Study|Withdrawal by Subject|1
999400|NCT00431964|3277446|P1|Overall Study|Withdrawal by Subject|2
999401|NCT00431964|3277445|P2|Overall Study|Physician Decision|2
999402|NCT00431964|3277446|P1|Overall Study|Physician Decision|2
999403|NCT00431964|3277445|P2|Overall Study|Lost to Follow-up|2
999404|NCT00431964|3277446|P1|Overall Study|Lost to Follow-up|1
999405|NCT00431964|3277445|P2|Overall Study|Adverse Event|0
999406|NCT00431964|3277446|P1|Overall Study|Adverse Event|1
999407|NCT00431951|3277456|P4|Overall Study|Adverse Event|0
999408|NCT00431951|3277457|P3|Overall Study|Adverse Event|1
999409|NCT00431951|3277458|P2|Overall Study|Adverse Event|0
999410|NCT00431951|3277459|P1|Overall Study|Adverse Event|0
999411|NCT00431951|3277456|P4|Overall Study|Withdrawal by Subject|0
999412|NCT00431951|3277457|P3|Overall Study|Withdrawal by Subject|0
999413|NCT00431951|3277458|P2|Overall Study|Withdrawal by Subject|1
999414|NCT00431951|3277459|P1|Overall Study|Withdrawal by Subject|0
999415|NCT00431951|3277456|P4|Overall Study|Lost to Follow-up|0
999416|NCT00431951|3277457|P3|Overall Study|Lost to Follow-up|0
999417|NCT00431951|3277458|P2|Overall Study|Lost to Follow-up|1
999418|NCT00431951|3277459|P1|Overall Study|Lost to Follow-up|0
999419|NCT00431951|3277456|P4|Overall Study|Inability to follow study procedures|2
999420|NCT00431951|3277457|P3|Overall Study|Inability to follow study procedures|1
999421|NCT00431951|3277458|P2|Overall Study|Inability to follow study procedures|0
999422|NCT00431951|3277459|P1|Overall Study|Inability to follow study procedures|1
999423|NCT00431847|3277521|P5|Overall Study|Protocol Violation|1
999424|NCT00431847|3277522|P4|Overall Study|Protocol Violation|0
999425|NCT00431847|3277523|P3|Overall Study|Protocol Violation|0
999426|NCT00431847|3277524|P2|Overall Study|Protocol Violation|0
999427|NCT00431847|3277525|P1|Overall Study|Protocol Violation|0
999428|NCT00431847|3277521|P5|Overall Study|completion of less than two study visits|0
999429|NCT00431847|3277522|P4|Overall Study|completion of less than two study visits|14
999430|NCT00431847|3277523|P3|Overall Study|completion of less than two study visits|4
999431|NCT00431847|3277524|P2|Overall Study|completion of less than two study visits|3
999432|NCT00431847|3277525|P1|Overall Study|completion of less than two study visits|6
999433|NCT00431834|3277599|P1|Overall Study|Lost to Follow-up|1
999434|NCT00431834|3277599|P1|Overall Study|Missed Endpoint Visit|2
999435|NCT00431834|3277599|P1|Overall Study|Death|3
999436|NCT00431834|3277599|P1|Overall Study|Withdrawal by Subject|7
999437|NCT00431496|3277615|P1|Overall Study|Protocol-specified criteria|5
999438|NCT00431496|3277615|P1|Overall Study|Withdrawal by Subject|2
999439|NCT00431496|3277615|P1|Overall Study|Lost to Follow-up|1
999440|NCT00431496|3277615|P1|Overall Study|Adverse Event|3
999441|NCT00431444|3277626|P2|Overall Study|Administrative Problems|1
999442|NCT00431444|3277627|P1|Overall Study|Administrative Problems|0
999443|NCT00431444|3277626|P2|Overall Study|Lost to Follow-up|0
999444|NCT00431444|3277627|P1|Overall Study|Lost to Follow-up|1
999445|NCT00431444|3277626|P2|Overall Study|Withdrawal by Subject|1
999446|NCT00431444|3277627|P1|Overall Study|Withdrawal by Subject|1
999447|NCT00431444|3277626|P2|Overall Study|Adverse Event|1
999448|NCT00431444|3277627|P1|Overall Study|Adverse Event|2
999449|NCT00431444|3277626|P2|Overall Study|Protocol Violation|4
999450|NCT00431444|3277627|P1|Overall Study|Protocol Violation|1
999451|NCT00431067|3277667|P1|Overall Study|Non-compliance,lost to follow-up|2
999452|NCT00431067|3277667|P1|Overall Study|Progressive disease|30
999453|NCT00431067|3277667|P1|Overall Study|Other Adverse Event|9
999454|NCT00430950|3277692|P2|Overall Study|concomitant medication,etc.|7
999455|NCT00430950|3277693|P1|Overall Study|concomitant medication,etc.|5
999456|NCT00430950|3277692|P2|Overall Study|Withdrawal by Subject|0
999457|NCT00430950|3277693|P1|Overall Study|Withdrawal by Subject|1
999458|NCT00430950|3277692|P2|Overall Study|Adverse Event|6
999459|NCT00430950|3277693|P1|Overall Study|Adverse Event|7
999460|NCT00430937|3277707|P2|Overall Study|Unable to classify|1
999461|NCT00430937|3277708|P1|Overall Study|Unable to classify|0
999462|NCT00430937|3277707|P2|Overall Study|Protocol discontinuation criteria met|2
999463|NCT00430937|3277708|P1|Overall Study|Protocol discontinuation criteria met|1
999464|NCT00430937|3277707|P2|Overall Study|Administrative reasons|0
999465|NCT00430937|3277708|P1|Overall Study|Administrative reasons|1
999466|NCT00430937|3277707|P2|Overall Study|Inappropriate enrollment|1
999467|NCT00430937|3277708|P1|Overall Study|Inappropriate enrollment|2
999468|NCT00430937|3277707|P2|Overall Study|Lack of Efficacy|5
999469|NCT00430937|3277708|P1|Overall Study|Lack of Efficacy|6
999470|NCT00430937|3277707|P2|Overall Study|Protocol Violation|2
999471|NCT00430937|3277708|P1|Overall Study|Protocol Violation|3
999472|NCT00430937|3277707|P2|Overall Study|Withdrawal by Subject|2
999473|NCT00430937|3277708|P1|Overall Study|Withdrawal by Subject|5
999474|NCT00430937|3277707|P2|Overall Study|Lost to Follow-up|6
999475|NCT00430937|3277708|P1|Overall Study|Lost to Follow-up|6
999476|NCT00430937|3277707|P2|Overall Study|Death|1
999477|NCT00430937|3277708|P1|Overall Study|Death|0
999478|NCT00430937|3277707|P2|Overall Study|Adverse Event|8
999479|NCT00430937|3277708|P1|Overall Study|Adverse Event|3
999480|NCT00430781|3277719|P3|End-of-Study Analysis; 28 July 2011|Other|0
999481|NCT00430781|3277720|P2|End-of-Study Analysis; 28 July 2011|Other|1
999482|NCT00430781|3277721|P1|End-of-Study Analysis; 28 July 2011|Other|4
999483|NCT00430781|3277719|P3|End-of-Study Analysis; 28 July 2011|Physician Decision|6
999484|NCT00430781|3277720|P2|End-of-Study Analysis; 28 July 2011|Physician Decision|6
999485|NCT00430781|3277721|P1|End-of-Study Analysis; 28 July 2011|Physician Decision|4
999486|NCT00430781|3277719|P3|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
999487|NCT00430781|3277720|P2|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5
999488|NCT00430781|3277721|P1|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
999489|NCT00430781|3277719|P3|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
999490|NCT00430781|3277720|P2|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2
999491|NCT00430781|3277721|P1|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
999492|NCT00430781|3277719|P3|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
999493|NCT00430781|3277720|P2|End-of-Study Analysis; 28 July 2011|Protocol Violation|1
999494|NCT00430781|3277721|P1|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
999495|NCT00430781|3277719|P3|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
999496|NCT00430781|3277720|P2|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
999497|NCT00430781|3277721|P1|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5
999498|NCT00430781|3277719|P3|Final Analysis; 31 July 2008|Ongoing|32
999499|NCT00430781|3277720|P2|Final Analysis; 31 July 2008|Ongoing|29
999500|NCT00430781|3277721|P1|Final Analysis; 31 July 2008|Ongoing|0
999501|NCT00430781|3277719|P3|Final Analysis; 31 July 2008|Other|0
999502|NCT00430781|3277720|P2|Final Analysis; 31 July 2008|Other|1
999503|NCT00430781|3277721|P1|Final Analysis; 31 July 2008|Other|0
999504|NCT00430781|3277719|P3|Final Analysis; 31 July 2008|Physician Decision|6
999505|NCT00430781|3277720|P2|Final Analysis; 31 July 2008|Physician Decision|6
999506|NCT00430781|3277721|P1|Final Analysis; 31 July 2008|Physician Decision|0
999507|NCT00430781|3277719|P3|Final Analysis; 31 July 2008|Withdrawal by Subject|7
999508|NCT00430781|3277720|P2|Final Analysis; 31 July 2008|Withdrawal by Subject|2
999509|NCT00430781|3277721|P1|Final Analysis; 31 July 2008|Withdrawal by Subject|0
999510|NCT00430781|3277719|P3|Final Analysis; 31 July 2008|Protocol Violation|0
999511|NCT00430781|3277720|P2|Final Analysis; 31 July 2008|Protocol Violation|1
999512|NCT00430781|3277721|P1|Final Analysis; 31 July 2008|Protocol Violation|0
999513|NCT00430781|3277719|P3|Final Analysis; 31 July 2008|Lost to Follow-up|3
999514|NCT00430781|3277720|P2|Final Analysis; 31 July 2008|Lost to Follow-up|0
999515|NCT00430781|3277721|P1|Final Analysis; 31 July 2008|Lost to Follow-up|0
999516|NCT00430781|3277719|P3|Interim Analysis; 11 February 2008|Ongoing|25
999517|NCT00430781|3277720|P2|Interim Analysis; 11 February 2008|Ongoing|20
999518|NCT00430781|3277721|P1|Interim Analysis; 11 February 2008|Ongoing|23
999519|NCT00430781|3277719|P3|Interim Analysis; 11 February 2008|Physician Decision|3
999520|NCT00430781|3277720|P2|Interim Analysis; 11 February 2008|Physician Decision|3
999521|NCT00430781|3277721|P1|Interim Analysis; 11 February 2008|Physician Decision|2
999522|NCT00430781|3277719|P3|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
999523|NCT00430781|3277720|P2|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
999524|NCT00430781|3277721|P1|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2
999525|NCT00430781|3277719|P3|Interim Analysis; 11 February 2008|Death|0
999526|NCT00430781|3277720|P2|Interim Analysis; 11 February 2008|Death|1
999527|NCT00430781|3277721|P1|Interim Analysis; 11 February 2008|Death|0
999528|NCT00430781|3277719|P3|Interim Analysis; 11 February 2008|Disease Progression|22
999529|NCT00430781|3277720|P2|Interim Analysis; 11 February 2008|Disease Progression|30
999530|NCT00430781|3277721|P1|Interim Analysis; 11 February 2008|Disease Progression|16
999531|NCT00430781|3277719|P3|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
999532|NCT00430781|3277720|P2|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
999533|NCT00430781|3277721|P1|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1
999534|NCT00430781|3277719|P3|Interim Analysis; 11 February 2008|Withdrawal by Subject|2
999535|NCT00430781|3277720|P2|Interim Analysis; 11 February 2008|Withdrawal by Subject|0
999536|NCT00430781|3277721|P1|Interim Analysis; 11 February 2008|Withdrawal by Subject|4
999537|NCT00430781|3277719|P3|Interim Analysis; 11 February 2008|Protocol Violation|0
999538|NCT00430781|3277720|P2|Interim Analysis; 11 February 2008|Protocol Violation|1
999539|NCT00430781|3277721|P1|Interim Analysis; 11 February 2008|Protocol Violation|0
999540|NCT00430781|3277719|P3|Interim Analysis; 11 February 2008|Lost to Follow-up|1
999541|NCT00430781|3277720|P2|Interim Analysis; 11 February 2008|Lost to Follow-up|0
999542|NCT00430781|3277721|P1|Interim Analysis; 11 February 2008|Lost to Follow-up|1
999543|NCT00430781|3277719|P3|Interim Analysis; 11 February 2008|Adverse Event|7
999544|NCT00430781|3277720|P2|Interim Analysis; 11 February 2008|Adverse Event|3
999545|NCT00430781|3277721|P1|Interim Analysis; 11 February 2008|Adverse Event|10
999546|NCT00430755|3277763|P1|Overall Study|Withdrawal by Subject|53
999547|NCT00430716|3277770|P3|Open Label Phase|Study terminated by sponsor|4
999548|NCT00430716|3277771|P2|Open Label Phase|Study terminated by sponsor|5
999549|NCT00430716|3277772|P1|Open Label Phase|Study terminated by sponsor|4
999550|NCT00430716|3277770|P3|Open Label Phase|Protocol Violation|0
999551|NCT00430716|3277771|P2|Open Label Phase|Protocol Violation|0
999552|NCT00430716|3277772|P1|Open Label Phase|Protocol Violation|1
999553|NCT00430716|3277770|P3|Open Label Phase|Other|1
999554|NCT00430716|3277771|P2|Open Label Phase|Other|1
999555|NCT00430716|3277772|P1|Open Label Phase|Other|3
999556|NCT00430716|3277770|P3|Open Label Phase|No longer willing to participate|1
999557|NCT00430716|3277771|P2|Open Label Phase|No longer willing to participate|1
999558|NCT00430716|3277772|P1|Open Label Phase|No longer willing to participate|0
999559|NCT00430716|3277770|P3|Open Label Phase|Lost to Follow-up|1
999560|NCT00430716|3277771|P2|Open Label Phase|Lost to Follow-up|0
999561|NCT00430716|3277772|P1|Open Label Phase|Lost to Follow-up|1
999562|NCT00430716|3277770|P3|Double Blind Phase|Not met eligibility criteria|0
999563|NCT00430716|3277771|P2|Double Blind Phase|Not met eligibility criteria|0
999564|NCT00430716|3277772|P1|Double Blind Phase|Not met eligibility criteria|1
999565|NCT00430716|3277770|P3|Double Blind Phase|Adverse Event|3
999566|NCT00430716|3277771|P2|Double Blind Phase|Adverse Event|1
999567|NCT00430716|3277772|P1|Double Blind Phase|Adverse Event|1
999568|NCT00430716|3277770|P3|Double Blind Phase|Study terminated by sponsor|2
999569|NCT00430716|3277771|P2|Double Blind Phase|Study terminated by sponsor|1
999570|NCT00430716|3277772|P1|Double Blind Phase|Study terminated by sponsor|1
999571|NCT00430716|3277770|P3|Double Blind Phase|Other|0
999572|NCT00430716|3277771|P2|Double Blind Phase|Other|2
999573|NCT00430716|3277772|P1|Double Blind Phase|Other|0
999574|NCT00430716|3277770|P3|Double Blind Phase|No longer willing to participate|1
999575|NCT00430716|3277771|P2|Double Blind Phase|No longer willing to participate|1
999576|NCT00430716|3277772|P1|Double Blind Phase|No longer willing to participate|2
999577|NCT00430716|3277770|P3|Double Blind Phase|Death|0
999578|NCT00430716|3277771|P2|Double Blind Phase|Death|0
999579|NCT00430716|3277772|P1|Double Blind Phase|Death|1
999580|NCT00430677|3277804|P3|Long-term Extension Period|Poor compliance/noncompliance|0
999581|NCT00430677|3277805|P2|Long-term Extension Period|Poor compliance/noncompliance|0
999582|NCT00430677|3277806|P1|Long-term Extension Period|Poor compliance/noncompliance|1
999583|NCT00430677|3277804|P3|Long-term Extension Period|Not specified|1
999584|NCT00430677|3277805|P2|Long-term Extension Period|Not specified|1
999585|NCT00430677|3277806|P1|Long-term Extension Period|Not specified|2
999586|NCT00430677|3277804|P3|Long-term Extension Period|Administrative reason by sponsor|46
999587|NCT00430677|3277805|P2|Long-term Extension Period|Administrative reason by sponsor|49
999588|NCT00430677|3277806|P1|Long-term Extension Period|Administrative reason by sponsor|41
999589|NCT00430677|3277804|P3|Long-term Extension Period|Pregnancy|0
999590|NCT00430677|3277805|P2|Long-term Extension Period|Pregnancy|1
999591|NCT00430677|3277806|P1|Long-term Extension Period|Pregnancy|1
999592|NCT00430677|3277804|P3|Long-term Extension Period|Withdrawal by Subject|2
999593|NCT00430677|3277805|P2|Long-term Extension Period|Withdrawal by Subject|1
999594|NCT00430677|3277806|P1|Long-term Extension Period|Withdrawal by Subject|5
999595|NCT00430677|3277804|P3|Long-term Extension Period|Lost to Follow-up|1
999596|NCT00430677|3277805|P2|Long-term Extension Period|Lost to Follow-up|1
999597|NCT00430677|3277806|P1|Long-term Extension Period|Lost to Follow-up|1
999598|NCT00430677|3277804|P3|Long-term Extension Period|Lack of Efficacy|8
999599|NCT00430677|3277805|P2|Long-term Extension Period|Lack of Efficacy|3
999600|NCT00430677|3277806|P1|Long-term Extension Period|Lack of Efficacy|5
999601|NCT00430677|3277804|P3|Long-term Extension Period|Adverse Event|5
999602|NCT00430677|3277805|P2|Long-term Extension Period|Adverse Event|2
999603|NCT00430677|3277806|P1|Long-term Extension Period|Adverse Event|3
999604|NCT00430677|3277804|P3|Long-term Extension Period|Death|0
999605|NCT00430677|3277805|P2|Long-term Extension Period|Death|0
999606|NCT00430677|3277806|P1|Long-term Extension Period|Death|1
999607|NCT00430677|3277804|P3|Short-term Period|Pregnancy|0
999608|NCT00430677|3277805|P2|Short-term Period|Pregnancy|2
999609|NCT00430677|3277806|P1|Short-term Period|Pregnancy|0
999610|NCT00430677|3277804|P3|Short-term Period|Poor compliance/ noncompliance|0
999611|NCT00430677|3277805|P2|Short-term Period|Poor compliance/ noncompliance|1
999612|NCT00430677|3277806|P1|Short-term Period|Poor compliance/ noncompliance|0
999613|NCT00430677|3277804|P3|Short-term Period|Participant no longer met study criteria|2
999614|NCT00430677|3277805|P2|Short-term Period|Participant no longer met study criteria|1
999615|NCT00430677|3277806|P1|Short-term Period|Participant no longer met study criteria|1
999616|NCT00430677|3277804|P3|Short-term Period|Withdrawal by Subject|2
999617|NCT00430677|3277805|P2|Short-term Period|Withdrawal by Subject|1
999618|NCT00430677|3277806|P1|Short-term Period|Withdrawal by Subject|1
999619|NCT00430677|3277804|P3|Short-term Period|Lack of Efficacy|4
999620|NCT00430677|3277805|P2|Short-term Period|Lack of Efficacy|6
999621|NCT00430677|3277806|P1|Short-term Period|Lack of Efficacy|5
999622|NCT00430677|3277804|P3|Short-term Period|Adverse Event|9
999623|NCT00430677|3277805|P2|Short-term Period|Adverse Event|13
999624|NCT00430677|3277806|P1|Short-term Period|Adverse Event|15
999625|NCT00430677|3277804|P3|Short-term Period|Death|5
999626|NCT00430677|3277805|P2|Short-term Period|Death|1
999627|NCT00430677|3277806|P1|Short-term Period|Death|1
999628|NCT00430638|3277929|P2|Overall Study|Not specified|2
999629|NCT00430638|3277930|P1|Overall Study|Not specified|2
999630|NCT00430638|3277929|P2|Overall Study|Non-compliant|1
999631|NCT00430638|3277930|P1|Overall Study|Non-compliant|2
999632|NCT00430638|3277929|P2|Overall Study|Withdrawal by Subject|6
999633|NCT00430638|3277930|P1|Overall Study|Withdrawal by Subject|4
999634|NCT00430638|3277929|P2|Overall Study|Protocol Violation|4
999635|NCT00430638|3277930|P1|Overall Study|Protocol Violation|6
999636|NCT00430638|3277929|P2|Overall Study|Lost to Follow-up|7
999637|NCT00430638|3277930|P1|Overall Study|Lost to Follow-up|1
999638|NCT00430638|3277929|P2|Overall Study|Uncontrolled blood pressure|13
999639|NCT00430638|3277930|P1|Overall Study|Uncontrolled blood pressure|48
999640|NCT00430638|3277929|P2|Overall Study|Adverse Event|15
999641|NCT00430638|3277930|P1|Overall Study|Adverse Event|15
999642|NCT00430573|3277965|P1|Overall Study|Withdrawal by Subject|5
999643|NCT00430508|3277974|P4|Overall Study|not specified|0
999644|NCT00430508|3277975|P3|Overall Study|not specified|3
999645|NCT00430508|3277976|P2|Overall Study|not specified|1
999646|NCT00430508|3277977|P1|Overall Study|not specified|1
999647|NCT00430508|3277974|P4|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
999648|NCT00430508|3277975|P3|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2
999649|NCT00430508|3277976|P2|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
999650|NCT00430508|3277977|P1|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0
999651|NCT00430508|3277974|P4|Overall Study|responder at visit 4|0
999652|NCT00430508|3277975|P3|Overall Study|responder at visit 4|2
999653|NCT00430508|3277976|P2|Overall Study|responder at visit 4|0
999654|NCT00430508|3277977|P1|Overall Study|responder at visit 4|0
999655|NCT00430508|3277974|P4|Overall Study|Withdrawal by Subject|1
999656|NCT00430508|3277975|P3|Overall Study|Withdrawal by Subject|1
999657|NCT00430508|3277976|P2|Overall Study|Withdrawal by Subject|1
999658|NCT00430508|3277977|P1|Overall Study|Withdrawal by Subject|0
999659|NCT00430508|3277974|P4|Overall Study|Adverse Event|3
999660|NCT00430508|3277975|P3|Overall Study|Adverse Event|5
999661|NCT00430508|3277976|P2|Overall Study|Adverse Event|3
999662|NCT00430508|3277977|P1|Overall Study|Adverse Event|2
999663|NCT00430495|3278015|P4|Overall Study|Randomized but not Treated|0
999664|NCT00430495|3278016|P3|Overall Study|Randomized but not Treated|0
999665|NCT00430495|3278017|P2|Overall Study|Randomized but not Treated|0
999666|NCT00430495|3278018|P1|Overall Study|Randomized but not Treated|2
999667|NCT00430495|3278015|P4|Overall Study|Other|4
999668|NCT00430495|3278016|P3|Overall Study|Other|5
999669|NCT00430495|3278017|P2|Overall Study|Other|2
999670|NCT00430495|3278018|P1|Overall Study|Other|8
999671|NCT00430495|3278015|P4|Overall Study|Disease Progression|0
999672|NCT00430495|3278016|P3|Overall Study|Disease Progression|0
999673|NCT00430495|3278017|P2|Overall Study|Disease Progression|1
999674|NCT00430495|3278018|P1|Overall Study|Disease Progression|1
999675|NCT00430495|3278015|P4|Overall Study|Protocol Violation|0
999676|NCT00430495|3278016|P3|Overall Study|Protocol Violation|1
999677|NCT00430495|3278017|P2|Overall Study|Protocol Violation|0
999678|NCT00430495|3278018|P1|Overall Study|Protocol Violation|1
999679|NCT00430495|3278015|P4|Overall Study|Lost to Follow-up|0
999680|NCT00430495|3278016|P3|Overall Study|Lost to Follow-up|4
999681|NCT00430495|3278017|P2|Overall Study|Lost to Follow-up|1
999682|NCT00430495|3278018|P1|Overall Study|Lost to Follow-up|0
999683|NCT00430495|3278015|P4|Overall Study|Death|0
999684|NCT00430495|3278016|P3|Overall Study|Death|1
999685|NCT00430495|3278017|P2|Overall Study|Death|0
999686|NCT00430495|3278018|P1|Overall Study|Death|0
999687|NCT00430495|3278015|P4|Overall Study|Adverse Event|0
999688|NCT00430495|3278016|P3|Overall Study|Adverse Event|2
999689|NCT00430495|3278017|P2|Overall Study|Adverse Event|3
999690|NCT00430495|3278018|P1|Overall Study|Adverse Event|2
999691|NCT00430352|3278056|P1|Overall Study|Not specified|48
999692|NCT00430352|3278056|P1|Overall Study|Death|5
999693|NCT00430352|3278056|P1|Overall Study|Adverse Event|16
999694|NCT00430352|3278056|P1|Overall Study|Withdrawal by Subject|11
999695|NCT00430352|3278056|P1|Overall Study|Disease progression|58
999696|NCT00430300|3278074|P4|Overall Study|Other|1
999697|NCT00430300|3278075|P3|Overall Study|Other|0
999698|NCT00430300|3278076|P2|Overall Study|Other|0
999699|NCT00430300|3278077|P1|Overall Study|Other|0
999700|NCT00430300|3278074|P4|Overall Study|Laboratory abnormality|0
999701|NCT00430300|3278075|P3|Overall Study|Laboratory abnormality|0
999702|NCT00430300|3278076|P2|Overall Study|Laboratory abnormality|0
999703|NCT00430300|3278077|P1|Overall Study|Laboratory abnormality|1
999704|NCT00430300|3278074|P4|Overall Study|Withdrawal by Subject|0
999705|NCT00430300|3278075|P3|Overall Study|Withdrawal by Subject|5
999706|NCT00430300|3278076|P2|Overall Study|Withdrawal by Subject|0
999707|NCT00430300|3278077|P1|Overall Study|Withdrawal by Subject|1
999708|NCT00430300|3278074|P4|Overall Study|Adverse Event|1
999709|NCT00430300|3278075|P3|Overall Study|Adverse Event|1
999710|NCT00430300|3278076|P2|Overall Study|Adverse Event|2
999711|NCT00430300|3278077|P1|Overall Study|Adverse Event|0
999712|NCT00430248|3278182|P3|Overall Study|Reason Not Specified|11
999713|NCT00430248|3278183|P2|Overall Study|Reason Not Specified|8
999714|NCT00430248|3278184|P1|Overall Study|Reason Not Specified|8
999715|NCT00430248|3278182|P3|Overall Study|Gout Flare|2
999716|NCT00430248|3278183|P2|Overall Study|Gout Flare|7
999717|NCT00430248|3278184|P1|Overall Study|Gout Flare|3
999718|NCT00430248|3278182|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
999719|NCT00430248|3278183|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
999720|NCT00430248|3278184|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|0
999721|NCT00430248|3278182|P3|Overall Study|Withdrawal by Subject|16
999722|NCT00430248|3278183|P2|Overall Study|Withdrawal by Subject|20
999723|NCT00430248|3278184|P1|Overall Study|Withdrawal by Subject|14
999724|NCT00430248|3278182|P3|Overall Study|Therapeutic Failure|1
999725|NCT00430248|3278183|P2|Overall Study|Therapeutic Failure|1
999726|NCT00430248|3278184|P1|Overall Study|Therapeutic Failure|1
999727|NCT00430248|3278182|P3|Overall Study|Lost to Follow-up|28
999728|NCT00430248|3278183|P2|Overall Study|Lost to Follow-up|33
999729|NCT00430248|3278184|P1|Overall Study|Lost to Follow-up|28
999730|NCT00430248|3278182|P3|Overall Study|Personal Reasons|9
999731|NCT00430248|3278183|P2|Overall Study|Personal Reasons|24
999732|NCT00430248|3278184|P1|Overall Study|Personal Reasons|12
999733|NCT00430248|3278182|P3|Overall Study|Protocol Violation|4
999734|NCT00430248|3278183|P2|Overall Study|Protocol Violation|2
999735|NCT00430248|3278184|P1|Overall Study|Protocol Violation|10
999736|NCT00430248|3278182|P3|Overall Study|Adverse Event|64
999737|NCT00430248|3278183|P2|Overall Study|Adverse Event|61
999738|NCT00430248|3278184|P1|Overall Study|Adverse Event|49
999739|NCT00430092|3278243|P3|Overall Study|Withdrawal by Subject|1
999740|NCT00430092|3278244|P2|Overall Study|Withdrawal by Subject|1
999741|NCT00430092|3278245|P1|Overall Study|Withdrawal by Subject|0
999742|NCT00430092|3278243|P3|Overall Study|Protocol Violation|1
999743|NCT00430092|3278244|P2|Overall Study|Protocol Violation|1
999744|NCT00430092|3278245|P1|Overall Study|Protocol Violation|0
999745|NCT00430092|3278243|P3|Overall Study|Lost to Follow-up|0
999746|NCT00430092|3278244|P2|Overall Study|Lost to Follow-up|0
999747|NCT00430092|3278245|P1|Overall Study|Lost to Follow-up|1
999748|NCT00430092|3278243|P3|Overall Study|Lack of Efficacy|54
999749|NCT00430092|3278244|P2|Overall Study|Lack of Efficacy|2
999750|NCT00430092|3278245|P1|Overall Study|Lack of Efficacy|5
999751|NCT00430092|3278243|P3|Overall Study|Adverse Event|1
999752|NCT00430092|3278244|P2|Overall Study|Adverse Event|0
999753|NCT00430092|3278245|P1|Overall Study|Adverse Event|0
999754|NCT00430027|3278250|P1|Overall Study|Study terminated|8
999755|NCT00429923|3278267|P3|Overall Study|Early Termination|0
999756|NCT00429923|3278268|P2|Overall Study|Early Termination|1
999757|NCT00429923|3278269|P1|Overall Study|Early Termination|0
999758|NCT00429923|3278267|P3|Overall Study|Withdrew Consent|1
999759|NCT00429923|3278268|P2|Overall Study|Withdrew Consent|0
999760|NCT00429923|3278269|P1|Overall Study|Withdrew Consent|1
999761|NCT00429923|3278267|P3|Overall Study|Lost to Follow-up|2
999762|NCT00429923|3278268|P2|Overall Study|Lost to Follow-up|0
999763|NCT00429923|3278269|P1|Overall Study|Lost to Follow-up|0
999764|NCT00429923|3278267|P3|Overall Study|Lack of Efficacy|33
999765|NCT00429923|3278268|P2|Overall Study|Lack of Efficacy|1
999766|NCT00429923|3278269|P1|Overall Study|Lack of Efficacy|4
999767|NCT00429923|3278267|P3|Overall Study|Adverse Event|3
999768|NCT00429923|3278268|P2|Overall Study|Adverse Event|2
999769|NCT00429923|3278269|P1|Overall Study|Adverse Event|0
999770|NCT00429793|3278274|P1|Overall Study|Non-measurable|1
999771|NCT00429793|3278274|P1|Overall Study|Never treated|1
999772|NCT00429793|3278274|P1|Overall Study|Required test not done|1
999773|NCT00429793|3278274|P1|Overall Study|Improper pre-protocol treatment|3
999774|NCT00429663|3278301|P2|Overall Study|Death|0
999775|NCT00429663|3278302|P1|Overall Study|Death|4
999776|NCT00429663|3278301|P2|Overall Study|Withdrawal by Subject|5
999777|NCT00429663|3278302|P1|Overall Study|Withdrawal by Subject|2
999778|NCT00429663|3278301|P2|Overall Study|Physician Decision|3
999779|NCT00429663|3278302|P1|Overall Study|Physician Decision|6
999780|NCT00429663|3278301|P2|Overall Study|Lost to Follow-up|31
999781|NCT00429663|3278302|P1|Overall Study|Lost to Follow-up|24
999782|NCT00429572|3278316|P1|Overall Study|Disease progression|1
999783|NCT00429494|3278328|P1|Overall Study|Death|6
999784|NCT00429494|3278328|P1|Overall Study|Withdrawal by Subject|9
999785|NCT00429416|3278332|P1|Overall Study|Death|1
999786|NCT00429364|3278351|P2|Overall Study|Pregnancy|1
999787|NCT00429364|3278352|P1|Overall Study|Pregnancy|0
999788|NCT00429364|3278351|P2|Overall Study|Underwent aortic root surgery|18
999789|NCT00429364|3278352|P1|Overall Study|Underwent aortic root surgery|10
999790|NCT00429364|3278351|P2|Overall Study|Death|1
999791|NCT00429364|3278352|P1|Overall Study|Death|0
999792|NCT00429364|3278351|P2|Overall Study|Lost to Follow-up|6
999793|NCT00429364|3278352|P1|Overall Study|Lost to Follow-up|7
999794|NCT00429364|3278351|P2|Overall Study|Physician Decision|2
999795|NCT00429364|3278352|P1|Overall Study|Physician Decision|4
999796|NCT00429364|3278351|P2|Overall Study|Withdrawal by Subject|5
999797|NCT00429364|3278352|P1|Overall Study|Withdrawal by Subject|11
999798|NCT00429299|3278411|P3|Overall Study|Withdrawal by Subject|3
999799|NCT00429299|3278412|P2|Overall Study|Withdrawal by Subject|1
999800|NCT00429299|3278413|P1|Overall Study|Withdrawal by Subject|0
999801|NCT00429299|3278411|P3|Overall Study|Protocol Violation|0
999802|NCT00429299|3278412|P2|Overall Study|Protocol Violation|0
999803|NCT00429299|3278413|P1|Overall Study|Protocol Violation|1
999804|NCT00429299|3278411|P3|Overall Study|Adverse Event|1
999805|NCT00429299|3278412|P2|Overall Study|Adverse Event|5
999806|NCT00429299|3278413|P1|Overall Study|Adverse Event|2
999807|NCT00429299|3278411|P3|Overall Study|Disease Progression|0
999808|NCT00429299|3278412|P2|Overall Study|Disease Progression|1
999809|NCT00429299|3278413|P1|Overall Study|Disease Progression|1
999810|NCT00429273|3278445|P3|Overall Study|Adverse Event|2
999811|NCT00429273|3278446|P2|Overall Study|Adverse Event|1
999812|NCT00429273|3278447|P1|Overall Study|Adverse Event|1
999813|NCT00429273|3278445|P3|Overall Study|Physician Decision|5
999814|NCT00429273|3278446|P2|Overall Study|Physician Decision|5
999815|NCT00429273|3278447|P1|Overall Study|Physician Decision|6
999816|NCT00429273|3278445|P3|Overall Study|Lost to Follow-up|2
999817|NCT00429273|3278446|P2|Overall Study|Lost to Follow-up|2
999818|NCT00429273|3278447|P1|Overall Study|Lost to Follow-up|1
999819|NCT00429182|3278455|P1|Overall Study|Not eligible|5
999820|NCT00429182|3278455|P1|Overall Study|Not evaluable, Disease Progression|2
999821|NCT00429169|3278462|P2|Overall Study|Ineligibility discovered after entry|1
999822|NCT00429169|3278463|P1|Overall Study|Ineligibility discovered after entry|2
999823|NCT00429169|3278462|P2|Overall Study|Lost to Follow-up|1
999824|NCT00429169|3278463|P1|Overall Study|Lost to Follow-up|0
999825|NCT00429104|3278483|P1|Overall Study|Protocol Violation|1
999826|NCT00429026|3278488|P1|Overall Study|Inevaluable for response.|40
999827|NCT00428948|3278515|P2|Overall Study|Protocol Deviation|1
999828|NCT00428948|3278516|P1|Overall Study|Protocol Deviation|1
999829|NCT00428948|3278515|P2|Overall Study|Subject Withdrew Consent|30
999830|NCT00428948|3278516|P1|Overall Study|Subject Withdrew Consent|50
999831|NCT00428948|3278515|P2|Overall Study|Investigator Withdrew Subject|4
999832|NCT00428948|3278516|P1|Overall Study|Investigator Withdrew Subject|3
999833|NCT00428948|3278515|P2|Overall Study|Subject Met Withdrawal Criteria|0
999834|NCT00428948|3278516|P1|Overall Study|Subject Met Withdrawal Criteria|4
999835|NCT00428948|3278515|P2|Overall Study|Adverse Event|24
999836|NCT00428948|3278516|P1|Overall Study|Adverse Event|148
999837|NCT00428948|3278515|P2|Overall Study|Lost to Follow-up|8
999838|NCT00428948|3278516|P1|Overall Study|Lost to Follow-up|15
999839|NCT00428844|3278544|P3|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
999840|NCT00428844|3278545|P2|Completed Test of Cure (TOC) Visit|Microbiologic failure|1
999841|NCT00428844|3278546|P1|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
999842|NCT00428844|3278544|P3|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
999843|NCT00428844|3278545|P2|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
999844|NCT00428844|3278546|P1|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2
999845|NCT00428844|3278544|P3|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
999846|NCT00428844|3278545|P2|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
999847|NCT00428844|3278546|P1|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1
999848|NCT00428844|3278544|P3|Completed Test of Cure (TOC) Visit|Protocol Violation|1
999849|NCT00428844|3278545|P2|Completed Test of Cure (TOC) Visit|Protocol Violation|0
999850|NCT00428844|3278546|P1|Completed Test of Cure (TOC) Visit|Protocol Violation|0
999851|NCT00428844|3278544|P3|Completed Test of Cure (TOC) Visit|Adverse Event|1
999852|NCT00428844|3278545|P2|Completed Test of Cure (TOC) Visit|Adverse Event|1
999853|NCT00428844|3278546|P1|Completed Test of Cure (TOC) Visit|Adverse Event|0
999854|NCT00428844|3278544|P3|Completed Study Drug Treatment|Randomized Not Treated|1
999855|NCT00428844|3278545|P2|Completed Study Drug Treatment|Randomized Not Treated|0
999856|NCT00428844|3278546|P1|Completed Study Drug Treatment|Randomized Not Treated|0
999857|NCT00428844|3278544|P3|Completed Study Drug Treatment|Withdrawal by Subject|1
999858|NCT00428844|3278545|P2|Completed Study Drug Treatment|Withdrawal by Subject|1
999859|NCT00428844|3278546|P1|Completed Study Drug Treatment|Withdrawal by Subject|0
999860|NCT00428844|3278544|P3|Completed Study Drug Treatment|Protocol Violation|1
999861|NCT00428844|3278545|P2|Completed Study Drug Treatment|Protocol Violation|1
999862|NCT00428844|3278546|P1|Completed Study Drug Treatment|Protocol Violation|0
999863|NCT00428844|3278544|P3|Completed Study Drug Treatment|Adverse Event|4
999864|NCT00428844|3278545|P2|Completed Study Drug Treatment|Adverse Event|4
999865|NCT00428844|3278546|P1|Completed Study Drug Treatment|Adverse Event|2
999866|NCT00428792|3278569|P2|Overall Study|Lost to Follow-up|1
999867|NCT00428792|3278570|P1|Overall Study|Lost to Follow-up|0
999868|NCT00428792|3278569|P2|Overall Study|Lack of Efficacy|3
999869|NCT00428792|3278570|P1|Overall Study|Lack of Efficacy|1
999870|NCT00428610|3278597|P3|Overall Study|Withdrawal by Subject|0
999871|NCT00428610|3278598|P2|Overall Study|Withdrawal by Subject|0
999872|NCT00428610|3278599|P1|Overall Study|Withdrawal by Subject|4
999873|NCT00428610|3278597|P3|Overall Study|Progressive Disease|22
999874|NCT00428610|3278598|P2|Overall Study|Progressive Disease|14
999875|NCT00428610|3278599|P1|Overall Study|Progressive Disease|42
999876|NCT00428610|3278597|P3|Overall Study|Investigator Decision|1
999877|NCT00428610|3278598|P2|Overall Study|Investigator Decision|1
999878|NCT00428610|3278599|P1|Overall Study|Investigator Decision|2
999879|NCT00428610|3278597|P3|Overall Study|Adverse Event|2
999880|NCT00428610|3278598|P2|Overall Study|Adverse Event|3
999881|NCT00428610|3278599|P1|Overall Study|Adverse Event|2
999882|NCT00428610|3278597|P3|Overall Study|Death Due to Progressive Disease|2
999883|NCT00428610|3278598|P2|Overall Study|Death Due to Progressive Disease|0
999884|NCT00428610|3278599|P1|Overall Study|Death Due to Progressive Disease|0
999885|NCT00428610|3278597|P3|Overall Study|Death Due to Adverse Event|5
999886|NCT00428610|3278598|P2|Overall Study|Death Due to Adverse Event|0
999887|NCT00428610|3278599|P1|Overall Study|Death Due to Adverse Event|3
999888|NCT00428597|3278633|P2|Overall Study|Death|3
999889|NCT00428597|3278634|P1|Overall Study|Death|1
999890|NCT00428597|3278633|P2|Overall Study|Pregnancy|0
999891|NCT00428597|3278634|P1|Overall Study|Pregnancy|1
999892|NCT00428597|3278633|P2|Overall Study|Lost to Follow-up|1
999893|NCT00428597|3278634|P1|Overall Study|Lost to Follow-up|0
999894|NCT00428597|3278633|P2|Overall Study|Other|1
999895|NCT00428597|3278634|P1|Overall Study|Other|1
999896|NCT00428597|3278633|P2|Overall Study|Withdrawal by Subject|1
999897|NCT00428597|3278634|P1|Overall Study|Withdrawal by Subject|2
999898|NCT00428597|3278633|P2|Overall Study|Protocol Violation|1
999899|NCT00428597|3278634|P1|Overall Study|Protocol Violation|2
999900|NCT00428597|3278633|P2|Overall Study|Global Deterioration of Health Status|5
999901|NCT00428597|3278634|P1|Overall Study|Global Deterioration of Health Status|1
999902|NCT00428597|3278633|P2|Overall Study|Adverse Event|7
999903|NCT00428597|3278634|P1|Overall Study|Adverse Event|15
999904|NCT00428597|3278633|P2|Overall Study|Study Terminated by Sponsor|16
999905|NCT00428597|3278634|P1|Overall Study|Study Terminated by Sponsor|41
999906|NCT00428597|3278633|P2|Overall Study|Objective Progression or Relapse|47
999907|NCT00428597|3278634|P1|Overall Study|Objective Progression or Relapse|19
999908|NCT00428597|3278633|P2|Overall Study|Randomized but not treated|3
999909|NCT00428597|3278634|P1|Overall Study|Randomized but not treated|3
999910|NCT00428441|3278701|P1|Overall Study|Lost to Follow-up|1
999911|NCT00428389|3278707|P2|Extension Phase|Administrative problems|1
999912|NCT00428389|3278708|P1|Extension Phase|Administrative problems|1
999913|NCT00428389|3278707|P2|Extension Phase|Protocol Violation|2
999914|NCT00428389|3278708|P1|Extension Phase|Protocol Violation|3
999915|NCT00428389|3278707|P2|Extension Phase|Death|0
999916|NCT00428389|3278708|P1|Extension Phase|Death|1
999917|NCT00428389|3278707|P2|Extension Phase|Lost to Follow-up|3
999918|NCT00428389|3278708|P1|Extension Phase|Lost to Follow-up|0
999919|NCT00428389|3278707|P2|Extension Phase|Withdrawal by Subject|6
999920|NCT00428389|3278708|P1|Extension Phase|Withdrawal by Subject|6
999921|NCT00428389|3278707|P2|Extension Phase|Lack of Efficacy|3
999922|NCT00428389|3278708|P1|Extension Phase|Lack of Efficacy|4
999923|NCT00428389|3278707|P2|Extension Phase|Adverse Event|11
999924|NCT00428389|3278708|P1|Extension Phase|Adverse Event|17
999925|NCT00428389|3278707|P2|Core Phase|Protocol deviation|2
999926|NCT00428389|3278708|P1|Core Phase|Protocol deviation|0
999927|NCT00428389|3278707|P2|Core Phase|Withdrawal by Subject|4
999928|NCT00428389|3278708|P1|Core Phase|Withdrawal by Subject|3
999929|NCT00428389|3278707|P2|Core Phase|Abnormal test procedure result(s)|1
999930|NCT00428389|3278708|P1|Core Phase|Abnormal test procedure result(s)|0
999931|NCT00428389|3278707|P2|Core Phase|Lack of Efficacy|0
999932|NCT00428389|3278708|P1|Core Phase|Lack of Efficacy|2
999933|NCT00428389|3278707|P2|Core Phase|Adverse Event|4
999934|NCT00428389|3278708|P1|Core Phase|Adverse Event|6
999935|NCT00428246|3278742|P3|Overall Study|Adverse Event|0
999936|NCT00428246|3278743|P2|Overall Study|Adverse Event|0
999937|NCT00428246|3278744|P1|Overall Study|Adverse Event|1
999938|NCT00428246|3278742|P3|Overall Study|Withdrawal by Subject|1
999939|NCT00428246|3278743|P2|Overall Study|Withdrawal by Subject|0
999940|NCT00428246|3278744|P1|Overall Study|Withdrawal by Subject|0
999941|NCT00428220|3278752|P1|Overall Study|Other|23
999942|NCT00428220|3278752|P1|Overall Study|Adverse Event|51
999943|NCT00428220|3278752|P1|Overall Study|Participant refused continued treatment|7
999944|NCT00428220|3278752|P1|Overall Study|Objective progression or relapse|123
999945|NCT00428220|3278752|P1|Overall Study|Lost to Follow-up|4
999946|NCT00428220|3278752|P1|Overall Study|Global deterioration of health status|7
999947|NCT00428220|3278752|P1|Overall Study|Participant died|8
999948|NCT00428116|3278777|P2|Overall Study|Lost to Follow-up|0
999949|NCT00428116|3278778|P1|Overall Study|Lost to Follow-up|1
999950|NCT00428116|3278777|P2|Overall Study|Withdrawal by Subject|0
999951|NCT00428116|3278778|P1|Overall Study|Withdrawal by Subject|1
999952|NCT00428116|3278777|P2|Overall Study|Death|0
999953|NCT00428116|3278778|P1|Overall Study|Death|1
999954|NCT00428090|3278790|P4|Overall Study|Raised Creatinine Value|1
999955|NCT00428090|3278791|P3|Overall Study|Raised Creatinine Value|0
999956|NCT00428090|3278792|P2|Overall Study|Raised Creatinine Value|0
999957|NCT00428090|3278793|P1|Overall Study|Raised Creatinine Value|0
999958|NCT00428090|3278790|P4|Overall Study|Excluded for heart insufficiency|0
999959|NCT00428090|3278791|P3|Overall Study|Excluded for heart insufficiency|1
999960|NCT00428090|3278792|P2|Overall Study|Excluded for heart insufficiency|0
999961|NCT00428090|3278793|P1|Overall Study|Excluded for heart insufficiency|0
999962|NCT00428090|3278790|P4|Overall Study|Serious adverse event|0
999963|NCT00428090|3278791|P3|Overall Study|Serious adverse event|1
999964|NCT00428090|3278792|P2|Overall Study|Serious adverse event|0
999965|NCT00428090|3278793|P1|Overall Study|Serious adverse event|0
999966|NCT00428090|3278790|P4|Overall Study|Deterioration of cognitive status|0
999967|NCT00428090|3278791|P3|Overall Study|Deterioration of cognitive status|1
999968|NCT00428090|3278792|P2|Overall Study|Deterioration of cognitive status|0
999969|NCT00428090|3278793|P1|Overall Study|Deterioration of cognitive status|0
999970|NCT00428090|3278790|P4|Overall Study|High MMSE scores|0
999971|NCT00428090|3278791|P3|Overall Study|High MMSE scores|1
999972|NCT00428090|3278792|P2|Overall Study|High MMSE scores|0
999973|NCT00428090|3278793|P1|Overall Study|High MMSE scores|0
999974|NCT00428090|3278790|P4|Overall Study|Insufficient AD documentation|0
999975|NCT00428090|3278791|P3|Overall Study|Insufficient AD documentation|1
999976|NCT00428090|3278792|P2|Overall Study|Insufficient AD documentation|0
999977|NCT00428090|3278793|P1|Overall Study|Insufficient AD documentation|0
999978|NCT00428090|3278790|P4|Overall Study|Excluded for concerning QTc value|0
999979|NCT00428090|3278791|P3|Overall Study|Excluded for concerning QTc value|1
999980|NCT00428090|3278792|P2|Overall Study|Excluded for concerning QTc value|0
999981|NCT00428090|3278793|P1|Overall Study|Excluded for concerning QTc value|0
999982|NCT00428090|3278790|P4|Overall Study|Worsening of AD|0
999983|NCT00428090|3278791|P3|Overall Study|Worsening of AD|1
999984|NCT00428090|3278792|P2|Overall Study|Worsening of AD|0
999985|NCT00428090|3278793|P1|Overall Study|Worsening of AD|0
999986|NCT00428090|3278790|P4|Overall Study|Mental status of par. was|0
999987|NCT00428090|3278791|P3|Overall Study|Mental status of par. was|0
999988|NCT00428090|3278792|P2|Overall Study|Mental status of par. was|1
999989|NCT00428090|3278793|P1|Overall Study|Mental status of par. was|0
999990|NCT00428090|3278790|P4|Overall Study|Medical monitor terminated par.|0
999991|NCT00428090|3278791|P3|Overall Study|Medical monitor terminated par.|0
999992|NCT00428090|3278792|P2|Overall Study|Medical monitor terminated par.|1
999993|NCT00428090|3278793|P1|Overall Study|Medical monitor terminated par.|0
999994|NCT00428090|3278790|P4|Overall Study|Visit 7 exceed the visit window|0
999995|NCT00428090|3278791|P3|Overall Study|Visit 7 exceed the visit window|0
999996|NCT00428090|3278792|P2|Overall Study|Visit 7 exceed the visit window|1
999997|NCT00428090|3278793|P1|Overall Study|Visit 7 exceed the visit window|0
999998|NCT00428090|3278790|P4|Overall Study|Death of par.|0
999999|NCT00428090|3278791|P3|Overall Study|Death of par.|1
1000000|NCT00428090|3278792|P2|Overall Study|Death of par.|0
1000001|NCT00428090|3278793|P1|Overall Study|Death of par.|1
1000002|NCT00428090|3278790|P4|Overall Study|Prohibited medication used for SAE|0
1000003|NCT00428090|3278791|P3|Overall Study|Prohibited medication used for SAE|0
1000004|NCT00428090|3278792|P2|Overall Study|Prohibited medication used for SAE|0
1000005|NCT00428090|3278793|P1|Overall Study|Prohibited medication used for SAE|1
1000006|NCT00428090|3278790|P4|Overall Study|Follow-Up visit not possible|0
1000007|NCT00428090|3278791|P3|Overall Study|Follow-Up visit not possible|0
1000008|NCT00428090|3278792|P2|Overall Study|Follow-Up visit not possible|0
1000009|NCT00428090|3278793|P1|Overall Study|Follow-Up visit not possible|1
1000010|NCT00428090|3278790|P4|Overall Study|Par. did not returned to visit|1
1000011|NCT00428090|3278791|P3|Overall Study|Par. did not returned to visit|0
1000012|NCT00428090|3278792|P2|Overall Study|Par. did not returned to visit|0
1000013|NCT00428090|3278793|P1|Overall Study|Par. did not returned to visit|1
1000014|NCT00428090|3278790|P4|Overall Study|Non-compliance|3
1000015|NCT00428090|3278791|P3|Overall Study|Non-compliance|1
1000016|NCT00428090|3278792|P2|Overall Study|Non-compliance|0
1000017|NCT00428090|3278793|P1|Overall Study|Non-compliance|4
1000018|NCT00428090|3278790|P4|Overall Study|Sponsor terminated study|0
1000019|NCT00428090|3278791|P3|Overall Study|Sponsor terminated study|0
1000020|NCT00428090|3278792|P2|Overall Study|Sponsor terminated study|1
1000021|NCT00428090|3278793|P1|Overall Study|Sponsor terminated study|0
1000022|NCT00428090|3278790|P4|Overall Study|Withdrawal by Subject|5
1000023|NCT00428090|3278791|P3|Overall Study|Withdrawal by Subject|15
1000024|NCT00428090|3278792|P2|Overall Study|Withdrawal by Subject|12
1000025|NCT00428090|3278793|P1|Overall Study|Withdrawal by Subject|10
1000026|NCT00428090|3278790|P4|Overall Study|Protocol Violation|3
1000027|NCT00428090|3278791|P3|Overall Study|Protocol Violation|3
1000028|NCT00428090|3278792|P2|Overall Study|Protocol Violation|1
1000029|NCT00428090|3278793|P1|Overall Study|Protocol Violation|3
1000030|NCT00428090|3278790|P4|Overall Study|Lost to Follow-up|4
1000031|NCT00428090|3278791|P3|Overall Study|Lost to Follow-up|1
1000032|NCT00428090|3278792|P2|Overall Study|Lost to Follow-up|6
1000033|NCT00428090|3278793|P1|Overall Study|Lost to Follow-up|3
1000034|NCT00428090|3278790|P4|Overall Study|Adverse Event|11
1000035|NCT00428090|3278791|P3|Overall Study|Adverse Event|10
1000036|NCT00428090|3278792|P2|Overall Study|Adverse Event|8
1000037|NCT00428090|3278793|P1|Overall Study|Adverse Event|10
1000038|NCT00427999|3278911|P1|Overall Study|Death|1
1000039|NCT00427999|3278911|P1|Overall Study|Withdrawal by Subject|9
1000040|NCT00427999|3278911|P1|Overall Study|Protocol Violation|2
1000041|NCT00427999|3278911|P1|Overall Study|Unsatisfactory therapeutic effect|13
1000042|NCT00427999|3278911|P1|Overall Study|Abnormal laboratory values|1
1000043|NCT00427999|3278911|P1|Overall Study|Adverse Event|6
1000044|NCT00427960|3278929|P2|Overall Study|Not Specified|1
1000045|NCT00427960|3278930|P1|Overall Study|Not Specified|0
1000046|NCT00427960|3278929|P2|Overall Study|Withdrawal by Subject|3
1000047|NCT00427960|3278930|P1|Overall Study|Withdrawal by Subject|0
1000048|NCT00427960|3278929|P2|Overall Study|Adverse Event|0
1000049|NCT00427960|3278930|P1|Overall Study|Adverse Event|2
1000050|NCT00427934|3278968|P4|Overall Study|Withdrawal by Subject|3
1000051|NCT00427934|3278969|P3|Overall Study|Withdrawal by Subject|1
1000052|NCT00427934|3278970|P2|Overall Study|Withdrawal by Subject|0
1000053|NCT00427934|3278971|P1|Overall Study|Withdrawal by Subject|0
1000054|NCT00427934|3278968|P4|Overall Study|Other|5
1000055|NCT00427934|3278969|P3|Overall Study|Other|11
1000056|NCT00427934|3278970|P2|Overall Study|Other|0
1000057|NCT00427934|3278971|P1|Overall Study|Other|0
1000058|NCT00427934|3278968|P4|Overall Study|Randomized But Did Not Receive Treatment|1
1000059|NCT00427934|3278969|P3|Overall Study|Randomized But Did Not Receive Treatment|1
1000060|NCT00427934|3278970|P2|Overall Study|Randomized But Did Not Receive Treatment|0
1000061|NCT00427934|3278971|P1|Overall Study|Randomized But Did Not Receive Treatment|0
1000062|NCT00427934|3278968|P4|Overall Study|Lack of Efficacy|2
1000063|NCT00427934|3278969|P3|Overall Study|Lack of Efficacy|5
1000064|NCT00427934|3278970|P2|Overall Study|Lack of Efficacy|0
1000065|NCT00427934|3278971|P1|Overall Study|Lack of Efficacy|0
1000066|NCT00427934|3278968|P4|Overall Study|Adverse Event|4
1000067|NCT00427934|3278969|P3|Overall Study|Adverse Event|5
1000068|NCT00427934|3278970|P2|Overall Study|Adverse Event|0
1000069|NCT00427934|3278971|P1|Overall Study|Adverse Event|1
1000070|NCT00427921|3279039|P1|Overall Study|Withdrew Consent + Lack of Efficacy|1
1000071|NCT00427921|3279039|P1|Overall Study|Adverse Event + Withdrawn from Study|1
1000072|NCT00427921|3279039|P1|Overall Study|Adverse Event + Lost Response|1
1000073|NCT00427921|3279039|P1|Overall Study|Adverse Event + No Therapeutic Benefit|1
1000074|NCT00427921|3279039|P1|Overall Study|Adverse Event + Worsening of CD|1
1000075|NCT00427921|3279039|P1|Overall Study|Adverse Event + No Response|1
1000076|NCT00427921|3279039|P1|Overall Study|Adverse Event + Withdrew Consent|1
1000077|NCT00427921|3279039|P1|Overall Study|Adverse Event + Hospitalization|1
1000078|NCT00427921|3279039|P1|Overall Study|Other reason not specified|10
1000079|NCT00427921|3279039|P1|Overall Study|Lost to Follow-up|2
1000080|NCT00427921|3279039|P1|Overall Study|Withdrawal by Subject|4
1000081|NCT00427921|3279039|P1|Overall Study|Adverse Event|26
1000082|NCT00427908|3279062|P4|Primary Phase|Adverse Event|0
1000083|NCT00427908|3279063|P3|Primary Phase|Adverse Event|0
1000084|NCT00427908|3279064|P2|Primary Phase|Adverse Event|1
1000085|NCT00427908|3279065|P1|Primary Phase|Adverse Event|0
1000086|NCT00427908|3279062|P4|Primary Phase|Withdrawal by Subject|0
1000087|NCT00427908|3279063|P3|Primary Phase|Withdrawal by Subject|1
1000088|NCT00427908|3279064|P2|Primary Phase|Withdrawal by Subject|2
1000089|NCT00427908|3279065|P1|Primary Phase|Withdrawal by Subject|1
1000090|NCT00427908|3279062|P4|Primary Phase|Lost to Follow-up|0
1000091|NCT00427908|3279063|P3|Primary Phase|Lost to Follow-up|2
1000092|NCT00427908|3279064|P2|Primary Phase|Lost to Follow-up|0
1000093|NCT00427908|3279065|P1|Primary Phase|Lost to Follow-up|4
1000094|NCT00427895|3279265|P8|Vax 2/Year 3 to 4|Failed to Return|0
1000095|NCT00427895|3279266|P7|Vax 2/Year 3 to 4|Failed to Return|0
1000096|NCT00427895|3279267|P6|Vax 2/Year 3 to 4|Failed to Return|0
1000097|NCT00427895|3279268|P5|Vax 2/Year 3 to 4|Failed to Return|1
1000098|NCT00427895|3279269|P4|Vax 2/Year 3 to 4|Failed to Return|0
1000099|NCT00427895|3279270|P3|Vax 2/Year 3 to 4|Failed to Return|0
1000100|NCT00427895|3279271|P2|Vax 2/Year 3 to 4|Failed to Return|0
1000101|NCT00427895|3279272|P1|Vax 2/Year 3 to 4|Failed to Return|0
1000102|NCT00427895|3279265|P8|Vax 2/Year 3 to 4|Protocol Violation|1
1000103|NCT00427895|3279266|P7|Vax 2/Year 3 to 4|Protocol Violation|0
1000104|NCT00427895|3279267|P6|Vax 2/Year 3 to 4|Protocol Violation|0
1000105|NCT00427895|3279268|P5|Vax 2/Year 3 to 4|Protocol Violation|0
1000106|NCT00427895|3279269|P4|Vax 2/Year 3 to 4|Protocol Violation|0
1000107|NCT00427895|3279270|P3|Vax 2/Year 3 to 4|Protocol Violation|0
1000108|NCT00427895|3279271|P2|Vax 2/Year 3 to 4|Protocol Violation|0
1000109|NCT00427895|3279272|P1|Vax 2/Year 3 to 4|Protocol Violation|0
1000110|NCT00427895|3279265|P8|Vax 2/Year 3 to 4|Lost to Follow-up|1
1000111|NCT00427895|3279266|P7|Vax 2/Year 3 to 4|Lost to Follow-up|0
1000112|NCT00427895|3279267|P6|Vax 2/Year 3 to 4|Lost to Follow-up|0
1000113|NCT00427895|3279268|P5|Vax 2/Year 3 to 4|Lost to Follow-up|0
1000114|NCT00427895|3279269|P4|Vax 2/Year 3 to 4|Lost to Follow-up|0
1000115|NCT00427895|3279270|P3|Vax 2/Year 3 to 4|Lost to Follow-up|0
1000116|NCT00427895|3279271|P2|Vax 2/Year 3 to 4|Lost to Follow-up|0
1000117|NCT00427895|3279272|P1|Vax 2/Year 3 to 4|Lost to Follow-up|0
1000118|NCT00427895|3279265|P8|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
1000119|NCT00427895|3279266|P7|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
1000120|NCT00427895|3279267|P6|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
1000121|NCT00427895|3279268|P5|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
1000122|NCT00427895|3279269|P4|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469
1000123|NCT00427895|3279270|P3|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159
1000124|NCT00427895|3279271|P2|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207
1000125|NCT00427895|3279272|P1|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188
1000126|NCT00427895|3279265|P8|Vax 1/Year 1 Follow-up|Other|0
1000127|NCT00427895|3279266|P7|Vax 1/Year 1 Follow-up|Other|0
1000128|NCT00427895|3279267|P6|Vax 1/Year 1 Follow-up|Other|0
1000129|NCT00427895|3279268|P5|Vax 1/Year 1 Follow-up|Other|0
1000130|NCT00427895|3279269|P4|Vax 1/Year 1 Follow-up|Other|2
1000131|NCT00427895|3279270|P3|Vax 1/Year 1 Follow-up|Other|0
1000132|NCT00427895|3279271|P2|Vax 1/Year 1 Follow-up|Other|0
1000133|NCT00427895|3279272|P1|Vax 1/Year 1 Follow-up|Other|0
1000134|NCT00427895|3279265|P8|Vax 1/Year 1 Follow-up|Failed to Return|0
1000135|NCT00427895|3279266|P7|Vax 1/Year 1 Follow-up|Failed to Return|0
1000136|NCT00427895|3279267|P6|Vax 1/Year 1 Follow-up|Failed to Return|0
1000137|NCT00427895|3279268|P5|Vax 1/Year 1 Follow-up|Failed to Return|0
1000138|NCT00427895|3279269|P4|Vax 1/Year 1 Follow-up|Failed to Return|5
1000139|NCT00427895|3279270|P3|Vax 1/Year 1 Follow-up|Failed to Return|12
1000140|NCT00427895|3279271|P2|Vax 1/Year 1 Follow-up|Failed to Return|0
1000141|NCT00427895|3279272|P1|Vax 1/Year 1 Follow-up|Failed to Return|0
1000142|NCT00427895|3279265|P8|Vax 1/Year 1 Follow-up|Death|0
1000143|NCT00427895|3279266|P7|Vax 1/Year 1 Follow-up|Death|0
1000144|NCT00427895|3279267|P6|Vax 1/Year 1 Follow-up|Death|0
1000145|NCT00427895|3279268|P5|Vax 1/Year 1 Follow-up|Death|0
1000146|NCT00427895|3279269|P4|Vax 1/Year 1 Follow-up|Death|0
1000147|NCT00427895|3279270|P3|Vax 1/Year 1 Follow-up|Death|0
1000148|NCT00427895|3279271|P2|Vax 1/Year 1 Follow-up|Death|0
1000149|NCT00427895|3279272|P1|Vax 1/Year 1 Follow-up|Death|1
1000150|NCT00427895|3279265|P8|Vax 1/Year 1 Follow-up|Adverse Event|0
1000151|NCT00427895|3279266|P7|Vax 1/Year 1 Follow-up|Adverse Event|0
1000152|NCT00427895|3279267|P6|Vax 1/Year 1 Follow-up|Adverse Event|0
1000153|NCT00427895|3279268|P5|Vax 1/Year 1 Follow-up|Adverse Event|0
1000154|NCT00427895|3279269|P4|Vax 1/Year 1 Follow-up|Adverse Event|0
1000155|NCT00427895|3279270|P3|Vax 1/Year 1 Follow-up|Adverse Event|0
1000156|NCT00427895|3279271|P2|Vax 1/Year 1 Follow-up|Adverse Event|1
1000157|NCT00427895|3279272|P1|Vax 1/Year 1 Follow-up|Adverse Event|0
1000158|NCT00427895|3279265|P8|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
1000159|NCT00427895|3279266|P7|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
1000160|NCT00427895|3279267|P6|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
1000161|NCT00427895|3279268|P5|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
1000162|NCT00427895|3279269|P4|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4
1000163|NCT00427895|3279270|P3|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5
1000164|NCT00427895|3279271|P2|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6
1000165|NCT00427895|3279272|P1|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3
1000166|NCT00427895|3279265|P8|Vax 1/Year 1 Follow-up|Protocol Violation|0
1000167|NCT00427895|3279266|P7|Vax 1/Year 1 Follow-up|Protocol Violation|0
1000168|NCT00427895|3279267|P6|Vax 1/Year 1 Follow-up|Protocol Violation|0
1000169|NCT00427895|3279268|P5|Vax 1/Year 1 Follow-up|Protocol Violation|0
1000170|NCT00427895|3279269|P4|Vax 1/Year 1 Follow-up|Protocol Violation|1
1000171|NCT00427895|3279270|P3|Vax 1/Year 1 Follow-up|Protocol Violation|0
1000172|NCT00427895|3279271|P2|Vax 1/Year 1 Follow-up|Protocol Violation|3
1000173|NCT00427895|3279272|P1|Vax 1/Year 1 Follow-up|Protocol Violation|3
1000174|NCT00427895|3279265|P8|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
1000175|NCT00427895|3279266|P7|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
1000176|NCT00427895|3279267|P6|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
1000177|NCT00427895|3279268|P5|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
1000178|NCT00427895|3279269|P4|Vax 1/Year 1 Follow-up|Lost to Follow-up|21
1000179|NCT00427895|3279270|P3|Vax 1/Year 1 Follow-up|Lost to Follow-up|2
1000180|NCT00427895|3279271|P2|Vax 1/Year 1 Follow-up|Lost to Follow-up|5
1000181|NCT00427895|3279272|P1|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
1000182|NCT00427895|3279265|P8|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
1000183|NCT00427895|3279266|P7|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
1000184|NCT00427895|3279267|P6|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
1000185|NCT00427895|3279268|P5|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
1000186|NCT00427895|3279269|P4|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352
1000187|NCT00427895|3279270|P3|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
1000188|NCT00427895|3279271|P2|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
1000189|NCT00427895|3279272|P1|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
1000190|NCT00427895|3279265|P8|Vax 1 Baseline/6-Month Follow-up|Other|0
1000191|NCT00427895|3279266|P7|Vax 1 Baseline/6-Month Follow-up|Other|0
1000192|NCT00427895|3279267|P6|Vax 1 Baseline/6-Month Follow-up|Other|0
1000193|NCT00427895|3279268|P5|Vax 1 Baseline/6-Month Follow-up|Other|0
1000194|NCT00427895|3279269|P4|Vax 1 Baseline/6-Month Follow-up|Other|2
1000195|NCT00427895|3279270|P3|Vax 1 Baseline/6-Month Follow-up|Other|1
1000196|NCT00427895|3279271|P2|Vax 1 Baseline/6-Month Follow-up|Other|0
1000197|NCT00427895|3279272|P1|Vax 1 Baseline/6-Month Follow-up|Other|0
1000198|NCT00427895|3279265|P8|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
1000199|NCT00427895|3279266|P7|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
1000200|NCT00427895|3279267|P6|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
1000201|NCT00427895|3279268|P5|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
1000202|NCT00427895|3279269|P4|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
1000203|NCT00427895|3279270|P3|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2
1000204|NCT00427895|3279271|P2|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3
1000205|NCT00427895|3279272|P1|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
1000206|NCT00427895|3279265|P8|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
1000207|NCT00427895|3279266|P7|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
1000208|NCT00427895|3279267|P6|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
1000209|NCT00427895|3279268|P5|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
1000210|NCT00427895|3279269|P4|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2
1000211|NCT00427895|3279270|P3|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
1000212|NCT00427895|3279271|P2|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
1000213|NCT00427895|3279272|P1|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
1000214|NCT00427895|3279265|P8|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
1000215|NCT00427895|3279266|P7|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
1000216|NCT00427895|3279267|P6|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
1000217|NCT00427895|3279268|P5|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
1000218|NCT00427895|3279269|P4|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7
1000219|NCT00427895|3279270|P3|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4
1000220|NCT00427895|3279271|P2|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
1000221|NCT00427895|3279272|P1|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
1000222|NCT00427895|3279265|P8|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
1000223|NCT00427895|3279266|P7|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
1000224|NCT00427895|3279267|P6|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
1000225|NCT00427895|3279268|P5|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
1000226|NCT00427895|3279269|P4|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
1000227|NCT00427895|3279270|P3|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
1000228|NCT00427895|3279271|P2|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
1000229|NCT00427895|3279272|P1|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
1000230|NCT00427895|3279265|P8|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
1000231|NCT00427895|3279266|P7|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
1000232|NCT00427895|3279267|P6|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
1000233|NCT00427895|3279268|P5|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
1000234|NCT00427895|3279269|P4|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2
1000235|NCT00427895|3279270|P3|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3
1000236|NCT00427895|3279271|P2|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
1000237|NCT00427895|3279272|P1|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4
1000238|NCT00427895|3279265|P8|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
1000239|NCT00427895|3279266|P7|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
1000240|NCT00427895|3279267|P6|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
1000241|NCT00427895|3279268|P5|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
1000242|NCT00427895|3279269|P4|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32
1000243|NCT00427895|3279270|P3|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4
1000244|NCT00427895|3279271|P2|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1
1000245|NCT00427895|3279272|P1|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
1000246|NCT00427778|3279347|P2|First Intervention (4 Weeks)|anxious about using ring|0
1000247|NCT00427778|3279348|P1|First Intervention (4 Weeks)|anxious about using ring|1
1000248|NCT00427778|3279347|P2|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1
1000249|NCT00427778|3279348|P1|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0
1000250|NCT00427778|3279347|P2|First Intervention (4 Weeks)|Not successfully fitted with ring|0
1000251|NCT00427778|3279348|P1|First Intervention (4 Weeks)|Not successfully fitted with ring|2
1000252|NCT00427778|3279347|P2|First Intervention (4 Weeks)|no longer interested|0
1000253|NCT00427778|3279348|P1|First Intervention (4 Weeks)|no longer interested|1
1000254|NCT00427700|3279373|P2|Overall Study|Pregnancy|2
1000255|NCT00427700|3279374|P1|Overall Study|Pregnancy|0
1000256|NCT00427700|3279373|P2|Overall Study|no induction of menses|4
1000257|NCT00427700|3279374|P1|Overall Study|no induction of menses|1
1000258|NCT00427700|3279373|P2|Overall Study|Lost to Follow-up|5
1000259|NCT00427700|3279374|P1|Overall Study|Lost to Follow-up|2
1000260|NCT00427635|3279390|P2|Study Completion to Safety Follow-up|Lost to Follow-up|1
1000261|NCT00427635|3279391|P1|Study Completion to Safety Follow-up|Lost to Follow-up|0
1000262|NCT00427635|3279390|P2|Treatment Phase|Withdrawal by Subject|0
1000263|NCT00427635|3279391|P1|Treatment Phase|Withdrawal by Subject|1
1000264|NCT00427349|3279423|P1|Overall Study|Never started therapy|1
1000265|NCT00427349|3279423|P1|Overall Study|Ineligible|1
1000266|NCT00427349|3279423|P1|Overall Study|Other|2
1000267|NCT00427349|3279423|P1|Overall Study|Alternative therapy|1
1000268|NCT00427349|3279423|P1|Overall Study|Withdrawal by Subject|3
1000269|NCT00427349|3279423|P1|Overall Study|Death|1
1000270|NCT00427349|3279423|P1|Overall Study|Adverse Event|14
1000271|NCT00427349|3279423|P1|Overall Study|Lack of Efficacy|23
1000272|NCT00427011|3279459|P1|Overall Study|Not specified|12
1000273|NCT00427011|3279459|P1|Overall Study|Lack of Efficacy|2
1000274|NCT00427011|3279459|P1|Overall Study|Withdrawal by Subject|1
1000275|NCT00427011|3279459|P1|Overall Study|Adverse Event|10
1000276|NCT00426842|3279474|P1|Overall Study|Lost to Follow-up|1
1000277|NCT00426764|3279480|P1|Overall Study|Other|2
1000278|NCT00426764|3279480|P1|Overall Study|Protocol Violation|1
1000279|NCT00426764|3279480|P1|Overall Study|Physician Decision|1
1000280|NCT00426764|3279480|P1|Overall Study|Withdrawal by Subject|3
1000281|NCT00426764|3279480|P1|Overall Study|Adverse Event|19
1000282|NCT00426764|3279480|P1|Overall Study|Progressive disease|72
1000283|NCT00426751|3279496|P2|Overall Study|Other Reasons|12
1000284|NCT00426751|3279497|P1|Overall Study|Other Reasons|7
1000285|NCT00426751|3279496|P2|Overall Study|Consent Withdrawn|1
1000286|NCT00426751|3279497|P1|Overall Study|Consent Withdrawn|0
1000287|NCT00426751|3279496|P2|Overall Study|Lost to Follow-up|6
1000288|NCT00426751|3279497|P1|Overall Study|Lost to Follow-up|7
1000289|NCT00426751|3279496|P2|Overall Study|Adverse Event|1
1000290|NCT00426751|3279497|P1|Overall Study|Adverse Event|8
1000291|NCT00426660|3279541|P1|Overall Study|Enrolled Not Treated|15
1000292|NCT00426660|3279541|P1|Overall Study|Protocol Violation|1
1000293|NCT00426660|3279541|P1|Overall Study|Withdrawal by Subject|18
1000294|NCT00426660|3279541|P1|Overall Study|Other|23
1000295|NCT00426660|3279541|P1|Overall Study|Lost to Follow-up|15
1000296|NCT00426660|3279541|P1|Overall Study|Insufficient Clinical Response|22
1000297|NCT00426660|3279541|P1|Overall Study|Adverse Event|23
1000298|NCT00426660|3279541|P1|Overall Study|Death|14
1000299|NCT00426556|3279572|P4|Phase II - Extension Phase|Adverse Event|2
1000300|NCT00426556|3279573|P3|Phase II - Extension Phase|Adverse Event|0
1000301|NCT00426556|3279574|P2|Phase II - Extension Phase|Adverse Event|0
1000302|NCT00426556|3279575|P1|Phase II - Extension Phase|Adverse Event|0
1000303|NCT00426556|3279572|P4|Phase II - Extension Phase|Disease Progression|21
1000304|NCT00426556|3279573|P3|Phase II - Extension Phase|Disease Progression|0
1000305|NCT00426556|3279574|P2|Phase II - Extension Phase|Disease Progression|0
1000306|NCT00426556|3279575|P1|Phase II - Extension Phase|Disease Progression|0
1000307|NCT00426556|3279572|P4|Phase II - Core Phase|Adverse Event|8
1000308|NCT00426556|3279573|P3|Phase II - Core Phase|Adverse Event|0
1000309|NCT00426556|3279574|P2|Phase II - Core Phase|Adverse Event|0
1000310|NCT00426556|3279575|P1|Phase II - Core Phase|Adverse Event|0
1000311|NCT00426556|3279572|P4|Phase II - Core Phase|Disease Progression|16
1000312|NCT00426556|3279573|P3|Phase II - Core Phase|Disease Progression|0
1000313|NCT00426556|3279574|P2|Phase II - Core Phase|Disease Progression|0
1000314|NCT00426556|3279575|P1|Phase II - Core Phase|Disease Progression|0
1000315|NCT00426556|3279572|P4|Phase II - Core Phase|Withdrawal by Subject|3
1000316|NCT00426556|3279573|P3|Phase II - Core Phase|Withdrawal by Subject|0
1000317|NCT00426556|3279574|P2|Phase II - Core Phase|Withdrawal by Subject|0
1000318|NCT00426556|3279575|P1|Phase II - Core Phase|Withdrawal by Subject|0
1000319|NCT00426556|3279572|P4|Phase I - Extension Phase|Disease Progression|0
1000320|NCT00426556|3279573|P3|Phase I - Extension Phase|Disease Progression|6
1000321|NCT00426556|3279574|P2|Phase I - Extension Phase|Disease Progression|5
1000322|NCT00426556|3279575|P1|Phase I - Extension Phase|Disease Progression|5
1000323|NCT00426556|3279572|P4|Phase I - Extension Phase|Adverse Event|0
1000324|NCT00426556|3279573|P3|Phase I - Extension Phase|Adverse Event|1
1000325|NCT00426556|3279574|P2|Phase I - Extension Phase|Adverse Event|1
1000326|NCT00426556|3279575|P1|Phase I - Extension Phase|Adverse Event|0
1000327|NCT00426556|3279572|P4|Phase I - Core Phase|Death|0
1000328|NCT00426556|3279573|P3|Phase I - Core Phase|Death|0
1000329|NCT00426556|3279574|P2|Phase I - Core Phase|Death|1
1000330|NCT00426556|3279575|P1|Phase I - Core Phase|Death|0
1000331|NCT00426556|3279572|P4|Phase I - Core Phase|Adverse Event|0
1000332|NCT00426556|3279573|P3|Phase I - Core Phase|Adverse Event|1
1000333|NCT00426556|3279574|P2|Phase I - Core Phase|Adverse Event|3
1000334|NCT00426556|3279575|P1|Phase I - Core Phase|Adverse Event|1
1000335|NCT00426556|3279572|P4|Phase I - Core Phase|Disease Progression|0
1000336|NCT00426556|3279573|P3|Phase I - Core Phase|Disease Progression|2
1000337|NCT00426556|3279574|P2|Phase I - Core Phase|Disease Progression|6
1000338|NCT00426556|3279575|P1|Phase I - Core Phase|Disease Progression|0
1000339|NCT00426361|3279600|P3|Overall Study|Withdrawal by Subject|0
1000340|NCT00426361|3279601|P2|Overall Study|Withdrawal by Subject|3
1000341|NCT00426361|3279602|P1|Overall Study|Withdrawal by Subject|1
1000342|NCT00426361|3279600|P3|Overall Study|Lost to Follow-up|5
1000343|NCT00426361|3279601|P2|Overall Study|Lost to Follow-up|2
1000344|NCT00426361|3279602|P1|Overall Study|Lost to Follow-up|3
1000345|NCT00426270|3279661|P1|Overall Study|Adverse Event|5
1000346|NCT00426270|3279661|P1|Overall Study|Incorrectly Enrolled in the Study|1
1000347|NCT00426231|3279671|P2|Overall Study|Withdrawal by Subject|12
1000348|NCT00426231|3279672|P1|Overall Study|Withdrawal by Subject|9
1000349|NCT00426127|3279695|P1|Overall Study|Removed due to disease progression|1
1000350|NCT00426127|3279695|P1|Overall Study|Adverse Event|1
1000351|NCT00425945|3279703|P2|Overall Study|Moved from area|1
1000352|NCT00425945|3279704|P1|Overall Study|Moved from area|0
1000353|NCT00425945|3279703|P2|Overall Study|Began cancer treatments|0
1000354|NCT00425945|3279704|P1|Overall Study|Began cancer treatments|1
1000355|NCT00425945|3279703|P2|Overall Study|Began hypertension medication|0
1000356|NCT00425945|3279704|P1|Overall Study|Began hypertension medication|1
1000357|NCT00425945|3279703|P2|Overall Study|Lost to Follow-up|2
1000358|NCT00425945|3279704|P1|Overall Study|Lost to Follow-up|0
1000359|NCT00425945|3279703|P2|Overall Study|Inconvenience|2
1000360|NCT00425945|3279704|P1|Overall Study|Inconvenience|0
1000361|NCT00425945|3279703|P2|Overall Study|Concern about Supplement|0
1000362|NCT00425945|3279704|P1|Overall Study|Concern about Supplement|2
1000363|NCT00425854|3279742|P2|Overall Study|Other Adverse Event|2
1000364|NCT00425854|3279743|P1|Overall Study|Other Adverse Event|2
1000365|NCT00425854|3279742|P2|Overall Study|Dose reduction toxicity AE|7
1000366|NCT00425854|3279743|P1|Overall Study|Dose reduction toxicity AE|8
1000367|NCT00425854|3279742|P2|Overall Study|Progressive Disease|12
1000368|NCT00425854|3279743|P1|Overall Study|Progressive Disease|19
1000369|NCT00425750|3279776|P1|Overall Study|Progression of disease|18
1000370|NCT00425750|3279776|P1|Overall Study|Adverse Event|3
1000371|NCT00425750|3279776|P1|Overall Study|Withdrawal by Subject|3
1000372|NCT00425750|3279776|P1|Overall Study|Death|1
1000373|NCT00425698|3279784|P2|Overall Study|Withdrawal by Subject|1
1000374|NCT00425698|3279785|P1|Overall Study|Withdrawal by Subject|0
1000375|NCT00425698|3279784|P2|Overall Study|Adverse Event|1
1000376|NCT00425698|3279785|P1|Overall Study|Adverse Event|3
1000377|NCT00425607|3279800|P1|Overall Study|Withdrawal by Subject|1
1000378|NCT00425607|3279800|P1|Overall Study|Death|1
1000379|NCT00425503|3279804|P1|Overall Study|Protocol Violation|1
1000380|NCT00425503|3279804|P1|Overall Study|Adverse Event|2
1000381|NCT00425438|3279816|P2|Overall Study|Termination by Sponsor|27
1000382|NCT00425438|3279817|P1|Overall Study|Termination by Sponsor|25
1000383|NCT00425373|3279851|P9|Overall Study|Lack of Efficacy|5
1000384|NCT00425373|3279852|P8|Overall Study|Lack of Efficacy|0
1000385|NCT00425373|3279853|P7|Overall Study|Lack of Efficacy|3
1000386|NCT00425373|3279854|P6|Overall Study|Lack of Efficacy|3
1000387|NCT00425373|3279855|P5|Overall Study|Lack of Efficacy|1
1000388|NCT00425373|3279856|P4|Overall Study|Lack of Efficacy|0
1000389|NCT00425373|3279857|P3|Overall Study|Lack of Efficacy|0
1000390|NCT00425373|3279858|P2|Overall Study|Lack of Efficacy|0
1000391|NCT00425373|3279859|P1|Overall Study|Lack of Efficacy|0
1000392|NCT00425373|3279851|P9|Overall Study|Withdrawal by Subject|2
1000393|NCT00425373|3279852|P8|Overall Study|Withdrawal by Subject|2
1000394|NCT00425373|3279853|P7|Overall Study|Withdrawal by Subject|2
1000395|NCT00425373|3279854|P6|Overall Study|Withdrawal by Subject|0
1000396|NCT00425373|3279855|P5|Overall Study|Withdrawal by Subject|4
1000397|NCT00425373|3279856|P4|Overall Study|Withdrawal by Subject|1
1000398|NCT00425373|3279857|P3|Overall Study|Withdrawal by Subject|2
1000399|NCT00425373|3279858|P2|Overall Study|Withdrawal by Subject|0
1000400|NCT00425373|3279859|P1|Overall Study|Withdrawal by Subject|2
1000401|NCT00425373|3279851|P9|Overall Study|Protocol Violation|3
1000402|NCT00425373|3279852|P8|Overall Study|Protocol Violation|5
1000403|NCT00425373|3279853|P7|Overall Study|Protocol Violation|0
1000404|NCT00425373|3279854|P6|Overall Study|Protocol Violation|0
1000405|NCT00425373|3279855|P5|Overall Study|Protocol Violation|0
1000406|NCT00425373|3279856|P4|Overall Study|Protocol Violation|0
1000407|NCT00425373|3279857|P3|Overall Study|Protocol Violation|1
1000408|NCT00425373|3279858|P2|Overall Study|Protocol Violation|0
1000409|NCT00425373|3279859|P1|Overall Study|Protocol Violation|1
1000410|NCT00425373|3279851|P9|Overall Study|Lost to Follow-up|0
1000411|NCT00425373|3279852|P8|Overall Study|Lost to Follow-up|0
1000412|NCT00425373|3279853|P7|Overall Study|Lost to Follow-up|0
1000413|NCT00425373|3279854|P6|Overall Study|Lost to Follow-up|0
1000414|NCT00425373|3279855|P5|Overall Study|Lost to Follow-up|1
1000415|NCT00425373|3279856|P4|Overall Study|Lost to Follow-up|0
1000416|NCT00425373|3279857|P3|Overall Study|Lost to Follow-up|0
1000417|NCT00425373|3279858|P2|Overall Study|Lost to Follow-up|1
1000418|NCT00425373|3279859|P1|Overall Study|Lost to Follow-up|0
1000419|NCT00425373|3279851|P9|Overall Study|Adverse Event|8
1000420|NCT00425373|3279852|P8|Overall Study|Adverse Event|3
1000421|NCT00425373|3279853|P7|Overall Study|Adverse Event|2
1000422|NCT00425373|3279854|P6|Overall Study|Adverse Event|6
1000423|NCT00425373|3279855|P5|Overall Study|Adverse Event|4
1000424|NCT00425373|3279856|P4|Overall Study|Adverse Event|1
1000425|NCT00425373|3279857|P3|Overall Study|Adverse Event|0
1000426|NCT00425373|3279858|P2|Overall Study|Adverse Event|2
1000427|NCT00425373|3279859|P1|Overall Study|Adverse Event|2
1000428|NCT00425308|3279917|P2|Overall Study|Death|0
1000429|NCT00425308|3279918|P1|Overall Study|Death|1
1000430|NCT00425308|3279917|P2|Overall Study|Withdrawal by Subject|0
1000431|NCT00425308|3279918|P1|Overall Study|Withdrawal by Subject|1
1000432|NCT00425308|3279917|P2|Overall Study|Adverse Event|1
1000433|NCT00425308|3279918|P1|Overall Study|Adverse Event|2
1000434|NCT00425269|3279948|P2|Overall Study|moved or medical reason|4
1000435|NCT00425269|3279949|P1|Overall Study|moved or medical reason|5
1000436|NCT00425269|3279948|P2|Overall Study|Lost to Follow-up|9
1000437|NCT00425269|3279949|P1|Overall Study|Lost to Follow-up|9
1000438|NCT00425269|3279948|P2|Overall Study|Pregnancy|7
1000439|NCT00425269|3279949|P1|Overall Study|Pregnancy|5
1000440|NCT00425113|3280027|P2|Overall Study|Withdrawal by Subject|0
1000441|NCT00425113|3280028|P1|Overall Study|Withdrawal by Subject|1
1000442|NCT00425113|3280027|P2|Overall Study|missing study drug more than 14 days|1
1000443|NCT00425113|3280028|P1|Overall Study|missing study drug more than 14 days|0
1000444|NCT00425113|3280027|P2|Overall Study|diagnosis of abdominal TB|1
1000445|NCT00425113|3280028|P1|Overall Study|diagnosis of abdominal TB|0
1000446|NCT00425113|3280027|P2|Overall Study|uncontrolled diabetes mellitus|0
1000447|NCT00425113|3280028|P1|Overall Study|uncontrolled diabetes mellitus|1
1000448|NCT00425100|3280036|P1|Overall Study|Withdrawal by Subject|7
1000449|NCT00425100|3280036|P1|Overall Study|Protocol Violation|4
1000450|NCT00425100|3280036|P1|Overall Study|Lost to Follow-up|2
1000451|NCT00425100|3280036|P1|Overall Study|Lack of Efficacy|4
1000452|NCT00425100|3280036|P1|Overall Study|Adverse Event|36
1000453|NCT00425061|3280080|P7|Overall Study|Other|1
1000454|NCT00425061|3280081|P6|Overall Study|Other|0
1000455|NCT00425061|3280082|P5|Overall Study|Other|3
1000456|NCT00425061|3280083|P4|Overall Study|Other|0
1000457|NCT00425061|3280084|P3|Overall Study|Other|0
1000458|NCT00425061|3280085|P2|Overall Study|Other|0
1000459|NCT00425061|3280086|P1|Overall Study|Other|0
1000460|NCT00425061|3280080|P7|Overall Study|Physician Decision|0
1000461|NCT00425061|3280081|P6|Overall Study|Physician Decision|0
1000462|NCT00425061|3280082|P5|Overall Study|Physician Decision|1
1000463|NCT00425061|3280083|P4|Overall Study|Physician Decision|0
1000464|NCT00425061|3280084|P3|Overall Study|Physician Decision|0
1000465|NCT00425061|3280085|P2|Overall Study|Physician Decision|0
1000466|NCT00425061|3280086|P1|Overall Study|Physician Decision|0
1000467|NCT00425061|3280080|P7|Overall Study|Sponsor's request|15
1000468|NCT00425061|3280081|P6|Overall Study|Sponsor's request|4
1000469|NCT00425061|3280082|P5|Overall Study|Sponsor's request|19
1000470|NCT00425061|3280083|P4|Overall Study|Sponsor's request|0
1000471|NCT00425061|3280084|P3|Overall Study|Sponsor's request|0
1000472|NCT00425061|3280085|P2|Overall Study|Sponsor's request|0
1000473|NCT00425061|3280086|P1|Overall Study|Sponsor's request|0
1000474|NCT00425061|3280080|P7|Overall Study|Withdrawal by Subject|3
1000475|NCT00425061|3280081|P6|Overall Study|Withdrawal by Subject|0
1000476|NCT00425061|3280082|P5|Overall Study|Withdrawal by Subject|1
1000477|NCT00425061|3280083|P4|Overall Study|Withdrawal by Subject|0
1000478|NCT00425061|3280084|P3|Overall Study|Withdrawal by Subject|0
1000479|NCT00425061|3280085|P2|Overall Study|Withdrawal by Subject|1
1000480|NCT00425061|3280086|P1|Overall Study|Withdrawal by Subject|0
1000481|NCT00425061|3280080|P7|Overall Study|Protocol Violation|0
1000482|NCT00425061|3280081|P6|Overall Study|Protocol Violation|0
1000483|NCT00425061|3280082|P5|Overall Study|Protocol Violation|0
1000484|NCT00425061|3280083|P4|Overall Study|Protocol Violation|0
1000485|NCT00425061|3280084|P3|Overall Study|Protocol Violation|0
1000486|NCT00425061|3280085|P2|Overall Study|Protocol Violation|0
1000487|NCT00425061|3280086|P1|Overall Study|Protocol Violation|1
1000488|NCT00425061|3280080|P7|Overall Study|Lost to Follow-up|0
1000489|NCT00425061|3280081|P6|Overall Study|Lost to Follow-up|0
1000490|NCT00425061|3280082|P5|Overall Study|Lost to Follow-up|0
1000491|NCT00425061|3280083|P4|Overall Study|Lost to Follow-up|0
1000492|NCT00425061|3280084|P3|Overall Study|Lost to Follow-up|0
1000493|NCT00425061|3280085|P2|Overall Study|Lost to Follow-up|1
1000494|NCT00425061|3280086|P1|Overall Study|Lost to Follow-up|0
1000495|NCT00425061|3280080|P7|Overall Study|Adverse Event|0
1000496|NCT00425061|3280081|P6|Overall Study|Adverse Event|0
1000497|NCT00425061|3280082|P5|Overall Study|Adverse Event|2
1000498|NCT00425061|3280083|P4|Overall Study|Adverse Event|2
1000499|NCT00425061|3280084|P3|Overall Study|Adverse Event|0
1000500|NCT00425061|3280085|P2|Overall Study|Adverse Event|0
1000501|NCT00425061|3280086|P1|Overall Study|Adverse Event|1
1000502|NCT00424827|3280202|P1|Overall Study|Adverse Event|1
1000503|NCT00424775|3280210|P2|Overall Study|Lack of Efficacy|0
1000504|NCT00424775|3280211|P1|Overall Study|Lack of Efficacy|1
1000505|NCT00424775|3280210|P2|Overall Study|Adverse Event|0
1000506|NCT00424775|3280211|P1|Overall Study|Adverse Event|2
1000507|NCT00424762|3280221|P2|Overall Study|Lost to Follow-up|3
1000508|NCT00424762|3280222|P1|Overall Study|Lost to Follow-up|2
1000509|NCT00424762|3280221|P2|Overall Study|Withdrawal by Subject|19
1000510|NCT00424762|3280222|P1|Overall Study|Withdrawal by Subject|18
1000511|NCT00424749|3280232|P1|Overall Study|Withdrawal by Subject|1
1000512|NCT00424645|3280239|P2|Overall Study|Death|0
1000513|NCT00424645|3280240|P1|Overall Study|Death|1
1000514|NCT00424632|3280248|P10|Overall Study|Other|0
1000515|NCT00424632|3280249|P9|Overall Study|Other|1
1000516|NCT00424632|3280250|P8|Overall Study|Other|0
1000517|NCT00424632|3280251|P7|Overall Study|Other|0
1000518|NCT00424632|3280252|P6|Overall Study|Other|0
1000519|NCT00424632|3280253|P5|Overall Study|Other|0
1000520|NCT00424632|3280254|P4|Overall Study|Other|1
1000521|NCT00424632|3280255|P3|Overall Study|Other|0
1000522|NCT00424632|3280256|P2|Overall Study|Other|0
1000523|NCT00424632|3280257|P1|Overall Study|Other|0
1000524|NCT00424632|3280248|P10|Overall Study|Objective progression or relapse|4
1000525|NCT00424632|3280249|P9|Overall Study|Objective progression or relapse|12
1000526|NCT00424632|3280250|P8|Overall Study|Objective progression or relapse|3
1000527|NCT00424632|3280251|P7|Overall Study|Objective progression or relapse|7
1000528|NCT00424632|3280252|P6|Overall Study|Objective progression or relapse|13
1000529|NCT00424632|3280253|P5|Overall Study|Objective progression or relapse|2
1000530|NCT00424632|3280254|P4|Overall Study|Objective progression or relapse|2
1000531|NCT00424632|3280255|P3|Overall Study|Objective progression or relapse|1
1000532|NCT00424632|3280256|P2|Overall Study|Objective progression or relapse|1
1000533|NCT00424632|3280257|P1|Overall Study|Objective progression or relapse|1
1000534|NCT00424632|3280248|P10|Overall Study|Global deterioration of health status|0
1000535|NCT00424632|3280249|P9|Overall Study|Global deterioration of health status|0
1000536|NCT00424632|3280250|P8|Overall Study|Global deterioration of health status|0
1000537|NCT00424632|3280251|P7|Overall Study|Global deterioration of health status|0
1000538|NCT00424632|3280252|P6|Overall Study|Global deterioration of health status|0
1000539|NCT00424632|3280253|P5|Overall Study|Global deterioration of health status|1
1000540|NCT00424632|3280254|P4|Overall Study|Global deterioration of health status|1
1000541|NCT00424632|3280255|P3|Overall Study|Global deterioration of health status|0
1000542|NCT00424632|3280256|P2|Overall Study|Global deterioration of health status|0
1000543|NCT00424632|3280257|P1|Overall Study|Global deterioration of health status|0
1000544|NCT00424632|3280248|P10|Overall Study|Adverse Event|2
1000545|NCT00424632|3280249|P9|Overall Study|Adverse Event|3
1000546|NCT00424632|3280250|P8|Overall Study|Adverse Event|0
1000547|NCT00424632|3280251|P7|Overall Study|Adverse Event|0
1000548|NCT00424632|3280252|P6|Overall Study|Adverse Event|0
1000549|NCT00424632|3280253|P5|Overall Study|Adverse Event|0
1000550|NCT00424632|3280254|P4|Overall Study|Adverse Event|0
1000551|NCT00424632|3280255|P3|Overall Study|Adverse Event|0
1000552|NCT00424632|3280256|P2|Overall Study|Adverse Event|0
1000553|NCT00424632|3280257|P1|Overall Study|Adverse Event|0
1000554|NCT00424632|3280248|P10|Overall Study|Death|0
1000555|NCT00424632|3280249|P9|Overall Study|Death|0
1000556|NCT00424632|3280250|P8|Overall Study|Death|0
1000557|NCT00424632|3280251|P7|Overall Study|Death|0
1000558|NCT00424632|3280252|P6|Overall Study|Death|2
1000559|NCT00424632|3280253|P5|Overall Study|Death|0
1000560|NCT00424632|3280254|P4|Overall Study|Death|0
1000561|NCT00424632|3280255|P3|Overall Study|Death|0
1000562|NCT00424632|3280256|P2|Overall Study|Death|0
1000563|NCT00424632|3280257|P1|Overall Study|Death|0
1000564|NCT00424593|3280427|P2|Dose-Blind Extension Period|Physician Decision|0
1000565|NCT00424593|3280428|P1|Dose-Blind Extension Period|Physician Decision|3
1000566|NCT00424593|3280427|P2|Dose-Blind Extension Period|Lost to Follow-up|0
1000567|NCT00424593|3280428|P1|Dose-Blind Extension Period|Lost to Follow-up|6
1000568|NCT00424593|3280427|P2|Dose-Blind Extension Period|Protocol Violation|0
1000569|NCT00424593|3280428|P1|Dose-Blind Extension Period|Protocol Violation|9
1000570|NCT00424593|3280427|P2|Dose-Blind Extension Period|Lack of Efficacy|0
1000571|NCT00424593|3280428|P1|Dose-Blind Extension Period|Lack of Efficacy|9
1000572|NCT00424593|3280427|P2|Dose-Blind Extension Period|Adverse Event|0
1000573|NCT00424593|3280428|P1|Dose-Blind Extension Period|Adverse Event|18
1000574|NCT00424593|3280427|P2|Dose-Blind Extension Period|Withdrawal by Subject|0
1000575|NCT00424593|3280428|P1|Dose-Blind Extension Period|Withdrawal by Subject|19
1000576|NCT00424593|3280427|P2|Acute Double-Blind Period|Lack of Efficacy|1
1000577|NCT00424593|3280428|P1|Acute Double-Blind Period|Lack of Efficacy|0
1000578|NCT00424593|3280427|P2|Acute Double-Blind Period|Lost to Follow-up|1
1000579|NCT00424593|3280428|P1|Acute Double-Blind Period|Lost to Follow-up|1
1000580|NCT00424593|3280427|P2|Acute Double-Blind Period|Physician Decision|2
1000581|NCT00424593|3280428|P1|Acute Double-Blind Period|Physician Decision|1
1000582|NCT00424593|3280427|P2|Acute Double-Blind Period|Protocol Violation|2
1000583|NCT00424593|3280428|P1|Acute Double-Blind Period|Protocol Violation|2
1000584|NCT00424593|3280427|P2|Acute Double-Blind Period|Withdrawal by Subject|10
1000585|NCT00424593|3280428|P1|Acute Double-Blind Period|Withdrawal by Subject|11
1000586|NCT00424593|3280427|P2|Acute Double-Blind Period|Adverse Event|7
1000587|NCT00424593|3280428|P1|Acute Double-Blind Period|Adverse Event|16
1000588|NCT00424528|3280492|P3|Overall Study|noncompliance with study requirements|2
1000589|NCT00424528|3280493|P2|Overall Study|noncompliance with study requirements|1
1000590|NCT00424528|3280494|P1|Overall Study|noncompliance with study requirements|2
1000591|NCT00424528|3280492|P3|Overall Study|Lost to Follow-up|0
1000592|NCT00424528|3280493|P2|Overall Study|Lost to Follow-up|1
1000593|NCT00424528|3280494|P1|Overall Study|Lost to Follow-up|0
1000594|NCT00424528|3280492|P3|Overall Study|Protocol Violation|0
1000595|NCT00424528|3280493|P2|Overall Study|Protocol Violation|1
1000596|NCT00424528|3280494|P1|Overall Study|Protocol Violation|1
1000597|NCT00424528|3280492|P3|Overall Study|Adverse Event|2
1000598|NCT00424528|3280493|P2|Overall Study|Adverse Event|1
1000599|NCT00424528|3280494|P1|Overall Study|Adverse Event|2
1000600|NCT00424515|3280549|P2|Overall Study|Withdrawal by Subject|0
1000601|NCT00424515|3280550|P1|Overall Study|Withdrawal by Subject|1
1000602|NCT00424515|3280549|P2|Overall Study|Intercurrent Illness|1
1000603|NCT00424515|3280550|P1|Overall Study|Intercurrent Illness|0
1000604|NCT00424515|3280549|P2|Overall Study|Adverse Event|1
1000605|NCT00424515|3280550|P1|Overall Study|Adverse Event|0
1000606|NCT00424515|3280549|P2|Overall Study|Progressive Disease|11
1000607|NCT00424515|3280550|P1|Overall Study|Progressive Disease|10
1000608|NCT00424489|3280569|P1|Overall Study|Death|3
1000609|NCT00424476|3280576|P3|Overall Study|Other|9
1000610|NCT00424476|3280577|P2|Overall Study|Other|3
1000611|NCT00424476|3280578|P1|Overall Study|Other|4
1000612|NCT00424476|3280576|P3|Overall Study|Physician Decision|3
1000613|NCT00424476|3280577|P2|Overall Study|Physician Decision|2
1000614|NCT00424476|3280578|P1|Overall Study|Physician Decision|3
1000615|NCT00424476|3280576|P3|Overall Study|Protocol Violation|3
1000616|NCT00424476|3280577|P2|Overall Study|Protocol Violation|2
1000617|NCT00424476|3280578|P1|Overall Study|Protocol Violation|7
1000618|NCT00424476|3280576|P3|Overall Study|Lost to Follow-up|3
1000619|NCT00424476|3280577|P2|Overall Study|Lost to Follow-up|6
1000620|NCT00424476|3280578|P1|Overall Study|Lost to Follow-up|4
1000621|NCT00424476|3280576|P3|Overall Study|Lack of Compliance|1
1000622|NCT00424476|3280577|P2|Overall Study|Lack of Compliance|1
1000623|NCT00424476|3280578|P1|Overall Study|Lack of Compliance|1
1000624|NCT00424476|3280576|P3|Overall Study|Lack of Efficacy|12
1000625|NCT00424476|3280577|P2|Overall Study|Lack of Efficacy|12
1000626|NCT00424476|3280578|P1|Overall Study|Lack of Efficacy|16
1000627|NCT00424476|3280576|P3|Overall Study|Adverse Event|15
1000628|NCT00424476|3280577|P2|Overall Study|Adverse Event|16
1000629|NCT00424476|3280578|P1|Overall Study|Adverse Event|19
1000630|NCT00424476|3280576|P3|Overall Study|Withdrawal by Subject|3
1000631|NCT00424476|3280577|P2|Overall Study|Withdrawal by Subject|6
1000632|NCT00424476|3280578|P1|Overall Study|Withdrawal by Subject|7
1000633|NCT00424463|3280604|P3|Overall Study|Patient’s convenience|1
1000634|NCT00424463|3280605|P2|Overall Study|Patient’s convenience|0
1000635|NCT00424463|3280606|P1|Overall Study|Patient’s convenience|0
1000636|NCT00424463|3280604|P3|Overall Study|Tracheotomy due to worsening of ALS|6
1000637|NCT00424463|3280605|P2|Overall Study|Tracheotomy due to worsening of ALS|7
1000638|NCT00424463|3280606|P1|Overall Study|Tracheotomy due to worsening of ALS|1
1000639|NCT00424463|3280604|P3|Overall Study|Withdrawal by Subject|5
1000640|NCT00424463|3280605|P2|Overall Study|Withdrawal by Subject|2
1000641|NCT00424463|3280606|P1|Overall Study|Withdrawal by Subject|4
1000642|NCT00424463|3280604|P3|Overall Study|Physician Decision|2
1000643|NCT00424463|3280605|P2|Overall Study|Physician Decision|2
1000644|NCT00424463|3280606|P1|Overall Study|Physician Decision|0
1000645|NCT00424463|3280604|P3|Overall Study|Adverse Event|2
1000646|NCT00424463|3280605|P2|Overall Study|Adverse Event|3
1000647|NCT00424463|3280606|P1|Overall Study|Adverse Event|2
1000648|NCT00424398|3280635|P3|Overall Study|Subject met exclusion criteria|0
1000649|NCT00424398|3280636|P2|Overall Study|Subject met exclusion criteria|0
1000650|NCT00424398|3280637|P1|Overall Study|Subject met exclusion criteria|1
1000651|NCT00424398|3280635|P3|Overall Study|Withdrawal by Subject|0
1000652|NCT00424398|3280636|P2|Overall Study|Withdrawal by Subject|1
1000653|NCT00424398|3280637|P1|Overall Study|Withdrawal by Subject|2
1000654|NCT00424385|3280681|P1|Cohort 1|Withdrawal by Subject|1
1000655|NCT00424385|3280681|P1|Cohort 0|Physician Decision|1
1000656|NCT00424385|3280681|P1|Cohort 0|Withdrawal by Subject|5
1000657|NCT00424372|3280688|P1|Overall Study|Lack of Efficacy|6
1000658|NCT00424372|3280688|P1|Overall Study|Protocol Violation|1
1000659|NCT00424372|3280688|P1|Overall Study|Withdrawal by Subject|4
1000660|NCT00424372|3280688|P1|Overall Study|Health deterioration|1
1000661|NCT00424372|3280688|P1|Overall Study|Adverse Event|18
1000662|NCT00424372|3280688|P1|Overall Study|Death|1
1000663|NCT00424346|3280700|P4|Extension Phase|Protocol Violation|0
1000664|NCT00424346|3280701|P3|Extension Phase|Protocol Violation|1
1000665|NCT00424346|3280702|P2|Extension Phase|Protocol Violation|1
1000666|NCT00424346|3280703|P1|Extension Phase|Protocol Violation|0
1000667|NCT00424346|3280700|P4|Extension Phase|Death|1
1000668|NCT00424346|3280701|P3|Extension Phase|Death|0
1000669|NCT00424346|3280702|P2|Extension Phase|Death|0
1000670|NCT00424346|3280703|P1|Extension Phase|Death|0
1000671|NCT00424346|3280700|P4|Extension Phase|Administrative Problems|35
1000672|NCT00424346|3280701|P3|Extension Phase|Administrative Problems|32
1000673|NCT00424346|3280702|P2|Extension Phase|Administrative Problems|69
1000674|NCT00424346|3280703|P1|Extension Phase|Administrative Problems|0
1000675|NCT00424346|3280700|P4|Extension Phase|Lost to Follow-up|0
1000676|NCT00424346|3280701|P3|Extension Phase|Lost to Follow-up|0
1000677|NCT00424346|3280702|P2|Extension Phase|Lost to Follow-up|2
1000678|NCT00424346|3280703|P1|Extension Phase|Lost to Follow-up|0
1000679|NCT00424346|3280700|P4|Extension Phase|Withdrawal by Subject|4
1000680|NCT00424346|3280701|P3|Extension Phase|Withdrawal by Subject|3
1000681|NCT00424346|3280702|P2|Extension Phase|Withdrawal by Subject|5
1000682|NCT00424346|3280703|P1|Extension Phase|Withdrawal by Subject|0
1000683|NCT00424346|3280700|P4|Extension Phase|Lack of Efficacy|11
1000684|NCT00424346|3280701|P3|Extension Phase|Lack of Efficacy|14
1000685|NCT00424346|3280702|P2|Extension Phase|Lack of Efficacy|16
1000686|NCT00424346|3280703|P1|Extension Phase|Lack of Efficacy|0
1000687|NCT00424346|3280700|P4|Extension Phase|Adverse Event|4
1000688|NCT00424346|3280701|P3|Extension Phase|Adverse Event|5
1000689|NCT00424346|3280702|P2|Extension Phase|Adverse Event|9
1000690|NCT00424346|3280703|P1|Extension Phase|Adverse Event|0
1000691|NCT00424346|3280700|P4|Core Study|Protocol Violation|0
1000692|NCT00424346|3280701|P3|Core Study|Protocol Violation|2
1000693|NCT00424346|3280702|P2|Core Study|Protocol Violation|0
1000694|NCT00424346|3280703|P1|Core Study|Protocol Violation|0
1000695|NCT00424346|3280700|P4|Core Study|Administrative Problems|0
1000696|NCT00424346|3280701|P3|Core Study|Administrative Problems|1
1000697|NCT00424346|3280702|P2|Core Study|Administrative Problems|0
1000698|NCT00424346|3280703|P1|Core Study|Administrative Problems|1
1000699|NCT00424346|3280700|P4|Core Study|Lost to Follow-up|0
1000700|NCT00424346|3280701|P3|Core Study|Lost to Follow-up|0
1000701|NCT00424346|3280702|P2|Core Study|Lost to Follow-up|1
1000702|NCT00424346|3280703|P1|Core Study|Lost to Follow-up|1
1000703|NCT00424346|3280700|P4|Core Study|Withdrawal by Subject|2
1000704|NCT00424346|3280701|P3|Core Study|Withdrawal by Subject|0
1000705|NCT00424346|3280702|P2|Core Study|Withdrawal by Subject|0
1000706|NCT00424346|3280703|P1|Core Study|Withdrawal by Subject|1
1000707|NCT00424346|3280700|P4|Core Study|Lack of Efficacy|4
1000708|NCT00424346|3280701|P3|Core Study|Lack of Efficacy|0
1000709|NCT00424346|3280702|P2|Core Study|Lack of Efficacy|3
1000710|NCT00424346|3280703|P1|Core Study|Lack of Efficacy|1
1000711|NCT00424346|3280700|P4|Core Study|Abnormal Laboratory Values|0
1000712|NCT00424346|3280701|P3|Core Study|Abnormal Laboratory Values|0
1000713|NCT00424346|3280702|P2|Core Study|Abnormal Laboratory Values|1
1000714|NCT00424346|3280703|P1|Core Study|Abnormal Laboratory Values|0
1000715|NCT00424346|3280700|P4|Core Study|Adverse Event|1
1000716|NCT00424346|3280701|P3|Core Study|Adverse Event|1
1000717|NCT00424346|3280702|P2|Core Study|Adverse Event|3
1000718|NCT00424346|3280703|P1|Core Study|Adverse Event|5
1000719|NCT00424294|3280818|P2|Overall Study|Randomized but not Treated|0
1000720|NCT00424294|3280819|P1|Overall Study|Randomized but not Treated|1
1000721|NCT00424294|3280818|P2|Overall Study|Other|2
1000722|NCT00424294|3280819|P1|Overall Study|Other|0
1000723|NCT00424294|3280818|P2|Overall Study|Withdrawal by Subject|2
1000724|NCT00424294|3280819|P1|Overall Study|Withdrawal by Subject|1
1000725|NCT00424294|3280818|P2|Overall Study|Lack of Efficacy|1
1000726|NCT00424294|3280819|P1|Overall Study|Lack of Efficacy|2
1000727|NCT00424294|3280818|P2|Overall Study|Adverse Event|10
1000728|NCT00424294|3280819|P1|Overall Study|Adverse Event|4
1000729|NCT00424255|3280886|P2|Overall Study|Sponsor Terminated Study|167
1000730|NCT00424255|3280887|P1|Overall Study|Sponsor Terminated Study|161
1000731|NCT00424255|3280886|P2|Overall Study|Disease Progression|2
1000732|NCT00424255|3280887|P1|Overall Study|Disease Progression|0
1000733|NCT00424255|3280886|P2|Overall Study|Fatigue|0
1000734|NCT00424255|3280887|P1|Overall Study|Fatigue|1
1000735|NCT00424255|3280886|P2|Overall Study|Non-compliance by Participants|0
1000736|NCT00424255|3280887|P1|Overall Study|Non-compliance by Participants|1
1000737|NCT00424255|3280886|P2|Overall Study|Cognitive Disturbance|0
1000738|NCT00424255|3280887|P1|Overall Study|Cognitive Disturbance|1
1000739|NCT00424255|3280886|P2|Overall Study|Physician Decision|7
1000740|NCT00424255|3280887|P1|Overall Study|Physician Decision|3
1000741|NCT00424255|3280886|P2|Overall Study|Withdrawal by Subject|38
1000742|NCT00424255|3280887|P1|Overall Study|Withdrawal by Subject|34
1000743|NCT00424255|3280886|P2|Overall Study|Protocol Violation|1
1000744|NCT00424255|3280887|P1|Overall Study|Protocol Violation|0
1000745|NCT00424255|3280886|P2|Overall Study|Lost to Follow-up|20
1000746|NCT00424255|3280887|P1|Overall Study|Lost to Follow-up|26
1000747|NCT00424255|3280886|P2|Overall Study|Death|111
1000748|NCT00424255|3280887|P1|Overall Study|Death|115
1000749|NCT00424190|3280935|P2|Overall Study|Other|21
1000750|NCT00424190|3280936|P1|Overall Study|Other|15
1000751|NCT00424190|3280935|P2|Overall Study|Diagnosis of osteomyelitis|1
1000752|NCT00424190|3280936|P1|Overall Study|Diagnosis of osteomyelitis|0
1000753|NCT00424190|3280935|P2|Overall Study|Request of sponsor or investigator|2
1000754|NCT00424190|3280936|P1|Overall Study|Request of sponsor or investigator|0
1000755|NCT00424190|3280935|P2|Overall Study|Noncompliance|2
1000756|NCT00424190|3280936|P1|Overall Study|Noncompliance|1
1000757|NCT00424190|3280935|P2|Overall Study|Death|0
1000758|NCT00424190|3280936|P1|Overall Study|Death|3
1000759|NCT00424190|3280935|P2|Overall Study|Withdrew consent|4
1000760|NCT00424190|3280936|P1|Overall Study|Withdrew consent|3
1000761|NCT00424177|3280942|P1|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1
1000762|NCT00424177|3280942|P1|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
1000763|NCT00424177|3280942|P1|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1
1000764|NCT00424177|3280942|P1|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
1000765|NCT00424177|3280942|P1|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1
1000766|NCT00424177|3280942|P1|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2
1000767|NCT00424177|3280942|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1
1000768|NCT00424177|3280942|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1
1000769|NCT00424177|3280942|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1
1000770|NCT00424177|3280942|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8
1000771|NCT00424047|3280971|P2|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0
1000772|NCT00424047|3280972|P1|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1
1000773|NCT00424047|3280971|P2|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3
1000774|NCT00424047|3280972|P1|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7
1000775|NCT00424047|3280971|P2|Long Term Extension (Up to 25 Jun 2013)|Other|4
1000776|NCT00424047|3280972|P1|Long Term Extension (Up to 25 Jun 2013)|Other|12
1000777|NCT00424047|3280971|P2|Long Term Extension (Up to 25 Jun 2013)|Death|1
1000778|NCT00424047|3280972|P1|Long Term Extension (Up to 25 Jun 2013)|Death|0
1000779|NCT00424047|3280971|P2|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0
1000780|NCT00424047|3280972|P1|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1
1000781|NCT00424047|3280971|P2|On Study at Time of Unblinding|Other|4
1000782|NCT00424047|3280972|P1|On Study at Time of Unblinding|Other|5
1000783|NCT00424047|3280971|P2|On Study at Time of Unblinding|Death|11
1000784|NCT00424047|3280972|P1|On Study at Time of Unblinding|Death|11
1000785|NCT00424047|3280971|P2|On Study at Time of Unblinding|Withdrawal by Subject|9
1000786|NCT00424047|3280972|P1|On Study at Time of Unblinding|Withdrawal by Subject|24
1000787|NCT00424047|3280971|P2|On Study at Time of Unblinding|Lack of Efficacy|3
1000788|NCT00424047|3280972|P1|On Study at Time of Unblinding|Lack of Efficacy|1
1000789|NCT00424047|3280971|P2|On Study at Time of Unblinding|Progression of disease|128
1000790|NCT00424047|3280972|P1|On Study at Time of Unblinding|Progression of disease|92
1000791|NCT00424047|3280971|P2|On Study at Time of Unblinding|Adverse Event|12
1000792|NCT00424047|3280972|P1|On Study at Time of Unblinding|Adverse Event|22
1000793|NCT00424047|3280971|P2|Blinded Treatment (Up to 03 Aug 2005)|Other|1
1000794|NCT00424047|3280972|P1|Blinded Treatment (Up to 03 Aug 2005)|Other|2
1000795|NCT00424047|3280971|P2|Blinded Treatment (Up to 03 Aug 2005)|Death|10
1000796|NCT00424047|3280972|P1|Blinded Treatment (Up to 03 Aug 2005)|Death|11
1000797|NCT00424047|3280971|P2|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8
1000798|NCT00424047|3280972|P1|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23
1000799|NCT00424047|3280971|P2|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3
1000800|NCT00424047|3280972|P1|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1
1000801|NCT00424047|3280971|P2|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122
1000802|NCT00424047|3280972|P1|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67
1000803|NCT00424047|3280971|P2|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12
1000804|NCT00424047|3280972|P1|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18
1000805|NCT00424021|3281004|P4|AMB-220-E Study Period|Physician Decision|1
1000806|NCT00424021|3281005|P3|AMB-220-E Study Period|Physician Decision|0
1000807|NCT00424021|3281006|P2|AMB-220-E Study Period|Physician Decision|0
1000808|NCT00424021|3281007|P1|AMB-220-E Study Period|Physician Decision|0
1000809|NCT00424021|3281004|P4|AMB-220-E Study Period|Lost to Follow-up|1
1000810|NCT00424021|3281005|P3|AMB-220-E Study Period|Lost to Follow-up|1
1000811|NCT00424021|3281006|P2|AMB-220-E Study Period|Lost to Follow-up|1
1000812|NCT00424021|3281007|P1|AMB-220-E Study Period|Lost to Follow-up|0
1000813|NCT00424021|3281004|P4|AMB-220-E Study Period|Death|1
1000814|NCT00424021|3281005|P3|AMB-220-E Study Period|Death|1
1000815|NCT00424021|3281006|P2|AMB-220-E Study Period|Death|0
1000816|NCT00424021|3281007|P1|AMB-220-E Study Period|Death|0
1000817|NCT00424021|3281004|P4|AMB-220-E Study Period|Adverse Event|7
1000818|NCT00424021|3281005|P3|AMB-220-E Study Period|Adverse Event|3
1000819|NCT00424021|3281006|P2|AMB-220-E Study Period|Adverse Event|1
1000820|NCT00424021|3281007|P1|AMB-220-E Study Period|Adverse Event|1
1000821|NCT00424021|3281004|P4|NCT00046319 Study Period|Lost to Follow-up|0
1000822|NCT00424021|3281005|P3|NCT00046319 Study Period|Lost to Follow-up|0
1000823|NCT00424021|3281006|P2|NCT00046319 Study Period|Lost to Follow-up|1
1000824|NCT00424021|3281007|P1|NCT00046319 Study Period|Lost to Follow-up|0
1000825|NCT00424021|3281004|P4|NCT00046319 Study Period|Sponsor discretion|0
1000826|NCT00424021|3281005|P3|NCT00046319 Study Period|Sponsor discretion|0
1000827|NCT00424021|3281006|P2|NCT00046319 Study Period|Sponsor discretion|1
1000828|NCT00424021|3281007|P1|NCT00046319 Study Period|Sponsor discretion|0
1000829|NCT00424021|3281004|P4|NCT00046319 Study Period|Withdrawal by Subject|0
1000830|NCT00424021|3281005|P3|NCT00046319 Study Period|Withdrawal by Subject|0
1000831|NCT00424021|3281006|P2|NCT00046319 Study Period|Withdrawal by Subject|1
1000832|NCT00424021|3281007|P1|NCT00046319 Study Period|Withdrawal by Subject|0
1000833|NCT00424021|3281004|P4|NCT00046319 Study Period|Adverse Event|1
1000834|NCT00424021|3281005|P3|NCT00046319 Study Period|Adverse Event|1
1000835|NCT00424021|3281006|P2|NCT00046319 Study Period|Adverse Event|0
1000836|NCT00424021|3281007|P1|NCT00046319 Study Period|Adverse Event|1
1000837|NCT00424008|3281050|P2|Overall Study|Administrative|257
1000838|NCT00424008|3281051|P1|Overall Study|Administrative|266
1000839|NCT00424008|3281050|P2|Overall Study|Did not meet protocol eligibility|21
1000840|NCT00424008|3281051|P1|Overall Study|Did not meet protocol eligibility|16
1000841|NCT00424008|3281050|P2|Overall Study|Noncompliance with protocol|7
1000842|NCT00424008|3281051|P1|Overall Study|Noncompliance with protocol|13
1000843|NCT00424008|3281050|P2|Overall Study|Withdrawal by Subject|8
1000844|NCT00424008|3281051|P1|Overall Study|Withdrawal by Subject|5
1000845|NCT00424008|3281050|P2|Overall Study|Lost to Follow-up|2
1000846|NCT00424008|3281051|P1|Overall Study|Lost to Follow-up|1
1000847|NCT00424008|3281050|P2|Overall Study|Lack of Efficacy|34
1000848|NCT00424008|3281051|P1|Overall Study|Lack of Efficacy|40
1000849|NCT00424008|3281050|P2|Overall Study|Adverse Event|6
1000850|NCT00424008|3281051|P1|Overall Study|Adverse Event|8
1000851|NCT00423943|3281066|P2|Overall Study|Withdrawal by Subject|1
1000852|NCT00423943|3281067|P1|Overall Study|Withdrawal by Subject|3
1000853|NCT00423930|3281081|P1|Overall Study|Withdrawal by Subject|2
1000854|NCT00423917|3281086|P1|Overall Study|Ineligible|1
1000855|NCT00423917|3281086|P1|Overall Study|Cancel|2
1000856|NCT00423891|3281099|P3|Post-Dosing Follow Up|Lost to Follow-up|0
1000857|NCT00423891|3281100|P2|Post-Dosing Follow Up|Lost to Follow-up|0
1000858|NCT00423891|3281101|P1|Post-Dosing Follow Up|Lost to Follow-up|2
1000859|NCT00423891|3281099|P3|Post-Dosing Follow Up|Withdrawal by Subject|2
1000860|NCT00423891|3281100|P2|Post-Dosing Follow Up|Withdrawal by Subject|3
1000861|NCT00423891|3281101|P1|Post-Dosing Follow Up|Withdrawal by Subject|0
1000862|NCT00423891|3281099|P3|Treatment|Lost to Follow-up|0
1000863|NCT00423891|3281100|P2|Treatment|Lost to Follow-up|0
1000864|NCT00423891|3281101|P1|Treatment|Lost to Follow-up|1
1000865|NCT00423891|3281099|P3|Treatment|Withdrawal by Subject|0
1000866|NCT00423891|3281100|P2|Treatment|Withdrawal by Subject|0
1000867|NCT00423891|3281101|P1|Treatment|Withdrawal by Subject|1
1000868|NCT00423891|3281099|P3|Enrolled|No longer met criteria|1
1000869|NCT00423891|3281100|P2|Enrolled|No longer met criteria|2
1000870|NCT00423891|3281101|P1|Enrolled|No longer met criteria|11
1000871|NCT00423891|3281099|P3|Enrolled|Lost to Follow-up|1
1000872|NCT00423891|3281100|P2|Enrolled|Lost to Follow-up|0
1000873|NCT00423891|3281101|P1|Enrolled|Lost to Follow-up|0
1000874|NCT00423891|3281099|P3|Enrolled|Withdrawal by Subject|1
1000875|NCT00423891|3281100|P2|Enrolled|Withdrawal by Subject|0
1000876|NCT00423891|3281101|P1|Enrolled|Withdrawal by Subject|0
1000877|NCT00423852|3281179|P1|Overall Study|Removed pior to the high-dose portion|3
1000878|NCT00423813|3281187|P3|Overall Study|Undergoing tests for Cushings Syndrome|1
1000879|NCT00423813|3281188|P2|Overall Study|Undergoing tests for Cushings Syndrome|0
1000880|NCT00423813|3281189|P1|Overall Study|Undergoing tests for Cushings Syndrome|0
1000881|NCT00423813|3281187|P3|Overall Study|Will start exclusionary medications|0
1000882|NCT00423813|3281188|P2|Overall Study|Will start exclusionary medications|1
1000883|NCT00423813|3281189|P1|Overall Study|Will start exclusionary medications|0
1000884|NCT00423813|3281187|P3|Overall Study|Subject started night shift work|0
1000885|NCT00423813|3281188|P2|Overall Study|Subject started night shift work|0
1000886|NCT00423813|3281189|P1|Overall Study|Subject started night shift work|1
1000887|NCT00423813|3281187|P3|Overall Study|Pregnancy|1
1000888|NCT00423813|3281188|P2|Overall Study|Pregnancy|0
1000889|NCT00423813|3281189|P1|Overall Study|Pregnancy|0
1000890|NCT00423813|3281187|P3|Overall Study|Protocol Violation|4
1000891|NCT00423813|3281188|P2|Overall Study|Protocol Violation|4
1000892|NCT00423813|3281189|P1|Overall Study|Protocol Violation|9
1000893|NCT00423813|3281187|P3|Overall Study|Sponsor Decision|0
1000894|NCT00423813|3281188|P2|Overall Study|Sponsor Decision|1
1000895|NCT00423813|3281189|P1|Overall Study|Sponsor Decision|0
1000896|NCT00423813|3281187|P3|Overall Study|Physician Decision|0
1000897|NCT00423813|3281188|P2|Overall Study|Physician Decision|0
1000898|NCT00423813|3281189|P1|Overall Study|Physician Decision|2
1000899|NCT00423813|3281187|P3|Overall Study|Lack of Efficacy|19
1000900|NCT00423813|3281188|P2|Overall Study|Lack of Efficacy|18
1000901|NCT00423813|3281189|P1|Overall Study|Lack of Efficacy|23
1000902|NCT00423813|3281187|P3|Overall Study|Lost to Follow-up|4
1000903|NCT00423813|3281188|P2|Overall Study|Lost to Follow-up|4
1000904|NCT00423813|3281189|P1|Overall Study|Lost to Follow-up|5
1000905|NCT00423813|3281187|P3|Overall Study|Withdrawal by Subject|5
1000906|NCT00423813|3281188|P2|Overall Study|Withdrawal by Subject|8
1000907|NCT00423813|3281189|P1|Overall Study|Withdrawal by Subject|6
1000908|NCT00423813|3281187|P3|Overall Study|Adverse Event|40
1000909|NCT00423813|3281188|P2|Overall Study|Adverse Event|30
1000910|NCT00423813|3281189|P1|Overall Study|Adverse Event|11
1000911|NCT00423800|3281199|P2|Overall Study|Protocol Violation|1
1000912|NCT00423800|3281200|P1|Overall Study|Protocol Violation|0
1000913|NCT00423735|3281212|P3|Overall Study|Ineligible / No protocol treatment|0
1000914|NCT00423735|3281213|P2|Overall Study|Ineligible / No protocol treatment|6
1000915|NCT00423735|3281214|P1|Overall Study|Ineligible / No protocol treatment|8
1000916|NCT00423722|3281237|P2|Overall Study|Withdrawal by Subject|2
1000917|NCT00423722|3281238|P1|Overall Study|Withdrawal by Subject|4
1000918|NCT00423722|3281237|P2|Overall Study|Unable to complete questionnaires|4
1000919|NCT00423722|3281238|P1|Overall Study|Unable to complete questionnaires|4
1000920|NCT00423722|3281237|P2|Overall Study|Declined to participate|3
1000921|NCT00423722|3281238|P1|Overall Study|Declined to participate|2
1000922|NCT00423722|3281237|P2|Overall Study|Death|4
1000923|NCT00423722|3281238|P1|Overall Study|Death|4
1000924|NCT00423670|3281280|P8|Follow-up Period|Non-compliance with protocol|2
1000925|NCT00423670|3281281|P7|Follow-up Period|Non-compliance with protocol|3
1000926|NCT00423670|3281282|P6|Follow-up Period|Non-compliance with protocol|0
1000927|NCT00423670|3281283|P5|Follow-up Period|Non-compliance with protocol|0
1000928|NCT00423670|3281284|P4|Follow-up Period|Non-compliance with protocol|1
1000929|NCT00423670|3281285|P3|Follow-up Period|Non-compliance with protocol|1
1000930|NCT00423670|3281286|P2|Follow-up Period|Non-compliance with protocol|0
1000931|NCT00423670|3281287|P1|Follow-up Period|Non-compliance with protocol|2
1000932|NCT00423670|3281280|P8|Follow-up Period|Subject withdrew (not treatment related)|1
1000933|NCT00423670|3281281|P7|Follow-up Period|Subject withdrew (not treatment related)|1
1000934|NCT00423670|3281282|P6|Follow-up Period|Subject withdrew (not treatment related)|0
1000935|NCT00423670|3281283|P5|Follow-up Period|Subject withdrew (not treatment related)|1
1000936|NCT00423670|3281284|P4|Follow-up Period|Subject withdrew (not treatment related)|1
1000937|NCT00423670|3281285|P3|Follow-up Period|Subject withdrew (not treatment related)|2
1000938|NCT00423670|3281286|P2|Follow-up Period|Subject withdrew (not treatment related)|4
1000939|NCT00423670|3281287|P1|Follow-up Period|Subject withdrew (not treatment related)|1
1000940|NCT00423670|3281280|P8|Follow-up Period|Lost to Follow-up|0
1000941|NCT00423670|3281281|P7|Follow-up Period|Lost to Follow-up|5
1000942|NCT00423670|3281282|P6|Follow-up Period|Lost to Follow-up|0
1000943|NCT00423670|3281283|P5|Follow-up Period|Lost to Follow-up|1
1000944|NCT00423670|3281284|P4|Follow-up Period|Lost to Follow-up|3
1000945|NCT00423670|3281285|P3|Follow-up Period|Lost to Follow-up|8
1000946|NCT00423670|3281286|P2|Follow-up Period|Lost to Follow-up|12
1000947|NCT00423670|3281287|P1|Follow-up Period|Lost to Follow-up|0
1000948|NCT00423670|3281280|P8|Treatment Period|Non-compliance with protocol|2
1000949|NCT00423670|3281281|P7|Treatment Period|Non-compliance with protocol|2
1000950|NCT00423670|3281282|P6|Treatment Period|Non-compliance with protocol|0
1000951|NCT00423670|3281283|P5|Treatment Period|Non-compliance with protocol|2
1000952|NCT00423670|3281284|P4|Treatment Period|Non-compliance with protocol|3
1000953|NCT00423670|3281285|P3|Treatment Period|Non-compliance with protocol|1
1000954|NCT00423670|3281286|P2|Treatment Period|Non-compliance with protocol|1
1000955|NCT00423670|3281287|P1|Treatment Period|Non-compliance with protocol|3
1000956|NCT00423670|3281280|P8|Treatment Period|Investigator decision|1
1000957|NCT00423670|3281281|P7|Treatment Period|Investigator decision|0
1000958|NCT00423670|3281282|P6|Treatment Period|Investigator decision|0
1000959|NCT00423670|3281283|P5|Treatment Period|Investigator decision|0
1000960|NCT00423670|3281284|P4|Treatment Period|Investigator decision|0
1000961|NCT00423670|3281285|P3|Treatment Period|Investigator decision|0
1000962|NCT00423670|3281286|P2|Treatment Period|Investigator decision|0
1000963|NCT00423670|3281287|P1|Treatment Period|Investigator decision|0
1000964|NCT00423670|3281280|P8|Treatment Period|Subject withdrew (not treatment related)|0
1000965|NCT00423670|3281281|P7|Treatment Period|Subject withdrew (not treatment related)|3
1000966|NCT00423670|3281282|P6|Treatment Period|Subject withdrew (not treatment related)|0
1000967|NCT00423670|3281283|P5|Treatment Period|Subject withdrew (not treatment related)|5
1000968|NCT00423670|3281284|P4|Treatment Period|Subject withdrew (not treatment related)|4
1000969|NCT00423670|3281285|P3|Treatment Period|Subject withdrew (not treatment related)|4
1000970|NCT00423670|3281286|P2|Treatment Period|Subject withdrew (not treatment related)|9
1000971|NCT00423670|3281287|P1|Treatment Period|Subject withdrew (not treatment related)|3
1000972|NCT00423670|3281280|P8|Treatment Period|Lost to Follow-up|1
1000973|NCT00423670|3281281|P7|Treatment Period|Lost to Follow-up|3
1000974|NCT00423670|3281282|P6|Treatment Period|Lost to Follow-up|0
1000975|NCT00423670|3281283|P5|Treatment Period|Lost to Follow-up|6
1000976|NCT00423670|3281284|P4|Treatment Period|Lost to Follow-up|1
1000977|NCT00423670|3281285|P3|Treatment Period|Lost to Follow-up|3
1000978|NCT00423670|3281286|P2|Treatment Period|Lost to Follow-up|1
1000979|NCT00423670|3281287|P1|Treatment Period|Lost to Follow-up|2
1000980|NCT00423670|3281280|P8|Treatment Period|Protocol-defined clinical event|15
1000981|NCT00423670|3281281|P7|Treatment Period|Protocol-defined clinical event|16
1000982|NCT00423670|3281282|P6|Treatment Period|Protocol-defined clinical event|4
1000983|NCT00423670|3281283|P5|Treatment Period|Protocol-defined clinical event|5
1000984|NCT00423670|3281284|P4|Treatment Period|Protocol-defined clinical event|12
1000985|NCT00423670|3281285|P3|Treatment Period|Protocol-defined clinical event|4
1000986|NCT00423670|3281286|P2|Treatment Period|Protocol-defined clinical event|7
1000987|NCT00423670|3281287|P1|Treatment Period|Protocol-defined clinical event|0
1000988|NCT00423670|3281280|P8|Treatment Period|Adverse Event|2
1000989|NCT00423670|3281281|P7|Treatment Period|Adverse Event|7
1000990|NCT00423670|3281282|P6|Treatment Period|Adverse Event|4
1000991|NCT00423670|3281283|P5|Treatment Period|Adverse Event|9
1000992|NCT00423670|3281284|P4|Treatment Period|Adverse Event|20
1000993|NCT00423670|3281285|P3|Treatment Period|Adverse Event|15
1000994|NCT00423670|3281286|P2|Treatment Period|Adverse Event|12
1000995|NCT00423670|3281287|P1|Treatment Period|Adverse Event|8
1000996|NCT00423670|3281280|P8|Treatment Period|Switched to Arm 8 at TW 24|0
1000997|NCT00423670|3281281|P7|Treatment Period|Switched to Arm 8 at TW 24|0
1000998|NCT00423670|3281282|P6|Treatment Period|Switched to Arm 8 at TW 24|0
1000999|NCT00423670|3281283|P5|Treatment Period|Switched to Arm 8 at TW 24|0
1001000|NCT00423670|3281284|P4|Treatment Period|Switched to Arm 8 at TW 24|0
1001001|NCT00423670|3281285|P3|Treatment Period|Switched to Arm 8 at TW 24|0
1001002|NCT00423670|3281286|P2|Treatment Period|Switched to Arm 8 at TW 24|0
1001003|NCT00423670|3281287|P1|Treatment Period|Switched to Arm 8 at TW 24|36
1001004|NCT00423657|3281345|P2|Overall Study|Request of sponsor/investigator|0
1001005|NCT00423657|3281346|P1|Overall Study|Request of sponsor/investigator|1
1001006|NCT00423657|3281345|P2|Overall Study|Other|16
1001007|NCT00423657|3281346|P1|Overall Study|Other|15
1001008|NCT00423657|3281345|P2|Overall Study|Non-compliance|1
1001009|NCT00423657|3281346|P1|Overall Study|Non-compliance|0
1001010|NCT00423657|3281345|P2|Overall Study|Withdrew consent|8
1001011|NCT00423657|3281346|P1|Overall Study|Withdrew consent|10
1001012|NCT00423605|3281352|P1|Overall Study|Not one of the pre-specified options|5
1001013|NCT00423605|3281352|P1|Overall Study|Protocol Violation|7
1001014|NCT00423605|3281352|P1|Overall Study|Physician Decision|8
1001015|NCT00423605|3281352|P1|Overall Study|Sponsor Decision|3
1001016|NCT00423605|3281352|P1|Overall Study|Lack of Efficacy|38
1001017|NCT00423605|3281352|P1|Overall Study|Lost to Follow-up|15
1001018|NCT00423605|3281352|P1|Overall Study|Withdrawal by Subject|36
1001019|NCT00423605|3281352|P1|Overall Study|Adverse Event|129
1001020|NCT00423592|3281356|P1|Overall Study|Adverse Event (post Week 12)|5
1001021|NCT00423592|3281356|P1|Overall Study|Adverse Event (through Week 12)|2
1001022|NCT00423579|3281377|P2|Overall Study|Diagnosis of diabetes|1
1001023|NCT00423579|3281378|P1|Overall Study|Diagnosis of diabetes|0
1001024|NCT00423579|3281377|P2|Overall Study|Protocol Violation|3
1001025|NCT00423579|3281378|P1|Overall Study|Protocol Violation|1
1001026|NCT00423579|3281377|P2|Overall Study|Lost to Follow-up|0
1001027|NCT00423579|3281378|P1|Overall Study|Lost to Follow-up|3
1001028|NCT00423488|3281386|P2|Overall Study|No post baseline data|0
1001029|NCT00423488|3281387|P1|Overall Study|No post baseline data|3
1001030|NCT00423488|3281386|P2|Overall Study|No evidence of study drug intake|1
1001031|NCT00423488|3281387|P1|Overall Study|No evidence of study drug intake|2
1001032|NCT00423449|3281393|P5|Overall Study|Protocol Violation|0
1001033|NCT00423449|3281394|P4|Overall Study|Protocol Violation|1
1001034|NCT00423449|3281395|P3|Overall Study|Protocol Violation|2
1001035|NCT00423449|3281396|P2|Overall Study|Protocol Violation|0
1001036|NCT00423449|3281397|P1|Overall Study|Protocol Violation|0
1001037|NCT00423449|3281393|P5|Overall Study|Not Specified|0
1001038|NCT00423449|3281394|P4|Overall Study|Not Specified|1
1001039|NCT00423449|3281395|P3|Overall Study|Not Specified|0
1001040|NCT00423449|3281396|P2|Overall Study|Not Specified|0
1001041|NCT00423449|3281397|P1|Overall Study|Not Specified|0
1001042|NCT00423449|3281393|P5|Overall Study|Laboratory Adverse Event|0
1001043|NCT00423449|3281394|P4|Overall Study|Laboratory Adverse Event|0
1001044|NCT00423449|3281395|P3|Overall Study|Laboratory Adverse Event|2
1001045|NCT00423449|3281396|P2|Overall Study|Laboratory Adverse Event|1
1001046|NCT00423449|3281397|P1|Overall Study|Laboratory Adverse Event|0
1001047|NCT00423449|3281393|P5|Overall Study|Progressive Disease|4
1001048|NCT00423449|3281394|P4|Overall Study|Progressive Disease|11
1001049|NCT00423449|3281395|P3|Overall Study|Progressive Disease|8
1001050|NCT00423449|3281396|P2|Overall Study|Progressive Disease|3
1001051|NCT00423449|3281397|P1|Overall Study|Progressive Disease|1
1001052|NCT00423449|3281393|P5|Overall Study|Death|1
1001053|NCT00423449|3281394|P4|Overall Study|Death|1
1001054|NCT00423449|3281395|P3|Overall Study|Death|2
1001055|NCT00423449|3281396|P2|Overall Study|Death|0
1001056|NCT00423449|3281397|P1|Overall Study|Death|1
1001057|NCT00423449|3281393|P5|Overall Study|Clinical Adverse Event|2
1001058|NCT00423449|3281394|P4|Overall Study|Clinical Adverse Event|8
1001059|NCT00423449|3281395|P3|Overall Study|Clinical Adverse Event|1
1001060|NCT00423449|3281396|P2|Overall Study|Clinical Adverse Event|0
1001061|NCT00423449|3281397|P1|Overall Study|Clinical Adverse Event|1
1001062|NCT00423332|3281444|P2|Overall Study|Unblinded before 12 weeks|3
1001063|NCT00423332|3281445|P1|Overall Study|Unblinded before 12 weeks|1
1001064|NCT00423332|3281444|P2|Overall Study|Progressive at Week 6|1
1001065|NCT00423332|3281445|P1|Overall Study|Progressive at Week 6|0
1001066|NCT00423332|3281444|P2|Overall Study|Condition under investigation worsened|1
1001067|NCT00423332|3281445|P1|Overall Study|Condition under investigation worsened|1
1001068|NCT00423332|3281444|P2|Overall Study|Withdrawal by Subject|0
1001069|NCT00423332|3281445|P1|Overall Study|Withdrawal by Subject|1
1001070|NCT00423332|3281444|P2|Overall Study|Adverse Event|2
1001071|NCT00423332|3281445|P1|Overall Study|Adverse Event|6
1001072|NCT00423319|3281464|P2|Overall Study|Not specified|22
1001073|NCT00423319|3281465|P1|Overall Study|Not specified|23
1001074|NCT00423319|3281464|P2|Overall Study|No longer meets study criteria|15
1001075|NCT00423319|3281465|P1|Overall Study|No longer meets study criteria|15
1001076|NCT00423319|3281464|P2|Overall Study|Poor compliance or noncompliance|1
1001077|NCT00423319|3281465|P1|Overall Study|Poor compliance or noncompliance|1
1001078|NCT00423319|3281464|P2|Overall Study|Lost to Follow-up|3
1001079|NCT00423319|3281465|P1|Overall Study|Lost to Follow-up|4
1001080|NCT00423319|3281464|P2|Overall Study|Withdrawal by Subject|99
1001081|NCT00423319|3281465|P1|Overall Study|Withdrawal by Subject|86
1001082|NCT00423319|3281464|P2|Overall Study|Adverse Event|112
1001083|NCT00423319|3281465|P1|Overall Study|Adverse Event|93
1001084|NCT00423319|3281464|P2|Overall Study|Death|0
1001085|NCT00423319|3281465|P1|Overall Study|Death|2
1001086|NCT00423293|3281497|P1|Overall Study|Ineligible / No protocol treatment|11
1001087|NCT00423267|3281503|P2|Period A|Administrative|0
1001088|NCT00423267|3281504|P1|Period A|Administrative|1
1001089|NCT00423267|3281503|P2|Period A|Non-compliance with protocol|0
1001090|NCT00423267|3281504|P1|Period A|Non-compliance with protocol|1
1001091|NCT00423267|3281503|P2|Period A|Withdrawal by Subject|1
1001092|NCT00423267|3281504|P1|Period A|Withdrawal by Subject|0
1001093|NCT00423189|3281524|P3|Overall Study|Death|0
1001094|NCT00423189|3281525|P2|Overall Study|Death|1
1001095|NCT00423189|3281526|P1|Overall Study|Death|0
1001096|NCT00423176|3281548|P2|Overall Study|Did not meet protocol eligibility|4
1001097|NCT00423176|3281549|P1|Overall Study|Did not meet protocol eligibility|2
1001098|NCT00423176|3281548|P2|Overall Study|Protocol Violation|3
1001099|NCT00423176|3281549|P1|Overall Study|Protocol Violation|1
1001100|NCT00423176|3281548|P2|Overall Study|Withdrawal by Subject|3
1001101|NCT00423176|3281549|P1|Overall Study|Withdrawal by Subject|4
1001102|NCT00423176|3281548|P2|Overall Study|Lost to Follow-up|7
1001103|NCT00423176|3281549|P1|Overall Study|Lost to Follow-up|4
1001104|NCT00423176|3281548|P2|Overall Study|Treatment Failure|6
1001105|NCT00423176|3281549|P1|Overall Study|Treatment Failure|1
1001106|NCT00423176|3281548|P2|Overall Study|Adverse Event|6
1001107|NCT00423176|3281549|P1|Overall Study|Adverse Event|4
1001108|NCT00423150|3281557|P1|Overall Study|Administrative|4
1001109|NCT00423150|3281557|P1|Overall Study|Non-compliance with protocol|1
1001110|NCT00423150|3281557|P1|Overall Study|Withdrawal by Subject|1
1001111|NCT00423150|3281557|P1|Overall Study|Progression of disease being studied|69
1001112|NCT00423150|3281557|P1|Overall Study|Adverse Event|11
1001113|NCT00423098|3281563|P2|Overall Study|Death|0
1001114|NCT00423098|3281564|P1|Overall Study|Death|2
1001115|NCT00423098|3281563|P2|Overall Study|Administrative problems|1
1001116|NCT00423098|3281564|P1|Overall Study|Administrative problems|0
1001117|NCT00423098|3281563|P2|Overall Study|Unsatisfactory therapeutic effect|1
1001118|NCT00423098|3281564|P1|Overall Study|Unsatisfactory therapeutic effect|0
1001119|NCT00423098|3281563|P2|Overall Study|Adverse Event|2
1001120|NCT00423098|3281564|P1|Overall Study|Adverse Event|1
1001121|NCT00423085|3281591|P4|52-Week Open-Label Extension Phase|Death|2
1001122|NCT00423085|3281592|P3|52-Week Open-Label Extension Phase|Death|0
1001123|NCT00423085|3281593|P2|52-Week Open-Label Extension Phase|Death|0
1001124|NCT00423085|3281594|P1|52-Week Open-Label Extension Phase|Death|0
1001125|NCT00423085|3281591|P4|52-Week Open-Label Extension Phase|Protocol deviation|9
1001126|NCT00423085|3281592|P3|52-Week Open-Label Extension Phase|Protocol deviation|0
1001127|NCT00423085|3281593|P2|52-Week Open-Label Extension Phase|Protocol deviation|0
1001128|NCT00423085|3281594|P1|52-Week Open-Label Extension Phase|Protocol deviation|0
1001129|NCT00423085|3281591|P4|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18
1001130|NCT00423085|3281592|P3|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
1001131|NCT00423085|3281593|P2|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
1001132|NCT00423085|3281594|P1|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
1001133|NCT00423085|3281591|P4|52-Week Open-Label Extension Phase|Withdrawal by Subject|37
1001134|NCT00423085|3281592|P3|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
1001135|NCT00423085|3281593|P2|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
1001136|NCT00423085|3281594|P1|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
1001137|NCT00423085|3281591|P4|52-Week Open-Label Extension Phase|Adverse Event|97
1001138|NCT00423085|3281592|P3|52-Week Open-Label Extension Phase|Adverse Event|0
1001139|NCT00423085|3281593|P2|52-Week Open-Label Extension Phase|Adverse Event|0
1001140|NCT00423085|3281594|P1|52-Week Open-Label Extension Phase|Adverse Event|0
1001141|NCT00423085|3281591|P4|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
1001142|NCT00423085|3281592|P3|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
1001143|NCT00423085|3281593|P2|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
1001144|NCT00423085|3281594|P1|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1
1001145|NCT00423085|3281591|P4|24-Week Double-Blind Treatment Phase|Death|0
1001146|NCT00423085|3281592|P3|24-Week Double-Blind Treatment Phase|Death|0
1001147|NCT00423085|3281593|P2|24-Week Double-Blind Treatment Phase|Death|1
1001148|NCT00423085|3281594|P1|24-Week Double-Blind Treatment Phase|Death|1
1001149|NCT00423085|3281591|P4|24-Week Double-Blind Treatment Phase|Protocol Violation|0
1001150|NCT00423085|3281592|P3|24-Week Double-Blind Treatment Phase|Protocol Violation|7
1001151|NCT00423085|3281593|P2|24-Week Double-Blind Treatment Phase|Protocol Violation|3
1001152|NCT00423085|3281594|P1|24-Week Double-Blind Treatment Phase|Protocol Violation|8
1001153|NCT00423085|3281591|P4|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
1001154|NCT00423085|3281592|P3|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
1001155|NCT00423085|3281593|P2|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6
1001156|NCT00423085|3281594|P1|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
1001157|NCT00423085|3281591|P4|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0
1001158|NCT00423085|3281592|P3|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11
1001159|NCT00423085|3281593|P2|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16
1001160|NCT00423085|3281594|P1|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8
1001161|NCT00423085|3281591|P4|24-Week Double-Blind Treatment Phase|Adverse Event|0
1001162|NCT00423085|3281592|P3|24-Week Double-Blind Treatment Phase|Adverse Event|34
1001163|NCT00423085|3281593|P2|24-Week Double-Blind Treatment Phase|Adverse Event|38
1001164|NCT00423085|3281594|P1|24-Week Double-Blind Treatment Phase|Adverse Event|21
1001165|NCT00423046|3281623|P2|Overall Study|Other|345
1001166|NCT00423046|3281624|P1|Overall Study|Other|340
1001167|NCT00422942|3281690|P1|Overall Study|Study terminated by Sponsor|3
1001168|NCT00422903|3281709|P2|Overall Study|Informed Consent Withdrawn|2
1001169|NCT00422903|3281710|P1|Overall Study|Informed Consent Withdrawn|1
1001170|NCT00422903|3281709|P2|Overall Study|Adverse Event|2
1001171|NCT00422903|3281710|P1|Overall Study|Adverse Event|0
1001172|NCT00422903|3281709|P2|Overall Study|Disease Progression|1
1001173|NCT00422903|3281710|P1|Overall Study|Disease Progression|3
1001174|NCT00422799|3281759|P1|Overall Study|Adverse Event|7
1001175|NCT00422799|3281759|P1|Overall Study|Withdrawal by Subject|6
1001176|NCT00422734|3281768|P2|Overall Study|Partner Decision|3
1001177|NCT00422734|3281769|P1|Overall Study|Partner Decision|0
1001178|NCT00422734|3281768|P2|Overall Study|Adverse Event|3
1001179|NCT00422734|3281769|P1|Overall Study|Adverse Event|0
1001180|NCT00422734|3281768|P2|Overall Study|Withdrawal by Subject|8
1001181|NCT00422734|3281769|P1|Overall Study|Withdrawal by Subject|12
1001182|NCT00422734|3281768|P2|Overall Study|Protocol Violation|6
1001183|NCT00422734|3281769|P1|Overall Study|Protocol Violation|1
1001184|NCT00422734|3281768|P2|Overall Study|Physician Decision|1
1001185|NCT00422734|3281769|P1|Overall Study|Physician Decision|1
1001186|NCT00422669|3281815|P3|Overall Study|The study was terminated early.|7
1001187|NCT00422669|3281816|P2|Overall Study|The study was terminated early.|100
1001188|NCT00422669|3281817|P1|Overall Study|The study was terminated early.|98
1001189|NCT00422591|3281845|P1|Overall Study|Withdrawal by Subject|2
1001190|NCT00422591|3281845|P1|Overall Study|Physician Decision|4
1001191|NCT00422513|3281853|P2|Overall Study|Death|7
1001192|NCT00422513|3281854|P1|Overall Study|Death|3
1001193|NCT00422513|3281853|P2|Overall Study|Adverse Event|4
1001194|NCT00422513|3281854|P1|Overall Study|Adverse Event|4
1001195|NCT00422513|3281853|P2|Overall Study|early termination of the study|80
1001196|NCT00422513|3281854|P1|Overall Study|early termination of the study|67
1001197|NCT00422513|3281853|P2|Overall Study|Withdrawal by Subject|1
1001198|NCT00422513|3281854|P1|Overall Study|Withdrawal by Subject|2
1001199|NCT00422513|3281853|P2|Overall Study|Refused Treatment|2
1001200|NCT00422513|3281854|P1|Overall Study|Refused Treatment|4
1001201|NCT00422513|3281853|P2|Overall Study|Protocol Violation|7
1001202|NCT00422513|3281854|P1|Overall Study|Protocol Violation|23
1001203|NCT00422513|3281853|P2|Overall Study|Lack of Efficacy|5
1001204|NCT00422513|3281854|P1|Overall Study|Lack of Efficacy|4
1001205|NCT00422422|3281871|P1|Overall Study|AE, non-serious non-fatal|5
1001206|NCT00422422|3281871|P1|Overall Study|SAE, non-fatal|1
1001207|NCT00422422|3281871|P1|Overall Study|Withdrawal by Subject|2
1001208|NCT00422422|3281871|P1|Overall Study|Protocol Violation|1
1001209|NCT00422422|3281871|P1|Overall Study|Lack of Efficacy|1
1001210|NCT00422383|3281888|P5|Overall Study|Withdrawal by Subject|1
1001211|NCT00422383|3281889|P4|Overall Study|Withdrawal by Subject|0
1001212|NCT00422383|3281890|P3|Overall Study|Withdrawal by Subject|0
1001213|NCT00422383|3281891|P2|Overall Study|Withdrawal by Subject|5
1001214|NCT00422383|3281892|P1|Overall Study|Withdrawal by Subject|5
1001215|NCT00422383|3281888|P5|Overall Study|Protocol Violation|0
1001216|NCT00422383|3281889|P4|Overall Study|Protocol Violation|0
1001217|NCT00422383|3281890|P3|Overall Study|Protocol Violation|1
1001218|NCT00422383|3281891|P2|Overall Study|Protocol Violation|1
1001219|NCT00422383|3281892|P1|Overall Study|Protocol Violation|1
1001220|NCT00422383|3281888|P5|Overall Study|Lost to Follow-up|1
1001221|NCT00422383|3281889|P4|Overall Study|Lost to Follow-up|0
1001222|NCT00422383|3281890|P3|Overall Study|Lost to Follow-up|0
1001223|NCT00422383|3281891|P2|Overall Study|Lost to Follow-up|1
1001224|NCT00422383|3281892|P1|Overall Study|Lost to Follow-up|0
1001225|NCT00422383|3281888|P5|Overall Study|Lack of Efficacy|1
1001226|NCT00422383|3281889|P4|Overall Study|Lack of Efficacy|1
1001227|NCT00422383|3281890|P3|Overall Study|Lack of Efficacy|2
1001228|NCT00422383|3281891|P2|Overall Study|Lack of Efficacy|4
1001229|NCT00422383|3281892|P1|Overall Study|Lack of Efficacy|4
1001230|NCT00422383|3281888|P5|Overall Study|Adverse Event|0
1001231|NCT00422383|3281889|P4|Overall Study|Adverse Event|1
1001232|NCT00422383|3281890|P3|Overall Study|Adverse Event|1
1001233|NCT00422383|3281891|P2|Overall Study|Adverse Event|3
1001234|NCT00422383|3281892|P1|Overall Study|Adverse Event|5
1001235|NCT00422292|3282035|P4|Overall Study|Withdrawal by Subject|13
1001236|NCT00422292|3282036|P3|Overall Study|Withdrawal by Subject|7
1001237|NCT00422292|3282037|P2|Overall Study|Withdrawal by Subject|25
1001238|NCT00422292|3282038|P1|Overall Study|Withdrawal by Subject|6
1001239|NCT00422292|3282035|P4|Overall Study|Lost to Follow-up|6
1001240|NCT00422292|3282036|P3|Overall Study|Lost to Follow-up|6
1001241|NCT00422292|3282037|P2|Overall Study|Lost to Follow-up|12
1001242|NCT00422292|3282038|P1|Overall Study|Lost to Follow-up|6
1001243|NCT00422292|3282035|P4|Overall Study|Protocol Violation|5
1001244|NCT00422292|3282036|P3|Overall Study|Protocol Violation|8
1001245|NCT00422292|3282037|P2|Overall Study|Protocol Violation|25
1001246|NCT00422292|3282038|P1|Overall Study|Protocol Violation|4
1001247|NCT00422292|3282035|P4|Overall Study|Adverse Event|0
1001248|NCT00422292|3282036|P3|Overall Study|Adverse Event|1
1001249|NCT00422292|3282037|P2|Overall Study|Adverse Event|0
1001250|NCT00422292|3282038|P1|Overall Study|Adverse Event|1
1001251|NCT00422292|3282035|P4|Overall Study|Serious adverse events|0
1001252|NCT00422292|3282036|P3|Overall Study|Serious adverse events|0
1001253|NCT00422292|3282037|P2|Overall Study|Serious adverse events|4
1001254|NCT00422292|3282038|P1|Overall Study|Serious adverse events|1
1001255|NCT00422227|3282077|P2|Overall Study|Withdrawal by Subject|4
1001256|NCT00422227|3282078|P1|Overall Study|Withdrawal by Subject|0
1001257|NCT00422227|3282077|P2|Overall Study|Lost to Follow-up|3
1001258|NCT00422227|3282078|P1|Overall Study|Lost to Follow-up|1
1001259|NCT00422227|3282077|P2|Overall Study|Adverse Event|8
1001260|NCT00422227|3282078|P1|Overall Study|Adverse Event|3
1001261|NCT00422162|3282108|P2|Overall Study|Didn't Receive Treatment|1
1001262|NCT00422162|3282109|P1|Overall Study|Didn't Receive Treatment|0
1001263|NCT00422162|3282108|P2|Overall Study|Not Specified|1
1001264|NCT00422162|3282109|P1|Overall Study|Not Specified|0
1001265|NCT00422162|3282108|P2|Overall Study|Non-Compliant with Protocol|1
1001266|NCT00422162|3282109|P1|Overall Study|Non-Compliant with Protocol|1
1001267|NCT00422162|3282108|P2|Overall Study|Lost to Follow-up|2
1001268|NCT00422162|3282109|P1|Overall Study|Lost to Follow-up|1
1001269|NCT00422162|3282108|P2|Overall Study|Withdrawal by Subject|6
1001270|NCT00422162|3282109|P1|Overall Study|Withdrawal by Subject|7
1001271|NCT00422162|3282108|P2|Overall Study|Lack of Efficacy|10
1001272|NCT00422162|3282109|P1|Overall Study|Lack of Efficacy|4
1001273|NCT00422162|3282108|P2|Overall Study|Adverse Event|9
1001274|NCT00422162|3282109|P1|Overall Study|Adverse Event|11
1001275|NCT00422097|3282169|P8|Dose Level 2|Still on treatment|0
1001276|NCT00422097|3282170|P7|Dose Level 2|Still on treatment|0
1001277|NCT00422097|3282171|P6|Dose Level 2|Still on treatment|0
1001278|NCT00422097|3282172|P5|Dose Level 2|Still on treatment|0
1001279|NCT00422097|3282173|P4|Dose Level 2|Still on treatment|0
1001280|NCT00422097|3282174|P3|Dose Level 2|Still on treatment|0
1001281|NCT00422097|3282175|P2|Dose Level 2|Still on treatment|1
1001282|NCT00422097|3282176|P1|Dose Level 2|Still on treatment|0
1001283|NCT00422058|3282241|P6|Open-Label Extension, Week 20-104|Other|18
1001284|NCT00422058|3282242|P5|Open-Label Extension, Week 20-104|Other|16
1001285|NCT00422058|3282243|P4|Open-Label Extension, Week 20-104|Other|13
1001286|NCT00422058|3282244|P3|Open-Label Extension, Week 20-104|Other|6
1001287|NCT00422058|3282245|P2|Open-Label Extension, Week 20-104|Other|14
1001288|NCT00422058|3282246|P1|Open-Label Extension, Week 20-104|Other|13
1001289|NCT00422058|3282241|P6|Open-Label Extension, Week 20-104|Lack of Efficacy|1
1001290|NCT00422058|3282242|P5|Open-Label Extension, Week 20-104|Lack of Efficacy|0
1001291|NCT00422058|3282243|P4|Open-Label Extension, Week 20-104|Lack of Efficacy|2
1001292|NCT00422058|3282244|P3|Open-Label Extension, Week 20-104|Lack of Efficacy|5
1001293|NCT00422058|3282245|P2|Open-Label Extension, Week 20-104|Lack of Efficacy|2
1001294|NCT00422058|3282246|P1|Open-Label Extension, Week 20-104|Lack of Efficacy|3
1001295|NCT00422058|3282241|P6|Open-Label Extension, Week 20-104|Protocol Violation|3
1001296|NCT00422058|3282242|P5|Open-Label Extension, Week 20-104|Protocol Violation|5
1001297|NCT00422058|3282243|P4|Open-Label Extension, Week 20-104|Protocol Violation|1
1001298|NCT00422058|3282244|P3|Open-Label Extension, Week 20-104|Protocol Violation|3
1001299|NCT00422058|3282245|P2|Open-Label Extension, Week 20-104|Protocol Violation|2
1001300|NCT00422058|3282246|P1|Open-Label Extension, Week 20-104|Protocol Violation|1
1001301|NCT00422058|3282241|P6|Open-Label Extension, Week 20-104|Adverse Event|0
1001302|NCT00422058|3282242|P5|Open-Label Extension, Week 20-104|Adverse Event|4
1001303|NCT00422058|3282243|P4|Open-Label Extension, Week 20-104|Adverse Event|4
1001304|NCT00422058|3282244|P3|Open-Label Extension, Week 20-104|Adverse Event|7
1001305|NCT00422058|3282245|P2|Open-Label Extension, Week 20-104|Adverse Event|4
1001306|NCT00422058|3282246|P1|Open-Label Extension, Week 20-104|Adverse Event|3
1001307|NCT00422058|3282241|P6|Open-Label Extension, Week 20-104|Not giving consent for extension|12
1001308|NCT00422058|3282242|P5|Open-Label Extension, Week 20-104|Not giving consent for extension|10
1001309|NCT00422058|3282243|P4|Open-Label Extension, Week 20-104|Not giving consent for extension|8
1001310|NCT00422058|3282244|P3|Open-Label Extension, Week 20-104|Not giving consent for extension|15
1001311|NCT00422058|3282245|P2|Open-Label Extension, Week 20-104|Not giving consent for extension|17
1001312|NCT00422058|3282246|P1|Open-Label Extension, Week 20-104|Not giving consent for extension|12
1001313|NCT00422058|3282241|P6|Double-Blind, Week 0-20|Other|10
1001314|NCT00422058|3282242|P5|Double-Blind, Week 0-20|Other|4
1001315|NCT00422058|3282243|P4|Double-Blind, Week 0-20|Other|8
1001316|NCT00422058|3282244|P3|Double-Blind, Week 0-20|Other|8
1001317|NCT00422058|3282245|P2|Double-Blind, Week 0-20|Other|3
1001318|NCT00422058|3282246|P1|Double-Blind, Week 0-20|Other|11
1001319|NCT00422058|3282241|P6|Double-Blind, Week 0-20|Lack of Efficacy|1
1001320|NCT00422058|3282242|P5|Double-Blind, Week 0-20|Lack of Efficacy|0
1001321|NCT00422058|3282243|P4|Double-Blind, Week 0-20|Lack of Efficacy|0
1001322|NCT00422058|3282244|P3|Double-Blind, Week 0-20|Lack of Efficacy|1
1001323|NCT00422058|3282245|P2|Double-Blind, Week 0-20|Lack of Efficacy|1
1001324|NCT00422058|3282246|P1|Double-Blind, Week 0-20|Lack of Efficacy|2
1001325|NCT00422058|3282241|P6|Double-Blind, Week 0-20|Protocol Violation|2
1001326|NCT00422058|3282242|P5|Double-Blind, Week 0-20|Protocol Violation|2
1001327|NCT00422058|3282243|P4|Double-Blind, Week 0-20|Protocol Violation|3
1001328|NCT00422058|3282244|P3|Double-Blind, Week 0-20|Protocol Violation|2
1001329|NCT00422058|3282245|P2|Double-Blind, Week 0-20|Protocol Violation|2
1001330|NCT00422058|3282246|P1|Double-Blind, Week 0-20|Protocol Violation|3
1001331|NCT00422058|3282241|P6|Double-Blind, Week 0-20|Adverse Event|3
1001332|NCT00422058|3282242|P5|Double-Blind, Week 0-20|Adverse Event|5
1001333|NCT00422058|3282243|P4|Double-Blind, Week 0-20|Adverse Event|9
1001334|NCT00422058|3282244|P3|Double-Blind, Week 0-20|Adverse Event|5
1001335|NCT00422058|3282245|P2|Double-Blind, Week 0-20|Adverse Event|4
1001336|NCT00422058|3282246|P1|Double-Blind, Week 0-20|Adverse Event|3
1001337|NCT00421993|3282387|P4|Overall Study|Subject transportation issues|1
1001338|NCT00421993|3282388|P3|Overall Study|Subject transportation issues|0
1001339|NCT00421993|3282389|P2|Overall Study|Subject transportation issues|0
1001340|NCT00421993|3282390|P1|Overall Study|Subject transportation issues|0
1001341|NCT00421993|3282387|P4|Overall Study|Pregnancy|2
1001342|NCT00421993|3282388|P3|Overall Study|Pregnancy|1
1001343|NCT00421993|3282389|P2|Overall Study|Pregnancy|1
1001344|NCT00421993|3282390|P1|Overall Study|Pregnancy|0
1001345|NCT00421993|3282387|P4|Overall Study|Lack of Efficacy|5
1001346|NCT00421993|3282388|P3|Overall Study|Lack of Efficacy|0
1001347|NCT00421993|3282389|P2|Overall Study|Lack of Efficacy|3
1001348|NCT00421993|3282390|P1|Overall Study|Lack of Efficacy|0
1001349|NCT00421993|3282387|P4|Overall Study|Protocol Violation|1
1001350|NCT00421993|3282388|P3|Overall Study|Protocol Violation|0
1001351|NCT00421993|3282389|P2|Overall Study|Protocol Violation|2
1001352|NCT00421993|3282390|P1|Overall Study|Protocol Violation|2
1001353|NCT00421993|3282387|P4|Overall Study|Adverse Event|4
1001354|NCT00421993|3282388|P3|Overall Study|Adverse Event|6
1001355|NCT00421993|3282389|P2|Overall Study|Adverse Event|1
1001356|NCT00421993|3282390|P1|Overall Study|Adverse Event|11
1001357|NCT00421993|3282387|P4|Overall Study|Lost to Follow-up|20
1001358|NCT00421993|3282388|P3|Overall Study|Lost to Follow-up|22
1001359|NCT00421993|3282389|P2|Overall Study|Lost to Follow-up|19
1001360|NCT00421993|3282390|P1|Overall Study|Lost to Follow-up|18
1001361|NCT00421993|3282387|P4|Overall Study|Withdrawal by Subject|24
1001362|NCT00421993|3282388|P3|Overall Study|Withdrawal by Subject|23
1001363|NCT00421993|3282389|P2|Overall Study|Withdrawal by Subject|23
1001364|NCT00421993|3282390|P1|Overall Study|Withdrawal by Subject|22
1001365|NCT00421928|3282427|P3|Overall Study|Death|0
1001366|NCT00421928|3282428|P2|Overall Study|Death|1
1001367|NCT00421928|3282429|P1|Overall Study|Death|0
1001368|NCT00421928|3282427|P3|Overall Study|All other|27
1001369|NCT00421928|3282428|P2|Overall Study|All other|21
1001370|NCT00421928|3282429|P1|Overall Study|All other|26
1001371|NCT00421928|3282427|P3|Overall Study|Study drug non-compliant|4
1001372|NCT00421928|3282428|P2|Overall Study|Study drug non-compliant|7
1001373|NCT00421928|3282429|P1|Overall Study|Study drug non-compliant|6
1001374|NCT00421928|3282427|P3|Overall Study|Lack of Efficacy|35
1001375|NCT00421928|3282428|P2|Overall Study|Lack of Efficacy|7
1001376|NCT00421928|3282429|P1|Overall Study|Lack of Efficacy|15
1001377|NCT00421928|3282427|P3|Overall Study|Withdrawal by Subject|43
1001378|NCT00421928|3282428|P2|Overall Study|Withdrawal by Subject|48
1001379|NCT00421928|3282429|P1|Overall Study|Withdrawal by Subject|50
1001380|NCT00421928|3282427|P3|Overall Study|Lost to Follow-up|3
1001381|NCT00421928|3282428|P2|Overall Study|Lost to Follow-up|0
1001382|NCT00421928|3282429|P1|Overall Study|Lost to Follow-up|5
1001383|NCT00421928|3282427|P3|Overall Study|Adverse Event|22
1001384|NCT00421928|3282428|P2|Overall Study|Adverse Event|140
1001385|NCT00421928|3282429|P1|Overall Study|Adverse Event|61
1001386|NCT00421889|3282464|P9|Overall Study|Lost to Follow-up|1
1001387|NCT00421889|3282465|P8|Overall Study|Lost to Follow-up|0
1001388|NCT00421889|3282466|P7|Overall Study|Lost to Follow-up|0
1001389|NCT00421889|3282467|P6|Overall Study|Lost to Follow-up|0
1001390|NCT00421889|3282468|P5|Overall Study|Lost to Follow-up|0
1001391|NCT00421889|3282469|P4|Overall Study|Lost to Follow-up|0
1001392|NCT00421889|3282470|P3|Overall Study|Lost to Follow-up|0
1001393|NCT00421889|3282471|P2|Overall Study|Lost to Follow-up|0
1001394|NCT00421889|3282472|P1|Overall Study|Lost to Follow-up|0
1001395|NCT00421889|3282464|P9|Overall Study|Patient/Investigator request|3
1001396|NCT00421889|3282465|P8|Overall Study|Patient/Investigator request|1
1001397|NCT00421889|3282466|P7|Overall Study|Patient/Investigator request|0
1001398|NCT00421889|3282467|P6|Overall Study|Patient/Investigator request|9
1001399|NCT00421889|3282468|P5|Overall Study|Patient/Investigator request|0
1001400|NCT00421889|3282469|P4|Overall Study|Patient/Investigator request|0
1001401|NCT00421889|3282470|P3|Overall Study|Patient/Investigator request|0
1001402|NCT00421889|3282471|P2|Overall Study|Patient/Investigator request|0
1001403|NCT00421889|3282472|P1|Overall Study|Patient/Investigator request|0
1001404|NCT00421889|3282464|P9|Overall Study|Progressive disease|5
1001405|NCT00421889|3282465|P8|Overall Study|Progressive disease|1
1001406|NCT00421889|3282466|P7|Overall Study|Progressive disease|3
1001407|NCT00421889|3282467|P6|Overall Study|Progressive disease|21
1001408|NCT00421889|3282468|P5|Overall Study|Progressive disease|2
1001409|NCT00421889|3282469|P4|Overall Study|Progressive disease|3
1001410|NCT00421889|3282470|P3|Overall Study|Progressive disease|2
1001411|NCT00421889|3282471|P2|Overall Study|Progressive disease|2
1001412|NCT00421889|3282472|P1|Overall Study|Progressive disease|3
1001413|NCT00421889|3282464|P9|Overall Study|Death|0
1001414|NCT00421889|3282465|P8|Overall Study|Death|0
1001415|NCT00421889|3282466|P7|Overall Study|Death|0
1001416|NCT00421889|3282467|P6|Overall Study|Death|1
1001417|NCT00421889|3282468|P5|Overall Study|Death|1
1001418|NCT00421889|3282469|P4|Overall Study|Death|0
1001419|NCT00421889|3282470|P3|Overall Study|Death|0
1001420|NCT00421889|3282471|P2|Overall Study|Death|0
1001421|NCT00421889|3282472|P1|Overall Study|Death|0
1001422|NCT00421889|3282464|P9|Overall Study|Withdrawal by Subject|0
1001423|NCT00421889|3282465|P8|Overall Study|Withdrawal by Subject|0
1001424|NCT00421889|3282466|P7|Overall Study|Withdrawal by Subject|0
1001425|NCT00421889|3282467|P6|Overall Study|Withdrawal by Subject|0
1001426|NCT00421889|3282468|P5|Overall Study|Withdrawal by Subject|2
1001427|NCT00421889|3282469|P4|Overall Study|Withdrawal by Subject|0
1001428|NCT00421889|3282470|P3|Overall Study|Withdrawal by Subject|0
1001429|NCT00421889|3282471|P2|Overall Study|Withdrawal by Subject|3
1001430|NCT00421889|3282472|P1|Overall Study|Withdrawal by Subject|1
1001431|NCT00421889|3282464|P9|Overall Study|Adverse Event|2
1001432|NCT00421889|3282465|P8|Overall Study|Adverse Event|0
1001433|NCT00421889|3282466|P7|Overall Study|Adverse Event|1
1001434|NCT00421889|3282467|P6|Overall Study|Adverse Event|4
1001435|NCT00421889|3282468|P5|Overall Study|Adverse Event|1
1001436|NCT00421889|3282469|P4|Overall Study|Adverse Event|1
1001437|NCT00421889|3282470|P3|Overall Study|Adverse Event|1
1001438|NCT00421889|3282471|P2|Overall Study|Adverse Event|0
1001439|NCT00421889|3282472|P1|Overall Study|Adverse Event|1
1001440|NCT00421733|3282517|P3|Overall Study|Protocol deviation|2
1001441|NCT00421733|3282518|P2|Overall Study|Protocol deviation|7
1001442|NCT00421733|3282519|P1|Overall Study|Protocol deviation|4
1001443|NCT00421733|3282517|P3|Overall Study|Sponsor request|3
1001444|NCT00421733|3282518|P2|Overall Study|Sponsor request|0
1001445|NCT00421733|3282519|P1|Overall Study|Sponsor request|1
1001446|NCT00421733|3282517|P3|Overall Study|Did not satisfy entry criteria|2
1001447|NCT00421733|3282518|P2|Overall Study|Did not satisfy entry criteria|3
1001448|NCT00421733|3282519|P1|Overall Study|Did not satisfy entry criteria|1
1001449|NCT00421733|3282517|P3|Overall Study|Administrative|0
1001450|NCT00421733|3282518|P2|Overall Study|Administrative|0
1001451|NCT00421733|3282519|P1|Overall Study|Administrative|2
1001452|NCT00421733|3282517|P3|Overall Study|Required dialysis|0
1001453|NCT00421733|3282518|P2|Overall Study|Required dialysis|0
1001454|NCT00421733|3282519|P1|Overall Study|Required dialysis|1
1001455|NCT00421733|3282517|P3|Overall Study|Death|0
1001456|NCT00421733|3282518|P2|Overall Study|Death|3
1001457|NCT00421733|3282519|P1|Overall Study|Death|0
1001458|NCT00421733|3282517|P3|Overall Study|Withdrawal by Subject|7
1001459|NCT00421733|3282518|P2|Overall Study|Withdrawal by Subject|2
1001460|NCT00421733|3282519|P1|Overall Study|Withdrawal by Subject|1
1001461|NCT00421733|3282517|P3|Overall Study|Lost to Follow-up|4
1001462|NCT00421733|3282518|P2|Overall Study|Lost to Follow-up|2
1001463|NCT00421733|3282519|P1|Overall Study|Lost to Follow-up|1
1001464|NCT00421733|3282517|P3|Overall Study|Adverse Event|2
1001465|NCT00421733|3282518|P2|Overall Study|Adverse Event|9
1001466|NCT00421733|3282519|P1|Overall Study|Adverse Event|4
1001467|NCT00421707|3282539|P2|Period 3:Treatment Period 2|Adverse Event|2
1001468|NCT00421707|3282540|P1|Period 3:Treatment Period 2|Adverse Event|0
1001469|NCT00421707|3282539|P2|Period 3:Treatment Period 2|Protocol Violation|0
1001470|NCT00421707|3282540|P1|Period 3:Treatment Period 2|Protocol Violation|1
1001471|NCT00421707|3282539|P2|Period 3:Treatment Period 2|Withdrawal by Subject|1
1001472|NCT00421707|3282540|P1|Period 3:Treatment Period 2|Withdrawal by Subject|1
1001473|NCT00421707|3282539|P2|Period 2: Washout|Other: Pregnancy|1
1001474|NCT00421707|3282540|P1|Period 2: Washout|Other: Pregnancy|0
1001475|NCT00421707|3282539|P2|Period 2: Washout|Lost to Follow-up|1
1001476|NCT00421707|3282540|P1|Period 2: Washout|Lost to Follow-up|0
1001477|NCT00421707|3282539|P2|Period 2: Washout|Withdrawal by Subject|1
1001478|NCT00421707|3282540|P1|Period 2: Washout|Withdrawal by Subject|0
1001479|NCT00421707|3282539|P2|Period 2: Washout|Adverse Event|1
1001480|NCT00421707|3282540|P1|Period 2: Washout|Adverse Event|1
1001481|NCT00421707|3282539|P2|Period 1: Treatment Period 1|Protocol Violation|0
1001482|NCT00421707|3282540|P1|Period 1: Treatment Period 1|Protocol Violation|1
1001483|NCT00421707|3282539|P2|Period 1: Treatment Period 1|Lost to Follow-up|2
1001484|NCT00421707|3282540|P1|Period 1: Treatment Period 1|Lost to Follow-up|2
1001485|NCT00421707|3282539|P2|Period 1: Treatment Period 1|Adverse Event|2
1001486|NCT00421707|3282540|P1|Period 1: Treatment Period 1|Adverse Event|7
1001487|NCT00421707|3282539|P2|Period 1: Treatment Period 1|Withdrawal by Subject|5
1001488|NCT00421707|3282540|P1|Period 1: Treatment Period 1|Withdrawal by Subject|1
1001489|NCT00421408|3282591|P2|Overall Study|Discountinued from treatment/ f/u cont.|25
1001490|NCT00421408|3282592|P1|Overall Study|Discountinued from treatment/ f/u cont.|12
1001491|NCT00421408|3282591|P2|Overall Study|Lost to Follow-up|20
1001492|NCT00421408|3282592|P1|Overall Study|Lost to Follow-up|30
1001493|NCT00421343|3282610|P1|Overall Study|Lost to follow-up|3
1001494|NCT00421343|3282610|P1|Overall Study|Withdrawal by Subject|2
1001495|NCT00421343|3282610|P1|Overall Study|Death|1
1001496|NCT00421174|3282616|P2|Overall Study|Ineligible due to infection|0
1001497|NCT00421174|3282617|P1|Overall Study|Ineligible due to infection|2
1001498|NCT00421174|3282616|P2|Overall Study|Withdrawal by Subject|1
1001499|NCT00421174|3282617|P1|Overall Study|Withdrawal by Subject|0
1001500|NCT00420927|3282662|P7|Period 2|Took prohibited medication|0
1001501|NCT00420927|3282663|P6|Period 2|Took prohibited medication|0
1001502|NCT00420927|3282664|P5|Period 2|Took prohibited medication|1
1001503|NCT00420927|3282665|P4|Period 2|Took prohibited medication|0
1001504|NCT00420927|3282666|P3|Period 2|Took prohibited medication|0
1001505|NCT00420927|3282667|P2|Period 2|Took prohibited medication|0
1001506|NCT00420927|3282668|P1|Period 2|Took prohibited medication|0
1001507|NCT00420927|3282662|P7|Period 2|Methotrexate intolerance|1
1001508|NCT00420927|3282663|P6|Period 2|Methotrexate intolerance|0
1001509|NCT00420927|3282664|P5|Period 2|Methotrexate intolerance|0
1001510|NCT00420927|3282665|P4|Period 2|Methotrexate intolerance|0
1001511|NCT00420927|3282666|P3|Period 2|Methotrexate intolerance|0
1001512|NCT00420927|3282667|P2|Period 2|Methotrexate intolerance|0
1001513|NCT00420927|3282668|P1|Period 2|Methotrexate intolerance|0
1001514|NCT00420927|3282662|P7|Period 2|Noncompliant with study drug|2
1001515|NCT00420927|3282663|P6|Period 2|Noncompliant with study drug|0
1001516|NCT00420927|3282664|P5|Period 2|Noncompliant with study drug|0
1001517|NCT00420927|3282665|P4|Period 2|Noncompliant with study drug|1
1001518|NCT00420927|3282666|P3|Period 2|Noncompliant with study drug|0
1001519|NCT00420927|3282667|P2|Period 2|Noncompliant with study drug|0
1001520|NCT00420927|3282668|P1|Period 2|Noncompliant with study drug|0
1001521|NCT00420927|3282662|P7|Period 2|Randomization error|0
1001522|NCT00420927|3282663|P6|Period 2|Randomization error|1
1001523|NCT00420927|3282664|P5|Period 2|Randomization error|1
1001524|NCT00420927|3282665|P4|Period 2|Randomization error|0
1001525|NCT00420927|3282666|P3|Period 2|Randomization error|0
1001526|NCT00420927|3282667|P2|Period 2|Randomization error|0
1001527|NCT00420927|3282668|P1|Period 2|Randomization error|0
1001528|NCT00420927|3282662|P7|Period 2|Sponsor decision|1
1001529|NCT00420927|3282663|P6|Period 2|Sponsor decision|0
1001530|NCT00420927|3282664|P5|Period 2|Sponsor decision|0
1001531|NCT00420927|3282665|P4|Period 2|Sponsor decision|0
1001532|NCT00420927|3282666|P3|Period 2|Sponsor decision|1
1001533|NCT00420927|3282667|P2|Period 2|Sponsor decision|0
1001534|NCT00420927|3282668|P1|Period 2|Sponsor decision|0
1001535|NCT00420927|3282662|P7|Period 2|Physician Decision|0
1001536|NCT00420927|3282663|P6|Period 2|Physician Decision|1
1001537|NCT00420927|3282664|P5|Period 2|Physician Decision|1
1001538|NCT00420927|3282665|P4|Period 2|Physician Decision|0
1001539|NCT00420927|3282666|P3|Period 2|Physician Decision|0
1001540|NCT00420927|3282667|P2|Period 2|Physician Decision|0
1001541|NCT00420927|3282668|P1|Period 2|Physician Decision|0
1001542|NCT00420927|3282662|P7|Period 2|Subject unable to find transportation|1
1001543|NCT00420927|3282663|P6|Period 2|Subject unable to find transportation|0
1001544|NCT00420927|3282664|P5|Period 2|Subject unable to find transportation|0
1001545|NCT00420927|3282665|P4|Period 2|Subject unable to find transportation|0
1001546|NCT00420927|3282666|P3|Period 2|Subject unable to find transportation|0
1001547|NCT00420927|3282667|P2|Period 2|Subject unable to find transportation|0
1001548|NCT00420927|3282668|P1|Period 2|Subject unable to find transportation|0
1001549|NCT00420927|3282662|P7|Period 2|Received wrong treatment/incorrect dose|1
1001550|NCT00420927|3282663|P6|Period 2|Received wrong treatment/incorrect dose|0
1001551|NCT00420927|3282664|P5|Period 2|Received wrong treatment/incorrect dose|0
1001552|NCT00420927|3282665|P4|Period 2|Received wrong treatment/incorrect dose|0
1001553|NCT00420927|3282666|P3|Period 2|Received wrong treatment/incorrect dose|0
1001554|NCT00420927|3282667|P2|Period 2|Received wrong treatment/incorrect dose|0
1001555|NCT00420927|3282668|P1|Period 2|Received wrong treatment/incorrect dose|0
1001556|NCT00420927|3282662|P7|Period 2|Lack of efficacy/Loss of efficacy|6
1001557|NCT00420927|3282663|P6|Period 2|Lack of efficacy/Loss of efficacy|2
1001558|NCT00420927|3282664|P5|Period 2|Lack of efficacy/Loss of efficacy|6
1001559|NCT00420927|3282665|P4|Period 2|Lack of efficacy/Loss of efficacy|1
1001560|NCT00420927|3282666|P3|Period 2|Lack of efficacy/Loss of efficacy|2
1001561|NCT00420927|3282667|P2|Period 2|Lack of efficacy/Loss of efficacy|0
1001562|NCT00420927|3282668|P1|Period 2|Lack of efficacy/Loss of efficacy|0
1001563|NCT00420927|3282662|P7|Period 2|Lost to Follow-up|9
1001564|NCT00420927|3282663|P6|Period 2|Lost to Follow-up|3
1001565|NCT00420927|3282664|P5|Period 2|Lost to Follow-up|6
1001566|NCT00420927|3282665|P4|Period 2|Lost to Follow-up|2
1001567|NCT00420927|3282666|P3|Period 2|Lost to Follow-up|2
1001568|NCT00420927|3282667|P2|Period 2|Lost to Follow-up|0
1001569|NCT00420927|3282668|P1|Period 2|Lost to Follow-up|0
1001570|NCT00420927|3282662|P7|Period 2|Withdrawal by Subject|12
1001571|NCT00420927|3282663|P6|Period 2|Withdrawal by Subject|2
1001572|NCT00420927|3282664|P5|Period 2|Withdrawal by Subject|11
1001573|NCT00420927|3282665|P4|Period 2|Withdrawal by Subject|3
1001574|NCT00420927|3282666|P3|Period 2|Withdrawal by Subject|1
1001575|NCT00420927|3282667|P2|Period 2|Withdrawal by Subject|0
1001576|NCT00420927|3282668|P1|Period 2|Withdrawal by Subject|0
1001577|NCT00420927|3282662|P7|Period 2|Adverse Event|20
1001578|NCT00420927|3282663|P6|Period 2|Adverse Event|6
1001579|NCT00420927|3282664|P5|Period 2|Adverse Event|17
1001580|NCT00420927|3282665|P4|Period 2|Adverse Event|3
1001581|NCT00420927|3282666|P3|Period 2|Adverse Event|7
1001582|NCT00420927|3282667|P2|Period 2|Adverse Event|0
1001583|NCT00420927|3282668|P1|Period 2|Adverse Event|0
1001584|NCT00420927|3282662|P7|Period 1|Took prohibited medication|0
1001585|NCT00420927|3282663|P6|Period 1|Took prohibited medication|0
1001586|NCT00420927|3282664|P5|Period 1|Took prohibited medication|0
1001587|NCT00420927|3282665|P4|Period 1|Took prohibited medication|0
1001588|NCT00420927|3282666|P3|Period 1|Took prohibited medication|0
1001589|NCT00420927|3282667|P2|Period 1|Took prohibited medication|3
1001590|NCT00420927|3282668|P1|Period 1|Took prohibited medication|1
1001591|NCT00420927|3282662|P7|Period 1|Failed to meet entry criteria|0
1001592|NCT00420927|3282663|P6|Period 1|Failed to meet entry criteria|0
1001593|NCT00420927|3282664|P5|Period 1|Failed to meet entry criteria|0
1001594|NCT00420927|3282665|P4|Period 1|Failed to meet entry criteria|0
1001595|NCT00420927|3282666|P3|Period 1|Failed to meet entry criteria|0
1001596|NCT00420927|3282667|P2|Period 1|Failed to meet entry criteria|7
1001597|NCT00420927|3282668|P1|Period 1|Failed to meet entry criteria|8
1001598|NCT00420927|3282662|P7|Period 1|Received wrong treatment/incorrect dose|0
1001599|NCT00420927|3282663|P6|Period 1|Received wrong treatment/incorrect dose|0
1001600|NCT00420927|3282664|P5|Period 1|Received wrong treatment/incorrect dose|0
1001601|NCT00420927|3282665|P4|Period 1|Received wrong treatment/incorrect dose|0
1001602|NCT00420927|3282666|P3|Period 1|Received wrong treatment/incorrect dose|0
1001603|NCT00420927|3282667|P2|Period 1|Received wrong treatment/incorrect dose|1
1001604|NCT00420927|3282668|P1|Period 1|Received wrong treatment/incorrect dose|0
1001605|NCT00420927|3282662|P7|Period 1|Subject received new diagnosis|0
1001606|NCT00420927|3282663|P6|Period 1|Subject received new diagnosis|0
1001607|NCT00420927|3282664|P5|Period 1|Subject received new diagnosis|0
1001608|NCT00420927|3282665|P4|Period 1|Subject received new diagnosis|0
1001609|NCT00420927|3282666|P3|Period 1|Subject received new diagnosis|0
1001610|NCT00420927|3282667|P2|Period 1|Subject received new diagnosis|2
1001611|NCT00420927|3282668|P1|Period 1|Subject received new diagnosis|0
1001612|NCT00420927|3282662|P7|Period 1|Study site closure|0
1001613|NCT00420927|3282663|P6|Period 1|Study site closure|0
1001614|NCT00420927|3282664|P5|Period 1|Study site closure|0
1001615|NCT00420927|3282665|P4|Period 1|Study site closure|0
1001616|NCT00420927|3282666|P3|Period 1|Study site closure|0
1001617|NCT00420927|3282667|P2|Period 1|Study site closure|1
1001618|NCT00420927|3282668|P1|Period 1|Study site closure|0
1001619|NCT00420927|3282662|P7|Period 1|Suspected tuberculosis/positive test|0
1001620|NCT00420927|3282663|P6|Period 1|Suspected tuberculosis/positive test|0
1001621|NCT00420927|3282664|P5|Period 1|Suspected tuberculosis/positive test|0
1001622|NCT00420927|3282665|P4|Period 1|Suspected tuberculosis/positive test|0
1001623|NCT00420927|3282666|P3|Period 1|Suspected tuberculosis/positive test|0
1001624|NCT00420927|3282667|P2|Period 1|Suspected tuberculosis/positive test|1
1001716|NCT00420745|3282882|P2|Overall Study|Protocol Violation|0
1001625|NCT00420927|3282668|P1|Period 1|Suspected tuberculosis/positive test|1
1001626|NCT00420927|3282662|P7|Period 1|Randomization error|0
1001627|NCT00420927|3282663|P6|Period 1|Randomization error|0
1001628|NCT00420927|3282664|P5|Period 1|Randomization error|0
1001629|NCT00420927|3282665|P4|Period 1|Randomization error|0
1001630|NCT00420927|3282666|P3|Period 1|Randomization error|0
1001631|NCT00420927|3282667|P2|Period 1|Randomization error|0
1001632|NCT00420927|3282668|P1|Period 1|Randomization error|1
1001633|NCT00420927|3282662|P7|Period 1|Noncompliant with study drug|0
1001634|NCT00420927|3282663|P6|Period 1|Noncompliant with study drug|0
1001635|NCT00420927|3282664|P5|Period 1|Noncompliant with study drug|0
1001636|NCT00420927|3282665|P4|Period 1|Noncompliant with study drug|0
1001637|NCT00420927|3282666|P3|Period 1|Noncompliant with study drug|0
1001638|NCT00420927|3282667|P2|Period 1|Noncompliant with study drug|1
1001639|NCT00420927|3282668|P1|Period 1|Noncompliant with study drug|1
1001640|NCT00420927|3282662|P7|Period 1|Subject moved/relocated|0
1001641|NCT00420927|3282663|P6|Period 1|Subject moved/relocated|0
1001642|NCT00420927|3282664|P5|Period 1|Subject moved/relocated|0
1001643|NCT00420927|3282665|P4|Period 1|Subject moved/relocated|0
1001644|NCT00420927|3282666|P3|Period 1|Subject moved/relocated|0
1001645|NCT00420927|3282667|P2|Period 1|Subject moved/relocated|2
1001646|NCT00420927|3282668|P1|Period 1|Subject moved/relocated|0
1001647|NCT00420927|3282662|P7|Period 1|Death|0
1001648|NCT00420927|3282663|P6|Period 1|Death|0
1001649|NCT00420927|3282664|P5|Period 1|Death|0
1001650|NCT00420927|3282665|P4|Period 1|Death|0
1001651|NCT00420927|3282666|P3|Period 1|Death|0
1001652|NCT00420927|3282667|P2|Period 1|Death|0
1001653|NCT00420927|3282668|P1|Period 1|Death|2
1001654|NCT00420927|3282662|P7|Period 1|Lack of efficacy/Loss of efficacy|0
1001655|NCT00420927|3282663|P6|Period 1|Lack of efficacy/Loss of efficacy|0
1001656|NCT00420927|3282664|P5|Period 1|Lack of efficacy/Loss of efficacy|0
1001657|NCT00420927|3282665|P4|Period 1|Lack of efficacy/Loss of efficacy|0
1001658|NCT00420927|3282666|P3|Period 1|Lack of efficacy/Loss of efficacy|0
1001659|NCT00420927|3282667|P2|Period 1|Lack of efficacy/Loss of efficacy|6
1001660|NCT00420927|3282668|P1|Period 1|Lack of efficacy/Loss of efficacy|1
1001661|NCT00420927|3282662|P7|Period 1|Lost to Follow-up|0
1001662|NCT00420927|3282663|P6|Period 1|Lost to Follow-up|0
1001663|NCT00420927|3282664|P5|Period 1|Lost to Follow-up|0
1001664|NCT00420927|3282665|P4|Period 1|Lost to Follow-up|0
1001665|NCT00420927|3282666|P3|Period 1|Lost to Follow-up|0
1001666|NCT00420927|3282667|P2|Period 1|Lost to Follow-up|6
1001667|NCT00420927|3282668|P1|Period 1|Lost to Follow-up|8
1001668|NCT00420927|3282662|P7|Period 1|Withdrawal by Subject|0
1001669|NCT00420927|3282663|P6|Period 1|Withdrawal by Subject|0
1001670|NCT00420927|3282664|P5|Period 1|Withdrawal by Subject|0
1001671|NCT00420927|3282665|P4|Period 1|Withdrawal by Subject|0
1001672|NCT00420927|3282666|P3|Period 1|Withdrawal by Subject|0
1001673|NCT00420927|3282667|P2|Period 1|Withdrawal by Subject|12
1001674|NCT00420927|3282668|P1|Period 1|Withdrawal by Subject|7
1001675|NCT00420927|3282662|P7|Period 1|Adverse Event|0
1001676|NCT00420927|3282663|P6|Period 1|Adverse Event|0
1001677|NCT00420927|3282664|P5|Period 1|Adverse Event|0
1001678|NCT00420927|3282665|P4|Period 1|Adverse Event|0
1001679|NCT00420927|3282666|P3|Period 1|Adverse Event|0
1001680|NCT00420927|3282667|P2|Period 1|Adverse Event|15
1001681|NCT00420927|3282668|P1|Period 1|Adverse Event|19
1001682|NCT00420849|3282772|P1|Overall Study|Lost to Follow-up|1
1001683|NCT00420849|3282772|P1|Overall Study|Protocol Violation|1
1001684|NCT00420849|3282772|P1|Overall Study|Transplant|8
1001685|NCT00420849|3282772|P1|Overall Study|Not specified|14
1001686|NCT00420849|3282772|P1|Overall Study|Death|18
1001687|NCT00420849|3282772|P1|Overall Study|Withdrawal by Subject|28
1001688|NCT00420849|3282772|P1|Overall Study|Adverse Event|107
1001689|NCT00420849|3282772|P1|Overall Study|Lack of Efficacy|154
1001690|NCT00420784|3282841|P4|Overall Study|Other|5
1001691|NCT00420784|3282842|P3|Overall Study|Other|0
1001692|NCT00420784|3282843|P2|Overall Study|Other|2
1001693|NCT00420784|3282844|P1|Overall Study|Other|1
1001694|NCT00420784|3282841|P4|Overall Study|Virologic Stopping Rule|67
1001695|NCT00420784|3282842|P3|Overall Study|Virologic Stopping Rule|41
1001696|NCT00420784|3282843|P2|Overall Study|Virologic Stopping Rule|26
1001697|NCT00420784|3282844|P1|Overall Study|Virologic Stopping Rule|17
1001698|NCT00420784|3282841|P4|Overall Study|Lost to Follow-up|1
1001699|NCT00420784|3282842|P3|Overall Study|Lost to Follow-up|2
1001700|NCT00420784|3282843|P2|Overall Study|Lost to Follow-up|0
1001701|NCT00420784|3282844|P1|Overall Study|Lost to Follow-up|0
1001702|NCT00420784|3282841|P4|Overall Study|Withdrawal by Subject|0
1001703|NCT00420784|3282842|P3|Overall Study|Withdrawal by Subject|0
1001704|NCT00420784|3282843|P2|Overall Study|Withdrawal by Subject|1
1001705|NCT00420784|3282844|P1|Overall Study|Withdrawal by Subject|0
1001706|NCT00420784|3282841|P4|Overall Study|Adverse Event|5
1001707|NCT00420784|3282842|P3|Overall Study|Adverse Event|10
1001708|NCT00420784|3282843|P2|Overall Study|Adverse Event|29
1001709|NCT00420784|3282844|P1|Overall Study|Adverse Event|11
1001710|NCT00420745|3282882|P2|Overall Study|Age limit exceeded for Dose 2|0
1001711|NCT00420745|3282883|P1|Overall Study|Age limit exceeded for Dose 2|1
1001712|NCT00420745|3282882|P2|Overall Study|Recurrent pneumonia & bronchitis|1
1001713|NCT00420745|3282883|P1|Overall Study|Recurrent pneumonia & bronchitis|0
1001714|NCT00420745|3282882|P2|Overall Study|Physician Decision|1
1001715|NCT00420745|3282883|P1|Overall Study|Physician Decision|1
1001717|NCT00420745|3282883|P1|Overall Study|Protocol Violation|1
1001718|NCT00420745|3282882|P2|Overall Study|Lost to Follow-up|2
1001719|NCT00420745|3282883|P1|Overall Study|Lost to Follow-up|10
1001720|NCT00420745|3282882|P2|Overall Study|Adverse Event|2
1001721|NCT00420745|3282883|P1|Overall Study|Adverse Event|2
1001722|NCT00420641|3282902|P3|Overall Study|Other|3
1001723|NCT00420641|3282903|P2|Overall Study|Other|4
1001724|NCT00420641|3282904|P1|Overall Study|Other|4
1001725|NCT00420641|3282902|P3|Overall Study|Non-compliance|4
1001726|NCT00420641|3282903|P2|Overall Study|Non-compliance|5
1001727|NCT00420641|3282904|P1|Overall Study|Non-compliance|7
1001728|NCT00420641|3282902|P3|Overall Study|Lack of Efficacy|4
1001729|NCT00420641|3282903|P2|Overall Study|Lack of Efficacy|5
1001730|NCT00420641|3282904|P1|Overall Study|Lack of Efficacy|6
1001731|NCT00420641|3282902|P3|Overall Study|Withdrawal by Subject|14
1001732|NCT00420641|3282903|P2|Overall Study|Withdrawal by Subject|21
1001733|NCT00420641|3282904|P1|Overall Study|Withdrawal by Subject|15
1001734|NCT00420641|3282902|P3|Overall Study|Protocol Violation|7
1001735|NCT00420641|3282903|P2|Overall Study|Protocol Violation|8
1001736|NCT00420641|3282904|P1|Overall Study|Protocol Violation|8
1001737|NCT00420641|3282902|P3|Overall Study|Lost to Follow-up|2
1001738|NCT00420641|3282903|P2|Overall Study|Lost to Follow-up|4
1001739|NCT00420641|3282904|P1|Overall Study|Lost to Follow-up|2
1001740|NCT00420641|3282902|P3|Overall Study|Adverse Event|10
1001741|NCT00420641|3282903|P2|Overall Study|Adverse Event|25
1001742|NCT00420641|3282904|P1|Overall Study|Adverse Event|3
1001743|NCT00420628|3282980|P2|Overall Study|Adverse Event|0
1001744|NCT00420628|3282981|P1|Overall Study|Adverse Event|1
1001745|NCT00420628|3282980|P2|Overall Study|Lost to Follow-up|2
1001746|NCT00420628|3282981|P1|Overall Study|Lost to Follow-up|3
1001747|NCT00420628|3282980|P2|Overall Study|Withdrawn by parent or gaurdian|2
1001748|NCT00420628|3282981|P1|Overall Study|Withdrawn by parent or gaurdian|5
1001749|NCT00420511|3282997|P2|Overall Study|Lost to Follow-up|0
1001750|NCT00420511|3282998|P1|Overall Study|Lost to Follow-up|1
1001751|NCT00420511|3282997|P2|Overall Study|Adverse Event|1
1001752|NCT00420511|3282998|P1|Overall Study|Adverse Event|1
1001753|NCT00420420|3283019|P2|Overall Study|sponsor decision (abnormal ECG @ screen)|0
1001754|NCT00420420|3283020|P1|Overall Study|sponsor decision (abnormal ECG @ screen)|1
1001755|NCT00420420|3283019|P2|Overall Study|Withdrawal by Subject|0
1001756|NCT00420420|3283020|P1|Overall Study|Withdrawal by Subject|1
1001757|NCT00420420|3283019|P2|Overall Study|Protocol Violation|1
1001758|NCT00420420|3283020|P1|Overall Study|Protocol Violation|1
1001759|NCT00420420|3283019|P2|Overall Study|Adverse Event|3
1001760|NCT00420420|3283020|P1|Overall Study|Adverse Event|5
1001761|NCT00420407|3283038|P2|Overall Study|Withdrawal by Subject|2
1001762|NCT00420407|3283039|P1|Overall Study|Withdrawal by Subject|0
1001763|NCT00420407|3283038|P2|Overall Study|subject identified as Jehovah's witness|0
1001764|NCT00420407|3283039|P1|Overall Study|subject identified as Jehovah's witness|1
1001765|NCT00420407|3283038|P2|Overall Study|subject identified as detainee|0
1001766|NCT00420407|3283039|P1|Overall Study|subject identified as detainee|1
1001767|NCT00420407|3283038|P2|Overall Study|Physician Decision|1
1001768|NCT00420407|3283039|P1|Overall Study|Physician Decision|2
1001769|NCT00420407|3283038|P2|Overall Study|Lost to Follow-up|3
1001770|NCT00420407|3283039|P1|Overall Study|Lost to Follow-up|0
1001771|NCT00420342|3283048|P3|Overall Study|Withdrawal by Subject|0
1001772|NCT00420342|3283049|P2|Overall Study|Withdrawal by Subject|2
1001773|NCT00420342|3283050|P1|Overall Study|Withdrawal by Subject|0
1001774|NCT00420342|3283048|P3|Overall Study|Lost to Follow-up|1
1001775|NCT00420342|3283049|P2|Overall Study|Lost to Follow-up|0
1001776|NCT00420342|3283050|P1|Overall Study|Lost to Follow-up|1
1001777|NCT00420316|3283093|P2|Overall Study|Lost to Follow-up|8
1001778|NCT00420316|3283094|P1|Overall Study|Lost to Follow-up|12
1001779|NCT00420316|3283093|P2|Overall Study|Withdrawal by Subject|1
1001780|NCT00420316|3283094|P1|Overall Study|Withdrawal by Subject|0
1001781|NCT00420303|3283118|P2|Overall Study|Physician Decision|1
1001782|NCT00420303|3283119|P1|Overall Study|Physician Decision|0
1001783|NCT00420303|3283118|P2|Overall Study|Lack of Efficacy|3
1001784|NCT00420303|3283119|P1|Overall Study|Lack of Efficacy|0
1001785|NCT00420303|3283118|P2|Overall Study|Serious Adverse Event|0
1001786|NCT00420303|3283119|P1|Overall Study|Serious Adverse Event|1
1001787|NCT00420290|3283131|P2|Overall Study|did not meet inclusion/exclusion|1
1001788|NCT00420290|3283132|P1|Overall Study|did not meet inclusion/exclusion|1
1001789|NCT00420290|3283131|P2|Overall Study|Withdrawal by Subject|2
1001790|NCT00420290|3283132|P1|Overall Study|Withdrawal by Subject|0
1001791|NCT00420290|3283131|P2|Overall Study|Adverse Event|1
1001792|NCT00420290|3283132|P1|Overall Study|Adverse Event|3
1001793|NCT00420238|3283148|P2|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
1001794|NCT00420238|3283149|P1|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
1001795|NCT00420238|3283148|P2|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0
1001796|NCT00420238|3283149|P1|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1
1001797|NCT00420238|3283148|P2|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1
1001798|NCT00420238|3283149|P1|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0
1001799|NCT00420238|3283148|P2|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1
1001800|NCT00420238|3283149|P1|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0
1001801|NCT00420238|3283148|P2|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2
1001802|NCT00420238|3283149|P1|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0
1001803|NCT00420238|3283148|P2|12 Week Double-Blind Treatment Period 1|Adverse Event|0
1001804|NCT00420238|3283149|P1|12 Week Double-Blind Treatment Period 1|Adverse Event|1
1001805|NCT00420212|3283288|P3|Overall Study|Other-Unspecified|18
1001806|NCT00420212|3283289|P2|Overall Study|Other-Unspecified|14
1001807|NCT00420212|3283290|P1|Overall Study|Other-Unspecified|21
1001808|NCT00420212|3283288|P3|Overall Study|Death|1
1001809|NCT00420212|3283289|P2|Overall Study|Death|0
1001810|NCT00420212|3283290|P1|Overall Study|Death|0
1001811|NCT00420212|3283288|P3|Overall Study|Protocol Violation|8
1001812|NCT00420212|3283289|P2|Overall Study|Protocol Violation|4
1001813|NCT00420212|3283290|P1|Overall Study|Protocol Violation|4
1001814|NCT00420212|3283288|P3|Overall Study|Physician Decision|3
1001815|NCT00420212|3283289|P2|Overall Study|Physician Decision|4
1001816|NCT00420212|3283290|P1|Overall Study|Physician Decision|4
1001817|NCT00420212|3283288|P3|Overall Study|Withdrawal by Subject|19
1001818|NCT00420212|3283289|P2|Overall Study|Withdrawal by Subject|22
1001819|NCT00420212|3283290|P1|Overall Study|Withdrawal by Subject|31
1001820|NCT00420212|3283288|P3|Overall Study|Lost to Follow-up|11
1001821|NCT00420212|3283289|P2|Overall Study|Lost to Follow-up|11
1001822|NCT00420212|3283290|P1|Overall Study|Lost to Follow-up|9
1001823|NCT00420212|3283288|P3|Overall Study|Adverse Event|36
1001824|NCT00420212|3283289|P2|Overall Study|Adverse Event|40
1001825|NCT00420212|3283290|P1|Overall Study|Adverse Event|22
1001826|NCT00420199|3283316|P2|Overall Study|Participant no longer met study criteria|0
1001827|NCT00420199|3283317|P1|Overall Study|Participant no longer met study criteria|1
1001828|NCT00420095|3283383|P2|Overall Study|Lost to Follow-up|0
1001829|NCT00420095|3283384|P1|Overall Study|Lost to Follow-up|1
1001830|NCT00420095|3283383|P2|Overall Study|Protocol Violation|1
1001831|NCT00420095|3283384|P1|Overall Study|Protocol Violation|1
1001832|NCT00420095|3283383|P2|Overall Study|Adverse Event|0
1001833|NCT00420095|3283384|P1|Overall Study|Adverse Event|1
1001834|NCT00420056|3283402|P1|Overall Study|Objective progression or relapse|17
1001835|NCT00420004|3283442|P3|Overall Study|Sponsor Decision|1
1001836|NCT00420004|3283443|P2|Overall Study|Sponsor Decision|3
1001837|NCT00420004|3283444|P1|Overall Study|Sponsor Decision|3
1001838|NCT00420004|3283442|P3|Overall Study|Withdrawal by Subject|14
1001839|NCT00420004|3283443|P2|Overall Study|Withdrawal by Subject|42
1001840|NCT00420004|3283444|P1|Overall Study|Withdrawal by Subject|67
1001841|NCT00420004|3283442|P3|Overall Study|Protocol Violation|3
1001842|NCT00420004|3283443|P2|Overall Study|Protocol Violation|4
1001843|NCT00420004|3283444|P1|Overall Study|Protocol Violation|5
1001844|NCT00420004|3283442|P3|Overall Study|Physician Decision|2
1001845|NCT00420004|3283443|P2|Overall Study|Physician Decision|4
1001846|NCT00420004|3283444|P1|Overall Study|Physician Decision|14
1001847|NCT00420004|3283442|P3|Overall Study|Entry Criteria Not Met|0
1001848|NCT00420004|3283443|P2|Overall Study|Entry Criteria Not Met|1
1001849|NCT00420004|3283444|P1|Overall Study|Entry Criteria Not Met|0
1001850|NCT00420004|3283442|P3|Overall Study|Lost to Follow-up|10
1001851|NCT00420004|3283443|P2|Overall Study|Lost to Follow-up|12
1001852|NCT00420004|3283444|P1|Overall Study|Lost to Follow-up|31
1001853|NCT00420004|3283442|P3|Overall Study|Lack of Efficacy|1
1001854|NCT00420004|3283443|P2|Overall Study|Lack of Efficacy|4
1001855|NCT00420004|3283444|P1|Overall Study|Lack of Efficacy|5
1001856|NCT00420004|3283442|P3|Overall Study|Adverse Event|1
1001857|NCT00420004|3283443|P2|Overall Study|Adverse Event|1
1001858|NCT00420004|3283444|P1|Overall Study|Adverse Event|4
1001859|NCT00419952|3283509|P2|Overall Study|Abnormal ECG|0
1001860|NCT00419952|3283510|P1|Overall Study|Abnormal ECG|1
1001861|NCT00419952|3283509|P2|Overall Study|Diary or medication non-compliance|4
1001862|NCT00419952|3283510|P1|Overall Study|Diary or medication non-compliance|2
1001863|NCT00419952|3283509|P2|Overall Study|Occurence of 2 or more exacerbations|0
1001864|NCT00419952|3283510|P1|Overall Study|Occurence of 2 or more exacerbations|2
1001865|NCT00419952|3283509|P2|Overall Study|Intake of prohibited medication|2
1001866|NCT00419952|3283510|P1|Overall Study|Intake of prohibited medication|2
1001867|NCT00419952|3283509|P2|Overall Study|Incorrectly enrolled|3
1001868|NCT00419952|3283510|P1|Overall Study|Incorrectly enrolled|10
1001869|NCT00419952|3283509|P2|Overall Study|Physician Decision|3
1001870|NCT00419952|3283510|P1|Overall Study|Physician Decision|1
1001871|NCT00419952|3283509|P2|Overall Study|Pregnancy|2
1001872|NCT00419952|3283510|P1|Overall Study|Pregnancy|4
1001873|NCT00419952|3283509|P2|Overall Study|Protocol Violation|24
1001874|NCT00419952|3283510|P1|Overall Study|Protocol Violation|32
1001875|NCT00419952|3283509|P2|Overall Study|Lost to Follow-up|34
1001876|NCT00419952|3283510|P1|Overall Study|Lost to Follow-up|43
1001877|NCT00419952|3283509|P2|Overall Study|Withdrawal by Subject|43
1001878|NCT00419952|3283510|P1|Overall Study|Withdrawal by Subject|44
1001879|NCT00419952|3283509|P2|Overall Study|Adverse Event|10
1001880|NCT00419952|3283510|P1|Overall Study|Adverse Event|8
1001881|NCT00419926|3283544|P2|Overall Study|Death|1
1001882|NCT00419926|3283545|P1|Overall Study|Death|2
1001883|NCT00419926|3283544|P2|Overall Study|Lost to Follow-up|2
1001884|NCT00419926|3283545|P1|Overall Study|Lost to Follow-up|1
1001885|NCT00419926|3283544|P2|Overall Study|Administrative Problem|4
1001886|NCT00419926|3283545|P1|Overall Study|Administrative Problem|4
1001887|NCT00419926|3283544|P2|Overall Study|Withdrawal by Subject|3
1001888|NCT00419926|3283545|P1|Overall Study|Withdrawal by Subject|7
1001889|NCT00419770|3283561|P2|Overall Study|Withdrawal by Subject|1
1001890|NCT00419770|3283562|P1|Overall Study|Withdrawal by Subject|5
1001891|NCT00419757|3283570|P2|Overall Study|Multiple reasons|1
1001892|NCT00419757|3283571|P1|Overall Study|Multiple reasons|3
1001893|NCT00419757|3283570|P2|Overall Study|Study specific discontinuation criteria|8
1001894|NCT00419757|3283571|P1|Overall Study|Study specific discontinuation criteria|4
1001895|NCT00419757|3283570|P2|Overall Study|Protocol Violation|3
1001896|NCT00419757|3283571|P1|Overall Study|Protocol Violation|2
1001897|NCT00419757|3283570|P2|Overall Study|Withdrawal by Subject|1
1001898|NCT00419757|3283571|P1|Overall Study|Withdrawal by Subject|7
1001899|NCT00419757|3283570|P2|Overall Study|Lost to Follow-up|4
1001900|NCT00419757|3283571|P1|Overall Study|Lost to Follow-up|1
1001901|NCT00419757|3283570|P2|Overall Study|Adverse Event|4
1001902|NCT00419757|3283571|P1|Overall Study|Adverse Event|1
1001903|NCT00419744|3283610|P3|Overall Study|Incorrect medication kit dispensed|1
1001904|NCT00419744|3283611|P2|Overall Study|Incorrect medication kit dispensed|0
1001905|NCT00419744|3283612|P1|Overall Study|Incorrect medication kit dispensed|0
1001906|NCT00419744|3283610|P3|Overall Study|Spirometry mouthpiece issues|2
1001907|NCT00419744|3283611|P2|Overall Study|Spirometry mouthpiece issues|1
1001908|NCT00419744|3283612|P1|Overall Study|Spirometry mouthpiece issues|0
1001909|NCT00419744|3283610|P3|Overall Study|Physician Decision|6
1001910|NCT00419744|3283611|P2|Overall Study|Physician Decision|5
1001911|NCT00419744|3283612|P1|Overall Study|Physician Decision|10
1001912|NCT00419744|3283610|P3|Overall Study|Moving out of state|1
1001913|NCT00419744|3283611|P2|Overall Study|Moving out of state|0
1001914|NCT00419744|3283612|P1|Overall Study|Moving out of state|2
1001915|NCT00419744|3283610|P3|Overall Study|Randomized in error|7
1001916|NCT00419744|3283611|P2|Overall Study|Randomized in error|6
1001917|NCT00419744|3283612|P1|Overall Study|Randomized in error|9
1001918|NCT00419744|3283610|P3|Overall Study|Protocol Violation|8
1001919|NCT00419744|3283611|P2|Overall Study|Protocol Violation|7
1001920|NCT00419744|3283612|P1|Overall Study|Protocol Violation|4
1001921|NCT00419744|3283610|P3|Overall Study|Lost to Follow-up|6
1001922|NCT00419744|3283611|P2|Overall Study|Lost to Follow-up|10
1001923|NCT00419744|3283612|P1|Overall Study|Lost to Follow-up|8
1001924|NCT00419744|3283610|P3|Overall Study|Withdrawal by Subject|52
1001925|NCT00419744|3283611|P2|Overall Study|Withdrawal by Subject|49
1001926|NCT00419744|3283612|P1|Overall Study|Withdrawal by Subject|45
1001927|NCT00419744|3283610|P3|Overall Study|Adverse Event|50
1001928|NCT00419744|3283611|P2|Overall Study|Adverse Event|40
1001929|NCT00419744|3283612|P1|Overall Study|Adverse Event|39
1001930|NCT00419393|3283654|P1|Overall Study|Other: Investigator decision|1
1001931|NCT00419393|3283654|P1|Overall Study|Other: Other health problems|1
1001932|NCT00419393|3283654|P1|Overall Study|Other: Site closure|1
1001933|NCT00419393|3283654|P1|Overall Study|Other: Subject had temporal lobectomy|1
1001934|NCT00419393|3283654|P1|Overall Study|Other: Sponsor request|3
1001935|NCT00419393|3283654|P1|Overall Study|Withdrawal by Subject|7
1001936|NCT00419393|3283654|P1|Overall Study|Protocol Violation|5
1001937|NCT00419393|3283654|P1|Overall Study|Adverse Event|5
1001938|NCT00419380|3283664|P2|Overall Study|Withdrawal by Subject|1
1001939|NCT00419380|3283665|P1|Overall Study|Withdrawal by Subject|0
1001940|NCT00419380|3283664|P2|Overall Study|Lost to Follow-up|1
1001941|NCT00419380|3283665|P1|Overall Study|Lost to Follow-up|0
1001942|NCT00419380|3283664|P2|Overall Study|Physician Decision|1
1001943|NCT00419380|3283665|P1|Overall Study|Physician Decision|0
1001944|NCT00419380|3283664|P2|Overall Study|Lack of Efficacy|7
1001945|NCT00419380|3283665|P1|Overall Study|Lack of Efficacy|1
1001946|NCT00419341|3283673|P1|Efficacy Period|Termination of study site|1
1001947|NCT00419341|3283673|P1|Efficacy Period|Non-compliance|1
1001948|NCT00419341|3283673|P1|Efficacy Period|Lost to Follow-up|1
1001949|NCT00419341|3283673|P1|Efficacy Period|Protocol Violation|1
1001950|NCT00419341|3283673|P1|Efficacy Period|Withdrawal by Subject|6
1001951|NCT00419341|3283673|P1|Wash in/Wash Out Period|Disqualifying laboratory results|1
1001952|NCT00419341|3283673|P1|Wash in/Wash Out Period|Adverse Event|2
1001953|NCT00419341|3283673|P1|Wash in/Wash Out Period|Withdrawal by Subject|8
1001954|NCT00419263|3283708|P3|Overall Study|Withdrawal by Subject|1
1001955|NCT00419263|3283709|P2|Overall Study|Withdrawal by Subject|0
1001956|NCT00419263|3283710|P1|Overall Study|Withdrawal by Subject|0
1001957|NCT00419263|3283708|P3|Overall Study|Adverse Event|1
1001958|NCT00419263|3283709|P2|Overall Study|Adverse Event|0
1001959|NCT00419263|3283710|P1|Overall Study|Adverse Event|0
1001960|NCT00419263|3283708|P3|Overall Study|Randomized in Error, Not Treated|0
1001961|NCT00419263|3283709|P2|Overall Study|Randomized in Error, Not Treated|1
1001962|NCT00419263|3283710|P1|Overall Study|Randomized in Error, Not Treated|1
1001963|NCT00419263|3283708|P3|Overall Study|Lost to Follow-up|1
1001964|NCT00419263|3283709|P2|Overall Study|Lost to Follow-up|1
1001965|NCT00419263|3283710|P1|Overall Study|Lost to Follow-up|2
1001966|NCT00419159|3283739|P2|Overall Study|Disease progression|76
1001967|NCT00419159|3283740|P1|Overall Study|Disease progression|79
1001968|NCT00419159|3283739|P2|Overall Study|Death|2
1001969|NCT00419159|3283740|P1|Overall Study|Death|2
1001970|NCT00419159|3283739|P2|Overall Study|Lost to Follow-up|1
1001971|NCT00419159|3283740|P1|Overall Study|Lost to Follow-up|0
1001972|NCT00419159|3283739|P2|Overall Study|Withdrawal by Subject|3
1001973|NCT00419159|3283740|P1|Overall Study|Withdrawal by Subject|10
1001974|NCT00419159|3283739|P2|Overall Study|Protocol Violation|0
1001975|NCT00419159|3283740|P1|Overall Study|Protocol Violation|1
1001976|NCT00419159|3283739|P2|Overall Study|Subject's no longer requires study drug|1
1001977|NCT00419159|3283740|P1|Overall Study|Subject's no longer requires study drug|0
1001978|NCT00419159|3283739|P2|Overall Study|Abnormal laboratory value(s)|2
1001979|NCT00419159|3283740|P1|Overall Study|Abnormal laboratory value(s)|0
1001980|NCT00419159|3283739|P2|Overall Study|Adverse Event|15
1001981|NCT00419159|3283740|P1|Overall Study|Adverse Event|7
1001982|NCT00419120|3283754|P1|Long Term Follow up Period|study ongoing|10
1001983|NCT00419094|3283761|P2|Overall Study|Other: No contact for extended period|1
1001984|NCT00419094|3283762|P1|Overall Study|Other: No contact for extended period|0
1001985|NCT00419094|3283761|P2|Overall Study|Other: Patient non-compliant|1
1001986|NCT00419094|3283762|P1|Overall Study|Other: Patient non-compliant|0
1001987|NCT00419094|3283761|P2|Overall Study|Other: Error determining exit criteria|0
1001988|NCT00419094|3283762|P1|Overall Study|Other: Error determining exit criteria|1
1001989|NCT00419094|3283761|P2|Overall Study|Withdrawal of consent|5
1001990|NCT00419094|3283762|P1|Overall Study|Withdrawal of consent|1
1001991|NCT00419094|3283761|P2|Overall Study|Protocol Violation|14
1001992|NCT00419094|3283762|P1|Overall Study|Protocol Violation|1
1001993|NCT00419094|3283761|P2|Overall Study|Lost to Follow-up|2
1001994|NCT00419094|3283762|P1|Overall Study|Lost to Follow-up|0
1001995|NCT00419094|3283761|P2|Overall Study|Lack of Efficacy|0
1001996|NCT00419094|3283762|P1|Overall Study|Lack of Efficacy|1
1001997|NCT00419094|3283761|P2|Overall Study|Adverse Event|7
1001998|NCT00419094|3283762|P1|Overall Study|Adverse Event|3
1001999|NCT00419003|3283776|P2|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0
1002000|NCT00419003|3283777|P1|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1
1002001|NCT00419003|3283776|P2|Phase I, Ketamine Infusion|Lack of Efficacy|6
1002002|NCT00419003|3283777|P1|Phase I, Ketamine Infusion|Lack of Efficacy|6
1002003|NCT00418938|3283831|P2|Overall Study|Ineligibility Determined|0
1002004|NCT00418938|3283832|P1|Overall Study|Ineligibility Determined|1
1002005|NCT00418938|3283831|P2|Overall Study|On-going|1
1002006|NCT00418938|3283832|P1|Overall Study|On-going|1
1002007|NCT00418938|3283831|P2|Overall Study|Adverse Event|1
1002008|NCT00418938|3283832|P1|Overall Study|Adverse Event|1
1002009|NCT00418938|3283831|P2|Overall Study|Lost to Follow-up|3
1002010|NCT00418938|3283832|P1|Overall Study|Lost to Follow-up|1
1002011|NCT00418938|3283831|P2|Overall Study|Withdrawal by Subject|15
1002012|NCT00418938|3283832|P1|Overall Study|Withdrawal by Subject|16
1002013|NCT00418938|3283831|P2|Overall Study|Administrative decision|3
1002014|NCT00418938|3283832|P1|Overall Study|Administrative decision|3
1002015|NCT00418938|3283831|P2|Overall Study|Reimbursement|0
1002016|NCT00418938|3283832|P1|Overall Study|Reimbursement|1
1002017|NCT00418886|3283852|P2|Overall Study|randomised but no treatment received|1
1002018|NCT00418886|3283853|P1|Overall Study|randomised but no treatment received|0
1002019|NCT00418886|3283852|P2|Overall Study|withdrawn due to other reason|0
1002020|NCT00418886|3283853|P1|Overall Study|withdrawn due to other reason|1
1002021|NCT00418886|3283852|P2|Overall Study|Lost to Follow-up|6
1002022|NCT00418886|3283853|P1|Overall Study|Lost to Follow-up|4
1002023|NCT00418886|3283852|P2|Overall Study|Withdrawal by Subject|10
1002024|NCT00418886|3283853|P1|Overall Study|Withdrawal by Subject|9
1002025|NCT00418886|3283852|P2|Overall Study|Death|147
1002026|NCT00418886|3283853|P1|Overall Study|Death|122
1002027|NCT00418886|3283852|P2|Overall Study|discontinue treatment survival follow up|91
1002028|NCT00418886|3283853|P1|Overall Study|discontinue treatment survival follow up|90
1002029|NCT00418834|3283879|P2|Overall Study|Withdrawal by Subject|7
1002030|NCT00418834|3283880|P1|Overall Study|Withdrawal by Subject|3
1002031|NCT00418834|3283879|P2|Overall Study|Protocol Violation|3
1002032|NCT00418834|3283880|P1|Overall Study|Protocol Violation|4
1002033|NCT00418834|3283879|P2|Overall Study|Lost to Follow-up|1
1002034|NCT00418834|3283880|P1|Overall Study|Lost to Follow-up|0
1002035|NCT00418834|3283879|P2|Overall Study|Adverse Event|9
1002036|NCT00418834|3283880|P1|Overall Study|Adverse Event|16
1002037|NCT00418717|3283940|P1|Treatment Period B - Weeks 5-12|Adverse Event|2
1002038|NCT00418717|3283940|P1|Treatment Period A - Weeks 1-4|Protocol Violation|1
1002039|NCT00418691|3283948|P3|Overall Study|Progressive Disease|1
1002040|NCT00418691|3283949|P2|Overall Study|Progressive Disease|0
1002041|NCT00418691|3283950|P1|Overall Study|Progressive Disease|1
1002042|NCT00418691|3283948|P3|Overall Study|Started new medication voiding entry|1
1002043|NCT00418691|3283949|P2|Overall Study|Started new medication voiding entry|0
1002044|NCT00418691|3283950|P1|Overall Study|Started new medication voiding entry|0
1002045|NCT00418691|3283948|P3|Overall Study|Lost to Follow-up|3
1002046|NCT00418691|3283949|P2|Overall Study|Lost to Follow-up|2
1002047|NCT00418691|3283950|P1|Overall Study|Lost to Follow-up|1
1002048|NCT00418665|3283961|P3|Treatment Extension|Death|1
1002049|NCT00418665|3283962|P2|Treatment Extension|Death|0
1002050|NCT00418665|3283963|P1|Treatment Extension|Death|0
1002051|NCT00418665|3283961|P3|Treatment Extension|Physician Decision|1
1002052|NCT00418665|3283962|P2|Treatment Extension|Physician Decision|2
1002053|NCT00418665|3283963|P1|Treatment Extension|Physician Decision|2
1002054|NCT00418665|3283961|P3|Treatment Extension|Requirement for alternative therapy|0
1002055|NCT00418665|3283962|P2|Treatment Extension|Requirement for alternative therapy|2
1002056|NCT00418665|3283963|P1|Treatment Extension|Requirement for alternative therapy|2
1002057|NCT00418665|3283961|P3|Treatment Extension|Withdrawal by Subject|0
1002058|NCT00418665|3283962|P2|Treatment Extension|Withdrawal by Subject|0
1002059|NCT00418665|3283963|P1|Treatment Extension|Withdrawal by Subject|1
1002060|NCT00418665|3283961|P3|Treatment Extension|Adverse Event|0
1002061|NCT00418665|3283962|P2|Treatment Extension|Adverse Event|0
1002062|NCT00418665|3283963|P1|Treatment Extension|Adverse Event|1
1002063|NCT00418665|3283961|P3|Treatment Period|Physician Decision|3
1002064|NCT00418665|3283962|P2|Treatment Period|Physician Decision|0
1002065|NCT00418665|3283963|P1|Treatment Period|Physician Decision|1
1002066|NCT00418665|3283961|P3|Treatment Period|Requirement for alternative therapy|0
1002067|NCT00418665|3283962|P2|Treatment Period|Requirement for alternative therapy|0
1002068|NCT00418665|3283963|P1|Treatment Period|Requirement for alternative therapy|1
1002069|NCT00418665|3283961|P3|Treatment Period|Withdrawal by Subject|1
1002070|NCT00418665|3283962|P2|Treatment Period|Withdrawal by Subject|3
1002071|NCT00418665|3283963|P1|Treatment Period|Withdrawal by Subject|0
1002072|NCT00418665|3283961|P3|Treatment Period|Adverse Event|0
1002073|NCT00418665|3283962|P2|Treatment Period|Adverse Event|2
1002074|NCT00418665|3283963|P1|Treatment Period|Adverse Event|2
1002075|NCT00418665|3283961|P3|Treatment Period|Ineligibility determined|0
1002076|NCT00418665|3283962|P2|Treatment Period|Ineligibility determined|1
1002077|NCT00418665|3283963|P1|Treatment Period|Ineligibility determined|1
1002078|NCT00418561|3283997|P3|Overall Study|Participant's (guardian's) decision|0
1002079|NCT00418561|3283998|P2|Overall Study|Participant's (guardian's) decision|1
1002080|NCT00418561|3283999|P1|Overall Study|Participant's (guardian's) decision|0
1002081|NCT00418522|3284069|P2|Overall Study|Randomized but did not receive treatment|4
1002082|NCT00418522|3284070|P1|Overall Study|Randomized but did not receive treatment|7
1002083|NCT00418522|3284069|P2|Overall Study|Other|23
1002084|NCT00418522|3284070|P1|Overall Study|Other|27
1002085|NCT00418522|3284069|P2|Overall Study|Withdrawal by Subject|7
1002086|NCT00418522|3284070|P1|Overall Study|Withdrawal by Subject|31
1002087|NCT00418522|3284069|P2|Overall Study|Lost to Follow-up|4
1002088|NCT00418522|3284070|P1|Overall Study|Lost to Follow-up|10
1002089|NCT00418522|3284069|P2|Overall Study|Lack of Efficacy|3
1002090|NCT00418522|3284070|P1|Overall Study|Lack of Efficacy|1
1002091|NCT00418522|3284069|P2|Overall Study|Adverse Event|1
1002092|NCT00418522|3284070|P1|Overall Study|Adverse Event|7
1002093|NCT00418379|3284117|P3|Year 5|Any other reason not above-mentioned|3
1002094|NCT00418379|3284118|P2|Year 5|Any other reason not above-mentioned|4
1002095|NCT00418379|3284119|P1|Year 5|Any other reason not above-mentioned|2
1002096|NCT00418379|3284117|P3|Year 5|Adverse Event|0
1002097|NCT00418379|3284118|P2|Year 5|Adverse Event|1
1002098|NCT00418379|3284119|P1|Year 5|Adverse Event|0
1002099|NCT00418379|3284117|P3|Year 4|Any other reason not above-mentioned|0
1002100|NCT00418379|3284118|P2|Year 4|Any other reason not above-mentioned|1
1002101|NCT00418379|3284119|P1|Year 4|Any other reason not above-mentioned|1
1002102|NCT00418379|3284117|P3|Year 4|Withdrawal by Subject|2
1002103|NCT00418379|3284118|P2|Year 4|Withdrawal by Subject|3
1002104|NCT00418379|3284119|P1|Year 4|Withdrawal by Subject|2
1002105|NCT00418379|3284117|P3|Year 4|Adverse Event|0
1002106|NCT00418379|3284118|P2|Year 4|Adverse Event|1
1002107|NCT00418379|3284119|P1|Year 4|Adverse Event|0
1002108|NCT00418379|3284117|P3|Year 3|Any other reason not above-mentioned|1
1002109|NCT00418379|3284118|P2|Year 3|Any other reason not above-mentioned|1
1002110|NCT00418379|3284119|P1|Year 3|Any other reason not above-mentioned|2
1002111|NCT00418379|3284117|P3|Year 3|Withdrawal by Subject|2
1002112|NCT00418379|3284118|P2|Year 3|Withdrawal by Subject|1
1002113|NCT00418379|3284119|P1|Year 3|Withdrawal by Subject|1
1002114|NCT00418379|3284117|P3|Year 2|Any other reason not above-mentioned|6
1002115|NCT00418379|3284118|P2|Year 2|Any other reason not above-mentioned|1
1002116|NCT00418379|3284119|P1|Year 2|Any other reason not above-mentioned|2
1002117|NCT00418379|3284117|P3|Year 2|Withdrawal by Subject|3
1002118|NCT00418379|3284118|P2|Year 2|Withdrawal by Subject|1
1002119|NCT00418379|3284119|P1|Year 2|Withdrawal by Subject|1
1002120|NCT00418379|3284117|P3|Year 2|Adverse Event|1
1002121|NCT00418379|3284118|P2|Year 2|Adverse Event|2
1002122|NCT00418379|3284119|P1|Year 2|Adverse Event|5
1002123|NCT00418379|3284117|P3|Year 1|Any other reason not above-mentioned|7
1002124|NCT00418379|3284118|P2|Year 1|Any other reason not above-mentioned|5
1002125|NCT00418379|3284119|P1|Year 1|Any other reason not above-mentioned|2
1002126|NCT00418379|3284117|P3|Year 1|Withdrawal by Subject|5
1002127|NCT00418379|3284118|P2|Year 1|Withdrawal by Subject|8
1002128|NCT00418379|3284119|P1|Year 1|Withdrawal by Subject|7
1002129|NCT00418379|3284117|P3|Year 1|Adverse Event|3
1002130|NCT00418379|3284118|P2|Year 1|Adverse Event|15
1002131|NCT00418379|3284119|P1|Year 1|Adverse Event|9
1002132|NCT00418314|3284129|P2|Overall Study|Withdrawal by Subject|2
1002133|NCT00418314|3284130|P1|Overall Study|Withdrawal by Subject|1
1002134|NCT00418184|3284160|P2|Double-blind Phase|Poor compliance|1
1002135|NCT00418184|3284161|P1|Double-blind Phase|Poor compliance|3
1002136|NCT00418184|3284160|P2|Double-blind Phase|Adverse Event|1
1002137|NCT00418184|3284161|P1|Double-blind Phase|Adverse Event|2
1002138|NCT00418184|3284160|P2|Double-blind Phase|Withdrawal by Subject|9
1002139|NCT00418184|3284161|P1|Double-blind Phase|Withdrawal by Subject|22
1002140|NCT00418145|3284169|P1|Overall Study|study terminated|6
1002141|NCT00417989|3284244|P2|Overall Study|Physician Decision|2
1002142|NCT00417989|3284245|P1|Overall Study|Physician Decision|5
1002143|NCT00417989|3284244|P2|Overall Study|Death|1
1002144|NCT00417989|3284245|P1|Overall Study|Death|0
1002145|NCT00417989|3284244|P2|Overall Study|Protocol Violation|0
1002146|NCT00417989|3284245|P1|Overall Study|Protocol Violation|1
1002147|NCT00417989|3284244|P2|Overall Study|Lost to Follow-up|6
1002148|NCT00417989|3284245|P1|Overall Study|Lost to Follow-up|1
1002149|NCT00417989|3284244|P2|Overall Study|Withdrawal by Subject|13
1002150|NCT00417989|3284245|P1|Overall Study|Withdrawal by Subject|13
1002151|NCT00417976|3284267|P1|Overall Study|Treatment -related toxicity|2
1002152|NCT00417976|3284267|P1|Overall Study|Non compliance unrelated to toxicity|1
1002153|NCT00417963|3284272|P1|Overall Study|Study device could not be deployed|3
1002154|NCT00417963|3284272|P1|Overall Study|Death|17
1002155|NCT00417963|3284272|P1|Overall Study|Withdrawal by Subject|18
1002156|NCT00417963|3284272|P1|Overall Study|Lost to Follow-up|3
1002157|NCT00417885|3284289|P1|Overall Study|Transferred to Another Sunitinib Study|2
1002158|NCT00417885|3284289|P1|Overall Study|Objective Progression or Relapse|3
1002159|NCT00417885|3284289|P1|Overall Study|Adverse Event|1
1002160|NCT00417612|3284300|P2|Overall Study|Lost to Follow-up|0
1002161|NCT00417612|3284301|P1|Overall Study|Lost to Follow-up|1
1002162|NCT00417612|3284300|P2|Overall Study|Protocol Violation|2
1002163|NCT00417612|3284301|P1|Overall Study|Protocol Violation|0
1002164|NCT00417612|3284300|P2|Overall Study|Adverse Event|0
1002165|NCT00417612|3284301|P1|Overall Study|Adverse Event|2
1002166|NCT00417612|3284300|P2|Overall Study|Errant diagnosis|1
1002167|NCT00417612|3284301|P1|Overall Study|Errant diagnosis|0
1002168|NCT00417482|3284327|P3|Phase B 2nd 16 Weeks|Death|0
1002169|NCT00417482|3284328|P2|Phase B 2nd 16 Weeks|Death|1
1002170|NCT00417482|3284329|P1|Phase B 2nd 16 Weeks|Death|1
1002171|NCT00417482|3284327|P3|Phase B 2nd 16 Weeks|Moved; unclear reason|0
1002172|NCT00417482|3284328|P2|Phase B 2nd 16 Weeks|Moved; unclear reason|0
1002173|NCT00417482|3284329|P1|Phase B 2nd 16 Weeks|Moved; unclear reason|1
1002174|NCT00417482|3284327|P3|Phase B 2nd 16 Weeks|Adverse Event|1
1002175|NCT00417482|3284328|P2|Phase B 2nd 16 Weeks|Adverse Event|0
1002176|NCT00417482|3284329|P1|Phase B 2nd 16 Weeks|Adverse Event|0
1002177|NCT00417482|3284327|P3|Phase B 2nd 16 Weeks|Lack of Efficacy|2
1002178|NCT00417482|3284328|P2|Phase B 2nd 16 Weeks|Lack of Efficacy|12
1002179|NCT00417482|3284329|P1|Phase B 2nd 16 Weeks|Lack of Efficacy|1
1002180|NCT00417482|3284327|P3|Phase B 1st 16 Weeks|Death|0
1002181|NCT00417482|3284328|P2|Phase B 1st 16 Weeks|Death|0
1002182|NCT00417482|3284329|P1|Phase B 1st 16 Weeks|Death|1
1002183|NCT00417482|3284327|P3|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
1002184|NCT00417482|3284328|P2|Phase B 1st 16 Weeks|Moved, Unclear reasons|3
1002185|NCT00417482|3284329|P1|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
1002186|NCT00417482|3284327|P3|Phase B 1st 16 Weeks|Adverse Event|1
1002187|NCT00417482|3284328|P2|Phase B 1st 16 Weeks|Adverse Event|0
1002188|NCT00417482|3284329|P1|Phase B 1st 16 Weeks|Adverse Event|2
1002189|NCT00417482|3284327|P3|Phase B 1st 16 Weeks|Lack of Efficacy|24
1002190|NCT00417482|3284328|P2|Phase B 1st 16 Weeks|Lack of Efficacy|8
1002191|NCT00417482|3284329|P1|Phase B 1st 16 Weeks|Lack of Efficacy|14
1002192|NCT00417248|3284368|P1|Overall Study|Lack of Efficacy|1
1002193|NCT00417248|3284368|P1|Overall Study|Death|1
1002194|NCT00417248|3284368|P1|Overall Study|Study Terminated|6
1002195|NCT00417170|3284375|P2|Overall Study|Lost to Follow-up|1
1002196|NCT00417170|3284376|P1|Overall Study|Lost to Follow-up|0
1002197|NCT00417170|3284375|P2|Overall Study|Withdrawal by Subject|1
1002198|NCT00417170|3284376|P1|Overall Study|Withdrawal by Subject|1
1002199|NCT00417170|3284375|P2|Overall Study|Adverse Event|1
1002200|NCT00417170|3284376|P1|Overall Study|Adverse Event|1
1002201|NCT00417079|3284392|P2|Overall Study|abnormal liver function tests|1
1002202|NCT00417079|3284393|P1|Overall Study|abnormal liver function tests|0
1002203|NCT00417079|3284392|P2|Overall Study|Patient unable to come to the clinic|1
1002204|NCT00417079|3284393|P1|Overall Study|Patient unable to come to the clinic|0
1002205|NCT00417079|3284392|P2|Overall Study|Withdrawal by subject's family|1
1002206|NCT00417079|3284393|P1|Overall Study|Withdrawal by subject's family|0
1002207|NCT00417079|3284392|P2|Overall Study|Screening error|1
1002208|NCT00417079|3284393|P1|Overall Study|Screening error|2
1002209|NCT00417079|3284392|P2|Overall Study|Clinical deterioration|0
1002210|NCT00417079|3284393|P1|Overall Study|Clinical deterioration|1
1002211|NCT00417079|3284392|P2|Overall Study|Non-confirmed Disease progression|1
1002212|NCT00417079|3284393|P1|Overall Study|Non-confirmed Disease progression|1
1002213|NCT00417079|3284392|P2|Overall Study|Investigator's decision|4
1002214|NCT00417079|3284393|P1|Overall Study|Investigator's decision|1
1002215|NCT00417079|3284392|P2|Overall Study|Screened failure|1
1002216|NCT00417079|3284393|P1|Overall Study|Screened failure|2
1002217|NCT00417079|3284392|P2|Overall Study|Not treated|7
1002218|NCT00417079|3284393|P1|Overall Study|Not treated|6
1002219|NCT00417079|3284392|P2|Overall Study|Withdrawal by Subject|8
1002220|NCT00417079|3284393|P1|Overall Study|Withdrawal by Subject|17
1002221|NCT00417079|3284392|P2|Overall Study|Lost to Follow-up|0
1002222|NCT00417079|3284393|P1|Overall Study|Lost to Follow-up|2
1002223|NCT00417079|3284392|P2|Overall Study|Non-compliance to protocol|1
1002224|NCT00417079|3284393|P1|Overall Study|Non-compliance to protocol|0
1002225|NCT00417079|3284392|P2|Overall Study|Adverse Event|67
1002226|NCT00417079|3284393|P1|Overall Study|Adverse Event|32
1002227|NCT00417079|3284392|P2|Overall Study|Disease progression|180
1002228|NCT00417079|3284393|P1|Overall Study|Disease progression|267
1002229|NCT00417027|3284416|P3|Overall Study|Protocol Violation|5
1002230|NCT00417027|3284417|P2|Overall Study|Protocol Violation|5
1002231|NCT00417027|3284418|P1|Overall Study|Protocol Violation|0
1002232|NCT00416949|3284444|P1|Overall Study|Patients refused to participate|5
1002233|NCT00416884|3284448|P1|Overall Study|Study terminated due to low accrual|1
1002234|NCT00416715|3284456|P1|Overall Study|Vitamin D levels not evaluable|8
1002235|NCT00416715|3284456|P1|Overall Study|Not evaluable for joint aches|7
1002236|NCT00416624|3284467|P4|Overall Study|Cancel|0
1002237|NCT00416624|3284468|P3|Overall Study|Cancel|0
1002238|NCT00416624|3284469|P2|Overall Study|Cancel|0
1002239|NCT00416624|3284470|P1|Overall Study|Cancel|1
1002240|NCT00416624|3284467|P4|Overall Study|Not Specified|5
1002241|NCT00416624|3284468|P3|Overall Study|Not Specified|5
1002242|NCT00416624|3284469|P2|Overall Study|Not Specified|11
1002243|NCT00416624|3284470|P1|Overall Study|Not Specified|8
1002244|NCT00416624|3284467|P4|Overall Study|Adverse Event|2
1002245|NCT00416624|3284468|P3|Overall Study|Adverse Event|2
1002246|NCT00416624|3284469|P2|Overall Study|Adverse Event|3
1002247|NCT00416624|3284470|P1|Overall Study|Adverse Event|8
1002248|NCT00416624|3284467|P4|Overall Study|Death|1
1002249|NCT00416624|3284468|P3|Overall Study|Death|7
1002250|NCT00416624|3284469|P2|Overall Study|Death|7
1002251|NCT00416624|3284470|P1|Overall Study|Death|4
1002252|NCT00416624|3284467|P4|Overall Study|Withdrawal by Subject|9
1002253|NCT00416624|3284468|P3|Overall Study|Withdrawal by Subject|4
1002254|NCT00416624|3284469|P2|Overall Study|Withdrawal by Subject|6
1002255|NCT00416624|3284470|P1|Overall Study|Withdrawal by Subject|1
1002256|NCT00416598|3284524|P1|Decitabine Maintenance|Physician discretion/other medical issue|9
1002257|NCT00416598|3284524|P1|Decitabine Maintenance|Alternative treatment|2
1002258|NCT00416598|3284524|P1|Decitabine Maintenance|Progression/relapse|38
1002259|NCT00416598|3284524|P1|Decitabine Maintenance|Withdrawal by Subject|18
1002260|NCT00416598|3284524|P1|Decitabine Maintenance|Adverse Event|5
1002261|NCT00416598|3284524|P1|Induction & Intensification|Failed induction|87
1002262|NCT00416598|3284524|P1|Induction & Intensification|Relapse/progression|29
1002263|NCT00416598|3284524|P1|Induction & Intensification|Physician discretion/other medical issue|45
1002264|NCT00416598|3284524|P1|Induction & Intensification|Alternative Treatment|135
1002265|NCT00416598|3284524|P1|Induction & Intensification|Withdrawal by Subject|46
1002266|NCT00416598|3284524|P1|Induction & Intensification|Death|32
1002267|NCT00416598|3284524|P1|Induction & Intensification|Adverse Event|38
1002268|NCT00416520|3284550|P4|Placebo-controlled Withdrawal Period|Protocol Violation|1
1002269|NCT00416520|3284551|P3|Placebo-controlled Withdrawal Period|Protocol Violation|1
1002270|NCT00416520|3284552|P2|Placebo-controlled Withdrawal Period|Protocol Violation|0
1002271|NCT00416520|3284553|P1|Placebo-controlled Withdrawal Period|Protocol Violation|0
1002272|NCT00416520|3284550|P4|Placebo-controlled Withdrawal Period|Lack of Efficacy|3
1002273|NCT00416520|3284551|P3|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
1002274|NCT00416520|3284552|P2|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
1002275|NCT00416520|3284553|P1|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
1002276|NCT00416520|3284550|P4|Placebo-controlled Withdrawal Period|Adverse Event|1
1002277|NCT00416520|3284551|P3|Placebo-controlled Withdrawal Period|Adverse Event|0
1002278|NCT00416520|3284552|P2|Placebo-controlled Withdrawal Period|Adverse Event|0
1002279|NCT00416520|3284553|P1|Placebo-controlled Withdrawal Period|Adverse Event|0
1002280|NCT00416520|3284550|P4|Open-label Period|Other Reasons|0
1002281|NCT00416520|3284551|P3|Open-label Period|Other Reasons|0
1002282|NCT00416520|3284552|P2|Open-label Period|Other Reasons|12
1002283|NCT00416520|3284553|P1|Open-label Period|Other Reasons|3
1002284|NCT00416520|3284550|P4|Open-label Period|Withdrawal by Subject|0
1002285|NCT00416520|3284551|P3|Open-label Period|Withdrawal by Subject|0
1002286|NCT00416520|3284552|P2|Open-label Period|Withdrawal by Subject|5
1002287|NCT00416520|3284553|P1|Open-label Period|Withdrawal by Subject|16
1002288|NCT00416520|3284550|P4|Open-label Period|Protocol Violation|0
1002289|NCT00416520|3284551|P3|Open-label Period|Protocol Violation|0
1002290|NCT00416520|3284552|P2|Open-label Period|Protocol Violation|3
1002291|NCT00416520|3284553|P1|Open-label Period|Protocol Violation|3
1002292|NCT00416520|3284550|P4|Open-label Period|Lack of Efficacy|0
1002293|NCT00416520|3284551|P3|Open-label Period|Lack of Efficacy|0
1002294|NCT00416520|3284552|P2|Open-label Period|Lack of Efficacy|1
1002295|NCT00416520|3284553|P1|Open-label Period|Lack of Efficacy|8
1002296|NCT00416520|3284550|P4|Open-label Period|Death|0
1002297|NCT00416520|3284551|P3|Open-label Period|Death|0
1002298|NCT00416520|3284552|P2|Open-label Period|Death|1
1002299|NCT00416520|3284553|P1|Open-label Period|Death|2
1002300|NCT00416520|3284550|P4|Open-label Period|Adverse Event|0
1002301|NCT00416520|3284551|P3|Open-label Period|Adverse Event|0
1002302|NCT00416520|3284552|P2|Open-label Period|Adverse Event|10
1002303|NCT00416520|3284553|P1|Open-label Period|Adverse Event|28
1002304|NCT00416455|3284582|P2|Overall Study|Inadequate pathology|2
1002305|NCT00416455|3284583|P1|Overall Study|Inadequate pathology|11
1002306|NCT00416455|3284582|P2|Overall Study|PET / CT poor quality|1
1002307|NCT00416455|3284583|P1|Overall Study|PET / CT poor quality|2
1002308|NCT00416455|3284582|P2|Overall Study|PET / CT not done|5
1002309|NCT00416455|3284583|P1|Overall Study|PET / CT not done|3
1002310|NCT00416312|3284595|P1|Overall Study|tumors not visible on imaging|2
1002311|NCT00416195|3284601|P2|Overall Study|Not Specified|1
1002312|NCT00416195|3284602|P1|Overall Study|Not Specified|0
1002313|NCT00416195|3284601|P2|Overall Study|Protocol Violation|1
1002314|NCT00416195|3284602|P1|Overall Study|Protocol Violation|1
1002315|NCT00416195|3284601|P2|Overall Study|Adverse Event|2
1002316|NCT00416195|3284602|P1|Overall Study|Adverse Event|1
1002317|NCT00416078|3284627|P2|Overall Study|Lost to Follow-up|2
1002318|NCT00416078|3284628|P1|Overall Study|Lost to Follow-up|4
1002319|NCT00416078|3284627|P2|Overall Study|Physician Decision|0
1002320|NCT00416078|3284628|P1|Overall Study|Physician Decision|1
1002321|NCT00416078|3284627|P2|Overall Study|Withdrawal by Subject|2
1002322|NCT00416078|3284628|P1|Overall Study|Withdrawal by Subject|3
1002323|NCT00416078|3284627|P2|Overall Study|Death|4
1002324|NCT00416078|3284628|P1|Overall Study|Death|3
1002325|NCT00415909|3284644|P1|Overall Study|Death|1
1002326|NCT00415909|3284644|P1|Overall Study|Withdrawal by Subject|2
1002327|NCT00415636|3284674|P6|Overall Study|Disease progression|1
1002328|NCT00415636|3284675|P5|Overall Study|Disease progression|0
1002329|NCT00415636|3284676|P4|Overall Study|Disease progression|3
1002330|NCT00415636|3284677|P3|Overall Study|Disease progression|0
1002331|NCT00415636|3284678|P2|Overall Study|Disease progression|0
1002332|NCT00415636|3284679|P1|Overall Study|Disease progression|0
1002333|NCT00415636|3284674|P6|Overall Study|Withdrawal by Subject|0
1002334|NCT00415636|3284675|P5|Overall Study|Withdrawal by Subject|1
1002335|NCT00415636|3284676|P4|Overall Study|Withdrawal by Subject|0
1002336|NCT00415636|3284677|P3|Overall Study|Withdrawal by Subject|0
1002337|NCT00415636|3284678|P2|Overall Study|Withdrawal by Subject|0
1002338|NCT00415636|3284679|P1|Overall Study|Withdrawal by Subject|0
1002339|NCT00415636|3284674|P6|Overall Study|Adverse Event|0
1002340|NCT00415636|3284675|P5|Overall Study|Adverse Event|1
1002341|NCT00415636|3284676|P4|Overall Study|Adverse Event|1
1002342|NCT00415636|3284677|P3|Overall Study|Adverse Event|0
1002343|NCT00415636|3284678|P2|Overall Study|Adverse Event|0
1002344|NCT00415636|3284679|P1|Overall Study|Adverse Event|0
1002345|NCT00415636|3284674|P6|Overall Study|Symptomatic deterioration|1
1002346|NCT00415636|3284675|P5|Overall Study|Symptomatic deterioration|0
1002347|NCT00415636|3284676|P4|Overall Study|Symptomatic deterioration|2
1002348|NCT00415636|3284677|P3|Overall Study|Symptomatic deterioration|1
1002349|NCT00415636|3284678|P2|Overall Study|Symptomatic deterioration|0
1002350|NCT00415636|3284679|P1|Overall Study|Symptomatic deterioration|1
1002351|NCT00415623|3284713|P2|Overall Study|Withdrawal by Subject|1
1002352|NCT00415623|3284714|P1|Overall Study|Withdrawal by Subject|1
1002353|NCT00415623|3284713|P2|Overall Study|Death|0
1002354|NCT00415623|3284714|P1|Overall Study|Death|1
1002355|NCT00415623|3284713|P2|Overall Study|Adverse Event|4
1002356|NCT00415623|3284714|P1|Overall Study|Adverse Event|3
1002357|NCT00415610|3284741|P3|Overall Study|Death|5
1002358|NCT00415610|3284742|P2|Overall Study|Death|2
1002359|NCT00415610|3284743|P1|Overall Study|Death|3
1002360|NCT00415597|3284763|P1|Treatment|Multiple Reasons|1
1002361|NCT00415597|3284763|P1|Treatment|Sponsor Decision|1
1002362|NCT00415597|3284763|P1|Treatment|Administrative|3
1002363|NCT00415597|3284763|P1|Treatment|Drug Screen|2
1002364|NCT00415597|3284763|P1|Treatment|Lost to Follow-up|28
1002365|NCT00415597|3284763|P1|Treatment|Withdrawal by Subject|51
1002366|NCT00415597|3284763|P1|Treatment|Physician Decision|3
1002367|NCT00415597|3284763|P1|Treatment|Protocol Violation|67
1002368|NCT00415597|3284763|P1|Treatment|Lack of Efficacy|39
1002369|NCT00415597|3284763|P1|Treatment|Adverse Event|110
1002370|NCT00415597|3284763|P1|Enrollment|Protocol Violation|1
1002371|NCT00415597|3284763|P1|Enrollment|Withdrawal by Subject|1
1002372|NCT00415532|3284771|P2|Safety Follow Up Period|Requirement for alternative therapy|1
1002373|NCT00415532|3284772|P1|Safety Follow Up Period|Requirement for alternative therapy|0
1002374|NCT00415532|3284771|P2|Safety Follow Up Period|Noncompliance|0
1002375|NCT00415532|3284772|P1|Safety Follow Up Period|Noncompliance|1
1002376|NCT00415532|3284771|P2|Safety Follow Up Period|Ineligibility determined|1
1002377|NCT00415532|3284772|P1|Safety Follow Up Period|Ineligibility determined|1
1002378|NCT00415532|3284771|P2|Safety Follow Up Period|Other|4
1002379|NCT00415532|3284772|P1|Safety Follow Up Period|Other|1
1002380|NCT00415532|3284771|P2|Safety Follow Up Period|Withdrawal by Subject|3
1002381|NCT00415532|3284772|P1|Safety Follow Up Period|Withdrawal by Subject|2
1002382|NCT00415532|3284771|P2|Safety Follow Up Period|Death|0
1002383|NCT00415532|3284772|P1|Safety Follow Up Period|Death|3
1002384|NCT00415532|3284771|P2|Safety Follow Up Period|Adverse Event|3
1002385|NCT00415532|3284772|P1|Safety Follow Up Period|Adverse Event|1
1002386|NCT00415532|3284771|P2|Treatment Period|Requirement for alternative therapy|0
1002387|NCT00415532|3284772|P1|Treatment Period|Requirement for alternative therapy|1
1002388|NCT00415532|3284771|P2|Treatment Period|Noncompliance|1
1002389|NCT00415532|3284772|P1|Treatment Period|Noncompliance|1
1002390|NCT00415532|3284771|P2|Treatment Period|Ineligibility determined|1
1002391|NCT00415532|3284772|P1|Treatment Period|Ineligibility determined|1
1002392|NCT00415532|3284771|P2|Treatment Period|Other|2
1002393|NCT00415532|3284772|P1|Treatment Period|Other|2
1002394|NCT00415532|3284771|P2|Treatment Period|Withdrawal by Subject|6
1002395|NCT00415532|3284772|P1|Treatment Period|Withdrawal by Subject|6
1002396|NCT00415532|3284771|P2|Treatment Period|Protocol Violation|0
1002397|NCT00415532|3284772|P1|Treatment Period|Protocol Violation|1
1002398|NCT00415532|3284771|P2|Treatment Period|Lost to Follow-up|1
1002399|NCT00415532|3284772|P1|Treatment Period|Lost to Follow-up|1
1002400|NCT00415532|3284771|P2|Treatment Period|Death|1
1002401|NCT00415532|3284772|P1|Treatment Period|Death|2
1002402|NCT00415532|3284771|P2|Treatment Period|Adverse Event|3
1002403|NCT00415532|3284772|P1|Treatment Period|Adverse Event|2
1002404|NCT00415519|3284794|P2|Overall Study|Patient’s convenience|0
1002405|NCT00415519|3284795|P1|Overall Study|Patient’s convenience|1
1002406|NCT00415519|3284794|P2|Overall Study|Withdrawal by Subject|0
1002407|NCT00415519|3284795|P1|Overall Study|Withdrawal by Subject|2
1002408|NCT00415519|3284794|P2|Overall Study|Adverse Event|0
1002409|NCT00415519|3284795|P1|Overall Study|Adverse Event|1
1002410|NCT00415194|3284835|P2|Overall Study|Death Due to AE (Other Causes)|15
1002411|NCT00415194|3284836|P1|Overall Study|Death Due to AE (Other Causes)|27
1002412|NCT00415194|3284835|P2|Overall Study|Death Due to Procedural Related AE|1
1002413|NCT00415194|3284836|P1|Overall Study|Death Due to Procedural Related AE|0
1002414|NCT00415194|3284835|P2|Overall Study|Death Due to Study Drug Related AE|1
1002415|NCT00415194|3284836|P1|Overall Study|Death Due to Study Drug Related AE|11
1002416|NCT00415194|3284835|P2|Overall Study|Death Due to Study Disease|29
1002417|NCT00415194|3284836|P1|Overall Study|Death Due to Study Disease|26
1002418|NCT00415194|3284835|P2|Overall Study|Withdrawal by Subject|21
1002419|NCT00415194|3284836|P1|Overall Study|Withdrawal by Subject|28
1002420|NCT00415194|3284835|P2|Overall Study|Protocol Violation|2
1002421|NCT00415194|3284836|P1|Overall Study|Protocol Violation|4
1002422|NCT00415194|3284835|P2|Overall Study|Progressive Disease|217
1002423|NCT00415194|3284836|P1|Overall Study|Progressive Disease|180
1002424|NCT00415194|3284835|P2|Overall Study|Physician Decision|16
1002425|NCT00415194|3284836|P1|Overall Study|Physician Decision|10
1002426|NCT00415194|3284835|P2|Overall Study|Lost to Follow-up|0
1002427|NCT00415194|3284836|P1|Overall Study|Lost to Follow-up|1
1002428|NCT00415194|3284835|P2|Overall Study|Entry Criteria Not Met|8
1002429|NCT00415194|3284836|P1|Overall Study|Entry Criteria Not Met|4
1002430|NCT00415194|3284835|P2|Overall Study|Adverse Event|32
1002431|NCT00415194|3284836|P1|Overall Study|Adverse Event|37
1002432|NCT00415168|3284852|P1|Overall Study|Withdrawal by Subject|6
1002433|NCT00415168|3284852|P1|Overall Study|Sponsor Decision|4
1002434|NCT00415168|3284852|P1|Overall Study|Physician Decision|13
1002435|NCT00415168|3284852|P1|Overall Study|Lost to Follow-up|3
1002436|NCT00415168|3284852|P1|Overall Study|Death|26
1002437|NCT00415051|3284862|P1|Overall Study|Protocol Violation|1
1002438|NCT00414973|3284873|P4|Overall Study|Death|0
1002439|NCT00414973|3284874|P3|Overall Study|Death|1
1002440|NCT00414973|3284875|P2|Overall Study|Death|0
1002441|NCT00414973|3284876|P1|Overall Study|Death|0
1002442|NCT00414973|3284873|P4|Overall Study|Sponsor Decision|0
1002443|NCT00414973|3284874|P3|Overall Study|Sponsor Decision|0
1002444|NCT00414973|3284875|P2|Overall Study|Sponsor Decision|0
1002445|NCT00414973|3284876|P1|Overall Study|Sponsor Decision|1
1002446|NCT00414973|3284873|P4|Overall Study|Lost to Follow-up|0
1002447|NCT00414973|3284874|P3|Overall Study|Lost to Follow-up|0
1002448|NCT00414973|3284875|P2|Overall Study|Lost to Follow-up|2
1002449|NCT00414973|3284876|P1|Overall Study|Lost to Follow-up|0
1002450|NCT00414973|3284873|P4|Overall Study|Protocol Violation|0
1002451|NCT00414973|3284874|P3|Overall Study|Protocol Violation|0
1002452|NCT00414973|3284875|P2|Overall Study|Protocol Violation|4
1002453|NCT00414973|3284876|P1|Overall Study|Protocol Violation|3
1002454|NCT00414973|3284873|P4|Overall Study|Adverse Event|0
1002455|NCT00414973|3284874|P3|Overall Study|Adverse Event|1
1002456|NCT00414973|3284875|P2|Overall Study|Adverse Event|0
1002457|NCT00414973|3284876|P1|Overall Study|Adverse Event|10
1002458|NCT00414973|3284873|P4|Overall Study|Withdrawal by Subject|0
1002459|NCT00414973|3284874|P3|Overall Study|Withdrawal by Subject|1
1002460|NCT00414973|3284875|P2|Overall Study|Withdrawal by Subject|4
1002461|NCT00414973|3284876|P1|Overall Study|Withdrawal by Subject|14
1002462|NCT00414908|3284896|P2|Overall Study|Protocol Violation|1
1002463|NCT00414908|3284897|P1|Overall Study|Protocol Violation|1
1002464|NCT00414726|3284934|P2|Overall Study|Withdrawal by Subject|1
1002465|NCT00414726|3284935|P1|Overall Study|Withdrawal by Subject|0
1002466|NCT00414661|3284970|P4|Overall Study|Other|0
1002467|NCT00414661|3284971|P3|Overall Study|Other|0
1002468|NCT00414661|3284972|P2|Overall Study|Other|3
1002469|NCT00414661|3284973|P1|Overall Study|Other|6
1002470|NCT00414661|3284970|P4|Overall Study|Withdrawal by Subject|2
1002471|NCT00414661|3284971|P3|Overall Study|Withdrawal by Subject|2
1002472|NCT00414661|3284972|P2|Overall Study|Withdrawal by Subject|2
1002473|NCT00414661|3284973|P1|Overall Study|Withdrawal by Subject|5
1002474|NCT00414661|3284970|P4|Overall Study|Lost to Follow-up|1
1002475|NCT00414661|3284971|P3|Overall Study|Lost to Follow-up|0
1002476|NCT00414661|3284972|P2|Overall Study|Lost to Follow-up|4
1002477|NCT00414661|3284973|P1|Overall Study|Lost to Follow-up|1
1002478|NCT00414661|3284970|P4|Overall Study|Death|0
1002479|NCT00414661|3284971|P3|Overall Study|Death|0
1002480|NCT00414661|3284972|P2|Overall Study|Death|5
1002481|NCT00414661|3284973|P1|Overall Study|Death|2
1002482|NCT00414609|3285018|P3|Extension Study|Death|17
1002483|NCT00414609|3285019|P2|Extension Study|Death|0
1002484|NCT00414609|3285020|P1|Extension Study|Death|0
1002485|NCT00414609|3285018|P3|Extension Study|Administrative problems|1
1002486|NCT00414609|3285019|P2|Extension Study|Administrative problems|0
1002487|NCT00414609|3285020|P1|Extension Study|Administrative problems|0
1002488|NCT00414609|3285018|P3|Extension Study|Lost to Follow-up|10
1002489|NCT00414609|3285019|P2|Extension Study|Lost to Follow-up|0
1002490|NCT00414609|3285020|P1|Extension Study|Lost to Follow-up|0
1002491|NCT00414609|3285018|P3|Extension Study|Withdrawal by Subject|13
1002492|NCT00414609|3285019|P2|Extension Study|Withdrawal by Subject|0
1002493|NCT00414609|3285020|P1|Extension Study|Withdrawal by Subject|0
1002494|NCT00414609|3285018|P3|Extension Study|Unsatisfactory therapeutic effect|2
1002495|NCT00414609|3285019|P2|Extension Study|Unsatisfactory therapeutic effect|0
1002496|NCT00414609|3285020|P1|Extension Study|Unsatisfactory therapeutic effect|0
1002497|NCT00414609|3285018|P3|Extension Study|Adverse Event|14
1002498|NCT00414609|3285019|P2|Extension Study|Adverse Event|0
1002499|NCT00414609|3285020|P1|Extension Study|Adverse Event|0
1002500|NCT00414609|3285018|P3|Core Study|Death|0
1002501|NCT00414609|3285019|P2|Core Study|Death|14
1002502|NCT00414609|3285020|P1|Core Study|Death|7
1002503|NCT00414609|3285018|P3|Core Study|Administrative problems|0
1002504|NCT00414609|3285019|P2|Core Study|Administrative problems|2
1002505|NCT00414609|3285020|P1|Core Study|Administrative problems|0
1002506|NCT00414609|3285018|P3|Core Study|Lost to Follow-up|0
1002507|NCT00414609|3285019|P2|Core Study|Lost to Follow-up|4
1002508|NCT00414609|3285020|P1|Core Study|Lost to Follow-up|7
1002509|NCT00414609|3285018|P3|Core Study|Patient withdrew consent|0
1002510|NCT00414609|3285019|P2|Core Study|Patient withdrew consent|11
1002511|NCT00414609|3285020|P1|Core Study|Patient withdrew consent|10
1002512|NCT00414609|3285018|P3|Core Study|Protocol deviation|0
1002513|NCT00414609|3285019|P2|Core Study|Protocol deviation|1
1002514|NCT00414609|3285020|P1|Core Study|Protocol deviation|0
1002515|NCT00414609|3285018|P3|Core Study|Abnormal test procedure results|0
1002516|NCT00414609|3285019|P2|Core Study|Abnormal test procedure results|1
1002517|NCT00414609|3285020|P1|Core Study|Abnormal test procedure results|1
1002518|NCT00414609|3285018|P3|Core Study|Abnormal laboratory values|0
1002519|NCT00414609|3285019|P2|Core Study|Abnormal laboratory values|1
1002520|NCT00414609|3285020|P1|Core Study|Abnormal laboratory values|0
1002521|NCT00414609|3285018|P3|Core Study|Adverse Event|0
1002522|NCT00414609|3285019|P2|Core Study|Adverse Event|11
1002523|NCT00414609|3285020|P1|Core Study|Adverse Event|9
1002524|NCT00414596|3285043|P1|Overall Study|Protocol Violation|2
1002525|NCT00414544|3285052|P1|Overall Study|Lost to Follow-up|14
1002526|NCT00414466|3285075|P4|Overall Study|Withdrawn by Sponsor|0
1002527|NCT00414466|3285076|P3|Overall Study|Withdrawn by Sponsor|0
1002528|NCT00414466|3285077|P2|Overall Study|Withdrawn by Sponsor|0
1002529|NCT00414466|3285078|P1|Overall Study|Withdrawn by Sponsor|1
1002530|NCT00414466|3285075|P4|Overall Study|Lack of Efficacy|0
1002531|NCT00414466|3285076|P3|Overall Study|Lack of Efficacy|0
1002532|NCT00414466|3285077|P2|Overall Study|Lack of Efficacy|0
1002533|NCT00414466|3285078|P1|Overall Study|Lack of Efficacy|1
1002534|NCT00414466|3285075|P4|Overall Study|Adverse Event|1
1002535|NCT00414466|3285076|P3|Overall Study|Adverse Event|1
1002536|NCT00414466|3285077|P2|Overall Study|Adverse Event|0
1002537|NCT00414466|3285078|P1|Overall Study|Adverse Event|0
1002538|NCT00414453|3285096|P1|Overall Study|Abnormal lab work|16
1002539|NCT00414440|3285144|P2|Extension Period|Not included in follow up period|8
1002540|NCT00414440|3285145|P1|Extension Period|Not included in follow up period|18
1002541|NCT00414440|3285144|P2|Extension Period|Withdrawal by Subject|7
1002542|NCT00414440|3285145|P1|Extension Period|Withdrawal by Subject|9
1002543|NCT00414440|3285144|P2|Extension Period|Death|2
1002544|NCT00414440|3285145|P1|Extension Period|Death|1
1002545|NCT00414440|3285144|P2|Extension Period|Administrative|16
1002546|NCT00414440|3285145|P1|Extension Period|Administrative|16
1002547|NCT00414440|3285144|P2|Extension Period|Other|1
1002548|NCT00414440|3285145|P1|Extension Period|Other|1
1002549|NCT00414440|3285144|P2|Extension Period|Did not consent to continue follow up|54
1002550|NCT00414440|3285145|P1|Extension Period|Did not consent to continue follow up|61
1002551|NCT00414440|3285144|P2|Extension Period|Lost to Follow-up|52
1002552|NCT00414440|3285145|P1|Extension Period|Lost to Follow-up|44
1002553|NCT00414440|3285144|P2|Core Period|Withdrawal by Subject|32
1002554|NCT00414440|3285145|P1|Core Period|Withdrawal by Subject|70
1002555|NCT00414388|3285159|P1|Overall Study|Adverse Event|1
1002556|NCT00414310|3285167|P2|Overall Study|Not treated|0
1002557|NCT00414310|3285168|P1|Overall Study|Not treated|1
1002558|NCT00414076|3285200|P2|Overall Study|Adverse Event|0
1002559|NCT00414076|3285201|P1|Overall Study|Adverse Event|1
1002560|NCT00414076|3285200|P2|Overall Study|Withdrawal by Subject|3
1002561|NCT00414076|3285201|P1|Overall Study|Withdrawal by Subject|1
1002562|NCT00414076|3285200|P2|Overall Study|Progression|2
1002563|NCT00414076|3285201|P1|Overall Study|Progression|1
1002564|NCT00414050|3285211|P4|Overall Study|Subject Moved|1
1002565|NCT00414050|3285212|P3|Overall Study|Subject Moved|0
1002566|NCT00414050|3285213|P2|Overall Study|Subject Moved|0
1002567|NCT00414050|3285214|P1|Overall Study|Subject Moved|0
1002568|NCT00414050|3285211|P4|Overall Study|Subject discontinued for other reason|1
1002569|NCT00414050|3285212|P3|Overall Study|Subject discontinued for other reason|2
1002570|NCT00414050|3285213|P2|Overall Study|Subject discontinued for other reason|2
1002571|NCT00414050|3285214|P1|Overall Study|Subject discontinued for other reason|1
1002572|NCT00414050|3285211|P4|Overall Study|Withdrawal by Subject|4
1002573|NCT00414050|3285212|P3|Overall Study|Withdrawal by Subject|2
1002574|NCT00414050|3285213|P2|Overall Study|Withdrawal by Subject|3
1002575|NCT00414050|3285214|P1|Overall Study|Withdrawal by Subject|5
1002576|NCT00414050|3285211|P4|Overall Study|Lost to Follow-up|1
1002577|NCT00414050|3285212|P3|Overall Study|Lost to Follow-up|1
1002578|NCT00414050|3285213|P2|Overall Study|Lost to Follow-up|2
1002579|NCT00414050|3285214|P1|Overall Study|Lost to Follow-up|2
1002580|NCT00414050|3285211|P4|Overall Study|Adverse Event|1
1002581|NCT00414050|3285212|P3|Overall Study|Adverse Event|1
1002582|NCT00414050|3285213|P2|Overall Study|Adverse Event|1
1002583|NCT00414050|3285214|P1|Overall Study|Adverse Event|1
1002584|NCT00414011|3285228|P1|Overall Study|Withdrawal by Subject|2
1002585|NCT00414011|3285228|P1|Overall Study|Physician Decision|3
1002586|NCT00413972|3285237|P4|Overall Study|Not Specified|1
1002587|NCT00413972|3285238|P3|Overall Study|Not Specified|0
1002588|NCT00413972|3285239|P2|Overall Study|Not Specified|0
1002589|NCT00413972|3285240|P1|Overall Study|Not Specified|0
1002590|NCT00413972|3285237|P4|Overall Study|Protocol Violation|0
1002591|NCT00413972|3285238|P3|Overall Study|Protocol Violation|2
1002592|NCT00413972|3285239|P2|Overall Study|Protocol Violation|0
1002593|NCT00413972|3285240|P1|Overall Study|Protocol Violation|0
1002594|NCT00413972|3285237|P4|Overall Study|Withdrawal by Subject|2
1002595|NCT00413972|3285238|P3|Overall Study|Withdrawal by Subject|7
1002596|NCT00413972|3285239|P2|Overall Study|Withdrawal by Subject|5
1002597|NCT00413972|3285240|P1|Overall Study|Withdrawal by Subject|4
1002598|NCT00413972|3285237|P4|Overall Study|Lost to Follow-up|0
1002599|NCT00413972|3285238|P3|Overall Study|Lost to Follow-up|1
1002600|NCT00413972|3285239|P2|Overall Study|Lost to Follow-up|2
1002601|NCT00413972|3285240|P1|Overall Study|Lost to Follow-up|1
1002602|NCT00413972|3285237|P4|Overall Study|Adverse Event|0
1002603|NCT00413972|3285238|P3|Overall Study|Adverse Event|0
1002604|NCT00413972|3285239|P2|Overall Study|Adverse Event|1
1002605|NCT00413972|3285240|P1|Overall Study|Adverse Event|2
1002606|NCT00413959|3285250|P1|Overall Study|Pt had only one cycle.|1
1002607|NCT00413920|3285257|P2|Overall Study|Graft Loss|3
1002608|NCT00413920|3285258|P1|Overall Study|Graft Loss|5
1002609|NCT00413920|3285257|P2|Overall Study|Death|5
1002610|NCT00413920|3285258|P1|Overall Study|Death|3
1002611|NCT00413920|3285257|P2|Overall Study|Lack of Efficacy|9
1002612|NCT00413920|3285258|P1|Overall Study|Lack of Efficacy|11
1002613|NCT00413920|3285257|P2|Overall Study|Adverse Event|11
1002614|NCT00413920|3285258|P1|Overall Study|Adverse Event|9
1002615|NCT00413894|3285273|P1|Overall Study|Other|18
1002616|NCT00413894|3285273|P1|Overall Study|Protocol Violation|11
1002617|NCT00413894|3285273|P1|Overall Study|Adverse Event|28
1002618|NCT00413894|3285273|P1|Overall Study|Hb <10 grams/deciliter|12
1002619|NCT00413894|3285273|P1|Overall Study|Administrative Reasons|1
1002620|NCT00413894|3285273|P1|Overall Study|Withdrawal by Subject|10
1002621|NCT00413777|3285290|P2|Fixed-dose Period|Withdrew Consent|1
1002622|NCT00413777|3285291|P1|Fixed-dose Period|Withdrew Consent|0
1002623|NCT00413777|3285290|P2|Fixed-dose Period|Met Withdrawal Criteria|0
1002624|NCT00413777|3285291|P1|Fixed-dose Period|Met Withdrawal Criteria|1
1002625|NCT00413777|3285290|P2|Fixed-dose Period|Adverse Event|1
1002626|NCT00413777|3285291|P1|Fixed-dose Period|Adverse Event|2
1002627|NCT00413777|3285290|P2|Fixed-dose Period|Lost to Follow-up|1
1002628|NCT00413777|3285291|P1|Fixed-dose Period|Lost to Follow-up|1
1002629|NCT00413699|3285339|P3|Extension Period|Adverse Event|2
1002630|NCT00413699|3285340|P2|Extension Period|Adverse Event|0
1002631|NCT00413699|3285341|P1|Extension Period|Adverse Event|0
1002632|NCT00413699|3285339|P3|Extension Period|Protocol Violation|1
1002633|NCT00413699|3285340|P2|Extension Period|Protocol Violation|0
1002634|NCT00413699|3285341|P1|Extension Period|Protocol Violation|0
1002635|NCT00413699|3285339|P3|Extension Period|No Longer Willing to Participate|2
1002636|NCT00413699|3285340|P2|Extension Period|No Longer Willing to Participate|0
1002637|NCT00413699|3285341|P1|Extension Period|No Longer Willing to Participate|0
1002638|NCT00413699|3285339|P3|Initial Period|No longer willing to participate|0
1002639|NCT00413699|3285340|P2|Initial Period|No longer willing to participate|368
1002640|NCT00413699|3285341|P1|Initial Period|No longer willing to participate|116
1002641|NCT00413699|3285339|P3|Initial Period|Missing end of study page|0
1002642|NCT00413699|3285340|P2|Initial Period|Missing end of study page|4
1002643|NCT00413699|3285341|P1|Initial Period|Missing end of study page|0
1002644|NCT00413699|3285339|P3|Initial Period|Adverse event not related to study drug|0
1002645|NCT00413699|3285340|P2|Initial Period|Adverse event not related to study drug|248
1002646|NCT00413699|3285341|P1|Initial Period|Adverse event not related to study drug|113
1002647|NCT00413699|3285339|P3|Initial Period|Adverse event related to study drug|0
1002648|NCT00413699|3285340|P2|Initial Period|Adverse event related to study drug|527
1002649|NCT00413699|3285341|P1|Initial Period|Adverse event related to study drug|178
1002650|NCT00413699|3285339|P3|Initial Period|Not specified|0
1002651|NCT00413699|3285340|P2|Initial Period|Not specified|211
1002652|NCT00413699|3285341|P1|Initial Period|Not specified|67
1002653|NCT00413699|3285339|P3|Initial Period|Study terminated by Sponsor|0
1002654|NCT00413699|3285340|P2|Initial Period|Study terminated by Sponsor|1
1002655|NCT00413699|3285341|P1|Initial Period|Study terminated by Sponsor|0
1002656|NCT00413699|3285339|P3|Initial Period|Medication error without adverse event|0
1002657|NCT00413699|3285340|P2|Initial Period|Medication error without adverse event|1
1002658|NCT00413699|3285341|P1|Initial Period|Medication error without adverse event|0
1002659|NCT00413699|3285339|P3|Initial Period|Did not meet entrance criteria|0
1002660|NCT00413699|3285340|P2|Initial Period|Did not meet entrance criteria|2
1002661|NCT00413699|3285341|P1|Initial Period|Did not meet entrance criteria|2
1002662|NCT00413699|3285339|P3|Initial Period|Pregnancy|0
1002663|NCT00413699|3285340|P2|Initial Period|Pregnancy|8
1002664|NCT00413699|3285341|P1|Initial Period|Pregnancy|10
1002665|NCT00413699|3285339|P3|Initial Period|Protocol Violation|0
1002666|NCT00413699|3285340|P2|Initial Period|Protocol Violation|89
1002667|NCT00413699|3285341|P1|Initial Period|Protocol Violation|38
1002668|NCT00413699|3285339|P3|Initial Period|Lost to Follow-up|0
1002669|NCT00413699|3285340|P2|Initial Period|Lost to Follow-up|101
1002670|NCT00413699|3285341|P1|Initial Period|Lost to Follow-up|31
1002671|NCT00413699|3285339|P3|Initial Period|Lack of Efficacy|0
1002672|NCT00413699|3285340|P2|Initial Period|Lack of Efficacy|115
1002673|NCT00413699|3285341|P1|Initial Period|Lack of Efficacy|59
1002674|NCT00413699|3285339|P3|Initial Period|Death|0
1002675|NCT00413699|3285340|P2|Initial Period|Death|30
1002676|NCT00413699|3285341|P1|Initial Period|Death|25
1002677|NCT00413660|3285423|P11|Post Week 12|Other|0
1002678|NCT00413660|3285424|P10|Post Week 12|Other|0
1002679|NCT00413660|3285425|P9|Post Week 12|Other|0
1002680|NCT00413660|3285426|P8|Post Week 12|Other|0
1002681|NCT00413660|3285427|P7|Post Week 12|Other|1
1002682|NCT00413660|3285428|P6|Post Week 12|Other|1
1002683|NCT00413660|3285429|P5|Post Week 12|Other|1
1002684|NCT00413660|3285430|P4|Post Week 12|Other|0
1002685|NCT00413660|3285431|P3|Post Week 12|Other|3
1002686|NCT00413660|3285432|P2|Post Week 12|Other|2
1002687|NCT00413660|3285433|P1|Post Week 12|Other|1
1002688|NCT00413660|3285423|P11|Post Week 12|Withdrawal by Subject|1
1002689|NCT00413660|3285424|P10|Post Week 12|Withdrawal by Subject|0
1002690|NCT00413660|3285425|P9|Post Week 12|Withdrawal by Subject|0
1002691|NCT00413660|3285426|P8|Post Week 12|Withdrawal by Subject|0
1002692|NCT00413660|3285427|P7|Post Week 12|Withdrawal by Subject|0
1002693|NCT00413660|3285428|P6|Post Week 12|Withdrawal by Subject|0
1002694|NCT00413660|3285429|P5|Post Week 12|Withdrawal by Subject|1
1002695|NCT00413660|3285430|P4|Post Week 12|Withdrawal by Subject|0
1002696|NCT00413660|3285431|P3|Post Week 12|Withdrawal by Subject|1
1002697|NCT00413660|3285432|P2|Post Week 12|Withdrawal by Subject|1
1002698|NCT00413660|3285433|P1|Post Week 12|Withdrawal by Subject|0
1002699|NCT00413660|3285423|P11|Post Week 12|Lost to Follow-up|0
1002700|NCT00413660|3285424|P10|Post Week 12|Lost to Follow-up|0
1002701|NCT00413660|3285425|P9|Post Week 12|Lost to Follow-up|0
1002702|NCT00413660|3285426|P8|Post Week 12|Lost to Follow-up|0
1002703|NCT00413660|3285427|P7|Post Week 12|Lost to Follow-up|0
1002704|NCT00413660|3285428|P6|Post Week 12|Lost to Follow-up|0
1002705|NCT00413660|3285429|P5|Post Week 12|Lost to Follow-up|0
1002706|NCT00413660|3285430|P4|Post Week 12|Lost to Follow-up|0
1002707|NCT00413660|3285431|P3|Post Week 12|Lost to Follow-up|1
1002708|NCT00413660|3285432|P2|Post Week 12|Lost to Follow-up|1
1002709|NCT00413660|3285433|P1|Post Week 12|Lost to Follow-up|0
1002710|NCT00413660|3285423|P11|Post Week 12|Lack of Efficacy|0
1002711|NCT00413660|3285424|P10|Post Week 12|Lack of Efficacy|1
1002712|NCT00413660|3285425|P9|Post Week 12|Lack of Efficacy|0
1002713|NCT00413660|3285426|P8|Post Week 12|Lack of Efficacy|0
1002714|NCT00413660|3285427|P7|Post Week 12|Lack of Efficacy|0
1002715|NCT00413660|3285428|P6|Post Week 12|Lack of Efficacy|0
1002716|NCT00413660|3285429|P5|Post Week 12|Lack of Efficacy|0
1002717|NCT00413660|3285430|P4|Post Week 12|Lack of Efficacy|0
1002718|NCT00413660|3285431|P3|Post Week 12|Lack of Efficacy|1
1002719|NCT00413660|3285432|P2|Post Week 12|Lack of Efficacy|0
1002720|NCT00413660|3285433|P1|Post Week 12|Lack of Efficacy|0
1002721|NCT00413660|3285423|P11|Post Week 12|Adverse Event|0
1002722|NCT00413660|3285424|P10|Post Week 12|Adverse Event|0
1002723|NCT00413660|3285425|P9|Post Week 12|Adverse Event|0
1002724|NCT00413660|3285426|P8|Post Week 12|Adverse Event|0
1002725|NCT00413660|3285427|P7|Post Week 12|Adverse Event|2
1002726|NCT00413660|3285428|P6|Post Week 12|Adverse Event|2
1002727|NCT00413660|3285429|P5|Post Week 12|Adverse Event|4
1002728|NCT00413660|3285430|P4|Post Week 12|Adverse Event|1
1002729|NCT00413660|3285431|P3|Post Week 12|Adverse Event|2
1002730|NCT00413660|3285432|P2|Post Week 12|Adverse Event|0
1002731|NCT00413660|3285433|P1|Post Week 12|Adverse Event|2
1002732|NCT00413660|3285423|P11|Up To Week 12|Other|0
1002733|NCT00413660|3285424|P10|Up To Week 12|Other|0
1002734|NCT00413660|3285425|P9|Up To Week 12|Other|0
1002735|NCT00413660|3285426|P8|Up To Week 12|Other|0
1002736|NCT00413660|3285427|P7|Up To Week 12|Other|3
1002737|NCT00413660|3285428|P6|Up To Week 12|Other|4
1002738|NCT00413660|3285429|P5|Up To Week 12|Other|2
1002739|NCT00413660|3285430|P4|Up To Week 12|Other|1
1002740|NCT00413660|3285431|P3|Up To Week 12|Other|6
1002741|NCT00413660|3285432|P2|Up To Week 12|Other|1
1002742|NCT00413660|3285433|P1|Up To Week 12|Other|3
1002743|NCT00413660|3285423|P11|Up To Week 12|Randomized, Not Treated|0
1002744|NCT00413660|3285424|P10|Up To Week 12|Randomized, Not Treated|0
1002745|NCT00413660|3285425|P9|Up To Week 12|Randomized, Not Treated|0
1002746|NCT00413660|3285426|P8|Up To Week 12|Randomized, Not Treated|0
1002747|NCT00413660|3285427|P7|Up To Week 12|Randomized, Not Treated|0
1002748|NCT00413660|3285428|P6|Up To Week 12|Randomized, Not Treated|0
1002749|NCT00413660|3285429|P5|Up To Week 12|Randomized, Not Treated|0
1002750|NCT00413660|3285430|P4|Up To Week 12|Randomized, Not Treated|1
1002751|NCT00413660|3285431|P3|Up To Week 12|Randomized, Not Treated|0
1002752|NCT00413660|3285432|P2|Up To Week 12|Randomized, Not Treated|0
1002753|NCT00413660|3285433|P1|Up To Week 12|Randomized, Not Treated|1
1002754|NCT00413660|3285423|P11|Up To Week 12|Withdrawal by Subject|0
1002755|NCT00413660|3285424|P10|Up To Week 12|Withdrawal by Subject|0
1002756|NCT00413660|3285425|P9|Up To Week 12|Withdrawal by Subject|0
1002757|NCT00413660|3285426|P8|Up To Week 12|Withdrawal by Subject|0
1002758|NCT00413660|3285427|P7|Up To Week 12|Withdrawal by Subject|2
1002759|NCT00413660|3285428|P6|Up To Week 12|Withdrawal by Subject|2
1002760|NCT00413660|3285429|P5|Up To Week 12|Withdrawal by Subject|0
1002761|NCT00413660|3285430|P4|Up To Week 12|Withdrawal by Subject|2
1002762|NCT00413660|3285431|P3|Up To Week 12|Withdrawal by Subject|0
1002763|NCT00413660|3285432|P2|Up To Week 12|Withdrawal by Subject|2
1002764|NCT00413660|3285433|P1|Up To Week 12|Withdrawal by Subject|0
1002765|NCT00413660|3285423|P11|Up To Week 12|Lost to Follow-up|0
1002766|NCT00413660|3285424|P10|Up To Week 12|Lost to Follow-up|0
1002767|NCT00413660|3285425|P9|Up To Week 12|Lost to Follow-up|0
1002768|NCT00413660|3285426|P8|Up To Week 12|Lost to Follow-up|0
1002769|NCT00413660|3285427|P7|Up To Week 12|Lost to Follow-up|0
1002770|NCT00413660|3285428|P6|Up To Week 12|Lost to Follow-up|0
1002771|NCT00413660|3285429|P5|Up To Week 12|Lost to Follow-up|1
1002772|NCT00413660|3285430|P4|Up To Week 12|Lost to Follow-up|0
1002773|NCT00413660|3285431|P3|Up To Week 12|Lost to Follow-up|0
1002774|NCT00413660|3285432|P2|Up To Week 12|Lost to Follow-up|1
1002775|NCT00413660|3285433|P1|Up To Week 12|Lost to Follow-up|0
1002776|NCT00413660|3285423|P11|Up To Week 12|Lack of Efficacy|0
1002777|NCT00413660|3285424|P10|Up To Week 12|Lack of Efficacy|0
1002778|NCT00413660|3285425|P9|Up To Week 12|Lack of Efficacy|0
1002779|NCT00413660|3285426|P8|Up To Week 12|Lack of Efficacy|0
1002780|NCT00413660|3285427|P7|Up To Week 12|Lack of Efficacy|5
1002781|NCT00413660|3285428|P6|Up To Week 12|Lack of Efficacy|0
1002782|NCT00413660|3285429|P5|Up To Week 12|Lack of Efficacy|0
1002783|NCT00413660|3285430|P4|Up To Week 12|Lack of Efficacy|0
1002784|NCT00413660|3285431|P3|Up To Week 12|Lack of Efficacy|0
1002785|NCT00413660|3285432|P2|Up To Week 12|Lack of Efficacy|0
1002786|NCT00413660|3285433|P1|Up To Week 12|Lack of Efficacy|2
1002787|NCT00413660|3285423|P11|Up To Week 12|Adverse Event|0
1002788|NCT00413660|3285424|P10|Up To Week 12|Adverse Event|0
1002789|NCT00413660|3285425|P9|Up To Week 12|Adverse Event|0
1002790|NCT00413660|3285426|P8|Up To Week 12|Adverse Event|0
1002791|NCT00413660|3285427|P7|Up To Week 12|Adverse Event|1
1002792|NCT00413660|3285428|P6|Up To Week 12|Adverse Event|4
1002793|NCT00413660|3285429|P5|Up To Week 12|Adverse Event|6
1002794|NCT00413660|3285430|P4|Up To Week 12|Adverse Event|4
1002795|NCT00413660|3285431|P3|Up To Week 12|Adverse Event|1
1002796|NCT00413660|3285432|P2|Up To Week 12|Adverse Event|3
1002797|NCT00413660|3285433|P1|Up To Week 12|Adverse Event|1
1002798|NCT00413413|3285836|P3|Double-Blind|Lost to Follow-up|2
1002799|NCT00413413|3285837|P2|Double-Blind|Lost to Follow-up|4
1002800|NCT00413413|3285838|P1|Double-Blind|Lost to Follow-up|3
1002801|NCT00413413|3285836|P3|Double-Blind|Subject withdrew consent|9
1002802|NCT00413413|3285837|P2|Double-Blind|Subject withdrew consent|6
1002803|NCT00413413|3285838|P1|Double-Blind|Subject withdrew consent|4
1002804|NCT00413413|3285836|P3|Double-Blind|Protocol deviation|1
1002805|NCT00413413|3285837|P2|Double-Blind|Protocol deviation|2
1002806|NCT00413413|3285838|P1|Double-Blind|Protocol deviation|1
1002807|NCT00413413|3285836|P3|Double-Blind|Unsatisfactory therapeutic effect|1
1002808|NCT00413413|3285837|P2|Double-Blind|Unsatisfactory therapeutic effect|2
1002809|NCT00413413|3285838|P1|Double-Blind|Unsatisfactory therapeutic effect|1
1002810|NCT00413413|3285836|P3|Double-Blind|Adverse Event|5
1002811|NCT00413413|3285837|P2|Double-Blind|Adverse Event|0
1002812|NCT00413413|3285838|P1|Double-Blind|Adverse Event|6
1002813|NCT00413413|3285836|P3|Single-Blind|Lost to Follow-up|0
1002814|NCT00413413|3285837|P2|Single-Blind|Lost to Follow-up|8
1002815|NCT00413413|3285838|P1|Single-Blind|Lost to Follow-up|0
1002816|NCT00413413|3285836|P3|Single-Blind|Withdrawal by Subject|0
1002817|NCT00413413|3285837|P2|Single-Blind|Withdrawal by Subject|27
1002818|NCT00413413|3285838|P1|Single-Blind|Withdrawal by Subject|0
1002819|NCT00413413|3285836|P3|Single-Blind|Protocol Violation|0
1002820|NCT00413413|3285837|P2|Single-Blind|Protocol Violation|16
1002821|NCT00413413|3285838|P1|Single-Blind|Protocol Violation|0
1002822|NCT00413413|3285836|P3|Single-Blind|Subject no longer requires study drug|0
1002823|NCT00413413|3285837|P2|Single-Blind|Subject no longer requires study drug|151
1002824|NCT00413413|3285838|P1|Single-Blind|Subject no longer requires study drug|0
1002825|NCT00413413|3285836|P3|Single-Blind|Lack of Efficacy|0
1002826|NCT00413413|3285837|P2|Single-Blind|Lack of Efficacy|5
1002827|NCT00413413|3285838|P1|Single-Blind|Lack of Efficacy|0
1002828|NCT00413413|3285836|P3|Single-Blind|Adverse Event|0
1002829|NCT00413413|3285837|P2|Single-Blind|Adverse Event|9
1002830|NCT00413413|3285838|P1|Single-Blind|Adverse Event|0
1002831|NCT00413374|3285891|P2|Overall Study|Surgery|0
1002832|NCT00413374|3285892|P1|Overall Study|Surgery|1
1002833|NCT00413374|3285891|P2|Overall Study|Lost to Follow-up|0
1002834|NCT00413374|3285892|P1|Overall Study|Lost to Follow-up|1
1002835|NCT00413374|3285891|P2|Overall Study|Adverse Event|0
1002836|NCT00413374|3285892|P1|Overall Study|Adverse Event|1
1002837|NCT00413374|3285891|P2|Overall Study|Ineligible due to screening criteria.|0
1002838|NCT00413374|3285892|P1|Overall Study|Ineligible due to screening criteria.|3
1002839|NCT00413283|3285923|P4|Overall Study|Not specified|0
1002840|NCT00413283|3285924|P3|Overall Study|Not specified|1
1002841|NCT00413283|3285925|P2|Overall Study|Not specified|0
1002842|NCT00413283|3285926|P1|Overall Study|Not specified|0
1002843|NCT00413283|3285923|P4|Overall Study|Requirement for alternative therapy|0
1002844|NCT00413283|3285924|P3|Overall Study|Requirement for alternative therapy|0
1002845|NCT00413283|3285925|P2|Overall Study|Requirement for alternative therapy|2
1002846|NCT00413283|3285926|P1|Overall Study|Requirement for alternative therapy|0
1002847|NCT00413283|3285923|P4|Overall Study|Protocol deviation|0
1002848|NCT00413283|3285924|P3|Overall Study|Protocol deviation|0
1002849|NCT00413283|3285925|P2|Overall Study|Protocol deviation|1
1002850|NCT00413283|3285926|P1|Overall Study|Protocol deviation|0
1002851|NCT00413283|3285923|P4|Overall Study|Ineligibility determined|1
1002852|NCT00413283|3285924|P3|Overall Study|Ineligibility determined|0
1002853|NCT00413283|3285925|P2|Overall Study|Ineligibility determined|0
1002854|NCT00413283|3285926|P1|Overall Study|Ineligibility determined|0
1002855|NCT00413283|3285923|P4|Overall Study|Adverse Event|1
1002856|NCT00413283|3285924|P3|Overall Study|Adverse Event|0
1002857|NCT00413283|3285925|P2|Overall Study|Adverse Event|0
1002858|NCT00413283|3285926|P1|Overall Study|Adverse Event|0
1002859|NCT00413283|3285923|P4|Overall Study|Death|1
1002860|NCT00413283|3285924|P3|Overall Study|Death|1
1002861|NCT00413283|3285925|P2|Overall Study|Death|0
1002862|NCT00413283|3285926|P1|Overall Study|Death|0
1002863|NCT00413283|3285923|P4|Overall Study|Withdrawal by Subject|1
1002864|NCT00413283|3285924|P3|Overall Study|Withdrawal by Subject|0
1002865|NCT00413283|3285925|P2|Overall Study|Withdrawal by Subject|0
1002866|NCT00413283|3285926|P1|Overall Study|Withdrawal by Subject|1
1002867|NCT00413244|3285958|P2|Overall Study|Withdrawal by Subject|1
1002868|NCT00413244|3285959|P1|Overall Study|Withdrawal by Subject|10
1002869|NCT00413231|3285987|P1|365-day to 60-month Post Treatment|Exited after surgical conversion|1
1002870|NCT00413231|3285987|P1|365-day to 60-month Post Treatment|Lost to Follow-up|4
1002871|NCT00413231|3285987|P1|365-day to 60-month Post Treatment|Withdrawal by Subject|5
1002872|NCT00413231|3285987|P1|365-day to 60-month Post Treatment|Death|36
1002873|NCT00413231|3285987|P1|30-day to 365-day Post Treatment|Death|13
1002874|NCT00413231|3285987|P1|0 to 30-day Post Treatment|Intend to treat, but not implanted|3
1002875|NCT00413231|3285987|P1|0 to 30-day Post Treatment|Death|5
1002876|NCT00413218|3286019|P2|Overall Study|Withdrawal by Subject|1
1002877|NCT00413218|3286020|P1|Overall Study|Withdrawal by Subject|9
1002878|NCT00413218|3286019|P2|Overall Study|Missing|0
1002879|NCT00413218|3286020|P1|Overall Study|Missing|1
1002880|NCT00413218|3286019|P2|Overall Study|Admin|14
1002881|NCT00413218|3286020|P1|Overall Study|Admin|20
1002882|NCT00413218|3286019|P2|Overall Study|Lost to Follow-up|17
1002883|NCT00413218|3286020|P1|Overall Study|Lost to Follow-up|14
1002884|NCT00413218|3286019|P2|Overall Study|Death|56
1002885|NCT00413218|3286020|P1|Overall Study|Death|57
1002886|NCT00413218|3286019|P2|Overall Study|Randomized but didn't receive study drug|8
1002887|NCT00413218|3286020|P1|Overall Study|Randomized but didn't receive study drug|2
1002888|NCT00413192|3286046|P4|Overall Study|Not treated|1
1002889|NCT00413192|3286047|P3|Overall Study|Not treated|0
1002890|NCT00413192|3286048|P2|Overall Study|Not treated|0
1002891|NCT00413192|3286049|P1|Overall Study|Not treated|0
1002892|NCT00413192|3286046|P4|Overall Study|Not specified|2
1002893|NCT00413192|3286047|P3|Overall Study|Not specified|1
1002894|NCT00413192|3286048|P2|Overall Study|Not specified|1
1002895|NCT00413192|3286049|P1|Overall Study|Not specified|5
1002896|NCT00413192|3286046|P4|Overall Study|Intercurrent death|0
1002897|NCT00413192|3286047|P3|Overall Study|Intercurrent death|0
1002898|NCT00413192|3286048|P2|Overall Study|Intercurrent death|1
1002899|NCT00413192|3286049|P1|Overall Study|Intercurrent death|0
1002900|NCT00413192|3286046|P4|Overall Study|Intercurrent illness|1
1002901|NCT00413192|3286047|P3|Overall Study|Intercurrent illness|0
1002902|NCT00413192|3286048|P2|Overall Study|Intercurrent illness|0
1002903|NCT00413192|3286049|P1|Overall Study|Intercurrent illness|0
1002904|NCT00413192|3286046|P4|Overall Study|Withdrawal by Subject|1
1002905|NCT00413192|3286047|P3|Overall Study|Withdrawal by Subject|0
1002906|NCT00413192|3286048|P2|Overall Study|Withdrawal by Subject|5
1002907|NCT00413192|3286049|P1|Overall Study|Withdrawal by Subject|3
1002908|NCT00413192|3286046|P4|Overall Study|Toxicity|2
1002909|NCT00413192|3286047|P3|Overall Study|Toxicity|2
1002910|NCT00413192|3286048|P2|Overall Study|Toxicity|2
1002911|NCT00413192|3286049|P1|Overall Study|Toxicity|3
1002912|NCT00413192|3286046|P4|Overall Study|Disease progression|25
1002913|NCT00413192|3286047|P3|Overall Study|Disease progression|16
1002914|NCT00413192|3286048|P2|Overall Study|Disease progression|31
1002915|NCT00413192|3286049|P1|Overall Study|Disease progression|26
1002916|NCT00413153|3286089|P2|Overall Study|Adverse Event|0
1002917|NCT00413153|3286090|P1|Overall Study|Adverse Event|1
1002918|NCT00413153|3286089|P2|Overall Study|Withdrawal by Subject|1
1002919|NCT00413153|3286090|P1|Overall Study|Withdrawal by Subject|1
1002920|NCT00413062|3286114|P2|Overall Study|Other reason|34
1002921|NCT00413062|3286115|P1|Overall Study|Other reason|70
1002922|NCT00413062|3286114|P2|Overall Study|Lost to Follow-up|73
1002923|NCT00413062|3286115|P1|Overall Study|Lost to Follow-up|175
1002924|NCT00413062|3286114|P2|Overall Study|Pregnancy wish|6
1002925|NCT00413062|3286115|P1|Overall Study|Pregnancy wish|17
1002926|NCT00413062|3286114|P2|Overall Study|Pregnancy|5
1002927|NCT00413062|3286115|P1|Overall Study|Pregnancy|15
1002928|NCT00413062|3286114|P2|Overall Study|Withdrawal of informed consent|36
1002929|NCT00413062|3286115|P1|Overall Study|Withdrawal of informed consent|111
1002930|NCT00413062|3286114|P2|Overall Study|Pre-treatment (serious) adverse event|0
1002931|NCT00413062|3286115|P1|Overall Study|Pre-treatment (serious) adverse event|1
1002932|NCT00413062|3286114|P2|Overall Study|Adverse event/serious adverse event|56
1002933|NCT00413062|3286115|P1|Overall Study|Adverse event/serious adverse event|289
1002934|NCT00413049|3286141|P2|Overall Study|Lack of Efficacy|0
1002935|NCT00413049|3286142|P1|Overall Study|Lack of Efficacy|1
1002936|NCT00413049|3286141|P2|Overall Study|Abnormal laboratory value(s)|0
1002937|NCT00413049|3286142|P1|Overall Study|Abnormal laboratory value(s)|1
1002938|NCT00413049|3286141|P2|Overall Study|Subject no longer requires study drug|1
1002939|NCT00413049|3286142|P1|Overall Study|Subject no longer requires study drug|0
1002940|NCT00413049|3286141|P2|Overall Study|Protocol Violation|1
1002941|NCT00413049|3286142|P1|Overall Study|Protocol Violation|3
1002942|NCT00413049|3286141|P2|Overall Study|Lost to Follow-up|3
1002943|NCT00413049|3286142|P1|Overall Study|Lost to Follow-up|2
1002944|NCT00413049|3286141|P2|Overall Study|Withdrawal by Subject|5
1002945|NCT00413049|3286142|P1|Overall Study|Withdrawal by Subject|7
1002946|NCT00413049|3286141|P2|Overall Study|Adverse Event|8
1002947|NCT00413049|3286142|P1|Overall Study|Adverse Event|10
1002948|NCT00413036|3286158|P1|Overall Study|Missing|2
1002949|NCT00413036|3286158|P1|Overall Study|Other|26
1002950|NCT00413036|3286158|P1|Overall Study|Death|9
1002951|NCT00413036|3286158|P1|Overall Study|Withdrawal by Subject|7
1002952|NCT00413036|3286158|P1|Overall Study|Lack of Efficacy|129
1002953|NCT00413036|3286158|P1|Overall Study|Adverse Event|44
1002954|NCT00413010|3286168|P2|Overall Study|Due to termination of the study|52
1002955|NCT00413010|3286169|P1|Overall Study|Due to termination of the study|54
1002956|NCT00413010|3286168|P2|Overall Study|Withdrawal by Subject|2
1002957|NCT00413010|3286169|P1|Overall Study|Withdrawal by Subject|7
1002958|NCT00413010|3286168|P2|Overall Study|Lost to Follow-up|0
1002959|NCT00413010|3286169|P1|Overall Study|Lost to Follow-up|3
1002960|NCT00413010|3286168|P2|Overall Study|Lack of Efficacy|3
1002961|NCT00413010|3286169|P1|Overall Study|Lack of Efficacy|0
1002962|NCT00413010|3286168|P2|Overall Study|Laboratory abnormality|2
1002963|NCT00413010|3286169|P1|Overall Study|Laboratory abnormality|0
1002964|NCT00413010|3286168|P2|Overall Study|Adverse Event|4
1002965|NCT00413010|3286169|P1|Overall Study|Adverse Event|8
1002966|NCT00412984|3286191|P2|Overall Study|Not Reported|12
1002967|NCT00412984|3286192|P1|Overall Study|Not Reported|11
1002968|NCT00412984|3286191|P2|Overall Study|Other Reason|92
1002969|NCT00412984|3286192|P1|Overall Study|Other Reason|80
1002970|NCT00412984|3286191|P2|Overall Study|Physician Refused to Continue Treatment|89
1002971|NCT00412984|3286192|P1|Overall Study|Physician Refused to Continue Treatment|81
1002972|NCT00412984|3286191|P2|Overall Study|Administrative Reason by Sponsor|8
1002973|NCT00412984|3286192|P1|Overall Study|Administrative Reason by Sponsor|11
1002974|NCT00412984|3286191|P2|Overall Study|Subject No Longer Meets Study Criteria|100
1002975|NCT00412984|3286192|P1|Overall Study|Subject No Longer Meets Study Criteria|87
1002976|NCT00412984|3286191|P2|Overall Study|Pregnancy|0
1002977|NCT00412984|3286192|P1|Overall Study|Pregnancy|1
1002978|NCT00412984|3286191|P2|Overall Study|Poor/Noncompliance|77
1002979|NCT00412984|3286192|P1|Overall Study|Poor/Noncompliance|57
1002980|NCT00412984|3286191|P2|Overall Study|Lost to Follow-up|39
1002981|NCT00412984|3286192|P1|Overall Study|Lost to Follow-up|51
1002982|NCT00412984|3286191|P2|Overall Study|Withdrawal by Subject|989
1002983|NCT00412984|3286192|P1|Overall Study|Withdrawal by Subject|921
1002984|NCT00412984|3286191|P2|Overall Study|Adverse Event|738
1002985|NCT00412984|3286192|P1|Overall Study|Adverse Event|679
1002986|NCT00412984|3286191|P2|Overall Study|Death|349
1002987|NCT00412984|3286192|P1|Overall Study|Death|331
1002988|NCT00412971|3286236|P2|Overall Study|Protocol Violation|1
1002989|NCT00412971|3286237|P1|Overall Study|Protocol Violation|13
1002990|NCT00412971|3286236|P2|Overall Study|Lost to Follow-up|9
1002991|NCT00412971|3286237|P1|Overall Study|Lost to Follow-up|17
1002992|NCT00412958|3286250|P4|Overall Study|Transport issue|0
1002993|NCT00412958|3286251|P3|Overall Study|Transport issue|0
1002994|NCT00412958|3286252|P2|Overall Study|Transport issue|1
1002995|NCT00412958|3286253|P1|Overall Study|Transport issue|0
1002996|NCT00412958|3286250|P4|Overall Study|Death|0
1002997|NCT00412958|3286251|P3|Overall Study|Death|0
1002998|NCT00412958|3286252|P2|Overall Study|Death|1
1002999|NCT00412958|3286253|P1|Overall Study|Death|0
1003000|NCT00412958|3286250|P4|Overall Study|Lost to Follow-up|0
1003001|NCT00412958|3286251|P3|Overall Study|Lost to Follow-up|0
1003002|NCT00412958|3286252|P2|Overall Study|Lost to Follow-up|1
1003003|NCT00412958|3286253|P1|Overall Study|Lost to Follow-up|0
1003004|NCT00412958|3286250|P4|Overall Study|Adverse Event|0
1003005|NCT00412958|3286251|P3|Overall Study|Adverse Event|0
1003006|NCT00412958|3286252|P2|Overall Study|Adverse Event|1
1003007|NCT00412958|3286253|P1|Overall Study|Adverse Event|0
1003008|NCT00412958|3286250|P4|Overall Study|Withdrawal by Subject|1
1003009|NCT00412958|3286251|P3|Overall Study|Withdrawal by Subject|0
1003010|NCT00412958|3286252|P2|Overall Study|Withdrawal by Subject|0
1003011|NCT00412958|3286253|P1|Overall Study|Withdrawal by Subject|3
1003012|NCT00412932|3286263|P1|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1
1003013|NCT00412932|3286263|P1|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1
1003014|NCT00412932|3286263|P1|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3
1003015|NCT00412932|3286263|P1|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3
1003016|NCT00412932|3286263|P1|Olmesartan 40 mg|Withdrawal by Subject|1
1003017|NCT00412932|3286263|P1|Olmesartan 40 mg|Lack of Efficacy|3
1003018|NCT00412932|3286263|P1|Olmesartan 40 mg|Adverse Event|4
1003019|NCT00412932|3286263|P1|Olmesartan (Olm) 20 mg|Other|1
1003020|NCT00412932|3286263|P1|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2
1003021|NCT00412932|3286263|P1|Olmesartan (Olm) 20 mg|Protocol Violation|1
1003022|NCT00412932|3286263|P1|Olmesartan (Olm) 20 mg|Lack of Efficacy|2
1003023|NCT00412932|3286263|P1|Olmesartan (Olm) 20 mg|Adverse Event|1
1003024|NCT00412893|3286274|P2|Overall Study|Randomized but Never Received Study Drug|6
1003025|NCT00412893|3286275|P1|Overall Study|Randomized but Never Received Study Drug|5
1003026|NCT00412893|3286274|P2|Overall Study|Administrative Reason|15
1003027|NCT00412893|3286275|P1|Overall Study|Administrative Reason|12
1003028|NCT00412893|3286274|P2|Overall Study|Did Not Cooperate|9
1003029|NCT00412893|3286275|P1|Overall Study|Did Not Cooperate|12
1003030|NCT00412893|3286274|P2|Overall Study|Other Protocol Violation|6
1003031|NCT00412893|3286275|P1|Overall Study|Other Protocol Violation|10
1003032|NCT00412893|3286274|P2|Overall Study|Violation of Selection at Entry|10
1003033|NCT00412893|3286275|P1|Overall Study|Violation of Selection at Entry|17
1003034|NCT00412893|3286274|P2|Overall Study|Lost to Follow-up|1
1003035|NCT00412893|3286275|P1|Overall Study|Lost to Follow-up|2
1003036|NCT00412893|3286274|P2|Overall Study|Insufficient Therapeutic Response|23
1003037|NCT00412893|3286275|P1|Overall Study|Insufficient Therapeutic Response|39
1003038|NCT00412893|3286274|P2|Overall Study|Death|21
1003039|NCT00412893|3286275|P1|Overall Study|Death|17
1003040|NCT00412893|3286274|P2|Overall Study|Adverse Event|53
1003041|NCT00412893|3286275|P1|Overall Study|Adverse Event|31
1003042|NCT00412854|3286313|P2|Overall Study|Withdrawn for other reasons|11
1003043|NCT00412854|3286314|P1|Overall Study|Withdrawn for other reasons|13
1003044|NCT00412854|3286313|P2|Overall Study|Withdrawn due to adverse events|5
1003045|NCT00412854|3286314|P1|Overall Study|Withdrawn due to adverse events|1
1003046|NCT00412750|3286358|P3|Overall Study|Lack of Efficacy|3
1003047|NCT00412750|3286359|P2|Overall Study|Lack of Efficacy|0
1003048|NCT00412750|3286360|P1|Overall Study|Lack of Efficacy|0
1003049|NCT00412750|3286358|P3|Overall Study|Withdrawal by Subject|2
1003050|NCT00412750|3286359|P2|Overall Study|Withdrawal by Subject|1
1003051|NCT00412750|3286360|P1|Overall Study|Withdrawal by Subject|0
1003052|NCT00412750|3286358|P3|Overall Study|Lost to Follow-up|1
1003053|NCT00412750|3286359|P2|Overall Study|Lost to Follow-up|0
1003054|NCT00412750|3286360|P1|Overall Study|Lost to Follow-up|1
1003055|NCT00412750|3286358|P3|Overall Study|Adverse Event|3
1003056|NCT00412750|3286359|P2|Overall Study|Adverse Event|3
1003057|NCT00412750|3286360|P1|Overall Study|Adverse Event|8
1003058|NCT00412750|3286358|P3|Overall Study|Administrative problems|14
1003059|NCT00412750|3286359|P2|Overall Study|Administrative problems|17
1003060|NCT00412750|3286360|P1|Overall Study|Administrative problems|21
1003061|NCT00412750|3286358|P3|Overall Study|Abnormal laboratory value(s)|0
1003062|NCT00412750|3286359|P2|Overall Study|Abnormal laboratory value(s)|0
1003063|NCT00412750|3286360|P1|Overall Study|Abnormal laboratory value(s)|1
1003064|NCT00412737|3286385|P2|Overall Study|Failure to Return|2
1003065|NCT00412737|3286386|P1|Overall Study|Failure to Return|6
1003066|NCT00412737|3286385|P2|Overall Study|Refused Treatment|2
1003067|NCT00412737|3286386|P1|Overall Study|Refused Treatment|6
1003068|NCT00412737|3286385|P2|Overall Study|Adverse Event|2
1003069|NCT00412737|3286386|P1|Overall Study|Adverse Event|3
1003070|NCT00412737|3286385|P2|Overall Study|Death|0
1003071|NCT00412737|3286386|P1|Overall Study|Death|1
1003072|NCT00412607|3286404|P1|Overall Study|Not meet inclusion/exclusion Criteria|15
1003073|NCT00412607|3286404|P1|Overall Study|Death|61
1003074|NCT00412607|3286404|P1|Overall Study|Lost to Follow-up|19
1003075|NCT00412607|3286404|P1|Overall Study|Withdrawal by Subject|9
1003076|NCT00412542|3286417|P2|Overall Study|Not Eligible|1
1003077|NCT00412542|3286418|P1|Overall Study|Not Eligible|0
1003078|NCT00412542|3286417|P2|Overall Study|Withdrawal by Subject|2
1003079|NCT00412542|3286418|P1|Overall Study|Withdrawal by Subject|0
1003080|NCT00412373|3286503|P2|Overall Study|Not Specified|2
1003081|NCT00412373|3286504|P1|Overall Study|Not Specified|2
1003082|NCT00412373|3286503|P2|Overall Study|Withdrawal by Subject|27
1003083|NCT00412373|3286504|P1|Overall Study|Withdrawal by Subject|8
1003084|NCT00412373|3286503|P2|Overall Study|Lost to Follow-up|13
1003085|NCT00412373|3286504|P1|Overall Study|Lost to Follow-up|7
1003086|NCT00412373|3286503|P2|Overall Study|Lack of Efficacy|22
1003087|NCT00412373|3286504|P1|Overall Study|Lack of Efficacy|16
1003088|NCT00412373|3286503|P2|Overall Study|Adverse Event|13
1003089|NCT00412373|3286504|P1|Overall Study|Adverse Event|8
1003090|NCT00412360|3286546|P2|Overall Study|Not Transplanted|2
1003091|NCT00412360|3286547|P1|Overall Study|Not Transplanted|1
1003092|NCT00412360|3286546|P2|Overall Study|Lost to Follow-up|1
1003093|NCT00412360|3286547|P1|Overall Study|Lost to Follow-up|0
1003094|NCT00412217|3286577|P2|Overall Study|Not Specified|1
1003095|NCT00412217|3286578|P1|Overall Study|Not Specified|1
1003096|NCT00412217|3286577|P2|Overall Study|Study Terminated by Sponsor|33
1003097|NCT00412217|3286578|P1|Overall Study|Study Terminated by Sponsor|26
1003098|NCT00412217|3286577|P2|Overall Study|Lost to Follow-up|4
1003099|NCT00412217|3286578|P1|Overall Study|Lost to Follow-up|1
1003100|NCT00412217|3286577|P2|Overall Study|Withdrawal by Subject|0
1003101|NCT00412217|3286578|P1|Overall Study|Withdrawal by Subject|2
1003102|NCT00412217|3286577|P2|Overall Study|Investigator Decision|0
1003103|NCT00412217|3286578|P1|Overall Study|Investigator Decision|1
1003104|NCT00412217|3286577|P2|Overall Study|Disease Progression|3
1003105|NCT00412217|3286578|P1|Overall Study|Disease Progression|2
1003106|NCT00412217|3286577|P2|Overall Study|Death|4
1003107|NCT00412217|3286578|P1|Overall Study|Death|5
1003108|NCT00412217|3286577|P2|Overall Study|Insufficient Data Available|3
1003109|NCT00412217|3286578|P1|Overall Study|Insufficient Data Available|8
1003110|NCT00412113|3286592|P2|Overall Study|did not receive treatment|0
1003111|NCT00412113|3286593|P1|Overall Study|did not receive treatment|1
1003112|NCT00412113|3286592|P2|Overall Study|Adverse Event|15
1003113|NCT00412113|3286593|P1|Overall Study|Adverse Event|11
1003114|NCT00412061|3286677|P2|Open Label Phase|New Cancer Therapy|1
1003115|NCT00412061|3286678|P1|Open Label Phase|New Cancer Therapy|0
1003116|NCT00412061|3286677|P2|Open Label Phase|Lost to Follow-up|2
1003117|NCT00412061|3286678|P1|Open Label Phase|Lost to Follow-up|0
1003118|NCT00412061|3286677|P2|Open Label Phase|Death|7
1003119|NCT00412061|3286678|P1|Open Label Phase|Death|0
1003120|NCT00412061|3286677|P2|Open Label Phase|Administrative Problems|13
1003121|NCT00412061|3286678|P1|Open Label Phase|Administrative Problems|0
1003122|NCT00412061|3286677|P2|Open Label Phase|Withdrawal by Subject|15
1003123|NCT00412061|3286678|P1|Open Label Phase|Withdrawal by Subject|0
1003124|NCT00412061|3286677|P2|Open Label Phase|Adverse Event|46
1003125|NCT00412061|3286678|P1|Open Label Phase|Adverse Event|0
1003126|NCT00412061|3286677|P2|Open Label Phase|Disease Progression|86
1003127|NCT00412061|3286678|P1|Open Label Phase|Disease Progression|0
1003128|NCT00412061|3286677|P2|Double Blind Phase|Lost to Follow-up|1
1003129|NCT00412061|3286678|P1|Double Blind Phase|Lost to Follow-up|0
1003130|NCT00412061|3286677|P2|Double Blind Phase|New Cander Therapy|1
1003131|NCT00412061|3286678|P1|Double Blind Phase|New Cander Therapy|1
1003132|NCT00412061|3286677|P2|Double Blind Phase|Protocol Violation|4
1003133|NCT00412061|3286678|P1|Double Blind Phase|Protocol Violation|3
1003134|NCT00412061|3286677|P2|Double Blind Phase|Death|3
1003135|NCT00412061|3286678|P1|Double Blind Phase|Death|6
1003136|NCT00412061|3286677|P2|Double Blind Phase|Withdrawal by Subject|20
1003137|NCT00412061|3286678|P1|Double Blind Phase|Withdrawal by Subject|18
1003138|NCT00412061|3286677|P2|Double Blind Phase|Final Primary Analysis|14
1003139|NCT00412061|3286678|P1|Double Blind Phase|Final Primary Analysis|26
1003140|NCT00412061|3286677|P2|Double Blind Phase|Adverse Event|16
1003141|NCT00412061|3286678|P1|Double Blind Phase|Adverse Event|61
1003142|NCT00412061|3286677|P2|Double Blind Phase|Disease Progression|154
1003143|NCT00412061|3286678|P1|Double Blind Phase|Disease Progression|101
1003144|NCT00411788|3286696|P1|Overall Study|Adverse Event|1
1003145|NCT00411788|3286696|P1|Overall Study|Protocol Violation|1
1003146|NCT00411762|3286705|P1|Overall Study|Withdrawal by Subject|5
1003147|NCT00411671|3286729|P1|Overall Study|Lost to Follow-up|3
1003148|NCT00411671|3286729|P1|Overall Study|Death|2
1003149|NCT00411671|3286729|P1|Overall Study|Adverse Event|15
1003150|NCT00411645|3286737|P2|Overall Study|Lost to Follow-up|0
1003151|NCT00411645|3286738|P1|Overall Study|Lost to Follow-up|2
1003152|NCT00411645|3286737|P2|Overall Study|Investigator/Sponsor Decision|7
1003153|NCT00411645|3286738|P1|Overall Study|Investigator/Sponsor Decision|10
1003154|NCT00411645|3286737|P2|Overall Study|Death|135
1003155|NCT00411645|3286738|P1|Overall Study|Death|56
1003156|NCT00411645|3286737|P2|Overall Study|Consent Withdrawn|22
1003157|NCT00411645|3286738|P1|Overall Study|Consent Withdrawn|13
1003158|NCT00411554|3286769|P2|Overall Study|Patient Moved|0
1003159|NCT00411554|3286770|P1|Overall Study|Patient Moved|1
1003160|NCT00411554|3286769|P2|Overall Study|Withdrawal by Subject|0
1003161|NCT00411554|3286770|P1|Overall Study|Withdrawal by Subject|3
1003162|NCT00411554|3286769|P2|Overall Study|Lack of Efficacy|5
1003163|NCT00411554|3286770|P1|Overall Study|Lack of Efficacy|2
1003164|NCT00411554|3286769|P2|Overall Study|Adverse Event|4
1003165|NCT00411554|3286770|P1|Overall Study|Adverse Event|2
1003166|NCT00411450|3286796|P1|Overall Study|Ongoing at time of data cut-off.|3
1003167|NCT00411216|3286839|P2|Overall Study|Ten participants were entered into the c|2
1003168|NCT00411216|3286840|P1|Overall Study|Ten participants were entered into the c|0
1003169|NCT00411151|3286846|P1|Overall Study|Trial prematurely closed|4
1003170|NCT00411151|3286846|P1|Overall Study|Protocol Violation|1
1003171|NCT00411151|3286846|P1|Overall Study|Lost to Follow-up|2
1003172|NCT00411151|3286846|P1|Overall Study|Withdrawal by Subject|2
1003173|NCT00411151|3286846|P1|Overall Study|Death|38
1003174|NCT00410813|3286890|P2|Overall Study|Death|2
1003175|NCT00410813|3286891|P1|Overall Study|Death|0
1003176|NCT00410813|3286890|P2|Overall Study|Ineligible|4
1003177|NCT00410813|3286891|P1|Overall Study|Ineligible|2
1003178|NCT00410813|3286890|P2|Overall Study|Not protocol specified|4
1003179|NCT00410813|3286891|P1|Overall Study|Not protocol specified|3
1003180|NCT00410813|3286890|P2|Overall Study|Progression|21
1003181|NCT00410813|3286891|P1|Overall Study|Progression|32
1003182|NCT00410813|3286890|P2|Overall Study|Adverse Event|11
1003183|NCT00410813|3286891|P1|Overall Study|Adverse Event|6
1003184|NCT00410761|3286928|P2|Overall Study|Never received randomised treatment|1
1003185|NCT00410761|3286929|P1|Overall Study|Never received randomised treatment|0
1003186|NCT00410761|3286928|P2|Overall Study|Other|9
1003187|NCT00410761|3286929|P1|Overall Study|Other|12
1003188|NCT00410761|3286928|P2|Overall Study|Withdrawal by Subject|4
1003189|NCT00410761|3286929|P1|Overall Study|Withdrawal by Subject|8
1003190|NCT00410761|3286928|P2|Overall Study|objective disease progression|55
1003191|NCT00410761|3286929|P1|Overall Study|objective disease progression|71
1003192|NCT00410761|3286928|P2|Overall Study|Adverse Event|3
1003193|NCT00410761|3286929|P1|Overall Study|Adverse Event|29
1003194|NCT00410605|3286949|P1|Overall Study|Transferred to another Institution|1
1003195|NCT00410605|3286949|P1|Overall Study|Stopped treatmen to collect stem cells|1
1003196|NCT00410605|3286949|P1|Overall Study|Started Non-Protocol Therapy|3
1003197|NCT00410605|3286949|P1|Overall Study|Withdrawal by Subject|5
1003198|NCT00410605|3286949|P1|Overall Study|Physician Decision|3
1003199|NCT00410605|3286949|P1|Overall Study|Adverse Event|12
1003200|NCT00410514|3286961|P3|Overall Study|Non-compliant with study procedures|2
1003201|NCT00410514|3286962|P2|Overall Study|Non-compliant with study procedures|0
1003202|NCT00410514|3286963|P1|Overall Study|Non-compliant with study procedures|0
1003203|NCT00410514|3286961|P3|Overall Study|Lost to Follow-up|2
1003204|NCT00410514|3286962|P2|Overall Study|Lost to Follow-up|0
1003205|NCT00410514|3286963|P1|Overall Study|Lost to Follow-up|0
1003206|NCT00410514|3286961|P3|Overall Study|Protocol Violation|1
1003207|NCT00410514|3286962|P2|Overall Study|Protocol Violation|1
1003208|NCT00410514|3286963|P1|Overall Study|Protocol Violation|0
1003209|NCT00410514|3286961|P3|Overall Study|Adverse Event|2
1003210|NCT00410514|3286962|P2|Overall Study|Adverse Event|2
1003211|NCT00410514|3286963|P1|Overall Study|Adverse Event|2
1003212|NCT00410410|3287046|P9|Open-Label Period (OL)|not specified|7
1003213|NCT00410410|3287047|P8|Open-Label Period (OL)|not specified|0
1003214|NCT00410410|3287048|P7|Open-Label Period (OL)|not specified|0
1003215|NCT00410410|3287049|P6|Open-Label Period (OL)|not specified|0
1003216|NCT00410410|3287050|P5|Open-Label Period (OL)|not specified|0
1003217|NCT00410410|3287051|P4|Open-Label Period (OL)|not specified|0
1003218|NCT00410410|3287052|P3|Open-Label Period (OL)|not specified|0
1003219|NCT00410410|3287053|P2|Open-Label Period (OL)|not specified|0
1003220|NCT00410410|3287054|P1|Open-Label Period (OL)|not specified|0
1003221|NCT00410410|3287046|P9|Open-Label Period (OL)|Administrative Reason By Sponsor|145
1003222|NCT00410410|3287047|P8|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1003223|NCT00410410|3287048|P7|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1003224|NCT00410410|3287049|P6|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1003225|NCT00410410|3287050|P5|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1003226|NCT00410410|3287051|P4|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1003227|NCT00410410|3287052|P3|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1003228|NCT00410410|3287053|P2|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1003229|NCT00410410|3287054|P1|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1003230|NCT00410410|3287046|P9|Open-Label Period (OL)|Pregnancy|1
1003231|NCT00410410|3287047|P8|Open-Label Period (OL)|Pregnancy|0
1003232|NCT00410410|3287048|P7|Open-Label Period (OL)|Pregnancy|0
1003233|NCT00410410|3287049|P6|Open-Label Period (OL)|Pregnancy|0
1003234|NCT00410410|3287050|P5|Open-Label Period (OL)|Pregnancy|0
1003235|NCT00410410|3287051|P4|Open-Label Period (OL)|Pregnancy|0
1003236|NCT00410410|3287052|P3|Open-Label Period (OL)|Pregnancy|0
1003237|NCT00410410|3287053|P2|Open-Label Period (OL)|Pregnancy|0
1003238|NCT00410410|3287054|P1|Open-Label Period (OL)|Pregnancy|0
1003239|NCT00410410|3287046|P9|Open-Label Period (OL)|Withdrawal by Subject|20
1003240|NCT00410410|3287047|P8|Open-Label Period (OL)|Withdrawal by Subject|0
1003241|NCT00410410|3287048|P7|Open-Label Period (OL)|Withdrawal by Subject|0
1003242|NCT00410410|3287049|P6|Open-Label Period (OL)|Withdrawal by Subject|0
1003243|NCT00410410|3287050|P5|Open-Label Period (OL)|Withdrawal by Subject|0
1003244|NCT00410410|3287051|P4|Open-Label Period (OL)|Withdrawal by Subject|0
1003245|NCT00410410|3287052|P3|Open-Label Period (OL)|Withdrawal by Subject|0
1003246|NCT00410410|3287053|P2|Open-Label Period (OL)|Withdrawal by Subject|0
1003247|NCT00410410|3287054|P1|Open-Label Period (OL)|Withdrawal by Subject|0
1003248|NCT00410410|3287046|P9|Open-Label Period (OL)|Lost to Follow-up|4
1003249|NCT00410410|3287047|P8|Open-Label Period (OL)|Lost to Follow-up|0
1003250|NCT00410410|3287048|P7|Open-Label Period (OL)|Lost to Follow-up|0
1003251|NCT00410410|3287049|P6|Open-Label Period (OL)|Lost to Follow-up|0
1003252|NCT00410410|3287050|P5|Open-Label Period (OL)|Lost to Follow-up|0
1003253|NCT00410410|3287051|P4|Open-Label Period (OL)|Lost to Follow-up|0
1003254|NCT00410410|3287052|P3|Open-Label Period (OL)|Lost to Follow-up|0
1003255|NCT00410410|3287053|P2|Open-Label Period (OL)|Lost to Follow-up|0
1003256|NCT00410410|3287054|P1|Open-Label Period (OL)|Lost to Follow-up|0
1003257|NCT00410410|3287046|P9|Open-Label Period (OL)|Lack of Efficacy|161
1003258|NCT00410410|3287047|P8|Open-Label Period (OL)|Lack of Efficacy|0
1003259|NCT00410410|3287048|P7|Open-Label Period (OL)|Lack of Efficacy|0
1003260|NCT00410410|3287049|P6|Open-Label Period (OL)|Lack of Efficacy|0
1003261|NCT00410410|3287050|P5|Open-Label Period (OL)|Lack of Efficacy|0
1003262|NCT00410410|3287051|P4|Open-Label Period (OL)|Lack of Efficacy|0
1003263|NCT00410410|3287052|P3|Open-Label Period (OL)|Lack of Efficacy|0
1003264|NCT00410410|3287053|P2|Open-Label Period (OL)|Lack of Efficacy|0
1003265|NCT00410410|3287054|P1|Open-Label Period (OL)|Lack of Efficacy|0
1003266|NCT00410410|3287046|P9|Open-Label Period (OL)|Adverse Event|10
1003267|NCT00410410|3287047|P8|Open-Label Period (OL)|Adverse Event|0
1003268|NCT00410410|3287048|P7|Open-Label Period (OL)|Adverse Event|0
1003269|NCT00410410|3287049|P6|Open-Label Period (OL)|Adverse Event|0
1003270|NCT00410410|3287050|P5|Open-Label Period (OL)|Adverse Event|0
1003271|NCT00410410|3287051|P4|Open-Label Period (OL)|Adverse Event|0
1003272|NCT00410410|3287052|P3|Open-Label Period (OL)|Adverse Event|0
1003273|NCT00410410|3287053|P2|Open-Label Period (OL)|Adverse Event|0
1003274|NCT00410410|3287054|P1|Open-Label Period (OL)|Adverse Event|0
1003275|NCT00410410|3287046|P9|Open-Label Period (OL)|Death|1
1003276|NCT00410410|3287047|P8|Open-Label Period (OL)|Death|0
1003277|NCT00410410|3287048|P7|Open-Label Period (OL)|Death|0
1003278|NCT00410410|3287049|P6|Open-Label Period (OL)|Death|0
1003279|NCT00410410|3287050|P5|Open-Label Period (OL)|Death|0
1003280|NCT00410410|3287051|P4|Open-Label Period (OL)|Death|0
1003281|NCT00410410|3287052|P3|Open-Label Period (OL)|Death|0
1003282|NCT00410410|3287053|P2|Open-Label Period (OL)|Death|0
1003283|NCT00410410|3287054|P1|Open-Label Period (OL)|Death|0
1003284|NCT00410410|3287046|P9|Maintenance Period (MP)|Administrative Reason By Sponsor|0
1003285|NCT00410410|3287047|P8|Maintenance Period (MP)|Administrative Reason By Sponsor|25
1003286|NCT00410410|3287048|P7|Maintenance Period (MP)|Administrative Reason By Sponsor|21
1003287|NCT00410410|3287049|P6|Maintenance Period (MP)|Administrative Reason By Sponsor|0
1003288|NCT00410410|3287050|P5|Maintenance Period (MP)|Administrative Reason By Sponsor|0
1003289|NCT00410410|3287051|P4|Maintenance Period (MP)|Administrative Reason By Sponsor|0
1003290|NCT00410410|3287052|P3|Maintenance Period (MP)|Administrative Reason By Sponsor|0
1003291|NCT00410410|3287053|P2|Maintenance Period (MP)|Administrative Reason By Sponsor|0
1003292|NCT00410410|3287054|P1|Maintenance Period (MP)|Administrative Reason By Sponsor|0
1003293|NCT00410410|3287046|P9|Maintenance Period (MP)|Withdrawal by Subject|0
1003294|NCT00410410|3287047|P8|Maintenance Period (MP)|Withdrawal by Subject|1
1003295|NCT00410410|3287048|P7|Maintenance Period (MP)|Withdrawal by Subject|1
1003296|NCT00410410|3287049|P6|Maintenance Period (MP)|Withdrawal by Subject|0
1003297|NCT00410410|3287050|P5|Maintenance Period (MP)|Withdrawal by Subject|0
1003298|NCT00410410|3287051|P4|Maintenance Period (MP)|Withdrawal by Subject|0
1003299|NCT00410410|3287052|P3|Maintenance Period (MP)|Withdrawal by Subject|0
1003300|NCT00410410|3287053|P2|Maintenance Period (MP)|Withdrawal by Subject|0
1003301|NCT00410410|3287054|P1|Maintenance Period (MP)|Withdrawal by Subject|0
1003302|NCT00410410|3287046|P9|Maintenance Period (MP)|Lost to Follow-up|0
1003303|NCT00410410|3287047|P8|Maintenance Period (MP)|Lost to Follow-up|2
1003304|NCT00410410|3287048|P7|Maintenance Period (MP)|Lost to Follow-up|1
1003305|NCT00410410|3287049|P6|Maintenance Period (MP)|Lost to Follow-up|0
1003306|NCT00410410|3287050|P5|Maintenance Period (MP)|Lost to Follow-up|0
1003307|NCT00410410|3287051|P4|Maintenance Period (MP)|Lost to Follow-up|0
1003308|NCT00410410|3287052|P3|Maintenance Period (MP)|Lost to Follow-up|0
1003309|NCT00410410|3287053|P2|Maintenance Period (MP)|Lost to Follow-up|0
1003310|NCT00410410|3287054|P1|Maintenance Period (MP)|Lost to Follow-up|0
1003311|NCT00410410|3287046|P9|Maintenance Period (MP)|Lack of Efficacy|0
1003312|NCT00410410|3287047|P8|Maintenance Period (MP)|Lack of Efficacy|24
1003313|NCT00410410|3287048|P7|Maintenance Period (MP)|Lack of Efficacy|25
1003314|NCT00410410|3287049|P6|Maintenance Period (MP)|Lack of Efficacy|0
1003315|NCT00410410|3287050|P5|Maintenance Period (MP)|Lack of Efficacy|0
1003316|NCT00410410|3287051|P4|Maintenance Period (MP)|Lack of Efficacy|0
1003317|NCT00410410|3287052|P3|Maintenance Period (MP)|Lack of Efficacy|0
1003318|NCT00410410|3287053|P2|Maintenance Period (MP)|Lack of Efficacy|0
1003319|NCT00410410|3287054|P1|Maintenance Period (MP)|Lack of Efficacy|0
1003320|NCT00410410|3287046|P9|Maintenance Period (MP)|Adverse Event|0
1003321|NCT00410410|3287047|P8|Maintenance Period (MP)|Adverse Event|3
1003322|NCT00410410|3287048|P7|Maintenance Period (MP)|Adverse Event|1
1003323|NCT00410410|3287049|P6|Maintenance Period (MP)|Adverse Event|0
1003324|NCT00410410|3287050|P5|Maintenance Period (MP)|Adverse Event|0
1003325|NCT00410410|3287051|P4|Maintenance Period (MP)|Adverse Event|0
1003326|NCT00410410|3287052|P3|Maintenance Period (MP)|Adverse Event|0
1003327|NCT00410410|3287053|P2|Maintenance Period (MP)|Adverse Event|0
1003328|NCT00410410|3287054|P1|Maintenance Period (MP)|Adverse Event|0
1003329|NCT00410410|3287046|P9|Maintenance Period (MP)|Death|0
1003330|NCT00410410|3287047|P8|Maintenance Period (MP)|Death|0
1003331|NCT00410410|3287048|P7|Maintenance Period (MP)|Death|1
1003332|NCT00410410|3287049|P6|Maintenance Period (MP)|Death|0
1003333|NCT00410410|3287050|P5|Maintenance Period (MP)|Death|0
1003334|NCT00410410|3287051|P4|Maintenance Period (MP)|Death|0
1003335|NCT00410410|3287052|P3|Maintenance Period (MP)|Death|0
1003336|NCT00410410|3287053|P2|Maintenance Period (MP)|Death|0
1003337|NCT00410410|3287054|P1|Maintenance Period (MP)|Death|0
1003338|NCT00410410|3287046|P9|Induction Period (IP)|not specified|0
1003339|NCT00410410|3287047|P8|Induction Period (IP)|not specified|0
1003340|NCT00410410|3287048|P7|Induction Period (IP)|not specified|0
1003341|NCT00410410|3287049|P6|Induction Period (IP)|not specified|0
1003342|NCT00410410|3287050|P5|Induction Period (IP)|not specified|0
1003343|NCT00410410|3287051|P4|Induction Period (IP)|not specified|0
1003344|NCT00410410|3287052|P3|Induction Period (IP)|not specified|1
1003345|NCT00410410|3287053|P2|Induction Period (IP)|not specified|0
1003346|NCT00410410|3287054|P1|Induction Period (IP)|not specified|0
1003347|NCT00410410|3287046|P9|Induction Period (IP)|Administrative Reason By Sponsor|0
1003348|NCT00410410|3287047|P8|Induction Period (IP)|Administrative Reason By Sponsor|0
1003349|NCT00410410|3287048|P7|Induction Period (IP)|Administrative Reason By Sponsor|0
1003350|NCT00410410|3287049|P6|Induction Period (IP)|Administrative Reason By Sponsor|21
1003351|NCT00410410|3287050|P5|Induction Period (IP)|Administrative Reason By Sponsor|22
1003352|NCT00410410|3287051|P4|Induction Period (IP)|Administrative Reason By Sponsor|0
1003353|NCT00410410|3287052|P3|Induction Period (IP)|Administrative Reason By Sponsor|0
1003354|NCT00410410|3287053|P2|Induction Period (IP)|Administrative Reason By Sponsor|0
1003355|NCT00410410|3287054|P1|Induction Period (IP)|Administrative Reason By Sponsor|0
1003356|NCT00410410|3287046|P9|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1003357|NCT00410410|3287047|P8|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1003358|NCT00410410|3287048|P7|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1003359|NCT00410410|3287049|P6|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1003360|NCT00410410|3287050|P5|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1003361|NCT00410410|3287051|P4|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1003362|NCT00410410|3287052|P3|Induction Period (IP)|Subject No Longer Meets Study Criteria|1
1003363|NCT00410410|3287053|P2|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1003364|NCT00410410|3287054|P1|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1003365|NCT00410410|3287046|P9|Induction Period (IP)|Withdrawal by Subject|0
1003366|NCT00410410|3287047|P8|Induction Period (IP)|Withdrawal by Subject|0
1003367|NCT00410410|3287048|P7|Induction Period (IP)|Withdrawal by Subject|0
1003368|NCT00410410|3287049|P6|Induction Period (IP)|Withdrawal by Subject|0
1003369|NCT00410410|3287050|P5|Induction Period (IP)|Withdrawal by Subject|2
1003370|NCT00410410|3287051|P4|Induction Period (IP)|Withdrawal by Subject|5
1003371|NCT00410410|3287052|P3|Induction Period (IP)|Withdrawal by Subject|3
1003372|NCT00410410|3287053|P2|Induction Period (IP)|Withdrawal by Subject|5
1003373|NCT00410410|3287054|P1|Induction Period (IP)|Withdrawal by Subject|3
1003374|NCT00410410|3287046|P9|Induction Period (IP)|Lost to Follow-up|0
1003375|NCT00410410|3287047|P8|Induction Period (IP)|Lost to Follow-up|0
1003376|NCT00410410|3287048|P7|Induction Period (IP)|Lost to Follow-up|0
1003377|NCT00410410|3287049|P6|Induction Period (IP)|Lost to Follow-up|1
1003378|NCT00410410|3287050|P5|Induction Period (IP)|Lost to Follow-up|0
1003379|NCT00410410|3287051|P4|Induction Period (IP)|Lost to Follow-up|3
1003380|NCT00410410|3287052|P3|Induction Period (IP)|Lost to Follow-up|2
1003381|NCT00410410|3287053|P2|Induction Period (IP)|Lost to Follow-up|2
1003382|NCT00410410|3287054|P1|Induction Period (IP)|Lost to Follow-up|2
1003383|NCT00410410|3287046|P9|Induction Period (IP)|Lack of Efficacy|0
1003384|NCT00410410|3287047|P8|Induction Period (IP)|Lack of Efficacy|0
1003385|NCT00410410|3287048|P7|Induction Period (IP)|Lack of Efficacy|0
1003386|NCT00410410|3287049|P6|Induction Period (IP)|Lack of Efficacy|7
1003387|NCT00410410|3287050|P5|Induction Period (IP)|Lack of Efficacy|7
1003388|NCT00410410|3287051|P4|Induction Period (IP)|Lack of Efficacy|8
1003389|NCT00410410|3287052|P3|Induction Period (IP)|Lack of Efficacy|8
1003390|NCT00410410|3287053|P2|Induction Period (IP)|Lack of Efficacy|24
1003391|NCT00410410|3287054|P1|Induction Period (IP)|Lack of Efficacy|26
1003392|NCT00410410|3287046|P9|Induction Period (IP)|Adverse Event|0
1003393|NCT00410410|3287047|P8|Induction Period (IP)|Adverse Event|0
1003394|NCT00410410|3287048|P7|Induction Period (IP)|Adverse Event|0
1003395|NCT00410410|3287049|P6|Induction Period (IP)|Adverse Event|0
1003396|NCT00410410|3287050|P5|Induction Period (IP)|Adverse Event|1
1003397|NCT00410410|3287051|P4|Induction Period (IP)|Adverse Event|4
1003398|NCT00410410|3287052|P3|Induction Period (IP)|Adverse Event|2
1003399|NCT00410410|3287053|P2|Induction Period (IP)|Adverse Event|4
1003400|NCT00410410|3287054|P1|Induction Period (IP)|Adverse Event|3
1003401|NCT00410410|3287046|P9|Induction Period (IP)|Death|0
1003402|NCT00410410|3287047|P8|Induction Period (IP)|Death|0
1003403|NCT00410410|3287048|P7|Induction Period (IP)|Death|0
1003404|NCT00410410|3287049|P6|Induction Period (IP)|Death|0
1003405|NCT00410410|3287050|P5|Induction Period (IP)|Death|0
1003406|NCT00410410|3287051|P4|Induction Period (IP)|Death|0
1003407|NCT00410410|3287052|P3|Induction Period (IP)|Death|0
1003408|NCT00410410|3287053|P2|Induction Period (IP)|Death|0
1003409|NCT00410410|3287054|P1|Induction Period (IP)|Death|1
1003410|NCT00410384|3287215|P3|Overall Study|Other|4
1003411|NCT00410384|3287216|P2|Overall Study|Other|8
1003412|NCT00410384|3287217|P1|Overall Study|Other|3
1003413|NCT00410384|3287215|P3|Overall Study|Physician Decision|4
1003414|NCT00410384|3287216|P2|Overall Study|Physician Decision|3
1003415|NCT00410384|3287217|P1|Overall Study|Physician Decision|3
1003416|NCT00410384|3287215|P3|Overall Study|Protocol Violation|6
1003417|NCT00410384|3287216|P2|Overall Study|Protocol Violation|6
1003418|NCT00410384|3287217|P1|Overall Study|Protocol Violation|6
1003419|NCT00410384|3287215|P3|Overall Study|Lost to Follow-up|6
1003420|NCT00410384|3287216|P2|Overall Study|Lost to Follow-up|6
1003421|NCT00410384|3287217|P1|Overall Study|Lost to Follow-up|4
1003422|NCT00410384|3287215|P3|Overall Study|Lack of Compliance|2
1003423|NCT00410384|3287216|P2|Overall Study|Lack of Compliance|2
1003424|NCT00410384|3287217|P1|Overall Study|Lack of Compliance|2
1003425|NCT00410384|3287215|P3|Overall Study|Lack of Efficacy|17
1003426|NCT00410384|3287216|P2|Overall Study|Lack of Efficacy|12
1003427|NCT00410384|3287217|P1|Overall Study|Lack of Efficacy|20
1003428|NCT00410384|3287215|P3|Overall Study|Adverse Event|23
1003429|NCT00410384|3287216|P2|Overall Study|Adverse Event|18
1003430|NCT00410384|3287217|P1|Overall Study|Adverse Event|23
1003431|NCT00410384|3287215|P3|Overall Study|Withdrawal by Subject|20
1003432|NCT00410384|3287216|P2|Overall Study|Withdrawal by Subject|17
1003433|NCT00410384|3287217|P1|Overall Study|Withdrawal by Subject|28
1003434|NCT00410202|3287290|P3|Off-treatment Follow up|Lost to Follow-up|0
1003435|NCT00410202|3287291|P2|Off-treatment Follow up|Lost to Follow-up|0
1003436|NCT00410202|3287292|P1|Off-treatment Follow up|Lost to Follow-up|1
1003437|NCT00410202|3287290|P3|Off-treatment Follow up|Follow up not required per protocol|1
1003438|NCT00410202|3287291|P2|Off-treatment Follow up|Follow up not required per protocol|0
1003439|NCT00410202|3287292|P1|Off-treatment Follow up|Follow up not required per protocol|3
1003440|NCT00410202|3287290|P3|Off-treatment Follow up|Continuing off-treatment follow up|11
1003441|NCT00410202|3287291|P2|Off-treatment Follow up|Continuing off-treatment follow up|8
1003442|NCT00410202|3287292|P1|Off-treatment Follow up|Continuing off-treatment follow up|10
1003443|NCT00410202|3287290|P3|On-Treatment|Other Reason|1
1003444|NCT00410202|3287291|P2|On-Treatment|Other Reason|0
1003445|NCT00410202|3287292|P1|On-Treatment|Other Reason|0
1003446|NCT00410202|3287290|P3|On-Treatment|Withdrawal by Subject|1
1003447|NCT00410202|3287291|P2|On-Treatment|Withdrawal by Subject|1
1003448|NCT00410202|3287292|P1|On-Treatment|Withdrawal by Subject|2
1003449|NCT00410202|3287290|P3|On-Treatment|Lack of Efficacy|0
1003450|NCT00410202|3287291|P2|On-Treatment|Lack of Efficacy|4
1003451|NCT00410202|3287292|P1|On-Treatment|Lack of Efficacy|1
1003452|NCT00410202|3287290|P3|On-Treatment|Lost to Follow-up|1
1003453|NCT00410202|3287291|P2|On-Treatment|Lost to Follow-up|0
1003454|NCT00410202|3287292|P1|On-Treatment|Lost to Follow-up|1
1003455|NCT00410202|3287290|P3|On-Treatment|Death|0
1003456|NCT00410202|3287291|P2|On-Treatment|Death|0
1003457|NCT00410202|3287292|P1|On-Treatment|Death|1
1003458|NCT00410202|3287290|P3|On-Treatment|Adverse Event|2
1003459|NCT00410202|3287291|P2|On-Treatment|Adverse Event|3
1003460|NCT00410202|3287292|P1|On-Treatment|Adverse Event|1
1003461|NCT00410202|3287290|P3|On-Treatment|Continuing treatment|66
1003462|NCT00410202|3287291|P2|On-Treatment|Continuing treatment|71
1003463|NCT00410202|3287292|P1|On-Treatment|Continuing treatment|69
1003464|NCT00410163|3287379|P2|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0
1003465|NCT00410163|3287380|P1|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1
1003466|NCT00410163|3287379|P2|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8
1003467|NCT00410163|3287380|P1|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4
1003468|NCT00410163|3287379|P2|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0
1003469|NCT00410163|3287380|P1|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1
1003470|NCT00410163|3287379|P2|Extended Follow-up (FU) Phase (2-5 Years|Death|1
1003471|NCT00410163|3287380|P1|Extended Follow-up (FU) Phase (2-5 Years|Death|1
1003472|NCT00410163|3287379|P2|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1
1003473|NCT00410163|3287380|P1|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3
1003474|NCT00410163|3287379|P2|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1
1003475|NCT00410163|3287380|P1|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0
1003476|NCT00410163|3287379|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0
1003477|NCT00410163|3287380|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1
1003478|NCT00410163|3287379|P2|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
1003479|NCT00410163|3287380|P1|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
1003480|NCT00410163|3287379|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0
1003481|NCT00410163|3287380|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1
1003482|NCT00410163|3287379|P2|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1
1003483|NCT00410163|3287380|P1|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2
1003484|NCT00410163|3287379|P2|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4
1003485|NCT00410163|3287380|P1|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0
1003486|NCT00410163|3287379|P2|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1
1003487|NCT00410163|3287380|P1|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2
1003488|NCT00410163|3287379|P2|Treatment and Follow-up Phase (2 Years)|Death|1
1003489|NCT00410163|3287380|P1|Treatment and Follow-up Phase (2 Years)|Death|1
1003490|NCT00410163|3287379|P2|Treatment and Follow-up Phase (2 Years)|Adverse Event|2
1003491|NCT00410163|3287380|P1|Treatment and Follow-up Phase (2 Years)|Adverse Event|4
1003492|NCT00410124|3287433|P2|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1
1003493|NCT00410124|3287434|P1|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0
1003494|NCT00410124|3287433|P2|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0
1003495|NCT00410124|3287434|P1|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1
1003496|NCT00410124|3287433|P2|Extension Phase - Open Label (45 Months)|Disease Progression|78
1003497|NCT00410124|3287434|P1|Extension Phase - Open Label (45 Months)|Disease Progression|56
1003498|NCT00410124|3287433|P2|Extension Phase - Open Label (45 Months)|Death|10
1003499|NCT00410124|3287434|P1|Extension Phase - Open Label (45 Months)|Death|2
1003500|NCT00410124|3287433|P2|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
1003501|NCT00410124|3287434|P1|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
1003502|NCT00410124|3287433|P2|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1
1003503|NCT00410124|3287434|P1|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0
1003504|NCT00410124|3287433|P2|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1
1003505|NCT00410124|3287434|P1|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0
1003506|NCT00410124|3287433|P2|Extension Phase - Open Label (45 Months)|Adverse Event|19
1003507|NCT00410124|3287434|P1|Extension Phase - Open Label (45 Months)|Adverse Event|7
1003508|NCT00410124|3287433|P2|Core Phase Double Blind (15 Months)|Disease Progression|124
1003509|NCT00410124|3287434|P1|Core Phase Double Blind (15 Months)|Disease Progression|137
1003510|NCT00410124|3287433|P2|Core Phase Double Blind (15 Months)|Death|4
1003511|NCT00410124|3287434|P1|Core Phase Double Blind (15 Months)|Death|7
1003512|NCT00410124|3287433|P2|Core Phase Double Blind (15 Months)|Administrative Problems|0
1003513|NCT00410124|3287434|P1|Core Phase Double Blind (15 Months)|Administrative Problems|2
1003514|NCT00410124|3287433|P2|Core Phase Double Blind (15 Months)|Lost to Follow-up|0
1003515|NCT00410124|3287434|P1|Core Phase Double Blind (15 Months)|Lost to Follow-up|4
1003516|NCT00410124|3287433|P2|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2
1003517|NCT00410124|3287434|P1|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13
1003518|NCT00410124|3287433|P2|Core Phase Double Blind (15 Months)|Protocol Violation|1
1003519|NCT00410124|3287434|P1|Core Phase Double Blind (15 Months)|Protocol Violation|2
1003520|NCT00410124|3287433|P2|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0
1003521|NCT00410124|3287434|P1|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1
1003522|NCT00410124|3287433|P2|Core Phase Double Blind (15 Months)|Adverse Event|2
1003523|NCT00410124|3287434|P1|Core Phase Double Blind (15 Months)|Adverse Event|36
1003524|NCT00410072|3287465|P2|After Week 48 to Week 96|Withdrawal by Subject|1
1003525|NCT00410072|3287466|P1|After Week 48 to Week 96|Withdrawal by Subject|0
1003526|NCT00410072|3287465|P2|After Week 48 to Week 96|Pregnancy|2
1003527|NCT00410072|3287466|P1|After Week 48 to Week 96|Pregnancy|0
1003528|NCT00410072|3287465|P2|After Week 48 to Week 96|Poor compliance/noncompliance|1
1003529|NCT00410072|3287466|P1|After Week 48 to Week 96|Poor compliance/noncompliance|0
1003530|NCT00410072|3287465|P2|After Week 48 to Week 96|Not specified|0
1003531|NCT00410072|3287466|P1|After Week 48 to Week 96|Not specified|2
1003532|NCT00410072|3287465|P2|After Week 48 to Week 96|Lost to Follow-up|4
1003533|NCT00410072|3287466|P1|After Week 48 to Week 96|Lost to Follow-up|2
1003534|NCT00410072|3287465|P2|After Week 48 to Week 96|Lack of Efficacy|0
1003535|NCT00410072|3287466|P1|After Week 48 to Week 96|Lack of Efficacy|1
1003536|NCT00410072|3287465|P2|After Week 48 to Week 96|Death|1
1003537|NCT00410072|3287466|P1|After Week 48 to Week 96|Death|0
1003538|NCT00410072|3287465|P2|After Week 48 to Week 96|Adverse Event|2
1003539|NCT00410072|3287466|P1|After Week 48 to Week 96|Adverse Event|1
1003540|NCT00410072|3287465|P2|Day 1 to Week 48|Withdrawal by Subject|2
1003541|NCT00410072|3287466|P1|Day 1 to Week 48|Withdrawal by Subject|0
1003542|NCT00410072|3287465|P2|Day 1 to Week 48|Pregnancy|2
1003543|NCT00410072|3287466|P1|Day 1 to Week 48|Pregnancy|0
1003544|NCT00410072|3287465|P2|Day 1 to Week 48|poor compliance/noncompliance|3
1003545|NCT00410072|3287466|P1|Day 1 to Week 48|poor compliance/noncompliance|0
1003546|NCT00410072|3287465|P2|Day 1 to Week 48|Not specified|1
1003547|NCT00410072|3287466|P1|Day 1 to Week 48|Not specified|0
1003548|NCT00410072|3287465|P2|Day 1 to Week 48|Lost to Follow-up|2
1003549|NCT00410072|3287466|P1|Day 1 to Week 48|Lost to Follow-up|5
1003550|NCT00410072|3287465|P2|Day 1 to Week 48|Adverse Event|2
1003551|NCT00410072|3287466|P1|Day 1 to Week 48|Adverse Event|1
1003552|NCT00410046|3287506|P1|Overall Study|Lost to Follow-up|1
1003553|NCT00410046|3287506|P1|Overall Study|Withdrawal by Subject|1
1003554|NCT00410046|3287506|P1|Overall Study|Adverse Event|3
1003555|NCT00409838|3287537|P2|Long-term Extension Period|Pregnancy|0
1003556|NCT00409838|3287538|P1|Long-term Extension Period|Pregnancy|1
1003557|NCT00409838|3287537|P2|Long-term Extension Period|Poor compliance/noncompliance|0
1003558|NCT00409838|3287538|P1|Long-term Extension Period|Poor compliance/noncompliance|1
1003559|NCT00409838|3287537|P2|Long-term Extension Period|Withdrawal by Subject|0
1003560|NCT00409838|3287538|P1|Long-term Extension Period|Withdrawal by Subject|3
1003561|NCT00409838|3287537|P2|Long-term Extension Period|Lack of Efficacy|0
1003562|NCT00409838|3287538|P1|Long-term Extension Period|Lack of Efficacy|2
1003563|NCT00409838|3287537|P2|Long-term Extension Period|Death|0
1003564|NCT00409838|3287538|P1|Long-term Extension Period|Death|1
1003565|NCT00409838|3287537|P2|Long-term Extension Period|Adverse Event|0
1003566|NCT00409838|3287538|P1|Long-term Extension Period|Adverse Event|10
1003567|NCT00409838|3287537|P2|Short-term Period|Never Treated|0
1003568|NCT00409838|3287538|P1|Short-term Period|Never Treated|1
1003569|NCT00409838|3287537|P2|Short-term Period|Withdrawal by Subject|3
1003570|NCT00409838|3287538|P1|Short-term Period|Withdrawal by Subject|2
1003571|NCT00409838|3287537|P2|Short-term Period|Lost to Follow-up|1
1003572|NCT00409838|3287538|P1|Short-term Period|Lost to Follow-up|0
1003573|NCT00409838|3287537|P2|Short-term Period|Adverse Event|1
1003574|NCT00409838|3287538|P1|Short-term Period|Adverse Event|0
1003575|NCT00409786|3287603|P1|Overall Study|Withdrawal by Subject|3
1003576|NCT00409773|3287612|P5|Overall Study|Lack of Eligibility|1
1003577|NCT00409773|3287613|P4|Overall Study|Lack of Eligibility|0
1003578|NCT00409773|3287614|P3|Overall Study|Lack of Eligibility|0
1003579|NCT00409773|3287615|P2|Overall Study|Lack of Eligibility|0
1003580|NCT00409773|3287616|P1|Overall Study|Lack of Eligibility|0
1003581|NCT00409773|3287612|P5|Overall Study|Withdrawal by Subject|1
1003582|NCT00409773|3287613|P4|Overall Study|Withdrawal by Subject|2
1003583|NCT00409773|3287614|P3|Overall Study|Withdrawal by Subject|0
1003584|NCT00409773|3287615|P2|Overall Study|Withdrawal by Subject|0
1003585|NCT00409773|3287616|P1|Overall Study|Withdrawal by Subject|0
1003586|NCT00409773|3287612|P5|Overall Study|Protocol Violation|1
1003587|NCT00409773|3287613|P4|Overall Study|Protocol Violation|3
1003588|NCT00409773|3287614|P3|Overall Study|Protocol Violation|3
1003589|NCT00409773|3287615|P2|Overall Study|Protocol Violation|2
1003590|NCT00409773|3287616|P1|Overall Study|Protocol Violation|0
1003591|NCT00409773|3287612|P5|Overall Study|Physician Decision|0
1003592|NCT00409773|3287613|P4|Overall Study|Physician Decision|2
1003593|NCT00409773|3287614|P3|Overall Study|Physician Decision|0
1003594|NCT00409773|3287615|P2|Overall Study|Physician Decision|0
1003595|NCT00409773|3287616|P1|Overall Study|Physician Decision|0
1003596|NCT00409773|3287612|P5|Overall Study|Lost to Follow-up|1
1003597|NCT00409773|3287613|P4|Overall Study|Lost to Follow-up|3
1003598|NCT00409773|3287614|P3|Overall Study|Lost to Follow-up|2
1003599|NCT00409773|3287615|P2|Overall Study|Lost to Follow-up|1
1003600|NCT00409773|3287616|P1|Overall Study|Lost to Follow-up|6
1003601|NCT00409773|3287612|P5|Overall Study|Adverse Event|6
1003602|NCT00409773|3287613|P4|Overall Study|Adverse Event|2
1003603|NCT00409773|3287614|P3|Overall Study|Adverse Event|4
1003604|NCT00409773|3287615|P2|Overall Study|Adverse Event|4
1003605|NCT00409773|3287616|P1|Overall Study|Adverse Event|3
1003606|NCT00409747|3287698|P1|Overall Study|Withdrawal by Subject|1
1003607|NCT00409708|3287705|P2|Washout|Lost to Follow-up|3
1003608|NCT00409708|3287706|P1|Washout|Lost to Follow-up|1
1003609|NCT00409708|3287705|P2|Washout|Withdrawal by Subject|5
1003610|NCT00409708|3287706|P1|Washout|Withdrawal by Subject|11
1003611|NCT00409708|3287705|P2|Washout|Protocol Violation|1
1003612|NCT00409708|3287706|P1|Washout|Protocol Violation|0
1003613|NCT00409708|3287705|P2|Washout|Lack of Efficacy|1
1003614|NCT00409708|3287706|P1|Washout|Lack of Efficacy|9
1003615|NCT00409708|3287705|P2|Treatment|Administrative problems|0
1003616|NCT00409708|3287706|P1|Treatment|Administrative problems|5
1003617|NCT00409708|3287705|P2|Treatment|Lost to Follow-up|6
1003618|NCT00409708|3287706|P1|Treatment|Lost to Follow-up|0
1003619|NCT00409708|3287705|P2|Treatment|Withdrawal by Subject|8
1003620|NCT00409708|3287706|P1|Treatment|Withdrawal by Subject|3
1003621|NCT00409708|3287705|P2|Treatment|Protocol Violation|2
1003622|NCT00409708|3287706|P1|Treatment|Protocol Violation|6
1003623|NCT00409708|3287705|P2|Treatment|Lack of Efficacy|1
1003624|NCT00409708|3287706|P1|Treatment|Lack of Efficacy|0
1003625|NCT00409708|3287705|P2|Treatment|Abnormal test procedure result(s)|0
1003626|NCT00409708|3287706|P1|Treatment|Abnormal test procedure result(s)|1
1003627|NCT00409682|3287727|P3|EOW Double-blind Maintenance Period|Non-compliance|1
1003628|NCT00409682|3287728|P2|EOW Double-blind Maintenance Period|Non-compliance|0
1003629|NCT00409682|3287729|P1|EOW Double-blind Maintenance Period|Non-compliance|0
1003630|NCT00409682|3287727|P3|EOW Double-blind Maintenance Period|Protocol Violation|1
1003631|NCT00409682|3287728|P2|EOW Double-blind Maintenance Period|Protocol Violation|4
1003632|NCT00409682|3287729|P1|EOW Double-blind Maintenance Period|Protocol Violation|0
1003633|NCT00409682|3287727|P3|EOW Double-blind Maintenance Period|Withdrawal by Subject|2
1003634|NCT00409682|3287728|P2|EOW Double-blind Maintenance Period|Withdrawal by Subject|4
1003635|NCT00409682|3287729|P1|EOW Double-blind Maintenance Period|Withdrawal by Subject|0
1003636|NCT00409682|3287727|P3|EOW Double-blind Maintenance Period|Lost to Follow-up|0
1003637|NCT00409682|3287728|P2|EOW Double-blind Maintenance Period|Lost to Follow-up|1
1003638|NCT00409682|3287729|P1|EOW Double-blind Maintenance Period|Lost to Follow-up|0
1003639|NCT00409682|3287727|P3|EOW Double-blind Maintenance Period|Lack of Efficacy|11
1003640|NCT00409682|3287728|P2|EOW Double-blind Maintenance Period|Lack of Efficacy|18
1003641|NCT00409682|3287729|P1|EOW Double-blind Maintenance Period|Lack of Efficacy|0
1003642|NCT00409682|3287727|P3|EOW Double-blind Maintenance Period|Adverse Event|12
1003643|NCT00409682|3287728|P2|EOW Double-blind Maintenance Period|Adverse Event|10
1003644|NCT00409682|3287729|P1|EOW Double-blind Maintenance Period|Adverse Event|0
1003645|NCT00409682|3287727|P3|Open-label Induction Period|Subject did not satisfy entry criteria|0
1003646|NCT00409682|3287728|P2|Open-label Induction Period|Subject did not satisfy entry criteria|0
1003647|NCT00409682|3287729|P1|Open-label Induction Period|Subject did not satisfy entry criteria|1
1003648|NCT00409682|3287727|P3|Open-label Induction Period|Protocol Violation|0
1003649|NCT00409682|3287728|P2|Open-label Induction Period|Protocol Violation|0
1003650|NCT00409682|3287729|P1|Open-label Induction Period|Protocol Violation|1
1003651|NCT00409682|3287727|P3|Open-label Induction Period|Lack of Efficacy|0
1003652|NCT00409682|3287728|P2|Open-label Induction Period|Lack of Efficacy|0
1003653|NCT00409682|3287729|P1|Open-label Induction Period|Lack of Efficacy|1
1003654|NCT00409682|3287727|P3|Open-label Induction Period|Adverse Event|0
1003655|NCT00409682|3287728|P2|Open-label Induction Period|Adverse Event|0
1003656|NCT00409682|3287729|P1|Open-label Induction Period|Adverse Event|1
1003657|NCT00409617|3287746|P1|Overall Study|Not described|14
1003658|NCT00409617|3287746|P1|Overall Study|Administrative reasons|1
1003659|NCT00409617|3287746|P1|Overall Study|Withdrawal by Subject|8
1003660|NCT00409617|3287746|P1|Overall Study|Protocol Violation|24
1003661|NCT00409617|3287746|P1|Overall Study|Lost to Follow-up|2
1003662|NCT00409617|3287746|P1|Overall Study|Lack of Efficacy|54
1003663|NCT00409617|3287746|P1|Overall Study|Adverse Event|57
1003664|NCT00409578|3287762|P4|Overall Study|Missing|1
1003665|NCT00409578|3287763|P3|Overall Study|Missing|0
1003666|NCT00409578|3287764|P2|Overall Study|Missing|1
1003667|NCT00409578|3287765|P1|Overall Study|Missing|0
1003668|NCT00409578|3287762|P4|Overall Study|Protocol Violation|1
1003669|NCT00409578|3287763|P3|Overall Study|Protocol Violation|3
1003670|NCT00409578|3287764|P2|Overall Study|Protocol Violation|2
1003671|NCT00409578|3287765|P1|Overall Study|Protocol Violation|3
1003672|NCT00409578|3287762|P4|Overall Study|Death|2
1003673|NCT00409578|3287763|P3|Overall Study|Death|4
1003674|NCT00409578|3287764|P2|Overall Study|Death|4
1003675|NCT00409578|3287765|P1|Overall Study|Death|2
1003676|NCT00409578|3287762|P4|Overall Study|Administrative problems|4
1003677|NCT00409578|3287763|P3|Overall Study|Administrative problems|2
1003678|NCT00409578|3287764|P2|Overall Study|Administrative problems|9
1003679|NCT00409578|3287765|P1|Overall Study|Administrative problems|8
1003680|NCT00409578|3287762|P4|Overall Study|Lost to Follow-up|2
1003681|NCT00409578|3287763|P3|Overall Study|Lost to Follow-up|2
1003682|NCT00409578|3287764|P2|Overall Study|Lost to Follow-up|0
1003683|NCT00409578|3287765|P1|Overall Study|Lost to Follow-up|2
1003684|NCT00409578|3287762|P4|Overall Study|Withdrawal by Subject|17
1003685|NCT00409578|3287763|P3|Overall Study|Withdrawal by Subject|16
1003686|NCT00409578|3287764|P2|Overall Study|Withdrawal by Subject|15
1003687|NCT00409578|3287765|P1|Overall Study|Withdrawal by Subject|8
1003688|NCT00409578|3287762|P4|Overall Study|Subject no longer requires study drug|1
1003689|NCT00409578|3287763|P3|Overall Study|Subject no longer requires study drug|0
1003690|NCT00409578|3287764|P2|Overall Study|Subject no longer requires study drug|0
1003691|NCT00409578|3287765|P1|Overall Study|Subject no longer requires study drug|0
1003692|NCT00409578|3287762|P4|Overall Study|Lack of Efficacy|2
1003693|NCT00409578|3287763|P3|Overall Study|Lack of Efficacy|0
1003694|NCT00409578|3287764|P2|Overall Study|Lack of Efficacy|0
1003695|NCT00409578|3287765|P1|Overall Study|Lack of Efficacy|0
1003696|NCT00409578|3287762|P4|Overall Study|Abnormal laboratory value(s)|4
1003697|NCT00409578|3287763|P3|Overall Study|Abnormal laboratory value(s)|2
1003698|NCT00409578|3287764|P2|Overall Study|Abnormal laboratory value(s)|2
1003699|NCT00409578|3287765|P1|Overall Study|Abnormal laboratory value(s)|2
1003700|NCT00409578|3287762|P4|Overall Study|Adverse Event|33
1003701|NCT00409578|3287763|P3|Overall Study|Adverse Event|25
1003702|NCT00409578|3287764|P2|Overall Study|Adverse Event|37
1003703|NCT00409578|3287765|P1|Overall Study|Adverse Event|27
1003704|NCT00409409|3287823|P2|Overall Study|Any other reason not above-mentioned|1
1003705|NCT00409409|3287824|P1|Overall Study|Any other reason not above-mentioned|0
1003706|NCT00409409|3287823|P2|Overall Study|Withdrawal by Subject|1
1003707|NCT00409409|3287824|P1|Overall Study|Withdrawal by Subject|1
1003708|NCT00409409|3287823|P2|Overall Study|Adverse Event|2
1003709|NCT00409409|3287824|P1|Overall Study|Adverse Event|7
1003710|NCT00409344|3287832|P2|Overall Study|no enrollment|0
1003711|NCT00409344|3287833|P1|Overall Study|no enrollment|0
1003712|NCT00409331|3287851|P1|Overall Study|Physician Decision|1
1003713|NCT00409188|3287873|P2|Overall Study|Ongoing at data cut-off|175
1003714|NCT00409188|3287874|P1|Overall Study|Ongoing at data cut-off|383
1003715|NCT00409175|3287890|P2|Overall Study|Liver transplantation|13
1003716|NCT00409175|3287891|P1|Overall Study|Liver transplantation|13
1003717|NCT00409175|3287890|P2|Overall Study|Negative genotype|1
1003718|NCT00409175|3287891|P1|Overall Study|Negative genotype|0
1003719|NCT00409175|3287890|P2|Overall Study|Withdrawal by Subject|2
1003720|NCT00409175|3287891|P1|Overall Study|Withdrawal by Subject|1
1003721|NCT00409175|3287890|P2|Overall Study|Adverse Event|3
1003722|NCT00409175|3287891|P1|Overall Study|Adverse Event|4
1003723|NCT00409006|3287917|P2|Overall Study|Physician Decision|2
1003724|NCT00409006|3287918|P1|Overall Study|Physician Decision|1
1003725|NCT00409006|3287917|P2|Overall Study|Withdrawal by Subject|2
1003726|NCT00409006|3287918|P1|Overall Study|Withdrawal by Subject|3
1003727|NCT00409006|3287917|P2|Overall Study|Lost to Follow-up|2
1003728|NCT00409006|3287918|P1|Overall Study|Lost to Follow-up|1
1003729|NCT00409006|3287917|P2|Overall Study|Death|6
1003730|NCT00409006|3287918|P1|Overall Study|Death|15
1003731|NCT00408993|3287934|P2|Overall Study|Withdrawal by Subject|3
1003732|NCT00408993|3287935|P1|Overall Study|Withdrawal by Subject|2
1003733|NCT00408993|3287934|P2|Overall Study|Lack of Efficacy|4
1003734|NCT00408993|3287935|P1|Overall Study|Lack of Efficacy|1
1003735|NCT00408993|3287934|P2|Overall Study|Protocol Violation|6
1003736|NCT00408993|3287935|P1|Overall Study|Protocol Violation|1
1003737|NCT00408993|3287934|P2|Overall Study|Adverse Event|4
1003738|NCT00408993|3287935|P1|Overall Study|Adverse Event|15
1003739|NCT00408928|3287967|P1|Overall Study|Infection indistinguishable from GVHD|1
1003740|NCT00408928|3287967|P1|Overall Study|Death|1
1003741|NCT00408928|3287967|P1|Overall Study|Withdrawal by Subject|1
1003742|NCT00408902|3287972|P1|Overall Study|Adverse Event|3
1003743|NCT00408902|3287972|P1|Overall Study|Lack of Efficacy|7
1003744|NCT00408876|3287982|P4|Overall Study|Physician Decision|0
1003745|NCT00408876|3287983|P3|Overall Study|Physician Decision|3
1003746|NCT00408876|3287984|P2|Overall Study|Physician Decision|0
1003747|NCT00408876|3287985|P1|Overall Study|Physician Decision|1
1003748|NCT00408876|3287982|P4|Overall Study|Protocol Violation|3
1003749|NCT00408876|3287983|P3|Overall Study|Protocol Violation|4
1003750|NCT00408876|3287984|P2|Overall Study|Protocol Violation|3
1003751|NCT00408876|3287985|P1|Overall Study|Protocol Violation|0
1003752|NCT00408876|3287982|P4|Overall Study|Lost to Follow-up|2
1003753|NCT00408876|3287983|P3|Overall Study|Lost to Follow-up|5
1003754|NCT00408876|3287984|P2|Overall Study|Lost to Follow-up|6
1003755|NCT00408876|3287985|P1|Overall Study|Lost to Follow-up|1
1003756|NCT00408876|3287982|P4|Overall Study|Lack of Efficacy|6
1003757|NCT00408876|3287983|P3|Overall Study|Lack of Efficacy|5
1003758|NCT00408876|3287984|P2|Overall Study|Lack of Efficacy|4
1003759|NCT00408876|3287985|P1|Overall Study|Lack of Efficacy|2
1003760|NCT00408876|3287982|P4|Overall Study|Withdrawal by Subject|14
1003761|NCT00408876|3287983|P3|Overall Study|Withdrawal by Subject|6
1003762|NCT00408876|3287984|P2|Overall Study|Withdrawal by Subject|6
1003763|NCT00408876|3287985|P1|Overall Study|Withdrawal by Subject|3
1003764|NCT00408876|3287982|P4|Overall Study|Adverse Event|10
1003765|NCT00408876|3287983|P3|Overall Study|Adverse Event|27
1003766|NCT00408876|3287984|P2|Overall Study|Adverse Event|17
1003767|NCT00408876|3287985|P1|Overall Study|Adverse Event|9
1003768|NCT00408694|3288235|P1|Overall Study|No protocol treatment|1
1003769|NCT00408694|3288235|P1|Overall Study|Ineligible|1
1003770|NCT00408681|3288247|P1|Overall Study|Adverse Event|7
1003771|NCT00408681|3288247|P1|Overall Study|Lack of Efficacy|2
1003772|NCT00408629|3288266|P2|Overall Study|Miscellaneous|15
1003773|NCT00408629|3288267|P1|Overall Study|Miscellaneous|11
1003774|NCT00408629|3288266|P2|Overall Study|Protocol Violation|5
1003775|NCT00408629|3288267|P1|Overall Study|Protocol Violation|1
1003776|NCT00408629|3288266|P2|Overall Study|Lack of Efficacy|73
1003777|NCT00408629|3288267|P1|Overall Study|Lack of Efficacy|63
1003778|NCT00408629|3288266|P2|Overall Study|Lost to Follow-up|1
1003779|NCT00408629|3288267|P1|Overall Study|Lost to Follow-up|1
1003780|NCT00408629|3288266|P2|Overall Study|Withdrawal by Subject|4
1003781|NCT00408629|3288267|P1|Overall Study|Withdrawal by Subject|8
1003782|NCT00408629|3288266|P2|Overall Study|Adverse Event|27
1003783|NCT00408629|3288267|P1|Overall Study|Adverse Event|13
1003784|NCT00408499|3288363|P5|Phase II- MTD Expansion|treatment delay|3
1003785|NCT00408499|3288364|P4|Phase II- MTD Expansion|treatment delay|0
1003786|NCT00408499|3288365|P3|Phase II- MTD Expansion|treatment delay|0
1003787|NCT00408499|3288366|P2|Phase II- MTD Expansion|treatment delay|0
1003788|NCT00408499|3288367|P1|Phase II- MTD Expansion|treatment delay|0
1003789|NCT00408499|3288363|P5|Phase II- MTD Expansion|Withdrawal by Subject|5
1003790|NCT00408499|3288364|P4|Phase II- MTD Expansion|Withdrawal by Subject|0
1003791|NCT00408499|3288365|P3|Phase II- MTD Expansion|Withdrawal by Subject|0
1003792|NCT00408499|3288366|P2|Phase II- MTD Expansion|Withdrawal by Subject|0
1003793|NCT00408499|3288367|P1|Phase II- MTD Expansion|Withdrawal by Subject|0
1003794|NCT00408499|3288363|P5|Phase II- MTD Expansion|Physician Decision|1
1003795|NCT00408499|3288364|P4|Phase II- MTD Expansion|Physician Decision|0
1003796|NCT00408499|3288365|P3|Phase II- MTD Expansion|Physician Decision|0
1003797|NCT00408499|3288366|P2|Phase II- MTD Expansion|Physician Decision|0
1003798|NCT00408499|3288367|P1|Phase II- MTD Expansion|Physician Decision|0
1003799|NCT00408499|3288363|P5|Phase II- MTD Expansion|Death|2
1003800|NCT00408499|3288364|P4|Phase II- MTD Expansion|Death|0
1003801|NCT00408499|3288365|P3|Phase II- MTD Expansion|Death|0
1003802|NCT00408499|3288366|P2|Phase II- MTD Expansion|Death|0
1003803|NCT00408499|3288367|P1|Phase II- MTD Expansion|Death|0
1003804|NCT00408499|3288363|P5|Phase II- MTD Expansion|Adverse Event|9
1003805|NCT00408499|3288364|P4|Phase II- MTD Expansion|Adverse Event|0
1003806|NCT00408499|3288365|P3|Phase II- MTD Expansion|Adverse Event|0
1003807|NCT00408499|3288366|P2|Phase II- MTD Expansion|Adverse Event|0
1003808|NCT00408499|3288367|P1|Phase II- MTD Expansion|Adverse Event|0
1003809|NCT00408499|3288363|P5|Phase 1: Dose Levels 1-4|Physician Decision|0
1003810|NCT00408499|3288364|P4|Phase 1: Dose Levels 1-4|Physician Decision|0
1003811|NCT00408499|3288365|P3|Phase 1: Dose Levels 1-4|Physician Decision|0
1003812|NCT00408499|3288366|P2|Phase 1: Dose Levels 1-4|Physician Decision|1
1003813|NCT00408499|3288367|P1|Phase 1: Dose Levels 1-4|Physician Decision|1
1003814|NCT00408499|3288363|P5|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
1003815|NCT00408499|3288364|P4|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
1003816|NCT00408499|3288365|P3|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
1003817|NCT00408499|3288366|P2|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
1003818|NCT00408499|3288367|P1|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
1003819|NCT00408499|3288363|P5|Phase 1: Dose Levels 1-4|Adverse Event|0
1003820|NCT00408499|3288364|P4|Phase 1: Dose Levels 1-4|Adverse Event|0
1003821|NCT00408499|3288365|P3|Phase 1: Dose Levels 1-4|Adverse Event|1
1003822|NCT00408499|3288366|P2|Phase 1: Dose Levels 1-4|Adverse Event|0
1003823|NCT00408499|3288367|P1|Phase 1: Dose Levels 1-4|Adverse Event|0
1003824|NCT00408421|3288384|P3|Treatment Re-Randomization|Withdrawal by Subject|0
1003825|NCT00408421|3288385|P2|Treatment Re-Randomization|Withdrawal by Subject|1
1003826|NCT00408421|3288386|P1|Treatment Re-Randomization|Withdrawal by Subject|2
1003827|NCT00408421|3288384|P3|Treatment Re-Randomization|Protocol Violation|0
1003828|NCT00408421|3288385|P2|Treatment Re-Randomization|Protocol Violation|1
1003829|NCT00408421|3288386|P1|Treatment Re-Randomization|Protocol Violation|1
1003830|NCT00408421|3288384|P3|Treatment Re-Randomization|Physician Decision|0
1003831|NCT00408421|3288385|P2|Treatment Re-Randomization|Physician Decision|3
1003832|NCT00408421|3288386|P1|Treatment Re-Randomization|Physician Decision|1
1003833|NCT00408421|3288384|P3|Treatment Re-Randomization|Lost to Follow-up|1
1003834|NCT00408421|3288385|P2|Treatment Re-Randomization|Lost to Follow-up|0
1003835|NCT00408421|3288386|P1|Treatment Re-Randomization|Lost to Follow-up|0
1003836|NCT00408421|3288384|P3|Treatment Re-Randomization|Lack of Efficacy|0
1003837|NCT00408421|3288385|P2|Treatment Re-Randomization|Lack of Efficacy|0
1003838|NCT00408421|3288386|P1|Treatment Re-Randomization|Lack of Efficacy|1
1003839|NCT00408421|3288384|P3|Treatment Re-Randomization|Adverse Event|4
1003840|NCT00408421|3288385|P2|Treatment Re-Randomization|Adverse Event|2
1003841|NCT00408421|3288386|P1|Treatment Re-Randomization|Adverse Event|2
1003842|NCT00408421|3288384|P3|Treatment Initial Randomization|Sponsor Decision|0
1003843|NCT00408421|3288385|P2|Treatment Initial Randomization|Sponsor Decision|0
1003844|NCT00408421|3288386|P1|Treatment Initial Randomization|Sponsor Decision|1
1003845|NCT00408421|3288384|P3|Treatment Initial Randomization|Entry Criteria Not Met|0
1003846|NCT00408421|3288385|P2|Treatment Initial Randomization|Entry Criteria Not Met|0
1003847|NCT00408421|3288386|P1|Treatment Initial Randomization|Entry Criteria Not Met|1
1003848|NCT00408421|3288384|P3|Treatment Initial Randomization|Withdrawal by Subject|0
1003849|NCT00408421|3288385|P2|Treatment Initial Randomization|Withdrawal by Subject|7
1003850|NCT00408421|3288386|P1|Treatment Initial Randomization|Withdrawal by Subject|7
1003851|NCT00408421|3288384|P3|Treatment Initial Randomization|Protocol Violation|0
1003852|NCT00408421|3288385|P2|Treatment Initial Randomization|Protocol Violation|1
1003853|NCT00408421|3288386|P1|Treatment Initial Randomization|Protocol Violation|0
1003854|NCT00408421|3288384|P3|Treatment Initial Randomization|Physician Decision|0
1003855|NCT00408421|3288385|P2|Treatment Initial Randomization|Physician Decision|0
1003856|NCT00408421|3288386|P1|Treatment Initial Randomization|Physician Decision|1
1003857|NCT00408421|3288384|P3|Treatment Initial Randomization|Lost to Follow-up|0
1003858|NCT00408421|3288385|P2|Treatment Initial Randomization|Lost to Follow-up|3
1003859|NCT00408421|3288386|P1|Treatment Initial Randomization|Lost to Follow-up|0
1003860|NCT00408421|3288384|P3|Treatment Initial Randomization|Lack of Efficacy|0
1003861|NCT00408421|3288385|P2|Treatment Initial Randomization|Lack of Efficacy|2
1003862|NCT00408421|3288386|P1|Treatment Initial Randomization|Lack of Efficacy|2
1003863|NCT00408421|3288384|P3|Treatment Initial Randomization|Adverse Event|0
1003864|NCT00408421|3288385|P2|Treatment Initial Randomization|Adverse Event|9
1003865|NCT00408421|3288386|P1|Treatment Initial Randomization|Adverse Event|5
1003866|NCT00408408|3288466|P6|Overall Study|No follow up data|3
1003867|NCT00408408|3288467|P5|Overall Study|No follow up data|5
1003868|NCT00408408|3288468|P4|Overall Study|No follow up data|7
1003869|NCT00408408|3288469|P3|Overall Study|No follow up data|0
1003870|NCT00408408|3288470|P2|Overall Study|No follow up data|3
1003871|NCT00408408|3288471|P1|Overall Study|No follow up data|2
1003872|NCT00408317|3288533|P2|Second Intervention Period|Withdrawal of consent|1
1003873|NCT00408317|3288534|P1|Second Intervention Period|Withdrawal of consent|0
1003874|NCT00408317|3288533|P2|Second Intervention Period|Protocol Violation|1
1003875|NCT00408317|3288534|P1|Second Intervention Period|Protocol Violation|0
1003876|NCT00408317|3288533|P2|Second Intervention Period|Adverse Event|0
1003877|NCT00408317|3288534|P1|Second Intervention Period|Adverse Event|2
1003878|NCT00408317|3288533|P2|First Intervention Period|Adverse Event|1
1003879|NCT00408317|3288534|P1|First Intervention Period|Adverse Event|0
1003880|NCT00407797|3288577|P1|Overall Study|Withdrawal by Subject|3
1003881|NCT00407797|3288577|P1|Overall Study|Other|7
1003882|NCT00407797|3288577|P1|Overall Study|Adverse Event|6
1003883|NCT00407797|3288577|P1|Overall Study|Lost to Follow-up|2
1003884|NCT00407758|3288592|P1|Overall Study|ineligible –improper prior treatment|1
1003885|NCT00407745|3288605|P2|Overall Study|Randomized, unknown if treated|1
1003886|NCT00407745|3288606|P1|Overall Study|Randomized, unknown if treated|0
1003887|NCT00407745|3288605|P2|Overall Study|Other|0
1003888|NCT00407745|3288606|P1|Overall Study|Other|2
1003889|NCT00407745|3288605|P2|Overall Study|Adverse Event|8
1003890|NCT00407745|3288606|P1|Overall Study|Adverse Event|8
1003891|NCT00407745|3288605|P2|Overall Study|Protocol Violation|3
1003892|NCT00407745|3288606|P1|Overall Study|Protocol Violation|5
1003893|NCT00407745|3288605|P2|Overall Study|Withdrawal by Subject|3
1003894|NCT00407745|3288606|P1|Overall Study|Withdrawal by Subject|3
1003895|NCT00407745|3288605|P2|Overall Study|Lack of Efficacy|2
1003896|NCT00407745|3288606|P1|Overall Study|Lack of Efficacy|1
1003897|NCT00407563|3288692|P1|Overall Study|Patient continues on treatment|1
1003898|NCT00407550|3288702|P2|Overall Study|Insurance or Other medical condition|1
1003899|NCT00407550|3288703|P1|Overall Study|Insurance or Other medical condition|2
1003900|NCT00407550|3288702|P2|Overall Study|Death|0
1003901|NCT00407550|3288703|P1|Overall Study|Death|1
1003902|NCT00407550|3288702|P2|Overall Study|Withdrawal by Subject|2
1003903|NCT00407550|3288703|P1|Overall Study|Withdrawal by Subject|0
1003904|NCT00407550|3288702|P2|Overall Study|Adverse Event|1
1003905|NCT00407550|3288703|P1|Overall Study|Adverse Event|0
1003906|NCT00407537|3288711|P2|Overall Study|Withdrawal by Subject|16
1003907|NCT00407537|3288712|P1|Overall Study|Withdrawal by Subject|34
1003908|NCT00407537|3288711|P2|Overall Study|Other|7
1003909|NCT00407537|3288712|P1|Overall Study|Other|6
1003910|NCT00407537|3288711|P2|Overall Study|Lost to Follow-up|19
1003911|NCT00407537|3288712|P1|Overall Study|Lost to Follow-up|12
1003912|NCT00407537|3288711|P2|Overall Study|Adverse Event|0
1003913|NCT00407537|3288712|P1|Overall Study|Adverse Event|36
1003914|NCT00407537|3288711|P2|Overall Study|Death|2
1003915|NCT00407537|3288712|P1|Overall Study|Death|5
1003916|NCT00407511|3288760|P1|Overall Study|Withdrawal by Subject|4
1003917|NCT00407511|3288760|P1|Overall Study|Other|5
1003918|NCT00407511|3288760|P1|Overall Study|Lost to Follow-up|4
1003919|NCT00407511|3288760|P1|Overall Study|Adverse Event|9
1003920|NCT00407030|3288806|P3|Extension Period - up to 68 Weeks|Physician Decision|0
1003921|NCT00407030|3288807|P2|Extension Period - up to 68 Weeks|Physician Decision|2
1003922|NCT00407030|3288808|P1|Extension Period - up to 68 Weeks|Physician Decision|1
1003923|NCT00407030|3288806|P3|Extension Period - up to 68 Weeks|Patient Decision|0
1003924|NCT00407030|3288807|P2|Extension Period - up to 68 Weeks|Patient Decision|2
1003925|NCT00407030|3288808|P1|Extension Period - up to 68 Weeks|Patient Decision|1
1003926|NCT00407030|3288806|P3|Extension Period - up to 68 Weeks|Lost to Follow-up|0
1003927|NCT00407030|3288807|P2|Extension Period - up to 68 Weeks|Lost to Follow-up|5
1003928|NCT00407030|3288808|P1|Extension Period - up to 68 Weeks|Lost to Follow-up|5
1003929|NCT00407030|3288806|P3|Extension Period - up to 68 Weeks|Consent Withdrawn|0
1003930|NCT00407030|3288807|P2|Extension Period - up to 68 Weeks|Consent Withdrawn|4
1003931|NCT00407030|3288808|P1|Extension Period - up to 68 Weeks|Consent Withdrawn|4
1003932|NCT00407030|3288806|P3|Extension Period - up to 68 Weeks|Adverse Event|0
1003933|NCT00407030|3288807|P2|Extension Period - up to 68 Weeks|Adverse Event|0
1003934|NCT00407030|3288808|P1|Extension Period - up to 68 Weeks|Adverse Event|1
1003935|NCT00407030|3288806|P3|Extension Period - up to 68 Weeks|Lack of Efficacy|0
1003936|NCT00407030|3288807|P2|Extension Period - up to 68 Weeks|Lack of Efficacy|11
1003937|NCT00407030|3288808|P1|Extension Period - up to 68 Weeks|Lack of Efficacy|11
1003938|NCT00407030|3288806|P3|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
1003939|NCT00407030|3288807|P2|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5
1003940|NCT00407030|3288808|P1|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
1003941|NCT00407030|3288806|P3|Main Period - 8 to 20 Weeks|Patient Decision|0
1003942|NCT00407030|3288807|P2|Main Period - 8 to 20 Weeks|Patient Decision|0
1003943|NCT00407030|3288808|P1|Main Period - 8 to 20 Weeks|Patient Decision|1
1003944|NCT00407030|3288806|P3|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1
1003945|NCT00407030|3288807|P2|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
1003946|NCT00407030|3288808|P1|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
1003947|NCT00407030|3288806|P3|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
1003948|NCT00407030|3288807|P2|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
1003949|NCT00407030|3288808|P1|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
1003950|NCT00407030|3288806|P3|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
1003951|NCT00407030|3288807|P2|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
1003952|NCT00407030|3288808|P1|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
1003953|NCT00407030|3288806|P3|Main Period - 8 to 20 Weeks|Lack of Efficacy|3
1003954|NCT00407030|3288807|P2|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
1003955|NCT00407030|3288808|P1|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
1003956|NCT00407030|3288806|P3|Main Period - 8 to 20 Weeks|Adverse Event|0
1003957|NCT00407030|3288807|P2|Main Period - 8 to 20 Weeks|Adverse Event|1
1003958|NCT00407030|3288808|P1|Main Period - 8 to 20 Weeks|Adverse Event|2
1003959|NCT00406848|3288836|P2|Overall Study|Sponsor Decision|1
1003960|NCT00406848|3288837|P1|Overall Study|Sponsor Decision|1
1003961|NCT00406848|3288836|P2|Overall Study|Physician Decision|2
1003962|NCT00406848|3288837|P1|Overall Study|Physician Decision|2
1003963|NCT00406848|3288836|P2|Overall Study|Lost to Follow-up|2
1003964|NCT00406848|3288837|P1|Overall Study|Lost to Follow-up|6
1003965|NCT00406848|3288836|P2|Overall Study|Protocol Violation|6
1003966|NCT00406848|3288837|P1|Overall Study|Protocol Violation|10
1003967|NCT00406848|3288836|P2|Overall Study|Lack of Efficacy|14
1003968|NCT00406848|3288837|P1|Overall Study|Lack of Efficacy|9
1003969|NCT00406848|3288836|P2|Overall Study|Adverse Event|7
1003970|NCT00406848|3288837|P1|Overall Study|Adverse Event|38
1003971|NCT00406848|3288836|P2|Overall Study|Withdrawal by Subject|22
1003972|NCT00406848|3288837|P1|Overall Study|Withdrawal by Subject|27
1003973|NCT00406783|3288901|P2|Overall Study|Protocol Violation|4
1003974|NCT00406783|3288902|P1|Overall Study|Protocol Violation|4
1003975|NCT00406783|3288901|P2|Overall Study|Withdrawal by Subject|4
1003976|NCT00406783|3288902|P1|Overall Study|Withdrawal by Subject|1
1003977|NCT00406783|3288901|P2|Overall Study|Lost to Follow-up|0
1003978|NCT00406783|3288902|P1|Overall Study|Lost to Follow-up|3
1003979|NCT00406783|3288901|P2|Overall Study|Treatment Failure|3
1003980|NCT00406783|3288902|P1|Overall Study|Treatment Failure|2
1003981|NCT00406783|3288901|P2|Overall Study|Adverse Event|4
1003982|NCT00406783|3288902|P1|Overall Study|Adverse Event|4
1003983|NCT00406718|3288917|P3|Overall Study|Lost to Follow-up|4
1003984|NCT00406718|3288918|P2|Overall Study|Lost to Follow-up|5
1003985|NCT00406718|3288919|P1|Overall Study|Lost to Follow-up|2
1003986|NCT00406718|3288917|P3|Overall Study|Withdrawal by Subject|4
1003987|NCT00406718|3288918|P2|Overall Study|Withdrawal by Subject|9
1003988|NCT00406718|3288919|P1|Overall Study|Withdrawal by Subject|2
1003989|NCT00406692|3288933|P1|Overall Study|Lack of Efficacy|1
1003990|NCT00406692|3288933|P1|Overall Study|Adverse Event|1
1003991|NCT00406692|3288933|P1|Overall Study|Physician Decision|1
1003992|NCT00406692|3288933|P1|Overall Study|Withdrawal by Subject|4
1003993|NCT00406653|3288943|P7|Open-Label Period|Refused followup|1
1003994|NCT00406653|3288944|P6|Open-Label Period|Refused followup|0
1003995|NCT00406653|3288945|P5|Open-Label Period|Refused followup|0
1003996|NCT00406653|3288946|P4|Open-Label Period|Refused followup|0
1003997|NCT00406653|3288947|P3|Open-Label Period|Refused followup|0
1003998|NCT00406653|3288948|P2|Open-Label Period|Refused followup|0
1003999|NCT00406653|3288949|P1|Open-Label Period|Refused followup|0
1004000|NCT00406653|3288943|P7|Open-Label Period|Discontinued by Sponsor|1
1004001|NCT00406653|3288944|P6|Open-Label Period|Discontinued by Sponsor|0
1004002|NCT00406653|3288945|P5|Open-Label Period|Discontinued by Sponsor|0
1004003|NCT00406653|3288946|P4|Open-Label Period|Discontinued by Sponsor|0
1004004|NCT00406653|3288947|P3|Open-Label Period|Discontinued by Sponsor|0
1004005|NCT00406653|3288948|P2|Open-Label Period|Discontinued by Sponsor|0
1004006|NCT00406653|3288949|P1|Open-Label Period|Discontinued by Sponsor|0
1004007|NCT00406653|3288943|P7|Open-Label Period|Declined participation but followup done|8
1004008|NCT00406653|3288944|P6|Open-Label Period|Declined participation but followup done|0
1004009|NCT00406653|3288945|P5|Open-Label Period|Declined participation but followup done|0
1004010|NCT00406653|3288946|P4|Open-Label Period|Declined participation but followup done|0
1004011|NCT00406653|3288947|P3|Open-Label Period|Declined participation but followup done|0
1004012|NCT00406653|3288948|P2|Open-Label Period|Declined participation but followup done|0
1004013|NCT00406653|3288949|P1|Open-Label Period|Declined participation but followup done|0
1004014|NCT00406653|3288943|P7|Open-Label Period|Administrative Reason By Sponsor|115
1004015|NCT00406653|3288944|P6|Open-Label Period|Administrative Reason By Sponsor|0
1004016|NCT00406653|3288945|P5|Open-Label Period|Administrative Reason By Sponsor|0
1004017|NCT00406653|3288946|P4|Open-Label Period|Administrative Reason By Sponsor|0
1004018|NCT00406653|3288947|P3|Open-Label Period|Administrative Reason By Sponsor|0
1004019|NCT00406653|3288948|P2|Open-Label Period|Administrative Reason By Sponsor|0
1004020|NCT00406653|3288949|P1|Open-Label Period|Administrative Reason By Sponsor|0
1004021|NCT00406653|3288943|P7|Open-Label Period|Pregnancy|2
1004022|NCT00406653|3288944|P6|Open-Label Period|Pregnancy|0
1004023|NCT00406653|3288945|P5|Open-Label Period|Pregnancy|0
1004024|NCT00406653|3288946|P4|Open-Label Period|Pregnancy|0
1004025|NCT00406653|3288947|P3|Open-Label Period|Pregnancy|0
1004026|NCT00406653|3288948|P2|Open-Label Period|Pregnancy|0
1004027|NCT00406653|3288949|P1|Open-Label Period|Pregnancy|0
1004028|NCT00406653|3288943|P7|Open-Label Period|Subject No Longer Meets Study Criteria|1
1004029|NCT00406653|3288944|P6|Open-Label Period|Subject No Longer Meets Study Criteria|0
1004030|NCT00406653|3288945|P5|Open-Label Period|Subject No Longer Meets Study Criteria|0
1004031|NCT00406653|3288946|P4|Open-Label Period|Subject No Longer Meets Study Criteria|0
1004032|NCT00406653|3288947|P3|Open-Label Period|Subject No Longer Meets Study Criteria|0
1004033|NCT00406653|3288948|P2|Open-Label Period|Subject No Longer Meets Study Criteria|0
1004034|NCT00406653|3288949|P1|Open-Label Period|Subject No Longer Meets Study Criteria|0
1004035|NCT00406653|3288943|P7|Open-Label Period|Withdrawal of Consent|11
1004036|NCT00406653|3288944|P6|Open-Label Period|Withdrawal of Consent|0
1004037|NCT00406653|3288945|P5|Open-Label Period|Withdrawal of Consent|0
1004038|NCT00406653|3288946|P4|Open-Label Period|Withdrawal of Consent|0
1004039|NCT00406653|3288947|P3|Open-Label Period|Withdrawal of Consent|0
1004040|NCT00406653|3288948|P2|Open-Label Period|Withdrawal of Consent|0
1004041|NCT00406653|3288949|P1|Open-Label Period|Withdrawal of Consent|0
1004042|NCT00406653|3288943|P7|Open-Label Period|Lost to Follow-up|6
1004043|NCT00406653|3288944|P6|Open-Label Period|Lost to Follow-up|0
1004044|NCT00406653|3288945|P5|Open-Label Period|Lost to Follow-up|0
1004045|NCT00406653|3288946|P4|Open-Label Period|Lost to Follow-up|0
1004046|NCT00406653|3288947|P3|Open-Label Period|Lost to Follow-up|0
1004047|NCT00406653|3288948|P2|Open-Label Period|Lost to Follow-up|0
1004048|NCT00406653|3288949|P1|Open-Label Period|Lost to Follow-up|0
1004049|NCT00406653|3288943|P7|Open-Label Period|Lack of Efficacy|160
1004050|NCT00406653|3288944|P6|Open-Label Period|Lack of Efficacy|0
1004051|NCT00406653|3288945|P5|Open-Label Period|Lack of Efficacy|0
1004052|NCT00406653|3288946|P4|Open-Label Period|Lack of Efficacy|0
1004053|NCT00406653|3288947|P3|Open-Label Period|Lack of Efficacy|0
1004054|NCT00406653|3288948|P2|Open-Label Period|Lack of Efficacy|0
1004055|NCT00406653|3288949|P1|Open-Label Period|Lack of Efficacy|0
1004056|NCT00406653|3288943|P7|Open-Label Period|Adverse Event|18
1004057|NCT00406653|3288944|P6|Open-Label Period|Adverse Event|0
1004058|NCT00406653|3288945|P5|Open-Label Period|Adverse Event|0
1004059|NCT00406653|3288946|P4|Open-Label Period|Adverse Event|0
1004060|NCT00406653|3288947|P3|Open-Label Period|Adverse Event|0
1004061|NCT00406653|3288948|P2|Open-Label Period|Adverse Event|0
1004062|NCT00406653|3288949|P1|Open-Label Period|Adverse Event|0
1004063|NCT00406653|3288943|P7|Open-Label Period|Death|1
1004064|NCT00406653|3288944|P6|Open-Label Period|Death|0
1004065|NCT00406653|3288945|P5|Open-Label Period|Death|0
1004066|NCT00406653|3288946|P4|Open-Label Period|Death|0
1004067|NCT00406653|3288947|P3|Open-Label Period|Death|0
1004068|NCT00406653|3288948|P2|Open-Label Period|Death|0
1004069|NCT00406653|3288949|P1|Open-Label Period|Death|0
1004070|NCT00406653|3288943|P7|Maintenance Period|Error in disease score evaluation|0
1004071|NCT00406653|3288944|P6|Maintenance Period|Error in disease score evaluation|0
1004072|NCT00406653|3288945|P5|Maintenance Period|Error in disease score evaluation|1
1004073|NCT00406653|3288946|P4|Maintenance Period|Error in disease score evaluation|0
1004074|NCT00406653|3288947|P3|Maintenance Period|Error in disease score evaluation|0
1004075|NCT00406653|3288948|P2|Maintenance Period|Error in disease score evaluation|0
1004076|NCT00406653|3288949|P1|Maintenance Period|Error in disease score evaluation|0
1004077|NCT00406653|3288943|P7|Maintenance Period|Administrative Reason By Sponsor|0
1004078|NCT00406653|3288944|P6|Maintenance Period|Administrative Reason By Sponsor|7
1004079|NCT00406653|3288945|P5|Maintenance Period|Administrative Reason By Sponsor|4
1004080|NCT00406653|3288946|P4|Maintenance Period|Administrative Reason By Sponsor|0
1004081|NCT00406653|3288947|P3|Maintenance Period|Administrative Reason By Sponsor|0
1004082|NCT00406653|3288948|P2|Maintenance Period|Administrative Reason By Sponsor|0
1004083|NCT00406653|3288949|P1|Maintenance Period|Administrative Reason By Sponsor|0
1004084|NCT00406653|3288943|P7|Maintenance Period|Pregnancy|0
1004085|NCT00406653|3288944|P6|Maintenance Period|Pregnancy|1
1004086|NCT00406653|3288945|P5|Maintenance Period|Pregnancy|0
1004087|NCT00406653|3288946|P4|Maintenance Period|Pregnancy|0
1004088|NCT00406653|3288947|P3|Maintenance Period|Pregnancy|0
1004089|NCT00406653|3288948|P2|Maintenance Period|Pregnancy|0
1004090|NCT00406653|3288949|P1|Maintenance Period|Pregnancy|0
1004091|NCT00406653|3288943|P7|Maintenance Period|Withdrawal of Consent|0
1004092|NCT00406653|3288944|P6|Maintenance Period|Withdrawal of Consent|0
1004093|NCT00406653|3288945|P5|Maintenance Period|Withdrawal of Consent|2
1004094|NCT00406653|3288946|P4|Maintenance Period|Withdrawal of Consent|0
1004095|NCT00406653|3288947|P3|Maintenance Period|Withdrawal of Consent|0
1004096|NCT00406653|3288948|P2|Maintenance Period|Withdrawal of Consent|0
1004097|NCT00406653|3288949|P1|Maintenance Period|Withdrawal of Consent|0
1004098|NCT00406653|3288943|P7|Maintenance Period|Lost to Follow-up|0
1004099|NCT00406653|3288944|P6|Maintenance Period|Lost to Follow-up|1
1004100|NCT00406653|3288945|P5|Maintenance Period|Lost to Follow-up|2
1004101|NCT00406653|3288946|P4|Maintenance Period|Lost to Follow-up|0
1004102|NCT00406653|3288947|P3|Maintenance Period|Lost to Follow-up|0
1004103|NCT00406653|3288948|P2|Maintenance Period|Lost to Follow-up|0
1004104|NCT00406653|3288949|P1|Maintenance Period|Lost to Follow-up|0
1004105|NCT00406653|3288943|P7|Maintenance Period|Lack of Efficacy|0
1004106|NCT00406653|3288944|P6|Maintenance Period|Lack of Efficacy|26
1004107|NCT00406653|3288945|P5|Maintenance Period|Lack of Efficacy|20
1004108|NCT00406653|3288946|P4|Maintenance Period|Lack of Efficacy|0
1004109|NCT00406653|3288947|P3|Maintenance Period|Lack of Efficacy|0
1004110|NCT00406653|3288948|P2|Maintenance Period|Lack of Efficacy|0
1004111|NCT00406653|3288949|P1|Maintenance Period|Lack of Efficacy|0
1004112|NCT00406653|3288943|P7|Maintenance Period|Adverse Event|0
1004113|NCT00406653|3288944|P6|Maintenance Period|Adverse Event|1
1004114|NCT00406653|3288945|P5|Maintenance Period|Adverse Event|1
1004115|NCT00406653|3288946|P4|Maintenance Period|Adverse Event|0
1004116|NCT00406653|3288947|P3|Maintenance Period|Adverse Event|0
1004117|NCT00406653|3288948|P2|Maintenance Period|Adverse Event|0
1004118|NCT00406653|3288949|P1|Maintenance Period|Adverse Event|0
1004119|NCT00406653|3288943|P7|Induction Period|Patient relocated|0
1004120|NCT00406653|3288944|P6|Induction Period|Patient relocated|0
1004121|NCT00406653|3288945|P5|Induction Period|Patient relocated|0
1004122|NCT00406653|3288946|P4|Induction Period|Patient relocated|0
1004123|NCT00406653|3288947|P3|Induction Period|Patient relocated|1
1004124|NCT00406653|3288948|P2|Induction Period|Patient relocated|0
1004125|NCT00406653|3288949|P1|Induction Period|Patient relocated|0
1004126|NCT00406653|3288943|P7|Induction Period|Incarcerated|0
1004127|NCT00406653|3288944|P6|Induction Period|Incarcerated|0
1004128|NCT00406653|3288945|P5|Induction Period|Incarcerated|0
1004129|NCT00406653|3288946|P4|Induction Period|Incarcerated|0
1004130|NCT00406653|3288947|P3|Induction Period|Incarcerated|1
1004131|NCT00406653|3288948|P2|Induction Period|Incarcerated|0
1004132|NCT00406653|3288949|P1|Induction Period|Incarcerated|0
1004133|NCT00406653|3288943|P7|Induction Period|Given prohibited drug|0
1004134|NCT00406653|3288944|P6|Induction Period|Given prohibited drug|0
1004135|NCT00406653|3288945|P5|Induction Period|Given prohibited drug|0
1004136|NCT00406653|3288946|P4|Induction Period|Given prohibited drug|0
1004137|NCT00406653|3288947|P3|Induction Period|Given prohibited drug|2
1004138|NCT00406653|3288948|P2|Induction Period|Given prohibited drug|1
1004139|NCT00406653|3288949|P1|Induction Period|Given prohibited drug|0
1004140|NCT00406653|3288943|P7|Induction Period|Declined participation but followup done|0
1004141|NCT00406653|3288944|P6|Induction Period|Declined participation but followup done|0
1004142|NCT00406653|3288945|P5|Induction Period|Declined participation but followup done|0
1004143|NCT00406653|3288946|P4|Induction Period|Declined participation but followup done|1
1004144|NCT00406653|3288947|P3|Induction Period|Declined participation but followup done|1
1004145|NCT00406653|3288948|P2|Induction Period|Declined participation but followup done|2
1004146|NCT00406653|3288949|P1|Induction Period|Declined participation but followup done|0
1004147|NCT00406653|3288943|P7|Induction Period|Pregnancy|0
1004148|NCT00406653|3288944|P6|Induction Period|Pregnancy|0
1004149|NCT00406653|3288945|P5|Induction Period|Pregnancy|0
1004150|NCT00406653|3288946|P4|Induction Period|Pregnancy|0
1004151|NCT00406653|3288947|P3|Induction Period|Pregnancy|0
1004152|NCT00406653|3288948|P2|Induction Period|Pregnancy|0
1004153|NCT00406653|3288949|P1|Induction Period|Pregnancy|1
1004154|NCT00406653|3288943|P7|Induction Period|Subject No Longer Meets Study Criteria|0
1004155|NCT00406653|3288944|P6|Induction Period|Subject No Longer Meets Study Criteria|0
1004156|NCT00406653|3288945|P5|Induction Period|Subject No Longer Meets Study Criteria|0
1004157|NCT00406653|3288946|P4|Induction Period|Subject No Longer Meets Study Criteria|2
1004158|NCT00406653|3288947|P3|Induction Period|Subject No Longer Meets Study Criteria|0
1004159|NCT00406653|3288948|P2|Induction Period|Subject No Longer Meets Study Criteria|0
1004160|NCT00406653|3288949|P1|Induction Period|Subject No Longer Meets Study Criteria|0
1004161|NCT00406653|3288943|P7|Induction Period|Withdrawal of Consent|0
1004162|NCT00406653|3288944|P6|Induction Period|Withdrawal of Consent|0
1004163|NCT00406653|3288945|P5|Induction Period|Withdrawal of Consent|0
1004164|NCT00406653|3288946|P4|Induction Period|Withdrawal of Consent|2
1004165|NCT00406653|3288947|P3|Induction Period|Withdrawal of Consent|1
1004166|NCT00406653|3288948|P2|Induction Period|Withdrawal of Consent|5
1004167|NCT00406653|3288949|P1|Induction Period|Withdrawal of Consent|2
1004168|NCT00406653|3288943|P7|Induction Period|Lost to Follow-up|0
1004169|NCT00406653|3288944|P6|Induction Period|Lost to Follow-up|0
1004170|NCT00406653|3288945|P5|Induction Period|Lost to Follow-up|0
1004171|NCT00406653|3288946|P4|Induction Period|Lost to Follow-up|0
1004172|NCT00406653|3288947|P3|Induction Period|Lost to Follow-up|0
1004173|NCT00406653|3288948|P2|Induction Period|Lost to Follow-up|2
1004174|NCT00406653|3288949|P1|Induction Period|Lost to Follow-up|0
1004175|NCT00406653|3288943|P7|Induction Period|Lack of Efficacy|0
1004176|NCT00406653|3288944|P6|Induction Period|Lack of Efficacy|0
1004177|NCT00406653|3288945|P5|Induction Period|Lack of Efficacy|0
1004178|NCT00406653|3288946|P4|Induction Period|Lack of Efficacy|10
1004179|NCT00406653|3288947|P3|Induction Period|Lack of Efficacy|8
1004180|NCT00406653|3288948|P2|Induction Period|Lack of Efficacy|14
1004181|NCT00406653|3288949|P1|Induction Period|Lack of Efficacy|11
1004182|NCT00406653|3288943|P7|Induction Period|Adverse Event|0
1004183|NCT00406653|3288944|P6|Induction Period|Adverse Event|0
1004184|NCT00406653|3288945|P5|Induction Period|Adverse Event|0
1004185|NCT00406653|3288946|P4|Induction Period|Adverse Event|11
1004186|NCT00406653|3288947|P3|Induction Period|Adverse Event|4
1004187|NCT00406653|3288948|P2|Induction Period|Adverse Event|10
1004188|NCT00406653|3288949|P1|Induction Period|Adverse Event|1
1004189|NCT00406640|3289030|P2|OL Extension Phase for Non-Responders|Lack of Efficacy|7
1004190|NCT00406640|3289031|P1|OL Extension Phase for Non-Responders|Lack of Efficacy|6
1004191|NCT00406640|3289030|P2|OL Extension Phase for Non-Responders|Withdrawal by Subject|6
1004192|NCT00406640|3289031|P1|OL Extension Phase for Non-Responders|Withdrawal by Subject|3
1004193|NCT00406640|3289030|P2|OL Extension Phase for Non-Responders|non-compliance|2
1004194|NCT00406640|3289031|P1|OL Extension Phase for Non-Responders|non-compliance|3
1004195|NCT00406640|3289030|P2|OL Extension Phase for Non-Responders|Lost to Follow-up|3
1004196|NCT00406640|3289031|P1|OL Extension Phase for Non-Responders|Lost to Follow-up|2
1004197|NCT00406640|3289030|P2|OL Extension Phase for Non-Responders|Physician Decision|0
1004198|NCT00406640|3289031|P1|OL Extension Phase for Non-Responders|Physician Decision|1
1004199|NCT00406640|3289030|P2|OL Extension Phase for Non-Responders|Failed to Return|0
1004200|NCT00406640|3289031|P1|OL Extension Phase for Non-Responders|Failed to Return|1
1004201|NCT00406640|3289030|P2|OL Extension Phase for Non-Responders|Adverse Event|6
1004202|NCT00406640|3289031|P1|OL Extension Phase for Non-Responders|Adverse Event|6
1004203|NCT00406640|3289030|P2|DB Continuation Phase for Responders|Lack of Efficacy|1
1004204|NCT00406640|3289031|P1|DB Continuation Phase for Responders|Lack of Efficacy|1
1004205|NCT00406640|3289030|P2|DB Continuation Phase for Responders|Withdrawal by Subject|6
1004206|NCT00406640|3289031|P1|DB Continuation Phase for Responders|Withdrawal by Subject|8
1004207|NCT00406640|3289030|P2|DB Continuation Phase for Responders|Protocol Violation|2
1004208|NCT00406640|3289031|P1|DB Continuation Phase for Responders|Protocol Violation|2
1004209|NCT00406640|3289030|P2|DB Continuation Phase for Responders|non-compliance|5
1004210|NCT00406640|3289031|P1|DB Continuation Phase for Responders|non-compliance|7
1004211|NCT00406640|3289030|P2|DB Continuation Phase for Responders|Lost to Follow-up|7
1004212|NCT00406640|3289031|P1|DB Continuation Phase for Responders|Lost to Follow-up|1
1004213|NCT00406640|3289030|P2|DB Continuation Phase for Responders|Physician Decision|3
1004214|NCT00406640|3289031|P1|DB Continuation Phase for Responders|Physician Decision|2
1004215|NCT00406640|3289030|P2|DB Continuation Phase for Responders|Failed to Return|2
1004216|NCT00406640|3289031|P1|DB Continuation Phase for Responders|Failed to Return|0
1004217|NCT00406640|3289030|P2|DB Continuation Phase for Responders|Death|0
1004218|NCT00406640|3289031|P1|DB Continuation Phase for Responders|Death|1
1004219|NCT00406640|3289030|P2|DB Continuation Phase for Responders|Adverse Event|11
1004220|NCT00406640|3289031|P1|DB Continuation Phase for Responders|Adverse Event|11
1004221|NCT00406640|3289030|P2|Acute Phase|Lack of Efficacy|3
1004222|NCT00406640|3289031|P1|Acute Phase|Lack of Efficacy|3
1004223|NCT00406640|3289030|P2|Acute Phase|Withdrawal by Subject|9
1004224|NCT00406640|3289031|P1|Acute Phase|Withdrawal by Subject|11
1004225|NCT00406640|3289030|P2|Acute Phase|Protocol Violation|2
1004226|NCT00406640|3289031|P1|Acute Phase|Protocol Violation|3
1004227|NCT00406640|3289030|P2|Acute Phase|Protocol deviation|10
1004228|NCT00406640|3289031|P1|Acute Phase|Protocol deviation|4
1004229|NCT00406640|3289030|P2|Acute Phase|Lost to Follow-up|4
1004230|NCT00406640|3289031|P1|Acute Phase|Lost to Follow-up|7
1004231|NCT00406640|3289030|P2|Acute Phase|Physician Decision|1
1004232|NCT00406640|3289031|P1|Acute Phase|Physician Decision|0
1004233|NCT00406640|3289030|P2|Acute Phase|Failed to Return|1
1004234|NCT00406640|3289031|P1|Acute Phase|Failed to Return|5
1004235|NCT00406640|3289030|P2|Acute Phase|Adverse Event|13
1004236|NCT00406640|3289031|P1|Acute Phase|Adverse Event|18
1004237|NCT00406393|3289063|P2|Overall Study|Did not undergo transplantation|1
1004238|NCT00406393|3289064|P1|Overall Study|Did not undergo transplantation|2
1004239|NCT00406367|3289094|P2|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0
1004240|NCT00406367|3289095|P1|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1
1004241|NCT00406367|3289094|P2|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0
1004242|NCT00406367|3289095|P1|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1
1004243|NCT00406367|3289094|P2|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0
1004244|NCT00406367|3289095|P1|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1
1004245|NCT00406367|3289094|P2|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0
1004246|NCT00406367|3289095|P1|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1
1004247|NCT00406367|3289094|P2|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0
1004248|NCT00406367|3289095|P1|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4
1004249|NCT00406367|3289094|P2|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
1004250|NCT00406367|3289095|P1|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
1004251|NCT00406367|3289094|P2|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0
1004252|NCT00406367|3289095|P1|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6
1004253|NCT00406367|3289094|P2|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0
1004254|NCT00406367|3289095|P1|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2
1004255|NCT00406367|3289094|P2|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1
1004256|NCT00406367|3289095|P1|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0
1004257|NCT00406367|3289094|P2|Main Period - 6 to 20 Weeks|Lost to Follow-up|1
1004258|NCT00406367|3289095|P1|Main Period - 6 to 20 Weeks|Lost to Follow-up|0
1004259|NCT00406367|3289094|P2|Main Period - 6 to 20 Weeks|Consent Withdrawn|0
1004260|NCT00406367|3289095|P1|Main Period - 6 to 20 Weeks|Consent Withdrawn|1
1004261|NCT00406367|3289094|P2|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0
1004262|NCT00406367|3289095|P1|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4
1004263|NCT00406354|3289110|P3|All Randomized and Treated Patients|Physician Decision|1
1004264|NCT00406354|3289111|P2|All Randomized and Treated Patients|Physician Decision|0
1004265|NCT00406354|3289112|P1|All Randomized and Treated Patients|Physician Decision|0
1004266|NCT00406354|3289110|P3|All Randomized and Treated Patients|Withdrawal by Subject|2
1004267|NCT00406354|3289111|P2|All Randomized and Treated Patients|Withdrawal by Subject|1
1004268|NCT00406354|3289112|P1|All Randomized and Treated Patients|Withdrawal by Subject|1
1004269|NCT00406354|3289110|P3|All Randomized and Treated Patients|Parent/Caregiver Decision|1
1004270|NCT00406354|3289111|P2|All Randomized and Treated Patients|Parent/Caregiver Decision|6
1004359|NCT00405756|3289454|P2|Open-label Extension|Adverse Event|3
1004271|NCT00406354|3289112|P1|All Randomized and Treated Patients|Parent/Caregiver Decision|2
1004272|NCT00406354|3289110|P3|All Randomized and Treated Patients|Adverse Event|1
1004273|NCT00406354|3289111|P2|All Randomized and Treated Patients|Adverse Event|2
1004274|NCT00406354|3289112|P1|All Randomized and Treated Patients|Adverse Event|6
1004275|NCT00406354|3289110|P3|All Randomized and Treated Patients|Lack of Efficacy|17
1004276|NCT00406354|3289111|P2|All Randomized and Treated Patients|Lack of Efficacy|4
1004277|NCT00406354|3289112|P1|All Randomized and Treated Patients|Lack of Efficacy|7
1004278|NCT00406354|3289110|P3|All Randomized Patients|Protocol Violation|1
1004279|NCT00406354|3289111|P2|All Randomized Patients|Protocol Violation|0
1004280|NCT00406354|3289112|P1|All Randomized Patients|Protocol Violation|0
1004281|NCT00406315|3289183|P1|Overall Study|Withdrawal by Subject|30
1004282|NCT00406315|3289183|P1|Overall Study|Lost to Follow-up|21
1004283|NCT00406315|3289183|P1|Overall Study|Other|33
1004284|NCT00406315|3289183|P1|Overall Study|Lack of Efficacy|13
1004285|NCT00406315|3289183|P1|Overall Study|Laboratory Abnormality|4
1004286|NCT00406315|3289183|P1|Overall Study|Adverse Event|39
1004287|NCT00406315|3289183|P1|Overall Study|Death|1
1004288|NCT00406029|3289293|P5|Overall Study|Randomized in Error|1
1004289|NCT00406029|3289294|P4|Overall Study|Randomized in Error|3
1004290|NCT00406029|3289295|P3|Overall Study|Randomized in Error|2
1004291|NCT00406029|3289296|P2|Overall Study|Randomized in Error|0
1004292|NCT00406029|3289297|P1|Overall Study|Randomized in Error|0
1004293|NCT00406029|3289293|P5|Overall Study|Did Not Meet Eligibility Criteria|0
1004294|NCT00406029|3289294|P4|Overall Study|Did Not Meet Eligibility Criteria|0
1004295|NCT00406029|3289295|P3|Overall Study|Did Not Meet Eligibility Criteria|1
1004296|NCT00406029|3289296|P2|Overall Study|Did Not Meet Eligibility Criteria|0
1004297|NCT00406029|3289297|P1|Overall Study|Did Not Meet Eligibility Criteria|0
1004298|NCT00406029|3289293|P5|Overall Study|Protocol Violation|0
1004299|NCT00406029|3289294|P4|Overall Study|Protocol Violation|2
1004300|NCT00406029|3289295|P3|Overall Study|Protocol Violation|0
1004301|NCT00406029|3289296|P2|Overall Study|Protocol Violation|2
1004302|NCT00406029|3289297|P1|Overall Study|Protocol Violation|1
1004303|NCT00406029|3289293|P5|Overall Study|Withdrawal by Subject|0
1004304|NCT00406029|3289294|P4|Overall Study|Withdrawal by Subject|2
1004305|NCT00406029|3289295|P3|Overall Study|Withdrawal by Subject|2
1004306|NCT00406029|3289296|P2|Overall Study|Withdrawal by Subject|4
1004307|NCT00406029|3289297|P1|Overall Study|Withdrawal by Subject|3
1004308|NCT00406029|3289293|P5|Overall Study|Adverse Event|7
1004309|NCT00406029|3289294|P4|Overall Study|Adverse Event|10
1004310|NCT00406029|3289295|P3|Overall Study|Adverse Event|5
1004311|NCT00406029|3289296|P2|Overall Study|Adverse Event|2
1004312|NCT00406029|3289297|P1|Overall Study|Adverse Event|12
1004313|NCT00405964|3289401|P2|Overall Study|Protocol Violation|6
1004314|NCT00405964|3289402|P1|Overall Study|Protocol Violation|11
1004315|NCT00405964|3289401|P2|Overall Study|Withdrawal by Subject|23
1004316|NCT00405964|3289402|P1|Overall Study|Withdrawal by Subject|19
1004317|NCT00405964|3289401|P2|Overall Study|Lost to Follow-up|5
1004318|NCT00405964|3289402|P1|Overall Study|Lost to Follow-up|5
1004319|NCT00405964|3289401|P2|Overall Study|Adverse Event|16
1004320|NCT00405964|3289402|P1|Overall Study|Adverse Event|7
1004321|NCT00405964|3289401|P2|Overall Study|Treatment Failure|45
1004322|NCT00405964|3289402|P1|Overall Study|Treatment Failure|17
1004323|NCT00405912|3289424|P3|Overall Study|Lost to Follow-up|4
1004324|NCT00405912|3289425|P2|Overall Study|Lost to Follow-up|8
1004325|NCT00405912|3289426|P1|Overall Study|Lost to Follow-up|4
1004326|NCT00405912|3289424|P3|Overall Study|Withdrawal by Subject|12
1004327|NCT00405912|3289425|P2|Overall Study|Withdrawal by Subject|11
1004328|NCT00405912|3289426|P1|Overall Study|Withdrawal by Subject|12
1004329|NCT00405821|3289439|P2|Overall Study|initiated ART|8
1004330|NCT00405821|3289440|P1|Overall Study|initiated ART|9
1004331|NCT00405821|3289439|P2|Overall Study|Protocol Violation|0
1004332|NCT00405821|3289440|P1|Overall Study|Protocol Violation|1
1004333|NCT00405821|3289439|P2|Overall Study|Lost to Follow-up|7
1004334|NCT00405821|3289440|P1|Overall Study|Lost to Follow-up|7
1004335|NCT00405821|3289439|P2|Overall Study|Death|7
1004336|NCT00405821|3289440|P1|Overall Study|Death|5
1004337|NCT00405756|3289453|P3|Follow-up|Lost to Follow-up|4
1004338|NCT00405756|3289454|P2|Follow-up|Lost to Follow-up|8
1004339|NCT00405756|3289455|P1|Follow-up|Lost to Follow-up|2
1004340|NCT00405756|3289453|P3|Follow-up|Death|24
1004341|NCT00405756|3289454|P2|Follow-up|Death|31
1004342|NCT00405756|3289455|P1|Follow-up|Death|21
1004343|NCT00405756|3289453|P3|Follow-up|Ongoing in Follow-up Period|60
1004344|NCT00405756|3289454|P2|Follow-up|Ongoing in Follow-up Period|51
1004345|NCT00405756|3289455|P1|Follow-up|Ongoing in Follow-up Period|52
1004346|NCT00405756|3289453|P3|Open-label Extension|Other|7
1004347|NCT00405756|3289454|P2|Open-label Extension|Other|1
1004348|NCT00405756|3289455|P1|Open-label Extension|Other|0
1004349|NCT00405756|3289453|P3|Open-label Extension|Death|4
1004350|NCT00405756|3289454|P2|Open-label Extension|Death|2
1004351|NCT00405756|3289455|P1|Open-label Extension|Death|1
1004352|NCT00405756|3289453|P3|Open-label Extension|Withdrawal by Subject|3
1004353|NCT00405756|3289454|P2|Open-label Extension|Withdrawal by Subject|3
1004354|NCT00405756|3289455|P1|Open-label Extension|Withdrawal by Subject|2
1004355|NCT00405756|3289453|P3|Open-label Extension|Disease Progression|26
1004356|NCT00405756|3289454|P2|Open-label Extension|Disease Progression|23
1004357|NCT00405756|3289455|P1|Open-label Extension|Disease Progression|8
1004358|NCT00405756|3289453|P3|Open-label Extension|Adverse Event|7
1004360|NCT00405756|3289455|P1|Open-label Extension|Adverse Event|1
1004361|NCT00405756|3289453|P3|Open-label Extension|Ongoing in Open Label Period|25
1004362|NCT00405756|3289454|P2|Open-label Extension|Ongoing in Open Label Period|15
1004363|NCT00405756|3289455|P1|Open-label Extension|Ongoing in Open Label Period|7
1004364|NCT00405756|3289453|P3|Double-blind Treatment|Not Specified|4
1004365|NCT00405756|3289454|P2|Double-blind Treatment|Not Specified|4
1004366|NCT00405756|3289455|P1|Double-blind Treatment|Not Specified|7
1004367|NCT00405756|3289453|P3|Double-blind Treatment|Protocol Violation|2
1004368|NCT00405756|3289454|P2|Double-blind Treatment|Protocol Violation|0
1004369|NCT00405756|3289455|P1|Double-blind Treatment|Protocol Violation|1
1004370|NCT00405756|3289453|P3|Double-blind Treatment|Death|4
1004371|NCT00405756|3289454|P2|Double-blind Treatment|Death|4
1004372|NCT00405756|3289455|P1|Double-blind Treatment|Death|4
1004373|NCT00405756|3289453|P3|Double-blind Treatment|Lost to Follow-up|0
1004374|NCT00405756|3289454|P2|Double-blind Treatment|Lost to Follow-up|0
1004375|NCT00405756|3289455|P1|Double-blind Treatment|Lost to Follow-up|1
1004376|NCT00405756|3289453|P3|Double-blind Treatment|Withdrawal by Subject|10
1004377|NCT00405756|3289454|P2|Double-blind Treatment|Withdrawal by Subject|9
1004378|NCT00405756|3289455|P1|Double-blind Treatment|Withdrawal by Subject|15
1004379|NCT00405756|3289453|P3|Double-blind Treatment|Lack of Efficacy|2
1004380|NCT00405756|3289454|P2|Double-blind Treatment|Lack of Efficacy|4
1004381|NCT00405756|3289455|P1|Double-blind Treatment|Lack of Efficacy|1
1004382|NCT00405756|3289453|P3|Double-blind Treatment|Disease Progression|102
1004383|NCT00405756|3289454|P2|Double-blind Treatment|Disease Progression|81
1004384|NCT00405756|3289455|P1|Double-blind Treatment|Disease Progression|47
1004385|NCT00405756|3289453|P3|Double-blind Treatment|Adverse Event|12
1004386|NCT00405756|3289454|P2|Double-blind Treatment|Adverse Event|27
1004387|NCT00405756|3289455|P1|Double-blind Treatment|Adverse Event|31
1004388|NCT00405756|3289453|P3|Double-blind Treatment|Ongoing in Double-blind Treatment|18
1004389|NCT00405756|3289454|P2|Double-blind Treatment|Ongoing in Double-blind Treatment|24
1004390|NCT00405756|3289455|P1|Double-blind Treatment|Ongoing in Double-blind Treatment|45
1004391|NCT00405652|3289566|P1|Overall Study|Adverse Event|4
1004392|NCT00405639|3289573|P2|Overall Study|Seizure prior to receiving BNP|0
1004393|NCT00405639|3289574|P1|Overall Study|Seizure prior to receiving BNP|1
1004394|NCT00405639|3289573|P2|Overall Study|Adverse Event|0
1004395|NCT00405639|3289574|P1|Overall Study|Adverse Event|1
1004396|NCT00405639|3289573|P2|Overall Study|Withdrawal by Subject|0
1004397|NCT00405639|3289574|P1|Overall Study|Withdrawal by Subject|1
1004398|NCT00405587|3289590|P4|Overall Study|Participant not dosed|0
1004399|NCT00405587|3289591|P3|Overall Study|Participant not dosed|0
1004400|NCT00405587|3289592|P2|Overall Study|Participant not dosed|1
1004401|NCT00405587|3289593|P1|Overall Study|Participant not dosed|0
1004402|NCT00405587|3289590|P4|Overall Study|Withdrawal by Subject|2
1004403|NCT00405587|3289591|P3|Overall Study|Withdrawal by Subject|0
1004404|NCT00405587|3289592|P2|Overall Study|Withdrawal by Subject|0
1004405|NCT00405587|3289593|P1|Overall Study|Withdrawal by Subject|0
1004406|NCT00405587|3289590|P4|Overall Study|Radiation induced necrosis|0
1004407|NCT00405587|3289591|P3|Overall Study|Radiation induced necrosis|0
1004408|NCT00405587|3289592|P2|Overall Study|Radiation induced necrosis|1
1004409|NCT00405587|3289593|P1|Overall Study|Radiation induced necrosis|0
1004410|NCT00405587|3289590|P4|Overall Study|Lost to Follow-up|0
1004411|NCT00405587|3289591|P3|Overall Study|Lost to Follow-up|1
1004412|NCT00405587|3289592|P2|Overall Study|Lost to Follow-up|1
1004413|NCT00405587|3289593|P1|Overall Study|Lost to Follow-up|0
1004414|NCT00405587|3289590|P4|Overall Study|Adverse Event|0
1004415|NCT00405587|3289591|P3|Overall Study|Adverse Event|0
1004416|NCT00405587|3289592|P2|Overall Study|Adverse Event|0
1004417|NCT00405587|3289593|P1|Overall Study|Adverse Event|1
1004418|NCT00405587|3289590|P4|Overall Study|Physician Decision|0
1004419|NCT00405587|3289591|P3|Overall Study|Physician Decision|0
1004420|NCT00405587|3289592|P2|Overall Study|Physician Decision|2
1004421|NCT00405587|3289593|P1|Overall Study|Physician Decision|3
1004422|NCT00405587|3289590|P4|Overall Study|Disease Progression|17
1004423|NCT00405587|3289591|P3|Overall Study|Disease Progression|21
1004424|NCT00405587|3289592|P2|Overall Study|Disease Progression|23
1004425|NCT00405587|3289593|P1|Overall Study|Disease Progression|22
1004426|NCT00405587|3289590|P4|Overall Study|Death|1
1004427|NCT00405587|3289591|P3|Overall Study|Death|0
1004428|NCT00405587|3289592|P2|Overall Study|Death|0
1004429|NCT00405587|3289593|P1|Overall Study|Death|0
1004430|NCT00405548|3289711|P2|Overall Study|Withdrawal by Subject|0
1004431|NCT00405548|3289712|P1|Overall Study|Withdrawal by Subject|1
1004432|NCT00405548|3289711|P2|Overall Study|Venous access failed during study day|0
1004433|NCT00405548|3289712|P1|Overall Study|Venous access failed during study day|1
1004434|NCT00405548|3289711|P2|Overall Study|Unable to self-administer shots|0
1004435|NCT00405548|3289712|P1|Overall Study|Unable to self-administer shots|1
1004436|NCT00405548|3289711|P2|Overall Study|Amyloidosis on study echo-exclusionary|1
1004437|NCT00405548|3289712|P1|Overall Study|Amyloidosis on study echo-exclusionary|0
1004438|NCT00405548|3289711|P2|Overall Study|Cognitive Memory problems on study day|0
1004439|NCT00405548|3289712|P1|Overall Study|Cognitive Memory problems on study day|1
1004440|NCT00405392|3289743|P2|Overall Study|Other|5
1004441|NCT00405392|3289744|P1|Overall Study|Other|1
1004442|NCT00405392|3289743|P2|Overall Study|Non-compliance|1
1004443|NCT00405392|3289744|P1|Overall Study|Non-compliance|0
1004444|NCT00405392|3289743|P2|Overall Study|Data missing|0
1004445|NCT00405392|3289744|P1|Overall Study|Data missing|2
1004446|NCT00405392|3289743|P2|Overall Study|Lost to Follow-up|2
1004447|NCT00405392|3289744|P1|Overall Study|Lost to Follow-up|1
1004448|NCT00405392|3289743|P2|Overall Study|Withdrawal by Subject|3
1004449|NCT00405392|3289744|P1|Overall Study|Withdrawal by Subject|4
1004450|NCT00405392|3289743|P2|Overall Study|Did not meet Eligibility criteria|2
1004451|NCT00405392|3289744|P1|Overall Study|Did not meet Eligibility criteria|7
1004452|NCT00405392|3289743|P2|Overall Study|Adverse Event|14
1004453|NCT00405392|3289744|P1|Overall Study|Adverse Event|15
1004454|NCT00405275|3289787|P2|Overall Study|Unwilling to continue|9
1004455|NCT00405275|3289788|P1|Overall Study|Unwilling to continue|10
1004456|NCT00405275|3289787|P2|Overall Study|Withdrawal by Subject|9
1004457|NCT00405275|3289788|P1|Overall Study|Withdrawal by Subject|7
1004458|NCT00405275|3289787|P2|Overall Study|Lost to Follow-up|1
1004459|NCT00405275|3289788|P1|Overall Study|Lost to Follow-up|5
1004460|NCT00405275|3289787|P2|Overall Study|Death|0
1004461|NCT00405275|3289788|P1|Overall Study|Death|1
1004462|NCT00405067|3289797|P3|Overall Study|Lost to Follow-up|1
1004463|NCT00405067|3289798|P2|Overall Study|Lost to Follow-up|0
1004464|NCT00405067|3289799|P1|Overall Study|Lost to Follow-up|0
1004465|NCT00405067|3289797|P3|Overall Study|Adverse Event|4
1004466|NCT00405067|3289798|P2|Overall Study|Adverse Event|9
1004467|NCT00405067|3289799|P1|Overall Study|Adverse Event|4
1004468|NCT00404924|3289836|P2|Overall Study|Randomised but not received treatment|1
1004469|NCT00404924|3289837|P1|Overall Study|Randomised but not received treatment|1
1004470|NCT00404924|3289836|P2|Overall Study|Not Specified|11
1004471|NCT00404924|3289837|P1|Overall Study|Not Specified|25
1004472|NCT00404924|3289836|P2|Overall Study|Withdrawal by Subject|13
1004473|NCT00404924|3289837|P1|Overall Study|Withdrawal by Subject|26
1004474|NCT00404924|3289836|P2|Overall Study|Lost to Follow-up|1
1004475|NCT00404924|3289837|P1|Overall Study|Lost to Follow-up|1
1004476|NCT00404924|3289836|P2|Overall Study|Condition under investigation worsened|264
1004477|NCT00404924|3289837|P1|Overall Study|Condition under investigation worsened|475
1004478|NCT00404924|3289836|P2|Overall Study|Adverse Event|16
1004479|NCT00404924|3289837|P1|Overall Study|Adverse Event|75
1004480|NCT00404820|3289855|P2|Overall Study|Other|2
1004481|NCT00404820|3289856|P1|Overall Study|Other|0
1004482|NCT00404820|3289855|P2|Overall Study|Death|0
1004483|NCT00404820|3289856|P1|Overall Study|Death|1
1004484|NCT00404820|3289855|P2|Overall Study|Administrative problems|0
1004485|NCT00404820|3289856|P1|Overall Study|Administrative problems|2
1004486|NCT00404820|3289855|P2|Overall Study|Lost to Follow-up|3
1004487|NCT00404820|3289856|P1|Overall Study|Lost to Follow-up|7
1004488|NCT00404820|3289855|P2|Overall Study|Withdrawal by Subject|3
1004489|NCT00404820|3289856|P1|Overall Study|Withdrawal by Subject|5
1004490|NCT00404820|3289855|P2|Overall Study|Adverse Event|16
1004491|NCT00404820|3289856|P1|Overall Study|Adverse Event|4
1004492|NCT00404768|3289878|P4|Part C|Researcher suspended study medication|1
1004493|NCT00404768|3289879|P3|Part C|Researcher suspended study medication|0
1004494|NCT00404768|3289880|P2|Part C|Researcher suspended study medication|0
1004495|NCT00404768|3289881|P1|Part C|Researcher suspended study medication|0
1004496|NCT00404768|3289878|P4|Part C|Investigator discretion|1
1004497|NCT00404768|3289879|P3|Part C|Investigator discretion|0
1004498|NCT00404768|3289880|P2|Part C|Investigator discretion|0
1004499|NCT00404768|3289881|P1|Part C|Investigator discretion|0
1004500|NCT00404768|3289878|P4|Part C|Treatment failure|1
1004501|NCT00404768|3289879|P3|Part C|Treatment failure|0
1004502|NCT00404768|3289880|P2|Part C|Treatment failure|0
1004503|NCT00404768|3289881|P1|Part C|Treatment failure|0
1004504|NCT00404768|3289878|P4|Part C|Lack of Efficacy|2
1004505|NCT00404768|3289879|P3|Part C|Lack of Efficacy|0
1004506|NCT00404768|3289880|P2|Part C|Lack of Efficacy|0
1004507|NCT00404768|3289881|P1|Part C|Lack of Efficacy|0
1004508|NCT00404768|3289878|P4|Part C|Active labor|1
1004509|NCT00404768|3289879|P3|Part C|Active labor|0
1004510|NCT00404768|3289880|P2|Part C|Active labor|0
1004511|NCT00404768|3289881|P1|Part C|Active labor|0
1004512|NCT00404768|3289878|P4|Part C|Unsatisfactory uterine response to IP|1
1004513|NCT00404768|3289879|P3|Part C|Unsatisfactory uterine response to IP|0
1004514|NCT00404768|3289880|P2|Part C|Unsatisfactory uterine response to IP|0
1004515|NCT00404768|3289881|P1|Part C|Unsatisfactory uterine response to IP|0
1004516|NCT00404768|3289878|P4|Part C|Participant delivered baby|1
1004517|NCT00404768|3289879|P3|Part C|Participant delivered baby|0
1004518|NCT00404768|3289880|P2|Part C|Participant delivered baby|0
1004519|NCT00404768|3289881|P1|Part C|Participant delivered baby|0
1004520|NCT00404768|3289878|P4|Part C|Physician withdrew the study medication|0
1004521|NCT00404768|3289879|P3|Part C|Physician withdrew the study medication|1
1004522|NCT00404768|3289880|P2|Part C|Physician withdrew the study medication|0
1004523|NCT00404768|3289881|P1|Part C|Physician withdrew the study medication|0
1004524|NCT00404768|3289878|P4|Part C|Participant did not respond to therapy|1
1004525|NCT00404768|3289879|P3|Part C|Participant did not respond to therapy|1
1004526|NCT00404768|3289880|P2|Part C|Participant did not respond to therapy|0
1004527|NCT00404768|3289881|P1|Part C|Participant did not respond to therapy|0
1004528|NCT00404768|3289878|P4|Part C|Early withdrawal from study medication|0
1004529|NCT00404768|3289879|P3|Part C|Early withdrawal from study medication|1
1004530|NCT00404768|3289880|P2|Part C|Early withdrawal from study medication|0
1004531|NCT00404768|3289881|P1|Part C|Early withdrawal from study medication|0
1004532|NCT00404768|3289878|P4|Part C|Withdrawal by Subject|1
1004533|NCT00404768|3289879|P3|Part C|Withdrawal by Subject|2
1004534|NCT00404768|3289880|P2|Part C|Withdrawal by Subject|0
1004535|NCT00404768|3289881|P1|Part C|Withdrawal by Subject|0
1004536|NCT00404768|3289878|P4|Part C|Lost to Follow-up|1
1004537|NCT00404768|3289879|P3|Part C|Lost to Follow-up|3
1004538|NCT00404768|3289880|P2|Part C|Lost to Follow-up|0
1004539|NCT00404768|3289881|P1|Part C|Lost to Follow-up|0
1004540|NCT00404768|3289878|P4|Part C|Adverse Event|3
1004541|NCT00404768|3289879|P3|Part C|Adverse Event|0
1004542|NCT00404768|3289880|P2|Part C|Adverse Event|0
1004543|NCT00404768|3289881|P1|Part C|Adverse Event|0
1004544|NCT00404768|3289878|P4|Part A and B|Withdrawn as delivery imminemnt|0
1004545|NCT00404768|3289879|P3|Part A and B|Withdrawn as delivery imminemnt|0
1004546|NCT00404768|3289880|P2|Part A and B|Withdrawn as delivery imminemnt|1
1004547|NCT00404768|3289881|P1|Part A and B|Withdrawn as delivery imminemnt|0
1004548|NCT00404768|3289878|P4|Part A and B|Withdrawn due to labor progression|0
1004549|NCT00404768|3289879|P3|Part A and B|Withdrawn due to labor progression|0
1004550|NCT00404768|3289880|P2|Part A and B|Withdrawn due to labor progression|0
1004551|NCT00404768|3289881|P1|Part A and B|Withdrawn due to labor progression|1
1004552|NCT00404755|3289942|P1|Phase II (Escitalopram)|Lost to Follow-up|2
1004553|NCT00404755|3289942|P1|Phase I (Bupropion)|Other|1
1004554|NCT00404755|3289942|P1|Phase I (Bupropion)|Adverse Event|3
1004555|NCT00404651|3289957|P4|Overall Study|Withdrawal by Subject|6
1004556|NCT00404651|3289958|P3|Overall Study|Withdrawal by Subject|16
1004557|NCT00404651|3289959|P2|Overall Study|Withdrawal by Subject|12
1004558|NCT00404651|3289960|P1|Overall Study|Withdrawal by Subject|14
1004559|NCT00404651|3289957|P4|Overall Study|Lost to Follow-up|10
1004560|NCT00404651|3289958|P3|Overall Study|Lost to Follow-up|13
1004561|NCT00404651|3289959|P2|Overall Study|Lost to Follow-up|11
1004562|NCT00404651|3289960|P1|Overall Study|Lost to Follow-up|15
1004563|NCT00404651|3289957|P4|Overall Study|Protocol Violation|5
1004564|NCT00404651|3289958|P3|Overall Study|Protocol Violation|14
1004565|NCT00404651|3289959|P2|Overall Study|Protocol Violation|5
1004566|NCT00404651|3289960|P1|Overall Study|Protocol Violation|10
1004567|NCT00404651|3289957|P4|Overall Study|Serious Adverse Event|0
1004568|NCT00404651|3289958|P3|Overall Study|Serious Adverse Event|2
1004569|NCT00404651|3289959|P2|Overall Study|Serious Adverse Event|0
1004570|NCT00404651|3289960|P1|Overall Study|Serious Adverse Event|0
1004571|NCT00404547|3289988|P2|Overall Study|Reason not stated|6
1004572|NCT00404547|3289989|P1|Overall Study|Reason not stated|3
1004573|NCT00404547|3289988|P2|Overall Study|Other|0
1004574|NCT00404547|3289989|P1|Overall Study|Other|4
1004575|NCT00404547|3289988|P2|Overall Study|Lack of compliance|1
1004576|NCT00404547|3289989|P1|Overall Study|Lack of compliance|5
1004577|NCT00404547|3289988|P2|Overall Study|Lost to Follow-up|9
1004578|NCT00404547|3289989|P1|Overall Study|Lost to Follow-up|20
1004579|NCT00404547|3289988|P2|Overall Study|Protocol Violation|1
1004580|NCT00404547|3289989|P1|Overall Study|Protocol Violation|0
1004581|NCT00404547|3289988|P2|Overall Study|Withdrawal by Subject|2
1004582|NCT00404547|3289989|P1|Overall Study|Withdrawal by Subject|19
1004583|NCT00404547|3289988|P2|Overall Study|Adverse Event|6
1004584|NCT00404547|3289989|P1|Overall Study|Adverse Event|39
1004585|NCT00404495|3289999|P2|Overall Study|Withdrawal by Subject|0
1004586|NCT00404495|3290000|P1|Overall Study|Withdrawal by Subject|1
1004587|NCT00404495|3289999|P2|Overall Study|Not specified|0
1004588|NCT00404495|3290000|P1|Overall Study|Not specified|1
1004589|NCT00404495|3289999|P2|Overall Study|Lost to Follow-up|0
1004590|NCT00404495|3290000|P1|Overall Study|Lost to Follow-up|5
1004591|NCT00404495|3289999|P2|Overall Study|Death|11
1004592|NCT00404495|3290000|P1|Overall Study|Death|37
1004593|NCT00404352|3290019|P9|Open Label Extension (up to 36 Months)|Other|2
1004594|NCT00404352|3290020|P8|Open Label Extension (up to 36 Months)|Other|0
1004595|NCT00404352|3290021|P7|Open Label Extension (up to 36 Months)|Other|0
1004596|NCT00404352|3290022|P6|Open Label Extension (up to 36 Months)|Other|0
1004597|NCT00404352|3290023|P5|Open Label Extension (up to 36 Months)|Other|0
1004598|NCT00404352|3290024|P4|Open Label Extension (up to 36 Months)|Other|0
1004599|NCT00404352|3290025|P3|Open Label Extension (up to 36 Months)|Other|0
1004600|NCT00404352|3290026|P2|Open Label Extension (up to 36 Months)|Other|0
1004601|NCT00404352|3290027|P1|Open Label Extension (up to 36 Months)|Other|0
1004602|NCT00404352|3290019|P9|Open Label Extension (up to 36 Months)|Adverse Event|0
1004603|NCT00404352|3290020|P8|Open Label Extension (up to 36 Months)|Adverse Event|1
1004604|NCT00404352|3290021|P7|Open Label Extension (up to 36 Months)|Adverse Event|1
1004605|NCT00404352|3290022|P6|Open Label Extension (up to 36 Months)|Adverse Event|0
1004606|NCT00404352|3290023|P5|Open Label Extension (up to 36 Months)|Adverse Event|0
1004607|NCT00404352|3290024|P4|Open Label Extension (up to 36 Months)|Adverse Event|0
1004608|NCT00404352|3290025|P3|Open Label Extension (up to 36 Months)|Adverse Event|0
1004609|NCT00404352|3290026|P2|Open Label Extension (up to 36 Months)|Adverse Event|0
1004610|NCT00404352|3290027|P1|Open Label Extension (up to 36 Months)|Adverse Event|0
1004611|NCT00404352|3290019|P9|Open Label (up to 24 Month)|Disease progression|0
1004612|NCT00404352|3290020|P8|Open Label (up to 24 Month)|Disease progression|0
1004613|NCT00404352|3290021|P7|Open Label (up to 24 Month)|Disease progression|0
1004614|NCT00404352|3290022|P6|Open Label (up to 24 Month)|Disease progression|0
1004615|NCT00404352|3290023|P5|Open Label (up to 24 Month)|Disease progression|0
1004616|NCT00404352|3290024|P4|Open Label (up to 24 Month)|Disease progression|1
1004617|NCT00404352|3290025|P3|Open Label (up to 24 Month)|Disease progression|0
1004618|NCT00404352|3290026|P2|Open Label (up to 24 Month)|Disease progression|0
1004619|NCT00404352|3290027|P1|Open Label (up to 24 Month)|Disease progression|0
1004620|NCT00404352|3290019|P9|Open Label (up to 24 Month)|Withdrawal by Subject|0
1004621|NCT00404352|3290020|P8|Open Label (up to 24 Month)|Withdrawal by Subject|0
1004622|NCT00404352|3290021|P7|Open Label (up to 24 Month)|Withdrawal by Subject|0
1004623|NCT00404352|3290022|P6|Open Label (up to 24 Month)|Withdrawal by Subject|5
1004624|NCT00404352|3290023|P5|Open Label (up to 24 Month)|Withdrawal by Subject|0
1004625|NCT00404352|3290024|P4|Open Label (up to 24 Month)|Withdrawal by Subject|0
1004626|NCT00404352|3290025|P3|Open Label (up to 24 Month)|Withdrawal by Subject|0
1004627|NCT00404352|3290026|P2|Open Label (up to 24 Month)|Withdrawal by Subject|0
1004628|NCT00404352|3290027|P1|Open Label (up to 24 Month)|Withdrawal by Subject|0
1004629|NCT00404352|3290019|P9|Open Label (up to 24 Month)|Lost to Follow-up|0
1004630|NCT00404352|3290020|P8|Open Label (up to 24 Month)|Lost to Follow-up|0
1004631|NCT00404352|3290021|P7|Open Label (up to 24 Month)|Lost to Follow-up|0
1004632|NCT00404352|3290022|P6|Open Label (up to 24 Month)|Lost to Follow-up|0
1004633|NCT00404352|3290023|P5|Open Label (up to 24 Month)|Lost to Follow-up|1
1004634|NCT00404352|3290024|P4|Open Label (up to 24 Month)|Lost to Follow-up|0
1004635|NCT00404352|3290025|P3|Open Label (up to 24 Month)|Lost to Follow-up|0
1004636|NCT00404352|3290026|P2|Open Label (up to 24 Month)|Lost to Follow-up|0
1004637|NCT00404352|3290027|P1|Open Label (up to 24 Month)|Lost to Follow-up|0
1004638|NCT00404352|3290019|P9|Open Label (up to 24 Month)|Pregnancy|0
1004639|NCT00404352|3290020|P8|Open Label (up to 24 Month)|Pregnancy|0
1004640|NCT00404352|3290021|P7|Open Label (up to 24 Month)|Pregnancy|0
1004641|NCT00404352|3290022|P6|Open Label (up to 24 Month)|Pregnancy|1
1004642|NCT00404352|3290023|P5|Open Label (up to 24 Month)|Pregnancy|0
1004643|NCT00404352|3290024|P4|Open Label (up to 24 Month)|Pregnancy|0
1004644|NCT00404352|3290025|P3|Open Label (up to 24 Month)|Pregnancy|0
1004645|NCT00404352|3290026|P2|Open Label (up to 24 Month)|Pregnancy|0
1004646|NCT00404352|3290027|P1|Open Label (up to 24 Month)|Pregnancy|0
1004647|NCT00404352|3290019|P9|Open Label (up to 24 Month)|Adverse Event|0
1004648|NCT00404352|3290020|P8|Open Label (up to 24 Month)|Adverse Event|0
1004649|NCT00404352|3290021|P7|Open Label (up to 24 Month)|Adverse Event|0
1004650|NCT00404352|3290022|P6|Open Label (up to 24 Month)|Adverse Event|1
1004651|NCT00404352|3290023|P5|Open Label (up to 24 Month)|Adverse Event|1
1004652|NCT00404352|3290024|P4|Open Label (up to 24 Month)|Adverse Event|2
1004653|NCT00404352|3290025|P3|Open Label (up to 24 Month)|Adverse Event|0
1004654|NCT00404352|3290026|P2|Open Label (up to 24 Month)|Adverse Event|0
1004655|NCT00404352|3290027|P1|Open Label (up to 24 Month)|Adverse Event|0
1004656|NCT00404352|3290019|P9|Double Blind (up to 24 Month)|Other|0
1004657|NCT00404352|3290020|P8|Double Blind (up to 24 Month)|Other|0
1004658|NCT00404352|3290021|P7|Double Blind (up to 24 Month)|Other|0
1004659|NCT00404352|3290022|P6|Double Blind (up to 24 Month)|Other|0
1004660|NCT00404352|3290023|P5|Double Blind (up to 24 Month)|Other|0
1004661|NCT00404352|3290024|P4|Double Blind (up to 24 Month)|Other|0
1004662|NCT00404352|3290025|P3|Double Blind (up to 24 Month)|Other|0
1004663|NCT00404352|3290026|P2|Double Blind (up to 24 Month)|Other|1
1004664|NCT00404352|3290027|P1|Double Blind (up to 24 Month)|Other|0
1004665|NCT00404352|3290019|P9|Double Blind (up to 24 Month)|Physician Decision|0
1004666|NCT00404352|3290020|P8|Double Blind (up to 24 Month)|Physician Decision|0
1004667|NCT00404352|3290021|P7|Double Blind (up to 24 Month)|Physician Decision|0
1004668|NCT00404352|3290022|P6|Double Blind (up to 24 Month)|Physician Decision|0
1004669|NCT00404352|3290023|P5|Double Blind (up to 24 Month)|Physician Decision|0
1004670|NCT00404352|3290024|P4|Double Blind (up to 24 Month)|Physician Decision|0
1004671|NCT00404352|3290025|P3|Double Blind (up to 24 Month)|Physician Decision|1
1004672|NCT00404352|3290026|P2|Double Blind (up to 24 Month)|Physician Decision|0
1004673|NCT00404352|3290027|P1|Double Blind (up to 24 Month)|Physician Decision|0
1004674|NCT00404352|3290019|P9|Double Blind (up to 24 Month)|Randomized but not treated|0
1004675|NCT00404352|3290020|P8|Double Blind (up to 24 Month)|Randomized but not treated|0
1004676|NCT00404352|3290021|P7|Double Blind (up to 24 Month)|Randomized but not treated|0
1004677|NCT00404352|3290022|P6|Double Blind (up to 24 Month)|Randomized but not treated|0
1004678|NCT00404352|3290023|P5|Double Blind (up to 24 Month)|Randomized but not treated|0
1004679|NCT00404352|3290024|P4|Double Blind (up to 24 Month)|Randomized but not treated|0
1004680|NCT00404352|3290025|P3|Double Blind (up to 24 Month)|Randomized but not treated|0
1004681|NCT00404352|3290026|P2|Double Blind (up to 24 Month)|Randomized but not treated|2
1004682|NCT00404352|3290027|P1|Double Blind (up to 24 Month)|Randomized but not treated|0
1004683|NCT00404352|3290019|P9|Double Blind (up to 24 Month)|Switched to open label phase|0
1004684|NCT00404352|3290020|P8|Double Blind (up to 24 Month)|Switched to open label phase|0
1004685|NCT00404352|3290021|P7|Double Blind (up to 24 Month)|Switched to open label phase|0
1004686|NCT00404352|3290022|P6|Double Blind (up to 24 Month)|Switched to open label phase|0
1004687|NCT00404352|3290023|P5|Double Blind (up to 24 Month)|Switched to open label phase|0
1004688|NCT00404352|3290024|P4|Double Blind (up to 24 Month)|Switched to open label phase|0
1004689|NCT00404352|3290025|P3|Double Blind (up to 24 Month)|Switched to open label phase|59
1004690|NCT00404352|3290026|P2|Double Blind (up to 24 Month)|Switched to open label phase|30
1004691|NCT00404352|3290027|P1|Double Blind (up to 24 Month)|Switched to open label phase|31
1004692|NCT00404352|3290019|P9|Double Blind (up to 24 Month)|Poor compliance|0
1004693|NCT00404352|3290020|P8|Double Blind (up to 24 Month)|Poor compliance|0
1004694|NCT00404352|3290021|P7|Double Blind (up to 24 Month)|Poor compliance|0
1004695|NCT00404352|3290022|P6|Double Blind (up to 24 Month)|Poor compliance|0
1004778|NCT00403845|3290153|P4|Treatment Period 3|Adverse Event|1
1004696|NCT00404352|3290023|P5|Double Blind (up to 24 Month)|Poor compliance|0
1004697|NCT00404352|3290024|P4|Double Blind (up to 24 Month)|Poor compliance|0
1004698|NCT00404352|3290025|P3|Double Blind (up to 24 Month)|Poor compliance|0
1004699|NCT00404352|3290026|P2|Double Blind (up to 24 Month)|Poor compliance|0
1004700|NCT00404352|3290027|P1|Double Blind (up to 24 Month)|Poor compliance|1
1004701|NCT00404352|3290019|P9|Double Blind (up to 24 Month)|Disease progression|0
1004702|NCT00404352|3290020|P8|Double Blind (up to 24 Month)|Disease progression|0
1004703|NCT00404352|3290021|P7|Double Blind (up to 24 Month)|Disease progression|0
1004704|NCT00404352|3290022|P6|Double Blind (up to 24 Month)|Disease progression|0
1004705|NCT00404352|3290023|P5|Double Blind (up to 24 Month)|Disease progression|0
1004706|NCT00404352|3290024|P4|Double Blind (up to 24 Month)|Disease progression|0
1004707|NCT00404352|3290025|P3|Double Blind (up to 24 Month)|Disease progression|2
1004708|NCT00404352|3290026|P2|Double Blind (up to 24 Month)|Disease progression|0
1004709|NCT00404352|3290027|P1|Double Blind (up to 24 Month)|Disease progression|3
1004710|NCT00404352|3290019|P9|Double Blind (up to 24 Month)|Withdrawal by Subject|0
1004711|NCT00404352|3290020|P8|Double Blind (up to 24 Month)|Withdrawal by Subject|0
1004712|NCT00404352|3290021|P7|Double Blind (up to 24 Month)|Withdrawal by Subject|0
1004713|NCT00404352|3290022|P6|Double Blind (up to 24 Month)|Withdrawal by Subject|0
1004714|NCT00404352|3290023|P5|Double Blind (up to 24 Month)|Withdrawal by Subject|0
1004715|NCT00404352|3290024|P4|Double Blind (up to 24 Month)|Withdrawal by Subject|0
1004716|NCT00404352|3290025|P3|Double Blind (up to 24 Month)|Withdrawal by Subject|7
1004717|NCT00404352|3290026|P2|Double Blind (up to 24 Month)|Withdrawal by Subject|8
1004718|NCT00404352|3290027|P1|Double Blind (up to 24 Month)|Withdrawal by Subject|11
1004719|NCT00404352|3290019|P9|Double Blind (up to 24 Month)|Lost to Follow-up|0
1004720|NCT00404352|3290020|P8|Double Blind (up to 24 Month)|Lost to Follow-up|0
1004721|NCT00404352|3290021|P7|Double Blind (up to 24 Month)|Lost to Follow-up|0
1004722|NCT00404352|3290022|P6|Double Blind (up to 24 Month)|Lost to Follow-up|0
1004723|NCT00404352|3290023|P5|Double Blind (up to 24 Month)|Lost to Follow-up|0
1004724|NCT00404352|3290024|P4|Double Blind (up to 24 Month)|Lost to Follow-up|0
1004725|NCT00404352|3290025|P3|Double Blind (up to 24 Month)|Lost to Follow-up|1
1004726|NCT00404352|3290026|P2|Double Blind (up to 24 Month)|Lost to Follow-up|2
1004727|NCT00404352|3290027|P1|Double Blind (up to 24 Month)|Lost to Follow-up|1
1004728|NCT00404352|3290019|P9|Double Blind (up to 24 Month)|Death|0
1004729|NCT00404352|3290020|P8|Double Blind (up to 24 Month)|Death|0
1004730|NCT00404352|3290021|P7|Double Blind (up to 24 Month)|Death|0
1004731|NCT00404352|3290022|P6|Double Blind (up to 24 Month)|Death|0
1004732|NCT00404352|3290023|P5|Double Blind (up to 24 Month)|Death|0
1004733|NCT00404352|3290024|P4|Double Blind (up to 24 Month)|Death|0
1004734|NCT00404352|3290025|P3|Double Blind (up to 24 Month)|Death|1
1004735|NCT00404352|3290026|P2|Double Blind (up to 24 Month)|Death|0
1004736|NCT00404352|3290027|P1|Double Blind (up to 24 Month)|Death|0
1004737|NCT00404352|3290019|P9|Double Blind (up to 24 Month)|Pregnancy|0
1004738|NCT00404352|3290020|P8|Double Blind (up to 24 Month)|Pregnancy|0
1004739|NCT00404352|3290021|P7|Double Blind (up to 24 Month)|Pregnancy|0
1004740|NCT00404352|3290022|P6|Double Blind (up to 24 Month)|Pregnancy|0
1004741|NCT00404352|3290023|P5|Double Blind (up to 24 Month)|Pregnancy|0
1004742|NCT00404352|3290024|P4|Double Blind (up to 24 Month)|Pregnancy|0
1004743|NCT00404352|3290025|P3|Double Blind (up to 24 Month)|Pregnancy|2
1004744|NCT00404352|3290026|P2|Double Blind (up to 24 Month)|Pregnancy|0
1004745|NCT00404352|3290027|P1|Double Blind (up to 24 Month)|Pregnancy|0
1004746|NCT00404352|3290019|P9|Double Blind (up to 24 Month)|Adverse Event|0
1004747|NCT00404352|3290020|P8|Double Blind (up to 24 Month)|Adverse Event|0
1004748|NCT00404352|3290021|P7|Double Blind (up to 24 Month)|Adverse Event|0
1004749|NCT00404352|3290022|P6|Double Blind (up to 24 Month)|Adverse Event|0
1004750|NCT00404352|3290023|P5|Double Blind (up to 24 Month)|Adverse Event|0
1004751|NCT00404352|3290024|P4|Double Blind (up to 24 Month)|Adverse Event|0
1004752|NCT00404352|3290025|P3|Double Blind (up to 24 Month)|Adverse Event|6
1004753|NCT00404352|3290026|P2|Double Blind (up to 24 Month)|Adverse Event|4
1004754|NCT00404352|3290027|P1|Double Blind (up to 24 Month)|Adverse Event|5
1004755|NCT00404248|3290062|P9|Overall Study|pts declining status|0
1004756|NCT00404248|3290063|P8|Overall Study|pts declining status|0
1004757|NCT00404248|3290064|P7|Overall Study|pts declining status|0
1004758|NCT00404248|3290065|P6|Overall Study|pts declining status|0
1004759|NCT00404248|3290066|P5|Overall Study|pts declining status|0
1004760|NCT00404248|3290067|P4|Overall Study|pts declining status|0
1004761|NCT00404248|3290068|P3|Overall Study|pts declining status|0
1004762|NCT00404248|3290069|P2|Overall Study|pts declining status|1
1004763|NCT00404248|3290070|P1|Overall Study|pts declining status|0
1004764|NCT00404235|3290103|P2|Overall Study|Withdrawal by Subject|2
1004765|NCT00404235|3290104|P1|Overall Study|Withdrawal by Subject|1
1004766|NCT00404092|3290122|P4|Overall Study|Adverse Event|0
1004767|NCT00404092|3290123|P3|Overall Study|Adverse Event|1
1004768|NCT00404092|3290124|P2|Overall Study|Adverse Event|0
1004769|NCT00404092|3290125|P1|Overall Study|Adverse Event|0
1004770|NCT00404092|3290122|P4|Overall Study|Death|0
1004771|NCT00404092|3290123|P3|Overall Study|Death|0
1004772|NCT00404092|3290124|P2|Overall Study|Death|0
1004773|NCT00404092|3290125|P1|Overall Study|Death|1
1004774|NCT00404079|3290141|P2|Overall Study|Lost to follow up, adverse event etc|20
1004775|NCT00404079|3290142|P1|Overall Study|Lost to follow up, adverse event etc|22
1004776|NCT00404066|3290148|P1|Overall Study|Withdrawal by Subject - Adverse event|2
1004777|NCT00404066|3290148|P1|Overall Study|Withdrawal by Subject - Pre-treatment|1
1004779|NCT00403845|3290154|P3|Treatment Period 3|Adverse Event|0
1004780|NCT00403845|3290155|P2|Treatment Period 3|Adverse Event|0
1004781|NCT00403845|3290156|P1|Treatment Period 3|Adverse Event|0
1004782|NCT00403845|3290153|P4|Treatment Period 3|Subject withdrew consent|1
1004783|NCT00403845|3290154|P3|Treatment Period 3|Subject withdrew consent|0
1004784|NCT00403845|3290155|P2|Treatment Period 3|Subject withdrew consent|0
1004785|NCT00403845|3290156|P1|Treatment Period 3|Subject withdrew consent|0
1004786|NCT00403845|3290153|P4|Treatment Period 2|Subject withdrew consent|0
1004787|NCT00403845|3290154|P3|Treatment Period 2|Subject withdrew consent|0
1004788|NCT00403845|3290155|P2|Treatment Period 2|Subject withdrew consent|0
1004789|NCT00403845|3290156|P1|Treatment Period 2|Subject withdrew consent|1
1004790|NCT00403845|3290153|P4|Treatment Period 1|Subject no longer needs study drug|1
1004791|NCT00403845|3290154|P3|Treatment Period 1|Subject no longer needs study drug|0
1004792|NCT00403845|3290155|P2|Treatment Period 1|Subject no longer needs study drug|0
1004793|NCT00403845|3290156|P1|Treatment Period 1|Subject no longer needs study drug|0
1004794|NCT00403845|3290153|P4|Treatment Period 1|Subject withdrew consent|0
1004795|NCT00403845|3290154|P3|Treatment Period 1|Subject withdrew consent|0
1004796|NCT00403845|3290155|P2|Treatment Period 1|Subject withdrew consent|0
1004797|NCT00403845|3290156|P1|Treatment Period 1|Subject withdrew consent|1
1004798|NCT00403767|3290180|P2|Overall Study|Missing/incomplete data|1
1004799|NCT00403767|3290181|P1|Overall Study|Missing/incomplete data|1
1004800|NCT00403767|3290180|P2|Overall Study|Study terminated by sponsor|69
1004801|NCT00403767|3290181|P1|Overall Study|Study terminated by sponsor|82
1004802|NCT00403767|3290180|P2|Overall Study|Clinical efficacy endpoint reached|332
1004803|NCT00403767|3290181|P1|Overall Study|Clinical efficacy endpoint reached|300
1004804|NCT00403767|3290180|P2|Overall Study|Protocol Violation|124
1004805|NCT00403767|3290181|P1|Overall Study|Protocol Violation|142
1004806|NCT00403767|3290180|P2|Overall Study|Lost to Follow-up|8
1004807|NCT00403767|3290181|P1|Overall Study|Lost to Follow-up|6
1004808|NCT00403767|3290180|P2|Overall Study|Investigator dec./not protocol-related|178
1004809|NCT00403767|3290181|P1|Overall Study|Investigator dec./not protocol-related|191
1004810|NCT00403767|3290180|P2|Overall Study|Consent withdrawn|673
1004811|NCT00403767|3290181|P1|Overall Study|Consent withdrawn|671
1004812|NCT00403767|3290180|P2|Overall Study|Non-compliant with study medication|164
1004813|NCT00403767|3290181|P1|Overall Study|Non-compliant with study medication|134
1004814|NCT00403767|3290180|P2|Overall Study|Adverse Event|919
1004815|NCT00403767|3290181|P1|Overall Study|Adverse Event|993
1004816|NCT00403754|3290205|P4|Core Treatment Period 2|Lack of Efficacy|0
1004817|NCT00403754|3290206|P3|Core Treatment Period 2|Lack of Efficacy|1
1004818|NCT00403754|3290207|P2|Core Treatment Period 2|Lack of Efficacy|0
1004819|NCT00403754|3290208|P1|Core Treatment Period 2|Lack of Efficacy|0
1004820|NCT00403754|3290205|P4|Core Treatment Period 1|Withdrawal by Subject|0
1004821|NCT00403754|3290206|P3|Core Treatment Period 1|Withdrawal by Subject|0
1004822|NCT00403754|3290207|P2|Core Treatment Period 1|Withdrawal by Subject|1
1004823|NCT00403754|3290208|P1|Core Treatment Period 1|Withdrawal by Subject|0
1004824|NCT00403585|3290235|P1|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4
1004825|NCT00403585|3290235|P1|Open-Label Phase; Extension Study|Withdrawal by Subject|2
1004826|NCT00403585|3290235|P1|Initial Treatment Phase|Lost to Follow-up|2
1004827|NCT00403546|3290246|P3|Randomized Trial|Early Terminations|16
1004828|NCT00403546|3290247|P2|Randomized Trial|Early Terminations|17
1004829|NCT00403546|3290248|P1|Randomized Trial|Early Terminations|0
1004830|NCT00403546|3290246|P3|Screening Phase|Terminated Prior to Randomization|0
1004831|NCT00403546|3290247|P2|Screening Phase|Terminated Prior to Randomization|0
1004832|NCT00403546|3290248|P1|Screening Phase|Terminated Prior to Randomization|5
1004833|NCT00403546|3290246|P3|Screening Phase|Adverse Event|0
1004834|NCT00403546|3290247|P2|Screening Phase|Adverse Event|0
1004835|NCT00403546|3290248|P1|Screening Phase|Adverse Event|1
1004836|NCT00403546|3290246|P3|Screening Phase|Screening Failure|0
1004837|NCT00403546|3290247|P2|Screening Phase|Screening Failure|0
1004838|NCT00403546|3290248|P1|Screening Phase|Screening Failure|22
1004839|NCT00403546|3290246|P3|Signed Informed Consent/Open-Label|Adverse Event|0
1004840|NCT00403546|3290247|P2|Signed Informed Consent/Open-Label|Adverse Event|0
1004841|NCT00403546|3290248|P1|Signed Informed Consent/Open-Label|Adverse Event|5
1004842|NCT00403546|3290246|P3|Signed Informed Consent/Open-Label|Terminated by Investigator|0
1004843|NCT00403546|3290247|P2|Signed Informed Consent/Open-Label|Terminated by Investigator|0
1004844|NCT00403546|3290248|P1|Signed Informed Consent/Open-Label|Terminated by Investigator|9
1004845|NCT00403546|3290246|P3|Signed Informed Consent/Open-Label|Early Termination|0
1004846|NCT00403546|3290247|P2|Signed Informed Consent/Open-Label|Early Termination|0
1004847|NCT00403546|3290248|P1|Signed Informed Consent/Open-Label|Early Termination|8
1004848|NCT00403546|3290246|P3|Signed Informed Consent/Open-Label|Withdrew Consent|0
1004849|NCT00403546|3290247|P2|Signed Informed Consent/Open-Label|Withdrew Consent|0
1004850|NCT00403546|3290248|P1|Signed Informed Consent/Open-Label|Withdrew Consent|6
1004851|NCT00403481|3290288|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1
1004852|NCT00403481|3290288|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1
1004853|NCT00403481|3290288|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1
1004854|NCT00403481|3290288|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1
1004855|NCT00403481|3290288|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1
1004856|NCT00403481|3290288|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2
1004857|NCT00403481|3290288|P1|Olm 40 mg|Other|1
1004858|NCT00403481|3290288|P1|Olm 40 mg|Withdrawal by Subject|1
1004859|NCT00403481|3290288|P1|Olm 40 mg|Protocol Violation|1
1004860|NCT00403481|3290288|P1|Olm 40 mg|Adverse Event|2
1004861|NCT00403481|3290288|P1|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1
1004862|NCT00403481|3290288|P1|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3
1004863|NCT00403481|3290288|P1|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1
1004864|NCT00403481|3290288|P1|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1
1004865|NCT00403455|3290303|P1|Overall Study|Withdrawal by Subject|1
1004866|NCT00403390|3290326|P2|Overall Study|non-compliant|0
1004867|NCT00403390|3290327|P1|Overall Study|non-compliant|1
1004868|NCT00403390|3290326|P2|Overall Study|samples lost|0
1004869|NCT00403390|3290327|P1|Overall Study|samples lost|1
1004870|NCT00403390|3290326|P2|Overall Study|Withdrawal by Subject|0
1004871|NCT00403390|3290327|P1|Overall Study|Withdrawal by Subject|1
1004872|NCT00403273|3290335|P2|Overall Study|pt. wanted to have a surgical procedure|1
1004873|NCT00403273|3290336|P1|Overall Study|pt. wanted to have a surgical procedure|0
1004874|NCT00403273|3290335|P2|Overall Study|Physician Decision|1
1004875|NCT00403273|3290336|P1|Overall Study|Physician Decision|0
1004876|NCT00403273|3290335|P2|Overall Study|Lost to Follow-up|2
1004877|NCT00403273|3290336|P1|Overall Study|Lost to Follow-up|3
1004878|NCT00403234|3290378|P4|Overall Study|Adverse Event|0
1004879|NCT00403234|3290379|P3|Overall Study|Adverse Event|1
1004880|NCT00403234|3290380|P2|Overall Study|Adverse Event|0
1004881|NCT00403234|3290381|P1|Overall Study|Adverse Event|1
1004882|NCT00403234|3290378|P4|Overall Study|Withdrawal by Subject|0
1004883|NCT00403234|3290379|P3|Overall Study|Withdrawal by Subject|0
1004884|NCT00403234|3290380|P2|Overall Study|Withdrawal by Subject|1
1004885|NCT00403234|3290381|P1|Overall Study|Withdrawal by Subject|0
1004886|NCT00403130|3290391|P1|Overall Study|Withdrawal by Subject|1
1004887|NCT00403130|3290391|P1|Overall Study|Lost to Follow up|1
1004888|NCT00403130|3290391|P1|Overall Study|Not Eligible|3
1004889|NCT00402987|3290444|P4|Overall Study|Lack of Efficacy|0
1004890|NCT00402987|3290445|P3|Overall Study|Lack of Efficacy|1
1004891|NCT00402987|3290446|P2|Overall Study|Lack of Efficacy|0
1004892|NCT00402987|3290447|P1|Overall Study|Lack of Efficacy|0
1004893|NCT00402831|3290619|P2|Overall Study|Non-compliance with protocol|1
1004894|NCT00402831|3290620|P1|Overall Study|Non-compliance with protocol|0
1004895|NCT00402831|3290619|P2|Overall Study|Lost to Follow-up|2
1004896|NCT00402831|3290620|P1|Overall Study|Lost to Follow-up|1
1004897|NCT00402740|3290652|P1|Overall Study|Subject disposition unknown.|1
1004898|NCT00402740|3290652|P1|Overall Study|No stent. Completed FU at 30 days.|5
1004899|NCT00402740|3290652|P1|Overall Study|Lost to Follow-up|6
1004900|NCT00402740|3290652|P1|Overall Study|Death|50
1004901|NCT00402740|3290652|P1|Overall Study|Withdrawal by Subject|18
1004902|NCT00402727|3290664|P2|Overall Study|non-compliance|1
1004903|NCT00402727|3290665|P1|Overall Study|non-compliance|0
1004904|NCT00402727|3290664|P2|Overall Study|supply problems|1
1004905|NCT00402727|3290665|P1|Overall Study|supply problems|2
1004906|NCT00402727|3290664|P2|Overall Study|Withdrawal by Subject|7
1004907|NCT00402727|3290665|P1|Overall Study|Withdrawal by Subject|3
1004908|NCT00402727|3290664|P2|Overall Study|Protocol Violation|4
1004909|NCT00402727|3290665|P1|Overall Study|Protocol Violation|0
1004910|NCT00402727|3290664|P2|Overall Study|Physician Decision|1
1004911|NCT00402727|3290665|P1|Overall Study|Physician Decision|1
1004912|NCT00402727|3290664|P2|Overall Study|Lost to Follow-up|11
1004913|NCT00402727|3290665|P1|Overall Study|Lost to Follow-up|24
1004914|NCT00402727|3290664|P2|Overall Study|Lack of Efficacy|3
1004915|NCT00402727|3290665|P1|Overall Study|Lack of Efficacy|1
1004916|NCT00402727|3290664|P2|Overall Study|Death|0
1004917|NCT00402727|3290665|P1|Overall Study|Death|1
1004918|NCT00402727|3290664|P2|Overall Study|Adverse Event|6
1004919|NCT00402727|3290665|P1|Overall Study|Adverse Event|10
1004920|NCT00402688|3290707|P3|Overall Study|Patient Left Town and Forgot Medication|1
1004921|NCT00402688|3290708|P2|Overall Study|Patient Left Town and Forgot Medication|0
1004922|NCT00402688|3290709|P1|Overall Study|Patient Left Town and Forgot Medication|0
1004923|NCT00402688|3290707|P3|Overall Study|Urine Cult. Yield Resistant to Levaquin|1
1004924|NCT00402688|3290708|P2|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
1004925|NCT00402688|3290709|P1|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
1004926|NCT00402688|3290707|P3|Overall Study|Culture Show Fluoroquinolone Resistance|0
1004927|NCT00402688|3290708|P2|Overall Study|Culture Show Fluoroquinolone Resistance|1
1004928|NCT00402688|3290709|P1|Overall Study|Culture Show Fluoroquinolone Resistance|0
1004929|NCT00402688|3290707|P3|Overall Study|Lost to Follow-up|2
1004930|NCT00402688|3290708|P2|Overall Study|Lost to Follow-up|0
1004931|NCT00402688|3290709|P1|Overall Study|Lost to Follow-up|1
1004932|NCT00402688|3290707|P3|Overall Study|Protocol Violation|1
1004933|NCT00402688|3290708|P2|Overall Study|Protocol Violation|1
1004934|NCT00402688|3290709|P1|Overall Study|Protocol Violation|1
1004935|NCT00402688|3290707|P3|Overall Study|Lack of Efficacy|5
1004936|NCT00402688|3290708|P2|Overall Study|Lack of Efficacy|4
1004937|NCT00402688|3290709|P1|Overall Study|Lack of Efficacy|4
1004938|NCT00402688|3290707|P3|Overall Study|Physician Decision|1
1004939|NCT00402688|3290708|P2|Overall Study|Physician Decision|0
1004940|NCT00402688|3290709|P1|Overall Study|Physician Decision|0
1004941|NCT00402688|3290707|P3|Overall Study|Withdrawal by Subject|1
1004942|NCT00402688|3290708|P2|Overall Study|Withdrawal by Subject|1
1004943|NCT00402688|3290709|P1|Overall Study|Withdrawal by Subject|3
1004944|NCT00402688|3290707|P3|Overall Study|Adverse Event|3
1004945|NCT00402688|3290708|P2|Overall Study|Adverse Event|9
1004946|NCT00402688|3290709|P1|Overall Study|Adverse Event|12
1004947|NCT00402649|3290732|P1|Overall Study|Withdrawal by Subject|1
1004948|NCT00402649|3290732|P1|Overall Study|Lost to Follow-up|1
1004949|NCT00402597|3290747|P5|Overall Study|reason not specified|20
1004950|NCT00402597|3290748|P4|Overall Study|reason not specified|14
1004951|NCT00402597|3290749|P3|Overall Study|reason not specified|27
1004952|NCT00402597|3290750|P2|Overall Study|reason not specified|4
1004953|NCT00402597|3290751|P1|Overall Study|reason not specified|30
1004954|NCT00402597|3290747|P5|Overall Study|Withdrawal by Subject|24
1004955|NCT00402597|3290748|P4|Overall Study|Withdrawal by Subject|15
1004956|NCT00402597|3290749|P3|Overall Study|Withdrawal by Subject|65
1004957|NCT00402597|3290750|P2|Overall Study|Withdrawal by Subject|16
1004958|NCT00402597|3290751|P1|Overall Study|Withdrawal by Subject|57
1004959|NCT00402597|3290747|P5|Overall Study|Lost to Follow-up|3
1004960|NCT00402597|3290748|P4|Overall Study|Lost to Follow-up|2
1004961|NCT00402597|3290749|P3|Overall Study|Lost to Follow-up|8
1004962|NCT00402597|3290750|P2|Overall Study|Lost to Follow-up|1
1004963|NCT00402597|3290751|P1|Overall Study|Lost to Follow-up|8
1004964|NCT00402597|3290747|P5|Overall Study|Adverse Event|71
1004965|NCT00402597|3290748|P4|Overall Study|Adverse Event|39
1004966|NCT00402597|3290749|P3|Overall Study|Adverse Event|106
1004967|NCT00402597|3290750|P2|Overall Study|Adverse Event|18
1004968|NCT00402597|3290751|P1|Overall Study|Adverse Event|81
1004969|NCT00402597|3290747|P5|Overall Study|Death|6
1004970|NCT00402597|3290748|P4|Overall Study|Death|4
1004971|NCT00402597|3290749|P3|Overall Study|Death|6
1004972|NCT00402597|3290750|P2|Overall Study|Death|7
1004973|NCT00402597|3290751|P1|Overall Study|Death|15
1004974|NCT00402363|3290792|P4|Overall Study|"Captured as Other"|2
1004975|NCT00402363|3290793|P3|Overall Study|"Captured as Other"|2
1004976|NCT00402363|3290794|P2|Overall Study|"Captured as Other"|2
1004977|NCT00402363|3290795|P1|Overall Study|"Captured as Other"|6
1004978|NCT00402363|3290792|P4|Overall Study|Lost to Follow-up|2
1004979|NCT00402363|3290793|P3|Overall Study|Lost to Follow-up|0
1004980|NCT00402363|3290794|P2|Overall Study|Lost to Follow-up|4
1004981|NCT00402363|3290795|P1|Overall Study|Lost to Follow-up|5
1004982|NCT00402363|3290792|P4|Overall Study|Protocol Violation|3
1004983|NCT00402363|3290793|P3|Overall Study|Protocol Violation|0
1004984|NCT00402363|3290794|P2|Overall Study|Protocol Violation|5
1004985|NCT00402363|3290795|P1|Overall Study|Protocol Violation|3
1004986|NCT00402363|3290792|P4|Overall Study|Withdrew Consent|1
1004987|NCT00402363|3290793|P3|Overall Study|Withdrew Consent|2
1004988|NCT00402363|3290794|P2|Overall Study|Withdrew Consent|5
1004989|NCT00402363|3290795|P1|Overall Study|Withdrew Consent|10
1004990|NCT00402363|3290792|P4|Overall Study|Adverse Event|2
1004991|NCT00402363|3290793|P3|Overall Study|Adverse Event|2
1004992|NCT00402363|3290794|P2|Overall Study|Adverse Event|14
1004993|NCT00402363|3290795|P1|Overall Study|Adverse Event|9
1004994|NCT00402337|3290858|P5|Overall Study|Other Reason|0
1004995|NCT00402337|3290859|P4|Overall Study|Other Reason|0
1004996|NCT00402337|3290860|P3|Overall Study|Other Reason|0
1004997|NCT00402337|3290861|P2|Overall Study|Other Reason|1
1004998|NCT00402337|3290862|P1|Overall Study|Other Reason|0
1004999|NCT00402337|3290858|P5|Overall Study|Physician Decision|0
1005000|NCT00402337|3290859|P4|Overall Study|Physician Decision|1
1005001|NCT00402337|3290860|P3|Overall Study|Physician Decision|0
1005002|NCT00402337|3290861|P2|Overall Study|Physician Decision|0
1005003|NCT00402337|3290862|P1|Overall Study|Physician Decision|0
1005004|NCT00402337|3290858|P5|Overall Study|Lost to Follow-up|0
1005005|NCT00402337|3290859|P4|Overall Study|Lost to Follow-up|2
1005006|NCT00402337|3290860|P3|Overall Study|Lost to Follow-up|1
1005007|NCT00402337|3290861|P2|Overall Study|Lost to Follow-up|0
1005008|NCT00402337|3290862|P1|Overall Study|Lost to Follow-up|0
1005009|NCT00402337|3290858|P5|Overall Study|Withdrawal by Subject|4
1005010|NCT00402337|3290859|P4|Overall Study|Withdrawal by Subject|6
1005011|NCT00402337|3290860|P3|Overall Study|Withdrawal by Subject|1
1005012|NCT00402337|3290861|P2|Overall Study|Withdrawal by Subject|3
1005013|NCT00402337|3290862|P1|Overall Study|Withdrawal by Subject|5
1005014|NCT00402337|3290858|P5|Overall Study|Noncompliance|2
1005015|NCT00402337|3290859|P4|Overall Study|Noncompliance|0
1005016|NCT00402337|3290860|P3|Overall Study|Noncompliance|0
1005017|NCT00402337|3290861|P2|Overall Study|Noncompliance|0
1005018|NCT00402337|3290862|P1|Overall Study|Noncompliance|0
1005019|NCT00402337|3290858|P5|Overall Study|Adverse Event|2
1005020|NCT00402337|3290859|P4|Overall Study|Adverse Event|3
1005021|NCT00402337|3290860|P3|Overall Study|Adverse Event|2
1005022|NCT00402337|3290861|P2|Overall Study|Adverse Event|2
1005023|NCT00402337|3290862|P1|Overall Study|Adverse Event|0
1005024|NCT00402324|3290901|P2|Overall Study|Death|0
1005025|NCT00402324|3290902|P1|Overall Study|Death|1
1005026|NCT00402324|3290901|P2|Overall Study|Adverse Event|4
1005027|NCT00402324|3290902|P1|Overall Study|Adverse Event|6
1005028|NCT00402324|3290901|P2|Overall Study|Lack of Efficacy|4
1005029|NCT00402324|3290902|P1|Overall Study|Lack of Efficacy|1
1005030|NCT00402324|3290901|P2|Overall Study|Sponsor Decision|5
1005031|NCT00402324|3290902|P1|Overall Study|Sponsor Decision|4
1005032|NCT00402324|3290901|P2|Overall Study|Physician Decision|4
1005033|NCT00402324|3290902|P1|Overall Study|Physician Decision|2
1005034|NCT00402324|3290901|P2|Overall Study|Withdrawal by Subject|2
1005035|NCT00402324|3290902|P1|Overall Study|Withdrawal by Subject|5
1005036|NCT00402324|3290901|P2|Overall Study|Protocol Violation|7
1005037|NCT00402324|3290902|P1|Overall Study|Protocol Violation|8
1005038|NCT00402324|3290901|P2|Overall Study|Protocol Entry Criteria Not Met|4
1005039|NCT00402324|3290902|P1|Overall Study|Protocol Entry Criteria Not Met|5
1005040|NCT00402324|3290901|P2|Overall Study|Lost to Follow-up|11
1005041|NCT00402324|3290902|P1|Overall Study|Lost to Follow-up|11
1005042|NCT00402285|3290935|P3|Overall Study|insufficient RNA quality|2
1005043|NCT00402285|3290936|P2|Overall Study|insufficient RNA quality|6
1005044|NCT00402285|3290937|P1|Overall Study|insufficient RNA quality|7
1005045|NCT00402246|3290945|P2|Overall Study|Deterioriating Condition|2
1005046|NCT00402246|3290946|P1|Overall Study|Deterioriating Condition|3
1005047|NCT00402246|3290945|P2|Overall Study|Center Closure|3
1005048|NCT00402246|3290946|P1|Overall Study|Center Closure|5
1005049|NCT00402246|3290945|P2|Overall Study|Patient's device explanted|2
1005050|NCT00402246|3290946|P1|Overall Study|Patient's device explanted|6
1005051|NCT00402246|3290945|P2|Overall Study|Heart Transplant|1
1005052|NCT00402246|3290946|P1|Overall Study|Heart Transplant|0
1005053|NCT00402246|3290945|P2|Overall Study|Insurance Issues|1
1005054|NCT00402246|3290946|P1|Overall Study|Insurance Issues|2
1005055|NCT00402246|3290945|P2|Overall Study|Missed Final Visit|2
1005056|NCT00402246|3290946|P1|Overall Study|Missed Final Visit|1
1005057|NCT00402246|3290945|P2|Overall Study|Protocol Violation|24
1005058|NCT00402246|3290946|P1|Overall Study|Protocol Violation|25
1005059|NCT00402246|3290945|P2|Overall Study|Physician Decision|26
1005060|NCT00402246|3290946|P1|Overall Study|Physician Decision|24
1005061|NCT00402246|3290945|P2|Overall Study|Withdrawal by Subject|87
1005062|NCT00402246|3290946|P1|Overall Study|Withdrawal by Subject|72
1005063|NCT00402246|3290945|P2|Overall Study|Lost to Follow-up|28
1005064|NCT00402246|3290946|P1|Overall Study|Lost to Follow-up|20
1005065|NCT00402246|3290945|P2|Overall Study|Death|58
1005066|NCT00402246|3290946|P1|Overall Study|Death|62
1005067|NCT00402233|3290980|P4|Overall Study|Worsening of other pre-existing disease|0
1005068|NCT00402233|3290981|P3|Overall Study|Worsening of other pre-existing disease|0
1005069|NCT00402233|3290982|P2|Overall Study|Worsening of other pre-existing disease|1
1005070|NCT00402233|3290983|P1|Overall Study|Worsening of other pre-existing disease|0
1005071|NCT00402233|3290980|P4|Overall Study|Worsening of disease under study|0
1005072|NCT00402233|3290981|P3|Overall Study|Worsening of disease under study|0
1005073|NCT00402233|3290982|P2|Overall Study|Worsening of disease under study|0
1005074|NCT00402233|3290983|P1|Overall Study|Worsening of disease under study|2
1005075|NCT00402233|3290980|P4|Overall Study|Withdrawal by Subject|2
1005076|NCT00402233|3290981|P3|Overall Study|Withdrawal by Subject|2
1005077|NCT00402233|3290982|P2|Overall Study|Withdrawal by Subject|1
1005078|NCT00402233|3290983|P1|Overall Study|Withdrawal by Subject|2
1005079|NCT00402233|3290980|P4|Overall Study|Protocol Violation|0
1005080|NCT00402233|3290981|P3|Overall Study|Protocol Violation|0
1005081|NCT00402233|3290982|P2|Overall Study|Protocol Violation|1
1005082|NCT00402233|3290983|P1|Overall Study|Protocol Violation|0
1005083|NCT00402233|3290980|P4|Overall Study|Adverse Event|9
1005084|NCT00402233|3290981|P3|Overall Study|Adverse Event|9
1005085|NCT00402233|3290982|P2|Overall Study|Adverse Event|7
1005086|NCT00402233|3290983|P1|Overall Study|Adverse Event|1
1005087|NCT00402168|3291018|P2|Switched From CNI to Belatacept in LT|Adverse Event|0
1005088|NCT00402168|3291019|P1|Switched From CNI to Belatacept in LT|Adverse Event|4
1005089|NCT00402168|3291018|P2|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0
1005090|NCT00402168|3291019|P1|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2
1005091|NCT00402168|3291018|P2|Long Term (LT)|non-specified|2
1005092|NCT00402168|3291019|P1|Long Term (LT)|non-specified|1
1005093|NCT00402168|3291018|P2|Long Term (LT)|Lack of Efficacy|2
1005094|NCT00402168|3291019|P1|Long Term (LT)|Lack of Efficacy|0
1005095|NCT00402168|3291018|P2|Long Term (LT)|Death|0
1005096|NCT00402168|3291019|P1|Long Term (LT)|Death|4
1005097|NCT00402168|3291018|P2|Long Term (LT)|Lost to Follow-up|0
1005098|NCT00402168|3291019|P1|Long Term (LT)|Lost to Follow-up|1
1005099|NCT00402168|3291018|P2|Long Term (LT)|Pregnancy|1
1005100|NCT00402168|3291019|P1|Long Term (LT)|Pregnancy|0
1005101|NCT00402168|3291018|P2|Long Term (LT)|Withdrawal by Subject|7
1005102|NCT00402168|3291019|P1|Long Term (LT)|Withdrawal by Subject|4
1005103|NCT00402168|3291018|P2|Long Term (LT)|Adverse Event|5
1005104|NCT00402168|3291019|P1|Long Term (LT)|Adverse Event|1
1005105|NCT00402168|3291018|P2|Treatment (up to 12 Months)|non-specified|1
1005106|NCT00402168|3291019|P1|Treatment (up to 12 Months)|non-specified|0
1005107|NCT00402168|3291018|P2|Treatment (up to 12 Months)|Lack of Efficacy|0
1005108|NCT00402168|3291019|P1|Treatment (up to 12 Months)|Lack of Efficacy|2
1005109|NCT00402168|3291018|P2|Treatment (up to 12 Months)|Death|1
1005110|NCT00402168|3291019|P1|Treatment (up to 12 Months)|Death|0
1005111|NCT00402168|3291018|P2|Randomized|Withdrawal by Subject|1
1005112|NCT00402168|3291019|P1|Randomized|Withdrawal by Subject|0
1005113|NCT00402168|3291018|P2|Randomized|Lost to Follow-up|0
1005114|NCT00402168|3291019|P1|Randomized|Lost to Follow-up|1
1005115|NCT00402103|3291076|P2|Overall Study|Administrative problems|0
1005116|NCT00402103|3291077|P1|Overall Study|Administrative problems|2
1005117|NCT00402103|3291076|P2|Overall Study|Lost to Follow-up|3
1005118|NCT00402103|3291077|P1|Overall Study|Lost to Follow-up|6
1005119|NCT00402103|3291076|P2|Overall Study|Patient withdrew consent|1
1005120|NCT00402103|3291077|P1|Overall Study|Patient withdrew consent|12
1005121|NCT00402103|3291076|P2|Overall Study|Protocol Deviation|0
1005122|NCT00402103|3291077|P1|Overall Study|Protocol Deviation|8
1005123|NCT00402103|3291076|P2|Overall Study|Condition no longer requires study drug|0
1005124|NCT00402103|3291077|P1|Overall Study|Condition no longer requires study drug|2
1005125|NCT00402103|3291076|P2|Overall Study|Unsatisfactory therapeutic effect|2
1005126|NCT00402103|3291077|P1|Overall Study|Unsatisfactory therapeutic effect|1
1005127|NCT00402103|3291076|P2|Overall Study|Adverse Event|7
1005128|NCT00402103|3291077|P1|Overall Study|Adverse Event|60
1005129|NCT00402051|3291093|P2|Overall Study|Lost to Follow-up|0
1005130|NCT00402051|3291094|P1|Overall Study|Lost to Follow-up|1
1005131|NCT00402051|3291093|P2|Overall Study|Death Due to Adverse Event|2
1005132|NCT00402051|3291094|P1|Overall Study|Death Due to Adverse Event|0
1005133|NCT00402051|3291093|P2|Overall Study|Death Due to Study Disease|1
1005134|NCT00402051|3291094|P1|Overall Study|Death Due to Study Disease|2
1005135|NCT00402051|3291093|P2|Overall Study|Death - Related to Study Drug|2
1005136|NCT00402051|3291094|P1|Overall Study|Death - Related to Study Drug|1
1005137|NCT00402051|3291093|P2|Overall Study|Withdrawal by Subject|3
1005138|NCT00402051|3291094|P1|Overall Study|Withdrawal by Subject|3
1005139|NCT00402051|3291093|P2|Overall Study|Physician Decision|3
1005140|NCT00402051|3291094|P1|Overall Study|Physician Decision|7
1005141|NCT00402051|3291093|P2|Overall Study|Adverse Event|4
1005142|NCT00402051|3291094|P1|Overall Study|Adverse Event|11
1005143|NCT00402051|3291093|P2|Overall Study|Progressive Disease|20
1005144|NCT00402051|3291094|P1|Overall Study|Progressive Disease|13
1005145|NCT00402025|3291111|P3|Overall Study|Participant Decision|1
1005146|NCT00402025|3291112|P2|Overall Study|Participant Decision|0
1005147|NCT00402025|3291113|P1|Overall Study|Participant Decision|0
1005148|NCT00402025|3291111|P3|Overall Study|Physician Decision|0
1005149|NCT00402025|3291112|P2|Overall Study|Physician Decision|1
1005150|NCT00402025|3291113|P1|Overall Study|Physician Decision|1
1005151|NCT00402025|3291111|P3|Overall Study|Disease Progression|2
1005152|NCT00402025|3291112|P2|Overall Study|Disease Progression|1
1005153|NCT00402025|3291113|P1|Overall Study|Disease Progression|1
1005154|NCT00402025|3291111|P3|Overall Study|Death|5
1005155|NCT00402025|3291112|P2|Overall Study|Death|1
1005156|NCT00402025|3291113|P1|Overall Study|Death|0
1005157|NCT00402025|3291111|P3|Overall Study|Adverse Event|2
1005158|NCT00402025|3291112|P2|Overall Study|Adverse Event|0
1005159|NCT00402025|3291113|P1|Overall Study|Adverse Event|0
1005160|NCT00401973|3291139|P3|Overall Study|Withdrawal by Subject|9
1005161|NCT00401973|3291140|P2|Overall Study|Withdrawal by Subject|12
1005162|NCT00401973|3291141|P1|Overall Study|Withdrawal by Subject|4
1005163|NCT00401973|3291139|P3|Overall Study|Sponsor Decision|0
1005164|NCT00401973|3291140|P2|Overall Study|Sponsor Decision|1
1005165|NCT00401973|3291141|P1|Overall Study|Sponsor Decision|0
1005166|NCT00401973|3291139|P3|Overall Study|Protocol Violation|3
1005167|NCT00401973|3291140|P2|Overall Study|Protocol Violation|2
1005168|NCT00401973|3291141|P1|Overall Study|Protocol Violation|1
1005169|NCT00401973|3291139|P3|Overall Study|Physician Decision|1
1005170|NCT00401973|3291140|P2|Overall Study|Physician Decision|0
1005171|NCT00401973|3291141|P1|Overall Study|Physician Decision|2
1005172|NCT00401973|3291139|P3|Overall Study|Lost to Follow-up|2
1005173|NCT00401973|3291140|P2|Overall Study|Lost to Follow-up|2
1005174|NCT00401973|3291141|P1|Overall Study|Lost to Follow-up|2
1005175|NCT00401973|3291139|P3|Overall Study|Lack of Efficacy|3
1005176|NCT00401973|3291140|P2|Overall Study|Lack of Efficacy|0
1005177|NCT00401973|3291141|P1|Overall Study|Lack of Efficacy|0
1005178|NCT00401973|3291139|P3|Overall Study|Clinical Relapse|1
1005179|NCT00401973|3291140|P2|Overall Study|Clinical Relapse|1
1005180|NCT00401973|3291141|P1|Overall Study|Clinical Relapse|0
1005181|NCT00401973|3291139|P3|Overall Study|Adverse Event|4
1005182|NCT00401973|3291140|P2|Overall Study|Adverse Event|8
1005183|NCT00401973|3291141|P1|Overall Study|Adverse Event|2
1005184|NCT00401960|3291180|P2|Overall Study|Death|0
1005185|NCT00401960|3291181|P1|Overall Study|Death|2
1005186|NCT00401960|3291180|P2|Overall Study|Lost to Follow-up|0
1005187|NCT00401960|3291181|P1|Overall Study|Lost to Follow-up|3
1005188|NCT00401843|3291211|P3|Overall Study|Received incorrect treatment|0
1005189|NCT00401843|3291212|P2|Overall Study|Received incorrect treatment|3
1005190|NCT00401843|3291213|P1|Overall Study|Received incorrect treatment|0
1005191|NCT00401843|3291211|P3|Overall Study|Randomized but not Treated|3
1005192|NCT00401843|3291212|P2|Overall Study|Randomized but not Treated|2
1005193|NCT00401843|3291213|P1|Overall Study|Randomized but not Treated|0
1005194|NCT00401843|3291211|P3|Overall Study|Withdrawal of consent to study agent|17
1005195|NCT00401843|3291212|P2|Overall Study|Withdrawal of consent to study agent|15
1005196|NCT00401843|3291213|P1|Overall Study|Withdrawal of consent to study agent|1
1005197|NCT00401843|3291211|P3|Overall Study|Withdrawal by Subject|5
1005198|NCT00401843|3291212|P2|Overall Study|Withdrawal by Subject|5
1005199|NCT00401843|3291213|P1|Overall Study|Withdrawal by Subject|1
1005200|NCT00401843|3291211|P3|Overall Study|Protocol Violation|1
1005201|NCT00401843|3291212|P2|Overall Study|Protocol Violation|0
1005202|NCT00401843|3291213|P1|Overall Study|Protocol Violation|0
1005203|NCT00401843|3291211|P3|Overall Study|Physician Decision|10
1005204|NCT00401843|3291212|P2|Overall Study|Physician Decision|16
1005205|NCT00401843|3291213|P1|Overall Study|Physician Decision|0
1005206|NCT00401843|3291211|P3|Overall Study|Other Unspecified|5
1005207|NCT00401843|3291212|P2|Overall Study|Other Unspecified|3
1005208|NCT00401843|3291213|P1|Overall Study|Other Unspecified|0
1005209|NCT00401843|3291211|P3|Overall Study|Lost to Follow-up|2
1005210|NCT00401843|3291212|P2|Overall Study|Lost to Follow-up|0
1005211|NCT00401843|3291213|P1|Overall Study|Lost to Follow-up|0
1005212|NCT00401843|3291211|P3|Overall Study|End of Study|2
1005213|NCT00401843|3291212|P2|Overall Study|End of Study|1
1005214|NCT00401843|3291213|P1|Overall Study|End of Study|1
1005215|NCT00401843|3291211|P3|Overall Study|Disease progression|49
1005216|NCT00401843|3291212|P2|Overall Study|Disease progression|60
1005217|NCT00401843|3291213|P1|Overall Study|Disease progression|10
1005218|NCT00401843|3291211|P3|Overall Study|Death|10
1005219|NCT00401843|3291212|P2|Overall Study|Death|8
1005220|NCT00401843|3291213|P1|Overall Study|Death|0
1005221|NCT00401843|3291211|P3|Overall Study|Adverse Event|27
1005222|NCT00401843|3291212|P2|Overall Study|Adverse Event|26
1005223|NCT00401843|3291213|P1|Overall Study|Adverse Event|7
1005224|NCT00401843|3291211|P3|Overall Study|Achieved Complete Response|11
1005225|NCT00401843|3291212|P2|Overall Study|Achieved Complete Response|5
1005226|NCT00401843|3291213|P1|Overall Study|Achieved Complete Response|1
1005227|NCT00401830|3291231|P2|Overall Study|Other: Personal / Family problems|0
1005228|NCT00401830|3291232|P1|Overall Study|Other: Personal / Family problems|1
1005229|NCT00401830|3291231|P2|Overall Study|Lost to Follow-up|3
1005230|NCT00401830|3291232|P1|Overall Study|Lost to Follow-up|1
1005231|NCT00401830|3291231|P2|Overall Study|Non-compliance with drug study|0
1005232|NCT00401830|3291232|P1|Overall Study|Non-compliance with drug study|1
1005233|NCT00401830|3291231|P2|Overall Study|Protocol Violation|3
1005234|NCT00401830|3291232|P1|Overall Study|Protocol Violation|3
1005235|NCT00401830|3291231|P2|Overall Study|Withdrawal by Subject|3
1005236|NCT00401830|3291232|P1|Overall Study|Withdrawal by Subject|4
1005237|NCT00401830|3291231|P2|Overall Study|Lack of Efficacy|5
1005238|NCT00401830|3291232|P1|Overall Study|Lack of Efficacy|11
1005239|NCT00401830|3291231|P2|Overall Study|Adverse Event|18
1005240|NCT00401830|3291232|P1|Overall Study|Adverse Event|10
1005241|NCT00401752|3291290|P2|Overall Study|Physician Decision|1
1005242|NCT00401752|3291291|P1|Overall Study|Physician Decision|1
1005243|NCT00401752|3291290|P2|Overall Study|Development of any exclusion criteria|2
1005244|NCT00401752|3291291|P1|Overall Study|Development of any exclusion criteria|4
1005245|NCT00401752|3291290|P2|Overall Study|Lost to Follow-up|4
1005246|NCT00401752|3291291|P1|Overall Study|Lost to Follow-up|1
1005247|NCT00401752|3291290|P2|Overall Study|Withdrawal by Subject|6
1005248|NCT00401752|3291291|P1|Overall Study|Withdrawal by Subject|2
1005249|NCT00401752|3291290|P2|Overall Study|Adverse Event|5
1005250|NCT00401752|3291291|P1|Overall Study|Adverse Event|2
1005251|NCT00401726|3291309|P2|Overall Study|Protocol Deviation|4
1005252|NCT00401726|3291310|P1|Overall Study|Protocol Deviation|9
1005253|NCT00401726|3291309|P2|Overall Study|Lack of Efficacy|6
1005254|NCT00401726|3291310|P1|Overall Study|Lack of Efficacy|4
1005255|NCT00401726|3291309|P2|Overall Study|Withdrawal by Subject|24
1005256|NCT00401726|3291310|P1|Overall Study|Withdrawal by Subject|18
1005257|NCT00401726|3291309|P2|Overall Study|Protocol Violation|3
1005258|NCT00401726|3291310|P1|Overall Study|Protocol Violation|6
1005259|NCT00401726|3291309|P2|Overall Study|Lost to Follow-up|20
1005260|NCT00401726|3291310|P1|Overall Study|Lost to Follow-up|23
1005261|NCT00401726|3291309|P2|Overall Study|Physician Decision|6
1005262|NCT00401726|3291310|P1|Overall Study|Physician Decision|3
1005263|NCT00401726|3291309|P2|Overall Study|Sponsor Request|1
1005264|NCT00401726|3291310|P1|Overall Study|Sponsor Request|0
1005265|NCT00401726|3291309|P2|Overall Study|Death|3
1005266|NCT00401726|3291310|P1|Overall Study|Death|0
1005267|NCT00401726|3291309|P2|Overall Study|Adverse Event|45
1005268|NCT00401726|3291310|P1|Overall Study|Adverse Event|34
1005269|NCT00401544|3291345|P4|Overall Study|Other|2
1005270|NCT00401544|3291346|P3|Overall Study|Other|2
1005271|NCT00401544|3291347|P2|Overall Study|Other|0
1005272|NCT00401544|3291348|P1|Overall Study|Other|0
1005273|NCT00401544|3291345|P4|Overall Study|Disease progression|0
1005274|NCT00401544|3291346|P3|Overall Study|Disease progression|0
1005275|NCT00401544|3291347|P2|Overall Study|Disease progression|1
1005276|NCT00401544|3291348|P1|Overall Study|Disease progression|0
1005277|NCT00401544|3291345|P4|Overall Study|Ineligibility determined|2
1005278|NCT00401544|3291346|P3|Overall Study|Ineligibility determined|0
1005279|NCT00401544|3291347|P2|Overall Study|Ineligibility determined|1
1005280|NCT00401544|3291348|P1|Overall Study|Ineligibility determined|0
1005281|NCT00401544|3291345|P4|Overall Study|Physician Decision|0
1005282|NCT00401544|3291346|P3|Overall Study|Physician Decision|0
1005283|NCT00401544|3291347|P2|Overall Study|Physician Decision|3
1005284|NCT00401544|3291348|P1|Overall Study|Physician Decision|1
1005285|NCT00401544|3291345|P4|Overall Study|Withdrawal by Subject|5
1005286|NCT00401544|3291346|P3|Overall Study|Withdrawal by Subject|6
1005287|NCT00401544|3291347|P2|Overall Study|Withdrawal by Subject|6
1005288|NCT00401544|3291348|P1|Overall Study|Withdrawal by Subject|7
1005289|NCT00401544|3291345|P4|Overall Study|Lost to Follow-up|1
1005290|NCT00401544|3291346|P3|Overall Study|Lost to Follow-up|1
1005291|NCT00401544|3291347|P2|Overall Study|Lost to Follow-up|0
1005292|NCT00401544|3291348|P1|Overall Study|Lost to Follow-up|2
1005293|NCT00401544|3291345|P4|Overall Study|Death|5
1005294|NCT00401544|3291346|P3|Overall Study|Death|2
1005295|NCT00401544|3291347|P2|Overall Study|Death|6
1005296|NCT00401544|3291348|P1|Overall Study|Death|3
1005297|NCT00401544|3291345|P4|Overall Study|Adverse Event|1
1005298|NCT00401544|3291346|P3|Overall Study|Adverse Event|1
1005299|NCT00401544|3291347|P2|Overall Study|Adverse Event|1
1005300|NCT00401544|3291348|P1|Overall Study|Adverse Event|5
1005301|NCT00401531|3291388|P2|Overall Study|Withdrawal by Subject|2
1005302|NCT00401531|3291389|P1|Overall Study|Withdrawal by Subject|3
1005303|NCT00401531|3291388|P2|Overall Study|Lost to Follow-up|1
1005304|NCT00401531|3291389|P1|Overall Study|Lost to Follow-up|1
1005305|NCT00401531|3291388|P2|Overall Study|Protocol Violation|7
1005306|NCT00401531|3291389|P1|Overall Study|Protocol Violation|3
1005307|NCT00401531|3291388|P2|Overall Study|Adverse Event|0
1005308|NCT00401531|3291389|P1|Overall Study|Adverse Event|2
1005309|NCT00401258|3291459|P1|Overall Study|Adverse Event|7
1005310|NCT00401245|3291474|P8|Double Blind Tapering Phase|Lack of Efficacy|0
1005311|NCT00401245|3291475|P7|Double Blind Tapering Phase|Lack of Efficacy|0
1005312|NCT00401245|3291476|P6|Double Blind Tapering Phase|Lack of Efficacy|1
1005313|NCT00401245|3291477|P5|Double Blind Tapering Phase|Lack of Efficacy|0
1005314|NCT00401245|3291478|P4|Double Blind Tapering Phase|Lack of Efficacy|0
1005315|NCT00401245|3291479|P3|Double Blind Tapering Phase|Lack of Efficacy|0
1005316|NCT00401245|3291480|P2|Double Blind Tapering Phase|Lack of Efficacy|0
1005317|NCT00401245|3291481|P1|Double Blind Tapering Phase|Lack of Efficacy|0
1005318|NCT00401245|3291474|P8|Double Blind Tapering Phase|Withdrawal by Subject|0
1005319|NCT00401245|3291475|P7|Double Blind Tapering Phase|Withdrawal by Subject|3
1005320|NCT00401245|3291476|P6|Double Blind Tapering Phase|Withdrawal by Subject|2
1005321|NCT00401245|3291477|P5|Double Blind Tapering Phase|Withdrawal by Subject|2
1005322|NCT00401245|3291478|P4|Double Blind Tapering Phase|Withdrawal by Subject|0
1005323|NCT00401245|3291479|P3|Double Blind Tapering Phase|Withdrawal by Subject|0
1005324|NCT00401245|3291480|P2|Double Blind Tapering Phase|Withdrawal by Subject|0
1005325|NCT00401245|3291481|P1|Double Blind Tapering Phase|Withdrawal by Subject|0
1005326|NCT00401245|3291474|P8|Double Blind Tapering Phase|Other|2
1005327|NCT00401245|3291475|P7|Double Blind Tapering Phase|Other|2
1005328|NCT00401245|3291476|P6|Double Blind Tapering Phase|Other|0
1005329|NCT00401245|3291477|P5|Double Blind Tapering Phase|Other|1
1005330|NCT00401245|3291478|P4|Double Blind Tapering Phase|Other|0
1005331|NCT00401245|3291479|P3|Double Blind Tapering Phase|Other|0
1005332|NCT00401245|3291480|P2|Double Blind Tapering Phase|Other|0
1005333|NCT00401245|3291481|P1|Double Blind Tapering Phase|Other|0
1005334|NCT00401245|3291474|P8|Double Blind Tapering Phase|Investigator request|1
1005335|NCT00401245|3291475|P7|Double Blind Tapering Phase|Investigator request|0
1005336|NCT00401245|3291476|P6|Double Blind Tapering Phase|Investigator request|0
1005337|NCT00401245|3291477|P5|Double Blind Tapering Phase|Investigator request|0
1005338|NCT00401245|3291478|P4|Double Blind Tapering Phase|Investigator request|0
1005339|NCT00401245|3291479|P3|Double Blind Tapering Phase|Investigator request|0
1005340|NCT00401245|3291480|P2|Double Blind Tapering Phase|Investigator request|0
1005341|NCT00401245|3291481|P1|Double Blind Tapering Phase|Investigator request|0
1005342|NCT00401245|3291474|P8|Double Blind Tapering Phase|Adverse Event|4
1005343|NCT00401245|3291475|P7|Double Blind Tapering Phase|Adverse Event|2
1005344|NCT00401245|3291476|P6|Double Blind Tapering Phase|Adverse Event|1
1005345|NCT00401245|3291477|P5|Double Blind Tapering Phase|Adverse Event|1
1005346|NCT00401245|3291478|P4|Double Blind Tapering Phase|Adverse Event|0
1005347|NCT00401245|3291479|P3|Double Blind Tapering Phase|Adverse Event|0
1005348|NCT00401245|3291480|P2|Double Blind Tapering Phase|Adverse Event|0
1005349|NCT00401245|3291481|P1|Double Blind Tapering Phase|Adverse Event|0
1005350|NCT00401245|3291474|P8|Open Label Phase|Lack of Efficacy|0
1005351|NCT00401245|3291475|P7|Open Label Phase|Lack of Efficacy|0
1005352|NCT00401245|3291476|P6|Open Label Phase|Lack of Efficacy|0
1005353|NCT00401245|3291477|P5|Open Label Phase|Lack of Efficacy|0
1005354|NCT00401245|3291478|P4|Open Label Phase|Lack of Efficacy|0
1005355|NCT00401245|3291479|P3|Open Label Phase|Lack of Efficacy|3
1005356|NCT00401245|3291480|P2|Open Label Phase|Lack of Efficacy|2
1005357|NCT00401245|3291481|P1|Open Label Phase|Lack of Efficacy|4
1005358|NCT00401245|3291474|P8|Open Label Phase|Withdrawal by Subject|0
1005359|NCT00401245|3291475|P7|Open Label Phase|Withdrawal by Subject|0
1005360|NCT00401245|3291476|P6|Open Label Phase|Withdrawal by Subject|0
1005361|NCT00401245|3291477|P5|Open Label Phase|Withdrawal by Subject|0
1005362|NCT00401245|3291478|P4|Open Label Phase|Withdrawal by Subject|1
1005363|NCT00401245|3291479|P3|Open Label Phase|Withdrawal by Subject|2
1005364|NCT00401245|3291480|P2|Open Label Phase|Withdrawal by Subject|3
1005365|NCT00401245|3291481|P1|Open Label Phase|Withdrawal by Subject|3
1005366|NCT00401245|3291474|P8|Open Label Phase|Protocol Violation|0
1005367|NCT00401245|3291475|P7|Open Label Phase|Protocol Violation|0
1005368|NCT00401245|3291476|P6|Open Label Phase|Protocol Violation|0
1005369|NCT00401245|3291477|P5|Open Label Phase|Protocol Violation|0
1005370|NCT00401245|3291478|P4|Open Label Phase|Protocol Violation|1
1005371|NCT00401245|3291479|P3|Open Label Phase|Protocol Violation|0
1005372|NCT00401245|3291480|P2|Open Label Phase|Protocol Violation|1
1005373|NCT00401245|3291481|P1|Open Label Phase|Protocol Violation|0
1005374|NCT00401245|3291474|P8|Open Label Phase|Other|0
1005375|NCT00401245|3291475|P7|Open Label Phase|Other|0
1005376|NCT00401245|3291476|P6|Open Label Phase|Other|0
1005377|NCT00401245|3291477|P5|Open Label Phase|Other|0
1005378|NCT00401245|3291478|P4|Open Label Phase|Other|8
1005379|NCT00401245|3291479|P3|Open Label Phase|Other|7
1005380|NCT00401245|3291480|P2|Open Label Phase|Other|8
1005381|NCT00401245|3291481|P1|Open Label Phase|Other|4
1005382|NCT00401245|3291474|P8|Open Label Phase|Lost to Follow-up|0
1005383|NCT00401245|3291475|P7|Open Label Phase|Lost to Follow-up|0
1005384|NCT00401245|3291476|P6|Open Label Phase|Lost to Follow-up|0
1005385|NCT00401245|3291477|P5|Open Label Phase|Lost to Follow-up|0
1005386|NCT00401245|3291478|P4|Open Label Phase|Lost to Follow-up|4
1005387|NCT00401245|3291479|P3|Open Label Phase|Lost to Follow-up|5
1005388|NCT00401245|3291480|P2|Open Label Phase|Lost to Follow-up|7
1005389|NCT00401245|3291481|P1|Open Label Phase|Lost to Follow-up|5
1005390|NCT00401245|3291474|P8|Open Label Phase|Adverse Event|0
1005391|NCT00401245|3291475|P7|Open Label Phase|Adverse Event|0
1005392|NCT00401245|3291476|P6|Open Label Phase|Adverse Event|0
1005393|NCT00401245|3291477|P5|Open Label Phase|Adverse Event|0
1005394|NCT00401245|3291478|P4|Open Label Phase|Adverse Event|7
1005395|NCT00401245|3291479|P3|Open Label Phase|Adverse Event|6
1005396|NCT00401245|3291480|P2|Open Label Phase|Adverse Event|14
1005397|NCT00401245|3291481|P1|Open Label Phase|Adverse Event|5
1005398|NCT00401245|3291474|P8|Between Titration and Open Label Phase|Did not enter the open label phase|0
1005399|NCT00401245|3291475|P7|Between Titration and Open Label Phase|Did not enter the open label phase|0
1005400|NCT00401245|3291476|P6|Between Titration and Open Label Phase|Did not enter the open label phase|0
1005401|NCT00401245|3291477|P5|Between Titration and Open Label Phase|Did not enter the open label phase|0
1005402|NCT00401245|3291478|P4|Between Titration and Open Label Phase|Did not enter the open label phase|2
1005403|NCT00401245|3291479|P3|Between Titration and Open Label Phase|Did not enter the open label phase|0
1005404|NCT00401245|3291480|P2|Between Titration and Open Label Phase|Did not enter the open label phase|2
1005405|NCT00401245|3291481|P1|Between Titration and Open Label Phase|Did not enter the open label phase|0
1005406|NCT00401245|3291474|P8|Double Blind Titration Phase|Withdrawal by Subject|0
1005407|NCT00401245|3291475|P7|Double Blind Titration Phase|Withdrawal by Subject|0
1005408|NCT00401245|3291476|P6|Double Blind Titration Phase|Withdrawal by Subject|0
1005409|NCT00401245|3291477|P5|Double Blind Titration Phase|Withdrawal by Subject|0
1005410|NCT00401245|3291478|P4|Double Blind Titration Phase|Withdrawal by Subject|2
1005411|NCT00401245|3291479|P3|Double Blind Titration Phase|Withdrawal by Subject|0
1005412|NCT00401245|3291480|P2|Double Blind Titration Phase|Withdrawal by Subject|1
1005413|NCT00401245|3291481|P1|Double Blind Titration Phase|Withdrawal by Subject|1
1005414|NCT00401245|3291474|P8|Double Blind Titration Phase|Protocol Violation|0
1005415|NCT00401245|3291475|P7|Double Blind Titration Phase|Protocol Violation|0
1005416|NCT00401245|3291476|P6|Double Blind Titration Phase|Protocol Violation|0
1005417|NCT00401245|3291477|P5|Double Blind Titration Phase|Protocol Violation|0
1005418|NCT00401245|3291478|P4|Double Blind Titration Phase|Protocol Violation|1
1005419|NCT00401245|3291479|P3|Double Blind Titration Phase|Protocol Violation|0
1005420|NCT00401245|3291480|P2|Double Blind Titration Phase|Protocol Violation|0
1005421|NCT00401245|3291481|P1|Double Blind Titration Phase|Protocol Violation|0
1005422|NCT00401245|3291474|P8|Double Blind Titration Phase|Other|0
1005423|NCT00401245|3291475|P7|Double Blind Titration Phase|Other|0
1005424|NCT00401245|3291476|P6|Double Blind Titration Phase|Other|0
1005425|NCT00401245|3291477|P5|Double Blind Titration Phase|Other|0
1005426|NCT00401245|3291478|P4|Double Blind Titration Phase|Other|0
1005427|NCT00401245|3291479|P3|Double Blind Titration Phase|Other|1
1005428|NCT00401245|3291480|P2|Double Blind Titration Phase|Other|0
1005429|NCT00401245|3291481|P1|Double Blind Titration Phase|Other|0
1005430|NCT00401245|3291474|P8|Double Blind Titration Phase|Adverse Event|0
1005431|NCT00401245|3291475|P7|Double Blind Titration Phase|Adverse Event|0
1005432|NCT00401245|3291476|P6|Double Blind Titration Phase|Adverse Event|0
1005433|NCT00401245|3291477|P5|Double Blind Titration Phase|Adverse Event|0
1005434|NCT00401245|3291478|P4|Double Blind Titration Phase|Adverse Event|12
1005435|NCT00401245|3291479|P3|Double Blind Titration Phase|Adverse Event|5
1005436|NCT00401245|3291480|P2|Double Blind Titration Phase|Adverse Event|2
1005437|NCT00401245|3291481|P1|Double Blind Titration Phase|Adverse Event|3
1005438|NCT00401193|3291549|P3|Overall Study|Other Event|2
1005439|NCT00401193|3291550|P2|Overall Study|Other Event|2
1005440|NCT00401193|3291551|P1|Overall Study|Other Event|3
1005441|NCT00401193|3291549|P3|Overall Study|Withdrawal by Subject|1
1005442|NCT00401193|3291550|P2|Overall Study|Withdrawal by Subject|0
1005443|NCT00401193|3291551|P1|Overall Study|Withdrawal by Subject|2
1005444|NCT00401193|3291549|P3|Overall Study|Lost to Follow-up|1
1005445|NCT00401193|3291550|P2|Overall Study|Lost to Follow-up|5
1005446|NCT00401193|3291551|P1|Overall Study|Lost to Follow-up|6
1005447|NCT00401193|3291549|P3|Overall Study|Protocol Violation|1
1005448|NCT00401193|3291550|P2|Overall Study|Protocol Violation|1
1005449|NCT00401193|3291551|P1|Overall Study|Protocol Violation|3
1005450|NCT00401193|3291549|P3|Overall Study|Adverse Event|1
1005451|NCT00401193|3291550|P2|Overall Study|Adverse Event|3
1005452|NCT00401193|3291551|P1|Overall Study|Adverse Event|1
1005453|NCT00400985|3291569|P1|Overall Study|Lost to Follow-up|9
1005454|NCT00400985|3291569|P1|Overall Study|Death|30
1005455|NCT00400985|3291569|P1|Overall Study|system modification|8
1005456|NCT00400985|3291569|P1|Overall Study|Withdrawal by Subject|5
1005457|NCT00400946|3291578|P5|Overall Study|Other|1
1005458|NCT00400946|3291579|P4|Overall Study|Other|0
1005459|NCT00400946|3291580|P3|Overall Study|Other|0
1005460|NCT00400946|3291581|P2|Overall Study|Other|0
1005461|NCT00400946|3291582|P1|Overall Study|Other|0
1005462|NCT00400946|3291578|P5|Overall Study|Clinical|9
1005463|NCT00400946|3291579|P4|Overall Study|Clinical|2
1005464|NCT00400946|3291580|P3|Overall Study|Clinical|0
1005465|NCT00400946|3291581|P2|Overall Study|Clinical|2
1005466|NCT00400946|3291582|P1|Overall Study|Clinical|1
1005467|NCT00400946|3291578|P5|Overall Study|Withdrawal by Subject|8
1005468|NCT00400946|3291579|P4|Overall Study|Withdrawal by Subject|5
1005469|NCT00400946|3291580|P3|Overall Study|Withdrawal by Subject|1
1005470|NCT00400946|3291581|P2|Overall Study|Withdrawal by Subject|5
1005471|NCT00400946|3291582|P1|Overall Study|Withdrawal by Subject|2
1005472|NCT00400946|3291578|P5|Overall Study|Transplant in CR1|1
1005473|NCT00400946|3291579|P4|Overall Study|Transplant in CR1|10
1005474|NCT00400946|3291580|P3|Overall Study|Transplant in CR1|0
1005475|NCT00400946|3291581|P2|Overall Study|Transplant in CR1|0
1005476|NCT00400946|3291582|P1|Overall Study|Transplant in CR1|0
1005477|NCT00400946|3291578|P5|Overall Study|Relapse|5
1005478|NCT00400946|3291579|P4|Overall Study|Relapse|1
1005479|NCT00400946|3291580|P3|Overall Study|Relapse|1
1005480|NCT00400946|3291581|P2|Overall Study|Relapse|2
1005481|NCT00400946|3291582|P1|Overall Study|Relapse|9
1005482|NCT00400946|3291578|P5|Overall Study|Remission Death|1
1005483|NCT00400946|3291579|P4|Overall Study|Remission Death|0
1005484|NCT00400946|3291580|P3|Overall Study|Remission Death|0
1005485|NCT00400946|3291581|P2|Overall Study|Remission Death|1
1005486|NCT00400946|3291582|P1|Overall Study|Remission Death|1
1005487|NCT00400946|3291578|P5|Overall Study|Lost to Follow-up|1
1005488|NCT00400946|3291579|P4|Overall Study|Lost to Follow-up|0
1005489|NCT00400946|3291580|P3|Overall Study|Lost to Follow-up|0
1005490|NCT00400946|3291581|P2|Overall Study|Lost to Follow-up|1
1005491|NCT00400946|3291582|P1|Overall Study|Lost to Follow-up|1
1005492|NCT00400946|3291578|P5|Overall Study|Induction Death|3
1005493|NCT00400946|3291579|P4|Overall Study|Induction Death|13
1005494|NCT00400946|3291580|P3|Overall Study|Induction Death|0
1005495|NCT00400946|3291581|P2|Overall Study|Induction Death|0
1005496|NCT00400946|3291582|P1|Overall Study|Induction Death|0
1005497|NCT00400946|3291578|P5|Overall Study|Induction Failure|8
1005498|NCT00400946|3291579|P4|Overall Study|Induction Failure|11
1005499|NCT00400946|3291580|P3|Overall Study|Induction Failure|0
1005500|NCT00400946|3291581|P2|Overall Study|Induction Failure|0
1005501|NCT00400946|3291582|P1|Overall Study|Induction Failure|0
1005502|NCT00400946|3291578|P5|Overall Study|Ineligible|1
1005503|NCT00400946|3291579|P4|Overall Study|Ineligible|5
1005504|NCT00400946|3291580|P3|Overall Study|Ineligible|0
1005505|NCT00400946|3291581|P2|Overall Study|Ineligible|0
1005506|NCT00400946|3291582|P1|Overall Study|Ineligible|0
1005507|NCT00400764|3291641|P5|Phase II|Withdrawal by Subject|0
1005508|NCT00400764|3291642|P4|Phase II|Withdrawal by Subject|1
1005509|NCT00400764|3291643|P3|Phase II|Withdrawal by Subject|1
1005510|NCT00400764|3291644|P2|Phase II|Withdrawal by Subject|0
1005511|NCT00400764|3291645|P1|Phase II|Withdrawal by Subject|0
1005512|NCT00400764|3291641|P5|Phase II|Patient began new, non-protocol, therapy|0
1005513|NCT00400764|3291642|P4|Phase II|Patient began new, non-protocol, therapy|0
1005514|NCT00400764|3291643|P3|Phase II|Patient began new, non-protocol, therapy|1
1005515|NCT00400764|3291644|P2|Phase II|Patient began new, non-protocol, therapy|0
1005516|NCT00400764|3291645|P1|Phase II|Patient began new, non-protocol, therapy|0
1005517|NCT00400764|3291641|P5|Phase II|Sponsor’s decision to terminate|11
1005518|NCT00400764|3291642|P4|Phase II|Sponsor’s decision to terminate|22
1005519|NCT00400764|3291643|P3|Phase II|Sponsor’s decision to terminate|18
1005520|NCT00400764|3291644|P2|Phase II|Sponsor’s decision to terminate|0
1005521|NCT00400764|3291645|P1|Phase II|Sponsor’s decision to terminate|0
1005522|NCT00400764|3291641|P5|Phase II|Physician Decision|0
1005523|NCT00400764|3291642|P4|Phase II|Physician Decision|1
1005524|NCT00400764|3291643|P3|Phase II|Physician Decision|1
1005525|NCT00400764|3291644|P2|Phase II|Physician Decision|0
1005526|NCT00400764|3291645|P1|Phase II|Physician Decision|0
1005527|NCT00400764|3291641|P5|Phase II|Lost to Follow-up|0
1005528|NCT00400764|3291642|P4|Phase II|Lost to Follow-up|0
1005529|NCT00400764|3291643|P3|Phase II|Lost to Follow-up|1
1005530|NCT00400764|3291644|P2|Phase II|Lost to Follow-up|0
1005531|NCT00400764|3291645|P1|Phase II|Lost to Follow-up|0
1005532|NCT00400764|3291641|P5|Phase II|Death|0
1005533|NCT00400764|3291642|P4|Phase II|Death|2
1005534|NCT00400764|3291643|P3|Phase II|Death|1
1005535|NCT00400764|3291644|P2|Phase II|Death|0
1005536|NCT00400764|3291645|P1|Phase II|Death|0
1005537|NCT00400764|3291641|P5|Phase Ib|Disease Progression|0
1005538|NCT00400764|3291642|P4|Phase Ib|Disease Progression|0
1005539|NCT00400764|3291643|P3|Phase Ib|Disease Progression|0
1005540|NCT00400764|3291644|P2|Phase Ib|Disease Progression|4
1005541|NCT00400764|3291645|P1|Phase Ib|Disease Progression|4
1005542|NCT00400764|3291641|P5|Phase Ib|Death|0
1005543|NCT00400764|3291642|P4|Phase Ib|Death|0
1005544|NCT00400764|3291643|P3|Phase Ib|Death|0
1005545|NCT00400764|3291644|P2|Phase Ib|Death|0
1005546|NCT00400764|3291645|P1|Phase Ib|Death|1
1005547|NCT00400764|3291641|P5|Phase Ib|Adverse Event|0
1005548|NCT00400764|3291642|P4|Phase Ib|Adverse Event|0
1005549|NCT00400764|3291643|P3|Phase Ib|Adverse Event|0
1005550|NCT00400764|3291644|P2|Phase Ib|Adverse Event|0
1005551|NCT00400764|3291645|P1|Phase Ib|Adverse Event|1
1005552|NCT00400712|3291698|P2|Overall Study|Physician Decision|4
1005553|NCT00400712|3291699|P1|Overall Study|Physician Decision|5
1005554|NCT00400712|3291698|P2|Overall Study|Withdrawal by Subject|12
1005555|NCT00400712|3291699|P1|Overall Study|Withdrawal by Subject|11
1005556|NCT00400712|3291698|P2|Overall Study|Death|0
1005557|NCT00400712|3291699|P1|Overall Study|Death|1
1005558|NCT00400569|3291734|P1|Overall Study|Death|1
1005559|NCT00400517|3291745|P1|Overall Study|Physician Decision|1
1005560|NCT00400517|3291745|P1|Overall Study|Withdrawal by Subject|1
1005561|NCT00400400|3291754|P2|Overall Study|Did not receive study drug|3
1005562|NCT00400400|3291755|P1|Overall Study|Did not receive study drug|1
1005563|NCT00400400|3291754|P2|Overall Study|Lost to Follow-up|1
1005564|NCT00400400|3291755|P1|Overall Study|Lost to Follow-up|0
1005565|NCT00400400|3291754|P2|Overall Study|Administrative Problem|0
1005566|NCT00400400|3291755|P1|Overall Study|Administrative Problem|1
1005567|NCT00400400|3291754|P2|Overall Study|Withdrawal by Subject|3
1005568|NCT00400400|3291755|P1|Overall Study|Withdrawal by Subject|1
1005569|NCT00400400|3291754|P2|Overall Study|Protocol Violation|0
1005570|NCT00400400|3291755|P1|Overall Study|Protocol Violation|2
1005571|NCT00400400|3291754|P2|Overall Study|Adverse Event|8
1005572|NCT00400400|3291755|P1|Overall Study|Adverse Event|9
1005573|NCT00400179|3291780|P2|Overall Study|Randomization error/patient ineligible|6
1005574|NCT00400179|3291781|P1|Overall Study|Randomization error/patient ineligible|1
1005575|NCT00400179|3291780|P2|Overall Study|Investigator judgment|1
1005576|NCT00400179|3291781|P1|Overall Study|Investigator judgment|0
1005577|NCT00400179|3291780|P2|Overall Study|Intercurrent illness|1
1005578|NCT00400179|3291781|P1|Overall Study|Intercurrent illness|0
1005579|NCT00400179|3291780|P2|Overall Study|Disease progression|1
1005580|NCT00400179|3291781|P1|Overall Study|Disease progression|1
1005581|NCT00400179|3291780|P2|Overall Study|Withdrew Consent|5
1005582|NCT00400179|3291781|P1|Overall Study|Withdrew Consent|1
1005583|NCT00400179|3291780|P2|Overall Study|Death|2
1005584|NCT00400179|3291781|P1|Overall Study|Death|1
1005585|NCT00400179|3291780|P2|Overall Study|Adverse Event|2
1005586|NCT00400179|3291781|P1|Overall Study|Adverse Event|2
1005587|NCT00400153|3291798|P3|Overall Study|Other reasons - not mentioned above|3
1005588|NCT00400153|3291799|P2|Overall Study|Other reasons - not mentioned above|5
1005589|NCT00400153|3291800|P1|Overall Study|Other reasons - not mentioned above|8
1005590|NCT00400153|3291798|P3|Overall Study|Withdrawal by Subject|10
1005591|NCT00400153|3291799|P2|Overall Study|Withdrawal by Subject|11
1005592|NCT00400153|3291800|P1|Overall Study|Withdrawal by Subject|12
1005593|NCT00400153|3291798|P3|Overall Study|Lost to Follow-up|4
1005594|NCT00400153|3291799|P2|Overall Study|Lost to Follow-up|1
1005595|NCT00400153|3291800|P1|Overall Study|Lost to Follow-up|2
1005596|NCT00400153|3291798|P3|Overall Study|Protocol Violation|9
1005597|NCT00400153|3291799|P2|Overall Study|Protocol Violation|4
1005598|NCT00400153|3291800|P1|Overall Study|Protocol Violation|7
1005599|NCT00400153|3291798|P3|Overall Study|AE due to other condition|15
1005600|NCT00400153|3291799|P2|Overall Study|AE due to other condition|14
1005601|NCT00400153|3291800|P1|Overall Study|AE due to other condition|3
1005602|NCT00400153|3291798|P3|Overall Study|AE due to other disease worsening|0
1005603|NCT00400153|3291799|P2|Overall Study|AE due to other disease worsening|1
1005604|NCT00400153|3291800|P1|Overall Study|AE due to other disease worsening|2
1005605|NCT00400153|3291798|P3|Overall Study|AE due to study disease worsening|20
1005606|NCT00400153|3291799|P2|Overall Study|AE due to study disease worsening|19
1005607|NCT00400153|3291800|P1|Overall Study|AE due to study disease worsening|14
1005608|NCT00399893|3292047|P2|Overall Study|Withdrawal by Subject|0
1005609|NCT00399893|3292048|P1|Overall Study|Withdrawal by Subject|1
1005610|NCT00399802|3292087|P2|Overall Study|Participant discontinued by mistake|1
1005611|NCT00399802|3292088|P1|Overall Study|Participant discontinued by mistake|0
1005612|NCT00399802|3292087|P2|Overall Study|Adverse Event|2
1005613|NCT00399802|3292088|P1|Overall Study|Adverse Event|0
1005614|NCT00399763|3292102|P2|Overall Study|Lost to Follow-up|3
1005615|NCT00399763|3292103|P1|Overall Study|Lost to Follow-up|2
1005616|NCT00399568|3292115|P2|Overall Study|Lost to Follow-up|2
1005617|NCT00399568|3292116|P1|Overall Study|Lost to Follow-up|2
1005618|NCT00399568|3292115|P2|Overall Study|Protocol non-compliance|2
1005619|NCT00399568|3292116|P1|Overall Study|Protocol non-compliance|2
1005620|NCT00399568|3292115|P2|Overall Study|Withdrawal by Subject|3
1005621|NCT00399568|3292116|P1|Overall Study|Withdrawal by Subject|7
1005622|NCT00399568|3292115|P2|Overall Study|Adverse Event|2
1005623|NCT00399568|3292116|P1|Overall Study|Adverse Event|1
1005624|NCT00399542|3292130|P2|Overall Study|Physician Decision|1
1005625|NCT00399542|3292131|P1|Overall Study|Physician Decision|0
1005626|NCT00399542|3292130|P2|Overall Study|Other|0
1005627|NCT00399542|3292131|P1|Overall Study|Other|1
1005628|NCT00399542|3292130|P2|Overall Study|Lost to Follow-up|6
1005629|NCT00399542|3292131|P1|Overall Study|Lost to Follow-up|6
1005630|NCT00399542|3292130|P2|Overall Study|Lack of Efficacy|8
1005631|NCT00399542|3292131|P1|Overall Study|Lack of Efficacy|18
1005632|NCT00399542|3292130|P2|Overall Study|Withdrawal by Subject|10
1005633|NCT00399542|3292131|P1|Overall Study|Withdrawal by Subject|28
1005634|NCT00399542|3292130|P2|Overall Study|Protocol Violation|3
1005635|NCT00399542|3292131|P1|Overall Study|Protocol Violation|13
1005636|NCT00399542|3292130|P2|Overall Study|Adverse Event|15
1005637|NCT00399542|3292131|P1|Overall Study|Adverse Event|18
1005638|NCT00399516|3292193|P1|Overall Study|Lost to Follow-up|2
1005639|NCT00399360|3292201|P4|Overall Study|Withdrawal by Subject|2
1005640|NCT00399360|3292202|P3|Overall Study|Withdrawal by Subject|0
1005641|NCT00399360|3292203|P2|Overall Study|Withdrawal by Subject|2
1005642|NCT00399360|3292204|P1|Overall Study|Withdrawal by Subject|0
1005643|NCT00399360|3292201|P4|Overall Study|Adverse Event|0
1005644|NCT00399360|3292202|P3|Overall Study|Adverse Event|1
1005645|NCT00399360|3292203|P2|Overall Study|Adverse Event|0
1005646|NCT00399360|3292204|P1|Overall Study|Adverse Event|0
1005647|NCT00399360|3292201|P4|Overall Study|Lost to Follow-up|4
1005648|NCT00399360|3292202|P3|Overall Study|Lost to Follow-up|2
1005649|NCT00399360|3292203|P2|Overall Study|Lost to Follow-up|1
1005650|NCT00399360|3292204|P1|Overall Study|Lost to Follow-up|2
1005651|NCT00399035|3292275|P3|Overall Study|Severe non-compliance with protocol|0
1005652|NCT00399035|3292276|P2|Overall Study|Severe non-compliance with protocol|1
1005653|NCT00399035|3292277|P1|Overall Study|Severe non-compliance with protocol|2
1005654|NCT00399035|3292275|P3|Overall Study|Incorrect enrolment/eligib not fulfilled|1
1005655|NCT00399035|3292276|P2|Overall Study|Incorrect enrolment/eligib not fulfilled|0
1005656|NCT00399035|3292277|P1|Overall Study|Incorrect enrolment/eligib not fulfilled|1
1005657|NCT00399035|3292275|P3|Overall Study|Withdrawal by Subject|12
1005658|NCT00399035|3292276|P2|Overall Study|Withdrawal by Subject|15
1005659|NCT00399035|3292277|P1|Overall Study|Withdrawal by Subject|19
1005660|NCT00399035|3292275|P3|Overall Study|Lost to Follow-up|5
1005661|NCT00399035|3292276|P2|Overall Study|Lost to Follow-up|1
1005662|NCT00399035|3292277|P1|Overall Study|Lost to Follow-up|2
1005663|NCT00399035|3292275|P3|Overall Study|Death|234
1005664|NCT00399035|3292276|P2|Overall Study|Death|141
1005665|NCT00399035|3292277|P1|Overall Study|Death|289
1005666|NCT00398866|3292313|P3|Overall Study|Unable to complete requirements of study|1
1005667|NCT00398866|3292314|P2|Overall Study|Unable to complete requirements of study|1
1005668|NCT00398866|3292315|P1|Overall Study|Unable to complete requirements of study|1
1005669|NCT00398866|3292313|P3|Overall Study|Withdrawal by Subject|2
1005670|NCT00398866|3292314|P2|Overall Study|Withdrawal by Subject|1
1005671|NCT00398866|3292315|P1|Overall Study|Withdrawal by Subject|5
1005672|NCT00398866|3292313|P3|Overall Study|Lost to Follow-up|4
1005673|NCT00398866|3292314|P2|Overall Study|Lost to Follow-up|6
1005674|NCT00398866|3292315|P1|Overall Study|Lost to Follow-up|7
1005675|NCT00398866|3292313|P3|Overall Study|Lack of Efficacy|1
1005676|NCT00398866|3292314|P2|Overall Study|Lack of Efficacy|0
1005677|NCT00398866|3292315|P1|Overall Study|Lack of Efficacy|0
1005678|NCT00398866|3292313|P3|Overall Study|Adverse Event|0
1005679|NCT00398866|3292314|P2|Overall Study|Adverse Event|0
1005680|NCT00398866|3292315|P1|Overall Study|Adverse Event|1
1005681|NCT00398632|3292326|P1|Overall Study|Lack of Efficacy|1
1005682|NCT00398632|3292326|P1|Overall Study|Withdrawal by Subject|1
1005683|NCT00398567|3292334|P3|Overall Study|Protocol Violation|1
1005684|NCT00398567|3292335|P2|Overall Study|Protocol Violation|0
1005685|NCT00398567|3292336|P1|Overall Study|Protocol Violation|0
1005686|NCT00398567|3292334|P3|Overall Study|Adverse Event|2
1005687|NCT00398567|3292335|P2|Overall Study|Adverse Event|0
1005688|NCT00398567|3292336|P1|Overall Study|Adverse Event|0
1005689|NCT00398567|3292334|P3|Overall Study|Withdrawal by Subject|4
1005690|NCT00398567|3292335|P2|Overall Study|Withdrawal by Subject|0
1005691|NCT00398567|3292336|P1|Overall Study|Withdrawal by Subject|1
1005692|NCT00398567|3292334|P3|Overall Study|Disease Progression|27
1005693|NCT00398567|3292335|P2|Overall Study|Disease Progression|4
1005694|NCT00398567|3292336|P1|Overall Study|Disease Progression|3
1005695|NCT00398411|3292390|P2|Overall Study|Death|1
1005696|NCT00398411|3292391|P1|Overall Study|Death|0
1005697|NCT00398320|3292414|P1|Overall Study|Physician Decision|1
1005698|NCT00398320|3292414|P1|Overall Study|Adverse Event|4
1005699|NCT00398320|3292414|P1|Overall Study|Death|1
1005700|NCT00398216|3292427|P5|Overall Study|entrance criteria|2
1005701|NCT00398216|3292428|P4|Overall Study|entrance criteria|0
1005702|NCT00398216|3292429|P3|Overall Study|entrance criteria|0
1005703|NCT00398216|3292430|P2|Overall Study|entrance criteria|0
1005704|NCT00398216|3292431|P1|Overall Study|entrance criteria|0
1005705|NCT00398216|3292427|P5|Overall Study|administrative reasons|3
1005706|NCT00398216|3292428|P4|Overall Study|administrative reasons|3
1005707|NCT00398216|3292429|P3|Overall Study|administrative reasons|4
1005708|NCT00398216|3292430|P2|Overall Study|administrative reasons|4
1005709|NCT00398216|3292431|P1|Overall Study|administrative reasons|3
1005710|NCT00398216|3292427|P5|Overall Study|Withdrawal by Subject|2
1005711|NCT00398216|3292428|P4|Overall Study|Withdrawal by Subject|1
1005712|NCT00398216|3292429|P3|Overall Study|Withdrawal by Subject|3
1005713|NCT00398216|3292430|P2|Overall Study|Withdrawal by Subject|0
1005714|NCT00398216|3292431|P1|Overall Study|Withdrawal by Subject|1
1005715|NCT00398216|3292427|P5|Overall Study|Death|0
1005716|NCT00398216|3292428|P4|Overall Study|Death|0
1005717|NCT00398216|3292429|P3|Overall Study|Death|0
1005718|NCT00398216|3292430|P2|Overall Study|Death|3
1005719|NCT00398216|3292431|P1|Overall Study|Death|0
1005720|NCT00398216|3292427|P5|Overall Study|Lost to Follow-up|1
1005721|NCT00398216|3292428|P4|Overall Study|Lost to Follow-up|4
1005722|NCT00398216|3292429|P3|Overall Study|Lost to Follow-up|4
1005723|NCT00398216|3292430|P2|Overall Study|Lost to Follow-up|6
1005724|NCT00398216|3292431|P1|Overall Study|Lost to Follow-up|1
1005725|NCT00398216|3292427|P5|Overall Study|Protocol Violation|5
1005726|NCT00398216|3292428|P4|Overall Study|Protocol Violation|7
1005727|NCT00398216|3292429|P3|Overall Study|Protocol Violation|5
1005728|NCT00398216|3292430|P2|Overall Study|Protocol Violation|4
1005729|NCT00398216|3292431|P1|Overall Study|Protocol Violation|2
1005730|NCT00398216|3292427|P5|Overall Study|Adverse Event|2
1005731|NCT00398216|3292428|P4|Overall Study|Adverse Event|7
1005732|NCT00398216|3292429|P3|Overall Study|Adverse Event|5
1005733|NCT00398216|3292430|P2|Overall Study|Adverse Event|2
1005734|NCT00398216|3292431|P1|Overall Study|Adverse Event|4
1005735|NCT00398138|3292458|P1|Overall Study|Adverse Event|2
1005736|NCT00398112|3292463|P1|Overall Study|Death|1
1005737|NCT00398112|3292463|P1|Overall Study|Withdrawal by Subject|3
1005738|NCT00398112|3292463|P1|Overall Study|Alternative treatment|1
1005739|NCT00398112|3292463|P1|Overall Study|Disease progression|9
1005740|NCT00398112|3292463|P1|Overall Study|Adverse Event|4
1005741|NCT00398086|3292474|P3|Overall Study|Withdrawal by Subject|0
1005742|NCT00398086|3292475|P2|Overall Study|Withdrawal by Subject|7
1005743|NCT00398086|3292476|P1|Overall Study|Withdrawal by Subject|5
1005744|NCT00398086|3292474|P3|Overall Study|Physician Decision|0
1005745|NCT00398086|3292475|P2|Overall Study|Physician Decision|4
1005746|NCT00398086|3292476|P1|Overall Study|Physician Decision|1
1005747|NCT00398086|3292474|P3|Overall Study|Adverse Event|0
1005748|NCT00398086|3292475|P2|Overall Study|Adverse Event|4
1005749|NCT00398086|3292476|P1|Overall Study|Adverse Event|1
1005750|NCT00398086|3292474|P3|Overall Study|Unacceptable Toxicity|2
1005751|NCT00398086|3292475|P2|Overall Study|Unacceptable Toxicity|8
1005752|NCT00398086|3292476|P1|Overall Study|Unacceptable Toxicity|2
1005753|NCT00398073|3292510|P2|Overall Study|Withdrawal by Subject|0
1005754|NCT00398073|3292511|P1|Overall Study|Withdrawal by Subject|1
1005755|NCT00398047|3292521|P1|Overall Study|all patient progressed before completion|3
1005756|NCT00397982|3292531|P1|Overall Study|Unrelated health issues|1
1005757|NCT00397982|3292531|P1|Overall Study|noncompliance|1
1005758|NCT00397982|3292531|P1|Overall Study|Adverse Event|1
1005759|NCT00397982|3292531|P1|Overall Study|Withdrawal by Subject|1
1005760|NCT00397943|3292545|P5|Overall Study|Unspecified reasons|0
1005761|NCT00397943|3292546|P4|Overall Study|Unspecified reasons|0
1005762|NCT00397943|3292547|P3|Overall Study|Unspecified reasons|0
1005763|NCT00397943|3292548|P2|Overall Study|Unspecified reasons|9
1005764|NCT00397943|3292549|P1|Overall Study|Unspecified reasons|12
1005765|NCT00397930|3292705|P2|Overall Study|Missing data|4
1005766|NCT00397930|3292706|P1|Overall Study|Missing data|0
1005767|NCT00397930|3292705|P2|Overall Study|Withdrawal by Subject|8
1005768|NCT00397930|3292706|P1|Overall Study|Withdrawal by Subject|0
1005769|NCT00397930|3292705|P2|Overall Study|Did not want to be in control group|1
1005770|NCT00397930|3292706|P1|Overall Study|Did not want to be in control group|0
1005771|NCT00397930|3292705|P2|Overall Study|Started own yoga program|1
1005772|NCT00397930|3292706|P1|Overall Study|Started own yoga program|1
1005773|NCT00397930|3292705|P2|Overall Study|Too time-consuming|9
1005774|NCT00397930|3292706|P1|Overall Study|Too time-consuming|2
1005775|NCT00397930|3292705|P2|Overall Study|Noncompliant|2
1005776|NCT00397930|3292706|P1|Overall Study|Noncompliant|3
1005777|NCT00397930|3292705|P2|Overall Study|Unknown reasons|14
1005778|NCT00397930|3292706|P1|Overall Study|Unknown reasons|9
1005779|NCT00397930|3292705|P2|Overall Study|Other medical|4
1005780|NCT00397930|3292706|P1|Overall Study|Other medical|9
1005781|NCT00397930|3292705|P2|Overall Study|Personal reasons|8
1005782|NCT00397930|3292706|P1|Overall Study|Personal reasons|14
1005783|NCT00397891|3292721|P5|Overall Study|Withdrawal by Subject|1
1005784|NCT00397891|3292722|P4|Overall Study|Withdrawal by Subject|0
1005785|NCT00397891|3292723|P3|Overall Study|Withdrawal by Subject|0
1005786|NCT00397891|3292724|P2|Overall Study|Withdrawal by Subject|0
1005787|NCT00397891|3292725|P1|Overall Study|Withdrawal by Subject|1
1005788|NCT00397631|3292895|P2|Overall Study|protocol discontinuation criteria|4
1005789|NCT00397631|3292896|P1|Overall Study|protocol discontinuation criteria|1
1005790|NCT00397631|3292895|P2|Overall Study|Withdrawal by Subject|14
1005791|NCT00397631|3292896|P1|Overall Study|Withdrawal by Subject|7
1005792|NCT00397631|3292895|P2|Overall Study|Protocol Violation|1
1005793|NCT00397631|3292896|P1|Overall Study|Protocol Violation|0
1005794|NCT00397631|3292895|P2|Overall Study|Physician Decision|0
1005795|NCT00397631|3292896|P1|Overall Study|Physician Decision|2
1005796|NCT00397631|3292895|P2|Overall Study|Lost to Follow-up|9
1005797|NCT00397631|3292896|P1|Overall Study|Lost to Follow-up|8
1005798|NCT00397631|3292895|P2|Overall Study|Lack of Efficacy|10
1005799|NCT00397631|3292896|P1|Overall Study|Lack of Efficacy|7
1005800|NCT00397631|3292895|P2|Overall Study|Adverse Event|6
1005801|NCT00397631|3292896|P1|Overall Study|Adverse Event|5
1005802|NCT00397540|3292908|P2|Overall Study|short follow-up duration < 12 months|0
1005803|NCT00397540|3292909|P1|Overall Study|short follow-up duration < 12 months|1
1005804|NCT00397514|3292915|P1|Overall Study|poor echocardiographic windows|1
1005805|NCT00397514|3292915|P1|Overall Study|early extubation|2
1005806|NCT00397514|3292915|P1|Overall Study|Not able to capture & pace LV intraoper.|4
1005807|NCT00397514|3292915|P1|Overall Study|Pacing wire malfunction|1
1005808|NCT00397514|3292915|P1|Overall Study|Withdrawal by Subject|1
1005809|NCT00397488|3292925|P1|Overall Study|Death|1
1005810|NCT00397488|3292925|P1|Overall Study|Adverse Event|3
1005811|NCT00397488|3292925|P1|Overall Study|Withdrawal by Subject|3
1005812|NCT00397254|3292945|P2|Overall Study|Lost to Follow-up|2
1005813|NCT00397254|3292946|P1|Overall Study|Lost to Follow-up|2
1005814|NCT00397215|3292968|P4|Month 6 (Day 180)|Other|0
1005815|NCT00397215|3292969|P3|Month 6 (Day 180)|Other|3
1005816|NCT00397215|3292970|P2|Month 6 (Day 180)|Other|0
1005817|NCT00397215|3292971|P1|Month 6 (Day 180)|Other|2
1005818|NCT00397215|3292968|P4|Month 6 (Day 180)|Adverse Event|0
1005819|NCT00397215|3292969|P3|Month 6 (Day 180)|Adverse Event|2
1005820|NCT00397215|3292970|P2|Month 6 (Day 180)|Adverse Event|3
1005821|NCT00397215|3292971|P1|Month 6 (Day 180)|Adverse Event|0
1005822|NCT00397215|3292968|P4|Month 0 (Day 0)|Other|3
1005823|NCT00397215|3292969|P3|Month 0 (Day 0)|Other|3
1005824|NCT00397215|3292970|P2|Month 0 (Day 0)|Other|1
1005825|NCT00397215|3292971|P1|Month 0 (Day 0)|Other|4
1005826|NCT00397215|3292968|P4|Month 0 (Day 0)|Withdrawal by Subject|1
1005827|NCT00397215|3292969|P3|Month 0 (Day 0)|Withdrawal by Subject|3
1005828|NCT00397215|3292970|P2|Month 0 (Day 0)|Withdrawal by Subject|3
1005829|NCT00397215|3292971|P1|Month 0 (Day 0)|Withdrawal by Subject|3
1005830|NCT00397215|3292968|P4|Month 0 (Day 0)|Adverse Event|0
1005831|NCT00397215|3292969|P3|Month 0 (Day 0)|Adverse Event|0
1005832|NCT00397215|3292970|P2|Month 0 (Day 0)|Adverse Event|1
1005833|NCT00397215|3292971|P1|Month 0 (Day 0)|Adverse Event|0
1005834|NCT00397189|3293107|P2|3 Weeks Period|Other|2
1005835|NCT00397189|3293108|P1|3 Weeks Period|Other|0
1005836|NCT00397189|3293107|P2|3 Weeks Period|Protocol Violation|3
1005837|NCT00397189|3293108|P1|3 Weeks Period|Protocol Violation|0
1005838|NCT00397189|3293107|P2|3 Weeks Period|Physician Decision|2
1005839|NCT00397189|3293108|P1|3 Weeks Period|Physician Decision|0
1005840|NCT00397189|3293107|P2|3 Weeks Period|Withdrawal by Subject|9
1005841|NCT00397189|3293108|P1|3 Weeks Period|Withdrawal by Subject|13
1005842|NCT00397189|3293107|P2|3 Weeks Period|Adverse Event|2
1005843|NCT00397189|3293108|P1|3 Weeks Period|Adverse Event|3
1005844|NCT00397189|3293107|P2|3 Weeks Period|Lost to Follow-up|4
1005845|NCT00397189|3293108|P1|3 Weeks Period|Lost to Follow-up|5
1005846|NCT00397046|3293135|P4|Overall Study|Disease Progression|5
1005847|NCT00397046|3293136|P3|Overall Study|Disease Progression|10
1005848|NCT00397046|3293137|P2|Overall Study|Disease Progression|3
1005849|NCT00397046|3293138|P1|Overall Study|Disease Progression|3
1005850|NCT00397033|3293160|P3|Overall Study|Other|2
1005851|NCT00397033|3293161|P2|Overall Study|Other|5
1005852|NCT00397033|3293162|P1|Overall Study|Other|0
1005853|NCT00397033|3293160|P3|Overall Study|Withdrawal by Subject|5
1005854|NCT00397033|3293161|P2|Overall Study|Withdrawal by Subject|7
1005855|NCT00397033|3293162|P1|Overall Study|Withdrawal by Subject|12
1005856|NCT00397033|3293160|P3|Overall Study|Lost to Follow-up|3
1005857|NCT00397033|3293161|P2|Overall Study|Lost to Follow-up|3
1005858|NCT00397033|3293162|P1|Overall Study|Lost to Follow-up|3
1005859|NCT00397033|3293160|P3|Overall Study|Lack of Efficacy|9
1005860|NCT00397033|3293161|P2|Overall Study|Lack of Efficacy|12
1005861|NCT00397033|3293162|P1|Overall Study|Lack of Efficacy|22
1005862|NCT00397033|3293160|P3|Overall Study|Adverse Event|4
1005863|NCT00397033|3293161|P2|Overall Study|Adverse Event|10
1005864|NCT00397033|3293162|P1|Overall Study|Adverse Event|7
1005865|NCT00396877|3293244|P2|Overall Study|Parent(s)/guardian(s)'s request|7
1005866|NCT00396877|3293245|P1|Overall Study|Parent(s)/guardian(s)'s request|4
1005867|NCT00396877|3293244|P2|Overall Study|Lost to Follow-up|1
1005868|NCT00396877|3293245|P1|Overall Study|Lost to Follow-up|2
1005869|NCT00396812|3293255|P1|Overall Study|Physician Decision|1
1005870|NCT00396656|3293267|P2|Second Treatment Period|Adverse Event|1
1005871|NCT00396656|3293268|P1|Second Treatment Period|Adverse Event|0
1005872|NCT00396656|3293267|P2|First Treatment Period|Withdrawal by Subject|2
1005873|NCT00396656|3293268|P1|First Treatment Period|Withdrawal by Subject|0
1005874|NCT00396630|3293286|P2|Overall Study|Not vaccinated at Visit 3|3
1005875|NCT00396630|3293287|P1|Overall Study|Not vaccinated at Visit 3|3
1005876|NCT00396630|3293286|P2|Overall Study|Withdrawal by Subject|1
1005877|NCT00396630|3293287|P1|Overall Study|Withdrawal by Subject|1
1005878|NCT00396630|3293286|P2|Overall Study|Lost to Follow-up|1
1005879|NCT00396630|3293287|P1|Overall Study|Lost to Follow-up|1
1005880|NCT00396591|3293307|P1|Overall Study|Participant request|1
1005881|NCT00396591|3293307|P1|Overall Study|Adverse Event|2
1005882|NCT00396591|3293307|P1|Overall Study|Disease Progression|13
1005883|NCT00396565|3293320|P3|Overall Study|Lack of Efficacy|11
1005884|NCT00396565|3293321|P2|Overall Study|Lack of Efficacy|64
1005885|NCT00396565|3293322|P1|Overall Study|Lack of Efficacy|32
1005886|NCT00396565|3293320|P3|Overall Study|Withdrawal by Subject|1
1005887|NCT00396565|3293321|P2|Overall Study|Withdrawal by Subject|13
1005888|NCT00396565|3293322|P1|Overall Study|Withdrawal by Subject|8
1005889|NCT00396565|3293320|P3|Overall Study|Adverse Event|3
1005890|NCT00396565|3293321|P2|Overall Study|Adverse Event|13
1005891|NCT00396565|3293322|P1|Overall Study|Adverse Event|5
1005892|NCT00396565|3293320|P3|Overall Study|Physician Decision|2
1005893|NCT00396565|3293321|P2|Overall Study|Physician Decision|1
1005894|NCT00396565|3293322|P1|Overall Study|Physician Decision|3
1005895|NCT00396409|3293347|P2|Period 2 - 2008|Lost to Follow-up|1
1005896|NCT00396409|3293348|P1|Period 2 - 2008|Lost to Follow-up|3
1005897|NCT00396409|3293347|P2|Period 2 - 2008|Withdrawal by Subject|1
1005898|NCT00396409|3293348|P1|Period 2 - 2008|Withdrawal by Subject|3
1005899|NCT00396409|3293347|P2|Period 2 - 2008|Protocol Violation|0
1005900|NCT00396409|3293348|P1|Period 2 - 2008|Protocol Violation|1
1005901|NCT00396409|3293347|P2|Between Period 1 and Period 2|Withdrawal by Subject|2
1005902|NCT00396409|3293348|P1|Between Period 1 and Period 2|Withdrawal by Subject|3
1005903|NCT00396409|3293347|P2|Period 1 - 2007|Lost to Follow-up|3
1005904|NCT00396409|3293348|P1|Period 1 - 2007|Lost to Follow-up|2
1005905|NCT00396409|3293347|P2|Period 1 - 2007|Withdrawal by Subject|1
1005906|NCT00396409|3293348|P1|Period 1 - 2007|Withdrawal by Subject|1
1005907|NCT00396409|3293347|P2|Period 1 - 2007|Lack of Efficacy|1
1005908|NCT00396409|3293348|P1|Period 1 - 2007|Lack of Efficacy|0
1005909|NCT00396409|3293347|P2|Period 1 - 2007|Adverse Event|1
1005910|NCT00396409|3293348|P1|Period 1 - 2007|Adverse Event|0
1005911|NCT00396383|3293378|P1|Overall Study|Lost to Follow-up|1
1005912|NCT00396383|3293378|P1|Overall Study|Death|2
1005913|NCT00396331|3293391|P1|Overall Study|Death|16
1005914|NCT00396331|3293391|P1|Overall Study|Lost to Follow-up|3
1005915|NCT00396331|3293391|P1|Overall Study|Did not go on to transplant|5
1005916|NCT00396331|3293391|P1|Overall Study|Failed to mobilize - no transplant|8
1005917|NCT00396318|3293444|P1|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5
1005918|NCT00396279|3293464|P1|Overall Study|Physician Decision|1
1005919|NCT00396279|3293464|P1|Overall Study|Withdrawal by Subject|1
1005920|NCT00396279|3293464|P1|Overall Study|Disease progression|2
1005921|NCT00396279|3293464|P1|Overall Study|Ongoing in study|26
1005922|NCT00396253|3293497|P1|Overall Study|Change in eligibility status|1
1005923|NCT00396253|3293497|P1|Overall Study|Physician Decision|1
1005924|NCT00396253|3293497|P1|Overall Study|Death|3
1005925|NCT00396253|3293497|P1|Overall Study|Withdrawal by Subject|7
1005926|NCT00396253|3293497|P1|Overall Study|Protocol Violation|1
1005927|NCT00396162|3293528|P2|Overall Study|Withdrawal by Subject|3
1005928|NCT00396162|3293529|P1|Overall Study|Withdrawal by Subject|2
1005929|NCT00396136|3293541|P1|Overall Study|Study device explanted|8
1005930|NCT00396136|3293541|P1|Overall Study|Lost to Follow-up|15
1005931|NCT00396136|3293541|P1|Overall Study|Withdrawal by Subject|59
1005932|NCT00396136|3293541|P1|Overall Study|Death|43
1005933|NCT00396097|3293548|P2|Overall Study|Insufficient Clinical Response|4
1005934|NCT00396097|3293549|P1|Overall Study|Insufficient Clinical Response|1
1005935|NCT00396097|3293548|P2|Overall Study|Adverse Event|5
1005936|NCT00396097|3293549|P1|Overall Study|Adverse Event|1
1005937|NCT00396097|3293548|P2|Overall Study|Protocol Violation|6
1005938|NCT00396097|3293549|P1|Overall Study|Protocol Violation|0
1005939|NCT00396097|3293548|P2|Overall Study|Not specified|5
1005940|NCT00396097|3293549|P1|Overall Study|Not specified|3
1005941|NCT00396097|3293548|P2|Overall Study|Lost to Follow-up|9
1005942|NCT00396097|3293549|P1|Overall Study|Lost to Follow-up|4
1005943|NCT00396097|3293548|P2|Overall Study|Withdrawal by Subject|17
1005944|NCT00396097|3293549|P1|Overall Study|Withdrawal by Subject|17
1005945|NCT00396084|3293577|P6|Overall Study|Withdrawal by Subject|0
1005946|NCT00396084|3293578|P5|Overall Study|Withdrawal by Subject|0
1005947|NCT00396084|3293579|P4|Overall Study|Withdrawal by Subject|1
1005948|NCT00396084|3293580|P3|Overall Study|Withdrawal by Subject|0
1005949|NCT00396084|3293581|P2|Overall Study|Withdrawal by Subject|0
1005950|NCT00396084|3293582|P1|Overall Study|Withdrawal by Subject|0
1005951|NCT00396084|3293577|P6|Overall Study|Adverse Event|2
1005952|NCT00396084|3293578|P5|Overall Study|Adverse Event|1
1005953|NCT00396084|3293579|P4|Overall Study|Adverse Event|0
1005954|NCT00396084|3293580|P3|Overall Study|Adverse Event|0
1005955|NCT00396084|3293581|P2|Overall Study|Adverse Event|0
1005956|NCT00396084|3293582|P1|Overall Study|Adverse Event|0
1005957|NCT00395967|3293711|P1|Follow-up Period|Lost to Follow-up|1
1005958|NCT00395967|3293711|P1|Follow-up Period|Death|1
1005959|NCT00395967|3293711|P1|Treatment Period|Failed Mobilization|1
1005960|NCT00395863|3293751|P2|Overall Study|Patients did not complete both exams|3
1005961|NCT00395863|3293752|P1|Overall Study|Patients did not complete both exams|2
1005962|NCT00395850|3293787|P4|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
1005963|NCT00395850|3293788|P3|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
1005964|NCT00395850|3293789|P2|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
1005965|NCT00395850|3293790|P1|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1
1005966|NCT00395850|3293787|P4|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
1005967|NCT00395850|3293788|P3|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
1005968|NCT00395850|3293789|P2|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
1005969|NCT00395850|3293790|P1|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1
1005970|NCT00395850|3293787|P4|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
1005971|NCT00395850|3293788|P3|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
1005972|NCT00395850|3293789|P2|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
1005973|NCT00395850|3293790|P1|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1
1005974|NCT00395850|3293787|P4|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4
1005975|NCT00395850|3293788|P3|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6
1005976|NCT00395850|3293789|P2|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
1005977|NCT00395850|3293790|P1|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
1005978|NCT00395850|3293787|P4|Pre-randomization Baseline/Induction|Inconsistent attendance|0
1005979|NCT00395850|3293788|P3|Pre-randomization Baseline/Induction|Inconsistent attendance|0
1005980|NCT00395850|3293789|P2|Pre-randomization Baseline/Induction|Inconsistent attendance|0
1005981|NCT00395850|3293790|P1|Pre-randomization Baseline/Induction|Inconsistent attendance|1
1005982|NCT00395850|3293787|P4|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
1005983|NCT00395850|3293788|P3|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
1005984|NCT00395850|3293789|P2|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
1005985|NCT00395850|3293790|P1|Pre-randomization Baseline/Induction|Withdrawal by Subject|4
1005986|NCT00395850|3293787|P4|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
1005987|NCT00395850|3293788|P3|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
1005988|NCT00395850|3293789|P2|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
1005989|NCT00395850|3293790|P1|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6
1005990|NCT00395746|3293807|P3|Overall Study|Unable to visit site on schedule|0
1005991|NCT00395746|3293808|P2|Overall Study|Unable to visit site on schedule|0
1005992|NCT00395746|3293809|P1|Overall Study|Unable to visit site on schedule|1
1005993|NCT00395746|3293807|P3|Overall Study|Difficultulty in use of device|1
1005994|NCT00395746|3293808|P2|Overall Study|Difficultulty in use of device|0
1005995|NCT00395746|3293809|P1|Overall Study|Difficultulty in use of device|0
1005996|NCT00395746|3293807|P3|Overall Study|Withdrawal of consent|1
1005997|NCT00395746|3293808|P2|Overall Study|Withdrawal of consent|0
1005998|NCT00395746|3293809|P1|Overall Study|Withdrawal of consent|0
1005999|NCT00395746|3293807|P3|Overall Study|Subject decision|1
1006000|NCT00395746|3293808|P2|Overall Study|Subject decision|0
1006001|NCT00395746|3293809|P1|Overall Study|Subject decision|0
1006002|NCT00395746|3293807|P3|Overall Study|Hypoglycaemia|0
1006003|NCT00395746|3293808|P2|Overall Study|Hypoglycaemia|1
1006004|NCT00395746|3293809|P1|Overall Study|Hypoglycaemia|2
1006005|NCT00395746|3293807|P3|Overall Study|Lack of Efficacy|17
1006006|NCT00395746|3293808|P2|Overall Study|Lack of Efficacy|0
1006007|NCT00395746|3293809|P1|Overall Study|Lack of Efficacy|2
1006008|NCT00395746|3293807|P3|Overall Study|Protocol Violation|0
1006009|NCT00395746|3293808|P2|Overall Study|Protocol Violation|1
1006010|NCT00395746|3293809|P1|Overall Study|Protocol Violation|0
1006011|NCT00395746|3293807|P3|Overall Study|Adverse Event|2
1006012|NCT00395746|3293808|P2|Overall Study|Adverse Event|2
1006013|NCT00395746|3293809|P1|Overall Study|Adverse Event|5
1006014|NCT00395733|3293855|P2|Period 2|Technical problems|0
1006015|NCT00395733|3293856|P1|Period 2|Technical problems|1
1006016|NCT00395733|3293855|P2|Period 2|Adverse Event|2
1006017|NCT00395733|3293856|P1|Period 2|Adverse Event|0
1006018|NCT00395733|3293855|P2|Period 2|Protocol Violation|1
1006019|NCT00395733|3293856|P1|Period 2|Protocol Violation|0
1006020|NCT00395733|3293855|P2|Period 2|Withdrawal by Subject|2
1006021|NCT00395733|3293856|P1|Period 2|Withdrawal by Subject|1
1006022|NCT00395694|3293880|P2|Continuation Phase|Withdrawal by Subject|2
1006023|NCT00395694|3293881|P1|Continuation Phase|Withdrawal by Subject|0
1006024|NCT00395694|3293880|P2|Continuation Phase|Poor Compliance|0
1006025|NCT00395694|3293881|P1|Continuation Phase|Poor Compliance|1
1006026|NCT00395694|3293880|P2|Continuation Phase|Withdrawal Due to Wishes of Family|0
1006027|NCT00395694|3293881|P1|Continuation Phase|Withdrawal Due to Wishes of Family|1
1006028|NCT00395694|3293880|P2|Continuation Phase|Lack of Efficacy|11
1006029|NCT00395694|3293881|P1|Continuation Phase|Lack of Efficacy|12
1006030|NCT00395694|3293880|P2|Continuation Phase|Adverse Event|0
1006031|NCT00395694|3293881|P1|Continuation Phase|Adverse Event|1
1006032|NCT00395694|3293880|P2|Escalation Phase + Maintenance Phase|Adverse Event|2
1006033|NCT00395694|3293881|P1|Escalation Phase + Maintenance Phase|Adverse Event|1
1006034|NCT00395642|3293912|P1|Overall Study|Withdrawal by Subject|1
1006035|NCT00395642|3293912|P1|Overall Study|Physician Decision|7
1006036|NCT00395642|3293912|P1|Overall Study|Lost to Follow-up|1
1006037|NCT00395642|3293912|P1|Overall Study|Death|4
1006038|NCT00395629|3293919|P3|Extension Study|Administrative problems|1
1006039|NCT00395629|3293920|P2|Extension Study|Administrative problems|0
1006040|NCT00395629|3293921|P1|Extension Study|Administrative problems|0
1006041|NCT00395629|3293919|P3|Extension Study|Adverse Event|2
1006042|NCT00395629|3293920|P2|Extension Study|Adverse Event|0
1006043|NCT00395629|3293921|P1|Extension Study|Adverse Event|0
1006044|NCT00395629|3293919|P3|Core Study|Lost to Follow-up|1
1006045|NCT00395629|3293920|P2|Core Study|Lost to Follow-up|0
1006046|NCT00395629|3293921|P1|Core Study|Lost to Follow-up|0
1006047|NCT00395629|3293919|P3|Core Study|Withdrawal by Subject|1
1006048|NCT00395629|3293920|P2|Core Study|Withdrawal by Subject|1
1006049|NCT00395629|3293921|P1|Core Study|Withdrawal by Subject|0
1006050|NCT00395629|3293919|P3|Core Study|Protocol Violation|0
1006051|NCT00395629|3293920|P2|Core Study|Protocol Violation|0
1006052|NCT00395629|3293921|P1|Core Study|Protocol Violation|1
1006053|NCT00395629|3293919|P3|Core Study|Abnormal laboratory value(s)|1
1006054|NCT00395629|3293920|P2|Core Study|Abnormal laboratory value(s)|0
1006055|NCT00395629|3293921|P1|Core Study|Abnormal laboratory value(s)|0
1006056|NCT00395629|3293919|P3|Core Study|Adverse Event|4
1006057|NCT00395629|3293920|P2|Core Study|Adverse Event|3
1006058|NCT00395629|3293921|P1|Core Study|Adverse Event|0
1006059|NCT00395512|3293939|P4|Overall Study|Hyperglycemic Rescue|6
1006060|NCT00395512|3293940|P3|Overall Study|Hyperglycemic Rescue|4
1006061|NCT00395512|3293941|P2|Overall Study|Hyperglycemic Rescue|10
1006062|NCT00395512|3293942|P1|Overall Study|Hyperglycemic Rescue|18
1006063|NCT00395512|3293939|P4|Overall Study|Other|0
1006064|NCT00395512|3293940|P3|Overall Study|Other|0
1006065|NCT00395512|3293941|P2|Overall Study|Other|1
1006066|NCT00395512|3293942|P1|Overall Study|Other|1
1006067|NCT00395512|3293939|P4|Overall Study|Physician Decision|2
1006068|NCT00395512|3293940|P3|Overall Study|Physician Decision|2
1006069|NCT00395512|3293941|P2|Overall Study|Physician Decision|4
1006070|NCT00395512|3293942|P1|Overall Study|Physician Decision|6
1006071|NCT00395512|3293939|P4|Overall Study|Withdrawal by Subject|12
1006072|NCT00395512|3293940|P3|Overall Study|Withdrawal by Subject|5
1006073|NCT00395512|3293941|P2|Overall Study|Withdrawal by Subject|5
1006074|NCT00395512|3293942|P1|Overall Study|Withdrawal by Subject|6
1006075|NCT00395512|3293939|P4|Overall Study|Lost to Follow-up|5
1006076|NCT00395512|3293940|P3|Overall Study|Lost to Follow-up|5
1006077|NCT00395512|3293941|P2|Overall Study|Lost to Follow-up|6
1006078|NCT00395512|3293942|P1|Overall Study|Lost to Follow-up|2
1006079|NCT00395512|3293939|P4|Overall Study|Protocol Violation|7
1006080|NCT00395512|3293940|P3|Overall Study|Protocol Violation|6
1006081|NCT00395512|3293941|P2|Overall Study|Protocol Violation|3
1006082|NCT00395512|3293942|P1|Overall Study|Protocol Violation|2
1006083|NCT00395512|3293939|P4|Overall Study|Adverse Event|6
1006084|NCT00395512|3293940|P3|Overall Study|Adverse Event|6
1006085|NCT00395512|3293941|P2|Overall Study|Adverse Event|8
1006086|NCT00395512|3293942|P1|Overall Study|Adverse Event|3
1006087|NCT00395486|3294114|P2|Overall Study|Lost to Follow-up|1
1006088|NCT00395486|3294115|P1|Overall Study|Lost to Follow-up|0
1006089|NCT00395486|3294114|P2|Overall Study|Withdrawal by Subject|2
1006090|NCT00395486|3294115|P1|Overall Study|Withdrawal by Subject|5
1006091|NCT00395486|3294114|P2|Overall Study|Adverse Event|2
1006092|NCT00395486|3294115|P1|Overall Study|Adverse Event|1
1006093|NCT00395460|3294145|P2|Overall Study|Withdrawal by Subject|0
1006094|NCT00395460|3294146|P1|Overall Study|Withdrawal by Subject|1
1006095|NCT00395447|3294170|P2|Overall Study|Withdrawl - Other (not subject)|17
1006096|NCT00395447|3294171|P1|Overall Study|Withdrawl - Other (not subject)|8
1006097|NCT00395447|3294170|P2|Overall Study|Withdrawal by Subject|19
1006098|NCT00395447|3294171|P1|Overall Study|Withdrawal by Subject|24
1006099|NCT00395447|3294170|P2|Overall Study|Lost to Follow-up|43
1006100|NCT00395447|3294171|P1|Overall Study|Lost to Follow-up|52
1006101|NCT00395447|3294170|P2|Overall Study|Death|32
1006102|NCT00395447|3294171|P1|Overall Study|Death|37
1006103|NCT00395343|3294179|P2|Overall Study|Other|2
1006104|NCT00395343|3294180|P1|Overall Study|Other|5
1006105|NCT00395343|3294179|P2|Overall Study|Withdrawal by Subject|12
1006106|NCT00395343|3294180|P1|Overall Study|Withdrawal by Subject|11
1006107|NCT00395343|3294179|P2|Overall Study|Protocol Violation|8
1006108|NCT00395343|3294180|P1|Overall Study|Protocol Violation|6
1006109|NCT00395343|3294179|P2|Overall Study|Physician Decision|4
1006110|NCT00395343|3294180|P1|Overall Study|Physician Decision|2
1006111|NCT00395343|3294179|P2|Overall Study|Lost to Follow-up|4
1006112|NCT00395343|3294180|P1|Overall Study|Lost to Follow-up|4
1006113|NCT00395343|3294179|P2|Overall Study|Lack of Efficacy|1
1006114|NCT00395343|3294180|P1|Overall Study|Lack of Efficacy|0
1006115|NCT00395343|3294179|P2|Overall Study|Adverse Event|5
1006116|NCT00395343|3294180|P1|Overall Study|Adverse Event|13
1006117|NCT00395304|3294198|P6|Treatment Period 3|Other|0
1006118|NCT00395304|3294199|P5|Treatment Period 3|Other|0
1006119|NCT00395304|3294200|P4|Treatment Period 3|Other|1
1006120|NCT00395304|3294201|P3|Treatment Period 3|Other|0
1006121|NCT00395304|3294202|P2|Treatment Period 3|Other|0
1006122|NCT00395304|3294203|P1|Treatment Period 3|Other|0
1006123|NCT00395304|3294198|P6|Treatment Period 3|Physician Decision|0
1006124|NCT00395304|3294199|P5|Treatment Period 3|Physician Decision|0
1006125|NCT00395304|3294200|P4|Treatment Period 3|Physician Decision|0
1006126|NCT00395304|3294201|P3|Treatment Period 3|Physician Decision|0
1006127|NCT00395304|3294202|P2|Treatment Period 3|Physician Decision|1
1006128|NCT00395304|3294203|P1|Treatment Period 3|Physician Decision|0
1006129|NCT00395304|3294198|P6|Treatment Period 3|Lost to Follow-up|0
1006130|NCT00395304|3294199|P5|Treatment Period 3|Lost to Follow-up|0
1006131|NCT00395304|3294200|P4|Treatment Period 3|Lost to Follow-up|0
1006132|NCT00395304|3294201|P3|Treatment Period 3|Lost to Follow-up|0
1006133|NCT00395304|3294202|P2|Treatment Period 3|Lost to Follow-up|1
1006134|NCT00395304|3294203|P1|Treatment Period 3|Lost to Follow-up|1
1006135|NCT00395304|3294198|P6|Treatment Period 3|Withdrawal by Subject|1
1006136|NCT00395304|3294199|P5|Treatment Period 3|Withdrawal by Subject|0
1006137|NCT00395304|3294200|P4|Treatment Period 3|Withdrawal by Subject|1
1006138|NCT00395304|3294201|P3|Treatment Period 3|Withdrawal by Subject|0
1006139|NCT00395304|3294202|P2|Treatment Period 3|Withdrawal by Subject|0
1006140|NCT00395304|3294203|P1|Treatment Period 3|Withdrawal by Subject|0
1006141|NCT00395304|3294198|P6|Treatment Period 2|Other|0
1006142|NCT00395304|3294199|P5|Treatment Period 2|Other|0
1006143|NCT00395304|3294200|P4|Treatment Period 2|Other|0
1006144|NCT00395304|3294201|P3|Treatment Period 2|Other|0
1006145|NCT00395304|3294202|P2|Treatment Period 2|Other|1
1006146|NCT00395304|3294203|P1|Treatment Period 2|Other|0
1006147|NCT00395304|3294198|P6|Treatment Period 2|Physician Decision|0
1006148|NCT00395304|3294199|P5|Treatment Period 2|Physician Decision|0
1006149|NCT00395304|3294200|P4|Treatment Period 2|Physician Decision|0
1006150|NCT00395304|3294201|P3|Treatment Period 2|Physician Decision|1
1006151|NCT00395304|3294202|P2|Treatment Period 2|Physician Decision|0
1006152|NCT00395304|3294203|P1|Treatment Period 2|Physician Decision|0
1006153|NCT00395304|3294198|P6|Treatment Period 2|Lost to Follow-up|0
1006154|NCT00395304|3294199|P5|Treatment Period 2|Lost to Follow-up|0
1006155|NCT00395304|3294200|P4|Treatment Period 2|Lost to Follow-up|0
1006156|NCT00395304|3294201|P3|Treatment Period 2|Lost to Follow-up|0
1006157|NCT00395304|3294202|P2|Treatment Period 2|Lost to Follow-up|3
1006158|NCT00395304|3294203|P1|Treatment Period 2|Lost to Follow-up|0
1006159|NCT00395304|3294198|P6|Treatment Period 2|Withdrawal by Subject|2
1006160|NCT00395304|3294199|P5|Treatment Period 2|Withdrawal by Subject|0
1006161|NCT00395304|3294200|P4|Treatment Period 2|Withdrawal by Subject|1
1006162|NCT00395304|3294201|P3|Treatment Period 2|Withdrawal by Subject|0
1006163|NCT00395304|3294202|P2|Treatment Period 2|Withdrawal by Subject|0
1006164|NCT00395304|3294203|P1|Treatment Period 2|Withdrawal by Subject|0
1006165|NCT00395304|3294198|P6|Treatment Period 1|Physician Decision|0
1006166|NCT00395304|3294199|P5|Treatment Period 1|Physician Decision|0
1006167|NCT00395304|3294200|P4|Treatment Period 1|Physician Decision|0
1006168|NCT00395304|3294201|P3|Treatment Period 1|Physician Decision|0
1006169|NCT00395304|3294202|P2|Treatment Period 1|Physician Decision|1
1006170|NCT00395304|3294203|P1|Treatment Period 1|Physician Decision|0
1006171|NCT00395304|3294198|P6|Treatment Period 1|Lost to Follow-up|1
1006172|NCT00395304|3294199|P5|Treatment Period 1|Lost to Follow-up|0
1006173|NCT00395304|3294200|P4|Treatment Period 1|Lost to Follow-up|1
1006174|NCT00395304|3294201|P3|Treatment Period 1|Lost to Follow-up|0
1006175|NCT00395304|3294202|P2|Treatment Period 1|Lost to Follow-up|0
1006176|NCT00395304|3294203|P1|Treatment Period 1|Lost to Follow-up|1
1006177|NCT00395304|3294198|P6|Treatment Period 1|Withdrawal by Subject|1
1006178|NCT00395304|3294199|P5|Treatment Period 1|Withdrawal by Subject|1
1006179|NCT00395304|3294200|P4|Treatment Period 1|Withdrawal by Subject|2
1006180|NCT00395304|3294201|P3|Treatment Period 1|Withdrawal by Subject|0
1006181|NCT00395304|3294202|P2|Treatment Period 1|Withdrawal by Subject|3
1006182|NCT00395304|3294203|P1|Treatment Period 1|Withdrawal by Subject|0
1006183|NCT00395226|3294279|P2|Overall Study|Lost to Follow-up|1
1006184|NCT00395226|3294280|P1|Overall Study|Lost to Follow-up|0
1006185|NCT00395226|3294279|P2|Overall Study|Withdrawal by Subject|1
1006186|NCT00395226|3294280|P1|Overall Study|Withdrawal by Subject|0
1006187|NCT00395226|3294279|P2|Overall Study|Adverse Event|3
1006188|NCT00395226|3294280|P1|Overall Study|Adverse Event|4
1006189|NCT00395083|3294327|P2|Overall Study|Developed another disease|3
1006190|NCT00395083|3294328|P1|Overall Study|Developed another disease|4
1006191|NCT00395083|3294327|P2|Overall Study|Withdrawal by Subject|5
1006192|NCT00395083|3294328|P1|Overall Study|Withdrawal by Subject|6
1006193|NCT00395018|3294394|P1|Off-Treatment Follow-up|Poor/non-compliance|1
1006194|NCT00395018|3294394|P1|Off-Treatment Follow-up|Lost to Follow-up|2
1006195|NCT00395018|3294394|P1|Off-Treatment Follow-up|Followup no longer required per protocol|1
1006196|NCT00395018|3294394|P1|On-Treatment|Subject no longer meets study criteria|2
1006197|NCT00395018|3294394|P1|On-Treatment|Poor/non-compliance|2
1006198|NCT00395018|3294394|P1|On-Treatment|Other Reason|2
1006199|NCT00395018|3294394|P1|On-Treatment|Death|4
1006200|NCT00394953|3294415|P2|Second Treatment Period|Not defined|8
1006201|NCT00394953|3294416|P1|Second Treatment Period|Not defined|3
1006202|NCT00394953|3294415|P2|Second Treatment Period|Renal transplant|6
1006203|NCT00394953|3294416|P1|Second Treatment Period|Renal transplant|4
1006204|NCT00394953|3294415|P2|Second Treatment Period|Lost to Follow-up|1
1006205|NCT00394953|3294416|P1|Second Treatment Period|Lost to Follow-up|0
1006206|NCT00394953|3294415|P2|Second Treatment Period|Withdrawal by Subject|3
1006207|NCT00394953|3294416|P1|Second Treatment Period|Withdrawal by Subject|3
1006208|NCT00394953|3294415|P2|Second Treatment Period|Lack of Efficacy|47
1006209|NCT00394953|3294416|P1|Second Treatment Period|Lack of Efficacy|9
1006210|NCT00394953|3294415|P2|Second Treatment Period|Death|4
1006211|NCT00394953|3294416|P1|Second Treatment Period|Death|8
1006212|NCT00394953|3294415|P2|Second Treatment Period|Adverse Event|5
1006213|NCT00394953|3294416|P1|Second Treatment Period|Adverse Event|2
1006214|NCT00394953|3294415|P2|First Treatment Period|Not defined|1
1006215|NCT00394953|3294416|P1|First Treatment Period|Not defined|4
1006216|NCT00394953|3294415|P2|First Treatment Period|Renal transplant|7
1006217|NCT00394953|3294416|P1|First Treatment Period|Renal transplant|11
1006218|NCT00394953|3294415|P2|First Treatment Period|Lost to Follow-up|1
1006219|NCT00394953|3294416|P1|First Treatment Period|Lost to Follow-up|0
1006220|NCT00394953|3294415|P2|First Treatment Period|Withdrawal by Subject|3
1006221|NCT00394953|3294416|P1|First Treatment Period|Withdrawal by Subject|6
1006222|NCT00394953|3294415|P2|First Treatment Period|Lack of Efficacy|1
1006223|NCT00394953|3294416|P1|First Treatment Period|Lack of Efficacy|1
1006224|NCT00394953|3294415|P2|First Treatment Period|Death|7
1006225|NCT00394953|3294416|P1|First Treatment Period|Death|6
1006226|NCT00394953|3294415|P2|First Treatment Period|Adverse Event|2
1006227|NCT00394953|3294416|P1|First Treatment Period|Adverse Event|1
1006228|NCT00394914|3294434|P3|Treatment Period|Did not meet protocol eligibility|1
1006229|NCT00394914|3294435|P2|Treatment Period|Did not meet protocol eligibility|1
1006230|NCT00394914|3294436|P1|Treatment Period|Did not meet protocol eligibility|0
1006231|NCT00394914|3294434|P3|Treatment Period|Noncompliance with protocol|2
1006232|NCT00394914|3294435|P2|Treatment Period|Noncompliance with protocol|3
1006233|NCT00394914|3294436|P1|Treatment Period|Noncompliance with protocol|0
1006234|NCT00394914|3294434|P3|Treatment Period|Withdrawal by Subject|2
1006235|NCT00394914|3294435|P2|Treatment Period|Withdrawal by Subject|2
1006236|NCT00394914|3294436|P1|Treatment Period|Withdrawal by Subject|0
1006237|NCT00394914|3294434|P3|Treatment Period|Lost to Follow-up|0
1006238|NCT00394914|3294435|P2|Treatment Period|Lost to Follow-up|1
1006239|NCT00394914|3294436|P1|Treatment Period|Lost to Follow-up|0
1006240|NCT00394914|3294434|P3|Treatment Period|Adverse Event|1
1006241|NCT00394914|3294435|P2|Treatment Period|Adverse Event|3
1006242|NCT00394914|3294436|P1|Treatment Period|Adverse Event|0
1006243|NCT00394901|3294464|P4|Double-blind Phase|Found not to meet entrance criteria|1
1006244|NCT00394901|3294465|P3|Double-blind Phase|Found not to meet entrance criteria|0
1006245|NCT00394901|3294466|P2|Double-blind Phase|Found not to meet entrance criteria|0
1006246|NCT00394901|3294467|P1|Double-blind Phase|Found not to meet entrance criteria|0
1006247|NCT00394901|3294464|P4|Double-blind Phase|Entry into another study was found|0
1006248|NCT00394901|3294465|P3|Double-blind Phase|Entry into another study was found|1
1006249|NCT00394901|3294466|P2|Double-blind Phase|Entry into another study was found|0
1006332|NCT00394771|3294760|P1|Overall Study|Adverse Event|10
1006250|NCT00394901|3294467|P1|Double-blind Phase|Entry into another study was found|0
1006251|NCT00394901|3294464|P4|Double-blind Phase|Lack of Compliance|0
1006252|NCT00394901|3294465|P3|Double-blind Phase|Lack of Compliance|0
1006253|NCT00394901|3294466|P2|Double-blind Phase|Lack of Compliance|3
1006254|NCT00394901|3294467|P1|Double-blind Phase|Lack of Compliance|0
1006255|NCT00394901|3294464|P4|Double-blind Phase|Subject's Personal Reason|1
1006256|NCT00394901|3294465|P3|Double-blind Phase|Subject's Personal Reason|0
1006257|NCT00394901|3294466|P2|Double-blind Phase|Subject's Personal Reason|0
1006258|NCT00394901|3294467|P1|Double-blind Phase|Subject's Personal Reason|1
1006259|NCT00394901|3294464|P4|Double-blind Phase|Death|0
1006260|NCT00394901|3294465|P3|Double-blind Phase|Death|0
1006261|NCT00394901|3294466|P2|Double-blind Phase|Death|0
1006262|NCT00394901|3294467|P1|Double-blind Phase|Death|1
1006263|NCT00394901|3294464|P4|Double-blind Phase|Protocol Violation|1
1006264|NCT00394901|3294465|P3|Double-blind Phase|Protocol Violation|0
1006265|NCT00394901|3294466|P2|Double-blind Phase|Protocol Violation|0
1006266|NCT00394901|3294467|P1|Double-blind Phase|Protocol Violation|0
1006267|NCT00394901|3294464|P4|Double-blind Phase|Lost to Follow-up|1
1006268|NCT00394901|3294465|P3|Double-blind Phase|Lost to Follow-up|0
1006269|NCT00394901|3294466|P2|Double-blind Phase|Lost to Follow-up|0
1006270|NCT00394901|3294467|P1|Double-blind Phase|Lost to Follow-up|0
1006271|NCT00394901|3294464|P4|Double-blind Phase|Withdrawal by Subject|0
1006272|NCT00394901|3294465|P3|Double-blind Phase|Withdrawal by Subject|0
1006273|NCT00394901|3294466|P2|Double-blind Phase|Withdrawal by Subject|0
1006274|NCT00394901|3294467|P1|Double-blind Phase|Withdrawal by Subject|2
1006275|NCT00394901|3294464|P4|Double-blind Phase|Lack of Efficacy|3
1006276|NCT00394901|3294465|P3|Double-blind Phase|Lack of Efficacy|1
1006277|NCT00394901|3294466|P2|Double-blind Phase|Lack of Efficacy|4
1006278|NCT00394901|3294467|P1|Double-blind Phase|Lack of Efficacy|6
1006279|NCT00394901|3294464|P4|Double-blind Phase|Adverse Event|20
1006280|NCT00394901|3294465|P3|Double-blind Phase|Adverse Event|16
1006281|NCT00394901|3294466|P2|Double-blind Phase|Adverse Event|7
1006282|NCT00394901|3294467|P1|Double-blind Phase|Adverse Event|5
1006283|NCT00394901|3294464|P4|Baseline Phase|Protocol Violation|0
1006284|NCT00394901|3294465|P3|Baseline Phase|Protocol Violation|1
1006285|NCT00394901|3294466|P2|Baseline Phase|Protocol Violation|0
1006286|NCT00394901|3294467|P1|Baseline Phase|Protocol Violation|0
1006287|NCT00394836|3294710|P2|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10
1006288|NCT00394836|3294711|P1|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7
1006289|NCT00394836|3294710|P2|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41
1006290|NCT00394836|3294711|P1|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13
1006291|NCT00394836|3294710|P2|Extended Follow-up Phase (2-5 Years)|Death|1
1006292|NCT00394836|3294711|P1|Extended Follow-up Phase (2-5 Years)|Death|0
1006293|NCT00394836|3294710|P2|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1
1006294|NCT00394836|3294711|P1|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0
1006295|NCT00394836|3294710|P2|Teatment or Follow-up Phase|Non compliance|1
1006296|NCT00394836|3294711|P1|Teatment or Follow-up Phase|Non compliance|0
1006297|NCT00394836|3294710|P2|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1
1006298|NCT00394836|3294711|P1|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0
1006299|NCT00394836|3294710|P2|Teatment or Follow-up Phase|Physician Decision|1
1006300|NCT00394836|3294711|P1|Teatment or Follow-up Phase|Physician Decision|0
1006301|NCT00394836|3294710|P2|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1
1006302|NCT00394836|3294711|P1|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0
1006303|NCT00394836|3294710|P2|Teatment or Follow-up Phase|Started alternative treatment|6
1006304|NCT00394836|3294711|P1|Teatment or Follow-up Phase|Started alternative treatment|0
1006305|NCT00394836|3294710|P2|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1
1006306|NCT00394836|3294711|P1|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0
1006307|NCT00394836|3294710|P2|Teatment or Follow-up Phase|Death|1
1006308|NCT00394836|3294711|P1|Teatment or Follow-up Phase|Death|0
1006309|NCT00394836|3294710|P2|Teatment or Follow-up Phase|Patient Refusal|2
1006310|NCT00394836|3294711|P1|Teatment or Follow-up Phase|Patient Refusal|1
1006311|NCT00394836|3294710|P2|Teatment or Follow-up Phase|Disease Progression|60
1006312|NCT00394836|3294711|P1|Teatment or Follow-up Phase|Disease Progression|27
1006313|NCT00394836|3294710|P2|Teatment or Follow-up Phase|Protocol Violation|2
1006314|NCT00394836|3294711|P1|Teatment or Follow-up Phase|Protocol Violation|0
1006315|NCT00394836|3294710|P2|Teatment or Follow-up Phase|Adverse Event|2
1006316|NCT00394836|3294711|P1|Teatment or Follow-up Phase|Adverse Event|0
1006317|NCT00394771|3294757|P4|Overall Study|Not specified|0
1006318|NCT00394771|3294758|P3|Overall Study|Not specified|1
1006319|NCT00394771|3294759|P2|Overall Study|Not specified|3
1006320|NCT00394771|3294760|P1|Overall Study|Not specified|3
1006321|NCT00394771|3294757|P4|Overall Study|Lost to Follow-up|10
1006322|NCT00394771|3294758|P3|Overall Study|Lost to Follow-up|13
1006323|NCT00394771|3294759|P2|Overall Study|Lost to Follow-up|15
1006324|NCT00394771|3294760|P1|Overall Study|Lost to Follow-up|15
1006325|NCT00394771|3294757|P4|Overall Study|Participant pregnant|2
1006326|NCT00394771|3294758|P3|Overall Study|Participant pregnant|2
1006327|NCT00394771|3294759|P2|Overall Study|Participant pregnant|1
1006328|NCT00394771|3294760|P1|Overall Study|Participant pregnant|0
1006329|NCT00394771|3294757|P4|Overall Study|Adverse Event|8
1006330|NCT00394771|3294758|P3|Overall Study|Adverse Event|12
1006331|NCT00394771|3294759|P2|Overall Study|Adverse Event|5
1006333|NCT00394771|3294757|P4|Overall Study|Withdrawal by Subject|12
1006334|NCT00394771|3294758|P3|Overall Study|Withdrawal by Subject|8
1006335|NCT00394771|3294759|P2|Overall Study|Withdrawal by Subject|6
1006336|NCT00394771|3294760|P1|Overall Study|Withdrawal by Subject|10
1006337|NCT00394771|3294757|P4|Overall Study|Protocol Violation|7
1006338|NCT00394771|3294758|P3|Overall Study|Protocol Violation|9
1006339|NCT00394771|3294759|P2|Overall Study|Protocol Violation|4
1006340|NCT00394771|3294760|P1|Overall Study|Protocol Violation|2
1006341|NCT00394771|3294757|P4|Overall Study|Did not meet protocol requirements|0
1006342|NCT00394771|3294758|P3|Overall Study|Did not meet protocol requirements|2
1006343|NCT00394771|3294759|P2|Overall Study|Did not meet protocol requirements|0
1006344|NCT00394771|3294760|P1|Overall Study|Did not meet protocol requirements|1
1006345|NCT00394706|3294830|P8|Overall Study|Lost to Follow-up|0
1006346|NCT00394706|3294831|P7|Overall Study|Lost to Follow-up|2
1006347|NCT00394706|3294832|P6|Overall Study|Lost to Follow-up|5
1006348|NCT00394706|3294833|P5|Overall Study|Lost to Follow-up|2
1006349|NCT00394706|3294834|P4|Overall Study|Lost to Follow-up|1
1006350|NCT00394706|3294835|P3|Overall Study|Lost to Follow-up|8
1006351|NCT00394706|3294836|P2|Overall Study|Lost to Follow-up|2
1006352|NCT00394706|3294837|P1|Overall Study|Lost to Follow-up|2
1006353|NCT00394706|3294830|P8|Overall Study|Withdrawal by Subject|0
1006354|NCT00394706|3294831|P7|Overall Study|Withdrawal by Subject|1
1006355|NCT00394706|3294832|P6|Overall Study|Withdrawal by Subject|2
1006356|NCT00394706|3294833|P5|Overall Study|Withdrawal by Subject|0
1006357|NCT00394706|3294834|P4|Overall Study|Withdrawal by Subject|0
1006358|NCT00394706|3294835|P3|Overall Study|Withdrawal by Subject|1
1006359|NCT00394706|3294836|P2|Overall Study|Withdrawal by Subject|0
1006360|NCT00394706|3294837|P1|Overall Study|Withdrawal by Subject|2
1006361|NCT00394654|3294869|P2|Overall Study|PARTICIPANT LEFT STDUY REGION|0
1006362|NCT00394654|3294870|P1|Overall Study|PARTICIPANT LEFT STDUY REGION|1
1006363|NCT00394654|3294869|P2|Overall Study|Lost to Follow-up|0
1006364|NCT00394654|3294870|P1|Overall Study|Lost to Follow-up|1
1006365|NCT00394589|3294935|P3|Overall Study|Protocol Violation|2
1006366|NCT00394589|3294936|P2|Overall Study|Protocol Violation|0
1006367|NCT00394589|3294937|P1|Overall Study|Protocol Violation|4
1006368|NCT00394589|3294935|P3|Overall Study|Lack of Efficacy|3
1006369|NCT00394589|3294936|P2|Overall Study|Lack of Efficacy|2
1006370|NCT00394589|3294937|P1|Overall Study|Lack of Efficacy|2
1006371|NCT00394589|3294935|P3|Overall Study|Adverse Event|2
1006372|NCT00394589|3294936|P2|Overall Study|Adverse Event|1
1006373|NCT00394589|3294937|P1|Overall Study|Adverse Event|2
1006374|NCT00394524|3294947|P2|Overall Study|Withdrawal by Subject|1
1006375|NCT00394524|3294948|P1|Overall Study|Withdrawal by Subject|0
1006376|NCT00394524|3294947|P2|Overall Study|Death|0
1006377|NCT00394524|3294948|P1|Overall Study|Death|1
1006378|NCT00394524|3294947|P2|Overall Study|Protocol Violation|3
1006379|NCT00394524|3294948|P1|Overall Study|Protocol Violation|2
1006380|NCT00394472|3294962|P2|Overall Study|Lost to Follow-up|1
1006381|NCT00394472|3294963|P1|Overall Study|Lost to Follow-up|0
1006382|NCT00394472|3294962|P2|Overall Study|Physician Decision|1
1006383|NCT00394472|3294963|P1|Overall Study|Physician Decision|0
1006384|NCT00394472|3294962|P2|Overall Study|Withdrawal by Subject|2
1006385|NCT00394472|3294963|P1|Overall Study|Withdrawal by Subject|0
1006386|NCT00394472|3294962|P2|Overall Study|Adverse Event|2
1006387|NCT00394472|3294963|P1|Overall Study|Adverse Event|4
1006388|NCT00394472|3294962|P2|Overall Study|incorrect enrolment|2
1006389|NCT00394472|3294963|P1|Overall Study|incorrect enrolment|4
1006390|NCT00394472|3294962|P2|Overall Study|Protocol Violation|3
1006391|NCT00394472|3294963|P1|Overall Study|Protocol Violation|1
1006392|NCT00394433|3294971|P1|Overall Study|Alternative Therapy|1
1006393|NCT00394433|3294971|P1|Overall Study|Adverse Event|2
1006394|NCT00394355|3294982|P4|Overall Study|Lack of Efficacy|3
1006395|NCT00394355|3294983|P3|Overall Study|Lack of Efficacy|2
1006396|NCT00394355|3294984|P2|Overall Study|Lack of Efficacy|0
1006397|NCT00394355|3294985|P1|Overall Study|Lack of Efficacy|0
1006398|NCT00394355|3294982|P4|Overall Study|Administrative|1
1006399|NCT00394355|3294983|P3|Overall Study|Administrative|1
1006400|NCT00394355|3294984|P2|Overall Study|Administrative|1
1006401|NCT00394355|3294985|P1|Overall Study|Administrative|0
1006402|NCT00394355|3294982|P4|Overall Study|Noncompliance with protocol|8
1006403|NCT00394355|3294983|P3|Overall Study|Noncompliance with protocol|10
1006404|NCT00394355|3294984|P2|Overall Study|Noncompliance with protocol|3
1006405|NCT00394355|3294985|P1|Overall Study|Noncompliance with protocol|4
1006406|NCT00394355|3294982|P4|Overall Study|Lost to Follow-up|3
1006407|NCT00394355|3294983|P3|Overall Study|Lost to Follow-up|4
1006408|NCT00394355|3294984|P2|Overall Study|Lost to Follow-up|5
1006409|NCT00394355|3294985|P1|Overall Study|Lost to Follow-up|7
1006410|NCT00394355|3294982|P4|Overall Study|Subject withdrawal - related to drug|0
1006411|NCT00394355|3294983|P3|Overall Study|Subject withdrawal - related to drug|0
1006412|NCT00394355|3294984|P2|Overall Study|Subject withdrawal - related to drug|0
1006413|NCT00394355|3294985|P1|Overall Study|Subject withdrawal - related to drug|1
1006414|NCT00394355|3294982|P4|Overall Study|Subject withdrawal - unrelated to drug|6
1006415|NCT00394355|3294983|P3|Overall Study|Subject withdrawal - unrelated to drug|10
1006416|NCT00394355|3294984|P2|Overall Study|Subject withdrawal - unrelated to drug|14
1006417|NCT00394355|3294985|P1|Overall Study|Subject withdrawal - unrelated to drug|12
1006418|NCT00394355|3294982|P4|Overall Study|Did not meet protocol eligibility|2
1006419|NCT00394355|3294983|P3|Overall Study|Did not meet protocol eligibility|4
1006420|NCT00394355|3294984|P2|Overall Study|Did not meet protocol eligibility|5
1006421|NCT00394355|3294985|P1|Overall Study|Did not meet protocol eligibility|1
1006422|NCT00394355|3294982|P4|Overall Study|Adverse Event|8
1006423|NCT00394355|3294983|P3|Overall Study|Adverse Event|7
1006424|NCT00394355|3294984|P2|Overall Study|Adverse Event|6
1006425|NCT00394355|3294985|P1|Overall Study|Adverse Event|10
1006426|NCT00394251|3295091|P2|Overall Study|Non-compliance, pt moved, pt/inv agree|2
1006427|NCT00394251|3295092|P1|Overall Study|Non-compliance, pt moved, pt/inv agree|2
1006428|NCT00394251|3295091|P2|Overall Study|Withdrawal by Subject|11
1006429|NCT00394251|3295092|P1|Overall Study|Withdrawal by Subject|7
1006430|NCT00394251|3295091|P2|Overall Study|Protocol Violation|1
1006431|NCT00394251|3295092|P1|Overall Study|Protocol Violation|0
1006432|NCT00394251|3295091|P2|Overall Study|Physician Decision|1
1006433|NCT00394251|3295092|P1|Overall Study|Physician Decision|1
1006434|NCT00394251|3295091|P2|Overall Study|Unacceptable Toxicity|18
1006435|NCT00394251|3295092|P1|Overall Study|Unacceptable Toxicity|20
1006436|NCT00394251|3295091|P2|Overall Study|Adverse Event|5
1006437|NCT00394251|3295092|P1|Overall Study|Adverse Event|7
1006438|NCT00394212|3295120|P2|Overall Study|Withdrawal by Subject|1
1006439|NCT00394212|3295121|P1|Overall Study|Withdrawal by Subject|4
1006440|NCT00394212|3295120|P2|Overall Study|Lost to Follow-up|0
1006441|NCT00394212|3295121|P1|Overall Study|Lost to Follow-up|3
1006442|NCT00394095|3295135|P2|Overall Study|Adverse Event|0
1006443|NCT00394095|3295136|P1|Overall Study|Adverse Event|1
1006444|NCT00394082|3295144|P1|Overall Study|Not specified|1
1006445|NCT00394082|3295144|P1|Overall Study|Withdrawal by Subject|2
1006446|NCT00394082|3295144|P1|Overall Study|Physician Decision|4
1006447|NCT00394082|3295144|P1|Overall Study|Adverse Event|4
1006448|NCT00394082|3295144|P1|Overall Study|Unacceptable toxicity|15
1006449|NCT00393939|3295166|P2|Overall Study|Not specified|45
1006450|NCT00393939|3295167|P1|Overall Study|Not specified|37
1006451|NCT00393939|3295166|P2|Overall Study|Withdrawal by Subject|7
1006452|NCT00393939|3295167|P1|Overall Study|Withdrawal by Subject|2
1006453|NCT00393939|3295166|P2|Overall Study|Objective progression or relapse|223
1006454|NCT00393939|3295167|P1|Overall Study|Objective progression or relapse|239
1006455|NCT00393939|3295166|P2|Overall Study|Sponsor|13
1006456|NCT00393939|3295167|P1|Overall Study|Sponsor|5
1006457|NCT00393939|3295166|P2|Overall Study|Death|4
1006458|NCT00393939|3295167|P1|Overall Study|Death|10
1006459|NCT00393939|3295166|P2|Overall Study|Lost to Follow-up|4
1006460|NCT00393939|3295167|P1|Overall Study|Lost to Follow-up|2
1006461|NCT00393939|3295166|P2|Overall Study|Protocol Violation|1
1006462|NCT00393939|3295167|P1|Overall Study|Protocol Violation|1
1006463|NCT00393913|3295185|P1|CPAP|TEchnical problem with CPAP|3
1006464|NCT00393913|3295185|P1|CPAP|Physician Decision|1
1006465|NCT00393913|3295185|P1|CPAP|Withdrawal by Subject|3
1006466|NCT00393913|3295185|P1|Initial Assessment|Withdrawal by Subject|16
1006467|NCT00393913|3295185|P1|Initial Assessment|diagnosed with other sleep disorder|21
1006468|NCT00393887|3295193|P2|Overall Study|Lost to Follow-up|9
1006469|NCT00393887|3295194|P1|Overall Study|Lost to Follow-up|11
1006470|NCT00393887|3295193|P2|Overall Study|Physician Decision|0
1006471|NCT00393887|3295194|P1|Overall Study|Physician Decision|5
1006472|NCT00393861|3295222|P1|Overall Study|Disease Progression|24
1006473|NCT00393861|3295222|P1|Overall Study|Adverse Event|2
1006474|NCT00393848|3295233|P4|Overall Study|Personal reasons|0
1006475|NCT00393848|3295234|P3|Overall Study|Personal reasons|2
1006476|NCT00393848|3295235|P2|Overall Study|Personal reasons|0
1006477|NCT00393848|3295236|P1|Overall Study|Personal reasons|0
1006478|NCT00393848|3295233|P4|Overall Study|Surgical schedule|1
1006479|NCT00393848|3295234|P3|Overall Study|Surgical schedule|0
1006480|NCT00393848|3295235|P2|Overall Study|Surgical schedule|0
1006481|NCT00393848|3295236|P1|Overall Study|Surgical schedule|0
1006482|NCT00393718|3295259|P2|Overall Study|Move|0
1006483|NCT00393718|3295260|P1|Overall Study|Move|1
1006484|NCT00393718|3295259|P2|Overall Study|Missed measurement|0
1006485|NCT00393718|3295260|P1|Overall Study|Missed measurement|1
1006486|NCT00393718|3295259|P2|Overall Study|Withdrawal of consent|1
1006487|NCT00393718|3295260|P1|Overall Study|Withdrawal of consent|2
1006488|NCT00393718|3295259|P2|Overall Study|Subject decision|0
1006489|NCT00393718|3295260|P1|Overall Study|Subject decision|5
1006490|NCT00393718|3295259|P2|Overall Study|Hypoglycaemia|2
1006491|NCT00393718|3295260|P1|Overall Study|Hypoglycaemia|3
1006492|NCT00393718|3295259|P2|Overall Study|Lack of Efficacy|9
1006493|NCT00393718|3295260|P1|Overall Study|Lack of Efficacy|10
1006494|NCT00393718|3295259|P2|Overall Study|Protocol Violation|2
1006495|NCT00393718|3295260|P1|Overall Study|Protocol Violation|1
1006496|NCT00393718|3295259|P2|Overall Study|Adverse Event|8
1006497|NCT00393718|3295260|P1|Overall Study|Adverse Event|20
1006498|NCT00393705|3295292|P2|Overall Study|Physician Decision|2
1006499|NCT00393705|3295293|P1|Overall Study|Physician Decision|2
1006500|NCT00393705|3295292|P2|Overall Study|Withdrawal by Subject|3
1006501|NCT00393705|3295293|P1|Overall Study|Withdrawal by Subject|5
1006502|NCT00393705|3295292|P2|Overall Study|Protocol Violation|3
1006503|NCT00393705|3295293|P1|Overall Study|Protocol Violation|4
1006504|NCT00393705|3295292|P2|Overall Study|Entry Criteria Not Met|10
1006505|NCT00393705|3295293|P1|Overall Study|Entry Criteria Not Met|10
1006506|NCT00393705|3295292|P2|Overall Study|Lost to Follow-up|2
1006507|NCT00393705|3295293|P1|Overall Study|Lost to Follow-up|2
1006508|NCT00393705|3295292|P2|Overall Study|Death|1
1006509|NCT00393705|3295293|P1|Overall Study|Death|0
1006510|NCT00393705|3295292|P2|Overall Study|Adverse Event|2
1006511|NCT00393705|3295293|P1|Overall Study|Adverse Event|0
1006512|NCT00393523|3295322|P5|Overall Study|Vaccine supply issue|0
1006513|NCT00393523|3295323|P4|Overall Study|Vaccine supply issue|0
1006514|NCT00393523|3295324|P3|Overall Study|Vaccine supply issue|1
1006515|NCT00393523|3295325|P2|Overall Study|Vaccine supply issue|0
1006516|NCT00393523|3295326|P1|Overall Study|Vaccine supply issue|0
1006517|NCT00393523|3295322|P5|Overall Study|Difficulties in specimen collection|0
1006518|NCT00393523|3295323|P4|Overall Study|Difficulties in specimen collection|0
1006519|NCT00393523|3295324|P3|Overall Study|Difficulties in specimen collection|1
1006520|NCT00393523|3295325|P2|Overall Study|Difficulties in specimen collection|0
1006521|NCT00393523|3295326|P1|Overall Study|Difficulties in specimen collection|0
1006522|NCT00393523|3295322|P5|Overall Study|Withdrawal by Subject|0
1006523|NCT00393523|3295323|P4|Overall Study|Withdrawal by Subject|3
1006524|NCT00393523|3295324|P3|Overall Study|Withdrawal by Subject|2
1006525|NCT00393523|3295325|P2|Overall Study|Withdrawal by Subject|7
1006526|NCT00393523|3295326|P1|Overall Study|Withdrawal by Subject|6
1006527|NCT00393523|3295322|P5|Overall Study|Protocol Violation|0
1006528|NCT00393523|3295323|P4|Overall Study|Protocol Violation|1
1006529|NCT00393523|3295324|P3|Overall Study|Protocol Violation|0
1006530|NCT00393523|3295325|P2|Overall Study|Protocol Violation|2
1006531|NCT00393523|3295326|P1|Overall Study|Protocol Violation|6
1006532|NCT00393523|3295322|P5|Overall Study|Lost to Follow-up|1
1006533|NCT00393523|3295323|P4|Overall Study|Lost to Follow-up|2
1006534|NCT00393523|3295324|P3|Overall Study|Lost to Follow-up|0
1006535|NCT00393523|3295325|P2|Overall Study|Lost to Follow-up|0
1006536|NCT00393523|3295326|P1|Overall Study|Lost to Follow-up|0
1006537|NCT00393510|3295343|P2|Overall Study|Physician Decision|9
1006538|NCT00393510|3295344|P1|Overall Study|Physician Decision|3
1006539|NCT00393484|3295356|P2|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18
1006540|NCT00393484|3295357|P1|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0
1006541|NCT00393484|3295356|P2|Open-label Period (Weeks 96 to 240)|Noncompliance|2
1006542|NCT00393484|3295357|P1|Open-label Period (Weeks 96 to 240)|Noncompliance|2
1006543|NCT00393484|3295356|P2|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2
1006544|NCT00393484|3295357|P1|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1
1006545|NCT00393484|3295356|P2|Open-label Period (Weeks 96 to 240)|Death|0
1006546|NCT00393484|3295357|P1|Open-label Period (Weeks 96 to 240)|Death|1
1006547|NCT00393484|3295356|P2|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1
1006548|NCT00393484|3295357|P1|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4
1006549|NCT00393484|3295356|P2|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2
1006550|NCT00393484|3295357|P1|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0
1006551|NCT00393484|3295356|P2|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6
1006552|NCT00393484|3295357|P1|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0
1006553|NCT00393484|3295356|P2|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3
1006554|NCT00393484|3295357|P1|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0
1006555|NCT00393484|3295356|P2|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0
1006556|NCT00393484|3295357|P1|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2
1006557|NCT00393484|3295356|P2|Double-blind Period (Day 1 to Week 96)|Adverse Event|1
1006558|NCT00393484|3295357|P1|Double-blind Period (Day 1 to Week 96)|Adverse Event|0
1006559|NCT00393458|3295393|P4|Overall Study|Subject no longer requires study drug|0
1006560|NCT00393458|3295394|P3|Overall Study|Subject no longer requires study drug|0
1006561|NCT00393458|3295395|P2|Overall Study|Subject no longer requires study drug|1
1006562|NCT00393458|3295396|P1|Overall Study|Subject no longer requires study drug|0
1006563|NCT00393458|3295393|P4|Overall Study|Abnormal test procedure result(s)|2
1006564|NCT00393458|3295394|P3|Overall Study|Abnormal test procedure result(s)|1
1006565|NCT00393458|3295395|P2|Overall Study|Abnormal test procedure result(s)|1
1006566|NCT00393458|3295396|P1|Overall Study|Abnormal test procedure result(s)|0
1006567|NCT00393458|3295393|P4|Overall Study|Death|5
1006568|NCT00393458|3295394|P3|Overall Study|Death|5
1006569|NCT00393458|3295395|P2|Overall Study|Death|1
1006570|NCT00393458|3295396|P1|Overall Study|Death|1
1006571|NCT00393458|3295393|P4|Overall Study|Abnormal laboratory value(s)|0
1006572|NCT00393458|3295394|P3|Overall Study|Abnormal laboratory value(s)|0
1006573|NCT00393458|3295395|P2|Overall Study|Abnormal laboratory value(s)|1
1006574|NCT00393458|3295396|P1|Overall Study|Abnormal laboratory value(s)|1
1006575|NCT00393458|3295393|P4|Overall Study|Lost to Follow-up|3
1006576|NCT00393458|3295394|P3|Overall Study|Lost to Follow-up|5
1006577|NCT00393458|3295395|P2|Overall Study|Lost to Follow-up|6
1006578|NCT00393458|3295396|P1|Overall Study|Lost to Follow-up|5
1006579|NCT00393458|3295393|P4|Overall Study|Administrative problems|2
1006580|NCT00393458|3295394|P3|Overall Study|Administrative problems|5
1006581|NCT00393458|3295395|P2|Overall Study|Administrative problems|8
1006582|NCT00393458|3295396|P1|Overall Study|Administrative problems|7
1006583|NCT00393458|3295393|P4|Overall Study|Protocol deviation|10
1006584|NCT00393458|3295394|P3|Overall Study|Protocol deviation|11
1006585|NCT00393458|3295395|P2|Overall Study|Protocol deviation|11
1006586|NCT00393458|3295396|P1|Overall Study|Protocol deviation|11
1006587|NCT00393458|3295393|P4|Overall Study|Unsatisfactory therapeutic effect|30
1006588|NCT00393458|3295394|P3|Overall Study|Unsatisfactory therapeutic effect|12
1006589|NCT00393458|3295395|P2|Overall Study|Unsatisfactory therapeutic effect|9
1006590|NCT00393458|3295396|P1|Overall Study|Unsatisfactory therapeutic effect|12
1006591|NCT00393458|3295393|P4|Overall Study|Subject withdrew consent|50
1006592|NCT00393458|3295394|P3|Overall Study|Subject withdrew consent|33
1006593|NCT00393458|3295395|P2|Overall Study|Subject withdrew consent|40
1006594|NCT00393458|3295396|P1|Overall Study|Subject withdrew consent|27
1006595|NCT00393458|3295393|P4|Overall Study|Adverse Event|35
1006596|NCT00393458|3295394|P3|Overall Study|Adverse Event|40
1006597|NCT00393458|3295395|P2|Overall Study|Adverse Event|24
1006598|NCT00393458|3295396|P1|Overall Study|Adverse Event|35
1006599|NCT00393367|3295423|P2|Overall Study|Withdrawal by Subject|2
1006600|NCT00393367|3295424|P1|Overall Study|Withdrawal by Subject|0
1006601|NCT00393367|3295423|P2|Overall Study|Protocol Violation|5
1006602|NCT00393367|3295424|P1|Overall Study|Protocol Violation|2
1006603|NCT00393094|3295452|P1|Disease Progression After Trtmt: Onstudy|Refused further treatment|1
1006604|NCT00393094|3295452|P1|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1
1006605|NCT00393042|3295463|P2|Second Intervetion|Protocol Violation|1
1006606|NCT00393042|3295464|P1|Second Intervetion|Protocol Violation|1
1006607|NCT00393042|3295463|P2|Second Intervetion|Lost to Follow-up|2
1006608|NCT00393042|3295464|P1|Second Intervetion|Lost to Follow-up|0
1006609|NCT00393042|3295463|P2|Second Intervetion|Lack of Efficacy|0
1006610|NCT00393042|3295464|P1|Second Intervetion|Lack of Efficacy|1
1006611|NCT00393042|3295463|P2|Second Intervetion|Withdrawal by Subject|2
1006612|NCT00393042|3295464|P1|Second Intervetion|Withdrawal by Subject|0
1006613|NCT00393042|3295463|P2|Second Intervetion|Adverse Event|3
1006614|NCT00393042|3295464|P1|Second Intervetion|Adverse Event|0
1006615|NCT00393042|3295463|P2|First Intervention|Adverse Event|1
1006616|NCT00393042|3295464|P1|First Intervention|Adverse Event|0
1006617|NCT00393042|3295463|P2|First Intervention|Protocol Violation|0
1006618|NCT00393042|3295464|P1|First Intervention|Protocol Violation|1
1006619|NCT00393042|3295463|P2|First Intervention|Lost to Follow-up|3
1006620|NCT00393042|3295464|P1|First Intervention|Lost to Follow-up|3
1006621|NCT00393042|3295463|P2|First Intervention|Withdrawal by Subject|2
1006622|NCT00393042|3295464|P1|First Intervention|Withdrawal by Subject|1
1006623|NCT00393029|3295536|P2|Overall Study|Not treated|1
1006624|NCT00393029|3295537|P1|Overall Study|Not treated|0
1006625|NCT00392925|3295558|P4|Randomization to Treatment Group Period|Lost to Follow-up|4
1006626|NCT00392925|3295559|P3|Randomization to Treatment Group Period|Lost to Follow-up|8
1006627|NCT00392925|3295560|P2|Randomization to Treatment Group Period|Lost to Follow-up|3
1006628|NCT00392925|3295561|P1|Randomization to Treatment Group Period|Lost to Follow-up|0
1006629|NCT00392925|3295558|P4|Randomization to Treatment Group Period|Protocol Violation|1
1006630|NCT00392925|3295559|P3|Randomization to Treatment Group Period|Protocol Violation|2
1006631|NCT00392925|3295560|P2|Randomization to Treatment Group Period|Protocol Violation|0
1006632|NCT00392925|3295561|P1|Randomization to Treatment Group Period|Protocol Violation|0
1006633|NCT00392925|3295558|P4|Randomization to Treatment Group Period|Adverse Event|5
1006634|NCT00392925|3295559|P3|Randomization to Treatment Group Period|Adverse Event|3
1006635|NCT00392925|3295560|P2|Randomization to Treatment Group Period|Adverse Event|3
1006636|NCT00392925|3295561|P1|Randomization to Treatment Group Period|Adverse Event|0
1006637|NCT00392925|3295558|P4|Randomization to Treatment Group Period|Withdrawal by Subject|8
1006638|NCT00392925|3295559|P3|Randomization to Treatment Group Period|Withdrawal by Subject|6
1006639|NCT00392925|3295560|P2|Randomization to Treatment Group Period|Withdrawal by Subject|2
1006640|NCT00392925|3295561|P1|Randomization to Treatment Group Period|Withdrawal by Subject|0
1006641|NCT00392925|3295558|P4|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
1006642|NCT00392925|3295559|P3|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
1006643|NCT00392925|3295560|P2|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
1006644|NCT00392925|3295561|P1|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16
1006645|NCT00392925|3295558|P4|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
1006646|NCT00392925|3295559|P3|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
1006647|NCT00392925|3295560|P2|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
1006648|NCT00392925|3295561|P1|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5
1006649|NCT00392925|3295558|P4|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
1006650|NCT00392925|3295559|P3|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
1006651|NCT00392925|3295560|P2|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
1006652|NCT00392925|3295561|P1|4 Week Lead-In Period - Non-Randomized|Physician Decision|1
1006653|NCT00392925|3295558|P4|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
1006654|NCT00392925|3295559|P3|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
1006655|NCT00392925|3295560|P2|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
1006656|NCT00392925|3295561|P1|4 Week Lead-In Period - Non-Randomized|Adverse Event|5
1006657|NCT00392925|3295558|P4|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
1006658|NCT00392925|3295559|P3|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
1006659|NCT00392925|3295560|P2|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
1006660|NCT00392925|3295561|P1|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11
1006661|NCT00392808|3295675|P4|Overall Study|Unable to withdraw blood|2
1006662|NCT00392808|3295676|P3|Overall Study|Unable to withdraw blood|1
1006663|NCT00392808|3295677|P2|Overall Study|Unable to withdraw blood|1
1006664|NCT00392808|3295678|P1|Overall Study|Unable to withdraw blood|3
1006665|NCT00392808|3295675|P4|Overall Study|Lost to Follow-up|2
1006666|NCT00392808|3295676|P3|Overall Study|Lost to Follow-up|1
1007529|NCT00385827|3298161|P2|Part 2|Death|0
1006667|NCT00392808|3295677|P2|Overall Study|Lost to Follow-up|2
1006668|NCT00392808|3295678|P1|Overall Study|Lost to Follow-up|3
1006669|NCT00392769|3295702|P1|Overall Study|Adverse Event|1
1006670|NCT00392769|3295702|P1|Overall Study|Clinical Deterioration|9
1006671|NCT00392665|3295754|P2|Overall Study|Lost to Follow-up|1
1006672|NCT00392665|3295755|P1|Overall Study|Lost to Follow-up|1
1006673|NCT00392665|3295754|P2|Overall Study|Death|14
1006674|NCT00392665|3295755|P1|Overall Study|Death|16
1006675|NCT00392379|3295781|P2|Overall Study|Adverse Event|1
1006676|NCT00392379|3295782|P1|Overall Study|Adverse Event|1
1006677|NCT00392379|3295781|P2|Overall Study|Lost to Follow-up|9
1006678|NCT00392379|3295782|P1|Overall Study|Lost to Follow-up|4
1006679|NCT00392379|3295781|P2|Overall Study|Withdrawal by Subject|28
1006680|NCT00392379|3295782|P1|Overall Study|Withdrawal by Subject|17
1006681|NCT00392288|3295795|P3|Overall Study|Other|1
1006682|NCT00392288|3295796|P2|Overall Study|Other|4
1006683|NCT00392288|3295797|P1|Overall Study|Other|3
1006684|NCT00392288|3295795|P3|Overall Study|Parent/legal guardian withdrawal|1
1006685|NCT00392288|3295796|P2|Overall Study|Parent/legal guardian withdrawal|2
1006686|NCT00392288|3295797|P1|Overall Study|Parent/legal guardian withdrawal|1
1006687|NCT00392288|3295795|P3|Overall Study|Withdrawal by Subject|2
1006688|NCT00392288|3295796|P2|Overall Study|Withdrawal by Subject|0
1006689|NCT00392288|3295797|P1|Overall Study|Withdrawal by Subject|1
1006690|NCT00392288|3295795|P3|Overall Study|Lost to Follow-up|1
1006691|NCT00392288|3295796|P2|Overall Study|Lost to Follow-up|1
1006692|NCT00392288|3295797|P1|Overall Study|Lost to Follow-up|1
1006693|NCT00392288|3295795|P3|Overall Study|Protocol Violation|1
1006694|NCT00392288|3295796|P2|Overall Study|Protocol Violation|3
1006695|NCT00392288|3295797|P1|Overall Study|Protocol Violation|1
1006696|NCT00392288|3295795|P3|Overall Study|Lack of Efficacy|3
1006697|NCT00392288|3295796|P2|Overall Study|Lack of Efficacy|5
1006698|NCT00392288|3295797|P1|Overall Study|Lack of Efficacy|8
1006699|NCT00392288|3295795|P3|Overall Study|Adverse Event|8
1006700|NCT00392288|3295796|P2|Overall Study|Adverse Event|7
1006701|NCT00392288|3295797|P1|Overall Study|Adverse Event|17
1006702|NCT00392223|3295822|P2|Overall Study|Withdrawal by Subject|2
1006703|NCT00392223|3295823|P1|Overall Study|Withdrawal by Subject|3
1006704|NCT00392223|3295822|P2|Overall Study|Protocol Violation|3
1006705|NCT00392223|3295823|P1|Overall Study|Protocol Violation|0
1006706|NCT00392223|3295822|P2|Overall Study|Lost to Follow-up|4
1006707|NCT00392223|3295823|P1|Overall Study|Lost to Follow-up|1
1006708|NCT00392223|3295822|P2|Overall Study|Adverse Event|4
1006709|NCT00392223|3295823|P1|Overall Study|Adverse Event|5
1006710|NCT00392210|3295841|P2|First Voiding Trial|Physician Decision|2
1006711|NCT00392210|3295842|P1|First Voiding Trial|Physician Decision|2
1006712|NCT00392197|3295850|P2|Overall Study|Withdrawal by Subject|6
1006713|NCT00392197|3295851|P1|Overall Study|Withdrawal by Subject|4
1006714|NCT00392197|3295850|P2|Overall Study|Protocol Violation|5
1006715|NCT00392197|3295851|P1|Overall Study|Protocol Violation|7
1006716|NCT00392197|3295850|P2|Overall Study|Physician Decision|2
1006717|NCT00392197|3295851|P1|Overall Study|Physician Decision|3
1006718|NCT00392197|3295850|P2|Overall Study|Lost to Follow-up|1
1006719|NCT00392197|3295851|P1|Overall Study|Lost to Follow-up|0
1006720|NCT00392197|3295850|P2|Overall Study|Lack of Efficacy|4
1006721|NCT00392197|3295851|P1|Overall Study|Lack of Efficacy|3
1006722|NCT00392197|3295850|P2|Overall Study|Adverse Event|12
1006723|NCT00392197|3295851|P1|Overall Study|Adverse Event|4
1006724|NCT00392171|3295859|P1|Overall Study|Disease progression|101
1006725|NCT00392171|3295859|P1|Overall Study|Did not meet inclusion criteria|4
1006726|NCT00391976|3295870|P3|Overall Study|Positive P. aeruginosa antibody test|31
1006727|NCT00391976|3295871|P2|Overall Study|Positive P. aeruginosa antibody test|0
1006728|NCT00391976|3295872|P1|Overall Study|Positive P. aeruginosa antibody test|0
1006729|NCT00391976|3295870|P3|Overall Study|Unable to classify|1
1006730|NCT00391976|3295871|P2|Overall Study|Unable to classify|0
1006731|NCT00391976|3295872|P1|Overall Study|Unable to classify|0
1006732|NCT00391976|3295870|P3|Overall Study|Recurrence/no eradication of infection|0
1006733|NCT00391976|3295871|P2|Overall Study|Recurrence/no eradication of infection|19
1006734|NCT00391976|3295872|P1|Overall Study|Recurrence/no eradication of infection|21
1006735|NCT00391976|3295870|P3|Overall Study|Protocol deviation/violation|1
1006736|NCT00391976|3295871|P2|Overall Study|Protocol deviation/violation|2
1006737|NCT00391976|3295872|P1|Overall Study|Protocol deviation/violation|4
1006738|NCT00391976|3295870|P3|Overall Study|Inappropriate enrollment|0
1006739|NCT00391976|3295871|P2|Overall Study|Inappropriate enrollment|1
1006740|NCT00391976|3295872|P1|Overall Study|Inappropriate enrollment|1
1006741|NCT00391976|3295870|P3|Overall Study|Lost to Follow-up|0
1006742|NCT00391976|3295871|P2|Overall Study|Lost to Follow-up|2
1006743|NCT00391976|3295872|P1|Overall Study|Lost to Follow-up|1
1006744|NCT00391976|3295870|P3|Overall Study|Withdrawal of consent|1
1006745|NCT00391976|3295871|P2|Overall Study|Withdrawal of consent|1
1006746|NCT00391976|3295872|P1|Overall Study|Withdrawal of consent|0
1006747|NCT00391976|3295870|P3|Overall Study|Adverse Event|1
1006748|NCT00391976|3295871|P2|Overall Study|Adverse Event|0
1006749|NCT00391976|3295872|P1|Overall Study|Adverse Event|0
1006750|NCT00391898|3295896|P2|Overall Study|Other|10
1006751|NCT00391898|3295897|P1|Overall Study|Other|8
1006752|NCT00391898|3295896|P2|Overall Study|Adverse Event|0
1006753|NCT00391898|3295897|P1|Overall Study|Adverse Event|3
1006754|NCT00391872|3295917|P2|Overall Study|Lost to Follow-up|0
1007530|NCT00385827|3298162|P1|Part 2|Death|0
1006755|NCT00391872|3295918|P1|Overall Study|Lost to Follow-up|2
1006756|NCT00391872|3295917|P2|Overall Study|Reason unknown|4
1006757|NCT00391872|3295918|P1|Overall Study|Reason unknown|2
1006758|NCT00391872|3295917|P2|Overall Study|Withdrawal by Subject|249
1006759|NCT00391872|3295918|P1|Overall Study|Withdrawal by Subject|296
1006760|NCT00391872|3295917|P2|Overall Study|Protocol Violation|2
1006761|NCT00391872|3295918|P1|Overall Study|Protocol Violation|7
1006762|NCT00391846|3295956|P2|Overall Study|Developed study specific DC criteria|1
1006763|NCT00391846|3295957|P1|Overall Study|Developed study specific DC criteria|0
1006764|NCT00391846|3295956|P2|Overall Study|Withdrawal by Subject|3
1006765|NCT00391846|3295957|P1|Overall Study|Withdrawal by Subject|2
1006766|NCT00391846|3295956|P2|Overall Study|Did not meet the required elig. crit|2
1006767|NCT00391846|3295957|P1|Overall Study|Did not meet the required elig. crit|2
1006768|NCT00391846|3295956|P2|Overall Study|Adverse Event|1
1006769|NCT00391846|3295957|P1|Overall Study|Adverse Event|4
1006770|NCT00391807|3295977|P1|Overall Study|Various|96
1006771|NCT00391807|3295977|P1|Overall Study|Protocol Violation|20
1006772|NCT00391807|3295977|P1|Overall Study|Withdrawal by Subject|147
1006773|NCT00391807|3295977|P1|Overall Study|Lost to Follow-up|227
1006774|NCT00391807|3295977|P1|Overall Study|Pregnancy|25
1006775|NCT00391807|3295977|P1|Overall Study|Adverse Event|177
1006776|NCT00391807|3295977|P1|Overall Study|Did not receive study medication|23
1006777|NCT00391768|3296004|P7|Overall Study|Lost to Follow-up|3
1006778|NCT00391768|3296005|P6|Overall Study|Lost to Follow-up|2
1006779|NCT00391768|3296006|P5|Overall Study|Lost to Follow-up|2
1006780|NCT00391768|3296007|P4|Overall Study|Lost to Follow-up|1
1006781|NCT00391768|3296008|P3|Overall Study|Lost to Follow-up|0
1006782|NCT00391768|3296009|P2|Overall Study|Lost to Follow-up|0
1006783|NCT00391768|3296010|P1|Overall Study|Lost to Follow-up|0
1006784|NCT00391768|3296004|P7|Overall Study|Withdrawal by Subject|1
1006785|NCT00391768|3296005|P6|Overall Study|Withdrawal by Subject|1
1006786|NCT00391768|3296006|P5|Overall Study|Withdrawal by Subject|0
1006787|NCT00391768|3296007|P4|Overall Study|Withdrawal by Subject|0
1006788|NCT00391768|3296008|P3|Overall Study|Withdrawal by Subject|1
1006789|NCT00391768|3296009|P2|Overall Study|Withdrawal by Subject|0
1006790|NCT00391768|3296010|P1|Overall Study|Withdrawal by Subject|0
1006791|NCT00391625|3296097|P1|Month 50|Physician Decision|1
1006792|NCT00391625|3296097|P1|Month 14|Withdrawal by Subject|1
1006793|NCT00391586|3296150|P1|Overall Study|Death|4
1006794|NCT00391586|3296150|P1|Overall Study|Physician Decision|2
1006795|NCT00391586|3296150|P1|Overall Study|Adverse Event|5
1006796|NCT00391586|3296150|P1|Overall Study|Progressive disease|13
1006797|NCT00391391|3296187|P4|Overall Study|Withdrawal by Subject|7
1006798|NCT00391391|3296188|P3|Overall Study|Withdrawal by Subject|10
1006799|NCT00391391|3296189|P2|Overall Study|Withdrawal by Subject|4
1006800|NCT00391391|3296190|P1|Overall Study|Withdrawal by Subject|6
1006801|NCT00391391|3296187|P4|Overall Study|Protocol Violation|7
1006802|NCT00391391|3296188|P3|Overall Study|Protocol Violation|6
1006803|NCT00391391|3296189|P2|Overall Study|Protocol Violation|3
1006804|NCT00391391|3296190|P1|Overall Study|Protocol Violation|2
1006805|NCT00391391|3296187|P4|Overall Study|Lost to Follow-up|4
1006806|NCT00391391|3296188|P3|Overall Study|Lost to Follow-up|7
1006807|NCT00391391|3296189|P2|Overall Study|Lost to Follow-up|3
1006808|NCT00391391|3296190|P1|Overall Study|Lost to Follow-up|1
1006809|NCT00391391|3296187|P4|Overall Study|Adverse Event|1
1006810|NCT00391391|3296188|P3|Overall Study|Adverse Event|0
1006811|NCT00391391|3296189|P2|Overall Study|Adverse Event|0
1006812|NCT00391391|3296190|P1|Overall Study|Adverse Event|0
1006813|NCT00391274|3296235|P2|Overall Study|Death Not Study Related|1
1006814|NCT00391274|3296236|P1|Overall Study|Death Not Study Related|0
1006815|NCT00391274|3296235|P2|Overall Study|Death Due to Indeterminate Cause|0
1006816|NCT00391274|3296236|P1|Overall Study|Death Due to Indeterminate Cause|1
1006817|NCT00391274|3296235|P2|Overall Study|Death Due to Adverse Event|3
1006818|NCT00391274|3296236|P1|Overall Study|Death Due to Adverse Event|1
1006819|NCT00391274|3296235|P2|Overall Study|Withdrawal by Subject|3
1006820|NCT00391274|3296236|P1|Overall Study|Withdrawal by Subject|0
1006821|NCT00391274|3296235|P2|Overall Study|Physician Decision|2
1006822|NCT00391274|3296236|P1|Overall Study|Physician Decision|4
1006823|NCT00391274|3296235|P2|Overall Study|Lost to Follow-up|3
1006824|NCT00391274|3296236|P1|Overall Study|Lost to Follow-up|0
1006825|NCT00391274|3296235|P2|Overall Study|Death Due to Study Disease|45
1006826|NCT00391274|3296236|P1|Overall Study|Death Due to Study Disease|55
1006827|NCT00391222|3296255|P4|Period III (Double-Blind Treatment)|Other|0
1006828|NCT00391222|3296256|P3|Period III (Double-Blind Treatment)|Other|6
1006829|NCT00391222|3296257|P2|Period III (Double-Blind Treatment)|Other|1
1006830|NCT00391222|3296258|P1|Period III (Double-Blind Treatment)|Other|6
1006831|NCT00391222|3296255|P4|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
1006832|NCT00391222|3296256|P3|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3
1006833|NCT00391222|3296257|P2|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1
1006834|NCT00391222|3296258|P1|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
1006835|NCT00391222|3296255|P4|Period III (Double-Blind Treatment)|Pregnancy|0
1006836|NCT00391222|3296256|P3|Period III (Double-Blind Treatment)|Pregnancy|0
1006837|NCT00391222|3296257|P2|Period III (Double-Blind Treatment)|Pregnancy|2
1006838|NCT00391222|3296258|P1|Period III (Double-Blind Treatment)|Pregnancy|0
1006839|NCT00391222|3296255|P4|Period III (Double-Blind Treatment)|Adverse Event|0
1006840|NCT00391222|3296256|P3|Period III (Double-Blind Treatment)|Adverse Event|4
1006841|NCT00391222|3296257|P2|Period III (Double-Blind Treatment)|Adverse Event|2
1006842|NCT00391222|3296258|P1|Period III (Double-Blind Treatment)|Adverse Event|5
1006843|NCT00391222|3296255|P4|Period III (Double-Blind Treatment)|Lost to Follow-up|0
1006844|NCT00391222|3296256|P3|Period III (Double-Blind Treatment)|Lost to Follow-up|4
1006845|NCT00391222|3296257|P2|Period III (Double-Blind Treatment)|Lost to Follow-up|4
1006846|NCT00391222|3296258|P1|Period III (Double-Blind Treatment)|Lost to Follow-up|2
1006847|NCT00391222|3296255|P4|Period III (Double-Blind Treatment)|Withdrawal by Subject|0
1006848|NCT00391222|3296256|P3|Period III (Double-Blind Treatment)|Withdrawal by Subject|6
1006849|NCT00391222|3296257|P2|Period III (Double-Blind Treatment)|Withdrawal by Subject|12
1006850|NCT00391222|3296258|P1|Period III (Double-Blind Treatment)|Withdrawal by Subject|15
1006851|NCT00391222|3296255|P4|Period II (Open-label Risperidone LAI)|Other|24
1006852|NCT00391222|3296256|P3|Period II (Open-label Risperidone LAI)|Other|0
1006853|NCT00391222|3296257|P2|Period II (Open-label Risperidone LAI)|Other|0
1006854|NCT00391222|3296258|P1|Period II (Open-label Risperidone LAI)|Other|0
1006855|NCT00391222|3296255|P4|Period II (Open-label Risperidone LAI)|Non-responder|97
1006856|NCT00391222|3296256|P3|Period II (Open-label Risperidone LAI)|Non-responder|0
1006857|NCT00391222|3296257|P2|Period II (Open-label Risperidone LAI)|Non-responder|0
1006858|NCT00391222|3296258|P1|Period II (Open-label Risperidone LAI)|Non-responder|0
1006859|NCT00391222|3296255|P4|Period II (Open-label Risperidone LAI)|Adverse Event|10
1006860|NCT00391222|3296256|P3|Period II (Open-label Risperidone LAI)|Adverse Event|0
1006861|NCT00391222|3296257|P2|Period II (Open-label Risperidone LAI)|Adverse Event|0
1006862|NCT00391222|3296258|P1|Period II (Open-label Risperidone LAI)|Adverse Event|0
1006863|NCT00391222|3296255|P4|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5
1006864|NCT00391222|3296256|P3|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
1006865|NCT00391222|3296257|P2|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
1006866|NCT00391222|3296258|P1|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
1006867|NCT00391222|3296255|P4|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26
1006868|NCT00391222|3296256|P3|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
1006869|NCT00391222|3296257|P2|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
1006870|NCT00391222|3296258|P1|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
1006871|NCT00391092|3296284|P2|Overall Study|Alive in follow-up|84
1006872|NCT00391092|3296285|P1|Overall Study|Alive in follow-up|88
1006873|NCT00391092|3296284|P2|Overall Study|Alive on treatment|33
1006874|NCT00391092|3296285|P1|Overall Study|Alive on treatment|29
1006875|NCT00391092|3296284|P2|Overall Study|Lost to Follow-up|18
1006876|NCT00391092|3296285|P1|Overall Study|Lost to Follow-up|13
1006877|NCT00391092|3296284|P2|Overall Study|Death|81
1006878|NCT00391092|3296285|P1|Overall Study|Death|78
1006879|NCT00391053|3296328|P4|Overall Study|Withdrawal by Subject|1
1006880|NCT00391053|3296329|P3|Overall Study|Withdrawal by Subject|1
1006881|NCT00391053|3296330|P2|Overall Study|Withdrawal by Subject|1
1006882|NCT00391053|3296331|P1|Overall Study|Withdrawal by Subject|5
1006883|NCT00391053|3296328|P4|Overall Study|Lost to Follow-up|5
1006884|NCT00391053|3296329|P3|Overall Study|Lost to Follow-up|0
1006885|NCT00391053|3296330|P2|Overall Study|Lost to Follow-up|0
1006886|NCT00391053|3296331|P1|Overall Study|Lost to Follow-up|1
1006887|NCT00391053|3296328|P4|Overall Study|Protocol Violation|0
1006888|NCT00391053|3296329|P3|Overall Study|Protocol Violation|0
1006889|NCT00391053|3296330|P2|Overall Study|Protocol Violation|0
1006890|NCT00391053|3296331|P1|Overall Study|Protocol Violation|2
1006891|NCT00391053|3296328|P4|Overall Study|Serious Adverse Events|4
1006892|NCT00391053|3296329|P3|Overall Study|Serious Adverse Events|1
1006893|NCT00391053|3296330|P2|Overall Study|Serious Adverse Events|0
1006894|NCT00391053|3296331|P1|Overall Study|Serious Adverse Events|1
1006895|NCT00391027|3296355|P2|Overall Study|Other|3
1006896|NCT00391027|3296356|P1|Overall Study|Other|4
1006897|NCT00391027|3296355|P2|Overall Study|Withdrawal by Subject|1
1006898|NCT00391027|3296356|P1|Overall Study|Withdrawal by Subject|10
1006899|NCT00391027|3296355|P2|Overall Study|Lack of Efficacy|0
1006900|NCT00391027|3296356|P1|Overall Study|Lack of Efficacy|3
1006901|NCT00391027|3296355|P2|Overall Study|Adverse Event|8
1006902|NCT00391027|3296356|P1|Overall Study|Adverse Event|8
1006903|NCT00390884|3296396|P2|Overall Study|Withdrawal by Subject|2
1006904|NCT00390884|3296397|P1|Overall Study|Withdrawal by Subject|2
1006905|NCT00390858|3296409|P2|Overall Study|Withdrawal by Subject|4
1006906|NCT00390858|3296410|P1|Overall Study|Withdrawal by Subject|3
1006907|NCT00390858|3296409|P2|Overall Study|Lack of Efficacy|1
1006908|NCT00390858|3296410|P1|Overall Study|Lack of Efficacy|0
1006909|NCT00390858|3296409|P2|Overall Study|Adverse Event|2
1006910|NCT00390858|3296410|P1|Overall Study|Adverse Event|6
1006911|NCT00390806|3296424|P2|Overall Study|Ongoing|2
1006912|NCT00390806|3296425|P1|Overall Study|Ongoing|4
1006913|NCT00390806|3296424|P2|Overall Study|Physician Decision|1
1006914|NCT00390806|3296425|P1|Overall Study|Physician Decision|0
1006915|NCT00390806|3296424|P2|Overall Study|Death|0
1006916|NCT00390806|3296425|P1|Overall Study|Death|1
1006917|NCT00390806|3296424|P2|Overall Study|Investigator Decision|6
1006918|NCT00390806|3296425|P1|Overall Study|Investigator Decision|4
1006919|NCT00390806|3296424|P2|Overall Study|Withdrawal by Subject|15
1006920|NCT00390806|3296425|P1|Overall Study|Withdrawal by Subject|12
1006921|NCT00390806|3296424|P2|Overall Study|Protocol Violation|2
1006922|NCT00390806|3296425|P1|Overall Study|Protocol Violation|2
1006923|NCT00390806|3296424|P2|Overall Study|Lost to Follow-up|6
1006924|NCT00390806|3296425|P1|Overall Study|Lost to Follow-up|7
1006925|NCT00390780|3296493|P2|Overall Study|SAE, death|1
1006926|NCT00390780|3296494|P1|Overall Study|SAE, death|0
1006927|NCT00390780|3296493|P2|Overall Study|Investigator decision, SAE, other reason|1
1006928|NCT00390780|3296494|P1|Overall Study|Investigator decision, SAE, other reason|0
1006929|NCT00390780|3296493|P2|Overall Study|Lost to follow up and other reasons|1
1006930|NCT00390780|3296494|P1|Overall Study|Lost to follow up and other reasons|0
1006931|NCT00390780|3296493|P2|Overall Study|Inclusion criteria not satisfied|2
1006932|NCT00390780|3296494|P1|Overall Study|Inclusion criteria not satisfied|0
1006933|NCT00390780|3296493|P2|Overall Study|Withdrawal by Subject|2
1006934|NCT00390780|3296494|P1|Overall Study|Withdrawal by Subject|1
1006935|NCT00390780|3296493|P2|Overall Study|Death|3
1006936|NCT00390780|3296494|P1|Overall Study|Death|1
1006937|NCT00390780|3296493|P2|Overall Study|Adverse Event|3
1006938|NCT00390780|3296494|P1|Overall Study|Adverse Event|2
1006939|NCT00390780|3296493|P2|Overall Study|Lost to Follow-up|6
1006940|NCT00390780|3296494|P1|Overall Study|Lost to Follow-up|3
1006941|NCT00390780|3296493|P2|Overall Study|Protocol Violation|4
1006942|NCT00390780|3296494|P1|Overall Study|Protocol Violation|6
1006943|NCT00390780|3296493|P2|Overall Study|Not completed|4
1006944|NCT00390780|3296494|P1|Overall Study|Not completed|10
1006945|NCT00390689|3296527|P3|Overall Study|Investigator's judgement|0
1006946|NCT00390689|3296528|P2|Overall Study|Investigator's judgement|0
1006947|NCT00390689|3296529|P1|Overall Study|Investigator's judgement|2
1006948|NCT00390689|3296527|P3|Overall Study|Protocol Violation|0
1006949|NCT00390689|3296528|P2|Overall Study|Protocol Violation|0
1006950|NCT00390689|3296529|P1|Overall Study|Protocol Violation|1
1006951|NCT00390689|3296527|P3|Overall Study|Lack of Efficacy|1
1006952|NCT00390689|3296528|P2|Overall Study|Lack of Efficacy|0
1006953|NCT00390689|3296529|P1|Overall Study|Lack of Efficacy|0
1006954|NCT00390689|3296527|P3|Overall Study|Adverse Event|2
1006955|NCT00390689|3296528|P2|Overall Study|Adverse Event|5
1006956|NCT00390689|3296529|P1|Overall Study|Adverse Event|2
1006957|NCT00390572|3296604|P2|Overall Study|health condition|1
1006958|NCT00390572|3296605|P1|Overall Study|health condition|0
1006959|NCT00390572|3296604|P2|Overall Study|Lost to Follow-up|4
1006960|NCT00390572|3296605|P1|Overall Study|Lost to Follow-up|8
1006961|NCT00390546|3296631|P2|Overall Study|Physician Decision|5
1006962|NCT00390546|3296632|P1|Overall Study|Physician Decision|5
1006963|NCT00390546|3296631|P2|Overall Study|Renal impairment|0
1006964|NCT00390546|3296632|P1|Overall Study|Renal impairment|1
1006965|NCT00390468|3296642|P1|Overall Study|Lack of Efficacy|1
1006966|NCT00390468|3296642|P1|Overall Study|Protocol Violation|2
1006967|NCT00390455|3296648|P2|Overall Study|Other Medical Reasons|11
1006968|NCT00390455|3296649|P1|Overall Study|Other Medical Reasons|7
1006969|NCT00390455|3296648|P2|Overall Study|Alternate Treatment|1
1006970|NCT00390455|3296649|P1|Overall Study|Alternate Treatment|0
1006971|NCT00390455|3296648|P2|Overall Study|Withdrawal by Subject|8
1006972|NCT00390455|3296649|P1|Overall Study|Withdrawal by Subject|8
1006973|NCT00390455|3296648|P2|Overall Study|Adverse Event|3
1006974|NCT00390455|3296649|P1|Overall Study|Adverse Event|17
1006975|NCT00390416|3296689|P1|Overall Study|Not treated|3
1006976|NCT00390416|3296689|P1|Overall Study|Withdrawal by Subject|1
1006977|NCT00390221|3296710|P3|Overall Study|Not Specified|2
1006978|NCT00390221|3296711|P2|Overall Study|Not Specified|4
1006979|NCT00390221|3296712|P1|Overall Study|Not Specified|3
1006980|NCT00390221|3296710|P3|Overall Study|Subject Non-compliance|2
1006981|NCT00390221|3296711|P2|Overall Study|Subject Non-compliance|0
1006982|NCT00390221|3296712|P1|Overall Study|Subject Non-compliance|1
1006983|NCT00390221|3296710|P3|Overall Study|Withdrawal by Subject|7
1006984|NCT00390221|3296711|P2|Overall Study|Withdrawal by Subject|9
1006985|NCT00390221|3296712|P1|Overall Study|Withdrawal by Subject|13
1006986|NCT00390221|3296710|P3|Overall Study|Investigator Decision|1
1006987|NCT00390221|3296711|P2|Overall Study|Investigator Decision|0
1006988|NCT00390221|3296712|P1|Overall Study|Investigator Decision|0
1006989|NCT00390221|3296710|P3|Overall Study|Adverse Event|3
1006990|NCT00390221|3296711|P2|Overall Study|Adverse Event|4
1006991|NCT00390221|3296712|P1|Overall Study|Adverse Event|1
1006992|NCT00390221|3296710|P3|Overall Study|Lost to Follow-up|0
1006993|NCT00390221|3296711|P2|Overall Study|Lost to Follow-up|3
1006994|NCT00390221|3296712|P1|Overall Study|Lost to Follow-up|0
1006995|NCT00390013|3296742|P4|Phase 2 First Treatment|Withdrawal by Subject|0
1006996|NCT00390013|3296743|P3|Phase 2 First Treatment|Withdrawal by Subject|0
1006997|NCT00390013|3296744|P2|Phase 2 First Treatment|Withdrawal by Subject|1
1006998|NCT00390013|3296745|P1|Phase 2 First Treatment|Withdrawal by Subject|0
1006999|NCT00390013|3296742|P4|Phase 2 First Treatment|tired|0
1007000|NCT00390013|3296743|P3|Phase 2 First Treatment|tired|0
1007001|NCT00390013|3296744|P2|Phase 2 First Treatment|tired|0
1007002|NCT00390013|3296745|P1|Phase 2 First Treatment|tired|1
1007003|NCT00390013|3296742|P4|Phase 1|tired|1
1007004|NCT00390013|3296743|P3|Phase 1|tired|0
1007005|NCT00390013|3296744|P2|Phase 1|tired|0
1007006|NCT00390013|3296745|P1|Phase 1|tired|0
1007007|NCT00389831|3296770|P2|Overall Study|Lost to Follow-up|1
1007008|NCT00389831|3296771|P1|Overall Study|Lost to Follow-up|0
1007009|NCT00389831|3296770|P2|Overall Study|Other reasons|2
1007010|NCT00389831|3296771|P1|Overall Study|Other reasons|0
1007011|NCT00389831|3296770|P2|Overall Study|Did not receive treatment.|2
1007012|NCT00389831|3296771|P1|Overall Study|Did not receive treatment.|0
1007013|NCT00389831|3296770|P2|Overall Study|Lack of Efficacy|2
1007014|NCT00389831|3296771|P1|Overall Study|Lack of Efficacy|0
1007015|NCT00389597|3296834|P4|Overall Study|Lost to Follow-up|6
1007016|NCT00389597|3296835|P3|Overall Study|Lost to Follow-up|4
1007017|NCT00389597|3296836|P2|Overall Study|Lost to Follow-up|6
1007018|NCT00389597|3296837|P1|Overall Study|Lost to Follow-up|8
1007019|NCT00389519|3296862|P4|Treated|Reason not specified|2
1007020|NCT00389519|3296863|P3|Treated|Reason not specified|0
1007021|NCT00389519|3296864|P2|Treated|Reason not specified|1
1007022|NCT00389519|3296865|P1|Treated|Reason not specified|1
1007023|NCT00389519|3296862|P4|Treated|Adverse Event|2
1007024|NCT00389519|3296863|P3|Treated|Adverse Event|0
1007025|NCT00389519|3296864|P2|Treated|Adverse Event|0
1007026|NCT00389519|3296865|P1|Treated|Adverse Event|1
1007027|NCT00389519|3296862|P4|Randomized|Did not receive study drug|0
1007028|NCT00389519|3296863|P3|Randomized|Did not receive study drug|0
1007029|NCT00389519|3296864|P2|Randomized|Did not receive study drug|0
1007030|NCT00389519|3296865|P1|Randomized|Did not receive study drug|2
1007031|NCT00389519|3296862|P4|Placebo Run-In|Reason not specified|0
1007032|NCT00389519|3296863|P3|Placebo Run-In|Reason not specified|0
1007033|NCT00389519|3296864|P2|Placebo Run-In|Reason not specified|0
1007034|NCT00389519|3296865|P1|Placebo Run-In|Reason not specified|40
1007035|NCT00389519|3296862|P4|Placebo Run-In|Withdrawal by Subject|0
1007036|NCT00389519|3296863|P3|Placebo Run-In|Withdrawal by Subject|0
1007037|NCT00389519|3296864|P2|Placebo Run-In|Withdrawal by Subject|0
1007038|NCT00389519|3296865|P1|Placebo Run-In|Withdrawal by Subject|19
1007039|NCT00389519|3296862|P4|Placebo Run-In|Did not meet blood pressure criteria|0
1007040|NCT00389519|3296863|P3|Placebo Run-In|Did not meet blood pressure criteria|0
1007041|NCT00389519|3296864|P2|Placebo Run-In|Did not meet blood pressure criteria|0
1007042|NCT00389519|3296865|P1|Placebo Run-In|Did not meet blood pressure criteria|119
1007043|NCT00389441|3296942|P1|Overall Study|Clinical progression|1
1007044|NCT00389441|3296942|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|2
1007045|NCT00389441|3296942|P1|Overall Study|Objective progression or relapse|26
1007046|NCT00389441|3296942|P1|Overall Study|Global deterioration of health status|4
1007047|NCT00389441|3296942|P1|Overall Study|Protocol Violation|1
1007048|NCT00389441|3296942|P1|Overall Study|Physician Decision|1
1007049|NCT00389441|3296942|P1|Overall Study|Withdrawal by Subject|4
1007050|NCT00389441|3296942|P1|Overall Study|Lost to Follow-up|2
1007051|NCT00389441|3296942|P1|Overall Study|Death|4
1007052|NCT00389441|3296942|P1|Overall Study|Adverse Event|7
1007053|NCT00389324|3296951|P1|Subcutaneous Phase|Lost to Follow-up|1
1007054|NCT00389324|3296951|P1|Subcutaneous Phase|Withdrawal by Subject|2
1007055|NCT00389324|3296951|P1|Subcutaneous Phase|Non-compliance with study medication|2
1007056|NCT00389324|3296951|P1|Subcutaneous Phase|Adverse Event|2
1007057|NCT00389324|3296951|P1|Run-In Phase|Withdrawal by Subject|1
1007058|NCT00389324|3296951|P1|Run-In Phase|Lost to Follow-up|1
1007059|NCT00389324|3296951|P1|Run-In Phase|Adverse Event|1
1007060|NCT00389207|3296961|P3|Overall Study|Not specified|9
1007061|NCT00389207|3296962|P2|Overall Study|Not specified|23
1007062|NCT00389207|3296963|P1|Overall Study|Not specified|17
1007063|NCT00389207|3296961|P3|Overall Study|Withdrawal by Subject|11
1007064|NCT00389207|3296962|P2|Overall Study|Withdrawal by Subject|7
1007065|NCT00389207|3296963|P1|Overall Study|Withdrawal by Subject|5
1007066|NCT00389207|3296961|P3|Overall Study|Lost to Follow-up|7
1007067|NCT00389207|3296962|P2|Overall Study|Lost to Follow-up|9
1007068|NCT00389207|3296963|P1|Overall Study|Lost to Follow-up|12
1007069|NCT00389207|3296961|P3|Overall Study|Protocol Violation|4
1007070|NCT00389207|3296962|P2|Overall Study|Protocol Violation|1
1007071|NCT00389207|3296963|P1|Overall Study|Protocol Violation|3
1007072|NCT00389207|3296961|P3|Overall Study|Adverse Event|10
1007073|NCT00389207|3296962|P2|Overall Study|Adverse Event|32
1007074|NCT00389207|3296963|P1|Overall Study|Adverse Event|26
1007075|NCT00389064|3297086|P2|Overall Study|Multiple Reasons|11
1007076|NCT00389064|3297087|P1|Overall Study|Multiple Reasons|9
1007077|NCT00389064|3297086|P2|Overall Study|Protocol Violation|0
1007078|NCT00389064|3297087|P1|Overall Study|Protocol Violation|2
1007079|NCT00389064|3297086|P2|Overall Study|Lost to Follow-up|2
1007080|NCT00389064|3297087|P1|Overall Study|Lost to Follow-up|1
1007081|NCT00389064|3297086|P2|Overall Study|Physician Decision|2
1007082|NCT00389064|3297087|P1|Overall Study|Physician Decision|2
1007083|NCT00389064|3297086|P2|Overall Study|Withdrawal by Subject|27
1007084|NCT00389064|3297087|P1|Overall Study|Withdrawal by Subject|17
1007085|NCT00389064|3297086|P2|Overall Study|Lack of Efficacy|14
1007086|NCT00389064|3297087|P1|Overall Study|Lack of Efficacy|3
1007087|NCT00389064|3297086|P2|Overall Study|Adverse Event|3
1007088|NCT00389064|3297087|P1|Overall Study|Adverse Event|11
1007089|NCT00388973|3297115|P2|Overall Study|Did not complete 2-week follow-up visit|17
1007090|NCT00388973|3297116|P1|Overall Study|Did not complete 2-week follow-up visit|17
1007091|NCT00388973|3297115|P2|Overall Study|Left region|1
1007092|NCT00388973|3297116|P1|Overall Study|Left region|0
1007093|NCT00388973|3297115|P2|Overall Study|Did not complete 61 days of treatment|4
1007094|NCT00388973|3297116|P1|Overall Study|Did not complete 61 days of treatment|5
1007095|NCT00388973|3297115|P2|Overall Study|Study specific Discontinuation Criteria|1
1007096|NCT00388973|3297116|P1|Overall Study|Study specific Discontinuation Criteria|0
1007097|NCT00388973|3297115|P2|Overall Study|Withdrawal by Subject|17
1007098|NCT00388973|3297116|P1|Overall Study|Withdrawal by Subject|14
1007099|NCT00388973|3297115|P2|Overall Study|Protocol Violation|0
1007100|NCT00388973|3297116|P1|Overall Study|Protocol Violation|3
1007101|NCT00388973|3297115|P2|Overall Study|Lack of Efficacy|12
1007102|NCT00388973|3297116|P1|Overall Study|Lack of Efficacy|1
1007103|NCT00388973|3297115|P2|Overall Study|Adverse Event|6
1007104|NCT00388973|3297116|P1|Overall Study|Adverse Event|16
1007105|NCT00388947|3297136|P1|Overall Study|Protocol Violation|47
1007106|NCT00388726|3297152|P2|Overall Study|Death|2
1007107|NCT00388726|3297153|P1|Overall Study|Death|3
1007108|NCT00388726|3297152|P2|Overall Study|Physician Decision|13
1007109|NCT00388726|3297153|P1|Overall Study|Physician Decision|18
1007110|NCT00388726|3297152|P2|Overall Study|Administrative|9
1007111|NCT00388726|3297153|P1|Overall Study|Administrative|6
1007112|NCT00388726|3297152|P2|Overall Study|Withdrawal by Subject|7
1007113|NCT00388726|3297153|P1|Overall Study|Withdrawal by Subject|10
1007114|NCT00388726|3297152|P2|Overall Study|Clinical Progression|36
1007115|NCT00388726|3297153|P1|Overall Study|Clinical Progression|61
1007116|NCT00388726|3297152|P2|Overall Study|Progressive Disease|153
1007117|NCT00388726|3297153|P1|Overall Study|Progressive Disease|336
1007118|NCT00388726|3297152|P2|Overall Study|Adverse Event|24
1007119|NCT00388726|3297153|P1|Overall Study|Adverse Event|50
1007120|NCT00388674|3297167|P2|End of Study|Not Reported|1
1007121|NCT00388674|3297168|P1|End of Study|Not Reported|0
1007122|NCT00388674|3297167|P2|End of Study|No Off-Treatment Status Data|30
1007123|NCT00388674|3297168|P1|End of Study|No Off-Treatment Status Data|22
1007124|NCT00388674|3297167|P2|End of Study|Participant Withdrew Consent|673
1007125|NCT00388674|3297168|P1|End of Study|Participant Withdrew Consent|437
1007126|NCT00388674|3297167|P2|End of Study|Not Defined|214
1007127|NCT00388674|3297168|P1|End of Study|Not Defined|135
1007128|NCT00388674|3297167|P2|End of Study|Non-Study Related Comorbidities|4
1007129|NCT00388674|3297168|P1|End of Study|Non-Study Related Comorbidities|3
1007130|NCT00388674|3297167|P2|End of Study|Malignancy (Non-HCC)|1
1007131|NCT00388674|3297168|P1|End of Study|Malignancy (Non-HCC)|1
1007132|NCT00388674|3297167|P2|End of Study|Lost to Follow-up|715
1007133|NCT00388674|3297168|P1|End of Study|Lost to Follow-up|587
1007134|NCT00388674|3297167|P2|End of Study|HCC|7
1007135|NCT00388674|3297168|P1|End of Study|HCC|8
1007136|NCT00388674|3297167|P2|End of Study|HBV Disease Progression (Non-HCC)|9
1007137|NCT00388674|3297168|P1|End of Study|HBV Disease Progression (Non-HCC)|3
1007138|NCT00388674|3297167|P2|End of Study|Death|262
1007139|NCT00388674|3297168|P1|End of Study|Death|239
1007140|NCT00388674|3297167|P2|End of Study|Administrative Reason By Sponsor|253
1007141|NCT00388674|3297168|P1|End of Study|Administrative Reason By Sponsor|299
1007142|NCT00388674|3297167|P2|Initial Treatment|Not Reported|12
1007143|NCT00388674|3297168|P1|Initial Treatment|Not Reported|10
1007144|NCT00388674|3297167|P2|Initial Treatment|No Off-Treatment Status Data|13
1007145|NCT00388674|3297168|P1|Initial Treatment|No Off-Treatment Status Data|11
1007146|NCT00388674|3297167|P2|Initial Treatment|Participant Request|673
1007147|NCT00388674|3297168|P1|Initial Treatment|Participant Request|501
1007148|NCT00388674|3297167|P2|Initial Treatment|Study Drug Toxicity|92
1007149|NCT00388674|3297168|P1|Initial Treatment|Study Drug Toxicity|5
1007150|NCT00388674|3297167|P2|Initial Treatment|Pregnancy|16
1007151|NCT00388674|3297168|P1|Initial Treatment|Pregnancy|26
1007152|NCT00388674|3297167|P2|Initial Treatment|Partial or inadequate Treatment|472
1007153|NCT00388674|3297168|P1|Initial Treatment|Partial or inadequate Treatment|112
1007154|NCT00388674|3297167|P2|Initial Treatment|Not Defined|172
1007155|NCT00388674|3297168|P1|Initial Treatment|Not Defined|125
1007156|NCT00388674|3297167|P2|Initial Treatment|Non-Study related Comorbidities|4
1007157|NCT00388674|3297168|P1|Initial Treatment|Non-Study related Comorbidities|3
1007158|NCT00388674|3297167|P2|Initial Treatment|Never Treated with Study Medication|7
1007159|NCT00388674|3297168|P1|Initial Treatment|Never Treated with Study Medication|1
1007160|NCT00388674|3297167|P2|Initial Treatment|Malignancy (Non-HCC)|3
1007161|NCT00388674|3297168|P1|Initial Treatment|Malignancy (Non-HCC)|7
1007162|NCT00388674|3297167|P2|Initial Treatment|Lost to Follow-up|624
1007163|NCT00388674|3297168|P1|Initial Treatment|Lost to Follow-up|526
1007164|NCT00388674|3297167|P2|Initial Treatment|HCC|20
1007165|NCT00388674|3297168|P1|Initial Treatment|HCC|12
1007166|NCT00388674|3297167|P2|Initial Treatment|Non-HCC HBV Disease Progression|17
1007167|NCT00388674|3297168|P1|Initial Treatment|Non-HCC HBV Disease Progression|11
1007168|NCT00388674|3297167|P2|Initial Treatment|Death|216
1007169|NCT00388674|3297168|P1|Initial Treatment|Death|215
1007170|NCT00388674|3297167|P2|Initial Treatment|Adverse Event|87
1007171|NCT00388674|3297168|P1|Initial Treatment|Adverse Event|22
1007172|NCT00388674|3297167|P2|Initial Treatment|Administrative Reason by Sponsor|158
1007173|NCT00388674|3297168|P1|Initial Treatment|Administrative Reason by Sponsor|241
1007174|NCT00388583|3297186|P2|Overall Study|Did not receive vaccine|1
1007175|NCT00388583|3297187|P1|Overall Study|Did not receive vaccine|0
1007176|NCT00388583|3297186|P2|Overall Study|Serious Adverse Event|0
1007177|NCT00388583|3297187|P1|Overall Study|Serious Adverse Event|2
1007178|NCT00388583|3297186|P2|Overall Study|Withdrawal by Subject|3
1007179|NCT00388583|3297187|P1|Overall Study|Withdrawal by Subject|3
1007180|NCT00388583|3297186|P2|Overall Study|Protocol Violation|0
1007181|NCT00388583|3297187|P1|Overall Study|Protocol Violation|1
1007182|NCT00388505|3297201|P2|Overall Study|Unable to classify|3
1007183|NCT00388505|3297202|P1|Overall Study|Unable to classify|4
1007184|NCT00388505|3297201|P2|Overall Study|Protocol Violation|5
1007185|NCT00388505|3297202|P1|Overall Study|Protocol Violation|6
1007186|NCT00388505|3297201|P2|Overall Study|Administrative Reason|0
1007187|NCT00388505|3297202|P1|Overall Study|Administrative Reason|1
1007188|NCT00388505|3297201|P2|Overall Study|Inappropriate Enrollment|1
1007189|NCT00388505|3297202|P1|Overall Study|Inappropriate Enrollment|0
1007190|NCT00388505|3297201|P2|Overall Study|Lost to Follow-up|3
1007191|NCT00388505|3297202|P1|Overall Study|Lost to Follow-up|5
1007192|NCT00388505|3297201|P2|Overall Study|Withdrawal by Subject|9
1007193|NCT00388505|3297202|P1|Overall Study|Withdrawal by Subject|24
1007194|NCT00388505|3297201|P2|Overall Study|Adverse Event or Death|17
1007195|NCT00388505|3297202|P1|Overall Study|Adverse Event or Death|43
1007196|NCT00388362|3297257|P1|Remained on Study Median of 514 Days|Death|2
1007197|NCT00388362|3297257|P1|Enrolled|Withdrawal by Subject|1
1007198|NCT00388362|3297257|P1|Enrolled|Loss insurance|1
1007199|NCT00388362|3297257|P1|Enrolled|Death|1
1007200|NCT00388362|3297257|P1|Enrolled|Adverse Event|9
1007201|NCT00388362|3297257|P1|Enrolled|Ineligible|1
1007202|NCT00388349|3297262|P2|Phase I Dose Escalation|Dose reduction due to DLT|3
1007203|NCT00388349|3297263|P1|Phase I Dose Escalation|Dose reduction due to DLT|0
1007204|NCT00388154|3297272|P1|Overall Study|Withdrawal by Subject|1
1007205|NCT00388037|3297277|P1|Overall Study|Protocol Violation|1
1007206|NCT00387894|3297285|P1|Overall Study|Withdrawal by Subject|1
1007207|NCT00387881|3297292|P2|Overall Study|Not otherwise specified|7
1007208|NCT00387881|3297293|P1|Overall Study|Not otherwise specified|11
1007209|NCT00387881|3297292|P2|Overall Study|No opportunity to treat headache|34
1007210|NCT00387881|3297293|P1|Overall Study|No opportunity to treat headache|32
1007211|NCT00387881|3297292|P2|Overall Study|Not eligible|7
1007212|NCT00387881|3297293|P1|Overall Study|Not eligible|6
1007213|NCT00387881|3297292|P2|Overall Study|Sponsor terminated Study|1
1007214|NCT00387881|3297293|P1|Overall Study|Sponsor terminated Study|0
1007215|NCT00387881|3297292|P2|Overall Study|Withdrawal by Subject|18
1007216|NCT00387881|3297293|P1|Overall Study|Withdrawal by Subject|15
1007217|NCT00387881|3297292|P2|Overall Study|Protocol Violation|12
1007218|NCT00387881|3297293|P1|Overall Study|Protocol Violation|2
1007219|NCT00387881|3297292|P2|Overall Study|Lost to Follow-up|23
1007220|NCT00387881|3297293|P1|Overall Study|Lost to Follow-up|23
1007221|NCT00387790|3297326|P1|Overall Study|Ineligible for study|2
1007222|NCT00387790|3297326|P1|Overall Study|Withdrawal by Subject|3
1007223|NCT00387790|3297326|P1|Overall Study|Physician Decision|2
1007224|NCT00387790|3297326|P1|Overall Study|Lack of Efficacy|2
1007225|NCT00387790|3297326|P1|Overall Study|Adverse Event|5
1007226|NCT00387764|3297332|P1|Overall Study|Death|7
1007227|NCT00387764|3297332|P1|Overall Study|Other|2
1007228|NCT00387764|3297332|P1|Overall Study|Physician Decision|1
1007229|NCT00387764|3297332|P1|Overall Study|Sponsor Terminated Study|1
1007230|NCT00387764|3297332|P1|Overall Study|Withdrawal by Subject|8
1007231|NCT00387764|3297332|P1|Overall Study|Adverse Event|12
1007232|NCT00387725|3297360|P4|Overall Study|Parent/legal guardian request|1
1007233|NCT00387725|3297361|P3|Overall Study|Parent/legal guardian request|1
1007234|NCT00387725|3297362|P2|Overall Study|Parent/legal guardian request|0
1007235|NCT00387725|3297363|P1|Overall Study|Parent/legal guardian request|0
1007236|NCT00387725|3297360|P4|Overall Study|Withdrawal by Subject|0
1007237|NCT00387725|3297361|P3|Overall Study|Withdrawal by Subject|1
1007238|NCT00387725|3297362|P2|Overall Study|Withdrawal by Subject|0
1007239|NCT00387725|3297363|P1|Overall Study|Withdrawal by Subject|1
1007240|NCT00387725|3297360|P4|Overall Study|Protocol Violation|0
1007241|NCT00387725|3297361|P3|Overall Study|Protocol Violation|0
1007242|NCT00387725|3297362|P2|Overall Study|Protocol Violation|1
1007243|NCT00387725|3297363|P1|Overall Study|Protocol Violation|0
1007244|NCT00387725|3297360|P4|Overall Study|Adverse Event|1
1007245|NCT00387725|3297361|P3|Overall Study|Adverse Event|0
1007246|NCT00387725|3297362|P2|Overall Study|Adverse Event|0
1007247|NCT00387725|3297363|P1|Overall Study|Adverse Event|0
1007248|NCT00387712|3297383|P2|Overall Study|Withdrawal by Subject|12
1007249|NCT00387712|3297384|P1|Overall Study|Withdrawal by Subject|6
1007250|NCT00387712|3297383|P2|Overall Study|Lost to Follow-up|20
1007251|NCT00387712|3297384|P1|Overall Study|Lost to Follow-up|17
1007252|NCT00387712|3297383|P2|Overall Study|Physician Decision|4
1007253|NCT00387712|3297384|P1|Overall Study|Physician Decision|6
1007254|NCT00387647|3297415|P1|Overall Study|Death|18
1007255|NCT00387426|3297455|P1|Overall Study|Disease Progression|3
1007256|NCT00387426|3297455|P1|Overall Study|Toxicities|4
1007257|NCT00387426|3297455|P1|Overall Study|Lack of Response|7
1007258|NCT00387348|3297462|P3|Overall Study|Adverse Event|1
1007259|NCT00387348|3297463|P2|Overall Study|Adverse Event|0
1007260|NCT00387348|3297464|P1|Overall Study|Adverse Event|1
1007261|NCT00387348|3297462|P3|Overall Study|Withdrawal by Subject|2
1007262|NCT00387348|3297463|P2|Overall Study|Withdrawal by Subject|2
1007263|NCT00387348|3297464|P1|Overall Study|Withdrawal by Subject|0
1007264|NCT00387348|3297462|P3|Overall Study|Physician Decision|1
1007265|NCT00387348|3297463|P2|Overall Study|Physician Decision|0
1007266|NCT00387348|3297464|P1|Overall Study|Physician Decision|1
1007267|NCT00387348|3297462|P3|Overall Study|Death|0
1007268|NCT00387348|3297463|P2|Overall Study|Death|1
1007269|NCT00387348|3297464|P1|Overall Study|Death|1
1007270|NCT00387153|3297493|P1|Overall Study|Lack of Response|4
1007271|NCT00387153|3297493|P1|Overall Study|Disease Progression|3
1007272|NCT00387153|3297493|P1|Overall Study|Adverse Event|1
1007273|NCT00387127|3297499|P2|Overall Study|Sponsor Unblinded|0
1007274|NCT00387127|3297500|P1|Overall Study|Sponsor Unblinded|1
1007275|NCT00387127|3297499|P2|Overall Study|Serious Adverse Event|1
1007276|NCT00387127|3297500|P1|Overall Study|Serious Adverse Event|1
1007277|NCT00387127|3297499|P2|Overall Study|Required by Protocol Amendment #4|10
1007278|NCT00387127|3297500|P1|Overall Study|Required by Protocol Amendment #4|12
1007279|NCT00387127|3297499|P2|Overall Study|Withdrawal by Subject|2
1007280|NCT00387127|3297500|P1|Overall Study|Withdrawal by Subject|3
1007281|NCT00387127|3297499|P2|Overall Study|Physician Decision|1
1007282|NCT00387127|3297500|P1|Overall Study|Physician Decision|0
1007283|NCT00387127|3297499|P2|Overall Study|Death|16
1007284|NCT00387127|3297500|P1|Overall Study|Death|16
1007285|NCT00387127|3297499|P2|Overall Study|Lost to Follow-up|4
1007286|NCT00387127|3297500|P1|Overall Study|Lost to Follow-up|0
1007287|NCT00387088|3297542|P2|Overall Study|Other|52
1007288|NCT00387088|3297543|P1|Overall Study|Other|58
1007289|NCT00387088|3297542|P2|Overall Study|Lost to Follow-up|28
1007290|NCT00387088|3297543|P1|Overall Study|Lost to Follow-up|22
1007291|NCT00387088|3297542|P2|Overall Study|Lack of Efficacy|67
1007292|NCT00387088|3297543|P1|Overall Study|Lack of Efficacy|28
1007293|NCT00387088|3297542|P2|Overall Study|Withdrawal by Subject|35
1007294|NCT00387088|3297543|P1|Overall Study|Withdrawal by Subject|20
1007295|NCT00387088|3297542|P2|Overall Study|Protocol Violation|35
1007296|NCT00387088|3297543|P1|Overall Study|Protocol Violation|47
1007297|NCT00387088|3297542|P2|Overall Study|Adverse Event|156
1007298|NCT00387088|3297543|P1|Overall Study|Adverse Event|143
1007299|NCT00387010|3297600|P1|Treatment Period|Participant reported study drug stolen|1
1007300|NCT00387010|3297600|P1|Treatment Period|Noncompliance with study procedures|3
1007301|NCT00387010|3297600|P1|Treatment Period|Noncompliance with study medication|2
1007302|NCT00387010|3297600|P1|Treatment Period|Withdrawal by Subject|1
1007303|NCT00387010|3297600|P1|Treatment Period|Adverse Event|4
1007304|NCT00387010|3297600|P1|Dose Titration Period|Noncompliance with study procedures|7
1007305|NCT00387010|3297600|P1|Dose Titration Period|Noncompliance with study medication|8
1007306|NCT00387010|3297600|P1|Dose Titration Period|Lost to Follow-up|2
1007307|NCT00387010|3297600|P1|Dose Titration Period|Protocol Violation|1
1007308|NCT00387010|3297600|P1|Dose Titration Period|Withdrawal by Subject|3
1007309|NCT00387010|3297600|P1|Dose Titration Period|Lack of Efficacy|5
1007310|NCT00387010|3297600|P1|Dose Titration Period|Adverse Event|12
1007311|NCT00386776|3297627|P1|Overall Study|Withdrawal by Subject|8
1007312|NCT00386607|3297637|P2|Extension|Unsatisfactory therapeutic effect|1
1007313|NCT00386607|3297638|P1|Extension|Unsatisfactory therapeutic effect|0
1007314|NCT00386607|3297637|P2|Extension|Patient withdrew consent|5
1007315|NCT00386607|3297638|P1|Extension|Patient withdrew consent|0
1007316|NCT00386607|3297637|P2|Extension|Lost to Follow-up|3
1007317|NCT00386607|3297638|P1|Extension|Lost to Follow-up|0
1007318|NCT00386607|3297637|P2|Extension|Administrative problems|1
1007319|NCT00386607|3297638|P1|Extension|Administrative problems|0
1007320|NCT00386607|3297637|P2|Extension|Abnormal laboratory value(s)|1
1007321|NCT00386607|3297638|P1|Extension|Abnormal laboratory value(s)|0
1007322|NCT00386607|3297637|P2|Extension|Adverse Event|6
1007323|NCT00386607|3297638|P1|Extension|Adverse Event|0
1007324|NCT00386607|3297637|P2|Core|Protocol Deviation|0
1007325|NCT00386607|3297638|P1|Core|Protocol Deviation|6
1007326|NCT00386607|3297637|P2|Core|Administrative problems|0
1007327|NCT00386607|3297638|P1|Core|Administrative problems|1
1007328|NCT00386607|3297637|P2|Core|Lost to Follow-up|0
1007329|NCT00386607|3297638|P1|Core|Lost to Follow-up|23
1007330|NCT00386607|3297637|P2|Core|Patient withdrew consent|0
1007331|NCT00386607|3297638|P1|Core|Patient withdrew consent|15
1007332|NCT00386607|3297637|P2|Core|Condition no longer requires study drug|0
1007333|NCT00386607|3297638|P1|Core|Condition no longer requires study drug|4
1007334|NCT00386607|3297637|P2|Core|Unsatisfactory therapeutic effect|0
1007335|NCT00386607|3297638|P1|Core|Unsatisfactory therapeutic effect|23
1007336|NCT00386607|3297637|P2|Core|Abnormal laboratory value(s)|0
1007337|NCT00386607|3297638|P1|Core|Abnormal laboratory value(s)|3
1007338|NCT00386607|3297637|P2|Core|Adverse Event|0
1007339|NCT00386607|3297638|P1|Core|Adverse Event|40
1007340|NCT00386425|3297666|P3|Overall Study|Withdrawal by Subject|0
1007341|NCT00386425|3297667|P2|Overall Study|Withdrawal by Subject|1
1007342|NCT00386425|3297668|P1|Overall Study|Withdrawal by Subject|0
1007343|NCT00386425|3297666|P3|Overall Study|Physician Decision|0
1007344|NCT00386425|3297667|P2|Overall Study|Physician Decision|0
1007345|NCT00386425|3297668|P1|Overall Study|Physician Decision|3
1007346|NCT00386360|3297694|P2|Overall Study|Did not take any study medication|2
1007347|NCT00386360|3297695|P1|Overall Study|Did not take any study medication|0
1007348|NCT00386360|3297694|P2|Overall Study|Withdrawal by Subject|6
1007349|NCT00386360|3297695|P1|Overall Study|Withdrawal by Subject|3
1007350|NCT00386360|3297694|P2|Overall Study|Protocol Violation|3
1007351|NCT00386360|3297695|P1|Overall Study|Protocol Violation|0
1007352|NCT00386360|3297694|P2|Overall Study|Lost to Follow-up|2
1007353|NCT00386360|3297695|P1|Overall Study|Lost to Follow-up|0
1007354|NCT00386360|3297694|P2|Overall Study|Physician Decision|2
1007355|NCT00386360|3297695|P1|Overall Study|Physician Decision|2
1007356|NCT00386360|3297694|P2|Overall Study|Adverse Event|2
1007357|NCT00386360|3297695|P1|Overall Study|Adverse Event|4
1007358|NCT00386334|3297729|P2|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1
1007359|NCT00386334|3297730|P1|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3
1007360|NCT00386334|3297729|P2|Double Blind Period|Other|3
1007361|NCT00386334|3297730|P1|Double Blind Period|Other|3
1007362|NCT00386334|3297729|P2|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5
1007363|NCT00386334|3297730|P1|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4
1007364|NCT00386334|3297729|P2|Double Blind Period|Lack of Efficacy|11
1007365|NCT00386334|3297730|P1|Double Blind Period|Lack of Efficacy|20
1007366|NCT00386334|3297729|P2|Double Blind Period|Withdrawal by Subject|13
1007367|NCT00386334|3297730|P1|Double Blind Period|Withdrawal by Subject|9
1007368|NCT00386334|3297729|P2|Double Blind Period|Protocol Violation|1
1007369|NCT00386334|3297730|P1|Double Blind Period|Protocol Violation|1
1007370|NCT00386334|3297729|P2|Double Blind Period|Adverse Event|14
1007371|NCT00386334|3297730|P1|Double Blind Period|Adverse Event|9
1007372|NCT00386308|3297874|P2|Overall Study|Other Event|1
1007373|NCT00386308|3297875|P1|Overall Study|Other Event|8
1007374|NCT00386308|3297874|P2|Overall Study|Withdrawal by Subject|2
1007375|NCT00386308|3297875|P1|Overall Study|Withdrawal by Subject|6
1007376|NCT00386308|3297874|P2|Overall Study|Lost to Follow-up|6
1007377|NCT00386308|3297875|P1|Overall Study|Lost to Follow-up|10
1007378|NCT00386308|3297874|P2|Overall Study|Lack of Efficacy|2
1007379|NCT00386308|3297875|P1|Overall Study|Lack of Efficacy|0
1007380|NCT00386308|3297874|P2|Overall Study|Protocol Violation|5
1007381|NCT00386308|3297875|P1|Overall Study|Protocol Violation|2
1007382|NCT00386308|3297874|P2|Overall Study|Adverse Event|3
1007383|NCT00386308|3297875|P1|Overall Study|Adverse Event|3
1007384|NCT00386152|3297922|P3|Overall Study|Withdrawal by Subject|10
1007385|NCT00386152|3297923|P2|Overall Study|Withdrawal by Subject|6
1007386|NCT00386152|3297924|P1|Overall Study|Withdrawal by Subject|3
1007387|NCT00386152|3297922|P3|Overall Study|Protocol Violation|2
1007388|NCT00386152|3297923|P2|Overall Study|Protocol Violation|5
1007389|NCT00386152|3297924|P1|Overall Study|Protocol Violation|3
1007390|NCT00386152|3297922|P3|Overall Study|Completed chemotherapy|1
1007391|NCT00386152|3297923|P2|Overall Study|Completed chemotherapy|5
1007392|NCT00386152|3297924|P1|Overall Study|Completed chemotherapy|4
1007393|NCT00386152|3297922|P3|Overall Study|Lost to Follow-up|0
1007394|NCT00386152|3297923|P2|Overall Study|Lost to Follow-up|0
1007395|NCT00386152|3297924|P1|Overall Study|Lost to Follow-up|1
1007396|NCT00386152|3297922|P3|Overall Study|Physician Decision|4
1007397|NCT00386152|3297923|P2|Overall Study|Physician Decision|10
1007398|NCT00386152|3297924|P1|Overall Study|Physician Decision|13
1007399|NCT00386152|3297922|P3|Overall Study|Disease progression|5
1007400|NCT00386152|3297923|P2|Overall Study|Disease progression|4
1007401|NCT00386152|3297924|P1|Overall Study|Disease progression|7
1007402|NCT00386152|3297922|P3|Overall Study|Death|1
1007403|NCT00386152|3297923|P2|Overall Study|Death|0
1007404|NCT00386152|3297924|P1|Overall Study|Death|3
1007405|NCT00386152|3297922|P3|Overall Study|Chang from original chemo stratification|6
1007406|NCT00386152|3297923|P2|Overall Study|Chang from original chemo stratification|5
1007407|NCT00386152|3297924|P1|Overall Study|Chang from original chemo stratification|4
1007408|NCT00386152|3297922|P3|Overall Study|Adverse Event|4
1007409|NCT00386152|3297923|P2|Overall Study|Adverse Event|5
1007410|NCT00386152|3297924|P1|Overall Study|Adverse Event|6
1007411|NCT00386100|3297943|P2|Overall Study|Participant randomized in error|0
1007412|NCT00386100|3297944|P1|Overall Study|Participant randomized in error|1
1007413|NCT00386100|3297943|P2|Overall Study|Hb1Ac >8%|1
1007414|NCT00386100|3297944|P1|Overall Study|Hb1Ac >8%|0
1007415|NCT00386100|3297943|P2|Overall Study|Out of country for 5 months|0
1007416|NCT00386100|3297944|P1|Overall Study|Out of country for 5 months|1
1007417|NCT00386100|3297943|P2|Overall Study|Positive pregnancy test|3
1007418|NCT00386100|3297944|P1|Overall Study|Positive pregnancy test|1
1007419|NCT00386100|3297943|P2|Overall Study|Osteoporosis|1
1007420|NCT00386100|3297944|P1|Overall Study|Osteoporosis|0
1007421|NCT00386100|3297943|P2|Overall Study|7.6% bone loss|0
1007422|NCT00386100|3297944|P1|Overall Study|7.6% bone loss|1
1007423|NCT00386100|3297943|P2|Overall Study|DBP 93 mmHg at randomization|0
1007424|NCT00386100|3297944|P1|Overall Study|DBP 93 mmHg at randomization|1
1007425|NCT00386100|3297943|P2|Overall Study|Bone loss by DXA bone scan|0
1007426|NCT00386100|3297944|P1|Overall Study|Bone loss by DXA bone scan|1
1007427|NCT00386100|3297943|P2|Overall Study|Bad metabolic control & patient security|0
1007428|NCT00386100|3297944|P1|Overall Study|Bad metabolic control & patient security|1
1007429|NCT00386100|3297943|P2|Overall Study|Osteoporosis findings on Visit 2 DXA|1
1007430|NCT00386100|3297944|P1|Overall Study|Osteoporosis findings on Visit 2 DXA|0
1007431|NCT00386100|3297943|P2|Overall Study|Participant's PCP wanted to stop drug|0
1007432|NCT00386100|3297944|P1|Overall Study|Participant's PCP wanted to stop drug|1
1007433|NCT00386100|3297943|P2|Overall Study|Didn't meet entry criteria|1
1007434|NCT00386100|3297944|P1|Overall Study|Didn't meet entry criteria|1
1007435|NCT00386100|3297943|P2|Overall Study|Excessive bone loss vs. baseline value|1
1007436|NCT00386100|3297944|P1|Overall Study|Excessive bone loss vs. baseline value|0
1007437|NCT00386100|3297943|P2|Overall Study|Participant moving out of state|0
1007438|NCT00386100|3297944|P1|Overall Study|Participant moving out of state|2
1007439|NCT00386100|3297943|P2|Overall Study|Participant's concern due to CPK levels|0
1007440|NCT00386100|3297944|P1|Overall Study|Participant's concern due to CPK levels|1
1007441|NCT00386100|3297943|P2|Overall Study|Laboratory findings|0
1007442|NCT00386100|3297944|P1|Overall Study|Laboratory findings|1
1007443|NCT00386100|3297943|P2|Overall Study|Visit 11 DXA showed excessive bone loss|1
1007444|NCT00386100|3297944|P1|Overall Study|Visit 11 DXA showed excessive bone loss|0
1007445|NCT00386100|3297943|P2|Overall Study|Consecutive elevated Hba1C|0
1007446|NCT00386100|3297944|P1|Overall Study|Consecutive elevated Hba1C|1
1007447|NCT00386100|3297943|P2|Overall Study|BMD <2.5|0
1007448|NCT00386100|3297944|P1|Overall Study|BMD <2.5|1
1007449|NCT00386100|3297943|P2|Overall Study|Bone mass density (BMD) loss >6%|4
1007450|NCT00386100|3297944|P1|Overall Study|Bone mass density (BMD) loss >6%|4
1007451|NCT00386100|3297943|P2|Overall Study|Withdrawal by Subject|31
1007452|NCT00386100|3297944|P1|Overall Study|Withdrawal by Subject|32
1007453|NCT00386100|3297943|P2|Overall Study|Protocol Violation|3
1007454|NCT00386100|3297944|P1|Overall Study|Protocol Violation|5
1007455|NCT00386100|3297943|P2|Overall Study|Non-compliance|19
1007456|NCT00386100|3297944|P1|Overall Study|Non-compliance|18
1007457|NCT00386100|3297943|P2|Overall Study|Lost to Follow-up|29
1007458|NCT00386100|3297944|P1|Overall Study|Lost to Follow-up|29
1007459|NCT00386100|3297943|P2|Overall Study|Insufficient therapeutic effect|6
1007460|NCT00386100|3297944|P1|Overall Study|Insufficient therapeutic effect|30
1007461|NCT00386100|3297943|P2|Overall Study|Death|1
1007462|NCT00386100|3297944|P1|Overall Study|Death|0
1007463|NCT00386100|3297943|P2|Overall Study|Adverse Event|25
1007464|NCT00386100|3297944|P1|Overall Study|Adverse Event|15
1007465|NCT00386100|3297943|P2|Overall Study|Did not receive study medication|4
1007466|NCT00386100|3297944|P1|Overall Study|Did not receive study medication|6
1007467|NCT00386022|3298008|P2|Plus Estrogen|Adverse Event|1
1007468|NCT00386022|3298009|P1|Plus Estrogen|Adverse Event|0
1007469|NCT00386022|3298008|P2|Plus Estrogen|Lost to Follow-up|0
1007470|NCT00386022|3298009|P1|Plus Estrogen|Lost to Follow-up|2
1007471|NCT00386009|3298019|P2|Overall Study|Withdrawal by Subject|4
1007472|NCT00386009|3298020|P1|Overall Study|Withdrawal by Subject|5
1007473|NCT00386009|3298019|P2|Overall Study|Sponsor Decision|1
1007474|NCT00386009|3298020|P1|Overall Study|Sponsor Decision|1
1007475|NCT00386009|3298019|P2|Overall Study|Protocol Violation|0
1007476|NCT00386009|3298020|P1|Overall Study|Protocol Violation|1
1007477|NCT00386009|3298019|P2|Overall Study|Lost to Follow-up|1
1007478|NCT00386009|3298020|P1|Overall Study|Lost to Follow-up|1
1007479|NCT00386009|3298019|P2|Overall Study|Entry Criteria Not Met|2
1007480|NCT00386009|3298020|P1|Overall Study|Entry Criteria Not Met|0
1007481|NCT00386009|3298019|P2|Overall Study|Death|0
1007482|NCT00386009|3298020|P1|Overall Study|Death|1
1007483|NCT00386009|3298019|P2|Overall Study|Adverse Event|2
1007484|NCT00386009|3298020|P1|Overall Study|Adverse Event|0
1007485|NCT00385944|3298065|P3|2nd Maintenance Dose Period|Invalid PD Data|0
1007486|NCT00385944|3298066|P2|2nd Maintenance Dose Period|Invalid PD Data|3
1007487|NCT00385944|3298067|P1|2nd Maintenance Dose Period|Invalid PD Data|2
1007488|NCT00385944|3298065|P3|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
1007489|NCT00385944|3298066|P2|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
1007490|NCT00385944|3298067|P1|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3
1007491|NCT00385944|3298065|P3|1st Maintenance Dose Period|Entry Criteria Exclusion|0
1007492|NCT00385944|3298066|P2|1st Maintenance Dose Period|Entry Criteria Exclusion|1
1007493|NCT00385944|3298067|P1|1st Maintenance Dose Period|Entry Criteria Exclusion|0
1007494|NCT00385944|3298065|P3|1st Maintenance Dose Period|Physician Decision|0
1007495|NCT00385944|3298066|P2|1st Maintenance Dose Period|Physician Decision|0
1007496|NCT00385944|3298067|P1|1st Maintenance Dose Period|Physician Decision|1
1007497|NCT00385918|3298110|P3|Intervention Phase After Randomization|Lost to Follow-up|0
1007498|NCT00385918|3298111|P2|Intervention Phase After Randomization|Lost to Follow-up|0
1007499|NCT00385918|3298112|P1|Intervention Phase After Randomization|Lost to Follow-up|1
1007500|NCT00385918|3298110|P3|Intervention Phase After Randomization|Physician Decision|0
1007501|NCT00385918|3298111|P2|Intervention Phase After Randomization|Physician Decision|0
1007502|NCT00385918|3298112|P1|Intervention Phase After Randomization|Physician Decision|1
1007503|NCT00385918|3298110|P3|Intervention Phase After Randomization|Withdrawal by Subject|0
1007504|NCT00385918|3298111|P2|Intervention Phase After Randomization|Withdrawal by Subject|0
1007505|NCT00385918|3298112|P1|Intervention Phase After Randomization|Withdrawal by Subject|1
1007506|NCT00385918|3298110|P3|Feasibility & Baseline Measurement Phase|Physician Decision|1
1007507|NCT00385918|3298111|P2|Feasibility & Baseline Measurement Phase|Physician Decision|0
1007508|NCT00385918|3298112|P1|Feasibility & Baseline Measurement Phase|Physician Decision|0
1007509|NCT00385918|3298110|P3|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5
1007510|NCT00385918|3298111|P2|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
1007511|NCT00385918|3298112|P1|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
1007512|NCT00385918|3298110|P3|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8
1007513|NCT00385918|3298111|P2|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
1007514|NCT00385918|3298112|P1|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
1007515|NCT00385840|3298136|P2|Overall Study|Lost to Follow-up|13
1007516|NCT00385840|3298137|P1|Overall Study|Lost to Follow-up|3
1007517|NCT00385840|3298136|P2|Overall Study|Adverse Event|1
1007518|NCT00385840|3298137|P1|Overall Study|Adverse Event|1
1007519|NCT00385827|3298160|P3|Part 2|Other|21
1007520|NCT00385827|3298161|P2|Part 2|Other|11
1007521|NCT00385827|3298162|P1|Part 2|Other|0
1007522|NCT00385827|3298160|P3|Part 2|Randomized but not treated|2
1007523|NCT00385827|3298161|P2|Part 2|Randomized but not treated|2
1007524|NCT00385827|3298162|P1|Part 2|Randomized but not treated|0
1007525|NCT00385827|3298160|P3|Part 2|Lack of Efficacy|13
1007526|NCT00385827|3298161|P2|Part 2|Lack of Efficacy|14
1007527|NCT00385827|3298162|P1|Part 2|Lack of Efficacy|0
1007528|NCT00385827|3298160|P3|Part 2|Death|2
1007531|NCT00385827|3298160|P3|Part 2|Adverse Event|10
1007532|NCT00385827|3298161|P2|Part 2|Adverse Event|6
1007533|NCT00385827|3298162|P1|Part 2|Adverse Event|0
1007534|NCT00385827|3298160|P3|Part 1|Other|0
1007535|NCT00385827|3298161|P2|Part 1|Other|0
1007536|NCT00385827|3298162|P1|Part 1|Other|1
1007537|NCT00385827|3298160|P3|Part 1|Lack of Efficacy|0
1007538|NCT00385827|3298161|P2|Part 1|Lack of Efficacy|0
1007539|NCT00385827|3298162|P1|Part 1|Lack of Efficacy|5
1007540|NCT00385827|3298160|P3|Part 1|Death|0
1007541|NCT00385827|3298161|P2|Part 1|Death|0
1007542|NCT00385827|3298162|P1|Part 1|Death|2
1007543|NCT00385827|3298160|P3|Part 1|Adverse Event|0
1007544|NCT00385827|3298161|P2|Part 1|Adverse Event|0
1007545|NCT00385827|3298162|P1|Part 1|Adverse Event|1
1007546|NCT00385762|3298206|P1|Overall Study|Lost to Follow-up|1
1007547|NCT00385762|3298206|P1|Overall Study|Adverse Event|1
1007548|NCT00385736|3298216|P3|Safety Analysis Set|Other|4
1007549|NCT00385736|3298217|P2|Safety Analysis Set|Other|4
1007550|NCT00385736|3298218|P1|Safety Analysis Set|Other|1
1007551|NCT00385736|3298216|P3|Safety Analysis Set|Protocol Violation|6
1007552|NCT00385736|3298217|P2|Safety Analysis Set|Protocol Violation|1
1007553|NCT00385736|3298218|P1|Safety Analysis Set|Protocol Violation|2
1007554|NCT00385736|3298216|P3|Safety Analysis Set|Lack of Efficacy|31
1007555|NCT00385736|3298217|P2|Safety Analysis Set|Lack of Efficacy|16
1007556|NCT00385736|3298218|P1|Safety Analysis Set|Lack of Efficacy|38
1007557|NCT00385736|3298216|P3|Safety Analysis Set|Lost to Follow-up|2
1007558|NCT00385736|3298217|P2|Safety Analysis Set|Lost to Follow-up|2
1007559|NCT00385736|3298218|P1|Safety Analysis Set|Lost to Follow-up|0
1007560|NCT00385736|3298216|P3|Safety Analysis Set|Withdrawal by Subject|14
1007561|NCT00385736|3298217|P2|Safety Analysis Set|Withdrawal by Subject|6
1007562|NCT00385736|3298218|P1|Safety Analysis Set|Withdrawal by Subject|6
1007563|NCT00385736|3298216|P3|Safety Analysis Set|Adverse Event|23
1007564|NCT00385736|3298217|P2|Safety Analysis Set|Adverse Event|15
1007565|NCT00385736|3298218|P1|Safety Analysis Set|Adverse Event|23
1007566|NCT00385736|3298216|P3|Efficacy Analysis Set - Maintenance|Other|4
1007567|NCT00385736|3298217|P2|Efficacy Analysis Set - Maintenance|Other|4
1007568|NCT00385736|3298218|P1|Efficacy Analysis Set - Maintenance|Other|0
1007569|NCT00385736|3298216|P3|Efficacy Analysis Set - Maintenance|Protocol Violation|6
1007570|NCT00385736|3298217|P2|Efficacy Analysis Set - Maintenance|Protocol Violation|1
1007571|NCT00385736|3298218|P1|Efficacy Analysis Set - Maintenance|Protocol Violation|2
1007572|NCT00385736|3298216|P3|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31
1007573|NCT00385736|3298217|P2|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16
1007574|NCT00385736|3298218|P1|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38
1007575|NCT00385736|3298216|P3|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
1007576|NCT00385736|3298217|P2|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
1007577|NCT00385736|3298218|P1|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0
1007578|NCT00385736|3298216|P3|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14
1007579|NCT00385736|3298217|P2|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
1007580|NCT00385736|3298218|P1|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
1007581|NCT00385736|3298216|P3|Efficacy Analysis Set - Maintenance|Adverse Event|23
1007582|NCT00385736|3298217|P2|Efficacy Analysis Set - Maintenance|Adverse Event|15
1007583|NCT00385736|3298218|P1|Efficacy Analysis Set - Maintenance|Adverse Event|23
1007584|NCT00385736|3298216|P3|Efficacy Analysis Set - Induction|Other|1
1007585|NCT00385736|3298217|P2|Efficacy Analysis Set - Induction|Other|0
1007586|NCT00385736|3298218|P1|Efficacy Analysis Set - Induction|Other|0
1007587|NCT00385736|3298216|P3|Efficacy Analysis Set - Induction|Protocol Violation|2
1007588|NCT00385736|3298217|P2|Efficacy Analysis Set - Induction|Protocol Violation|0
1007589|NCT00385736|3298218|P1|Efficacy Analysis Set - Induction|Protocol Violation|0
1007590|NCT00385736|3298216|P3|Efficacy Analysis Set - Induction|Lack of Efficacy|1
1007591|NCT00385736|3298217|P2|Efficacy Analysis Set - Induction|Lack of Efficacy|2
1007592|NCT00385736|3298218|P1|Efficacy Analysis Set - Induction|Lack of Efficacy|4
1007593|NCT00385736|3298216|P3|Efficacy Analysis Set - Induction|Lost to Follow-up|0
1007594|NCT00385736|3298217|P2|Efficacy Analysis Set - Induction|Lost to Follow-up|2
1007595|NCT00385736|3298218|P1|Efficacy Analysis Set - Induction|Lost to Follow-up|0
1007596|NCT00385736|3298216|P3|Efficacy Analysis Set - Induction|Withdrawal by Subject|1
1007597|NCT00385736|3298217|P2|Efficacy Analysis Set - Induction|Withdrawal by Subject|2
1007598|NCT00385736|3298218|P1|Efficacy Analysis Set - Induction|Withdrawal by Subject|0
1007599|NCT00385736|3298216|P3|Efficacy Analysis Set - Induction|Adverse Event|4
1007600|NCT00385736|3298217|P2|Efficacy Analysis Set - Induction|Adverse Event|6
1007601|NCT00385736|3298218|P1|Efficacy Analysis Set - Induction|Adverse Event|5
1007602|NCT00385723|3298263|P3|Overall Study|Withdrawal by Subject|2
1007603|NCT00385723|3298264|P2|Overall Study|Withdrawal by Subject|0
1007604|NCT00385723|3298265|P1|Overall Study|Withdrawal by Subject|1
1007605|NCT00385723|3298263|P3|Overall Study|Lost to Follow-up|0
1007606|NCT00385723|3298264|P2|Overall Study|Lost to Follow-up|1
1007607|NCT00385723|3298265|P1|Overall Study|Lost to Follow-up|1
1007608|NCT00385684|3298279|P2|SECOND INTERVENTION OF PHASE A|study drug recall|1
1007609|NCT00385684|3298280|P1|SECOND INTERVENTION OF PHASE A|study drug recall|0
1007610|NCT00385684|3298279|P2|SECOND INTERVENTION OF PHASE A|Adverse Event|1
1007611|NCT00385684|3298280|P1|SECOND INTERVENTION OF PHASE A|Adverse Event|0
1007612|NCT00385684|3298279|P2|FIRST INTERVENTION OF PHASE A|Death|0
1007613|NCT00385684|3298280|P1|FIRST INTERVENTION OF PHASE A|Death|1
1007614|NCT00385671|3298289|P3|Overall Study|Withdrawal by Subject|4
1007615|NCT00385671|3298290|P2|Overall Study|Withdrawal by Subject|4
1007616|NCT00385671|3298291|P1|Overall Study|Withdrawal by Subject|4
1007617|NCT00385671|3298289|P3|Overall Study|Sponsor Decision|1
1007618|NCT00385671|3298290|P2|Overall Study|Sponsor Decision|2
1007619|NCT00385671|3298291|P1|Overall Study|Sponsor Decision|2
1007620|NCT00385671|3298289|P3|Overall Study|Protocol Violation|1
1007621|NCT00385671|3298290|P2|Overall Study|Protocol Violation|2
1007622|NCT00385671|3298291|P1|Overall Study|Protocol Violation|5
1007623|NCT00385671|3298289|P3|Overall Study|Physician Decision|2
1007624|NCT00385671|3298290|P2|Overall Study|Physician Decision|1
1007625|NCT00385671|3298291|P1|Overall Study|Physician Decision|2
1007626|NCT00385671|3298289|P3|Overall Study|Lost to Follow-up|5
1007627|NCT00385671|3298290|P2|Overall Study|Lost to Follow-up|6
1007628|NCT00385671|3298291|P1|Overall Study|Lost to Follow-up|6
1007629|NCT00385671|3298289|P3|Overall Study|Lack of Efficacy|5
1007630|NCT00385671|3298290|P2|Overall Study|Lack of Efficacy|9
1007631|NCT00385671|3298291|P1|Overall Study|Lack of Efficacy|5
1007632|NCT00385671|3298289|P3|Overall Study|Adverse Event|18
1007633|NCT00385671|3298290|P2|Overall Study|Adverse Event|27
1007634|NCT00385671|3298291|P1|Overall Study|Adverse Event|14
1007635|NCT00385593|3298447|P2|Overall Study|Incorrect randomization|1
1007636|NCT00385593|3298448|P1|Overall Study|Incorrect randomization|0
1007637|NCT00385593|3298447|P2|Overall Study|Incorrect inclusion|0
1007638|NCT00385593|3298448|P1|Overall Study|Incorrect inclusion|2
1007639|NCT00385593|3298447|P2|Overall Study|Several reasons|15
1007640|NCT00385593|3298448|P1|Overall Study|Several reasons|17
1007641|NCT00385593|3298447|P2|Overall Study|Protocol Violation|4
1007642|NCT00385593|3298448|P1|Overall Study|Protocol Violation|7
1007643|NCT00385593|3298447|P2|Overall Study|Lost to Follow-up|8
1007644|NCT00385593|3298448|P1|Overall Study|Lost to Follow-up|12
1007645|NCT00385593|3298447|P2|Overall Study|Withdrawal by Subject|7
1007646|NCT00385593|3298448|P1|Overall Study|Withdrawal by Subject|17
1007647|NCT00385593|3298447|P2|Overall Study|Adverse Event|2
1007648|NCT00385593|3298448|P1|Overall Study|Adverse Event|3
1007649|NCT00385541|3298558|P2|Overall Study|severe pain, clinician requested unblind|1
1007650|NCT00385541|3298559|P1|Overall Study|severe pain, clinician requested unblind|0
1007651|NCT00385255|3298593|P2|Overall Study|Lost to Follow-up|58
1007652|NCT00385255|3298594|P1|Overall Study|Lost to Follow-up|20
1007653|NCT00385255|3298593|P2|Overall Study|Migrated/moved from study area|1
1007654|NCT00385255|3298594|P1|Overall Study|Migrated/moved from study area|0
1007655|NCT00385255|3298593|P2|Overall Study|Withdrawal by Subject|8
1007656|NCT00385255|3298594|P1|Overall Study|Withdrawal by Subject|0
1007657|NCT00385255|3298593|P2|Overall Study|Protocol Violation|4
1007658|NCT00385255|3298594|P1|Overall Study|Protocol Violation|0
1007659|NCT00385255|3298593|P2|Overall Study|Serious Adverse Event|2
1007660|NCT00385255|3298594|P1|Overall Study|Serious Adverse Event|1
1007661|NCT00385203|3298673|P2|Overall Study|Incorrect enrollment|0
1007662|NCT00385203|3298674|P1|Overall Study|Incorrect enrollment|2
1007663|NCT00385203|3298673|P2|Overall Study|Condition under investigation worsened|3
1007664|NCT00385203|3298674|P1|Overall Study|Condition under investigation worsened|18
1007665|NCT00385203|3298673|P2|Overall Study|Death|0
1007666|NCT00385203|3298674|P1|Overall Study|Death|1
1007667|NCT00385203|3298673|P2|Overall Study|Adverse Event|4
1007668|NCT00385203|3298674|P1|Overall Study|Adverse Event|5
1007669|NCT00384956|3298762|P1|Overall Study|Ineligible (acute myeloid leukemia)|3
1007670|NCT00384930|3298779|P5|Overall Study|Didn't Receive Double-Blind Study Drug|0
1007671|NCT00384930|3298780|P4|Overall Study|Didn't Receive Double-Blind Study Drug|0
1007672|NCT00384930|3298781|P3|Overall Study|Didn't Receive Double-Blind Study Drug|0
1007673|NCT00384930|3298782|P2|Overall Study|Didn't Receive Double-Blind Study Drug|1
1007674|NCT00384930|3298783|P1|Overall Study|Didn't Receive Double-Blind Study Drug|1
1007675|NCT00384930|3298779|P5|Overall Study|Withdrawal by Subject|16
1007676|NCT00384930|3298780|P4|Overall Study|Withdrawal by Subject|6
1007677|NCT00384930|3298781|P3|Overall Study|Withdrawal by Subject|7
1007678|NCT00384930|3298782|P2|Overall Study|Withdrawal by Subject|7
1007679|NCT00384930|3298783|P1|Overall Study|Withdrawal by Subject|9
1007680|NCT00384930|3298779|P5|Overall Study|Sponsor Decision|0
1007681|NCT00384930|3298780|P4|Overall Study|Sponsor Decision|5
1007682|NCT00384930|3298781|P3|Overall Study|Sponsor Decision|0
1007683|NCT00384930|3298782|P2|Overall Study|Sponsor Decision|4
1007684|NCT00384930|3298783|P1|Overall Study|Sponsor Decision|3
1007685|NCT00384930|3298779|P5|Overall Study|Protocol Violation|4
1007686|NCT00384930|3298780|P4|Overall Study|Protocol Violation|6
1007687|NCT00384930|3298781|P3|Overall Study|Protocol Violation|1
1007688|NCT00384930|3298782|P2|Overall Study|Protocol Violation|0
1007689|NCT00384930|3298783|P1|Overall Study|Protocol Violation|1
1007690|NCT00384930|3298779|P5|Overall Study|Physician Decision|1
1007691|NCT00384930|3298780|P4|Overall Study|Physician Decision|0
1007692|NCT00384930|3298781|P3|Overall Study|Physician Decision|1
1007693|NCT00384930|3298782|P2|Overall Study|Physician Decision|1
1007694|NCT00384930|3298783|P1|Overall Study|Physician Decision|0
1007695|NCT00384930|3298779|P5|Overall Study|Lost to Follow-up|6
1007696|NCT00384930|3298780|P4|Overall Study|Lost to Follow-up|4
1007697|NCT00384930|3298781|P3|Overall Study|Lost to Follow-up|0
1007698|NCT00384930|3298782|P2|Overall Study|Lost to Follow-up|3
1007699|NCT00384930|3298783|P1|Overall Study|Lost to Follow-up|5
1007700|NCT00384930|3298779|P5|Overall Study|Lack of Efficacy|2
1007701|NCT00384930|3298780|P4|Overall Study|Lack of Efficacy|1
1007702|NCT00384930|3298781|P3|Overall Study|Lack of Efficacy|2
1007703|NCT00384930|3298782|P2|Overall Study|Lack of Efficacy|1
1007704|NCT00384930|3298783|P1|Overall Study|Lack of Efficacy|1
1007705|NCT00384930|3298779|P5|Overall Study|Entry Criteria Not Met|4
1007706|NCT00384930|3298780|P4|Overall Study|Entry Criteria Not Met|8
1007707|NCT00384930|3298781|P3|Overall Study|Entry Criteria Not Met|7
1007708|NCT00384930|3298782|P2|Overall Study|Entry Criteria Not Met|6
1007709|NCT00384930|3298783|P1|Overall Study|Entry Criteria Not Met|2
1007710|NCT00384930|3298779|P5|Overall Study|Adverse Event|14
1007711|NCT00384930|3298780|P4|Overall Study|Adverse Event|11
1007712|NCT00384930|3298781|P3|Overall Study|Adverse Event|12
1007713|NCT00384930|3298782|P2|Overall Study|Adverse Event|4
1007714|NCT00384930|3298783|P1|Overall Study|Adverse Event|5
1007715|NCT00384839|3298862|P1|Overall Study|Ineligible|2
1007716|NCT00384839|3298862|P1|Overall Study|Patient Request|1
1007717|NCT00384839|3298862|P1|Overall Study|Investigator Request|1
1007718|NCT00384839|3298862|P1|Overall Study|Adverse Event|4
1007719|NCT00384397|3298902|P3|Overall Study|Withdrawal by Subject|15
1007720|NCT00384397|3298903|P2|Overall Study|Withdrawal by Subject|17
1007721|NCT00384397|3298904|P1|Overall Study|Withdrawal by Subject|14
1007722|NCT00384397|3298902|P3|Overall Study|Lost to Follow-up|3
1007723|NCT00384397|3298903|P2|Overall Study|Lost to Follow-up|13
1007724|NCT00384397|3298904|P1|Overall Study|Lost to Follow-up|11
1007725|NCT00384397|3298902|P3|Overall Study|Protocol Violation|13
1007726|NCT00384397|3298903|P2|Overall Study|Protocol Violation|15
1007727|NCT00384397|3298904|P1|Overall Study|Protocol Violation|7
1007728|NCT00384397|3298902|P3|Overall Study|Adverse Event|2
1007729|NCT00384397|3298903|P2|Overall Study|Adverse Event|1
1007730|NCT00384397|3298904|P1|Overall Study|Adverse Event|0
1007731|NCT00384332|3298923|P2|Overall Study|Lost to Follow-up|0
1007732|NCT00384332|3298924|P1|Overall Study|Lost to Follow-up|4
1007733|NCT00384293|3298934|P3|Post-randomization Period|Patient Randomized in Error|1
1007734|NCT00384293|3298935|P2|Post-randomization Period|Patient Randomized in Error|0
1007735|NCT00384293|3298936|P1|Post-randomization Period|Patient Randomized in Error|0
1007736|NCT00384293|3298934|P3|Post-randomization Period|Trial Termination|204
1007737|NCT00384293|3298935|P2|Post-randomization Period|Trial Termination|180
1007738|NCT00384293|3298936|P1|Post-randomization Period|Trial Termination|0
1007739|NCT00384293|3298934|P3|Post-randomization Period|Withdrawal by Subject|6
1007740|NCT00384293|3298935|P2|Post-randomization Period|Withdrawal by Subject|8
1007741|NCT00384293|3298936|P1|Post-randomization Period|Withdrawal by Subject|0
1007742|NCT00384293|3298934|P3|Post-randomization Period|Protocol Violation|0
1007743|NCT00384293|3298935|P2|Post-randomization Period|Protocol Violation|1
1007744|NCT00384293|3298936|P1|Post-randomization Period|Protocol Violation|0
1007745|NCT00384293|3298934|P3|Post-randomization Period|Lost to Follow-up|1
1007746|NCT00384293|3298935|P2|Post-randomization Period|Lost to Follow-up|2
1007747|NCT00384293|3298936|P1|Post-randomization Period|Lost to Follow-up|0
1007748|NCT00384293|3298934|P3|Post-randomization Period|Adverse Event|7
1007749|NCT00384293|3298935|P2|Post-randomization Period|Adverse Event|23
1007750|NCT00384293|3298936|P1|Post-randomization Period|Adverse Event|0
1007751|NCT00384293|3298934|P3|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
1007752|NCT00384293|3298935|P2|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
1007753|NCT00384293|3298936|P1|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1
1007754|NCT00384293|3298934|P3|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
1007755|NCT00384293|3298935|P2|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
1007756|NCT00384293|3298936|P1|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2
1007757|NCT00384293|3298934|P3|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
1007758|NCT00384293|3298935|P2|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
1007759|NCT00384293|3298936|P1|MK0524A Active Run-In, Pre-randomization|Trial Termination|16
1007760|NCT00384293|3298934|P3|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
1007761|NCT00384293|3298935|P2|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
1007762|NCT00384293|3298936|P1|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340
1007763|NCT00384293|3298934|P3|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
1007764|NCT00384293|3298935|P2|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
1007765|NCT00384293|3298936|P1|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24
1007766|NCT00384293|3298934|P3|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
1007767|NCT00384293|3298935|P2|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
1007768|NCT00384293|3298936|P1|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1
1007769|NCT00384293|3298934|P3|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
1007770|NCT00384293|3298935|P2|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
1007771|NCT00384293|3298936|P1|MK0524A Active Run-In, Pre-randomization|Adverse Event|120
1007772|NCT00384189|3298960|P4|Overall Study|Reason Not Specified|40
1007773|NCT00384189|3298961|P3|Overall Study|Reason Not Specified|58
1007774|NCT00384189|3298962|P2|Overall Study|Reason Not Specified|57
1007775|NCT00384189|3298963|P1|Overall Study|Reason Not Specified|50
1007776|NCT00384176|3299024|P3|Overall Study|Liver metastases, colon resec. planned|0
1007777|NCT00384176|3299025|P2|Overall Study|Liver metastases, colon resec. planned|0
1007778|NCT00384176|3299026|P1|Overall Study|Liver metastases, colon resec. planned|1
1007779|NCT00384176|3299024|P3|Overall Study|Physician Decision|0
1007780|NCT00384176|3299025|P2|Overall Study|Physician Decision|2
1007781|NCT00384176|3299026|P1|Overall Study|Physician Decision|0
1007782|NCT00384176|3299024|P3|Overall Study|Did not receive study treatment|1
1007783|NCT00384176|3299025|P2|Overall Study|Did not receive study treatment|1
1007784|NCT00384176|3299026|P1|Overall Study|Did not receive study treatment|0
1007785|NCT00384176|3299024|P3|Overall Study|Toxicity of treatment|0
1007786|NCT00384176|3299025|P2|Overall Study|Toxicity of treatment|0
1007787|NCT00384176|3299026|P1|Overall Study|Toxicity of treatment|1
1007788|NCT00384176|3299024|P3|Overall Study|Longer QTC as Visit 1|0
1007789|NCT00384176|3299025|P2|Overall Study|Longer QTC as Visit 1|0
1007790|NCT00384176|3299026|P1|Overall Study|Longer QTC as Visit 1|1
1007791|NCT00384176|3299024|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|0
1007792|NCT00384176|3299025|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|3
1007793|NCT00384176|3299026|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|2
1007794|NCT00384176|3299024|P3|Overall Study|Lost to Follow-up|4
1007795|NCT00384176|3299025|P2|Overall Study|Lost to Follow-up|18
1007796|NCT00384176|3299026|P1|Overall Study|Lost to Follow-up|16
1007797|NCT00384176|3299024|P3|Overall Study|Withdrawal by Subject|22
1007798|NCT00384176|3299025|P2|Overall Study|Withdrawal by Subject|48
1007799|NCT00384176|3299026|P1|Overall Study|Withdrawal by Subject|52
1007800|NCT00384176|3299024|P3|Overall Study|Death|105
1007801|NCT00384176|3299025|P2|Overall Study|Death|247
1007802|NCT00384176|3299026|P1|Overall Study|Death|239
1007803|NCT00384085|3299052|P3|Overall Study|Patient required surgery|0
1007804|NCT00384085|3299053|P2|Overall Study|Patient required surgery|1
1007805|NCT00384085|3299054|P1|Overall Study|Patient required surgery|0
1007806|NCT00384085|3299052|P3|Overall Study|Patient moved|1
1007807|NCT00384085|3299053|P2|Overall Study|Patient moved|0
1007808|NCT00384085|3299054|P1|Overall Study|Patient moved|1
1007809|NCT00384085|3299052|P3|Overall Study|Sponsor decision|1
1007810|NCT00384085|3299053|P2|Overall Study|Sponsor decision|2
1007811|NCT00384085|3299054|P1|Overall Study|Sponsor decision|1
1007812|NCT00384085|3299052|P3|Overall Study|Loss of site personnel|1
1007813|NCT00384085|3299053|P2|Overall Study|Loss of site personnel|0
1007814|NCT00384085|3299054|P1|Overall Study|Loss of site personnel|1
1007815|NCT00384085|3299052|P3|Overall Study|Physician Decision|0
1007816|NCT00384085|3299053|P2|Overall Study|Physician Decision|0
1007817|NCT00384085|3299054|P1|Overall Study|Physician Decision|1
1007818|NCT00384085|3299052|P3|Overall Study|Patient non-compliant|5
1007819|NCT00384085|3299053|P2|Overall Study|Patient non-compliant|4
1007820|NCT00384085|3299054|P1|Overall Study|Patient non-compliant|4
1007821|NCT00384085|3299052|P3|Overall Study|Withdrawal by Subject|29
1007822|NCT00384085|3299053|P2|Overall Study|Withdrawal by Subject|19
1007823|NCT00384085|3299054|P1|Overall Study|Withdrawal by Subject|14
1007824|NCT00384085|3299052|P3|Overall Study|Progressive Disease|0
1007825|NCT00384085|3299053|P2|Overall Study|Progressive Disease|1
1007826|NCT00384085|3299054|P1|Overall Study|Progressive Disease|0
1007827|NCT00384085|3299052|P3|Overall Study|Lost to Follow-up|10
1007828|NCT00384085|3299053|P2|Overall Study|Lost to Follow-up|9
1007829|NCT00384085|3299054|P1|Overall Study|Lost to Follow-up|9
1007830|NCT00384085|3299052|P3|Overall Study|Protocol Violation|2
1007831|NCT00384085|3299053|P2|Overall Study|Protocol Violation|2
1007832|NCT00384085|3299054|P1|Overall Study|Protocol Violation|2
1007833|NCT00384085|3299052|P3|Overall Study|No longer Requires Study Treatment|1
1007834|NCT00384085|3299053|P2|Overall Study|No longer Requires Study Treatment|0
1007835|NCT00384085|3299054|P1|Overall Study|No longer Requires Study Treatment|1
1007836|NCT00384085|3299052|P3|Overall Study|Lack of Efficacy|2
1007837|NCT00384085|3299053|P2|Overall Study|Lack of Efficacy|3
1007838|NCT00384085|3299054|P1|Overall Study|Lack of Efficacy|0
1007839|NCT00384085|3299052|P3|Overall Study|Adverse Event|4
1007840|NCT00384085|3299053|P2|Overall Study|Adverse Event|5
1007841|NCT00384085|3299054|P1|Overall Study|Adverse Event|5
1007842|NCT00384059|3299080|P2|Toddler Dose|Failed to return|1
1007843|NCT00384059|3299081|P1|Toddler Dose|Failed to return|0
1007844|NCT00384059|3299080|P2|Toddler Dose|Lost to Follow-up|1
1007845|NCT00384059|3299081|P1|Toddler Dose|Lost to Follow-up|1
1007846|NCT00384059|3299080|P2|After Infant Series|Lost to Follow-up|1
1007847|NCT00384059|3299081|P1|After Infant Series|Lost to Follow-up|0
1007848|NCT00384059|3299080|P2|After Infant Series|Physician Decision|1
1007849|NCT00384059|3299081|P1|After Infant Series|Physician Decision|0
1007850|NCT00384059|3299080|P2|After Infant Series|Adverse Event|1
1007851|NCT00384059|3299081|P1|After Infant Series|Adverse Event|0
1007852|NCT00384059|3299080|P2|After Infant Series|Failed to Return|2
1007853|NCT00384059|3299081|P1|After Infant Series|Failed to Return|0
1007854|NCT00384059|3299080|P2|After Infant Series|Withdrawal by Subject|2
1007855|NCT00384059|3299081|P1|After Infant Series|Withdrawal by Subject|2
1007856|NCT00384059|3299080|P2|After Infant Series|Protocol Violation|3
1007857|NCT00384059|3299081|P1|After Infant Series|Protocol Violation|2
1007858|NCT00384059|3299080|P2|Infant Series|Lost to Follow-up|1
1007859|NCT00384059|3299081|P1|Infant Series|Lost to Follow-up|0
1007860|NCT00384059|3299080|P2|Infant Series|Protocol Violation|2
1007861|NCT00384059|3299081|P1|Infant Series|Protocol Violation|1
1007862|NCT00384059|3299080|P2|Infant Series|Adverse Event|2
1007863|NCT00384059|3299081|P1|Infant Series|Adverse Event|1
1007864|NCT00384059|3299080|P2|Infant Series|Withdrawal by Subject|2
1007865|NCT00384059|3299081|P1|Infant Series|Withdrawal by Subject|2
1007866|NCT00384059|3299080|P2|Infant Series|Not consented|6
1007867|NCT00384059|3299081|P1|Infant Series|Not consented|2
1007868|NCT00384033|3299131|P4|Overall Study|Randomized but not treated|2
1007869|NCT00384033|3299132|P3|Overall Study|Randomized but not treated|10
1007870|NCT00384033|3299133|P2|Overall Study|Randomized but not treated|7
1007871|NCT00384033|3299134|P1|Overall Study|Randomized but not treated|3
1007872|NCT00384033|3299131|P4|Overall Study|Lack of Efficacy|1
1007873|NCT00384033|3299132|P3|Overall Study|Lack of Efficacy|3
1007874|NCT00384033|3299133|P2|Overall Study|Lack of Efficacy|3
1007875|NCT00384033|3299134|P1|Overall Study|Lack of Efficacy|7
1007876|NCT00384033|3299131|P4|Overall Study|Withdrawal by Subject|2
1007877|NCT00384033|3299132|P3|Overall Study|Withdrawal by Subject|5
1007878|NCT00384033|3299133|P2|Overall Study|Withdrawal by Subject|2
1007879|NCT00384033|3299134|P1|Overall Study|Withdrawal by Subject|6
1007880|NCT00384033|3299131|P4|Overall Study|Protocol Violation|6
1007881|NCT00384033|3299132|P3|Overall Study|Protocol Violation|5
1007882|NCT00384033|3299133|P2|Overall Study|Protocol Violation|0
1007883|NCT00384033|3299134|P1|Overall Study|Protocol Violation|5
1007884|NCT00384033|3299131|P4|Overall Study|Other|0
1007885|NCT00384033|3299132|P3|Overall Study|Other|0
1007886|NCT00384033|3299133|P2|Overall Study|Other|0
1007887|NCT00384033|3299134|P1|Overall Study|Other|2
1007888|NCT00384033|3299131|P4|Overall Study|Lost to Follow-up|7
1007889|NCT00384033|3299132|P3|Overall Study|Lost to Follow-up|7
1007890|NCT00384033|3299133|P2|Overall Study|Lost to Follow-up|12
1007891|NCT00384033|3299134|P1|Overall Study|Lost to Follow-up|6
1007892|NCT00384033|3299131|P4|Overall Study|Physician Decision|0
1007893|NCT00384033|3299132|P3|Overall Study|Physician Decision|0
1007894|NCT00384033|3299133|P2|Overall Study|Physician Decision|0
1007895|NCT00384033|3299134|P1|Overall Study|Physician Decision|1
1007896|NCT00384033|3299131|P4|Overall Study|Failed to return|2
1007897|NCT00384033|3299132|P3|Overall Study|Failed to return|2
1007898|NCT00384033|3299133|P2|Overall Study|Failed to return|3
1007899|NCT00384033|3299134|P1|Overall Study|Failed to return|1
1007900|NCT00384033|3299131|P4|Overall Study|Adverse Event|20
1007901|NCT00384033|3299132|P3|Overall Study|Adverse Event|11
1007902|NCT00384033|3299133|P2|Overall Study|Adverse Event|8
1007903|NCT00384033|3299134|P1|Overall Study|Adverse Event|10
1007904|NCT00383786|3299187|P2|Overall Study|Physician Decision|1
1007905|NCT00383786|3299188|P1|Overall Study|Physician Decision|0
1007906|NCT00383786|3299187|P2|Overall Study|Withdrawal by Subject|5
1007907|NCT00383786|3299188|P1|Overall Study|Withdrawal by Subject|2
1007908|NCT00383786|3299187|P2|Overall Study|Protocol Violation|6
1007909|NCT00383786|3299188|P1|Overall Study|Protocol Violation|2
1007910|NCT00383721|3299238|P5|26-Week Treatment Safety Extension|Administrative|0
1007911|NCT00383721|3299239|P4|26-Week Treatment Safety Extension|Administrative|1
1007912|NCT00383721|3299240|P3|26-Week Treatment Safety Extension|Administrative|3
1007913|NCT00383721|3299241|P2|26-Week Treatment Safety Extension|Administrative|2
1007914|NCT00383721|3299242|P1|26-Week Treatment Safety Extension|Administrative|1
1007915|NCT00383721|3299238|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
1007916|NCT00383721|3299239|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
1007917|NCT00383721|3299240|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
1007918|NCT00383721|3299241|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
1007919|NCT00383721|3299242|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
1007920|NCT00383721|3299238|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
1007921|NCT00383721|3299239|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|4
1007922|NCT00383721|3299240|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
1007923|NCT00383721|3299241|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
1007924|NCT00383721|3299242|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|2
1007925|NCT00383721|3299238|P5|26-Week Treatment Safety Extension|Participant withdrawal related|0
1007926|NCT00383721|3299239|P4|26-Week Treatment Safety Extension|Participant withdrawal related|1
1007927|NCT00383721|3299240|P3|26-Week Treatment Safety Extension|Participant withdrawal related|1
1007928|NCT00383721|3299241|P2|26-Week Treatment Safety Extension|Participant withdrawal related|1
1007929|NCT00383721|3299242|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
1007930|NCT00383721|3299238|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
1007931|NCT00383721|3299239|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7
1007932|NCT00383721|3299240|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
1007933|NCT00383721|3299241|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4
1007934|NCT00383721|3299242|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
1007935|NCT00383721|3299238|P5|26-Week Treatment Safety Extension|Lost to Follow-up|0
1007936|NCT00383721|3299239|P4|26-Week Treatment Safety Extension|Lost to Follow-up|1
1007937|NCT00383721|3299240|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
1007938|NCT00383721|3299241|P2|26-Week Treatment Safety Extension|Lost to Follow-up|0
1007939|NCT00383721|3299242|P1|26-Week Treatment Safety Extension|Lost to Follow-up|2
1007940|NCT00383721|3299238|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
1007941|NCT00383721|3299239|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
1007942|NCT00383721|3299240|P3|26-Week Treatment Safety Extension|Lack of Efficacy|4
1007943|NCT00383721|3299241|P2|26-Week Treatment Safety Extension|Lack of Efficacy|2
1007944|NCT00383721|3299242|P1|26-Week Treatment Safety Extension|Lack of Efficacy|0
1007945|NCT00383721|3299238|P5|26-Week Treatment Safety Extension|Adverse Event|0
1007946|NCT00383721|3299239|P4|26-Week Treatment Safety Extension|Adverse Event|1
1007947|NCT00383721|3299240|P3|26-Week Treatment Safety Extension|Adverse Event|10
1007948|NCT00383721|3299241|P2|26-Week Treatment Safety Extension|Adverse Event|7
1007949|NCT00383721|3299242|P1|26-Week Treatment Safety Extension|Adverse Event|6
1007950|NCT00383721|3299238|P5|26-Week Double-Blind Treatment Period|Ongoing|0
1007951|NCT00383721|3299239|P4|26-Week Double-Blind Treatment Period|Ongoing|0
1007952|NCT00383721|3299240|P3|26-Week Double-Blind Treatment Period|Ongoing|0
1007953|NCT00383721|3299241|P2|26-Week Double-Blind Treatment Period|Ongoing|0
1007954|NCT00383721|3299242|P1|26-Week Double-Blind Treatment Period|Ongoing|1
1007955|NCT00383721|3299238|P5|26-Week Double-Blind Treatment Period|Administrative|3
1007956|NCT00383721|3299239|P4|26-Week Double-Blind Treatment Period|Administrative|3
1007957|NCT00383721|3299240|P3|26-Week Double-Blind Treatment Period|Administrative|3
1007958|NCT00383721|3299241|P2|26-Week Double-Blind Treatment Period|Administrative|3
1007959|NCT00383721|3299242|P1|26-Week Double-Blind Treatment Period|Administrative|1
1007960|NCT00383721|3299238|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13
1007961|NCT00383721|3299239|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4
1007962|NCT00383721|3299240|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11
1007963|NCT00383721|3299241|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
1007964|NCT00383721|3299242|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
1007965|NCT00383721|3299238|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
1007966|NCT00383721|3299239|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
1007967|NCT00383721|3299240|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
1007968|NCT00383721|3299241|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
1007969|NCT00383721|3299242|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7
1007970|NCT00383721|3299238|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|9
1007971|NCT00383721|3299239|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|8
1007972|NCT00383721|3299240|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|6
1007973|NCT00383721|3299241|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
1007974|NCT00383721|3299242|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|5
1007975|NCT00383721|3299238|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11
1007976|NCT00383721|3299239|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
1007977|NCT00383721|3299240|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15
1007978|NCT00383721|3299241|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
1007979|NCT00383721|3299242|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4
1007980|NCT00383721|3299238|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|4
1007981|NCT00383721|3299239|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
1007982|NCT00383721|3299240|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
1007983|NCT00383721|3299241|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
1007984|NCT00383721|3299242|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
1007985|NCT00383721|3299238|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
1007986|NCT00383721|3299239|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|4
1007987|NCT00383721|3299240|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
1007988|NCT00383721|3299241|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
1007989|NCT00383721|3299242|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|1
1007990|NCT00383721|3299238|P5|26-Week Double-Blind Treatment Period|Adverse Event|13
1007991|NCT00383721|3299239|P4|26-Week Double-Blind Treatment Period|Adverse Event|14
1007992|NCT00383721|3299240|P3|26-Week Double-Blind Treatment Period|Adverse Event|7
1007993|NCT00383721|3299241|P2|26-Week Double-Blind Treatment Period|Adverse Event|5
1007994|NCT00383721|3299242|P1|26-Week Double-Blind Treatment Period|Adverse Event|11
1007995|NCT00383708|3299279|P1|Co-administration Period|Adverse Event|5
1007996|NCT00383708|3299279|P1|Run-in Period|Claustrophobia|1
1007997|NCT00383708|3299279|P1|Run-in Period|Adverse Event|2
1007998|NCT00383708|3299279|P1|Run-in Period|Protocol Violation|4
1007999|NCT00383708|3299279|P1|Enrolment Through Start Treatment|Did not meet entry criteria|32
1008000|NCT00383708|3299279|P1|Enrolment Through Start Treatment|Withdrawal by Subject|1
1008001|NCT00383552|3299348|P4|Overall Study|Administrative|1
1008002|NCT00383552|3299349|P3|Overall Study|Administrative|1
1008003|NCT00383552|3299350|P2|Overall Study|Administrative|0
1008004|NCT00383552|3299351|P1|Overall Study|Administrative|1
1008005|NCT00383552|3299348|P4|Overall Study|Did not meet protocol eligibility|3
1008006|NCT00383552|3299349|P3|Overall Study|Did not meet protocol eligibility|2
1008007|NCT00383552|3299350|P2|Overall Study|Did not meet protocol eligibility|6
1008008|NCT00383552|3299351|P1|Overall Study|Did not meet protocol eligibility|8
1008009|NCT00383552|3299348|P4|Overall Study|Noncompliance with the protocol|10
1008010|NCT00383552|3299349|P3|Overall Study|Noncompliance with the protocol|8
1008011|NCT00383552|3299350|P2|Overall Study|Noncompliance with the protocol|6
1008012|NCT00383552|3299351|P1|Overall Study|Noncompliance with the protocol|11
1008013|NCT00383552|3299348|P4|Overall Study|Did not wish to continue (related)|3
1008014|NCT00383552|3299349|P3|Overall Study|Did not wish to continue (related)|2
1008015|NCT00383552|3299350|P2|Overall Study|Did not wish to continue (related)|0
1008016|NCT00383552|3299351|P1|Overall Study|Did not wish to continue (related)|1
1008017|NCT00383552|3299348|P4|Overall Study|Did not wish to continue (unrelated)|6
1008018|NCT00383552|3299349|P3|Overall Study|Did not wish to continue (unrelated)|5
1008019|NCT00383552|3299350|P2|Overall Study|Did not wish to continue (unrelated)|9
1008020|NCT00383552|3299351|P1|Overall Study|Did not wish to continue (unrelated)|4
1008021|NCT00383552|3299348|P4|Overall Study|Lost to Follow-up|1
1008022|NCT00383552|3299349|P3|Overall Study|Lost to Follow-up|5
1008023|NCT00383552|3299350|P2|Overall Study|Lost to Follow-up|1
1008024|NCT00383552|3299351|P1|Overall Study|Lost to Follow-up|0
1008025|NCT00383552|3299348|P4|Overall Study|Lack of Efficacy|42
1008026|NCT00383552|3299349|P3|Overall Study|Lack of Efficacy|29
1008027|NCT00383552|3299350|P2|Overall Study|Lack of Efficacy|13
1008028|NCT00383552|3299351|P1|Overall Study|Lack of Efficacy|4
1008029|NCT00383552|3299348|P4|Overall Study|Adverse Event|6
1008030|NCT00383552|3299349|P3|Overall Study|Adverse Event|9
1008031|NCT00383552|3299350|P2|Overall Study|Adverse Event|6
1008032|NCT00383552|3299351|P1|Overall Study|Adverse Event|7
1008033|NCT00383500|3299393|P3|Overall Study|Lost to Follow-up|2
1008034|NCT00383500|3299394|P2|Overall Study|Lost to Follow-up|0
1008035|NCT00383500|3299395|P1|Overall Study|Lost to Follow-up|0
1008036|NCT00383500|3299393|P3|Overall Study|Withdrawal by Subject|0
1008037|NCT00383500|3299394|P2|Overall Study|Withdrawal by Subject|3
1008038|NCT00383500|3299395|P1|Overall Study|Withdrawal by Subject|8
1008039|NCT00383435|3299411|P5|26-Week Treatment Safety Extension|Administrative|0
1008040|NCT00383435|3299412|P4|26-Week Treatment Safety Extension|Administrative|1
1008041|NCT00383435|3299413|P3|26-Week Treatment Safety Extension|Administrative|0
1008042|NCT00383435|3299414|P2|26-Week Treatment Safety Extension|Administrative|1
1008043|NCT00383435|3299415|P1|26-Week Treatment Safety Extension|Administrative|1
1008044|NCT00383435|3299411|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
1008045|NCT00383435|3299412|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
1008046|NCT00383435|3299413|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
1008047|NCT00383435|3299414|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
1008048|NCT00383435|3299415|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
1008049|NCT00383435|3299411|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
1008050|NCT00383435|3299412|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|1
1008051|NCT00383435|3299413|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
1008052|NCT00383435|3299414|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
1008053|NCT00383435|3299415|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|4
1008054|NCT00383435|3299411|P5|26-Week Treatment Safety Extension|Participant withdrawal related|1
1008055|NCT00383435|3299412|P4|26-Week Treatment Safety Extension|Participant withdrawal related|0
1008056|NCT00383435|3299413|P3|26-Week Treatment Safety Extension|Participant withdrawal related|2
1008057|NCT00383435|3299414|P2|26-Week Treatment Safety Extension|Participant withdrawal related|0
1008058|NCT00383435|3299415|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
1008059|NCT00383435|3299411|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
1008060|NCT00383435|3299412|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
1008061|NCT00383435|3299413|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
1008062|NCT00383435|3299414|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
1008063|NCT00383435|3299415|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
1008064|NCT00383435|3299411|P5|26-Week Treatment Safety Extension|Lost to Follow-up|1
1008065|NCT00383435|3299412|P4|26-Week Treatment Safety Extension|Lost to Follow-up|0
1008066|NCT00383435|3299413|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
1008067|NCT00383435|3299414|P2|26-Week Treatment Safety Extension|Lost to Follow-up|2
1008068|NCT00383435|3299415|P1|26-Week Treatment Safety Extension|Lost to Follow-up|0
1008069|NCT00383435|3299411|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
1008070|NCT00383435|3299412|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
1008071|NCT00383435|3299413|P3|26-Week Treatment Safety Extension|Lack of Efficacy|1
1008072|NCT00383435|3299414|P2|26-Week Treatment Safety Extension|Lack of Efficacy|1
1008073|NCT00383435|3299415|P1|26-Week Treatment Safety Extension|Lack of Efficacy|1
1008074|NCT00383435|3299411|P5|26-Week Treatment Safety Extension|Adverse Event|1
1008075|NCT00383435|3299412|P4|26-Week Treatment Safety Extension|Adverse Event|5
1008076|NCT00383435|3299413|P3|26-Week Treatment Safety Extension|Adverse Event|5
1008077|NCT00383435|3299414|P2|26-Week Treatment Safety Extension|Adverse Event|2
1008078|NCT00383435|3299415|P1|26-Week Treatment Safety Extension|Adverse Event|4
1008079|NCT00383435|3299411|P5|26-Week Double-Blind Treatment Period|Administrative|1
1008080|NCT00383435|3299412|P4|26-Week Double-Blind Treatment Period|Administrative|1
1008081|NCT00383435|3299413|P3|26-Week Double-Blind Treatment Period|Administrative|1
1008082|NCT00383435|3299414|P2|26-Week Double-Blind Treatment Period|Administrative|3
1008083|NCT00383435|3299415|P1|26-Week Double-Blind Treatment Period|Administrative|5
1008084|NCT00383435|3299411|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
1008085|NCT00383435|3299412|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
1008086|NCT00383435|3299413|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9
1008087|NCT00383435|3299414|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8
1008088|NCT00383435|3299415|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10
1008089|NCT00383435|3299411|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
1008090|NCT00383435|3299412|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
1008091|NCT00383435|3299413|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3
1008092|NCT00383435|3299414|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
1008093|NCT00383435|3299415|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1
1008094|NCT00383435|3299411|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
1008095|NCT00383435|3299412|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
1008096|NCT00383435|3299413|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
1008097|NCT00383435|3299414|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
1008098|NCT00383435|3299415|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|2
1008099|NCT00383435|3299411|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17
1008100|NCT00383435|3299412|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
1008101|NCT00383435|3299413|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14
1008102|NCT00383435|3299414|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
1008103|NCT00383435|3299415|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7
1008104|NCT00383435|3299411|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
1008105|NCT00383435|3299412|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
1008106|NCT00383435|3299413|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
1008107|NCT00383435|3299414|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
1008108|NCT00383435|3299415|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
1008109|NCT00383435|3299411|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
1008110|NCT00383435|3299412|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|5
1008111|NCT00383435|3299413|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
1008112|NCT00383435|3299414|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|2
1008113|NCT00383435|3299415|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
1008114|NCT00383435|3299411|P5|26-Week Double-Blind Treatment Period|Adverse Event|8
1008115|NCT00383435|3299412|P4|26-Week Double-Blind Treatment Period|Adverse Event|6
1008116|NCT00383435|3299413|P3|26-Week Double-Blind Treatment Period|Adverse Event|8
1008117|NCT00383435|3299414|P2|26-Week Double-Blind Treatment Period|Adverse Event|2
1008118|NCT00383435|3299415|P1|26-Week Double-Blind Treatment Period|Adverse Event|10
1008119|NCT00383331|3299454|P2|Overall Study|Protocol Violation|1
1008120|NCT00383331|3299455|P1|Overall Study|Protocol Violation|0
1008121|NCT00383292|3299474|P3|Overall Study|Other|0
1008122|NCT00383292|3299475|P2|Overall Study|Other|0
1008123|NCT00383292|3299476|P1|Overall Study|Other|1
1008124|NCT00383292|3299474|P3|Overall Study|Withdrawal by Subject|2
1008125|NCT00383292|3299475|P2|Overall Study|Withdrawal by Subject|2
1008126|NCT00383292|3299476|P1|Overall Study|Withdrawal by Subject|3
1008127|NCT00383292|3299474|P3|Overall Study|Physician Decision|1
1008128|NCT00383292|3299475|P2|Overall Study|Physician Decision|0
1008129|NCT00383292|3299476|P1|Overall Study|Physician Decision|4
1008130|NCT00383292|3299474|P3|Overall Study|Death|3
1008131|NCT00383292|3299475|P2|Overall Study|Death|3
1008132|NCT00383292|3299476|P1|Overall Study|Death|3
1008133|NCT00383292|3299474|P3|Overall Study|Adverse Event|2
1008134|NCT00383292|3299475|P2|Overall Study|Adverse Event|1
1008135|NCT00383292|3299476|P1|Overall Study|Adverse Event|4
1008136|NCT00383240|3299517|P4|Overall Study|Administrative|0
1008137|NCT00383240|3299518|P3|Overall Study|Administrative|0
1008138|NCT00383240|3299519|P2|Overall Study|Administrative|1
1008139|NCT00383240|3299520|P1|Overall Study|Administrative|1
1008140|NCT00383240|3299517|P4|Overall Study|Did not meet protocol eligibility|3
1008141|NCT00383240|3299518|P3|Overall Study|Did not meet protocol eligibility|9
1008142|NCT00383240|3299519|P2|Overall Study|Did not meet protocol eligibility|4
1008143|NCT00383240|3299520|P1|Overall Study|Did not meet protocol eligibility|9
1008144|NCT00383240|3299517|P4|Overall Study|Protocol Violation|6
1008145|NCT00383240|3299518|P3|Overall Study|Protocol Violation|9
1008146|NCT00383240|3299519|P2|Overall Study|Protocol Violation|5
1008147|NCT00383240|3299520|P1|Overall Study|Protocol Violation|4
1008148|NCT00383240|3299517|P4|Overall Study|Withdrawal by subjects, reasons related|5
1008149|NCT00383240|3299518|P3|Overall Study|Withdrawal by subjects, reasons related|3
1008150|NCT00383240|3299519|P2|Overall Study|Withdrawal by subjects, reasons related|1
1008151|NCT00383240|3299520|P1|Overall Study|Withdrawal by subjects, reasons related|0
1008152|NCT00383240|3299517|P4|Overall Study|Withdrawal by subject, reasons unrelated|8
1008153|NCT00383240|3299518|P3|Overall Study|Withdrawal by subject, reasons unrelated|8
1008154|NCT00383240|3299519|P2|Overall Study|Withdrawal by subject, reasons unrelated|3
1008155|NCT00383240|3299520|P1|Overall Study|Withdrawal by subject, reasons unrelated|6
1008156|NCT00383240|3299517|P4|Overall Study|Lost to Follow-up|2
1008157|NCT00383240|3299518|P3|Overall Study|Lost to Follow-up|0
1008158|NCT00383240|3299519|P2|Overall Study|Lost to Follow-up|0
1008159|NCT00383240|3299520|P1|Overall Study|Lost to Follow-up|3
1008160|NCT00383240|3299517|P4|Overall Study|Treatment Failure|46
1008161|NCT00383240|3299518|P3|Overall Study|Treatment Failure|47
1008162|NCT00383240|3299519|P2|Overall Study|Treatment Failure|13
1008163|NCT00383240|3299520|P1|Overall Study|Treatment Failure|8
1008164|NCT00383240|3299517|P4|Overall Study|Adverse Event|7
1008165|NCT00383240|3299518|P3|Overall Study|Adverse Event|9
1008166|NCT00383240|3299519|P2|Overall Study|Adverse Event|6
1008167|NCT00383240|3299520|P1|Overall Study|Adverse Event|4
1008168|NCT00383162|3299551|P2|Migraine Attack 2 (Period 2)|Unknown reason|3
1008169|NCT00383162|3299552|P1|Migraine Attack 2 (Period 2)|Unknown reason|0
1008170|NCT00383162|3299551|P2|Migraine Attack 2 (Period 2)|Adverse Event|0
1008171|NCT00383162|3299552|P1|Migraine Attack 2 (Period 2)|Adverse Event|1
1008172|NCT00383162|3299551|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
1008173|NCT00383162|3299552|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
1008174|NCT00383162|3299551|P2|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3
1008175|NCT00383162|3299552|P1|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1
1008176|NCT00383162|3299551|P2|Migraine Attack 1 (Period 1)|Non-compliant|0
1008177|NCT00383162|3299552|P1|Migraine Attack 1 (Period 1)|Non-compliant|3
1008178|NCT00383162|3299551|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0
1008179|NCT00383162|3299552|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2
1008180|NCT00383162|3299551|P2|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2
1008181|NCT00383162|3299552|P1|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4
1008182|NCT00383162|3299551|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
1008183|NCT00383162|3299552|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|8
1008184|NCT00383162|3299551|P2|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4
1008185|NCT00383162|3299552|P1|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3
1008186|NCT00383149|3299594|P1|Overall Study|Participant Withdrew Consent|1
1008187|NCT00383149|3299594|P1|Overall Study|Request to Discontinue Treatment|4
1008188|NCT00383149|3299594|P1|Overall Study|Study Drug Toxicity|4
1008189|NCT00383149|3299594|P1|Overall Study|Other|1
1008190|NCT00383149|3299594|P1|Overall Study|Lost to Follow-up|1
1008191|NCT00383149|3299594|P1|Overall Study|Disease Progression|38
1008192|NCT00383149|3299594|P1|Overall Study|Death|2
1008193|NCT00383149|3299594|P1|Overall Study|Adverse Event not Related to Study Drug|3
1008194|NCT00383123|3299613|P2|Overall Study|Other reason|6
1008195|NCT00383123|3299614|P1|Overall Study|Other reason|10
1008196|NCT00383123|3299613|P2|Overall Study|Withdrawal by Subject|18
1008197|NCT00383123|3299614|P1|Overall Study|Withdrawal by Subject|27
1008198|NCT00383123|3299613|P2|Overall Study|Protocol Violation|1
1008199|NCT00383123|3299614|P1|Overall Study|Protocol Violation|5
1008200|NCT00383123|3299613|P2|Overall Study|Lost to Follow-up|61
1008201|NCT00383123|3299614|P1|Overall Study|Lost to Follow-up|68
1008202|NCT00383123|3299613|P2|Overall Study|Adverse Event|0
1008203|NCT00383123|3299614|P1|Overall Study|Adverse Event|1
1008204|NCT00383084|3299655|P2|Overall Study|Withdrawal by Subject|10
1008205|NCT00383084|3299656|P1|Overall Study|Withdrawal by Subject|12
1008206|NCT00383019|3299687|P2|Overall Study|Withdrawal by Subject|1
1008207|NCT00383019|3299688|P1|Overall Study|Withdrawal by Subject|0
1008208|NCT00383019|3299687|P2|Overall Study|Adverse Event|1
1008209|NCT00383019|3299688|P1|Overall Study|Adverse Event|5
1008210|NCT00382993|3299710|P2|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
1008211|NCT00382993|3299711|P1|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
1008212|NCT00382993|3299710|P2|Migraine Attack 2 (Period 2)|Protocol Violation|1
1008213|NCT00382993|3299711|P1|Migraine Attack 2 (Period 2)|Protocol Violation|0
1008214|NCT00382993|3299710|P2|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1
1008215|NCT00382993|3299711|P1|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0
1008216|NCT00382993|3299710|P2|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1
1008217|NCT00382993|3299711|P1|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0
1008218|NCT00382993|3299710|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
1008219|NCT00382993|3299711|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
1008220|NCT00382993|3299710|P2|Migraine Attack 1 (Period 1)|Other (no additional data present)|5
1008221|NCT00382993|3299711|P1|Migraine Attack 1 (Period 1)|Other (no additional data present)|3
1008222|NCT00382993|3299710|P2|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
1008223|NCT00382993|3299711|P1|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
1008224|NCT00382993|3299710|P2|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5
1008225|NCT00382993|3299711|P1|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0
1008226|NCT00382993|3299710|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3
1008227|NCT00382993|3299711|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1
1008228|NCT00382993|3299710|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|2
1008229|NCT00382993|3299711|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
1008230|NCT00382967|3299755|P2|Overall Study|Protocol Violation|1
1008231|NCT00382967|3299756|P1|Overall Study|Protocol Violation|1
1008232|NCT00382863|3299781|P2|Overall Study|Withdrawal by Subject|25
1008233|NCT00382863|3299782|P1|Overall Study|Withdrawal by Subject|5
1008234|NCT00382863|3299781|P2|Overall Study|Lost to Follow-up|2
1008235|NCT00382863|3299782|P1|Overall Study|Lost to Follow-up|1
1008236|NCT00382863|3299781|P2|Overall Study|Death|9
1008237|NCT00382863|3299782|P1|Overall Study|Death|9
1008238|NCT00382733|3299849|P5|Overall Study|Withdrawal by Subject|0
1008239|NCT00382733|3299850|P4|Overall Study|Withdrawal by Subject|0
1008240|NCT00382733|3299851|P3|Overall Study|Withdrawal by Subject|0
1008241|NCT00382733|3299852|P2|Overall Study|Withdrawal by Subject|1
1008242|NCT00382733|3299853|P1|Overall Study|Withdrawal by Subject|0
1008243|NCT00382720|3299874|P3|Overall Study|Discontinued at end of study|2
1008244|NCT00382720|3299875|P2|Overall Study|Discontinued at end of study|1
1008245|NCT00382720|3299876|P1|Overall Study|Discontinued at end of study|0
1008246|NCT00382720|3299874|P3|Overall Study|Investigator/Clinical decision|6
1008247|NCT00382720|3299875|P2|Overall Study|Investigator/Clinical decision|6
1008248|NCT00382720|3299876|P1|Overall Study|Investigator/Clinical decision|5
1008249|NCT00382720|3299874|P3|Overall Study|Good prognosis|0
1008250|NCT00382720|3299875|P2|Overall Study|Good prognosis|1
1008251|NCT00382720|3299876|P1|Overall Study|Good prognosis|0
1008252|NCT00382720|3299874|P3|Overall Study|Clinically progressive disease|0
1008253|NCT00382720|3299875|P2|Overall Study|Clinically progressive disease|1
1008254|NCT00382720|3299876|P1|Overall Study|Clinically progressive disease|0
1008255|NCT00382720|3299874|P3|Overall Study|Patient did not receive study medication|4
1008256|NCT00382720|3299875|P2|Overall Study|Patient did not receive study medication|1
1008257|NCT00382720|3299876|P1|Overall Study|Patient did not receive study medication|1
1008258|NCT00382720|3299874|P3|Overall Study|Surgery|4
1008259|NCT00382720|3299875|P2|Overall Study|Surgery|1
1008260|NCT00382720|3299876|P1|Overall Study|Surgery|1
1008261|NCT00382720|3299874|P3|Overall Study|Withdrawal by Subject|12
1008262|NCT00382720|3299875|P2|Overall Study|Withdrawal by Subject|20
1008263|NCT00382720|3299876|P1|Overall Study|Withdrawal by Subject|11
1008264|NCT00382720|3299874|P3|Overall Study|Withdrew consent|2
1008265|NCT00382720|3299875|P2|Overall Study|Withdrew consent|1
1008266|NCT00382720|3299876|P1|Overall Study|Withdrew consent|1
1008267|NCT00382720|3299874|P3|Overall Study|Progressive disease|38
1008268|NCT00382720|3299875|P2|Overall Study|Progressive disease|28
1008269|NCT00382720|3299876|P1|Overall Study|Progressive disease|37
1008270|NCT00382720|3299874|P3|Overall Study|Death|2
1008271|NCT00382720|3299875|P2|Overall Study|Death|1
1008272|NCT00382720|3299876|P1|Overall Study|Death|0
1008273|NCT00382720|3299874|P3|Overall Study|Protocol Violation|1
1008274|NCT00382720|3299875|P2|Overall Study|Protocol Violation|5
1008275|NCT00382720|3299876|P1|Overall Study|Protocol Violation|2
1008276|NCT00382720|3299874|P3|Overall Study|Adverse Event|15
1008277|NCT00382720|3299875|P2|Overall Study|Adverse Event|23
1008278|NCT00382720|3299876|P1|Overall Study|Adverse Event|21
1008279|NCT00382408|3299901|P2|Overall Study|Not specified|35
1008280|NCT00382408|3299902|P1|Overall Study|Not specified|100
1008281|NCT00382408|3299901|P2|Overall Study|Lost to Follow-up|8
1008282|NCT00382408|3299902|P1|Overall Study|Lost to Follow-up|19
1008283|NCT00382408|3299901|P2|Overall Study|Pregnancy|0
1008284|NCT00382408|3299902|P1|Overall Study|Pregnancy|2
1008285|NCT00382408|3299901|P2|Overall Study|Withdrawal by Subject|6
1008286|NCT00382408|3299902|P1|Overall Study|Withdrawal by Subject|17
1008287|NCT00382408|3299901|P2|Overall Study|Physician Decision|0
1008288|NCT00382408|3299902|P1|Overall Study|Physician Decision|1
1008289|NCT00382408|3299901|P2|Overall Study|Protocol Violation|2
1008290|NCT00382408|3299902|P1|Overall Study|Protocol Violation|2
1008291|NCT00382408|3299901|P2|Overall Study|Did not meet protocol requirement|3
1008292|NCT00382408|3299902|P1|Overall Study|Did not meet protocol requirement|3
1008293|NCT00382291|3299929|P3|Overall Study|Lack of Efficacy|1
1008294|NCT00382291|3299930|P2|Overall Study|Lack of Efficacy|0
1008295|NCT00382291|3299931|P1|Overall Study|Lack of Efficacy|0
1008296|NCT00382291|3299929|P3|Overall Study|Physician Decision|0
1008297|NCT00382291|3299930|P2|Overall Study|Physician Decision|1
1008298|NCT00382291|3299931|P1|Overall Study|Physician Decision|0
1008299|NCT00382291|3299929|P3|Overall Study|Withdrawal by Subject|0
1008300|NCT00382291|3299930|P2|Overall Study|Withdrawal by Subject|2
1008301|NCT00382291|3299931|P1|Overall Study|Withdrawal by Subject|0
1008302|NCT00382291|3299929|P3|Overall Study|Temporary study suspension|5
1008303|NCT00382291|3299930|P2|Overall Study|Temporary study suspension|2
1008304|NCT00382291|3299931|P1|Overall Study|Temporary study suspension|2
1008305|NCT00382291|3299929|P3|Overall Study|Protocol Violation|0
1008306|NCT00382291|3299930|P2|Overall Study|Protocol Violation|0
1008307|NCT00382291|3299931|P1|Overall Study|Protocol Violation|1
1008308|NCT00382291|3299929|P3|Overall Study|Adverse Event|2
1008309|NCT00382291|3299930|P2|Overall Study|Adverse Event|2
1008310|NCT00382291|3299931|P1|Overall Study|Adverse Event|1
1008311|NCT00382174|3299944|P3|Overall Study|Wounds merged|2
1008312|NCT00382174|3299945|P2|Overall Study|Wounds merged|2
1008313|NCT00382174|3299946|P1|Overall Study|Wounds merged|0
1008314|NCT00382174|3299944|P3|Overall Study|Failed to meet criteria|1
1008315|NCT00382174|3299945|P2|Overall Study|Failed to meet criteria|1
1008316|NCT00382174|3299946|P1|Overall Study|Failed to meet criteria|0
1008317|NCT00382174|3299944|P3|Overall Study|Physician Decision|2
1008318|NCT00382174|3299945|P2|Overall Study|Physician Decision|2
1008319|NCT00382174|3299946|P1|Overall Study|Physician Decision|0
1008320|NCT00382174|3299944|P3|Overall Study|Non compliance|1
1008321|NCT00382174|3299945|P2|Overall Study|Non compliance|0
1008322|NCT00382174|3299946|P1|Overall Study|Non compliance|1
1008323|NCT00382174|3299944|P3|Overall Study|Withdrawal by Subject|5
1008324|NCT00382174|3299945|P2|Overall Study|Withdrawal by Subject|4
1008325|NCT00382174|3299946|P1|Overall Study|Withdrawal by Subject|1
1008326|NCT00382174|3299944|P3|Overall Study|Adverse Event|5
1008327|NCT00382174|3299945|P2|Overall Study|Adverse Event|4
1008328|NCT00382174|3299946|P1|Overall Study|Adverse Event|1
1008329|NCT00382174|3299944|P3|Overall Study|Lost to Follow-up|5
1008330|NCT00382174|3299945|P2|Overall Study|Lost to Follow-up|4
1008331|NCT00382174|3299946|P1|Overall Study|Lost to Follow-up|1
1008332|NCT00382109|3299974|P2|Overall Study|consent withdrawal|1
1008333|NCT00382109|3299975|P1|Overall Study|consent withdrawal|0
1008334|NCT00382109|3299974|P2|Overall Study|Other|2
1008335|NCT00382109|3299975|P1|Overall Study|Other|0
1008336|NCT00382109|3299974|P2|Overall Study|ineligible|0
1008337|NCT00382109|3299975|P1|Overall Study|ineligible|2
1008338|NCT00382109|3299974|P2|Overall Study|Withdrawal by Subject|0
1008339|NCT00382109|3299975|P1|Overall Study|Withdrawal by Subject|1
1008340|NCT00382109|3299974|P2|Overall Study|Physician Decision|1
1008341|NCT00382109|3299975|P1|Overall Study|Physician Decision|6
1008342|NCT00382109|3299974|P2|Overall Study|Adverse Event|0
1008343|NCT00382109|3299975|P1|Overall Study|Adverse Event|3
1008344|NCT00382018|3300014|P4|Overall Study|Other, not protocol specified|1
1008345|NCT00382018|3300015|P3|Overall Study|Other, not protocol specified|3
1008346|NCT00382018|3300016|P2|Overall Study|Other, not protocol specified|16
1008347|NCT00382018|3300017|P1|Overall Study|Other, not protocol specified|0
1008348|NCT00382018|3300014|P4|Overall Study|Withdrawal by Subject|4
1008349|NCT00382018|3300015|P3|Overall Study|Withdrawal by Subject|3
1008350|NCT00382018|3300016|P2|Overall Study|Withdrawal by Subject|4
1008351|NCT00382018|3300017|P1|Overall Study|Withdrawal by Subject|0
1008352|NCT00382018|3300014|P4|Overall Study|Death|11
1008353|NCT00382018|3300015|P3|Overall Study|Death|7
1008354|NCT00382018|3300016|P2|Overall Study|Death|9
1008355|NCT00382018|3300017|P1|Overall Study|Death|0
1008356|NCT00382018|3300014|P4|Overall Study|Progression|43
1008357|NCT00382018|3300015|P3|Overall Study|Progression|51
1008358|NCT00382018|3300016|P2|Overall Study|Progression|136
1008359|NCT00382018|3300017|P1|Overall Study|Progression|0
1008360|NCT00381940|3300040|P1|Overall Study|Ineligible|1
1008361|NCT00381940|3300040|P1|Overall Study|Protocol Violation|1
1008362|NCT00381940|3300040|P1|Overall Study|Lack of Efficacy|3
1008363|NCT00381888|3300044|P1|Overall Study|Adverse Event|1
1008364|NCT00381888|3300044|P1|Overall Study|Surgery was cancelled|2
1008365|NCT00381888|3300044|P1|Overall Study|Had laparoscopic surgery|2
1008366|NCT00381888|3300044|P1|Overall Study|Protocol Violation|9
1008367|NCT00381888|3300044|P1|Overall Study|Physician Decision|1
1008368|NCT00381888|3300044|P1|Overall Study|Withdrawal by Subject|1
1008369|NCT00381888|3300044|P1|Overall Study|Death|1
1008370|NCT00381849|3300055|P2|Wash Out|Withdrawal by Subject|1
1008371|NCT00381849|3300056|P1|Wash Out|Withdrawal by Subject|0
1008372|NCT00381797|3300083|P5|Overall Study|Ineligible|0
1008373|NCT00381797|3300084|P4|Overall Study|Ineligible|1
1008374|NCT00381797|3300085|P3|Overall Study|Ineligible|0
1008375|NCT00381797|3300086|P2|Overall Study|Ineligible|0
1008376|NCT00381797|3300087|P1|Overall Study|Ineligible|0
1008377|NCT00381797|3300083|P5|Overall Study|Withdrawal by Subject|2
1008378|NCT00381797|3300084|P4|Overall Study|Withdrawal by Subject|0
1008379|NCT00381797|3300085|P3|Overall Study|Withdrawal by Subject|0
1008380|NCT00381797|3300086|P2|Overall Study|Withdrawal by Subject|1
1008381|NCT00381797|3300087|P1|Overall Study|Withdrawal by Subject|1
1008382|NCT00381706|3300162|P3|Overall Study|Never treated|1
1008383|NCT00381706|3300163|P2|Overall Study|Never treated|2
1008384|NCT00381706|3300164|P1|Overall Study|Never treated|7
1008385|NCT00381693|3300187|P1|Overall Study|Progression|2
1008386|NCT00381693|3300187|P1|Overall Study|Patient Choice|1
1008387|NCT00381693|3300187|P1|Overall Study|Adverse Event|4
1008388|NCT00381693|3300187|P1|Overall Study|Death|1
1008389|NCT00381680|3300196|P2|Overall Study|Ineligible|1
1008390|NCT00381680|3300197|P1|Overall Study|Ineligible|3
1008391|NCT00381680|3300196|P2|Overall Study|Other not otherwise specified|2
1008392|NCT00381680|3300197|P1|Overall Study|Other not otherwise specified|7
1008393|NCT00381680|3300196|P2|Overall Study|Progression|1
1008394|NCT00381680|3300197|P1|Overall Study|Progression|1
1008395|NCT00381680|3300196|P2|Overall Study|Induction Failure|1
1008396|NCT00381680|3300197|P1|Overall Study|Induction Failure|4
1008397|NCT00381680|3300196|P2|Overall Study|Relapse|9
1008398|NCT00381680|3300197|P1|Overall Study|Relapse|18
1008399|NCT00381680|3300196|P2|Overall Study|Stem Cell Transplant|10
1008400|NCT00381680|3300197|P1|Overall Study|Stem Cell Transplant|26
1008401|NCT00381680|3300196|P2|Overall Study|Delay initiation|0
1008402|NCT00381680|3300197|P1|Overall Study|Delay initiation|1
1008403|NCT00381680|3300196|P2|Overall Study|Secondary Malignancy|0
1008404|NCT00381680|3300197|P1|Overall Study|Secondary Malignancy|3
1008405|NCT00381680|3300196|P2|Overall Study|Alternative Therapy|5
1008406|NCT00381680|3300197|P1|Overall Study|Alternative Therapy|11
1008407|NCT00381680|3300196|P2|Overall Study|Entry onto another COG Trial|2
1008408|NCT00381680|3300197|P1|Overall Study|Entry onto another COG Trial|1
1008409|NCT00381680|3300196|P2|Overall Study|Withdrawal by Subject|1
1008410|NCT00381680|3300197|P1|Overall Study|Withdrawal by Subject|3
1008411|NCT00381680|3300196|P2|Overall Study|Physician Decision|6
1008412|NCT00381680|3300197|P1|Overall Study|Physician Decision|25
1008413|NCT00381680|3300196|P2|Overall Study|Lost to Follow-up|2
1008414|NCT00381680|3300197|P1|Overall Study|Lost to Follow-up|3
1008415|NCT00381680|3300196|P2|Overall Study|Death|7
1008416|NCT00381680|3300197|P1|Overall Study|Death|10
1008417|NCT00381680|3300196|P2|Overall Study|Adverse Event|3
1008418|NCT00381680|3300197|P1|Overall Study|Adverse Event|9
1008419|NCT00381641|3300214|P2|Overall Study|Withdrawal by Subject|2
1008420|NCT00381641|3300215|P1|Overall Study|Withdrawal by Subject|0
1008421|NCT00381615|3300248|P4|Overall Study|Protocol Violation|0
1008422|NCT00381615|3300249|P3|Overall Study|Protocol Violation|1
1008423|NCT00381615|3300250|P2|Overall Study|Protocol Violation|0
1008424|NCT00381615|3300251|P1|Overall Study|Protocol Violation|0
1008425|NCT00381615|3300248|P4|Overall Study|Lost to Follow-up|1
1008426|NCT00381615|3300249|P3|Overall Study|Lost to Follow-up|0
1008427|NCT00381615|3300250|P2|Overall Study|Lost to Follow-up|2
1008428|NCT00381615|3300251|P1|Overall Study|Lost to Follow-up|3
1008429|NCT00381615|3300248|P4|Overall Study|Withdrawal by Subject|1
1008430|NCT00381615|3300249|P3|Overall Study|Withdrawal by Subject|0
1008431|NCT00381615|3300250|P2|Overall Study|Withdrawal by Subject|3
1008432|NCT00381615|3300251|P1|Overall Study|Withdrawal by Subject|1
1008433|NCT00381563|3300303|P2|Overall Study|Protocol Violation|1
1008434|NCT00381563|3300304|P1|Overall Study|Protocol Violation|0
1008435|NCT00381563|3300303|P2|Overall Study|Lost to Follow-up|0
1008436|NCT00381563|3300304|P1|Overall Study|Lost to Follow-up|2
1008437|NCT00381563|3300303|P2|Overall Study|Withdrawal by Subject|5
1008438|NCT00381563|3300304|P1|Overall Study|Withdrawal by Subject|5
1008439|NCT00381485|3300319|P4|Double-Blind Treatment Period|Administrative|1
1008440|NCT00381485|3300320|P3|Double-Blind Treatment Period|Administrative|0
1008441|NCT00381485|3300321|P2|Double-Blind Treatment Period|Administrative|1
1008442|NCT00381485|3300322|P1|Double-Blind Treatment Period|Administrative|0
1008443|NCT00381485|3300319|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1
1008444|NCT00381485|3300320|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
1008445|NCT00381485|3300321|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
1008446|NCT00381485|3300322|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
1008447|NCT00381485|3300319|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4
1008448|NCT00381485|3300320|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1
1008449|NCT00381485|3300321|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2
1008450|NCT00381485|3300322|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0
1008451|NCT00381485|3300319|P4|Double-Blind Treatment Period|Did not meet protocol eligibility|5
1008452|NCT00381485|3300320|P3|Double-Blind Treatment Period|Did not meet protocol eligibility|7
1008453|NCT00381485|3300321|P2|Double-Blind Treatment Period|Did not meet protocol eligibility|5
1008454|NCT00381485|3300322|P1|Double-Blind Treatment Period|Did not meet protocol eligibility|0
1008455|NCT00381485|3300319|P4|Double-Blind Treatment Period|Noncompliance with protocol|3
1008456|NCT00381485|3300320|P3|Double-Blind Treatment Period|Noncompliance with protocol|3
1008457|NCT00381485|3300321|P2|Double-Blind Treatment Period|Noncompliance with protocol|9
1008458|NCT00381485|3300322|P1|Double-Blind Treatment Period|Noncompliance with protocol|0
1008459|NCT00381485|3300319|P4|Double-Blind Treatment Period|Lost to Follow-up|1
1008460|NCT00381485|3300320|P3|Double-Blind Treatment Period|Lost to Follow-up|1
1008461|NCT00381485|3300321|P2|Double-Blind Treatment Period|Lost to Follow-up|0
1008462|NCT00381485|3300322|P1|Double-Blind Treatment Period|Lost to Follow-up|0
1008463|NCT00381485|3300319|P4|Double-Blind Treatment Period|Lack of Efficacy|13
1008464|NCT00381485|3300320|P3|Double-Blind Treatment Period|Lack of Efficacy|11
1008465|NCT00381485|3300321|P2|Double-Blind Treatment Period|Lack of Efficacy|8
1008466|NCT00381485|3300322|P1|Double-Blind Treatment Period|Lack of Efficacy|0
1008467|NCT00381485|3300319|P4|Double-Blind Treatment Period|Adverse Event|5
1008468|NCT00381485|3300320|P3|Double-Blind Treatment Period|Adverse Event|2
1008469|NCT00381485|3300321|P2|Double-Blind Treatment Period|Adverse Event|2
1008470|NCT00381485|3300322|P1|Double-Blind Treatment Period|Adverse Event|0
1008471|NCT00381485|3300319|P4|Open-Label Run-In Period|Treatment failure|0
1008472|NCT00381485|3300320|P3|Open-Label Run-In Period|Treatment failure|0
1008473|NCT00381485|3300321|P2|Open-Label Run-In Period|Treatment failure|0
1008474|NCT00381485|3300322|P1|Open-Label Run-In Period|Treatment failure|1
1008475|NCT00381485|3300319|P4|Open-Label Run-In Period|Lost to Follow-up|0
1008476|NCT00381485|3300320|P3|Open-Label Run-In Period|Lost to Follow-up|0
1008477|NCT00381485|3300321|P2|Open-Label Run-In Period|Lost to Follow-up|0
1008478|NCT00381485|3300322|P1|Open-Label Run-In Period|Lost to Follow-up|3
1008479|NCT00381485|3300319|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
1008480|NCT00381485|3300320|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
1008481|NCT00381485|3300321|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
1008482|NCT00381485|3300322|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1
1008483|NCT00381485|3300319|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
1008484|NCT00381485|3300320|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
1008485|NCT00381485|3300321|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
1008486|NCT00381485|3300322|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16
1008487|NCT00381485|3300319|P4|Open-Label Run-In Period|Did not meet protocol eligibility|0
1008488|NCT00381485|3300320|P3|Open-Label Run-In Period|Did not meet protocol eligibility|0
1008489|NCT00381485|3300321|P2|Open-Label Run-In Period|Did not meet protocol eligibility|0
1008490|NCT00381485|3300322|P1|Open-Label Run-In Period|Did not meet protocol eligibility|76
1008491|NCT00381485|3300319|P4|Open-Label Run-In Period|Adverse Event|0
1008492|NCT00381485|3300320|P3|Open-Label Run-In Period|Adverse Event|0
1008493|NCT00381485|3300321|P2|Open-Label Run-In Period|Adverse Event|0
1008494|NCT00381485|3300322|P1|Open-Label Run-In Period|Adverse Event|9
1008495|NCT00381381|3300340|P1|Overall Study|Withdrawal by Subject|9
1008496|NCT00381381|3300340|P1|Overall Study|Lost to Follow-up|52
1008497|NCT00381381|3300340|P1|Overall Study|Adverse Event|3
1008498|NCT00381303|3300349|P2|Overall Study|Subject primary physician's decision|0
1008499|NCT00381303|3300350|P1|Overall Study|Subject primary physician's decision|1
1008500|NCT00381303|3300349|P2|Overall Study|Subject did not continue visits|0
1008501|NCT00381303|3300350|P1|Overall Study|Subject did not continue visits|1
1008502|NCT00381303|3300349|P2|Overall Study|Subject was too busy for appointments|0
1008503|NCT00381303|3300350|P1|Overall Study|Subject was too busy for appointments|1
1008504|NCT00381303|3300349|P2|Overall Study|No virologic response by week 12|0
1008676|NCT00379899|3300847|P1|Overall Study|Noncompliance|1
1008505|NCT00381303|3300350|P1|Overall Study|No virologic response by week 12|1
1008506|NCT00381303|3300349|P2|Overall Study|Subject taking too many different meds|0
1008507|NCT00381303|3300350|P1|Overall Study|Subject taking too many different meds|1
1008508|NCT00381303|3300349|P2|Overall Study|Subject moved out of state|0
1008509|NCT00381303|3300350|P1|Overall Study|Subject moved out of state|2
1008510|NCT00381303|3300349|P2|Overall Study|Physician's decision to close the site|1
1008511|NCT00381303|3300350|P1|Overall Study|Physician's decision to close the site|3
1008512|NCT00381303|3300349|P2|Overall Study|Physician Decision|0
1008513|NCT00381303|3300350|P1|Overall Study|Physician Decision|1
1008514|NCT00381303|3300349|P2|Overall Study|Pregnancy|0
1008515|NCT00381303|3300350|P1|Overall Study|Pregnancy|2
1008516|NCT00381303|3300349|P2|Overall Study|Ineligible to continue the trial|1
1008517|NCT00381303|3300350|P1|Overall Study|Ineligible to continue the trial|2
1008518|NCT00381303|3300349|P2|Overall Study|Virologic failure|4
1008519|NCT00381303|3300350|P1|Overall Study|Virologic failure|6
1008520|NCT00381303|3300349|P2|Overall Study|Withdrawal by Subject|6
1008521|NCT00381303|3300350|P1|Overall Study|Withdrawal by Subject|13
1008522|NCT00381303|3300349|P2|Overall Study|Non-Adherence|6
1008523|NCT00381303|3300350|P1|Overall Study|Non-Adherence|13
1008524|NCT00381303|3300349|P2|Overall Study|AE/HIV-related event|6
1008525|NCT00381303|3300350|P1|Overall Study|AE/HIV-related event|22
1008526|NCT00381303|3300349|P2|Overall Study|Lost to Follow-up|9
1008527|NCT00381303|3300350|P1|Overall Study|Lost to Follow-up|25
1008528|NCT00381238|3300410|P1|Overall Study|Disease progression|1
1008529|NCT00381238|3300410|P1|Overall Study|Withdrew by physician|1
1008530|NCT00381238|3300410|P1|Overall Study|Lack of Efficacy|2
1008531|NCT00381238|3300410|P1|Overall Study|Withdrawal by Subject|4
1008532|NCT00381238|3300410|P1|Overall Study|Protocol Violation|1
1008533|NCT00381238|3300410|P1|Overall Study|Adverse Event|3
1008534|NCT00381095|3300426|P2|Overall Study|Adverse Event|7
1008535|NCT00381095|3300427|P1|Overall Study|Adverse Event|2
1008536|NCT00381095|3300426|P2|Overall Study|Withdrawal by Subject|3
1008537|NCT00381095|3300427|P1|Overall Study|Withdrawal by Subject|3
1008538|NCT00381095|3300426|P2|Overall Study|Protocol Violation|1
1008539|NCT00381095|3300427|P1|Overall Study|Protocol Violation|1
1008540|NCT00381095|3300426|P2|Overall Study|Other|2
1008541|NCT00381095|3300427|P1|Overall Study|Other|2
1008542|NCT00381095|3300426|P2|Overall Study|Lack of Efficacy|4
1008543|NCT00381095|3300427|P1|Overall Study|Lack of Efficacy|2
1008544|NCT00381095|3300426|P2|Overall Study|Death|4
1008545|NCT00381095|3300427|P1|Overall Study|Death|3
1008546|NCT00381043|3300459|P2|Overall Study|incarcerated|0
1008547|NCT00381043|3300460|P1|Overall Study|incarcerated|1
1008548|NCT00381043|3300459|P2|Overall Study|wanted more care|1
1008549|NCT00381043|3300460|P1|Overall Study|wanted more care|0
1008550|NCT00381043|3300459|P2|Overall Study|Withdrawal by Subject|1
1008551|NCT00381043|3300460|P1|Overall Study|Withdrawal by Subject|3
1008552|NCT00381043|3300459|P2|Overall Study|Lost to Follow-up|6
1008553|NCT00381043|3300460|P1|Overall Study|Lost to Follow-up|8
1008554|NCT00380978|3300486|P2|Overall Study|Parous patient|0
1008555|NCT00380978|3300487|P1|Overall Study|Parous patient|1
1008556|NCT00380978|3300486|P2|Overall Study|Allocation prior to analgesia request|2
1008557|NCT00380978|3300487|P1|Overall Study|Allocation prior to analgesia request|1
1008558|NCT00380978|3300486|P2|Overall Study|Wrong study envelope|2
1008559|NCT00380978|3300487|P1|Overall Study|Wrong study envelope|0
1008560|NCT00380978|3300486|P2|Overall Study|Refused allocated intervention|6
1008561|NCT00380978|3300487|P1|Overall Study|Refused allocated intervention|0
1008562|NCT00380874|3300509|P2|Overall Study|Not related to study drug|2
1008563|NCT00380874|3300510|P1|Overall Study|Not related to study drug|3
1008564|NCT00380874|3300509|P2|Overall Study|Withdrawal by Subject|1
1008565|NCT00380874|3300510|P1|Overall Study|Withdrawal by Subject|2
1008566|NCT00380874|3300509|P2|Overall Study|Death|0
1008567|NCT00380874|3300510|P1|Overall Study|Death|1
1008568|NCT00380874|3300509|P2|Overall Study|Adverse Event|7
1008569|NCT00380874|3300510|P1|Overall Study|Adverse Event|7
1008570|NCT00380718|3300535|P1|Overall Study|Death after 30-day post-therapy followup|17
1008571|NCT00380718|3300535|P1|Overall Study|Adverse Event|1
1008572|NCT00380692|3300547|P2|Study Period III - Open Label|Parent/Caregiver Decision|1
1008573|NCT00380692|3300548|P1|Study Period III - Open Label|Parent/Caregiver Decision|1
1008574|NCT00380692|3300547|P2|Study Period III - Open Label|Lack of Efficacy|4
1008575|NCT00380692|3300548|P1|Study Period III - Open Label|Lack of Efficacy|0
1008576|NCT00380692|3300547|P2|Study Period III - Open Label|Physician Decision|3
1008577|NCT00380692|3300548|P1|Study Period III - Open Label|Physician Decision|0
1008578|NCT00380692|3300547|P2|Study Period III - Open Label|Withdrawal by Subject|1
1008579|NCT00380692|3300548|P1|Study Period III - Open Label|Withdrawal by Subject|0
1008580|NCT00380692|3300547|P2|Study Period III - Open Label|Protocol Violation|0
1008581|NCT00380692|3300548|P1|Study Period III - Open Label|Protocol Violation|0
1008582|NCT00380692|3300547|P2|Study Period III - Open Label|Adverse Event|3
1008583|NCT00380692|3300548|P1|Study Period III - Open Label|Adverse Event|5
1008584|NCT00380692|3300547|P2|Study Period II - Double Blind|Parent/Caregiver Decision|0
1008585|NCT00380692|3300548|P1|Study Period II - Double Blind|Parent/Caregiver Decision|1
1008586|NCT00380692|3300547|P2|Study Period II - Double Blind|Lack of Efficacy|0
1008587|NCT00380692|3300548|P1|Study Period II - Double Blind|Lack of Efficacy|1
1008588|NCT00380692|3300547|P2|Study Period II - Double Blind|Physician Decision|1
1008589|NCT00380692|3300548|P1|Study Period II - Double Blind|Physician Decision|0
1008590|NCT00380692|3300547|P2|Study Period II - Double Blind|Withdrawal by Subject|0
1008591|NCT00380692|3300548|P1|Study Period II - Double Blind|Withdrawal by Subject|0
1008592|NCT00380692|3300547|P2|Study Period II - Double Blind|Protocol Violation|2
1008593|NCT00380692|3300548|P1|Study Period II - Double Blind|Protocol Violation|2
1008594|NCT00380692|3300547|P2|Study Period II - Double Blind|Adverse Event|0
1008595|NCT00380692|3300548|P1|Study Period II - Double Blind|Adverse Event|1
1008596|NCT00380588|3300596|P2|Overall Study|Physician Decision|0
1008597|NCT00380588|3300597|P1|Overall Study|Physician Decision|2
1008598|NCT00380588|3300596|P2|Overall Study|Withdrawal by Subject|3
1008599|NCT00380588|3300597|P1|Overall Study|Withdrawal by Subject|1
1008600|NCT00380588|3300596|P2|Overall Study|Adverse Event|3
1008601|NCT00380588|3300597|P1|Overall Study|Adverse Event|7
1008602|NCT00380588|3300596|P2|Overall Study|Next Cycle Not Started|0
1008603|NCT00380588|3300597|P1|Overall Study|Next Cycle Not Started|4
1008604|NCT00380588|3300596|P2|Overall Study|Unequivocal Disease Progression|34
1008605|NCT00380588|3300597|P1|Overall Study|Unequivocal Disease Progression|25
1008606|NCT00380393|3300611|P2|Month 14|Others|6
1008607|NCT00380393|3300612|P1|Month 14|Others|6
1008608|NCT00380393|3300611|P2|Month 14|Protocol Violation|0
1008609|NCT00380393|3300612|P1|Month 14|Protocol Violation|2
1008610|NCT00380393|3300611|P2|Month 14|Migrated/moved from study area|42
1008611|NCT00380393|3300612|P1|Month 14|Migrated/moved from study area|39
1008612|NCT00380393|3300611|P2|Month 14|Lost to Follow-up|1
1008613|NCT00380393|3300612|P1|Month 14|Lost to Follow-up|0
1008614|NCT00380393|3300611|P2|Month 14|Death|0
1008615|NCT00380393|3300612|P1|Month 14|Death|1
1008616|NCT00380393|3300611|P2|Month 14|Withdrawal by Subject|7
1008617|NCT00380393|3300612|P1|Month 14|Withdrawal by Subject|9
1008618|NCT00380393|3300611|P2|Month 8 (Cross-sectional Visit)|Others|4
1008619|NCT00380393|3300612|P1|Month 8 (Cross-sectional Visit)|Others|5
1008620|NCT00380393|3300611|P2|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
1008621|NCT00380393|3300612|P1|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
1008622|NCT00380393|3300611|P2|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29
1008623|NCT00380393|3300612|P1|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37
1008624|NCT00380393|3300611|P2|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1
1008625|NCT00380393|3300612|P1|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0
1008626|NCT00380393|3300611|P2|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5
1008627|NCT00380393|3300612|P1|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6
1008628|NCT00380367|3300660|P1|Overall Study|Withdrawal by Subject|1
1008629|NCT00380367|3300660|P1|Overall Study|Lost to Follow-up|1
1008630|NCT00380250|3300667|P2|Overall Study|Physician Decision|0
1008631|NCT00380250|3300668|P1|Overall Study|Physician Decision|1
1008632|NCT00380250|3300667|P2|Overall Study|Lost to Follow-up|5
1008633|NCT00380250|3300668|P1|Overall Study|Lost to Follow-up|14
1008634|NCT00380250|3300667|P2|Overall Study|Protocol Violation|5
1008635|NCT00380250|3300668|P1|Overall Study|Protocol Violation|15
1008636|NCT00380250|3300667|P2|Overall Study|Lack of Efficacy|8
1008637|NCT00380250|3300668|P1|Overall Study|Lack of Efficacy|10
1008638|NCT00380250|3300667|P2|Overall Study|Adverse Event|9
1008639|NCT00380250|3300668|P1|Overall Study|Adverse Event|20
1008640|NCT00380250|3300667|P2|Overall Study|Withdrawal by Subject|28
1008641|NCT00380250|3300668|P1|Overall Study|Withdrawal by Subject|39
1008642|NCT00380081|3300736|P6|Overall Study|Family Emergency|1
1008643|NCT00380081|3300737|P5|Overall Study|Family Emergency|0
1008644|NCT00380081|3300738|P4|Overall Study|Family Emergency|0
1008645|NCT00380081|3300739|P3|Overall Study|Family Emergency|0
1008646|NCT00380081|3300740|P2|Overall Study|Family Emergency|0
1008647|NCT00380081|3300741|P1|Overall Study|Family Emergency|0
1008648|NCT00380081|3300736|P6|Overall Study|Withdrawal by Subject|0
1008649|NCT00380081|3300737|P5|Overall Study|Withdrawal by Subject|1
1008650|NCT00380081|3300738|P4|Overall Study|Withdrawal by Subject|0
1008651|NCT00380081|3300739|P3|Overall Study|Withdrawal by Subject|0
1008652|NCT00380081|3300740|P2|Overall Study|Withdrawal by Subject|0
1008653|NCT00380081|3300741|P1|Overall Study|Withdrawal by Subject|0
1008654|NCT00380068|3300791|P1|Overall Study|Lack of Efficacy|5
1008655|NCT00380068|3300791|P1|Overall Study|Partipant moved away|1
1008656|NCT00380068|3300791|P1|Overall Study|Physician Decision|2
1008657|NCT00380068|3300791|P1|Overall Study|Lung transplant|3
1008658|NCT00380068|3300791|P1|Overall Study|Addition of other PAH therapeutic agent|1
1008659|NCT00380068|3300791|P1|Overall Study|Lost to Follow-up|1
1008660|NCT00380068|3300791|P1|Overall Study|Not compliant|6
1008661|NCT00380068|3300791|P1|Overall Study|Withdrawal by Subject|10
1008662|NCT00380068|3300791|P1|Overall Study|Adverse Event|40
1008663|NCT00379912|3300823|P2|Overall Study|Lack of Efficacy|0
1008664|NCT00379912|3300824|P1|Overall Study|Lack of Efficacy|1
1008665|NCT00379899|3300846|P2|Overall Study|Other|1
1008666|NCT00379899|3300847|P1|Overall Study|Other|3
1008667|NCT00379899|3300846|P2|Overall Study|Other protocol-specified criteria|4
1008668|NCT00379899|3300847|P1|Overall Study|Other protocol-specified criteria|3
1008669|NCT00379899|3300846|P2|Overall Study|Coronary artery bypass graft|1
1008670|NCT00379899|3300847|P1|Overall Study|Coronary artery bypass graft|1
1008671|NCT00379899|3300846|P2|Overall Study|Renal transplantation|4
1008672|NCT00379899|3300847|P1|Overall Study|Renal transplantation|5
1008673|NCT00379899|3300846|P2|Overall Study|Parathyroidectomy|2
1008674|NCT00379899|3300847|P1|Overall Study|Parathyroidectomy|0
1008675|NCT00379899|3300846|P2|Overall Study|Noncompliance|1
1008677|NCT00379899|3300846|P2|Overall Study|Ineligibility determined|1
1008678|NCT00379899|3300847|P1|Overall Study|Ineligibility determined|0
1008679|NCT00379899|3300846|P2|Overall Study|Withdrawal by Subject|5
1008680|NCT00379899|3300847|P1|Overall Study|Withdrawal by Subject|5
1008681|NCT00379899|3300846|P2|Overall Study|Physician Decision|4
1008682|NCT00379899|3300847|P1|Overall Study|Physician Decision|3
1008683|NCT00379899|3300846|P2|Overall Study|Lost to Follow-up|4
1008684|NCT00379899|3300847|P1|Overall Study|Lost to Follow-up|2
1008685|NCT00379899|3300846|P2|Overall Study|Death|10
1008686|NCT00379899|3300847|P1|Overall Study|Death|10
1008687|NCT00379899|3300846|P2|Overall Study|Adverse Event|3
1008688|NCT00379899|3300847|P1|Overall Study|Adverse Event|7
1008689|NCT00379834|3300875|P1|Overall Study|Time constraints|2
1008690|NCT00379808|3301027|P2|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1
1008691|NCT00379808|3301028|P1|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0
1008692|NCT00379795|3301049|P5|Overall Study|Sponsor's decision|10
1008693|NCT00379795|3301050|P4|Overall Study|Sponsor's decision|47
1008694|NCT00379795|3301051|P3|Overall Study|Sponsor's decision|54
1008695|NCT00379795|3301052|P2|Overall Study|Sponsor's decision|17
1008696|NCT00379795|3301053|P1|Overall Study|Sponsor's decision|257
1008697|NCT00379795|3301049|P5|Overall Study|Subjects condition mandated intervention|7
1008698|NCT00379795|3301050|P4|Overall Study|Subjects condition mandated intervention|5
1008699|NCT00379795|3301051|P3|Overall Study|Subjects condition mandated intervention|7
1008700|NCT00379795|3301052|P2|Overall Study|Subjects condition mandated intervention|9
1008701|NCT00379795|3301053|P1|Overall Study|Subjects condition mandated intervention|34
1008702|NCT00379795|3301049|P5|Overall Study|Verteporfin photodynamic therapy in eye|0
1008703|NCT00379795|3301050|P4|Overall Study|Verteporfin photodynamic therapy in eye|1
1008704|NCT00379795|3301051|P3|Overall Study|Verteporfin photodynamic therapy in eye|0
1008705|NCT00379795|3301052|P2|Overall Study|Verteporfin photodynamic therapy in eye|0
1008706|NCT00379795|3301053|P1|Overall Study|Verteporfin photodynamic therapy in eye|3
1008707|NCT00379795|3301049|P5|Overall Study|Subject non-compliance|1
1008708|NCT00379795|3301050|P4|Overall Study|Subject non-compliance|0
1008709|NCT00379795|3301051|P3|Overall Study|Subject non-compliance|0
1008710|NCT00379795|3301052|P2|Overall Study|Subject non-compliance|2
1008711|NCT00379795|3301053|P1|Overall Study|Subject non-compliance|7
1008712|NCT00379795|3301049|P5|Overall Study|Withdrawal by Subject|14
1008713|NCT00379795|3301050|P4|Overall Study|Withdrawal by Subject|7
1008714|NCT00379795|3301051|P3|Overall Study|Withdrawal by Subject|19
1008715|NCT00379795|3301052|P2|Overall Study|Withdrawal by Subject|11
1008716|NCT00379795|3301053|P1|Overall Study|Withdrawal by Subject|94
1008717|NCT00379795|3301049|P5|Overall Study|Physician Decision|2
1008718|NCT00379795|3301050|P4|Overall Study|Physician Decision|2
1008719|NCT00379795|3301051|P3|Overall Study|Physician Decision|2
1008720|NCT00379795|3301052|P2|Overall Study|Physician Decision|0
1008721|NCT00379795|3301053|P1|Overall Study|Physician Decision|25
1008722|NCT00379795|3301049|P5|Overall Study|Lost to Follow-up|4
1008723|NCT00379795|3301050|P4|Overall Study|Lost to Follow-up|1
1008724|NCT00379795|3301051|P3|Overall Study|Lost to Follow-up|2
1008725|NCT00379795|3301052|P2|Overall Study|Lost to Follow-up|1
1008726|NCT00379795|3301053|P1|Overall Study|Lost to Follow-up|8
1008727|NCT00379795|3301049|P5|Overall Study|Adverse Event|4
1008728|NCT00379795|3301050|P4|Overall Study|Adverse Event|1
1008729|NCT00379795|3301051|P3|Overall Study|Adverse Event|3
1008730|NCT00379795|3301052|P2|Overall Study|Adverse Event|3
1008731|NCT00379795|3301053|P1|Overall Study|Adverse Event|17
1008732|NCT00379795|3301049|P5|Overall Study|Death|7
1008733|NCT00379795|3301050|P4|Overall Study|Death|4
1008734|NCT00379795|3301051|P3|Overall Study|Death|6
1008735|NCT00379795|3301052|P2|Overall Study|Death|8
1008736|NCT00379795|3301053|P1|Overall Study|Death|31
1008737|NCT00379769|3301083|P6|Observational Follow-up|Unknown; Reason Not Provided|1
1008738|NCT00379769|3301084|P5|Observational Follow-up|Unknown; Reason Not Provided|1
1008739|NCT00379769|3301085|P4|Observational Follow-up|Unknown; Reason Not Provided|0
1008740|NCT00379769|3301086|P3|Observational Follow-up|Unknown; Reason Not Provided|0
1008741|NCT00379769|3301087|P2|Observational Follow-up|Unknown; Reason Not Provided|0
1008742|NCT00379769|3301088|P1|Observational Follow-up|Unknown; Reason Not Provided|0
1008743|NCT00379769|3301083|P6|Observational Follow-up|Participant Moved|1
1008744|NCT00379769|3301084|P5|Observational Follow-up|Participant Moved|0
1008745|NCT00379769|3301085|P4|Observational Follow-up|Participant Moved|0
1008746|NCT00379769|3301086|P3|Observational Follow-up|Participant Moved|0
1008747|NCT00379769|3301087|P2|Observational Follow-up|Participant Moved|0
1008748|NCT00379769|3301088|P1|Observational Follow-up|Participant Moved|0
1008749|NCT00379769|3301083|P6|Observational Follow-up|Site Closed Early|7
1008750|NCT00379769|3301084|P5|Observational Follow-up|Site Closed Early|6
1008751|NCT00379769|3301085|P4|Observational Follow-up|Site Closed Early|0
1008752|NCT00379769|3301086|P3|Observational Follow-up|Site Closed Early|0
1008753|NCT00379769|3301087|P2|Observational Follow-up|Site Closed Early|0
1008754|NCT00379769|3301088|P1|Observational Follow-up|Site Closed Early|0
1008755|NCT00379769|3301083|P6|Observational Follow-up|Physician Decision|8
1008756|NCT00379769|3301084|P5|Observational Follow-up|Physician Decision|8
1008757|NCT00379769|3301085|P4|Observational Follow-up|Physician Decision|0
1008758|NCT00379769|3301086|P3|Observational Follow-up|Physician Decision|0
1008759|NCT00379769|3301087|P2|Observational Follow-up|Physician Decision|0
1008760|NCT00379769|3301088|P1|Observational Follow-up|Physician Decision|0
1008761|NCT00379769|3301083|P6|Observational Follow-up|Entered into Another Clinical Trial|22
1008762|NCT00379769|3301084|P5|Observational Follow-up|Entered into Another Clinical Trial|18
1008763|NCT00379769|3301085|P4|Observational Follow-up|Entered into Another Clinical Trial|0
1008764|NCT00379769|3301086|P3|Observational Follow-up|Entered into Another Clinical Trial|0
1008765|NCT00379769|3301087|P2|Observational Follow-up|Entered into Another Clinical Trial|0
1008766|NCT00379769|3301088|P1|Observational Follow-up|Entered into Another Clinical Trial|0
1008767|NCT00379769|3301083|P6|Observational Follow-up|Withdrawal by Subject|12
1008768|NCT00379769|3301084|P5|Observational Follow-up|Withdrawal by Subject|12
1008769|NCT00379769|3301085|P4|Observational Follow-up|Withdrawal by Subject|0
1008770|NCT00379769|3301086|P3|Observational Follow-up|Withdrawal by Subject|0
1008771|NCT00379769|3301087|P2|Observational Follow-up|Withdrawal by Subject|0
1008772|NCT00379769|3301088|P1|Observational Follow-up|Withdrawal by Subject|0
1008773|NCT00379769|3301083|P6|Observational Follow-up|Lost to Follow-up|27
1008774|NCT00379769|3301084|P5|Observational Follow-up|Lost to Follow-up|25
1008775|NCT00379769|3301085|P4|Observational Follow-up|Lost to Follow-up|0
1008776|NCT00379769|3301086|P3|Observational Follow-up|Lost to Follow-up|0
1008777|NCT00379769|3301087|P2|Observational Follow-up|Lost to Follow-up|0
1008778|NCT00379769|3301088|P1|Observational Follow-up|Lost to Follow-up|0
1008779|NCT00379769|3301083|P6|Observational Follow-up|Adverse Event|0
1008780|NCT00379769|3301084|P5|Observational Follow-up|Adverse Event|1
1008781|NCT00379769|3301085|P4|Observational Follow-up|Adverse Event|0
1008782|NCT00379769|3301086|P3|Observational Follow-up|Adverse Event|0
1008783|NCT00379769|3301087|P2|Observational Follow-up|Adverse Event|0
1008784|NCT00379769|3301088|P1|Observational Follow-up|Adverse Event|0
1008785|NCT00379769|3301083|P6|Observational Follow-up|Death|70
1008786|NCT00379769|3301084|P5|Observational Follow-up|Death|78
1008787|NCT00379769|3301085|P4|Observational Follow-up|Death|0
1008788|NCT00379769|3301086|P3|Observational Follow-up|Death|0
1008789|NCT00379769|3301087|P2|Observational Follow-up|Death|0
1008790|NCT00379769|3301088|P1|Observational Follow-up|Death|0
1008791|NCT00379769|3301083|P6|Main Study|Reason unspecified|0
1008792|NCT00379769|3301084|P5|Main Study|Reason unspecified|0
1008793|NCT00379769|3301085|P4|Main Study|Reason unspecified|0
1008794|NCT00379769|3301086|P3|Main Study|Reason unspecified|1
1008795|NCT00379769|3301087|P2|Main Study|Reason unspecified|0
1008796|NCT00379769|3301088|P1|Main Study|Reason unspecified|0
1008797|NCT00379769|3301083|P6|Main Study|Investigator refused to log temperature|0
1008798|NCT00379769|3301084|P5|Main Study|Investigator refused to log temperature|0
1008799|NCT00379769|3301085|P4|Main Study|Investigator refused to log temperature|0
1008800|NCT00379769|3301086|P3|Main Study|Investigator refused to log temperature|1
1008801|NCT00379769|3301087|P2|Main Study|Investigator refused to log temperature|0
1008802|NCT00379769|3301088|P1|Main Study|Investigator refused to log temperature|0
1008803|NCT00379769|3301083|P6|Main Study|Risk of heart failure|0
1008804|NCT00379769|3301084|P5|Main Study|Risk of heart failure|0
1008805|NCT00379769|3301085|P4|Main Study|Risk of heart failure|0
1008806|NCT00379769|3301086|P3|Main Study|Risk of heart failure|0
1008807|NCT00379769|3301087|P2|Main Study|Risk of heart failure|1
1008808|NCT00379769|3301088|P1|Main Study|Risk of heart failure|0
1008809|NCT00379769|3301083|P6|Main Study|Personal reasons|0
1008810|NCT00379769|3301084|P5|Main Study|Personal reasons|0
1008811|NCT00379769|3301085|P4|Main Study|Personal reasons|0
1008812|NCT00379769|3301086|P3|Main Study|Personal reasons|0
1008813|NCT00379769|3301087|P2|Main Study|Personal reasons|0
1008814|NCT00379769|3301088|P1|Main Study|Personal reasons|1
1008815|NCT00379769|3301083|P6|Main Study|Participant completed study at visit 27|0
1008816|NCT00379769|3301084|P5|Main Study|Participant completed study at visit 27|0
1008817|NCT00379769|3301085|P4|Main Study|Participant completed study at visit 27|0
1008818|NCT00379769|3301086|P3|Main Study|Participant completed study at visit 27|0
1008819|NCT00379769|3301087|P2|Main Study|Participant completed study at visit 27|0
1008820|NCT00379769|3301088|P1|Main Study|Participant completed study at visit 27|1
1008821|NCT00379769|3301083|P6|Main Study|Physician Decision|0
1008822|NCT00379769|3301084|P5|Main Study|Physician Decision|0
1008823|NCT00379769|3301085|P4|Main Study|Physician Decision|1
1008824|NCT00379769|3301086|P3|Main Study|Physician Decision|1
1008825|NCT00379769|3301087|P2|Main Study|Physician Decision|2
1008826|NCT00379769|3301088|P1|Main Study|Physician Decision|2
1008827|NCT00379769|3301083|P6|Main Study|Participant did not take study drug|0
1008828|NCT00379769|3301084|P5|Main Study|Participant did not take study drug|0
1008829|NCT00379769|3301085|P4|Main Study|Participant did not take study drug|0
1008830|NCT00379769|3301086|P3|Main Study|Participant did not take study drug|1
1008831|NCT00379769|3301087|P2|Main Study|Participant did not take study drug|0
1008832|NCT00379769|3301088|P1|Main Study|Participant did not take study drug|0
1008833|NCT00379769|3301083|P6|Main Study|Entry criteria violation|0
1008834|NCT00379769|3301084|P5|Main Study|Entry criteria violation|0
1008835|NCT00379769|3301085|P4|Main Study|Entry criteria violation|1
1008836|NCT00379769|3301086|P3|Main Study|Entry criteria violation|1
1008837|NCT00379769|3301087|P2|Main Study|Entry criteria violation|0
1008838|NCT00379769|3301088|P1|Main Study|Entry criteria violation|0
1008839|NCT00379769|3301083|P6|Main Study|Site closed|0
1008840|NCT00379769|3301084|P5|Main Study|Site closed|0
1008841|NCT00379769|3301085|P4|Main Study|Site closed|8
1008842|NCT00379769|3301086|P3|Main Study|Site closed|4
1008843|NCT00379769|3301087|P2|Main Study|Site closed|4
1008844|NCT00379769|3301088|P1|Main Study|Site closed|4
1008845|NCT00379769|3301083|P6|Main Study|Prohibited glucose lowering medication|0
1008846|NCT00379769|3301084|P5|Main Study|Prohibited glucose lowering medication|0
1008847|NCT00379769|3301085|P4|Main Study|Prohibited glucose lowering medication|1
1008848|NCT00379769|3301086|P3|Main Study|Prohibited glucose lowering medication|0
1008849|NCT00379769|3301087|P2|Main Study|Prohibited glucose lowering medication|3
1008850|NCT00379769|3301088|P1|Main Study|Prohibited glucose lowering medication|0
1008851|NCT00379769|3301083|P6|Main Study|Poor compliance|0
1008852|NCT00379769|3301084|P5|Main Study|Poor compliance|0
1008853|NCT00379769|3301085|P4|Main Study|Poor compliance|1
1008854|NCT00379769|3301086|P3|Main Study|Poor compliance|2
1008855|NCT00379769|3301087|P2|Main Study|Poor compliance|2
1008856|NCT00379769|3301088|P1|Main Study|Poor compliance|3
1008857|NCT00379769|3301083|P6|Main Study|Participant moved|0
1008858|NCT00379769|3301084|P5|Main Study|Participant moved|0
1008859|NCT00379769|3301085|P4|Main Study|Participant moved|3
1008860|NCT00379769|3301086|P3|Main Study|Participant moved|3
1008861|NCT00379769|3301087|P2|Main Study|Participant moved|2
1008862|NCT00379769|3301088|P1|Main Study|Participant moved|3
1008863|NCT00379769|3301083|P6|Main Study|Moved to survival status follow-up only|0
1008864|NCT00379769|3301084|P5|Main Study|Moved to survival status follow-up only|0
1008865|NCT00379769|3301085|P4|Main Study|Moved to survival status follow-up only|36
1008866|NCT00379769|3301086|P3|Main Study|Moved to survival status follow-up only|32
1008867|NCT00379769|3301087|P2|Main Study|Moved to survival status follow-up only|25
1008868|NCT00379769|3301088|P1|Main Study|Moved to survival status follow-up only|27
1008869|NCT00379769|3301083|P6|Main Study|Withdrawal by Subject|0
1008870|NCT00379769|3301084|P5|Main Study|Withdrawal by Subject|0
1008871|NCT00379769|3301085|P4|Main Study|Withdrawal by Subject|70
1008872|NCT00379769|3301086|P3|Main Study|Withdrawal by Subject|72
1008873|NCT00379769|3301087|P2|Main Study|Withdrawal by Subject|56
1008874|NCT00379769|3301088|P1|Main Study|Withdrawal by Subject|46
1008875|NCT00379769|3301083|P6|Main Study|Lost to Follow-up|0
1008876|NCT00379769|3301084|P5|Main Study|Lost to Follow-up|0
1008877|NCT00379769|3301085|P4|Main Study|Lost to Follow-up|26
1008878|NCT00379769|3301086|P3|Main Study|Lost to Follow-up|25
1008879|NCT00379769|3301087|P2|Main Study|Lost to Follow-up|29
1008880|NCT00379769|3301088|P1|Main Study|Lost to Follow-up|29
1008881|NCT00379769|3301083|P6|Main Study|Adverse Event|0
1008882|NCT00379769|3301084|P5|Main Study|Adverse Event|0
1008883|NCT00379769|3301085|P4|Main Study|Adverse Event|11
1008884|NCT00379769|3301086|P3|Main Study|Adverse Event|10
1008885|NCT00379769|3301087|P2|Main Study|Adverse Event|8
1008886|NCT00379769|3301088|P1|Main Study|Adverse Event|5
1008887|NCT00379769|3301083|P6|Main Study|Death|0
1008888|NCT00379769|3301084|P5|Main Study|Death|0
1008889|NCT00379769|3301085|P4|Main Study|Death|72
1008890|NCT00379769|3301086|P3|Main Study|Death|54
1008891|NCT00379769|3301087|P2|Main Study|Death|67
1008892|NCT00379769|3301088|P1|Main Study|Death|57
1008893|NCT00379639|3301247|P5|Overall Study|Other|0
1008894|NCT00379639|3301248|P4|Overall Study|Other|0
1008895|NCT00379639|3301249|P3|Overall Study|Other|3
1008896|NCT00379639|3301250|P2|Overall Study|Other|0
1008897|NCT00379639|3301251|P1|Overall Study|Other|0
1008898|NCT00379639|3301247|P5|Overall Study|Lost to Follow-up|0
1008899|NCT00379639|3301248|P4|Overall Study|Lost to Follow-up|1
1008900|NCT00379639|3301249|P3|Overall Study|Lost to Follow-up|0
1008901|NCT00379639|3301250|P2|Overall Study|Lost to Follow-up|0
1008902|NCT00379639|3301251|P1|Overall Study|Lost to Follow-up|0
1008903|NCT00379639|3301247|P5|Overall Study|Adverse Event|1
1008904|NCT00379639|3301248|P4|Overall Study|Adverse Event|0
1008905|NCT00379639|3301249|P3|Overall Study|Adverse Event|1
1008906|NCT00379639|3301250|P2|Overall Study|Adverse Event|0
1008907|NCT00379639|3301251|P1|Overall Study|Adverse Event|0
1008908|NCT00379639|3301247|P5|Overall Study|Symptomatic Deterioration|1
1008909|NCT00379639|3301248|P4|Overall Study|Symptomatic Deterioration|0
1008910|NCT00379639|3301249|P3|Overall Study|Symptomatic Deterioration|1
1008911|NCT00379639|3301250|P2|Overall Study|Symptomatic Deterioration|0
1008912|NCT00379639|3301251|P1|Overall Study|Symptomatic Deterioration|0
1008913|NCT00379639|3301247|P5|Overall Study|Physician Decision|0
1008914|NCT00379639|3301248|P4|Overall Study|Physician Decision|1
1008915|NCT00379639|3301249|P3|Overall Study|Physician Decision|1
1008916|NCT00379639|3301250|P2|Overall Study|Physician Decision|2
1008917|NCT00379639|3301251|P1|Overall Study|Physician Decision|0
1008918|NCT00379639|3301247|P5|Overall Study|Disease Progression|4
1008919|NCT00379639|3301248|P4|Overall Study|Disease Progression|4
1008920|NCT00379639|3301249|P3|Overall Study|Disease Progression|3
1008921|NCT00379639|3301250|P2|Overall Study|Disease Progression|3
1008922|NCT00379639|3301251|P1|Overall Study|Disease Progression|3
1008923|NCT00379587|3301273|P1|Overall Study|Lost to Follow-up|2
1008924|NCT00379353|3301287|P2|Overall Study|Conflicting drug treatment|1
1008925|NCT00379353|3301288|P1|Overall Study|Conflicting drug treatment|0
1008926|NCT00379353|3301287|P2|Overall Study|Non-compliance|0
1008927|NCT00379353|3301288|P1|Overall Study|Non-compliance|1
1008928|NCT00379353|3301287|P2|Overall Study|Cardiac Tamponade|0
1008929|NCT00379353|3301288|P1|Overall Study|Cardiac Tamponade|1
1008930|NCT00379353|3301287|P2|Overall Study|Death|0
1008931|NCT00379353|3301288|P1|Overall Study|Death|1
1008932|NCT00379353|3301287|P2|Overall Study|Withdrawal by Subject|2
1008933|NCT00379353|3301288|P1|Overall Study|Withdrawal by Subject|5
1008934|NCT00379353|3301287|P2|Overall Study|Hospitalization|3
1008935|NCT00379353|3301288|P1|Overall Study|Hospitalization|3
1008936|NCT00379340|3301323|P5|Overall Study|Delayed nephrectomy and anaplasia|1
1008937|NCT00379340|3301324|P4|Overall Study|Delayed nephrectomy and anaplasia|1
1008938|NCT00379340|3301325|P3|Overall Study|Delayed nephrectomy and anaplasia|0
1008939|NCT00379340|3301326|P2|Overall Study|Delayed nephrectomy and anaplasia|0
1008940|NCT00379340|3301327|P1|Overall Study|Delayed nephrectomy and anaplasia|0
1008941|NCT00379340|3301323|P5|Overall Study|On more than 1 tumor therapeutic study|0
1008942|NCT00379340|3301324|P4|Overall Study|On more than 1 tumor therapeutic study|2
1008943|NCT00379340|3301325|P3|Overall Study|On more than 1 tumor therapeutic study|0
1008944|NCT00379340|3301326|P2|Overall Study|On more than 1 tumor therapeutic study|0
1008945|NCT00379340|3301327|P1|Overall Study|On more than 1 tumor therapeutic study|0
1008946|NCT00379340|3301323|P5|Overall Study|Refusal of further protocol therapy|7
1008947|NCT00379340|3301324|P4|Overall Study|Refusal of further protocol therapy|1
1008948|NCT00379340|3301325|P3|Overall Study|Refusal of further protocol therapy|1
1008949|NCT00379340|3301326|P2|Overall Study|Refusal of further protocol therapy|0
1008950|NCT00379340|3301327|P1|Overall Study|Refusal of further protocol therapy|1
1008951|NCT00379340|3301323|P5|Overall Study|Withdrawal by Subject|0
1008952|NCT00379340|3301324|P4|Overall Study|Withdrawal by Subject|1
1008953|NCT00379340|3301325|P3|Overall Study|Withdrawal by Subject|0
1008954|NCT00379340|3301326|P2|Overall Study|Withdrawal by Subject|0
1008955|NCT00379340|3301327|P1|Overall Study|Withdrawal by Subject|0
1008956|NCT00379340|3301323|P5|Overall Study|Physician Decision|3
1008957|NCT00379340|3301324|P4|Overall Study|Physician Decision|2
1008958|NCT00379340|3301325|P3|Overall Study|Physician Decision|1
1008959|NCT00379340|3301326|P2|Overall Study|Physician Decision|2
1008960|NCT00379340|3301327|P1|Overall Study|Physician Decision|6
1008961|NCT00379340|3301323|P5|Overall Study|Lack of Efficacy|3
1008962|NCT00379340|3301324|P4|Overall Study|Lack of Efficacy|4
1008963|NCT00379340|3301325|P3|Overall Study|Lack of Efficacy|0
1008964|NCT00379340|3301326|P2|Overall Study|Lack of Efficacy|1
1008965|NCT00379340|3301327|P1|Overall Study|Lack of Efficacy|6
1008966|NCT00379340|3301323|P5|Overall Study|Death|0
1008967|NCT00379340|3301324|P4|Overall Study|Death|2
1008968|NCT00379340|3301325|P3|Overall Study|Death|0
1008969|NCT00379340|3301326|P2|Overall Study|Death|0
1008970|NCT00379340|3301327|P1|Overall Study|Death|0
1008971|NCT00379288|3301344|P4|Overall Study|Administrative|1
1008972|NCT00379288|3301345|P3|Overall Study|Administrative|0
1008973|NCT00379288|3301346|P2|Overall Study|Administrative|2
1008974|NCT00379288|3301347|P1|Overall Study|Administrative|2
1008975|NCT00379288|3301344|P4|Overall Study|Did not meet protocol eligibility|2
1008976|NCT00379288|3301345|P3|Overall Study|Did not meet protocol eligibility|0
1008977|NCT00379288|3301346|P2|Overall Study|Did not meet protocol eligibility|1
1008978|NCT00379288|3301347|P1|Overall Study|Did not meet protocol eligibility|0
1008979|NCT00379288|3301344|P4|Overall Study|Noncompliance with protocol|1
1008980|NCT00379288|3301345|P3|Overall Study|Noncompliance with protocol|2
1008981|NCT00379288|3301346|P2|Overall Study|Noncompliance with protocol|6
1008982|NCT00379288|3301347|P1|Overall Study|Noncompliance with protocol|8
1008983|NCT00379288|3301344|P4|Overall Study|Subject withdrew-related to study drug|1
1008984|NCT00379288|3301345|P3|Overall Study|Subject withdrew-related to study drug|0
1008985|NCT00379288|3301346|P2|Overall Study|Subject withdrew-related to study drug|0
1008986|NCT00379288|3301347|P1|Overall Study|Subject withdrew-related to study drug|1
1008987|NCT00379288|3301344|P4|Overall Study|Subject withdrew-unrelated to study drug|2
1008988|NCT00379288|3301345|P3|Overall Study|Subject withdrew-unrelated to study drug|4
1008989|NCT00379288|3301346|P2|Overall Study|Subject withdrew-unrelated to study drug|3
1008990|NCT00379288|3301347|P1|Overall Study|Subject withdrew-unrelated to study drug|0
1008991|NCT00379288|3301344|P4|Overall Study|Lost to Follow-up|0
1008992|NCT00379288|3301345|P3|Overall Study|Lost to Follow-up|2
1008993|NCT00379288|3301346|P2|Overall Study|Lost to Follow-up|3
1008994|NCT00379288|3301347|P1|Overall Study|Lost to Follow-up|3
1008995|NCT00379288|3301344|P4|Overall Study|Treatment Failure|1
1008996|NCT00379288|3301345|P3|Overall Study|Treatment Failure|0
1008997|NCT00379288|3301346|P2|Overall Study|Treatment Failure|1
1008998|NCT00379288|3301347|P1|Overall Study|Treatment Failure|0
1008999|NCT00379288|3301344|P4|Overall Study|Adverse Event|0
1009000|NCT00379288|3301345|P3|Overall Study|Adverse Event|2
1009001|NCT00379288|3301346|P2|Overall Study|Adverse Event|6
1009002|NCT00379288|3301347|P1|Overall Study|Adverse Event|5
1009003|NCT00379236|3301359|P3|Open-label Extension|Not specified|7
1009004|NCT00379236|3301360|P2|Open-label Extension|Not specified|0
1009005|NCT00379236|3301361|P1|Open-label Extension|Not specified|0
1009006|NCT00379236|3301359|P3|Open-label Extension|Use of exclusionary medication|3
1009007|NCT00379236|3301360|P2|Open-label Extension|Use of exclusionary medication|0
1009008|NCT00379236|3301361|P1|Open-label Extension|Use of exclusionary medication|0
1009009|NCT00379236|3301359|P3|Open-label Extension|Lost to Follow-up|12
1009010|NCT00379236|3301360|P2|Open-label Extension|Lost to Follow-up|0
1009011|NCT00379236|3301361|P1|Open-label Extension|Lost to Follow-up|0
1009012|NCT00379236|3301359|P3|Open-label Extension|Withdrawal by Subject|13
1009013|NCT00379236|3301360|P2|Open-label Extension|Withdrawal by Subject|0
1009014|NCT00379236|3301361|P1|Open-label Extension|Withdrawal by Subject|0
1009015|NCT00379236|3301359|P3|Open-label Extension|Protocol Violation|7
1009016|NCT00379236|3301360|P2|Open-label Extension|Protocol Violation|0
1009017|NCT00379236|3301361|P1|Open-label Extension|Protocol Violation|0
1009018|NCT00379236|3301359|P3|Open-label Extension|Adverse Event|13
1009019|NCT00379236|3301360|P2|Open-label Extension|Adverse Event|0
1009020|NCT00379236|3301361|P1|Open-label Extension|Adverse Event|0
1009021|NCT00379236|3301359|P3|Double-blind|Data could not be retrieved|0
1009022|NCT00379236|3301360|P2|Double-blind|Data could not be retrieved|2
1009023|NCT00379236|3301361|P1|Double-blind|Data could not be retrieved|2
1009024|NCT00379236|3301359|P3|Double-blind|Not specified|0
1009025|NCT00379236|3301360|P2|Double-blind|Not specified|7
1009026|NCT00379236|3301361|P1|Double-blind|Not specified|3
1009027|NCT00379236|3301359|P3|Double-blind|Use of exclusionary medication|0
1009028|NCT00379236|3301360|P2|Double-blind|Use of exclusionary medication|2
1009029|NCT00379236|3301361|P1|Double-blind|Use of exclusionary medication|1
1009030|NCT00379236|3301359|P3|Double-blind|Lost to Follow-up|0
1009031|NCT00379236|3301360|P2|Double-blind|Lost to Follow-up|3
1009032|NCT00379236|3301361|P1|Double-blind|Lost to Follow-up|4
1009033|NCT00379236|3301359|P3|Double-blind|Withdrawal by Subject|0
1009034|NCT00379236|3301360|P2|Double-blind|Withdrawal by Subject|13
1009035|NCT00379236|3301361|P1|Double-blind|Withdrawal by Subject|12
1009036|NCT00379236|3301359|P3|Double-blind|Protocol Violation|0
1009037|NCT00379236|3301360|P2|Double-blind|Protocol Violation|3
1009038|NCT00379236|3301361|P1|Double-blind|Protocol Violation|3
1009039|NCT00379236|3301359|P3|Double-blind|Adverse Event|0
1009040|NCT00379236|3301360|P2|Double-blind|Adverse Event|6
1009041|NCT00379236|3301361|P1|Double-blind|Adverse Event|11
1009042|NCT00379210|3301406|P2|Overall Study|Withdrawal by Subject|7
1009043|NCT00379210|3301407|P1|Overall Study|Withdrawal by Subject|10
1009044|NCT00379080|3301430|P3|Overall Study|Withdrawal by Subject|0
1009045|NCT00379080|3301431|P2|Overall Study|Withdrawal by Subject|4
1009046|NCT00379080|3301432|P1|Overall Study|Withdrawal by Subject|0
1009047|NCT00378898|3301477|P2|Overall Study|Protocol Violation|1
1009048|NCT00378898|3301478|P1|Overall Study|Protocol Violation|1
1009049|NCT00378898|3301477|P2|Overall Study|Withdrawal by Subject|5
1009050|NCT00378898|3301478|P1|Overall Study|Withdrawal by Subject|10
1009051|NCT00378703|3301490|P4|Overall Study|Other|3
1009052|NCT00378703|3301491|P3|Overall Study|Other|2
1009053|NCT00378703|3301492|P2|Overall Study|Other|1
1009054|NCT00378703|3301493|P1|Overall Study|Other|1
1009055|NCT00378703|3301490|P4|Overall Study|Never started treatment|0
1009056|NCT00378703|3301491|P3|Overall Study|Never started treatment|0
1009057|NCT00378703|3301492|P2|Overall Study|Never started treatment|4
1009058|NCT00378703|3301493|P1|Overall Study|Never started treatment|1
1009059|NCT00378703|3301490|P4|Overall Study|Ineligible|7
1009060|NCT00378703|3301491|P3|Overall Study|Ineligible|7
1009061|NCT00378703|3301492|P2|Overall Study|Ineligible|7
1009062|NCT00378703|3301493|P1|Overall Study|Ineligible|4
1009063|NCT00378703|3301490|P4|Overall Study|Relocation|0
1009064|NCT00378703|3301491|P3|Overall Study|Relocation|1
1009065|NCT00378703|3301492|P2|Overall Study|Relocation|0
1009066|NCT00378703|3301493|P1|Overall Study|Relocation|0
1009067|NCT00378703|3301490|P4|Overall Study|Adverse events and progressive disease|1
1009068|NCT00378703|3301491|P3|Overall Study|Adverse events and progressive disease|0
1009069|NCT00378703|3301492|P2|Overall Study|Adverse events and progressive disease|0
1009070|NCT00378703|3301493|P1|Overall Study|Adverse events and progressive disease|0
1009071|NCT00378703|3301490|P4|Overall Study|Joint decision of physician and patient|0
1009072|NCT00378703|3301491|P3|Overall Study|Joint decision of physician and patient|0
1009073|NCT00378703|3301492|P2|Overall Study|Joint decision of physician and patient|0
1009074|NCT00378703|3301493|P1|Overall Study|Joint decision of physician and patient|1
1009075|NCT00378703|3301490|P4|Overall Study|Surgery|1
1009076|NCT00378703|3301491|P3|Overall Study|Surgery|0
1009077|NCT00378703|3301492|P2|Overall Study|Surgery|0
1009078|NCT00378703|3301493|P1|Overall Study|Surgery|1
1009079|NCT00378703|3301490|P4|Overall Study|Symptomatic deterioration|2
1009080|NCT00378703|3301491|P3|Overall Study|Symptomatic deterioration|0
1009081|NCT00378703|3301492|P2|Overall Study|Symptomatic deterioration|1
1009082|NCT00378703|3301493|P1|Overall Study|Symptomatic deterioration|0
1009083|NCT00378703|3301490|P4|Overall Study|Other complicated disease|0
1009084|NCT00378703|3301491|P3|Overall Study|Other complicated disease|2
1009085|NCT00378703|3301492|P2|Overall Study|Other complicated disease|2
1009086|NCT00378703|3301493|P1|Overall Study|Other complicated disease|0
1009087|NCT00378703|3301490|P4|Overall Study|Alternative therapy|0
1009088|NCT00378703|3301491|P3|Overall Study|Alternative therapy|0
1009089|NCT00378703|3301492|P2|Overall Study|Alternative therapy|2
1009090|NCT00378703|3301493|P1|Overall Study|Alternative therapy|4
1009091|NCT00378703|3301490|P4|Overall Study|Physician Decision|0
1009092|NCT00378703|3301491|P3|Overall Study|Physician Decision|1
1009093|NCT00378703|3301492|P2|Overall Study|Physician Decision|4
1009094|NCT00378703|3301493|P1|Overall Study|Physician Decision|1
1009095|NCT00378703|3301490|P4|Overall Study|Withdrawal by Subject|7
1009096|NCT00378703|3301491|P3|Overall Study|Withdrawal by Subject|5
1009097|NCT00378703|3301492|P2|Overall Study|Withdrawal by Subject|8
1009098|NCT00378703|3301493|P1|Overall Study|Withdrawal by Subject|4
1009099|NCT00378703|3301490|P4|Overall Study|Death|3
1009100|NCT00378703|3301491|P3|Overall Study|Death|4
1009101|NCT00378703|3301492|P2|Overall Study|Death|2
1009102|NCT00378703|3301493|P1|Overall Study|Death|2
1009103|NCT00378703|3301490|P4|Overall Study|Adverse Event|18
1009104|NCT00378703|3301491|P3|Overall Study|Adverse Event|20
1009105|NCT00378703|3301492|P2|Overall Study|Adverse Event|17
1009106|NCT00378703|3301493|P1|Overall Study|Adverse Event|11
1009107|NCT00378703|3301490|P4|Overall Study|Disease progression|49
1009108|NCT00378703|3301491|P3|Overall Study|Disease progression|48
1009109|NCT00378703|3301492|P2|Overall Study|Disease progression|43
1009110|NCT00378703|3301493|P1|Overall Study|Disease progression|59
1009111|NCT00378599|3301515|P1|Overall Study|Withdrawal by Subject|5
1009112|NCT00378599|3301515|P1|Overall Study|Treatment failure|7
1009113|NCT00378599|3301515|P1|Overall Study|Protocol Violation|2
1009114|NCT00378599|3301515|P1|Overall Study|Adverse Event|38
1009115|NCT00378573|3301519|P1|Follow-up|Withdrawal by Subject|1
1009116|NCT00378573|3301519|P1|Follow-up|Lost to Follow-up|1
1009117|NCT00378573|3301519|P1|Follow-up|Death|12
1009118|NCT00378573|3301519|P1|Treatment Period|Sponsor decision to close study|1
1009119|NCT00378573|3301519|P1|Treatment Period|Disease Progression|4
1009120|NCT00378573|3301519|P1|Treatment Period|Withdrawal by Subject|2
1009121|NCT00378573|3301519|P1|Treatment Period|Physician Decision|1
1009122|NCT00378573|3301519|P1|Treatment Period|Adverse Event|9
1009123|NCT00378560|3301527|P2|Overall Study|Laboratory test values abnormal|0
1009124|NCT00378560|3301528|P1|Overall Study|Laboratory test values abnormal|1
1009125|NCT00378560|3301527|P2|Overall Study|Pregnancy|5
1009126|NCT00378560|3301528|P1|Overall Study|Pregnancy|7
1009127|NCT00378560|3301527|P2|Overall Study|Moved|3
1009128|NCT00378560|3301528|P1|Overall Study|Moved|4
1009129|NCT00378560|3301527|P2|Overall Study|Withdrawal by Subject|21
1009130|NCT00378560|3301528|P1|Overall Study|Withdrawal by Subject|17
1009131|NCT00378560|3301527|P2|Overall Study|Protocol Violation|0
1009132|NCT00378560|3301528|P1|Overall Study|Protocol Violation|2
1009133|NCT00378560|3301527|P2|Overall Study|Lost to Follow-up|29
1009134|NCT00378560|3301528|P1|Overall Study|Lost to Follow-up|24
1009135|NCT00378560|3301527|P2|Overall Study|Adverse Event|0
1009136|NCT00378560|3301528|P1|Overall Study|Adverse Event|1
1009137|NCT00378534|3301542|P1|Overall Study|Subjects did not receive a transplant|3
1009138|NCT00378534|3301542|P1|Overall Study|Donors|57
1009139|NCT00378508|3301548|P2|Overall Study|Lost to Follow-up|0
1009140|NCT00378508|3301549|P1|Overall Study|Lost to Follow-up|1
1009141|NCT00378508|3301548|P2|Overall Study|Withdrawal by Subject|3
1009142|NCT00378508|3301549|P1|Overall Study|Withdrawal by Subject|1
1009143|NCT00378378|3301568|P3|Overall Study|Non-compliance with protocol|1
1009144|NCT00378378|3301569|P2|Overall Study|Non-compliance with protocol|0
1009145|NCT00378378|3301570|P1|Overall Study|Non-compliance with protocol|0
1009146|NCT00378378|3301568|P3|Overall Study|Treatment Failure|1
1009147|NCT00378378|3301569|P2|Overall Study|Treatment Failure|0
1009148|NCT00378378|3301570|P1|Overall Study|Treatment Failure|0
1009149|NCT00378378|3301568|P3|Overall Study|Withdrawal by Subject|0
1009150|NCT00378378|3301569|P2|Overall Study|Withdrawal by Subject|1
1009151|NCT00378378|3301570|P1|Overall Study|Withdrawal by Subject|0
1009152|NCT00378209|3301616|P1|Overall Study|Treatment delay|1
1009153|NCT00378209|3301616|P1|Overall Study|Death|1
1009154|NCT00378209|3301616|P1|Overall Study|Physician Decision|3
1009155|NCT00378209|3301616|P1|Overall Study|Initiation of non-protocol therapy|3
1009156|NCT00378209|3301616|P1|Overall Study|Adverse Event|3
1009157|NCT00378209|3301616|P1|Overall Study|Progressive disease|11
1009158|NCT00378105|3301626|P2|Overall Study|necessity to increase lenalidomide dose|1
1009159|NCT00378105|3301627|P1|Overall Study|necessity to increase lenalidomide dose|0
1009160|NCT00378105|3301626|P2|Overall Study|Going non-protocol therapy|1
1009161|NCT00378105|3301627|P1|Overall Study|Going non-protocol therapy|0
1009162|NCT00378105|3301626|P2|Overall Study|Physician Decision|2
1009163|NCT00378105|3301627|P1|Overall Study|Physician Decision|0
1009164|NCT00378105|3301626|P2|Overall Study|remain on study|11
1009165|NCT00378105|3301627|P1|Overall Study|remain on study|3
1009166|NCT00378105|3301626|P2|Overall Study|Progressive disease|3
1009167|NCT00378105|3301627|P1|Overall Study|Progressive disease|3
1009168|NCT00378105|3301626|P2|Overall Study|Going to transplant|8
1009169|NCT00378105|3301627|P1|Overall Study|Going to transplant|7
1009170|NCT00378105|3301626|P2|Overall Study|Death|0
1009171|NCT00378105|3301627|P1|Overall Study|Death|1
1009172|NCT00378105|3301626|P2|Overall Study|Withdrawal by Subject|3
1009173|NCT00378105|3301627|P1|Overall Study|Withdrawal by Subject|3
1009174|NCT00378105|3301626|P2|Overall Study|Adverse Event|1
1009175|NCT00378105|3301627|P1|Overall Study|Adverse Event|3
1009176|NCT00378079|3301639|P3|Overall Study|Lost to Follow-up|0
1009177|NCT00378079|3301640|P2|Overall Study|Lost to Follow-up|1
1009178|NCT00378079|3301641|P1|Overall Study|Lost to Follow-up|6
1009179|NCT00378014|3301663|P2|Extension (Month 12 to Month 59)|Lack of Efficacy|1
1009180|NCT00378014|3301664|P1|Extension (Month 12 to Month 59)|Lack of Efficacy|3
1009181|NCT00378014|3301663|P2|Extension (Month 12 to Month 59)|Withdrawal by Subject|3
1009182|NCT00378014|3301664|P1|Extension (Month 12 to Month 59)|Withdrawal by Subject|0
1009183|NCT00378014|3301663|P2|Extension (Month 12 to Month 59)|Lost to Follow-up|1
1009184|NCT00378014|3301664|P1|Extension (Month 12 to Month 59)|Lost to Follow-up|1
1009185|NCT00378014|3301663|P2|Extension (Month 12 to Month 59)|Administrative problems|0
1009186|NCT00378014|3301664|P1|Extension (Month 12 to Month 59)|Administrative problems|1
1009187|NCT00378014|3301663|P2|Extension (Month 12 to Month 59)|Death|2
1009188|NCT00378014|3301664|P1|Extension (Month 12 to Month 59)|Death|1
1009189|NCT00378014|3301663|P2|Extension (Month 12 to Month 59)|Adverse Event|7
1009190|NCT00378014|3301664|P1|Extension (Month 12 to Month 59)|Adverse Event|8
1009191|NCT00378014|3301663|P2|Core (Randomization to Month 11)|Lack of Efficacy|1
1009192|NCT00378014|3301664|P1|Core (Randomization to Month 11)|Lack of Efficacy|0
1009193|NCT00378014|3301663|P2|Core (Randomization to Month 11)|Protocol deviation|1
1009194|NCT00378014|3301664|P1|Core (Randomization to Month 11)|Protocol deviation|0
1009195|NCT00378014|3301663|P2|Core (Randomization to Month 11)|Withdrawal by Subject|2
1009196|NCT00378014|3301664|P1|Core (Randomization to Month 11)|Withdrawal by Subject|5
1009197|NCT00378014|3301663|P2|Core (Randomization to Month 11)|Lost to Follow-up|1
1009198|NCT00378014|3301664|P1|Core (Randomization to Month 11)|Lost to Follow-up|0
1009199|NCT00378014|3301663|P2|Core (Randomization to Month 11)|Administrative Problems|2
1009200|NCT00378014|3301664|P1|Core (Randomization to Month 11)|Administrative Problems|2
1009201|NCT00378014|3301663|P2|Core (Randomization to Month 11)|Death|3
1009202|NCT00378014|3301664|P1|Core (Randomization to Month 11)|Death|5
1009203|NCT00378014|3301663|P2|Core (Randomization to Month 11)|Graft loss|2
1009204|NCT00378014|3301664|P1|Core (Randomization to Month 11)|Graft loss|1
1009205|NCT00378014|3301663|P2|Core (Randomization to Month 11)|Adverse Event|0
1009206|NCT00378014|3301664|P1|Core (Randomization to Month 11)|Adverse Event|1
1009207|NCT00377962|3301690|P2|Extension Study: 12-24 Months|Unspecified reason|3
1009208|NCT00377962|3301691|P1|Extension Study: 12-24 Months|Unspecified reason|0
1009209|NCT00377962|3301690|P2|Extension Study: 12-24 Months|Abnormal laboratory value|0
1009210|NCT00377962|3301691|P1|Extension Study: 12-24 Months|Abnormal laboratory value|1
1009211|NCT00377962|3301690|P2|Extension Study: 12-24 Months|Adverse Event|0
1009212|NCT00377962|3301691|P1|Extension Study: 12-24 Months|Adverse Event|8
1009213|NCT00377962|3301690|P2|Extension Study: 12-24 Months|Death|1
1009214|NCT00377962|3301691|P1|Extension Study: 12-24 Months|Death|1
1009215|NCT00377962|3301690|P2|Core Study: 0-12 Months|Unspecified reasons|4
1009216|NCT00377962|3301691|P1|Core Study: 0-12 Months|Unspecified reasons|1
1009217|NCT00377962|3301690|P2|Core Study: 0-12 Months|Administrative Reason|1
1009218|NCT00377962|3301691|P1|Core Study: 0-12 Months|Administrative Reason|1
1009219|NCT00377962|3301690|P2|Core Study: 0-12 Months|Withdrew Consent|2
1009220|NCT00377962|3301691|P1|Core Study: 0-12 Months|Withdrew Consent|5
1009221|NCT00377962|3301690|P2|Core Study: 0-12 Months|Death|0
1009222|NCT00377962|3301691|P1|Core Study: 0-12 Months|Death|3
1009223|NCT00377962|3301690|P2|Core Study: 0-12 Months|Adverse Event|2
1009224|NCT00377962|3301691|P1|Core Study: 0-12 Months|Adverse Event|18
1009225|NCT00377858|3301727|P2|Overall Study|Death|3
1009226|NCT00377858|3301728|P1|Overall Study|Death|0
1009227|NCT00377858|3301727|P2|Overall Study|Sponsor Decision|2
1009228|NCT00377858|3301728|P1|Overall Study|Sponsor Decision|1
1009229|NCT00377858|3301727|P2|Overall Study|Entry Criteria Not Met|0
1009230|NCT00377858|3301728|P1|Overall Study|Entry Criteria Not Met|2
1009231|NCT00377858|3301727|P2|Overall Study|Adverse Event|1
1009232|NCT00377858|3301728|P1|Overall Study|Adverse Event|2
1009233|NCT00377858|3301727|P2|Overall Study|Protocol Violation|4
1009234|NCT00377858|3301728|P1|Overall Study|Protocol Violation|3
1009235|NCT00377858|3301727|P2|Overall Study|Physician Decision|5
1009236|NCT00377858|3301728|P1|Overall Study|Physician Decision|5
1009237|NCT00377858|3301727|P2|Overall Study|Lost to Follow-up|1
1009238|NCT00377858|3301728|P1|Overall Study|Lost to Follow-up|6
1009239|NCT00377858|3301727|P2|Overall Study|Withdrawal by Subject|11
1009240|NCT00377858|3301728|P1|Overall Study|Withdrawal by Subject|12
1009241|NCT00377819|3301781|P2|Overall Study|Protocol Violation|1
1009242|NCT00377819|3301782|P1|Overall Study|Protocol Violation|1
1009243|NCT00377819|3301781|P2|Overall Study|Lost to Follow-up|1
1009244|NCT00377819|3301782|P1|Overall Study|Lost to Follow-up|0
1009245|NCT00377819|3301781|P2|Overall Study|Death|1
1009246|NCT00377819|3301782|P1|Overall Study|Death|0
1009247|NCT00377819|3301781|P2|Overall Study|Withdrawal by Subject|4
1009248|NCT00377819|3301782|P1|Overall Study|Withdrawal by Subject|10
1009249|NCT00377819|3301781|P2|Overall Study|Adverse Event|3
1009250|NCT00377819|3301782|P1|Overall Study|Adverse Event|2
1009251|NCT00377676|3301811|P2|Overall Study|not specified|58
1009252|NCT00377676|3301812|P1|Overall Study|not specified|118
1009253|NCT00377676|3301811|P2|Overall Study|Lost to Follow-up|56
1009254|NCT00377676|3301812|P1|Overall Study|Lost to Follow-up|120
1009255|NCT00377676|3301811|P2|Overall Study|Withdrawal by Subject|72
1009256|NCT00377676|3301812|P1|Overall Study|Withdrawal by Subject|187
1009257|NCT00377676|3301811|P2|Overall Study|Death|2
1009258|NCT00377676|3301812|P1|Overall Study|Death|5
1009259|NCT00377676|3301811|P2|Overall Study|Protocol Violation|27
1009260|NCT00377676|3301812|P1|Overall Study|Protocol Violation|33
1009261|NCT00377676|3301811|P2|Overall Study|Adverse Event|107
1009262|NCT00377676|3301812|P1|Overall Study|Adverse Event|498
1009263|NCT00377637|3301828|P4|Maintenance Phase|Death|1
1009264|NCT00377637|3301829|P3|Maintenance Phase|Death|0
1009265|NCT00377637|3301830|P2|Maintenance Phase|Death|0
1009266|NCT00377637|3301831|P1|Maintenance Phase|Death|0
1009267|NCT00377637|3301828|P4|Maintenance Phase|Study medication stopped > 14 days|1
1009268|NCT00377637|3301829|P3|Maintenance Phase|Study medication stopped > 14 days|0
1009269|NCT00377637|3301830|P2|Maintenance Phase|Study medication stopped > 14 days|0
1009270|NCT00377637|3301831|P1|Maintenance Phase|Study medication stopped > 14 days|0
1009271|NCT00377637|3301828|P4|Maintenance Phase|Non-compliance|1
1009272|NCT00377637|3301829|P3|Maintenance Phase|Non-compliance|1
1009273|NCT00377637|3301830|P2|Maintenance Phase|Non-compliance|0
1009274|NCT00377637|3301831|P1|Maintenance Phase|Non-compliance|0
1009275|NCT00377637|3301828|P4|Maintenance Phase|Sponsor decision|3
1009276|NCT00377637|3301829|P3|Maintenance Phase|Sponsor decision|2
1009277|NCT00377637|3301830|P2|Maintenance Phase|Sponsor decision|0
1009278|NCT00377637|3301831|P1|Maintenance Phase|Sponsor decision|0
1009279|NCT00377637|3301828|P4|Maintenance Phase|Withdrawal by Subject|3
1009280|NCT00377637|3301829|P3|Maintenance Phase|Withdrawal by Subject|3
1009281|NCT00377637|3301830|P2|Maintenance Phase|Withdrawal by Subject|0
1009282|NCT00377637|3301831|P1|Maintenance Phase|Withdrawal by Subject|0
1009283|NCT00377637|3301828|P4|Maintenance Phase|Lost to Follow-up|1
1009284|NCT00377637|3301829|P3|Maintenance Phase|Lost to Follow-up|3
1009285|NCT00377637|3301830|P2|Maintenance Phase|Lost to Follow-up|0
1009286|NCT00377637|3301831|P1|Maintenance Phase|Lost to Follow-up|0
1009287|NCT00377637|3301828|P4|Maintenance Phase|Physician Decision|4
1009288|NCT00377637|3301829|P3|Maintenance Phase|Physician Decision|5
1009289|NCT00377637|3301830|P2|Maintenance Phase|Physician Decision|0
1009290|NCT00377637|3301831|P1|Maintenance Phase|Physician Decision|0
1009291|NCT00377637|3301828|P4|Maintenance Phase|Adverse Event|43
1009292|NCT00377637|3301829|P3|Maintenance Phase|Adverse Event|29
1009293|NCT00377637|3301830|P2|Maintenance Phase|Adverse Event|0
1009294|NCT00377637|3301831|P1|Maintenance Phase|Adverse Event|0
1009295|NCT00377637|3301828|P4|Induction Phase|Reason for withdrawal is not noted|0
1009296|NCT00377637|3301829|P3|Induction Phase|Reason for withdrawal is not noted|0
1009297|NCT00377637|3301830|P2|Induction Phase|Reason for withdrawal is not noted|0
1009298|NCT00377637|3301831|P1|Induction Phase|Reason for withdrawal is not noted|2
1009299|NCT00377637|3301828|P4|Induction Phase|Non-Compliance|0
1009300|NCT00377637|3301829|P3|Induction Phase|Non-Compliance|0
1009301|NCT00377637|3301830|P2|Induction Phase|Non-Compliance|0
1009302|NCT00377637|3301831|P1|Induction Phase|Non-Compliance|1
1009303|NCT00377637|3301828|P4|Induction Phase|Sponsor decision|0
1009304|NCT00377637|3301829|P3|Induction Phase|Sponsor decision|0
1009305|NCT00377637|3301830|P2|Induction Phase|Sponsor decision|2
1009306|NCT00377637|3301831|P1|Induction Phase|Sponsor decision|1
1009307|NCT00377637|3301828|P4|Induction Phase|Physician Decision|0
1009308|NCT00377637|3301829|P3|Induction Phase|Physician Decision|0
1009309|NCT00377637|3301830|P2|Induction Phase|Physician Decision|1
1009310|NCT00377637|3301831|P1|Induction Phase|Physician Decision|3
1009311|NCT00377637|3301828|P4|Induction Phase|Withdrawal by Subject|0
1009312|NCT00377637|3301829|P3|Induction Phase|Withdrawal by Subject|0
1009313|NCT00377637|3301830|P2|Induction Phase|Withdrawal by Subject|6
1009314|NCT00377637|3301831|P1|Induction Phase|Withdrawal by Subject|5
1009315|NCT00377637|3301828|P4|Induction Phase|Death|0
1009316|NCT00377637|3301829|P3|Induction Phase|Death|0
1009317|NCT00377637|3301830|P2|Induction Phase|Death|3
1009318|NCT00377637|3301831|P1|Induction Phase|Death|1
1009319|NCT00377637|3301828|P4|Induction Phase|Lost to Follow-up|0
1009320|NCT00377637|3301829|P3|Induction Phase|Lost to Follow-up|0
1009321|NCT00377637|3301830|P2|Induction Phase|Lost to Follow-up|1
1009322|NCT00377637|3301831|P1|Induction Phase|Lost to Follow-up|2
1009323|NCT00377637|3301828|P4|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
1009324|NCT00377637|3301829|P3|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
1009325|NCT00377637|3301830|P2|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1
1009326|NCT00377637|3301831|P1|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
1009327|NCT00377637|3301828|P4|Induction Phase|Deterioration/serum creatinine|0
1009328|NCT00377637|3301829|P3|Induction Phase|Deterioration/serum creatinine|0
1009329|NCT00377637|3301830|P2|Induction Phase|Deterioration/serum creatinine|0
1009330|NCT00377637|3301831|P1|Induction Phase|Deterioration/serum creatinine|2
1009331|NCT00377637|3301828|P4|Induction Phase|Adverse Event|0
1009332|NCT00377637|3301829|P3|Induction Phase|Adverse Event|0
1009333|NCT00377637|3301830|P2|Induction Phase|Adverse Event|21
1009334|NCT00377637|3301831|P1|Induction Phase|Adverse Event|12
1009335|NCT00377611|3301867|P2|Overall Study|Other|3
1009336|NCT00377611|3301868|P1|Overall Study|Other|0
1009337|NCT00377611|3301867|P2|Overall Study|Lost to Follow-up|16
1009338|NCT00377611|3301868|P1|Overall Study|Lost to Follow-up|18
1009339|NCT00377611|3301867|P2|Overall Study|Withdrawal by Subject|5
1009340|NCT00377611|3301868|P1|Overall Study|Withdrawal by Subject|0
1009341|NCT00377611|3301867|P2|Overall Study|Protocol Violation|0
1009342|NCT00377611|3301868|P1|Overall Study|Protocol Violation|2
1009343|NCT00377611|3301867|P2|Overall Study|Adverse Event|9
1009344|NCT00377611|3301868|P1|Overall Study|Adverse Event|2
1009345|NCT00377520|3301970|P1|Overall Study|Ineligible (Prior radiation)|1
1009346|NCT00377455|3301975|P1|Overall Study|Withdrawal by Subject|1
1009347|NCT00377429|3301983|P1|Overall Study|Patient non-compliance|1
1009348|NCT00377429|3301983|P1|Overall Study|Physician Decision|1
1009349|NCT00377429|3301983|P1|Overall Study|Adverse Event|8
1009350|NCT00377429|3301983|P1|Overall Study|Withdrawal by Subject|5
1009351|NCT00377403|3301994|P2|Overall Study|Unable to contact for telephone intervie|7
1009352|NCT00377403|3301995|P1|Overall Study|Unable to contact for telephone intervie|4
1009353|NCT00377364|3302003|P2|Overall Study|Withdrawal by Subject|0
1009354|NCT00377364|3302004|P1|Overall Study|Withdrawal by Subject|1
1009355|NCT00377364|3302003|P2|Overall Study|Lost to Follow-up|0
1009356|NCT00377364|3302004|P1|Overall Study|Lost to Follow-up|1
1009357|NCT00377312|3302030|P2|Overall Study|Adverse Event|1
1009358|NCT00377312|3302031|P1|Overall Study|Adverse Event|1
1009359|NCT00377299|3302063|P2|Overall Study|Withdrawal by Subject|4
1009360|NCT00377299|3302064|P1|Overall Study|Withdrawal by Subject|5
1009361|NCT00377299|3302063|P2|Overall Study|Adverse Event|1
1009362|NCT00377299|3302064|P1|Overall Study|Adverse Event|0
1009363|NCT00377299|3302063|P2|Overall Study|Lost to Follow-up|19
1009364|NCT00377299|3302064|P1|Overall Study|Lost to Follow-up|14
1009365|NCT00377260|3302080|P2|Overall Study|Withdrawal by Subject|4
1009366|NCT00377260|3302081|P1|Overall Study|Withdrawal by Subject|2
1009367|NCT00377260|3302080|P2|Overall Study|Lost to Follow-up|1
1009368|NCT00377260|3302081|P1|Overall Study|Lost to Follow-up|0
1009369|NCT00377234|3302135|P2|Overall Study|Not assigned|2
1009370|NCT00377234|3302136|P1|Overall Study|Not assigned|3
1009371|NCT00377234|3302135|P2|Overall Study|Administrative|1
1009372|NCT00377234|3302136|P1|Overall Study|Administrative|2
1009373|NCT00377234|3302135|P2|Overall Study|Lost to Follow-up|2
1009374|NCT00377234|3302136|P1|Overall Study|Lost to Follow-up|4
1009375|NCT00377234|3302135|P2|Overall Study|Withdrawal by Subject|9
1009376|NCT00377234|3302136|P1|Overall Study|Withdrawal by Subject|11
1009377|NCT00377234|3302135|P2|Overall Study|Adverse Event|17
1009378|NCT00377234|3302136|P1|Overall Study|Adverse Event|14
1009379|NCT00377156|3302154|P2|Overall Study|Other|2
1009380|NCT00377156|3302155|P1|Overall Study|Other|5
1009381|NCT00377156|3302154|P2|Overall Study|Disability or language problem|1
1009382|NCT00377156|3302155|P1|Overall Study|Disability or language problem|0
1009383|NCT00377156|3302154|P2|Overall Study|Ineligible|1
1009384|NCT00377156|3302155|P1|Overall Study|Ineligible|0
1009385|NCT00377156|3302154|P2|Overall Study|Refused testing|1
1009386|NCT00377156|3302155|P1|Overall Study|Refused testing|0
1009387|NCT00377156|3302154|P2|Overall Study|Cancellation|0
1009388|NCT00377156|3302155|P1|Overall Study|Cancellation|1
1009389|NCT00377156|3302154|P2|Overall Study|Had follow-up <90 d|6
1009390|NCT00377156|3302155|P1|Overall Study|Had follow-up <90 d|3
1009391|NCT00377156|3302154|P2|Overall Study|Withdrawal by Subject|24
1009392|NCT00377156|3302155|P1|Overall Study|Withdrawal by Subject|16
1009393|NCT00377156|3302154|P2|Overall Study|Death|19
1009394|NCT00377156|3302155|P1|Overall Study|Death|23
1009395|NCT00376961|3302169|P2|Maintenance|Ineligible|3
1009396|NCT00376961|3302170|P1|Maintenance|Ineligible|0
1009397|NCT00376961|3302169|P2|Maintenance|Progression/relapse|18
1009398|NCT00376961|3302170|P1|Maintenance|Progression/relapse|0
1009399|NCT00376961|3302169|P2|Maintenance|Refusal Unrelated to Adverse Event|1
1009400|NCT00376961|3302170|P1|Maintenance|Refusal Unrelated to Adverse Event|0
1009401|NCT00376961|3302169|P2|Maintenance|Adverse Event|1
1009402|NCT00376961|3302170|P1|Maintenance|Adverse Event|0
1009403|NCT00376961|3302169|P2|Initial Registration|Ineligible|0
1009404|NCT00376961|3302170|P1|Initial Registration|Ineligible|3
1009405|NCT00376961|3302169|P2|Initial Registration|Progression/relapse|0
1009406|NCT00376961|3302170|P1|Initial Registration|Progression/relapse|1
1009407|NCT00376961|3302169|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
1009408|NCT00376961|3302170|P1|Initial Registration|Refusal Unrelated to Adverse Event|2
1009409|NCT00376961|3302169|P2|Initial Registration|Adverse Event|0
1009410|NCT00376961|3302170|P1|Initial Registration|Adverse Event|1
1009411|NCT00376688|3302236|P1|Overall Study|Death|1
1009412|NCT00376688|3302236|P1|Overall Study|Adverse Event|3
1009413|NCT00376675|3302242|P2|Overall Study|Other Reason|7
1009414|NCT00376675|3302243|P1|Overall Study|Other Reason|1
1009415|NCT00376675|3302242|P2|Overall Study|Adverse Event|5
1009416|NCT00376675|3302243|P1|Overall Study|Adverse Event|10
1009417|NCT00376675|3302242|P2|Overall Study|Withdrawal by Subject|2
1009418|NCT00376675|3302243|P1|Overall Study|Withdrawal by Subject|9
1009419|NCT00376532|3302292|P2|Overall Study|Lack sufficient blood sample|6
1009420|NCT00376532|3302293|P1|Overall Study|Lack sufficient blood sample|6
1009421|NCT00376506|3302303|P2|Overall Study|Death|2
1009422|NCT00376506|3302304|P1|Overall Study|Death|0
1009423|NCT00376259|3302335|P2|Overall Study|Patient request|0
1009424|NCT00376259|3302336|P1|Overall Study|Patient request|1
1009425|NCT00376259|3302335|P2|Overall Study|Sponsor request - study termination|21
1009426|NCT00376259|3302336|P1|Overall Study|Sponsor request - study termination|21
1009427|NCT00376220|3302350|P2|Overall Study|Withdrawal by Subject|2
1009428|NCT00376220|3302351|P1|Overall Study|Withdrawal by Subject|3
1009429|NCT00376220|3302350|P2|Overall Study|Lost to Follow-up|10
1009430|NCT00376220|3302351|P1|Overall Study|Lost to Follow-up|7
1009431|NCT00376168|3302359|P2|Overall Study|Pregnancy|0
1009432|NCT00376168|3302360|P1|Overall Study|Pregnancy|1
1009433|NCT00376168|3302359|P2|Overall Study|Adverse Event|1
1009434|NCT00376168|3302360|P1|Overall Study|Adverse Event|1
1009435|NCT00375934|3302401|P2|Overall Study|Physician Decision|1
1009436|NCT00375934|3302402|P1|Overall Study|Physician Decision|0
1009437|NCT00375934|3302401|P2|Overall Study|Lack of Efficacy|2
1009438|NCT00375934|3302402|P1|Overall Study|Lack of Efficacy|0
1009439|NCT00375934|3302401|P2|Overall Study|Withdrawal by Subject|2
1009440|NCT00375934|3302402|P1|Overall Study|Withdrawal by Subject|2
1009441|NCT00375934|3302401|P2|Overall Study|Adverse Event|1
1009442|NCT00375934|3302402|P1|Overall Study|Adverse Event|1
1009443|NCT00375752|3302430|P2|Overall Study|Administrative Problems|1
1009444|NCT00375752|3302431|P1|Overall Study|Administrative Problems|0
1009445|NCT00375752|3302430|P2|Overall Study|Protocol Violation|2
1009446|NCT00375752|3302431|P1|Overall Study|Protocol Violation|0
1009447|NCT00375752|3302430|P2|Overall Study|Abnormal Laboratory Value(s)|1
1009448|NCT00375752|3302431|P1|Overall Study|Abnormal Laboratory Value(s)|1
1009449|NCT00375752|3302430|P2|Overall Study|Withdrawal by Subject|1
1009450|NCT00375752|3302431|P1|Overall Study|Withdrawal by Subject|6
1009451|NCT00375752|3302430|P2|Overall Study|Adverse Event|6
1009452|NCT00375752|3302431|P1|Overall Study|Adverse Event|1
1009453|NCT00375752|3302430|P2|Overall Study|Lack of Efficacy|4
1009454|NCT00375752|3302431|P1|Overall Study|Lack of Efficacy|4
1009455|NCT00375674|3302462|P2|Overall Study|Enrolled but not treated|2
1009456|NCT00375674|3302463|P1|Overall Study|Enrolled but not treated|3
1009457|NCT00375674|3302462|P2|Overall Study|Lost to Follow-up|15
1009458|NCT00375674|3302463|P1|Overall Study|Lost to Follow-up|17
1009459|NCT00375674|3302462|P2|Overall Study|Participants refused further follow-up|30
1009460|NCT00375674|3302463|P1|Overall Study|Participants refused further follow-up|31
1009461|NCT00375674|3302462|P2|Overall Study|Death|76
1009462|NCT00375674|3302463|P1|Overall Study|Death|67
1009463|NCT00375674|3302462|P2|Overall Study|Not specified|18
1009464|NCT00375674|3302463|P1|Overall Study|Not specified|26
1009465|NCT00375609|3302492|P3|Overall Study|Neurologist Wanted Pt to start Plavix|0
1009466|NCT00375609|3302493|P2|Overall Study|Neurologist Wanted Pt to start Plavix|0
1009467|NCT00375609|3302494|P1|Overall Study|Neurologist Wanted Pt to start Plavix|1
1009468|NCT00375609|3302492|P3|Overall Study|Withdrawal by Subject|0
1009469|NCT00375609|3302493|P2|Overall Study|Withdrawal by Subject|4
1009470|NCT00375609|3302494|P1|Overall Study|Withdrawal by Subject|1
1009471|NCT00375609|3302492|P3|Overall Study|Physician Decision|1
1009472|NCT00375609|3302493|P2|Overall Study|Physician Decision|0
1009473|NCT00375609|3302494|P1|Overall Study|Physician Decision|0
1009474|NCT00375609|3302492|P3|Overall Study|Lost to Follow-up|0
1009475|NCT00375609|3302493|P2|Overall Study|Lost to Follow-up|0
1009476|NCT00375609|3302494|P1|Overall Study|Lost to Follow-up|1
1009477|NCT00375609|3302492|P3|Overall Study|Adverse Event|0
1009478|NCT00375609|3302493|P2|Overall Study|Adverse Event|3
1009479|NCT00375609|3302494|P1|Overall Study|Adverse Event|0
1009480|NCT00375609|3302492|P3|Overall Study|Did not receive treatment|0
1009481|NCT00375609|3302493|P2|Overall Study|Did not receive treatment|0
1009482|NCT00375609|3302494|P1|Overall Study|Did not receive treatment|1
1009483|NCT00375518|3302510|P2|Overall Study|Death|1
1009484|NCT00375518|3302511|P1|Overall Study|Death|0
1009485|NCT00375518|3302510|P2|Overall Study|Patient Not Treated|6
1009486|NCT00375518|3302511|P1|Overall Study|Patient Not Treated|6
1009487|NCT00375518|3302510|P2|Overall Study|Withdrawal by Subject|10
1009488|NCT00375518|3302511|P1|Overall Study|Withdrawal by Subject|2
1009489|NCT00375505|3302519|P2|Overall Study|Adverse Event|2
1009490|NCT00375505|3302520|P1|Overall Study|Adverse Event|1
1009491|NCT00375492|3302564|P2|Overall Study|Withdrawal by Subject|6
1009492|NCT00375492|3302565|P1|Overall Study|Withdrawal by Subject|6
1009493|NCT00375492|3302564|P2|Overall Study|Sponsor Decision|1
1009494|NCT00375492|3302565|P1|Overall Study|Sponsor Decision|0
1009495|NCT00375492|3302564|P2|Overall Study|Protocol Violation|3
1009496|NCT00375492|3302565|P1|Overall Study|Protocol Violation|6
1009497|NCT00375492|3302564|P2|Overall Study|Physician Decision|4
1009498|NCT00375492|3302565|P1|Overall Study|Physician Decision|0
1009499|NCT00375492|3302564|P2|Overall Study|Lost to Follow-up|5
1009500|NCT00375492|3302565|P1|Overall Study|Lost to Follow-up|10
1009501|NCT00375492|3302564|P2|Overall Study|Loss of Glucose Control|1
1009502|NCT00375492|3302565|P1|Overall Study|Loss of Glucose Control|0
1009503|NCT00375492|3302564|P2|Overall Study|Entry Criteria Not Met|1
1009504|NCT00375492|3302565|P1|Overall Study|Entry Criteria Not Met|0
1009505|NCT00375492|3302564|P2|Overall Study|Adverse Event|5
1009506|NCT00375492|3302565|P1|Overall Study|Adverse Event|4
1009507|NCT00375427|3302595|P2|Overall Study|Death|10
1009508|NCT00375427|3302596|P1|Overall Study|Death|11
1009509|NCT00375427|3302595|P2|Overall Study|Administrative reasons|1
1009510|NCT00375427|3302596|P1|Overall Study|Administrative reasons|0
1009511|NCT00375427|3302595|P2|Overall Study|Lost to Follow-up|1
1009512|NCT00375427|3302596|P1|Overall Study|Lost to Follow-up|1
1009513|NCT00375427|3302595|P2|Overall Study|Withdrawal by Subject|13
1009514|NCT00375427|3302596|P1|Overall Study|Withdrawal by Subject|9
1009515|NCT00375427|3302595|P2|Overall Study|Protocol Violation|8
1009516|NCT00375427|3302596|P1|Overall Study|Protocol Violation|10
1009517|NCT00375427|3302595|P2|Overall Study|Patient no longer requires study drug|7
1009518|NCT00375427|3302596|P1|Overall Study|Patient no longer requires study drug|3
1009519|NCT00375427|3302595|P2|Overall Study|Unsatisfactory therapeutic effect|4
1009520|NCT00375427|3302596|P1|Overall Study|Unsatisfactory therapeutic effect|4
1009521|NCT00375427|3302595|P2|Overall Study|Abnormal laboratory value(s)|2
1009522|NCT00375427|3302596|P1|Overall Study|Abnormal laboratory value(s)|1
1009523|NCT00375427|3302595|P2|Overall Study|Abnormal test procedure result(s)|1
1009524|NCT00375427|3302596|P1|Overall Study|Abnormal test procedure result(s)|0
1009525|NCT00375427|3302595|P2|Overall Study|Adverse Event|27
1009526|NCT00375427|3302596|P1|Overall Study|Adverse Event|21
1009527|NCT00375219|3302621|P3|Overall Study|Withdrawal by Subject|0
1009528|NCT00375219|3302622|P2|Overall Study|Withdrawal by Subject|0
1009529|NCT00375219|3302623|P1|Overall Study|Withdrawal by Subject|1
1009530|NCT00375219|3302621|P3|Overall Study|Cord blood transplantation|0
1009531|NCT00375219|3302622|P2|Overall Study|Cord blood transplantation|0
1009532|NCT00375219|3302623|P1|Overall Study|Cord blood transplantation|1
1009533|NCT00375219|3302621|P3|Overall Study|Allograft|0
1009534|NCT00375219|3302622|P2|Overall Study|Allograft|0
1009535|NCT00375219|3302623|P1|Overall Study|Allograft|2
1009536|NCT00375219|3302621|P3|Overall Study|Specific tyrosine kinase inhibitor avail|0
1009537|NCT00375219|3302622|P2|Overall Study|Specific tyrosine kinase inhibitor avail|0
1009538|NCT00375219|3302623|P1|Overall Study|Specific tyrosine kinase inhibitor avail|1
1009539|NCT00375219|3302621|P3|Overall Study|Hematologic resistance|0
1009540|NCT00375219|3302622|P2|Overall Study|Hematologic resistance|0
1009541|NCT00375219|3302623|P1|Overall Study|Hematologic resistance|1
1009542|NCT00375219|3302621|P3|Overall Study|Death|7
1009543|NCT00375219|3302622|P2|Overall Study|Death|3
1009544|NCT00375219|3302623|P1|Overall Study|Death|4
1009545|NCT00375219|3302621|P3|Overall Study|Disease progression|12
1009546|NCT00375219|3302622|P2|Overall Study|Disease progression|9
1009547|NCT00375219|3302623|P1|Overall Study|Disease progression|18
1009548|NCT00375219|3302621|P3|Overall Study|Lost to Follow-up|0
1009549|NCT00375219|3302622|P2|Overall Study|Lost to Follow-up|1
1009550|NCT00375219|3302623|P1|Overall Study|Lost to Follow-up|1
1009551|NCT00375219|3302621|P3|Overall Study|Request of Patient, PI, Sponsor or RA|0
1009552|NCT00375219|3302622|P2|Overall Study|Request of Patient, PI, Sponsor or RA|3
1009553|NCT00375219|3302623|P1|Overall Study|Request of Patient, PI, Sponsor or RA|5
1009554|NCT00375219|3302621|P3|Overall Study|Protocol Violation|1
1009555|NCT00375219|3302622|P2|Overall Study|Protocol Violation|0
1009556|NCT00375219|3302623|P1|Overall Study|Protocol Violation|1
1009557|NCT00375219|3302621|P3|Overall Study|Adverse Event|1
1009558|NCT00375219|3302622|P2|Overall Study|Adverse Event|2
1009559|NCT00375219|3302623|P1|Overall Study|Adverse Event|8
1009560|NCT00375219|3302621|P3|Overall Study|Failure to achieve a response|0
1009561|NCT00375219|3302622|P2|Overall Study|Failure to achieve a response|2
1009562|NCT00375219|3302623|P1|Overall Study|Failure to achieve a response|16
1009563|NCT00374907|3302691|P2|116-Week Short-term + Long-term Period|Lost to Follow-up|1
1009564|NCT00374907|3302692|P1|116-Week Short-term + Long-term Period|Lost to Follow-up|1
1009565|NCT00374907|3302691|P2|116-Week Short-term + Long-term Period|Adverse Event|2
1009566|NCT00374907|3302692|P1|116-Week Short-term + Long-term Period|Adverse Event|0
1009567|NCT00374907|3302691|P2|116-Week Short-term + Long-term Period|Lack of Efficacy|2
1009568|NCT00374907|3302692|P1|116-Week Short-term + Long-term Period|Lack of Efficacy|4
1009569|NCT00374907|3302691|P2|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9
1009570|NCT00374907|3302692|P1|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8
1009571|NCT00374907|3302691|P2|12-Week Short-term Period|Subject Withdrew Consent|1
1009572|NCT00374907|3302692|P1|12-Week Short-term Period|Subject Withdrew Consent|3
1009573|NCT00374868|3302704|P1|Overall Study|Other - Not Specified|1
1009574|NCT00374868|3302704|P1|Overall Study|Death|2
1009575|NCT00374868|3302704|P1|Overall Study|Lost to Follow-up|1
1009576|NCT00374868|3302704|P1|Overall Study|Physician Decision|13
1009577|NCT00374868|3302704|P1|Overall Study|Progressive Disease|7
1009578|NCT00374868|3302704|P1|Overall Study|Adverse Event|12
1009579|NCT00374556|3302768|P2|Overall Study|excluded at baseline due to medical cond|1
1009580|NCT00374556|3302769|P1|Overall Study|excluded at baseline due to medical cond|0
1009581|NCT00374556|3302768|P2|Overall Study|Lost to Follow-up|0
1009582|NCT00374556|3302769|P1|Overall Study|Lost to Follow-up|1
1009583|NCT00374452|3302830|P2|Overall Study|Withdrawal by Subject|2
1009584|NCT00374452|3302831|P1|Overall Study|Withdrawal by Subject|0
1009585|NCT00374452|3302830|P2|Overall Study|Left clinic after intervention started|1
1009586|NCT00374452|3302831|P1|Overall Study|Left clinic after intervention started|1
1009587|NCT00374452|3302830|P2|Overall Study|Change in job role before intervention|1
1009588|NCT00374452|3302831|P1|Overall Study|Change in job role before intervention|0
1009589|NCT00374452|3302830|P2|Overall Study|Left clinic before intervention started|1
1009590|NCT00374452|3302831|P1|Overall Study|Left clinic before intervention started|4
1009591|NCT00374322|3302844|P2|Overall Study|Did Not Receive Study Medication|6
1009592|NCT00374322|3302845|P1|Overall Study|Did Not Receive Study Medication|8
1009593|NCT00374322|3302844|P2|Overall Study|Withdrew Consent During Follow-up|5
1009594|NCT00374322|3302845|P1|Overall Study|Withdrew Consent During Follow-up|0
1009595|NCT00374322|3302844|P2|Overall Study|Noncompliance with Study Requirements|1
1009596|NCT00374322|3302845|P1|Overall Study|Noncompliance with Study Requirements|0
1009597|NCT00374322|3302844|P2|Overall Study|Started Another Chemotherapy Regimen|1
1009598|NCT00374322|3302845|P1|Overall Study|Started Another Chemotherapy Regimen|0
1009599|NCT00374322|3302844|P2|Overall Study|Participant Changed Physician|0
1009600|NCT00374322|3302845|P1|Overall Study|Participant Changed Physician|1
1009601|NCT00374322|3302844|P2|Overall Study|Site Closed|2
1009602|NCT00374322|3302845|P1|Overall Study|Site Closed|2
1009603|NCT00374322|3302844|P2|Overall Study|Severe Toxicity|0
1009604|NCT00374322|3302845|P1|Overall Study|Severe Toxicity|1
1009605|NCT00374322|3302844|P2|Overall Study|Seen in FU by a Non-Primary Investigator|0
1009606|NCT00374322|3302845|P1|Overall Study|Seen in FU by a Non-Primary Investigator|1
1009607|NCT00374322|3302844|P2|Overall Study|FU by a Non-Principal Investigator (PI)|3
1009608|NCT00374322|3302845|P1|Overall Study|FU by a Non-Principal Investigator (PI)|2
1009609|NCT00374322|3302844|P2|Overall Study|Sponsor Decision|3
1009610|NCT00374322|3302845|P1|Overall Study|Sponsor Decision|2
1009611|NCT00374322|3302844|P2|Overall Study|Par. Consented to Survival FU Only|1
1009612|NCT00374322|3302845|P1|Overall Study|Par. Consented to Survival FU Only|3
1009613|NCT00374322|3302844|P2|Overall Study|Physician Decision|32
1009614|NCT00374322|3302845|P1|Overall Study|Physician Decision|36
1009615|NCT00374322|3302844|P2|Overall Study|Sponsor Terminated Study|990
1009616|NCT00374322|3302845|P1|Overall Study|Sponsor Terminated Study|866
1009617|NCT00374322|3302844|P2|Overall Study|Withdrawal by Subject|167
1009618|NCT00374322|3302845|P1|Overall Study|Withdrawal by Subject|235
1009619|NCT00374322|3302844|P2|Overall Study|Protocol Violation|3
1009620|NCT00374322|3302845|P1|Overall Study|Protocol Violation|8
1009621|NCT00374322|3302844|P2|Overall Study|Lost to Follow-up|90
1009622|NCT00374322|3302845|P1|Overall Study|Lost to Follow-up|92
1009623|NCT00374140|3302936|P1|Overall Study|Protocol Violation|1
1009624|NCT00374140|3302936|P1|Overall Study|Lost to Follow-up|1
1009625|NCT00374127|3302943|P1|Overall Study|Pregnancy|1
1009626|NCT00374127|3302943|P1|Overall Study|Protocol Violation|5
1009627|NCT00374127|3302943|P1|Overall Study|Blood could not be drawn.|2
1009628|NCT00374127|3302943|P1|Overall Study|Did not inhale during smoking procedure.|3
1009629|NCT00373958|3302992|P2|Toddler Dose|Withdrawn after infant series|25
1009630|NCT00373958|3302993|P1|Toddler Dose|Withdrawn after infant series|22
1009631|NCT00373958|3302992|P2|Toddler Dose|Protocol Violation|1
1009632|NCT00373958|3302993|P1|Toddler Dose|Protocol Violation|0
1009633|NCT00373958|3302992|P2|Toddler Dose|Failed to return|2
1009634|NCT00373958|3302993|P1|Toddler Dose|Failed to return|1
1009635|NCT00373958|3302992|P2|Toddler Dose|Withdrawal by Subject|2
1009636|NCT00373958|3302993|P1|Toddler Dose|Withdrawal by Subject|2
1009637|NCT00373958|3302992|P2|Toddler Dose|Lost to Follow-up|8
1009638|NCT00373958|3302993|P1|Toddler Dose|Lost to Follow-up|5
1009639|NCT00373958|3302992|P2|Infant Series|Physician Decision|1
1009640|NCT00373958|3302993|P1|Infant Series|Physician Decision|1
1009641|NCT00373958|3302992|P2|Infant Series|Adverse Event|1
1009642|NCT00373958|3302993|P1|Infant Series|Adverse Event|3
1009643|NCT00373958|3302992|P2|Infant Series|Consent was not received|0
1009644|NCT00373958|3302993|P1|Infant Series|Consent was not received|1
1009645|NCT00373958|3302992|P2|Infant Series|Child relocated|0
1009646|NCT00373958|3302993|P1|Infant Series|Child relocated|1
1009647|NCT00373958|3302992|P2|Infant Series|Lost Kaiser coverage|0
1009648|NCT00373958|3302993|P1|Infant Series|Lost Kaiser coverage|4
1009649|NCT00373958|3302992|P2|Infant Series|Protocol Violation|7
1009650|NCT00373958|3302993|P1|Infant Series|Protocol Violation|3
1009651|NCT00373958|3302992|P2|Infant Series|Lost to Follow-up|5
1009652|NCT00373958|3302993|P1|Infant Series|Lost to Follow-up|6
1009653|NCT00373958|3302992|P2|Infant Series|Failed to return|13
1009654|NCT00373958|3302993|P1|Infant Series|Failed to return|8
1009655|NCT00373958|3302992|P2|Infant Series|Withdrawal by Subject|15
1009656|NCT00373958|3302993|P1|Infant Series|Withdrawal by Subject|13
1009657|NCT00373880|3303041|P1|Overall Study|Protocol Violation|14
1009658|NCT00373880|3303041|P1|Overall Study|Arrested|1
1009659|NCT00373880|3303041|P1|Overall Study|Physician Decision|3
1009660|NCT00373685|3303086|P2|Overall Study|Randomized, not treated|77
1009661|NCT00373685|3303087|P1|Overall Study|Randomized, not treated|51
1009662|NCT00373685|3303086|P2|Overall Study|Final Status Unknown|4
1009663|NCT00373685|3303087|P1|Overall Study|Final Status Unknown|12
1009664|NCT00373685|3303086|P2|Overall Study|Protocol Violation|182
1009665|NCT00373685|3303087|P1|Overall Study|Protocol Violation|191
1009666|NCT00373685|3303086|P2|Overall Study|Other|146
1009667|NCT00373685|3303087|P1|Overall Study|Other|149
1009668|NCT00373685|3303086|P2|Overall Study|No longer willing to participate|352
1009669|NCT00373685|3303087|P1|Overall Study|No longer willing to participate|337
1009670|NCT00373685|3303086|P2|Overall Study|Lost to follow up|103
1009671|NCT00373685|3303087|P1|Overall Study|Lost to follow up|83
1009672|NCT00373685|3303086|P2|Overall Study|Did not meet entrance criteria|184
1009673|NCT00373685|3303087|P1|Overall Study|Did not meet entrance criteria|167
1009674|NCT00373685|3303086|P2|Overall Study|Insufficient clinical response|119
1009675|NCT00373685|3303087|P1|Overall Study|Insufficient clinical response|169
1009676|NCT00373685|3303086|P2|Overall Study|Adverse Event|253
1009677|NCT00373685|3303087|P1|Overall Study|Adverse Event|278
1009678|NCT00373685|3303086|P2|Overall Study|Death|1
1009679|NCT00373685|3303087|P1|Overall Study|Death|2
1009680|NCT00373529|3303121|P1|Overall Study|Consent violation|1
1009681|NCT00373529|3303121|P1|Overall Study|Failed independent confirmation of AML|3
1009682|NCT00373529|3303121|P1|Overall Study|Not specified|8
1009683|NCT00373529|3303121|P1|Overall Study|Need for treatment prohibited by study|1
1009684|NCT00373529|3303121|P1|Overall Study|Death|16
1009685|NCT00373529|3303121|P1|Overall Study|Disease recurrence|10
1009686|NCT00373529|3303121|P1|Overall Study|Treatment failure|36
1009687|NCT00373529|3303121|P1|Overall Study|Adverse Event|7
1009688|NCT00373529|3303121|P1|Overall Study|Withdrawal by Subject|7
1009689|NCT00373529|3303121|P1|Overall Study|Physician Decision|19
1009690|NCT00373490|3303133|P2|Overall Study|Withdrawal by Subject|1
1009691|NCT00373490|3303134|P1|Overall Study|Withdrawal by Subject|0
1009692|NCT00373490|3303133|P2|Overall Study|Lack of Efficacy|4
1009693|NCT00373490|3303134|P1|Overall Study|Lack of Efficacy|9
1009694|NCT00373490|3303133|P2|Overall Study|Adverse Event|1
1009695|NCT00373490|3303134|P1|Overall Study|Adverse Event|0
1009696|NCT00373425|3303157|P5|Overall Study|Death|0
1009697|NCT00373425|3303158|P4|Overall Study|Death|1
1009698|NCT00373425|3303159|P3|Overall Study|Death|3
1009699|NCT00373425|3303160|P2|Overall Study|Death|0
1009700|NCT00373425|3303161|P1|Overall Study|Death|7
1009701|NCT00373425|3303157|P5|Overall Study|Medical/ethical/noncompliance reason|5
1009702|NCT00373425|3303158|P4|Overall Study|Medical/ethical/noncompliance reason|2
1009703|NCT00373425|3303159|P3|Overall Study|Medical/ethical/noncompliance reason|10
1009704|NCT00373425|3303160|P2|Overall Study|Medical/ethical/noncompliance reason|9
1009705|NCT00373425|3303161|P1|Overall Study|Medical/ethical/noncompliance reason|21
1009706|NCT00373425|3303157|P5|Overall Study|Patient request|7
1009707|NCT00373425|3303158|P4|Overall Study|Patient request|6
1009708|NCT00373425|3303159|P3|Overall Study|Patient request|43
1009709|NCT00373425|3303160|P2|Overall Study|Patient request|18
1009710|NCT00373425|3303161|P1|Overall Study|Patient request|35
1009711|NCT00373425|3303157|P5|Overall Study|Adverse Event|34
1009712|NCT00373425|3303158|P4|Overall Study|Adverse Event|0
1009713|NCT00373425|3303159|P3|Overall Study|Adverse Event|59
1009714|NCT00373425|3303160|P2|Overall Study|Adverse Event|22
1009715|NCT00373425|3303161|P1|Overall Study|Adverse Event|191
1009716|NCT00373425|3303157|P5|Overall Study|Relapse of NSCLC|26
1009717|NCT00373425|3303158|P4|Overall Study|Relapse of NSCLC|2
1009718|NCT00373425|3303159|P3|Overall Study|Relapse of NSCLC|19
1009719|NCT00373425|3303160|P2|Overall Study|Relapse of NSCLC|104
1009720|NCT00373425|3303161|P1|Overall Study|Relapse of NSCLC|116
1009721|NCT00373295|3303256|P6|Intervention 1 (8 Days)|Withdrawal by Subject|0
1009722|NCT00373295|3303257|P5|Intervention 1 (8 Days)|Withdrawal by Subject|1
1009723|NCT00373295|3303258|P4|Intervention 1 (8 Days)|Withdrawal by Subject|0
1009724|NCT00373295|3303259|P3|Intervention 1 (8 Days)|Withdrawal by Subject|0
1009725|NCT00373295|3303260|P2|Intervention 1 (8 Days)|Withdrawal by Subject|2
1009726|NCT00373295|3303261|P1|Intervention 1 (8 Days)|Withdrawal by Subject|0
1009727|NCT00373256|3303282|P2|Overall Study|Study Terminated by Sponsor|13
1009728|NCT00373256|3303283|P1|Overall Study|Study Terminated by Sponsor|41
1009729|NCT00373256|3303282|P2|Overall Study|Protocol Violation|2
1009730|NCT00373256|3303283|P1|Overall Study|Protocol Violation|0
1009731|NCT00373256|3303282|P2|Overall Study|Other|107
1009732|NCT00373256|3303283|P1|Overall Study|Other|73
1009733|NCT00373256|3303282|P2|Overall Study|Refused Treatment-Reason Other Than AE|7
1009734|NCT00373256|3303283|P1|Overall Study|Refused Treatment-Reason Other Than AE|4
1009735|NCT00373256|3303282|P2|Overall Study|Objective Progression or Relapse|104
1009736|NCT00373256|3303283|P1|Overall Study|Objective Progression or Relapse|111
1009737|NCT00373256|3303282|P2|Overall Study|Death|8
1009738|NCT00373256|3303283|P1|Overall Study|Death|9
1009739|NCT00373256|3303282|P2|Overall Study|Lost to Follow-up|1
1009740|NCT00373256|3303283|P1|Overall Study|Lost to Follow-up|2
1009741|NCT00373256|3303282|P2|Overall Study|Adverse Event (AE)|5
1009742|NCT00373256|3303283|P1|Overall Study|Adverse Event (AE)|1
1009743|NCT00373113|3303309|P2|Overall Study|Withdrawal by Subject|15
1009744|NCT00373113|3303310|P1|Overall Study|Withdrawal by Subject|10
1009745|NCT00373113|3303309|P2|Overall Study|Protocol Violation|1
1009746|NCT00373113|3303310|P1|Overall Study|Protocol Violation|5
1009747|NCT00373113|3303309|P2|Overall Study|Other|17
1009748|NCT00373113|3303310|P1|Overall Study|Other|14
1009749|NCT00373113|3303309|P2|Overall Study|Objective progression or relapse|169
1009750|NCT00373113|3303310|P1|Overall Study|Objective progression or relapse|150
1009751|NCT00373113|3303309|P2|Overall Study|Lost to Follow-up|3
1009752|NCT00373113|3303310|P1|Overall Study|Lost to Follow-up|1
1009753|NCT00373113|3303309|P2|Overall Study|Global deterioration of health status|7
1009754|NCT00373113|3303310|P1|Overall Study|Global deterioration of health status|10
1009755|NCT00373113|3303309|P2|Overall Study|Study terminated by sponsor|1
1009756|NCT00373113|3303310|P1|Overall Study|Study terminated by sponsor|9
1009757|NCT00373113|3303309|P2|Overall Study|Adverse Event|24
1009758|NCT00373113|3303310|P1|Overall Study|Adverse Event|38
1009759|NCT00373113|3303309|P2|Overall Study|Death|7
1009760|NCT00373113|3303310|P1|Overall Study|Death|1
1009761|NCT00372996|3303332|P4|Overall Study|Not specified|7
1009762|NCT00372996|3303333|P3|Overall Study|Not specified|7
1009763|NCT00372996|3303334|P2|Overall Study|Not specified|2
1009764|NCT00372996|3303335|P1|Overall Study|Not specified|10
1009765|NCT00372996|3303332|P4|Overall Study|Study Terminated by Sponsor|0
1009766|NCT00372996|3303333|P3|Overall Study|Study Terminated by Sponsor|4
1009767|NCT00372996|3303334|P2|Overall Study|Study Terminated by Sponsor|0
1009768|NCT00372996|3303335|P1|Overall Study|Study Terminated by Sponsor|4
1009769|NCT00372996|3303332|P4|Overall Study|Withdrawal by Subject|5
1009770|NCT00372996|3303333|P3|Overall Study|Withdrawal by Subject|9
1009771|NCT00372996|3303334|P2|Overall Study|Withdrawal by Subject|6
1009772|NCT00372996|3303335|P1|Overall Study|Withdrawal by Subject|12
1009773|NCT00372996|3303332|P4|Overall Study|Lost to Follow-up|1
1009774|NCT00372996|3303333|P3|Overall Study|Lost to Follow-up|0
1009775|NCT00372996|3303334|P2|Overall Study|Lost to Follow-up|2
1009776|NCT00372996|3303335|P1|Overall Study|Lost to Follow-up|0
1009777|NCT00372996|3303332|P4|Overall Study|Death|7
1009778|NCT00372996|3303333|P3|Overall Study|Death|8
1009779|NCT00372996|3303334|P2|Overall Study|Death|4
1009780|NCT00372996|3303335|P1|Overall Study|Death|11
1009781|NCT00372905|3303420|P4|Follow up Until Relapse or Progression|Other|0
1009782|NCT00372905|3303421|P3|Follow up Until Relapse or Progression|Other|0
1009783|NCT00372905|3303422|P2|Follow up Until Relapse or Progression|Other|1
1009784|NCT00372905|3303423|P1|Follow up Until Relapse or Progression|Other|0
1009785|NCT00372905|3303420|P4|Follow up Until Relapse or Progression|Study closed|3
1009786|NCT00372905|3303421|P3|Follow up Until Relapse or Progression|Study closed|0
1009787|NCT00372905|3303422|P2|Follow up Until Relapse or Progression|Study closed|0
1009788|NCT00372905|3303423|P1|Follow up Until Relapse or Progression|Study closed|0
1009789|NCT00372905|3303420|P4|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2
1009790|NCT00372905|3303421|P3|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
1009791|NCT00372905|3303422|P2|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
1009792|NCT00372905|3303423|P1|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
1009793|NCT00372905|3303420|P4|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
1009794|NCT00372905|3303421|P3|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1
1009795|NCT00372905|3303422|P2|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
1009796|NCT00372905|3303423|P1|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
1009797|NCT00372905|3303420|P4|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
1009798|NCT00372905|3303421|P3|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2
1009799|NCT00372905|3303422|P2|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
1009800|NCT00372905|3303423|P1|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
1009801|NCT00372905|3303420|P4|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
1009802|NCT00372905|3303421|P3|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
1009803|NCT00372905|3303422|P2|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
1009804|NCT00372905|3303423|P1|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2
1009805|NCT00372775|3303435|P1|Overall Study|Not Treated|2
1009806|NCT00372775|3303435|P1|Overall Study|Not specified|1
1009807|NCT00372775|3303435|P1|Overall Study|Withdrawal by Subject|1
1009808|NCT00372775|3303435|P1|Overall Study|Global deterioration of health status|6
1009809|NCT00372775|3303435|P1|Overall Study|Objective progression or relapse|30
1009810|NCT00372775|3303435|P1|Overall Study|Death|15
1009811|NCT00372775|3303435|P1|Overall Study|Adverse Event|8
1009812|NCT00372697|3303457|P2|Overall Study|Protocol Violation|1
1009813|NCT00372697|3303458|P1|Overall Study|Protocol Violation|1
1009814|NCT00372619|3303483|P7|Overall Study|Inevaluable|0
1009815|NCT00372619|3303484|P6|Overall Study|Inevaluable|1
1009816|NCT00372619|3303485|P5|Overall Study|Inevaluable|0
1009817|NCT00372619|3303486|P4|Overall Study|Inevaluable|0
1009818|NCT00372619|3303487|P3|Overall Study|Inevaluable|0
1009819|NCT00372619|3303488|P2|Overall Study|Inevaluable|0
1009820|NCT00372619|3303489|P1|Overall Study|Inevaluable|0
1009821|NCT00372619|3303483|P7|Overall Study|Ineligible|0
1009822|NCT00372619|3303484|P6|Overall Study|Ineligible|2
1009823|NCT00372619|3303485|P5|Overall Study|Ineligible|0
1009824|NCT00372619|3303486|P4|Overall Study|Ineligible|0
1009825|NCT00372619|3303487|P3|Overall Study|Ineligible|0
1009826|NCT00372619|3303488|P2|Overall Study|Ineligible|0
1009827|NCT00372619|3303489|P1|Overall Study|Ineligible|0
1009828|NCT00372593|3303522|P3|Overall Study|Ineligible|1
1009829|NCT00372593|3303523|P2|Overall Study|Ineligible|21
1009830|NCT00372593|3303524|P1|Overall Study|Ineligible|20
1009831|NCT00372593|3303522|P3|Overall Study|Physician Decision|0
1009832|NCT00372593|3303523|P2|Overall Study|Physician Decision|41
1009833|NCT00372593|3303524|P1|Overall Study|Physician Decision|42
1009834|NCT00372593|3303522|P3|Overall Study|Lost to Follow-up|0
1009835|NCT00372593|3303523|P2|Overall Study|Lost to Follow-up|0
1009836|NCT00372593|3303524|P1|Overall Study|Lost to Follow-up|1
1009837|NCT00372593|3303522|P3|Overall Study|Lack of Efficacy|2
1009838|NCT00372593|3303523|P2|Overall Study|Lack of Efficacy|71
1009839|NCT00372593|3303524|P1|Overall Study|Lack of Efficacy|82
1009840|NCT00372593|3303522|P3|Overall Study|Death|1
1009841|NCT00372593|3303523|P2|Overall Study|Death|20
1009842|NCT00372593|3303524|P1|Overall Study|Death|16
1009843|NCT00372593|3303522|P3|Overall Study|Adverse Event|0
1009844|NCT00372593|3303523|P2|Overall Study|Adverse Event|45
1009845|NCT00372593|3303524|P1|Overall Study|Adverse Event|43
1009846|NCT00372567|3303553|P3|Phase 3 Study|study terminated by sponsor|5
1009847|NCT00372567|3303554|P2|Phase 3 Study|study terminated by sponsor|8
1009848|NCT00372567|3303555|P1|Phase 3 Study|study terminated by sponsor|13
1009849|NCT00372567|3303553|P3|Phase 3 Study|not specified|1
1009850|NCT00372567|3303554|P2|Phase 3 Study|not specified|2
1009851|NCT00372567|3303555|P1|Phase 3 Study|not specified|2
1009852|NCT00372567|3303553|P3|Phase 3 Study|Global deterioration of health status|0
1009853|NCT00372567|3303554|P2|Phase 3 Study|Global deterioration of health status|1
1009854|NCT00372567|3303555|P1|Phase 3 Study|Global deterioration of health status|0
1009855|NCT00372567|3303553|P3|Phase 3 Study|Objective progression or relapse|4
1009856|NCT00372567|3303554|P2|Phase 3 Study|Objective progression or relapse|13
1009857|NCT00372567|3303555|P1|Phase 3 Study|Objective progression or relapse|10
1009858|NCT00372567|3303553|P3|Phase 3 Study|Protocol Violation|1
1009859|NCT00372567|3303554|P2|Phase 3 Study|Protocol Violation|0
1009860|NCT00372567|3303555|P1|Phase 3 Study|Protocol Violation|0
1009861|NCT00372567|3303553|P3|Phase 3 Study|Death|0
1009862|NCT00372567|3303554|P2|Phase 3 Study|Death|1
1009863|NCT00372567|3303555|P1|Phase 3 Study|Death|1
1009864|NCT00372567|3303553|P3|Phase 3 Study|Adverse Event|1
1009865|NCT00372567|3303554|P2|Phase 3 Study|Adverse Event|1
1009866|NCT00372567|3303555|P1|Phase 3 Study|Adverse Event|5
1009867|NCT00372528|3303583|P1|Overall Study|Other|1
1009868|NCT00372528|3303583|P1|Overall Study|Study Terminated by Sponsor|18
1009869|NCT00372528|3303583|P1|Overall Study|Adverse Event|1
1009870|NCT00372528|3303583|P1|Overall Study|Lack of Efficacy|1
1009871|NCT00372489|3303588|P1|Overall Study|Sponsor Decision to Terminate Study|41
1009872|NCT00372489|3303588|P1|Overall Study|Renal transplant|6
1009873|NCT00372489|3303588|P1|Overall Study|Patient Relocation|2
1009874|NCT00372489|3303588|P1|Overall Study|Withdrawal by Subject|5
1009875|NCT00372489|3303588|P1|Overall Study|Physician Decision|3
1009876|NCT00372489|3303588|P1|Overall Study|Lost to Follow-up|3
1009877|NCT00372489|3303588|P1|Overall Study|Lack of Efficacy|1
1009878|NCT00372489|3303588|P1|Overall Study|Adverse Event|18
1009879|NCT00372424|3303592|P1|Overall Study|Enrolled, Not Treated|1
1009880|NCT00372424|3303592|P1|Overall Study|Other|7
1009881|NCT00372424|3303592|P1|Overall Study|Objective Progression or Relapse|14
1009882|NCT00372424|3303592|P1|Overall Study|Death|1
1009883|NCT00372424|3303592|P1|Overall Study|Withdrawal by Subject|1
1009884|NCT00372424|3303592|P1|Overall Study|Adverse Event|2
1009885|NCT00372411|3303606|P3|Overall Study|Adverse Event|0
1009886|NCT00372411|3303607|P2|Overall Study|Adverse Event|1
1009887|NCT00372411|3303608|P1|Overall Study|Adverse Event|1
1009888|NCT00372411|3303606|P3|Overall Study|Lost to Follow-up|1
1009889|NCT00372411|3303607|P2|Overall Study|Lost to Follow-up|1
1009890|NCT00372411|3303608|P1|Overall Study|Lost to Follow-up|1
1009891|NCT00372411|3303606|P3|Overall Study|Death|1
1009892|NCT00372411|3303607|P2|Overall Study|Death|2
1009893|NCT00372411|3303608|P1|Overall Study|Death|0
1009894|NCT00372411|3303606|P3|Overall Study|Withdrawal by Subject|1
1009895|NCT00372411|3303607|P2|Overall Study|Withdrawal by Subject|4
1009896|NCT00372411|3303608|P1|Overall Study|Withdrawal by Subject|3
1009897|NCT00372385|3303632|P4|Overall Study|Virologic Stopping Rule|0
1009898|NCT00372385|3303633|P3|Overall Study|Virologic Stopping Rule|0
1009899|NCT00372385|3303634|P2|Overall Study|Virologic Stopping Rule|0
1009900|NCT00372385|3303635|P1|Overall Study|Virologic Stopping Rule|17
1009901|NCT00372385|3303632|P4|Overall Study|Ineligibility due to Exclusion Criterion|0
1009902|NCT00372385|3303633|P3|Overall Study|Ineligibility due to Exclusion Criterion|0
1009903|NCT00372385|3303634|P2|Overall Study|Ineligibility due to Exclusion Criterion|0
1009904|NCT00372385|3303635|P1|Overall Study|Ineligibility due to Exclusion Criterion|1
1009905|NCT00372385|3303632|P4|Overall Study|No Response|0
1009906|NCT00372385|3303633|P3|Overall Study|No Response|0
1009907|NCT00372385|3303634|P2|Overall Study|No Response|1
1009908|NCT00372385|3303635|P1|Overall Study|No Response|1
1009909|NCT00372385|3303632|P4|Overall Study|Refusal of Treatment|0
1009910|NCT00372385|3303633|P3|Overall Study|Refusal of Treatment|0
1009911|NCT00372385|3303634|P2|Overall Study|Refusal of Treatment|6
1009912|NCT00372385|3303635|P1|Overall Study|Refusal of Treatment|3
1009913|NCT00372385|3303632|P4|Overall Study|Withdrawal by Subject|0
1009914|NCT00372385|3303633|P3|Overall Study|Withdrawal by Subject|0
1009915|NCT00372385|3303634|P2|Overall Study|Withdrawal by Subject|1
1009916|NCT00372385|3303635|P1|Overall Study|Withdrawal by Subject|2
1009917|NCT00372385|3303632|P4|Overall Study|Lost to Follow-up|0
1009918|NCT00372385|3303633|P3|Overall Study|Lost to Follow-up|0
1009919|NCT00372385|3303634|P2|Overall Study|Lost to Follow-up|0
1009920|NCT00372385|3303635|P1|Overall Study|Lost to Follow-up|2
1009921|NCT00372385|3303632|P4|Overall Study|Physician Decision|0
1009922|NCT00372385|3303633|P3|Overall Study|Physician Decision|0
1009923|NCT00372385|3303634|P2|Overall Study|Physician Decision|0
1009924|NCT00372385|3303635|P1|Overall Study|Physician Decision|1
1009925|NCT00372385|3303632|P4|Overall Study|Noncompliance|1
1009926|NCT00372385|3303633|P3|Overall Study|Noncompliance|1
1009927|NCT00372385|3303634|P2|Overall Study|Noncompliance|1
1009928|NCT00372385|3303635|P1|Overall Study|Noncompliance|0
1009929|NCT00372385|3303632|P4|Overall Study|Adverse Event|7
1009930|NCT00372385|3303633|P3|Overall Study|Adverse Event|9
1009931|NCT00372385|3303634|P2|Overall Study|Adverse Event|11
1009932|NCT00372385|3303635|P1|Overall Study|Adverse Event|6
1009933|NCT00372190|3303664|P2|Overall Study|Lost to Follow-up|1
1009934|NCT00372190|3303665|P1|Overall Study|Lost to Follow-up|3
1009935|NCT00372112|3303681|P4|Overall Study|Other-protocol violation|0
1009936|NCT00372112|3303682|P3|Overall Study|Other-protocol violation|1
1009937|NCT00372112|3303683|P2|Overall Study|Other-protocol violation|0
1009938|NCT00372112|3303684|P1|Overall Study|Other-protocol violation|0
1009939|NCT00372112|3303681|P4|Overall Study|Hepatitis B|0
1009940|NCT00372112|3303682|P3|Overall Study|Hepatitis B|0
1009941|NCT00372112|3303683|P2|Overall Study|Hepatitis B|0
1009942|NCT00372112|3303684|P1|Overall Study|Hepatitis B|1
1009943|NCT00372112|3303681|P4|Overall Study|PR >240 at Visit 3|1
1009944|NCT00372112|3303682|P3|Overall Study|PR >240 at Visit 3|0
1009945|NCT00372112|3303683|P2|Overall Study|PR >240 at Visit 3|0
1009946|NCT00372112|3303684|P1|Overall Study|PR >240 at Visit 3|0
1009947|NCT00372112|3303681|P4|Overall Study|Exacerbation|1
1009948|NCT00372112|3303682|P3|Overall Study|Exacerbation|0
1009949|NCT00372112|3303683|P2|Overall Study|Exacerbation|0
1009950|NCT00372112|3303684|P1|Overall Study|Exacerbation|0
1009951|NCT00372112|3303681|P4|Overall Study|Withdrawal by Subject|1
1009952|NCT00372112|3303682|P3|Overall Study|Withdrawal by Subject|2
1009953|NCT00372112|3303683|P2|Overall Study|Withdrawal by Subject|0
1009954|NCT00372112|3303684|P1|Overall Study|Withdrawal by Subject|0
1009955|NCT00372112|3303681|P4|Overall Study|Adverse Event|1
1009956|NCT00372112|3303682|P3|Overall Study|Adverse Event|1
1009957|NCT00372112|3303683|P2|Overall Study|Adverse Event|1
1009958|NCT00372112|3303684|P1|Overall Study|Adverse Event|0
1009959|NCT00372060|3303815|P2|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0
1009960|NCT00372060|3303816|P1|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2
1009961|NCT00372060|3303815|P2|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8
1009962|NCT00372060|3303816|P1|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9
1009963|NCT00372060|3303815|P2|Period II - Open-label (Weeks 12-52)|Adverse Event|0
1009964|NCT00372060|3303816|P1|Period II - Open-label (Weeks 12-52)|Adverse Event|3
1009965|NCT00372060|3303815|P2|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0
1009966|NCT00372060|3303816|P1|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1
1009967|NCT00372060|3303815|P2|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1
1009968|NCT00372060|3303816|P1|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0
1009969|NCT00372060|3303815|P2|Period I - Double-blind (Weeks 0-12)|Adverse Event|0
1009970|NCT00372060|3303816|P1|Period I - Double-blind (Weeks 0-12)|Adverse Event|2
1009971|NCT00371865|3303831|P2|Overall Study|Withdrawal by Subject|10
1009972|NCT00371865|3303832|P1|Overall Study|Withdrawal by Subject|12
1009973|NCT00371865|3303831|P2|Overall Study|Protocol Violation|2
1009974|NCT00371865|3303832|P1|Overall Study|Protocol Violation|3
1009975|NCT00371865|3303831|P2|Overall Study|Lack of Efficacy|2
1009976|NCT00371865|3303832|P1|Overall Study|Lack of Efficacy|0
1009977|NCT00371839|3303849|P3|Overall Study|Lost to Follow-up|2
1009978|NCT00371839|3303850|P2|Overall Study|Lost to Follow-up|3
1009979|NCT00371839|3303851|P1|Overall Study|Lost to Follow-up|6
1009980|NCT00371839|3303849|P3|Overall Study|Withdrawal by Subject|0
1009981|NCT00371839|3303850|P2|Overall Study|Withdrawal by Subject|4
1009982|NCT00371839|3303851|P1|Overall Study|Withdrawal by Subject|7
1009983|NCT00371839|3303849|P3|Overall Study|Death|0
1009984|NCT00371839|3303850|P2|Overall Study|Death|0
1009985|NCT00371839|3303851|P1|Overall Study|Death|4
1009986|NCT00371826|3303860|P3|Extension Phase (24 Months)|Administrative problems|2
1009987|NCT00371826|3303861|P2|Extension Phase (24 Months)|Administrative problems|0
1009988|NCT00371826|3303862|P1|Extension Phase (24 Months)|Administrative problems|0
1009989|NCT00371826|3303860|P3|Extension Phase (24 Months)|Subject withdrew consent|0
1009990|NCT00371826|3303861|P2|Extension Phase (24 Months)|Subject withdrew consent|2
1009991|NCT00371826|3303862|P1|Extension Phase (24 Months)|Subject withdrew consent|1
1009992|NCT00371826|3303860|P3|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
1009993|NCT00371826|3303861|P2|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2
1009994|NCT00371826|3303862|P1|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
1009995|NCT00371826|3303860|P3|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
1009996|NCT00371826|3303861|P2|Extension Phase (24 Months)|Abnormal test procedure result(s)|1
1009997|NCT00371826|3303862|P1|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
1009998|NCT00371826|3303860|P3|Extension Phase (24 Months)|Adverse Event|0
1009999|NCT00371826|3303861|P2|Extension Phase (24 Months)|Adverse Event|5
1010000|NCT00371826|3303862|P1|Extension Phase (24 Months)|Adverse Event|4
1010001|NCT00371826|3303860|P3|Core Phase (12 Months)|Graft Loss|0
1010002|NCT00371826|3303861|P2|Core Phase (12 Months)|Graft Loss|1
1010003|NCT00371826|3303862|P1|Core Phase (12 Months)|Graft Loss|0
1010004|NCT00371826|3303860|P3|Core Phase (12 Months)|Administrative problems|8
1010005|NCT00371826|3303861|P2|Core Phase (12 Months)|Administrative problems|0
1010006|NCT00371826|3303862|P1|Core Phase (12 Months)|Administrative problems|1
1010007|NCT00371826|3303860|P3|Core Phase (12 Months)|Subject withdrew consent|3
1010008|NCT00371826|3303861|P2|Core Phase (12 Months)|Subject withdrew consent|0
1010009|NCT00371826|3303862|P1|Core Phase (12 Months)|Subject withdrew consent|0
1010010|NCT00371826|3303860|P3|Core Phase (12 Months)|Protocol Violation|1
1010011|NCT00371826|3303861|P2|Core Phase (12 Months)|Protocol Violation|0
1010012|NCT00371826|3303862|P1|Core Phase (12 Months)|Protocol Violation|1
1010013|NCT00371826|3303860|P3|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2
1010014|NCT00371826|3303861|P2|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3
1010015|NCT00371826|3303862|P1|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6
1010016|NCT00371826|3303860|P3|Core Phase (12 Months)|Abnormal test procedure result(s)|1
1010017|NCT00371826|3303861|P2|Core Phase (12 Months)|Abnormal test procedure result(s)|0
1010018|NCT00371826|3303862|P1|Core Phase (12 Months)|Abnormal test procedure result(s)|1
1010019|NCT00371826|3303860|P3|Core Phase (12 Months)|Adverse Event|9
1010020|NCT00371826|3303861|P2|Core Phase (12 Months)|Adverse Event|4
1010021|NCT00371826|3303862|P1|Core Phase (12 Months)|Adverse Event|15
1010022|NCT00371787|3303986|P2|Overall Study|Withdrawal by Subject|1
1010023|NCT00371787|3303987|P1|Overall Study|Withdrawal by Subject|3
1010024|NCT00371761|3304001|P2|Overall Study|Study termination|3
1010025|NCT00371761|3304002|P1|Overall Study|Study termination|4
1010026|NCT00371761|3304001|P2|Overall Study|Investigator Judgment|3
1010027|NCT00371761|3304002|P1|Overall Study|Investigator Judgment|2
1010028|NCT00371761|3304001|P2|Overall Study|Withdrawal by Subject|3
1010029|NCT00371761|3304002|P1|Overall Study|Withdrawal by Subject|1
1010030|NCT00371761|3304001|P2|Overall Study|Adverse Event|1
1010031|NCT00371761|3304002|P1|Overall Study|Adverse Event|1
1010032|NCT00371683|3304010|P2|Follow-Up Period - Randomized Patients|non-specified|12
1010033|NCT00371683|3304011|P1|Follow-Up Period - Randomized Patients|non-specified|6
1010034|NCT00371683|3304010|P2|Follow-Up Period - Randomized Patients|Lost to Follow-up|39
1010035|NCT00371683|3304011|P1|Follow-Up Period - Randomized Patients|Lost to Follow-up|38
1010036|NCT00371683|3304010|P2|Follow-Up Period - Randomized Patients|Death|2
1010037|NCT00371683|3304011|P1|Follow-Up Period - Randomized Patients|Death|0
1010038|NCT00371683|3304010|P2|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19
1010039|NCT00371683|3304011|P1|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17
1010040|NCT00371683|3304010|P2|DB Treatment Period-Randomized Patients|non-specified|8
1010041|NCT00371683|3304011|P1|DB Treatment Period-Randomized Patients|non-specified|9
1010042|NCT00371683|3304010|P2|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0
1010043|NCT00371683|3304011|P1|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1
1010044|NCT00371683|3304010|P2|DB Treatment Period-Randomized Patients|No longer meets study criteria|2
1010045|NCT00371683|3304011|P1|DB Treatment Period-Randomized Patients|No longer meets study criteria|1
1010046|NCT00371683|3304010|P2|DB Treatment Period-Randomized Patients|Lost to Follow-up|1
1010047|NCT00371683|3304011|P1|DB Treatment Period-Randomized Patients|Lost to Follow-up|0
1010048|NCT00371683|3304010|P2|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37
1010049|NCT00371683|3304011|P1|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18
1010050|NCT00371683|3304010|P2|DB Treatment Period-Randomized Patients|Adverse Event|58
1010051|NCT00371683|3304011|P1|DB Treatment Period-Randomized Patients|Adverse Event|60
1010052|NCT00371683|3304010|P2|DB Treatment Period-Randomized Patients|Death|1
1010053|NCT00371683|3304011|P1|DB Treatment Period-Randomized Patients|Death|1
1010054|NCT00371566|3304079|P2|Follow Up Phase|Lost to Follow-up|0
1010055|NCT00371566|3304080|P1|Follow Up Phase|Lost to Follow-up|1
1010056|NCT00371566|3304079|P2|Follow Up Phase|Physician Decision|1
1010057|NCT00371566|3304080|P1|Follow Up Phase|Physician Decision|1
1010058|NCT00371566|3304079|P2|Follow Up Phase|Withdrawal by Subject|1
1010059|NCT00371566|3304080|P1|Follow Up Phase|Withdrawal by Subject|0
1010060|NCT00371566|3304079|P2|Follow Up Phase|Disease progression|0
1010061|NCT00371566|3304080|P1|Follow Up Phase|Disease progression|1
1010062|NCT00371566|3304079|P2|Follow Up Phase|Death|5
1010063|NCT00371566|3304080|P1|Follow Up Phase|Death|0
1010064|NCT00371566|3304079|P2|Chemoradiation Phase|Death|0
1010065|NCT00371566|3304080|P1|Chemoradiation Phase|Death|2
1010066|NCT00371566|3304079|P2|Chemoradiation Phase|Progressive Disease|1
1010067|NCT00371566|3304080|P1|Chemoradiation Phase|Progressive Disease|1
1010068|NCT00371566|3304079|P2|Chemoradiation Phase|Non compliant|1
1010069|NCT00371566|3304080|P1|Chemoradiation Phase|Non compliant|0
1010070|NCT00371566|3304079|P2|Chemoradiation Phase|Withdrawal by Subject|1
1010071|NCT00371566|3304080|P1|Chemoradiation Phase|Withdrawal by Subject|0
1010072|NCT00371566|3304079|P2|Chemoradiation Phase|Physician Decision|0
1010073|NCT00371566|3304080|P1|Chemoradiation Phase|Physician Decision|2
1010074|NCT00371566|3304079|P2|Treatment Phase|Protocol Violation|1
1010075|NCT00371566|3304080|P1|Treatment Phase|Protocol Violation|0
1010076|NCT00371566|3304079|P2|Treatment Phase|Adverse Event|1
1010077|NCT00371566|3304080|P1|Treatment Phase|Adverse Event|0
1010078|NCT00371566|3304079|P2|Treatment Phase|Withdrawal by Subject|1
1010079|NCT00371566|3304080|P1|Treatment Phase|Withdrawal by Subject|0
1010080|NCT00371462|3304165|P2|Overall Study|Other|8
1010081|NCT00371462|3304166|P1|Overall Study|Other|7
1010082|NCT00371462|3304165|P2|Overall Study|Withdrawal by Subject|0
1010083|NCT00371462|3304166|P1|Overall Study|Withdrawal by Subject|1
1010084|NCT00371397|3304190|P12|Session 1|Withdrawal by Subject|0
1010085|NCT00371397|3304191|P11|Session 1|Withdrawal by Subject|0
1010086|NCT00371397|3304192|P10|Session 1|Withdrawal by Subject|0
1010087|NCT00371397|3304193|P9|Session 1|Withdrawal by Subject|0
1010088|NCT00371397|3304194|P8|Session 1|Withdrawal by Subject|1
1010089|NCT00371397|3304195|P7|Session 1|Withdrawal by Subject|0
1010090|NCT00371397|3304196|P6|Session 1|Withdrawal by Subject|0
1010091|NCT00371397|3304197|P5|Session 1|Withdrawal by Subject|0
1010092|NCT00371397|3304198|P4|Session 1|Withdrawal by Subject|0
1010093|NCT00371397|3304199|P3|Session 1|Withdrawal by Subject|0
1010094|NCT00371397|3304200|P2|Session 1|Withdrawal by Subject|0
1010095|NCT00371397|3304201|P1|Session 1|Withdrawal by Subject|1
1010096|NCT00371345|3304209|P2|Overall Study|Participant Withdrew Consent|1
1010097|NCT00371345|3304210|P1|Overall Study|Participant Withdrew Consent|0
1010098|NCT00371345|3304209|P2|Overall Study|Participant Request|1
1010099|NCT00371345|3304210|P1|Overall Study|Participant Request|1
1010100|NCT00371345|3304209|P2|Overall Study|Adverse event(AE Unrelated to Study Drug|2
1010101|NCT00371345|3304210|P1|Overall Study|Adverse event(AE Unrelated to Study Drug|1
1010102|NCT00371345|3304209|P2|Overall Study|Study Drug Toxicity|7
1010103|NCT00371345|3304210|P1|Overall Study|Study Drug Toxicity|1
1010104|NCT00371345|3304209|P2|Overall Study|Disease Progression|35
1010105|NCT00371345|3304210|P1|Overall Study|Disease Progression|21
1010106|NCT00371254|3304311|P2|Overall Study|Withdrawal by Subject|1
1010107|NCT00371254|3304312|P1|Overall Study|Withdrawal by Subject|0
1010108|NCT00371254|3304311|P2|Overall Study|Lost to Follow-up|1
1010109|NCT00371254|3304312|P1|Overall Study|Lost to Follow-up|0
1010110|NCT00371254|3304311|P2|Overall Study|Adverse event unrelated to study drug|1
1010111|NCT00371254|3304312|P1|Overall Study|Adverse event unrelated to study drug|0
1010112|NCT00371254|3304311|P2|Overall Study|Investigator Decision|0
1010113|NCT00371254|3304312|P1|Overall Study|Investigator Decision|2
1010114|NCT00371254|3304311|P2|Overall Study|Subject request|0
1010115|NCT00371254|3304312|P1|Overall Study|Subject request|5
1010116|NCT00371254|3304311|P2|Overall Study|Study drug toxicity|5
1010117|NCT00371254|3304312|P1|Overall Study|Study drug toxicity|3
1010118|NCT00371254|3304311|P2|Overall Study|Disease progression|13
1010119|NCT00371254|3304312|P1|Overall Study|Disease progression|13
1010120|NCT00371150|3304395|P2|Overall Study|Lost to Follow-up|2
1010121|NCT00371150|3304396|P1|Overall Study|Lost to Follow-up|3
1010122|NCT00371137|3304431|P3|Overall Study|Protocol Violation|1
1010123|NCT00371137|3304432|P2|Overall Study|Protocol Violation|1
1010124|NCT00371137|3304433|P1|Overall Study|Protocol Violation|2
1010125|NCT00371137|3304431|P3|Overall Study|Physician Decision|1
1010126|NCT00371137|3304432|P2|Overall Study|Physician Decision|1
1010127|NCT00371137|3304433|P1|Overall Study|Physician Decision|1
1010128|NCT00371137|3304431|P3|Overall Study|Sponsor Decision|2
1010129|NCT00371137|3304432|P2|Overall Study|Sponsor Decision|1
1010130|NCT00371137|3304433|P1|Overall Study|Sponsor Decision|2
1010131|NCT00371137|3304431|P3|Overall Study|Lack of Efficacy|13
1010132|NCT00371137|3304432|P2|Overall Study|Lack of Efficacy|12
1010133|NCT00371137|3304433|P1|Overall Study|Lack of Efficacy|30
1010134|NCT00371137|3304431|P3|Overall Study|Lost to Follow-up|5
1010135|NCT00371137|3304432|P2|Overall Study|Lost to Follow-up|3
1010136|NCT00371137|3304433|P1|Overall Study|Lost to Follow-up|6
1010137|NCT00371137|3304431|P3|Overall Study|Withdrawal by Subject|15
1010138|NCT00371137|3304432|P2|Overall Study|Withdrawal by Subject|10
1010139|NCT00371137|3304433|P1|Overall Study|Withdrawal by Subject|11
1010140|NCT00371137|3304431|P3|Overall Study|Adverse Event|42
1010141|NCT00371137|3304432|P2|Overall Study|Adverse Event|35
1010142|NCT00371137|3304433|P1|Overall Study|Adverse Event|20
1010143|NCT00370682|3304476|P3|Overall Study|Lost to Follow-up|1
1010144|NCT00370682|3304477|P2|Overall Study|Lost to Follow-up|1
1010145|NCT00370682|3304478|P1|Overall Study|Lost to Follow-up|0
1010146|NCT00370682|3304476|P3|Overall Study|Moved from area|0
1010147|NCT00370682|3304477|P2|Overall Study|Moved from area|2
1010148|NCT00370682|3304478|P1|Overall Study|Moved from area|0
1010149|NCT00370552|3304520|P3|Overall Study|Planned radiation for palliation|0
1010150|NCT00370552|3304521|P2|Overall Study|Planned radiation for palliation|1
1010151|NCT00370552|3304522|P1|Overall Study|Planned radiation for palliation|0
1010152|NCT00370552|3304520|P3|Overall Study|High risk of allergic reaction|0
1010153|NCT00370552|3304521|P2|Overall Study|High risk of allergic reaction|1
1010154|NCT00370552|3304522|P1|Overall Study|High risk of allergic reaction|0
1010155|NCT00370552|3304520|P3|Overall Study|Investigator decision|0
1010156|NCT00370552|3304521|P2|Overall Study|Investigator decision|1
1010157|NCT00370552|3304522|P1|Overall Study|Investigator decision|2
1010158|NCT00370552|3304520|P3|Overall Study|Physician Decision|0
1010159|NCT00370552|3304521|P2|Overall Study|Physician Decision|1
1010160|NCT00370552|3304522|P1|Overall Study|Physician Decision|1
1010161|NCT00370552|3304520|P3|Overall Study|Never treated|0
1010162|NCT00370552|3304521|P2|Overall Study|Never treated|0
1010163|NCT00370552|3304522|P1|Overall Study|Never treated|1
1010164|NCT00370552|3304520|P3|Overall Study|Still on treatment|2
1010165|NCT00370552|3304521|P2|Overall Study|Still on treatment|3
1010166|NCT00370552|3304522|P1|Overall Study|Still on treatment|1
1010167|NCT00370552|3304520|P3|Overall Study|Withdrawal by Subject|1
1010168|NCT00370552|3304521|P2|Overall Study|Withdrawal by Subject|0
1010169|NCT00370552|3304522|P1|Overall Study|Withdrawal by Subject|2
1010170|NCT00370552|3304520|P3|Overall Study|Study drug toxicity|6
1010171|NCT00370552|3304521|P2|Overall Study|Study drug toxicity|8
1010172|NCT00370552|3304522|P1|Overall Study|Study drug toxicity|11
1010173|NCT00370552|3304520|P3|Overall Study|Poor or noncompliance|1
1010174|NCT00370552|3304521|P2|Overall Study|Poor or noncompliance|0
1010175|NCT00370552|3304522|P1|Overall Study|Poor or noncompliance|0
1010176|NCT00370552|3304520|P3|Overall Study|Maximum clinical benefit|5
1010177|NCT00370552|3304521|P2|Overall Study|Maximum clinical benefit|5
1010178|NCT00370552|3304522|P1|Overall Study|Maximum clinical benefit|3
1010179|NCT00370552|3304520|P3|Overall Study|Disease progression|15
1010180|NCT00370552|3304521|P2|Overall Study|Disease progression|23
1010181|NCT00370552|3304522|P1|Overall Study|Disease progression|23
1010182|NCT00370552|3304520|P3|Overall Study|Adverse Event|2
1010183|NCT00370552|3304521|P2|Overall Study|Adverse Event|2
1010184|NCT00370552|3304522|P1|Overall Study|Adverse Event|2
1010185|NCT00370396|3304563|P3|Overall Study|Lost to Follow-up|0
1010186|NCT00370396|3304564|P2|Overall Study|Lost to Follow-up|1
1010187|NCT00370396|3304565|P1|Overall Study|Lost to Follow-up|11
1010188|NCT00370396|3304563|P3|Overall Study|Withdrawal by Subject|1
1010189|NCT00370396|3304564|P2|Overall Study|Withdrawal by Subject|0
1010190|NCT00370396|3304565|P1|Overall Study|Withdrawal by Subject|0
1010191|NCT00370331|3304619|P2|Overall Study|Protocol Violation|1
1010192|NCT00370331|3304620|P1|Overall Study|Protocol Violation|1
1010193|NCT00370331|3304619|P2|Overall Study|Non-compliance|1
1010194|NCT00370331|3304620|P1|Overall Study|Non-compliance|0
1010195|NCT00370331|3304619|P2|Overall Study|Lack of Efficacy|1
1010196|NCT00370331|3304620|P1|Overall Study|Lack of Efficacy|0
1010197|NCT00370331|3304619|P2|Overall Study|Lost to Follow-up|3
1010198|NCT00370331|3304620|P1|Overall Study|Lost to Follow-up|0
1010199|NCT00370331|3304619|P2|Overall Study|Withdrawal by Subject|4
1010200|NCT00370331|3304620|P1|Overall Study|Withdrawal by Subject|2
1010201|NCT00370331|3304619|P2|Overall Study|Adverse Event|13
1010202|NCT00370331|3304620|P1|Overall Study|Adverse Event|4
1010203|NCT00370292|3304646|P1|Overall Study|Physician Decision|2
1010204|NCT00370292|3304646|P1|Overall Study|Adverse Event|7
1010205|NCT00370292|3304646|P1|Overall Study|Disease Progression|4
1010206|NCT00370149|3304659|P2|Overall Study|Antibiotic coated dressing placed|1
1010207|NCT00370149|3304660|P1|Overall Study|Antibiotic coated dressing placed|0
1010208|NCT00370149|3304659|P2|Overall Study|Pre-existing infection|1
1010209|NCT00370149|3304660|P1|Overall Study|Pre-existing infection|0
1010210|NCT00370149|3304659|P2|Overall Study|Catheter inserted in wrong vessel-|1
1010211|NCT00370149|3304660|P1|Overall Study|Catheter inserted in wrong vessel-|2
1010212|NCT00370149|3304659|P2|Overall Study|Protocol Violation|0
1010213|NCT00370149|3304660|P1|Overall Study|Protocol Violation|1
1010214|NCT00370149|3304659|P2|Overall Study|Physician Decision|16
1010215|NCT00370149|3304660|P1|Overall Study|Physician Decision|16
1010216|NCT00370071|3304670|P1|Overall Study|Withdrawal by Subject|2
1010217|NCT00370032|3304687|P2|Follow-up Period|Withdrawal by Subject|0
1010218|NCT00370032|3304688|P1|Follow-up Period|Withdrawal by Subject|1
1010219|NCT00370032|3304687|P2|Washout Period|Adverse Event|0
1010220|NCT00370032|3304688|P1|Washout Period|Adverse Event|1
1010221|NCT00370032|3304687|P2|Washout Period|Lost to Follow-up|1
1010222|NCT00370032|3304688|P1|Washout Period|Lost to Follow-up|0
1010223|NCT00370032|3304687|P2|Washout Period|Withdrawal by Subject|1
1010224|NCT00370032|3304688|P1|Washout Period|Withdrawal by Subject|0
1010225|NCT00370032|3304687|P2|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1
1010226|NCT00370032|3304688|P1|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0
1010227|NCT00369967|3304708|P2|Overall Study|Lost to Follow-up|12
1010228|NCT00369967|3304709|P1|Overall Study|Lost to Follow-up|23
1010229|NCT00369941|3304727|P2|Overall Study|Miscellaneous|3
1010230|NCT00369941|3304728|P1|Overall Study|Miscellaneous|3
1010231|NCT00369941|3304727|P2|Overall Study|Study Site Terminated|0
1010232|NCT00369941|3304728|P1|Overall Study|Study Site Terminated|2
1010233|NCT00369941|3304727|P2|Overall Study|Employment Interfered with Study Visits|0
1010234|NCT00369941|3304728|P1|Overall Study|Employment Interfered with Study Visits|1
1010235|NCT00369941|3304727|P2|Overall Study|Treatment with Prohibited Medication|1
1010236|NCT00369941|3304728|P1|Overall Study|Treatment with Prohibited Medication|3
1010237|NCT00369941|3304727|P2|Overall Study|Moved|5
1010238|NCT00369941|3304728|P1|Overall Study|Moved|11
1010239|NCT00369941|3304727|P2|Overall Study|Completed, Did Not Enter Extension|6
1010240|NCT00369941|3304728|P1|Overall Study|Completed, Did Not Enter Extension|5
1010241|NCT00369941|3304727|P2|Overall Study|Pregnancy|2
1010242|NCT00369941|3304728|P1|Overall Study|Pregnancy|4
1010243|NCT00369941|3304727|P2|Overall Study|Withdrawal by Subject|18
1010244|NCT00369941|3304728|P1|Overall Study|Withdrawal by Subject|5
1010245|NCT00369941|3304727|P2|Overall Study|Protocol Violation|3
1010246|NCT00369941|3304728|P1|Overall Study|Protocol Violation|5
1010247|NCT00369941|3304727|P2|Overall Study|Lost to Follow-up|22
1010248|NCT00369941|3304728|P1|Overall Study|Lost to Follow-up|12
1010249|NCT00369941|3304727|P2|Overall Study|Lack of Efficacy|10
1010250|NCT00369941|3304728|P1|Overall Study|Lack of Efficacy|6
1010251|NCT00369941|3304727|P2|Overall Study|Adverse Event|28
1010252|NCT00369941|3304728|P1|Overall Study|Adverse Event|14
1010253|NCT00369941|3304727|P2|Overall Study|Never Treated|2
1010254|NCT00369941|3304728|P1|Overall Study|Never Treated|1
1010255|NCT00369915|3304893|P2|Overall Study|W/drawl by investigators|1
1010256|NCT00369915|3304894|P1|Overall Study|W/drawl by investigators|0
1010257|NCT00369915|3304893|P2|Overall Study|Withdrawal by Subject|1
1010258|NCT00369915|3304894|P1|Overall Study|Withdrawal by Subject|4
1010259|NCT00369915|3304893|P2|Overall Study|expected side effects|1
1010260|NCT00369915|3304894|P1|Overall Study|expected side effects|2
1010261|NCT00369824|3304908|P6|Overall Study|Other|3
1010262|NCT00369824|3304909|P5|Overall Study|Other|1
1010263|NCT00369824|3304910|P4|Overall Study|Other|2
1010264|NCT00369824|3304911|P3|Overall Study|Other|0
1010265|NCT00369824|3304912|P2|Overall Study|Other|0
1010266|NCT00369824|3304913|P1|Overall Study|Other|0
1010267|NCT00369824|3304908|P6|Overall Study|Lost to Follow-up|6
1010268|NCT00369824|3304909|P5|Overall Study|Lost to Follow-up|9
1010269|NCT00369824|3304910|P4|Overall Study|Lost to Follow-up|8
1010270|NCT00369824|3304911|P3|Overall Study|Lost to Follow-up|7
1010271|NCT00369824|3304912|P2|Overall Study|Lost to Follow-up|11
1010272|NCT00369824|3304913|P1|Overall Study|Lost to Follow-up|6
1010273|NCT00369824|3304908|P6|Overall Study|Withdrawal by Subject|2
1010274|NCT00369824|3304909|P5|Overall Study|Withdrawal by Subject|6
1010275|NCT00369824|3304910|P4|Overall Study|Withdrawal by Subject|4
1010276|NCT00369824|3304911|P3|Overall Study|Withdrawal by Subject|5
1010277|NCT00369824|3304912|P2|Overall Study|Withdrawal by Subject|5
1010278|NCT00369824|3304913|P1|Overall Study|Withdrawal by Subject|9
1010279|NCT00369824|3304908|P6|Overall Study|Protocol Violation|0
1010280|NCT00369824|3304909|P5|Overall Study|Protocol Violation|1
1010281|NCT00369824|3304910|P4|Overall Study|Protocol Violation|1
1010282|NCT00369824|3304911|P3|Overall Study|Protocol Violation|0
1010283|NCT00369824|3304912|P2|Overall Study|Protocol Violation|1
1010284|NCT00369824|3304913|P1|Overall Study|Protocol Violation|0
1010285|NCT00369824|3304908|P6|Overall Study|Adverse Event|0
1010286|NCT00369824|3304909|P5|Overall Study|Adverse Event|1
1010287|NCT00369824|3304910|P4|Overall Study|Adverse Event|0
1010288|NCT00369824|3304911|P3|Overall Study|Adverse Event|0
1010289|NCT00369824|3304912|P2|Overall Study|Adverse Event|2
1010290|NCT00369824|3304913|P1|Overall Study|Adverse Event|0
1010291|NCT00369785|3305013|P2|Overall Study|Multiple reasons|5
1010292|NCT00369785|3305014|P1|Overall Study|Multiple reasons|6
1010293|NCT00369785|3305013|P2|Overall Study|Progression|4
1010294|NCT00369785|3305014|P1|Overall Study|Progression|4
1010295|NCT00369785|3305013|P2|Overall Study|Never started|2
1010296|NCT00369785|3305014|P1|Overall Study|Never started|0
1010297|NCT00369785|3305013|P2|Overall Study|Toxicity|4
1010298|NCT00369785|3305014|P1|Overall Study|Toxicity|6
1010299|NCT00369785|3305013|P2|Overall Study|Withdrawal by Subject|6
1010300|NCT00369785|3305014|P1|Overall Study|Withdrawal by Subject|7
1010301|NCT00369785|3305013|P2|Overall Study|Death|2
1010302|NCT00369785|3305014|P1|Overall Study|Death|1
1010303|NCT00369785|3305013|P2|Overall Study|Physician Decision|2
1010304|NCT00369785|3305014|P1|Overall Study|Physician Decision|3
1010305|NCT00369707|3305035|P1|Follow up for 2 Years After Treatment|Other|2
1010306|NCT00369707|3305035|P1|Follow up for 2 Years After Treatment|Death|1
1010307|NCT00369707|3305035|P1|Maintenance Period (up to 4 Cycles)|Progressive disease|4
1010308|NCT00369707|3305035|P1|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2
1010309|NCT00369707|3305035|P1|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2
1010310|NCT00369707|3305035|P1|Induction Part B (2 Cycles)|Progressive disease|1
1010311|NCT00369707|3305035|P1|Induction Part B (2 Cycles)|Inadequate response/MD decision|1
1010312|NCT00369707|3305035|P1|Induction Part B (2 Cycles)|Withdrawal by Subject|2
1010313|NCT00369707|3305035|P1|Induction Part B (2 Cycles)|Adverse Event|3
1010314|NCT00369681|3305048|P1|Overall Study|Death|1
1010315|NCT00369668|3305058|P3|Overall Study|Lack of Efficacy|7
1010316|NCT00369668|3305059|P2|Overall Study|Lack of Efficacy|5
1010317|NCT00369668|3305060|P1|Overall Study|Lack of Efficacy|4
1010318|NCT00369655|3305074|P1|Overall Study|Refusal of further treatment|2
1010319|NCT00369629|3305083|P4|Follow up for 1 Year|stopped being followed as study closed|0
1010320|NCT00369629|3305084|P3|Follow up for 1 Year|stopped being followed as study closed|2
1010321|NCT00369629|3305085|P2|Follow up for 1 Year|stopped being followed as study closed|0
1010322|NCT00369629|3305086|P1|Follow up for 1 Year|stopped being followed as study closed|0
1010323|NCT00369629|3305083|P4|Follow up for 1 Year|Lost to Follow-up|0
1010324|NCT00369629|3305084|P3|Follow up for 1 Year|Lost to Follow-up|0
1010325|NCT00369629|3305085|P2|Follow up for 1 Year|Lost to Follow-up|1
1010326|NCT00369629|3305086|P1|Follow up for 1 Year|Lost to Follow-up|0
1010327|NCT00369629|3305083|P4|Follow up for 1 Year|Death|0
1010328|NCT00369629|3305084|P3|Follow up for 1 Year|Death|1
1010329|NCT00369629|3305085|P2|Follow up for 1 Year|Death|1
1010330|NCT00369629|3305086|P1|Follow up for 1 Year|Death|2
1010331|NCT00369629|3305083|P4|Completed 4 More Cycles|Progressive disease|0
1010332|NCT00369629|3305084|P3|Completed 4 More Cycles|Progressive disease|2
1010333|NCT00369629|3305085|P2|Completed 4 More Cycles|Progressive disease|1
1010334|NCT00369629|3305086|P1|Completed 4 More Cycles|Progressive disease|2
1010335|NCT00369629|3305083|P4|Completed 4 More Cycles|Withdrawal by Subject|0
1010336|NCT00369629|3305084|P3|Completed 4 More Cycles|Withdrawal by Subject|0
1010337|NCT00369629|3305085|P2|Completed 4 More Cycles|Withdrawal by Subject|1
1010338|NCT00369629|3305086|P1|Completed 4 More Cycles|Withdrawal by Subject|2
1010339|NCT00369629|3305083|P4|Moved on to 4 More Cycles|Progressive Disease|0
1010340|NCT00369629|3305084|P3|Moved on to 4 More Cycles|Progressive Disease|1
1010341|NCT00369629|3305085|P2|Moved on to 4 More Cycles|Progressive Disease|0
1010342|NCT00369629|3305086|P1|Moved on to 4 More Cycles|Progressive Disease|0
1010343|NCT00369629|3305083|P4|Treated 2 Cycles/Reached First Response|Progressive disease|0
1010344|NCT00369629|3305084|P3|Treated 2 Cycles/Reached First Response|Progressive disease|0
1010345|NCT00369629|3305085|P2|Treated 2 Cycles/Reached First Response|Progressive disease|0
1010346|NCT00369629|3305086|P1|Treated 2 Cycles/Reached First Response|Progressive disease|2
1010347|NCT00369629|3305083|P4|Treated 2 Cycles/Reached First Response|Adverse Event|0
1010348|NCT00369629|3305084|P3|Treated 2 Cycles/Reached First Response|Adverse Event|1
1010349|NCT00369629|3305085|P2|Treated 2 Cycles/Reached First Response|Adverse Event|0
1010350|NCT00369629|3305086|P1|Treated 2 Cycles/Reached First Response|Adverse Event|0
1010351|NCT00369629|3305083|P4|Treated 2 Cycles/Reached First Response|Physician Decision|0
1010352|NCT00369629|3305084|P3|Treated 2 Cycles/Reached First Response|Physician Decision|1
1010353|NCT00369629|3305085|P2|Treated 2 Cycles/Reached First Response|Physician Decision|1
1010354|NCT00369629|3305086|P1|Treated 2 Cycles/Reached First Response|Physician Decision|0
1010355|NCT00369577|3305117|P3|Overall Study|Withdrawal by Subject|1
1010356|NCT00369577|3305118|P2|Overall Study|Withdrawal by Subject|0
1010357|NCT00369577|3305119|P1|Overall Study|Withdrawal by Subject|0
1010358|NCT00369486|3305156|P5|34-Week Visit|Dropped|3
1010359|NCT00369486|3305157|P4|34-Week Visit|Dropped|3
1010360|NCT00369486|3305158|P3|34-Week Visit|Dropped|1
1010361|NCT00369486|3305159|P2|34-Week Visit|Dropped|1
1010362|NCT00369486|3305160|P1|34-Week Visit|Dropped|0
1010363|NCT00369486|3305156|P5|17-Week Visit|Missed visit|1
1010364|NCT00369486|3305157|P4|17-Week Visit|Missed visit|1
1010365|NCT00369486|3305158|P3|17-Week Visit|Missed visit|1
1010366|NCT00369486|3305159|P2|17-Week Visit|Missed visit|0
1010367|NCT00369486|3305160|P1|17-Week Visit|Missed visit|0
1010368|NCT00369486|3305156|P5|8-Week Visit|Dropped|0
1010369|NCT00369486|3305157|P4|8-Week Visit|Dropped|1
1010370|NCT00369486|3305158|P3|8-Week Visit|Dropped|0
1010371|NCT00369486|3305159|P2|8-Week Visit|Dropped|0
1010372|NCT00369486|3305160|P1|8-Week Visit|Dropped|0
1010373|NCT00369486|3305156|P5|8-Week Visit|Missed visit|1
1010374|NCT00369486|3305157|P4|8-Week Visit|Missed visit|0
1010375|NCT00369486|3305158|P3|8-Week Visit|Missed visit|0
1010376|NCT00369486|3305159|P2|8-Week Visit|Missed visit|1
1010377|NCT00369486|3305160|P1|8-Week Visit|Missed visit|0
1010378|NCT00369486|3305156|P5|4-Week Visit|Dropped|0
1010379|NCT00369486|3305157|P4|4-Week Visit|Dropped|0
1010380|NCT00369486|3305158|P3|4-Week Visit|Dropped|1
1010381|NCT00369486|3305159|P2|4-Week Visit|Dropped|0
1010382|NCT00369486|3305160|P1|4-Week Visit|Dropped|0
1010383|NCT00369486|3305156|P5|4-Week Visit|Missed visit|1
1010384|NCT00369486|3305157|P4|4-Week Visit|Missed visit|2
1010385|NCT00369486|3305158|P3|4-Week Visit|Missed visit|0
1010386|NCT00369486|3305159|P2|4-Week Visit|Missed visit|2
1010387|NCT00369486|3305160|P1|4-Week Visit|Missed visit|2
1010388|NCT00369382|3305199|P2|Overall Study|Other|0
1010389|NCT00369382|3305200|P1|Overall Study|Other|1
1010390|NCT00369382|3305199|P2|Overall Study|Randomized, not treated|0
1010391|NCT00369382|3305200|P1|Overall Study|Randomized, not treated|2
1010392|NCT00369382|3305199|P2|Overall Study|Withdrawal by Subject|0
1010393|NCT00369382|3305200|P1|Overall Study|Withdrawal by Subject|5
1010394|NCT00369382|3305199|P2|Overall Study|Physician Decision|1
1010395|NCT00369382|3305200|P1|Overall Study|Physician Decision|2
1010396|NCT00369382|3305199|P2|Overall Study|Death|2
1010397|NCT00369382|3305200|P1|Overall Study|Death|0
1010398|NCT00369343|3305233|P2|Open-label Phase|did not take study drug|2
1010399|NCT00369343|3305234|P1|Open-label Phase|did not take study drug|1
1010400|NCT00369343|3305233|P2|Open-label Phase|Lack of continuance tolerability|4
1010401|NCT00369343|3305234|P1|Open-label Phase|Lack of continuance tolerability|3
1010402|NCT00369343|3305233|P2|Open-label Phase|Lack of Efficacy|3
1010403|NCT00369343|3305234|P1|Open-label Phase|Lack of Efficacy|4
1010404|NCT00369343|3305233|P2|Open-label Phase|Withdrawal by Subject|6
1010405|NCT00369343|3305234|P1|Open-label Phase|Withdrawal by Subject|15
1010406|NCT00369343|3305233|P2|Open-label Phase|Protocol Violation|3
1010407|NCT00369343|3305234|P1|Open-label Phase|Protocol Violation|1
1010408|NCT00369343|3305233|P2|Open-label Phase|inadvertently reported study completers|2
1010409|NCT00369343|3305234|P1|Open-label Phase|inadvertently reported study completers|3
1010410|NCT00369343|3305233|P2|Open-label Phase|Lost to Follow-up|3
1010411|NCT00369343|3305234|P1|Open-label Phase|Lost to Follow-up|5
1010412|NCT00369343|3305233|P2|Open-label Phase|Physician Decision|0
1010413|NCT00369343|3305234|P1|Open-label Phase|Physician Decision|2
1010414|NCT00369343|3305233|P2|Open-label Phase|Failed to return|0
1010415|NCT00369343|3305234|P1|Open-label Phase|Failed to return|4
1010416|NCT00369343|3305233|P2|Open-label Phase|Adverse Event|7
1010417|NCT00369343|3305234|P1|Open-label Phase|Adverse Event|19
1010418|NCT00369343|3305233|P2|Double-blind Phase|Protocol deviation|0
1010419|NCT00369343|3305234|P1|Double-blind Phase|Protocol deviation|4
1010420|NCT00369343|3305233|P2|Double-blind Phase|Lack of Efficacy|4
1010421|NCT00369343|3305234|P1|Double-blind Phase|Lack of Efficacy|0
1010422|NCT00369343|3305233|P2|Double-blind Phase|Withdrawal by Subject|6
1010423|NCT00369343|3305234|P1|Double-blind Phase|Withdrawal by Subject|8
1010424|NCT00369343|3305233|P2|Double-blind Phase|Protocol Violation|0
1010425|NCT00369343|3305234|P1|Double-blind Phase|Protocol Violation|2
1010426|NCT00369343|3305233|P2|Double-blind Phase|Lost to Follow-up|2
1010427|NCT00369343|3305234|P1|Double-blind Phase|Lost to Follow-up|9
1010428|NCT00369343|3305233|P2|Double-blind Phase|Failed to return|0
1010429|NCT00369343|3305234|P1|Double-blind Phase|Failed to return|2
1010430|NCT00369343|3305233|P2|Double-blind Phase|Adverse Event|4
1010431|NCT00369343|3305234|P1|Double-blind Phase|Adverse Event|19
1010432|NCT00369317|3305267|P1|Overall Study|Ineligible|1
1010433|NCT00369317|3305267|P1|Overall Study|Withdrawal by Subject|8
1010434|NCT00369317|3305267|P1|Overall Study|Physician Decision|2
1010435|NCT00369317|3305267|P1|Overall Study|Lack of Efficacy|5
1010436|NCT00369317|3305267|P1|Overall Study|Death|1
1010437|NCT00369317|3305267|P1|Overall Study|Adverse Event|3
1010438|NCT00369278|3305283|P2|Overall Study|Graft loss|2
1010439|NCT00369278|3305284|P1|Overall Study|Graft loss|1
1010440|NCT00369278|3305283|P2|Overall Study|Lost to Follow-up|0
1010441|NCT00369278|3305284|P1|Overall Study|Lost to Follow-up|1
1010442|NCT00369278|3305283|P2|Overall Study|Withdrawal by Subject|2
1010443|NCT00369278|3305284|P1|Overall Study|Withdrawal by Subject|2
1010444|NCT00369278|3305283|P2|Overall Study|Protocol Violation|1
1010445|NCT00369278|3305284|P1|Overall Study|Protocol Violation|2
1010446|NCT00369278|3305283|P2|Overall Study|Unsatisfactory therapeutic effect|5
1010447|NCT00369278|3305284|P1|Overall Study|Unsatisfactory therapeutic effect|4
1010448|NCT00369278|3305283|P2|Overall Study|Adverse Event|11
1010449|NCT00369278|3305284|P1|Overall Study|Adverse Event|14
1010450|NCT00369265|3305300|P2|Overall Study|Study terminated|7
1010451|NCT00369265|3305301|P1|Overall Study|Study terminated|4
1010452|NCT00369161|3305322|P2|Overall Study|Administrative Problem|2
1010453|NCT00369161|3305323|P1|Overall Study|Administrative Problem|2
1010454|NCT00369161|3305322|P2|Overall Study|Graft loss|0
1010455|NCT00369161|3305323|P1|Overall Study|Graft loss|4
1010456|NCT00369161|3305322|P2|Overall Study|Death|2
1010457|NCT00369161|3305323|P1|Overall Study|Death|1
1010458|NCT00369161|3305322|P2|Overall Study|Withdrawal by Subject|3
1010459|NCT00369161|3305323|P1|Overall Study|Withdrawal by Subject|2
1010460|NCT00369161|3305322|P2|Overall Study|Protocol Violation|2
1010461|NCT00369161|3305323|P1|Overall Study|Protocol Violation|0
1010462|NCT00369161|3305322|P2|Overall Study|Lack of Efficacy|1
1010463|NCT00369161|3305323|P1|Overall Study|Lack of Efficacy|3
1010464|NCT00369161|3305322|P2|Overall Study|Abnormal laboratory value|1
1010465|NCT00369161|3305323|P1|Overall Study|Abnormal laboratory value|0
1010466|NCT00369161|3305322|P2|Overall Study|Adverse Event|13
1010467|NCT00369161|3305323|P1|Overall Study|Adverse Event|15
1010468|NCT00369122|3305333|P1|Overall Study|No protocol treatment|1
1010469|NCT00369122|3305333|P1|Overall Study|Ineligible|10
1010470|NCT00368992|3305340|P1|Overall Study|Not Specified|9
1010471|NCT00368992|3305340|P1|Overall Study|Death|4
1010472|NCT00368992|3305340|P1|Overall Study|Adverse Event|26
1010473|NCT00368992|3305340|P1|Overall Study|Lack of Efficacy|63
1010474|NCT00368992|3305340|P1|Overall Study|Refused treatment|3
1010475|NCT00368992|3305340|P1|Overall Study|Ineligible|5
1010476|NCT00368979|3305349|P2|Overall Study|Withdrawal by Subject|9
1010477|NCT00368979|3305350|P1|Overall Study|Withdrawal by Subject|5
1010478|NCT00368979|3305349|P2|Overall Study|Protocol Violation|1
1010479|NCT00368979|3305350|P1|Overall Study|Protocol Violation|2
1010480|NCT00368979|3305349|P2|Overall Study|Lost to Follow-up|0
1010481|NCT00368979|3305350|P1|Overall Study|Lost to Follow-up|1
1010482|NCT00368979|3305349|P2|Overall Study|Not specified|1
1010483|NCT00368979|3305350|P1|Overall Study|Not specified|3
1010484|NCT00368979|3305349|P2|Overall Study|Lack of Efficacy|3
1010485|NCT00368979|3305350|P1|Overall Study|Lack of Efficacy|5
1010486|NCT00368979|3305349|P2|Overall Study|Adverse Event|16
1010487|NCT00368979|3305350|P1|Overall Study|Adverse Event|9
1010488|NCT00368966|3305366|P2|Toddler Dose|Lost to Follow-up|2
1010489|NCT00368966|3305367|P1|Toddler Dose|Lost to Follow-up|0
1010490|NCT00368966|3305366|P2|Toddler Dose|Withdrawal by Subject|1
1010491|NCT00368966|3305367|P1|Toddler Dose|Withdrawal by Subject|1
1010492|NCT00368966|3305366|P2|After Infant|Lost to Follow-up|1
1010493|NCT00368966|3305367|P1|After Infant|Lost to Follow-up|0
1010494|NCT00368966|3305366|P2|After Infant|Death|0
1010495|NCT00368966|3305367|P1|After Infant|Death|1
1010496|NCT00368966|3305366|P2|After Infant|Withdrawal by Subject|1
1010497|NCT00368966|3305367|P1|After Infant|Withdrawal by Subject|1
1010498|NCT00368966|3305366|P2|After Infant|Adverse Event|2
1010499|NCT00368966|3305367|P1|After Infant|Adverse Event|1
1010500|NCT00368966|3305366|P2|After Infant|Failed to return|1
1010501|NCT00368966|3305367|P1|After Infant|Failed to return|3
1010502|NCT00368966|3305366|P2|Infant Series|Failed to return|0
1010503|NCT00368966|3305367|P1|Infant Series|Failed to return|1
1010504|NCT00368966|3305366|P2|Infant Series|Adverse Event|1
1010505|NCT00368966|3305367|P1|Infant Series|Adverse Event|0
1010506|NCT00368966|3305366|P2|Infant Series|Failed to meet eligibility criteria|1
1010507|NCT00368966|3305367|P1|Infant Series|Failed to meet eligibility criteria|0
1010508|NCT00368966|3305366|P2|Infant Series|Randomization error|1
1010509|NCT00368966|3305367|P1|Infant Series|Randomization error|0
1010510|NCT00368966|3305366|P2|Infant Series|Lost to Follow-up|0
1010511|NCT00368966|3305367|P1|Infant Series|Lost to Follow-up|2
1010512|NCT00368966|3305366|P2|Infant Series|Protocol Violation|1
1010513|NCT00368966|3305367|P1|Infant Series|Protocol Violation|2
1010514|NCT00368966|3305366|P2|Infant Series|Withdrawal by Subject|6
1010515|NCT00368966|3305367|P1|Infant Series|Withdrawal by Subject|11
1010516|NCT00368927|3305438|P2|Overall Study|Physician Decision|0
1010517|NCT00368927|3305439|P1|Overall Study|Physician Decision|1
1010518|NCT00368927|3305438|P2|Overall Study|Withdrawal by Subject|2
1010519|NCT00368927|3305439|P1|Overall Study|Withdrawal by Subject|1
1010520|NCT00368927|3305438|P2|Overall Study|Adverse Event|1
1010521|NCT00368927|3305439|P1|Overall Study|Adverse Event|1
1010522|NCT00368927|3305438|P2|Overall Study|Lost to Follow-up|0
1010523|NCT00368927|3305439|P1|Overall Study|Lost to Follow-up|2
1010524|NCT00368875|3305447|P2|Overall Study|Alternative Therapy|1
1010525|NCT00368875|3305448|P1|Overall Study|Alternative Therapy|1
1010526|NCT00368875|3305447|P2|Overall Study|Other Reason|2
1010527|NCT00368875|3305448|P1|Overall Study|Other Reason|0
1010528|NCT00368875|3305447|P2|Overall Study|Withdrawal by Subject|6
1010529|NCT00368875|3305448|P1|Overall Study|Withdrawal by Subject|2
1010530|NCT00368875|3305447|P2|Overall Study|Progressive disease|27
1010531|NCT00368875|3305448|P1|Overall Study|Progressive disease|3
1010532|NCT00368875|3305447|P2|Overall Study|Adverse Event|12
1010533|NCT00368875|3305448|P1|Overall Study|Adverse Event|0
1010534|NCT00368849|3305456|P2|Overall Study|Physician Decision|1
1010535|NCT00368849|3305457|P1|Overall Study|Physician Decision|0
1010536|NCT00368849|3305456|P2|Overall Study|Withdrawal by Subject|1
1010537|NCT00368849|3305457|P1|Overall Study|Withdrawal by Subject|0
1010538|NCT00368745|3305473|P2|Double-blind Treatment Period|Other|6
1010539|NCT00368745|3305474|P1|Double-blind Treatment Period|Other|7
1010540|NCT00368745|3305473|P2|Double-blind Treatment Period|Withdrawal by Subject|3
1010541|NCT00368745|3305474|P1|Double-blind Treatment Period|Withdrawal by Subject|5
1010542|NCT00368745|3305473|P2|Double-blind Treatment Period|Lost to Follow-up|0
1010543|NCT00368745|3305474|P1|Double-blind Treatment Period|Lost to Follow-up|1
1010544|NCT00368745|3305473|P2|Double-blind Treatment Period|Lack of Efficacy|16
1010545|NCT00368745|3305474|P1|Double-blind Treatment Period|Lack of Efficacy|7
1010546|NCT00368745|3305473|P2|Double-blind Treatment Period|Adverse Event|6
1010547|NCT00368745|3305474|P1|Double-blind Treatment Period|Adverse Event|6
1010548|NCT00368641|3305527|P2|Overall Study|Sponsor decision to terminate study|5
1010549|NCT00368641|3305528|P1|Overall Study|Sponsor decision to terminate study|2
1010550|NCT00368641|3305527|P2|Overall Study|Withdrawal by Subject|0
1010551|NCT00368641|3305528|P1|Overall Study|Withdrawal by Subject|1
1010552|NCT00368641|3305527|P2|Overall Study|Death|0
1010553|NCT00368641|3305528|P1|Overall Study|Death|1
1010554|NCT00368641|3305527|P2|Overall Study|Adverse Event|1
1010555|NCT00368641|3305528|P1|Overall Study|Adverse Event|2
1010556|NCT00368550|3305536|P2|Overall Study|Withdrawal by Subject|10
1010557|NCT00368550|3305537|P1|Overall Study|Withdrawal by Subject|17
1010558|NCT00368550|3305536|P2|Overall Study|Lack of Efficacy|9
1010559|NCT00368550|3305537|P1|Overall Study|Lack of Efficacy|4
1010560|NCT00368550|3305536|P2|Overall Study|Adverse Event|4
1010561|NCT00368550|3305537|P1|Overall Study|Adverse Event|7
1010562|NCT00368537|3305549|P2|Baseline Participants|Patient uncompliant|1
1010563|NCT00368537|3305550|P1|Baseline Participants|Patient uncompliant|0
1010564|NCT00368537|3305549|P2|Baseline Participants|No susceptibility|0
1010565|NCT00368537|3305550|P1|Baseline Participants|No susceptibility|1
1010566|NCT00368537|3305549|P2|Baseline Participants|Death|2
1010567|NCT00368537|3305550|P1|Baseline Participants|Death|1
1010568|NCT00368537|3305549|P2|Baseline Participants|Withdrawal by Subject|4
1010569|NCT00368537|3305550|P1|Baseline Participants|Withdrawal by Subject|6
1010570|NCT00368537|3305549|P2|Baseline Participants|Lost to Follow-up|17
1010571|NCT00368537|3305550|P1|Baseline Participants|Lost to Follow-up|16
1010572|NCT00368537|3305549|P2|Randomization|No study drug dosed|6
1010573|NCT00368537|3305550|P1|Randomization|No study drug dosed|13
1010574|NCT00368472|3305564|P1|Overall Study|Missing Final Disposition Date|1
1010575|NCT00368472|3305564|P1|Overall Study|Not Specified|32
1010576|NCT00368472|3305564|P1|Overall Study|Diary non-compliance|1
1010577|NCT00368472|3305564|P1|Overall Study|Withdrawal by Subject|40
1010578|NCT00368472|3305564|P1|Overall Study|Request of Investigator or Sponsor|3
1010579|NCT00368472|3305564|P1|Overall Study|Protocol Violation|2
1010580|NCT00368472|3305564|P1|Overall Study|Medication non-compliance|4
1010581|NCT00368472|3305564|P1|Overall Study|Adverse Event|22
1010582|NCT00368277|3305623|P2|Overall Study|Lost to Follow-up|6
1010583|NCT00368277|3305624|P1|Overall Study|Lost to Follow-up|8
1010584|NCT00368277|3305623|P2|Overall Study|Patient withdrew consent|28
1010585|NCT00368277|3305624|P1|Overall Study|Patient withdrew consent|32
1010586|NCT00368277|3305623|P2|Overall Study|Protocol deviation|0
1010587|NCT00368277|3305624|P1|Overall Study|Protocol deviation|7
1010588|NCT00368277|3305623|P2|Overall Study|Unsatisfactory therapeutic effect|24
1010589|NCT00368277|3305624|P1|Overall Study|Unsatisfactory therapeutic effect|31
1010590|NCT00368277|3305623|P2|Overall Study|Death|1
1010591|NCT00368277|3305624|P1|Overall Study|Death|2
1010592|NCT00368277|3305623|P2|Overall Study|Adverse Event|49
1010593|NCT00368277|3305624|P1|Overall Study|Adverse Event|33
1010594|NCT00368251|3305639|P3|Overall Study|AE, non-serious non-fatal|1
1010595|NCT00368251|3305640|P2|Overall Study|AE, non-serious non-fatal|0
1010596|NCT00368251|3305641|P1|Overall Study|AE, non-serious non-fatal|0
1010597|NCT00368251|3305639|P3|Overall Study|SAE, non-fatal|0
1010598|NCT00368251|3305640|P2|Overall Study|SAE, non-fatal|0
1010599|NCT00368251|3305641|P1|Overall Study|SAE, non-fatal|1
1010600|NCT00368108|3305664|P3|Overall Study|Not Specified|1
1010601|NCT00368108|3305665|P2|Overall Study|Not Specified|7
1010602|NCT00368108|3305666|P1|Overall Study|Not Specified|3
1010603|NCT00368108|3305664|P3|Overall Study|Physician Decision|1
1010604|NCT00368108|3305665|P2|Overall Study|Physician Decision|0
1010605|NCT00368108|3305666|P1|Overall Study|Physician Decision|2
1010606|NCT00368108|3305664|P3|Overall Study|Lack of Efficacy|5
1010607|NCT00368108|3305665|P2|Overall Study|Lack of Efficacy|8
1010608|NCT00368108|3305666|P1|Overall Study|Lack of Efficacy|7
1010609|NCT00368108|3305664|P3|Overall Study|Withdrawal by Subject|5
1010610|NCT00368108|3305665|P2|Overall Study|Withdrawal by Subject|3
1010611|NCT00368108|3305666|P1|Overall Study|Withdrawal by Subject|9
1010612|NCT00368108|3305664|P3|Overall Study|Protocol Violation|9
1010613|NCT00368108|3305665|P2|Overall Study|Protocol Violation|9
1010614|NCT00368108|3305666|P1|Overall Study|Protocol Violation|5
1010615|NCT00368108|3305664|P3|Overall Study|Abnormal Laboratory Value|3
1010616|NCT00368108|3305665|P2|Overall Study|Abnormal Laboratory Value|0
1010617|NCT00368108|3305666|P1|Overall Study|Abnormal Laboratory Value|0
1010618|NCT00368108|3305664|P3|Overall Study|Adverse Event|44
1010619|NCT00368108|3305665|P2|Overall Study|Adverse Event|26
1010620|NCT00368108|3305666|P1|Overall Study|Adverse Event|38
1010621|NCT00368069|3305685|P2|Overall Study|no blood sampling possible|1
1010622|NCT00368069|3305686|P1|Overall Study|no blood sampling possible|0
1010623|NCT00368069|3305685|P2|Overall Study|Withdrawal of Consent|1
1010624|NCT00368069|3305686|P1|Overall Study|Withdrawal of Consent|2
1010625|NCT00368069|3305685|P2|Overall Study|Protocol Violation|2
1010626|NCT00368069|3305686|P1|Overall Study|Protocol Violation|0
1010627|NCT00368069|3305685|P2|Overall Study|Lost to Follow-up|0
1010628|NCT00368069|3305686|P1|Overall Study|Lost to Follow-up|1
1010629|NCT00368069|3305685|P2|Overall Study|Lack of Efficacy|1
1010630|NCT00368069|3305686|P1|Overall Study|Lack of Efficacy|0
1010631|NCT00368069|3305685|P2|Overall Study|Adverse Event|2
1010632|NCT00368069|3305686|P1|Overall Study|Adverse Event|5
1010633|NCT00367991|3305704|P2|Overall Study|Adverse Event|1
1010634|NCT00367991|3305705|P1|Overall Study|Adverse Event|1
1010635|NCT00367991|3305704|P2|Overall Study|Withdrawal by Subject|1
1010636|NCT00367991|3305705|P1|Overall Study|Withdrawal by Subject|1
1010637|NCT00367835|3305723|P2|Overall Study|History of lead poisoning|1
1010638|NCT00367835|3305724|P1|Overall Study|History of lead poisoning|0
1010639|NCT00367835|3305723|P2|Overall Study|Did not respond to calls|0
1010640|NCT00367835|3305724|P1|Overall Study|Did not respond to calls|1
1010641|NCT00367835|3305723|P2|Overall Study|refused blood collection|0
1010642|NCT00367835|3305724|P1|Overall Study|refused blood collection|1
1010643|NCT00367835|3305723|P2|Overall Study|Subject in juvenile detention center|0
1010644|NCT00367835|3305724|P1|Overall Study|Subject in juvenile detention center|1
1010645|NCT00367835|3305723|P2|Overall Study|Lack of Efficacy|12
1010646|NCT00367835|3305724|P1|Overall Study|Lack of Efficacy|3
1010647|NCT00367835|3305723|P2|Overall Study|Lost to Follow-up|4
1010648|NCT00367835|3305724|P1|Overall Study|Lost to Follow-up|1
1010649|NCT00367835|3305723|P2|Overall Study|Withdrawal by Subject|6
1010650|NCT00367835|3305724|P1|Overall Study|Withdrawal by Subject|7
1010651|NCT00367835|3305723|P2|Overall Study|Protocol Violation|7
1010652|NCT00367835|3305724|P1|Overall Study|Protocol Violation|1
1010653|NCT00367835|3305723|P2|Overall Study|Adverse Event|1
1010654|NCT00367835|3305724|P1|Overall Study|Adverse Event|14
1010655|NCT00367770|3305750|P1|Overall Study|Withdrawal by Subject|1
1010656|NCT00367770|3305750|P1|Overall Study|Adverse Event|1
1010657|NCT00367744|3305758|P2|Overall Study|Lost to Follow-up|5
1010658|NCT00367744|3305759|P1|Overall Study|Lost to Follow-up|4
1010659|NCT00367640|3305788|P4|Overall Study|Any other reason not above-mentioned|4
1010660|NCT00367640|3305789|P3|Overall Study|Any other reason not above-mentioned|3
1010661|NCT00367640|3305790|P2|Overall Study|Any other reason not above-mentioned|5
1010662|NCT00367640|3305791|P1|Overall Study|Any other reason not above-mentioned|7
1010663|NCT00367640|3305788|P4|Overall Study|Withdrawal by Subject|6
1010664|NCT00367640|3305789|P3|Overall Study|Withdrawal by Subject|8
1010665|NCT00367640|3305790|P2|Overall Study|Withdrawal by Subject|11
1010666|NCT00367640|3305791|P1|Overall Study|Withdrawal by Subject|8
1010667|NCT00367640|3305788|P4|Overall Study|Adverse Event|0
1010668|NCT00367640|3305789|P3|Overall Study|Adverse Event|8
1010669|NCT00367640|3305790|P2|Overall Study|Adverse Event|6
1010670|NCT00367640|3305791|P1|Overall Study|Adverse Event|3
1010671|NCT00367484|3305807|P1|Overall Study|Lack of Efficacy|1
1010672|NCT00367484|3305807|P1|Overall Study|The choice of the patient|1
1010673|NCT00367484|3305807|P1|Overall Study|Protocol Violation|1
1010674|NCT00367484|3305807|P1|Overall Study|Lost to Follow-up|1
1010675|NCT00367484|3305807|P1|Overall Study|Travel to USA|1
1010676|NCT00367484|3305807|P1|Overall Study|Withdrew informed consent|5
1010677|NCT00367484|3305807|P1|Overall Study|Adverse Event|7
1010678|NCT00367432|3305811|P2|Second Period (up to 54 Months)|Other Reason|2
1010679|NCT00367432|3305812|P1|Second Period (up to 54 Months)|Other Reason|6
1010680|NCT00367432|3305811|P2|Second Period (up to 54 Months)|Withdrawal by Subject|5
1010681|NCT00367432|3305812|P1|Second Period (up to 54 Months)|Withdrawal by Subject|8
1010682|NCT00367432|3305811|P2|Second Period (up to 54 Months)|Lost to Follow-up|1
1010683|NCT00367432|3305812|P1|Second Period (up to 54 Months)|Lost to Follow-up|0
1010684|NCT00367432|3305811|P2|Second Period (up to 54 Months)|Lack of Efficacy|5
1010685|NCT00367432|3305812|P1|Second Period (up to 54 Months)|Lack of Efficacy|59
1010686|NCT00367432|3305811|P2|Second Period (up to 54 Months)|Adverse Event|3
1010687|NCT00367432|3305812|P1|Second Period (up to 54 Months)|Adverse Event|14
1010688|NCT00367432|3305811|P2|First Period (16 Weeks)|Other Reason|0
1010689|NCT00367432|3305812|P1|First Period (16 Weeks)|Other Reason|2
1010690|NCT00367432|3305811|P2|First Period (16 Weeks)|Withdrawal by Subject|0
1010691|NCT00367432|3305812|P1|First Period (16 Weeks)|Withdrawal by Subject|6
1010692|NCT00367432|3305811|P2|First Period (16 Weeks)|Lack of Efficacy|0
1010693|NCT00367432|3305812|P1|First Period (16 Weeks)|Lack of Efficacy|24
1010694|NCT00367432|3305811|P2|First Period (16 Weeks)|Adverse Event|0
1010695|NCT00367432|3305812|P1|First Period (16 Weeks)|Adverse Event|6
1010696|NCT00367341|3305839|P2|Overall Study|Protocol Violation|0
1010697|NCT00367341|3305840|P1|Overall Study|Protocol Violation|1
1010698|NCT00367341|3305839|P2|Overall Study|Physician Decision|0
1010699|NCT00367341|3305840|P1|Overall Study|Physician Decision|1
1010700|NCT00367237|3305850|P2|Overall Study|Protocol Violation|5
1010701|NCT00367237|3305851|P1|Overall Study|Protocol Violation|2
1010702|NCT00367237|3305850|P2|Overall Study|Withdrawal by Subject|4
1010703|NCT00367237|3305851|P1|Overall Study|Withdrawal by Subject|0
1010704|NCT00367237|3305850|P2|Overall Study|Lost to Follow-up|0
1010705|NCT00367237|3305851|P1|Overall Study|Lost to Follow-up|1
1010706|NCT00367237|3305850|P2|Overall Study|Adverse Event|2
1010707|NCT00367237|3305851|P1|Overall Study|Adverse Event|7
1010708|NCT00367133|3305860|P3|2 Years|Missed visit|4
1010709|NCT00367133|3305861|P2|2 Years|Missed visit|5
1010710|NCT00367133|3305862|P1|2 Years|Missed visit|4
1010711|NCT00367133|3305860|P3|2 Years|Dropped|33
1010712|NCT00367133|3305861|P2|2 Years|Dropped|19
1010713|NCT00367133|3305862|P1|2 Years|Dropped|34
1010714|NCT00367133|3305860|P3|2 Years|Death|12
1010715|NCT00367133|3305861|P2|2 Years|Death|12
1010716|NCT00367133|3305862|P1|2 Years|Death|20
1010717|NCT00367055|3305914|P2|Overall Study|Participant Living too Far from Hospital|1
1010718|NCT00367055|3305915|P1|Overall Study|Participant Living too Far from Hospital|0
1010719|NCT00367055|3305914|P2|Overall Study|Stopping Criterion Met|1
1010720|NCT00367055|3305915|P1|Overall Study|Stopping Criterion Met|0
1010721|NCT00367055|3305914|P2|Overall Study|Protocol Violation|1
1010722|NCT00367055|3305915|P1|Overall Study|Protocol Violation|0
1010723|NCT00367055|3305914|P2|Overall Study|Lost to Follow-up|1
1010724|NCT00367055|3305915|P1|Overall Study|Lost to Follow-up|1
1010725|NCT00367055|3305914|P2|Overall Study|Lack of Efficacy|2
1010726|NCT00367055|3305915|P1|Overall Study|Lack of Efficacy|1
1010727|NCT00367055|3305914|P2|Overall Study|Patient's Willing|2
1010728|NCT00367055|3305915|P1|Overall Study|Patient's Willing|3
1010729|NCT00367055|3305914|P2|Overall Study|Adverse Event|3
1010730|NCT00367055|3305915|P1|Overall Study|Adverse Event|6
1010731|NCT00366899|3305931|P2|Toddler Dose|Protocol Violation|0
1010732|NCT00366899|3305932|P1|Toddler Dose|Protocol Violation|1
1010733|NCT00366899|3305931|P2|Toddler Dose|Withdrawal by Subject|1
1010734|NCT00366899|3305932|P1|Toddler Dose|Withdrawal by Subject|1
1010735|NCT00366899|3305931|P2|After Infant Series|Protocol Violation|0
1010736|NCT00366899|3305932|P1|After Infant Series|Protocol Violation|1
1010737|NCT00366899|3305931|P2|After Infant Series|Adverse Event|2
1010738|NCT00366899|3305932|P1|After Infant Series|Adverse Event|1
1010739|NCT00366899|3305931|P2|After Infant Series|Withdrawal by Subject|4
1010740|NCT00366899|3305932|P1|After Infant Series|Withdrawal by Subject|1
1010741|NCT00366899|3305931|P2|After Infant Series|Lost to Follow-up|3
1010742|NCT00366899|3305932|P1|After Infant Series|Lost to Follow-up|4
1010743|NCT00366899|3305931|P2|Infant Series|Randomized but not consented|0
1010744|NCT00366899|3305932|P1|Infant Series|Randomized but not consented|1
1010745|NCT00366899|3305931|P2|Infant Series|Physician Decision|0
1010746|NCT00366899|3305932|P1|Infant Series|Physician Decision|1
1010747|NCT00366899|3305931|P2|Infant Series|Adverse Event|1
1010748|NCT00366899|3305932|P1|Infant Series|Adverse Event|0
1010749|NCT00366899|3305931|P2|Infant Series|Lost to Follow-up|2
1010750|NCT00366899|3305932|P1|Infant Series|Lost to Follow-up|0
1010751|NCT00366899|3305931|P2|Infant Series|Failed to return|1
1010752|NCT00366899|3305932|P1|Infant Series|Failed to return|1
1010753|NCT00366899|3305931|P2|Infant Series|Protocol Violation|1
1010754|NCT00366899|3305932|P1|Infant Series|Protocol Violation|2
1010755|NCT00366899|3305931|P2|Infant Series|Withdrawal by Subject|7
1010756|NCT00366899|3305932|P1|Infant Series|Withdrawal by Subject|4
1010757|NCT00366678|3305992|P3|Toddler Dose|protocol deviation|0
1010758|NCT00366678|3305993|P2|Toddler Dose|protocol deviation|0
1010759|NCT00366678|3305994|P1|Toddler Dose|protocol deviation|1
1010760|NCT00366678|3305992|P3|Toddler Dose|Withdrawal by Subject|0
1010761|NCT00366678|3305993|P2|Toddler Dose|Withdrawal by Subject|0
1010762|NCT00366678|3305994|P1|Toddler Dose|Withdrawal by Subject|1
1010763|NCT00366678|3305992|P3|Toddler Dose|Failed to return|0
1010764|NCT00366678|3305993|P2|Toddler Dose|Failed to return|0
1010765|NCT00366678|3305994|P1|Toddler Dose|Failed to return|1
1010766|NCT00366678|3305992|P3|Toddler Dose|Protocol Violation|0
1010767|NCT00366678|3305993|P2|Toddler Dose|Protocol Violation|1
1010768|NCT00366678|3305994|P1|Toddler Dose|Protocol Violation|2
1010769|NCT00366678|3305992|P3|After Infant|Protocol Violation|0
1010770|NCT00366678|3305993|P2|After Infant|Protocol Violation|0
1010771|NCT00366678|3305994|P1|After Infant|Protocol Violation|1
1010772|NCT00366678|3305992|P3|After Infant|Adverse Event|0
1010773|NCT00366678|3305993|P2|After Infant|Adverse Event|0
1010774|NCT00366678|3305994|P1|After Infant|Adverse Event|1
1010775|NCT00366678|3305992|P3|After Infant|Failed to return|0
1010776|NCT00366678|3305993|P2|After Infant|Failed to return|5
1010777|NCT00366678|3305994|P1|After Infant|Failed to return|5
1010778|NCT00366678|3305992|P3|After Infant|Lost to Follow-up|0
1010779|NCT00366678|3305993|P2|After Infant|Lost to Follow-up|1
1010780|NCT00366678|3305994|P1|After Infant|Lost to Follow-up|2
1010781|NCT00366678|3305992|P3|After Infant|Withdrawal by Subject|0
1010782|NCT00366678|3305993|P2|After Infant|Withdrawal by Subject|4
1010783|NCT00366678|3305994|P1|After Infant|Withdrawal by Subject|8
1010784|NCT00366678|3305992|P3|Infant Series|Adverse Event|0
1010785|NCT00366678|3305993|P2|Infant Series|Adverse Event|0
1010786|NCT00366678|3305994|P1|Infant Series|Adverse Event|1
1010787|NCT00366678|3305992|P3|Infant Series|Failed to return|0
1010788|NCT00366678|3305993|P2|Infant Series|Failed to return|1
1010789|NCT00366678|3305994|P1|Infant Series|Failed to return|1
1010790|NCT00366678|3305992|P3|Infant Series|Protocol Violation|0
1010791|NCT00366678|3305993|P2|Infant Series|Protocol Violation|3
1010792|NCT00366678|3305994|P1|Infant Series|Protocol Violation|4
1010793|NCT00366678|3305992|P3|Infant Series|Withdrawal by Subject|0
1010794|NCT00366678|3305993|P2|Infant Series|Withdrawal by Subject|6
1010795|NCT00366678|3305994|P1|Infant Series|Withdrawal by Subject|8
1010796|NCT00366548|3306076|P2|After Infant Series|Lost to Follow-up|0
1010797|NCT00366548|3306077|P1|After Infant Series|Lost to Follow-up|1
1010798|NCT00366548|3306076|P2|After Infant Series|Adverse Event|0
1010799|NCT00366548|3306077|P1|After Infant Series|Adverse Event|2
1010800|NCT00366548|3306076|P2|After Infant Series|Withdrawal by Subject|1
1010801|NCT00366548|3306077|P1|After Infant Series|Withdrawal by Subject|3
1010802|NCT00366548|3306076|P2|Infant Series|Withdrawal by Subject|1
1010803|NCT00366548|3306077|P1|Infant Series|Withdrawal by Subject|3
1010804|NCT00366548|3306076|P2|Infant Series|Protocol Violation|1
1010805|NCT00366548|3306077|P1|Infant Series|Protocol Violation|0
1010806|NCT00366548|3306076|P2|Infant Series|Adverse Event|3
1010807|NCT00366548|3306077|P1|Infant Series|Adverse Event|1
1010808|NCT00366535|3306113|P2|Second Phase: 12 Weeks|Withdrawal by Subject|2
1010809|NCT00366535|3306114|P1|Second Phase: 12 Weeks|Withdrawal by Subject|2
1010810|NCT00366535|3306113|P2|Second Phase: 12 Weeks|Adverse Event|1
1010811|NCT00366535|3306114|P1|Second Phase: 12 Weeks|Adverse Event|1
1010812|NCT00366535|3306113|P2|First Phase: 12 Weeks|Withdrawal by Subject|5
1010813|NCT00366535|3306114|P1|First Phase: 12 Weeks|Withdrawal by Subject|2
1010814|NCT00366535|3306113|P2|First Phase: 12 Weeks|Adverse Event|3
1010815|NCT00366535|3306114|P1|First Phase: 12 Weeks|Adverse Event|1
1010816|NCT00366457|3306128|P1|Overall Study|never began study therapy|2
1010817|NCT00366444|3306137|P2|Overall Study|Lack of Efficacy|1
1010818|NCT00366444|3306138|P1|Overall Study|Lack of Efficacy|0
1010819|NCT00366444|3306137|P2|Overall Study|Withdrawal by Subject|1
1010820|NCT00366444|3306138|P1|Overall Study|Withdrawal by Subject|1
1010821|NCT00366340|3306166|P2|Toddler Dose|Parent/legal guardian request|1
1010822|NCT00366340|3306167|P1|Toddler Dose|Parent/legal guardian request|0
1010823|NCT00366340|3306166|P2|Toddler Dose|Failed to return|0
1010824|NCT00366340|3306167|P1|Toddler Dose|Failed to return|1
1010825|NCT00366340|3306166|P2|After the Infant Series|Lost to Follow-up|1
1010826|NCT00366340|3306167|P1|After the Infant Series|Lost to Follow-up|0
1010827|NCT00366340|3306166|P2|After the Infant Series|Adverse Event|1
1010828|NCT00366340|3306167|P1|After the Infant Series|Adverse Event|0
1010829|NCT00366340|3306166|P2|After the Infant Series|Protocol Violation|2
1010830|NCT00366340|3306167|P1|After the Infant Series|Protocol Violation|2
1010831|NCT00366340|3306166|P2|After the Infant Series|Failed to return|1
1010832|NCT00366340|3306167|P1|After the Infant Series|Failed to return|0
1010833|NCT00366340|3306166|P2|After the Infant Series|Parent/legal guardian request|1
1010834|NCT00366340|3306167|P1|After the Infant Series|Parent/legal guardian request|1
1010835|NCT00366340|3306166|P2|Infant Series|Failure to return|0
1010836|NCT00366340|3306167|P1|Infant Series|Failure to return|1
1010837|NCT00366340|3306166|P2|Infant Series|Lost to Follow-up|1
1010838|NCT00366340|3306167|P1|Infant Series|Lost to Follow-up|1
1010839|NCT00366340|3306166|P2|Infant Series|Adverse Event|2
1010840|NCT00366340|3306167|P1|Infant Series|Adverse Event|0
1010841|NCT00366340|3306166|P2|Infant Series|Withdrawal by Subject|3
1010842|NCT00366340|3306167|P1|Infant Series|Withdrawal by Subject|3
1010843|NCT00366340|3306166|P2|Infant Series|Protocol Violation|4
1010844|NCT00366340|3306167|P1|Infant Series|Protocol Violation|3
1010845|NCT00366301|3306225|P4|Overall Study|Withdrawal by Subject|1
1010846|NCT00366301|3306226|P3|Overall Study|Withdrawal by Subject|1
1010847|NCT00366301|3306227|P2|Overall Study|Withdrawal by Subject|2
1010848|NCT00366301|3306228|P1|Overall Study|Withdrawal by Subject|4
1010849|NCT00366301|3306225|P4|Overall Study|Lost to Follow-up|7
1010850|NCT00366301|3306226|P3|Overall Study|Lost to Follow-up|3
1010851|NCT00366301|3306227|P2|Overall Study|Lost to Follow-up|4
1010852|NCT00366301|3306228|P1|Overall Study|Lost to Follow-up|4
1010853|NCT00366249|3306244|P2|Overall Study|Most due to osteomylitis status|20
1010854|NCT00366249|3306245|P1|Overall Study|Most due to osteomylitis status|31
1010855|NCT00366249|3306244|P2|Overall Study|Lack of Efficacy|21
1010856|NCT00366249|3306245|P1|Overall Study|Lack of Efficacy|21
1010857|NCT00366249|3306244|P2|Overall Study|Withdrawal by Subject|4
1010858|NCT00366249|3306245|P1|Overall Study|Withdrawal by Subject|18
1010859|NCT00366249|3306244|P2|Overall Study|Protocol Violation|2
1010860|NCT00366249|3306245|P1|Overall Study|Protocol Violation|1
1010861|NCT00366249|3306244|P2|Overall Study|Lost to Follow-up|0
1010862|NCT00366249|3306245|P1|Overall Study|Lost to Follow-up|2
1010863|NCT00366249|3306244|P2|Overall Study|Physician Decision|2
1010864|NCT00366249|3306245|P1|Overall Study|Physician Decision|5
1010865|NCT00366249|3306244|P2|Overall Study|Death|1
1010866|NCT00366249|3306245|P1|Overall Study|Death|0
1010867|NCT00366249|3306244|P2|Overall Study|Adverse Event|28
1010868|NCT00366249|3306245|P1|Overall Study|Adverse Event|53
1010869|NCT00365976|3306279|P2|Overall Study|Withdrawal by Subject|5
1010870|NCT00365976|3306280|P1|Overall Study|Withdrawal by Subject|1
1010871|NCT00365846|3306418|P1|Overall Study|Lost to Follow-up|1
1010872|NCT00365716|3306443|P7|Extension 2|Withdrawal by Subject|5
1010873|NCT00365716|3306444|P6|Extension 2|Withdrawal by Subject|0
1010874|NCT00365716|3306445|P5|Extension 2|Withdrawal by Subject|0
1010875|NCT00365716|3306446|P4|Extension 2|Withdrawal by Subject|0
1010876|NCT00365716|3306447|P3|Extension 2|Withdrawal by Subject|0
1010877|NCT00365716|3306448|P2|Extension 2|Withdrawal by Subject|0
1010878|NCT00365716|3306449|P1|Extension 2|Withdrawal by Subject|0
1010879|NCT00365716|3306443|P7|Extension 2|Other|3
1010880|NCT00365716|3306444|P6|Extension 2|Other|0
1010881|NCT00365716|3306445|P5|Extension 2|Other|0
1010882|NCT00365716|3306446|P4|Extension 2|Other|0
1010883|NCT00365716|3306447|P3|Extension 2|Other|0
1010884|NCT00365716|3306448|P2|Extension 2|Other|0
1010885|NCT00365716|3306449|P1|Extension 2|Other|0
1010886|NCT00365716|3306443|P7|Extension 2|Lost to Follow-up|2
1010887|NCT00365716|3306444|P6|Extension 2|Lost to Follow-up|0
1010888|NCT00365716|3306445|P5|Extension 2|Lost to Follow-up|0
1010889|NCT00365716|3306446|P4|Extension 2|Lost to Follow-up|0
1010890|NCT00365716|3306447|P3|Extension 2|Lost to Follow-up|0
1010891|NCT00365716|3306448|P2|Extension 2|Lost to Follow-up|0
1010892|NCT00365716|3306449|P1|Extension 2|Lost to Follow-up|0
1010893|NCT00365716|3306443|P7|Extension 1|Protocol Violation|0
1010894|NCT00365716|3306444|P6|Extension 1|Protocol Violation|1
1010895|NCT00365716|3306445|P5|Extension 1|Protocol Violation|0
1010896|NCT00365716|3306446|P4|Extension 1|Protocol Violation|0
1010897|NCT00365716|3306447|P3|Extension 1|Protocol Violation|0
1010898|NCT00365716|3306448|P2|Extension 1|Protocol Violation|0
1010899|NCT00365716|3306449|P1|Extension 1|Protocol Violation|0
1010900|NCT00365716|3306443|P7|Extension 1|Pregnancy|0
1010901|NCT00365716|3306444|P6|Extension 1|Pregnancy|4
1010902|NCT00365716|3306445|P5|Extension 1|Pregnancy|0
1010903|NCT00365716|3306446|P4|Extension 1|Pregnancy|0
1010904|NCT00365716|3306447|P3|Extension 1|Pregnancy|0
1010905|NCT00365716|3306448|P2|Extension 1|Pregnancy|0
1010906|NCT00365716|3306449|P1|Extension 1|Pregnancy|0
1010907|NCT00365716|3306443|P7|Extension 1|Withdrawal by Subject|0
1010908|NCT00365716|3306444|P6|Extension 1|Withdrawal by Subject|3
1010909|NCT00365716|3306445|P5|Extension 1|Withdrawal by Subject|0
1010910|NCT00365716|3306446|P4|Extension 1|Withdrawal by Subject|0
1010911|NCT00365716|3306447|P3|Extension 1|Withdrawal by Subject|0
1010912|NCT00365716|3306448|P2|Extension 1|Withdrawal by Subject|0
1010913|NCT00365716|3306449|P1|Extension 1|Withdrawal by Subject|0
1010914|NCT00365716|3306443|P7|Extension 1|Moved|0
1010915|NCT00365716|3306444|P6|Extension 1|Moved|4
1010916|NCT00365716|3306445|P5|Extension 1|Moved|0
1010917|NCT00365716|3306446|P4|Extension 1|Moved|0
1010918|NCT00365716|3306447|P3|Extension 1|Moved|0
1010919|NCT00365716|3306448|P2|Extension 1|Moved|0
1010920|NCT00365716|3306449|P1|Extension 1|Moved|0
1010921|NCT00365716|3306443|P7|Extension 1|Other|0
1010922|NCT00365716|3306444|P6|Extension 1|Other|9
1010923|NCT00365716|3306445|P5|Extension 1|Other|0
1010924|NCT00365716|3306446|P4|Extension 1|Other|0
1010925|NCT00365716|3306447|P3|Extension 1|Other|0
1010926|NCT00365716|3306448|P2|Extension 1|Other|0
1010927|NCT00365716|3306449|P1|Extension 1|Other|0
1010928|NCT00365716|3306443|P7|Extension 1|Lost to Follow-up|0
1010929|NCT00365716|3306444|P6|Extension 1|Lost to Follow-up|1
1010930|NCT00365716|3306445|P5|Extension 1|Lost to Follow-up|0
1010931|NCT00365716|3306446|P4|Extension 1|Lost to Follow-up|0
1010932|NCT00365716|3306447|P3|Extension 1|Lost to Follow-up|0
1010933|NCT00365716|3306448|P2|Extension 1|Lost to Follow-up|0
1010934|NCT00365716|3306449|P1|Extension 1|Lost to Follow-up|0
1010935|NCT00365716|3306443|P7|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
1010936|NCT00365716|3306444|P6|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
1010937|NCT00365716|3306445|P5|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3
1010938|NCT00365716|3306446|P4|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
1010939|NCT00365716|3306447|P3|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13
1010940|NCT00365716|3306448|P2|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
1010941|NCT00365716|3306449|P1|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7
1010942|NCT00365716|3306443|P7|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
1010943|NCT00365716|3306444|P6|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
1010944|NCT00365716|3306445|P5|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
1010945|NCT00365716|3306446|P4|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
1010946|NCT00365716|3306447|P3|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
1010947|NCT00365716|3306448|P2|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
1010948|NCT00365716|3306449|P1|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
1010949|NCT00365716|3306443|P7|Long Term Follow-up (Month 7 toMonth 36)|Other|0
1010950|NCT00365716|3306444|P6|Long Term Follow-up (Month 7 toMonth 36)|Other|0
1010951|NCT00365716|3306445|P5|Long Term Follow-up (Month 7 toMonth 36)|Other|1
1010952|NCT00365716|3306446|P4|Long Term Follow-up (Month 7 toMonth 36)|Other|0
1010953|NCT00365716|3306447|P3|Long Term Follow-up (Month 7 toMonth 36)|Other|0
1010954|NCT00365716|3306448|P2|Long Term Follow-up (Month 7 toMonth 36)|Other|0
1010955|NCT00365716|3306449|P1|Long Term Follow-up (Month 7 toMonth 36)|Other|2
1010956|NCT00365716|3306443|P7|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
1010957|NCT00365716|3306444|P6|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
1010958|NCT00365716|3306445|P5|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
1010959|NCT00365716|3306446|P4|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
1010960|NCT00365716|3306447|P3|Long Term Follow-up (Month 7 toMonth 36)|Moved|1
1010961|NCT00365716|3306448|P2|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
1010962|NCT00365716|3306449|P1|Long Term Follow-up (Month 7 toMonth 36)|Moved|3
1010963|NCT00365716|3306443|P7|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
1010964|NCT00365716|3306444|P6|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
1010965|NCT00365716|3306445|P5|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3
1010966|NCT00365716|3306446|P4|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4
1010967|NCT00365716|3306447|P3|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5
1010968|NCT00365716|3306448|P2|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8
1010969|NCT00365716|3306449|P1|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6
1010970|NCT00365716|3306443|P7|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
1010971|NCT00365716|3306444|P6|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
1010972|NCT00365716|3306445|P5|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75
1010973|NCT00365716|3306446|P4|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69
1010974|NCT00365716|3306447|P3|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
1010975|NCT00365716|3306448|P2|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
1010976|NCT00365716|3306449|P1|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114
1010977|NCT00365716|3306443|P7|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
1010978|NCT00365716|3306444|P6|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
1010979|NCT00365716|3306445|P5|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3
1010980|NCT00365716|3306446|P4|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4
1010981|NCT00365716|3306447|P3|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
1010982|NCT00365716|3306448|P2|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9
1010983|NCT00365716|3306449|P1|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
1010984|NCT00365716|3306443|P7|Base Study (Day 1 to Month 7)|Protocol Violation|0
1010985|NCT00365716|3306444|P6|Base Study (Day 1 to Month 7)|Protocol Violation|0
1010986|NCT00365716|3306445|P5|Base Study (Day 1 to Month 7)|Protocol Violation|2
1010987|NCT00365716|3306446|P4|Base Study (Day 1 to Month 7)|Protocol Violation|1
1010988|NCT00365716|3306447|P3|Base Study (Day 1 to Month 7)|Protocol Violation|0
1010989|NCT00365716|3306448|P2|Base Study (Day 1 to Month 7)|Protocol Violation|2
1010990|NCT00365716|3306449|P1|Base Study (Day 1 to Month 7)|Protocol Violation|1
1010991|NCT00365716|3306443|P7|Base Study (Day 1 to Month 7)|Pregnancy|0
1010992|NCT00365716|3306444|P6|Base Study (Day 1 to Month 7)|Pregnancy|0
1010993|NCT00365716|3306445|P5|Base Study (Day 1 to Month 7)|Pregnancy|1
1010994|NCT00365716|3306446|P4|Base Study (Day 1 to Month 7)|Pregnancy|1
1010995|NCT00365716|3306447|P3|Base Study (Day 1 to Month 7)|Pregnancy|3
1010996|NCT00365716|3306448|P2|Base Study (Day 1 to Month 7)|Pregnancy|2
1010997|NCT00365716|3306449|P1|Base Study (Day 1 to Month 7)|Pregnancy|3
1010998|NCT00365716|3306443|P7|Base Study (Day 1 to Month 7)|Other|0
1010999|NCT00365716|3306444|P6|Base Study (Day 1 to Month 7)|Other|0
1011000|NCT00365716|3306445|P5|Base Study (Day 1 to Month 7)|Other|0
1011001|NCT00365716|3306446|P4|Base Study (Day 1 to Month 7)|Other|0
1011002|NCT00365716|3306447|P3|Base Study (Day 1 to Month 7)|Other|0
1011003|NCT00365716|3306448|P2|Base Study (Day 1 to Month 7)|Other|1
1011004|NCT00365716|3306449|P1|Base Study (Day 1 to Month 7)|Other|0
1011005|NCT00365716|3306443|P7|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
1011006|NCT00365716|3306444|P6|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
1011007|NCT00365716|3306445|P5|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
1011008|NCT00365716|3306446|P4|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
1011009|NCT00365716|3306447|P3|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
1011010|NCT00365716|3306448|P2|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
1011011|NCT00365716|3306449|P1|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
1011012|NCT00365716|3306443|P7|Base Study (Day 1 to Month 7)|Adverse Event|0
1011013|NCT00365716|3306444|P6|Base Study (Day 1 to Month 7)|Adverse Event|0
1011014|NCT00365716|3306445|P5|Base Study (Day 1 to Month 7)|Adverse Event|1
1011015|NCT00365716|3306446|P4|Base Study (Day 1 to Month 7)|Adverse Event|0
1011016|NCT00365716|3306447|P3|Base Study (Day 1 to Month 7)|Adverse Event|0
1011017|NCT00365716|3306448|P2|Base Study (Day 1 to Month 7)|Adverse Event|2
1011018|NCT00365716|3306449|P1|Base Study (Day 1 to Month 7)|Adverse Event|0
1011019|NCT00365716|3306443|P7|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
1011020|NCT00365716|3306444|P6|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
1011021|NCT00365716|3306445|P5|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
1011022|NCT00365716|3306446|P4|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
1011023|NCT00365716|3306447|P3|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
1011024|NCT00365716|3306448|P2|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2
1011025|NCT00365716|3306449|P1|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1
1011026|NCT00365547|3306470|P1|Overall Study|Withdrawal by Subject|1
1011027|NCT00365547|3306470|P1|Overall Study|Screen failure|1
1011028|NCT00365547|3306470|P1|Overall Study|Insurance did not cover Avastin|1
1011029|NCT00365508|3306480|P2|Overall Study|Lost to Follow-up|154
1011030|NCT00365508|3306481|P1|Overall Study|Lost to Follow-up|139
1011031|NCT00365456|3306489|P2|Trial Period III (12 Months)|Other|1
1011032|NCT00365456|3306490|P1|Trial Period III (12 Months)|Other|1
1011033|NCT00365456|3306489|P2|Trial Period III (12 Months)|Withdrawal by Subject|1
1011034|NCT00365456|3306490|P1|Trial Period III (12 Months)|Withdrawal by Subject|4
1011035|NCT00365456|3306489|P2|Trial Period III (12 Months)|Adverse Event|3
1011036|NCT00365456|3306490|P1|Trial Period III (12 Months)|Adverse Event|13
1011037|NCT00365456|3306489|P2|Trial Period II (12 Months)|Other|1
1011038|NCT00365456|3306490|P1|Trial Period II (12 Months)|Other|0
1011039|NCT00365456|3306489|P2|Trial Period II (12 Months)|Withdrawal by Subject|5
1011040|NCT00365456|3306490|P1|Trial Period II (12 Months)|Withdrawal by Subject|0
1011041|NCT00365456|3306489|P2|Trial Period II (12 Months)|Non-compliance|2
1011042|NCT00365456|3306490|P1|Trial Period II (12 Months)|Non-compliance|0
1011043|NCT00365456|3306489|P2|Trial Period II (12 Months)|Adverse Event|6
1011044|NCT00365456|3306490|P1|Trial Period II (12 Months)|Adverse Event|0
1011045|NCT00365456|3306489|P2|Trial Period I (12 Months)|Other|0
1011046|NCT00365456|3306490|P1|Trial Period I (12 Months)|Other|11
1011047|NCT00365456|3306489|P2|Trial Period I (12 Months)|Withdrawal by Subject|0
1011048|NCT00365456|3306490|P1|Trial Period I (12 Months)|Withdrawal by Subject|27
1011049|NCT00365456|3306489|P2|Trial Period I (12 Months)|Non-compliance|0
1011050|NCT00365456|3306490|P1|Trial Period I (12 Months)|Non-compliance|3
1011051|NCT00365456|3306489|P2|Trial Period I (12 Months)|Adverse Event|0
1011052|NCT00365456|3306490|P1|Trial Period I (12 Months)|Adverse Event|84
1011053|NCT00365378|3306512|P3|Extension|Other|31
1011054|NCT00365378|3306513|P2|Extension|Other|0
1011055|NCT00365378|3306514|P1|Extension|Other|0
1011056|NCT00365378|3306512|P3|Extension|Withdrawal by Subject|98
1011057|NCT00365378|3306513|P2|Extension|Withdrawal by Subject|0
1011058|NCT00365378|3306514|P1|Extension|Withdrawal by Subject|0
1011059|NCT00365378|3306512|P3|Extension|Protocol Violation|2
1011060|NCT00365378|3306513|P2|Extension|Protocol Violation|0
1011061|NCT00365378|3306514|P1|Extension|Protocol Violation|0
1011062|NCT00365378|3306512|P3|Extension|Lost to Follow-up|57
1011063|NCT00365378|3306513|P2|Extension|Lost to Follow-up|0
1011064|NCT00365378|3306514|P1|Extension|Lost to Follow-up|0
1011065|NCT00365378|3306512|P3|Extension|Moved|8
1011066|NCT00365378|3306513|P2|Extension|Moved|0
1011067|NCT00365378|3306514|P1|Extension|Moved|0
1011068|NCT00365378|3306512|P3|Extension|Adverse Event|1
1011069|NCT00365378|3306513|P2|Extension|Adverse Event|0
1011070|NCT00365378|3306514|P1|Extension|Adverse Event|0
1011071|NCT00365378|3306512|P3|Follow-up (Month 7 Though Month 48)|Other|0
1011072|NCT00365378|3306513|P2|Follow-up (Month 7 Though Month 48)|Other|21
1011073|NCT00365378|3306514|P1|Follow-up (Month 7 Though Month 48)|Other|11
1011074|NCT00365378|3306512|P3|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0
1011075|NCT00365378|3306513|P2|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104
1011076|NCT00365378|3306514|P1|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73
1011077|NCT00365378|3306512|P3|Follow-up (Month 7 Though Month 48)|Protocol Violation|0
1011078|NCT00365378|3306513|P2|Follow-up (Month 7 Though Month 48)|Protocol Violation|2
1011079|NCT00365378|3306514|P1|Follow-up (Month 7 Though Month 48)|Protocol Violation|1
1011080|NCT00365378|3306512|P3|Follow-up (Month 7 Though Month 48)|Pregnancy|0
1011081|NCT00365378|3306513|P2|Follow-up (Month 7 Though Month 48)|Pregnancy|1
1011082|NCT00365378|3306514|P1|Follow-up (Month 7 Though Month 48)|Pregnancy|0
1011083|NCT00365378|3306512|P3|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0
1011084|NCT00365378|3306513|P2|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69
1011085|NCT00365378|3306514|P1|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67
1011086|NCT00365378|3306512|P3|Follow-up (Month 7 Though Month 48)|Moved|0
1011087|NCT00365378|3306513|P2|Follow-up (Month 7 Though Month 48)|Moved|5
1011088|NCT00365378|3306514|P1|Follow-up (Month 7 Though Month 48)|Moved|6
1011089|NCT00365378|3306512|P3|Vaccination (Day 1 to Month 7)|Other|0
1011090|NCT00365378|3306513|P2|Vaccination (Day 1 to Month 7)|Other|9
1011091|NCT00365378|3306514|P1|Vaccination (Day 1 to Month 7)|Other|17
1011092|NCT00365378|3306512|P3|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0
1011093|NCT00365378|3306513|P2|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44
1011094|NCT00365378|3306514|P1|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50
1011095|NCT00365378|3306512|P3|Vaccination (Day 1 to Month 7)|Protocol Violation|0
1011096|NCT00365378|3306513|P2|Vaccination (Day 1 to Month 7)|Protocol Violation|13
1011097|NCT00365378|3306514|P1|Vaccination (Day 1 to Month 7)|Protocol Violation|22
1011098|NCT00365378|3306512|P3|Vaccination (Day 1 to Month 7)|Pregnancy|0
1011099|NCT00365378|3306513|P2|Vaccination (Day 1 to Month 7)|Pregnancy|14
1011100|NCT00365378|3306514|P1|Vaccination (Day 1 to Month 7)|Pregnancy|19
1011101|NCT00365378|3306512|P3|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0
1011102|NCT00365378|3306513|P2|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75
1011103|NCT00365378|3306514|P1|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88
1011104|NCT00365378|3306512|P3|Vaccination (Day 1 to Month 7)|Adverse Event|0
1011105|NCT00365378|3306513|P2|Vaccination (Day 1 to Month 7)|Adverse Event|5
1011106|NCT00365378|3306514|P1|Vaccination (Day 1 to Month 7)|Adverse Event|4
1011107|NCT00365378|3306512|P3|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0
1011108|NCT00365378|3306513|P2|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7
1011109|NCT00365378|3306514|P1|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11
1011110|NCT00365365|3306528|P3|Overall Study|Patient/physician decision|1
1011111|NCT00365365|3306529|P2|Overall Study|Patient/physician decision|0
1011112|NCT00365365|3306530|P1|Overall Study|Patient/physician decision|0
1011113|NCT00365365|3306528|P3|Overall Study|Second malignancy|0
1011114|NCT00365365|3306529|P2|Overall Study|Second malignancy|1
1011115|NCT00365365|3306530|P1|Overall Study|Second malignancy|0
1011116|NCT00365365|3306528|P3|Overall Study|Withdrew consent|0
1011117|NCT00365365|3306529|P2|Overall Study|Withdrew consent|1
1011118|NCT00365365|3306530|P1|Overall Study|Withdrew consent|1
1011119|NCT00365365|3306528|P3|Overall Study|New cancer|0
1011120|NCT00365365|3306529|P2|Overall Study|New cancer|0
1011121|NCT00365365|3306530|P1|Overall Study|New cancer|1
1011122|NCT00365365|3306528|P3|Overall Study|Moved|0
1011123|NCT00365365|3306529|P2|Overall Study|Moved|0
1011124|NCT00365365|3306530|P1|Overall Study|Moved|2
1011125|NCT00365365|3306528|P3|Overall Study|Adverse Event|3
1011126|NCT00365365|3306529|P2|Overall Study|Adverse Event|6
1011127|NCT00365365|3306530|P1|Overall Study|Adverse Event|6
1011128|NCT00365365|3306528|P3|Overall Study|Disease progression/relapse|7
1011129|NCT00365365|3306529|P2|Overall Study|Disease progression/relapse|6
1011130|NCT00365365|3306530|P1|Overall Study|Disease progression/relapse|9
1011131|NCT00365365|3306528|P3|Overall Study|Subject's request|1
1011132|NCT00365365|3306529|P2|Overall Study|Subject's request|13
1011133|NCT00365365|3306530|P1|Overall Study|Subject's request|11
1011134|NCT00365365|3306528|P3|Overall Study|Death|0
1011135|NCT00365365|3306529|P2|Overall Study|Death|3
1011136|NCT00365365|3306530|P1|Overall Study|Death|1
1011137|NCT00365365|3306528|P3|Overall Study|Lost to Follow-up|3
1011138|NCT00365365|3306529|P2|Overall Study|Lost to Follow-up|3
1011139|NCT00365365|3306530|P1|Overall Study|Lost to Follow-up|3
1011140|NCT00365365|3306528|P3|Overall Study|Poor compliance to protocol|0
1011141|NCT00365365|3306529|P2|Overall Study|Poor compliance to protocol|1
1011142|NCT00365365|3306530|P1|Overall Study|Poor compliance to protocol|0
1011143|NCT00365365|3306528|P3|Overall Study|Randomized but not treated|0
1011144|NCT00365365|3306529|P2|Overall Study|Randomized but not treated|2
1011145|NCT00365365|3306530|P1|Overall Study|Randomized but not treated|0
1011146|NCT00365352|3306547|P3|Overall Study|Withdrawal of Participant by Sponsor|0
1011147|NCT00365352|3306548|P2|Overall Study|Withdrawal of Participant by Sponsor|0
1011148|NCT00365352|3306549|P1|Overall Study|Withdrawal of Participant by Sponsor|1
1011149|NCT00365352|3306547|P3|Overall Study|Lost to Follow-up|0
1011150|NCT00365352|3306548|P2|Overall Study|Lost to Follow-up|1
1011151|NCT00365352|3306549|P1|Overall Study|Lost to Follow-up|1
1011152|NCT00365352|3306547|P3|Overall Study|Non-Compliance (after Randomization)|1
1011153|NCT00365352|3306548|P2|Overall Study|Non-Compliance (after Randomization)|0
1011154|NCT00365352|3306549|P1|Overall Study|Non-Compliance (after Randomization)|1
1011155|NCT00365352|3306547|P3|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2
1011156|NCT00365352|3306548|P2|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
1011157|NCT00365352|3306549|P1|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
1011158|NCT00365352|3306547|P3|Overall Study|Lack of Efficacy|0
1011159|NCT00365352|3306548|P2|Overall Study|Lack of Efficacy|0
1011160|NCT00365352|3306549|P1|Overall Study|Lack of Efficacy|3
1011161|NCT00365352|3306547|P3|Overall Study|Participant Withdrew Consent|4
1011162|NCT00365352|3306548|P2|Overall Study|Participant Withdrew Consent|3
1011163|NCT00365352|3306549|P1|Overall Study|Participant Withdrew Consent|8
1011164|NCT00365352|3306547|P3|Overall Study|Adverse Event|8
1011165|NCT00365352|3306548|P2|Overall Study|Adverse Event|7
1011166|NCT00365352|3306549|P1|Overall Study|Adverse Event|6
1011167|NCT00365300|3306633|P2|Double-blind Phase|Lack of Efficacy|6
1011168|NCT00365300|3306634|P1|Double-blind Phase|Lack of Efficacy|6
1011169|NCT00365300|3306633|P2|Double-blind Phase|Protocol Violation|1
1011170|NCT00365300|3306634|P1|Double-blind Phase|Protocol Violation|3
1011171|NCT00365300|3306633|P2|Double-blind Phase|Withdrawal by Subject|1
1011172|NCT00365300|3306634|P1|Double-blind Phase|Withdrawal by Subject|0
1011173|NCT00365300|3306633|P2|Double-blind Phase|Noncompliance|1
1011174|NCT00365300|3306634|P1|Double-blind Phase|Noncompliance|1
1011175|NCT00365300|3306633|P2|Double-blind Phase|Failed to return|0
1011176|NCT00365300|3306634|P1|Double-blind Phase|Failed to return|1
1011177|NCT00365300|3306633|P2|Open-label Phase|Patient skipped open label phase|0
1011178|NCT00365300|3306634|P1|Open-label Phase|Patient skipped open label phase|1
1011179|NCT00365300|3306633|P2|Open-label Phase|Lack of Efficacy|0
1011180|NCT00365300|3306634|P1|Open-label Phase|Lack of Efficacy|1
1011181|NCT00365300|3306633|P2|Open-label Phase|Protocol Violation|0
1011182|NCT00365300|3306634|P1|Open-label Phase|Protocol Violation|1
1011183|NCT00365300|3306633|P2|Open-label Phase|Parent/Legal Guardian Request|0
1011184|NCT00365300|3306634|P1|Open-label Phase|Parent/Legal Guardian Request|4
1011185|NCT00365300|3306633|P2|Open-label Phase|Noncompliance|0
1011186|NCT00365300|3306634|P1|Open-label Phase|Noncompliance|9
1011187|NCT00365300|3306633|P2|Open-label Phase|Physician Decision|0
1011188|NCT00365300|3306634|P1|Open-label Phase|Physician Decision|1
1011189|NCT00365300|3306633|P2|Open-label Phase|Failed to Return|0
1011190|NCT00365300|3306634|P1|Open-label Phase|Failed to Return|1
1011191|NCT00365300|3306633|P2|Open-label Phase|Adverse Event|0
1011192|NCT00365300|3306634|P1|Open-label Phase|Adverse Event|4
1011193|NCT00365105|3306699|P2|Overall Study|Lost to Follow-up|0
1011194|NCT00365105|3306700|P1|Overall Study|Lost to Follow-up|1
1011195|NCT00365105|3306699|P2|Overall Study|Withdrawal by Subject|1
1011196|NCT00365105|3306700|P1|Overall Study|Withdrawal by Subject|1
1011197|NCT00365105|3306699|P2|Overall Study|Protocol Violation|3
1011198|NCT00365105|3306700|P1|Overall Study|Protocol Violation|4
1011199|NCT00364923|3306736|P1|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24
1011200|NCT00364923|3306736|P1|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4
1011201|NCT00364858|3306745|P2|Overall Study|Clinical baseline issue|1
1011202|NCT00364858|3306746|P1|Overall Study|Clinical baseline issue|0
1011203|NCT00364858|3306745|P2|Overall Study|Return to Q2 regimen|1
1011204|NCT00364858|3306746|P1|Overall Study|Return to Q2 regimen|0
1011205|NCT00364858|3306745|P2|Overall Study|Non-compliant|0
1011206|NCT00364858|3306746|P1|Overall Study|Non-compliant|1
1011207|NCT00364858|3306745|P2|Overall Study|Discontinuation at baseline|0
1011208|NCT00364858|3306746|P1|Overall Study|Discontinuation at baseline|1
1011209|NCT00364858|3306745|P2|Overall Study|Clinical failure|13
1011210|NCT00364858|3306746|P1|Overall Study|Clinical failure|2
1011211|NCT00364858|3306745|P2|Overall Study|Pregnancy|1
1011212|NCT00364858|3306746|P1|Overall Study|Pregnancy|1
1011213|NCT00364858|3306745|P2|Overall Study|Withdrawal by Subject|1
1011214|NCT00364858|3306746|P1|Overall Study|Withdrawal by Subject|1
1011215|NCT00364858|3306745|P2|Overall Study|Adverse Event|5
1011216|NCT00364858|3306746|P1|Overall Study|Adverse Event|1
1011217|NCT00364845|3306761|P2|Overall Study|Death|1
1011218|NCT00364845|3306762|P1|Overall Study|Death|0
1011219|NCT00364845|3306761|P2|Overall Study|Lost to Follow-up|1
1011220|NCT00364845|3306762|P1|Overall Study|Lost to Follow-up|0
1011221|NCT00364845|3306761|P2|Overall Study|Physician Decision|8
1011222|NCT00364845|3306762|P1|Overall Study|Physician Decision|8
1011223|NCT00364845|3306761|P2|Overall Study|Withdrawal by Subject|1
1011224|NCT00364845|3306762|P1|Overall Study|Withdrawal by Subject|2
1011225|NCT00364845|3306761|P2|Overall Study|Adverse Event|0
1011226|NCT00364845|3306762|P1|Overall Study|Adverse Event|1
1011227|NCT00364832|3306783|P12|Extension Year 2|Early Withdrawals|3
1011228|NCT00364832|3306784|P11|Extension Year 2|Early Withdrawals|5
1011229|NCT00364832|3306785|P10|Extension Year 2|Early Withdrawals|5
1011230|NCT00364832|3306786|P9|Extension Year 2|Early Withdrawals|0
1011231|NCT00364832|3306787|P8|Extension Year 2|Early Withdrawals|0
1011232|NCT00364832|3306788|P7|Extension Year 2|Early Withdrawals|0
1011233|NCT00364832|3306789|P6|Extension Year 2|Early Withdrawals|0
1011234|NCT00364832|3306790|P5|Extension Year 2|Early Withdrawals|0
1011235|NCT00364832|3306791|P4|Extension Year 2|Early Withdrawals|0
1011236|NCT00364832|3306792|P3|Extension Year 2|Early Withdrawals|0
1011237|NCT00364832|3306793|P2|Extension Year 2|Early Withdrawals|0
1011238|NCT00364832|3306794|P1|Extension Year 2|Early Withdrawals|0
1011239|NCT00364832|3306783|P12|Extension Year 1|Early Withdrawals|10
1011240|NCT00364832|3306784|P11|Extension Year 1|Early Withdrawals|2
1011241|NCT00364832|3306785|P10|Extension Year 1|Early Withdrawals|4
1011242|NCT00364832|3306786|P9|Extension Year 1|Early Withdrawals|0
1011243|NCT00364832|3306787|P8|Extension Year 1|Early Withdrawals|0
1011244|NCT00364832|3306788|P7|Extension Year 1|Early Withdrawals|0
1011245|NCT00364832|3306789|P6|Extension Year 1|Early Withdrawals|0
1011246|NCT00364832|3306790|P5|Extension Year 1|Early Withdrawals|0
1011247|NCT00364832|3306791|P4|Extension Year 1|Early Withdrawals|0
1011248|NCT00364832|3306792|P3|Extension Year 1|Early Withdrawals|0
1011249|NCT00364832|3306793|P2|Extension Year 1|Early Withdrawals|0
1011250|NCT00364832|3306794|P1|Extension Year 1|Early Withdrawals|0
1011251|NCT00364832|3306783|P12|Core Period|Early Withdrawals|0
1011252|NCT00364832|3306784|P11|Core Period|Early Withdrawals|0
1011253|NCT00364832|3306785|P10|Core Period|Early Withdrawals|0
1011254|NCT00364832|3306786|P9|Core Period|Early Withdrawals|0
1011255|NCT00364832|3306787|P8|Core Period|Early Withdrawals|1
1011256|NCT00364832|3306788|P7|Core Period|Early Withdrawals|4
1011257|NCT00364832|3306789|P6|Core Period|Early Withdrawals|0
1011258|NCT00364832|3306790|P5|Core Period|Early Withdrawals|0
1011259|NCT00364832|3306791|P4|Core Period|Early Withdrawals|1
1011260|NCT00364832|3306792|P3|Core Period|Early Withdrawals|1
1011261|NCT00364832|3306793|P2|Core Period|Early Withdrawals|2
1011262|NCT00364832|3306794|P1|Core Period|Early Withdrawals|2
1011263|NCT00364793|3306859|P4|Overall Study|Withdrawal by Subject|0
1011264|NCT00364793|3306860|P3|Overall Study|Withdrawal by Subject|0
1011265|NCT00364793|3306861|P2|Overall Study|Withdrawal by Subject|1
1011266|NCT00364793|3306862|P1|Overall Study|Withdrawal by Subject|0
1011267|NCT00364793|3306859|P4|Overall Study|No longer meets criteria|1
1011268|NCT00364793|3306860|P3|Overall Study|No longer meets criteria|0
1011269|NCT00364793|3306861|P2|Overall Study|No longer meets criteria|0
1011270|NCT00364793|3306862|P1|Overall Study|No longer meets criteria|0
1011271|NCT00364793|3306859|P4|Overall Study|Poor or non-compliance|1
1011272|NCT00364793|3306860|P3|Overall Study|Poor or non-compliance|0
1011273|NCT00364793|3306861|P2|Overall Study|Poor or non-compliance|1
1011274|NCT00364793|3306862|P1|Overall Study|Poor or non-compliance|1
1011275|NCT00364793|3306859|P4|Overall Study|Lost to Follow-up|0
1011276|NCT00364793|3306860|P3|Overall Study|Lost to Follow-up|2
1011277|NCT00364793|3306861|P2|Overall Study|Lost to Follow-up|0
1011278|NCT00364793|3306862|P1|Overall Study|Lost to Follow-up|1
1011279|NCT00364793|3306859|P4|Overall Study|Lack of Efficacy|1
1011280|NCT00364793|3306860|P3|Overall Study|Lack of Efficacy|1
1011281|NCT00364793|3306861|P2|Overall Study|Lack of Efficacy|3
1011282|NCT00364793|3306862|P1|Overall Study|Lack of Efficacy|3
1011283|NCT00364793|3306859|P4|Overall Study|Death|0
1011284|NCT00364793|3306860|P3|Overall Study|Death|1
1011285|NCT00364793|3306861|P2|Overall Study|Death|0
1011286|NCT00364793|3306862|P1|Overall Study|Death|1
1011287|NCT00364793|3306859|P4|Overall Study|Adverse Event|0
1011288|NCT00364793|3306860|P3|Overall Study|Adverse Event|0
1011289|NCT00364793|3306861|P2|Overall Study|Adverse Event|0
1011290|NCT00364793|3306862|P1|Overall Study|Adverse Event|2
1011291|NCT00364611|3306998|P2|Overall Study|Receiving Liver Ablation|1
1011292|NCT00364611|3306999|P1|Overall Study|Receiving Liver Ablation|0
1011293|NCT00364611|3306998|P2|Overall Study|Presumed CR on Study|1
1011294|NCT00364611|3306999|P1|Overall Study|Presumed CR on Study|0
1011295|NCT00364611|3306998|P2|Overall Study|Found Ineligible|0
1011296|NCT00364611|3306999|P1|Overall Study|Found Ineligible|1
1011297|NCT00364611|3306998|P2|Overall Study|Investigator decision|2
1011298|NCT00364611|3306999|P1|Overall Study|Investigator decision|2
1011299|NCT00364611|3306998|P2|Overall Study|Disease Progression|8
1011300|NCT00364611|3306999|P1|Overall Study|Disease Progression|38
1011301|NCT00364611|3306998|P2|Overall Study|Participant's Request|4
1011302|NCT00364611|3306999|P1|Overall Study|Participant's Request|3
1011303|NCT00364611|3306998|P2|Overall Study|Adverse Event|4
1011304|NCT00364611|3306999|P1|Overall Study|Adverse Event|7
1011305|NCT00364611|3306998|P2|Overall Study|Did not receive study medication|1
1011306|NCT00364611|3306999|P1|Overall Study|Did not receive study medication|0
1011307|NCT00364533|3307022|P5|Overall Study|Protocol Violation|0
1011308|NCT00364533|3307023|P4|Overall Study|Protocol Violation|0
1011309|NCT00364533|3307024|P3|Overall Study|Protocol Violation|0
1011310|NCT00364533|3307025|P2|Overall Study|Protocol Violation|1
1011311|NCT00364533|3307026|P1|Overall Study|Protocol Violation|1
1011312|NCT00364533|3307022|P5|Overall Study|Non-compliance|0
1011313|NCT00364533|3307023|P4|Overall Study|Non-compliance|0
1011314|NCT00364533|3307024|P3|Overall Study|Non-compliance|0
1011315|NCT00364533|3307025|P2|Overall Study|Non-compliance|0
1011316|NCT00364533|3307026|P1|Overall Study|Non-compliance|1
1011317|NCT00364533|3307022|P5|Overall Study|Variations in drug compliance|0
1011318|NCT00364533|3307023|P4|Overall Study|Variations in drug compliance|0
1011319|NCT00364533|3307024|P3|Overall Study|Variations in drug compliance|1
1011320|NCT00364533|3307025|P2|Overall Study|Variations in drug compliance|1
1011321|NCT00364533|3307026|P1|Overall Study|Variations in drug compliance|2
1011322|NCT00364533|3307022|P5|Overall Study|Subject discharged from hospital|1
1011323|NCT00364533|3307023|P4|Overall Study|Subject discharged from hospital|3
1011324|NCT00364533|3307024|P3|Overall Study|Subject discharged from hospital|2
1011325|NCT00364533|3307025|P2|Overall Study|Subject discharged from hospital|1
1011326|NCT00364533|3307026|P1|Overall Study|Subject discharged from hospital|4
1011327|NCT00364533|3307022|P5|Overall Study|Lack of Efficacy|42
1011328|NCT00364533|3307023|P4|Overall Study|Lack of Efficacy|17
1011329|NCT00364533|3307024|P3|Overall Study|Lack of Efficacy|21
1011330|NCT00364533|3307025|P2|Overall Study|Lack of Efficacy|22
1011331|NCT00364533|3307026|P1|Overall Study|Lack of Efficacy|22
1011332|NCT00364533|3307022|P5|Overall Study|Withdrawal by Subject|6
1011333|NCT00364533|3307023|P4|Overall Study|Withdrawal by Subject|6
1011334|NCT00364533|3307024|P3|Overall Study|Withdrawal by Subject|6
1011335|NCT00364533|3307025|P2|Overall Study|Withdrawal by Subject|8
1011336|NCT00364533|3307026|P1|Overall Study|Withdrawal by Subject|4
1011337|NCT00364533|3307022|P5|Overall Study|Adverse Event|2
1011338|NCT00364533|3307023|P4|Overall Study|Adverse Event|5
1011339|NCT00364533|3307024|P3|Overall Study|Adverse Event|15
1011340|NCT00364533|3307025|P2|Overall Study|Adverse Event|7
1011341|NCT00364533|3307026|P1|Overall Study|Adverse Event|8
1011342|NCT00364351|3307059|P2|Overall Study|Randomised treatment not started|3
1011343|NCT00364351|3307060|P1|Overall Study|Randomised treatment not started|0
1011344|NCT00364351|3307059|P2|Overall Study|Patient could not travel to site|1
1011345|NCT00364351|3307060|P1|Overall Study|Patient could not travel to site|0
1011346|NCT00364351|3307059|P2|Overall Study|Investigator error|2
1011347|NCT00364351|3307060|P1|Overall Study|Investigator error|0
1011348|NCT00364351|3307059|P2|Overall Study|Poor treatment compliance|3
1011349|NCT00364351|3307060|P1|Overall Study|Poor treatment compliance|0
1011350|NCT00364351|3307059|P2|Overall Study|Sponsor decision|0
1011351|NCT00364351|3307060|P1|Overall Study|Sponsor decision|1
1011352|NCT00364351|3307059|P2|Overall Study|Incorrect enrollment|1
1011353|NCT00364351|3307060|P1|Overall Study|Incorrect enrollment|1
1011354|NCT00364351|3307059|P2|Overall Study|Withdrawal by Subject|29
1011355|NCT00364351|3307060|P1|Overall Study|Withdrawal by Subject|30
1011356|NCT00364351|3307059|P2|Overall Study|Lost to Follow-up|1
1011357|NCT00364351|3307060|P1|Overall Study|Lost to Follow-up|1
1011358|NCT00364351|3307059|P2|Overall Study|Prohibited concomitant medication|2
1011359|NCT00364351|3307060|P1|Overall Study|Prohibited concomitant medication|0
1011360|NCT00364351|3307059|P2|Overall Study|Condition under investigation worsened|497
1011361|NCT00364351|3307060|P1|Overall Study|Condition under investigation worsened|469
1011362|NCT00364351|3307059|P2|Overall Study|Adverse Event|44
1011363|NCT00364351|3307060|P1|Overall Study|Adverse Event|90
1011364|NCT00364286|3307078|P1|Overall Study|Adverse Event|2
1011365|NCT00364286|3307078|P1|Overall Study|Withdrawal by Subject|1
1011366|NCT00364182|3307085|P3|Third Intervention|Lost to Follow-up|1
1011367|NCT00364182|3307086|P2|Third Intervention|Lost to Follow-up|0
1011368|NCT00364182|3307087|P1|Third Intervention|Lost to Follow-up|0
1011369|NCT00364182|3307085|P3|Third Intervention|non-compliance|0
1011370|NCT00364182|3307086|P2|Third Intervention|non-compliance|1
1011371|NCT00364182|3307087|P1|Third Intervention|non-compliance|0
1011372|NCT00364182|3307085|P3|Second Intervention|Adverse Event|1
1011373|NCT00364182|3307086|P2|Second Intervention|Adverse Event|0
1011374|NCT00364182|3307087|P1|Second Intervention|Adverse Event|0
1011375|NCT00364182|3307085|P3|Second Intervention|Protocol Violation|0
1011376|NCT00364182|3307086|P2|Second Intervention|Protocol Violation|1
1011377|NCT00364182|3307087|P1|Second Intervention|Protocol Violation|0
1011378|NCT00364182|3307085|P3|Second Intervention|non-compliance|1
1011379|NCT00364182|3307086|P2|Second Intervention|non-compliance|1
1011380|NCT00364182|3307087|P1|Second Intervention|non-compliance|0
1011381|NCT00364182|3307085|P3|First Intervention|Withdrawal by Subject|0
1011382|NCT00364182|3307086|P2|First Intervention|Withdrawal by Subject|0
1011383|NCT00364182|3307087|P1|First Intervention|Withdrawal by Subject|2
1011384|NCT00364182|3307085|P3|First Intervention|Secondary prophylaxis|0
1011385|NCT00364182|3307086|P2|First Intervention|Secondary prophylaxis|0
1011386|NCT00364182|3307087|P1|First Intervention|Secondary prophylaxis|1
1011387|NCT00364156|3307121|P2|Overall Study|Protocol Violation|1
1011388|NCT00364156|3307122|P1|Overall Study|Protocol Violation|6
1011389|NCT00364156|3307121|P2|Overall Study|Withdrawal by Subject|80
1011390|NCT00364156|3307122|P1|Overall Study|Withdrawal by Subject|73
1011391|NCT00364130|3307130|P2|Post Intervention Follow-up Period|Lost to Follow-up|11
1011392|NCT00364130|3307131|P1|Post Intervention Follow-up Period|Lost to Follow-up|5
1011393|NCT00364130|3307130|P2|Intervention Period|Withdrawal by Subject|5
1011394|NCT00364130|3307131|P1|Intervention Period|Withdrawal by Subject|4
1011395|NCT00364130|3307130|P2|Intervention Period|Pregnancy|0
1011396|NCT00364130|3307131|P1|Intervention Period|Pregnancy|1
1011397|NCT00364130|3307130|P2|Intervention Period|Lost to Follow-up|3
1011398|NCT00364130|3307131|P1|Intervention Period|Lost to Follow-up|4
1011399|NCT00364013|3307153|P2|Overall Study|Ongoing|13
1011400|NCT00364013|3307154|P1|Overall Study|Ongoing|20
1011401|NCT00364013|3307153|P2|Overall Study|Other|47
1011402|NCT00364013|3307154|P1|Overall Study|Other|41
1011403|NCT00364013|3307153|P2|Overall Study|Protocol-specified criteria|6
1011404|NCT00364013|3307154|P1|Overall Study|Protocol-specified criteria|6
1011405|NCT00364013|3307153|P2|Overall Study|Lost to Follow-up|3
1011406|NCT00364013|3307154|P1|Overall Study|Lost to Follow-up|10
1011407|NCT00364013|3307153|P2|Overall Study|Physician Decision|3
1011408|NCT00364013|3307154|P1|Overall Study|Physician Decision|3
1011409|NCT00364013|3307153|P2|Overall Study|Withdrawal by Subject|18
1011410|NCT00364013|3307154|P1|Overall Study|Withdrawal by Subject|13
1011411|NCT00364013|3307153|P2|Overall Study|Adverse Event|3
1011412|NCT00364013|3307154|P1|Overall Study|Adverse Event|4
1011413|NCT00364013|3307153|P2|Overall Study|Ineligibility determined|2
1011414|NCT00364013|3307154|P1|Overall Study|Ineligibility determined|4
1011415|NCT00363896|3307182|P2|Overall Study|Other|2
1011416|NCT00363896|3307183|P1|Overall Study|Other|1
1011417|NCT00363896|3307182|P2|Overall Study|Non-fulfilment of entry criteria|0
1011418|NCT00363896|3307183|P1|Overall Study|Non-fulfilment of entry criteria|1
1011419|NCT00363896|3307182|P2|Overall Study|Lost to Follow-up|0
1011420|NCT00363896|3307183|P1|Overall Study|Lost to Follow-up|3
1011421|NCT00363896|3307182|P2|Overall Study|Protocol Violation|1
1011422|NCT00363896|3307183|P1|Overall Study|Protocol Violation|6
1011423|NCT00363896|3307182|P2|Overall Study|Lack of Efficacy|8
1011424|NCT00363896|3307183|P1|Overall Study|Lack of Efficacy|12
1011425|NCT00363896|3307182|P2|Overall Study|COPD exacerbation|7
1011426|NCT00363896|3307183|P1|Overall Study|COPD exacerbation|13
1011427|NCT00363896|3307182|P2|Overall Study|Adverse Event|13
1011428|NCT00363896|3307183|P1|Overall Study|Adverse Event|24
1011429|NCT00363896|3307182|P2|Overall Study|Withdrawal by Subject|16
1011430|NCT00363896|3307183|P1|Overall Study|Withdrawal by Subject|29
1011431|NCT00363766|3307224|P2|Overall Study|Physician Decision|2
1011432|NCT00363766|3307225|P1|Overall Study|Physician Decision|1
1011433|NCT00363766|3307224|P2|Overall Study|Withdrawal by Subject|0
1011434|NCT00363766|3307225|P1|Overall Study|Withdrawal by Subject|2
1011435|NCT00363766|3307224|P2|Overall Study|Not Disease Related Death|4
1011436|NCT00363766|3307225|P1|Overall Study|Not Disease Related Death|3
1011437|NCT00363766|3307224|P2|Overall Study|Disease Related Death|3
1011438|NCT00363766|3307225|P1|Overall Study|Disease Related Death|1
1011439|NCT00363766|3307224|P2|Overall Study|Adverse Event|2
1011440|NCT00363766|3307225|P1|Overall Study|Adverse Event|10
1011441|NCT00363766|3307224|P2|Overall Study|Progressive Disease|9
1011442|NCT00363766|3307225|P1|Overall Study|Progressive Disease|15
1011443|NCT00363649|3307254|P2|Overall Study|Adverse Event|0
1011444|NCT00363649|3307255|P1|Overall Study|Adverse Event|6
1011445|NCT00363649|3307254|P2|Overall Study|Withdrawal by Subject|1
1011446|NCT00363649|3307255|P1|Overall Study|Withdrawal by Subject|1
1011447|NCT00363545|3307271|P2|Overall Study|Others|0
1011448|NCT00363545|3307272|P1|Overall Study|Others|1
1011449|NCT00363545|3307271|P2|Overall Study|Lost to follow-up (complete vaccination)|17
1011450|NCT00363545|3307272|P1|Overall Study|Lost to follow-up (complete vaccination)|14
1011451|NCT00363545|3307271|P2|Overall Study|Lost to follow-up (incompl. vaccination)|18
1011452|NCT00363545|3307272|P1|Overall Study|Lost to follow-up (incompl. vaccination)|14
1011453|NCT00363545|3307271|P2|Overall Study|Migrated/moved from study area|6
1011454|NCT00363545|3307272|P1|Overall Study|Migrated/moved from study area|3
1011455|NCT00363545|3307271|P2|Overall Study|Withdrawal by Subject|15
1011456|NCT00363545|3307272|P1|Overall Study|Withdrawal by Subject|12
1011457|NCT00363545|3307271|P2|Overall Study|Serious Adverse Event|1
1011458|NCT00363545|3307272|P1|Overall Study|Serious Adverse Event|0
1011459|NCT00363480|3307290|P1|Overall Study|Participant discontinued on its own|1
1011460|NCT00363480|3307290|P1|Overall Study|Non-compliance of subject|1
1011461|NCT00363480|3307290|P1|Overall Study|Withdrawal by Subject|5
1011462|NCT00363480|3307290|P1|Overall Study|Lost to Follow-up|5
1011463|NCT00363480|3307290|P1|Overall Study|Adverse Event|4
1011464|NCT00363480|3307290|P1|Overall Study|Criteria for treatment period not fulfil|1
1011465|NCT00363467|3307310|P1|Overall Study|Physician Decision|1
1011466|NCT00363415|3307320|P2|Overall Study|Protocol Violation|4
1011467|NCT00363415|3307321|P1|Overall Study|Protocol Violation|1
1011468|NCT00363415|3307320|P2|Overall Study|Lost to Follow-up|3
1011469|NCT00363415|3307321|P1|Overall Study|Lost to Follow-up|3
1011470|NCT00363415|3307320|P2|Overall Study|Withdrawal by Subject|15
1011471|NCT00363415|3307321|P1|Overall Study|Withdrawal by Subject|9
1011472|NCT00363415|3307320|P2|Overall Study|Entry Criteria Not Met|10
1011473|NCT00363415|3307321|P1|Overall Study|Entry Criteria Not Met|11
1011474|NCT00363415|3307320|P2|Overall Study|Physician Decision|35
1011475|NCT00363415|3307321|P1|Overall Study|Physician Decision|18
1011476|NCT00363415|3307320|P2|Overall Study|Adverse Event|15
1011477|NCT00363415|3307321|P1|Overall Study|Adverse Event|24
1011478|NCT00363415|3307320|P2|Overall Study|Death|29
1011479|NCT00363415|3307321|P1|Overall Study|Death|32
1011480|NCT00363415|3307320|P2|Overall Study|Sponsor Decision|31
1011481|NCT00363415|3307321|P1|Overall Study|Sponsor Decision|67
1011482|NCT00363415|3307320|P2|Overall Study|Progressive Disease|107
1011483|NCT00363415|3307321|P1|Overall Study|Progressive Disease|196
1011484|NCT00363311|3307339|P2|Overall Study|Participant Moved to Louisiana|1
1011485|NCT00363311|3307340|P1|Overall Study|Participant Moved to Louisiana|0
1011486|NCT00363311|3307339|P2|Overall Study|Withdrawn per Instructions of Monitor|1
1011487|NCT00363311|3307340|P1|Overall Study|Withdrawn per Instructions of Monitor|0
1011488|NCT00363311|3307339|P2|Overall Study|Participant Withdrew Waiting for Surgery|1
1011489|NCT00363311|3307340|P1|Overall Study|Participant Withdrew Waiting for Surgery|0
1011490|NCT00363311|3307339|P2|Overall Study|Participant Moved to Another Country|0
1011491|NCT00363311|3307340|P1|Overall Study|Participant Moved to Another Country|1
1011492|NCT00363311|3307339|P2|Overall Study|Participant Opted for Treatment|0
1011493|NCT00363311|3307340|P1|Overall Study|Participant Opted for Treatment|1
1011494|NCT00363311|3307339|P2|Overall Study|Prostate Volume/PSA Doubled|0
1011495|NCT00363311|3307340|P1|Overall Study|Prostate Volume/PSA Doubled|1
1011496|NCT00363311|3307339|P2|Overall Study|Participant Refused Biopsy|0
1011497|NCT00363311|3307340|P1|Overall Study|Participant Refused Biopsy|1
1011498|NCT00363311|3307339|P2|Overall Study|Non-Compliance|1
1011499|NCT00363311|3307340|P1|Overall Study|Non-Compliance|1
1011500|NCT00363311|3307339|P2|Overall Study|Disease Progression|26
1011501|NCT00363311|3307340|P1|Overall Study|Disease Progression|46
1011502|NCT00363311|3307339|P2|Overall Study|Sponsor Terminated Study|2
1011503|NCT00363311|3307340|P1|Overall Study|Sponsor Terminated Study|2
1011504|NCT00363311|3307339|P2|Overall Study|Physician Decision|1
1011505|NCT00363311|3307340|P1|Overall Study|Physician Decision|1
1011506|NCT00363311|3307339|P2|Overall Study|Withdrawal by Subject|6
1011507|NCT00363311|3307340|P1|Overall Study|Withdrawal by Subject|12
1011508|NCT00363311|3307339|P2|Overall Study|Protocol Violation|2
1011509|NCT00363311|3307340|P1|Overall Study|Protocol Violation|1
1011510|NCT00363311|3307339|P2|Overall Study|Lost to Follow-up|0
1011511|NCT00363311|3307340|P1|Overall Study|Lost to Follow-up|3
1011512|NCT00363311|3307339|P2|Overall Study|Adverse Event|4
1011513|NCT00363311|3307340|P1|Overall Study|Adverse Event|6
1011514|NCT00363298|3307406|P2|4-week Study Continuation Phase|Lack of Efficacy|0
1011515|NCT00363298|3307407|P1|4-week Study Continuation Phase|Lack of Efficacy|1
1011516|NCT00363298|3307406|P2|First Study Week|Lack of Efficacy|5
1011517|NCT00363298|3307407|P1|First Study Week|Lack of Efficacy|6
1011518|NCT00363246|3307415|P1|Overall Study|Eligibility changed due to Hospice move|5
1011519|NCT00363246|3307415|P1|Overall Study|Subject expressed security concerns|2
1011520|NCT00363246|3307415|P1|Overall Study|Stopped using wheelchair|11
1011521|NCT00363246|3307415|P1|Overall Study|Bad health|6
1011522|NCT00363246|3307415|P1|Overall Study|Lost to Follow-up|14
1011523|NCT00363246|3307415|P1|Overall Study|Withdrawal by Subject|19
1011524|NCT00363246|3307415|P1|Overall Study|Death|40
1011525|NCT00363142|3307433|P2|Overall Study|Withdrawal by Subject|1
1011526|NCT00363142|3307434|P1|Overall Study|Withdrawal by Subject|3
1011527|NCT00363142|3307433|P2|Overall Study|Non-compliance|1
1011528|NCT00363142|3307434|P1|Overall Study|Non-compliance|1
1011529|NCT00363142|3307433|P2|Overall Study|Lost to Follow-up|0
1011530|NCT00363142|3307434|P1|Overall Study|Lost to Follow-up|1
1011531|NCT00363142|3307433|P2|Overall Study|Lack of Efficacy|1
1011532|NCT00363142|3307434|P1|Overall Study|Lack of Efficacy|0
1011533|NCT00363142|3307433|P2|Overall Study|Adverse Event|0
1011534|NCT00363142|3307434|P1|Overall Study|Adverse Event|2
1011535|NCT00363129|3307463|P2|Overall Study|Other Reasons|3
1011536|NCT00363129|3307464|P1|Overall Study|Other Reasons|6
1011537|NCT00363129|3307463|P2|Overall Study|Death|1
1011538|NCT00363129|3307464|P1|Overall Study|Death|0
1011539|NCT00363129|3307463|P2|Overall Study|Other Medical Problems|4
1011540|NCT00363129|3307464|P1|Overall Study|Other Medical Problems|2
1011541|NCT00363129|3307463|P2|Overall Study|Alternate Treatment|4
1011542|NCT00363129|3307464|P1|Overall Study|Alternate Treatment|2
1011543|NCT00363129|3307463|P2|Overall Study|Adverse Event|3
1011544|NCT00363129|3307464|P1|Overall Study|Adverse Event|8
1011545|NCT00363129|3307463|P2|Overall Study|Withdrawal by Subject|18
1011546|NCT00363129|3307464|P1|Overall Study|Withdrawal by Subject|11
1011547|NCT00363051|3307507|P2|Overall Study|Death|2
1011548|NCT00363051|3307508|P1|Overall Study|Death|3
1011549|NCT00363051|3307507|P2|Overall Study|Protocol Violation|2
1011550|NCT00363051|3307508|P1|Overall Study|Protocol Violation|0
1011551|NCT00363051|3307507|P2|Overall Study|Lost to Follow-up|1
1011552|NCT00363051|3307508|P1|Overall Study|Lost to Follow-up|0
1011553|NCT00363051|3307507|P2|Overall Study|Withdrawal by Subject|3
1011554|NCT00363051|3307508|P1|Overall Study|Withdrawal by Subject|11
1011555|NCT00363051|3307507|P2|Overall Study|New Cancer Therapy|1
1011556|NCT00363051|3307508|P1|Overall Study|New Cancer Therapy|2
1011557|NCT00363051|3307507|P2|Overall Study|Adverse Event|12
1011558|NCT00363051|3307508|P1|Overall Study|Adverse Event|21
1011559|NCT00363051|3307507|P2|Overall Study|Adminstrative problems|1
1011560|NCT00363051|3307508|P1|Overall Study|Adminstrative problems|1
1011561|NCT00362648|3307557|P4|Overall Study|Withdrawal by Subject|6
1011562|NCT00362648|3307558|P3|Overall Study|Withdrawal by Subject|2
1011563|NCT00362648|3307559|P2|Overall Study|Withdrawal by Subject|42
1011564|NCT00362648|3307560|P1|Overall Study|Withdrawal by Subject|48
1011565|NCT00362648|3307557|P4|Overall Study|Protocol Violation|2
1011566|NCT00362648|3307558|P3|Overall Study|Protocol Violation|2
1011567|NCT00362648|3307559|P2|Overall Study|Protocol Violation|2
1011568|NCT00362648|3307560|P1|Overall Study|Protocol Violation|4
1011569|NCT00362648|3307557|P4|Overall Study|Lost to Follow-up|3
1011570|NCT00362648|3307558|P3|Overall Study|Lost to Follow-up|4
1011571|NCT00362648|3307559|P2|Overall Study|Lost to Follow-up|69
1011572|NCT00362648|3307560|P1|Overall Study|Lost to Follow-up|62
1011573|NCT00362648|3307557|P4|Overall Study|Adverse Event|0
1011574|NCT00362648|3307558|P3|Overall Study|Adverse Event|1
1011575|NCT00362648|3307559|P2|Overall Study|Adverse Event|21
1011576|NCT00362648|3307560|P1|Overall Study|Adverse Event|12
1011577|NCT00362609|3307578|P2|Overall Study|Protocol Violation|1
1011578|NCT00362609|3307579|P1|Overall Study|Protocol Violation|0
1011579|NCT00362609|3307578|P2|Overall Study|Withdrawal by Subject|1
1011580|NCT00362609|3307579|P1|Overall Study|Withdrawal by Subject|0
1011581|NCT00362414|3307660|P1|Overall Study|Adverse Event|1
1011582|NCT00362414|3307660|P1|Overall Study|Death|2
1011583|NCT00362375|3307689|P2|Overall Study|Lost to Follow-up|35
1011584|NCT00362375|3307690|P1|Overall Study|Lost to Follow-up|40
1011585|NCT00362336|3307707|P3|Overall Study|Withdrawal by Subject|1
1011586|NCT00362336|3307708|P2|Overall Study|Withdrawal by Subject|3
1011587|NCT00362336|3307709|P1|Overall Study|Withdrawal by Subject|3
1011588|NCT00362336|3307707|P3|Overall Study|Lost to Follow-up|0
1011589|NCT00362336|3307708|P2|Overall Study|Lost to Follow-up|4
1011590|NCT00362336|3307709|P1|Overall Study|Lost to Follow-up|6
1011591|NCT00362336|3307707|P3|Overall Study|Protocol Violation|1
1011592|NCT00362336|3307708|P2|Overall Study|Protocol Violation|0
1011593|NCT00362336|3307709|P1|Overall Study|Protocol Violation|0
1011594|NCT00362336|3307707|P3|Overall Study|Serious Adverse Event|1
1011595|NCT00362336|3307708|P2|Overall Study|Serious Adverse Event|0
1011596|NCT00362336|3307709|P1|Overall Study|Serious Adverse Event|1
1011597|NCT00362297|3307737|P2|Arm 1 (Initial Drug Assignment)|Lost to Follow-up|4
1011598|NCT00362297|3307738|P1|Arm 1 (Initial Drug Assignment)|Lost to Follow-up|0
1011599|NCT00362232|3307746|P2|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7
1011600|NCT00362232|3307747|P1|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8
1011601|NCT00362232|3307746|P2|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28
1011602|NCT00362232|3307747|P1|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27
1011603|NCT00362232|3307746|P2|Follow-up (30 (+ 5) Days)|Death|1
1011604|NCT00362232|3307747|P1|Follow-up (30 (+ 5) Days)|Death|1
1011605|NCT00362232|3307746|P2|Follow-up (30 (+ 5) Days)|Adverse Event|3
1011606|NCT00362232|3307747|P1|Follow-up (30 (+ 5) Days)|Adverse Event|2
1011607|NCT00362232|3307746|P2|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18
1011608|NCT00362232|3307747|P1|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10
1011609|NCT00362232|3307746|P2|Treatment (12 +/- 2 Days)|Technical Problems|0
1011610|NCT00362232|3307747|P1|Treatment (12 +/- 2 Days)|Technical Problems|1
1011611|NCT00362232|3307746|P2|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0
1011612|NCT00362232|3307747|P1|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9
1011613|NCT00362232|3307746|P2|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47
1011614|NCT00362232|3307747|P1|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49
1011615|NCT00362232|3307746|P2|Treatment (12 +/- 2 Days)|Protocol Violation|21
1011616|NCT00362232|3307747|P1|Treatment (12 +/- 2 Days)|Protocol Violation|22
1011617|NCT00362232|3307746|P2|Treatment (12 +/- 2 Days)|Physician Decision|5
1011618|NCT00362232|3307747|P1|Treatment (12 +/- 2 Days)|Physician Decision|2
1011619|NCT00362232|3307746|P2|Treatment (12 +/- 2 Days)|Lost to Follow-up|1
1011620|NCT00362232|3307747|P1|Treatment (12 +/- 2 Days)|Lost to Follow-up|3
1011621|NCT00362232|3307746|P2|Treatment (12 +/- 2 Days)|Death|3
1011622|NCT00362232|3307747|P1|Treatment (12 +/- 2 Days)|Death|1
1011623|NCT00362232|3307746|P2|Treatment (12 +/- 2 Days)|Adverse Event|56
1011624|NCT00362232|3307747|P1|Treatment (12 +/- 2 Days)|Adverse Event|62
1011625|NCT00362180|3307792|P9|Treated Period|Adverse Event|0
1011626|NCT00362180|3307793|P8|Treated Period|Adverse Event|1
1011627|NCT00362180|3307794|P7|Treated Period|Adverse Event|0
1011628|NCT00362180|3307795|P6|Treated Period|Adverse Event|1
1011629|NCT00362180|3307796|P5|Treated Period|Adverse Event|0
1011630|NCT00362180|3307797|P4|Treated Period|Adverse Event|0
1011631|NCT00362180|3307798|P3|Treated Period|Adverse Event|0
1011632|NCT00362180|3307799|P2|Treated Period|Adverse Event|0
1011633|NCT00362180|3307800|P1|Treated Period|Adverse Event|0
1011634|NCT00362180|3307792|P9|Treated Period|Withdrawal by Subject|0
1011635|NCT00362180|3307793|P8|Treated Period|Withdrawal by Subject|0
1011636|NCT00362180|3307794|P7|Treated Period|Withdrawal by Subject|0
1011637|NCT00362180|3307795|P6|Treated Period|Withdrawal by Subject|0
1011638|NCT00362180|3307796|P5|Treated Period|Withdrawal by Subject|0
1011639|NCT00362180|3307797|P4|Treated Period|Withdrawal by Subject|0
1011640|NCT00362180|3307798|P3|Treated Period|Withdrawal by Subject|0
1011641|NCT00362180|3307799|P2|Treated Period|Withdrawal by Subject|0
1011642|NCT00362180|3307800|P1|Treated Period|Withdrawal by Subject|1
1011643|NCT00362115|3307872|P7|Overall Study|Other|0
1011644|NCT00362115|3307873|P6|Overall Study|Other|1
1011645|NCT00362115|3307874|P5|Overall Study|Other|0
1011646|NCT00362115|3307875|P4|Overall Study|Other|1
1011647|NCT00362115|3307876|P3|Overall Study|Other|0
1011648|NCT00362115|3307877|P2|Overall Study|Other|1
1011649|NCT00362115|3307878|P1|Overall Study|Other|0
1011650|NCT00362115|3307872|P7|Overall Study|Physician Decision|3
1011651|NCT00362115|3307873|P6|Overall Study|Physician Decision|0
1011652|NCT00362115|3307874|P5|Overall Study|Physician Decision|0
1011653|NCT00362115|3307875|P4|Overall Study|Physician Decision|0
1011654|NCT00362115|3307876|P3|Overall Study|Physician Decision|0
1011655|NCT00362115|3307877|P2|Overall Study|Physician Decision|0
1011656|NCT00362115|3307878|P1|Overall Study|Physician Decision|0
1011657|NCT00362115|3307872|P7|Overall Study|Lack of Efficacy|3
1011658|NCT00362115|3307873|P6|Overall Study|Lack of Efficacy|0
1011659|NCT00362115|3307874|P5|Overall Study|Lack of Efficacy|2
1011660|NCT00362115|3307875|P4|Overall Study|Lack of Efficacy|2
1011661|NCT00362115|3307876|P3|Overall Study|Lack of Efficacy|5
1011662|NCT00362115|3307877|P2|Overall Study|Lack of Efficacy|0
1011663|NCT00362115|3307878|P1|Overall Study|Lack of Efficacy|1
1011664|NCT00362115|3307872|P7|Overall Study|Withdrawal by Subject|4
1011665|NCT00362115|3307873|P6|Overall Study|Withdrawal by Subject|3
1011666|NCT00362115|3307874|P5|Overall Study|Withdrawal by Subject|1
1011667|NCT00362115|3307875|P4|Overall Study|Withdrawal by Subject|0
1011668|NCT00362115|3307876|P3|Overall Study|Withdrawal by Subject|1
1011669|NCT00362115|3307877|P2|Overall Study|Withdrawal by Subject|3
1011670|NCT00362115|3307878|P1|Overall Study|Withdrawal by Subject|1
1011671|NCT00362115|3307872|P7|Overall Study|Lost to Follow-up|1
1011672|NCT00362115|3307873|P6|Overall Study|Lost to Follow-up|0
1011673|NCT00362115|3307874|P5|Overall Study|Lost to Follow-up|2
1011674|NCT00362115|3307875|P4|Overall Study|Lost to Follow-up|0
1011675|NCT00362115|3307876|P3|Overall Study|Lost to Follow-up|0
1011676|NCT00362115|3307877|P2|Overall Study|Lost to Follow-up|1
1011677|NCT00362115|3307878|P1|Overall Study|Lost to Follow-up|0
1011678|NCT00362115|3307872|P7|Overall Study|Protocol Violation|0
1011679|NCT00362115|3307873|P6|Overall Study|Protocol Violation|1
1011680|NCT00362115|3307874|P5|Overall Study|Protocol Violation|0
1011681|NCT00362115|3307875|P4|Overall Study|Protocol Violation|0
1011682|NCT00362115|3307876|P3|Overall Study|Protocol Violation|0
1011683|NCT00362115|3307877|P2|Overall Study|Protocol Violation|0
1011684|NCT00362115|3307878|P1|Overall Study|Protocol Violation|0
1011685|NCT00362115|3307872|P7|Overall Study|Adverse Event|1
1011686|NCT00362115|3307873|P6|Overall Study|Adverse Event|2
1011687|NCT00362115|3307874|P5|Overall Study|Adverse Event|2
1011688|NCT00362115|3307875|P4|Overall Study|Adverse Event|1
1011689|NCT00362115|3307876|P3|Overall Study|Adverse Event|1
1011690|NCT00362115|3307877|P2|Overall Study|Adverse Event|1
1011691|NCT00362115|3307878|P1|Overall Study|Adverse Event|0
1011692|NCT00361634|3308051|P1|Overall Study|Withdrawal by Subject|1
1011693|NCT00361634|3308051|P1|Overall Study|Lost to Follow-up|1
1011694|NCT00361569|3308080|P4|Overall Study|Not specified by investigator|1
1011695|NCT00361569|3308081|P3|Overall Study|Not specified by investigator|0
1011696|NCT00361569|3308082|P2|Overall Study|Not specified by investigator|0
1011697|NCT00361569|3308083|P1|Overall Study|Not specified by investigator|2
1011698|NCT00361569|3308080|P4|Overall Study|Lost to Follow-up|2
1011699|NCT00361569|3308081|P3|Overall Study|Lost to Follow-up|3
1011700|NCT00361569|3308082|P2|Overall Study|Lost to Follow-up|3
1011701|NCT00361569|3308083|P1|Overall Study|Lost to Follow-up|2
1011702|NCT00361569|3308080|P4|Overall Study|Adverse Event|2
1011703|NCT00361569|3308081|P3|Overall Study|Adverse Event|2
1011704|NCT00361569|3308082|P2|Overall Study|Adverse Event|5
1011705|NCT00361569|3308083|P1|Overall Study|Adverse Event|3
1011706|NCT00361569|3308080|P4|Overall Study|Withdrawal by Subject|14
1011707|NCT00361569|3308081|P3|Overall Study|Withdrawal by Subject|9
1011708|NCT00361569|3308082|P2|Overall Study|Withdrawal by Subject|1
1011709|NCT00361569|3308083|P1|Overall Study|Withdrawal by Subject|2
1011710|NCT00361569|3308080|P4|Overall Study|Protocol Violation|2
1011711|NCT00361569|3308081|P3|Overall Study|Protocol Violation|4
1011712|NCT00361569|3308082|P2|Overall Study|Protocol Violation|2
1011713|NCT00361569|3308083|P1|Overall Study|Protocol Violation|3
1011714|NCT00361504|3308107|P2|Overall Study|All other|3
1011715|NCT00361504|3308108|P1|Overall Study|All other|28
1011716|NCT00361504|3308107|P2|Overall Study|Study medication non compliant|15
1011717|NCT00361504|3308108|P1|Overall Study|Study medication non compliant|42
1011718|NCT00361504|3308107|P2|Overall Study|Resolution of Pain|0
1011719|NCT00361504|3308108|P1|Overall Study|Resolution of Pain|2
1011720|NCT00361504|3308107|P2|Overall Study|Lack of Efficacy|7
1011721|NCT00361504|3308108|P1|Overall Study|Lack of Efficacy|72
1011722|NCT00361504|3308107|P2|Overall Study|Adverse Event|82
1011723|NCT00361504|3308108|P1|Overall Study|Adverse Event|203
1011724|NCT00361504|3308107|P2|Overall Study|Lost to Follow-up|7
1011725|NCT00361504|3308108|P1|Overall Study|Lost to Follow-up|40
1011726|NCT00361504|3308107|P2|Overall Study|Withdrawal by Subject|31
1011727|NCT00361504|3308108|P1|Overall Study|Withdrawal by Subject|94
1011728|NCT00361335|3308149|P7|SC Period: Week E0 to Week E24|Lack of Efficacy|3
1011729|NCT00361335|3308150|P6|SC Period: Week E0 to Week E24|Lack of Efficacy|0
1011730|NCT00361335|3308151|P5|SC Period: Week E0 to Week E24|Lack of Efficacy|0
1011731|NCT00361335|3308152|P4|SC Period: Week E0 to Week E24|Lack of Efficacy|0
1011732|NCT00361335|3308153|P3|SC Period: Week E0 to Week E24|Lack of Efficacy|2
1011733|NCT00361335|3308154|P2|SC Period: Week E0 to Week E24|Lack of Efficacy|0
1011734|NCT00361335|3308155|P1|SC Period: Week E0 to Week E24|Lack of Efficacy|0
1011735|NCT00361335|3308149|P7|SC Period: Week E0 to Week E24|Not specified|2
1011736|NCT00361335|3308150|P6|SC Period: Week E0 to Week E24|Not specified|1
1011737|NCT00361335|3308151|P5|SC Period: Week E0 to Week E24|Not specified|0
1011738|NCT00361335|3308152|P4|SC Period: Week E0 to Week E24|Not specified|1
1011739|NCT00361335|3308153|P3|SC Period: Week E0 to Week E24|Not specified|0
1011740|NCT00361335|3308154|P2|SC Period: Week E0 to Week E24|Not specified|0
1011741|NCT00361335|3308155|P1|SC Period: Week E0 to Week E24|Not specified|1
1011742|NCT00361335|3308149|P7|SC Period: Week E0 to Week E24|Worsening of RA|0
1011743|NCT00361335|3308150|P6|SC Period: Week E0 to Week E24|Worsening of RA|0
1011744|NCT00361335|3308151|P5|SC Period: Week E0 to Week E24|Worsening of RA|0
1011745|NCT00361335|3308152|P4|SC Period: Week E0 to Week E24|Worsening of RA|1
1011746|NCT00361335|3308153|P3|SC Period: Week E0 to Week E24|Worsening of RA|1
1011747|NCT00361335|3308154|P2|SC Period: Week E0 to Week E24|Worsening of RA|1
1011748|NCT00361335|3308155|P1|SC Period: Week E0 to Week E24|Worsening of RA|0
1011749|NCT00361335|3308149|P7|SC Period: Week E0 to Week E24|Death|1
1011750|NCT00361335|3308150|P6|SC Period: Week E0 to Week E24|Death|0
1011751|NCT00361335|3308151|P5|SC Period: Week E0 to Week E24|Death|0
1011752|NCT00361335|3308152|P4|SC Period: Week E0 to Week E24|Death|0
1011753|NCT00361335|3308153|P3|SC Period: Week E0 to Week E24|Death|0
1011754|NCT00361335|3308154|P2|SC Period: Week E0 to Week E24|Death|0
1011755|NCT00361335|3308155|P1|SC Period: Week E0 to Week E24|Death|0
1011756|NCT00361335|3308149|P7|SC Period: Week E0 to Week E24|Lost to Follow-up|1
1011757|NCT00361335|3308150|P6|SC Period: Week E0 to Week E24|Lost to Follow-up|0
1011758|NCT00361335|3308151|P5|SC Period: Week E0 to Week E24|Lost to Follow-up|0
1011759|NCT00361335|3308152|P4|SC Period: Week E0 to Week E24|Lost to Follow-up|0
1011760|NCT00361335|3308153|P3|SC Period: Week E0 to Week E24|Lost to Follow-up|1
1011761|NCT00361335|3308154|P2|SC Period: Week E0 to Week E24|Lost to Follow-up|0
1011762|NCT00361335|3308155|P1|SC Period: Week E0 to Week E24|Lost to Follow-up|1
1011763|NCT00361335|3308149|P7|SC Period: Week E0 to Week E24|Adverse Event|2
1011764|NCT00361335|3308150|P6|SC Period: Week E0 to Week E24|Adverse Event|0
1011765|NCT00361335|3308151|P5|SC Period: Week E0 to Week E24|Adverse Event|0
1011766|NCT00361335|3308152|P4|SC Period: Week E0 to Week E24|Adverse Event|2
1011767|NCT00361335|3308153|P3|SC Period: Week E0 to Week E24|Adverse Event|1
1011768|NCT00361335|3308154|P2|SC Period: Week E0 to Week E24|Adverse Event|2
1011769|NCT00361335|3308155|P1|SC Period: Week E0 to Week E24|Adverse Event|0
1011770|NCT00361335|3308149|P7|IV Period: Baseline to E0|Lack of Efficacy|0
1011771|NCT00361335|3308150|P6|IV Period: Baseline to E0|Lack of Efficacy|0
1011772|NCT00361335|3308151|P5|IV Period: Baseline to E0|Lack of Efficacy|8
1011773|NCT00361335|3308152|P4|IV Period: Baseline to E0|Lack of Efficacy|7
1011774|NCT00361335|3308153|P3|IV Period: Baseline to E0|Lack of Efficacy|3
1011775|NCT00361335|3308154|P2|IV Period: Baseline to E0|Lack of Efficacy|9
1011776|NCT00361335|3308155|P1|IV Period: Baseline to E0|Lack of Efficacy|5
1011777|NCT00361335|3308149|P7|IV Period: Baseline to E0|Not specified|0
1011778|NCT00361335|3308150|P6|IV Period: Baseline to E0|Not specified|0
1011779|NCT00361335|3308151|P5|IV Period: Baseline to E0|Not specified|2
1011780|NCT00361335|3308152|P4|IV Period: Baseline to E0|Not specified|3
1011781|NCT00361335|3308153|P3|IV Period: Baseline to E0|Not specified|9
1011782|NCT00361335|3308154|P2|IV Period: Baseline to E0|Not specified|9
1011783|NCT00361335|3308155|P1|IV Period: Baseline to E0|Not specified|2
1011784|NCT00361335|3308149|P7|IV Period: Baseline to E0|Worsening of RA|0
1011785|NCT00361335|3308150|P6|IV Period: Baseline to E0|Worsening of RA|0
1011786|NCT00361335|3308151|P5|IV Period: Baseline to E0|Worsening of RA|2
1011787|NCT00361335|3308152|P4|IV Period: Baseline to E0|Worsening of RA|4
1011788|NCT00361335|3308153|P3|IV Period: Baseline to E0|Worsening of RA|1
1011789|NCT00361335|3308154|P2|IV Period: Baseline to E0|Worsening of RA|5
1011790|NCT00361335|3308155|P1|IV Period: Baseline to E0|Worsening of RA|0
1011791|NCT00361335|3308149|P7|IV Period: Baseline to E0|Protocol-prohibited medications|0
1011792|NCT00361335|3308150|P6|IV Period: Baseline to E0|Protocol-prohibited medications|0
1011793|NCT00361335|3308151|P5|IV Period: Baseline to E0|Protocol-prohibited medications|0
1011794|NCT00361335|3308152|P4|IV Period: Baseline to E0|Protocol-prohibited medications|0
1011795|NCT00361335|3308153|P3|IV Period: Baseline to E0|Protocol-prohibited medications|1
1011796|NCT00361335|3308154|P2|IV Period: Baseline to E0|Protocol-prohibited medications|0
1011797|NCT00361335|3308155|P1|IV Period: Baseline to E0|Protocol-prohibited medications|0
1011798|NCT00361335|3308149|P7|IV Period: Baseline to E0|Discontinued oral study agent|0
1011799|NCT00361335|3308150|P6|IV Period: Baseline to E0|Discontinued oral study agent|0
1011800|NCT00361335|3308151|P5|IV Period: Baseline to E0|Discontinued oral study agent|2
1011801|NCT00361335|3308152|P4|IV Period: Baseline to E0|Discontinued oral study agent|1
1011802|NCT00361335|3308153|P3|IV Period: Baseline to E0|Discontinued oral study agent|1
1011803|NCT00361335|3308154|P2|IV Period: Baseline to E0|Discontinued oral study agent|1
1011804|NCT00361335|3308155|P1|IV Period: Baseline to E0|Discontinued oral study agent|2
1011805|NCT00361335|3308149|P7|IV Period: Baseline to E0|Death|0
1011806|NCT00361335|3308150|P6|IV Period: Baseline to E0|Death|0
1011807|NCT00361335|3308151|P5|IV Period: Baseline to E0|Death|0
1011808|NCT00361335|3308152|P4|IV Period: Baseline to E0|Death|1
1011809|NCT00361335|3308153|P3|IV Period: Baseline to E0|Death|1
1011810|NCT00361335|3308154|P2|IV Period: Baseline to E0|Death|1
1011811|NCT00361335|3308155|P1|IV Period: Baseline to E0|Death|1
1011812|NCT00361335|3308149|P7|IV Period: Baseline to E0|Lost to Follow-up|0
1011813|NCT00361335|3308150|P6|IV Period: Baseline to E0|Lost to Follow-up|0
1011814|NCT00361335|3308151|P5|IV Period: Baseline to E0|Lost to Follow-up|2
1011815|NCT00361335|3308152|P4|IV Period: Baseline to E0|Lost to Follow-up|2
1011816|NCT00361335|3308153|P3|IV Period: Baseline to E0|Lost to Follow-up|0
1011817|NCT00361335|3308154|P2|IV Period: Baseline to E0|Lost to Follow-up|0
1011818|NCT00361335|3308155|P1|IV Period: Baseline to E0|Lost to Follow-up|1
1011819|NCT00361335|3308149|P7|IV Period: Baseline to E0|Adverse Event|0
1011820|NCT00361335|3308150|P6|IV Period: Baseline to E0|Adverse Event|0
1011821|NCT00361335|3308151|P5|IV Period: Baseline to E0|Adverse Event|8
1011822|NCT00361335|3308152|P4|IV Period: Baseline to E0|Adverse Event|9
1011823|NCT00361335|3308153|P3|IV Period: Baseline to E0|Adverse Event|5
1011824|NCT00361335|3308154|P2|IV Period: Baseline to E0|Adverse Event|4
1011825|NCT00361335|3308155|P1|IV Period: Baseline to E0|Adverse Event|9
1011826|NCT00361296|3308199|P1|Overall Study|Lack of Efficacy|2
1011827|NCT00361296|3308199|P1|Overall Study|Physician Decision|1
1011828|NCT00361283|3308206|P1|Overall Study|Lost to Follow-up|27
1011829|NCT00361270|3308214|P4|Overall Study|Adverse Event|0
1011830|NCT00361270|3308215|P3|Overall Study|Adverse Event|1
1011831|NCT00361270|3308216|P2|Overall Study|Adverse Event|1
1011832|NCT00361270|3308217|P1|Overall Study|Adverse Event|0
1011833|NCT00361270|3308214|P4|Overall Study|Problems with Transportation|0
1011834|NCT00361270|3308215|P3|Overall Study|Problems with Transportation|0
1011835|NCT00361270|3308216|P2|Overall Study|Problems with Transportation|0
1011836|NCT00361270|3308217|P1|Overall Study|Problems with Transportation|4
1011837|NCT00361270|3308214|P4|Overall Study|Afraid of Hypnosis|0
1011838|NCT00361270|3308215|P3|Overall Study|Afraid of Hypnosis|0
1011839|NCT00361270|3308216|P2|Overall Study|Afraid of Hypnosis|2
1011840|NCT00361270|3308217|P1|Overall Study|Afraid of Hypnosis|1
1011841|NCT00361270|3308214|P4|Overall Study|Withdrawal by Subject|7
1011842|NCT00361270|3308215|P3|Overall Study|Withdrawal by Subject|3
1011843|NCT00361270|3308216|P2|Overall Study|Withdrawal by Subject|6
1011844|NCT00361270|3308217|P1|Overall Study|Withdrawal by Subject|6
1011845|NCT00361270|3308214|P4|Overall Study|Protocol Violation|4
1011846|NCT00361270|3308215|P3|Overall Study|Protocol Violation|5
1011847|NCT00361270|3308216|P2|Overall Study|Protocol Violation|4
1011848|NCT00361270|3308217|P1|Overall Study|Protocol Violation|9
1011849|NCT00361270|3308214|P4|Overall Study|Physician Decision|0
1011850|NCT00361270|3308215|P3|Overall Study|Physician Decision|1
1011851|NCT00361270|3308216|P2|Overall Study|Physician Decision|0
1011852|NCT00361270|3308217|P1|Overall Study|Physician Decision|0
1011853|NCT00361270|3308214|P4|Overall Study|Lost to Follow-up|0
1011854|NCT00361270|3308215|P3|Overall Study|Lost to Follow-up|0
1011855|NCT00361270|3308216|P2|Overall Study|Lost to Follow-up|1
1011856|NCT00361270|3308217|P1|Overall Study|Lost to Follow-up|4
1011857|NCT00361270|3308214|P4|Overall Study|Death|2
1011858|NCT00361270|3308215|P3|Overall Study|Death|0
1011859|NCT00361270|3308216|P2|Overall Study|Death|0
1011860|NCT00361270|3308217|P1|Overall Study|Death|0
1011861|NCT00361231|3308290|P1|Overall Study|Adverse Event|6
1011862|NCT00361231|3308290|P1|Overall Study|Withdrawal by Subject|4
1011863|NCT00361231|3308290|P1|Overall Study|Radiographic disease progression|16
1011864|NCT00361231|3308290|P1|Overall Study|Symptomatic deterioration|5
1011865|NCT00361231|3308290|P1|Overall Study|Physician Decision|3
1011866|NCT00361218|3308295|P1|Overall Study|terminated / withdrawn due to toxicity /|5
1011867|NCT00361218|3308295|P1|Overall Study|Personal Reasons|7
1011868|NCT00361218|3308295|P1|Overall Study|Lost to Follow-up|11
1011869|NCT00360698|3308374|P2|Treatment Period|Early termination by error|1
1011870|NCT00360698|3308375|P1|Treatment Period|Early termination by error|0
1011871|NCT00360698|3308374|P2|Treatment Period|Non compliance with treatment procedure|0
1011872|NCT00360698|3308375|P1|Treatment Period|Non compliance with treatment procedure|1
1011873|NCT00360698|3308374|P2|Run-In|Need of insulin with meals|1
1011874|NCT00360698|3308375|P1|Run-In|Need of insulin with meals|0
1011875|NCT00360698|3308374|P2|Run-In|Patient personal reasons|2
1011876|NCT00360698|3308375|P1|Run-In|Patient personal reasons|0
1011877|NCT00360698|3308374|P2|Run-In|Patient did not meet inclusion criteria|1
1011878|NCT00360698|3308375|P1|Run-In|Patient did not meet inclusion criteria|0
1011879|NCT00360698|3308374|P2|Run-In|Sponsor request|2
1011880|NCT00360698|3308375|P1|Run-In|Sponsor request|0
1011881|NCT00360698|3308374|P2|Run-In|Non compliance with treatment procedure|1
1011882|NCT00360698|3308375|P1|Run-In|Non compliance with treatment procedure|0
1011883|NCT00360698|3308374|P2|Run-In|Withdrawal by Subject|2
1011884|NCT00360698|3308375|P1|Run-In|Withdrawal by Subject|0
1011885|NCT00360698|3308374|P2|Run-In|Physician Decision|1
1011886|NCT00360698|3308375|P1|Run-In|Physician Decision|0
1011887|NCT00360568|3308420|P2|Overall Study|Withdrawal by Subject|3
1011888|NCT00360568|3308421|P1|Overall Study|Withdrawal by Subject|0
1011889|NCT00360568|3308420|P2|Overall Study|Lack of Efficacy|0
1011890|NCT00360568|3308421|P1|Overall Study|Lack of Efficacy|1
1011891|NCT00360568|3308420|P2|Overall Study|Adverse Event|2
1011892|NCT00360568|3308421|P1|Overall Study|Adverse Event|1
1011893|NCT00360529|3308552|P3|Overall Study|Reason discontinued not explained above|11
1011894|NCT00360529|3308553|P2|Overall Study|Reason discontinued not explained above|9
1011895|NCT00360529|3308554|P1|Overall Study|Reason discontinued not explained above|4
1011896|NCT00360529|3308552|P3|Overall Study|Lack of Efficacy|5
1011897|NCT00360529|3308553|P2|Overall Study|Lack of Efficacy|6
1011898|NCT00360529|3308554|P1|Overall Study|Lack of Efficacy|8
1011899|NCT00360529|3308552|P3|Overall Study|Withdrawal by Subject|18
1011900|NCT00360529|3308553|P2|Overall Study|Withdrawal by Subject|14
1011901|NCT00360529|3308554|P1|Overall Study|Withdrawal by Subject|22
1011902|NCT00360529|3308552|P3|Overall Study|Lost to Follow-up|13
1011903|NCT00360529|3308553|P2|Overall Study|Lost to Follow-up|10
1011904|NCT00360529|3308554|P1|Overall Study|Lost to Follow-up|14
1011905|NCT00360529|3308552|P3|Overall Study|Protocol Violation|11
1011906|NCT00360529|3308553|P2|Overall Study|Protocol Violation|3
1011907|NCT00360529|3308554|P1|Overall Study|Protocol Violation|3
1011908|NCT00360529|3308552|P3|Overall Study|Adverse Event|33
1011909|NCT00360529|3308553|P2|Overall Study|Adverse Event|23
1011910|NCT00360529|3308554|P1|Overall Study|Adverse Event|10
1011911|NCT00360490|3308582|P2|Overall Study|Withdrawal by Subject|3
1011912|NCT00360490|3308583|P1|Overall Study|Withdrawal by Subject|1
1011913|NCT00360490|3308582|P2|Overall Study|Protocol Violation|4
1011914|NCT00360490|3308583|P1|Overall Study|Protocol Violation|0
1011915|NCT00360490|3308582|P2|Overall Study|Physician Decision|1
1011916|NCT00360490|3308583|P1|Overall Study|Physician Decision|2
1011917|NCT00360490|3308582|P2|Overall Study|Lost to Follow-up|1
1011918|NCT00360490|3308583|P1|Overall Study|Lost to Follow-up|2
1011919|NCT00360490|3308582|P2|Overall Study|Adverse Event|2
1011920|NCT00360490|3308583|P1|Overall Study|Adverse Event|4
1011921|NCT00360412|3308618|P2|Overall Study|Study termination by Sponsor|469
1011922|NCT00360412|3308619|P1|Overall Study|Study termination by Sponsor|214
1011923|NCT00360412|3308618|P2|Overall Study|Not specified|6
1011924|NCT00360412|3308619|P1|Overall Study|Not specified|5
1011925|NCT00360412|3308618|P2|Overall Study|Physician Decision|4
1011926|NCT00360412|3308619|P1|Overall Study|Physician Decision|2
1011927|NCT00360412|3308618|P2|Overall Study|Lack of therapeutic efficacy|61
1011928|NCT00360412|3308619|P1|Overall Study|Lack of therapeutic efficacy|46
1011929|NCT00360412|3308618|P2|Overall Study|Patient withdrew consent|52
1011930|NCT00360412|3308619|P1|Overall Study|Patient withdrew consent|27
1011931|NCT00360412|3308618|P2|Overall Study|Protocol Violation|5
1011932|NCT00360412|3308619|P1|Overall Study|Protocol Violation|2
1011933|NCT00360412|3308618|P2|Overall Study|Adverse Event|65
1011934|NCT00360412|3308619|P1|Overall Study|Adverse Event|37
1011935|NCT00360334|3308666|P2|Overall Study|Subject decision|2
1011936|NCT00360334|3308667|P1|Overall Study|Subject decision|8
1011937|NCT00360334|3308666|P2|Overall Study|Entry criterion not met|2
1011938|NCT00360334|3308667|P1|Overall Study|Entry criterion not met|1
1011939|NCT00360334|3308666|P2|Overall Study|Lack of Efficacy|1
1011940|NCT00360334|3308667|P1|Overall Study|Lack of Efficacy|0
1011941|NCT00360334|3308666|P2|Overall Study|Physician Decision|3
1011942|NCT00360334|3308667|P1|Overall Study|Physician Decision|2
1011943|NCT00360334|3308666|P2|Overall Study|Protocol Violation|1
1011944|NCT00360334|3308667|P1|Overall Study|Protocol Violation|1
1011945|NCT00360334|3308666|P2|Overall Study|Adverse Event|4
1011946|NCT00360334|3308667|P1|Overall Study|Adverse Event|7
1011947|NCT00360308|3308730|P3|Overall Study|Study termination by sponsor|44
1011948|NCT00360308|3308731|P2|Overall Study|Study termination by sponsor|55
1011949|NCT00360308|3308732|P1|Overall Study|Study termination by sponsor|43
1011950|NCT00360308|3308730|P3|Overall Study|Not Specified|1
1011951|NCT00360308|3308731|P2|Overall Study|Not Specified|1
1011952|NCT00360308|3308732|P1|Overall Study|Not Specified|2
1011953|NCT00360308|3308730|P3|Overall Study|Lack of Efficacy|2
1011954|NCT00360308|3308731|P2|Overall Study|Lack of Efficacy|0
1011955|NCT00360308|3308732|P1|Overall Study|Lack of Efficacy|3
1011956|NCT00360308|3308730|P3|Overall Study|Withdrawal by Subject|14
1011957|NCT00360308|3308731|P2|Overall Study|Withdrawal by Subject|7
1011958|NCT00360308|3308732|P1|Overall Study|Withdrawal by Subject|11
1011959|NCT00360308|3308730|P3|Overall Study|Protocol Violation|2
1011960|NCT00360308|3308731|P2|Overall Study|Protocol Violation|1
1011961|NCT00360308|3308732|P1|Overall Study|Protocol Violation|2
1011962|NCT00360308|3308730|P3|Overall Study|Abnormal Laboratory Value(s)|0
1011963|NCT00360308|3308731|P2|Overall Study|Abnormal Laboratory Value(s)|1
1011964|NCT00360308|3308732|P1|Overall Study|Abnormal Laboratory Value(s)|0
1011965|NCT00360308|3308730|P3|Overall Study|Adverse Event|25
1011966|NCT00360308|3308731|P2|Overall Study|Adverse Event|14
1011967|NCT00360308|3308732|P1|Overall Study|Adverse Event|15
1011968|NCT00360282|3308749|P4|Second Intervention|Adverse Event|0
1011969|NCT00360282|3308750|P3|Second Intervention|Adverse Event|0
1011970|NCT00360282|3308751|P2|Second Intervention|Adverse Event|1
1011971|NCT00360282|3308752|P1|Second Intervention|Adverse Event|0
1011972|NCT00360282|3308749|P4|Washout 1-3 Weeks|Lost to Follow-up|0
1011973|NCT00360282|3308750|P3|Washout 1-3 Weeks|Lost to Follow-up|1
1011974|NCT00360282|3308751|P2|Washout 1-3 Weeks|Lost to Follow-up|0
1011975|NCT00360282|3308752|P1|Washout 1-3 Weeks|Lost to Follow-up|0
1011976|NCT00360269|3308764|P2|Overall Study|Withdrawal by Subject|1
1011977|NCT00360269|3308765|P1|Overall Study|Withdrawal by Subject|1
1011978|NCT00360269|3308764|P2|Overall Study|Adverse Event|0
1011979|NCT00360269|3308765|P1|Overall Study|Adverse Event|1
1011980|NCT00360269|3308764|P2|Overall Study|Physician Decision|2
1011981|NCT00360269|3308765|P1|Overall Study|Physician Decision|1
1011982|NCT00360269|3308764|P2|Overall Study|Lost to Follow-up|9
1011983|NCT00360269|3308765|P1|Overall Study|Lost to Follow-up|7
1011984|NCT00360230|3308807|P7|Overall Study|Death|1
1011985|NCT00360230|3308808|P6|Overall Study|Death|1
1011986|NCT00360230|3308809|P5|Overall Study|Death|0
1011987|NCT00360230|3308810|P4|Overall Study|Death|0
1011988|NCT00360230|3308811|P3|Overall Study|Death|0
1011989|NCT00360230|3308812|P2|Overall Study|Death|1
1011990|NCT00360230|3308813|P1|Overall Study|Death|0
1011991|NCT00360230|3308807|P7|Overall Study|Protocol Violation|0
1011992|NCT00360230|3308808|P6|Overall Study|Protocol Violation|1
1011993|NCT00360230|3308809|P5|Overall Study|Protocol Violation|0
1011994|NCT00360230|3308810|P4|Overall Study|Protocol Violation|0
1011995|NCT00360230|3308811|P3|Overall Study|Protocol Violation|0
1011996|NCT00360230|3308812|P2|Overall Study|Protocol Violation|0
1011997|NCT00360230|3308813|P1|Overall Study|Protocol Violation|0
1011998|NCT00360230|3308807|P7|Overall Study|Not specified|0
1011999|NCT00360230|3308808|P6|Overall Study|Not specified|0
1012000|NCT00360230|3308809|P5|Overall Study|Not specified|0
1012001|NCT00360230|3308810|P4|Overall Study|Not specified|0
1012002|NCT00360230|3308811|P3|Overall Study|Not specified|0
1012003|NCT00360230|3308812|P2|Overall Study|Not specified|0
1012004|NCT00360230|3308813|P1|Overall Study|Not specified|1
1012005|NCT00360230|3308807|P7|Overall Study|Migrated|1
1012006|NCT00360230|3308808|P6|Overall Study|Migrated|1
1012007|NCT00360230|3308809|P5|Overall Study|Migrated|4
1012008|NCT00360230|3308810|P4|Overall Study|Migrated|1
1012009|NCT00360230|3308811|P3|Overall Study|Migrated|3
1012010|NCT00360230|3308812|P2|Overall Study|Migrated|1
1012011|NCT00360230|3308813|P1|Overall Study|Migrated|4
1012012|NCT00360230|3308807|P7|Overall Study|Withdrawal by Subject|0
1012013|NCT00360230|3308808|P6|Overall Study|Withdrawal by Subject|1
1012014|NCT00360230|3308809|P5|Overall Study|Withdrawal by Subject|1
1012015|NCT00360230|3308810|P4|Overall Study|Withdrawal by Subject|1
1012016|NCT00360230|3308811|P3|Overall Study|Withdrawal by Subject|0
1012017|NCT00360230|3308812|P2|Overall Study|Withdrawal by Subject|1
1012018|NCT00360230|3308813|P1|Overall Study|Withdrawal by Subject|1
1012019|NCT00359801|3308969|P2|Overall Study|Sponsor Decision|16
1012020|NCT00359801|3308970|P1|Overall Study|Sponsor Decision|17
1012021|NCT00359801|3308969|P2|Overall Study|Final Status Unknown: missing data|4
1012022|NCT00359801|3308970|P1|Overall Study|Final Status Unknown: missing data|7
1012023|NCT00359801|3308969|P2|Overall Study|Other|46
1012024|NCT00359801|3308970|P1|Overall Study|Other|66
1012025|NCT00359801|3308969|P2|Overall Study|Withdrawal by Subject|96
1012026|NCT00359801|3308970|P1|Overall Study|Withdrawal by Subject|143
1012027|NCT00359801|3308969|P2|Overall Study|Lost to Follow-up|58
1012028|NCT00359801|3308970|P1|Overall Study|Lost to Follow-up|72
1012029|NCT00359788|3309004|P2|Overall Study|Protocol Violation|2
1012030|NCT00359788|3309005|P1|Overall Study|Protocol Violation|4
1012031|NCT00359788|3309004|P2|Overall Study|Withdrawal by Subject|1
1012032|NCT00359788|3309005|P1|Overall Study|Withdrawal by Subject|4
1012033|NCT00359788|3309004|P2|Overall Study|Lost to Follow-up|2
1012034|NCT00359788|3309005|P1|Overall Study|Lost to Follow-up|3
1012035|NCT00359788|3309004|P2|Overall Study|Lack of Efficacy|2
1012036|NCT00359788|3309005|P1|Overall Study|Lack of Efficacy|1
1012037|NCT00359788|3309004|P2|Overall Study|Adverse Event|10
1012038|NCT00359788|3309005|P1|Overall Study|Adverse Event|11
1012039|NCT00359762|3309239|P5|Period III|Subject Decision|0
1012040|NCT00359762|3309240|P4|Period III|Subject Decision|20
1012041|NCT00359762|3309241|P3|Period III|Subject Decision|8
1012042|NCT00359762|3309242|P2|Period III|Subject Decision|7
1012043|NCT00359762|3309243|P1|Period III|Subject Decision|0
1012044|NCT00359762|3309239|P5|Period III|Entry Criteria Not Met|0
1012045|NCT00359762|3309240|P4|Period III|Entry Criteria Not Met|1
1012046|NCT00359762|3309241|P3|Period III|Entry Criteria Not Met|0
1012047|NCT00359762|3309242|P2|Period III|Entry Criteria Not Met|1
1012048|NCT00359762|3309243|P1|Period III|Entry Criteria Not Met|0
1012049|NCT00359762|3309239|P5|Period III|Lost to follow up|0
1012050|NCT00359762|3309240|P4|Period III|Lost to follow up|2
1012051|NCT00359762|3309241|P3|Period III|Lost to follow up|1
1012052|NCT00359762|3309242|P2|Period III|Lost to follow up|1
1012053|NCT00359762|3309243|P1|Period III|Lost to follow up|0
1012054|NCT00359762|3309239|P5|Period III|Lack of Efficacy|0
1012055|NCT00359762|3309240|P4|Period III|Lack of Efficacy|9
1012056|NCT00359762|3309241|P3|Period III|Lack of Efficacy|5
1012057|NCT00359762|3309242|P2|Period III|Lack of Efficacy|7
1012058|NCT00359762|3309243|P1|Period III|Lack of Efficacy|0
1012059|NCT00359762|3309239|P5|Period III|Physician Decision|0
1012060|NCT00359762|3309240|P4|Period III|Physician Decision|15
1012061|NCT00359762|3309241|P3|Period III|Physician Decision|9
1012062|NCT00359762|3309242|P2|Period III|Physician Decision|5
1012063|NCT00359762|3309243|P1|Period III|Physician Decision|0
1012064|NCT00359762|3309239|P5|Period III|Adverse Event|0
1012065|NCT00359762|3309240|P4|Period III|Adverse Event|10
1012066|NCT00359762|3309241|P3|Period III|Adverse Event|4
1012067|NCT00359762|3309242|P2|Period III|Adverse Event|3
1012068|NCT00359762|3309243|P1|Period III|Adverse Event|0
1012069|NCT00359762|3309239|P5|Period III|Protocol Violation|0
1012070|NCT00359762|3309240|P4|Period III|Protocol Violation|8
1012071|NCT00359762|3309241|P3|Period III|Protocol Violation|3
1012072|NCT00359762|3309242|P2|Period III|Protocol Violation|5
1012073|NCT00359762|3309243|P1|Period III|Protocol Violation|0
1012074|NCT00359762|3309239|P5|Period II|Subject Decision|70
1012075|NCT00359762|3309240|P4|Period II|Subject Decision|0
1012076|NCT00359762|3309241|P3|Period II|Subject Decision|0
1012077|NCT00359762|3309242|P2|Period II|Subject Decision|0
1012078|NCT00359762|3309243|P1|Period II|Subject Decision|50
1012079|NCT00359762|3309239|P5|Period II|Entry Criteria Not Met|4
1012080|NCT00359762|3309240|P4|Period II|Entry Criteria Not Met|0
1012081|NCT00359762|3309241|P3|Period II|Entry Criteria Not Met|0
1012082|NCT00359762|3309242|P2|Period II|Entry Criteria Not Met|0
1012083|NCT00359762|3309243|P1|Period II|Entry Criteria Not Met|8
1012084|NCT00359762|3309239|P5|Period II|Lost to follow up|5
1012085|NCT00359762|3309240|P4|Period II|Lost to follow up|0
1012086|NCT00359762|3309241|P3|Period II|Lost to follow up|0
1012087|NCT00359762|3309242|P2|Period II|Lost to follow up|0
1012088|NCT00359762|3309243|P1|Period II|Lost to follow up|5
1012089|NCT00359762|3309239|P5|Period II|Lack of Efficacy|8
1012090|NCT00359762|3309240|P4|Period II|Lack of Efficacy|0
1012091|NCT00359762|3309241|P3|Period II|Lack of Efficacy|0
1012092|NCT00359762|3309242|P2|Period II|Lack of Efficacy|0
1012093|NCT00359762|3309243|P1|Period II|Lack of Efficacy|11
1012094|NCT00359762|3309239|P5|Period II|Death|4
1012095|NCT00359762|3309240|P4|Period II|Death|0
1012096|NCT00359762|3309241|P3|Period II|Death|0
1012097|NCT00359762|3309242|P2|Period II|Death|0
1012098|NCT00359762|3309243|P1|Period II|Death|2
1012099|NCT00359762|3309239|P5|Period II|Physician Decision|23
1012100|NCT00359762|3309240|P4|Period II|Physician Decision|0
1012101|NCT00359762|3309241|P3|Period II|Physician Decision|0
1012102|NCT00359762|3309242|P2|Period II|Physician Decision|0
1012103|NCT00359762|3309243|P1|Period II|Physician Decision|17
1012104|NCT00359762|3309239|P5|Period II|Protocol Violation|11
1012105|NCT00359762|3309240|P4|Period II|Protocol Violation|0
1012106|NCT00359762|3309241|P3|Period II|Protocol Violation|0
1012107|NCT00359762|3309242|P2|Period II|Protocol Violation|0
1012108|NCT00359762|3309243|P1|Period II|Protocol Violation|18
1012109|NCT00359762|3309239|P5|Period II|Adverse Event|49
1012110|NCT00359762|3309240|P4|Period II|Adverse Event|0
1012111|NCT00359762|3309241|P3|Period II|Adverse Event|0
1012112|NCT00359762|3309242|P2|Period II|Adverse Event|0
1012113|NCT00359762|3309243|P1|Period II|Adverse Event|17
1012114|NCT00359632|3309317|P2|Overall Study|Non-compliance with visit schedule|0
1012115|NCT00359632|3309318|P1|Overall Study|Non-compliance with visit schedule|1
1012116|NCT00359632|3309317|P2|Overall Study|Adverse Event|0
1012117|NCT00359632|3309318|P1|Overall Study|Adverse Event|1
1012118|NCT00359632|3309317|P2|Overall Study|Death|0
1012119|NCT00359632|3309318|P1|Overall Study|Death|2
1012120|NCT00359619|3309332|P7|Overall Study|Lost to Follow-up|0
1012121|NCT00359619|3309333|P6|Overall Study|Lost to Follow-up|5
1012122|NCT00359619|3309334|P5|Overall Study|Lost to Follow-up|1
1012123|NCT00359619|3309335|P4|Overall Study|Lost to Follow-up|1
1012124|NCT00359619|3309336|P3|Overall Study|Lost to Follow-up|2
1012125|NCT00359619|3309337|P2|Overall Study|Lost to Follow-up|4
1012126|NCT00359619|3309338|P1|Overall Study|Lost to Follow-up|4
1012127|NCT00359619|3309332|P7|Overall Study|Other|0
1012128|NCT00359619|3309333|P6|Overall Study|Other|0
1012129|NCT00359619|3309334|P5|Overall Study|Other|0
1012130|NCT00359619|3309335|P4|Overall Study|Other|0
1012131|NCT00359619|3309336|P3|Overall Study|Other|0
1012132|NCT00359619|3309337|P2|Overall Study|Other|0
1012133|NCT00359619|3309338|P1|Overall Study|Other|1
1012134|NCT00359619|3309332|P7|Overall Study|Withdrawal by Subject|3
1012135|NCT00359619|3309333|P6|Overall Study|Withdrawal by Subject|0
1012136|NCT00359619|3309334|P5|Overall Study|Withdrawal by Subject|2
1012137|NCT00359619|3309335|P4|Overall Study|Withdrawal by Subject|2
1012138|NCT00359619|3309336|P3|Overall Study|Withdrawal by Subject|4
1012139|NCT00359619|3309337|P2|Overall Study|Withdrawal by Subject|1
1012140|NCT00359619|3309338|P1|Overall Study|Withdrawal by Subject|3
1012141|NCT00359619|3309332|P7|Overall Study|Adverse Event|1
1012142|NCT00359619|3309333|P6|Overall Study|Adverse Event|0
1012143|NCT00359619|3309334|P5|Overall Study|Adverse Event|0
1012144|NCT00359619|3309335|P4|Overall Study|Adverse Event|0
1012145|NCT00359619|3309336|P3|Overall Study|Adverse Event|1
1012146|NCT00359619|3309337|P2|Overall Study|Adverse Event|0
1012147|NCT00359619|3309338|P1|Overall Study|Adverse Event|0
1012148|NCT00359424|3309468|P2|Overall Study|follow up not conducted|0
1012149|NCT00359424|3309469|P1|Overall Study|follow up not conducted|2
1012150|NCT00359424|3309468|P2|Overall Study|Withdrawal by Subject|2
1012151|NCT00359424|3309469|P1|Overall Study|Withdrawal by Subject|10
1012152|NCT00359424|3309468|P2|Overall Study|Lost to Follow-up|7
1012153|NCT00359424|3309469|P1|Overall Study|Lost to Follow-up|19
1012154|NCT00359424|3309468|P2|Overall Study|Death|58
1012155|NCT00359424|3309469|P1|Overall Study|Death|99
1012156|NCT00359281|3309508|P9|Overall Study|Withdrawal by Subject|0
1012157|NCT00359281|3309509|P8|Overall Study|Withdrawal by Subject|0
1012158|NCT00359281|3309510|P7|Overall Study|Withdrawal by Subject|1
1012159|NCT00359281|3309511|P6|Overall Study|Withdrawal by Subject|0
1012160|NCT00359281|3309512|P5|Overall Study|Withdrawal by Subject|0
1012161|NCT00359281|3309513|P4|Overall Study|Withdrawal by Subject|0
1012162|NCT00359281|3309514|P3|Overall Study|Withdrawal by Subject|0
1012163|NCT00359281|3309515|P2|Overall Study|Withdrawal by Subject|0
1012164|NCT00359281|3309516|P1|Overall Study|Withdrawal by Subject|0
1012165|NCT00359281|3309508|P9|Overall Study|Adverse Event|0
1012166|NCT00359281|3309509|P8|Overall Study|Adverse Event|0
1012167|NCT00359281|3309510|P7|Overall Study|Adverse Event|1
1012168|NCT00359281|3309511|P6|Overall Study|Adverse Event|0
1012169|NCT00359281|3309512|P5|Overall Study|Adverse Event|0
1012170|NCT00359281|3309513|P4|Overall Study|Adverse Event|0
1012171|NCT00359281|3309514|P3|Overall Study|Adverse Event|0
1012172|NCT00359281|3309515|P2|Overall Study|Adverse Event|0
1012173|NCT00359281|3309516|P1|Overall Study|Adverse Event|1
1012174|NCT00359073|3309579|P2|Overall Study|developed RV16 antibody|1
1012175|NCT00359073|3309580|P1|Overall Study|developed RV16 antibody|0
1012176|NCT00359073|3309579|P2|Overall Study|Eligibility criteria no longer met|0
1012177|NCT00359073|3309580|P1|Overall Study|Eligibility criteria no longer met|3
1012178|NCT00359073|3309579|P2|Overall Study|Withdrawal by Subject|1
1012179|NCT00359073|3309580|P1|Overall Study|Withdrawal by Subject|1
1012180|NCT00359021|3309592|P2|Overall Study|Pregnancy|0
1012181|NCT00359021|3309593|P1|Overall Study|Pregnancy|1
1012182|NCT00359021|3309592|P2|Overall Study|Not specified|1
1012183|NCT00359021|3309593|P1|Overall Study|Not specified|4
1012184|NCT00359021|3309592|P2|Overall Study|Lost to Follow-up|0
1012185|NCT00359021|3309593|P1|Overall Study|Lost to Follow-up|1
1012186|NCT00359021|3309592|P2|Overall Study|Withdrawal by Subject|9
1012187|NCT00359021|3309593|P1|Overall Study|Withdrawal by Subject|2
1012188|NCT00359021|3309592|P2|Overall Study|Subject Reached A Virologic Endpoint|32
1012189|NCT00359021|3309593|P1|Overall Study|Subject Reached A Virologic Endpoint|45
1012190|NCT00359021|3309592|P2|Overall Study|Subject Ineligible To Continue The Trial|0
1012191|NCT00359021|3309593|P1|Overall Study|Subject Ineligible To Continue The Trial|1
1012192|NCT00359021|3309592|P2|Overall Study|Subject Non-Compliant|2
1012193|NCT00359021|3309593|P1|Overall Study|Subject Non-Compliant|1
1012194|NCT00359021|3309592|P2|Overall Study|Adverse Event|8
1012195|NCT00359021|3309593|P1|Overall Study|Adverse Event|26
1012196|NCT00358956|3309605|P1|Overall Study|Withdrawal by Subject|1
1012197|NCT00358956|3309605|P1|Overall Study|condition under investigation worsened|4
1012198|NCT00358956|3309605|P1|Overall Study|Adverse Event|3
1012199|NCT00358917|3309617|P2|Overall Study|Unable to Continue Participation|2
1012200|NCT00358917|3309618|P1|Overall Study|Unable to Continue Participation|2
1012201|NCT00358917|3309617|P2|Overall Study|Virologic failure|8
1012202|NCT00358917|3309618|P1|Overall Study|Virologic failure|11
1012203|NCT00358917|3309617|P2|Overall Study|Death|3
1012204|NCT00358917|3309618|P1|Overall Study|Death|2
1012205|NCT00358917|3309617|P2|Overall Study|Noncompliance|11
1012206|NCT00358917|3309618|P1|Overall Study|Noncompliance|12
1012207|NCT00358917|3309617|P2|Overall Study|Lost to Follow-up|17
1012208|NCT00358917|3309618|P1|Overall Study|Lost to Follow-up|20
1012209|NCT00358917|3309617|P2|Overall Study|Withdrawal by Subject|7
1012210|NCT00358917|3309618|P1|Overall Study|Withdrawal by Subject|5
1012211|NCT00358917|3309617|P2|Overall Study|Adverse Event|21
1012212|NCT00358917|3309618|P1|Overall Study|Adverse Event|14
1012213|NCT00358826|3309636|P8|MDCT Substudy|Withdrawal by Subject|0
1012214|NCT00358826|3309637|P7|MDCT Substudy|Withdrawal by Subject|0
1012215|NCT00358826|3309638|P6|MDCT Substudy|Withdrawal by Subject|1
1012216|NCT00358826|3309639|P5|MDCT Substudy|Withdrawal by Subject|0
1012217|NCT00358826|3309640|P4|MDCT Substudy|Withdrawal by Subject|0
1012218|NCT00358826|3309641|P3|MDCT Substudy|Withdrawal by Subject|0
1012219|NCT00358826|3309642|P2|MDCT Substudy|Withdrawal by Subject|0
1012220|NCT00358826|3309643|P1|MDCT Substudy|Withdrawal by Subject|0
1012221|NCT00358826|3309636|P8|MDCT Substudy|Lost to Follow-up|0
1012222|NCT00358826|3309637|P7|MDCT Substudy|Lost to Follow-up|0
1012223|NCT00358826|3309638|P6|MDCT Substudy|Lost to Follow-up|1
1012224|NCT00358826|3309639|P5|MDCT Substudy|Lost to Follow-up|0
1012225|NCT00358826|3309640|P4|MDCT Substudy|Lost to Follow-up|0
1012226|NCT00358826|3309641|P3|MDCT Substudy|Lost to Follow-up|0
1012227|NCT00358826|3309642|P2|MDCT Substudy|Lost to Follow-up|0
1012228|NCT00358826|3309643|P1|MDCT Substudy|Lost to Follow-up|0
1012229|NCT00358826|3309636|P8|MDCT Substudy|Adverse Event|0
1012230|NCT00358826|3309637|P7|MDCT Substudy|Adverse Event|0
1012231|NCT00358826|3309638|P6|MDCT Substudy|Adverse Event|0
1012232|NCT00358826|3309639|P5|MDCT Substudy|Adverse Event|1
1012233|NCT00358826|3309640|P4|MDCT Substudy|Adverse Event|0
1012234|NCT00358826|3309641|P3|MDCT Substudy|Adverse Event|0
1012235|NCT00358826|3309642|P2|MDCT Substudy|Adverse Event|0
1012236|NCT00358826|3309643|P1|MDCT Substudy|Adverse Event|0
1012237|NCT00358826|3309636|P8|Core Study|Physician Decision|0
1012238|NCT00358826|3309637|P7|Core Study|Physician Decision|0
1012239|NCT00358826|3309638|P6|Core Study|Physician Decision|0
1012240|NCT00358826|3309639|P5|Core Study|Physician Decision|0
1012241|NCT00358826|3309640|P4|Core Study|Physician Decision|0
1012242|NCT00358826|3309641|P3|Core Study|Physician Decision|1
1012243|NCT00358826|3309642|P2|Core Study|Physician Decision|0
1012244|NCT00358826|3309643|P1|Core Study|Physician Decision|0
1012245|NCT00358826|3309636|P8|Core Study|Lost to Follow-up|0
1012246|NCT00358826|3309637|P7|Core Study|Lost to Follow-up|0
1012247|NCT00358826|3309638|P6|Core Study|Lost to Follow-up|0
1012248|NCT00358826|3309639|P5|Core Study|Lost to Follow-up|0
1012249|NCT00358826|3309640|P4|Core Study|Lost to Follow-up|1
1012250|NCT00358826|3309641|P3|Core Study|Lost to Follow-up|0
1012251|NCT00358826|3309642|P2|Core Study|Lost to Follow-up|0
1012252|NCT00358826|3309643|P1|Core Study|Lost to Follow-up|0
1012253|NCT00358826|3309636|P8|Core Study|Withdrawal by Subject|0
1012254|NCT00358826|3309637|P7|Core Study|Withdrawal by Subject|0
1012255|NCT00358826|3309638|P6|Core Study|Withdrawal by Subject|0
1012256|NCT00358826|3309639|P5|Core Study|Withdrawal by Subject|0
1012257|NCT00358826|3309640|P4|Core Study|Withdrawal by Subject|0
1012258|NCT00358826|3309641|P3|Core Study|Withdrawal by Subject|0
1012259|NCT00358826|3309642|P2|Core Study|Withdrawal by Subject|2
1012260|NCT00358826|3309643|P1|Core Study|Withdrawal by Subject|2
1012261|NCT00358826|3309636|P8|Core Study|Adverse Event|0
1012262|NCT00358826|3309637|P7|Core Study|Adverse Event|0
1012263|NCT00358826|3309638|P6|Core Study|Adverse Event|0
1012264|NCT00358826|3309639|P5|Core Study|Adverse Event|0
1012265|NCT00358826|3309640|P4|Core Study|Adverse Event|1
1012266|NCT00358826|3309641|P3|Core Study|Adverse Event|1
1012267|NCT00358826|3309642|P2|Core Study|Adverse Event|3
1012268|NCT00358826|3309643|P1|Core Study|Adverse Event|1
1012269|NCT00358670|3309710|P2|Overall Study|Administrative|125
1012270|NCT00358670|3309711|P1|Overall Study|Administrative|153
1012271|NCT00358670|3309710|P2|Overall Study|Did Not Meet Protocol Eligibility|3
1012272|NCT00358670|3309711|P1|Overall Study|Did Not Meet Protocol Eligibility|0
1012273|NCT00358670|3309710|P2|Overall Study|Protocol Defined Clinical Event|1
1012274|NCT00358670|3309711|P1|Overall Study|Protocol Defined Clinical Event|0
1012275|NCT00358670|3309710|P2|Overall Study|Withdrawal by Subject|24
1012276|NCT00358670|3309711|P1|Overall Study|Withdrawal by Subject|13
1012277|NCT00358670|3309710|P2|Overall Study|Lost to Follow-up|5
1012278|NCT00358670|3309711|P1|Overall Study|Lost to Follow-up|4
1012279|NCT00358670|3309710|P2|Overall Study|Protocol Violation|9
1012280|NCT00358670|3309711|P1|Overall Study|Protocol Violation|6
1012281|NCT00358670|3309710|P2|Overall Study|Lack of Efficacy|23
1012282|NCT00358670|3309711|P1|Overall Study|Lack of Efficacy|20
1012283|NCT00358670|3309710|P2|Overall Study|Adverse Event|29
1012284|NCT00358670|3309711|P1|Overall Study|Adverse Event|26
1012285|NCT00358644|3309725|P1|Overall Study|Patient not eligible for study|1
1012286|NCT00358644|3309725|P1|Overall Study|Physician Decision|6
1012287|NCT00358644|3309725|P1|Overall Study|Withdrawal by Subject|4
1012288|NCT00358644|3309725|P1|Overall Study|Death|11
1012289|NCT00358644|3309725|P1|Overall Study|Adverse Event|7
1012290|NCT00358644|3309725|P1|Overall Study|Progressive Disease|21
1012291|NCT00358527|3309748|P2|Overall Study|Administrative|1
1012292|NCT00358527|3309749|P1|Overall Study|Administrative|2
1012293|NCT00358527|3309748|P2|Overall Study|Non-compliance with protocol|1
1012294|NCT00358527|3309749|P1|Overall Study|Non-compliance with protocol|6
1012295|NCT00358527|3309748|P2|Overall Study|Withdrawal by Subject|1
1012296|NCT00358527|3309749|P1|Overall Study|Withdrawal by Subject|1
1012297|NCT00358527|3309748|P2|Overall Study|Adverse Event|0
1012298|NCT00358527|3309749|P1|Overall Study|Adverse Event|4
1012299|NCT00358449|3309799|P3|Overall Study|Steriod Inhaler was Increased|1
1012300|NCT00358449|3309800|P2|Overall Study|Steriod Inhaler was Increased|0
1012301|NCT00358449|3309801|P1|Overall Study|Steriod Inhaler was Increased|0
1012302|NCT00358449|3309799|P3|Overall Study|Lack of Efficacy|0
1012303|NCT00358449|3309800|P2|Overall Study|Lack of Efficacy|1
1012304|NCT00358449|3309801|P1|Overall Study|Lack of Efficacy|0
1012305|NCT00358449|3309799|P3|Overall Study|Withdrawal by Subject|0
1012306|NCT00358449|3309800|P2|Overall Study|Withdrawal by Subject|0
1012307|NCT00358449|3309801|P1|Overall Study|Withdrawal by Subject|2
1012308|NCT00358449|3309799|P3|Overall Study|Lost to Follow-up|0
1012309|NCT00358449|3309800|P2|Overall Study|Lost to Follow-up|0
1012310|NCT00358449|3309801|P1|Overall Study|Lost to Follow-up|1
1012311|NCT00358449|3309799|P3|Overall Study|Adverse Event|1
1012312|NCT00358449|3309800|P2|Overall Study|Adverse Event|0
1012313|NCT00358449|3309801|P1|Overall Study|Adverse Event|1
1012314|NCT00358436|3309904|P2|Overall Study|Other|1
1012315|NCT00358436|3309905|P1|Overall Study|Other|6
1012316|NCT00358436|3309904|P2|Overall Study|COPD exacerbation|10
1012317|NCT00358436|3309905|P1|Overall Study|COPD exacerbation|22
1012318|NCT00358436|3309904|P2|Overall Study|Non-fulfilment of inclusion/exclusion|0
1012319|NCT00358436|3309905|P1|Overall Study|Non-fulfilment of inclusion/exclusion|4
1012320|NCT00358436|3309904|P2|Overall Study|Withdrawal by Subject|17
1012321|NCT00358436|3309905|P1|Overall Study|Withdrawal by Subject|40
1012322|NCT00358436|3309904|P2|Overall Study|Protocol Violation|3
1012323|NCT00358436|3309905|P1|Overall Study|Protocol Violation|8
1012324|NCT00358436|3309904|P2|Overall Study|Lost to Follow-up|6
1012325|NCT00358436|3309905|P1|Overall Study|Lost to Follow-up|11
1012326|NCT00358436|3309904|P2|Overall Study|Lack of Efficacy|36
1012327|NCT00358436|3309905|P1|Overall Study|Lack of Efficacy|34
1012328|NCT00358436|3309904|P2|Overall Study|Adverse Event|13
1012329|NCT00358436|3309905|P1|Overall Study|Adverse Event|29
1012330|NCT00358215|3309976|P2|Overall Study|Did not receive investigational product|3
1012331|NCT00358215|3309977|P1|Overall Study|Did not receive investigational product|2
1012332|NCT00358215|3309976|P2|Overall Study|Other|14
1012333|NCT00358215|3309977|P1|Overall Study|Other|21
1012334|NCT00358215|3309976|P2|Overall Study|Pregnancy|0
1012335|NCT00358215|3309977|P1|Overall Study|Pregnancy|1
1012336|NCT00358215|3309976|P2|Overall Study|Protocol Violation|59
1012337|NCT00358215|3309977|P1|Overall Study|Protocol Violation|64
1012338|NCT00358215|3309976|P2|Overall Study|Death|281
1012339|NCT00358215|3309977|P1|Overall Study|Death|265
1012340|NCT00358215|3309976|P2|Overall Study|Lost to Follow-up|22
1012341|NCT00358215|3309977|P1|Overall Study|Lost to Follow-up|16
1012342|NCT00358215|3309976|P2|Overall Study|Physician Decision|39
1012343|NCT00358215|3309977|P1|Overall Study|Physician Decision|47
1012344|NCT00358215|3309976|P2|Overall Study|Participant request|64
1012345|NCT00358215|3309977|P1|Overall Study|Participant request|65
1012346|NCT00358215|3309976|P2|Overall Study|Withdrawal by Subject|102
1012347|NCT00358215|3309977|P1|Overall Study|Withdrawal by Subject|111
1012348|NCT00358215|3309976|P2|Overall Study|Adverse Event|65
1012349|NCT00358215|3309977|P1|Overall Study|Adverse Event|83
1012350|NCT00358215|3309976|P2|Overall Study|Ineligibility determined|3
1012351|NCT00358215|3309977|P1|Overall Study|Ineligibility determined|4
1012352|NCT00358150|3309991|P1|Overall Study|Undefined|3
1012353|NCT00358150|3309991|P1|Overall Study|Withdrawal by Subject|1
1012354|NCT00358150|3309991|P1|Overall Study|Adverse Event|3
1012355|NCT00357994|3310020|P2|Overall Study|Protocol Violation|0
1012356|NCT00357994|3310021|P1|Overall Study|Protocol Violation|1
1012357|NCT00357994|3310020|P2|Overall Study|Lack of Efficacy|1
1012358|NCT00357994|3310021|P1|Overall Study|Lack of Efficacy|0
1012359|NCT00357994|3310020|P2|Overall Study|Adverse Event|2
1012360|NCT00357994|3310021|P1|Overall Study|Adverse Event|1
1012361|NCT00357968|3310075|P2|First Maintenance Dose Phase|Withdrawal by Subject|2
1012362|NCT00357968|3310076|P1|First Maintenance Dose Phase|Withdrawal by Subject|1
1012363|NCT00357968|3310075|P2|First Maintenance Dose Phase|Not a PCI patient|42
1012364|NCT00357968|3310076|P1|First Maintenance Dose Phase|Not a PCI patient|47
1012365|NCT00357903|3310129|P2|Overall Study|Other|10
1012366|NCT00357903|3310130|P1|Overall Study|Other|49
1012367|NCT00357903|3310129|P2|Overall Study|Response status|9
1012368|NCT00357903|3310130|P1|Overall Study|Response status|61
1012369|NCT00357903|3310129|P2|Overall Study|Protocol issues|3
1012370|NCT00357903|3310130|P1|Overall Study|Protocol issues|14
1012371|NCT00357903|3310129|P2|Overall Study|Completed month 12 only|1
1012372|NCT00357903|3310130|P1|Overall Study|Completed month 12 only|0
1012373|NCT00357903|3310129|P2|Overall Study|Withdrawal by Subject|7
1012374|NCT00357903|3310130|P1|Overall Study|Withdrawal by Subject|57
1012375|NCT00357903|3310129|P2|Overall Study|Physician Decision|5
1012376|NCT00357903|3310130|P1|Overall Study|Physician Decision|39
1012377|NCT00357903|3310129|P2|Overall Study|Lost to Follow-up|4
1012378|NCT00357903|3310130|P1|Overall Study|Lost to Follow-up|23
1012379|NCT00357903|3310129|P2|Overall Study|Death|0
1012380|NCT00357903|3310130|P1|Overall Study|Death|33
1012381|NCT00357903|3310129|P2|Overall Study|Adverse Event|4
1012382|NCT00357903|3310130|P1|Overall Study|Adverse Event|87
1012383|NCT00357877|3310170|P2|Overall Study|Other|2
1012384|NCT00357877|3310171|P1|Overall Study|Other|0
1012385|NCT00357877|3310170|P2|Overall Study|Administrative withdrawal|1
1012386|NCT00357877|3310171|P1|Overall Study|Administrative withdrawal|1
1012387|NCT00357877|3310170|P2|Overall Study|Withdrawal by Subject|3
1012388|NCT00357877|3310171|P1|Overall Study|Withdrawal by Subject|3
1012389|NCT00357877|3310170|P2|Overall Study|Lost to Follow-up|23
1012390|NCT00357877|3310171|P1|Overall Study|Lost to Follow-up|20
1012391|NCT00357877|3310170|P2|Overall Study|Death|1
1012392|NCT00357877|3310171|P1|Overall Study|Death|2
1012393|NCT00357760|3310185|P2|Overall Study|To receive hospice care|1
1012394|NCT00357760|3310186|P1|Overall Study|To receive hospice care|0
1012395|NCT00357760|3310185|P2|Overall Study|Protocol Violation|1
1012396|NCT00357760|3310186|P1|Overall Study|Protocol Violation|0
1012397|NCT00357760|3310185|P2|Overall Study|Physician Decision|1
1012398|NCT00357760|3310186|P1|Overall Study|Physician Decision|2
1012399|NCT00357760|3310185|P2|Overall Study|Ineligible|2
1012400|NCT00357760|3310186|P1|Overall Study|Ineligible|0
1012401|NCT00357760|3310185|P2|Overall Study|Never started treatment|1
1012402|NCT00357760|3310186|P1|Overall Study|Never started treatment|2
1012403|NCT00357760|3310185|P2|Overall Study|Withdrawal by Subject|2
1012404|NCT00357760|3310186|P1|Overall Study|Withdrawal by Subject|0
1012405|NCT00357760|3310185|P2|Overall Study|Alternative therapy|0
1012406|NCT00357760|3310186|P1|Overall Study|Alternative therapy|1
1012407|NCT00357760|3310185|P2|Overall Study|Death|3
1012408|NCT00357760|3310186|P1|Overall Study|Death|0
1012409|NCT00357760|3310185|P2|Overall Study|Adverse Event|7
1012410|NCT00357760|3310186|P1|Overall Study|Adverse Event|10
1012411|NCT00357760|3310185|P2|Overall Study|Disease progression|17
1012412|NCT00357760|3310186|P1|Overall Study|Disease progression|44
1012413|NCT00357656|3310207|P2|Overall Study|Other, No surgery performed|3
1012414|NCT00357656|3310208|P1|Overall Study|Other, No surgery performed|0
1012415|NCT00357552|3310259|P1|Weeks 24 to 104|Not able to get to clinic|2
1012416|NCT00357552|3310259|P1|Weeks 24 to 104|Death|3
1012417|NCT00357552|3310259|P1|Weeks 0 to 24|Death|1
1012418|NCT00357552|3310259|P1|Screening|Did not meet eligibility criteria|84
1012419|NCT00357500|3310274|P1|Overall Study|Not Started Protocol Therapy|4
1012420|NCT00357500|3310274|P1|Overall Study|Progressive Disease|65
1012421|NCT00357500|3310274|P1|Overall Study|Withdrawal by Subject|5
1012422|NCT00357500|3310274|P1|Overall Study|Adverse Event|3
1012423|NCT00357396|3310283|P2|Overall Study|Adverse Event|0
1012424|NCT00357396|3310284|P1|Overall Study|Adverse Event|1
1012425|NCT00357370|3310292|P3|Cohort 2|Withdrawal by Subject|0
1012426|NCT00357370|3310293|P2|Cohort 2|Withdrawal by Subject|2
1012427|NCT00357370|3310294|P1|Cohort 2|Withdrawal by Subject|0
1012428|NCT00357370|3310292|P3|Cohort 2|non-compliance, not met criteria, etc|0
1012429|NCT00357370|3310293|P2|Cohort 2|non-compliance, not met criteria, etc|1
1012430|NCT00357370|3310294|P1|Cohort 2|non-compliance, not met criteria, etc|1
1012431|NCT00357370|3310292|P3|Cohort 2|Lost to Follow-up|0
1012432|NCT00357370|3310293|P2|Cohort 2|Lost to Follow-up|1
1012433|NCT00357370|3310294|P1|Cohort 2|Lost to Follow-up|0
1012434|NCT00357370|3310292|P3|Cohort 2|Adverse Event|1
1012435|NCT00357370|3310293|P2|Cohort 2|Adverse Event|1
1012436|NCT00357370|3310294|P1|Cohort 2|Adverse Event|1
1012437|NCT00357370|3310292|P3|Cohort 2|Lack of Efficacy|1
1012438|NCT00357370|3310293|P2|Cohort 2|Lack of Efficacy|2
1012439|NCT00357370|3310294|P1|Cohort 2|Lack of Efficacy|0
1012440|NCT00357110|3310340|P2|Overall Study|Early study termination|5
1012441|NCT00357110|3310341|P1|Overall Study|Early study termination|5
1012442|NCT00357097|3310349|P2|Overall Study|Increase of RLS Symptoms|1
1012443|NCT00357097|3310350|P1|Overall Study|Increase of RLS Symptoms|0
1012444|NCT00357097|3310349|P2|Overall Study|Other|1
1012445|NCT00357097|3310350|P1|Overall Study|Other|1
1012446|NCT00357097|3310349|P2|Overall Study|Met Exclusion Criteria|1
1012447|NCT00357097|3310350|P1|Overall Study|Met Exclusion Criteria|3
1012448|NCT00357097|3310349|P2|Overall Study|Lack of Efficacy|8
1012449|NCT00357097|3310350|P1|Overall Study|Lack of Efficacy|2
1012450|NCT00357097|3310349|P2|Overall Study|Non-compliance|2
1012451|NCT00357097|3310350|P1|Overall Study|Non-compliance|1
1012452|NCT00357097|3310349|P2|Overall Study|Withdrawal by Subject|7
1012453|NCT00357097|3310350|P1|Overall Study|Withdrawal by Subject|8
1012454|NCT00357097|3310349|P2|Overall Study|Adverse Event|6
1012455|NCT00357097|3310350|P1|Overall Study|Adverse Event|34
1012456|NCT00357097|3310349|P2|Overall Study|Did not meet inclusion criteria|3
1012457|NCT00357097|3310350|P1|Overall Study|Did not meet inclusion criteria|5
1012458|NCT00357006|3310404|P3|Overall Study|Withdrawal by Subject|2
1012459|NCT00357006|3310405|P2|Overall Study|Withdrawal by Subject|3
1012460|NCT00357006|3310406|P1|Overall Study|Withdrawal by Subject|1
1012461|NCT00357006|3310404|P3|Overall Study|Lost to Follow-up|1
1012462|NCT00357006|3310405|P2|Overall Study|Lost to Follow-up|2
1012463|NCT00357006|3310406|P1|Overall Study|Lost to Follow-up|1
1012464|NCT00356915|3310417|P3|Overall Study|Miscellaneous reasons|3
1012465|NCT00356915|3310418|P2|Overall Study|Miscellaneous reasons|8
1012466|NCT00356915|3310419|P1|Overall Study|Miscellaneous reasons|11
1012467|NCT00356915|3310417|P3|Overall Study|Adverse Event|8
1012468|NCT00356915|3310418|P2|Overall Study|Adverse Event|31
1012469|NCT00356915|3310419|P1|Overall Study|Adverse Event|21
1012470|NCT00356915|3310417|P3|Overall Study|Physician Decision|0
1012471|NCT00356915|3310418|P2|Overall Study|Physician Decision|2
1012472|NCT00356915|3310419|P1|Overall Study|Physician Decision|0
1012473|NCT00356915|3310417|P3|Overall Study|Administrative Decision|1
1012474|NCT00356915|3310418|P2|Overall Study|Administrative Decision|0
1012475|NCT00356915|3310419|P1|Overall Study|Administrative Decision|0
1012476|NCT00356915|3310417|P3|Overall Study|Lost to Follow-up|14
1012477|NCT00356915|3310418|P2|Overall Study|Lost to Follow-up|34
1012478|NCT00356915|3310419|P1|Overall Study|Lost to Follow-up|27
1012479|NCT00356915|3310417|P3|Overall Study|Lack of Efficacy|3
1012480|NCT00356915|3310418|P2|Overall Study|Lack of Efficacy|0
1012481|NCT00356915|3310419|P1|Overall Study|Lack of Efficacy|0
1012482|NCT00356915|3310417|P3|Overall Study|Withdrawal by Subject|10
1012483|NCT00356915|3310418|P2|Overall Study|Withdrawal by Subject|14
1012484|NCT00356915|3310419|P1|Overall Study|Withdrawal by Subject|14
1012485|NCT00356915|3310417|P3|Overall Study|Protocol Violation|2
1012486|NCT00356915|3310418|P2|Overall Study|Protocol Violation|3
1012487|NCT00356915|3310419|P1|Overall Study|Protocol Violation|2
1012488|NCT00356915|3310417|P3|Overall Study|Non compliance|1
1012489|NCT00356915|3310418|P2|Overall Study|Non compliance|2
1012490|NCT00356915|3310419|P1|Overall Study|Non compliance|1
1012491|NCT00356889|3310436|P1|Overall Study|Adverse Event|1
1012492|NCT00356889|3310436|P1|Overall Study|Protocol Violation|2
1012493|NCT00356863|3310445|P2|Overall Study|Lost to Follow-up|43
1012494|NCT00356863|3310446|P1|Overall Study|Lost to Follow-up|76
1012495|NCT00356863|3310445|P2|Overall Study|Death|32
1012496|NCT00356863|3310446|P1|Overall Study|Death|16
1012497|NCT00356811|3310472|P1|Overall Study|Site Closed during Follow-up|2
1012498|NCT00356811|3310472|P1|Overall Study|Study Is Terminating|3
1012499|NCT00356811|3310472|P1|Overall Study|Participant Could Not Make a Checkup|1
1012500|NCT00356811|3310472|P1|Overall Study|Withdrawal by Subject|6
1012501|NCT00356811|3310472|P1|Overall Study|Lost to Follow-up|2
1012502|NCT00356811|3310472|P1|Overall Study|Death|35
1012503|NCT00356759|3310487|P2|Overall Study|Intercurrent disease or persistent extre|2
1012504|NCT00356759|3310488|P1|Overall Study|Intercurrent disease or persistent extre|5
1012505|NCT00356759|3310487|P2|Overall Study|Lost to Follow-up|1
1012506|NCT00356759|3310488|P1|Overall Study|Lost to Follow-up|1
1012507|NCT00356759|3310487|P2|Overall Study|Adverse Event|3
1012508|NCT00356759|3310488|P1|Overall Study|Adverse Event|1
1012509|NCT00356759|3310487|P2|Overall Study|Withdrawal by Subject|2
1012510|NCT00356759|3310488|P1|Overall Study|Withdrawal by Subject|2
1012511|NCT00356759|3310487|P2|Overall Study|Death|2
1012512|NCT00356759|3310488|P1|Overall Study|Death|5
1012513|NCT00356603|3310506|P2|Overall Study|Other|3
1012514|NCT00356603|3310507|P1|Overall Study|Other|6
1012515|NCT00356590|3310521|P1|Overall Study|Other|52
1012516|NCT00356590|3310521|P1|Overall Study|Response status|28
1012517|NCT00356590|3310521|P1|Overall Study|Protocol issues|6
1012518|NCT00356590|3310521|P1|Overall Study|Completed month 12 only|2
1012519|NCT00356590|3310521|P1|Overall Study|Withdrawal by Subject|41
1012520|NCT00356590|3310521|P1|Overall Study|Physician Decision|46
1012521|NCT00356590|3310521|P1|Overall Study|Lost to Follow-up|35
1012522|NCT00356590|3310521|P1|Overall Study|Death|10
1012523|NCT00356590|3310521|P1|Overall Study|Adverse Event|54
1012524|NCT00356525|3310557|P4|Overall Study|Sponsor Decision|1
1012525|NCT00356525|3310558|P3|Overall Study|Sponsor Decision|0
1012526|NCT00356525|3310559|P2|Overall Study|Sponsor Decision|0
1012527|NCT00356525|3310560|P1|Overall Study|Sponsor Decision|0
1012528|NCT00356525|3310557|P4|Overall Study|Death|1
1012529|NCT00356525|3310558|P3|Overall Study|Death|0
1012530|NCT00356525|3310559|P2|Overall Study|Death|0
1012531|NCT00356525|3310560|P1|Overall Study|Death|0
1012532|NCT00356525|3310557|P4|Overall Study|Withdrawal by Subject|3
1012533|NCT00356525|3310558|P3|Overall Study|Withdrawal by Subject|0
1012534|NCT00356525|3310559|P2|Overall Study|Withdrawal by Subject|1
1012535|NCT00356525|3310560|P1|Overall Study|Withdrawal by Subject|1
1012536|NCT00356525|3310557|P4|Overall Study|Protocol Entry Criteria Not Met|0
1012537|NCT00356525|3310558|P3|Overall Study|Protocol Entry Criteria Not Met|0
1012538|NCT00356525|3310559|P2|Overall Study|Protocol Entry Criteria Not Met|0
1012539|NCT00356525|3310560|P1|Overall Study|Protocol Entry Criteria Not Met|1
1012540|NCT00356525|3310557|P4|Overall Study|Physician Decision|1
1012541|NCT00356525|3310558|P3|Overall Study|Physician Decision|2
1012542|NCT00356525|3310559|P2|Overall Study|Physician Decision|2
1012543|NCT00356525|3310560|P1|Overall Study|Physician Decision|2
1012544|NCT00356525|3310557|P4|Overall Study|Lost to Follow-up|0
1012545|NCT00356525|3310558|P3|Overall Study|Lost to Follow-up|0
1012546|NCT00356525|3310559|P2|Overall Study|Lost to Follow-up|0
1012547|NCT00356525|3310560|P1|Overall Study|Lost to Follow-up|1
1012548|NCT00356525|3310557|P4|Overall Study|Adverse Event|1
1012549|NCT00356525|3310558|P3|Overall Study|Adverse Event|1
1012550|NCT00356525|3310559|P2|Overall Study|Adverse Event|3
1012551|NCT00356525|3310560|P1|Overall Study|Adverse Event|1
1012552|NCT00356525|3310557|P4|Overall Study|Progressive Disease|2
1012553|NCT00356525|3310558|P3|Overall Study|Progressive Disease|4
1012554|NCT00356525|3310559|P2|Overall Study|Progressive Disease|5
1012555|NCT00356525|3310560|P1|Overall Study|Progressive Disease|8
1012556|NCT00356421|3310601|P2|Overall Study|Not related to study drug|3
1012557|NCT00356421|3310602|P1|Overall Study|Not related to study drug|5
1012558|NCT00356421|3310601|P2|Overall Study|Related to study drug|12
1012559|NCT00356421|3310602|P1|Overall Study|Related to study drug|15
1012560|NCT00356421|3310601|P2|Overall Study|Withdrawal by Subject|2
1012561|NCT00356421|3310602|P1|Overall Study|Withdrawal by Subject|9
1012562|NCT00356421|3310601|P2|Overall Study|Lack of Efficacy|0
1012563|NCT00356421|3310602|P1|Overall Study|Lack of Efficacy|3
1012564|NCT00356408|3310642|P1|Overall Study|Other: Subject chose commerical dosing|1
1012565|NCT00356408|3310642|P1|Overall Study|Other: Failed to meet Inc/Exc criteria|1
1012566|NCT00356408|3310642|P1|Overall Study|Other: Azathioprine stopped|1
1012567|NCT00356408|3310642|P1|Overall Study|Other: Sponsor request|1
1012568|NCT00356408|3310642|P1|Overall Study|Other: Principal investigator discretion|3
1012569|NCT00356408|3310642|P1|Overall Study|Withdrawal by Subject|6
1012570|NCT00356408|3310642|P1|Overall Study|Lost to Follow-up|2
1012571|NCT00356408|3310642|P1|Overall Study|Lack of Efficacy|36
1012572|NCT00356408|3310642|P1|Overall Study|Adverse Event|9
1012573|NCT00356369|3310659|P2|Active Phase|Withdrawal by Subject|1
1012574|NCT00356369|3310660|P1|Active Phase|Withdrawal by Subject|2
1012575|NCT00356278|3310742|P3|Overall Study|Withdrawal by Subject|19
1012576|NCT00356278|3310743|P2|Overall Study|Withdrawal by Subject|15
1012577|NCT00356278|3310744|P1|Overall Study|Withdrawal by Subject|25
1012578|NCT00356265|3310782|P3|Overall Study|Withdrawal by Subject|1
1012579|NCT00356265|3310783|P2|Overall Study|Withdrawal by Subject|0
1012580|NCT00356265|3310784|P1|Overall Study|Withdrawal by Subject|0
1012581|NCT00356200|3310796|P2|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2
1012582|NCT00356200|3310797|P1|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0
1012583|NCT00356200|3310796|P2|Cohort 1: 10 ug/ml|Lack of Efficacy|0
1012584|NCT00356200|3310797|P1|Cohort 1: 10 ug/ml|Lack of Efficacy|1
1012585|NCT00356148|3310826|P2|Overall Study|Reoperation within 30 days|1
1012586|NCT00356148|3310827|P1|Overall Study|Reoperation within 30 days|2
1012587|NCT00356135|3310838|P3|Overall Study|Subject non-compliance|3
1012588|NCT00356135|3310839|P2|Overall Study|Subject non-compliance|1
1012589|NCT00356135|3310840|P1|Overall Study|Subject non-compliance|1
1012590|NCT00356135|3310838|P3|Overall Study|Physician Decision|1
1012591|NCT00356135|3310839|P2|Overall Study|Physician Decision|1
1012592|NCT00356135|3310840|P1|Overall Study|Physician Decision|1
1012593|NCT00356135|3310838|P3|Overall Study|Lost to Follow-up|1
1012594|NCT00356135|3310839|P2|Overall Study|Lost to Follow-up|0
1012595|NCT00356135|3310840|P1|Overall Study|Lost to Follow-up|0
1012596|NCT00356135|3310838|P3|Overall Study|Adverse Event|0
1012597|NCT00356135|3310839|P2|Overall Study|Adverse Event|0
1012598|NCT00356135|3310840|P1|Overall Study|Adverse Event|1
1012599|NCT00356135|3310838|P3|Overall Study|Protocol Violation|0
1012600|NCT00356135|3310839|P2|Overall Study|Protocol Violation|0
1012601|NCT00356135|3310840|P1|Overall Study|Protocol Violation|1
1012602|NCT00356122|3310862|P1|FOLLOW-UP|Other|2
1012603|NCT00356122|3310862|P1|FOLLOW-UP|Lost to Follow-up|2
1012604|NCT00356122|3310862|P1|FOLLOW-UP|Death|37
1012605|NCT00356122|3310862|P1|TREATMENT|Did not receive study medication|1
1012606|NCT00356122|3310862|P1|TREATMENT|Other|4
1012607|NCT00356122|3310862|P1|TREATMENT|Subject's request|4
1012608|NCT00356122|3310862|P1|TREATMENT|Adverse Event|10
1012609|NCT00356122|3310862|P1|TREATMENT|Lack of Efficacy|26
1012610|NCT00355784|3310970|P3|Overall Study|Withdrawal by Subject|2
1012611|NCT00355784|3310971|P2|Overall Study|Withdrawal by Subject|0
1012612|NCT00355784|3310972|P1|Overall Study|Withdrawal by Subject|0
1012613|NCT00355615|3311021|P5|40-week Rosuvastatin Open Label Period|investigational site closed|1
1012614|NCT00355615|3311022|P4|40-week Rosuvastatin Open Label Period|investigational site closed|0
1012615|NCT00355615|3311023|P3|40-week Rosuvastatin Open Label Period|investigational site closed|0
1012616|NCT00355615|3311024|P2|40-week Rosuvastatin Open Label Period|investigational site closed|0
1012617|NCT00355615|3311025|P1|40-week Rosuvastatin Open Label Period|investigational site closed|0
1012618|NCT00355615|3311021|P5|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3
1012619|NCT00355615|3311022|P4|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
1012620|NCT00355615|3311023|P3|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
1012621|NCT00355615|3311024|P2|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
1012622|NCT00355615|3311025|P1|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
1012623|NCT00355615|3311021|P5|40-week Rosuvastatin Open Label Period|Protocol Violation|1
1012624|NCT00355615|3311022|P4|40-week Rosuvastatin Open Label Period|Protocol Violation|0
1012625|NCT00355615|3311023|P3|40-week Rosuvastatin Open Label Period|Protocol Violation|0
1012626|NCT00355615|3311024|P2|40-week Rosuvastatin Open Label Period|Protocol Violation|0
1012627|NCT00355615|3311025|P1|40-week Rosuvastatin Open Label Period|Protocol Violation|0
1012628|NCT00355615|3311021|P5|40-week Rosuvastatin Open Label Period|Adverse Event|4
1012629|NCT00355615|3311022|P4|40-week Rosuvastatin Open Label Period|Adverse Event|0
1012630|NCT00355615|3311023|P3|40-week Rosuvastatin Open Label Period|Adverse Event|0
1012631|NCT00355615|3311024|P2|40-week Rosuvastatin Open Label Period|Adverse Event|0
1012632|NCT00355615|3311025|P1|40-week Rosuvastatin Open Label Period|Adverse Event|0
1012633|NCT00355615|3311021|P5|Randomized Double Blind Period|Protocol Violation|0
1012634|NCT00355615|3311022|P4|Randomized Double Blind Period|Protocol Violation|1
1012635|NCT00355615|3311023|P3|Randomized Double Blind Period|Protocol Violation|1
1012636|NCT00355615|3311024|P2|Randomized Double Blind Period|Protocol Violation|0
1012637|NCT00355615|3311025|P1|Randomized Double Blind Period|Protocol Violation|0
1012638|NCT00355615|3311021|P5|Randomized Double Blind Period|Adverse Event|0
1012639|NCT00355615|3311022|P4|Randomized Double Blind Period|Adverse Event|0
1012640|NCT00355615|3311023|P3|Randomized Double Blind Period|Adverse Event|0
1012641|NCT00355615|3311024|P2|Randomized Double Blind Period|Adverse Event|0
1012642|NCT00355615|3311025|P1|Randomized Double Blind Period|Adverse Event|1
1012643|NCT00355472|3311084|P1|Overall Study|Physician Decision|1
1012644|NCT00355368|3311130|P2|Overall Study|cardiac arrest prior to intubation|2
1012645|NCT00355368|3311131|P1|Overall Study|cardiac arrest prior to intubation|2
1012646|NCT00355368|3311130|P2|Overall Study|Protocol Violation|7
1012647|NCT00355368|3311131|P1|Overall Study|Protocol Violation|8
1012648|NCT00355342|3311145|P2|Overall Study|Use of protocol excluded medication|1
1012649|NCT00355342|3311146|P1|Overall Study|Use of protocol excluded medication|0
1012650|NCT00355342|3311145|P2|Overall Study|Protocol Violation|1
1012651|NCT00355342|3311146|P1|Overall Study|Protocol Violation|0
1012652|NCT00355342|3311145|P2|Overall Study|Study management|1
1012653|NCT00355342|3311146|P1|Overall Study|Study management|0
1012654|NCT00355342|3311145|P2|Overall Study|Participant discontinued study drug|1
1012655|NCT00355342|3311146|P1|Overall Study|Participant discontinued study drug|0
1012656|NCT00355342|3311145|P2|Overall Study|Participant relocated|1
1012657|NCT00355342|3311146|P1|Overall Study|Participant relocated|0
1012658|NCT00355342|3311145|P2|Overall Study|Withdrawal by participant and physician|0
1012659|NCT00355342|3311146|P1|Overall Study|Withdrawal by participant and physician|1
1012660|NCT00355342|3311145|P2|Overall Study|Non-compliance with Dexa scans|0
1012661|NCT00355342|3311146|P1|Overall Study|Non-compliance with Dexa scans|1
1012662|NCT00355342|3311145|P2|Overall Study|Dispensed wrong study drug kit|0
1012663|NCT00355342|3311146|P1|Overall Study|Dispensed wrong study drug kit|1
1012664|NCT00355342|3311145|P2|Overall Study|COPD exacerbation|1
1012665|NCT00355342|3311146|P1|Overall Study|COPD exacerbation|1
1012666|NCT00355342|3311145|P2|Overall Study|Use of prohibited medication|0
1012667|NCT00355342|3311146|P1|Overall Study|Use of prohibited medication|1
1012668|NCT00355342|3311145|P2|Overall Study|Overcompliant-PI discretion|0
1012669|NCT00355342|3311146|P1|Overall Study|Overcompliant-PI discretion|1
1012670|NCT00355342|3311145|P2|Overall Study|Sponsor terminated study|2
1012671|NCT00355342|3311146|P1|Overall Study|Sponsor terminated study|2
1012672|NCT00355342|3311145|P2|Overall Study|Withdrawal by Subject|11
1012673|NCT00355342|3311146|P1|Overall Study|Withdrawal by Subject|14
1012674|NCT00355342|3311145|P2|Overall Study|Lost to Follow-up|2
1012675|NCT00355342|3311146|P1|Overall Study|Lost to Follow-up|4
1012676|NCT00355342|3311145|P2|Overall Study|Adverse Event|15
1012677|NCT00355342|3311146|P1|Overall Study|Adverse Event|13
1012678|NCT00355147|3311173|P2|Overall Study|Withdrawal by Subject|12
1012679|NCT00355147|3311174|P1|Overall Study|Withdrawal by Subject|8
1012680|NCT00355147|3311173|P2|Overall Study|Lost to Follow-up|8
1012681|NCT00355147|3311174|P1|Overall Study|Lost to Follow-up|10
1012682|NCT00355134|3311193|P5|Extension Phase|Protocol Violation|0
1012683|NCT00355134|3311194|P4|Extension Phase|Protocol Violation|1
1012684|NCT00355134|3311195|P3|Extension Phase|Protocol Violation|0
1012685|NCT00355134|3311196|P2|Extension Phase|Protocol Violation|0
1012686|NCT00355134|3311197|P1|Extension Phase|Protocol Violation|0
1012687|NCT00355134|3311193|P5|Extension Phase|Abnormal test procedure result(s)|1
1012688|NCT00355134|3311194|P4|Extension Phase|Abnormal test procedure result(s)|0
1012689|NCT00355134|3311195|P3|Extension Phase|Abnormal test procedure result(s)|0
1012690|NCT00355134|3311196|P2|Extension Phase|Abnormal test procedure result(s)|1
1012691|NCT00355134|3311197|P1|Extension Phase|Abnormal test procedure result(s)|0
1012692|NCT00355134|3311193|P5|Extension Phase|Unsatisfactory therapeutic effect|1
1012693|NCT00355134|3311194|P4|Extension Phase|Unsatisfactory therapeutic effect|0
1012694|NCT00355134|3311195|P3|Extension Phase|Unsatisfactory therapeutic effect|0
1012695|NCT00355134|3311196|P2|Extension Phase|Unsatisfactory therapeutic effect|4
1012696|NCT00355134|3311197|P1|Extension Phase|Unsatisfactory therapeutic effect|3
1012697|NCT00355134|3311193|P5|Extension Phase|Administrative problems|1
1012698|NCT00355134|3311194|P4|Extension Phase|Administrative problems|1
1012699|NCT00355134|3311195|P3|Extension Phase|Administrative problems|0
1012700|NCT00355134|3311196|P2|Extension Phase|Administrative problems|4
1012701|NCT00355134|3311197|P1|Extension Phase|Administrative problems|2
1012702|NCT00355134|3311193|P5|Extension Phase|Abnormal laboratory value(s)|2
1012703|NCT00355134|3311194|P4|Extension Phase|Abnormal laboratory value(s)|2
1012704|NCT00355134|3311195|P3|Extension Phase|Abnormal laboratory value(s)|0
1012705|NCT00355134|3311196|P2|Extension Phase|Abnormal laboratory value(s)|2
1012706|NCT00355134|3311197|P1|Extension Phase|Abnormal laboratory value(s)|4
1012707|NCT00355134|3311193|P5|Extension Phase|Lost to Follow-up|4
1012708|NCT00355134|3311194|P4|Extension Phase|Lost to Follow-up|2
1012709|NCT00355134|3311195|P3|Extension Phase|Lost to Follow-up|0
1012710|NCT00355134|3311196|P2|Extension Phase|Lost to Follow-up|6
1012711|NCT00355134|3311197|P1|Extension Phase|Lost to Follow-up|2
1012712|NCT00355134|3311193|P5|Extension Phase|Adverse Event|5
1012713|NCT00355134|3311194|P4|Extension Phase|Adverse Event|3
1012714|NCT00355134|3311195|P3|Extension Phase|Adverse Event|0
1012715|NCT00355134|3311196|P2|Extension Phase|Adverse Event|9
1012716|NCT00355134|3311197|P1|Extension Phase|Adverse Event|13
1012717|NCT00355134|3311193|P5|Extension Phase|Withdrawal by Subject|5
1012718|NCT00355134|3311194|P4|Extension Phase|Withdrawal by Subject|7
1012719|NCT00355134|3311195|P3|Extension Phase|Withdrawal by Subject|0
1012720|NCT00355134|3311196|P2|Extension Phase|Withdrawal by Subject|11
1012721|NCT00355134|3311197|P1|Extension Phase|Withdrawal by Subject|7
1012722|NCT00355134|3311193|P5|Core Phase|Condition no longer requires study drug|0
1012723|NCT00355134|3311194|P4|Core Phase|Condition no longer requires study drug|0
1012724|NCT00355134|3311195|P3|Core Phase|Condition no longer requires study drug|1
1012725|NCT00355134|3311196|P2|Core Phase|Condition no longer requires study drug|0
1012726|NCT00355134|3311197|P1|Core Phase|Condition no longer requires study drug|1
1012727|NCT00355134|3311193|P5|Core Phase|Abnormal test procedure result(s)|0
1012728|NCT00355134|3311194|P4|Core Phase|Abnormal test procedure result(s)|0
1012729|NCT00355134|3311195|P3|Core Phase|Abnormal test procedure result(s)|1
1012730|NCT00355134|3311196|P2|Core Phase|Abnormal test procedure result(s)|2
1012731|NCT00355134|3311197|P1|Core Phase|Abnormal test procedure result(s)|1
1012732|NCT00355134|3311193|P5|Core Phase|Protocol Violation|0
1012733|NCT00355134|3311194|P4|Core Phase|Protocol Violation|0
1012734|NCT00355134|3311195|P3|Core Phase|Protocol Violation|2
1012735|NCT00355134|3311196|P2|Core Phase|Protocol Violation|2
1012736|NCT00355134|3311197|P1|Core Phase|Protocol Violation|3
1012737|NCT00355134|3311193|P5|Core Phase|Administrative problems|0
1012738|NCT00355134|3311194|P4|Core Phase|Administrative problems|0
1012739|NCT00355134|3311195|P3|Core Phase|Administrative problems|5
1012740|NCT00355134|3311196|P2|Core Phase|Administrative problems|3
1012741|NCT00355134|3311197|P1|Core Phase|Administrative problems|5
1012742|NCT00355134|3311193|P5|Core Phase|Unsatisfactory therapeutic effect|0
1012743|NCT00355134|3311194|P4|Core Phase|Unsatisfactory therapeutic effect|0
1012744|NCT00355134|3311195|P3|Core Phase|Unsatisfactory therapeutic effect|17
1012745|NCT00355134|3311196|P2|Core Phase|Unsatisfactory therapeutic effect|6
1012746|NCT00355134|3311197|P1|Core Phase|Unsatisfactory therapeutic effect|10
1012747|NCT00355134|3311193|P5|Core Phase|Abnormal laboratory value(s)|0
1012748|NCT00355134|3311194|P4|Core Phase|Abnormal laboratory value(s)|0
1012749|NCT00355134|3311195|P3|Core Phase|Abnormal laboratory value(s)|2
1012750|NCT00355134|3311196|P2|Core Phase|Abnormal laboratory value(s)|14
1012751|NCT00355134|3311197|P1|Core Phase|Abnormal laboratory value(s)|19
1012752|NCT00355134|3311193|P5|Core Phase|Lost to Follow-up|0
1012753|NCT00355134|3311194|P4|Core Phase|Lost to Follow-up|0
1012754|NCT00355134|3311195|P3|Core Phase|Lost to Follow-up|21
1012755|NCT00355134|3311196|P2|Core Phase|Lost to Follow-up|13
1012756|NCT00355134|3311197|P1|Core Phase|Lost to Follow-up|17
1012757|NCT00355134|3311193|P5|Core Phase|Adverse Event|0
1012758|NCT00355134|3311194|P4|Core Phase|Adverse Event|0
1012759|NCT00355134|3311195|P3|Core Phase|Adverse Event|16
1012760|NCT00355134|3311196|P2|Core Phase|Adverse Event|22
1012761|NCT00355134|3311197|P1|Core Phase|Adverse Event|28
1012762|NCT00355134|3311193|P5|Core Phase|Withdrawal by Subject|0
1012763|NCT00355134|3311194|P4|Core Phase|Withdrawal by Subject|0
1012764|NCT00355134|3311195|P3|Core Phase|Withdrawal by Subject|35
1012765|NCT00355134|3311196|P2|Core Phase|Withdrawal by Subject|24
1012766|NCT00355134|3311197|P1|Core Phase|Withdrawal by Subject|35
1012767|NCT00355121|3311240|P3|Overall Study|Serious adverse events|0
1012768|NCT00355121|3311241|P2|Overall Study|Serious adverse events|2
1012769|NCT00355121|3311242|P1|Overall Study|Serious adverse events|0
1012770|NCT00355121|3311240|P3|Overall Study|Withdrawal by Subject|2
1012771|NCT00355121|3311241|P2|Overall Study|Withdrawal by Subject|10
1012772|NCT00355121|3311242|P1|Overall Study|Withdrawal by Subject|9
1012773|NCT00355121|3311240|P3|Overall Study|Lost to Follow-up|1
1012774|NCT00355121|3311241|P2|Overall Study|Lost to Follow-up|7
1012775|NCT00355121|3311242|P1|Overall Study|Lost to Follow-up|4
1012776|NCT00355121|3311240|P3|Overall Study|Protocol Violation|1
1012777|NCT00355121|3311241|P2|Overall Study|Protocol Violation|9
1012778|NCT00355121|3311242|P1|Overall Study|Protocol Violation|7
1012779|NCT00355121|3311240|P3|Overall Study|Adverse Event|0
1012780|NCT00355121|3311241|P2|Overall Study|Adverse Event|1
1012781|NCT00355121|3311242|P1|Overall Study|Adverse Event|0
1012782|NCT00355121|3311240|P3|Overall Study|Did not receive study vaccine|1
1012783|NCT00355121|3311241|P2|Overall Study|Did not receive study vaccine|0
1012784|NCT00355121|3311242|P1|Overall Study|Did not receive study vaccine|1
1012785|NCT00355082|3311273|P3|Continuation Phase|Ran Out of Drug Due to Travel|0
1012786|NCT00355082|3311274|P2|Continuation Phase|Ran Out of Drug Due to Travel|0
1012787|NCT00355082|3311275|P1|Continuation Phase|Ran Out of Drug Due to Travel|1
1012788|NCT00355082|3311273|P3|Continuation Phase|Scheduling Error|0
1012789|NCT00355082|3311274|P2|Continuation Phase|Scheduling Error|0
1012790|NCT00355082|3311275|P1|Continuation Phase|Scheduling Error|1
1012791|NCT00355082|3311273|P3|Continuation Phase|Site Closed by Sponsor|0
1012792|NCT00355082|3311274|P2|Continuation Phase|Site Closed by Sponsor|0
1012793|NCT00355082|3311275|P1|Continuation Phase|Site Closed by Sponsor|8
1012794|NCT00355082|3311273|P3|Continuation Phase|Lack of Efficacy|0
1012795|NCT00355082|3311274|P2|Continuation Phase|Lack of Efficacy|0
1012796|NCT00355082|3311275|P1|Continuation Phase|Lack of Efficacy|5
1012797|NCT00355082|3311273|P3|Continuation Phase|Withdrawal by Subject|0
1012798|NCT00355082|3311274|P2|Continuation Phase|Withdrawal by Subject|0
1012799|NCT00355082|3311275|P1|Continuation Phase|Withdrawal by Subject|4
1012800|NCT00355082|3311273|P3|Continuation Phase|Protocol Violation|1
1012801|NCT00355082|3311274|P2|Continuation Phase|Protocol Violation|0
1012802|NCT00355082|3311275|P1|Continuation Phase|Protocol Violation|1
1012803|NCT00355082|3311273|P3|Continuation Phase|Lost to Follow-up|1
1012804|NCT00355082|3311274|P2|Continuation Phase|Lost to Follow-up|0
1012805|NCT00355082|3311275|P1|Continuation Phase|Lost to Follow-up|2
1012806|NCT00355082|3311273|P3|Continuation Phase|Adverse Event|1
1012807|NCT00355082|3311274|P2|Continuation Phase|Adverse Event|0
1012808|NCT00355082|3311275|P1|Continuation Phase|Adverse Event|2
1012809|NCT00355082|3311273|P3|Double-Blind (DB) Treatment Phase|Pregnancy|0
1012810|NCT00355082|3311274|P2|Double-Blind (DB) Treatment Phase|Pregnancy|1
1012811|NCT00355082|3311275|P1|Double-Blind (DB) Treatment Phase|Pregnancy|0
1012812|NCT00355082|3311273|P3|Double-Blind (DB) Treatment Phase|Protocol Violation|0
1012813|NCT00355082|3311274|P2|Double-Blind (DB) Treatment Phase|Protocol Violation|4
1012814|NCT00355082|3311275|P1|Double-Blind (DB) Treatment Phase|Protocol Violation|0
1012815|NCT00355082|3311273|P3|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
1012816|NCT00355082|3311274|P2|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4
1012817|NCT00355082|3311275|P1|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
1012818|NCT00355082|3311273|P3|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0
1012819|NCT00355082|3311274|P2|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7
1012820|NCT00355082|3311275|P1|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6
1012821|NCT00355082|3311273|P3|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0
1012822|NCT00355082|3311274|P2|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8
1012823|NCT00355082|3311275|P1|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9
1012824|NCT00355082|3311273|P3|Double-Blind (DB) Treatment Phase|Adverse Event|0
1012825|NCT00355082|3311274|P2|Double-Blind (DB) Treatment Phase|Adverse Event|10
1012826|NCT00355082|3311275|P1|Double-Blind (DB) Treatment Phase|Adverse Event|4
1012827|NCT00355030|3311297|P2|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
1012828|NCT00355030|3311298|P1|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
1012829|NCT00355030|3311297|P2|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1
1012830|NCT00355030|3311298|P1|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0
1012831|NCT00355030|3311297|P2|Study Period 1 Treatment|Other|6
1012832|NCT00355030|3311298|P1|Study Period 1 Treatment|Other|2
1012833|NCT00355030|3311297|P2|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1
1012834|NCT00355030|3311298|P1|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0
1012835|NCT00355030|3311297|P2|Study Period 1 Treatment|Sponsor Decision|32
1012836|NCT00355030|3311298|P1|Study Period 1 Treatment|Sponsor Decision|34
1012837|NCT00355030|3311297|P2|Study Period 1 Treatment|Physician Decision|1
1012838|NCT00355030|3311298|P1|Study Period 1 Treatment|Physician Decision|0
1012839|NCT00355030|3311297|P2|Study Period 1 Treatment|Parent/Caregiver Decision|2
1012840|NCT00355030|3311298|P1|Study Period 1 Treatment|Parent/Caregiver Decision|1
1012841|NCT00355030|3311297|P2|Study Period 1 Treatment|Withdrawal by Subject|1
1012842|NCT00355030|3311298|P1|Study Period 1 Treatment|Withdrawal by Subject|4
1012843|NCT00355030|3311297|P2|Study Period 1 Treatment|Lost to Follow-up|0
1012844|NCT00355030|3311298|P1|Study Period 1 Treatment|Lost to Follow-up|3
1012845|NCT00355030|3311297|P2|Study Period 1 Treatment|Adverse Event|1
1012846|NCT00355030|3311298|P1|Study Period 1 Treatment|Adverse Event|1
1012847|NCT00354835|3311337|P2|Overall Study|Refusal of further therapy|8
1012848|NCT00354835|3311338|P1|Overall Study|Refusal of further therapy|3
1012849|NCT00354835|3311337|P2|Overall Study|Adverse Event|0
1012850|NCT00354835|3311338|P1|Overall Study|Adverse Event|6
1012851|NCT00354835|3311337|P2|Overall Study|Disease progression or relapse|22
1012852|NCT00354835|3311338|P1|Overall Study|Disease progression or relapse|15
1012853|NCT00354835|3311337|P2|Overall Study|Ineligible|16
1012854|NCT00354835|3311338|P1|Overall Study|Ineligible|17
1012855|NCT00354835|3311337|P2|Overall Study|Withdrawal by Subject|1
1012856|NCT00354835|3311338|P1|Overall Study|Withdrawal by Subject|2
1012857|NCT00354835|3311337|P2|Overall Study|Physician Decision|13
1012858|NCT00354835|3311338|P1|Overall Study|Physician Decision|8
1012859|NCT00354835|3311337|P2|Overall Study|Death|1
1012860|NCT00354835|3311338|P1|Overall Study|Death|1
1012861|NCT00354744|3311377|P1|Overall Study|Withdrawal by Subject|14
1012862|NCT00354744|3311377|P1|Overall Study|Physician Decision|11
1012863|NCT00354744|3311377|P1|Overall Study|Lost to Follow-up|2
1012864|NCT00354744|3311377|P1|Overall Study|Lack of Efficacy|11
1012865|NCT00354744|3311377|P1|Overall Study|Death|2
1012866|NCT00354744|3311377|P1|Overall Study|Adverse Event|2
1012867|NCT00354679|3311382|P1|Overall Study|Patient Not Treated|1
1012868|NCT00354614|3311391|P1|Overall Study|Lack of Efficacy|28
1012869|NCT00354601|3311395|P1|Overall Study|progression|1
1012870|NCT00354601|3311395|P1|Overall Study|Protocol Violation|1
1012871|NCT00354432|3311415|P4|Overall Study|Off/Toxicity|5
1012872|NCT00354432|3311416|P3|Overall Study|Off/Toxicity|5
1012873|NCT00354432|3311417|P2|Overall Study|Off/Toxicity|7
1012874|NCT00354432|3311418|P1|Overall Study|Off/Toxicity|3
1012875|NCT00354432|3311415|P4|Overall Study|Adverse Event|5
1012876|NCT00354432|3311416|P3|Overall Study|Adverse Event|5
1012877|NCT00354432|3311417|P2|Overall Study|Adverse Event|1
1012878|NCT00354432|3311418|P1|Overall Study|Adverse Event|3
1012879|NCT00354341|3311434|P2|Overall Study|Other|2
1012880|NCT00354341|3311435|P1|Overall Study|Other|1
1012881|NCT00354341|3311434|P2|Overall Study|Failure to return|1
1012882|NCT00354341|3311435|P1|Overall Study|Failure to return|0
1012883|NCT00354341|3311434|P2|Overall Study|Refused treatment|2
1012884|NCT00354341|3311435|P1|Overall Study|Refused treatment|1
1012885|NCT00354341|3311434|P2|Overall Study|Death|2
1012886|NCT00354341|3311435|P1|Overall Study|Death|0
1012887|NCT00354341|3311434|P2|Overall Study|Adverse Event|0
1012888|NCT00354341|3311435|P1|Overall Study|Adverse Event|1
1012889|NCT00354172|3311457|P1|Overall Study|Did not receive transplant|1
1012890|NCT00354159|3311477|P2|Long-term Follow-up|Study Closed|34
1012891|NCT00354159|3311478|P1|Long-term Follow-up|Study Closed|29
1012892|NCT00354159|3311477|P2|Long-term Follow-up|Death|11
1012893|NCT00354159|3311478|P1|Long-term Follow-up|Death|14
1012894|NCT00354159|3311477|P2|Long-term Follow-up|Lost to Follow-up|0
1012895|NCT00354159|3311478|P1|Long-term Follow-up|Lost to Follow-up|1
1012896|NCT00354159|3311477|P2|Long-term Follow-up|Physician Decision|122
1012897|NCT00354159|3311478|P1|Long-term Follow-up|Physician Decision|127
1012898|NCT00354159|3311477|P2|Long-term Follow-up|Withdrawal by Subject|9
1012899|NCT00354159|3311478|P1|Long-term Follow-up|Withdrawal by Subject|9
1012900|NCT00354159|3311477|P2|Randomized Study Period|Death|9
1012901|NCT00354159|3311478|P1|Randomized Study Period|Death|7
1012902|NCT00354159|3311477|P2|Randomized Study Period|Lost to Follow-up|0
1012903|NCT00354159|3311478|P1|Randomized Study Period|Lost to Follow-up|4
1012904|NCT00354159|3311477|P2|Randomized Study Period|Physician Decision|10
1012905|NCT00354159|3311478|P1|Randomized Study Period|Physician Decision|6
1012906|NCT00354159|3311477|P2|Randomized Study Period|Withdrawal by Subject|3
1012907|NCT00354159|3311478|P1|Randomized Study Period|Withdrawal by Subject|5
1012908|NCT00354107|3311521|P1|Overall Study|Withdrawal by Subject|1
1012909|NCT00354107|3311521|P1|Overall Study|Physician Decision|2
1012910|NCT00354107|3311521|P1|Overall Study|Adverse Event|2
1012911|NCT00354029|3311531|P2|Overall Study|Protocol Violation|2
1012912|NCT00354029|3311532|P1|Overall Study|Protocol Violation|4
1012913|NCT00353873|3311544|P2|Overall Study|Withdrawal by Subject|1
1012914|NCT00353873|3311545|P1|Overall Study|Withdrawal by Subject|1
1012915|NCT00353873|3311544|P2|Overall Study|Physician Decision|0
1012916|NCT00353873|3311545|P1|Overall Study|Physician Decision|2
1012917|NCT00353873|3311544|P2|Overall Study|Adverse Event|0
1012918|NCT00353873|3311545|P1|Overall Study|Adverse Event|1
1012919|NCT00353873|3311544|P2|Overall Study|Exacerbation|0
1012920|NCT00353873|3311545|P1|Overall Study|Exacerbation|1
1012921|NCT00353873|3311544|P2|Overall Study|Protocol Violation|2
1012922|NCT00353873|3311545|P1|Overall Study|Protocol Violation|1
1012923|NCT00353704|3311574|P2|Overall Study|Protocol Violation|1
1012924|NCT00353704|3311575|P1|Overall Study|Protocol Violation|3
1012925|NCT00353496|3311610|P2|Overall Study|Not otherwise specified|2
1012926|NCT00353496|3311611|P1|Overall Study|Not otherwise specified|4
1012927|NCT00353496|3311610|P2|Overall Study|Physician Decision|9
1012928|NCT00353496|3311611|P1|Overall Study|Physician Decision|6
1012929|NCT00353496|3311610|P2|Overall Study|Withdrawal by Subject|4
1012930|NCT00353496|3311611|P1|Overall Study|Withdrawal by Subject|3
1012931|NCT00353496|3311610|P2|Overall Study|Protocol Violation|2
1012932|NCT00353496|3311611|P1|Overall Study|Protocol Violation|2
1012933|NCT00353496|3311610|P2|Overall Study|Adverse Event|0
1012934|NCT00353496|3311611|P1|Overall Study|Adverse Event|1
1012935|NCT00353366|3311664|P1|Overall Study|Other|135
1012936|NCT00353366|3311664|P1|Overall Study|Adverse Event|8
1012937|NCT00353262|3311691|P1|Overall Study|Break from Chemotherapy|1
1012938|NCT00353262|3311691|P1|Overall Study|Surgery|4
1012939|NCT00353262|3311691|P1|Overall Study|Progression|1
1012940|NCT00353262|3311691|P1|Overall Study|Insufficient Therapeutic Response|13
1012941|NCT00353262|3311691|P1|Overall Study|Withdrawal by Subject|2
1012942|NCT00353262|3311691|P1|Overall Study|Adverse Event|8
1012943|NCT00352885|3311732|P2|Overall Study|Side effects of IL-2 administration|0
1012944|NCT00352885|3311733|P1|Overall Study|Side effects of IL-2 administration|1
1012945|NCT00352885|3311732|P2|Overall Study|Progression of metastatic melanoma|3
1012946|NCT00352885|3311733|P1|Overall Study|Progression of metastatic melanoma|5
1012947|NCT00352885|3311732|P2|Overall Study|Development of major depression|1
1012948|NCT00352885|3311733|P1|Overall Study|Development of major depression|0
1012949|NCT00352885|3311732|P2|Overall Study|Withdrawal by Subject|3
1012950|NCT00352885|3311733|P1|Overall Study|Withdrawal by Subject|0
1012951|NCT00352846|3311751|P2|Overall Study|Death|1
1012952|NCT00352846|3311752|P1|Overall Study|Death|0
1012953|NCT00352846|3311751|P2|Overall Study|Non-compliance|0
1012954|NCT00352846|3311752|P1|Overall Study|Non-compliance|2
1012955|NCT00352846|3311751|P2|Overall Study|Ineligible|2
1012956|NCT00352846|3311752|P1|Overall Study|Ineligible|3
1012957|NCT00352846|3311751|P2|Overall Study|Withdrawal by Subject|8
1012958|NCT00352846|3311752|P1|Overall Study|Withdrawal by Subject|3
1012959|NCT00352846|3311751|P2|Overall Study|Disease progression|2
1012960|NCT00352846|3311752|P1|Overall Study|Disease progression|0
1012961|NCT00352755|3311763|P1|Overall Study|Adverse Event|1
1012962|NCT00352755|3311763|P1|Overall Study|Physician Decision|1
1012963|NCT00352690|3311773|P2|Overall Study|Determined to be ineligible|0
1012964|NCT00352690|3311774|P1|Overall Study|Determined to be ineligible|2
1012965|NCT00352664|3311794|P2|Overall Study|Withdrawal by Subject|0
1012966|NCT00352664|3311795|P1|Overall Study|Withdrawal by Subject|7
1012967|NCT00352534|3311812|P7|Final Risk Group Assignment|Death|0
1012968|NCT00352534|3311813|P6|Final Risk Group Assignment|Death|2
1012969|NCT00352534|3311814|P5|Final Risk Group Assignment|Death|0
1012970|NCT00352534|3311815|P4|Final Risk Group Assignment|Death|0
1012971|NCT00352534|3311816|P3|Final Risk Group Assignment|Death|0
1012972|NCT00352534|3311817|P2|Final Risk Group Assignment|Death|0
1012973|NCT00352534|3311818|P1|Final Risk Group Assignment|Death|0
1012974|NCT00352534|3311812|P7|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11
1012975|NCT00352534|3311813|P6|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1012976|NCT00352534|3311814|P5|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1012977|NCT00352534|3311815|P4|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1012978|NCT00352534|3311816|P3|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1012979|NCT00352534|3311817|P2|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1012980|NCT00352534|3311818|P1|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1012981|NCT00352534|3311812|P7|Final Risk Group Assignment|Enrollment onto another COG study|28
1012982|NCT00352534|3311813|P6|Final Risk Group Assignment|Enrollment onto another COG study|0
1012983|NCT00352534|3311814|P5|Final Risk Group Assignment|Enrollment onto another COG study|0
1012984|NCT00352534|3311815|P4|Final Risk Group Assignment|Enrollment onto another COG study|0
1012985|NCT00352534|3311816|P3|Final Risk Group Assignment|Enrollment onto another COG study|0
1012986|NCT00352534|3311817|P2|Final Risk Group Assignment|Enrollment onto another COG study|0
1012987|NCT00352534|3311818|P1|Final Risk Group Assignment|Enrollment onto another COG study|0
1012988|NCT00352534|3311812|P7|Final Risk Group Assignment|Ineligible|0
1012989|NCT00352534|3311813|P6|Final Risk Group Assignment|Ineligible|13
1012990|NCT00352534|3311814|P5|Final Risk Group Assignment|Ineligible|0
1012991|NCT00352534|3311815|P4|Final Risk Group Assignment|Ineligible|1
1012992|NCT00352534|3311816|P3|Final Risk Group Assignment|Ineligible|3
1012993|NCT00352534|3311817|P2|Final Risk Group Assignment|Ineligible|0
1012994|NCT00352534|3311818|P1|Final Risk Group Assignment|Ineligible|0
1012995|NCT00352534|3311812|P7|Final Risk Group Assignment|Withdrawal by Subject|0
1012996|NCT00352534|3311813|P6|Final Risk Group Assignment|Withdrawal by Subject|3
1012997|NCT00352534|3311814|P5|Final Risk Group Assignment|Withdrawal by Subject|0
1012998|NCT00352534|3311815|P4|Final Risk Group Assignment|Withdrawal by Subject|0
1012999|NCT00352534|3311816|P3|Final Risk Group Assignment|Withdrawal by Subject|0
1013000|NCT00352534|3311817|P2|Final Risk Group Assignment|Withdrawal by Subject|0
1013001|NCT00352534|3311818|P1|Final Risk Group Assignment|Withdrawal by Subject|0
1013002|NCT00352534|3311812|P7|Final Risk Group Assignment|Physician Decision|0
1013003|NCT00352534|3311813|P6|Final Risk Group Assignment|Physician Decision|8
1013004|NCT00352534|3311814|P5|Final Risk Group Assignment|Physician Decision|0
1013005|NCT00352534|3311815|P4|Final Risk Group Assignment|Physician Decision|0
1013006|NCT00352534|3311816|P3|Final Risk Group Assignment|Physician Decision|0
1013007|NCT00352534|3311817|P2|Final Risk Group Assignment|Physician Decision|0
1013008|NCT00352534|3311818|P1|Final Risk Group Assignment|Physician Decision|0
1013009|NCT00352534|3311812|P7|Final Risk Group Assignment|Lack of Efficacy|0
1013010|NCT00352534|3311813|P6|Final Risk Group Assignment|Lack of Efficacy|19
1013011|NCT00352534|3311814|P5|Final Risk Group Assignment|Lack of Efficacy|1
1013012|NCT00352534|3311815|P4|Final Risk Group Assignment|Lack of Efficacy|2
1013013|NCT00352534|3311816|P3|Final Risk Group Assignment|Lack of Efficacy|0
1013014|NCT00352534|3311817|P2|Final Risk Group Assignment|Lack of Efficacy|0
1013015|NCT00352534|3311818|P1|Final Risk Group Assignment|Lack of Efficacy|0
1013016|NCT00352534|3311812|P7|Initial Staging|Ineligible|0
1013017|NCT00352534|3311813|P6|Initial Staging|Ineligible|0
1013018|NCT00352534|3311814|P5|Initial Staging|Ineligible|0
1013019|NCT00352534|3311815|P4|Initial Staging|Ineligible|0
1013020|NCT00352534|3311816|P3|Initial Staging|Ineligible|0
1013021|NCT00352534|3311817|P2|Initial Staging|Ineligible|9
1013022|NCT00352534|3311818|P1|Initial Staging|Ineligible|8
1013023|NCT00352417|3311835|P2|Overall Study|Schedule Change|1
1013024|NCT00352417|3311836|P1|Overall Study|Schedule Change|2
1013025|NCT00352417|3311835|P2|Overall Study|Lost to Follow-up|0
1013026|NCT00352417|3311836|P1|Overall Study|Lost to Follow-up|1
1013027|NCT00352417|3311835|P2|Overall Study|Withdrawal by Subject|2
1013028|NCT00352417|3311836|P1|Overall Study|Withdrawal by Subject|1
1013029|NCT00352417|3311835|P2|Overall Study|Protocol Violation|2
1013030|NCT00352417|3311836|P1|Overall Study|Protocol Violation|0
1013031|NCT00352417|3311835|P2|Overall Study|Adverse Event|0
1013032|NCT00352417|3311836|P1|Overall Study|Adverse Event|1
1013033|NCT00352365|3311850|P1|Maintenance Therapy|Not eligible|4
1013034|NCT00352365|3311850|P1|Maintenance Therapy|Not protocol specified|3
1013035|NCT00352365|3311850|P1|Maintenance Therapy|Death|2
1013036|NCT00352365|3311850|P1|Maintenance Therapy|Progression/Relapse|3
1013037|NCT00352365|3311850|P1|Induction Therapy|Death before starting protocol therapy|1
1013038|NCT00352365|3311850|P1|Induction Therapy|Not eligible|3
1013039|NCT00352365|3311850|P1|Induction Therapy|Not protocol specified|1
1013040|NCT00352365|3311850|P1|Induction Therapy|Death|7
1013041|NCT00352365|3311850|P1|Induction Therapy|Progression/Relapse|8
1013042|NCT00352365|3311850|P1|Induction Therapy|Adverse Event|7
1013043|NCT00352118|3311860|P1|Overall Study|Physician Decision|4
1013044|NCT00352105|3311870|P1|Overall Study|Protocol Violation|2
1013045|NCT00352105|3311870|P1|Overall Study|Adverse Event|19
1013046|NCT00352105|3311870|P1|Overall Study|Lack of Efficacy|9
1013047|NCT00352105|3311870|P1|Overall Study|Withdrawal by Subject|5
1013048|NCT00352105|3311870|P1|Overall Study|Death|5
1013049|NCT00352053|3311881|P2|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1
1013050|NCT00352053|3311882|P1|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0
1013051|NCT00352053|3311881|P2|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
1013052|NCT00352053|3311882|P1|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
1013053|NCT00352053|3311881|P2|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
1013054|NCT00352053|3311882|P1|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
1013055|NCT00352053|3311881|P2|Second Extension Phase (Weeks 144-240)|Physician Decision|4
1013056|NCT00352053|3311882|P1|Second Extension Phase (Weeks 144-240)|Physician Decision|4
1013057|NCT00352053|3311881|P2|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0
1013058|NCT00352053|3311882|P1|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1
1013059|NCT00352053|3311881|P2|First Extension Phase (Weeks 48-144)|Pregnancy|0
1013060|NCT00352053|3311882|P1|First Extension Phase (Weeks 48-144)|Pregnancy|1
1013061|NCT00352053|3311881|P2|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4
1013062|NCT00352053|3311882|P1|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1
1013063|NCT00352053|3311881|P2|First Extension Phase (Weeks 48-144)|Physician Decision|13
1013064|NCT00352053|3311882|P1|First Extension Phase (Weeks 48-144)|Physician Decision|9
1013065|NCT00352053|3311881|P2|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0
1013066|NCT00352053|3311882|P1|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1
1013067|NCT00352053|3311881|P2|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1
1013068|NCT00352053|3311882|P1|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0
1013069|NCT00352053|3311881|P2|Double-Blind Phase (Through Week 48)|Adverse Event|0
1013070|NCT00352053|3311882|P1|Double-Blind Phase (Through Week 48)|Adverse Event|1
1013071|NCT00352053|3311881|P2|Double-Blind Phase (Through Week 48)|Physician Decision|2
1013072|NCT00352053|3311882|P1|Double-Blind Phase (Through Week 48)|Physician Decision|2
1013073|NCT00352053|3311881|P2|Double-Blind Phase (Through Week 48)|Virologic Failure|10
1013074|NCT00352053|3311882|P1|Double-Blind Phase (Through Week 48)|Virologic Failure|14
1013075|NCT00352027|3312049|P1|Overall Study|Progressive disease|3
1013076|NCT00351819|3312348|P2|Overall Study|Enrolled in another trial|1
1013077|NCT00351819|3312349|P1|Overall Study|Enrolled in another trial|0
1013078|NCT00351819|3312348|P2|Overall Study|Incarcerated|1
1013079|NCT00351819|3312349|P1|Overall Study|Incarcerated|0
1013080|NCT00351819|3312348|P2|Overall Study|Non-compliance|1
1013081|NCT00351819|3312349|P1|Overall Study|Non-compliance|0
1013082|NCT00351819|3312348|P2|Overall Study|Unprofessional behavior|0
1013083|NCT00351819|3312349|P1|Overall Study|Unprofessional behavior|1
1013084|NCT00351819|3312348|P2|Overall Study|Traumatic ankle fracture|0
1013085|NCT00351819|3312349|P1|Overall Study|Traumatic ankle fracture|1
1013086|NCT00351819|3312348|P2|Overall Study|Elevated PSA|1
1013087|NCT00351819|3312349|P1|Overall Study|Elevated PSA|1
1013088|NCT00351819|3312348|P2|Overall Study|Withdrawal by Subject|4
1013089|NCT00351819|3312349|P1|Overall Study|Withdrawal by Subject|0
1013090|NCT00351819|3312348|P2|Overall Study|Lost to Follow-up|4
1013091|NCT00351819|3312349|P1|Overall Study|Lost to Follow-up|4
1013092|NCT00351533|3312420|P2|Overall Study|Withdrawal by Subject|1
1013093|NCT00351533|3312421|P1|Overall Study|Withdrawal by Subject|0
1013094|NCT00351533|3312420|P2|Overall Study|Physician Decision|1
1013095|NCT00351533|3312421|P1|Overall Study|Physician Decision|0
1013096|NCT00351533|3312420|P2|Overall Study|Lost to Follow-up|3
1013097|NCT00351533|3312421|P1|Overall Study|Lost to Follow-up|1
1013098|NCT00351533|3312420|P2|Overall Study|Extubated before first BAL|0
1013099|NCT00351533|3312421|P1|Overall Study|Extubated before first BAL|1
1013100|NCT00351468|3312481|P1|Overall Study|Protocol Violation|3
1013101|NCT00351468|3312481|P1|Overall Study|Lost to Follow-up|4
1013102|NCT00351468|3312481|P1|Overall Study|Non-compliance|8
1013103|NCT00351468|3312481|P1|Overall Study|Lack of Efficacy|32
1013104|NCT00351468|3312481|P1|Overall Study|Various -follow up w clinical team|39
1013105|NCT00351468|3312481|P1|Overall Study|Withdrawal by Subject|39
1013106|NCT00351468|3312481|P1|Overall Study|Adverse Event|42
1013107|NCT00351377|3312505|P1|Overall Study|Unsatisfactory therapeutic effect|1
1013108|NCT00351377|3312505|P1|Overall Study|Death|1
1013109|NCT00351377|3312505|P1|Overall Study|Adverse Event|5
1013110|NCT00351351|3312519|P2|Overall Study|surgical access pbs; device issues|4
1013111|NCT00351351|3312520|P1|Overall Study|surgical access pbs; device issues|9
1013112|NCT00351273|3312546|P3|Overall Study|Lost to Follow-up|5
1013113|NCT00351273|3312547|P2|Overall Study|Lost to Follow-up|2
1013114|NCT00351273|3312548|P1|Overall Study|Lost to Follow-up|1
1013115|NCT00350870|3312591|P4|Overall Study|Physician Decision|1
1013116|NCT00350870|3312592|P3|Overall Study|Physician Decision|1
1013117|NCT00350870|3312593|P2|Overall Study|Physician Decision|0
1013118|NCT00350870|3312594|P1|Overall Study|Physician Decision|1
1013119|NCT00350870|3312591|P4|Overall Study|Withdrawal by Subject|14
1013120|NCT00350870|3312592|P3|Overall Study|Withdrawal by Subject|15
1013121|NCT00350870|3312593|P2|Overall Study|Withdrawal by Subject|17
1013122|NCT00350870|3312594|P1|Overall Study|Withdrawal by Subject|21
1013123|NCT00350844|3312608|P1|Overall Study|Lost to Follow-up|1
1013124|NCT00350792|3312612|P1|Overall Study|Lack of Efficacy|11
1013125|NCT00350792|3312612|P1|Overall Study|Physician Decision|2
1013126|NCT00350792|3312612|P1|Overall Study|Withdrawal by Subject|4
1013127|NCT00350792|3312612|P1|Overall Study|Protocol Violation|1
1013128|NCT00350792|3312612|P1|Overall Study|Death Not Study Drug Related|2
1013129|NCT00350792|3312612|P1|Overall Study|Death from Study Drug Toxicity|1
1013130|NCT00350792|3312612|P1|Overall Study|Death from Study Disease|1
1013131|NCT00350792|3312612|P1|Overall Study|Adverse Event|11
1013132|NCT00350779|3312622|P2|Overall Study|Non-compliance with study procedures|1
1013133|NCT00350779|3312623|P1|Overall Study|Non-compliance with study procedures|0
1013134|NCT00350779|3312622|P2|Overall Study|Patient Moved|1
1013135|NCT00350779|3312623|P1|Overall Study|Patient Moved|2
1013136|NCT00350779|3312622|P2|Overall Study|Withdrawal by Subject|8
1013137|NCT00350779|3312623|P1|Overall Study|Withdrawal by Subject|9
1013138|NCT00350779|3312622|P2|Overall Study|Protocol Violation|1
1013139|NCT00350779|3312623|P1|Overall Study|Protocol Violation|3
1013140|NCT00350779|3312622|P2|Overall Study|Physician Decision|4
1013141|NCT00350779|3312623|P1|Overall Study|Physician Decision|2
1013142|NCT00350779|3312622|P2|Overall Study|Lost to Follow-up|0
1013143|NCT00350779|3312623|P1|Overall Study|Lost to Follow-up|2
1013144|NCT00350779|3312622|P2|Overall Study|Lack of Efficacy|4
1013145|NCT00350779|3312623|P1|Overall Study|Lack of Efficacy|0
1013146|NCT00350779|3312622|P2|Overall Study|Adverse Event|2
1013147|NCT00350779|3312623|P1|Overall Study|Adverse Event|4
1013148|NCT00350727|3312644|P3|Phase II|Enrolled in Rollover Study|1
1013149|NCT00350727|3312645|P2|Phase II|Enrolled in Rollover Study|0
1013150|NCT00350727|3312646|P1|Phase II|Enrolled in Rollover Study|0
1013151|NCT00350727|3312644|P3|Phase II|Sponsor Terminated Study|1
1013152|NCT00350727|3312645|P2|Phase II|Sponsor Terminated Study|0
1013153|NCT00350727|3312646|P1|Phase II|Sponsor Terminated Study|0
1013154|NCT00350727|3312644|P3|Phase II|Death|2
1013155|NCT00350727|3312645|P2|Phase II|Death|0
1013156|NCT00350727|3312646|P1|Phase II|Death|0
1013157|NCT00350727|3312644|P3|Phase II|Adverse Event|1
1013158|NCT00350727|3312645|P2|Phase II|Adverse Event|1
1013159|NCT00350727|3312646|P1|Phase II|Adverse Event|0
1013160|NCT00350727|3312644|P3|Phase II|Withdrawal by Subject|1
1013161|NCT00350727|3312645|P2|Phase II|Withdrawal by Subject|2
1013162|NCT00350727|3312646|P1|Phase II|Withdrawal by Subject|0
1013163|NCT00350727|3312644|P3|Phase II|Clinical Deterioration|0
1013164|NCT00350727|3312645|P2|Phase II|Clinical Deterioration|1
1013165|NCT00350727|3312646|P1|Phase II|Clinical Deterioration|0
1013166|NCT00350727|3312644|P3|Phase II|Disease Progression|16
1013167|NCT00350727|3312645|P2|Phase II|Disease Progression|15
1013168|NCT00350727|3312646|P1|Phase II|Disease Progression|0
1013169|NCT00350727|3312644|P3|Phase I: Dose Escalation|Transition to Extension Phase|0
1013170|NCT00350727|3312645|P2|Phase I: Dose Escalation|Transition to Extension Phase|0
1013171|NCT00350727|3312646|P1|Phase I: Dose Escalation|Transition to Extension Phase|3
1013172|NCT00350727|3312644|P3|Phase I: Dose Escalation|Physician Decision|0
1013173|NCT00350727|3312645|P2|Phase I: Dose Escalation|Physician Decision|0
1013174|NCT00350727|3312646|P1|Phase I: Dose Escalation|Physician Decision|1
1013175|NCT00350727|3312644|P3|Phase I: Dose Escalation|Death|0
1013176|NCT00350727|3312645|P2|Phase I: Dose Escalation|Death|0
1013177|NCT00350727|3312646|P1|Phase I: Dose Escalation|Death|1
1013178|NCT00350727|3312644|P3|Phase I: Dose Escalation|Lack of Efficacy|0
1013179|NCT00350727|3312645|P2|Phase I: Dose Escalation|Lack of Efficacy|0
1013180|NCT00350727|3312646|P1|Phase I: Dose Escalation|Lack of Efficacy|25
1013181|NCT00350727|3312644|P3|Phase I: Dose Escalation|Adverse Event|0
1013182|NCT00350727|3312645|P2|Phase I: Dose Escalation|Adverse Event|0
1013183|NCT00350727|3312646|P1|Phase I: Dose Escalation|Adverse Event|4
1013184|NCT00350636|3312790|P2|Overall Study|Other|2
1013185|NCT00350636|3312791|P1|Overall Study|Other|1
1013186|NCT00350636|3312790|P2|Overall Study|Physician Decision|2
1013187|NCT00350636|3312791|P1|Overall Study|Physician Decision|0
1013188|NCT00350636|3312790|P2|Overall Study|Lost to Follow-up|8
1013189|NCT00350636|3312791|P1|Overall Study|Lost to Follow-up|9
1013190|NCT00350636|3312790|P2|Overall Study|Withdrawal by Subject|17
1013191|NCT00350636|3312791|P1|Overall Study|Withdrawal by Subject|13
1013192|NCT00350636|3312790|P2|Overall Study|Protocol Violation|3
1013193|NCT00350636|3312791|P1|Overall Study|Protocol Violation|1
1013194|NCT00350636|3312790|P2|Overall Study|Adverse Event|13
1013195|NCT00350636|3312791|P1|Overall Study|Adverse Event|19
1013196|NCT00350623|3312810|P3|Overall Study|patient traveling outside the country|1
1013197|NCT00350623|3312811|P2|Overall Study|patient traveling outside the country|0
1013198|NCT00350623|3312812|P1|Overall Study|patient traveling outside the country|0
1013199|NCT00350623|3312810|P3|Overall Study|Withdrawal by Subject|1
1013200|NCT00350623|3312811|P2|Overall Study|Withdrawal by Subject|1
1013201|NCT00350623|3312812|P1|Overall Study|Withdrawal by Subject|0
1013202|NCT00350623|3312810|P3|Overall Study|Lost to Follow-up|4
1013203|NCT00350623|3312811|P2|Overall Study|Lost to Follow-up|3
1013204|NCT00350623|3312812|P1|Overall Study|Lost to Follow-up|8
1013205|NCT00350545|3312820|P1|Overall Study|Withdrawal by Subject|2
1013206|NCT00350519|3312839|P2|Overall Study|Withdrawal by Subject|2
1013207|NCT00350519|3312840|P1|Overall Study|Withdrawal by Subject|3
1013208|NCT00350519|3312839|P2|Overall Study|Protocol Violation|2
1013209|NCT00350519|3312840|P1|Overall Study|Protocol Violation|1
1013210|NCT00350519|3312839|P2|Overall Study|Physician Decision|1
1013211|NCT00350519|3312840|P1|Overall Study|Physician Decision|0
1013212|NCT00350519|3312839|P2|Overall Study|Death|1
1013213|NCT00350519|3312840|P1|Overall Study|Death|0
1013214|NCT00350402|3312854|P2|Overall Study|Lost to Follow-up|1
1013215|NCT00350402|3312855|P1|Overall Study|Lost to Follow-up|1
1013216|NCT00350272|3312928|P2|Open-Label 84 Week Treatment|Sponsor decision|1
1013217|NCT00350272|3312929|P1|Open-Label 84 Week Treatment|Sponsor decision|2
1013218|NCT00350272|3312928|P2|Open-Label 84 Week Treatment|Physician Decision|2
1013219|NCT00350272|3312929|P1|Open-Label 84 Week Treatment|Physician Decision|1
1013220|NCT00350272|3312928|P2|Open-Label 84 Week Treatment|Withdrawal by Subject|2
1013221|NCT00350272|3312929|P1|Open-Label 84 Week Treatment|Withdrawal by Subject|1
1013222|NCT00350272|3312928|P2|Open-Label 84 Week Treatment|Lost to Follow-up|2
1013223|NCT00350272|3312929|P1|Open-Label 84 Week Treatment|Lost to Follow-up|3
1013224|NCT00350272|3312928|P2|Open-Label 84 Week Treatment|Adverse Event|1
1013225|NCT00350272|3312929|P1|Open-Label 84 Week Treatment|Adverse Event|2
1013226|NCT00350272|3312928|P2|Blinded 12 Week Treatment|Sponsor decision|1
1013227|NCT00350272|3312929|P1|Blinded 12 Week Treatment|Sponsor decision|0
1013228|NCT00350272|3312928|P2|Blinded 12 Week Treatment|Physician Decision|1
1013229|NCT00350272|3312929|P1|Blinded 12 Week Treatment|Physician Decision|2
1013230|NCT00350272|3312928|P2|Blinded 12 Week Treatment|Withdrawal by Subject|0
1013231|NCT00350272|3312929|P1|Blinded 12 Week Treatment|Withdrawal by Subject|3
1013232|NCT00350272|3312928|P2|Blinded 12 Week Treatment|Lost to Follow-up|0
1013233|NCT00350272|3312929|P1|Blinded 12 Week Treatment|Lost to Follow-up|2
1013234|NCT00350272|3312928|P2|Blinded 12 Week Treatment|Death|0
1013235|NCT00350272|3312929|P1|Blinded 12 Week Treatment|Death|1
1013236|NCT00350272|3312928|P2|Blinded 12 Week Treatment|Adverse Event|0
1013237|NCT00350272|3312929|P1|Blinded 12 Week Treatment|Adverse Event|1
1013238|NCT00350207|3312951|P3|Overall Study|Other|1
1013239|NCT00350207|3312952|P2|Overall Study|Other|3
1013240|NCT00350207|3312953|P1|Overall Study|Other|1
1013241|NCT00350207|3312951|P3|Overall Study|Withdrawal by Subject|1
1013242|NCT00350207|3312952|P2|Overall Study|Withdrawal by Subject|1
1013243|NCT00350207|3312953|P1|Overall Study|Withdrawal by Subject|0
1013244|NCT00350207|3312951|P3|Overall Study|Lost to Follow-up|1
1013245|NCT00350207|3312952|P2|Overall Study|Lost to Follow-up|0
1013246|NCT00350207|3312953|P1|Overall Study|Lost to Follow-up|1
1013247|NCT00350207|3312951|P3|Overall Study|Lack of Efficacy|2
1013248|NCT00350207|3312952|P2|Overall Study|Lack of Efficacy|0
1013249|NCT00350207|3312953|P1|Overall Study|Lack of Efficacy|1
1013250|NCT00350207|3312951|P3|Overall Study|Adverse Event|2
1013251|NCT00350207|3312952|P2|Overall Study|Adverse Event|2
1013252|NCT00350207|3312953|P1|Overall Study|Adverse Event|5
1013253|NCT00349921|3313167|P4|First Spinal Injection|Adverse Event|0
1013254|NCT00349921|3313168|P3|First Spinal Injection|Adverse Event|1
1013255|NCT00349921|3313169|P2|First Spinal Injection|Adverse Event|0
1013256|NCT00349921|3313170|P1|First Spinal Injection|Adverse Event|0
1013257|NCT00349921|3313167|P4|First Spinal Injection|Physician Decision|0
1013258|NCT00349921|3313168|P3|First Spinal Injection|Physician Decision|0
1013259|NCT00349921|3313169|P2|First Spinal Injection|Physician Decision|0
1013260|NCT00349921|3313170|P1|First Spinal Injection|Physician Decision|1
1013261|NCT00349908|3313181|P2|Overall Study|Withdrawal by Subject|4
1013262|NCT00349908|3313182|P1|Overall Study|Withdrawal by Subject|0
1013263|NCT00349752|3313208|P2|Overall Study|Other:History of squamous cell carcinoma|0
1013264|NCT00349752|3313209|P1|Overall Study|Other:History of squamous cell carcinoma|1
1013265|NCT00349752|3313208|P2|Overall Study|Other: Inadvertently unblinded|0
1013266|NCT00349752|3313209|P1|Overall Study|Other: Inadvertently unblinded|1
1013267|NCT00349752|3313208|P2|Overall Study|Other: Ineligible|0
1013268|NCT00349752|3313209|P1|Overall Study|Other: Ineligible|1
1013269|NCT00349752|3313208|P2|Overall Study|Other: Patient's steroid use|0
1013270|NCT00349752|3313209|P1|Overall Study|Other: Patient's steroid use|1
1013271|NCT00349752|3313208|P2|Overall Study|Other: Patient stopped steroids|1
1013272|NCT00349752|3313209|P1|Overall Study|Other: Patient stopped steroids|0
1013273|NCT00349752|3313208|P2|Overall Study|Other: Non compliance|1
1013274|NCT00349752|3313209|P1|Overall Study|Other: Non compliance|0
1013275|NCT00349752|3313208|P2|Overall Study|Other: Required exclusionary medication|1
1013276|NCT00349752|3313209|P1|Overall Study|Other: Required exclusionary medication|0
1013277|NCT00349752|3313208|P2|Overall Study|Personal reasons|5
1013278|NCT00349752|3313209|P1|Overall Study|Personal reasons|6
1013279|NCT00349752|3313208|P2|Overall Study|Lost to Follow-up|2
1013280|NCT00349752|3313209|P1|Overall Study|Lost to Follow-up|4
1013281|NCT00349752|3313208|P2|Overall Study|Lack of Efficacy|42
1013282|NCT00349752|3313209|P1|Overall Study|Lack of Efficacy|37
1013283|NCT00349752|3313208|P2|Overall Study|Adverse Event|12
1013284|NCT00349752|3313209|P1|Overall Study|Adverse Event|8
1013285|NCT00349622|3313262|P2|Overall Study|Withdrawal by Subject|9
1013286|NCT00349622|3313263|P1|Overall Study|Withdrawal by Subject|5
1013287|NCT00349622|3313262|P2|Overall Study|Lost to Follow-up|1
1013288|NCT00349622|3313263|P1|Overall Study|Lost to Follow-up|5
1013289|NCT00349622|3313262|P2|Overall Study|Death|86
1013290|NCT00349622|3313263|P1|Overall Study|Death|168
1013291|NCT00349349|3313300|P3|Overall Study|New Malignancy (Bladder Cancer)|0
1013292|NCT00349349|3313301|P2|Overall Study|New Malignancy (Bladder Cancer)|1
1013293|NCT00349349|3313302|P1|Overall Study|New Malignancy (Bladder Cancer)|0
1013294|NCT00349349|3313300|P3|Overall Study|No Response|0
1013295|NCT00349349|3313301|P2|Overall Study|No Response|3
1013296|NCT00349349|3313302|P1|Overall Study|No Response|0
1013297|NCT00349349|3313300|P3|Overall Study|Physician Decision|1
1013298|NCT00349349|3313301|P2|Overall Study|Physician Decision|2
1013299|NCT00349349|3313302|P1|Overall Study|Physician Decision|1
1013300|NCT00349349|3313300|P3|Overall Study|Participant Reduced General Condition|0
1013301|NCT00349349|3313301|P2|Overall Study|Participant Reduced General Condition|1
1013302|NCT00349349|3313302|P1|Overall Study|Participant Reduced General Condition|0
1013303|NCT00349349|3313300|P3|Overall Study|Other Treatment Selected|0
1013304|NCT00349349|3313301|P2|Overall Study|Other Treatment Selected|0
1013305|NCT00349349|3313302|P1|Overall Study|Other Treatment Selected|2
1013306|NCT00349349|3313300|P3|Overall Study|Death|1
1013307|NCT00349349|3313301|P2|Overall Study|Death|10
1013308|NCT00349349|3313302|P1|Overall Study|Death|13
1013309|NCT00349349|3313300|P3|Overall Study|Withdrawn due to Disease Progression|1
1013310|NCT00349349|3313301|P2|Overall Study|Withdrawn due to Disease Progression|37
1013311|NCT00349349|3313302|P1|Overall Study|Withdrawn due to Disease Progression|27
1013312|NCT00349349|3313300|P3|Overall Study|Withdrawal by Subject|1
1013313|NCT00349349|3313301|P2|Overall Study|Withdrawal by Subject|2
1013314|NCT00349349|3313302|P1|Overall Study|Withdrawal by Subject|5
1013315|NCT00349349|3313300|P3|Overall Study|Adverse Event|2
1013316|NCT00349349|3313301|P2|Overall Study|Adverse Event|6
1013317|NCT00349349|3313302|P1|Overall Study|Adverse Event|5
1013318|NCT00348933|3313391|P1|Overall Study|Adverse Event|7
1013319|NCT00348933|3313391|P1|Overall Study|Protocol Violation|2
1013320|NCT00348933|3313391|P1|Overall Study|Lost to Follow-up|6
1013321|NCT00348933|3313391|P1|Overall Study|Withdrawal by Subject|10
1013322|NCT00348881|3313399|P2|Overall Study|Serious Adverse Event|2
1013323|NCT00348881|3313400|P1|Overall Study|Serious Adverse Event|0
1013324|NCT00348881|3313399|P2|Overall Study|Adverse Event|0
1013325|NCT00348881|3313400|P1|Overall Study|Adverse Event|2
1013326|NCT00348881|3313399|P2|Overall Study|Withdrawal by Subject|4
1013327|NCT00348881|3313400|P1|Overall Study|Withdrawal by Subject|3
1013328|NCT00348881|3313399|P2|Overall Study|Lost to Follow-up|6
1013329|NCT00348881|3313400|P1|Overall Study|Lost to Follow-up|12
1013330|NCT00348816|3313412|P1|Overall Study|Noncompliance with radiation treatment|1
1013331|NCT00348790|3313419|P1|Completed Treatment|Unable to travel to study site|1
1013332|NCT00348790|3313419|P1|Completed Treatment|Required surgery|2
1013333|NCT00348790|3313419|P1|Completed Treatment|Adverse Event|4
1013334|NCT00348790|3313419|P1|Completed Treatment|Disease progression|14
1013335|NCT00348790|3313419|P1|Completed Treatment|Withdrawal by Subject|4
1013336|NCT00348686|3313431|P1|Overall Study|Multiple Reasons|8
1013337|NCT00348686|3313431|P1|Overall Study|Lost to Follow-up|2
1013338|NCT00348686|3313431|P1|Overall Study|Protocol Violation|6
1013339|NCT00348686|3313431|P1|Overall Study|Adverse Event|5
1013340|NCT00348686|3313431|P1|Overall Study|Withdrawal by Subject|45
1013341|NCT00348673|3313448|P9|Stage 1|Randomized but not Treated|0
1013342|NCT00348673|3313449|P8|Stage 1|Randomized but not Treated|0
1013343|NCT00348673|3313450|P7|Stage 1|Randomized but not Treated|0
1013344|NCT00348673|3313451|P6|Stage 1|Randomized but not Treated|0
1013345|NCT00348673|3313452|P5|Stage 1|Randomized but not Treated|0
1013346|NCT00348673|3313453|P4|Stage 1|Randomized but not Treated|0
1013347|NCT00348673|3313454|P3|Stage 1|Randomized but not Treated|1
1013348|NCT00348673|3313455|P2|Stage 1|Randomized but not Treated|0
1013349|NCT00348673|3313456|P1|Stage 1|Randomized but not Treated|0
1013350|NCT00348556|3313503|P1|Overall Study|Adverse Event|1
1013351|NCT00348374|3313510|P2|Overall Study|randomized but did not receive treatment|7
1013352|NCT00348374|3313511|P1|Overall Study|randomized but did not receive treatment|0
1013353|NCT00348374|3313510|P2|Overall Study|ongoing at date of cutoff|1
1013354|NCT00348374|3313511|P1|Overall Study|ongoing at date of cutoff|1
1013355|NCT00348374|3313510|P2|Overall Study|Other|12
1013356|NCT00348374|3313511|P1|Overall Study|Other|11
1013357|NCT00348374|3313510|P2|Overall Study|Withdrawal by Subject|5
1013358|NCT00348374|3313511|P1|Overall Study|Withdrawal by Subject|5
1013359|NCT00348374|3313510|P2|Overall Study|Lost to Follow-up|3
1013360|NCT00348374|3313511|P1|Overall Study|Lost to Follow-up|1
1013361|NCT00348374|3313510|P2|Overall Study|Adverse Event|4
1013362|NCT00348374|3313511|P1|Overall Study|Adverse Event|1
1013363|NCT00348348|3313558|P2|Overall Study|Adverse event probably related to study|0
1013364|NCT00348348|3313559|P1|Overall Study|Adverse event probably related to study|1
1013365|NCT00348348|3313558|P2|Overall Study|Worsening of BC - Unlikely related|2
1013366|NCT00348348|3313559|P1|Overall Study|Worsening of BC - Unlikely related|1
1013367|NCT00348348|3313558|P2|Overall Study|Worsening of BC - Unrelated to study|3
1013368|NCT00348348|3313559|P1|Overall Study|Worsening of BC - Unrelated to study|0
1013369|NCT00348348|3313558|P2|Overall Study|Dissallowed Meds - possibly releated|1
1013370|NCT00348348|3313559|P1|Overall Study|Dissallowed Meds - possibly releated|1
1013371|NCT00348348|3313558|P2|Overall Study|Dissallowed Meds - unlikley related|1
1013372|NCT00348348|3313559|P1|Overall Study|Dissallowed Meds - unlikley related|1
1013373|NCT00348348|3313558|P2|Overall Study|Dissallowed Meds - unrelated to study|3
1013374|NCT00348348|3313559|P1|Overall Study|Dissallowed Meds - unrelated to study|1
1013375|NCT00348348|3313558|P2|Overall Study|Not specified|4
1013376|NCT00348348|3313559|P1|Overall Study|Not specified|7
1013377|NCT00348348|3313558|P2|Overall Study|Withdrawal by Subject|1
1013378|NCT00348348|3313559|P1|Overall Study|Withdrawal by Subject|4
1013379|NCT00348348|3313558|P2|Overall Study|Lost to Follow-up|10
1013380|NCT00348348|3313559|P1|Overall Study|Lost to Follow-up|8
1013381|NCT00348348|3313558|P2|Overall Study|Lack of Efficacy|1
1013382|NCT00348348|3313559|P1|Overall Study|Lack of Efficacy|1
1013383|NCT00348348|3313558|P2|Overall Study|Adverse event - unrelated to study drug|1
1013384|NCT00348348|3313559|P1|Overall Study|Adverse event - unrelated to study drug|0
1013385|NCT00348309|3313574|P3|Overall Study|HCV career|1
1013386|NCT00348309|3313575|P2|Overall Study|HCV career|0
1013387|NCT00348309|3313576|P1|Overall Study|HCV career|0
1013388|NCT00348309|3313574|P3|Overall Study|Cardiologist recommendations|1
1013389|NCT00348309|3313575|P2|Overall Study|Cardiologist recommendations|0
1013390|NCT00348309|3313576|P1|Overall Study|Cardiologist recommendations|0
1013391|NCT00348309|3313574|P3|Overall Study|ECG abnormal|2
1013392|NCT00348309|3313575|P2|Overall Study|ECG abnormal|0
1013393|NCT00348309|3313576|P1|Overall Study|ECG abnormal|0
1013394|NCT00348309|3313574|P3|Overall Study|Adverse event not attended|1
1013395|NCT00348309|3313575|P2|Overall Study|Adverse event not attended|0
1013396|NCT00348309|3313576|P1|Overall Study|Adverse event not attended|0
1013397|NCT00348309|3313574|P3|Overall Study|Site closure|1
1013398|NCT00348309|3313575|P2|Overall Study|Site closure|0
1013399|NCT00348309|3313576|P1|Overall Study|Site closure|0
1013400|NCT00348309|3313574|P3|Overall Study|Increased dose of Aricept|1
1013401|NCT00348309|3313575|P2|Overall Study|Increased dose of Aricept|0
1013402|NCT00348309|3313576|P1|Overall Study|Increased dose of Aricept|0
1013403|NCT00348309|3313574|P3|Overall Study|Medical Monitor decision|1
1013404|NCT00348309|3313575|P2|Overall Study|Medical Monitor decision|0
1013405|NCT00348309|3313576|P1|Overall Study|Medical Monitor decision|0
1013406|NCT00348309|3313574|P3|Overall Study|Forgot often medication|0
1013407|NCT00348309|3313575|P2|Overall Study|Forgot often medication|1
1013408|NCT00348309|3313576|P1|Overall Study|Forgot often medication|0
1013409|NCT00348309|3313574|P3|Overall Study|Sponsor refuseal|1
1013410|NCT00348309|3313575|P2|Overall Study|Sponsor refuseal|1
1013411|NCT00348309|3313576|P1|Overall Study|Sponsor refuseal|0
1013412|NCT00348309|3313574|P3|Overall Study|Participant was hospitalized|0
1013413|NCT00348309|3313575|P2|Overall Study|Participant was hospitalized|1
1013414|NCT00348309|3313576|P1|Overall Study|Participant was hospitalized|0
1013415|NCT00348309|3313574|P3|Overall Study|A foul of exclusion criteria|0
1013416|NCT00348309|3313575|P2|Overall Study|A foul of exclusion criteria|1
1013417|NCT00348309|3313576|P1|Overall Study|A foul of exclusion criteria|0
1013418|NCT00348309|3313574|P3|Overall Study|Ineffectiveness of treatment|0
1013419|NCT00348309|3313575|P2|Overall Study|Ineffectiveness of treatment|1
1013420|NCT00348309|3313576|P1|Overall Study|Ineffectiveness of treatment|0
1013421|NCT00348309|3313574|P3|Overall Study|Decision of sponsor|0
1013422|NCT00348309|3313575|P2|Overall Study|Decision of sponsor|0
1013423|NCT00348309|3313576|P1|Overall Study|Decision of sponsor|1
1013424|NCT00348309|3313574|P3|Overall Study|Participant died|1
1013425|NCT00348309|3313575|P2|Overall Study|Participant died|1
1013426|NCT00348309|3313576|P1|Overall Study|Participant died|2
1013427|NCT00348309|3313574|P3|Overall Study|Did not appear in time for Visit 3|0
1013428|NCT00348309|3313575|P2|Overall Study|Did not appear in time for Visit 3|0
1013429|NCT00348309|3313576|P1|Overall Study|Did not appear in time for Visit 3|1
1013430|NCT00348309|3313574|P3|Overall Study|Worsening of alzheimer|1
1013431|NCT00348309|3313575|P2|Overall Study|Worsening of alzheimer|0
1013432|NCT00348309|3313576|P1|Overall Study|Worsening of alzheimer|1
1013433|NCT00348309|3313574|P3|Overall Study|Cognitive and behaviour worsening|0
1013434|NCT00348309|3313575|P2|Overall Study|Cognitive and behaviour worsening|0
1013435|NCT00348309|3313576|P1|Overall Study|Cognitive and behaviour worsening|2
1013436|NCT00348309|3313574|P3|Overall Study|Worsened neurodegenerative disease|0
1013437|NCT00348309|3313575|P2|Overall Study|Worsened neurodegenerative disease|0
1013438|NCT00348309|3313576|P1|Overall Study|Worsened neurodegenerative disease|1
1013439|NCT00348309|3313574|P3|Overall Study|No disponibility of medication|0
1013440|NCT00348309|3313575|P2|Overall Study|No disponibility of medication|0
1013441|NCT00348309|3313576|P1|Overall Study|No disponibility of medication|1
1013442|NCT00348309|3313574|P3|Overall Study|Principal investigator's decision|0
1013443|NCT00348309|3313575|P2|Overall Study|Principal investigator's decision|0
1013444|NCT00348309|3313576|P1|Overall Study|Principal investigator's decision|1
1013445|NCT00348309|3313574|P3|Overall Study|PI closing medical practice|0
1013446|NCT00348309|3313575|P2|Overall Study|PI closing medical practice|0
1013447|NCT00348309|3313576|P1|Overall Study|PI closing medical practice|1
1013448|NCT00348309|3313574|P3|Overall Study|Unable to complete ET visit|0
1013449|NCT00348309|3313575|P2|Overall Study|Unable to complete ET visit|0
1013450|NCT00348309|3313576|P1|Overall Study|Unable to complete ET visit|1
1013451|NCT00348309|3313574|P3|Overall Study|Caregiver withdrawal|7
1013452|NCT00348309|3313575|P2|Overall Study|Caregiver withdrawal|0
1013453|NCT00348309|3313576|P1|Overall Study|Caregiver withdrawal|3
1013454|NCT00348309|3313574|P3|Overall Study|Use of prohibited medication|2
1013455|NCT00348309|3313575|P2|Overall Study|Use of prohibited medication|2
1013456|NCT00348309|3313576|P1|Overall Study|Use of prohibited medication|5
1013457|NCT00348309|3313574|P3|Overall Study|Caregiver sick|0
1013458|NCT00348309|3313575|P2|Overall Study|Caregiver sick|0
1013459|NCT00348309|3313576|P1|Overall Study|Caregiver sick|1
1013460|NCT00348309|3313574|P3|Overall Study|Wrong bottle allocated|0
1013461|NCT00348309|3313575|P2|Overall Study|Wrong bottle allocated|0
1013462|NCT00348309|3313576|P1|Overall Study|Wrong bottle allocated|1
1013463|NCT00348309|3313574|P3|Overall Study|Lack of insight, dementia|0
1013464|NCT00348309|3313575|P2|Overall Study|Lack of insight, dementia|0
1013465|NCT00348309|3313576|P1|Overall Study|Lack of insight, dementia|1
1013466|NCT00348309|3313574|P3|Overall Study|Death of caregiver|1
1013467|NCT00348309|3313575|P2|Overall Study|Death of caregiver|0
1013468|NCT00348309|3313576|P1|Overall Study|Death of caregiver|1
1013469|NCT00348309|3313574|P3|Overall Study|Non-compliance|8
1013470|NCT00348309|3313575|P2|Overall Study|Non-compliance|6
1013471|NCT00348309|3313576|P1|Overall Study|Non-compliance|8
1013472|NCT00348309|3313574|P3|Overall Study|Withdrawal by Subject|40
1013473|NCT00348309|3313575|P2|Overall Study|Withdrawal by Subject|37
1013474|NCT00348309|3313576|P1|Overall Study|Withdrawal by Subject|33
1013475|NCT00348309|3313574|P3|Overall Study|Protocol Violation|7
1013476|NCT00348309|3313575|P2|Overall Study|Protocol Violation|12
1013477|NCT00348309|3313576|P1|Overall Study|Protocol Violation|7
1013478|NCT00348309|3313574|P3|Overall Study|Lost to Follow-up|4
1013479|NCT00348309|3313575|P2|Overall Study|Lost to Follow-up|7
1013480|NCT00348309|3313576|P1|Overall Study|Lost to Follow-up|6
1013481|NCT00348309|3313574|P3|Overall Study|Adverse Event|63
1013482|NCT00348309|3313575|P2|Overall Study|Adverse Event|28
1013483|NCT00348309|3313576|P1|Overall Study|Adverse Event|56
1013484|NCT00348283|3313649|P2|Open Label|Sponsor decision|1
1013485|NCT00348283|3313650|P1|Open Label|Sponsor decision|0
1013486|NCT00348283|3313649|P2|Open Label|Pregnancy|1
1013487|NCT00348283|3313650|P1|Open Label|Pregnancy|0
1013488|NCT00348283|3313649|P2|Open Label|Subject moved to the United States|1
1013489|NCT00348283|3313650|P1|Open Label|Subject moved to the United States|0
1013490|NCT00348283|3313649|P2|Open Label|Administrative reasons|5
1013491|NCT00348283|3313650|P1|Open Label|Administrative reasons|0
1013492|NCT00348283|3313649|P2|Open Label|Lack of Efficacy|13
1013493|NCT00348283|3313650|P1|Open Label|Lack of Efficacy|0
1013494|NCT00348283|3313649|P2|Open Label|Lost to Follow-up|1
1013495|NCT00348283|3313650|P1|Open Label|Lost to Follow-up|0
1013496|NCT00348283|3313649|P2|Open Label|Withdrawal by Subject|4
1013497|NCT00348283|3313650|P1|Open Label|Withdrawal by Subject|0
1013498|NCT00348283|3313649|P2|Open Label|Adverse Event|8
1013499|NCT00348283|3313650|P1|Open Label|Adverse Event|0
1013500|NCT00348283|3313649|P2|Double Blind|Pregnancy|1
1013501|NCT00348283|3313650|P1|Double Blind|Pregnancy|0
1013502|NCT00348283|3313649|P2|Double Blind|Lack of Efficacy|2
1013503|NCT00348283|3313650|P1|Double Blind|Lack of Efficacy|2
1013504|NCT00348283|3313649|P2|Double Blind|Protocol Violation|1
1013505|NCT00348283|3313650|P1|Double Blind|Protocol Violation|0
1013506|NCT00348283|3313649|P2|Double Blind|Withdrawal by Subject|1
1013507|NCT00348283|3313650|P1|Double Blind|Withdrawal by Subject|1
1013508|NCT00348283|3313649|P2|Double Blind|Adverse Event|5
1013509|NCT00348283|3313650|P1|Double Blind|Adverse Event|2
1013510|NCT00348283|3313649|P2|Induction|Protocol Violation|4
1013511|NCT00348283|3313650|P1|Induction|Protocol Violation|0
1013512|NCT00348283|3313649|P2|Induction|Adverse Event|2
1013513|NCT00348283|3313650|P1|Induction|Adverse Event|0
1013514|NCT00348140|3313669|P3|Overall Study|Memory declined|1
1013515|NCT00348140|3313670|P2|Overall Study|Memory declined|0
1013516|NCT00348140|3313671|P1|Overall Study|Memory declined|0
1013517|NCT00348140|3313669|P3|Overall Study|Exclusion criteria met|1
1013518|NCT00348140|3313670|P2|Overall Study|Exclusion criteria met|0
1013519|NCT00348140|3313671|P1|Overall Study|Exclusion criteria met|0
1013520|NCT00348140|3313669|P3|Overall Study|Participant died|0
1013521|NCT00348140|3313670|P2|Overall Study|Participant died|1
1013522|NCT00348140|3313671|P1|Overall Study|Participant died|0
1013523|NCT00348140|3313669|P3|Overall Study|Abnormal ECG|3
1013524|NCT00348140|3313670|P2|Overall Study|Abnormal ECG|1
1013525|NCT00348140|3313671|P1|Overall Study|Abnormal ECG|0
1013526|NCT00348140|3313669|P3|Overall Study|Serious adverse event|0
1013527|NCT00348140|3313670|P2|Overall Study|Serious adverse event|1
1013528|NCT00348140|3313671|P1|Overall Study|Serious adverse event|0
1013529|NCT00348140|3313669|P3|Overall Study|Increased risk of cardiac infarction|0
1013530|NCT00348140|3313670|P2|Overall Study|Increased risk of cardiac infarction|1
1013531|NCT00348140|3313671|P1|Overall Study|Increased risk of cardiac infarction|0
1013532|NCT00348140|3313669|P3|Overall Study|Disease progression|5
1013533|NCT00348140|3313670|P2|Overall Study|Disease progression|2
1013534|NCT00348140|3313671|P1|Overall Study|Disease progression|1
1013535|NCT00348140|3313669|P3|Overall Study|Use of prohibited drug|2
1013536|NCT00348140|3313670|P2|Overall Study|Use of prohibited drug|0
1013537|NCT00348140|3313671|P1|Overall Study|Use of prohibited drug|1
1013538|NCT00348140|3313669|P3|Overall Study|Decided to discontinue on their own|1
1013539|NCT00348140|3313670|P2|Overall Study|Decided to discontinue on their own|4
1013540|NCT00348140|3313671|P1|Overall Study|Decided to discontinue on their own|1
1013541|NCT00348140|3313669|P3|Overall Study|Investigator decided to discontinue|4
1013542|NCT00348140|3313670|P2|Overall Study|Investigator decided to discontinue|1
1013543|NCT00348140|3313671|P1|Overall Study|Investigator decided to discontinue|4
1013544|NCT00348140|3313669|P3|Overall Study|Screen failure|0
1013545|NCT00348140|3313670|P2|Overall Study|Screen failure|0
1013546|NCT00348140|3313671|P1|Overall Study|Screen failure|1
1013547|NCT00348140|3313669|P3|Overall Study|Participant unwell|0
1013548|NCT00348140|3313670|P2|Overall Study|Participant unwell|0
1013549|NCT00348140|3313671|P1|Overall Study|Participant unwell|1
1013550|NCT00348140|3313669|P3|Overall Study|Unmet inclusion-exclusion criteria|1
1013551|NCT00348140|3313670|P2|Overall Study|Unmet inclusion-exclusion criteria|0
1013552|NCT00348140|3313671|P1|Overall Study|Unmet inclusion-exclusion criteria|1
1013553|NCT00348140|3313669|P3|Overall Study|Administration related|1
1013554|NCT00348140|3313670|P2|Overall Study|Administration related|1
1013555|NCT00348140|3313671|P1|Overall Study|Administration related|3
1013556|NCT00348140|3313669|P3|Overall Study|Efficacy related|0
1013557|NCT00348140|3313670|P2|Overall Study|Efficacy related|1
1013558|NCT00348140|3313671|P1|Overall Study|Efficacy related|1
1013559|NCT00348140|3313669|P3|Overall Study|Participant hospitalised|0
1013560|NCT00348140|3313670|P2|Overall Study|Participant hospitalised|0
1013561|NCT00348140|3313671|P1|Overall Study|Participant hospitalised|3
1013562|NCT00348140|3313669|P3|Overall Study|Caregiver related|3
1013563|NCT00348140|3313670|P2|Overall Study|Caregiver related|7
1013564|NCT00348140|3313671|P1|Overall Study|Caregiver related|4
1013565|NCT00348140|3313669|P3|Overall Study|Conditional medication increased dose|0
1013566|NCT00348140|3313670|P2|Overall Study|Conditional medication increased dose|0
1013567|NCT00348140|3313671|P1|Overall Study|Conditional medication increased dose|1
1013568|NCT00348140|3313669|P3|Overall Study|Participant at risk due to study drug|0
1013569|NCT00348140|3313670|P2|Overall Study|Participant at risk due to study drug|0
1013570|NCT00348140|3313671|P1|Overall Study|Participant at risk due to study drug|2
1013571|NCT00348140|3313669|P3|Overall Study|Non-compliance|5
1013572|NCT00348140|3313670|P2|Overall Study|Non-compliance|13
1013573|NCT00348140|3313671|P1|Overall Study|Non-compliance|8
1013574|NCT00348140|3313669|P3|Overall Study|Withdrawal by Subject|40
1013575|NCT00348140|3313670|P2|Overall Study|Withdrawal by Subject|40
1013576|NCT00348140|3313671|P1|Overall Study|Withdrawal by Subject|32
1013577|NCT00348140|3313669|P3|Overall Study|Protocol Violation|14
1013578|NCT00348140|3313670|P2|Overall Study|Protocol Violation|13
1013579|NCT00348140|3313671|P1|Overall Study|Protocol Violation|12
1013580|NCT00348140|3313669|P3|Overall Study|Lost to Follow-up|4
1013581|NCT00348140|3313670|P2|Overall Study|Lost to Follow-up|4
1013582|NCT00348140|3313671|P1|Overall Study|Lost to Follow-up|4
1013583|NCT00348140|3313669|P3|Overall Study|Adverse Event|78
1013584|NCT00348140|3313670|P2|Overall Study|Adverse Event|49
1013585|NCT00348140|3313671|P1|Overall Study|Adverse Event|46
1013586|NCT00347958|3313769|P1|Overall Study|Withdrawal by Subject|1
1013587|NCT00347958|3313769|P1|Overall Study|Protocol Violation|2
1013588|NCT00347958|3313769|P1|Overall Study|Adverse Event|1
1013589|NCT00347932|3313778|P2|Overall Study|Did not meet inclusion criteria|8
1013590|NCT00347932|3313779|P1|Overall Study|Did not meet inclusion criteria|4
1013591|NCT00347932|3313778|P2|Overall Study|Withdrawal by Subject|16
1013592|NCT00347932|3313779|P1|Overall Study|Withdrawal by Subject|10
1013593|NCT00347932|3313778|P2|Overall Study|Lost to Follow-up|9
1013594|NCT00347932|3313779|P1|Overall Study|Lost to Follow-up|10
1013595|NCT00347932|3313778|P2|Overall Study|Lack of Efficacy|14
1013596|NCT00347932|3313779|P1|Overall Study|Lack of Efficacy|3
1013597|NCT00347932|3313778|P2|Overall Study|Adverse Event|5
1013598|NCT00347932|3313779|P1|Overall Study|Adverse Event|4
1013599|NCT00347919|3313794|P3|Overall Study|Missing|2
1013600|NCT00347919|3313795|P2|Overall Study|Missing|1
1013601|NCT00347919|3313796|P1|Overall Study|Missing|2
1013602|NCT00347919|3313794|P3|Overall Study|Par. Started Other Treatment|1
1013603|NCT00347919|3313795|P2|Overall Study|Par. Started Other Treatment|1
1013604|NCT00347919|3313796|P1|Overall Study|Par. Started Other Treatment|1
1013605|NCT00347919|3313794|P3|Overall Study|Death|19
1013606|NCT00347919|3313795|P2|Overall Study|Death|42
1013607|NCT00347919|3313796|P1|Overall Study|Death|35
1013608|NCT00347919|3313794|P3|Overall Study|Sponsor terminated study|16
1013609|NCT00347919|3313795|P2|Overall Study|Sponsor terminated study|10
1013610|NCT00347919|3313796|P1|Overall Study|Sponsor terminated study|15
1013611|NCT00347919|3313794|P3|Overall Study|Physician Decision|0
1013612|NCT00347919|3313795|P2|Overall Study|Physician Decision|1
1013613|NCT00347919|3313796|P1|Overall Study|Physician Decision|1
1013614|NCT00347919|3313794|P3|Overall Study|Withdrawal by Subject|0
1013615|NCT00347919|3313795|P2|Overall Study|Withdrawal by Subject|8
1013616|NCT00347919|3313796|P1|Overall Study|Withdrawal by Subject|6
1013617|NCT00347919|3313794|P3|Overall Study|Lost to Follow-up|0
1013618|NCT00347919|3313795|P2|Overall Study|Lost to Follow-up|13
1013619|NCT00347919|3313796|P1|Overall Study|Lost to Follow-up|11
1013620|NCT00347776|3313819|P3|12 Month Follow-up|Reached endpoint|9
1013621|NCT00347776|3313820|P2|12 Month Follow-up|Reached endpoint|6
1013622|NCT00347776|3313821|P1|12 Month Follow-up|Reached endpoint|13
1013623|NCT00347776|3313819|P3|12 Month Follow-up|Death|4
1013624|NCT00347776|3313820|P2|12 Month Follow-up|Death|4
1013625|NCT00347776|3313821|P1|12 Month Follow-up|Death|3
1013626|NCT00347776|3313819|P3|12 Month Follow-up|Lost to Follow-up|6
1013627|NCT00347776|3313820|P2|12 Month Follow-up|Lost to Follow-up|6
1013628|NCT00347776|3313821|P1|12 Month Follow-up|Lost to Follow-up|7
1013629|NCT00347776|3313819|P3|6 Month Follow-up|reached endpont|15
1013630|NCT00347776|3313820|P2|6 Month Follow-up|reached endpont|12
1013631|NCT00347776|3313821|P1|6 Month Follow-up|reached endpont|20
1013632|NCT00347776|3313819|P3|6 Month Follow-up|Death|3
1013633|NCT00347776|3313820|P2|6 Month Follow-up|Death|1
1013634|NCT00347776|3313821|P1|6 Month Follow-up|Death|2
1013635|NCT00347776|3313819|P3|1.5 Month Follow-up|reached the endpoint|12
1013636|NCT00347776|3313820|P2|1.5 Month Follow-up|reached the endpoint|8
1013637|NCT00347776|3313821|P1|1.5 Month Follow-up|reached the endpoint|12
1013638|NCT00347776|3313819|P3|1.5 Month Follow-up|Death|0
1013639|NCT00347776|3313820|P2|1.5 Month Follow-up|Death|0
1013640|NCT00347776|3313821|P1|1.5 Month Follow-up|Death|2
1013641|NCT00347438|3313833|P1|Overall Study|Physician Decision|1
1013642|NCT00347438|3313833|P1|Overall Study|Withdrawal by Subject|1
1013643|NCT00347360|3313855|P15|Overall Study|Visits conflicted with new job|0
1013644|NCT00347360|3313856|P14|Overall Study|Visits conflicted with new job|0
1013645|NCT00347360|3313857|P13|Overall Study|Visits conflicted with new job|0
1013646|NCT00347360|3313858|P12|Overall Study|Visits conflicted with new job|0
1013647|NCT00347360|3313859|P11|Overall Study|Visits conflicted with new job|0
1013648|NCT00347360|3313860|P10|Overall Study|Visits conflicted with new job|0
1013649|NCT00347360|3313861|P9|Overall Study|Visits conflicted with new job|0
1013650|NCT00347360|3313862|P8|Overall Study|Visits conflicted with new job|0
1013651|NCT00347360|3313863|P7|Overall Study|Visits conflicted with new job|1
1013652|NCT00347360|3313864|P6|Overall Study|Visits conflicted with new job|0
1013653|NCT00347360|3313865|P5|Overall Study|Visits conflicted with new job|0
1013654|NCT00347360|3313866|P4|Overall Study|Visits conflicted with new job|0
1013655|NCT00347360|3313867|P3|Overall Study|Visits conflicted with new job|0
1013656|NCT00347360|3313868|P2|Overall Study|Visits conflicted with new job|0
1013657|NCT00347360|3313869|P1|Overall Study|Visits conflicted with new job|0
1013658|NCT00347360|3313855|P15|Overall Study|Subject refuse to sign updated consent|1
1013659|NCT00347360|3313856|P14|Overall Study|Subject refuse to sign updated consent|0
1013660|NCT00347360|3313857|P13|Overall Study|Subject refuse to sign updated consent|0
1013661|NCT00347360|3313858|P12|Overall Study|Subject refuse to sign updated consent|0
1013662|NCT00347360|3313859|P11|Overall Study|Subject refuse to sign updated consent|0
1013663|NCT00347360|3313860|P10|Overall Study|Subject refuse to sign updated consent|0
1013664|NCT00347360|3313861|P9|Overall Study|Subject refuse to sign updated consent|0
1013665|NCT00347360|3313862|P8|Overall Study|Subject refuse to sign updated consent|0
1013666|NCT00347360|3313863|P7|Overall Study|Subject refuse to sign updated consent|0
1013667|NCT00347360|3313864|P6|Overall Study|Subject refuse to sign updated consent|0
1013668|NCT00347360|3313865|P5|Overall Study|Subject refuse to sign updated consent|0
1013669|NCT00347360|3313866|P4|Overall Study|Subject refuse to sign updated consent|0
1013670|NCT00347360|3313867|P3|Overall Study|Subject refuse to sign updated consent|0
1013671|NCT00347360|3313868|P2|Overall Study|Subject refuse to sign updated consent|0
1013672|NCT00347360|3313869|P1|Overall Study|Subject refuse to sign updated consent|0
1013673|NCT00347360|3313855|P15|Overall Study|Subject left town, ran out of study drug|0
1013674|NCT00347360|3313856|P14|Overall Study|Subject left town, ran out of study drug|1
1013675|NCT00347360|3313857|P13|Overall Study|Subject left town, ran out of study drug|0
1013676|NCT00347360|3313858|P12|Overall Study|Subject left town, ran out of study drug|0
1013677|NCT00347360|3313859|P11|Overall Study|Subject left town, ran out of study drug|0
1013678|NCT00347360|3313860|P10|Overall Study|Subject left town, ran out of study drug|0
1013679|NCT00347360|3313861|P9|Overall Study|Subject left town, ran out of study drug|0
1013680|NCT00347360|3313862|P8|Overall Study|Subject left town, ran out of study drug|0
1013681|NCT00347360|3313863|P7|Overall Study|Subject left town, ran out of study drug|0
1013682|NCT00347360|3313864|P6|Overall Study|Subject left town, ran out of study drug|0
1013683|NCT00347360|3313865|P5|Overall Study|Subject left town, ran out of study drug|0
1013684|NCT00347360|3313866|P4|Overall Study|Subject left town, ran out of study drug|0
1013685|NCT00347360|3313867|P3|Overall Study|Subject left town, ran out of study drug|0
1013686|NCT00347360|3313868|P2|Overall Study|Subject left town, ran out of study drug|0
1013687|NCT00347360|3313869|P1|Overall Study|Subject left town, ran out of study drug|0
1013688|NCT00347360|3313855|P15|Overall Study|Prolonged duration between visits|0
1013689|NCT00347360|3313856|P14|Overall Study|Prolonged duration between visits|0
1013690|NCT00347360|3313857|P13|Overall Study|Prolonged duration between visits|1
1013691|NCT00347360|3313858|P12|Overall Study|Prolonged duration between visits|0
1013692|NCT00347360|3313859|P11|Overall Study|Prolonged duration between visits|0
1013693|NCT00347360|3313860|P10|Overall Study|Prolonged duration between visits|0
1013694|NCT00347360|3313861|P9|Overall Study|Prolonged duration between visits|0
1013695|NCT00347360|3313862|P8|Overall Study|Prolonged duration between visits|0
1013696|NCT00347360|3313863|P7|Overall Study|Prolonged duration between visits|0
1013697|NCT00347360|3313864|P6|Overall Study|Prolonged duration between visits|0
1013698|NCT00347360|3313865|P5|Overall Study|Prolonged duration between visits|0
1013699|NCT00347360|3313866|P4|Overall Study|Prolonged duration between visits|0
1013700|NCT00347360|3313867|P3|Overall Study|Prolonged duration between visits|0
1013701|NCT00347360|3313868|P2|Overall Study|Prolonged duration between visits|0
1013702|NCT00347360|3313869|P1|Overall Study|Prolonged duration between visits|0
1013703|NCT00347360|3313855|P15|Overall Study|Failed inclusion criteria #4|0
1013704|NCT00347360|3313856|P14|Overall Study|Failed inclusion criteria #4|0
1013705|NCT00347360|3313857|P13|Overall Study|Failed inclusion criteria #4|0
1013706|NCT00347360|3313858|P12|Overall Study|Failed inclusion criteria #4|1
1013707|NCT00347360|3313859|P11|Overall Study|Failed inclusion criteria #4|0
1013708|NCT00347360|3313860|P10|Overall Study|Failed inclusion criteria #4|0
1013709|NCT00347360|3313861|P9|Overall Study|Failed inclusion criteria #4|0
1013710|NCT00347360|3313862|P8|Overall Study|Failed inclusion criteria #4|0
1013711|NCT00347360|3313863|P7|Overall Study|Failed inclusion criteria #4|0
1013712|NCT00347360|3313864|P6|Overall Study|Failed inclusion criteria #4|0
1013713|NCT00347360|3313865|P5|Overall Study|Failed inclusion criteria #4|0
1013714|NCT00347360|3313866|P4|Overall Study|Failed inclusion criteria #4|0
1013715|NCT00347360|3313867|P3|Overall Study|Failed inclusion criteria #4|0
1013716|NCT00347360|3313868|P2|Overall Study|Failed inclusion criteria #4|0
1013717|NCT00347360|3313869|P1|Overall Study|Failed inclusion criteria #4|0
1013718|NCT00347360|3313855|P15|Overall Study|Randomized in error|0
1013719|NCT00347360|3313856|P14|Overall Study|Randomized in error|0
1013720|NCT00347360|3313857|P13|Overall Study|Randomized in error|0
1013721|NCT00347360|3313858|P12|Overall Study|Randomized in error|1
1013722|NCT00347360|3313859|P11|Overall Study|Randomized in error|0
1013723|NCT00347360|3313860|P10|Overall Study|Randomized in error|0
1013724|NCT00347360|3313861|P9|Overall Study|Randomized in error|0
1013725|NCT00347360|3313862|P8|Overall Study|Randomized in error|0
1013726|NCT00347360|3313863|P7|Overall Study|Randomized in error|0
1013727|NCT00347360|3313864|P6|Overall Study|Randomized in error|0
1013728|NCT00347360|3313865|P5|Overall Study|Randomized in error|0
1013729|NCT00347360|3313866|P4|Overall Study|Randomized in error|0
1013730|NCT00347360|3313867|P3|Overall Study|Randomized in error|0
1013731|NCT00347360|3313868|P2|Overall Study|Randomized in error|0
1013732|NCT00347360|3313869|P1|Overall Study|Randomized in error|0
1013733|NCT00347360|3313855|P15|Overall Study|Did not meet criteria before ABPM|0
1013734|NCT00347360|3313856|P14|Overall Study|Did not meet criteria before ABPM|0
1013735|NCT00347360|3313857|P13|Overall Study|Did not meet criteria before ABPM|0
1013736|NCT00347360|3313858|P12|Overall Study|Did not meet criteria before ABPM|0
1013737|NCT00347360|3313859|P11|Overall Study|Did not meet criteria before ABPM|1
1013738|NCT00347360|3313860|P10|Overall Study|Did not meet criteria before ABPM|0
1013739|NCT00347360|3313861|P9|Overall Study|Did not meet criteria before ABPM|0
1013740|NCT00347360|3313862|P8|Overall Study|Did not meet criteria before ABPM|0
1013741|NCT00347360|3313863|P7|Overall Study|Did not meet criteria before ABPM|0
1013742|NCT00347360|3313864|P6|Overall Study|Did not meet criteria before ABPM|0
1013743|NCT00347360|3313865|P5|Overall Study|Did not meet criteria before ABPM|0
1013744|NCT00347360|3313866|P4|Overall Study|Did not meet criteria before ABPM|0
1013745|NCT00347360|3313867|P3|Overall Study|Did not meet criteria before ABPM|0
1013746|NCT00347360|3313868|P2|Overall Study|Did not meet criteria before ABPM|0
1013747|NCT00347360|3313869|P1|Overall Study|Did not meet criteria before ABPM|0
1013748|NCT00347360|3313855|P15|Overall Study|PI recommended early withdrawal|0
1013749|NCT00347360|3313856|P14|Overall Study|PI recommended early withdrawal|0
1013750|NCT00347360|3313857|P13|Overall Study|PI recommended early withdrawal|0
1013751|NCT00347360|3313858|P12|Overall Study|PI recommended early withdrawal|0
1013752|NCT00347360|3313859|P11|Overall Study|PI recommended early withdrawal|0
1013753|NCT00347360|3313860|P10|Overall Study|PI recommended early withdrawal|1
1013754|NCT00347360|3313861|P9|Overall Study|PI recommended early withdrawal|0
1013755|NCT00347360|3313862|P8|Overall Study|PI recommended early withdrawal|0
1013756|NCT00347360|3313863|P7|Overall Study|PI recommended early withdrawal|0
1013757|NCT00347360|3313864|P6|Overall Study|PI recommended early withdrawal|0
1013758|NCT00347360|3313865|P5|Overall Study|PI recommended early withdrawal|0
1013759|NCT00347360|3313866|P4|Overall Study|PI recommended early withdrawal|0
1013760|NCT00347360|3313867|P3|Overall Study|PI recommended early withdrawal|0
1013761|NCT00347360|3313868|P2|Overall Study|PI recommended early withdrawal|0
1013762|NCT00347360|3313869|P1|Overall Study|PI recommended early withdrawal|0
1013763|NCT00347360|3313855|P15|Overall Study|Abnormal lab values|0
1013764|NCT00347360|3313856|P14|Overall Study|Abnormal lab values|0
1013765|NCT00347360|3313857|P13|Overall Study|Abnormal lab values|0
1013766|NCT00347360|3313858|P12|Overall Study|Abnormal lab values|0
1013767|NCT00347360|3313859|P11|Overall Study|Abnormal lab values|0
1013768|NCT00347360|3313860|P10|Overall Study|Abnormal lab values|0
1013769|NCT00347360|3313861|P9|Overall Study|Abnormal lab values|0
1013770|NCT00347360|3313862|P8|Overall Study|Abnormal lab values|0
1013771|NCT00347360|3313863|P7|Overall Study|Abnormal lab values|1
1013772|NCT00347360|3313864|P6|Overall Study|Abnormal lab values|0
1013773|NCT00347360|3313865|P5|Overall Study|Abnormal lab values|0
1013774|NCT00347360|3313866|P4|Overall Study|Abnormal lab values|0
1013775|NCT00347360|3313867|P3|Overall Study|Abnormal lab values|0
1013776|NCT00347360|3313868|P2|Overall Study|Abnormal lab values|0
1013777|NCT00347360|3313869|P1|Overall Study|Abnormal lab values|0
1013778|NCT00347360|3313855|P15|Overall Study|Subject did not meet end of study ABPM|0
1013779|NCT00347360|3313856|P14|Overall Study|Subject did not meet end of study ABPM|1
1013780|NCT00347360|3313857|P13|Overall Study|Subject did not meet end of study ABPM|1
1013781|NCT00347360|3313858|P12|Overall Study|Subject did not meet end of study ABPM|0
1013782|NCT00347360|3313859|P11|Overall Study|Subject did not meet end of study ABPM|1
1013783|NCT00347360|3313860|P10|Overall Study|Subject did not meet end of study ABPM|0
1013784|NCT00347360|3313861|P9|Overall Study|Subject did not meet end of study ABPM|0
1013785|NCT00347360|3313862|P8|Overall Study|Subject did not meet end of study ABPM|0
1013786|NCT00347360|3313863|P7|Overall Study|Subject did not meet end of study ABPM|1
1013787|NCT00347360|3313864|P6|Overall Study|Subject did not meet end of study ABPM|0
1013788|NCT00347360|3313865|P5|Overall Study|Subject did not meet end of study ABPM|0
1013789|NCT00347360|3313866|P4|Overall Study|Subject did not meet end of study ABPM|0
1013790|NCT00347360|3313867|P3|Overall Study|Subject did not meet end of study ABPM|0
1013791|NCT00347360|3313868|P2|Overall Study|Subject did not meet end of study ABPM|0
1013792|NCT00347360|3313869|P1|Overall Study|Subject did not meet end of study ABPM|0
1013793|NCT00347360|3313855|P15|Overall Study|P.I. recommended due to blood pressure|0
1013794|NCT00347360|3313856|P14|Overall Study|P.I. recommended due to blood pressure|0
1013795|NCT00347360|3313857|P13|Overall Study|P.I. recommended due to blood pressure|0
1013796|NCT00347360|3313858|P12|Overall Study|P.I. recommended due to blood pressure|0
1013797|NCT00347360|3313859|P11|Overall Study|P.I. recommended due to blood pressure|0
1013798|NCT00347360|3313860|P10|Overall Study|P.I. recommended due to blood pressure|0
1013799|NCT00347360|3313861|P9|Overall Study|P.I. recommended due to blood pressure|0
1013800|NCT00347360|3313862|P8|Overall Study|P.I. recommended due to blood pressure|0
1013801|NCT00347360|3313863|P7|Overall Study|P.I. recommended due to blood pressure|0
1013802|NCT00347360|3313864|P6|Overall Study|P.I. recommended due to blood pressure|0
1013803|NCT00347360|3313865|P5|Overall Study|P.I. recommended due to blood pressure|1
1013804|NCT00347360|3313866|P4|Overall Study|P.I. recommended due to blood pressure|0
1013805|NCT00347360|3313867|P3|Overall Study|P.I. recommended due to blood pressure|0
1013806|NCT00347360|3313868|P2|Overall Study|P.I. recommended due to blood pressure|0
1013807|NCT00347360|3313869|P1|Overall Study|P.I. recommended due to blood pressure|0
1013808|NCT00347360|3313855|P15|Overall Study|Per sponsors instruction|0
1013809|NCT00347360|3313856|P14|Overall Study|Per sponsors instruction|0
1013810|NCT00347360|3313857|P13|Overall Study|Per sponsors instruction|0
1013811|NCT00347360|3313858|P12|Overall Study|Per sponsors instruction|0
1013812|NCT00347360|3313859|P11|Overall Study|Per sponsors instruction|0
1013813|NCT00347360|3313860|P10|Overall Study|Per sponsors instruction|0
1013814|NCT00347360|3313861|P9|Overall Study|Per sponsors instruction|0
1013815|NCT00347360|3313862|P8|Overall Study|Per sponsors instruction|0
1013816|NCT00347360|3313863|P7|Overall Study|Per sponsors instruction|0
1013817|NCT00347360|3313864|P6|Overall Study|Per sponsors instruction|0
1013818|NCT00347360|3313865|P5|Overall Study|Per sponsors instruction|0
1013819|NCT00347360|3313866|P4|Overall Study|Per sponsors instruction|0
1013820|NCT00347360|3313867|P3|Overall Study|Per sponsors instruction|0
1013821|NCT00347360|3313868|P2|Overall Study|Per sponsors instruction|1
1013822|NCT00347360|3313869|P1|Overall Study|Per sponsors instruction|0
1013823|NCT00347360|3313855|P15|Overall Study|Reason not listed/blank|0
1013824|NCT00347360|3313856|P14|Overall Study|Reason not listed/blank|1
1013825|NCT00347360|3313857|P13|Overall Study|Reason not listed/blank|0
1013826|NCT00347360|3313858|P12|Overall Study|Reason not listed/blank|0
1013827|NCT00347360|3313859|P11|Overall Study|Reason not listed/blank|0
1013828|NCT00347360|3313860|P10|Overall Study|Reason not listed/blank|0
1013829|NCT00347360|3313861|P9|Overall Study|Reason not listed/blank|0
1013830|NCT00347360|3313862|P8|Overall Study|Reason not listed/blank|0
1013831|NCT00347360|3313863|P7|Overall Study|Reason not listed/blank|1
1013832|NCT00347360|3313864|P6|Overall Study|Reason not listed/blank|0
1013833|NCT00347360|3313865|P5|Overall Study|Reason not listed/blank|0
1013834|NCT00347360|3313866|P4|Overall Study|Reason not listed/blank|0
1013835|NCT00347360|3313867|P3|Overall Study|Reason not listed/blank|0
1013836|NCT00347360|3313868|P2|Overall Study|Reason not listed/blank|0
1013837|NCT00347360|3313869|P1|Overall Study|Reason not listed/blank|1
1013838|NCT00347360|3313855|P15|Overall Study|Lack of Efficacy|0
1013839|NCT00347360|3313856|P14|Overall Study|Lack of Efficacy|0
1013840|NCT00347360|3313857|P13|Overall Study|Lack of Efficacy|0
1013841|NCT00347360|3313858|P12|Overall Study|Lack of Efficacy|0
1013842|NCT00347360|3313859|P11|Overall Study|Lack of Efficacy|0
1013843|NCT00347360|3313860|P10|Overall Study|Lack of Efficacy|0
1013844|NCT00347360|3313861|P9|Overall Study|Lack of Efficacy|1
1013845|NCT00347360|3313862|P8|Overall Study|Lack of Efficacy|1
1013846|NCT00347360|3313863|P7|Overall Study|Lack of Efficacy|0
1013847|NCT00347360|3313864|P6|Overall Study|Lack of Efficacy|1
1013848|NCT00347360|3313865|P5|Overall Study|Lack of Efficacy|0
1013849|NCT00347360|3313866|P4|Overall Study|Lack of Efficacy|1
1013850|NCT00347360|3313867|P3|Overall Study|Lack of Efficacy|3
1013851|NCT00347360|3313868|P2|Overall Study|Lack of Efficacy|1
1013852|NCT00347360|3313869|P1|Overall Study|Lack of Efficacy|1
1013853|NCT00347360|3313855|P15|Overall Study|Withdrawal by Subject|1
1013854|NCT00347360|3313856|P14|Overall Study|Withdrawal by Subject|2
1013855|NCT00347360|3313857|P13|Overall Study|Withdrawal by Subject|4
1013856|NCT00347360|3313858|P12|Overall Study|Withdrawal by Subject|3
1013857|NCT00347360|3313859|P11|Overall Study|Withdrawal by Subject|0
1013858|NCT00347360|3313860|P10|Overall Study|Withdrawal by Subject|1
1013859|NCT00347360|3313861|P9|Overall Study|Withdrawal by Subject|1
1013860|NCT00347360|3313862|P8|Overall Study|Withdrawal by Subject|1
1013861|NCT00347360|3313863|P7|Overall Study|Withdrawal by Subject|1
1013862|NCT00347360|3313864|P6|Overall Study|Withdrawal by Subject|2
1013863|NCT00347360|3313865|P5|Overall Study|Withdrawal by Subject|1
1013864|NCT00347360|3313866|P4|Overall Study|Withdrawal by Subject|4
1013865|NCT00347360|3313867|P3|Overall Study|Withdrawal by Subject|2
1013866|NCT00347360|3313868|P2|Overall Study|Withdrawal by Subject|1
1013867|NCT00347360|3313869|P1|Overall Study|Withdrawal by Subject|0
1013868|NCT00347360|3313855|P15|Overall Study|Protocol Violation|0
1013869|NCT00347360|3313856|P14|Overall Study|Protocol Violation|1
1013870|NCT00347360|3313857|P13|Overall Study|Protocol Violation|0
1013871|NCT00347360|3313858|P12|Overall Study|Protocol Violation|0
1013872|NCT00347360|3313859|P11|Overall Study|Protocol Violation|0
1013873|NCT00347360|3313860|P10|Overall Study|Protocol Violation|2
1013874|NCT00347360|3313861|P9|Overall Study|Protocol Violation|1
1013875|NCT00347360|3313862|P8|Overall Study|Protocol Violation|0
1013876|NCT00347360|3313863|P7|Overall Study|Protocol Violation|0
1013877|NCT00347360|3313864|P6|Overall Study|Protocol Violation|2
1013878|NCT00347360|3313865|P5|Overall Study|Protocol Violation|1
1013879|NCT00347360|3313866|P4|Overall Study|Protocol Violation|2
1013880|NCT00347360|3313867|P3|Overall Study|Protocol Violation|1
1013881|NCT00347360|3313868|P2|Overall Study|Protocol Violation|3
1013882|NCT00347360|3313869|P1|Overall Study|Protocol Violation|2
1013883|NCT00347360|3313855|P15|Overall Study|Lost to Follow-up|0
1013884|NCT00347360|3313856|P14|Overall Study|Lost to Follow-up|0
1013885|NCT00347360|3313857|P13|Overall Study|Lost to Follow-up|1
1013886|NCT00347360|3313858|P12|Overall Study|Lost to Follow-up|0
1013887|NCT00347360|3313859|P11|Overall Study|Lost to Follow-up|0
1013888|NCT00347360|3313860|P10|Overall Study|Lost to Follow-up|2
1013889|NCT00347360|3313861|P9|Overall Study|Lost to Follow-up|1
1013890|NCT00347360|3313862|P8|Overall Study|Lost to Follow-up|1
1013891|NCT00347360|3313863|P7|Overall Study|Lost to Follow-up|0
1013892|NCT00347360|3313864|P6|Overall Study|Lost to Follow-up|1
1013893|NCT00347360|3313865|P5|Overall Study|Lost to Follow-up|1
1013894|NCT00347360|3313866|P4|Overall Study|Lost to Follow-up|2
1013895|NCT00347360|3313867|P3|Overall Study|Lost to Follow-up|0
1013896|NCT00347360|3313868|P2|Overall Study|Lost to Follow-up|0
1013897|NCT00347360|3313869|P1|Overall Study|Lost to Follow-up|0
1013898|NCT00347360|3313855|P15|Overall Study|Adverse Event|2
1013899|NCT00347360|3313856|P14|Overall Study|Adverse Event|2
1013900|NCT00347360|3313857|P13|Overall Study|Adverse Event|3
1013901|NCT00347360|3313858|P12|Overall Study|Adverse Event|1
1013902|NCT00347360|3313859|P11|Overall Study|Adverse Event|3
1013903|NCT00347360|3313860|P10|Overall Study|Adverse Event|3
1013904|NCT00347360|3313861|P9|Overall Study|Adverse Event|2
1013905|NCT00347360|3313862|P8|Overall Study|Adverse Event|0
1013906|NCT00347360|3313863|P7|Overall Study|Adverse Event|2
1013907|NCT00347360|3313864|P6|Overall Study|Adverse Event|2
1013908|NCT00347360|3313865|P5|Overall Study|Adverse Event|1
1013909|NCT00347360|3313866|P4|Overall Study|Adverse Event|4
1013910|NCT00347360|3313867|P3|Overall Study|Adverse Event|0
1013911|NCT00347360|3313868|P2|Overall Study|Adverse Event|2
1013912|NCT00347360|3313869|P1|Overall Study|Adverse Event|1
1013913|NCT00347269|3314057|P2|Overall Study|Death|3
1013914|NCT00347269|3314058|P1|Overall Study|Death|2
1013915|NCT00347269|3314057|P2|Overall Study|Withdrawal by Subject|38
1013916|NCT00347269|3314058|P1|Overall Study|Withdrawal by Subject|18
1013917|NCT00347269|3314057|P2|Overall Study|Lost to Follow-up|65
1013918|NCT00347269|3314058|P1|Overall Study|Lost to Follow-up|74
1013919|NCT00347009|3314073|P1|Overall Study|Serious Adverse Event|1
1013920|NCT00347009|3314073|P1|Overall Study|Increased ALT/HBV DNA|1
1013921|NCT00347009|3314073|P1|Overall Study|Insufficient Viral Suppression|3
1013922|NCT00347009|3314073|P1|Overall Study|Adverse Laboratory Experience|1
1013923|NCT00347009|3314073|P1|Overall Study|Protocol Violation|2
1013924|NCT00347009|3314073|P1|Overall Study|Lost to Follow-up|4
1013925|NCT00347009|3314073|P1|Overall Study|Physician Decision|5
1013926|NCT00347009|3314073|P1|Overall Study|Withdrawal by Subject|3
1013927|NCT00347009|3314073|P1|Overall Study|Adverse Event|6
1013928|NCT00347009|3314073|P1|Overall Study|Death|1
1013929|NCT00346775|3314094|P2|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0
1013930|NCT00346775|3314095|P1|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1
1013931|NCT00346775|3314094|P2|Period 1: Intervention Period 1|Protocol Violation|2
1013932|NCT00346775|3314095|P1|Period 1: Intervention Period 1|Protocol Violation|3
1013933|NCT00346775|3314094|P2|Period 1: Intervention Period 1|Lost to Follow-up|1
1013934|NCT00346775|3314095|P1|Period 1: Intervention Period 1|Lost to Follow-up|1
1013935|NCT00346697|3314107|P2|Overall Study|Lost to Follow-up|1
1013936|NCT00346697|3314108|P1|Overall Study|Lost to Follow-up|0
1013937|NCT00346632|3314144|P10|Overall Study|Not Stated|1
1013938|NCT00346632|3314145|P9|Overall Study|Not Stated|2
1013939|NCT00346632|3314146|P8|Overall Study|Not Stated|2
1013940|NCT00346632|3314147|P7|Overall Study|Not Stated|0
1013941|NCT00346632|3314148|P6|Overall Study|Not Stated|0
1013942|NCT00346632|3314149|P5|Overall Study|Not Stated|0
1013943|NCT00346632|3314150|P4|Overall Study|Not Stated|0
1013944|NCT00346632|3314151|P3|Overall Study|Not Stated|0
1013945|NCT00346632|3314152|P2|Overall Study|Not Stated|1
1013946|NCT00346632|3314153|P1|Overall Study|Not Stated|1
1013947|NCT00346632|3314144|P10|Overall Study|Switched to alternative treatment|0
1013948|NCT00346632|3314145|P9|Overall Study|Switched to alternative treatment|0
1013949|NCT00346632|3314146|P8|Overall Study|Switched to alternative treatment|0
1013950|NCT00346632|3314147|P7|Overall Study|Switched to alternative treatment|0
1013951|NCT00346632|3314148|P6|Overall Study|Switched to alternative treatment|0
1013952|NCT00346632|3314149|P5|Overall Study|Switched to alternative treatment|0
1013953|NCT00346632|3314150|P4|Overall Study|Switched to alternative treatment|0
1013954|NCT00346632|3314151|P3|Overall Study|Switched to alternative treatment|1
1013955|NCT00346632|3314152|P2|Overall Study|Switched to alternative treatment|0
1013956|NCT00346632|3314153|P1|Overall Study|Switched to alternative treatment|0
1013957|NCT00346632|3314144|P10|Overall Study|Withdrawal by Subject|0
1013958|NCT00346632|3314145|P9|Overall Study|Withdrawal by Subject|0
1013959|NCT00346632|3314146|P8|Overall Study|Withdrawal by Subject|0
1013960|NCT00346632|3314147|P7|Overall Study|Withdrawal by Subject|1
1013961|NCT00346632|3314148|P6|Overall Study|Withdrawal by Subject|0
1013962|NCT00346632|3314149|P5|Overall Study|Withdrawal by Subject|0
1013963|NCT00346632|3314150|P4|Overall Study|Withdrawal by Subject|0
1013964|NCT00346632|3314151|P3|Overall Study|Withdrawal by Subject|0
1013965|NCT00346632|3314152|P2|Overall Study|Withdrawal by Subject|0
1013966|NCT00346632|3314153|P1|Overall Study|Withdrawal by Subject|0
1013967|NCT00346632|3314144|P10|Overall Study|Protocol Violation|0
1013968|NCT00346632|3314145|P9|Overall Study|Protocol Violation|0
1013969|NCT00346632|3314146|P8|Overall Study|Protocol Violation|0
1013970|NCT00346632|3314147|P7|Overall Study|Protocol Violation|1
1013971|NCT00346632|3314148|P6|Overall Study|Protocol Violation|0
1013972|NCT00346632|3314149|P5|Overall Study|Protocol Violation|0
1013973|NCT00346632|3314150|P4|Overall Study|Protocol Violation|0
1013974|NCT00346632|3314151|P3|Overall Study|Protocol Violation|0
1013975|NCT00346632|3314152|P2|Overall Study|Protocol Violation|0
1013976|NCT00346632|3314153|P1|Overall Study|Protocol Violation|0
1013977|NCT00346632|3314144|P10|Overall Study|Death|0
1013978|NCT00346632|3314145|P9|Overall Study|Death|0
1013979|NCT00346632|3314146|P8|Overall Study|Death|0
1013980|NCT00346632|3314147|P7|Overall Study|Death|0
1013981|NCT00346632|3314148|P6|Overall Study|Death|0
1013982|NCT00346632|3314149|P5|Overall Study|Death|0
1013983|NCT00346632|3314150|P4|Overall Study|Death|0
1013984|NCT00346632|3314151|P3|Overall Study|Death|1
1013985|NCT00346632|3314152|P2|Overall Study|Death|0
1013986|NCT00346632|3314153|P1|Overall Study|Death|0
1013987|NCT00346632|3314144|P10|Overall Study|Adverse Event|0
1013988|NCT00346632|3314145|P9|Overall Study|Adverse Event|0
1013989|NCT00346632|3314146|P8|Overall Study|Adverse Event|0
1013990|NCT00346632|3314147|P7|Overall Study|Adverse Event|1
1013991|NCT00346632|3314148|P6|Overall Study|Adverse Event|1
1013992|NCT00346632|3314149|P5|Overall Study|Adverse Event|1
1013993|NCT00346632|3314150|P4|Overall Study|Adverse Event|0
1013994|NCT00346632|3314151|P3|Overall Study|Adverse Event|0
1013995|NCT00346632|3314152|P2|Overall Study|Adverse Event|0
1013996|NCT00346632|3314153|P1|Overall Study|Adverse Event|0
1013997|NCT00346632|3314144|P10|Overall Study|Progressive Disease|2
1013998|NCT00346632|3314145|P9|Overall Study|Progressive Disease|2
1013999|NCT00346632|3314146|P8|Overall Study|Progressive Disease|2
1014000|NCT00346632|3314147|P7|Overall Study|Progressive Disease|2
1014001|NCT00346632|3314148|P6|Overall Study|Progressive Disease|1
1014002|NCT00346632|3314149|P5|Overall Study|Progressive Disease|3
1014003|NCT00346632|3314150|P4|Overall Study|Progressive Disease|3
1014004|NCT00346632|3314151|P3|Overall Study|Progressive Disease|4
1014005|NCT00346632|3314152|P2|Overall Study|Progressive Disease|2
1014006|NCT00346632|3314153|P1|Overall Study|Progressive Disease|2
1014007|NCT00346398|3314303|P2|Overall Study|Withdrawal by Subject|2
1014008|NCT00346398|3314304|P1|Overall Study|Withdrawal by Subject|0
1014009|NCT00346398|3314303|P2|Overall Study|Lost to Follow-up|0
1014010|NCT00346398|3314304|P1|Overall Study|Lost to Follow-up|3
1014011|NCT00346333|3314316|P2|Overall Study|unwilling or unable to continue|8
1014012|NCT00346333|3314317|P1|Overall Study|unwilling or unable to continue|4
1014013|NCT00346333|3314316|P2|Overall Study|Death|0
1014014|NCT00346333|3314317|P1|Overall Study|Death|1
1014015|NCT00346268|3314333|P2|Overall Study|Participant refused|3
1014016|NCT00346268|3314334|P1|Overall Study|Participant refused|0
1014017|NCT00346268|3314333|P2|Overall Study|Protocol Violation|0
1014018|NCT00346268|3314334|P1|Overall Study|Protocol Violation|1
1014019|NCT00346268|3314333|P2|Overall Study|Adverse Event|0
1014020|NCT00346268|3314334|P1|Overall Study|Adverse Event|1
1014021|NCT00346216|3314369|P3|Overall Study|Missing Subject Summary Status|62
1014022|NCT00346216|3314370|P2|Overall Study|Missing Subject Summary Status|61
1014023|NCT00346216|3314371|P1|Overall Study|Missing Subject Summary Status|62
1014024|NCT00346216|3314369|P3|Overall Study|Study terminated by sponsor|8
1014025|NCT00346216|3314370|P2|Overall Study|Study terminated by sponsor|4
1014026|NCT00346216|3314371|P1|Overall Study|Study terminated by sponsor|11
1014027|NCT00346216|3314369|P3|Overall Study|Death|228
1014028|NCT00346216|3314370|P2|Overall Study|Death|192
1014029|NCT00346216|3314371|P1|Overall Study|Death|189
1014030|NCT00346216|3314369|P3|Overall Study|Does not meet entrance criteria|8
1014031|NCT00346216|3314370|P2|Overall Study|Does not meet entrance criteria|10
1014032|NCT00346216|3314371|P1|Overall Study|Does not meet entrance criteria|13
1014033|NCT00346216|3314369|P3|Overall Study|Physician Decision|59
1014034|NCT00346216|3314370|P2|Overall Study|Physician Decision|76
1014035|NCT00346216|3314371|P1|Overall Study|Physician Decision|80
1014036|NCT00346216|3314369|P3|Overall Study|Lost to Follow-up|542
1014037|NCT00346216|3314370|P2|Overall Study|Lost to Follow-up|588
1014038|NCT00346216|3314371|P1|Overall Study|Lost to Follow-up|611
1014039|NCT00346216|3314369|P3|Overall Study|Withdrawal by Subject|651
1014040|NCT00346216|3314370|P2|Overall Study|Withdrawal by Subject|692
1014041|NCT00346216|3314371|P1|Overall Study|Withdrawal by Subject|661
1014042|NCT00346216|3314369|P3|Overall Study|No longer willing to participate|585
1014043|NCT00346216|3314370|P2|Overall Study|No longer willing to participate|606
1014044|NCT00346216|3314371|P1|Overall Study|No longer willing to participate|600
1014045|NCT00346216|3314369|P3|Overall Study|Not specified|205
1014046|NCT00346216|3314370|P2|Overall Study|Not specified|231
1014047|NCT00346216|3314371|P1|Overall Study|Not specified|181
1014048|NCT00346164|3314392|P4|Overall Study|Inability to start week 16 tx on time|11
1014049|NCT00346164|3314393|P3|Overall Study|Inability to start week 16 tx on time|0
1014050|NCT00346164|3314394|P2|Overall Study|Inability to start week 16 tx on time|0
1014051|NCT00346164|3314395|P1|Overall Study|Inability to start week 16 tx on time|0
1014052|NCT00346164|3314392|P4|Overall Study|Refusal of further protocol therapy|15
1014053|NCT00346164|3314393|P3|Overall Study|Refusal of further protocol therapy|3
1014054|NCT00346164|3314394|P2|Overall Study|Refusal of further protocol therapy|1
1014055|NCT00346164|3314395|P1|Overall Study|Refusal of further protocol therapy|0
1014056|NCT00346164|3314392|P4|Overall Study|Ineligible|23
1014057|NCT00346164|3314393|P3|Overall Study|Ineligible|2
1014058|NCT00346164|3314394|P2|Overall Study|Ineligible|2
1014059|NCT00346164|3314395|P1|Overall Study|Ineligible|11
1014060|NCT00346164|3314392|P4|Overall Study|Withdrawal by Subject|0
1014061|NCT00346164|3314393|P3|Overall Study|Withdrawal by Subject|2
1014062|NCT00346164|3314394|P2|Overall Study|Withdrawal by Subject|0
1014063|NCT00346164|3314395|P1|Overall Study|Withdrawal by Subject|0
1014064|NCT00346164|3314392|P4|Overall Study|Protocol Violation|4
1014065|NCT00346164|3314393|P3|Overall Study|Protocol Violation|10
1014066|NCT00346164|3314394|P2|Overall Study|Protocol Violation|2
1014067|NCT00346164|3314395|P1|Overall Study|Protocol Violation|6
1014068|NCT00346164|3314392|P4|Overall Study|Physician Decision|27
1014069|NCT00346164|3314393|P3|Overall Study|Physician Decision|2
1014070|NCT00346164|3314394|P2|Overall Study|Physician Decision|1
1014071|NCT00346164|3314395|P1|Overall Study|Physician Decision|0
1014072|NCT00346164|3314392|P4|Overall Study|Lack of Efficacy|25
1014073|NCT00346164|3314393|P3|Overall Study|Lack of Efficacy|7
1014074|NCT00346164|3314394|P2|Overall Study|Lack of Efficacy|1
1014075|NCT00346164|3314395|P1|Overall Study|Lack of Efficacy|0
1014076|NCT00346164|3314392|P4|Overall Study|Adverse Event|1
1014077|NCT00346164|3314393|P3|Overall Study|Adverse Event|0
1014078|NCT00346164|3314394|P2|Overall Study|Adverse Event|0
1014079|NCT00346164|3314395|P1|Overall Study|Adverse Event|0
1014080|NCT00346151|3314430|P1|Overall Study|Withdrawal by Subject|3
1014081|NCT00346073|3314450|P2|Overall Study|Lost to Follow-up|24
1014082|NCT00346073|3314451|P1|Overall Study|Lost to Follow-up|39
1014083|NCT00346073|3314450|P2|Overall Study|Serious Adverse Event|0
1014084|NCT00346073|3314451|P1|Overall Study|Serious Adverse Event|2
1014085|NCT00346034|3314485|P1|Overall Study|Not Willing to Follow Dosing Regimen|1
1014086|NCT00346034|3314485|P1|Overall Study|Patient Stopped Taking Study Drug|1
1014087|NCT00346034|3314485|P1|Overall Study|Withdrawal by Subject|13
1014088|NCT00346034|3314485|P1|Overall Study|Lack of Efficacy|8
1014089|NCT00346034|3314485|P1|Overall Study|Adverse Event|34
1014090|NCT00345878|3314525|P2|Overall Study|Other|0
1014091|NCT00345878|3314526|P1|Overall Study|Other|1
1014092|NCT00345878|3314525|P2|Overall Study|Lost to Follow-up|1
1014093|NCT00345878|3314526|P1|Overall Study|Lost to Follow-up|2
1014094|NCT00345878|3314525|P2|Overall Study|Adverse Event|0
1014095|NCT00345878|3314526|P1|Overall Study|Adverse Event|1
1014096|NCT00345839|3314544|P2|Overall Study|Lost to Follow-up|61
1014097|NCT00345839|3314545|P1|Overall Study|Lost to Follow-up|58
1014098|NCT00345839|3314544|P2|Overall Study|Withdrawal by Subject|98
1014099|NCT00345839|3314545|P1|Overall Study|Withdrawal by Subject|91
1014100|NCT00345683|3314571|P2|Overall Study|Other|2
1014101|NCT00345683|3314572|P1|Overall Study|Other|6
1014102|NCT00345683|3314571|P2|Overall Study|Lost to Follow-up|7
1014103|NCT00345683|3314572|P1|Overall Study|Lost to Follow-up|19
1014104|NCT00345631|3314595|P3|Overall Study|Other reasons|1
1014105|NCT00345631|3314596|P2|Overall Study|Other reasons|0
1014106|NCT00345631|3314597|P1|Overall Study|Other reasons|0
1014107|NCT00345631|3314595|P3|Overall Study|Lost to Follow-up|4
1014108|NCT00345631|3314596|P2|Overall Study|Lost to Follow-up|7
1014109|NCT00345631|3314597|P1|Overall Study|Lost to Follow-up|3
1014110|NCT00345631|3314595|P3|Overall Study|Adverse Event|0
1014111|NCT00345631|3314596|P2|Overall Study|Adverse Event|1
1014112|NCT00345631|3314597|P1|Overall Study|Adverse Event|0
1014113|NCT00345631|3314595|P3|Overall Study|Withdrawal by Subject|1
1014114|NCT00345631|3314596|P2|Overall Study|Withdrawal by Subject|0
1014115|NCT00345631|3314597|P1|Overall Study|Withdrawal by Subject|1
1014116|NCT00345605|3314629|P2|Arm 2, Opposite Treatment|Adverse Event|0
1014117|NCT00345605|3314630|P1|Arm 2, Opposite Treatment|Adverse Event|1
1014118|NCT00345605|3314629|P2|Arm 1|Adverse Event|1
1014119|NCT00345605|3314630|P1|Arm 1|Adverse Event|0
1014120|NCT00345592|3314650|P2|Overall Study|Withdrawal by Subject|8
1014121|NCT00345592|3314651|P1|Overall Study|Withdrawal by Subject|11
1014122|NCT00345592|3314650|P2|Overall Study|Death|16
1014123|NCT00345592|3314651|P1|Overall Study|Death|14
1014124|NCT00345579|3314659|P2|Overall Study|Other|1
1014125|NCT00345579|3314660|P1|Overall Study|Other|9
1014126|NCT00345579|3314659|P2|Overall Study|Lost to Follow-up|36
1014127|NCT00345579|3314660|P1|Overall Study|Lost to Follow-up|82
1014128|NCT00345579|3314659|P2|Overall Study|Withdrawal by Subject|17
1014129|NCT00345579|3314660|P1|Overall Study|Withdrawal by Subject|50
1014130|NCT00345579|3314659|P2|Overall Study|Protocol Violation|5
1014131|NCT00345579|3314660|P1|Overall Study|Protocol Violation|14
1014132|NCT00345579|3314659|P2|Overall Study|Adverse Event|6
1014133|NCT00345579|3314660|P1|Overall Study|Adverse Event|9
1014134|NCT00345540|3314680|P1|Overall Study|Withdrawal by Subject|1
1014135|NCT00345397|3314686|P1|Overall Study|Death|1
1014136|NCT00345293|3314724|P2|Overall Study|Withdrawal by Subject|0
1014137|NCT00345293|3314725|P1|Overall Study|Withdrawal by Subject|1
1014138|NCT00345293|3314724|P2|Overall Study|Unable to access line for sample|0
1014139|NCT00345293|3314725|P1|Overall Study|Unable to access line for sample|1
1014140|NCT00345046|3314771|P3|Overall Study|Protocol Violation|2
1014141|NCT00345046|3314772|P2|Overall Study|Protocol Violation|1
1014142|NCT00345046|3314773|P1|Overall Study|Protocol Violation|1
1014143|NCT00344968|3314803|P3|Overall Study|Other|0
1014144|NCT00344968|3314804|P2|Overall Study|Other|1
1014145|NCT00344968|3314805|P1|Overall Study|Other|0
1014146|NCT00344968|3314803|P3|Overall Study|Death|31
1014147|NCT00344968|3314804|P2|Overall Study|Death|27
1014148|NCT00344968|3314805|P1|Overall Study|Death|11
1014149|NCT00344968|3314803|P3|Overall Study|Lost to Follow-up|37
1014150|NCT00344968|3314804|P2|Overall Study|Lost to Follow-up|37
1014151|NCT00344968|3314805|P1|Overall Study|Lost to Follow-up|24
1014152|NCT00344968|3314803|P3|Overall Study|Withdrawal by Subject|27
1014153|NCT00344968|3314804|P2|Overall Study|Withdrawal by Subject|31
1014154|NCT00344968|3314805|P1|Overall Study|Withdrawal by Subject|14
1014155|NCT00344968|3314803|P3|Overall Study|Protocol Violation|5
1014156|NCT00344968|3314804|P2|Overall Study|Protocol Violation|2
1014157|NCT00344968|3314805|P1|Overall Study|Protocol Violation|2
1014158|NCT00344968|3314803|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
1014159|NCT00344968|3314804|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
1014160|NCT00344968|3314805|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
1014161|NCT00344968|3314803|P3|Overall Study|Adverse Event|15
1014162|NCT00344968|3314804|P2|Overall Study|Adverse Event|4
1014163|NCT00344968|3314805|P1|Overall Study|Adverse Event|5
1014164|NCT00344773|3314816|P1|Overall Study|Not Eligible for the study|2
1014165|NCT00344773|3314816|P1|Overall Study|Withdrawal by Subject|1
1014166|NCT00344773|3314816|P1|Overall Study|Objective Disease Progression|16
1014167|NCT00344773|3314816|P1|Overall Study|Adverse Event|2
1014168|NCT00344500|3314839|P3|Overall Study|Not Noted|0
1014169|NCT00344500|3314840|P2|Overall Study|Not Noted|3
1014170|NCT00344500|3314841|P1|Overall Study|Not Noted|1
1014171|NCT00344500|3314839|P3|Overall Study|Protocol Violation|1
1014172|NCT00344500|3314840|P2|Overall Study|Protocol Violation|7
1014173|NCT00344500|3314841|P1|Overall Study|Protocol Violation|4
1014174|NCT00344500|3314839|P3|Overall Study|Withdrawal by Subject|0
1014175|NCT00344500|3314840|P2|Overall Study|Withdrawal by Subject|10
1014176|NCT00344500|3314841|P1|Overall Study|Withdrawal by Subject|7
1014177|NCT00344500|3314839|P3|Overall Study|Lost to Follow-up|1
1014178|NCT00344500|3314840|P2|Overall Study|Lost to Follow-up|13
1014179|NCT00344500|3314841|P1|Overall Study|Lost to Follow-up|5
1014180|NCT00344500|3314839|P3|Overall Study|Adverse Event|0
1014181|NCT00344500|3314840|P2|Overall Study|Adverse Event|2
1014182|NCT00344500|3314841|P1|Overall Study|Adverse Event|6
1014183|NCT00344487|3314852|P1|Overall Study|immunologic failure|1
1014184|NCT00344461|3314856|P1|Overall Study|Withdrawal by Subject|2
1014185|NCT00344461|3314856|P1|Overall Study|Protocol Violation|6
1014186|NCT00344461|3314856|P1|Overall Study|Physician Decision|2
1014187|NCT00344461|3314856|P1|Overall Study|Lost to Follow-up|2
1014188|NCT00344461|3314856|P1|Overall Study|Lack of Efficacy|2
1014189|NCT00344461|3314856|P1|Overall Study|Death|1
1014190|NCT00344461|3314856|P1|Overall Study|Adverse Event|6
1014191|NCT00344448|3314867|P2|Open Label|Study terminated|0
1014192|NCT00344448|3314868|P1|Open Label|Study terminated|1
1014193|NCT00344448|3314867|P2|Open Label|Withdrawal by Subject|1
1014194|NCT00344448|3314868|P1|Open Label|Withdrawal by Subject|1
1014195|NCT00344448|3314867|P2|Double Blind, Placebo Controlled|Study terminated|0
1014196|NCT00344448|3314868|P1|Double Blind, Placebo Controlled|Study terminated|1
1014197|NCT00344448|3314867|P2|Double Blind, Placebo Controlled|Withdrawal by Subject|0
1014198|NCT00344448|3314868|P1|Double Blind, Placebo Controlled|Withdrawal by Subject|1
1014199|NCT00344448|3314867|P2|Screening|Withdrawal by Subject|1
1014200|NCT00344448|3314868|P1|Screening|Withdrawal by Subject|0
1014201|NCT00344305|3314887|P2|Overall Study|Participant was not contacted in window|1
1014202|NCT00344305|3314888|P1|Overall Study|Participant was not contacted in window|0
1014203|NCT00344305|3314887|P2|Overall Study|Lost to Follow-up|0
1014204|NCT00344305|3314888|P1|Overall Study|Lost to Follow-up|2
1014205|NCT00344032|3314938|P2|Overall Study|Physician Decision|1
1014206|NCT00344032|3314939|P1|Overall Study|Physician Decision|4
1014207|NCT00344032|3314938|P2|Overall Study|Lost to Follow-up|6
1014208|NCT00344032|3314939|P1|Overall Study|Lost to Follow-up|4
1014209|NCT00344032|3314938|P2|Overall Study|Withdrawal by Subject|2
1014210|NCT00344032|3314939|P1|Overall Study|Withdrawal by Subject|6
1014211|NCT00344032|3314938|P2|Overall Study|Adverse Event|1
1014212|NCT00344032|3314939|P1|Overall Study|Adverse Event|0
1014213|NCT00344019|3314958|P3|Overall Study|did not meet final inclusion criteria|74
1014214|NCT00344019|3314959|P2|Overall Study|did not meet final inclusion criteria|0
1014215|NCT00344019|3314960|P1|Overall Study|did not meet final inclusion criteria|0
1014216|NCT00343915|3314978|P2|Primary Study|Other|0
1014217|NCT00343915|3314979|P1|Primary Study|Other|1
1014218|NCT00343915|3314978|P2|Primary Study|Lost to Follow-up|3
1014219|NCT00343915|3314979|P1|Primary Study|Lost to Follow-up|2
1014220|NCT00343915|3314978|P2|Primary Study|Withdrawal by Subject|0
1014221|NCT00343915|3314979|P1|Primary Study|Withdrawal by Subject|1
1014222|NCT00343889|3315005|P2|Overall Study|Protocol Violation|0
1014223|NCT00343889|3315006|P1|Overall Study|Protocol Violation|1
1014224|NCT00343889|3315005|P2|Overall Study|Withdrawal by Subject|1
1014225|NCT00343889|3315006|P1|Overall Study|Withdrawal by Subject|0
1014226|NCT00343889|3315005|P2|Overall Study|Lost to Follow-up|0
1014227|NCT00343889|3315006|P1|Overall Study|Lost to Follow-up|2
1014228|NCT00343512|3315089|P1|Overall Study|Withdrawal by Subject|2
1014229|NCT00343382|3315177|P3|Overall Study|Other Reason Not Specified|4
1014230|NCT00343382|3315178|P2|Overall Study|Other Reason Not Specified|2
1014231|NCT00343382|3315179|P1|Overall Study|Other Reason Not Specified|1
1014232|NCT00343382|3315177|P3|Overall Study|Withdrawal by Subject|6
1014233|NCT00343382|3315178|P2|Overall Study|Withdrawal by Subject|2
1014234|NCT00343382|3315179|P1|Overall Study|Withdrawal by Subject|1
1014235|NCT00343382|3315177|P3|Overall Study|Adverse Event|7
1014236|NCT00343382|3315178|P2|Overall Study|Adverse Event|10
1014237|NCT00343382|3315179|P1|Overall Study|Adverse Event|2
1014238|NCT00343291|3315198|P2|Overall Study|Other|5
1014239|NCT00343291|3315199|P1|Overall Study|Other|8
1014240|NCT00343291|3315198|P2|Overall Study|Withdrawal by Subject|2
1014241|NCT00343291|3315199|P1|Overall Study|Withdrawal by Subject|0
1014242|NCT00343291|3315198|P2|Overall Study|Progressive disease|34
1014243|NCT00343291|3315199|P1|Overall Study|Progressive disease|33
1014244|NCT00343291|3315198|P2|Overall Study|Death|2
1014245|NCT00343291|3315199|P1|Overall Study|Death|3
1014246|NCT00343291|3315198|P2|Overall Study|Adverse Event|13
1014247|NCT00343291|3315199|P1|Overall Study|Adverse Event|13
1014248|NCT00343252|3315215|P2|18 Months (All Treated Participants)|Withdrawal by Subject|20
1014249|NCT00343252|3315216|P1|18 Months (All Treated Participants)|Withdrawal by Subject|36
1014250|NCT00343252|3315215|P2|18 Months (All Treated Participants)|Sponsor Decision|5
1014251|NCT00343252|3315216|P1|18 Months (All Treated Participants)|Sponsor Decision|8
1014252|NCT00343252|3315215|P2|18 Months (All Treated Participants)|Protocol Violation|3
1014253|NCT00343252|3315216|P1|18 Months (All Treated Participants)|Protocol Violation|3
1014254|NCT00343252|3315215|P2|18 Months (All Treated Participants)|Physician Decision|7
1014255|NCT00343252|3315216|P1|18 Months (All Treated Participants)|Physician Decision|4
1014256|NCT00343252|3315215|P2|18 Months (All Treated Participants)|Lost to Follow-up|7
1014257|NCT00343252|3315216|P1|18 Months (All Treated Participants)|Lost to Follow-up|3
1014258|NCT00343252|3315215|P2|18 Months (All Treated Participants)|Lack of Efficacy|1
1014259|NCT00343252|3315216|P1|18 Months (All Treated Participants)|Lack of Efficacy|1
1014260|NCT00343252|3315215|P2|18 Months (All Treated Participants)|Entry Criteria Not Met|10
1014261|NCT00343252|3315216|P1|18 Months (All Treated Participants)|Entry Criteria Not Met|11
1014262|NCT00343252|3315215|P2|18 Months (All Treated Participants)|Death|5
1014263|NCT00343252|3315216|P1|18 Months (All Treated Participants)|Death|4
1014264|NCT00343252|3315215|P2|18 Months (All Treated Participants)|Adverse Event|23
1014265|NCT00343252|3315216|P1|18 Months (All Treated Participants)|Adverse Event|31
1014266|NCT00343252|3315215|P2|12 Months (All Treated Participants)|Withdrawal by Subject|17
1014267|NCT00343252|3315216|P1|12 Months (All Treated Participants)|Withdrawal by Subject|33
1014268|NCT00343252|3315215|P2|12 Months (All Treated Participants)|Sponsor Decision|6
1014269|NCT00343252|3315216|P1|12 Months (All Treated Participants)|Sponsor Decision|9
1014270|NCT00343252|3315215|P2|12 Months (All Treated Participants)|Protocol Violation|2
1014271|NCT00343252|3315216|P1|12 Months (All Treated Participants)|Protocol Violation|3
1014272|NCT00343252|3315215|P2|12 Months (All Treated Participants)|Physician Decision|5
1014273|NCT00343252|3315216|P1|12 Months (All Treated Participants)|Physician Decision|4
1014274|NCT00343252|3315215|P2|12 Months (All Treated Participants)|Lost to Follow-up|5
1014275|NCT00343252|3315216|P1|12 Months (All Treated Participants)|Lost to Follow-up|1
1014276|NCT00343252|3315215|P2|12 Months (All Treated Participants)|Lack of Efficacy|1
1014277|NCT00343252|3315216|P1|12 Months (All Treated Participants)|Lack of Efficacy|1
1014278|NCT00343252|3315215|P2|12 Months (All Treated Participants)|Entry Criteria Not Met|10
1014279|NCT00343252|3315216|P1|12 Months (All Treated Participants)|Entry Criteria Not Met|10
1014280|NCT00343252|3315215|P2|12 Months (All Treated Participants)|Death|3
1014281|NCT00343252|3315216|P1|12 Months (All Treated Participants)|Death|3
1014282|NCT00343252|3315215|P2|12 Months (All Treated Participants)|Adverse Event|20
1014283|NCT00343252|3315216|P1|12 Months (All Treated Participants)|Adverse Event|22
1014284|NCT00343252|3315215|P2|6 Months (All Treated Participants)|Withdrawal by Subject|9
1014285|NCT00343252|3315216|P1|6 Months (All Treated Participants)|Withdrawal by Subject|19
1014286|NCT00343252|3315215|P2|6 Months (All Treated Participants)|Sponsor Decision|4
1014287|NCT00343252|3315216|P1|6 Months (All Treated Participants)|Sponsor Decision|7
1014288|NCT00343252|3315215|P2|6 Months (All Treated Participants)|Protocol Violation|2
1014289|NCT00343252|3315216|P1|6 Months (All Treated Participants)|Protocol Violation|2
1014290|NCT00343252|3315215|P2|6 Months (All Treated Participants)|Physician Decision|3
1014291|NCT00343252|3315216|P1|6 Months (All Treated Participants)|Physician Decision|1
1014292|NCT00343252|3315215|P2|6 Months (All Treated Participants)|Lost to Follow-up|4
1014293|NCT00343252|3315216|P1|6 Months (All Treated Participants)|Lost to Follow-up|0
1014294|NCT00343252|3315215|P2|6 Months (All Treated Participants)|Lack of Efficacy|1
1014295|NCT00343252|3315216|P1|6 Months (All Treated Participants)|Lack of Efficacy|0
1014296|NCT00343252|3315215|P2|6 Months (All Treated Participants)|Entry Criteria Not Met|8
1014297|NCT00343252|3315216|P1|6 Months (All Treated Participants)|Entry Criteria Not Met|10
1014298|NCT00343252|3315215|P2|6 Months (All Treated Participants)|Death|2
1014299|NCT00343252|3315216|P1|6 Months (All Treated Participants)|Death|0
1014300|NCT00343252|3315215|P2|6 Months (All Treated Participants)|Adverse Event|11
1014301|NCT00343252|3315216|P1|6 Months (All Treated Participants)|Adverse Event|17
1014302|NCT00342628|3315281|P3|Overall Study|moved residence|1
1014303|NCT00342628|3315282|P2|Overall Study|moved residence|1
1014304|NCT00342628|3315283|P1|Overall Study|moved residence|0
1014305|NCT00342628|3315281|P3|Overall Study|Death|0
1014306|NCT00342628|3315282|P2|Overall Study|Death|1
1014307|NCT00342628|3315283|P1|Overall Study|Death|1
1014308|NCT00342628|3315281|P3|Overall Study|Withdrawal by Subject|18
1014309|NCT00342628|3315282|P2|Overall Study|Withdrawal by Subject|19
1014310|NCT00342628|3315283|P1|Overall Study|Withdrawal by Subject|19
1014311|NCT00340834|3315349|P5|Extension Phase of Study|Death|1
1014312|NCT00340834|3315350|P4|Extension Phase of Study|Death|0
1014313|NCT00340834|3315351|P3|Extension Phase of Study|Death|0
1014314|NCT00340834|3315352|P2|Extension Phase of Study|Death|0
1014315|NCT00340834|3315353|P1|Extension Phase of Study|Death|0
1014316|NCT00340834|3315349|P5|Extension Phase of Study|Protocol Violation|0
1014317|NCT00340834|3315350|P4|Extension Phase of Study|Protocol Violation|0
1014318|NCT00340834|3315351|P3|Extension Phase of Study|Protocol Violation|0
1014319|NCT00340834|3315352|P2|Extension Phase of Study|Protocol Violation|0
1014320|NCT00340834|3315353|P1|Extension Phase of Study|Protocol Violation|3
1014321|NCT00340834|3315349|P5|Extension Phase of Study|Abnormal test procedure result(s)|2
1014322|NCT00340834|3315350|P4|Extension Phase of Study|Abnormal test procedure result(s)|0
1014323|NCT00340834|3315351|P3|Extension Phase of Study|Abnormal test procedure result(s)|0
1014324|NCT00340834|3315352|P2|Extension Phase of Study|Abnormal test procedure result(s)|1
1014325|NCT00340834|3315353|P1|Extension Phase of Study|Abnormal test procedure result(s)|0
1014326|NCT00340834|3315349|P5|Extension Phase of Study|Administrative problems|1
1014327|NCT00340834|3315350|P4|Extension Phase of Study|Administrative problems|1
1014328|NCT00340834|3315351|P3|Extension Phase of Study|Administrative problems|0
1014329|NCT00340834|3315352|P2|Extension Phase of Study|Administrative problems|0
1014330|NCT00340834|3315353|P1|Extension Phase of Study|Administrative problems|3
1014331|NCT00340834|3315349|P5|Extension Phase of Study|Subject no longer requires study drug|2
1014332|NCT00340834|3315350|P4|Extension Phase of Study|Subject no longer requires study drug|0
1014333|NCT00340834|3315351|P3|Extension Phase of Study|Subject no longer requires study drug|0
1014334|NCT00340834|3315352|P2|Extension Phase of Study|Subject no longer requires study drug|0
1014335|NCT00340834|3315353|P1|Extension Phase of Study|Subject no longer requires study drug|4
1014336|NCT00340834|3315349|P5|Extension Phase of Study|Lost to Follow-up|3
1014337|NCT00340834|3315350|P4|Extension Phase of Study|Lost to Follow-up|2
1014338|NCT00340834|3315351|P3|Extension Phase of Study|Lost to Follow-up|0
1014339|NCT00340834|3315352|P2|Extension Phase of Study|Lost to Follow-up|1
1014340|NCT00340834|3315353|P1|Extension Phase of Study|Lost to Follow-up|1
1014341|NCT00340834|3315349|P5|Extension Phase of Study|Unsatisfactory therapeutic effect|9
1014342|NCT00340834|3315350|P4|Extension Phase of Study|Unsatisfactory therapeutic effect|4
1014343|NCT00340834|3315351|P3|Extension Phase of Study|Unsatisfactory therapeutic effect|0
1014344|NCT00340834|3315352|P2|Extension Phase of Study|Unsatisfactory therapeutic effect|7
1014345|NCT00340834|3315353|P1|Extension Phase of Study|Unsatisfactory therapeutic effect|13
1014346|NCT00340834|3315349|P5|Extension Phase of Study|Abnormal laboratory value(s)|4
1014347|NCT00340834|3315350|P4|Extension Phase of Study|Abnormal laboratory value(s)|13
1014348|NCT00340834|3315351|P3|Extension Phase of Study|Abnormal laboratory value(s)|0
1014349|NCT00340834|3315352|P2|Extension Phase of Study|Abnormal laboratory value(s)|13
1014350|NCT00340834|3315353|P1|Extension Phase of Study|Abnormal laboratory value(s)|14
1014351|NCT00340834|3315349|P5|Extension Phase of Study|Adverse Event|7
1014352|NCT00340834|3315350|P4|Extension Phase of Study|Adverse Event|19
1014353|NCT00340834|3315351|P3|Extension Phase of Study|Adverse Event|0
1014354|NCT00340834|3315352|P2|Extension Phase of Study|Adverse Event|22
1014355|NCT00340834|3315353|P1|Extension Phase of Study|Adverse Event|21
1014356|NCT00340834|3315349|P5|Extension Phase of Study|Subject withdrew consent|15
1014357|NCT00340834|3315350|P4|Extension Phase of Study|Subject withdrew consent|12
1014358|NCT00340834|3315351|P3|Extension Phase of Study|Subject withdrew consent|0
1014359|NCT00340834|3315352|P2|Extension Phase of Study|Subject withdrew consent|31
1014360|NCT00340834|3315353|P1|Extension Phase of Study|Subject withdrew consent|26
1014361|NCT00340834|3315349|P5|Extension Phase of Study|Subject did not receive study drug|0
1014362|NCT00340834|3315350|P4|Extension Phase of Study|Subject did not receive study drug|2
1014363|NCT00340834|3315351|P3|Extension Phase of Study|Subject did not receive study drug|0
1014364|NCT00340834|3315352|P2|Extension Phase of Study|Subject did not receive study drug|1
1014365|NCT00340834|3315353|P1|Extension Phase of Study|Subject did not receive study drug|0
1014366|NCT00340834|3315349|P5|Core Phase of Study|Protocol Violation|0
1014367|NCT00340834|3315350|P4|Core Phase of Study|Protocol Violation|0
1014368|NCT00340834|3315351|P3|Core Phase of Study|Protocol Violation|2
1014369|NCT00340834|3315352|P2|Core Phase of Study|Protocol Violation|0
1014370|NCT00340834|3315353|P1|Core Phase of Study|Protocol Violation|0
1014371|NCT00340834|3315349|P5|Core Phase of Study|Death|0
1014372|NCT00340834|3315350|P4|Core Phase of Study|Death|0
1014373|NCT00340834|3315351|P3|Core Phase of Study|Death|0
1014374|NCT00340834|3315352|P2|Core Phase of Study|Death|0
1014375|NCT00340834|3315353|P1|Core Phase of Study|Death|2
1014376|NCT00340834|3315349|P5|Core Phase of Study|Lost to Follow-up|0
1014377|NCT00340834|3315350|P4|Core Phase of Study|Lost to Follow-up|0
1014378|NCT00340834|3315351|P3|Core Phase of Study|Lost to Follow-up|4
1014379|NCT00340834|3315352|P2|Core Phase of Study|Lost to Follow-up|1
1014380|NCT00340834|3315353|P1|Core Phase of Study|Lost to Follow-up|1
1014381|NCT00340834|3315349|P5|Core Phase of Study|Abnormal test procedure result(s)|0
1014382|NCT00340834|3315350|P4|Core Phase of Study|Abnormal test procedure result(s)|0
1014383|NCT00340834|3315351|P3|Core Phase of Study|Abnormal test procedure result(s)|3
1014384|NCT00340834|3315352|P2|Core Phase of Study|Abnormal test procedure result(s)|3
1014385|NCT00340834|3315353|P1|Core Phase of Study|Abnormal test procedure result(s)|4
1014386|NCT00340834|3315349|P5|Core Phase of Study|Abnormal laboratory value(s)|0
1014387|NCT00340834|3315350|P4|Core Phase of Study|Abnormal laboratory value(s)|0
1014388|NCT00340834|3315351|P3|Core Phase of Study|Abnormal laboratory value(s)|1
1014389|NCT00340834|3315352|P2|Core Phase of Study|Abnormal laboratory value(s)|6
1014390|NCT00340834|3315353|P1|Core Phase of Study|Abnormal laboratory value(s)|4
1014391|NCT00340834|3315349|P5|Core Phase of Study|Lack of Efficacy|0
1014392|NCT00340834|3315350|P4|Core Phase of Study|Lack of Efficacy|0
1014393|NCT00340834|3315351|P3|Core Phase of Study|Lack of Efficacy|7
1014394|NCT00340834|3315352|P2|Core Phase of Study|Lack of Efficacy|3
1014395|NCT00340834|3315353|P1|Core Phase of Study|Lack of Efficacy|3
1014396|NCT00340834|3315349|P5|Core Phase of Study|Administrative Problems|0
1014397|NCT00340834|3315350|P4|Core Phase of Study|Administrative Problems|0
1014398|NCT00340834|3315351|P3|Core Phase of Study|Administrative Problems|7
1014399|NCT00340834|3315352|P2|Core Phase of Study|Administrative Problems|2
1014400|NCT00340834|3315353|P1|Core Phase of Study|Administrative Problems|6
1014401|NCT00340834|3315349|P5|Core Phase of Study|Withdrawal by Subject|0
1014402|NCT00340834|3315350|P4|Core Phase of Study|Withdrawal by Subject|0
1014403|NCT00340834|3315351|P3|Core Phase of Study|Withdrawal by Subject|16
1014404|NCT00340834|3315352|P2|Core Phase of Study|Withdrawal by Subject|9
1014405|NCT00340834|3315353|P1|Core Phase of Study|Withdrawal by Subject|11
1014406|NCT00340834|3315349|P5|Core Phase of Study|Adverse Event|0
1014407|NCT00340834|3315350|P4|Core Phase of Study|Adverse Event|0
1014408|NCT00340834|3315351|P3|Core Phase of Study|Adverse Event|9
1014409|NCT00340834|3315352|P2|Core Phase of Study|Adverse Event|9
1014410|NCT00340834|3315353|P1|Core Phase of Study|Adverse Event|26
1014411|NCT00340704|3315387|P9|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28
1014412|NCT00340704|3315388|P8|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11
1014413|NCT00340704|3315389|P7|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53
1014414|NCT00340704|3315390|P6|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3
1014415|NCT00340704|3315391|P5|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
1014416|NCT00340704|3315392|P4|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
1014417|NCT00340704|3315393|P3|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
1014418|NCT00340704|3315394|P2|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
1014419|NCT00340704|3315395|P1|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
1014420|NCT00340704|3315387|P9|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
1014421|NCT00340704|3315388|P8|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
1014422|NCT00340704|3315389|P7|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
1014423|NCT00340704|3315390|P6|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3
1014424|NCT00340704|3315391|P5|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1
1014425|NCT00340704|3315392|P4|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
1014426|NCT00340704|3315393|P3|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
1014427|NCT00340704|3315394|P2|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
1014428|NCT00340704|3315395|P1|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
1014429|NCT00340704|3315387|P9|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1014430|NCT00340704|3315388|P8|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1014431|NCT00340704|3315389|P7|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1014432|NCT00340704|3315390|P6|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1
1014433|NCT00340704|3315391|P5|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1014434|NCT00340704|3315392|P4|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1014435|NCT00340704|3315393|P3|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1014436|NCT00340704|3315394|P2|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1014437|NCT00340704|3315395|P1|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1014438|NCT00340704|3315387|P9|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
1014439|NCT00340704|3315388|P8|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
1014440|NCT00340704|3315389|P7|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
1014441|NCT00340704|3315390|P6|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
1014442|NCT00340704|3315391|P5|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4
1014443|NCT00340704|3315392|P4|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2
1014444|NCT00340704|3315393|P3|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
1014445|NCT00340704|3315394|P2|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
1014446|NCT00340704|3315395|P1|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
1014447|NCT00340704|3315387|P9|PK Study|Not treated|0
1014448|NCT00340704|3315388|P8|PK Study|Not treated|0
1014449|NCT00340704|3315389|P7|PK Study|Not treated|0
1014450|NCT00340704|3315390|P6|PK Study|Not treated|0
1014451|NCT00340704|3315391|P5|PK Study|Not treated|0
1014452|NCT00340704|3315392|P4|PK Study|Not treated|0
1014453|NCT00340704|3315393|P3|PK Study|Not treated|1
1014454|NCT00340704|3315394|P2|PK Study|Not treated|0
1014455|NCT00340704|3315395|P1|PK Study|Not treated|0
1014456|NCT00340704|3315387|P9|PK Study|Adverse Event|0
1014457|NCT00340704|3315388|P8|PK Study|Adverse Event|0
1014458|NCT00340704|3315389|P7|PK Study|Adverse Event|0
1014459|NCT00340704|3315390|P6|PK Study|Adverse Event|0
1014460|NCT00340704|3315391|P5|PK Study|Adverse Event|0
1014461|NCT00340704|3315392|P4|PK Study|Adverse Event|0
1014462|NCT00340704|3315393|P3|PK Study|Adverse Event|0
1014463|NCT00340704|3315394|P2|PK Study|Adverse Event|1
1014464|NCT00340704|3315395|P1|PK Study|Adverse Event|0
1014465|NCT00340678|3315501|P4|Overall Study|Lost to Follow-up|0
1014466|NCT00340678|3315502|P3|Overall Study|Lost to Follow-up|0
1014467|NCT00340678|3315503|P2|Overall Study|Lost to Follow-up|0
1014468|NCT00340678|3315504|P1|Overall Study|Lost to Follow-up|1
1014469|NCT00339833|3315531|P2|Overall Study|Error in data records|0
1014470|NCT00339833|3315532|P1|Overall Study|Error in data records|1
1014471|NCT00339833|3315531|P2|Overall Study|anaemia or excess drop in glycaemia|0
1014472|NCT00339833|3315532|P1|Overall Study|anaemia or excess drop in glycaemia|2
1014473|NCT00339833|3315531|P2|Overall Study|Poor venous access|2
1014474|NCT00339833|3315532|P1|Overall Study|Poor venous access|2
1014475|NCT00339833|3315531|P2|Overall Study|minor infection|1
1014476|NCT00339833|3315532|P1|Overall Study|minor infection|0
1014477|NCT00339833|3315531|P2|Overall Study|Chest pain|1
1014478|NCT00339833|3315532|P1|Overall Study|Chest pain|0
1014479|NCT00339833|3315531|P2|Overall Study|indigestion|1
1014480|NCT00339833|3315532|P1|Overall Study|indigestion|0
1014481|NCT00339833|3315531|P2|Overall Study|toothache|1
1014482|NCT00339833|3315532|P1|Overall Study|toothache|0
1014483|NCT00339833|3315531|P2|Overall Study|Withdrawal by Subject|2
1014484|NCT00339833|3315532|P1|Overall Study|Withdrawal by Subject|1
1014485|NCT00339183|3315542|P2|Overall Study|Ongoing|13
1014486|NCT00339183|3315543|P1|Overall Study|Ongoing|20
1014487|NCT00339183|3315542|P2|Overall Study|Other|40
1014488|NCT00339183|3315543|P1|Overall Study|Other|46
1014489|NCT00339183|3315542|P2|Overall Study|Missing reason|1
1014490|NCT00339183|3315543|P1|Overall Study|Missing reason|3
1014491|NCT00339183|3315542|P2|Overall Study|Protocol-specified criteria|8
1014492|NCT00339183|3315543|P1|Overall Study|Protocol-specified criteria|12
1014493|NCT00339183|3315542|P2|Overall Study|Lost to Follow-up|17
1014494|NCT00339183|3315543|P1|Overall Study|Lost to Follow-up|17
1014495|NCT00339183|3315542|P2|Overall Study|Physician Decision|4
1014496|NCT00339183|3315543|P1|Overall Study|Physician Decision|2
1014497|NCT00339183|3315542|P2|Overall Study|Withdrawal by Subject|19
1014498|NCT00339183|3315543|P1|Overall Study|Withdrawal by Subject|16
1014499|NCT00339183|3315542|P2|Overall Study|Adverse Event|3
1014500|NCT00339183|3315543|P1|Overall Study|Adverse Event|5
1014501|NCT00339144|3315572|P3|Overall Study|Participant's request to discontinuation|1
1014502|NCT00339144|3315573|P2|Overall Study|Participant's request to discontinuation|0
1014503|NCT00339144|3315574|P1|Overall Study|Participant's request to discontinuation|1
1014504|NCT00339144|3315572|P3|Overall Study|Study drug toxicity|1
1014505|NCT00339144|3315573|P2|Overall Study|Study drug toxicity|1
1014506|NCT00339144|3315574|P1|Overall Study|Study drug toxicity|3
1014507|NCT00339144|3315572|P3|Overall Study|Disease progression|2
1014508|NCT00339144|3315573|P2|Overall Study|Disease progression|2
1014509|NCT00339144|3315574|P1|Overall Study|Disease progression|5
1014510|NCT00339040|3315679|P2|Stage II|Site closing|0
1014511|NCT00339040|3315680|P1|Stage II|Site closing|2
1014512|NCT00339040|3315679|P2|Stage II|Not able to attend clinic|0
1014513|NCT00339040|3315680|P1|Stage II|Not able to attend clinic|1
1014514|NCT00339040|3315679|P2|Stage II|Protocol Violation|0
1014515|NCT00339040|3315680|P1|Stage II|Protocol Violation|3
1014516|NCT00339040|3315679|P2|Stage II|Withdrawal by Subject|2
1014517|NCT00339040|3315680|P1|Stage II|Withdrawal by Subject|1
1014518|NCT00339040|3315679|P2|Stage II|Lost to Follow-up|0
1014519|NCT00339040|3315680|P1|Stage II|Lost to Follow-up|3
1014520|NCT00339040|3315679|P2|Stage I|Protocol Violation|1
1014521|NCT00339040|3315680|P1|Stage I|Protocol Violation|1
1014522|NCT00339040|3315679|P2|Stage I|Not able to attend clinic|0
1014523|NCT00339040|3315680|P1|Stage I|Not able to attend clinic|1
1014524|NCT00338962|3315707|P4|Overall Study|Poor Compliance|0
1014525|NCT00338962|3315708|P3|Overall Study|Poor Compliance|2
1014526|NCT00338962|3315709|P2|Overall Study|Poor Compliance|0
1014527|NCT00338962|3315710|P1|Overall Study|Poor Compliance|0
1014528|NCT00338962|3315707|P4|Overall Study|Adverse Event|0
1014529|NCT00338962|3315708|P3|Overall Study|Adverse Event|2
1014530|NCT00338962|3315709|P2|Overall Study|Adverse Event|0
1014531|NCT00338962|3315710|P1|Overall Study|Adverse Event|0
1014532|NCT00338962|3315707|P4|Overall Study|Moved|0
1014533|NCT00338962|3315708|P3|Overall Study|Moved|0
1014534|NCT00338962|3315709|P2|Overall Study|Moved|1
1014535|NCT00338962|3315710|P1|Overall Study|Moved|0
1014536|NCT00338962|3315707|P4|Overall Study|Time Constraint|0
1014537|NCT00338962|3315708|P3|Overall Study|Time Constraint|0
1014538|NCT00338962|3315709|P2|Overall Study|Time Constraint|0
1014539|NCT00338962|3315710|P1|Overall Study|Time Constraint|2
1014540|NCT00338962|3315707|P4|Overall Study|No Transportation|0
1014541|NCT00338962|3315708|P3|Overall Study|No Transportation|0
1014542|NCT00338962|3315709|P2|Overall Study|No Transportation|0
1014543|NCT00338962|3315710|P1|Overall Study|No Transportation|2
1014544|NCT00338962|3315707|P4|Overall Study|Withdrawal by Subject|0
1014545|NCT00338962|3315708|P3|Overall Study|Withdrawal by Subject|0
1014546|NCT00338962|3315709|P2|Overall Study|Withdrawal by Subject|0
1014547|NCT00338962|3315710|P1|Overall Study|Withdrawal by Subject|1
1014548|NCT00338962|3315707|P4|Overall Study|Lost to Follow-up|3
1014549|NCT00338962|3315708|P3|Overall Study|Lost to Follow-up|2
1014550|NCT00338962|3315709|P2|Overall Study|Lost to Follow-up|3
1014551|NCT00338962|3315710|P1|Overall Study|Lost to Follow-up|3
1014552|NCT00338884|3315732|P1|Overall Study|Randomized But Did Not Receive Treatment|1
1014553|NCT00338884|3315732|P1|Overall Study|Lost to Follow-up|1
1014554|NCT00338884|3315732|P1|Overall Study|Withdrawal by Subject|3
1014555|NCT00338884|3315732|P1|Overall Study|Global Deterioration of Health Status|3
1014556|NCT00338884|3315732|P1|Overall Study|Other|4
1014557|NCT00338884|3315732|P1|Overall Study|Death|8
1014558|NCT00338884|3315732|P1|Overall Study|Adverse Event|14
1014559|NCT00338884|3315732|P1|Overall Study|Objective Disease Progression or Relapse|44
1014560|NCT00338806|3315766|P2|Follow-up|Lost to Follow-up|3
1014561|NCT00338806|3315767|P1|Follow-up|Lost to Follow-up|1
1014562|NCT00338806|3315766|P2|Acute Phase|Withdrawal by Subject|1
1014563|NCT00338806|3315767|P1|Acute Phase|Withdrawal by Subject|0
1014564|NCT00338741|3315829|P2|Overall Study|Lost to Follow-up|0
1014565|NCT00338741|3315830|P1|Overall Study|Lost to Follow-up|2
1014566|NCT00338455|3315861|P2|Overall Study|Physician Decision|0
1014567|NCT00338455|3315862|P1|Overall Study|Physician Decision|1
1014568|NCT00338455|3315861|P2|Overall Study|Death|1
1014569|NCT00338455|3315862|P1|Overall Study|Death|2
1014570|NCT00338286|3315876|P2|Overall Study|Other|93
1014571|NCT00338286|3315877|P1|Overall Study|Other|103
1014572|NCT00338286|3315876|P2|Overall Study|Lost to Follow-up|66
1014573|NCT00338286|3315877|P1|Overall Study|Lost to Follow-up|80
1014574|NCT00338286|3315876|P2|Overall Study|Withdrawal by Subject|54
1014575|NCT00338286|3315877|P1|Overall Study|Withdrawal by Subject|50
1014576|NCT00338104|3315894|P3|Overall Study|Protocol Violation|3
1014577|NCT00338104|3315895|P2|Overall Study|Protocol Violation|1
1014578|NCT00338104|3315896|P1|Overall Study|Protocol Violation|2
1014579|NCT00337935|3315919|P2|Overall Study|Lack of Efficacy|1
1014580|NCT00337935|3315920|P1|Overall Study|Lack of Efficacy|0
1014581|NCT00337935|3315919|P2|Overall Study|Other|1
1014582|NCT00337935|3315920|P1|Overall Study|Other|0
1014583|NCT00337935|3315919|P2|Overall Study|Withdrawal by Subject|7
1014584|NCT00337935|3315920|P1|Overall Study|Withdrawal by Subject|1
1014585|NCT00337935|3315919|P2|Overall Study|Protocol Violation|3
1014586|NCT00337935|3315920|P1|Overall Study|Protocol Violation|4
1014587|NCT00337935|3315919|P2|Overall Study|Lost to Follow-up|1
1014588|NCT00337935|3315920|P1|Overall Study|Lost to Follow-up|0
1014589|NCT00337935|3315919|P2|Overall Study|Physician Decision|1
1014590|NCT00337935|3315920|P1|Overall Study|Physician Decision|1
1014591|NCT00337935|3315919|P2|Overall Study|Death|8
1014592|NCT00337935|3315920|P1|Overall Study|Death|2
1014593|NCT00337935|3315919|P2|Overall Study|Adverse Event|5
1014594|NCT00337935|3315920|P1|Overall Study|Adverse Event|2
1014595|NCT00337818|3315933|P3|Overall Study|Lost to Follow-up|107
1014596|NCT00337818|3315934|P2|Overall Study|Lost to Follow-up|91
1014597|NCT00337818|3315935|P1|Overall Study|Lost to Follow-up|289
1014598|NCT00337779|3315957|P2|Overall Study|Death|1
1014599|NCT00337779|3315958|P1|Overall Study|Death|0
1014600|NCT00337779|3315957|P2|Overall Study|Pregnancy|2
1014601|NCT00337779|3315958|P1|Overall Study|Pregnancy|3
1014602|NCT00337779|3315957|P2|Overall Study|Adverse Event|51
1014603|NCT00337779|3315958|P1|Overall Study|Adverse Event|28
1014604|NCT00337779|3315957|P2|Overall Study|Lost to Follow-up|5
1014605|NCT00337779|3315958|P1|Overall Study|Lost to Follow-up|6
1014606|NCT00337779|3315957|P2|Overall Study|Protocol Violation|1
1014607|NCT00337779|3315958|P1|Overall Study|Protocol Violation|1
1014608|NCT00337779|3315957|P2|Overall Study|Physician Decision|6
1014609|NCT00337779|3315958|P1|Overall Study|Physician Decision|3
1014610|NCT00337779|3315957|P2|Overall Study|Sponsor decision|1
1014611|NCT00337779|3315958|P1|Overall Study|Sponsor decision|1
1014612|NCT00337779|3315957|P2|Overall Study|Withdrawal by Subject|12
1014613|NCT00337779|3315958|P1|Overall Study|Withdrawal by Subject|10
1014614|NCT00337727|3315970|P2|Overall Study|Withdrawal by Subject|5
1014615|NCT00337727|3315971|P1|Overall Study|Withdrawal by Subject|3
1014616|NCT00337727|3315970|P2|Overall Study|Protocol Violation|0
1014617|NCT00337727|3315971|P1|Overall Study|Protocol Violation|4
1014618|NCT00337727|3315970|P2|Overall Study|Physician Decision|0
1014619|NCT00337727|3315971|P1|Overall Study|Physician Decision|1
1014620|NCT00337727|3315970|P2|Overall Study|Lost to Follow-up|4
1014621|NCT00337727|3315971|P1|Overall Study|Lost to Follow-up|5
1014622|NCT00337727|3315970|P2|Overall Study|Adverse Event|3
1014623|NCT00337727|3315971|P1|Overall Study|Adverse Event|5
1014624|NCT00337675|3315982|P3|Overall Study|Trial Terminated|2
1014625|NCT00337675|3315983|P2|Overall Study|Trial Terminated|0
1014626|NCT00337675|3315984|P1|Overall Study|Trial Terminated|0
1014627|NCT00337675|3315982|P3|Overall Study|Progressive Disease|0
1014628|NCT00337675|3315983|P2|Overall Study|Progressive Disease|2
1014629|NCT00337675|3315984|P1|Overall Study|Progressive Disease|0
1014630|NCT00337675|3315982|P3|Overall Study|Withdrawal by Subject|19
1014631|NCT00337675|3315983|P2|Overall Study|Withdrawal by Subject|25
1014632|NCT00337675|3315984|P1|Overall Study|Withdrawal by Subject|25
1014633|NCT00337675|3315982|P3|Overall Study|Protocol Violation|19
1014634|NCT00337675|3315983|P2|Overall Study|Protocol Violation|24
1014635|NCT00337675|3315984|P1|Overall Study|Protocol Violation|21
1014636|NCT00337675|3315982|P3|Overall Study|Physician Decision|14
1014637|NCT00337675|3315983|P2|Overall Study|Physician Decision|17
1014638|NCT00337675|3315984|P1|Overall Study|Physician Decision|9
1014639|NCT00337675|3315982|P3|Overall Study|Lost to Follow-up|17
1014640|NCT00337675|3315983|P2|Overall Study|Lost to Follow-up|19
1014641|NCT00337675|3315984|P1|Overall Study|Lost to Follow-up|22
1014642|NCT00337675|3315982|P3|Overall Study|Lack of Efficacy|9
1014643|NCT00337675|3315983|P2|Overall Study|Lack of Efficacy|7
1014644|NCT00337675|3315984|P1|Overall Study|Lack of Efficacy|10
1014645|NCT00337675|3315982|P3|Overall Study|Adverse Event|19
1014646|NCT00337675|3315983|P2|Overall Study|Adverse Event|9
1014647|NCT00337675|3315984|P1|Overall Study|Adverse Event|10
1014648|NCT00337662|3316001|P4|Study Period III|Clinical Relapse|0
1014649|NCT00337662|3316002|P3|Study Period III|Clinical Relapse|0
1014650|NCT00337662|3316003|P2|Study Period III|Clinical Relapse|0
1014651|NCT00337662|3316004|P1|Study Period III|Clinical Relapse|1
1014652|NCT00337662|3316001|P4|Study Period III|Sponsor Decision|0
1014653|NCT00337662|3316002|P3|Study Period III|Sponsor Decision|1
1014654|NCT00337662|3316003|P2|Study Period III|Sponsor Decision|0
1014655|NCT00337662|3316004|P1|Study Period III|Sponsor Decision|1
1014656|NCT00337662|3316001|P4|Study Period III|Parent/Caregiver Decision|0
1014657|NCT00337662|3316002|P3|Study Period III|Parent/Caregiver Decision|2
1014658|NCT00337662|3316003|P2|Study Period III|Parent/Caregiver Decision|0
1014659|NCT00337662|3316004|P1|Study Period III|Parent/Caregiver Decision|0
1014660|NCT00337662|3316001|P4|Study Period III|Lack of Efficacy|0
1014661|NCT00337662|3316002|P3|Study Period III|Lack of Efficacy|2
1014662|NCT00337662|3316003|P2|Study Period III|Lack of Efficacy|4
1014663|NCT00337662|3316004|P1|Study Period III|Lack of Efficacy|4
1014664|NCT00337662|3316001|P4|Study Period III|Entry Criteria Not Met|0
1014665|NCT00337662|3316002|P3|Study Period III|Entry Criteria Not Met|3
1014666|NCT00337662|3316003|P2|Study Period III|Entry Criteria Not Met|1
1014667|NCT00337662|3316004|P1|Study Period III|Entry Criteria Not Met|4
1014668|NCT00337662|3316001|P4|Study Period III|Physician Decision|0
1014669|NCT00337662|3316002|P3|Study Period III|Physician Decision|0
1014670|NCT00337662|3316003|P2|Study Period III|Physician Decision|5
1014671|NCT00337662|3316004|P1|Study Period III|Physician Decision|6
1014672|NCT00337662|3316001|P4|Study Period III|Protocol Violation|0
1014673|NCT00337662|3316002|P3|Study Period III|Protocol Violation|2
1014674|NCT00337662|3316003|P2|Study Period III|Protocol Violation|8
1014675|NCT00337662|3316004|P1|Study Period III|Protocol Violation|3
1014676|NCT00337662|3316001|P4|Study Period III|Adverse Event|0
1014677|NCT00337662|3316002|P3|Study Period III|Adverse Event|8
1014678|NCT00337662|3316003|P2|Study Period III|Adverse Event|10
1014679|NCT00337662|3316004|P1|Study Period III|Adverse Event|9
1014680|NCT00337662|3316001|P4|Study Period III|Withdrawal by Subject|0
1014681|NCT00337662|3316002|P3|Study Period III|Withdrawal by Subject|12
1014682|NCT00337662|3316003|P2|Study Period III|Withdrawal by Subject|14
1014683|NCT00337662|3316004|P1|Study Period III|Withdrawal by Subject|18
1014684|NCT00337662|3316001|P4|Study Period III|Lost to Follow-up|0
1014685|NCT00337662|3316002|P3|Study Period III|Lost to Follow-up|14
1014686|NCT00337662|3316003|P2|Study Period III|Lost to Follow-up|16
1014687|NCT00337662|3316004|P1|Study Period III|Lost to Follow-up|14
1014688|NCT00337662|3316001|P4|Study Period II|Parent/Caregiver Decision|1
1014689|NCT00337662|3316002|P3|Study Period II|Parent/Caregiver Decision|0
1014690|NCT00337662|3316003|P2|Study Period II|Parent/Caregiver Decision|0
1014691|NCT00337662|3316004|P1|Study Period II|Parent/Caregiver Decision|0
1014692|NCT00337662|3316001|P4|Study Period II|Sponsor Decision|2
1014693|NCT00337662|3316002|P3|Study Period II|Sponsor Decision|0
1014694|NCT00337662|3316003|P2|Study Period II|Sponsor Decision|0
1014695|NCT00337662|3316004|P1|Study Period II|Sponsor Decision|0
1014696|NCT00337662|3316001|P4|Study Period II|Lack of Efficacy|7
1014697|NCT00337662|3316002|P3|Study Period II|Lack of Efficacy|0
1014698|NCT00337662|3316003|P2|Study Period II|Lack of Efficacy|0
1014699|NCT00337662|3316004|P1|Study Period II|Lack of Efficacy|0
1014700|NCT00337662|3316001|P4|Study Period II|Protocol Violation|6
1014701|NCT00337662|3316002|P3|Study Period II|Protocol Violation|0
1014702|NCT00337662|3316003|P2|Study Period II|Protocol Violation|0
1014703|NCT00337662|3316004|P1|Study Period II|Protocol Violation|0
1014704|NCT00337662|3316001|P4|Study Period II|Entry Criteria Not Met|6
1014705|NCT00337662|3316002|P3|Study Period II|Entry Criteria Not Met|0
1014706|NCT00337662|3316003|P2|Study Period II|Entry Criteria Not Met|0
1014707|NCT00337662|3316004|P1|Study Period II|Entry Criteria Not Met|0
1014708|NCT00337662|3316001|P4|Study Period II|Physician Decision|13
1014709|NCT00337662|3316002|P3|Study Period II|Physician Decision|0
1014710|NCT00337662|3316003|P2|Study Period II|Physician Decision|0
1014711|NCT00337662|3316004|P1|Study Period II|Physician Decision|0
1014712|NCT00337662|3316001|P4|Study Period II|Adverse Event|16
1014713|NCT00337662|3316002|P3|Study Period II|Adverse Event|0
1014714|NCT00337662|3316003|P2|Study Period II|Adverse Event|0
1014715|NCT00337662|3316004|P1|Study Period II|Adverse Event|0
1014716|NCT00337662|3316001|P4|Study Period II|Withdrawal by Subject|20
1014717|NCT00337662|3316002|P3|Study Period II|Withdrawal by Subject|0
1014718|NCT00337662|3316003|P2|Study Period II|Withdrawal by Subject|0
1014719|NCT00337662|3316004|P1|Study Period II|Withdrawal by Subject|0
1014720|NCT00337662|3316001|P4|Study Period II|Lost to Follow-up|35
1014721|NCT00337662|3316002|P3|Study Period II|Lost to Follow-up|0
1014722|NCT00337662|3316003|P2|Study Period II|Lost to Follow-up|0
1014723|NCT00337662|3316004|P1|Study Period II|Lost to Follow-up|0
1014724|NCT00337610|3316058|P2|Overall Study|Withdrawal by Subject|5
1014725|NCT00337610|3316059|P1|Overall Study|Withdrawal by Subject|6
1014726|NCT00337610|3316058|P2|Overall Study|Lost to Follow-up|3
1014727|NCT00337610|3316059|P1|Overall Study|Lost to Follow-up|3
1014728|NCT00337610|3316058|P2|Overall Study|Lack of Efficacy|3
1014729|NCT00337610|3316059|P1|Overall Study|Lack of Efficacy|6
1014730|NCT00337610|3316058|P2|Overall Study|Death|1
1014731|NCT00337610|3316059|P1|Overall Study|Death|0
1014732|NCT00337610|3316058|P2|Overall Study|Adverse Event|2
1014733|NCT00337610|3316059|P1|Overall Study|Adverse Event|2
1014734|NCT00337571|3316075|P4|Overall Study|High Potassium level|1
1014735|NCT00337571|3316076|P3|Overall Study|High Potassium level|0
1014736|NCT00337571|3316077|P2|Overall Study|High Potassium level|0
1014737|NCT00337571|3316078|P1|Overall Study|High Potassium level|0
1014738|NCT00337571|3316075|P4|Overall Study|No longer met study criteria|0
1014739|NCT00337571|3316076|P3|Overall Study|No longer met study criteria|0
1014740|NCT00337571|3316077|P2|Overall Study|No longer met study criteria|0
1014741|NCT00337571|3316078|P1|Overall Study|No longer met study criteria|1
1014742|NCT00337571|3316075|P4|Overall Study|Poor/noncompliance|1
1014743|NCT00337571|3316076|P3|Overall Study|Poor/noncompliance|1
1014744|NCT00337571|3316077|P2|Overall Study|Poor/noncompliance|1
1014745|NCT00337571|3316078|P1|Overall Study|Poor/noncompliance|1
1014746|NCT00337571|3316075|P4|Overall Study|Lost to Follow-up|1
1014747|NCT00337571|3316076|P3|Overall Study|Lost to Follow-up|0
1014748|NCT00337571|3316077|P2|Overall Study|Lost to Follow-up|1
1014749|NCT00337571|3316078|P1|Overall Study|Lost to Follow-up|3
1014750|NCT00337571|3316075|P4|Overall Study|Withdrawal by Subject|0
1014751|NCT00337571|3316076|P3|Overall Study|Withdrawal by Subject|1
1014752|NCT00337571|3316077|P2|Overall Study|Withdrawal by Subject|2
1014753|NCT00337571|3316078|P1|Overall Study|Withdrawal by Subject|2
1014754|NCT00337571|3316075|P4|Overall Study|Adverse Event|4
1014755|NCT00337571|3316076|P3|Overall Study|Adverse Event|8
1014756|NCT00337571|3316077|P2|Overall Study|Adverse Event|5
1014757|NCT00337571|3316078|P1|Overall Study|Adverse Event|4
1014758|NCT00337571|3316075|P4|Overall Study|Lack of Efficacy|0
1014759|NCT00337571|3316076|P3|Overall Study|Lack of Efficacy|0
1014760|NCT00337571|3316077|P2|Overall Study|Lack of Efficacy|0
1014761|NCT00337571|3316078|P1|Overall Study|Lack of Efficacy|3
1014762|NCT00337467|3316116|P1|Overall Study|Subject No Longer Met Study Criteria|2
1014763|NCT00337467|3316116|P1|Overall Study|Lost to Follow-up|2
1014764|NCT00337467|3316116|P1|Overall Study|Pregnancy|1
1014765|NCT00337467|3316116|P1|Overall Study|Subject Withdrew Consent|2
1014766|NCT00337467|3316116|P1|Overall Study|Adverse Event|3
1014767|NCT00337428|3316135|P2|Overall Study|Anorexia|0
1014768|NCT00337428|3316136|P1|Overall Study|Anorexia|1
1014769|NCT00337428|3316135|P2|Overall Study|Unwilling to Continue|0
1014770|NCT00337428|3316136|P1|Overall Study|Unwilling to Continue|1
1014771|NCT00337428|3316135|P2|Overall Study|Lack of Time|1
1014772|NCT00337428|3316136|P1|Overall Study|Lack of Time|1
1014773|NCT00337428|3316135|P2|Overall Study|Withdrawal by Subject|2
1014774|NCT00337428|3316136|P1|Overall Study|Withdrawal by Subject|1
1014775|NCT00337285|3316187|P1|Overall Study|Lack of protocol compliance|7
1014776|NCT00337285|3316187|P1|Overall Study|Physician Decision|1
1014777|NCT00337285|3316187|P1|Overall Study|Death|1
1014778|NCT00337285|3316187|P1|Overall Study|Lack of Efficacy|11
1014779|NCT00337285|3316187|P1|Overall Study|Protocol Violation|27
1014780|NCT00337285|3316187|P1|Overall Study|Adverse Event|28
1014781|NCT00337285|3316187|P1|Overall Study|Lost to Follow-up|41
1014782|NCT00337285|3316187|P1|Overall Study|Withdrawal by Subject|42
1014783|NCT00337272|3316195|P2|Withdrawal Period|Non-compliance|1
1014784|NCT00337272|3316196|P1|Withdrawal Period|Non-compliance|0
1014785|NCT00337272|3316195|P2|Treatment Period|Withdrawal by Subject|1
1014786|NCT00337272|3316196|P1|Treatment Period|Withdrawal by Subject|0
1014787|NCT00337272|3316195|P2|Treatment Period|Non-compliance|1
1014788|NCT00337272|3316196|P1|Treatment Period|Non-compliance|1
1014789|NCT00337272|3316195|P2|Screening Period (Pre-randomization)|Screen failure|0
1014790|NCT00337272|3316196|P1|Screening Period (Pre-randomization)|Screen failure|3
1014791|NCT00337272|3316195|P2|Screening Period (Pre-randomization)|Non-compliance|0
1014792|NCT00337272|3316196|P1|Screening Period (Pre-randomization)|Non-compliance|1
1014793|NCT00337272|3316195|P2|Screening Period (Pre-randomization)|Withdrawal by Subject|0
1014794|NCT00337272|3316196|P1|Screening Period (Pre-randomization)|Withdrawal by Subject|2
1014795|NCT00337207|3316216|P1|Overall Study|Withdrawal by Subject|3
1014796|NCT00337194|3316224|P2|Overall Study|Subsequent non-protocol therapy|1
1014797|NCT00337194|3316225|P1|Overall Study|Subsequent non-protocol therapy|3
1014798|NCT00337194|3316224|P2|Overall Study|Disease progression|2
1014799|NCT00337194|3316225|P1|Overall Study|Disease progression|1
1014800|NCT00337194|3316224|P2|Overall Study|Withdrawal by Subject|0
1014801|NCT00337194|3316225|P1|Overall Study|Withdrawal by Subject|1
1014802|NCT00337194|3316224|P2|Overall Study|Death|0
1014803|NCT00337194|3316225|P1|Overall Study|Death|2
1014804|NCT00337194|3316224|P2|Overall Study|Adverse Event|1
1014805|NCT00337194|3316225|P1|Overall Study|Adverse Event|5
1014806|NCT00337168|3316249|P1|Overall Study|Did not start therapy|1
1014807|NCT00337168|3316249|P1|Overall Study|Not protocol specified|2
1014808|NCT00337168|3316249|P1|Overall Study|Death|5
1014809|NCT00337129|3316256|P1|Overall Study|not protocol specified|1
1014810|NCT00337129|3316256|P1|Overall Study|Death|2
1014811|NCT00337129|3316256|P1|Overall Study|Lack of Efficacy|32
1014812|NCT00337129|3316256|P1|Overall Study|Withdrawal by Subject|1
1014813|NCT00337129|3316256|P1|Overall Study|Adverse Event|4
1014814|NCT00337103|3316265|P2|Overall Study|Death|0
1014815|NCT00337103|3316266|P1|Overall Study|Death|1
1014816|NCT00337103|3316265|P2|Overall Study|Lost to Follow-up|2
1014817|NCT00337103|3316266|P1|Overall Study|Lost to Follow-up|1
1014818|NCT00337103|3316265|P2|Overall Study|Entry Criteria Not Met|1
1014819|NCT00337103|3316266|P1|Overall Study|Entry Criteria Not Met|4
1014820|NCT00337103|3316265|P2|Overall Study|Not specified|6
1014821|NCT00337103|3316266|P1|Overall Study|Not specified|5
1014822|NCT00337103|3316265|P2|Overall Study|Withdrawal by Subject|5
1014823|NCT00337103|3316266|P1|Overall Study|Withdrawal by Subject|8
1014824|NCT00337103|3316265|P2|Overall Study|Physician Decision|14
1014825|NCT00337103|3316266|P1|Overall Study|Physician Decision|15
1014826|NCT00337103|3316265|P2|Overall Study|Clinical Progression|24
1014827|NCT00337103|3316266|P1|Overall Study|Clinical Progression|27
1014828|NCT00337103|3316265|P2|Overall Study|Subject Choice|27
1014829|NCT00337103|3316266|P1|Overall Study|Subject Choice|34
1014830|NCT00337103|3316265|P2|Overall Study|Adverse Event|59
1014831|NCT00337103|3316266|P1|Overall Study|Adverse Event|45
1014832|NCT00337103|3316265|P2|Overall Study|Progressive Disease|405
1014833|NCT00337103|3316266|P1|Overall Study|Progressive Disease|409
1014834|NCT00337077|3316277|P3|Overall Study|Ineligible|1
1014835|NCT00337077|3316278|P2|Overall Study|Ineligible|1
1014836|NCT00337077|3316279|P1|Overall Study|Ineligible|1
1014837|NCT00337077|3316277|P3|Overall Study|Never started treatment|0
1014838|NCT00337077|3316278|P2|Overall Study|Never started treatment|1
1014839|NCT00337077|3316279|P1|Overall Study|Never started treatment|1
1014840|NCT00337077|3316277|P3|Overall Study|Physician Decision|2
1014841|NCT00337077|3316278|P2|Overall Study|Physician Decision|4
1014842|NCT00337077|3316279|P1|Overall Study|Physician Decision|1
1014843|NCT00337077|3316277|P3|Overall Study|Alternative therapy|0
1014844|NCT00337077|3316278|P2|Overall Study|Alternative therapy|0
1014845|NCT00337077|3316279|P1|Overall Study|Alternative therapy|1
1014846|NCT00337077|3316277|P3|Overall Study|Withdrawal by Subject|2
1014847|NCT00337077|3316278|P2|Overall Study|Withdrawal by Subject|2
1014848|NCT00337077|3316279|P1|Overall Study|Withdrawal by Subject|7
1014849|NCT00337077|3316277|P3|Overall Study|Death|0
1014850|NCT00337077|3316278|P2|Overall Study|Death|1
1014851|NCT00337077|3316279|P1|Overall Study|Death|0
1014852|NCT00337077|3316277|P3|Overall Study|Adverse Event|1
1014853|NCT00337077|3316278|P2|Overall Study|Adverse Event|7
1014854|NCT00337077|3316279|P1|Overall Study|Adverse Event|7
1014855|NCT00337077|3316277|P3|Overall Study|Progressive disease|19
1014856|NCT00337077|3316278|P2|Overall Study|Progressive disease|37
1014857|NCT00337077|3316279|P1|Overall Study|Progressive disease|25
1014858|NCT00336895|3316294|P1|Overall Study|screen failed|1
1014859|NCT00336895|3316294|P1|Overall Study|Physician Decision|1
1014860|NCT00336895|3316294|P1|Overall Study|nausea and upset stomach|1
1014861|NCT00336895|3316294|P1|Overall Study|diarrhea|1
1014862|NCT00336856|3316300|P1|Overall Study|Found ineligible at time of analysis|1
1014863|NCT00336856|3316300|P1|Overall Study|Withdrawal by Subject|3
1014864|NCT00336583|3316348|P1|Overall Study|Death|1
1014865|NCT00336583|3316348|P1|Overall Study|Lost to Follow-up|1
1014866|NCT00336544|3316355|P2|Overall Study|Other|5
1014867|NCT00336544|3316356|P1|Overall Study|Other|3
1014868|NCT00336544|3316355|P2|Overall Study|Withdrawal by Subject|3
1014869|NCT00336544|3316356|P1|Overall Study|Withdrawal by Subject|4
1014870|NCT00336544|3316355|P2|Overall Study|Adverse Event|9
1014871|NCT00336544|3316356|P1|Overall Study|Adverse Event|4
1014872|NCT00336544|3316355|P2|Overall Study|Lack of Efficacy|5
1014873|NCT00336544|3316356|P1|Overall Study|Lack of Efficacy|8
1014874|NCT00336505|3316370|P2|Overall Study|Other|7
1014875|NCT00336505|3316371|P1|Overall Study|Other|7
1014876|NCT00336505|3316370|P2|Overall Study|Withdrawal by Subject|3
1014877|NCT00336505|3316371|P1|Overall Study|Withdrawal by Subject|5
1014878|NCT00336505|3316370|P2|Overall Study|Lost to Follow-up|4
1014879|NCT00336505|3316371|P1|Overall Study|Lost to Follow-up|7
1014880|NCT00336505|3316370|P2|Overall Study|Lack of Efficacy|4
1014881|NCT00336505|3316371|P1|Overall Study|Lack of Efficacy|8
1014882|NCT00336505|3316370|P2|Overall Study|Adverse Event|9
1014883|NCT00336505|3316371|P1|Overall Study|Adverse Event|10
1014884|NCT00336492|3316386|P3|Overall Study|Other|1
1014885|NCT00336492|3316387|P2|Overall Study|Other|0
1014886|NCT00336492|3316388|P1|Overall Study|Other|5
1014887|NCT00336492|3316386|P3|Overall Study|Lack of Efficacy|4
1014888|NCT00336492|3316387|P2|Overall Study|Lack of Efficacy|1
1014889|NCT00336492|3316388|P1|Overall Study|Lack of Efficacy|6
1014890|NCT00336492|3316386|P3|Overall Study|Adverse Event|6
1014891|NCT00336492|3316387|P2|Overall Study|Adverse Event|3
1014892|NCT00336492|3316388|P1|Overall Study|Adverse Event|4
1014893|NCT00336479|3316400|P4|Overall Study|Virologic Stopping Rule|0
1014894|NCT00336479|3316401|P3|Overall Study|Virologic Stopping Rule|0
1014895|NCT00336479|3316402|P2|Overall Study|Virologic Stopping Rule|0
1014896|NCT00336479|3316403|P1|Overall Study|Virologic Stopping Rule|20
1014897|NCT00336479|3316400|P4|Overall Study|Other|0
1014898|NCT00336479|3316401|P3|Overall Study|Other|1
1014899|NCT00336479|3316402|P2|Overall Study|Other|0
1014900|NCT00336479|3316403|P1|Overall Study|Other|0
1014901|NCT00336479|3316400|P4|Overall Study|Withdrawal by Subject|0
1014902|NCT00336479|3316401|P3|Overall Study|Withdrawal by Subject|3
1014903|NCT00336479|3316402|P2|Overall Study|Withdrawal by Subject|2
1014904|NCT00336479|3316403|P1|Overall Study|Withdrawal by Subject|3
1014905|NCT00336479|3316400|P4|Overall Study|Lost to Follow-up|0
1014906|NCT00336479|3316401|P3|Overall Study|Lost to Follow-up|0
1014907|NCT00336479|3316402|P2|Overall Study|Lost to Follow-up|2
1014908|NCT00336479|3316403|P1|Overall Study|Lost to Follow-up|3
1014909|NCT00336479|3316400|P4|Overall Study|Physician Decision|0
1014910|NCT00336479|3316401|P3|Overall Study|Physician Decision|1
1014911|NCT00336479|3316402|P2|Overall Study|Physician Decision|3
1014912|NCT00336479|3316403|P1|Overall Study|Physician Decision|2
1014913|NCT00336479|3316400|P4|Overall Study|Noncompliant|0
1014914|NCT00336479|3316401|P3|Overall Study|Noncompliant|3
1014915|NCT00336479|3316402|P2|Overall Study|Noncompliant|7
1014916|NCT00336479|3316403|P1|Overall Study|Noncompliant|1
1014917|NCT00336479|3316400|P4|Overall Study|Adverse Event|4
1014918|NCT00336479|3316401|P3|Overall Study|Adverse Event|18
1014919|NCT00336479|3316402|P2|Overall Study|Adverse Event|11
1014920|NCT00336479|3316403|P1|Overall Study|Adverse Event|8
1014921|NCT00336284|3316492|P2|Overall Study|Withdrawal by Physician or Subject|64
1014922|NCT00336284|3316493|P1|Overall Study|Withdrawal by Physician or Subject|102
1014923|NCT00336284|3316492|P2|Overall Study|Lost to Follow-up|61
1014924|NCT00336284|3316493|P1|Overall Study|Lost to Follow-up|82
1014925|NCT00336284|3316492|P2|Overall Study|Death|26
1014926|NCT00336284|3316493|P1|Overall Study|Death|52
1014927|NCT00336024|3316511|P2|Overall Study|Ineligible|7
1014928|NCT00336024|3316512|P1|Overall Study|Ineligible|7
1014929|NCT00336024|3316511|P2|Overall Study|Progressive Disease|7
1014930|NCT00336024|3316512|P1|Overall Study|Progressive Disease|4
1014931|NCT00336024|3316511|P2|Overall Study|Failure to fulfill consolidation|1
1014932|NCT00336024|3316512|P1|Overall Study|Failure to fulfill consolidation|1
1014933|NCT00336024|3316511|P2|Overall Study|Withdrawal by Subject|2
1014934|NCT00336024|3316512|P1|Overall Study|Withdrawal by Subject|1
1014935|NCT00336024|3316511|P2|Overall Study|Protocol Violation|0
1014936|NCT00336024|3316512|P1|Overall Study|Protocol Violation|1
1014937|NCT00336024|3316511|P2|Overall Study|Physician Decision|1
1014938|NCT00336024|3316512|P1|Overall Study|Physician Decision|4
1014939|NCT00336024|3316511|P2|Overall Study|Death|1
1014940|NCT00336024|3316512|P1|Overall Study|Death|2
1014941|NCT00335972|3316546|P2|Overall Study|not given treatments|3
1014942|NCT00335972|3316547|P1|Overall Study|not given treatments|0
1014943|NCT00335959|3316557|P1|Overall Study|Ineligible|1
1014944|NCT00335959|3316557|P1|Overall Study|Adverse Event|2
1014945|NCT00335829|3316562|P1|Overall Study|Adverse Event|1
1014946|NCT00335829|3316562|P1|Overall Study|Lost to Follow-up|1
1014947|NCT00335829|3316562|P1|Overall Study|Withdrawal by Subject|1
1014948|NCT00335777|3316576|P1|Treated 2 Headaches Per Protocol|Treated 1 early and 1 late out of protoc|12
1014949|NCT00335777|3316576|P1|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1
1014950|NCT00335777|3316576|P1|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18
1014951|NCT00335777|3316576|P1|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6
1014952|NCT00335777|3316576|P1|Enrolled and Dispensed Study Medication|Lost to Follow-up|5
1014953|NCT00335764|3316586|P5|Overall Study|wrong histology|1
1014954|NCT00335764|3316587|P4|Overall Study|wrong histology|0
1014955|NCT00335764|3316588|P3|Overall Study|wrong histology|0
1014956|NCT00335764|3316589|P2|Overall Study|wrong histology|0
1014957|NCT00335764|3316590|P1|Overall Study|wrong histology|1
1014958|NCT00335738|3316639|P2|Overall Study|Ineligible|4
1014959|NCT00335738|3316640|P1|Overall Study|Ineligible|3
1014960|NCT00335738|3316639|P2|Overall Study|Withdrawal by Subject|0
1014961|NCT00335738|3316640|P1|Overall Study|Withdrawal by Subject|2
1014962|NCT00335738|3316639|P2|Overall Study|Physician Decision|0
1014963|NCT00335738|3316640|P1|Overall Study|Physician Decision|6
1014964|NCT00335556|3316672|P6|Overall Study|Refusal of further protocol therapy|0
1014965|NCT00335556|3316673|P5|Overall Study|Refusal of further protocol therapy|0
1014966|NCT00335556|3316674|P4|Overall Study|Refusal of further protocol therapy|1
1014967|NCT00335556|3316675|P3|Overall Study|Refusal of further protocol therapy|0
1014968|NCT00335556|3316676|P2|Overall Study|Refusal of further protocol therapy|4
1014969|NCT00335556|3316677|P1|Overall Study|Refusal of further protocol therapy|0
1014970|NCT00335556|3316672|P6|Overall Study|Ineligible|0
1014971|NCT00335556|3316673|P5|Overall Study|Ineligible|0
1014972|NCT00335556|3316674|P4|Overall Study|Ineligible|0
1014973|NCT00335556|3316675|P3|Overall Study|Ineligible|0
1014974|NCT00335556|3316676|P2|Overall Study|Ineligible|0
1014975|NCT00335556|3316677|P1|Overall Study|Ineligible|2
1014976|NCT00335556|3316672|P6|Overall Study|Physician Decision|0
1014977|NCT00335556|3316673|P5|Overall Study|Physician Decision|0
1014978|NCT00335556|3316674|P4|Overall Study|Physician Decision|1
1014979|NCT00335556|3316675|P3|Overall Study|Physician Decision|2
1014980|NCT00335556|3316676|P2|Overall Study|Physician Decision|6
1014981|NCT00335556|3316677|P1|Overall Study|Physician Decision|0
1014982|NCT00335556|3316672|P6|Overall Study|Lack of Efficacy|1
1014983|NCT00335556|3316673|P5|Overall Study|Lack of Efficacy|0
1014984|NCT00335556|3316674|P4|Overall Study|Lack of Efficacy|3
1014985|NCT00335556|3316675|P3|Overall Study|Lack of Efficacy|3
1014986|NCT00335556|3316676|P2|Overall Study|Lack of Efficacy|19
1014987|NCT00335556|3316677|P1|Overall Study|Lack of Efficacy|0
1014988|NCT00335556|3316672|P6|Overall Study|Death|0
1014989|NCT00335556|3316673|P5|Overall Study|Death|1
1014990|NCT00335556|3316674|P4|Overall Study|Death|0
1014991|NCT00335556|3316675|P3|Overall Study|Death|0
1014992|NCT00335556|3316676|P2|Overall Study|Death|5
1014993|NCT00335556|3316677|P1|Overall Study|Death|0
1014994|NCT00335452|3316739|P4|Overall Study|Lost to Follow-up|2
1014995|NCT00335452|3316740|P3|Overall Study|Lost to Follow-up|1
1014996|NCT00335452|3316741|P2|Overall Study|Lost to Follow-up|3
1014997|NCT00335452|3316742|P1|Overall Study|Lost to Follow-up|2
1014998|NCT00335452|3316739|P4|Overall Study|Death|129
1014999|NCT00335452|3316740|P3|Overall Study|Death|158
1015000|NCT00335452|3316741|P2|Overall Study|Death|144
1015001|NCT00335452|3316742|P1|Overall Study|Death|156
1015002|NCT00335322|3316767|P3|Overall Study|Randomised but withdrew prior to ART sta|2
1015003|NCT00335322|3316768|P2|Overall Study|Randomised but withdrew prior to ART sta|2
1015004|NCT00335322|3316769|P1|Overall Study|Randomised but withdrew prior to ART sta|1
1015005|NCT00335153|3316814|P1|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2
1015006|NCT00335153|3316814|P1|Post-PEG-J Long-Term Treatment Period|Administrative|13
1015007|NCT00335153|3316814|P1|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13
1015008|NCT00335153|3316814|P1|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2
1015009|NCT00335153|3316814|P1|Post-PEG-J Long-Term Treatment Period|Adverse Event|22
1015010|NCT00335153|3316814|P1|Nasojejunal (NJ) Test Period|Protocol Violation|7
1015011|NCT00335153|3316814|P1|Nasojejunal (NJ) Test Period|Administrative|1
1015012|NCT00335153|3316814|P1|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12
1015013|NCT00335153|3316814|P1|Nasojejunal (NJ) Test Period|Lack of Efficacy|5
1015014|NCT00335153|3316814|P1|Nasojejunal (NJ) Test Period|Adverse Event|5
1015015|NCT00335140|3316851|P1|Overall Study|Ineligible|1
1015016|NCT00334958|3316857|P2|Overall Study|Not specified|2
1015017|NCT00334958|3316858|P1|Overall Study|Not specified|1
1015018|NCT00334958|3316857|P2|Overall Study|Adverse Event|12
1015019|NCT00334958|3316858|P1|Overall Study|Adverse Event|27
1015020|NCT00334958|3316857|P2|Overall Study|Withdrawal by Subject|4
1015021|NCT00334958|3316858|P1|Overall Study|Withdrawal by Subject|7
1015022|NCT00334958|3316857|P2|Overall Study|Request of the investigator or sponsor|1
1015023|NCT00334958|3316858|P1|Overall Study|Request of the investigator or sponsor|0
1015024|NCT00334958|3316857|P2|Overall Study|Protocol Violation|2
1015025|NCT00334958|3316858|P1|Overall Study|Protocol Violation|2
1015026|NCT00334958|3316857|P2|Overall Study|Medication Noncompliance|3
1015027|NCT00334958|3316858|P1|Overall Study|Medication Noncompliance|0
1015028|NCT00334893|3316872|P2|Overall Study|Not Treated|0
1015029|NCT00334893|3316873|P1|Overall Study|Not Treated|1
1015030|NCT00334815|3316883|P2|Overall Study|Physician Decision|4
1015031|NCT00334815|3316884|P1|Overall Study|Physician Decision|2
1015032|NCT00334815|3316883|P2|Overall Study|patient refused treatment|1
1015033|NCT00334815|3316884|P1|Overall Study|patient refused treatment|0
1015034|NCT00334815|3316883|P2|Overall Study|ineligible|1
1015035|NCT00334815|3316884|P1|Overall Study|ineligible|1
1015036|NCT00334815|3316883|P2|Overall Study|Progression|0
1015037|NCT00334815|3316884|P1|Overall Study|Progression|1
1015038|NCT00334815|3316883|P2|Overall Study|Death|2
1015039|NCT00334815|3316884|P1|Overall Study|Death|0
1015040|NCT00334815|3316883|P2|Overall Study|Adverse Event|2
1015041|NCT00334815|3316884|P1|Overall Study|Adverse Event|3
1015042|NCT00334802|3316898|P2|Overall Study|Criteria for Starting Next Cycle Not Met|1
1015043|NCT00334802|3316899|P1|Overall Study|Criteria for Starting Next Cycle Not Met|0
1015044|NCT00334802|3316898|P2|Overall Study|Adverse Event|3
1015045|NCT00334802|3316899|P1|Overall Study|Adverse Event|0
1015046|NCT00334802|3316898|P2|Overall Study|Withdrawal by Subject|4
1015047|NCT00334802|3316899|P1|Overall Study|Withdrawal by Subject|0
1015048|NCT00334802|3316898|P2|Overall Study|Physician Decision|0
1015049|NCT00334802|3316899|P1|Overall Study|Physician Decision|1
1015050|NCT00334802|3316898|P2|Overall Study|Patient Condition Aggrevated|0
1015051|NCT00334802|3316899|P1|Overall Study|Patient Condition Aggrevated|1
1015052|NCT00334802|3316898|P2|Overall Study|Lack of Efficacy|3
1015053|NCT00334802|3316899|P1|Overall Study|Lack of Efficacy|1
1015054|NCT00334802|3316898|P2|Overall Study|Toxicity|5
1015055|NCT00334802|3316899|P1|Overall Study|Toxicity|1
1015056|NCT00334802|3316898|P2|Overall Study|Progressive Disease|24
1015057|NCT00334802|3316899|P1|Overall Study|Progressive Disease|2
1015058|NCT00334542|3316932|P1|Overall Study|New cancer diagnosis|1
1015059|NCT00334542|3316932|P1|Overall Study|Withdrawal by Subject|1
1015060|NCT00334542|3316932|P1|Overall Study|Adverse Event|3
1015061|NCT00334295|3316937|P1|Overall Study|Patients received fewer than 3 injection|5
1015062|NCT00334282|3316947|P2|Overall Study|Death|100
1015063|NCT00334282|3316948|P1|Overall Study|Death|194
1015064|NCT00334282|3316947|P2|Overall Study|Withdrawal by Subject|3
1015065|NCT00334282|3316948|P1|Overall Study|Withdrawal by Subject|17
1015066|NCT00334282|3316947|P2|Overall Study|Lost to Follow-up|5
1015067|NCT00334282|3316948|P1|Overall Study|Lost to Follow-up|11
1015068|NCT00334113|3316979|P2|Overall Study|Withdrawal by Subject|1
1015069|NCT00334113|3316980|P1|Overall Study|Withdrawal by Subject|0
1015070|NCT00334113|3316979|P2|Overall Study|Lost to Follow-up|2
1015071|NCT00334113|3316980|P1|Overall Study|Lost to Follow-up|2
1015072|NCT00333983|3317003|P3|Overall Study|Withdrawal by Subject|1
1015073|NCT00333983|3317004|P2|Overall Study|Withdrawal by Subject|3
1015074|NCT00333983|3317005|P1|Overall Study|Withdrawal by Subject|0
1015075|NCT00333983|3317003|P3|Overall Study|Adverse Event|1
1015076|NCT00333983|3317004|P2|Overall Study|Adverse Event|1
1015077|NCT00333983|3317005|P1|Overall Study|Adverse Event|1
1015078|NCT00333983|3317003|P3|Overall Study|Lost to Follow-up|0
1015079|NCT00333983|3317004|P2|Overall Study|Lost to Follow-up|1
1015080|NCT00333983|3317005|P1|Overall Study|Lost to Follow-up|2
1015081|NCT00333970|3317015|P2|Overall Study|Withdrawal by Subject|7
1015082|NCT00333970|3317016|P1|Overall Study|Withdrawal by Subject|13
1015083|NCT00333866|3317031|P4|Overall Study|Randomized but not Treated|1
1015084|NCT00333866|3317032|P3|Overall Study|Randomized but not Treated|2
1015085|NCT00333866|3317033|P2|Overall Study|Randomized but not Treated|3
1015086|NCT00333866|3317034|P1|Overall Study|Randomized but not Treated|5
1015087|NCT00333866|3317031|P4|Overall Study|Withdrawal by Subject|9
1015088|NCT00333866|3317032|P3|Overall Study|Withdrawal by Subject|4
1015089|NCT00333866|3317033|P2|Overall Study|Withdrawal by Subject|14
1015090|NCT00333866|3317034|P1|Overall Study|Withdrawal by Subject|8
1015091|NCT00333866|3317031|P4|Overall Study|Lost to Follow-up|2
1015092|NCT00333866|3317032|P3|Overall Study|Lost to Follow-up|2
1015093|NCT00333866|3317033|P2|Overall Study|Lost to Follow-up|2
1015094|NCT00333866|3317034|P1|Overall Study|Lost to Follow-up|1
1015095|NCT00333866|3317031|P4|Overall Study|Lack of Efficacy|5
1015096|NCT00333866|3317032|P3|Overall Study|Lack of Efficacy|3
1015097|NCT00333866|3317033|P2|Overall Study|Lack of Efficacy|6
1015098|NCT00333866|3317034|P1|Overall Study|Lack of Efficacy|8
1015099|NCT00333866|3317031|P4|Overall Study|Other|2
1015100|NCT00333866|3317032|P3|Overall Study|Other|2
1015101|NCT00333866|3317033|P2|Overall Study|Other|2
1015102|NCT00333866|3317034|P1|Overall Study|Other|3
1015103|NCT00333866|3317031|P4|Overall Study|Adverse Event|47
1015104|NCT00333866|3317032|P3|Overall Study|Adverse Event|38
1015105|NCT00333866|3317033|P2|Overall Study|Adverse Event|37
1015106|NCT00333866|3317034|P1|Overall Study|Adverse Event|23
1015107|NCT00333840|3317094|P4|Second-line Treatment Period|Death|9
1015108|NCT00333840|3317095|P3|Second-line Treatment Period|Death|0
1015109|NCT00333840|3317096|P2|Second-line Treatment Period|Death|0
1015110|NCT00333840|3317097|P1|Second-line Treatment Period|Death|0
1015111|NCT00333840|3317094|P4|Second-line Treatment Period|Administrative problems|7
1015112|NCT00333840|3317095|P3|Second-line Treatment Period|Administrative problems|0
1015113|NCT00333840|3317096|P2|Second-line Treatment Period|Administrative problems|0
1015114|NCT00333840|3317097|P1|Second-line Treatment Period|Administrative problems|0
1015115|NCT00333840|3317094|P4|Second-line Treatment Period|Lost to Follow-up|6
1015116|NCT00333840|3317095|P3|Second-line Treatment Period|Lost to Follow-up|0
1015117|NCT00333840|3317096|P2|Second-line Treatment Period|Lost to Follow-up|0
1015118|NCT00333840|3317097|P1|Second-line Treatment Period|Lost to Follow-up|0
1015119|NCT00333840|3317094|P4|Second-line Treatment Period|Subject withdrew consent|34
1015120|NCT00333840|3317095|P3|Second-line Treatment Period|Subject withdrew consent|0
1015121|NCT00333840|3317096|P2|Second-line Treatment Period|Subject withdrew consent|0
1015122|NCT00333840|3317097|P1|Second-line Treatment Period|Subject withdrew consent|0
1015123|NCT00333840|3317094|P4|Second-line Treatment Period|Protocol Violation|10
1015124|NCT00333840|3317095|P3|Second-line Treatment Period|Protocol Violation|1
1015125|NCT00333840|3317096|P2|Second-line Treatment Period|Protocol Violation|0
1015126|NCT00333840|3317097|P1|Second-line Treatment Period|Protocol Violation|0
1015127|NCT00333840|3317094|P4|Second-line Treatment Period|No longer required study drug|14
1015128|NCT00333840|3317095|P3|Second-line Treatment Period|No longer required study drug|1
1015129|NCT00333840|3317096|P2|Second-line Treatment Period|No longer required study drug|0
1015130|NCT00333840|3317097|P1|Second-line Treatment Period|No longer required study drug|0
1015131|NCT00333840|3317094|P4|Second-line Treatment Period|Unsatisfactory therapeutic effect|70
1015132|NCT00333840|3317095|P3|Second-line Treatment Period|Unsatisfactory therapeutic effect|9
1015133|NCT00333840|3317096|P2|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
1015134|NCT00333840|3317097|P1|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
1015135|NCT00333840|3317094|P4|Second-line Treatment Period|Abnormal procedure|1
1015136|NCT00333840|3317095|P3|Second-line Treatment Period|Abnormal procedure|0
1015137|NCT00333840|3317096|P2|Second-line Treatment Period|Abnormal procedure|0
1015138|NCT00333840|3317097|P1|Second-line Treatment Period|Abnormal procedure|0
1015139|NCT00333840|3317094|P4|Second-line Treatment Period|Abnormal Laboratory Values|3
1015140|NCT00333840|3317095|P3|Second-line Treatment Period|Abnormal Laboratory Values|0
1015141|NCT00333840|3317096|P2|Second-line Treatment Period|Abnormal Laboratory Values|0
1015142|NCT00333840|3317097|P1|Second-line Treatment Period|Abnormal Laboratory Values|0
1015143|NCT00333840|3317094|P4|Second-line Treatment Period|Adverse Event|34
1015144|NCT00333840|3317095|P3|Second-line Treatment Period|Adverse Event|3
1015145|NCT00333840|3317096|P2|Second-line Treatment Period|Adverse Event|0
1015146|NCT00333840|3317097|P1|Second-line Treatment Period|Adverse Event|0
1015147|NCT00333840|3317094|P4|First-line Treatment Period|Crossed over to other treatment arm|0
1015148|NCT00333840|3317095|P3|First-line Treatment Period|Crossed over to other treatment arm|0
1015149|NCT00333840|3317096|P2|First-line Treatment Period|Crossed over to other treatment arm|363
1015150|NCT00333840|3317097|P1|First-line Treatment Period|Crossed over to other treatment arm|14
1015151|NCT00333840|3317094|P4|First-line Treatment Period|Death|0
1015152|NCT00333840|3317095|P3|First-line Treatment Period|Death|0
1015153|NCT00333840|3317096|P2|First-line Treatment Period|Death|2
1015154|NCT00333840|3317097|P1|First-line Treatment Period|Death|19
1015155|NCT00333840|3317094|P4|First-line Treatment Period|Administrative problems|0
1015156|NCT00333840|3317095|P3|First-line Treatment Period|Administrative problems|0
1015157|NCT00333840|3317096|P2|First-line Treatment Period|Administrative problems|6
1015158|NCT00333840|3317097|P1|First-line Treatment Period|Administrative problems|12
1015159|NCT00333840|3317094|P4|First-line Treatment Period|Lost to Follow-up|0
1015160|NCT00333840|3317095|P3|First-line Treatment Period|Lost to Follow-up|0
1015161|NCT00333840|3317096|P2|First-line Treatment Period|Lost to Follow-up|6
1015162|NCT00333840|3317097|P1|First-line Treatment Period|Lost to Follow-up|15
1015163|NCT00333840|3317094|P4|First-line Treatment Period|Subject withdrew consent|0
1015164|NCT00333840|3317095|P3|First-line Treatment Period|Subject withdrew consent|0
1015165|NCT00333840|3317096|P2|First-line Treatment Period|Subject withdrew consent|77
1015166|NCT00333840|3317097|P1|First-line Treatment Period|Subject withdrew consent|57
1015167|NCT00333840|3317094|P4|First-line Treatment Period|Protocol Violation|0
1015168|NCT00333840|3317095|P3|First-line Treatment Period|Protocol Violation|0
1015169|NCT00333840|3317096|P2|First-line Treatment Period|Protocol Violation|17
1015170|NCT00333840|3317097|P1|First-line Treatment Period|Protocol Violation|17
1015171|NCT00333840|3317094|P4|First-line Treatment Period|No longer required study drug|0
1015172|NCT00333840|3317095|P3|First-line Treatment Period|No longer required study drug|0
1015173|NCT00333840|3317096|P2|First-line Treatment Period|No longer required study drug|8
1015174|NCT00333840|3317097|P1|First-line Treatment Period|No longer required study drug|21
1015175|NCT00333840|3317094|P4|First-line Treatment Period|Unsatisfactory therapeutic effect|0
1015176|NCT00333840|3317095|P3|First-line Treatment Period|Unsatisfactory therapeutic effect|0
1015177|NCT00333840|3317096|P2|First-line Treatment Period|Unsatisfactory therapeutic effect|29
1015178|NCT00333840|3317097|P1|First-line Treatment Period|Unsatisfactory therapeutic effect|88
1015179|NCT00333840|3317094|P4|First-line Treatment Period|Abnormal procedure|0
1015180|NCT00333840|3317095|P3|First-line Treatment Period|Abnormal procedure|0
1015181|NCT00333840|3317096|P2|First-line Treatment Period|Abnormal procedure|0
1015182|NCT00333840|3317097|P1|First-line Treatment Period|Abnormal procedure|2
1015183|NCT00333840|3317094|P4|First-line Treatment Period|Abnormal laboratory values|0
1015184|NCT00333840|3317095|P3|First-line Treatment Period|Abnormal laboratory values|0
1015185|NCT00333840|3317096|P2|First-line Treatment Period|Abnormal laboratory values|1
1015186|NCT00333840|3317097|P1|First-line Treatment Period|Abnormal laboratory values|3
1015187|NCT00333840|3317094|P4|First-line Treatment Period|Adverse Event|0
1015188|NCT00333840|3317095|P3|First-line Treatment Period|Adverse Event|0
1015189|NCT00333840|3317096|P2|First-line Treatment Period|Adverse Event|37
1015190|NCT00333840|3317097|P1|First-line Treatment Period|Adverse Event|38
1015191|NCT00333801|3317143|P2|Overall Study|Withdrawal by Subject|1
1015192|NCT00333801|3317144|P1|Overall Study|Withdrawal by Subject|0
1015193|NCT00333801|3317143|P2|Overall Study|Incarcerated|2
1015194|NCT00333801|3317144|P1|Overall Study|Incarcerated|1
1015195|NCT00333801|3317143|P2|Overall Study|Lost to Follow-up|0
1015196|NCT00333801|3317144|P1|Overall Study|Lost to Follow-up|2
1015197|NCT00333801|3317143|P2|Overall Study|Moved to another state|3
1015198|NCT00333801|3317144|P1|Overall Study|Moved to another state|5
1015199|NCT00333788|3317162|P1|Overall Study|Other: Signed consent for another study|1
1015200|NCT00333788|3317162|P1|Overall Study|Other: Physician decision|1
1015201|NCT00333788|3317162|P1|Overall Study|Other: Medical monitor decision|1
1015202|NCT00333788|3317162|P1|Overall Study|Other: Subject in need of an Entocort|1
1015203|NCT00333788|3317162|P1|Overall Study|Other: Sponsor decision|1
1015204|NCT00333788|3317162|P1|Overall Study|Other: Quality of life concern|1
1015205|NCT00333788|3317162|P1|Overall Study|Other: Investigator decision|1
1015206|NCT00333788|3317162|P1|Overall Study|Other: Recurrent squamaous cell cancer|1
1015207|NCT00333788|3317162|P1|Overall Study|Other: Moved|2
1015208|NCT00333788|3317162|P1|Overall Study|Other: Non-compliance|2
1015209|NCT00333788|3317162|P1|Overall Study|Withdrawal by Subject|24
1015210|NCT00333788|3317162|P1|Overall Study|Lost to Follow-up|2
1015211|NCT00333788|3317162|P1|Overall Study|Lack of Efficacy|80
1015212|NCT00333788|3317162|P1|Overall Study|Adverse Event|44
1015213|NCT00333775|3317192|P3|Overall Study|Lost to Follow-up|8
1015214|NCT00333775|3317193|P2|Overall Study|Lost to Follow-up|7
1015215|NCT00333775|3317194|P1|Overall Study|Lost to Follow-up|10
1015216|NCT00333775|3317192|P3|Overall Study|In Follow−up When Study Stopped|96
1015217|NCT00333775|3317193|P2|Overall Study|In Follow−up When Study Stopped|92
1015218|NCT00333775|3317194|P1|Overall Study|In Follow−up When Study Stopped|87
1015219|NCT00333775|3317192|P3|Overall Study|Death|143
1015220|NCT00333775|3317193|P2|Overall Study|Death|149
1015221|NCT00333775|3317194|P1|Overall Study|Death|144
1015222|NCT00333619|3317233|P2|Overall Study|Lost to Follow-up|3
1015223|NCT00333619|3317234|P1|Overall Study|Lost to Follow-up|3
1015224|NCT00333619|3317233|P2|Overall Study|Withdrawal by Subject|1
1015225|NCT00333619|3317234|P1|Overall Study|Withdrawal by Subject|6
1015226|NCT00333619|3317233|P2|Overall Study|Death|6
1015227|NCT00333619|3317234|P1|Overall Study|Death|12
1015228|NCT00333359|3317252|P2|Overall Study|Withdrew before Receiving One Dose|6
1015229|NCT00333359|3317253|P1|Overall Study|Withdrew before Receiving One Dose|2
1015230|NCT00333359|3317252|P2|Overall Study|Treatment Failure|8
1015231|NCT00333359|3317253|P1|Overall Study|Treatment Failure|3
1015232|NCT00333359|3317252|P2|Overall Study|Termination or Withdrawal by Sponsor|1
1015233|NCT00333359|3317253|P1|Overall Study|Termination or Withdrawal by Sponsor|1
1015234|NCT00333359|3317252|P2|Overall Study|Lost to Follow-up|25
1015235|NCT00333359|3317253|P1|Overall Study|Lost to Follow-up|15
1015236|NCT00333359|3317252|P2|Overall Study|Protocol Non-compliance|8
1015237|NCT00333359|3317253|P1|Overall Study|Protocol Non-compliance|2
1015238|NCT00333359|3317252|P2|Overall Study|Physician Decision|2
1015239|NCT00333359|3317253|P1|Overall Study|Physician Decision|2
1015240|NCT00333359|3317252|P2|Overall Study|Withdrawal by Subject|37
1015241|NCT00333359|3317253|P1|Overall Study|Withdrawal by Subject|19
1015242|NCT00333359|3317252|P2|Overall Study|Adverse Event|35
1015243|NCT00333359|3317253|P1|Overall Study|Adverse Event|29
1015244|NCT00333229|3317296|P2|Overall Study|Lack of Efficacy|1
1015245|NCT00333229|3317297|P1|Overall Study|Lack of Efficacy|0
1015246|NCT00333138|3317314|P3|Extension Study (Month6 to End of Study)|Death|0
1015247|NCT00333138|3317315|P2|Extension Study (Month6 to End of Study)|Death|1
1015248|NCT00333138|3317316|P1|Extension Study (Month6 to End of Study)|Death|0
1015249|NCT00333138|3317314|P3|Extension Study (Month6 to End of Study)|Lost to Follow-up|0
1015250|NCT00333138|3317315|P2|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
1015251|NCT00333138|3317316|P1|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
1015252|NCT00333138|3317314|P3|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0
1015253|NCT00333138|3317315|P2|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1
1015254|NCT00333138|3317316|P1|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2
1015255|NCT00333138|3317314|P3|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
1015256|NCT00333138|3317315|P2|Extension Study (Month6 to End of Study)|Lack of Efficacy|4
1015257|NCT00333138|3317316|P1|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
1015258|NCT00333138|3317314|P3|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
1015259|NCT00333138|3317315|P2|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13
1015260|NCT00333138|3317316|P1|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
1015261|NCT00333138|3317314|P3|Extension Study (Month6 to End of Study)|Protocol Violation|3
1015262|NCT00333138|3317315|P2|Extension Study (Month6 to End of Study)|Protocol Violation|0
1015263|NCT00333138|3317316|P1|Extension Study (Month6 to End of Study)|Protocol Violation|0
1015264|NCT00333138|3317314|P3|Extension Study (Month6 to End of Study)|Adverse Event|15
1015265|NCT00333138|3317315|P2|Extension Study (Month6 to End of Study)|Adverse Event|19
1015266|NCT00333138|3317316|P1|Extension Study (Month6 to End of Study)|Adverse Event|15
1015267|NCT00333138|3317314|P3|Extension Study (Month6 to End of Study)|Administrative problems|2
1015268|NCT00333138|3317315|P2|Extension Study (Month6 to End of Study)|Administrative problems|1
1015269|NCT00333138|3317316|P1|Extension Study (Month6 to End of Study)|Administrative problems|1
1015270|NCT00333138|3317314|P3|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
1015271|NCT00333138|3317315|P2|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
1015272|NCT00333138|3317316|P1|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3
1015273|NCT00333138|3317314|P3|Core Study (6 Months)|Laboratory abnormality|1
1015274|NCT00333138|3317315|P2|Core Study (6 Months)|Laboratory abnormality|0
1015275|NCT00333138|3317316|P1|Core Study (6 Months)|Laboratory abnormality|0
1015276|NCT00333138|3317314|P3|Core Study (6 Months)|Protocol Violation|1
1015277|NCT00333138|3317315|P2|Core Study (6 Months)|Protocol Violation|0
1015278|NCT00333138|3317316|P1|Core Study (6 Months)|Protocol Violation|1
1015279|NCT00333138|3317314|P3|Core Study (6 Months)|Lack of Efficacy|0
1015280|NCT00333138|3317315|P2|Core Study (6 Months)|Lack of Efficacy|0
1015281|NCT00333138|3317316|P1|Core Study (6 Months)|Lack of Efficacy|1
1015282|NCT00333138|3317314|P3|Core Study (6 Months)|Withdrawal by Subject|2
1015283|NCT00333138|3317315|P2|Core Study (6 Months)|Withdrawal by Subject|1
1015284|NCT00333138|3317316|P1|Core Study (6 Months)|Withdrawal by Subject|1
1015285|NCT00333138|3317314|P3|Core Study (6 Months)|Adverse Event|8
1015286|NCT00333138|3317315|P2|Core Study (6 Months)|Adverse Event|5
1015287|NCT00333138|3317316|P1|Core Study (6 Months)|Adverse Event|4
1015288|NCT00332839|3317355|P2|Follow-up (Months 12 - 60)|Death|1
1015289|NCT00332839|3317356|P1|Follow-up (Months 12 - 60)|Death|1
1015290|NCT00332839|3317355|P2|Follow-up (Months 12 - 60)|Lost to Follow-up|1
1015291|NCT00332839|3317356|P1|Follow-up (Months 12 - 60)|Lost to Follow-up|2
1015292|NCT00332839|3317355|P2|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
1015293|NCT00332839|3317356|P1|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
1015294|NCT00332839|3317355|P2|Core (Months 0 - 12)|Adverse Event|15
1015295|NCT00332839|3317356|P1|Core (Months 0 - 12)|Adverse Event|5
1015296|NCT00332839|3317355|P2|Core (Months 0 - 12)|Protocol deviation|1
1015297|NCT00332839|3317356|P1|Core (Months 0 - 12)|Protocol deviation|1
1015298|NCT00332839|3317355|P2|Core (Months 0 - 12)|Withdrawal by Subject|1
1015299|NCT00332839|3317356|P1|Core (Months 0 - 12)|Withdrawal by Subject|3
1015300|NCT00332839|3317355|P2|Core (Months 0 - 12)|Administrative problems|1
1015301|NCT00332839|3317356|P1|Core (Months 0 - 12)|Administrative problems|1
1015302|NCT00332709|3317387|P2|Overall Study|Abnormal test procedure result|0
1015303|NCT00332709|3317388|P1|Overall Study|Abnormal test procedure result|1
1015304|NCT00332709|3317387|P2|Overall Study|Administrative Problems|3
1015305|NCT00332709|3317388|P1|Overall Study|Administrative Problems|0
1015306|NCT00332709|3317387|P2|Overall Study|Lost to Follow-up|0
1015307|NCT00332709|3317388|P1|Overall Study|Lost to Follow-up|2
1015308|NCT00332709|3317387|P2|Overall Study|Withdrawal by Subject|3
1015309|NCT00332709|3317388|P1|Overall Study|Withdrawal by Subject|2
1015310|NCT00332709|3317387|P2|Overall Study|Adverse Event|14
1015311|NCT00332709|3317388|P1|Overall Study|Adverse Event|11
1015312|NCT00332696|3317412|P2|Overall Study|Withdrawal by Subject|0
1015313|NCT00332696|3317413|P1|Overall Study|Withdrawal by Subject|1
1015314|NCT00332696|3317412|P2|Overall Study|Lost to Follow-up|1
1015315|NCT00332696|3317413|P1|Overall Study|Lost to Follow-up|0
1015316|NCT00332696|3317412|P2|Overall Study|Condition does not justify treatment|2
1015317|NCT00332696|3317413|P1|Overall Study|Condition does not justify treatment|0
1015318|NCT00332696|3317412|P2|Overall Study|Adverse Event|2
1015319|NCT00332696|3317413|P1|Overall Study|Adverse Event|1
1015320|NCT00332696|3317412|P2|Overall Study|Insufficient therapeutic effect|11
1015321|NCT00332696|3317413|P1|Overall Study|Insufficient therapeutic effect|4
1015322|NCT00332696|3317412|P2|Overall Study|Death|14
1015323|NCT00332696|3317413|P1|Overall Study|Death|24
1015324|NCT00332488|3317489|P3|Transfer Treatment Phase (Weeks 12 – 24)|Various|5
1015325|NCT00332488|3317490|P2|Transfer Treatment Phase (Weeks 12 – 24)|Various|0
1015326|NCT00332488|3317491|P1|Transfer Treatment Phase (Weeks 12 – 24)|Various|0
1015327|NCT00332488|3317489|P3|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|8
1015328|NCT00332488|3317490|P2|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|2
1015329|NCT00332488|3317491|P1|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|2
1015330|NCT00332488|3317489|P3|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|1
1015331|NCT00332488|3317490|P2|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|0
1015332|NCT00332488|3317491|P1|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|0
1015333|NCT00332488|3317489|P3|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|3
1015334|NCT00332488|3317490|P2|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|0
1015335|NCT00332488|3317491|P1|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|0
1015336|NCT00332488|3317489|P3|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|1
1015337|NCT00332488|3317490|P2|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|0
1015338|NCT00332488|3317491|P1|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|0
1015339|NCT00332488|3317489|P3|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|3
1015340|NCT00332488|3317490|P2|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|0
1015341|NCT00332488|3317491|P1|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|0
1015342|NCT00332488|3317489|P3|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0
1015343|NCT00332488|3317490|P2|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1
1015344|NCT00332488|3317491|P1|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3
1015345|NCT00332488|3317489|P3|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0
1015346|NCT00332488|3317490|P2|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3
1015347|NCT00332488|3317491|P1|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1
1015348|NCT00332488|3317489|P3|Initial Treatment Phase (Weeks 0 - 12)|Various|20
1015349|NCT00332488|3317490|P2|Initial Treatment Phase (Weeks 0 - 12)|Various|0
1015350|NCT00332488|3317491|P1|Initial Treatment Phase (Weeks 0 - 12)|Various|4
1015351|NCT00332488|3317489|P3|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20
1015352|NCT00332488|3317490|P2|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10
1015353|NCT00332488|3317491|P1|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21
1015354|NCT00332488|3317489|P3|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10
1015355|NCT00332488|3317490|P2|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2
1015356|NCT00332488|3317491|P1|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13
1015357|NCT00332488|3317489|P3|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6
1015358|NCT00332488|3317490|P2|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2
1015359|NCT00332488|3317491|P1|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8
1015360|NCT00332462|3317503|P1|Overall Study|Graft Loss|2
1015361|NCT00332462|3317503|P1|Overall Study|Death|3
1015362|NCT00332462|3317503|P1|Overall Study|no longer requires study drug|1
1015363|NCT00332462|3317503|P1|Overall Study|Unsatisfactory therapeutic effect|4
1015364|NCT00332462|3317503|P1|Overall Study|Abnormal Lab Value|1
1015365|NCT00332462|3317503|P1|Overall Study|Adverse Event|5
1015366|NCT00332332|3317510|P1|Overall Study|Did not receive study treatment|16
1015367|NCT00332332|3317510|P1|Overall Study|Not specified|18
1015368|NCT00332332|3317510|P1|Overall Study|Disease progression|2
1015369|NCT00332332|3317510|P1|Overall Study|Noncompliance|2
1015370|NCT00332332|3317510|P1|Overall Study|Protocol deviation|4
1015371|NCT00332332|3317510|P1|Overall Study|Lost to Follow-up|3
1015372|NCT00332332|3317510|P1|Overall Study|Physician Decision|1
1015373|NCT00332332|3317510|P1|Overall Study|Withdrawal by Subject|8
1015374|NCT00332332|3317510|P1|Overall Study|Death|1
1015375|NCT00332332|3317510|P1|Overall Study|Adverse Event|13
1015376|NCT00332241|3317519|P2|Overall Study|Lost to Follow-up|1
1015377|NCT00332241|3317520|P1|Overall Study|Lost to Follow-up|4
1015378|NCT00332241|3317519|P2|Overall Study|Withdrawal by Subject|1
1015379|NCT00332241|3317520|P1|Overall Study|Withdrawal by Subject|2
1015380|NCT00332241|3317519|P2|Overall Study|Adverse Event|5
1015381|NCT00332241|3317520|P1|Overall Study|Adverse Event|3
1015382|NCT00332241|3317519|P2|Overall Study|Lack of Efficacy|1
1015383|NCT00332241|3317520|P1|Overall Study|Lack of Efficacy|6
1015384|NCT00332202|3317542|P2|Overall Study|Death|2
1015385|NCT00332202|3317543|P1|Overall Study|Death|5
1015386|NCT00332202|3317542|P2|Overall Study|Progressive Disease|60
1015387|NCT00332202|3317543|P1|Overall Study|Progressive Disease|106
1015388|NCT00332202|3317542|P2|Overall Study|Withdrawal by Subject|17
1015389|NCT00332202|3317543|P1|Overall Study|Withdrawal by Subject|36
1015390|NCT00332202|3317542|P2|Overall Study|Sponsor Decision|2
1015391|NCT00332202|3317543|P1|Overall Study|Sponsor Decision|1
1015392|NCT00332202|3317542|P2|Overall Study|Protocol Violation|2
1015393|NCT00332202|3317543|P1|Overall Study|Protocol Violation|7
1015394|NCT00332202|3317542|P2|Overall Study|Protocol Entry Criteria Not Met|5
1015395|NCT00332202|3317543|P1|Overall Study|Protocol Entry Criteria Not Met|6
1015396|NCT00332202|3317542|P2|Overall Study|Physician Decision|8
1015397|NCT00332202|3317543|P1|Overall Study|Physician Decision|6
1015398|NCT00332202|3317542|P2|Overall Study|Lost to Follow-up|1
1015399|NCT00332202|3317543|P1|Overall Study|Lost to Follow-up|2
1015400|NCT00332202|3317542|P2|Overall Study|Adverse Event|28
1015401|NCT00332202|3317543|P1|Overall Study|Adverse Event|72
1015402|NCT00332189|3317572|P1|Overall Study|Moved out of country|2
1015403|NCT00332189|3317572|P1|Overall Study|Lack of Efficacy|4
1015404|NCT00332189|3317572|P1|Overall Study|Withdrawal by Subject|9
1015405|NCT00332189|3317572|P1|Overall Study|Uncooperative/Noncompliant|3
1015406|NCT00332189|3317572|P1|Overall Study|Adverse Event|3
1015407|NCT00331864|3317614|P2|Overall Study|Death|0
1015408|NCT00331864|3317615|P1|Overall Study|Death|6
1015409|NCT00331864|3317614|P2|Overall Study|Administrative Problems|0
1015410|NCT00331864|3317615|P1|Overall Study|Administrative Problems|1
1015411|NCT00331864|3317614|P2|Overall Study|Lost to Follow-up|3
1015412|NCT00331864|3317615|P1|Overall Study|Lost to Follow-up|4
1015413|NCT00331864|3317614|P2|Overall Study|Withdrawal by Subject|0
1015414|NCT00331864|3317615|P1|Overall Study|Withdrawal by Subject|10
1015415|NCT00331864|3317614|P2|Overall Study|Protocol Violation|0
1015416|NCT00331864|3317615|P1|Overall Study|Protocol Violation|3
1015417|NCT00331864|3317614|P2|Overall Study|Lack of Efficacy|0
1015418|NCT00331864|3317615|P1|Overall Study|Lack of Efficacy|4
1015419|NCT00331864|3317614|P2|Overall Study|Adverse Event|1
1015420|NCT00331864|3317615|P1|Overall Study|Adverse Event|30
1015421|NCT00331799|3317634|P1|Overall Study|Sedation|1
1015422|NCT00331799|3317634|P1|Overall Study|Withdrawal by Subject|2
1015423|NCT00331773|3317640|P2|Overall Study|Protocol Violation|3
1015424|NCT00331773|3317641|P1|Overall Study|Protocol Violation|10
1015425|NCT00331773|3317640|P2|Overall Study|Withdrawal by Subject|4
1015426|NCT00331773|3317641|P1|Overall Study|Withdrawal by Subject|6
1015427|NCT00331760|3317669|P2|Overall Study|Ineligible / no protocol treatment|8
1015428|NCT00331760|3317670|P1|Overall Study|Ineligible / no protocol treatment|15
1015429|NCT00331682|3317676|P1|Overall Study|Adverse Event|1
1015430|NCT00331552|3317684|P2|Period 3: Phase II|Severe Nausea|0
1015431|NCT00331552|3317685|P1|Period 3: Phase II|Severe Nausea|1
1015432|NCT00331552|3317684|P2|Period 3: Phase II|Neurological Symptoms|0
1015433|NCT00331552|3317685|P1|Period 3: Phase II|Neurological Symptoms|1
1015434|NCT00331422|3317699|P1|Overall Study|Did not receive entire study regimen|5
1015435|NCT00331409|3317708|P1|Overall Study|Lack of Efficacy|4
1015436|NCT00331344|3317716|P9|Phase II|Death|4
1015437|NCT00331344|3317717|P8|Phase II|Death|0
1015438|NCT00331344|3317718|P7|Phase II|Death|0
1015439|NCT00331344|3317719|P6|Phase II|Death|0
1015440|NCT00331344|3317720|P5|Phase II|Death|0
1015441|NCT00331344|3317721|P4|Phase II|Death|0
1015442|NCT00331344|3317722|P3|Phase II|Death|0
1015443|NCT00331344|3317723|P2|Phase II|Death|0
1015444|NCT00331344|3317724|P1|Phase II|Death|0
1015445|NCT00331344|3317716|P9|Phase I|Adverse Event|0
1015446|NCT00331344|3317717|P8|Phase I|Adverse Event|1
1015447|NCT00331344|3317718|P7|Phase I|Adverse Event|0
1015448|NCT00331344|3317719|P6|Phase I|Adverse Event|2
1015449|NCT00331344|3317720|P5|Phase I|Adverse Event|2
1015450|NCT00331344|3317721|P4|Phase I|Adverse Event|1
1015451|NCT00331344|3317722|P3|Phase I|Adverse Event|0
1015452|NCT00331344|3317723|P2|Phase I|Adverse Event|0
1015453|NCT00331344|3317724|P1|Phase I|Adverse Event|0
1015454|NCT00331006|3317761|P1|Follow-Up Phase II|Lost to Follow-up|3
1015455|NCT00331006|3317761|P1|Follow-Up Phase I|Lost to Follow-up|1
1015456|NCT00331006|3317761|P1|Treatment Phase|Withdrawal by Subject|1
1015457|NCT00331006|3317761|P1|Screening Phase|Ineligible for treatment phase|4
1015458|NCT00331006|3317761|P1|Screening Phase|Lost to Follow-up|1
1015459|NCT00331006|3317761|P1|Screening Phase|enrollment halted|1
1015460|NCT00331006|3317761|P1|Screening Phase|Withdrawal by Subject|1
1015461|NCT00330967|3317774|P2|Overall Study|Physician Decision|9
1015462|NCT00330967|3317775|P1|Overall Study|Physician Decision|0
1015463|NCT00330967|3317774|P2|Overall Study|Withdrawal by Subject|5
1015464|NCT00330967|3317775|P1|Overall Study|Withdrawal by Subject|0
1015465|NCT00330928|3317786|P1|Overall Study|IVUS could not be performed.|1
1015466|NCT00330928|3317786|P1|Overall Study|Death|1
1015467|NCT00330928|3317786|P1|Overall Study|Physician Decision|9
1015468|NCT00330928|3317786|P1|Overall Study|Lost to Follow-up|6
1015469|NCT00330759|3317828|P2|Overall Study|Other|44
1015470|NCT00330759|3317829|P1|Overall Study|Other|36
1015471|NCT00330759|3317828|P2|Overall Study|Ineligibility determined|1
1015472|NCT00330759|3317829|P1|Overall Study|Ineligibility determined|2
1015473|NCT00330759|3317828|P2|Overall Study|Protocol deviation|2
1015474|NCT00330759|3317829|P1|Overall Study|Protocol deviation|0
1015475|NCT00330759|3317828|P2|Overall Study|Physician Decision|2
1015476|NCT00330759|3317829|P1|Overall Study|Physician Decision|1
1015477|NCT00330759|3317828|P2|Overall Study|Noncompliance|17
1015478|NCT00330759|3317829|P1|Overall Study|Noncompliance|15
1015479|NCT00330759|3317828|P2|Overall Study|Lost to Follow-up|22
1015480|NCT00330759|3317829|P1|Overall Study|Lost to Follow-up|16
1015481|NCT00330759|3317828|P2|Overall Study|Participant request|22
1015482|NCT00330759|3317829|P1|Overall Study|Participant request|31
1015483|NCT00330759|3317828|P2|Overall Study|Adverse Event|36
1015484|NCT00330759|3317829|P1|Overall Study|Adverse Event|48
1015485|NCT00330759|3317828|P2|Overall Study|Withdrawal by Subject|124
1015486|NCT00330759|3317829|P1|Overall Study|Withdrawal by Subject|143
1015487|NCT00330759|3317828|P2|Overall Study|Disease progression|126
1015488|NCT00330759|3317829|P1|Overall Study|Disease progression|104
1015489|NCT00330759|3317828|P2|Overall Study|Death|310
1015490|NCT00330759|3317829|P1|Overall Study|Death|316
1015491|NCT00330681|3317850|P2|Overall Study|Tracheotomy due to worsening of ALS|2
1015492|NCT00330681|3317851|P1|Overall Study|Tracheotomy due to worsening of ALS|1
1015493|NCT00330681|3317850|P2|Overall Study|Withdrawal by Subject|5
1015494|NCT00330681|3317851|P1|Overall Study|Withdrawal by Subject|5
1015495|NCT00330681|3317850|P2|Overall Study|Protocol Violation|1
1015496|NCT00330681|3317851|P1|Overall Study|Protocol Violation|0
1015497|NCT00330681|3317850|P2|Overall Study|Adverse Event|6
1015498|NCT00330681|3317851|P1|Overall Study|Adverse Event|3
1015499|NCT00330668|3317873|P1|Overall Study|Patient started Lupron|1
1015500|NCT00330668|3317873|P1|Overall Study|Use of exclusionary medication|1
1015501|NCT00330668|3317873|P1|Overall Study|Lack of Efficacy|1
1015502|NCT00330668|3317873|P1|Overall Study|Sponsor's decision|76
1015503|NCT00330668|3317873|P1|Overall Study|Withdrawal by Subject|20
1015504|NCT00330668|3317873|P1|Overall Study|Non-Compliance|5
1015505|NCT00330668|3317873|P1|Overall Study|Lost to Follow-up|9
1015506|NCT00330668|3317873|P1|Overall Study|Adverse Event|1
1015507|NCT00330616|3317880|P1|Overall Study|Not specified|1
1015508|NCT00330616|3317880|P1|Overall Study|Withdrawal by Subject|4
1015509|NCT00330616|3317880|P1|Overall Study|Lost to Follow-up|2
1015510|NCT00330616|3317880|P1|Overall Study|Lack of Efficacy|1
1015511|NCT00330616|3317880|P1|Overall Study|Adverse Event|13
1015512|NCT00330460|3317906|P2|Overall Study|Other|0
1015513|NCT00330460|3317907|P1|Overall Study|Other|1
1015514|NCT00330460|3317906|P2|Overall Study|Noncompliance|1
1015515|NCT00330460|3317907|P1|Overall Study|Noncompliance|2
1015516|NCT00330460|3317906|P2|Overall Study|Lost to Follow-up|3
1015517|NCT00330460|3317907|P1|Overall Study|Lost to Follow-up|8
1015518|NCT00330460|3317906|P2|Overall Study|Ineligibility determined|3
1015519|NCT00330460|3317907|P1|Overall Study|Ineligibility determined|1
1015520|NCT00330460|3317906|P2|Overall Study|Death|1
1015521|NCT00330460|3317907|P1|Overall Study|Death|1
1015522|NCT00330460|3317906|P2|Overall Study|Withdrawal by Subject|17
1015523|NCT00330460|3317907|P1|Overall Study|Withdrawal by Subject|18
1015524|NCT00330460|3317906|P2|Overall Study|Adverse Event|8
1015525|NCT00330460|3317907|P1|Overall Study|Adverse Event|10
1015526|NCT00330460|3317906|P2|Overall Study|Physician Decision|0
1015527|NCT00330460|3317907|P1|Overall Study|Physician Decision|1
1015528|NCT00330343|3317950|P1|Overall Study|Lost to Follow-up|5
1015529|NCT00330187|3317958|P4|Overall Study|Withdrawal by Subject|4
1015530|NCT00330187|3317959|P3|Overall Study|Withdrawal by Subject|4
1015531|NCT00330187|3317960|P2|Overall Study|Withdrawal by Subject|5
1015532|NCT00330187|3317961|P1|Overall Study|Withdrawal by Subject|8
1015533|NCT00330187|3317958|P4|Overall Study|Lost to Follow-up|10
1015534|NCT00330187|3317959|P3|Overall Study|Lost to Follow-up|14
1015535|NCT00330187|3317960|P2|Overall Study|Lost to Follow-up|13
1015536|NCT00330187|3317961|P1|Overall Study|Lost to Follow-up|12
1015537|NCT00330174|3317973|P2|Overall Study|Miscellaneous reasons|1
1015538|NCT00330174|3317974|P1|Overall Study|Miscellaneous reasons|7
1015539|NCT00330174|3317973|P2|Overall Study|Excessive missed visits|8
1015540|NCT00330174|3317974|P1|Overall Study|Excessive missed visits|3
1015541|NCT00330174|3317973|P2|Overall Study|Clinical deterioration|2
1015542|NCT00330174|3317974|P1|Overall Study|Clinical deterioration|1
1015543|NCT00330174|3317973|P2|Overall Study|Lost to Follow-up|1
1015544|NCT00330174|3317974|P1|Overall Study|Lost to Follow-up|4
1015545|NCT00330174|3317973|P2|Overall Study|Withdrawal by Subject|7
1015546|NCT00330174|3317974|P1|Overall Study|Withdrawal by Subject|7
1015547|NCT00329901|3317998|P3|Overall Study|Unable to classify|0
1015548|NCT00329901|3317999|P2|Overall Study|Unable to classify|2
1015549|NCT00329901|3318000|P1|Overall Study|Unable to classify|2
1015550|NCT00329901|3317998|P3|Overall Study|Protocol Violation|1
1015551|NCT00329901|3317999|P2|Overall Study|Protocol Violation|0
1015552|NCT00329901|3318000|P1|Overall Study|Protocol Violation|1
1015553|NCT00329901|3317998|P3|Overall Study|Lost to Follow-up|1
1015554|NCT00329901|3317999|P2|Overall Study|Lost to Follow-up|0
1015555|NCT00329901|3318000|P1|Overall Study|Lost to Follow-up|2
1015556|NCT00329901|3317998|P3|Overall Study|Withdrawal by Subject|2
1015557|NCT00329901|3317999|P2|Overall Study|Withdrawal by Subject|3
1015558|NCT00329901|3318000|P1|Overall Study|Withdrawal by Subject|4
1015559|NCT00329849|3318030|P2|Overall Study|Withdrawal by Subject|4
1015560|NCT00329849|3318031|P1|Overall Study|Withdrawal by Subject|6
1015561|NCT00329797|3318057|P2|Overall Study|Withdrawal by Subject|6
1015562|NCT00329797|3318058|P1|Overall Study|Withdrawal by Subject|6
1015563|NCT00329797|3318057|P2|Overall Study|Protocol Violation|0
1015564|NCT00329797|3318058|P1|Overall Study|Protocol Violation|1
1015565|NCT00329784|3318074|P4|Overall Study|Other|0
1015566|NCT00329784|3318075|P3|Overall Study|Other|0
1015567|NCT00329784|3318076|P2|Overall Study|Other|2
1015568|NCT00329784|3318077|P1|Overall Study|Other|1
1015569|NCT00329784|3318074|P4|Overall Study|Withdrawal by Subject|0
1015570|NCT00329784|3318075|P3|Overall Study|Withdrawal by Subject|0
1015571|NCT00329784|3318076|P2|Overall Study|Withdrawal by Subject|2
1015572|NCT00329784|3318077|P1|Overall Study|Withdrawal by Subject|4
1015573|NCT00329784|3318074|P4|Overall Study|Lost to Follow-up|0
1015574|NCT00329784|3318075|P3|Overall Study|Lost to Follow-up|0
1015575|NCT00329784|3318076|P2|Overall Study|Lost to Follow-up|1
1015576|NCT00329784|3318077|P1|Overall Study|Lost to Follow-up|0
1015577|NCT00329745|3318105|P2|Overall Study|Lost to Follow-up|101
1015578|NCT00329745|3318106|P1|Overall Study|Lost to Follow-up|86
1015579|NCT00329745|3318105|P2|Overall Study|Withdrawal by Subject|1
1015580|NCT00329745|3318106|P1|Overall Study|Withdrawal by Subject|0
1015581|NCT00329745|3318105|P2|Overall Study|Protocol Violation|0
1015582|NCT00329745|3318106|P1|Overall Study|Protocol Violation|1
1015583|NCT00329719|3318126|P4|Overall Study|Lost to Follow-up|1
1015584|NCT00329719|3318127|P3|Overall Study|Lost to Follow-up|0
1015585|NCT00329719|3318128|P2|Overall Study|Lost to Follow-up|0
1015586|NCT00329719|3318129|P1|Overall Study|Lost to Follow-up|0
1015587|NCT00329641|3318151|P1|Overall Study|Other reason, not protocol specified|1
1015588|NCT00329641|3318151|P1|Overall Study|Adverse Event|3
1015589|NCT00329641|3318151|P1|Overall Study|Not eligible|1
1015590|NCT00329641|3318151|P1|Overall Study|Did not start treatment|1
1015591|NCT00329602|3318160|P3|40-Week Open-Label Treatment Phase|Captured as Other|4
1015592|NCT00329602|3318161|P2|40-Week Open-Label Treatment Phase|Captured as Other|0
1015593|NCT00329602|3318162|P1|40-Week Open-Label Treatment Phase|Captured as Other|0
1015594|NCT00329602|3318160|P3|40-Week Open-Label Treatment Phase|Lack of Efficacy|9
1015595|NCT00329602|3318161|P2|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
1015596|NCT00329602|3318162|P1|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
1015597|NCT00329602|3318160|P3|40-Week Open-Label Treatment Phase|Protocol Violation|2
1015598|NCT00329602|3318161|P2|40-Week Open-Label Treatment Phase|Protocol Violation|0
1015599|NCT00329602|3318162|P1|40-Week Open-Label Treatment Phase|Protocol Violation|0
1015600|NCT00329602|3318160|P3|40-Week Open-Label Treatment Phase|Lost to Follow-up|1
1015601|NCT00329602|3318161|P2|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
1015602|NCT00329602|3318162|P1|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
1015603|NCT00329602|3318160|P3|40-Week Open-Label Treatment Phase|Adverse Event|20
1015604|NCT00329602|3318161|P2|40-Week Open-Label Treatment Phase|Adverse Event|0
1015605|NCT00329602|3318162|P1|40-Week Open-Label Treatment Phase|Adverse Event|0
1015606|NCT00329602|3318160|P3|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0
1015607|NCT00329602|3318161|P2|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99
1015608|NCT00329602|3318162|P1|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119
1015609|NCT00329550|3318200|P3|Overall Study|Due to Relocation|1
1015610|NCT00329550|3318201|P2|Overall Study|Due to Relocation|0
1015611|NCT00329550|3318202|P1|Overall Study|Due to Relocation|0
1015612|NCT00329550|3318200|P3|Overall Study|Withdrawal of Consent|1
1015613|NCT00329550|3318201|P2|Overall Study|Withdrawal of Consent|0
1015614|NCT00329550|3318202|P1|Overall Study|Withdrawal of Consent|1
1015615|NCT00329550|3318200|P3|Overall Study|Adverse Event|2
1015616|NCT00329550|3318201|P2|Overall Study|Adverse Event|4
1015617|NCT00329550|3318202|P1|Overall Study|Adverse Event|3
1015618|NCT00329420|3318467|P3|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
1015619|NCT00329420|3318468|P2|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
1015620|NCT00329420|3318469|P1|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1
1015621|NCT00329420|3318467|P3|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0
1015622|NCT00329420|3318468|P2|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
1015623|NCT00329420|3318469|P1|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
1015624|NCT00329420|3318467|P3|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
1015625|NCT00329420|3318468|P2|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
1015626|NCT00329420|3318469|P1|4-weekly Dosing Phase (Responders Only)|Adverse Event|2
1015627|NCT00329420|3318467|P3|Re-induction Phase|Did not respond to re-induction|7
1015628|NCT00329420|3318468|P2|Re-induction Phase|Did not respond to re-induction|5
1015629|NCT00329420|3318469|P1|Re-induction Phase|Did not respond to re-induction|6
1015630|NCT00329420|3318467|P3|Re-induction Phase|Withdrawal of Consent|1
1015631|NCT00329420|3318468|P2|Re-induction Phase|Withdrawal of Consent|0
1015632|NCT00329420|3318469|P1|Re-induction Phase|Withdrawal of Consent|0
1015633|NCT00329420|3318467|P3|Re-induction Phase|Lack of Efficacy|0
1015634|NCT00329420|3318468|P2|Re-induction Phase|Lack of Efficacy|1
1015635|NCT00329420|3318469|P1|Re-induction Phase|Lack of Efficacy|0
1015636|NCT00329407|3318848|P1|Overall Study|Withdrawal by Subject|1
1015637|NCT00329238|3318855|P2|Overall Study|Other reason (not specified)|54
1015638|NCT00329238|3318856|P1|Overall Study|Other reason (not specified)|40
1015639|NCT00329238|3318855|P2|Overall Study|Withdrawal by Subject|58
1015640|NCT00329238|3318856|P1|Overall Study|Withdrawal by Subject|64
1015641|NCT00329238|3318855|P2|Overall Study|Lost to Follow-up|6
1015642|NCT00329238|3318856|P1|Overall Study|Lost to Follow-up|2
1015643|NCT00329238|3318855|P2|Overall Study|Protocol Violation|34
1015644|NCT00329238|3318856|P1|Overall Study|Protocol Violation|23
1015645|NCT00329238|3318855|P2|Overall Study|Adverse Event|129
1015646|NCT00329238|3318856|P1|Overall Study|Adverse Event|147
1015647|NCT00329160|3318892|P1|Overall Study|Incomplete IVUS|45
1015648|NCT00329160|3318892|P1|Overall Study|Did not Receive Study Drug|1
1015649|NCT00329160|3318892|P1|Overall Study|Protocol Violation|2
1015650|NCT00329160|3318892|P1|Overall Study|Withdrawal by Subject|13
1015651|NCT00329160|3318892|P1|Overall Study|Adverse Event|27
1015652|NCT00329108|3318901|P2|Overall Study|Protocol Violation|2
1015653|NCT00329108|3318902|P1|Overall Study|Protocol Violation|0
1015654|NCT00329108|3318901|P2|Overall Study|withdrew patient after SAE resolved|0
1015655|NCT00329108|3318902|P1|Overall Study|withdrew patient after SAE resolved|1
1015656|NCT00329108|3318901|P2|Overall Study|study terminated by sponsor|0
1015657|NCT00329108|3318902|P1|Overall Study|study terminated by sponsor|1
1015658|NCT00329108|3318901|P2|Overall Study|Subject no longer willing to participate|2
1015659|NCT00329108|3318902|P1|Overall Study|Subject no longer willing to participate|2
1015660|NCT00329108|3318901|P2|Overall Study|symptomatic deterioration|1
1015661|NCT00329108|3318902|P1|Overall Study|symptomatic deterioration|1
1015662|NCT00329108|3318901|P2|Overall Study|Withdrawal by Subject|2
1015663|NCT00329108|3318902|P1|Overall Study|Withdrawal by Subject|0
1015664|NCT00329108|3318901|P2|Overall Study|Lack of Efficacy|3
1015665|NCT00329108|3318902|P1|Overall Study|Lack of Efficacy|3
1015666|NCT00329108|3318901|P2|Overall Study|Adverse Event|2
1015667|NCT00329108|3318902|P1|Overall Study|Adverse Event|2
1015668|NCT00329030|3318910|P2|Overall Study|Ineligible Pathology|1
1015669|NCT00329030|3318911|P1|Overall Study|Ineligible Pathology|1
1015670|NCT00329030|3318910|P2|Overall Study|Progressive Disease|2
1015671|NCT00329030|3318911|P1|Overall Study|Progressive Disease|6
1015672|NCT00329030|3318910|P2|Overall Study|Withdrawal by Subject|3
1015673|NCT00329030|3318911|P1|Overall Study|Withdrawal by Subject|1
1015674|NCT00328926|3318942|P3|Overall Study|Lack of ovarian response|0
1015675|NCT00328926|3318943|P2|Overall Study|Lack of ovarian response|1
1015676|NCT00328926|3318944|P1|Overall Study|Lack of ovarian response|0
1015677|NCT00328926|3318942|P3|Overall Study|In vitro fertilization treatment|1
1015678|NCT00328926|3318943|P2|Overall Study|In vitro fertilization treatment|0
1015679|NCT00328926|3318944|P1|Overall Study|In vitro fertilization treatment|0
1015680|NCT00328926|3318942|P3|Overall Study|Death|1
1015681|NCT00328926|3318943|P2|Overall Study|Death|0
1015682|NCT00328926|3318944|P1|Overall Study|Death|0
1015683|NCT00328926|3318942|P3|Overall Study|Lost to Follow-up|0
1015684|NCT00328926|3318943|P2|Overall Study|Lost to Follow-up|1
1015685|NCT00328926|3318944|P1|Overall Study|Lost to Follow-up|0
1015686|NCT00328926|3318942|P3|Overall Study|Pregnancy|0
1015687|NCT00328926|3318943|P2|Overall Study|Pregnancy|1
1015688|NCT00328926|3318944|P1|Overall Study|Pregnancy|2
1015689|NCT00328783|3318969|P1|Overall Study|Withdrawal by Subject|1
1015690|NCT00328783|3318969|P1|Overall Study|No heart in RT field|4
1015691|NCT00328783|3318969|P1|Overall Study|Could not tolerate ABC|21
1015692|NCT00328627|3318995|P12|Overall Study|Other|0
1015693|NCT00328627|3318996|P11|Overall Study|Other|1
1015694|NCT00328627|3318997|P10|Overall Study|Other|1
1015695|NCT00328627|3318998|P9|Overall Study|Other|0
1015696|NCT00328627|3318999|P8|Overall Study|Other|0
1015697|NCT00328627|3319000|P7|Overall Study|Other|1
1015698|NCT00328627|3319001|P6|Overall Study|Other|0
1015699|NCT00328627|3319002|P5|Overall Study|Other|0
1015700|NCT00328627|3319003|P4|Overall Study|Other|1
1015701|NCT00328627|3319004|P3|Overall Study|Other|0
1015702|NCT00328627|3319005|P2|Overall Study|Other|0
1015703|NCT00328627|3319006|P1|Overall Study|Other|0
1015704|NCT00328627|3318995|P12|Overall Study|Physician Decision|0
1015705|NCT00328627|3318996|P11|Overall Study|Physician Decision|1
1015706|NCT00328627|3318997|P10|Overall Study|Physician Decision|2
1015707|NCT00328627|3318998|P9|Overall Study|Physician Decision|3
1015708|NCT00328627|3318999|P8|Overall Study|Physician Decision|0
1015709|NCT00328627|3319000|P7|Overall Study|Physician Decision|1
1015710|NCT00328627|3319001|P6|Overall Study|Physician Decision|1
1015711|NCT00328627|3319002|P5|Overall Study|Physician Decision|1
1015712|NCT00328627|3319003|P4|Overall Study|Physician Decision|2
1015713|NCT00328627|3319004|P3|Overall Study|Physician Decision|1
1015714|NCT00328627|3319005|P2|Overall Study|Physician Decision|3
1015715|NCT00328627|3319006|P1|Overall Study|Physician Decision|4
1015716|NCT00328627|3318995|P12|Overall Study|Pregnancy|0
1015717|NCT00328627|3318996|P11|Overall Study|Pregnancy|0
1015718|NCT00328627|3318997|P10|Overall Study|Pregnancy|0
1015719|NCT00328627|3318998|P9|Overall Study|Pregnancy|0
1015720|NCT00328627|3318999|P8|Overall Study|Pregnancy|0
1015721|NCT00328627|3319000|P7|Overall Study|Pregnancy|0
1015722|NCT00328627|3319001|P6|Overall Study|Pregnancy|0
1015723|NCT00328627|3319002|P5|Overall Study|Pregnancy|0
1015724|NCT00328627|3319003|P4|Overall Study|Pregnancy|0
1015725|NCT00328627|3319004|P3|Overall Study|Pregnancy|0
1015726|NCT00328627|3319005|P2|Overall Study|Pregnancy|1
1015727|NCT00328627|3319006|P1|Overall Study|Pregnancy|0
1015728|NCT00328627|3318995|P12|Overall Study|Withdrawal by Subject|7
1015729|NCT00328627|3318996|P11|Overall Study|Withdrawal by Subject|2
1015730|NCT00328627|3318997|P10|Overall Study|Withdrawal by Subject|5
1015731|NCT00328627|3318998|P9|Overall Study|Withdrawal by Subject|4
1015732|NCT00328627|3318999|P8|Overall Study|Withdrawal by Subject|4
1015733|NCT00328627|3319000|P7|Overall Study|Withdrawal by Subject|4
1015734|NCT00328627|3319001|P6|Overall Study|Withdrawal by Subject|5
1015735|NCT00328627|3319002|P5|Overall Study|Withdrawal by Subject|2
1015736|NCT00328627|3319003|P4|Overall Study|Withdrawal by Subject|6
1015737|NCT00328627|3319004|P3|Overall Study|Withdrawal by Subject|5
1015738|NCT00328627|3319005|P2|Overall Study|Withdrawal by Subject|4
1015739|NCT00328627|3319006|P1|Overall Study|Withdrawal by Subject|5
1015740|NCT00328627|3318995|P12|Overall Study|Lost to Follow-up|1
1015741|NCT00328627|3318996|P11|Overall Study|Lost to Follow-up|0
1015742|NCT00328627|3318997|P10|Overall Study|Lost to Follow-up|2
1015743|NCT00328627|3318998|P9|Overall Study|Lost to Follow-up|3
1015744|NCT00328627|3318999|P8|Overall Study|Lost to Follow-up|0
1015745|NCT00328627|3319000|P7|Overall Study|Lost to Follow-up|3
1015746|NCT00328627|3319001|P6|Overall Study|Lost to Follow-up|2
1015747|NCT00328627|3319002|P5|Overall Study|Lost to Follow-up|0
1015748|NCT00328627|3319003|P4|Overall Study|Lost to Follow-up|4
1015749|NCT00328627|3319004|P3|Overall Study|Lost to Follow-up|2
1015750|NCT00328627|3319005|P2|Overall Study|Lost to Follow-up|2
1015751|NCT00328627|3319006|P1|Overall Study|Lost to Follow-up|4
1015752|NCT00328627|3318995|P12|Overall Study|Protocol Violation|2
1015753|NCT00328627|3318996|P11|Overall Study|Protocol Violation|6
1015754|NCT00328627|3318997|P10|Overall Study|Protocol Violation|4
1015755|NCT00328627|3318998|P9|Overall Study|Protocol Violation|1
1015756|NCT00328627|3318999|P8|Overall Study|Protocol Violation|2
1015757|NCT00328627|3319000|P7|Overall Study|Protocol Violation|6
1015758|NCT00328627|3319001|P6|Overall Study|Protocol Violation|5
1015759|NCT00328627|3319002|P5|Overall Study|Protocol Violation|5
1015760|NCT00328627|3319003|P4|Overall Study|Protocol Violation|8
1015761|NCT00328627|3319004|P3|Overall Study|Protocol Violation|2
1015762|NCT00328627|3319005|P2|Overall Study|Protocol Violation|2
1015763|NCT00328627|3319006|P1|Overall Study|Protocol Violation|2
1015764|NCT00328627|3318995|P12|Overall Study|Adverse Event|4
1015765|NCT00328627|3318996|P11|Overall Study|Adverse Event|5
1015766|NCT00328627|3318997|P10|Overall Study|Adverse Event|7
1015767|NCT00328627|3318998|P9|Overall Study|Adverse Event|0
1015768|NCT00328627|3318999|P8|Overall Study|Adverse Event|2
1015769|NCT00328627|3319000|P7|Overall Study|Adverse Event|1
1015770|NCT00328627|3319001|P6|Overall Study|Adverse Event|2
1015771|NCT00328627|3319002|P5|Overall Study|Adverse Event|1
1015772|NCT00328627|3319003|P4|Overall Study|Adverse Event|3
1015773|NCT00328627|3319004|P3|Overall Study|Adverse Event|2
1015774|NCT00328627|3319005|P2|Overall Study|Adverse Event|1
1015775|NCT00328627|3319006|P1|Overall Study|Adverse Event|3
1015776|NCT00328627|3318995|P12|Overall Study|Hyperglycemic Rescue|2
1015777|NCT00328627|3318996|P11|Overall Study|Hyperglycemic Rescue|3
1015778|NCT00328627|3318997|P10|Overall Study|Hyperglycemic Rescue|11
1015779|NCT00328627|3318998|P9|Overall Study|Hyperglycemic Rescue|6
1015780|NCT00328627|3318999|P8|Overall Study|Hyperglycemic Rescue|6
1015781|NCT00328627|3319000|P7|Overall Study|Hyperglycemic Rescue|19
1015782|NCT00328627|3319001|P6|Overall Study|Hyperglycemic Rescue|5
1015783|NCT00328627|3319002|P5|Overall Study|Hyperglycemic Rescue|6
1015784|NCT00328627|3319003|P4|Overall Study|Hyperglycemic Rescue|13
1015785|NCT00328627|3319004|P3|Overall Study|Hyperglycemic Rescue|16
1015786|NCT00328627|3319005|P2|Overall Study|Hyperglycemic Rescue|18
1015787|NCT00328627|3319006|P1|Overall Study|Hyperglycemic Rescue|41
1015788|NCT00328562|3320543|P1|Overall Study|Disease progression|1
1015789|NCT00328510|3320552|P2|Overall Study|Treatment changed to a single fraction|1
1015790|NCT00328510|3320553|P1|Overall Study|Treatment changed to a single fraction|1
1015791|NCT00328510|3320552|P2|Overall Study|Severe kyphosis, could not use mask|1
1015792|NCT00328510|3320553|P1|Overall Study|Severe kyphosis, could not use mask|0
1015793|NCT00328510|3320552|P2|Overall Study|Withdrawal by Subject|2
1015794|NCT00328510|3320553|P1|Overall Study|Withdrawal by Subject|4
1015795|NCT00328510|3320552|P2|Overall Study|Dentition problems, could not use frame|0
1015796|NCT00328510|3320553|P1|Overall Study|Dentition problems, could not use frame|1
1015797|NCT00328510|3320552|P2|Overall Study|Gag disorder, could not use frame|0
1015798|NCT00328510|3320553|P1|Overall Study|Gag disorder, could not use frame|4
1015799|NCT00328198|3320568|P1|Follow-up|Death|31
1015800|NCT00328198|3320568|P1|Follow-up|Lost to Follow-up|4
1015801|NCT00328198|3320568|P1|Treatment|Confirmed complete response, MRD -|3
1015802|NCT00328198|3320568|P1|Treatment|Non-compliance|1
1015803|NCT00328198|3320568|P1|Treatment|Evidence of disease progression|2
1015804|NCT00328198|3320568|P1|Treatment|Withdrawal by Subject|5
1015805|NCT00328198|3320568|P1|Treatment|Physician Decision|5
1015806|NCT00328198|3320568|P1|Treatment|Death|1
1015807|NCT00328198|3320568|P1|Treatment|Adverse Event|21
1015808|NCT00328172|3320583|P5|Overall Study|Other reason (not specified)|0
1015809|NCT00328172|3320584|P4|Overall Study|Other reason (not specified)|0
1015810|NCT00328172|3320585|P3|Overall Study|Other reason (not specified)|1
1015811|NCT00328172|3320586|P2|Overall Study|Other reason (not specified)|0
1015812|NCT00328172|3320587|P1|Overall Study|Other reason (not specified)|3
1015813|NCT00328172|3320583|P5|Overall Study|Lack of Efficacy|3
1015814|NCT00328172|3320584|P4|Overall Study|Lack of Efficacy|4
1015815|NCT00328172|3320585|P3|Overall Study|Lack of Efficacy|4
1015816|NCT00328172|3320586|P2|Overall Study|Lack of Efficacy|9
1015817|NCT00328172|3320587|P1|Overall Study|Lack of Efficacy|14
1015818|NCT00328172|3320583|P5|Overall Study|Withdrawal by Subject|0
1015819|NCT00328172|3320584|P4|Overall Study|Withdrawal by Subject|6
1015820|NCT00328172|3320585|P3|Overall Study|Withdrawal by Subject|1
1015821|NCT00328172|3320586|P2|Overall Study|Withdrawal by Subject|1
1015822|NCT00328172|3320587|P1|Overall Study|Withdrawal by Subject|1
1015823|NCT00328172|3320583|P5|Overall Study|Lost to Follow-up|1
1015824|NCT00328172|3320584|P4|Overall Study|Lost to Follow-up|1
1015825|NCT00328172|3320585|P3|Overall Study|Lost to Follow-up|2
1015826|NCT00328172|3320586|P2|Overall Study|Lost to Follow-up|1
1015827|NCT00328172|3320587|P1|Overall Study|Lost to Follow-up|1
1015828|NCT00328172|3320583|P5|Overall Study|Protocol Violation|0
1015829|NCT00328172|3320584|P4|Overall Study|Protocol Violation|0
1015830|NCT00328172|3320585|P3|Overall Study|Protocol Violation|1
1015831|NCT00328172|3320586|P2|Overall Study|Protocol Violation|1
1015832|NCT00328172|3320587|P1|Overall Study|Protocol Violation|0
1015833|NCT00328172|3320583|P5|Overall Study|Adverse Event|1
1015834|NCT00328172|3320584|P4|Overall Study|Adverse Event|2
1015835|NCT00328172|3320585|P3|Overall Study|Adverse Event|1
1015836|NCT00328172|3320586|P2|Overall Study|Adverse Event|2
1015837|NCT00328172|3320587|P1|Overall Study|Adverse Event|3
1015838|NCT00328094|3320611|P2|Overall Study|Physician Decision|3
1015839|NCT00328094|3320612|P1|Overall Study|Physician Decision|3
1015840|NCT00327717|3320646|P2|Overall Study|Withdrawal by Subject|7
1015841|NCT00327717|3320647|P1|Overall Study|Withdrawal by Subject|3
1015842|NCT00327717|3320646|P2|Overall Study|Lack of Efficacy|1
1015843|NCT00327717|3320647|P1|Overall Study|Lack of Efficacy|0
1015844|NCT00327717|3320646|P2|Overall Study|Adverse Event|6
1015845|NCT00327717|3320647|P1|Overall Study|Adverse Event|6
1015846|NCT00327470|3320673|P2|Overall Study|Death|4
1015847|NCT00327470|3320674|P1|Overall Study|Death|1
1015848|NCT00327470|3320673|P2|Overall Study|Withdrawal by Subject|12
1015849|NCT00327470|3320674|P1|Overall Study|Withdrawal by Subject|6
1015850|NCT00327470|3320673|P2|Overall Study|Lost to Follow-up|3
1015851|NCT00327470|3320674|P1|Overall Study|Lost to Follow-up|1
1015852|NCT00327470|3320673|P2|Overall Study|Other|9
1015853|NCT00327470|3320674|P1|Overall Study|Other|5
1015854|NCT00327470|3320673|P2|Overall Study|Lack of Efficacy|19
1015855|NCT00327470|3320674|P1|Overall Study|Lack of Efficacy|7
1015856|NCT00327470|3320673|P2|Overall Study|Adverse Event|14
1015857|NCT00327470|3320674|P1|Overall Study|Adverse Event|9
1015858|NCT00327470|3320673|P2|Overall Study|Randomized, but not treated|2
1015859|NCT00327470|3320674|P1|Overall Study|Randomized, but not treated|0
1015860|NCT00327444|3320694|P2|Open Label Treatment (OL) Period|Ongoing Treatment|0
1015861|NCT00327444|3320695|P1|Open Label Treatment (OL) Period|Ongoing Treatment|1
1015862|NCT00327444|3320694|P2|Open Label Treatment (OL) Period|Worsening dyspnea|1
1015863|NCT00327444|3320695|P1|Open Label Treatment (OL) Period|Worsening dyspnea|0
1015864|NCT00327444|3320694|P2|Open Label Treatment (OL) Period|Adverse Event|2
1015865|NCT00327444|3320695|P1|Open Label Treatment (OL) Period|Adverse Event|2
1015866|NCT00327444|3320694|P2|Open Label Treatment (OL) Period|Disease progression|7
1015867|NCT00327444|3320695|P1|Open Label Treatment (OL) Period|Disease progression|8
1015868|NCT00327444|3320694|P2|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10
1015869|NCT00327444|3320695|P1|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11
1015870|NCT00327444|3320694|P2|Double Blind Treatment (DB) Period|Subject request|1
1015871|NCT00327444|3320695|P1|Double Blind Treatment (DB) Period|Subject request|0
1015872|NCT00327444|3320694|P2|Double Blind Treatment (DB) Period|Adverse Event|5
1015873|NCT00327444|3320695|P1|Double Blind Treatment (DB) Period|Adverse Event|5
1015874|NCT00327444|3320694|P2|Double Blind Treatment (DB) Period|Disease progression|13
1015875|NCT00327444|3320695|P1|Double Blind Treatment (DB) Period|Disease progression|10
1015876|NCT00327340|3320713|P2|Overall Study|Adverse Event|3
1015877|NCT00327340|3320714|P1|Overall Study|Adverse Event|3
1015878|NCT00327340|3320713|P2|Overall Study|Symptomatic Disease|2
1015879|NCT00327340|3320714|P1|Overall Study|Symptomatic Disease|0
1015880|NCT00327340|3320713|P2|Overall Study|Disease Progression|19
1015881|NCT00327340|3320714|P1|Overall Study|Disease Progression|10
1015882|NCT00327340|3320713|P2|Overall Study|Physician Decision|1
1015883|NCT00327340|3320714|P1|Overall Study|Physician Decision|1
1015884|NCT00327340|3320713|P2|Overall Study|Withdrawal by Subject|5
1015885|NCT00327340|3320714|P1|Overall Study|Withdrawal by Subject|1
1015886|NCT00327171|3320728|P2|Overall Study|Other|0
1015887|NCT00327171|3320729|P1|Overall Study|Other|1
1015888|NCT00327171|3320728|P2|Overall Study|Undisclosed history of ischemia|1
1015889|NCT00327171|3320729|P1|Overall Study|Undisclosed history of ischemia|0
1015890|NCT00327171|3320728|P2|Overall Study|Clinical progression|8
1015891|NCT00327171|3320729|P1|Overall Study|Clinical progression|12
1015892|NCT00327171|3320728|P2|Overall Study|Investigator/participant request|8
1015893|NCT00327171|3320729|P1|Overall Study|Investigator/participant request|1
1015894|NCT00327171|3320728|P2|Overall Study|Disease progression/lack of efficacy|69
1015895|NCT00327171|3320729|P1|Overall Study|Disease progression/lack of efficacy|68
1015896|NCT00327171|3320728|P2|Overall Study|Adverse Event|23
1015897|NCT00327171|3320729|P1|Overall Study|Adverse Event|23
1015898|NCT00327171|3320728|P2|Overall Study|Did not receive study medication|0
1015899|NCT00327171|3320729|P1|Overall Study|Did not receive study medication|3
1015900|NCT00327015|3320761|P4|Overall Study|Administrative Reason by Sponsor|1
1015901|NCT00327015|3320762|P3|Overall Study|Administrative Reason by Sponsor|2
1015902|NCT00327015|3320763|P2|Overall Study|Administrative Reason by Sponsor|2
1015903|NCT00327015|3320764|P1|Overall Study|Administrative Reason by Sponsor|1
1015904|NCT00327015|3320761|P4|Overall Study|Pregnancy|1
1015905|NCT00327015|3320762|P3|Overall Study|Pregnancy|1
1015906|NCT00327015|3320763|P2|Overall Study|Pregnancy|2
1015907|NCT00327015|3320764|P1|Overall Study|Pregnancy|0
1015908|NCT00327015|3320761|P4|Overall Study|Death|3
1015909|NCT00327015|3320762|P3|Overall Study|Death|2
1015910|NCT00327015|3320763|P2|Overall Study|Death|2
1015911|NCT00327015|3320764|P1|Overall Study|Death|1
1015912|NCT00327015|3320761|P4|Overall Study|Physician Decision|2
1015913|NCT00327015|3320762|P3|Overall Study|Physician Decision|3
1015914|NCT00327015|3320763|P2|Overall Study|Physician Decision|1
1015915|NCT00327015|3320764|P1|Overall Study|Physician Decision|0
1015916|NCT00327015|3320761|P4|Overall Study|Poor/Noncompliance|5
1015917|NCT00327015|3320762|P3|Overall Study|Poor/Noncompliance|4
1015918|NCT00327015|3320763|P2|Overall Study|Poor/Noncompliance|8
1015919|NCT00327015|3320764|P1|Overall Study|Poor/Noncompliance|11
1015920|NCT00327015|3320761|P4|Overall Study|Subject no longer meets study criteria|7
1015921|NCT00327015|3320762|P3|Overall Study|Subject no longer meets study criteria|8
1015922|NCT00327015|3320763|P2|Overall Study|Subject no longer meets study criteria|2
1015923|NCT00327015|3320764|P1|Overall Study|Subject no longer meets study criteria|4
1015924|NCT00327015|3320761|P4|Overall Study|Adverse Event|14
1015925|NCT00327015|3320762|P3|Overall Study|Adverse Event|14
1015926|NCT00327015|3320763|P2|Overall Study|Adverse Event|10
1015927|NCT00327015|3320764|P1|Overall Study|Adverse Event|14
1015928|NCT00327015|3320761|P4|Overall Study|Lost to Follow-up|22
1015929|NCT00327015|3320762|P3|Overall Study|Lost to Follow-up|29
1015930|NCT00327015|3320763|P2|Overall Study|Lost to Follow-up|23
1015931|NCT00327015|3320764|P1|Overall Study|Lost to Follow-up|22
1015932|NCT00327015|3320761|P4|Overall Study|Withdrawal of Consent by Subject|25
1015933|NCT00327015|3320762|P3|Overall Study|Withdrawal of Consent by Subject|28
1015934|NCT00327015|3320763|P2|Overall Study|Withdrawal of Consent by Subject|24
1015935|NCT00327015|3320764|P1|Overall Study|Withdrawal of Consent by Subject|20
1015936|NCT00327015|3320761|P4|Overall Study|Lack of Efficacy|29
1015937|NCT00327015|3320762|P3|Overall Study|Lack of Efficacy|35
1015938|NCT00327015|3320763|P2|Overall Study|Lack of Efficacy|18
1015939|NCT00327015|3320764|P1|Overall Study|Lack of Efficacy|18
1015940|NCT00326963|3320806|P1|Overall Study|Administrative / other|1
1015941|NCT00326963|3320806|P1|Overall Study|Other protocol violation|1
1015942|NCT00326963|3320806|P1|Overall Study|Violation of selection criteria at entry|2
1015943|NCT00326963|3320806|P1|Overall Study|Refused treatment / did not cooperate|5
1015944|NCT00326963|3320806|P1|Overall Study|Withdrawal by Subject|10
1015945|NCT00326963|3320806|P1|Overall Study|Failure to return|10
1015946|NCT00326963|3320806|P1|Overall Study|Death|1
1015947|NCT00326963|3320806|P1|Overall Study|Injection site reaction|1
1015948|NCT00326963|3320806|P1|Overall Study|Adverse Event|2
1015949|NCT00326950|3320826|P1|Overall Study|Progressive Disease|1
1015950|NCT00326911|3320848|P2|Overall Study|Withdrawal by subject prior to treatment|1
1015951|NCT00326911|3320849|P1|Overall Study|Withdrawal by subject prior to treatment|0
1015952|NCT00326911|3320848|P2|Overall Study|Physician decision prior to treatment|0
1015953|NCT00326911|3320849|P1|Overall Study|Physician decision prior to treatment|1
1015954|NCT00326911|3320848|P2|Overall Study|Hospitalization prior to treatment|1
1015955|NCT00326911|3320849|P1|Overall Study|Hospitalization prior to treatment|0
1015956|NCT00326898|3320902|P3|Overall Study|Other/Missing/Unknown|32
1015957|NCT00326898|3320903|P2|Overall Study|Other/Missing/Unknown|28
1015958|NCT00326898|3320904|P1|Overall Study|Other/Missing/Unknown|33
1015959|NCT00326898|3320902|P3|Overall Study|Other complicating disease|4
1015960|NCT00326898|3320903|P2|Overall Study|Other complicating disease|5
1015961|NCT00326898|3320904|P1|Overall Study|Other complicating disease|5
1015962|NCT00326898|3320902|P3|Overall Study|Alternative therapy|0
1015963|NCT00326898|3320903|P2|Overall Study|Alternative therapy|0
1015964|NCT00326898|3320904|P1|Overall Study|Alternative therapy|1
1015965|NCT00326898|3320902|P3|Overall Study|Withdrawal by Subject|32
1015966|NCT00326898|3320903|P2|Overall Study|Withdrawal by Subject|128
1015967|NCT00326898|3320904|P1|Overall Study|Withdrawal by Subject|134
1015968|NCT00326898|3320902|P3|Overall Study|Death|0
1015969|NCT00326898|3320903|P2|Overall Study|Death|0
1015970|NCT00326898|3320904|P1|Overall Study|Death|2
1015971|NCT00326898|3320902|P3|Overall Study|Adverse Event|33
1015972|NCT00326898|3320903|P2|Overall Study|Adverse Event|128
1015973|NCT00326898|3320904|P1|Overall Study|Adverse Event|124
1015974|NCT00326898|3320902|P3|Overall Study|Disease progression|102
1015975|NCT00326898|3320903|P2|Overall Study|Disease progression|54
1015976|NCT00326898|3320904|P1|Overall Study|Disease progression|52
1015977|NCT00326885|3320921|P1|Overall Study|Hospice withdrew consent|2
1015978|NCT00326885|3320921|P1|Overall Study|Physician Decision|1
1015979|NCT00326885|3320921|P1|Overall Study|Withdrawal by Subject|3
1015980|NCT00326885|3320921|P1|Overall Study|Adverse Event|1
1015981|NCT00326716|3320952|P4|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
1015982|NCT00326716|3320953|P3|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
1015983|NCT00326716|3320954|P2|Pre-Natal Mothers|Discontinued ATV Before Delivery|2
1015984|NCT00326716|3320955|P1|Pre-Natal Mothers|Discontinued ATV Before Delivery|1
1015985|NCT00326612|3321027|P2|Overall Study|They did not have a seizure requiring tx|137
1015986|NCT00326612|3321028|P1|Overall Study|They did not have a seizure requiring tx|129
1015987|NCT00326599|3321050|P4|Overall Study|Other Unspecified Reason|1
1015988|NCT00326599|3321051|P3|Overall Study|Other Unspecified Reason|2
1015989|NCT00326599|3321052|P2|Overall Study|Other Unspecified Reason|0
1015990|NCT00326599|3321053|P1|Overall Study|Other Unspecified Reason|0
1015991|NCT00326599|3321050|P4|Overall Study|Death|2
1015992|NCT00326599|3321051|P3|Overall Study|Death|1
1015993|NCT00326599|3321052|P2|Overall Study|Death|0
1015994|NCT00326599|3321053|P1|Overall Study|Death|0
1015995|NCT00326599|3321050|P4|Overall Study|Alternate Treatment|0
1015996|NCT00326599|3321051|P3|Overall Study|Alternate Treatment|0
1015997|NCT00326599|3321052|P2|Overall Study|Alternate Treatment|0
1015998|NCT00326599|3321053|P1|Overall Study|Alternate Treatment|1
1015999|NCT00326599|3321050|P4|Overall Study|Disease Progression|11
1016000|NCT00326599|3321051|P3|Overall Study|Disease Progression|13
1016001|NCT00326599|3321052|P2|Overall Study|Disease Progression|1
1016002|NCT00326599|3321053|P1|Overall Study|Disease Progression|3
1016003|NCT00326599|3321050|P4|Overall Study|Adverse Event|3
1016004|NCT00326599|3321051|P3|Overall Study|Adverse Event|32
1016005|NCT00326599|3321052|P2|Overall Study|Adverse Event|0
1016006|NCT00326599|3321053|P1|Overall Study|Adverse Event|1
1016007|NCT00326599|3321050|P4|Overall Study|Withdrawal by Subject|2
1016008|NCT00326599|3321051|P3|Overall Study|Withdrawal by Subject|5
1016009|NCT00326599|3321052|P2|Overall Study|Withdrawal by Subject|0
1016010|NCT00326599|3321053|P1|Overall Study|Withdrawal by Subject|1
1016011|NCT00326495|3321072|P1|Overall Study|Subject off study before assessment|1
1016012|NCT00326495|3321072|P1|Overall Study|Refused further treatment|2
1016013|NCT00326495|3321072|P1|Overall Study|Disease progression before treatment|1
1016014|NCT00326495|3321072|P1|Overall Study|Switched to alternative treatment|1
1016015|NCT00326417|3321079|P4|Overall Study|Death|0
1016016|NCT00326417|3321080|P3|Overall Study|Death|0
1016017|NCT00326417|3321081|P2|Overall Study|Death|0
1016018|NCT00326417|3321082|P1|Overall Study|Death|7
1016019|NCT00326417|3321079|P4|Overall Study|Arm Closed|3
1016020|NCT00326417|3321080|P3|Overall Study|Arm Closed|0
1016021|NCT00326417|3321081|P2|Overall Study|Arm Closed|0
1016022|NCT00326417|3321082|P1|Overall Study|Arm Closed|7
1016023|NCT00326417|3321079|P4|Overall Study|Withdrawal by Subject|0
1016024|NCT00326417|3321080|P3|Overall Study|Withdrawal by Subject|1
1016025|NCT00326417|3321081|P2|Overall Study|Withdrawal by Subject|0
1016026|NCT00326417|3321082|P1|Overall Study|Withdrawal by Subject|0
1016027|NCT00326183|3321109|P2|Overall Study|Adverse Event|0
1016028|NCT00326183|3321110|P1|Overall Study|Adverse Event|1
1016029|NCT00326183|3321109|P2|Overall Study|Other|13
1016030|NCT00326183|3321110|P1|Overall Study|Other|47
1016031|NCT00326183|3321109|P2|Overall Study|Subject Moved|4
1016032|NCT00326183|3321110|P1|Overall Study|Subject Moved|7
1016033|NCT00326183|3321109|P2|Overall Study|Withdrawal by Subject|7
1016034|NCT00326183|3321110|P1|Overall Study|Withdrawal by Subject|35
1016035|NCT00326183|3321109|P2|Overall Study|Protocol Violation|3
1016036|NCT00326183|3321110|P1|Overall Study|Protocol Violation|6
1016037|NCT00326183|3321109|P2|Overall Study|Lost to Follow-up|56
1016038|NCT00326183|3321110|P1|Overall Study|Lost to Follow-up|104
1016039|NCT00326118|3321142|P2|Active Phase|Withdrawal by Subject|1
1016040|NCT00326118|3321143|P1|Active Phase|Withdrawal by Subject|4
1016041|NCT00326001|3321179|P2|Overall Study|Physician Decision|3
1016042|NCT00326001|3321180|P1|Overall Study|Physician Decision|3
1016043|NCT00326001|3321179|P2|Overall Study|Adverse Event|5
1016044|NCT00326001|3321180|P1|Overall Study|Adverse Event|4
1016045|NCT00325897|3321194|P2|Overall Study|Lost to Follow-up|13
1016046|NCT00325897|3321195|P1|Overall Study|Lost to Follow-up|12
1016047|NCT00325819|3321215|P2|Overall Study|Lost to Follow-up|3
1016048|NCT00325819|3321216|P1|Overall Study|Lost to Follow-up|3
1016049|NCT00325819|3321215|P2|Overall Study|Did not take a dose of study product|9
1016050|NCT00325819|3321216|P1|Overall Study|Did not take a dose of study product|4
1016051|NCT00325819|3321215|P2|Overall Study|Study product lost in mail|1
1016052|NCT00325819|3321216|P1|Overall Study|Study product lost in mail|2
1016053|NCT00325754|3321243|P2|Overall Study|Adverse Event|1
1016054|NCT00325754|3321244|P1|Overall Study|Adverse Event|4
1016055|NCT00325468|3321290|P5|Overall Study|site closure etc|1
1016056|NCT00325468|3321291|P4|Overall Study|site closure etc|8
1016057|NCT00325468|3321292|P3|Overall Study|site closure etc|1
1016058|NCT00325468|3321293|P2|Overall Study|site closure etc|2
1016059|NCT00325468|3321294|P1|Overall Study|site closure etc|4
1016060|NCT00325468|3321290|P5|Overall Study|Withdrawal by Subject|4
1016061|NCT00325468|3321291|P4|Overall Study|Withdrawal by Subject|14
1016062|NCT00325468|3321292|P3|Overall Study|Withdrawal by Subject|0
1016063|NCT00325468|3321293|P2|Overall Study|Withdrawal by Subject|1
1016064|NCT00325468|3321294|P1|Overall Study|Withdrawal by Subject|3
1016065|NCT00325468|3321290|P5|Overall Study|Physician Decision|0
1016066|NCT00325468|3321291|P4|Overall Study|Physician Decision|1
1016067|NCT00325468|3321292|P3|Overall Study|Physician Decision|0
1016068|NCT00325468|3321293|P2|Overall Study|Physician Decision|1
1016069|NCT00325468|3321294|P1|Overall Study|Physician Decision|1
1016070|NCT00325468|3321290|P5|Overall Study|Lost to Follow-up|2
1016071|NCT00325468|3321291|P4|Overall Study|Lost to Follow-up|2
1016072|NCT00325468|3321292|P3|Overall Study|Lost to Follow-up|1
1016073|NCT00325468|3321293|P2|Overall Study|Lost to Follow-up|0
1016074|NCT00325468|3321294|P1|Overall Study|Lost to Follow-up|0
1016075|NCT00325468|3321290|P5|Overall Study|Death|0
1016076|NCT00325468|3321291|P4|Overall Study|Death|4
1016077|NCT00325468|3321292|P3|Overall Study|Death|2
1016078|NCT00325468|3321293|P2|Overall Study|Death|0
1016079|NCT00325468|3321294|P1|Overall Study|Death|2
1016080|NCT00325468|3321290|P5|Overall Study|Adverse Event|1
1016081|NCT00325468|3321291|P4|Overall Study|Adverse Event|5
1016082|NCT00325468|3321292|P3|Overall Study|Adverse Event|0
1016083|NCT00325468|3321293|P2|Overall Study|Adverse Event|1
1016084|NCT00325468|3321294|P1|Overall Study|Adverse Event|1
1016085|NCT00325416|3321377|P2|Phase II: Treatment at MTD|Withdrawal by Subject|1
1016086|NCT00325416|3321378|P1|Phase II: Treatment at MTD|Withdrawal by Subject|0
1016087|NCT00325416|3321377|P2|Phase II: Treatment at MTD|denial of insurance coverage|1
1016088|NCT00325416|3321378|P1|Phase II: Treatment at MTD|denial of insurance coverage|0
1016089|NCT00325416|3321377|P2|Phase I: Dose Escalation|Inability to collect adequate stem cells|1
1016090|NCT00325416|3321378|P1|Phase I: Dose Escalation|Inability to collect adequate stem cells|0
1016091|NCT00325416|3321377|P2|Phase I: Dose Escalation|Withdrawal by Subject|2
1016092|NCT00325416|3321378|P1|Phase I: Dose Escalation|Withdrawal by Subject|7
1016093|NCT00325416|3321377|P2|Phase I: Dose Escalation|Denial of insurance coverage|4
1016094|NCT00325416|3321378|P1|Phase I: Dose Escalation|Denial of insurance coverage|7
1016095|NCT00325416|3321377|P2|Phase I: Dose Escalation|Pre-transplant screen failure|9
1016096|NCT00325416|3321378|P1|Phase I: Dose Escalation|Pre-transplant screen failure|8
1016097|NCT00325234|3321431|P2|Overall Study|Progressive Disease|37
1016098|NCT00325234|3321432|P1|Overall Study|Progressive Disease|34
1016099|NCT00325234|3321431|P2|Overall Study|Physician Decision|12
1016100|NCT00325234|3321432|P1|Overall Study|Physician Decision|17
1016101|NCT00325234|3321431|P2|Overall Study|Subject Decision|8
1016102|NCT00325234|3321432|P1|Overall Study|Subject Decision|6
1016103|NCT00325234|3321431|P2|Overall Study|Entry Criteria Not Met|2
1016104|NCT00325234|3321432|P1|Overall Study|Entry Criteria Not Met|1
1016105|NCT00325234|3321431|P2|Overall Study|Death due to Study Disease|0
1016106|NCT00325234|3321432|P1|Overall Study|Death due to Study Disease|1
1016107|NCT00325234|3321431|P2|Overall Study|Adverse Event|7
1016108|NCT00325234|3321432|P1|Overall Study|Adverse Event|10
1016109|NCT00325195|3321451|P3|Received Intervention: ITT Population|Protocol violation/non-compliance|0
1016110|NCT00325195|3321452|P2|Received Intervention: ITT Population|Protocol violation/non-compliance|1
1016111|NCT00325195|3321453|P1|Received Intervention: ITT Population|Protocol violation/non-compliance|1
1016112|NCT00325195|3321451|P3|Received Intervention: ITT Population|Lost to Follow-up|2
1016113|NCT00325195|3321452|P2|Received Intervention: ITT Population|Lost to Follow-up|0
1016114|NCT00325195|3321453|P1|Received Intervention: ITT Population|Lost to Follow-up|0
1016115|NCT00325195|3321451|P3|Received Intervention: ITT Population|Withdrawal by Subject|1
1016116|NCT00325195|3321452|P2|Received Intervention: ITT Population|Withdrawal by Subject|6
1016117|NCT00325195|3321453|P1|Received Intervention: ITT Population|Withdrawal by Subject|7
1016118|NCT00325195|3321451|P3|Received Intervention: ITT Population|Death|0
1016119|NCT00325195|3321452|P2|Received Intervention: ITT Population|Death|1
1016120|NCT00325195|3321453|P1|Received Intervention: ITT Population|Death|3
1016121|NCT00325195|3321451|P3|Received Intervention: ITT Population|Adverse Event|1
1016122|NCT00325195|3321452|P2|Received Intervention: ITT Population|Adverse Event|17
1016123|NCT00325195|3321453|P1|Received Intervention: ITT Population|Adverse Event|15
1016124|NCT00325195|3321451|P3|Randomized|Not dosed|3
1016125|NCT00325195|3321452|P2|Randomized|Not dosed|5
1016126|NCT00325195|3321453|P1|Randomized|Not dosed|5
1016127|NCT00325156|3321476|P1|Overall Study|Withdrawal by Subject|31
1016128|NCT00325156|3321476|P1|Overall Study|Other|1
1016129|NCT00325156|3321476|P1|Overall Study|Lost to follow-up (incompl. vaccination)|16
1016130|NCT00325156|3321476|P1|Overall Study|Adverse event, non-fatal|3
1016131|NCT00325156|3321476|P1|Overall Study|Migrated/moved from study area|12
1016132|NCT00325156|3321476|P1|Overall Study|Lost to follow-up (complete vaccination)|41
1016133|NCT00325156|3321476|P1|Overall Study|Protocol Violation|8
1016134|NCT00325143|3321483|P1|Overall Study|Withdrawal by Subject|8
1016135|NCT00325143|3321483|P1|Overall Study|Lost to follow-up(incompl. vacc. course)|4
1016136|NCT00325143|3321483|P1|Overall Study|Migrated/moved from study area|1
1016137|NCT00325143|3321483|P1|Overall Study|Lost to follow-up(complete vacc. course)|13
1016138|NCT00325130|3321493|P2|Overall Study|Patient Discontinued for Other|0
1016139|NCT00325130|3321494|P1|Overall Study|Patient Discontinued for Other|1
1016140|NCT00325130|3321493|P2|Overall Study|Moved|1
1016141|NCT00325130|3321494|P1|Overall Study|Moved|0
1016142|NCT00325130|3321493|P2|Overall Study|Protocol Deviation|1
1016143|NCT00325130|3321494|P1|Overall Study|Protocol Deviation|0
1016144|NCT00325130|3321493|P2|Overall Study|Withdrawal by Subject|14
1016145|NCT00325130|3321494|P1|Overall Study|Withdrawal by Subject|12
1016146|NCT00325130|3321493|P2|Overall Study|Lost to Follow-up|14
1016147|NCT00325130|3321494|P1|Overall Study|Lost to Follow-up|6
1016148|NCT00325039|3321551|P2|Overall Study|Lost to Follow-up|14
1016149|NCT00325039|3321552|P1|Overall Study|Lost to Follow-up|18
1016150|NCT00324987|3321568|P2|Overall Study|symptomatic deterioration, toxicity, etc|3
1016151|NCT00324987|3321569|P1|Overall Study|symptomatic deterioration, toxicity, etc|2
1016152|NCT00324987|3321568|P2|Overall Study|Progression|1
1016153|NCT00324987|3321569|P1|Overall Study|Progression|1
1016154|NCT00324987|3321568|P2|Overall Study|Withdrawal by Subject|1
1016155|NCT00324987|3321569|P1|Overall Study|Withdrawal by Subject|1
1016156|NCT00324987|3321568|P2|Overall Study|Adverse Event|1
1016157|NCT00324987|3321569|P1|Overall Study|Adverse Event|2
1016158|NCT00324961|3321583|P1|Overall Study|Other|2
1016159|NCT00324961|3321583|P1|Overall Study|Protocol Violation|3
1016160|NCT00324961|3321583|P1|Overall Study|Lost to Follow-up|22
1016161|NCT00324961|3321583|P1|Overall Study|Consent Withdrawn|11
1016162|NCT00324961|3321583|P1|Overall Study|Adverse Event|5
1016163|NCT00324805|3321634|P2|Overall Study|Did not start therapy|17
1016164|NCT00324805|3321635|P1|Overall Study|Did not start therapy|12
1016165|NCT00324805|3321634|P2|Overall Study|Other|2
1016166|NCT00324805|3321635|P1|Overall Study|Other|0
1016167|NCT00324805|3321634|P2|Overall Study|Other reasons|26
1016168|NCT00324805|3321635|P1|Overall Study|Other reasons|7
1016169|NCT00324805|3321634|P2|Overall Study|Other complicating disease|9
1016170|NCT00324805|3321635|P1|Overall Study|Other complicating disease|1
1016171|NCT00324805|3321634|P2|Overall Study|Alternative therapy|8
1016172|NCT00324805|3321635|P1|Overall Study|Alternative therapy|4
1016173|NCT00324805|3321634|P2|Overall Study|Death|9
1016174|NCT00324805|3321635|P1|Overall Study|Death|6
1016175|NCT00324805|3321634|P2|Overall Study|Withdrawal by Subject|174
1016176|NCT00324805|3321635|P1|Overall Study|Withdrawal by Subject|51
1016177|NCT00324805|3321634|P2|Overall Study|Progression|35
1016178|NCT00324805|3321635|P1|Overall Study|Progression|7
1016179|NCT00324805|3321634|P2|Overall Study|Adverse Event|203
1016180|NCT00324805|3321635|P1|Overall Study|Adverse Event|62
1016181|NCT00324740|3321660|P3|Overall Study|Withdrawal by Subject|1
1016182|NCT00324740|3321661|P2|Overall Study|Withdrawal by Subject|0
1016183|NCT00324740|3321662|P1|Overall Study|Withdrawal by Subject|1
1016184|NCT00324675|3321682|P2|Overall Study|Adverse Event|0
1016185|NCT00324675|3321683|P1|Overall Study|Adverse Event|1
1016186|NCT00324649|3321691|P2|Overall Study|Noncompliance|0
1016187|NCT00324649|3321692|P1|Overall Study|Noncompliance|1
1016188|NCT00324649|3321691|P2|Overall Study|Withdrawal by Subject|1
1016189|NCT00324649|3321692|P1|Overall Study|Withdrawal by Subject|0
1016190|NCT00324649|3321691|P2|Overall Study|Adverse Event|4
1016191|NCT00324649|3321692|P1|Overall Study|Adverse Event|1
1016192|NCT00324233|3321823|P2|Second Period|Protocol Violation|6
1016193|NCT00324233|3321824|P1|Second Period|Protocol Violation|4
1016194|NCT00324233|3321823|P2|Second Period|unable to insert catheter|1
1016195|NCT00324233|3321824|P1|Second Period|unable to insert catheter|1
1016196|NCT00324233|3321823|P2|First Period|unable to insert catheter|0
1016197|NCT00324233|3321824|P1|First Period|unable to insert catheter|1
1016198|NCT00324168|3321832|P2|Overall Study|Patient did not visit in f/u window|9
1016199|NCT00324168|3321833|P1|Overall Study|Patient did not visit in f/u window|6
1016200|NCT00324168|3321832|P2|Overall Study|Death|3
1016201|NCT00324168|3321833|P1|Overall Study|Death|3
1016202|NCT00324168|3321832|P2|Overall Study|Lost to Follow-up|18
1016203|NCT00324168|3321833|P1|Overall Study|Lost to Follow-up|19
1016204|NCT00324155|3321861|P2|Follow-up Phase|On-going participants still on drug|6
1016205|NCT00324155|3321862|P1|Follow-up Phase|On-going participants still on drug|11
1016206|NCT00324155|3321861|P2|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0
1016207|NCT00324155|3321862|P1|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1
1016208|NCT00324155|3321861|P2|Received Treatment in Maintenance Phase|Adverse Event|3
1016209|NCT00324155|3321862|P1|Received Treatment in Maintenance Phase|Adverse Event|0
1016210|NCT00324155|3321861|P2|Received Treatment in Maintenance Phase|Withdrawal by Subject|3
1016211|NCT00324155|3321862|P1|Received Treatment in Maintenance Phase|Withdrawal by Subject|1
1016212|NCT00324155|3321861|P2|Received Treatment in Maintenance Phase|Study Drug Toxicity|0
1016213|NCT00324155|3321862|P1|Received Treatment in Maintenance Phase|Study Drug Toxicity|4
1016214|NCT00324155|3321861|P2|Received Treatment in Maintenance Phase|Disease Progression|41
1016215|NCT00324155|3321862|P1|Received Treatment in Maintenance Phase|Disease Progression|26
1016216|NCT00324155|3321861|P2|Received Treatment in Induction Phase|Physician Decision|0
1016217|NCT00324155|3321862|P1|Received Treatment in Induction Phase|Physician Decision|2
1016218|NCT00324155|3321861|P2|Received Treatment in Induction Phase|Withdrawal by Subject|5
1016219|NCT00324155|3321862|P1|Received Treatment in Induction Phase|Withdrawal by Subject|6
1016220|NCT00324155|3321861|P2|Received Treatment in Induction Phase|Adverse Event|7
1016221|NCT00324155|3321862|P1|Received Treatment in Induction Phase|Adverse Event|6
1016222|NCT00324155|3321861|P2|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8
1016223|NCT00324155|3321862|P1|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9
1016224|NCT00324155|3321861|P2|Received Treatment in Induction Phase|Death|15
1016225|NCT00324155|3321862|P1|Received Treatment in Induction Phase|Death|8
1016226|NCT00324155|3321861|P2|Received Treatment in Induction Phase|Study Drug Toxicity|10
1016227|NCT00324155|3321862|P1|Received Treatment in Induction Phase|Study Drug Toxicity|83
1016228|NCT00324155|3321861|P2|Received Treatment in Induction Phase|Disease Progression|152
1016229|NCT00324155|3321862|P1|Received Treatment in Induction Phase|Disease Progression|88
1016230|NCT00324155|3321861|P2|Enrolled and Randomized|Lost to Follow-up|1
1016231|NCT00324155|3321862|P1|Enrolled and Randomized|Lost to Follow-up|0
1016232|NCT00324155|3321861|P2|Enrolled and Randomized|No longer met study criteria|0
1016233|NCT00324155|3321862|P1|Enrolled and Randomized|No longer met study criteria|3
1016234|NCT00324116|3321892|P1|Overall Study|Other|5
1016235|NCT00324116|3321892|P1|Overall Study|Withdrawal by Subject|5
1016236|NCT00324116|3321892|P1|Overall Study|Lack of Efficacy|17
1016237|NCT00324116|3321892|P1|Overall Study|Adverse Event|5
1016238|NCT00324038|3321904|P2|Overall Study|Other|13
1016239|NCT00324038|3321905|P1|Overall Study|Other|6
1016240|NCT00324038|3321904|P2|Overall Study|Lost to Follow-up|2
1016241|NCT00324038|3321905|P1|Overall Study|Lost to Follow-up|0
1016242|NCT00324038|3321904|P2|Overall Study|Lack of Efficacy|13
1016243|NCT00324038|3321905|P1|Overall Study|Lack of Efficacy|5
1016244|NCT00324038|3321904|P2|Overall Study|Adverse Event|23
1016245|NCT00324038|3321905|P1|Overall Study|Adverse Event|38
1016246|NCT00323882|3321916|P5|Overall Study|Not Specified|1
1016247|NCT00323882|3321917|P4|Overall Study|Not Specified|1
1016248|NCT00323882|3321918|P3|Overall Study|Not Specified|0
1016249|NCT00323882|3321919|P2|Overall Study|Not Specified|0
1016250|NCT00323882|3321920|P1|Overall Study|Not Specified|0
1016251|NCT00323882|3321916|P5|Overall Study|Lost to Follow-up|1
1016252|NCT00323882|3321917|P4|Overall Study|Lost to Follow-up|0
1016253|NCT00323882|3321918|P3|Overall Study|Lost to Follow-up|1
1016254|NCT00323882|3321919|P2|Overall Study|Lost to Follow-up|0
1016255|NCT00323882|3321920|P1|Overall Study|Lost to Follow-up|0
1016256|NCT00323882|3321916|P5|Overall Study|Death|5
1016257|NCT00323882|3321917|P4|Overall Study|Death|0
1016258|NCT00323882|3321918|P3|Overall Study|Death|1
1016259|NCT00323882|3321919|P2|Overall Study|Death|1
1016260|NCT00323882|3321920|P1|Overall Study|Death|0
1016261|NCT00323882|3321916|P5|Overall Study|Disease Progression|22
1016262|NCT00323882|3321917|P4|Overall Study|Disease Progression|5
1016263|NCT00323882|3321918|P3|Overall Study|Disease Progression|10
1016264|NCT00323882|3321919|P2|Overall Study|Disease Progression|4
1016265|NCT00323882|3321920|P1|Overall Study|Disease Progression|6
1016266|NCT00323882|3321916|P5|Overall Study|Adverse Event|3
1016267|NCT00323882|3321917|P4|Overall Study|Adverse Event|1
1016268|NCT00323882|3321918|P3|Overall Study|Adverse Event|1
1016269|NCT00323882|3321919|P2|Overall Study|Adverse Event|1
1016270|NCT00323882|3321920|P1|Overall Study|Adverse Event|2
1016271|NCT00323869|3321991|P1|Overall Study|Death|1
1016272|NCT00323622|3322047|P8|Overall Study|Death|2
1016273|NCT00323622|3322048|P7|Overall Study|Death|0
1016274|NCT00323622|3322049|P6|Overall Study|Death|0
1016275|NCT00323622|3322050|P5|Overall Study|Death|7
1016276|NCT00323622|3322051|P4|Overall Study|Death|0
1016277|NCT00323622|3322052|P3|Overall Study|Death|0
1016278|NCT00323622|3322053|P2|Overall Study|Death|1
1016279|NCT00323622|3322054|P1|Overall Study|Death|1
1016280|NCT00323622|3322047|P8|Overall Study|Other|13
1016281|NCT00323622|3322048|P7|Overall Study|Other|5
1016282|NCT00323622|3322049|P6|Overall Study|Other|74
1016283|NCT00323622|3322050|P5|Overall Study|Other|32
1016284|NCT00323622|3322051|P4|Overall Study|Other|12
1016285|NCT00323622|3322052|P3|Overall Study|Other|4
1016286|NCT00323622|3322053|P2|Overall Study|Other|91
1016287|NCT00323622|3322054|P1|Overall Study|Other|30
1016288|NCT00323609|3322096|P4|Overall Study|Other reason|9
1016289|NCT00323609|3322097|P3|Overall Study|Other reason|4
1016290|NCT00323609|3322098|P2|Overall Study|Other reason|8
1016291|NCT00323609|3322099|P1|Overall Study|Other reason|11
1016292|NCT00323609|3322096|P4|Overall Study|Logistical withdrawal|1
1016293|NCT00323609|3322097|P3|Overall Study|Logistical withdrawal|0
1016294|NCT00323609|3322098|P2|Overall Study|Logistical withdrawal|5
1016295|NCT00323609|3322099|P1|Overall Study|Logistical withdrawal|9
1016296|NCT00323609|3322096|P4|Overall Study|Unrelenting or severe back pain|0
1016297|NCT00323609|3322097|P3|Overall Study|Unrelenting or severe back pain|0
1016298|NCT00323609|3322098|P2|Overall Study|Unrelenting or severe back pain|1
1016299|NCT00323609|3322099|P1|Overall Study|Unrelenting or severe back pain|1
1016300|NCT00323609|3322096|P4|Overall Study|Sponsor discontinued trial|0
1016301|NCT00323609|3322097|P3|Overall Study|Sponsor discontinued trial|0
1016302|NCT00323609|3322098|P2|Overall Study|Sponsor discontinued trial|29
1016303|NCT00323609|3322099|P1|Overall Study|Sponsor discontinued trial|29
1016304|NCT00323609|3322096|P4|Overall Study|Other non-VCF-related medical condition|0
1016305|NCT00323609|3322097|P3|Overall Study|Other non-VCF-related medical condition|0
1016306|NCT00323609|3322098|P2|Overall Study|Other non-VCF-related medical condition|2
1016307|NCT00323609|3322099|P1|Overall Study|Other non-VCF-related medical condition|3
1016308|NCT00323609|3322096|P4|Overall Study|Withdrawal by Subject|4
1016309|NCT00323609|3322097|P3|Overall Study|Withdrawal by Subject|4
1016310|NCT00323609|3322098|P2|Overall Study|Withdrawal by Subject|23
1016311|NCT00323609|3322099|P1|Overall Study|Withdrawal by Subject|11
1016312|NCT00323609|3322096|P4|Overall Study|Physician Decision|1
1016313|NCT00323609|3322097|P3|Overall Study|Physician Decision|0
1016314|NCT00323609|3322098|P2|Overall Study|Physician Decision|0
1016315|NCT00323609|3322099|P1|Overall Study|Physician Decision|2
1016316|NCT00323609|3322096|P4|Overall Study|Lost to Follow-up|0
1016317|NCT00323609|3322097|P3|Overall Study|Lost to Follow-up|0
1016318|NCT00323609|3322098|P2|Overall Study|Lost to Follow-up|10
1016319|NCT00323609|3322099|P1|Overall Study|Lost to Follow-up|9
1016320|NCT00323609|3322096|P4|Overall Study|Death|0
1016321|NCT00323609|3322097|P3|Overall Study|Death|0
1016322|NCT00323609|3322098|P2|Overall Study|Death|21
1016323|NCT00323609|3322099|P1|Overall Study|Death|16
1016324|NCT00323557|3322135|P2|Overall Study|Physician Decision|0
1016325|NCT00323557|3322136|P1|Overall Study|Physician Decision|1
1016326|NCT00323492|3322145|P3|Study Phase 2|Protocol Violation|0
1016327|NCT00323492|3322146|P2|Study Phase 2|Protocol Violation|0
1016328|NCT00323492|3322147|P1|Study Phase 2|Protocol Violation|1
1016329|NCT00323492|3322145|P3|Study Phase 2|Noncompliance with study schedule|1
1016330|NCT00323492|3322146|P2|Study Phase 2|Noncompliance with study schedule|0
1016331|NCT00323492|3322147|P1|Study Phase 2|Noncompliance with study schedule|0
1016332|NCT00323492|3322145|P3|Study Phase 2|Withdrawal by Subject|0
1016333|NCT00323492|3322146|P2|Study Phase 2|Withdrawal by Subject|1
1016334|NCT00323492|3322147|P1|Study Phase 2|Withdrawal by Subject|0
1016335|NCT00323492|3322145|P3|Study Phase 2|Lost to Follow-up|0
1016336|NCT00323492|3322146|P2|Study Phase 2|Lost to Follow-up|0
1016337|NCT00323492|3322147|P1|Study Phase 2|Lost to Follow-up|1
1016338|NCT00323492|3322145|P3|Study Phase 2|Physician Decision|0
1016339|NCT00323492|3322146|P2|Study Phase 2|Physician Decision|0
1016340|NCT00323492|3322147|P1|Study Phase 2|Physician Decision|1
1016341|NCT00323492|3322145|P3|Study Phase 2|Adverse Event|0
1016342|NCT00323492|3322146|P2|Study Phase 2|Adverse Event|0
1016343|NCT00323492|3322147|P1|Study Phase 2|Adverse Event|1
1016344|NCT00323492|3322145|P3|Study Phase 1|Adverse Event|0
1016345|NCT00323492|3322146|P2|Study Phase 1|Adverse Event|0
1016346|NCT00323492|3322147|P1|Study Phase 1|Adverse Event|2
1016347|NCT00323479|3322178|P1|Overall Study|house moving|1
1016348|NCT00323479|3322178|P1|Overall Study|Protocol Violation|3
1016349|NCT00323479|3322178|P1|Overall Study|Withdrawal by Subject|2
1016350|NCT00323479|3322178|P1|Overall Study|Adverse Event|2
1016351|NCT00323414|3322211|P2|Overall Study|Withdrawal by Subject|1
1016352|NCT00323414|3322212|P1|Overall Study|Withdrawal by Subject|0
1016353|NCT00323310|3322234|P1|Overall Study|did not complete the 24-hr f-up visit|1
1016354|NCT00323310|3322234|P1|Overall Study|a parent refused blood draw|1
1016355|NCT00323310|3322234|P1|Overall Study|Withdrawal by Subject|1
1016356|NCT00323297|3322249|P2|Part B (Open-label)|Protocol Violation|1
1016357|NCT00323297|3322250|P1|Part B (Open-label)|Protocol Violation|0
1016358|NCT00323297|3322249|P2|Part B (Open-label)|Adverse Event|5
1016359|NCT00323297|3322250|P1|Part B (Open-label)|Adverse Event|5
1016360|NCT00323297|3322249|P2|Part B (Open-label)|Lack of Efficacy|1
1016361|NCT00323297|3322250|P1|Part B (Open-label)|Lack of Efficacy|3
1016362|NCT00323297|3322249|P2|Part B (Open-label)|Withdrawal by Subject|3
1016363|NCT00323297|3322250|P1|Part B (Open-label)|Withdrawal by Subject|1
1016364|NCT00323297|3322249|P2|Part B (Open-label)|Reason unspecified|1
1016365|NCT00323297|3322250|P1|Part B (Open-label)|Reason unspecified|0
1016366|NCT00323297|3322249|P2|Part B (Open-label)|Death|1
1016367|NCT00323297|3322250|P1|Part B (Open-label)|Death|0
1016368|NCT00323297|3322249|P2|Part A (Double Blind Randomized)|Related adverse event|2
1016369|NCT00323297|3322250|P1|Part A (Double Blind Randomized)|Related adverse event|2
1016370|NCT00323297|3322249|P2|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0
1016371|NCT00323297|3322250|P1|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1
1016372|NCT00323297|3322249|P2|Part A (Double Blind Randomized)|Unrelated adverse event|0
1016373|NCT00323297|3322250|P1|Part A (Double Blind Randomized)|Unrelated adverse event|1
1016374|NCT00323297|3322249|P2|Part A (Double Blind Randomized)|Protocol Violation|3
1016375|NCT00323297|3322250|P1|Part A (Double Blind Randomized)|Protocol Violation|1
1016376|NCT00323297|3322249|P2|Part A (Double Blind Randomized)|Death|1
1016377|NCT00323297|3322250|P1|Part A (Double Blind Randomized)|Death|0
1016378|NCT00323297|3322249|P2|Part A (Double Blind Randomized)|Reason unspecified|1
1016379|NCT00323297|3322250|P1|Part A (Double Blind Randomized)|Reason unspecified|0
1016380|NCT00323258|3322290|P2|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2
1016381|NCT00323258|3322291|P1|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1
1016382|NCT00323258|3322290|P2|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10
1016383|NCT00323258|3322291|P1|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12
1016384|NCT00323258|3322290|P2|Secondary Outcome (6 Mon Refill Records)|Death|2
1016385|NCT00323258|3322291|P1|Secondary Outcome (6 Mon Refill Records)|Death|1
1016386|NCT00323258|3322290|P2|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1
1016387|NCT00323258|3322291|P1|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2
1016388|NCT00323258|3322290|P2|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5
1016389|NCT00323258|3322291|P1|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1
1016390|NCT00323258|3322290|P2|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11
1016391|NCT00323258|3322291|P1|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12
1016392|NCT00323258|3322290|P2|Primary Outcome (Phone Call at 6 Months)|Death|2
1016393|NCT00323258|3322291|P1|Primary Outcome (Phone Call at 6 Months)|Death|1
1016394|NCT00323115|3322316|P1|Adjuvant Therapy & Survival Follow-Up|Death|8
1016395|NCT00323115|3322316|P1|Vaccine Administration|Adverse Event|1
1016396|NCT00323063|3322343|P2|Overall Study|brain mets discovered prior to treatment|0
1016397|NCT00323063|3322344|P1|Overall Study|brain mets discovered prior to treatment|1
1016398|NCT00323063|3322343|P2|Overall Study|Adverse Event|0
1016399|NCT00323063|3322344|P1|Overall Study|Adverse Event|1
1016400|NCT00322881|3322361|P1|Overall Study|Disease Progression|2
1016401|NCT00322881|3322361|P1|Overall Study|Adverse Event|1
1016402|NCT00322881|3322361|P1|Overall Study|Death|2
1016403|NCT00322868|3322365|P1|Overall Study|disease progression|1
1016404|NCT00322842|3322390|P2|Overall Study|Death|0
1016405|NCT00322842|3322391|P1|Overall Study|Death|1
1016406|NCT00322842|3322390|P2|Overall Study|Refused transplant|0
1016407|NCT00322842|3322391|P1|Overall Study|Refused transplant|1
1016408|NCT00322842|3322390|P2|Overall Study|Lost to Follow-up|1
1016409|NCT00322842|3322391|P1|Overall Study|Lost to Follow-up|0
1016410|NCT00322842|3322390|P2|Overall Study|Withdrawal by Subject|1
1016411|NCT00322842|3322391|P1|Overall Study|Withdrawal by Subject|0
1016412|NCT00322712|3322429|P1|Overall Study|treated with bevacizumab not cetuximab|1
1016413|NCT00322621|3322433|P3|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
1016414|NCT00322621|3322434|P2|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
1016415|NCT00322621|3322435|P1|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0
1016416|NCT00322621|3322433|P3|Period III - Maintenance / Rescue Phase|Death|0
1016417|NCT00322621|3322434|P2|Period III - Maintenance / Rescue Phase|Death|1
1016418|NCT00322621|3322435|P1|Period III - Maintenance / Rescue Phase|Death|0
1016419|NCT00322621|3322433|P3|Period III - Maintenance / Rescue Phase|Protocol Violation|5
1016420|NCT00322621|3322434|P2|Period III - Maintenance / Rescue Phase|Protocol Violation|2
1016421|NCT00322621|3322435|P1|Period III - Maintenance / Rescue Phase|Protocol Violation|0
1016422|NCT00322621|3322433|P3|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1
1016423|NCT00322621|3322434|P2|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7
1016424|NCT00322621|3322435|P1|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0
1016425|NCT00322621|3322433|P3|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24
1016426|NCT00322621|3322434|P2|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4
1016427|NCT00322621|3322435|P1|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0
1016428|NCT00322621|3322433|P3|Period III - Maintenance / Rescue Phase|Adverse Event|5
1016429|NCT00322621|3322434|P2|Period III - Maintenance / Rescue Phase|Adverse Event|14
1016430|NCT00322621|3322435|P1|Period III - Maintenance / Rescue Phase|Adverse Event|0
1016431|NCT00322621|3322433|P3|Period II - Acute Therapy Phase|Physician Decision|0
1016432|NCT00322621|3322434|P2|Period II - Acute Therapy Phase|Physician Decision|0
1016433|NCT00322621|3322435|P1|Period II - Acute Therapy Phase|Physician Decision|1
1016434|NCT00322621|3322433|P3|Period II - Acute Therapy Phase|Protocol Violation|0
1016435|NCT00322621|3322434|P2|Period II - Acute Therapy Phase|Protocol Violation|0
1016436|NCT00322621|3322435|P1|Period II - Acute Therapy Phase|Protocol Violation|2
1016437|NCT00322621|3322433|P3|Period II - Acute Therapy Phase|Withdrawal by Subject|0
1016438|NCT00322621|3322434|P2|Period II - Acute Therapy Phase|Withdrawal by Subject|0
1016439|NCT00322621|3322435|P1|Period II - Acute Therapy Phase|Withdrawal by Subject|8
1016440|NCT00322621|3322433|P3|Period II - Acute Therapy Phase|Lack of Efficacy|0
1016441|NCT00322621|3322434|P2|Period II - Acute Therapy Phase|Lack of Efficacy|0
1016442|NCT00322621|3322435|P1|Period II - Acute Therapy Phase|Lack of Efficacy|1
1016443|NCT00322621|3322433|P3|Period II - Acute Therapy Phase|Adverse Event|0
1016444|NCT00322621|3322434|P2|Period II - Acute Therapy Phase|Adverse Event|0
1016445|NCT00322621|3322435|P1|Period II - Acute Therapy Phase|Adverse Event|20
1016446|NCT00322556|3322487|P1|Overall Study|Other Reason|7
1016447|NCT00322556|3322487|P1|Overall Study|Lost to Follow-up|3
1016448|NCT00322556|3322487|P1|Overall Study|Withdrawal by Subject|1
1016449|NCT00322556|3322487|P1|Overall Study|Adverse Event|1
1016450|NCT00322491|3322503|P2|Overall Study|Death|2
1016451|NCT00322491|3322504|P1|Overall Study|Death|1
1016452|NCT00322491|3322503|P2|Overall Study|Adverse Event|0
1016453|NCT00322491|3322504|P1|Overall Study|Adverse Event|1
1016454|NCT00322452|3322594|P2|Overall Study|Death|227
1016455|NCT00322452|3322595|P1|Overall Study|Death|223
1016456|NCT00322452|3322594|P2|Overall Study|Withdrawal by Subject|46
1016457|NCT00322452|3322595|P1|Overall Study|Withdrawal by Subject|19
1016458|NCT00322452|3322594|P2|Overall Study|Lost to Follow-up|2
1016459|NCT00322452|3322595|P1|Overall Study|Lost to Follow-up|5
1016460|NCT00322452|3322594|P2|Overall Study|Eligibility criteria not fulfilled|1
1016461|NCT00322452|3322595|P1|Overall Study|Eligibility criteria not fulfilled|0
1016462|NCT00322387|3322646|P2|Follow-up Period|Death|0
1016463|NCT00322387|3322647|P1|Follow-up Period|Death|1
1016464|NCT00322387|3322646|P2|Follow-up Period|Final assessment not done|3
1016465|NCT00322387|3322647|P1|Follow-up Period|Final assessment not done|1
1016466|NCT00322387|3322646|P2|Treatment Period|Adverse Event|1
1016467|NCT00322387|3322647|P1|Treatment Period|Adverse Event|0
1016468|NCT00322374|3322681|P4|Second Escalation|Study Drug Toxicity|0
1016469|NCT00322374|3322682|P3|Second Escalation|Study Drug Toxicity|1
1016470|NCT00322374|3322683|P2|Second Escalation|Study Drug Toxicity|0
1016471|NCT00322374|3322684|P1|Second Escalation|Study Drug Toxicity|0
1016472|NCT00322374|3322681|P4|Second Escalation|Physician Decision|0
1016473|NCT00322374|3322682|P3|Second Escalation|Physician Decision|5
1016474|NCT00322374|3322683|P2|Second Escalation|Physician Decision|0
1016475|NCT00322374|3322684|P1|Second Escalation|Physician Decision|0
1016476|NCT00322374|3322681|P4|First Escalation|Participant Request|0
1016477|NCT00322374|3322682|P3|First Escalation|Participant Request|0
1016478|NCT00322374|3322683|P2|First Escalation|Participant Request|1
1016479|NCT00322374|3322684|P1|First Escalation|Participant Request|0
1016480|NCT00322374|3322681|P4|First Escalation|Study Drug Toxicity|0
1016481|NCT00322374|3322682|P3|First Escalation|Study Drug Toxicity|0
1016482|NCT00322374|3322683|P2|First Escalation|Study Drug Toxicity|11
1016483|NCT00322374|3322684|P1|First Escalation|Study Drug Toxicity|0
1016484|NCT00322374|3322681|P4|First Escalation|Physician Decision|0
1016485|NCT00322374|3322682|P3|First Escalation|Physician Decision|0
1016486|NCT00322374|3322683|P2|First Escalation|Physician Decision|12
1016487|NCT00322374|3322684|P1|First Escalation|Physician Decision|0
1016488|NCT00322374|3322681|P4|First Escalation|Documented Disease Progression|0
1016489|NCT00322374|3322682|P3|First Escalation|Documented Disease Progression|0
1016490|NCT00322374|3322683|P2|First Escalation|Documented Disease Progression|6
1016491|NCT00322374|3322684|P1|First Escalation|Documented Disease Progression|0
1016492|NCT00322374|3322681|P4|Starting Dose|Study Drug Toxicity|0
1016493|NCT00322374|3322682|P3|Starting Dose|Study Drug Toxicity|0
1016494|NCT00322374|3322683|P2|Starting Dose|Study Drug Toxicity|0
1016495|NCT00322374|3322684|P1|Starting Dose|Study Drug Toxicity|4
1016496|NCT00322374|3322681|P4|Starting Dose|Physician Decision|0
1016497|NCT00322374|3322682|P3|Starting Dose|Physician Decision|0
1016498|NCT00322374|3322683|P2|Starting Dose|Physician Decision|0
1016499|NCT00322374|3322684|P1|Starting Dose|Physician Decision|2
1016500|NCT00322348|3322734|P2|Overall Study|Reasons not specified|1
1016501|NCT00322348|3322735|P1|Overall Study|Reasons not specified|5
1016502|NCT00322348|3322734|P2|Overall Study|Disease Progression|25
1016503|NCT00322348|3322735|P1|Overall Study|Disease Progression|30
1016504|NCT00322348|3322734|P2|Overall Study|Death|2
1016505|NCT00322348|3322735|P1|Overall Study|Death|0
1016506|NCT00322348|3322734|P2|Overall Study|Lost to Follow-up|0
1016507|NCT00322348|3322735|P1|Overall Study|Lost to Follow-up|1
1016508|NCT00322348|3322734|P2|Overall Study|Withdrawal by Subject|4
1016509|NCT00322348|3322735|P1|Overall Study|Withdrawal by Subject|1
1016510|NCT00322348|3322734|P2|Overall Study|Adverse Event|1
1016511|NCT00322348|3322735|P1|Overall Study|Adverse Event|0
1016512|NCT00322153|3322826|P2|Overall Study|Withdrawn for other reasons|4
1016513|NCT00322153|3322827|P1|Overall Study|Withdrawn for other reasons|5
1016514|NCT00322153|3322826|P2|Overall Study|Lost to Follow-up|4
1016515|NCT00322153|3322827|P1|Overall Study|Lost to Follow-up|5
1016516|NCT00322153|3322826|P2|Overall Study|Lack of Efficacy|3
1016517|NCT00322153|3322827|P1|Overall Study|Lack of Efficacy|8
1016518|NCT00322153|3322826|P2|Overall Study|Withdrawal by Subject|10
1016519|NCT00322153|3322827|P1|Overall Study|Withdrawal by Subject|18
1016520|NCT00322153|3322826|P2|Overall Study|Protocol Violation|14
1016521|NCT00322153|3322827|P1|Overall Study|Protocol Violation|6
1016522|NCT00322153|3322826|P2|Overall Study|Adverse Event|34
1016523|NCT00322153|3322827|P1|Overall Study|Adverse Event|21
1016524|NCT00322049|3322860|P4|Overall Study|Infected with Dengue during study|0
1016525|NCT00322049|3322861|P3|Overall Study|Infected with Dengue during study|0
1016526|NCT00322049|3322862|P2|Overall Study|Infected with Dengue during study|1
1016527|NCT00322049|3322863|P1|Overall Study|Infected with Dengue during study|0
1016528|NCT00322049|3322860|P4|Overall Study|Moved out of area|1
1016529|NCT00322049|3322861|P3|Overall Study|Moved out of area|0
1016530|NCT00322049|3322862|P2|Overall Study|Moved out of area|0
1016531|NCT00322049|3322863|P1|Overall Study|Moved out of area|0
1016532|NCT00321984|3322896|P3|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
1016533|NCT00321984|3322897|P2|Overall Study|Per Sponsor Due to High Baseline Gastrin|1
1016534|NCT00321984|3322898|P1|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
1016535|NCT00321984|3322896|P3|Overall Study|Per Investigator Request|0
1016536|NCT00321984|3322897|P2|Overall Study|Per Investigator Request|0
1016537|NCT00321984|3322898|P1|Overall Study|Per Investigator Request|1
1016538|NCT00321984|3322896|P3|Overall Study|Per Subject Request|0
1016539|NCT00321984|3322897|P2|Overall Study|Per Subject Request|0
1016540|NCT00321984|3322898|P1|Overall Study|Per Subject Request|1
1016541|NCT00321984|3322896|P3|Overall Study|Pregnancy|0
1016542|NCT00321984|3322897|P2|Overall Study|Pregnancy|1
1016543|NCT00321984|3322898|P1|Overall Study|Pregnancy|0
1016544|NCT00321984|3322896|P3|Overall Study|Noncompliant|2
1016545|NCT00321984|3322897|P2|Overall Study|Noncompliant|0
1016546|NCT00321984|3322898|P1|Overall Study|Noncompliant|0
1016547|NCT00321984|3322896|P3|Overall Study|Lack of Efficacy|3
1016548|NCT00321984|3322897|P2|Overall Study|Lack of Efficacy|1
1016549|NCT00321984|3322898|P1|Overall Study|Lack of Efficacy|3
1016550|NCT00321984|3322896|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
1016551|NCT00321984|3322897|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|1
1016552|NCT00321984|3322898|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|3
1016553|NCT00321984|3322896|P3|Overall Study|Withdrawal by Subject|5
1016554|NCT00321984|3322897|P2|Overall Study|Withdrawal by Subject|6
1016555|NCT00321984|3322898|P1|Overall Study|Withdrawal by Subject|8
1016556|NCT00321984|3322896|P3|Overall Study|Lost to Follow-up|2
1016557|NCT00321984|3322897|P2|Overall Study|Lost to Follow-up|4
1016558|NCT00321984|3322898|P1|Overall Study|Lost to Follow-up|2
1016559|NCT00321984|3322896|P3|Overall Study|Protocol Violation|1
1016560|NCT00321984|3322897|P2|Overall Study|Protocol Violation|1
1016561|NCT00321984|3322898|P1|Overall Study|Protocol Violation|0
1016562|NCT00321984|3322896|P3|Overall Study|Adverse Event|8
1016563|NCT00321984|3322897|P2|Overall Study|Adverse Event|6
1016564|NCT00321984|3322898|P1|Overall Study|Adverse Event|9
1016565|NCT00321932|3322926|P2|Overall Study|Missing data|1
1016566|NCT00321932|3322927|P1|Overall Study|Missing data|2
1016567|NCT00321932|3322926|P2|Overall Study|Early relapse|8
1016568|NCT00321932|3322927|P1|Overall Study|Early relapse|2
1016569|NCT00321932|3322926|P2|Overall Study|Withdrawal by Subject|6
1016570|NCT00321932|3322927|P1|Overall Study|Withdrawal by Subject|3
1016571|NCT00321932|3322926|P2|Overall Study|Death|6
1016572|NCT00321932|3322927|P1|Overall Study|Death|3
1016573|NCT00321919|3322951|P2|Overall Study|Other withdrawal reason|6
1016574|NCT00321919|3322952|P1|Overall Study|Other withdrawal reason|7
1016575|NCT00321919|3322951|P2|Overall Study|Failure to Return|1
1016576|NCT00321919|3322952|P1|Overall Study|Failure to Return|3
1016577|NCT00321919|3322951|P2|Overall Study|Other Protocol Violation|3
1016578|NCT00321919|3322952|P1|Overall Study|Other Protocol Violation|2
1016579|NCT00321919|3322951|P2|Overall Study|Refused Treatment|14
1016580|NCT00321919|3322952|P1|Overall Study|Refused Treatment|23
1016581|NCT00321919|3322951|P2|Overall Study|Violation of Selection Criteria at Entry|1
1016582|NCT00321919|3322952|P1|Overall Study|Violation of Selection Criteria at Entry|1
1016583|NCT00321919|3322951|P2|Overall Study|Insufficient Therapeutic Response|0
1016584|NCT00321919|3322952|P1|Overall Study|Insufficient Therapeutic Response|1
1016585|NCT00321919|3322951|P2|Overall Study|Death|17
1016586|NCT00321919|3322952|P1|Overall Study|Death|21
1016587|NCT00321919|3322951|P2|Overall Study|Adverse Event|10
1016588|NCT00321919|3322952|P1|Overall Study|Adverse Event|17
1016589|NCT00321906|3322994|P2|Overall Study|Withdrawal by Subject|4
1016590|NCT00321906|3322995|P1|Overall Study|Withdrawal by Subject|0
1016591|NCT00321906|3322994|P2|Overall Study|Lost to Follow-up|2
1016592|NCT00321906|3322995|P1|Overall Study|Lost to Follow-up|1
1016593|NCT00321906|3322994|P2|Overall Study|Death|6
1016594|NCT00321906|3322995|P1|Overall Study|Death|9
1016595|NCT00321906|3322994|P2|Overall Study|Adverse Event|44
1016596|NCT00321906|3322995|P1|Overall Study|Adverse Event|36
1016597|NCT00321893|3323017|P2|Overall Study|Adverse Event|3
1016598|NCT00321893|3323018|P1|Overall Study|Adverse Event|6
1016599|NCT00321893|3323017|P2|Overall Study|Lost to Follow-up|1
1016600|NCT00321893|3323018|P1|Overall Study|Lost to Follow-up|2
1016601|NCT00321893|3323017|P2|Overall Study|Non-Compliance/Refusal|10
1016602|NCT00321893|3323018|P1|Overall Study|Non-Compliance/Refusal|16
1016603|NCT00321854|3323032|P2|Overall Study|Other|1
1016604|NCT00321854|3323033|P1|Overall Study|Other|1
1016605|NCT00321854|3323032|P2|Overall Study|Withdrawal by Subject|17
1016606|NCT00321854|3323033|P1|Overall Study|Withdrawal by Subject|6
1016607|NCT00321854|3323032|P2|Overall Study|Lost to Follow-up|2
1016608|NCT00321854|3323033|P1|Overall Study|Lost to Follow-up|0
1016609|NCT00321854|3323032|P2|Overall Study|Protocol Violation|5
1016610|NCT00321854|3323033|P1|Overall Study|Protocol Violation|6
1016611|NCT00321854|3323032|P2|Overall Study|Lack of Efficacy|14
1016612|NCT00321854|3323033|P1|Overall Study|Lack of Efficacy|9
1016613|NCT00321854|3323032|P2|Overall Study|Adverse Event|43
1016614|NCT00321854|3323033|P1|Overall Study|Adverse Event|41
1016615|NCT00321828|3323151|P1|Overall Study|No follow up data|1
1016616|NCT00321828|3323151|P1|Overall Study|Ineligible|3
1016617|NCT00321789|3323157|P2|Overall Study|Protocol Violation|3
1016618|NCT00321789|3323158|P1|Overall Study|Protocol Violation|5
1016619|NCT00321789|3323157|P2|Overall Study|Withdrawal by Subject|6
1016620|NCT00321789|3323158|P1|Overall Study|Withdrawal by Subject|6
1016621|NCT00321789|3323157|P2|Overall Study|Lost to Follow-up|7
1016622|NCT00321789|3323158|P1|Overall Study|Lost to Follow-up|4
1016623|NCT00321763|3323190|P4|Overall Study|Lost to Follow-up|4
1016624|NCT00321763|3323191|P3|Overall Study|Lost to Follow-up|5
1016625|NCT00321763|3323192|P2|Overall Study|Lost to Follow-up|1
1016626|NCT00321763|3323193|P1|Overall Study|Lost to Follow-up|3
1016627|NCT00321763|3323190|P4|Overall Study|Withdrawal by Subject|0
1016628|NCT00321763|3323191|P3|Overall Study|Withdrawal by Subject|1
1016629|NCT00321763|3323192|P2|Overall Study|Withdrawal by Subject|0
1016630|NCT00321763|3323193|P1|Overall Study|Withdrawal by Subject|2
1016631|NCT00321763|3323190|P4|Overall Study|Adverse Event|1
1016632|NCT00321763|3323191|P3|Overall Study|Adverse Event|0
1016633|NCT00321763|3323192|P2|Overall Study|Adverse Event|1
1016634|NCT00321763|3323193|P1|Overall Study|Adverse Event|1
1016635|NCT00321737|3323253|P3|Overall Study|Subject Request/ Subject Unavailable|2
1016636|NCT00321737|3323254|P2|Overall Study|Subject Request/ Subject Unavailable|0
1016637|NCT00321737|3323255|P1|Overall Study|Subject Request/ Subject Unavailable|0
1016638|NCT00321737|3323253|P3|Overall Study|Noncompliance|0
1016639|NCT00321737|3323254|P2|Overall Study|Noncompliance|0
1016640|NCT00321737|3323255|P1|Overall Study|Noncompliance|2
1016641|NCT00321737|3323253|P3|Overall Study|Pregnancy|0
1016642|NCT00321737|3323254|P2|Overall Study|Pregnancy|2
1016643|NCT00321737|3323255|P1|Overall Study|Pregnancy|0
1016644|NCT00321737|3323253|P3|Overall Study|Therapeutic Failure|2
1016645|NCT00321737|3323254|P2|Overall Study|Therapeutic Failure|0
1016646|NCT00321737|3323255|P1|Overall Study|Therapeutic Failure|6
1016647|NCT00321737|3323253|P3|Overall Study|Possible Barrett's Esophagus|1
1016648|NCT00321737|3323254|P2|Overall Study|Possible Barrett's Esophagus|1
1016649|NCT00321737|3323255|P1|Overall Study|Possible Barrett's Esophagus|2
1016650|NCT00321737|3323253|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|0
1016651|NCT00321737|3323254|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|0
1016652|NCT00321737|3323255|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|1
1016653|NCT00321737|3323253|P3|Overall Study|Protocol Violation|1
1016654|NCT00321737|3323254|P2|Overall Study|Protocol Violation|0
1016655|NCT00321737|3323255|P1|Overall Study|Protocol Violation|0
1016656|NCT00321737|3323253|P3|Overall Study|Withdrawal by Subject|17
1016657|NCT00321737|3323254|P2|Overall Study|Withdrawal by Subject|12
1016658|NCT00321737|3323255|P1|Overall Study|Withdrawal by Subject|19
1016659|NCT00321737|3323253|P3|Overall Study|Lost to Follow-up|6
1016660|NCT00321737|3323254|P2|Overall Study|Lost to Follow-up|5
1016661|NCT00321737|3323255|P1|Overall Study|Lost to Follow-up|5
1016662|NCT00321737|3323253|P3|Overall Study|Adverse Event|6
1016663|NCT00321737|3323254|P2|Overall Study|Adverse Event|3
1016664|NCT00321737|3323255|P1|Overall Study|Adverse Event|11
1016665|NCT00321737|3323253|P3|Overall Study|Relapse of Erosive Esophagitis|19
1016666|NCT00321737|3323254|P2|Overall Study|Relapse of Erosive Esophagitis|25
1016667|NCT00321737|3323255|P1|Overall Study|Relapse of Erosive Esophagitis|76
1016668|NCT00321711|3323283|P5|Part B|Death|1
1016669|NCT00321711|3323284|P4|Part B|Death|2
1016670|NCT00321711|3323285|P3|Part B|Death|0
1016671|NCT00321711|3323286|P2|Part B|Death|0
1016672|NCT00321711|3323287|P1|Part B|Death|0
1016673|NCT00321711|3323283|P5|Part B|Physician Decision|2
1016674|NCT00321711|3323284|P4|Part B|Physician Decision|1
1016675|NCT00321711|3323285|P3|Part B|Physician Decision|0
1016676|NCT00321711|3323286|P2|Part B|Physician Decision|0
1016677|NCT00321711|3323287|P1|Part B|Physician Decision|0
1016678|NCT00321711|3323283|P5|Part B|Disease progression|0
1016679|NCT00321711|3323284|P4|Part B|Disease progression|1
1016680|NCT00321711|3323285|P3|Part B|Disease progression|0
1016681|NCT00321711|3323286|P2|Part B|Disease progression|0
1016682|NCT00321711|3323287|P1|Part B|Disease progression|0
1016683|NCT00321711|3323283|P5|Part B|Adverse Event|1
1016684|NCT00321711|3323284|P4|Part B|Adverse Event|2
1016685|NCT00321711|3323285|P3|Part B|Adverse Event|0
1016686|NCT00321711|3323286|P2|Part B|Adverse Event|0
1016687|NCT00321711|3323287|P1|Part B|Adverse Event|0
1016688|NCT00321711|3323283|P5|Part B|Noncompliance|1
1016689|NCT00321711|3323284|P4|Part B|Noncompliance|0
1016690|NCT00321711|3323285|P3|Part B|Noncompliance|0
1016691|NCT00321711|3323286|P2|Part B|Noncompliance|0
1016692|NCT00321711|3323287|P1|Part B|Noncompliance|0
1016693|NCT00321711|3323283|P5|Part A|Protocol deviation|0
1016694|NCT00321711|3323284|P4|Part A|Protocol deviation|0
1016695|NCT00321711|3323285|P3|Part A|Protocol deviation|1
1016696|NCT00321711|3323286|P2|Part A|Protocol deviation|0
1016697|NCT00321711|3323287|P1|Part A|Protocol deviation|0
1016698|NCT00321711|3323283|P5|Part A|Other|0
1016699|NCT00321711|3323284|P4|Part A|Other|0
1016700|NCT00321711|3323285|P3|Part A|Other|3
1016701|NCT00321711|3323286|P2|Part A|Other|2
1016702|NCT00321711|3323287|P1|Part A|Other|1
1016703|NCT00321711|3323283|P5|Part A|Physician Decision|0
1016704|NCT00321711|3323284|P4|Part A|Physician Decision|0
1016705|NCT00321711|3323285|P3|Part A|Physician Decision|3
1016706|NCT00321711|3323286|P2|Part A|Physician Decision|1
1016707|NCT00321711|3323287|P1|Part A|Physician Decision|0
1016708|NCT00321711|3323283|P5|Part A|Requirement for alternative therapy|0
1016709|NCT00321711|3323284|P4|Part A|Requirement for alternative therapy|0
1016710|NCT00321711|3323285|P3|Part A|Requirement for alternative therapy|1
1016711|NCT00321711|3323286|P2|Part A|Requirement for alternative therapy|2
1016712|NCT00321711|3323287|P1|Part A|Requirement for alternative therapy|0
1016713|NCT00321711|3323283|P5|Part A|Disease progression|0
1016714|NCT00321711|3323284|P4|Part A|Disease progression|0
1016715|NCT00321711|3323285|P3|Part A|Disease progression|0
1016716|NCT00321711|3323286|P2|Part A|Disease progression|1
1016717|NCT00321711|3323287|P1|Part A|Disease progression|0
1016718|NCT00321711|3323283|P5|Part A|Withdrawal by Subject|0
1016719|NCT00321711|3323284|P4|Part A|Withdrawal by Subject|0
1016720|NCT00321711|3323285|P3|Part A|Withdrawal by Subject|1
1016721|NCT00321711|3323286|P2|Part A|Withdrawal by Subject|1
1016722|NCT00321711|3323287|P1|Part A|Withdrawal by Subject|1
1016723|NCT00321711|3323283|P5|Part A|Adverse Event|0
1016724|NCT00321711|3323284|P4|Part A|Adverse Event|0
1016725|NCT00321711|3323285|P3|Part A|Adverse Event|2
1016726|NCT00321711|3323286|P2|Part A|Adverse Event|3
1016727|NCT00321711|3323287|P1|Part A|Adverse Event|3
1016728|NCT00321685|3323337|P1|Overall Study|Ineligible|2
1016729|NCT00321685|3323337|P1|Overall Study|Not start protocol therapy|2
1016730|NCT00321685|3323337|P1|Overall Study|Other|5
1016731|NCT00321685|3323337|P1|Overall Study|Complicating disese|1
1016732|NCT00321685|3323337|P1|Overall Study|Alternative therapy|1
1016733|NCT00321685|3323337|P1|Overall Study|Withdrawal by Subject|8
1016734|NCT00321685|3323337|P1|Overall Study|Death|2
1016735|NCT00321685|3323337|P1|Overall Study|Adverse Event|18
1016736|NCT00321672|3323349|P4|Overall Study|Extensive travel required for new job|0
1016737|NCT00321672|3323350|P3|Overall Study|Extensive travel required for new job|0
1016738|NCT00321672|3323351|P2|Overall Study|Extensive travel required for new job|1
1016739|NCT00321672|3323352|P1|Overall Study|Extensive travel required for new job|0
1016740|NCT00321672|3323349|P4|Overall Study|Diagnosis of testicular cancer|0
1016741|NCT00321672|3323350|P3|Overall Study|Diagnosis of testicular cancer|0
1016742|NCT00321672|3323351|P2|Overall Study|Diagnosis of testicular cancer|1
1016743|NCT00321672|3323352|P1|Overall Study|Diagnosis of testicular cancer|0
1016744|NCT00321672|3323349|P4|Overall Study|Protocol Violation|0
1016745|NCT00321672|3323350|P3|Overall Study|Protocol Violation|1
1016746|NCT00321672|3323351|P2|Overall Study|Protocol Violation|0
1016747|NCT00321672|3323352|P1|Overall Study|Protocol Violation|0
1016748|NCT00321672|3323349|P4|Overall Study|Moved out of state|0
1016749|NCT00321672|3323350|P3|Overall Study|Moved out of state|1
1016750|NCT00321672|3323351|P2|Overall Study|Moved out of state|1
1016751|NCT00321672|3323352|P1|Overall Study|Moved out of state|0
1016752|NCT00321672|3323349|P4|Overall Study|Incarcerated|0
1016753|NCT00321672|3323350|P3|Overall Study|Incarcerated|2
1016754|NCT00321672|3323351|P2|Overall Study|Incarcerated|0
1016755|NCT00321672|3323352|P1|Overall Study|Incarcerated|0
1016756|NCT00321672|3323349|P4|Overall Study|Too far to travel for visits|0
1016757|NCT00321672|3323350|P3|Overall Study|Too far to travel for visits|0
1016758|NCT00321672|3323351|P2|Overall Study|Too far to travel for visits|0
1016759|NCT00321672|3323352|P1|Overall Study|Too far to travel for visits|1
1016760|NCT00321672|3323349|P4|Overall Study|Death|0
1016761|NCT00321672|3323350|P3|Overall Study|Death|0
1016762|NCT00321672|3323351|P2|Overall Study|Death|0
1016763|NCT00321672|3323352|P1|Overall Study|Death|1
1016764|NCT00321672|3323349|P4|Overall Study|Lost to Follow-up|2
1016765|NCT00321672|3323350|P3|Overall Study|Lost to Follow-up|4
1016766|NCT00321672|3323351|P2|Overall Study|Lost to Follow-up|0
1016767|NCT00321672|3323352|P1|Overall Study|Lost to Follow-up|2
1016768|NCT00321672|3323349|P4|Overall Study|Lack of Efficacy|0
1016769|NCT00321672|3323350|P3|Overall Study|Lack of Efficacy|0
1016770|NCT00321672|3323351|P2|Overall Study|Lack of Efficacy|1
1016771|NCT00321672|3323352|P1|Overall Study|Lack of Efficacy|1
1016772|NCT00321672|3323349|P4|Overall Study|Adverse Event|0
1016773|NCT00321672|3323350|P3|Overall Study|Adverse Event|0
1016774|NCT00321672|3323351|P2|Overall Study|Adverse Event|1
1016775|NCT00321672|3323352|P1|Overall Study|Adverse Event|1
1016776|NCT00321672|3323349|P4|Overall Study|Noncompliance|0
1016777|NCT00321672|3323350|P3|Overall Study|Noncompliance|1
1016778|NCT00321672|3323351|P2|Overall Study|Noncompliance|2
1016779|NCT00321672|3323352|P1|Overall Study|Noncompliance|1
1016780|NCT00321672|3323349|P4|Overall Study|Withdrawal by Subject|0
1016781|NCT00321672|3323350|P3|Overall Study|Withdrawal by Subject|2
1016782|NCT00321672|3323351|P2|Overall Study|Withdrawal by Subject|1
1016783|NCT00321672|3323352|P1|Overall Study|Withdrawal by Subject|5
1016784|NCT00321646|3323378|P1|Neoadjuvant Chemotherapy|Disease progression|1
1016785|NCT00321646|3323378|P1|Neoadjuvant Chemotherapy|Adverse Event|2
1016786|NCT00321646|3323378|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
1016787|NCT00321620|3323385|P2|Overall Study|Other|33
1016788|NCT00321620|3323386|P1|Overall Study|Other|42
1016789|NCT00321620|3323385|P2|Overall Study|Participant request|52
1016790|NCT00321620|3323386|P1|Overall Study|Participant request|75
1016791|NCT00321620|3323385|P2|Overall Study|Ineligibility determined|3
1016792|NCT00321620|3323386|P1|Overall Study|Ineligibility determined|2
1016793|NCT00321620|3323385|P2|Overall Study|Protocol deviation|3
1016794|NCT00321620|3323386|P1|Overall Study|Protocol deviation|4
1016795|NCT00321620|3323385|P2|Overall Study|Noncompliance|7
1016796|NCT00321620|3323386|P1|Overall Study|Noncompliance|14
1016797|NCT00321620|3323385|P2|Overall Study|Physician Decision|1
1016798|NCT00321620|3323386|P1|Overall Study|Physician Decision|4
1016799|NCT00321620|3323385|P2|Overall Study|Lost to Follow-up|9
1016800|NCT00321620|3323386|P1|Overall Study|Lost to Follow-up|13
1016801|NCT00321620|3323385|P2|Overall Study|Adverse Event|56
1016802|NCT00321620|3323386|P1|Overall Study|Adverse Event|43
1016803|NCT00321620|3323385|P2|Overall Study|Disease progression|117
1016804|NCT00321620|3323386|P1|Overall Study|Disease progression|113
1016805|NCT00321620|3323385|P2|Overall Study|Withdrawal by Subject|147
1016806|NCT00321620|3323386|P1|Overall Study|Withdrawal by Subject|164
1016807|NCT00321620|3323385|P2|Overall Study|Death|294
1016808|NCT00321620|3323386|P1|Overall Study|Death|269
1016809|NCT00321464|3323416|P2|Overall Study|Other|18
1016810|NCT00321464|3323417|P1|Overall Study|Other|21
1016811|NCT00321464|3323416|P2|Overall Study|Ineligibility determined|1
1016812|NCT00321464|3323417|P1|Overall Study|Ineligibility determined|2
1016813|NCT00321464|3323416|P2|Overall Study|Protocol deviation|2
1016814|NCT00321464|3323417|P1|Overall Study|Protocol deviation|0
1016815|NCT00321464|3323416|P2|Overall Study|Lost to Follow-up|8
1016816|NCT00321464|3323417|P1|Overall Study|Lost to Follow-up|7
1016817|NCT00321464|3323416|P2|Overall Study|Noncompliance|10
1016818|NCT00321464|3323417|P1|Overall Study|Noncompliance|4
1016819|NCT00321464|3323416|P2|Overall Study|Physician Decision|14
1016820|NCT00321464|3323417|P1|Overall Study|Physician Decision|15
1016821|NCT00321464|3323416|P2|Overall Study|Adverse Event|28
1016822|NCT00321464|3323417|P1|Overall Study|Adverse Event|43
1016823|NCT00321464|3323416|P2|Overall Study|Participant request|61
1016824|NCT00321464|3323417|P1|Overall Study|Participant request|57
1016825|NCT00321464|3323416|P2|Overall Study|Withdrawal by Subject|118
1016826|NCT00321464|3323417|P1|Overall Study|Withdrawal by Subject|117
1016827|NCT00321464|3323416|P2|Overall Study|Disease progression|124
1016828|NCT00321464|3323417|P1|Overall Study|Disease progression|124
1016829|NCT00321464|3323416|P2|Overall Study|Death|174
1016830|NCT00321464|3323417|P1|Overall Study|Death|169
1016831|NCT00321373|3323430|P3|Overall Study|Other|1
1016832|NCT00321373|3323431|P2|Overall Study|Other|0
1016833|NCT00321373|3323432|P1|Overall Study|Other|0
1016834|NCT00321373|3323430|P3|Overall Study|Withdrawal by Subject|0
1016835|NCT00321373|3323431|P2|Overall Study|Withdrawal by Subject|0
1016836|NCT00321373|3323432|P1|Overall Study|Withdrawal by Subject|1
1016837|NCT00321373|3323430|P3|Overall Study|Lost to Follow-up|1
1016838|NCT00321373|3323431|P2|Overall Study|Lost to Follow-up|0
1016839|NCT00321373|3323432|P1|Overall Study|Lost to Follow-up|1
1016840|NCT00321373|3323430|P3|Overall Study|Adverse Event|1
1016841|NCT00321373|3323431|P2|Overall Study|Adverse Event|0
1016842|NCT00321373|3323432|P1|Overall Study|Adverse Event|0
1016843|NCT00320801|3323472|P4|Extension Phase|Lost to Follow-up|3
1016844|NCT00320801|3323473|P3|Extension Phase|Lost to Follow-up|0
1016845|NCT00320801|3323474|P2|Extension Phase|Lost to Follow-up|0
1016846|NCT00320801|3323475|P1|Extension Phase|Lost to Follow-up|0
1016847|NCT00320801|3323472|P4|Extension Phase|Lack of Efficacy|2
1016848|NCT00320801|3323473|P3|Extension Phase|Lack of Efficacy|0
1016849|NCT00320801|3323474|P2|Extension Phase|Lack of Efficacy|0
1016850|NCT00320801|3323475|P1|Extension Phase|Lack of Efficacy|0
1016851|NCT00320801|3323472|P4|Extension Phase|Administrative|29
1016852|NCT00320801|3323473|P3|Extension Phase|Administrative|0
1016853|NCT00320801|3323474|P2|Extension Phase|Administrative|0
1016854|NCT00320801|3323475|P1|Extension Phase|Administrative|0
1016855|NCT00320801|3323472|P4|Extension Phase|Adverse Event|8
1016856|NCT00320801|3323473|P3|Extension Phase|Adverse Event|0
1016857|NCT00320801|3323474|P2|Extension Phase|Adverse Event|0
1016858|NCT00320801|3323475|P1|Extension Phase|Adverse Event|0
1016859|NCT00320801|3323472|P4|Extension Phase|Withdrawal by Subject|6
1016860|NCT00320801|3323473|P3|Extension Phase|Withdrawal by Subject|0
1016861|NCT00320801|3323474|P2|Extension Phase|Withdrawal by Subject|0
1016862|NCT00320801|3323475|P1|Extension Phase|Withdrawal by Subject|0
1016863|NCT00320801|3323472|P4|Double-blind Phase|Lack of Efficacy|0
1016864|NCT00320801|3323473|P3|Double-blind Phase|Lack of Efficacy|1
1016865|NCT00320801|3323474|P2|Double-blind Phase|Lack of Efficacy|9
1016866|NCT00320801|3323475|P1|Double-blind Phase|Lack of Efficacy|0
1016867|NCT00320801|3323472|P4|Double-blind Phase|Administrative|0
1016868|NCT00320801|3323473|P3|Double-blind Phase|Administrative|4
1016869|NCT00320801|3323474|P2|Double-blind Phase|Administrative|0
1016870|NCT00320801|3323475|P1|Double-blind Phase|Administrative|0
1016871|NCT00320801|3323472|P4|Double-blind Phase|Adverse Event|0
1016872|NCT00320801|3323473|P3|Double-blind Phase|Adverse Event|8
1016873|NCT00320801|3323474|P2|Double-blind Phase|Adverse Event|2
1016874|NCT00320801|3323475|P1|Double-blind Phase|Adverse Event|0
1016875|NCT00320801|3323472|P4|Double-blind Phase|Withdrawal by Subject|0
1016876|NCT00320801|3323473|P3|Double-blind Phase|Withdrawal by Subject|1
1016877|NCT00320801|3323474|P2|Double-blind Phase|Withdrawal by Subject|0
1016878|NCT00320801|3323475|P1|Double-blind Phase|Withdrawal by Subject|0
1016879|NCT00320801|3323472|P4|Open-label Run-in Period|Did not qualify|0
1016880|NCT00320801|3323473|P3|Open-label Run-in Period|Did not qualify|0
1016881|NCT00320801|3323474|P2|Open-label Run-in Period|Did not qualify|0
1016882|NCT00320801|3323475|P1|Open-label Run-in Period|Did not qualify|1
1016883|NCT00320801|3323472|P4|Open-label Run-in Period|Lost to Follow-up|0
1016884|NCT00320801|3323473|P3|Open-label Run-in Period|Lost to Follow-up|0
1016885|NCT00320801|3323474|P2|Open-label Run-in Period|Lost to Follow-up|0
1016886|NCT00320801|3323475|P1|Open-label Run-in Period|Lost to Follow-up|2
1016887|NCT00320801|3323472|P4|Open-label Run-in Period|Lack of Efficacy|0
1016888|NCT00320801|3323473|P3|Open-label Run-in Period|Lack of Efficacy|0
1016889|NCT00320801|3323474|P2|Open-label Run-in Period|Lack of Efficacy|0
1016890|NCT00320801|3323475|P1|Open-label Run-in Period|Lack of Efficacy|44
1016891|NCT00320801|3323472|P4|Open-label Run-in Period|Administrative|0
1016892|NCT00320801|3323473|P3|Open-label Run-in Period|Administrative|0
1016893|NCT00320801|3323474|P2|Open-label Run-in Period|Administrative|0
1016894|NCT00320801|3323475|P1|Open-label Run-in Period|Administrative|10
1016895|NCT00320801|3323472|P4|Open-label Run-in Period|Adverse Event|0
1016896|NCT00320801|3323473|P3|Open-label Run-in Period|Adverse Event|0
1016897|NCT00320801|3323474|P2|Open-label Run-in Period|Adverse Event|0
1016898|NCT00320801|3323475|P1|Open-label Run-in Period|Adverse Event|33
1016899|NCT00320801|3323472|P4|Open-label Run-in Period|Withdrawal by Subject|0
1016900|NCT00320801|3323473|P3|Open-label Run-in Period|Withdrawal by Subject|0
1016901|NCT00320801|3323474|P2|Open-label Run-in Period|Withdrawal by Subject|0
1016902|NCT00320801|3323475|P1|Open-label Run-in Period|Withdrawal by Subject|2
1016903|NCT00320788|3323490|P5|Overall Study|Withdrawal by Subject|1
1016904|NCT00320788|3323491|P4|Overall Study|Withdrawal by Subject|3
1016905|NCT00320788|3323492|P3|Overall Study|Withdrawal by Subject|0
1016906|NCT00320788|3323493|P2|Overall Study|Withdrawal by Subject|0
1016907|NCT00320788|3323494|P1|Overall Study|Withdrawal by Subject|3
1016908|NCT00320788|3323490|P5|Overall Study|Protocol Violation|1
1016909|NCT00320788|3323491|P4|Overall Study|Protocol Violation|0
1016910|NCT00320788|3323492|P3|Overall Study|Protocol Violation|0
1016911|NCT00320788|3323493|P2|Overall Study|Protocol Violation|0
1016912|NCT00320788|3323494|P1|Overall Study|Protocol Violation|0
1016913|NCT00320788|3323490|P5|Overall Study|Physician Decision|0
1016914|NCT00320788|3323491|P4|Overall Study|Physician Decision|0
1016915|NCT00320788|3323492|P3|Overall Study|Physician Decision|0
1016916|NCT00320788|3323493|P2|Overall Study|Physician Decision|1
1016917|NCT00320788|3323494|P1|Overall Study|Physician Decision|1
1016918|NCT00320788|3323490|P5|Overall Study|Other|1
1016919|NCT00320788|3323491|P4|Overall Study|Other|1
1016920|NCT00320788|3323492|P3|Overall Study|Other|1
1016921|NCT00320788|3323493|P2|Overall Study|Other|2
1016922|NCT00320788|3323494|P1|Overall Study|Other|1
1016923|NCT00320788|3323490|P5|Overall Study|Decision by the Sponsor|1
1016924|NCT00320788|3323491|P4|Overall Study|Decision by the Sponsor|0
1016925|NCT00320788|3323492|P3|Overall Study|Decision by the Sponsor|0
1016926|NCT00320788|3323493|P2|Overall Study|Decision by the Sponsor|1
1016927|NCT00320788|3323494|P1|Overall Study|Decision by the Sponsor|1
1016928|NCT00320788|3323490|P5|Overall Study|Lost to Follow-up|0
1016929|NCT00320788|3323491|P4|Overall Study|Lost to Follow-up|0
1016930|NCT00320788|3323492|P3|Overall Study|Lost to Follow-up|1
1016931|NCT00320788|3323493|P2|Overall Study|Lost to Follow-up|2
1016932|NCT00320788|3323494|P1|Overall Study|Lost to Follow-up|0
1016933|NCT00320788|3323490|P5|Overall Study|Death|1
1016934|NCT00320788|3323491|P4|Overall Study|Death|0
1016935|NCT00320788|3323492|P3|Overall Study|Death|1
1016936|NCT00320788|3323493|P2|Overall Study|Death|0
1016937|NCT00320788|3323494|P1|Overall Study|Death|0
1016938|NCT00320788|3323490|P5|Overall Study|Adverse Event|0
1016939|NCT00320788|3323491|P4|Overall Study|Adverse Event|1
1016940|NCT00320788|3323492|P3|Overall Study|Adverse Event|0
1016941|NCT00320788|3323493|P2|Overall Study|Adverse Event|0
1016942|NCT00320788|3323494|P1|Overall Study|Adverse Event|0
1016943|NCT00320710|3323548|P3|Overall Study|Lost to Follow-up|0
1016944|NCT00320710|3323549|P2|Overall Study|Lost to Follow-up|0
1016945|NCT00320710|3323550|P1|Overall Study|Lost to Follow-up|1
1016946|NCT00320710|3323548|P3|Overall Study|Adverse Event|1
1016947|NCT00320710|3323549|P2|Overall Study|Adverse Event|14
1016948|NCT00320710|3323550|P1|Overall Study|Adverse Event|18
1016949|NCT00320710|3323548|P3|Overall Study|Abnormal laboratory value(s)|0
1016950|NCT00320710|3323549|P2|Overall Study|Abnormal laboratory value(s)|3
1016951|NCT00320710|3323550|P1|Overall Study|Abnormal laboratory value(s)|12
1016952|NCT00320710|3323548|P3|Overall Study|Abnormal test procedure result(s)|0
1016953|NCT00320710|3323549|P2|Overall Study|Abnormal test procedure result(s)|0
1016954|NCT00320710|3323550|P1|Overall Study|Abnormal test procedure result(s)|2
1016955|NCT00320710|3323548|P3|Overall Study|Protocol Violation|0
1016956|NCT00320710|3323549|P2|Overall Study|Protocol Violation|5
1016957|NCT00320710|3323550|P1|Overall Study|Protocol Violation|6
1016958|NCT00320710|3323548|P3|Overall Study|Withdrawal by Subject|1
1016959|NCT00320710|3323549|P2|Overall Study|Withdrawal by Subject|26
1016960|NCT00320710|3323550|P1|Overall Study|Withdrawal by Subject|20
1016961|NCT00320710|3323548|P3|Overall Study|Administrative problems|0
1016962|NCT00320710|3323549|P2|Overall Study|Administrative problems|2
1016963|NCT00320710|3323550|P1|Overall Study|Administrative problems|1
1016964|NCT00320710|3323548|P3|Overall Study|Death|1
1016965|NCT00320710|3323549|P2|Overall Study|Death|7
1016966|NCT00320710|3323550|P1|Overall Study|Death|10
1016967|NCT00320710|3323548|P3|Overall Study|Disease progression|2
1016968|NCT00320710|3323549|P2|Overall Study|Disease progression|19
1016969|NCT00320710|3323550|P1|Overall Study|Disease progression|24
1016970|NCT00320606|3323580|P1|Overall Study|Withdrawal by Subject|1
1016971|NCT00320606|3323580|P1|Overall Study|Protocol Violation|1
1016972|NCT00320606|3323580|P1|Overall Study|Adverse Event|1
1016973|NCT00320593|3323596|P2|Overall Study|Withdrawal by clinical center|0
1016974|NCT00320593|3323597|P1|Overall Study|Withdrawal by clinical center|1
1016975|NCT00320593|3323596|P2|Overall Study|Withdrawal by Subject|1
1016976|NCT00320593|3323597|P1|Overall Study|Withdrawal by Subject|2
1016977|NCT00320593|3323596|P2|Overall Study|Moved to another state|0
1016978|NCT00320593|3323597|P1|Overall Study|Moved to another state|1
1016979|NCT00320593|3323596|P2|Overall Study|Lost to Follow-up|0
1016980|NCT00320593|3323597|P1|Overall Study|Lost to Follow-up|3
1016981|NCT00320541|3323621|P2|Overall Study|Protocol Entry Criterion Not Met|0
1016982|NCT00320541|3323622|P1|Overall Study|Protocol Entry Criterion Not Met|1
1016983|NCT00320541|3323621|P2|Overall Study|Death due to Adverse Event(s)|0
1016984|NCT00320541|3323622|P1|Overall Study|Death due to Adverse Event(s)|1
1016985|NCT00320541|3323621|P2|Overall Study|Death due to Study Disease|3
1016986|NCT00320541|3323622|P1|Overall Study|Death due to Study Disease|1
1016987|NCT00320541|3323621|P2|Overall Study|Sponsor Decision|1
1016988|NCT00320541|3323622|P1|Overall Study|Sponsor Decision|2
1016989|NCT00320541|3323621|P2|Overall Study|Other|4
1016990|NCT00320541|3323622|P1|Overall Study|Other|3
1016991|NCT00320541|3323621|P2|Overall Study|Physician Decision|13
1016992|NCT00320541|3323622|P1|Overall Study|Physician Decision|9
1016993|NCT00320541|3323621|P2|Overall Study|Withdrawal by Subject|16
1016994|NCT00320541|3323622|P1|Overall Study|Withdrawal by Subject|12
1016995|NCT00320541|3323621|P2|Overall Study|Protocol Violation|1
1016996|NCT00320541|3323622|P1|Overall Study|Protocol Violation|0
1016997|NCT00320541|3323621|P2|Overall Study|Adverse Event|19
1016998|NCT00320541|3323622|P1|Overall Study|Adverse Event|21
1016999|NCT00320528|3323649|P3|Study Period III|Atomoxetine Commercially Available|90
1017000|NCT00320528|3323650|P2|Study Period III|Atomoxetine Commercially Available|25
1017001|NCT00320528|3323651|P1|Study Period III|Atomoxetine Commercially Available|68
1017002|NCT00320528|3323649|P3|Study Period III|Sponsor Decision|1
1017003|NCT00320528|3323650|P2|Study Period III|Sponsor Decision|0
1017004|NCT00320528|3323651|P1|Study Period III|Sponsor Decision|0
1017005|NCT00320528|3323649|P3|Study Period III|Physician Decision|2
1017006|NCT00320528|3323650|P2|Study Period III|Physician Decision|1
1017007|NCT00320528|3323651|P1|Study Period III|Physician Decision|0
1017008|NCT00320528|3323649|P3|Study Period III|Protocol Violation|0
1017009|NCT00320528|3323650|P2|Study Period III|Protocol Violation|1
1017010|NCT00320528|3323651|P1|Study Period III|Protocol Violation|0
1017011|NCT00320528|3323649|P3|Study Period III|Parent/Caregiver Decision|11
1017012|NCT00320528|3323650|P2|Study Period III|Parent/Caregiver Decision|3
1017013|NCT00320528|3323651|P1|Study Period III|Parent/Caregiver Decision|14
1017014|NCT00320528|3323649|P3|Study Period III|Lack of Efficacy|0
1017015|NCT00320528|3323650|P2|Study Period III|Lack of Efficacy|0
1017016|NCT00320528|3323651|P1|Study Period III|Lack of Efficacy|2
1017017|NCT00320528|3323649|P3|Study Period III|Withdrawal by Subject|2
1017018|NCT00320528|3323650|P2|Study Period III|Withdrawal by Subject|1
1017019|NCT00320528|3323651|P1|Study Period III|Withdrawal by Subject|1
1017020|NCT00320528|3323649|P3|Study Period III|Lost to Follow-up|0
1017021|NCT00320528|3323650|P2|Study Period III|Lost to Follow-up|0
1017022|NCT00320528|3323651|P1|Study Period III|Lost to Follow-up|1
1017023|NCT00320528|3323649|P3|Study Period III|Adverse Event|0
1017024|NCT00320528|3323650|P2|Study Period III|Adverse Event|0
1017025|NCT00320528|3323651|P1|Study Period III|Adverse Event|1
1017026|NCT00320528|3323649|P3|Study Period II|Entry Criteria Exclusion|2
1017027|NCT00320528|3323650|P2|Study Period II|Entry Criteria Exclusion|2
1017028|NCT00320528|3323651|P1|Study Period II|Entry Criteria Exclusion|0
1017029|NCT00320528|3323649|P3|Study Period II|Withdrawal by Subject|1
1017030|NCT00320528|3323650|P2|Study Period II|Withdrawal by Subject|1
1017031|NCT00320528|3323651|P1|Study Period II|Withdrawal by Subject|0
1017032|NCT00320528|3323649|P3|Study Period II|Parent/Caregiver Decision|11
1017033|NCT00320528|3323650|P2|Study Period II|Parent/Caregiver Decision|3
1017034|NCT00320528|3323651|P1|Study Period II|Parent/Caregiver Decision|8
1017035|NCT00320528|3323649|P3|Study Period II|Adverse Event|8
1017036|NCT00320528|3323650|P2|Study Period II|Adverse Event|4
1017037|NCT00320528|3323651|P1|Study Period II|Adverse Event|3
1017038|NCT00320515|3323686|P1|Overall Study|Withdrawal by Subject|8
1017039|NCT00320515|3323686|P1|Overall Study|Physician Decision|2
1017040|NCT00320515|3323686|P1|Overall Study|Lost to Follow-up|6
1017041|NCT00320515|3323686|P1|Overall Study|Death|33
1017042|NCT00320489|3323695|P2|Overall Study|Withdrawal by Subject|41
1017043|NCT00320489|3323696|P1|Overall Study|Withdrawal by Subject|39
1017044|NCT00320489|3323695|P2|Overall Study|Sponsor Decision|3
1017045|NCT00320489|3323696|P1|Overall Study|Sponsor Decision|3
1017046|NCT00320489|3323695|P2|Overall Study|Protocol Violation|4
1017047|NCT00320489|3323696|P1|Overall Study|Protocol Violation|4
1017048|NCT00320489|3323695|P2|Overall Study|Physician Decision|8
1017049|NCT00320489|3323696|P1|Overall Study|Physician Decision|8
1017050|NCT00320489|3323695|P2|Overall Study|Lost to Follow-up|22
1017051|NCT00320489|3323696|P1|Overall Study|Lost to Follow-up|21
1017052|NCT00320489|3323695|P2|Overall Study|Lack of Efficacy|7
1017053|NCT00320489|3323696|P1|Overall Study|Lack of Efficacy|16
1017054|NCT00320489|3323695|P2|Overall Study|Entry Criteria Exclusion|4
1017055|NCT00320489|3323696|P1|Overall Study|Entry Criteria Exclusion|2
1017056|NCT00320489|3323695|P2|Overall Study|Death|2
1017057|NCT00320489|3323696|P1|Overall Study|Death|0
1017058|NCT00320489|3323695|P2|Overall Study|Clinical Relapse|20
1017059|NCT00320489|3323696|P1|Overall Study|Clinical Relapse|26
1017060|NCT00320489|3323695|P2|Overall Study|Adverse Event|25
1017061|NCT00320489|3323696|P1|Overall Study|Adverse Event|26
1017062|NCT00320424|3323752|P1|Overall Study|Other|3
1017063|NCT00320424|3323752|P1|Overall Study|Adverse Event|3
1017064|NCT00320411|3323766|P1|Overall Study|No investigational product admin.|4
1017065|NCT00320398|3323789|P2|Overall Study|Other|0
1017066|NCT00320398|3323790|P1|Overall Study|Other|1
1017067|NCT00320398|3323789|P2|Overall Study|Adverse Event|4
1017068|NCT00320398|3323790|P1|Overall Study|Adverse Event|1
1017069|NCT00320385|3323818|P2|Overall Study|Adverse Event|1
1017070|NCT00320385|3323819|P1|Overall Study|Adverse Event|0
1017071|NCT00320385|3323818|P2|Overall Study|Withdrew Consent|0
1017072|NCT00320385|3323819|P1|Overall Study|Withdrew Consent|1
1017073|NCT00320385|3323818|P2|Overall Study|Serious Adverse Event|0
1017074|NCT00320385|3323819|P1|Overall Study|Serious Adverse Event|1
1017075|NCT00320385|3323818|P2|Overall Study|Death|2
1017076|NCT00320385|3323819|P1|Overall Study|Death|1
1017077|NCT00320385|3323818|P2|Overall Study|Investigator Decision|1
1017078|NCT00320385|3323819|P1|Overall Study|Investigator Decision|0
1017079|NCT00320385|3323818|P2|Overall Study|Sponsor Terminated Study|1
1017080|NCT00320385|3323819|P1|Overall Study|Sponsor Terminated Study|2
1017081|NCT00320385|3323818|P2|Overall Study|Withdrawal by Subject|7
1017082|NCT00320385|3323819|P1|Overall Study|Withdrawal by Subject|6
1017083|NCT00320385|3323818|P2|Overall Study|Lost to Follow-up|10
1017084|NCT00320385|3323819|P1|Overall Study|Lost to Follow-up|7
1017085|NCT00320372|3323842|P2|Overall Study|Other (i.e. lost to f/u, site closure)|71
1017086|NCT00320372|3323843|P1|Overall Study|Other (i.e. lost to f/u, site closure)|86
1017087|NCT00320372|3323842|P2|Overall Study|Did not Meet (I/E)|1
1017088|NCT00320372|3323843|P1|Overall Study|Did not Meet (I/E)|3
1017089|NCT00320372|3323842|P2|Overall Study|Non-Compliance|39
1017090|NCT00320372|3323843|P1|Overall Study|Non-Compliance|40
1017091|NCT00320372|3323842|P2|Overall Study|Withdrawal by Subject|37
1017092|NCT00320372|3323843|P1|Overall Study|Withdrawal by Subject|55
1017093|NCT00320372|3323842|P2|Overall Study|Death|8
1017094|NCT00320372|3323843|P1|Overall Study|Death|7
1017095|NCT00320372|3323842|P2|Overall Study|Physician Decision|7
1017096|NCT00320372|3323843|P1|Overall Study|Physician Decision|4
1017097|NCT00320255|3323883|P6|Overall Study|Not specified|0
1017098|NCT00320255|3323884|P5|Overall Study|Not specified|0
1017099|NCT00320255|3323885|P4|Overall Study|Not specified|0
1017100|NCT00320255|3323886|P3|Overall Study|Not specified|1
1017101|NCT00320255|3323887|P2|Overall Study|Not specified|2
1017102|NCT00320255|3323888|P1|Overall Study|Not specified|3
1017103|NCT00320255|3323883|P6|Overall Study|No longer meets study criteria|0
1017104|NCT00320255|3323884|P5|Overall Study|No longer meets study criteria|0
1017105|NCT00320255|3323885|P4|Overall Study|No longer meets study criteria|1
1017106|NCT00320255|3323886|P3|Overall Study|No longer meets study criteria|0
1017107|NCT00320255|3323887|P2|Overall Study|No longer meets study criteria|0
1017108|NCT00320255|3323888|P1|Overall Study|No longer meets study criteria|0
1017109|NCT00320255|3323883|P6|Overall Study|Poor compliance/noncompliance|0
1017110|NCT00320255|3323884|P5|Overall Study|Poor compliance/noncompliance|0
1017111|NCT00320255|3323885|P4|Overall Study|Poor compliance/noncompliance|1
1017112|NCT00320255|3323886|P3|Overall Study|Poor compliance/noncompliance|0
1017113|NCT00320255|3323887|P2|Overall Study|Poor compliance/noncompliance|1
1017114|NCT00320255|3323888|P1|Overall Study|Poor compliance/noncompliance|1
1017115|NCT00320255|3323883|P6|Overall Study|Withdrawal by Subject|0
1017116|NCT00320255|3323884|P5|Overall Study|Withdrawal by Subject|0
1017117|NCT00320255|3323885|P4|Overall Study|Withdrawal by Subject|4
1017118|NCT00320255|3323886|P3|Overall Study|Withdrawal by Subject|2
1017119|NCT00320255|3323887|P2|Overall Study|Withdrawal by Subject|2
1017120|NCT00320255|3323888|P1|Overall Study|Withdrawal by Subject|1
1017121|NCT00320255|3323883|P6|Overall Study|Adverse Event|0
1017122|NCT00320255|3323884|P5|Overall Study|Adverse Event|0
1017123|NCT00320255|3323885|P4|Overall Study|Adverse Event|2
1017124|NCT00320255|3323886|P3|Overall Study|Adverse Event|3
1017125|NCT00320255|3323887|P2|Overall Study|Adverse Event|2
1017126|NCT00320255|3323888|P1|Overall Study|Adverse Event|5
1017127|NCT00320255|3323883|P6|Overall Study|Lack of Efficacy|0
1017128|NCT00320255|3323884|P5|Overall Study|Lack of Efficacy|0
1017129|NCT00320255|3323885|P4|Overall Study|Lack of Efficacy|0
1017130|NCT00320255|3323886|P3|Overall Study|Lack of Efficacy|0
1017131|NCT00320255|3323887|P2|Overall Study|Lack of Efficacy|0
1017132|NCT00320255|3323888|P1|Overall Study|Lack of Efficacy|1
1017133|NCT00320216|3323981|P5|Overall Study|Other|3
1017134|NCT00320216|3323982|P4|Overall Study|Other|1
1017135|NCT00320216|3323983|P3|Overall Study|Other|5
1017136|NCT00320216|3323984|P2|Overall Study|Other|2
1017137|NCT00320216|3323985|P1|Overall Study|Other|7
1017138|NCT00320216|3323981|P5|Overall Study|Lost to Follow-up|0
1017139|NCT00320216|3323982|P4|Overall Study|Lost to Follow-up|0
1017140|NCT00320216|3323983|P3|Overall Study|Lost to Follow-up|0
1017141|NCT00320216|3323984|P2|Overall Study|Lost to Follow-up|0
1017142|NCT00320216|3323985|P1|Overall Study|Lost to Follow-up|3
1017143|NCT00320216|3323981|P5|Overall Study|Lack of Efficacy|1
1017144|NCT00320216|3323982|P4|Overall Study|Lack of Efficacy|0
1017145|NCT00320216|3323983|P3|Overall Study|Lack of Efficacy|1
1017146|NCT00320216|3323984|P2|Overall Study|Lack of Efficacy|2
1017147|NCT00320216|3323985|P1|Overall Study|Lack of Efficacy|6
1017148|NCT00320216|3323981|P5|Overall Study|Adverse Event|2
1017149|NCT00320216|3323982|P4|Overall Study|Adverse Event|2
1017150|NCT00320216|3323983|P3|Overall Study|Adverse Event|0
1017151|NCT00320216|3323984|P2|Overall Study|Adverse Event|6
1017152|NCT00320216|3323985|P1|Overall Study|Adverse Event|0
1017153|NCT00320190|3324019|P2|Long-term (12-month) Extension|Withdrawal by Subject|0
1017154|NCT00320190|3324020|P1|Long-term (12-month) Extension|Withdrawal by Subject|1
1017155|NCT00320190|3324019|P2|Long-term (12-month) Extension|Lack of major molecular response|2
1017156|NCT00320190|3324020|P1|Long-term (12-month) Extension|Lack of major molecular response|1
1017157|NCT00320190|3324019|P2|Long-term (12-month) Extension|Sponsor terminated study|0
1017158|NCT00320190|3324020|P1|Long-term (12-month) Extension|Sponsor terminated study|7
1017159|NCT00320190|3324019|P2|First 12 Months|Withdrawal by Subject|1
1017160|NCT00320190|3324020|P1|First 12 Months|Withdrawal by Subject|0
1017161|NCT00320190|3324019|P2|First 12 Months|Study drug toxicity|1
1017162|NCT00320190|3324020|P1|First 12 Months|Study drug toxicity|0
1017163|NCT00320190|3324019|P2|First 12 Months|Investigator request|1
1017164|NCT00320190|3324020|P1|First 12 Months|Investigator request|0
1017165|NCT00320190|3324019|P2|First 12 Months|Adverse event unrelated to study drug|0
1017166|NCT00320190|3324020|P1|First 12 Months|Adverse event unrelated to study drug|1
1017167|NCT00320190|3324019|P2|First 12 Months|Enrollment failure|1
1017168|NCT00320190|3324020|P1|First 12 Months|Enrollment failure|0
1017169|NCT00320190|3324019|P2|First 12 Months|Lost to Follow-up|1
1017170|NCT00320190|3324020|P1|First 12 Months|Lost to Follow-up|0
1017171|NCT00320190|3324019|P2|First 12 Months|Sponsor terminated study|2
1017172|NCT00320190|3324020|P1|First 12 Months|Sponsor terminated study|2
1017173|NCT00320190|3324019|P2|First 12 Months|Completed but did not enter extension|3
1017174|NCT00320190|3324020|P1|First 12 Months|Completed but did not enter extension|5
1017175|NCT00320112|3324040|P2|Overall Study|Death|1
1017176|NCT00320112|3324041|P1|Overall Study|Death|2
1017177|NCT00320112|3324040|P2|Overall Study|Withdrawal by Subject|0
1017178|NCT00320112|3324041|P1|Overall Study|Withdrawal by Subject|3
1017179|NCT00320112|3324040|P2|Overall Study|Lost to Follow-up|4
1017180|NCT00320112|3324041|P1|Overall Study|Lost to Follow-up|3
1017181|NCT00319982|3324055|P2|Overall Study|Withdrawal by Subject|0
1017182|NCT00319982|3324056|P1|Overall Study|Withdrawal by Subject|1
1017183|NCT00319956|3324076|P2|Overall Study|Death|24
1017184|NCT00319956|3324077|P1|Overall Study|Death|20
1017185|NCT00319839|3324089|P1|Overall Study|Withdrawal by Subject|1
1017186|NCT00319839|3324089|P1|Overall Study|Adverse Event|5
1017187|NCT00319735|3324105|P1|Overall Study|Death|2
1017188|NCT00319696|3324118|P1|Overall Study|Lost to Follow-up|3
1017189|NCT00319696|3324118|P1|Overall Study|administrative|7
1017190|NCT00319696|3324118|P1|Overall Study|withdrawal of consent|14
1017191|NCT00319696|3324118|P1|Overall Study|Adverse Event|36
1017192|NCT00319592|3324155|P2|Overall Study|Physician Decision|1
1017193|NCT00319592|3324156|P1|Overall Study|Physician Decision|0
1017194|NCT00319592|3324155|P2|Overall Study|Protocol Violation|0
1017195|NCT00319592|3324156|P1|Overall Study|Protocol Violation|1
1017196|NCT00319553|3324172|P2|Overall Study|Withdrawal by Subject|1
1017197|NCT00319553|3324173|P1|Overall Study|Withdrawal by Subject|1
1017198|NCT00319553|3324172|P2|Overall Study|Lost to Follow-up|1
1017199|NCT00319553|3324173|P1|Overall Study|Lost to Follow-up|2
1017200|NCT00319553|3324172|P2|Overall Study|Protocol Violation|2
1017201|NCT00319553|3324173|P1|Overall Study|Protocol Violation|1
1017202|NCT00319501|3324187|P2|Open-label Extension Period|Withdrawal by Subject|0
1017203|NCT00319501|3324188|P1|Open-label Extension Period|Withdrawal by Subject|2
1017204|NCT00319501|3324187|P2|Open-label Extension Period|Sponsor request|0
1017205|NCT00319501|3324188|P1|Open-label Extension Period|Sponsor request|26
1017206|NCT00319501|3324187|P2|Open-label Extension Period|Principal investigator decision|0
1017207|NCT00319501|3324188|P1|Open-label Extension Period|Principal investigator decision|2
1017208|NCT00319501|3324187|P2|Open-label Extension Period|Not specified|0
1017209|NCT00319501|3324188|P1|Open-label Extension Period|Not specified|1
1017210|NCT00319501|3324187|P2|Open-label Extension Period|Did not receive treatment|0
1017211|NCT00319501|3324188|P1|Open-label Extension Period|Did not receive treatment|18
1017212|NCT00319501|3324187|P2|Open-label Extension Period|Adverse Event|0
1017213|NCT00319501|3324188|P1|Open-label Extension Period|Adverse Event|2
1017214|NCT00319501|3324187|P2|Open-label Period|Not specified|0
1017215|NCT00319501|3324188|P1|Open-label Period|Not specified|11
1017216|NCT00319501|3324187|P2|Open-label Period|Did not receive treatment|0
1017217|NCT00319501|3324188|P1|Open-label Period|Did not receive treatment|33
1017218|NCT00319501|3324187|P2|Open-label Period|Lost to Follow-up|0
1017219|NCT00319501|3324188|P1|Open-label Period|Lost to Follow-up|5
1017220|NCT00319501|3324187|P2|Open-label Period|Sponsor request|0
1017221|NCT00319501|3324188|P1|Open-label Period|Sponsor request|12
1017222|NCT00319501|3324187|P2|Open-label Period|Principal Investigator decision|0
1017223|NCT00319501|3324188|P1|Open-label Period|Principal Investigator decision|6
1017224|NCT00319501|3324187|P2|Open-label Period|Withdrawal by Subject|0
1017225|NCT00319501|3324188|P1|Open-label Period|Withdrawal by Subject|38
1017226|NCT00319501|3324187|P2|Open-label Period|Protocol Violation|0
1017227|NCT00319501|3324188|P1|Open-label Period|Protocol Violation|6
1017228|NCT00319501|3324187|P2|Open-label Period|Adverse Event|0
1017229|NCT00319501|3324188|P1|Open-label Period|Adverse Event|5
1017230|NCT00319501|3324187|P2|Double-blind Period|Did not receive treatment|29
1017231|NCT00319501|3324188|P1|Double-blind Period|Did not receive treatment|42
1017232|NCT00319501|3324187|P2|Double-blind Period|Sponsor Request|0
1017233|NCT00319501|3324188|P1|Double-blind Period|Sponsor Request|1
1017234|NCT00319501|3324187|P2|Double-blind Period|Withdrawal by Subject|3
1017235|NCT00319501|3324188|P1|Double-blind Period|Withdrawal by Subject|0
1017236|NCT00319449|3324214|P2|Overall Study|Noncompliance with the protocol|0
1017237|NCT00319449|3324215|P1|Overall Study|Noncompliance with the protocol|1
1017238|NCT00319449|3324214|P2|Overall Study|Subject did not wish to continue|0
1017239|NCT00319449|3324215|P1|Overall Study|Subject did not wish to continue|1
1017240|NCT00319436|3324227|P2|Overall Study|Withdrawal by Subject|7
1017241|NCT00319436|3324228|P1|Overall Study|Withdrawal by Subject|6
1017242|NCT00319254|3324246|P1|Overall Study|Enrolled, Not Treated|2
1017243|NCT00319254|3324246|P1|Overall Study|Lost to Follow-up|2
1017244|NCT00319254|3324246|P1|Overall Study|Death|46
1017245|NCT00319254|3324246|P1|Overall Study|Withdrawal by Subject|4
1017246|NCT00319111|3324259|P1|Overall Study|Treatment failure|1
1017247|NCT00319111|3324259|P1|Overall Study|Administrative|2
1017248|NCT00319111|3324259|P1|Overall Study|Lack of clinical improvement|4
1017249|NCT00319111|3324259|P1|Overall Study|Death|9
1017250|NCT00319111|3324259|P1|Overall Study|Withdrawal of consent|11
1017251|NCT00319111|3324259|P1|Overall Study|Adverse Event|20
1017252|NCT00319098|3324273|P2|Overall Study|Protocol Violation|1
1017253|NCT00319098|3324274|P1|Overall Study|Protocol Violation|3
1017254|NCT00319098|3324273|P2|Overall Study|Others|8
1017255|NCT00319098|3324274|P1|Overall Study|Others|33
1017256|NCT00319098|3324273|P2|Overall Study|Lost to Follow-up|13
1017257|NCT00319098|3324274|P1|Overall Study|Lost to Follow-up|37
1017258|NCT00319098|3324273|P2|Overall Study|Migrated/moved from study area|1
1017259|NCT00319098|3324274|P1|Overall Study|Migrated/moved from study area|2
1017260|NCT00319098|3324273|P2|Overall Study|Withdrawal by Subject|8
1017261|NCT00319098|3324274|P1|Overall Study|Withdrawal by Subject|37
1017262|NCT00319098|3324273|P2|Overall Study|Adverse Event|1
1017263|NCT00319098|3324274|P1|Overall Study|Adverse Event|20
1017264|NCT00319098|3324273|P2|Overall Study|Serious adverse event|0
1017265|NCT00319098|3324274|P1|Overall Study|Serious adverse event|3
1017266|NCT00319046|3324332|P1|Overall Study|administrative reason|1
1017267|NCT00319046|3324332|P1|Overall Study|withdrawal of subject's consent|7
1017268|NCT00319020|3324341|P2|Overall Study|Adverse Event|1
1017269|NCT00319020|3324342|P1|Overall Study|Adverse Event|0
1017270|NCT00319020|3324341|P2|Overall Study|Treatment failure|1
1017271|NCT00319020|3324342|P1|Overall Study|Treatment failure|0
1017272|NCT00319020|3324341|P2|Overall Study|Transplant|1
1017273|NCT00319020|3324342|P1|Overall Study|Transplant|0
1017274|NCT00319020|3324341|P2|Overall Study|Disease progression|2
1017275|NCT00319020|3324342|P1|Overall Study|Disease progression|0
1017276|NCT00319020|3324341|P2|Overall Study|Administrative reason|5
1017277|NCT00319020|3324342|P1|Overall Study|Administrative reason|0
1017278|NCT00319020|3324341|P2|Overall Study|F-1 completed but not enrolled in F-2|0
1017279|NCT00319020|3324342|P1|Overall Study|F-1 completed but not enrolled in F-2|1
1017280|NCT00319020|3324341|P2|Overall Study|Withdrawal by Subject|1
1017281|NCT00319020|3324342|P1|Overall Study|Withdrawal by Subject|4
1017282|NCT00319020|3324341|P2|Overall Study|Death|2
1017283|NCT00319020|3324342|P1|Overall Study|Death|2
1017284|NCT00318656|3324414|P2|Overall Study|Did not receive any treatment|1
1017285|NCT00318656|3324415|P1|Overall Study|Did not receive any treatment|0
1017286|NCT00318656|3324414|P2|Overall Study|Took Avandamet instead of Glim/Met|1
1017287|NCT00318656|3324415|P1|Overall Study|Took Avandamet instead of Glim/Met|0
1017288|NCT00318565|3324472|P1|Overall Study|Excluded per protocol|24
1017289|NCT00318474|3324479|P2|Overall Study|Trial terminated|7
1017290|NCT00318474|3324480|P1|Overall Study|Trial terminated|10
1017291|NCT00318474|3324479|P2|Overall Study|Post-therapy hyperflycemia|1
1017292|NCT00318474|3324480|P1|Overall Study|Post-therapy hyperflycemia|0
1017293|NCT00318474|3324479|P2|Overall Study|Fall in GFR|3
1017294|NCT00318474|3324480|P1|Overall Study|Fall in GFR|3
1017295|NCT00318474|3324479|P2|Overall Study|Withdrawal by Subject|2
1017296|NCT00318474|3324480|P1|Overall Study|Withdrawal by Subject|3
1017297|NCT00318474|3324479|P2|Overall Study|Protocol Violation|0
1017298|NCT00318474|3324480|P1|Overall Study|Protocol Violation|1
1017299|NCT00318474|3324479|P2|Overall Study|Pregnancy|2
1017300|NCT00318474|3324480|P1|Overall Study|Pregnancy|0
1017301|NCT00318474|3324479|P2|Overall Study|Lost to Follow-up|1
1017302|NCT00318474|3324480|P1|Overall Study|Lost to Follow-up|0
1017303|NCT00318474|3324479|P2|Overall Study|Adverse Event|1
1017304|NCT00318474|3324480|P1|Overall Study|Adverse Event|1
1017305|NCT00318461|3324491|P5|Open-Label Extension, 18 Months|Protocol Violation|6
1017306|NCT00318461|3324492|P4|Open-Label Extension, 18 Months|Protocol Violation|4
1017307|NCT00318461|3324493|P3|Open-Label Extension, 18 Months|Protocol Violation|3
1017308|NCT00318461|3324494|P2|Open-Label Extension, 18 Months|Protocol Violation|5
1017309|NCT00318461|3324495|P1|Open-Label Extension, 18 Months|Protocol Violation|7
1017310|NCT00318461|3324491|P5|Open-Label Extension, 18 Months|Lack of Efficacy|63
1017311|NCT00318461|3324492|P4|Open-Label Extension, 18 Months|Lack of Efficacy|27
1017312|NCT00318461|3324493|P3|Open-Label Extension, 18 Months|Lack of Efficacy|37
1017313|NCT00318461|3324494|P2|Open-Label Extension, 18 Months|Lack of Efficacy|33
1017314|NCT00318461|3324495|P1|Open-Label Extension, 18 Months|Lack of Efficacy|41
1017315|NCT00318461|3324491|P5|Open-Label Extension, 18 Months|Adverse Event|6
1017316|NCT00318461|3324492|P4|Open-Label Extension, 18 Months|Adverse Event|1
1017317|NCT00318461|3324493|P3|Open-Label Extension, 18 Months|Adverse Event|6
1017318|NCT00318461|3324494|P2|Open-Label Extension, 18 Months|Adverse Event|8
1017319|NCT00318461|3324495|P1|Open-Label Extension, 18 Months|Adverse Event|11
1017320|NCT00318461|3324491|P5|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22
1017321|NCT00318461|3324492|P4|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11
1017322|NCT00318461|3324493|P3|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27
1017323|NCT00318461|3324494|P2|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14
1017324|NCT00318461|3324495|P1|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19
1017325|NCT00318461|3324491|P5|Double-Blind, 6 Months|Fear of experiencing AE again|0
1017326|NCT00318461|3324492|P4|Double-Blind, 6 Months|Fear of experiencing AE again|0
1017327|NCT00318461|3324493|P3|Double-Blind, 6 Months|Fear of experiencing AE again|0
1017328|NCT00318461|3324494|P2|Double-Blind, 6 Months|Fear of experiencing AE again|1
1017329|NCT00318461|3324495|P1|Double-Blind, 6 Months|Fear of experiencing AE again|0
1017330|NCT00318461|3324491|P5|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1
1017331|NCT00318461|3324492|P4|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
1017332|NCT00318461|3324493|P3|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
1017333|NCT00318461|3324494|P2|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
1017334|NCT00318461|3324495|P1|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
1017335|NCT00318461|3324491|P5|Double-Blind, 6 Months|Hyperglicaemia|0
1017336|NCT00318461|3324492|P4|Double-Blind, 6 Months|Hyperglicaemia|1
1017337|NCT00318461|3324493|P3|Double-Blind, 6 Months|Hyperglicaemia|0
1017338|NCT00318461|3324494|P2|Double-Blind, 6 Months|Hyperglicaemia|0
1017339|NCT00318461|3324495|P1|Double-Blind, 6 Months|Hyperglicaemia|0
1017340|NCT00318461|3324491|P5|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2
1017341|NCT00318461|3324492|P4|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
1017342|NCT00318461|3324493|P3|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
1017343|NCT00318461|3324494|P2|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
1017344|NCT00318461|3324495|P1|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
1017345|NCT00318461|3324491|P5|Double-Blind, 6 Months|Lack of time|0
1017346|NCT00318461|3324492|P4|Double-Blind, 6 Months|Lack of time|0
1017347|NCT00318461|3324493|P3|Double-Blind, 6 Months|Lack of time|0
1017348|NCT00318461|3324494|P2|Double-Blind, 6 Months|Lack of time|0
1017349|NCT00318461|3324495|P1|Double-Blind, 6 Months|Lack of time|1
1017350|NCT00318461|3324491|P5|Double-Blind, 6 Months|Investigator decision|1
1017351|NCT00318461|3324492|P4|Double-Blind, 6 Months|Investigator decision|0
1017352|NCT00318461|3324493|P3|Double-Blind, 6 Months|Investigator decision|0
1017353|NCT00318461|3324494|P2|Double-Blind, 6 Months|Investigator decision|0
1017354|NCT00318461|3324495|P1|Double-Blind, 6 Months|Investigator decision|0
1017355|NCT00318461|3324491|P5|Double-Blind, 6 Months|Work commitment|1
1017356|NCT00318461|3324492|P4|Double-Blind, 6 Months|Work commitment|0
1017357|NCT00318461|3324493|P3|Double-Blind, 6 Months|Work commitment|0
1017358|NCT00318461|3324494|P2|Double-Blind, 6 Months|Work commitment|0
1017359|NCT00318461|3324495|P1|Double-Blind, 6 Months|Work commitment|0
1017360|NCT00318461|3324491|P5|Double-Blind, 6 Months|FPG exceeds limits/too high|0
1017361|NCT00318461|3324492|P4|Double-Blind, 6 Months|FPG exceeds limits/too high|2
1017362|NCT00318461|3324493|P3|Double-Blind, 6 Months|FPG exceeds limits/too high|0
1017363|NCT00318461|3324494|P2|Double-Blind, 6 Months|FPG exceeds limits/too high|0
1017364|NCT00318461|3324495|P1|Double-Blind, 6 Months|FPG exceeds limits/too high|1
1017365|NCT00318461|3324491|P5|Double-Blind, 6 Months|Tendency to low blood glucose levels|1
1017366|NCT00318461|3324492|P4|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
1017367|NCT00318461|3324493|P3|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
1017368|NCT00318461|3324494|P2|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
1017369|NCT00318461|3324495|P1|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
1017370|NCT00318461|3324491|P5|Double-Blind, 6 Months|Move|0
1017371|NCT00318461|3324492|P4|Double-Blind, 6 Months|Move|0
1017372|NCT00318461|3324493|P3|Double-Blind, 6 Months|Move|0
1017373|NCT00318461|3324494|P2|Double-Blind, 6 Months|Move|1
1017374|NCT00318461|3324495|P1|Double-Blind, 6 Months|Move|0
1017375|NCT00318461|3324491|P5|Double-Blind, 6 Months|Subject decision/No wish to continue|2
1017376|NCT00318461|3324492|P4|Double-Blind, 6 Months|Subject decision/No wish to continue|0
1017377|NCT00318461|3324493|P3|Double-Blind, 6 Months|Subject decision/No wish to continue|1
1017378|NCT00318461|3324494|P2|Double-Blind, 6 Months|Subject decision/No wish to continue|2
1017379|NCT00318461|3324495|P1|Double-Blind, 6 Months|Subject decision/No wish to continue|0
1017380|NCT00318461|3324491|P5|Double-Blind, 6 Months|Consent withdrawn|4
1017381|NCT00318461|3324492|P4|Double-Blind, 6 Months|Consent withdrawn|10
1017382|NCT00318461|3324493|P3|Double-Blind, 6 Months|Consent withdrawn|4
1017383|NCT00318461|3324494|P2|Double-Blind, 6 Months|Consent withdrawn|3
1017384|NCT00318461|3324495|P1|Double-Blind, 6 Months|Consent withdrawn|0
1017385|NCT00318461|3324491|P5|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
1017386|NCT00318461|3324492|P4|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
1017387|NCT00318461|3324493|P3|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
1017388|NCT00318461|3324494|P2|Double-Blind, 6 Months|Poor compliance/Non-compliance|1
1017389|NCT00318461|3324495|P1|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
1017390|NCT00318461|3324491|P5|Double-Blind, 6 Months|Lost to follow up|0
1017391|NCT00318461|3324492|P4|Double-Blind, 6 Months|Lost to follow up|0
1017392|NCT00318461|3324493|P3|Double-Blind, 6 Months|Lost to follow up|0
1017393|NCT00318461|3324494|P2|Double-Blind, 6 Months|Lost to follow up|1
1017394|NCT00318461|3324495|P1|Double-Blind, 6 Months|Lost to follow up|0
1017395|NCT00318461|3324491|P5|Double-Blind, 6 Months|Protocol Violation|5
1017396|NCT00318461|3324492|P4|Double-Blind, 6 Months|Protocol Violation|4
1017397|NCT00318461|3324493|P3|Double-Blind, 6 Months|Protocol Violation|4
1017398|NCT00318461|3324494|P2|Double-Blind, 6 Months|Protocol Violation|4
1017399|NCT00318461|3324495|P1|Double-Blind, 6 Months|Protocol Violation|2
1017400|NCT00318461|3324491|P5|Double-Blind, 6 Months|Lack of Efficacy|9
1017401|NCT00318461|3324492|P4|Double-Blind, 6 Months|Lack of Efficacy|29
1017402|NCT00318461|3324493|P3|Double-Blind, 6 Months|Lack of Efficacy|13
1017403|NCT00318461|3324494|P2|Double-Blind, 6 Months|Lack of Efficacy|8
1017404|NCT00318461|3324495|P1|Double-Blind, 6 Months|Lack of Efficacy|19
1017405|NCT00318461|3324491|P5|Double-Blind, 6 Months|Adverse Event|8
1017406|NCT00318461|3324492|P4|Double-Blind, 6 Months|Adverse Event|2
1017407|NCT00318461|3324493|P3|Double-Blind, 6 Months|Adverse Event|29
1017408|NCT00318461|3324494|P2|Double-Blind, 6 Months|Adverse Event|23
1017409|NCT00318461|3324495|P1|Double-Blind, 6 Months|Adverse Event|11
1017410|NCT00318370|3324594|P3|Period 3|Other|3
1017411|NCT00318370|3324595|P2|Period 3|Other|0
1017412|NCT00318370|3324596|P1|Period 3|Other|0
1017413|NCT00318370|3324594|P3|Period 3|Withdrawal by Subject|3
1017414|NCT00318370|3324595|P2|Period 3|Withdrawal by Subject|0
1017415|NCT00318370|3324596|P1|Period 3|Withdrawal by Subject|0
1017416|NCT00318370|3324594|P3|Period 3|Physician Decision|1
1017417|NCT00318370|3324595|P2|Period 3|Physician Decision|0
1017418|NCT00318370|3324596|P1|Period 3|Physician Decision|0
1017419|NCT00318370|3324594|P3|Period 3|Death|1
1017420|NCT00318370|3324595|P2|Period 3|Death|0
1017421|NCT00318370|3324596|P1|Period 3|Death|0
1017422|NCT00318370|3324594|P3|Period 3|Lack of Efficacy|24
1017423|NCT00318370|3324595|P2|Period 3|Lack of Efficacy|0
1017424|NCT00318370|3324596|P1|Period 3|Lack of Efficacy|0
1017425|NCT00318370|3324594|P3|Period 3|Adverse Event|1
1017426|NCT00318370|3324595|P2|Period 3|Adverse Event|0
1017427|NCT00318370|3324596|P1|Period 3|Adverse Event|0
1017428|NCT00318370|3324594|P3|Period 2|Other|0
1017429|NCT00318370|3324595|P2|Period 2|Other|1
1017430|NCT00318370|3324596|P1|Period 2|Other|0
1017431|NCT00318370|3324594|P3|Period 2|Withdrawal by Subject|0
1017432|NCT00318370|3324595|P2|Period 2|Withdrawal by Subject|1
1017433|NCT00318370|3324596|P1|Period 2|Withdrawal by Subject|0
1017434|NCT00318370|3324594|P3|Period 2|Physician Decision|0
1017435|NCT00318370|3324595|P2|Period 2|Physician Decision|1
1017436|NCT00318370|3324596|P1|Period 2|Physician Decision|0
1017437|NCT00318370|3324594|P3|Period 2|Lack of Efficacy|0
1017438|NCT00318370|3324595|P2|Period 2|Lack of Efficacy|5
1017439|NCT00318370|3324596|P1|Period 2|Lack of Efficacy|0
1017440|NCT00318370|3324594|P3|Period 2|Adverse Event|0
1017441|NCT00318370|3324595|P2|Period 2|Adverse Event|3
1017442|NCT00318370|3324596|P1|Period 2|Adverse Event|0
1017443|NCT00318370|3324594|P3|Period 1|Withdrawal by Subject|0
1017444|NCT00318370|3324595|P2|Period 1|Withdrawal by Subject|0
1017445|NCT00318370|3324596|P1|Period 1|Withdrawal by Subject|1
1017446|NCT00318370|3324594|P3|Period 1|Physician Decision|0
1017447|NCT00318370|3324595|P2|Period 1|Physician Decision|0
1017448|NCT00318370|3324596|P1|Period 1|Physician Decision|1
1017449|NCT00318370|3324594|P3|Period 1|Lack of Efficacy|0
1017450|NCT00318370|3324595|P2|Period 1|Lack of Efficacy|0
1017451|NCT00318370|3324596|P1|Period 1|Lack of Efficacy|5
1017452|NCT00318149|3324621|P6|Overall Study|Adverse Event|2
1017453|NCT00318149|3324622|P5|Overall Study|Adverse Event|0
1017454|NCT00318149|3324623|P4|Overall Study|Adverse Event|0
1017455|NCT00318149|3324624|P3|Overall Study|Adverse Event|0
1017456|NCT00318149|3324625|P2|Overall Study|Adverse Event|0
1017457|NCT00318149|3324626|P1|Overall Study|Adverse Event|0
1017458|NCT00317642|3324772|P2|Overall Study|AML Not Centrally Confirmed|5
1017459|NCT00317642|3324773|P1|Overall Study|AML Not Centrally Confirmed|1
1017460|NCT00317642|3324772|P2|Overall Study|Referred For Transplantation|0
1017461|NCT00317642|3324773|P1|Overall Study|Referred For Transplantation|1
1017462|NCT00317642|3324772|P2|Overall Study|Withdrawal by Subject|1
1017463|NCT00317642|3324773|P1|Overall Study|Withdrawal by Subject|0
1017464|NCT00317642|3324772|P2|Overall Study|Not Continue to Consolidation|0
1017465|NCT00317642|3324773|P1|Overall Study|Not Continue to Consolidation|2
1017466|NCT00317642|3324772|P2|Overall Study|Death|7
1017467|NCT00317642|3324773|P1|Overall Study|Death|14
1017468|NCT00317642|3324772|P2|Overall Study|Disease Recurrence|2
1017469|NCT00317642|3324773|P1|Overall Study|Disease Recurrence|1
1017470|NCT00317642|3324772|P2|Overall Study|Treatment Failure|102
1017471|NCT00317642|3324773|P1|Overall Study|Treatment Failure|56
1017472|NCT00317642|3324772|P2|Overall Study|Adverse Event|5
1017473|NCT00317642|3324773|P1|Overall Study|Adverse Event|17
1017474|NCT00317642|3324772|P2|Overall Study|Participant declined treatment|3
1017475|NCT00317642|3324773|P1|Overall Study|Participant declined treatment|14
1017476|NCT00317642|3324772|P2|Overall Study|Physician Decision|7
1017477|NCT00317642|3324773|P1|Overall Study|Physician Decision|15
1017478|NCT00317642|3324772|P2|Overall Study|Not Received Either Study Drug|3
1017479|NCT00317642|3324773|P1|Overall Study|Not Received Either Study Drug|1
1017480|NCT00317473|3324852|P6|Overall Study|Other|0
1017481|NCT00317473|3324853|P5|Overall Study|Other|0
1017482|NCT00317473|3324854|P4|Overall Study|Other|0
1017483|NCT00317473|3324855|P3|Overall Study|Other|0
1017484|NCT00317473|3324856|P2|Overall Study|Other|2
1017485|NCT00317473|3324857|P1|Overall Study|Other|0
1017486|NCT00317473|3324852|P6|Overall Study|Death|0
1017487|NCT00317473|3324853|P5|Overall Study|Death|0
1017488|NCT00317473|3324854|P4|Overall Study|Death|0
1017489|NCT00317473|3324855|P3|Overall Study|Death|0
1017490|NCT00317473|3324856|P2|Overall Study|Death|0
1017491|NCT00317473|3324857|P1|Overall Study|Death|1
1017492|NCT00317473|3324852|P6|Overall Study|Relocation|2
1017493|NCT00317473|3324853|P5|Overall Study|Relocation|5
1017494|NCT00317473|3324854|P4|Overall Study|Relocation|1
1017495|NCT00317473|3324855|P3|Overall Study|Relocation|1
1017496|NCT00317473|3324856|P2|Overall Study|Relocation|0
1017497|NCT00317473|3324857|P1|Overall Study|Relocation|1
1017498|NCT00317473|3324852|P6|Overall Study|Withdrawal by Subject|1
1017499|NCT00317473|3324853|P5|Overall Study|Withdrawal by Subject|3
1017500|NCT00317473|3324854|P4|Overall Study|Withdrawal by Subject|1
1017501|NCT00317473|3324855|P3|Overall Study|Withdrawal by Subject|2
1017502|NCT00317473|3324856|P2|Overall Study|Withdrawal by Subject|1
1017503|NCT00317473|3324857|P1|Overall Study|Withdrawal by Subject|2
1017504|NCT00317109|3324896|P2|Overall Study|Migated/moved from study area|0
1017505|NCT00317109|3324897|P1|Overall Study|Migated/moved from study area|1
1017506|NCT00317109|3324896|P2|Overall Study|Withdrawal by Subject|0
1017507|NCT00317109|3324897|P1|Overall Study|Withdrawal by Subject|2
1017508|NCT00317044|3324934|P3|Overall Study|Multiple Reasons|6
1017509|NCT00317044|3324935|P2|Overall Study|Multiple Reasons|2
1017510|NCT00317044|3324936|P1|Overall Study|Multiple Reasons|6
1017511|NCT00317044|3324934|P3|Overall Study|Lost to Follow-up|3
1017512|NCT00317044|3324935|P2|Overall Study|Lost to Follow-up|2
1017513|NCT00317044|3324936|P1|Overall Study|Lost to Follow-up|0
1017514|NCT00317044|3324934|P3|Overall Study|Withdrawal by Subject|12
1017515|NCT00317044|3324935|P2|Overall Study|Withdrawal by Subject|7
1017516|NCT00317044|3324936|P1|Overall Study|Withdrawal by Subject|10
1017517|NCT00317044|3324934|P3|Overall Study|Adverse Event|4
1017518|NCT00317044|3324935|P2|Overall Study|Adverse Event|7
1017519|NCT00317044|3324936|P1|Overall Study|Adverse Event|4
1017520|NCT00317044|3324934|P3|Overall Study|Protocol Violation|20
1017521|NCT00317044|3324935|P2|Overall Study|Protocol Violation|22
1017522|NCT00317044|3324936|P1|Overall Study|Protocol Violation|28
1017523|NCT00316914|3324982|P2|Overall Study|Missing end of treatment documentation|15
1017524|NCT00316914|3324983|P1|Overall Study|Missing end of treatment documentation|14
1017525|NCT00316914|3324982|P2|Overall Study|Other Problems|11
1017526|NCT00316914|3324983|P1|Overall Study|Other Problems|6
1017527|NCT00316914|3324982|P2|Overall Study|Adverse Event|7
1017528|NCT00316914|3324983|P1|Overall Study|Adverse Event|8
1017529|NCT00316914|3324982|P2|Overall Study|Withdrawal by Subject|3
1017530|NCT00316914|3324983|P1|Overall Study|Withdrawal by Subject|5
1017531|NCT00316888|3325013|P2|Overall Study|Not start protocol therapy|1
1017532|NCT00316888|3325014|P1|Overall Study|Not start protocol therapy|0
1017533|NCT00316888|3325013|P2|Overall Study|Withdrawal by Subject|2
1017534|NCT00316888|3325014|P1|Overall Study|Withdrawal by Subject|2
1017535|NCT00316888|3325013|P2|Overall Study|Adverse Event|5
1017536|NCT00316888|3325014|P1|Overall Study|Adverse Event|4
1017537|NCT00316719|3325036|P2|Overall Study|Consent withdrawn|0
1017538|NCT00316719|3325037|P1|Overall Study|Consent withdrawn|2
1017539|NCT00316719|3325036|P2|Overall Study|Adverse Event|6
1017540|NCT00316719|3325037|P1|Overall Study|Adverse Event|0
1017541|NCT00316706|3325063|P2|Overall Study|Lost to Follow-up|48
1017542|NCT00316706|3325064|P1|Overall Study|Lost to Follow-up|38
1017543|NCT00316693|3325080|P2|Overall Study|Other|44
1017544|NCT00316693|3325081|P1|Overall Study|Other|38
1017545|NCT00316693|3325080|P2|Overall Study|Lost to Follow-up|34
1017546|NCT00316693|3325081|P1|Overall Study|Lost to Follow-up|26
1017547|NCT00316693|3325080|P2|Overall Study|Withdrawal by Subject|6
1017548|NCT00316693|3325081|P1|Overall Study|Withdrawal by Subject|6
1017549|NCT00316693|3325080|P2|Overall Study|Protocol Violation|0
1017550|NCT00316693|3325081|P1|Overall Study|Protocol Violation|1
1017551|NCT00316693|3325080|P2|Overall Study|Adverse Event|1
1017552|NCT00316693|3325081|P1|Overall Study|Adverse Event|6
1017553|NCT00316303|3325134|P2|Overall Study|Lost to Follow-up|16
1017554|NCT00316303|3325135|P1|Overall Study|Lost to Follow-up|11
1017555|NCT00316277|3325151|P2|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1
1017556|NCT00316277|3325152|P1|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0
1017557|NCT00316277|3325151|P2|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18
1017558|NCT00316277|3325152|P1|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19
1017559|NCT00316277|3325151|P2|Phase 1 (12 Weeks)|Eligible for Phase 2|225
1017560|NCT00316277|3325152|P1|Phase 1 (12 Weeks)|Eligible for Phase 2|220
1017561|NCT00316277|3325151|P2|Phase 1 (12 Weeks)|Investigator-initiated termination|0
1017562|NCT00316277|3325152|P1|Phase 1 (12 Weeks)|Investigator-initiated termination|2
1017563|NCT00316277|3325151|P2|Phase 1 (12 Weeks)|Lost to Follow-up|75
1017564|NCT00316277|3325152|P1|Phase 1 (12 Weeks)|Lost to Follow-up|88
1017565|NCT00316264|3325173|P3|Overall Study|not specified|0
1017566|NCT00316264|3325174|P2|Overall Study|not specified|1
1017567|NCT00316264|3325175|P1|Overall Study|not specified|1
1017568|NCT00316264|3325173|P3|Overall Study|Death|0
1017569|NCT00316264|3325174|P2|Overall Study|Death|0
1017570|NCT00316264|3325175|P1|Overall Study|Death|2
1017571|NCT00316264|3325173|P3|Overall Study|Withdrawal of Consent|6
1017572|NCT00316264|3325174|P2|Overall Study|Withdrawal of Consent|5
1017573|NCT00316264|3325175|P1|Overall Study|Withdrawal of Consent|3
1017574|NCT00316264|3325173|P3|Overall Study|Lost to Follow-up|0
1017575|NCT00316264|3325174|P2|Overall Study|Lost to Follow-up|1
1017576|NCT00316264|3325175|P1|Overall Study|Lost to Follow-up|0
1017577|NCT00316225|3325243|P1|Overall Study|Death|2
1017578|NCT00316225|3325243|P1|Overall Study|Withdrawal by Subject|3
1017579|NCT00316225|3325243|P1|Overall Study|Progressive Disease|15
1017580|NCT00316225|3325243|P1|Overall Study|Physician Decision|3
1017581|NCT00316225|3325243|P1|Overall Study|Adverse Event|2
1017582|NCT00316199|3325252|P1|Overall Study|Lost to Follow-up|2
1017583|NCT00316199|3325252|P1|Overall Study|Death|8
1017584|NCT00316199|3325252|P1|Overall Study|Adverse Event|2
1017585|NCT00316186|3325260|P1|Overall Study|Other|1
1017586|NCT00316186|3325260|P1|Overall Study|Lost to Follow-up|1
1017587|NCT00316186|3325260|P1|Overall Study|Disease Progression|4
1017588|NCT00316186|3325260|P1|Overall Study|Adverse Event|6
1017589|NCT00316173|3325274|P2|Treatment Phase|Study Follow-up Stopped|34
1017590|NCT00316173|3325275|P1|Treatment Phase|Study Follow-up Stopped|0
1017591|NCT00316173|3325274|P2|Treatment Phase|Withdrawal by Subject|1
1017592|NCT00316173|3325275|P1|Treatment Phase|Withdrawal by Subject|0
1017593|NCT00316173|3325274|P2|Treatment Phase|Lost to Follow-up|3
1017594|NCT00316173|3325275|P1|Treatment Phase|Lost to Follow-up|0
1017595|NCT00316173|3325274|P2|Treatment Phase|Lack of Efficacy|3
1017596|NCT00316173|3325275|P1|Treatment Phase|Lack of Efficacy|0
1017597|NCT00316173|3325274|P2|Treatment Phase|Adverse Event|1
1017598|NCT00316173|3325275|P1|Treatment Phase|Adverse Event|0
1017599|NCT00316173|3325274|P2|Run-in Phase|Study Follow-up Stopped|0
1017600|NCT00316173|3325275|P1|Run-in Phase|Study Follow-up Stopped|5
1017601|NCT00316173|3325274|P2|Run-in Phase|Protocol Violation|0
1017602|NCT00316173|3325275|P1|Run-in Phase|Protocol Violation|1
1017603|NCT00316173|3325274|P2|Run-in Phase|Adverse Event|0
1017604|NCT00316173|3325275|P1|Run-in Phase|Adverse Event|1
1017605|NCT00316121|3325288|P2|Overall Study|Subject did not have 24 month visit|0
1017606|NCT00316121|3325289|P1|Overall Study|Subject did not have 24 month visit|1
1017607|NCT00316121|3325288|P2|Overall Study|Subject no show for visit x 3|0
1017608|NCT00316121|3325289|P1|Overall Study|Subject no show for visit x 3|1
1017609|NCT00316121|3325288|P2|Overall Study|Subject refused to return|0
1017610|NCT00316121|3325289|P1|Overall Study|Subject refused to return|1
1017611|NCT00316121|3325288|P2|Overall Study|Subject relocated|1
1017612|NCT00316121|3325289|P1|Overall Study|Subject relocated|1
1017613|NCT00316121|3325288|P2|Overall Study|Reason is missing|0
1017614|NCT00316121|3325289|P1|Overall Study|Reason is missing|1
1017615|NCT00316121|3325288|P2|Overall Study|Withdrawal by Subject|0
1017616|NCT00316121|3325289|P1|Overall Study|Withdrawal by Subject|2
1017617|NCT00316121|3325288|P2|Overall Study|Lost to Follow-up|8
1017618|NCT00316121|3325289|P1|Overall Study|Lost to Follow-up|14
1017619|NCT00316121|3325288|P2|Overall Study|Death|0
1017620|NCT00316121|3325289|P1|Overall Study|Death|1
1017621|NCT00316082|3325300|P5|Overall Study|Administrative reason by sponsor|0
1017622|NCT00316082|3325301|P4|Overall Study|Administrative reason by sponsor|0
1017623|NCT00316082|3325302|P3|Overall Study|Administrative reason by sponsor|1
1017624|NCT00316082|3325303|P2|Overall Study|Administrative reason by sponsor|0
1017625|NCT00316082|3325304|P1|Overall Study|Administrative reason by sponsor|0
1017626|NCT00316082|3325300|P5|Overall Study|Death|0
1017627|NCT00316082|3325301|P4|Overall Study|Death|0
1017628|NCT00316082|3325302|P3|Overall Study|Death|1
1017629|NCT00316082|3325303|P2|Overall Study|Death|0
1017630|NCT00316082|3325304|P1|Overall Study|Death|0
1017631|NCT00316082|3325300|P5|Overall Study|Physician Decision|1
1017632|NCT00316082|3325301|P4|Overall Study|Physician Decision|1
1017633|NCT00316082|3325302|P3|Overall Study|Physician Decision|2
1017634|NCT00316082|3325303|P2|Overall Study|Physician Decision|1
1017635|NCT00316082|3325304|P1|Overall Study|Physician Decision|1
1017636|NCT00316082|3325300|P5|Overall Study|Subject no longer meets study criteria|1
1017637|NCT00316082|3325301|P4|Overall Study|Subject no longer meets study criteria|2
1017638|NCT00316082|3325302|P3|Overall Study|Subject no longer meets study criteria|2
1017639|NCT00316082|3325303|P2|Overall Study|Subject no longer meets study criteria|1
1017640|NCT00316082|3325304|P1|Overall Study|Subject no longer meets study criteria|3
1017641|NCT00316082|3325300|P5|Overall Study|Adverse Event|3
1017642|NCT00316082|3325301|P4|Overall Study|Adverse Event|1
1017643|NCT00316082|3325302|P3|Overall Study|Adverse Event|5
1017644|NCT00316082|3325303|P2|Overall Study|Adverse Event|2
1017645|NCT00316082|3325304|P1|Overall Study|Adverse Event|4
1017646|NCT00316082|3325300|P5|Overall Study|Poor/noncompliance|4
1017647|NCT00316082|3325301|P4|Overall Study|Poor/noncompliance|1
1017648|NCT00316082|3325302|P3|Overall Study|Poor/noncompliance|4
1017649|NCT00316082|3325303|P2|Overall Study|Poor/noncompliance|1
1017650|NCT00316082|3325304|P1|Overall Study|Poor/noncompliance|6
1017651|NCT00316082|3325300|P5|Overall Study|Lost to Follow-up|6
1017652|NCT00316082|3325301|P4|Overall Study|Lost to Follow-up|8
1017653|NCT00316082|3325302|P3|Overall Study|Lost to Follow-up|7
1017654|NCT00316082|3325303|P2|Overall Study|Lost to Follow-up|6
1017655|NCT00316082|3325304|P1|Overall Study|Lost to Follow-up|7
1017656|NCT00316082|3325300|P5|Overall Study|Withdrawal of Consent by Subject|5
1017657|NCT00316082|3325301|P4|Overall Study|Withdrawal of Consent by Subject|9
1017658|NCT00316082|3325302|P3|Overall Study|Withdrawal of Consent by Subject|2
1017659|NCT00316082|3325303|P2|Overall Study|Withdrawal of Consent by Subject|8
1017660|NCT00316082|3325304|P1|Overall Study|Withdrawal of Consent by Subject|10
1017661|NCT00316082|3325300|P5|Overall Study|Lack of Efficacy|6
1017662|NCT00316082|3325301|P4|Overall Study|Lack of Efficacy|4
1017663|NCT00316082|3325302|P3|Overall Study|Lack of Efficacy|3
1017664|NCT00316082|3325303|P2|Overall Study|Lack of Efficacy|3
1017665|NCT00316082|3325304|P1|Overall Study|Lack of Efficacy|2
1017666|NCT00316017|3325335|P3|Overall Study|Protocol Violation|19
1017667|NCT00316017|3325336|P2|Overall Study|Protocol Violation|13
1017668|NCT00316017|3325337|P1|Overall Study|Protocol Violation|11
1017669|NCT00316004|3325411|P3|Overall Study|Subject was not given study fluid.|21
1017670|NCT00316004|3325412|P2|Overall Study|Subject was not given study fluid.|14
1017671|NCT00316004|3325413|P1|Overall Study|Subject was not given study fluid.|14
1017672|NCT00315731|3325484|P1|Overall Study|Death|5
1017673|NCT00315731|3325484|P1|Overall Study|Lost to Follow-up|1
1017674|NCT00315705|3325512|P1|Phase 2|Death|7
1017675|NCT00315705|3325512|P1|Phase 2|Other|1
1017676|NCT00315705|3325512|P1|Phase 2|Scheduled for transplant|8
1017677|NCT00315705|3325512|P1|Phase 2|Disease relapse|1
1017678|NCT00315705|3325512|P1|Phase 2|Failure to achieve response|3
1017679|NCT00315705|3325512|P1|Phase 2|Adverse Event|1
1017680|NCT00315705|3325512|P1|Phase 2|Physician Decision|4
1017681|NCT00315705|3325512|P1|Phase 1|Death|3
1017682|NCT00315705|3325512|P1|Phase 1|Scheduled for transplant|9
1017683|NCT00315705|3325512|P1|Phase 1|Disease relapse|4
1017684|NCT00315705|3325512|P1|Phase 1|Failure to achieve response|8
1017685|NCT00315705|3325512|P1|Phase 1|Refused further treatment|1
1017686|NCT00315458|3325573|P4|Overall Study|Did not qualify|0
1017687|NCT00315458|3325574|P3|Overall Study|Did not qualify|1
1017688|NCT00315458|3325575|P2|Overall Study|Did not qualify|0
1017689|NCT00315458|3325576|P1|Overall Study|Did not qualify|0
1017690|NCT00315458|3325573|P4|Overall Study|Lack of Efficacy|1
1017691|NCT00315458|3325574|P3|Overall Study|Lack of Efficacy|20
1017692|NCT00315458|3325575|P2|Overall Study|Lack of Efficacy|0
1017693|NCT00315458|3325576|P1|Overall Study|Lack of Efficacy|0
1017694|NCT00315458|3325573|P4|Overall Study|Withdrawal by Subject|2
1017695|NCT00315458|3325574|P3|Overall Study|Withdrawal by Subject|0
1017696|NCT00315458|3325575|P2|Overall Study|Withdrawal by Subject|3
1017697|NCT00315458|3325576|P1|Overall Study|Withdrawal by Subject|0
1017698|NCT00315458|3325573|P4|Overall Study|Lost to Follow-up|2
1017699|NCT00315458|3325574|P3|Overall Study|Lost to Follow-up|0
1017700|NCT00315458|3325575|P2|Overall Study|Lost to Follow-up|2
1017701|NCT00315458|3325576|P1|Overall Study|Lost to Follow-up|1
1017702|NCT00315458|3325573|P4|Overall Study|Adverse Event|3
1017703|NCT00315458|3325574|P3|Overall Study|Adverse Event|23
1017704|NCT00315458|3325575|P2|Overall Study|Adverse Event|4
1017705|NCT00315458|3325576|P1|Overall Study|Adverse Event|2
1017706|NCT00315458|3325573|P4|Overall Study|Administrative|21
1017707|NCT00315458|3325574|P3|Overall Study|Administrative|8
1017708|NCT00315458|3325575|P2|Overall Study|Administrative|3
1017709|NCT00315458|3325576|P1|Overall Study|Administrative|0
1017710|NCT00315445|3325589|P3|Overall Study|Other|0
1017711|NCT00315445|3325590|P2|Overall Study|Other|3
1017712|NCT00315445|3325591|P1|Overall Study|Other|1
1017713|NCT00315445|3325589|P3|Overall Study|Protocol Violation|1
1017714|NCT00315445|3325590|P2|Overall Study|Protocol Violation|0
1017715|NCT00315445|3325591|P1|Overall Study|Protocol Violation|2
1017716|NCT00315445|3325589|P3|Overall Study|Lost to Follow-up|1
1017717|NCT00315445|3325590|P2|Overall Study|Lost to Follow-up|0
1017718|NCT00315445|3325591|P1|Overall Study|Lost to Follow-up|1
1017719|NCT00315445|3325589|P3|Overall Study|Lack of Efficacy|7
1017720|NCT00315445|3325590|P2|Overall Study|Lack of Efficacy|1
1017721|NCT00315445|3325591|P1|Overall Study|Lack of Efficacy|16
1017722|NCT00315445|3325589|P3|Overall Study|Adverse Event|15
1017723|NCT00315445|3325590|P2|Overall Study|Adverse Event|12
1017724|NCT00315445|3325591|P1|Overall Study|Adverse Event|7
1017725|NCT00315055|3325881|P2|Overall Study|Lost to Follow-up|1
1017726|NCT00315055|3325882|P1|Overall Study|Lost to Follow-up|1
1017727|NCT00315055|3325881|P2|Overall Study|Protocol Violation|4
1017728|NCT00315055|3325882|P1|Overall Study|Protocol Violation|2
1017729|NCT00314951|3325900|P2|Follow-up|mITT failure|34
1017730|NCT00314951|3325901|P1|Follow-up|mITT failure|44
1017731|NCT00314951|3325900|P2|Treatment|Didn't meet criteria for mITT population|11
1017732|NCT00314951|3325901|P1|Treatment|Didn't meet criteria for mITT population|16
1017733|NCT00314808|3325911|P1|Overall Study|Withdrawal by Subject/PI without AE|4
1017734|NCT00314808|3325911|P1|Overall Study|Disease Progression without AE|4
1017735|NCT00314574|3325921|P2|Overall Study|Data unknown at database lock|1
1017736|NCT00314574|3325922|P1|Overall Study|Data unknown at database lock|0
1017737|NCT00314574|3325921|P2|Overall Study|Pregnancy|4
1017738|NCT00314574|3325922|P1|Overall Study|Pregnancy|6
1017739|NCT00314574|3325921|P2|Overall Study|Physician Decision|15
1017740|NCT00314574|3325922|P1|Overall Study|Physician Decision|22
1017741|NCT00314574|3325921|P2|Overall Study|Withdrawal by Subject|22
1017742|NCT00314574|3325922|P1|Overall Study|Withdrawal by Subject|33
1017743|NCT00314574|3325921|P2|Overall Study|Lost to Follow-up|25
1017744|NCT00314574|3325922|P1|Overall Study|Lost to Follow-up|19
1017745|NCT00314574|3325921|P2|Overall Study|Adverse Event|16
1017746|NCT00314574|3325922|P1|Overall Study|Adverse Event|11
1017747|NCT00314574|3325921|P2|Overall Study|Death|0
1017748|NCT00314574|3325922|P1|Overall Study|Death|3
1017749|NCT00314366|3325938|P2|Overall Study|not treated due to patient medical condi|0
1017750|NCT00314366|3325939|P1|Overall Study|not treated due to patient medical condi|1
1017751|NCT00314340|3325984|P1|Overall Study|lost interest|1
1017752|NCT00314327|3325990|P1|Overall Study|Withdrawal by Subject|1
1017753|NCT00314262|3325995|P1|Overall Study|Physician Decision|1
1017754|NCT00314262|3325995|P1|Overall Study|Withdrawal by Subject|2
1017755|NCT00314262|3325995|P1|Overall Study|Adverse Event|2
1017756|NCT00314249|3326003|P2|Overall Study|Non-Compliant|6
1017757|NCT00314249|3326004|P1|Overall Study|Non-Compliant|5
1017758|NCT00314249|3326003|P2|Overall Study|Withdrawn for other reasons|1
1017759|NCT00314249|3326004|P1|Overall Study|Withdrawn for other reasons|4
1017760|NCT00314249|3326003|P2|Overall Study|Physician Decision|1
1017761|NCT00314249|3326004|P1|Overall Study|Physician Decision|1
1017762|NCT00314249|3326003|P2|Overall Study|Lost to Follow-up|9
1017763|NCT00314249|3326004|P1|Overall Study|Lost to Follow-up|15
1017764|NCT00314249|3326003|P2|Overall Study|Withdrawal by Subject|28
1017765|NCT00314249|3326004|P1|Overall Study|Withdrawal by Subject|21
1017766|NCT00314249|3326003|P2|Overall Study|Lack of Efficacy|24
1017767|NCT00314249|3326004|P1|Overall Study|Lack of Efficacy|33
1017768|NCT00314249|3326003|P2|Overall Study|Adverse Event|94
1017769|NCT00314249|3326004|P1|Overall Study|Adverse Event|73
1017770|NCT00314145|3326037|P2|Overall Study|Sponsor Decision|0
1017771|NCT00314145|3326038|P1|Overall Study|Sponsor Decision|2
1017772|NCT00314145|3326037|P2|Overall Study|Protocol Violation|0
1017773|NCT00314145|3326038|P1|Overall Study|Protocol Violation|3
1017774|NCT00314145|3326037|P2|Overall Study|Adverse Event|3
1017775|NCT00314145|3326038|P1|Overall Study|Adverse Event|0
1017776|NCT00314145|3326037|P2|Overall Study|Physician Decision|4
1017777|NCT00314145|3326038|P1|Overall Study|Physician Decision|3
1017778|NCT00314145|3326037|P2|Overall Study|Lost to Follow-up|12
1017779|NCT00314145|3326038|P1|Overall Study|Lost to Follow-up|5
1017780|NCT00314145|3326037|P2|Overall Study|Withdrawal by Subject|10
1017781|NCT00314145|3326038|P1|Overall Study|Withdrawal by Subject|8
1017782|NCT00314132|3326052|P2|Overall Study|Physician Decision|0
1017783|NCT00314132|3326053|P1|Overall Study|Physician Decision|1
1017784|NCT00314132|3326052|P2|Overall Study|Adverse Event|0
1017785|NCT00314132|3326053|P1|Overall Study|Adverse Event|1
1017786|NCT00314132|3326052|P2|Overall Study|Withdrawal by Subject|5
1017787|NCT00314132|3326053|P1|Overall Study|Withdrawal by Subject|3
1017788|NCT00314132|3326052|P2|Overall Study|Lost to Follow-up|13
1017789|NCT00314132|3326053|P1|Overall Study|Lost to Follow-up|3
1017790|NCT00313911|3326074|P2|Overall Study|Did not meet age criteria|1
1017791|NCT00313911|3326075|P1|Overall Study|Did not meet age criteria|1
1017792|NCT00313911|3326074|P2|Overall Study|Withdrawal by Subject|12
1017793|NCT00313911|3326075|P1|Overall Study|Withdrawal by Subject|39
1017794|NCT00313911|3326074|P2|Overall Study|Lost to Follow-up|14
1017795|NCT00313911|3326075|P1|Overall Study|Lost to Follow-up|27
1017796|NCT00313911|3326074|P2|Overall Study|Protocol Violation|10
1017797|NCT00313911|3326075|P1|Overall Study|Protocol Violation|19
1017798|NCT00313911|3326074|P2|Overall Study|Adverse Event|3
1017799|NCT00313911|3326075|P1|Overall Study|Adverse Event|2
1017800|NCT00313911|3326074|P2|Overall Study|Serious adverse event|1
1017801|NCT00313911|3326075|P1|Overall Study|Serious adverse event|6
1017802|NCT00313846|3326089|P2|Overall Study|Administrative|3
1017803|NCT00313846|3326090|P1|Overall Study|Administrative|2
1017804|NCT00313846|3326089|P2|Overall Study|Adverse Event|8
1017805|NCT00313846|3326090|P1|Overall Study|Adverse Event|1
1017806|NCT00313846|3326089|P2|Overall Study|Withdrawal by Subject|0
1017807|NCT00313846|3326090|P1|Overall Study|Withdrawal by Subject|2
1017808|NCT00313820|3326101|P2|Pregabalin or Placebo Treatment Period|Other|3
1017809|NCT00313820|3326102|P1|Pregabalin or Placebo Treatment Period|Other|2
1017810|NCT00313820|3326101|P2|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4
1017811|NCT00313820|3326102|P1|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6
1017812|NCT00313820|3326101|P2|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7
1017813|NCT00313820|3326102|P1|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0
1017814|NCT00313820|3326101|P2|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1
1017815|NCT00313820|3326102|P1|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0
1017816|NCT00313820|3326101|P2|Pregabalin or Placebo Treatment Period|Adverse Event|4
1017817|NCT00313820|3326102|P1|Pregabalin or Placebo Treatment Period|Adverse Event|9
1017818|NCT00313820|3326101|P2|Assigned to Treatment|Other|0
1017819|NCT00313820|3326102|P1|Assigned to Treatment|Other|1
1017820|NCT00313781|3326140|P3|After Crossover|Other|18
1017821|NCT00313781|3326141|P2|After Crossover|Other|0
1017822|NCT00313781|3326142|P1|After Crossover|Other|0
1017823|NCT00313781|3326140|P3|After Crossover|Withdrawal by Subject|3
1017824|NCT00313781|3326141|P2|After Crossover|Withdrawal by Subject|0
1017825|NCT00313781|3326142|P1|After Crossover|Withdrawal by Subject|0
1017826|NCT00313781|3326140|P3|After Crossover|Death|6
1017827|NCT00313781|3326141|P2|After Crossover|Death|0
1017828|NCT00313781|3326142|P1|After Crossover|Death|0
1017829|NCT00313781|3326140|P3|Before Crossover|Randomized, not treated|0
1017830|NCT00313781|3326141|P2|Before Crossover|Randomized, not treated|0
1017831|NCT00313781|3326142|P1|Before Crossover|Randomized, not treated|5
1017832|NCT00313781|3326140|P3|Before Crossover|Crossover|0
1017833|NCT00313781|3326141|P2|Before Crossover|Crossover|37
1017834|NCT00313781|3326142|P1|Before Crossover|Crossover|0
1017835|NCT00313781|3326140|P3|Before Crossover|Other|0
1017836|NCT00313781|3326141|P2|Before Crossover|Other|30
1017837|NCT00313781|3326142|P1|Before Crossover|Other|45
1017838|NCT00313781|3326140|P3|Before Crossover|Withdrawal by Subject|0
1017839|NCT00313781|3326141|P2|Before Crossover|Withdrawal by Subject|1
1017840|NCT00313781|3326142|P1|Before Crossover|Withdrawal by Subject|3
1017841|NCT00313781|3326140|P3|Before Crossover|Lost to Follow-up|0
1017842|NCT00313781|3326141|P2|Before Crossover|Lost to Follow-up|3
1017843|NCT00313781|3326142|P1|Before Crossover|Lost to Follow-up|0
1017844|NCT00313781|3326140|P3|Before Crossover|Death|0
1017845|NCT00313781|3326141|P2|Before Crossover|Death|8
1017846|NCT00313781|3326142|P1|Before Crossover|Death|22
1017847|NCT00313716|3326182|P6|Overall Study|Withdrawal by Subject|0
1017848|NCT00313716|3326183|P5|Overall Study|Withdrawal by Subject|1
1017849|NCT00313716|3326184|P4|Overall Study|Withdrawal by Subject|0
1017850|NCT00313716|3326185|P3|Overall Study|Withdrawal by Subject|1
1017851|NCT00313716|3326186|P2|Overall Study|Withdrawal by Subject|1
1017852|NCT00313716|3326187|P1|Overall Study|Withdrawal by Subject|0
1017853|NCT00313716|3326182|P6|Overall Study|Lost to Follow-up|4
1017854|NCT00313716|3326183|P5|Overall Study|Lost to Follow-up|0
1017855|NCT00313716|3326184|P4|Overall Study|Lost to Follow-up|1
1017856|NCT00313716|3326185|P3|Overall Study|Lost to Follow-up|2
1017857|NCT00313716|3326186|P2|Overall Study|Lost to Follow-up|5
1017858|NCT00313716|3326187|P1|Overall Study|Lost to Follow-up|2
1017859|NCT00313716|3326182|P6|Overall Study|Death|9
1017860|NCT00313716|3326183|P5|Overall Study|Death|5
1017861|NCT00313716|3326184|P4|Overall Study|Death|3
1017862|NCT00313716|3326185|P3|Overall Study|Death|9
1017863|NCT00313716|3326186|P2|Overall Study|Death|2
1017864|NCT00313716|3326187|P1|Overall Study|Death|3
1017865|NCT00313703|3326214|P4|Overall Study|Lost to Follow-up|12
1017866|NCT00313703|3326215|P3|Overall Study|Lost to Follow-up|5
1017867|NCT00313703|3326216|P2|Overall Study|Lost to Follow-up|2
1017868|NCT00313703|3326217|P1|Overall Study|Lost to Follow-up|11
1017869|NCT00313612|3326233|P2|Overall Study|Patient never received treatment|1
1017870|NCT00313612|3326234|P1|Overall Study|Patient never received treatment|0
1017871|NCT00313586|3326246|P4|Overall Study|Death before starting treatment|0
1017872|NCT00313586|3326247|P3|Overall Study|Death before starting treatment|0
1017873|NCT00313586|3326248|P2|Overall Study|Death before starting treatment|0
1017874|NCT00313586|3326249|P1|Overall Study|Death before starting treatment|1
1017875|NCT00313586|3326246|P4|Overall Study|Moved|0
1017876|NCT00313586|3326247|P3|Overall Study|Moved|0
1017877|NCT00313586|3326248|P2|Overall Study|Moved|1
1017878|NCT00313586|3326249|P1|Overall Study|Moved|0
1017879|NCT00313586|3326246|P4|Overall Study|Lost insurance|0
1017880|NCT00313586|3326247|P3|Overall Study|Lost insurance|0
1017881|NCT00313586|3326248|P2|Overall Study|Lost insurance|1
1017882|NCT00313586|3326249|P1|Overall Study|Lost insurance|0
1017883|NCT00313586|3326246|P4|Overall Study|Absolute neutrophil count not recovered|0
1017884|NCT00313586|3326247|P3|Overall Study|Absolute neutrophil count not recovered|0
1017885|NCT00313586|3326248|P2|Overall Study|Absolute neutrophil count not recovered|1
1017886|NCT00313586|3326249|P1|Overall Study|Absolute neutrophil count not recovered|2
1017887|NCT00313586|3326246|P4|Overall Study|Physician Decision|0
1017888|NCT00313586|3326247|P3|Overall Study|Physician Decision|0
1017889|NCT00313586|3326248|P2|Overall Study|Physician Decision|1
1017890|NCT00313586|3326249|P1|Overall Study|Physician Decision|2
1017891|NCT00313586|3326246|P4|Overall Study|Did not achieve HI-major/better response|1
1017892|NCT00313586|3326247|P3|Overall Study|Did not achieve HI-major/better response|2
1017893|NCT00313586|3326248|P2|Overall Study|Did not achieve HI-major/better response|7
1017894|NCT00313586|3326249|P1|Overall Study|Did not achieve HI-major/better response|10
1017895|NCT00313586|3326246|P4|Overall Study|Other complicating disease|0
1017896|NCT00313586|3326247|P3|Overall Study|Other complicating disease|0
1017897|NCT00313586|3326248|P2|Overall Study|Other complicating disease|2
1017898|NCT00313586|3326249|P1|Overall Study|Other complicating disease|2
1017899|NCT00313586|3326246|P4|Overall Study|Alternative therapy|0
1017900|NCT00313586|3326247|P3|Overall Study|Alternative therapy|2
1017901|NCT00313586|3326248|P2|Overall Study|Alternative therapy|6
1017902|NCT00313586|3326249|P1|Overall Study|Alternative therapy|3
1017903|NCT00313586|3326246|P4|Overall Study|Withdrawal by Subject|2
1017904|NCT00313586|3326247|P3|Overall Study|Withdrawal by Subject|6
1017905|NCT00313586|3326248|P2|Overall Study|Withdrawal by Subject|6
1017906|NCT00313586|3326249|P1|Overall Study|Withdrawal by Subject|13
1017907|NCT00313586|3326246|P4|Overall Study|Death|7
1017908|NCT00313586|3326247|P3|Overall Study|Death|1
1017909|NCT00313586|3326248|P2|Overall Study|Death|8
1017910|NCT00313586|3326249|P1|Overall Study|Death|11
1017911|NCT00313586|3326246|P4|Overall Study|Adverse Event|10
1017912|NCT00313586|3326247|P3|Overall Study|Adverse Event|3
1017913|NCT00313586|3326248|P2|Overall Study|Adverse Event|18
1017914|NCT00313586|3326249|P1|Overall Study|Adverse Event|12
1017915|NCT00313586|3326246|P4|Overall Study|Disease progression|3
1017916|NCT00313586|3326247|P3|Overall Study|Disease progression|10
1017917|NCT00313586|3326248|P2|Overall Study|Disease progression|19
1017918|NCT00313586|3326249|P1|Overall Study|Disease progression|14
1017919|NCT00313313|3326268|P3|Overall Study|Subject No Longer Meets Study Criteria|2
1017920|NCT00313313|3326269|P2|Overall Study|Subject No Longer Meets Study Criteria|3
1017921|NCT00313313|3326270|P1|Overall Study|Subject No Longer Meets Study Criteria|0
1017922|NCT00313313|3326268|P3|Overall Study|Death|2
1017923|NCT00313313|3326269|P2|Overall Study|Death|0
1017924|NCT00313313|3326270|P1|Overall Study|Death|0
1017925|NCT00313313|3326268|P3|Overall Study|Pregnancy|0
1017926|NCT00313313|3326269|P2|Overall Study|Pregnancy|2
1017927|NCT00313313|3326270|P1|Overall Study|Pregnancy|1
1017928|NCT00313313|3326268|P3|Overall Study|Poor/Noncompliance|2
1017929|NCT00313313|3326269|P2|Overall Study|Poor/Noncompliance|6
1017930|NCT00313313|3326270|P1|Overall Study|Poor/Noncompliance|3
1017931|NCT00313313|3326268|P3|Overall Study|Physician Decision|4
1017932|NCT00313313|3326269|P2|Overall Study|Physician Decision|6
1017933|NCT00313313|3326270|P1|Overall Study|Physician Decision|2
1017934|NCT00313313|3326268|P3|Overall Study|Adverse Event|12
1017935|NCT00313313|3326269|P2|Overall Study|Adverse Event|16
1017936|NCT00313313|3326270|P1|Overall Study|Adverse Event|15
1017937|NCT00313313|3326268|P3|Overall Study|Lost to Follow-up|9
1017938|NCT00313313|3326269|P2|Overall Study|Lost to Follow-up|7
1017939|NCT00313313|3326270|P1|Overall Study|Lost to Follow-up|10
1017940|NCT00313313|3326268|P3|Overall Study|Withdrawal of consent by subject|31
1017941|NCT00313313|3326269|P2|Overall Study|Withdrawal of consent by subject|17
1017942|NCT00313313|3326270|P1|Overall Study|Withdrawal of consent by subject|18
1017943|NCT00313313|3326268|P3|Overall Study|Lack of Efficacy|20
1017944|NCT00313313|3326269|P2|Overall Study|Lack of Efficacy|9
1017945|NCT00313313|3326270|P1|Overall Study|Lack of Efficacy|14
1017946|NCT00313300|3326292|P5|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
1017947|NCT00313300|3326293|P4|Follow-Up(30days)-Randomized Phase B|missing end of study status|2
1017948|NCT00313300|3326294|P3|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
1017949|NCT00313300|3326295|P2|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
1017950|NCT00313300|3326296|P1|Follow-Up(30days)-Randomized Phase B|missing end of study status|1
1017951|NCT00313300|3326292|P5|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1
1017952|NCT00313300|3326293|P4|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2
1017953|NCT00313300|3326294|P3|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
1017954|NCT00313300|3326295|P2|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
1017955|NCT00313300|3326296|P1|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
1017956|NCT00313300|3326292|P5|Follow-Up(30days)-Randomized Phase B|Death|0
1017957|NCT00313300|3326293|P4|Follow-Up(30days)-Randomized Phase B|Death|0
1017958|NCT00313300|3326294|P3|Follow-Up(30days)-Randomized Phase B|Death|0
1017959|NCT00313300|3326295|P2|Follow-Up(30days)-Randomized Phase B|Death|0
1017960|NCT00313300|3326296|P1|Follow-Up(30days)-Randomized Phase B|Death|1
1017961|NCT00313300|3326292|P5|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
1017962|NCT00313300|3326293|P4|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
1017963|NCT00313300|3326294|P3|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2
1017964|NCT00313300|3326295|P2|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0
1017965|NCT00313300|3326296|P1|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
1017966|NCT00313300|3326292|P5|Follow-Up(30days)-Randomized Phase A|Death|0
1017967|NCT00313300|3326293|P4|Follow-Up(30days)-Randomized Phase A|Death|0
1017968|NCT00313300|3326294|P3|Follow-Up(30days)-Randomized Phase A|Death|0
1017969|NCT00313300|3326295|P2|Follow-Up(30days)-Randomized Phase A|Death|1
1017970|NCT00313300|3326296|P1|Follow-Up(30days)-Randomized Phase A|Death|0
1017971|NCT00313300|3326292|P5|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
1017972|NCT00313300|3326293|P4|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
1017973|NCT00313300|3326294|P3|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2
1017974|NCT00313300|3326295|P2|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
1017975|NCT00313300|3326296|P1|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
1017976|NCT00313300|3326292|P5|Randomized in Phase B (26 Weeks)|non-specified|0
1017977|NCT00313300|3326293|P4|Randomized in Phase B (26 Weeks)|non-specified|0
1017978|NCT00313300|3326294|P3|Randomized in Phase B (26 Weeks)|non-specified|0
1017979|NCT00313300|3326295|P2|Randomized in Phase B (26 Weeks)|non-specified|0
1017980|NCT00313300|3326296|P1|Randomized in Phase B (26 Weeks)|non-specified|1
1017981|NCT00313300|3326292|P5|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164
1017982|NCT00313300|3326293|P4|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193
1017983|NCT00313300|3326294|P3|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0
1017984|NCT00313300|3326295|P2|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1
1017985|NCT00313300|3326296|P1|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2
1017986|NCT00313300|3326292|P5|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
1017987|NCT00313300|3326293|P4|Randomized in Phase B (26 Weeks)|no longer meets criteria|0
1017988|NCT00313300|3326294|P3|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
1017989|NCT00313300|3326295|P2|Randomized in Phase B (26 Weeks)|no longer meets criteria|3
1017990|NCT00313300|3326296|P1|Randomized in Phase B (26 Weeks)|no longer meets criteria|9
1017991|NCT00313300|3326292|P5|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
1017992|NCT00313300|3326293|P4|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
1017993|NCT00313300|3326294|P3|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
1017994|NCT00313300|3326295|P2|Randomized in Phase B (26 Weeks)|poor/non-compliance|1
1017995|NCT00313300|3326296|P1|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
1017996|NCT00313300|3326292|P5|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
1017997|NCT00313300|3326293|P4|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
1017998|NCT00313300|3326294|P3|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
1017999|NCT00313300|3326295|P2|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
1018000|NCT00313300|3326296|P1|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5
1018001|NCT00313300|3326292|P5|Randomized in Phase B (26 Weeks)|Death|1
1018002|NCT00313300|3326293|P4|Randomized in Phase B (26 Weeks)|Death|0
1018003|NCT00313300|3326294|P3|Randomized in Phase B (26 Weeks)|Death|1
1018004|NCT00313300|3326295|P2|Randomized in Phase B (26 Weeks)|Death|3
1018005|NCT00313300|3326296|P1|Randomized in Phase B (26 Weeks)|Death|5
1018006|NCT00313300|3326292|P5|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
1018007|NCT00313300|3326293|P4|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15
1018008|NCT00313300|3326294|P3|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
1018009|NCT00313300|3326295|P2|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14
1018010|NCT00313300|3326296|P1|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35
1018011|NCT00313300|3326292|P5|Randomized in Phase B (26 Weeks)|Adverse Event|19
1018012|NCT00313300|3326293|P4|Randomized in Phase B (26 Weeks)|Adverse Event|23
1018013|NCT00313300|3326294|P3|Randomized in Phase B (26 Weeks)|Adverse Event|12
1018014|NCT00313300|3326295|P2|Randomized in Phase B (26 Weeks)|Adverse Event|9
1018015|NCT00313300|3326296|P1|Randomized in Phase B (26 Weeks)|Adverse Event|34
1018016|NCT00313300|3326292|P5|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
1018017|NCT00313300|3326293|P4|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
1018018|NCT00313300|3326294|P3|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
1018019|NCT00313300|3326295|P2|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
1018020|NCT00313300|3326296|P1|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1
1018021|NCT00313300|3326292|P5|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
1018022|NCT00313300|3326293|P4|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
1018023|NCT00313300|3326294|P3|Randomized in Phase A (26 Weeks)|no longer meets criteria|2
1018024|NCT00313300|3326295|P2|Randomized in Phase A (26 Weeks)|no longer meets criteria|3
1018025|NCT00313300|3326296|P1|Randomized in Phase A (26 Weeks)|no longer meets criteria|4
1018026|NCT00313300|3326292|P5|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
1018027|NCT00313300|3326293|P4|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
1018028|NCT00313300|3326294|P3|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1
1018029|NCT00313300|3326295|P2|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2
1018030|NCT00313300|3326296|P1|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3
1018031|NCT00313300|3326292|P5|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
1018032|NCT00313300|3326293|P4|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
1018033|NCT00313300|3326294|P3|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2
1018034|NCT00313300|3326295|P2|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
1018035|NCT00313300|3326296|P1|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
1018036|NCT00313300|3326292|P5|Randomized in Phase A (26 Weeks)|Death|0
1018037|NCT00313300|3326293|P4|Randomized in Phase A (26 Weeks)|Death|0
1018038|NCT00313300|3326294|P3|Randomized in Phase A (26 Weeks)|Death|0
1018039|NCT00313300|3326295|P2|Randomized in Phase A (26 Weeks)|Death|4
1018040|NCT00313300|3326296|P1|Randomized in Phase A (26 Weeks)|Death|3
1018041|NCT00313300|3326292|P5|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
1018042|NCT00313300|3326293|P4|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
1018043|NCT00313300|3326294|P3|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13
1018044|NCT00313300|3326295|P2|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12
1018045|NCT00313300|3326296|P1|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20
1018046|NCT00313300|3326292|P5|Randomized in Phase A (26 Weeks)|Adverse Event|0
1018047|NCT00313300|3326293|P4|Randomized in Phase A (26 Weeks)|Adverse Event|0
1018048|NCT00313300|3326294|P3|Randomized in Phase A (26 Weeks)|Adverse Event|17
1018049|NCT00313300|3326295|P2|Randomized in Phase A (26 Weeks)|Adverse Event|14
1018050|NCT00313300|3326296|P1|Randomized in Phase A (26 Weeks)|Adverse Event|19
1018051|NCT00313170|3326366|P3|Overall Study|brain mets. after randomisation|1
1018052|NCT00313170|3326367|P2|Overall Study|brain mets. after randomisation|0
1018053|NCT00313170|3326368|P1|Overall Study|brain mets. after randomisation|0
1018054|NCT00313170|3326366|P3|Overall Study|dosing error|1
1018055|NCT00313170|3326367|P2|Overall Study|dosing error|0
1018056|NCT00313170|3326368|P1|Overall Study|dosing error|0
1018057|NCT00313170|3326366|P3|Overall Study|Clinical progression|0
1018058|NCT00313170|3326367|P2|Overall Study|Clinical progression|0
1018059|NCT00313170|3326368|P1|Overall Study|Clinical progression|1
1018060|NCT00313170|3326366|P3|Overall Study|Lost to Follow-up|1
1018061|NCT00313170|3326367|P2|Overall Study|Lost to Follow-up|0
1018062|NCT00313170|3326368|P1|Overall Study|Lost to Follow-up|0
1018063|NCT00313170|3326366|P3|Overall Study|Incorrect enrollment|1
1018064|NCT00313170|3326367|P2|Overall Study|Incorrect enrollment|1
1018065|NCT00313170|3326368|P1|Overall Study|Incorrect enrollment|0
1018066|NCT00313170|3326366|P3|Overall Study|Withdrawal by Subject|1
1018067|NCT00313170|3326367|P2|Overall Study|Withdrawal by Subject|1
1018068|NCT00313170|3326368|P1|Overall Study|Withdrawal by Subject|1
1018069|NCT00313170|3326366|P3|Overall Study|Disease progression|27
1018070|NCT00313170|3326367|P2|Overall Study|Disease progression|26
1018071|NCT00313170|3326368|P1|Overall Study|Disease progression|31
1018072|NCT00313170|3326366|P3|Overall Study|Adverse Event|0
1018073|NCT00313170|3326367|P2|Overall Study|Adverse Event|2
1018074|NCT00313170|3326368|P1|Overall Study|Adverse Event|2
1018075|NCT00313170|3326366|P3|Overall Study|Death|0
1018076|NCT00313170|3326367|P2|Overall Study|Death|4
1018077|NCT00313170|3326368|P1|Overall Study|Death|1
1018078|NCT00313144|3326384|P1|Overall Study|Due to termination of the study|66
1018079|NCT00313144|3326384|P1|Overall Study|Change to different product|1
1018080|NCT00313144|3326384|P1|Overall Study|Insurance (homecare provider) change|1
1018081|NCT00313144|3326384|P1|Overall Study|Liver transplant|1
1018082|NCT00313144|3326384|P1|Overall Study|Adverse event - transient|5
1018083|NCT00313144|3326384|P1|Overall Study|Physician Decision|4
1018084|NCT00313144|3326384|P1|Overall Study|Terminated by sponsor/ homecare provider|4
1018085|NCT00313144|3326384|P1|Overall Study|Withdrawal by Subject|4
1018086|NCT00313144|3326384|P1|Overall Study|Lost to Follow-up|5
1018087|NCT00313144|3326384|P1|Overall Study|Death|7
1018088|NCT00313144|3326384|P1|Overall Study|Discontinue Aralast ≥4 consecutive doses|12
1018089|NCT00313014|3326471|P3|Overall Study|Lack of Efficacy|16
1018090|NCT00313014|3326472|P2|Overall Study|Lack of Efficacy|25
1018091|NCT00313014|3326473|P1|Overall Study|Lack of Efficacy|52
1018092|NCT00313014|3326471|P3|Overall Study|Administrative|14
1018093|NCT00313014|3326472|P2|Overall Study|Administrative|6
1018094|NCT00313014|3326473|P1|Overall Study|Administrative|9
1018095|NCT00313014|3326471|P3|Overall Study|Lost to Follow-up|10
1018096|NCT00313014|3326472|P2|Overall Study|Lost to Follow-up|6
1018097|NCT00313014|3326473|P1|Overall Study|Lost to Follow-up|7
1018098|NCT00313014|3326471|P3|Overall Study|Adverse Event|16
1018099|NCT00313014|3326472|P2|Overall Study|Adverse Event|29
1018100|NCT00313014|3326473|P1|Overall Study|Adverse Event|14
1018101|NCT00313014|3326471|P3|Overall Study|Withdrawal by Subject|5
1018102|NCT00313014|3326472|P2|Overall Study|Withdrawal by Subject|7
1018103|NCT00313014|3326473|P1|Overall Study|Withdrawal by Subject|11
1018104|NCT00312897|3326504|P2|Overall Study|discontinued prior to getting treatment|3
1018105|NCT00312897|3326505|P1|Overall Study|discontinued prior to getting treatment|0
1018106|NCT00312897|3326504|P2|Overall Study|Pregnancy|0
1018107|NCT00312897|3326505|P1|Overall Study|Pregnancy|1
1018108|NCT00312897|3326504|P2|Overall Study|Withdrawal by Subject|3
1018109|NCT00312897|3326505|P1|Overall Study|Withdrawal by Subject|1
1018110|NCT00312897|3326504|P2|Overall Study|Physician Decision|0
1018111|NCT00312897|3326505|P1|Overall Study|Physician Decision|1
1018112|NCT00312897|3326504|P2|Overall Study|Lost to Follow-up|0
1018113|NCT00312897|3326505|P1|Overall Study|Lost to Follow-up|2
1018114|NCT00312897|3326504|P2|Overall Study|Adverse Event|0
1018115|NCT00312897|3326505|P1|Overall Study|Adverse Event|1
1018116|NCT00312858|3326530|P2|Overall Study|Other|12
1018117|NCT00312858|3326531|P1|Overall Study|Other|9
1018118|NCT00312858|3326530|P2|Overall Study|Participant Moved|10
1018119|NCT00312858|3326531|P1|Overall Study|Participant Moved|11
1018120|NCT00312858|3326530|P2|Overall Study|Withdraw by Participant|20
1018121|NCT00312858|3326531|P1|Overall Study|Withdraw by Participant|20
1018122|NCT00312858|3326530|P2|Overall Study|Protocol Violation|8
1018123|NCT00312858|3326531|P1|Overall Study|Protocol Violation|3
1018124|NCT00312858|3326530|P2|Overall Study|Lost to Follow-up|42
1018125|NCT00312858|3326531|P1|Overall Study|Lost to Follow-up|25
1018126|NCT00312858|3326530|P2|Overall Study|Adverse Event|1
1018127|NCT00312858|3326531|P1|Overall Study|Adverse Event|0
1018128|NCT00312845|3326585|P2|Overall Study|Other|5
1018129|NCT00312845|3326586|P1|Overall Study|Other|6
1018130|NCT00312845|3326585|P2|Overall Study|Lost to Follow-up|0
1018131|NCT00312845|3326586|P1|Overall Study|Lost to Follow-up|2
1018132|NCT00312845|3326585|P2|Overall Study|Disease Progression|77
1018133|NCT00312845|3326586|P1|Overall Study|Disease Progression|56
1018134|NCT00312845|3326585|P2|Overall Study|Withdrawal by Subject|6
1018135|NCT00312845|3326586|P1|Overall Study|Withdrawal by Subject|14
1018136|NCT00312845|3326585|P2|Overall Study|Death|2
1018137|NCT00312845|3326586|P1|Overall Study|Death|2
1018138|NCT00312845|3326585|P2|Overall Study|Adverse Event|5
1018139|NCT00312845|3326586|P1|Overall Study|Adverse Event|19
1018140|NCT00312728|3326594|P1|Overall Study|Other|1
1018141|NCT00312728|3326594|P1|Overall Study|Other|10
1018142|NCT00312728|3326594|P1|Overall Study|Protocol Violation|2
1018143|NCT00312728|3326594|P1|Overall Study|Required non-protocol cancer treatment|2
1018144|NCT00312728|3326594|P1|Overall Study|Withdrawal by Subject|10
1018145|NCT00312728|3326594|P1|Overall Study|Adverse Event|32
1018146|NCT00312728|3326594|P1|Overall Study|Progressive disease|53
1018147|NCT00312702|3326606|P3|Immunization Phase|Lost to Follow-up|0
1018148|NCT00312702|3326607|P2|Immunization Phase|Lost to Follow-up|1
1018149|NCT00312702|3326608|P1|Immunization Phase|Lost to Follow-up|0
1018150|NCT00312663|3326621|P3|Immunization Phase|Adverse Event|0
1018151|NCT00312663|3326622|P2|Immunization Phase|Adverse Event|1
1018152|NCT00312663|3326623|P1|Immunization Phase|Adverse Event|0
1018153|NCT00312572|3326636|P2|Overall Study|Lack of Efficacy|2
1018154|NCT00312572|3326637|P1|Overall Study|Lack of Efficacy|1
1018155|NCT00312572|3326636|P2|Overall Study|Administrative|2
1018156|NCT00312572|3326637|P1|Overall Study|Administrative|4
1018157|NCT00312572|3326636|P2|Overall Study|Lost to Follow-up|1
1018158|NCT00312572|3326637|P1|Overall Study|Lost to Follow-up|1
1018159|NCT00312572|3326636|P2|Overall Study|Adverse Event|16
1018160|NCT00312572|3326637|P1|Overall Study|Adverse Event|10
1018161|NCT00312494|3326648|P3|Overall Study|Other|1
1018162|NCT00312494|3326649|P2|Overall Study|Other|10
1018163|NCT00312494|3326650|P1|Overall Study|Other|10
1018164|NCT00312494|3326648|P3|Overall Study|Withdrawal by Subject|10
1018165|NCT00312494|3326649|P2|Overall Study|Withdrawal by Subject|9
1018166|NCT00312494|3326650|P1|Overall Study|Withdrawal by Subject|6
1018167|NCT00312494|3326648|P3|Overall Study|Lost to Follow-up|8
1018168|NCT00312494|3326649|P2|Overall Study|Lost to Follow-up|8
1018169|NCT00312494|3326650|P1|Overall Study|Lost to Follow-up|8
1018170|NCT00312494|3326648|P3|Overall Study|Laboratory abnormality|0
1018171|NCT00312494|3326649|P2|Overall Study|Laboratory abnormality|0
1018172|NCT00312494|3326650|P1|Overall Study|Laboratory abnormality|1
1018173|NCT00312494|3326648|P3|Overall Study|Lack of Efficacy|8
1018174|NCT00312494|3326649|P2|Overall Study|Lack of Efficacy|6
1018175|NCT00312494|3326650|P1|Overall Study|Lack of Efficacy|4
1018176|NCT00312494|3326648|P3|Overall Study|Adverse Event|11
1018177|NCT00312494|3326649|P2|Overall Study|Adverse Event|15
1018178|NCT00312494|3326650|P1|Overall Study|Adverse Event|33
1018179|NCT00312494|3326648|P3|Overall Study|Randomized; not treated with study drug|5
1018180|NCT00312494|3326649|P2|Overall Study|Randomized; not treated with study drug|10
1018181|NCT00312494|3326650|P1|Overall Study|Randomized; not treated with study drug|9
1018182|NCT00312377|3326684|P2|Overall Study|Site ended participation in study|0
1018183|NCT00312377|3326685|P1|Overall Study|Site ended participation in study|1
1018184|NCT00312377|3326684|P2|Overall Study|Discontinue treatment survival follow up|200
1018185|NCT00312377|3326685|P1|Overall Study|Discontinue treatment survival follow up|202
1018186|NCT00312377|3326684|P2|Overall Study|Randomised but never received treatment|6
1018187|NCT00312377|3326685|P1|Overall Study|Randomised but never received treatment|6
1018188|NCT00312377|3326684|P2|Overall Study|Non-compliance|2
1018189|NCT00312377|3326685|P1|Overall Study|Non-compliance|0
1018190|NCT00312377|3326684|P2|Overall Study|Lost to Follow-up|12
1018191|NCT00312377|3326685|P1|Overall Study|Lost to Follow-up|9
1018192|NCT00312377|3326684|P2|Overall Study|Withdrawal by Subject|30
1018193|NCT00312377|3326685|P1|Overall Study|Withdrawal by Subject|23
1018194|NCT00312377|3326684|P2|Overall Study|Death|418
1018195|NCT00312377|3326685|P1|Overall Study|Death|403
1018196|NCT00312338|3326709|P2|Overall Study|Subsequent infection|0
1018197|NCT00312338|3326710|P1|Overall Study|Subsequent infection|2
1018198|NCT00312338|3326709|P2|Overall Study|Withdrawal by Subject|0
1018199|NCT00312338|3326710|P1|Overall Study|Withdrawal by Subject|4
1018200|NCT00312338|3326709|P2|Overall Study|Lost to Follow-up|1
1018201|NCT00312338|3326710|P1|Overall Study|Lost to Follow-up|9
1018202|NCT00312338|3326709|P2|Overall Study|Adverse Event|2
1018203|NCT00312338|3326710|P1|Overall Study|Adverse Event|7
1018204|NCT00312221|3326723|P4|Double-blind Phase|Lack of Efficacy|10
1018205|NCT00312221|3326724|P3|Double-blind Phase|Lack of Efficacy|6
1018206|NCT00312221|3326725|P2|Double-blind Phase|Lack of Efficacy|17
1018207|NCT00312221|3326726|P1|Double-blind Phase|Lack of Efficacy|0
1018208|NCT00312221|3326723|P4|Double-blind Phase|Administrative|33
1018209|NCT00312221|3326724|P3|Double-blind Phase|Administrative|37
1018210|NCT00312221|3326725|P2|Double-blind Phase|Administrative|26
1018211|NCT00312221|3326726|P1|Double-blind Phase|Administrative|0
1018212|NCT00312221|3326723|P4|Double-blind Phase|Lost to Follow-up|2
1018213|NCT00312221|3326724|P3|Double-blind Phase|Lost to Follow-up|2
1018214|NCT00312221|3326725|P2|Double-blind Phase|Lost to Follow-up|0
1018215|NCT00312221|3326726|P1|Double-blind Phase|Lost to Follow-up|0
1018216|NCT00312221|3326723|P4|Double-blind Phase|Adverse Event|18
1018217|NCT00312221|3326724|P3|Double-blind Phase|Adverse Event|19
1018218|NCT00312221|3326725|P2|Double-blind Phase|Adverse Event|10
1018219|NCT00312221|3326726|P1|Double-blind Phase|Adverse Event|0
1018220|NCT00312221|3326723|P4|Double-blind Phase|Withdrawal by Subject|7
1018221|NCT00312221|3326724|P3|Double-blind Phase|Withdrawal by Subject|8
1018222|NCT00312221|3326725|P2|Double-blind Phase|Withdrawal by Subject|6
1018223|NCT00312221|3326726|P1|Double-blind Phase|Withdrawal by Subject|0
1018224|NCT00312221|3326723|P4|Open-label Run-in Period|Did not qualify|0
1018225|NCT00312221|3326724|P3|Open-label Run-in Period|Did not qualify|0
1018226|NCT00312221|3326725|P2|Open-label Run-in Period|Did not qualify|0
1018227|NCT00312221|3326726|P1|Open-label Run-in Period|Did not qualify|5
1018228|NCT00312221|3326723|P4|Open-label Run-in Period|Lack of Efficacy|0
1018229|NCT00312221|3326724|P3|Open-label Run-in Period|Lack of Efficacy|0
1018230|NCT00312221|3326725|P2|Open-label Run-in Period|Lack of Efficacy|0
1018231|NCT00312221|3326726|P1|Open-label Run-in Period|Lack of Efficacy|102
1018232|NCT00312221|3326723|P4|Open-label Run-in Period|Administrative|0
1018233|NCT00312221|3326724|P3|Open-label Run-in Period|Administrative|0
1018234|NCT00312221|3326725|P2|Open-label Run-in Period|Administrative|0
1018235|NCT00312221|3326726|P1|Open-label Run-in Period|Administrative|42
1018236|NCT00312221|3326723|P4|Open-label Run-in Period|Lost to Follow-up|0
1018237|NCT00312221|3326724|P3|Open-label Run-in Period|Lost to Follow-up|0
1018238|NCT00312221|3326725|P2|Open-label Run-in Period|Lost to Follow-up|0
1018239|NCT00312221|3326726|P1|Open-label Run-in Period|Lost to Follow-up|5
1018240|NCT00312221|3326723|P4|Open-label Run-in Period|Adverse Event|0
1018241|NCT00312221|3326724|P3|Open-label Run-in Period|Adverse Event|0
1018242|NCT00312221|3326725|P2|Open-label Run-in Period|Adverse Event|0
1018243|NCT00312221|3326726|P1|Open-label Run-in Period|Adverse Event|74
1018244|NCT00312221|3326723|P4|Open-label Run-in Period|Withdrawal by Subject|0
1018245|NCT00312221|3326724|P3|Open-label Run-in Period|Withdrawal by Subject|0
1018246|NCT00312221|3326725|P2|Open-label Run-in Period|Withdrawal by Subject|0
1018247|NCT00312221|3326726|P1|Open-label Run-in Period|Withdrawal by Subject|6
1018248|NCT00312208|3326746|P2|Overall Study|Not specified|7
1018249|NCT00312208|3326747|P1|Overall Study|Not specified|5
1018250|NCT00312208|3326746|P2|Overall Study|Withdrawal by Subject|42
1018251|NCT00312208|3326747|P1|Overall Study|Withdrawal by Subject|53
1018252|NCT00312208|3326746|P2|Overall Study|Lost to Follow-up|5
1018253|NCT00312208|3326747|P1|Overall Study|Lost to Follow-up|3
1018254|NCT00312208|3326746|P2|Overall Study|Lack of Efficacy|4
1018255|NCT00312208|3326747|P1|Overall Study|Lack of Efficacy|7
1018256|NCT00312208|3326746|P2|Overall Study|Death|1
1018257|NCT00312208|3326747|P1|Overall Study|Death|2
1018258|NCT00312208|3326746|P2|Overall Study|Protocol Violation|3
1018259|NCT00312208|3326747|P1|Overall Study|Protocol Violation|5
1018260|NCT00312208|3326746|P2|Overall Study|Adverse Event|61
1018261|NCT00312208|3326747|P1|Overall Study|Adverse Event|97
1018262|NCT00312195|3326757|P2|Overall Study|Protocol Violation|0
1018263|NCT00312195|3326758|P1|Overall Study|Protocol Violation|1
1018264|NCT00312195|3326757|P2|Overall Study|Lost to Follow-up|0
1018265|NCT00312195|3326758|P1|Overall Study|Lost to Follow-up|1
1018266|NCT00312195|3326757|P2|Overall Study|Adverse Event|6
1018267|NCT00312195|3326758|P1|Overall Study|Adverse Event|4
1018268|NCT00311584|3326785|P2|Overall Study|ineligible|2
1018269|NCT00311584|3326786|P1|Overall Study|ineligible|2
1018270|NCT00311584|3326785|P2|Overall Study|Withdrawal by Subject|1
1018271|NCT00311584|3326786|P1|Overall Study|Withdrawal by Subject|1
1018272|NCT00311584|3326785|P2|Overall Study|Physician Decision|5
1018273|NCT00311584|3326786|P1|Overall Study|Physician Decision|4
1018274|NCT00311584|3326785|P2|Overall Study|Lack of Efficacy|15
1018275|NCT00311584|3326786|P1|Overall Study|Lack of Efficacy|12
1018276|NCT00311584|3326785|P2|Overall Study|Death|0
1018277|NCT00311584|3326786|P1|Overall Study|Death|1
1018278|NCT00311402|3326794|P2|Overall Study|IRB's rejection etc.|3
1018279|NCT00311402|3326795|P1|Overall Study|IRB's rejection etc.|10
1018280|NCT00311402|3326794|P2|Overall Study|Protocol Violation|6
1018281|NCT00311402|3326795|P1|Overall Study|Protocol Violation|7
1018282|NCT00311402|3326794|P2|Overall Study|Lack of Efficacy|42
1018283|NCT00311402|3326795|P1|Overall Study|Lack of Efficacy|58
1018284|NCT00311402|3326794|P2|Overall Study|Withdrawal by Subject|18
1018285|NCT00311402|3326795|P1|Overall Study|Withdrawal by Subject|17
1018286|NCT00311402|3326794|P2|Overall Study|Lost to Follow-up|3
1018287|NCT00311402|3326795|P1|Overall Study|Lost to Follow-up|0
1018288|NCT00311402|3326794|P2|Overall Study|Adverse Event|105
1018289|NCT00311402|3326795|P1|Overall Study|Adverse Event|118
1018290|NCT00311363|3326844|P3|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
1018291|NCT00311363|3326845|P2|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1
1018292|NCT00311363|3326846|P1|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
1018293|NCT00311363|3326844|P3|12-Week Double-Blind Treatment Period|Protocol Violation|2
1018294|NCT00311363|3326845|P2|12-Week Double-Blind Treatment Period|Protocol Violation|1
1018295|NCT00311363|3326846|P1|12-Week Double-Blind Treatment Period|Protocol Violation|0
1018296|NCT00311363|3326844|P3|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4
1018297|NCT00311363|3326845|P2|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2
1018298|NCT00311363|3326846|P1|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0
1018299|NCT00311363|3326844|P3|12-Week Double-Blind Treatment Period|Lack of Efficacy|4
1018300|NCT00311363|3326845|P2|12-Week Double-Blind Treatment Period|Lack of Efficacy|6
1018301|NCT00311363|3326846|P1|12-Week Double-Blind Treatment Period|Lack of Efficacy|0
1018302|NCT00311363|3326844|P3|12-Week Double-Blind Treatment Period|Lost to Follow-up|2
1018303|NCT00311363|3326845|P2|12-Week Double-Blind Treatment Period|Lost to Follow-up|1
1018304|NCT00311363|3326846|P1|12-Week Double-Blind Treatment Period|Lost to Follow-up|0
1018305|NCT00311363|3326844|P3|12-Week Double-Blind Treatment Period|Adverse Event|0
1018306|NCT00311363|3326845|P2|12-Week Double-Blind Treatment Period|Adverse Event|3
1018307|NCT00311363|3326846|P1|12-Week Double-Blind Treatment Period|Adverse Event|0
1018308|NCT00311363|3326844|P3|24-Week Single-Blind Treatment Period|Death|0
1018309|NCT00311363|3326845|P2|24-Week Single-Blind Treatment Period|Death|0
1018310|NCT00311363|3326846|P1|24-Week Single-Blind Treatment Period|Death|1
1018311|NCT00311363|3326844|P3|24-Week Single-Blind Treatment Period|Pregnancy|0
1018312|NCT00311363|3326845|P2|24-Week Single-Blind Treatment Period|Pregnancy|0
1018313|NCT00311363|3326846|P1|24-Week Single-Blind Treatment Period|Pregnancy|1
1018314|NCT00311363|3326844|P3|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
1018315|NCT00311363|3326845|P2|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
1018316|NCT00311363|3326846|P1|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1
1018317|NCT00311363|3326844|P3|24-Week Single-Blind Treatment Period|Elective Surgery|0
1018318|NCT00311363|3326845|P2|24-Week Single-Blind Treatment Period|Elective Surgery|0
1018319|NCT00311363|3326846|P1|24-Week Single-Blind Treatment Period|Elective Surgery|1
1018320|NCT00311363|3326844|P3|24-Week Single-Blind Treatment Period|Protocol Violation|0
1018321|NCT00311363|3326845|P2|24-Week Single-Blind Treatment Period|Protocol Violation|0
1018322|NCT00311363|3326846|P1|24-Week Single-Blind Treatment Period|Protocol Violation|8
1018323|NCT00311363|3326844|P3|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
1018324|NCT00311363|3326845|P2|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
1018325|NCT00311363|3326846|P1|24-Week Single-Blind Treatment Period|Lost to Follow-up|12
1018326|NCT00311363|3326844|P3|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
1018327|NCT00311363|3326845|P2|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
1018328|NCT00311363|3326846|P1|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27
1018329|NCT00311363|3326844|P3|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
1018330|NCT00311363|3326845|P2|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
1018331|NCT00311363|3326846|P1|24-Week Single-Blind Treatment Period|Lack of Efficacy|13
1018332|NCT00311363|3326844|P3|24-Week Single-Blind Treatment Period|Adverse Event|0
1018333|NCT00311363|3326845|P2|24-Week Single-Blind Treatment Period|Adverse Event|0
1018334|NCT00311363|3326846|P1|24-Week Single-Blind Treatment Period|Adverse Event|42
1018335|NCT00311311|3326906|P2|Overall Study|Lack of ancillary assistance|1
1018336|NCT00311311|3326907|P1|Overall Study|Lack of ancillary assistance|0
1018337|NCT00311311|3326906|P2|Overall Study|Death|0
1018338|NCT00311311|3326907|P1|Overall Study|Death|1
1018339|NCT00311311|3326906|P2|Overall Study|Study Termination by Sponsor|4
1018340|NCT00311311|3326907|P1|Overall Study|Study Termination by Sponsor|3
1018341|NCT00311311|3326906|P2|Overall Study|Noncompliance|1
1018342|NCT00311311|3326907|P1|Overall Study|Noncompliance|0
1018343|NCT00311311|3326906|P2|Overall Study|Withdrawal by Subject|1
1018344|NCT00311311|3326907|P1|Overall Study|Withdrawal by Subject|1
1018345|NCT00311311|3326906|P2|Overall Study|Adverse Event|2
1018346|NCT00311311|3326907|P1|Overall Study|Adverse Event|3
1018347|NCT00311181|3326957|P1|Overall Study|Final DFTs were not obtained|96
1018348|NCT00311155|3326963|P1|Overall Study|Did not meet entry criteria|55
1018349|NCT00311155|3326963|P1|Overall Study|Withdrawal by Subject|17
1018350|NCT00311155|3326963|P1|Overall Study|Adverse Event|21
1018351|NCT00310856|3326975|P3|Overall Study|Unable to classify|0
1018352|NCT00310856|3326976|P2|Overall Study|Unable to classify|0
1018353|NCT00310856|3326977|P1|Overall Study|Unable to classify|1
1018354|NCT00310856|3326975|P3|Overall Study|Inappropriate enrollment|0
1018355|NCT00310856|3326976|P2|Overall Study|Inappropriate enrollment|1
1018356|NCT00310856|3326977|P1|Overall Study|Inappropriate enrollment|1
1018357|NCT00310856|3326975|P3|Overall Study|Lost to Follow-up|6
1018358|NCT00310856|3326976|P2|Overall Study|Lost to Follow-up|2
1018359|NCT00310856|3326977|P1|Overall Study|Lost to Follow-up|1
1018360|NCT00310856|3326975|P3|Overall Study|Withdrawal by Subject|2
1018361|NCT00310856|3326976|P2|Overall Study|Withdrawal by Subject|2
1018362|NCT00310856|3326977|P1|Overall Study|Withdrawal by Subject|2
1018363|NCT00310817|3327001|P4|Overall Study|Unable to classify|0
1018364|NCT00310817|3327002|P3|Overall Study|Unable to classify|0
1018365|NCT00310817|3327003|P2|Overall Study|Unable to classify|1
1018366|NCT00310817|3327004|P1|Overall Study|Unable to classify|3
1018367|NCT00310817|3327001|P4|Overall Study|Protocol Violation|1
1018368|NCT00310817|3327002|P3|Overall Study|Protocol Violation|1
1018369|NCT00310817|3327003|P2|Overall Study|Protocol Violation|1
1018370|NCT00310817|3327004|P1|Overall Study|Protocol Violation|1
1018371|NCT00310817|3327001|P4|Overall Study|Inappropriate Enrollment|0
1018372|NCT00310817|3327002|P3|Overall Study|Inappropriate Enrollment|1
1018373|NCT00310817|3327003|P2|Overall Study|Inappropriate Enrollment|0
1018374|NCT00310817|3327004|P1|Overall Study|Inappropriate Enrollment|1
1018375|NCT00310817|3327001|P4|Overall Study|Lost to Follow-up|0
1018376|NCT00310817|3327002|P3|Overall Study|Lost to Follow-up|0
1018377|NCT00310817|3327003|P2|Overall Study|Lost to Follow-up|1
1018378|NCT00310817|3327004|P1|Overall Study|Lost to Follow-up|2
1018379|NCT00310817|3327001|P4|Overall Study|Withdrawal by Subject|7
1018380|NCT00310817|3327002|P3|Overall Study|Withdrawal by Subject|6
1018381|NCT00310817|3327003|P2|Overall Study|Withdrawal by Subject|4
1018382|NCT00310817|3327004|P1|Overall Study|Withdrawal by Subject|1
1018383|NCT00310817|3327001|P4|Overall Study|AE or Death|0
1018384|NCT00310817|3327002|P3|Overall Study|AE or Death|0
1018385|NCT00310817|3327003|P2|Overall Study|AE or Death|1
1018386|NCT00310817|3327004|P1|Overall Study|AE or Death|3
1018387|NCT00310804|3327092|P2|Overall Study|Withdrawal by Subject|0
1018388|NCT00310804|3327093|P1|Overall Study|Withdrawal by Subject|3
1018389|NCT00310804|3327092|P2|Overall Study|Lost to Follow-up|0
1018390|NCT00310804|3327093|P1|Overall Study|Lost to Follow-up|2
1018391|NCT00310440|3327152|P2|Overall Study|Missed 12 Month Visit|4
1018392|NCT00310440|3327153|P1|Overall Study|Missed 12 Month Visit|7
1018393|NCT00310440|3327152|P2|Overall Study|Withdrawal by Subject|1
1018394|NCT00310440|3327153|P1|Overall Study|Withdrawal by Subject|2
1018395|NCT00310440|3327152|P2|Overall Study|Lost to Follow-up|8
1018396|NCT00310440|3327153|P1|Overall Study|Lost to Follow-up|17
1018397|NCT00310388|3327217|P2|Safety Follow-up Continuation Phase|Study Closed/Terminated|2
1018398|NCT00310388|3327218|P1|Safety Follow-up Continuation Phase|Study Closed/Terminated|0
1018399|NCT00310388|3327217|P2|Safety Follow-up Continuation Phase|Withdrawal by Subject|5
1018400|NCT00310388|3327218|P1|Safety Follow-up Continuation Phase|Withdrawal by Subject|0
1018401|NCT00310388|3327217|P2|Safety Follow-up Continuation Phase|Adverse Event|1
1018402|NCT00310388|3327218|P1|Safety Follow-up Continuation Phase|Adverse Event|0
1018403|NCT00310388|3327217|P2|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5
1018404|NCT00310388|3327218|P1|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0
1018405|NCT00310388|3327217|P2|Primary Reporting Phase|Other|0
1018406|NCT00310388|3327218|P1|Primary Reporting Phase|Other|1
1018407|NCT00310388|3327217|P2|Primary Reporting Phase|Missing|0
1018408|NCT00310388|3327218|P1|Primary Reporting Phase|Missing|1
1018409|NCT00310388|3327217|P2|Primary Reporting Phase|Participant retired the informed consent|0
1018410|NCT00310388|3327218|P1|Primary Reporting Phase|Participant retired the informed consent|1
1018411|NCT00310388|3327217|P2|Primary Reporting Phase|Participant passed away|0
1018412|NCT00310388|3327218|P1|Primary Reporting Phase|Participant passed away|1
1018413|NCT00310388|3327217|P2|Primary Reporting Phase|Due to pigmentation risk concerns|0
1018414|NCT00310388|3327218|P1|Primary Reporting Phase|Due to pigmentation risk concerns|2
1018415|NCT00310388|3327217|P2|Primary Reporting Phase|Ongoing SAE from parent study|0
1018416|NCT00310388|3327218|P1|Primary Reporting Phase|Ongoing SAE from parent study|1
1018417|NCT00310388|3327217|P2|Primary Reporting Phase|Termination of study at sponsor request|0
1018418|NCT00310388|3327218|P1|Primary Reporting Phase|Termination of study at sponsor request|3
1018419|NCT00310388|3327217|P2|Primary Reporting Phase|Participant Immigrated to New Zealand|0
1018420|NCT00310388|3327218|P1|Primary Reporting Phase|Participant Immigrated to New Zealand|1
1018421|NCT00310388|3327217|P2|Primary Reporting Phase|Discontinuation of study|0
1018422|NCT00310388|3327218|P1|Primary Reporting Phase|Discontinuation of study|1
1018423|NCT00310388|3327217|P2|Primary Reporting Phase|Ministry of Health decision|0
1018424|NCT00310388|3327218|P1|Primary Reporting Phase|Ministry of Health decision|25
1018425|NCT00310388|3327217|P2|Primary Reporting Phase|Participant request|0
1018426|NCT00310388|3327218|P1|Primary Reporting Phase|Participant request|2
1018427|NCT00310388|3327217|P2|Primary Reporting Phase|Participant request unrelated to study|0
1018428|NCT00310388|3327218|P1|Primary Reporting Phase|Participant request unrelated to study|2
1018429|NCT00310388|3327217|P2|Primary Reporting Phase|Failed to return|0
1018430|NCT00310388|3327218|P1|Primary Reporting Phase|Failed to return|8
1018431|NCT00310388|3327217|P2|Primary Reporting Phase|Request of the sponsor|0
1018432|NCT00310388|3327218|P1|Primary Reporting Phase|Request of the sponsor|19
1018433|NCT00310388|3327217|P2|Primary Reporting Phase|Physician Decision|0
1018434|NCT00310388|3327218|P1|Primary Reporting Phase|Physician Decision|2
1018435|NCT00310388|3327217|P2|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0
1018436|NCT00310388|3327218|P1|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3
1018437|NCT00310388|3327217|P2|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0
1018438|NCT00310388|3327218|P1|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3
1018439|NCT00310388|3327217|P2|Primary Reporting Phase|Change in participant medical condition|0
1018440|NCT00310388|3327218|P1|Primary Reporting Phase|Change in participant medical condition|3
1018441|NCT00310388|3327217|P2|Primary Reporting Phase|Pregnancy|0
1018442|NCT00310388|3327218|P1|Primary Reporting Phase|Pregnancy|3
1018443|NCT00310388|3327217|P2|Primary Reporting Phase|Protocol Violation|0
1018444|NCT00310388|3327218|P1|Primary Reporting Phase|Protocol Violation|10
1018445|NCT00310388|3327217|P2|Primary Reporting Phase|Withdrawal by Subject|0
1018446|NCT00310388|3327218|P1|Primary Reporting Phase|Withdrawal by Subject|97
1018447|NCT00310388|3327217|P2|Primary Reporting Phase|Lack of Efficacy|0
1018448|NCT00310388|3327218|P1|Primary Reporting Phase|Lack of Efficacy|56
1018449|NCT00310388|3327217|P2|Primary Reporting Phase|Adverse Event|0
1018450|NCT00310388|3327218|P1|Primary Reporting Phase|Adverse Event|101
1018451|NCT00310375|3327260|P3|Safety Follow-up Continuation Phase|Lost to Follow-up|1
1018452|NCT00310375|3327261|P2|Safety Follow-up Continuation Phase|Lost to Follow-up|0
1018453|NCT00310375|3327262|P1|Safety Follow-up Continuation Phase|Lost to Follow-up|0
1018454|NCT00310375|3327260|P3|Primary Reporting Phase|Request of Ethics Committee|0
1018455|NCT00310375|3327261|P2|Primary Reporting Phase|Request of Ethics Committee|1
1018456|NCT00310375|3327262|P1|Primary Reporting Phase|Request of Ethics Committee|0
1018457|NCT00310375|3327260|P3|Primary Reporting Phase|Par. switched to commercial product|0
1018458|NCT00310375|3327261|P2|Primary Reporting Phase|Par. switched to commercial product|1
1018459|NCT00310375|3327262|P1|Primary Reporting Phase|Par. switched to commercial product|0
1018460|NCT00310375|3327260|P3|Primary Reporting Phase|Missed study drug for 2 months|0
1018461|NCT00310375|3327261|P2|Primary Reporting Phase|Missed study drug for 2 months|0
1018462|NCT00310375|3327262|P1|Primary Reporting Phase|Missed study drug for 2 months|1
1018463|NCT00310375|3327260|P3|Primary Reporting Phase|Site closure|0
1018464|NCT00310375|3327261|P2|Primary Reporting Phase|Site closure|0
1018465|NCT00310375|3327262|P1|Primary Reporting Phase|Site closure|3
1018466|NCT00310375|3327260|P3|Primary Reporting Phase|Missed study drug >5 days|0
1018467|NCT00310375|3327261|P2|Primary Reporting Phase|Missed study drug >5 days|0
1018468|NCT00310375|3327262|P1|Primary Reporting Phase|Missed study drug >5 days|1
1018469|NCT00310375|3327260|P3|Primary Reporting Phase|Going for temporal lobectomy|0
1018470|NCT00310375|3327261|P2|Primary Reporting Phase|Going for temporal lobectomy|0
1018471|NCT00310375|3327262|P1|Primary Reporting Phase|Going for temporal lobectomy|1
1018472|NCT00310375|3327260|P3|Primary Reporting Phase|Participant request unrelated to study|0
1018473|NCT00310375|3327261|P2|Primary Reporting Phase|Participant request unrelated to study|2
1018474|NCT00310375|3327262|P1|Primary Reporting Phase|Participant request unrelated to study|1
1018475|NCT00310375|3327260|P3|Primary Reporting Phase|Failed to return|0
1018476|NCT00310375|3327261|P2|Primary Reporting Phase|Failed to return|3
1018477|NCT00310375|3327262|P1|Primary Reporting Phase|Failed to return|1
1018478|NCT00310375|3327260|P3|Primary Reporting Phase|Request of the sponsor|0
1018479|NCT00310375|3327261|P2|Primary Reporting Phase|Request of the sponsor|2
1018480|NCT00310375|3327262|P1|Primary Reporting Phase|Request of the sponsor|2
1018481|NCT00310375|3327260|P3|Primary Reporting Phase|Physician Decision|0
1018482|NCT00310375|3327261|P2|Primary Reporting Phase|Physician Decision|3
1018483|NCT00310375|3327262|P1|Primary Reporting Phase|Physician Decision|5
1018484|NCT00310375|3327260|P3|Primary Reporting Phase|Transaminase >5 upper limit of normal|0
1018485|NCT00310375|3327261|P2|Primary Reporting Phase|Transaminase >5 upper limit of normal|1
1018486|NCT00310375|3327262|P1|Primary Reporting Phase|Transaminase >5 upper limit of normal|2
1018487|NCT00310375|3327260|P3|Primary Reporting Phase|Change in Par medical condition|0
1018488|NCT00310375|3327261|P2|Primary Reporting Phase|Change in Par medical condition|0
1018489|NCT00310375|3327262|P1|Primary Reporting Phase|Change in Par medical condition|2
1018490|NCT00310375|3327260|P3|Primary Reporting Phase|Protocol Violation|0
1018491|NCT00310375|3327261|P2|Primary Reporting Phase|Protocol Violation|5
1018492|NCT00310375|3327262|P1|Primary Reporting Phase|Protocol Violation|8
1018493|NCT00310375|3327260|P3|Primary Reporting Phase|Withdrawal by Subject|0
1018494|NCT00310375|3327261|P2|Primary Reporting Phase|Withdrawal by Subject|7
1018495|NCT00310375|3327262|P1|Primary Reporting Phase|Withdrawal by Subject|10
1018496|NCT00310375|3327260|P3|Primary Reporting Phase|Pregnancy|0
1018497|NCT00310375|3327261|P2|Primary Reporting Phase|Pregnancy|2
1018498|NCT00310375|3327262|P1|Primary Reporting Phase|Pregnancy|2
1018499|NCT00310375|3327260|P3|Primary Reporting Phase|Lack of Efficacy|0
1018500|NCT00310375|3327261|P2|Primary Reporting Phase|Lack of Efficacy|19
1018501|NCT00310375|3327262|P1|Primary Reporting Phase|Lack of Efficacy|24
1018502|NCT00310375|3327260|P3|Primary Reporting Phase|Adverse Event|0
1018503|NCT00310375|3327261|P2|Primary Reporting Phase|Adverse Event|22
1018504|NCT00310375|3327262|P1|Primary Reporting Phase|Adverse Event|28
1018505|NCT00310037|3327361|P2|Overall Study|Non-protocol treatment|0
1018506|NCT00310037|3327362|P1|Overall Study|Non-protocol treatment|1
1018507|NCT00310037|3327361|P2|Overall Study|Progression|0
1018508|NCT00310037|3327362|P1|Overall Study|Progression|6
1018509|NCT00310037|3327361|P2|Overall Study|Withdrawal by Subject|3
1018510|NCT00310037|3327362|P1|Overall Study|Withdrawal by Subject|4
1018511|NCT00310037|3327361|P2|Overall Study|Adverse Event|14
1018512|NCT00310037|3327362|P1|Overall Study|Adverse Event|7
1018513|NCT00309985|3327376|P2|Overall Study|Chemotherapy discontinued only|0
1018514|NCT00309985|3327377|P1|Overall Study|Chemotherapy discontinued only|1
1018515|NCT00309985|3327376|P2|Overall Study|Non-compliance|0
1018516|NCT00309985|3327377|P1|Overall Study|Non-compliance|1
1018517|NCT00309985|3327376|P2|Overall Study|Complicating disease|0
1018518|NCT00309985|3327377|P1|Overall Study|Complicating disease|1
1018519|NCT00309985|3327376|P2|Overall Study|Never started treatment|0
1018520|NCT00309985|3327377|P1|Overall Study|Never started treatment|7
1018521|NCT00309985|3327376|P2|Overall Study|Physician Decision|0
1018522|NCT00309985|3327377|P1|Overall Study|Physician Decision|3
1018523|NCT00309985|3327376|P2|Overall Study|Withdrawal by Subject|1
1018524|NCT00309985|3327377|P1|Overall Study|Withdrawal by Subject|5
1018525|NCT00309985|3327376|P2|Overall Study|Death|0
1018526|NCT00309985|3327377|P1|Overall Study|Death|2
1018527|NCT00309985|3327376|P2|Overall Study|Adverse Event|0
1018528|NCT00309985|3327377|P1|Overall Study|Adverse Event|30
1018529|NCT00309985|3327376|P2|Overall Study|Disease progression|0
1018530|NCT00309985|3327377|P1|Overall Study|Disease progression|12
1018531|NCT00309946|3327393|P1|Overall Study|Withdrawal by Subject|1
1018532|NCT00309907|3327399|P1|Overall Study|Major infectious event|4
1018533|NCT00309907|3327399|P1|Overall Study|Ineligible|11
1018534|NCT00309907|3327399|P1|Overall Study|Physician Decision|1
1018535|NCT00309907|3327399|P1|Overall Study|Death|4
1018536|NCT00309777|3327412|P4|Overall Study|Death|0
1018537|NCT00309777|3327413|P3|Overall Study|Death|0
1018538|NCT00309777|3327414|P2|Overall Study|Death|1
1018539|NCT00309777|3327415|P1|Overall Study|Death|0
1018540|NCT00309777|3327412|P4|Overall Study|Lost to Follow-up|0
1018541|NCT00309777|3327413|P3|Overall Study|Lost to Follow-up|1
1018542|NCT00309777|3327414|P2|Overall Study|Lost to Follow-up|0
1018543|NCT00309777|3327415|P1|Overall Study|Lost to Follow-up|0
1018544|NCT00309777|3327412|P4|Overall Study|Withdrawal by Subject|2
1018545|NCT00309777|3327413|P3|Overall Study|Withdrawal by Subject|7
1018546|NCT00309777|3327414|P2|Overall Study|Withdrawal by Subject|5
1018547|NCT00309777|3327415|P1|Overall Study|Withdrawal by Subject|6
1018548|NCT00309777|3327412|P4|Overall Study|Protocol Violation|1
1018549|NCT00309777|3327413|P3|Overall Study|Protocol Violation|3
1018550|NCT00309777|3327414|P2|Overall Study|Protocol Violation|1
1018551|NCT00309777|3327415|P1|Overall Study|Protocol Violation|4
1018552|NCT00309777|3327412|P4|Overall Study|Adverse Event|1
1018553|NCT00309777|3327413|P3|Overall Study|Adverse Event|8
1018554|NCT00309777|3327414|P2|Overall Study|Adverse Event|2
1018555|NCT00309777|3327415|P1|Overall Study|Adverse Event|13
1018556|NCT00309608|3327456|P5|Overall Study|Other incl. Lack of efficacy|0
1018557|NCT00309608|3327457|P4|Overall Study|Other incl. Lack of efficacy|4
1018558|NCT00309608|3327458|P3|Overall Study|Other incl. Lack of efficacy|3
1018559|NCT00309608|3327459|P2|Overall Study|Other incl. Lack of efficacy|4
1018560|NCT00309608|3327460|P1|Overall Study|Other incl. Lack of efficacy|10
1018561|NCT00309608|3327456|P5|Overall Study|Withdrawal by Subject|0
1018562|NCT00309608|3327457|P4|Overall Study|Withdrawal by Subject|0
1018563|NCT00309608|3327458|P3|Overall Study|Withdrawal by Subject|2
1018564|NCT00309608|3327459|P2|Overall Study|Withdrawal by Subject|4
1018565|NCT00309608|3327460|P1|Overall Study|Withdrawal by Subject|1
1018566|NCT00309608|3327456|P5|Overall Study|Lost to Follow-up|1
1018567|NCT00309608|3327457|P4|Overall Study|Lost to Follow-up|0
1018568|NCT00309608|3327458|P3|Overall Study|Lost to Follow-up|2
1018569|NCT00309608|3327459|P2|Overall Study|Lost to Follow-up|0
1018570|NCT00309608|3327460|P1|Overall Study|Lost to Follow-up|0
1018571|NCT00309608|3327456|P5|Overall Study|Protocol Violation|0
1018572|NCT00309608|3327457|P4|Overall Study|Protocol Violation|0
1018573|NCT00309608|3327458|P3|Overall Study|Protocol Violation|0
1018574|NCT00309608|3327459|P2|Overall Study|Protocol Violation|0
1018575|NCT00309608|3327460|P1|Overall Study|Protocol Violation|2
1018576|NCT00309608|3327456|P5|Overall Study|Adverse Event|3
1018577|NCT00309608|3327457|P4|Overall Study|Adverse Event|2
1018578|NCT00309608|3327458|P3|Overall Study|Adverse Event|3
1018579|NCT00309608|3327459|P2|Overall Study|Adverse Event|5
1018580|NCT00309608|3327460|P1|Overall Study|Adverse Event|1
1018581|NCT00309452|3327508|P2|Overall Study|Withdrawal by Subject|0
1018582|NCT00309452|3327509|P1|Overall Study|Withdrawal by Subject|3
1018583|NCT00309387|3327537|P2|Overall Study|Lost to Follow-up|86
1018584|NCT00309387|3327538|P1|Overall Study|Lost to Follow-up|70
1018585|NCT00309387|3327537|P2|Overall Study|Death|73
1018586|NCT00309387|3327538|P1|Overall Study|Death|72
1018587|NCT00309244|3327556|P2|Overall Study|Death|1
1018588|NCT00309244|3327557|P1|Overall Study|Death|4
1018589|NCT00309244|3327556|P2|Overall Study|Randomized but not dosed|12
1018590|NCT00309244|3327557|P1|Overall Study|Randomized but not dosed|11
1018591|NCT00309244|3327556|P2|Overall Study|Various|7
1018592|NCT00309244|3327557|P1|Overall Study|Various|7
1018593|NCT00309244|3327556|P2|Overall Study|Withdrawal by Subject|32
1018594|NCT00309244|3327557|P1|Overall Study|Withdrawal by Subject|50
1018595|NCT00309244|3327556|P2|Overall Study|Protocol Violation|3
1018596|NCT00309244|3327557|P1|Overall Study|Protocol Violation|6
1018597|NCT00309244|3327556|P2|Overall Study|Physician Decision|8
1018598|NCT00309244|3327557|P1|Overall Study|Physician Decision|5
1018599|NCT00309244|3327556|P2|Overall Study|Lost to Follow-up|22
1018600|NCT00309244|3327557|P1|Overall Study|Lost to Follow-up|6
1018601|NCT00309244|3327556|P2|Overall Study|Adverse Event|12
1018602|NCT00309244|3327557|P1|Overall Study|Adverse Event|29
1018603|NCT00309166|3327579|P2|Overall Study|Withdrawal by Subject|3
1018604|NCT00309166|3327580|P1|Overall Study|Withdrawal by Subject|4
1018605|NCT00309166|3327579|P2|Overall Study|Adverse event, non-fatal|0
1018606|NCT00309166|3327580|P1|Overall Study|Adverse event, non-fatal|1
1018607|NCT00308997|3327608|P2|Overall Study|Unable to tolerate intervention|0
1018608|NCT00308997|3327609|P1|Overall Study|Unable to tolerate intervention|1
1018609|NCT00308997|3327608|P2|Overall Study|Subject feigned clinical data|1
1018610|NCT00308997|3327609|P1|Overall Study|Subject feigned clinical data|0
1018611|NCT00308737|3327628|P3|Overall Study|Various|8
1018612|NCT00308737|3327629|P2|Overall Study|Various|20
1018613|NCT00308737|3327630|P1|Overall Study|Various|32
1018614|NCT00308737|3327628|P3|Overall Study|Withdrawal by Subject|18
1018615|NCT00308737|3327629|P2|Overall Study|Withdrawal by Subject|166
1018616|NCT00308737|3327630|P1|Overall Study|Withdrawal by Subject|218
1018617|NCT00308737|3327628|P3|Overall Study|Protocol Violation|5
1018618|NCT00308737|3327629|P2|Overall Study|Protocol Violation|9
1018619|NCT00308737|3327630|P1|Overall Study|Protocol Violation|34
1018620|NCT00308737|3327628|P3|Overall Study|Physician Decision|1
1018621|NCT00308737|3327629|P2|Overall Study|Physician Decision|2
1018622|NCT00308737|3327630|P1|Overall Study|Physician Decision|15
1018623|NCT00308737|3327628|P3|Overall Study|Lost to Follow-up|5
1018624|NCT00308737|3327629|P2|Overall Study|Lost to Follow-up|80
1018625|NCT00308737|3327630|P1|Overall Study|Lost to Follow-up|56
1018626|NCT00308737|3327628|P3|Overall Study|Death|0
1018627|NCT00308737|3327629|P2|Overall Study|Death|3
1018628|NCT00308737|3327630|P1|Overall Study|Death|4
1018629|NCT00308737|3327628|P3|Overall Study|Adverse Event|0
1018630|NCT00308737|3327629|P2|Overall Study|Adverse Event|9
1018631|NCT00308737|3327630|P1|Overall Study|Adverse Event|104
1018632|NCT00308711|3327670|P3|Overall Study|Subject incarcerated, data not allowed|1
1018633|NCT00308711|3327671|P2|Overall Study|Subject incarcerated, data not allowed|0
1018634|NCT00308711|3327672|P1|Overall Study|Subject incarcerated, data not allowed|0
1018635|NCT00308711|3327670|P3|Overall Study|Baby not born within 7 days of treatment|2
1018636|NCT00308711|3327671|P2|Overall Study|Baby not born within 7 days of treatment|2
1018637|NCT00308711|3327672|P1|Overall Study|Baby not born within 7 days of treatment|1
1018638|NCT00308711|3327670|P3|Overall Study|Lost to Follow-up|0
1018639|NCT00308711|3327671|P2|Overall Study|Lost to Follow-up|1
1018640|NCT00308711|3327672|P1|Overall Study|Lost to Follow-up|0
1018641|NCT00308711|3327670|P3|Overall Study|Protocol Violation|1
1018642|NCT00308711|3327671|P2|Overall Study|Protocol Violation|1
1018643|NCT00308711|3327672|P1|Overall Study|Protocol Violation|0
1018644|NCT00308711|3327670|P3|Overall Study|Withdrawal by Subject|1
1018645|NCT00308711|3327671|P2|Overall Study|Withdrawal by Subject|0
1018646|NCT00308711|3327672|P1|Overall Study|Withdrawal by Subject|1
1018647|NCT00308620|3327707|P3|Overall Study|Lost to Follow-up|1
1018648|NCT00308620|3327708|P2|Overall Study|Lost to Follow-up|0
1018649|NCT00308620|3327709|P1|Overall Study|Lost to Follow-up|0
1018650|NCT00308620|3327707|P3|Overall Study|Death|0
1018651|NCT00308620|3327708|P2|Overall Study|Death|1
1018652|NCT00308620|3327709|P1|Overall Study|Death|1
1018653|NCT00308581|3327718|P3|Randomized Maintenance Phase|Unknown reason|0
1018654|NCT00308581|3327719|P2|Randomized Maintenance Phase|Unknown reason|0
1018655|NCT00308581|3327720|P1|Randomized Maintenance Phase|Unknown reason|3
1018656|NCT00308581|3327718|P3|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0
1018657|NCT00308581|3327719|P2|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59
1018658|NCT00308581|3327720|P1|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82
1018659|NCT00308581|3327718|P3|Randomized Maintenance Phase|Withdrawal by Subject|0
1018660|NCT00308581|3327719|P2|Randomized Maintenance Phase|Withdrawal by Subject|4
1018661|NCT00308581|3327720|P1|Randomized Maintenance Phase|Withdrawal by Subject|1
1018662|NCT00308581|3327718|P3|Randomized Maintenance Phase|Lost to Follow-up|0
1018663|NCT00308581|3327719|P2|Randomized Maintenance Phase|Lost to Follow-up|2
1018664|NCT00308581|3327720|P1|Randomized Maintenance Phase|Lost to Follow-up|0
1018665|NCT00308581|3327718|P3|Randomized Maintenance Phase|Lack of Efficacy|0
1018666|NCT00308581|3327719|P2|Randomized Maintenance Phase|Lack of Efficacy|21
1018667|NCT00308581|3327720|P1|Randomized Maintenance Phase|Lack of Efficacy|9
1018668|NCT00308581|3327718|P3|Randomized Maintenance Phase|Adverse Event|0
1018669|NCT00308581|3327719|P2|Randomized Maintenance Phase|Adverse Event|17
1018670|NCT00308581|3327720|P1|Randomized Maintenance Phase|Adverse Event|10
1018671|NCT00308581|3327718|P3|Induction Phase|Unknown reason|3
1018672|NCT00308581|3327719|P2|Induction Phase|Unknown reason|0
1018673|NCT00308581|3327720|P1|Induction Phase|Unknown reason|0
1018674|NCT00308581|3327718|P3|Induction Phase|Withdrawal by Subject|5
1018675|NCT00308581|3327719|P2|Induction Phase|Withdrawal by Subject|0
1018676|NCT00308581|3327720|P1|Induction Phase|Withdrawal by Subject|0
1018677|NCT00308581|3327718|P3|Induction Phase|Lack of Efficacy|121
1018678|NCT00308581|3327719|P2|Induction Phase|Lack of Efficacy|0
1018679|NCT00308581|3327720|P1|Induction Phase|Lack of Efficacy|0
1018680|NCT00308581|3327718|P3|Induction Phase|Adverse Event|37
1018681|NCT00308581|3327719|P2|Induction Phase|Adverse Event|0
1018682|NCT00308581|3327720|P1|Induction Phase|Adverse Event|0
1018683|NCT00308555|3327846|P2|Overall Study|Physician Decision|0
1018684|NCT00308555|3327847|P1|Overall Study|Physician Decision|2
1018685|NCT00308555|3327846|P2|Overall Study|Withdrawal by Subject|0
1018686|NCT00308555|3327847|P1|Overall Study|Withdrawal by Subject|1
1018687|NCT00308308|3327864|P2|Overall Study|Other|0
1018688|NCT00308308|3327865|P1|Overall Study|Other|1
1018689|NCT00308308|3327864|P2|Overall Study|Randomized but not dosed|16
1018690|NCT00308308|3327865|P1|Overall Study|Randomized but not dosed|8
1018691|NCT00308308|3327864|P2|Overall Study|Various|5
1018692|NCT00308308|3327865|P1|Overall Study|Various|7
1018693|NCT00308308|3327864|P2|Overall Study|Withdrawal by Subject|19
1018694|NCT00308308|3327865|P1|Overall Study|Withdrawal by Subject|47
1018695|NCT00308308|3327864|P2|Overall Study|Protocol Violation|14
1018696|NCT00308308|3327865|P1|Overall Study|Protocol Violation|3
1018697|NCT00308308|3327864|P2|Overall Study|Physician Decision|7
1018698|NCT00308308|3327865|P1|Overall Study|Physician Decision|15
1018699|NCT00308308|3327864|P2|Overall Study|Lost to Follow-up|5
1018700|NCT00308308|3327865|P1|Overall Study|Lost to Follow-up|5
1018701|NCT00308308|3327864|P2|Overall Study|Adverse Event|2
1018702|NCT00308308|3327865|P1|Overall Study|Adverse Event|17
1018703|NCT00308139|3327900|P2|Overall Study|Other|0
1018704|NCT00308139|3327901|P1|Overall Study|Other|1
1018705|NCT00308139|3327900|P2|Overall Study|Administrative|4
1018706|NCT00308139|3327901|P1|Overall Study|Administrative|1
1018707|NCT00308139|3327900|P2|Overall Study|Loss of Glucose Control|7
1018708|NCT00308139|3327901|P1|Overall Study|Loss of Glucose Control|5
1018709|NCT00308139|3327900|P2|Overall Study|Investigator Decision|10
1018710|NCT00308139|3327901|P1|Overall Study|Investigator Decision|11
1018711|NCT00308139|3327900|P2|Overall Study|Withdrawal of Consent|42
1018712|NCT00308139|3327901|P1|Overall Study|Withdrawal of Consent|40
1018713|NCT00308139|3327900|P2|Overall Study|Protocol Violation|2
1018714|NCT00308139|3327901|P1|Overall Study|Protocol Violation|3
1018715|NCT00308139|3327900|P2|Overall Study|Lost to Follow-up|8
1018716|NCT00308139|3327901|P1|Overall Study|Lost to Follow-up|13
1018717|NCT00308139|3327900|P2|Overall Study|Adverse Event|14
1018718|NCT00308139|3327901|P1|Overall Study|Adverse Event|20
1018719|NCT00308113|3327975|P4|Overall Study|Protocol closure|1
1018720|NCT00308113|3327976|P3|Overall Study|Protocol closure|0
1018721|NCT00308113|3327977|P2|Overall Study|Protocol closure|0
1018722|NCT00308113|3327978|P1|Overall Study|Protocol closure|0
1018723|NCT00308087|3327998|P2|Overall Study|Not Specified|3
1018724|NCT00308087|3327999|P1|Overall Study|Not Specified|4
1018725|NCT00308087|3327998|P2|Overall Study|Withdrawal by Subject|1
1018726|NCT00308087|3327999|P1|Overall Study|Withdrawal by Subject|2
1018727|NCT00308087|3327998|P2|Overall Study|Study Closure|12
1018728|NCT00308087|3327999|P1|Overall Study|Study Closure|11
1018729|NCT00308087|3327998|P2|Overall Study|Progressive Disease|21
1018730|NCT00308087|3327999|P1|Overall Study|Progressive Disease|19
1018731|NCT00308074|3328015|P1|Overall Study|Withdrawal by Subject|1
1018732|NCT00307931|3328032|P1|Overall Study|Adverse Event|1
1018733|NCT00307801|3328049|P2|Overall Study|Pregnancy|1
1018734|NCT00307801|3328050|P1|Overall Study|Pregnancy|0
1018735|NCT00307801|3328049|P2|Overall Study|No reason specified|0
1018736|NCT00307801|3328050|P1|Overall Study|No reason specified|2
1018737|NCT00307801|3328049|P2|Overall Study|Protocol Violation|2
1018738|NCT00307801|3328050|P1|Overall Study|Protocol Violation|3
1018739|NCT00307801|3328049|P2|Overall Study|Frustration with e-diary|0
1018740|NCT00307801|3328050|P1|Overall Study|Frustration with e-diary|1
1018741|NCT00307801|3328049|P2|Overall Study|Lost to Follow-up, moved abroad|1
1018742|NCT00307801|3328050|P1|Overall Study|Lost to Follow-up, moved abroad|1
1018743|NCT00307801|3328049|P2|Overall Study|Lack of Efficacy|2
1018744|NCT00307801|3328050|P1|Overall Study|Lack of Efficacy|0
1018745|NCT00307801|3328049|P2|Overall Study|Wrong Randomization|0
1018746|NCT00307801|3328050|P1|Overall Study|Wrong Randomization|1
1018747|NCT00307801|3328049|P2|Overall Study|Decreased Libido (AE at discontinuation)|1
1018748|NCT00307801|3328050|P1|Overall Study|Decreased Libido (AE at discontinuation)|0
1018749|NCT00307801|3328049|P2|Overall Study|Adverse event (AE)/Withdrawal of consent|0
1018750|NCT00307801|3328050|P1|Overall Study|Adverse event (AE)/Withdrawal of consent|2
1018751|NCT00307801|3328049|P2|Overall Study|Non-compliance, not taken all tablets|2
1018752|NCT00307801|3328050|P1|Overall Study|Non-compliance, not taken all tablets|1
1018753|NCT00307801|3328049|P2|Overall Study|Withdrawal by Subject|4
1018754|NCT00307801|3328050|P1|Overall Study|Withdrawal by Subject|9
1018755|NCT00307801|3328049|P2|Overall Study|Adverse Event|4
1018756|NCT00307801|3328050|P1|Overall Study|Adverse Event|12
1018757|NCT00307736|3328162|P4|Overall Study|Withdrawal by Subject|0
1018758|NCT00307736|3328163|P3|Overall Study|Withdrawal by Subject|2
1018759|NCT00307736|3328164|P2|Overall Study|Withdrawal by Subject|0
1018760|NCT00307736|3328165|P1|Overall Study|Withdrawal by Subject|0
1018761|NCT00307736|3328162|P4|Overall Study|Adverse Event|3
1018762|NCT00307736|3328163|P3|Overall Study|Adverse Event|1
1018763|NCT00307736|3328164|P2|Overall Study|Adverse Event|0
1018764|NCT00307736|3328165|P1|Overall Study|Adverse Event|0
1018765|NCT00307684|3328176|P3|Double Blind Phase|Lack of Efficacy|0
1018766|NCT00307684|3328177|P2|Double Blind Phase|Lack of Efficacy|5
1018767|NCT00307684|3328178|P1|Double Blind Phase|Lack of Efficacy|2
1018768|NCT00307684|3328176|P3|Open Label Phase|other|6
1018769|NCT00307684|3328177|P2|Open Label Phase|other|0
1018770|NCT00307684|3328178|P1|Open Label Phase|other|0
1018771|NCT00307684|3328176|P3|Open Label Phase|non compliance|5
1018772|NCT00307684|3328177|P2|Open Label Phase|non compliance|0
1018773|NCT00307684|3328178|P1|Open Label Phase|non compliance|0
1018774|NCT00307684|3328176|P3|Open Label Phase|Lost to Follow-up|11
1018775|NCT00307684|3328177|P2|Open Label Phase|Lost to Follow-up|0
1018776|NCT00307684|3328178|P1|Open Label Phase|Lost to Follow-up|0
1018777|NCT00307684|3328176|P3|Open Label Phase|Withdrawal by Subject|15
1018778|NCT00307684|3328177|P2|Open Label Phase|Withdrawal by Subject|0
1018779|NCT00307684|3328178|P1|Open Label Phase|Withdrawal by Subject|0
1018780|NCT00307684|3328176|P3|Open Label Phase|Adverse Event|16
1018781|NCT00307684|3328177|P2|Open Label Phase|Adverse Event|0
1018782|NCT00307684|3328178|P1|Open Label Phase|Adverse Event|0
1018783|NCT00307684|3328176|P3|Open Label Phase|Lack of Efficacy|3
1018784|NCT00307684|3328177|P2|Open Label Phase|Lack of Efficacy|0
1018785|NCT00307684|3328178|P1|Open Label Phase|Lack of Efficacy|0
1018786|NCT00307489|3328206|P2|Week 48 Through Week 168|Seroconversion|0
1018787|NCT00307489|3328207|P1|Week 48 Through Week 168|Seroconversion|1
1018788|NCT00307489|3328206|P2|Week 48 Through Week 168|Lost to Follow-up|1
1018789|NCT00307489|3328207|P1|Week 48 Through Week 168|Lost to Follow-up|0
1018790|NCT00307489|3328206|P2|Week 48 Through Week 168|Death|1
1018791|NCT00307489|3328207|P1|Week 48 Through Week 168|Death|0
1018792|NCT00307489|3328206|P2|Week 48 Through Week 168|Lack of Efficacy|2
1018793|NCT00307489|3328207|P1|Week 48 Through Week 168|Lack of Efficacy|2
1018794|NCT00307489|3328206|P2|Week 48 Through Week 168|Withdrawal by Subject|2
1018795|NCT00307489|3328207|P1|Week 48 Through Week 168|Withdrawal by Subject|1
1018796|NCT00307489|3328206|P2|Week 48 Through Week 168|Physician Decision|0
1018797|NCT00307489|3328207|P1|Week 48 Through Week 168|Physician Decision|1
1018798|NCT00307489|3328206|P2|Week 48 Through Week 168|Adverse Event|0
1018799|NCT00307489|3328207|P1|Week 48 Through Week 168|Adverse Event|1
1018800|NCT00307489|3328206|P2|Baseline Through Week 48|Withdrawal by Subject|1
1018801|NCT00307489|3328207|P1|Baseline Through Week 48|Withdrawal by Subject|0
1018802|NCT00307489|3328206|P2|Baseline Through Week 48|Physician Decision|0
1018803|NCT00307489|3328207|P1|Baseline Through Week 48|Physician Decision|1
1018804|NCT00307489|3328206|P2|Baseline Through Week 48|Lost to Follow-up|1
1018805|NCT00307489|3328207|P1|Baseline Through Week 48|Lost to Follow-up|0
1018806|NCT00307437|3328252|P7|After Controlled Period|Other|28
1018807|NCT00307437|3328253|P6|After Controlled Period|Other|40
1018808|NCT00307437|3328254|P5|After Controlled Period|Other|9
1018809|NCT00307437|3328255|P4|After Controlled Period|Other|15
1018810|NCT00307437|3328256|P3|After Controlled Period|Other|0
1018811|NCT00307437|3328257|P2|After Controlled Period|Other|0
1018812|NCT00307437|3328258|P1|After Controlled Period|Other|0
1018813|NCT00307437|3328252|P7|After Controlled Period|Lost to Follow-up|18
1018814|NCT00307437|3328253|P6|After Controlled Period|Lost to Follow-up|13
1018815|NCT00307437|3328254|P5|After Controlled Period|Lost to Follow-up|12
1018816|NCT00307437|3328255|P4|After Controlled Period|Lost to Follow-up|7
1018817|NCT00307437|3328256|P3|After Controlled Period|Lost to Follow-up|0
1018818|NCT00307437|3328257|P2|After Controlled Period|Lost to Follow-up|0
1018819|NCT00307437|3328258|P1|After Controlled Period|Lost to Follow-up|0
1018820|NCT00307437|3328252|P7|After Controlled Period|Lack of Efficacy|24
1018821|NCT00307437|3328253|P6|After Controlled Period|Lack of Efficacy|37
1018822|NCT00307437|3328254|P5|After Controlled Period|Lack of Efficacy|17
1018823|NCT00307437|3328255|P4|After Controlled Period|Lack of Efficacy|15
1018824|NCT00307437|3328256|P3|After Controlled Period|Lack of Efficacy|0
1018825|NCT00307437|3328257|P2|After Controlled Period|Lack of Efficacy|0
1018826|NCT00307437|3328258|P1|After Controlled Period|Lack of Efficacy|0
1018827|NCT00307437|3328252|P7|After Controlled Period|Death|3
1018828|NCT00307437|3328253|P6|After Controlled Period|Death|1
1018829|NCT00307437|3328254|P5|After Controlled Period|Death|1
1018830|NCT00307437|3328255|P4|After Controlled Period|Death|3
1018831|NCT00307437|3328256|P3|After Controlled Period|Death|0
1018832|NCT00307437|3328257|P2|After Controlled Period|Death|0
1018833|NCT00307437|3328258|P1|After Controlled Period|Death|0
1018834|NCT00307437|3328252|P7|After Controlled Period|Adverse Event|40
1018835|NCT00307437|3328253|P6|After Controlled Period|Adverse Event|31
1018836|NCT00307437|3328254|P5|After Controlled Period|Adverse Event|16
1018837|NCT00307437|3328255|P4|After Controlled Period|Adverse Event|18
1018838|NCT00307437|3328256|P3|After Controlled Period|Adverse Event|0
1018839|NCT00307437|3328257|P2|After Controlled Period|Adverse Event|0
1018840|NCT00307437|3328258|P1|After Controlled Period|Adverse Event|0
1018841|NCT00307437|3328252|P7|Controlled Period|Other|0
1018842|NCT00307437|3328253|P6|Controlled Period|Other|0
1018843|NCT00307437|3328254|P5|Controlled Period|Other|0
1018844|NCT00307437|3328255|P4|Controlled Period|Other|0
1018845|NCT00307437|3328256|P3|Controlled Period|Other|3
1018846|NCT00307437|3328257|P2|Controlled Period|Other|1
1018847|NCT00307437|3328258|P1|Controlled Period|Other|5
1018848|NCT00307437|3328252|P7|Controlled Period|Lost to Follow-up|0
1018849|NCT00307437|3328253|P6|Controlled Period|Lost to Follow-up|0
1018850|NCT00307437|3328254|P5|Controlled Period|Lost to Follow-up|0
1018851|NCT00307437|3328255|P4|Controlled Period|Lost to Follow-up|0
1018852|NCT00307437|3328256|P3|Controlled Period|Lost to Follow-up|0
1018853|NCT00307437|3328257|P2|Controlled Period|Lost to Follow-up|3
1018854|NCT00307437|3328258|P1|Controlled Period|Lost to Follow-up|2
1018855|NCT00307437|3328252|P7|Controlled Period|Lack of Efficacy|0
1018856|NCT00307437|3328253|P6|Controlled Period|Lack of Efficacy|0
1018857|NCT00307437|3328254|P5|Controlled Period|Lack of Efficacy|0
1018858|NCT00307437|3328255|P4|Controlled Period|Lack of Efficacy|0
1018859|NCT00307437|3328256|P3|Controlled Period|Lack of Efficacy|0
1018860|NCT00307437|3328257|P2|Controlled Period|Lack of Efficacy|0
1018861|NCT00307437|3328258|P1|Controlled Period|Lack of Efficacy|2
1018862|NCT00307437|3328252|P7|Controlled Period|Death|0
1018863|NCT00307437|3328253|P6|Controlled Period|Death|0
1018864|NCT00307437|3328254|P5|Controlled Period|Death|0
1018865|NCT00307437|3328255|P4|Controlled Period|Death|0
1018866|NCT00307437|3328256|P3|Controlled Period|Death|1
1018867|NCT00307437|3328257|P2|Controlled Period|Death|0
1018868|NCT00307437|3328258|P1|Controlled Period|Death|0
1018869|NCT00307437|3328252|P7|Controlled Period|Adverse Event|0
1018870|NCT00307437|3328253|P6|Controlled Period|Adverse Event|0
1018871|NCT00307437|3328254|P5|Controlled Period|Adverse Event|0
1018872|NCT00307437|3328255|P4|Controlled Period|Adverse Event|0
1018873|NCT00307437|3328256|P3|Controlled Period|Adverse Event|5
1018874|NCT00307437|3328257|P2|Controlled Period|Adverse Event|2
1018875|NCT00307437|3328258|P1|Controlled Period|Adverse Event|7
1018876|NCT00307333|3328284|P2|Overall Study|Lost to Follow-up|3
1018877|NCT00307333|3328285|P1|Overall Study|Lost to Follow-up|11
1018878|NCT00307294|3328297|P1|Overall Study|Withdrawal by Subject|1
1018879|NCT00307164|3328306|P2|Overall Study|Lost to Follow-up|1
1018880|NCT00307164|3328307|P1|Overall Study|Lost to Follow-up|6
1018881|NCT00307164|3328306|P2|Overall Study|Not compliant with requirements|4
1018882|NCT00307164|3328307|P1|Overall Study|Not compliant with requirements|4
1018883|NCT00307164|3328306|P2|Overall Study|Withdrawal by Subject|8
1018884|NCT00307164|3328307|P1|Overall Study|Withdrawal by Subject|1
1018885|NCT00307164|3328306|P2|Overall Study|Subject/parent not able to get to clinic|1
1018886|NCT00307164|3328307|P1|Overall Study|Subject/parent not able to get to clinic|2
1018887|NCT00307164|3328306|P2|Overall Study|Severe debilitation, unable to continue|0
1018888|NCT00307164|3328307|P1|Overall Study|Severe debilitation, unable to continue|1
1018889|NCT00307164|3328306|P2|Overall Study|Death|0
1018890|NCT00307164|3328307|P1|Overall Study|Death|1
1018891|NCT00307151|3328347|P4|Overall Study|Clinic unable to contact subject|1
1018892|NCT00307151|3328348|P3|Overall Study|Clinic unable to contact subject|1
1018893|NCT00307151|3328349|P2|Overall Study|Clinic unable to contact subject|3
1018894|NCT00307151|3328350|P1|Overall Study|Clinic unable to contact subject|3
1018895|NCT00307151|3328347|P4|Overall Study|Not willing to adhere to study reqs|2
1018896|NCT00307151|3328348|P3|Overall Study|Not willing to adhere to study reqs|2
1018897|NCT00307151|3328349|P2|Overall Study|Not willing to adhere to study reqs|0
1018898|NCT00307151|3328350|P1|Overall Study|Not willing to adhere to study reqs|2
1018899|NCT00307151|3328347|P4|Overall Study|Withdrew consent|3
1018900|NCT00307151|3328348|P3|Overall Study|Withdrew consent|1
1018901|NCT00307151|3328349|P2|Overall Study|Withdrew consent|1
1018902|NCT00307151|3328350|P1|Overall Study|Withdrew consent|0
1018903|NCT00307151|3328347|P4|Overall Study|Subject unable to get to clinic|2
1018904|NCT00307151|3328348|P3|Overall Study|Subject unable to get to clinic|6
1018905|NCT00307151|3328349|P2|Overall Study|Subject unable to get to clinic|0
1018906|NCT00307151|3328350|P1|Overall Study|Subject unable to get to clinic|1
1018907|NCT00307151|3328347|P4|Overall Study|Severe debilitation, unable to continue|0
1018908|NCT00307151|3328348|P3|Overall Study|Severe debilitation, unable to continue|0
1018909|NCT00307151|3328349|P2|Overall Study|Severe debilitation, unable to continue|0
1018910|NCT00307151|3328350|P1|Overall Study|Severe debilitation, unable to continue|1
1018911|NCT00307151|3328347|P4|Overall Study|Death|3
1018912|NCT00307151|3328348|P3|Overall Study|Death|10
1018913|NCT00307151|3328349|P2|Overall Study|Death|3
1018914|NCT00307151|3328350|P1|Overall Study|Death|4
1018915|NCT00307125|3328394|P3|Pilot Phase|Withdrawal by Subject|1
1018916|NCT00307125|3328395|P2|Pilot Phase|Withdrawal by Subject|1
1018917|NCT00307125|3328396|P1|Pilot Phase|Withdrawal by Subject|0
1018918|NCT00307125|3328394|P3|Pilot Phase|Lost to Follow-up|0
1018919|NCT00307125|3328395|P2|Pilot Phase|Lost to Follow-up|1
1018920|NCT00307125|3328396|P1|Pilot Phase|Lost to Follow-up|0
1018921|NCT00307125|3328394|P3|Screening Phase|Coronary artery bypass|0
1018922|NCT00307125|3328395|P2|Screening Phase|Coronary artery bypass|0
1018923|NCT00307125|3328396|P1|Screening Phase|Coronary artery bypass|1
1018924|NCT00307125|3328394|P3|Screening Phase|AMR and treated with rituximab|0
1018925|NCT00307125|3328395|P2|Screening Phase|AMR and treated with rituximab|0
1018926|NCT00307125|3328396|P1|Screening Phase|AMR and treated with rituximab|1
1018927|NCT00307125|3328394|P3|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
1018928|NCT00307125|3328395|P2|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
1018929|NCT00307125|3328396|P1|Screening Phase|Sample of Anti-HLA Ab was not obtained|1
1018930|NCT00307125|3328394|P3|Screening Phase|Screen Error|0
1018931|NCT00307125|3328395|P2|Screening Phase|Screen Error|0
1018932|NCT00307125|3328396|P1|Screening Phase|Screen Error|1
1018933|NCT00307125|3328394|P3|Screening Phase|Ineligible|0
1018934|NCT00307125|3328395|P2|Screening Phase|Ineligible|0
1018935|NCT00307125|3328396|P1|Screening Phase|Ineligible|1
1018936|NCT00307125|3328394|P3|Screening Phase|PAK|0
1018937|NCT00307125|3328395|P2|Screening Phase|PAK|0
1018938|NCT00307125|3328396|P1|Screening Phase|PAK|1
1018939|NCT00307125|3328394|P3|Screening Phase|Malignancy|0
1018940|NCT00307125|3328395|P2|Screening Phase|Malignancy|0
1018941|NCT00307125|3328396|P1|Screening Phase|Malignancy|1
1018942|NCT00307125|3328394|P3|Screening Phase|Metastatic colon cancer|0
1018943|NCT00307125|3328395|P2|Screening Phase|Metastatic colon cancer|0
1018944|NCT00307125|3328396|P1|Screening Phase|Metastatic colon cancer|1
1018945|NCT00307125|3328394|P3|Screening Phase|Developed acute leukemia|0
1018946|NCT00307125|3328395|P2|Screening Phase|Developed acute leukemia|0
1018947|NCT00307125|3328396|P1|Screening Phase|Developed acute leukemia|1
1018948|NCT00307125|3328394|P3|Screening Phase|Try to get pregnant|0
1018949|NCT00307125|3328395|P2|Screening Phase|Try to get pregnant|0
1018950|NCT00307125|3328396|P1|Screening Phase|Try to get pregnant|1
1018951|NCT00307125|3328394|P3|Screening Phase|Ineligible for pilot|0
1018952|NCT00307125|3328395|P2|Screening Phase|Ineligible for pilot|0
1018953|NCT00307125|3328396|P1|Screening Phase|Ineligible for pilot|4
1018954|NCT00307125|3328394|P3|Screening Phase|Received Pancreas Transplant|0
1018955|NCT00307125|3328395|P2|Screening Phase|Received Pancreas Transplant|0
1018956|NCT00307125|3328396|P1|Screening Phase|Received Pancreas Transplant|8
1018957|NCT00307125|3328394|P3|Screening Phase|Moved or transferred facilities|0
1018958|NCT00307125|3328395|P2|Screening Phase|Moved or transferred facilities|0
1018959|NCT00307125|3328396|P1|Screening Phase|Moved or transferred facilities|34
1018960|NCT00307125|3328394|P3|Screening Phase|Scheduling issues/Non-compliance|0
1018961|NCT00307125|3328395|P2|Screening Phase|Scheduling issues/Non-compliance|0
1018962|NCT00307125|3328396|P1|Screening Phase|Scheduling issues/Non-compliance|55
1018963|NCT00307125|3328394|P3|Screening Phase|Follow-up period ended on Dec 31, 2011|0
1018964|NCT00307125|3328395|P2|Screening Phase|Follow-up period ended on Dec 31, 2011|0
1018965|NCT00307125|3328396|P1|Screening Phase|Follow-up period ended on Dec 31, 2011|83
1018966|NCT00307125|3328394|P3|Screening Phase|Graft Failure|0
1018967|NCT00307125|3328395|P2|Screening Phase|Graft Failure|0
1018968|NCT00307125|3328396|P1|Screening Phase|Graft Failure|8
1018969|NCT00307125|3328394|P3|Screening Phase|Graft Loss|0
1018970|NCT00307125|3328395|P2|Screening Phase|Graft Loss|0
1018971|NCT00307125|3328396|P1|Screening Phase|Graft Loss|3
1018972|NCT00307125|3328394|P3|Screening Phase|Study Terminated|0
1018973|NCT00307125|3328395|P2|Screening Phase|Study Terminated|0
1018974|NCT00307125|3328396|P1|Screening Phase|Study Terminated|17
1018975|NCT00307125|3328394|P3|Screening Phase|Sponsor Decision|0
1018976|NCT00307125|3328395|P2|Screening Phase|Sponsor Decision|0
1018977|NCT00307125|3328396|P1|Screening Phase|Sponsor Decision|4
1018978|NCT00307125|3328394|P3|Screening Phase|Physician Decision|0
1018979|NCT00307125|3328395|P2|Screening Phase|Physician Decision|0
1018980|NCT00307125|3328396|P1|Screening Phase|Physician Decision|26
1018981|NCT00307125|3328394|P3|Screening Phase|Withdrawal by Subject|0
1018982|NCT00307125|3328395|P2|Screening Phase|Withdrawal by Subject|0
1018983|NCT00307125|3328396|P1|Screening Phase|Withdrawal by Subject|77
1018984|NCT00307125|3328394|P3|Screening Phase|Death|0
1018985|NCT00307125|3328395|P2|Screening Phase|Death|0
1018986|NCT00307125|3328396|P1|Screening Phase|Death|10
1018987|NCT00307125|3328394|P3|Screening Phase|Lost to Follow-up|0
1018988|NCT00307125|3328395|P2|Screening Phase|Lost to Follow-up|0
1018989|NCT00307125|3328396|P1|Screening Phase|Lost to Follow-up|87
1018990|NCT00307125|3328394|P3|Screening Phase|Protocol Violation|0
1018991|NCT00307125|3328395|P2|Screening Phase|Protocol Violation|0
1018992|NCT00307125|3328396|P1|Screening Phase|Protocol Violation|27
1018993|NCT00307125|3328394|P3|Screening Phase|Adverse Event|0
1018994|NCT00307125|3328395|P2|Screening Phase|Adverse Event|0
1018995|NCT00307125|3328396|P1|Screening Phase|Adverse Event|1
1018996|NCT00307086|3328418|P1|Overall Study|ineligible|5
1018997|NCT00307047|3328424|P2|Overall Study|All death, all MI, all Revascularization|16
1018998|NCT00307047|3328425|P1|Overall Study|All death, all MI, all Revascularization|27
1018999|NCT00307047|3328424|P2|Overall Study|Lost to follow-up for other reasons|1
1019000|NCT00307047|3328425|P1|Overall Study|Lost to follow-up for other reasons|0
1019001|NCT00307047|3328424|P2|Overall Study|Physician Decision|2
1019002|NCT00307047|3328425|P1|Overall Study|Physician Decision|1
1019003|NCT00307047|3328424|P2|Overall Study|Withdrawal by Subject|6
1019004|NCT00307047|3328425|P1|Overall Study|Withdrawal by Subject|6
1019005|NCT00307047|3328424|P2|Overall Study|Lost to Follow-up|24
1019006|NCT00307047|3328425|P1|Overall Study|Lost to Follow-up|35
1019007|NCT00307034|3328563|P2|Overall Study|Lost to Follow-up|3
1019008|NCT00307034|3328564|P1|Overall Study|Lost to Follow-up|0
1019009|NCT00307034|3328563|P2|Overall Study|Withdrawal by Subject|2
1019010|NCT00307034|3328564|P1|Overall Study|Withdrawal by Subject|1
1019011|NCT00307034|3328563|P2|Overall Study|Adverse Event|2
1019012|NCT00307034|3328564|P1|Overall Study|Adverse Event|1
1019013|NCT00306891|3328615|P4|Part B|Development of study specific disc crit.|1
1019014|NCT00306891|3328616|P3|Part B|Development of study specific disc crit.|0
1019015|NCT00306891|3328617|P2|Part B|Development of study specific disc crit.|0
1019016|NCT00306891|3328618|P1|Part B|Development of study specific disc crit.|0
1019017|NCT00306891|3328615|P4|Part B|Condition under investigation worsened|8
1019018|NCT00306891|3328616|P3|Part B|Condition under investigation worsened|2
1019019|NCT00306891|3328617|P2|Part B|Condition under investigation worsened|0
1019020|NCT00306891|3328618|P1|Part B|Condition under investigation worsened|0
1019021|NCT00306891|3328615|P4|Part B|Withdrawal by Subject|1
1019022|NCT00306891|3328616|P3|Part B|Withdrawal by Subject|3
1019023|NCT00306891|3328617|P2|Part B|Withdrawal by Subject|0
1019024|NCT00306891|3328618|P1|Part B|Withdrawal by Subject|0
1019025|NCT00306891|3328615|P4|Part B|Adverse Event|5
1019026|NCT00306891|3328616|P3|Part B|Adverse Event|5
1019027|NCT00306891|3328617|P2|Part B|Adverse Event|0
1019028|NCT00306891|3328618|P1|Part B|Adverse Event|0
1019029|NCT00306891|3328615|P4|Part B|Death|2
1019030|NCT00306891|3328616|P3|Part B|Death|1
1019031|NCT00306891|3328617|P2|Part B|Death|0
1019032|NCT00306891|3328618|P1|Part B|Death|0
1019033|NCT00306891|3328615|P4|Part A|QTC interval outwith elig. criteria|0
1019034|NCT00306891|3328616|P3|Part A|QTC interval outwith elig. criteria|0
1019035|NCT00306891|3328617|P2|Part A|QTC interval outwith elig. criteria|0
1019036|NCT00306891|3328618|P1|Part A|QTC interval outwith elig. criteria|1
1019037|NCT00306891|3328615|P4|Part A|Suspicion of second malignancy|0
1019038|NCT00306891|3328616|P3|Part A|Suspicion of second malignancy|0
1019039|NCT00306891|3328617|P2|Part A|Suspicion of second malignancy|1
1019040|NCT00306891|3328618|P1|Part A|Suspicion of second malignancy|0
1019041|NCT00306891|3328615|P4|Part A|Reaccumul. of ascites following drainage|0
1019042|NCT00306891|3328616|P3|Part A|Reaccumul. of ascites following drainage|0
1019043|NCT00306891|3328617|P2|Part A|Reaccumul. of ascites following drainage|1
1019044|NCT00306891|3328618|P1|Part A|Reaccumul. of ascites following drainage|0
1019045|NCT00306891|3328615|P4|Part A|Partial bowel obstruction|0
1019046|NCT00306891|3328616|P3|Part A|Partial bowel obstruction|0
1019047|NCT00306891|3328617|P2|Part A|Partial bowel obstruction|0
1019048|NCT00306891|3328618|P1|Part A|Partial bowel obstruction|1
1019049|NCT00306891|3328615|P4|Part A|Incorrect enrol/entry crit not fulfilled|0
1019050|NCT00306891|3328616|P3|Part A|Incorrect enrol/entry crit not fulfilled|0
1019051|NCT00306891|3328617|P2|Part A|Incorrect enrol/entry crit not fulfilled|1
1019052|NCT00306891|3328618|P1|Part A|Incorrect enrol/entry crit not fulfilled|0
1019053|NCT00306891|3328615|P4|Part A|Condition under investigation worsened|0
1019054|NCT00306891|3328616|P3|Part A|Condition under investigation worsened|0
1019055|NCT00306891|3328617|P2|Part A|Condition under investigation worsened|2
1019056|NCT00306891|3328618|P1|Part A|Condition under investigation worsened|2
1019057|NCT00306891|3328615|P4|Part A|Withdrawal by Subject|0
1019058|NCT00306891|3328616|P3|Part A|Withdrawal by Subject|0
1019059|NCT00306891|3328617|P2|Part A|Withdrawal by Subject|1
1019060|NCT00306891|3328618|P1|Part A|Withdrawal by Subject|1
1019061|NCT00306852|3328641|P2|Overall Study|Lost to Follow-up|24
1019062|NCT00306852|3328642|P1|Overall Study|Lost to Follow-up|15
1019063|NCT00306852|3328641|P2|Overall Study|Death|14
1019064|NCT00306852|3328642|P1|Overall Study|Death|14
1019065|NCT00306787|3328660|P2|Overall Study|Abnormal laboratory value(s)|0
1019066|NCT00306787|3328661|P1|Overall Study|Abnormal laboratory value(s)|1
1019067|NCT00306787|3328660|P2|Overall Study|Administrative problems|0
1019068|NCT00306787|3328661|P1|Overall Study|Administrative problems|4
1019069|NCT00306787|3328660|P2|Overall Study|Lost to Follow-up|6
1019070|NCT00306787|3328661|P1|Overall Study|Lost to Follow-up|9
1019071|NCT00306787|3328660|P2|Overall Study|Withdrawal by Subject|9
1019072|NCT00306787|3328661|P1|Overall Study|Withdrawal by Subject|2
1019073|NCT00306787|3328660|P2|Overall Study|Protocol Violation|10
1019074|NCT00306787|3328661|P1|Overall Study|Protocol Violation|8
1019075|NCT00306787|3328660|P2|Overall Study|Lack of Efficacy|0
1019076|NCT00306787|3328661|P1|Overall Study|Lack of Efficacy|1
1019077|NCT00306787|3328660|P2|Overall Study|Adverse Event|1
1019078|NCT00306787|3328661|P1|Overall Study|Adverse Event|1
1019079|NCT00306787|3328660|P2|Overall Study|Discontinued without taking study drug|215
1019080|NCT00306787|3328661|P1|Overall Study|Discontinued without taking study drug|208
1019081|NCT00306670|3328679|P2|Overall Study|patients recruited; Genentech, the st|2
1019082|NCT00306670|3328680|P1|Overall Study|patients recruited; Genentech, the st|0
1019083|NCT00306592|3328686|P2|Overall Study|48-week Treatment Period Ongoing|20
1019084|NCT00306592|3328687|P1|Overall Study|48-week Treatment Period Ongoing|0
1019085|NCT00306592|3328686|P2|Overall Study|Other|2
1019086|NCT00306592|3328687|P1|Overall Study|Other|1
1019087|NCT00306592|3328686|P2|Overall Study|Not Specified|10
1019088|NCT00306592|3328687|P1|Overall Study|Not Specified|5
1019089|NCT00306592|3328686|P2|Overall Study|Voluntary|6
1019090|NCT00306592|3328687|P1|Overall Study|Voluntary|10
1019091|NCT00306592|3328686|P2|Overall Study|Persistent Antibodies|3
1019092|NCT00306592|3328687|P1|Overall Study|Persistent Antibodies|6
1019093|NCT00306592|3328686|P2|Overall Study|Noncompliance|2
1019094|NCT00306592|3328687|P1|Overall Study|Noncompliance|0
1019095|NCT00306592|3328686|P2|Overall Study|Lost to Follow-up|0
1019096|NCT00306592|3328687|P1|Overall Study|Lost to Follow-up|1
1019097|NCT00306592|3328686|P2|Overall Study|Adverse Event|15
1019098|NCT00306592|3328687|P1|Overall Study|Adverse Event|8
1019099|NCT00306527|3328697|P4|Overall Study|Death|2
1019100|NCT00306527|3328698|P3|Overall Study|Death|1
1019101|NCT00306527|3328699|P2|Overall Study|Death|0
1019102|NCT00306527|3328700|P1|Overall Study|Death|1
1019103|NCT00306527|3328697|P4|Overall Study|Adverse Event|1
1019104|NCT00306527|3328698|P3|Overall Study|Adverse Event|1
1019105|NCT00306527|3328699|P2|Overall Study|Adverse Event|0
1019106|NCT00306527|3328700|P1|Overall Study|Adverse Event|0
1019107|NCT00306527|3328697|P4|Overall Study|Withdrawal by Subject|3
1019108|NCT00306527|3328698|P3|Overall Study|Withdrawal by Subject|0
1019109|NCT00306527|3328699|P2|Overall Study|Withdrawal by Subject|3
1019110|NCT00306527|3328700|P1|Overall Study|Withdrawal by Subject|2
1019111|NCT00306527|3328697|P4|Overall Study|Lost to Follow-up|0
1019112|NCT00306527|3328698|P3|Overall Study|Lost to Follow-up|3
1019113|NCT00306527|3328699|P2|Overall Study|Lost to Follow-up|4
1019114|NCT00306527|3328700|P1|Overall Study|Lost to Follow-up|3
1019115|NCT00306384|3328769|P3|Overall Study|Site closure|0
1019116|NCT00306384|3328770|P2|Overall Study|Site closure|0
1019117|NCT00306384|3328771|P1|Overall Study|Site closure|2
1019118|NCT00306384|3328769|P3|Overall Study|Other|32
1019119|NCT00306384|3328770|P2|Overall Study|Other|70
1019120|NCT00306384|3328771|P1|Overall Study|Other|80
1019121|NCT00306384|3328769|P3|Overall Study|Investigator discretion|21
1019122|NCT00306384|3328770|P2|Overall Study|Investigator discretion|31
1019123|NCT00306384|3328771|P1|Overall Study|Investigator discretion|28
1019124|NCT00306384|3328769|P3|Overall Study|Lack of Efficacy|38
1019125|NCT00306384|3328770|P2|Overall Study|Lack of Efficacy|40
1019126|NCT00306384|3328771|P1|Overall Study|Lack of Efficacy|26
1019127|NCT00306384|3328769|P3|Overall Study|Pregnancy|1
1019128|NCT00306384|3328770|P2|Overall Study|Pregnancy|1
1019129|NCT00306384|3328771|P1|Overall Study|Pregnancy|3
1019130|NCT00306384|3328769|P3|Overall Study|Study termination|1
1019131|NCT00306384|3328770|P2|Overall Study|Study termination|0
1019132|NCT00306384|3328771|P1|Overall Study|Study termination|1
1019133|NCT00306384|3328769|P3|Overall Study|Voluntary withdrawal|91
1019134|NCT00306384|3328770|P2|Overall Study|Voluntary withdrawal|187
1019135|NCT00306384|3328771|P1|Overall Study|Voluntary withdrawal|199
1019136|NCT00306384|3328769|P3|Overall Study|Lost to Follow-up|35
1019137|NCT00306384|3328770|P2|Overall Study|Lost to Follow-up|41
1019138|NCT00306384|3328771|P1|Overall Study|Lost to Follow-up|57
1019139|NCT00306384|3328769|P3|Overall Study|Major protocol deviation|18
1019140|NCT00306384|3328770|P2|Overall Study|Major protocol deviation|51
1019141|NCT00306384|3328771|P1|Overall Study|Major protocol deviation|43
1019142|NCT00306384|3328769|P3|Overall Study|Adverse Event|40
1019143|NCT00306384|3328770|P2|Overall Study|Adverse Event|87
1019144|NCT00306384|3328771|P1|Overall Study|Adverse Event|103
1019145|NCT00306293|3328803|P2|Period 2 (Day 67 to Day 126 )|Pregnancy|0
1019146|NCT00306293|3328804|P1|Period 2 (Day 67 to Day 126 )|Pregnancy|1
1019147|NCT00306293|3328803|P2|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1
1019148|NCT00306293|3328804|P1|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0
1019149|NCT00306293|3328803|P2|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0
1019150|NCT00306293|3328804|P1|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1
1019151|NCT00306293|3328803|P2|Period 2 (Day 67 to Day 126 )|Adverse Event|0
1019152|NCT00306293|3328804|P1|Period 2 (Day 67 to Day 126 )|Adverse Event|1
1019153|NCT00306293|3328803|P2|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
1019154|NCT00306293|3328804|P1|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
1019155|NCT00306293|3328803|P2|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
1019156|NCT00306293|3328804|P1|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
1019157|NCT00306293|3328803|P2|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4
1019158|NCT00306293|3328804|P1|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3
1019159|NCT00306293|3328803|P2|Period 1 (Day 1 to Day 60)|Adverse Event|0
1019160|NCT00306293|3328804|P1|Period 1 (Day 1 to Day 60)|Adverse Event|1
1019161|NCT00306202|3328825|P3|Overall Study|Still on treatment|0
1019162|NCT00306202|3328826|P2|Overall Study|Still on treatment|1
1019163|NCT00306202|3328827|P1|Overall Study|Still on treatment|6
1019164|NCT00306189|3328987|P4|Overall Study|Other|0
1019165|NCT00306189|3328988|P3|Overall Study|Other|0
1019166|NCT00306189|3328989|P2|Overall Study|Other|0
1019167|NCT00306189|3328990|P1|Overall Study|Other|1
1019168|NCT00306189|3328987|P4|Overall Study|Ineligibility determined|1
1019169|NCT00306189|3328988|P3|Overall Study|Ineligibility determined|1
1019170|NCT00306189|3328989|P2|Overall Study|Ineligibility determined|1
1019171|NCT00306189|3328990|P1|Overall Study|Ineligibility determined|1
1019172|NCT00306189|3328987|P4|Overall Study|Withdrawal by Subject|1
1019173|NCT00306189|3328988|P3|Overall Study|Withdrawal by Subject|8
1019174|NCT00306189|3328989|P2|Overall Study|Withdrawal by Subject|2
1019175|NCT00306189|3328990|P1|Overall Study|Withdrawal by Subject|4
1019176|NCT00306189|3328987|P4|Overall Study|Adverse Event|2
1019177|NCT00306189|3328988|P3|Overall Study|Adverse Event|2
1019178|NCT00306189|3328989|P2|Overall Study|Adverse Event|3
1019179|NCT00306189|3328990|P1|Overall Study|Adverse Event|3
1019180|NCT00306189|3328987|P4|Overall Study|Physician Decision|1
1019181|NCT00306189|3328988|P3|Overall Study|Physician Decision|0
1019182|NCT00306189|3328989|P2|Overall Study|Physician Decision|0
1019183|NCT00306189|3328990|P1|Overall Study|Physician Decision|0
1019184|NCT00305877|3329017|P2|Overall Study|Transportation issue with daily RT|1
1019185|NCT00305877|3329018|P1|Overall Study|Transportation issue with daily RT|0
1019186|NCT00305877|3329017|P2|Overall Study|Ineligible|1
1019187|NCT00305877|3329018|P1|Overall Study|Ineligible|2
1019188|NCT00305877|3329017|P2|Overall Study|Never start treatment|5
1019189|NCT00305877|3329018|P1|Overall Study|Never start treatment|2
1019190|NCT00305877|3329017|P2|Overall Study|Physician Decision|1
1019191|NCT00305877|3329018|P1|Overall Study|Physician Decision|1
1019192|NCT00305877|3329017|P2|Overall Study|Withdrawal by Subject|2
1019193|NCT00305877|3329018|P1|Overall Study|Withdrawal by Subject|4
1019194|NCT00305877|3329017|P2|Overall Study|Death|1
1019195|NCT00305877|3329018|P1|Overall Study|Death|0
1019196|NCT00305877|3329017|P2|Overall Study|Adverse Event|14
1019197|NCT00305877|3329018|P1|Overall Study|Adverse Event|9
1019198|NCT00305877|3329017|P2|Overall Study|Lack of Efficacy|9
1019199|NCT00305877|3329018|P1|Overall Study|Lack of Efficacy|6
1019200|NCT00305864|3329032|P4|Overall Study|Ineligible / No protocol treatment|13
1019201|NCT00305864|3329033|P3|Overall Study|Ineligible / No protocol treatment|1
1019202|NCT00305864|3329034|P2|Overall Study|Ineligible / No protocol treatment|1
1019203|NCT00305864|3329035|P1|Overall Study|Ineligible / No protocol treatment|0
1019204|NCT00305773|3329048|P2|Overall Study|All other reasons|2
1019205|NCT00305773|3329049|P1|Overall Study|All other reasons|3
1019206|NCT00305773|3329048|P2|Overall Study|Disease Progression|3
1019207|NCT00305773|3329049|P1|Overall Study|Disease Progression|1
1019208|NCT00305773|3329048|P2|Overall Study|Withdrawal by Subject|4
1019209|NCT00305773|3329049|P1|Overall Study|Withdrawal by Subject|1
1019210|NCT00305773|3329048|P2|Overall Study|Physician Decision|1
1019211|NCT00305773|3329049|P1|Overall Study|Physician Decision|1
1019212|NCT00305773|3329048|P2|Overall Study|Alternative Treatment|4
1019213|NCT00305773|3329049|P1|Overall Study|Alternative Treatment|4
1019214|NCT00305773|3329048|P2|Overall Study|Adverse Event|2
1019215|NCT00305773|3329049|P1|Overall Study|Adverse Event|1
1019216|NCT00305773|3329048|P2|Overall Study|Death|2
1019217|NCT00305773|3329049|P1|Overall Study|Death|3
1019218|NCT00305604|3329080|P2|Overall Study|Patient moved|0
1019219|NCT00305604|3329081|P1|Overall Study|Patient moved|1
1019220|NCT00305604|3329080|P2|Overall Study|Withdrawal by Subject|21
1019221|NCT00305604|3329081|P1|Overall Study|Withdrawal by Subject|12
1019222|NCT00305604|3329080|P2|Overall Study|Protocol Violation|1
1019223|NCT00305604|3329081|P1|Overall Study|Protocol Violation|2
1019224|NCT00305604|3329080|P2|Overall Study|Lost to Follow-up|4
1019225|NCT00305604|3329081|P1|Overall Study|Lost to Follow-up|0
1019226|NCT00305604|3329080|P2|Overall Study|Lack of Efficacy|18
1019227|NCT00305604|3329081|P1|Overall Study|Lack of Efficacy|11
1019228|NCT00305604|3329080|P2|Overall Study|Adverse Event|3
1019229|NCT00305604|3329081|P1|Overall Study|Adverse Event|6
1019230|NCT00305448|3329225|P3|Overall Study|Tumor Marker Elevation|1
1019231|NCT00305448|3329226|P2|Overall Study|Tumor Marker Elevation|0
1019232|NCT00305448|3329227|P1|Overall Study|Tumor Marker Elevation|0
1019233|NCT00305448|3329225|P3|Overall Study|Subjective Disease Progression|2
1019234|NCT00305448|3329226|P2|Overall Study|Subjective Disease Progression|2
1019235|NCT00305448|3329227|P1|Overall Study|Subjective Disease Progression|1
1019236|NCT00305448|3329225|P3|Overall Study|Disease Progression|28
1019237|NCT00305448|3329226|P2|Overall Study|Disease Progression|31
1019238|NCT00305448|3329227|P1|Overall Study|Disease Progression|27
1019239|NCT00305448|3329225|P3|Overall Study|Adverse Event|1
1019240|NCT00305448|3329226|P2|Overall Study|Adverse Event|0
1019241|NCT00305448|3329227|P1|Overall Study|Adverse Event|1
1019242|NCT00305448|3329225|P3|Overall Study|Withdrawal by Subject|1
1019243|NCT00305448|3329226|P2|Overall Study|Withdrawal by Subject|0
1019244|NCT00305448|3329227|P1|Overall Study|Withdrawal by Subject|2
1019245|NCT00305448|3329225|P3|Overall Study|Protocol Violation|0
1019246|NCT00305448|3329226|P2|Overall Study|Protocol Violation|1
1019247|NCT00305448|3329227|P1|Overall Study|Protocol Violation|0
1019248|NCT00305253|3329249|P2|Overall Study|Withdrawal by Subject|1
1019249|NCT00305253|3329250|P1|Overall Study|Withdrawal by Subject|0
1019250|NCT00305227|3329262|P2|Overall Study|Lost to Follow-up|6
1019251|NCT00305227|3329263|P1|Overall Study|Lost to Follow-up|7
1019252|NCT00305110|3329310|P1|Overall Study|Missing data|29
1019253|NCT00305058|3329321|P2|Overall Study|Missing outcome data|2
1019254|NCT00305058|3329322|P1|Overall Study|Missing outcome data|3
1019255|NCT00305058|3329321|P2|Overall Study|Missing data collection instrument|2
1019256|NCT00305058|3329322|P1|Overall Study|Missing data collection instrument|3
1019257|NCT00305058|3329321|P2|Overall Study|Participant too young|0
1019258|NCT00305058|3329322|P1|Overall Study|Participant too young|1
1019259|NCT00304954|3329338|P4|Overall Study|Adverse Event|0
1019260|NCT00304954|3329339|P3|Overall Study|Adverse Event|0
1019261|NCT00304954|3329340|P2|Overall Study|Adverse Event|0
1019262|NCT00304954|3329341|P1|Overall Study|Adverse Event|1
1019263|NCT00304954|3329338|P4|Overall Study|Withdrawal by Subject|0
1019264|NCT00304954|3329339|P3|Overall Study|Withdrawal by Subject|1
1019265|NCT00304954|3329340|P2|Overall Study|Withdrawal by Subject|0
1019266|NCT00304954|3329341|P1|Overall Study|Withdrawal by Subject|0
1019267|NCT00304915|3329361|P2|Overall Study|Withdrawal by Subject|0
1019268|NCT00304915|3329362|P1|Overall Study|Withdrawal by Subject|3
1019269|NCT00304915|3329361|P2|Overall Study|Death|5
1019270|NCT00304915|3329362|P1|Overall Study|Death|4
1019271|NCT00304915|3329361|P2|Overall Study|Lost to Follow-up|11
1019272|NCT00304915|3329362|P1|Overall Study|Lost to Follow-up|11
1019273|NCT00304356|3329407|P1|Nitazoxanide|Physician Decision|1
1019274|NCT00304356|3329407|P1|Nitazoxanide|Physician Decision|1
1019275|NCT00304356|3329407|P1|Nitazoxanide|Physician Decision|1
1019276|NCT00304356|3329407|P1|Nitazoxanide|number is 0|1
1019277|NCT00304356|3329407|P1|Nitazoxanide|Physician Decision|1
1019278|NCT00304356|3329407|P1|Nitazoxanide|Physician Decision|5
1019279|NCT00304278|3329411|P1|Overall Study|PT had medical condition preventing TX|1
1019280|NCT00304278|3329411|P1|Overall Study|lack of insurance coverage for chemoRT|1
1019281|NCT00304083|3329460|P2|Overall Study|Other|2
1019282|NCT00304083|3329461|P1|Overall Study|Other|5
1019283|NCT00304083|3329460|P2|Overall Study|Disease Progression|1
1019284|NCT00304083|3329461|P1|Overall Study|Disease Progression|5
1019285|NCT00304083|3329460|P2|Overall Study|Physician Decision|3
1019286|NCT00304083|3329461|P1|Overall Study|Physician Decision|8
1019287|NCT00304083|3329460|P2|Overall Study|Withdrawal by Subject|2
1019288|NCT00304083|3329461|P1|Overall Study|Withdrawal by Subject|4
1019289|NCT00304070|3329480|P3|Overall Study|Progressive Disease|4
1019290|NCT00304070|3329481|P2|Overall Study|Progressive Disease|7
1019291|NCT00304070|3329482|P1|Overall Study|Progressive Disease|3
1019292|NCT00304070|3329480|P3|Overall Study|Withdrawal by Subject|1
1019293|NCT00304070|3329481|P2|Overall Study|Withdrawal by Subject|0
1019294|NCT00304070|3329482|P1|Overall Study|Withdrawal by Subject|0
1019295|NCT00304070|3329480|P3|Overall Study|Physician Decision|3
1019296|NCT00304070|3329481|P2|Overall Study|Physician Decision|0
1019297|NCT00304070|3329482|P1|Overall Study|Physician Decision|0
1019298|NCT00304070|3329480|P3|Overall Study|Lost to Follow-up|1
1019299|NCT00304070|3329481|P2|Overall Study|Lost to Follow-up|0
1019300|NCT00304070|3329482|P1|Overall Study|Lost to Follow-up|0
1019301|NCT00304070|3329480|P3|Overall Study|Death|3
1019302|NCT00304070|3329481|P2|Overall Study|Death|0
1019303|NCT00304070|3329482|P1|Overall Study|Death|0
1019304|NCT00304031|3329497|P3|Randomization to Adjuvant TMZ Arm|No follow-up collected|2
1019305|NCT00304031|3329498|P2|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
1019306|NCT00304031|3329499|P1|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
1019307|NCT00304031|3329497|P3|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|0
1019308|NCT00304031|3329498|P2|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|0
1019309|NCT00304031|3329499|P1|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|37
1019310|NCT00304031|3329497|P3|Concomitant Radiation Therapy and TMZ|Other complicating disease|0
1019311|NCT00304031|3329498|P2|Concomitant Radiation Therapy and TMZ|Other complicating disease|0
1019312|NCT00304031|3329499|P1|Concomitant Radiation Therapy and TMZ|Other complicating disease|1
1019313|NCT00304031|3329497|P3|Concomitant Radiation Therapy and TMZ|Toxicity|0
1019314|NCT00304031|3329498|P2|Concomitant Radiation Therapy and TMZ|Toxicity|0
1019315|NCT00304031|3329499|P1|Concomitant Radiation Therapy and TMZ|Toxicity|10
1019316|NCT00304031|3329497|P3|Concomitant Radiation Therapy and TMZ|Physician preference|0
1019317|NCT00304031|3329498|P2|Concomitant Radiation Therapy and TMZ|Physician preference|0
1019318|NCT00304031|3329499|P1|Concomitant Radiation Therapy and TMZ|Physician preference|15
1019319|NCT00304031|3329497|P3|Concomitant Radiation Therapy and TMZ|Death|0
1019320|NCT00304031|3329498|P2|Concomitant Radiation Therapy and TMZ|Death|0
1019321|NCT00304031|3329499|P1|Concomitant Radiation Therapy and TMZ|Death|18
1019322|NCT00304031|3329497|P3|Concomitant Radiation Therapy and TMZ|Patient refusal|0
1019323|NCT00304031|3329498|P2|Concomitant Radiation Therapy and TMZ|Patient refusal|0
1019324|NCT00304031|3329499|P1|Concomitant Radiation Therapy and TMZ|Patient refusal|19
1019325|NCT00304031|3329497|P3|Concomitant Radiation Therapy and TMZ|Disease progression|0
1019326|NCT00304031|3329498|P2|Concomitant Radiation Therapy and TMZ|Disease progression|0
1019327|NCT00304031|3329499|P1|Concomitant Radiation Therapy and TMZ|Disease progression|48
1019328|NCT00304031|3329497|P3|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|0
1019329|NCT00304031|3329498|P2|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|0
1019330|NCT00304031|3329499|P1|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|144
1019331|NCT00304031|3329497|P3|Registration|Ineligible|0
1019332|NCT00304031|3329498|P2|Registration|Ineligible|0
1019333|NCT00304031|3329499|P1|Registration|Ineligible|48
1019334|NCT00303953|3329530|P1|Overall Study|Physician Decision|1
1019335|NCT00303953|3329530|P1|Overall Study|Lack of Efficacy|12
1019336|NCT00303953|3329530|P1|Overall Study|Adverse Event|4
1019337|NCT00303953|3329530|P1|Overall Study|Death|1
1019338|NCT00303953|3329530|P1|Overall Study|Ineligible|1
1019339|NCT00303667|3329565|P2|Overall Study|Death|4
1019340|NCT00303667|3329566|P1|Overall Study|Death|0
1019341|NCT00303628|3329590|P2|Overall Study|Other|9
1019342|NCT00303628|3329591|P1|Overall Study|Other|8
1019343|NCT00303628|3329590|P2|Overall Study|Not start protocol therapy|5
1019344|NCT00303628|3329591|P1|Overall Study|Not start protocol therapy|3
1019345|NCT00303628|3329590|P2|Overall Study|Other complicating disease|1
1019346|NCT00303628|3329591|P1|Overall Study|Other complicating disease|0
1019347|NCT00303628|3329590|P2|Overall Study|Alternative therapy|0
1019348|NCT00303628|3329591|P1|Overall Study|Alternative therapy|2
1019349|NCT00303628|3329590|P2|Overall Study|Withdrawal by Subject|20
1019350|NCT00303628|3329591|P1|Overall Study|Withdrawal by Subject|11
1019351|NCT00303628|3329590|P2|Overall Study|Death|1
1019352|NCT00303628|3329591|P1|Overall Study|Death|0
1019353|NCT00303628|3329590|P2|Overall Study|Adverse Event|36
1019354|NCT00303628|3329591|P1|Overall Study|Adverse Event|26
1019355|NCT00303628|3329590|P2|Overall Study|Disease progression|1
1019356|NCT00303628|3329591|P1|Overall Study|Disease progression|0
1019357|NCT00303602|3329609|P2|Overall Study|Protocol Violation|0
1019358|NCT00303602|3329610|P1|Overall Study|Protocol Violation|1
1019359|NCT00303602|3329609|P2|Overall Study|Noncompliance|2
1019360|NCT00303602|3329610|P1|Overall Study|Noncompliance|2
1019361|NCT00303602|3329609|P2|Overall Study|Physician Decision|1
1019362|NCT00303602|3329610|P1|Overall Study|Physician Decision|2
1019363|NCT00303602|3329609|P2|Overall Study|Protocol entry criteria not met|2
1019364|NCT00303602|3329610|P1|Overall Study|Protocol entry criteria not met|2
1019365|NCT00303602|3329609|P2|Overall Study|Lost to Follow-up|2
1019366|NCT00303602|3329610|P1|Overall Study|Lost to Follow-up|5
1019367|NCT00303602|3329609|P2|Overall Study|Withdrawal by Subject|6
1019368|NCT00303602|3329610|P1|Overall Study|Withdrawal by Subject|5
1019369|NCT00303602|3329609|P2|Overall Study|Adverse Event|2
1019370|NCT00303602|3329610|P1|Overall Study|Adverse Event|2
1019371|NCT00303485|3329656|P2|Overall Study|Withdrawal by Subject|0
1019372|NCT00303485|3329657|P1|Overall Study|Withdrawal by Subject|1
1019373|NCT00303485|3329656|P2|Overall Study|Failure to return|1
1019374|NCT00303485|3329657|P1|Overall Study|Failure to return|0
1019375|NCT00303485|3329656|P2|Overall Study|Adverse Event/Intercurrent Illness|1
1019376|NCT00303485|3329657|P1|Overall Study|Adverse Event/Intercurrent Illness|0
1019377|NCT00303472|3329688|P7|Treatment Extension (Optional)|Disease Progression (to AML)|0
1019378|NCT00303472|3329689|P6|Treatment Extension (Optional)|Disease Progression (to AML)|1
1019379|NCT00303472|3329690|P5|Treatment Extension (Optional)|Disease Progression (to AML)|0
1019380|NCT00303472|3329691|P4|Treatment Extension (Optional)|Disease Progression (to AML)|0
1019381|NCT00303472|3329692|P3|Treatment Extension (Optional)|Disease Progression (to AML)|0
1019382|NCT00303472|3329693|P2|Treatment Extension (Optional)|Disease Progression (to AML)|0
1019383|NCT00303472|3329694|P1|Treatment Extension (Optional)|Disease Progression (to AML)|1
1019384|NCT00303472|3329688|P7|Treatment Extension (Optional)|Not specified|0
1019385|NCT00303472|3329689|P6|Treatment Extension (Optional)|Not specified|0
1019386|NCT00303472|3329690|P5|Treatment Extension (Optional)|Not specified|1
1019387|NCT00303472|3329691|P4|Treatment Extension (Optional)|Not specified|2
1019388|NCT00303472|3329692|P3|Treatment Extension (Optional)|Not specified|4
1019389|NCT00303472|3329693|P2|Treatment Extension (Optional)|Not specified|2
1019390|NCT00303472|3329694|P1|Treatment Extension (Optional)|Not specified|0
1019391|NCT00303472|3329688|P7|Treatment Extension (Optional)|Withdrawal by Subject|0
1019392|NCT00303472|3329689|P6|Treatment Extension (Optional)|Withdrawal by Subject|0
1019393|NCT00303472|3329690|P5|Treatment Extension (Optional)|Withdrawal by Subject|1
1019394|NCT00303472|3329691|P4|Treatment Extension (Optional)|Withdrawal by Subject|2
1019395|NCT00303472|3329692|P3|Treatment Extension (Optional)|Withdrawal by Subject|1
1019396|NCT00303472|3329693|P2|Treatment Extension (Optional)|Withdrawal by Subject|0
1019397|NCT00303472|3329694|P1|Treatment Extension (Optional)|Withdrawal by Subject|1
1019398|NCT00303472|3329688|P7|Treatment Extension (Optional)|Physician Decision|0
1019399|NCT00303472|3329689|P6|Treatment Extension (Optional)|Physician Decision|0
1019400|NCT00303472|3329690|P5|Treatment Extension (Optional)|Physician Decision|2
1019401|NCT00303472|3329691|P4|Treatment Extension (Optional)|Physician Decision|3
1019402|NCT00303472|3329692|P3|Treatment Extension (Optional)|Physician Decision|2
1019403|NCT00303472|3329693|P2|Treatment Extension (Optional)|Physician Decision|4
1019404|NCT00303472|3329694|P1|Treatment Extension (Optional)|Physician Decision|0
1019405|NCT00303472|3329688|P7|Treatment Extension (Optional)|Lost to Follow-up|0
1019406|NCT00303472|3329689|P6|Treatment Extension (Optional)|Lost to Follow-up|0
1019407|NCT00303472|3329690|P5|Treatment Extension (Optional)|Lost to Follow-up|0
1019408|NCT00303472|3329691|P4|Treatment Extension (Optional)|Lost to Follow-up|1
1019409|NCT00303472|3329692|P3|Treatment Extension (Optional)|Lost to Follow-up|0
1019410|NCT00303472|3329693|P2|Treatment Extension (Optional)|Lost to Follow-up|0
1019411|NCT00303472|3329694|P1|Treatment Extension (Optional)|Lost to Follow-up|0
1019412|NCT00303472|3329688|P7|Treatment Extension (Optional)|Death|0
1019413|NCT00303472|3329689|P6|Treatment Extension (Optional)|Death|0
1019414|NCT00303472|3329690|P5|Treatment Extension (Optional)|Death|0
1019415|NCT00303472|3329691|P4|Treatment Extension (Optional)|Death|0
1019416|NCT00303472|3329692|P3|Treatment Extension (Optional)|Death|1
1019417|NCT00303472|3329693|P2|Treatment Extension (Optional)|Death|0
1019418|NCT00303472|3329694|P1|Treatment Extension (Optional)|Death|2
1019419|NCT00303472|3329688|P7|Treatment Extension (Optional)|Adverse Event|0
1019420|NCT00303472|3329689|P6|Treatment Extension (Optional)|Adverse Event|0
1019421|NCT00303472|3329690|P5|Treatment Extension (Optional)|Adverse Event|0
1019422|NCT00303472|3329691|P4|Treatment Extension (Optional)|Adverse Event|0
1019423|NCT00303472|3329692|P3|Treatment Extension (Optional)|Adverse Event|1
1019424|NCT00303472|3329693|P2|Treatment Extension (Optional)|Adverse Event|0
1019425|NCT00303472|3329694|P1|Treatment Extension (Optional)|Adverse Event|1
1019426|NCT00303472|3329688|P7|Treatment Period|Disease Progression (to AML)|0
1019427|NCT00303472|3329689|P6|Treatment Period|Disease Progression (to AML)|0
1019428|NCT00303472|3329690|P5|Treatment Period|Disease Progression (to AML)|1
1019429|NCT00303472|3329691|P4|Treatment Period|Disease Progression (to AML)|0
1019430|NCT00303472|3329692|P3|Treatment Period|Disease Progression (to AML)|0
1019431|NCT00303472|3329693|P2|Treatment Period|Disease Progression (to AML)|0
1019432|NCT00303472|3329694|P1|Treatment Period|Disease Progression (to AML)|0
1019433|NCT00303472|3329688|P7|Treatment Period|Not specified|1
1019434|NCT00303472|3329689|P6|Treatment Period|Not specified|0
1019435|NCT00303472|3329690|P5|Treatment Period|Not specified|1
1019436|NCT00303472|3329691|P4|Treatment Period|Not specified|0
1019437|NCT00303472|3329692|P3|Treatment Period|Not specified|0
1019438|NCT00303472|3329693|P2|Treatment Period|Not specified|0
1019439|NCT00303472|3329694|P1|Treatment Period|Not specified|0
1019440|NCT00303472|3329688|P7|Treatment Period|Withdrawal by Subject|0
1019441|NCT00303472|3329689|P6|Treatment Period|Withdrawal by Subject|1
1019442|NCT00303472|3329690|P5|Treatment Period|Withdrawal by Subject|0
1019443|NCT00303472|3329691|P4|Treatment Period|Withdrawal by Subject|1
1019444|NCT00303472|3329692|P3|Treatment Period|Withdrawal by Subject|0
1019445|NCT00303472|3329693|P2|Treatment Period|Withdrawal by Subject|0
1019446|NCT00303472|3329694|P1|Treatment Period|Withdrawal by Subject|0
1019447|NCT00303472|3329688|P7|Treatment Period|Death|1
1019448|NCT00303472|3329689|P6|Treatment Period|Death|0
1019449|NCT00303472|3329690|P5|Treatment Period|Death|0
1019450|NCT00303472|3329691|P4|Treatment Period|Death|1
1019451|NCT00303472|3329692|P3|Treatment Period|Death|0
1019452|NCT00303472|3329693|P2|Treatment Period|Death|0
1019453|NCT00303472|3329694|P1|Treatment Period|Death|0
1019454|NCT00303472|3329688|P7|Treatment Period|Adverse Event|0
1019455|NCT00303472|3329689|P6|Treatment Period|Adverse Event|0
1019456|NCT00303472|3329690|P5|Treatment Period|Adverse Event|1
1019457|NCT00303472|3329691|P4|Treatment Period|Adverse Event|0
1019458|NCT00303472|3329692|P3|Treatment Period|Adverse Event|0
1019459|NCT00303472|3329693|P2|Treatment Period|Adverse Event|0
1019460|NCT00303472|3329694|P1|Treatment Period|Adverse Event|0
1019461|NCT00303459|3329754|P2|Overall Study|Lung transplantation|1
1019462|NCT00303459|3329755|P1|Overall Study|Lung transplantation|1
1019463|NCT00303459|3329754|P2|Overall Study|Decision by the investigator|7
1019464|NCT00303459|3329755|P1|Overall Study|Decision by the investigator|5
1019465|NCT00303459|3329754|P2|Overall Study|Administrative reason|7
1019466|NCT00303459|3329755|P1|Overall Study|Administrative reason|7
1019467|NCT00303459|3329754|P2|Overall Study|Lost to Follow-up|4
1019468|NCT00303459|3329755|P1|Overall Study|Lost to Follow-up|5
1019469|NCT00303459|3329754|P2|Overall Study|Withdrawal of consent|26
1019470|NCT00303459|3329755|P1|Overall Study|Withdrawal of consent|32
1019471|NCT00303459|3329754|P2|Overall Study|Death|44
1019472|NCT00303459|3329755|P1|Overall Study|Death|33
1019473|NCT00303446|3329781|P2|Overall Study|Physician Decision|1
1019474|NCT00303446|3329782|P1|Overall Study|Physician Decision|0
1019475|NCT00303446|3329781|P2|Overall Study|Death|1
1019476|NCT00303446|3329782|P1|Overall Study|Death|0
1019477|NCT00303446|3329781|P2|Overall Study|Withdrawal by Subject|2
1019478|NCT00303446|3329782|P1|Overall Study|Withdrawal by Subject|2
1019479|NCT00303329|3329818|P2|Overall Study|Stopped at end of extension 1|0
1019480|NCT00303329|3329819|P1|Overall Study|Stopped at end of extension 1|1
1019481|NCT00303329|3329818|P2|Overall Study|Stopped at end of core|9
1019482|NCT00303329|3329819|P1|Overall Study|Stopped at end of core|3
1019483|NCT00303329|3329818|P2|Overall Study|Death|12
1019484|NCT00303329|3329819|P1|Overall Study|Death|2
1019485|NCT00303329|3329818|P2|Overall Study|Administrative problems|0
1019486|NCT00303329|3329819|P1|Overall Study|Administrative problems|1
1019487|NCT00303329|3329818|P2|Overall Study|Lost to Follow-up|1
1019488|NCT00303329|3329819|P1|Overall Study|Lost to Follow-up|0
1019489|NCT00303329|3329818|P2|Overall Study|Withdrawal by Subject|15
1019490|NCT00303329|3329819|P1|Overall Study|Withdrawal by Subject|9
1019491|NCT00303329|3329818|P2|Overall Study|Protocol Violation|0
1019492|NCT00303329|3329819|P1|Overall Study|Protocol Violation|3
1019493|NCT00303329|3329818|P2|Overall Study|Condition no longer requires study drug|8
1019494|NCT00303329|3329819|P1|Overall Study|Condition no longer requires study drug|0
1019495|NCT00303329|3329818|P2|Overall Study|Unsatisfactory therapeutic effect|2
1019496|NCT00303329|3329819|P1|Overall Study|Unsatisfactory therapeutic effect|9
1019497|NCT00303329|3329818|P2|Overall Study|Abnormal Laboratory Values|1
1019498|NCT00303329|3329819|P1|Overall Study|Abnormal Laboratory Values|0
1019499|NCT00303329|3329818|P2|Overall Study|Adverse Event|14
1019500|NCT00303329|3329819|P1|Overall Study|Adverse Event|7
1019501|NCT00303316|3329833|P2|Overall Study|Withdrawal by Subject|2
1019502|NCT00303316|3329834|P1|Overall Study|Withdrawal by Subject|1
1019503|NCT00303316|3329833|P2|Overall Study|Lost to Follow-up|1
1019504|NCT00303316|3329834|P1|Overall Study|Lost to Follow-up|0
1019505|NCT00303316|3329833|P2|Overall Study|Protocol Violation|0
1019506|NCT00303316|3329834|P1|Overall Study|Protocol Violation|1
1019507|NCT00303186|3329846|P1|Overall Study|Other|52
1019508|NCT00303108|3329880|P3|Overall Study|ineligible|0
1019509|NCT00303108|3329881|P2|Overall Study|ineligible|1
1019510|NCT00303108|3329882|P1|Overall Study|ineligible|2
1019511|NCT00303108|3329880|P3|Overall Study|Failed Entry|1
1019512|NCT00303108|3329881|P2|Overall Study|Failed Entry|0
1019513|NCT00303108|3329882|P1|Overall Study|Failed Entry|1
1019514|NCT00303108|3329880|P3|Overall Study|Patient Request|8
1019515|NCT00303108|3329881|P2|Overall Study|Patient Request|2
1019516|NCT00303108|3329882|P1|Overall Study|Patient Request|4
1019517|NCT00303108|3329880|P3|Overall Study|Adverse Event|7
1019518|NCT00303108|3329881|P2|Overall Study|Adverse Event|6
1019519|NCT00303108|3329882|P1|Overall Study|Adverse Event|5
1019520|NCT00303069|3329902|P4|Overall Study|Recruitment into Army Reserves|0
1019521|NCT00303069|3329903|P3|Overall Study|Recruitment into Army Reserves|1
1019522|NCT00303069|3329904|P2|Overall Study|Recruitment into Army Reserves|0
1019523|NCT00303069|3329905|P1|Overall Study|Recruitment into Army Reserves|0
1019524|NCT00303069|3329902|P4|Overall Study|subject moved|0
1019525|NCT00303069|3329903|P3|Overall Study|subject moved|0
1019526|NCT00303069|3329904|P2|Overall Study|subject moved|0
1019527|NCT00303069|3329905|P1|Overall Study|subject moved|1
1019528|NCT00303069|3329902|P4|Overall Study|Lost to Follow-up|2
1019529|NCT00303069|3329903|P3|Overall Study|Lost to Follow-up|0
1019530|NCT00303069|3329904|P2|Overall Study|Lost to Follow-up|0
1019531|NCT00303069|3329905|P1|Overall Study|Lost to Follow-up|1
1019532|NCT00302952|3329925|P2|Overall Study|Elevated SGOT (AST) lab value|1
1019533|NCT00302952|3329926|P1|Overall Study|Elevated SGOT (AST) lab value|0
1019534|NCT00302952|3329925|P2|Overall Study|Withdrawal by Subject|3
1019535|NCT00302952|3329926|P1|Overall Study|Withdrawal by Subject|2
1019536|NCT00302952|3329925|P2|Overall Study|Physician Decision|1
1019537|NCT00302952|3329926|P1|Overall Study|Physician Decision|1
1019538|NCT00302731|3329976|P4|Overall Study|cancer unrelated to study discovered|0
1019539|NCT00302731|3329977|P3|Overall Study|cancer unrelated to study discovered|1
1019540|NCT00302731|3329978|P2|Overall Study|cancer unrelated to study discovered|0
1019541|NCT00302731|3329979|P1|Overall Study|cancer unrelated to study discovered|1
1019542|NCT00302731|3329976|P4|Overall Study|Protocol Violation|0
1019543|NCT00302731|3329977|P3|Overall Study|Protocol Violation|0
1019544|NCT00302731|3329978|P2|Overall Study|Protocol Violation|0
1019545|NCT00302731|3329979|P1|Overall Study|Protocol Violation|1
1019546|NCT00302731|3329976|P4|Overall Study|Withdrawal by Subject|0
1019547|NCT00302731|3329977|P3|Overall Study|Withdrawal by Subject|0
1019548|NCT00302731|3329978|P2|Overall Study|Withdrawal by Subject|1
1019549|NCT00302731|3329979|P1|Overall Study|Withdrawal by Subject|1
1019550|NCT00302731|3329976|P4|Overall Study|Adverse Event|0
1019551|NCT00302731|3329977|P3|Overall Study|Adverse Event|2
1019552|NCT00302731|3329978|P2|Overall Study|Adverse Event|2
1019553|NCT00302731|3329979|P1|Overall Study|Adverse Event|0
1019554|NCT00302731|3329976|P4|Overall Study|Lost to Follow-up|0
1019555|NCT00302731|3329977|P3|Overall Study|Lost to Follow-up|0
1019556|NCT00302731|3329978|P2|Overall Study|Lost to Follow-up|2
1019557|NCT00302731|3329979|P1|Overall Study|Lost to Follow-up|1
1019558|NCT00302718|3330005|P4|Overall Study|Participant left primary care setting|1
1019559|NCT00302718|3330006|P3|Overall Study|Participant left primary care setting|2
1019560|NCT00302718|3330007|P2|Overall Study|Participant left primary care setting|0
1019561|NCT00302718|3330008|P1|Overall Study|Participant left primary care setting|0
1019562|NCT00302718|3330005|P4|Overall Study|Withdrawal by Subject|0
1019563|NCT00302718|3330006|P3|Overall Study|Withdrawal by Subject|0
1019564|NCT00302718|3330007|P2|Overall Study|Withdrawal by Subject|1
1019565|NCT00302718|3330008|P1|Overall Study|Withdrawal by Subject|0
1019566|NCT00302718|3330005|P4|Overall Study|Participant left the hospital|1
1019567|NCT00302718|3330006|P3|Overall Study|Participant left the hospital|0
1019568|NCT00302718|3330007|P2|Overall Study|Participant left the hospital|0
1019569|NCT00302718|3330008|P1|Overall Study|Participant left the hospital|1
1019570|NCT00302458|3330040|P1|Overall Study|Withdrawal by Subject|1
1019571|NCT00302458|3330040|P1|Overall Study|Ineligible after screening|1
1019572|NCT00302458|3330040|P1|Overall Study|Lost to Follow-up|1
1019573|NCT00302328|3330051|P3|Overall Study|Physician Decision|0
1019574|NCT00302328|3330052|P2|Overall Study|Physician Decision|1
1019575|NCT00302328|3330053|P1|Overall Study|Physician Decision|0
1019576|NCT00302211|3330070|P5|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
1019577|NCT00302211|3330071|P4|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1
1019578|NCT00302211|3330072|P3|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
1019579|NCT00302211|3330073|P2|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
1019580|NCT00302211|3330074|P1|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
1019581|NCT00302211|3330070|P5|Open Label-Patients From Double-Blind|PH requiring lung transplant|1
1019582|NCT00302211|3330071|P4|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
1019583|NCT00302211|3330072|P3|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
1019584|NCT00302211|3330073|P2|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
1019585|NCT00302211|3330074|P1|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
1019586|NCT00302211|3330070|P5|Open Label-Patients From Double-Blind|Lost to Follow-up|1
1019587|NCT00302211|3330071|P4|Open Label-Patients From Double-Blind|Lost to Follow-up|0
1019588|NCT00302211|3330072|P3|Open Label-Patients From Double-Blind|Lost to Follow-up|0
1019589|NCT00302211|3330073|P2|Open Label-Patients From Double-Blind|Lost to Follow-up|0
1019590|NCT00302211|3330074|P1|Open Label-Patients From Double-Blind|Lost to Follow-up|0
1019591|NCT00302211|3330070|P5|Open Label-Patients From Double-Blind|Death|1
1019592|NCT00302211|3330071|P4|Open Label-Patients From Double-Blind|Death|1
1019593|NCT00302211|3330072|P3|Open Label-Patients From Double-Blind|Death|0
1019594|NCT00302211|3330073|P2|Open Label-Patients From Double-Blind|Death|0
1019595|NCT00302211|3330074|P1|Open Label-Patients From Double-Blind|Death|0
1019596|NCT00302211|3330070|P5|Open Label-Patients From Double-Blind|Disease progression|2
1019597|NCT00302211|3330071|P4|Open Label-Patients From Double-Blind|Disease progression|1
1019598|NCT00302211|3330072|P3|Open Label-Patients From Double-Blind|Disease progression|0
1019599|NCT00302211|3330073|P2|Open Label-Patients From Double-Blind|Disease progression|0
1019600|NCT00302211|3330074|P1|Open Label-Patients From Double-Blind|Disease progression|0
1019601|NCT00302211|3330070|P5|Open Label-Patients From Double-Blind|Investigator's judgement|0
1019602|NCT00302211|3330071|P4|Open Label-Patients From Double-Blind|Investigator's judgement|1
1019603|NCT00302211|3330072|P3|Open Label-Patients From Double-Blind|Investigator's judgement|0
1019604|NCT00302211|3330073|P2|Open Label-Patients From Double-Blind|Investigator's judgement|0
1019605|NCT00302211|3330074|P1|Open Label-Patients From Double-Blind|Investigator's judgement|0
1019606|NCT00302211|3330070|P5|Open Label-Patients From Double-Blind|Adverse Event|0
1019607|NCT00302211|3330071|P4|Open Label-Patients From Double-Blind|Adverse Event|1
1019608|NCT00302211|3330072|P3|Open Label-Patients From Double-Blind|Adverse Event|0
1019609|NCT00302211|3330073|P2|Open Label-Patients From Double-Blind|Adverse Event|0
1019610|NCT00302211|3330074|P1|Open Label-Patients From Double-Blind|Adverse Event|0
1019611|NCT00302211|3330070|P5|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
1019612|NCT00302211|3330071|P4|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
1019613|NCT00302211|3330072|P3|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
1019614|NCT00302211|3330073|P2|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
1019615|NCT00302211|3330074|P1|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
1019616|NCT00302211|3330070|P5|Double Blind Period (New Patients)|Disease progression|0
1019617|NCT00302211|3330071|P4|Double Blind Period (New Patients)|Disease progression|0
1019618|NCT00302211|3330072|P3|Double Blind Period (New Patients)|Disease progression|1
1019619|NCT00302211|3330073|P2|Double Blind Period (New Patients)|Disease progression|1
1019620|NCT00302211|3330074|P1|Double Blind Period (New Patients)|Disease progression|0
1019621|NCT00302211|3330070|P5|Double Blind Period (New Patients)|Investigator's judgement|0
1019622|NCT00302211|3330071|P4|Double Blind Period (New Patients)|Investigator's judgement|0
1019623|NCT00302211|3330072|P3|Double Blind Period (New Patients)|Investigator's judgement|0
1019624|NCT00302211|3330073|P2|Double Blind Period (New Patients)|Investigator's judgement|0
1019625|NCT00302211|3330074|P1|Double Blind Period (New Patients)|Investigator's judgement|1
1019626|NCT00302211|3330070|P5|Double Blind Period (New Patients)|Adverse Event|0
1019627|NCT00302211|3330071|P4|Double Blind Period (New Patients)|Adverse Event|0
1019628|NCT00302211|3330072|P3|Double Blind Period (New Patients)|Adverse Event|3
1019629|NCT00302211|3330073|P2|Double Blind Period (New Patients)|Adverse Event|0
1019630|NCT00302211|3330074|P1|Double Blind Period (New Patients)|Adverse Event|0
1019631|NCT00302211|3330070|P5|Double Blind Period (New Patients)|Withdrawal by Subject|0
1019632|NCT00302211|3330071|P4|Double Blind Period (New Patients)|Withdrawal by Subject|0
1019633|NCT00302211|3330072|P3|Double Blind Period (New Patients)|Withdrawal by Subject|0
1019634|NCT00302211|3330073|P2|Double Blind Period (New Patients)|Withdrawal by Subject|1
1019635|NCT00302211|3330074|P1|Double Blind Period (New Patients)|Withdrawal by Subject|2
1019636|NCT00302159|3330086|P1|Overall Study|pt started Avastin|1
1019637|NCT00302159|3330086|P1|Overall Study|pt declined before treatment started|1
1019638|NCT00302107|3330108|P2|Overall Study|Adverse Event|0
1019639|NCT00302107|3330109|P1|Overall Study|Adverse Event|1
1019640|NCT00302107|3330108|P2|Overall Study|Withdrawal by Subject|3
1019641|NCT00302107|3330109|P1|Overall Study|Withdrawal by Subject|0
1019642|NCT00302107|3330108|P2|Overall Study|Relocation|1
1019643|NCT00302107|3330109|P1|Overall Study|Relocation|0
1019644|NCT00302107|3330108|P2|Overall Study|Protocol Violation|0
1019645|NCT00302107|3330109|P1|Overall Study|Protocol Violation|1
1019646|NCT00302107|3330108|P2|Overall Study|Lost to Follow-up|5
1019647|NCT00302107|3330109|P1|Overall Study|Lost to Follow-up|6
1019648|NCT00302081|3330118|P3|Overall Study|Other|5
1019649|NCT00302081|3330119|P2|Overall Study|Other|6
1019650|NCT00302081|3330120|P1|Overall Study|Other|13
1019651|NCT00302081|3330118|P3|Overall Study|Death|0
1019652|NCT00302081|3330119|P2|Overall Study|Death|1
1019653|NCT00302081|3330120|P1|Overall Study|Death|2
1019654|NCT00302081|3330118|P3|Overall Study|Lack of Efficacy|5
1019655|NCT00302081|3330119|P2|Overall Study|Lack of Efficacy|0
1019656|NCT00302081|3330120|P1|Overall Study|Lack of Efficacy|1
1019657|NCT00302081|3330118|P3|Overall Study|Protocol Violation|2
1019658|NCT00302081|3330119|P2|Overall Study|Protocol Violation|1
1019659|NCT00302081|3330120|P1|Overall Study|Protocol Violation|5
1019660|NCT00302081|3330118|P3|Overall Study|Withdrawal by Subject|8
1019661|NCT00302081|3330119|P2|Overall Study|Withdrawal by Subject|12
1019662|NCT00302081|3330120|P1|Overall Study|Withdrawal by Subject|8
1019663|NCT00302081|3330118|P3|Overall Study|Lost to Follow-up|28
1019664|NCT00302081|3330119|P2|Overall Study|Lost to Follow-up|18
1019665|NCT00302081|3330120|P1|Overall Study|Lost to Follow-up|21
1019666|NCT00302081|3330118|P3|Overall Study|Adverse Event|4
1019667|NCT00302081|3330119|P2|Overall Study|Adverse Event|5
1019668|NCT00302081|3330120|P1|Overall Study|Adverse Event|6
1019669|NCT00302003|3330177|P1|Overall Study|Protocol Violation|1
1019670|NCT00302003|3330177|P1|Overall Study|Ineligible|9
1019671|NCT00302003|3330177|P1|Overall Study|Withdrawal by Subject|5
1019672|NCT00302003|3330177|P1|Overall Study|Physician Decision|2
1019673|NCT00302003|3330177|P1|Overall Study|Lost to Follow-up|1
1019674|NCT00302003|3330177|P1|Overall Study|Lack of Efficacy|62
1019675|NCT00301964|3330184|P1|Overall Study|Inadequate pathology|1
1019676|NCT00301964|3330184|P1|Overall Study|Wrong primary|1
1019677|NCT00301964|3330184|P1|Overall Study|Second primary|2
1019678|NCT00301834|3330205|P1|Overall Study|Death|1
1019679|NCT00301821|3330214|P1|Overall Study|Cancel|1
1019680|NCT00301821|3330214|P1|Overall Study|Ineligible|25
1019681|NCT00301808|3330221|P1|Overall Study|Lack of Efficacy|4
1019682|NCT00301808|3330221|P1|Overall Study|Death|3
1019683|NCT00301808|3330221|P1|Overall Study|Adverse Event|5
1019684|NCT00301366|3330246|P1|Overall Study|Adverse Event|1
1019685|NCT00301262|3330252|P2|Open Label Phase (OL)|Other|0
1019686|NCT00301262|3330253|P1|Open Label Phase (OL)|Other|2
1019687|NCT00301262|3330252|P2|Open Label Phase (OL)|Lost to Follow-up|2
1019688|NCT00301262|3330253|P1|Open Label Phase (OL)|Lost to Follow-up|1
1019689|NCT00301262|3330252|P2|Open Label Phase (OL)|Adverse Event|0
1019690|NCT00301262|3330253|P1|Open Label Phase (OL)|Adverse Event|1
1019691|NCT00301262|3330252|P2|Double Blind Phase (DB)|Other|4
1019692|NCT00301262|3330253|P1|Double Blind Phase (DB)|Other|1
1019693|NCT00301262|3330252|P2|Double Blind Phase (DB)|Withdrawal by Subject|5
1019694|NCT00301262|3330253|P1|Double Blind Phase (DB)|Withdrawal by Subject|5
1019695|NCT00301262|3330252|P2|Double Blind Phase (DB)|Lost to Follow-up|3
1019696|NCT00301262|3330253|P1|Double Blind Phase (DB)|Lost to Follow-up|3
1019697|NCT00301262|3330252|P2|Double Blind Phase (DB)|Lack of Efficacy|1
1019698|NCT00301262|3330253|P1|Double Blind Phase (DB)|Lack of Efficacy|0
1019699|NCT00301262|3330252|P2|Double Blind Phase (DB)|Adverse Event|0
1019700|NCT00301262|3330253|P1|Double Blind Phase (DB)|Adverse Event|1
1019701|NCT00301080|3330411|P5|Original Version (2 Arms & 4 Weeks)|Never received drug|0
1019702|NCT00301080|3330412|P4|Original Version (2 Arms & 4 Weeks)|Never received drug|0
1019703|NCT00301080|3330413|P3|Original Version (2 Arms & 4 Weeks)|Never received drug|0
1019704|NCT00301080|3330414|P2|Original Version (2 Arms & 4 Weeks)|Never received drug|0
1019705|NCT00301080|3330415|P1|Original Version (2 Arms & 4 Weeks)|Never received drug|1
1019706|NCT00300885|3330450|P2|Follow-up|Withdrawal by Subject|25
1019707|NCT00300885|3330451|P1|Follow-up|Withdrawal by Subject|26
1019708|NCT00300885|3330450|P2|Follow-up|Lost to Follow-up|7
1019709|NCT00300885|3330451|P1|Follow-up|Lost to Follow-up|11
1019710|NCT00300885|3330450|P2|Follow-up|Death|163
1019711|NCT00300885|3330451|P1|Follow-up|Death|141
1019712|NCT00300885|3330450|P2|Treatment|Non-compliant with study medication|4
1019713|NCT00300885|3330451|P1|Treatment|Non-compliant with study medication|3
1019714|NCT00300885|3330450|P2|Treatment|Random code broken (subject died)|1
1019715|NCT00300885|3330451|P1|Treatment|Random code broken (subject died)|0
1019716|NCT00300885|3330450|P2|Treatment|Disease progression|238
1019717|NCT00300885|3330451|P1|Treatment|Disease progression|171
1019718|NCT00300885|3330450|P2|Treatment|Withdrawal by Subject|23
1019719|NCT00300885|3330451|P1|Treatment|Withdrawal by Subject|26
1019720|NCT00300885|3330450|P2|Treatment|Protocol Violation|11
1019721|NCT00300885|3330451|P1|Treatment|Protocol Violation|11
1019722|NCT00300885|3330450|P2|Treatment|Physician Decision|5
1019723|NCT00300885|3330451|P1|Treatment|Physician Decision|4
1019724|NCT00300885|3330450|P2|Treatment|Lost to Follow-up|2
1019725|NCT00300885|3330451|P1|Treatment|Lost to Follow-up|3
1019726|NCT00300885|3330450|P2|Treatment|Lack of Efficacy|1
1019727|NCT00300885|3330451|P1|Treatment|Lack of Efficacy|1
1019728|NCT00300885|3330450|P2|Treatment|Death|7
1019729|NCT00300885|3330451|P1|Treatment|Death|20
1019730|NCT00300885|3330450|P2|Treatment|Adverse Event|82
1019731|NCT00300885|3330451|P1|Treatment|Adverse Event|134
1019732|NCT00300781|3330469|P2|Overall Study|Lost to Follow-up|1
1019733|NCT00300781|3330470|P1|Overall Study|Lost to Follow-up|0
1019734|NCT00300781|3330469|P2|Overall Study|Symptomatic Deterioration|0
1019735|NCT00300781|3330470|P1|Overall Study|Symptomatic Deterioration|1
1019736|NCT00300781|3330469|P2|Overall Study|Not Recorded|1
1019737|NCT00300781|3330470|P1|Overall Study|Not Recorded|0
1019738|NCT00300781|3330469|P2|Overall Study|Physician Decision|0
1019739|NCT00300781|3330470|P1|Overall Study|Physician Decision|1
1019740|NCT00300781|3330469|P2|Overall Study|Withdrawal by Subject|2
1019741|NCT00300781|3330470|P1|Overall Study|Withdrawal by Subject|1
1019742|NCT00300781|3330469|P2|Overall Study|Adverse Event|6
1019743|NCT00300781|3330470|P1|Overall Study|Adverse Event|5
1019744|NCT00300781|3330469|P2|Overall Study|Disease Progression|52
1019745|NCT00300781|3330470|P1|Overall Study|Disease Progression|55
1019746|NCT00300755|3330485|P3|Overall Study|Protocol Violation|1
1019747|NCT00300755|3330486|P2|Overall Study|Protocol Violation|0
1019748|NCT00300755|3330487|P1|Overall Study|Protocol Violation|0
1019749|NCT00300755|3330485|P3|Overall Study|Withdrawal by Subject|0
1019750|NCT00300755|3330486|P2|Overall Study|Withdrawal by Subject|2
1019751|NCT00300755|3330487|P1|Overall Study|Withdrawal by Subject|0
1019752|NCT00300755|3330485|P3|Overall Study|Adverse Event|1
1019753|NCT00300755|3330486|P2|Overall Study|Adverse Event|2
1019754|NCT00300755|3330487|P1|Overall Study|Adverse Event|1
1019755|NCT00300495|3330521|P2|Overall Study|Protocol Violation|1
1019756|NCT00300495|3330522|P1|Overall Study|Protocol Violation|4
1019757|NCT00300365|3330789|P2|Overall Study|Adverse Event|2
1019758|NCT00300365|3330790|P1|Overall Study|Adverse Event|0
1019759|NCT00300365|3330789|P2|Overall Study|Withdrawal by Subject|0
1019760|NCT00300365|3330790|P1|Overall Study|Withdrawal by Subject|1
1019761|NCT00300365|3330789|P2|Overall Study|Physician Decision|0
1019762|NCT00300365|3330790|P1|Overall Study|Physician Decision|2
1019763|NCT00300365|3330789|P2|Overall Study|Lost to Follow-up|0
1019764|NCT00300365|3330790|P1|Overall Study|Lost to Follow-up|1
1019765|NCT00300274|3330799|P3|Overall Study|Re-transplant|1
1019766|NCT00300274|3330800|P2|Overall Study|Re-transplant|0
1019767|NCT00300274|3330801|P1|Overall Study|Re-transplant|0
1019768|NCT00300274|3330799|P3|Overall Study|Death|25
1019769|NCT00300274|3330800|P2|Overall Study|Death|20
1019770|NCT00300274|3330801|P1|Overall Study|Death|31
1019771|NCT00300274|3330799|P3|Overall Study|Lost to Follow-up|5
1019772|NCT00300274|3330800|P2|Overall Study|Lost to Follow-up|4
1019773|NCT00300274|3330801|P1|Overall Study|Lost to Follow-up|3
1019774|NCT00300274|3330799|P3|Overall Study|Withdrawal by Subject|14
1019775|NCT00300274|3330800|P2|Overall Study|Withdrawal by Subject|3
1019776|NCT00300274|3330801|P1|Overall Study|Withdrawal by Subject|12
1019777|NCT00299975|3330860|P3|Overall Study|Physician Decision|1
1019778|NCT00299975|3330861|P2|Overall Study|Physician Decision|0
1019779|NCT00299975|3330862|P1|Overall Study|Physician Decision|0
1019780|NCT00299975|3330860|P3|Overall Study|Withdrawal by Subject|3
1019781|NCT00299975|3330861|P2|Overall Study|Withdrawal by Subject|1
1019782|NCT00299975|3330862|P1|Overall Study|Withdrawal by Subject|0
1019783|NCT00299975|3330860|P3|Overall Study|Lost to Follow-up|0
1019784|NCT00299975|3330861|P2|Overall Study|Lost to Follow-up|0
1019785|NCT00299975|3330862|P1|Overall Study|Lost to Follow-up|1
1019786|NCT00299975|3330860|P3|Overall Study|Lack of Efficacy|1
1019787|NCT00299975|3330861|P2|Overall Study|Lack of Efficacy|0
1019788|NCT00299975|3330862|P1|Overall Study|Lack of Efficacy|1
1019789|NCT00299975|3330860|P3|Overall Study|Pregnancy|1
1019790|NCT00299975|3330861|P2|Overall Study|Pregnancy|0
1019791|NCT00299975|3330862|P1|Overall Study|Pregnancy|0
1019792|NCT00299975|3330860|P3|Overall Study|Adverse Event|2
1019793|NCT00299975|3330861|P2|Overall Study|Adverse Event|0
1019794|NCT00299975|3330862|P1|Overall Study|Adverse Event|1
1019795|NCT00299702|3330919|P2|Overall Study|Admin issues, sponsor decision, etc.|9
1019796|NCT00299702|3330920|P1|Overall Study|Admin issues, sponsor decision, etc.|5
1019797|NCT00299702|3330919|P2|Overall Study|Insufficient Response|3
1019798|NCT00299702|3330920|P1|Overall Study|Insufficient Response|4
1019799|NCT00299702|3330919|P2|Overall Study|Pregnancy|1
1019800|NCT00299702|3330920|P1|Overall Study|Pregnancy|0
1019801|NCT00299702|3330919|P2|Overall Study|Withdrawal by Subject|23
1019802|NCT00299702|3330920|P1|Overall Study|Withdrawal by Subject|25
1019803|NCT00299702|3330919|P2|Overall Study|Lost to Follow-up|10
1019804|NCT00299702|3330920|P1|Overall Study|Lost to Follow-up|18
1019805|NCT00299702|3330919|P2|Overall Study|Adverse Event|4
1019806|NCT00299702|3330920|P1|Overall Study|Adverse Event|0
1019807|NCT00299702|3330919|P2|Overall Study|Death|0
1019808|NCT00299702|3330920|P1|Overall Study|Death|1
1019809|NCT00299546|3330935|P3|Overall Study|Not treated|1
1019810|NCT00299546|3330936|P2|Overall Study|Not treated|1
1019811|NCT00299546|3330937|P1|Overall Study|Not treated|0
1019812|NCT00299546|3330935|P3|Overall Study|Not specified|19
1019813|NCT00299546|3330936|P2|Overall Study|Not specified|26
1019814|NCT00299546|3330937|P1|Overall Study|Not specified|24
1019815|NCT00299546|3330935|P3|Overall Study|Unsatisfactory therapeutic effect|34
1019816|NCT00299546|3330936|P2|Overall Study|Unsatisfactory therapeutic effect|39
1019817|NCT00299546|3330937|P1|Overall Study|Unsatisfactory therapeutic effect|34
1019818|NCT00299546|3330935|P3|Overall Study|Adverse Event|27
1019819|NCT00299546|3330936|P2|Overall Study|Adverse Event|22
1019820|NCT00299546|3330937|P1|Overall Study|Adverse Event|37
1019821|NCT00299546|3330935|P3|Overall Study|Lost to Follow-up|5
1019822|NCT00299546|3330936|P2|Overall Study|Lost to Follow-up|2
1019823|NCT00299546|3330937|P1|Overall Study|Lost to Follow-up|2
1019824|NCT00299546|3330935|P3|Overall Study|Death|0
1019825|NCT00299546|3330936|P2|Overall Study|Death|2
1019826|NCT00299546|3330937|P1|Overall Study|Death|3
1019827|NCT00299494|3330968|P6|Overall Study|Other - site closure|1
1019828|NCT00299494|3330969|P5|Overall Study|Other - site closure|1
1019829|NCT00299494|3330970|P4|Overall Study|Other - site closure|1
1019830|NCT00299494|3330971|P3|Overall Study|Other - site closure|0
1019831|NCT00299494|3330972|P2|Overall Study|Other - site closure|0
1019832|NCT00299494|3330973|P1|Overall Study|Other - site closure|0
1019833|NCT00299494|3330968|P6|Overall Study|Other - Unspecified|1
1019834|NCT00299494|3330969|P5|Overall Study|Other - Unspecified|3
1019835|NCT00299494|3330970|P4|Overall Study|Other - Unspecified|0
1019836|NCT00299494|3330971|P3|Overall Study|Other - Unspecified|0
1019837|NCT00299494|3330972|P2|Overall Study|Other - Unspecified|0
1019838|NCT00299494|3330973|P1|Overall Study|Other - Unspecified|0
1019839|NCT00299494|3330968|P6|Overall Study|Lost to Follow-up|1
1019840|NCT00299494|3330969|P5|Overall Study|Lost to Follow-up|3
1019841|NCT00299494|3330970|P4|Overall Study|Lost to Follow-up|0
1019842|NCT00299494|3330971|P3|Overall Study|Lost to Follow-up|0
1019843|NCT00299494|3330972|P2|Overall Study|Lost to Follow-up|0
1019844|NCT00299494|3330973|P1|Overall Study|Lost to Follow-up|0
1019845|NCT00299494|3330968|P6|Overall Study|Death|19
1019846|NCT00299494|3330969|P5|Overall Study|Death|18
1019847|NCT00299494|3330970|P4|Overall Study|Death|6
1019848|NCT00299494|3330971|P3|Overall Study|Death|4
1019849|NCT00299494|3330972|P2|Overall Study|Death|1
1019850|NCT00299494|3330973|P1|Overall Study|Death|3
1019851|NCT00299494|3330968|P6|Overall Study|Physician Decision|0
1019852|NCT00299494|3330969|P5|Overall Study|Physician Decision|1
1019853|NCT00299494|3330970|P4|Overall Study|Physician Decision|0
1019854|NCT00299494|3330971|P3|Overall Study|Physician Decision|0
1019855|NCT00299494|3330972|P2|Overall Study|Physician Decision|0
1019856|NCT00299494|3330973|P1|Overall Study|Physician Decision|0
1019857|NCT00299494|3330968|P6|Overall Study|Withdrawal by Subject|4
1019858|NCT00299494|3330969|P5|Overall Study|Withdrawal by Subject|1
1019859|NCT00299494|3330970|P4|Overall Study|Withdrawal by Subject|3
1019860|NCT00299494|3330971|P3|Overall Study|Withdrawal by Subject|0
1019861|NCT00299494|3330972|P2|Overall Study|Withdrawal by Subject|0
1019862|NCT00299494|3330973|P1|Overall Study|Withdrawal by Subject|0
1019863|NCT00299156|3331102|P3|Period 2 (Randomized)|Screen Failure|0
1019864|NCT00299156|3331103|P2|Period 2 (Randomized)|Screen Failure|1
1019865|NCT00299156|3331104|P1|Period 2 (Randomized)|Screen Failure|0
1019866|NCT00299130|3331115|P3|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4
1019867|NCT00299130|3331116|P2|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3
1019868|NCT00299130|3331117|P1|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0
1019869|NCT00299130|3331115|P3|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
1019870|NCT00299130|3331116|P2|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
1019871|NCT00299130|3331117|P1|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0
1019872|NCT00299130|3331115|P3|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
1019873|NCT00299130|3331116|P2|Extended SFU (ESFU) (up to 5.1 Years)|Death|3
1019874|NCT00299130|3331117|P1|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
1019875|NCT00299130|3331115|P3|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21
1019876|NCT00299130|3331116|P2|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
1019877|NCT00299130|3331117|P1|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
1019878|NCT00299130|3331115|P3|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
1019879|NCT00299130|3331116|P2|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1
1019880|NCT00299130|3331117|P1|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
1019881|NCT00299130|3331115|P3|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15
1019882|NCT00299130|3331116|P2|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7
1019883|NCT00299130|3331117|P1|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14
1019884|NCT00299130|3331115|P3|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2
1019885|NCT00299130|3331116|P2|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
1019886|NCT00299130|3331117|P1|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
1019887|NCT00299130|3331115|P3|Safety Follow-up (SFU) (48 Weeks)|Death|3
1019888|NCT00299130|3331116|P2|Safety Follow-up (SFU) (48 Weeks)|Death|5
1019889|NCT00299130|3331117|P1|Safety Follow-up (SFU) (48 Weeks)|Death|4
1019890|NCT00299130|3331115|P3|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
1019891|NCT00299130|3331116|P2|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9
1019892|NCT00299130|3331117|P1|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
1019893|NCT00299130|3331115|P3|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
1019894|NCT00299130|3331116|P2|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
1019895|NCT00299130|3331117|P1|Treatment Period (up to 5 Years)|Withdrawal by Subject|0
1019896|NCT00299130|3331115|P3|Treatment Period (up to 5 Years)|Reason not Specified|4
1019897|NCT00299130|3331116|P2|Treatment Period (up to 5 Years)|Reason not Specified|6
1019898|NCT00299130|3331117|P1|Treatment Period (up to 5 Years)|Reason not Specified|4
1019899|NCT00299130|3331115|P3|Treatment Period (up to 5 Years)|Failure to Return|6
1019900|NCT00299130|3331116|P2|Treatment Period (up to 5 Years)|Failure to Return|6
1019901|NCT00299130|3331117|P1|Treatment Period (up to 5 Years)|Failure to Return|4
1019902|NCT00299130|3331115|P3|Treatment Period (up to 5 Years)|Refused Treatment|19
1019903|NCT00299130|3331116|P2|Treatment Period (up to 5 Years)|Refused Treatment|12
1019904|NCT00299130|3331117|P1|Treatment Period (up to 5 Years)|Refused Treatment|12
1019905|NCT00299130|3331115|P3|Treatment Period (up to 5 Years)|Protocol Violation|0
1019906|NCT00299130|3331116|P2|Treatment Period (up to 5 Years)|Protocol Violation|1
1019907|NCT00299130|3331117|P1|Treatment Period (up to 5 Years)|Protocol Violation|0
1019908|NCT00299130|3331115|P3|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
1019909|NCT00299130|3331116|P2|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
1019910|NCT00299130|3331117|P1|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19
1019911|NCT00299130|3331115|P3|Treatment Period (up to 5 Years)|Death|1
1019912|NCT00299130|3331116|P2|Treatment Period (up to 5 Years)|Death|3
1019913|NCT00299130|3331117|P1|Treatment Period (up to 5 Years)|Death|1
1019914|NCT00299130|3331115|P3|Treatment Period (up to 5 Years)|Adverse Event|13
1019915|NCT00299130|3331116|P2|Treatment Period (up to 5 Years)|Adverse Event|8
1019916|NCT00299130|3331117|P1|Treatment Period (up to 5 Years)|Adverse Event|13
1019917|NCT00299104|3331222|P3|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
1019918|NCT00299104|3331223|P2|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
1019919|NCT00299104|3331224|P1|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1
1019920|NCT00299104|3331222|P3|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8
1019921|NCT00299104|3331223|P2|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4
1019922|NCT00299104|3331224|P1|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2
1019923|NCT00299104|3331222|P3|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
1019924|NCT00299104|3331223|P2|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
1019925|NCT00299104|3331224|P1|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
1019926|NCT00299104|3331222|P3|Extended Safety Follow-Up (ESFU) Period|Death|0
1019927|NCT00299104|3331223|P2|Extended Safety Follow-Up (ESFU) Period|Death|1
1019928|NCT00299104|3331224|P1|Extended Safety Follow-Up (ESFU) Period|Death|0
1019929|NCT00299104|3331222|P3|Safety Follow-Up (SFU) Period|Administrative reasons|5
1019930|NCT00299104|3331223|P2|Safety Follow-Up (SFU) Period|Administrative reasons|7
1019931|NCT00299104|3331224|P1|Safety Follow-Up (SFU) Period|Administrative reasons|27
1019932|NCT00299104|3331222|P3|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11
1019933|NCT00299104|3331223|P2|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21
1019934|NCT00299104|3331224|P1|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16
1019935|NCT00299104|3331222|P3|Safety Follow-Up (SFU) Period|Lost to Follow-up|20
1019936|NCT00299104|3331223|P2|Safety Follow-Up (SFU) Period|Lost to Follow-up|11
1019937|NCT00299104|3331224|P1|Safety Follow-Up (SFU) Period|Lost to Follow-up|9
1019938|NCT00299104|3331222|P3|Safety Follow-Up (SFU) Period|Death|1
1019939|NCT00299104|3331223|P2|Safety Follow-Up (SFU) Period|Death|2
1019940|NCT00299104|3331224|P1|Safety Follow-Up (SFU) Period|Death|3
1019941|NCT00299104|3331222|P3|Treatment Period|Administrative reasons|137
1019942|NCT00299104|3331223|P2|Treatment Period|Administrative reasons|120
1019943|NCT00299104|3331224|P1|Treatment Period|Administrative reasons|106
1019944|NCT00299104|3331222|P3|Treatment Period|Withdrew consent|9
1019945|NCT00299104|3331223|P2|Treatment Period|Withdrew consent|19
1019946|NCT00299104|3331224|P1|Treatment Period|Withdrew consent|14
1019947|NCT00299104|3331222|P3|Treatment Period|Refused treatment|2
1019948|NCT00299104|3331223|P2|Treatment Period|Refused treatment|2
1019949|NCT00299104|3331224|P1|Treatment Period|Refused treatment|9
1019950|NCT00299104|3331222|P3|Treatment Period|Protocol Violation|0
1019951|NCT00299104|3331223|P2|Treatment Period|Protocol Violation|1
1019952|NCT00299104|3331224|P1|Treatment Period|Protocol Violation|1
1019953|NCT00299104|3331222|P3|Treatment Period|Violation of selection criteria|0
1019954|NCT00299104|3331223|P2|Treatment Period|Violation of selection criteria|2
1019955|NCT00299104|3331224|P1|Treatment Period|Violation of selection criteria|1
1019956|NCT00299104|3331222|P3|Treatment Period|Failure to return|8
1019957|NCT00299104|3331223|P2|Treatment Period|Failure to return|8
1019958|NCT00299104|3331224|P1|Treatment Period|Failure to return|9
1019959|NCT00299104|3331222|P3|Treatment Period|Insufficient therapeutic response|8
1019960|NCT00299104|3331223|P2|Treatment Period|Insufficient therapeutic response|13
1019961|NCT00299104|3331224|P1|Treatment Period|Insufficient therapeutic response|34
1019962|NCT00299104|3331222|P3|Treatment Period|Death|1
1019963|NCT00299104|3331223|P2|Treatment Period|Death|1
1019964|NCT00299104|3331224|P1|Treatment Period|Death|1
1019965|NCT00299104|3331222|P3|Treatment Period|Adverse Event|7
1019966|NCT00299104|3331223|P2|Treatment Period|Adverse Event|9
1019967|NCT00299104|3331224|P1|Treatment Period|Adverse Event|14
1019968|NCT00298896|3331334|P1|Overall Study|Assigned to treatment in error|1
1019969|NCT00298896|3331334|P1|Overall Study|Withdrawal by Subject|2
1019970|NCT00298896|3331334|P1|Overall Study|Disease Progression|41
1019971|NCT00298896|3331334|P1|Overall Study|Intercurrent Illness|1
1019972|NCT00298896|3331334|P1|Overall Study|Physician Decision|2
1019973|NCT00298896|3331334|P1|Overall Study|Death|3
1019974|NCT00298766|3331339|P1|Overall Study|Other|4
1019975|NCT00298766|3331339|P1|Overall Study|Subjects overall condition deterioration|4
1019976|NCT00298766|3331339|P1|Overall Study|Deterioration in KPS and organ function|1
1019977|NCT00298766|3331339|P1|Overall Study|Progression of amyloid markers|4
1019978|NCT00298766|3331339|P1|Overall Study|Treatment ongoing|4
1019979|NCT00298766|3331339|P1|Overall Study|Withdrawal by Subject|9
1019980|NCT00298766|3331339|P1|Overall Study|Death|2
1019981|NCT00298766|3331339|P1|Overall Study|Adverse Event|18
1019982|NCT00298740|3331348|P1|Overall Study|Withdrawal by Subject|3
1019983|NCT00298740|3331348|P1|Overall Study|Lack of Efficacy|6
1019984|NCT00298363|3331402|P3|Overall Study|Lack of Efficacy|0
1019985|NCT00298363|3331403|P2|Overall Study|Lack of Efficacy|3
1019986|NCT00298363|3331404|P1|Overall Study|Lack of Efficacy|2
1019987|NCT00298363|3331402|P3|Overall Study|Adverse Event|2
1019988|NCT00298363|3331403|P2|Overall Study|Adverse Event|2
1019989|NCT00298363|3331404|P1|Overall Study|Adverse Event|5
1019990|NCT00298363|3331402|P3|Overall Study|Withdrawal by Subject|3
1019991|NCT00298363|3331403|P2|Overall Study|Withdrawal by Subject|1
1019992|NCT00298363|3331404|P1|Overall Study|Withdrawal by Subject|5
1019993|NCT00298363|3331402|P3|Overall Study|Protocol Violation|0
1019994|NCT00298363|3331403|P2|Overall Study|Protocol Violation|1
1019995|NCT00298363|3331404|P1|Overall Study|Protocol Violation|1
1019996|NCT00298363|3331402|P3|Overall Study|Physician Decision|0
1019997|NCT00298363|3331403|P2|Overall Study|Physician Decision|1
1019998|NCT00298363|3331404|P1|Overall Study|Physician Decision|4
1019999|NCT00298363|3331402|P3|Overall Study|Lost to Follow-up|1
1020000|NCT00298363|3331403|P2|Overall Study|Lost to Follow-up|0
1020001|NCT00298363|3331404|P1|Overall Study|Lost to Follow-up|0
1020002|NCT00298272|3331562|P2|Safety Follow-up Phase|Administrative/Other Reason|1
1020003|NCT00298272|3331563|P1|Safety Follow-up Phase|Administrative/Other Reason|1
1020004|NCT00298272|3331562|P2|Safety Follow-up Phase|Withdrawal by Subject|2
1020005|NCT00298272|3331563|P1|Safety Follow-up Phase|Withdrawal by Subject|2
1020006|NCT00298272|3331562|P2|Safety Follow-up Phase|Failure to Return|1
1020007|NCT00298272|3331563|P1|Safety Follow-up Phase|Failure to Return|1
1020008|NCT00298272|3331562|P2|Open Label Retreatment Phase|Administrative/Other Reason|0
1020009|NCT00298272|3331563|P1|Open Label Retreatment Phase|Administrative/Other Reason|2
1020010|NCT00298272|3331562|P2|Open Label Retreatment Phase|Withdrawal by Subject|0
1020011|NCT00298272|3331563|P1|Open Label Retreatment Phase|Withdrawal by Subject|1
1020012|NCT00298272|3331562|P2|Open Label Retreatment Phase|Protocol Violation|1
1020013|NCT00298272|3331563|P1|Open Label Retreatment Phase|Protocol Violation|2
1020014|NCT00298272|3331562|P2|Open Label Retreatment Phase|Failure to Return|0
1020015|NCT00298272|3331563|P1|Open Label Retreatment Phase|Failure to Return|1
1020016|NCT00298272|3331562|P2|Open Label Retreatment Phase|Insufficient Therapeutic Response|1
1020017|NCT00298272|3331563|P1|Open Label Retreatment Phase|Insufficient Therapeutic Response|2
1020018|NCT00298272|3331562|P2|Open Label Retreatment Phase|Adverse Event|2
1020019|NCT00298272|3331563|P1|Open Label Retreatment Phase|Adverse Event|1
1020020|NCT00298272|3331562|P2|Double-blind Phase|Withdrawal by Subject|0
1020021|NCT00298272|3331563|P1|Double-blind Phase|Withdrawal by Subject|2
1020022|NCT00298272|3331562|P2|Double-blind Phase|Protocol Violation|0
1020023|NCT00298272|3331563|P1|Double-blind Phase|Protocol Violation|2
1020024|NCT00298272|3331562|P2|Double-blind Phase|Failure to Return|0
1020025|NCT00298272|3331563|P1|Double-blind Phase|Failure to Return|2
1020026|NCT00298272|3331562|P2|Double-blind Phase|Adverse Event|0
1020027|NCT00298272|3331563|P1|Double-blind Phase|Adverse Event|2
1020028|NCT00297830|3331628|P3|12 Month Visit|Withdrawal by Subject|0
1020029|NCT00297830|3331629|P2|12 Month Visit|Withdrawal by Subject|3
1020030|NCT00297830|3331630|P1|12 Month Visit|Withdrawal by Subject|0
1020031|NCT00297830|3331628|P3|12 Month Visit|Adverse Event|0
1020032|NCT00297830|3331629|P2|12 Month Visit|Adverse Event|3
1020033|NCT00297830|3331630|P1|12 Month Visit|Adverse Event|0
1020034|NCT00297830|3331628|P3|12 Month Visit|Lost to Follow-up|0
1020035|NCT00297830|3331629|P2|12 Month Visit|Lost to Follow-up|0
1020036|NCT00297830|3331630|P1|12 Month Visit|Lost to Follow-up|1
1020037|NCT00297830|3331628|P3|6 Month Visit|Adverse Event|0
1020038|NCT00297830|3331629|P2|6 Month Visit|Adverse Event|1
1020039|NCT00297830|3331630|P1|6 Month Visit|Adverse Event|0
1020040|NCT00297830|3331628|P3|6 Month Visit|Withdrawal by Subject|1
1020041|NCT00297830|3331629|P2|6 Month Visit|Withdrawal by Subject|1
1020042|NCT00297830|3331630|P1|6 Month Visit|Withdrawal by Subject|2
1020043|NCT00297830|3331628|P3|6 Month Visit|Death|2
1020044|NCT00297830|3331629|P2|6 Month Visit|Death|0
1020045|NCT00297830|3331630|P1|6 Month Visit|Death|1
1020046|NCT00297778|3331649|P2|Overall Study|Other|1
1020047|NCT00297778|3331650|P1|Overall Study|Other|0
1020048|NCT00297778|3331649|P2|Overall Study|Non-compliant with trial protocol|3
1020049|NCT00297778|3331650|P1|Overall Study|Non-compliant with trial protocol|0
1020050|NCT00297778|3331649|P2|Overall Study|Lack of Efficacy|1
1020051|NCT00297778|3331650|P1|Overall Study|Lack of Efficacy|2
1020052|NCT00297778|3331649|P2|Overall Study|Withdrawal by Subject|5
1020053|NCT00297778|3331650|P1|Overall Study|Withdrawal by Subject|1
1020054|NCT00297778|3331649|P2|Overall Study|Adverse Event|10
1020055|NCT00297778|3331650|P1|Overall Study|Adverse Event|16
1020056|NCT00297648|3331684|P1|Overall Study|Other: Incompliance|1
1020057|NCT00297648|3331684|P1|Overall Study|Withdrawal by Subject|3
1020058|NCT00297648|3331684|P1|Overall Study|Lost to Follow-up|1
1020059|NCT00297648|3331684|P1|Overall Study|Lack of Efficacy|18
1020060|NCT00297648|3331684|P1|Overall Study|Adverse Event|13
1020061|NCT00297492|3331730|P3|6 Month Follow-up|Lost to Follow-up|27
1020062|NCT00297492|3331731|P2|6 Month Follow-up|Lost to Follow-up|49
1020063|NCT00297492|3331732|P1|6 Month Follow-up|Lost to Follow-up|63
1020064|NCT00297492|3331730|P3|Set Quit Date|Lost to Follow-up|5
1020065|NCT00297492|3331731|P2|Set Quit Date|Lost to Follow-up|13
1020066|NCT00297492|3331732|P1|Set Quit Date|Lost to Follow-up|7
1020067|NCT00297427|3331742|P2|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0
1020068|NCT00297427|3331743|P1|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2
1020069|NCT00297427|3331742|P2|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0
1020070|NCT00297427|3331743|P1|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3
1020071|NCT00297427|3331742|P2|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0
1020072|NCT00297427|3331743|P1|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29
1020073|NCT00297427|3331742|P2|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0
1020074|NCT00297427|3331743|P1|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1
1020075|NCT00297427|3331742|P2|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0
1020076|NCT00297427|3331743|P1|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15
1020077|NCT00297427|3331742|P2|Phase 1: Initial Intervention|Death|1
1020078|NCT00297427|3331743|P1|Phase 1: Initial Intervention|Death|0
1020079|NCT00297427|3331742|P2|Phase 1: Initial Intervention|Lost to Follow-up|3
1020080|NCT00297427|3331743|P1|Phase 1: Initial Intervention|Lost to Follow-up|0
1020081|NCT00297427|3331742|P2|Phase 1: Initial Intervention|Withdrawal by Subject|5
1020082|NCT00297427|3331743|P1|Phase 1: Initial Intervention|Withdrawal by Subject|8
1020083|NCT00297258|3331784|P1|Overall Study|Interruption: Cold/Flu-like Symptoms|1
1020084|NCT00297258|3331784|P1|Overall Study|Switch to Commercial Treatment|1
1020085|NCT00297258|3331784|P1|Overall Study|Surgery Performed on Target Lesion|1
1020086|NCT00297258|3331784|P1|Overall Study|Radiotherapy to Destroy Last Lesion|1
1020087|NCT00297258|3331784|P1|Overall Study|Deteriorization of General Condition|1
1020088|NCT00297258|3331784|P1|Overall Study|Intercurrent Death|2
1020089|NCT00297258|3331784|P1|Overall Study|Intercurrent Illness|3
1020090|NCT00297258|3331784|P1|Overall Study|Patient Refusal: Not Related to Toxicity|2
1020091|NCT00297258|3331784|P1|Overall Study|Toxicity (or Toxic Death)|10
1020092|NCT00297258|3331784|P1|Overall Study|Disease Progression, Relapse, Death|120
1020093|NCT00297232|3331803|P1|Overall Study|Other|1
1020094|NCT00297232|3331803|P1|Overall Study|No data available after Week 264|161
1020095|NCT00297232|3331803|P1|Overall Study|Did Not Enroll to Week 480|17
1020096|NCT00297232|3331803|P1|Overall Study|Did Not Enroll to Week 264|34
1020097|NCT00297232|3331803|P1|Overall Study|Investigator Withdrew From Program|19
1020098|NCT00297232|3331803|P1|Overall Study|Persistently Positive Antibodies|11
1020099|NCT00297232|3331803|P1|Overall Study|Subject Withdrew Consent|37
1020100|NCT00297232|3331803|P1|Overall Study|Subject Relocated|7
1020101|NCT00297232|3331803|P1|Overall Study|Sponsor Decision|34
1020102|NCT00297232|3331803|P1|Overall Study|Miscellaneous|5
1020103|NCT00297232|3331803|P1|Overall Study|Anti-JCV Antibody Positive|13
1020104|NCT00297232|3331803|P1|Overall Study|Fear of PML|10
1020105|NCT00297232|3331803|P1|Overall Study|Disease Progression|8
1020106|NCT00297232|3331803|P1|Overall Study|Switched to Commercial Tysabri|22
1020107|NCT00297232|3331803|P1|Overall Study|Anti-natalizumab Positive|8
1020108|NCT00297232|3331803|P1|Overall Study|Death|9
1020109|NCT00297232|3331803|P1|Overall Study|Subject was Noncompliant|9
1020110|NCT00297232|3331803|P1|Overall Study|Voluntary Withdrawal|120
1020111|NCT00297232|3331803|P1|Overall Study|Adverse Event|63
1020112|NCT00297232|3331803|P1|Overall Study|Lost to Follow-up|10
1020113|NCT00297232|3331803|P1|Overall Study|Lack of Efficacy|7
1020114|NCT00297167|3331809|P3|Second Double-blind Intervention Period|Protocol Violation|0
1020115|NCT00297167|3331810|P2|Second Double-blind Intervention Period|Protocol Violation|0
1020116|NCT00297167|3331811|P1|Second Double-blind Intervention Period|Protocol Violation|1
1020117|NCT00297167|3331809|P3|Open-label Dose Normalization Period 1|Withdrawal by Subject|1
1020118|NCT00297167|3331810|P2|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
1020119|NCT00297167|3331811|P1|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
1020120|NCT00297037|3331875|P2|Overall Study|Withdrawal by Subject|0
1020121|NCT00297037|3331876|P1|Overall Study|Withdrawal by Subject|2
1020122|NCT00296816|3331888|P1|Overall Study|ineligibility due to radiation treatment|1
1020123|NCT00296816|3331888|P1|Overall Study|Proteinuria|1
1020124|NCT00296816|3331888|P1|Overall Study|Neuropathy/patient preference|1
1020125|NCT00296816|3331888|P1|Overall Study|Urine protein/creatinine ratio delay|1
1020126|NCT00296816|3331888|P1|Overall Study|Noncompliance/decision to discontinue|1
1020127|NCT00296816|3331888|P1|Overall Study|Relocation to Florida|1
1020128|NCT00296816|3331888|P1|Overall Study|Poor performance status|1
1020129|NCT00296816|3331888|P1|Overall Study|Progression based on CA-125 (biomarker)|2
1020130|NCT00296816|3331888|P1|Overall Study|Missing for end of treatment|4
1020131|NCT00296816|3331888|P1|Overall Study|Non-compliance|1
1020132|NCT00296816|3331888|P1|Overall Study|Investigator/Participant request|5
1020133|NCT00296816|3331888|P1|Overall Study|Adverse Event|18
1020134|NCT00296816|3331888|P1|Overall Study|Disease Progression|37
1020135|NCT00296647|3331905|P5|Overall Study|Withdrawal by Subject|19
1020136|NCT00296647|3331906|P4|Overall Study|Withdrawal by Subject|16
1020137|NCT00296647|3331907|P3|Overall Study|Withdrawal by Subject|32
1020138|NCT00296647|3331908|P2|Overall Study|Withdrawal by Subject|27
1020139|NCT00296647|3331909|P1|Overall Study|Withdrawal by Subject|28
1020140|NCT00296647|3331905|P5|Overall Study|Death|1
1020141|NCT00296647|3331906|P4|Overall Study|Death|1
1020142|NCT00296647|3331907|P3|Overall Study|Death|2
1020143|NCT00296647|3331908|P2|Overall Study|Death|1
1020144|NCT00296647|3331909|P1|Overall Study|Death|4
1020145|NCT00296517|3331923|P2|Dose Level 3 - Weeks 3-12|Not specified|2
1020146|NCT00296517|3331924|P1|Dose Level 3 - Weeks 3-12|Not specified|0
1020147|NCT00296517|3331923|P2|Dose Level 3 - Weeks 3-12|Non - Compliance|0
1020148|NCT00296517|3331924|P1|Dose Level 3 - Weeks 3-12|Non - Compliance|1
1020149|NCT00296517|3331923|P2|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18
1020150|NCT00296517|3331924|P1|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7
1020151|NCT00296517|3331923|P2|Dose Level 3 - Weeks 3-12|Protocol Violation|0
1020152|NCT00296517|3331924|P1|Dose Level 3 - Weeks 3-12|Protocol Violation|1
1020153|NCT00296517|3331923|P2|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2
1020154|NCT00296517|3331924|P1|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3
1020155|NCT00296517|3331923|P2|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6
1020156|NCT00296517|3331924|P1|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3
1020157|NCT00296517|3331923|P2|Dose Level 3 - Weeks 3-12|Adverse Event|34
1020158|NCT00296517|3331924|P1|Dose Level 3 - Weeks 3-12|Adverse Event|30
1020159|NCT00296517|3331923|P2|Dose Level 2 - Week 2|Withdrawal by Subject|0
1020160|NCT00296517|3331924|P1|Dose Level 2 - Week 2|Withdrawal by Subject|1
1020161|NCT00296517|3331923|P2|Dose Level 2 - Week 2|Adverse Event|5
1020162|NCT00296517|3331924|P1|Dose Level 2 - Week 2|Adverse Event|1
1020163|NCT00296504|3331960|P9|Final Analysis|Poor Adherence|1
1020164|NCT00296504|3331961|P8|Final Analysis|Poor Adherence|0
1020165|NCT00296504|3331962|P7|Final Analysis|Poor Adherence|0
1020166|NCT00296504|3331963|P6|Final Analysis|Poor Adherence|0
1020167|NCT00296504|3331964|P5|Final Analysis|Poor Adherence|0
1020168|NCT00296504|3331965|P4|Final Analysis|Poor Adherence|0
1020169|NCT00296504|3331966|P3|Final Analysis|Poor Adherence|0
1020170|NCT00296504|3331967|P2|Final Analysis|Poor Adherence|0
1020171|NCT00296504|3331968|P1|Final Analysis|Poor Adherence|0
1020172|NCT00296504|3331960|P9|Final Analysis|Participant Moved to Another Country|1
1020173|NCT00296504|3331961|P8|Final Analysis|Participant Moved to Another Country|0
1020174|NCT00296504|3331962|P7|Final Analysis|Participant Moved to Another Country|0
1020175|NCT00296504|3331963|P6|Final Analysis|Participant Moved to Another Country|0
1020176|NCT00296504|3331964|P5|Final Analysis|Participant Moved to Another Country|0
1020177|NCT00296504|3331965|P4|Final Analysis|Participant Moved to Another Country|0
1020178|NCT00296504|3331966|P3|Final Analysis|Participant Moved to Another Country|0
1020179|NCT00296504|3331967|P2|Final Analysis|Participant Moved to Another Country|0
1020180|NCT00296504|3331968|P1|Final Analysis|Participant Moved to Another Country|0
1020181|NCT00296504|3331960|P9|Final Analysis|Tuberculosis|1
1020182|NCT00296504|3331961|P8|Final Analysis|Tuberculosis|0
1020183|NCT00296504|3331962|P7|Final Analysis|Tuberculosis|0
1020184|NCT00296504|3331963|P6|Final Analysis|Tuberculosis|0
1020185|NCT00296504|3331964|P5|Final Analysis|Tuberculosis|0
1020186|NCT00296504|3331965|P4|Final Analysis|Tuberculosis|0
1020187|NCT00296504|3331966|P3|Final Analysis|Tuberculosis|0
1020188|NCT00296504|3331967|P2|Final Analysis|Tuberculosis|0
1020189|NCT00296504|3331968|P1|Final Analysis|Tuberculosis|0
1020190|NCT00296504|3331960|P9|Final Analysis|Pregnancy|4
1020191|NCT00296504|3331961|P8|Final Analysis|Pregnancy|0
1020192|NCT00296504|3331962|P7|Final Analysis|Pregnancy|0
1020193|NCT00296504|3331963|P6|Final Analysis|Pregnancy|0
1020194|NCT00296504|3331964|P5|Final Analysis|Pregnancy|0
1020195|NCT00296504|3331965|P4|Final Analysis|Pregnancy|0
1020196|NCT00296504|3331966|P3|Final Analysis|Pregnancy|0
1020197|NCT00296504|3331967|P2|Final Analysis|Pregnancy|0
1020198|NCT00296504|3331968|P1|Final Analysis|Pregnancy|0
1020199|NCT00296504|3331960|P9|Final Analysis|Adverse Event|2
1020200|NCT00296504|3331961|P8|Final Analysis|Adverse Event|0
1020201|NCT00296504|3331962|P7|Final Analysis|Adverse Event|0
1020202|NCT00296504|3331963|P6|Final Analysis|Adverse Event|0
1020203|NCT00296504|3331964|P5|Final Analysis|Adverse Event|0
1020204|NCT00296504|3331965|P4|Final Analysis|Adverse Event|0
1020205|NCT00296504|3331966|P3|Final Analysis|Adverse Event|0
1020206|NCT00296504|3331967|P2|Final Analysis|Adverse Event|0
1020207|NCT00296504|3331968|P1|Final Analysis|Adverse Event|0
1020208|NCT00296504|3331960|P9|Final Analysis|Insufficient Viral Load Response|6
1020209|NCT00296504|3331961|P8|Final Analysis|Insufficient Viral Load Response|0
1020210|NCT00296504|3331962|P7|Final Analysis|Insufficient Viral Load Response|0
1020211|NCT00296504|3331963|P6|Final Analysis|Insufficient Viral Load Response|0
1020212|NCT00296504|3331964|P5|Final Analysis|Insufficient Viral Load Response|0
1020213|NCT00296504|3331965|P4|Final Analysis|Insufficient Viral Load Response|0
1020214|NCT00296504|3331966|P3|Final Analysis|Insufficient Viral Load Response|0
1020215|NCT00296504|3331967|P2|Final Analysis|Insufficient Viral Load Response|0
1020216|NCT00296504|3331968|P1|Final Analysis|Insufficient Viral Load Response|0
1020217|NCT00296504|3331960|P9|Final Analysis|Lost to Follow-up|5
1020218|NCT00296504|3331961|P8|Final Analysis|Lost to Follow-up|0
1020219|NCT00296504|3331962|P7|Final Analysis|Lost to Follow-up|0
1020220|NCT00296504|3331963|P6|Final Analysis|Lost to Follow-up|0
1020221|NCT00296504|3331964|P5|Final Analysis|Lost to Follow-up|0
1020222|NCT00296504|3331965|P4|Final Analysis|Lost to Follow-up|0
1020223|NCT00296504|3331966|P3|Final Analysis|Lost to Follow-up|0
1020224|NCT00296504|3331967|P2|Final Analysis|Lost to Follow-up|0
1020225|NCT00296504|3331968|P1|Final Analysis|Lost to Follow-up|0
1020226|NCT00296504|3331960|P9|Final Analysis|Withdrawal by Subject|1
1020227|NCT00296504|3331961|P8|Final Analysis|Withdrawal by Subject|0
1020228|NCT00296504|3331962|P7|Final Analysis|Withdrawal by Subject|0
1020229|NCT00296504|3331963|P6|Final Analysis|Withdrawal by Subject|0
1020230|NCT00296504|3331964|P5|Final Analysis|Withdrawal by Subject|0
1020231|NCT00296504|3331965|P4|Final Analysis|Withdrawal by Subject|0
1020232|NCT00296504|3331966|P3|Final Analysis|Withdrawal by Subject|0
1020233|NCT00296504|3331967|P2|Final Analysis|Withdrawal by Subject|0
1020234|NCT00296504|3331968|P1|Final Analysis|Withdrawal by Subject|0
1020235|NCT00296504|3331960|P9|Interim Analysis|Ongoing|0
1020236|NCT00296504|3331961|P8|Interim Analysis|Ongoing|1
1020237|NCT00296504|3331962|P7|Interim Analysis|Ongoing|30
1020238|NCT00296504|3331963|P6|Interim Analysis|Ongoing|0
1020239|NCT00296504|3331964|P5|Interim Analysis|Ongoing|0
1020240|NCT00296504|3331965|P4|Interim Analysis|Ongoing|22
1020241|NCT00296504|3331966|P3|Interim Analysis|Ongoing|16
1020242|NCT00296504|3331967|P2|Interim Analysis|Ongoing|12
1020243|NCT00296504|3331968|P1|Interim Analysis|Ongoing|32
1020244|NCT00296504|3331960|P9|Interim Analysis|Participant Needed Interferon|0
1020245|NCT00296504|3331961|P8|Interim Analysis|Participant Needed Interferon|1
1020246|NCT00296504|3331962|P7|Interim Analysis|Participant Needed Interferon|0
1020247|NCT00296504|3331963|P6|Interim Analysis|Participant Needed Interferon|0
1020248|NCT00296504|3331964|P5|Interim Analysis|Participant Needed Interferon|0
1020249|NCT00296504|3331965|P4|Interim Analysis|Participant Needed Interferon|0
1020250|NCT00296504|3331966|P3|Interim Analysis|Participant Needed Interferon|0
1020251|NCT00296504|3331967|P2|Interim Analysis|Participant Needed Interferon|0
1020252|NCT00296504|3331968|P1|Interim Analysis|Participant Needed Interferon|0
1020253|NCT00296504|3331960|P9|Interim Analysis|Study Ended|0
1020254|NCT00296504|3331961|P8|Interim Analysis|Study Ended|0
1020255|NCT00296504|3331962|P7|Interim Analysis|Study Ended|1
1020256|NCT00296504|3331963|P6|Interim Analysis|Study Ended|0
1020257|NCT00296504|3331964|P5|Interim Analysis|Study Ended|0
1020258|NCT00296504|3331965|P4|Interim Analysis|Study Ended|0
1020259|NCT00296504|3331966|P3|Interim Analysis|Study Ended|0
1020260|NCT00296504|3331967|P2|Interim Analysis|Study Ended|0
1020261|NCT00296504|3331968|P1|Interim Analysis|Study Ended|0
1020262|NCT00296504|3331960|P9|Interim Analysis|Participant Stopped HIV Medications|0
1020263|NCT00296504|3331961|P8|Interim Analysis|Participant Stopped HIV Medications|0
1020264|NCT00296504|3331962|P7|Interim Analysis|Participant Stopped HIV Medications|1
1020265|NCT00296504|3331963|P6|Interim Analysis|Participant Stopped HIV Medications|0
1020266|NCT00296504|3331964|P5|Interim Analysis|Participant Stopped HIV Medications|0
1020267|NCT00296504|3331965|P4|Interim Analysis|Participant Stopped HIV Medications|0
1020268|NCT00296504|3331966|P3|Interim Analysis|Participant Stopped HIV Medications|0
1020269|NCT00296504|3331967|P2|Interim Analysis|Participant Stopped HIV Medications|0
1020270|NCT00296504|3331968|P1|Interim Analysis|Participant Stopped HIV Medications|0
1020271|NCT00296504|3331960|P9|Interim Analysis|Physician and Participant Decision|0
1020272|NCT00296504|3331961|P8|Interim Analysis|Physician and Participant Decision|0
1020273|NCT00296504|3331962|P7|Interim Analysis|Physician and Participant Decision|0
1020274|NCT00296504|3331963|P6|Interim Analysis|Physician and Participant Decision|1
1020275|NCT00296504|3331964|P5|Interim Analysis|Physician and Participant Decision|0
1020276|NCT00296504|3331965|P4|Interim Analysis|Physician and Participant Decision|0
1020277|NCT00296504|3331966|P3|Interim Analysis|Physician and Participant Decision|0
1020278|NCT00296504|3331967|P2|Interim Analysis|Physician and Participant Decision|0
1020279|NCT00296504|3331968|P1|Interim Analysis|Physician and Participant Decision|0
1020280|NCT00296504|3331960|P9|Interim Analysis|Participant Stopped|0
1020281|NCT00296504|3331961|P8|Interim Analysis|Participant Stopped|0
1020282|NCT00296504|3331962|P7|Interim Analysis|Participant Stopped|0
1020283|NCT00296504|3331963|P6|Interim Analysis|Participant Stopped|0
1020284|NCT00296504|3331964|P5|Interim Analysis|Participant Stopped|1
1020285|NCT00296504|3331965|P4|Interim Analysis|Participant Stopped|0
1020286|NCT00296504|3331966|P3|Interim Analysis|Participant Stopped|0
1020287|NCT00296504|3331967|P2|Interim Analysis|Participant Stopped|0
1020288|NCT00296504|3331968|P1|Interim Analysis|Participant Stopped|0
1020289|NCT00296504|3331960|P9|Interim Analysis|Inclusion in Other Protocol|0
1020290|NCT00296504|3331961|P8|Interim Analysis|Inclusion in Other Protocol|0
1020291|NCT00296504|3331962|P7|Interim Analysis|Inclusion in Other Protocol|0
1020292|NCT00296504|3331963|P6|Interim Analysis|Inclusion in Other Protocol|0
1020293|NCT00296504|3331964|P5|Interim Analysis|Inclusion in Other Protocol|0
1020294|NCT00296504|3331965|P4|Interim Analysis|Inclusion in Other Protocol|1
1020295|NCT00296504|3331966|P3|Interim Analysis|Inclusion in Other Protocol|0
1020296|NCT00296504|3331967|P2|Interim Analysis|Inclusion in Other Protocol|0
1020297|NCT00296504|3331968|P1|Interim Analysis|Inclusion in Other Protocol|0
1020298|NCT00296504|3331960|P9|Interim Analysis|Missed Schedule Date|0
1020299|NCT00296504|3331961|P8|Interim Analysis|Missed Schedule Date|0
1020300|NCT00296504|3331962|P7|Interim Analysis|Missed Schedule Date|0
1020301|NCT00296504|3331963|P6|Interim Analysis|Missed Schedule Date|0
1020302|NCT00296504|3331964|P5|Interim Analysis|Missed Schedule Date|0
1020303|NCT00296504|3331965|P4|Interim Analysis|Missed Schedule Date|0
1020304|NCT00296504|3331966|P3|Interim Analysis|Missed Schedule Date|0
1020305|NCT00296504|3331967|P2|Interim Analysis|Missed Schedule Date|0
1020306|NCT00296504|3331968|P1|Interim Analysis|Missed Schedule Date|1
1020307|NCT00296504|3331960|P9|Interim Analysis|Lack of Personnel at Site|0
1020308|NCT00296504|3331961|P8|Interim Analysis|Lack of Personnel at Site|0
1020309|NCT00296504|3331962|P7|Interim Analysis|Lack of Personnel at Site|0
1020310|NCT00296504|3331963|P6|Interim Analysis|Lack of Personnel at Site|0
1020311|NCT00296504|3331964|P5|Interim Analysis|Lack of Personnel at Site|0
1020312|NCT00296504|3331965|P4|Interim Analysis|Lack of Personnel at Site|0
1020313|NCT00296504|3331966|P3|Interim Analysis|Lack of Personnel at Site|0
1020314|NCT00296504|3331967|P2|Interim Analysis|Lack of Personnel at Site|0
1020315|NCT00296504|3331968|P1|Interim Analysis|Lack of Personnel at Site|1
1020316|NCT00296504|3331960|P9|Interim Analysis|Site Closing|0
1020317|NCT00296504|3331961|P8|Interim Analysis|Site Closing|0
1020318|NCT00296504|3331962|P7|Interim Analysis|Site Closing|2
1020319|NCT00296504|3331963|P6|Interim Analysis|Site Closing|1
1020320|NCT00296504|3331964|P5|Interim Analysis|Site Closing|0
1020321|NCT00296504|3331965|P4|Interim Analysis|Site Closing|0
1020322|NCT00296504|3331966|P3|Interim Analysis|Site Closing|0
1020323|NCT00296504|3331967|P2|Interim Analysis|Site Closing|0
1020324|NCT00296504|3331968|P1|Interim Analysis|Site Closing|1
1020325|NCT00296504|3331960|P9|Interim Analysis|Non-adherence|0
1020326|NCT00296504|3331961|P8|Interim Analysis|Non-adherence|1
1020327|NCT00296504|3331962|P7|Interim Analysis|Non-adherence|0
1020328|NCT00296504|3331963|P6|Interim Analysis|Non-adherence|0
1020329|NCT00296504|3331964|P5|Interim Analysis|Non-adherence|1
1020330|NCT00296504|3331965|P4|Interim Analysis|Non-adherence|0
1020331|NCT00296504|3331966|P3|Interim Analysis|Non-adherence|0
1020332|NCT00296504|3331967|P2|Interim Analysis|Non-adherence|0
1020333|NCT00296504|3331968|P1|Interim Analysis|Non-adherence|2
1020334|NCT00296504|3331960|P9|Interim Analysis|Principle Investigator Terminated Study|0
1020335|NCT00296504|3331961|P8|Interim Analysis|Principle Investigator Terminated Study|0
1020336|NCT00296504|3331962|P7|Interim Analysis|Principle Investigator Terminated Study|0
1020337|NCT00296504|3331963|P6|Interim Analysis|Principle Investigator Terminated Study|0
1020338|NCT00296504|3331964|P5|Interim Analysis|Principle Investigator Terminated Study|0
1020339|NCT00296504|3331965|P4|Interim Analysis|Principle Investigator Terminated Study|0
1020340|NCT00296504|3331966|P3|Interim Analysis|Principle Investigator Terminated Study|1
1020341|NCT00296504|3331967|P2|Interim Analysis|Principle Investigator Terminated Study|0
1020342|NCT00296504|3331968|P1|Interim Analysis|Principle Investigator Terminated Study|0
1020343|NCT00296504|3331960|P9|Interim Analysis|Principle Investigator Discretion|0
1020344|NCT00296504|3331961|P8|Interim Analysis|Principle Investigator Discretion|0
1020345|NCT00296504|3331962|P7|Interim Analysis|Principle Investigator Discretion|0
1020346|NCT00296504|3331963|P6|Interim Analysis|Principle Investigator Discretion|0
1020347|NCT00296504|3331964|P5|Interim Analysis|Principle Investigator Discretion|0
1020348|NCT00296504|3331965|P4|Interim Analysis|Principle Investigator Discretion|1
1020349|NCT00296504|3331966|P3|Interim Analysis|Principle Investigator Discretion|1
1020350|NCT00296504|3331967|P2|Interim Analysis|Principle Investigator Discretion|0
1020351|NCT00296504|3331968|P1|Interim Analysis|Principle Investigator Discretion|2
1020352|NCT00296504|3331960|P9|Interim Analysis|Physician Decision|0
1020353|NCT00296504|3331961|P8|Interim Analysis|Physician Decision|0
1020354|NCT00296504|3331962|P7|Interim Analysis|Physician Decision|0
1020355|NCT00296504|3331963|P6|Interim Analysis|Physician Decision|0
1020356|NCT00296504|3331964|P5|Interim Analysis|Physician Decision|0
1020357|NCT00296504|3331965|P4|Interim Analysis|Physician Decision|0
1020358|NCT00296504|3331966|P3|Interim Analysis|Physician Decision|1
1020359|NCT00296504|3331967|P2|Interim Analysis|Physician Decision|0
1020360|NCT00296504|3331968|P1|Interim Analysis|Physician Decision|0
1020361|NCT00296504|3331960|P9|Interim Analysis|Resistance to FPV|0
1020362|NCT00296504|3331961|P8|Interim Analysis|Resistance to FPV|0
1020363|NCT00296504|3331962|P7|Interim Analysis|Resistance to FPV|0
1020364|NCT00296504|3331963|P6|Interim Analysis|Resistance to FPV|0
1020365|NCT00296504|3331964|P5|Interim Analysis|Resistance to FPV|0
1020366|NCT00296504|3331965|P4|Interim Analysis|Resistance to FPV|0
1020367|NCT00296504|3331966|P3|Interim Analysis|Resistance to FPV|1
1020368|NCT00296504|3331967|P2|Interim Analysis|Resistance to FPV|0
1020369|NCT00296504|3331968|P1|Interim Analysis|Resistance to FPV|0
1020370|NCT00296504|3331960|P9|Interim Analysis|Participant Was Incarcerated|0
1020371|NCT00296504|3331961|P8|Interim Analysis|Participant Was Incarcerated|0
1020372|NCT00296504|3331962|P7|Interim Analysis|Participant Was Incarcerated|0
1020373|NCT00296504|3331963|P6|Interim Analysis|Participant Was Incarcerated|0
1020374|NCT00296504|3331964|P5|Interim Analysis|Participant Was Incarcerated|0
1020375|NCT00296504|3331965|P4|Interim Analysis|Participant Was Incarcerated|0
1020376|NCT00296504|3331966|P3|Interim Analysis|Participant Was Incarcerated|1
1020377|NCT00296504|3331967|P2|Interim Analysis|Participant Was Incarcerated|0
1020378|NCT00296504|3331968|P1|Interim Analysis|Participant Was Incarcerated|2
1020379|NCT00296504|3331960|P9|Interim Analysis|Participant Moved|0
1020380|NCT00296504|3331961|P8|Interim Analysis|Participant Moved|0
1020381|NCT00296504|3331962|P7|Interim Analysis|Participant Moved|1
1020382|NCT00296504|3331963|P6|Interim Analysis|Participant Moved|1
1020383|NCT00296504|3331964|P5|Interim Analysis|Participant Moved|0
1020384|NCT00296504|3331965|P4|Interim Analysis|Participant Moved|0
1020385|NCT00296504|3331966|P3|Interim Analysis|Participant Moved|1
1020386|NCT00296504|3331967|P2|Interim Analysis|Participant Moved|0
1020387|NCT00296504|3331968|P1|Interim Analysis|Participant Moved|1
1020388|NCT00296504|3331960|P9|Interim Analysis|Participant Had Problems with Alcohol|0
1020389|NCT00296504|3331961|P8|Interim Analysis|Participant Had Problems with Alcohol|0
1020390|NCT00296504|3331962|P7|Interim Analysis|Participant Had Problems with Alcohol|0
1020391|NCT00296504|3331963|P6|Interim Analysis|Participant Had Problems with Alcohol|0
1020392|NCT00296504|3331964|P5|Interim Analysis|Participant Had Problems with Alcohol|0
1020393|NCT00296504|3331965|P4|Interim Analysis|Participant Had Problems with Alcohol|0
1020394|NCT00296504|3331966|P3|Interim Analysis|Participant Had Problems with Alcohol|1
1020395|NCT00296504|3331967|P2|Interim Analysis|Participant Had Problems with Alcohol|0
1020396|NCT00296504|3331968|P1|Interim Analysis|Participant Had Problems with Alcohol|0
1020397|NCT00296504|3331960|P9|Interim Analysis|To Simplify Treatment|0
1020398|NCT00296504|3331961|P8|Interim Analysis|To Simplify Treatment|0
1020399|NCT00296504|3331962|P7|Interim Analysis|To Simplify Treatment|2
1020400|NCT00296504|3331963|P6|Interim Analysis|To Simplify Treatment|0
1020401|NCT00296504|3331964|P5|Interim Analysis|To Simplify Treatment|0
1020402|NCT00296504|3331965|P4|Interim Analysis|To Simplify Treatment|0
1020403|NCT00296504|3331966|P3|Interim Analysis|To Simplify Treatment|1
1020404|NCT00296504|3331967|P2|Interim Analysis|To Simplify Treatment|0
1020405|NCT00296504|3331968|P1|Interim Analysis|To Simplify Treatment|0
1020406|NCT00296504|3331960|P9|Interim Analysis|Participant Wanted to Become Pregnant|0
1020407|NCT00296504|3331961|P8|Interim Analysis|Participant Wanted to Become Pregnant|0
1020408|NCT00296504|3331962|P7|Interim Analysis|Participant Wanted to Become Pregnant|0
1020409|NCT00296504|3331963|P6|Interim Analysis|Participant Wanted to Become Pregnant|1
1020410|NCT00296504|3331964|P5|Interim Analysis|Participant Wanted to Become Pregnant|0
1020411|NCT00296504|3331965|P4|Interim Analysis|Participant Wanted to Become Pregnant|0
1020412|NCT00296504|3331966|P3|Interim Analysis|Participant Wanted to Become Pregnant|2
1020413|NCT00296504|3331967|P2|Interim Analysis|Participant Wanted to Become Pregnant|0
1020414|NCT00296504|3331968|P1|Interim Analysis|Participant Wanted to Become Pregnant|0
1020415|NCT00296504|3331960|P9|Interim Analysis|Participant Non-compliant|0
1020416|NCT00296504|3331961|P8|Interim Analysis|Participant Non-compliant|2
1020417|NCT00296504|3331962|P7|Interim Analysis|Participant Non-compliant|6
1020418|NCT00296504|3331963|P6|Interim Analysis|Participant Non-compliant|3
1020419|NCT00296504|3331964|P5|Interim Analysis|Participant Non-compliant|1
1020420|NCT00296504|3331965|P4|Interim Analysis|Participant Non-compliant|1
1020421|NCT00296504|3331966|P3|Interim Analysis|Participant Non-compliant|2
1020422|NCT00296504|3331967|P2|Interim Analysis|Participant Non-compliant|1
1020423|NCT00296504|3331968|P1|Interim Analysis|Participant Non-compliant|0
1020424|NCT00296504|3331960|P9|Interim Analysis|Death|0
1020425|NCT00296504|3331961|P8|Interim Analysis|Death|0
1020426|NCT00296504|3331962|P7|Interim Analysis|Death|0
1020427|NCT00296504|3331963|P6|Interim Analysis|Death|0
1020428|NCT00296504|3331964|P5|Interim Analysis|Death|0
1020429|NCT00296504|3331965|P4|Interim Analysis|Death|0
1020430|NCT00296504|3331966|P3|Interim Analysis|Death|3
1020431|NCT00296504|3331967|P2|Interim Analysis|Death|0
1020432|NCT00296504|3331968|P1|Interim Analysis|Death|1
1020433|NCT00296504|3331960|P9|Interim Analysis|Pregnancy|0
1020434|NCT00296504|3331961|P8|Interim Analysis|Pregnancy|1
1020435|NCT00296504|3331962|P7|Interim Analysis|Pregnancy|1
1020436|NCT00296504|3331963|P6|Interim Analysis|Pregnancy|1
1020437|NCT00296504|3331964|P5|Interim Analysis|Pregnancy|0
1020438|NCT00296504|3331965|P4|Interim Analysis|Pregnancy|2
1020439|NCT00296504|3331966|P3|Interim Analysis|Pregnancy|4
1020440|NCT00296504|3331967|P2|Interim Analysis|Pregnancy|1
1020441|NCT00296504|3331968|P1|Interim Analysis|Pregnancy|4
1020442|NCT00296504|3331960|P9|Interim Analysis|Switched to Commercially Available Drug|0
1020443|NCT00296504|3331961|P8|Interim Analysis|Switched to Commercially Available Drug|4
1020444|NCT00296504|3331962|P7|Interim Analysis|Switched to Commercially Available Drug|3
1020445|NCT00296504|3331963|P6|Interim Analysis|Switched to Commercially Available Drug|5
1020446|NCT00296504|3331964|P5|Interim Analysis|Switched to Commercially Available Drug|0
1020447|NCT00296504|3331965|P4|Interim Analysis|Switched to Commercially Available Drug|1
1020448|NCT00296504|3331966|P3|Interim Analysis|Switched to Commercially Available Drug|4
1020449|NCT00296504|3331967|P2|Interim Analysis|Switched to Commercially Available Drug|0
1020450|NCT00296504|3331968|P1|Interim Analysis|Switched to Commercially Available Drug|2
1020451|NCT00296504|3331960|P9|Interim Analysis|Insufficient CD4 Response|0
1020452|NCT00296504|3331961|P8|Interim Analysis|Insufficient CD4 Response|0
1020453|NCT00296504|3331962|P7|Interim Analysis|Insufficient CD4 Response|0
1020454|NCT00296504|3331963|P6|Interim Analysis|Insufficient CD4 Response|1
1020455|NCT00296504|3331964|P5|Interim Analysis|Insufficient CD4 Response|1
1020456|NCT00296504|3331965|P4|Interim Analysis|Insufficient CD4 Response|0
1020457|NCT00296504|3331966|P3|Interim Analysis|Insufficient CD4 Response|0
1020458|NCT00296504|3331967|P2|Interim Analysis|Insufficient CD4 Response|0
1020459|NCT00296504|3331968|P1|Interim Analysis|Insufficient CD4 Response|0
1020460|NCT00296504|3331960|P9|Interim Analysis|Protocol Violation|0
1020461|NCT00296504|3331961|P8|Interim Analysis|Protocol Violation|1
1020462|NCT00296504|3331962|P7|Interim Analysis|Protocol Violation|0
1020463|NCT00296504|3331963|P6|Interim Analysis|Protocol Violation|0
1020464|NCT00296504|3331964|P5|Interim Analysis|Protocol Violation|1
1020465|NCT00296504|3331965|P4|Interim Analysis|Protocol Violation|0
1020466|NCT00296504|3331966|P3|Interim Analysis|Protocol Violation|2
1020467|NCT00296504|3331967|P2|Interim Analysis|Protocol Violation|0
1020468|NCT00296504|3331968|P1|Interim Analysis|Protocol Violation|0
1020469|NCT00296504|3331960|P9|Interim Analysis|Adverse Event|0
1020470|NCT00296504|3331961|P8|Interim Analysis|Adverse Event|5
1020471|NCT00296504|3331962|P7|Interim Analysis|Adverse Event|4
1020472|NCT00296504|3331963|P6|Interim Analysis|Adverse Event|3
1020473|NCT00296504|3331964|P5|Interim Analysis|Adverse Event|6
1020474|NCT00296504|3331965|P4|Interim Analysis|Adverse Event|4
1020475|NCT00296504|3331966|P3|Interim Analysis|Adverse Event|13
1020476|NCT00296504|3331967|P2|Interim Analysis|Adverse Event|0
1020477|NCT00296504|3331968|P1|Interim Analysis|Adverse Event|0
1020478|NCT00296504|3331960|P9|Interim Analysis|Insufficient Viral Load Response|0
1020479|NCT00296504|3331961|P8|Interim Analysis|Insufficient Viral Load Response|24
1020480|NCT00296504|3331962|P7|Interim Analysis|Insufficient Viral Load Response|2
1020481|NCT00296504|3331963|P6|Interim Analysis|Insufficient Viral Load Response|9
1020482|NCT00296504|3331964|P5|Interim Analysis|Insufficient Viral Load Response|7
1020483|NCT00296504|3331965|P4|Interim Analysis|Insufficient Viral Load Response|2
1020484|NCT00296504|3331966|P3|Interim Analysis|Insufficient Viral Load Response|12
1020485|NCT00296504|3331967|P2|Interim Analysis|Insufficient Viral Load Response|1
1020486|NCT00296504|3331968|P1|Interim Analysis|Insufficient Viral Load Response|5
1020487|NCT00296504|3331960|P9|Interim Analysis|Clinical Progression|0
1020488|NCT00296504|3331961|P8|Interim Analysis|Clinical Progression|2
1020489|NCT00296504|3331962|P7|Interim Analysis|Clinical Progression|1
1020490|NCT00296504|3331963|P6|Interim Analysis|Clinical Progression|2
1020491|NCT00296504|3331964|P5|Interim Analysis|Clinical Progression|0
1020492|NCT00296504|3331965|P4|Interim Analysis|Clinical Progression|1
1020493|NCT00296504|3331966|P3|Interim Analysis|Clinical Progression|1
1020494|NCT00296504|3331967|P2|Interim Analysis|Clinical Progression|0
1020495|NCT00296504|3331968|P1|Interim Analysis|Clinical Progression|1
1020496|NCT00296504|3331960|P9|Interim Analysis|Lost to Follow-up|0
1020497|NCT00296504|3331961|P8|Interim Analysis|Lost to Follow-up|4
1020498|NCT00296504|3331962|P7|Interim Analysis|Lost to Follow-up|11
1020499|NCT00296504|3331963|P6|Interim Analysis|Lost to Follow-up|4
1020500|NCT00296504|3331964|P5|Interim Analysis|Lost to Follow-up|14
1020501|NCT00296504|3331965|P4|Interim Analysis|Lost to Follow-up|8
1020502|NCT00296504|3331966|P3|Interim Analysis|Lost to Follow-up|26
1020503|NCT00296504|3331967|P2|Interim Analysis|Lost to Follow-up|3
1020504|NCT00296504|3331968|P1|Interim Analysis|Lost to Follow-up|13
1020505|NCT00296504|3331960|P9|Interim Analysis|Withdrawal by Subject|0
1020506|NCT00296504|3331961|P8|Interim Analysis|Withdrawal by Subject|3
1020507|NCT00296504|3331962|P7|Interim Analysis|Withdrawal by Subject|9
1020508|NCT00296504|3331963|P6|Interim Analysis|Withdrawal by Subject|5
1020509|NCT00296504|3331964|P5|Interim Analysis|Withdrawal by Subject|5
1020510|NCT00296504|3331965|P4|Interim Analysis|Withdrawal by Subject|0
1020511|NCT00296504|3331966|P3|Interim Analysis|Withdrawal by Subject|12
1020512|NCT00296504|3331967|P2|Interim Analysis|Withdrawal by Subject|0
1020513|NCT00296504|3331968|P1|Interim Analysis|Withdrawal by Subject|8
1020514|NCT00296491|3332061|P4|Overall Study|Lost to Follow-up|0
1020515|NCT00296491|3332062|P3|Overall Study|Lost to Follow-up|2
1020516|NCT00296491|3332063|P2|Overall Study|Lost to Follow-up|2
1020517|NCT00296491|3332064|P1|Overall Study|Lost to Follow-up|0
1020518|NCT00296491|3332061|P4|Overall Study|Non-Compliance|14
1020519|NCT00296491|3332062|P3|Overall Study|Non-Compliance|10
1020520|NCT00296491|3332063|P2|Overall Study|Non-Compliance|13
1020521|NCT00296491|3332064|P1|Overall Study|Non-Compliance|12
1020522|NCT00296491|3332061|P4|Overall Study|Withdrawal by Subject|2
1020523|NCT00296491|3332062|P3|Overall Study|Withdrawal by Subject|3
1020524|NCT00296491|3332063|P2|Overall Study|Withdrawal by Subject|3
1020525|NCT00296491|3332064|P1|Overall Study|Withdrawal by Subject|7
1020526|NCT00296491|3332061|P4|Overall Study|Withdrawn due to Asthma|4
1020527|NCT00296491|3332062|P3|Overall Study|Withdrawn due to Asthma|0
1020528|NCT00296491|3332063|P2|Overall Study|Withdrawn due to Asthma|0
1020529|NCT00296491|3332064|P1|Overall Study|Withdrawn due to Asthma|0
1020530|NCT00296491|3332061|P4|Overall Study|Adverse Event|4
1020531|NCT00296491|3332062|P3|Overall Study|Adverse Event|1
1020532|NCT00296491|3332063|P2|Overall Study|Adverse Event|3
1020533|NCT00296491|3332064|P1|Overall Study|Adverse Event|1
1020534|NCT00296491|3332061|P4|Overall Study|Protocol Violation|3
1020535|NCT00296491|3332062|P3|Overall Study|Protocol Violation|2
1020536|NCT00296491|3332063|P2|Overall Study|Protocol Violation|6
1020537|NCT00296491|3332064|P1|Overall Study|Protocol Violation|4
1020538|NCT00296491|3332061|P4|Overall Study|Low Pollen Counts|16
1020539|NCT00296491|3332062|P3|Overall Study|Low Pollen Counts|25
1020540|NCT00296491|3332063|P2|Overall Study|Low Pollen Counts|26
1020541|NCT00296491|3332064|P1|Overall Study|Low Pollen Counts|18
1020542|NCT00296400|3332093|P3|Overall Study|Pregnancy|0
1020543|NCT00296400|3332094|P2|Overall Study|Pregnancy|2
1020544|NCT00296400|3332095|P1|Overall Study|Pregnancy|1
1020545|NCT00296400|3332093|P3|Overall Study|Visit 10 was performed earlier|0
1020546|NCT00296400|3332094|P2|Overall Study|Visit 10 was performed earlier|1
1020547|NCT00296400|3332095|P1|Overall Study|Visit 10 was performed earlier|0
1020548|NCT00296400|3332093|P3|Overall Study|Study specific discontinuation criteria|1
1020549|NCT00296400|3332094|P2|Overall Study|Study specific discontinuation criteria|0
1020550|NCT00296400|3332095|P1|Overall Study|Study specific discontinuation criteria|0
1020551|NCT00296400|3332093|P3|Overall Study|Lost to Follow-up|2
1020552|NCT00296400|3332094|P2|Overall Study|Lost to Follow-up|1
1020553|NCT00296400|3332095|P1|Overall Study|Lost to Follow-up|1
1020554|NCT00296400|3332093|P3|Overall Study|Protocol Violation|1
1020555|NCT00296400|3332094|P2|Overall Study|Protocol Violation|1
1020556|NCT00296400|3332095|P1|Overall Study|Protocol Violation|1
1020557|NCT00296400|3332093|P3|Overall Study|Incorrect enrollment|0
1020558|NCT00296400|3332094|P2|Overall Study|Incorrect enrollment|0
1020559|NCT00296400|3332095|P1|Overall Study|Incorrect enrollment|2
1020560|NCT00296400|3332093|P3|Overall Study|Withdrawal by Subject|2
1020561|NCT00296400|3332094|P2|Overall Study|Withdrawal by Subject|6
1020562|NCT00296400|3332095|P1|Overall Study|Withdrawal by Subject|5
1020563|NCT00296400|3332093|P3|Overall Study|Adverse Event|7
1020564|NCT00296400|3332094|P2|Overall Study|Adverse Event|7
1020565|NCT00296400|3332095|P1|Overall Study|Adverse Event|7
1020566|NCT00296374|3332319|P3|Overall Study|Not specified|1
1020567|NCT00296374|3332320|P2|Overall Study|Not specified|0
1020568|NCT00296374|3332321|P1|Overall Study|Not specified|0
1020569|NCT00296374|3332319|P3|Overall Study|Pregnancy|2
1020570|NCT00296374|3332320|P2|Overall Study|Pregnancy|0
1020571|NCT00296374|3332321|P1|Overall Study|Pregnancy|0
1020572|NCT00296374|3332319|P3|Overall Study|Nephrologist introduced ACE|0
1020573|NCT00296374|3332320|P2|Overall Study|Nephrologist introduced ACE|1
1020574|NCT00296374|3332321|P1|Overall Study|Nephrologist introduced ACE|0
1020575|NCT00296374|3332319|P3|Overall Study|Stopped drug before end of study visit|0
1020576|NCT00296374|3332320|P2|Overall Study|Stopped drug before end of study visit|1
1020577|NCT00296374|3332321|P1|Overall Study|Stopped drug before end of study visit|0
1020578|NCT00296374|3332319|P3|Overall Study|Relocated to another state|0
1020579|NCT00296374|3332320|P2|Overall Study|Relocated to another state|0
1020580|NCT00296374|3332321|P1|Overall Study|Relocated to another state|1
1020581|NCT00296374|3332319|P3|Overall Study|Lost to Follow-up|1
1020582|NCT00296374|3332320|P2|Overall Study|Lost to Follow-up|1
1020583|NCT00296374|3332321|P1|Overall Study|Lost to Follow-up|3
1020584|NCT00296374|3332319|P3|Overall Study|Protocol Violation|3
1020585|NCT00296374|3332320|P2|Overall Study|Protocol Violation|2
1020586|NCT00296374|3332321|P1|Overall Study|Protocol Violation|1
1020587|NCT00296374|3332319|P3|Overall Study|Incorrect enrollment|4
1020588|NCT00296374|3332320|P2|Overall Study|Incorrect enrollment|3
1020589|NCT00296374|3332321|P1|Overall Study|Incorrect enrollment|3
1020590|NCT00296374|3332319|P3|Overall Study|Withdrawal by Subject|11
1020591|NCT00296374|3332320|P2|Overall Study|Withdrawal by Subject|5
1020592|NCT00296374|3332321|P1|Overall Study|Withdrawal by Subject|3
1020593|NCT00296374|3332319|P3|Overall Study|Adverse Event|7
1020594|NCT00296374|3332320|P2|Overall Study|Adverse Event|10
1020595|NCT00296374|3332321|P1|Overall Study|Adverse Event|14
1020596|NCT00296335|3332544|P2|Overall Study|Physician Decision|11
1020597|NCT00296335|3332545|P1|Overall Study|Physician Decision|3
1020598|NCT00296335|3332544|P2|Overall Study|Lost to Follow-up|33
1020599|NCT00296335|3332545|P1|Overall Study|Lost to Follow-up|7
1020600|NCT00296335|3332544|P2|Overall Study|Adverse Event|27
1020601|NCT00296335|3332545|P1|Overall Study|Adverse Event|17
1020602|NCT00296335|3332544|P2|Overall Study|Recurrence|51
1020603|NCT00296335|3332545|P1|Overall Study|Recurrence|3
1020604|NCT00296244|3332585|P2|Overall Study|Underwent retransplant|1
1020605|NCT00296244|3332586|P1|Overall Study|Underwent retransplant|0
1020606|NCT00296140|3332650|P2|Overall Study|Discharge to Nursing Home|0
1020607|NCT00296140|3332651|P1|Overall Study|Discharge to Nursing Home|1
1020608|NCT00296140|3332650|P2|Overall Study|Withdrawal by Subject|0
1020609|NCT00296140|3332651|P1|Overall Study|Withdrawal by Subject|1
1020610|NCT00296140|3332650|P2|Overall Study|Lost to Follow-up|0
1020611|NCT00296140|3332651|P1|Overall Study|Lost to Follow-up|1
1020612|NCT00296036|3332663|P6|Overall Study|Protocol Violation|3
1020613|NCT00296036|3332664|P5|Overall Study|Protocol Violation|0
1020614|NCT00296036|3332665|P4|Overall Study|Protocol Violation|0
1020615|NCT00296036|3332666|P3|Overall Study|Protocol Violation|0
1020616|NCT00296036|3332667|P2|Overall Study|Protocol Violation|0
1020617|NCT00296036|3332668|P1|Overall Study|Protocol Violation|0
1020618|NCT00296036|3332663|P6|Overall Study|Withdrawal by Subject|1
1020619|NCT00296036|3332664|P5|Overall Study|Withdrawal by Subject|2
1020620|NCT00296036|3332665|P4|Overall Study|Withdrawal by Subject|1
1020621|NCT00296036|3332666|P3|Overall Study|Withdrawal by Subject|2
1020622|NCT00296036|3332667|P2|Overall Study|Withdrawal by Subject|0
1020623|NCT00296036|3332668|P1|Overall Study|Withdrawal by Subject|1
1020624|NCT00295932|3332705|P11|Overall Study|Not Treated|1
1020625|NCT00295932|3332706|P10|Overall Study|Not Treated|0
1020626|NCT00295932|3332707|P9|Overall Study|Not Treated|0
1020627|NCT00295932|3332708|P8|Overall Study|Not Treated|0
1020628|NCT00295932|3332709|P7|Overall Study|Not Treated|0
1020629|NCT00295932|3332710|P6|Overall Study|Not Treated|0
1020630|NCT00295932|3332711|P5|Overall Study|Not Treated|0
1020631|NCT00295932|3332712|P4|Overall Study|Not Treated|0
1020632|NCT00295932|3332713|P3|Overall Study|Not Treated|0
1020633|NCT00295932|3332714|P2|Overall Study|Not Treated|0
1020634|NCT00295932|3332715|P1|Overall Study|Not Treated|0
1020635|NCT00295880|3332749|P1|Overall Study|Unit randomization did not occur|1
1020636|NCT00295880|3332749|P1|Overall Study|IBMI unit could not be volume reduced|1
1020637|NCT00295854|3332763|P3|Overall Study|not specified|1
1020638|NCT00295854|3332764|P2|Overall Study|not specified|5
1020639|NCT00295854|3332765|P1|Overall Study|not specified|3
1020640|NCT00295854|3332763|P3|Overall Study|required a prohibited medication|0
1020641|NCT00295854|3332764|P2|Overall Study|required a prohibited medication|0
1020642|NCT00295854|3332765|P1|Overall Study|required a prohibited medication|1
1020643|NCT00295854|3332763|P3|Overall Study|did not continue to meet criteria|2
1020644|NCT00295854|3332764|P2|Overall Study|did not continue to meet criteria|1
1020645|NCT00295854|3332765|P1|Overall Study|did not continue to meet criteria|1
1020646|NCT00295854|3332763|P3|Overall Study|Withdrawal by Subject|4
1020647|NCT00295854|3332764|P2|Overall Study|Withdrawal by Subject|7
1020648|NCT00295854|3332765|P1|Overall Study|Withdrawal by Subject|3
1020649|NCT00295854|3332763|P3|Overall Study|Lost to Follow-up|1
1020650|NCT00295854|3332764|P2|Overall Study|Lost to Follow-up|0
1020651|NCT00295854|3332765|P1|Overall Study|Lost to Follow-up|2
1020652|NCT00295854|3332763|P3|Overall Study|Protocol Violation|1
1020653|NCT00295854|3332764|P2|Overall Study|Protocol Violation|1
1020654|NCT00295854|3332765|P1|Overall Study|Protocol Violation|1
1020655|NCT00295854|3332763|P3|Overall Study|Adverse Event|6
1020656|NCT00295854|3332764|P2|Overall Study|Adverse Event|7
1020657|NCT00295854|3332765|P1|Overall Study|Adverse Event|7
1020658|NCT00295750|3332779|P3|Overall Study|Protocol Violation|2
1020659|NCT00295750|3332780|P2|Overall Study|Protocol Violation|4
1020660|NCT00295750|3332781|P1|Overall Study|Protocol Violation|2
1020661|NCT00295750|3332779|P3|Overall Study|Withdrawal by Subject|7
1020662|NCT00295750|3332780|P2|Overall Study|Withdrawal by Subject|4
1020663|NCT00295750|3332781|P1|Overall Study|Withdrawal by Subject|9
1020664|NCT00295750|3332779|P3|Overall Study|Randomized but never received trial drug|3
1020665|NCT00295750|3332780|P2|Overall Study|Randomized but never received trial drug|3
1020666|NCT00295750|3332781|P1|Overall Study|Randomized but never received trial drug|4
1020667|NCT00295750|3332779|P3|Overall Study|Personal reasons|0
1020668|NCT00295750|3332780|P2|Overall Study|Personal reasons|1
1020669|NCT00295750|3332781|P1|Overall Study|Personal reasons|0
1020670|NCT00295750|3332779|P3|Overall Study|Disease progression|0
1020671|NCT00295750|3332780|P2|Overall Study|Disease progression|1
1020672|NCT00295750|3332781|P1|Overall Study|Disease progression|2
1020673|NCT00295750|3332779|P3|Overall Study|Trial drug errors|0
1020674|NCT00295750|3332780|P2|Overall Study|Trial drug errors|1
1020675|NCT00295750|3332781|P1|Overall Study|Trial drug errors|1
1020676|NCT00295750|3332779|P3|Overall Study|Administrative errors|5
1020677|NCT00295750|3332780|P2|Overall Study|Administrative errors|4
1020678|NCT00295750|3332781|P1|Overall Study|Administrative errors|2
1020679|NCT00295750|3332779|P3|Overall Study|Taking prohibited therapy|2
1020680|NCT00295750|3332780|P2|Overall Study|Taking prohibited therapy|3
1020681|NCT00295750|3332781|P1|Overall Study|Taking prohibited therapy|2
1020682|NCT00295750|3332779|P3|Overall Study|Lost to Follow-up|1
1020683|NCT00295750|3332780|P2|Overall Study|Lost to Follow-up|4
1020684|NCT00295750|3332781|P1|Overall Study|Lost to Follow-up|1
1020685|NCT00295750|3332779|P3|Overall Study|Lack of Efficacy|0
1020686|NCT00295750|3332780|P2|Overall Study|Lack of Efficacy|1
1020687|NCT00295750|3332781|P1|Overall Study|Lack of Efficacy|1
1020688|NCT00295750|3332779|P3|Overall Study|Adverse Event|12
1020689|NCT00295750|3332780|P2|Overall Study|Adverse Event|15
1020690|NCT00295750|3332781|P1|Overall Study|Adverse Event|19
1020691|NCT00295633|3332816|P3|Overall Study|Administrative reason by sponsor|1
1020692|NCT00295633|3332817|P2|Overall Study|Administrative reason by sponsor|0
1020693|NCT00295633|3332818|P1|Overall Study|Administrative reason by sponsor|0
1020694|NCT00295633|3332816|P3|Overall Study|Death|0
1020695|NCT00295633|3332817|P2|Overall Study|Death|1
1020696|NCT00295633|3332818|P1|Overall Study|Death|1
1020697|NCT00295633|3332816|P3|Overall Study|Subject No Longer Meets Study Criteria|3
1020698|NCT00295633|3332817|P2|Overall Study|Subject No Longer Meets Study Criteria|3
1020699|NCT00295633|3332818|P1|Overall Study|Subject No Longer Meets Study Criteria|0
1020700|NCT00295633|3332816|P3|Overall Study|Poor/Noncompliance|6
1020701|NCT00295633|3332817|P2|Overall Study|Poor/Noncompliance|2
1020702|NCT00295633|3332818|P1|Overall Study|Poor/Noncompliance|2
1020703|NCT00295633|3332816|P3|Overall Study|Physician Decision|8
1020704|NCT00295633|3332817|P2|Overall Study|Physician Decision|10
1020705|NCT00295633|3332818|P1|Overall Study|Physician Decision|9
1020706|NCT00295633|3332816|P3|Overall Study|Lost to Follow-up|7
1020707|NCT00295633|3332817|P2|Overall Study|Lost to Follow-up|11
1020708|NCT00295633|3332818|P1|Overall Study|Lost to Follow-up|6
1020709|NCT00295633|3332816|P3|Overall Study|Adverse Event|9
1020710|NCT00295633|3332817|P2|Overall Study|Adverse Event|17
1020711|NCT00295633|3332818|P1|Overall Study|Adverse Event|9
1020712|NCT00295633|3332816|P3|Overall Study|Withdrawal of consent by subject|26
1020713|NCT00295633|3332817|P2|Overall Study|Withdrawal of consent by subject|16
1020714|NCT00295633|3332818|P1|Overall Study|Withdrawal of consent by subject|16
1020715|NCT00295633|3332816|P3|Overall Study|Lack of Efficacy|16
1020716|NCT00295633|3332817|P2|Overall Study|Lack of Efficacy|7
1020717|NCT00295633|3332818|P1|Overall Study|Lack of Efficacy|19
1020718|NCT00295490|3332845|P4|Overall Study|Other|1
1020719|NCT00295490|3332846|P3|Overall Study|Other|0
1020720|NCT00295490|3332847|P2|Overall Study|Other|2
1020721|NCT00295490|3332848|P1|Overall Study|Other|0
1020722|NCT00295490|3332845|P4|Overall Study|Adverse Event|0
1020723|NCT00295490|3332846|P3|Overall Study|Adverse Event|0
1020724|NCT00295490|3332847|P2|Overall Study|Adverse Event|0
1020725|NCT00295490|3332848|P1|Overall Study|Adverse Event|1
1020726|NCT00295490|3332845|P4|Overall Study|Lost to Follow-up|0
1020727|NCT00295490|3332846|P3|Overall Study|Lost to Follow-up|1
1020728|NCT00295490|3332847|P2|Overall Study|Lost to Follow-up|0
1020729|NCT00295490|3332848|P1|Overall Study|Lost to Follow-up|0
1020730|NCT00295490|3332845|P4|Overall Study|Withdrawal by Subject|1
1020731|NCT00295490|3332846|P3|Overall Study|Withdrawal by Subject|0
1020732|NCT00295490|3332847|P2|Overall Study|Withdrawal by Subject|2
1020733|NCT00295490|3332848|P1|Overall Study|Withdrawal by Subject|0
1020734|NCT00295490|3332845|P4|Overall Study|Protocol Violation|3
1020735|NCT00295490|3332846|P3|Overall Study|Protocol Violation|3
1020736|NCT00295490|3332847|P2|Overall Study|Protocol Violation|0
1020737|NCT00295490|3332848|P1|Overall Study|Protocol Violation|0
1020738|NCT00295022|3332898|P3|Overall Study|Withdrawal by Subject|2
1020739|NCT00295022|3332899|P2|Overall Study|Withdrawal by Subject|0
1020740|NCT00295022|3332900|P1|Overall Study|Withdrawal by Subject|0
1020741|NCT00295022|3332898|P3|Overall Study|Lost to Follow-up|1
1020742|NCT00295022|3332899|P2|Overall Study|Lost to Follow-up|0
1020743|NCT00295022|3332900|P1|Overall Study|Lost to Follow-up|0
1020744|NCT00295022|3332898|P3|Overall Study|Adverse Event|2
1020745|NCT00295022|3332899|P2|Overall Study|Adverse Event|1
1020746|NCT00295022|3332900|P1|Overall Study|Adverse Event|1
1020747|NCT00294762|3333016|P2|Overall Study|Did not receive study treatment|3
1020748|NCT00294762|3333017|P1|Overall Study|Did not receive study treatment|3
1020749|NCT00294723|3333036|P3|Additional Open-Label Extension 91 Weeks|Not specified in study report|3
1020750|NCT00294723|3333037|P2|Additional Open-Label Extension 91 Weeks|Not specified in study report|5
1020751|NCT00294723|3333038|P1|Additional Open-Label Extension 91 Weeks|Not specified in study report|2
1020752|NCT00294723|3333036|P3|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
1020753|NCT00294723|3333037|P2|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
1020754|NCT00294723|3333038|P1|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
1020755|NCT00294723|3333036|P3|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16
1020756|NCT00294723|3333037|P2|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14
1020757|NCT00294723|3333038|P1|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24
1020758|NCT00294723|3333036|P3|Additional Open-Label Extension 91 Weeks|Adverse Event|0
1020759|NCT00294723|3333037|P2|Additional Open-Label Extension 91 Weeks|Adverse Event|1
1020760|NCT00294723|3333038|P1|Additional Open-Label Extension 91 Weeks|Adverse Event|1
1020761|NCT00294723|3333036|P3|Open-Label Extension 52 Weeks|Not specified in study report|14
1020762|NCT00294723|3333037|P2|Open-Label Extension 52 Weeks|Not specified in study report|16
1020763|NCT00294723|3333038|P1|Open-Label Extension 52 Weeks|Not specified in study report|19
1020764|NCT00294723|3333036|P3|Open-Label Extension 52 Weeks|Protocol Violation|3
1020765|NCT00294723|3333037|P2|Open-Label Extension 52 Weeks|Protocol Violation|3
1020766|NCT00294723|3333038|P1|Open-Label Extension 52 Weeks|Protocol Violation|4
1020767|NCT00294723|3333036|P3|Open-Label Extension 52 Weeks|Lack of Efficacy|21
1020768|NCT00294723|3333037|P2|Open-Label Extension 52 Weeks|Lack of Efficacy|15
1020769|NCT00294723|3333038|P1|Open-Label Extension 52 Weeks|Lack of Efficacy|12
1020770|NCT00294723|3333036|P3|Open-Label Extension 52 Weeks|Adverse Event|2
1020771|NCT00294723|3333037|P2|Open-Label Extension 52 Weeks|Adverse Event|5
1020772|NCT00294723|3333038|P1|Open-Label Extension 52 Weeks|Adverse Event|5
1020773|NCT00294723|3333036|P3|Double-Blind Period 52 Weeks|Not specified in study report|51
1020774|NCT00294723|3333037|P2|Double-Blind Period 52 Weeks|Not specified in study report|38
1020775|NCT00294723|3333038|P1|Double-Blind Period 52 Weeks|Not specified in study report|36
1020776|NCT00294723|3333036|P3|Double-Blind Period 52 Weeks|Protocol Violation|5
1020777|NCT00294723|3333037|P2|Double-Blind Period 52 Weeks|Protocol Violation|11
1020778|NCT00294723|3333038|P1|Double-Blind Period 52 Weeks|Protocol Violation|11
1020779|NCT00294723|3333036|P3|Double-Blind Period 52 Weeks|Lack of Efficacy|25
1020780|NCT00294723|3333037|P2|Double-Blind Period 52 Weeks|Lack of Efficacy|15
1020781|NCT00294723|3333038|P1|Double-Blind Period 52 Weeks|Lack of Efficacy|9
1020782|NCT00294723|3333036|P3|Double-Blind Period 52 Weeks|Adverse Event|15
1020783|NCT00294723|3333037|P2|Double-Blind Period 52 Weeks|Adverse Event|25
1020784|NCT00294723|3333038|P1|Double-Blind Period 52 Weeks|Adverse Event|18
1020785|NCT00294684|3333099|P2|Overall Study|Lost to Follow-up|8
1020786|NCT00294684|3333100|P1|Overall Study|Lost to Follow-up|5
1020787|NCT00294671|3333140|P2|Overall Study|Death|1
1020788|NCT00294671|3333141|P1|Overall Study|Death|0
1020789|NCT00294671|3333140|P2|Overall Study|Non-compliance|0
1020790|NCT00294671|3333141|P1|Overall Study|Non-compliance|1
1020791|NCT00294671|3333140|P2|Overall Study|Lost to Follow-up|3
1020792|NCT00294671|3333141|P1|Overall Study|Lost to Follow-up|1
1020793|NCT00294671|3333140|P2|Overall Study|Non-drug related AE|2
1020794|NCT00294671|3333141|P1|Overall Study|Non-drug related AE|3
1020795|NCT00294671|3333140|P2|Overall Study|Drug related adverse event (AE)|2
1020796|NCT00294671|3333141|P1|Overall Study|Drug related adverse event (AE)|4
1020797|NCT00294671|3333140|P2|Overall Study|Liver transplant|9
1020798|NCT00294671|3333141|P1|Overall Study|Liver transplant|7
1020799|NCT00294671|3333140|P2|Overall Study|Lack of Efficacy|23
1020800|NCT00294671|3333141|P1|Overall Study|Lack of Efficacy|11
1020801|NCT00294658|3333157|P2|Overall Study|Patient and family were not satisfied|1
1020802|NCT00294658|3333158|P1|Overall Study|Patient and family were not satisfied|0
1020803|NCT00294658|3333157|P2|Overall Study|Found to have invasive thymoma|0
1020804|NCT00294658|3333158|P1|Overall Study|Found to have invasive thymoma|1
1020805|NCT00294658|3333157|P2|Overall Study|Withdrawal by Subject|4
1020806|NCT00294658|3333158|P1|Overall Study|Withdrawal by Subject|0
1020807|NCT00294658|3333157|P2|Overall Study|Pregnancy|1
1020808|NCT00294658|3333158|P1|Overall Study|Pregnancy|0
1020809|NCT00294658|3333157|P2|Overall Study|Physician Decision|2
1020810|NCT00294658|3333158|P1|Overall Study|Physician Decision|1
1020811|NCT00294658|3333157|P2|Overall Study|Lost to Follow-up|0
1020812|NCT00294658|3333158|P1|Overall Study|Lost to Follow-up|4
1020813|NCT00294658|3333157|P2|Overall Study|Death|1
1020814|NCT00294658|3333158|P1|Overall Study|Death|0
1020815|NCT00294645|3333222|P2|Overall Study|Other|10
1020816|NCT00294645|3333223|P1|Overall Study|Other|4
1020817|NCT00294645|3333222|P2|Overall Study|Physician Decision|20
1020818|NCT00294645|3333223|P1|Overall Study|Physician Decision|15
1020819|NCT00294645|3333222|P2|Overall Study|Withdrawal by Subject|34
1020820|NCT00294645|3333223|P1|Overall Study|Withdrawal by Subject|18
1020821|NCT00294645|3333222|P2|Overall Study|Lost to Follow-up|10
1020822|NCT00294645|3333223|P1|Overall Study|Lost to Follow-up|1
1020823|NCT00294645|3333222|P2|Overall Study|Death|18
1020824|NCT00294645|3333223|P1|Overall Study|Death|10
1020825|NCT00294554|3333257|P2|Overall Study|Physician Decision|1
1020826|NCT00294554|3333258|P1|Overall Study|Physician Decision|0
1020827|NCT00294554|3333257|P2|Overall Study|Lack of Efficacy|1
1020828|NCT00294554|3333258|P1|Overall Study|Lack of Efficacy|0
1020829|NCT00294398|3333285|P2|Overall Study|Lost to Follow-up|26
1020830|NCT00294398|3333286|P1|Overall Study|Lost to Follow-up|21
1020831|NCT00294060|3333294|P1|Overall Study|Device explanted/not replaced|23
1020832|NCT00294060|3333294|P1|Overall Study|Medical condition|3
1020833|NCT00294060|3333294|P1|Overall Study|Physician Decision|797
1020834|NCT00294060|3333294|P1|Overall Study|Withdrawal by Subject|11
1020835|NCT00294060|3333294|P1|Overall Study|Lost to Follow-up|55
1020836|NCT00294060|3333294|P1|Overall Study|Other|59
1020837|NCT00294060|3333294|P1|Overall Study|Death|225
1020838|NCT00294047|3333302|P2|Month 84|No consent for Month 84 Follow-up|754
1020839|NCT00294047|3333303|P1|Month 84|No consent for Month 84 Follow-up|731
1020840|NCT00294047|3333302|P2|Month 84|Visit missed|1
1020841|NCT00294047|3333303|P1|Month 84|Visit missed|0
1020842|NCT00294047|3333302|P2|Month 84|Under investigation locally|0
1020843|NCT00294047|3333303|P1|Month 84|Under investigation locally|1
1020844|NCT00294047|3333302|P2|Month 84|Unable to reach study site|0
1020845|NCT00294047|3333303|P1|Month 84|Unable to reach study site|1
1020846|NCT00294047|3333302|P2|Month 84|Transport reimbursement delayed|1
1020847|NCT00294047|3333303|P1|Month 84|Transport reimbursement delayed|0
1020848|NCT00294047|3333302|P2|Month 84|Subject does not want male physician|0
1020849|NCT00294047|3333303|P1|Month 84|Subject does not want male physician|1
1020850|NCT00294047|3333302|P2|Month 84|Personal reason|4
1020851|NCT00294047|3333303|P1|Month 84|Personal reason|2
1020852|NCT00294047|3333302|P2|Month 84|Lack of time|1
1020853|NCT00294047|3333303|P1|Month 84|Lack of time|3
1020854|NCT00294047|3333302|P2|Month 84|Family problems|2
1020855|NCT00294047|3333303|P1|Month 84|Family problems|2
1020856|NCT00294047|3333302|P2|Month 84|Center closed, subject did not transfer|0
1020857|NCT00294047|3333303|P1|Month 84|Center closed, subject did not transfer|1
1020858|NCT00294047|3333302|P2|Month 84|Work related reasons|2
1020859|NCT00294047|3333303|P1|Month 84|Work related reasons|4
1020860|NCT00294047|3333302|P2|Month 84|Absent Cervix|0
1020861|NCT00294047|3333303|P1|Month 84|Absent Cervix|2
1020862|NCT00294047|3333302|P2|Month 84|Lost to Follow-up|190
1020863|NCT00294047|3333303|P1|Month 84|Lost to Follow-up|187
1020864|NCT00294047|3333302|P2|Month 84|Withdrawal by Subject|31
1020865|NCT00294047|3333303|P1|Month 84|Withdrawal by Subject|33
1020866|NCT00294047|3333302|P2|Month 84|Protocol Violation|1
1020867|NCT00294047|3333303|P1|Month 84|Protocol Violation|1
1020868|NCT00294047|3333302|P2|Month 84|Adverse Event|2
1020869|NCT00294047|3333303|P1|Month 84|Adverse Event|4
1020870|NCT00294047|3333302|P2|Month 48|Other|14
1020871|NCT00294047|3333303|P1|Month 48|Other|10
1020872|NCT00294047|3333302|P2|Month 48|Lost to Follow-up|287
1020873|NCT00294047|3333303|P1|Month 48|Lost to Follow-up|272
1020874|NCT00294047|3333302|P2|Month 48|Withdrawal by Subject|115
1020875|NCT00294047|3333303|P1|Month 48|Withdrawal by Subject|111
1020876|NCT00294047|3333302|P2|Month 48|Protocol Violation|4
1020877|NCT00294047|3333303|P1|Month 48|Protocol Violation|4
1020878|NCT00294047|3333302|P2|Month 48|Adverse Event|13
1020879|NCT00294047|3333303|P1|Month 48|Adverse Event|28
1020880|NCT00293813|3333408|P3|Overall Study|Noncompliance|0
1020881|NCT00293813|3333409|P2|Overall Study|Noncompliance|1
1020882|NCT00293813|3333410|P1|Overall Study|Noncompliance|0
1020883|NCT00293813|3333408|P3|Overall Study|Lost to Follow-up|3
1020884|NCT00293813|3333409|P2|Overall Study|Lost to Follow-up|2
1020885|NCT00293813|3333410|P1|Overall Study|Lost to Follow-up|3
1020886|NCT00293813|3333408|P3|Overall Study|Withdrawal by Subject|4
1020887|NCT00293813|3333409|P2|Overall Study|Withdrawal by Subject|4
1020888|NCT00293813|3333410|P1|Overall Study|Withdrawal by Subject|7
1020889|NCT00293813|3333408|P3|Overall Study|Adverse Event|1
1020890|NCT00293813|3333409|P2|Overall Study|Adverse Event|1
1020891|NCT00293813|3333410|P1|Overall Study|Adverse Event|3
1020892|NCT00293813|3333408|P3|Overall Study|Physician Decision|0
1020893|NCT00293813|3333409|P2|Overall Study|Physician Decision|1
1020894|NCT00293813|3333410|P1|Overall Study|Physician Decision|0
1020895|NCT00293722|3333421|P1|Overall Study|Other|427
1020896|NCT00293709|3333435|P1|Overall Study|Other|47
1020897|NCT00293579|3333449|P1|Overall Study|Withdrawal by Subject|1
1020898|NCT00293462|3333468|P3|Overall Study|Physician Decision|0
1020899|NCT00293462|3333469|P2|Overall Study|Physician Decision|1
1020900|NCT00293462|3333470|P1|Overall Study|Physician Decision|0
1020901|NCT00293462|3333468|P3|Overall Study|Low radiation dose in oral cavity|0
1020902|NCT00293462|3333469|P2|Overall Study|Low radiation dose in oral cavity|1
1020903|NCT00293462|3333470|P1|Overall Study|Low radiation dose in oral cavity|0
1020904|NCT00293462|3333468|P3|Overall Study|Possible Tracheostomy leakage|0
1020905|NCT00293462|3333469|P2|Overall Study|Possible Tracheostomy leakage|1
1020906|NCT00293462|3333470|P1|Overall Study|Possible Tracheostomy leakage|0
1020907|NCT00293462|3333468|P3|Overall Study|Ischemic stroke after chemotherapy|1
1020908|NCT00293462|3333469|P2|Overall Study|Ischemic stroke after chemotherapy|0
1020909|NCT00293462|3333470|P1|Overall Study|Ischemic stroke after chemotherapy|0
1020910|NCT00293462|3333468|P3|Overall Study|Blood clot after chemotherapy|1
1020911|NCT00293462|3333469|P2|Overall Study|Blood clot after chemotherapy|0
1020912|NCT00293462|3333470|P1|Overall Study|Blood clot after chemotherapy|0
1020913|NCT00293462|3333468|P3|Overall Study|Went back to his home country|1
1020914|NCT00293462|3333469|P2|Overall Study|Went back to his home country|0
1020915|NCT00293462|3333470|P1|Overall Study|Went back to his home country|0
1020916|NCT00293462|3333468|P3|Overall Study|No Show|1
1020917|NCT00293462|3333469|P2|Overall Study|No Show|0
1020918|NCT00293462|3333470|P1|Overall Study|No Show|0
1020919|NCT00293462|3333468|P3|Overall Study|Refuse Radiation Treatment|0
1020920|NCT00293462|3333469|P2|Overall Study|Refuse Radiation Treatment|0
1020921|NCT00293462|3333470|P1|Overall Study|Refuse Radiation Treatment|1
1020922|NCT00293462|3333468|P3|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
1020923|NCT00293462|3333469|P2|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1
1020924|NCT00293462|3333470|P1|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
1020925|NCT00293462|3333468|P3|Overall Study|Change Treatment Regimen (ineligible)|0
1020926|NCT00293462|3333469|P2|Overall Study|Change Treatment Regimen (ineligible)|0
1020927|NCT00293462|3333470|P1|Overall Study|Change Treatment Regimen (ineligible)|1
1020928|NCT00293462|3333468|P3|Overall Study|Lost to Follow-up|0
1020929|NCT00293462|3333469|P2|Overall Study|Lost to Follow-up|1
1020930|NCT00293462|3333470|P1|Overall Study|Lost to Follow-up|0
1020931|NCT00293462|3333468|P3|Overall Study|Death|0
1020932|NCT00293462|3333469|P2|Overall Study|Death|0
1020933|NCT00293462|3333470|P1|Overall Study|Death|1
1020934|NCT00293462|3333468|P3|Overall Study|Withdrawal by Subject|6
1020935|NCT00293462|3333469|P2|Overall Study|Withdrawal by Subject|3
1020936|NCT00293462|3333470|P1|Overall Study|Withdrawal by Subject|4
1020937|NCT00293397|3333489|P1|Overall Study|Death|2
1020938|NCT00293384|3333499|P1|Overall Study|Ineligible|2
1020939|NCT00293384|3333499|P1|Overall Study|Missed dosage/study drug|1
1020940|NCT00293384|3333499|P1|Overall Study|Non-compliance|2
1020941|NCT00293293|3333508|P2|Overall Study|Patient discontinued chemotherapy|1
1020942|NCT00293293|3333509|P1|Overall Study|Patient discontinued chemotherapy|0
1020943|NCT00293293|3333508|P2|Overall Study|"Patient too anxious to complete trial"|0
1020944|NCT00293293|3333509|P1|Overall Study|"Patient too anxious to complete trial"|1
1020945|NCT00293293|3333508|P2|Overall Study|Withdrawal by Subject|1
1020946|NCT00293293|3333509|P1|Overall Study|Withdrawal by Subject|1
1020947|NCT00293267|3333537|P2|Open-Label Post Virologic Failure Phase|Other Reason|5
1020948|NCT00293267|3333538|P1|Open-Label Post Virologic Failure Phase|Other Reason|4
1020949|NCT00293267|3333537|P2|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2
1020950|NCT00293267|3333538|P1|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0
1020951|NCT00293267|3333537|P2|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2
1020952|NCT00293267|3333538|P1|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0
1020953|NCT00293267|3333537|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
1020954|NCT00293267|3333538|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
1020955|NCT00293267|3333537|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4
1020956|NCT00293267|3333538|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2
1020957|NCT00293267|3333537|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19
1020958|NCT00293267|3333538|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23
1020959|NCT00293267|3333537|P2|Open-Label Post Virologic Failure Phase|Adverse Event|3
1020960|NCT00293267|3333538|P1|Open-Label Post Virologic Failure Phase|Adverse Event|2
1020961|NCT00293267|3333537|P2|Extension - Open-Label Week 157-240|Other Reason|1
1020962|NCT00293267|3333538|P1|Extension - Open-Label Week 157-240|Other Reason|3
1020963|NCT00293267|3333537|P2|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0
1020964|NCT00293267|3333538|P1|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2
1020965|NCT00293267|3333537|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
1020966|NCT00293267|3333538|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|2
1020967|NCT00293267|3333537|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
1020968|NCT00293267|3333538|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|1
1020969|NCT00293267|3333537|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
1020970|NCT00293267|3333538|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|7
1020971|NCT00293267|3333537|P2|Extension - Open-Label Week 157-240|Adverse Event|0
1020972|NCT00293267|3333538|P1|Extension - Open-Label Week 157-240|Adverse Event|5
1020973|NCT00293267|3333537|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6
1020974|NCT00293267|3333538|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
1020975|NCT00293267|3333537|P2|Extension - Double-Blind Week 49-156|Other Reason|0
1020976|NCT00293267|3333538|P1|Extension - Double-Blind Week 49-156|Other Reason|7
1020977|NCT00293267|3333537|P2|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0
1020978|NCT00293267|3333538|P1|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2
1020979|NCT00293267|3333537|P2|Extension - Double-Blind Week 49-156|Death|0
1020980|NCT00293267|3333538|P1|Extension - Double-Blind Week 49-156|Death|3
1020981|NCT00293267|3333537|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4
1020982|NCT00293267|3333538|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13
1020983|NCT00293267|3333537|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|0
1020984|NCT00293267|3333538|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|4
1020985|NCT00293267|3333537|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|1
1020986|NCT00293267|3333538|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|7
1020987|NCT00293267|3333537|P2|Extension - Double-Blind Week 49-156|Adverse Event|4
1020988|NCT00293267|3333538|P1|Extension - Double-Blind Week 49-156|Adverse Event|1
1020989|NCT00293267|3333537|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60
1020990|NCT00293267|3333538|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33
1020991|NCT00293267|3333537|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
1020992|NCT00293267|3333538|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
1020993|NCT00293267|3333537|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
1020994|NCT00293267|3333538|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
1020995|NCT00293267|3333537|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
1020996|NCT00293267|3333538|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0
1020997|NCT00293267|3333537|P2|Primary Study - Double-Blind Week 0-48|Death|3
1020998|NCT00293267|3333538|P1|Primary Study - Double-Blind Week 0-48|Death|3
1020999|NCT00293267|3333537|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
1021000|NCT00293267|3333538|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|1
1021001|NCT00293267|3333537|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
1021002|NCT00293267|3333538|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
1021003|NCT00293254|3333578|P2|Open-Label Post Virologic Failure Phase|Other Reason|2
1021004|NCT00293254|3333579|P1|Open-Label Post Virologic Failure Phase|Other Reason|1
1021005|NCT00293254|3333578|P2|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
1021006|NCT00293254|3333579|P1|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
1021007|NCT00293254|3333578|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0
1021008|NCT00293254|3333579|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3
1021009|NCT00293254|3333578|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3
1021010|NCT00293254|3333579|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6
1021011|NCT00293254|3333578|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14
1021012|NCT00293254|3333579|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16
1021013|NCT00293254|3333578|P2|Open-Label Post Virologic Failure Phase|Adverse Event|7
1021014|NCT00293254|3333579|P1|Open-Label Post Virologic Failure Phase|Adverse Event|4
1021015|NCT00293254|3333578|P2|Extension - Open-Label Week 157-240|Other Reason|0
1021016|NCT00293254|3333579|P1|Extension - Open-Label Week 157-240|Other Reason|4
1021017|NCT00293254|3333578|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
1021018|NCT00293254|3333579|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|2
1021019|NCT00293254|3333578|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|0
1021020|NCT00293254|3333579|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
1021021|NCT00293254|3333578|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
1021022|NCT00293254|3333579|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|1
1021023|NCT00293254|3333578|P2|Extension - Open-Label Week 157-240|Adverse Event|1
1021024|NCT00293254|3333579|P1|Extension - Open-Label Week 157-240|Adverse Event|2
1021025|NCT00293254|3333578|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7
1021026|NCT00293254|3333579|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
1021027|NCT00293254|3333578|P2|Extension - Double-Blind Week 49-156|Other Reason|2
1021028|NCT00293254|3333579|P1|Extension - Double-Blind Week 49-156|Other Reason|10
1021029|NCT00293254|3333578|P2|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3
1021030|NCT00293254|3333579|P1|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6
1021031|NCT00293254|3333578|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8
1021032|NCT00293254|3333579|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12
1021033|NCT00293254|3333578|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
1021034|NCT00293254|3333579|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
1021035|NCT00293254|3333578|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|4
1021036|NCT00293254|3333579|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|3
1021037|NCT00293254|3333578|P2|Extension - Double-Blind Week 49-156|Death|1
1021038|NCT00293254|3333579|P1|Extension - Double-Blind Week 49-156|Death|4
1021039|NCT00293254|3333578|P2|Extension - Double-Blind Week 49-156|Adverse Event|1
1021040|NCT00293254|3333579|P1|Extension - Double-Blind Week 49-156|Adverse Event|4
1021041|NCT00293254|3333578|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57
1021042|NCT00293254|3333579|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35
1021043|NCT00293254|3333578|P2|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0
1021044|NCT00293254|3333579|P1|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1
1021045|NCT00293254|3333578|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
1021046|NCT00293254|3333579|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5
1021047|NCT00293254|3333578|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
1021048|NCT00293254|3333579|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3
1021049|NCT00293254|3333578|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
1021050|NCT00293254|3333579|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
1021051|NCT00293254|3333578|P2|Primary Study - Double-Blind Week 0-48|Death|2
1021052|NCT00293254|3333579|P1|Primary Study - Double-Blind Week 0-48|Death|5
1021053|NCT00293254|3333578|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
1021054|NCT00293254|3333579|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|2
1021055|NCT00293254|3333578|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
1021056|NCT00293254|3333579|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
1021057|NCT00293241|3333619|P2|Overall Study|Withdrawal by Subject|8
1021058|NCT00293241|3333620|P1|Overall Study|Withdrawal by Subject|4
1021059|NCT00293241|3333619|P2|Overall Study|Physician Decision|17
1021060|NCT00293241|3333620|P1|Overall Study|Physician Decision|23
1021061|NCT00293241|3333619|P2|Overall Study|Lost to Follow-up|16
1021062|NCT00293241|3333620|P1|Overall Study|Lost to Follow-up|9
1021063|NCT00293059|3333664|P2|Overall Study|missing|5
1021064|NCT00293059|3333665|P1|Overall Study|missing|3
1021065|NCT00293059|3333664|P2|Overall Study|Noncompliant - sanitary pads collection|1
1021066|NCT00293059|3333665|P1|Overall Study|Noncompliant - sanitary pads collection|0
1021067|NCT00293059|3333664|P2|Overall Study|Participant stopped study drug|0
1021068|NCT00293059|3333665|P1|Overall Study|Participant stopped study drug|1
1021069|NCT00293059|3333664|P2|Overall Study|Participant moved out of state|0
1021070|NCT00293059|3333665|P1|Overall Study|Participant moved out of state|1
1021071|NCT00293059|3333664|P2|Overall Study|Withdrawal by Subject|5
1021072|NCT00293059|3333665|P1|Overall Study|Withdrawal by Subject|11
1021073|NCT00293059|3333664|P2|Overall Study|Protocol Violation|0
1021074|NCT00293059|3333665|P1|Overall Study|Protocol Violation|2
1021075|NCT00293059|3333664|P2|Overall Study|Pregnancy|1
1021076|NCT00293059|3333665|P1|Overall Study|Pregnancy|1
1021077|NCT00293059|3333664|P2|Overall Study|Lost to Follow-up|3
1021078|NCT00293059|3333665|P1|Overall Study|Lost to Follow-up|2
1021079|NCT00293059|3333664|P2|Overall Study|Lack of Efficacy|0
1021080|NCT00293059|3333665|P1|Overall Study|Lack of Efficacy|2
1021081|NCT00293059|3333664|P2|Overall Study|Adverse Event|4
1021082|NCT00293059|3333665|P1|Overall Study|Adverse Event|12
1021083|NCT00293020|3333777|P1|Overall Study|No dose taken|1
1021084|NCT00293020|3333777|P1|Overall Study|Other Reason|22
1021085|NCT00293020|3333777|P1|Overall Study|Physician Decision|21
1021086|NCT00293020|3333777|P1|Overall Study|Protocol Violation|6
1021087|NCT00293020|3333777|P1|Overall Study|Lost to Follow-up|4
1021088|NCT00293020|3333777|P1|Overall Study|Lack of Efficacy|12
1021089|NCT00293020|3333777|P1|Overall Study|Death|32
1021090|NCT00293020|3333777|P1|Overall Study|Adverse Event|30
1021091|NCT00293020|3333777|P1|Overall Study|Withdrawal by Subject|34
1021092|NCT00292981|3333781|P1|Overall Study|Not specified|3
1021093|NCT00292981|3333781|P1|Overall Study|Withdrawal by Subject|22
1021094|NCT00292981|3333781|P1|Overall Study|Lost to Follow-up|13
1021095|NCT00292981|3333781|P1|Overall Study|Adverse Event|1
1021096|NCT00292942|3333792|P4|Overall Study|Adverse Event|1
1021097|NCT00292942|3333793|P3|Overall Study|Adverse Event|0
1021098|NCT00292942|3333794|P2|Overall Study|Adverse Event|0
1021099|NCT00292942|3333795|P1|Overall Study|Adverse Event|0
1021100|NCT00292942|3333792|P4|Overall Study|Withdrawal by Subject|0
1021101|NCT00292942|3333793|P3|Overall Study|Withdrawal by Subject|1
1021102|NCT00292942|3333794|P2|Overall Study|Withdrawal by Subject|0
1021103|NCT00292942|3333795|P1|Overall Study|Withdrawal by Subject|0
1021104|NCT00292461|3333841|P2|Overall Study|Lost to Follow-up|0
1021105|NCT00292461|3333842|P1|Overall Study|Lost to Follow-up|1
1021106|NCT00292461|3333841|P2|Overall Study|Protocol Violation|3
1021107|NCT00292461|3333842|P1|Overall Study|Protocol Violation|4
1021108|NCT00292461|3333841|P2|Overall Study|Withdrawal by Subject|1
1021109|NCT00292461|3333842|P1|Overall Study|Withdrawal by Subject|0
1021110|NCT00292461|3333841|P2|Overall Study|Lack of Efficacy|0
1021111|NCT00292461|3333842|P1|Overall Study|Lack of Efficacy|1
1021112|NCT00292461|3333841|P2|Overall Study|Adverse Event|2
1021113|NCT00292461|3333842|P1|Overall Study|Adverse Event|4
1021114|NCT00292370|3333857|P3|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5
1021115|NCT00292370|3333858|P2|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1
1021116|NCT00292370|3333859|P1|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0
1021117|NCT00292370|3333857|P3|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2
1021118|NCT00292370|3333858|P2|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3
1021119|NCT00292370|3333859|P1|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0
1021120|NCT00292370|3333857|P3|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
1021121|NCT00292370|3333858|P2|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
1021122|NCT00292370|3333859|P1|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4
1021123|NCT00292370|3333857|P3|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
1021124|NCT00292370|3333858|P2|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
1021125|NCT00292370|3333859|P1|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8
1021126|NCT00292370|3333857|P3|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
1021127|NCT00292370|3333858|P2|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
1021128|NCT00292370|3333859|P1|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22
1021129|NCT00292370|3333857|P3|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
1021130|NCT00292370|3333858|P2|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
1021131|NCT00292370|3333859|P1|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12
1021132|NCT00292318|3333868|P2|Overall Study|Study terminated by officials|1
1021133|NCT00292318|3333869|P1|Overall Study|Study terminated by officials|2
1021134|NCT00292227|3333879|P3|Patch Period|Withdrawal by Subject|1
1021135|NCT00292227|3333880|P2|Patch Period|Withdrawal by Subject|0
1021136|NCT00292227|3333881|P1|Patch Period|Withdrawal by Subject|0
1021137|NCT00292227|3333879|P3|Patch Period|Adverse Event|2
1021138|NCT00292227|3333880|P2|Patch Period|Adverse Event|0
1021139|NCT00292227|3333881|P1|Patch Period|Adverse Event|1
1021140|NCT00292188|3333963|P3|Double-Blind|Laboratory Abnormality|1
1021141|NCT00292188|3333964|P2|Double-Blind|Laboratory Abnormality|0
1021142|NCT00292188|3333965|P1|Double-Blind|Laboratory Abnormality|0
1021143|NCT00292188|3333963|P3|Double-Blind|Withdrawal by Subject|3
1021144|NCT00292188|3333964|P2|Double-Blind|Withdrawal by Subject|0
1021145|NCT00292188|3333965|P1|Double-Blind|Withdrawal by Subject|0
1021146|NCT00292188|3333963|P3|Double-Blind|Other|4
1021147|NCT00292188|3333964|P2|Double-Blind|Other|3
1021148|NCT00292188|3333965|P1|Double-Blind|Other|0
1021149|NCT00292188|3333963|P3|Double-Blind|Lost to Follow-up|0
1021150|NCT00292188|3333964|P2|Double-Blind|Lost to Follow-up|1
1021151|NCT00292188|3333965|P1|Double-Blind|Lost to Follow-up|0
1021152|NCT00292188|3333963|P3|Double-Blind|Lack of Efficacy|12
1021153|NCT00292188|3333964|P2|Double-Blind|Lack of Efficacy|2
1021154|NCT00292188|3333965|P1|Double-Blind|Lack of Efficacy|0
1021155|NCT00292188|3333963|P3|Double-Blind|Adverse Event|9
1021156|NCT00292188|3333964|P2|Double-Blind|Adverse Event|25
1021157|NCT00292188|3333965|P1|Double-Blind|Adverse Event|0
1021158|NCT00292188|3333963|P3|Single-Blind|Did not receive treatment|0
1021159|NCT00292188|3333964|P2|Single-Blind|Did not receive treatment|0
1021160|NCT00292188|3333965|P1|Single-Blind|Did not receive treatment|1
1021161|NCT00292188|3333963|P3|Single-Blind|Withdrawal by Subject|0
1021162|NCT00292188|3333964|P2|Single-Blind|Withdrawal by Subject|0
1021163|NCT00292188|3333965|P1|Single-Blind|Withdrawal by Subject|12
1021164|NCT00292188|3333963|P3|Single-Blind|Other|0
1021165|NCT00292188|3333964|P2|Single-Blind|Other|0
1021166|NCT00292188|3333965|P1|Single-Blind|Other|77
1021167|NCT00292188|3333963|P3|Single-Blind|Lost to Follow-up|0
1021168|NCT00292188|3333964|P2|Single-Blind|Lost to Follow-up|0
1021169|NCT00292188|3333965|P1|Single-Blind|Lost to Follow-up|3
1021170|NCT00292188|3333963|P3|Single-Blind|Laboratory Abnormality|0
1021171|NCT00292188|3333964|P2|Single-Blind|Laboratory Abnormality|0
1021172|NCT00292188|3333965|P1|Single-Blind|Laboratory Abnormality|5
1021173|NCT00292188|3333963|P3|Single-Blind|Lack of Efficacy|0
1021174|NCT00292188|3333964|P2|Single-Blind|Lack of Efficacy|0
1021175|NCT00292188|3333965|P1|Single-Blind|Lack of Efficacy|2
1021176|NCT00292188|3333963|P3|Single-Blind|Adverse Event|0
1021177|NCT00292188|3333964|P2|Single-Blind|Adverse Event|0
1021178|NCT00292188|3333965|P1|Single-Blind|Adverse Event|14
1021179|NCT00291642|3334082|P5|Overall Study|Intake of prohibited medication|0
1021180|NCT00291642|3334083|P4|Overall Study|Intake of prohibited medication|0
1021181|NCT00291642|3334084|P3|Overall Study|Intake of prohibited medication|0
1021182|NCT00291642|3334085|P2|Overall Study|Intake of prohibited medication|0
1021183|NCT00291642|3334086|P1|Overall Study|Intake of prohibited medication|1
1021184|NCT00291642|3334082|P5|Overall Study|Patient missed visit|0
1021185|NCT00291642|3334083|P4|Overall Study|Patient missed visit|0
1021186|NCT00291642|3334084|P3|Overall Study|Patient missed visit|1
1021187|NCT00291642|3334085|P2|Overall Study|Patient missed visit|0
1021188|NCT00291642|3334086|P1|Overall Study|Patient missed visit|0
1021189|NCT00291642|3334082|P5|Overall Study|Adverse Event|1
1021190|NCT00291642|3334083|P4|Overall Study|Adverse Event|0
1021191|NCT00291642|3334084|P3|Overall Study|Adverse Event|1
1021192|NCT00291642|3334085|P2|Overall Study|Adverse Event|0
1021193|NCT00291642|3334086|P1|Overall Study|Adverse Event|1
1021194|NCT00291577|3334138|P1|Overall Study|Lack of Efficacy|14
1021195|NCT00291577|3334138|P1|Overall Study|Withdrawal by Subject|2
1021196|NCT00291577|3334138|P1|Overall Study|Other|4
1021197|NCT00291577|3334138|P1|Overall Study|Adverse Event|1
1021198|NCT00291551|3334157|P1|Overall Study|Withdrawal by Subject|6
1021199|NCT00291551|3334157|P1|Overall Study|Death|7
1021200|NCT00291330|3334205|P2|Overall Study|Other|1
1021201|NCT00291330|3334206|P1|Overall Study|Other|3
1021202|NCT00291330|3334205|P2|Overall Study|Withdrawal by Subject|25
1021203|NCT00291330|3334206|P1|Overall Study|Withdrawal by Subject|22
1021204|NCT00291330|3334205|P2|Overall Study|Lost to Follow-up|11
1021205|NCT00291330|3334206|P1|Overall Study|Lost to Follow-up|16
1021206|NCT00291330|3334205|P2|Overall Study|Protocol Violation|20
1021207|NCT00291330|3334206|P1|Overall Study|Protocol Violation|13
1021208|NCT00291330|3334205|P2|Overall Study|Adverse Event|40
1021209|NCT00291330|3334206|P1|Overall Study|Adverse Event|47
1021210|NCT00291187|3334248|P4|Overall Study|Protocol Violation- No Drug Administered|0
1021211|NCT00291187|3334249|P3|Overall Study|Protocol Violation- No Drug Administered|1
1021212|NCT00291187|3334250|P2|Overall Study|Protocol Violation- No Drug Administered|0
1021213|NCT00291187|3334251|P1|Overall Study|Protocol Violation- No Drug Administered|0
1021214|NCT00291018|3334295|P3|Overall Study|Lost to Follow-up|18
1021215|NCT00291018|3334296|P2|Overall Study|Lost to Follow-up|4
1021216|NCT00291018|3334297|P1|Overall Study|Lost to Follow-up|3
1021217|NCT00291018|3334295|P3|Overall Study|Failures|5
1021218|NCT00291018|3334296|P2|Overall Study|Failures|12
1021219|NCT00291018|3334297|P1|Overall Study|Failures|5
1021220|NCT00291018|3334295|P3|Overall Study|Withdrawal by Subject|1
1021221|NCT00291018|3334296|P2|Overall Study|Withdrawal by Subject|8
1021222|NCT00291018|3334297|P1|Overall Study|Withdrawal by Subject|2
1021223|NCT00291018|3334295|P3|Overall Study|Death|4
1021224|NCT00291018|3334296|P2|Overall Study|Death|3
1021225|NCT00291018|3334297|P1|Overall Study|Death|3
1021226|NCT00291018|3334295|P3|Overall Study|Not Consented or Declined PAS|15
1021227|NCT00291018|3334296|P2|Overall Study|Not Consented or Declined PAS|15
1021228|NCT00291018|3334297|P1|Overall Study|Not Consented or Declined PAS|12
1021229|NCT00290888|3334337|P2|Overall Study|Physician Decision|1
1021230|NCT00290888|3334338|P1|Overall Study|Physician Decision|3
1021231|NCT00290771|3334355|P2|Overall Study|Lost to Follow-up|1
1021232|NCT00290771|3334356|P1|Overall Study|Lost to Follow-up|0
1021233|NCT00290771|3334355|P2|Overall Study|Protocol Violation|0
1021234|NCT00290771|3334356|P1|Overall Study|Protocol Violation|2
1021235|NCT00290771|3334355|P2|Overall Study|Administrative problems|1
1021236|NCT00290771|3334356|P1|Overall Study|Administrative problems|2
1021237|NCT00290771|3334355|P2|Overall Study|Withdrawal by Subject|6
1021238|NCT00290771|3334356|P1|Overall Study|Withdrawal by Subject|5
1021239|NCT00290771|3334355|P2|Overall Study|Adverse Event|6
1021240|NCT00290771|3334356|P1|Overall Study|Adverse Event|12
1021241|NCT00290771|3334355|P2|Overall Study|Death|10
1021242|NCT00290771|3334356|P1|Overall Study|Death|11
1021243|NCT00290771|3334355|P2|Overall Study|Disease progression|73
1021244|NCT00290771|3334356|P1|Overall Study|Disease progression|95
1021245|NCT00290758|3334380|P2|Post Intervention rFNA|<4000 Epithelial Cells|5
1021246|NCT00290758|3334381|P1|Post Intervention rFNA|<4000 Epithelial Cells|6
1021247|NCT00290758|3334380|P2|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1
1021248|NCT00290758|3334381|P1|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0
1021249|NCT00290758|3334380|P2|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0
1021250|NCT00290758|3334381|P1|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1
1021251|NCT00290758|3334380|P2|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5
1021252|NCT00290758|3334381|P1|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0
1021253|NCT00290758|3334380|P2|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
1021254|NCT00290758|3334381|P1|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
1021255|NCT00290758|3334380|P2|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1
1021256|NCT00290758|3334381|P1|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3
1021257|NCT00290758|3334380|P2|Pre-Intervention rFNA Through Follow-Up|ConMeds|0
1021258|NCT00290758|3334381|P1|Pre-Intervention rFNA Through Follow-Up|ConMeds|1
1021259|NCT00290758|3334380|P2|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2
1021260|NCT00290758|3334381|P1|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1
1021261|NCT00290732|3334403|P5|Overall Study|Inability to instill drug intraductally.|0
1021262|NCT00290732|3334404|P4|Overall Study|Inability to instill drug intraductally.|0
1021263|NCT00290732|3334405|P3|Overall Study|Inability to instill drug intraductally.|1
1021264|NCT00290732|3334406|P2|Overall Study|Inability to instill drug intraductally.|1
1021265|NCT00290732|3334407|P1|Overall Study|Inability to instill drug intraductally.|0
1021266|NCT00290693|3334425|P1|Overall Study|Withdrawal by Subject|2
1021267|NCT00290407|3334474|P1|Overall Study|Physician Decision|2
1021268|NCT00290342|3334481|P2|Overall Study|Lost to Follow-up|0
1021269|NCT00290342|3334482|P1|Overall Study|Lost to Follow-up|1
1021270|NCT00290342|3334481|P2|Overall Study|Withdrawal by Subject|4
1021271|NCT00290342|3334482|P1|Overall Study|Withdrawal by Subject|6
1021272|NCT00290342|3334481|P2|Overall Study|Other|1
1021273|NCT00290342|3334482|P1|Overall Study|Other|0
1021274|NCT00290290|3334537|P2|Overall Study|Underwent clean surgical procedure|12
1021275|NCT00290290|3334538|P1|Overall Study|Underwent clean surgical procedure|13
1021276|NCT00290290|3334537|P2|Overall Study|Withdrawal by Subject|2
1021277|NCT00290290|3334538|P1|Overall Study|Withdrawal by Subject|2
1021278|NCT00290290|3334537|P2|Overall Study|Death|4
1021279|NCT00290290|3334538|P1|Overall Study|Death|3
1021280|NCT00290251|3334544|P3|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
1021281|NCT00290251|3334545|P2|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
1021282|NCT00290251|3334546|P1|Treatment 2 (Months 4 - 6)|Lost to Follow-up|2
1021283|NCT00290251|3334544|P3|Treatment 1 (Months 1 - 3)|Out of body experience|0
1021284|NCT00290251|3334545|P2|Treatment 1 (Months 1 - 3)|Out of body experience|0
1021285|NCT00290251|3334546|P1|Treatment 1 (Months 1 - 3)|Out of body experience|1
1021286|NCT00290251|3334544|P3|Treatment 1 (Months 1 - 3)|headache|0
1021287|NCT00290251|3334545|P2|Treatment 1 (Months 1 - 3)|headache|1
1021288|NCT00290251|3334546|P1|Treatment 1 (Months 1 - 3)|headache|0
1021289|NCT00290251|3334544|P3|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|2
1021290|NCT00290251|3334545|P2|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
1021291|NCT00290251|3334546|P1|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
1021292|NCT00290238|3334558|P2|Overall Study|Withdrawal by Subject|13
1021293|NCT00290238|3334559|P1|Overall Study|Withdrawal by Subject|15
1021294|NCT00290238|3334558|P2|Overall Study|Lost to Follow-up|1
1021295|NCT00290238|3334559|P1|Overall Study|Lost to Follow-up|0
1021296|NCT00290238|3334558|P2|Overall Study|Study terminated|27
1021297|NCT00290238|3334559|P1|Overall Study|Study terminated|27
1021298|NCT00290186|3334584|P2|Overall Study|Withdrawal by Subject|1
1021299|NCT00290186|3334585|P1|Overall Study|Withdrawal by Subject|0
1021300|NCT00290186|3334584|P2|Overall Study|Study was terminated prior to 3-month te|1
1021301|NCT00290186|3334585|P1|Overall Study|Study was terminated prior to 3-month te|1
1021302|NCT00290186|3334584|P2|Overall Study|Lost to Follow-up|2
1021303|NCT00290186|3334585|P1|Overall Study|Lost to Follow-up|3
1021304|NCT00290186|3334584|P2|Overall Study|Adverse Event|1
1021305|NCT00290186|3334585|P1|Overall Study|Adverse Event|1
1021306|NCT00289991|3334636|P2|Overall Study|Other|14
1021307|NCT00289991|3334637|P1|Overall Study|Other|5
1021308|NCT00289991|3334636|P2|Overall Study|Withdrawal by Subject|12
1021309|NCT00289991|3334637|P1|Overall Study|Withdrawal by Subject|2
1021310|NCT00289991|3334636|P2|Overall Study|Lost to Follow-up|1
1021311|NCT00289991|3334637|P1|Overall Study|Lost to Follow-up|0
1021312|NCT00289991|3334636|P2|Overall Study|Fungal breakthrough infection|1
1021313|NCT00289991|3334637|P1|Overall Study|Fungal breakthrough infection|0
1021314|NCT00289991|3334636|P2|Overall Study|Failure of prophylaxis|1
1021315|NCT00289991|3334637|P1|Overall Study|Failure of prophylaxis|1
1021316|NCT00289991|3334636|P2|Overall Study|Adverse Event|13
1021317|NCT00289991|3334637|P1|Overall Study|Adverse Event|15
1021318|NCT00289991|3334636|P2|Overall Study|Death|38
1021319|NCT00289991|3334637|P1|Overall Study|Death|35
1021320|NCT00289978|3334662|P3|Overall Study|Death|2
1021321|NCT00289978|3334663|P2|Overall Study|Death|0
1021322|NCT00289978|3334664|P1|Overall Study|Death|1
1021323|NCT00289978|3334662|P3|Overall Study|Abnormal test procedure result(s)|1
1021324|NCT00289978|3334663|P2|Overall Study|Abnormal test procedure result(s)|1
1021325|NCT00289978|3334664|P1|Overall Study|Abnormal test procedure result(s)|2
1021326|NCT00289978|3334662|P3|Overall Study|Protocol Violation|4
1021327|NCT00289978|3334663|P2|Overall Study|Protocol Violation|5
1021328|NCT00289978|3334664|P1|Overall Study|Protocol Violation|5
1021329|NCT00289978|3334662|P3|Overall Study|Lost to Follow-up|7
1021330|NCT00289978|3334663|P2|Overall Study|Lost to Follow-up|5
1021331|NCT00289978|3334664|P1|Overall Study|Lost to Follow-up|3
1021332|NCT00289978|3334662|P3|Overall Study|Abnormal laboratory value(s)|1
1021333|NCT00289978|3334663|P2|Overall Study|Abnormal laboratory value(s)|9
1021334|NCT00289978|3334664|P1|Overall Study|Abnormal laboratory value(s)|20
1021335|NCT00289978|3334662|P3|Overall Study|Lack of Efficacy|25
1021336|NCT00289978|3334663|P2|Overall Study|Lack of Efficacy|6
1021337|NCT00289978|3334664|P1|Overall Study|Lack of Efficacy|13
1021338|NCT00289978|3334662|P3|Overall Study|Adverse Event|18
1021339|NCT00289978|3334663|P2|Overall Study|Adverse Event|13
1021340|NCT00289978|3334664|P1|Overall Study|Adverse Event|22
1021341|NCT00289978|3334662|P3|Overall Study|Withdrawal by Subject|28
1021342|NCT00289978|3334663|P2|Overall Study|Withdrawal by Subject|17
1021343|NCT00289978|3334664|P1|Overall Study|Withdrawal by Subject|31
1021344|NCT00289913|3334683|P5|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
1021345|NCT00289913|3334684|P4|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
1021346|NCT00289913|3334685|P3|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
1021347|NCT00289913|3334686|P2|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1
1021348|NCT00289913|3334687|P1|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
1021349|NCT00289913|3334683|P5|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1
1021350|NCT00289913|3334684|P4|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
1021351|NCT00289913|3334685|P3|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
1021352|NCT00289913|3334686|P2|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
1021353|NCT00289913|3334687|P1|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
1021354|NCT00289913|3334683|P5|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
1021355|NCT00289913|3334684|P4|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
1021356|NCT00289913|3334685|P3|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
1021357|NCT00289913|3334686|P2|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
1021358|NCT00289913|3334687|P1|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
1021359|NCT00289913|3334683|P5|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4
1021360|NCT00289913|3334684|P4|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
1021361|NCT00289913|3334685|P3|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0
1021362|NCT00289913|3334686|P2|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2
1021363|NCT00289913|3334687|P1|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
1021364|NCT00289913|3334683|P5|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1
1021365|NCT00289913|3334684|P4|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
1021366|NCT00289913|3334685|P3|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
1021367|NCT00289913|3334686|P2|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
1021368|NCT00289913|3334687|P1|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
1021369|NCT00289913|3334683|P5|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
1021370|NCT00289913|3334684|P4|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1
1021371|NCT00289913|3334685|P3|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
1021372|NCT00289913|3334686|P2|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
1021373|NCT00289913|3334687|P1|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
1021374|NCT00289913|3334683|P5|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
1021375|NCT00289913|3334684|P4|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
1021376|NCT00289913|3334685|P3|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1
1021377|NCT00289913|3334686|P2|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3
1021378|NCT00289913|3334687|P1|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8
1021379|NCT00289913|3334683|P5|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1021380|NCT00289913|3334684|P4|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1021381|NCT00289913|3334685|P3|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1021382|NCT00289913|3334686|P2|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1
1021383|NCT00289913|3334687|P1|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1021384|NCT00289913|3334683|P5|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9
1021385|NCT00289913|3334684|P4|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
1021386|NCT00289913|3334685|P3|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
1021387|NCT00289913|3334686|P2|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
1021388|NCT00289913|3334687|P1|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
1021389|NCT00289913|3334683|P5|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7
1021390|NCT00289913|3334684|P4|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
1021391|NCT00289913|3334685|P3|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
1021392|NCT00289913|3334686|P2|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
1021393|NCT00289913|3334687|P1|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
1021394|NCT00289913|3334683|P5|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6
1021395|NCT00289913|3334684|P4|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
1021396|NCT00289913|3334685|P3|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
1021397|NCT00289913|3334686|P2|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
1021398|NCT00289913|3334687|P1|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
1021399|NCT00289913|3334683|P5|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11
1021400|NCT00289913|3334684|P4|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
1021401|NCT00289913|3334685|P3|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
1021402|NCT00289913|3334686|P2|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
1021403|NCT00289913|3334687|P1|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
1021404|NCT00289913|3334683|P5|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7
1021405|NCT00289913|3334684|P4|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
1021406|NCT00289913|3334685|P3|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
1021407|NCT00289913|3334686|P2|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
1021408|NCT00289913|3334687|P1|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
1021409|NCT00289913|3334683|P5|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
1021410|NCT00289913|3334684|P4|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
1021411|NCT00289913|3334685|P3|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
1021412|NCT00289913|3334686|P2|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
1021413|NCT00289913|3334687|P1|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1
1021414|NCT00289913|3334683|P5|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
1021415|NCT00289913|3334684|P4|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
1021416|NCT00289913|3334685|P3|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2
1021417|NCT00289913|3334686|P2|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1
1021418|NCT00289913|3334687|P1|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
1021419|NCT00289913|3334683|P5|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
1021420|NCT00289913|3334684|P4|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3
1021421|NCT00289913|3334685|P3|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
1021422|NCT00289913|3334686|P2|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5
1021423|NCT00289913|3334687|P1|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2
1021424|NCT00289913|3334683|P5|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
1021425|NCT00289913|3334684|P4|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
1021426|NCT00289913|3334685|P3|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3
1021427|NCT00289913|3334686|P2|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
1021428|NCT00289913|3334687|P1|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
1021429|NCT00289913|3334683|P5|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
1021430|NCT00289913|3334684|P4|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
1021431|NCT00289913|3334685|P3|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
1021432|NCT00289913|3334686|P2|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
1021433|NCT00289913|3334687|P1|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
1021434|NCT00289913|3334683|P5|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
1021435|NCT00289913|3334684|P4|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
1021436|NCT00289913|3334685|P3|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1
1021437|NCT00289913|3334686|P2|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2
1021438|NCT00289913|3334687|P1|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3
1021439|NCT00289913|3334683|P5|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
1021440|NCT00289913|3334684|P4|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
1021441|NCT00289913|3334685|P3|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
1021442|NCT00289913|3334686|P2|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1
1021443|NCT00289913|3334687|P1|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
1021444|NCT00289913|3334683|P5|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0
1021445|NCT00289913|3334684|P4|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
1021446|NCT00289913|3334685|P3|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
1021447|NCT00289913|3334686|P2|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11
1021448|NCT00289913|3334687|P1|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8
1021449|NCT00289913|3334683|P5|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1021450|NCT00289913|3334684|P4|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1021451|NCT00289913|3334685|P3|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1
1021452|NCT00289913|3334686|P2|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1021453|NCT00289913|3334687|P1|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1021454|NCT00289913|3334683|P5|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
1021455|NCT00289913|3334684|P4|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
1021456|NCT00289913|3334685|P3|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2
1021457|NCT00289913|3334686|P2|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
1021458|NCT00289913|3334687|P1|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1
1021459|NCT00289913|3334683|P5|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
1021460|NCT00289913|3334684|P4|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6
1021461|NCT00289913|3334685|P3|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5
1021462|NCT00289913|3334686|P2|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8
1021463|NCT00289913|3334687|P1|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
1021464|NCT00289913|3334683|P5|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5
1021465|NCT00289913|3334684|P4|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
1021466|NCT00289913|3334685|P3|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
1021467|NCT00289913|3334686|P2|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1
1021468|NCT00289913|3334687|P1|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2
1021469|NCT00289913|3334683|P5|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
1021470|NCT00289913|3334684|P4|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
1021471|NCT00289913|3334685|P3|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
1021472|NCT00289913|3334686|P2|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2
1021473|NCT00289913|3334687|P1|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1
1021474|NCT00289913|3334683|P5|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
1021475|NCT00289913|3334684|P4|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1
1021476|NCT00289913|3334685|P3|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
1021477|NCT00289913|3334686|P2|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
1021478|NCT00289913|3334687|P1|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
1021479|NCT00289913|3334683|P5|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1
1021480|NCT00289913|3334684|P4|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
1021481|NCT00289913|3334685|P3|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
1021482|NCT00289913|3334686|P2|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
1021483|NCT00289913|3334687|P1|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
1021484|NCT00289913|3334683|P5|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
1021485|NCT00289913|3334684|P4|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
1021486|NCT00289913|3334685|P3|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0
1021487|NCT00289913|3334686|P2|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
1021488|NCT00289913|3334687|P1|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
1021489|NCT00289913|3334683|P5|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1
1021490|NCT00289913|3334684|P4|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
1021491|NCT00289913|3334685|P3|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
1021492|NCT00289913|3334686|P2|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
1021493|NCT00289913|3334687|P1|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3
1021494|NCT00289913|3334683|P5|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1021495|NCT00289913|3334684|P4|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1021496|NCT00289913|3334685|P3|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1021497|NCT00289913|3334686|P2|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1
1021498|NCT00289913|3334687|P1|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1021499|NCT00289900|3334718|P6|Overall Study|Not treated|0
1021500|NCT00289900|3334719|P5|Overall Study|Not treated|0
1021501|NCT00289900|3334720|P4|Overall Study|Not treated|0
1021502|NCT00289900|3334721|P3|Overall Study|Not treated|0
1021503|NCT00289900|3334722|P2|Overall Study|Not treated|1
1021504|NCT00289900|3334723|P1|Overall Study|Not treated|0
1021505|NCT00289900|3334718|P6|Overall Study|site terminated|0
1021506|NCT00289900|3334719|P5|Overall Study|site terminated|0
1021507|NCT00289900|3334720|P4|Overall Study|site terminated|0
1021508|NCT00289900|3334721|P3|Overall Study|site terminated|1
1021509|NCT00289900|3334722|P2|Overall Study|site terminated|0
1021510|NCT00289900|3334723|P1|Overall Study|site terminated|1
1021511|NCT00289900|3334718|P6|Overall Study|Protocol Violation|4
1021512|NCT00289900|3334719|P5|Overall Study|Protocol Violation|7
1021513|NCT00289900|3334720|P4|Overall Study|Protocol Violation|6
1021514|NCT00289900|3334721|P3|Overall Study|Protocol Violation|2
1021515|NCT00289900|3334722|P2|Overall Study|Protocol Violation|9
1021516|NCT00289900|3334723|P1|Overall Study|Protocol Violation|3
1021517|NCT00289900|3334718|P6|Overall Study|Withdrawal by Subject|11
1021518|NCT00289900|3334719|P5|Overall Study|Withdrawal by Subject|12
1021519|NCT00289900|3334720|P4|Overall Study|Withdrawal by Subject|18
1021520|NCT00289900|3334721|P3|Overall Study|Withdrawal by Subject|8
1021521|NCT00289900|3334722|P2|Overall Study|Withdrawal by Subject|21
1021522|NCT00289900|3334723|P1|Overall Study|Withdrawal by Subject|10
1021523|NCT00289900|3334718|P6|Overall Study|Participant moved|1
1021524|NCT00289900|3334719|P5|Overall Study|Participant moved|1
1021525|NCT00289900|3334720|P4|Overall Study|Participant moved|1
1021526|NCT00289900|3334721|P3|Overall Study|Participant moved|0
1021527|NCT00289900|3334722|P2|Overall Study|Participant moved|0
1021528|NCT00289900|3334723|P1|Overall Study|Participant moved|1
1021529|NCT00289900|3334718|P6|Overall Study|Other|0
1021530|NCT00289900|3334719|P5|Overall Study|Other|1
1021531|NCT00289900|3334720|P4|Overall Study|Other|5
1021532|NCT00289900|3334721|P3|Overall Study|Other|0
1021533|NCT00289900|3334722|P2|Overall Study|Other|0
1021534|NCT00289900|3334723|P1|Overall Study|Other|0
1021535|NCT00289900|3334718|P6|Overall Study|Participant had flushing|4
1021536|NCT00289900|3334719|P5|Overall Study|Participant had flushing|0
1021537|NCT00289900|3334720|P4|Overall Study|Participant had flushing|2
1021538|NCT00289900|3334721|P3|Overall Study|Participant had flushing|1
1021539|NCT00289900|3334722|P2|Overall Study|Participant had flushing|42
1021540|NCT00289900|3334723|P1|Overall Study|Participant had flushing|18
1021541|NCT00289900|3334718|P6|Overall Study|Lost to Follow-up|8
1021542|NCT00289900|3334719|P5|Overall Study|Lost to Follow-up|4
1021543|NCT00289900|3334720|P4|Overall Study|Lost to Follow-up|8
1021544|NCT00289900|3334721|P3|Overall Study|Lost to Follow-up|8
1021545|NCT00289900|3334722|P2|Overall Study|Lost to Follow-up|7
1021546|NCT00289900|3334723|P1|Overall Study|Lost to Follow-up|7
1021547|NCT00289900|3334718|P6|Overall Study|Adverse Event|33
1021548|NCT00289900|3334719|P5|Overall Study|Adverse Event|20
1021549|NCT00289900|3334720|P4|Overall Study|Adverse Event|19
1021550|NCT00289900|3334721|P3|Overall Study|Adverse Event|13
1021551|NCT00289900|3334722|P2|Overall Study|Adverse Event|40
1021552|NCT00289900|3334723|P1|Overall Study|Adverse Event|28
1021553|NCT00289887|3334827|P2|Overall Study|Other|3
1021554|NCT00289887|3334828|P1|Overall Study|Other|7
1021555|NCT00289887|3334827|P2|Overall Study|Withdrawal by Subject|8
1021556|NCT00289887|3334828|P1|Overall Study|Withdrawal by Subject|3
1021557|NCT00289887|3334827|P2|Overall Study|Protocol Violation|1
1021558|NCT00289887|3334828|P1|Overall Study|Protocol Violation|3
1021559|NCT00289887|3334827|P2|Overall Study|Lost to Follow-up|3
1021560|NCT00289887|3334828|P1|Overall Study|Lost to Follow-up|3
1021561|NCT00289887|3334827|P2|Overall Study|Lack of Efficacy|11
1021562|NCT00289887|3334828|P1|Overall Study|Lack of Efficacy|3
1021563|NCT00289887|3334827|P2|Overall Study|Adverse Event|3
1021564|NCT00289887|3334828|P1|Overall Study|Adverse Event|3
1021565|NCT00289874|3334846|P2|Overall Study|Did not meet eligibility|0
1021566|NCT00289874|3334847|P1|Overall Study|Did not meet eligibility|1
1021567|NCT00289874|3334846|P2|Overall Study|Protocol Violation|2
1021568|NCT00289874|3334847|P1|Overall Study|Protocol Violation|3
1021569|NCT00289874|3334846|P2|Overall Study|Lost to Follow-up|1
1021570|NCT00289874|3334847|P1|Overall Study|Lost to Follow-up|1
1021571|NCT00289874|3334846|P2|Overall Study|Adverse Event|5
1021572|NCT00289874|3334847|P1|Overall Study|Adverse Event|1
1021573|NCT00289848|3334857|P2|Overall Study|Open-Label AHA Treatment Requested|1
1021574|NCT00289848|3334858|P1|Overall Study|Open-Label AHA Treatment Requested|0
1021575|NCT00289848|3334857|P2|Overall Study|Patient Moved|2
1021576|NCT00289848|3334858|P1|Overall Study|Patient Moved|6
1021577|NCT00289848|3334857|P2|Overall Study|Withdrawal by Subject|11
1021578|NCT00289848|3334858|P1|Overall Study|Withdrawal by Subject|5
1021579|NCT00289848|3334857|P2|Overall Study|Protocol Violation|2
1021580|NCT00289848|3334858|P1|Overall Study|Protocol Violation|5
1021581|NCT00289848|3334857|P2|Overall Study|Lost to Follow-up|1
1021582|NCT00289848|3334858|P1|Overall Study|Lost to Follow-up|3
1021583|NCT00289848|3334857|P2|Overall Study|Lack of Efficacy|24
1021584|NCT00289848|3334858|P1|Overall Study|Lack of Efficacy|20
1021585|NCT00289848|3334857|P2|Overall Study|Death|0
1021586|NCT00289848|3334858|P1|Overall Study|Death|1
1021587|NCT00289848|3334857|P2|Overall Study|Adverse Event|4
1021588|NCT00289848|3334858|P1|Overall Study|Adverse Event|6
1021589|NCT00289783|3334870|P2|Fourth Dose Phase|Other|10
1021590|NCT00289783|3334871|P1|Fourth Dose Phase|Other|22
1021591|NCT00289783|3334870|P2|Fourth Dose Phase|Migration from the study area|1
1021592|NCT00289783|3334871|P1|Fourth Dose Phase|Migration from the study area|1
1021593|NCT00289783|3334870|P2|Fourth Dose Phase|Lost to Follow-up|12
1021594|NCT00289783|3334871|P1|Fourth Dose Phase|Lost to Follow-up|53
1021595|NCT00289783|3334870|P2|Fourth Dose Phase|Withdrawal by Subject|1
1021596|NCT00289783|3334871|P1|Fourth Dose Phase|Withdrawal by Subject|10
1021597|NCT00289783|3334870|P2|Fourth Dose Phase|Adverse Event|0
1021598|NCT00289783|3334871|P1|Fourth Dose Phase|Adverse Event|1
1021599|NCT00289783|3334870|P2|Primary Phase|Other|12
1021600|NCT00289783|3334871|P1|Primary Phase|Other|32
1021601|NCT00289783|3334870|P2|Primary Phase|Migration from the study area|10
1021602|NCT00289783|3334871|P1|Primary Phase|Migration from the study area|26
1021603|NCT00289783|3334870|P2|Primary Phase|Lost to Follow-up|14
1021604|NCT00289783|3334871|P1|Primary Phase|Lost to Follow-up|60
1021605|NCT00289783|3334870|P2|Primary Phase|Withdrawal by Subject|40
1021606|NCT00289783|3334871|P1|Primary Phase|Withdrawal by Subject|93
1021607|NCT00289783|3334870|P2|Primary Phase|Protocol Violation|6
1021608|NCT00289783|3334871|P1|Primary Phase|Protocol Violation|27
1021609|NCT00289783|3334870|P2|Primary Phase|Adverse Event|1
1021610|NCT00289783|3334871|P1|Primary Phase|Adverse Event|10
1021611|NCT00289770|3335049|P1|Year 15|Withdrawal by Subject|1
1021612|NCT00289731|3335095|P3|Overall Study|Other|0
1021613|NCT00289731|3335096|P2|Overall Study|Other|0
1021614|NCT00289731|3335097|P1|Overall Study|Other|1
1021615|NCT00289731|3335095|P3|Overall Study|Adverse Event|2
1021616|NCT00289731|3335096|P2|Overall Study|Adverse Event|2
1021617|NCT00289731|3335097|P1|Overall Study|Adverse Event|1
1021618|NCT00289536|3335209|P3|Period 3|Lost to Follow-up|1
1021619|NCT00289536|3335210|P2|Period 3|Lost to Follow-up|0
1021620|NCT00289536|3335211|P1|Period 3|Lost to Follow-up|0
1021621|NCT00289458|3335257|P3|Overall Study|Withdrawal by Subject|4
1021622|NCT00289458|3335258|P2|Overall Study|Withdrawal by Subject|2
1021623|NCT00289458|3335259|P1|Overall Study|Withdrawal by Subject|2
1021624|NCT00289458|3335257|P3|Overall Study|Physician Decision|2
1021625|NCT00289458|3335258|P2|Overall Study|Physician Decision|4
1021626|NCT00289458|3335259|P1|Overall Study|Physician Decision|3
1021627|NCT00289458|3335257|P3|Overall Study|Death|0
1021628|NCT00289458|3335258|P2|Overall Study|Death|0
1021629|NCT00289458|3335259|P1|Overall Study|Death|1
1021630|NCT00289289|3335320|P3|Overall Study|Other Exit Reason|12
1021631|NCT00289289|3335321|P2|Overall Study|Other Exit Reason|4
1021632|NCT00289289|3335322|P1|Overall Study|Other Exit Reason|6
1021633|NCT00289289|3335320|P3|Overall Study|Did not meet inclusion/exclusion|6
1021634|NCT00289289|3335321|P2|Overall Study|Did not meet inclusion/exclusion|0
1021635|NCT00289289|3335322|P1|Overall Study|Did not meet inclusion/exclusion|0
1021636|NCT00289289|3335320|P3|Overall Study|Non-study device implanted|3
1021637|NCT00289289|3335321|P2|Overall Study|Non-study device implanted|1
1021638|NCT00289289|3335322|P1|Overall Study|Non-study device implanted|2
1021639|NCT00289289|3335320|P3|Overall Study|Physician Decision|6
1021640|NCT00289289|3335321|P2|Overall Study|Physician Decision|0
1021641|NCT00289289|3335322|P1|Overall Study|Physician Decision|1
1021642|NCT00289289|3335320|P3|Overall Study|No implant attempted|1
1021643|NCT00289289|3335321|P2|Overall Study|No implant attempted|0
1021644|NCT00289289|3335322|P1|Overall Study|No implant attempted|0
1021645|NCT00289289|3335320|P3|Overall Study|Death|5
1021646|NCT00289289|3335321|P2|Overall Study|Death|2
1021647|NCT00289289|3335322|P1|Overall Study|Death|4
1021648|NCT00289289|3335320|P3|Overall Study|Lost to Follow-up|1
1021649|NCT00289289|3335321|P2|Overall Study|Lost to Follow-up|0
1021650|NCT00289289|3335322|P1|Overall Study|Lost to Follow-up|1
1021651|NCT00289289|3335320|P3|Overall Study|Withdrawal by Subject|15
1021652|NCT00289289|3335321|P2|Overall Study|Withdrawal by Subject|3
1021653|NCT00289289|3335322|P1|Overall Study|Withdrawal by Subject|5
1021654|NCT00289276|3335337|P2|Second Part of FAST Study (Expansion)|Lost to Follow-up|1
1021655|NCT00289276|3335338|P1|Second Part of FAST Study (Expansion)|Lost to Follow-up|0
1021656|NCT00289276|3335337|P2|Second Part of FAST Study (Expansion)|Death|2
1021657|NCT00289276|3335338|P1|Second Part of FAST Study (Expansion)|Death|0
1021658|NCT00289198|3335373|P2|Overall Study|Other: Impossible to come on visit|1
1021659|NCT00289198|3335374|P1|Overall Study|Other: Impossible to come on visit|0
1021660|NCT00289198|3335373|P2|Overall Study|Other: Miscalculation of the visit date|22
1021661|NCT00289198|3335374|P1|Overall Study|Other: Miscalculation of the visit date|21
1021662|NCT00289198|3335373|P2|Overall Study|Other: Unable to attend on schedule|1
1021663|NCT00289198|3335374|P1|Overall Study|Other: Unable to attend on schedule|2
1021664|NCT00289198|3335373|P2|Overall Study|Other: Physician's decision|1
1021665|NCT00289198|3335374|P1|Overall Study|Other: Physician's decision|0
1021666|NCT00289198|3335373|P2|Overall Study|Other: Low compliance|1
1021667|NCT00289198|3335374|P1|Overall Study|Other: Low compliance|0
1021668|NCT00289198|3335373|P2|Overall Study|Lack of Efficacy|0
1021669|NCT00289198|3335374|P1|Overall Study|Lack of Efficacy|2
1021670|NCT00289198|3335373|P2|Overall Study|Withdrawal by Subject|1
1021671|NCT00289198|3335374|P1|Overall Study|Withdrawal by Subject|4
1021672|NCT00289198|3335373|P2|Overall Study|Protocol Violation|1
1021673|NCT00289198|3335374|P1|Overall Study|Protocol Violation|2
1021674|NCT00289198|3335373|P2|Overall Study|Adverse Event|2
1021675|NCT00289198|3335374|P1|Overall Study|Adverse Event|0
1021676|NCT00289185|3335424|P2|Overall Study|Death|1
1021677|NCT00289185|3335425|P1|Overall Study|Death|1
1021678|NCT00289185|3335424|P2|Overall Study|Lost to Follow-up|17
1021679|NCT00289185|3335425|P1|Overall Study|Lost to Follow-up|23
1021680|NCT00289185|3335424|P2|Overall Study|Withdrawal by Subject|8
1021681|NCT00289185|3335425|P1|Overall Study|Withdrawal by Subject|4
1021682|NCT00289133|3335472|P2|Overall Study|Lost to Follow-up|115
1021683|NCT00289133|3335473|P1|Overall Study|Lost to Follow-up|92
1021684|NCT00289133|3335472|P2|Overall Study|Revision|6
1021685|NCT00289133|3335473|P1|Overall Study|Revision|8
1021686|NCT00289133|3335472|P2|Overall Study|Physician Decision|45
1021687|NCT00289133|3335473|P1|Overall Study|Physician Decision|41
1021688|NCT00289133|3335472|P2|Overall Study|Lost to Follow-up - Hurricane Katri|74
1021689|NCT00289133|3335473|P1|Overall Study|Lost to Follow-up - Hurricane Katri|73
1021690|NCT00289133|3335472|P2|Overall Study|Death|10
1021691|NCT00289133|3335473|P1|Overall Study|Death|5
1021692|NCT00289133|3335472|P2|Overall Study|Withdrawal by Subject|10
1021693|NCT00289133|3335473|P1|Overall Study|Withdrawal by Subject|9
1021694|NCT00289133|3335472|P2|Overall Study|Protocol Violation|38
1021695|NCT00289133|3335473|P1|Overall Study|Protocol Violation|32
1021696|NCT00289133|3335472|P2|Overall Study|Non-study device implanted|0
1021697|NCT00289133|3335473|P1|Overall Study|Non-study device implanted|12
1021698|NCT00289016|3335529|P1|Overall Study|Other|1
1021699|NCT00289016|3335529|P1|Overall Study|Adverse Event|1
1021700|NCT00289016|3335529|P1|Overall Study|Withdrawal by Subject|2
1021701|NCT00289016|3335529|P1|Overall Study|Unrelated Medical Condition or Accident|2
1021702|NCT00289016|3335529|P1|Overall Study|Death|2
1021703|NCT00289016|3335529|P1|Overall Study|Disease Progression|29
1021704|NCT00288912|3335541|P3|Overall Study|Withdrawal by Subject|12
1021705|NCT00288912|3335542|P2|Overall Study|Withdrawal by Subject|5
1021706|NCT00288912|3335543|P1|Overall Study|Withdrawal by Subject|4
1021707|NCT00288912|3335541|P3|Overall Study|Lost to Follow-up|9
1021708|NCT00288912|3335542|P2|Overall Study|Lost to Follow-up|6
1021709|NCT00288912|3335543|P1|Overall Study|Lost to Follow-up|9
1021710|NCT00288912|3335541|P3|Overall Study|Developed exclusion criterion|7
1021711|NCT00288912|3335542|P2|Overall Study|Developed exclusion criterion|6
1021712|NCT00288912|3335543|P1|Overall Study|Developed exclusion criterion|4
1021713|NCT00288860|3335583|P2|Overall Study|Lost to Follow-up|71
1021714|NCT00288860|3335584|P1|Overall Study|Lost to Follow-up|74
1021715|NCT00288860|3335583|P2|Overall Study|Withdrawal by Subject|15
1021716|NCT00288860|3335584|P1|Overall Study|Withdrawal by Subject|20
1021717|NCT00288860|3335583|P2|Overall Study|Death|3
1021718|NCT00288860|3335584|P1|Overall Study|Death|4
1021719|NCT00288860|3335583|P2|Overall Study|Did not complete intake|8
1021720|NCT00288860|3335584|P1|Overall Study|Did not complete intake|4
1021721|NCT00288704|3335597|P3|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1
1021722|NCT00288704|3335598|P2|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
1021723|NCT00288704|3335599|P1|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
1021724|NCT00288704|3335597|P3|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15
1021725|NCT00288704|3335598|P2|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
1021726|NCT00288704|3335599|P1|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
1021727|NCT00288704|3335597|P3|Open-Label Extension (OLE) Weeks 24-117|Death|2
1021728|NCT00288704|3335598|P2|Open-Label Extension (OLE) Weeks 24-117|Death|0
1021729|NCT00288704|3335599|P1|Open-Label Extension (OLE) Weeks 24-117|Death|0
1021730|NCT00288704|3335597|P3|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1
1021731|NCT00288704|3335598|P2|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
1021732|NCT00288704|3335599|P1|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
1021733|NCT00288704|3335597|P3|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1
1021734|NCT00288704|3335598|P2|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
1021735|NCT00288704|3335599|P1|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
1021736|NCT00288704|3335597|P3|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
1021737|NCT00288704|3335598|P2|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1
1021738|NCT00288704|3335599|P1|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
1021739|NCT00288704|3335597|P3|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
1021740|NCT00288704|3335598|P2|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1
1021741|NCT00288704|3335599|P1|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
1021742|NCT00288639|3335626|P1|Overall Study|Other|1
1021743|NCT00288639|3335626|P1|Overall Study|Withdrawal by Subject|2
1021744|NCT00288639|3335626|P1|Overall Study|Lack of Efficacy|4
1021745|NCT00288639|3335626|P1|Overall Study|Adverse Event|5
1021746|NCT00288626|3335643|P1|Overall Study|Withdrawal by Subject|4
1021747|NCT00288626|3335643|P1|Overall Study|Death|3
1021748|NCT00288587|3335677|P2|Overall Study|Severe Aortic Stenosis|0
1021749|NCT00288587|3335678|P1|Overall Study|Severe Aortic Stenosis|1
1021750|NCT00288587|3335677|P2|Overall Study|Physician Decision|2
1021751|NCT00288587|3335678|P1|Overall Study|Physician Decision|0
1021752|NCT00288587|3335677|P2|Overall Study|Adverse Event|1
1021753|NCT00288587|3335678|P1|Overall Study|Adverse Event|0
1021754|NCT00288587|3335677|P2|Overall Study|Transplant|3
1021755|NCT00288587|3335678|P1|Overall Study|Transplant|0
1021756|NCT00288587|3335677|P2|Overall Study|Death|4
1021757|NCT00288587|3335678|P1|Overall Study|Death|4
1021758|NCT00288509|3335721|P1|Treatment Cycle 4|Treatment stopped according to protocol|1
1021759|NCT00288509|3335721|P1|Treatment Cycle 4|Physician Decision|4
1021760|NCT00288509|3335721|P1|Treatment Cycle 4|Withdrawal by Subject|3
1021761|NCT00288509|3335721|P1|Treatment Cycle 3|Treatment stopped according to protocol|1
1021762|NCT00288509|3335721|P1|Treatment Cycle 3|Lost to Follow-up|2
1021763|NCT00288509|3335721|P1|Treatment Cycle 3|Withdrawal by Subject|1
1021764|NCT00288509|3335721|P1|Treatment Cycle 3|Lack of Efficacy|1
1021765|NCT00288509|3335721|P1|Treatment Cycle 2|Withdrawal by Subject|2
1021766|NCT00288509|3335721|P1|Treatment Cycle 2|Lack of Efficacy|1
1021767|NCT00288509|3335721|P1|Treatment Cycle 1|Treatment stopped according to protocol|1
1021768|NCT00288509|3335721|P1|Treatment Cycle 1|Lost to Follow-up|2
1021769|NCT00288509|3335721|P1|Treatment Cycle 1|Withdrawal by Subject|1
1021770|NCT00288509|3335721|P1|Treatment Cycle 1|Lack of Efficacy|1
1021771|NCT00288509|3335721|P1|Treatment Cycle 1|Adverse Event|1
1021772|NCT00288080|3335730|P2|Overall Study|Protocol Violation|20
1021773|NCT00288080|3335731|P1|Overall Study|Protocol Violation|25
1021774|NCT00288080|3335730|P2|Overall Study|Withdrawal by Subject|3
1021775|NCT00288080|3335731|P1|Overall Study|Withdrawal by Subject|1
1021776|NCT00288054|3335753|P1|Overall Study|Not protocol specified|2
1021777|NCT00288054|3335753|P1|Overall Study|Withdrawal by Subject|1
1021778|NCT00288054|3335753|P1|Overall Study|Adverse Event|3
1021779|NCT00288054|3335753|P1|Overall Study|Lack of Efficacy|16
1021780|NCT00288054|3335753|P1|Overall Study|Protocol Violation|2
1021781|NCT00288015|3335761|P1|Follow up for Survival x 2 Years|Other|9
1021782|NCT00288015|3335761|P1|Follow up for Survival x 2 Years|Lost to Follow-up|4
1021783|NCT00288015|3335761|P1|Follow up for Survival x 2 Years|Death|13
1021784|NCT00288015|3335761|P1|Continued Bevacizumab Cycle 3+|Disease progressed|7
1021785|NCT00288015|3335761|P1|First Response Assessment|Physician Decision|2
1021786|NCT00288015|3335761|P1|First Response Assessment|Death|1
1021787|NCT00288015|3335761|P1|First Response Assessment|Withdrawal by Subject|1
1021788|NCT00288015|3335761|P1|Bevacizumab Treatment Cycles 1-2|Physician Decision|1
1021789|NCT00288015|3335761|P1|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1
1021790|NCT00287586|3335837|P2|Overall Study|Recurrent Melanoma|1
1021791|NCT00287586|3335838|P1|Overall Study|Recurrent Melanoma|0
1021792|NCT00287586|3335837|P2|Overall Study|Itchy Swollen Eyes|1
1021793|NCT00287586|3335838|P1|Overall Study|Itchy Swollen Eyes|0
1021794|NCT00287586|3335837|P2|Overall Study|Bradycardia|1
1021795|NCT00287586|3335838|P1|Overall Study|Bradycardia|0
1021796|NCT00287586|3335837|P2|Overall Study|Mood Swings and Irritability|1
1021797|NCT00287586|3335838|P1|Overall Study|Mood Swings and Irritability|0
1021798|NCT00287586|3335837|P2|Overall Study|Mastodynia and Gynecomastia|1
1021799|NCT00287586|3335838|P1|Overall Study|Mastodynia and Gynecomastia|0
1021800|NCT00287586|3335837|P2|Overall Study|Retroperitoneal Cancer|1
1021801|NCT00287586|3335838|P1|Overall Study|Retroperitoneal Cancer|0
1021802|NCT00287586|3335837|P2|Overall Study|Elevated IPSS Score|1
1021803|NCT00287586|3335838|P1|Overall Study|Elevated IPSS Score|0
1021804|NCT00287586|3335837|P2|Overall Study|Lung Cancer|2
1021805|NCT00287586|3335838|P1|Overall Study|Lung Cancer|0
1021806|NCT00287586|3335837|P2|Overall Study|Major Depression|2
1021807|NCT00287586|3335838|P1|Overall Study|Major Depression|0
1021808|NCT00287586|3335837|P2|Overall Study|Enrolled in Another Study|0
1021809|NCT00287586|3335838|P1|Overall Study|Enrolled in Another Study|1
1021810|NCT00287586|3335837|P2|Overall Study|Nonadherence|1
1021811|NCT00287586|3335838|P1|Overall Study|Nonadherence|1
1021812|NCT00287586|3335837|P2|Overall Study|Inappropriate Behaviour with Staff|0
1021813|NCT00287586|3335838|P1|Overall Study|Inappropriate Behaviour with Staff|1
1021814|NCT00287586|3335837|P2|Overall Study|Shoulder Pain|0
1021815|NCT00287586|3335838|P1|Overall Study|Shoulder Pain|1
1021816|NCT00287586|3335837|P2|Overall Study|Sleep Apnea|0
1021817|NCT00287586|3335838|P1|Overall Study|Sleep Apnea|1
1021818|NCT00287586|3335837|P2|Overall Study|Pancreatic Cancer|3
1021819|NCT00287586|3335838|P1|Overall Study|Pancreatic Cancer|1
1021820|NCT00287586|3335837|P2|Overall Study|Cognitive Impairment|0
1021821|NCT00287586|3335838|P1|Overall Study|Cognitive Impairment|1
1021822|NCT00287586|3335837|P2|Overall Study|Lower Urinary Tract Symptoms|0
1021823|NCT00287586|3335838|P1|Overall Study|Lower Urinary Tract Symptoms|1
1021824|NCT00287586|3335837|P2|Overall Study|Myocardial Infarction|0
1021825|NCT00287586|3335838|P1|Overall Study|Myocardial Infarction|1
1021826|NCT00287586|3335837|P2|Overall Study|Stroke|0
1021827|NCT00287586|3335838|P1|Overall Study|Stroke|2
1021828|NCT00287586|3335837|P2|Overall Study|Elevated Prostate Specific Antigen|0
1021829|NCT00287586|3335838|P1|Overall Study|Elevated Prostate Specific Antigen|2
1021830|NCT00287586|3335837|P2|Overall Study|Rash|0
1021831|NCT00287586|3335838|P1|Overall Study|Rash|3
1021832|NCT00287586|3335837|P2|Overall Study|Elevated Hematocrit|0
1021833|NCT00287586|3335838|P1|Overall Study|Elevated Hematocrit|3
1021834|NCT00287586|3335837|P2|Overall Study|Death|3
1021835|NCT00287586|3335838|P1|Overall Study|Death|2
1021836|NCT00287586|3335837|P2|Overall Study|Lost to Follow-up|4
1021837|NCT00287586|3335838|P1|Overall Study|Lost to Follow-up|5
1021838|NCT00287586|3335837|P2|Overall Study|Withdrew Consent|30
1021839|NCT00287586|3335838|P1|Overall Study|Withdrew Consent|19
1021840|NCT00287365|3335874|P1|Overall Study|sample not acquired|13
1021841|NCT00287118|3335896|P1|Overall Study|Not specified|7
1021842|NCT00287118|3335896|P1|Overall Study|Protocol Violation|2
1021843|NCT00287118|3335896|P1|Overall Study|Lost to Follow-up|1
1021844|NCT00287118|3335896|P1|Overall Study|Lack of Efficacy|11
1021845|NCT00287118|3335896|P1|Overall Study|Death|1
1021846|NCT00287118|3335896|P1|Overall Study|Adverse Event|30
1021847|NCT00287079|3335902|P2|Overall Study|Other|0
1021848|NCT00287079|3335903|P1|Overall Study|Other|3
1021849|NCT00287079|3335902|P2|Overall Study|Protocol Violation|0
1021850|NCT00287079|3335903|P1|Overall Study|Protocol Violation|1
1021851|NCT00287079|3335902|P2|Overall Study|Adverse Event|0
1021852|NCT00287079|3335903|P1|Overall Study|Adverse Event|5
1021853|NCT00287079|3335902|P2|Overall Study|Non-qualifying relapse|0
1021854|NCT00287079|3335903|P1|Overall Study|Non-qualifying relapse|1
1021855|NCT00287079|3335902|P2|Overall Study|Qualifying relapse|1
1021856|NCT00287079|3335903|P1|Overall Study|Qualifying relapse|12
1021857|NCT00286754|3335931|P3|Overall Study|Moved out of state|1
1021858|NCT00286754|3335932|P2|Overall Study|Moved out of state|0
1021859|NCT00286754|3335933|P1|Overall Study|Moved out of state|0
1021860|NCT00286754|3335931|P3|Overall Study|Lost to Follow-up|6
1021861|NCT00286754|3335932|P2|Overall Study|Lost to Follow-up|14
1021862|NCT00286754|3335933|P1|Overall Study|Lost to Follow-up|12
1021863|NCT00286754|3335931|P3|Overall Study|Withdrawal by Subject|0
1021864|NCT00286754|3335932|P2|Overall Study|Withdrawal by Subject|2
1021865|NCT00286754|3335933|P1|Overall Study|Withdrawal by Subject|6
1021866|NCT00286754|3335931|P3|Overall Study|Adverse Event|3
1021867|NCT00286754|3335932|P2|Overall Study|Adverse Event|2
1021868|NCT00286754|3335933|P1|Overall Study|Adverse Event|2
1021869|NCT00286494|3335988|P3|Overall Study|Protocol Violation|2
1021870|NCT00286494|3335989|P2|Overall Study|Protocol Violation|1
1021871|NCT00286494|3335990|P1|Overall Study|Protocol Violation|1
1021872|NCT00286494|3335988|P3|Overall Study|Lost to Follow-up|3
1021873|NCT00286494|3335989|P2|Overall Study|Lost to Follow-up|1
1021874|NCT00286494|3335990|P1|Overall Study|Lost to Follow-up|3
1021875|NCT00286494|3335988|P3|Overall Study|Physician Decision|1
1021876|NCT00286494|3335989|P2|Overall Study|Physician Decision|5
1021877|NCT00286494|3335990|P1|Overall Study|Physician Decision|5
1021878|NCT00286494|3335988|P3|Overall Study|Adverse Event|6
1021879|NCT00286494|3335989|P2|Overall Study|Adverse Event|8
1021880|NCT00286494|3335990|P1|Overall Study|Adverse Event|3
1021881|NCT00286494|3335988|P3|Overall Study|Withdrawal by Subject|9
1021882|NCT00286494|3335989|P2|Overall Study|Withdrawal by Subject|10
1021883|NCT00286494|3335990|P1|Overall Study|Withdrawal by Subject|2
1021884|NCT00286494|3335988|P3|Overall Study|Hyperglycemic rescue|18
1021885|NCT00286494|3335989|P2|Overall Study|Hyperglycemic rescue|19
1021886|NCT00286494|3335990|P1|Overall Study|Hyperglycemic rescue|12
1021887|NCT00286468|3336151|P3|Overall Study|Physician Decision|1
1021888|NCT00286468|3336152|P2|Overall Study|Physician Decision|2
1021889|NCT00286468|3336153|P1|Overall Study|Physician Decision|3
1021890|NCT00286468|3336151|P3|Overall Study|Withdrawal by Subject|11
1021891|NCT00286468|3336152|P2|Overall Study|Withdrawal by Subject|8
1021892|NCT00286468|3336153|P1|Overall Study|Withdrawal by Subject|3
1021893|NCT00286468|3336151|P3|Overall Study|Lost to Follow-up|2
1021894|NCT00286468|3336152|P2|Overall Study|Lost to Follow-up|1
1021895|NCT00286468|3336153|P1|Overall Study|Lost to Follow-up|1
1021896|NCT00286468|3336151|P3|Overall Study|Protocol Violation|1
1021897|NCT00286468|3336152|P2|Overall Study|Protocol Violation|3
1021898|NCT00286468|3336153|P1|Overall Study|Protocol Violation|0
1021899|NCT00286468|3336151|P3|Overall Study|Adverse Event|4
1021900|NCT00286468|3336152|P2|Overall Study|Adverse Event|6
1021901|NCT00286468|3336153|P1|Overall Study|Adverse Event|2
1021902|NCT00286468|3336151|P3|Overall Study|Hyperglycemic Rescue|31
1021903|NCT00286468|3336152|P2|Overall Study|Hyperglycemic Rescue|30
1021904|NCT00286468|3336153|P1|Overall Study|Hyperglycemic Rescue|28
1021905|NCT00286455|3336314|P3|Overall Study|Withdrawal by Subject|7
1021906|NCT00286455|3336315|P2|Overall Study|Withdrawal by Subject|8
1021907|NCT00286455|3336316|P1|Overall Study|Withdrawal by Subject|0
1021908|NCT00286455|3336314|P3|Overall Study|Participant Non-compliance|0
1021909|NCT00286455|3336315|P2|Overall Study|Participant Non-compliance|0
1021910|NCT00286455|3336316|P1|Overall Study|Participant Non-compliance|1
1021911|NCT00286455|3336314|P3|Overall Study|Protocol Violation|0
1021912|NCT00286455|3336315|P2|Overall Study|Protocol Violation|1
1021913|NCT00286455|3336316|P1|Overall Study|Protocol Violation|1
1021914|NCT00286455|3336314|P3|Overall Study|Physician Decision|2
1021915|NCT00286455|3336315|P2|Overall Study|Physician Decision|0
1021916|NCT00286455|3336316|P1|Overall Study|Physician Decision|3
1021917|NCT00286455|3336314|P3|Overall Study|Lost to Follow-up|3
1021918|NCT00286455|3336315|P2|Overall Study|Lost to Follow-up|3
1021919|NCT00286455|3336316|P1|Overall Study|Lost to Follow-up|0
1021920|NCT00286455|3336314|P3|Overall Study|Adverse Event|2
1021921|NCT00286455|3336315|P2|Overall Study|Adverse Event|3
1021922|NCT00286455|3336316|P1|Overall Study|Adverse Event|1
1021923|NCT00286455|3336314|P3|Overall Study|Hyperglycemia rescue|10
1021924|NCT00286455|3336315|P2|Overall Study|Hyperglycemia rescue|13
1021925|NCT00286455|3336316|P1|Overall Study|Hyperglycemia rescue|19
1021926|NCT00286442|3336495|P3|Overall Study|Withdrawal by Subject|2
1021927|NCT00286442|3336496|P2|Overall Study|Withdrawal by Subject|14
1021928|NCT00286442|3336497|P1|Overall Study|Withdrawal by Subject|2
1021929|NCT00286442|3336495|P3|Overall Study|Administrative Error|0
1021930|NCT00286442|3336496|P2|Overall Study|Administrative Error|1
1021931|NCT00286442|3336497|P1|Overall Study|Administrative Error|1
1021932|NCT00286442|3336495|P3|Overall Study|Physician Decision|1
1021933|NCT00286442|3336496|P2|Overall Study|Physician Decision|1
1021934|NCT00286442|3336497|P1|Overall Study|Physician Decision|1
1021935|NCT00286442|3336495|P3|Overall Study|Lost to Follow-up|1
1021936|NCT00286442|3336496|P2|Overall Study|Lost to Follow-up|2
1021937|NCT00286442|3336497|P1|Overall Study|Lost to Follow-up|5
1021938|NCT00286442|3336495|P3|Overall Study|Protocol Violation|2
1021939|NCT00286442|3336496|P2|Overall Study|Protocol Violation|4
1021940|NCT00286442|3336497|P1|Overall Study|Protocol Violation|2
1021941|NCT00286442|3336495|P3|Overall Study|Adverse Event|1
1021942|NCT00286442|3336496|P2|Overall Study|Adverse Event|6
1021943|NCT00286442|3336497|P1|Overall Study|Adverse Event|7
1021944|NCT00286442|3336495|P3|Overall Study|Hyperglycemic Rescue|25
1021945|NCT00286442|3336496|P2|Overall Study|Hyperglycemic Rescue|17
1021946|NCT00286442|3336497|P1|Overall Study|Hyperglycemic Rescue|19
1021947|NCT00286429|3336658|P3|Overall Study|Administrative Decision|0
1021948|NCT00286429|3336659|P2|Overall Study|Administrative Decision|1
1021949|NCT00286429|3336660|P1|Overall Study|Administrative Decision|0
1021950|NCT00286429|3336658|P3|Overall Study|Administrative Error|1
1021951|NCT00286429|3336659|P2|Overall Study|Administrative Error|1
1021952|NCT00286429|3336660|P1|Overall Study|Administrative Error|1
1021953|NCT00286429|3336658|P3|Overall Study|Withdrawal by Subject|6
1021954|NCT00286429|3336659|P2|Overall Study|Withdrawal by Subject|2
1021955|NCT00286429|3336660|P1|Overall Study|Withdrawal by Subject|3
1021956|NCT00286429|3336658|P3|Overall Study|Protocol Violation|4
1021957|NCT00286429|3336659|P2|Overall Study|Protocol Violation|5
1021958|NCT00286429|3336660|P1|Overall Study|Protocol Violation|3
1021959|NCT00286429|3336658|P3|Overall Study|Physician Decision|7
1021960|NCT00286429|3336659|P2|Overall Study|Physician Decision|7
1021961|NCT00286429|3336660|P1|Overall Study|Physician Decision|10
1021962|NCT00286429|3336658|P3|Overall Study|Lost to Follow-up|3
1021963|NCT00286429|3336659|P2|Overall Study|Lost to Follow-up|4
1021964|NCT00286429|3336660|P1|Overall Study|Lost to Follow-up|2
1021965|NCT00286429|3336658|P3|Overall Study|Lack of Efficacy|25
1021966|NCT00286429|3336659|P2|Overall Study|Lack of Efficacy|27
1021967|NCT00286429|3336660|P1|Overall Study|Lack of Efficacy|52
1021968|NCT00286429|3336658|P3|Overall Study|Adverse Event|6
1021969|NCT00286429|3336659|P2|Overall Study|Adverse Event|1
1021970|NCT00286429|3336660|P1|Overall Study|Adverse Event|4
1021971|NCT00286221|3336776|P4|Overall Study|Unrecognized exclusion criteria met|0
1021972|NCT00286221|3336777|P3|Overall Study|Unrecognized exclusion criteria met|0
1021973|NCT00286221|3336778|P2|Overall Study|Unrecognized exclusion criteria met|1
1021974|NCT00286221|3336779|P1|Overall Study|Unrecognized exclusion criteria met|0
1021975|NCT00286221|3336776|P4|Overall Study|Inability to trigger PCA|0
1021976|NCT00286221|3336777|P3|Overall Study|Inability to trigger PCA|0
1021977|NCT00286221|3336778|P2|Overall Study|Inability to trigger PCA|0
1021978|NCT00286221|3336779|P1|Overall Study|Inability to trigger PCA|2
1021979|NCT00286221|3336776|P4|Overall Study|Unanticipated Neurosurgical Complication|2
1021980|NCT00286221|3336777|P3|Overall Study|Unanticipated Neurosurgical Complication|3
1021981|NCT00286221|3336778|P2|Overall Study|Unanticipated Neurosurgical Complication|3
1021982|NCT00286221|3336779|P1|Overall Study|Unanticipated Neurosurgical Complication|6
1021983|NCT00286221|3336776|P4|Overall Study|Protocol Violation|4
1021984|NCT00286221|3336777|P3|Overall Study|Protocol Violation|6
1021985|NCT00286221|3336778|P2|Overall Study|Protocol Violation|1
1021986|NCT00286221|3336779|P1|Overall Study|Protocol Violation|2
1021987|NCT00286156|3336805|P3|Overall Study|AE: pneumonia|0
1021988|NCT00286156|3336806|P2|Overall Study|AE: pneumonia|0
1021989|NCT00286156|3336807|P1|Overall Study|AE: pneumonia|1
1021990|NCT00286156|3336805|P3|Overall Study|AE: nephrotic-range proteinuruia|0
1021991|NCT00286156|3336806|P2|Overall Study|AE: nephrotic-range proteinuruia|0
1021992|NCT00286156|3336807|P1|Overall Study|AE: nephrotic-range proteinuruia|1
1021993|NCT00286156|3336805|P3|Overall Study|AE: pulmonary embolus|0
1021994|NCT00286156|3336806|P2|Overall Study|AE: pulmonary embolus|1
1021995|NCT00286156|3336807|P1|Overall Study|AE: pulmonary embolus|0
1021996|NCT00286156|3336805|P3|Overall Study|Missed 12 month visit|1
1021997|NCT00286156|3336806|P2|Overall Study|Missed 12 month visit|0
1021998|NCT00286156|3336807|P1|Overall Study|Missed 12 month visit|0
1021999|NCT00286091|3336820|P2|Open-label Treatment Phase|Missing End of Study Information|1
1022000|NCT00286091|3336821|P1|Open-label Treatment Phase|Missing End of Study Information|0
1022001|NCT00286091|3336820|P2|Open-label Treatment Phase|Protocol-specified Criteria|0
1022002|NCT00286091|3336821|P1|Open-label Treatment Phase|Protocol-specified Criteria|1
1022003|NCT00286091|3336820|P2|Open-label Treatment Phase|Lost to Follow-up|1
1022004|NCT00286091|3336821|P1|Open-label Treatment Phase|Lost to Follow-up|0
1022005|NCT00286091|3336820|P2|Open-label Treatment Phase|Noncompliance|1
1022006|NCT00286091|3336821|P1|Open-label Treatment Phase|Noncompliance|3
1022007|NCT00286091|3336820|P2|Open-label Treatment Phase|Disease Progression|3
1022008|NCT00286091|3336821|P1|Open-label Treatment Phase|Disease Progression|9
1022009|NCT00286091|3336820|P2|Open-label Treatment Phase|Death|7
1022010|NCT00286091|3336821|P1|Open-label Treatment Phase|Death|10
1022011|NCT00286091|3336820|P2|Open-label Treatment Phase|Withdrawal by Subject|10
1022012|NCT00286091|3336821|P1|Open-label Treatment Phase|Withdrawal by Subject|14
1022013|NCT00286091|3336820|P2|Open-label Treatment Phase|Other|11
1022014|NCT00286091|3336821|P1|Open-label Treatment Phase|Other|11
1022015|NCT00286091|3336820|P2|Open-label Treatment Phase|Adverse Event|16
1022016|NCT00286091|3336821|P1|Open-label Treatment Phase|Adverse Event|5
1022017|NCT00286091|3336820|P2|Open-label Treatment Phase|Physician Decision|21
1022018|NCT00286091|3336821|P1|Open-label Treatment Phase|Physician Decision|24
1022019|NCT00286091|3336820|P2|Double-blind Treatment Phase|Ineligibility Determined|2
1022020|NCT00286091|3336821|P1|Double-blind Treatment Phase|Ineligibility Determined|1
1022021|NCT00286091|3336820|P2|Double-blind Treatment Phase|Protocol Deviation|3
1022022|NCT00286091|3336821|P1|Double-blind Treatment Phase|Protocol Deviation|1
1022023|NCT00286091|3336820|P2|Double-blind Treatment Phase|Lost to Follow-up|4
1022024|NCT00286091|3336821|P1|Double-blind Treatment Phase|Lost to Follow-up|11
1022025|NCT00286091|3336820|P2|Double-blind Treatment Phase|Noncompliance|8
1022026|NCT00286091|3336821|P1|Double-blind Treatment Phase|Noncompliance|8
1022027|NCT00286091|3336820|P2|Double-blind Treatment Phase|Administrative Decision|21
1022028|NCT00286091|3336821|P1|Double-blind Treatment Phase|Administrative Decision|20
1022029|NCT00286091|3336820|P2|Double-blind Treatment Phase|Other|33
1022030|NCT00286091|3336821|P1|Double-blind Treatment Phase|Other|25
1022031|NCT00286091|3336820|P2|Double-blind Treatment Phase|Disease Progression|35
1022032|NCT00286091|3336821|P1|Double-blind Treatment Phase|Disease Progression|22
1022033|NCT00286091|3336820|P2|Double-blind Treatment Phase|Adverse Event|40
1022034|NCT00286091|3336821|P1|Double-blind Treatment Phase|Adverse Event|28
1022035|NCT00286091|3336820|P2|Double-blind Treatment Phase|Death|65
1022036|NCT00286091|3336821|P1|Double-blind Treatment Phase|Death|58
1022037|NCT00286091|3336820|P2|Double-blind Treatment Phase|Protocol-Specified Criteria|269
1022038|NCT00286091|3336821|P1|Double-blind Treatment Phase|Protocol-Specified Criteria|307
1022039|NCT00286091|3336820|P2|Double-blind Treatment Phase|Withdrawal by Subject|113
1022040|NCT00286091|3336821|P1|Double-blind Treatment Phase|Withdrawal by Subject|103
1022041|NCT00285857|3336844|P1|Overall Study|Adverse Event|1
1022042|NCT00285857|3336844|P1|Overall Study|Inadequate initial breast cytology|1
1022043|NCT00285857|3336844|P1|Overall Study|Withdrawal by Subject|2
1022044|NCT00285818|3336857|P2|Overall Study|Lost to Follow-up|0
1022045|NCT00285818|3336858|P1|Overall Study|Lost to Follow-up|1
1022046|NCT00285818|3336857|P2|Overall Study|Withdrawal by Subject|2
1022047|NCT00285818|3336858|P1|Overall Study|Withdrawal by Subject|3
1022048|NCT00285649|3336903|P3|Overall Study|Withdrawal by Subject|2
1022049|NCT00285649|3336904|P2|Overall Study|Withdrawal by Subject|2
1022050|NCT00285649|3336905|P1|Overall Study|Withdrawal by Subject|3
1022051|NCT00285649|3336903|P3|Overall Study|Lost to Follow-up|4
1022052|NCT00285649|3336904|P2|Overall Study|Lost to Follow-up|4
1022053|NCT00285649|3336905|P1|Overall Study|Lost to Follow-up|6
1022054|NCT00285584|3336915|P2|Month 6|Lost to Follow-up|1
1022055|NCT00285584|3336916|P1|Month 6|Lost to Follow-up|0
1022056|NCT00285584|3336915|P2|Month 3|Withdrawal by Subject|0
1022057|NCT00285584|3336916|P1|Month 3|Withdrawal by Subject|1
1022058|NCT00285584|3336915|P2|Month 3|Lost to Follow-up|3
1022059|NCT00285584|3336916|P1|Month 3|Lost to Follow-up|3
1022060|NCT00285207|3336948|P2|Overall Study|non-compliance|1
1022061|NCT00285207|3336949|P1|Overall Study|non-compliance|0
1022062|NCT00285207|3336948|P2|Overall Study|Pregnancy|1
1022063|NCT00285207|3336949|P1|Overall Study|Pregnancy|1
1022064|NCT00285207|3336948|P2|Overall Study|Withdrawal by Subject|2
1022065|NCT00285207|3336949|P1|Overall Study|Withdrawal by Subject|5
1022066|NCT00285207|3336948|P2|Overall Study|Lost to Follow-up|2
1022067|NCT00285207|3336949|P1|Overall Study|Lost to Follow-up|3
1022068|NCT00285012|3336957|P2|Received Study Tx|Other|5
1022069|NCT00285012|3336958|P1|Received Study Tx|Other|5
1022070|NCT00285012|3336957|P2|Received Study Tx|Withdrawal by Subject|43
1022071|NCT00285012|3336958|P1|Received Study Tx|Withdrawal by Subject|31
1022072|NCT00285012|3336957|P2|Received Study Tx|Lost to Follow-up|31
1022073|NCT00285012|3336958|P1|Received Study Tx|Lost to Follow-up|29
1022074|NCT00285012|3336957|P2|Received Study Tx|Lack of Efficacy|3
1022075|NCT00285012|3336958|P1|Received Study Tx|Lack of Efficacy|0
1022076|NCT00285012|3336957|P2|Received Study Tx|Adverse Event|11
1022077|NCT00285012|3336958|P1|Received Study Tx|Adverse Event|5
1022078|NCT00285012|3336957|P2|Received Study Tx|Death|1
1022079|NCT00285012|3336958|P1|Received Study Tx|Death|2
1022080|NCT00285012|3336957|P2|Assigned to Study Treatment (Tx)|Other|3
1022081|NCT00285012|3336958|P1|Assigned to Study Treatment (Tx)|Other|2
1022082|NCT00284934|3336984|P2|Overall Study|Other reasons|1
1022083|NCT00284934|3336985|P1|Overall Study|Other reasons|3
1022084|NCT00284934|3336984|P2|Overall Study|Adverse Event|2
1022085|NCT00284934|3336985|P1|Overall Study|Adverse Event|1
1022086|NCT00284856|3337000|P3|Overall Study|Other|4
1022087|NCT00284856|3337001|P2|Overall Study|Other|5
1022088|NCT00284856|3337002|P1|Overall Study|Other|4
1022089|NCT00284856|3337000|P3|Overall Study|Withdrawal by Subject|18
1022090|NCT00284856|3337001|P2|Overall Study|Withdrawal by Subject|16
1022091|NCT00284856|3337002|P1|Overall Study|Withdrawal by Subject|12
1022092|NCT00284856|3337000|P3|Overall Study|Protocol Violation|5
1022093|NCT00284856|3337001|P2|Overall Study|Protocol Violation|4
1022094|NCT00284856|3337002|P1|Overall Study|Protocol Violation|5
1022095|NCT00284856|3337000|P3|Overall Study|Lost to Follow-up|22
1022096|NCT00284856|3337001|P2|Overall Study|Lost to Follow-up|21
1022097|NCT00284856|3337002|P1|Overall Study|Lost to Follow-up|25
1022098|NCT00284856|3337000|P3|Overall Study|Lack of Efficacy|8
1022099|NCT00284856|3337001|P2|Overall Study|Lack of Efficacy|1
1022100|NCT00284856|3337002|P1|Overall Study|Lack of Efficacy|2
1022101|NCT00284856|3337000|P3|Overall Study|Adverse Event|3
1022102|NCT00284856|3337001|P2|Overall Study|Adverse Event|3
1022103|NCT00284856|3337002|P1|Overall Study|Adverse Event|3
1022104|NCT00284141|3337101|P1|Overall Study|Ongoing treatment|2
1022105|NCT00284141|3337101|P1|Overall Study|Did not take study medication|2
1022106|NCT00284141|3337101|P1|Overall Study|Pneumonia|1
1022107|NCT00284141|3337101|P1|Overall Study|General decline|1
1022108|NCT00284141|3337101|P1|Overall Study|Clinical deterioration / death|2
1022109|NCT00284141|3337101|P1|Overall Study|Symptomatic / Clinical Progression|11
1022110|NCT00284141|3337101|P1|Overall Study|Participant's request|9
1022111|NCT00284141|3337101|P1|Overall Study|Adverse Event|19
1022112|NCT00284141|3337101|P1|Overall Study|Disease Progression / Lack of efficacy|51
1022113|NCT00284089|3337124|P4|Extension Phase|Withdrawal by Subject|3
1022114|NCT00284089|3337125|P3|Extension Phase|Withdrawal by Subject|1
1022115|NCT00284089|3337126|P2|Extension Phase|Withdrawal by Subject|0
1022116|NCT00284089|3337127|P1|Extension Phase|Withdrawal by Subject|0
1022117|NCT00284089|3337124|P4|Extension Phase|Protocol Violation|0
1022118|NCT00284089|3337125|P3|Extension Phase|Protocol Violation|1
1022119|NCT00284089|3337126|P2|Extension Phase|Protocol Violation|0
1022120|NCT00284089|3337127|P1|Extension Phase|Protocol Violation|0
1022121|NCT00284089|3337124|P4|Extension Phase|condition no longer requires study drug|7
1022122|NCT00284089|3337125|P3|Extension Phase|condition no longer requires study drug|2
1022123|NCT00284089|3337126|P2|Extension Phase|condition no longer requires study drug|0
1022124|NCT00284089|3337127|P1|Extension Phase|condition no longer requires study drug|2
1022125|NCT00284089|3337124|P4|Extension Phase|Adverse Event|2
1022126|NCT00284089|3337125|P3|Extension Phase|Adverse Event|2
1022127|NCT00284089|3337126|P2|Extension Phase|Adverse Event|0
1022128|NCT00284089|3337127|P1|Extension Phase|Adverse Event|0
1022129|NCT00284089|3337124|P4|Multiple Dose Phase|Death|1
1022130|NCT00284089|3337125|P3|Multiple Dose Phase|Death|1
1022131|NCT00284089|3337126|P2|Multiple Dose Phase|Death|0
1022132|NCT00284089|3337127|P1|Multiple Dose Phase|Death|0
1022133|NCT00284089|3337124|P4|Multiple Dose Phase|Withdrawal by Subject|2
1022134|NCT00284089|3337125|P3|Multiple Dose Phase|Withdrawal by Subject|1
1022135|NCT00284089|3337126|P2|Multiple Dose Phase|Withdrawal by Subject|0
1022136|NCT00284089|3337127|P1|Multiple Dose Phase|Withdrawal by Subject|0
1022137|NCT00284089|3337124|P4|Multiple Dose Phase|Protocol Violation|0
1022138|NCT00284089|3337125|P3|Multiple Dose Phase|Protocol Violation|1
1022139|NCT00284089|3337126|P2|Multiple Dose Phase|Protocol Violation|0
1022140|NCT00284089|3337127|P1|Multiple Dose Phase|Protocol Violation|0
1022141|NCT00284089|3337124|P4|Multiple Dose Phase|Adverse Event|1
1022142|NCT00284089|3337125|P3|Multiple Dose Phase|Adverse Event|1
1022143|NCT00284089|3337126|P2|Multiple Dose Phase|Adverse Event|0
1022144|NCT00284089|3337127|P1|Multiple Dose Phase|Adverse Event|1
1022145|NCT00284050|3337156|P3|Overall Study|Death|0
1022146|NCT00284050|3337157|P2|Overall Study|Death|0
1022147|NCT00284050|3337158|P1|Overall Study|Death|1
1022148|NCT00284050|3337156|P3|Overall Study|Lost to Follow-up|1
1022149|NCT00284050|3337157|P2|Overall Study|Lost to Follow-up|0
1022150|NCT00284050|3337158|P1|Overall Study|Lost to Follow-up|1
1022151|NCT00284050|3337156|P3|Overall Study|Withdrawal by Subject|2
1022152|NCT00284050|3337157|P2|Overall Study|Withdrawal by Subject|2
1022153|NCT00284050|3337158|P1|Overall Study|Withdrawal by Subject|2
1022154|NCT00284050|3337156|P3|Overall Study|Protocol Violation|2
1022155|NCT00284050|3337157|P2|Overall Study|Protocol Violation|1
1022156|NCT00284050|3337158|P1|Overall Study|Protocol Violation|0
1022157|NCT00284050|3337156|P3|Overall Study|Lack of Efficacy|3
1022158|NCT00284050|3337157|P2|Overall Study|Lack of Efficacy|1
1022159|NCT00284050|3337158|P1|Overall Study|Lack of Efficacy|0
1022160|NCT00284050|3337156|P3|Overall Study|Adverse Event|1
1022161|NCT00284050|3337157|P2|Overall Study|Adverse Event|1
1022162|NCT00284050|3337158|P1|Overall Study|Adverse Event|1
1022163|NCT00283959|3337172|P1|Extension Period|Low Compliance|1
1022164|NCT00283868|3337184|P2|Overall Study|Lost to Follow-up|8
1022165|NCT00283868|3337185|P1|Overall Study|Lost to Follow-up|7
1022166|NCT00283842|3337202|P5|Overall Study|Lost to Follow-up|1
1022167|NCT00283842|3337203|P4|Overall Study|Lost to Follow-up|1
1022168|NCT00283842|3337204|P3|Overall Study|Lost to Follow-up|4
1022169|NCT00283842|3337205|P2|Overall Study|Lost to Follow-up|2
1022170|NCT00283842|3337206|P1|Overall Study|Lost to Follow-up|0
1022171|NCT00283842|3337202|P5|Overall Study|Lack of Efficacy|3
1022172|NCT00283842|3337203|P4|Overall Study|Lack of Efficacy|0
1022173|NCT00283842|3337204|P3|Overall Study|Lack of Efficacy|1
1022174|NCT00283842|3337205|P2|Overall Study|Lack of Efficacy|3
1022175|NCT00283842|3337206|P1|Overall Study|Lack of Efficacy|1
1022176|NCT00283842|3337202|P5|Overall Study|Withdrawal by Subject|4
1022177|NCT00283842|3337203|P4|Overall Study|Withdrawal by Subject|5
1022178|NCT00283842|3337204|P3|Overall Study|Withdrawal by Subject|1
1022179|NCT00283842|3337205|P2|Overall Study|Withdrawal by Subject|1
1022180|NCT00283842|3337206|P1|Overall Study|Withdrawal by Subject|2
1022181|NCT00283842|3337202|P5|Overall Study|Protocol deviation|2
1022182|NCT00283842|3337203|P4|Overall Study|Protocol deviation|0
1022183|NCT00283842|3337204|P3|Overall Study|Protocol deviation|0
1022184|NCT00283842|3337205|P2|Overall Study|Protocol deviation|0
1022185|NCT00283842|3337206|P1|Overall Study|Protocol deviation|0
1022186|NCT00283842|3337202|P5|Overall Study|Protocol Violation|0
1022187|NCT00283842|3337203|P4|Overall Study|Protocol Violation|0
1022188|NCT00283842|3337204|P3|Overall Study|Protocol Violation|4
1022189|NCT00283842|3337205|P2|Overall Study|Protocol Violation|5
1022190|NCT00283842|3337206|P1|Overall Study|Protocol Violation|1
1022191|NCT00283842|3337202|P5|Overall Study|Adverse Event|5
1022192|NCT00283842|3337203|P4|Overall Study|Adverse Event|21
1022193|NCT00283842|3337204|P3|Overall Study|Adverse Event|21
1022194|NCT00283842|3337205|P2|Overall Study|Adverse Event|7
1022195|NCT00283842|3337206|P1|Overall Study|Adverse Event|8
1022196|NCT00283803|3337238|P1|Overall Study|Withdrawal by Subject|4
1022197|NCT00283803|3337238|P1|Overall Study|Physician Decision|9
1022198|NCT00283712|3337246|P2|Overall Study|Death|1
1022199|NCT00283712|3337247|P1|Overall Study|Death|0
1022200|NCT00283686|3337285|P4|Overall Study|Less than full participation|12
1022201|NCT00283686|3337286|P3|Overall Study|Less than full participation|6
1022202|NCT00283686|3337287|P2|Overall Study|Less than full participation|9
1022203|NCT00283686|3337288|P1|Overall Study|Less than full participation|7
1022204|NCT00283686|3337285|P4|Overall Study|Lost to Follow-up|20
1022205|NCT00283686|3337286|P3|Overall Study|Lost to Follow-up|26
1022206|NCT00283686|3337287|P2|Overall Study|Lost to Follow-up|31
1022207|NCT00283686|3337288|P1|Overall Study|Lost to Follow-up|21
1022208|NCT00283686|3337285|P4|Overall Study|Death|0
1022209|NCT00283686|3337286|P3|Overall Study|Death|1
1022210|NCT00283686|3337287|P2|Overall Study|Death|1
1022211|NCT00283686|3337288|P1|Overall Study|Death|1
1022212|NCT00283595|3337332|P2|Overall Study|Withdrawal by Subject|2
1022213|NCT00283595|3337333|P1|Overall Study|Withdrawal by Subject|1
1022214|NCT00283439|3337358|P4|Overall Study|Not specified|0
1022215|NCT00283439|3337359|P3|Overall Study|Not specified|0
1022216|NCT00283439|3337360|P2|Overall Study|Not specified|0
1022217|NCT00283439|3337361|P1|Overall Study|Not specified|1
1022218|NCT00283439|3337358|P4|Overall Study|Treatment discontinued|3
1022219|NCT00283439|3337359|P3|Overall Study|Treatment discontinued|1
1022220|NCT00283439|3337360|P2|Overall Study|Treatment discontinued|2
1022221|NCT00283439|3337361|P1|Overall Study|Treatment discontinued|0
1022222|NCT00283439|3337358|P4|Overall Study|Stem cell transplant|3
1022223|NCT00283439|3337359|P3|Overall Study|Stem cell transplant|4
1022224|NCT00283439|3337360|P2|Overall Study|Stem cell transplant|6
1022225|NCT00283439|3337361|P1|Overall Study|Stem cell transplant|6
1022226|NCT00283439|3337358|P4|Overall Study|Requirement for alternative therapy|2
1022227|NCT00283439|3337359|P3|Overall Study|Requirement for alternative therapy|5
1022228|NCT00283439|3337360|P2|Overall Study|Requirement for alternative therapy|2
1022229|NCT00283439|3337361|P1|Overall Study|Requirement for alternative therapy|1
1022230|NCT00283439|3337358|P4|Overall Study|Disease progression|0
1022231|NCT00283439|3337359|P3|Overall Study|Disease progression|0
1022232|NCT00283439|3337360|P2|Overall Study|Disease progression|1
1022233|NCT00283439|3337361|P1|Overall Study|Disease progression|0
1022234|NCT00283439|3337358|P4|Overall Study|Death|0
1022235|NCT00283439|3337359|P3|Overall Study|Death|1
1022236|NCT00283439|3337360|P2|Overall Study|Death|0
1022237|NCT00283439|3337361|P1|Overall Study|Death|0
1022238|NCT00283439|3337358|P4|Overall Study|Adverse Event|1
1022239|NCT00283439|3337359|P3|Overall Study|Adverse Event|0
1022240|NCT00283439|3337360|P2|Overall Study|Adverse Event|0
1022241|NCT00283439|3337361|P1|Overall Study|Adverse Event|0
1022242|NCT00283400|3337387|P4|Overall Study|Death|0
1022243|NCT00283400|3337388|P3|Overall Study|Death|1
1022244|NCT00283400|3337389|P2|Overall Study|Death|0
1022245|NCT00283400|3337390|P1|Overall Study|Death|1
1022246|NCT00283400|3337387|P4|Overall Study|Withdrawal by Subject|0
1022247|NCT00283400|3337388|P3|Overall Study|Withdrawal by Subject|0
1022248|NCT00283400|3337389|P2|Overall Study|Withdrawal by Subject|1
1022249|NCT00283400|3337390|P1|Overall Study|Withdrawal by Subject|1
1022250|NCT00283387|3337408|P2|First Intervention|Withdrawal by Subject|1
1022251|NCT00283387|3337409|P1|First Intervention|Withdrawal by Subject|0
1022252|NCT00283387|3337408|P2|First Intervention|Subject non-compliant|1
1022253|NCT00283387|3337409|P1|First Intervention|Subject non-compliant|1
1022254|NCT00283296|3337415|P1|Overall Study|in-home trial not completed|5
1022255|NCT00283244|3337424|P3|Overall Study|Clinical deterioration|3
1022256|NCT00283244|3337425|P2|Overall Study|Clinical deterioration|3
1022257|NCT00283244|3337426|P1|Overall Study|Clinical deterioration|1
1022258|NCT00283244|3337424|P3|Overall Study|Medical illness (other complicating dz)|6
1022259|NCT00283244|3337425|P2|Overall Study|Medical illness (other complicating dz)|3
1022260|NCT00283244|3337426|P1|Overall Study|Medical illness (other complicating dz)|4
1022261|NCT00283244|3337424|P3|Overall Study|Physician Decision|1
1022262|NCT00283244|3337425|P2|Overall Study|Physician Decision|0
1022263|NCT00283244|3337426|P1|Overall Study|Physician Decision|0
1022264|NCT00283244|3337424|P3|Overall Study|Withdrawal by Subject|2
1022265|NCT00283244|3337425|P2|Overall Study|Withdrawal by Subject|2
1022266|NCT00283244|3337426|P1|Overall Study|Withdrawal by Subject|1
1022267|NCT00283244|3337424|P3|Overall Study|Lack of Efficacy|26
1022268|NCT00283244|3337425|P2|Overall Study|Lack of Efficacy|32
1022269|NCT00283244|3337426|P1|Overall Study|Lack of Efficacy|8
1022270|NCT00283244|3337424|P3|Overall Study|Death|2
1022271|NCT00283244|3337425|P2|Overall Study|Death|3
1022272|NCT00283244|3337426|P1|Overall Study|Death|4
1022273|NCT00283244|3337424|P3|Overall Study|Adverse Event|11
1022274|NCT00283244|3337425|P2|Overall Study|Adverse Event|8
1022275|NCT00283244|3337426|P1|Overall Study|Adverse Event|0
1022276|NCT00283062|3337462|P4|Overall Study|chemotherapy not completed (cycle 6)|0
1022277|NCT00283062|3337463|P3|Overall Study|chemotherapy not completed (cycle 6)|0
1022278|NCT00283062|3337464|P2|Overall Study|chemotherapy not completed (cycle 6)|0
1022279|NCT00283062|3337465|P1|Overall Study|chemotherapy not completed (cycle 6)|1
1022280|NCT00283062|3337462|P4|Overall Study|Undefined|4
1022281|NCT00283062|3337463|P3|Overall Study|Undefined|1
1022282|NCT00283062|3337464|P2|Overall Study|Undefined|1
1022283|NCT00283062|3337465|P1|Overall Study|Undefined|0
1022284|NCT00283062|3337462|P4|Overall Study|Participant did not wish to continue|0
1022285|NCT00283062|3337463|P3|Overall Study|Participant did not wish to continue|1
1022286|NCT00283062|3337464|P2|Overall Study|Participant did not wish to continue|2
1022287|NCT00283062|3337465|P1|Overall Study|Participant did not wish to continue|3
1022288|NCT00283062|3337462|P4|Overall Study|Progressive disease|0
1022289|NCT00283062|3337463|P3|Overall Study|Progressive disease|1
1022290|NCT00283062|3337464|P2|Overall Study|Progressive disease|0
1022291|NCT00283062|3337465|P1|Overall Study|Progressive disease|0
1022292|NCT00283062|3337462|P4|Overall Study|Lost to Follow-up|0
1022293|NCT00283062|3337463|P3|Overall Study|Lost to Follow-up|1
1022294|NCT00283062|3337464|P2|Overall Study|Lost to Follow-up|0
1022295|NCT00283062|3337465|P1|Overall Study|Lost to Follow-up|1
1022296|NCT00283062|3337462|P4|Overall Study|Adverse Event|0
1022297|NCT00283062|3337463|P3|Overall Study|Adverse Event|1
1022298|NCT00283062|3337464|P2|Overall Study|Adverse Event|0
1022299|NCT00283062|3337465|P1|Overall Study|Adverse Event|2
1022300|NCT00283062|3337462|P4|Overall Study|Did not receive any study medication|45
1022301|NCT00283062|3337463|P3|Overall Study|Did not receive any study medication|36
1022302|NCT00283062|3337464|P2|Overall Study|Did not receive any study medication|4
1022303|NCT00283062|3337465|P1|Overall Study|Did not receive any study medication|5
1022304|NCT00283049|3337498|P3|Overall Study|No longer requires study treatment|1
1022305|NCT00283049|3337499|P2|Overall Study|No longer requires study treatment|0
1022306|NCT00283049|3337500|P1|Overall Study|No longer requires study treatment|0
1022307|NCT00283049|3337498|P3|Overall Study|Discontinuation of Study|20
1022308|NCT00283049|3337499|P2|Overall Study|Discontinuation of Study|16
1022309|NCT00283049|3337500|P1|Overall Study|Discontinuation of Study|18
1022310|NCT00283049|3337498|P3|Overall Study|Withdrawal by Subject|19
1022311|NCT00283049|3337499|P2|Overall Study|Withdrawal by Subject|24
1022312|NCT00283049|3337500|P1|Overall Study|Withdrawal by Subject|26
1022313|NCT00283049|3337498|P3|Overall Study|Lost to Follow-up|5
1022314|NCT00283049|3337499|P2|Overall Study|Lost to Follow-up|2
1022315|NCT00283049|3337500|P1|Overall Study|Lost to Follow-up|4
1022316|NCT00283049|3337498|P3|Overall Study|Lack of Efficacy|1
1022317|NCT00283049|3337499|P2|Overall Study|Lack of Efficacy|1
1022318|NCT00283049|3337500|P1|Overall Study|Lack of Efficacy|0
1022319|NCT00283049|3337498|P3|Overall Study|Death|1
1022320|NCT00283049|3337499|P2|Overall Study|Death|1
1022321|NCT00283049|3337500|P1|Overall Study|Death|1
1022322|NCT00283049|3337498|P3|Overall Study|Protocol Violation|3
1022323|NCT00283049|3337499|P2|Overall Study|Protocol Violation|0
1022324|NCT00283049|3337500|P1|Overall Study|Protocol Violation|3
1022325|NCT00283049|3337498|P3|Overall Study|Adverse Event|4
1022326|NCT00283049|3337499|P2|Overall Study|Adverse Event|1
1022327|NCT00283049|3337500|P1|Overall Study|Adverse Event|6
1022328|NCT00282984|3337528|P2|Overall Study|Protocol Violation|0
1022329|NCT00282984|3337529|P1|Overall Study|Protocol Violation|2
1022330|NCT00282984|3337528|P2|Overall Study|in prison|1
1022331|NCT00282984|3337529|P1|Overall Study|in prison|0
1022332|NCT00282984|3337528|P2|Overall Study|lack of motivation|0
1022333|NCT00282984|3337529|P1|Overall Study|lack of motivation|1
1022334|NCT00282984|3337528|P2|Overall Study|Participant used antipsychosis meds|1
1022335|NCT00282984|3337529|P1|Overall Study|Participant used antipsychosis meds|0
1022336|NCT00282984|3337528|P2|Overall Study|Participant only allowed phone follow-up|1
1022337|NCT00282984|3337529|P1|Overall Study|Participant only allowed phone follow-up|0
1022338|NCT00282984|3337528|P2|Overall Study|Participant stopped study medication|2
1022339|NCT00282984|3337529|P1|Overall Study|Participant stopped study medication|2
1022340|NCT00282984|3337528|P2|Overall Study|Withdrawal by Participant|34
1022341|NCT00282984|3337529|P1|Overall Study|Withdrawal by Participant|22
1022342|NCT00282984|3337528|P2|Overall Study|Lost to Follow-up|10
1022343|NCT00282984|3337529|P1|Overall Study|Lost to Follow-up|14
1022344|NCT00282984|3337528|P2|Overall Study|Lack of Efficacy|2
1022345|NCT00282984|3337529|P1|Overall Study|Lack of Efficacy|0
1022346|NCT00282984|3337528|P2|Overall Study|Adverse Event|5
1022347|NCT00282984|3337529|P1|Overall Study|Adverse Event|8
1022348|NCT00282984|3337528|P2|Overall Study|Death|5
1022349|NCT00282984|3337529|P1|Overall Study|Death|2
1022350|NCT00282919|3337566|P1|Overall Study|Asymptomatic Parasitemia|2
1022351|NCT00282919|3337566|P1|Overall Study|Withdrawal by Subject|1
1022352|NCT00282919|3337566|P1|Overall Study|Lack of Efficacy|4
1022353|NCT00282867|3337581|P3|Overall Study|d/c prior to prim outcome, 3 m f/u done|0
1022354|NCT00282867|3337582|P2|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
1022355|NCT00282867|3337583|P1|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
1022356|NCT00282568|3337680|P1|Extended Treatment Period|Lost to Follow-up|2
1022357|NCT00282568|3337680|P1|Extended Treatment Period|Physician Decision|1
1022358|NCT00282568|3337680|P1|Extended Treatment Period|Non-compliance|4
1022359|NCT00282568|3337680|P1|Extended Treatment Period|Adverse Event|17
1022360|NCT00282568|3337680|P1|Pharmacokinetic Treatment Period|Enrolled erroneously|1
1022361|NCT00282568|3337680|P1|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2
1022362|NCT00282464|3337706|P2|Overall Study|dropped due to missed visits|1
1022363|NCT00282464|3337707|P1|Overall Study|dropped due to missed visits|0
1022364|NCT00282464|3337706|P2|Overall Study|dispensed wrong kit|1
1022365|NCT00282464|3337707|P1|Overall Study|dispensed wrong kit|0
1022366|NCT00282464|3337706|P2|Overall Study|family crisis|1
1022367|NCT00282464|3337707|P1|Overall Study|family crisis|0
1022368|NCT00282464|3337706|P2|Overall Study|patient incarcerated|1
1022369|NCT00282464|3337707|P1|Overall Study|patient incarcerated|0
1022370|NCT00282464|3337706|P2|Overall Study|patient no show|1
1022371|NCT00282464|3337707|P1|Overall Study|patient no show|0
1022372|NCT00282464|3337706|P2|Overall Study|patient non-compliant|0
1022373|NCT00282464|3337707|P1|Overall Study|patient non-compliant|3
1022374|NCT00282464|3337706|P2|Overall Study|Patient moved|0
1022375|NCT00282464|3337707|P1|Overall Study|Patient moved|1
1022376|NCT00282464|3337706|P2|Overall Study|Protocol Violation|7
1022377|NCT00282464|3337707|P1|Overall Study|Protocol Violation|0
1022378|NCT00282464|3337706|P2|Overall Study|laboratory abnormality|2
1022379|NCT00282464|3337707|P1|Overall Study|laboratory abnormality|1
1022380|NCT00282464|3337706|P2|Overall Study|Withdrawal by Subject|10
1022381|NCT00282464|3337707|P1|Overall Study|Withdrawal by Subject|24
1022382|NCT00282464|3337706|P2|Overall Study|Lost to Follow-up|10
1022383|NCT00282464|3337707|P1|Overall Study|Lost to Follow-up|10
1022384|NCT00282464|3337706|P2|Overall Study|Lack of Efficacy|8
1022385|NCT00282464|3337707|P1|Overall Study|Lack of Efficacy|8
1022386|NCT00282464|3337706|P2|Overall Study|Adverse Event|20
1022387|NCT00282464|3337707|P1|Overall Study|Adverse Event|26
1022388|NCT00282438|3337757|P2|Overall Study|Death|1
1022389|NCT00282438|3337758|P1|Overall Study|Death|0
1022390|NCT00282438|3337757|P2|Overall Study|Lack of Efficacy|0
1022391|NCT00282438|3337758|P1|Overall Study|Lack of Efficacy|1
1022392|NCT00282412|3337768|P1|Overall Study|Death|2
1022393|NCT00282347|3337774|P2|B Cell Follow-up Period|Reason Not Specified|0
1022394|NCT00282347|3337775|P1|B Cell Follow-up Period|Reason Not Specified|2
1022395|NCT00282347|3337774|P2|B Cell Follow-up Period|Physician Decision|0
1022396|NCT00282347|3337775|P1|B Cell Follow-up Period|Physician Decision|1
1022397|NCT00282347|3337774|P2|B Cell Follow-up Period|Withdrawal by Subject|0
1022398|NCT00282347|3337775|P1|B Cell Follow-up Period|Withdrawal by Subject|2
1022399|NCT00282347|3337774|P2|Safety Follow-up Period|Protocol Deviation|2
1022400|NCT00282347|3337775|P1|Safety Follow-up Period|Protocol Deviation|0
1022401|NCT00282347|3337774|P2|Safety Follow-up Period|Physician Decision|1
1022402|NCT00282347|3337775|P1|Safety Follow-up Period|Physician Decision|1
1022403|NCT00282347|3337774|P2|Safety Follow-up Period|Withdrawal by Subject|1
1022404|NCT00282347|3337775|P1|Safety Follow-up Period|Withdrawal by Subject|2
1022405|NCT00282347|3337774|P2|Safety Follow-up Period|Lost to Follow-up|2
1022406|NCT00282347|3337775|P1|Safety Follow-up Period|Lost to Follow-up|0
1022407|NCT00282347|3337774|P2|Treatment Period|Physician Decision|1
1022408|NCT00282347|3337775|P1|Treatment Period|Physician Decision|0
1022409|NCT00282347|3337774|P2|Treatment Period|Withdrawal by Subject|3
1022410|NCT00282347|3337775|P1|Treatment Period|Withdrawal by Subject|1
1022411|NCT00282347|3337774|P2|Treatment Period|Lost to Follow-up|5
1022412|NCT00282347|3337775|P1|Treatment Period|Lost to Follow-up|2
1022413|NCT00282347|3337774|P2|Treatment Period|Death|0
1022414|NCT00282347|3337775|P1|Treatment Period|Death|2
1022415|NCT00282334|3337801|P2|Overall Study|Withdrawal by Subject|5
1022416|NCT00282334|3337802|P1|Overall Study|Withdrawal by Subject|8
1022417|NCT00282308|3337810|P3|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12
1022418|NCT00282308|3337811|P2|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
1022419|NCT00282308|3337812|P1|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
1022420|NCT00282308|3337810|P3|Safety Follow-up Period|Physician Decision to Withdraw|1
1022421|NCT00282308|3337811|P2|Safety Follow-up Period|Physician Decision to Withdraw|0
1022422|NCT00282308|3337812|P1|Safety Follow-up Period|Physician Decision to Withdraw|0
1022423|NCT00282308|3337810|P3|Safety Follow-up Period|Lost to Follow-up|5
1022424|NCT00282308|3337811|P2|Safety Follow-up Period|Lost to Follow-up|0
1022425|NCT00282308|3337812|P1|Safety Follow-up Period|Lost to Follow-up|0
1022426|NCT00282308|3337810|P3|Safety Follow-up Period|Adverse Event|1
1022427|NCT00282308|3337811|P2|Safety Follow-up Period|Adverse Event|0
1022428|NCT00282308|3337812|P1|Safety Follow-up Period|Adverse Event|0
1022429|NCT00282308|3337810|P3|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1
1022430|NCT00282308|3337811|P2|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
1022431|NCT00282308|3337812|P1|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
1022432|NCT00282308|3337810|P3|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1
1022433|NCT00282308|3337811|P2|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
1022434|NCT00282308|3337812|P1|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
1022435|NCT00282308|3337810|P3|Optional Extension Re-treatment Period|Adverse Event|4
1022436|NCT00282308|3337811|P2|Optional Extension Re-treatment Period|Adverse Event|0
1022437|NCT00282308|3337812|P1|Optional Extension Re-treatment Period|Adverse Event|0
1022438|NCT00282308|3337810|P3|Treatment Period|Not Treated with Study Drug|0
1022439|NCT00282308|3337811|P2|Treatment Period|Not Treated with Study Drug|0
1022440|NCT00282308|3337812|P1|Treatment Period|Not Treated with Study Drug|1
1022441|NCT00282308|3337810|P3|Treatment Period|Adverse Event|0
1022442|NCT00282308|3337811|P2|Treatment Period|Adverse Event|2
1022443|NCT00282308|3337812|P1|Treatment Period|Adverse Event|0
1022444|NCT00282308|3337810|P3|Treatment Period|Subject/Guardian Decision to Withdraw|0
1022445|NCT00282308|3337811|P2|Treatment Period|Subject/Guardian Decision to Withdraw|4
1022446|NCT00282308|3337812|P1|Treatment Period|Subject/Guardian Decision to Withdraw|2
1022447|NCT00282308|3337810|P3|Treatment Period|Lost to Follow-up|0
1022448|NCT00282308|3337811|P2|Treatment Period|Lost to Follow-up|0
1022449|NCT00282308|3337812|P1|Treatment Period|Lost to Follow-up|1
1022450|NCT00282295|3337842|P3|Overall Study|Other|0
1022451|NCT00282295|3337843|P2|Overall Study|Other|1
1022452|NCT00282295|3337844|P1|Overall Study|Other|0
1022453|NCT00282295|3337842|P3|Overall Study|Lost to Follow-up|2
1022454|NCT00282295|3337843|P2|Overall Study|Lost to Follow-up|7
1022455|NCT00282295|3337844|P1|Overall Study|Lost to Follow-up|1
1022456|NCT00282295|3337842|P3|Overall Study|Withdrawal by Subject|4
1022457|NCT00282295|3337843|P2|Overall Study|Withdrawal by Subject|6
1022458|NCT00282295|3337844|P1|Overall Study|Withdrawal by Subject|2
1022459|NCT00282295|3337842|P3|Overall Study|Protocol Violation|1
1022460|NCT00282295|3337843|P2|Overall Study|Protocol Violation|2
1022461|NCT00282295|3337844|P1|Overall Study|Protocol Violation|0
1022462|NCT00282295|3337842|P3|Overall Study|Serious Adverse Events|1
1022463|NCT00282295|3337843|P2|Overall Study|Serious Adverse Events|0
1022464|NCT00282295|3337844|P1|Overall Study|Serious Adverse Events|0
1022465|NCT00282295|3337842|P3|Overall Study|Adverse Event|0
1022466|NCT00282295|3337843|P2|Overall Study|Adverse Event|1
1022467|NCT00282295|3337844|P1|Overall Study|Adverse Event|0
1022468|NCT00282256|3337899|P1|Extension Treatment Period|Adverse Event|2
1022469|NCT00282256|3337899|P1|Pharmacokinetic Treatment Period|Poor venous access|1
1022470|NCT00282243|3337920|P1|Extension Treatment Period|Physician Decision|1
1022471|NCT00282243|3337920|P1|Extension Treatment Period|Non-compliance|2
1022472|NCT00282243|3337920|P1|Extension Treatment Period|Withdrawal by Subject|4
1022473|NCT00282243|3337920|P1|Extension Treatment Period|Adverse Event|15
1022474|NCT00282243|3337920|P1|Pharmacokinetic Treatment Period|Withdrawal by Subject|2
1022475|NCT00282243|3337920|P1|Pharmacokinetic Treatment Period|Adverse Event|3
1022476|NCT00282152|3337946|P2|Overall Study|Withdrawal by Subject|0
1022477|NCT00282152|3337947|P1|Overall Study|Withdrawal by Subject|1
1022478|NCT00282113|3337968|P3|Overall Study|Removed at parents request|0
1022479|NCT00282113|3337969|P2|Overall Study|Removed at parents request|0
1022480|NCT00282113|3337970|P1|Overall Study|Removed at parents request|1
1022481|NCT00282087|3337984|P1|Overall Study|Death|1
1022482|NCT00282048|3337997|P1|Overall Study|Ongoing|1
1022483|NCT00282048|3337997|P1|Overall Study|Other|8
1022484|NCT00282048|3337997|P1|Overall Study|Withdrawal by Subject|1
1022485|NCT00282048|3337997|P1|Overall Study|Adverse Event|22
1022486|NCT00282048|3337997|P1|Overall Study|Lack of Efficacy|30
1022487|NCT00281957|3338011|P2|Overall Study|Refusal unrelated to adverse events|1
1022488|NCT00281957|3338012|P1|Overall Study|Refusal unrelated to adverse events|0
1022489|NCT00281957|3338011|P2|Overall Study|Did not start treatment|1
1022490|NCT00281957|3338012|P1|Overall Study|Did not start treatment|3
1022491|NCT00281957|3338011|P2|Overall Study|Not eligible|2
1022492|NCT00281957|3338012|P1|Overall Study|Not eligible|1
1022493|NCT00281957|3338011|P2|Overall Study|Not protocol specified|1
1022494|NCT00281957|3338012|P1|Overall Study|Not protocol specified|8
1022495|NCT00281957|3338011|P2|Overall Study|Progression/relapse|35
1022496|NCT00281957|3338012|P1|Overall Study|Progression/relapse|47
1022497|NCT00281957|3338011|P2|Overall Study|Death|0
1022498|NCT00281957|3338012|P1|Overall Study|Death|1
1022499|NCT00281957|3338011|P2|Overall Study|Adverse Event|2
1022500|NCT00281957|3338012|P1|Overall Study|Adverse Event|7
1022501|NCT00281840|3338086|P1|Overall Study|Complicating Disease|1
1022502|NCT00281840|3338086|P1|Overall Study|exceed maximum delay in treatment|1
1022503|NCT00281840|3338086|P1|Overall Study|Disease Progression|2
1022504|NCT00281840|3338086|P1|Overall Study|Withdrawal by Subject|3
1022505|NCT00281840|3338086|P1|Overall Study|Physician Decision|6
1022506|NCT00281840|3338086|P1|Overall Study|Adverse Event|12
1022507|NCT00281697|3338102|P2|Overall Study|Did not receive study drug|2
1022508|NCT00281697|3338103|P1|Overall Study|Did not receive study drug|3
1022509|NCT00281697|3338102|P2|Overall Study|Subject/guardian's decision to withdraw|6
1022510|NCT00281697|3338103|P1|Overall Study|Subject/guardian's decision to withdraw|33
1022511|NCT00281697|3338102|P2|Overall Study|Physician's decision to withdraw|12
1022512|NCT00281697|3338103|P1|Overall Study|Physician's decision to withdraw|15
1022513|NCT00281697|3338102|P2|Overall Study|Not specified|6
1022514|NCT00281697|3338103|P1|Overall Study|Not specified|5
1022515|NCT00281697|3338102|P2|Overall Study|Disease progression|149
1022516|NCT00281697|3338103|P1|Overall Study|Disease progression|279
1022517|NCT00281697|3338102|P2|Overall Study|Death|3
1022518|NCT00281697|3338103|P1|Overall Study|Death|8
1022519|NCT00281697|3338102|P2|Overall Study|Adverse Event|15
1022520|NCT00281697|3338103|P1|Overall Study|Adverse Event|54
1022521|NCT00281697|3338102|P2|Overall Study|> 60 days since last dose of study drug|4
1022522|NCT00281697|3338103|P1|Overall Study|> 60 days since last dose of study drug|4
1022523|NCT00281658|3338121|P3|Open-label Monotherapy Extension Phase|Withdrawal by Subject|1
1022524|NCT00281658|3338122|P2|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
1022525|NCT00281658|3338123|P1|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
1022526|NCT00281658|3338121|P3|Open-label Monotherapy Extension Phase|Lost to Follow-up|3
1022527|NCT00281658|3338122|P2|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
1022528|NCT00281658|3338123|P1|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
1022529|NCT00281658|3338121|P3|Open-label Monotherapy Extension Phase|Death|97
1022530|NCT00281658|3338122|P2|Open-label Monotherapy Extension Phase|Death|0
1022531|NCT00281658|3338123|P1|Open-label Monotherapy Extension Phase|Death|0
1022532|NCT00281658|3338121|P3|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
1022533|NCT00281658|3338122|P2|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|1
1022534|NCT00281658|3338123|P1|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
1022535|NCT00281658|3338121|P3|Double-blind, Randomized Phase|Participant Entered New Protocol|0
1022536|NCT00281658|3338122|P2|Double-blind, Randomized Phase|Participant Entered New Protocol|1
1022537|NCT00281658|3338123|P1|Double-blind, Randomized Phase|Participant Entered New Protocol|1
1022538|NCT00281658|3338121|P3|Double-blind, Randomized Phase|Withdrawal by Subject|0
1022539|NCT00281658|3338122|P2|Double-blind, Randomized Phase|Withdrawal by Subject|1
1022540|NCT00281658|3338123|P1|Double-blind, Randomized Phase|Withdrawal by Subject|4
1022541|NCT00281658|3338121|P3|Double-blind, Randomized Phase|Lost to Follow-up|0
1022542|NCT00281658|3338122|P2|Double-blind, Randomized Phase|Lost to Follow-up|5
1022543|NCT00281658|3338123|P1|Double-blind, Randomized Phase|Lost to Follow-up|12
1022544|NCT00281658|3338121|P3|Double-blind, Randomized Phase|Death|0
1022545|NCT00281658|3338122|P2|Double-blind, Randomized Phase|Death|46
1022546|NCT00281658|3338123|P1|Double-blind, Randomized Phase|Death|120
1022547|NCT00281632|3338140|P1|Overall Study|Ongoing|3
1022548|NCT00281632|3338140|P1|Overall Study|Physician Decision|1
1022549|NCT00281632|3338140|P1|Overall Study|Death|1
1022550|NCT00281632|3338140|P1|Overall Study|Disease Progression|22
1022551|NCT00281632|3338140|P1|Overall Study|Withdrawal by Subject|2
1022552|NCT00281632|3338140|P1|Overall Study|Adverse Event|7
1022553|NCT00281580|3338182|P16|Overall Study|Randomised in error; pregnancy; moving|2
1022554|NCT00281580|3338183|P15|Overall Study|Randomised in error; pregnancy; moving|1
1022555|NCT00281580|3338184|P14|Overall Study|Randomised in error; pregnancy; moving|0
1022556|NCT00281580|3338185|P13|Overall Study|Randomised in error; pregnancy; moving|2
1022557|NCT00281580|3338186|P12|Overall Study|Randomised in error; pregnancy; moving|1
1022558|NCT00281580|3338187|P11|Overall Study|Randomised in error; pregnancy; moving|1
1022559|NCT00281580|3338188|P10|Overall Study|Randomised in error; pregnancy; moving|1
1022560|NCT00281580|3338189|P9|Overall Study|Randomised in error; pregnancy; moving|2
1022561|NCT00281580|3338190|P8|Overall Study|Randomised in error; pregnancy; moving|0
1022562|NCT00281580|3338191|P7|Overall Study|Randomised in error; pregnancy; moving|1
1022563|NCT00281580|3338192|P6|Overall Study|Randomised in error; pregnancy; moving|0
1022564|NCT00281580|3338193|P5|Overall Study|Randomised in error; pregnancy; moving|0
1022565|NCT00281580|3338194|P4|Overall Study|Randomised in error; pregnancy; moving|2
1022566|NCT00281580|3338195|P3|Overall Study|Randomised in error; pregnancy; moving|0
1022567|NCT00281580|3338196|P2|Overall Study|Randomised in error; pregnancy; moving|0
1022568|NCT00281580|3338197|P1|Overall Study|Randomised in error; pregnancy; moving|0
1022569|NCT00281580|3338182|P16|Overall Study|Lost to Follow-up|0
1022570|NCT00281580|3338183|P15|Overall Study|Lost to Follow-up|0
1022571|NCT00281580|3338184|P14|Overall Study|Lost to Follow-up|0
1022572|NCT00281580|3338185|P13|Overall Study|Lost to Follow-up|1
1022573|NCT00281580|3338186|P12|Overall Study|Lost to Follow-up|0
1022574|NCT00281580|3338187|P11|Overall Study|Lost to Follow-up|1
1022575|NCT00281580|3338188|P10|Overall Study|Lost to Follow-up|1
1022576|NCT00281580|3338189|P9|Overall Study|Lost to Follow-up|2
1022577|NCT00281580|3338190|P8|Overall Study|Lost to Follow-up|1
1022578|NCT00281580|3338191|P7|Overall Study|Lost to Follow-up|0
1022579|NCT00281580|3338192|P6|Overall Study|Lost to Follow-up|1
1022580|NCT00281580|3338193|P5|Overall Study|Lost to Follow-up|0
1022581|NCT00281580|3338194|P4|Overall Study|Lost to Follow-up|3
1022582|NCT00281580|3338195|P3|Overall Study|Lost to Follow-up|0
1022583|NCT00281580|3338196|P2|Overall Study|Lost to Follow-up|0
1022584|NCT00281580|3338197|P1|Overall Study|Lost to Follow-up|0
1022585|NCT00281580|3338182|P16|Overall Study|Lack of Efficacy|0
1022586|NCT00281580|3338183|P15|Overall Study|Lack of Efficacy|1
1022587|NCT00281580|3338184|P14|Overall Study|Lack of Efficacy|2
1022588|NCT00281580|3338185|P13|Overall Study|Lack of Efficacy|0
1022589|NCT00281580|3338186|P12|Overall Study|Lack of Efficacy|1
1022590|NCT00281580|3338187|P11|Overall Study|Lack of Efficacy|0
1022591|NCT00281580|3338188|P10|Overall Study|Lack of Efficacy|0
1022592|NCT00281580|3338189|P9|Overall Study|Lack of Efficacy|0
1022593|NCT00281580|3338190|P8|Overall Study|Lack of Efficacy|0
1022594|NCT00281580|3338191|P7|Overall Study|Lack of Efficacy|0
1022595|NCT00281580|3338192|P6|Overall Study|Lack of Efficacy|0
1022596|NCT00281580|3338193|P5|Overall Study|Lack of Efficacy|2
1022597|NCT00281580|3338194|P4|Overall Study|Lack of Efficacy|6
1022598|NCT00281580|3338195|P3|Overall Study|Lack of Efficacy|1
1022599|NCT00281580|3338196|P2|Overall Study|Lack of Efficacy|1
1022600|NCT00281580|3338197|P1|Overall Study|Lack of Efficacy|2
1022601|NCT00281580|3338182|P16|Overall Study|Withdrawal by Subject|5
1022602|NCT00281580|3338183|P15|Overall Study|Withdrawal by Subject|1
1022603|NCT00281580|3338184|P14|Overall Study|Withdrawal by Subject|2
1022604|NCT00281580|3338185|P13|Overall Study|Withdrawal by Subject|2
1022605|NCT00281580|3338186|P12|Overall Study|Withdrawal by Subject|1
1022606|NCT00281580|3338187|P11|Overall Study|Withdrawal by Subject|1
1022607|NCT00281580|3338188|P10|Overall Study|Withdrawal by Subject|4
1022608|NCT00281580|3338189|P9|Overall Study|Withdrawal by Subject|1
1022609|NCT00281580|3338190|P8|Overall Study|Withdrawal by Subject|0
1022610|NCT00281580|3338191|P7|Overall Study|Withdrawal by Subject|2
1022611|NCT00281580|3338192|P6|Overall Study|Withdrawal by Subject|2
1022612|NCT00281580|3338193|P5|Overall Study|Withdrawal by Subject|1
1022613|NCT00281580|3338194|P4|Overall Study|Withdrawal by Subject|1
1022614|NCT00281580|3338195|P3|Overall Study|Withdrawal by Subject|1
1022615|NCT00281580|3338196|P2|Overall Study|Withdrawal by Subject|0
1022616|NCT00281580|3338197|P1|Overall Study|Withdrawal by Subject|3
1022617|NCT00281580|3338182|P16|Overall Study|Protocol Violation|3
1022618|NCT00281580|3338183|P15|Overall Study|Protocol Violation|1
1022619|NCT00281580|3338184|P14|Overall Study|Protocol Violation|1
1022620|NCT00281580|3338185|P13|Overall Study|Protocol Violation|0
1022621|NCT00281580|3338186|P12|Overall Study|Protocol Violation|2
1022622|NCT00281580|3338187|P11|Overall Study|Protocol Violation|1
1022623|NCT00281580|3338188|P10|Overall Study|Protocol Violation|0
1022624|NCT00281580|3338189|P9|Overall Study|Protocol Violation|2
1022625|NCT00281580|3338190|P8|Overall Study|Protocol Violation|0
1022626|NCT00281580|3338191|P7|Overall Study|Protocol Violation|1
1022627|NCT00281580|3338192|P6|Overall Study|Protocol Violation|0
1022628|NCT00281580|3338193|P5|Overall Study|Protocol Violation|0
1022629|NCT00281580|3338194|P4|Overall Study|Protocol Violation|1
1022630|NCT00281580|3338195|P3|Overall Study|Protocol Violation|1
1022631|NCT00281580|3338196|P2|Overall Study|Protocol Violation|0
1022632|NCT00281580|3338197|P1|Overall Study|Protocol Violation|0
1022633|NCT00281580|3338182|P16|Overall Study|Adverse Event|3
1022634|NCT00281580|3338183|P15|Overall Study|Adverse Event|3
1022635|NCT00281580|3338184|P14|Overall Study|Adverse Event|2
1022636|NCT00281580|3338185|P13|Overall Study|Adverse Event|8
1022637|NCT00281580|3338186|P12|Overall Study|Adverse Event|5
1022638|NCT00281580|3338187|P11|Overall Study|Adverse Event|0
1022639|NCT00281580|3338188|P10|Overall Study|Adverse Event|6
1022640|NCT00281580|3338189|P9|Overall Study|Adverse Event|1
1022641|NCT00281580|3338190|P8|Overall Study|Adverse Event|0
1022642|NCT00281580|3338191|P7|Overall Study|Adverse Event|1
1022643|NCT00281580|3338192|P6|Overall Study|Adverse Event|0
1022644|NCT00281580|3338193|P5|Overall Study|Adverse Event|1
1022645|NCT00281580|3338194|P4|Overall Study|Adverse Event|4
1022646|NCT00281580|3338195|P3|Overall Study|Adverse Event|2
1022647|NCT00281580|3338196|P2|Overall Study|Adverse Event|0
1022648|NCT00281580|3338197|P1|Overall Study|Adverse Event|2
1022649|NCT00281528|3338544|P3|Overall Study|Other|5
1022650|NCT00281528|3338545|P2|Overall Study|Other|3
1022651|NCT00281528|3338546|P1|Overall Study|Other|6
1022652|NCT00281528|3338544|P3|Overall Study|Withdrawal by Subject|7
1022653|NCT00281528|3338545|P2|Overall Study|Withdrawal by Subject|5
1022654|NCT00281528|3338546|P1|Overall Study|Withdrawal by Subject|5
1022655|NCT00281528|3338544|P3|Overall Study|Protocol Violation|1
1022656|NCT00281528|3338545|P2|Overall Study|Protocol Violation|0
1022657|NCT00281528|3338546|P1|Overall Study|Protocol Violation|1
1022658|NCT00281528|3338544|P3|Overall Study|Physician Decision|5
1022659|NCT00281528|3338545|P2|Overall Study|Physician Decision|4
1022660|NCT00281528|3338546|P1|Overall Study|Physician Decision|11
1022661|NCT00281528|3338544|P3|Overall Study|Adverse Event-unrelated to treatment|2
1022662|NCT00281528|3338545|P2|Overall Study|Adverse Event-unrelated to treatment|0
1022663|NCT00281528|3338546|P1|Overall Study|Adverse Event-unrelated to treatment|3
1022664|NCT00281528|3338544|P3|Overall Study|Unacceptable Toxicity-related to trt|32
1022665|NCT00281528|3338545|P2|Overall Study|Unacceptable Toxicity-related to trt|24
1022666|NCT00281528|3338546|P1|Overall Study|Unacceptable Toxicity-related to trt|21
1022667|NCT00281528|3338544|P3|Overall Study|Progressive Disease|27
1022668|NCT00281528|3338545|P2|Overall Study|Progressive Disease|18
1022669|NCT00281528|3338546|P1|Overall Study|Progressive Disease|28
1022670|NCT00281320|3338597|P2|Overall Study|Not specified|1
1022671|NCT00281320|3338598|P1|Overall Study|Not specified|3
1022672|NCT00281320|3338597|P2|Overall Study|Lost to Follow-up|2
1022673|NCT00281320|3338598|P1|Overall Study|Lost to Follow-up|1
1022674|NCT00281320|3338597|P2|Overall Study|Withdrawal by Subject|6
1022675|NCT00281320|3338598|P1|Overall Study|Withdrawal by Subject|5
1022676|NCT00281320|3338597|P2|Overall Study|Lack of Efficacy|3
1022677|NCT00281320|3338598|P1|Overall Study|Lack of Efficacy|4
1022678|NCT00281320|3338597|P2|Overall Study|Adverse Event|9
1022679|NCT00281320|3338598|P1|Overall Study|Adverse Event|12
1022680|NCT00281099|3338620|P2|Overall Study|Heart Transplant/Device Exit/Changeout|4
1022681|NCT00281099|3338621|P1|Overall Study|Heart Transplant/Device Exit/Changeout|5
1022682|NCT00281099|3338620|P2|Overall Study|Physician Decision|72
1022683|NCT00281099|3338621|P1|Overall Study|Physician Decision|79
1022684|NCT00281099|3338620|P2|Overall Study|Withdrawal by Subject|70
1022685|NCT00281099|3338621|P1|Overall Study|Withdrawal by Subject|65
1022686|NCT00281099|3338620|P2|Overall Study|Lost to Follow-up|19
1022687|NCT00281099|3338621|P1|Overall Study|Lost to Follow-up|10
1022688|NCT00281099|3338620|P2|Overall Study|Death|57
1022689|NCT00281099|3338621|P1|Overall Study|Death|46
1022690|NCT00280917|3338670|P4|Overall Study|Noncompliance|0
1022691|NCT00280917|3338671|P3|Overall Study|Noncompliance|2
1022692|NCT00280917|3338672|P2|Overall Study|Noncompliance|1
1022693|NCT00280917|3338673|P1|Overall Study|Noncompliance|0
1022694|NCT00280917|3338670|P4|Overall Study|Withdrawal by Subject|1
1022695|NCT00280917|3338671|P3|Overall Study|Withdrawal by Subject|0
1022696|NCT00280917|3338672|P2|Overall Study|Withdrawal by Subject|2
1022697|NCT00280917|3338673|P1|Overall Study|Withdrawal by Subject|0
1022698|NCT00280917|3338670|P4|Overall Study|Change Therapy|0
1022699|NCT00280917|3338671|P3|Overall Study|Change Therapy|0
1022700|NCT00280917|3338672|P2|Overall Study|Change Therapy|2
1022701|NCT00280917|3338673|P1|Overall Study|Change Therapy|1
1022702|NCT00280917|3338670|P4|Overall Study|Adverse Event|1
1022703|NCT00280917|3338671|P3|Overall Study|Adverse Event|4
1022704|NCT00280917|3338672|P2|Overall Study|Adverse Event|1
1022705|NCT00280917|3338673|P1|Overall Study|Adverse Event|1
1022706|NCT00280748|3338696|P1|Overall Study|Extra-cranial disease progression|1
1022707|NCT00280748|3338696|P1|Overall Study|Decline in performance|3
1022708|NCT00280735|3338706|P1|Overall Study|Intercurrent Illness|2
1022709|NCT00280735|3338706|P1|Overall Study|Withdrawal by Subject|8
1022710|NCT00280735|3338706|P1|Overall Study|Lack of Efficacy|3
1022711|NCT00280735|3338706|P1|Overall Study|Adverse Event|5
1022712|NCT00280683|3338718|P2|Overall Study|Adverse Event|1
1022713|NCT00280683|3338719|P1|Overall Study|Adverse Event|1
1022714|NCT00280683|3338718|P2|Overall Study|Withdrawal by Subject|2
1022715|NCT00280683|3338719|P1|Overall Study|Withdrawal by Subject|1
1022716|NCT00280566|3338729|P3|Period 2 Double Blind|miscellaneous|5
1022717|NCT00280566|3338730|P2|Period 2 Double Blind|miscellaneous|10
1022718|NCT00280566|3338731|P1|Period 2 Double Blind|miscellaneous|0
1022719|NCT00280566|3338729|P3|Period 2 Double Blind|Withdrawal by Subject|9
1022720|NCT00280566|3338730|P2|Period 2 Double Blind|Withdrawal by Subject|9
1022721|NCT00280566|3338731|P1|Period 2 Double Blind|Withdrawal by Subject|0
1022722|NCT00280566|3338729|P3|Period 2 Double Blind|Lost to Follow-up|6
1022723|NCT00280566|3338730|P2|Period 2 Double Blind|Lost to Follow-up|3
1022724|NCT00280566|3338731|P1|Period 2 Double Blind|Lost to Follow-up|0
1022725|NCT00280566|3338729|P3|Period 2 Double Blind|Adverse Event|15
1022726|NCT00280566|3338730|P2|Period 2 Double Blind|Adverse Event|11
1022727|NCT00280566|3338731|P1|Period 2 Double Blind|Adverse Event|0
1022728|NCT00280566|3338729|P3|Period 2 Double Blind|Laboratory Abnormality|0
1022729|NCT00280566|3338730|P2|Period 2 Double Blind|Laboratory Abnormality|1
1022730|NCT00280566|3338731|P1|Period 2 Double Blind|Laboratory Abnormality|0
1022731|NCT00280566|3338729|P3|Period 2 Double Blind|Lack of Efficacy|22
1022732|NCT00280566|3338730|P2|Period 2 Double Blind|Lack of Efficacy|9
1022733|NCT00280566|3338731|P1|Period 2 Double Blind|Lack of Efficacy|0
1022734|NCT00280566|3338729|P3|Period 1 Open Label Ziprasidone|Miscellaneous|0
1022735|NCT00280566|3338730|P2|Period 1 Open Label Ziprasidone|Miscellaneous|0
1022736|NCT00280566|3338731|P1|Period 1 Open Label Ziprasidone|Miscellaneous|50
1022737|NCT00280566|3338729|P3|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
1022738|NCT00280566|3338730|P2|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
1022739|NCT00280566|3338731|P1|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76
1022740|NCT00280566|3338729|P3|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
1022741|NCT00280566|3338730|P2|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
1022742|NCT00280566|3338731|P1|Period 1 Open Label Ziprasidone|Lost to Follow-up|35
1022743|NCT00280566|3338729|P3|Period 1 Open Label Ziprasidone|Adverse Event|0
1022744|NCT00280566|3338730|P2|Period 1 Open Label Ziprasidone|Adverse Event|0
1022745|NCT00280566|3338731|P1|Period 1 Open Label Ziprasidone|Adverse Event|148
1022746|NCT00280566|3338729|P3|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
1022747|NCT00280566|3338730|P2|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
1022748|NCT00280566|3338731|P1|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3
1022749|NCT00280566|3338729|P3|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
1022750|NCT00280566|3338730|P2|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
1022751|NCT00280566|3338731|P1|Period 1 Open Label Ziprasidone|Lack of Efficacy|31
1022752|NCT00280397|3338756|P1|Overall Study|Adverse Event|1
1022753|NCT00280293|3338822|P2|Overall Study|Adverse Event|1
1022754|NCT00280293|3338823|P1|Overall Study|Adverse Event|0
1022755|NCT00280293|3338822|P2|Overall Study|Incarceration/Legal Reasons|1
1022756|NCT00280293|3338823|P1|Overall Study|Incarceration/Legal Reasons|1
1022757|NCT00280293|3338822|P2|Overall Study|Withdrawal by Subject|5
1022758|NCT00280293|3338823|P1|Overall Study|Withdrawal by Subject|3
1022759|NCT00280293|3338822|P2|Overall Study|Lost to Follow-up|12
1022760|NCT00280293|3338823|P1|Overall Study|Lost to Follow-up|14
1022761|NCT00280293|3338822|P2|Overall Study|Physician Decision|4
1022762|NCT00280293|3338823|P1|Overall Study|Physician Decision|5
1022763|NCT00280293|3338822|P2|Overall Study|Protocol Violation|0
1022764|NCT00280293|3338823|P1|Overall Study|Protocol Violation|3
1022765|NCT00280150|3338846|P4|Overall Study|Declining Performance Status|1
1022766|NCT00280150|3338847|P3|Overall Study|Declining Performance Status|0
1022767|NCT00280150|3338848|P2|Overall Study|Declining Performance Status|0
1022768|NCT00280150|3338849|P1|Overall Study|Declining Performance Status|0
1022769|NCT00280150|3338846|P4|Overall Study|Did not get consolidation therapy|0
1022770|NCT00280150|3338847|P3|Overall Study|Did not get consolidation therapy|3
1022771|NCT00280150|3338848|P2|Overall Study|Did not get consolidation therapy|0
1022772|NCT00280150|3338849|P1|Overall Study|Did not get consolidation therapy|3
1022773|NCT00280150|3338846|P4|Overall Study|Withdrawal by Subject|1
1022774|NCT00280150|3338847|P3|Overall Study|Withdrawal by Subject|0
1022775|NCT00280150|3338848|P2|Overall Study|Withdrawal by Subject|0
1022776|NCT00280150|3338849|P1|Overall Study|Withdrawal by Subject|0
1022777|NCT00280150|3338846|P4|Overall Study|Protocol Violation|1
1022778|NCT00280150|3338847|P3|Overall Study|Protocol Violation|0
1022779|NCT00280150|3338848|P2|Overall Study|Protocol Violation|0
1022780|NCT00280150|3338849|P1|Overall Study|Protocol Violation|0
1022781|NCT00280150|3338846|P4|Overall Study|Physician Decision|1
1022782|NCT00280150|3338847|P3|Overall Study|Physician Decision|0
1022783|NCT00280150|3338848|P2|Overall Study|Physician Decision|0
1022784|NCT00280150|3338849|P1|Overall Study|Physician Decision|0
1022785|NCT00280150|3338846|P4|Overall Study|Lack of Efficacy|3
1022786|NCT00280150|3338847|P3|Overall Study|Lack of Efficacy|0
1022787|NCT00280150|3338848|P2|Overall Study|Lack of Efficacy|0
1022788|NCT00280150|3338849|P1|Overall Study|Lack of Efficacy|0
1022789|NCT00280150|3338846|P4|Overall Study|Adverse Event|3
1022790|NCT00280150|3338847|P3|Overall Study|Adverse Event|2
1022791|NCT00280150|3338848|P2|Overall Study|Adverse Event|1
1022792|NCT00280150|3338849|P1|Overall Study|Adverse Event|0
1022793|NCT00280059|3338864|P2|Efficacy Assessment Phase|Withdrawal by Subject|25
1022794|NCT00280059|3338865|P1|Efficacy Assessment Phase|Withdrawal by Subject|26
1022795|NCT00280059|3338864|P2|Efficacy Assessment Phase|Other|8
1022796|NCT00280059|3338865|P1|Efficacy Assessment Phase|Other|7
1022797|NCT00280059|3338864|P2|Efficacy Assessment Phase|Lost to Follow-up|13
1022798|NCT00280059|3338865|P1|Efficacy Assessment Phase|Lost to Follow-up|6
1022799|NCT00280059|3338864|P2|Efficacy Assessment Phase|Lack of Efficacy|3
1022800|NCT00280059|3338865|P1|Efficacy Assessment Phase|Lack of Efficacy|19
1022801|NCT00280059|3338864|P2|Efficacy Assessment Phase|Laboratory abnormaility|0
1022802|NCT00280059|3338865|P1|Efficacy Assessment Phase|Laboratory abnormaility|1
1022803|NCT00280059|3338864|P2|Efficacy Assessment Phase|Adverse Event|31
1022804|NCT00280059|3338865|P1|Efficacy Assessment Phase|Adverse Event|33
1022805|NCT00280059|3338864|P2|Efficacy Assessment Phase|Death|0
1022806|NCT00280059|3338865|P1|Efficacy Assessment Phase|Death|2
1022807|NCT00279916|3338929|P2|Overall Study|Lost to Follow-up|2
1022808|NCT00279916|3338930|P1|Overall Study|Lost to Follow-up|3
1022809|NCT00279916|3338929|P2|Overall Study|Withdrawal by Subject|3
1022810|NCT00279916|3338930|P1|Overall Study|Withdrawal by Subject|4
1022811|NCT00279812|3338956|P6|Overall Study|Adverse Event|1
1022812|NCT00279812|3338957|P5|Overall Study|Adverse Event|2
1022813|NCT00279812|3338958|P4|Overall Study|Adverse Event|0
1022814|NCT00279812|3338959|P3|Overall Study|Adverse Event|1
1022815|NCT00279812|3338960|P2|Overall Study|Adverse Event|1
1022816|NCT00279812|3338961|P1|Overall Study|Adverse Event|0
1022817|NCT00279812|3338956|P6|Overall Study|Withdrawal by Subject|0
1022818|NCT00279812|3338957|P5|Overall Study|Withdrawal by Subject|0
1022819|NCT00279812|3338958|P4|Overall Study|Withdrawal by Subject|0
1022820|NCT00279812|3338959|P3|Overall Study|Withdrawal by Subject|2
1022821|NCT00279812|3338960|P2|Overall Study|Withdrawal by Subject|4
1022822|NCT00279812|3338961|P1|Overall Study|Withdrawal by Subject|0
1022823|NCT00279812|3338956|P6|Overall Study|Protocol Violation|0
1022824|NCT00279812|3338957|P5|Overall Study|Protocol Violation|1
1022825|NCT00279812|3338958|P4|Overall Study|Protocol Violation|0
1022826|NCT00279812|3338959|P3|Overall Study|Protocol Violation|0
1022827|NCT00279812|3338960|P2|Overall Study|Protocol Violation|1
1022828|NCT00279812|3338961|P1|Overall Study|Protocol Violation|1
1022829|NCT00279708|3338989|P2|Overall Study|Adverse Event|1
1022830|NCT00279708|3338990|P1|Overall Study|Adverse Event|1
1022831|NCT00279708|3338989|P2|Overall Study|Withdrawal by Subject|3
1022832|NCT00279708|3338990|P1|Overall Study|Withdrawal by Subject|2
1022833|NCT00279305|3339019|P2|Overall Study|FDA Safety Alert|1
1022834|NCT00279305|3339020|P1|Overall Study|FDA Safety Alert|4
1022835|NCT00279305|3339019|P2|Overall Study|Dificulting establishing IV|0
1022836|NCT00279305|3339020|P1|Overall Study|Dificulting establishing IV|1
1022837|NCT00279305|3339019|P2|Overall Study|Withdrawal by Subject|0
1022838|NCT00279305|3339020|P1|Overall Study|Withdrawal by Subject|2
1022839|NCT00279305|3339019|P2|Overall Study|Pregnancy|0
1022840|NCT00279305|3339020|P1|Overall Study|Pregnancy|1
1022841|NCT00279214|3339028|P2|Overall Study|Physician Decision|2
1022842|NCT00279214|3339029|P1|Overall Study|Physician Decision|3
1022843|NCT00279201|3339059|P6|Intensification Addendum|Death|0
1022844|NCT00279201|3339060|P5|Intensification Addendum|Death|1
1022845|NCT00279201|3339061|P4|Intensification Addendum|Death|0
1022846|NCT00279201|3339062|P3|Intensification Addendum|Death|0
1022847|NCT00279201|3339063|P2|Intensification Addendum|Death|0
1022848|NCT00279201|3339064|P1|Intensification Addendum|Death|0
1022849|NCT00279201|3339059|P6|Intensification Addendum|Lack of Efficacy|0
1022850|NCT00279201|3339060|P5|Intensification Addendum|Lack of Efficacy|1
1022851|NCT00279201|3339061|P4|Intensification Addendum|Lack of Efficacy|1
1022852|NCT00279201|3339062|P3|Intensification Addendum|Lack of Efficacy|0
1022853|NCT00279201|3339063|P2|Intensification Addendum|Lack of Efficacy|0
1022854|NCT00279201|3339064|P1|Intensification Addendum|Lack of Efficacy|0
1022855|NCT00279201|3339059|P6|Intensification Addendum|Entry Criteria Exclusion|0
1022856|NCT00279201|3339060|P5|Intensification Addendum|Entry Criteria Exclusion|0
1022857|NCT00279201|3339061|P4|Intensification Addendum|Entry Criteria Exclusion|0
1022858|NCT00279201|3339062|P3|Intensification Addendum|Entry Criteria Exclusion|1
1022859|NCT00279201|3339063|P2|Intensification Addendum|Entry Criteria Exclusion|0
1022860|NCT00279201|3339064|P1|Intensification Addendum|Entry Criteria Exclusion|0
1022861|NCT00279201|3339059|P6|Intensification Addendum|Sponsor Decision|1
1022862|NCT00279201|3339060|P5|Intensification Addendum|Sponsor Decision|1
1022863|NCT00279201|3339061|P4|Intensification Addendum|Sponsor Decision|0
1022864|NCT00279201|3339062|P3|Intensification Addendum|Sponsor Decision|0
1022865|NCT00279201|3339063|P2|Intensification Addendum|Sponsor Decision|0
1022866|NCT00279201|3339064|P1|Intensification Addendum|Sponsor Decision|0
1022867|NCT00279201|3339059|P6|Intensification Addendum|Physician Decision|2
1022868|NCT00279201|3339060|P5|Intensification Addendum|Physician Decision|3
1022869|NCT00279201|3339061|P4|Intensification Addendum|Physician Decision|1
1022870|NCT00279201|3339062|P3|Intensification Addendum|Physician Decision|4
1022871|NCT00279201|3339063|P2|Intensification Addendum|Physician Decision|0
1022872|NCT00279201|3339064|P1|Intensification Addendum|Physician Decision|0
1022873|NCT00279201|3339059|P6|Intensification Addendum|Adverse Event|3
1022874|NCT00279201|3339060|P5|Intensification Addendum|Adverse Event|1
1022875|NCT00279201|3339061|P4|Intensification Addendum|Adverse Event|4
1022876|NCT00279201|3339062|P3|Intensification Addendum|Adverse Event|0
1022877|NCT00279201|3339063|P2|Intensification Addendum|Adverse Event|0
1022878|NCT00279201|3339064|P1|Intensification Addendum|Adverse Event|0
1022879|NCT00279201|3339059|P6|Intensification Addendum|Protocol Violation|6
1022880|NCT00279201|3339060|P5|Intensification Addendum|Protocol Violation|6
1022881|NCT00279201|3339061|P4|Intensification Addendum|Protocol Violation|2
1022882|NCT00279201|3339062|P3|Intensification Addendum|Protocol Violation|2
1022883|NCT00279201|3339063|P2|Intensification Addendum|Protocol Violation|0
1022884|NCT00279201|3339064|P1|Intensification Addendum|Protocol Violation|0
1022885|NCT00279201|3339059|P6|Intensification Addendum|Lost to Follow-up|7
1022886|NCT00279201|3339060|P5|Intensification Addendum|Lost to Follow-up|7
1022887|NCT00279201|3339061|P4|Intensification Addendum|Lost to Follow-up|6
1022888|NCT00279201|3339062|P3|Intensification Addendum|Lost to Follow-up|4
1022889|NCT00279201|3339063|P2|Intensification Addendum|Lost to Follow-up|0
1022890|NCT00279201|3339064|P1|Intensification Addendum|Lost to Follow-up|0
1022891|NCT00279201|3339059|P6|Intensification Addendum|Withdrawal by Subject|18
1022892|NCT00279201|3339060|P5|Intensification Addendum|Withdrawal by Subject|9
1022893|NCT00279201|3339061|P4|Intensification Addendum|Withdrawal by Subject|14
1022894|NCT00279201|3339062|P3|Intensification Addendum|Withdrawal by Subject|12
1022895|NCT00279201|3339063|P2|Intensification Addendum|Withdrawal by Subject|0
1022896|NCT00279201|3339064|P1|Intensification Addendum|Withdrawal by Subject|0
1022897|NCT00279201|3339059|P6|Maintenance|HbA1c>7.5%|0
1022898|NCT00279201|3339060|P5|Maintenance|HbA1c>7.5%|0
1022899|NCT00279201|3339061|P4|Maintenance|HbA1c>7.5%|0
1022900|NCT00279201|3339062|P3|Maintenance|HbA1c>7.5%|0
1022901|NCT00279201|3339063|P2|Maintenance|HbA1c>7.5%|126
1022902|NCT00279201|3339064|P1|Maintenance|HbA1c>7.5%|123
1022903|NCT00279201|3339059|P6|Maintenance|Sponsor Decision|0
1022904|NCT00279201|3339060|P5|Maintenance|Sponsor Decision|0
1022905|NCT00279201|3339061|P4|Maintenance|Sponsor Decision|0
1022906|NCT00279201|3339062|P3|Maintenance|Sponsor Decision|0
1022907|NCT00279201|3339063|P2|Maintenance|Sponsor Decision|0
1022908|NCT00279201|3339064|P1|Maintenance|Sponsor Decision|4
1022909|NCT00279201|3339059|P6|Maintenance|Physician Decision|0
1022910|NCT00279201|3339060|P5|Maintenance|Physician Decision|0
1022911|NCT00279201|3339061|P4|Maintenance|Physician Decision|0
1022912|NCT00279201|3339062|P3|Maintenance|Physician Decision|0
1022913|NCT00279201|3339063|P2|Maintenance|Physician Decision|9
1022914|NCT00279201|3339064|P1|Maintenance|Physician Decision|9
1022915|NCT00279201|3339059|P6|Maintenance|Withdrawal by Subject|0
1022916|NCT00279201|3339060|P5|Maintenance|Withdrawal by Subject|0
1022917|NCT00279201|3339061|P4|Maintenance|Withdrawal by Subject|0
1022918|NCT00279201|3339062|P3|Maintenance|Withdrawal by Subject|0
1022919|NCT00279201|3339063|P2|Maintenance|Withdrawal by Subject|18
1022920|NCT00279201|3339064|P1|Maintenance|Withdrawal by Subject|18
1022921|NCT00279201|3339059|P6|Maintenance|Protocol Violation|0
1022922|NCT00279201|3339060|P5|Maintenance|Protocol Violation|0
1022923|NCT00279201|3339061|P4|Maintenance|Protocol Violation|0
1022924|NCT00279201|3339062|P3|Maintenance|Protocol Violation|0
1022925|NCT00279201|3339063|P2|Maintenance|Protocol Violation|24
1022926|NCT00279201|3339064|P1|Maintenance|Protocol Violation|16
1022927|NCT00279201|3339059|P6|Maintenance|Entry Criteria Exclusion|0
1022928|NCT00279201|3339060|P5|Maintenance|Entry Criteria Exclusion|0
1022929|NCT00279201|3339061|P4|Maintenance|Entry Criteria Exclusion|0
1022930|NCT00279201|3339062|P3|Maintenance|Entry Criteria Exclusion|0
1022931|NCT00279201|3339063|P2|Maintenance|Entry Criteria Exclusion|4
1022932|NCT00279201|3339064|P1|Maintenance|Entry Criteria Exclusion|1
1022933|NCT00279201|3339059|P6|Maintenance|Lost to Follow-up|0
1022934|NCT00279201|3339060|P5|Maintenance|Lost to Follow-up|0
1022935|NCT00279201|3339061|P4|Maintenance|Lost to Follow-up|0
1022936|NCT00279201|3339062|P3|Maintenance|Lost to Follow-up|0
1022937|NCT00279201|3339063|P2|Maintenance|Lost to Follow-up|13
1022938|NCT00279201|3339064|P1|Maintenance|Lost to Follow-up|17
1022939|NCT00279201|3339059|P6|Maintenance|Death|0
1022940|NCT00279201|3339060|P5|Maintenance|Death|0
1022941|NCT00279201|3339061|P4|Maintenance|Death|0
1022942|NCT00279201|3339062|P3|Maintenance|Death|0
1022943|NCT00279201|3339063|P2|Maintenance|Death|4
1022944|NCT00279201|3339064|P1|Maintenance|Death|4
1022945|NCT00279201|3339059|P6|Maintenance|Adverse Event|0
1022946|NCT00279201|3339060|P5|Maintenance|Adverse Event|0
1022947|NCT00279201|3339061|P4|Maintenance|Adverse Event|0
1022948|NCT00279201|3339062|P3|Maintenance|Adverse Event|0
1022949|NCT00279201|3339063|P2|Maintenance|Adverse Event|4
1022950|NCT00279201|3339064|P1|Maintenance|Adverse Event|4
1022951|NCT00279201|3339059|P6|Maintenance|Discontinuation Antihyperglycemic Drugs|0
1022952|NCT00279201|3339060|P5|Maintenance|Discontinuation Antihyperglycemic Drugs|0
1022953|NCT00279201|3339061|P4|Maintenance|Discontinuation Antihyperglycemic Drugs|0
1022954|NCT00279201|3339062|P3|Maintenance|Discontinuation Antihyperglycemic Drugs|0
1022955|NCT00279201|3339063|P2|Maintenance|Discontinuation Antihyperglycemic Drugs|2
1022956|NCT00279201|3339064|P1|Maintenance|Discontinuation Antihyperglycemic Drugs|3
1022957|NCT00279201|3339059|P6|Maintenance|Lack of Efficacy|0
1022958|NCT00279201|3339060|P5|Maintenance|Lack of Efficacy|0
1022959|NCT00279201|3339061|P4|Maintenance|Lack of Efficacy|0
1022960|NCT00279201|3339062|P3|Maintenance|Lack of Efficacy|0
1022961|NCT00279201|3339063|P2|Maintenance|Lack of Efficacy|30
1022962|NCT00279201|3339064|P1|Maintenance|Lack of Efficacy|32
1022963|NCT00279201|3339059|P6|Initiation|Discontinuation Oral Antihyperglycemics|0
1022964|NCT00279201|3339060|P5|Initiation|Discontinuation Oral Antihyperglycemics|0
1022965|NCT00279201|3339061|P4|Initiation|Discontinuation Oral Antihyperglycemics|0
1022966|NCT00279201|3339062|P3|Initiation|Discontinuation Oral Antihyperglycemics|0
1022967|NCT00279201|3339063|P2|Initiation|Discontinuation Oral Antihyperglycemics|1
1022968|NCT00279201|3339064|P1|Initiation|Discontinuation Oral Antihyperglycemics|0
1022969|NCT00279201|3339059|P6|Initiation|Sponsor Decision|0
1022970|NCT00279201|3339060|P5|Initiation|Sponsor Decision|0
1022971|NCT00279201|3339061|P4|Initiation|Sponsor Decision|0
1022972|NCT00279201|3339062|P3|Initiation|Sponsor Decision|0
1022973|NCT00279201|3339063|P2|Initiation|Sponsor Decision|5
1022974|NCT00279201|3339064|P1|Initiation|Sponsor Decision|13
1022975|NCT00279201|3339059|P6|Initiation|Physician Decision|0
1022976|NCT00279201|3339060|P5|Initiation|Physician Decision|0
1022977|NCT00279201|3339061|P4|Initiation|Physician Decision|0
1022978|NCT00279201|3339062|P3|Initiation|Physician Decision|0
1022979|NCT00279201|3339063|P2|Initiation|Physician Decision|18
1022980|NCT00279201|3339064|P1|Initiation|Physician Decision|15
1022981|NCT00279201|3339059|P6|Initiation|Withdrawal by Subject|0
1022982|NCT00279201|3339060|P5|Initiation|Withdrawal by Subject|0
1022983|NCT00279201|3339061|P4|Initiation|Withdrawal by Subject|0
1022984|NCT00279201|3339062|P3|Initiation|Withdrawal by Subject|0
1022985|NCT00279201|3339063|P2|Initiation|Withdrawal by Subject|41
1022986|NCT00279201|3339064|P1|Initiation|Withdrawal by Subject|35
1022987|NCT00279201|3339059|P6|Initiation|Protocol Violation|0
1022988|NCT00279201|3339060|P5|Initiation|Protocol Violation|0
1022989|NCT00279201|3339061|P4|Initiation|Protocol Violation|0
1022990|NCT00279201|3339062|P3|Initiation|Protocol Violation|0
1022991|NCT00279201|3339063|P2|Initiation|Protocol Violation|10
1022992|NCT00279201|3339064|P1|Initiation|Protocol Violation|9
1022993|NCT00279201|3339059|P6|Initiation|Entry Criteria Exclusion|0
1022994|NCT00279201|3339060|P5|Initiation|Entry Criteria Exclusion|0
1022995|NCT00279201|3339061|P4|Initiation|Entry Criteria Exclusion|0
1022996|NCT00279201|3339062|P3|Initiation|Entry Criteria Exclusion|0
1022997|NCT00279201|3339063|P2|Initiation|Entry Criteria Exclusion|9
1022998|NCT00279201|3339064|P1|Initiation|Entry Criteria Exclusion|7
1022999|NCT00279201|3339059|P6|Initiation|Lost to Follow-up|0
1023000|NCT00279201|3339060|P5|Initiation|Lost to Follow-up|0
1023001|NCT00279201|3339061|P4|Initiation|Lost to Follow-up|0
1023002|NCT00279201|3339062|P3|Initiation|Lost to Follow-up|0
1023003|NCT00279201|3339063|P2|Initiation|Lost to Follow-up|41
1023004|NCT00279201|3339064|P1|Initiation|Lost to Follow-up|42
1023005|NCT00279201|3339059|P6|Initiation|Adverse Event|0
1023006|NCT00279201|3339060|P5|Initiation|Adverse Event|0
1023007|NCT00279201|3339061|P4|Initiation|Adverse Event|0
1023008|NCT00279201|3339062|P3|Initiation|Adverse Event|0
1023009|NCT00279201|3339063|P2|Initiation|Adverse Event|15
1023010|NCT00279201|3339064|P1|Initiation|Adverse Event|6
1023011|NCT00279201|3339059|P6|Initiation|Death|0
1023012|NCT00279201|3339060|P5|Initiation|Death|0
1023013|NCT00279201|3339061|P4|Initiation|Death|0
1023014|NCT00279201|3339062|P3|Initiation|Death|0
1023015|NCT00279201|3339063|P2|Initiation|Death|5
1023016|NCT00279201|3339064|P1|Initiation|Death|1
1023017|NCT00278993|3339208|P1|Overall Study|Not Otherwise Specified|4
1023018|NCT00278993|3339208|P1|Overall Study|Physician Decision|9
1023019|NCT00278993|3339208|P1|Overall Study|Progressive Disease|65
1023020|NCT00278993|3339208|P1|Overall Study|Withdrawal by Subject|5
1023021|NCT00278993|3339208|P1|Overall Study|Adverse Event|24
1023022|NCT00278954|3339216|P1|Overall Study|Withdrawal by Subject|1
1023023|NCT00278954|3339216|P1|Overall Study|Lost to Follow-up|1
1023024|NCT00278954|3339216|P1|Overall Study|Adverse Event|3
1023025|NCT00278915|3339224|P1|Overall Study|Lack of Efficacy|1
1023026|NCT00278889|3339260|P3|Overall Study|Death|17
1023027|NCT00278889|3339261|P2|Overall Study|Death|21
1023028|NCT00278889|3339262|P1|Overall Study|Death|24
1023029|NCT00278889|3339260|P3|Overall Study|Lost to Follow-up|0
1023030|NCT00278889|3339261|P2|Overall Study|Lost to Follow-up|1
1023031|NCT00278889|3339262|P1|Overall Study|Lost to Follow-up|1
1023032|NCT00278889|3339260|P3|Overall Study|Withdrawal by Subject|3
1023033|NCT00278889|3339261|P2|Overall Study|Withdrawal by Subject|5
1023034|NCT00278889|3339262|P1|Overall Study|Withdrawal by Subject|0
1023035|NCT00278564|3339310|P1|Overall Study|Lack of Efficacy|4
1023036|NCT00278512|3339327|P2|Overall Study|Death|0
1023037|NCT00278512|3339328|P1|Overall Study|Death|1
1023038|NCT00278473|3339336|P2|Overall Study|drop out|3
1023039|NCT00278473|3339337|P1|Overall Study|drop out|4
1023040|NCT00278395|3339353|P1|Overall Study|Nonevaluable|1
1023041|NCT00278395|3339353|P1|Overall Study|Adverse Event|2
1023042|NCT00278161|3339369|P1|Overall Study|Death|11
1023043|NCT00277355|3339417|P2|Overall Study|Physician Decision|0
1023044|NCT00277355|3339418|P1|Overall Study|Physician Decision|1
1023045|NCT00277355|3339417|P2|Overall Study|Death|0
1023046|NCT00277355|3339418|P1|Overall Study|Death|3
1023047|NCT00277355|3339417|P2|Overall Study|Adverse Event|0
1023048|NCT00277355|3339418|P1|Overall Study|Adverse Event|5
1023049|NCT00277355|3339417|P2|Overall Study|Lost to Follow-up|2
1023050|NCT00277355|3339418|P1|Overall Study|Lost to Follow-up|2
1023051|NCT00277355|3339417|P2|Overall Study|Withdrawal by Subject|3
1023052|NCT00277355|3339418|P1|Overall Study|Withdrawal by Subject|3
1023053|NCT00277212|3339426|P3|Phase 2 - Double-Blind Treatment|Other reasons|5
1023054|NCT00277212|3339427|P2|Phase 2 - Double-Blind Treatment|Other reasons|7
1023055|NCT00277212|3339428|P1|Phase 2 - Double-Blind Treatment|Other reasons|0
1023056|NCT00277212|3339426|P3|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3
1023057|NCT00277212|3339427|P2|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1
1023058|NCT00277212|3339428|P1|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0
1023059|NCT00277212|3339426|P3|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6
1023060|NCT00277212|3339427|P2|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4
1023061|NCT00277212|3339428|P1|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0
1023062|NCT00277212|3339426|P3|Phase 2 - Double-Blind Treatment|Pregnancy|2
1023063|NCT00277212|3339427|P2|Phase 2 - Double-Blind Treatment|Pregnancy|2
1023064|NCT00277212|3339428|P1|Phase 2 - Double-Blind Treatment|Pregnancy|0
1023065|NCT00277212|3339426|P3|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8
1023066|NCT00277212|3339427|P2|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7
1023067|NCT00277212|3339428|P1|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0
1023068|NCT00277212|3339426|P3|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
1023069|NCT00277212|3339427|P2|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
1023070|NCT00277212|3339428|P1|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0
1023071|NCT00277212|3339426|P3|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16
1023072|NCT00277212|3339427|P2|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17
1023073|NCT00277212|3339428|P1|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0
1023074|NCT00277212|3339426|P3|Phase 2 - Double-Blind Treatment|Adverse Event|16
1023075|NCT00277212|3339427|P2|Phase 2 - Double-Blind Treatment|Adverse Event|10
1023076|NCT00277212|3339428|P1|Phase 2 - Double-Blind Treatment|Adverse Event|0
1023077|NCT00277212|3339426|P3|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39
1023078|NCT00277212|3339427|P2|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54
1023079|NCT00277212|3339428|P1|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0
1023080|NCT00277212|3339426|P3|Phase 1 - Single-Blind Treatment|Other Reasons|0
1023081|NCT00277212|3339427|P2|Phase 1 - Single-Blind Treatment|Other Reasons|0
1023082|NCT00277212|3339428|P1|Phase 1 - Single-Blind Treatment|Other Reasons|12
1023083|NCT00277212|3339426|P3|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
1023084|NCT00277212|3339427|P2|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
1023085|NCT00277212|3339428|P1|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1
1023086|NCT00277212|3339426|P3|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
1023087|NCT00277212|3339427|P2|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
1023088|NCT00277212|3339428|P1|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44
1023089|NCT00277212|3339426|P3|Phase 1 - Single-Blind Treatment|Pregnancy|0
1023090|NCT00277212|3339427|P2|Phase 1 - Single-Blind Treatment|Pregnancy|0
1023091|NCT00277212|3339428|P1|Phase 1 - Single-Blind Treatment|Pregnancy|6
1023092|NCT00277212|3339426|P3|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
1023093|NCT00277212|3339427|P2|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
1023094|NCT00277212|3339428|P1|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35
1023095|NCT00277212|3339426|P3|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
1023096|NCT00277212|3339427|P2|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
1023097|NCT00277212|3339428|P1|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87
1023098|NCT00277212|3339426|P3|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
1023099|NCT00277212|3339427|P2|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
1023100|NCT00277212|3339428|P1|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96
1023101|NCT00277212|3339426|P3|Phase 1 - Single-Blind Treatment|Adverse Event|0
1023102|NCT00277212|3339427|P2|Phase 1 - Single-Blind Treatment|Adverse Event|0
1023103|NCT00277212|3339428|P1|Phase 1 - Single-Blind Treatment|Adverse Event|93
1023104|NCT00277212|3339426|P3|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
1023105|NCT00277212|3339427|P2|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
1023106|NCT00277212|3339428|P1|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61
1023107|NCT00277095|3339466|P1|Overall Study|Physician Decision|1
1023108|NCT00277095|3339466|P1|Overall Study|Missed Follow-up|9
1023109|NCT00277095|3339466|P1|Overall Study|Lost to Follow-up|2
1023110|NCT00277095|3339466|P1|Overall Study|Explanted|7
1023111|NCT00277095|3339466|P1|Overall Study|Death|2
1023112|NCT00276744|3339475|P1|PART A|Reason unknown|98
1023113|NCT00276614|3339479|P1|Overall Study|Progression of disease under study|3
1023114|NCT00276484|3339490|P2|Overall Study|Could not take time off work|1
1023115|NCT00276484|3339491|P1|Overall Study|Could not take time off work|0
1023116|NCT00276484|3339490|P2|Overall Study|Withdrawal by Subject|3
1023117|NCT00276484|3339491|P1|Overall Study|Withdrawal by Subject|4
1023118|NCT00276484|3339490|P2|Overall Study|Protocol Violation|1
1023119|NCT00276484|3339491|P1|Overall Study|Protocol Violation|0
1023120|NCT00276484|3339490|P2|Overall Study|Lost to Follow-up|1
1023121|NCT00276484|3339491|P1|Overall Study|Lost to Follow-up|1
1023122|NCT00276484|3339490|P2|Overall Study|Adverse Event|7
1023123|NCT00276484|3339491|P1|Overall Study|Adverse Event|4
1023124|NCT00276458|3339523|P2|Overall Study|Protocol Violation|3
1023125|NCT00276458|3339524|P1|Overall Study|Protocol Violation|4
1023126|NCT00276458|3339523|P2|Overall Study|Lost to Follow-up|2
1023127|NCT00276458|3339524|P1|Overall Study|Lost to Follow-up|2
1023128|NCT00276458|3339523|P2|Overall Study|Adverse Event|2
1023129|NCT00276458|3339524|P1|Overall Study|Adverse Event|0
1023130|NCT00276419|3339558|P2|First Intervention|Withdrawal by Subject|2
1023131|NCT00276419|3339559|P1|First Intervention|Withdrawal by Subject|0
1023132|NCT00276419|3339558|P2|First Intervention|Adverse Event|0
1023133|NCT00276419|3339559|P1|First Intervention|Adverse Event|1
1023134|NCT00276380|3339602|P2|Overall Study|Abnormal aPPT Levels|1
1023135|NCT00276380|3339603|P1|Overall Study|Abnormal aPPT Levels|0
1023136|NCT00276380|3339602|P2|Overall Study|Death|3
1023137|NCT00276380|3339603|P1|Overall Study|Death|5
1023138|NCT00276380|3339602|P2|Overall Study|Withdrawal by Subject|6
1023139|NCT00276380|3339603|P1|Overall Study|Withdrawal by Subject|3
1023140|NCT00276380|3339602|P2|Overall Study|Lost to Follow-up|1
1023141|NCT00276380|3339603|P1|Overall Study|Lost to Follow-up|1
1023142|NCT00276380|3339602|P2|Overall Study|Adverse Event|3
1023143|NCT00276380|3339603|P1|Overall Study|Adverse Event|5
1023144|NCT00276159|3339658|P1|Overall Study|Did not receive all 24 doses of 852A|6
1023145|NCT00276094|3339668|P3|Overall Study|Other-Study medication lost|1
1023146|NCT00276094|3339669|P2|Overall Study|Other-Study medication lost|0
1023147|NCT00276094|3339670|P1|Overall Study|Other-Study medication lost|0
1023148|NCT00276094|3339668|P3|Overall Study|Other-Relocation|0
1023149|NCT00276094|3339669|P2|Overall Study|Other-Relocation|1
1023150|NCT00276094|3339670|P1|Overall Study|Other-Relocation|0
1023151|NCT00276094|3339668|P3|Overall Study|Other-Repeat safety labs-exclusionary|0
1023152|NCT00276094|3339669|P2|Overall Study|Other-Repeat safety labs-exclusionary|1
1023153|NCT00276094|3339670|P1|Overall Study|Other-Repeat safety labs-exclusionary|0
1023154|NCT00276094|3339668|P3|Overall Study|Other-Refused follow-up visit|0
1023155|NCT00276094|3339669|P2|Overall Study|Other-Refused follow-up visit|0
1023156|NCT00276094|3339670|P1|Overall Study|Other-Refused follow-up visit|1
1023157|NCT00276094|3339668|P3|Overall Study|Other-Lack of efficacy|0
1023158|NCT00276094|3339669|P2|Overall Study|Other-Lack of efficacy|0
1023159|NCT00276094|3339670|P1|Overall Study|Other-Lack of efficacy|1
1023160|NCT00276094|3339668|P3|Overall Study|Other-Scheduled gastroplasty|0
1023161|NCT00276094|3339669|P2|Overall Study|Other-Scheduled gastroplasty|0
1023162|NCT00276094|3339670|P1|Overall Study|Other-Scheduled gastroplasty|1
1023163|NCT00276094|3339668|P3|Overall Study|Other-Subject moved out of country|0
1023164|NCT00276094|3339669|P2|Overall Study|Other-Subject moved out of country|0
1023165|NCT00276094|3339670|P1|Overall Study|Other-Subject moved out of country|1
1023166|NCT00276094|3339668|P3|Overall Study|Lost to Follow-up|4
1023167|NCT00276094|3339669|P2|Overall Study|Lost to Follow-up|6
1023168|NCT00276094|3339670|P1|Overall Study|Lost to Follow-up|8
1023169|NCT00276094|3339668|P3|Overall Study|Protocol Violation|10
1023170|NCT00276094|3339669|P2|Overall Study|Protocol Violation|7
1023171|NCT00276094|3339670|P1|Overall Study|Protocol Violation|16
1023172|NCT00276094|3339668|P3|Overall Study|Withdrawal by Subject|12
1023173|NCT00276094|3339669|P2|Overall Study|Withdrawal by Subject|14
1023174|NCT00276094|3339670|P1|Overall Study|Withdrawal by Subject|14
1023175|NCT00276094|3339668|P3|Overall Study|Adverse Event|11
1023176|NCT00276094|3339669|P2|Overall Study|Adverse Event|13
1023177|NCT00276094|3339670|P1|Overall Study|Adverse Event|15
1023178|NCT00276016|3339723|P6|Intervention 1|Withdrawal by Subject|0
1023179|NCT00276016|3339724|P5|Intervention 1|Withdrawal by Subject|0
1023180|NCT00276016|3339725|P4|Intervention 1|Withdrawal by Subject|0
1023181|NCT00276016|3339726|P3|Intervention 1|Withdrawal by Subject|0
1023182|NCT00276016|3339727|P2|Intervention 1|Withdrawal by Subject|1
1023183|NCT00276016|3339728|P1|Intervention 1|Withdrawal by Subject|0
1023184|NCT00275821|3339774|P3|Overall Study|Protocol Violation|0
1023185|NCT00275821|3339775|P2|Overall Study|Protocol Violation|1
1023186|NCT00275821|3339776|P1|Overall Study|Protocol Violation|5
1023187|NCT00275821|3339774|P3|Overall Study|Lack of Efficacy|0
1023188|NCT00275821|3339775|P2|Overall Study|Lack of Efficacy|1
1023189|NCT00275821|3339776|P1|Overall Study|Lack of Efficacy|2
1023190|NCT00275821|3339774|P3|Overall Study|Death|1
1023191|NCT00275821|3339775|P2|Overall Study|Death|2
1023192|NCT00275821|3339776|P1|Overall Study|Death|0
1023193|NCT00275821|3339774|P3|Overall Study|Lost to Follow-up|1
1023194|NCT00275821|3339775|P2|Overall Study|Lost to Follow-up|1
1023195|NCT00275821|3339776|P1|Overall Study|Lost to Follow-up|0
1023196|NCT00275821|3339774|P3|Overall Study|Withdrawal by Subject|1
1023197|NCT00275821|3339775|P2|Overall Study|Withdrawal by Subject|2
1023198|NCT00275821|3339776|P1|Overall Study|Withdrawal by Subject|0
1023199|NCT00275821|3339774|P3|Overall Study|Administrative problems|4
1023200|NCT00275821|3339775|P2|Overall Study|Administrative problems|4
1023201|NCT00275821|3339776|P1|Overall Study|Administrative problems|3
1023202|NCT00275821|3339774|P3|Overall Study|Adverse Event|5
1023203|NCT00275821|3339775|P2|Overall Study|Adverse Event|12
1023204|NCT00275821|3339776|P1|Overall Study|Adverse Event|4
1023205|NCT00275561|3339795|P2|Overall Study|Family Issues|2
1023206|NCT00275561|3339796|P1|Overall Study|Family Issues|0
1023207|NCT00275561|3339795|P2|Overall Study|Scheduling|2
1023208|NCT00275561|3339796|P1|Overall Study|Scheduling|1
1023209|NCT00275561|3339795|P2|Overall Study|Travel|1
1023210|NCT00275561|3339796|P1|Overall Study|Travel|1
1023211|NCT00275561|3339795|P2|Overall Study|Withdrawal by Subject|1
1023212|NCT00275561|3339796|P1|Overall Study|Withdrawal by Subject|0
1023213|NCT00275509|3339808|P2|Overall Study|graft thrombosis, post-operative day #8|1
1023214|NCT00275509|3339809|P1|Overall Study|graft thrombosis, post-operative day #8|0
1023215|NCT00275340|3339832|P2|Overall Study|Lost to Follow-up|4
1023216|NCT00275340|3339833|P1|Overall Study|Lost to Follow-up|2
1023217|NCT00275301|3339837|P1|Overall Study|Adverse Event|5
1023218|NCT00275262|3339856|P2|Overall Study|Started Chemotherapy|0
1023219|NCT00275262|3339857|P1|Overall Study|Started Chemotherapy|1
1023220|NCT00275262|3339856|P2|Overall Study|Death|0
1023221|NCT00275262|3339857|P1|Overall Study|Death|1
1023222|NCT00275262|3339856|P2|Overall Study|Protocol Violation|2
1023223|NCT00275262|3339857|P1|Overall Study|Protocol Violation|0
1023224|NCT00275262|3339856|P2|Overall Study|Lost to Follow-up|2
1023225|NCT00275262|3339857|P1|Overall Study|Lost to Follow-up|0
1023226|NCT00275262|3339856|P2|Overall Study|Disease progression|5
1023227|NCT00275262|3339857|P1|Overall Study|Disease progression|2
1023228|NCT00275262|3339856|P2|Overall Study|Adverse Event|0
1023229|NCT00275262|3339857|P1|Overall Study|Adverse Event|2
1023230|NCT00275028|3339871|P1|Overall Study|Physician Decision|2
1023231|NCT00275028|3339871|P1|Overall Study|Progressive Disease|30
1023232|NCT00275028|3339871|P1|Overall Study|Adverse Event|9
1023233|NCT00275028|3339871|P1|Overall Study|Withdrawal by Subject|5
1023234|NCT00275028|3339871|P1|Overall Study|Withdrew consent before treatment began|1
1023235|NCT00275002|3339878|P2|Overall Study|Adverse Event|1
1023236|NCT00275002|3339879|P1|Overall Study|Adverse Event|0
1023237|NCT00275002|3339878|P2|Overall Study|Disease progression|15
1023238|NCT00275002|3339879|P1|Overall Study|Disease progression|21
1023239|NCT00275002|3339878|P2|Overall Study|Death|0
1023240|NCT00275002|3339879|P1|Overall Study|Death|1
1023241|NCT00274937|3339887|P1|Overall Study|Progressive Disease|4
1023242|NCT00274937|3339887|P1|Overall Study|Withdrawal by Subject|6
1023243|NCT00274937|3339887|P1|Overall Study|Physician Decision|10
1023244|NCT00274924|3339899|P3|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
1023245|NCT00274924|3339900|P2|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1
1023246|NCT00274924|3339901|P1|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
1023247|NCT00274924|3339899|P3|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
1023248|NCT00274924|3339900|P2|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1
1023249|NCT00274924|3339901|P1|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
1023250|NCT00274924|3339899|P3|Step 2 (Tx Based on Mid-treatment PET)|Death|0
1023251|NCT00274924|3339900|P2|Step 2 (Tx Based on Mid-treatment PET)|Death|1
1023252|NCT00274924|3339901|P1|Step 2 (Tx Based on Mid-treatment PET)|Death|0
1023253|NCT00274924|3339899|P3|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
1023254|NCT00274924|3339900|P2|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
1023255|NCT00274924|3339901|P1|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1
1023256|NCT00274924|3339899|P3|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
1023257|NCT00274924|3339900|P2|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
1023258|NCT00274924|3339901|P1|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1
1023259|NCT00274924|3339899|P3|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
1023260|NCT00274924|3339900|P2|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
1023261|NCT00274924|3339901|P1|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1
1023262|NCT00274924|3339899|P3|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0
1023263|NCT00274924|3339900|P2|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15
1023264|NCT00274924|3339901|P1|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4
1023265|NCT00274924|3339899|P3|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1
1023266|NCT00274924|3339900|P2|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
1023267|NCT00274924|3339901|P1|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
1023268|NCT00274924|3339899|P3|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1
1023269|NCT00274924|3339900|P2|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
1023270|NCT00274924|3339901|P1|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
1023271|NCT00274924|3339899|P3|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1
1023272|NCT00274924|3339900|P2|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
1023273|NCT00274924|3339901|P1|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
1023274|NCT00274924|3339899|P3|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1
1023275|NCT00274924|3339900|P2|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
1023276|NCT00274924|3339901|P1|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
1023277|NCT00274924|3339899|P3|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1
1023278|NCT00274924|3339900|P2|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
1023279|NCT00274924|3339901|P1|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
1023280|NCT00274924|3339899|P3|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1
1023281|NCT00274924|3339900|P2|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14
1023282|NCT00274924|3339901|P1|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4
1023283|NCT00274846|3339910|P1|Overall Study|Did not receive adequate NK cells|1
1023284|NCT00274742|3339934|P6|Overall Study|Other|0
1023285|NCT00274742|3339935|P5|Overall Study|Other|2
1023286|NCT00274742|3339936|P4|Overall Study|Other|0
1023287|NCT00274742|3339937|P3|Overall Study|Other|0
1023288|NCT00274742|3339938|P2|Overall Study|Other|3
1023289|NCT00274742|3339939|P1|Overall Study|Other|0
1023290|NCT00274742|3339934|P6|Overall Study|Disease Progression|0
1023291|NCT00274742|3339935|P5|Overall Study|Disease Progression|1
1023292|NCT00274742|3339936|P4|Overall Study|Disease Progression|0
1023293|NCT00274742|3339937|P3|Overall Study|Disease Progression|1
1023294|NCT00274742|3339938|P2|Overall Study|Disease Progression|1
1023295|NCT00274742|3339939|P1|Overall Study|Disease Progression|0
1023296|NCT00274742|3339934|P6|Overall Study|End of Study|0
1023297|NCT00274742|3339935|P5|Overall Study|End of Study|0
1023298|NCT00274742|3339936|P4|Overall Study|End of Study|1
1023299|NCT00274742|3339937|P3|Overall Study|End of Study|0
1023300|NCT00274742|3339938|P2|Overall Study|End of Study|0
1023301|NCT00274742|3339939|P1|Overall Study|End of Study|0
1023302|NCT00274742|3339934|P6|Overall Study|Lost to Follow-up|0
1023303|NCT00274742|3339935|P5|Overall Study|Lost to Follow-up|1
1023304|NCT00274742|3339936|P4|Overall Study|Lost to Follow-up|0
1023305|NCT00274742|3339937|P3|Overall Study|Lost to Follow-up|0
1023306|NCT00274742|3339938|P2|Overall Study|Lost to Follow-up|0
1023307|NCT00274742|3339939|P1|Overall Study|Lost to Follow-up|0
1023308|NCT00274742|3339934|P6|Overall Study|Adverse Event|3
1023309|NCT00274742|3339935|P5|Overall Study|Adverse Event|12
1023310|NCT00274742|3339936|P4|Overall Study|Adverse Event|4
1023311|NCT00274742|3339937|P3|Overall Study|Adverse Event|1
1023312|NCT00274742|3339938|P2|Overall Study|Adverse Event|4
1023313|NCT00274742|3339939|P1|Overall Study|Adverse Event|0
1023314|NCT00274716|3339977|P6|Phase B|Lost to Follow-up|0
1023315|NCT00274716|3339978|P5|Phase B|Lost to Follow-up|0
1023316|NCT00274716|3339979|P4|Phase B|Lost to Follow-up|0
1023317|NCT00274716|3339980|P3|Phase B|Lost to Follow-up|0
1023318|NCT00274716|3339981|P2|Phase B|Lost to Follow-up|1
1023319|NCT00274716|3339982|P1|Phase B|Lost to Follow-up|0
1023320|NCT00274716|3339977|P6|Phase B|Other non-reported reason|0
1023321|NCT00274716|3339978|P5|Phase B|Other non-reported reason|0
1023322|NCT00274716|3339979|P4|Phase B|Other non-reported reason|1
1023323|NCT00274716|3339980|P3|Phase B|Other non-reported reason|1
1023324|NCT00274716|3339981|P2|Phase B|Other non-reported reason|0
1023325|NCT00274716|3339982|P1|Phase B|Other non-reported reason|0
1023326|NCT00274716|3339977|P6|Phase B|Participant moved|0
1023327|NCT00274716|3339978|P5|Phase B|Participant moved|0
1023328|NCT00274716|3339979|P4|Phase B|Participant moved|0
1023329|NCT00274716|3339980|P3|Phase B|Participant moved|0
1023330|NCT00274716|3339981|P2|Phase B|Participant moved|0
1023331|NCT00274716|3339982|P1|Phase B|Participant moved|1
1023332|NCT00274716|3339977|P6|Phase B|Withdrawal by Subject|0
1023333|NCT00274716|3339978|P5|Phase B|Withdrawal by Subject|0
1023334|NCT00274716|3339979|P4|Phase B|Withdrawal by Subject|0
1023335|NCT00274716|3339980|P3|Phase B|Withdrawal by Subject|0
1023336|NCT00274716|3339981|P2|Phase B|Withdrawal by Subject|1
1023337|NCT00274716|3339982|P1|Phase B|Withdrawal by Subject|0
1023338|NCT00274716|3339977|P6|Phase B|Protocol Violation|0
1023339|NCT00274716|3339978|P5|Phase B|Protocol Violation|0
1023340|NCT00274716|3339979|P4|Phase B|Protocol Violation|0
1023341|NCT00274716|3339980|P3|Phase B|Protocol Violation|0
1023342|NCT00274716|3339981|P2|Phase B|Protocol Violation|2
1023343|NCT00274716|3339982|P1|Phase B|Protocol Violation|0
1023344|NCT00274716|3339977|P6|Phase B|Adverse Event|1
1023345|NCT00274716|3339978|P5|Phase B|Adverse Event|0
1023346|NCT00274716|3339979|P4|Phase B|Adverse Event|0
1023347|NCT00274716|3339980|P3|Phase B|Adverse Event|2
1023348|NCT00274716|3339981|P2|Phase B|Adverse Event|0
1023349|NCT00274716|3339982|P1|Phase B|Adverse Event|0
1023350|NCT00274716|3339977|P6|Phase A|Completed but did not enter Phase B|1
1023351|NCT00274716|3339978|P5|Phase A|Completed but did not enter Phase B|1
1023352|NCT00274716|3339979|P4|Phase A|Completed but did not enter Phase B|2
1023353|NCT00274716|3339980|P3|Phase A|Completed but did not enter Phase B|2
1023354|NCT00274716|3339981|P2|Phase A|Completed but did not enter Phase B|2
1023355|NCT00274716|3339982|P1|Phase A|Completed but did not enter Phase B|1
1023356|NCT00274716|3339977|P6|Phase A|Adverse Event|0
1023357|NCT00274716|3339978|P5|Phase A|Adverse Event|2
1023358|NCT00274716|3339979|P4|Phase A|Adverse Event|0
1023359|NCT00274716|3339980|P3|Phase A|Adverse Event|3
1023360|NCT00274716|3339981|P2|Phase A|Adverse Event|3
1023361|NCT00274716|3339982|P1|Phase A|Adverse Event|2
1023362|NCT00274716|3339977|P6|Phase A|Withdrawal by Subject|1
1023363|NCT00274716|3339978|P5|Phase A|Withdrawal by Subject|0
1023364|NCT00274716|3339979|P4|Phase A|Withdrawal by Subject|3
1023365|NCT00274716|3339980|P3|Phase A|Withdrawal by Subject|1
1023366|NCT00274716|3339981|P2|Phase A|Withdrawal by Subject|2
1023367|NCT00274716|3339982|P1|Phase A|Withdrawal by Subject|2
1023368|NCT00274716|3339977|P6|Phase A|Met criteria for discontinuation|0
1023369|NCT00274716|3339978|P5|Phase A|Met criteria for discontinuation|0
1023370|NCT00274716|3339979|P4|Phase A|Met criteria for discontinuation|0
1023371|NCT00274716|3339980|P3|Phase A|Met criteria for discontinuation|0
1023372|NCT00274716|3339981|P2|Phase A|Met criteria for discontinuation|1
1023373|NCT00274716|3339982|P1|Phase A|Met criteria for discontinuation|1
1023374|NCT00274716|3339977|P6|Phase A|Protocol Violation|0
1023375|NCT00274716|3339978|P5|Phase A|Protocol Violation|0
1023376|NCT00274716|3339979|P4|Phase A|Protocol Violation|1
1023377|NCT00274716|3339980|P3|Phase A|Protocol Violation|0
1023378|NCT00274716|3339981|P2|Phase A|Protocol Violation|0
1023379|NCT00274716|3339982|P1|Phase A|Protocol Violation|1
1023380|NCT00274716|3339977|P6|Phase A|Site Terminated|0
1023381|NCT00274716|3339978|P5|Phase A|Site Terminated|0
1023382|NCT00274716|3339979|P4|Phase A|Site Terminated|1
1023383|NCT00274716|3339980|P3|Phase A|Site Terminated|0
1023384|NCT00274716|3339981|P2|Phase A|Site Terminated|0
1023385|NCT00274716|3339982|P1|Phase A|Site Terminated|0
1023386|NCT00274716|3339977|P6|Phase A|Participant moved|1
1023387|NCT00274716|3339978|P5|Phase A|Participant moved|0
1023388|NCT00274716|3339979|P4|Phase A|Participant moved|0
1023389|NCT00274716|3339980|P3|Phase A|Participant moved|1
1023390|NCT00274716|3339981|P2|Phase A|Participant moved|0
1023391|NCT00274716|3339982|P1|Phase A|Participant moved|0
1023392|NCT00274716|3339977|P6|Phase A|Other non-reported reason|1
1023393|NCT00274716|3339978|P5|Phase A|Other non-reported reason|0
1023394|NCT00274716|3339979|P4|Phase A|Other non-reported reason|2
1023395|NCT00274716|3339980|P3|Phase A|Other non-reported reason|1
1023396|NCT00274716|3339981|P2|Phase A|Other non-reported reason|2
1023397|NCT00274716|3339982|P1|Phase A|Other non-reported reason|4
1023398|NCT00274651|3340044|P2|Overall Study|Physician Decision|7
1023399|NCT00274651|3340045|P1|Overall Study|Physician Decision|8
1023400|NCT00274651|3340044|P2|Overall Study|Withdrawal by Subject|1
1023401|NCT00274651|3340045|P1|Overall Study|Withdrawal by Subject|0
1023402|NCT00274651|3340044|P2|Overall Study|Death|3
1023403|NCT00274651|3340045|P1|Overall Study|Death|1
1023404|NCT00274651|3340044|P2|Overall Study|Lack of Efficacy|6
1023405|NCT00274651|3340045|P1|Overall Study|Lack of Efficacy|13
1023406|NCT00274651|3340044|P2|Overall Study|Adverse Event|3
1023407|NCT00274651|3340045|P1|Overall Study|Adverse Event|6
1023408|NCT00274625|3340060|P2|Overall Study|Excluded from analysis|8
1023409|NCT00274625|3340061|P1|Overall Study|Excluded from analysis|14
1023410|NCT00274625|3340060|P2|Overall Study|Lost to Follow-up|54
1023411|NCT00274625|3340061|P1|Overall Study|Lost to Follow-up|46
1023412|NCT00274469|3340069|P2|Overall Study|Reasons not specified|8
1023413|NCT00274469|3340070|P1|Overall Study|Reasons not specified|5
1023414|NCT00274469|3340069|P2|Overall Study|Withdrawal by Subject|0
1023415|NCT00274469|3340070|P1|Overall Study|Withdrawal by Subject|2
1023416|NCT00274469|3340069|P2|Overall Study|Condition under investigation worsened|38
1023417|NCT00274469|3340070|P1|Overall Study|Condition under investigation worsened|28
1023418|NCT00274469|3340069|P2|Overall Study|Adverse Event|3
1023419|NCT00274469|3340070|P1|Overall Study|Adverse Event|2
1023420|NCT00274469|3340069|P2|Overall Study|Death|1
1023421|NCT00274469|3340070|P1|Overall Study|Death|1
1023422|NCT00274456|3340088|P4|Overall Study|Withdrawal by Subject|13
1023423|NCT00274456|3340089|P3|Overall Study|Withdrawal by Subject|9
1023424|NCT00274456|3340090|P2|Overall Study|Withdrawal by Subject|13
1023425|NCT00274456|3340091|P1|Overall Study|Withdrawal by Subject|18
1023426|NCT00274456|3340088|P4|Overall Study|Lost to Follow-up|0
1023427|NCT00274456|3340089|P3|Overall Study|Lost to Follow-up|1
1023428|NCT00274456|3340090|P2|Overall Study|Lost to Follow-up|0
1023429|NCT00274456|3340091|P1|Overall Study|Lost to Follow-up|0
1023430|NCT00274456|3340088|P4|Overall Study|Physician Decision|13
1023431|NCT00274456|3340089|P3|Overall Study|Physician Decision|6
1023432|NCT00274456|3340090|P2|Overall Study|Physician Decision|5
1023433|NCT00274456|3340091|P1|Overall Study|Physician Decision|7
1023434|NCT00274456|3340088|P4|Overall Study|Adverse Event|2
1023435|NCT00274456|3340089|P3|Overall Study|Adverse Event|2
1023436|NCT00274456|3340090|P2|Overall Study|Adverse Event|1
1023437|NCT00274456|3340091|P1|Overall Study|Adverse Event|0
1023438|NCT00274456|3340088|P4|Overall Study|Unacceptable toxicity|16
1023439|NCT00274456|3340089|P3|Overall Study|Unacceptable toxicity|12
1023440|NCT00274456|3340090|P2|Overall Study|Unacceptable toxicity|5
1023441|NCT00274456|3340091|P1|Overall Study|Unacceptable toxicity|10
1023442|NCT00274456|3340088|P4|Overall Study|Still on treatment|1
1023443|NCT00274456|3340089|P3|Overall Study|Still on treatment|5
1023444|NCT00274456|3340090|P2|Overall Study|Still on treatment|3
1023445|NCT00274456|3340091|P1|Overall Study|Still on treatment|2
1023446|NCT00274287|3340133|P1|Overall Study|subject non-compliance|1
1023447|NCT00274287|3340133|P1|Overall Study|Withdrawal by Subject|1
1023448|NCT00274261|3340139|P2|Overall Study|Lost to Follow-up|75
1023449|NCT00274261|3340140|P1|Overall Study|Lost to Follow-up|106
1023450|NCT00274261|3340139|P2|Overall Study|Protocol Violation|42
1023451|NCT00274261|3340140|P1|Overall Study|Protocol Violation|71
1023452|NCT00274261|3340139|P2|Overall Study|Withdrawal by Subject|126
1023453|NCT00274261|3340140|P1|Overall Study|Withdrawal by Subject|179
1023454|NCT00274261|3340139|P2|Overall Study|Pregnancy|83
1023455|NCT00274261|3340140|P1|Overall Study|Pregnancy|114
1023456|NCT00274261|3340139|P2|Overall Study|Adverse Event|11
1023457|NCT00274261|3340140|P1|Overall Study|Adverse Event|19
1023458|NCT00273858|3340179|P1|Overall Study|Adverse Event|81
1023459|NCT00273858|3340179|P1|Overall Study|Withdrawal by Subject|21
1023460|NCT00273858|3340179|P1|Overall Study|Lost to Follow-up|101
1023461|NCT00273858|3340179|P1|Overall Study|Not completed 24 month observation time|334
1023462|NCT00273182|3340238|P1|Overall Study|Site exit, system change, 36 m FU missed|36
1023463|NCT00273182|3340238|P1|Overall Study|Device/System Explant|154
1023464|NCT00273182|3340238|P1|Overall Study|Withdrawal by Subject|257
1023465|NCT00273182|3340238|P1|Overall Study|Lost to Follow-up|88
1023466|NCT00273182|3340238|P1|Overall Study|Death|450
1023467|NCT00273052|3340248|P2|Overall Study|Worsening serum lipid levels|2
1023468|NCT00273052|3340249|P1|Overall Study|Worsening serum lipid levels|0
1023469|NCT00273052|3340248|P2|Overall Study|Not specified|0
1023470|NCT00273052|3340249|P1|Overall Study|Not specified|2
1023471|NCT00273052|3340248|P2|Overall Study|Non-Compliance|1
1023472|NCT00273052|3340249|P1|Overall Study|Non-Compliance|3
1023473|NCT00273052|3340248|P2|Overall Study|Lack of Efficacy|4
1023474|NCT00273052|3340249|P1|Overall Study|Lack of Efficacy|6
1023475|NCT00273052|3340248|P2|Overall Study|Lost to Follow-up|25
1023476|NCT00273052|3340249|P1|Overall Study|Lost to Follow-up|7
1023477|NCT00273052|3340248|P2|Overall Study|Protocol Violation|18
1023478|NCT00273052|3340249|P1|Overall Study|Protocol Violation|14
1023479|NCT00273052|3340248|P2|Overall Study|Adverse Event|19
1023480|NCT00273052|3340249|P1|Overall Study|Adverse Event|21
1023481|NCT00273052|3340248|P2|Overall Study|Withdrawal by Subject|19
1023482|NCT00273052|3340249|P1|Overall Study|Withdrawal by Subject|16
1023483|NCT00272987|3340284|P3|Overall Study|Ongoing|15
1023484|NCT00272987|3340285|P2|Overall Study|Ongoing|14
1023485|NCT00272987|3340286|P1|Overall Study|Ongoing|20
1023486|NCT00272987|3340284|P3|Overall Study|Missed >3 Visits|1
1023487|NCT00272987|3340285|P2|Overall Study|Missed >3 Visits|0
1023488|NCT00272987|3340286|P1|Overall Study|Missed >3 Visits|0
1023489|NCT00272987|3340284|P3|Overall Study|Withdrawal by Subject|3
1023490|NCT00272987|3340285|P2|Overall Study|Withdrawal by Subject|0
1023491|NCT00272987|3340286|P1|Overall Study|Withdrawal by Subject|0
1023492|NCT00272987|3340284|P3|Overall Study|Adverse Event|0
1023493|NCT00272987|3340285|P2|Overall Study|Adverse Event|0
1023494|NCT00272987|3340286|P1|Overall Study|Adverse Event|1
1023495|NCT00272961|3340350|P5|Treatment Phase: Week 3 Up to Week 12|Other|2
1023496|NCT00272961|3340351|P4|Treatment Phase: Week 3 Up to Week 12|Other|2
1023497|NCT00272961|3340352|P3|Treatment Phase: Week 3 Up to Week 12|Other|3
1023498|NCT00272961|3340353|P2|Treatment Phase: Week 3 Up to Week 12|Other|3
1023499|NCT00272961|3340354|P1|Treatment Phase: Week 3 Up to Week 12|Other|1
1023500|NCT00272961|3340350|P5|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
1023501|NCT00272961|3340351|P4|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
1023502|NCT00272961|3340352|P3|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
1023503|NCT00272961|3340353|P2|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
1023504|NCT00272961|3340354|P1|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
1023505|NCT00272961|3340350|P5|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2
1023506|NCT00272961|3340351|P4|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
1023507|NCT00272961|3340352|P3|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
1023508|NCT00272961|3340353|P2|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
1023509|NCT00272961|3340354|P1|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
1023510|NCT00272961|3340350|P5|Placebo Run-in Phase: Up to Week 2|Other|0
1023511|NCT00272961|3340351|P4|Placebo Run-in Phase: Up to Week 2|Other|0
1023512|NCT00272961|3340352|P3|Placebo Run-in Phase: Up to Week 2|Other|0
1023513|NCT00272961|3340353|P2|Placebo Run-in Phase: Up to Week 2|Other|0
1023514|NCT00272961|3340354|P1|Placebo Run-in Phase: Up to Week 2|Other|2
1023515|NCT00272961|3340350|P5|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
1023516|NCT00272961|3340351|P4|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
1023517|NCT00272961|3340352|P3|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
1023518|NCT00272961|3340353|P2|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
1023519|NCT00272961|3340354|P1|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2
1023520|NCT00272961|3340350|P5|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
1023521|NCT00272961|3340351|P4|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
1023522|NCT00272961|3340352|P3|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
1023523|NCT00272961|3340353|P2|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
1023524|NCT00272961|3340354|P1|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5
1023525|NCT00272961|3340350|P5|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
1023526|NCT00272961|3340351|P4|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
1023527|NCT00272961|3340352|P3|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
1023528|NCT00272961|3340353|P2|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
1023529|NCT00272961|3340354|P1|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1
1023530|NCT00272961|3340350|P5|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
1023531|NCT00272961|3340351|P4|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
1023532|NCT00272961|3340352|P3|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
1023533|NCT00272961|3340353|P2|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
1023534|NCT00272961|3340354|P1|Placebo Run-in Phase: Up to Week 2|Physician Decision|1
1023535|NCT00272844|3340411|P1|Overall Study|Withdrawal by Subject|5
1023536|NCT00272792|3340419|P2|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1
1023537|NCT00272792|3340420|P1|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0
1023538|NCT00272792|3340419|P2|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0
1023539|NCT00272792|3340420|P1|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1
1023540|NCT00272792|3340419|P2|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2
1023541|NCT00272792|3340420|P1|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0
1023542|NCT00272792|3340419|P2|Part 1: Responsiveness|Lost to Follow-up|0
1023543|NCT00272792|3340420|P1|Part 1: Responsiveness|Lost to Follow-up|1
1023544|NCT00272779|3340430|P2|Baseline Through Week 96|Continuing on treatment|38
1023545|NCT00272779|3340431|P1|Baseline Through Week 96|Continuing on treatment|61
1023546|NCT00272779|3340430|P2|Baseline Through Week 96|Never treated|3
1023547|NCT00272779|3340431|P1|Baseline Through Week 96|Never treated|2
1023548|NCT00272779|3340430|P2|Baseline Through Week 96|Pregnancy at Week 96|0
1023549|NCT00272779|3340431|P1|Baseline Through Week 96|Pregnancy at Week 96|1
1023550|NCT00272779|3340430|P2|Baseline Through Week 96|Poor/non compliance at Week 96]|0
1023551|NCT00272779|3340431|P1|Baseline Through Week 96|Poor/non compliance at Week 96]|2
1023552|NCT00272779|3340430|P2|Baseline Through Week 96|Lost to follow-up at Week 96|0
1023553|NCT00272779|3340431|P1|Baseline Through Week 96|Lost to follow-up at Week 96|1
1023554|NCT00272779|3340430|P2|Baseline Through Week 96|Changed address before Week 96|1
1023555|NCT00272779|3340431|P1|Baseline Through Week 96|Changed address before Week 96|0
1023556|NCT00272779|3340430|P2|Baseline Through Week 96|Withdrew consent before Week 96|18
1023557|NCT00272779|3340431|P1|Baseline Through Week 96|Withdrew consent before Week 96|5
1023558|NCT00272779|3340430|P2|Baseline Through Week 96|No longer meets criteria before Week 96|3
1023559|NCT00272779|3340431|P1|Baseline Through Week 96|No longer meets criteria before Week 96|4
1023560|NCT00272779|3340430|P2|Baseline Through Week 96|Pregnancy before Week 96|7
1023561|NCT00272779|3340431|P1|Baseline Through Week 96|Pregnancy before Week 96|5
1023562|NCT00272779|3340430|P2|Baseline Through Week 96|Poor/non compliance before Week 96|16
1023563|NCT00272779|3340431|P1|Baseline Through Week 96|Poor/non compliance before Week 96|12
1023564|NCT00272779|3340430|P2|Baseline Through Week 96|Participant Imprisoned before Week 96|0
1023565|NCT00272779|3340431|P1|Baseline Through Week 96|Participant Imprisoned before Week 96|1
1023566|NCT00272779|3340430|P2|Baseline Through Week 96|Lost to follow up before Week 96|13
1023567|NCT00272779|3340431|P1|Baseline Through Week 96|Lost to follow up before Week 96|10
1023568|NCT00272779|3340430|P2|Baseline Through Week 96|Lack of efficacy before Week 96|10
1023569|NCT00272779|3340431|P1|Baseline Through Week 96|Lack of efficacy before Week 96|16
1023570|NCT00272779|3340430|P2|Baseline Through Week 96|Death before Week 96|5
1023571|NCT00272779|3340431|P1|Baseline Through Week 96|Death before Week 96|6
1023572|NCT00272779|3340430|P2|Baseline Through Week 96|Adverse event before Week 96|22
1023573|NCT00272779|3340431|P1|Baseline Through Week 96|Adverse event before Week 96|13
1023574|NCT00272779|3340430|P2|Baseline Through Week 48|Never treated|3
1023575|NCT00272779|3340431|P1|Baseline Through Week 48|Never treated|2
1023576|NCT00272779|3340430|P2|Baseline Through Week 48|Lost to follow-up on/after Week 48|3
1023577|NCT00272779|3340431|P1|Baseline Through Week 48|Lost to follow-up on/after Week 48|0
1023578|NCT00272779|3340430|P2|Baseline Through Week 48|Continuing treatment|368
1023579|NCT00272779|3340431|P1|Baseline Through Week 48|Continuing treatment|385
1023580|NCT00272779|3340430|P2|Baseline Through Week 48|Withdrew consent on/after Week 48|2
1023581|NCT00272779|3340431|P1|Baseline Through Week 48|Withdrew consent on/after Week 48|0
1023582|NCT00272779|3340430|P2|Baseline Through Week 48|Pregnancy on/after Week 48|2
1023583|NCT00272779|3340431|P1|Baseline Through Week 48|Pregnancy on/after Week 48|1
1023584|NCT00272779|3340430|P2|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
1023585|NCT00272779|3340431|P1|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
1023586|NCT00272779|3340430|P2|Baseline Through Week 48|Poor/non compliance on/after Week|2
1023587|NCT00272779|3340431|P1|Baseline Through Week 48|Poor/non compliance on/after Week|2
1023588|NCT00272779|3340430|P2|Baseline Through Week 48|Lack of efficacy on/after Week 48|1
1023589|NCT00272779|3340431|P1|Baseline Through Week 48|Lack of efficacy on/after Week 48|7
1023590|NCT00272779|3340430|P2|Baseline Through Week 48|Death on/after Week 48|1
1023591|NCT00272779|3340431|P1|Baseline Through Week 48|Death on/after Week 48|1
1023592|NCT00272779|3340430|P2|Baseline Through Week 48|Adverse event on/after Week 48|1
1023593|NCT00272779|3340431|P1|Baseline Through Week 48|Adverse event on/after Week 48|1
1023594|NCT00272779|3340430|P2|Baseline Through Week 48|Chose different site before wk 48|1
1023595|NCT00272779|3340431|P1|Baseline Through Week 48|Chose different site before wk 48|0
1023596|NCT00272779|3340430|P2|Baseline Through Week 48|Participant's decision before wk 48|1
1023597|NCT00272779|3340431|P1|Baseline Through Week 48|Participant's decision before wk 48|0
1023598|NCT00272779|3340430|P2|Baseline Through Week 48|Withdrew consent before Week 48|13
1023599|NCT00272779|3340431|P1|Baseline Through Week 48|Withdrew consent before Week 48|4
1023600|NCT00272779|3340430|P2|Baseline Through Week 48|No longer meets criteria before Week 48|0
1023601|NCT00272779|3340431|P1|Baseline Through Week 48|No longer meets criteria before Week 48|1
1023602|NCT00272779|3340430|P2|Baseline Through Week 48|Pregnancy before Week 48|2
1023603|NCT00272779|3340431|P1|Baseline Through Week 48|Pregnancy before Week 48|2
1023604|NCT00272779|3340430|P2|Baseline Through Week 48|Poor/non compliance before Week 48|9
1023605|NCT00272779|3340431|P1|Baseline Through Week 48|Poor/non compliance before Week 48|6
1023606|NCT00272779|3340430|P2|Baseline Through Week 48|Viral load rebound before Week 48|0
1023607|NCT00272779|3340431|P1|Baseline Through Week 48|Viral load rebound before Week 48|1
1023608|NCT00272779|3340430|P2|Baseline Through Week 48|Lost to follow-up before Week 48|6
1023609|NCT00272779|3340431|P1|Baseline Through Week 48|Lost to follow-up before Week 48|6
1023610|NCT00272779|3340430|P2|Baseline Through Week 48|Lack of efficacy before Week 48|8
1023611|NCT00272779|3340431|P1|Baseline Through Week 48|Lack of efficacy before Week 48|5
1023612|NCT00272779|3340430|P2|Baseline Through Week 48|Death before Week 48|4
1023613|NCT00272779|3340431|P1|Baseline Through Week 48|Death before Week 48|4
1023614|NCT00272779|3340430|P2|Baseline Through Week 48|Adverse event before Week 48|14
1023615|NCT00272779|3340431|P1|Baseline Through Week 48|Adverse event before Week 48|10
1023616|NCT00272038|3340671|P1|Overall Study|withdrew before they received 2 cycles|7
1023617|NCT00271947|3340677|P1|Overall Study|Lost to Follow-up|1
1023618|NCT00271856|3340683|P2|Overall Study|Lost to Follow-up|11
1023619|NCT00271856|3340684|P1|Overall Study|Lost to Follow-up|10
1023620|NCT00271856|3340683|P2|Overall Study|Withdrawal by Subject|7
1023621|NCT00271856|3340684|P1|Overall Study|Withdrawal by Subject|1
1023622|NCT00271817|3340703|P3|Part 2|LDL < 50 mg/dL|4
1023623|NCT00271817|3340704|P2|Part 2|LDL < 50 mg/dL|3
1023624|NCT00271817|3340705|P1|Part 2|LDL < 50 mg/dL|0
1023625|NCT00271817|3340703|P3|Part 2|Withdrawal by Subject|13
1023626|NCT00271817|3340704|P2|Part 2|Withdrawal by Subject|2
1023627|NCT00271817|3340705|P1|Part 2|Withdrawal by Subject|0
1023628|NCT00271817|3340703|P3|Part 2|Patient Moved|5
1023629|NCT00271817|3340704|P2|Part 2|Patient Moved|0
1023630|NCT00271817|3340705|P1|Part 2|Patient Moved|0
1023631|NCT00271817|3340703|P3|Part 2|Protocol Violation|5
1023632|NCT00271817|3340704|P2|Part 2|Protocol Violation|3
1023633|NCT00271817|3340705|P1|Part 2|Protocol Violation|0
1023634|NCT00271817|3340703|P3|Part 2|Lost to Follow-up|18
1023635|NCT00271817|3340704|P2|Part 2|Lost to Follow-up|6
1023636|NCT00271817|3340705|P1|Part 2|Lost to Follow-up|0
1023637|NCT00271817|3340703|P3|Part 2|Lack of Efficacy|6
1023638|NCT00271817|3340704|P2|Part 2|Lack of Efficacy|1
1023639|NCT00271817|3340705|P1|Part 2|Lack of Efficacy|0
1023640|NCT00271817|3340703|P3|Part 2|Adverse Event|33
1023641|NCT00271817|3340704|P2|Part 2|Adverse Event|17
1023642|NCT00271817|3340705|P1|Part 2|Adverse Event|0
1023643|NCT00271817|3340703|P3|Part 1|LDL < 50 mg/dL|48
1023644|NCT00271817|3340704|P2|Part 1|LDL < 50 mg/dL|4
1023645|NCT00271817|3340705|P1|Part 1|LDL < 50 mg/dL|1
1023646|NCT00271817|3340703|P3|Part 1|Withdrawal by Subject|45
1023647|NCT00271817|3340704|P2|Part 1|Withdrawal by Subject|17
1023648|NCT00271817|3340705|P1|Part 1|Withdrawal by Subject|23
1023649|NCT00271817|3340703|P3|Part 1|Patient Moved|5
1023650|NCT00271817|3340704|P2|Part 1|Patient Moved|1
1023651|NCT00271817|3340705|P1|Part 1|Patient Moved|3
1023652|NCT00271817|3340703|P3|Part 1|Protocol Violation|7
1023653|NCT00271817|3340704|P2|Part 1|Protocol Violation|4
1023654|NCT00271817|3340705|P1|Part 1|Protocol Violation|5
1023655|NCT00271817|3340703|P3|Part 1|Lost to Follow-up|24
1023656|NCT00271817|3340704|P2|Part 1|Lost to Follow-up|8
1023657|NCT00271817|3340705|P1|Part 1|Lost to Follow-up|6
1023658|NCT00271817|3340703|P3|Part 1|Adverse Event|156
1023659|NCT00271817|3340704|P2|Part 1|Adverse Event|25
1023660|NCT00271817|3340705|P1|Part 1|Adverse Event|68
1023661|NCT00271609|3340747|P2|Overall Study|Withdrawal by Subject|0
1023662|NCT00271609|3340748|P1|Overall Study|Withdrawal by Subject|2
1023663|NCT00271609|3340747|P2|Overall Study|Adverse Event|3
1023664|NCT00271609|3340748|P1|Overall Study|Adverse Event|11
1023665|NCT00271596|3340758|P2|Overall Study|Withdrawal by Subject|1
1023666|NCT00271596|3340759|P1|Overall Study|Withdrawal by Subject|0
1023667|NCT00271596|3340758|P2|Overall Study|Protocol Violation|0
1023668|NCT00271596|3340759|P1|Overall Study|Protocol Violation|1
1023669|NCT00271544|3340794|P1|Overall Study|Implant not attempted|4
1023670|NCT00271544|3340794|P1|Overall Study|Model 4196 lead not attempted|9
1023671|NCT00271544|3340794|P1|Overall Study|Subjects did not receive a 4196 lead|7
1023672|NCT00271024|3340899|P4|Overall Study|Time Commitment, Scheduling, or Travel|4
1023673|NCT00271024|3340900|P3|Overall Study|Time Commitment, Scheduling, or Travel|4
1023674|NCT00271024|3340901|P2|Overall Study|Time Commitment, Scheduling, or Travel|2
1023675|NCT00271024|3340902|P1|Overall Study|Time Commitment, Scheduling, or Travel|6
1023676|NCT00271024|3340899|P4|Overall Study|Unpleasant Reaction To Tablet|2
1023677|NCT00271024|3340900|P3|Overall Study|Unpleasant Reaction To Tablet|4
1023678|NCT00271024|3340901|P2|Overall Study|Unpleasant Reaction To Tablet|3
1023679|NCT00271024|3340902|P1|Overall Study|Unpleasant Reaction To Tablet|1
1023680|NCT00271024|3340899|P4|Overall Study|Protocol Violation|11
1023681|NCT00271024|3340900|P3|Overall Study|Protocol Violation|5
1023682|NCT00271024|3340901|P2|Overall Study|Protocol Violation|6
1023683|NCT00271024|3340902|P1|Overall Study|Protocol Violation|1
1023684|NCT00271024|3340899|P4|Overall Study|Unknown/Unspecified|4
1023685|NCT00271024|3340900|P3|Overall Study|Unknown/Unspecified|8
1023686|NCT00271024|3340901|P2|Overall Study|Unknown/Unspecified|11
1023687|NCT00271024|3340902|P1|Overall Study|Unknown/Unspecified|11
1023688|NCT00271024|3340899|P4|Overall Study|Lost Interest|3
1023689|NCT00271024|3340900|P3|Overall Study|Lost Interest|2
1023690|NCT00271024|3340901|P2|Overall Study|Lost Interest|4
1023691|NCT00271024|3340902|P1|Overall Study|Lost Interest|3
1023692|NCT00270998|3340952|P3|12 Month Follow-up|Received/desired alternate treatment|1
1023693|NCT00270998|3340953|P2|12 Month Follow-up|Received/desired alternate treatment|4
1023694|NCT00270998|3340954|P1|12 Month Follow-up|Received/desired alternate treatment|1
1023695|NCT00270998|3340952|P3|12 Month Follow-up|Personal/family health|1
1023696|NCT00270998|3340953|P2|12 Month Follow-up|Personal/family health|5
1023697|NCT00270998|3340954|P1|12 Month Follow-up|Personal/family health|0
1023698|NCT00270998|3340952|P3|12 Month Follow-up|Pessary did not fit|0
1023699|NCT00270998|3340953|P2|12 Month Follow-up|Pessary did not fit|0
1023700|NCT00270998|3340954|P1|12 Month Follow-up|Pessary did not fit|1
1023701|NCT00270998|3340952|P3|12 Month Follow-up|Withdrawal by Subject|16
1023702|NCT00270998|3340953|P2|12 Month Follow-up|Withdrawal by Subject|12
1023703|NCT00270998|3340954|P1|12 Month Follow-up|Withdrawal by Subject|7
1023704|NCT00270998|3340952|P3|12 Month Follow-up|Lack of Efficacy|3
1023705|NCT00270998|3340953|P2|12 Month Follow-up|Lack of Efficacy|4
1023706|NCT00270998|3340954|P1|12 Month Follow-up|Lack of Efficacy|5
1023707|NCT00270998|3340952|P3|3 Month Follow-up|Received/desired alternate treatment|2
1023708|NCT00270998|3340953|P2|3 Month Follow-up|Received/desired alternate treatment|5
1023709|NCT00270998|3340954|P1|3 Month Follow-up|Received/desired alternate treatment|13
1023710|NCT00270998|3340952|P3|3 Month Follow-up|Personal/family health|0
1023711|NCT00270998|3340953|P2|3 Month Follow-up|Personal/family health|1
1023712|NCT00270998|3340954|P1|3 Month Follow-up|Personal/family health|1
1023713|NCT00270998|3340952|P3|3 Month Follow-up|Pessary did not fit|0
1023714|NCT00270998|3340953|P2|3 Month Follow-up|Pessary did not fit|0
1023715|NCT00270998|3340954|P1|3 Month Follow-up|Pessary did not fit|12
1023716|NCT00270998|3340952|P3|3 Month Follow-up|Withdrawal by Subject|15
1023717|NCT00270998|3340953|P2|3 Month Follow-up|Withdrawal by Subject|14
1023718|NCT00270998|3340954|P1|3 Month Follow-up|Withdrawal by Subject|11
1023719|NCT00270998|3340952|P3|3 Month Follow-up|Lack of Efficacy|1
1023720|NCT00270998|3340953|P2|3 Month Follow-up|Lack of Efficacy|2
1023721|NCT00270998|3340954|P1|3 Month Follow-up|Lack of Efficacy|1
1023722|NCT00270998|3340952|P3|3 Month Follow-up|Adverse Event|0
1023723|NCT00270998|3340953|P2|3 Month Follow-up|Adverse Event|0
1023724|NCT00270998|3340954|P1|3 Month Follow-up|Adverse Event|1
1023725|NCT00270894|3340983|P1|Overall Study|Withdrawal by Subject|1
1023726|NCT00270894|3340983|P1|Overall Study|Adverse Event|1
1023727|NCT00270855|3340995|P2|Overall Study|Withdrawal by Subject|8
1023728|NCT00270855|3340996|P1|Overall Study|Withdrawal by Subject|8
1023729|NCT00270257|3341132|P2|Overall Study|Data Safety Monitoring Board (DSMB) halt|424
1023730|NCT00270257|3341133|P1|Overall Study|Data Safety Monitoring Board (DSMB) halt|412
1023731|NCT00270231|3341151|P2|Second Intervention|Lost to Follow-up|1
1023732|NCT00270231|3341152|P1|Second Intervention|Lost to Follow-up|0
1023733|NCT00270231|3341151|P2|Washout Period|Lost to Follow-up|0
1023734|NCT00270231|3341152|P1|Washout Period|Lost to Follow-up|1
1023735|NCT00270231|3341151|P2|First Intervention|Lost to Follow-up|1
1023736|NCT00270231|3341152|P1|First Intervention|Lost to Follow-up|1
1023737|NCT00270205|3341162|P4|Overall Study|Lost to Follow-up|1
1023738|NCT00270205|3341163|P3|Overall Study|Lost to Follow-up|0
1023739|NCT00270205|3341164|P2|Overall Study|Lost to Follow-up|0
1023740|NCT00270205|3341165|P1|Overall Study|Lost to Follow-up|1
1023741|NCT00269919|3341283|P1|Overall Study|Started but not treated|1
1023742|NCT00269919|3341283|P1|Overall Study|Other|26
1023743|NCT00269633|3341302|P2|Overall Study|Withdrawal by Subject|0
1023744|NCT00269633|3341303|P1|Overall Study|Withdrawal by Subject|1
1023745|NCT00269477|3341313|P4|Overall Study|Missed post-vaccination blood draw|0
1023746|NCT00269477|3341314|P3|Overall Study|Missed post-vaccination blood draw|0
1023747|NCT00269477|3341315|P2|Overall Study|Missed post-vaccination blood draw|1
1023748|NCT00269477|3341316|P1|Overall Study|Missed post-vaccination blood draw|0
1023749|NCT00269477|3341313|P4|Overall Study|Protocol Violation|0
1023750|NCT00269477|3341314|P3|Overall Study|Protocol Violation|1
1023751|NCT00269477|3341315|P2|Overall Study|Protocol Violation|5
1023752|NCT00269477|3341316|P1|Overall Study|Protocol Violation|5
1023753|NCT00269152|3341332|P2|Overall Study|Protocol Violation|1
1023754|NCT00269152|3341333|P1|Overall Study|Protocol Violation|0
1023755|NCT00269152|3341332|P2|Overall Study|Physician Decision|3
1023756|NCT00269152|3341333|P1|Overall Study|Physician Decision|2
1023757|NCT00269152|3341332|P2|Overall Study|Withdrawal by Subject|3
1023758|NCT00269152|3341333|P1|Overall Study|Withdrawal by Subject|7
1023759|NCT00269152|3341332|P2|Overall Study|Adverse Event|3
1023760|NCT00269152|3341333|P1|Overall Study|Adverse Event|9
1023761|NCT00269113|3341349|P2|Overall Study|Not specified|2
1023762|NCT00269113|3341350|P1|Overall Study|Not specified|0
1023763|NCT00269113|3341349|P2|Overall Study|Protocol Violation|5
1023764|NCT00269113|3341350|P1|Overall Study|Protocol Violation|15
1023765|NCT00269113|3341349|P2|Overall Study|Lost to Follow-up|1
1023766|NCT00269113|3341350|P1|Overall Study|Lost to Follow-up|2
1023767|NCT00269113|3341349|P2|Overall Study|Death|2
1023768|NCT00269113|3341350|P1|Overall Study|Death|6
1023769|NCT00269113|3341349|P2|Overall Study|Withdrawal by Subject|2
1023770|NCT00269113|3341350|P1|Overall Study|Withdrawal by Subject|0
1023771|NCT00269113|3341349|P2|Overall Study|Early Improvement|0
1023772|NCT00269113|3341350|P1|Overall Study|Early Improvement|2
1023773|NCT00269113|3341349|P2|Overall Study|Lack of Efficacy|18
1023774|NCT00269113|3341350|P1|Overall Study|Lack of Efficacy|35
1023775|NCT00269113|3341349|P2|Overall Study|Adverse Event|7
1023776|NCT00269113|3341350|P1|Overall Study|Adverse Event|14
1023777|NCT00268996|3341370|P2|Overall Study|Other|1
1023778|NCT00268996|3341371|P1|Overall Study|Other|1
1023779|NCT00268996|3341370|P2|Overall Study|Non-compliance|0
1023780|NCT00268996|3341371|P1|Overall Study|Non-compliance|1
1023781|NCT00268996|3341370|P2|Overall Study|Withdrawal by Subject|11
1023782|NCT00268996|3341371|P1|Overall Study|Withdrawal by Subject|5
1023783|NCT00268996|3341370|P2|Overall Study|Lost to Follow-up|1
1023784|NCT00268996|3341371|P1|Overall Study|Lost to Follow-up|3
1023785|NCT00268996|3341370|P2|Overall Study|Adverse Event|7
1023786|NCT00268996|3341371|P1|Overall Study|Adverse Event|11
1023787|NCT00268983|3341415|P2|Overall Study|Death|0
1023788|NCT00268983|3341416|P1|Overall Study|Death|3
1023789|NCT00268905|3341459|P3|Overall Study|Clinical Progression|1
1023790|NCT00268905|3341460|P2|Overall Study|Clinical Progression|4
1023791|NCT00268905|3341461|P1|Overall Study|Clinical Progression|9
1023792|NCT00268905|3341459|P3|Overall Study|Physician Decision|1
1023793|NCT00268905|3341460|P2|Overall Study|Physician Decision|0
1023794|NCT00268905|3341461|P1|Overall Study|Physician Decision|3
1023795|NCT00268905|3341459|P3|Overall Study|Progressive Disease|3
1023796|NCT00268905|3341460|P2|Overall Study|Progressive Disease|4
1023797|NCT00268905|3341461|P1|Overall Study|Progressive Disease|28
1023798|NCT00268905|3341459|P3|Overall Study|Withdrawal by Subject|3
1023799|NCT00268905|3341460|P2|Overall Study|Withdrawal by Subject|0
1023800|NCT00268905|3341461|P1|Overall Study|Withdrawal by Subject|0
1023801|NCT00268905|3341459|P3|Overall Study|Lost to Follow-up|0
1023802|NCT00268905|3341460|P2|Overall Study|Lost to Follow-up|1
1023803|NCT00268905|3341461|P1|Overall Study|Lost to Follow-up|0
1023804|NCT00268905|3341459|P3|Overall Study|Adverse Event|4
1023805|NCT00268905|3341460|P2|Overall Study|Adverse Event|0
1023806|NCT00268905|3341461|P1|Overall Study|Adverse Event|3
1023807|NCT00268892|3341478|P3|Overall Study|Trial Site Closed|2
1023808|NCT00268892|3341479|P2|Overall Study|Trial Site Closed|2
1023809|NCT00268892|3341480|P1|Overall Study|Trial Site Closed|4
1023810|NCT00268892|3341478|P3|Overall Study|Disease Progression|0
1023811|NCT00268892|3341479|P2|Overall Study|Disease Progression|1
1023812|NCT00268892|3341480|P1|Overall Study|Disease Progression|1
1023813|NCT00268892|3341478|P3|Overall Study|Protocol Violation|0
1023814|NCT00268892|3341479|P2|Overall Study|Protocol Violation|1
1023815|NCT00268892|3341480|P1|Overall Study|Protocol Violation|0
1023816|NCT00268892|3341478|P3|Overall Study|Lost to Follow-up|4
1023817|NCT00268892|3341479|P2|Overall Study|Lost to Follow-up|2
1023818|NCT00268892|3341480|P1|Overall Study|Lost to Follow-up|5
1023819|NCT00268892|3341478|P3|Overall Study|Physician Decision|0
1023820|NCT00268892|3341479|P2|Overall Study|Physician Decision|1
1023821|NCT00268892|3341480|P1|Overall Study|Physician Decision|0
1023822|NCT00268892|3341478|P3|Overall Study|Withdrawal by Subject|13
1023823|NCT00268892|3341479|P2|Overall Study|Withdrawal by Subject|15
1023824|NCT00268892|3341480|P1|Overall Study|Withdrawal by Subject|14
1023825|NCT00268892|3341478|P3|Overall Study|Lack of Efficacy|0
1023826|NCT00268892|3341479|P2|Overall Study|Lack of Efficacy|3
1023827|NCT00268892|3341480|P1|Overall Study|Lack of Efficacy|1
1023828|NCT00268892|3341478|P3|Overall Study|Adverse Event|20
1023829|NCT00268892|3341479|P2|Overall Study|Adverse Event|17
1023830|NCT00268892|3341480|P1|Overall Study|Adverse Event|14
1023831|NCT00268463|3341499|P2|Overall Study|study terminated due to low accrual|12
1023832|NCT00268463|3341500|P1|Overall Study|study terminated due to low accrual|10
1023833|NCT00268437|3341516|P1|Overall Study|Ineligible|1
1023834|NCT00268346|3341523|P2|Overall Study|Withdrawal by Subject|1
1023835|NCT00268346|3341524|P1|Overall Study|Withdrawal by Subject|0
1023836|NCT00268346|3341523|P2|Overall Study|Death|1
1023837|NCT00268346|3341524|P1|Overall Study|Death|0
1023838|NCT00268346|3341523|P2|Overall Study|Adverse Event|1
1023839|NCT00268346|3341524|P1|Overall Study|Adverse Event|0
1023840|NCT00268242|3341530|P1|Overall Study|Death|1
1023841|NCT00268203|3341539|P1|Overall Study|Completed 2 Years of Follow-up|62
1023842|NCT00268203|3341539|P1|Overall Study|Reason Not Specified|34
1023843|NCT00268203|3341539|P1|Overall Study|Death|84
1023844|NCT00268203|3341539|P1|Overall Study|Progressive Disease|359
1023845|NCT00268203|3341539|P1|Overall Study|Received Other NHL Therapy|7
1023846|NCT00268203|3341539|P1|Overall Study|Withdrawal by Subject|9
1023847|NCT00268203|3341539|P1|Overall Study|Lost to Follow-up|92
1023848|NCT00267969|3341553|P7|After Controlled Period|Not specified|25
1023849|NCT00267969|3341554|P6|After Controlled Period|Not specified|22
1023850|NCT00267969|3341555|P5|After Controlled Period|Not specified|11
1023851|NCT00267969|3341556|P4|After Controlled Period|Not specified|13
1023852|NCT00267969|3341557|P3|After Controlled Period|Not specified|0
1023853|NCT00267969|3341558|P2|After Controlled Period|Not specified|0
1023854|NCT00267969|3341559|P1|After Controlled Period|Not specified|0
1023855|NCT00267969|3341553|P7|After Controlled Period|Lost to Follow-up|10
1023856|NCT00267969|3341554|P6|After Controlled Period|Lost to Follow-up|9
1023857|NCT00267969|3341555|P5|After Controlled Period|Lost to Follow-up|8
1023858|NCT00267969|3341556|P4|After Controlled Period|Lost to Follow-up|5
1023859|NCT00267969|3341557|P3|After Controlled Period|Lost to Follow-up|0
1023860|NCT00267969|3341558|P2|After Controlled Period|Lost to Follow-up|0
1023861|NCT00267969|3341559|P1|After Controlled Period|Lost to Follow-up|0
1023862|NCT00267969|3341553|P7|After Controlled Period|Lack of Efficacy|15
1023863|NCT00267969|3341554|P6|After Controlled Period|Lack of Efficacy|28
1023864|NCT00267969|3341555|P5|After Controlled Period|Lack of Efficacy|6
1023865|NCT00267969|3341556|P4|After Controlled Period|Lack of Efficacy|10
1023866|NCT00267969|3341557|P3|After Controlled Period|Lack of Efficacy|0
1023867|NCT00267969|3341558|P2|After Controlled Period|Lack of Efficacy|0
1023868|NCT00267969|3341559|P1|After Controlled Period|Lack of Efficacy|0
1023869|NCT00267969|3341553|P7|After Controlled Period|Death|1
1023870|NCT00267969|3341554|P6|After Controlled Period|Death|0
1023871|NCT00267969|3341555|P5|After Controlled Period|Death|2
1023872|NCT00267969|3341556|P4|After Controlled Period|Death|1
1023873|NCT00267969|3341557|P3|After Controlled Period|Death|0
1023874|NCT00267969|3341558|P2|After Controlled Period|Death|0
1023875|NCT00267969|3341559|P1|After Controlled Period|Death|0
1023876|NCT00267969|3341553|P7|After Controlled Period|Adverse Event|21
1023877|NCT00267969|3341554|P6|After Controlled Period|Adverse Event|23
1023878|NCT00267969|3341555|P5|After Controlled Period|Adverse Event|8
1023879|NCT00267969|3341556|P4|After Controlled Period|Adverse Event|7
1023880|NCT00267969|3341557|P3|After Controlled Period|Adverse Event|0
1023881|NCT00267969|3341558|P2|After Controlled Period|Adverse Event|0
1023882|NCT00267969|3341559|P1|After Controlled Period|Adverse Event|0
1023883|NCT00267969|3341553|P7|Controlled Period|Not specified|0
1023884|NCT00267969|3341554|P6|Controlled Period|Not specified|0
1023885|NCT00267969|3341555|P5|Controlled Period|Not specified|0
1023886|NCT00267969|3341556|P4|Controlled Period|Not specified|0
1023887|NCT00267969|3341557|P3|Controlled Period|Not specified|6
1023888|NCT00267969|3341558|P2|Controlled Period|Not specified|1
1023889|NCT00267969|3341559|P1|Controlled Period|Not specified|2
1023890|NCT00267969|3341553|P7|Controlled Period|Randomized but not treated|0
1023891|NCT00267969|3341554|P6|Controlled Period|Randomized but not treated|0
1023892|NCT00267969|3341555|P5|Controlled Period|Randomized but not treated|0
1023893|NCT00267969|3341556|P4|Controlled Period|Randomized but not treated|0
1023894|NCT00267969|3341557|P3|Controlled Period|Randomized but not treated|1
1023895|NCT00267969|3341558|P2|Controlled Period|Randomized but not treated|0
1023896|NCT00267969|3341559|P1|Controlled Period|Randomized but not treated|0
1023897|NCT00267969|3341553|P7|Controlled Period|Lost to Follow-up|0
1023898|NCT00267969|3341554|P6|Controlled Period|Lost to Follow-up|0
1023899|NCT00267969|3341555|P5|Controlled Period|Lost to Follow-up|0
1023900|NCT00267969|3341556|P4|Controlled Period|Lost to Follow-up|0
1023901|NCT00267969|3341557|P3|Controlled Period|Lost to Follow-up|1
1023902|NCT00267969|3341558|P2|Controlled Period|Lost to Follow-up|0
1023903|NCT00267969|3341559|P1|Controlled Period|Lost to Follow-up|1
1023904|NCT00267969|3341553|P7|Controlled Period|Lack of Efficacy|0
1023905|NCT00267969|3341554|P6|Controlled Period|Lack of Efficacy|0
1023906|NCT00267969|3341555|P5|Controlled Period|Lack of Efficacy|0
1023907|NCT00267969|3341556|P4|Controlled Period|Lack of Efficacy|0
1023908|NCT00267969|3341557|P3|Controlled Period|Lack of Efficacy|1
1023909|NCT00267969|3341558|P2|Controlled Period|Lack of Efficacy|0
1023910|NCT00267969|3341559|P1|Controlled Period|Lack of Efficacy|3
1023911|NCT00267969|3341553|P7|Controlled Period|Adverse Event|0
1023912|NCT00267969|3341554|P6|Controlled Period|Adverse Event|0
1023913|NCT00267969|3341555|P5|Controlled Period|Adverse Event|0
1023914|NCT00267969|3341556|P4|Controlled Period|Adverse Event|0
1023915|NCT00267969|3341557|P3|Controlled Period|Adverse Event|2
1023916|NCT00267969|3341558|P2|Controlled Period|Adverse Event|0
1023917|NCT00267969|3341559|P1|Controlled Period|Adverse Event|6
1023918|NCT00267956|3341585|P4|After Controlled Period|Withdrew consent|0
1023919|NCT00267956|3341586|P3|After Controlled Period|Withdrew consent|1
1023920|NCT00267956|3341587|P2|After Controlled Period|Withdrew consent|0
1023921|NCT00267956|3341588|P1|After Controlled Period|Withdrew consent|0
1023922|NCT00267956|3341585|P4|After Controlled Period|Lost to Follow-up|0
1023923|NCT00267956|3341586|P3|After Controlled Period|Lost to Follow-up|1
1023924|NCT00267956|3341587|P2|After Controlled Period|Lost to Follow-up|0
1023925|NCT00267956|3341588|P1|After Controlled Period|Lost to Follow-up|0
1023926|NCT00267956|3341585|P4|After Controlled Period|Lack of Efficacy|1
1023927|NCT00267956|3341586|P3|After Controlled Period|Lack of Efficacy|1
1023928|NCT00267956|3341587|P2|After Controlled Period|Lack of Efficacy|0
1023929|NCT00267956|3341588|P1|After Controlled Period|Lack of Efficacy|0
1023930|NCT00267956|3341585|P4|After Controlled Period|Adverse Event|1
1023931|NCT00267956|3341586|P3|After Controlled Period|Adverse Event|2
1023932|NCT00267956|3341587|P2|After Controlled Period|Adverse Event|0
1023933|NCT00267956|3341588|P1|After Controlled Period|Adverse Event|0
1023934|NCT00267956|3341585|P4|Controlled Period|Withdrew consent|0
1023935|NCT00267956|3341586|P3|Controlled Period|Withdrew consent|0
1023936|NCT00267956|3341587|P2|Controlled Period|Withdrew consent|1
1023937|NCT00267956|3341588|P1|Controlled Period|Withdrew consent|3
1023938|NCT00267956|3341585|P4|Controlled Period|Lost to Follow-up|0
1023939|NCT00267956|3341586|P3|Controlled Period|Lost to Follow-up|0
1023940|NCT00267956|3341587|P2|Controlled Period|Lost to Follow-up|0
1023941|NCT00267956|3341588|P1|Controlled Period|Lost to Follow-up|2
1023942|NCT00267956|3341585|P4|Controlled Period|Lack of Efficacy|0
1023943|NCT00267956|3341586|P3|Controlled Period|Lack of Efficacy|0
1023944|NCT00267956|3341587|P2|Controlled Period|Lack of Efficacy|2
1023945|NCT00267956|3341588|P1|Controlled Period|Lack of Efficacy|4
1023946|NCT00267956|3341585|P4|Controlled Period|Adverse Event|0
1023947|NCT00267956|3341586|P3|Controlled Period|Adverse Event|0
1023948|NCT00267956|3341587|P2|Controlled Period|Adverse Event|1
1023949|NCT00267956|3341588|P1|Controlled Period|Adverse Event|4
1023950|NCT00267748|3341620|P3|Randomized Period|randomized but not treated|3
1023951|NCT00267748|3341621|P2|Randomized Period|randomized but not treated|0
1023952|NCT00267748|3341622|P1|Randomized Period|randomized but not treated|0
1023953|NCT00267748|3341620|P3|Randomized Period|Other|6
1023954|NCT00267748|3341621|P2|Randomized Period|Other|9
1023955|NCT00267748|3341622|P1|Randomized Period|Other|0
1023956|NCT00267748|3341620|P3|Randomized Period|Withdrawal by Subject|2
1023957|NCT00267748|3341621|P2|Randomized Period|Withdrawal by Subject|9
1023958|NCT00267748|3341622|P1|Randomized Period|Withdrawal by Subject|0
1023959|NCT00267748|3341620|P3|Randomized Period|Objective progression or relapse|86
1023960|NCT00267748|3341621|P2|Randomized Period|Objective progression or relapse|77
1023961|NCT00267748|3341622|P1|Randomized Period|Objective progression or relapse|0
1023962|NCT00267748|3341620|P3|Randomized Period|Lost to Follow-up|0
1023963|NCT00267748|3341621|P2|Randomized Period|Lost to Follow-up|1
1023964|NCT00267748|3341622|P1|Randomized Period|Lost to Follow-up|0
1023965|NCT00267748|3341620|P3|Randomized Period|Global deterioration of health status|7
1023966|NCT00267748|3341621|P2|Randomized Period|Global deterioration of health status|6
1023967|NCT00267748|3341622|P1|Randomized Period|Global deterioration of health status|0
1023968|NCT00267748|3341620|P3|Randomized Period|Adverse Event|25
1023969|NCT00267748|3341621|P2|Randomized Period|Adverse Event|23
1023970|NCT00267748|3341622|P1|Randomized Period|Adverse Event|0
1023971|NCT00267748|3341620|P3|Randomized Period|Death|3
1023972|NCT00267748|3341621|P2|Randomized Period|Death|2
1023973|NCT00267748|3341622|P1|Randomized Period|Death|0
1023974|NCT00267748|3341620|P3|Non-randomized Period|Other|0
1023975|NCT00267748|3341621|P2|Non-randomized Period|Other|0
1023976|NCT00267748|3341622|P1|Non-randomized Period|Other|3
1023977|NCT00267748|3341620|P3|Non-randomized Period|Participant not willing to participate|0
1023978|NCT00267748|3341621|P2|Non-randomized Period|Participant not willing to participate|0
1023979|NCT00267748|3341622|P1|Non-randomized Period|Participant not willing to participate|1
1023980|NCT00267748|3341620|P3|Non-randomized Period|Death|0
1023981|NCT00267748|3341621|P2|Non-randomized Period|Death|0
1023982|NCT00267748|3341622|P1|Non-randomized Period|Death|1
1023983|NCT00267748|3341620|P3|Non-randomized Period|Adverse Event|0
1023984|NCT00267748|3341621|P2|Non-randomized Period|Adverse Event|0
1023985|NCT00267748|3341622|P1|Non-randomized Period|Adverse Event|8
1023986|NCT00267748|3341620|P3|Non-randomized Period|Progressive disease|0
1023987|NCT00267748|3341621|P2|Non-randomized Period|Progressive disease|0
1023988|NCT00267748|3341622|P1|Non-randomized Period|Progressive disease|10
1023989|NCT00267488|3341679|P1|Overall Study|Other (Disease Progression)|1
1023990|NCT00267488|3341679|P1|Overall Study|Protocol Violation|1
1023991|NCT00267488|3341679|P1|Overall Study|Sponsor Terminated Study|9
1023992|NCT00267202|3341703|P2|Overall Study|Lost to Follow-up|0
1023993|NCT00267202|3341704|P1|Overall Study|Lost to Follow-up|3
1023994|NCT00267202|3341703|P2|Overall Study|Administrative problems|1
1023995|NCT00267202|3341704|P1|Overall Study|Administrative problems|2
1023996|NCT00267202|3341703|P2|Overall Study|Protocol Violation|3
1023997|NCT00267202|3341704|P1|Overall Study|Protocol Violation|2
1023998|NCT00267202|3341703|P2|Overall Study|Adverse Event|7
1023999|NCT00267202|3341704|P1|Overall Study|Adverse Event|13
1024000|NCT00267202|3341703|P2|Overall Study|Withdrawal by Subject|15
1024001|NCT00267202|3341704|P1|Overall Study|Withdrawal by Subject|12
1024002|NCT00267202|3341703|P2|Overall Study|Unsatisfactory therapeutic effect|8
1024003|NCT00267202|3341704|P1|Overall Study|Unsatisfactory therapeutic effect|21
1024004|NCT00267189|3341725|P2|Overall Study|Missing|0
1024005|NCT00267189|3341726|P1|Overall Study|Missing|3
1024006|NCT00267189|3341725|P2|Overall Study|Death|0
1024007|NCT00267189|3341726|P1|Overall Study|Death|1
1024008|NCT00267189|3341725|P2|Overall Study|Patient withdrew consent|1
1024009|NCT00267189|3341726|P1|Overall Study|Patient withdrew consent|1
1024010|NCT00267150|3341736|P1|Overall Study|Adverse Event|1
1024011|NCT00267098|3341760|P8|Overall Study|Sponsor withdrew subject|0
1024012|NCT00267098|3341761|P7|Overall Study|Sponsor withdrew subject|0
1024013|NCT00267098|3341762|P6|Overall Study|Sponsor withdrew subject|0
1024014|NCT00267098|3341763|P5|Overall Study|Sponsor withdrew subject|0
1024015|NCT00267098|3341764|P4|Overall Study|Sponsor withdrew subject|1
1024016|NCT00267098|3341765|P3|Overall Study|Sponsor withdrew subject|0
1024017|NCT00267098|3341766|P2|Overall Study|Sponsor withdrew subject|0
1024018|NCT00267098|3341767|P1|Overall Study|Sponsor withdrew subject|0
1024019|NCT00267098|3341760|P8|Overall Study|Subject listed for heart transplant|0
1024020|NCT00267098|3341761|P7|Overall Study|Subject listed for heart transplant|1
1024021|NCT00267098|3341762|P6|Overall Study|Subject listed for heart transplant|0
1024022|NCT00267098|3341763|P5|Overall Study|Subject listed for heart transplant|0
1024023|NCT00267098|3341764|P4|Overall Study|Subject listed for heart transplant|0
1024024|NCT00267098|3341765|P3|Overall Study|Subject listed for heart transplant|0
1024025|NCT00267098|3341766|P2|Overall Study|Subject listed for heart transplant|0
1024026|NCT00267098|3341767|P1|Overall Study|Subject listed for heart transplant|0
1024027|NCT00267098|3341760|P8|Overall Study|Non-Medtronic LV Lead Implanted|0
1024028|NCT00267098|3341761|P7|Overall Study|Non-Medtronic LV Lead Implanted|0
1024029|NCT00267098|3341762|P6|Overall Study|Non-Medtronic LV Lead Implanted|0
1024030|NCT00267098|3341763|P5|Overall Study|Non-Medtronic LV Lead Implanted|2
1024031|NCT00267098|3341764|P4|Overall Study|Non-Medtronic LV Lead Implanted|0
1024032|NCT00267098|3341765|P3|Overall Study|Non-Medtronic LV Lead Implanted|0
1024033|NCT00267098|3341766|P2|Overall Study|Non-Medtronic LV Lead Implanted|0
1024034|NCT00267098|3341767|P1|Overall Study|Non-Medtronic LV Lead Implanted|0
1024035|NCT00267098|3341760|P8|Overall Study|Explanted Medtronic device|0
1024036|NCT00267098|3341761|P7|Overall Study|Explanted Medtronic device|0
1024037|NCT00267098|3341762|P6|Overall Study|Explanted Medtronic device|0
1024038|NCT00267098|3341763|P5|Overall Study|Explanted Medtronic device|0
1024039|NCT00267098|3341764|P4|Overall Study|Explanted Medtronic device|1
1024040|NCT00267098|3341765|P3|Overall Study|Explanted Medtronic device|0
1024041|NCT00267098|3341766|P2|Overall Study|Explanted Medtronic device|0
1024042|NCT00267098|3341767|P1|Overall Study|Explanted Medtronic device|0
1024043|NCT00267098|3341760|P8|Overall Study|Site closure|0
1024044|NCT00267098|3341761|P7|Overall Study|Site closure|1
1024045|NCT00267098|3341762|P6|Overall Study|Site closure|1
1024046|NCT00267098|3341763|P5|Overall Study|Site closure|0
1024047|NCT00267098|3341764|P4|Overall Study|Site closure|1
1024048|NCT00267098|3341765|P3|Overall Study|Site closure|0
1024049|NCT00267098|3341766|P2|Overall Study|Site closure|0
1024050|NCT00267098|3341767|P1|Overall Study|Site closure|0
1024051|NCT00267098|3341760|P8|Overall Study|Unsuccessful Implant Exit Per Protocol|0
1024052|NCT00267098|3341761|P7|Overall Study|Unsuccessful Implant Exit Per Protocol|0
1024053|NCT00267098|3341762|P6|Overall Study|Unsuccessful Implant Exit Per Protocol|0
1024054|NCT00267098|3341763|P5|Overall Study|Unsuccessful Implant Exit Per Protocol|0
1024055|NCT00267098|3341764|P4|Overall Study|Unsuccessful Implant Exit Per Protocol|0
1024056|NCT00267098|3341765|P3|Overall Study|Unsuccessful Implant Exit Per Protocol|0
1024057|NCT00267098|3341766|P2|Overall Study|Unsuccessful Implant Exit Per Protocol|51
1024058|NCT00267098|3341767|P1|Overall Study|Unsuccessful Implant Exit Per Protocol|0
1024059|NCT00267098|3341760|P8|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1024060|NCT00267098|3341761|P7|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1024061|NCT00267098|3341762|P6|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1024062|NCT00267098|3341763|P5|Overall Study|Inclusion/Exclusion Criteria Not Met|2
1024063|NCT00267098|3341764|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1024064|NCT00267098|3341765|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1024065|NCT00267098|3341766|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1024066|NCT00267098|3341767|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|96
1024067|NCT00267098|3341760|P8|Overall Study|Physician Decision|0
1024068|NCT00267098|3341761|P7|Overall Study|Physician Decision|3
1024069|NCT00267098|3341762|P6|Overall Study|Physician Decision|4
1024070|NCT00267098|3341763|P5|Overall Study|Physician Decision|5
1024071|NCT00267098|3341764|P4|Overall Study|Physician Decision|11
1024072|NCT00267098|3341765|P3|Overall Study|Physician Decision|7
1024073|NCT00267098|3341766|P2|Overall Study|Physician Decision|0
1024074|NCT00267098|3341767|P1|Overall Study|Physician Decision|5
1024075|NCT00267098|3341760|P8|Overall Study|Withdrawal by Subject|5
1024076|NCT00267098|3341761|P7|Overall Study|Withdrawal by Subject|12
1024077|NCT00267098|3341762|P6|Overall Study|Withdrawal by Subject|9
1024078|NCT00267098|3341763|P5|Overall Study|Withdrawal by Subject|12
1024079|NCT00267098|3341764|P4|Overall Study|Withdrawal by Subject|21
1024080|NCT00267098|3341765|P3|Overall Study|Withdrawal by Subject|24
1024081|NCT00267098|3341766|P2|Overall Study|Withdrawal by Subject|0
1024082|NCT00267098|3341767|P1|Overall Study|Withdrawal by Subject|8
1024083|NCT00267098|3341760|P8|Overall Study|Lost to Follow-up|1
1024084|NCT00267098|3341761|P7|Overall Study|Lost to Follow-up|1
1024085|NCT00267098|3341762|P6|Overall Study|Lost to Follow-up|3
1024086|NCT00267098|3341763|P5|Overall Study|Lost to Follow-up|2
1024087|NCT00267098|3341764|P4|Overall Study|Lost to Follow-up|5
1024088|NCT00267098|3341765|P3|Overall Study|Lost to Follow-up|6
1024089|NCT00267098|3341766|P2|Overall Study|Lost to Follow-up|0
1024090|NCT00267098|3341767|P1|Overall Study|Lost to Follow-up|0
1024091|NCT00267098|3341760|P8|Overall Study|Death|9
1024092|NCT00267098|3341761|P7|Overall Study|Death|28
1024093|NCT00267098|3341762|P6|Overall Study|Death|23
1024094|NCT00267098|3341763|P5|Overall Study|Death|14
1024095|NCT00267098|3341764|P4|Overall Study|Death|66
1024096|NCT00267098|3341765|P3|Overall Study|Death|57
1024097|NCT00267098|3341766|P2|Overall Study|Death|0
1024098|NCT00267098|3341767|P1|Overall Study|Death|0
1024099|NCT00267046|3341910|P2|Overall Study|Radiation|1
1024100|NCT00267046|3341911|P1|Overall Study|Radiation|0
1024101|NCT00267046|3341910|P2|Overall Study|Withdrawal by Subject|0
1024102|NCT00267046|3341911|P1|Overall Study|Withdrawal by Subject|1
1024103|NCT00267046|3341910|P2|Overall Study|Surgery|1
1024104|NCT00267046|3341911|P1|Overall Study|Surgery|3
1024105|NCT00267046|3341910|P2|Overall Study|Open-label palifermin|7
1024106|NCT00267046|3341911|P1|Overall Study|Open-label palifermin|2
1024107|NCT00267046|3341910|P2|Overall Study|Chemotoxicity|0
1024108|NCT00267046|3341911|P1|Overall Study|Chemotoxicity|2
1024109|NCT00267046|3341910|P2|Overall Study|Disease progression|2
1024110|NCT00267046|3341911|P1|Overall Study|Disease progression|4
1024111|NCT00267007|3341921|P2|Overall Study|Adverse Event|0
1024112|NCT00267007|3341922|P1|Overall Study|Adverse Event|1
1024113|NCT00267007|3341921|P2|Overall Study|Non-compliance|1
1024114|NCT00267007|3341922|P1|Overall Study|Non-compliance|0
1024115|NCT00267007|3341921|P2|Overall Study|Lost to Follow-up|0
1024116|NCT00267007|3341922|P1|Overall Study|Lost to Follow-up|1
1024117|NCT00267007|3341921|P2|Overall Study|Withdrawal by Subject|0
1024118|NCT00267007|3341922|P1|Overall Study|Withdrawal by Subject|6
1024119|NCT00266877|3341933|P3|Overall Study|Concomitant Radiotherapy|0
1024120|NCT00266877|3341934|P2|Overall Study|Concomitant Radiotherapy|1
1024121|NCT00266877|3341935|P1|Overall Study|Concomitant Radiotherapy|0
1024122|NCT00266877|3341933|P3|Overall Study|Hospitalization|0
1024123|NCT00266877|3341934|P2|Overall Study|Hospitalization|0
1024124|NCT00266877|3341935|P1|Overall Study|Hospitalization|1
1024125|NCT00266877|3341933|P3|Overall Study|Symptomatic Deterioration|1
1024126|NCT00266877|3341934|P2|Overall Study|Symptomatic Deterioration|3
1024127|NCT00266877|3341935|P1|Overall Study|Symptomatic Deterioration|6
1024128|NCT00266877|3341933|P3|Overall Study|Disease Progression|23
1024129|NCT00266877|3341934|P2|Overall Study|Disease Progression|37
1024130|NCT00266877|3341935|P1|Overall Study|Disease Progression|72
1024131|NCT00266877|3341933|P3|Overall Study|Withdrawal by Subject|1
1024132|NCT00266877|3341934|P2|Overall Study|Withdrawal by Subject|1
1024133|NCT00266877|3341935|P1|Overall Study|Withdrawal by Subject|3
1024134|NCT00266877|3341933|P3|Overall Study|Physician Decision|1
1024135|NCT00266877|3341934|P2|Overall Study|Physician Decision|1
1024136|NCT00266877|3341935|P1|Overall Study|Physician Decision|2
1024137|NCT00266877|3341933|P3|Overall Study|Adverse Event|1
1024138|NCT00266877|3341934|P2|Overall Study|Adverse Event|4
1024139|NCT00266877|3341935|P1|Overall Study|Adverse Event|6
1024140|NCT00266877|3341933|P3|Overall Study|Death|1
1024141|NCT00266877|3341934|P2|Overall Study|Death|1
1024142|NCT00266877|3341935|P1|Overall Study|Death|1
1024143|NCT00266864|3341954|P2|Overall Study|Withdrawal by Subject|1
1024144|NCT00266864|3341955|P1|Overall Study|Withdrawal by Subject|1
1024145|NCT00266864|3341954|P2|Overall Study|Lost to Follow-up|1
1024146|NCT00266864|3341955|P1|Overall Study|Lost to Follow-up|4
1024147|NCT00266825|3341964|P2|Completed Follow-Up|Withdrawal by Subject|5
1024148|NCT00266825|3341965|P1|Completed Follow-Up|Withdrawal by Subject|11
1024149|NCT00266825|3341964|P2|Completed Follow-Up|Lost to Follow-up|19
1024150|NCT00266825|3341965|P1|Completed Follow-Up|Lost to Follow-up|14
1024151|NCT00266812|3341991|P2|Overall Study|Discontinued before starting study drug|0
1024152|NCT00266812|3341992|P1|Overall Study|Discontinued before starting study drug|4
1024153|NCT00266812|3341991|P2|Overall Study|Withdrawal by Subject|2
1024154|NCT00266812|3341992|P1|Overall Study|Withdrawal by Subject|0
1024155|NCT00266812|3341991|P2|Overall Study|Protocol Violation|1
1024156|NCT00266812|3341992|P1|Overall Study|Protocol Violation|0
1024157|NCT00266812|3341991|P2|Overall Study|Adverse Event|1
1024158|NCT00266812|3341992|P1|Overall Study|Adverse Event|3
1024159|NCT00266812|3341991|P2|Overall Study|Death|4
1024160|NCT00266812|3341992|P1|Overall Study|Death|5
1024161|NCT00266812|3341991|P2|Overall Study|Disease Progression|3
1024162|NCT00266812|3341992|P1|Overall Study|Disease Progression|9
1024163|NCT00266695|3342015|P1|Overall Study|Withdrawal by Subject|15
1024164|NCT00266695|3342015|P1|Overall Study|Lost to Follow-up|3
1024165|NCT00266695|3342015|P1|Overall Study|Physician Decision|1
1024166|NCT00266695|3342015|P1|Overall Study|Death|9
1024167|NCT00266695|3342015|P1|Overall Study|Adverse Event|1
1024168|NCT00266656|3342027|P2|Overall Study|Parent/Caregiver Decision|2
1024169|NCT00266656|3342028|P1|Overall Study|Parent/Caregiver Decision|1
1024170|NCT00266656|3342027|P2|Overall Study|Did Not Reach Final Height|8
1024171|NCT00266656|3342028|P1|Overall Study|Did Not Reach Final Height|4
1024172|NCT00266656|3342027|P2|Overall Study|Withdrawal by Subject|2
1024173|NCT00266656|3342028|P1|Overall Study|Withdrawal by Subject|4
1024174|NCT00266656|3342027|P2|Overall Study|Lost to Follow-up|1
1024175|NCT00266656|3342028|P1|Overall Study|Lost to Follow-up|4
1024176|NCT00266656|3342027|P2|Overall Study|Death|0
1024177|NCT00266656|3342028|P1|Overall Study|Death|1
1024178|NCT00266630|3342052|P2|Overall Study|Not Specified|11
1024179|NCT00266630|3342053|P1|Overall Study|Not Specified|19
1024180|NCT00266630|3342052|P2|Overall Study|Lost to Follow-up|0
1024181|NCT00266630|3342053|P1|Overall Study|Lost to Follow-up|1
1024182|NCT00266630|3342052|P2|Overall Study|Withdrawal by Subject|2
1024183|NCT00266630|3342053|P1|Overall Study|Withdrawal by Subject|10
1024184|NCT00266630|3342052|P2|Overall Study|Physician Decision|2
1024185|NCT00266630|3342053|P1|Overall Study|Physician Decision|1
1024186|NCT00266630|3342052|P2|Overall Study|Protocol Violation|3
1024187|NCT00266630|3342053|P1|Overall Study|Protocol Violation|1
1024188|NCT00266630|3342052|P2|Overall Study|Entry Criteria not met|0
1024189|NCT00266630|3342053|P1|Overall Study|Entry Criteria not met|1
1024190|NCT00266630|3342052|P2|Overall Study|Lack of Efficacy|4
1024191|NCT00266630|3342053|P1|Overall Study|Lack of Efficacy|1
1024192|NCT00266630|3342052|P2|Overall Study|Adverse Event|6
1024193|NCT00266630|3342053|P1|Overall Study|Adverse Event|8
1024194|NCT00266409|3342095|P4|Overall Study|Other|0
1024195|NCT00266409|3342096|P3|Overall Study|Other|2
1024196|NCT00266409|3342097|P2|Overall Study|Other|4
1024197|NCT00266409|3342098|P1|Overall Study|Other|7
1024198|NCT00266409|3342095|P4|Overall Study|Protocol Violation|2
1024199|NCT00266409|3342096|P3|Overall Study|Protocol Violation|4
1024200|NCT00266409|3342097|P2|Overall Study|Protocol Violation|3
1024201|NCT00266409|3342098|P1|Overall Study|Protocol Violation|5
1024202|NCT00266409|3342095|P4|Overall Study|Withdrawal by Subject|9
1024203|NCT00266409|3342096|P3|Overall Study|Withdrawal by Subject|3
1024204|NCT00266409|3342097|P2|Overall Study|Withdrawal by Subject|10
1024205|NCT00266409|3342098|P1|Overall Study|Withdrawal by Subject|6
1024206|NCT00266409|3342095|P4|Overall Study|Lost to Follow-up|8
1024207|NCT00266409|3342096|P3|Overall Study|Lost to Follow-up|6
1024208|NCT00266409|3342097|P2|Overall Study|Lost to Follow-up|21
1024209|NCT00266409|3342098|P1|Overall Study|Lost to Follow-up|18
1024210|NCT00266409|3342095|P4|Overall Study|Adverse Event|1
1024211|NCT00266409|3342096|P3|Overall Study|Adverse Event|1
1024212|NCT00266409|3342097|P2|Overall Study|Adverse Event|2
1024213|NCT00266409|3342098|P1|Overall Study|Adverse Event|7
1024214|NCT00266409|3342095|P4|Overall Study|Lack of Efficacy|2
1024215|NCT00266409|3342096|P3|Overall Study|Lack of Efficacy|1
1024216|NCT00266409|3342097|P2|Overall Study|Lack of Efficacy|6
1024217|NCT00266409|3342098|P1|Overall Study|Lack of Efficacy|2
1024218|NCT00266227|3342386|P3|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0
1024219|NCT00266227|3342387|P2|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10
1024220|NCT00266227|3342388|P1|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15
1024221|NCT00266227|3342386|P3|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0
1024222|NCT00266227|3342387|P2|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29
1024223|NCT00266227|3342388|P1|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41
1024224|NCT00266227|3342386|P3|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
1024225|NCT00266227|3342387|P2|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
1024226|NCT00266227|3342388|P1|Retreatment: Week 48 to Week 72|Lost to Follow-up|1
1024227|NCT00266227|3342386|P3|Retreatment: Week 48 to Week 72|Adverse Event|0
1024228|NCT00266227|3342387|P2|Retreatment: Week 48 to Week 72|Adverse Event|2
1024229|NCT00266227|3342388|P1|Retreatment: Week 48 to Week 72|Adverse Event|6
1024230|NCT00266227|3342386|P3|Retreatment: Week 48 to Week 72|Death|0
1024231|NCT00266227|3342387|P2|Retreatment: Week 48 to Week 72|Death|1
1024232|NCT00266227|3342388|P1|Retreatment: Week 48 to Week 72|Death|1
1024233|NCT00266227|3342386|P3|Retreatment: Up to Week 48|Pregnancy|0
1024234|NCT00266227|3342387|P2|Retreatment: Up to Week 48|Pregnancy|0
1024235|NCT00266227|3342388|P1|Retreatment: Up to Week 48|Pregnancy|1
1024236|NCT00266227|3342386|P3|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0
1024237|NCT00266227|3342387|P2|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2
1024238|NCT00266227|3342388|P1|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4
1024239|NCT00266227|3342386|P3|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0
1024240|NCT00266227|3342387|P2|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14
1024241|NCT00266227|3342388|P1|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11
1024242|NCT00266227|3342386|P3|Retreatment: Up to Week 48|Lost to Follow-up|0
1024243|NCT00266227|3342387|P2|Retreatment: Up to Week 48|Lost to Follow-up|0
1024244|NCT00266227|3342388|P1|Retreatment: Up to Week 48|Lost to Follow-up|3
1024245|NCT00266227|3342386|P3|Retreatment: Up to Week 48|Adverse Event|0
1024246|NCT00266227|3342387|P2|Retreatment: Up to Week 48|Adverse Event|7
1024247|NCT00266227|3342388|P1|Retreatment: Up to Week 48|Adverse Event|7
1024248|NCT00266227|3342386|P3|Retreatment: Up to Week 48|Death|0
1024249|NCT00266227|3342387|P2|Retreatment: Up to Week 48|Death|0
1024250|NCT00266227|3342388|P1|Retreatment: Up to Week 48|Death|1
1024251|NCT00266227|3342386|P3|Initial Treatment|Pregnancy|1
1024252|NCT00266227|3342387|P2|Initial Treatment|Pregnancy|0
1024253|NCT00266227|3342388|P1|Initial Treatment|Pregnancy|0
1024254|NCT00266227|3342386|P3|Initial Treatment|Physician decision to withdraw|12
1024255|NCT00266227|3342387|P2|Initial Treatment|Physician decision to withdraw|0
1024256|NCT00266227|3342388|P1|Initial Treatment|Physician decision to withdraw|0
1024257|NCT00266227|3342386|P3|Initial Treatment|Subject/Guardian decision to withdraw|45
1024258|NCT00266227|3342387|P2|Initial Treatment|Subject/Guardian decision to withdraw|0
1024259|NCT00266227|3342388|P1|Initial Treatment|Subject/Guardian decision to withdraw|0
1024260|NCT00266227|3342386|P3|Initial Treatment|Lost to Follow-up|6
1024261|NCT00266227|3342387|P2|Initial Treatment|Lost to Follow-up|0
1024262|NCT00266227|3342388|P1|Initial Treatment|Lost to Follow-up|0
1024263|NCT00266227|3342386|P3|Initial Treatment|Adverse Event|13
1024264|NCT00266227|3342387|P2|Initial Treatment|Adverse Event|0
1024265|NCT00266227|3342388|P1|Initial Treatment|Adverse Event|0
1024266|NCT00266032|3342442|P3|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1
1024267|NCT00266032|3342443|P2|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2
1024268|NCT00266032|3342444|P1|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10
1024269|NCT00266032|3342442|P3|Open-label Safety Extension|Withdrawal by Subject|12
1024270|NCT00266032|3342443|P2|Open-label Safety Extension|Withdrawal by Subject|3
1024271|NCT00266032|3342444|P1|Open-label Safety Extension|Withdrawal by Subject|19
1024272|NCT00266032|3342442|P3|Open-label Safety Extension|Protocol Violation|2
1024273|NCT00266032|3342443|P2|Open-label Safety Extension|Protocol Violation|3
1024274|NCT00266032|3342444|P1|Open-label Safety Extension|Protocol Violation|1
1024275|NCT00266032|3342442|P3|Open-label Safety Extension|Pregnancy|2
1024276|NCT00266032|3342443|P2|Open-label Safety Extension|Pregnancy|1
1024277|NCT00266032|3342444|P1|Open-label Safety Extension|Pregnancy|4
1024278|NCT00266032|3342442|P3|Open-label Safety Extension|Lost to Follow-up|4
1024279|NCT00266032|3342443|P2|Open-label Safety Extension|Lost to Follow-up|5
1024280|NCT00266032|3342444|P1|Open-label Safety Extension|Lost to Follow-up|2
1024281|NCT00266032|3342442|P3|Open-label Safety Extension|Adverse Event|4
1024282|NCT00266032|3342443|P2|Open-label Safety Extension|Adverse Event|0
1024283|NCT00266032|3342444|P1|Open-label Safety Extension|Adverse Event|5
1024284|NCT00266032|3342442|P3|Treatment|patient moved/wish for pregnancy/no need|8
1024285|NCT00266032|3342443|P2|Treatment|patient moved/wish for pregnancy/no need|5
1024286|NCT00266032|3342444|P1|Treatment|patient moved/wish for pregnancy/no need|13
1024287|NCT00266032|3342442|P3|Treatment|Withdrawal by Subject|12
1024288|NCT00266032|3342443|P2|Treatment|Withdrawal by Subject|13
1024289|NCT00266032|3342444|P1|Treatment|Withdrawal by Subject|28
1024290|NCT00266032|3342442|P3|Treatment|Protocol Violation|13
1024291|NCT00266032|3342443|P2|Treatment|Protocol Violation|14
1024292|NCT00266032|3342444|P1|Treatment|Protocol Violation|6
1024293|NCT00266032|3342442|P3|Treatment|Pregnancy|2
1024294|NCT00266032|3342443|P2|Treatment|Pregnancy|2
1024295|NCT00266032|3342444|P1|Treatment|Pregnancy|3
1024296|NCT00266032|3342442|P3|Treatment|Lost to Follow-up|2
1024297|NCT00266032|3342443|P2|Treatment|Lost to Follow-up|4
1024298|NCT00266032|3342444|P1|Treatment|Lost to Follow-up|19
1024299|NCT00266032|3342442|P3|Treatment|Adverse Event|10
1024300|NCT00266032|3342443|P2|Treatment|Adverse Event|26
1024301|NCT00266032|3342444|P1|Treatment|Adverse Event|42
1024302|NCT00265941|3342474|P2|Overall Study|Lost to Follow-up|1
1024303|NCT00265941|3342475|P1|Overall Study|Lost to Follow-up|1
1024304|NCT00265941|3342474|P2|Overall Study|Protocol Violation|25
1024305|NCT00265941|3342475|P1|Overall Study|Protocol Violation|22
1024306|NCT00265889|3342507|P1|Overall Study|Insurance denied the request|3
1024307|NCT00265889|3342507|P1|Overall Study|Protocol Violation|1
1024308|NCT00265889|3342507|P1|Overall Study|Physician Decision|1
1024309|NCT00265785|3342534|P1|Overall Study|Did not receive protocol treatment|2
1024310|NCT00265785|3342534|P1|Overall Study|Ineligible|1
1024311|NCT00265785|3342534|P1|Overall Study|Not protocol specified|2
1024312|NCT00265785|3342534|P1|Overall Study|Progression/Relapse|15
1024313|NCT00265785|3342534|P1|Overall Study|Withdrawal by Subject|3
1024314|NCT00265785|3342534|P1|Overall Study|Adverse Event|4
1024315|NCT00265759|3342547|P4|Overall Study|Discontinued due to intolerability|1
1024316|NCT00265759|3342548|P3|Overall Study|Discontinued due to intolerability|0
1024317|NCT00265759|3342549|P2|Overall Study|Discontinued due to intolerability|0
1024318|NCT00265759|3342550|P1|Overall Study|Discontinued due to intolerability|0
1024319|NCT00265759|3342547|P4|Overall Study|Bilateral disease|2
1024320|NCT00265759|3342548|P3|Overall Study|Bilateral disease|0
1024321|NCT00265759|3342549|P2|Overall Study|Bilateral disease|0
1024322|NCT00265759|3342550|P1|Overall Study|Bilateral disease|0
1024323|NCT00265759|3342547|P4|Overall Study|Ineligible|1
1024324|NCT00265759|3342548|P3|Overall Study|Ineligible|0
1024325|NCT00265759|3342549|P2|Overall Study|Ineligible|0
1024326|NCT00265759|3342550|P1|Overall Study|Ineligible|0
1024327|NCT00265759|3342547|P4|Overall Study|Cancel|3
1024328|NCT00265759|3342548|P3|Overall Study|Cancel|0
1024329|NCT00265759|3342549|P2|Overall Study|Cancel|0
1024330|NCT00265759|3342550|P1|Overall Study|Cancel|0
1024331|NCT00265759|3342547|P4|Overall Study|Withdrawal by Subject|2
1024332|NCT00265759|3342548|P3|Overall Study|Withdrawal by Subject|2
1024333|NCT00265759|3342549|P2|Overall Study|Withdrawal by Subject|1
1024334|NCT00265759|3342550|P1|Overall Study|Withdrawal by Subject|0
1024335|NCT00265395|3342617|P2|Overall Study|Administrative|1
1024336|NCT00265395|3342618|P1|Overall Study|Administrative|0
1024337|NCT00265395|3342617|P2|Overall Study|Lack of Efficacy|1
1024338|NCT00265395|3342618|P1|Overall Study|Lack of Efficacy|0
1024339|NCT00265395|3342617|P2|Overall Study|Protocol Violation|2
1024340|NCT00265395|3342618|P1|Overall Study|Protocol Violation|2
1024341|NCT00265395|3342617|P2|Overall Study|Withdrawal by Subject|6
1024342|NCT00265395|3342618|P1|Overall Study|Withdrawal by Subject|1
1024343|NCT00265395|3342617|P2|Overall Study|Lost to Follow-up|1
1024344|NCT00265395|3342618|P1|Overall Study|Lost to Follow-up|2
1024345|NCT00265395|3342617|P2|Overall Study|Adverse Event|6
1024346|NCT00265395|3342618|P1|Overall Study|Adverse Event|3
1024347|NCT00265382|3342623|P1|Overall Study|Death|1
1024348|NCT00265382|3342623|P1|Overall Study|Study terminated by sponsor|94
1024349|NCT00265382|3342623|P1|Overall Study|Withdrawal by Subject|13
1024350|NCT00265382|3342623|P1|Overall Study|Miscellaneous|6
1024351|NCT00265382|3342623|P1|Overall Study|Lack of Efficacy|6
1024352|NCT00265382|3342623|P1|Overall Study|Lost to Follow-up|3
1024353|NCT00265382|3342623|P1|Overall Study|Laboratory Abnormality|1
1024354|NCT00265382|3342623|P1|Overall Study|Adverse Event|21
1024355|NCT00265343|3342643|P2|Overall Study|Other|3
1024356|NCT00265343|3342644|P1|Overall Study|Other|8
1024357|NCT00265343|3342643|P2|Overall Study|Withdrawal by Subject|9
1024358|NCT00265343|3342644|P1|Overall Study|Withdrawal by Subject|3
1024359|NCT00265343|3342643|P2|Overall Study|Adverse Event|7
1024360|NCT00265343|3342644|P1|Overall Study|Adverse Event|10
1024361|NCT00265330|3342652|P1|Overall Study|Protocol Violation|1
1024362|NCT00265330|3342652|P1|Overall Study|Withdrew Consent|1
1024363|NCT00265330|3342652|P1|Overall Study|Principal Investigators Request|1
1024364|NCT00265330|3342652|P1|Overall Study|Site Closed by Sponsor|1
1024365|NCT00265330|3342652|P1|Overall Study|Discharged from Unit for Long Term Care|1
1024366|NCT00265330|3342652|P1|Overall Study|Began Taking Formulary Geodon|1
1024367|NCT00265330|3342652|P1|Overall Study|Family Scheduling Conflicts|1
1024368|NCT00265330|3342652|P1|Overall Study|Lack of Efficacy|4
1024369|NCT00265330|3342652|P1|Overall Study|Patient Wanted to Start Psychotherapy|1
1024370|NCT00265330|3342652|P1|Overall Study|Withdrawal by Subject|34
1024371|NCT00265330|3342652|P1|Overall Study|Lost to Follow-up|8
1024372|NCT00265330|3342652|P1|Overall Study|Adverse Event|41
1024373|NCT00265317|3342678|P4|Phase 2|Other|1
1024374|NCT00265317|3342679|P3|Phase 2|Other|1
1024375|NCT00265317|3342680|P2|Phase 2|Other|0
1024376|NCT00265317|3342681|P1|Phase 2|Other|0
1024377|NCT00265317|3342678|P4|Phase 2|Study terminated by sponsor|0
1024378|NCT00265317|3342679|P3|Phase 2|Study terminated by sponsor|1
1024379|NCT00265317|3342680|P2|Phase 2|Study terminated by sponsor|0
1024380|NCT00265317|3342681|P1|Phase 2|Study terminated by sponsor|0
1024381|NCT00265317|3342678|P4|Phase 2|Withdrawal/other than adverse event|1
1024382|NCT00265317|3342679|P3|Phase 2|Withdrawal/other than adverse event|2
1024383|NCT00265317|3342680|P2|Phase 2|Withdrawal/other than adverse event|0
1024384|NCT00265317|3342681|P1|Phase 2|Withdrawal/other than adverse event|0
1024385|NCT00265317|3342678|P4|Phase 2|Lost to Follow-up|1
1024386|NCT00265317|3342679|P3|Phase 2|Lost to Follow-up|0
1024387|NCT00265317|3342680|P2|Phase 2|Lost to Follow-up|0
1024388|NCT00265317|3342681|P1|Phase 2|Lost to Follow-up|0
1024389|NCT00265317|3342678|P4|Phase 2|Protocol Violation|4
1024390|NCT00265317|3342679|P3|Phase 2|Protocol Violation|1
1024391|NCT00265317|3342680|P2|Phase 2|Protocol Violation|0
1024392|NCT00265317|3342681|P1|Phase 2|Protocol Violation|0
1024393|NCT00265317|3342678|P4|Phase 2|Death|15
1024394|NCT00265317|3342679|P3|Phase 2|Death|12
1024395|NCT00265317|3342680|P2|Phase 2|Death|0
1024396|NCT00265317|3342681|P1|Phase 2|Death|0
1024397|NCT00265317|3342678|P4|Phase 2|Adverse Event|5
1024398|NCT00265317|3342679|P3|Phase 2|Adverse Event|7
1024399|NCT00265317|3342680|P2|Phase 2|Adverse Event|0
1024400|NCT00265317|3342681|P1|Phase 2|Adverse Event|0
1024401|NCT00265317|3342678|P4|Phase 2|Global deterioration of health status|0
1024402|NCT00265317|3342679|P3|Phase 2|Global deterioration of health status|3
1024403|NCT00265317|3342680|P2|Phase 2|Global deterioration of health status|0
1024404|NCT00265317|3342681|P1|Phase 2|Global deterioration of health status|0
1024405|NCT00265317|3342678|P4|Phase 2|Objective progression or relapse|38
1024406|NCT00265317|3342679|P3|Phase 2|Objective progression or relapse|37
1024407|NCT00265317|3342680|P2|Phase 2|Objective progression or relapse|0
1024408|NCT00265317|3342681|P1|Phase 2|Objective progression or relapse|0
1024409|NCT00265317|3342678|P4|Lead-In|Withdrawal/other than adverse event|0
1024410|NCT00265317|3342679|P3|Lead-In|Withdrawal/other than adverse event|0
1024411|NCT00265317|3342680|P2|Lead-In|Withdrawal/other than adverse event|0
1024412|NCT00265317|3342681|P1|Lead-In|Withdrawal/other than adverse event|1
1024413|NCT00265317|3342678|P4|Lead-In|Death|0
1024414|NCT00265317|3342679|P3|Lead-In|Death|0
1024415|NCT00265317|3342680|P2|Lead-In|Death|5
1024416|NCT00265317|3342681|P1|Lead-In|Death|3
1024417|NCT00265317|3342678|P4|Lead-In|Adverse Event|0
1024418|NCT00265317|3342679|P3|Lead-In|Adverse Event|0
1024419|NCT00265317|3342680|P2|Lead-In|Adverse Event|1
1024420|NCT00265317|3342681|P1|Lead-In|Adverse Event|2
1024421|NCT00265317|3342678|P4|Lead-In|Objective progression or relapse|0
1024422|NCT00265317|3342679|P3|Lead-In|Objective progression or relapse|0
1024423|NCT00265317|3342680|P2|Lead-In|Objective progression or relapse|11
1024424|NCT00265317|3342681|P1|Lead-In|Objective progression or relapse|6
1024425|NCT00265239|3342796|P2|Overall Study|Adverse Event|1
1024426|NCT00265239|3342797|P1|Overall Study|Adverse Event|2
1024427|NCT00265122|3342819|P6|Intervention Period 2 (Weeks 8 to 28):|Not specified|0
1024428|NCT00265122|3342820|P5|Intervention Period 2 (Weeks 8 to 28):|Not specified|0
1024429|NCT00265122|3342821|P4|Intervention Period 2 (Weeks 8 to 28):|Not specified|1
1024430|NCT00265122|3342822|P3|Intervention Period 2 (Weeks 8 to 28):|Not specified|1
1024431|NCT00265122|3342823|P2|Intervention Period 2 (Weeks 8 to 28):|Not specified|0
1024432|NCT00265122|3342824|P1|Intervention Period 2 (Weeks 8 to 28):|Not specified|4
1024433|NCT00265122|3342819|P6|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
1024434|NCT00265122|3342820|P5|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
1024435|NCT00265122|3342821|P4|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
1024436|NCT00265122|3342822|P3|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
1024437|NCT00265122|3342823|P2|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
1024438|NCT00265122|3342824|P1|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
1024439|NCT00265122|3342819|P6|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0
1024440|NCT00265122|3342820|P5|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
1024441|NCT00265122|3342821|P4|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
1024442|NCT00265122|3342822|P3|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
1024443|NCT00265122|3342823|P2|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
1024444|NCT00265122|3342824|P1|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2
1024445|NCT00265122|3342819|P6|Intervention Period 1 (Weeks 0 to 8):|Not specified|0
1024446|NCT00265122|3342820|P5|Intervention Period 1 (Weeks 0 to 8):|Not specified|0
1024447|NCT00265122|3342821|P4|Intervention Period 1 (Weeks 0 to 8):|Not specified|1
1024448|NCT00265122|3342822|P3|Intervention Period 1 (Weeks 0 to 8):|Not specified|2
1024449|NCT00265122|3342823|P2|Intervention Period 1 (Weeks 0 to 8):|Not specified|1
1024450|NCT00265122|3342824|P1|Intervention Period 1 (Weeks 0 to 8):|Not specified|0
1024451|NCT00265122|3342819|P6|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
1024452|NCT00265122|3342820|P5|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
1024453|NCT00265122|3342821|P4|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
1024454|NCT00265122|3342822|P3|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
1024455|NCT00265122|3342823|P2|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
1024456|NCT00265122|3342824|P1|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
1024457|NCT00265122|3342819|P6|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
1024458|NCT00265122|3342820|P5|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
1024459|NCT00265122|3342821|P4|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
1024460|NCT00265122|3342822|P3|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3
1024461|NCT00265122|3342823|P2|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
1024462|NCT00265122|3342824|P1|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
1024463|NCT00265109|3342846|P1|Overall Study|Adverse Event|1
1024464|NCT00265109|3342846|P1|Overall Study|Withdrawal by Subject|5
1024465|NCT00265096|3342853|P3|Overall Study|Not Specified|10
1024466|NCT00265096|3342854|P2|Overall Study|Not Specified|19
1024467|NCT00265096|3342855|P1|Overall Study|Not Specified|11
1024468|NCT00265096|3342853|P3|Overall Study|Unsatisfactory therapeutic effect|6
1024469|NCT00265096|3342854|P2|Overall Study|Unsatisfactory therapeutic effect|8
1024470|NCT00265096|3342855|P1|Overall Study|Unsatisfactory therapeutic effect|9
1024471|NCT00265096|3342853|P3|Overall Study|Death|2
1024472|NCT00265096|3342854|P2|Overall Study|Death|1
1024473|NCT00265096|3342855|P1|Overall Study|Death|0
1024474|NCT00265096|3342853|P3|Overall Study|Lost to Follow-up|3
1024475|NCT00265096|3342854|P2|Overall Study|Lost to Follow-up|5
1024476|NCT00265096|3342855|P1|Overall Study|Lost to Follow-up|2
1024477|NCT00265096|3342853|P3|Overall Study|Adverse Event|18
1024478|NCT00265096|3342854|P2|Overall Study|Adverse Event|18
1024479|NCT00265096|3342855|P1|Overall Study|Adverse Event|14
1024480|NCT00265083|3342887|P3|Overall Study|Not specified|9
1024481|NCT00265083|3342888|P2|Overall Study|Not specified|12
1024482|NCT00265083|3342889|P1|Overall Study|Not specified|1
1024483|NCT00265083|3342887|P3|Overall Study|Unsatisfactory therapeutic effect|14
1024484|NCT00265083|3342888|P2|Overall Study|Unsatisfactory therapeutic effect|13
1024485|NCT00265083|3342889|P1|Overall Study|Unsatisfactory therapeutic effect|8
1024486|NCT00265083|3342887|P3|Overall Study|Lost to Follow-up|4
1024487|NCT00265083|3342888|P2|Overall Study|Lost to Follow-up|4
1024488|NCT00265083|3342889|P1|Overall Study|Lost to Follow-up|3
1024489|NCT00265083|3342887|P3|Overall Study|Adverse Event|15
1024490|NCT00265083|3342888|P2|Overall Study|Adverse Event|13
1024491|NCT00265083|3342889|P1|Overall Study|Adverse Event|5
1024492|NCT00264875|3342910|P1|Overall Study|Withdrawal by Subject|7
1024493|NCT00264875|3342910|P1|Overall Study|Protocol Violation|11
1024494|NCT00264875|3342910|P1|Overall Study|Lost to Follow-up|6
1024495|NCT00264875|3342910|P1|Overall Study|Adverse Event|6
1024496|NCT00264849|3342916|P2|Overall Study|Administrative Problems|0
1024497|NCT00264849|3342917|P1|Overall Study|Administrative Problems|2
1024498|NCT00264849|3342916|P2|Overall Study|Death|1
1024499|NCT00264849|3342917|P1|Overall Study|Death|0
1024500|NCT00264849|3342916|P2|Overall Study|Lost to Follow-up|2
1024501|NCT00264849|3342917|P1|Overall Study|Lost to Follow-up|0
1024502|NCT00264849|3342916|P2|Overall Study|Lack of Efficacy|6
1024503|NCT00264849|3342917|P1|Overall Study|Lack of Efficacy|1
1024504|NCT00264849|3342916|P2|Overall Study|Protocol Violation|3
1024505|NCT00264849|3342917|P1|Overall Study|Protocol Violation|5
1024506|NCT00264849|3342916|P2|Overall Study|Withdrawal by Subject|11
1024507|NCT00264849|3342917|P1|Overall Study|Withdrawal by Subject|7
1024508|NCT00264849|3342916|P2|Overall Study|Adverse Event|2
1024509|NCT00264849|3342917|P1|Overall Study|Adverse Event|7
1024510|NCT00264810|3342951|P2|Open Label Evaluation Period|Pursue Other Treatment Options|3
1024511|NCT00264810|3342952|P1|Open Label Evaluation Period|Pursue Other Treatment Options|2
1024512|NCT00264810|3342951|P2|Open Label Evaluation Period|Death|2
1024513|NCT00264810|3342952|P1|Open Label Evaluation Period|Death|3
1024514|NCT00264810|3342951|P2|Open Label Evaluation Period|Explant due to infection|1
1024515|NCT00264810|3342952|P1|Open Label Evaluation Period|Explant due to infection|1
1024516|NCT00264810|3342951|P2|Blinded Evaluation Period|Explant due to infection|1
1024517|NCT00264810|3342952|P1|Blinded Evaluation Period|Explant due to infection|1
1024518|NCT00264810|3342951|P2|Stimulation Optimization Period|Death|1
1024519|NCT00264810|3342952|P1|Stimulation Optimization Period|Death|0
1024520|NCT00264810|3342951|P2|Stimulation Optimization Period|Withdrawal by Subject|0
1024521|NCT00264810|3342952|P1|Stimulation Optimization Period|Withdrawal by Subject|1
1024522|NCT00264810|3342951|P2|Baseline|Other|1
1024523|NCT00264810|3342952|P1|Baseline|Other|0
1024524|NCT00264810|3342951|P2|Baseline|Did not Meet/Maintain Study I/E Criteria|2
1024525|NCT00264810|3342952|P1|Baseline|Did not Meet/Maintain Study I/E Criteria|1
1024526|NCT00264810|3342951|P2|Baseline|Insufficient Seizure Frequency|2
1024527|NCT00264810|3342952|P1|Baseline|Insufficient Seizure Frequency|2
1024528|NCT00264810|3342951|P2|Baseline|Subject Compliance Failure|3
1024529|NCT00264810|3342952|P1|Baseline|Subject Compliance Failure|3
1024530|NCT00264810|3342951|P2|Baseline|Physician Decision|8
1024531|NCT00264810|3342952|P1|Baseline|Physician Decision|7
1024532|NCT00264810|3342951|P2|Baseline|Withdrawal by Subject|10
1024533|NCT00264810|3342952|P1|Baseline|Withdrawal by Subject|10
1024534|NCT00264797|3342962|P2|Overall Study|Other|4
1024535|NCT00264797|3342963|P1|Overall Study|Other|3
1024536|NCT00264797|3342962|P2|Overall Study|Feels treatment not necessary, not worki|1
1024537|NCT00264797|3342963|P1|Overall Study|Feels treatment not necessary, not worki|0
1024538|NCT00264797|3342962|P2|Overall Study|Pressure/advice from Outsiders|1
1024539|NCT00264797|3342963|P1|Overall Study|Pressure/advice from Outsiders|1
1024540|NCT00264797|3342962|P2|Overall Study|Incarceration|5
1024541|NCT00264797|3342963|P1|Overall Study|Incarceration|4
1024542|NCT00264797|3342962|P2|Overall Study|Practical Problems|3
1024543|NCT00264797|3342963|P1|Overall Study|Practical Problems|2
1024544|NCT00264797|3342962|P2|Overall Study|Moved from area|1
1024545|NCT00264797|3342963|P1|Overall Study|Moved from area|3
1024546|NCT00264797|3342962|P2|Overall Study|Lost to Follow-up|17
1024547|NCT00264797|3342963|P1|Overall Study|Lost to Follow-up|9
1024548|NCT00264797|3342962|P2|Overall Study|Withdrawal by Subject|11
1024549|NCT00264797|3342963|P1|Overall Study|Withdrawal by Subject|11
1024550|NCT00264576|3342985|P2|Overall Study|Lost to Follow-up|1
1024551|NCT00264576|3342986|P1|Overall Study|Lost to Follow-up|1
1024552|NCT00264550|3343010|P4|Overall Study|Not specified|9
1024553|NCT00264550|3343011|P3|Overall Study|Not specified|3
1024554|NCT00264550|3343012|P2|Overall Study|Not specified|7
1024555|NCT00264550|3343013|P1|Overall Study|Not specified|13
1024556|NCT00264550|3343010|P4|Overall Study|Discontinued oral study agent|0
1024557|NCT00264550|3343011|P3|Overall Study|Discontinued oral study agent|0
1024558|NCT00264550|3343012|P2|Overall Study|Discontinued oral study agent|1
1024559|NCT00264550|3343013|P1|Overall Study|Discontinued oral study agent|0
1024560|NCT00264550|3343010|P4|Overall Study|Unsatisfactory therapeutic effect|6
1024561|NCT00264550|3343011|P3|Overall Study|Unsatisfactory therapeutic effect|4
1024562|NCT00264550|3343012|P2|Overall Study|Unsatisfactory therapeutic effect|11
1024563|NCT00264550|3343013|P1|Overall Study|Unsatisfactory therapeutic effect|4
1024564|NCT00264550|3343010|P4|Overall Study|Adverse Event|14
1024565|NCT00264550|3343011|P3|Overall Study|Adverse Event|9
1024566|NCT00264550|3343012|P2|Overall Study|Adverse Event|18
1024567|NCT00264550|3343013|P1|Overall Study|Adverse Event|23
1024568|NCT00264550|3343010|P4|Overall Study|Lost to Follow-up|1
1024569|NCT00264550|3343011|P3|Overall Study|Lost to Follow-up|1
1024570|NCT00264550|3343012|P2|Overall Study|Lost to Follow-up|1
1024571|NCT00264550|3343013|P1|Overall Study|Lost to Follow-up|3
1024572|NCT00264550|3343010|P4|Overall Study|Death|0
1024573|NCT00264550|3343011|P3|Overall Study|Death|0
1024574|NCT00264550|3343012|P2|Overall Study|Death|3
1024575|NCT00264550|3343013|P1|Overall Study|Death|0
1024576|NCT00264537|3343052|P4|Overall Study|Not treated|0
1024577|NCT00264537|3343053|P3|Overall Study|Not treated|1
1024578|NCT00264537|3343054|P2|Overall Study|Not treated|2
1024579|NCT00264537|3343055|P1|Overall Study|Not treated|0
1024580|NCT00264537|3343052|P4|Overall Study|Not specified|11
1024581|NCT00264537|3343053|P3|Overall Study|Not specified|10
1024582|NCT00264537|3343054|P2|Overall Study|Not specified|11
1024583|NCT00264537|3343055|P1|Overall Study|Not specified|21
1024584|NCT00264537|3343052|P4|Overall Study|Unsatisfactory therapeutic effect|7
1024585|NCT00264537|3343053|P3|Overall Study|Unsatisfactory therapeutic effect|5
1024586|NCT00264537|3343054|P2|Overall Study|Unsatisfactory therapeutic effect|6
1024587|NCT00264537|3343055|P1|Overall Study|Unsatisfactory therapeutic effect|5
1024588|NCT00264537|3343052|P4|Overall Study|Adverse Event|34
1024589|NCT00264537|3343053|P3|Overall Study|Adverse Event|24
1024590|NCT00264537|3343054|P2|Overall Study|Adverse Event|32
1024591|NCT00264537|3343055|P1|Overall Study|Adverse Event|21
1024592|NCT00264537|3343052|P4|Overall Study|Lost to Follow-up|6
1024593|NCT00264537|3343053|P3|Overall Study|Lost to Follow-up|7
1024594|NCT00264537|3343054|P2|Overall Study|Lost to Follow-up|4
1024595|NCT00264537|3343055|P1|Overall Study|Lost to Follow-up|3
1024596|NCT00264537|3343052|P4|Overall Study|Death|2
1024597|NCT00264537|3343053|P3|Overall Study|Death|3
1024598|NCT00264537|3343054|P2|Overall Study|Death|3
1024599|NCT00264537|3343055|P1|Overall Study|Death|0
1024600|NCT00264498|3343087|P2|Crossover Treatment|Withdrawal by Subject|0
1024601|NCT00264498|3343088|P1|Crossover Treatment|Withdrawal by Subject|1
1024602|NCT00264498|3343087|P2|Crossover Treatment|Study closure|1
1024603|NCT00264498|3343088|P1|Crossover Treatment|Study closure|0
1024604|NCT00264498|3343087|P2|Crossover Treatment|Objective disease progression|5
1024605|NCT00264498|3343088|P1|Crossover Treatment|Objective disease progression|4
1024606|NCT00264498|3343087|P2|Crossover Treatment|Death|3
1024607|NCT00264498|3343088|P1|Crossover Treatment|Death|1
1024608|NCT00264498|3343087|P2|Randomized Treatment|Protocol Violation|0
1024609|NCT00264498|3343088|P1|Randomized Treatment|Protocol Violation|1
1024610|NCT00264498|3343087|P2|Randomized Treatment|Study Closure|0
1024611|NCT00264498|3343088|P1|Randomized Treatment|Study Closure|1
1024612|NCT00264498|3343087|P2|Randomized Treatment|Incorrectly randomized|0
1024613|NCT00264498|3343088|P1|Randomized Treatment|Incorrectly randomized|1
1024614|NCT00264498|3343087|P2|Randomized Treatment|Physician Decision|0
1024615|NCT00264498|3343088|P1|Randomized Treatment|Physician Decision|1
1024616|NCT00264498|3343087|P2|Randomized Treatment|Objective disease Progression|14
1024617|NCT00264498|3343088|P1|Randomized Treatment|Objective disease Progression|13
1024618|NCT00264498|3343087|P2|Randomized Treatment|Withdrawal by Subject|1
1024619|NCT00264498|3343088|P1|Randomized Treatment|Withdrawal by Subject|0
1024620|NCT00264498|3343087|P2|Randomized Treatment|Death|3
1024621|NCT00264498|3343088|P1|Randomized Treatment|Death|0
1024622|NCT00264303|3343111|P2|Overall Study|Various reasons listed in study report|7
1024623|NCT00264303|3343112|P1|Overall Study|Various reasons listed in study report|6
1024624|NCT00264303|3343111|P2|Overall Study|Withdrawal by Subject|3
1024625|NCT00264303|3343112|P1|Overall Study|Withdrawal by Subject|2
1024626|NCT00264303|3343111|P2|Overall Study|Lost to Follow-up|3
1024627|NCT00264303|3343112|P1|Overall Study|Lost to Follow-up|3
1024628|NCT00264303|3343111|P2|Overall Study|Lack of Efficacy|13
1024629|NCT00264303|3343112|P1|Overall Study|Lack of Efficacy|10
1024630|NCT00264303|3343111|P2|Overall Study|Adverse Event|3
1024631|NCT00264303|3343112|P1|Overall Study|Adverse Event|4
1024632|NCT00264290|3343130|P2|Intervention (8 Weeks)|Adverse Event|0
1024633|NCT00264290|3343131|P1|Intervention (8 Weeks)|Adverse Event|1
1024634|NCT00264238|3343137|P1|Overall Study|Protocol Violation|1
1024635|NCT00264147|3343149|P6|Treatment II Period|Pre-scheduled total hip replacement|1
1024636|NCT00264147|3343150|P5|Treatment II Period|Pre-scheduled total hip replacement|0
1024637|NCT00264147|3343151|P4|Treatment II Period|Pre-scheduled total hip replacement|0
1024638|NCT00264147|3343152|P3|Treatment II Period|Pre-scheduled total hip replacement|0
1024639|NCT00264147|3343153|P2|Treatment II Period|Pre-scheduled total hip replacement|0
1024640|NCT00264147|3343154|P1|Treatment II Period|Pre-scheduled total hip replacement|0
1024641|NCT00264147|3343149|P6|Treatment II Period|Withdrawal by Subject|2
1024642|NCT00264147|3343150|P5|Treatment II Period|Withdrawal by Subject|3
1024643|NCT00264147|3343151|P4|Treatment II Period|Withdrawal by Subject|0
1024644|NCT00264147|3343152|P3|Treatment II Period|Withdrawal by Subject|0
1024645|NCT00264147|3343153|P2|Treatment II Period|Withdrawal by Subject|0
1024646|NCT00264147|3343154|P1|Treatment II Period|Withdrawal by Subject|0
1024647|NCT00264147|3343149|P6|Treatment II Period|Lost to Follow-up|1
1024648|NCT00264147|3343150|P5|Treatment II Period|Lost to Follow-up|1
1024649|NCT00264147|3343151|P4|Treatment II Period|Lost to Follow-up|0
1024650|NCT00264147|3343152|P3|Treatment II Period|Lost to Follow-up|0
1024651|NCT00264147|3343153|P2|Treatment II Period|Lost to Follow-up|0
1024652|NCT00264147|3343154|P1|Treatment II Period|Lost to Follow-up|0
1024653|NCT00264147|3343149|P6|Treatment II Period|Lack of Efficacy|19
1024654|NCT00264147|3343150|P5|Treatment II Period|Lack of Efficacy|20
1024655|NCT00264147|3343151|P4|Treatment II Period|Lack of Efficacy|0
1024656|NCT00264147|3343152|P3|Treatment II Period|Lack of Efficacy|0
1024657|NCT00264147|3343153|P2|Treatment II Period|Lack of Efficacy|0
1024658|NCT00264147|3343154|P1|Treatment II Period|Lack of Efficacy|0
1024659|NCT00264147|3343149|P6|Treatment II Period|Laboratory Adverse Event|1
1024660|NCT00264147|3343150|P5|Treatment II Period|Laboratory Adverse Event|0
1024661|NCT00264147|3343151|P4|Treatment II Period|Laboratory Adverse Event|0
1024662|NCT00264147|3343152|P3|Treatment II Period|Laboratory Adverse Event|0
1024663|NCT00264147|3343153|P2|Treatment II Period|Laboratory Adverse Event|0
1024664|NCT00264147|3343154|P1|Treatment II Period|Laboratory Adverse Event|0
1024665|NCT00264147|3343149|P6|Treatment II Period|Adverse Event|9
1024666|NCT00264147|3343150|P5|Treatment II Period|Adverse Event|9
1024667|NCT00264147|3343151|P4|Treatment II Period|Adverse Event|0
1024668|NCT00264147|3343152|P3|Treatment II Period|Adverse Event|0
1024669|NCT00264147|3343153|P2|Treatment II Period|Adverse Event|0
1024670|NCT00264147|3343154|P1|Treatment II Period|Adverse Event|0
1024671|NCT00264147|3343149|P6|Treatment I Period|Reassigned to Treatment II Period|0
1024672|NCT00264147|3343150|P5|Treatment I Period|Reassigned to Treatment II Period|45
1024673|NCT00264147|3343151|P4|Treatment I Period|Reassigned to Treatment II Period|63
1024674|NCT00264147|3343152|P3|Treatment I Period|Reassigned to Treatment II Period|65
1024675|NCT00264147|3343153|P2|Treatment I Period|Reassigned to Treatment II Period|72
1024676|NCT00264147|3343154|P1|Treatment I Period|Reassigned to Treatment II Period|84
1024677|NCT00264147|3343149|P6|Treatment I Period|Unblinded due to Serious Adverse Event|0
1024678|NCT00264147|3343150|P5|Treatment I Period|Unblinded due to Serious Adverse Event|0
1024679|NCT00264147|3343151|P4|Treatment I Period|Unblinded due to Serious Adverse Event|0
1024680|NCT00264147|3343152|P3|Treatment I Period|Unblinded due to Serious Adverse Event|1
1024681|NCT00264147|3343153|P2|Treatment I Period|Unblinded due to Serious Adverse Event|0
1024682|NCT00264147|3343154|P1|Treatment I Period|Unblinded due to Serious Adverse Event|0
1024683|NCT00264147|3343149|P6|Treatment I Period|Patient out of town for an extended time|0
1024684|NCT00264147|3343150|P5|Treatment I Period|Patient out of town for an extended time|0
1024685|NCT00264147|3343151|P4|Treatment I Period|Patient out of town for an extended time|0
1024686|NCT00264147|3343152|P3|Treatment I Period|Patient out of town for an extended time|0
1024687|NCT00264147|3343153|P2|Treatment I Period|Patient out of town for an extended time|1
1024688|NCT00264147|3343154|P1|Treatment I Period|Patient out of town for an extended time|0
1024689|NCT00264147|3343149|P6|Treatment I Period|Withdrawal by Subject|0
1024690|NCT00264147|3343150|P5|Treatment I Period|Withdrawal by Subject|2
1024691|NCT00264147|3343151|P4|Treatment I Period|Withdrawal by Subject|2
1024692|NCT00264147|3343152|P3|Treatment I Period|Withdrawal by Subject|0
1024693|NCT00264147|3343153|P2|Treatment I Period|Withdrawal by Subject|0
1024694|NCT00264147|3343154|P1|Treatment I Period|Withdrawal by Subject|2
1024695|NCT00264147|3343149|P6|Treatment I Period|Protocol Violation|0
1024696|NCT00264147|3343150|P5|Treatment I Period|Protocol Violation|0
1024697|NCT00264147|3343151|P4|Treatment I Period|Protocol Violation|0
1024698|NCT00264147|3343152|P3|Treatment I Period|Protocol Violation|0
1024699|NCT00264147|3343153|P2|Treatment I Period|Protocol Violation|2
1024700|NCT00264147|3343154|P1|Treatment I Period|Protocol Violation|2
1024701|NCT00264147|3343149|P6|Treatment I Period|Lost to Follow-up|0
1024702|NCT00264147|3343150|P5|Treatment I Period|Lost to Follow-up|1
1024703|NCT00264147|3343151|P4|Treatment I Period|Lost to Follow-up|1
1024704|NCT00264147|3343152|P3|Treatment I Period|Lost to Follow-up|0
1024705|NCT00264147|3343153|P2|Treatment I Period|Lost to Follow-up|0
1024706|NCT00264147|3343154|P1|Treatment I Period|Lost to Follow-up|1
1024707|NCT00264147|3343149|P6|Treatment I Period|Lack of Efficacy|0
1024708|NCT00264147|3343150|P5|Treatment I Period|Lack of Efficacy|1
1024709|NCT00264147|3343151|P4|Treatment I Period|Lack of Efficacy|0
1024710|NCT00264147|3343152|P3|Treatment I Period|Lack of Efficacy|8
1024711|NCT00264147|3343153|P2|Treatment I Period|Lack of Efficacy|2
1024712|NCT00264147|3343154|P1|Treatment I Period|Lack of Efficacy|6
1024713|NCT00264147|3343149|P6|Treatment I Period|Laboratory Adverse Event|0
1024714|NCT00264147|3343150|P5|Treatment I Period|Laboratory Adverse Event|0
1024715|NCT00264147|3343151|P4|Treatment I Period|Laboratory Adverse Event|1
1024716|NCT00264147|3343152|P3|Treatment I Period|Laboratory Adverse Event|0
1024717|NCT00264147|3343153|P2|Treatment I Period|Laboratory Adverse Event|0
1024718|NCT00264147|3343154|P1|Treatment I Period|Laboratory Adverse Event|0
1024719|NCT00264147|3343149|P6|Treatment I Period|Adverse Event|0
1024720|NCT00264147|3343150|P5|Treatment I Period|Adverse Event|7
1024721|NCT00264147|3343151|P4|Treatment I Period|Adverse Event|5
1024722|NCT00264147|3343152|P3|Treatment I Period|Adverse Event|3
1024723|NCT00264147|3343153|P2|Treatment I Period|Adverse Event|6
1024724|NCT00264147|3343154|P1|Treatment I Period|Adverse Event|3
1024725|NCT00264004|3343197|P4|Overall Study|Not treated|2
1024726|NCT00264004|3343198|P3|Overall Study|Not treated|2
1024727|NCT00264004|3343199|P2|Overall Study|Not treated|0
1024728|NCT00264004|3343200|P1|Overall Study|Not treated|3
1024729|NCT00264004|3343197|P4|Overall Study|Cond. under inv. worsened|4
1024730|NCT00264004|3343198|P3|Overall Study|Cond. under inv. worsened|3
1024731|NCT00264004|3343199|P2|Overall Study|Cond. under inv. worsened|5
1024732|NCT00264004|3343200|P1|Overall Study|Cond. under inv. worsened|9
1024733|NCT00264004|3343197|P4|Overall Study|Development study specific disc. crit.|0
1024734|NCT00264004|3343198|P3|Overall Study|Development study specific disc. crit.|1
1024735|NCT00264004|3343199|P2|Overall Study|Development study specific disc. crit.|0
1024736|NCT00264004|3343200|P1|Overall Study|Development study specific disc. crit.|1
1024737|NCT00264004|3343197|P4|Overall Study|Not specified|3
1024738|NCT00264004|3343198|P3|Overall Study|Not specified|0
1024739|NCT00264004|3343199|P2|Overall Study|Not specified|2
1024740|NCT00264004|3343200|P1|Overall Study|Not specified|2
1024741|NCT00264004|3343197|P4|Overall Study|Withdrawal by Subject|2
1024742|NCT00264004|3343198|P3|Overall Study|Withdrawal by Subject|2
1024743|NCT00264004|3343199|P2|Overall Study|Withdrawal by Subject|1
1024744|NCT00264004|3343200|P1|Overall Study|Withdrawal by Subject|0
1024745|NCT00264004|3343197|P4|Overall Study|Adverse Event|4
1024746|NCT00264004|3343198|P3|Overall Study|Adverse Event|6
1024747|NCT00264004|3343199|P2|Overall Study|Adverse Event|3
1024748|NCT00264004|3343200|P1|Overall Study|Adverse Event|2
1024749|NCT00263887|3343228|P2|Overall Study|Lack of Efficacy|1
1024750|NCT00263887|3343229|P1|Overall Study|Lack of Efficacy|0
1024751|NCT00263887|3343228|P2|Overall Study|Disease progression|1
1024752|NCT00263887|3343229|P1|Overall Study|Disease progression|0
1024753|NCT00263887|3343228|P2|Overall Study|Adverse Event|2
1024754|NCT00263887|3343229|P1|Overall Study|Adverse Event|0
1024755|NCT00263887|3343228|P2|Overall Study|Too ill to attend visit|0
1024756|NCT00263887|3343229|P1|Overall Study|Too ill to attend visit|1
1024757|NCT00263887|3343228|P2|Overall Study|Lung transplantation|2
1024758|NCT00263887|3343229|P1|Overall Study|Lung transplantation|1
1024759|NCT00263887|3343228|P2|Overall Study|Withdrawal by Subject|1
1024760|NCT00263887|3343229|P1|Overall Study|Withdrawal by Subject|1
1024761|NCT00263757|3343237|P2|Overall Study|Adverse Event|3
1024762|NCT00263757|3343238|P1|Overall Study|Adverse Event|3
1024763|NCT00263757|3343237|P2|Overall Study|Screen failure|1
1024764|NCT00263757|3343238|P1|Overall Study|Screen failure|0
1024765|NCT00263757|3343237|P2|Overall Study|Withdrawal by Subject|4
1024766|NCT00263757|3343238|P1|Overall Study|Withdrawal by Subject|5
1024767|NCT00263666|3343250|P2|Overall Study|Withdrawal by Subject|1
1024768|NCT00263666|3343251|P1|Overall Study|Withdrawal by Subject|0
1024769|NCT00263666|3343250|P2|Overall Study|Lost to Follow-up|2
1024770|NCT00263666|3343251|P1|Overall Study|Lost to Follow-up|1
1024771|NCT00263666|3343250|P2|Overall Study|Adverse Event|8
1024772|NCT00263666|3343251|P1|Overall Study|Adverse Event|6
1024773|NCT00263328|3343305|P3|Overall Study|Adverse Event|4
1024774|NCT00263328|3343306|P2|Overall Study|Adverse Event|1
1024775|NCT00263328|3343307|P1|Overall Study|Adverse Event|1
1024776|NCT00263328|3343305|P3|Overall Study|Not specified|1
1024777|NCT00263328|3343306|P2|Overall Study|Not specified|0
1024778|NCT00263328|3343307|P1|Overall Study|Not specified|3
1024779|NCT00263328|3343305|P3|Overall Study|Withdrawal by Subject|1
1024780|NCT00263328|3343306|P2|Overall Study|Withdrawal by Subject|0
1024781|NCT00263328|3343307|P1|Overall Study|Withdrawal by Subject|3
1024782|NCT00263328|3343305|P3|Overall Study|Lost to Follow-up|0
1024783|NCT00263328|3343306|P2|Overall Study|Lost to Follow-up|1
1024784|NCT00263328|3343307|P1|Overall Study|Lost to Follow-up|1
1024785|NCT00263328|3343305|P3|Overall Study|Death|1
1024786|NCT00263328|3343306|P2|Overall Study|Death|0
1024787|NCT00263328|3343307|P1|Overall Study|Death|0
1024788|NCT00263211|3343465|P2|Overall Study|Disease Progression|1
1024789|NCT00263211|3343466|P1|Overall Study|Disease Progression|0
1024790|NCT00263211|3343465|P2|Overall Study|Protocol Violation|0
1024791|NCT00263211|3343466|P1|Overall Study|Protocol Violation|1
1024792|NCT00263211|3343465|P2|Overall Study|Withdrawal by Subject|0
1024793|NCT00263211|3343466|P1|Overall Study|Withdrawal by Subject|3
1024794|NCT00263211|3343465|P2|Overall Study|Death|0
1024795|NCT00263211|3343466|P1|Overall Study|Death|1
1024796|NCT00262951|3343517|P1|Overall Study|Off treatment for other disease|1
1024797|NCT00262951|3343517|P1|Overall Study|Alternative treatment|3
1024798|NCT00262951|3343517|P1|Overall Study|Withdrawal by Subject|1
1024799|NCT00262951|3343517|P1|Overall Study|Death|1
1024800|NCT00262951|3343517|P1|Overall Study|Adverse Event|7
1024801|NCT00262951|3343517|P1|Overall Study|Progressive disease/relapse|3
1024802|NCT00262925|3343522|P1|Overall Study|Other|1
1024803|NCT00262925|3343522|P1|Overall Study|alternative therapy|1
1024804|NCT00262925|3343522|P1|Overall Study|Death|2
1024805|NCT00262925|3343522|P1|Overall Study|Adverse Event|4
1024806|NCT00262925|3343522|P1|Overall Study|Lack of Efficacy|3
1024807|NCT00262873|3343528|P1|Overall Study|Withdrawal by Subject|5
1024808|NCT00262873|3343528|P1|Overall Study|Adverse Event|3
1024809|NCT00262860|3343539|P1|Overall Study|Adverse Event|2
1024810|NCT00262847|3343548|P3|Overall Study|Did not receive study treatment|4
1024811|NCT00262847|3343549|P2|Overall Study|Did not receive study treatment|1
1024812|NCT00262847|3343550|P1|Overall Study|Did not receive study treatment|4
1024813|NCT00262847|3343548|P3|Overall Study|Other Reasons|27
1024814|NCT00262847|3343549|P2|Overall Study|Other Reasons|88
1024815|NCT00262847|3343550|P1|Overall Study|Other Reasons|79
1024816|NCT00262847|3343548|P3|Overall Study|Concomitant disease|4
1024817|NCT00262847|3343549|P2|Overall Study|Concomitant disease|2
1024818|NCT00262847|3343550|P1|Overall Study|Concomitant disease|3
1024819|NCT00262847|3343548|P3|Overall Study|Death|11
1024820|NCT00262847|3343549|P2|Overall Study|Death|8
1024821|NCT00262847|3343550|P1|Overall Study|Death|8
1024822|NCT00262847|3343548|P3|Overall Study|Adverse Event|108
1024823|NCT00262847|3343549|P2|Overall Study|Adverse Event|88
1024824|NCT00262847|3343550|P1|Overall Study|Adverse Event|74
1024825|NCT00262847|3343548|P3|Overall Study|Patient Refusal|47
1024826|NCT00262847|3343549|P2|Overall Study|Patient Refusal|52
1024827|NCT00262847|3343550|P1|Overall Study|Patient Refusal|41
1024828|NCT00262847|3343548|P3|Overall Study|Disease Progression|195
1024829|NCT00262847|3343549|P2|Overall Study|Disease Progression|274
1024830|NCT00262847|3343550|P1|Overall Study|Disease Progression|309
1024831|NCT00262834|3343569|P2|Overall Study|Surgery delayed/tissue not collected|4
1024832|NCT00262834|3343570|P1|Overall Study|Surgery delayed/tissue not collected|1
1024833|NCT00262821|3343583|P2|Overall Study|Inevaluable - inadequate data|4
1024834|NCT00262821|3343584|P1|Overall Study|Inevaluable - inadequate data|0
1024835|NCT00262821|3343583|P2|Overall Study|Ineligible - required test not done|4
1024836|NCT00262821|3343584|P1|Overall Study|Ineligible - required test not done|1
1024837|NCT00262821|3343583|P2|Overall Study|Ineligible - elevated creatinine|2
1024838|NCT00262821|3343584|P1|Overall Study|Ineligible - elevated creatinine|0
1024839|NCT00262821|3343583|P2|Overall Study|Ineligible - inadequate pathology|3
1024840|NCT00262821|3343584|P1|Overall Study|Ineligible - inadequate pathology|1
1024841|NCT00262821|3343583|P2|Overall Study|Ineligible - wrong primary|1
1024842|NCT00262821|3343584|P1|Overall Study|Ineligible - wrong primary|0
1024843|NCT00262821|3343583|P2|Overall Study|Ineligible - wrong cell type|2
1024844|NCT00262821|3343584|P1|Overall Study|Ineligible - wrong cell type|2
1024845|NCT00262821|3343583|P2|Overall Study|Ineligible - wrong stage|3
1024846|NCT00262821|3343584|P1|Overall Study|Ineligible - wrong stage|0
1024847|NCT00262743|3343596|P2|Overall Study|Disease progression|3
1024848|NCT00262743|3343597|P1|Overall Study|Disease progression|0
1024849|NCT00262743|3343596|P2|Overall Study|Adverse Event|9
1024850|NCT00262743|3343597|P1|Overall Study|Adverse Event|0
1024851|NCT00262600|3343632|P3|Overall Study|Not Specified|62
1024852|NCT00262600|3343633|P2|Overall Study|Not Specified|59
1024853|NCT00262600|3343634|P1|Overall Study|Not Specified|58
1024854|NCT00262600|3343632|P3|Overall Study|Not Treated|24
1024855|NCT00262600|3343633|P2|Overall Study|Not Treated|17
1024856|NCT00262600|3343634|P1|Overall Study|Not Treated|32
1024857|NCT00262600|3343632|P3|Overall Study|Withdrawal by Subject|139
1024858|NCT00262600|3343633|P2|Overall Study|Withdrawal by Subject|145
1024859|NCT00262600|3343634|P1|Overall Study|Withdrawal by Subject|128
1024860|NCT00262600|3343632|P3|Overall Study|Lost to Follow-up|41
1024861|NCT00262600|3343633|P2|Overall Study|Lost to Follow-up|31
1024862|NCT00262600|3343634|P1|Overall Study|Lost to Follow-up|17
1024863|NCT00262522|3343661|P4|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
1024864|NCT00262522|3343662|P3|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9
1024865|NCT00262522|3343663|P2|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
1024866|NCT00262522|3343664|P1|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10
1024867|NCT00262522|3343661|P4|Study Start Through 96 Weeks|Virologic failure|0
1024868|NCT00262522|3343662|P3|Study Start Through 96 Weeks|Virologic failure|8
1024869|NCT00262522|3343663|P2|Study Start Through 96 Weeks|Virologic failure|0
1024870|NCT00262522|3343664|P1|Study Start Through 96 Weeks|Virologic failure|5
1024871|NCT00262522|3343661|P4|Study Start Through 96 Weeks|Death|0
1024872|NCT00262522|3343662|P3|Study Start Through 96 Weeks|Death|2
1024873|NCT00262522|3343663|P2|Study Start Through 96 Weeks|Death|0
1024874|NCT00262522|3343664|P1|Study Start Through 96 Weeks|Death|2
1024875|NCT00262522|3343661|P4|Study Start Through 96 Weeks|Noncompliance|0
1024876|NCT00262522|3343662|P3|Study Start Through 96 Weeks|Noncompliance|11
1024877|NCT00262522|3343663|P2|Study Start Through 96 Weeks|Noncompliance|0
1024878|NCT00262522|3343664|P1|Study Start Through 96 Weeks|Noncompliance|6
1024879|NCT00262522|3343661|P4|Study Start Through 96 Weeks|Lost to Follow-up|0
1024880|NCT00262522|3343662|P3|Study Start Through 96 Weeks|Lost to Follow-up|18
1024881|NCT00262522|3343663|P2|Study Start Through 96 Weeks|Lost to Follow-up|0
1024882|NCT00262522|3343664|P1|Study Start Through 96 Weeks|Lost to Follow-up|19
1024883|NCT00262522|3343661|P4|Study Start Through 96 Weeks|Withdrawal by Subject|0
1024884|NCT00262522|3343662|P3|Study Start Through 96 Weeks|Withdrawal by Subject|13
1024885|NCT00262522|3343663|P2|Study Start Through 96 Weeks|Withdrawal by Subject|0
1024886|NCT00262522|3343664|P1|Study Start Through 96 Weeks|Withdrawal by Subject|15
1024887|NCT00262522|3343661|P4|Study Start Through 96 Weeks|Adverse Event|0
1024888|NCT00262522|3343662|P3|Study Start Through 96 Weeks|Adverse Event|16
1024889|NCT00262522|3343663|P2|Study Start Through 96 Weeks|Adverse Event|0
1024890|NCT00262522|3343664|P1|Study Start Through 96 Weeks|Adverse Event|20
1024891|NCT00262522|3343661|P4|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
1024892|NCT00262522|3343662|P3|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7
1024893|NCT00262522|3343663|P2|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
1024894|NCT00262522|3343664|P1|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8
1024895|NCT00262522|3343661|P4|Study Start Through 48 Weeks|Virologic failure|0
1024896|NCT00262522|3343662|P3|Study Start Through 48 Weeks|Virologic failure|4
1024897|NCT00262522|3343663|P2|Study Start Through 48 Weeks|Virologic failure|0
1024898|NCT00262522|3343664|P1|Study Start Through 48 Weeks|Virologic failure|2
1024899|NCT00262522|3343661|P4|Study Start Through 48 Weeks|Death|0
1024900|NCT00262522|3343662|P3|Study Start Through 48 Weeks|Death|1
1024901|NCT00262522|3343663|P2|Study Start Through 48 Weeks|Death|0
1024902|NCT00262522|3343664|P1|Study Start Through 48 Weeks|Death|2
1024903|NCT00262522|3343661|P4|Study Start Through 48 Weeks|Noncompliance|0
1024904|NCT00262522|3343662|P3|Study Start Through 48 Weeks|Noncompliance|8
1024905|NCT00262522|3343663|P2|Study Start Through 48 Weeks|Noncompliance|0
1024906|NCT00262522|3343664|P1|Study Start Through 48 Weeks|Noncompliance|3
1024907|NCT00262522|3343661|P4|Study Start Through 48 Weeks|Lost to Follow-up|0
1024908|NCT00262522|3343662|P3|Study Start Through 48 Weeks|Lost to Follow-up|14
1024909|NCT00262522|3343663|P2|Study Start Through 48 Weeks|Lost to Follow-up|0
1024910|NCT00262522|3343664|P1|Study Start Through 48 Weeks|Lost to Follow-up|8
1024911|NCT00262522|3343661|P4|Study Start Through 48 Weeks|Withdrawal by Subject|0
1024912|NCT00262522|3343662|P3|Study Start Through 48 Weeks|Withdrawal by Subject|11
1024913|NCT00262522|3343663|P2|Study Start Through 48 Weeks|Withdrawal by Subject|0
1024914|NCT00262522|3343664|P1|Study Start Through 48 Weeks|Withdrawal by Subject|10
1024915|NCT00262522|3343661|P4|Study Start Through 48 Weeks|Adverse Event|0
1024916|NCT00262522|3343662|P3|Study Start Through 48 Weeks|Adverse Event|10
1024917|NCT00262522|3343663|P2|Study Start Through 48 Weeks|Adverse Event|0
1024918|NCT00262522|3343664|P1|Study Start Through 48 Weeks|Adverse Event|16
1024919|NCT00262522|3343661|P4|Study Start Through 8 Weeks|Death|0
1024920|NCT00262522|3343662|P3|Study Start Through 8 Weeks|Death|0
1024921|NCT00262522|3343663|P2|Study Start Through 8 Weeks|Death|0
1024922|NCT00262522|3343664|P1|Study Start Through 8 Weeks|Death|1
1024923|NCT00262522|3343661|P4|Study Start Through 8 Weeks|Noncompliance|2
1024924|NCT00262522|3343662|P3|Study Start Through 8 Weeks|Noncompliance|2
1024925|NCT00262522|3343663|P2|Study Start Through 8 Weeks|Noncompliance|0
1024926|NCT00262522|3343664|P1|Study Start Through 8 Weeks|Noncompliance|0
1024927|NCT00262522|3343661|P4|Study Start Through 8 Weeks|Lost to Follow-up|2
1024928|NCT00262522|3343662|P3|Study Start Through 8 Weeks|Lost to Follow-up|3
1024929|NCT00262522|3343663|P2|Study Start Through 8 Weeks|Lost to Follow-up|2
1024930|NCT00262522|3343664|P1|Study Start Through 8 Weeks|Lost to Follow-up|1
1024931|NCT00262522|3343661|P4|Study Start Through 8 Weeks|Withdrawal by Subject|0
1024932|NCT00262522|3343662|P3|Study Start Through 8 Weeks|Withdrawal by Subject|3
1024933|NCT00262522|3343663|P2|Study Start Through 8 Weeks|Withdrawal by Subject|1
1024934|NCT00262522|3343664|P1|Study Start Through 8 Weeks|Withdrawal by Subject|1
1024935|NCT00262522|3343661|P4|Study Start Through 8 Weeks|Adverse Event|1
1024936|NCT00262522|3343662|P3|Study Start Through 8 Weeks|Adverse Event|3
1024937|NCT00262522|3343663|P2|Study Start Through 8 Weeks|Adverse Event|2
1024938|NCT00262522|3343664|P1|Study Start Through 8 Weeks|Adverse Event|1
1024939|NCT00262314|3343693|P1|Overall Study|Administrative withdrawal|30
1024940|NCT00262314|3343693|P1|Overall Study|Lost to Follow-up|70
1024941|NCT00262314|3343693|P1|Overall Study|Not specified|95
1024942|NCT00262314|3343693|P1|Overall Study|Patient's decision|92
1024943|NCT00262314|3343693|P1|Overall Study|Death|12
1024944|NCT00262314|3343693|P1|Overall Study|Changing physicians|38
1024945|NCT00262301|3343711|P3|Double-blind Phase|"worsening of HAE symptoms"|0
1024946|NCT00262301|3343712|P2|Double-blind Phase|"worsening of HAE symptoms"|1
1024947|NCT00262301|3343713|P1|Double-blind Phase|"worsening of HAE symptoms"|0
1024948|NCT00262301|3343711|P3|Double-blind Phase|Lost to Follow-up|0
1024949|NCT00262301|3343712|P2|Double-blind Phase|Lost to Follow-up|0
1024950|NCT00262301|3343713|P1|Double-blind Phase|Lost to Follow-up|1
1024951|NCT00262223|3343726|P2|12-month Post-treatment Follow-up|Lost to Follow-up|7
1024952|NCT00262223|3343727|P1|12-month Post-treatment Follow-up|Lost to Follow-up|7
1024953|NCT00262223|3343726|P2|6-month Post-treatment Follow-up|Lost to Follow-up|1
1024954|NCT00262223|3343727|P1|6-month Post-treatment Follow-up|Lost to Follow-up|6
1024955|NCT00262223|3343726|P2|1-week Post-treatment Follow-up|Lost to Follow-up|4
1024956|NCT00262223|3343727|P1|1-week Post-treatment Follow-up|Lost to Follow-up|4
1024957|NCT00262223|3343726|P2|Treatment Phase|Adverse Event|2
1024958|NCT00262223|3343727|P1|Treatment Phase|Adverse Event|1
1024959|NCT00262223|3343726|P2|Treatment Phase|Withdrawal by Subject|6
1024960|NCT00262223|3343727|P1|Treatment Phase|Withdrawal by Subject|3
1024961|NCT00262119|3343738|P3|Overall Study|Death|16
1024962|NCT00262119|3343739|P2|Overall Study|Death|19
1024963|NCT00262119|3343740|P1|Overall Study|Death|20
1024964|NCT00262119|3343738|P3|Overall Study|Lost to Follow-up|42
1024965|NCT00262119|3343739|P2|Overall Study|Lost to Follow-up|51
1024966|NCT00262119|3343740|P1|Overall Study|Lost to Follow-up|38
1024967|NCT00262080|3343760|P3|Repeat Dose Treatment Period|enrolled in EDEMA4|0
1024968|NCT00262080|3343761|P2|Repeat Dose Treatment Period|enrolled in EDEMA4|0
1024969|NCT00262080|3343762|P1|Repeat Dose Treatment Period|enrolled in EDEMA4|1
1024970|NCT00262080|3343760|P3|Repeat Dose Treatment Period|Decision to discontinue the study|2
1024971|NCT00262080|3343761|P2|Repeat Dose Treatment Period|Decision to discontinue the study|0
1024972|NCT00262080|3343762|P1|Repeat Dose Treatment Period|Decision to discontinue the study|0
1024973|NCT00262080|3343760|P3|Repeat Dose Treatment Period|Lost to Follow-up|2
1024974|NCT00262080|3343761|P2|Repeat Dose Treatment Period|Lost to Follow-up|0
1024975|NCT00262080|3343762|P1|Repeat Dose Treatment Period|Lost to Follow-up|2
1024976|NCT00262080|3343760|P3|Repeat Dose Treatment Period|Withdrawal by Subject|1
1024977|NCT00262080|3343761|P2|Repeat Dose Treatment Period|Withdrawal by Subject|1
1024978|NCT00262080|3343762|P1|Repeat Dose Treatment Period|Withdrawal by Subject|0
1024979|NCT00262080|3343760|P3|Repeat Dose Treatment Period|Adverse Event|0
1024980|NCT00262080|3343761|P2|Repeat Dose Treatment Period|Adverse Event|0
1024981|NCT00262080|3343762|P1|Repeat Dose Treatment Period|Adverse Event|1
1024982|NCT00262080|3343760|P3|Double Blind Treatment Period|Lost to Follow-up|0
1024983|NCT00262080|3343761|P2|Double Blind Treatment Period|Lost to Follow-up|0
1024984|NCT00262080|3343762|P1|Double Blind Treatment Period|Lost to Follow-up|1
1024985|NCT00262067|3343782|P4|Overall Study|Patient Withdrew for Survival Follow-up|9
1024986|NCT00262067|3343783|P3|Overall Study|Patient Withdrew for Survival Follow-up|23
1024987|NCT00262067|3343784|P2|Overall Study|Patient Withdrew for Survival Follow-up|7
1024988|NCT00262067|3343785|P1|Overall Study|Patient Withdrew for Survival Follow-up|23
1024989|NCT00262067|3343782|P4|Overall Study|Sponsor's Decision to Terminate Study|0
1024990|NCT00262067|3343783|P3|Overall Study|Sponsor's Decision to Terminate Study|0
1024991|NCT00262067|3343784|P2|Overall Study|Sponsor's Decision to Terminate Study|0
1024992|NCT00262067|3343785|P1|Overall Study|Sponsor's Decision to Terminate Study|1
1024993|NCT00262067|3343782|P4|Overall Study|Lost to Follow-up|5
1024994|NCT00262067|3343783|P3|Overall Study|Lost to Follow-up|7
1024995|NCT00262067|3343784|P2|Overall Study|Lost to Follow-up|4
1024996|NCT00262067|3343785|P1|Overall Study|Lost to Follow-up|5
1024997|NCT00262067|3343782|P4|Overall Study|Death|99
1024998|NCT00262067|3343783|P3|Overall Study|Death|186
1024999|NCT00262067|3343784|P2|Overall Study|Death|89
1025000|NCT00262067|3343785|P1|Overall Study|Death|190
1025001|NCT00262041|3343819|P3|Overall Study|Unable to classify|0
1025002|NCT00262041|3343820|P2|Overall Study|Unable to classify|0
1025003|NCT00262041|3343821|P1|Overall Study|Unable to classify|1
1025004|NCT00262041|3343819|P3|Overall Study|Lost to Follow-up|5
1025005|NCT00262041|3343820|P2|Overall Study|Lost to Follow-up|1
1025006|NCT00262041|3343821|P1|Overall Study|Lost to Follow-up|1
1025007|NCT00262041|3343819|P3|Overall Study|Withdrawal by Subject|1
1025008|NCT00262041|3343820|P2|Overall Study|Withdrawal by Subject|3
1025009|NCT00262041|3343821|P1|Overall Study|Withdrawal by Subject|0
1025010|NCT00262028|3343850|P9|Overall Study|Unable to classify|1
1025011|NCT00262028|3343851|P8|Overall Study|Unable to classify|0
1025012|NCT00262028|3343852|P7|Overall Study|Unable to classify|0
1025013|NCT00262028|3343853|P6|Overall Study|Unable to classify|0
1025014|NCT00262028|3343854|P5|Overall Study|Unable to classify|0
1025015|NCT00262028|3343855|P4|Overall Study|Unable to classify|0
1025016|NCT00262028|3343856|P3|Overall Study|Unable to classify|0
1025017|NCT00262028|3343857|P2|Overall Study|Unable to classify|3
1025018|NCT00262028|3343858|P1|Overall Study|Unable to classify|0
1025019|NCT00262028|3343850|P9|Overall Study|Protocol Violation|0
1025020|NCT00262028|3343851|P8|Overall Study|Protocol Violation|0
1025021|NCT00262028|3343852|P7|Overall Study|Protocol Violation|0
1025022|NCT00262028|3343853|P6|Overall Study|Protocol Violation|0
1025023|NCT00262028|3343854|P5|Overall Study|Protocol Violation|0
1025024|NCT00262028|3343855|P4|Overall Study|Protocol Violation|1
1025025|NCT00262028|3343856|P3|Overall Study|Protocol Violation|0
1025026|NCT00262028|3343857|P2|Overall Study|Protocol Violation|0
1025027|NCT00262028|3343858|P1|Overall Study|Protocol Violation|0
1025028|NCT00262028|3343850|P9|Overall Study|Administrative Reason|10
1025029|NCT00262028|3343851|P8|Overall Study|Administrative Reason|6
1025030|NCT00262028|3343852|P7|Overall Study|Administrative Reason|4
1025031|NCT00262028|3343853|P6|Overall Study|Administrative Reason|7
1025032|NCT00262028|3343854|P5|Overall Study|Administrative Reason|6
1025033|NCT00262028|3343855|P4|Overall Study|Administrative Reason|12
1025034|NCT00262028|3343856|P3|Overall Study|Administrative Reason|9
1025035|NCT00262028|3343857|P2|Overall Study|Administrative Reason|14
1025036|NCT00262028|3343858|P1|Overall Study|Administrative Reason|11
1025037|NCT00262028|3343850|P9|Overall Study|Lost to Follow-up|6
1025038|NCT00262028|3343851|P8|Overall Study|Lost to Follow-up|5
1025039|NCT00262028|3343852|P7|Overall Study|Lost to Follow-up|3
1025040|NCT00262028|3343853|P6|Overall Study|Lost to Follow-up|3
1025041|NCT00262028|3343854|P5|Overall Study|Lost to Follow-up|4
1025042|NCT00262028|3343855|P4|Overall Study|Lost to Follow-up|5
1025043|NCT00262028|3343856|P3|Overall Study|Lost to Follow-up|5
1025044|NCT00262028|3343857|P2|Overall Study|Lost to Follow-up|7
1025045|NCT00262028|3343858|P1|Overall Study|Lost to Follow-up|7
1025046|NCT00262028|3343850|P9|Overall Study|Withdrawal by Subject|2
1025047|NCT00262028|3343851|P8|Overall Study|Withdrawal by Subject|7
1025048|NCT00262028|3343852|P7|Overall Study|Withdrawal by Subject|5
1025049|NCT00262028|3343853|P6|Overall Study|Withdrawal by Subject|3
1025050|NCT00262028|3343854|P5|Overall Study|Withdrawal by Subject|2
1025051|NCT00262028|3343855|P4|Overall Study|Withdrawal by Subject|5
1025052|NCT00262028|3343856|P3|Overall Study|Withdrawal by Subject|6
1025053|NCT00262028|3343857|P2|Overall Study|Withdrawal by Subject|3
1025054|NCT00262028|3343858|P1|Overall Study|Withdrawal by Subject|6
1025055|NCT00262002|3343920|P7|Overall Study|Unable to classify|2
1025056|NCT00262002|3343921|P6|Overall Study|Unable to classify|0
1025057|NCT00262002|3343922|P5|Overall Study|Unable to classify|0
1025058|NCT00262002|3343923|P4|Overall Study|Unable to classify|0
1025059|NCT00262002|3343924|P3|Overall Study|Unable to classify|0
1025060|NCT00262002|3343925|P2|Overall Study|Unable to classify|0
1025061|NCT00262002|3343926|P1|Overall Study|Unable to classify|0
1025062|NCT00262002|3343920|P7|Overall Study|Protocol Violation|2
1025063|NCT00262002|3343921|P6|Overall Study|Protocol Violation|3
1025064|NCT00262002|3343922|P5|Overall Study|Protocol Violation|5
1025065|NCT00262002|3343923|P4|Overall Study|Protocol Violation|2
1025066|NCT00262002|3343924|P3|Overall Study|Protocol Violation|0
1025067|NCT00262002|3343925|P2|Overall Study|Protocol Violation|2
1025068|NCT00262002|3343926|P1|Overall Study|Protocol Violation|3
1025069|NCT00262002|3343920|P7|Overall Study|Inapropriate enrollment|0
1025070|NCT00262002|3343921|P6|Overall Study|Inapropriate enrollment|0
1025071|NCT00262002|3343922|P5|Overall Study|Inapropriate enrollment|0
1025072|NCT00262002|3343923|P4|Overall Study|Inapropriate enrollment|0
1025073|NCT00262002|3343924|P3|Overall Study|Inapropriate enrollment|0
1025074|NCT00262002|3343925|P2|Overall Study|Inapropriate enrollment|1
1025075|NCT00262002|3343926|P1|Overall Study|Inapropriate enrollment|0
1025076|NCT00262002|3343920|P7|Overall Study|Lost to Follow-up|0
1025077|NCT00262002|3343921|P6|Overall Study|Lost to Follow-up|1
1025078|NCT00262002|3343922|P5|Overall Study|Lost to Follow-up|0
1025079|NCT00262002|3343923|P4|Overall Study|Lost to Follow-up|2
1025080|NCT00262002|3343924|P3|Overall Study|Lost to Follow-up|0
1025081|NCT00262002|3343925|P2|Overall Study|Lost to Follow-up|0
1025082|NCT00262002|3343926|P1|Overall Study|Lost to Follow-up|2
1025083|NCT00262002|3343920|P7|Overall Study|Withdrawal by Subject|2
1025084|NCT00262002|3343921|P6|Overall Study|Withdrawal by Subject|2
1025085|NCT00262002|3343922|P5|Overall Study|Withdrawal by Subject|2
1025086|NCT00262002|3343923|P4|Overall Study|Withdrawal by Subject|1
1025087|NCT00262002|3343924|P3|Overall Study|Withdrawal by Subject|0
1025088|NCT00262002|3343925|P2|Overall Study|Withdrawal by Subject|2
1025089|NCT00262002|3343926|P1|Overall Study|Withdrawal by Subject|4
1025090|NCT00262002|3343920|P7|Overall Study|Adverse Event|0
1025091|NCT00262002|3343921|P6|Overall Study|Adverse Event|1
1025092|NCT00262002|3343922|P5|Overall Study|Adverse Event|0
1025093|NCT00262002|3343923|P4|Overall Study|Adverse Event|0
1025094|NCT00262002|3343924|P3|Overall Study|Adverse Event|0
1025095|NCT00262002|3343925|P2|Overall Study|Adverse Event|1
1025096|NCT00262002|3343926|P1|Overall Study|Adverse Event|2
1025097|NCT00261950|3344019|P1|Overall Study|Protocol specified Criteria|11
1025098|NCT00261950|3344019|P1|Overall Study|Physician Decision|1
1025099|NCT00261950|3344019|P1|Overall Study|not specified|1
1025100|NCT00261950|3344019|P1|Overall Study|Withdrawal by Subject|5
1025101|NCT00261950|3344019|P1|Overall Study|Death|6
1025102|NCT00261950|3344019|P1|Overall Study|Lost to Follow-up|2
1025103|NCT00261846|3344044|P12|Period 2: Part 2 (Efficacy)|Extension study|1
1025104|NCT00261846|3344045|P11|Period 2: Part 2 (Efficacy)|Extension study|1
1025105|NCT00261846|3344046|P10|Period 2: Part 2 (Efficacy)|Extension study|9
1025106|NCT00261846|3344047|P9|Period 2: Part 2 (Efficacy)|Extension study|5
1025107|NCT00261846|3344048|P8|Period 2: Part 2 (Efficacy)|Extension study|9
1025108|NCT00261846|3344049|P7|Period 2: Part 2 (Efficacy)|Extension study|4
1025109|NCT00261846|3344050|P6|Period 2: Part 2 (Efficacy)|Extension study|0
1025110|NCT00261846|3344051|P5|Period 2: Part 2 (Efficacy)|Extension study|27
1025111|NCT00261846|3344052|P4|Period 2: Part 2 (Efficacy)|Extension study|61
1025112|NCT00261846|3344053|P3|Period 2: Part 2 (Efficacy)|Extension study|0
1025113|NCT00261846|3344054|P2|Period 2: Part 2 (Efficacy)|Extension study|0
1025114|NCT00261846|3344055|P1|Period 2: Part 2 (Efficacy)|Extension study|0
1025115|NCT00261846|3344044|P12|Period 2: Part 2 (Efficacy)|Death|22
1025116|NCT00261846|3344045|P11|Period 2: Part 2 (Efficacy)|Death|44
1025117|NCT00261846|3344046|P10|Period 2: Part 2 (Efficacy)|Death|30
1025118|NCT00261846|3344047|P9|Period 2: Part 2 (Efficacy)|Death|3
1025119|NCT00261846|3344048|P8|Period 2: Part 2 (Efficacy)|Death|12
1025120|NCT00261846|3344049|P7|Period 2: Part 2 (Efficacy)|Death|10
1025121|NCT00261846|3344050|P6|Period 2: Part 2 (Efficacy)|Death|1
1025122|NCT00261846|3344051|P5|Period 2: Part 2 (Efficacy)|Death|7
1025123|NCT00261846|3344052|P4|Period 2: Part 2 (Efficacy)|Death|37
1025124|NCT00261846|3344053|P3|Period 2: Part 2 (Efficacy)|Death|0
1025125|NCT00261846|3344054|P2|Period 2: Part 2 (Efficacy)|Death|0
1025126|NCT00261846|3344055|P1|Period 2: Part 2 (Efficacy)|Death|0
1025127|NCT00261846|3344044|P12|Period 2: Part 2 (Efficacy)|Other|0
1025128|NCT00261846|3344045|P11|Period 2: Part 2 (Efficacy)|Other|0
1025129|NCT00261846|3344046|P10|Period 2: Part 2 (Efficacy)|Other|4
1025130|NCT00261846|3344047|P9|Period 2: Part 2 (Efficacy)|Other|4
1025131|NCT00261846|3344048|P8|Period 2: Part 2 (Efficacy)|Other|5
1025132|NCT00261846|3344049|P7|Period 2: Part 2 (Efficacy)|Other|1
1025133|NCT00261846|3344050|P6|Period 2: Part 2 (Efficacy)|Other|0
1025134|NCT00261846|3344051|P5|Period 2: Part 2 (Efficacy)|Other|4
1025135|NCT00261846|3344052|P4|Period 2: Part 2 (Efficacy)|Other|15
1025136|NCT00261846|3344053|P3|Period 2: Part 2 (Efficacy)|Other|0
1025137|NCT00261846|3344054|P2|Period 2: Part 2 (Efficacy)|Other|0
1025138|NCT00261846|3344055|P1|Period 2: Part 2 (Efficacy)|Other|0
1025139|NCT00261846|3344044|P12|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
1025140|NCT00261846|3344045|P11|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
1025141|NCT00261846|3344046|P10|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
1025142|NCT00261846|3344047|P9|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1
1025143|NCT00261846|3344048|P8|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
1025144|NCT00261846|3344049|P7|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
1025145|NCT00261846|3344050|P6|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
1025146|NCT00261846|3344051|P5|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
1025147|NCT00261846|3344052|P4|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12
1025148|NCT00261846|3344053|P3|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
1025149|NCT00261846|3344054|P2|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
1025150|NCT00261846|3344055|P1|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
1025151|NCT00261846|3344044|P12|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
1025152|NCT00261846|3344045|P11|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
1025153|NCT00261846|3344046|P10|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2
1025154|NCT00261846|3344047|P9|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
1025155|NCT00261846|3344048|P8|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
1025156|NCT00261846|3344049|P7|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
1025157|NCT00261846|3344050|P6|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1
1025158|NCT00261846|3344051|P5|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8
1025159|NCT00261846|3344052|P4|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9
1025160|NCT00261846|3344053|P3|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
1025161|NCT00261846|3344054|P2|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
1025162|NCT00261846|3344055|P1|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
1025163|NCT00261846|3344044|P12|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1025164|NCT00261846|3344045|P11|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1025165|NCT00261846|3344046|P10|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1025166|NCT00261846|3344047|P9|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
1025167|NCT00261846|3344048|P8|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1025168|NCT00261846|3344049|P7|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1025169|NCT00261846|3344050|P6|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1025170|NCT00261846|3344051|P5|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1025171|NCT00261846|3344052|P4|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
1025172|NCT00261846|3344053|P3|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1025173|NCT00261846|3344054|P2|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1025174|NCT00261846|3344055|P1|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1025175|NCT00261846|3344044|P12|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1025176|NCT00261846|3344045|P11|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1025177|NCT00261846|3344046|P10|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1025178|NCT00261846|3344047|P9|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1025179|NCT00261846|3344048|P8|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1025180|NCT00261846|3344049|P7|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1025181|NCT00261846|3344050|P6|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1025182|NCT00261846|3344051|P5|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1025183|NCT00261846|3344052|P4|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1025184|NCT00261846|3344053|P3|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12
1025185|NCT00261846|3344054|P2|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
1025186|NCT00261846|3344055|P1|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
1025187|NCT00261833|3344314|P2|Overall Study|Not interested in being participant|1
1025188|NCT00261833|3344315|P1|Overall Study|Not interested in being participant|0
1025189|NCT00261833|3344314|P2|Overall Study|Missing reason|0
1025190|NCT00261833|3344315|P1|Overall Study|Missing reason|1
1025191|NCT00261833|3344314|P2|Overall Study|Lung transplantation|1
1025192|NCT00261833|3344315|P1|Overall Study|Lung transplantation|1
1025193|NCT00261833|3344314|P2|Overall Study|Suspicion of pulmonary cancer|1
1025194|NCT00261833|3344315|P1|Overall Study|Suspicion of pulmonary cancer|0
1025195|NCT00261833|3344314|P2|Overall Study|Protocol Violation|1
1025196|NCT00261833|3344315|P1|Overall Study|Protocol Violation|0
1025197|NCT00261833|3344314|P2|Overall Study|Withdrawal by Subject|7
1025198|NCT00261833|3344315|P1|Overall Study|Withdrawal by Subject|5
1025199|NCT00261833|3344314|P2|Overall Study|Adverse Event|4
1025200|NCT00261833|3344315|P1|Overall Study|Adverse Event|1
1025201|NCT00261833|3344314|P2|Overall Study|Death|3
1025202|NCT00261833|3344315|P1|Overall Study|Death|1
1025203|NCT00261716|3344349|P2|Overall Study|Lost to Follow-up|2
1025204|NCT00261716|3344350|P1|Overall Study|Lost to Follow-up|0
1025205|NCT00261716|3344349|P2|Overall Study|Withdrawal by Subject|8
1025206|NCT00261716|3344350|P1|Overall Study|Withdrawal by Subject|6
1025207|NCT00261495|3344370|P2|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
1025208|NCT00261495|3344371|P1|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
1025209|NCT00261495|3344370|P2|Extension Phase (Weeks 24 to 52)|Non-compliance|0
1025210|NCT00261495|3344371|P1|Extension Phase (Weeks 24 to 52)|Non-compliance|1
1025211|NCT00261495|3344370|P2|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
1025212|NCT00261495|3344371|P1|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
1025213|NCT00261495|3344370|P2|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
1025214|NCT00261495|3344371|P1|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
1025215|NCT00261495|3344370|P2|Extension Phase (Weeks 24 to 52)|Adverse Event|1
1025216|NCT00261495|3344371|P1|Extension Phase (Weeks 24 to 52)|Adverse Event|4
1025217|NCT00261495|3344370|P2|Extension Phase (Weeks 24 to 52)|Other|2
1025218|NCT00261495|3344371|P1|Extension Phase (Weeks 24 to 52)|Other|4
1025219|NCT00261495|3344370|P2|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0
1025220|NCT00261495|3344371|P1|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2
1025221|NCT00261495|3344370|P2|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0
1025222|NCT00261495|3344371|P1|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2
1025223|NCT00261495|3344370|P2|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
1025224|NCT00261495|3344371|P1|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
1025225|NCT00261495|3344370|P2|Maintenance Phase (Weeks 4 to 24)|Other|5
1025226|NCT00261495|3344371|P1|Maintenance Phase (Weeks 4 to 24)|Other|6
1025227|NCT00261495|3344370|P2|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2
1025228|NCT00261495|3344371|P1|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5
1025229|NCT00261495|3344370|P2|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5
1025230|NCT00261495|3344371|P1|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1
1025231|NCT00261495|3344370|P2|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5
1025232|NCT00261495|3344371|P1|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6
1025233|NCT00261495|3344370|P2|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10
1025234|NCT00261495|3344371|P1|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14
1025235|NCT00261495|3344370|P2|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20
1025236|NCT00261495|3344371|P1|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29
1025237|NCT00261495|3344370|P2|Titration Phase (Weeks 0 to 4)|Protocol Violation|4
1025238|NCT00261495|3344371|P1|Titration Phase (Weeks 0 to 4)|Protocol Violation|1
1025239|NCT00261495|3344370|P2|Titration Phase (Weeks 0 to 4)|Non-compliance|5
1025240|NCT00261495|3344371|P1|Titration Phase (Weeks 0 to 4)|Non-compliance|2
1025241|NCT00261495|3344370|P2|Titration Phase (Weeks 0 to 4)|Physician Decision|1
1025242|NCT00261495|3344371|P1|Titration Phase (Weeks 0 to 4)|Physician Decision|3
1025243|NCT00261495|3344370|P2|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
1025244|NCT00261495|3344371|P1|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
1025245|NCT00261495|3344370|P2|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11
1025246|NCT00261495|3344371|P1|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6
1025247|NCT00261495|3344370|P2|Titration Phase (Weeks 0 to 4)|Adverse Event|36
1025248|NCT00261495|3344371|P1|Titration Phase (Weeks 0 to 4)|Adverse Event|28
1025249|NCT00261443|3344535|P3|4: Extension Phase|Lost to Follow-up|0
1025250|NCT00261443|3344536|P2|4: Extension Phase|Lost to Follow-up|1
1025251|NCT00261443|3344537|P1|4: Extension Phase|Lost to Follow-up|0
1025252|NCT00261443|3344535|P3|4: Extension Phase|Withdrawal by Subject|2
1025253|NCT00261443|3344536|P2|4: Extension Phase|Withdrawal by Subject|1
1025254|NCT00261443|3344537|P1|4: Extension Phase|Withdrawal by Subject|0
1025255|NCT00261443|3344535|P3|4: Extension Phase|Adverse Event|0
1025256|NCT00261443|3344536|P2|4: Extension Phase|Adverse Event|1
1025257|NCT00261443|3344537|P1|4: Extension Phase|Adverse Event|0
1025258|NCT00261443|3344535|P3|3: Assessment of Relapse|Other Reasons|3
1025259|NCT00261443|3344536|P2|3: Assessment of Relapse|Other Reasons|4
1025260|NCT00261443|3344537|P1|3: Assessment of Relapse|Other Reasons|0
1025261|NCT00261443|3344535|P3|3: Assessment of Relapse|Administrative Reason By Sponsor|2
1025262|NCT00261443|3344536|P2|3: Assessment of Relapse|Administrative Reason By Sponsor|0
1025263|NCT00261443|3344537|P1|3: Assessment of Relapse|Administrative Reason By Sponsor|0
1025264|NCT00261443|3344535|P3|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1
1025265|NCT00261443|3344536|P2|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2
1025266|NCT00261443|3344537|P1|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0
1025267|NCT00261443|3344535|P3|3: Assessment of Relapse|Pregnancy|1
1025268|NCT00261443|3344536|P2|3: Assessment of Relapse|Pregnancy|2
1025269|NCT00261443|3344537|P1|3: Assessment of Relapse|Pregnancy|0
1025270|NCT00261443|3344535|P3|3: Assessment of Relapse|Poor/Noncompliance|3
1025271|NCT00261443|3344536|P2|3: Assessment of Relapse|Poor/Noncompliance|5
1025272|NCT00261443|3344537|P1|3: Assessment of Relapse|Poor/Noncompliance|0
1025273|NCT00261443|3344535|P3|3: Assessment of Relapse|Lost to Follow-up|6
1025274|NCT00261443|3344536|P2|3: Assessment of Relapse|Lost to Follow-up|7
1025275|NCT00261443|3344537|P1|3: Assessment of Relapse|Lost to Follow-up|0
1025276|NCT00261443|3344535|P3|3: Assessment of Relapse|Death|1
1025277|NCT00261443|3344536|P2|3: Assessment of Relapse|Death|0
1025278|NCT00261443|3344537|P1|3: Assessment of Relapse|Death|0
1025279|NCT00261443|3344535|P3|3: Assessment of Relapse|Withdrawal by Subject|15
1025280|NCT00261443|3344536|P2|3: Assessment of Relapse|Withdrawal by Subject|14
1025356|NCT00260208|3344851|P2|Overall Study|Missing|16
1025281|NCT00261443|3344537|P1|3: Assessment of Relapse|Withdrawal by Subject|0
1025282|NCT00261443|3344535|P3|3: Assessment of Relapse|Adverse Event|19
1025283|NCT00261443|3344536|P2|3: Assessment of Relapse|Adverse Event|15
1025284|NCT00261443|3344537|P1|3: Assessment of Relapse|Adverse Event|0
1025285|NCT00261443|3344535|P3|3: Assessment of Relapse|Lack of Efficacy|14
1025286|NCT00261443|3344536|P2|3: Assessment of Relapse|Lack of Efficacy|31
1025287|NCT00261443|3344537|P1|3: Assessment of Relapse|Lack of Efficacy|0
1025288|NCT00261443|3344535|P3|2: Stability & Maintenance of Stability|Other Reasons|0
1025289|NCT00261443|3344536|P2|2: Stability & Maintenance of Stability|Other Reasons|0
1025290|NCT00261443|3344537|P1|2: Stability & Maintenance of Stability|Other Reasons|13
1025291|NCT00261443|3344535|P3|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
1025292|NCT00261443|3344536|P2|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
1025293|NCT00261443|3344537|P1|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1
1025294|NCT00261443|3344535|P3|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
1025295|NCT00261443|3344536|P2|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
1025296|NCT00261443|3344537|P1|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32
1025297|NCT00261443|3344535|P3|2: Stability & Maintenance of Stability|Pregnancy|0
1025298|NCT00261443|3344536|P2|2: Stability & Maintenance of Stability|Pregnancy|0
1025299|NCT00261443|3344537|P1|2: Stability & Maintenance of Stability|Pregnancy|1
1025300|NCT00261443|3344535|P3|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
1025301|NCT00261443|3344536|P2|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
1025302|NCT00261443|3344537|P1|2: Stability & Maintenance of Stability|Poor/Noncompliance|33
1025303|NCT00261443|3344535|P3|2: Stability & Maintenance of Stability|Lost to Follow-up|0
1025304|NCT00261443|3344536|P2|2: Stability & Maintenance of Stability|Lost to Follow-up|0
1025305|NCT00261443|3344537|P1|2: Stability & Maintenance of Stability|Lost to Follow-up|59
1025306|NCT00261443|3344535|P3|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
1025307|NCT00261443|3344536|P2|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
1025308|NCT00261443|3344537|P1|2: Stability & Maintenance of Stability|Withdrawal by Subject|65
1025309|NCT00261443|3344535|P3|2: Stability & Maintenance of Stability|Adverse Event|0
1025310|NCT00261443|3344536|P2|2: Stability & Maintenance of Stability|Adverse Event|0
1025311|NCT00261443|3344537|P1|2: Stability & Maintenance of Stability|Adverse Event|93
1025312|NCT00261443|3344535|P3|2: Stability & Maintenance of Stability|Lack of Efficacy|0
1025313|NCT00261443|3344536|P2|2: Stability & Maintenance of Stability|Lack of Efficacy|0
1025314|NCT00261443|3344537|P1|2: Stability & Maintenance of Stability|Lack of Efficacy|43
1025315|NCT00261443|3344535|P3|1: Confirmation of Partial Nonresponse|Other Reasons|0
1025316|NCT00261443|3344536|P2|1: Confirmation of Partial Nonresponse|Other Reasons|0
1025317|NCT00261443|3344537|P1|1: Confirmation of Partial Nonresponse|Other Reasons|16
1025318|NCT00261443|3344535|P3|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
1025319|NCT00261443|3344536|P2|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
1025320|NCT00261443|3344537|P1|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307
1025321|NCT00261443|3344535|P3|1: Confirmation of Partial Nonresponse|Pregnancy|0
1025322|NCT00261443|3344536|P2|1: Confirmation of Partial Nonresponse|Pregnancy|0
1025323|NCT00261443|3344537|P1|1: Confirmation of Partial Nonresponse|Pregnancy|1
1025324|NCT00261443|3344535|P3|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
1025325|NCT00261443|3344536|P2|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
1025326|NCT00261443|3344537|P1|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23
1025327|NCT00261443|3344535|P3|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
1025328|NCT00261443|3344536|P2|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
1025329|NCT00261443|3344537|P1|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111
1025330|NCT00261443|3344535|P3|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
1025331|NCT00261443|3344536|P2|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
1025332|NCT00261443|3344537|P1|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93
1025333|NCT00261443|3344535|P3|1: Confirmation of Partial Nonresponse|Adverse Event|0
1025334|NCT00261443|3344536|P2|1: Confirmation of Partial Nonresponse|Adverse Event|0
1025335|NCT00261443|3344537|P1|1: Confirmation of Partial Nonresponse|Adverse Event|33
1025336|NCT00260832|3344805|P2|Overall Study|Protocol Violation|1
1025337|NCT00260832|3344806|P1|Overall Study|Protocol Violation|3
1025338|NCT00260832|3344805|P2|Overall Study|Not Specified|7
1025339|NCT00260832|3344806|P1|Overall Study|Not Specified|10
1025340|NCT00260832|3344805|P2|Overall Study|Death|62
1025341|NCT00260832|3344806|P1|Overall Study|Death|43
1025342|NCT00260832|3344805|P2|Overall Study|Physician Decision|9
1025343|NCT00260832|3344806|P1|Overall Study|Physician Decision|15
1025344|NCT00260832|3344805|P2|Overall Study|Withdrawal by Subject|17
1025345|NCT00260832|3344806|P1|Overall Study|Withdrawal by Subject|15
1025346|NCT00260832|3344805|P2|Overall Study|Progression|96
1025347|NCT00260832|3344806|P1|Overall Study|Progression|116
1025348|NCT00260832|3344805|P2|Overall Study|Adverse Event|19
1025349|NCT00260832|3344806|P1|Overall Study|Adverse Event|26
1025350|NCT00260533|3344833|P2|Overall Study|Other|3
1025351|NCT00260533|3344834|P1|Overall Study|Other|3
1025352|NCT00260429|3344842|P2|Overall Study|scheduled hand surgery|0
1025353|NCT00260429|3344843|P1|Overall Study|scheduled hand surgery|1
1025354|NCT00260429|3344842|P2|Overall Study|failure to follow appointments|0
1025355|NCT00260429|3344843|P1|Overall Study|failure to follow appointments|1
1025357|NCT00260208|3344852|P1|Overall Study|Missing|18
1025358|NCT00260208|3344851|P2|Overall Study|Death|10
1025359|NCT00260208|3344852|P1|Overall Study|Death|12
1025360|NCT00260208|3344851|P2|Overall Study|Lost to Follow-up|1
1025361|NCT00260208|3344852|P1|Overall Study|Lost to Follow-up|6
1025362|NCT00260208|3344851|P2|Overall Study|Subject withdrew consent|7
1025363|NCT00260208|3344852|P1|Overall Study|Subject withdrew consent|11
1025364|NCT00260065|3344895|P1|Overall Study|Medication Noncompliance|1
1025365|NCT00260065|3344895|P1|Overall Study|Not otherwise specified|8
1025366|NCT00260065|3344895|P1|Overall Study|Physician Decision|19
1025367|NCT00260065|3344895|P1|Overall Study|Withdrawal by Subject|13
1025368|NCT00260065|3344895|P1|Overall Study|Death|13
1025369|NCT00260065|3344895|P1|Overall Study|Adverse Event|17
1025370|NCT00260065|3344895|P1|Overall Study|Progressive Disease|22
1025371|NCT00259857|3344902|P2|24 Months Treatment|Lost to Follow-up|3
1025372|NCT00259857|3344903|P1|24 Months Treatment|Lost to Follow-up|0
1025373|NCT00259857|3344902|P2|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2
1025374|NCT00259857|3344903|P1|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1
1025375|NCT00259740|3344921|P2|Overall Study|Requirement for alternative therapy|4
1025376|NCT00259740|3344922|P1|Overall Study|Requirement for alternative therapy|0
1025377|NCT00259740|3344921|P2|Overall Study|Other|0
1025378|NCT00259740|3344922|P1|Overall Study|Other|3
1025379|NCT00259740|3344921|P2|Overall Study|Ongoing|3
1025380|NCT00259740|3344922|P1|Overall Study|Ongoing|17
1025381|NCT00259740|3344921|P2|Overall Study|Disease progression|36
1025382|NCT00259740|3344922|P1|Overall Study|Disease progression|19
1025383|NCT00259740|3344921|P2|Overall Study|Death|1
1025384|NCT00259740|3344922|P1|Overall Study|Death|1
1025385|NCT00259740|3344921|P2|Overall Study|Withdrawal by Subject|6
1025386|NCT00259740|3344922|P1|Overall Study|Withdrawal by Subject|2
1025387|NCT00259740|3344921|P2|Overall Study|Adverse Event|2
1025388|NCT00259740|3344922|P1|Overall Study|Adverse Event|0
1025389|NCT00259740|3344921|P2|Overall Study|Physician Decision|1
1025390|NCT00259740|3344922|P1|Overall Study|Physician Decision|1
1025391|NCT00259649|3344932|P1|Overall Study|irregular menses|3
1025392|NCT00259649|3344932|P1|Overall Study|Lost to Follow-up|7
1025393|NCT00259610|3344940|P4|Overall Study|Serious Adverse Event|2
1025394|NCT00259610|3344941|P3|Overall Study|Serious Adverse Event|2
1025395|NCT00259610|3344942|P2|Overall Study|Serious Adverse Event|2
1025396|NCT00259610|3344943|P1|Overall Study|Serious Adverse Event|8
1025397|NCT00259610|3344940|P4|Overall Study|Adverse Event|2
1025398|NCT00259610|3344941|P3|Overall Study|Adverse Event|5
1025399|NCT00259610|3344942|P2|Overall Study|Adverse Event|4
1025400|NCT00259610|3344943|P1|Overall Study|Adverse Event|3
1025401|NCT00259610|3344940|P4|Overall Study|non medical reason|3
1025402|NCT00259610|3344941|P3|Overall Study|non medical reason|10
1025403|NCT00259610|3344942|P2|Overall Study|non medical reason|2
1025404|NCT00259610|3344943|P1|Overall Study|non medical reason|6
1025405|NCT00259610|3344940|P4|Overall Study|Death|0
1025406|NCT00259610|3344941|P3|Overall Study|Death|2
1025407|NCT00259610|3344942|P2|Overall Study|Death|1
1025408|NCT00259610|3344943|P1|Overall Study|Death|1
1025409|NCT00259610|3344940|P4|Overall Study|Physician Decision|2
1025410|NCT00259610|3344941|P3|Overall Study|Physician Decision|7
1025411|NCT00259610|3344942|P2|Overall Study|Physician Decision|4
1025412|NCT00259610|3344943|P1|Overall Study|Physician Decision|6
1025413|NCT00259610|3344940|P4|Overall Study|Lost to Follow-up|15
1025414|NCT00259610|3344941|P3|Overall Study|Lost to Follow-up|18
1025415|NCT00259610|3344942|P2|Overall Study|Lost to Follow-up|8
1025416|NCT00259610|3344943|P1|Overall Study|Lost to Follow-up|19
1025417|NCT00259610|3344940|P4|Overall Study|Withdrawal by Subject|19
1025418|NCT00259610|3344941|P3|Overall Study|Withdrawal by Subject|29
1025419|NCT00259610|3344942|P2|Overall Study|Withdrawal by Subject|25
1025420|NCT00259610|3344943|P1|Overall Study|Withdrawal by Subject|33
1025421|NCT00259298|3344957|P1|Overall Study|Physician Decision|2
1025422|NCT00259298|3344957|P1|Overall Study|Withdrawal by Subject|1
1025423|NCT00259272|3344975|P4|Overall Study|Lost to Follow-up|1
1025424|NCT00259272|3344976|P3|Overall Study|Lost to Follow-up|0
1025425|NCT00259272|3344977|P2|Overall Study|Lost to Follow-up|0
1025426|NCT00259272|3344978|P1|Overall Study|Lost to Follow-up|1
1025427|NCT00259272|3344975|P4|Overall Study|Withdrawal by Subject|7
1025428|NCT00259272|3344976|P3|Overall Study|Withdrawal by Subject|2
1025429|NCT00259272|3344977|P2|Overall Study|Withdrawal by Subject|2
1025430|NCT00259272|3344978|P1|Overall Study|Withdrawal by Subject|4
1025431|NCT00259272|3344975|P4|Overall Study|Sponsor Decision|0
1025432|NCT00259272|3344976|P3|Overall Study|Sponsor Decision|0
1025433|NCT00259272|3344977|P2|Overall Study|Sponsor Decision|1
1025434|NCT00259272|3344978|P1|Overall Study|Sponsor Decision|0
1025435|NCT00259272|3344975|P4|Overall Study|Protocol Violation|1
1025436|NCT00259272|3344976|P3|Overall Study|Protocol Violation|0
1025437|NCT00259272|3344977|P2|Overall Study|Protocol Violation|0
1025438|NCT00259272|3344978|P1|Overall Study|Protocol Violation|2
1025439|NCT00259272|3344975|P4|Overall Study|Physician Decision|3
1025440|NCT00259272|3344976|P3|Overall Study|Physician Decision|1
1025441|NCT00259272|3344977|P2|Overall Study|Physician Decision|2
1025442|NCT00259272|3344978|P1|Overall Study|Physician Decision|1
1025443|NCT00259272|3344975|P4|Overall Study|Lack of Efficacy|6
1025444|NCT00259272|3344976|P3|Overall Study|Lack of Efficacy|2
1025445|NCT00259272|3344977|P2|Overall Study|Lack of Efficacy|1
1025446|NCT00259272|3344978|P1|Overall Study|Lack of Efficacy|5
1025447|NCT00259272|3344975|P4|Overall Study|Adverse Event|3
1025448|NCT00259272|3344976|P3|Overall Study|Adverse Event|0
1025449|NCT00259272|3344977|P2|Overall Study|Adverse Event|1
1025450|NCT00259272|3344978|P1|Overall Study|Adverse Event|2
1025451|NCT00259012|3345074|P2|Overall Study|Protocol Violation|1
1025452|NCT00259012|3345075|P1|Overall Study|Protocol Violation|1
1025453|NCT00259012|3345074|P2|Overall Study|Lost to Follow-up|1
1025454|NCT00259012|3345075|P1|Overall Study|Lost to Follow-up|0
1025455|NCT00259012|3345074|P2|Overall Study|Physician Decision|1
1025456|NCT00259012|3345075|P1|Overall Study|Physician Decision|0
1025457|NCT00259012|3345074|P2|Overall Study|Withdrawal by Subject|0
1025458|NCT00259012|3345075|P1|Overall Study|Withdrawal by Subject|1
1025459|NCT00259012|3345074|P2|Overall Study|Adverse Event|1
1025460|NCT00259012|3345075|P1|Overall Study|Adverse Event|0
1025461|NCT00258895|3345115|P2|Overall Study|Withdrawal by Subject|0
1025462|NCT00258895|3345116|P1|Overall Study|Withdrawal by Subject|1
1025463|NCT00258895|3345115|P2|Overall Study|Protocol Violation|2
1025464|NCT00258895|3345116|P1|Overall Study|Protocol Violation|6
1025465|NCT00258895|3345115|P2|Overall Study|Lost to Follow-up|1
1025466|NCT00258895|3345116|P1|Overall Study|Lost to Follow-up|3
1025467|NCT00258856|3345152|P4|Overall Study|Non-compliance|1
1025468|NCT00258856|3345153|P3|Overall Study|Non-compliance|0
1025469|NCT00258856|3345154|P2|Overall Study|Non-compliance|0
1025470|NCT00258856|3345155|P1|Overall Study|Non-compliance|2
1025471|NCT00258856|3345152|P4|Overall Study|Lost to Follow-up|0
1025472|NCT00258856|3345153|P3|Overall Study|Lost to Follow-up|2
1025473|NCT00258856|3345154|P2|Overall Study|Lost to Follow-up|0
1025474|NCT00258856|3345155|P1|Overall Study|Lost to Follow-up|1
1025475|NCT00258674|3345196|P3|Overall Study|Death|34
1025476|NCT00258674|3345197|P2|Overall Study|Death|53
1025477|NCT00258674|3345198|P1|Overall Study|Death|32
1025478|NCT00258440|3345257|P3|Overall Study|Withdrawal by Subject|1
1025479|NCT00258440|3345258|P2|Overall Study|Withdrawal by Subject|0
1025480|NCT00258440|3345259|P1|Overall Study|Withdrawal by Subject|0
1025481|NCT00258154|3345292|P2|Overall Study|Patient Moved|1
1025482|NCT00258154|3345293|P1|Overall Study|Patient Moved|3
1025483|NCT00258154|3345292|P2|Overall Study|Withdrawal by Subject|4
1025484|NCT00258154|3345293|P1|Overall Study|Withdrawal by Subject|3
1025485|NCT00258154|3345292|P2|Overall Study|Protocol Violation|1
1025486|NCT00258154|3345293|P1|Overall Study|Protocol Violation|2
1025487|NCT00258154|3345292|P2|Overall Study|Lost to Follow-up|1
1025488|NCT00258154|3345293|P1|Overall Study|Lost to Follow-up|0
1025489|NCT00258154|3345292|P2|Overall Study|Adverse Event|0
1025490|NCT00258154|3345293|P1|Overall Study|Adverse Event|1
1025491|NCT00257920|3345377|P2|Period: Second Intervention|Other|1
1025492|NCT00257920|3345378|P1|Period: Second Intervention|Other|2
1025493|NCT00257920|3345377|P2|Period: Washout Period of Two Weeks|Lost to Follow-up|1
1025494|NCT00257920|3345378|P1|Period: Washout Period of Two Weeks|Lost to Follow-up|0
1025495|NCT00257660|3345434|P2|Overall Study|No longer wanted to do blood draws|0
1025496|NCT00257660|3345435|P1|Overall Study|No longer wanted to do blood draws|1
1025497|NCT00257660|3345434|P2|Overall Study|PI & Subject Schedule Conflicts|0
1025498|NCT00257660|3345435|P1|Overall Study|PI & Subject Schedule Conflicts|1
1025499|NCT00257660|3345434|P2|Overall Study|Lost to Follow-up|0
1025500|NCT00257660|3345435|P1|Overall Study|Lost to Follow-up|1
1025501|NCT00257660|3345434|P2|Overall Study|Withdrawal by Subject|0
1025502|NCT00257660|3345435|P1|Overall Study|Withdrawal by Subject|2
1025503|NCT00257660|3345434|P2|Overall Study|Lack of Efficacy|23
1025504|NCT00257660|3345435|P1|Overall Study|Lack of Efficacy|5
1025505|NCT00257608|3345465|P3|Post Chemotherapy Phase|Not treated|7
1025506|NCT00257608|3345466|P2|Post Chemotherapy Phase|Not treated|4
1025507|NCT00257608|3345467|P1|Post Chemotherapy Phase|Not treated|0
1025508|NCT00257608|3345465|P3|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
1025509|NCT00257608|3345466|P2|Post Chemotherapy Phase|Sponsor's decision to terminate study|1
1025510|NCT00257608|3345467|P1|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
1025511|NCT00257608|3345465|P3|Post Chemotherapy Phase|Physician Decision|11
1025512|NCT00257608|3345466|P2|Post Chemotherapy Phase|Physician Decision|8
1025513|NCT00257608|3345467|P1|Post Chemotherapy Phase|Physician Decision|0
1025514|NCT00257608|3345465|P3|Post Chemotherapy Phase|Lost to Follow-up|1
1025515|NCT00257608|3345466|P2|Post Chemotherapy Phase|Lost to Follow-up|0
1025516|NCT00257608|3345467|P1|Post Chemotherapy Phase|Lost to Follow-up|0
1025517|NCT00257608|3345465|P3|Post Chemotherapy Phase|Unrelated intercurrent illness|1
1025518|NCT00257608|3345466|P2|Post Chemotherapy Phase|Unrelated intercurrent illness|0
1025519|NCT00257608|3345467|P1|Post Chemotherapy Phase|Unrelated intercurrent illness|0
1025520|NCT00257608|3345465|P3|Post Chemotherapy Phase|Patient's decision to discontinue|8
1025521|NCT00257608|3345466|P2|Post Chemotherapy Phase|Patient's decision to discontinue|4
1025522|NCT00257608|3345467|P1|Post Chemotherapy Phase|Patient's decision to discontinue|0
1025523|NCT00257608|3345465|P3|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
1025524|NCT00257608|3345466|P2|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
1025525|NCT00257608|3345467|P1|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0
1025526|NCT00257608|3345465|P3|Post Chemotherapy Phase|Unwillingness or inability to comply|5
1025527|NCT00257608|3345466|P2|Post Chemotherapy Phase|Unwillingness or inability to comply|4
1025528|NCT00257608|3345467|P1|Post Chemotherapy Phase|Unwillingness or inability to comply|0
1025529|NCT00257608|3345465|P3|Post Chemotherapy Phase|Disease progression|168
1025530|NCT00257608|3345466|P2|Post Chemotherapy Phase|Disease progression|204
1025531|NCT00257608|3345467|P1|Post Chemotherapy Phase|Disease progression|0
1025532|NCT00257608|3345465|P3|Post Chemotherapy Phase|Adverse Event|38
1025533|NCT00257608|3345466|P2|Post Chemotherapy Phase|Adverse Event|34
1025534|NCT00257608|3345467|P1|Post Chemotherapy Phase|Adverse Event|0
1025535|NCT00257608|3345465|P3|Chemotherapy Phase|Physician Decision|0
1025536|NCT00257608|3345466|P2|Chemotherapy Phase|Physician Decision|0
1025537|NCT00257608|3345467|P1|Chemotherapy Phase|Physician Decision|28
1025538|NCT00257608|3345465|P3|Chemotherapy Phase|Unrelated intercurrent illness|0
1025539|NCT00257608|3345466|P2|Chemotherapy Phase|Unrelated intercurrent illness|0
1025540|NCT00257608|3345467|P1|Chemotherapy Phase|Unrelated intercurrent illness|3
1025541|NCT00257608|3345465|P3|Chemotherapy Phase|Patient's decision to discontinue|0
1025542|NCT00257608|3345466|P2|Chemotherapy Phase|Patient's decision to discontinue|0
1025543|NCT00257608|3345467|P1|Chemotherapy Phase|Patient's decision to discontinue|35
1025544|NCT00257608|3345465|P3|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
1025545|NCT00257608|3345466|P2|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
1025546|NCT00257608|3345467|P1|Chemotherapy Phase|Need for concomitant/ancillary therapy|27
1025547|NCT00257608|3345465|P3|Chemotherapy Phase|Unwillingness or inability to comply|0
1025548|NCT00257608|3345466|P2|Chemotherapy Phase|Unwillingness or inability to comply|0
1025549|NCT00257608|3345467|P1|Chemotherapy Phase|Unwillingness or inability to comply|6
1025550|NCT00257608|3345465|P3|Chemotherapy Phase|Disease progression|0
1025551|NCT00257608|3345466|P2|Chemotherapy Phase|Disease progression|0
1025552|NCT00257608|3345467|P1|Chemotherapy Phase|Disease progression|139
1025553|NCT00257608|3345465|P3|Chemotherapy Phase|Adverse Event|0
1025554|NCT00257608|3345466|P2|Chemotherapy Phase|Adverse Event|0
1025555|NCT00257608|3345467|P1|Chemotherapy Phase|Adverse Event|138
1025556|NCT00257556|3345493|P2|Overall Study|other reason|6
1025557|NCT00257556|3345494|P1|Overall Study|other reason|4
1025558|NCT00257556|3345493|P2|Overall Study|Did not meet hCG criterion|0
1025559|NCT00257556|3345494|P1|Overall Study|Did not meet hCG criterion|3
1025560|NCT00257556|3345493|P2|Overall Study|Physician Decision|0
1025561|NCT00257556|3345494|P1|Overall Study|Physician Decision|6
1025562|NCT00257556|3345493|P2|Overall Study|Adverse Event|4
1025563|NCT00257556|3345494|P1|Overall Study|Adverse Event|1
1025564|NCT00257192|3345538|P2|Overall Study|Miscellaneous|4
1025565|NCT00257192|3345539|P1|Overall Study|Miscellaneous|0
1025566|NCT00257192|3345538|P2|Overall Study|Study terminated by sponsor|0
1025567|NCT00257192|3345539|P1|Overall Study|Study terminated by sponsor|1
1025568|NCT00257192|3345538|P2|Overall Study|Randomized but not treated|1
1025569|NCT00257192|3345539|P1|Overall Study|Randomized but not treated|0
1025570|NCT00257192|3345538|P2|Overall Study|Withdrawal by Subject|2
1025571|NCT00257192|3345539|P1|Overall Study|Withdrawal by Subject|14
1025572|NCT00257192|3345538|P2|Overall Study|Insufficient clinical response|18
1025573|NCT00257192|3345539|P1|Overall Study|Insufficient clinical response|18
1025574|NCT00257192|3345538|P2|Overall Study|Lost to Follow-up|3
1025575|NCT00257192|3345539|P1|Overall Study|Lost to Follow-up|3
1025576|NCT00257192|3345538|P2|Overall Study|Laboratory abnormality|1
1025577|NCT00257192|3345539|P1|Overall Study|Laboratory abnormality|1
1025578|NCT00257192|3345538|P2|Overall Study|Adverse Event|10
1025579|NCT00257192|3345539|P1|Overall Study|Adverse Event|21
1025580|NCT00257166|3345583|P2|Overall Study|Randomized, but not treated|0
1025581|NCT00257166|3345584|P1|Overall Study|Randomized, but not treated|1
1025582|NCT00257166|3345583|P2|Overall Study|Other|21
1025583|NCT00257166|3345584|P1|Overall Study|Other|16
1025584|NCT00257166|3345583|P2|Overall Study|Withdrawal by Subject|2
1025585|NCT00257166|3345584|P1|Overall Study|Withdrawal by Subject|9
1025586|NCT00257166|3345583|P2|Overall Study|Lost to Follow-up|1
1025587|NCT00257166|3345584|P1|Overall Study|Lost to Follow-up|8
1025588|NCT00257166|3345583|P2|Overall Study|Laboratory abnormality|0
1025589|NCT00257166|3345584|P1|Overall Study|Laboratory abnormality|1
1025590|NCT00257166|3345583|P2|Overall Study|Adverse Event|13
1025591|NCT00257166|3345584|P1|Overall Study|Adverse Event|18
1025592|NCT00257010|3345596|P1|Overall Study|no headache reported|9
1025593|NCT00257010|3345596|P1|Overall Study|various|11
1025594|NCT00257010|3345596|P1|Overall Study|Adverse Event|10
1025595|NCT00257010|3345596|P1|Overall Study|Withdrawal by Subject|34
1025596|NCT00257010|3345596|P1|Overall Study|Lost to Follow-up|53
1025597|NCT00257010|3345596|P1|Overall Study|Lack of Efficacy|11
1025598|NCT00256997|3345607|P2|Overall Study|Investigator Withdrew Participant|1
1025599|NCT00256997|3345608|P1|Overall Study|Investigator Withdrew Participant|2
1025600|NCT00256997|3345607|P2|Overall Study|Participant Non-compliant|6
1025601|NCT00256997|3345608|P1|Overall Study|Participant Non-compliant|3
1025602|NCT00256997|3345607|P2|Overall Study|End of Study (As Per Sponsor)|24
1025603|NCT00256997|3345608|P1|Overall Study|End of Study (As Per Sponsor)|12
1025604|NCT00256997|3345607|P2|Overall Study|Other|8
1025605|NCT00256997|3345608|P1|Overall Study|Other|5
1025606|NCT00256997|3345607|P2|Overall Study|Started but not treated|0
1025607|NCT00256997|3345608|P1|Overall Study|Started but not treated|2
1025608|NCT00256997|3345607|P2|Overall Study|Withdrawal by Subject|3
1025609|NCT00256997|3345608|P1|Overall Study|Withdrawal by Subject|13
1025610|NCT00256997|3345607|P2|Overall Study|Lost to Follow-up|5
1025611|NCT00256997|3345608|P1|Overall Study|Lost to Follow-up|3
1025612|NCT00256997|3345607|P2|Overall Study|Adverse Event|0
1025613|NCT00256997|3345608|P1|Overall Study|Adverse Event|4
1025614|NCT00256997|3345607|P2|Overall Study|Death|0
1025615|NCT00256997|3345608|P1|Overall Study|Death|2
1025616|NCT00256997|3345607|P2|Overall Study|Lack of Efficacy|4
1025617|NCT00256997|3345608|P1|Overall Study|Lack of Efficacy|1
1025618|NCT00256997|3345607|P2|Overall Study|Protocol Violation|4
1025619|NCT00256997|3345608|P1|Overall Study|Protocol Violation|1
1025620|NCT00256867|3345650|P8|Overall Study|Withdrawal by participant|0
1025621|NCT00256867|3345651|P7|Overall Study|Withdrawal by participant|0
1025622|NCT00256867|3345652|P6|Overall Study|Withdrawal by participant|1
1025623|NCT00256867|3345653|P5|Overall Study|Withdrawal by participant|0
1025624|NCT00256867|3345654|P4|Overall Study|Withdrawal by participant|0
1025625|NCT00256867|3345655|P3|Overall Study|Withdrawal by participant|0
1025626|NCT00256867|3345656|P2|Overall Study|Withdrawal by participant|0
1025627|NCT00256867|3345657|P1|Overall Study|Withdrawal by participant|0
1025628|NCT00256867|3345650|P8|Overall Study|Participant out of assessment window|0
1025629|NCT00256867|3345651|P7|Overall Study|Participant out of assessment window|0
1025630|NCT00256867|3345652|P6|Overall Study|Participant out of assessment window|0
1025631|NCT00256867|3345653|P5|Overall Study|Participant out of assessment window|0
1025632|NCT00256867|3345654|P4|Overall Study|Participant out of assessment window|0
1025633|NCT00256867|3345655|P3|Overall Study|Participant out of assessment window|1
1025634|NCT00256867|3345656|P2|Overall Study|Participant out of assessment window|0
1025635|NCT00256867|3345657|P1|Overall Study|Participant out of assessment window|0
1025636|NCT00256867|3345650|P8|Overall Study|Participant travelled Overseas|0
1025637|NCT00256867|3345651|P7|Overall Study|Participant travelled Overseas|0
1025638|NCT00256867|3345652|P6|Overall Study|Participant travelled Overseas|0
1025639|NCT00256867|3345653|P5|Overall Study|Participant travelled Overseas|0
1025640|NCT00256867|3345654|P4|Overall Study|Participant travelled Overseas|0
1025641|NCT00256867|3345655|P3|Overall Study|Participant travelled Overseas|0
1025642|NCT00256867|3345656|P2|Overall Study|Participant travelled Overseas|1
1025643|NCT00256867|3345657|P1|Overall Study|Participant travelled Overseas|0
1025644|NCT00256867|3345650|P8|Overall Study|Non-compliance with study medication|1
1025645|NCT00256867|3345651|P7|Overall Study|Non-compliance with study medication|0
1025646|NCT00256867|3345652|P6|Overall Study|Non-compliance with study medication|0
1025647|NCT00256867|3345653|P5|Overall Study|Non-compliance with study medication|0
1025648|NCT00256867|3345654|P4|Overall Study|Non-compliance with study medication|0
1025649|NCT00256867|3345655|P3|Overall Study|Non-compliance with study medication|0
1025650|NCT00256867|3345656|P2|Overall Study|Non-compliance with study medication|0
1025651|NCT00256867|3345657|P1|Overall Study|Non-compliance with study medication|0
1025652|NCT00256867|3345650|P8|Overall Study|Investigator's Decision|0
1025653|NCT00256867|3345651|P7|Overall Study|Investigator's Decision|0
1025654|NCT00256867|3345652|P6|Overall Study|Investigator's Decision|0
1025655|NCT00256867|3345653|P5|Overall Study|Investigator's Decision|1
1025656|NCT00256867|3345654|P4|Overall Study|Investigator's Decision|0
1025657|NCT00256867|3345655|P3|Overall Study|Investigator's Decision|0
1025658|NCT00256867|3345656|P2|Overall Study|Investigator's Decision|0
1025659|NCT00256867|3345657|P1|Overall Study|Investigator's Decision|0
1025660|NCT00256867|3345650|P8|Overall Study|Glycemia over 13.3 millimole per litre|1
1025661|NCT00256867|3345651|P7|Overall Study|Glycemia over 13.3 millimole per litre|0
1025662|NCT00256867|3345652|P6|Overall Study|Glycemia over 13.3 millimole per litre|0
1025663|NCT00256867|3345653|P5|Overall Study|Glycemia over 13.3 millimole per litre|0
1025664|NCT00256867|3345654|P4|Overall Study|Glycemia over 13.3 millimole per litre|0
1025665|NCT00256867|3345655|P3|Overall Study|Glycemia over 13.3 millimole per litre|0
1025666|NCT00256867|3345656|P2|Overall Study|Glycemia over 13.3 millimole per litre|0
1025667|NCT00256867|3345657|P1|Overall Study|Glycemia over 13.3 millimole per litre|0
1025668|NCT00256867|3345650|P8|Overall Study|Fasting plasma glucose >240 mg/dL|0
1025669|NCT00256867|3345651|P7|Overall Study|Fasting plasma glucose >240 mg/dL|0
1025670|NCT00256867|3345652|P6|Overall Study|Fasting plasma glucose >240 mg/dL|0
1025671|NCT00256867|3345653|P5|Overall Study|Fasting plasma glucose >240 mg/dL|0
1025672|NCT00256867|3345654|P4|Overall Study|Fasting plasma glucose >240 mg/dL|0
1025673|NCT00256867|3345655|P3|Overall Study|Fasting plasma glucose >240 mg/dL|0
1025674|NCT00256867|3345656|P2|Overall Study|Fasting plasma glucose >240 mg/dL|1
1025675|NCT00256867|3345657|P1|Overall Study|Fasting plasma glucose >240 mg/dL|0
1025676|NCT00256867|3345650|P8|Overall Study|Withdrawal by Subject|2
1025677|NCT00256867|3345651|P7|Overall Study|Withdrawal by Subject|3
1025678|NCT00256867|3345652|P6|Overall Study|Withdrawal by Subject|2
1025679|NCT00256867|3345653|P5|Overall Study|Withdrawal by Subject|2
1025680|NCT00256867|3345654|P4|Overall Study|Withdrawal by Subject|1
1025681|NCT00256867|3345655|P3|Overall Study|Withdrawal by Subject|1
1025682|NCT00256867|3345656|P2|Overall Study|Withdrawal by Subject|0
1025683|NCT00256867|3345657|P1|Overall Study|Withdrawal by Subject|0
1025684|NCT00256867|3345650|P8|Overall Study|Protocol Violation|1
1025685|NCT00256867|3345651|P7|Overall Study|Protocol Violation|0
1025686|NCT00256867|3345652|P6|Overall Study|Protocol Violation|1
1025687|NCT00256867|3345653|P5|Overall Study|Protocol Violation|0
1025688|NCT00256867|3345654|P4|Overall Study|Protocol Violation|1
1025689|NCT00256867|3345655|P3|Overall Study|Protocol Violation|0
1025690|NCT00256867|3345656|P2|Overall Study|Protocol Violation|0
1025691|NCT00256867|3345657|P1|Overall Study|Protocol Violation|0
1025692|NCT00256867|3345650|P8|Overall Study|Lost to Follow-up|2
1025693|NCT00256867|3345651|P7|Overall Study|Lost to Follow-up|1
1025694|NCT00256867|3345652|P6|Overall Study|Lost to Follow-up|0
1025695|NCT00256867|3345653|P5|Overall Study|Lost to Follow-up|2
1025696|NCT00256867|3345654|P4|Overall Study|Lost to Follow-up|3
1025697|NCT00256867|3345655|P3|Overall Study|Lost to Follow-up|2
1025698|NCT00256867|3345656|P2|Overall Study|Lost to Follow-up|2
1025699|NCT00256867|3345657|P1|Overall Study|Lost to Follow-up|2
1025700|NCT00256867|3345650|P8|Overall Study|Adverse Event|4
1025701|NCT00256867|3345651|P7|Overall Study|Adverse Event|1
1025702|NCT00256867|3345652|P6|Overall Study|Adverse Event|2
1025703|NCT00256867|3345653|P5|Overall Study|Adverse Event|2
1025704|NCT00256867|3345654|P4|Overall Study|Adverse Event|1
1025705|NCT00256867|3345655|P3|Overall Study|Adverse Event|1
1025706|NCT00256867|3345656|P2|Overall Study|Adverse Event|1
1025707|NCT00256867|3345657|P1|Overall Study|Adverse Event|0
1025708|NCT00256750|3345744|P3|Long Term Extension (LTE; 84 Months)|Not Specified|5
1025709|NCT00256750|3345745|P2|Long Term Extension (LTE; 84 Months)|Not Specified|4
1025710|NCT00256750|3345746|P1|Long Term Extension (LTE; 84 Months)|Not Specified|5
1025711|NCT00256750|3345744|P3|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0
1025712|NCT00256750|3345745|P2|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
1025713|NCT00256750|3345746|P1|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
1025714|NCT00256750|3345744|P3|Long Term Extension (LTE; 84 Months)|Pregnancy|2
1025715|NCT00256750|3345745|P2|Long Term Extension (LTE; 84 Months)|Pregnancy|1
1025716|NCT00256750|3345746|P1|Long Term Extension (LTE; 84 Months)|Pregnancy|0
1025717|NCT00256750|3345744|P3|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
1025718|NCT00256750|3345745|P2|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
1025719|NCT00256750|3345746|P1|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4
1025720|NCT00256750|3345744|P3|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0
1025721|NCT00256750|3345745|P2|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3
1025722|NCT00256750|3345746|P1|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6
1025723|NCT00256750|3345744|P3|Long Term Extension (LTE; 84 Months)|Death|4
1025724|NCT00256750|3345745|P2|Long Term Extension (LTE; 84 Months)|Death|4
1025725|NCT00256750|3345746|P1|Long Term Extension (LTE; 84 Months)|Death|9
1025726|NCT00256750|3345744|P3|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
1025727|NCT00256750|3345745|P2|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
1025728|NCT00256750|3345746|P1|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4
1025729|NCT00256750|3345744|P3|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1
1025730|NCT00256750|3345745|P2|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4
1025731|NCT00256750|3345746|P1|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5
1025732|NCT00256750|3345744|P3|Long Term Extension (LTE; 84 Months)|Adverse Event|14
1025733|NCT00256750|3345745|P2|Long Term Extension (LTE; 84 Months)|Adverse Event|11
1025734|NCT00256750|3345746|P1|Long Term Extension (LTE; 84 Months)|Adverse Event|13
1025735|NCT00256750|3345744|P3|Post-Transplant Treated (36 Months)|Not specified|1
1025736|NCT00256750|3345745|P2|Post-Transplant Treated (36 Months)|Not specified|1
1025737|NCT00256750|3345746|P1|Post-Transplant Treated (36 Months)|Not specified|0
1025738|NCT00256750|3345744|P3|Post-Transplant Treated (36 Months)|Protocol Violation|0
1025739|NCT00256750|3345745|P2|Post-Transplant Treated (36 Months)|Protocol Violation|1
1025740|NCT00256750|3345746|P1|Post-Transplant Treated (36 Months)|Protocol Violation|0
1025741|NCT00256750|3345744|P3|Post-Transplant Treated (36 Months)|Lack of Efficacy|0
1025742|NCT00256750|3345745|P2|Post-Transplant Treated (36 Months)|Lack of Efficacy|1
1025743|NCT00256750|3345746|P1|Post-Transplant Treated (36 Months)|Lack of Efficacy|4
1025744|NCT00256750|3345744|P3|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1
1025745|NCT00256750|3345745|P2|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
1025746|NCT00256750|3345746|P1|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
1025747|NCT00256750|3345744|P3|Post-Transplant Treated (36 Months)|Death|1
1025748|NCT00256750|3345745|P2|Post-Transplant Treated (36 Months)|Death|2
1025749|NCT00256750|3345746|P1|Post-Transplant Treated (36 Months)|Death|0
1025750|NCT00256750|3345744|P3|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
1025751|NCT00256750|3345745|P2|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0
1025752|NCT00256750|3345746|P1|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
1025753|NCT00256750|3345744|P3|Post-Transplant Treated (36 Months)|Adverse Event|2
1025754|NCT00256750|3345745|P2|Post-Transplant Treated (36 Months)|Adverse Event|1
1025755|NCT00256750|3345746|P1|Post-Transplant Treated (36 Months)|Adverse Event|5
1025756|NCT00256750|3345744|P3|Post-Transplant Treated (24 Months)|Not Specified|1
1025757|NCT00256750|3345745|P2|Post-Transplant Treated (24 Months)|Not Specified|0
1025758|NCT00256750|3345746|P1|Post-Transplant Treated (24 Months)|Not Specified|2
1025759|NCT00256750|3345744|P3|Post-Transplant Treated (24 Months)|Lack of Efficacy|2
1025760|NCT00256750|3345745|P2|Post-Transplant Treated (24 Months)|Lack of Efficacy|3
1025761|NCT00256750|3345746|P1|Post-Transplant Treated (24 Months)|Lack of Efficacy|4
1025762|NCT00256750|3345744|P3|Post-Transplant Treated (24 Months)|Death|0
1025763|NCT00256750|3345745|P2|Post-Transplant Treated (24 Months)|Death|0
1025764|NCT00256750|3345746|P1|Post-Transplant Treated (24 Months)|Death|3
1025765|NCT00256750|3345744|P3|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0
1025766|NCT00256750|3345745|P2|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1
1025767|NCT00256750|3345746|P1|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5
1025768|NCT00256750|3345744|P3|Post-Transplant Treated (24 Months)|Adverse Event|6
1025769|NCT00256750|3345745|P2|Post-Transplant Treated (24 Months)|Adverse Event|3
1025770|NCT00256750|3345746|P1|Post-Transplant Treated (24 Months)|Adverse Event|7
1025771|NCT00256750|3345744|P3|Post-Transplant Treated (12 Months)|Protocol Violation|0
1025772|NCT00256750|3345745|P2|Post-Transplant Treated (12 Months)|Protocol Violation|0
1025773|NCT00256750|3345746|P1|Post-Transplant Treated (12 Months)|Protocol Violation|2
1025774|NCT00256750|3345744|P3|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5
1025775|NCT00256750|3345745|P2|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3
1025776|NCT00256750|3345746|P1|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0
1025777|NCT00256750|3345744|P3|Post-Transplant Treated (12 Months)|Not Specified|2
1025778|NCT00256750|3345745|P2|Post-Transplant Treated (12 Months)|Not Specified|4
1025779|NCT00256750|3345746|P1|Post-Transplant Treated (12 Months)|Not Specified|5
1025780|NCT00256750|3345744|P3|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
1025781|NCT00256750|3345745|P2|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
1025782|NCT00256750|3345746|P1|Post-Transplant Treated (12 Months)|Lost to Follow-up|1
1025783|NCT00256750|3345744|P3|Post-Transplant Treated (12 Months)|Lack of Efficacy|27
1025784|NCT00256750|3345745|P2|Post-Transplant Treated (12 Months)|Lack of Efficacy|22
1025785|NCT00256750|3345746|P1|Post-Transplant Treated (12 Months)|Lack of Efficacy|10
1025786|NCT00256750|3345744|P3|Post-Transplant Treated (12 Months)|Death|4
1025787|NCT00256750|3345745|P2|Post-Transplant Treated (12 Months)|Death|2
1025788|NCT00256750|3345746|P1|Post-Transplant Treated (12 Months)|Death|3
1025789|NCT00256750|3345744|P3|Post-Transplant Treated (12 Months)|Adverse Event|8
1025790|NCT00256750|3345745|P2|Post-Transplant Treated (12 Months)|Adverse Event|12
1025791|NCT00256750|3345746|P1|Post-Transplant Treated (12 Months)|Adverse Event|20
1025792|NCT00256750|3345744|P3|Transplanted Pre-Treatment|Death|0
1025793|NCT00256750|3345745|P2|Transplanted Pre-Treatment|Death|0
1025794|NCT00256750|3345746|P1|Transplanted Pre-Treatment|Death|1
1025795|NCT00256750|3345744|P3|Transplanted Pre-Treatment|Not Specified|0
1025796|NCT00256750|3345745|P2|Transplanted Pre-Treatment|Not Specified|0
1025797|NCT00256750|3345746|P1|Transplanted Pre-Treatment|Not Specified|2
1025798|NCT00256750|3345744|P3|Transplanted Pre-Treatment|Withdrawal by Subject|0
1025799|NCT00256750|3345745|P2|Transplanted Pre-Treatment|Withdrawal by Subject|0
1025800|NCT00256750|3345746|P1|Transplanted Pre-Treatment|Withdrawal by Subject|3
1025801|NCT00256724|3345882|P2|Overall Study|Protocol Violation|3
1025802|NCT00256724|3345883|P1|Overall Study|Protocol Violation|3
1025803|NCT00256724|3345882|P2|Overall Study|Physician Decision|5
1025804|NCT00256724|3345883|P1|Overall Study|Physician Decision|2
1025805|NCT00256698|3345893|P2|Overall Study|Prematurely Discontinued|0
1025806|NCT00256698|3345894|P1|Overall Study|Prematurely Discontinued|1
1025807|NCT00256698|3345893|P2|Overall Study|withdrawn due to osteoporosis|0
1025808|NCT00256698|3345894|P1|Overall Study|withdrawn due to osteoporosis|1
1025809|NCT00256698|3345893|P2|Overall Study|still ongoing at data cut-off|46
1025810|NCT00256698|3345894|P1|Overall Study|still ongoing at data cut-off|41
1025811|NCT00256698|3345893|P2|Overall Study|disease progression|105
1025812|NCT00256698|3345894|P1|Overall Study|disease progression|97
1025813|NCT00256698|3345893|P2|Overall Study|Lost to Follow-up|3
1025814|NCT00256698|3345894|P1|Overall Study|Lost to Follow-up|1
1025815|NCT00256698|3345893|P2|Overall Study|Protocol Violation|5
1025816|NCT00256698|3345894|P1|Overall Study|Protocol Violation|6
1025817|NCT00256698|3345893|P2|Overall Study|Adverse Event|6
1025818|NCT00256698|3345894|P1|Overall Study|Adverse Event|13
1025819|NCT00256698|3345893|P2|Overall Study|Withdrawal by Subject|7
1025820|NCT00256698|3345894|P1|Overall Study|Withdrawal by Subject|7
1025821|NCT00256308|3345912|P1|Overall Study|Death|2
1025822|NCT00256295|3345920|P1|Overall Study|Death|1
1025823|NCT00256295|3345920|P1|Overall Study|Withdrawal by Subject|3
1025824|NCT00256282|3345926|P1|Overall Study|Physician Decision|1
1025825|NCT00256282|3345926|P1|Overall Study|Adverse Event|3
1025826|NCT00256282|3345926|P1|Overall Study|Disease progression, relapse during acti|12
1025827|NCT00256243|3345931|P1|Overall Study|Not treated|1
1025828|NCT00256243|3345931|P1|Overall Study|Death|7
1025829|NCT00256243|3345931|P1|Overall Study|Lost to Follow-up|2
1025830|NCT00256204|3345940|P4|Overall Study|Need for additional prohibited treatment|25
1025831|NCT00256204|3345941|P3|Overall Study|Need for additional prohibited treatment|27
1025832|NCT00256204|3345942|P2|Overall Study|Need for additional prohibited treatment|28
1025833|NCT00256204|3345943|P1|Overall Study|Need for additional prohibited treatment|38
1025834|NCT00256204|3345940|P4|Overall Study|Withdrawal by Subject|5
1025835|NCT00256204|3345941|P3|Overall Study|Withdrawal by Subject|7
1025836|NCT00256204|3345942|P2|Overall Study|Withdrawal by Subject|6
1025837|NCT00256204|3345943|P1|Overall Study|Withdrawal by Subject|17
1025838|NCT00256204|3345940|P4|Overall Study|Physician Decision|2
1025839|NCT00256204|3345941|P3|Overall Study|Physician Decision|1
1025840|NCT00256204|3345942|P2|Overall Study|Physician Decision|0
1025841|NCT00256204|3345943|P1|Overall Study|Physician Decision|0
1025842|NCT00256204|3345940|P4|Overall Study|Protocol Violation|1
1025843|NCT00256204|3345941|P3|Overall Study|Protocol Violation|2
1025844|NCT00256204|3345942|P2|Overall Study|Protocol Violation|0
1025845|NCT00256204|3345943|P1|Overall Study|Protocol Violation|1
1025846|NCT00256204|3345940|P4|Overall Study|Lost to Follow-up|2
1025847|NCT00256204|3345941|P3|Overall Study|Lost to Follow-up|1
1025848|NCT00256204|3345942|P2|Overall Study|Lost to Follow-up|1
1025849|NCT00256204|3345943|P1|Overall Study|Lost to Follow-up|1
1025850|NCT00256204|3345940|P4|Overall Study|Death|0
1025851|NCT00256204|3345941|P3|Overall Study|Death|0
1025852|NCT00256204|3345942|P2|Overall Study|Death|1
1025853|NCT00256204|3345943|P1|Overall Study|Death|0
1025854|NCT00256204|3345940|P4|Overall Study|Adverse Event|14
1025855|NCT00256204|3345941|P3|Overall Study|Adverse Event|16
1025856|NCT00256204|3345942|P2|Overall Study|Adverse Event|14
1025857|NCT00256204|3345943|P1|Overall Study|Adverse Event|10
1025858|NCT00256126|3345958|P2|Overall Study|Other|2
1025859|NCT00256126|3345959|P1|Overall Study|Other|1
1025860|NCT00256126|3345958|P2|Overall Study|Adverse Event|0
1025861|NCT00256126|3345959|P1|Overall Study|Adverse Event|1
1025862|NCT00255840|3345998|P2|Overall Study|Discontinued intervention|56
1025863|NCT00255840|3345999|P1|Overall Study|Discontinued intervention|53
1025864|NCT00255840|3345998|P2|Overall Study|Lost to Follow-up|14
1025865|NCT00255840|3345999|P1|Overall Study|Lost to Follow-up|10
1025866|NCT00255723|3346012|P2|Overall Study|Response Data Not Available|0
1025867|NCT00255723|3346013|P1|Overall Study|Response Data Not Available|1
1025868|NCT00255723|3346012|P2|Overall Study|Death|1
1025869|NCT00255723|3346013|P1|Overall Study|Death|0
1025870|NCT00255723|3346012|P2|Overall Study|Adverse Event|1
1025871|NCT00255723|3346013|P1|Overall Study|Adverse Event|1
1025872|NCT00255190|3346026|P2|Overall Study|Various|23
1025873|NCT00255190|3346027|P1|Overall Study|Various|4
1025874|NCT00255190|3346026|P2|Overall Study|Erosive esophagitis not healed|20
1025875|NCT00255190|3346027|P1|Overall Study|Erosive esophagitis not healed|0
1025876|NCT00255190|3346026|P2|Overall Study|Inclusion/Exclusion criteria not met|1
1025877|NCT00255190|3346027|P1|Overall Study|Inclusion/Exclusion criteria not met|0
1025878|NCT00255190|3346026|P2|Overall Study|Withdrew Consent|48
1025879|NCT00255190|3346027|P1|Overall Study|Withdrew Consent|17
1025880|NCT00255190|3346026|P2|Overall Study|Lost to Follow-up|27
1025881|NCT00255190|3346027|P1|Overall Study|Lost to Follow-up|10
1025882|NCT00255190|3346026|P2|Overall Study|Protocol Violation|2
1025883|NCT00255190|3346027|P1|Overall Study|Protocol Violation|2
1025884|NCT00255190|3346026|P2|Overall Study|Adverse Event|36
1025885|NCT00255190|3346027|P1|Overall Study|Adverse Event|17
1025886|NCT00255164|3346111|P3|Overall Study|Therapeutic Failure|3
1025887|NCT00255164|3346112|P2|Overall Study|Therapeutic Failure|2
1025888|NCT00255164|3346113|P1|Overall Study|Therapeutic Failure|11
1025889|NCT00255164|3346111|P3|Overall Study|Esophageal Stricture|1
1025890|NCT00255164|3346112|P2|Overall Study|Esophageal Stricture|0
1025891|NCT00255164|3346113|P1|Overall Study|Esophageal Stricture|0
1025892|NCT00255164|3346111|P3|Overall Study|Possible Barrett's Esophagus|8
1025893|NCT00255164|3346112|P2|Overall Study|Possible Barrett's Esophagus|3
1025894|NCT00255164|3346113|P1|Overall Study|Possible Barrett's Esophagus|1
1025895|NCT00255164|3346111|P3|Overall Study|Relapse of Erosive Esophagitis|12
1025896|NCT00255164|3346112|P2|Overall Study|Relapse of Erosive Esophagitis|16
1025897|NCT00255164|3346113|P1|Overall Study|Relapse of Erosive Esophagitis|78
1025898|NCT00255164|3346111|P3|Overall Study|Subject Request/Subject Unavailable|2
1025899|NCT00255164|3346112|P2|Overall Study|Subject Request/Subject Unavailable|1
1025900|NCT00255164|3346113|P1|Overall Study|Subject Request/Subject Unavailable|1
1025901|NCT00255164|3346111|P3|Overall Study|Noncompliance|2
1025902|NCT00255164|3346112|P2|Overall Study|Noncompliance|1
1025903|NCT00255164|3346113|P1|Overall Study|Noncompliance|0
1025904|NCT00255164|3346111|P3|Overall Study|Withdrawal by Subject|8
1025905|NCT00255164|3346112|P2|Overall Study|Withdrawal by Subject|17
1025906|NCT00255164|3346113|P1|Overall Study|Withdrawal by Subject|18
1025907|NCT00255164|3346111|P3|Overall Study|Lost to Follow-up|4
1025908|NCT00255164|3346112|P2|Overall Study|Lost to Follow-up|3
1025909|NCT00255164|3346113|P1|Overall Study|Lost to Follow-up|4
1025910|NCT00255164|3346111|P3|Overall Study|Adverse Event|9
1025911|NCT00255164|3346112|P2|Overall Study|Adverse Event|6
1025912|NCT00255164|3346113|P1|Overall Study|Adverse Event|10
1025913|NCT00255151|3346139|P3|Overall Study|Therapeutic Failure|3
1025914|NCT00255151|3346140|P2|Overall Study|Therapeutic Failure|2
1025915|NCT00255151|3346141|P1|Overall Study|Therapeutic Failure|11
1025916|NCT00255151|3346139|P3|Overall Study|Esophageal Stricture|1
1025917|NCT00255151|3346140|P2|Overall Study|Esophageal Stricture|0
1025918|NCT00255151|3346141|P1|Overall Study|Esophageal Stricture|0
1025919|NCT00255151|3346139|P3|Overall Study|Possible Barrett's Esophagus|8
1025920|NCT00255151|3346140|P2|Overall Study|Possible Barrett's Esophagus|3
1025921|NCT00255151|3346141|P1|Overall Study|Possible Barrett's Esophagus|1
1025922|NCT00255151|3346139|P3|Overall Study|Relapse of Erosive Esophagitis|12
1025923|NCT00255151|3346140|P2|Overall Study|Relapse of Erosive Esophagitis|16
1025924|NCT00255151|3346141|P1|Overall Study|Relapse of Erosive Esophagitis|78
1025925|NCT00255151|3346139|P3|Overall Study|Subject Request/Subject Unavailable|2
1025926|NCT00255151|3346140|P2|Overall Study|Subject Request/Subject Unavailable|1
1025927|NCT00255151|3346141|P1|Overall Study|Subject Request/Subject Unavailable|1
1025928|NCT00255151|3346139|P3|Overall Study|Noncompliance|2
1025929|NCT00255151|3346140|P2|Overall Study|Noncompliance|1
1025930|NCT00255151|3346141|P1|Overall Study|Noncompliance|0
1025931|NCT00255151|3346139|P3|Overall Study|Withdrawal by Subject|8
1025932|NCT00255151|3346140|P2|Overall Study|Withdrawal by Subject|17
1025933|NCT00255151|3346141|P1|Overall Study|Withdrawal by Subject|18
1025934|NCT00255151|3346139|P3|Overall Study|Lost to Follow-up|4
1025935|NCT00255151|3346140|P2|Overall Study|Lost to Follow-up|3
1025936|NCT00255151|3346141|P1|Overall Study|Lost to Follow-up|4
1025937|NCT00255151|3346139|P3|Overall Study|Adverse Event|9
1025938|NCT00255151|3346140|P2|Overall Study|Adverse Event|6
1025939|NCT00255151|3346141|P1|Overall Study|Adverse Event|10
1025940|NCT00255086|3346175|P2|Overall Study|Protocol Violation|1
1025941|NCT00255086|3346176|P1|Overall Study|Protocol Violation|1
1025942|NCT00255086|3346175|P2|Overall Study|Adverse Event|1
1025943|NCT00255086|3346176|P1|Overall Study|Adverse Event|1
1025944|NCT00255047|3346188|P4|Overall Study|Withdrawal by Subject|18
1025945|NCT00255047|3346189|P3|Overall Study|Withdrawal by Subject|25
1025946|NCT00255047|3346190|P2|Overall Study|Withdrawal by Subject|23
1025947|NCT00255047|3346191|P1|Overall Study|Withdrawal by Subject|24
1025948|NCT00255047|3346188|P4|Overall Study|Lost to Follow-up|6
1025949|NCT00255047|3346189|P3|Overall Study|Lost to Follow-up|5
1025950|NCT00255047|3346190|P2|Overall Study|Lost to Follow-up|8
1025951|NCT00255047|3346191|P1|Overall Study|Lost to Follow-up|9
1025952|NCT00255047|3346188|P4|Overall Study|Protocol Violation|20
1025953|NCT00255047|3346189|P3|Overall Study|Protocol Violation|16
1025954|NCT00255047|3346190|P2|Overall Study|Protocol Violation|13
1025955|NCT00255047|3346191|P1|Overall Study|Protocol Violation|13
1025956|NCT00255047|3346188|P4|Overall Study|Adverse Event|1
1025957|NCT00255047|3346189|P3|Overall Study|Adverse Event|2
1025958|NCT00255047|3346190|P2|Overall Study|Adverse Event|3
1025959|NCT00255047|3346191|P1|Overall Study|Adverse Event|0
1025960|NCT00255047|3346188|P4|Overall Study|Serious Adverse Events|1
1025961|NCT00255047|3346189|P3|Overall Study|Serious Adverse Events|2
1025962|NCT00255047|3346190|P2|Overall Study|Serious Adverse Events|1
1025963|NCT00255047|3346191|P1|Overall Study|Serious Adverse Events|2
1025964|NCT00255034|3346215|P2|Overall Study|Withdrawal by Subject|38
1025965|NCT00255034|3346216|P1|Overall Study|Withdrawal by Subject|15
1025966|NCT00255008|3346226|P4|Overall Study|Other|2
1025967|NCT00255008|3346227|P3|Overall Study|Other|3
1025968|NCT00255008|3346228|P2|Overall Study|Other|0
1025969|NCT00255008|3346229|P1|Overall Study|Other|7
1025970|NCT00255008|3346226|P4|Overall Study|Adverse lab experience|0
1025971|NCT00255008|3346227|P3|Overall Study|Adverse lab experience|0
1025972|NCT00255008|3346228|P2|Overall Study|Adverse lab experience|0
1025973|NCT00255008|3346229|P1|Overall Study|Adverse lab experience|1
1025974|NCT00255008|3346226|P4|Overall Study|Sponsor request|17
1025975|NCT00255008|3346227|P3|Overall Study|Sponsor request|8
1025976|NCT00255008|3346228|P2|Overall Study|Sponsor request|3
1025977|NCT00255008|3346229|P1|Overall Study|Sponsor request|18
1025978|NCT00255008|3346226|P4|Overall Study|Withdrew consent|0
1025979|NCT00255008|3346227|P3|Overall Study|Withdrew consent|2
1025980|NCT00255008|3346228|P2|Overall Study|Withdrew consent|0
1025981|NCT00255008|3346229|P1|Overall Study|Withdrew consent|0
1025982|NCT00255008|3346226|P4|Overall Study|Did not meet viral reduction criteria|1
1025983|NCT00255008|3346227|P3|Overall Study|Did not meet viral reduction criteria|0
1025984|NCT00255008|3346228|P2|Overall Study|Did not meet viral reduction criteria|5
1025985|NCT00255008|3346229|P1|Overall Study|Did not meet viral reduction criteria|4
1025986|NCT00255008|3346226|P4|Overall Study|Lost to Follow-up|2
1025987|NCT00255008|3346227|P3|Overall Study|Lost to Follow-up|1
1025988|NCT00255008|3346228|P2|Overall Study|Lost to Follow-up|0
1025989|NCT00255008|3346229|P1|Overall Study|Lost to Follow-up|1
1025990|NCT00255008|3346226|P4|Overall Study|Adverse Event|0
1025991|NCT00255008|3346227|P3|Overall Study|Adverse Event|2
1025992|NCT00255008|3346228|P2|Overall Study|Adverse Event|1
1025993|NCT00255008|3346229|P1|Overall Study|Adverse Event|1
1025994|NCT00254982|3346265|P2|Overall Study|Abnormal liver function tests|1
1025995|NCT00254982|3346266|P1|Overall Study|Abnormal liver function tests|2
1025996|NCT00254982|3346265|P2|Overall Study|Opportunistic infection|0
1025997|NCT00254982|3346266|P1|Overall Study|Opportunistic infection|1
1025998|NCT00254982|3346265|P2|Overall Study|Malignancy|2
1025999|NCT00254982|3346266|P1|Overall Study|Malignancy|0
1026000|NCT00254982|3346265|P2|Overall Study|Diagnosis of Tuberculosis|1
1026001|NCT00254982|3346266|P1|Overall Study|Diagnosis of Tuberculosis|1
1026002|NCT00254982|3346265|P2|Overall Study|Protocol deviation|1
1026003|NCT00254982|3346266|P1|Overall Study|Protocol deviation|1
1026004|NCT00254982|3346265|P2|Overall Study|Inclusion/exclusion criteria violation|2
1026005|NCT00254982|3346266|P1|Overall Study|Inclusion/exclusion criteria violation|0
1026006|NCT00254982|3346265|P2|Overall Study|Withdrawal by Subject|1
1026007|NCT00254982|3346266|P1|Overall Study|Withdrawal by Subject|1
1026008|NCT00254982|3346265|P2|Overall Study|Adverse Event|16
1026009|NCT00254982|3346266|P1|Overall Study|Adverse Event|18
1026010|NCT00254982|3346265|P2|Overall Study|Lost to Follow-up|3
1026011|NCT00254982|3346266|P1|Overall Study|Lost to Follow-up|5
1026012|NCT00254982|3346265|P2|Overall Study|Lack of Efficacy|3
1026013|NCT00254982|3346266|P1|Overall Study|Lack of Efficacy|5
1026014|NCT00254982|3346265|P2|Overall Study|Not specified|1
1026015|NCT00254982|3346266|P1|Overall Study|Not specified|2
1026016|NCT00254566|3346278|P2|Overall Study|Lost to Follow-up|2
1026017|NCT00254566|3346279|P1|Overall Study|Lost to Follow-up|7
1026018|NCT00254566|3346278|P2|Overall Study|Withdrawal by Subject|6
1026019|NCT00254566|3346279|P1|Overall Study|Withdrawal by Subject|5
1026020|NCT00254566|3346278|P2|Overall Study|Other|5
1026021|NCT00254566|3346279|P1|Overall Study|Other|1
1026022|NCT00254566|3346278|P2|Overall Study|Lack of Efficacy|9
1026023|NCT00254566|3346279|P1|Overall Study|Lack of Efficacy|12
1026024|NCT00254566|3346278|P2|Overall Study|Adverse Event|4
1026025|NCT00254566|3346279|P1|Overall Study|Adverse Event|5
1026026|NCT00254566|3346278|P2|Overall Study|Death|0
1026027|NCT00254566|3346279|P1|Overall Study|Death|1
1026028|NCT00254540|3346303|P2|Overall Study|Laboratory Test Abnormality|1
1026029|NCT00254540|3346304|P1|Overall Study|Laboratory Test Abnormality|0
1026030|NCT00254540|3346303|P2|Overall Study|Death|1
1026031|NCT00254540|3346304|P1|Overall Study|Death|0
1026032|NCT00254540|3346303|P2|Overall Study|Lack of Efficacy|13
1026033|NCT00254540|3346304|P1|Overall Study|Lack of Efficacy|13
1026034|NCT00254540|3346303|P2|Overall Study|Adverse Event|7
1026035|NCT00254540|3346304|P1|Overall Study|Adverse Event|6
1026036|NCT00254501|3346333|P2|Overall Study|Lost to Follow-up|1
1026037|NCT00254501|3346334|P1|Overall Study|Lost to Follow-up|1
1026038|NCT00254293|3346374|P7|LTE Open Label Fixed Dosing|not specified|1
1026039|NCT00254293|3346375|P6|LTE Open Label Fixed Dosing|not specified|0
1026040|NCT00254293|3346376|P5|LTE Open Label Fixed Dosing|not specified|0
1026041|NCT00254293|3346377|P4|LTE Open Label Fixed Dosing|not specified|0
1026042|NCT00254293|3346378|P3|LTE Open Label Fixed Dosing|not specified|0
1026043|NCT00254293|3346379|P2|LTE Open Label Fixed Dosing|not specified|0
1026044|NCT00254293|3346380|P1|LTE Open Label Fixed Dosing|not specified|0
1026045|NCT00254293|3346374|P7|LTE Open Label Fixed Dosing|Poor or non-compliance|1
1026046|NCT00254293|3346375|P6|LTE Open Label Fixed Dosing|Poor or non-compliance|0
1026047|NCT00254293|3346376|P5|LTE Open Label Fixed Dosing|Poor or non-compliance|0
1026048|NCT00254293|3346377|P4|LTE Open Label Fixed Dosing|Poor or non-compliance|0
1026049|NCT00254293|3346378|P3|LTE Open Label Fixed Dosing|Poor or non-compliance|0
1026050|NCT00254293|3346379|P2|LTE Open Label Fixed Dosing|Poor or non-compliance|0
1026051|NCT00254293|3346380|P1|LTE Open Label Fixed Dosing|Poor or non-compliance|0
1026052|NCT00254293|3346374|P7|LTE Open Label Fixed Dosing|Withdrawal by Subject|3
1026053|NCT00254293|3346375|P6|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
1026054|NCT00254293|3346376|P5|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
1026055|NCT00254293|3346377|P4|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
1026056|NCT00254293|3346378|P3|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
1026057|NCT00254293|3346379|P2|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
1026058|NCT00254293|3346380|P1|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
1026059|NCT00254293|3346374|P7|LTE Open Label Fixed Dosing|Lost to Follow-up|1
1026060|NCT00254293|3346375|P6|LTE Open Label Fixed Dosing|Lost to Follow-up|0
1026061|NCT00254293|3346376|P5|LTE Open Label Fixed Dosing|Lost to Follow-up|0
1026062|NCT00254293|3346377|P4|LTE Open Label Fixed Dosing|Lost to Follow-up|0
1026063|NCT00254293|3346378|P3|LTE Open Label Fixed Dosing|Lost to Follow-up|0
1026064|NCT00254293|3346379|P2|LTE Open Label Fixed Dosing|Lost to Follow-up|0
1026065|NCT00254293|3346380|P1|LTE Open Label Fixed Dosing|Lost to Follow-up|0
1026066|NCT00254293|3346374|P7|LTE Open Label Fixed Dosing|Lack of Efficacy|3
1026067|NCT00254293|3346375|P6|LTE Open Label Fixed Dosing|Lack of Efficacy|0
1026068|NCT00254293|3346376|P5|LTE Open Label Fixed Dosing|Lack of Efficacy|0
1026069|NCT00254293|3346377|P4|LTE Open Label Fixed Dosing|Lack of Efficacy|0
1026070|NCT00254293|3346378|P3|LTE Open Label Fixed Dosing|Lack of Efficacy|0
1026071|NCT00254293|3346379|P2|LTE Open Label Fixed Dosing|Lack of Efficacy|0
1026072|NCT00254293|3346380|P1|LTE Open Label Fixed Dosing|Lack of Efficacy|0
1026073|NCT00254293|3346374|P7|LTE Open Label Fixed Dosing|Adverse Event|1
1026074|NCT00254293|3346375|P6|LTE Open Label Fixed Dosing|Adverse Event|0
1026075|NCT00254293|3346376|P5|LTE Open Label Fixed Dosing|Adverse Event|0
1026076|NCT00254293|3346377|P4|LTE Open Label Fixed Dosing|Adverse Event|0
1026077|NCT00254293|3346378|P3|LTE Open Label Fixed Dosing|Adverse Event|0
1026078|NCT00254293|3346379|P2|LTE Open Label Fixed Dosing|Adverse Event|0
1026079|NCT00254293|3346380|P1|LTE Open Label Fixed Dosing|Adverse Event|0
1026080|NCT00254293|3346374|P7|LTE Open Label Fixed Dosing|Death|3
1026081|NCT00254293|3346375|P6|LTE Open Label Fixed Dosing|Death|0
1026082|NCT00254293|3346376|P5|LTE Open Label Fixed Dosing|Death|0
1026083|NCT00254293|3346377|P4|LTE Open Label Fixed Dosing|Death|0
1026084|NCT00254293|3346378|P3|LTE Open Label Fixed Dosing|Death|0
1026085|NCT00254293|3346379|P2|LTE Open Label Fixed Dosing|Death|0
1026086|NCT00254293|3346380|P1|LTE Open Label Fixed Dosing|Death|0
1026087|NCT00254293|3346374|P7|LTE Open Label Variable SC Dosing|not specified|0
1026088|NCT00254293|3346375|P6|LTE Open Label Variable SC Dosing|not specified|0
1026089|NCT00254293|3346376|P5|LTE Open Label Variable SC Dosing|not specified|0
1026090|NCT00254293|3346377|P4|LTE Open Label Variable SC Dosing|not specified|0
1026091|NCT00254293|3346378|P3|LTE Open Label Variable SC Dosing|not specified|2
1026092|NCT00254293|3346379|P2|LTE Open Label Variable SC Dosing|not specified|0
1026093|NCT00254293|3346380|P1|LTE Open Label Variable SC Dosing|not specified|0
1026094|NCT00254293|3346374|P7|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
1026095|NCT00254293|3346375|P6|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
1026096|NCT00254293|3346376|P5|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
1026097|NCT00254293|3346377|P4|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
1026098|NCT00254293|3346378|P3|LTE Open Label Variable SC Dosing|Poor or non-compliance|1
1026099|NCT00254293|3346379|P2|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
1026100|NCT00254293|3346380|P1|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
1026101|NCT00254293|3346374|P7|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
1026102|NCT00254293|3346375|P6|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
1026103|NCT00254293|3346376|P5|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
1026104|NCT00254293|3346377|P4|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
1026105|NCT00254293|3346378|P3|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1
1026106|NCT00254293|3346379|P2|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
1026107|NCT00254293|3346380|P1|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
1026108|NCT00254293|3346374|P7|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
1026109|NCT00254293|3346375|P6|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
1026110|NCT00254293|3346376|P5|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
1026190|NCT00253370|3346621|P1|Overall Study|Non-protocol therapy|1
1026111|NCT00254293|3346377|P4|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
1026112|NCT00254293|3346378|P3|LTE Open Label Variable SC Dosing|Lost to Follow-up|1
1026113|NCT00254293|3346379|P2|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
1026114|NCT00254293|3346380|P1|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
1026115|NCT00254293|3346374|P7|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
1026116|NCT00254293|3346375|P6|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
1026117|NCT00254293|3346376|P5|LTE Open Label Variable SC Dosing|Lack of Efficacy|1
1026118|NCT00254293|3346377|P4|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
1026119|NCT00254293|3346378|P3|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
1026120|NCT00254293|3346379|P2|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
1026121|NCT00254293|3346380|P1|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
1026122|NCT00254293|3346374|P7|LTE Open Label Variable SC Dosing|Adverse Event|0
1026123|NCT00254293|3346375|P6|LTE Open Label Variable SC Dosing|Adverse Event|0
1026124|NCT00254293|3346376|P5|LTE Open Label Variable SC Dosing|Adverse Event|1
1026125|NCT00254293|3346377|P4|LTE Open Label Variable SC Dosing|Adverse Event|0
1026126|NCT00254293|3346378|P3|LTE Open Label Variable SC Dosing|Adverse Event|2
1026127|NCT00254293|3346379|P2|LTE Open Label Variable SC Dosing|Adverse Event|0
1026128|NCT00254293|3346380|P1|LTE Open Label Variable SC Dosing|Adverse Event|1
1026129|NCT00254293|3346374|P7|LTE Open Label Variable SC Dosing|Death|0
1026130|NCT00254293|3346375|P6|LTE Open Label Variable SC Dosing|Death|0
1026131|NCT00254293|3346376|P5|LTE Open Label Variable SC Dosing|Death|0
1026132|NCT00254293|3346377|P4|LTE Open Label Variable SC Dosing|Death|0
1026133|NCT00254293|3346378|P3|LTE Open Label Variable SC Dosing|Death|1
1026134|NCT00254293|3346379|P2|LTE Open Label Variable SC Dosing|Death|0
1026135|NCT00254293|3346380|P1|LTE Open Label Variable SC Dosing|Death|0
1026136|NCT00254293|3346374|P7|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
1026137|NCT00254293|3346375|P6|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
1026138|NCT00254293|3346376|P5|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
1026139|NCT00254293|3346377|P4|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
1026140|NCT00254293|3346378|P3|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2
1026141|NCT00254293|3346379|P2|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
1026142|NCT00254293|3346380|P1|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
1026143|NCT00254293|3346374|P7|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
1026144|NCT00254293|3346375|P6|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
1026145|NCT00254293|3346376|P5|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
1026146|NCT00254293|3346377|P4|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
1026147|NCT00254293|3346378|P3|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1
1026148|NCT00254293|3346379|P2|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
1026149|NCT00254293|3346380|P1|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
1026150|NCT00254293|3346374|P7|Short Term (12 Week) Randomized Dosing|Adverse Event|0
1026151|NCT00254293|3346375|P6|Short Term (12 Week) Randomized Dosing|Adverse Event|0
1026152|NCT00254293|3346376|P5|Short Term (12 Week) Randomized Dosing|Adverse Event|0
1026153|NCT00254293|3346377|P4|Short Term (12 Week) Randomized Dosing|Adverse Event|1
1026154|NCT00254293|3346378|P3|Short Term (12 Week) Randomized Dosing|Adverse Event|0
1026155|NCT00254293|3346379|P2|Short Term (12 Week) Randomized Dosing|Adverse Event|1
1026156|NCT00254293|3346380|P1|Short Term (12 Week) Randomized Dosing|Adverse Event|0
1026157|NCT00254163|3346463|P2|Overall Study|Other|8
1026158|NCT00254163|3346464|P1|Overall Study|Other|8
1026159|NCT00254163|3346463|P2|Overall Study|Death|1
1026160|NCT00254163|3346464|P1|Overall Study|Death|0
1026161|NCT00254163|3346463|P2|Overall Study|Progressive disease|1
1026162|NCT00254163|3346464|P1|Overall Study|Progressive disease|0
1026163|NCT00254163|3346463|P2|Overall Study|Failed entry|3
1026164|NCT00254163|3346464|P1|Overall Study|Failed entry|1
1026165|NCT00254163|3346463|P2|Overall Study|Investigator request|3
1026166|NCT00254163|3346464|P1|Overall Study|Investigator request|1
1026167|NCT00254163|3346463|P2|Overall Study|Patient request/withdrew consent|4
1026168|NCT00254163|3346464|P1|Overall Study|Patient request/withdrew consent|6
1026169|NCT00254163|3346463|P2|Overall Study|Adverse Event|26
1026170|NCT00254163|3346464|P1|Overall Study|Adverse Event|29
1026171|NCT00253747|3346515|P2|Overall Study|Administrative Discharge (1), Other (2)|2
1026172|NCT00253747|3346516|P1|Overall Study|Administrative Discharge (1), Other (2)|1
1026173|NCT00253747|3346515|P2|Overall Study|Withdrawal by Subject|11
1026174|NCT00253747|3346516|P1|Overall Study|Withdrawal by Subject|10
1026175|NCT00253747|3346515|P2|Overall Study|Lost to Follow-up|14
1026176|NCT00253747|3346516|P1|Overall Study|Lost to Follow-up|13
1026177|NCT00253643|3346569|P4|Overall Study|Non-Compliance|2
1026178|NCT00253643|3346570|P3|Overall Study|Non-Compliance|0
1026179|NCT00253643|3346571|P2|Overall Study|Non-Compliance|0
1026180|NCT00253643|3346572|P1|Overall Study|Non-Compliance|0
1026181|NCT00253643|3346569|P4|Overall Study|Withdrawal by Subject|1
1026182|NCT00253643|3346570|P3|Overall Study|Withdrawal by Subject|1
1026183|NCT00253643|3346571|P2|Overall Study|Withdrawal by Subject|0
1026184|NCT00253643|3346572|P1|Overall Study|Withdrawal by Subject|0
1026185|NCT00253630|3346586|P1|Overall Study|ineligible|2
1026186|NCT00253448|3346602|P1|Overall Study|Withdrawal by Subject|1
1026187|NCT00253370|3346621|P1|Overall Study|Abdominal pain due to disease|1
1026188|NCT00253370|3346621|P1|Overall Study|Protocol Violation|1
1026189|NCT00253370|3346621|P1|Overall Study|Physician Decision|1
1026191|NCT00253370|3346621|P1|Overall Study|Withdrawal by Subject|6
1026192|NCT00253370|3346621|P1|Overall Study|Death|2
1026193|NCT00253370|3346621|P1|Overall Study|Disease progression|13
1026194|NCT00253370|3346621|P1|Overall Study|Adverse Event|18
1026195|NCT00252733|3346667|P2|Overall Study|Multiple Reasons|14
1026196|NCT00252733|3346668|P1|Overall Study|Multiple Reasons|14
1026197|NCT00252733|3346667|P2|Overall Study|Lost to Follow-up|6
1026198|NCT00252733|3346668|P1|Overall Study|Lost to Follow-up|12
1026199|NCT00252733|3346667|P2|Overall Study|Death|5
1026200|NCT00252733|3346668|P1|Overall Study|Death|7
1026201|NCT00252733|3346667|P2|Overall Study|Withdrawal by Subject|67
1026202|NCT00252733|3346668|P1|Overall Study|Withdrawal by Subject|73
1026203|NCT00252720|3346678|P2|Overall Study|Mainly patients lost to follow-up|18
1026204|NCT00252720|3346679|P1|Overall Study|Mainly patients lost to follow-up|7
1026205|NCT00252720|3346678|P2|Overall Study|Moving|42
1026206|NCT00252720|3346679|P1|Overall Study|Moving|23
1026207|NCT00252720|3346678|P2|Overall Study|Death|8
1026208|NCT00252720|3346679|P1|Overall Study|Death|7
1026209|NCT00252720|3346678|P2|Overall Study|Withdrawal by Subject|97
1026210|NCT00252720|3346679|P1|Overall Study|Withdrawal by Subject|95
1026211|NCT00252694|3346693|P2|Overall Study|Patient Moving|16
1026212|NCT00252694|3346694|P1|Overall Study|Patient Moving|17
1026213|NCT00252694|3346693|P2|Overall Study|Mostly Lost to Follow Up|13
1026214|NCT00252694|3346694|P1|Overall Study|Mostly Lost to Follow Up|8
1026215|NCT00252694|3346693|P2|Overall Study|Death|34
1026216|NCT00252694|3346694|P1|Overall Study|Death|36
1026217|NCT00252694|3346693|P2|Overall Study|Withdrawal by Subject|91
1026218|NCT00252694|3346694|P1|Overall Study|Withdrawal by Subject|83
1026219|NCT00252564|3346742|P2|Overall Study|Withdrawal by Subject|2
1026220|NCT00252564|3346743|P1|Overall Study|Withdrawal by Subject|0
1026221|NCT00252564|3346742|P2|Overall Study|Patient Request|5
1026222|NCT00252564|3346743|P1|Overall Study|Patient Request|4
1026223|NCT00252564|3346742|P2|Overall Study|Lost to Follow-up|0
1026224|NCT00252564|3346743|P1|Overall Study|Lost to Follow-up|1
1026225|NCT00252564|3346742|P2|Overall Study|Physician Decision|0
1026226|NCT00252564|3346743|P1|Overall Study|Physician Decision|1
1026227|NCT00252564|3346742|P2|Overall Study|Protocol Violation|0
1026228|NCT00252564|3346743|P1|Overall Study|Protocol Violation|0
1026229|NCT00252564|3346742|P2|Overall Study|Death|3
1026230|NCT00252564|3346743|P1|Overall Study|Death|0
1026231|NCT00252564|3346742|P2|Overall Study|Disease Progression|20
1026232|NCT00252564|3346743|P1|Overall Study|Disease Progression|14
1026233|NCT00252564|3346742|P2|Overall Study|Unrelated Complication|1
1026234|NCT00252564|3346743|P1|Overall Study|Unrelated Complication|2
1026235|NCT00252564|3346742|P2|Overall Study|Adverse Event|13
1026236|NCT00252564|3346743|P1|Overall Study|Adverse Event|17
1026237|NCT00252499|3346783|P3|Overall Study|Lost to Follow-up|0
1026238|NCT00252499|3346784|P2|Overall Study|Lost to Follow-up|0
1026239|NCT00252499|3346785|P1|Overall Study|Lost to Follow-up|1
1026240|NCT00252239|3346817|P4|Overall Study|Lost to Follow-up|0
1026241|NCT00252239|3346818|P3|Overall Study|Lost to Follow-up|2
1026242|NCT00252239|3346819|P2|Overall Study|Lost to Follow-up|0
1026243|NCT00252239|3346820|P1|Overall Study|Lost to Follow-up|0
1026244|NCT00252239|3346817|P4|Overall Study|Withdrawal by Subject|1
1026245|NCT00252239|3346818|P3|Overall Study|Withdrawal by Subject|0
1026246|NCT00252239|3346819|P2|Overall Study|Withdrawal by Subject|0
1026247|NCT00252239|3346820|P1|Overall Study|Withdrawal by Subject|1
1026248|NCT00252187|3346832|P2|Overall Study|Withdrawal by Subject|0
1026249|NCT00252187|3346833|P1|Overall Study|Withdrawal by Subject|1
1026250|NCT00252187|3346832|P2|Overall Study|Adverse Event|1
1026251|NCT00252187|3346833|P1|Overall Study|Adverse Event|3
1026252|NCT00252174|3346856|P3|Overall Study|Withdrawal by Subject|0
1026253|NCT00252174|3346857|P2|Overall Study|Withdrawal by Subject|1
1026254|NCT00252174|3346858|P1|Overall Study|Withdrawal by Subject|0
1026255|NCT00252057|3346898|P2|Overall Study|Participant previously enrolled|1
1026256|NCT00252057|3346899|P1|Overall Study|Participant previously enrolled|0
1026257|NCT00252057|3346898|P2|Overall Study|Death|2
1026258|NCT00252057|3346899|P1|Overall Study|Death|1
1026259|NCT00252057|3346898|P2|Overall Study|Withdrawal by Subject|5
1026260|NCT00252057|3346899|P1|Overall Study|Withdrawal by Subject|2
1026261|NCT00251979|3346907|P2|Overall Study|Death|5
1026262|NCT00251979|3346908|P1|Overall Study|Death|3
1026263|NCT00251979|3346907|P2|Overall Study|Lost to Follow-up|6
1026264|NCT00251979|3346908|P1|Overall Study|Lost to Follow-up|8
1026265|NCT00251979|3346907|P2|Overall Study|Withdrawal by Subject|7
1026266|NCT00251979|3346908|P1|Overall Study|Withdrawal by Subject|13
1026267|NCT00251979|3346907|P2|Overall Study|Adverse Event|17
1026268|NCT00251979|3346908|P1|Overall Study|Adverse Event|11
1026269|NCT00251979|3346907|P2|Overall Study|Protocol Violation|5
1026270|NCT00251979|3346908|P1|Overall Study|Protocol Violation|3
1026271|NCT00251927|3346940|P2|Overall Study|Study procedure non-compliance|6
1026272|NCT00251927|3346941|P1|Overall Study|Study procedure non-compliance|5
1026273|NCT00251927|3346940|P2|Overall Study|Study-specific discont. achieved|2
1026274|NCT00251927|3346941|P1|Overall Study|Study-specific discont. achieved|13
1026275|NCT00251927|3346940|P2|Overall Study|Withdrawal by Subject|25
1026276|NCT00251927|3346941|P1|Overall Study|Withdrawal by Subject|40
1026277|NCT00251927|3346940|P2|Overall Study|Pregnancy|0
1026278|NCT00251927|3346941|P1|Overall Study|Pregnancy|2
1026279|NCT00251927|3346940|P2|Overall Study|Protocol Violation|2
1026280|NCT00251927|3346941|P1|Overall Study|Protocol Violation|1
1026281|NCT00251927|3346940|P2|Overall Study|Lost to Follow-up|8
1026282|NCT00251927|3346941|P1|Overall Study|Lost to Follow-up|22
1026283|NCT00251927|3346940|P2|Overall Study|Lack of Efficacy|16
1026284|NCT00251927|3346941|P1|Overall Study|Lack of Efficacy|22
1026285|NCT00251927|3346940|P2|Overall Study|Adverse Event|15
1026286|NCT00251927|3346941|P1|Overall Study|Adverse Event|3
1026287|NCT00251758|3346993|P3|Overall Study|Per Investigator Request|0
1026288|NCT00251758|3346994|P2|Overall Study|Per Investigator Request|0
1026289|NCT00251758|3346995|P1|Overall Study|Per Investigator Request|1
1026290|NCT00251758|3346993|P3|Overall Study|Per Subject Request|1
1026291|NCT00251758|3346994|P2|Overall Study|Per Subject Request|0
1026292|NCT00251758|3346995|P1|Overall Study|Per Subject Request|0
1026293|NCT00251758|3346993|P3|Overall Study|Pregnancy|0
1026294|NCT00251758|3346994|P2|Overall Study|Pregnancy|1
1026295|NCT00251758|3346995|P1|Overall Study|Pregnancy|0
1026296|NCT00251758|3346993|P3|Overall Study|Noncompliant|2
1026297|NCT00251758|3346994|P2|Overall Study|Noncompliant|2
1026298|NCT00251758|3346995|P1|Overall Study|Noncompliant|0
1026299|NCT00251758|3346993|P3|Overall Study|Lack of Efficacy|0
1026300|NCT00251758|3346994|P2|Overall Study|Lack of Efficacy|0
1026301|NCT00251758|3346995|P1|Overall Study|Lack of Efficacy|3
1026302|NCT00251758|3346993|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
1026303|NCT00251758|3346994|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
1026304|NCT00251758|3346995|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
1026305|NCT00251758|3346993|P3|Overall Study|Withdrawal by Subject|3
1026306|NCT00251758|3346994|P2|Overall Study|Withdrawal by Subject|7
1026307|NCT00251758|3346995|P1|Overall Study|Withdrawal by Subject|13
1026308|NCT00251758|3346993|P3|Overall Study|Lost to Follow-up|5
1026309|NCT00251758|3346994|P2|Overall Study|Lost to Follow-up|2
1026310|NCT00251758|3346995|P1|Overall Study|Lost to Follow-up|4
1026311|NCT00251758|3346993|P3|Overall Study|Adverse Event|11
1026312|NCT00251758|3346994|P2|Overall Study|Adverse Event|9
1026313|NCT00251758|3346995|P1|Overall Study|Adverse Event|7
1026314|NCT00251745|3347015|P3|Overall Study|Per Investigator Request|0
1026315|NCT00251745|3347016|P2|Overall Study|Per Investigator Request|0
1026316|NCT00251745|3347017|P1|Overall Study|Per Investigator Request|1
1026317|NCT00251745|3347015|P3|Overall Study|Per Subject Request|1
1026318|NCT00251745|3347016|P2|Overall Study|Per Subject Request|0
1026319|NCT00251745|3347017|P1|Overall Study|Per Subject Request|0
1026320|NCT00251745|3347015|P3|Overall Study|Pregnancy|0
1026321|NCT00251745|3347016|P2|Overall Study|Pregnancy|1
1026322|NCT00251745|3347017|P1|Overall Study|Pregnancy|0
1026323|NCT00251745|3347015|P3|Overall Study|Noncompliant|2
1026324|NCT00251745|3347016|P2|Overall Study|Noncompliant|2
1026325|NCT00251745|3347017|P1|Overall Study|Noncompliant|0
1026326|NCT00251745|3347015|P3|Overall Study|Lack of Efficacy|0
1026327|NCT00251745|3347016|P2|Overall Study|Lack of Efficacy|0
1026328|NCT00251745|3347017|P1|Overall Study|Lack of Efficacy|3
1026329|NCT00251745|3347015|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
1026330|NCT00251745|3347016|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
1026331|NCT00251745|3347017|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
1026332|NCT00251745|3347015|P3|Overall Study|Withdrawal by Subject|3
1026333|NCT00251745|3347016|P2|Overall Study|Withdrawal by Subject|7
1026334|NCT00251745|3347017|P1|Overall Study|Withdrawal by Subject|13
1026335|NCT00251745|3347015|P3|Overall Study|Lost to Follow-up|5
1026336|NCT00251745|3347016|P2|Overall Study|Lost to Follow-up|2
1026337|NCT00251745|3347017|P1|Overall Study|Lost to Follow-up|4
1026338|NCT00251745|3347015|P3|Overall Study|Adverse Event|11
1026339|NCT00251745|3347016|P2|Overall Study|Adverse Event|9
1026340|NCT00251745|3347017|P1|Overall Study|Adverse Event|7
1026341|NCT00251719|3347037|P3|Overall Study|Barrett's esophagus|0
1026342|NCT00251719|3347038|P2|Overall Study|Barrett's esophagus|2
1026343|NCT00251719|3347039|P1|Overall Study|Barrett's esophagus|2
1026344|NCT00251719|3347037|P3|Overall Study|Noncompliance|1
1026345|NCT00251719|3347038|P2|Overall Study|Noncompliance|3
1026346|NCT00251719|3347039|P1|Overall Study|Noncompliance|2
1026347|NCT00251719|3347037|P3|Overall Study|Investigator decision|0
1026348|NCT00251719|3347038|P2|Overall Study|Investigator decision|1
1026349|NCT00251719|3347039|P1|Overall Study|Investigator decision|1
1026350|NCT00251719|3347037|P3|Overall Study|Inclusion/exclusion criteria not met|2
1026351|NCT00251719|3347038|P2|Overall Study|Inclusion/exclusion criteria not met|6
1026352|NCT00251719|3347039|P1|Overall Study|Inclusion/exclusion criteria not met|12
1026353|NCT00251719|3347037|P3|Overall Study|Lack of Efficacy|0
1026354|NCT00251719|3347038|P2|Overall Study|Lack of Efficacy|1
1026355|NCT00251719|3347039|P1|Overall Study|Lack of Efficacy|2
1026356|NCT00251719|3347037|P3|Overall Study|Withdrawal by Subject|11
1026357|NCT00251719|3347038|P2|Overall Study|Withdrawal by Subject|12
1026358|NCT00251719|3347039|P1|Overall Study|Withdrawal by Subject|14
1026359|NCT00251719|3347037|P3|Overall Study|Lost to Follow-up|8
1026360|NCT00251719|3347038|P2|Overall Study|Lost to Follow-up|11
1026361|NCT00251719|3347039|P1|Overall Study|Lost to Follow-up|5
1026362|NCT00251719|3347037|P3|Overall Study|Protocol Violation|1
1026363|NCT00251719|3347038|P2|Overall Study|Protocol Violation|1
1026364|NCT00251719|3347039|P1|Overall Study|Protocol Violation|1
1026365|NCT00251719|3347037|P3|Overall Study|Adverse Event|7
1026366|NCT00251719|3347038|P2|Overall Study|Adverse Event|8
1026367|NCT00251719|3347039|P1|Overall Study|Adverse Event|14
1026368|NCT00251693|3347065|P3|Overall Study|Abnormal laboratory findings|1
1026369|NCT00251693|3347066|P2|Overall Study|Abnormal laboratory findings|0
1026370|NCT00251693|3347067|P1|Overall Study|Abnormal laboratory findings|0
1026371|NCT00251693|3347065|P3|Overall Study|Subject request/subject unavailable|0
1026372|NCT00251693|3347066|P2|Overall Study|Subject request/subject unavailable|2
1026373|NCT00251693|3347067|P1|Overall Study|Subject request/subject unavailable|1
1026374|NCT00251693|3347065|P3|Overall Study|Possible Barrett's esophagus|2
1026375|NCT00251693|3347066|P2|Overall Study|Possible Barrett's esophagus|5
1026376|NCT00251693|3347067|P1|Overall Study|Possible Barrett's esophagus|3
1026377|NCT00251693|3347065|P3|Overall Study|Noncompliant|2
1026378|NCT00251693|3347066|P2|Overall Study|Noncompliant|0
1026379|NCT00251693|3347067|P1|Overall Study|Noncompliant|0
1026380|NCT00251693|3347065|P3|Overall Study|Inclusion/exclusion criteria not met|8
1026381|NCT00251693|3347066|P2|Overall Study|Inclusion/exclusion criteria not met|3
1026382|NCT00251693|3347067|P1|Overall Study|Inclusion/exclusion criteria not met|5
1026383|NCT00251693|3347065|P3|Overall Study|Lack of Efficacy|0
1026384|NCT00251693|3347066|P2|Overall Study|Lack of Efficacy|1
1026385|NCT00251693|3347067|P1|Overall Study|Lack of Efficacy|0
1026386|NCT00251693|3347065|P3|Overall Study|Withdrawal by Subject|14
1026387|NCT00251693|3347066|P2|Overall Study|Withdrawal by Subject|17
1026388|NCT00251693|3347067|P1|Overall Study|Withdrawal by Subject|11
1026389|NCT00251693|3347065|P3|Overall Study|Lost to Follow-up|8
1026390|NCT00251693|3347066|P2|Overall Study|Lost to Follow-up|7
1026391|NCT00251693|3347067|P1|Overall Study|Lost to Follow-up|12
1026392|NCT00251693|3347065|P3|Overall Study|Protocol Violation|2
1026393|NCT00251693|3347066|P2|Overall Study|Protocol Violation|0
1026394|NCT00251693|3347067|P1|Overall Study|Protocol Violation|2
1026395|NCT00251693|3347065|P3|Overall Study|Adverse Event|9
1026396|NCT00251693|3347066|P2|Overall Study|Adverse Event|9
1026397|NCT00251693|3347067|P1|Overall Study|Adverse Event|17
1026398|NCT00251641|3347092|P2|Overall Study|Switched Treatment|63
1026399|NCT00251641|3347093|P1|Overall Study|Switched Treatment|9
1026400|NCT00251641|3347092|P2|Overall Study|Did not Meet protocol Eligibility|1
1026401|NCT00251641|3347093|P1|Overall Study|Did not Meet protocol Eligibility|2
1026402|NCT00251641|3347092|P2|Overall Study|Protocol Violation|2
1026403|NCT00251641|3347093|P1|Overall Study|Protocol Violation|10
1026404|NCT00251641|3347092|P2|Overall Study|Withdrawal by Subject|8
1026405|NCT00251641|3347093|P1|Overall Study|Withdrawal by Subject|6
1026406|NCT00251641|3347092|P2|Overall Study|Lost to Follow-up|3
1026407|NCT00251641|3347093|P1|Overall Study|Lost to Follow-up|3
1026408|NCT00251641|3347092|P2|Overall Study|Progression of Disease|2
1026409|NCT00251641|3347093|P1|Overall Study|Progression of Disease|0
1026410|NCT00251641|3347092|P2|Overall Study|Lack of Efficacy|1
1026411|NCT00251641|3347093|P1|Overall Study|Lack of Efficacy|2
1026412|NCT00251641|3347092|P2|Overall Study|Adverse Event|8
1026413|NCT00251641|3347093|P1|Overall Study|Adverse Event|80
1026414|NCT00251589|3347111|P4|Overall Study|Discontinued due to progressive disease|1
1026415|NCT00251589|3347112|P3|Overall Study|Discontinued due to progressive disease|0
1026416|NCT00251589|3347113|P2|Overall Study|Discontinued due to progressive disease|1
1026417|NCT00251589|3347114|P1|Overall Study|Discontinued due to progressive disease|9
1026418|NCT00251589|3347111|P4|Overall Study|Withdrawal by Subject|0
1026419|NCT00251589|3347112|P3|Overall Study|Withdrawal by Subject|0
1026420|NCT00251589|3347113|P2|Overall Study|Withdrawal by Subject|1
1026421|NCT00251589|3347114|P1|Overall Study|Withdrawal by Subject|1
1026422|NCT00251589|3347111|P4|Overall Study|Adverse Event|1
1026423|NCT00251589|3347112|P3|Overall Study|Adverse Event|2
1026424|NCT00251589|3347113|P2|Overall Study|Adverse Event|1
1026425|NCT00251589|3347114|P1|Overall Study|Adverse Event|5
1026426|NCT00251316|3347151|P2|Overall Study|Physician Decision|3
1026427|NCT00251316|3347152|P1|Overall Study|Physician Decision|2
1026428|NCT00251004|3347191|P3|Overall Study|Graft Loss|8
1026429|NCT00251004|3347192|P2|Overall Study|Graft Loss|13
1026430|NCT00251004|3347193|P1|Overall Study|Graft Loss|12
1026431|NCT00251004|3347191|P3|Overall Study|Lost to Follow-up|1
1026432|NCT00251004|3347192|P2|Overall Study|Lost to Follow-up|2
1026433|NCT00251004|3347193|P1|Overall Study|Lost to Follow-up|1
1026434|NCT00251004|3347191|P3|Overall Study|Death|8
1026435|NCT00251004|3347192|P2|Overall Study|Death|10
1026436|NCT00251004|3347193|P1|Overall Study|Death|9
1026437|NCT00251004|3347191|P3|Overall Study|Withdrawal by Subject|14
1026438|NCT00251004|3347192|P2|Overall Study|Withdrawal by Subject|16
1026439|NCT00251004|3347193|P1|Overall Study|Withdrawal by Subject|23
1026440|NCT00250835|3347217|P1|Overall Study|Withdrawal by Subject|1
1026441|NCT00250718|3347226|P1|Overall Study|Withdrawal by Subject|1
1026442|NCT00250718|3347226|P1|Overall Study|Adverse Event|1
1026443|NCT00250718|3347226|P1|Overall Study|Death|1
1026444|NCT00250705|3347231|P1|Overall Study|Lack of Efficacy|2
1026445|NCT00250679|3347242|P3|Overall Study|various single events: hip surgery,diary|1
1026446|NCT00250679|3347243|P2|Overall Study|various single events: hip surgery,diary|1
1026447|NCT00250679|3347244|P1|Overall Study|various single events: hip surgery,diary|3
1026448|NCT00250679|3347242|P3|Overall Study|Non-compliance|0
1026449|NCT00250679|3347243|P2|Overall Study|Non-compliance|1
1026450|NCT00250679|3347244|P1|Overall Study|Non-compliance|1
1026451|NCT00250679|3347242|P3|Overall Study|Moved|0
1026452|NCT00250679|3347243|P2|Overall Study|Moved|1
1026453|NCT00250679|3347244|P1|Overall Study|Moved|1
1026454|NCT00250679|3347242|P3|Overall Study|Technical Holter issues|2
1026455|NCT00250679|3347243|P2|Overall Study|Technical Holter issues|0
1026456|NCT00250679|3347244|P1|Overall Study|Technical Holter issues|1
1026457|NCT00250679|3347242|P3|Overall Study|Lack of Efficacy|3
1026458|NCT00250679|3347243|P2|Overall Study|Lack of Efficacy|1
1026459|NCT00250679|3347244|P1|Overall Study|Lack of Efficacy|0
1026460|NCT00250679|3347242|P3|Overall Study|Does Not Meet Entry Criteria|2
1026461|NCT00250679|3347243|P2|Overall Study|Does Not Meet Entry Criteria|4
1026462|NCT00250679|3347244|P1|Overall Study|Does Not Meet Entry Criteria|1
1026463|NCT00250679|3347242|P3|Overall Study|Lost to Follow-up|2
1026464|NCT00250679|3347243|P2|Overall Study|Lost to Follow-up|4
1026465|NCT00250679|3347244|P1|Overall Study|Lost to Follow-up|3
1026466|NCT00250679|3347242|P3|Overall Study|Withdrawal by Subject|15
1026467|NCT00250679|3347243|P2|Overall Study|Withdrawal by Subject|18
1026468|NCT00250679|3347244|P1|Overall Study|Withdrawal by Subject|15
1026469|NCT00250679|3347242|P3|Overall Study|Protocol Violation|3
1026470|NCT00250679|3347243|P2|Overall Study|Protocol Violation|4
1026471|NCT00250679|3347244|P1|Overall Study|Protocol Violation|2
1026472|NCT00250679|3347242|P3|Overall Study|Adverse Event|16
1026473|NCT00250679|3347243|P2|Overall Study|Adverse Event|15
1026474|NCT00250679|3347244|P1|Overall Study|Adverse Event|12
1026475|NCT00250588|3347345|P3|Overall Study|Lost to Follow-up|13
1026476|NCT00250588|3347346|P2|Overall Study|Lost to Follow-up|13
1026477|NCT00250588|3347347|P1|Overall Study|Lost to Follow-up|6
1026478|NCT00250588|3347345|P3|Overall Study|Withdrawal by Subject|0
1026479|NCT00250588|3347346|P2|Overall Study|Withdrawal by Subject|6
1026480|NCT00250588|3347347|P1|Overall Study|Withdrawal by Subject|3
1026481|NCT00250458|3347395|P2|Overall Study|Not Specified|0
1026482|NCT00250458|3347396|P1|Overall Study|Not Specified|1
1026483|NCT00250458|3347395|P2|Overall Study|Qualifying migraine but did not treat|3
1026484|NCT00250458|3347396|P1|Overall Study|Qualifying migraine but did not treat|3
1026485|NCT00250458|3347395|P2|Overall Study|Lack of Migraine Attack|9
1026486|NCT00250458|3347396|P1|Overall Study|Lack of Migraine Attack|20
1026487|NCT00250458|3347395|P2|Overall Study|Withdrawal by Subject|2
1026488|NCT00250458|3347396|P1|Overall Study|Withdrawal by Subject|4
1026489|NCT00250458|3347395|P2|Overall Study|Protocol Violation|1
1026490|NCT00250458|3347396|P1|Overall Study|Protocol Violation|0
1026491|NCT00250458|3347395|P2|Overall Study|Lost to Follow-up|2
1026492|NCT00250458|3347396|P1|Overall Study|Lost to Follow-up|4
1026493|NCT00250432|3347406|P2|Overall Study|Pt was considered untreatable|1
1026494|NCT00250432|3347407|P1|Overall Study|Pt was considered untreatable|0
1026495|NCT00250432|3347406|P2|Overall Study|Pt died out of posttherapy report period|5
1026496|NCT00250432|3347407|P1|Overall Study|Pt died out of posttherapy report period|6
1026497|NCT00250432|3347406|P2|Overall Study|Withdrawal by Subject|2
1026498|NCT00250432|3347407|P1|Overall Study|Withdrawal by Subject|6
1026499|NCT00250432|3347406|P2|Overall Study|Protocol Violation|3
1026500|NCT00250432|3347407|P1|Overall Study|Protocol Violation|0
1026501|NCT00250432|3347406|P2|Overall Study|Patient Moved|1
1026502|NCT00250432|3347407|P1|Overall Study|Patient Moved|0
1026503|NCT00250432|3347406|P2|Overall Study|Lost to Follow-up|5
1026504|NCT00250432|3347407|P1|Overall Study|Lost to Follow-up|6
1026505|NCT00250432|3347406|P2|Overall Study|Lack of Efficacy|1
1026506|NCT00250432|3347407|P1|Overall Study|Lack of Efficacy|2
1026507|NCT00250432|3347406|P2|Overall Study|Adverse Event|29
1026508|NCT00250432|3347407|P1|Overall Study|Adverse Event|25
1026509|NCT00250276|3347419|P4|Overall Study|Lost to Follow-up|8
1026510|NCT00250276|3347420|P3|Overall Study|Lost to Follow-up|13
1026511|NCT00250276|3347421|P2|Overall Study|Lost to Follow-up|18
1026512|NCT00250276|3347422|P1|Overall Study|Lost to Follow-up|11
1026513|NCT00250276|3347419|P4|Overall Study|Migrated/moved from study area|7
1026514|NCT00250276|3347420|P3|Overall Study|Migrated/moved from study area|2
1026515|NCT00250276|3347421|P2|Overall Study|Migrated/moved from study area|0
1026516|NCT00250276|3347422|P1|Overall Study|Migrated/moved from study area|3
1026517|NCT00250276|3347419|P4|Overall Study|Withdrawal by Subject|2
1026518|NCT00250276|3347420|P3|Overall Study|Withdrawal by Subject|3
1026519|NCT00250276|3347421|P2|Overall Study|Withdrawal by Subject|2
1026520|NCT00250276|3347422|P1|Overall Study|Withdrawal by Subject|1
1026521|NCT00250276|3347419|P4|Overall Study|Protocol Violation|0
1026522|NCT00250276|3347420|P3|Overall Study|Protocol Violation|0
1026523|NCT00250276|3347421|P2|Overall Study|Protocol Violation|1
1026524|NCT00250276|3347422|P1|Overall Study|Protocol Violation|0
1026525|NCT00250276|3347419|P4|Overall Study|Non-serious Adverse Event|2
1026526|NCT00250276|3347420|P3|Overall Study|Non-serious Adverse Event|0
1026527|NCT00250276|3347421|P2|Overall Study|Non-serious Adverse Event|0
1026528|NCT00250276|3347422|P1|Overall Study|Non-serious Adverse Event|2
1026529|NCT00250276|3347419|P4|Overall Study|Serious Adverse Event|0
1026530|NCT00250276|3347420|P3|Overall Study|Serious Adverse Event|1
1026531|NCT00250276|3347421|P2|Overall Study|Serious Adverse Event|0
1026532|NCT00250276|3347422|P1|Overall Study|Serious Adverse Event|0
1026533|NCT00249873|3347502|P2|Overall Study|Thromboembolic/outcome event|122
1026534|NCT00249873|3347503|P1|Overall Study|Thromboembolic/outcome event|82
1026535|NCT00249873|3347502|P2|Overall Study|Event related to cardiac condition|21
1026536|NCT00249873|3347503|P1|Overall Study|Event related to cardiac condition|12
1026537|NCT00249873|3347502|P2|Overall Study|Surgery/ procedure|9
1026538|NCT00249873|3347503|P1|Overall Study|Surgery/ procedure|9
1026539|NCT00249873|3347502|P2|Overall Study|Study drug intolerance|0
1026540|NCT00249873|3347503|P1|Overall Study|Study drug intolerance|5
1026541|NCT00249873|3347502|P2|Overall Study|Oral anticoagulant required|157
1026542|NCT00249873|3347503|P1|Overall Study|Oral anticoagulant required|159
1026543|NCT00249873|3347502|P2|Overall Study|Angiotensin II receptor blocker required|0
1026544|NCT00249873|3347503|P1|Overall Study|Angiotensin II receptor blocker required|1
1026545|NCT00249873|3347502|P2|Overall Study|Open label clopidogrel required|42
1026546|NCT00249873|3347503|P1|Overall Study|Open label clopidogrel required|31
1026547|NCT00249873|3347502|P2|Overall Study|Physician withdrew consent|60
1026548|NCT00249873|3347503|P1|Overall Study|Physician withdrew consent|59
1026549|NCT00249873|3347502|P2|Overall Study|Patient not wish to continue after May08|4
1026550|NCT00249873|3347503|P1|Overall Study|Patient not wish to continue after May08|3
1026551|NCT00249873|3347502|P2|Overall Study|Other contraindicated medication|0
1026552|NCT00249873|3347503|P1|Overall Study|Other contraindicated medication|1
1026553|NCT00249873|3347502|P2|Overall Study|Other non serious Adverse Event|108
1026554|NCT00249873|3347503|P1|Overall Study|Other non serious Adverse Event|112
1026555|NCT00249873|3347502|P2|Overall Study|Non-compliance|46
1026556|NCT00249873|3347503|P1|Overall Study|Non-compliance|41
1026557|NCT00249873|3347502|P2|Overall Study|Minor bleeding|37
1026558|NCT00249873|3347503|P1|Overall Study|Minor bleeding|99
1026559|NCT00249873|3347502|P2|Overall Study|Lost to Follow-up|7
1026560|NCT00249873|3347503|P1|Overall Study|Lost to Follow-up|4
1026561|NCT00249873|3347502|P2|Overall Study|Withdrawal by Subject|466
1026562|NCT00249873|3347503|P1|Overall Study|Withdrawal by Subject|504
1026563|NCT00249873|3347502|P2|Overall Study|Contraindication to oral anticoagulant|8
1026564|NCT00249873|3347503|P1|Overall Study|Contraindication to oral anticoagulant|4
1026565|NCT00249873|3347502|P2|Overall Study|Qualifying condition not present|23
1026566|NCT00249873|3347503|P1|Overall Study|Qualifying condition not present|20
1026567|NCT00249873|3347502|P2|Overall Study|Other Serious Adverse Event|97
1026568|NCT00249873|3347503|P1|Overall Study|Other Serious Adverse Event|86
1026569|NCT00249873|3347502|P2|Overall Study|Serious haemorrhagic Adverse Event|30
1026570|NCT00249873|3347503|P1|Overall Study|Serious haemorrhagic Adverse Event|74
1026571|NCT00249873|3347502|P2|Overall Study|Severe allergic reaction|1
1026572|NCT00249873|3347503|P1|Overall Study|Severe allergic reaction|8
1026573|NCT00249873|3347502|P2|Overall Study|Significant thrombocytopenia|8
1026574|NCT00249873|3347503|P1|Overall Study|Significant thrombocytopenia|9
1026575|NCT00249873|3347502|P2|Overall Study|Not treated|8
1026576|NCT00249873|3347503|P1|Overall Study|Not treated|7
1026577|NCT00249834|3347523|P8|Overall Study|Protocol Violation|0
1026578|NCT00249834|3347524|P7|Overall Study|Protocol Violation|0
1026579|NCT00249834|3347525|P6|Overall Study|Protocol Violation|2
1026580|NCT00249834|3347526|P5|Overall Study|Protocol Violation|5
1026581|NCT00249834|3347527|P4|Overall Study|Protocol Violation|8
1026582|NCT00249834|3347528|P3|Overall Study|Protocol Violation|14
1026583|NCT00249834|3347529|P2|Overall Study|Protocol Violation|19
1026584|NCT00249834|3347530|P1|Overall Study|Protocol Violation|0
1026585|NCT00249834|3347523|P8|Overall Study|Failure of down-regulation|0
1026586|NCT00249834|3347524|P7|Overall Study|Failure of down-regulation|1
1026587|NCT00249834|3347525|P6|Overall Study|Failure of down-regulation|0
1026588|NCT00249834|3347526|P5|Overall Study|Failure of down-regulation|0
1026589|NCT00249834|3347527|P4|Overall Study|Failure of down-regulation|0
1026590|NCT00249834|3347528|P3|Overall Study|Failure of down-regulation|0
1026591|NCT00249834|3347529|P2|Overall Study|Failure of down-regulation|0
1026592|NCT00249834|3347530|P1|Overall Study|Failure of down-regulation|0
1026593|NCT00249834|3347523|P8|Overall Study|Ovarian stimulation failed|0
1026594|NCT00249834|3347524|P7|Overall Study|Ovarian stimulation failed|0
1026595|NCT00249834|3347525|P6|Overall Study|Ovarian stimulation failed|0
1026596|NCT00249834|3347526|P5|Overall Study|Ovarian stimulation failed|0
1026597|NCT00249834|3347527|P4|Overall Study|Ovarian stimulation failed|0
1026598|NCT00249834|3347528|P3|Overall Study|Ovarian stimulation failed|0
1026599|NCT00249834|3347529|P2|Overall Study|Ovarian stimulation failed|0
1026600|NCT00249834|3347530|P1|Overall Study|Ovarian stimulation failed|1
1026601|NCT00249821|3347579|P2|Overall Study|Technical problem|1
1026602|NCT00249821|3347580|P1|Overall Study|Technical problem|0
1026603|NCT00249808|3347600|P1|Overall Study|Did Not Provide Post-Baseline Data|11
1026604|NCT00249808|3347600|P1|Overall Study|Lack of Efficacy|52
1026605|NCT00249808|3347600|P1|Overall Study|Adverse Event|81
1026606|NCT00249808|3347600|P1|Overall Study|Lost to Follow-up|8
1026607|NCT00249808|3347600|P1|Overall Study|Protocol Violation|3
1026608|NCT00249808|3347600|P1|Overall Study|Other|27
1026609|NCT00249795|3347608|P2|Overall Study|Missing|1
1026610|NCT00249795|3347609|P1|Overall Study|Missing|0
1026611|NCT00249795|3347608|P2|Overall Study|Lost to Follow-up|2
1026612|NCT00249795|3347609|P1|Overall Study|Lost to Follow-up|0
1026613|NCT00249795|3347608|P2|Overall Study|Site not agree to continue after May08|1
1026614|NCT00249795|3347609|P1|Overall Study|Site not agree to continue after May08|1
1026615|NCT00249795|3347608|P2|Overall Study|Patient not wish to continue after May08|6
1026616|NCT00249795|3347609|P1|Overall Study|Patient not wish to continue after May08|4
1026617|NCT00249795|3347608|P2|Overall Study|Event related to cardiac condition|16
1026618|NCT00249795|3347609|P1|Overall Study|Event related to cardiac condition|17
1026619|NCT00249795|3347608|P2|Overall Study|Other contraindicated medication|1
1026620|NCT00249795|3347609|P1|Overall Study|Other contraindicated medication|1
1026621|NCT00249795|3347608|P2|Overall Study|Hypotension (non-symptomatic)|5
1026622|NCT00249795|3347609|P1|Overall Study|Hypotension (non-symptomatic)|5
1026623|NCT00249795|3347608|P2|Overall Study|Lightheadedness / dizziness|11
1026624|NCT00249795|3347609|P1|Overall Study|Lightheadedness / dizziness|15
1026625|NCT00249795|3347608|P2|Overall Study|Angiotensin II receptor blocker required|58
1026626|NCT00249795|3347609|P1|Overall Study|Angiotensin II receptor blocker required|35
1026627|NCT00249795|3347608|P2|Overall Study|Surgery / procedure|5
1026628|NCT00249795|3347609|P1|Overall Study|Surgery / procedure|4
1026629|NCT00249795|3347608|P2|Overall Study|Physician withdrew consent|63
1026630|NCT00249795|3347609|P1|Overall Study|Physician withdrew consent|71
1026631|NCT00249795|3347608|P2|Overall Study|Other adverse events (non-serious)|159
1026632|NCT00249795|3347609|P1|Overall Study|Other adverse events (non-serious)|188
1026633|NCT00249795|3347608|P2|Overall Study|Study drug intolerance|3
1026634|NCT00249795|3347609|P1|Overall Study|Study drug intolerance|3
1026635|NCT00249795|3347608|P2|Overall Study|Non-compliance|69
1026636|NCT00249795|3347609|P1|Overall Study|Non-compliance|71
1026637|NCT00249795|3347608|P2|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3
1026638|NCT00249795|3347609|P1|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7
1026639|NCT00249795|3347608|P2|Overall Study|Oral anticoagulant required|0
1026640|NCT00249795|3347609|P1|Overall Study|Oral anticoagulant required|2
1026641|NCT00249795|3347608|P2|Overall Study|Thromboembolic / outcome event|45
1026642|NCT00249795|3347609|P1|Overall Study|Thromboembolic / outcome event|39
1026643|NCT00249795|3347608|P2|Overall Study|Withdrawal by Subject|742
1026644|NCT00249795|3347609|P1|Overall Study|Withdrawal by Subject|678
1026645|NCT00249795|3347608|P2|Overall Study|Qualifying condition not present|29
1026646|NCT00249795|3347609|P1|Overall Study|Qualifying condition not present|26
1026647|NCT00249795|3347608|P2|Overall Study|Other Serious Adverse Event|93
1026648|NCT00249795|3347609|P1|Overall Study|Other Serious Adverse Event|84
1026649|NCT00249795|3347608|P2|Overall Study|Symptomatic hypotension|64
1026650|NCT00249795|3347609|P1|Overall Study|Symptomatic hypotension|127
1026651|NCT00249795|3347608|P2|Overall Study|Not treated|14
1026652|NCT00249795|3347609|P1|Overall Study|Not treated|16
1026653|NCT00249613|3347629|P2|12 Month Follow-up|Lost to Follow-up|8
1026654|NCT00249613|3347630|P1|12 Month Follow-up|Lost to Follow-up|10
1026655|NCT00249613|3347629|P2|12 Month Follow-up|Withdrawal by Subject|6
1026656|NCT00249613|3347630|P1|12 Month Follow-up|Withdrawal by Subject|6
1026657|NCT00249613|3347629|P2|12 Month Follow-up|Death|1
1026658|NCT00249613|3347630|P1|12 Month Follow-up|Death|1
1026659|NCT00249444|3347671|P2|Overall Study|life event|1
1026660|NCT00249444|3347672|P1|Overall Study|life event|0
1026661|NCT00249444|3347671|P2|Overall Study|Adverse Event|1
1026662|NCT00249444|3347672|P1|Overall Study|Adverse Event|1
1026663|NCT00249444|3347671|P2|Overall Study|non-compliant|11
1026664|NCT00249444|3347672|P1|Overall Study|non-compliant|9
1026665|NCT00249444|3347671|P2|Overall Study|Lost to Follow-up|2
1026666|NCT00249444|3347672|P1|Overall Study|Lost to Follow-up|2
1026667|NCT00249288|3347697|P2|Overall Study|Withdrawal by Subject|2
1026668|NCT00249288|3347698|P1|Overall Study|Withdrawal by Subject|2
1026669|NCT00249288|3347697|P2|Overall Study|Lost to Follow-up|3
1026670|NCT00249288|3347698|P1|Overall Study|Lost to Follow-up|3
1026671|NCT00249002|3347790|P1|Overall Study|Other|2
1026672|NCT00249002|3347790|P1|Overall Study|Study cancellation|3
1026673|NCT00249002|3347790|P1|Overall Study|Adverse Event|2
1026674|NCT00248833|3347809|P3|Overall Study|Other|0
1026675|NCT00248833|3347810|P2|Overall Study|Other|1
1026676|NCT00248833|3347811|P1|Overall Study|Other|0
1026677|NCT00248833|3347809|P3|Overall Study|Lost to Follow-up|1
1026678|NCT00248833|3347810|P2|Overall Study|Lost to Follow-up|1
1026679|NCT00248833|3347811|P1|Overall Study|Lost to Follow-up|1
1026680|NCT00248833|3347809|P3|Overall Study|Withdrawal by Subject|1
1026681|NCT00248833|3347810|P2|Overall Study|Withdrawal by Subject|1
1026682|NCT00248833|3347811|P1|Overall Study|Withdrawal by Subject|0
1026683|NCT00248833|3347809|P3|Overall Study|Adverse Event|0
1026684|NCT00248833|3347810|P2|Overall Study|Adverse Event|0
1026685|NCT00248833|3347811|P1|Overall Study|Adverse Event|2
1026686|NCT00248794|3347847|P3|Overall Study|Lost to Follow-up|3
1026687|NCT00248794|3347848|P2|Overall Study|Lost to Follow-up|8
1026688|NCT00248794|3347849|P1|Overall Study|Lost to Follow-up|6
1026689|NCT00248651|3347899|P3|Overall Study|Withdrawal by Subject|32
1026690|NCT00248651|3347900|P2|Overall Study|Withdrawal by Subject|40
1026691|NCT00248651|3347901|P1|Overall Study|Withdrawal by Subject|28
1026692|NCT00248625|3347937|P2|Overall Study|Withdrawal by Subject|2
1026693|NCT00248625|3347938|P1|Overall Study|Withdrawal by Subject|0
1026694|NCT00248495|3348027|P1|Overall Study|Withdrawal by Subject|1
1026695|NCT00248287|3348038|P2|Overall Study|Other|2
1026696|NCT00248287|3348039|P1|Overall Study|Other|3
1026697|NCT00248287|3348038|P2|Overall Study|Patient Request|3
1026698|NCT00248287|3348039|P1|Overall Study|Patient Request|5
1026699|NCT00248287|3348038|P2|Overall Study|Investigator Request|3
1026700|NCT00248287|3348039|P1|Overall Study|Investigator Request|4
1026701|NCT00248287|3348038|P2|Overall Study|Lost to Follow-up|1
1026702|NCT00248287|3348039|P1|Overall Study|Lost to Follow-up|0
1026703|NCT00248287|3348038|P2|Overall Study|Death|0
1026704|NCT00248287|3348039|P1|Overall Study|Death|1
1026705|NCT00248287|3348038|P2|Overall Study|Adverse Event|10
1026706|NCT00248287|3348039|P1|Overall Study|Adverse Event|11
1026707|NCT00248170|3348053|P2|Overall Study|Protocol deviation|19
1026708|NCT00248170|3348054|P1|Overall Study|Protocol deviation|17
1026709|NCT00248170|3348053|P2|Overall Study|Abnormal laboratory values|0
1026710|NCT00248170|3348054|P1|Overall Study|Abnormal laboratory values|4
1026711|NCT00248170|3348053|P2|Overall Study|Abnormal test procedure(s) result|61
1026712|NCT00248170|3348054|P1|Overall Study|Abnormal test procedure(s) result|49
1026713|NCT00248170|3348053|P2|Overall Study|Administrative problems|25
1026714|NCT00248170|3348054|P1|Overall Study|Administrative problems|22
1026715|NCT00248170|3348053|P2|Overall Study|Adverse Event|296
1026716|NCT00248170|3348054|P1|Overall Study|Adverse Event|311
1026717|NCT00248170|3348053|P2|Overall Study|Death|47
1026718|NCT00248170|3348054|P1|Overall Study|Death|28
1026719|NCT00248170|3348053|P2|Overall Study|Disease progression|216
1026720|NCT00248170|3348054|P1|Overall Study|Disease progression|196
1026721|NCT00248170|3348053|P2|Overall Study|Lost to Follow-up|35
1026722|NCT00248170|3348054|P1|Overall Study|Lost to Follow-up|28
1026723|NCT00248170|3348053|P2|Overall Study|Protocol Violation|30
1026724|NCT00248170|3348054|P1|Overall Study|Protocol Violation|35
1026725|NCT00248170|3348053|P2|Overall Study|Withdrawal by Subject|79
1026726|NCT00248170|3348054|P1|Overall Study|Withdrawal by Subject|71
1026727|NCT00247962|3348076|P2|Overall Study|Lack of Efficacy|2
1026728|NCT00247962|3348077|P1|Overall Study|Lack of Efficacy|4
1026729|NCT00247962|3348076|P2|Overall Study|Withdrawal by Subject|2
1026730|NCT00247962|3348077|P1|Overall Study|Withdrawal by Subject|3
1026731|NCT00247962|3348076|P2|Overall Study|Protocol Violation|1
1026732|NCT00247962|3348077|P1|Overall Study|Protocol Violation|1
1026733|NCT00247962|3348076|P2|Overall Study|Physician Decision|1
1026734|NCT00247962|3348077|P1|Overall Study|Physician Decision|0
1026735|NCT00247962|3348076|P2|Overall Study|Lost to Follow-up|1
1026736|NCT00247962|3348077|P1|Overall Study|Lost to Follow-up|3
1026737|NCT00247962|3348076|P2|Overall Study|Adverse Event|12
1026738|NCT00247962|3348077|P1|Overall Study|Adverse Event|15
1026739|NCT00247676|3348085|P1|Overall Study|Withdrawal by Subject|2
1026740|NCT00247676|3348085|P1|Overall Study|Other|3
1026741|NCT00247676|3348085|P1|Overall Study|Lack of Efficacy|15
1026742|NCT00247676|3348085|P1|Overall Study|Adverse Event|11
1026743|NCT00247676|3348085|P1|Overall Study|Death|5
1026744|NCT00247611|3348130|P2|Baselined|Completed baseline only|8
1026745|NCT00247611|3348131|P1|Baselined|Completed baseline only|9
1026746|NCT00247611|3348130|P2|Baselined|Completed baseline, never placed on ARVs|5
1026747|NCT00247611|3348131|P1|Baselined|Completed baseline, never placed on ARVs|8
1026748|NCT00247416|3348149|P2|Overall Study|3 patients were found to be ineligible|2
1026749|NCT00247416|3348150|P1|Overall Study|3 patients were found to be ineligible|1
1026750|NCT00247273|3348191|P2|Overall Study|Did not take any study drug|0
1026751|NCT00247273|3348192|P1|Overall Study|Did not take any study drug|2
1026752|NCT00247273|3348191|P2|Overall Study|Withdrawal by Subject|47
1026753|NCT00247273|3348192|P1|Overall Study|Withdrawal by Subject|46
1026754|NCT00247273|3348191|P2|Overall Study|Lost to Follow-up|7
1026755|NCT00247273|3348192|P1|Overall Study|Lost to Follow-up|7
1026756|NCT00247273|3348191|P2|Overall Study|Physician Decision|3
1026757|NCT00247273|3348192|P1|Overall Study|Physician Decision|6
1026758|NCT00247273|3348191|P2|Overall Study|Adverse Event|80
1026759|NCT00247273|3348192|P1|Overall Study|Adverse Event|85
1026760|NCT00246805|3348238|P2|Phase 1|Lost to Follow-up|0
1026761|NCT00246805|3348239|P1|Phase 1|Lost to Follow-up|1
1026762|NCT00246753|3348245|P1|Overall Study|Unacceptable toxicity|2
1026763|NCT00246753|3348245|P1|Overall Study|Adverse Event|2
1026764|NCT00246753|3348245|P1|Overall Study|Physician Decision|2
1026765|NCT00246753|3348245|P1|Overall Study|Withdrawal by Subject|2
1026766|NCT00246740|3348253|P2|Initial Enrollment|Other|2
1026767|NCT00246740|3348254|P1|Initial Enrollment|Other|1
1026768|NCT00246740|3348253|P2|Initial Enrollment|Surgery schedule change|4
1026769|NCT00246740|3348254|P1|Initial Enrollment|Surgery schedule change|4
1026770|NCT00246740|3348253|P2|Initial Enrollment|Additional surgery scheduled|2
1026771|NCT00246740|3348254|P1|Initial Enrollment|Additional surgery scheduled|0
1026772|NCT00246740|3348253|P2|Initial Enrollment|Death|0
1026773|NCT00246740|3348254|P1|Initial Enrollment|Death|1
1026774|NCT00246571|3348278|P2|Overall Study|Crossover participants|74
1026775|NCT00246571|3348279|P1|Overall Study|Crossover participants|0
1026776|NCT00246571|3348278|P2|Overall Study|Laboratory abnormalities|0
1026777|NCT00246571|3348279|P1|Overall Study|Laboratory abnormalities|1
1026778|NCT00246571|3348278|P2|Overall Study|Did not meet entrance criteria|1
1026779|NCT00246571|3348279|P1|Overall Study|Did not meet entrance criteria|2
1026780|NCT00246571|3348278|P2|Overall Study|Sponsor|1
1026781|NCT00246571|3348279|P1|Overall Study|Sponsor|0
1026782|NCT00246571|3348278|P2|Overall Study|Death|3
1026783|NCT00246571|3348279|P1|Overall Study|Death|17
1026784|NCT00246571|3348278|P2|Overall Study|Lack of Efficacy|21
1026785|NCT00246571|3348279|P1|Overall Study|Lack of Efficacy|84
1026786|NCT00246571|3348278|P2|Overall Study|Withdrawal by Subject|3
1026787|NCT00246571|3348279|P1|Overall Study|Withdrawal by Subject|2
1026788|NCT00246571|3348278|P2|Overall Study|Protocol Violation|1
1026789|NCT00246571|3348279|P1|Overall Study|Protocol Violation|0
1026790|NCT00246571|3348278|P2|Overall Study|Adverse Event|0
1026791|NCT00246571|3348279|P1|Overall Study|Adverse Event|7
1026792|NCT00246376|3348344|P5|Overall Study|Lost to Follow-up|13
1026793|NCT00246376|3348345|P4|Overall Study|Lost to Follow-up|16
1026794|NCT00246376|3348346|P3|Overall Study|Lost to Follow-up|11
1026795|NCT00246376|3348347|P2|Overall Study|Lost to Follow-up|11
1026796|NCT00246376|3348348|P1|Overall Study|Lost to Follow-up|2
1026797|NCT00246376|3348344|P5|Overall Study|Adverse Event|1
1026798|NCT00246376|3348345|P4|Overall Study|Adverse Event|3
1026799|NCT00246376|3348346|P3|Overall Study|Adverse Event|1
1026800|NCT00246376|3348347|P2|Overall Study|Adverse Event|3
1026801|NCT00246376|3348348|P1|Overall Study|Adverse Event|2
1026802|NCT00246376|3348344|P5|Overall Study|Dropped/withdrew during dietary run-in|3
1026803|NCT00246376|3348345|P4|Overall Study|Dropped/withdrew during dietary run-in|7
1026804|NCT00246376|3348346|P3|Overall Study|Dropped/withdrew during dietary run-in|4
1026805|NCT00246376|3348347|P2|Overall Study|Dropped/withdrew during dietary run-in|5
1026806|NCT00246376|3348348|P1|Overall Study|Dropped/withdrew during dietary run-in|11
1026807|NCT00246337|3348399|P9|Overall Study|Reported as completing trial in error|0
1026808|NCT00246337|3348400|P8|Overall Study|Reported as completing trial in error|1
1026809|NCT00246337|3348401|P7|Overall Study|Reported as completing trial in error|0
1026810|NCT00246337|3348402|P6|Overall Study|Reported as completing trial in error|0
1026811|NCT00246337|3348403|P5|Overall Study|Reported as completing trial in error|0
1026812|NCT00246337|3348404|P4|Overall Study|Reported as completing trial in error|0
1026813|NCT00246337|3348405|P3|Overall Study|Reported as completing trial in error|0
1026814|NCT00246337|3348406|P2|Overall Study|Reported as completing trial in error|0
1026815|NCT00246337|3348407|P1|Overall Study|Reported as completing trial in error|0
1026816|NCT00246337|3348399|P9|Overall Study|Protocol Violator|0
1026817|NCT00246337|3348400|P8|Overall Study|Protocol Violator|0
1026818|NCT00246337|3348401|P7|Overall Study|Protocol Violator|0
1026819|NCT00246337|3348402|P6|Overall Study|Protocol Violator|0
1026820|NCT00246337|3348403|P5|Overall Study|Protocol Violator|0
1026821|NCT00246337|3348404|P4|Overall Study|Protocol Violator|0
1026822|NCT00246337|3348405|P3|Overall Study|Protocol Violator|0
1026823|NCT00246337|3348406|P2|Overall Study|Protocol Violator|0
1026824|NCT00246337|3348407|P1|Overall Study|Protocol Violator|1
1026825|NCT00246337|3348399|P9|Overall Study|Overwhelmed|0
1026826|NCT00246337|3348400|P8|Overall Study|Overwhelmed|0
1026827|NCT00246337|3348401|P7|Overall Study|Overwhelmed|0
1026828|NCT00246337|3348402|P6|Overall Study|Overwhelmed|1
1026829|NCT00246337|3348403|P5|Overall Study|Overwhelmed|0
1026830|NCT00246337|3348404|P4|Overall Study|Overwhelmed|0
1026831|NCT00246337|3348405|P3|Overall Study|Overwhelmed|0
1026832|NCT00246337|3348406|P2|Overall Study|Overwhelmed|0
1026833|NCT00246337|3348407|P1|Overall Study|Overwhelmed|0
1026834|NCT00246337|3348399|P9|Overall Study|Abnormal baseline lab values|4
1026835|NCT00246337|3348400|P8|Overall Study|Abnormal baseline lab values|0
1026836|NCT00246337|3348401|P7|Overall Study|Abnormal baseline lab values|2
1026837|NCT00246337|3348402|P6|Overall Study|Abnormal baseline lab values|2
1026838|NCT00246337|3348403|P5|Overall Study|Abnormal baseline lab values|0
1026839|NCT00246337|3348404|P4|Overall Study|Abnormal baseline lab values|0
1026840|NCT00246337|3348405|P3|Overall Study|Abnormal baseline lab values|2
1026841|NCT00246337|3348406|P2|Overall Study|Abnormal baseline lab values|0
1026842|NCT00246337|3348407|P1|Overall Study|Abnormal baseline lab values|7
1026843|NCT00246337|3348399|P9|Overall Study|Site Terminated|2
1026844|NCT00246337|3348400|P8|Overall Study|Site Terminated|6
1026845|NCT00246337|3348401|P7|Overall Study|Site Terminated|1
1026846|NCT00246337|3348402|P6|Overall Study|Site Terminated|7
1026847|NCT00246337|3348403|P5|Overall Study|Site Terminated|0
1026848|NCT00246337|3348404|P4|Overall Study|Site Terminated|0
1026849|NCT00246337|3348405|P3|Overall Study|Site Terminated|0
1026850|NCT00246337|3348406|P2|Overall Study|Site Terminated|0
1026851|NCT00246337|3348407|P1|Overall Study|Site Terminated|10
1026852|NCT00246337|3348399|P9|Overall Study|Lack of Qualifying Event|5
1026853|NCT00246337|3348400|P8|Overall Study|Lack of Qualifying Event|2
1026854|NCT00246337|3348401|P7|Overall Study|Lack of Qualifying Event|3
1026855|NCT00246337|3348402|P6|Overall Study|Lack of Qualifying Event|3
1026856|NCT00246337|3348403|P5|Overall Study|Lack of Qualifying Event|1
1026857|NCT00246337|3348404|P4|Overall Study|Lack of Qualifying Event|1
1026858|NCT00246337|3348405|P3|Overall Study|Lack of Qualifying Event|1
1026859|NCT00246337|3348406|P2|Overall Study|Lack of Qualifying Event|2
1026860|NCT00246337|3348407|P1|Overall Study|Lack of Qualifying Event|8
1026861|NCT00246337|3348399|P9|Overall Study|Withdrawal by Subject|0
1026862|NCT00246337|3348400|P8|Overall Study|Withdrawal by Subject|1
1026863|NCT00246337|3348401|P7|Overall Study|Withdrawal by Subject|1
1026864|NCT00246337|3348402|P6|Overall Study|Withdrawal by Subject|0
1026865|NCT00246337|3348403|P5|Overall Study|Withdrawal by Subject|0
1026866|NCT00246337|3348404|P4|Overall Study|Withdrawal by Subject|0
1026867|NCT00246337|3348405|P3|Overall Study|Withdrawal by Subject|0
1026868|NCT00246337|3348406|P2|Overall Study|Withdrawal by Subject|0
1026869|NCT00246337|3348407|P1|Overall Study|Withdrawal by Subject|2
1026870|NCT00246337|3348399|P9|Overall Study|Protocol Violation|0
1026871|NCT00246337|3348400|P8|Overall Study|Protocol Violation|1
1026872|NCT00246337|3348401|P7|Overall Study|Protocol Violation|1
1026873|NCT00246337|3348402|P6|Overall Study|Protocol Violation|0
1026874|NCT00246337|3348403|P5|Overall Study|Protocol Violation|1
1026875|NCT00246337|3348404|P4|Overall Study|Protocol Violation|0
1026876|NCT00246337|3348405|P3|Overall Study|Protocol Violation|0
1026877|NCT00246337|3348406|P2|Overall Study|Protocol Violation|0
1026878|NCT00246337|3348407|P1|Overall Study|Protocol Violation|1
1026879|NCT00246337|3348399|P9|Overall Study|Lost to Follow-up|0
1026880|NCT00246337|3348400|P8|Overall Study|Lost to Follow-up|2
1026881|NCT00246337|3348401|P7|Overall Study|Lost to Follow-up|1
1026882|NCT00246337|3348402|P6|Overall Study|Lost to Follow-up|2
1026883|NCT00246337|3348403|P5|Overall Study|Lost to Follow-up|2
1026884|NCT00246337|3348404|P4|Overall Study|Lost to Follow-up|0
1026885|NCT00246337|3348405|P3|Overall Study|Lost to Follow-up|0
1026886|NCT00246337|3348406|P2|Overall Study|Lost to Follow-up|0
1026887|NCT00246337|3348407|P1|Overall Study|Lost to Follow-up|3
1026888|NCT00246324|3348454|P1|Overall Study|Withdrawal by Subject|1
1026889|NCT00246259|3348461|P2|Overall Study|randomly assigned, not eligible for ITT|6
1026890|NCT00246259|3348462|P1|Overall Study|randomly assigned, not eligible for ITT|2
1026891|NCT00246259|3348461|P2|Overall Study|Withdrawal by Subject|1
1026892|NCT00246259|3348462|P1|Overall Study|Withdrawal by Subject|5
1026893|NCT00246259|3348461|P2|Overall Study|Lost to Follow-up|4
1026894|NCT00246259|3348462|P1|Overall Study|Lost to Follow-up|3
1026895|NCT00246259|3348461|P2|Overall Study|Adverse Event|0
1026896|NCT00246259|3348462|P1|Overall Study|Adverse Event|5
1026897|NCT00246259|3348461|P2|Overall Study|Investigator withdrew participant|0
1026898|NCT00246259|3348462|P1|Overall Study|Investigator withdrew participant|2
1026899|NCT00246259|3348461|P2|Overall Study|Lack of Efficacy|2
1026900|NCT00246259|3348462|P1|Overall Study|Lack of Efficacy|2
1026901|NCT00246259|3348461|P2|Overall Study|Participant non-compliant|9
1026902|NCT00246259|3348462|P1|Overall Study|Participant non-compliant|4
1026903|NCT00246259|3348461|P2|Overall Study|Not stable by Week 18|1
1026904|NCT00246259|3348462|P1|Overall Study|Not stable by Week 18|2
1026905|NCT00246259|3348461|P2|Overall Study|Other|3
1026906|NCT00246259|3348462|P1|Overall Study|Other|3
1026907|NCT00246090|3348496|P1|Overall Study|Not Otherwise Specified|10
1026908|NCT00246090|3348496|P1|Overall Study|Physician Decision|11
1026909|NCT00246090|3348496|P1|Overall Study|Clinical Progression|30
1026910|NCT00246090|3348496|P1|Overall Study|Progressive Disease|212
1026911|NCT00246090|3348496|P1|Overall Study|Withdrawal by Subject|7
1026912|NCT00246090|3348496|P1|Overall Study|Adverse Event|25
1026913|NCT00246025|3348505|P4|Overall Study|unsuitable medical history was found|1
1026914|NCT00246025|3348506|P3|Overall Study|unsuitable medical history was found|0
1026915|NCT00246025|3348507|P2|Overall Study|unsuitable medical history was found|0
1026916|NCT00246025|3348508|P1|Overall Study|unsuitable medical history was found|0
1026917|NCT00246025|3348505|P4|Overall Study|Withdrawal by Subject|2
1026918|NCT00246025|3348506|P3|Overall Study|Withdrawal by Subject|1
1026919|NCT00246025|3348507|P2|Overall Study|Withdrawal by Subject|0
1026920|NCT00246025|3348508|P1|Overall Study|Withdrawal by Subject|3
1026921|NCT00246025|3348505|P4|Overall Study|Adverse Event|10
1026922|NCT00246025|3348506|P3|Overall Study|Adverse Event|9
1026923|NCT00246025|3348507|P2|Overall Study|Adverse Event|9
1026924|NCT00246025|3348508|P1|Overall Study|Adverse Event|7
1026925|NCT00246012|3348567|P9|Overall Study|Randomly assigned but not treated|0
1026926|NCT00246012|3348568|P8|Overall Study|Randomly assigned but not treated|0
1026927|NCT00246012|3348569|P7|Overall Study|Randomly assigned but not treated|1
1026928|NCT00246012|3348570|P6|Overall Study|Randomly assigned but not treated|1
1026929|NCT00246012|3348571|P5|Overall Study|Randomly assigned but not treated|0
1026930|NCT00246012|3348572|P4|Overall Study|Randomly assigned but not treated|0
1026931|NCT00246012|3348573|P3|Overall Study|Randomly assigned but not treated|0
1026932|NCT00246012|3348574|P2|Overall Study|Randomly assigned but not treated|0
1026933|NCT00246012|3348575|P1|Overall Study|Randomly assigned but not treated|0
1026934|NCT00246012|3348567|P9|Overall Study|Other|0
1026935|NCT00246012|3348568|P8|Overall Study|Other|1
1026936|NCT00246012|3348569|P7|Overall Study|Other|0
1026937|NCT00246012|3348570|P6|Overall Study|Other|0
1026938|NCT00246012|3348571|P5|Overall Study|Other|0
1026939|NCT00246012|3348572|P4|Overall Study|Other|0
1026940|NCT00246012|3348573|P3|Overall Study|Other|0
1026941|NCT00246012|3348574|P2|Overall Study|Other|0
1026942|NCT00246012|3348575|P1|Overall Study|Other|0
1026943|NCT00246012|3348567|P9|Overall Study|Disease progression|26
1026944|NCT00246012|3348568|P8|Overall Study|Disease progression|27
1026945|NCT00246012|3348569|P7|Overall Study|Disease progression|30
1026946|NCT00246012|3348570|P6|Overall Study|Disease progression|25
1026947|NCT00246012|3348571|P5|Overall Study|Disease progression|3
1026948|NCT00246012|3348572|P4|Overall Study|Disease progression|3
1026949|NCT00246012|3348573|P3|Overall Study|Disease progression|2
1026950|NCT00246012|3348574|P2|Overall Study|Disease progression|1
1026951|NCT00246012|3348575|P1|Overall Study|Disease progression|3
1026952|NCT00246012|3348567|P9|Overall Study|Withdrawal by Subject|0
1026953|NCT00246012|3348568|P8|Overall Study|Withdrawal by Subject|0
1026954|NCT00246012|3348569|P7|Overall Study|Withdrawal by Subject|0
1026955|NCT00246012|3348570|P6|Overall Study|Withdrawal by Subject|1
1026956|NCT00246012|3348571|P5|Overall Study|Withdrawal by Subject|0
1026957|NCT00246012|3348572|P4|Overall Study|Withdrawal by Subject|0
1026958|NCT00246012|3348573|P3|Overall Study|Withdrawal by Subject|0
1026959|NCT00246012|3348574|P2|Overall Study|Withdrawal by Subject|0
1026960|NCT00246012|3348575|P1|Overall Study|Withdrawal by Subject|0
1026961|NCT00246012|3348567|P9|Overall Study|Adverse Event|2
1026962|NCT00246012|3348568|P8|Overall Study|Adverse Event|0
1026963|NCT00246012|3348569|P7|Overall Study|Adverse Event|0
1026964|NCT00246012|3348570|P6|Overall Study|Adverse Event|1
1026965|NCT00246012|3348571|P5|Overall Study|Adverse Event|0
1026966|NCT00246012|3348572|P4|Overall Study|Adverse Event|0
1026967|NCT00246012|3348573|P3|Overall Study|Adverse Event|0
1026968|NCT00246012|3348574|P2|Overall Study|Adverse Event|0
1026969|NCT00246012|3348575|P1|Overall Study|Adverse Event|0
1026970|NCT00245960|3348670|P2|Overall Study|Lack of Efficacy|6
1026971|NCT00245960|3348671|P1|Overall Study|Lack of Efficacy|4
1026972|NCT00245960|3348670|P2|Overall Study|Withdrawal by Subject|7
1026973|NCT00245960|3348671|P1|Overall Study|Withdrawal by Subject|5
1026974|NCT00245960|3348670|P2|Overall Study|Protocol Violation|3
1026975|NCT00245960|3348671|P1|Overall Study|Protocol Violation|4
1026976|NCT00245960|3348670|P2|Overall Study|Lost to Follow-up|2
1026977|NCT00245960|3348671|P1|Overall Study|Lost to Follow-up|2
1026978|NCT00245960|3348670|P2|Overall Study|Adverse Event|10
1026979|NCT00245960|3348671|P1|Overall Study|Adverse Event|14
1026980|NCT00245856|3348679|P2|Period Two|Withdrawal by Subject|1
1026981|NCT00245856|3348680|P1|Period Two|Withdrawal by Subject|0
1026982|NCT00245570|3348696|P6|Washout Between Periods III and IV|Adverse Event|0
1026983|NCT00245570|3348697|P5|Washout Between Periods III and IV|Adverse Event|0
1026984|NCT00245570|3348698|P4|Washout Between Periods III and IV|Adverse Event|0
1026985|NCT00245570|3348699|P3|Washout Between Periods III and IV|Adverse Event|0
1026986|NCT00245570|3348700|P2|Washout Between Periods III and IV|Adverse Event|1
1026987|NCT00245570|3348701|P1|Washout Between Periods III and IV|Adverse Event|0
1026988|NCT00245466|3348835|P3|Overall Study|Administrative reasons|0
1026989|NCT00245466|3348836|P2|Overall Study|Administrative reasons|1
1026990|NCT00245466|3348837|P1|Overall Study|Administrative reasons|0
1026991|NCT00245466|3348835|P3|Overall Study|Death|0
1026992|NCT00245466|3348836|P2|Overall Study|Death|2
1026993|NCT00245466|3348837|P1|Overall Study|Death|0
1026994|NCT00245466|3348835|P3|Overall Study|Protocol Violation|2
1026995|NCT00245466|3348836|P2|Overall Study|Protocol Violation|2
1026996|NCT00245466|3348837|P1|Overall Study|Protocol Violation|1
1026997|NCT00245466|3348835|P3|Overall Study|Disease progression|1
1026998|NCT00245466|3348836|P2|Overall Study|Disease progression|3
1026999|NCT00245466|3348837|P1|Overall Study|Disease progression|0
1027000|NCT00245466|3348835|P3|Overall Study|Lost to Follow-up|0
1027001|NCT00245466|3348836|P2|Overall Study|Lost to Follow-up|0
1027002|NCT00245466|3348837|P1|Overall Study|Lost to Follow-up|3
1027003|NCT00245466|3348835|P3|Overall Study|Withdrawal by Subject|1
1027004|NCT00245466|3348836|P2|Overall Study|Withdrawal by Subject|2
1027005|NCT00245466|3348837|P1|Overall Study|Withdrawal by Subject|2
1027006|NCT00245466|3348835|P3|Overall Study|Insufficient PSA and testosterone suppr|3
1027007|NCT00245466|3348836|P2|Overall Study|Insufficient PSA and testosterone suppr|0
1027008|NCT00245466|3348837|P1|Overall Study|Insufficient PSA and testosterone suppr|0
1027009|NCT00245466|3348835|P3|Overall Study|Insufficient testosterone suppr|21
1027010|NCT00245466|3348836|P2|Overall Study|Insufficient testosterone suppr|12
1027011|NCT00245466|3348837|P1|Overall Study|Insufficient testosterone suppr|12
1027012|NCT00245466|3348835|P3|Overall Study|Low prostate specific antigen suppr|5
1027013|NCT00245466|3348836|P2|Overall Study|Low prostate specific antigen suppr|14
1027014|NCT00245466|3348837|P1|Overall Study|Low prostate specific antigen suppr|16
1027015|NCT00245466|3348835|P3|Overall Study|Adverse Event|4
1027016|NCT00245466|3348836|P2|Overall Study|Adverse Event|8
1027017|NCT00245466|3348837|P1|Overall Study|Adverse Event|2
1027018|NCT00245102|3348880|P6|Overall Study|Clinical progression|0
1027019|NCT00245102|3348881|P5|Overall Study|Clinical progression|0
1027020|NCT00245102|3348882|P4|Overall Study|Clinical progression|0
1027021|NCT00245102|3348883|P3|Overall Study|Clinical progression|0
1027022|NCT00245102|3348884|P2|Overall Study|Clinical progression|0
1027023|NCT00245102|3348885|P1|Overall Study|Clinical progression|1
1027024|NCT00245102|3348880|P6|Overall Study|Participant needed surgery|0
1027025|NCT00245102|3348881|P5|Overall Study|Participant needed surgery|0
1027026|NCT00245102|3348882|P4|Overall Study|Participant needed surgery|0
1027027|NCT00245102|3348883|P3|Overall Study|Participant needed surgery|1
1027028|NCT00245102|3348884|P2|Overall Study|Participant needed surgery|0
1027029|NCT00245102|3348885|P1|Overall Study|Participant needed surgery|0
1027030|NCT00245102|3348880|P6|Overall Study|Decline in performance|2
1027031|NCT00245102|3348881|P5|Overall Study|Decline in performance|0
1027032|NCT00245102|3348882|P4|Overall Study|Decline in performance|1
1027033|NCT00245102|3348883|P3|Overall Study|Decline in performance|0
1027034|NCT00245102|3348884|P2|Overall Study|Decline in performance|2
1027035|NCT00245102|3348885|P1|Overall Study|Decline in performance|0
1027036|NCT00245102|3348880|P6|Overall Study|Adverse Event|2
1027037|NCT00245102|3348881|P5|Overall Study|Adverse Event|0
1027038|NCT00245102|3348882|P4|Overall Study|Adverse Event|1
1027039|NCT00245102|3348883|P3|Overall Study|Adverse Event|5
1027040|NCT00245102|3348884|P2|Overall Study|Adverse Event|2
1027041|NCT00245102|3348885|P1|Overall Study|Adverse Event|4
1027042|NCT00245102|3348880|P6|Overall Study|Death|0
1027043|NCT00245102|3348881|P5|Overall Study|Death|0
1027044|NCT00245102|3348882|P4|Overall Study|Death|1
1027045|NCT00245102|3348883|P3|Overall Study|Death|0
1027046|NCT00245102|3348884|P2|Overall Study|Death|0
1027047|NCT00245102|3348885|P1|Overall Study|Death|0
1027048|NCT00245102|3348880|P6|Overall Study|Protocol Violation|0
1027049|NCT00245102|3348881|P5|Overall Study|Protocol Violation|0
1027050|NCT00245102|3348882|P4|Overall Study|Protocol Violation|0
1027051|NCT00245102|3348883|P3|Overall Study|Protocol Violation|0
1027052|NCT00245102|3348884|P2|Overall Study|Protocol Violation|0
1027053|NCT00245102|3348885|P1|Overall Study|Protocol Violation|1
1027054|NCT00245102|3348880|P6|Overall Study|Not Treated|0
1027055|NCT00245102|3348881|P5|Overall Study|Not Treated|0
1027056|NCT00245102|3348882|P4|Overall Study|Not Treated|0
1027057|NCT00245102|3348883|P3|Overall Study|Not Treated|1
1027058|NCT00245102|3348884|P2|Overall Study|Not Treated|0
1027059|NCT00245102|3348885|P1|Overall Study|Not Treated|1
1027060|NCT00245063|3348901|P2|Overall Study|Death|0
1027061|NCT00245063|3348902|P1|Overall Study|Death|1
1027062|NCT00245063|3348901|P2|Overall Study|Adverse Event|5
1027063|NCT00245063|3348902|P1|Overall Study|Adverse Event|6
1027064|NCT00245050|3348910|P2|Overall Study|Adverse Event|2
1027065|NCT00245050|3348911|P1|Overall Study|Adverse Event|3
1027066|NCT00245037|3348919|P1|Overall Study|Death|17
1027067|NCT00245011|3348929|P1|Overall Study|Lack of Efficacy|1
1027068|NCT00244933|3348941|P1|Overall Study|Not response evaluable|2
1027069|NCT00244881|3348945|P1|Overall Study|Withdrawal by Subject|3
1027070|NCT00244855|3348953|P2|Overall Study|Withdrawal by Subject|1
1027071|NCT00244855|3348954|P1|Overall Study|Withdrawal by Subject|0
1027072|NCT00244764|3348962|P1|Overall Study|Developed Secondary Malignancy|1
1027073|NCT00244764|3348962|P1|Overall Study|Sponsor Terminated Study|2
1027074|NCT00244764|3348962|P1|Overall Study|Primary Investigator Discretion|2
1027075|NCT00244764|3348962|P1|Overall Study|Participant was Hospitalized until Death|1
1027076|NCT00244764|3348962|P1|Overall Study|Declining Performance Status|1
1027077|NCT00244764|3348962|P1|Overall Study|Off Study Medication for >21 Days|1
1027078|NCT00244764|3348962|P1|Overall Study|Death|1
1027079|NCT00244764|3348962|P1|Overall Study|Protocol Violation|2
1027080|NCT00244764|3348962|P1|Overall Study|Disease Progression|13
1027081|NCT00244764|3348962|P1|Overall Study|Withdrawal by Subject|12
1027082|NCT00244764|3348962|P1|Overall Study|Lost to Follow-up|23
1027083|NCT00244764|3348962|P1|Overall Study|Adverse Event|37
1027084|NCT00244751|3348972|P3|Overall Study|Participant randomized by mistake|1
1027085|NCT00244751|3348973|P2|Overall Study|Participant randomized by mistake|0
1027086|NCT00244751|3348974|P1|Overall Study|Participant randomized by mistake|0
1027087|NCT00244751|3348972|P3|Overall Study|Safety reasons|0
1027088|NCT00244751|3348973|P2|Overall Study|Safety reasons|1
1027089|NCT00244751|3348974|P1|Overall Study|Safety reasons|0
1027090|NCT00244751|3348972|P3|Overall Study|Lack of compliance with protocol|0
1027091|NCT00244751|3348973|P2|Overall Study|Lack of compliance with protocol|1
1027092|NCT00244751|3348974|P1|Overall Study|Lack of compliance with protocol|0
1027093|NCT00244751|3348972|P3|Overall Study|Elevated liver enzymes|0
1027094|NCT00244751|3348973|P2|Overall Study|Elevated liver enzymes|0
1027095|NCT00244751|3348974|P1|Overall Study|Elevated liver enzymes|1
1027096|NCT00244751|3348972|P3|Overall Study|Withdrawal by Subject|3
1027097|NCT00244751|3348973|P2|Overall Study|Withdrawal by Subject|5
1027098|NCT00244751|3348974|P1|Overall Study|Withdrawal by Subject|7
1027099|NCT00244751|3348972|P3|Overall Study|Protocol Violation|1
1027100|NCT00244751|3348973|P2|Overall Study|Protocol Violation|0
1027101|NCT00244751|3348974|P1|Overall Study|Protocol Violation|1
1027102|NCT00244751|3348972|P3|Overall Study|Lost to Follow-up|0
1027103|NCT00244751|3348973|P2|Overall Study|Lost to Follow-up|1
1027104|NCT00244751|3348974|P1|Overall Study|Lost to Follow-up|0
1027105|NCT00244751|3348972|P3|Overall Study|Adverse Event|5
1027106|NCT00244751|3348973|P2|Overall Study|Adverse Event|7
1027107|NCT00244751|3348974|P1|Overall Study|Adverse Event|7
1027108|NCT00244725|3349075|P4|Overall Study|Failed to follow-up|1
1027109|NCT00244725|3349076|P3|Overall Study|Failed to follow-up|1
1027110|NCT00244725|3349077|P2|Overall Study|Failed to follow-up|0
1027111|NCT00244725|3349078|P1|Overall Study|Failed to follow-up|0
1027112|NCT00244725|3349075|P4|Overall Study|Vomit|0
1027113|NCT00244725|3349076|P3|Overall Study|Vomit|1
1027114|NCT00244725|3349077|P2|Overall Study|Vomit|0
1027115|NCT00244725|3349078|P1|Overall Study|Vomit|0
1027116|NCT00244725|3349075|P4|Overall Study|Administrative reason|0
1027117|NCT00244725|3349076|P3|Overall Study|Administrative reason|1
1027118|NCT00244725|3349077|P2|Overall Study|Administrative reason|0
1027119|NCT00244725|3349078|P1|Overall Study|Administrative reason|0
1027120|NCT00244725|3349075|P4|Overall Study|Confirmed venous thromboembolism (VTE)|0
1027121|NCT00244725|3349076|P3|Overall Study|Confirmed venous thromboembolism (VTE)|0
1027122|NCT00244725|3349077|P2|Overall Study|Confirmed venous thromboembolism (VTE)|1
1027123|NCT00244725|3349078|P1|Overall Study|Confirmed venous thromboembolism (VTE)|0
1027124|NCT00244725|3349075|P4|Overall Study|Received prohibited medication|1
1027125|NCT00244725|3349076|P3|Overall Study|Received prohibited medication|0
1027126|NCT00244725|3349077|P2|Overall Study|Received prohibited medication|1
1027127|NCT00244725|3349078|P1|Overall Study|Received prohibited medication|0
1027128|NCT00244725|3349075|P4|Overall Study|Headache|0
1027129|NCT00244725|3349076|P3|Overall Study|Headache|0
1027130|NCT00244725|3349077|P2|Overall Study|Headache|1
1027131|NCT00244725|3349078|P1|Overall Study|Headache|0
1027132|NCT00244725|3349075|P4|Overall Study|Rehab Refused to allow participantion|0
1027133|NCT00244725|3349076|P3|Overall Study|Rehab Refused to allow participantion|0
1027134|NCT00244725|3349077|P2|Overall Study|Rehab Refused to allow participantion|1
1027135|NCT00244725|3349078|P1|Overall Study|Rehab Refused to allow participantion|0
1027136|NCT00244725|3349075|P4|Overall Study|Mediciation Error|0
1027137|NCT00244725|3349076|P3|Overall Study|Mediciation Error|0
1027138|NCT00244725|3349077|P2|Overall Study|Mediciation Error|1
1027139|NCT00244725|3349078|P1|Overall Study|Mediciation Error|0
1027140|NCT00244725|3349075|P4|Overall Study|Sponsor withdrew the participant|1
1027141|NCT00244725|3349076|P3|Overall Study|Sponsor withdrew the participant|0
1027142|NCT00244725|3349077|P2|Overall Study|Sponsor withdrew the participant|0
1027143|NCT00244725|3349078|P1|Overall Study|Sponsor withdrew the participant|1
1027144|NCT00244725|3349075|P4|Overall Study|Liver function test abnormality|1
1027145|NCT00244725|3349076|P3|Overall Study|Liver function test abnormality|0
1027146|NCT00244725|3349077|P2|Overall Study|Liver function test abnormality|0
1027147|NCT00244725|3349078|P1|Overall Study|Liver function test abnormality|2
1027148|NCT00244725|3349075|P4|Overall Study|Withdrwal by participant|1
1027149|NCT00244725|3349076|P3|Overall Study|Withdrwal by participant|0
1027150|NCT00244725|3349077|P2|Overall Study|Withdrwal by participant|0
1027151|NCT00244725|3349078|P1|Overall Study|Withdrwal by participant|1
1027152|NCT00244725|3349075|P4|Overall Study|Adverse Events|4
1027153|NCT00244725|3349076|P3|Overall Study|Adverse Events|4
1027154|NCT00244725|3349077|P2|Overall Study|Adverse Events|1
1027155|NCT00244725|3349078|P1|Overall Study|Adverse Events|3
1027156|NCT00244725|3349075|P4|Overall Study|Physician Decision|2
1027157|NCT00244725|3349076|P3|Overall Study|Physician Decision|1
1027158|NCT00244725|3349077|P2|Overall Study|Physician Decision|0
1027159|NCT00244725|3349078|P1|Overall Study|Physician Decision|3
1027160|NCT00244725|3349075|P4|Overall Study|Not meet treatment eligibility criteria|0
1027161|NCT00244725|3349076|P3|Overall Study|Not meet treatment eligibility criteria|0
1027162|NCT00244725|3349077|P2|Overall Study|Not meet treatment eligibility criteria|2
1027163|NCT00244725|3349078|P1|Overall Study|Not meet treatment eligibility criteria|1
1027164|NCT00244725|3349075|P4|Overall Study|Withdrawal by Subject|8
1027165|NCT00244725|3349076|P3|Overall Study|Withdrawal by Subject|7
1027166|NCT00244725|3349077|P2|Overall Study|Withdrawal by Subject|7
1027167|NCT00244725|3349078|P1|Overall Study|Withdrawal by Subject|9
1027168|NCT00244725|3349075|P4|Overall Study|Lost to Follow-up|2
1027169|NCT00244725|3349076|P3|Overall Study|Lost to Follow-up|9
1027170|NCT00244725|3349077|P2|Overall Study|Lost to Follow-up|4
1027171|NCT00244725|3349078|P1|Overall Study|Lost to Follow-up|3
1027172|NCT00244712|3349134|P2|Overall Study|Protocol Violation, disease progression|11
1027173|NCT00244712|3349135|P1|Overall Study|Protocol Violation, disease progression|13
1027174|NCT00244712|3349134|P2|Overall Study|Withdrawal by Subject|23
1027175|NCT00244712|3349135|P1|Overall Study|Withdrawal by Subject|13
1027176|NCT00244712|3349134|P2|Overall Study|Lost to Follow-up|52
1027177|NCT00244712|3349135|P1|Overall Study|Lost to Follow-up|45
1027178|NCT00244712|3349134|P2|Overall Study|Lack of Compliance|11
1027179|NCT00244712|3349135|P1|Overall Study|Lack of Compliance|10
1027180|NCT00244712|3349134|P2|Overall Study|Protocol-Defined Virologic Failure|6
1027181|NCT00244712|3349135|P1|Overall Study|Protocol-Defined Virologic Failure|8
1027182|NCT00244712|3349134|P2|Overall Study|Adverse Event|21
1027183|NCT00244712|3349135|P1|Overall Study|Adverse Event|20
1027184|NCT00244621|3349170|P3|Open-label Treatment Period|Moved abroad|1
1027185|NCT00244621|3349171|P2|Open-label Treatment Period|Moved abroad|0
1027186|NCT00244621|3349172|P1|Open-label Treatment Period|Moved abroad|0
1027187|NCT00244621|3349170|P3|Open-label Treatment Period|Adverse Event|1
1027188|NCT00244621|3349171|P2|Open-label Treatment Period|Adverse Event|0
1027189|NCT00244621|3349172|P1|Open-label Treatment Period|Adverse Event|0
1027190|NCT00244621|3349170|P3|Open-label Treatment Period|Withdrawal by Subject|0
1027191|NCT00244621|3349171|P2|Open-label Treatment Period|Withdrawal by Subject|0
1027192|NCT00244621|3349172|P1|Open-label Treatment Period|Withdrawal by Subject|1
1027193|NCT00244621|3349170|P3|Open-label Treatment Period|Lost to Follow-up|0
1027194|NCT00244621|3349171|P2|Open-label Treatment Period|Lost to Follow-up|1
1027195|NCT00244621|3349172|P1|Open-label Treatment Period|Lost to Follow-up|0
1027196|NCT00244621|3349170|P3|Double-blind Treatment Period|Multiple Reasons|1
1027197|NCT00244621|3349171|P2|Double-blind Treatment Period|Multiple Reasons|1
1027198|NCT00244621|3349172|P1|Double-blind Treatment Period|Multiple Reasons|2
1027199|NCT00244621|3349170|P3|Double-blind Treatment Period|Lack of Efficacy|0
1027200|NCT00244621|3349171|P2|Double-blind Treatment Period|Lack of Efficacy|1
1027201|NCT00244621|3349172|P1|Double-blind Treatment Period|Lack of Efficacy|0
1027202|NCT00244621|3349170|P3|Double-blind Treatment Period|Withdrawal by Subject|0
1027203|NCT00244621|3349171|P2|Double-blind Treatment Period|Withdrawal by Subject|1
1027204|NCT00244621|3349172|P1|Double-blind Treatment Period|Withdrawal by Subject|0
1027205|NCT00244621|3349170|P3|Double-blind Treatment Period|Lost to Follow-up|1
1027206|NCT00244621|3349171|P2|Double-blind Treatment Period|Lost to Follow-up|0
1027207|NCT00244621|3349172|P1|Double-blind Treatment Period|Lost to Follow-up|0
1027208|NCT00244374|3349189|P5|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
1027209|NCT00244374|3349190|P4|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
1027210|NCT00244374|3349191|P3|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
1027211|NCT00244374|3349192|P2|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
1027212|NCT00244374|3349193|P1|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12
1027213|NCT00244374|3349189|P5|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
1027214|NCT00244374|3349190|P4|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
1027215|NCT00244374|3349191|P3|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
1027216|NCT00244374|3349192|P2|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
1027217|NCT00244374|3349193|P1|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4
1027218|NCT00244374|3349189|P5|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
1027219|NCT00244374|3349190|P4|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
1027220|NCT00244374|3349191|P3|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
1027221|NCT00244374|3349192|P2|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
1027222|NCT00244374|3349193|P1|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34
1027223|NCT00244374|3349189|P5|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
1027224|NCT00244374|3349190|P4|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
1027225|NCT00244374|3349191|P3|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
1027226|NCT00244374|3349192|P2|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
1027227|NCT00244374|3349193|P1|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51
1027228|NCT00244374|3349189|P5|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
1027229|NCT00244374|3349190|P4|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
1027230|NCT00244374|3349191|P3|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
1027231|NCT00244374|3349192|P2|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
1027232|NCT00244374|3349193|P1|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172
1027233|NCT00244374|3349189|P5|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
1027234|NCT00244374|3349190|P4|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
1027235|NCT00244374|3349191|P3|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
1027236|NCT00244374|3349192|P2|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
1027237|NCT00244374|3349193|P1|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1
1027238|NCT00244374|3349189|P5|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
1027239|NCT00244374|3349190|P4|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
1027240|NCT00244374|3349191|P3|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
1027241|NCT00244374|3349192|P2|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
1027242|NCT00244374|3349193|P1|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14
1027243|NCT00244374|3349189|P5|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
1027244|NCT00244374|3349190|P4|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
1027245|NCT00244374|3349191|P3|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
1027246|NCT00244374|3349192|P2|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
1027247|NCT00244374|3349193|P1|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17
1027248|NCT00244374|3349189|P5|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
1027249|NCT00244374|3349190|P4|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
1027250|NCT00244374|3349191|P3|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
1027251|NCT00244374|3349192|P2|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
1027252|NCT00244374|3349193|P1|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105
1027253|NCT00243932|3349249|P3|Stage 1: Dose Selection|Lost to Follow-up|0
1027254|NCT00243932|3349250|P2|Stage 1: Dose Selection|Lost to Follow-up|0
1027255|NCT00243932|3349251|P1|Stage 1: Dose Selection|Lost to Follow-up|2
1027256|NCT00243919|3349262|P3|Overall Study|Physician Decision|0
1027257|NCT00243919|3349263|P2|Overall Study|Physician Decision|1
1027258|NCT00243919|3349264|P1|Overall Study|Physician Decision|1
1027259|NCT00243919|3349262|P3|Overall Study|Administrative Error|0
1027260|NCT00243919|3349263|P2|Overall Study|Administrative Error|0
1027261|NCT00243919|3349264|P1|Overall Study|Administrative Error|1
1027262|NCT00243919|3349262|P3|Overall Study|Lost to Follow-up|3
1027263|NCT00243919|3349263|P2|Overall Study|Lost to Follow-up|7
1027264|NCT00243919|3349264|P1|Overall Study|Lost to Follow-up|6
1027265|NCT00243919|3349262|P3|Overall Study|Withdrawal by Subject|2
1027266|NCT00243919|3349263|P2|Overall Study|Withdrawal by Subject|6
1027267|NCT00243919|3349264|P1|Overall Study|Withdrawal by Subject|6
1027268|NCT00243919|3349262|P3|Overall Study|Death|6
1027269|NCT00243919|3349263|P2|Overall Study|Death|4
1027270|NCT00243919|3349264|P1|Overall Study|Death|3
1027271|NCT00243659|3349307|P2|Overall Study|Protocol Violation|2
1027272|NCT00243659|3349308|P1|Overall Study|Protocol Violation|1
1027273|NCT00243659|3349307|P2|Overall Study|Withdrawal by Subject|1
1027274|NCT00243659|3349308|P1|Overall Study|Withdrawal by Subject|1
1027275|NCT00243503|3349316|P1|Overall Study|Other|1
1027276|NCT00243503|3349316|P1|Overall Study|Death|1
1027277|NCT00243503|3349316|P1|Overall Study|Lack of Efficacy|44
1027278|NCT00243503|3349316|P1|Overall Study|Withdrawal by Subject|1
1027279|NCT00243503|3349316|P1|Overall Study|Adverse Event|11
1027280|NCT00243412|3349333|P2|Overall Study|not specified|1
1027281|NCT00243412|3349334|P1|Overall Study|not specified|1
1027282|NCT00243412|3349333|P2|Overall Study|Withdrawal by Subject|5
1027283|NCT00243412|3349334|P1|Overall Study|Withdrawal by Subject|4
1027284|NCT00243412|3349333|P2|Overall Study|Physician Decision|1
1027285|NCT00243412|3349334|P1|Overall Study|Physician Decision|1
1027286|NCT00243412|3349333|P2|Overall Study|Lost to Follow-up|1
1027287|NCT00243412|3349334|P1|Overall Study|Lost to Follow-up|0
1027288|NCT00243412|3349333|P2|Overall Study|Adverse Event|2
1027289|NCT00243412|3349334|P1|Overall Study|Adverse Event|4
1027290|NCT00243412|3349333|P2|Overall Study|Death|1
1027291|NCT00243412|3349334|P1|Overall Study|Death|0
1027292|NCT00243386|3349360|P3|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
1027293|NCT00243386|3349361|P2|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1
1027294|NCT00243386|3349362|P1|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
1027295|NCT00243386|3349360|P3|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
1027296|NCT00243386|3349361|P2|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2
1027297|NCT00243386|3349362|P1|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
1027298|NCT00243386|3349360|P3|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
1027299|NCT00243386|3349361|P2|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
1027300|NCT00243386|3349362|P1|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1
1027301|NCT00243386|3349360|P3|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
1027302|NCT00243386|3349361|P2|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
1027303|NCT00243386|3349362|P1|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1
1027304|NCT00243386|3349360|P3|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
1027305|NCT00243386|3349361|P2|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
1027306|NCT00243386|3349362|P1|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1
1027307|NCT00243386|3349360|P3|On-Demand Regimen (Study Part 1)|Screen Failures|0
1027308|NCT00243386|3349361|P2|On-Demand Regimen (Study Part 1)|Screen Failures|0
1027309|NCT00243386|3349362|P1|On-Demand Regimen (Study Part 1)|Screen Failures|2
1027310|NCT00243386|3349360|P3|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
1027311|NCT00243386|3349361|P2|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
1027312|NCT00243386|3349362|P1|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1
1027313|NCT00243386|3349360|P3|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
1027314|NCT00243386|3349361|P2|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
1027315|NCT00243386|3349362|P1|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1
1027316|NCT00243347|3349427|P1|Overall Study|Condition worsened|7
1027317|NCT00243347|3349427|P1|Overall Study|Withdrawal by Subject|5
1027318|NCT00243347|3349427|P1|Overall Study|Death|1
1027319|NCT00243347|3349427|P1|Overall Study|Adverse Event|2
1027320|NCT00243347|3349427|P1|Overall Study|Lack of Efficacy|4
1027321|NCT00243269|3349436|P4|Overall Study|Lost to Follow-up|3
1027322|NCT00243269|3349437|P3|Overall Study|Lost to Follow-up|1
1027323|NCT00243269|3349438|P2|Overall Study|Lost to Follow-up|0
1027324|NCT00243269|3349439|P1|Overall Study|Lost to Follow-up|1
1027325|NCT00243269|3349436|P4|Overall Study|Protocol Violation|1
1027326|NCT00243269|3349437|P3|Overall Study|Protocol Violation|0
1027327|NCT00243269|3349438|P2|Overall Study|Protocol Violation|1
1027328|NCT00243269|3349439|P1|Overall Study|Protocol Violation|2
1027329|NCT00243074|3349466|P1|Overall Study|Did not receive any treatment|1
1027330|NCT00243074|3349466|P1|Overall Study|not protocol specified|1
1027331|NCT00243074|3349466|P1|Overall Study|Death|2
1027332|NCT00243074|3349466|P1|Overall Study|Lack of Efficacy|36
1027333|NCT00243074|3349466|P1|Overall Study|Withdrawal by Subject|2
1027334|NCT00243074|3349466|P1|Overall Study|Adverse Event|6
1027335|NCT00243074|3349466|P1|Overall Study|Ineligible|6
1027336|NCT00243022|3349492|P2|Overall Study|Difficult Travel Distance|1
1027337|NCT00243022|3349493|P1|Overall Study|Difficult Travel Distance|0
1027338|NCT00243022|3349492|P2|Overall Study|Death|0
1027339|NCT00243022|3349493|P1|Overall Study|Death|1
1027340|NCT00243022|3349492|P2|Overall Study|Withdrawal by Subject|0
1027341|NCT00243022|3349493|P1|Overall Study|Withdrawal by Subject|1
1027342|NCT00242710|3349515|P4|Study Extension (up to Year 2)|Withdrawal by Subject|1
1027343|NCT00242710|3349516|P3|Study Extension (up to Year 2)|Withdrawal by Subject|4
1027344|NCT00242710|3349517|P2|Study Extension (up to Year 2)|Withdrawal by Subject|6
1027345|NCT00242710|3349518|P1|Study Extension (up to Year 2)|Withdrawal by Subject|10
1027346|NCT00242710|3349515|P4|Study Extension (up to Year 2)|Protocol Violation|1
1027347|NCT00242710|3349516|P3|Study Extension (up to Year 2)|Protocol Violation|0
1027348|NCT00242710|3349517|P2|Study Extension (up to Year 2)|Protocol Violation|2
1027349|NCT00242710|3349518|P1|Study Extension (up to Year 2)|Protocol Violation|0
1027350|NCT00242710|3349515|P4|Study Extension (up to Year 2)|Other|3
1027351|NCT00242710|3349516|P3|Study Extension (up to Year 2)|Other|4
1027352|NCT00242710|3349517|P2|Study Extension (up to Year 2)|Other|5
1027353|NCT00242710|3349518|P1|Study Extension (up to Year 2)|Other|3
1027354|NCT00242710|3349515|P4|Study Extension (up to Year 2)|Lost to Follow-up|0
1027355|NCT00242710|3349516|P3|Study Extension (up to Year 2)|Lost to Follow-up|5
1027356|NCT00242710|3349517|P2|Study Extension (up to Year 2)|Lost to Follow-up|7
1027357|NCT00242710|3349518|P1|Study Extension (up to Year 2)|Lost to Follow-up|7
1027358|NCT00242710|3349515|P4|Study Extension (up to Year 2)|Death|1
1027359|NCT00242710|3349516|P3|Study Extension (up to Year 2)|Death|0
1027360|NCT00242710|3349517|P2|Study Extension (up to Year 2)|Death|0
1027361|NCT00242710|3349518|P1|Study Extension (up to Year 2)|Death|0
1027362|NCT00242710|3349515|P4|Study Extension (up to Year 2)|Adverse Event|4
1027363|NCT00242710|3349516|P3|Study Extension (up to Year 2)|Adverse Event|2
1027364|NCT00242710|3349517|P2|Study Extension (up to Year 2)|Adverse Event|9
1027365|NCT00242710|3349518|P1|Study Extension (up to Year 2)|Adverse Event|7
1027366|NCT00242710|3349515|P4|Period Between Core Study and Extension|Withdrawal by Subject|28
1027367|NCT00242710|3349516|P3|Period Between Core Study and Extension|Withdrawal by Subject|24
1027368|NCT00242710|3349517|P2|Period Between Core Study and Extension|Withdrawal by Subject|63
1027369|NCT00242710|3349518|P1|Period Between Core Study and Extension|Withdrawal by Subject|75
1027370|NCT00242710|3349515|P4|Period Between Core Study and Extension|Protocol Violation|1
1027371|NCT00242710|3349516|P3|Period Between Core Study and Extension|Protocol Violation|2
1027372|NCT00242710|3349517|P2|Period Between Core Study and Extension|Protocol Violation|0
1027373|NCT00242710|3349518|P1|Period Between Core Study and Extension|Protocol Violation|0
1027374|NCT00242710|3349515|P4|Period Between Core Study and Extension|Extension not Available|7
1027456|NCT00242567|3349634|P2|Overall Study|Lack of Efficacy|2
1027375|NCT00242710|3349516|P3|Period Between Core Study and Extension|Extension not Available|8
1027376|NCT00242710|3349517|P2|Period Between Core Study and Extension|Extension not Available|21
1027377|NCT00242710|3349518|P1|Period Between Core Study and Extension|Extension not Available|17
1027378|NCT00242710|3349515|P4|Period Between Core Study and Extension|Other|11
1027379|NCT00242710|3349516|P3|Period Between Core Study and Extension|Other|9
1027380|NCT00242710|3349517|P2|Period Between Core Study and Extension|Other|24
1027381|NCT00242710|3349518|P1|Period Between Core Study and Extension|Other|24
1027382|NCT00242710|3349515|P4|Period Between Core Study and Extension|Physician Decision|0
1027383|NCT00242710|3349516|P3|Period Between Core Study and Extension|Physician Decision|0
1027384|NCT00242710|3349517|P2|Period Between Core Study and Extension|Physician Decision|1
1027385|NCT00242710|3349518|P1|Period Between Core Study and Extension|Physician Decision|1
1027386|NCT00242710|3349515|P4|Period Between Core Study and Extension|Adverse Event|2
1027387|NCT00242710|3349516|P3|Period Between Core Study and Extension|Adverse Event|5
1027388|NCT00242710|3349517|P2|Period Between Core Study and Extension|Adverse Event|3
1027389|NCT00242710|3349518|P1|Period Between Core Study and Extension|Adverse Event|2
1027390|NCT00242710|3349515|P4|Core Study (up to Year 1)|Randomized but not Treated|2
1027391|NCT00242710|3349516|P3|Core Study (up to Year 1)|Randomized but not Treated|4
1027392|NCT00242710|3349517|P2|Core Study (up to Year 1)|Randomized but not Treated|4
1027393|NCT00242710|3349518|P1|Core Study (up to Year 1)|Randomized but not Treated|12
1027394|NCT00242710|3349515|P4|Core Study (up to Year 1)|Lack of Efficacy|0
1027395|NCT00242710|3349516|P3|Core Study (up to Year 1)|Lack of Efficacy|0
1027396|NCT00242710|3349517|P2|Core Study (up to Year 1)|Lack of Efficacy|0
1027397|NCT00242710|3349518|P1|Core Study (up to Year 1)|Lack of Efficacy|1
1027398|NCT00242710|3349515|P4|Core Study (up to Year 1)|Withdrawal by Subject|6
1027399|NCT00242710|3349516|P3|Core Study (up to Year 1)|Withdrawal by Subject|15
1027400|NCT00242710|3349517|P2|Core Study (up to Year 1)|Withdrawal by Subject|16
1027401|NCT00242710|3349518|P1|Core Study (up to Year 1)|Withdrawal by Subject|27
1027402|NCT00242710|3349515|P4|Core Study (up to Year 1)|Protocol Violation|3
1027403|NCT00242710|3349516|P3|Core Study (up to Year 1)|Protocol Violation|1
1027404|NCT00242710|3349517|P2|Core Study (up to Year 1)|Protocol Violation|9
1027405|NCT00242710|3349518|P1|Core Study (up to Year 1)|Protocol Violation|2
1027406|NCT00242710|3349515|P4|Core Study (up to Year 1)|Other|2
1027407|NCT00242710|3349516|P3|Core Study (up to Year 1)|Other|0
1027408|NCT00242710|3349517|P2|Core Study (up to Year 1)|Other|1
1027409|NCT00242710|3349518|P1|Core Study (up to Year 1)|Other|6
1027410|NCT00242710|3349515|P4|Core Study (up to Year 1)|Lost to Follow-up|3
1027411|NCT00242710|3349516|P3|Core Study (up to Year 1)|Lost to Follow-up|7
1027412|NCT00242710|3349517|P2|Core Study (up to Year 1)|Lost to Follow-up|8
1027413|NCT00242710|3349518|P1|Core Study (up to Year 1)|Lost to Follow-up|8
1027414|NCT00242710|3349515|P4|Core Study (up to Year 1)|Physician Decision|1
1027415|NCT00242710|3349516|P3|Core Study (up to Year 1)|Physician Decision|0
1027416|NCT00242710|3349517|P2|Core Study (up to Year 1)|Physician Decision|1
1027417|NCT00242710|3349518|P1|Core Study (up to Year 1)|Physician Decision|0
1027418|NCT00242710|3349515|P4|Core Study (up to Year 1)|Death|0
1027419|NCT00242710|3349516|P3|Core Study (up to Year 1)|Death|1
1027420|NCT00242710|3349517|P2|Core Study (up to Year 1)|Death|0
1027421|NCT00242710|3349518|P1|Core Study (up to Year 1)|Death|0
1027422|NCT00242710|3349515|P4|Core Study (up to Year 1)|Adverse Event|14
1027423|NCT00242710|3349516|P3|Core Study (up to Year 1)|Adverse Event|23
1027424|NCT00242710|3349517|P2|Core Study (up to Year 1)|Adverse Event|25
1027425|NCT00242710|3349518|P1|Core Study (up to Year 1)|Adverse Event|30
1027426|NCT00242658|3349575|P2|Overall Study|Lost to Follow-up|19
1027427|NCT00242658|3349576|P1|Overall Study|Lost to Follow-up|22
1027428|NCT00242580|3349607|P3|Overall Study|Death|1
1027429|NCT00242580|3349608|P2|Overall Study|Death|2
1027430|NCT00242580|3349609|P1|Overall Study|Death|1
1027431|NCT00242580|3349607|P3|Overall Study|Lost to Follow-up|0
1027432|NCT00242580|3349608|P2|Overall Study|Lost to Follow-up|3
1027433|NCT00242580|3349609|P1|Overall Study|Lost to Follow-up|0
1027434|NCT00242580|3349607|P3|Overall Study|Subject withdrew consent|5
1027435|NCT00242580|3349608|P2|Overall Study|Subject withdrew consent|2
1027436|NCT00242580|3349609|P1|Overall Study|Subject withdrew consent|2
1027437|NCT00242580|3349607|P3|Overall Study|Protocol Violation|1
1027438|NCT00242580|3349608|P2|Overall Study|Protocol Violation|0
1027439|NCT00242580|3349609|P1|Overall Study|Protocol Violation|0
1027440|NCT00242580|3349607|P3|Overall Study|Unsatisfactory therapeutic effect|5
1027441|NCT00242580|3349608|P2|Overall Study|Unsatisfactory therapeutic effect|5
1027442|NCT00242580|3349609|P1|Overall Study|Unsatisfactory therapeutic effect|4
1027443|NCT00242580|3349607|P3|Overall Study|Adverse Event|2
1027444|NCT00242580|3349608|P2|Overall Study|Adverse Event|0
1027445|NCT00242580|3349609|P1|Overall Study|Adverse Event|3
1027446|NCT00242567|3349634|P2|Overall Study|Other|9
1027447|NCT00242567|3349635|P1|Overall Study|Other|14
1027448|NCT00242567|3349634|P2|Overall Study|Use of an inhibitor of bone resorption|2
1027449|NCT00242567|3349635|P1|Overall Study|Use of an inhibitor of bone resorption|0
1027450|NCT00242567|3349634|P2|Overall Study|Protocol Violation|12
1027451|NCT00242567|3349635|P1|Overall Study|Protocol Violation|12
1027452|NCT00242567|3349634|P2|Overall Study|Withdrawal by Subject|28
1027453|NCT00242567|3349635|P1|Overall Study|Withdrawal by Subject|33
1027454|NCT00242567|3349634|P2|Overall Study|Lost to Follow-up|19
1027455|NCT00242567|3349635|P1|Overall Study|Lost to Follow-up|9
1027457|NCT00242567|3349635|P1|Overall Study|Lack of Efficacy|2
1027458|NCT00242567|3349634|P2|Overall Study|Symptomatic deterioration|3
1027459|NCT00242567|3349635|P1|Overall Study|Symptomatic deterioration|9
1027460|NCT00242567|3349634|P2|Overall Study|Disease Progression|22
1027461|NCT00242567|3349635|P1|Overall Study|Disease Progression|17
1027462|NCT00242567|3349634|P2|Overall Study|Adverse Event|43
1027463|NCT00242567|3349635|P1|Overall Study|Adverse Event|70
1027464|NCT00242216|3349682|P2|Overall Study|no medicaiton dispensed|1
1027465|NCT00242216|3349683|P1|Overall Study|no medicaiton dispensed|1
1027466|NCT00242216|3349682|P2|Overall Study|Lack of Efficacy|2
1027467|NCT00242216|3349683|P1|Overall Study|Lack of Efficacy|1
1027468|NCT00242216|3349682|P2|Overall Study|Death|2
1027469|NCT00242216|3349683|P1|Overall Study|Death|4
1027470|NCT00242216|3349682|P2|Overall Study|Lost to Follow-up|17
1027471|NCT00242216|3349683|P1|Overall Study|Lost to Follow-up|12
1027472|NCT00241839|3349721|P2|Overall Study|Adverse Event|1
1027473|NCT00241839|3349722|P1|Overall Study|Adverse Event|1
1027474|NCT00241839|3349721|P2|Overall Study|Withdrawal by Subject|17
1027475|NCT00241839|3349722|P1|Overall Study|Withdrawal by Subject|18
1027476|NCT00241644|3349738|P4|Second Efficacy Period (Year 2)|Consenting parent passed away|2
1027477|NCT00241644|3349739|P3|Second Efficacy Period (Year 2)|Consenting parent passed away|2
1027478|NCT00241644|3349740|P2|Second Efficacy Period (Year 2)|Consenting parent passed away|1
1027479|NCT00241644|3349741|P1|Second Efficacy Period (Year 2)|Consenting parent passed away|1
1027480|NCT00241644|3349738|P4|Second Efficacy Period (Year 2)|Lost to Follow-up|86
1027481|NCT00241644|3349739|P3|Second Efficacy Period (Year 2)|Lost to Follow-up|46
1027482|NCT00241644|3349740|P2|Second Efficacy Period (Year 2)|Lost to Follow-up|43
1027483|NCT00241644|3349741|P1|Second Efficacy Period (Year 2)|Lost to Follow-up|43
1027484|NCT00241644|3349738|P4|Second Efficacy Period (Year 2)|Withdrawal by Subject|7
1027485|NCT00241644|3349739|P3|Second Efficacy Period (Year 2)|Withdrawal by Subject|2
1027486|NCT00241644|3349740|P2|Second Efficacy Period (Year 2)|Withdrawal by Subject|3
1027487|NCT00241644|3349741|P1|Second Efficacy Period (Year 2)|Withdrawal by Subject|4
1027488|NCT00241644|3349738|P4|Second Efficacy Period (Year 2)|Protocol Violation|3
1027489|NCT00241644|3349739|P3|Second Efficacy Period (Year 2)|Protocol Violation|2
1027490|NCT00241644|3349740|P2|Second Efficacy Period (Year 2)|Protocol Violation|1
1027491|NCT00241644|3349741|P1|Second Efficacy Period (Year 2)|Protocol Violation|2
1027492|NCT00241644|3349738|P4|Second Efficacy Period (Year 2)|Adverse Event|20
1027493|NCT00241644|3349739|P3|Second Efficacy Period (Year 2)|Adverse Event|12
1027494|NCT00241644|3349740|P2|Second Efficacy Period (Year 2)|Adverse Event|9
1027495|NCT00241644|3349741|P1|Second Efficacy Period (Year 2)|Adverse Event|11
1027496|NCT00241644|3349738|P4|First Efficacy Period (Year 1)|Subject's parent passed away|1
1027497|NCT00241644|3349739|P3|First Efficacy Period (Year 1)|Subject's parent passed away|0
1027498|NCT00241644|3349740|P2|First Efficacy Period (Year 1)|Subject's parent passed away|1
1027499|NCT00241644|3349741|P1|First Efficacy Period (Year 1)|Subject's parent passed away|0
1027500|NCT00241644|3349738|P4|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
1027501|NCT00241644|3349739|P3|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1
1027502|NCT00241644|3349740|P2|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
1027503|NCT00241644|3349741|P1|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
1027504|NCT00241644|3349738|P4|First Efficacy Period (Year 1)|Return dates not reliable|1
1027505|NCT00241644|3349739|P3|First Efficacy Period (Year 1)|Return dates not reliable|0
1027506|NCT00241644|3349740|P2|First Efficacy Period (Year 1)|Return dates not reliable|0
1027507|NCT00241644|3349741|P1|First Efficacy Period (Year 1)|Return dates not reliable|1
1027508|NCT00241644|3349738|P4|First Efficacy Period (Year 1)|Non-compliance|3
1027509|NCT00241644|3349739|P3|First Efficacy Period (Year 1)|Non-compliance|2
1027510|NCT00241644|3349740|P2|First Efficacy Period (Year 1)|Non-compliance|1
1027511|NCT00241644|3349741|P1|First Efficacy Period (Year 1)|Non-compliance|2
1027512|NCT00241644|3349738|P4|First Efficacy Period (Year 1)|Lost to Follow-up|258
1027513|NCT00241644|3349739|P3|First Efficacy Period (Year 1)|Lost to Follow-up|116
1027514|NCT00241644|3349740|P2|First Efficacy Period (Year 1)|Lost to Follow-up|142
1027515|NCT00241644|3349741|P1|First Efficacy Period (Year 1)|Lost to Follow-up|116
1027516|NCT00241644|3349738|P4|First Efficacy Period (Year 1)|Withdrawal by Subject|133
1027517|NCT00241644|3349739|P3|First Efficacy Period (Year 1)|Withdrawal by Subject|81
1027518|NCT00241644|3349740|P2|First Efficacy Period (Year 1)|Withdrawal by Subject|74
1027519|NCT00241644|3349741|P1|First Efficacy Period (Year 1)|Withdrawal by Subject|59
1027520|NCT00241644|3349738|P4|First Efficacy Period (Year 1)|Protocol Violation|8
1027521|NCT00241644|3349739|P3|First Efficacy Period (Year 1)|Protocol Violation|4
1027522|NCT00241644|3349740|P2|First Efficacy Period (Year 1)|Protocol Violation|5
1027523|NCT00241644|3349741|P1|First Efficacy Period (Year 1)|Protocol Violation|3
1027524|NCT00241644|3349738|P4|First Efficacy Period (Year 1)|Adverse Event|91
1027525|NCT00241644|3349739|P3|First Efficacy Period (Year 1)|Adverse Event|45
1027526|NCT00241644|3349740|P2|First Efficacy Period (Year 1)|Adverse Event|45
1027527|NCT00241644|3349741|P1|First Efficacy Period (Year 1)|Adverse Event|46
1027528|NCT00241358|3349826|P3|Overall Study|Determined to be not ineligible|1
1027529|NCT00241358|3349827|P2|Overall Study|Determined to be not ineligible|1
1027530|NCT00241358|3349828|P1|Overall Study|Determined to be not ineligible|0
1027531|NCT00241280|3349861|P2|Overall Study|Excessive Dryness|1
1027532|NCT00241280|3349862|P1|Overall Study|Excessive Dryness|0
1027533|NCT00241280|3349861|P2|Overall Study|Coating on Lens|0
1027534|NCT00241280|3349862|P1|Overall Study|Coating on Lens|1
1027535|NCT00241280|3349861|P2|Overall Study|History of Ocular Surgery|1
1027536|NCT00241280|3349862|P1|Overall Study|History of Ocular Surgery|0
1027537|NCT00241280|3349861|P2|Overall Study|Scheduling Conflict|2
1027538|NCT00241280|3349862|P1|Overall Study|Scheduling Conflict|0
1027539|NCT00241280|3349861|P2|Overall Study|Unacceptable Fit|1
1027540|NCT00241280|3349862|P1|Overall Study|Unacceptable Fit|0
1027541|NCT00241280|3349861|P2|Overall Study|Dispensed incorrect test article|2
1027542|NCT00241280|3349862|P1|Overall Study|Dispensed incorrect test article|1
1027543|NCT00241280|3349861|P2|Overall Study|Subject Ineligible/Dispensed|6
1027544|NCT00241280|3349862|P1|Overall Study|Subject Ineligible/Dispensed|9
1027545|NCT00241280|3349861|P2|Overall Study|Diabetic|0
1027546|NCT00241280|3349862|P1|Overall Study|Diabetic|1
1027547|NCT00241280|3349861|P2|Overall Study|Unsatisfactory Visual Response|1
1027548|NCT00241280|3349862|P1|Overall Study|Unsatisfactory Visual Response|1
1027549|NCT00241280|3349861|P2|Overall Study|Unsatisfactory Physiological Response|1
1027550|NCT00241280|3349862|P1|Overall Study|Unsatisfactory Physiological Response|1
1027551|NCT00241280|3349861|P2|Overall Study|Relocation|4
1027552|NCT00241280|3349862|P1|Overall Study|Relocation|4
1027553|NCT00241280|3349861|P2|Overall Study|Protocol Violation|10
1027554|NCT00241280|3349862|P1|Overall Study|Protocol Violation|4
1027555|NCT00241280|3349861|P2|Overall Study|Withdrawal by Subject|4
1027556|NCT00241280|3349862|P1|Overall Study|Withdrawal by Subject|7
1027557|NCT00241280|3349861|P2|Overall Study|Lost to Follow-up|8
1027558|NCT00241280|3349862|P1|Overall Study|Lost to Follow-up|5
1027559|NCT00241280|3349861|P2|Overall Study|Pregnancy|5
1027560|NCT00241280|3349862|P1|Overall Study|Pregnancy|1
1027561|NCT00241280|3349861|P2|Overall Study|Discomfort|16
1027562|NCT00241280|3349862|P1|Overall Study|Discomfort|11
1027563|NCT00241280|3349861|P2|Overall Study|Adverse Event|6
1027564|NCT00241280|3349862|P1|Overall Study|Adverse Event|2
1027565|NCT00240994|3349877|P1|Overall Study|Graft failure|1
1027566|NCT00240994|3349877|P1|Overall Study|Protocol Violation|1
1027567|NCT00240994|3349877|P1|Overall Study|Lost to Follow-up|1
1027568|NCT00240331|3350012|P2|Overall Study|Option selected by investigator|2
1027569|NCT00240331|3350013|P1|Overall Study|Option selected by investigator|1
1027570|NCT00240331|3350012|P2|Overall Study|Withdrawal by Subject|132
1027571|NCT00240331|3350013|P1|Overall Study|Withdrawal by Subject|125
1027572|NCT00240110|3350056|P2|Overall Study|Lost to Follow-up|7
1027573|NCT00240110|3350057|P1|Overall Study|Lost to Follow-up|6
1027574|NCT00240097|3350065|P1|Part II|did not continue from Part I|23
1027575|NCT00240097|3350065|P1|Part I|unevaluable|1
1027576|NCT00240097|3350065|P1|Part I|histology|1
1027577|NCT00240097|3350065|P1|Part I|Death|1
1027578|NCT00240097|3350065|P1|Part I|Adverse Event|1
1027579|NCT00240071|3350075|P1|Overall Study|Withdrawal by Subject|3
1027580|NCT00239928|3350080|P1|Overall Study|Withdrawal by Subject|2
1027581|NCT00239928|3350080|P1|Overall Study|Not need to continue study|3
1027582|NCT00239928|3350080|P1|Overall Study|Adverse Event|4
1027583|NCT00239928|3350080|P1|Overall Study|Lack of Efficacy|1
1027584|NCT00239837|3350092|P2|Overall Study|Lost to Follow-up|7
1027585|NCT00239837|3350093|P1|Overall Study|Lost to Follow-up|3
1027586|NCT00239720|3350120|P2|Overall Study|Lost to Follow-up|1
1027587|NCT00239720|3350121|P1|Overall Study|Lost to Follow-up|0
1027588|NCT00239720|3350120|P2|Overall Study|Adverse Event|0
1027589|NCT00239720|3350121|P1|Overall Study|Adverse Event|1
1027590|NCT00239681|3350129|P2|Overall Study|No information chacked on CaseReportForm|84
1027591|NCT00239681|3350130|P1|Overall Study|No information chacked on CaseReportForm|90
1027592|NCT00239681|3350129|P2|Overall Study|Physician Decision|17
1027593|NCT00239681|3350130|P1|Overall Study|Physician Decision|13
1027594|NCT00239681|3350129|P2|Overall Study|Protocol Violation|4
1027595|NCT00239681|3350130|P1|Overall Study|Protocol Violation|4
1027596|NCT00239681|3350129|P2|Overall Study|Lost to Follow-up|22
1027597|NCT00239681|3350130|P1|Overall Study|Lost to Follow-up|28
1027598|NCT00239681|3350129|P2|Overall Study|Withdrawal by Subject|489
1027599|NCT00239681|3350130|P1|Overall Study|Withdrawal by Subject|458
1027600|NCT00239681|3350129|P2|Overall Study|Adverse Event|99
1027601|NCT00239681|3350130|P1|Overall Study|Adverse Event|100
1027602|NCT00239356|3350185|P2|Overall Study|Drug available on market|2
1027603|NCT00239356|3350186|P1|Overall Study|Drug available on market|11
1027604|NCT00239356|3350185|P2|Overall Study|Administrative reason|1
1027605|NCT00239356|3350186|P1|Overall Study|Administrative reason|0
1027606|NCT00239356|3350185|P2|Overall Study|Pregnancy|0
1027607|NCT00239356|3350186|P1|Overall Study|Pregnancy|1
1027608|NCT00239356|3350185|P2|Overall Study|poor/non-compliance|0
1027609|NCT00239356|3350186|P1|Overall Study|poor/non-compliance|2
1027610|NCT00239356|3350185|P2|Overall Study|Lost to Follow-up|0
1027611|NCT00239356|3350186|P1|Overall Study|Lost to Follow-up|3
1027612|NCT00239356|3350185|P2|Overall Study|Withdrawal by Subject|6
1027613|NCT00239356|3350186|P1|Overall Study|Withdrawal by Subject|15
1027614|NCT00239356|3350185|P2|Overall Study|Adverse Event|0
1027615|NCT00239356|3350186|P1|Overall Study|Adverse Event|6
1027616|NCT00239356|3350185|P2|Overall Study|Lack of Efficacy|0
1027617|NCT00239356|3350186|P1|Overall Study|Lack of Efficacy|1
1027618|NCT00239226|3350208|P4|Overall Study|Lost to Follow-up|0
1027619|NCT00239226|3350209|P3|Overall Study|Lost to Follow-up|1
1027620|NCT00239226|3350210|P2|Overall Study|Lost to Follow-up|0
1027621|NCT00239226|3350211|P1|Overall Study|Lost to Follow-up|1
1027622|NCT00239226|3350208|P4|Overall Study|permAF during stabilization period|3
1027623|NCT00239226|3350209|P3|Overall Study|permAF during stabilization period|0
1027624|NCT00239226|3350210|P2|Overall Study|permAF during stabilization period|0
1027625|NCT00239226|3350211|P1|Overall Study|permAF during stabilization period|0
1027626|NCT00239005|3350223|P2|Overall Study|Lost to Follow-up|1
1027627|NCT00239005|3350224|P1|Overall Study|Lost to Follow-up|0
1027628|NCT00239005|3350223|P2|Overall Study|Subj. cond. no longer needs study drug|1
1027629|NCT00239005|3350224|P1|Overall Study|Subj. cond. no longer needs study drug|0
1027630|NCT00239005|3350223|P2|Overall Study|Protocol Violation|0
1027631|NCT00239005|3350224|P1|Overall Study|Protocol Violation|1
1027632|NCT00239005|3350223|P2|Overall Study|Unsatisfactory Therapeutic effect|0
1027633|NCT00239005|3350224|P1|Overall Study|Unsatisfactory Therapeutic effect|2
1027634|NCT00239005|3350223|P2|Overall Study|Withdrawal by Subject|4
1027635|NCT00239005|3350224|P1|Overall Study|Withdrawal by Subject|3
1027636|NCT00239005|3350223|P2|Overall Study|Adverse Event|6
1027637|NCT00239005|3350224|P1|Overall Study|Adverse Event|6
1027638|NCT00238433|3350240|P1|Overall Study|Death|1
1027639|NCT00238433|3350240|P1|Overall Study|Lost to Follow-up|1
1027640|NCT00238433|3350240|P1|Overall Study|Screen failure|1
1027641|NCT00238420|3350247|P2|Overall Study|Protocol Violation|1
1027642|NCT00238420|3350248|P1|Overall Study|Protocol Violation|1
1027643|NCT00238303|3350265|P3|Overall Study|Adverse Event|3
1027644|NCT00238303|3350266|P2|Overall Study|Adverse Event|1
1027645|NCT00238303|3350267|P1|Overall Study|Adverse Event|0
1027646|NCT00238303|3350265|P3|Overall Study|Poor tolerance of study treatment|1
1027647|NCT00238303|3350266|P2|Overall Study|Poor tolerance of study treatment|0
1027648|NCT00238303|3350267|P1|Overall Study|Poor tolerance of study treatment|1
1027649|NCT00238303|3350265|P3|Overall Study|Other Medical Problems|2
1027650|NCT00238303|3350266|P2|Overall Study|Other Medical Problems|0
1027651|NCT00238303|3350267|P1|Overall Study|Other Medical Problems|2
1027652|NCT00238303|3350265|P3|Overall Study|Death|1
1027653|NCT00238303|3350266|P2|Overall Study|Death|0
1027654|NCT00238303|3350267|P1|Overall Study|Death|1
1027655|NCT00238303|3350265|P3|Overall Study|Withdrawal by Subject|2
1027656|NCT00238303|3350266|P2|Overall Study|Withdrawal by Subject|1
1027657|NCT00238303|3350267|P1|Overall Study|Withdrawal by Subject|11
1027658|NCT00238264|3350284|P1|Overall Study|Ineligible|7
1027659|NCT00238264|3350284|P1|Overall Study|Withdrawal by Subject|4
1027660|NCT00238264|3350284|P1|Overall Study|Lost to Follow-up|18
1027661|NCT00238264|3350284|P1|Overall Study|Death|7
1027662|NCT00238238|3350297|P3|Overall Study|Withdrawal by Subject|0
1027663|NCT00238238|3350298|P2|Overall Study|Withdrawal by Subject|3
1027664|NCT00238238|3350299|P1|Overall Study|Withdrawal by Subject|0
1027665|NCT00238121|3350312|P2|Overall Study|Adverse Event|1
1027666|NCT00238121|3350313|P1|Overall Study|Adverse Event|2
1027667|NCT00238121|3350312|P2|Overall Study|Withdrawal by Subject|1
1027668|NCT00238121|3350313|P1|Overall Study|Withdrawal by Subject|1
1027669|NCT00237809|3350339|P4|Overall Study|Lost to Follow-up|9
1027670|NCT00237809|3350340|P3|Overall Study|Lost to Follow-up|9
1027671|NCT00237809|3350341|P2|Overall Study|Lost to Follow-up|10
1027672|NCT00237809|3350342|P1|Overall Study|Lost to Follow-up|11
1027673|NCT00237796|3350378|P2|Overall Study|Baseline and one other ILSS required|5
1027674|NCT00237796|3350379|P1|Overall Study|Baseline and one other ILSS required|10
1027675|NCT00237744|3350413|P3|Overall Study|Withdrawal by Subject|0
1027676|NCT00237744|3350414|P2|Overall Study|Withdrawal by Subject|1
1027677|NCT00237744|3350415|P1|Overall Study|Withdrawal by Subject|3
1027678|NCT00237692|3350441|P4|Overall Study|Withdrawal by Subject|4
1027679|NCT00237692|3350442|P3|Overall Study|Withdrawal by Subject|10
1027680|NCT00237692|3350443|P2|Overall Study|Withdrawal by Subject|6
1027681|NCT00237692|3350444|P1|Overall Study|Withdrawal by Subject|4
1027682|NCT00237692|3350441|P4|Overall Study|Excluded - did not meet criteria|9
1027683|NCT00237692|3350442|P3|Overall Study|Excluded - did not meet criteria|5
1027684|NCT00237692|3350443|P2|Overall Study|Excluded - did not meet criteria|3
1027685|NCT00237692|3350444|P1|Overall Study|Excluded - did not meet criteria|4
1027686|NCT00237692|3350441|P4|Overall Study|Death|3
1027687|NCT00237692|3350442|P3|Overall Study|Death|2
1027688|NCT00237692|3350443|P2|Overall Study|Death|2
1027689|NCT00237692|3350444|P1|Overall Study|Death|1
1027690|NCT00237692|3350441|P4|Overall Study|Lost to Follow-up|3
1027691|NCT00237692|3350442|P3|Overall Study|Lost to Follow-up|5
1027692|NCT00237692|3350443|P2|Overall Study|Lost to Follow-up|3
1027693|NCT00237692|3350444|P1|Overall Study|Lost to Follow-up|9
1027694|NCT00237458|3350484|P1|Overall Study|Withdrawal by Subject|1
1027695|NCT00237458|3350484|P1|Overall Study|Adverse Event|1
1027696|NCT00237458|3350484|P1|Overall Study|Lack of Efficacy|1
1027697|NCT00237185|3350502|P2|Extension|Death|1
1027698|NCT00237185|3350503|P1|Extension|Death|1
1027699|NCT00237185|3350502|P2|Extension|Administrative problems|0
1027700|NCT00237185|3350503|P1|Extension|Administrative problems|1
1027701|NCT00237185|3350502|P2|Extension|Lost to Follow-up|0
1027702|NCT00237185|3350503|P1|Extension|Lost to Follow-up|1
1027703|NCT00237185|3350502|P2|Extension|Withdrawal by Subject|2
1027704|NCT00237185|3350503|P1|Extension|Withdrawal by Subject|3
1027705|NCT00237185|3350502|P2|Extension|Condition no longer required study drug|1
1027706|NCT00237185|3350503|P1|Extension|Condition no longer required study drug|0
1027707|NCT00237185|3350502|P2|Extension|Lack of Efficacy|14
1027708|NCT00237185|3350503|P1|Extension|Lack of Efficacy|9
1027709|NCT00237185|3350502|P2|Extension|Abnormal laboratory value|1
1027710|NCT00237185|3350503|P1|Extension|Abnormal laboratory value|0
1027711|NCT00237185|3350502|P2|Extension|Adverse Event|0
1027712|NCT00237185|3350503|P1|Extension|Adverse Event|1
1027713|NCT00237185|3350502|P2|Core|Determined ineligible post randomization|0
1027714|NCT00237185|3350503|P1|Core|Determined ineligible post randomization|1
1027715|NCT00237185|3350502|P2|Core|Death|0
1027716|NCT00237185|3350503|P1|Core|Death|4
1027717|NCT00237185|3350502|P2|Core|Administrative problems|1
1027718|NCT00237185|3350503|P1|Core|Administrative problems|0
1027719|NCT00237185|3350502|P2|Core|Withdrawal by Subject|4
1027720|NCT00237185|3350503|P1|Core|Withdrawal by Subject|4
1027721|NCT00237185|3350502|P2|Core|Protocol Violation|1
1027722|NCT00237185|3350503|P1|Core|Protocol Violation|1
1027723|NCT00237185|3350502|P2|Core|Lack of Efficacy|23
1027724|NCT00237185|3350503|P1|Core|Lack of Efficacy|30
1027725|NCT00237185|3350502|P2|Core|Abnormal test procedure results|0
1027726|NCT00237185|3350503|P1|Core|Abnormal test procedure results|1
1027727|NCT00237185|3350502|P2|Core|Abnormal laboratory value|4
1027728|NCT00237185|3350503|P1|Core|Abnormal laboratory value|0
1027729|NCT00237185|3350502|P2|Core|Adverse Event|4
1027730|NCT00237185|3350503|P1|Core|Adverse Event|3
1027731|NCT00237042|3350534|P3|Long Term (12 Month) Follow up|Lost to Follow-up|9
1027732|NCT00237042|3350535|P2|Long Term (12 Month) Follow up|Lost to Follow-up|9
1027733|NCT00237042|3350536|P1|Long Term (12 Month) Follow up|Lost to Follow-up|11
1027734|NCT00237042|3350534|P3|Short Term (6 Month) Follow up|Lost to Follow-up|11
1027735|NCT00237042|3350535|P2|Short Term (6 Month) Follow up|Lost to Follow-up|8
1027736|NCT00237042|3350536|P1|Short Term (6 Month) Follow up|Lost to Follow-up|9
1027737|NCT00237042|3350534|P3|Treatment|Completed no treatment|21
1027738|NCT00237042|3350535|P2|Treatment|Completed no treatment|5
1027739|NCT00237042|3350536|P1|Treatment|Completed no treatment|5
1027740|NCT00237042|3350534|P3|Treatment|Moved out of state|1
1027741|NCT00237042|3350535|P2|Treatment|Moved out of state|1
1027742|NCT00237042|3350536|P1|Treatment|Moved out of state|1
1027743|NCT00237042|3350534|P3|Treatment|Became ineligible post-randomization|16
1027744|NCT00237042|3350535|P2|Treatment|Became ineligible post-randomization|1
1027745|NCT00237042|3350536|P1|Treatment|Became ineligible post-randomization|0
1027746|NCT00236899|3350610|P4|Overall Study|Lack of Efficacy|23
1027747|NCT00236899|3350611|P3|Overall Study|Lack of Efficacy|25
1027748|NCT00236899|3350612|P2|Overall Study|Lack of Efficacy|18
1027749|NCT00236899|3350613|P1|Overall Study|Lack of Efficacy|18
1027750|NCT00236899|3350610|P4|Overall Study|Satisfactory Response|1
1027751|NCT00236899|3350611|P3|Overall Study|Satisfactory Response|0
1027752|NCT00236899|3350612|P2|Overall Study|Satisfactory Response|0
1027753|NCT00236899|3350613|P1|Overall Study|Satisfactory Response|2
1027754|NCT00236899|3350610|P4|Overall Study|Physician Decision|6
1027755|NCT00236899|3350611|P3|Overall Study|Physician Decision|7
1027756|NCT00236899|3350612|P2|Overall Study|Physician Decision|8
1027757|NCT00236899|3350613|P1|Overall Study|Physician Decision|7
1027758|NCT00236899|3350610|P4|Overall Study|Withdrawal by Subject|2
1027759|NCT00236899|3350611|P3|Overall Study|Withdrawal by Subject|5
1027760|NCT00236899|3350612|P2|Overall Study|Withdrawal by Subject|4
1027761|NCT00236899|3350613|P1|Overall Study|Withdrawal by Subject|6
1027762|NCT00236899|3350610|P4|Overall Study|Protocol Violation|0
1027763|NCT00236899|3350611|P3|Overall Study|Protocol Violation|0
1027764|NCT00236899|3350612|P2|Overall Study|Protocol Violation|0
1027765|NCT00236899|3350613|P1|Overall Study|Protocol Violation|1
1027766|NCT00236899|3350610|P4|Overall Study|Entry Criteria Exclusion|0
1027767|NCT00236899|3350611|P3|Overall Study|Entry Criteria Exclusion|1
1027768|NCT00236899|3350612|P2|Overall Study|Entry Criteria Exclusion|1
1027769|NCT00236899|3350613|P1|Overall Study|Entry Criteria Exclusion|0
1027770|NCT00236899|3350610|P4|Overall Study|Lost to Follow-up|0
1027771|NCT00236899|3350611|P3|Overall Study|Lost to Follow-up|0
1027772|NCT00236899|3350612|P2|Overall Study|Lost to Follow-up|1
1027773|NCT00236899|3350613|P1|Overall Study|Lost to Follow-up|0
1027774|NCT00236899|3350610|P4|Overall Study|Death (Study Drug Toxicity)|0
1027775|NCT00236899|3350611|P3|Overall Study|Death (Study Drug Toxicity)|0
1027776|NCT00236899|3350612|P2|Overall Study|Death (Study Drug Toxicity)|0
1027777|NCT00236899|3350613|P1|Overall Study|Death (Study Drug Toxicity)|1
1027778|NCT00236899|3350610|P4|Overall Study|Death (Not Study Related)|0
1027779|NCT00236899|3350611|P3|Overall Study|Death (Not Study Related)|0
1027780|NCT00236899|3350612|P2|Overall Study|Death (Not Study Related)|0
1027781|NCT00236899|3350613|P1|Overall Study|Death (Not Study Related)|2
1027782|NCT00236899|3350610|P4|Overall Study|Death (Study Disease)|0
1027783|NCT00236899|3350611|P3|Overall Study|Death (Study Disease)|0
1027784|NCT00236899|3350612|P2|Overall Study|Death (Study Disease)|4
1027785|NCT00236899|3350613|P1|Overall Study|Death (Study Disease)|1
1027786|NCT00236899|3350610|P4|Overall Study|Adverse Event (Not Study Related)|7
1027787|NCT00236899|3350611|P3|Overall Study|Adverse Event (Not Study Related)|4
1027788|NCT00236899|3350612|P2|Overall Study|Adverse Event (Not Study Related)|3
1027789|NCT00236899|3350613|P1|Overall Study|Adverse Event (Not Study Related)|3
1027790|NCT00236899|3350610|P4|Overall Study|Adverse Event (Study Related)|1
1027791|NCT00236899|3350611|P3|Overall Study|Adverse Event (Study Related)|2
1027792|NCT00236899|3350612|P2|Overall Study|Adverse Event (Study Related)|1
1027793|NCT00236899|3350613|P1|Overall Study|Adverse Event (Study Related)|1
1027794|NCT00236197|3350645|P2|Overall Study|Other|2
1027795|NCT00236197|3350646|P1|Overall Study|Other|0
1027796|NCT00236197|3350645|P2|Overall Study|Medication non-compliance|2
1027797|NCT00236197|3350646|P1|Overall Study|Medication non-compliance|1
1027798|NCT00236197|3350645|P2|Overall Study|Protocol Violation|3
1027799|NCT00236197|3350646|P1|Overall Study|Protocol Violation|0
1027800|NCT00236197|3350645|P2|Overall Study|Lost to Follow-up|5
1027801|NCT00236197|3350646|P1|Overall Study|Lost to Follow-up|1
1027802|NCT00236197|3350645|P2|Overall Study|Withdrawal by Subject|2
1027803|NCT00236197|3350646|P1|Overall Study|Withdrawal by Subject|3
1027804|NCT00236184|3350654|P2|Overall Study|other|2
1027805|NCT00236184|3350655|P1|Overall Study|other|1
1027806|NCT00236184|3350654|P2|Overall Study|non-compliance with study drug|1
1027807|NCT00236184|3350655|P1|Overall Study|non-compliance with study drug|2
1027808|NCT00236184|3350654|P2|Overall Study|Protocol Violation|0
1027809|NCT00236184|3350655|P1|Overall Study|Protocol Violation|3
1027810|NCT00236184|3350654|P2|Overall Study|Withdrawal by Subject|0
1027811|NCT00236184|3350655|P1|Overall Study|Withdrawal by Subject|3
1027812|NCT00236184|3350654|P2|Overall Study|Physician Decision|1
1027813|NCT00236184|3350655|P1|Overall Study|Physician Decision|1
1027814|NCT00236184|3350654|P2|Overall Study|Lost to Follow-up|4
1027815|NCT00236184|3350655|P1|Overall Study|Lost to Follow-up|3
1027816|NCT00236184|3350654|P2|Overall Study|Lack of Efficacy|1
1027817|NCT00236184|3350655|P1|Overall Study|Lack of Efficacy|0
1027818|NCT00236184|3350654|P2|Overall Study|Adverse Event|2
1027819|NCT00236184|3350655|P1|Overall Study|Adverse Event|5
1027820|NCT00236080|3350666|P5|Overall Study|Miscellaneous|0
1027821|NCT00236080|3350667|P4|Overall Study|Miscellaneous|0
1027822|NCT00236080|3350668|P3|Overall Study|Miscellaneous|1
1027823|NCT00236080|3350669|P2|Overall Study|Miscellaneous|0
1027824|NCT00236080|3350670|P1|Overall Study|Miscellaneous|0
1027825|NCT00236080|3350666|P5|Overall Study|Withdrawal by Subject|0
1027826|NCT00236080|3350667|P4|Overall Study|Withdrawal by Subject|0
1027827|NCT00236080|3350668|P3|Overall Study|Withdrawal by Subject|0
1027828|NCT00236080|3350669|P2|Overall Study|Withdrawal by Subject|0
1027829|NCT00236080|3350670|P1|Overall Study|Withdrawal by Subject|1
1027830|NCT00236080|3350666|P5|Overall Study|Physician Decision|1
1027831|NCT00236080|3350667|P4|Overall Study|Physician Decision|1
1027832|NCT00236080|3350668|P3|Overall Study|Physician Decision|1
1027833|NCT00236080|3350669|P2|Overall Study|Physician Decision|0
1027834|NCT00236080|3350670|P1|Overall Study|Physician Decision|1
1027835|NCT00236080|3350666|P5|Overall Study|Lost to Follow-up|0
1027836|NCT00236080|3350667|P4|Overall Study|Lost to Follow-up|0
1027837|NCT00236080|3350668|P3|Overall Study|Lost to Follow-up|0
1027838|NCT00236080|3350669|P2|Overall Study|Lost to Follow-up|1
1027839|NCT00236080|3350670|P1|Overall Study|Lost to Follow-up|0
1027840|NCT00236080|3350666|P5|Overall Study|Adverse Event|0
1027841|NCT00236080|3350667|P4|Overall Study|Adverse Event|1
1027842|NCT00236080|3350668|P3|Overall Study|Adverse Event|3
1027843|NCT00236080|3350669|P2|Overall Study|Adverse Event|0
1027844|NCT00236080|3350670|P1|Overall Study|Adverse Event|0
1027845|NCT00235989|3350691|P6|Extension Treatment Period (ET)|´Other´ not further itemized|0
1027846|NCT00235989|3350692|P5|Extension Treatment Period (ET)|´Other´ not further itemized|0
1027847|NCT00235989|3350693|P4|Extension Treatment Period (ET)|´Other´ not further itemized|2
1027848|NCT00235989|3350694|P3|Extension Treatment Period (ET)|´Other´ not further itemized|1
1027849|NCT00235989|3350695|P2|Extension Treatment Period (ET)|´Other´ not further itemized|3
1027850|NCT00235989|3350696|P1|Extension Treatment Period (ET)|´Other´ not further itemized|2
1027851|NCT00235989|3350691|P6|Extension Treatment Period (ET)|Withdrawal by Subject|0
1027852|NCT00235989|3350692|P5|Extension Treatment Period (ET)|Withdrawal by Subject|0
1027853|NCT00235989|3350693|P4|Extension Treatment Period (ET)|Withdrawal by Subject|4
1027854|NCT00235989|3350694|P3|Extension Treatment Period (ET)|Withdrawal by Subject|1
1027855|NCT00235989|3350695|P2|Extension Treatment Period (ET)|Withdrawal by Subject|1
1027856|NCT00235989|3350696|P1|Extension Treatment Period (ET)|Withdrawal by Subject|1
1027857|NCT00235989|3350691|P6|Extension Treatment Period (ET)|Lost to Follow-up|0
1027858|NCT00235989|3350692|P5|Extension Treatment Period (ET)|Lost to Follow-up|0
1027859|NCT00235989|3350693|P4|Extension Treatment Period (ET)|Lost to Follow-up|0
1027860|NCT00235989|3350694|P3|Extension Treatment Period (ET)|Lost to Follow-up|1
1027861|NCT00235989|3350695|P2|Extension Treatment Period (ET)|Lost to Follow-up|0
1027862|NCT00235989|3350696|P1|Extension Treatment Period (ET)|Lost to Follow-up|2
1027863|NCT00235989|3350691|P6|Extension Treatment Period (ET)|Adverse Event|0
1027864|NCT00235989|3350692|P5|Extension Treatment Period (ET)|Adverse Event|0
1027865|NCT00235989|3350693|P4|Extension Treatment Period (ET)|Adverse Event|0
1027866|NCT00235989|3350694|P3|Extension Treatment Period (ET)|Adverse Event|2
1027867|NCT00235989|3350695|P2|Extension Treatment Period (ET)|Adverse Event|0
1027868|NCT00235989|3350696|P1|Extension Treatment Period (ET)|Adverse Event|3
1027869|NCT00235989|3350691|P6|Core Treatment Period (CT)|Lost to Follow-up|2
1027870|NCT00235989|3350692|P5|Core Treatment Period (CT)|Lost to Follow-up|0
1027871|NCT00235989|3350693|P4|Core Treatment Period (CT)|Lost to Follow-up|0
1027872|NCT00235989|3350694|P3|Core Treatment Period (CT)|Lost to Follow-up|0
1027873|NCT00235989|3350695|P2|Core Treatment Period (CT)|Lost to Follow-up|0
1027874|NCT00235989|3350696|P1|Core Treatment Period (CT)|Lost to Follow-up|0
1027875|NCT00235872|3350710|P1|Overall Study|Administrative reason|61
1027876|NCT00235872|3350710|P1|Overall Study|Withdrawal by Subject|50
1027877|NCT00235872|3350710|P1|Overall Study|Lost to Follow-up|1
1027878|NCT00235872|3350710|P1|Overall Study|Death|1
1027879|NCT00235872|3350710|P1|Overall Study|Adverse Event|34
1027880|NCT00235755|3350741|P3|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
1027881|NCT00235755|3350742|P2|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
1027882|NCT00235755|3350743|P1|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1
1027883|NCT00235755|3350741|P3|12-Week Maintenance Phase|Withdrawal by Subject|3
1027884|NCT00235755|3350742|P2|12-Week Maintenance Phase|Withdrawal by Subject|8
1027885|NCT00235755|3350743|P1|12-Week Maintenance Phase|Withdrawal by Subject|0
1027886|NCT00235755|3350741|P3|12-Week Maintenance Phase|Protocol Violation|2
1027887|NCT00235755|3350742|P2|12-Week Maintenance Phase|Protocol Violation|4
1027888|NCT00235755|3350743|P1|12-Week Maintenance Phase|Protocol Violation|0
1027889|NCT00235755|3350741|P3|12-Week Maintenance Phase|Lack of Efficacy|0
1027890|NCT00235755|3350742|P2|12-Week Maintenance Phase|Lack of Efficacy|0
1027891|NCT00235755|3350743|P1|12-Week Maintenance Phase|Lack of Efficacy|5
1027892|NCT00235755|3350741|P3|12-Week Maintenance Phase|Lost to Follow-up|0
1027893|NCT00235755|3350742|P2|12-Week Maintenance Phase|Lost to Follow-up|3
1027894|NCT00235755|3350743|P1|12-Week Maintenance Phase|Lost to Follow-up|2
1027895|NCT00235755|3350741|P3|12-Week Maintenance Phase|Adverse Event|26
1027896|NCT00235755|3350742|P2|12-Week Maintenance Phase|Adverse Event|12
1027897|NCT00235755|3350743|P1|12-Week Maintenance Phase|Adverse Event|8
1027898|NCT00235755|3350741|P3|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
1027899|NCT00235755|3350742|P2|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
1027900|NCT00235755|3350743|P1|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1
1027901|NCT00235755|3350741|P3|4-Week Titration Phase|Randomization Occurred in Error|0
1027902|NCT00235755|3350742|P2|4-Week Titration Phase|Randomization Occurred in Error|0
1027903|NCT00235755|3350743|P1|4-Week Titration Phase|Randomization Occurred in Error|1
1027904|NCT00235755|3350741|P3|4-Week Titration Phase|Participant Did Not Receive Study Drug|1
1027905|NCT00235755|3350742|P2|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
1027906|NCT00235755|3350743|P1|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
1027907|NCT00235755|3350741|P3|4-Week Titration Phase|Withdrawal by Subject|3
1027908|NCT00235755|3350742|P2|4-Week Titration Phase|Withdrawal by Subject|2
1027909|NCT00235755|3350743|P1|4-Week Titration Phase|Withdrawal by Subject|1
1027910|NCT00235755|3350741|P3|4-Week Titration Phase|Protocol Violation|1
1027911|NCT00235755|3350742|P2|4-Week Titration Phase|Protocol Violation|2
1027912|NCT00235755|3350743|P1|4-Week Titration Phase|Protocol Violation|2
1027913|NCT00235755|3350741|P3|4-Week Titration Phase|Lost to Follow-up|1
1027914|NCT00235755|3350742|P2|4-Week Titration Phase|Lost to Follow-up|1
1027915|NCT00235755|3350743|P1|4-Week Titration Phase|Lost to Follow-up|0
1027916|NCT00235755|3350741|P3|4-Week Titration Phase|Adverse Event|20
1027917|NCT00235755|3350742|P2|4-Week Titration Phase|Adverse Event|14
1027918|NCT00235755|3350743|P1|4-Week Titration Phase|Adverse Event|6
1027919|NCT00235716|3350821|P4|Overall Study|Physician Decision|3
1027920|NCT00235716|3350822|P3|Overall Study|Physician Decision|1
1027921|NCT00235716|3350823|P2|Overall Study|Physician Decision|1
1027922|NCT00235716|3350824|P1|Overall Study|Physician Decision|0
1027923|NCT00235716|3350821|P4|Overall Study|Adverse Event|0
1027924|NCT00235716|3350822|P3|Overall Study|Adverse Event|1
1027925|NCT00235716|3350823|P2|Overall Study|Adverse Event|1
1027926|NCT00235716|3350824|P1|Overall Study|Adverse Event|1
1027927|NCT00235716|3350821|P4|Overall Study|Lost to Follow-up|10
1027928|NCT00235716|3350822|P3|Overall Study|Lost to Follow-up|14
1027929|NCT00235716|3350823|P2|Overall Study|Lost to Follow-up|7
1027930|NCT00235716|3350824|P1|Overall Study|Lost to Follow-up|12
1027931|NCT00235716|3350821|P4|Overall Study|Withdrawal by Subject|18
1027932|NCT00235716|3350822|P3|Overall Study|Withdrawal by Subject|17
1027933|NCT00235716|3350823|P2|Overall Study|Withdrawal by Subject|19
1027934|NCT00235716|3350824|P1|Overall Study|Withdrawal by Subject|23
1027935|NCT00235716|3350821|P4|Overall Study|Death|31
1027936|NCT00235716|3350822|P3|Overall Study|Death|32
1027937|NCT00235716|3350823|P2|Overall Study|Death|39
1027938|NCT00235716|3350824|P1|Overall Study|Death|26
1027939|NCT00235443|3350887|P6|Overall Study|Other reasons for premature termination|6
1027940|NCT00235443|3350888|P5|Overall Study|Other reasons for premature termination|3
1027941|NCT00235443|3350889|P4|Overall Study|Other reasons for premature termination|7
1027942|NCT00235443|3350890|P3|Overall Study|Other reasons for premature termination|6
1027943|NCT00235443|3350891|P2|Overall Study|Other reasons for premature termination|6
1027944|NCT00235443|3350892|P1|Overall Study|Other reasons for premature termination|1
1027945|NCT00235443|3350887|P6|Overall Study|Unsatisfactory compliance|0
1027946|NCT00235443|3350888|P5|Overall Study|Unsatisfactory compliance|1
1027947|NCT00235443|3350889|P4|Overall Study|Unsatisfactory compliance|4
1027948|NCT00235443|3350890|P3|Overall Study|Unsatisfactory compliance|3
1027949|NCT00235443|3350891|P2|Overall Study|Unsatisfactory compliance|2
1027950|NCT00235443|3350892|P1|Overall Study|Unsatisfactory compliance|0
1027951|NCT00235443|3350887|P6|Overall Study|Lost to Follow-up|3
1027952|NCT00235443|3350888|P5|Overall Study|Lost to Follow-up|4
1027953|NCT00235443|3350889|P4|Overall Study|Lost to Follow-up|6
1027954|NCT00235443|3350890|P3|Overall Study|Lost to Follow-up|6
1027955|NCT00235443|3350891|P2|Overall Study|Lost to Follow-up|8
1027956|NCT00235443|3350892|P1|Overall Study|Lost to Follow-up|0
1027957|NCT00235443|3350887|P6|Overall Study|Withdrawal by Subject|12
1027958|NCT00235443|3350888|P5|Overall Study|Withdrawal by Subject|10
1027959|NCT00235443|3350889|P4|Overall Study|Withdrawal by Subject|24
1027960|NCT00235443|3350890|P3|Overall Study|Withdrawal by Subject|25
1027961|NCT00235443|3350891|P2|Overall Study|Withdrawal by Subject|9
1027962|NCT00235443|3350892|P1|Overall Study|Withdrawal by Subject|3
1027963|NCT00235443|3350887|P6|Overall Study|Lack of Efficacy|9
1027964|NCT00235443|3350888|P5|Overall Study|Lack of Efficacy|2
1027965|NCT00235443|3350889|P4|Overall Study|Lack of Efficacy|12
1027966|NCT00235443|3350890|P3|Overall Study|Lack of Efficacy|5
1027967|NCT00235443|3350891|P2|Overall Study|Lack of Efficacy|1
1027968|NCT00235443|3350892|P1|Overall Study|Lack of Efficacy|0
1027969|NCT00235443|3350887|P6|Overall Study|Adverse Event|15
1027970|NCT00235443|3350888|P5|Overall Study|Adverse Event|10
1027971|NCT00235443|3350889|P4|Overall Study|Adverse Event|44
1027972|NCT00235443|3350890|P3|Overall Study|Adverse Event|17
1027973|NCT00235443|3350891|P2|Overall Study|Adverse Event|12
1027974|NCT00235443|3350892|P1|Overall Study|Adverse Event|4
1027975|NCT00235391|3351033|P6|Overall Study|Death|0
1027976|NCT00235391|3351034|P5|Overall Study|Death|0
1027977|NCT00235391|3351035|P4|Overall Study|Death|4
1027978|NCT00235391|3351036|P3|Overall Study|Death|1
1027979|NCT00235391|3351037|P2|Overall Study|Death|0
1027980|NCT00235391|3351038|P1|Overall Study|Death|0
1027981|NCT00235391|3351033|P6|Overall Study|Administrative problems|0
1027982|NCT00235391|3351034|P5|Overall Study|Administrative problems|0
1027983|NCT00235391|3351035|P4|Overall Study|Administrative problems|1
1027984|NCT00235391|3351036|P3|Overall Study|Administrative problems|0
1027985|NCT00235391|3351037|P2|Overall Study|Administrative problems|0
1027986|NCT00235391|3351038|P1|Overall Study|Administrative problems|0
1027987|NCT00235391|3351033|P6|Overall Study|Lost to Follow-up|0
1027988|NCT00235391|3351034|P5|Overall Study|Lost to Follow-up|0
1027989|NCT00235391|3351035|P4|Overall Study|Lost to Follow-up|16
1027990|NCT00235391|3351036|P3|Overall Study|Lost to Follow-up|3
1027991|NCT00235391|3351037|P2|Overall Study|Lost to Follow-up|3
1027992|NCT00235391|3351038|P1|Overall Study|Lost to Follow-up|0
1027993|NCT00235391|3351033|P6|Overall Study|Withdrawal by Subject|0
1027994|NCT00235391|3351034|P5|Overall Study|Withdrawal by Subject|5
1027995|NCT00235391|3351035|P4|Overall Study|Withdrawal by Subject|61
1027996|NCT00235391|3351036|P3|Overall Study|Withdrawal by Subject|3
1027997|NCT00235391|3351037|P2|Overall Study|Withdrawal by Subject|3
1027998|NCT00235391|3351038|P1|Overall Study|Withdrawal by Subject|2
1027999|NCT00235391|3351033|P6|Overall Study|Protocol deviation|0
1028000|NCT00235391|3351034|P5|Overall Study|Protocol deviation|0
1028001|NCT00235391|3351035|P4|Overall Study|Protocol deviation|11
1028002|NCT00235391|3351036|P3|Overall Study|Protocol deviation|1
1028003|NCT00235391|3351037|P2|Overall Study|Protocol deviation|0
1028004|NCT00235391|3351038|P1|Overall Study|Protocol deviation|0
1028005|NCT00235391|3351033|P6|Overall Study|Condition no longer requires treatment|0
1028006|NCT00235391|3351034|P5|Overall Study|Condition no longer requires treatment|1
1028007|NCT00235391|3351035|P4|Overall Study|Condition no longer requires treatment|11
1028008|NCT00235391|3351036|P3|Overall Study|Condition no longer requires treatment|0
1028009|NCT00235391|3351037|P2|Overall Study|Condition no longer requires treatment|0
1028010|NCT00235391|3351038|P1|Overall Study|Condition no longer requires treatment|3
1028011|NCT00235391|3351033|P6|Overall Study|Unsatisfactory therapeutic effect|0
1028012|NCT00235391|3351034|P5|Overall Study|Unsatisfactory therapeutic effect|0
1028013|NCT00235391|3351035|P4|Overall Study|Unsatisfactory therapeutic effect|17
1028014|NCT00235391|3351036|P3|Overall Study|Unsatisfactory therapeutic effect|2
1028015|NCT00235391|3351037|P2|Overall Study|Unsatisfactory therapeutic effect|2
1028016|NCT00235391|3351038|P1|Overall Study|Unsatisfactory therapeutic effect|0
1028017|NCT00235391|3351033|P6|Overall Study|Abnormal laboratory value(s)|2
1028018|NCT00235391|3351034|P5|Overall Study|Abnormal laboratory value(s)|1
1028019|NCT00235391|3351035|P4|Overall Study|Abnormal laboratory value(s)|27
1028020|NCT00235391|3351036|P3|Overall Study|Abnormal laboratory value(s)|4
1028021|NCT00235391|3351037|P2|Overall Study|Abnormal laboratory value(s)|5
1028022|NCT00235391|3351038|P1|Overall Study|Abnormal laboratory value(s)|3
1028023|NCT00235391|3351033|P6|Overall Study|Adverse Event|2
1028024|NCT00235391|3351034|P5|Overall Study|Adverse Event|5
1028025|NCT00235391|3351035|P4|Overall Study|Adverse Event|72
1028026|NCT00235391|3351036|P3|Overall Study|Adverse Event|10
1028027|NCT00235391|3351037|P2|Overall Study|Adverse Event|5
1028028|NCT00235391|3351038|P1|Overall Study|Adverse Event|4
1028029|NCT00235326|3351055|P2|Overall Study|Lost to Follow-up|1400
1028030|NCT00235326|3351056|P1|Overall Study|Lost to Follow-up|746
1028031|NCT00234533|3351096|P1|Overall Study|Enrolled but not treated|3
1028032|NCT00234533|3351096|P1|Overall Study|Adverse Event|2
1028033|NCT00234533|3351096|P1|Overall Study|Withdrawal by Subject|6
1028034|NCT00234494|3351115|P1|Overall Study|Protocol Violation|2
1028035|NCT00234104|3351161|P4|Overall Study|Physician Decision|2
1028036|NCT00234104|3351162|P3|Overall Study|Physician Decision|2
1028037|NCT00234104|3351163|P2|Overall Study|Physician Decision|1
1028038|NCT00234104|3351164|P1|Overall Study|Physician Decision|0
1028039|NCT00234104|3351161|P4|Overall Study|Protocol Violation|1
1028040|NCT00234104|3351162|P3|Overall Study|Protocol Violation|0
1028041|NCT00234104|3351163|P2|Overall Study|Protocol Violation|0
1028042|NCT00234104|3351164|P1|Overall Study|Protocol Violation|0
1028043|NCT00234104|3351161|P4|Overall Study|Adverse Event|5
1028044|NCT00234104|3351162|P3|Overall Study|Adverse Event|3
1028045|NCT00234104|3351163|P2|Overall Study|Adverse Event|0
1028046|NCT00234104|3351164|P1|Overall Study|Adverse Event|4
1028047|NCT00234065|3351205|P2|Overall Study|Not Classified|112
1028048|NCT00234065|3351206|P1|Overall Study|Not Classified|111
1028049|NCT00234065|3351205|P2|Overall Study|Physician Decision|22
1028050|NCT00234065|3351206|P1|Overall Study|Physician Decision|23
1028051|NCT00234065|3351205|P2|Overall Study|Withdrawal by Subject|56
1028052|NCT00234065|3351206|P1|Overall Study|Withdrawal by Subject|73
1028053|NCT00234065|3351205|P2|Overall Study|Adverse Event|166
1028054|NCT00234065|3351206|P1|Overall Study|Adverse Event|268
1028055|NCT00234039|3351222|P1|Overall Study|No Protocol Treatment Received|2
1028056|NCT00234039|3351222|P1|Overall Study|Ineligible|9
1028057|NCT00234039|3351222|P1|Overall Study|Other - Not Protocol Specified|3
1028058|NCT00234039|3351222|P1|Overall Study|Progression/relapse|34
1028059|NCT00234039|3351222|P1|Overall Study|Adverse Event|2
1028060|NCT00233987|3351229|P1|Overall Study|Ineligible|4
1028061|NCT00233987|3351229|P1|Overall Study|Eligible but No Treatment Received|2
1028062|NCT00233987|3351229|P1|Overall Study|Other - Not Protocol Specified|5
1028063|NCT00233987|3351229|P1|Overall Study|Reason Under Review|1
1028064|NCT00233987|3351229|P1|Overall Study|Lack of Efficacy|2
1028065|NCT00233987|3351229|P1|Overall Study|Withdrawal by Subject|1
1028066|NCT00233948|3351238|P6|Overall Study|Adverse Event|0
1028067|NCT00233948|3351239|P5|Overall Study|Adverse Event|0
1028068|NCT00233948|3351240|P4|Overall Study|Adverse Event|0
1028069|NCT00233948|3351241|P3|Overall Study|Adverse Event|0
1028070|NCT00233948|3351242|P2|Overall Study|Adverse Event|0
1028071|NCT00233948|3351243|P1|Overall Study|Adverse Event|1
1028072|NCT00233454|3351267|P1|Overall Study|Death|6
1028073|NCT00233402|3351275|P2|Overall Study|Lost to follow up etc|21
1028074|NCT00233402|3351276|P1|Overall Study|Lost to follow up etc|3
1028075|NCT00233402|3351275|P2|Overall Study|No Ta/T1|94
1028076|NCT00233402|3351276|P1|Overall Study|No Ta/T1|89
1028077|NCT00233402|3351275|P2|Overall Study|No pathology data|9
1028078|NCT00233402|3351276|P1|Overall Study|No pathology data|12
1028079|NCT00233324|3351291|P4|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
1028080|NCT00233324|3351292|P3|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13
1028081|NCT00233324|3351293|P2|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
1028082|NCT00233324|3351294|P1|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8
1028083|NCT00233324|3351291|P4|Follow up at 18-22 Months Corrected Age|Death|4
1028084|NCT00233324|3351292|P3|Follow up at 18-22 Months Corrected Age|Death|5
1028085|NCT00233324|3351293|P2|Follow up at 18-22 Months Corrected Age|Death|7
1028086|NCT00233324|3351294|P1|Follow up at 18-22 Months Corrected Age|Death|5
1028087|NCT00233324|3351291|P4|Main Study|Death|47
1028088|NCT00233324|3351292|P3|Main Study|Death|62
1028089|NCT00233324|3351293|P2|Main Study|Death|60
1028090|NCT00233324|3351294|P1|Main Study|Death|68
1028091|NCT00233064|3351348|P2|Overall Study|Moved to Dom. Republic|0
1028092|NCT00233064|3351349|P1|Overall Study|Moved to Dom. Republic|1
1028093|NCT00233064|3351348|P2|Overall Study|Protocol Violation|0
1028094|NCT00233064|3351349|P1|Overall Study|Protocol Violation|1
1028095|NCT00233064|3351348|P2|Overall Study|Relocation|1
1028096|NCT00233064|3351349|P1|Overall Study|Relocation|0
1028097|NCT00233064|3351348|P2|Overall Study|Death|1
1028098|NCT00233064|3351349|P1|Overall Study|Death|0
1028099|NCT00233064|3351348|P2|Overall Study|Withdrawal by Subject|3
1028100|NCT00233064|3351349|P1|Overall Study|Withdrawal by Subject|5
1028101|NCT00233064|3351348|P2|Overall Study|Lost to Follow-up|7
1028102|NCT00233064|3351349|P1|Overall Study|Lost to Follow-up|7
1028103|NCT00232596|3351375|P2|12-Week Maintenance Phase|Other|3
1028104|NCT00232596|3351376|P1|12-Week Maintenance Phase|Other|1
1028105|NCT00232596|3351375|P2|12-Week Maintenance Phase|Protocol Violation|1
1028106|NCT00232596|3351376|P1|12-Week Maintenance Phase|Protocol Violation|3
1028107|NCT00232596|3351375|P2|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2
1028108|NCT00232596|3351376|P1|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1
1028109|NCT00232596|3351375|P2|12-Week Maintenance Phase|Adverse Event|22
1028110|NCT00232596|3351376|P1|12-Week Maintenance Phase|Adverse Event|7
1028111|NCT00232596|3351375|P2|6-Week Titration Phase|Participant Did Not Receive Study Drug|1
1028112|NCT00232596|3351376|P1|6-Week Titration Phase|Participant Did Not Receive Study Drug|0
1028113|NCT00232596|3351375|P2|6-Week Titration Phase|Other|3
1028114|NCT00232596|3351376|P1|6-Week Titration Phase|Other|3
1028115|NCT00232596|3351375|P2|6-Week Titration Phase|Participant Request Unrelated to Study|0
1028116|NCT00232596|3351376|P1|6-Week Titration Phase|Participant Request Unrelated to Study|1
1028117|NCT00232596|3351375|P2|6-Week Titration Phase|Protocol Violation|3
1028118|NCT00232596|3351376|P1|6-Week Titration Phase|Protocol Violation|1
1028119|NCT00232596|3351375|P2|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2
1028120|NCT00232596|3351376|P1|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1
1028121|NCT00232596|3351375|P2|6-Week Titration Phase|Failed to Return|1
1028122|NCT00232596|3351376|P1|6-Week Titration Phase|Failed to Return|2
1028123|NCT00232596|3351375|P2|6-Week Titration Phase|Adverse Event|19
1028124|NCT00232596|3351376|P1|6-Week Titration Phase|Adverse Event|6
1028125|NCT00232557|3351467|P2|Overall Study|Lost to Follow-up|5
1028126|NCT00232557|3351468|P1|Overall Study|Lost to Follow-up|3
1028127|NCT00232544|3351478|P2|Overall Study|Lost to Follow-up|15
1028128|NCT00232544|3351479|P1|Overall Study|Lost to Follow-up|20
1028129|NCT00232180|3351510|P3|Open Label Phase|Randomized but not treated|1
1028130|NCT00232180|3351511|P2|Open Label Phase|Randomized but not treated|0
1028131|NCT00232180|3351512|P1|Open Label Phase|Randomized but not treated|0
1028132|NCT00232180|3351510|P3|Open Label Phase|Laboratory abnormality|10
1028133|NCT00232180|3351511|P2|Open Label Phase|Laboratory abnormality|0
1028134|NCT00232180|3351512|P1|Open Label Phase|Laboratory abnormality|0
1028135|NCT00232180|3351510|P3|Open Label Phase|Adverse Event|25
1028136|NCT00232180|3351511|P2|Open Label Phase|Adverse Event|0
1028137|NCT00232180|3351512|P1|Open Label Phase|Adverse Event|0
1028138|NCT00232180|3351510|P3|Open Label Phase|Other|16
1028139|NCT00232180|3351511|P2|Open Label Phase|Other|0
1028140|NCT00232180|3351512|P1|Open Label Phase|Other|0
1028141|NCT00232180|3351510|P3|Open Label Phase|Withdrawal by Subject|37
1028142|NCT00232180|3351511|P2|Open Label Phase|Withdrawal by Subject|0
1028143|NCT00232180|3351512|P1|Open Label Phase|Withdrawal by Subject|0
1028144|NCT00232180|3351510|P3|Open Label Phase|Study terminated by sponsor|3
1028145|NCT00232180|3351511|P2|Open Label Phase|Study terminated by sponsor|0
1028146|NCT00232180|3351512|P1|Open Label Phase|Study terminated by sponsor|0
1028147|NCT00232180|3351510|P3|Open Label Phase|Protocol Violation|3
1028148|NCT00232180|3351511|P2|Open Label Phase|Protocol Violation|0
1028149|NCT00232180|3351512|P1|Open Label Phase|Protocol Violation|0
1028150|NCT00232180|3351510|P3|Open Label Phase|Lost to Follow-up|5
1028151|NCT00232180|3351511|P2|Open Label Phase|Lost to Follow-up|0
1028152|NCT00232180|3351512|P1|Open Label Phase|Lost to Follow-up|0
1028153|NCT00232180|3351510|P3|Open Label Phase|Death|48
1028154|NCT00232180|3351511|P2|Open Label Phase|Death|0
1028155|NCT00232180|3351512|P1|Open Label Phase|Death|0
1028156|NCT00232180|3351510|P3|Double-blind (DB) Phase|Laboratory abnormality|0
1028157|NCT00232180|3351511|P2|Double-blind (DB) Phase|Laboratory abnormality|7
1028158|NCT00232180|3351512|P1|Double-blind (DB) Phase|Laboratory abnormality|6
1028159|NCT00232180|3351510|P3|Double-blind (DB) Phase|Randomized but not treated|0
1028160|NCT00232180|3351511|P2|Double-blind (DB) Phase|Randomized but not treated|4
1028161|NCT00232180|3351512|P1|Double-blind (DB) Phase|Randomized but not treated|3
1028162|NCT00232180|3351510|P3|Double-blind (DB) Phase|Other|0
1028163|NCT00232180|3351511|P2|Double-blind (DB) Phase|Other|75
1028164|NCT00232180|3351512|P1|Double-blind (DB) Phase|Other|70
1028165|NCT00232180|3351510|P3|Double-blind (DB) Phase|Adverse Event|0
1028166|NCT00232180|3351511|P2|Double-blind (DB) Phase|Adverse Event|100
1028167|NCT00232180|3351512|P1|Double-blind (DB) Phase|Adverse Event|83
1028168|NCT00232180|3351510|P3|Double-blind (DB) Phase|Protocol Violation|0
1028169|NCT00232180|3351511|P2|Double-blind (DB) Phase|Protocol Violation|21
1028170|NCT00232180|3351512|P1|Double-blind (DB) Phase|Protocol Violation|28
1028171|NCT00232180|3351510|P3|Double-blind (DB) Phase|Withdrawal by Subject|0
1028172|NCT00232180|3351511|P2|Double-blind (DB) Phase|Withdrawal by Subject|148
1028173|NCT00232180|3351512|P1|Double-blind (DB) Phase|Withdrawal by Subject|131
1028174|NCT00232180|3351510|P3|Double-blind (DB) Phase|Lost to Follow-up|0
1028175|NCT00232180|3351511|P2|Double-blind (DB) Phase|Lost to Follow-up|28
1028176|NCT00232180|3351512|P1|Double-blind (DB) Phase|Lost to Follow-up|34
1028177|NCT00232180|3351510|P3|Double-blind (DB) Phase|Death|0
1028178|NCT00232180|3351511|P2|Double-blind (DB) Phase|Death|222
1028179|NCT00232180|3351512|P1|Double-blind (DB) Phase|Death|186
1028180|NCT00232141|3351557|P2|Overall Study|Withdrawal by Subject|3
1028181|NCT00232141|3351558|P1|Overall Study|Withdrawal by Subject|5
1028182|NCT00232141|3351557|P2|Overall Study|Other|10
1028183|NCT00232141|3351558|P1|Overall Study|Other|8
1028184|NCT00232141|3351557|P2|Overall Study|Lost to Follow-up|6
1028185|NCT00232141|3351558|P1|Overall Study|Lost to Follow-up|9
1028186|NCT00232141|3351557|P2|Overall Study|Lack of Efficacy|3
1028187|NCT00232141|3351558|P1|Overall Study|Lack of Efficacy|0
1028188|NCT00232141|3351557|P2|Overall Study|Adverse Event|4
1028189|NCT00232141|3351558|P1|Overall Study|Adverse Event|9
1028190|NCT00231894|3351628|P2|Overall Study|Withdrawal by Subject|1
1028191|NCT00231894|3351629|P1|Overall Study|Withdrawal by Subject|1
1028192|NCT00231816|3351653|P2|Overall Study|Not Specified|1
1028193|NCT00231816|3351654|P1|Overall Study|Not Specified|2
1028194|NCT00231816|3351653|P2|Overall Study|Withdrawal by Subject|3
1028195|NCT00231816|3351654|P1|Overall Study|Withdrawal by Subject|3
1028196|NCT00231816|3351653|P2|Overall Study|Protocol Violation|3
1028197|NCT00231816|3351654|P1|Overall Study|Protocol Violation|2
1028198|NCT00231816|3351653|P2|Overall Study|Lost to Follow-up|5
1028199|NCT00231816|3351654|P1|Overall Study|Lost to Follow-up|8
1028200|NCT00231816|3351653|P2|Overall Study|Adverse Event|0
1028201|NCT00231816|3351654|P1|Overall Study|Adverse Event|1
1028202|NCT00231777|3351669|P2|Overall Study|Other|2
1028203|NCT00231777|3351670|P1|Overall Study|Other|3
1028204|NCT00231777|3351669|P2|Overall Study|Lost to Follow-up|0
1028205|NCT00231777|3351670|P1|Overall Study|Lost to Follow-up|3
1028206|NCT00231478|3351684|P2|Overall Study|Administrative|2
1028207|NCT00231478|3351685|P1|Overall Study|Administrative|3
1028208|NCT00231478|3351684|P2|Overall Study|Adverse Event|1
1028209|NCT00231478|3351685|P1|Overall Study|Adverse Event|0
1028210|NCT00231478|3351684|P2|Overall Study|Withdrawal by Subject|0
1028211|NCT00231478|3351685|P1|Overall Study|Withdrawal by Subject|1
1028212|NCT00231478|3351684|P2|Overall Study|Refused Treatment|1
1028213|NCT00231478|3351685|P1|Overall Study|Refused Treatment|1
1028214|NCT00231478|3351684|P2|Overall Study|Protocol Violation|2
1028215|NCT00231478|3351685|P1|Overall Study|Protocol Violation|3
1028216|NCT00231465|3351697|P1|Overall Study|Did not have follow up CT scans|1
1028217|NCT00231465|3351697|P1|Overall Study|Completed only one cycle|1
1028218|NCT00231179|3351717|P2|Overall Study|Withdrawal by Subject|3
1028219|NCT00231179|3351718|P1|Overall Study|Withdrawal by Subject|3
1028220|NCT00231179|3351717|P2|Overall Study|Lost to Follow-up|21
1028221|NCT00231179|3351718|P1|Overall Study|Lost to Follow-up|21
1028222|NCT00231114|3351745|P2|Post-Treatment Period|Withdrawal by Subject|0
1028223|NCT00231114|3351746|P1|Post-Treatment Period|Withdrawal by Subject|1
1028224|NCT00231114|3351745|P2|Post-Treatment Period|Physician Decision|0
1028225|NCT00231114|3351746|P1|Post-Treatment Period|Physician Decision|1
1028226|NCT00231114|3351745|P2|Post-Treatment Period|Lost to Follow-up|1
1028227|NCT00231114|3351746|P1|Post-Treatment Period|Lost to Follow-up|6
1028228|NCT00231114|3351745|P2|Treatment Period|Death: Motor Vehicle Accident|0
1028229|NCT00231114|3351746|P1|Treatment Period|Death: Motor Vehicle Accident|1
1028230|NCT00231114|3351745|P2|Randomized|Withdrawal by Subject|3
1028231|NCT00231114|3351746|P1|Randomized|Withdrawal by Subject|6
1028232|NCT00231062|3351782|P1|Overall Study|Physician Decision|6
1028233|NCT00230971|3351790|P2|Baseline Participants|Reintervention|0
1028234|NCT00230971|3351791|P1|Baseline Participants|Reintervention|1
1028235|NCT00230971|3351790|P2|Baseline Participants|Failure to return|1
1028236|NCT00230971|3351791|P1|Baseline Participants|Failure to return|1
1028237|NCT00230971|3351790|P2|Baseline Participants|No bacteria observed|0
1028238|NCT00230971|3351791|P1|Baseline Participants|No bacteria observed|1
1028239|NCT00230971|3351790|P2|Baseline Participants|Adverse Event|0
1028240|NCT00230971|3351791|P1|Baseline Participants|Adverse Event|1
1028241|NCT00230971|3351790|P2|Baseline Participants|Withdrawal by Subject|1
1028242|NCT00230971|3351791|P1|Baseline Participants|Withdrawal by Subject|7
1028243|NCT00230971|3351790|P2|Baseline Participants|Death|5
1028244|NCT00230971|3351791|P1|Baseline Participants|Death|6
1028245|NCT00230971|3351790|P2|Baseline Participants|Lost to Follow-up|12
1028246|NCT00230971|3351791|P1|Baseline Participants|Lost to Follow-up|5
1028247|NCT00230971|3351790|P2|Randomization|No study drug administered|3
1028248|NCT00230971|3351791|P1|Randomization|No study drug administered|3
1028249|NCT00230282|3351829|P1|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2
1028250|NCT00230282|3351829|P1|Fludarabine + Cyclophosphamide|Change in diagnosis|1
1028251|NCT00230282|3351829|P1|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1
1028252|NCT00230282|3351829|P1|Fludarabine + Cyclophosphamide|Lost to Follow-up|4
1028253|NCT00230178|3351837|P3|Overall Study|Various other reasons|4
1028254|NCT00230178|3351838|P2|Overall Study|Various other reasons|2
1028255|NCT00230178|3351839|P1|Overall Study|Various other reasons|3
1028256|NCT00230178|3351837|P3|Overall Study|Withdrawal by Subject|1
1028257|NCT00230178|3351838|P2|Overall Study|Withdrawal by Subject|0
1028258|NCT00230178|3351839|P1|Overall Study|Withdrawal by Subject|0
1028259|NCT00230178|3351837|P3|Overall Study|Adverse Event|2
1028260|NCT00230178|3351838|P2|Overall Study|Adverse Event|5
1028261|NCT00230178|3351839|P1|Overall Study|Adverse Event|1
1028262|NCT00230048|3351891|P2|Overall Study|Lost to Follow-up|18
1028263|NCT00230048|3351892|P1|Overall Study|Lost to Follow-up|13
1028264|NCT00229931|3351950|P2|Overall Study|Lost to Follow-up|2
1028265|NCT00229931|3351951|P1|Overall Study|Lost to Follow-up|3
1028266|NCT00229931|3351950|P2|Overall Study|Death|0
1028267|NCT00229931|3351951|P1|Overall Study|Death|1
1028268|NCT00229723|3351966|P7|Maintenance Phase|Other|1
1028269|NCT00229723|3351967|P6|Maintenance Phase|Other|3
1028270|NCT00229723|3351968|P5|Maintenance Phase|Other|3
1028271|NCT00229723|3351969|P4|Maintenance Phase|Other|2
1028272|NCT00229723|3351970|P3|Maintenance Phase|Other|1
1028273|NCT00229723|3351971|P2|Maintenance Phase|Other|4
1028274|NCT00229723|3351972|P1|Maintenance Phase|Other|5
1028275|NCT00229723|3351966|P7|Maintenance Phase|Severe non-compliance|0
1028276|NCT00229723|3351967|P6|Maintenance Phase|Severe non-compliance|0
1028277|NCT00229723|3351968|P5|Maintenance Phase|Severe non-compliance|1
1028278|NCT00229723|3351969|P4|Maintenance Phase|Severe non-compliance|0
1028279|NCT00229723|3351970|P3|Maintenance Phase|Severe non-compliance|0
1028280|NCT00229723|3351971|P2|Maintenance Phase|Severe non-compliance|1
1028281|NCT00229723|3351972|P1|Maintenance Phase|Severe non-compliance|3
1028282|NCT00229723|3351966|P7|Maintenance Phase|Informed consent withdrawn|0
1028283|NCT00229723|3351967|P6|Maintenance Phase|Informed consent withdrawn|1
1028284|NCT00229723|3351968|P5|Maintenance Phase|Informed consent withdrawn|1
1028285|NCT00229723|3351969|P4|Maintenance Phase|Informed consent withdrawn|1
1028286|NCT00229723|3351970|P3|Maintenance Phase|Informed consent withdrawn|0
1028287|NCT00229723|3351971|P2|Maintenance Phase|Informed consent withdrawn|0
1028288|NCT00229723|3351972|P1|Maintenance Phase|Informed consent withdrawn|1
1028289|NCT00229723|3351966|P7|Maintenance Phase|Lost to Follow-up|1
1028290|NCT00229723|3351967|P6|Maintenance Phase|Lost to Follow-up|0
1028291|NCT00229723|3351968|P5|Maintenance Phase|Lost to Follow-up|0
1028292|NCT00229723|3351969|P4|Maintenance Phase|Lost to Follow-up|2
1028293|NCT00229723|3351970|P3|Maintenance Phase|Lost to Follow-up|2
1028294|NCT00229723|3351971|P2|Maintenance Phase|Lost to Follow-up|1
1028295|NCT00229723|3351972|P1|Maintenance Phase|Lost to Follow-up|0
1028296|NCT00229723|3351966|P7|Maintenance Phase|Clinical progression|1
1028297|NCT00229723|3351967|P6|Maintenance Phase|Clinical progression|1
1028298|NCT00229723|3351968|P5|Maintenance Phase|Clinical progression|1
1028299|NCT00229723|3351969|P4|Maintenance Phase|Clinical progression|2
1028300|NCT00229723|3351970|P3|Maintenance Phase|Clinical progression|2
1028301|NCT00229723|3351971|P2|Maintenance Phase|Clinical progression|1
1028302|NCT00229723|3351972|P1|Maintenance Phase|Clinical progression|4
1028303|NCT00229723|3351966|P7|Maintenance Phase|Objective disease progression|5
1028304|NCT00229723|3351967|P6|Maintenance Phase|Objective disease progression|9
1028305|NCT00229723|3351968|P5|Maintenance Phase|Objective disease progression|2
1028306|NCT00229723|3351969|P4|Maintenance Phase|Objective disease progression|6
1028307|NCT00229723|3351970|P3|Maintenance Phase|Objective disease progression|3
1028308|NCT00229723|3351971|P2|Maintenance Phase|Objective disease progression|5
1028309|NCT00229723|3351972|P1|Maintenance Phase|Objective disease progression|5
1028310|NCT00229723|3351966|P7|Maintenance Phase|Adverse Event|2
1028311|NCT00229723|3351967|P6|Maintenance Phase|Adverse Event|5
1028312|NCT00229723|3351968|P5|Maintenance Phase|Adverse Event|7
1028313|NCT00229723|3351969|P4|Maintenance Phase|Adverse Event|4
1028314|NCT00229723|3351970|P3|Maintenance Phase|Adverse Event|1
1028315|NCT00229723|3351971|P2|Maintenance Phase|Adverse Event|2
1028316|NCT00229723|3351972|P1|Maintenance Phase|Adverse Event|7
1028317|NCT00229723|3351966|P7|Concomitant Phase|Other|0
1028318|NCT00229723|3351967|P6|Concomitant Phase|Other|2
1028319|NCT00229723|3351968|P5|Concomitant Phase|Other|0
1028320|NCT00229723|3351969|P4|Concomitant Phase|Other|1
1028321|NCT00229723|3351970|P3|Concomitant Phase|Other|1
1028322|NCT00229723|3351971|P2|Concomitant Phase|Other|0
1028323|NCT00229723|3351972|P1|Concomitant Phase|Other|3
1028324|NCT00229723|3351966|P7|Concomitant Phase|Severe non-compliance|0
1028325|NCT00229723|3351967|P6|Concomitant Phase|Severe non-compliance|0
1028326|NCT00229723|3351968|P5|Concomitant Phase|Severe non-compliance|1
1028327|NCT00229723|3351969|P4|Concomitant Phase|Severe non-compliance|0
1028328|NCT00229723|3351970|P3|Concomitant Phase|Severe non-compliance|0
1028329|NCT00229723|3351971|P2|Concomitant Phase|Severe non-compliance|1
1028330|NCT00229723|3351972|P1|Concomitant Phase|Severe non-compliance|0
1028331|NCT00229723|3351966|P7|Concomitant Phase|Informed consent withdrawn|0
1028332|NCT00229723|3351967|P6|Concomitant Phase|Informed consent withdrawn|0
1028333|NCT00229723|3351968|P5|Concomitant Phase|Informed consent withdrawn|0
1028334|NCT00229723|3351969|P4|Concomitant Phase|Informed consent withdrawn|2
1028335|NCT00229723|3351970|P3|Concomitant Phase|Informed consent withdrawn|0
1028336|NCT00229723|3351971|P2|Concomitant Phase|Informed consent withdrawn|2
1028337|NCT00229723|3351972|P1|Concomitant Phase|Informed consent withdrawn|3
1028338|NCT00229723|3351966|P7|Concomitant Phase|Lost to Follow-up|0
1028339|NCT00229723|3351967|P6|Concomitant Phase|Lost to Follow-up|0
1028340|NCT00229723|3351968|P5|Concomitant Phase|Lost to Follow-up|1
1028341|NCT00229723|3351969|P4|Concomitant Phase|Lost to Follow-up|0
1028342|NCT00229723|3351970|P3|Concomitant Phase|Lost to Follow-up|0
1028343|NCT00229723|3351971|P2|Concomitant Phase|Lost to Follow-up|0
1028344|NCT00229723|3351972|P1|Concomitant Phase|Lost to Follow-up|0
1028345|NCT00229723|3351966|P7|Concomitant Phase|Clinical progression|1
1028346|NCT00229723|3351967|P6|Concomitant Phase|Clinical progression|0
1028347|NCT00229723|3351968|P5|Concomitant Phase|Clinical progression|0
1028348|NCT00229723|3351969|P4|Concomitant Phase|Clinical progression|0
1028349|NCT00229723|3351970|P3|Concomitant Phase|Clinical progression|0
1028350|NCT00229723|3351971|P2|Concomitant Phase|Clinical progression|0
1028351|NCT00229723|3351972|P1|Concomitant Phase|Clinical progression|0
1028352|NCT00229723|3351966|P7|Concomitant Phase|Objective disease progression|0
1028353|NCT00229723|3351967|P6|Concomitant Phase|Objective disease progression|0
1028354|NCT00229723|3351968|P5|Concomitant Phase|Objective disease progression|0
1028355|NCT00229723|3351969|P4|Concomitant Phase|Objective disease progression|0
1028356|NCT00229723|3351970|P3|Concomitant Phase|Objective disease progression|0
1028357|NCT00229723|3351971|P2|Concomitant Phase|Objective disease progression|0
1028358|NCT00229723|3351972|P1|Concomitant Phase|Objective disease progression|0
1028359|NCT00229723|3351966|P7|Concomitant Phase|Adverse Event|2
1028360|NCT00229723|3351967|P6|Concomitant Phase|Adverse Event|1
1028361|NCT00229723|3351968|P5|Concomitant Phase|Adverse Event|0
1028362|NCT00229723|3351969|P4|Concomitant Phase|Adverse Event|2
1028363|NCT00229723|3351970|P3|Concomitant Phase|Adverse Event|5
1028364|NCT00229723|3351971|P2|Concomitant Phase|Adverse Event|2
1028365|NCT00229723|3351972|P1|Concomitant Phase|Adverse Event|4
1028366|NCT00229658|3352025|P2|Overall Study|Withdrawal of consent|39
1028367|NCT00229658|3352026|P1|Overall Study|Withdrawal of consent|46
1028368|NCT00229658|3352025|P2|Overall Study|Serious Adverse Event|2
1028369|NCT00229658|3352026|P1|Overall Study|Serious Adverse Event|2
1028370|NCT00229658|3352025|P2|Overall Study|Lost to Follow-up|55
1028371|NCT00229658|3352026|P1|Overall Study|Lost to Follow-up|82
1028372|NCT00229658|3352025|P2|Overall Study|Other|60
1028373|NCT00229658|3352026|P1|Overall Study|Other|80
1028374|NCT00229658|3352025|P2|Overall Study|Investigator decision|10
1028375|NCT00229658|3352026|P1|Overall Study|Investigator decision|13
1028376|NCT00229658|3352025|P2|Overall Study|Administrative|1
1028377|NCT00229658|3352026|P1|Overall Study|Administrative|2
1028378|NCT00229203|3352062|P2|Overall Study|Withdrawal by Subject|4
1028379|NCT00229203|3352063|P1|Overall Study|Withdrawal by Subject|1
1028380|NCT00229203|3352062|P2|Overall Study|Other|3
1028381|NCT00229203|3352063|P1|Overall Study|Other|3
1028382|NCT00229203|3352062|P2|Overall Study|Death|2
1028383|NCT00229203|3352063|P1|Overall Study|Death|4
1028384|NCT00229203|3352062|P2|Overall Study|Toxicity|1
1028385|NCT00229203|3352063|P1|Overall Study|Toxicity|6
1028386|NCT00229203|3352062|P2|Overall Study|Progressive disease|9
1028387|NCT00229203|3352063|P1|Overall Study|Progressive disease|18
1028388|NCT00228917|3352087|P4|Overall Study|Migrated/moved from study area|0
1028389|NCT00228917|3352088|P3|Overall Study|Migrated/moved from study area|0
1028390|NCT00228917|3352089|P2|Overall Study|Migrated/moved from study area|3
1028391|NCT00228917|3352090|P1|Overall Study|Migrated/moved from study area|0
1028392|NCT00228917|3352087|P4|Overall Study|Lost to Follow-up|0
1028393|NCT00228917|3352088|P3|Overall Study|Lost to Follow-up|0
1028394|NCT00228917|3352089|P2|Overall Study|Lost to Follow-up|0
1028395|NCT00228917|3352090|P1|Overall Study|Lost to Follow-up|1
1028396|NCT00228813|3352116|P1|Overall Study|Death|4
1028397|NCT00228566|3352122|P1|Overall Study|Miscellaneous|1
1028398|NCT00228566|3352122|P1|Overall Study|Withdrawal by Subject|4
1028399|NCT00228566|3352122|P1|Overall Study|Physician Decision|5
1028400|NCT00228566|3352122|P1|Overall Study|Lost to Follow-up|16
1028401|NCT00228566|3352122|P1|Overall Study|Lack of Efficacy|14
1028402|NCT00228566|3352122|P1|Overall Study|Adverse Event|31
1028403|NCT00228553|3352126|P1|Overall Study|Miscellaneous|46
1028404|NCT00228553|3352126|P1|Overall Study|Pregnancy|2
1028405|NCT00228553|3352126|P1|Overall Study|Withdrawal by Subject|115
1028406|NCT00228553|3352126|P1|Overall Study|Protocol Violation|6
1028407|NCT00228553|3352126|P1|Overall Study|Physician Decision|48
1028408|NCT00228553|3352126|P1|Overall Study|Lost to Follow-up|67
1028409|NCT00228553|3352126|P1|Overall Study|Lack of Efficacy|34
1028410|NCT00228553|3352126|P1|Overall Study|Adverse Event|112
1028411|NCT00228384|3352132|P2|Overall Study|Physician Decision|1
1028412|NCT00228384|3352133|P1|Overall Study|Physician Decision|0
1028413|NCT00228384|3352132|P2|Overall Study|Withdrawal by Subject|10
1028414|NCT00228384|3352133|P1|Overall Study|Withdrawal by Subject|9
1028415|NCT00228384|3352132|P2|Overall Study|Surgical Intervention (bypass)|5
1028416|NCT00228384|3352133|P1|Overall Study|Surgical Intervention (bypass)|5
1028417|NCT00228384|3352132|P2|Overall Study|Lost to Follow-up|10
1028418|NCT00228384|3352133|P1|Overall Study|Lost to Follow-up|6
1028419|NCT00228384|3352132|P2|Overall Study|Death|3
1028420|NCT00228384|3352133|P1|Overall Study|Death|9
1028421|NCT00227903|3352184|P2|Overall Study|Miscarriage|0
1028422|NCT00227903|3352185|P1|Overall Study|Miscarriage|1
1028423|NCT00227903|3352184|P2|Overall Study|Lost to Follow-up|3
1028424|NCT00227903|3352185|P1|Overall Study|Lost to Follow-up|1
1028425|NCT00227903|3352184|P2|Overall Study|Subject moved out of area|2
1028426|NCT00227903|3352185|P1|Overall Study|Subject moved out of area|1
1028427|NCT00227903|3352184|P2|Overall Study|Withdrawal by Subject|5
1028428|NCT00227903|3352185|P1|Overall Study|Withdrawal by Subject|2
1028429|NCT00227877|3352249|P4|12-months Follow-up|Lost to Follow-up|26
1028430|NCT00227877|3352250|P3|12-months Follow-up|Lost to Follow-up|30
1028431|NCT00227877|3352251|P2|12-months Follow-up|Lost to Follow-up|189
1028432|NCT00227877|3352252|P1|12-months Follow-up|Lost to Follow-up|232
1028433|NCT00227877|3352249|P4|12-months Follow-up|Completed late|0
1028434|NCT00227877|3352250|P3|12-months Follow-up|Completed late|1
1028435|NCT00227877|3352251|P2|12-months Follow-up|Completed late|74
1028436|NCT00227877|3352252|P1|12-months Follow-up|Completed late|78
1028437|NCT00227877|3352249|P4|3-months Follow-up|Lost to Follow-up|13
1028438|NCT00227877|3352250|P3|3-months Follow-up|Lost to Follow-up|18
1028439|NCT00227877|3352251|P2|3-months Follow-up|Lost to Follow-up|139
1028440|NCT00227877|3352252|P1|3-months Follow-up|Lost to Follow-up|178
1028441|NCT00227877|3352249|P4|3-months Follow-up|Completed late|8
1028442|NCT00227877|3352250|P3|3-months Follow-up|Completed late|34
1028443|NCT00227877|3352251|P2|3-months Follow-up|Completed late|128
1028444|NCT00227877|3352252|P1|3-months Follow-up|Completed late|135
1028445|NCT00227877|3352249|P4|Post-visit Checklist|Lost to Follow-up|0
1028446|NCT00227877|3352250|P3|Post-visit Checklist|Lost to Follow-up|1
1028447|NCT00227877|3352251|P2|Post-visit Checklist|Lost to Follow-up|13
1028448|NCT00227877|3352252|P1|Post-visit Checklist|Lost to Follow-up|24
1028449|NCT00227877|3352249|P4|Pre-visit Assessment|Technical difficulties|0
1028450|NCT00227877|3352250|P3|Pre-visit Assessment|Technical difficulties|0
1028451|NCT00227877|3352251|P2|Pre-visit Assessment|Technical difficulties|3
1028452|NCT00227877|3352252|P1|Pre-visit Assessment|Technical difficulties|7
1028453|NCT00227721|3352288|P1|Overall Study|On study, but never treated.|1
1028454|NCT00227591|3352292|P1|Overall Study|Withdrawal by Subject|1
1028455|NCT00227539|3352296|P1|Overall Study|Protocol Violation|1
1028456|NCT00227370|3352304|P2|Overall Study|Other reasons|1
1028457|NCT00227370|3352305|P1|Overall Study|Other reasons|2
1028458|NCT00227370|3352304|P2|Overall Study|Physician Decision|6
1028459|NCT00227370|3352305|P1|Overall Study|Physician Decision|9
1028460|NCT00227370|3352304|P2|Overall Study|Adverse Event|11
1028461|NCT00227370|3352305|P1|Overall Study|Adverse Event|6
1028462|NCT00227370|3352304|P2|Overall Study|Death|4
1028463|NCT00227370|3352305|P1|Overall Study|Death|3
1028464|NCT00227370|3352304|P2|Overall Study|Withdrawal by Subject|2
1028465|NCT00227370|3352305|P1|Overall Study|Withdrawal by Subject|1
1028466|NCT00227344|3352325|P2|Overall Study|study terminated early|5
1028467|NCT00227344|3352326|P1|Overall Study|study terminated early|12
1028468|NCT00227305|3352346|P1|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1
1028469|NCT00227305|3352346|P1|Overall Study|LEAVING TOWN FOR 6 WEEKS|1
1028470|NCT00227305|3352346|P1|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1
1028471|NCT00227305|3352346|P1|Overall Study|Physician Decision|3
1028472|NCT00227305|3352346|P1|Overall Study|Lack of Efficacy|7
1028473|NCT00227305|3352346|P1|Overall Study|MOVED OUT OF AREA|3
1028474|NCT00227305|3352346|P1|Overall Study|Study specific discontinuation|13
1028475|NCT00227305|3352346|P1|Overall Study|Lost to Follow-up|33
1028476|NCT00227305|3352346|P1|Overall Study|Withdrawal by Subject|42
1028477|NCT00227305|3352346|P1|Overall Study|Adverse Event|40
1028478|NCT00227266|3352363|P3|Overall Study|Excessive weight gain|2
1028479|NCT00227266|3352364|P2|Overall Study|Excessive weight gain|0
1028480|NCT00227266|3352365|P1|Overall Study|Excessive weight gain|0
1028481|NCT00227266|3352363|P3|Overall Study|Protocol Violation|1
1028482|NCT00227266|3352364|P2|Overall Study|Protocol Violation|0
1028483|NCT00227266|3352365|P1|Overall Study|Protocol Violation|1
1028484|NCT00227266|3352363|P3|Overall Study|Withdrawal by Subject|1
1028485|NCT00227266|3352364|P2|Overall Study|Withdrawal by Subject|0
1028486|NCT00227266|3352365|P1|Overall Study|Withdrawal by Subject|0
1028487|NCT00226941|3352395|P4|Overall Study|Withdrawn by investigator - unrelated AE|1
1028488|NCT00226941|3352396|P3|Overall Study|Withdrawn by investigator - unrelated AE|0
1028489|NCT00226941|3352397|P2|Overall Study|Withdrawn by investigator - unrelated AE|0
1028490|NCT00226941|3352398|P1|Overall Study|Withdrawn by investigator - unrelated AE|0
1028491|NCT00226941|3352395|P4|Overall Study|Withdrawal by subject - toxicity|1
1028492|NCT00226941|3352396|P3|Overall Study|Withdrawal by subject - toxicity|0
1028493|NCT00226941|3352397|P2|Overall Study|Withdrawal by subject - toxicity|0
1028494|NCT00226941|3352398|P1|Overall Study|Withdrawal by subject - toxicity|0
1028495|NCT00226811|3352432|P1|Overall Study|Withdrawal by Subject|2
1028496|NCT00226811|3352432|P1|Overall Study|Lack of Efficacy|55
1028497|NCT00226811|3352432|P1|Overall Study|Adverse Event|11
1028498|NCT00226811|3352432|P1|Overall Study|Death|8
1028499|NCT00226655|3352442|P1|Overall Study|Clinical deterioration|10
1028500|NCT00226655|3352442|P1|Overall Study|Physician Decision|6
1028501|NCT00226655|3352442|P1|Overall Study|Adverse Event|35
1028502|NCT00226655|3352442|P1|Overall Study|Withdrawal by Subject|15
1028503|NCT00226655|3352442|P1|Overall Study|Death|13
1028504|NCT00225758|3352481|P1|Overall Study|Adverse Event|4
1028505|NCT00225277|3352513|P2|Overall Study|Other|9
1028506|NCT00225277|3352514|P1|Overall Study|Other|7
1028507|NCT00225277|3352513|P2|Overall Study|Withdrawal by Subject|34
1028508|NCT00225277|3352514|P1|Overall Study|Withdrawal by Subject|40
1028509|NCT00225277|3352513|P2|Overall Study|Protocol Violation|3
1028510|NCT00225277|3352514|P1|Overall Study|Protocol Violation|6
1028511|NCT00225277|3352513|P2|Overall Study|Physician Decision|8
1028512|NCT00225277|3352514|P1|Overall Study|Physician Decision|6
1028513|NCT00225277|3352513|P2|Overall Study|Lost to Follow-up|6
1028514|NCT00225277|3352514|P1|Overall Study|Lost to Follow-up|4
1028515|NCT00225277|3352513|P2|Overall Study|Lack of Efficacy|1
1028516|NCT00225277|3352514|P1|Overall Study|Lack of Efficacy|4
1028517|NCT00225277|3352513|P2|Overall Study|Adverse Event|34
1028518|NCT00225277|3352514|P1|Overall Study|Adverse Event|30
1028519|NCT00225251|3352532|P2|Overall Study|Withdrawal by Subject|1
1028520|NCT00225251|3352533|P1|Overall Study|Withdrawal by Subject|1
1028521|NCT00225212|3352547|P1|Overall Study|Intercurrent illness|1
1028522|NCT00225212|3352547|P1|Overall Study|Adverse Event|2
1028523|NCT00225212|3352547|P1|Overall Study|Death|1
1028524|NCT00225212|3352547|P1|Overall Study|Disease progression|2
1028525|NCT00225147|3352556|P4|Open-label Phase|Withdrawal by Subject|6
1028526|NCT00225147|3352557|P3|Open-label Phase|Withdrawal by Subject|0
1028527|NCT00225147|3352558|P2|Open-label Phase|Withdrawal by Subject|0
1028528|NCT00225147|3352559|P1|Open-label Phase|Withdrawal by Subject|0
1028529|NCT00225147|3352556|P4|Open-label Phase|Lost to Follow-up|4
1028530|NCT00225147|3352557|P3|Open-label Phase|Lost to Follow-up|0
1028531|NCT00225147|3352558|P2|Open-label Phase|Lost to Follow-up|0
1028532|NCT00225147|3352559|P1|Open-label Phase|Lost to Follow-up|0
1028533|NCT00224874|3352606|P4|Overall Study|Withdrawal by Subject|0
1028534|NCT00224874|3352607|P3|Overall Study|Withdrawal by Subject|1
1028535|NCT00224874|3352608|P2|Overall Study|Withdrawal by Subject|0
1028536|NCT00224874|3352609|P1|Overall Study|Withdrawal by Subject|0
1028537|NCT00224770|3352654|P3|Overall Study|Lost to Follow-up|0
1028538|NCT00224770|3352655|P2|Overall Study|Lost to Follow-up|2
1028539|NCT00224770|3352656|P1|Overall Study|Lost to Follow-up|4
1028540|NCT00224484|3352691|P3|Overall Study|Reaon not specified|2
1028541|NCT00224484|3352692|P2|Overall Study|Reaon not specified|4
1028542|NCT00224484|3352693|P1|Overall Study|Reaon not specified|5
1028543|NCT00224484|3352691|P3|Overall Study|Lost to Follow-up|36
1028544|NCT00224484|3352692|P2|Overall Study|Lost to Follow-up|28
1028545|NCT00224484|3352693|P1|Overall Study|Lost to Follow-up|66
1028546|NCT00224484|3352691|P3|Overall Study|Migrated/moved from study area|5
1028547|NCT00224484|3352692|P2|Overall Study|Migrated/moved from study area|5
1028548|NCT00224484|3352693|P1|Overall Study|Migrated/moved from study area|18
1028549|NCT00224484|3352691|P3|Overall Study|Withdrawal by Subject|16
1028550|NCT00224484|3352692|P2|Overall Study|Withdrawal by Subject|18
1028551|NCT00224484|3352693|P1|Overall Study|Withdrawal by Subject|49
1028552|NCT00224484|3352691|P3|Overall Study|Protocol Violation|0
1028553|NCT00224484|3352692|P2|Overall Study|Protocol Violation|2
1028554|NCT00224484|3352693|P1|Overall Study|Protocol Violation|2
1028555|NCT00224484|3352691|P3|Overall Study|Non-Serious Adverse Event|3
1028556|NCT00224484|3352692|P2|Overall Study|Non-Serious Adverse Event|7
1028557|NCT00224484|3352693|P1|Overall Study|Non-Serious Adverse Event|5
1028558|NCT00224484|3352691|P3|Overall Study|Serious Adverse Event|0
1028559|NCT00224484|3352692|P2|Overall Study|Serious Adverse Event|1
1028560|NCT00224484|3352693|P1|Overall Study|Serious Adverse Event|1
1028561|NCT00224133|3352757|P1|Overall Study|Not specified|14
1028562|NCT00224133|3352757|P1|Overall Study|Physician Decision|1
1028563|NCT00224133|3352757|P1|Overall Study|Lost to Follow-up|21
1028564|NCT00224133|3352757|P1|Overall Study|Lack of Efficacy|58
1028565|NCT00224133|3352757|P1|Overall Study|Withdrawal by Subject|33
1028566|NCT00224133|3352757|P1|Overall Study|Protocol Violation|6
1028567|NCT00224133|3352757|P1|Overall Study|Adverse Event|93
1028568|NCT00224120|3352763|P2|Overall Study|Not specified|5
1028569|NCT00224120|3352764|P1|Overall Study|Not specified|4
1028570|NCT00224120|3352763|P2|Overall Study|Lost to Follow-up|3
1028571|NCT00224120|3352764|P1|Overall Study|Lost to Follow-up|2
1028572|NCT00224120|3352763|P2|Overall Study|Lack of Efficacy|2
1028573|NCT00224120|3352764|P1|Overall Study|Lack of Efficacy|0
1028574|NCT00224120|3352763|P2|Overall Study|Withdrawal by Subject|10
1028575|NCT00224120|3352764|P1|Overall Study|Withdrawal by Subject|5
1028576|NCT00224120|3352763|P2|Overall Study|Protocol Violation|0
1028577|NCT00224120|3352764|P1|Overall Study|Protocol Violation|1
1028578|NCT00224120|3352763|P2|Overall Study|Adverse Event|4
1028579|NCT00224120|3352764|P1|Overall Study|Adverse Event|10
1028580|NCT00224107|3352774|P2|Overall Study|Not specified|1
1028581|NCT00224107|3352775|P1|Overall Study|Not specified|1
1028582|NCT00224107|3352774|P2|Overall Study|Physician Decision|0
1028583|NCT00224107|3352775|P1|Overall Study|Physician Decision|1
1028584|NCT00224107|3352774|P2|Overall Study|Lost to Follow-up|0
1028585|NCT00224107|3352775|P1|Overall Study|Lost to Follow-up|4
1028586|NCT00224107|3352774|P2|Overall Study|Lack of Efficacy|0
1028587|NCT00224107|3352775|P1|Overall Study|Lack of Efficacy|2
1028588|NCT00224107|3352774|P2|Overall Study|Withdrawal by Subject|4
1028589|NCT00224107|3352775|P1|Overall Study|Withdrawal by Subject|1
1028590|NCT00224107|3352774|P2|Overall Study|Protocol Violation|3
1028591|NCT00224107|3352775|P1|Overall Study|Protocol Violation|2
1028592|NCT00224107|3352774|P2|Overall Study|Adverse Event|6
1028593|NCT00224107|3352775|P1|Overall Study|Adverse Event|20
1028594|NCT00224055|3352785|P2|Overall Study|Not Specified|0
1028595|NCT00224055|3352786|P1|Overall Study|Not Specified|1
1028596|NCT00224055|3352785|P2|Overall Study|Withdrawal by Subject|2
1028597|NCT00224055|3352786|P1|Overall Study|Withdrawal by Subject|0
1028598|NCT00224055|3352785|P2|Overall Study|Inclusion Violation|6
1028599|NCT00224055|3352786|P1|Overall Study|Inclusion Violation|3
1028600|NCT00224055|3352785|P2|Overall Study|Protocol Violation|1
1028601|NCT00224055|3352786|P1|Overall Study|Protocol Violation|1
1028602|NCT00224055|3352785|P2|Overall Study|Lost to Follow-up|2
1028603|NCT00224055|3352786|P1|Overall Study|Lost to Follow-up|1
1028604|NCT00224055|3352785|P2|Overall Study|Adverse Event|3
1028605|NCT00224055|3352786|P1|Overall Study|Adverse Event|9
1028606|NCT00224042|3352796|P2|Overall Study|Not specified|0
1028607|NCT00224042|3352797|P1|Overall Study|Not specified|2
1028608|NCT00224042|3352796|P2|Overall Study|Did not meet lab incusion criteria|3
1028609|NCT00224042|3352797|P1|Overall Study|Did not meet lab incusion criteria|2
1028610|NCT00224042|3352796|P2|Overall Study|Physician Decision|1
1028611|NCT00224042|3352797|P1|Overall Study|Physician Decision|0
1028612|NCT00224042|3352796|P2|Overall Study|Protocol Violation|1
1028613|NCT00224042|3352797|P1|Overall Study|Protocol Violation|0
1028614|NCT00224042|3352796|P2|Overall Study|Adverse Event|1
1028615|NCT00224042|3352797|P1|Overall Study|Adverse Event|2
1028616|NCT00224029|3352809|P1|Overall Study|Other|1
1028617|NCT00224029|3352809|P1|Overall Study|Withdrawal by Subject|4
1028618|NCT00224029|3352809|P1|Overall Study|Lost to Follow-up|1
1028619|NCT00224016|3352815|P2|Maintenance Period|Lost to Follow-up|1
1028620|NCT00224016|3352816|P1|Maintenance Period|Lost to Follow-up|0
1028621|NCT00224016|3352815|P2|Maintenance Period|Withdrawal by Subject|0
1028622|NCT00224016|3352816|P1|Maintenance Period|Withdrawal by Subject|2
1028623|NCT00224016|3352815|P2|Titration Period|Lost to Follow-up|0
1028624|NCT00224016|3352816|P1|Titration Period|Lost to Follow-up|1
1028625|NCT00224016|3352815|P2|Titration Period|Withdrawal by Subject|1
1028626|NCT00224016|3352816|P1|Titration Period|Withdrawal by Subject|0
1028627|NCT00224003|3352824|P1|Overall Study|unk|3
1028628|NCT00224003|3352824|P1|Overall Study|Withdrawal by Subject|1
1028629|NCT00224003|3352824|P1|Overall Study|Protocol Violation|2
1028630|NCT00224003|3352824|P1|Overall Study|Adverse Event|1
1028631|NCT00223977|3352831|P3|Overall Study|not specified|0
1028632|NCT00223977|3352832|P2|Overall Study|not specified|0
1028633|NCT00223977|3352833|P1|Overall Study|not specified|1
1028634|NCT00223977|3352831|P3|Overall Study|Withdrawal by Subject|2
1028635|NCT00223977|3352832|P2|Overall Study|Withdrawal by Subject|1
1028636|NCT00223977|3352833|P1|Overall Study|Withdrawal by Subject|1
1028637|NCT00223977|3352831|P3|Overall Study|Protocol Violation|1
1028638|NCT00223977|3352832|P2|Overall Study|Protocol Violation|0
1028639|NCT00223977|3352833|P1|Overall Study|Protocol Violation|0
1028640|NCT00223977|3352831|P3|Overall Study|Adverse Event|0
1028641|NCT00223977|3352832|P2|Overall Study|Adverse Event|10
1028642|NCT00223977|3352833|P1|Overall Study|Adverse Event|7
1028643|NCT00223808|3352867|P3|Overall Study|<5 hrs therapy before discharge|5
1028644|NCT00223808|3352868|P2|Overall Study|<5 hrs therapy before discharge|5
1028645|NCT00223808|3352869|P1|Overall Study|<5 hrs therapy before discharge|3
1028646|NCT00223795|3352886|P2|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
1028647|NCT00223795|3352887|P1|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
1028648|NCT00223795|3352886|P2|First Intervention - Eight Weeks|Lost to Follow-up|9
1028649|NCT00223795|3352887|P1|First Intervention - Eight Weeks|Lost to Follow-up|7
1028650|NCT00223496|3352965|P1|Overall Study|Physician Decision|2
1028651|NCT00223496|3352965|P1|Overall Study|Withdrawal by Subject|1
1028652|NCT00223496|3352965|P1|Overall Study|Lack of Efficacy|6
1028653|NCT00223496|3352965|P1|Overall Study|Lost to Follow-up|4
1028654|NCT00223496|3352965|P1|Overall Study|screen failure|9
1028655|NCT00223080|3352986|P2|Overall Study|Adverse Event|1
1028656|NCT00223080|3352987|P1|Overall Study|Adverse Event|0
1028657|NCT00223080|3352986|P2|Overall Study|Reason not provided|140
1028658|NCT00223080|3352987|P1|Overall Study|Reason not provided|141
1028659|NCT00223080|3352986|P2|Overall Study|Other|11
1028660|NCT00223080|3352987|P1|Overall Study|Other|14
1028661|NCT00223080|3352986|P2|Overall Study|Death|74
1028662|NCT00223080|3352987|P1|Overall Study|Death|85
1028663|NCT00223080|3352986|P2|Overall Study|Lost to Follow-up|284
1028664|NCT00223080|3352987|P1|Overall Study|Lost to Follow-up|259
1028665|NCT00223080|3352986|P2|Overall Study|Moved from study area|47
1028666|NCT00223080|3352987|P1|Overall Study|Moved from study area|37
1028667|NCT00223080|3352986|P2|Overall Study|Non-compliant|7
1028668|NCT00223080|3352987|P1|Overall Study|Non-compliant|7
1028669|NCT00223080|3352986|P2|Overall Study|Required contraindicated med|1
1028670|NCT00223080|3352987|P1|Overall Study|Required contraindicated med|0
1028671|NCT00223080|3352986|P2|Overall Study|Withdrawal by Subject|232
1028672|NCT00223080|3352987|P1|Overall Study|Withdrawal by Subject|253
1028673|NCT00222729|3353005|P1|Overall Study|Adverse Event|3
1028674|NCT00222105|3353012|P1|Overall Study|Death|2
1028675|NCT00222105|3353012|P1|Overall Study|Treatment delays|2
1028676|NCT00222105|3353012|P1|Overall Study|Adverse Event|8
1028677|NCT00222105|3353012|P1|Overall Study|Withdrawal by Subject|1
1028678|NCT00222105|3353012|P1|Overall Study|Removed due to wrong diagnosis|1
1028679|NCT00221195|3353033|P2|Overall Study|Lost to Follow-up|1
1028680|NCT00221195|3353034|P1|Overall Study|Lost to Follow-up|0
1028681|NCT00221195|3353033|P2|Overall Study|Death|1
1028682|NCT00221195|3353034|P1|Overall Study|Death|1
1028683|NCT00221195|3353033|P2|Overall Study|Withdrawal by Subject|1
1028684|NCT00221195|3353034|P1|Overall Study|Withdrawal by Subject|4
1028685|NCT00221104|3353056|P2|Overall Study|Others|47
1028686|NCT00221104|3353057|P1|Overall Study|Others|37
1028687|NCT00221104|3353056|P2|Overall Study|Withdrawal by Subject|29
1028688|NCT00221104|3353057|P1|Overall Study|Withdrawal by Subject|42
1028689|NCT00221104|3353056|P2|Overall Study|Protocol Violation|0
1028690|NCT00221104|3353057|P1|Overall Study|Protocol Violation|2
1028691|NCT00221104|3353056|P2|Overall Study|Physician Decision|0
1028692|NCT00221104|3353057|P1|Overall Study|Physician Decision|1
1028693|NCT00221104|3353056|P2|Overall Study|Adverse Event|0
1028694|NCT00221104|3353057|P1|Overall Study|Adverse Event|1
1028695|NCT00220805|3353090|P2|Overall Study|Develop. of choroidal neovascularization|8
1028696|NCT00220805|3353091|P1|Overall Study|Develop. of choroidal neovascularization|3
1028697|NCT00220805|3353090|P2|Overall Study|Lack of Efficacy|0
1028698|NCT00220805|3353091|P1|Overall Study|Lack of Efficacy|1
1028699|NCT00220805|3353090|P2|Overall Study|Withdrawal by Subject|0
1028700|NCT00220805|3353091|P1|Overall Study|Withdrawal by Subject|3
1028701|NCT00220805|3353090|P2|Overall Study|Adverse Event|3
1028702|NCT00220805|3353091|P1|Overall Study|Adverse Event|1
1028703|NCT00220779|3353112|P3|Overall Study|Lack of Efficacy|1
1028704|NCT00220779|3353113|P2|Overall Study|Lack of Efficacy|0
1028705|NCT00220779|3353114|P1|Overall Study|Lack of Efficacy|3
1028706|NCT00220779|3353112|P3|Overall Study|Pregnancy|2
1028707|NCT00220779|3353113|P2|Overall Study|Pregnancy|0
1028708|NCT00220779|3353114|P1|Overall Study|Pregnancy|0
1028709|NCT00220779|3353112|P3|Overall Study|Too time consuming|0
1028710|NCT00220779|3353113|P2|Overall Study|Too time consuming|0
1028711|NCT00220779|3353114|P1|Overall Study|Too time consuming|1
1028712|NCT00220779|3353112|P3|Overall Study|Non-compliance|0
1028713|NCT00220779|3353113|P2|Overall Study|Non-compliance|0
1028714|NCT00220779|3353114|P1|Overall Study|Non-compliance|1
1028715|NCT00220779|3353112|P3|Overall Study|Withdrawal by Subject|1
1028716|NCT00220779|3353113|P2|Overall Study|Withdrawal by Subject|4
1028717|NCT00220779|3353114|P1|Overall Study|Withdrawal by Subject|1
1028718|NCT00220779|3353112|P3|Overall Study|Adverse Event|0
1028719|NCT00220779|3353113|P2|Overall Study|Adverse Event|0
1028720|NCT00220779|3353114|P1|Overall Study|Adverse Event|1
1028721|NCT00220740|3353124|P2|Efficacy Period|Entered Rescue Treatment with IGIV-C|45
1028722|NCT00220740|3353125|P1|Efficacy Period|Entered Rescue Treatment with IGIV-C|0
1028723|NCT00220740|3353124|P2|Efficacy Period|Protocol Violation|0
1028724|NCT00220740|3353125|P1|Efficacy Period|Protocol Violation|1
1028725|NCT00220740|3353124|P2|Efficacy Period|Withdrawal by Subject|0
1028726|NCT00220740|3353125|P1|Efficacy Period|Withdrawal by Subject|1
1028727|NCT00220740|3353124|P2|Efficacy Period|Adverse Event|1
1028728|NCT00220740|3353125|P1|Efficacy Period|Adverse Event|1
1028729|NCT00220740|3353124|P2|Efficacy Period|Entered rescue treatment with placebo|0
1028730|NCT00220740|3353125|P1|Efficacy Period|Entered rescue treatment with placebo|23
1028731|NCT00220727|3353139|P2|Second Infusion (Week <6)|Pt did not meet study requirement|0
1028732|NCT00220727|3353140|P1|Second Infusion (Week <6)|Pt did not meet study requirement|1
1028733|NCT00220701|3353156|P2|Overall Study|Lost to Follow-up|4
1028734|NCT00220701|3353157|P1|Overall Study|Lost to Follow-up|5
1028735|NCT00220636|3353173|P1|Overall Study|Withdrawal by Subject|4
1028736|NCT00219557|3353183|P3|Phase 2|Treatment not received|3
1028737|NCT00219557|3353184|P2|Phase 2|Treatment not received|1
1028738|NCT00219557|3353185|P1|Phase 2|Treatment not received|0
1028739|NCT00219557|3353183|P3|Phase 2|Withdrawal by Subject|5
1028740|NCT00219557|3353184|P2|Phase 2|Withdrawal by Subject|9
1028741|NCT00219557|3353185|P1|Phase 2|Withdrawal by Subject|0
1028742|NCT00219557|3353183|P3|Phase 2|Other|6
1028743|NCT00219557|3353184|P2|Phase 2|Other|8
1028744|NCT00219557|3353185|P1|Phase 2|Other|0
1028745|NCT00219557|3353183|P3|Phase 2|Death|2
1028746|NCT00219557|3353184|P2|Phase 2|Death|8
1028747|NCT00219557|3353185|P1|Phase 2|Death|0
1028748|NCT00219557|3353183|P3|Phase 2|Adverse Event|2
1028749|NCT00219557|3353184|P2|Phase 2|Adverse Event|22
1028750|NCT00219557|3353185|P1|Phase 2|Adverse Event|0
1028751|NCT00219557|3353183|P3|Phase 2|Lack of Efficacy|15
1028752|NCT00219557|3353184|P2|Phase 2|Lack of Efficacy|21
1028753|NCT00219557|3353185|P1|Phase 2|Lack of Efficacy|0
1028754|NCT00219557|3353183|P3|Phase 1|Started chemotherapy at other institute|0
1028755|NCT00219557|3353184|P2|Phase 1|Started chemotherapy at other institute|0
1028756|NCT00219557|3353185|P1|Phase 1|Started chemotherapy at other institute|1
1028757|NCT00219557|3353183|P3|Phase 1|Withdrawal by Subject|0
1028758|NCT00219557|3353184|P2|Phase 1|Withdrawal by Subject|0
1028759|NCT00219557|3353185|P1|Phase 1|Withdrawal by Subject|1
1028760|NCT00219557|3353183|P3|Phase 1|Adverse Event|0
1028761|NCT00219557|3353184|P2|Phase 1|Adverse Event|0
1028762|NCT00219557|3353185|P1|Phase 1|Adverse Event|2
1028763|NCT00219557|3353183|P3|Phase 1|Lack of Efficacy|0
1028764|NCT00219557|3353184|P2|Phase 1|Lack of Efficacy|0
1028765|NCT00219557|3353185|P1|Phase 1|Lack of Efficacy|3
1028766|NCT00219544|3353213|P2|Single Blind Treatment Period|Withdrawal by Subject|0
1028767|NCT00219544|3353214|P1|Single Blind Treatment Period|Withdrawal by Subject|1
1028768|NCT00219544|3353213|P2|Single Blind Treatment Period|Investigator decision to withdraw|0
1028769|NCT00219544|3353214|P1|Single Blind Treatment Period|Investigator decision to withdraw|1
1028770|NCT00219544|3353213|P2|Single Blind Treatment Period|Lost to Follow-up|0
1028771|NCT00219544|3353214|P1|Single Blind Treatment Period|Lost to Follow-up|2
1028772|NCT00219544|3353213|P2|Single Blind Treatment Period|Protocol Violation|0
1028773|NCT00219544|3353214|P1|Single Blind Treatment Period|Protocol Violation|4
1028774|NCT00219544|3353213|P2|Single Blind Treatment Period|Adverse Event|0
1028775|NCT00219544|3353214|P1|Single Blind Treatment Period|Adverse Event|9
1028776|NCT00219544|3353213|P2|Single Blind Treatment Period|Lack of Efficacy|0
1028777|NCT00219544|3353214|P1|Single Blind Treatment Period|Lack of Efficacy|5
1028778|NCT00219349|3353252|P1|Escitalopram Phase|Withdrawal by Subject|3
1028779|NCT00219349|3353252|P1|Cognitive Behavioral Therapy Phase|Protocol Violation|2
1028780|NCT00219349|3353252|P1|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2
1028781|NCT00219349|3353252|P1|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6
1028782|NCT00219284|3353265|P2|Extension Phase - 8 Weeks|Lost to Follow-up|2
1028783|NCT00219284|3353266|P1|Extension Phase - 8 Weeks|Lost to Follow-up|0
1028784|NCT00219284|3353265|P2|Extension Phase - 8 Weeks|Withdrawal by Subject|2
1028785|NCT00219284|3353266|P1|Extension Phase - 8 Weeks|Withdrawal by Subject|0
1028786|NCT00219284|3353265|P2|Extension Phase - 8 Weeks|Adverse Event|3
1028787|NCT00219284|3353266|P1|Extension Phase - 8 Weeks|Adverse Event|2
1028788|NCT00219284|3353265|P2|Treatment Phase - 16 Weeks|Lost to Follow-up|2
1028789|NCT00219284|3353266|P1|Treatment Phase - 16 Weeks|Lost to Follow-up|1
1028790|NCT00219284|3353265|P2|Treatment Phase - 16 Weeks|Withdrawal by Subject|9
1028791|NCT00219284|3353266|P1|Treatment Phase - 16 Weeks|Withdrawal by Subject|5
1028792|NCT00219284|3353265|P2|Treatment Phase - 16 Weeks|Protocol Violation|5
1028793|NCT00219284|3353266|P1|Treatment Phase - 16 Weeks|Protocol Violation|9
1028794|NCT00219284|3353265|P2|Treatment Phase - 16 Weeks|Lack of Efficacy|10
1028795|NCT00219284|3353266|P1|Treatment Phase - 16 Weeks|Lack of Efficacy|3
1028796|NCT00219284|3353265|P2|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1
1028797|NCT00219284|3353266|P1|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0
1028798|NCT00219284|3353265|P2|Treatment Phase - 16 Weeks|Adverse Event|24
1028799|NCT00219284|3353266|P1|Treatment Phase - 16 Weeks|Adverse Event|26
1028800|NCT00219141|3353291|P3|Overall Study|Condition no longer requires study drug|0
1028801|NCT00219141|3353292|P2|Overall Study|Condition no longer requires study drug|0
1028802|NCT00219141|3353293|P1|Overall Study|Condition no longer requires study drug|1
1028803|NCT00219141|3353291|P3|Overall Study|Withdrawal by Subject|5
1028804|NCT00219141|3353292|P2|Overall Study|Withdrawal by Subject|3
1028805|NCT00219141|3353293|P1|Overall Study|Withdrawal by Subject|1
1028806|NCT00219141|3353291|P3|Overall Study|Protocol Violation|1
1028807|NCT00219141|3353292|P2|Overall Study|Protocol Violation|1
1028808|NCT00219141|3353293|P1|Overall Study|Protocol Violation|3
1028809|NCT00219141|3353291|P3|Overall Study|Lost to Follow-up|1
1028810|NCT00219141|3353292|P2|Overall Study|Lost to Follow-up|4
1028811|NCT00219141|3353293|P1|Overall Study|Lost to Follow-up|2
1028812|NCT00219141|3353291|P3|Overall Study|Administrative problems|0
1028813|NCT00219141|3353292|P2|Overall Study|Administrative problems|1
1028814|NCT00219141|3353293|P1|Overall Study|Administrative problems|0
1028815|NCT00219141|3353291|P3|Overall Study|Lack of Efficacy|0
1028816|NCT00219141|3353292|P2|Overall Study|Lack of Efficacy|2
1028817|NCT00219141|3353293|P1|Overall Study|Lack of Efficacy|3
1028818|NCT00219141|3353291|P3|Overall Study|Adverse Event|5
1028819|NCT00219141|3353292|P2|Overall Study|Adverse Event|10
1028820|NCT00219141|3353293|P1|Overall Study|Adverse Event|4
1028821|NCT00218634|3353339|P2|Overall Study|Lost to Follow-up|15
1028822|NCT00218634|3353340|P1|Overall Study|Lost to Follow-up|8
1028823|NCT00218543|3353360|P1|Overall Study|Adverse Event|2
1028824|NCT00218543|3353360|P1|Overall Study|Physician Decision|3
1028825|NCT00218543|3353360|P1|Overall Study|Withdrawal by Subject|1
1028826|NCT00218543|3353360|P1|Overall Study|relocated|1
1028827|NCT00218543|3353360|P1|Overall Study|Lost to Follow-up|8
1028828|NCT00218296|3353466|P2|Overall Study|Randomized but did not enter treatment|67
1028829|NCT00218296|3353467|P1|Overall Study|Randomized but did not enter treatment|66
1028830|NCT00218296|3353466|P2|Overall Study|Withdrawal by Subject|47
1028831|NCT00218296|3353467|P1|Overall Study|Withdrawal by Subject|36
1028832|NCT00218296|3353466|P2|Overall Study|Lost to Follow-up|7
1028833|NCT00218296|3353467|P1|Overall Study|Lost to Follow-up|9
1028834|NCT00217971|3353570|P2|Overall Study|non compliant|0
1028835|NCT00217971|3353571|P1|Overall Study|non compliant|1
1028836|NCT00217971|3353570|P2|Overall Study|Withdrawal by Subject|12
1028837|NCT00217971|3353571|P1|Overall Study|Withdrawal by Subject|7
1028838|NCT00217971|3353570|P2|Overall Study|Physician Decision|1
1028839|NCT00217971|3353571|P1|Overall Study|Physician Decision|0
1028840|NCT00217971|3353570|P2|Overall Study|Lost to Follow-up|19
1028841|NCT00217971|3353571|P1|Overall Study|Lost to Follow-up|15
1028842|NCT00217971|3353570|P2|Overall Study|Adverse Event|1
1028843|NCT00217971|3353571|P1|Overall Study|Adverse Event|1
1028844|NCT00217672|3353586|P2|Follow-up|Lost to Follow-up|0
1028845|NCT00217672|3353587|P1|Follow-up|Lost to Follow-up|1
1028846|NCT00217672|3353586|P2|Follow-up|Withdrawal by Subject|0
1028847|NCT00217672|3353587|P1|Follow-up|Withdrawal by Subject|4
1028848|NCT00217672|3353586|P2|Treatment|secondary malignancy|0
1028849|NCT00217672|3353587|P1|Treatment|secondary malignancy|1
1028850|NCT00217672|3353586|P2|Treatment|Death|0
1028851|NCT00217672|3353587|P1|Treatment|Death|2
1028852|NCT00217672|3353586|P2|Treatment|insurance issues|1
1028853|NCT00217672|3353587|P1|Treatment|insurance issues|1
1028854|NCT00217672|3353586|P2|Treatment|Physician Decision|0
1028855|NCT00217672|3353587|P1|Treatment|Physician Decision|6
1028856|NCT00217672|3353586|P2|Treatment|reqd treatment not permitted by protocol|0
1028857|NCT00217672|3353587|P1|Treatment|reqd treatment not permitted by protocol|6
1028858|NCT00217672|3353586|P2|Treatment|Adverse Event|2
1028859|NCT00217672|3353587|P1|Treatment|Adverse Event|18
1028860|NCT00217672|3353586|P2|Treatment|disease progression|4
1028861|NCT00217672|3353587|P1|Treatment|disease progression|33
1028862|NCT00217672|3353586|P2|Allocation|Ineligible|0
1028863|NCT00217672|3353587|P1|Allocation|Ineligible|2
1028864|NCT00217620|3353593|P1|Overall Study|Never received treatment|1
1028865|NCT00217620|3353593|P1|Overall Study|Ineligible|13
1028866|NCT00217620|3353593|P1|Overall Study|Not Protocol Specified|4
1028867|NCT00217620|3353593|P1|Overall Study|Progression|31
1028868|NCT00217620|3353593|P1|Overall Study|Adverse Event|2
1028869|NCT00217581|3353608|P1|Overall Study|Withdrawal by Subject|1
1028870|NCT00217464|3353637|P1|Overall Study|not specified|2
1028871|NCT00217464|3353637|P1|Overall Study|Progression|15
1028872|NCT00217425|3353653|P1|Overall Study|Other|4
1028873|NCT00217425|3353653|P1|Overall Study|Other complicating disease|1
1028874|NCT00217425|3353653|P1|Overall Study|Withdrawal by Subject|4
1028875|NCT00217425|3353653|P1|Overall Study|Adverse Event|8
1028876|NCT00217425|3353653|P1|Overall Study|Lack of Efficacy|13
1028877|NCT00217425|3353653|P1|Overall Study|Patient ineligible|5
1028878|NCT00217425|3353653|P1|Overall Study|Never started treatment|2
1028879|NCT00217087|3353667|P2|Overall Study|completed less than 12 months return|18
1028880|NCT00217087|3353668|P1|Overall Study|completed less than 12 months return|10
1028881|NCT00217087|3353667|P2|Overall Study|decided to have esophagectomy|2
1028882|NCT00217087|3353668|P1|Overall Study|decided to have esophagectomy|1
1028883|NCT00217022|3353682|P2|Overall Study|Withdrawal by Subject|1
1028884|NCT00217022|3353683|P1|Overall Study|Withdrawal by Subject|1
1028885|NCT00216736|3353693|P2|Overall Study|Lost to Follow-up|1
1028886|NCT00216736|3353694|P1|Overall Study|Lost to Follow-up|1
1028887|NCT00216671|3353708|P2|Overall Study|Insufficient Response Adverse Event|1
1028888|NCT00216671|3353709|P1|Overall Study|Insufficient Response Adverse Event|2
1028889|NCT00216671|3353708|P2|Overall Study|Ineligible, no efficacy data|2
1028890|NCT00216671|3353709|P1|Overall Study|Ineligible, no efficacy data|2
1028891|NCT00216671|3353708|P2|Overall Study|Patient Moved|1
1028892|NCT00216671|3353709|P1|Overall Study|Patient Moved|0
1028893|NCT00216671|3353708|P2|Overall Study|Investigator Illness|1
1028894|NCT00216671|3353709|P1|Overall Study|Investigator Illness|0
1028895|NCT00216671|3353708|P2|Overall Study|Relapse|0
1028896|NCT00216671|3353709|P1|Overall Study|Relapse|1
1028897|NCT00216671|3353708|P2|Overall Study|Protocol Violation|5
1028898|NCT00216671|3353709|P1|Overall Study|Protocol Violation|3
1028899|NCT00216671|3353708|P2|Overall Study|Physician Decision|1
1028900|NCT00216671|3353709|P1|Overall Study|Physician Decision|1
1028901|NCT00216671|3353708|P2|Overall Study|Ineligible|2
1028902|NCT00216671|3353709|P1|Overall Study|Ineligible|0
1028903|NCT00216671|3353708|P2|Overall Study|Non compliant|2
1028904|NCT00216671|3353709|P1|Overall Study|Non compliant|2
1028905|NCT00216671|3353708|P2|Overall Study|Lost to Follow-up|5
1028906|NCT00216671|3353709|P1|Overall Study|Lost to Follow-up|3
1028907|NCT00216671|3353708|P2|Overall Study|Insufficient Response|4
1028908|NCT00216671|3353709|P1|Overall Study|Insufficient Response|9
1028909|NCT00216671|3353708|P2|Overall Study|No Need to Continue Medication|1
1028910|NCT00216671|3353709|P1|Overall Study|No Need to Continue Medication|1
1028911|NCT00216671|3353708|P2|Overall Study|Refused Injections|13
1028912|NCT00216671|3353709|P1|Overall Study|Refused Injections|3
1028913|NCT00216671|3353708|P2|Overall Study|Withdrawal by Subject|2
1028914|NCT00216671|3353709|P1|Overall Study|Withdrawal by Subject|4
1028915|NCT00216671|3353708|P2|Overall Study|Pregnancy|1
1028916|NCT00216671|3353709|P1|Overall Study|Pregnancy|0
1028917|NCT00216671|3353708|P2|Overall Study|Adverse Event|9
1028918|NCT00216671|3353709|P1|Overall Study|Adverse Event|4
1028919|NCT00216476|3353727|P3|Overall Study|Patient Moved|0
1028920|NCT00216476|3353728|P2|Overall Study|Patient Moved|2
1028921|NCT00216476|3353729|P1|Overall Study|Patient Moved|2
1028922|NCT00216476|3353727|P3|Overall Study|Protocol Deviation|0
1028923|NCT00216476|3353728|P2|Overall Study|Protocol Deviation|1
1028924|NCT00216476|3353729|P1|Overall Study|Protocol Deviation|5
1028925|NCT00216476|3353727|P3|Overall Study|Administrative Reasons|0
1028926|NCT00216476|3353728|P2|Overall Study|Administrative Reasons|1
1028927|NCT00216476|3353729|P1|Overall Study|Administrative Reasons|1
1028928|NCT00216476|3353727|P3|Overall Study|Higher dose/Extra Medication Required|2
1028929|NCT00216476|3353728|P2|Overall Study|Higher dose/Extra Medication Required|0
1028930|NCT00216476|3353729|P1|Overall Study|Higher dose/Extra Medication Required|2
1028931|NCT00216476|3353727|P3|Overall Study|Non-compliance|1
1028932|NCT00216476|3353728|P2|Overall Study|Non-compliance|4
1028933|NCT00216476|3353729|P1|Overall Study|Non-compliance|0
1028934|NCT00216476|3353727|P3|Overall Study|No Further Need for Treatment|1
1028935|NCT00216476|3353728|P2|Overall Study|No Further Need for Treatment|4
1028936|NCT00216476|3353729|P1|Overall Study|No Further Need for Treatment|3
1028937|NCT00216476|3353727|P3|Overall Study|Refuses Injection|0
1028938|NCT00216476|3353728|P2|Overall Study|Refuses Injection|0
1028939|NCT00216476|3353729|P1|Overall Study|Refuses Injection|11
1028940|NCT00216476|3353727|P3|Overall Study|Other|1
1028941|NCT00216476|3353728|P2|Overall Study|Other|0
1028942|NCT00216476|3353729|P1|Overall Study|Other|0
1028943|NCT00216476|3353727|P3|Overall Study|Pregnancy|1
1028944|NCT00216476|3353728|P2|Overall Study|Pregnancy|1
1028945|NCT00216476|3353729|P1|Overall Study|Pregnancy|0
1028946|NCT00216476|3353727|P3|Overall Study|Death|0
1028947|NCT00216476|3353728|P2|Overall Study|Death|0
1028948|NCT00216476|3353729|P1|Overall Study|Death|2
1028949|NCT00216476|3353727|P3|Overall Study|Lack of Efficacy|0
1028950|NCT00216476|3353728|P2|Overall Study|Lack of Efficacy|3
1028951|NCT00216476|3353729|P1|Overall Study|Lack of Efficacy|4
1028952|NCT00216476|3353727|P3|Overall Study|Adverse Event|1
1028953|NCT00216476|3353728|P2|Overall Study|Adverse Event|10
1028954|NCT00216476|3353729|P1|Overall Study|Adverse Event|6
1028955|NCT00216476|3353727|P3|Overall Study|Lost to Follow-up|1
1028956|NCT00216476|3353728|P2|Overall Study|Lost to Follow-up|9
1028957|NCT00216476|3353729|P1|Overall Study|Lost to Follow-up|10
1028958|NCT00216476|3353727|P3|Overall Study|Withdrawal by Subject|9
1028959|NCT00216476|3353728|P2|Overall Study|Withdrawal by Subject|72
1028960|NCT00216476|3353729|P1|Overall Study|Withdrawal by Subject|59
1028961|NCT00216203|3353766|P1|Overall Study|Withdrawal by Subject|2
1028962|NCT00216086|3353796|P1|Overall Study|Social Reasons|2
1028963|NCT00216086|3353796|P1|Overall Study|Diagnosis of Metastatic Disease|1
1028964|NCT00216086|3353796|P1|Overall Study|Protocol Violation|1
1028965|NCT00215943|3353828|P2|Overall Study|Other complications|1
1028966|NCT00215943|3353829|P1|Overall Study|Other complications|3
1028967|NCT00215943|3353828|P2|Overall Study|Other disease|1
1028968|NCT00215943|3353829|P1|Overall Study|Other disease|0
1028969|NCT00215943|3353828|P2|Overall Study|Adverse Event|6
1028970|NCT00215943|3353829|P1|Overall Study|Adverse Event|3
1028971|NCT00215943|3353828|P2|Overall Study|Alternate therapy|1
1028972|NCT00215943|3353829|P1|Overall Study|Alternate therapy|0
1028973|NCT00215943|3353828|P2|Overall Study|Disease Progression|5
1028974|NCT00215943|3353829|P1|Overall Study|Disease Progression|3
1028975|NCT00215683|3353854|P3|Overall Study|Intermittent therapy required|0
1028976|NCT00215683|3353855|P2|Overall Study|Intermittent therapy required|1
1028977|NCT00215683|3353856|P1|Overall Study|Intermittent therapy required|0
1028978|NCT00215683|3353854|P3|Overall Study|No study drug available|0
1028979|NCT00215683|3353855|P2|Overall Study|No study drug available|1
1028980|NCT00215683|3353856|P1|Overall Study|No study drug available|0
1028981|NCT00215683|3353854|P3|Overall Study|Difficult to attend visits|0
1028982|NCT00215683|3353855|P2|Overall Study|Difficult to attend visits|1
1028983|NCT00215683|3353856|P1|Overall Study|Difficult to attend visits|0
1028984|NCT00215683|3353854|P3|Overall Study|Physician Decision|1
1028985|NCT00215683|3353855|P2|Overall Study|Physician Decision|0
1028986|NCT00215683|3353856|P1|Overall Study|Physician Decision|0
1028987|NCT00215683|3353854|P3|Overall Study|Withdrawal by Subject|13
1028988|NCT00215683|3353855|P2|Overall Study|Withdrawal by Subject|4
1028989|NCT00215683|3353856|P1|Overall Study|Withdrawal by Subject|9
1028990|NCT00215683|3353854|P3|Overall Study|Lost to Follow-up|1
1028991|NCT00215683|3353855|P2|Overall Study|Lost to Follow-up|2
1028992|NCT00215683|3353856|P1|Overall Study|Lost to Follow-up|0
1028993|NCT00215683|3353854|P3|Overall Study|Lack of Efficacy|2
1028994|NCT00215683|3353855|P2|Overall Study|Lack of Efficacy|1
1028995|NCT00215683|3353856|P1|Overall Study|Lack of Efficacy|5
1028996|NCT00215683|3353854|P3|Overall Study|Adverse Event|15
1028997|NCT00215683|3353855|P2|Overall Study|Adverse Event|16
1028998|NCT00215683|3353856|P1|Overall Study|Adverse Event|15
1028999|NCT00215657|3353875|P8|Overall Study|Not specified|1
1029000|NCT00215657|3353876|P7|Overall Study|Not specified|6
1029001|NCT00215657|3353877|P6|Overall Study|Not specified|4
1029002|NCT00215657|3353878|P5|Overall Study|Not specified|5
1029003|NCT00215657|3353879|P4|Overall Study|Not specified|3
1029004|NCT00215657|3353880|P3|Overall Study|Not specified|2
1029005|NCT00215657|3353881|P2|Overall Study|Not specified|1
1029006|NCT00215657|3353882|P1|Overall Study|Not specified|3
1029007|NCT00215657|3353875|P8|Overall Study|Insufficient testosterone response|7
1029008|NCT00215657|3353876|P7|Overall Study|Insufficient testosterone response|4
1029009|NCT00215657|3353877|P6|Overall Study|Insufficient testosterone response|12
1029010|NCT00215657|3353878|P5|Overall Study|Insufficient testosterone response|8
1029011|NCT00215657|3353879|P4|Overall Study|Insufficient testosterone response|12
1029012|NCT00215657|3353880|P3|Overall Study|Insufficient testosterone response|1
1029013|NCT00215657|3353881|P2|Overall Study|Insufficient testosterone response|4
1029014|NCT00215657|3353882|P1|Overall Study|Insufficient testosterone response|5
1029015|NCT00215657|3353875|P8|Overall Study|Insuff prostate specific antigen resp|2
1029016|NCT00215657|3353876|P7|Overall Study|Insuff prostate specific antigen resp|3
1029017|NCT00215657|3353877|P6|Overall Study|Insuff prostate specific antigen resp|2
1029018|NCT00215657|3353878|P5|Overall Study|Insuff prostate specific antigen resp|1
1029019|NCT00215657|3353879|P4|Overall Study|Insuff prostate specific antigen resp|2
1029020|NCT00215657|3353880|P3|Overall Study|Insuff prostate specific antigen resp|2
1029021|NCT00215657|3353881|P2|Overall Study|Insuff prostate specific antigen resp|2
1029022|NCT00215657|3353882|P1|Overall Study|Insuff prostate specific antigen resp|3
1029023|NCT00215657|3353875|P8|Overall Study|Withdrawal by Subject|3
1029024|NCT00215657|3353876|P7|Overall Study|Withdrawal by Subject|10
1029025|NCT00215657|3353877|P6|Overall Study|Withdrawal by Subject|1
1029026|NCT00215657|3353878|P5|Overall Study|Withdrawal by Subject|6
1029027|NCT00215657|3353879|P4|Overall Study|Withdrawal by Subject|1
1029028|NCT00215657|3353880|P3|Overall Study|Withdrawal by Subject|3
1029029|NCT00215657|3353881|P2|Overall Study|Withdrawal by Subject|3
1029030|NCT00215657|3353882|P1|Overall Study|Withdrawal by Subject|6
1029031|NCT00215657|3353875|P8|Overall Study|Adverse Event|3
1029032|NCT00215657|3353876|P7|Overall Study|Adverse Event|0
1029033|NCT00215657|3353877|P6|Overall Study|Adverse Event|1
1029034|NCT00215657|3353878|P5|Overall Study|Adverse Event|3
1029035|NCT00215657|3353879|P4|Overall Study|Adverse Event|0
1029036|NCT00215657|3353880|P3|Overall Study|Adverse Event|3
1029037|NCT00215657|3353881|P2|Overall Study|Adverse Event|1
1029038|NCT00215657|3353882|P1|Overall Study|Adverse Event|5
1029039|NCT00215644|3353910|P2|Overall Study|Randomized but Not Treated|0
1029040|NCT00215644|3353911|P1|Overall Study|Randomized but Not Treated|1
1029041|NCT00215644|3353910|P2|Overall Study|Other|15
1029042|NCT00215644|3353911|P1|Overall Study|Other|3
1029043|NCT00215644|3353910|P2|Overall Study|Withdrawal by Subject|0
1029044|NCT00215644|3353911|P1|Overall Study|Withdrawal by Subject|1
1029045|NCT00215644|3353910|P2|Overall Study|Death|2
1029046|NCT00215644|3353911|P1|Overall Study|Death|1
1029047|NCT00215644|3353910|P2|Overall Study|Adverse Event|9
1029048|NCT00215644|3353911|P1|Overall Study|Adverse Event|2
1029049|NCT00215644|3353910|P2|Overall Study|Disease Progression|10
1029050|NCT00215644|3353911|P1|Overall Study|Disease Progression|28
1029051|NCT00215553|3353938|P7|Overall Study|Adverse Event|0
1029052|NCT00215553|3353939|P6|Overall Study|Adverse Event|6
1029053|NCT00215553|3353940|P5|Overall Study|Adverse Event|2
1029054|NCT00215553|3353941|P4|Overall Study|Adverse Event|1
1029055|NCT00215553|3353942|P3|Overall Study|Adverse Event|2
1029056|NCT00215553|3353943|P2|Overall Study|Adverse Event|1
1029057|NCT00215553|3353944|P1|Overall Study|Adverse Event|0
1029058|NCT00215540|3353977|P3|Overall Study|Withdrew from study medication|0
1029059|NCT00215540|3353978|P2|Overall Study|Withdrew from study medication|0
1029060|NCT00215540|3353979|P1|Overall Study|Withdrew from study medication|1
1029061|NCT00215150|3354014|P1|Randomization Phase Placebo|Withdrawal by Subject|1
1029062|NCT00215150|3354014|P1|Randomization Phase Ziprasidone|Withdrawal by Subject|1
1029063|NCT00215150|3354014|P1|Randomization Phase Ziprasidone|Lost to Follow-up|2
1029064|NCT00215150|3354014|P1|Open Label Phase|Did not meet randomization criteria|9
1029065|NCT00215150|3354014|P1|Open Label Phase|Did not complete a post base visit|13
1029066|NCT00215150|3354014|P1|Open Label Phase|Withdrawal by Subject|1
1029067|NCT00215150|3354014|P1|Open Label Phase|Lost to Follow-up|7
1029068|NCT00215137|3354022|P3|Randomization Period|Withdrawal by Subject|0
1029069|NCT00215137|3354023|P2|Randomization Period|Withdrawal by Subject|1
1029070|NCT00215137|3354024|P1|Randomization Period|Withdrawal by Subject|0
1029071|NCT00215137|3354022|P3|Randomization Period|Lost to Follow-up|0
1029072|NCT00215137|3354023|P2|Randomization Period|Lost to Follow-up|1
1029073|NCT00215137|3354024|P1|Randomization Period|Lost to Follow-up|0
1029074|NCT00215137|3354022|P3|Open Label Escitalopram|Lack of Efficacy|0
1029075|NCT00215137|3354023|P2|Open Label Escitalopram|Lack of Efficacy|0
1029076|NCT00215137|3354024|P1|Open Label Escitalopram|Lack of Efficacy|1
1029077|NCT00214500|3354122|P1|Extension Period|Withdrawal by Subject|2
1029078|NCT00214500|3354122|P1|Treatment Period|Adverse Event|1
1029079|NCT00214461|3354143|P4|Overall Study|Withdrawal by Subject|0
1029080|NCT00214461|3354144|P3|Overall Study|Withdrawal by Subject|1
1029081|NCT00214461|3354145|P2|Overall Study|Withdrawal by Subject|0
1029082|NCT00214461|3354146|P1|Overall Study|Withdrawal by Subject|0
1029083|NCT00214461|3354143|P4|Overall Study|Adverse Event|1
1029084|NCT00214461|3354144|P3|Overall Study|Adverse Event|1
1029085|NCT00214461|3354145|P2|Overall Study|Adverse Event|0
1029086|NCT00214461|3354146|P1|Overall Study|Adverse Event|0
1029087|NCT00214383|3354162|P2|Overall Study|Lost to Follow-up|26
1029088|NCT00214383|3354163|P1|Overall Study|Lost to Follow-up|16
1029089|NCT00214201|3354175|P2|Overall Study|Death|2
1029090|NCT00214201|3354176|P1|Overall Study|Death|0
1029091|NCT00214201|3354175|P2|Overall Study|Withdrawal by Subject|0
1029092|NCT00214201|3354176|P1|Overall Study|Withdrawal by Subject|2
1029093|NCT00214136|3354191|P1|Overall Study|Death|5
1029094|NCT00214019|3354196|P1|Overall Study|Screen Failed prior to randomization|17
1029095|NCT00214019|3354196|P1|Overall Study|Withdrawal by Subject|2
1029096|NCT00214019|3354196|P1|Overall Study|Lost to Follow-up|11
1029097|NCT00213980|3354205|P2|Overall Study|Failed to obtain all 3 DXAs|3
1029098|NCT00213980|3354206|P1|Overall Study|Failed to obtain all 3 DXAs|1
1029099|NCT00213980|3354205|P2|Overall Study|Developed ovarian cancer|0
1029100|NCT00213980|3354206|P1|Overall Study|Developed ovarian cancer|1
1029101|NCT00213980|3354205|P2|Overall Study|Disease progression|2
1029102|NCT00213980|3354206|P1|Overall Study|Disease progression|0
1029103|NCT00213980|3354205|P2|Overall Study|Adverse Event|1
1029104|NCT00213980|3354206|P1|Overall Study|Adverse Event|1
1029105|NCT00213980|3354205|P2|Overall Study|Withdrawal by Subject|1
1029106|NCT00213980|3354206|P1|Overall Study|Withdrawal by Subject|3
1029107|NCT00213148|3354235|P5|Cycle 3 (1 Month)|Other|0
1029108|NCT00213148|3354236|P4|Cycle 3 (1 Month)|Other|1
1029109|NCT00213148|3354237|P3|Cycle 3 (1 Month)|Other|1
1029110|NCT00213148|3354238|P2|Cycle 3 (1 Month)|Other|0
1029111|NCT00213148|3354239|P1|Cycle 3 (1 Month)|Other|0
1029112|NCT00213148|3354235|P5|Cycle 3 (1 Month)|Lost to Follow-up|1
1029113|NCT00213148|3354236|P4|Cycle 3 (1 Month)|Lost to Follow-up|0
1029114|NCT00213148|3354237|P3|Cycle 3 (1 Month)|Lost to Follow-up|0
1029115|NCT00213148|3354238|P2|Cycle 3 (1 Month)|Lost to Follow-up|2
1029116|NCT00213148|3354239|P1|Cycle 3 (1 Month)|Lost to Follow-up|0
1029117|NCT00213148|3354235|P5|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6
1029118|NCT00213148|3354236|P4|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
1029119|NCT00213148|3354237|P3|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
1029120|NCT00213148|3354238|P2|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1
1029121|NCT00213148|3354239|P1|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10
1029122|NCT00213148|3354235|P5|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
1029123|NCT00213148|3354236|P4|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
1029124|NCT00213148|3354237|P3|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
1029125|NCT00213148|3354238|P2|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
1029126|NCT00213148|3354239|P1|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1
1029127|NCT00213148|3354235|P5|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
1029128|NCT00213148|3354236|P4|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
1029129|NCT00213148|3354237|P3|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
1029130|NCT00213148|3354238|P2|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1
1029131|NCT00213148|3354239|P1|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
1029132|NCT00213148|3354235|P5|Cycle 2 (1 Month)|Other|7
1029133|NCT00213148|3354236|P4|Cycle 2 (1 Month)|Other|8
1029134|NCT00213148|3354237|P3|Cycle 2 (1 Month)|Other|2
1029135|NCT00213148|3354238|P2|Cycle 2 (1 Month)|Other|1
1029136|NCT00213148|3354239|P1|Cycle 2 (1 Month)|Other|2
1029137|NCT00213148|3354235|P5|Cycle 2 (1 Month)|Lack of Efficacy|16
1029138|NCT00213148|3354236|P4|Cycle 2 (1 Month)|Lack of Efficacy|6
1029139|NCT00213148|3354237|P3|Cycle 2 (1 Month)|Lack of Efficacy|7
1029140|NCT00213148|3354238|P2|Cycle 2 (1 Month)|Lack of Efficacy|3
1029141|NCT00213148|3354239|P1|Cycle 2 (1 Month)|Lack of Efficacy|1
1029142|NCT00213148|3354235|P5|Cycle 2 (1 Month)|Lost to Follow-up|1
1029143|NCT00213148|3354236|P4|Cycle 2 (1 Month)|Lost to Follow-up|2
1029144|NCT00213148|3354237|P3|Cycle 2 (1 Month)|Lost to Follow-up|2
1029145|NCT00213148|3354238|P2|Cycle 2 (1 Month)|Lost to Follow-up|0
1029146|NCT00213148|3354239|P1|Cycle 2 (1 Month)|Lost to Follow-up|0
1029147|NCT00213148|3354235|P5|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
1029148|NCT00213148|3354236|P4|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8
1029149|NCT00213148|3354237|P3|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
1029150|NCT00213148|3354238|P2|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0
1029151|NCT00213148|3354239|P1|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15
1029152|NCT00213148|3354235|P5|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1
1029153|NCT00213148|3354236|P4|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
1029154|NCT00213148|3354237|P3|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
1029155|NCT00213148|3354238|P2|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
1029156|NCT00213148|3354239|P1|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
1029157|NCT00213148|3354235|P5|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
1029158|NCT00213148|3354236|P4|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1
1029159|NCT00213148|3354237|P3|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
1029160|NCT00213148|3354238|P2|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
1029161|NCT00213148|3354239|P1|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
1029162|NCT00213148|3354235|P5|Cycle 1 (1 Month)|Other|7
1029163|NCT00213148|3354236|P4|Cycle 1 (1 Month)|Other|2
1029164|NCT00213148|3354237|P3|Cycle 1 (1 Month)|Other|2
1029165|NCT00213148|3354238|P2|Cycle 1 (1 Month)|Other|0
1029166|NCT00213148|3354239|P1|Cycle 1 (1 Month)|Other|3
1029167|NCT00213148|3354235|P5|Cycle 1 (1 Month)|Protocol Violation|0
1029168|NCT00213148|3354236|P4|Cycle 1 (1 Month)|Protocol Violation|0
1029169|NCT00213148|3354237|P3|Cycle 1 (1 Month)|Protocol Violation|1
1029170|NCT00213148|3354238|P2|Cycle 1 (1 Month)|Protocol Violation|0
1029171|NCT00213148|3354239|P1|Cycle 1 (1 Month)|Protocol Violation|1
1029172|NCT00213148|3354235|P5|Cycle 1 (1 Month)|Lack of Efficacy|8
1029173|NCT00213148|3354236|P4|Cycle 1 (1 Month)|Lack of Efficacy|5
1029174|NCT00213148|3354237|P3|Cycle 1 (1 Month)|Lack of Efficacy|8
1029175|NCT00213148|3354238|P2|Cycle 1 (1 Month)|Lack of Efficacy|0
1029176|NCT00213148|3354239|P1|Cycle 1 (1 Month)|Lack of Efficacy|4
1029177|NCT00213148|3354235|P5|Cycle 1 (1 Month)|Adverse Event|0
1029178|NCT00213148|3354236|P4|Cycle 1 (1 Month)|Adverse Event|0
1029179|NCT00213148|3354237|P3|Cycle 1 (1 Month)|Adverse Event|1
1029180|NCT00213148|3354238|P2|Cycle 1 (1 Month)|Adverse Event|0
1029181|NCT00213148|3354239|P1|Cycle 1 (1 Month)|Adverse Event|0
1029182|NCT00213148|3354235|P5|Cycle 1 (1 Month)|Lost to Follow-up|1
1029183|NCT00213148|3354236|P4|Cycle 1 (1 Month)|Lost to Follow-up|2
1029184|NCT00213148|3354237|P3|Cycle 1 (1 Month)|Lost to Follow-up|2
1029185|NCT00213148|3354238|P2|Cycle 1 (1 Month)|Lost to Follow-up|0
1029186|NCT00213148|3354239|P1|Cycle 1 (1 Month)|Lost to Follow-up|1
1029187|NCT00213135|3354266|P3|Overall Study|Other|15
1029188|NCT00213135|3354267|P2|Overall Study|Other|12
1029189|NCT00213135|3354268|P1|Overall Study|Other|21
1029190|NCT00213135|3354266|P3|Overall Study|Disease progression|21
1029191|NCT00213135|3354267|P2|Overall Study|Disease progression|5
1029192|NCT00213135|3354268|P1|Overall Study|Disease progression|4
1029193|NCT00213135|3354266|P3|Overall Study|Death|2
1029194|NCT00213135|3354267|P2|Overall Study|Death|1
1029195|NCT00213135|3354268|P1|Overall Study|Death|1
1029196|NCT00213135|3354266|P3|Overall Study|Protocol Violation|10
1029197|NCT00213135|3354267|P2|Overall Study|Protocol Violation|4
1029198|NCT00213135|3354268|P1|Overall Study|Protocol Violation|4
1029199|NCT00213135|3354266|P3|Overall Study|Lost to Follow-up|4
1029200|NCT00213135|3354267|P2|Overall Study|Lost to Follow-up|8
1029201|NCT00213135|3354268|P1|Overall Study|Lost to Follow-up|11
1029202|NCT00213135|3354266|P3|Overall Study|Adverse Event|5
1029203|NCT00213135|3354267|P2|Overall Study|Adverse Event|5
1029204|NCT00213135|3354268|P1|Overall Study|Adverse Event|9
1029205|NCT00212758|3354285|P2|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
1029206|NCT00212758|3354286|P1|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
1029207|NCT00212758|3354285|P2|Standard Therapy of GH (12 Months)|Adverse Event|0
1029208|NCT00212758|3354286|P1|Standard Therapy of GH (12 Months)|Adverse Event|1
1029209|NCT00212355|3354292|P1|Overall Study|A change of address|1
1029210|NCT00212355|3354292|P1|Overall Study|Withdrawal by Subject|1
1029211|NCT00212355|3354292|P1|Overall Study|Adverse Event|1
1029212|NCT00212134|3354313|P2|Phase 3 (Age 10 Years)|On Going|21
1029213|NCT00212134|3354314|P1|Phase 3 (Age 10 Years)|On Going|21
1029214|NCT00211887|3354335|P3|Overall Study|Side effects|5
1029215|NCT00211887|3354336|P2|Overall Study|Side effects|13
1029216|NCT00211887|3354337|P1|Overall Study|Side effects|19
1029217|NCT00211887|3354335|P3|Overall Study|Other medical reason|7
1029218|NCT00211887|3354336|P2|Overall Study|Other medical reason|11
1029219|NCT00211887|3354337|P1|Overall Study|Other medical reason|15
1029220|NCT00211887|3354335|P3|Overall Study|Non-medical reason|8
1029221|NCT00211887|3354336|P2|Overall Study|Non-medical reason|14
1029222|NCT00211887|3354337|P1|Overall Study|Non-medical reason|31
1029223|NCT00211887|3354335|P3|Overall Study|Lost to Follow-up|9
1029224|NCT00211887|3354336|P2|Overall Study|Lost to Follow-up|13
1029225|NCT00211887|3354337|P1|Overall Study|Lost to Follow-up|28
1029226|NCT00211887|3354335|P3|Overall Study|Death|1
1029227|NCT00211887|3354336|P2|Overall Study|Death|1
1029228|NCT00211887|3354337|P1|Overall Study|Death|1
1029229|NCT00211887|3354335|P3|Overall Study|Adverse Event|6
1029230|NCT00211887|3354336|P2|Overall Study|Adverse Event|4
1029231|NCT00211887|3354337|P1|Overall Study|Adverse Event|8
1029232|NCT00211809|3354354|P1|Overall Study|side effects|2
1029233|NCT00211809|3354354|P1|Overall Study|Pregnancy|1
1029234|NCT00211809|3354354|P1|Overall Study|Lost to Follow-up|2
1029235|NCT00211809|3354354|P1|Overall Study|Lack of Efficacy|1
1029236|NCT00211536|3354381|P2|Overall Study|Adverse Event|0
1029237|NCT00211536|3354382|P1|Overall Study|Adverse Event|2
1029238|NCT00211536|3354381|P2|Overall Study|Physician Decision|5
1029239|NCT00211536|3354382|P1|Overall Study|Physician Decision|0
1029240|NCT00211536|3354381|P2|Overall Study|Withdrawal by Subject|2
1029241|NCT00211536|3354382|P1|Overall Study|Withdrawal by Subject|2
1029242|NCT00211510|3354398|P2|Overall Study|Withdrawal by Subject|1
1029243|NCT00211510|3354399|P1|Overall Study|Withdrawal by Subject|3
1029244|NCT00211510|3354398|P2|Overall Study|Physician Decision|1
1029245|NCT00211510|3354399|P1|Overall Study|Physician Decision|3
1029246|NCT00211237|3354417|P3|12 Months|unrelated medical problem|1
1029247|NCT00211237|3354418|P2|12 Months|unrelated medical problem|0
1029248|NCT00211237|3354419|P1|12 Months|unrelated medical problem|0
1029249|NCT00211237|3354417|P3|12 Months|Withdrew|1
1029250|NCT00211237|3354418|P2|12 Months|Withdrew|0
1029251|NCT00211237|3354419|P1|12 Months|Withdrew|0
1029252|NCT00211237|3354417|P3|12 Months|Lost to Follow-up|1
1029253|NCT00211237|3354418|P2|12 Months|Lost to Follow-up|0
1029254|NCT00211237|3354419|P1|12 Months|Lost to Follow-up|1
1029255|NCT00211237|3354417|P3|12 Months|Death|3
1029256|NCT00211237|3354418|P2|12 Months|Death|2
1029257|NCT00211237|3354419|P1|12 Months|Death|8
1029258|NCT00211237|3354417|P3|6 Months|Could not comply with protocol|0
1029259|NCT00211237|3354418|P2|6 Months|Could not comply with protocol|2
1029260|NCT00211237|3354419|P1|6 Months|Could not comply with protocol|0
1029261|NCT00211237|3354417|P3|6 Months|Lost to Follow-up|0
1029262|NCT00211237|3354418|P2|6 Months|Lost to Follow-up|0
1029263|NCT00211237|3354419|P1|6 Months|Lost to Follow-up|2
1029264|NCT00211237|3354417|P3|6 Months|Death|3
1029265|NCT00211237|3354418|P2|6 Months|Death|0
1029266|NCT00211237|3354419|P1|6 Months|Death|6
1029267|NCT00211237|3354417|P3|3 Months|Non-medical problem|1
1029268|NCT00211237|3354418|P2|3 Months|Non-medical problem|0
1029269|NCT00211237|3354419|P1|3 Months|Non-medical problem|0
1029270|NCT00211237|3354417|P3|3 Months|Withdrew|0
1029271|NCT00211237|3354418|P2|3 Months|Withdrew|1
1029272|NCT00211237|3354419|P1|3 Months|Withdrew|0
1029273|NCT00211237|3354417|P3|3 Months|Could not comply with protocol|0
1029274|NCT00211237|3354418|P2|3 Months|Could not comply with protocol|0
1029275|NCT00211237|3354419|P1|3 Months|Could not comply with protocol|1
1029276|NCT00211237|3354417|P3|3 Months|Death|0
1029277|NCT00211237|3354418|P2|3 Months|Death|3
1029278|NCT00211237|3354419|P1|3 Months|Death|7
1029279|NCT00211237|3354417|P3|1 Month|Non-medical problem|0
1029280|NCT00211237|3354418|P2|1 Month|Non-medical problem|2
1029281|NCT00211237|3354419|P1|1 Month|Non-medical problem|0
1029282|NCT00211237|3354417|P3|1 Month|Additional surgery needed|0
1029283|NCT00211237|3354418|P2|1 Month|Additional surgery needed|0
1029284|NCT00211237|3354419|P1|1 Month|Additional surgery needed|1
1029285|NCT00211237|3354417|P3|1 Month|Withdrew|0
1029286|NCT00211237|3354418|P2|1 Month|Withdrew|4
1029287|NCT00211237|3354419|P1|1 Month|Withdrew|0
1029288|NCT00211237|3354417|P3|1 Month|Lost to Follow-up|0
1029289|NCT00211237|3354418|P2|1 Month|Lost to Follow-up|2
1029290|NCT00211237|3354419|P1|1 Month|Lost to Follow-up|0
1029291|NCT00211237|3354417|P3|1 Month|Death|0
1029292|NCT00211237|3354418|P2|1 Month|Death|1
1029293|NCT00211237|3354419|P1|1 Month|Death|2
1029294|NCT00211237|3354417|P3|Baseline|Refused random assignment|0
1029295|NCT00211237|3354418|P2|Baseline|Refused random assignment|0
1029296|NCT00211237|3354419|P1|Baseline|Refused random assignment|1
1029297|NCT00211237|3354417|P3|Baseline|Withdrew|0
1029298|NCT00211237|3354418|P2|Baseline|Withdrew|3
1029299|NCT00211237|3354419|P1|Baseline|Withdrew|1
1029300|NCT00211172|3354511|P2|Overall Study|Died or lost health plan eligibility|32
1029301|NCT00211172|3354512|P1|Overall Study|Died or lost health plan eligibility|39
1029302|NCT00211081|3354518|P1|Overall Study|Withdrawal by Subject|2
1029303|NCT00210639|3354530|P2|Overall Study|Not specified|12
1029304|NCT00210639|3354531|P1|Overall Study|Not specified|18
1029305|NCT00210639|3354530|P2|Overall Study|Withdrawal by Subject|1
1029306|NCT00210639|3354531|P1|Overall Study|Withdrawal by Subject|8
1029307|NCT00210639|3354530|P2|Overall Study|Lost to Follow-up|29
1029308|NCT00210639|3354531|P1|Overall Study|Lost to Follow-up|37
1029309|NCT00210626|3354539|P2|Overall Study|Not Specified|5
1029310|NCT00210626|3354540|P1|Overall Study|Not Specified|4
1029311|NCT00210626|3354539|P2|Overall Study|Sponser Request|0
1029312|NCT00210626|3354540|P1|Overall Study|Sponser Request|1
1029313|NCT00210626|3354539|P2|Overall Study|Physician Decision|2
1029314|NCT00210626|3354540|P1|Overall Study|Physician Decision|0
1029315|NCT00210626|3354539|P2|Overall Study|Withdrawal by Subject|20
1029316|NCT00210626|3354540|P1|Overall Study|Withdrawal by Subject|29
1029317|NCT00210626|3354539|P2|Overall Study|Death|0
1029318|NCT00210626|3354540|P1|Overall Study|Death|1
1029319|NCT00210626|3354539|P2|Overall Study|Lost to Follow-up|11
1029320|NCT00210626|3354540|P1|Overall Study|Lost to Follow-up|11
1029321|NCT00210626|3354539|P2|Overall Study|Protocol Violation|5
1029322|NCT00210626|3354540|P1|Overall Study|Protocol Violation|1
1029323|NCT00210626|3354539|P2|Overall Study|Adverse Event|2
1029324|NCT00210626|3354540|P1|Overall Study|Adverse Event|1
1029325|NCT00210470|3354548|P1|Overall Study|Subject did not continue to surgery|1
1029326|NCT00209560|3354554|P2|Overall Study|Lack of Efficacy|0
1029327|NCT00209560|3354555|P1|Overall Study|Lack of Efficacy|1
1029328|NCT00209339|3354574|P1|At 5 Years Follow-up|Death|1
1029329|NCT00209339|3354574|P1|At 5 Years Follow-up|Withdrawal because of other reasons|5
1029330|NCT00209339|3354574|P1|At 5 Years Follow-up|Withdrawal by Subject|2
1029331|NCT00209339|3354574|P1|At 4 Years Follow-up|Death|1
1029332|NCT00209339|3354574|P1|At 4 Years Follow-up|Withdrawal by Subject|4
1029333|NCT00209339|3354574|P1|At 3 Years Follow-up|Withdrawal by Subject|1
1029334|NCT00209339|3354574|P1|At 24 Months Follow-up|Death|1
1029335|NCT00209339|3354574|P1|At 24 Months Follow-up|Withdrawal because of other reasons|6
1029336|NCT00209339|3354574|P1|At 24 Months Follow-up|Withdrawal by Subject|4
1029337|NCT00209339|3354574|P1|At 12 Months Follow-up|No MitraClip Device Implanted|6
1029338|NCT00209339|3354574|P1|At 12 Months Follow-up|Death|1
1029339|NCT00209339|3354574|P1|At 12 Months Follow-up|Withdrawal by Subject|8
1029340|NCT00209274|3354658|P2|Overall Study|Randomized not treated (RNT)|15
1029341|NCT00209274|3354659|P1|Overall Study|Randomized not treated (RNT)|6
1029342|NCT00209274|3354658|P2|Overall Study|Withdrawal by Subject|15
1029343|NCT00209274|3354659|P1|Overall Study|Withdrawal by Subject|30
1029344|NCT00209274|3354658|P2|Overall Study|Death|15
1029345|NCT00209274|3354659|P1|Overall Study|Death|32
1029346|NCT00209274|3354658|P2|Overall Study|Missed visit|2
1029347|NCT00209274|3354659|P1|Overall Study|Missed visit|3
1029348|NCT00209170|3354979|P2|Overall Study|Lack of Efficacy|1
1029349|NCT00209170|3354980|P1|Overall Study|Lack of Efficacy|0
1029350|NCT00209170|3354979|P2|Overall Study|Withdrawal by Subject|1
1029351|NCT00209170|3354980|P1|Overall Study|Withdrawal by Subject|2
1029352|NCT00209170|3354979|P2|Overall Study|Adverse Event|1
1029353|NCT00209170|3354980|P1|Overall Study|Adverse Event|0
1029354|NCT00209131|3354988|P2|Overall Study|Lack of personnel due to turnovers.|11
1029355|NCT00209131|3354989|P1|Overall Study|Lack of personnel due to turnovers.|15
1029356|NCT00209092|3354999|P2|Overall Study|Withdrawal by Subject|0
1029357|NCT00209092|3355000|P1|Overall Study|Withdrawal by Subject|1
1029358|NCT00209092|3354999|P2|Overall Study|Adverse Event|1
1029359|NCT00209092|3355000|P1|Overall Study|Adverse Event|0
1029360|NCT00209092|3354999|P2|Overall Study|Progression of disease|1
1029361|NCT00209092|3355000|P1|Overall Study|Progression of disease|7
1029362|NCT00209027|3355010|P2|Overall Study|study terminated|0
1029363|NCT00209027|3355011|P1|Overall Study|study terminated|10
1029364|NCT00208767|3355035|P2|Overall Study|Lost to Follow-up|3
1029365|NCT00208767|3355036|P1|Overall Study|Lost to Follow-up|3
1029366|NCT00208767|3355035|P2|Overall Study|Death|0
1029367|NCT00208767|3355036|P1|Overall Study|Death|1
1029368|NCT00208767|3355035|P2|Overall Study|Withdrawal by Subject|3
1029369|NCT00208767|3355036|P1|Overall Study|Withdrawal by Subject|14
1029370|NCT00208767|3355035|P2|Overall Study|Adverse Event|1
1029371|NCT00208767|3355036|P1|Overall Study|Adverse Event|9
1029372|NCT00208325|3355064|P4|Overall Study|Mis-Randomized|0
1029373|NCT00208325|3355065|P3|Overall Study|Mis-Randomized|0
1029374|NCT00208325|3355066|P2|Overall Study|Mis-Randomized|20
1029375|NCT00208325|3355067|P1|Overall Study|Mis-Randomized|17
1029376|NCT00208325|3355064|P4|Overall Study|Other|0
1029377|NCT00208325|3355065|P3|Overall Study|Other|1
1029378|NCT00208325|3355066|P2|Overall Study|Other|1
1029379|NCT00208325|3355067|P1|Overall Study|Other|2
1029380|NCT00208325|3355064|P4|Overall Study|Does not wish to Continue in Study|2
1029381|NCT00208325|3355065|P3|Overall Study|Does not wish to Continue in Study|3
1029382|NCT00208325|3355066|P2|Overall Study|Does not wish to Continue in Study|8
1029383|NCT00208325|3355067|P1|Overall Study|Does not wish to Continue in Study|5
1029384|NCT00208325|3355064|P4|Overall Study|Unsurfaced to Resurfaced Patella|3
1029385|NCT00208325|3355065|P3|Overall Study|Unsurfaced to Resurfaced Patella|1
1029386|NCT00208325|3355066|P2|Overall Study|Unsurfaced to Resurfaced Patella|4
1029387|NCT00208325|3355067|P1|Overall Study|Unsurfaced to Resurfaced Patella|4
1029388|NCT00208325|3355064|P4|Overall Study|Lost to Follow-up|0
1029389|NCT00208325|3355065|P3|Overall Study|Lost to Follow-up|2
1029390|NCT00208325|3355066|P2|Overall Study|Lost to Follow-up|0
1029391|NCT00208325|3355067|P1|Overall Study|Lost to Follow-up|1
1029392|NCT00208325|3355064|P4|Overall Study|Revision|4
1029393|NCT00208325|3355065|P3|Overall Study|Revision|0
1029394|NCT00208325|3355066|P2|Overall Study|Revision|1
1029395|NCT00208325|3355067|P1|Overall Study|Revision|4
1029396|NCT00208325|3355064|P4|Overall Study|Withdrawal by Subject|0
1029397|NCT00208325|3355065|P3|Overall Study|Withdrawal by Subject|0
1029398|NCT00208325|3355066|P2|Overall Study|Withdrawal by Subject|1
1029399|NCT00208325|3355067|P1|Overall Study|Withdrawal by Subject|0
1029400|NCT00208325|3355064|P4|Overall Study|Death|5
1029401|NCT00208325|3355065|P3|Overall Study|Death|7
1029402|NCT00208325|3355066|P2|Overall Study|Death|19
1029403|NCT00208325|3355067|P1|Overall Study|Death|18
1029404|NCT00207740|3355202|P4|Overall Study|Not Specified|5
1029405|NCT00207740|3355203|P3|Overall Study|Not Specified|7
1029406|NCT00207740|3355204|P2|Overall Study|Not Specified|10
1029407|NCT00207740|3355205|P1|Overall Study|Not Specified|2
1029408|NCT00207740|3355202|P4|Overall Study|Sponsor Directive|21
1029409|NCT00207740|3355203|P3|Overall Study|Sponsor Directive|16
1029410|NCT00207740|3355204|P2|Overall Study|Sponsor Directive|15
1029411|NCT00207740|3355205|P1|Overall Study|Sponsor Directive|22
1029412|NCT00207740|3355202|P4|Overall Study|Death|1
1029413|NCT00207740|3355203|P3|Overall Study|Death|0
1029414|NCT00207740|3355204|P2|Overall Study|Death|0
1029415|NCT00207740|3355205|P1|Overall Study|Death|0
1029416|NCT00207740|3355202|P4|Overall Study|Lost to Follow-up|1
1029417|NCT00207740|3355203|P3|Overall Study|Lost to Follow-up|1
1029418|NCT00207740|3355204|P2|Overall Study|Lost to Follow-up|2
1029419|NCT00207740|3355205|P1|Overall Study|Lost to Follow-up|0
1029420|NCT00207740|3355202|P4|Overall Study|Unsatisfactory therapeutic effect|4
1029421|NCT00207740|3355203|P3|Overall Study|Unsatisfactory therapeutic effect|2
1029422|NCT00207740|3355204|P2|Overall Study|Unsatisfactory therapeutic effect|0
1029423|NCT00207740|3355205|P1|Overall Study|Unsatisfactory therapeutic effect|1
1029424|NCT00207740|3355202|P4|Overall Study|Adverse Event|11
1029425|NCT00207740|3355203|P3|Overall Study|Adverse Event|14
1029426|NCT00207740|3355204|P2|Overall Study|Adverse Event|14
1029427|NCT00207740|3355205|P1|Overall Study|Adverse Event|4
1029428|NCT00207727|3355251|P5|Overall Study|Not specified|33
1029429|NCT00207727|3355252|P4|Overall Study|Not specified|37
1029430|NCT00207727|3355253|P3|Overall Study|Not specified|41
1029431|NCT00207727|3355254|P2|Overall Study|Not specified|41
1029432|NCT00207727|3355255|P1|Overall Study|Not specified|38
1029433|NCT00207727|3355251|P5|Overall Study|Lost to Follow-up|0
1029434|NCT00207727|3355252|P4|Overall Study|Lost to Follow-up|0
1029435|NCT00207727|3355253|P3|Overall Study|Lost to Follow-up|0
1029436|NCT00207727|3355254|P2|Overall Study|Lost to Follow-up|1
1029437|NCT00207727|3355255|P1|Overall Study|Lost to Follow-up|0
1029438|NCT00207727|3355251|P5|Overall Study|Withdrawal by Subject|1
1029439|NCT00207727|3355252|P4|Overall Study|Withdrawal by Subject|0
1029440|NCT00207727|3355253|P3|Overall Study|Withdrawal by Subject|0
1029441|NCT00207727|3355254|P2|Overall Study|Withdrawal by Subject|0
1029442|NCT00207727|3355255|P1|Overall Study|Withdrawal by Subject|0
1029443|NCT00207714|3355282|P5|Overall Study|Other|0
1029444|NCT00207714|3355283|P4|Overall Study|Other|1
1029445|NCT00207714|3355284|P3|Overall Study|Other|5
1029446|NCT00207714|3355285|P2|Overall Study|Other|2
1029447|NCT00207714|3355286|P1|Overall Study|Other|3
1029448|NCT00207714|3355282|P5|Overall Study|Unsatisfactory therapeutic effect|4
1029449|NCT00207714|3355283|P4|Overall Study|Unsatisfactory therapeutic effect|4
1029450|NCT00207714|3355284|P3|Overall Study|Unsatisfactory therapeutic effect|1
1029451|NCT00207714|3355285|P2|Overall Study|Unsatisfactory therapeutic effect|3
1029452|NCT00207714|3355286|P1|Overall Study|Unsatisfactory therapeutic effect|5
1029453|NCT00207714|3355282|P5|Overall Study|Adverse Event|1
1029454|NCT00207714|3355283|P4|Overall Study|Adverse Event|3
1029455|NCT00207714|3355284|P3|Overall Study|Adverse Event|4
1029456|NCT00207714|3355285|P2|Overall Study|Adverse Event|2
1029457|NCT00207714|3355286|P1|Overall Study|Adverse Event|6
1029458|NCT00207142|3355308|P4|Maintenance Phase/Rescue Phase|Lack of Efficacy|1
1029459|NCT00207142|3355309|P3|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
1029460|NCT00207142|3355310|P2|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
1029461|NCT00207142|3355311|P1|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
1029462|NCT00207142|3355308|P4|Maintenance Phase/Rescue Phase|Death|1
1029463|NCT00207142|3355309|P3|Maintenance Phase/Rescue Phase|Death|0
1029464|NCT00207142|3355310|P2|Maintenance Phase/Rescue Phase|Death|0
1029465|NCT00207142|3355311|P1|Maintenance Phase/Rescue Phase|Death|0
1029466|NCT00207142|3355308|P4|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1
1029467|NCT00207142|3355309|P3|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
1029468|NCT00207142|3355310|P2|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
1029469|NCT00207142|3355311|P1|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0
1029470|NCT00207142|3355308|P4|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
1029471|NCT00207142|3355309|P3|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1
1029472|NCT00207142|3355310|P2|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
1029473|NCT00207142|3355311|P1|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
1029474|NCT00207142|3355308|P4|Maintenance Phase/Rescue Phase|Pregnancy|0
1029475|NCT00207142|3355309|P3|Maintenance Phase/Rescue Phase|Pregnancy|2
1029476|NCT00207142|3355310|P2|Maintenance Phase/Rescue Phase|Pregnancy|2
1029477|NCT00207142|3355311|P1|Maintenance Phase/Rescue Phase|Pregnancy|0
1029478|NCT00207142|3355308|P4|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
1029479|NCT00207142|3355309|P3|Maintenance Phase/Rescue Phase|Poor/noncompliance|2
1029480|NCT00207142|3355310|P2|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
1029481|NCT00207142|3355311|P1|Maintenance Phase/Rescue Phase|Poor/noncompliance|0
1029482|NCT00207142|3355308|P4|Maintenance Phase/Rescue Phase|RTV intake impossible|0
1029483|NCT00207142|3355309|P3|Maintenance Phase/Rescue Phase|RTV intake impossible|1
1029484|NCT00207142|3355310|P2|Maintenance Phase/Rescue Phase|RTV intake impossible|0
1029485|NCT00207142|3355311|P1|Maintenance Phase/Rescue Phase|RTV intake impossible|0
1029486|NCT00207142|3355308|P4|Maintenance Phase/Rescue Phase|Lost to Follow-up|2
1029487|NCT00207142|3355309|P3|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
1029488|NCT00207142|3355310|P2|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
1029489|NCT00207142|3355311|P1|Maintenance Phase/Rescue Phase|Lost to Follow-up|0
1029490|NCT00207142|3355308|P4|Maintenance Phase/Rescue Phase|Adverse Event|1
1029491|NCT00207142|3355309|P3|Maintenance Phase/Rescue Phase|Adverse Event|4
1029492|NCT00207142|3355310|P2|Maintenance Phase/Rescue Phase|Adverse Event|1
1029493|NCT00207142|3355311|P1|Maintenance Phase/Rescue Phase|Adverse Event|0
1029494|NCT00207142|3355308|P4|Induction Phase|Missing lab data|0
1029495|NCT00207142|3355309|P3|Induction Phase|Missing lab data|0
1029496|NCT00207142|3355310|P2|Induction Phase|Missing lab data|0
1029497|NCT00207142|3355311|P1|Induction Phase|Missing lab data|1
1029498|NCT00207142|3355308|P4|Induction Phase|Incarceration|0
1029499|NCT00207142|3355309|P3|Induction Phase|Incarceration|0
1029500|NCT00207142|3355310|P2|Induction Phase|Incarceration|0
1029501|NCT00207142|3355311|P1|Induction Phase|Incarceration|1
1029502|NCT00207142|3355308|P4|Induction Phase|Withdrawal by Subject|0
1029503|NCT00207142|3355309|P3|Induction Phase|Withdrawal by Subject|0
1029504|NCT00207142|3355310|P2|Induction Phase|Withdrawal by Subject|0
1029505|NCT00207142|3355311|P1|Induction Phase|Withdrawal by Subject|4
1029506|NCT00207142|3355308|P4|Induction Phase|Subject no longer meets study criteria|0
1029507|NCT00207142|3355309|P3|Induction Phase|Subject no longer meets study criteria|0
1029508|NCT00207142|3355310|P2|Induction Phase|Subject no longer meets study criteria|0
1029509|NCT00207142|3355311|P1|Induction Phase|Subject no longer meets study criteria|3
1029510|NCT00207142|3355308|P4|Induction Phase|Pregnancy|0
1029511|NCT00207142|3355309|P3|Induction Phase|Pregnancy|0
1029512|NCT00207142|3355310|P2|Induction Phase|Pregnancy|0
1029513|NCT00207142|3355311|P1|Induction Phase|Pregnancy|1
1029514|NCT00207142|3355308|P4|Induction Phase|Poor/noncompliance|0
1029515|NCT00207142|3355309|P3|Induction Phase|Poor/noncompliance|0
1029516|NCT00207142|3355310|P2|Induction Phase|Poor/noncompliance|0
1029517|NCT00207142|3355311|P1|Induction Phase|Poor/noncompliance|2
1029518|NCT00207142|3355308|P4|Induction Phase|Physician Decision|0
1029519|NCT00207142|3355309|P3|Induction Phase|Physician Decision|0
1029520|NCT00207142|3355310|P2|Induction Phase|Physician Decision|0
1029521|NCT00207142|3355311|P1|Induction Phase|Physician Decision|2
1029522|NCT00207142|3355308|P4|Induction Phase|Lost to Follow-up|0
1029523|NCT00207142|3355309|P3|Induction Phase|Lost to Follow-up|0
1029524|NCT00207142|3355310|P2|Induction Phase|Lost to Follow-up|0
1029525|NCT00207142|3355311|P1|Induction Phase|Lost to Follow-up|5
1029526|NCT00207142|3355308|P4|Induction Phase|Lack of Efficacy|0
1029527|NCT00207142|3355309|P3|Induction Phase|Lack of Efficacy|0
1029528|NCT00207142|3355310|P2|Induction Phase|Lack of Efficacy|0
1029529|NCT00207142|3355311|P1|Induction Phase|Lack of Efficacy|1
1029530|NCT00207142|3355308|P4|Induction Phase|Death|0
1029531|NCT00207142|3355309|P3|Induction Phase|Death|0
1029532|NCT00207142|3355310|P2|Induction Phase|Death|0
1029533|NCT00207142|3355311|P1|Induction Phase|Death|1
1029534|NCT00207142|3355308|P4|Induction Phase|Adverse Event|0
1029535|NCT00207142|3355309|P3|Induction Phase|Adverse Event|0
1029536|NCT00207142|3355310|P2|Induction Phase|Adverse Event|0
1029537|NCT00207142|3355311|P1|Induction Phase|Adverse Event|9
1029538|NCT00207090|3355348|P1|Overall Study|Physician Decision|1
1029539|NCT00207090|3355348|P1|Overall Study|Disease progression/relapse|2
1029540|NCT00207090|3355348|P1|Overall Study|Chest wall mass larger|1
1029541|NCT00207090|3355348|P1|Overall Study|Study drug toxicity|3
1029542|NCT00206726|3355377|P1|Overall Study|Withdrawal by Subject|8
1029543|NCT00206726|3355377|P1|Overall Study|Protocol Violation|1
1029544|NCT00206726|3355377|P1|Overall Study|Death|4
1029545|NCT00206726|3355377|P1|Overall Study|Adverse Event|17
1029546|NCT00206726|3355377|P1|Overall Study|Bone marrow transplant|1
1029547|NCT00206726|3355377|P1|Overall Study|Placed on new protocol|1
1029548|NCT00206726|3355377|P1|Overall Study|Progressive disease or relapsed disease|18
1029549|NCT00206726|3355377|P1|Overall Study|Delayed recovery of blood counts|1
1029550|NCT00206518|3355388|P2|Overall Study|Protocol Violation|1
1029551|NCT00206518|3355389|P1|Overall Study|Protocol Violation|1
1029552|NCT00206518|3355388|P2|Overall Study|Physician Decision|0
1029553|NCT00206518|3355389|P1|Overall Study|Physician Decision|1
1029554|NCT00206518|3355388|P2|Overall Study|Adverse Event|1
1029555|NCT00206518|3355389|P1|Overall Study|Adverse Event|2
1029556|NCT00206518|3355388|P2|Overall Study|Lack of Efficacy|4
1029557|NCT00206518|3355389|P1|Overall Study|Lack of Efficacy|6
1029558|NCT00206440|3355401|P2|Overall Study|Adverse Event|2
1029559|NCT00206440|3355402|P1|Overall Study|Adverse Event|4
1029560|NCT00206440|3355401|P2|Overall Study|Protocol Violation|2
1029561|NCT00206440|3355402|P1|Overall Study|Protocol Violation|1
1029562|NCT00206427|3355408|P1|Overall Study|Adverse Event|2
1029563|NCT00206323|3355418|P2|Overall Study|Lost to Follow-up|1
1029564|NCT00206323|3355419|P1|Overall Study|Lost to Follow-up|1
1029565|NCT00206323|3355418|P2|Overall Study|Adverse Event|1
1029566|NCT00206323|3355419|P1|Overall Study|Adverse Event|1
1029567|NCT00206323|3355418|P2|Overall Study|Lack of Efficacy|1
1029568|NCT00206323|3355419|P1|Overall Study|Lack of Efficacy|4
1029569|NCT00206102|3355427|P2|Overall Study|None of those categories|36
1029570|NCT00206102|3355428|P1|Overall Study|None of those categories|42
1029571|NCT00206102|3355427|P2|Overall Study|Study-specific discontinuation criteria|17
1029572|NCT00206102|3355428|P1|Overall Study|Study-specific discontinuation criteria|18
1029573|NCT00206102|3355427|P2|Overall Study|Withdrawal by Subject|101
1029574|NCT00206102|3355428|P1|Overall Study|Withdrawal by Subject|118
1029575|NCT00206102|3355427|P2|Overall Study|Lost to Follow-up|66
1029576|NCT00206102|3355428|P1|Overall Study|Lost to Follow-up|95
1029577|NCT00206102|3355427|P2|Overall Study|Lack of therapeutic response|11
1029578|NCT00206102|3355428|P1|Overall Study|Lack of therapeutic response|16
1029579|NCT00206102|3355427|P2|Overall Study|Protocol Violation|2
1029580|NCT00206102|3355428|P1|Overall Study|Protocol Violation|0
1029581|NCT00206102|3355427|P2|Overall Study|Adverse Event|82
1029582|NCT00206102|3355428|P1|Overall Study|Adverse Event|119
1029583|NCT00206076|3355464|P2|Overall Study|Withdrawal by Subject|1
1029584|NCT00206076|3355465|P1|Overall Study|Withdrawal by Subject|1
1029585|NCT00206076|3355464|P2|Overall Study|Physician Decision|0
1029586|NCT00206076|3355465|P1|Overall Study|Physician Decision|2
1029587|NCT00205881|3355475|P1|Overall Study|Withdrawal by Subject|16
1029588|NCT00205855|3355480|P1|Overall Study|Withdrawal by Subject|5
1029589|NCT00205855|3355480|P1|Overall Study|Only received temporary implants|16
1029590|NCT00205803|3355486|P2|Toddler Dose|Lost to Follow-up|3
1029591|NCT00205803|3355487|P1|Toddler Dose|Lost to Follow-up|2
1029592|NCT00205803|3355486|P2|After Infant Series|Other|4
1029593|NCT00205803|3355487|P1|After Infant Series|Other|10
1029594|NCT00205803|3355486|P2|After Infant Series|Withdrawal by Subject|4
1029595|NCT00205803|3355487|P1|After Infant Series|Withdrawal by Subject|1
1029596|NCT00205803|3355486|P2|After Infant Series|Physician Decision|2
1029597|NCT00205803|3355487|P1|After Infant Series|Physician Decision|3
1029598|NCT00205803|3355486|P2|After Infant Series|Lost to Follow-up|1
1029599|NCT00205803|3355487|P1|After Infant Series|Lost to Follow-up|2
1029600|NCT00205803|3355486|P2|After Infant Series|Protocol Violation|1
1029601|NCT00205803|3355487|P1|After Infant Series|Protocol Violation|1
1029602|NCT00205803|3355486|P2|After Infant Series|Adverse Event|1
1029603|NCT00205803|3355487|P1|After Infant Series|Adverse Event|1
1029604|NCT00205803|3355486|P2|Infant Series|Sponsor request|0
1029605|NCT00205803|3355487|P1|Infant Series|Sponsor request|1
1029606|NCT00205803|3355486|P2|Infant Series|Non-compliant|0
1029607|NCT00205803|3355487|P1|Infant Series|Non-compliant|1
1029608|NCT00205803|3355486|P2|Infant Series|Lost Kaiser coverage|1
1029609|NCT00205803|3355487|P1|Infant Series|Lost Kaiser coverage|0
1029610|NCT00205803|3355486|P2|Infant Series|Protocol Violation|0
1029611|NCT00205803|3355487|P1|Infant Series|Protocol Violation|1
1029612|NCT00205803|3355486|P2|Infant Series|Physician Decision|1
1029613|NCT00205803|3355487|P1|Infant Series|Physician Decision|3
1029614|NCT00205803|3355486|P2|Infant Series|Withdrawal by Subject|5
1029615|NCT00205803|3355487|P1|Infant Series|Withdrawal by Subject|2
1029616|NCT00205803|3355486|P2|Infant Series|Lost to Follow-up|4
1029617|NCT00205803|3355487|P1|Infant Series|Lost to Follow-up|10
1029618|NCT00205777|3355543|P6|Study Extension II|Enrolled but not treated|131
1029619|NCT00205777|3355544|P5|Study Extension II|Enrolled but not treated|0
1029620|NCT00205777|3355545|P4|Study Extension II|Enrolled but not treated|71
1029621|NCT00205777|3355546|P3|Study Extension II|Enrolled but not treated|0
1029622|NCT00205777|3355547|P2|Study Extension II|Enrolled but not treated|0
1029623|NCT00205777|3355548|P1|Study Extension II|Enrolled but not treated|0
1029624|NCT00205777|3355543|P6|Study Extension II|Other Event|20
1029625|NCT00205777|3355544|P5|Study Extension II|Other Event|0
1029626|NCT00205777|3355545|P4|Study Extension II|Other Event|12
1029627|NCT00205777|3355546|P3|Study Extension II|Other Event|0
1029628|NCT00205777|3355547|P2|Study Extension II|Other Event|0
1029629|NCT00205777|3355548|P1|Study Extension II|Other Event|0
1029630|NCT00205777|3355543|P6|Study Extension II|Failed to return|26
1029631|NCT00205777|3355544|P5|Study Extension II|Failed to return|0
1029632|NCT00205777|3355545|P4|Study Extension II|Failed to return|14
1029633|NCT00205777|3355546|P3|Study Extension II|Failed to return|0
1029634|NCT00205777|3355547|P2|Study Extension II|Failed to return|0
1029635|NCT00205777|3355548|P1|Study Extension II|Failed to return|0
1029636|NCT00205777|3355543|P6|Study Extension II|Lack of Efficacy|1
1029637|NCT00205777|3355544|P5|Study Extension II|Lack of Efficacy|0
1029638|NCT00205777|3355545|P4|Study Extension II|Lack of Efficacy|0
1029639|NCT00205777|3355546|P3|Study Extension II|Lack of Efficacy|0
1029640|NCT00205777|3355547|P2|Study Extension II|Lack of Efficacy|0
1029641|NCT00205777|3355548|P1|Study Extension II|Lack of Efficacy|0
1029642|NCT00205777|3355543|P6|Study Extension II|Protocol Violation|10
1029643|NCT00205777|3355544|P5|Study Extension II|Protocol Violation|0
1029644|NCT00205777|3355545|P4|Study Extension II|Protocol Violation|1
1029645|NCT00205777|3355546|P3|Study Extension II|Protocol Violation|0
1029646|NCT00205777|3355547|P2|Study Extension II|Protocol Violation|0
1029647|NCT00205777|3355548|P1|Study Extension II|Protocol Violation|0
1029648|NCT00205777|3355543|P6|Study Extension II|Withdrawal by Subject|59
1029649|NCT00205777|3355544|P5|Study Extension II|Withdrawal by Subject|0
1029650|NCT00205777|3355545|P4|Study Extension II|Withdrawal by Subject|35
1029651|NCT00205777|3355546|P3|Study Extension II|Withdrawal by Subject|0
1029652|NCT00205777|3355547|P2|Study Extension II|Withdrawal by Subject|0
1029653|NCT00205777|3355548|P1|Study Extension II|Withdrawal by Subject|0
1029654|NCT00205777|3355543|P6|Study Extension II|Death|5
1029655|NCT00205777|3355544|P5|Study Extension II|Death|0
1029656|NCT00205777|3355545|P4|Study Extension II|Death|2
1029657|NCT00205777|3355546|P3|Study Extension II|Death|0
1029658|NCT00205777|3355547|P2|Study Extension II|Death|0
1029659|NCT00205777|3355548|P1|Study Extension II|Death|0
1029660|NCT00205777|3355543|P6|Study Extension II|Adverse Event|30
1029661|NCT00205777|3355544|P5|Study Extension II|Adverse Event|0
1029662|NCT00205777|3355545|P4|Study Extension II|Adverse Event|14
1029663|NCT00205777|3355546|P3|Study Extension II|Adverse Event|0
1029664|NCT00205777|3355547|P2|Study Extension II|Adverse Event|0
1029665|NCT00205777|3355548|P1|Study Extension II|Adverse Event|0
1029666|NCT00205777|3355543|P6|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
1029667|NCT00205777|3355544|P5|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258
1029668|NCT00205777|3355545|P4|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240
1029669|NCT00205777|3355546|P3|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
1029670|NCT00205777|3355547|P2|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
1029671|NCT00205777|3355548|P1|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273
1029672|NCT00205777|3355543|P6|Study Extension I|Withdrawn as per protocol|0
1029673|NCT00205777|3355544|P5|Study Extension I|Withdrawn as per protocol|0
1029674|NCT00205777|3355545|P4|Study Extension I|Withdrawn as per protocol|0
1029675|NCT00205777|3355546|P3|Study Extension I|Withdrawn as per protocol|1070
1029676|NCT00205777|3355547|P2|Study Extension I|Withdrawn as per protocol|0
1029677|NCT00205777|3355548|P1|Study Extension I|Withdrawn as per protocol|0
1029678|NCT00205777|3355543|P6|Study Extension I|Other Event|0
1029679|NCT00205777|3355544|P5|Study Extension I|Other Event|29
1029680|NCT00205777|3355545|P4|Study Extension I|Other Event|34
1029681|NCT00205777|3355546|P3|Study Extension I|Other Event|0
1029682|NCT00205777|3355547|P2|Study Extension I|Other Event|0
1029683|NCT00205777|3355548|P1|Study Extension I|Other Event|34
1029684|NCT00205777|3355543|P6|Study Extension I|Failed to return|0
1029685|NCT00205777|3355544|P5|Study Extension I|Failed to return|13
1029686|NCT00205777|3355545|P4|Study Extension I|Failed to return|17
1029687|NCT00205777|3355546|P3|Study Extension I|Failed to return|0
1029688|NCT00205777|3355547|P2|Study Extension I|Failed to return|0
1029689|NCT00205777|3355548|P1|Study Extension I|Failed to return|15
1029690|NCT00205777|3355543|P6|Study Extension I|Lack of Efficacy|0
1029691|NCT00205777|3355544|P5|Study Extension I|Lack of Efficacy|2
1029692|NCT00205777|3355545|P4|Study Extension I|Lack of Efficacy|1
1029693|NCT00205777|3355546|P3|Study Extension I|Lack of Efficacy|0
1029694|NCT00205777|3355547|P2|Study Extension I|Lack of Efficacy|0
1029695|NCT00205777|3355548|P1|Study Extension I|Lack of Efficacy|0
1029696|NCT00205777|3355543|P6|Study Extension I|Protocol Violation|0
1029697|NCT00205777|3355544|P5|Study Extension I|Protocol Violation|8
1029698|NCT00205777|3355545|P4|Study Extension I|Protocol Violation|8
1029699|NCT00205777|3355546|P3|Study Extension I|Protocol Violation|0
1029700|NCT00205777|3355547|P2|Study Extension I|Protocol Violation|0
1029701|NCT00205777|3355548|P1|Study Extension I|Protocol Violation|4
1029702|NCT00205777|3355543|P6|Study Extension I|Withdrawal by Subject|0
1029703|NCT00205777|3355544|P5|Study Extension I|Withdrawal by Subject|89
1029704|NCT00205777|3355545|P4|Study Extension I|Withdrawal by Subject|106
1029705|NCT00205777|3355546|P3|Study Extension I|Withdrawal by Subject|0
1029706|NCT00205777|3355547|P2|Study Extension I|Withdrawal by Subject|0
1029707|NCT00205777|3355548|P1|Study Extension I|Withdrawal by Subject|99
1029708|NCT00205777|3355543|P6|Study Extension I|Death|0
1029709|NCT00205777|3355544|P5|Study Extension I|Death|2
1029710|NCT00205777|3355545|P4|Study Extension I|Death|1
1029711|NCT00205777|3355546|P3|Study Extension I|Death|0
1029712|NCT00205777|3355547|P2|Study Extension I|Death|0
1029713|NCT00205777|3355548|P1|Study Extension I|Death|5
1029714|NCT00205777|3355543|P6|Study Extension I|Adverse Event|0
1029715|NCT00205777|3355544|P5|Study Extension I|Adverse Event|58
1029716|NCT00205777|3355545|P4|Study Extension I|Adverse Event|61
1029717|NCT00205777|3355546|P3|Study Extension I|Adverse Event|0
1029718|NCT00205777|3355547|P2|Study Extension I|Adverse Event|0
1029719|NCT00205777|3355548|P1|Study Extension I|Adverse Event|57
1029720|NCT00205777|3355543|P6|Completed Core Study, Entered SE I|Other Event|0
1029721|NCT00205777|3355544|P5|Completed Core Study, Entered SE I|Other Event|0
1029722|NCT00205777|3355545|P4|Completed Core Study, Entered SE I|Other Event|50
1029723|NCT00205777|3355546|P3|Completed Core Study, Entered SE I|Other Event|47
1029724|NCT00205777|3355547|P2|Completed Core Study, Entered SE I|Other Event|46
1029725|NCT00205777|3355548|P1|Completed Core Study, Entered SE I|Other Event|52
1029726|NCT00205777|3355543|P6|Completed Core Study, Entered SE I|Withdrawal by Subject|0
1029727|NCT00205777|3355544|P5|Completed Core Study, Entered SE I|Withdrawal by Subject|0
1029728|NCT00205777|3355545|P4|Completed Core Study, Entered SE I|Withdrawal by Subject|174
1029729|NCT00205777|3355546|P3|Completed Core Study, Entered SE I|Withdrawal by Subject|160
1029730|NCT00205777|3355547|P2|Completed Core Study, Entered SE I|Withdrawal by Subject|158
1029731|NCT00205777|3355548|P1|Completed Core Study, Entered SE I|Withdrawal by Subject|180
1029732|NCT00205777|3355543|P6|Core Study (Up to 3 Years)|Randomized but not treated|0
1029733|NCT00205777|3355544|P5|Core Study (Up to 3 Years)|Randomized but not treated|0
1029734|NCT00205777|3355545|P4|Core Study (Up to 3 Years)|Randomized but not treated|29
1029735|NCT00205777|3355546|P3|Core Study (Up to 3 Years)|Randomized but not treated|35
1029736|NCT00205777|3355547|P2|Core Study (Up to 3 Years)|Randomized but not treated|32
1029737|NCT00205777|3355548|P1|Core Study (Up to 3 Years)|Randomized but not treated|21
1029738|NCT00205777|3355543|P6|Core Study (Up to 3 Years)|Lack of Efficacy|0
1029739|NCT00205777|3355544|P5|Core Study (Up to 3 Years)|Lack of Efficacy|0
1029740|NCT00205777|3355545|P4|Core Study (Up to 3 Years)|Lack of Efficacy|75
1029741|NCT00205777|3355546|P3|Core Study (Up to 3 Years)|Lack of Efficacy|39
1029742|NCT00205777|3355547|P2|Core Study (Up to 3 Years)|Lack of Efficacy|52
1029743|NCT00205777|3355548|P1|Core Study (Up to 3 Years)|Lack of Efficacy|52
1029744|NCT00205777|3355543|P6|Core Study (Up to 3 Years)|Protocol Violation|0
1029745|NCT00205777|3355544|P5|Core Study (Up to 3 Years)|Protocol Violation|0
1029746|NCT00205777|3355545|P4|Core Study (Up to 3 Years)|Protocol Violation|42
1029747|NCT00205777|3355546|P3|Core Study (Up to 3 Years)|Protocol Violation|50
1029748|NCT00205777|3355547|P2|Core Study (Up to 3 Years)|Protocol Violation|55
1029749|NCT00205777|3355548|P1|Core Study (Up to 3 Years)|Protocol Violation|53
1029750|NCT00205777|3355543|P6|Core Study (Up to 3 Years)|Withdrawal by Subject|0
1029751|NCT00205777|3355544|P5|Core Study (Up to 3 Years)|Withdrawal by Subject|0
1029752|NCT00205777|3355545|P4|Core Study (Up to 3 Years)|Withdrawal by Subject|162
1029753|NCT00205777|3355546|P3|Core Study (Up to 3 Years)|Withdrawal by Subject|149
1029754|NCT00205777|3355547|P2|Core Study (Up to 3 Years)|Withdrawal by Subject|169
1029755|NCT00205777|3355548|P1|Core Study (Up to 3 Years)|Withdrawal by Subject|144
1029756|NCT00205777|3355543|P6|Core Study (Up to 3 Years)|Other Event|0
1029757|NCT00205777|3355544|P5|Core Study (Up to 3 Years)|Other Event|0
1029758|NCT00205777|3355545|P4|Core Study (Up to 3 Years)|Other Event|58
1029759|NCT00205777|3355546|P3|Core Study (Up to 3 Years)|Other Event|41
1029760|NCT00205777|3355547|P2|Core Study (Up to 3 Years)|Other Event|52
1029761|NCT00205777|3355548|P1|Core Study (Up to 3 Years)|Other Event|49
1029762|NCT00205777|3355543|P6|Core Study (Up to 3 Years)|Failed to return|0
1029763|NCT00205777|3355544|P5|Core Study (Up to 3 Years)|Failed to return|0
1029764|NCT00205777|3355545|P4|Core Study (Up to 3 Years)|Failed to return|27
1029765|NCT00205777|3355546|P3|Core Study (Up to 3 Years)|Failed to return|27
1029766|NCT00205777|3355547|P2|Core Study (Up to 3 Years)|Failed to return|25
1029767|NCT00205777|3355548|P1|Core Study (Up to 3 Years)|Failed to return|40
1029768|NCT00205777|3355543|P6|Core Study (Up to 3 Years)|Death|0
1029769|NCT00205777|3355544|P5|Core Study (Up to 3 Years)|Death|0
1029770|NCT00205777|3355545|P4|Core Study (Up to 3 Years)|Death|7
1029771|NCT00205777|3355546|P3|Core Study (Up to 3 Years)|Death|14
1029772|NCT00205777|3355547|P2|Core Study (Up to 3 Years)|Death|7
1029773|NCT00205777|3355548|P1|Core Study (Up to 3 Years)|Death|9
1029774|NCT00205777|3355543|P6|Core Study (Up to 3 Years)|Adverse Event|0
1029775|NCT00205777|3355544|P5|Core Study (Up to 3 Years)|Adverse Event|0
1029776|NCT00205777|3355545|P4|Core Study (Up to 3 Years)|Adverse Event|232
1029777|NCT00205777|3355546|P3|Core Study (Up to 3 Years)|Adverse Event|252
1029778|NCT00205777|3355547|P2|Core Study (Up to 3 Years)|Adverse Event|267
1029779|NCT00205777|3355548|P1|Core Study (Up to 3 Years)|Adverse Event|260
1029780|NCT00205712|3355757|P2|Overall Study|Lost to Follow-up|1
1029781|NCT00205712|3355758|P1|Overall Study|Lost to Follow-up|0
1029782|NCT00205699|3355771|P3|Overall Study|Lack of Efficacy|0
1029783|NCT00205699|3355772|P2|Overall Study|Lack of Efficacy|1
1029784|NCT00205699|3355773|P1|Overall Study|Lack of Efficacy|0
1029785|NCT00205699|3355771|P3|Overall Study|Withdrawal by Subject|1
1029786|NCT00205699|3355772|P2|Overall Study|Withdrawal by Subject|2
1029787|NCT00205699|3355773|P1|Overall Study|Withdrawal by Subject|1
1029788|NCT00205699|3355771|P3|Overall Study|Adverse Event|0
1029789|NCT00205699|3355772|P2|Overall Study|Adverse Event|0
1029790|NCT00205699|3355773|P1|Overall Study|Adverse Event|1
1029791|NCT00205699|3355771|P3|Overall Study|Lost to Follow-up|5
1029792|NCT00205699|3355772|P2|Overall Study|Lost to Follow-up|3
1029793|NCT00205699|3355773|P1|Overall Study|Lost to Follow-up|1
1029794|NCT00203996|3355867|P10|Overall Study|Scheduling issue|0
1029795|NCT00203996|3355868|P9|Overall Study|Scheduling issue|0
1029796|NCT00203996|3355869|P8|Overall Study|Scheduling issue|2
1029797|NCT00203996|3355870|P7|Overall Study|Scheduling issue|0
1029798|NCT00203996|3355871|P6|Overall Study|Scheduling issue|0
1029799|NCT00203996|3355872|P5|Overall Study|Scheduling issue|0
1029800|NCT00203996|3355873|P4|Overall Study|Scheduling issue|0
1029801|NCT00203996|3355874|P3|Overall Study|Scheduling issue|0
1029802|NCT00203996|3355875|P2|Overall Study|Scheduling issue|0
1029803|NCT00203996|3355876|P1|Overall Study|Scheduling issue|0
1029804|NCT00203996|3355867|P10|Overall Study|CPAP machine malfunction|0
1029805|NCT00203996|3355868|P9|Overall Study|CPAP machine malfunction|0
1029806|NCT00203996|3355869|P8|Overall Study|CPAP machine malfunction|0
1029807|NCT00203996|3355870|P7|Overall Study|CPAP machine malfunction|0
1029808|NCT00203996|3355871|P6|Overall Study|CPAP machine malfunction|0
1029809|NCT00203996|3355872|P5|Overall Study|CPAP machine malfunction|0
1029810|NCT00203996|3355873|P4|Overall Study|CPAP machine malfunction|1
1029811|NCT00203996|3355874|P3|Overall Study|CPAP machine malfunction|0
1029812|NCT00203996|3355875|P2|Overall Study|CPAP machine malfunction|0
1029813|NCT00203996|3355876|P1|Overall Study|CPAP machine malfunction|0
1029814|NCT00203996|3355867|P10|Overall Study|Physician Decision|1
1029815|NCT00203996|3355868|P9|Overall Study|Physician Decision|0
1029816|NCT00203996|3355869|P8|Overall Study|Physician Decision|0
1029817|NCT00203996|3355870|P7|Overall Study|Physician Decision|0
1029818|NCT00203996|3355871|P6|Overall Study|Physician Decision|0
1029819|NCT00203996|3355872|P5|Overall Study|Physician Decision|0
1029820|NCT00203996|3355873|P4|Overall Study|Physician Decision|2
1029821|NCT00203996|3355874|P3|Overall Study|Physician Decision|0
1029822|NCT00203996|3355875|P2|Overall Study|Physician Decision|0
1029823|NCT00203996|3355876|P1|Overall Study|Physician Decision|0
1029824|NCT00203996|3355867|P10|Overall Study|Protocol Violation|0
1029825|NCT00203996|3355868|P9|Overall Study|Protocol Violation|0
1029826|NCT00203996|3355869|P8|Overall Study|Protocol Violation|0
1029827|NCT00203996|3355870|P7|Overall Study|Protocol Violation|0
1029828|NCT00203996|3355871|P6|Overall Study|Protocol Violation|0
1029829|NCT00203996|3355872|P5|Overall Study|Protocol Violation|1
1029830|NCT00203996|3355873|P4|Overall Study|Protocol Violation|6
1029831|NCT00203996|3355874|P3|Overall Study|Protocol Violation|0
1029832|NCT00203996|3355875|P2|Overall Study|Protocol Violation|0
1029833|NCT00203996|3355876|P1|Overall Study|Protocol Violation|0
1029834|NCT00203996|3355867|P10|Overall Study|Lost to Follow-up|0
1029835|NCT00203996|3355868|P9|Overall Study|Lost to Follow-up|0
1029836|NCT00203996|3355869|P8|Overall Study|Lost to Follow-up|0
1029837|NCT00203996|3355870|P7|Overall Study|Lost to Follow-up|0
1029838|NCT00203996|3355871|P6|Overall Study|Lost to Follow-up|0
1029839|NCT00203996|3355872|P5|Overall Study|Lost to Follow-up|0
1029840|NCT00203996|3355873|P4|Overall Study|Lost to Follow-up|1
1029841|NCT00203996|3355874|P3|Overall Study|Lost to Follow-up|0
1029842|NCT00203996|3355875|P2|Overall Study|Lost to Follow-up|0
1029843|NCT00203996|3355876|P1|Overall Study|Lost to Follow-up|0
1029844|NCT00203892|3355943|P3|Overall Study|Death|0
1029845|NCT00203892|3355944|P2|Overall Study|Death|0
1029846|NCT00203892|3355945|P1|Overall Study|Death|1
1029847|NCT00203892|3355943|P3|Overall Study|Physician Decision|0
1029848|NCT00203892|3355944|P2|Overall Study|Physician Decision|2
1029849|NCT00203892|3355945|P1|Overall Study|Physician Decision|1
1029850|NCT00203502|3355956|P1|Overall Study|Death|1
1029851|NCT00203476|3355967|P3|Overall Study|Withdrawal by Subject|0
1029852|NCT00203476|3355968|P2|Overall Study|Withdrawal by Subject|1
1029853|NCT00203476|3355969|P1|Overall Study|Withdrawal by Subject|0
1029854|NCT00203476|3355967|P3|Overall Study|Lost to Follow-up|0
1029855|NCT00203476|3355968|P2|Overall Study|Lost to Follow-up|0
1029856|NCT00203476|3355969|P1|Overall Study|Lost to Follow-up|1
1029857|NCT00203424|3355986|P1|Follow-up Period|Lost to Follow-up|1
1029858|NCT00203424|3355986|P1|Follow-up Period|progressive disease|4
1029859|NCT00203424|3355986|P1|Follow-up Period|Withdrawal by Subject|1
1029860|NCT00203424|3355986|P1|Treatment Period|progressive disease|2
1029861|NCT00203424|3355986|P1|Treatment Period|Adverse Event|5
1029862|NCT00203424|3355986|P1|Treatment Period|Withdrawal by Subject|4
1029863|NCT00203411|3355993|P1|Follow-up|Progressive Disease|4
1029864|NCT00203307|3356002|P2|First Intervention|Adverse Event|0
1029865|NCT00203307|3356003|P1|First Intervention|Adverse Event|2
1029866|NCT00203294|3356011|P2|Overall Study|Withdrawal by Subject|13
1029867|NCT00203294|3356012|P1|Overall Study|Withdrawal by Subject|8
1029868|NCT00203268|3356018|P1|Early Treatment|Withdrawal by Subject|1
1029869|NCT00203268|3356018|P1|Early Treatment|Lost to Follow-up|1
1029870|NCT00203268|3356018|P1|Early Treatment|only treated one headache|2
1029871|NCT00203242|3356024|P1|Overall Study|Lost to Follow-up|1
1029872|NCT00203047|3356076|P2|Overall Study|Not specified|5
1029873|NCT00203047|3356077|P1|Overall Study|Not specified|5
1029874|NCT00203047|3356076|P2|Overall Study|Pregnancy|0
1029875|NCT00203047|3356077|P1|Overall Study|Pregnancy|3
1029876|NCT00203047|3356076|P2|Overall Study|Death|2
1029877|NCT00203047|3356077|P1|Overall Study|Death|1
1029878|NCT00203047|3356076|P2|Overall Study|Adverse Event|18
1029879|NCT00203047|3356077|P1|Overall Study|Adverse Event|8
1029880|NCT00203047|3356076|P2|Overall Study|Lost to Follow-up|5
1029881|NCT00203047|3356077|P1|Overall Study|Lost to Follow-up|11
1029882|NCT00203047|3356076|P2|Overall Study|Protocol Violation|0
1029883|NCT00203047|3356077|P1|Overall Study|Protocol Violation|1
1029884|NCT00203047|3356076|P2|Overall Study|Non-compliance|8
1029885|NCT00203047|3356077|P1|Overall Study|Non-compliance|4
1029886|NCT00203047|3356076|P2|Overall Study|Physician Decision|7
1029887|NCT00203047|3356077|P1|Overall Study|Physician Decision|8
1029888|NCT00203047|3356076|P2|Overall Study|Teva requested participant withdrawal|1
1029889|NCT00203047|3356077|P1|Overall Study|Teva requested participant withdrawal|1
1029890|NCT00203047|3356076|P2|Overall Study|Withdrawal by Subject|47
1029891|NCT00203047|3356077|P1|Overall Study|Withdrawal by Subject|13
1029892|NCT00203047|3356076|P2|Overall Study|Ongoing: not in database - Jan 29, 2009|1
1029893|NCT00203047|3356077|P1|Overall Study|Ongoing: not in database - Jan 29, 2009|5
1029894|NCT00203047|3356076|P2|Overall Study|Ongoing: in database - January 29, 2009|109
1029895|NCT00203047|3356077|P1|Overall Study|Ongoing: in database - January 29, 2009|131
1029896|NCT00202878|3356091|P2|Overall Study|Withdrawal by Subject|808
1029897|NCT00202878|3356092|P1|Overall Study|Withdrawal by Subject|795
1029898|NCT00202878|3356091|P2|Overall Study|Site Closure|36
1029899|NCT00202878|3356092|P1|Overall Study|Site Closure|39
1029900|NCT00202878|3356091|P2|Overall Study|Lost to Follow-up|49
1029901|NCT00202878|3356092|P1|Overall Study|Lost to Follow-up|44
1029902|NCT00202878|3356091|P2|Overall Study|Only Vital Status Known|356
1029903|NCT00202878|3356092|P1|Overall Study|Only Vital Status Known|357
1029904|NCT00202878|3356091|P2|Overall Study|Death|968
1029905|NCT00202878|3356092|P1|Overall Study|Death|964
1029906|NCT00202839|3356106|P2|Overall Study|Lost to Follow-up|2
1029907|NCT00202839|3356107|P1|Overall Study|Lost to Follow-up|3
1029908|NCT00202839|3356106|P2|Overall Study|Protocol Violation|1
1029909|NCT00202839|3356107|P1|Overall Study|Protocol Violation|2
1029910|NCT00202839|3356106|P2|Overall Study|Withdrawal by Subject|2
1029911|NCT00202839|3356107|P1|Overall Study|Withdrawal by Subject|6
1029912|NCT00202839|3356106|P2|Overall Study|Physician Decision|0
1029913|NCT00202839|3356107|P1|Overall Study|Physician Decision|12
1029914|NCT00202839|3356106|P2|Overall Study|Adverse Event|5
1029915|NCT00202839|3356107|P1|Overall Study|Adverse Event|1
1029916|NCT00202644|3356122|P2|Overall Study|Other|1
1029917|NCT00202644|3356123|P1|Overall Study|Other|9
1029918|NCT00202644|3356122|P2|Overall Study|Lost to Follow-up|1
1029919|NCT00202644|3356123|P1|Overall Study|Lost to Follow-up|0
1029920|NCT00202644|3356122|P2|Overall Study|Lack of Efficacy|6
1029921|NCT00202644|3356123|P1|Overall Study|Lack of Efficacy|6
1029922|NCT00202644|3356122|P2|Overall Study|Withdrawal by Subject|6
1029923|NCT00202644|3356123|P1|Overall Study|Withdrawal by Subject|8
1029924|NCT00202644|3356122|P2|Overall Study|Adverse Event|13
1029925|NCT00202644|3356123|P1|Overall Study|Adverse Event|12
1029926|NCT00201851|3356184|P3|Overall Study|Ineligible post enrollment|1
1029927|NCT00201851|3356185|P2|Overall Study|Ineligible post enrollment|1
1029928|NCT00201851|3356186|P1|Overall Study|Ineligible post enrollment|6
1029929|NCT00201851|3356184|P3|Overall Study|Lost to Follow-up|0
1029930|NCT00201851|3356185|P2|Overall Study|Lost to Follow-up|1
1029931|NCT00201851|3356186|P1|Overall Study|Lost to Follow-up|2
1029932|NCT00201643|3356258|P2|Overall Study|Withdrawal by Subject|4
1029933|NCT00201643|3356259|P1|Overall Study|Withdrawal by Subject|5
1029934|NCT00201201|3356323|P2|Overall Study|Withdrawal by Subject|5
1029935|NCT00201201|3356324|P1|Overall Study|Withdrawal by Subject|5
1029936|NCT00201201|3356323|P2|Overall Study|Death|2
1029937|NCT00201201|3356324|P1|Overall Study|Death|0
1029938|NCT00201006|3356362|P3|Overall Study|Adverse Event|1
1029939|NCT00201006|3356363|P2|Overall Study|Adverse Event|0
1029940|NCT00201006|3356364|P1|Overall Study|Adverse Event|1
1029941|NCT00201006|3356362|P3|Overall Study|Withdrawal by Subject|3
1029942|NCT00201006|3356363|P2|Overall Study|Withdrawal by Subject|2
1029943|NCT00201006|3356364|P1|Overall Study|Withdrawal by Subject|7
1029944|NCT00200967|3356374|P2|Run-out Period|Lost to Follow-up|0
1029945|NCT00200967|3356375|P1|Run-out Period|Lost to Follow-up|1
1029946|NCT00200967|3356374|P2|Second Treatment Period|Withdrawal by Subject|2
1029947|NCT00200967|3356375|P1|Second Treatment Period|Withdrawal by Subject|1
1029948|NCT00200967|3356374|P2|Wash-out Period|Lost to Follow-up|1
1029949|NCT00200967|3356375|P1|Wash-out Period|Lost to Follow-up|0
1029950|NCT00200967|3356374|P2|First Treatment Period|Pregnancy|0
1029951|NCT00200967|3356375|P1|First Treatment Period|Pregnancy|1
1029952|NCT00200967|3356374|P2|First Treatment Period|Withdrawal by Subject|1
1029953|NCT00200967|3356375|P1|First Treatment Period|Withdrawal by Subject|5
1029954|NCT00200356|3356416|P2|Overall Study|Nontreatment|0
1029955|NCT00200356|3356417|P1|Overall Study|Nontreatment|1
1029956|NCT00200356|3356416|P2|Overall Study|Protocol Violation|4
1029957|NCT00200356|3356417|P1|Overall Study|Protocol Violation|4
1029958|NCT00200356|3356416|P2|Overall Study|Lack of Efficacy|3
1029959|NCT00200356|3356417|P1|Overall Study|Lack of Efficacy|3
1029960|NCT00200057|3356484|P1|Overall Study|Death|1
1029961|NCT00200057|3356484|P1|Overall Study|Infection|1
1029962|NCT00200057|3356484|P1|Overall Study|Change in medical condition|1
1029963|NCT00200057|3356484|P1|Overall Study|Withdrawal by Subject|1
1029964|NCT00200057|3356484|P1|Overall Study|Exited due to terminal illness of PI|2
1029965|NCT00200057|3356484|P1|Overall Study|Lack of Efficacy|3
1029966|NCT00199875|3356508|P5|Overall Study|Withdrawal by Subject|1
1029967|NCT00199875|3356509|P4|Overall Study|Withdrawal by Subject|0
1029968|NCT00199875|3356510|P3|Overall Study|Withdrawal by Subject|0
1029969|NCT00199875|3356511|P2|Overall Study|Withdrawal by Subject|0
1029970|NCT00199875|3356512|P1|Overall Study|Withdrawal by Subject|0
1029971|NCT00199381|3356534|P1|Overall Study|Study termination by Sponsor|323
1029972|NCT00199381|3356534|P1|Overall Study|Not including due to early termination|37
1029973|NCT00199381|3356534|P1|Overall Study|Lack of Efficacy|27
1029974|NCT00199381|3356534|P1|Overall Study|Protocol Violation|6
1029975|NCT00199381|3356534|P1|Overall Study|Adverse Event|73
1029976|NCT00199381|3356534|P1|Overall Study|Withdrawal by Subject|38
1029977|NCT00198822|3356541|P3|Overall Study|Lost to Follow-up|21
1029978|NCT00198822|3356542|P2|Overall Study|Lost to Follow-up|20
1029979|NCT00198822|3356543|P1|Overall Study|Lost to Follow-up|14
1029980|NCT00198133|3356562|P2|Overall Study|Physician Decision|0
1029981|NCT00198133|3356563|P1|Overall Study|Physician Decision|1
1029982|NCT00198133|3356562|P2|Overall Study|Withdrawal by Subject|0
1029983|NCT00198133|3356563|P1|Overall Study|Withdrawal by Subject|1
1029984|NCT00198133|3356562|P2|Overall Study|Adverse Event|3
1029985|NCT00198133|3356563|P1|Overall Study|Adverse Event|1
1029986|NCT00198133|3356562|P2|Overall Study|Disease progression|5
1029987|NCT00198133|3356563|P1|Overall Study|Disease progression|2
1029988|NCT00198029|3356606|P1|Overall Study|Withdrawal by Subject|4
1029989|NCT00197496|3356613|P2|Follow-up|Lost to Follow-up|1
1029990|NCT00197496|3356614|P1|Follow-up|Lost to Follow-up|2
1029991|NCT00197496|3356613|P2|Baseline to Discharge|Protocol Violation|1
1029992|NCT00197496|3356614|P1|Baseline to Discharge|Protocol Violation|0
1029993|NCT00197496|3356613|P2|Baseline to Discharge|Physician Decision|1
1029994|NCT00197496|3356614|P1|Baseline to Discharge|Physician Decision|0
1029995|NCT00197496|3356613|P2|Baseline to Discharge|MRSA|0
1029996|NCT00197496|3356614|P1|Baseline to Discharge|MRSA|1
1029997|NCT00197496|3356613|P2|Baseline to Discharge|not interested|0
1029998|NCT00197496|3356614|P1|Baseline to Discharge|not interested|1
1029999|NCT00197236|3356662|P3|Overall Study|Returned out of specified time window|1
1030000|NCT00197236|3356663|P2|Overall Study|Returned out of specified time window|0
1030001|NCT00197236|3356664|P1|Overall Study|Returned out of specified time window|0
1030002|NCT00197236|3356662|P3|Overall Study|Study drug/medication expiration|3
1030003|NCT00197236|3356663|P2|Overall Study|Study drug/medication expiration|0
1030004|NCT00197236|3356664|P1|Overall Study|Study drug/medication expiration|1
1030005|NCT00197236|3356662|P3|Overall Study|Withdrawal by Subject|11
1030006|NCT00197236|3356663|P2|Overall Study|Withdrawal by Subject|3
1030007|NCT00197236|3356664|P1|Overall Study|Withdrawal by Subject|7
1030008|NCT00197236|3356662|P3|Overall Study|Protocol Violation|1
1030009|NCT00197236|3356663|P2|Overall Study|Protocol Violation|0
1030010|NCT00197236|3356664|P1|Overall Study|Protocol Violation|0
1030011|NCT00197236|3356662|P3|Overall Study|Lost to Follow-up|6
1030012|NCT00197236|3356663|P2|Overall Study|Lost to Follow-up|14
1030013|NCT00197236|3356664|P1|Overall Study|Lost to Follow-up|5
1030014|NCT00197236|3356662|P3|Overall Study|Adverse Event|1
1030015|NCT00197236|3356663|P2|Overall Study|Adverse Event|0
1030016|NCT00197236|3356664|P1|Overall Study|Adverse Event|1
1030017|NCT00197145|3356738|P2|Period 2 : Open Label Phase|Other|0
1030018|NCT00197145|3356739|P1|Period 2 : Open Label Phase|Other|1
1030019|NCT00197145|3356738|P2|Period 2 : Open Label Phase|Were ongoing till data freeze|0
1030020|NCT00197145|3356739|P1|Period 2 : Open Label Phase|Were ongoing till data freeze|3
1030021|NCT00197145|3356738|P2|Period 2 : Open Label Phase|Availability of alternative ART|0
1030022|NCT00197145|3356739|P1|Period 2 : Open Label Phase|Availability of alternative ART|2
1030023|NCT00197145|3356738|P2|Period 2 : Open Label Phase|Protocol defined virological failure|0
1030024|NCT00197145|3356739|P1|Period 2 : Open Label Phase|Protocol defined virological failure|3
1030025|NCT00197145|3356738|P2|Period 2 : Open Label Phase|Insufficient viral load response|0
1030026|NCT00197145|3356739|P1|Period 2 : Open Label Phase|Insufficient viral load response|1
1030027|NCT00197145|3356738|P2|Period 1: Randomized Treatment Phase|Other|2
1030028|NCT00197145|3356739|P1|Period 1: Randomized Treatment Phase|Other|2
1030029|NCT00197145|3356738|P2|Period 1: Randomized Treatment Phase|Sponsor terminated study|8
1030030|NCT00197145|3356739|P1|Period 1: Randomized Treatment Phase|Sponsor terminated study|10
1030031|NCT00197145|3356738|P2|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
1030032|NCT00197145|3356739|P1|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
1030033|NCT00197106|3356810|P3|Overall Treatment Period|Withdrawal by Subject|2
1030034|NCT00197106|3356811|P2|Overall Treatment Period|Withdrawal by Subject|0
1030035|NCT00197106|3356812|P1|Overall Treatment Period|Withdrawal by Subject|0
1030036|NCT00197106|3356810|P3|Overall Treatment Period|Protocol Violation|2
1030037|NCT00197106|3356811|P2|Overall Treatment Period|Protocol Violation|0
1030038|NCT00197106|3356812|P1|Overall Treatment Period|Protocol Violation|0
1030039|NCT00197106|3356810|P3|Overall Treatment Period|Lost to Follow-up|2
1030040|NCT00197106|3356811|P2|Overall Treatment Period|Lost to Follow-up|0
1030041|NCT00197106|3356812|P1|Overall Treatment Period|Lost to Follow-up|0
1030042|NCT00197106|3356810|P3|Overall Treatment Period|Lack of Efficacy|0
1030043|NCT00197106|3356811|P2|Overall Treatment Period|Lack of Efficacy|1
1030044|NCT00197106|3356812|P1|Overall Treatment Period|Lack of Efficacy|0
1030045|NCT00197106|3356810|P3|4-Week Run-In Period|Did not meet entry criteria|0
1030046|NCT00197106|3356811|P2|4-Week Run-In Period|Did not meet entry criteria|0
1030047|NCT00197106|3356812|P1|4-Week Run-In Period|Did not meet entry criteria|99
1030048|NCT00197028|3356848|P2|Overall Study|Other|6
1030049|NCT00197028|3356849|P1|Overall Study|Other|3
1030050|NCT00197028|3356848|P2|Overall Study|Lost to Follow-up|0
1030051|NCT00197028|3356849|P1|Overall Study|Lost to Follow-up|1
1030052|NCT00197028|3356848|P2|Overall Study|Withdrawal by Subject|12
1030053|NCT00197028|3356849|P1|Overall Study|Withdrawal by Subject|8
1030054|NCT00197028|3356848|P2|Overall Study|Protocol Violation|1
1030055|NCT00197028|3356849|P1|Overall Study|Protocol Violation|2
1030056|NCT00197028|3356848|P2|Overall Study|Adverse Event|2
1030057|NCT00197028|3356849|P1|Overall Study|Adverse Event|2
1030058|NCT00197015|3356892|P3|Overall Study|Other|2
1030059|NCT00197015|3356893|P2|Overall Study|Other|3
1030060|NCT00197015|3356894|P1|Overall Study|Other|2
1030061|NCT00197015|3356892|P3|Overall Study|Lost to Follow-up|37
1030062|NCT00197015|3356893|P2|Overall Study|Lost to Follow-up|46
1030063|NCT00197015|3356894|P1|Overall Study|Lost to Follow-up|28
1030064|NCT00197015|3356892|P3|Overall Study|Withdrawal by Subject|34
1030065|NCT00197015|3356893|P2|Overall Study|Withdrawal by Subject|37
1030066|NCT00197015|3356894|P1|Overall Study|Withdrawal by Subject|17
1030067|NCT00197015|3356892|P3|Overall Study|Protocol Violation|3
1030068|NCT00197015|3356893|P2|Overall Study|Protocol Violation|3
1030069|NCT00197015|3356894|P1|Overall Study|Protocol Violation|0
1030070|NCT00197015|3356892|P3|Overall Study|Adverse Event|1
1030071|NCT00197015|3356893|P2|Overall Study|Adverse Event|0
1030072|NCT00197015|3356894|P1|Overall Study|Adverse Event|3
1030073|NCT00197002|3356953|P3|Overall Study|Others|1
1030074|NCT00197002|3356954|P2|Overall Study|Others|1
1030075|NCT00197002|3356955|P1|Overall Study|Others|3
1030076|NCT00197002|3356953|P3|Overall Study|Lost to follow-up (compl. vaccination)|1
1030077|NCT00197002|3356954|P2|Overall Study|Lost to follow-up (compl. vaccination)|2
1030078|NCT00197002|3356955|P1|Overall Study|Lost to follow-up (compl. vaccination)|2
1030079|NCT00197002|3356953|P3|Overall Study|Lost to follow-up (incompl. vaccination)|5
1030080|NCT00197002|3356954|P2|Overall Study|Lost to follow-up (incompl. vaccination)|4
1030081|NCT00197002|3356955|P1|Overall Study|Lost to follow-up (incompl. vaccination)|4
1030082|NCT00197002|3356953|P3|Overall Study|Migrated/moved from study area|1
1030083|NCT00197002|3356954|P2|Overall Study|Migrated/moved from study area|5
1030084|NCT00197002|3356955|P1|Overall Study|Migrated/moved from study area|3
1030085|NCT00197002|3356953|P3|Overall Study|Withdrawal by Subject|7
1030086|NCT00197002|3356954|P2|Overall Study|Withdrawal by Subject|5
1030087|NCT00197002|3356955|P1|Overall Study|Withdrawal by Subject|9
1030088|NCT00197002|3356953|P3|Overall Study|Protocol Violation|2
1030089|NCT00197002|3356954|P2|Overall Study|Protocol Violation|0
1030090|NCT00197002|3356955|P1|Overall Study|Protocol Violation|1
1030091|NCT00197002|3356953|P3|Overall Study|Adverse Event|0
1030092|NCT00197002|3356954|P2|Overall Study|Adverse Event|1
1030093|NCT00197002|3356955|P1|Overall Study|Adverse Event|0
1030094|NCT00196976|3357006|P14|Booster Study|Lost to Follow-up|0
1030095|NCT00196976|3357007|P13|Booster Study|Lost to Follow-up|0
1030096|NCT00196976|3357008|P12|Booster Study|Lost to Follow-up|2
1030097|NCT00196976|3357009|P11|Booster Study|Lost to Follow-up|1
1030098|NCT00196976|3357010|P10|Booster Study|Lost to Follow-up|0
1030099|NCT00196976|3357011|P9|Booster Study|Lost to Follow-up|0
1030100|NCT00196976|3357012|P8|Booster Study|Lost to Follow-up|0
1030101|NCT00196976|3357013|P7|Booster Study|Lost to Follow-up|0
1030102|NCT00196976|3357014|P6|Booster Study|Lost to Follow-up|0
1030103|NCT00196976|3357015|P5|Booster Study|Lost to Follow-up|0
1030104|NCT00196976|3357016|P4|Booster Study|Lost to Follow-up|0
1030105|NCT00196976|3357017|P3|Booster Study|Lost to Follow-up|0
1030106|NCT00196976|3357018|P2|Booster Study|Lost to Follow-up|0
1030107|NCT00196976|3357019|P1|Booster Study|Lost to Follow-up|0
1030108|NCT00196976|3357006|P14|Booster Study|Withdrawal by Subject|0
1030109|NCT00196976|3357007|P13|Booster Study|Withdrawal by Subject|0
1030110|NCT00196976|3357008|P12|Booster Study|Withdrawal by Subject|0
1030111|NCT00196976|3357009|P11|Booster Study|Withdrawal by Subject|1
1030112|NCT00196976|3357010|P10|Booster Study|Withdrawal by Subject|0
1030113|NCT00196976|3357011|P9|Booster Study|Withdrawal by Subject|0
1030114|NCT00196976|3357012|P8|Booster Study|Withdrawal by Subject|0
1030115|NCT00196976|3357013|P7|Booster Study|Withdrawal by Subject|0
1030116|NCT00196976|3357014|P6|Booster Study|Withdrawal by Subject|0
1030117|NCT00196976|3357015|P5|Booster Study|Withdrawal by Subject|0
1030118|NCT00196976|3357016|P4|Booster Study|Withdrawal by Subject|0
1030119|NCT00196976|3357017|P3|Booster Study|Withdrawal by Subject|0
1030120|NCT00196976|3357018|P2|Booster Study|Withdrawal by Subject|0
1030121|NCT00196976|3357019|P1|Booster Study|Withdrawal by Subject|0
1030122|NCT00196976|3357006|P14|Primary Study|Other|0
1030123|NCT00196976|3357007|P13|Primary Study|Other|0
1030124|NCT00196976|3357008|P12|Primary Study|Other|0
1030125|NCT00196976|3357009|P11|Primary Study|Other|0
1030126|NCT00196976|3357010|P10|Primary Study|Other|0
1030127|NCT00196976|3357011|P9|Primary Study|Other|0
1030128|NCT00196976|3357012|P8|Primary Study|Other|0
1030129|NCT00196976|3357013|P7|Primary Study|Other|0
1030130|NCT00196976|3357014|P6|Primary Study|Other|0
1030131|NCT00196976|3357015|P5|Primary Study|Other|0
1030132|NCT00196976|3357016|P4|Primary Study|Other|0
1030133|NCT00196976|3357017|P3|Primary Study|Other|2
1030134|NCT00196976|3357018|P2|Primary Study|Other|0
1030135|NCT00196976|3357019|P1|Primary Study|Other|0
1030136|NCT00196976|3357006|P14|Primary Study|Lost to Follow-up|0
1030137|NCT00196976|3357007|P13|Primary Study|Lost to Follow-up|0
1030138|NCT00196976|3357008|P12|Primary Study|Lost to Follow-up|0
1030139|NCT00196976|3357009|P11|Primary Study|Lost to Follow-up|0
1030140|NCT00196976|3357010|P10|Primary Study|Lost to Follow-up|0
1030141|NCT00196976|3357011|P9|Primary Study|Lost to Follow-up|0
1030142|NCT00196976|3357012|P8|Primary Study|Lost to Follow-up|2
1030143|NCT00196976|3357013|P7|Primary Study|Lost to Follow-up|0
1030144|NCT00196976|3357014|P6|Primary Study|Lost to Follow-up|1
1030145|NCT00196976|3357015|P5|Primary Study|Lost to Follow-up|1
1030146|NCT00196976|3357016|P4|Primary Study|Lost to Follow-up|0
1030147|NCT00196976|3357017|P3|Primary Study|Lost to Follow-up|0
1030148|NCT00196976|3357018|P2|Primary Study|Lost to Follow-up|0
1030149|NCT00196976|3357019|P1|Primary Study|Lost to Follow-up|0
1030150|NCT00196976|3357006|P14|Primary Study|Withdrawal by Subject|0
1030151|NCT00196976|3357007|P13|Primary Study|Withdrawal by Subject|0
1030152|NCT00196976|3357008|P12|Primary Study|Withdrawal by Subject|0
1030153|NCT00196976|3357009|P11|Primary Study|Withdrawal by Subject|0
1030154|NCT00196976|3357010|P10|Primary Study|Withdrawal by Subject|1
1030155|NCT00196976|3357011|P9|Primary Study|Withdrawal by Subject|0
1030156|NCT00196976|3357012|P8|Primary Study|Withdrawal by Subject|0
1030157|NCT00196976|3357013|P7|Primary Study|Withdrawal by Subject|0
1030158|NCT00196976|3357014|P6|Primary Study|Withdrawal by Subject|1
1030159|NCT00196976|3357015|P5|Primary Study|Withdrawal by Subject|2
1030160|NCT00196976|3357016|P4|Primary Study|Withdrawal by Subject|1
1030161|NCT00196976|3357017|P3|Primary Study|Withdrawal by Subject|1
1030162|NCT00196976|3357018|P2|Primary Study|Withdrawal by Subject|0
1030163|NCT00196976|3357019|P1|Primary Study|Withdrawal by Subject|1
1030164|NCT00196976|3357006|P14|Primary Study|Protocol Violation|0
1030165|NCT00196976|3357007|P13|Primary Study|Protocol Violation|0
1030166|NCT00196976|3357008|P12|Primary Study|Protocol Violation|0
1030167|NCT00196976|3357009|P11|Primary Study|Protocol Violation|0
1030168|NCT00196976|3357010|P10|Primary Study|Protocol Violation|0
1030169|NCT00196976|3357011|P9|Primary Study|Protocol Violation|0
1030170|NCT00196976|3357012|P8|Primary Study|Protocol Violation|0
1030171|NCT00196976|3357013|P7|Primary Study|Protocol Violation|0
1030172|NCT00196976|3357014|P6|Primary Study|Protocol Violation|0
1030173|NCT00196976|3357015|P5|Primary Study|Protocol Violation|0
1030174|NCT00196976|3357016|P4|Primary Study|Protocol Violation|0
1030175|NCT00196976|3357017|P3|Primary Study|Protocol Violation|1
1030176|NCT00196976|3357018|P2|Primary Study|Protocol Violation|1
1030177|NCT00196976|3357019|P1|Primary Study|Protocol Violation|0
1030178|NCT00196976|3357006|P14|Primary Study|Migrated from study area|0
1030179|NCT00196976|3357007|P13|Primary Study|Migrated from study area|0
1030180|NCT00196976|3357008|P12|Primary Study|Migrated from study area|0
1030181|NCT00196976|3357009|P11|Primary Study|Migrated from study area|0
1030182|NCT00196976|3357010|P10|Primary Study|Migrated from study area|0
1030183|NCT00196976|3357011|P9|Primary Study|Migrated from study area|0
1030184|NCT00196976|3357012|P8|Primary Study|Migrated from study area|1
1030185|NCT00196976|3357013|P7|Primary Study|Migrated from study area|0
1030186|NCT00196976|3357014|P6|Primary Study|Migrated from study area|0
1030187|NCT00196976|3357015|P5|Primary Study|Migrated from study area|0
1030188|NCT00196976|3357016|P4|Primary Study|Migrated from study area|0
1030189|NCT00196976|3357017|P3|Primary Study|Migrated from study area|0
1030190|NCT00196976|3357018|P2|Primary Study|Migrated from study area|0
1030191|NCT00196976|3357019|P1|Primary Study|Migrated from study area|0
1030192|NCT00196937|3357215|P3|Overall Study|Withdrawal by Subject|3
1030193|NCT00196937|3357216|P2|Overall Study|Withdrawal by Subject|0
1030194|NCT00196937|3357217|P1|Overall Study|Withdrawal by Subject|0
1030195|NCT00196937|3357215|P3|Overall Study|Lost to Follow-up|3
1030196|NCT00196937|3357216|P2|Overall Study|Lost to Follow-up|3
1030197|NCT00196937|3357217|P1|Overall Study|Lost to Follow-up|4
1030198|NCT00196937|3357215|P3|Overall Study|Subject did not come due to holidays|0
1030199|NCT00196937|3357216|P2|Overall Study|Subject did not come due to holidays|1
1030200|NCT00196937|3357217|P1|Overall Study|Subject did not come due to holidays|3
1030201|NCT00196937|3357215|P3|Overall Study|Adverse Event|1
1030202|NCT00196937|3357216|P2|Overall Study|Adverse Event|1
1030203|NCT00196937|3357217|P1|Overall Study|Adverse Event|2
1030204|NCT00196326|3357265|P1|Overall Study|Not specified|22
1030205|NCT00196326|3357265|P1|Overall Study|Lost to Follow-up|304
1030206|NCT00196326|3357265|P1|Overall Study|Pregnancy|34
1030207|NCT00196326|3357265|P1|Overall Study|Adverse Event|253
1030208|NCT00196326|3357265|P1|Overall Study|Withdrawal by Subject|225
1030209|NCT00196326|3357265|P1|Overall Study|Physician Decision|3
1030210|NCT00196326|3357265|P1|Overall Study|Non-compliance with the protocol|81
1030211|NCT00196326|3357265|P1|Overall Study|Did not meet protocol requirements|64
1030212|NCT00196313|3357273|P2|Overall Study|Lost to Follow-up|2
1030213|NCT00196313|3357274|P1|Overall Study|Lost to Follow-up|2
1030214|NCT00196313|3357273|P2|Overall Study|Subject Pregnant|1
1030215|NCT00196313|3357274|P1|Overall Study|Subject Pregnant|1
1030216|NCT00196313|3357273|P2|Overall Study|Adverse Event|1
1030217|NCT00196313|3357274|P1|Overall Study|Adverse Event|3
1030218|NCT00196313|3357273|P2|Overall Study|Withdrawal by Subject|1
1030219|NCT00196313|3357274|P1|Overall Study|Withdrawal by Subject|3
1030220|NCT00196313|3357273|P2|Overall Study|Protocol Violation|3
1030221|NCT00196313|3357274|P1|Overall Study|Protocol Violation|2
1030222|NCT00196196|3357288|P1|Overall Study|Did not have required condition (hydroce|5
1030223|NCT00196196|3357288|P1|Overall Study|Withdrawal by Subject|2
1030224|NCT00196105|3357296|P3|Overall Study|Lost to Follow-up|7
1030225|NCT00196105|3357297|P2|Overall Study|Lost to Follow-up|5
1030226|NCT00196105|3357298|P1|Overall Study|Lost to Follow-up|4
1030227|NCT00195819|3357318|P2|Open-label|Withdrawal by Subject|5
1030228|NCT00195819|3357319|P1|Open-label|Withdrawal by Subject|0
1030229|NCT00195819|3357318|P2|Open-label|Moved|1
1030230|NCT00195819|3357319|P1|Open-label|Moved|0
1030231|NCT00195819|3357318|P2|Open-label|Protocol Violation|2
1030232|NCT00195819|3357319|P1|Open-label|Protocol Violation|0
1030233|NCT00195819|3357318|P2|Open-label|Pregnancy|1
1030234|NCT00195819|3357319|P1|Open-label|Pregnancy|0
1030235|NCT00195819|3357318|P2|Open-label|Lack of Efficacy|2
1030236|NCT00195819|3357319|P1|Open-label|Lack of Efficacy|0
1030237|NCT00195819|3357318|P2|Open-label|Adverse Event|9
1030238|NCT00195819|3357319|P1|Open-label|Adverse Event|0
1030239|NCT00195819|3357318|P2|Double-Blind|Moved|0
1030240|NCT00195819|3357319|P1|Double-Blind|Moved|1
1030241|NCT00195819|3357318|P2|Double-Blind|Withdrawal by Subject|0
1030242|NCT00195819|3357319|P1|Double-Blind|Withdrawal by Subject|1
1030243|NCT00195715|3357369|P1|Overall Study|Sponsor discretion - trial ended early|1
1030244|NCT00195715|3357369|P1|Overall Study|Sponsor discontinued trial|1
1030245|NCT00195715|3357369|P1|Overall Study|Colonic stricture|1
1030246|NCT00195715|3357369|P1|Overall Study|Ineligible|1
1030247|NCT00195715|3357369|P1|Overall Study|Increased infection rate|1
1030248|NCT00195715|3357369|P1|Overall Study|Planned surgery|2
1030249|NCT00195715|3357369|P1|Overall Study|Use of prohibited medication|2
1030250|NCT00195715|3357369|P1|Overall Study|Subject wants to get pregnant|4
1030251|NCT00195715|3357369|P1|Overall Study|Investigator's decision|2
1030252|NCT00195715|3357369|P1|Overall Study|Administrative reasons|2
1030253|NCT00195715|3357369|P1|Overall Study|Sponsor stopped study|1
1030254|NCT00195715|3357369|P1|Overall Study|Loss of response/no improvement|3
1030255|NCT00195715|3357369|P1|Overall Study|Subject choice|3
1030256|NCT00195715|3357369|P1|Overall Study|Subject started commercial Humira|5
1030257|NCT00195715|3357369|P1|Overall Study|Subject non-compliance|6
1030258|NCT00195715|3357369|P1|Overall Study|Subject moved/relocated|7
1030259|NCT00195715|3357369|P1|Overall Study|Investigative site closure|8
1030260|NCT00195715|3357369|P1|Overall Study|Pregnancy|14
1030261|NCT00195715|3357369|P1|Overall Study|Lack of Efficacy|93
1030262|NCT00195715|3357369|P1|Overall Study|Protocol Violation|13
1030263|NCT00195715|3357369|P1|Overall Study|Lost to Follow-up|27
1030264|NCT00195715|3357369|P1|Overall Study|Withdrawal by Subject|58
1030265|NCT00195715|3357369|P1|Overall Study|Adverse Event|122
1030266|NCT00195676|3357469|P1|Period R - Retreatment 16 Weeks|Other reasons|6
1030267|NCT00195676|3357469|P1|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9
1030268|NCT00195676|3357469|P1|Period R - Retreatment 16 Weeks|Lost to Follow-up|11
1030269|NCT00195676|3357469|P1|Period R - Retreatment 16 Weeks|Lack of Efficacy|5
1030270|NCT00195676|3357469|P1|Period R - Retreatment 16 Weeks|Adverse Event|4
1030271|NCT00195676|3357469|P1|Period W (Withdrawal) - No Treatment|Other reasons|18
1030272|NCT00195676|3357469|P1|Period W (Withdrawal) - No Treatment|Administrative reasons|1
1030273|NCT00195676|3357469|P1|Period W (Withdrawal) - No Treatment|Period W Close-out|129
1030274|NCT00195676|3357469|P1|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397
1030275|NCT00195676|3357469|P1|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46
1030276|NCT00195676|3357469|P1|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11
1030277|NCT00195676|3357469|P1|Period W (Withdrawal) - No Treatment|Death|2
1030278|NCT00195676|3357469|P1|Period W (Withdrawal) - No Treatment|Adverse Event|4
1030279|NCT00195676|3357469|P1|Period O - Open-label Treatment|Other reasons|68
1030280|NCT00195676|3357469|P1|Period O - Open-label Treatment|Administrative reasons|2
1030281|NCT00195676|3357469|P1|Period O - Open-label Treatment|Withdrawal by Subject|147
1030282|NCT00195676|3357469|P1|Period O - Open-label Treatment|Protocol Violation|12
1030283|NCT00195676|3357469|P1|Period O - Open-label Treatment|Lost to Follow-up|91
1030284|NCT00195676|3357469|P1|Period O - Open-label Treatment|Lack of Efficacy|198
1030285|NCT00195676|3357469|P1|Period O - Open-label Treatment|Death|6
1030286|NCT00195676|3357469|P1|Period O - Open-label Treatment|Adverse Event|82
1030287|NCT00195663|3357483|P3|Open-Label Extension Period|Administrative reasons|13
1030288|NCT00195663|3357484|P2|Open-Label Extension Period|Administrative reasons|11
1030289|NCT00195663|3357485|P1|Open-Label Extension Period|Administrative reasons|11
1030290|NCT00195663|3357483|P3|Open-Label Extension Period|Lack of Efficacy|12
1030291|NCT00195663|3357484|P2|Open-Label Extension Period|Lack of Efficacy|6
1030292|NCT00195663|3357485|P1|Open-Label Extension Period|Lack of Efficacy|14
1030293|NCT00195663|3357483|P3|Open-Label Extension Period|Withdrawal by Subject|22
1030294|NCT00195663|3357484|P2|Open-Label Extension Period|Withdrawal by Subject|15
1030295|NCT00195663|3357485|P1|Open-Label Extension Period|Withdrawal by Subject|16
1030296|NCT00195663|3357483|P3|Open-Label Extension Period|Death|2
1030297|NCT00195663|3357484|P2|Open-Label Extension Period|Death|2
1030298|NCT00195663|3357485|P1|Open-Label Extension Period|Death|2
1030299|NCT00195663|3357483|P3|Open-Label Extension Period|Protocol Violation|4
1030300|NCT00195663|3357484|P2|Open-Label Extension Period|Protocol Violation|4
1030301|NCT00195663|3357485|P1|Open-Label Extension Period|Protocol Violation|3
1030302|NCT00195663|3357483|P3|Open-Label Extension Period|Recovery|2
1030303|NCT00195663|3357484|P2|Open-Label Extension Period|Recovery|2
1030304|NCT00195663|3357485|P1|Open-Label Extension Period|Recovery|0
1030305|NCT00195663|3357483|P3|Open-Label Extension Period|Lost to Follow-up|6
1030306|NCT00195663|3357484|P2|Open-Label Extension Period|Lost to Follow-up|2
1030307|NCT00195663|3357485|P1|Open-Label Extension Period|Lost to Follow-up|9
1030308|NCT00195663|3357483|P3|Open-Label Extension Period|Adverse Event|36
1030309|NCT00195663|3357484|P2|Open-Label Extension Period|Adverse Event|32
1030310|NCT00195663|3357485|P1|Open-Label Extension Period|Adverse Event|21
1030311|NCT00195663|3357483|P3|2-year Double-blind Treatment Period|Administrative reasons|9
1030312|NCT00195663|3357484|P2|2-year Double-blind Treatment Period|Administrative reasons|2
1030313|NCT00195663|3357485|P1|2-year Double-blind Treatment Period|Administrative reasons|3
1030314|NCT00195663|3357483|P3|2-year Double-blind Treatment Period|Recovery|1
1030315|NCT00195663|3357484|P2|2-year Double-blind Treatment Period|Recovery|0
1030316|NCT00195663|3357485|P1|2-year Double-blind Treatment Period|Recovery|1
1030317|NCT00195663|3357483|P3|2-year Double-blind Treatment Period|Planned selection criteria|0
1030318|NCT00195663|3357484|P2|2-year Double-blind Treatment Period|Planned selection criteria|1
1030319|NCT00195663|3357485|P1|2-year Double-blind Treatment Period|Planned selection criteria|0
1030320|NCT00195663|3357483|P3|2-year Double-blind Treatment Period|Protocol Violation|4
1030321|NCT00195663|3357484|P2|2-year Double-blind Treatment Period|Protocol Violation|6
1030322|NCT00195663|3357485|P1|2-year Double-blind Treatment Period|Protocol Violation|6
1030323|NCT00195663|3357483|P3|2-year Double-blind Treatment Period|Lack of Efficacy|13
1030324|NCT00195663|3357484|P2|2-year Double-blind Treatment Period|Lack of Efficacy|52
1030325|NCT00195663|3357485|P1|2-year Double-blind Treatment Period|Lack of Efficacy|47
1030326|NCT00195663|3357483|P3|2-year Double-blind Treatment Period|Withdrawal by Subject|12
1030327|NCT00195663|3357484|P2|2-year Double-blind Treatment Period|Withdrawal by Subject|18
1030328|NCT00195663|3357485|P1|2-year Double-blind Treatment Period|Withdrawal by Subject|15
1030329|NCT00195663|3357483|P3|2-year Double-blind Treatment Period|Lost to Follow-up|1
1030330|NCT00195663|3357484|P2|2-year Double-blind Treatment Period|Lost to Follow-up|0
1030331|NCT00195663|3357485|P1|2-year Double-blind Treatment Period|Lost to Follow-up|0
1030332|NCT00195663|3357483|P3|2-year Double-blind Treatment Period|Death|0
1030333|NCT00195663|3357484|P2|2-year Double-blind Treatment Period|Death|2
1030334|NCT00195663|3357485|P1|2-year Double-blind Treatment Period|Death|0
1030335|NCT00195663|3357483|P3|2-year Double-blind Treatment Period|Adverse Event|32
1030336|NCT00195663|3357484|P2|2-year Double-blind Treatment Period|Adverse Event|27
1030337|NCT00195663|3357485|P1|2-year Double-blind Treatment Period|Adverse Event|21
1030338|NCT00195650|3357579|P1|Overall Study|Administrative reasons|83
1030339|NCT00195650|3357579|P1|Overall Study|Protocol Violation|15
1030340|NCT00195650|3357579|P1|Overall Study|Death|23
1030341|NCT00195650|3357579|P1|Overall Study|Lost to Follow-up|44
1030342|NCT00195650|3357579|P1|Overall Study|Withdrawal by Subject|67
1030343|NCT00195650|3357579|P1|Overall Study|Lack of Efficacy|99
1030344|NCT00195650|3357579|P1|Overall Study|Adverse Event|194
1030345|NCT00195507|3357595|P2|Overall Study|Protocol Deviation|3
1030346|NCT00195507|3357596|P1|Overall Study|Protocol Deviation|6
1030347|NCT00195507|3357595|P2|Overall Study|Withdrawal by Subject|23
1030348|NCT00195507|3357596|P1|Overall Study|Withdrawal by Subject|16
1030349|NCT00195507|3357595|P2|Overall Study|Lack of Efficacy|67
1030350|NCT00195507|3357596|P1|Overall Study|Lack of Efficacy|40
1030351|NCT00195507|3357595|P2|Overall Study|Protocol Violation|4
1030352|NCT00195507|3357596|P1|Overall Study|Protocol Violation|5
1030353|NCT00195507|3357595|P2|Overall Study|Lost to Follow-up|2
1030354|NCT00195507|3357596|P1|Overall Study|Lost to Follow-up|3
1030355|NCT00195507|3357595|P2|Overall Study|Physician Decision|2
1030356|NCT00195507|3357596|P1|Overall Study|Physician Decision|1
1030357|NCT00195507|3357595|P2|Overall Study|Failed to Return|3
1030358|NCT00195507|3357596|P1|Overall Study|Failed to Return|4
1030359|NCT00195507|3357595|P2|Overall Study|Death|1
1030360|NCT00195507|3357596|P1|Overall Study|Death|0
1030361|NCT00195507|3357595|P2|Overall Study|Adverse Event|13
1030362|NCT00195507|3357596|P1|Overall Study|Adverse Event|24
1030363|NCT00195494|3357610|P6|Year 2|System toxicity|0
1030364|NCT00195494|3357611|P5|Year 2|System toxicity|0
1030365|NCT00195494|3357612|P4|Year 2|System toxicity|1
1030366|NCT00195494|3357613|P3|Year 2|System toxicity|0
1030367|NCT00195494|3357614|P2|Year 2|System toxicity|0
1030368|NCT00195494|3357615|P1|Year 2|System toxicity|0
1030369|NCT00195494|3357610|P6|Year 2|Withdrawal by Subject|0
1030370|NCT00195494|3357611|P5|Year 2|Withdrawal by Subject|0
1030371|NCT00195494|3357612|P4|Year 2|Withdrawal by Subject|3
1030372|NCT00195494|3357613|P3|Year 2|Withdrawal by Subject|4
1030373|NCT00195494|3357614|P2|Year 2|Withdrawal by Subject|5
1030374|NCT00195494|3357615|P1|Year 2|Withdrawal by Subject|1
1030375|NCT00195494|3357610|P6|Year 2|Physician Decision|0
1030376|NCT00195494|3357611|P5|Year 2|Physician Decision|0
1030377|NCT00195494|3357612|P4|Year 2|Physician Decision|0
1030378|NCT00195494|3357613|P3|Year 2|Physician Decision|0
1030379|NCT00195494|3357614|P2|Year 2|Physician Decision|1
1030380|NCT00195494|3357615|P1|Year 2|Physician Decision|1
1030381|NCT00195494|3357610|P6|Year 2|Protocol deviation|0
1030382|NCT00195494|3357611|P5|Year 2|Protocol deviation|0
1030383|NCT00195494|3357612|P4|Year 2|Protocol deviation|0
1030384|NCT00195494|3357613|P3|Year 2|Protocol deviation|0
1030385|NCT00195494|3357614|P2|Year 2|Protocol deviation|1
1030386|NCT00195494|3357615|P1|Year 2|Protocol deviation|0
1030387|NCT00195494|3357610|P6|Year 2|Missed >4 consecutive doses|0
1030388|NCT00195494|3357611|P5|Year 2|Missed >4 consecutive doses|0
1030389|NCT00195494|3357612|P4|Year 2|Missed >4 consecutive doses|0
1030390|NCT00195494|3357613|P3|Year 2|Missed >4 consecutive doses|1
1030391|NCT00195494|3357614|P2|Year 2|Missed >4 consecutive doses|1
1030392|NCT00195494|3357615|P1|Year 2|Missed >4 consecutive doses|1
1030393|NCT00195494|3357610|P6|Year 2|Lost to Follow-up|0
1030394|NCT00195494|3357611|P5|Year 2|Lost to Follow-up|0
1030395|NCT00195494|3357612|P4|Year 2|Lost to Follow-up|1
1030396|NCT00195494|3357613|P3|Year 2|Lost to Follow-up|1
1030397|NCT00195494|3357614|P2|Year 2|Lost to Follow-up|0
1030398|NCT00195494|3357615|P1|Year 2|Lost to Follow-up|0
1030399|NCT00195494|3357610|P6|Year 2|Compliance|0
1030400|NCT00195494|3357611|P5|Year 2|Compliance|0
1030401|NCT00195494|3357612|P4|Year 2|Compliance|2
1030402|NCT00195494|3357613|P3|Year 2|Compliance|0
1030403|NCT00195494|3357614|P2|Year 2|Compliance|0
1030404|NCT00195494|3357615|P1|Year 2|Compliance|1
1030405|NCT00195494|3357610|P6|Year 2|Lack of Efficacy|0
1030406|NCT00195494|3357611|P5|Year 2|Lack of Efficacy|0
1030407|NCT00195494|3357612|P4|Year 2|Lack of Efficacy|7
1030408|NCT00195494|3357613|P3|Year 2|Lack of Efficacy|7
1030409|NCT00195494|3357614|P2|Year 2|Lack of Efficacy|1
1030410|NCT00195494|3357615|P1|Year 2|Lack of Efficacy|0
1030411|NCT00195494|3357610|P6|Year 2|Adverse Event|0
1030412|NCT00195494|3357611|P5|Year 2|Adverse Event|0
1030413|NCT00195494|3357612|P4|Year 2|Adverse Event|9
1030414|NCT00195494|3357613|P3|Year 2|Adverse Event|5
1030415|NCT00195494|3357614|P2|Year 2|Adverse Event|7
1030416|NCT00195494|3357615|P1|Year 2|Adverse Event|3
1030417|NCT00195494|3357610|P6|Year 1|Protocol Violation|1
1030418|NCT00195494|3357611|P5|Year 1|Protocol Violation|1
1030419|NCT00195494|3357612|P4|Year 1|Protocol Violation|0
1030420|NCT00195494|3357613|P3|Year 1|Protocol Violation|0
1030421|NCT00195494|3357614|P2|Year 1|Protocol Violation|0
1030422|NCT00195494|3357615|P1|Year 1|Protocol Violation|0
1030423|NCT00195494|3357610|P6|Year 1|Withdrawal by Subject|9
1030424|NCT00195494|3357611|P5|Year 1|Withdrawal by Subject|8
1030425|NCT00195494|3357612|P4|Year 1|Withdrawal by Subject|0
1030426|NCT00195494|3357613|P3|Year 1|Withdrawal by Subject|0
1030427|NCT00195494|3357614|P2|Year 1|Withdrawal by Subject|0
1030428|NCT00195494|3357615|P1|Year 1|Withdrawal by Subject|0
1030429|NCT00195494|3357610|P6|Year 1|Physician Decision|0
1030430|NCT00195494|3357611|P5|Year 1|Physician Decision|1
1030431|NCT00195494|3357612|P4|Year 1|Physician Decision|0
1030432|NCT00195494|3357613|P3|Year 1|Physician Decision|0
1030433|NCT00195494|3357614|P2|Year 1|Physician Decision|0
1030434|NCT00195494|3357615|P1|Year 1|Physician Decision|0
1030435|NCT00195494|3357610|P6|Year 1|Protocol deviation|3
1030436|NCT00195494|3357611|P5|Year 1|Protocol deviation|2
1030437|NCT00195494|3357612|P4|Year 1|Protocol deviation|0
1030438|NCT00195494|3357613|P3|Year 1|Protocol deviation|0
1030439|NCT00195494|3357614|P2|Year 1|Protocol deviation|0
1030440|NCT00195494|3357615|P1|Year 1|Protocol deviation|0
1030441|NCT00195494|3357610|P6|Year 1|Missed >4 consecutive doses|2
1030442|NCT00195494|3357611|P5|Year 1|Missed >4 consecutive doses|3
1030443|NCT00195494|3357612|P4|Year 1|Missed >4 consecutive doses|0
1030444|NCT00195494|3357613|P3|Year 1|Missed >4 consecutive doses|0
1030445|NCT00195494|3357614|P2|Year 1|Missed >4 consecutive doses|0
1030446|NCT00195494|3357615|P1|Year 1|Missed >4 consecutive doses|0
1030447|NCT00195494|3357610|P6|Year 1|Lost to Follow-up|0
1030448|NCT00195494|3357611|P5|Year 1|Lost to Follow-up|1
1030449|NCT00195494|3357612|P4|Year 1|Lost to Follow-up|0
1030450|NCT00195494|3357613|P3|Year 1|Lost to Follow-up|0
1030451|NCT00195494|3357614|P2|Year 1|Lost to Follow-up|0
1030452|NCT00195494|3357615|P1|Year 1|Lost to Follow-up|0
1030453|NCT00195494|3357610|P6|Year 1|Compliance|1
1030454|NCT00195494|3357611|P5|Year 1|Compliance|5
1030455|NCT00195494|3357612|P4|Year 1|Compliance|0
1030456|NCT00195494|3357613|P3|Year 1|Compliance|0
1030457|NCT00195494|3357614|P2|Year 1|Compliance|0
1030458|NCT00195494|3357615|P1|Year 1|Compliance|0
1030459|NCT00195494|3357610|P6|Year 1|Lack of Efficacy|9
1030460|NCT00195494|3357611|P5|Year 1|Lack of Efficacy|24
1030461|NCT00195494|3357612|P4|Year 1|Lack of Efficacy|0
1030462|NCT00195494|3357613|P3|Year 1|Lack of Efficacy|0
1030463|NCT00195494|3357614|P2|Year 1|Lack of Efficacy|0
1030464|NCT00195494|3357615|P1|Year 1|Lack of Efficacy|0
1030465|NCT00195494|3357610|P6|Year 1|System Toxicity|1
1030466|NCT00195494|3357611|P5|Year 1|System Toxicity|0
1030467|NCT00195494|3357612|P4|Year 1|System Toxicity|0
1030468|NCT00195494|3357613|P3|Year 1|System Toxicity|0
1030469|NCT00195494|3357614|P2|Year 1|System Toxicity|0
1030470|NCT00195494|3357615|P1|Year 1|System Toxicity|0
1030471|NCT00195494|3357610|P6|Year 1|Adverse Event|27
1030472|NCT00195494|3357611|P5|Year 1|Adverse Event|34
1030473|NCT00195494|3357612|P4|Year 1|Adverse Event|0
1030474|NCT00195494|3357613|P3|Year 1|Adverse Event|0
1030475|NCT00195494|3357614|P2|Year 1|Adverse Event|0
1030476|NCT00195494|3357615|P1|Year 1|Adverse Event|0
1030477|NCT00195442|3357633|P1|Overall Study|Other|14
1030478|NCT00195442|3357633|P1|Overall Study|Poor cooperation|2
1030479|NCT00195442|3357633|P1|Overall Study|No reason specified|4
1030480|NCT00195442|3357633|P1|Overall Study|Death|7
1030481|NCT00195442|3357633|P1|Overall Study|Intermittent product shortage|21
1030482|NCT00195442|3357633|P1|Overall Study|Switch to other Factor VIII preparation|23
1030483|NCT00195442|3357633|P1|Overall Study|Lost to Follow-up|27
1030484|NCT00195442|3357633|P1|Overall Study|Less than expected therapeutic effect|38
1030485|NCT00195429|3357652|P2|Overall Study|Lost to Follow-up|0
1030486|NCT00195429|3357653|P1|Overall Study|Lost to Follow-up|1
1030487|NCT00195429|3357652|P2|Overall Study|Lack of Efficacy|1
1030488|NCT00195429|3357653|P1|Overall Study|Lack of Efficacy|2
1030489|NCT00195429|3357652|P2|Overall Study|Adverse Event|4
1030490|NCT00195429|3357653|P1|Overall Study|Adverse Event|2
1030491|NCT00195351|3357669|P2|Overall Study|Lack of Efficacy|1
1030492|NCT00195351|3357670|P1|Overall Study|Lack of Efficacy|0
1030493|NCT00195351|3357669|P2|Overall Study|Death|1
1030494|NCT00195351|3357670|P1|Overall Study|Death|3
1030495|NCT00195351|3357669|P2|Overall Study|Protocol Deviation|2
1030496|NCT00195351|3357670|P1|Overall Study|Protocol Deviation|3
1030497|NCT00195351|3357669|P2|Overall Study|Withdrawal by Subject|3
1030498|NCT00195351|3357670|P1|Overall Study|Withdrawal by Subject|6
1030499|NCT00195351|3357669|P2|Overall Study|Lost to Follow-up|9
1030500|NCT00195351|3357670|P1|Overall Study|Lost to Follow-up|9
1030501|NCT00195338|3357680|P1|Overall Study|Early closure of the site|4
1030502|NCT00195338|3357680|P1|Overall Study|Lack of Efficacy|1
1030503|NCT00195338|3357680|P1|Overall Study|Adverse Event|5
1030504|NCT00195338|3357680|P1|Overall Study|Lost to Follow-up|2
1030505|NCT00195273|3357690|P2|Overall Study|Procedural complications|3
1030506|NCT00195273|3357691|P1|Overall Study|Procedural complications|9
1030507|NCT00195273|3357690|P2|Overall Study|Lack of Efficacy|1
1030508|NCT00195273|3357691|P1|Overall Study|Lack of Efficacy|3
1030509|NCT00195273|3357690|P2|Overall Study|Protocol deviation|1
1030510|NCT00195273|3357691|P1|Overall Study|Protocol deviation|0
1030511|NCT00195273|3357690|P2|Overall Study|Adverse Event|9
1030512|NCT00195273|3357691|P1|Overall Study|Adverse Event|9
1030513|NCT00195260|3357705|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3
1030514|NCT00195260|3357706|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4
1030515|NCT00195260|3357707|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6
1030516|NCT00195260|3357708|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1030517|NCT00195260|3357709|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1030518|NCT00195260|3357710|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1030519|NCT00195260|3357711|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1030520|NCT00195260|3357712|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1030521|NCT00195260|3357713|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1030522|NCT00195260|3357714|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1030523|NCT00195260|3357715|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1030524|NCT00195260|3357705|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3
1030525|NCT00195260|3357706|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2
1030526|NCT00195260|3357707|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1
1030527|NCT00195260|3357708|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1030528|NCT00195260|3357709|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1030529|NCT00195260|3357710|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1030530|NCT00195260|3357711|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1030531|NCT00195260|3357712|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1030532|NCT00195260|3357713|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1030533|NCT00195260|3357714|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1030534|NCT00195260|3357715|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1030535|NCT00195260|3357705|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2
1030536|NCT00195260|3357706|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3
1030537|NCT00195260|3357707|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5
1030538|NCT00195260|3357708|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1030539|NCT00195260|3357709|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1030540|NCT00195260|3357710|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1030541|NCT00195260|3357711|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1030542|NCT00195260|3357712|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1030543|NCT00195260|3357713|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1030544|NCT00195260|3357714|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1030545|NCT00195260|3357715|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1030546|NCT00195260|3357705|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15
1030547|NCT00195260|3357706|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29
1030548|NCT00195260|3357707|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21
1030549|NCT00195260|3357708|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1030550|NCT00195260|3357709|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1030551|NCT00195260|3357710|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1030552|NCT00195260|3357711|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1030553|NCT00195260|3357712|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1030554|NCT00195260|3357713|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1030555|NCT00195260|3357714|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1030556|NCT00195260|3357715|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1030557|NCT00195260|3357705|P11|Part 1: Dose Escalation|Symptomatic Deterioration|0
1030558|NCT00195260|3357706|P10|Part 1: Dose Escalation|Symptomatic Deterioration|0
1030559|NCT00195260|3357707|P9|Part 1: Dose Escalation|Symptomatic Deterioration|0
1030560|NCT00195260|3357708|P8|Part 1: Dose Escalation|Symptomatic Deterioration|0
1030561|NCT00195260|3357709|P7|Part 1: Dose Escalation|Symptomatic Deterioration|0
1030562|NCT00195260|3357710|P6|Part 1: Dose Escalation|Symptomatic Deterioration|1
1030563|NCT00195260|3357711|P5|Part 1: Dose Escalation|Symptomatic Deterioration|0
1030564|NCT00195260|3357712|P4|Part 1: Dose Escalation|Symptomatic Deterioration|0
1030565|NCT00195260|3357713|P3|Part 1: Dose Escalation|Symptomatic Deterioration|1
1030566|NCT00195260|3357714|P2|Part 1: Dose Escalation|Symptomatic Deterioration|1
1030567|NCT00195260|3357715|P1|Part 1: Dose Escalation|Symptomatic Deterioration|1
1030568|NCT00195260|3357705|P11|Part 1: Dose Escalation|Disease Progression|0
1030569|NCT00195260|3357706|P10|Part 1: Dose Escalation|Disease Progression|0
1030570|NCT00195260|3357707|P9|Part 1: Dose Escalation|Disease Progression|0
1030571|NCT00195260|3357708|P8|Part 1: Dose Escalation|Disease Progression|4
1030572|NCT00195260|3357709|P7|Part 1: Dose Escalation|Disease Progression|7
1030573|NCT00195260|3357710|P6|Part 1: Dose Escalation|Disease Progression|6
1030574|NCT00195260|3357711|P5|Part 1: Dose Escalation|Disease Progression|4
1030575|NCT00195260|3357712|P4|Part 1: Dose Escalation|Disease Progression|6
1030576|NCT00195260|3357713|P3|Part 1: Dose Escalation|Disease Progression|5
1030577|NCT00195260|3357714|P2|Part 1: Dose Escalation|Disease Progression|2
1030578|NCT00195260|3357715|P1|Part 1: Dose Escalation|Disease Progression|3
1030579|NCT00195260|3357705|P11|Part 1: Dose Escalation|Death|0
1030580|NCT00195260|3357706|P10|Part 1: Dose Escalation|Death|0
1030581|NCT00195260|3357707|P9|Part 1: Dose Escalation|Death|0
1030582|NCT00195260|3357708|P8|Part 1: Dose Escalation|Death|1
1030583|NCT00195260|3357709|P7|Part 1: Dose Escalation|Death|0
1030584|NCT00195260|3357710|P6|Part 1: Dose Escalation|Death|0
1030585|NCT00195260|3357711|P5|Part 1: Dose Escalation|Death|0
1030586|NCT00195260|3357712|P4|Part 1: Dose Escalation|Death|0
1030587|NCT00195260|3357713|P3|Part 1: Dose Escalation|Death|0
1030588|NCT00195260|3357714|P2|Part 1: Dose Escalation|Death|0
1030589|NCT00195260|3357715|P1|Part 1: Dose Escalation|Death|0
1030590|NCT00195260|3357705|P11|Part 1: Dose Escalation|Withdrawal by Subject|0
1030591|NCT00195260|3357706|P10|Part 1: Dose Escalation|Withdrawal by Subject|0
1030592|NCT00195260|3357707|P9|Part 1: Dose Escalation|Withdrawal by Subject|0
1030593|NCT00195260|3357708|P8|Part 1: Dose Escalation|Withdrawal by Subject|1
1030594|NCT00195260|3357709|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
1030595|NCT00195260|3357710|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
1030596|NCT00195260|3357711|P5|Part 1: Dose Escalation|Withdrawal by Subject|2
1030597|NCT00195260|3357712|P4|Part 1: Dose Escalation|Withdrawal by Subject|0
1030598|NCT00195260|3357713|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
1030599|NCT00195260|3357714|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
1030600|NCT00195260|3357715|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
1030601|NCT00195260|3357705|P11|Part 1: Dose Escalation|Adverse Event|0
1030602|NCT00195260|3357706|P10|Part 1: Dose Escalation|Adverse Event|0
1030603|NCT00195260|3357707|P9|Part 1: Dose Escalation|Adverse Event|0
1030604|NCT00195260|3357708|P8|Part 1: Dose Escalation|Adverse Event|0
1030605|NCT00195260|3357709|P7|Part 1: Dose Escalation|Adverse Event|3
1030606|NCT00195260|3357710|P6|Part 1: Dose Escalation|Adverse Event|0
1030607|NCT00195260|3357711|P5|Part 1: Dose Escalation|Adverse Event|1
1030608|NCT00195260|3357712|P4|Part 1: Dose Escalation|Adverse Event|1
1030609|NCT00195260|3357713|P3|Part 1: Dose Escalation|Adverse Event|0
1030610|NCT00195260|3357714|P2|Part 1: Dose Escalation|Adverse Event|1
1030611|NCT00195260|3357715|P1|Part 1: Dose Escalation|Adverse Event|0
1030612|NCT00194987|3357883|P2|Overall Study|Withdrawal by Subject|3
1030613|NCT00194987|3357884|P1|Overall Study|Withdrawal by Subject|0
1030614|NCT00194792|3357917|P1|Overall Study|Withdrawal by Subject|1
1030615|NCT00194675|3357941|P2|Overall Study|Death|0
1030616|NCT00194675|3357942|P1|Overall Study|Death|1
1030617|NCT00194675|3357941|P2|Overall Study|Protocol Violation|0
1030618|NCT00194675|3357942|P1|Overall Study|Protocol Violation|1
1030619|NCT00194675|3357941|P2|Overall Study|"withdrew due to edgy feeling"|0
1030620|NCT00194675|3357942|P1|Overall Study|"withdrew due to edgy feeling"|1
1030621|NCT00194675|3357941|P2|Overall Study|lack of interest|1
1030622|NCT00194675|3357942|P1|Overall Study|lack of interest|1
1030623|NCT00194675|3357941|P2|Overall Study|Lost to Follow-up|1
1030624|NCT00194675|3357942|P1|Overall Study|Lost to Follow-up|1
1030625|NCT00194077|3357996|P2|Overall Study|Withdrawal by Subject|1
1030626|NCT00194077|3357997|P1|Overall Study|Withdrawal by Subject|1
1030627|NCT00194077|3357996|P2|Overall Study|Study nonadherence|0
1030628|NCT00194077|3357997|P1|Overall Study|Study nonadherence|1
1030629|NCT00194077|3357996|P2|Overall Study|Lack of Efficacy|29
1030630|NCT00194077|3357997|P1|Overall Study|Lack of Efficacy|22
1030631|NCT00194025|3358003|P1|Overall Study|non-adherence with study medication|4
1030632|NCT00194025|3358003|P1|Overall Study|Adverse Event|1
1030633|NCT00194012|3358018|P2|Open Label Extension (OLE)|Lack of Efficacy|0
1030634|NCT00194012|3358019|P1|Open Label Extension (OLE)|Lack of Efficacy|1
1030635|NCT00194012|3358018|P2|Open Label Extension (OLE)|Lost to Follow-up|5
1030636|NCT00194012|3358019|P1|Open Label Extension (OLE)|Lost to Follow-up|3
1030637|NCT00194012|3358018|P2|Open Label Extension (OLE)|Drowsiness; Jittery|1
1030638|NCT00194012|3358019|P1|Open Label Extension (OLE)|Drowsiness; Jittery|0
1030639|NCT00194012|3358018|P2|Open Label Extension (OLE)|Weight Gain|0
1030640|NCT00194012|3358019|P1|Open Label Extension (OLE)|Weight Gain|1
1030641|NCT00194012|3358018|P2|Randomized Phase|Oral/nasal twitching|1
1030642|NCT00194012|3358019|P1|Randomized Phase|Oral/nasal twitching|0
1030643|NCT00194012|3358018|P2|Randomized Phase|Emesis and enuresis|1
1030644|NCT00194012|3358019|P1|Randomized Phase|Emesis and enuresis|0
1030645|NCT00194012|3358018|P2|Randomized Phase|Participant reported having a rash|0
1030646|NCT00194012|3358019|P1|Randomized Phase|Participant reported having a rash|1
1030647|NCT00194012|3358018|P2|Randomized Phase|Adverse Event|1
1030648|NCT00194012|3358019|P1|Randomized Phase|Adverse Event|2
1030649|NCT00194012|3358018|P2|Randomized Phase|Withdrawal by Subject|3
1030650|NCT00194012|3358019|P1|Randomized Phase|Withdrawal by Subject|3
1030651|NCT00194012|3358018|P2|Randomized Phase|Study nonadherence|1
1030652|NCT00194012|3358019|P1|Randomized Phase|Study nonadherence|2
1030653|NCT00194012|3358018|P2|Randomized Phase|Lack of Efficacy|18
1030654|NCT00194012|3358019|P1|Randomized Phase|Lack of Efficacy|8
1030655|NCT00193609|3358055|P1|Overall Study|Adverse Event|2
1030656|NCT00193609|3358055|P1|Overall Study|Lack of Efficacy|2
1030657|NCT00193479|3358082|P1|Induction Chemotherapy|Disease Progression|1
1030658|NCT00193479|3358082|P1|Induction Chemotherapy|Adverse Event|2
1030659|NCT00193206|3358123|P1|Postoperative Therapy|Protocol Violation|1
1030660|NCT00193206|3358123|P1|Postoperative Therapy|Lack of Efficacy|1
1030661|NCT00193206|3358123|P1|Postoperative Therapy|Intercurrent Illness|2
1030662|NCT00193206|3358123|P1|Postoperative Therapy|Physician Decision|3
1030663|NCT00193206|3358123|P1|Postoperative Therapy|Withdrawal by Subject|7
1030664|NCT00193206|3358123|P1|Preoperative Therapy|False Positive Pregnancy Test|1
1030665|NCT00193206|3358123|P1|Preoperative Therapy|Withdrawal by Subject|2
1030666|NCT00193206|3358123|P1|Preoperative Therapy|Adverse Event|2
1030667|NCT00193206|3358123|P1|Preoperative Therapy|Lack of Efficacy|2
1030668|NCT00193180|3358127|P1|Overall Study|Protocol Violation|1
1030669|NCT00193180|3358127|P1|Overall Study|Adverse Event|8
1030670|NCT00193180|3358127|P1|Overall Study|Lack of Efficacy|1
1030671|NCT00193063|3358142|P1|Overall Study|Adverse Event|1
1030672|NCT00193063|3358142|P1|Overall Study|Lack of Efficacy|3
1030673|NCT00193050|3358148|P1|Adjuvant|Lack of Efficacy|2
1030674|NCT00193050|3358148|P1|Adjuvant|Intercurrent Hospitalization|3
1030675|NCT00193050|3358148|P1|Adjuvant|Physician Decision|5
1030676|NCT00193050|3358148|P1|Neoadjuvant Treatment|Adverse Event|2
1030677|NCT00193050|3358148|P1|Neoadjuvant Treatment|Physician Decision|2
1030678|NCT00193050|3358148|P1|Neoadjuvant Treatment|Intercurrent Illness|3
1030679|NCT00193050|3358148|P1|Neoadjuvant Treatment|Lack of Efficacy|2
1030680|NCT00192647|3358165|P2|Overall Study|Other/Administrative|3
1030681|NCT00192647|3358166|P1|Overall Study|Other/Administrative|5
1030682|NCT00192647|3358165|P2|Overall Study|Failure to Return|13
1030683|NCT00192647|3358166|P1|Overall Study|Failure to Return|11
1030684|NCT00192647|3358165|P2|Overall Study|Refused Treatment/Did not Cooperate|8
1030685|NCT00192647|3358166|P1|Overall Study|Refused Treatment/Did not Cooperate|10
1030686|NCT00192647|3358165|P2|Overall Study|Protocol Violation|1
1030687|NCT00192647|3358166|P1|Overall Study|Protocol Violation|3
1030688|NCT00192647|3358165|P2|Overall Study|Entry Criteria Violation|6
1030689|NCT00192647|3358166|P1|Overall Study|Entry Criteria Violation|6
1030690|NCT00192647|3358165|P2|Overall Study|Insufficient Therapeutic Response|83
1030691|NCT00192647|3358166|P1|Overall Study|Insufficient Therapeutic Response|53
1030692|NCT00192647|3358165|P2|Overall Study|Laboratory Test Abnormality|2
1030693|NCT00192647|3358166|P1|Overall Study|Laboratory Test Abnormality|4
1030694|NCT00192647|3358165|P2|Overall Study|Adverse Event|29
1030695|NCT00192647|3358166|P1|Overall Study|Adverse Event|35
1030696|NCT00192647|3358165|P2|Overall Study|Death|1
1030697|NCT00192647|3358166|P1|Overall Study|Death|1
1030698|NCT00192296|3358186|P4|Overall Study|Withdrawal by Subject|0
1030699|NCT00192296|3358187|P3|Overall Study|Withdrawal by Subject|0
1030700|NCT00192296|3358188|P2|Overall Study|Withdrawal by Subject|1
1030701|NCT00192296|3358189|P1|Overall Study|Withdrawal by Subject|0
1030702|NCT00192075|3358245|P2|Overall Study|Other|2
1030703|NCT00192075|3358246|P1|Overall Study|Other|5
1030704|NCT00192075|3358245|P2|Overall Study|Unacceptable Toxicity Exhibited by Drug|1
1030705|NCT00192075|3358246|P1|Overall Study|Unacceptable Toxicity Exhibited by Drug|2
1030706|NCT00192075|3358245|P2|Overall Study|Patient Non-Compliance|1
1030707|NCT00192075|3358246|P1|Overall Study|Patient Non-Compliance|0
1030708|NCT00192075|3358245|P2|Overall Study|Withdrawal by Subject|5
1030709|NCT00192075|3358246|P1|Overall Study|Withdrawal by Subject|5
1030710|NCT00192075|3358245|P2|Overall Study|Physician Decision|0
1030711|NCT00192075|3358246|P1|Overall Study|Physician Decision|3
1030712|NCT00192075|3358245|P2|Overall Study|Lack of Efficacy|0
1030713|NCT00192075|3358246|P1|Overall Study|Lack of Efficacy|0
1030714|NCT00192075|3358245|P2|Overall Study|Death|1
1030715|NCT00192075|3358246|P1|Overall Study|Death|0
1030716|NCT00192075|3358245|P2|Overall Study|Adverse Event|3
1030717|NCT00192075|3358246|P1|Overall Study|Adverse Event|1
1030718|NCT00192075|3358245|P2|Overall Study|Disease Progression|6
1030719|NCT00192075|3358246|P1|Overall Study|Disease Progression|23
1030720|NCT00192036|3358271|P1|Overall Study|Unknown or Not Specified|5
1030721|NCT00192036|3358271|P1|Overall Study|Death|1
1030722|NCT00192036|3358271|P1|Overall Study|Clinical Disease Progression|1
1030723|NCT00192036|3358271|P1|Overall Study|Objective Tumor Progression|4
1030724|NCT00192036|3358271|P1|Overall Study|Patient/Physician Perception|1
1030725|NCT00192036|3358271|P1|Overall Study|Adverse Event|6
1030726|NCT00192036|3358271|P1|Overall Study|Protocol Violation|3
1030727|NCT00192023|3358281|P2|Period IV - Optional Open-Label|Physician Decision|0
1030728|NCT00192023|3358282|P1|Period IV - Optional Open-Label|Physician Decision|9
1030729|NCT00192023|3358281|P2|Period IV - Optional Open-Label|Withdrawal by Subject|0
1030730|NCT00192023|3358282|P1|Period IV - Optional Open-Label|Withdrawal by Subject|4
1030731|NCT00192023|3358281|P2|Period IV - Optional Open-Label|Protocol Violation|0
1030732|NCT00192023|3358282|P1|Period IV - Optional Open-Label|Protocol Violation|1
1030733|NCT00192023|3358281|P2|Period IV - Optional Open-Label|Lost to Follow-up|0
1030734|NCT00192023|3358282|P1|Period IV - Optional Open-Label|Lost to Follow-up|2
1030735|NCT00192023|3358281|P2|Period IV - Optional Open-Label|Patient/Caregiver Decision|0
1030736|NCT00192023|3358282|P1|Period IV - Optional Open-Label|Patient/Caregiver Decision|46
1030737|NCT00192023|3358281|P2|Period IV - Optional Open-Label|Lack of Efficacy|0
1030738|NCT00192023|3358282|P1|Period IV - Optional Open-Label|Lack of Efficacy|7
1030739|NCT00192023|3358281|P2|Period IV - Optional Open-Label|Adverse Event|0
1030740|NCT00192023|3358282|P1|Period IV - Optional Open-Label|Adverse Event|6
1030741|NCT00192023|3358281|P2|Period III - Double-Blind|Parent/Caregiver Decision|0
1030742|NCT00192023|3358282|P1|Period III - Double-Blind|Parent/Caregiver Decision|2
1030743|NCT00192023|3358281|P2|Period III - Double-Blind|Physician Decision|0
1030744|NCT00192023|3358282|P1|Period III - Double-Blind|Physician Decision|2
1030745|NCT00192023|3358281|P2|Period III - Double-Blind|Adverse Event|0
1030746|NCT00192023|3358282|P1|Period III - Double-Blind|Adverse Event|3
1030747|NCT00191984|3358304|P1|Overall Study|Physician Decision|4
1030748|NCT00191984|3358304|P1|Overall Study|Withdrawal by Subject|7
1030749|NCT00191984|3358304|P1|Overall Study|Entry Criteria Exclusion|1
1030750|NCT00191984|3358304|P1|Overall Study|Death|2
1030751|NCT00191984|3358304|P1|Overall Study|Adverse Event|4
1030752|NCT00191984|3358304|P1|Overall Study|Disease Progression|21
1030753|NCT00191945|3358314|P2|Double-Blind Acute Treatment|Physician Decision|2
1030754|NCT00191945|3358315|P1|Double-Blind Acute Treatment|Physician Decision|0
1030755|NCT00191945|3358314|P2|Double-Blind Acute Treatment|Non Protocol Compliance|0
1030756|NCT00191945|3358315|P1|Double-Blind Acute Treatment|Non Protocol Compliance|3
1030757|NCT00191945|3358314|P2|Double-Blind Acute Treatment|Lost to Follow-up|1
1030758|NCT00191945|3358315|P1|Double-Blind Acute Treatment|Lost to Follow-up|0
1030759|NCT00191945|3358314|P2|Double-Blind Acute Treatment|Parent's Decision|0
1030760|NCT00191945|3358315|P1|Double-Blind Acute Treatment|Parent's Decision|3
1030761|NCT00191906|3358351|P4|Study Period III|Lack of Efficacy|0
1030762|NCT00191906|3358352|P3|Study Period III|Lack of Efficacy|0
1030763|NCT00191906|3358353|P2|Study Period III|Lack of Efficacy|3
1030764|NCT00191906|3358354|P1|Study Period III|Lack of Efficacy|3
1030765|NCT00191906|3358351|P4|Study Period III|Parent/Caregiver Decision|0
1030766|NCT00191906|3358352|P3|Study Period III|Parent/Caregiver Decision|0
1030767|NCT00191906|3358353|P2|Study Period III|Parent/Caregiver Decision|0
1030768|NCT00191906|3358354|P1|Study Period III|Parent/Caregiver Decision|1
1030769|NCT00191906|3358351|P4|Study Period III|Lost to Follow-up|0
1030770|NCT00191906|3358352|P3|Study Period III|Lost to Follow-up|0
1030771|NCT00191906|3358353|P2|Study Period III|Lost to Follow-up|1
1030772|NCT00191906|3358354|P1|Study Period III|Lost to Follow-up|0
1030773|NCT00191906|3358351|P4|Study Period III|Adverse Event|0
1030774|NCT00191906|3358352|P3|Study Period III|Adverse Event|0
1030775|NCT00191906|3358353|P2|Study Period III|Adverse Event|0
1030776|NCT00191906|3358354|P1|Study Period III|Adverse Event|1
1030777|NCT00191906|3358351|P4|Study Period II|Entry Criteria Exclusion|0
1030778|NCT00191906|3358352|P3|Study Period II|Entry Criteria Exclusion|1
1030779|NCT00191906|3358353|P2|Study Period II|Entry Criteria Exclusion|0
1030780|NCT00191906|3358354|P1|Study Period II|Entry Criteria Exclusion|0
1030781|NCT00191906|3358351|P4|Study Period II|Parent/Caregiver Decision|0
1030782|NCT00191906|3358352|P3|Study Period II|Parent/Caregiver Decision|0
1030783|NCT00191906|3358353|P2|Study Period II|Parent/Caregiver Decision|1
1030784|NCT00191906|3358354|P1|Study Period II|Parent/Caregiver Decision|0
1030785|NCT00191906|3358351|P4|Study Period II|Withdrawal by Subject|0
1030786|NCT00191906|3358352|P3|Study Period II|Withdrawal by Subject|0
1030787|NCT00191906|3358353|P2|Study Period II|Withdrawal by Subject|3
1030788|NCT00191906|3358354|P1|Study Period II|Withdrawal by Subject|0
1030789|NCT00191906|3358351|P4|Study Period II|Adverse Event|0
1030790|NCT00191906|3358352|P3|Study Period II|Adverse Event|0
1030791|NCT00191906|3358353|P2|Study Period II|Adverse Event|1
1030792|NCT00191906|3358354|P1|Study Period II|Adverse Event|0
1030793|NCT00191854|3358397|P3|Overall Study|Screen Failure|1
1030794|NCT00191854|3358398|P2|Overall Study|Screen Failure|0
1030795|NCT00191854|3358399|P1|Overall Study|Screen Failure|0
1030796|NCT00191854|3358397|P3|Overall Study|Sponsor Decision|1
1030797|NCT00191854|3358398|P2|Overall Study|Sponsor Decision|0
1030798|NCT00191854|3358399|P1|Overall Study|Sponsor Decision|0
1030799|NCT00191854|3358397|P3|Overall Study|Withdrawal by Subject|3
1030800|NCT00191854|3358398|P2|Overall Study|Withdrawal by Subject|2
1030801|NCT00191854|3358399|P1|Overall Study|Withdrawal by Subject|4
1030802|NCT00191854|3358397|P3|Overall Study|Lost to Follow-up|5
1030803|NCT00191854|3358398|P2|Overall Study|Lost to Follow-up|5
1030804|NCT00191854|3358399|P1|Overall Study|Lost to Follow-up|7
1030805|NCT00191854|3358397|P3|Overall Study|Death|29
1030806|NCT00191854|3358398|P2|Overall Study|Death|23
1030807|NCT00191854|3358399|P1|Overall Study|Death|26
1030808|NCT00191815|3358419|P1|Overall Study|Withdrawal by Subject|7
1030809|NCT00191815|3358419|P1|Overall Study|Physician Decision|2
1030810|NCT00191815|3358419|P1|Overall Study|Protocol Violation|3
1030811|NCT00191815|3358419|P1|Overall Study|Death|2
1030812|NCT00191815|3358419|P1|Overall Study|Disease progression or relapse|24
1030813|NCT00191815|3358419|P1|Overall Study|Adverse Event|2
1030814|NCT00191789|3358431|P1|Overall Study|Death - Not Study-Drug Related|1
1030815|NCT00191789|3358431|P1|Overall Study|Progressive Disease/Lack of Efficacy|2
1030816|NCT00191789|3358431|P1|Overall Study|Death - Possibly Study Drug Related|4
1030817|NCT00191789|3358431|P1|Overall Study|Withdrawal by Subject|4
1030818|NCT00191789|3358431|P1|Overall Study|Patient/Physician: Satisfactory Response|4
1030819|NCT00191789|3358431|P1|Overall Study|Patient: Satisfactory Response|5
1030820|NCT00191789|3358431|P1|Overall Study|Adverse Event|5
1030821|NCT00191724|3358448|P5|Overall Study|Withdrawal by Subject|0
1030822|NCT00191724|3358449|P4|Overall Study|Withdrawal by Subject|1
1030823|NCT00191724|3358450|P3|Overall Study|Withdrawal by Subject|0
1030824|NCT00191724|3358451|P2|Overall Study|Withdrawal by Subject|0
1030825|NCT00191724|3358452|P1|Overall Study|Withdrawal by Subject|0
1030826|NCT00191724|3358448|P5|Overall Study|Lost to Follow-up|3
1030827|NCT00191724|3358449|P4|Overall Study|Lost to Follow-up|2
1030828|NCT00191724|3358450|P3|Overall Study|Lost to Follow-up|0
1030829|NCT00191724|3358451|P2|Overall Study|Lost to Follow-up|1
1030830|NCT00191724|3358452|P1|Overall Study|Lost to Follow-up|1
1030831|NCT00191724|3358448|P5|Overall Study|Adverse Event|0
1030832|NCT00191724|3358449|P4|Overall Study|Adverse Event|0
1030833|NCT00191724|3358450|P3|Overall Study|Adverse Event|1
1030834|NCT00191724|3358451|P2|Overall Study|Adverse Event|0
1030835|NCT00191724|3358452|P1|Overall Study|Adverse Event|0
1030836|NCT00191646|3358481|P2|Overall Study|Missing Data|11
1030837|NCT00191646|3358482|P1|Overall Study|Missing Data|18
1030838|NCT00191646|3358481|P2|Overall Study|Other|34
1030839|NCT00191646|3358482|P1|Overall Study|Other|33
1030840|NCT00191646|3358481|P2|Overall Study|Death|8
1030841|NCT00191646|3358482|P1|Overall Study|Death|6
1030842|NCT00191646|3358481|P2|Overall Study|Protocol Violation|7
1030843|NCT00191646|3358482|P1|Overall Study|Protocol Violation|5
1030844|NCT00191646|3358481|P2|Overall Study|Withdrawal by Subject|39
1030845|NCT00191646|3358482|P1|Overall Study|Withdrawal by Subject|58
1030846|NCT00191646|3358481|P2|Overall Study|Physician Decision|11
1030847|NCT00191646|3358482|P1|Overall Study|Physician Decision|20
1030848|NCT00191646|3358481|P2|Overall Study|Disease Progression|6
1030849|NCT00191646|3358482|P1|Overall Study|Disease Progression|5
1030850|NCT00191646|3358481|P2|Overall Study|Toxicity|37
1030851|NCT00191646|3358482|P1|Overall Study|Toxicity|26
1030852|NCT00191477|3358502|P2|Overall Study|Discontinued Prior to Instillation|14
1030853|NCT00191477|3358503|P1|Overall Study|Discontinued Prior to Instillation|13
1030854|NCT00191477|3358502|P2|Overall Study|Pathological Specimen Lost|0
1030855|NCT00191477|3358503|P1|Overall Study|Pathological Specimen Lost|1
1030856|NCT00191477|3358502|P2|Overall Study|Not Eligible|38
1030857|NCT00191477|3358503|P1|Overall Study|Not Eligible|41
1030858|NCT00191477|3358502|P2|Overall Study|Other|0
1030859|NCT00191477|3358503|P1|Overall Study|Other|2
1030860|NCT00191477|3358502|P2|Overall Study|Withdrawal by Subject|0
1030861|NCT00191477|3358503|P1|Overall Study|Withdrawal by Subject|2
1030862|NCT00191477|3358502|P2|Overall Study|Treatment Change|0
1030863|NCT00191477|3358503|P1|Overall Study|Treatment Change|2
1030864|NCT00191477|3358502|P2|Overall Study|Protocol Violation|1
1030865|NCT00191477|3358503|P1|Overall Study|Protocol Violation|1
1030866|NCT00191477|3358502|P2|Overall Study|Lost to Follow-up|21
1030867|NCT00191477|3358503|P1|Overall Study|Lost to Follow-up|23
1030868|NCT00191477|3358502|P2|Overall Study|Death, Other Cause|6
1030869|NCT00191477|3358503|P1|Overall Study|Death, Other Cause|3
1030870|NCT00191477|3358502|P2|Overall Study|Death, Study Disease|1
1030871|NCT00191477|3358503|P1|Overall Study|Death, Study Disease|1
1030872|NCT00191477|3358502|P2|Overall Study|Tumor Recurrence|48
1030873|NCT00191477|3358503|P1|Overall Study|Tumor Recurrence|49
1030874|NCT00191451|3358522|P3|Overall Study|Reason Not Specified|3
1030875|NCT00191451|3358523|P2|Overall Study|Reason Not Specified|1
1030876|NCT00191451|3358524|P1|Overall Study|Reason Not Specified|2
1030877|NCT00191451|3358522|P3|Overall Study|Ineligible|0
1030878|NCT00191451|3358523|P2|Overall Study|Ineligible|1
1030879|NCT00191451|3358524|P1|Overall Study|Ineligible|0
1030880|NCT00191451|3358522|P3|Overall Study|Sponsor Decision|0
1030881|NCT00191451|3358523|P2|Overall Study|Sponsor Decision|0
1030882|NCT00191451|3358524|P1|Overall Study|Sponsor Decision|1
1030883|NCT00191451|3358522|P3|Overall Study|Physician Decision|6
1030884|NCT00191451|3358523|P2|Overall Study|Physician Decision|9
1030885|NCT00191451|3358524|P1|Overall Study|Physician Decision|2
1030886|NCT00191451|3358522|P3|Overall Study|Withdrawal by Subject|5
1030887|NCT00191451|3358523|P2|Overall Study|Withdrawal by Subject|3
1030888|NCT00191451|3358524|P1|Overall Study|Withdrawal by Subject|2
1030889|NCT00191386|3358544|P1|Overall Study|Lack of Efficacy|15
1030890|NCT00191386|3358544|P1|Overall Study|Physician Decision|11
1030891|NCT00191386|3358544|P1|Overall Study|Withdrawal by Subject|96
1030892|NCT00191386|3358544|P1|Overall Study|Protocol Violation|18
1030893|NCT00191386|3358544|P1|Overall Study|Entry Criteria Exclusion|3
1030894|NCT00191386|3358544|P1|Overall Study|Lost to Follow-up|1
1030895|NCT00191386|3358544|P1|Overall Study|Adverse Event|16
1030896|NCT00191334|3358551|P1|Overall Study|Withdrawal by Subject|4
1030897|NCT00191334|3358551|P1|Overall Study|Physician Decision|1
1030898|NCT00191334|3358551|P1|Overall Study|Disease Progression or Relapse|8
1030899|NCT00191334|3358551|P1|Overall Study|Adverse Event|4
1030900|NCT00191308|3358559|P1|Overall Study|Adverse Event|1
1030901|NCT00191282|3358569|P2|Overall Study|Lost to Follow-up|31
1030902|NCT00191282|3358570|P1|Overall Study|Lost to Follow-up|24
1030903|NCT00191282|3358569|P2|Overall Study|Sponsor's decision|2
1030904|NCT00191282|3358570|P1|Overall Study|Sponsor's decision|2
1030905|NCT00191282|3358569|P2|Overall Study|Severity of outcome|5
1030906|NCT00191282|3358570|P1|Overall Study|Severity of outcome|2
1030907|NCT00191282|3358569|P2|Overall Study|Protocol Violation|12
1030908|NCT00191282|3358570|P1|Overall Study|Protocol Violation|9
1030909|NCT00191282|3358569|P2|Overall Study|Protocol entry criteria not met|9
1030910|NCT00191282|3358570|P1|Overall Study|Protocol entry criteria not met|14
1030911|NCT00191282|3358569|P2|Overall Study|Physician Decision|15
1030912|NCT00191282|3358570|P1|Overall Study|Physician Decision|18
1030913|NCT00191282|3358569|P2|Overall Study|Withdrawal by Subject|44
1030914|NCT00191282|3358570|P1|Overall Study|Withdrawal by Subject|59
1030915|NCT00191282|3358569|P2|Overall Study|Patient moved|14
1030916|NCT00191282|3358570|P1|Overall Study|Patient moved|11
1030917|NCT00191282|3358569|P2|Overall Study|Noncompliance|17
1030918|NCT00191282|3358570|P1|Overall Study|Noncompliance|14
1030919|NCT00191282|3358569|P2|Overall Study|Lack of Efficacy|6
1030920|NCT00191282|3358570|P1|Overall Study|Lack of Efficacy|11
1030921|NCT00191282|3358569|P2|Overall Study|Death|51
1030922|NCT00191282|3358570|P1|Overall Study|Death|51
1030923|NCT00191282|3358569|P2|Overall Study|Adverse Event|6
1030924|NCT00191282|3358570|P1|Overall Study|Adverse Event|5
1030925|NCT00191269|3358630|P2|Overall Study|Physician Decision|3
1030926|NCT00191269|3358631|P1|Overall Study|Physician Decision|0
1030927|NCT00191269|3358630|P2|Overall Study|Pathologic Aggrevation|1
1030928|NCT00191269|3358631|P1|Overall Study|Pathologic Aggrevation|0
1030929|NCT00191269|3358630|P2|Overall Study|Withdrawal by Subject|1
1030930|NCT00191269|3358631|P1|Overall Study|Withdrawal by Subject|0
1030931|NCT00191269|3358630|P2|Overall Study|Lack of Efficacy|5
1030932|NCT00191269|3358631|P1|Overall Study|Lack of Efficacy|1
1030933|NCT00191269|3358630|P2|Overall Study|Progression of Disease|42
1030934|NCT00191269|3358631|P1|Overall Study|Progression of Disease|4
1030935|NCT00191269|3358630|P2|Overall Study|Adverse Event|4
1030936|NCT00191269|3358631|P1|Overall Study|Adverse Event|1
1030937|NCT00191269|3358630|P2|Overall Study|Protocol Violation|2
1030938|NCT00191269|3358631|P1|Overall Study|Protocol Violation|0
1030939|NCT00191191|3358647|P2|Overall Study|Good Clinical Practice Violation|1
1030940|NCT00191191|3358648|P1|Overall Study|Good Clinical Practice Violation|0
1030941|NCT00191191|3358647|P2|Overall Study|Physician Decision|2
1030942|NCT00191191|3358648|P1|Overall Study|Physician Decision|3
1030943|NCT00191191|3358647|P2|Overall Study|Lost to Follow-up|0
1030944|NCT00191191|3358648|P1|Overall Study|Lost to Follow-up|1
1030945|NCT00191191|3358647|P2|Overall Study|Family/Caregiver Decision|7
1030946|NCT00191191|3358648|P1|Overall Study|Family/Caregiver Decision|5
1030947|NCT00191191|3358647|P2|Overall Study|Toxicity After Dose Reduction|8
1030948|NCT00191191|3358648|P1|Overall Study|Toxicity After Dose Reduction|7
1030949|NCT00191191|3358647|P2|Overall Study|Progressive Disease|72
1030950|NCT00191191|3358648|P1|Overall Study|Progressive Disease|84
1030951|NCT00191191|3358647|P2|Overall Study|Adverse Event|21
1030952|NCT00191191|3358648|P1|Overall Study|Adverse Event|11
1030953|NCT00191191|3358647|P2|Overall Study|Treated with Another Systemic Agent|1
1030954|NCT00191191|3358648|P1|Overall Study|Treated with Another Systemic Agent|1
1030955|NCT00191191|3358647|P2|Overall Study|Entry Criteria Exclusion|0
1030956|NCT00191191|3358648|P1|Overall Study|Entry Criteria Exclusion|2
1030957|NCT00191165|3358664|P2|Overall Study|Participant Moved Away|1
1030958|NCT00191165|3358665|P1|Overall Study|Participant Moved Away|0
1030959|NCT00191165|3358664|P2|Overall Study|Protocol Violation|1
1030960|NCT00191165|3358665|P1|Overall Study|Protocol Violation|0
1030961|NCT00191165|3358664|P2|Overall Study|Adverse Event|0
1030962|NCT00191165|3358665|P1|Overall Study|Adverse Event|2
1030963|NCT00191152|3358677|P2|Crossover Treatment|Not Specified|3
1030964|NCT00191152|3358678|P1|Crossover Treatment|Not Specified|4
1030965|NCT00191152|3358677|P2|Crossover Treatment|Lost to Follow-up|1
1030966|NCT00191152|3358678|P1|Crossover Treatment|Lost to Follow-up|2
1030967|NCT00191152|3358677|P2|Crossover Treatment|Withdrawal by Subject|9
1030968|NCT00191152|3358678|P1|Crossover Treatment|Withdrawal by Subject|6
1030969|NCT00191152|3358677|P2|Crossover Treatment|Physician Decision|7
1030970|NCT00191152|3358678|P1|Crossover Treatment|Physician Decision|7
1030971|NCT00191152|3358677|P2|Crossover Treatment|Adverse Event|8
1030972|NCT00191152|3358678|P1|Crossover Treatment|Adverse Event|8
1030973|NCT00191152|3358677|P2|Initial Treatment|not specified|21
1030974|NCT00191152|3358678|P1|Initial Treatment|not specified|18
1030975|NCT00191152|3358677|P2|Initial Treatment|Lost to Follow-up|6
1030976|NCT00191152|3358678|P1|Initial Treatment|Lost to Follow-up|0
1030977|NCT00191152|3358677|P2|Initial Treatment|Withdrawal by Subject|28
1030978|NCT00191152|3358678|P1|Initial Treatment|Withdrawal by Subject|40
1030979|NCT00191152|3358677|P2|Initial Treatment|Physician Decision|31
1030980|NCT00191152|3358678|P1|Initial Treatment|Physician Decision|40
1030981|NCT00191152|3358677|P2|Initial Treatment|Adverse Event|67
1030982|NCT00191152|3358678|P1|Initial Treatment|Adverse Event|43
1030983|NCT00191139|3358710|P2|Overall Study|Other|2
1030984|NCT00191139|3358711|P1|Overall Study|Other|1
1030985|NCT00191139|3358710|P2|Overall Study|Disease Progression|1
1030986|NCT00191139|3358711|P1|Overall Study|Disease Progression|0
1030987|NCT00191139|3358710|P2|Overall Study|Withdrawal by Subject|3
1030988|NCT00191139|3358711|P1|Overall Study|Withdrawal by Subject|0
1030989|NCT00191139|3358710|P2|Overall Study|Death|0
1030990|NCT00191139|3358711|P1|Overall Study|Death|2
1030991|NCT00191139|3358710|P2|Overall Study|Adverse Event|6
1030992|NCT00191139|3358711|P1|Overall Study|Adverse Event|2
1030993|NCT00191113|3358727|P2|Core Study|Death|0
1030994|NCT00191113|3358728|P1|Core Study|Death|1
1030995|NCT00191113|3358727|P2|Core Study|Lack of Efficacy|2
1030996|NCT00191113|3358728|P1|Core Study|Lack of Efficacy|0
1030997|NCT00191113|3358727|P2|Core Study|Adverse Event|2
1030998|NCT00191113|3358728|P1|Core Study|Adverse Event|0
1030999|NCT00191113|3358727|P2|Core Study|Lost to Follow-up|0
1031000|NCT00191113|3358728|P1|Core Study|Lost to Follow-up|3
1031001|NCT00191113|3358727|P2|Core Study|Protocol Violation|2
1031002|NCT00191113|3358728|P1|Core Study|Protocol Violation|6
1031003|NCT00191113|3358727|P2|Core Study|Withdrawal by Subject|9
1031004|NCT00191113|3358728|P1|Core Study|Withdrawal by Subject|25
1031005|NCT00191100|3358770|P2|Overall Study|Reason Not Specified|1
1031006|NCT00191100|3358771|P1|Overall Study|Reason Not Specified|0
1031007|NCT00191100|3358770|P2|Overall Study|Death from Other Cause|0
1031008|NCT00191100|3358771|P1|Overall Study|Death from Other Cause|1
1031009|NCT00191100|3358770|P2|Overall Study|Protocol Violation|1
1031010|NCT00191100|3358771|P1|Overall Study|Protocol Violation|1
1031011|NCT00191100|3358770|P2|Overall Study|Death from Study Drug Toxicity|0
1031012|NCT00191100|3358771|P1|Overall Study|Death from Study Drug Toxicity|2
1031013|NCT00191100|3358770|P2|Overall Study|Physician Decision|1
1031014|NCT00191100|3358771|P1|Overall Study|Physician Decision|3
1031015|NCT00191100|3358770|P2|Overall Study|Lack of Efficacy, Stable Disease|0
1031016|NCT00191100|3358771|P1|Overall Study|Lack of Efficacy, Stable Disease|1
1031017|NCT00191100|3358770|P2|Overall Study|Lack of Efficacy, Progressive Disease|2
1031018|NCT00191100|3358771|P1|Overall Study|Lack of Efficacy, Progressive Disease|1
1031019|NCT00191100|3358770|P2|Overall Study|Clinical Relapse|1
1031020|NCT00191100|3358771|P1|Overall Study|Clinical Relapse|2
1031021|NCT00191100|3358770|P2|Overall Study|Protocol Entry Criteria Not Met|1
1031022|NCT00191100|3358771|P1|Overall Study|Protocol Entry Criteria Not Met|2
1031023|NCT00191100|3358770|P2|Overall Study|Withdrawal by Subject|3
1031024|NCT00191100|3358771|P1|Overall Study|Withdrawal by Subject|9
1031025|NCT00191100|3358770|P2|Overall Study|Patient Moved|1
1031026|NCT00191100|3358771|P1|Overall Study|Patient Moved|0
1031027|NCT00191100|3358770|P2|Overall Study|Lost to Follow-up|0
1031028|NCT00191100|3358771|P1|Overall Study|Lost to Follow-up|2
1031029|NCT00191100|3358770|P2|Overall Study|Adverse Event|1
1031030|NCT00191100|3358771|P1|Overall Study|Adverse Event|18
1031031|NCT00190983|3358787|P1|Overall Study|Inevaluable (never treated)|2
1031032|NCT00190775|3358796|P2|Overall Study|Exclusion Criteria Met|3
1031033|NCT00190775|3358797|P1|Overall Study|Exclusion Criteria Met|1
1031034|NCT00190775|3358796|P2|Overall Study|Protocol Violation|1
1031035|NCT00190775|3358797|P1|Overall Study|Protocol Violation|0
1031036|NCT00190775|3358796|P2|Overall Study|Noncompliance|5
1031037|NCT00190775|3358797|P1|Overall Study|Noncompliance|3
1031038|NCT00190775|3358796|P2|Overall Study|Physician Decision|0
1031039|NCT00190775|3358797|P1|Overall Study|Physician Decision|3
1031040|NCT00190775|3358796|P2|Overall Study|Sponsor Decision|0
1031041|NCT00190775|3358797|P1|Overall Study|Sponsor Decision|1
1031042|NCT00190775|3358796|P2|Overall Study|Withdrawal by Subject|13
1031043|NCT00190775|3358797|P1|Overall Study|Withdrawal by Subject|24
1031044|NCT00190775|3358796|P2|Overall Study|Participant Moved|1
1031045|NCT00190775|3358797|P1|Overall Study|Participant Moved|0
1031046|NCT00190775|3358796|P2|Overall Study|Lost to Follow-up|23
1031047|NCT00190775|3358797|P1|Overall Study|Lost to Follow-up|31
1031048|NCT00190775|3358796|P2|Overall Study|Lack of Efficacy|32
1031049|NCT00190775|3358797|P1|Overall Study|Lack of Efficacy|28
1031050|NCT00190775|3358796|P2|Overall Study|Satisfactory Response|0
1031051|NCT00190775|3358797|P1|Overall Study|Satisfactory Response|1
1031052|NCT00190775|3358796|P2|Overall Study|Adverse Event|22
1031053|NCT00190775|3358797|P1|Overall Study|Adverse Event|57
1031054|NCT00190749|3358868|P2|Overall Study|Sponsor Decision|0
1031055|NCT00190749|3358869|P1|Overall Study|Sponsor Decision|1
1031056|NCT00190749|3358868|P2|Overall Study|Reason Not Specified|2
1031057|NCT00190749|3358869|P1|Overall Study|Reason Not Specified|0
1031058|NCT00190749|3358868|P2|Overall Study|Lack of Efficacy|3
1031059|NCT00190749|3358869|P1|Overall Study|Lack of Efficacy|2
1031060|NCT00190749|3358868|P2|Overall Study|Adverse Event|5
1031061|NCT00190749|3358869|P1|Overall Study|Adverse Event|0
1031062|NCT00190749|3358868|P2|Overall Study|Protocol Violation|4
1031063|NCT00190749|3358869|P1|Overall Study|Protocol Violation|5
1031064|NCT00190749|3358868|P2|Overall Study|Withdrawal by Subject|6
1031065|NCT00190749|3358869|P1|Overall Study|Withdrawal by Subject|10
1031066|NCT00190749|3358868|P2|Overall Study|Lost to Follow-up|11
1031067|NCT00190749|3358869|P1|Overall Study|Lost to Follow-up|8
1031068|NCT00190684|3358933|P1|Overall Study|Study Period V Completed|1
1031069|NCT00190684|3358933|P1|Overall Study|Study Period III Completed|103
1031070|NCT00190684|3358933|P1|Overall Study|Protocol Violation|123
1031071|NCT00190684|3358933|P1|Overall Study|Physician Decision|84
1031072|NCT00190684|3358933|P1|Overall Study|Sponsor's decision|17
1031073|NCT00190684|3358933|P1|Overall Study|Clinical relapse|67
1031074|NCT00190684|3358933|P1|Overall Study|Patient Decision|432
1031075|NCT00190684|3358933|P1|Overall Study|Patient moved|60
1031076|NCT00190684|3358933|P1|Overall Study|Lost to Follow-up|232
1031077|NCT00190684|3358933|P1|Overall Study|Lack of efficacy|204
1031078|NCT00190684|3358933|P1|Overall Study|Satisfactory response|80
1031079|NCT00190684|3358933|P1|Overall Study|Adverse Event|86
1031080|NCT00190671|3358954|P2|Overall Study|Withdrawal by Subject|2
1031081|NCT00190671|3358955|P1|Overall Study|Withdrawal by Subject|0
1031082|NCT00190671|3358954|P2|Overall Study|Protocol Violation|1
1031083|NCT00190671|3358955|P1|Overall Study|Protocol Violation|0
1031084|NCT00190671|3358954|P2|Overall Study|Death from Other Causes|2
1031085|NCT00190671|3358955|P1|Overall Study|Death from Other Causes|0
1031086|NCT00190671|3358954|P2|Overall Study|Death from Study-Drug Toxicity|2
1031087|NCT00190671|3358955|P1|Overall Study|Death from Study-Drug Toxicity|0
1031088|NCT00190671|3358954|P2|Overall Study|Clinical Relapse|1
1031089|NCT00190671|3358955|P1|Overall Study|Clinical Relapse|0
1031090|NCT00190671|3358954|P2|Overall Study|Adverse Event|2
1031091|NCT00190671|3358955|P1|Overall Study|Adverse Event|3
1031092|NCT00190671|3358954|P2|Overall Study|Death from Study Disease|1
1031093|NCT00190671|3358955|P1|Overall Study|Death from Study Disease|1
1031094|NCT00190671|3358954|P2|Overall Study|Lack of Efficacy|24
1031095|NCT00190671|3358955|P1|Overall Study|Lack of Efficacy|19
1031096|NCT00190671|3358954|P2|Overall Study|Satisfactory Response|7
1031097|NCT00190671|3358955|P1|Overall Study|Satisfactory Response|4
1031098|NCT00189540|3358975|P2|Overall Study|Death|1
1031099|NCT00189540|3358976|P1|Overall Study|Death|4
1031100|NCT00189540|3358975|P2|Overall Study|Withdrawal by Subject|0
1031101|NCT00189540|3358976|P1|Overall Study|Withdrawal by Subject|3
1031102|NCT00189488|3358994|P2|Overall Study|Other|0
1031103|NCT00189488|3358995|P1|Overall Study|Other|1
1031104|NCT00189488|3358994|P2|Overall Study|Death|8
1031105|NCT00189488|3358995|P1|Overall Study|Death|5
1031106|NCT00189488|3358994|P2|Overall Study|Administrative Decision|2
1031107|NCT00189488|3358995|P1|Overall Study|Administrative Decision|0
1031108|NCT00189488|3358994|P2|Overall Study|Disease progression|4
1031109|NCT00189488|3358995|P1|Overall Study|Disease progression|2
1031110|NCT00189488|3358994|P2|Overall Study|Withdrawal by Subject|6
1031111|NCT00189488|3358995|P1|Overall Study|Withdrawal by Subject|2
1031112|NCT00189488|3358994|P2|Overall Study|Adverse Event|1
1031113|NCT00189488|3358995|P1|Overall Study|Adverse Event|2
1031114|NCT00189488|3358994|P2|Overall Study|Protocol deviation|1
1031115|NCT00189488|3358995|P1|Overall Study|Protocol deviation|2
1031116|NCT00189488|3358994|P2|Overall Study|Ineligibility determined|0
1031117|NCT00189488|3358995|P1|Overall Study|Ineligibility determined|1
1031118|NCT00189462|3359026|P2|Overall Study|Lost to Follow-up|20
1031119|NCT00189462|3359027|P1|Overall Study|Lost to Follow-up|18
1031120|NCT00189462|3359026|P2|Overall Study|Lack of Efficacy|1
1031121|NCT00189462|3359027|P1|Overall Study|Lack of Efficacy|5
1031122|NCT00189423|3359044|P2|Overall Study|Lost to Follow-up|10
1031123|NCT00189423|3359045|P1|Overall Study|Lost to Follow-up|10
1031124|NCT00189423|3359044|P2|Overall Study|Withdrawal by Subject|9
1031125|NCT00189423|3359045|P1|Overall Study|Withdrawal by Subject|9
1031126|NCT00189423|3359044|P2|Overall Study|Death|747
1031127|NCT00189423|3359045|P1|Overall Study|Death|746
1031128|NCT00189306|3359067|P1|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20
1031129|NCT00189306|3359067|P1|Long-Term Follow-up|Lost to Follow-up|9
1031130|NCT00189306|3359067|P1|Long-Term Follow-up|Intercurrent disease|2
1031131|NCT00189306|3359067|P1|Long-Term Follow-up|Withdrawal by Subject|1
1031132|NCT00189306|3359067|P1|Long-Term Follow-up|Death|4
1031133|NCT00189306|3359067|P1|Long-Term Follow-up|Adverse Event|2
1031134|NCT00189306|3359067|P1|Posttreatment Period|Local skin reaction/sign|1
1031135|NCT00189306|3359067|P1|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5
1031136|NCT00189306|3359067|P1|Posttreatment Period|Protocol Violation|1
1031137|NCT00189306|3359067|P1|Posttreatment Period|Target lesion excised|1
1031138|NCT00189306|3359067|P1|Posttreatment Period|Noncompliance|1
1031139|NCT00189306|3359067|P1|Posttreatment Period|Withdrawal by Subject|2
1031140|NCT00189306|3359067|P1|Posttreatment Period|Death|1
1031141|NCT00189306|3359067|P1|Treatment Period|Protocol Violation|1
1031142|NCT00189306|3359067|P1|Treatment Period|Adverse Event|2
1031143|NCT00189306|3359067|P1|Treatment Period|Withdrawal by Subject|2
1031144|NCT00189202|3359072|P1|Overall Study|Physician Decision|5
1031145|NCT00187889|3359113|P2|Overall Study|Withdrawal by Subject|4
1031146|NCT00187889|3359114|P1|Overall Study|Withdrawal by Subject|6
1031147|NCT00187486|3359156|P1|Overall Study|Protocol Violation|1
1031148|NCT00187135|3359207|P6|Visit Three|Study Discontinued|6
1031149|NCT00187135|3359208|P5|Visit Three|Study Discontinued|7
1031150|NCT00187135|3359209|P4|Visit Three|Study Discontinued|7
1031151|NCT00187135|3359210|P3|Visit Three|Study Discontinued|7
1031152|NCT00187135|3359211|P2|Visit Three|Study Discontinued|6
1031153|NCT00187135|3359212|P1|Visit Three|Study Discontinued|7
1031154|NCT00187135|3359207|P6|Visit Three|Withdrawal by Subject|0
1031155|NCT00187135|3359208|P5|Visit Three|Withdrawal by Subject|0
1031156|NCT00187135|3359209|P4|Visit Three|Withdrawal by Subject|2
1031157|NCT00187135|3359210|P3|Visit Three|Withdrawal by Subject|1
1031158|NCT00187135|3359211|P2|Visit Three|Withdrawal by Subject|1
1031159|NCT00187135|3359212|P1|Visit Three|Withdrawal by Subject|0
1031160|NCT00187135|3359207|P6|Visit Three|Death|0
1031161|NCT00187135|3359208|P5|Visit Three|Death|1
1031162|NCT00187135|3359209|P4|Visit Three|Death|0
1031163|NCT00187135|3359210|P3|Visit Three|Death|1
1031164|NCT00187135|3359211|P2|Visit Three|Death|0
1031165|NCT00187135|3359212|P1|Visit Three|Death|0
1031166|NCT00187135|3359207|P6|Visit Two|Study Discontinued|6
1031167|NCT00187135|3359208|P5|Visit Two|Study Discontinued|5
1031168|NCT00187135|3359209|P4|Visit Two|Study Discontinued|7
1031169|NCT00187135|3359210|P3|Visit Two|Study Discontinued|1
1031170|NCT00187135|3359211|P2|Visit Two|Study Discontinued|2
1031171|NCT00187135|3359212|P1|Visit Two|Study Discontinued|3
1031172|NCT00187135|3359207|P6|Visit Two|Withdrawal by Subject|1
1031173|NCT00187135|3359208|P5|Visit Two|Withdrawal by Subject|1
1031174|NCT00187135|3359209|P4|Visit Two|Withdrawal by Subject|0
1031175|NCT00187135|3359210|P3|Visit Two|Withdrawal by Subject|1
1031176|NCT00187135|3359211|P2|Visit Two|Withdrawal by Subject|1
1031177|NCT00187135|3359212|P1|Visit Two|Withdrawal by Subject|1
1031178|NCT00187135|3359207|P6|Visit Two|Physician Decision|0
1031179|NCT00187135|3359208|P5|Visit Two|Physician Decision|0
1031180|NCT00187135|3359209|P4|Visit Two|Physician Decision|0
1031181|NCT00187135|3359210|P3|Visit Two|Physician Decision|0
1031182|NCT00187135|3359211|P2|Visit Two|Physician Decision|0
1031183|NCT00187135|3359212|P1|Visit Two|Physician Decision|1
1031184|NCT00187135|3359207|P6|Visit Two|Death|1
1031185|NCT00187135|3359208|P5|Visit Two|Death|0
1031186|NCT00187135|3359209|P4|Visit Two|Death|1
1031187|NCT00187135|3359210|P3|Visit Two|Death|0
1031188|NCT00187135|3359211|P2|Visit Two|Death|0
1031189|NCT00187135|3359212|P1|Visit Two|Death|0
1031190|NCT00187135|3359207|P6|Visit One|Physician Decision|1
1031191|NCT00187135|3359208|P5|Visit One|Physician Decision|0
1031192|NCT00187135|3359209|P4|Visit One|Physician Decision|0
1031193|NCT00187135|3359210|P3|Visit One|Physician Decision|0
1031194|NCT00187135|3359211|P2|Visit One|Physician Decision|1
1031195|NCT00187135|3359212|P1|Visit One|Physician Decision|3
1031196|NCT00187135|3359207|P6|Visit One|Withdrawal by Subject|1
1031197|NCT00187135|3359208|P5|Visit One|Withdrawal by Subject|0
1031198|NCT00187135|3359209|P4|Visit One|Withdrawal by Subject|0
1031199|NCT00187135|3359210|P3|Visit One|Withdrawal by Subject|0
1031200|NCT00187135|3359211|P2|Visit One|Withdrawal by Subject|0
1031201|NCT00187135|3359212|P1|Visit One|Withdrawal by Subject|1
1031202|NCT00187096|3359235|P3|Overall Study|unacceptable toxicity|1
1031203|NCT00187096|3359236|P2|Overall Study|unacceptable toxicity|0
1031204|NCT00187096|3359237|P1|Overall Study|unacceptable toxicity|0
1031205|NCT00186901|3359275|P3|Overall Study|Bone Mineral Density > 0|149
1031206|NCT00186901|3359276|P2|Overall Study|Bone Mineral Density > 0|0
1031207|NCT00186901|3359277|P1|Overall Study|Bone Mineral Density > 0|0
1031208|NCT00186901|3359275|P3|Overall Study|Limited adherence to study requirements|0
1031209|NCT00186901|3359276|P2|Overall Study|Limited adherence to study requirements|23
1031210|NCT00186901|3359277|P1|Overall Study|Limited adherence to study requirements|20
1031211|NCT00186901|3359275|P3|Overall Study|Open label|0
1031212|NCT00186901|3359276|P2|Overall Study|Open label|2
1031213|NCT00186901|3359277|P1|Overall Study|Open label|3
1031214|NCT00186901|3359275|P3|Overall Study|Withdrawal by Subject|0
1031215|NCT00186901|3359276|P2|Overall Study|Withdrawal by Subject|5
1031216|NCT00186901|3359277|P1|Overall Study|Withdrawal by Subject|4
1031217|NCT00186901|3359275|P3|Overall Study|ALL relapse or second malignancy|0
1031218|NCT00186901|3359276|P2|Overall Study|ALL relapse or second malignancy|2
1031219|NCT00186901|3359277|P1|Overall Study|ALL relapse or second malignancy|1
1031220|NCT00186901|3359275|P3|Overall Study|Bone Mineral Density dropped > 5%|0
1031221|NCT00186901|3359276|P2|Overall Study|Bone Mineral Density dropped > 5%|7
1031222|NCT00186901|3359277|P1|Overall Study|Bone Mineral Density dropped > 5%|9
1031223|NCT00186901|3359275|P3|Overall Study|Lost to Follow-up|0
1031224|NCT00186901|3359276|P2|Overall Study|Lost to Follow-up|3
1031225|NCT00186901|3359277|P1|Overall Study|Lost to Follow-up|6
1031226|NCT00186901|3359275|P3|Overall Study|Pregnancy|0
1031227|NCT00186901|3359276|P2|Overall Study|Pregnancy|3
1031228|NCT00186901|3359277|P1|Overall Study|Pregnancy|6
1031229|NCT00186888|3359317|P3|Overall Study|Relapse or progression of disease|0
1031230|NCT00186888|3359318|P2|Overall Study|Relapse or progression of disease|2
1031231|NCT00186888|3359319|P1|Overall Study|Relapse or progression of disease|4
1031232|NCT00186888|3359317|P3|Overall Study|Toxicity|0
1031233|NCT00186888|3359318|P2|Overall Study|Toxicity|1
1031234|NCT00186888|3359319|P1|Overall Study|Toxicity|0
1031235|NCT00186628|3359411|P1|Overall Study|Withdrawal by subject (before treatment)|1
1031236|NCT00186628|3359411|P1|Overall Study|Death|2
1031237|NCT00186537|3359422|P3|Overall Study|ALT > 1.5 x ULN|0
1031238|NCT00186537|3359423|P2|Overall Study|ALT > 1.5 x ULN|0
1031239|NCT00186537|3359424|P1|Overall Study|ALT > 1.5 x ULN|3
1031240|NCT00186537|3359422|P3|Overall Study|Withdrawal by Subject|3
1031241|NCT00186537|3359423|P2|Overall Study|Withdrawal by Subject|0
1031242|NCT00186537|3359424|P1|Overall Study|Withdrawal by Subject|4
1031243|NCT00186485|3359438|P1|Overall Study|Lost to Follow-up|3
1031244|NCT00186186|3359450|P1|Overall Study|Not reported as to reason|2
1031245|NCT00186186|3359450|P1|Overall Study|Withdrawal by Subject|3
1031246|NCT00186186|3359450|P1|Overall Study|Lack of Efficacy|3
1031247|NCT00186121|3359455|P1|Overall Study|Not eligible (no treatment)|1
1031248|NCT00186121|3359455|P1|Overall Study|Underwent oophorectomy (no treatment)|1
1031249|NCT00186121|3359455|P1|Overall Study|Subject withdrawal (no treatment)|1
1031250|NCT00186043|3359489|P2|Overall Study|Protocol Violation|1
1031251|NCT00186043|3359490|P1|Overall Study|Protocol Violation|2
1031252|NCT00186043|3359489|P2|Overall Study|Adverse Event|3
1031253|NCT00186043|3359490|P1|Overall Study|Adverse Event|7
1031254|NCT00186043|3359489|P2|Overall Study|Withdrawal by Subject|0
1031255|NCT00186043|3359490|P1|Overall Study|Withdrawal by Subject|1
1031256|NCT00186043|3359489|P2|Overall Study|Lost to Follow-up|6
1031257|NCT00186043|3359490|P1|Overall Study|Lost to Follow-up|4
1031258|NCT00186043|3359489|P2|Overall Study|Lack of Efficacy|3
1031259|NCT00186043|3359490|P1|Overall Study|Lack of Efficacy|1
1031260|NCT00185965|3359517|P2|Overall Study|Adverse Event|1
1031261|NCT00185965|3359518|P1|Overall Study|Adverse Event|0
1031262|NCT00185731|3359543|P1|Overall Study|Not Eligible|1
1031263|NCT00185731|3359543|P1|Overall Study|Withdrawal by Subject|1
1031264|NCT00185640|3359560|P1|Overall Study|Death|138
1031265|NCT00185640|3359560|P1|Overall Study|Withdrawal by Subject|3
1031266|NCT00185640|3359560|P1|Overall Study|Not Eligible|4
1031267|NCT00185614|3359569|P1|Inter-treatment Period|Lack of allogenic donor|1
1031268|NCT00185614|3359569|P1|Inter-treatment Period|Relapse|2
1031269|NCT00185614|3359569|P1|Inter-treatment Period|Physician Decision|1
1031270|NCT00185588|3359581|P4|Overall Study|Physician Decision|0
1031271|NCT00185588|3359582|P3|Overall Study|Physician Decision|1
1031272|NCT00185588|3359583|P2|Overall Study|Physician Decision|0
1031273|NCT00185588|3359584|P1|Overall Study|Physician Decision|0
1031274|NCT00185588|3359581|P4|Overall Study|Withdrawal by Subject|0
1031275|NCT00185588|3359582|P3|Overall Study|Withdrawal by Subject|0
1031276|NCT00185588|3359583|P2|Overall Study|Withdrawal by Subject|1
1031277|NCT00185588|3359584|P1|Overall Study|Withdrawal by Subject|0
1031278|NCT00185588|3359581|P4|Overall Study|Lost to Follow-up|2
1031279|NCT00185588|3359582|P3|Overall Study|Lost to Follow-up|1
1031280|NCT00185588|3359583|P2|Overall Study|Lost to Follow-up|0
1031281|NCT00185588|3359584|P1|Overall Study|Lost to Follow-up|0
1031282|NCT00185588|3359581|P4|Overall Study|Adverse Event|2
1031283|NCT00185588|3359582|P3|Overall Study|Adverse Event|4
1031284|NCT00185588|3359583|P2|Overall Study|Adverse Event|1
1031285|NCT00185588|3359584|P1|Overall Study|Adverse Event|3
1031286|NCT00185458|3359598|P1|HRT Phase|Withdrawal by Subject|3
1031287|NCT00185458|3359598|P1|HRT Phase|Protocol Violation|2
1031288|NCT00185458|3359598|P1|HRT Phase|Lost to Follow-up|4
1031289|NCT00185458|3359598|P1|HRT Phase|Adverse Event|18
1031290|NCT00185458|3359598|P1|Contraception Phase|Withdrawal by Subject|7
1031291|NCT00185458|3359598|P1|Contraception Phase|Physician Decision|2
1031292|NCT00185458|3359598|P1|Contraception Phase|Protocol Violation|2
1031293|NCT00185458|3359598|P1|Contraception Phase|Lost to Follow-up|10
1031294|NCT00185458|3359598|P1|Contraception Phase|Adverse Event|37
1031295|NCT00185380|3359661|P3|Overall Study|personal reason|1
1031296|NCT00185380|3359662|P2|Overall Study|personal reason|1
1031297|NCT00185380|3359663|P1|Overall Study|personal reason|6
1031298|NCT00185380|3359661|P3|Overall Study|Could not attend visits|4
1031299|NCT00185380|3359662|P2|Overall Study|Could not attend visits|0
1031300|NCT00185380|3359663|P1|Overall Study|Could not attend visits|2
1031301|NCT00185380|3359661|P3|Overall Study|No need for contraception|3
1031302|NCT00185380|3359662|P2|Overall Study|No need for contraception|3
1031303|NCT00185380|3359663|P1|Overall Study|No need for contraception|3
1031304|NCT00185380|3359661|P3|Overall Study|Planned pregnancy|12
1031305|NCT00185380|3359662|P2|Overall Study|Planned pregnancy|12
1031306|NCT00185380|3359663|P1|Overall Study|Planned pregnancy|9
1031307|NCT00185380|3359661|P3|Overall Study|Failed insertion|2
1031308|NCT00185380|3359662|P2|Overall Study|Failed insertion|1
1031309|NCT00185380|3359663|P1|Overall Study|Failed insertion|1
1031310|NCT00185380|3359661|P3|Overall Study|Withdrawal by Subject|0
1031311|NCT00185380|3359662|P2|Overall Study|Withdrawal by Subject|2
1031312|NCT00185380|3359663|P1|Overall Study|Withdrawal by Subject|1
1031313|NCT00185380|3359661|P3|Overall Study|Protocol Violation|1
1031314|NCT00185380|3359662|P2|Overall Study|Protocol Violation|2
1031315|NCT00185380|3359663|P1|Overall Study|Protocol Violation|2
1031316|NCT00185380|3359661|P3|Overall Study|Pregnancy|0
1031317|NCT00185380|3359662|P2|Overall Study|Pregnancy|4
1031318|NCT00185380|3359663|P1|Overall Study|Pregnancy|1
1031319|NCT00185380|3359661|P3|Overall Study|Lost to Follow-up|3
1031320|NCT00185380|3359662|P2|Overall Study|Lost to Follow-up|4
1031321|NCT00185380|3359663|P1|Overall Study|Lost to Follow-up|0
1031322|NCT00185380|3359661|P3|Overall Study|Adverse Event|48
1031323|NCT00185380|3359662|P2|Overall Study|Adverse Event|43
1031324|NCT00185380|3359663|P1|Overall Study|Adverse Event|41
1031325|NCT00185211|3359691|P2|Follow-up Study (91031 - This Study)|other disease modif. treatment|2
1031326|NCT00185211|3359692|P1|Follow-up Study (91031 - This Study)|other disease modif. treatment|0
1031327|NCT00185211|3359691|P2|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21
1031328|NCT00185211|3359692|P1|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13
1031329|NCT00185211|3359691|P2|Follow-up Study (91031 - This Study)|Pregnancy|1
1031330|NCT00185211|3359692|P1|Follow-up Study (91031 - This Study)|Pregnancy|0
1031331|NCT00185211|3359691|P2|Follow-up Study (91031 - This Study)|Physician Decision|0
1031332|NCT00185211|3359692|P1|Follow-up Study (91031 - This Study)|Physician Decision|1
1031333|NCT00185211|3359691|P2|Follow-up Study (91031 - This Study)|Lost to Follow-up|4
1031334|NCT00185211|3359692|P1|Follow-up Study (91031 - This Study)|Lost to Follow-up|6
1031335|NCT00185211|3359691|P2|Follow-up Study (91031 - This Study)|Lack of Efficacy|0
1031336|NCT00185211|3359692|P1|Follow-up Study (91031 - This Study)|Lack of Efficacy|1
1031337|NCT00185211|3359691|P2|Follow-up Study (91031 - This Study)|Adverse Event|6
1031338|NCT00185211|3359692|P1|Follow-up Study (91031 - This Study)|Adverse Event|5
1031339|NCT00185211|3359691|P2|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0
1031340|NCT00185211|3359692|P1|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1
1031341|NCT00185211|3359691|P2|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1
1031342|NCT00185211|3359692|P1|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0
1031343|NCT00185211|3359691|P2|Placebo-controlled Study (92012)|Withdrawal by Subject|7
1031344|NCT00185211|3359692|P1|Placebo-controlled Study (92012)|Withdrawal by Subject|9
1031345|NCT00185211|3359691|P2|Placebo-controlled Study (92012)|Lost to Follow-up|2
1031346|NCT00185211|3359692|P1|Placebo-controlled Study (92012)|Lost to Follow-up|3
1031347|NCT00185211|3359691|P2|Placebo-controlled Study (92012)|Adverse Event|0
1031348|NCT00185211|3359692|P1|Placebo-controlled Study (92012)|Adverse Event|8
1031349|NCT00184600|3359765|P3|Overall Study|Unclassified|3
1031350|NCT00184600|3359766|P2|Overall Study|Unclassified|5
1031351|NCT00184600|3359767|P1|Overall Study|Unclassified|4
1031352|NCT00184600|3359765|P3|Overall Study|Withdrawal by Subject|12
1031353|NCT00184600|3359766|P2|Overall Study|Withdrawal by Subject|28
1031354|NCT00184600|3359767|P1|Overall Study|Withdrawal by Subject|20
1031355|NCT00184600|3359765|P3|Overall Study|Protocol Violation|3
1031356|NCT00184600|3359766|P2|Overall Study|Protocol Violation|2
1031357|NCT00184600|3359767|P1|Overall Study|Protocol Violation|2
1031358|NCT00184600|3359765|P3|Overall Study|Lost to Follow-up|1
1031359|NCT00184600|3359766|P2|Overall Study|Lost to Follow-up|6
1031360|NCT00184600|3359767|P1|Overall Study|Lost to Follow-up|4
1031361|NCT00184600|3359765|P3|Overall Study|Lack of Efficacy|3
1031362|NCT00184600|3359766|P2|Overall Study|Lack of Efficacy|1
1031363|NCT00184600|3359767|P1|Overall Study|Lack of Efficacy|3
1031364|NCT00184600|3359765|P3|Overall Study|Death|7
1031365|NCT00184600|3359766|P2|Overall Study|Death|9
1031366|NCT00184600|3359767|P1|Overall Study|Death|3
1031367|NCT00184600|3359765|P3|Overall Study|Adverse Event|5
1031368|NCT00184600|3359766|P2|Overall Study|Adverse Event|0
1031369|NCT00184600|3359767|P1|Overall Study|Adverse Event|9
1031370|NCT00184093|3359858|P1|Overall Study|Withdrawal by Subject|2
1031371|NCT00184093|3359858|P1|Overall Study|Physician Decision|1
1031372|NCT00184093|3359858|P1|Overall Study|Lost to Follow-up|3
1031373|NCT00184093|3359858|P1|Overall Study|Adverse Event|3
1031374|NCT00184054|3359863|P1|Overall Study|Adverse Event|1
1031375|NCT00184028|3359868|P1|Overall Study|Non-compliance|2
1031376|NCT00184028|3359868|P1|Overall Study|Withdrawal by Subject|1
1031377|NCT00184028|3359868|P1|Overall Study|Adverse Event|2
1031378|NCT00184028|3359868|P1|Overall Study|Lack of Efficacy|4
1031379|NCT00184028|3359868|P1|Overall Study|Death|1
1031380|NCT00184002|3359873|P1|Overall Study|Withdrawal by Subject|4
1031381|NCT00184002|3359873|P1|Overall Study|Physician Decision|1
1031382|NCT00184002|3359873|P1|Overall Study|Death|3
1031383|NCT00184002|3359873|P1|Overall Study|Adverse Event|9
1031384|NCT00183872|3359899|P1|Overall Study|Drug delayed more than 28 days|2
1031385|NCT00183872|3359899|P1|Overall Study|Withdrawal by Subject|2
1031386|NCT00183872|3359899|P1|Overall Study|Adverse Event|9
1031387|NCT00183872|3359899|P1|Overall Study|Death|3
1031388|NCT00183625|3359928|P4|Overall Study|Withdrawal by Subject|14
1031389|NCT00183625|3359929|P3|Overall Study|Withdrawal by Subject|19
1031390|NCT00183625|3359930|P2|Overall Study|Withdrawal by Subject|18
1031391|NCT00183625|3359931|P1|Overall Study|Withdrawal by Subject|18
1031392|NCT00183430|3360028|P2|Overall Study|Withdrawal by Subject|0
1031393|NCT00183430|3360029|P1|Overall Study|Withdrawal by Subject|1
1031394|NCT00183430|3360028|P2|Overall Study|did not meet inclusion criteria|0
1031395|NCT00183430|3360029|P1|Overall Study|did not meet inclusion criteria|1
1031396|NCT00183430|3360028|P2|Overall Study|Lost to Follow-up|0
1031397|NCT00183430|3360029|P1|Overall Study|Lost to Follow-up|3
1031398|NCT00183430|3360028|P2|Overall Study|Adverse Event|0
1031399|NCT00183430|3360029|P1|Overall Study|Adverse Event|1
1031400|NCT00183391|3360041|P2|Block 2 - 5 Weeks|Withdrawal by Subject|2
1031401|NCT00183391|3360042|P1|Block 2 - 5 Weeks|Withdrawal by Subject|4
1031402|NCT00183391|3360041|P2|Block 1 - 5 Weeks|Withdrawal by Subject|14
1031403|NCT00183391|3360042|P1|Block 1 - 5 Weeks|Withdrawal by Subject|13
1031404|NCT00183274|3360115|P6|Phase 3: Double-Blind|Relapsed|2
1031405|NCT00183274|3360116|P5|Phase 3: Double-Blind|Relapsed|11
1031406|NCT00183274|3360117|P4|Phase 3: Double-Blind|Relapsed|1
1031407|NCT00183274|3360118|P3|Phase 3: Double-Blind|Relapsed|0
1031408|NCT00183274|3360119|P2|Phase 3: Double-Blind|Relapsed|0
1031409|NCT00183274|3360120|P1|Phase 3: Double-Blind|Relapsed|0
1031410|NCT00183274|3360115|P6|Phase 3: Double-Blind|Withdrawal by Subject|2
1031411|NCT00183274|3360116|P5|Phase 3: Double-Blind|Withdrawal by Subject|9
1031412|NCT00183274|3360117|P4|Phase 3: Double-Blind|Withdrawal by Subject|1
1031413|NCT00183274|3360118|P3|Phase 3: Double-Blind|Withdrawal by Subject|0
1031414|NCT00183274|3360119|P2|Phase 3: Double-Blind|Withdrawal by Subject|0
1031415|NCT00183274|3360120|P1|Phase 3: Double-Blind|Withdrawal by Subject|0
1031416|NCT00183274|3360115|P6|Phase 2: Double-Blind|Withdrawal by Subject|0
1031417|NCT00183274|3360116|P5|Phase 2: Double-Blind|Withdrawal by Subject|0
1031418|NCT00183274|3360117|P4|Phase 2: Double-Blind|Withdrawal by Subject|0
1031419|NCT00183274|3360118|P3|Phase 2: Double-Blind|Withdrawal by Subject|14
1031420|NCT00183274|3360119|P2|Phase 2: Double-Blind|Withdrawal by Subject|18
1031421|NCT00183274|3360120|P1|Phase 2: Double-Blind|Withdrawal by Subject|0
1031422|NCT00183274|3360115|P6|Phase 2: Double-Blind|Relapsed|0
1031423|NCT00183274|3360116|P5|Phase 2: Double-Blind|Relapsed|0
1031424|NCT00183274|3360117|P4|Phase 2: Double-Blind|Relapsed|0
1031425|NCT00183274|3360118|P3|Phase 2: Double-Blind|Relapsed|29
1031426|NCT00183274|3360119|P2|Phase 2: Double-Blind|Relapsed|8
1031427|NCT00183274|3360120|P1|Phase 2: Double-Blind|Relapsed|0
1031428|NCT00183274|3360115|P6|Phase 1: Open-Label|Other|0
1031429|NCT00183274|3360116|P5|Phase 1: Open-Label|Other|0
1031430|NCT00183274|3360117|P4|Phase 1: Open-Label|Other|0
1031431|NCT00183274|3360118|P3|Phase 1: Open-Label|Other|0
1031432|NCT00183274|3360119|P2|Phase 1: Open-Label|Other|0
1031433|NCT00183274|3360120|P1|Phase 1: Open-Label|Other|9
1031434|NCT00183274|3360115|P6|Phase 1: Open-Label|Lost to Follow-up|0
1031435|NCT00183274|3360116|P5|Phase 1: Open-Label|Lost to Follow-up|0
1031436|NCT00183274|3360117|P4|Phase 1: Open-Label|Lost to Follow-up|0
1031437|NCT00183274|3360118|P3|Phase 1: Open-Label|Lost to Follow-up|0
1031438|NCT00183274|3360119|P2|Phase 1: Open-Label|Lost to Follow-up|0
1031439|NCT00183274|3360120|P1|Phase 1: Open-Label|Lost to Follow-up|33
1031440|NCT00183274|3360115|P6|Phase 1: Open-Label|Withdrawal by Subject|0
1031441|NCT00183274|3360116|P5|Phase 1: Open-Label|Withdrawal by Subject|0
1031442|NCT00183274|3360117|P4|Phase 1: Open-Label|Withdrawal by Subject|0
1031443|NCT00183274|3360118|P3|Phase 1: Open-Label|Withdrawal by Subject|0
1031444|NCT00183274|3360119|P2|Phase 1: Open-Label|Withdrawal by Subject|0
1031445|NCT00183274|3360120|P1|Phase 1: Open-Label|Withdrawal by Subject|13
1031446|NCT00183274|3360115|P6|Phase 1: Open-Label|Protocol Violation|0
1031447|NCT00183274|3360116|P5|Phase 1: Open-Label|Protocol Violation|0
1031448|NCT00183274|3360117|P4|Phase 1: Open-Label|Protocol Violation|0
1031449|NCT00183274|3360118|P3|Phase 1: Open-Label|Protocol Violation|0
1031450|NCT00183274|3360119|P2|Phase 1: Open-Label|Protocol Violation|0
1031451|NCT00183274|3360120|P1|Phase 1: Open-Label|Protocol Violation|11
1031452|NCT00183274|3360115|P6|Phase 1: Open-Label|Lack of Efficacy|0
1031453|NCT00183274|3360116|P5|Phase 1: Open-Label|Lack of Efficacy|0
1031454|NCT00183274|3360117|P4|Phase 1: Open-Label|Lack of Efficacy|0
1031455|NCT00183274|3360118|P3|Phase 1: Open-Label|Lack of Efficacy|0
1031456|NCT00183274|3360119|P2|Phase 1: Open-Label|Lack of Efficacy|0
1031457|NCT00183274|3360120|P1|Phase 1: Open-Label|Lack of Efficacy|13
1031458|NCT00183274|3360115|P6|Phase 1: Open-Label|Adverse Event|0
1031459|NCT00183274|3360116|P5|Phase 1: Open-Label|Adverse Event|0
1031460|NCT00183274|3360117|P4|Phase 1: Open-Label|Adverse Event|0
1031461|NCT00183274|3360118|P3|Phase 1: Open-Label|Adverse Event|0
1031462|NCT00183274|3360119|P2|Phase 1: Open-Label|Adverse Event|0
1031463|NCT00183274|3360120|P1|Phase 1: Open-Label|Adverse Event|31
1031464|NCT00183248|3360137|P2|Overall Study|Focal glomerulosclerosis proteinuria|0
1031465|NCT00183248|3360138|P1|Overall Study|Focal glomerulosclerosis proteinuria|1
1031466|NCT00183248|3360137|P2|Overall Study|Lost to Follow-up|1
1031467|NCT00183248|3360138|P1|Overall Study|Lost to Follow-up|0
1031468|NCT00183196|3360159|P3|Overall Study|Required more intensive care|2
1031469|NCT00183196|3360160|P2|Overall Study|Required more intensive care|1
1031470|NCT00183196|3360161|P1|Overall Study|Required more intensive care|0
1031471|NCT00183196|3360159|P3|Overall Study|Legal event|1
1031472|NCT00183196|3360160|P2|Overall Study|Legal event|1
1031473|NCT00183196|3360161|P1|Overall Study|Legal event|1
1031474|NCT00183196|3360159|P3|Overall Study|Adverse Event|2
1031475|NCT00183196|3360160|P2|Overall Study|Adverse Event|2
1031476|NCT00183196|3360161|P1|Overall Study|Adverse Event|1
1031477|NCT00183196|3360159|P3|Overall Study|Withdrawal by Subject|13
1031478|NCT00183196|3360160|P2|Overall Study|Withdrawal by Subject|11
1031479|NCT00183196|3360161|P1|Overall Study|Withdrawal by Subject|18
1031480|NCT00182689|3360244|P2|Overall Study|Never received treatment|0
1031481|NCT00182689|3360245|P1|Overall Study|Never received treatment|1
1031482|NCT00182689|3360244|P2|Overall Study|Ineligible|4
1031483|NCT00182689|3360245|P1|Overall Study|Ineligible|1
1031484|NCT00182689|3360244|P2|Overall Study|not protocol specified|3
1031485|NCT00182689|3360245|P1|Overall Study|not protocol specified|0
1031486|NCT00182689|3360244|P2|Overall Study|Death|0
1031487|NCT00182689|3360245|P1|Overall Study|Death|1
1031488|NCT00182689|3360244|P2|Overall Study|Progression|29
1031489|NCT00182689|3360245|P1|Overall Study|Progression|27
1031490|NCT00182689|3360244|P2|Overall Study|Withdrawal by Subject|2
1031491|NCT00182689|3360245|P1|Overall Study|Withdrawal by Subject|2
1031492|NCT00182689|3360244|P2|Overall Study|Adverse Event|11
1031493|NCT00182689|3360245|P1|Overall Study|Adverse Event|8
1031494|NCT00182637|3360255|P1|Overall Study|Disease Progression|1
1031495|NCT00182637|3360255|P1|Overall Study|Adverse Event|2
1031496|NCT00182091|3360265|P4|Overall Study|Withdrawal by Subject|0
1031497|NCT00182091|3360266|P3|Overall Study|Withdrawal by Subject|0
1031498|NCT00182091|3360267|P2|Overall Study|Withdrawal by Subject|0
1031499|NCT00182091|3360268|P1|Overall Study|Withdrawal by Subject|1
1031500|NCT00182078|3360284|P2|Overall Study|Withdrawal by Subject|0
1031501|NCT00182078|3360285|P1|Overall Study|Withdrawal by Subject|1
1031502|NCT00181883|3360304|P1|Overall Study|Lost to Follow-up|1
1031503|NCT00181883|3360304|P1|Overall Study|Withdrawal by Subject|4
1031504|NCT00181883|3360304|P1|Overall Study|Treatment Limiting AEs|3
1031505|NCT00181883|3360304|P1|Overall Study|Lack of Efficacy|2
1031506|NCT00181844|3360308|P1|Exposed to Study Medication|Difficulty meeting study schedule|2
1031507|NCT00181844|3360308|P1|Exposed to Study Medication|Withdrawal by Subject|1
1031508|NCT00181844|3360308|P1|Exposed to Study Medication|Non-compliance|2
1031509|NCT00181844|3360308|P1|Exposed to Study Medication|Lack of Efficacy|2
1031510|NCT00181844|3360308|P1|Exposed to Study Medication|Adverse Event|10
1031511|NCT00181844|3360308|P1|Signed Consent|Did not meet entrance criteria|7
1031512|NCT00181844|3360308|P1|Signed Consent|Withdrawal by Subject|5
1031513|NCT00181766|3360312|P1|Overall Study|non-compliance|2
1031514|NCT00181766|3360312|P1|Overall Study|Adverse Event|4
1031515|NCT00181766|3360312|P1|Overall Study|Lost to Follow-up|6
1031516|NCT00181155|3360373|P2|Overall Study|Withdrawal by Subject|0
1031517|NCT00181155|3360374|P1|Overall Study|Withdrawal by Subject|1
1031518|NCT00181155|3360373|P2|Overall Study|Physician Decision|0
1031519|NCT00181155|3360374|P1|Overall Study|Physician Decision|1
1031520|NCT00180479|3360413|P2|Overall Study|Informed consent not signed|1
1031521|NCT00180479|3360414|P1|Overall Study|Informed consent not signed|0
1031522|NCT00180479|3360413|P2|Overall Study|Withdrawal by Subject|3
1031523|NCT00180479|3360414|P1|Overall Study|Withdrawal by Subject|3
1031524|NCT00180479|3360413|P2|Overall Study|Lost to Follow-up|7
1031525|NCT00180479|3360414|P1|Overall Study|Lost to Follow-up|9
1031526|NCT00180479|3360413|P2|Overall Study|Death|2
1031527|NCT00180479|3360414|P1|Overall Study|Death|4
1031528|NCT00179959|3360524|P2|Overall Study|Withdrawal by Subject|2
1031529|NCT00179959|3360525|P1|Overall Study|Withdrawal by Subject|3
1031530|NCT00179959|3360524|P2|Overall Study|Lost to Follow-up|1
1031531|NCT00179959|3360525|P1|Overall Study|Lost to Follow-up|3
1031532|NCT00179673|3360531|P1|Overall Study|Other Observations and options|14
1031533|NCT00179673|3360531|P1|Overall Study|Death|4
1031534|NCT00179673|3360531|P1|Overall Study|Withdrawal by Subject|3
1031535|NCT00179673|3360531|P1|Overall Study|Lack of Efficacy|15
1031536|NCT00179673|3360531|P1|Overall Study|Adverse Event|7
1031537|NCT00179660|3360539|P1|Overall Study|Other - Unspecified|9
1031538|NCT00179660|3360539|P1|Overall Study|Death|3
1031539|NCT00179660|3360539|P1|Overall Study|Lost to Follow-up|1
1031540|NCT00179660|3360539|P1|Overall Study|Withdrawal by Subject|2
1031541|NCT00179660|3360539|P1|Overall Study|Lack of therapeutic effect|28
1031542|NCT00179660|3360539|P1|Overall Study|Adverse Event|7
1031543|NCT00179647|3360548|P1|Overall Study|Not specified|960
1031544|NCT00179647|3360548|P1|Overall Study|Death|94
1031545|NCT00179647|3360548|P1|Overall Study|Lost to Follow-up|4
1031546|NCT00179647|3360548|P1|Overall Study|Withdrawal by Subject|83
1031547|NCT00179647|3360548|P1|Overall Study|Lack of Efficacy|478
1031548|NCT00179647|3360548|P1|Overall Study|Adverse Event|294
1031549|NCT00179621|3360555|P4|Open-Label Period|Other|2
1031550|NCT00179621|3360556|P3|Open-Label Period|Other|1
1031551|NCT00179621|3360557|P2|Open-Label Period|Other|1
1031552|NCT00179621|3360558|P1|Open-Label Period|Other|0
1031553|NCT00179621|3360555|P4|Open-Label Period|Death|2
1031554|NCT00179621|3360556|P3|Open-Label Period|Death|1
1031555|NCT00179621|3360557|P2|Open-Label Period|Death|0
1031556|NCT00179621|3360558|P1|Open-Label Period|Death|0
1031557|NCT00179621|3360555|P4|Open-Label Period|Withdrawal by Subject|2
1031558|NCT00179621|3360556|P3|Open-Label Period|Withdrawal by Subject|2
1031559|NCT00179621|3360557|P2|Open-Label Period|Withdrawal by Subject|2
1031560|NCT00179621|3360558|P1|Open-Label Period|Withdrawal by Subject|0
1031561|NCT00179621|3360555|P4|Open-Label Period|Adverse Event|6
1031562|NCT00179621|3360556|P3|Open-Label Period|Adverse Event|5
1031563|NCT00179621|3360557|P2|Open-Label Period|Adverse Event|6
1031564|NCT00179621|3360558|P1|Open-Label Period|Adverse Event|0
1031565|NCT00179621|3360555|P4|Open-Label Period|Lack of Therapeutic Effect|31
1031566|NCT00179621|3360556|P3|Open-Label Period|Lack of Therapeutic Effect|19
1031567|NCT00179621|3360557|P2|Open-Label Period|Lack of Therapeutic Effect|19
1031568|NCT00179621|3360558|P1|Open-Label Period|Lack of Therapeutic Effect|0
1031569|NCT00179621|3360555|P4|Double-Blind Period|Other|0
1031570|NCT00179621|3360556|P3|Double-Blind Period|Other|2
1031571|NCT00179621|3360557|P2|Double-Blind Period|Other|2
1031572|NCT00179621|3360558|P1|Double-Blind Period|Other|0
1031573|NCT00179621|3360555|P4|Double-Blind Period|Protocol Violation|0
1031574|NCT00179621|3360556|P3|Double-Blind Period|Protocol Violation|0
1031575|NCT00179621|3360557|P2|Double-Blind Period|Protocol Violation|0
1031576|NCT00179621|3360558|P1|Double-Blind Period|Protocol Violation|1
1031577|NCT00179621|3360555|P4|Double-Blind Period|Death|0
1031578|NCT00179621|3360556|P3|Double-Blind Period|Death|2
1031579|NCT00179621|3360557|P2|Double-Blind Period|Death|1
1031580|NCT00179621|3360558|P1|Double-Blind Period|Death|0
1031581|NCT00179621|3360555|P4|Double-Blind Period|Withdrawal by Subject|0
1031582|NCT00179621|3360556|P3|Double-Blind Period|Withdrawal by Subject|3
1031583|NCT00179621|3360557|P2|Double-Blind Period|Withdrawal by Subject|1
1031584|NCT00179621|3360558|P1|Double-Blind Period|Withdrawal by Subject|2
1031585|NCT00179621|3360555|P4|Double-Blind Period|Adverse Event|0
1031586|NCT00179621|3360556|P3|Double-Blind Period|Adverse Event|4
1031587|NCT00179621|3360557|P2|Double-Blind Period|Adverse Event|7
1031588|NCT00179621|3360558|P1|Double-Blind Period|Adverse Event|2
1031589|NCT00179621|3360555|P4|Double-Blind Period|Lack of Therapeutic Effect|0
1031590|NCT00179621|3360556|P3|Double-Blind Period|Lack of Therapeutic Effect|19
1031591|NCT00179621|3360557|P2|Double-Blind Period|Lack of Therapeutic Effect|35
1031592|NCT00179621|3360558|P1|Double-Blind Period|Lack of Therapeutic Effect|59
1031593|NCT00179517|3360611|P2|Overall Study|Withdrawal by Subject|1
1031594|NCT00179517|3360612|P1|Overall Study|Withdrawal by Subject|2
1031595|NCT00179413|3360650|P2|Overall Study|Withdrawal by Subject|95
1031596|NCT00179413|3360651|P1|Overall Study|Withdrawal by Subject|87
1031597|NCT00179413|3360650|P2|Overall Study|Adverse Event|20
1031598|NCT00179413|3360651|P1|Overall Study|Adverse Event|38
1031599|NCT00179309|3360663|P2|Treatment|Allergy|0
1031600|NCT00179309|3360664|P1|Treatment|Allergy|1
1031601|NCT00179309|3360663|P2|Treatment|Withdrawal by Subject|2
1031602|NCT00179309|3360664|P1|Treatment|Withdrawal by Subject|1
1031603|NCT00179309|3360663|P2|Treatment|Toxicity|3
1031604|NCT00179309|3360664|P1|Treatment|Toxicity|2
1031605|NCT00178685|3360716|P3|Overall Study|Withdrawal by Subject|7
1031606|NCT00178685|3360717|P2|Overall Study|Withdrawal by Subject|14
1031607|NCT00178685|3360718|P1|Overall Study|Withdrawal by Subject|8
1031608|NCT00178685|3360716|P3|Overall Study|Lost to Follow-up|183
1031609|NCT00178685|3360717|P2|Overall Study|Lost to Follow-up|187
1031610|NCT00178685|3360718|P1|Overall Study|Lost to Follow-up|100
1031611|NCT00178685|3360716|P3|Overall Study|Death|6
1031612|NCT00178685|3360717|P2|Overall Study|Death|3
1031613|NCT00178685|3360718|P1|Overall Study|Death|3
1031614|NCT00178633|3360729|P1|Overall Study|Lost to Follow-up|6
1031615|NCT00178464|3360759|P1|Overall Study|Physician Decision|1
1031616|NCT00178464|3360759|P1|Overall Study|Withdrawal by Subject|1
1031617|NCT00178399|3360764|P1|Overall Study|Lost to Follow-up|1
1031618|NCT00178399|3360764|P1|Overall Study|Withdrawal by Subject|8
1031619|NCT00178399|3360764|P1|Overall Study|Physician Decision|4
1031620|NCT00178256|3360771|P4|Overall Study|Cancer progression|1
1031621|NCT00178256|3360772|P3|Overall Study|Cancer progression|0
1031622|NCT00178256|3360773|P2|Overall Study|Cancer progression|0
1031623|NCT00178256|3360774|P1|Overall Study|Cancer progression|2
1031624|NCT00178256|3360771|P4|Overall Study|Death|1
1031625|NCT00178256|3360772|P3|Overall Study|Death|0
1031626|NCT00178256|3360773|P2|Overall Study|Death|1
1031627|NCT00178256|3360774|P1|Overall Study|Death|0
1031628|NCT00178256|3360771|P4|Overall Study|Adverse Event|0
1031629|NCT00178256|3360772|P3|Overall Study|Adverse Event|0
1031630|NCT00178256|3360773|P2|Overall Study|Adverse Event|0
1031631|NCT00178256|3360774|P1|Overall Study|Adverse Event|2
1031632|NCT00178126|3360813|P2|Overall Study|did not receive intervention|6
1031633|NCT00178126|3360814|P1|Overall Study|did not receive intervention|4
1031634|NCT00178126|3360813|P2|Overall Study|Lost to Follow-up|21
1031635|NCT00178126|3360814|P1|Overall Study|Lost to Follow-up|21
1031636|NCT00177671|3360856|P2|Overall Study|Physician Decision|8
1031637|NCT00177671|3360857|P1|Overall Study|Physician Decision|12
1031638|NCT00177671|3360856|P2|Overall Study|Adverse Event|0
1031639|NCT00177671|3360857|P1|Overall Study|Adverse Event|6
1031640|NCT00177671|3360856|P2|Overall Study|medical complications|0
1031641|NCT00177671|3360857|P1|Overall Study|medical complications|2
1031642|NCT00177671|3360856|P2|Overall Study|Withdrawal by Subject|6
1031643|NCT00177671|3360857|P1|Overall Study|Withdrawal by Subject|5
1031644|NCT00177307|3360869|P1|Overall Study|Withdrawal by Subject|1
1031645|NCT00177294|3360878|P2|Overall Study|Withdrawal by Subject|5
1031646|NCT00177294|3360879|P1|Overall Study|Withdrawal by Subject|7
1031647|NCT00177216|3360893|P3|Overall Study|Withdrawal by Subject|1
1031648|NCT00177216|3360894|P2|Overall Study|Withdrawal by Subject|3
1031649|NCT00177216|3360895|P1|Overall Study|Withdrawal by Subject|6
1031650|NCT00177164|3360911|P2|Overall Study|Pregnancy|1
1031651|NCT00177164|3360912|P1|Overall Study|Pregnancy|0
1031652|NCT00177164|3360911|P2|Overall Study|Lack of Efficacy|1
1031653|NCT00177164|3360912|P1|Overall Study|Lack of Efficacy|2
1031654|NCT00177164|3360911|P2|Overall Study|discharge from hospital|0
1031655|NCT00177164|3360912|P1|Overall Study|discharge from hospital|1
1031656|NCT00177164|3360911|P2|Overall Study|Adverse Event|0
1031657|NCT00177164|3360912|P1|Overall Study|Adverse Event|1
1031658|NCT00177164|3360911|P2|Overall Study|increase in alcohol and drug use|2
1031659|NCT00177164|3360912|P1|Overall Study|increase in alcohol and drug use|1
1031660|NCT00177164|3360911|P2|Overall Study|Lost to Follow-up|5
1031661|NCT00177164|3360912|P1|Overall Study|Lost to Follow-up|4
1031662|NCT00177164|3360911|P2|Overall Study|Protocol Violation|7
1031663|NCT00177164|3360912|P1|Overall Study|Protocol Violation|0
1031664|NCT00176644|3361077|P1|Overall Study|Withdrawal by Subject|1
1031665|NCT00176605|3361090|P1|Overall Study|Withdrawal by Subject|2
1031666|NCT00176488|3361101|P1|Overall Study|Initiated Cycle 1 Day 1 only|1
1031667|NCT00176462|3361109|P2|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3
1031668|NCT00176462|3361110|P1|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0
1031669|NCT00176462|3361109|P2|Intensive Continuation (8X8-week Cycles)|Death|0
1031670|NCT00176462|3361110|P1|Intensive Continuation (8X8-week Cycles)|Death|1
1031671|NCT00176462|3361109|P2|Consolidation (12 Weeks)|Not documented|1
1031672|NCT00176462|3361110|P1|Consolidation (12 Weeks)|Not documented|0
1031673|NCT00176462|3361109|P2|Consolidation (12 Weeks)|Lack of Efficacy|2
1031674|NCT00176462|3361110|P1|Consolidation (12 Weeks)|Lack of Efficacy|0
1031675|NCT00176462|3361109|P2|Consolidation (12 Weeks)|Adverse Event|1
1031676|NCT00176462|3361110|P1|Consolidation (12 Weeks)|Adverse Event|0
1031677|NCT00176462|3361109|P2|Consolidation (12 Weeks)|Patient moved to another state|1
1031678|NCT00176462|3361110|P1|Consolidation (12 Weeks)|Patient moved to another state|0
1031679|NCT00176462|3361109|P2|Induction (4 Weeks)|Lack of Efficacy|1
1031680|NCT00176462|3361110|P1|Induction (4 Weeks)|Lack of Efficacy|0
1031681|NCT00176462|3361109|P2|Induction (4 Weeks)|Death|2
1031682|NCT00176462|3361110|P1|Induction (4 Weeks)|Death|1
1031683|NCT00176462|3361109|P2|Induction (4 Weeks)|Withdrawal by Subject|2
1031684|NCT00176462|3361110|P1|Induction (4 Weeks)|Withdrawal by Subject|0
1031685|NCT00176254|3361130|P1|Overall Study|Lost to Follow-up|1
1031686|NCT00175877|3361158|P1|Overall Study|Withdrawal by subject & Other|1
1031687|NCT00175877|3361158|P1|Overall Study|AE & Other|1
1031688|NCT00175877|3361158|P1|Overall Study|Other Reason|20
1031689|NCT00175877|3361158|P1|Overall Study|Protocol Violation|15
1031690|NCT00175877|3361158|P1|Overall Study|Lack of Efficacy|26
1031691|NCT00175877|3361158|P1|Overall Study|Lost to Follow-up|9
1031692|NCT00175877|3361158|P1|Overall Study|Withdrawal by Subject|141
1031693|NCT00175877|3361158|P1|Overall Study|Adverse Event|136
1031694|NCT00175825|3361193|P4|Overall Study|Withdrawal by Subject|0
1031695|NCT00175825|3361194|P3|Overall Study|Withdrawal by Subject|0
1031696|NCT00175825|3361195|P2|Overall Study|Withdrawal by Subject|0
1031697|NCT00175825|3361196|P1|Overall Study|Withdrawal by Subject|1
1031698|NCT00175825|3361193|P4|Overall Study|Lost to Follow-up|0
1031699|NCT00175825|3361194|P3|Overall Study|Lost to Follow-up|0
1031700|NCT00175825|3361195|P2|Overall Study|Lost to Follow-up|2
1031701|NCT00175825|3361196|P1|Overall Study|Lost to Follow-up|1
1031702|NCT00175825|3361193|P4|Overall Study|Adverse Event|1
1031703|NCT00175825|3361194|P3|Overall Study|Adverse Event|1
1031704|NCT00175825|3361195|P2|Overall Study|Adverse Event|2
1031705|NCT00175825|3361196|P1|Overall Study|Adverse Event|3
1031706|NCT00175019|3361249|P3|Overall Study|Reason Not Specified|11
1031707|NCT00175019|3361250|P2|Overall Study|Reason Not Specified|34
1031708|NCT00175019|3361251|P1|Overall Study|Reason Not Specified|40
1031709|NCT00175019|3361249|P3|Overall Study|Gout Flare|0
1031710|NCT00175019|3361250|P2|Overall Study|Gout Flare|3
1031711|NCT00175019|3361251|P1|Overall Study|Gout Flare|2
1031712|NCT00175019|3361249|P3|Overall Study|Therapeutic Failure|22
1031713|NCT00175019|3361250|P2|Overall Study|Therapeutic Failure|38
1031714|NCT00175019|3361251|P1|Overall Study|Therapeutic Failure|10
1031715|NCT00175019|3361249|P3|Overall Study|Personal Reason(s)|8
1031716|NCT00175019|3361250|P2|Overall Study|Personal Reason(s)|31
1031717|NCT00175019|3361251|P1|Overall Study|Personal Reason(s)|39
1031718|NCT00175019|3361249|P3|Overall Study|Did not continue under Amendment 4|2
1031719|NCT00175019|3361250|P2|Overall Study|Did not continue under Amendment 4|1
1031720|NCT00175019|3361251|P1|Overall Study|Did not continue under Amendment 4|1
1031721|NCT00175019|3361249|P3|Overall Study|Lost to Follow-up|9
1031722|NCT00175019|3361250|P2|Overall Study|Lost to Follow-up|39
1031723|NCT00175019|3361251|P1|Overall Study|Lost to Follow-up|42
1031724|NCT00175019|3361249|P3|Overall Study|Protocol Violation|3
1031725|NCT00175019|3361250|P2|Overall Study|Protocol Violation|3
1031726|NCT00175019|3361251|P1|Overall Study|Protocol Violation|6
1031727|NCT00175019|3361249|P3|Overall Study|Adverse Event|2
1031728|NCT00175019|3361250|P2|Overall Study|Adverse Event|22
1031729|NCT00175019|3361251|P1|Overall Study|Adverse Event|54
1031730|NCT00174967|3361304|P4|Overall Study|Not Specified|0
1031731|NCT00174967|3361305|P3|Overall Study|Not Specified|0
1031732|NCT00174967|3361306|P2|Overall Study|Not Specified|1
1031733|NCT00174967|3361307|P1|Overall Study|Not Specified|0
1031734|NCT00174967|3361304|P4|Overall Study|Gout Flare|1
1031735|NCT00174967|3361305|P3|Overall Study|Gout Flare|0
1031736|NCT00174967|3361306|P2|Overall Study|Gout Flare|0
1031737|NCT00174967|3361307|P1|Overall Study|Gout Flare|0
1031738|NCT00174967|3361304|P4|Overall Study|Adverse Event|1
1031739|NCT00174967|3361305|P3|Overall Study|Adverse Event|2
1031740|NCT00174967|3361306|P2|Overall Study|Adverse Event|2
1031741|NCT00174967|3361307|P1|Overall Study|Adverse Event|1
1031742|NCT00174954|3361353|P1|Overall Study|Physician Decision|1
1031743|NCT00174954|3361353|P1|Overall Study|No tophi found in MRI|1
1031744|NCT00174954|3361353|P1|Overall Study|Adverse Event|2
1031745|NCT00174941|3361361|P4|Overall Study|Reason Not Specified|9
1031746|NCT00174941|3361362|P3|Overall Study|Reason Not Specified|2
1031747|NCT00174941|3361363|P2|Overall Study|Reason Not Specified|6
1031748|NCT00174941|3361364|P1|Overall Study|Reason Not Specified|1
1031749|NCT00174941|3361361|P4|Overall Study|Gout Flare|8
1031750|NCT00174941|3361362|P3|Overall Study|Gout Flare|4
1031751|NCT00174941|3361363|P2|Overall Study|Gout Flare|4
1031752|NCT00174941|3361364|P1|Overall Study|Gout Flare|0
1031753|NCT00174941|3361361|P4|Overall Study|Personal Reason(s)|22
1031754|NCT00174941|3361362|P3|Overall Study|Personal Reason(s)|8
1031755|NCT00174941|3361363|P2|Overall Study|Personal Reason(s)|14
1031756|NCT00174941|3361364|P1|Overall Study|Personal Reason(s)|0
1031757|NCT00174941|3361361|P4|Overall Study|Lost to Follow-up|5
1031758|NCT00174941|3361362|P3|Overall Study|Lost to Follow-up|2
1031759|NCT00174941|3361363|P2|Overall Study|Lost to Follow-up|3
1031760|NCT00174941|3361364|P1|Overall Study|Lost to Follow-up|0
1031761|NCT00174941|3361361|P4|Overall Study|Protocol Violation|1
1031762|NCT00174941|3361362|P3|Overall Study|Protocol Violation|0
1031763|NCT00174941|3361363|P2|Overall Study|Protocol Violation|1
1031764|NCT00174941|3361364|P1|Overall Study|Protocol Violation|0
1031765|NCT00174941|3361361|P4|Overall Study|Adverse Event|13
1031766|NCT00174941|3361362|P3|Overall Study|Adverse Event|2
1031767|NCT00174941|3361363|P2|Overall Study|Adverse Event|10
1031768|NCT00174941|3361364|P1|Overall Study|Adverse Event|1
1031769|NCT00174915|3361439|P5|Overall Study|Therapeutic Failure|3
1031770|NCT00174915|3361440|P4|Overall Study|Therapeutic Failure|1
1031771|NCT00174915|3361441|P3|Overall Study|Therapeutic Failure|2
1031772|NCT00174915|3361442|P2|Overall Study|Therapeutic Failure|3
1031773|NCT00174915|3361443|P1|Overall Study|Therapeutic Failure|6
1031774|NCT00174915|3361439|P5|Overall Study|Protocol Violation|3
1031775|NCT00174915|3361440|P4|Overall Study|Protocol Violation|6
1031776|NCT00174915|3361441|P3|Overall Study|Protocol Violation|3
1031777|NCT00174915|3361442|P2|Overall Study|Protocol Violation|3
1031778|NCT00174915|3361443|P1|Overall Study|Protocol Violation|6
1031779|NCT00174915|3361439|P5|Overall Study|Gout Flare|0
1031780|NCT00174915|3361440|P4|Overall Study|Gout Flare|1
1031781|NCT00174915|3361441|P3|Overall Study|Gout Flare|8
1031782|NCT00174915|3361442|P2|Overall Study|Gout Flare|6
1031783|NCT00174915|3361443|P1|Overall Study|Gout Flare|13
1031784|NCT00174915|3361439|P5|Overall Study|Other|3
1031785|NCT00174915|3361440|P4|Overall Study|Other|5
1031786|NCT00174915|3361441|P3|Overall Study|Other|6
1031787|NCT00174915|3361442|P2|Overall Study|Other|8
1031788|NCT00174915|3361443|P1|Overall Study|Other|15
1031789|NCT00174915|3361439|P5|Overall Study|Personal Reason(s)|9
1031790|NCT00174915|3361440|P4|Overall Study|Personal Reason(s)|9
1031791|NCT00174915|3361441|P3|Overall Study|Personal Reason(s)|9
1031792|NCT00174915|3361442|P2|Overall Study|Personal Reason(s)|16
1031793|NCT00174915|3361443|P1|Overall Study|Personal Reason(s)|16
1031794|NCT00174915|3361439|P5|Overall Study|Adverse Event|5
1031795|NCT00174915|3361440|P4|Overall Study|Adverse Event|18
1031796|NCT00174915|3361441|P3|Overall Study|Adverse Event|11
1031797|NCT00174915|3361442|P2|Overall Study|Adverse Event|16
1031798|NCT00174915|3361443|P1|Overall Study|Adverse Event|18
1031799|NCT00174915|3361439|P5|Overall Study|Lost to Follow-up|10
1031800|NCT00174915|3361440|P4|Overall Study|Lost to Follow-up|17
1031801|NCT00174915|3361441|P3|Overall Study|Lost to Follow-up|9
1031802|NCT00174915|3361442|P2|Overall Study|Lost to Follow-up|17
1031803|NCT00174915|3361443|P1|Overall Study|Lost to Follow-up|19
1031804|NCT00174785|3361502|P2|Overall Study|Not pre-specified/Not coded|70
1031805|NCT00174785|3361503|P1|Overall Study|Not pre-specified/Not coded|56
1031806|NCT00174785|3361502|P2|Overall Study|Family request|8
1031807|NCT00174785|3361503|P1|Overall Study|Family request|6
1031808|NCT00174785|3361502|P2|Overall Study|Other prohibited medication|3
1031809|NCT00174785|3361503|P1|Overall Study|Other prohibited medication|5
1031810|NCT00174785|3361502|P2|Overall Study|Prohibited antiarrhythmic medication|88
1031811|NCT00174785|3361503|P1|Overall Study|Prohibited antiarrhythmic medication|39
1031812|NCT00174785|3361502|P2|Overall Study|Atrial Fibrillation/Flutter recurrence|167
1031813|NCT00174785|3361503|P1|Overall Study|Atrial Fibrillation/Flutter recurrence|110
1031814|NCT00174785|3361502|P2|Overall Study|Withdrawal by Subject|175
1031815|NCT00174785|3361503|P1|Overall Study|Withdrawal by Subject|173
1031816|NCT00174785|3361502|P2|Overall Study|Protocol Violation|14
1031817|NCT00174785|3361503|P1|Overall Study|Protocol Violation|14
1031818|NCT00174785|3361502|P2|Overall Study|Adverse Event|191
1031819|NCT00174785|3361503|P1|Overall Study|Adverse Event|293
1031820|NCT00174460|3361519|P2|Overall Study|Withdrawal by Subject|1
1031821|NCT00174460|3361520|P1|Overall Study|Withdrawal by Subject|0
1031822|NCT00174447|3361566|P1|Overall Study|Administrative reason/Other|2
1031823|NCT00174447|3361566|P1|Overall Study|Lack of Efficacy|1
1031824|NCT00174447|3361566|P1|Overall Study|Protocol Violation|1
1031825|NCT00174447|3361566|P1|Overall Study|Withdrawal by Subject|15
1031826|NCT00174447|3361566|P1|Overall Study|Adverse Event|19
1031827|NCT00174382|3361575|P1|Overall Study|Lost to Follow-up|1
1031828|NCT00174382|3361575|P1|Overall Study|Subject felt pill not effective enough|1
1031829|NCT00174382|3361575|P1|Overall Study|Arrived early for last visit in error|1
1031830|NCT00174382|3361575|P1|Overall Study|Protocol Violation|3
1031831|NCT00174382|3361575|P1|Overall Study|Withdrawal by Subject|6
1031832|NCT00174382|3361575|P1|Overall Study|Adverse Event|19
1031833|NCT00174382|3361575|P1|Overall Study|Death|2
1031834|NCT00174291|3361594|P2|Overall Study|Withdrawal by Subject|3
1031835|NCT00174291|3361595|P1|Overall Study|Withdrawal by Subject|3
1031836|NCT00174291|3361594|P2|Overall Study|Study terminated by sponsor|0
1031837|NCT00174291|3361595|P1|Overall Study|Study terminated by sponsor|1
1031838|NCT00174291|3361594|P2|Overall Study|Protocol Violation|2
1031839|NCT00174291|3361595|P1|Overall Study|Protocol Violation|0
1031840|NCT00174291|3361594|P2|Overall Study|Lost to Follow-up|1
1031841|NCT00174291|3361595|P1|Overall Study|Lost to Follow-up|1
1031842|NCT00174265|3361625|P2|Overall Study|Other (Not specified)|10
1031843|NCT00174265|3361626|P1|Overall Study|Other (Not specified)|16
1031844|NCT00174265|3361625|P2|Overall Study|Lost to Follow-up|0
1031845|NCT00174265|3361626|P1|Overall Study|Lost to Follow-up|1
1031846|NCT00174265|3361625|P2|Overall Study|Withdrawal by Subject|5
1031847|NCT00174265|3361626|P1|Overall Study|Withdrawal by Subject|3
1031848|NCT00174265|3361625|P2|Overall Study|Lack of Efficacy|2
1031849|NCT00174265|3361626|P1|Overall Study|Lack of Efficacy|2
1031850|NCT00174265|3361625|P2|Overall Study|Adverse Event|4
1031851|NCT00174265|3361626|P1|Overall Study|Adverse Event|7
1031852|NCT00174252|3361634|P1|Overall Study|Protocol Violation|2
1031853|NCT00174187|3361669|P3|Period 2 (After 3 Years)|Other|5
1031854|NCT00174187|3361670|P2|Period 2 (After 3 Years)|Other|0
1031855|NCT00174187|3361671|P1|Period 2 (After 3 Years)|Other|0
1031856|NCT00174187|3361669|P3|Period 2 (After 3 Years)|Withdrawal by Subject|1
1031857|NCT00174187|3361670|P2|Period 2 (After 3 Years)|Withdrawal by Subject|0
1031858|NCT00174187|3361671|P1|Period 2 (After 3 Years)|Withdrawal by Subject|0
1031859|NCT00174187|3361669|P3|Period 2 (After 3 Years)|Lost to Follow-up|2
1031860|NCT00174187|3361670|P2|Period 2 (After 3 Years)|Lost to Follow-up|0
1031861|NCT00174187|3361671|P1|Period 2 (After 3 Years)|Lost to Follow-up|0
1031862|NCT00174187|3361669|P3|Between Period 1 and Period 2|Consented, not assigned to treatment|3
1031863|NCT00174187|3361670|P2|Between Period 1 and Period 2|Consented, not assigned to treatment|0
1031864|NCT00174187|3361671|P1|Between Period 1 and Period 2|Consented, not assigned to treatment|0
1031865|NCT00174187|3361669|P3|Between Period 1 and Period 2|Did not consent to continue treatment|2
1031866|NCT00174187|3361670|P2|Between Period 1 and Period 2|Did not consent to continue treatment|0
1031867|NCT00174187|3361671|P1|Between Period 1 and Period 2|Did not consent to continue treatment|0
1031868|NCT00174187|3361669|P3|Period 1 (up to 3 Years)|Other|0
1031869|NCT00174187|3361670|P2|Period 1 (up to 3 Years)|Other|1
1031870|NCT00174187|3361671|P1|Period 1 (up to 3 Years)|Other|0
1031871|NCT00174187|3361669|P3|Period 1 (up to 3 Years)|Withdrawal by Subject|0
1031872|NCT00174187|3361670|P2|Period 1 (up to 3 Years)|Withdrawal by Subject|1
1031873|NCT00174187|3361671|P1|Period 1 (up to 3 Years)|Withdrawal by Subject|0
1031874|NCT00174187|3361669|P3|Period 1 (up to 3 Years)|Non compliance|0
1031875|NCT00174187|3361670|P2|Period 1 (up to 3 Years)|Non compliance|1
1031876|NCT00174187|3361671|P1|Period 1 (up to 3 Years)|Non compliance|0
1031877|NCT00174187|3361669|P3|Period 1 (up to 3 Years)|Serious adverse event|0
1031878|NCT00174187|3361670|P2|Period 1 (up to 3 Years)|Serious adverse event|1
1031879|NCT00174187|3361671|P1|Period 1 (up to 3 Years)|Serious adverse event|0
1031880|NCT00172185|3361736|P4|Overall Study|Withdrawal by Subject|0
1031881|NCT00172185|3361737|P3|Overall Study|Withdrawal by Subject|1
1031882|NCT00172185|3361738|P2|Overall Study|Withdrawal by Subject|0
1031883|NCT00172185|3361739|P1|Overall Study|Withdrawal by Subject|0
1031884|NCT00172185|3361736|P4|Overall Study|SPONSOR Decision|0
1031885|NCT00172185|3361737|P3|Overall Study|SPONSOR Decision|0
1031886|NCT00172185|3361738|P2|Overall Study|SPONSOR Decision|1
1031887|NCT00172185|3361739|P1|Overall Study|SPONSOR Decision|0
1031888|NCT00172185|3361736|P4|Overall Study|Physician Decision|0
1031889|NCT00172185|3361737|P3|Overall Study|Physician Decision|1
1031890|NCT00172185|3361738|P2|Overall Study|Physician Decision|0
1031891|NCT00172185|3361739|P1|Overall Study|Physician Decision|0
1031892|NCT00172185|3361736|P4|Overall Study|Adverse Event|4
1031893|NCT00172185|3361737|P3|Overall Study|Adverse Event|3
1031894|NCT00172185|3361738|P2|Overall Study|Adverse Event|1
1031895|NCT00172185|3361739|P1|Overall Study|Adverse Event|0
1031896|NCT00172042|3361755|P2|Overall Study|Death|42
1031897|NCT00172042|3361756|P1|Overall Study|Death|42
1031898|NCT00172042|3361755|P2|Overall Study|Administrative problems|10
1031899|NCT00172042|3361756|P1|Overall Study|Administrative problems|13
1031900|NCT00172042|3361755|P2|Overall Study|Lost to Follow-up|5
1031901|NCT00172042|3361756|P1|Overall Study|Lost to Follow-up|3
1031902|NCT00172042|3361755|P2|Overall Study|Withdrawal by Subject|25
1031903|NCT00172042|3361756|P1|Overall Study|Withdrawal by Subject|37
1031904|NCT00172042|3361755|P2|Overall Study|Protocol Violation|7
1031905|NCT00172042|3361756|P1|Overall Study|Protocol Violation|8
1031906|NCT00172042|3361755|P2|Overall Study|Patient no longer requires study drug|8
1031907|NCT00172042|3361756|P1|Overall Study|Patient no longer requires study drug|10
1031908|NCT00172042|3361755|P2|Overall Study|Unsatisfactory therapeutic effect|11
1031909|NCT00172042|3361756|P1|Overall Study|Unsatisfactory therapeutic effect|13
1031910|NCT00172042|3361755|P2|Overall Study|Abnormal test procedure(s)|3
1031911|NCT00172042|3361756|P1|Overall Study|Abnormal test procedure(s)|0
1031912|NCT00172042|3361755|P2|Overall Study|Abnormal laboratory value(s)|1
1031913|NCT00172042|3361756|P1|Overall Study|Abnormal laboratory value(s)|5
1031914|NCT00172042|3361755|P2|Overall Study|Adverse Event|13
1031915|NCT00172042|3361756|P1|Overall Study|Adverse Event|27
1031916|NCT00171925|3361778|P2|Overall Study|Death|2
1031917|NCT00171925|3361779|P1|Overall Study|Death|1
1031918|NCT00171925|3361778|P2|Overall Study|Administrative problems|11
1031919|NCT00171925|3361779|P1|Overall Study|Administrative problems|10
1031920|NCT00171925|3361778|P2|Overall Study|Lost to Follow-up|2
1031921|NCT00171925|3361779|P1|Overall Study|Lost to Follow-up|2
1031922|NCT00171925|3361778|P2|Overall Study|Withdrawal by Subject|9
1031923|NCT00171925|3361779|P1|Overall Study|Withdrawal by Subject|6
1031924|NCT00171925|3361778|P2|Overall Study|Protocol Violation|1
1031925|NCT00171925|3361779|P1|Overall Study|Protocol Violation|1
1031926|NCT00171925|3361778|P2|Overall Study|Adverse Event|6
1031927|NCT00171925|3361779|P1|Overall Study|Adverse Event|10
1031928|NCT00171873|3361791|P2|Overall Study|Switched to Octreotide|1
1031929|NCT00171873|3361792|P1|Overall Study|Switched to Octreotide|0
1031930|NCT00171873|3361791|P2|Overall Study|Adverse Event|0
1031931|NCT00171873|3361792|P1|Overall Study|Adverse Event|5
1031932|NCT00171873|3361791|P2|Overall Study|Withdrawal by Subject|2
1031933|NCT00171873|3361792|P1|Overall Study|Withdrawal by Subject|4
1031934|NCT00171834|3361805|P7|Overall Study|Treatment Duration Completed|0
1031935|NCT00171834|3361806|P6|Overall Study|Treatment Duration Completed|1
1031936|NCT00171834|3361807|P5|Overall Study|Treatment Duration Completed|2
1031937|NCT00171834|3361808|P4|Overall Study|Treatment Duration Completed|0
1031938|NCT00171834|3361809|P3|Overall Study|Treatment Duration Completed|1
1031939|NCT00171834|3361810|P2|Overall Study|Treatment Duration Completed|0
1031940|NCT00171834|3361811|P1|Overall Study|Treatment Duration Completed|0
1031941|NCT00171834|3361805|P7|Overall Study|Disease Progression|3
1031942|NCT00171834|3361806|P6|Overall Study|Disease Progression|18
1031943|NCT00171834|3361807|P5|Overall Study|Disease Progression|2
1031944|NCT00171834|3361808|P4|Overall Study|Disease Progression|9
1031945|NCT00171834|3361809|P3|Overall Study|Disease Progression|8
1031946|NCT00171834|3361810|P2|Overall Study|Disease Progression|8
1031947|NCT00171834|3361811|P1|Overall Study|Disease Progression|4
1031948|NCT00171834|3361805|P7|Overall Study|Death from study indication|0
1031949|NCT00171834|3361806|P6|Overall Study|Death from study indication|0
1031950|NCT00171834|3361807|P5|Overall Study|Death from study indication|1
1031951|NCT00171834|3361808|P4|Overall Study|Death from study indication|0
1031952|NCT00171834|3361809|P3|Overall Study|Death from study indication|0
1031953|NCT00171834|3361810|P2|Overall Study|Death from study indication|1
1031954|NCT00171834|3361811|P1|Overall Study|Death from study indication|0
1031955|NCT00171834|3361805|P7|Overall Study|Withdrawal by Subject|0
1031956|NCT00171834|3361806|P6|Overall Study|Withdrawal by Subject|1
1031957|NCT00171834|3361807|P5|Overall Study|Withdrawal by Subject|1
1031958|NCT00171834|3361808|P4|Overall Study|Withdrawal by Subject|1
1031959|NCT00171834|3361809|P3|Overall Study|Withdrawal by Subject|0
1031960|NCT00171834|3361810|P2|Overall Study|Withdrawal by Subject|2
1031961|NCT00171834|3361811|P1|Overall Study|Withdrawal by Subject|0
1031962|NCT00171834|3361805|P7|Overall Study|Adverse Event|1
1031963|NCT00171834|3361806|P6|Overall Study|Adverse Event|15
1031964|NCT00171834|3361807|P5|Overall Study|Adverse Event|2
1031965|NCT00171834|3361808|P4|Overall Study|Adverse Event|2
1031966|NCT00171834|3361809|P3|Overall Study|Adverse Event|3
1031967|NCT00171834|3361810|P2|Overall Study|Adverse Event|1
1031968|NCT00171834|3361811|P1|Overall Study|Adverse Event|2
1031969|NCT00171704|3361851|P2|Overall Study|Protocol Violation|1
1031970|NCT00171704|3361852|P1|Overall Study|Protocol Violation|0
1031971|NCT00171704|3361851|P2|Overall Study|Withdrawal by Subject|3
1031972|NCT00171704|3361852|P1|Overall Study|Withdrawal by Subject|1
1031973|NCT00171704|3361851|P2|Overall Study|Death|2
1031974|NCT00171704|3361852|P1|Overall Study|Death|2
1031975|NCT00171704|3361851|P2|Overall Study|Administrative Problems|1
1031976|NCT00171704|3361852|P1|Overall Study|Administrative Problems|2
1031977|NCT00171704|3361851|P2|Overall Study|New therapy for 2nd non-breast prim canc|0
1031978|NCT00171704|3361852|P1|Overall Study|New therapy for 2nd non-breast prim canc|1
1031979|NCT00171704|3361851|P2|Overall Study|Disease Progression|9
1031980|NCT00171704|3361852|P1|Overall Study|Disease Progression|14
1031981|NCT00171704|3361851|P2|Overall Study|Adverse Event|33
1031982|NCT00171704|3361852|P1|Overall Study|Adverse Event|24
1031983|NCT00171340|3361874|P2|Overall Study|Death|6
1031984|NCT00171340|3361875|P1|Overall Study|Death|6
1031985|NCT00171340|3361874|P2|Overall Study|Administrative Problems|2
1031986|NCT00171340|3361875|P1|Overall Study|Administrative Problems|5
1031987|NCT00171340|3361874|P2|Overall Study|No Longer Required Study Drug|1
1031988|NCT00171340|3361875|P1|Overall Study|No Longer Required Study Drug|1
1031989|NCT00171340|3361874|P2|Overall Study|Abnormal Test Procedure Results|11
1031990|NCT00171340|3361875|P1|Overall Study|Abnormal Test Procedure Results|6
1031991|NCT00171340|3361874|P2|Overall Study|Abnormal Laboratory Results|0
1031992|NCT00171340|3361875|P1|Overall Study|Abnormal Laboratory Results|2
1031993|NCT00171340|3361874|P2|Overall Study|Lost to Follow-up|5
1031994|NCT00171340|3361875|P1|Overall Study|Lost to Follow-up|0
1031995|NCT00171340|3361874|P2|Overall Study|Withdrawal by Subject|19
1031996|NCT00171340|3361875|P1|Overall Study|Withdrawal by Subject|22
1031997|NCT00171340|3361874|P2|Overall Study|Protocol Violation|8
1031998|NCT00171340|3361875|P1|Overall Study|Protocol Violation|7
1031999|NCT00171340|3361874|P2|Overall Study|Lack of Efficacy|41
1032000|NCT00171340|3361875|P1|Overall Study|Lack of Efficacy|29
1032001|NCT00171340|3361874|P2|Overall Study|Adverse Event|42
1032002|NCT00171340|3361875|P1|Overall Study|Adverse Event|46
1032003|NCT00171314|3361891|P2|Overall Study|Death|1
1032004|NCT00171314|3361892|P1|Overall Study|Death|2
1032005|NCT00171314|3361891|P2|Overall Study|Lost to Follow-up|3
1032006|NCT00171314|3361892|P1|Overall Study|Lost to Follow-up|1
1032007|NCT00171314|3361891|P2|Overall Study|Administrative Problems|3
1032008|NCT00171314|3361892|P1|Overall Study|Administrative Problems|4
1032009|NCT00171314|3361891|P2|Overall Study|Protocol Violation|7
1032010|NCT00171314|3361892|P1|Overall Study|Protocol Violation|3
1032011|NCT00171314|3361891|P2|Overall Study|Abnormal Test Procedure Results|3
1032012|NCT00171314|3361892|P1|Overall Study|Abnormal Test Procedure Results|9
1032013|NCT00171314|3361891|P2|Overall Study|Withdrawal by Subject|6
1032014|NCT00171314|3361892|P1|Overall Study|Withdrawal by Subject|9
1032015|NCT00171314|3361891|P2|Overall Study|Lack of Efficacy|14
1032016|NCT00171314|3361892|P1|Overall Study|Lack of Efficacy|19
1032017|NCT00171314|3361891|P2|Overall Study|Adverse Event|41
1032018|NCT00171314|3361892|P1|Overall Study|Adverse Event|44
1032019|NCT00171301|3361908|P2|Overall Study|Withdrawal by Subject|1
1032020|NCT00171301|3361909|P1|Overall Study|Withdrawal by Subject|0
1032021|NCT00171301|3361908|P2|Overall Study|Protocol Violation|2
1032022|NCT00171301|3361909|P1|Overall Study|Protocol Violation|0
1032023|NCT00171301|3361908|P2|Overall Study|Lost to Follow-up|2
1032024|NCT00171301|3361909|P1|Overall Study|Lost to Follow-up|6
1032025|NCT00171301|3361908|P2|Overall Study|Adverse Event|2
1032026|NCT00171301|3361909|P1|Overall Study|Adverse Event|1
1032027|NCT00171301|3361908|P2|Overall Study|Death|2
1032028|NCT00171301|3361909|P1|Overall Study|Death|1
1032029|NCT00171210|3361922|P2|Overall Study|Stopped at end of extension 1|1
1032030|NCT00171210|3361923|P1|Overall Study|Stopped at end of extension 1|0
1032031|NCT00171210|3361922|P2|Overall Study|Stopped at end of core|32
1032032|NCT00171210|3361923|P1|Overall Study|Stopped at end of core|0
1032033|NCT00171210|3361922|P2|Overall Study|Death|3
1032034|NCT00171210|3361923|P1|Overall Study|Death|2
1032035|NCT00171210|3361922|P2|Overall Study|Administrative problems|1
1032036|NCT00171210|3361923|P1|Overall Study|Administrative problems|1
1032037|NCT00171210|3361922|P2|Overall Study|Lost to Follow-up|0
1032038|NCT00171210|3361923|P1|Overall Study|Lost to Follow-up|1
1032039|NCT00171210|3361922|P2|Overall Study|Withdrawal by Subject|30
1032040|NCT00171210|3361923|P1|Overall Study|Withdrawal by Subject|32
1032041|NCT00171210|3361922|P2|Overall Study|Protocol Violation|2
1032042|NCT00171210|3361923|P1|Overall Study|Protocol Violation|0
1032043|NCT00171210|3361922|P2|Overall Study|Unsatisfactory therapeutic effect|15
1032044|NCT00171210|3361923|P1|Overall Study|Unsatisfactory therapeutic effect|11
1032045|NCT00171210|3361922|P2|Overall Study|Abnormal test procedure result(s)|1
1032046|NCT00171210|3361923|P1|Overall Study|Abnormal test procedure result(s)|0
1032047|NCT00171210|3361922|P2|Overall Study|Abnormal laboratory value(s)|3
1032048|NCT00171210|3361923|P1|Overall Study|Abnormal laboratory value(s)|6
1032049|NCT00171210|3361922|P2|Overall Study|Adverse Event|27
1032050|NCT00171210|3361923|P1|Overall Study|Adverse Event|16
1032051|NCT00171054|3361953|P2|Overall Study|Condition no longer required study drug|1
1032052|NCT00171054|3361954|P1|Overall Study|Condition no longer required study drug|0
1032053|NCT00171054|3361953|P2|Overall Study|Adverse Event|8
1032054|NCT00171054|3361954|P1|Overall Study|Adverse Event|8
1032055|NCT00171054|3361953|P2|Overall Study|Lost to Follow-up|1
1032056|NCT00171054|3361954|P1|Overall Study|Lost to Follow-up|0
1032057|NCT00171054|3361953|P2|Overall Study|Patient withdrew consent|0
1032058|NCT00171054|3361954|P1|Overall Study|Patient withdrew consent|1
1032059|NCT00171054|3361953|P2|Overall Study|Protocol Violation|2
1032060|NCT00171054|3361954|P1|Overall Study|Protocol Violation|1
1032061|NCT00170950|3361986|P2|Overall Study|Termination Data Not Recorded|22
1032062|NCT00170950|3361987|P1|Overall Study|Termination Data Not Recorded|17
1032063|NCT00170950|3361986|P2|Overall Study|Missing|1
1032064|NCT00170950|3361987|P1|Overall Study|Missing|2
1032065|NCT00170950|3361986|P2|Overall Study|Lost to Follow-up|115
1032066|NCT00170950|3361987|P1|Overall Study|Lost to Follow-up|134
1032067|NCT00170950|3361986|P2|Overall Study|Withdrawal by Subject|498
1032068|NCT00170950|3361987|P1|Overall Study|Withdrawal by Subject|496
1032069|NCT00170950|3361986|P2|Overall Study|Death|274
1032070|NCT00170950|3361987|P1|Overall Study|Death|236
1032071|NCT00170846|3362000|P3|Overall Study|Reason Missing|0
1032072|NCT00170846|3362001|P2|Overall Study|Reason Missing|1
1032073|NCT00170846|3362002|P1|Overall Study|Reason Missing|0
1032074|NCT00170846|3362000|P3|Overall Study|Death|3
1032075|NCT00170846|3362001|P2|Overall Study|Death|3
1032076|NCT00170846|3362002|P1|Overall Study|Death|0
1032077|NCT00170846|3362000|P3|Overall Study|Lost to Follow-up|2
1032078|NCT00170846|3362001|P2|Overall Study|Lost to Follow-up|3
1032079|NCT00170846|3362002|P1|Overall Study|Lost to Follow-up|6
1032080|NCT00170846|3362000|P3|Overall Study|Subject withdrew Informed Consent|8
1032081|NCT00170846|3362001|P2|Overall Study|Subject withdrew Informed Consent|12
1032082|NCT00170846|3362002|P1|Overall Study|Subject withdrew Informed Consent|5
1032083|NCT00169442|3362034|P6|Overall Study|Lost to follow-up (compl. vaccination)|0
1032084|NCT00169442|3362035|P5|Overall Study|Lost to follow-up (compl. vaccination)|0
1032085|NCT00169442|3362036|P4|Overall Study|Lost to follow-up (compl. vaccination)|0
1032086|NCT00169442|3362037|P3|Overall Study|Lost to follow-up (compl. vaccination)|0
1032087|NCT00169442|3362038|P2|Overall Study|Lost to follow-up (compl. vaccination)|1
1032088|NCT00169442|3362039|P1|Overall Study|Lost to follow-up (compl. vaccination)|0
1032089|NCT00169442|3362034|P6|Overall Study|Lost to follow-up (incompl. vaccination)|0
1032090|NCT00169442|3362035|P5|Overall Study|Lost to follow-up (incompl. vaccination)|1
1032091|NCT00169442|3362036|P4|Overall Study|Lost to follow-up (incompl. vaccination)|0
1032092|NCT00169442|3362037|P3|Overall Study|Lost to follow-up (incompl. vaccination)|0
1032093|NCT00169442|3362038|P2|Overall Study|Lost to follow-up (incompl. vaccination)|0
1032094|NCT00169442|3362039|P1|Overall Study|Lost to follow-up (incompl. vaccination)|0
1032095|NCT00169442|3362034|P6|Overall Study|Migrated/moved from study area|2
1032096|NCT00169442|3362035|P5|Overall Study|Migrated/moved from study area|0
1032097|NCT00169442|3362036|P4|Overall Study|Migrated/moved from study area|0
1032098|NCT00169442|3362037|P3|Overall Study|Migrated/moved from study area|0
1032099|NCT00169442|3362038|P2|Overall Study|Migrated/moved from study area|0
1032100|NCT00169442|3362039|P1|Overall Study|Migrated/moved from study area|0
1032101|NCT00169442|3362034|P6|Overall Study|Withdrawal by Subject|0
1032102|NCT00169442|3362035|P5|Overall Study|Withdrawal by Subject|0
1032103|NCT00169442|3362036|P4|Overall Study|Withdrawal by Subject|0
1032104|NCT00169442|3362037|P3|Overall Study|Withdrawal by Subject|1
1032105|NCT00169442|3362038|P2|Overall Study|Withdrawal by Subject|0
1032106|NCT00169442|3362039|P1|Overall Study|Withdrawal by Subject|0
1032107|NCT00169104|3362148|P2|Overall Study|Physician Decision|1
1032108|NCT00169104|3362149|P1|Overall Study|Physician Decision|0
1032109|NCT00169104|3362148|P2|Overall Study|Protocol Violation|1
1032110|NCT00169104|3362149|P1|Overall Study|Protocol Violation|0
1032111|NCT00169104|3362148|P2|Overall Study|Withdrawal by Subject|0
1032112|NCT00169104|3362149|P1|Overall Study|Withdrawal by Subject|2
1032113|NCT00168844|3362163|P3|Overall Study|Other|9
1032114|NCT00168844|3362164|P2|Overall Study|Other|7
1032115|NCT00168844|3362165|P1|Overall Study|Other|6
1032116|NCT00168844|3362163|P3|Overall Study|Protocol Violation|4
1032117|NCT00168844|3362164|P2|Overall Study|Protocol Violation|2
1032118|NCT00168844|3362165|P1|Overall Study|Protocol Violation|2
1032119|NCT00168844|3362163|P3|Overall Study|Withdrawal by Subject|19
1032120|NCT00168844|3362164|P2|Overall Study|Withdrawal by Subject|9
1032121|NCT00168844|3362165|P1|Overall Study|Withdrawal by Subject|12
1032122|NCT00168844|3362163|P3|Overall Study|Lost to Follow-up|11
1032123|NCT00168844|3362164|P2|Overall Study|Lost to Follow-up|5
1032124|NCT00168844|3362165|P1|Overall Study|Lost to Follow-up|4
1032125|NCT00168844|3362163|P3|Overall Study|Adverse Event|48
1032126|NCT00168844|3362164|P2|Overall Study|Adverse Event|32
1032127|NCT00168844|3362165|P1|Overall Study|Adverse Event|31
1032128|NCT00168831|3362347|P3|Overall Study|Other|6
1032129|NCT00168831|3362348|P2|Overall Study|Other|3
1032130|NCT00168831|3362349|P1|Overall Study|Other|6
1032131|NCT00168831|3362347|P3|Overall Study|Protocol Violation|11
1032132|NCT00168831|3362348|P2|Overall Study|Protocol Violation|11
1032133|NCT00168831|3362349|P1|Overall Study|Protocol Violation|6
1032134|NCT00168831|3362347|P3|Overall Study|Withdrawal by Subject|19
1032135|NCT00168831|3362348|P2|Overall Study|Withdrawal by Subject|14
1032136|NCT00168831|3362349|P1|Overall Study|Withdrawal by Subject|7
1032137|NCT00168831|3362347|P3|Overall Study|Lost to Follow-up|4
1032138|NCT00168831|3362348|P2|Overall Study|Lost to Follow-up|6
1032139|NCT00168831|3362349|P1|Overall Study|Lost to Follow-up|5
1032140|NCT00168831|3362347|P3|Overall Study|Adverse Event|74
1032141|NCT00168831|3362348|P2|Overall Study|Adverse Event|47
1032142|NCT00168831|3362349|P1|Overall Study|Adverse Event|36
1032143|NCT00168818|3362531|P3|Treatment|not specified|31
1032144|NCT00168818|3362532|P2|Treatment|not specified|29
1032145|NCT00168818|3362533|P1|Treatment|not specified|23
1032146|NCT00168818|3362531|P3|Treatment|Withdrawal by Subject|22
1032147|NCT00168818|3362532|P2|Treatment|Withdrawal by Subject|20
1032148|NCT00168818|3362533|P1|Treatment|Withdrawal by Subject|25
1032149|NCT00168818|3362531|P3|Treatment|Lost to Follow-up|1
1032150|NCT00168818|3362532|P2|Treatment|Lost to Follow-up|2
1032151|NCT00168818|3362533|P1|Treatment|Lost to Follow-up|0
1032152|NCT00168818|3362531|P3|Treatment|Protocol Violation|11
1032153|NCT00168818|3362532|P2|Treatment|Protocol Violation|11
1032154|NCT00168818|3362533|P1|Treatment|Protocol Violation|8
1032155|NCT00168818|3362531|P3|Treatment|Adverse Event|68
1032156|NCT00168818|3362532|P2|Treatment|Adverse Event|89
1032157|NCT00168818|3362533|P1|Treatment|Adverse Event|77
1032158|NCT00168818|3362531|P3|Overall Study|not specified|30
1032159|NCT00168818|3362532|P2|Overall Study|not specified|24
1032160|NCT00168818|3362533|P1|Overall Study|not specified|22
1032161|NCT00168818|3362531|P3|Overall Study|Withdrawal by Subject|37
1032162|NCT00168818|3362532|P2|Overall Study|Withdrawal by Subject|41
1032163|NCT00168818|3362533|P1|Overall Study|Withdrawal by Subject|43
1032164|NCT00168818|3362531|P3|Overall Study|Lost to Follow-up|15
1032165|NCT00168818|3362532|P2|Overall Study|Lost to Follow-up|4
1032166|NCT00168818|3362533|P1|Overall Study|Lost to Follow-up|13
1032167|NCT00168818|3362531|P3|Overall Study|Protocol Violation|11
1032168|NCT00168818|3362532|P2|Overall Study|Protocol Violation|11
1032169|NCT00168818|3362533|P1|Overall Study|Protocol Violation|16
1032170|NCT00168818|3362531|P3|Overall Study|Adverse Event|31
1032171|NCT00168818|3362532|P2|Overall Study|Adverse Event|29
1032172|NCT00168818|3362533|P1|Overall Study|Adverse Event|23
1032173|NCT00168805|3362577|P3|Treatment|not specified|17
1032174|NCT00168805|3362578|P2|Treatment|not specified|18
1032175|NCT00168805|3362579|P1|Treatment|not specified|18
1032176|NCT00168805|3362577|P3|Treatment|Withdrawal by Subject|8
1032177|NCT00168805|3362578|P2|Treatment|Withdrawal by Subject|7
1032178|NCT00168805|3362579|P1|Treatment|Withdrawal by Subject|3
1032179|NCT00168805|3362577|P3|Treatment|Protocol Violation|5
1032180|NCT00168805|3362578|P2|Treatment|Protocol Violation|5
1032181|NCT00168805|3362579|P1|Treatment|Protocol Violation|3
1032182|NCT00168805|3362577|P3|Treatment|Adverse Event|32
1032183|NCT00168805|3362578|P2|Treatment|Adverse Event|26
1032184|NCT00168805|3362579|P1|Treatment|Adverse Event|25
1032185|NCT00168805|3362577|P3|Overall Study|not specified|22
1032186|NCT00168805|3362578|P2|Overall Study|not specified|21
1032187|NCT00168805|3362579|P1|Overall Study|not specified|24
1032188|NCT00168805|3362577|P3|Overall Study|Withdrawal by Subject|21
1032189|NCT00168805|3362578|P2|Overall Study|Withdrawal by Subject|18
1032190|NCT00168805|3362579|P1|Overall Study|Withdrawal by Subject|16
1032191|NCT00168805|3362577|P3|Overall Study|Lost to Follow-up|11
1032192|NCT00168805|3362578|P2|Overall Study|Lost to Follow-up|17
1032193|NCT00168805|3362579|P1|Overall Study|Lost to Follow-up|12
1032194|NCT00168805|3362577|P3|Overall Study|Protocol Violation|8
1032195|NCT00168805|3362578|P2|Overall Study|Protocol Violation|11
1032196|NCT00168805|3362579|P1|Overall Study|Protocol Violation|12
1032197|NCT00168805|3362577|P3|Overall Study|Adverse Event|16
1032198|NCT00168805|3362578|P2|Overall Study|Adverse Event|11
1032199|NCT00168805|3362579|P1|Overall Study|Adverse Event|7
1032200|NCT00168103|3362815|P4|Overall Study|Lost to Follow-up|0
1032201|NCT00168103|3362816|P3|Overall Study|Lost to Follow-up|0
1032202|NCT00168103|3362817|P2|Overall Study|Lost to Follow-up|3
1032203|NCT00168103|3362818|P1|Overall Study|Lost to Follow-up|1
1032204|NCT00168103|3362815|P4|Overall Study|Withdrawal by Subject|0
1032205|NCT00168103|3362816|P3|Overall Study|Withdrawal by Subject|1
1032206|NCT00168103|3362817|P2|Overall Study|Withdrawal by Subject|2
1032207|NCT00168103|3362818|P1|Overall Study|Withdrawal by Subject|1
1032208|NCT00168064|3362840|P2|Overall Study|Various|3
1032209|NCT00168064|3362841|P1|Overall Study|Various|4
1032210|NCT00168064|3362840|P2|Overall Study|Subject's Best interest|2
1032211|NCT00168064|3362841|P1|Overall Study|Subject's Best interest|2
1032212|NCT00168064|3362840|P2|Overall Study|Concurrent Illness|3
1032213|NCT00168064|3362841|P1|Overall Study|Concurrent Illness|4
1032214|NCT00168064|3362840|P2|Overall Study|Non-compliance|3
1032215|NCT00168064|3362841|P1|Overall Study|Non-compliance|2
1032216|NCT00168064|3362840|P2|Overall Study|Lost to Follow-up|3
1032217|NCT00168064|3362841|P1|Overall Study|Lost to Follow-up|4
1032218|NCT00168064|3362840|P2|Overall Study|Lack of Efficacy|4
1032219|NCT00168064|3362841|P1|Overall Study|Lack of Efficacy|4
1032220|NCT00168064|3362840|P2|Overall Study|Withdrawal by Subject|4
1032221|NCT00168064|3362841|P1|Overall Study|Withdrawal by Subject|3
1032222|NCT00168064|3362840|P2|Overall Study|Adverse Event|22
1032223|NCT00168064|3362841|P1|Overall Study|Adverse Event|26
1032224|NCT00168038|3362849|P1|Overall Study|Therapy failure|1
1032225|NCT00168038|3362849|P1|Overall Study|Adverse Event|1
1032226|NCT00167778|3362861|P1|Overall Study|Withdrawal by Subject|1
1032227|NCT00167414|3362927|P1|Overall Study|Death|10
1032228|NCT00167310|3362952|P2|Overall Study|Withdrawal by Subject|7
1032229|NCT00167310|3362953|P1|Overall Study|Withdrawal by Subject|3
1032230|NCT00167310|3362952|P2|Overall Study|Protocol Violation|3
1032231|NCT00167310|3362953|P1|Overall Study|Protocol Violation|5
1032232|NCT00167245|3362963|P2|Overall Study|Drowsy|0
1032233|NCT00167245|3362964|P1|Overall Study|Drowsy|1
1032234|NCT00167245|3362963|P2|Overall Study|Incarcerated|2
1032235|NCT00167245|3362964|P1|Overall Study|Incarcerated|3
1032236|NCT00167245|3362963|P2|Overall Study|Withdrawal by Subject|8
1032237|NCT00167245|3362964|P1|Overall Study|Withdrawal by Subject|5
1032238|NCT00167245|3362963|P2|Overall Study|Lost to Follow-up|31
1032239|NCT00167245|3362964|P1|Overall Study|Lost to Follow-up|20
1032240|NCT00166712|3363014|P2|Overall Study|Physician Decision|2
1032241|NCT00166712|3363015|P1|Overall Study|Physician Decision|0
1032242|NCT00166712|3363014|P2|Overall Study|Withdrawal by Subject|2
1032243|NCT00166712|3363015|P1|Overall Study|Withdrawal by Subject|1
1032244|NCT00166712|3363014|P2|Overall Study|Adverse Event|0
1032245|NCT00166712|3363015|P1|Overall Study|Adverse Event|1
1032246|NCT00166712|3363014|P2|Overall Study|Death|1
1032247|NCT00166712|3363015|P1|Overall Study|Death|0
1032248|NCT00166517|3363032|P2|Overall Study|Withdrawal by Subject|1
1032249|NCT00166517|3363033|P1|Overall Study|Withdrawal by Subject|0
1032250|NCT00166517|3363032|P2|Overall Study|Protocol Violation|1
1032251|NCT00166517|3363033|P1|Overall Study|Protocol Violation|4
1032252|NCT00166517|3363032|P2|Overall Study|Lost to Follow-up|0
1032253|NCT00166517|3363033|P1|Overall Study|Lost to Follow-up|1
1032254|NCT00166504|3363043|P2|Overall Study|Withdrawal by Subject|0
1032255|NCT00166504|3363044|P1|Overall Study|Withdrawal by Subject|1
1032256|NCT00166504|3363043|P2|Overall Study|Lost to Follow-up|1
1032257|NCT00166504|3363044|P1|Overall Study|Lost to Follow-up|1
1032258|NCT00166504|3363043|P2|Overall Study|Adverse Event|3
1032259|NCT00166504|3363044|P1|Overall Study|Adverse Event|3
1032260|NCT00166296|3363061|P2|Overall Study|Lost to Follow-up|2
1032261|NCT00166296|3363062|P1|Overall Study|Lost to Follow-up|4
1032262|NCT00166296|3363061|P2|Overall Study|Adverse Event|4
1032263|NCT00166296|3363062|P1|Overall Study|Adverse Event|2
1032264|NCT00166296|3363061|P2|Overall Study|Withdrawal by Subject|3
1032265|NCT00166296|3363062|P1|Overall Study|Withdrawal by Subject|1
1032266|NCT00166114|3363114|P2|Overall Study|Adverse Event|1
1032267|NCT00166114|3363115|P1|Overall Study|Adverse Event|2
1032268|NCT00166114|3363114|P2|Overall Study|Withdrawal by Subject|4
1032269|NCT00166114|3363115|P1|Overall Study|Withdrawal by Subject|10
1032270|NCT00166114|3363114|P2|Overall Study|Protocol Violation|1
1032271|NCT00166114|3363115|P1|Overall Study|Protocol Violation|2
1032272|NCT00165984|3363132|P1|Overall Study|Death|15
1032273|NCT00165841|3363150|P2|Overall Study|Medication Noncompliance|1
1032274|NCT00165841|3363151|P1|Overall Study|Medication Noncompliance|1
1032275|NCT00165841|3363150|P2|Overall Study|Other|5
1032276|NCT00165841|3363151|P1|Overall Study|Other|3
1032277|NCT00165841|3363150|P2|Overall Study|Protocol Violation|8
1032278|NCT00165841|3363151|P1|Overall Study|Protocol Violation|6
1032279|NCT00165841|3363150|P2|Overall Study|Physician Decision|0
1032280|NCT00165841|3363151|P1|Overall Study|Physician Decision|1
1032281|NCT00165841|3363150|P2|Overall Study|Withdrawal by Subject|8
1032282|NCT00165841|3363151|P1|Overall Study|Withdrawal by Subject|7
1032283|NCT00165841|3363150|P2|Overall Study|Lost to Follow-up|4
1032284|NCT00165841|3363151|P1|Overall Study|Lost to Follow-up|4
1032285|NCT00165841|3363150|P2|Overall Study|Lack of Efficacy|33
1032286|NCT00165841|3363151|P1|Overall Study|Lack of Efficacy|6
1032287|NCT00165841|3363150|P2|Overall Study|Adverse Event|3
1032288|NCT00165841|3363151|P1|Overall Study|Adverse Event|2
1032289|NCT00165789|3363161|P4|Overall Study|Withdrawal by Subject|2
1032290|NCT00165789|3363162|P3|Overall Study|Withdrawal by Subject|1
1032291|NCT00165789|3363163|P2|Overall Study|Withdrawal by Subject|1
1032292|NCT00165789|3363164|P1|Overall Study|Withdrawal by Subject|0
1032293|NCT00165789|3363161|P4|Overall Study|Adverse Event|12
1032294|NCT00165789|3363162|P3|Overall Study|Adverse Event|0
1032295|NCT00165789|3363163|P2|Overall Study|Adverse Event|3
1032296|NCT00165789|3363164|P1|Overall Study|Adverse Event|0
1032297|NCT00165776|3363218|P4|Overall Study|Worsening of Cervical Dystonia|1
1032298|NCT00165776|3363219|P3|Overall Study|Worsening of Cervical Dystonia|0
1032299|NCT00165776|3363220|P2|Overall Study|Worsening of Cervical Dystonia|0
1032300|NCT00165776|3363221|P1|Overall Study|Worsening of Cervical Dystonia|0
1032301|NCT00165776|3363218|P4|Overall Study|Withdrawal by Subject|0
1032302|NCT00165776|3363219|P3|Overall Study|Withdrawal by Subject|2
1032303|NCT00165776|3363220|P2|Overall Study|Withdrawal by Subject|1
1032304|NCT00165776|3363221|P1|Overall Study|Withdrawal by Subject|4
1032305|NCT00165776|3363218|P4|Overall Study|Lack of Efficacy|1
1032306|NCT00165776|3363219|P3|Overall Study|Lack of Efficacy|0
1032307|NCT00165776|3363220|P2|Overall Study|Lack of Efficacy|0
1032308|NCT00165776|3363221|P1|Overall Study|Lack of Efficacy|0
1032309|NCT00165698|3363257|P2|Overall Study|Not Taken/Lost the medicine|2
1032310|NCT00165698|3363258|P1|Overall Study|Not Taken/Lost the medicine|1
1032311|NCT00165698|3363257|P2|Overall Study|Protocol Violation|0
1032312|NCT00165698|3363258|P1|Overall Study|Protocol Violation|1
1032313|NCT00165698|3363257|P2|Overall Study|Withdrawal by Subject|1
1032314|NCT00165698|3363258|P1|Overall Study|Withdrawal by Subject|2
1032315|NCT00165698|3363257|P2|Overall Study|Lost to Follow-up|2
1032316|NCT00165698|3363258|P1|Overall Study|Lost to Follow-up|2
1032317|NCT00165698|3363257|P2|Overall Study|Adverse Event|10
1032318|NCT00165698|3363258|P1|Overall Study|Adverse Event|2
1032319|NCT00165672|3363284|P2|Overall Study|Adverse Event|1
1032320|NCT00165672|3363285|P1|Overall Study|Adverse Event|0
1032321|NCT00165646|3363294|P3|Overall Study|Protocol Violation|0
1032322|NCT00165646|3363295|P2|Overall Study|Protocol Violation|0
1032323|NCT00165646|3363296|P1|Overall Study|Protocol Violation|1
1032324|NCT00165646|3363294|P3|Overall Study|Physician Decision|2
1032325|NCT00165646|3363295|P2|Overall Study|Physician Decision|0
1032326|NCT00165646|3363296|P1|Overall Study|Physician Decision|2
1032327|NCT00165646|3363294|P3|Overall Study|Withdrawal by Subject|1
1032328|NCT00165646|3363295|P2|Overall Study|Withdrawal by Subject|2
1032329|NCT00165646|3363296|P1|Overall Study|Withdrawal by Subject|0
1032330|NCT00165646|3363294|P3|Overall Study|Lack of Efficacy|0
1032331|NCT00165646|3363295|P2|Overall Study|Lack of Efficacy|2
1032332|NCT00165646|3363296|P1|Overall Study|Lack of Efficacy|1
1032333|NCT00165646|3363294|P3|Overall Study|Adverse Event|1
1032334|NCT00165646|3363295|P2|Overall Study|Adverse Event|1
1032335|NCT00165646|3363296|P1|Overall Study|Adverse Event|1
1032336|NCT00165503|3363304|P1|Overall Study|Unresectable|3
1032337|NCT00165503|3363304|P1|Overall Study|Lost to Follow-up|12
1032338|NCT00165503|3363304|P1|Overall Study|Death|1
1032339|NCT00163657|3363311|P3|Overall Study|Other reason|3
1032340|NCT00163657|3363312|P2|Overall Study|Other reason|1
1032341|NCT00163657|3363313|P1|Overall Study|Other reason|0
1032342|NCT00163657|3363311|P3|Overall Study|Lost to Follow-up|10
1032343|NCT00163657|3363312|P2|Overall Study|Lost to Follow-up|3
1032344|NCT00163657|3363313|P1|Overall Study|Lost to Follow-up|1
1032345|NCT00163657|3363311|P3|Overall Study|Non Compliance|0
1032346|NCT00163657|3363312|P2|Overall Study|Non Compliance|0
1032347|NCT00163657|3363313|P1|Overall Study|Non Compliance|1
1032348|NCT00163657|3363311|P3|Overall Study|Physician Decision|1
1032349|NCT00163657|3363312|P2|Overall Study|Physician Decision|1
1032350|NCT00163657|3363313|P1|Overall Study|Physician Decision|0
1032351|NCT00163657|3363311|P3|Overall Study|Withdrawal by Subject|2
1032352|NCT00163657|3363312|P2|Overall Study|Withdrawal by Subject|3
1032353|NCT00163657|3363313|P1|Overall Study|Withdrawal by Subject|2
1032354|NCT00163657|3363311|P3|Overall Study|graft loss|2
1032355|NCT00163657|3363312|P2|Overall Study|graft loss|1
1032356|NCT00163657|3363313|P1|Overall Study|graft loss|4
1032357|NCT00163657|3363311|P3|Overall Study|Death|19
1032358|NCT00163657|3363312|P2|Overall Study|Death|14
1032359|NCT00163657|3363313|P1|Overall Study|Death|12
1032360|NCT00163215|3363403|P1|Overall Study|Other|7
1032361|NCT00163215|3363403|P1|Overall Study|Withdrawal by Subject|5
1032362|NCT00163215|3363403|P1|Overall Study|Lack of Efficacy|3
1032363|NCT00163189|3363423|P1|Overall Study|Did not meet continuation criterion|16
1032364|NCT00163189|3363423|P1|Overall Study|Withdrawal by Subject|11
1032365|NCT00163189|3363423|P1|Overall Study|Study terminated by sponsor|11
1032366|NCT00163189|3363423|P1|Overall Study|Lack of Efficacy|7
1032367|NCT00163189|3363423|P1|Overall Study|Adverse Event|6
1032368|NCT00163189|3363423|P1|Overall Study|Death|3
1032369|NCT00163189|3363423|P1|Overall Study|Protocol Violation|2
1032370|NCT00163189|3363423|P1|Overall Study|Lost to Follow-up|1
1032371|NCT00163189|3363423|P1|Overall Study|Other|6
1032372|NCT00163020|3363447|P2|Overall Study|Lost to Follow-up|2
1032373|NCT00163020|3363448|P1|Overall Study|Lost to Follow-up|0
1032374|NCT00162981|3363488|P2|Overall Study|Physician Decision|0
1032375|NCT00162981|3363489|P1|Overall Study|Physician Decision|1
1032376|NCT00162981|3363488|P2|Overall Study|Withdrawal by Subject|1
1032377|NCT00162981|3363489|P1|Overall Study|Withdrawal by Subject|1
1032378|NCT00162981|3363488|P2|Overall Study|Adverse Event|5
1032379|NCT00162981|3363489|P1|Overall Study|Adverse Event|2
1032380|NCT00162942|3363505|P2|Overall Study|2 or more consecutive treatments missed|0
1032381|NCT00162942|3363506|P1|Overall Study|2 or more consecutive treatments missed|1
1032382|NCT00162942|3363505|P2|Overall Study|Flare During Active Treatment|3
1032383|NCT00162942|3363506|P1|Overall Study|Flare During Active Treatment|7
1032384|NCT00162942|3363505|P2|Overall Study|Lack of Efficacy|0
1032385|NCT00162942|3363506|P1|Overall Study|Lack of Efficacy|1
1032386|NCT00162942|3363505|P2|Overall Study|Alternate Therapy|2
1032387|NCT00162942|3363506|P1|Overall Study|Alternate Therapy|6
1032388|NCT00162942|3363505|P2|Overall Study|Enter Open-Label Study|35
1032389|NCT00162942|3363506|P1|Overall Study|Enter Open-Label Study|76
1032390|NCT00162942|3363505|P2|Overall Study|Physician Decision|0
1032391|NCT00162942|3363506|P1|Overall Study|Physician Decision|1
1032392|NCT00162942|3363505|P2|Overall Study|Withdrawal by Subject|6
1032393|NCT00162942|3363506|P1|Overall Study|Withdrawal by Subject|3
1032394|NCT00162942|3363505|P2|Overall Study|Death|0
1032395|NCT00162942|3363506|P1|Overall Study|Death|1
1032396|NCT00162942|3363505|P2|Overall Study|Adverse Event|6
1032397|NCT00162942|3363506|P1|Overall Study|Adverse Event|10
1032398|NCT00162773|3363554|P1|Overall Study|P.I, Left institution. Study terminated|22
1032399|NCT00162370|3363558|P1|Efficacy Population|Lost to Follow-up|51
1032400|NCT00162266|3363566|P4|Open-Label Period|Other Reasons|15
1032401|NCT00162266|3363567|P3|Open-Label Period|Other Reasons|0
1032402|NCT00162266|3363568|P2|Open-Label Period|Other Reasons|0
1032403|NCT00162266|3363569|P1|Open-Label Period|Other Reasons|0
1032404|NCT00162266|3363566|P4|Open-Label Period|Administrative Reason By Sponsor|9
1032405|NCT00162266|3363567|P3|Open-Label Period|Administrative Reason By Sponsor|0
1032406|NCT00162266|3363568|P2|Open-Label Period|Administrative Reason By Sponsor|0
1032407|NCT00162266|3363569|P1|Open-Label Period|Administrative Reason By Sponsor|0
1032408|NCT00162266|3363566|P4|Open-Label Period|Withdrawal by Subject|31
1032409|NCT00162266|3363567|P3|Open-Label Period|Withdrawal by Subject|0
1032410|NCT00162266|3363568|P2|Open-Label Period|Withdrawal by Subject|0
1032411|NCT00162266|3363569|P1|Open-Label Period|Withdrawal by Subject|0
1032412|NCT00162266|3363566|P4|Open-Label Period|Lost to Follow-up|3
1032413|NCT00162266|3363567|P3|Open-Label Period|Lost to Follow-up|0
1032414|NCT00162266|3363568|P2|Open-Label Period|Lost to Follow-up|0
1032415|NCT00162266|3363569|P1|Open-Label Period|Lost to Follow-up|0
1032416|NCT00162266|3363566|P4|Open-Label Period|Lack of Efficacy|26
1032417|NCT00162266|3363567|P3|Open-Label Period|Lack of Efficacy|0
1032418|NCT00162266|3363568|P2|Open-Label Period|Lack of Efficacy|0
1032419|NCT00162266|3363569|P1|Open-Label Period|Lack of Efficacy|0
1032420|NCT00162266|3363566|P4|Open-Label Period|Adverse Event|46
1032421|NCT00162266|3363567|P3|Open-Label Period|Adverse Event|0
1032422|NCT00162266|3363568|P2|Open-Label Period|Adverse Event|0
1032423|NCT00162266|3363569|P1|Open-Label Period|Adverse Event|0
1032424|NCT00162266|3363566|P4|Open-Label Period|Death|7
1032425|NCT00162266|3363567|P3|Open-Label Period|Death|0
1032426|NCT00162266|3363568|P2|Open-Label Period|Death|0
1032427|NCT00162266|3363569|P1|Open-Label Period|Death|0
1032428|NCT00162266|3363566|P4|Double-Blind Period|Withdrawal by Subject|0
1032429|NCT00162266|3363567|P3|Double-Blind Period|Withdrawal by Subject|6
1032430|NCT00162266|3363568|P2|Double-Blind Period|Withdrawal by Subject|2
1032431|NCT00162266|3363569|P1|Double-Blind Period|Withdrawal by Subject|5
1032432|NCT00162266|3363566|P4|Double-Blind Period|Lack of Efficacy|0
1032433|NCT00162266|3363567|P3|Double-Blind Period|Lack of Efficacy|30
1032434|NCT00162266|3363568|P2|Double-Blind Period|Lack of Efficacy|17
1032435|NCT00162266|3363569|P1|Double-Blind Period|Lack of Efficacy|13
1032436|NCT00162266|3363566|P4|Double-Blind Period|Other Reason|0
1032437|NCT00162266|3363567|P3|Double-Blind Period|Other Reason|1
1032438|NCT00162266|3363568|P2|Double-Blind Period|Other Reason|0
1032439|NCT00162266|3363569|P1|Double-Blind Period|Other Reason|1
1032440|NCT00162266|3363566|P4|Double-Blind Period|Lost to Follow-up|0
1032441|NCT00162266|3363567|P3|Double-Blind Period|Lost to Follow-up|0
1032442|NCT00162266|3363568|P2|Double-Blind Period|Lost to Follow-up|2
1032443|NCT00162266|3363569|P1|Double-Blind Period|Lost to Follow-up|1
1032444|NCT00162266|3363566|P4|Double-Blind Period|Death|0
1032445|NCT00162266|3363567|P3|Double-Blind Period|Death|0
1032446|NCT00162266|3363568|P2|Double-Blind Period|Death|1
1032447|NCT00162266|3363569|P1|Double-Blind Period|Death|0
1032448|NCT00162266|3363566|P4|Double-Blind Period|Adverse Event|0
1032449|NCT00162266|3363567|P3|Double-Blind Period|Adverse Event|11
1032450|NCT00162266|3363568|P2|Double-Blind Period|Adverse Event|9
1032451|NCT00162266|3363569|P1|Double-Blind Period|Adverse Event|5
1032452|NCT00162136|3363770|P1|Overall Study|Withdrawal by Subject|1
1032453|NCT00162136|3363770|P1|Overall Study|Study Drug Toxicity|4
1032454|NCT00162136|3363770|P1|Overall Study|Investigator Request|5
1032455|NCT00162136|3363770|P1|Overall Study|Disease Progression/Relapse|23
1032456|NCT00162136|3363770|P1|Overall Study|Death|1
1032457|NCT00162136|3363770|P1|Overall Study|Adverse Event|1
1032458|NCT00162123|3363802|P8|Overall Study|Follow-up only (not treated or assessed)|57
1032459|NCT00162123|3363803|P7|Overall Study|Follow-up only (not treated or assessed)|0
1032460|NCT00162123|3363804|P6|Overall Study|Follow-up only (not treated or assessed)|0
1032461|NCT00162123|3363805|P5|Overall Study|Follow-up only (not treated or assessed)|0
1032462|NCT00162123|3363806|P4|Overall Study|Follow-up only (not treated or assessed)|0
1032463|NCT00162123|3363807|P3|Overall Study|Follow-up only (not treated or assessed)|0
1032464|NCT00162123|3363808|P2|Overall Study|Follow-up only (not treated or assessed)|0
1032465|NCT00162123|3363809|P1|Overall Study|Follow-up only (not treated or assessed)|0
1032466|NCT00162123|3363802|P8|Overall Study|Tumor assessment only (not treated)|1
1032467|NCT00162123|3363803|P7|Overall Study|Tumor assessment only (not treated)|0
1032468|NCT00162123|3363804|P6|Overall Study|Tumor assessment only (not treated)|0
1032469|NCT00162123|3363805|P5|Overall Study|Tumor assessment only (not treated)|0
1032470|NCT00162123|3363806|P4|Overall Study|Tumor assessment only (not treated)|0
1032471|NCT00162123|3363807|P3|Overall Study|Tumor assessment only (not treated)|0
1032472|NCT00162123|3363808|P2|Overall Study|Tumor assessment only (not treated)|0
1032473|NCT00162123|3363809|P1|Overall Study|Tumor assessment only (not treated)|0
1032474|NCT00162123|3363802|P8|Overall Study|Physician Decision|0
1032475|NCT00162123|3363803|P7|Overall Study|Physician Decision|1
1032476|NCT00162123|3363804|P6|Overall Study|Physician Decision|1
1032477|NCT00162123|3363805|P5|Overall Study|Physician Decision|0
1032478|NCT00162123|3363806|P4|Overall Study|Physician Decision|0
1032479|NCT00162123|3363807|P3|Overall Study|Physician Decision|0
1032480|NCT00162123|3363808|P2|Overall Study|Physician Decision|2
1032481|NCT00162123|3363809|P1|Overall Study|Physician Decision|1
1032482|NCT00162123|3363802|P8|Overall Study|Not specified (after start of treatment)|0
1032483|NCT00162123|3363803|P7|Overall Study|Not specified (after start of treatment)|0
1032484|NCT00162123|3363804|P6|Overall Study|Not specified (after start of treatment)|0
1032485|NCT00162123|3363805|P5|Overall Study|Not specified (after start of treatment)|3
1032486|NCT00162123|3363806|P4|Overall Study|Not specified (after start of treatment)|0
1032487|NCT00162123|3363807|P3|Overall Study|Not specified (after start of treatment)|0
1032488|NCT00162123|3363808|P2|Overall Study|Not specified (after start of treatment)|0
1032489|NCT00162123|3363809|P1|Overall Study|Not specified (after start of treatment)|0
1032490|NCT00162123|3363802|P8|Overall Study|Not specified (before treatment)|0
1032491|NCT00162123|3363803|P7|Overall Study|Not specified (before treatment)|0
1032492|NCT00162123|3363804|P6|Overall Study|Not specified (before treatment)|1
1032493|NCT00162123|3363805|P5|Overall Study|Not specified (before treatment)|12
1032494|NCT00162123|3363806|P4|Overall Study|Not specified (before treatment)|0
1032495|NCT00162123|3363807|P3|Overall Study|Not specified (before treatment)|0
1032496|NCT00162123|3363808|P2|Overall Study|Not specified (before treatment)|0
1032497|NCT00162123|3363809|P1|Overall Study|Not specified (before treatment)|2
1032498|NCT00162123|3363802|P8|Overall Study|Adverse Event|0
1032499|NCT00162123|3363803|P7|Overall Study|Adverse Event|0
1032500|NCT00162123|3363804|P6|Overall Study|Adverse Event|0
1032501|NCT00162123|3363805|P5|Overall Study|Adverse Event|1
1032502|NCT00162123|3363806|P4|Overall Study|Adverse Event|2
1032503|NCT00162123|3363807|P3|Overall Study|Adverse Event|0
1032504|NCT00162123|3363808|P2|Overall Study|Adverse Event|2
1032505|NCT00162123|3363809|P1|Overall Study|Adverse Event|1
1032506|NCT00162123|3363802|P8|Overall Study|Deterioration without progression|0
1032507|NCT00162123|3363803|P7|Overall Study|Deterioration without progression|0
1032508|NCT00162123|3363804|P6|Overall Study|Deterioration without progression|0
1032509|NCT00162123|3363805|P5|Overall Study|Deterioration without progression|1
1032510|NCT00162123|3363806|P4|Overall Study|Deterioration without progression|0
1032511|NCT00162123|3363807|P3|Overall Study|Deterioration without progression|3
1032512|NCT00162123|3363808|P2|Overall Study|Deterioration without progression|2
1032513|NCT00162123|3363809|P1|Overall Study|Deterioration without progression|2
1032514|NCT00162123|3363802|P8|Overall Study|Withdrawal by Subject|0
1032515|NCT00162123|3363803|P7|Overall Study|Withdrawal by Subject|1
1032516|NCT00162123|3363804|P6|Overall Study|Withdrawal by Subject|2
1032517|NCT00162123|3363805|P5|Overall Study|Withdrawal by Subject|1
1032518|NCT00162123|3363806|P4|Overall Study|Withdrawal by Subject|1
1032519|NCT00162123|3363807|P3|Overall Study|Withdrawal by Subject|2
1032520|NCT00162123|3363808|P2|Overall Study|Withdrawal by Subject|0
1032521|NCT00162123|3363809|P1|Overall Study|Withdrawal by Subject|2
1032522|NCT00162123|3363802|P8|Overall Study|Death|0
1032523|NCT00162123|3363803|P7|Overall Study|Death|0
1032524|NCT00162123|3363804|P6|Overall Study|Death|1
1032525|NCT00162123|3363805|P5|Overall Study|Death|1
1032526|NCT00162123|3363806|P4|Overall Study|Death|1
1032527|NCT00162123|3363807|P3|Overall Study|Death|1
1032528|NCT00162123|3363808|P2|Overall Study|Death|3
1032529|NCT00162123|3363809|P1|Overall Study|Death|3
1032530|NCT00162123|3363802|P8|Overall Study|Study drug toxicity|0
1032531|NCT00162123|3363803|P7|Overall Study|Study drug toxicity|1
1032532|NCT00162123|3363804|P6|Overall Study|Study drug toxicity|1
1032533|NCT00162123|3363805|P5|Overall Study|Study drug toxicity|4
1032534|NCT00162123|3363806|P4|Overall Study|Study drug toxicity|0
1032535|NCT00162123|3363807|P3|Overall Study|Study drug toxicity|5
1032536|NCT00162123|3363808|P2|Overall Study|Study drug toxicity|1
1032537|NCT00162123|3363809|P1|Overall Study|Study drug toxicity|6
1032538|NCT00162123|3363802|P8|Overall Study|Disease progression|0
1032539|NCT00162123|3363803|P7|Overall Study|Disease progression|1
1032540|NCT00162123|3363804|P6|Overall Study|Disease progression|3
1032541|NCT00162123|3363805|P5|Overall Study|Disease progression|8
1032542|NCT00162123|3363806|P4|Overall Study|Disease progression|4
1032543|NCT00162123|3363807|P3|Overall Study|Disease progression|10
1032544|NCT00162123|3363808|P2|Overall Study|Disease progression|19
1032545|NCT00162123|3363809|P1|Overall Study|Disease progression|27
1032546|NCT00162097|3363842|P4|Overall Study|Participant no longer met study criteria|1
1032547|NCT00162097|3363843|P3|Overall Study|Participant no longer met study criteria|0
1032548|NCT00162097|3363844|P2|Overall Study|Participant no longer met study criteria|0
1032549|NCT00162097|3363845|P1|Overall Study|Participant no longer met study criteria|0
1032550|NCT00162032|3363907|P2|Overall Study|Reason not specified|0
1032551|NCT00162032|3363908|P1|Overall Study|Reason not specified|1
1032552|NCT00162032|3363907|P2|Overall Study|Lost to Follow-up|2
1032553|NCT00162032|3363908|P1|Overall Study|Lost to Follow-up|4
1032554|NCT00161616|3363918|P2|Overall Study|Protocol deviation|0
1032555|NCT00161616|3363919|P1|Overall Study|Protocol deviation|1
1032556|NCT00161616|3363918|P2|Overall Study|Lost to Follow-up|13
1032557|NCT00161616|3363919|P1|Overall Study|Lost to Follow-up|17
1032558|NCT00161616|3363918|P2|Overall Study|Death|1
1032559|NCT00161616|3363919|P1|Overall Study|Death|1
1032560|NCT00161616|3363918|P2|Overall Study|Physician Decision|0
1032561|NCT00161616|3363919|P1|Overall Study|Physician Decision|1
1032562|NCT00161616|3363918|P2|Overall Study|Withdrawal by Subject|5
1032563|NCT00161616|3363919|P1|Overall Study|Withdrawal by Subject|6
1032564|NCT00161213|3363951|P1|Overall Study|Evaluable for toxicity but not response|1
1032565|NCT00161213|3363951|P1|Overall Study|Withdrawal by Subject|1
1032566|NCT00160706|3363958|P1|Overall Study|Other Reason|11
1032567|NCT00160706|3363958|P1|Overall Study|Lack of Efficacy and Other|1
1032568|NCT00160706|3363958|P1|Overall Study|Lack of Efficacy|42
1032569|NCT00160706|3363958|P1|Overall Study|Lost to Follow-up and Other|1
1032570|NCT00160706|3363958|P1|Overall Study|Lost to Follow-up|4
1032571|NCT00160706|3363958|P1|Overall Study|Physician Decision and Other|3
1032572|NCT00160706|3363958|P1|Overall Study|Physician Decision|10
1032573|NCT00160706|3363958|P1|Overall Study|Withdrawal by Subject and Other|12
1032574|NCT00160706|3363958|P1|Overall Study|Withdrawal by Subject|41
1032575|NCT00160706|3363958|P1|Overall Study|Protocol Violation|3
1032576|NCT00160706|3363958|P1|Overall Study|Adverse Event and Other Reason|105
1032577|NCT00160706|3363958|P1|Overall Study|Adverse Event|53
1032578|NCT00160693|3363970|P1|Overall Study|Study terminated by sponsor|15
1032579|NCT00160693|3363970|P1|Overall Study|Withdrawal by Subject|54
1032580|NCT00160693|3363970|P1|Overall Study|Lost to Follow-up|15
1032581|NCT00160693|3363970|P1|Overall Study|Protocol Violation|24
1032582|NCT00160693|3363970|P1|Overall Study|Lack of Efficacy|30
1032583|NCT00160693|3363970|P1|Overall Study|Adverse Event|97
1032584|NCT00160641|3363987|P1|Overall Study|Other|9
1032585|NCT00160641|3363987|P1|Overall Study|Protocol Violation|3
1032586|NCT00160641|3363987|P1|Overall Study|Lack of Efficacy|12
1032587|NCT00160641|3363987|P1|Overall Study|Lost to Follow-up|8
1032588|NCT00160641|3363987|P1|Overall Study|Withdrawal by Subject|87
1032589|NCT00160641|3363987|P1|Overall Study|Adverse Event|102
1032590|NCT00160563|3364021|P3|Overall Study|Missing reason|0
1032591|NCT00160563|3364022|P2|Overall Study|Missing reason|1
1032592|NCT00160563|3364023|P1|Overall Study|Missing reason|0
1032593|NCT00160563|3364021|P3|Overall Study|Other (listed in the study report)|81
1032594|NCT00160563|3364022|P2|Overall Study|Other (listed in the study report)|40
1032595|NCT00160563|3364023|P1|Overall Study|Other (listed in the study report)|48
1032596|NCT00160563|3364021|P3|Overall Study|Withdrawal by Subject|3
1032597|NCT00160563|3364022|P2|Overall Study|Withdrawal by Subject|2
1032598|NCT00160563|3364023|P1|Overall Study|Withdrawal by Subject|1
1032599|NCT00160563|3364021|P3|Overall Study|Protocol Violation|3
1032600|NCT00160563|3364022|P2|Overall Study|Protocol Violation|0
1032601|NCT00160563|3364023|P1|Overall Study|Protocol Violation|0
1032602|NCT00160563|3364021|P3|Overall Study|Lost to Follow-up|2
1032603|NCT00160563|3364022|P2|Overall Study|Lost to Follow-up|1
1032604|NCT00160563|3364023|P1|Overall Study|Lost to Follow-up|1
1032605|NCT00160563|3364021|P3|Overall Study|Adverse Event|1
1032606|NCT00160563|3364022|P2|Overall Study|Adverse Event|1
1032607|NCT00160563|3364023|P1|Overall Study|Adverse Event|1
1032608|NCT00160524|3364035|P1|Overall Study|Other|20
1032609|NCT00160524|3364035|P1|Overall Study|Lack of Efficacy and Other|1
1032610|NCT00160524|3364035|P1|Overall Study|Lack of Efficacy|21
1032611|NCT00160524|3364035|P1|Overall Study|Lost to Follow-up and Other|1
1032612|NCT00160524|3364035|P1|Overall Study|Lost to Follow-up|13
1032613|NCT00160524|3364035|P1|Overall Study|Physician Decision and Other|6
1032614|NCT00160524|3364035|P1|Overall Study|Physician Decision|27
1032615|NCT00160524|3364035|P1|Overall Study|Withdrawal by Subject and Other|17
1032616|NCT00160524|3364035|P1|Overall Study|Withdrawal by Subject|141
1032617|NCT00160524|3364035|P1|Overall Study|Protocol Violation and Other|2
1032618|NCT00160524|3364035|P1|Overall Study|Protocol Violation|16
1032619|NCT00160524|3364035|P1|Overall Study|Adverse Event and Other|94
1032620|NCT00160524|3364035|P1|Overall Study|Adverse Event|119
1032621|NCT00160251|3364052|P8|Post-amendment 2|Lost to follow-up/withdrawal by subject|11
1032622|NCT00160251|3364053|P7|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
1032623|NCT00160251|3364054|P6|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
1032624|NCT00160251|3364055|P5|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
1032625|NCT00160251|3364056|P4|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
1032626|NCT00160251|3364057|P3|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
1032627|NCT00160251|3364058|P2|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
1032628|NCT00160251|3364059|P1|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
1032629|NCT00160251|3364052|P8|Post-amendment 2|Lack of Efficacy|24
1032630|NCT00160251|3364053|P7|Post-amendment 2|Lack of Efficacy|0
1032631|NCT00160251|3364054|P6|Post-amendment 2|Lack of Efficacy|0
1032632|NCT00160251|3364055|P5|Post-amendment 2|Lack of Efficacy|0
1032633|NCT00160251|3364056|P4|Post-amendment 2|Lack of Efficacy|0
1032634|NCT00160251|3364057|P3|Post-amendment 2|Lack of Efficacy|0
1032635|NCT00160251|3364058|P2|Post-amendment 2|Lack of Efficacy|0
1032636|NCT00160251|3364059|P1|Post-amendment 2|Lack of Efficacy|0
1032637|NCT00160251|3364052|P8|Post-amendment 2|Adverse Event|20
1032638|NCT00160251|3364053|P7|Post-amendment 2|Adverse Event|0
1032639|NCT00160251|3364054|P6|Post-amendment 2|Adverse Event|0
1032640|NCT00160251|3364055|P5|Post-amendment 2|Adverse Event|0
1032641|NCT00160251|3364056|P4|Post-amendment 2|Adverse Event|0
1032642|NCT00160251|3364057|P3|Post-amendment 2|Adverse Event|0
1032643|NCT00160251|3364058|P2|Post-amendment 2|Adverse Event|0
1032644|NCT00160251|3364059|P1|Post-amendment 2|Adverse Event|0
1032645|NCT00160251|3364052|P8|Prior to Amendment 2|Completed Treatment Phase|0
1032646|NCT00160251|3364053|P7|Prior to Amendment 2|Completed Treatment Phase|0
1032647|NCT00160251|3364054|P6|Prior to Amendment 2|Completed Treatment Phase|23
1032648|NCT00160251|3364055|P5|Prior to Amendment 2|Completed Treatment Phase|0
1032649|NCT00160251|3364056|P4|Prior to Amendment 2|Completed Treatment Phase|0
1032650|NCT00160251|3364057|P3|Prior to Amendment 2|Completed Treatment Phase|0
1032651|NCT00160251|3364058|P2|Prior to Amendment 2|Completed Treatment Phase|0
1032652|NCT00160251|3364059|P1|Prior to Amendment 2|Completed Treatment Phase|3
1032653|NCT00160251|3364052|P8|Prior to Amendment 2|Noncompliance with protocol|0
1032654|NCT00160251|3364053|P7|Prior to Amendment 2|Noncompliance with protocol|0
1032655|NCT00160251|3364054|P6|Prior to Amendment 2|Noncompliance with protocol|0
1032656|NCT00160251|3364055|P5|Prior to Amendment 2|Noncompliance with protocol|0
1032657|NCT00160251|3364056|P4|Prior to Amendment 2|Noncompliance with protocol|0
1032658|NCT00160251|3364057|P3|Prior to Amendment 2|Noncompliance with protocol|0
1032659|NCT00160251|3364058|P2|Prior to Amendment 2|Noncompliance with protocol|0
1032660|NCT00160251|3364059|P1|Prior to Amendment 2|Noncompliance with protocol|1
1032661|NCT00160251|3364052|P8|Prior to Amendment 2|Withdrawal by Subject|0
1032662|NCT00160251|3364053|P7|Prior to Amendment 2|Withdrawal by Subject|3
1032663|NCT00160251|3364054|P6|Prior to Amendment 2|Withdrawal by Subject|3
1032664|NCT00160251|3364055|P5|Prior to Amendment 2|Withdrawal by Subject|2
1032665|NCT00160251|3364056|P4|Prior to Amendment 2|Withdrawal by Subject|4
1032666|NCT00160251|3364057|P3|Prior to Amendment 2|Withdrawal by Subject|3
1032667|NCT00160251|3364058|P2|Prior to Amendment 2|Withdrawal by Subject|1
1032668|NCT00160251|3364059|P1|Prior to Amendment 2|Withdrawal by Subject|3
1032669|NCT00160251|3364052|P8|Prior to Amendment 2|Lost to Follow-up|0
1032670|NCT00160251|3364053|P7|Prior to Amendment 2|Lost to Follow-up|0
1032671|NCT00160251|3364054|P6|Prior to Amendment 2|Lost to Follow-up|1
1032672|NCT00160251|3364055|P5|Prior to Amendment 2|Lost to Follow-up|1
1032673|NCT00160251|3364056|P4|Prior to Amendment 2|Lost to Follow-up|0
1032674|NCT00160251|3364057|P3|Prior to Amendment 2|Lost to Follow-up|1
1032675|NCT00160251|3364058|P2|Prior to Amendment 2|Lost to Follow-up|0
1032676|NCT00160251|3364059|P1|Prior to Amendment 2|Lost to Follow-up|0
1032677|NCT00160251|3364052|P8|Prior to Amendment 2|Lack of Efficacy|0
1032678|NCT00160251|3364053|P7|Prior to Amendment 2|Lack of Efficacy|0
1032679|NCT00160251|3364054|P6|Prior to Amendment 2|Lack of Efficacy|55
1032680|NCT00160251|3364055|P5|Prior to Amendment 2|Lack of Efficacy|24
1032681|NCT00160251|3364056|P4|Prior to Amendment 2|Lack of Efficacy|35
1032682|NCT00160251|3364057|P3|Prior to Amendment 2|Lack of Efficacy|37
1032683|NCT00160251|3364058|P2|Prior to Amendment 2|Lack of Efficacy|4
1032684|NCT00160251|3364059|P1|Prior to Amendment 2|Lack of Efficacy|0
1032685|NCT00160251|3364052|P8|Prior to Amendment 2|Adverse Event|0
1032686|NCT00160251|3364053|P7|Prior to Amendment 2|Adverse Event|1
1032687|NCT00160251|3364054|P6|Prior to Amendment 2|Adverse Event|1
1032688|NCT00160251|3364055|P5|Prior to Amendment 2|Adverse Event|1
1032689|NCT00160251|3364056|P4|Prior to Amendment 2|Adverse Event|1
1032690|NCT00160251|3364057|P3|Prior to Amendment 2|Adverse Event|3
1032691|NCT00160251|3364058|P2|Prior to Amendment 2|Adverse Event|1
1032692|NCT00160251|3364059|P1|Prior to Amendment 2|Adverse Event|2
1032693|NCT00160199|3364135|P2|Overall Study|Protocol Violation|8
1032694|NCT00160199|3364136|P1|Overall Study|Protocol Violation|8
1032695|NCT00160199|3364135|P2|Overall Study|Administrative|1
1032696|NCT00160199|3364136|P1|Overall Study|Administrative|0
1032697|NCT00160199|3364135|P2|Overall Study|Withdrawal by Subject|6
1032698|NCT00160199|3364136|P1|Overall Study|Withdrawal by Subject|4
1032699|NCT00160199|3364135|P2|Overall Study|Lost to Follow-up|7
1032700|NCT00160199|3364136|P1|Overall Study|Lost to Follow-up|7
1032701|NCT00160199|3364135|P2|Overall Study|Lack of Efficacy|1
1032702|NCT00160199|3364136|P1|Overall Study|Lack of Efficacy|0
1032703|NCT00160199|3364135|P2|Overall Study|Adverse Event|14
1032704|NCT00160199|3364136|P1|Overall Study|Adverse Event|5
1032705|NCT00159913|3364193|P4|Overall Study|Protocol Violation|0
1032706|NCT00159913|3364194|P3|Overall Study|Protocol Violation|1
1032707|NCT00159913|3364195|P2|Overall Study|Protocol Violation|0
1032708|NCT00159913|3364196|P1|Overall Study|Protocol Violation|1
1032709|NCT00159913|3364193|P4|Overall Study|Lost to Follow-up|1
1032710|NCT00159913|3364194|P3|Overall Study|Lost to Follow-up|0
1032711|NCT00159913|3364195|P2|Overall Study|Lost to Follow-up|0
1032712|NCT00159913|3364196|P1|Overall Study|Lost to Follow-up|0
1032713|NCT00159913|3364193|P4|Overall Study|Withdrawal by Subject|1
1032714|NCT00159913|3364194|P3|Overall Study|Withdrawal by Subject|0
1032715|NCT00159913|3364195|P2|Overall Study|Withdrawal by Subject|0
1032716|NCT00159913|3364196|P1|Overall Study|Withdrawal by Subject|0
1032717|NCT00159913|3364193|P4|Overall Study|Adverse Event|0
1032718|NCT00159913|3364194|P3|Overall Study|Adverse Event|1
1032719|NCT00159913|3364195|P2|Overall Study|Adverse Event|0
1032720|NCT00159913|3364196|P1|Overall Study|Adverse Event|1
1032721|NCT00159874|3364270|P7|Overall Study|Pregnancy|0
1032722|NCT00159874|3364271|P6|Overall Study|Pregnancy|0
1032723|NCT00159874|3364272|P5|Overall Study|Pregnancy|0
1032724|NCT00159874|3364273|P4|Overall Study|Pregnancy|0
1032725|NCT00159874|3364274|P3|Overall Study|Pregnancy|0
1032726|NCT00159874|3364275|P2|Overall Study|Pregnancy|1
1032727|NCT00159874|3364276|P1|Overall Study|Pregnancy|1
1032728|NCT00159874|3364270|P7|Overall Study|Withdrawal by Subject|1
1032729|NCT00159874|3364271|P6|Overall Study|Withdrawal by Subject|2
1032730|NCT00159874|3364272|P5|Overall Study|Withdrawal by Subject|3
1032731|NCT00159874|3364273|P4|Overall Study|Withdrawal by Subject|4
1032732|NCT00159874|3364274|P3|Overall Study|Withdrawal by Subject|8
1032733|NCT00159874|3364275|P2|Overall Study|Withdrawal by Subject|6
1032734|NCT00159874|3364276|P1|Overall Study|Withdrawal by Subject|2
1032735|NCT00159874|3364270|P7|Overall Study|Death|0
1032736|NCT00159874|3364271|P6|Overall Study|Death|2
1032737|NCT00159874|3364272|P5|Overall Study|Death|1
1032738|NCT00159874|3364273|P4|Overall Study|Death|0
1032739|NCT00159874|3364274|P3|Overall Study|Death|15
1032740|NCT00159874|3364275|P2|Overall Study|Death|8
1032741|NCT00159874|3364276|P1|Overall Study|Death|3
1032742|NCT00159874|3364270|P7|Overall Study|Protocol Violation|0
1032743|NCT00159874|3364271|P6|Overall Study|Protocol Violation|0
1032744|NCT00159874|3364272|P5|Overall Study|Protocol Violation|0
1032745|NCT00159874|3364273|P4|Overall Study|Protocol Violation|0
1032746|NCT00159874|3364274|P3|Overall Study|Protocol Violation|2
1032747|NCT00159874|3364275|P2|Overall Study|Protocol Violation|5
1032748|NCT00159874|3364276|P1|Overall Study|Protocol Violation|0
1032749|NCT00159874|3364270|P7|Overall Study|Not specified|3
1032750|NCT00159874|3364271|P6|Overall Study|Not specified|1
1032751|NCT00159874|3364272|P5|Overall Study|Not specified|2
1032752|NCT00159874|3364273|P4|Overall Study|Not specified|0
1032753|NCT00159874|3364274|P3|Overall Study|Not specified|8
1032754|NCT00159874|3364275|P2|Overall Study|Not specified|8
1032755|NCT00159874|3364276|P1|Overall Study|Not specified|8
1032756|NCT00159874|3364270|P7|Overall Study|Lost to Follow-up|1
1032757|NCT00159874|3364271|P6|Overall Study|Lost to Follow-up|2
1032758|NCT00159874|3364272|P5|Overall Study|Lost to Follow-up|1
1032759|NCT00159874|3364273|P4|Overall Study|Lost to Follow-up|0
1032760|NCT00159874|3364274|P3|Overall Study|Lost to Follow-up|3
1032761|NCT00159874|3364275|P2|Overall Study|Lost to Follow-up|0
1032762|NCT00159874|3364276|P1|Overall Study|Lost to Follow-up|1
1032763|NCT00159874|3364270|P7|Overall Study|Lack of Efficacy|0
1032764|NCT00159874|3364271|P6|Overall Study|Lack of Efficacy|3
1032765|NCT00159874|3364272|P5|Overall Study|Lack of Efficacy|0
1032766|NCT00159874|3364273|P4|Overall Study|Lack of Efficacy|1
1032767|NCT00159874|3364274|P3|Overall Study|Lack of Efficacy|1
1032768|NCT00159874|3364275|P2|Overall Study|Lack of Efficacy|0
1032769|NCT00159874|3364276|P1|Overall Study|Lack of Efficacy|2
1032770|NCT00159874|3364270|P7|Overall Study|Does Not Meet Entrance Criteria|0
1032771|NCT00159874|3364271|P6|Overall Study|Does Not Meet Entrance Criteria|0
1032772|NCT00159874|3364272|P5|Overall Study|Does Not Meet Entrance Criteria|0
1032773|NCT00159874|3364273|P4|Overall Study|Does Not Meet Entrance Criteria|0
1032774|NCT00159874|3364274|P3|Overall Study|Does Not Meet Entrance Criteria|1
1032775|NCT00159874|3364275|P2|Overall Study|Does Not Meet Entrance Criteria|0
1032776|NCT00159874|3364276|P1|Overall Study|Does Not Meet Entrance Criteria|1
1032777|NCT00159874|3364270|P7|Overall Study|Adverse Event|0
1032778|NCT00159874|3364271|P6|Overall Study|Adverse Event|2
1032779|NCT00159874|3364272|P5|Overall Study|Adverse Event|1
1032780|NCT00159874|3364273|P4|Overall Study|Adverse Event|1
1032781|NCT00159874|3364274|P3|Overall Study|Adverse Event|5
1032782|NCT00159874|3364275|P2|Overall Study|Adverse Event|2
1032783|NCT00159874|3364276|P1|Overall Study|Adverse Event|2
1032784|NCT00159861|3364446|P2|Extension Study - up to 3 Years|Withdrawal by Subject|9
1032785|NCT00159861|3364447|P1|Extension Study - up to 3 Years|Withdrawal by Subject|7
1032786|NCT00159861|3364446|P2|Extension Study - up to 3 Years|Reason Unspecified|19
1032787|NCT00159861|3364447|P1|Extension Study - up to 3 Years|Reason Unspecified|12
1032788|NCT00159861|3364446|P2|Extension Study - up to 3 Years|Lack of Efficacy|1
1032789|NCT00159861|3364447|P1|Extension Study - up to 3 Years|Lack of Efficacy|5
1032790|NCT00159861|3364446|P2|Extension Study - up to 3 Years|Adverse Event|14
1032791|NCT00159861|3364447|P1|Extension Study - up to 3 Years|Adverse Event|14
1032792|NCT00159861|3364446|P2|Extension Study - up to 3 Years|Death|28
1032793|NCT00159861|3364447|P1|Extension Study - up to 3 Years|Death|24
1032794|NCT00159861|3364446|P2|Core Study - 16 Weeks|Randomized but not Treated|0
1032795|NCT00159861|3364447|P1|Core Study - 16 Weeks|Randomized but not Treated|2
1032796|NCT00159861|3364446|P2|Core Study - 16 Weeks|Subject Defaulted|0
1032797|NCT00159861|3364447|P1|Core Study - 16 Weeks|Subject Defaulted|1
1032798|NCT00159861|3364446|P2|Core Study - 16 Weeks|Reason Unspecified|3
1032799|NCT00159861|3364447|P1|Core Study - 16 Weeks|Reason Unspecified|5
1032800|NCT00159861|3364446|P2|Core Study - 16 Weeks|Lack of Efficacy|3
1032801|NCT00159861|3364447|P1|Core Study - 16 Weeks|Lack of Efficacy|2
1032802|NCT00159861|3364446|P2|Core Study - 16 Weeks|Adverse Event|6
1032803|NCT00159861|3364447|P1|Core Study - 16 Weeks|Adverse Event|12
1032804|NCT00159861|3364446|P2|Core Study - 16 Weeks|Death|0
1032805|NCT00159861|3364447|P1|Core Study - 16 Weeks|Death|3
1032806|NCT00159822|3364468|P1|Post-treatment Follow-up Period|Reason unspecified|1
1032807|NCT00159822|3364468|P1|Post-treatment Follow-up Period|Withdrawal by Subject|1
1032808|NCT00159822|3364468|P1|Post-treatment Follow-up Period|Death|1
1032809|NCT00159822|3364468|P1|Voriconazole Treatment Period|Withdrawal by Subject|2
1032810|NCT00159822|3364468|P1|Voriconazole Treatment Period|Lost to Follow-up|2
1032811|NCT00159822|3364468|P1|Voriconazole Treatment Period|Protocol Violation|2
1032812|NCT00159822|3364468|P1|Voriconazole Treatment Period|Death|4
1032813|NCT00159822|3364468|P1|Voriconazole Treatment Period|Adverse Event|9
1032814|NCT00159822|3364468|P1|Voriconazole Treatment Period|Lack of Efficacy|3
1032815|NCT00159783|3364486|P3|Overall Study|not specified|4
1032816|NCT00159783|3364487|P2|Overall Study|not specified|2
1032817|NCT00159783|3364488|P1|Overall Study|not specified|0
1032818|NCT00159783|3364486|P3|Overall Study|Lost to Follow-up|11
1032819|NCT00159783|3364487|P2|Overall Study|Lost to Follow-up|5
1032820|NCT00159783|3364488|P1|Overall Study|Lost to Follow-up|6
1032821|NCT00159783|3364486|P3|Overall Study|Withdrawal by Subject|12
1032822|NCT00159783|3364487|P2|Overall Study|Withdrawal by Subject|11
1032823|NCT00159783|3364488|P1|Overall Study|Withdrawal by Subject|7
1032824|NCT00159783|3364486|P3|Overall Study|Lack of Efficacy|3
1032825|NCT00159783|3364487|P2|Overall Study|Lack of Efficacy|2
1032826|NCT00159783|3364488|P1|Overall Study|Lack of Efficacy|1
1032827|NCT00159783|3364486|P3|Overall Study|Adverse Event|9
1032828|NCT00159783|3364487|P2|Overall Study|Adverse Event|7
1032829|NCT00159783|3364488|P1|Overall Study|Adverse Event|5
1032830|NCT00159432|3364518|P1|Overall Study|Lack of Efficacy|8
1032831|NCT00159432|3364518|P1|Overall Study|Death|1
1032832|NCT00159432|3364518|P1|Overall Study|Adverse Event|1
1032833|NCT00158756|3364545|P5|Overall Study|Serious adverse event|0
1032834|NCT00158756|3364546|P4|Overall Study|Serious adverse event|0
1032835|NCT00158756|3364547|P3|Overall Study|Serious adverse event|1
1032836|NCT00158756|3364548|P2|Overall Study|Serious adverse event|0
1032837|NCT00158756|3364549|P1|Overall Study|Serious adverse event|0
1032838|NCT00158756|3364545|P5|Overall Study|Adverse Event|0
1032839|NCT00158756|3364546|P4|Overall Study|Adverse Event|0
1032840|NCT00158756|3364547|P3|Overall Study|Adverse Event|1
1032841|NCT00158756|3364548|P2|Overall Study|Adverse Event|0
1032842|NCT00158756|3364549|P1|Overall Study|Adverse Event|0
1032843|NCT00158756|3364545|P5|Overall Study|Withdrawal by Subject|3
1032844|NCT00158756|3364546|P4|Overall Study|Withdrawal by Subject|1
1032845|NCT00158756|3364547|P3|Overall Study|Withdrawal by Subject|6
1032846|NCT00158756|3364548|P2|Overall Study|Withdrawal by Subject|0
1032847|NCT00158756|3364549|P1|Overall Study|Withdrawal by Subject|5
1032848|NCT00158600|3364655|P2|Overall Study|Withdrawal by Subject|2
1032849|NCT00158600|3364656|P1|Overall Study|Withdrawal by Subject|2
1032850|NCT00158600|3364655|P2|Overall Study|Death|0
1032851|NCT00158600|3364656|P1|Overall Study|Death|1
1032852|NCT00158600|3364655|P2|Overall Study|Adverse Event|1
1032853|NCT00158600|3364656|P1|Overall Study|Adverse Event|2
1032854|NCT00158600|3364655|P2|Overall Study|unable to commit time to study|1
1032855|NCT00158600|3364656|P1|Overall Study|unable to commit time to study|0
1032856|NCT00158262|3364681|P2|Overall Study|Lost to Follow-up|1
1032857|NCT00158262|3364682|P1|Overall Study|Lost to Follow-up|1
1032858|NCT00158184|3364743|P2|Overall Study|Adverse Event|1
1032859|NCT00158184|3364744|P1|Overall Study|Adverse Event|1
1032860|NCT00158184|3364743|P2|Overall Study|failed for follow unit/study rules|0
1032861|NCT00158184|3364744|P1|Overall Study|failed for follow unit/study rules|2
1032862|NCT00158184|3364743|P2|Overall Study|personal issues|1
1032863|NCT00158184|3364744|P1|Overall Study|personal issues|3
1032864|NCT00158054|3364754|P2|Overall Study|Unavailable for follow up|3
1032865|NCT00158054|3364755|P1|Overall Study|Unavailable for follow up|7
1032866|NCT00158054|3364754|P2|Overall Study|Refused to continue|0
1032867|NCT00158054|3364755|P1|Overall Study|Refused to continue|3
1032868|NCT00157950|3364769|P2|Overall Study|Death|0
1032869|NCT00157950|3364770|P1|Overall Study|Death|1
1032870|NCT00157820|3364787|P3|2nd 8 Months|Premature cross-over|9
1032871|NCT00157820|3364788|P2|2nd 8 Months|Premature cross-over|7
1032872|NCT00157820|3364789|P1|2nd 8 Months|Premature cross-over|1
1032873|NCT00157820|3364787|P3|2nd 8 Months|Lost to Follow-up|2
1032874|NCT00157820|3364788|P2|2nd 8 Months|Lost to Follow-up|5
1032875|NCT00157820|3364789|P1|2nd 8 Months|Lost to Follow-up|1
1032876|NCT00157820|3364787|P3|2nd 8 Months|Death|3
1032877|NCT00157820|3364788|P2|2nd 8 Months|Death|1
1032878|NCT00157820|3364789|P1|2nd 8 Months|Death|3
1032879|NCT00157820|3364787|P3|1st 8 Month|Premature cross-over|2
1032880|NCT00157820|3364788|P2|1st 8 Month|Premature cross-over|2
1032881|NCT00157820|3364789|P1|1st 8 Month|Premature cross-over|0
1032882|NCT00157820|3364787|P3|1st 8 Month|Lost to Follow-up|1
1032883|NCT00157820|3364788|P2|1st 8 Month|Lost to Follow-up|2
1032884|NCT00157820|3364789|P1|1st 8 Month|Lost to Follow-up|1
1032885|NCT00157820|3364787|P3|1st 8 Month|Death|3
1032886|NCT00157820|3364788|P2|1st 8 Month|Death|8
1032887|NCT00157820|3364789|P1|1st 8 Month|Death|7
1032888|NCT00157820|3364787|P3|Randomized|Protocol Violation|2
1032889|NCT00157820|3364788|P2|Randomized|Protocol Violation|1
1032890|NCT00157820|3364789|P1|Randomized|Protocol Violation|2
1032891|NCT00157820|3364787|P3|Randomized|Withdrawal by Subject|3
1032892|NCT00157820|3364788|P2|Randomized|Withdrawal by Subject|2
1032893|NCT00157820|3364789|P1|Randomized|Withdrawal by Subject|1
1032894|NCT00157820|3364787|P3|Randomized|Physician Decision|3
1032895|NCT00157820|3364788|P2|Randomized|Physician Decision|2
1032896|NCT00157820|3364789|P1|Randomized|Physician Decision|4
1032897|NCT00157755|3364802|P6|Overall Study|Study completion|2
1032898|NCT00157755|3364803|P5|Overall Study|Study completion|1
1032899|NCT00157755|3364804|P4|Overall Study|Study completion|0
1032900|NCT00157755|3364805|P3|Overall Study|Study completion|0
1032901|NCT00157755|3364806|P2|Overall Study|Study completion|0
1032902|NCT00157755|3364807|P1|Overall Study|Study completion|0
1032903|NCT00157755|3364802|P6|Overall Study|Subject non-compliance|1
1032904|NCT00157755|3364803|P5|Overall Study|Subject non-compliance|0
1032905|NCT00157755|3364804|P4|Overall Study|Subject non-compliance|0
1032906|NCT00157755|3364805|P3|Overall Study|Subject non-compliance|0
1032907|NCT00157755|3364806|P2|Overall Study|Subject non-compliance|0
1032908|NCT00157755|3364807|P1|Overall Study|Subject non-compliance|0
1032909|NCT00157755|3364802|P6|Overall Study|Study site closure|0
1032910|NCT00157755|3364803|P5|Overall Study|Study site closure|0
1032911|NCT00157755|3364804|P4|Overall Study|Study site closure|0
1032912|NCT00157755|3364805|P3|Overall Study|Study site closure|0
1032913|NCT00157755|3364806|P2|Overall Study|Study site closure|1
1032914|NCT00157755|3364807|P1|Overall Study|Study site closure|0
1032915|NCT00157755|3364802|P6|Overall Study|Medical reason|0
1032916|NCT00157755|3364803|P5|Overall Study|Medical reason|0
1032917|NCT00157755|3364804|P4|Overall Study|Medical reason|1
1032918|NCT00157755|3364805|P3|Overall Study|Medical reason|1
1032919|NCT00157755|3364806|P2|Overall Study|Medical reason|0
1032920|NCT00157755|3364807|P1|Overall Study|Medical reason|0
1032921|NCT00157755|3364802|P6|Overall Study|Explant due to infection|0
1032922|NCT00157755|3364803|P5|Overall Study|Explant due to infection|0
1032923|NCT00157755|3364804|P4|Overall Study|Explant due to infection|0
1032924|NCT00157755|3364805|P3|Overall Study|Explant due to infection|1
1032925|NCT00157755|3364806|P2|Overall Study|Explant due to infection|0
1032926|NCT00157755|3364807|P1|Overall Study|Explant due to infection|0
1032927|NCT00157755|3364802|P6|Overall Study|Withdrawal by Subject|2
1032928|NCT00157755|3364803|P5|Overall Study|Withdrawal by Subject|1
1032929|NCT00157755|3364804|P4|Overall Study|Withdrawal by Subject|1
1032930|NCT00157755|3364805|P3|Overall Study|Withdrawal by Subject|1
1032931|NCT00157755|3364806|P2|Overall Study|Withdrawal by Subject|0
1032932|NCT00157755|3364807|P1|Overall Study|Withdrawal by Subject|0
1032933|NCT00157755|3364802|P6|Overall Study|Lost to Follow-up|0
1032934|NCT00157755|3364803|P5|Overall Study|Lost to Follow-up|0
1032935|NCT00157755|3364804|P4|Overall Study|Lost to Follow-up|0
1032936|NCT00157755|3364805|P3|Overall Study|Lost to Follow-up|1
1032937|NCT00157755|3364806|P2|Overall Study|Lost to Follow-up|0
1032938|NCT00157755|3364807|P1|Overall Study|Lost to Follow-up|0
1032939|NCT00157755|3364802|P6|Overall Study|Death|0
1032940|NCT00157755|3364803|P5|Overall Study|Death|0
1032941|NCT00157755|3364804|P4|Overall Study|Death|2
1032942|NCT00157755|3364805|P3|Overall Study|Death|3
1032943|NCT00157755|3364806|P2|Overall Study|Death|3
1032944|NCT00157755|3364807|P1|Overall Study|Death|2
1032945|NCT00157248|3364843|P4|Overall Study|site closures, subject moving|9
1032946|NCT00157248|3364844|P3|Overall Study|site closures, subject moving|3
1032947|NCT00157248|3364845|P2|Overall Study|site closures, subject moving|7
1032948|NCT00157248|3364846|P1|Overall Study|site closures, subject moving|7
1032949|NCT00157248|3364843|P4|Overall Study|Withdrawal by Subject|3
1032950|NCT00157248|3364844|P3|Overall Study|Withdrawal by Subject|3
1032951|NCT00157248|3364845|P2|Overall Study|Withdrawal by Subject|4
1032952|NCT00157248|3364846|P1|Overall Study|Withdrawal by Subject|1
1032953|NCT00157248|3364843|P4|Overall Study|Lost to Follow-up|0
1032954|NCT00157248|3364844|P3|Overall Study|Lost to Follow-up|0
1032955|NCT00157248|3364845|P2|Overall Study|Lost to Follow-up|1
1032956|NCT00157248|3364846|P1|Overall Study|Lost to Follow-up|0
1032957|NCT00157248|3364843|P4|Overall Study|Protocol Violation|2
1032958|NCT00157248|3364844|P3|Overall Study|Protocol Violation|2
1032959|NCT00157248|3364845|P2|Overall Study|Protocol Violation|0
1032960|NCT00157248|3364846|P1|Overall Study|Protocol Violation|4
1032961|NCT00157248|3364843|P4|Overall Study|Adverse Event|33
1032962|NCT00157248|3364844|P3|Overall Study|Adverse Event|13
1032963|NCT00157248|3364845|P2|Overall Study|Adverse Event|25
1032964|NCT00157248|3364846|P1|Overall Study|Adverse Event|36
1032965|NCT00157209|3364952|P2|Overall Study|Ongoing at data cut-off|0
1032966|NCT00157209|3364953|P1|Overall Study|Ongoing at data cut-off|10
1032967|NCT00157196|3364967|P1|Overall Study|Ongoing at data cut-off|9
1032968|NCT00157157|3364973|P1|Overall Study|Inclusion not met- baseline FVIII value|1
1032969|NCT00157157|3364973|P1|Overall Study|Met exclusion criteria|1
1032970|NCT00157157|3364973|P1|Overall Study|Enrolled in another study|1
1032971|NCT00157157|3364973|P1|Overall Study|Lost to Follow-up|1
1032972|NCT00157157|3364973|P1|Overall Study|Physician Decision|1
1032973|NCT00157157|3364973|P1|Overall Study|Withdrawal by Subject|6
1032974|NCT00157014|3365000|P4|Overall Study|Withdrawal by Subject|0
1032975|NCT00157014|3365001|P3|Overall Study|Withdrawal by Subject|0
1032976|NCT00157014|3365002|P2|Overall Study|Withdrawal by Subject|0
1032977|NCT00157014|3365003|P1|Overall Study|Withdrawal by Subject|1
1032978|NCT00157014|3365000|P4|Overall Study|Patient would not receive transplant|0
1032979|NCT00157014|3365001|P3|Overall Study|Patient would not receive transplant|0
1032980|NCT00157014|3365002|P2|Overall Study|Patient would not receive transplant|1
1032981|NCT00157014|3365003|P1|Overall Study|Patient would not receive transplant|0
1032982|NCT00157014|3365000|P4|Overall Study|Patient unable to return in nursing home|0
1032983|NCT00157014|3365001|P3|Overall Study|Patient unable to return in nursing home|0
1032984|NCT00157014|3365002|P2|Overall Study|Patient unable to return in nursing home|0
1032985|NCT00157014|3365003|P1|Overall Study|Patient unable to return in nursing home|1
1032986|NCT00157014|3365000|P4|Overall Study|Patient withdrawn by investigator|0
1032987|NCT00157014|3365001|P3|Overall Study|Patient withdrawn by investigator|0
1032988|NCT00157014|3365002|P2|Overall Study|Patient withdrawn by investigator|0
1032989|NCT00157014|3365003|P1|Overall Study|Patient withdrawn by investigator|1
1032990|NCT00157014|3365000|P4|Overall Study|Medications withdrawn on family request|0
1032991|NCT00157014|3365001|P3|Overall Study|Medications withdrawn on family request|0
1032992|NCT00157014|3365002|P2|Overall Study|Medications withdrawn on family request|1
1032993|NCT00157014|3365003|P1|Overall Study|Medications withdrawn on family request|0
1032994|NCT00157014|3365000|P4|Overall Study|Physician Decision|0
1032995|NCT00157014|3365001|P3|Overall Study|Physician Decision|0
1032996|NCT00157014|3365002|P2|Overall Study|Physician Decision|1
1032997|NCT00157014|3365003|P1|Overall Study|Physician Decision|0
1032998|NCT00157014|3365000|P4|Overall Study|Death|1
1032999|NCT00157014|3365001|P3|Overall Study|Death|1
1033000|NCT00157014|3365002|P2|Overall Study|Death|2
1033001|NCT00157014|3365003|P1|Overall Study|Death|4
1033002|NCT00156819|3365119|P3|Overall Study|Lost to Follow-up|3
1033003|NCT00156819|3365120|P2|Overall Study|Lost to Follow-up|1
1033004|NCT00156819|3365121|P1|Overall Study|Lost to Follow-up|1
1033005|NCT00156533|3365138|P4|Overall Study|Failed Screening|1
1033006|NCT00156533|3365139|P3|Overall Study|Failed Screening|1
1033007|NCT00156533|3365140|P2|Overall Study|Failed Screening|0
1033008|NCT00156533|3365141|P1|Overall Study|Failed Screening|1
1033009|NCT00156533|3365138|P4|Overall Study|Withdrawal by Subject|1
1033010|NCT00156533|3365139|P3|Overall Study|Withdrawal by Subject|0
1033011|NCT00156533|3365140|P2|Overall Study|Withdrawal by Subject|0
1033012|NCT00156533|3365141|P1|Overall Study|Withdrawal by Subject|1
1033013|NCT00156533|3365138|P4|Overall Study|Withdrawn - Medication Expiration|0
1033014|NCT00156533|3365139|P3|Overall Study|Withdrawn - Medication Expiration|1
1033015|NCT00156533|3365140|P2|Overall Study|Withdrawn - Medication Expiration|2
1033016|NCT00156533|3365141|P1|Overall Study|Withdrawn - Medication Expiration|0
1033017|NCT00156065|3365175|P3|Overall Study|Other|3
1033018|NCT00156065|3365176|P2|Overall Study|Other|9
1033019|NCT00156065|3365177|P1|Overall Study|Other|2
1033020|NCT00156065|3365175|P3|Overall Study|Lost to Follow-up|1
1033021|NCT00156065|3365176|P2|Overall Study|Lost to Follow-up|7
1033022|NCT00156065|3365177|P1|Overall Study|Lost to Follow-up|5
1033023|NCT00156065|3365175|P3|Overall Study|Withdrawal by Subject|16
1033024|NCT00156065|3365176|P2|Overall Study|Withdrawal by Subject|26
1033025|NCT00156065|3365177|P1|Overall Study|Withdrawal by Subject|13
1033026|NCT00156065|3365175|P3|Overall Study|Lack of Efficacy|3
1033027|NCT00156065|3365176|P2|Overall Study|Lack of Efficacy|9
1033028|NCT00156065|3365177|P1|Overall Study|Lack of Efficacy|2
1033029|NCT00156065|3365175|P3|Overall Study|Adverse Event|4
1033030|NCT00156065|3365176|P2|Overall Study|Adverse Event|11
1033031|NCT00156065|3365177|P1|Overall Study|Adverse Event|8
1033032|NCT00156065|3365175|P3|Overall Study|Enrolled But Never Received Treatment|0
1033033|NCT00156065|3365176|P2|Overall Study|Enrolled But Never Received Treatment|1
1033034|NCT00156065|3365177|P1|Overall Study|Enrolled But Never Received Treatment|1
1033035|NCT00154375|3365211|P2|Overall Study|Suspected progression of disease|30
1033036|NCT00154375|3365212|P1|Overall Study|Suspected progression of disease|44
1033037|NCT00154375|3365211|P2|Overall Study|Protocol Violation|1
1033038|NCT00154375|3365212|P1|Overall Study|Protocol Violation|0
1033039|NCT00154375|3365211|P2|Overall Study|Abnormal laboratory value(s)|2
1033040|NCT00154375|3365212|P1|Overall Study|Abnormal laboratory value(s)|0
1033041|NCT00154375|3365211|P2|Overall Study|Lost to Follow-up|1
1033042|NCT00154375|3365212|P1|Overall Study|Lost to Follow-up|2
1033043|NCT00154375|3365211|P2|Overall Study|Study drug no longer required|3
1033044|NCT00154375|3365212|P1|Overall Study|Study drug no longer required|5
1033045|NCT00154375|3365211|P2|Overall Study|Death|13
1033046|NCT00154375|3365212|P1|Overall Study|Death|5
1033047|NCT00154375|3365211|P2|Overall Study|Withdrawal by Subject|10
1033048|NCT00154375|3365212|P1|Overall Study|Withdrawal by Subject|14
1033049|NCT00154375|3365211|P2|Overall Study|Adverse Event|20
1033050|NCT00154375|3365212|P1|Overall Study|Adverse Event|18
1033051|NCT00154375|3365211|P2|Overall Study|Unsatisfactory therapeutic effect|26
1033052|NCT00154375|3365212|P1|Overall Study|Unsatisfactory therapeutic effect|25
1033053|NCT00154310|3365223|P2|Overall Study|Death|1
1033054|NCT00154310|3365224|P1|Overall Study|Death|0
1033055|NCT00154310|3365223|P2|Overall Study|Administrative problems|1
1033056|NCT00154310|3365224|P1|Overall Study|Administrative problems|0
1033057|NCT00154310|3365223|P2|Overall Study|Lost to Follow-up|8
1033058|NCT00154310|3365224|P1|Overall Study|Lost to Follow-up|0
1033059|NCT00154310|3365223|P2|Overall Study|Withdrawal by Subject|3
1033060|NCT00154310|3365224|P1|Overall Study|Withdrawal by Subject|9
1033061|NCT00154310|3365223|P2|Overall Study|Protocol Violation|2
1033062|NCT00154310|3365224|P1|Overall Study|Protocol Violation|4
1033063|NCT00154310|3365223|P2|Overall Study|Lack of Efficacy|4
1033064|NCT00154310|3365224|P1|Overall Study|Lack of Efficacy|5
1033065|NCT00154310|3365223|P2|Overall Study|Adverse Event|9
1033066|NCT00154310|3365224|P1|Overall Study|Adverse Event|19
1033067|NCT00154297|3365240|P2|Overall Study|Lost to Follow-up|0
1033068|NCT00154297|3365241|P1|Overall Study|Lost to Follow-up|3
1033069|NCT00154297|3365240|P2|Overall Study|Withdrawal by Subject|5
1033070|NCT00154297|3365241|P1|Overall Study|Withdrawal by Subject|0
1033071|NCT00154297|3365240|P2|Overall Study|Death|2
1033072|NCT00154297|3365241|P1|Overall Study|Death|5
1033073|NCT00154284|3365259|P2|Overall Study|Protocol Violation|1
1033074|NCT00154284|3365260|P1|Overall Study|Protocol Violation|0
1033075|NCT00154284|3365259|P2|Overall Study|Lack of Efficacy|2
1033076|NCT00154284|3365260|P1|Overall Study|Lack of Efficacy|1
1033077|NCT00154284|3365259|P2|Overall Study|Abnormal laboratory value(s)|1
1033078|NCT00154284|3365260|P1|Overall Study|Abnormal laboratory value(s)|0
1033079|NCT00154284|3365259|P2|Overall Study|Adverse Event|9
1033080|NCT00154284|3365260|P1|Overall Study|Adverse Event|6
1033081|NCT00154102|3365274|P2|Overall Study|investigational study phase ongoing|2
1033082|NCT00154102|3365275|P1|Overall Study|investigational study phase ongoing|7
1033083|NCT00154063|3365311|P2|Overall Study|Not specified|3
1033084|NCT00154063|3365312|P1|Overall Study|Not specified|3
1033085|NCT00154063|3365311|P2|Overall Study|Withdrawal by Subject|9
1033086|NCT00154063|3365312|P1|Overall Study|Withdrawal by Subject|4
1033087|NCT00154063|3365311|P2|Overall Study|Investigator or Sponsor Request|1
1033088|NCT00154063|3365312|P1|Overall Study|Investigator or Sponsor Request|0
1033089|NCT00154063|3365311|P2|Overall Study|Protocol Violation|1
1033090|NCT00154063|3365312|P1|Overall Study|Protocol Violation|1
1033091|NCT00154063|3365311|P2|Overall Study|Adverse Event|8
1033092|NCT00154063|3365312|P1|Overall Study|Adverse Event|4
1033093|NCT00153920|3365374|P1|Overall Study|Progressive Disease before Trt|1
1033094|NCT00153920|3365374|P1|Overall Study|Withdrawal of Consent before Trt|1
1033095|NCT00153920|3365374|P1|Overall Study|Non-Protocol Therapy|1
1033096|NCT00153920|3365374|P1|Overall Study|Withdrawal by Subject|1
1033097|NCT00153920|3365374|P1|Overall Study|Death|2
1033098|NCT00153920|3365374|P1|Overall Study|Lack of Response|3
1033099|NCT00153920|3365374|P1|Overall Study|Physician Decision|3
1033100|NCT00153920|3365374|P1|Overall Study|Progressive Disease|9
1033101|NCT00153920|3365374|P1|Overall Study|Adverse Event|9
1033102|NCT00153816|3365389|P6|Overall Study|Follow-up exam done, histology missing|2
1033103|NCT00153816|3365390|P5|Overall Study|Follow-up exam done, histology missing|1
1033104|NCT00153816|3365391|P4|Overall Study|Follow-up exam done, histology missing|3
1033105|NCT00153816|3365392|P3|Overall Study|Follow-up exam done, histology missing|3
1033106|NCT00153816|3365393|P2|Overall Study|Follow-up exam done, histology missing|3
1033107|NCT00153816|3365394|P1|Overall Study|Follow-up exam done, histology missing|2
1033108|NCT00153816|3365389|P6|Overall Study|Follow-up exam not done|9
1033109|NCT00153816|3365390|P5|Overall Study|Follow-up exam not done|8
1033110|NCT00153816|3365391|P4|Overall Study|Follow-up exam not done|10
1033111|NCT00153816|3365392|P3|Overall Study|Follow-up exam not done|11
1033112|NCT00153816|3365393|P2|Overall Study|Follow-up exam not done|7
1033113|NCT00153816|3365394|P1|Overall Study|Follow-up exam not done|8
1033114|NCT00153816|3365389|P6|Overall Study|Withdrawal by Subject|5
1033115|NCT00153816|3365390|P5|Overall Study|Withdrawal by Subject|1
1033116|NCT00153816|3365391|P4|Overall Study|Withdrawal by Subject|4
1033117|NCT00153816|3365392|P3|Overall Study|Withdrawal by Subject|9
1033118|NCT00153816|3365393|P2|Overall Study|Withdrawal by Subject|9
1033119|NCT00153816|3365394|P1|Overall Study|Withdrawal by Subject|9
1033120|NCT00153816|3365389|P6|Overall Study|Lost to Follow-up|9
1033121|NCT00153816|3365390|P5|Overall Study|Lost to Follow-up|7
1033122|NCT00153816|3365391|P4|Overall Study|Lost to Follow-up|8
1033123|NCT00153816|3365392|P3|Overall Study|Lost to Follow-up|5
1033124|NCT00153816|3365393|P2|Overall Study|Lost to Follow-up|8
1033125|NCT00153816|3365394|P1|Overall Study|Lost to Follow-up|7
1033126|NCT00153816|3365389|P6|Overall Study|Death|2
1033127|NCT00153816|3365390|P5|Overall Study|Death|0
1033128|NCT00153816|3365391|P4|Overall Study|Death|6
1033129|NCT00153816|3365392|P3|Overall Study|Death|4
1033130|NCT00153816|3365393|P2|Overall Study|Death|5
1033131|NCT00153816|3365394|P1|Overall Study|Death|6
1033132|NCT00153179|3365416|P4|Study Visit Day 2|Withdrawal by Subject|2
1033133|NCT00153179|3365417|P3|Study Visit Day 2|Withdrawal by Subject|2
1033134|NCT00153179|3365418|P2|Study Visit Day 2|Withdrawal by Subject|0
1033135|NCT00153179|3365419|P1|Study Visit Day 2|Withdrawal by Subject|1
1033136|NCT00153101|3365451|P5|Overall Study|Withdrawal by Subject|5
1033137|NCT00153101|3365452|P4|Overall Study|Withdrawal by Subject|3
1033138|NCT00153101|3365453|P3|Overall Study|Withdrawal by Subject|3
1033139|NCT00153101|3365454|P2|Overall Study|Withdrawal by Subject|4
1033140|NCT00153101|3365455|P1|Overall Study|Withdrawal by Subject|3
1033141|NCT00153101|3365451|P5|Overall Study|Lost to Follow-up|5
1033142|NCT00153101|3365452|P4|Overall Study|Lost to Follow-up|5
1033143|NCT00153101|3365453|P3|Overall Study|Lost to Follow-up|12
1033144|NCT00153101|3365454|P2|Overall Study|Lost to Follow-up|14
1033145|NCT00153101|3365455|P1|Overall Study|Lost to Follow-up|14
1033146|NCT00153062|3365563|P4|Overall Study|Other|0
1033147|NCT00153062|3365564|P3|Overall Study|Other|1
1033148|NCT00153062|3365565|P2|Overall Study|Other|0
1033149|NCT00153062|3365566|P1|Overall Study|Other|0
1033150|NCT00153062|3365563|P4|Overall Study|No disposition data available|1
1033151|NCT00153062|3365564|P3|Overall Study|No disposition data available|1
1033152|NCT00153062|3365565|P2|Overall Study|No disposition data available|1
1033153|NCT00153062|3365566|P1|Overall Study|No disposition data available|1
1033154|NCT00153062|3365563|P4|Overall Study|Protocol Violation|1
1033155|NCT00153062|3365564|P3|Overall Study|Protocol Violation|1
1033156|NCT00153062|3365565|P2|Overall Study|Protocol Violation|2
1033157|NCT00153062|3365566|P1|Overall Study|Protocol Violation|0
1033158|NCT00153062|3365563|P4|Overall Study|Adverse Event|0
1033159|NCT00153062|3365564|P3|Overall Study|Adverse Event|1
1033160|NCT00153062|3365565|P2|Overall Study|Adverse Event|1
1033161|NCT00153062|3365566|P1|Overall Study|Adverse Event|0
1033162|NCT00153062|3365563|P4|Overall Study|Lost to Follow-up|16
1033163|NCT00153062|3365564|P3|Overall Study|Lost to Follow-up|15
1033164|NCT00153062|3365565|P2|Overall Study|Lost to Follow-up|20
1033165|NCT00153062|3365566|P1|Overall Study|Lost to Follow-up|12
1033166|NCT00153062|3365563|P4|Overall Study|Withdrawal by Subject|28
1033167|NCT00153062|3365564|P3|Overall Study|Withdrawal by Subject|27
1033168|NCT00153062|3365565|P2|Overall Study|Withdrawal by Subject|30
1033169|NCT00153062|3365566|P1|Overall Study|Withdrawal by Subject|14
1033170|NCT00153062|3365563|P4|Overall Study|Death|365
1033171|NCT00153062|3365564|P3|Overall Study|Death|369
1033172|NCT00153062|3365565|P2|Overall Study|Death|352
1033173|NCT00153062|3365566|P1|Overall Study|Death|360
1033174|NCT00152971|3365585|P3|Treatment|not specified|10
1033175|NCT00152971|3365586|P2|Treatment|not specified|11
1033176|NCT00152971|3365587|P1|Treatment|not specified|9
1033177|NCT00152971|3365585|P3|Treatment|Withdrawal by Subject|5
1033178|NCT00152971|3365586|P2|Treatment|Withdrawal by Subject|4
1033179|NCT00152971|3365587|P1|Treatment|Withdrawal by Subject|4
1033180|NCT00152971|3365585|P3|Treatment|Lost to Follow-up|1
1033181|NCT00152971|3365586|P2|Treatment|Lost to Follow-up|2
1033182|NCT00152971|3365587|P1|Treatment|Lost to Follow-up|1
1033183|NCT00152971|3365585|P3|Treatment|Protocol Violation|10
1033184|NCT00152971|3365586|P2|Treatment|Protocol Violation|6
1033185|NCT00152971|3365587|P1|Treatment|Protocol Violation|8
1033186|NCT00152971|3365585|P3|Treatment|Adverse Event|54
1033187|NCT00152971|3365586|P2|Treatment|Adverse Event|40
1033188|NCT00152971|3365587|P1|Treatment|Adverse Event|49
1033189|NCT00152971|3365585|P3|Overall Study|not specified|5
1033190|NCT00152971|3365586|P2|Overall Study|not specified|5
1033191|NCT00152971|3365587|P1|Overall Study|not specified|3
1033192|NCT00152971|3365585|P3|Overall Study|Withdrawal by Subject|14
1033193|NCT00152971|3365586|P2|Overall Study|Withdrawal by Subject|8
1033194|NCT00152971|3365587|P1|Overall Study|Withdrawal by Subject|9
1033195|NCT00152971|3365585|P3|Overall Study|Lost to Follow-up|13
1033196|NCT00152971|3365586|P2|Overall Study|Lost to Follow-up|14
1033197|NCT00152971|3365587|P1|Overall Study|Lost to Follow-up|17
1033198|NCT00152971|3365585|P3|Overall Study|Protocol Violation|8
1033199|NCT00152971|3365586|P2|Overall Study|Protocol Violation|11
1033200|NCT00152971|3365587|P1|Overall Study|Protocol Violation|10
1033201|NCT00152971|3365585|P3|Overall Study|Adverse Event|9
1033202|NCT00152971|3365586|P2|Overall Study|Adverse Event|10
1033203|NCT00152971|3365587|P1|Overall Study|Adverse Event|12
1033204|NCT00152763|3365623|P4|Overall Study|Lost to Follow-up|13
1033205|NCT00152763|3365624|P3|Overall Study|Lost to Follow-up|2
1033206|NCT00152763|3365625|P2|Overall Study|Lost to Follow-up|4
1033207|NCT00152763|3365626|P1|Overall Study|Lost to Follow-up|6
1033208|NCT00152763|3365623|P4|Overall Study|Death|1
1033209|NCT00152763|3365624|P3|Overall Study|Death|2
1033210|NCT00152763|3365625|P2|Overall Study|Death|1
1033211|NCT00152763|3365626|P1|Overall Study|Death|4
1033212|NCT00152516|3365742|P1|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1
1033213|NCT00152516|3365742|P1|Overall Study|Other: Underwent Surgery for Epilepsy|1
1033214|NCT00152516|3365742|P1|Overall Study|Other: Moved Out Of State|1
1033215|NCT00152516|3365742|P1|Overall Study|Other: Primary Care Physician's Decision|1
1033216|NCT00152516|3365742|P1|Overall Study|Other: Non-Compliance|2
1033217|NCT00152516|3365742|P1|Overall Study|Other: Parents Withdrew Consent|2
1033218|NCT00152516|3365742|P1|Overall Study|Other: Given Commercial Drug in Error|2
1033219|NCT00152516|3365742|P1|Overall Study|Other: Mother Refused To Cooperate|1
1033220|NCT00152516|3365742|P1|Overall Study|Protocol Violation|3
1033221|NCT00152516|3365742|P1|Overall Study|Withdrawal by Subject|8
1033222|NCT00152516|3365742|P1|Overall Study|Lost to Follow-up|5
1033223|NCT00152516|3365742|P1|Overall Study|Lack and Loss of Efficacy|30
1033224|NCT00152516|3365742|P1|Overall Study|Adverse Event|18
1033225|NCT00152009|3365770|P4|Overall Study|Sponsor's decision|3
1033226|NCT00152009|3365771|P3|Overall Study|Sponsor's decision|1
1033227|NCT00152009|3365772|P2|Overall Study|Sponsor's decision|3
1033228|NCT00152009|3365773|P1|Overall Study|Sponsor's decision|3
1033229|NCT00152009|3365770|P4|Overall Study|ECG abnormalities|1
1033230|NCT00152009|3365771|P3|Overall Study|ECG abnormalities|2
1033231|NCT00152009|3365772|P2|Overall Study|ECG abnormalities|2
1033232|NCT00152009|3365773|P1|Overall Study|ECG abnormalities|2
1033233|NCT00152009|3365770|P4|Overall Study|Lack of Efficacy|15
1033234|NCT00152009|3365771|P3|Overall Study|Lack of Efficacy|7
1033235|NCT00152009|3365772|P2|Overall Study|Lack of Efficacy|6
1033236|NCT00152009|3365773|P1|Overall Study|Lack of Efficacy|8
1033237|NCT00152009|3365770|P4|Overall Study|Lost to Follow-up|3
1033238|NCT00152009|3365771|P3|Overall Study|Lost to Follow-up|3
1033239|NCT00152009|3365772|P2|Overall Study|Lost to Follow-up|4
1033240|NCT00152009|3365773|P1|Overall Study|Lost to Follow-up|2
1033241|NCT00152009|3365770|P4|Overall Study|Withdrawal by Subject|9
1033242|NCT00152009|3365771|P3|Overall Study|Withdrawal by Subject|4
1033243|NCT00152009|3365772|P2|Overall Study|Withdrawal by Subject|3
1033244|NCT00152009|3365773|P1|Overall Study|Withdrawal by Subject|2
1033245|NCT00152009|3365770|P4|Overall Study|Protocol Violation|1
1033246|NCT00152009|3365771|P3|Overall Study|Protocol Violation|0
1033247|NCT00152009|3365772|P2|Overall Study|Protocol Violation|0
1033248|NCT00152009|3365773|P1|Overall Study|Protocol Violation|3
1033249|NCT00152009|3365770|P4|Overall Study|Adverse Event|1
1033250|NCT00152009|3365771|P3|Overall Study|Adverse Event|20
1033251|NCT00152009|3365772|P2|Overall Study|Adverse Event|13
1033252|NCT00152009|3365773|P1|Overall Study|Adverse Event|9
1033253|NCT00151996|3365805|P2|Overall Study|Sponsor's decision|2
1033254|NCT00151996|3365806|P1|Overall Study|Sponsor's decision|0
1033255|NCT00151996|3365805|P2|Overall Study|Protocol Violation|2
1033256|NCT00151996|3365806|P1|Overall Study|Protocol Violation|1
1033257|NCT00151996|3365805|P2|Overall Study|Withdrawal by Subject|1
1033258|NCT00151996|3365806|P1|Overall Study|Withdrawal by Subject|1
1033259|NCT00151996|3365805|P2|Overall Study|Adverse Event|2
1033260|NCT00151996|3365806|P1|Overall Study|Adverse Event|3
1033261|NCT00151892|3365822|P2|Overall Study|Lack of study medication at center|1
1033262|NCT00151892|3365823|P1|Overall Study|Lack of study medication at center|0
1033263|NCT00151892|3365822|P2|Overall Study|Used prohibited corticosteroids|0
1033264|NCT00151892|3365823|P1|Overall Study|Used prohibited corticosteroids|1
1033265|NCT00151892|3365822|P2|Overall Study|Did not return for a visit|0
1033266|NCT00151892|3365823|P1|Overall Study|Did not return for a visit|1
1033267|NCT00151892|3365822|P2|Overall Study|Pregnancy|1
1033268|NCT00151892|3365823|P1|Overall Study|Pregnancy|0
1033269|NCT00151892|3365822|P2|Overall Study|Non-compliance|1
1033270|NCT00151892|3365823|P1|Overall Study|Non-compliance|0
1033271|NCT00151892|3365822|P2|Overall Study|Protocol Violation|3
1033272|NCT00151892|3365823|P1|Overall Study|Protocol Violation|3
1033273|NCT00151892|3365822|P2|Overall Study|Adverse Event|3
1033274|NCT00151892|3365823|P1|Overall Study|Adverse Event|6
1033275|NCT00151892|3365822|P2|Overall Study|Lost to Follow-up|10
1033276|NCT00151892|3365823|P1|Overall Study|Lost to Follow-up|5
1033277|NCT00151892|3365822|P2|Overall Study|Patient request|7
1033278|NCT00151892|3365823|P1|Overall Study|Patient request|10
1033279|NCT00151892|3365822|P2|Overall Study|Lack of Efficacy|57
1033280|NCT00151892|3365823|P1|Overall Study|Lack of Efficacy|50
1033281|NCT00151775|3365868|P12|Period 4: Open Label|Protocol Violation|0
1033282|NCT00151775|3365869|P11|Period 4: Open Label|Protocol Violation|0
1033283|NCT00151775|3365870|P10|Period 4: Open Label|Protocol Violation|0
1033284|NCT00151775|3365871|P9|Period 4: Open Label|Protocol Violation|0
1033285|NCT00151775|3365872|P8|Period 4: Open Label|Protocol Violation|0
1033286|NCT00151775|3365873|P7|Period 4: Open Label|Protocol Violation|0
1033287|NCT00151775|3365874|P6|Period 4: Open Label|Protocol Violation|0
1033288|NCT00151775|3365875|P5|Period 4: Open Label|Protocol Violation|1
1033289|NCT00151775|3365876|P4|Period 4: Open Label|Protocol Violation|0
1033290|NCT00151775|3365877|P3|Period 4: Open Label|Protocol Violation|0
1033291|NCT00151775|3365878|P2|Period 4: Open Label|Protocol Violation|0
1033292|NCT00151775|3365879|P1|Period 4: Open Label|Protocol Violation|0
1033293|NCT00151775|3365868|P12|Period 4: Open Label|Physician Decision|0
1033294|NCT00151775|3365869|P11|Period 4: Open Label|Physician Decision|0
1033295|NCT00151775|3365870|P10|Period 4: Open Label|Physician Decision|2
1033296|NCT00151775|3365871|P9|Period 4: Open Label|Physician Decision|0
1033297|NCT00151775|3365872|P8|Period 4: Open Label|Physician Decision|0
1033298|NCT00151775|3365873|P7|Period 4: Open Label|Physician Decision|0
1033299|NCT00151775|3365874|P6|Period 4: Open Label|Physician Decision|0
1033300|NCT00151775|3365875|P5|Period 4: Open Label|Physician Decision|0
1033301|NCT00151775|3365876|P4|Period 4: Open Label|Physician Decision|0
1033302|NCT00151775|3365877|P3|Period 4: Open Label|Physician Decision|0
1033303|NCT00151775|3365878|P2|Period 4: Open Label|Physician Decision|0
1033304|NCT00151775|3365879|P1|Period 4: Open Label|Physician Decision|0
1033305|NCT00151775|3365868|P12|Period 4: Open Label|Other|0
1033306|NCT00151775|3365869|P11|Period 4: Open Label|Other|0
1033307|NCT00151775|3365870|P10|Period 4: Open Label|Other|3
1033308|NCT00151775|3365871|P9|Period 4: Open Label|Other|0
1033309|NCT00151775|3365872|P8|Period 4: Open Label|Other|0
1033310|NCT00151775|3365873|P7|Period 4: Open Label|Other|0
1033311|NCT00151775|3365874|P6|Period 4: Open Label|Other|0
1033312|NCT00151775|3365875|P5|Period 4: Open Label|Other|1
1033313|NCT00151775|3365876|P4|Period 4: Open Label|Other|0
1033314|NCT00151775|3365877|P3|Period 4: Open Label|Other|0
1033315|NCT00151775|3365878|P2|Period 4: Open Label|Other|0
1033316|NCT00151775|3365879|P1|Period 4: Open Label|Other|0
1033317|NCT00151775|3365868|P12|Period 4: Open Label|Non-compliance with protocol|0
1033318|NCT00151775|3365869|P11|Period 4: Open Label|Non-compliance with protocol|0
1033319|NCT00151775|3365870|P10|Period 4: Open Label|Non-compliance with protocol|4
1033320|NCT00151775|3365871|P9|Period 4: Open Label|Non-compliance with protocol|0
1033321|NCT00151775|3365872|P8|Period 4: Open Label|Non-compliance with protocol|0
1033322|NCT00151775|3365873|P7|Period 4: Open Label|Non-compliance with protocol|0
1033323|NCT00151775|3365874|P6|Period 4: Open Label|Non-compliance with protocol|0
1033324|NCT00151775|3365875|P5|Period 4: Open Label|Non-compliance with protocol|4
1033325|NCT00151775|3365876|P4|Period 4: Open Label|Non-compliance with protocol|0
1033326|NCT00151775|3365877|P3|Period 4: Open Label|Non-compliance with protocol|0
1033327|NCT00151775|3365878|P2|Period 4: Open Label|Non-compliance with protocol|0
1033328|NCT00151775|3365879|P1|Period 4: Open Label|Non-compliance with protocol|0
1033329|NCT00151775|3365868|P12|Period 4: Open Label|Lost to Follow-up|0
1033330|NCT00151775|3365869|P11|Period 4: Open Label|Lost to Follow-up|0
1033331|NCT00151775|3365870|P10|Period 4: Open Label|Lost to Follow-up|7
1033332|NCT00151775|3365871|P9|Period 4: Open Label|Lost to Follow-up|0
1033333|NCT00151775|3365872|P8|Period 4: Open Label|Lost to Follow-up|0
1033334|NCT00151775|3365873|P7|Period 4: Open Label|Lost to Follow-up|0
1033335|NCT00151775|3365874|P6|Period 4: Open Label|Lost to Follow-up|0
1033336|NCT00151775|3365875|P5|Period 4: Open Label|Lost to Follow-up|17
1033337|NCT00151775|3365876|P4|Period 4: Open Label|Lost to Follow-up|0
1033338|NCT00151775|3365877|P3|Period 4: Open Label|Lost to Follow-up|0
1033339|NCT00151775|3365878|P2|Period 4: Open Label|Lost to Follow-up|0
1033340|NCT00151775|3365879|P1|Period 4: Open Label|Lost to Follow-up|0
1033341|NCT00151775|3365868|P12|Period 4: Open Label|Adverse Event|0
1033342|NCT00151775|3365869|P11|Period 4: Open Label|Adverse Event|0
1033343|NCT00151775|3365870|P10|Period 4: Open Label|Adverse Event|2
1033344|NCT00151775|3365871|P9|Period 4: Open Label|Adverse Event|0
1033345|NCT00151775|3365872|P8|Period 4: Open Label|Adverse Event|0
1033346|NCT00151775|3365873|P7|Period 4: Open Label|Adverse Event|0
1033347|NCT00151775|3365874|P6|Period 4: Open Label|Adverse Event|0
1033348|NCT00151775|3365875|P5|Period 4: Open Label|Adverse Event|1
1033349|NCT00151775|3365876|P4|Period 4: Open Label|Adverse Event|0
1033350|NCT00151775|3365877|P3|Period 4: Open Label|Adverse Event|0
1033351|NCT00151775|3365878|P2|Period 4: Open Label|Adverse Event|0
1033352|NCT00151775|3365879|P1|Period 4: Open Label|Adverse Event|0
1033353|NCT00151775|3365868|P12|Period 4: Open Label|Withdrawal by Subject|0
1033354|NCT00151775|3365869|P11|Period 4: Open Label|Withdrawal by Subject|0
1033355|NCT00151775|3365870|P10|Period 4: Open Label|Withdrawal by Subject|2
1033356|NCT00151775|3365871|P9|Period 4: Open Label|Withdrawal by Subject|0
1033357|NCT00151775|3365872|P8|Period 4: Open Label|Withdrawal by Subject|0
1033358|NCT00151775|3365873|P7|Period 4: Open Label|Withdrawal by Subject|0
1033359|NCT00151775|3365874|P6|Period 4: Open Label|Withdrawal by Subject|0
1033360|NCT00151775|3365875|P5|Period 4: Open Label|Withdrawal by Subject|5
1033361|NCT00151775|3365876|P4|Period 4: Open Label|Withdrawal by Subject|0
1033362|NCT00151775|3365877|P3|Period 4: Open Label|Withdrawal by Subject|0
1033363|NCT00151775|3365878|P2|Period 4: Open Label|Withdrawal by Subject|0
1033364|NCT00151775|3365879|P1|Period 4: Open Label|Withdrawal by Subject|0
1033365|NCT00151775|3365868|P12|Period 4: Open Label|Increased blood pressure|0
1033366|NCT00151775|3365869|P11|Period 4: Open Label|Increased blood pressure|0
1033367|NCT00151775|3365870|P10|Period 4: Open Label|Increased blood pressure|1
1033368|NCT00151775|3365871|P9|Period 4: Open Label|Increased blood pressure|0
1033369|NCT00151775|3365872|P8|Period 4: Open Label|Increased blood pressure|0
1033370|NCT00151775|3365873|P7|Period 4: Open Label|Increased blood pressure|0
1033371|NCT00151775|3365874|P6|Period 4: Open Label|Increased blood pressure|0
1033372|NCT00151775|3365875|P5|Period 4: Open Label|Increased blood pressure|1
1033373|NCT00151775|3365876|P4|Period 4: Open Label|Increased blood pressure|0
1033374|NCT00151775|3365877|P3|Period 4: Open Label|Increased blood pressure|0
1033375|NCT00151775|3365878|P2|Period 4: Open Label|Increased blood pressure|0
1033376|NCT00151775|3365879|P1|Period 4: Open Label|Increased blood pressure|0
1033377|NCT00151775|3365868|P12|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1
1033378|NCT00151775|3365869|P11|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1033379|NCT00151775|3365870|P10|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1033380|NCT00151775|3365871|P9|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1033381|NCT00151775|3365872|P8|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1033382|NCT00151775|3365873|P7|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1033383|NCT00151775|3365874|P6|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1033384|NCT00151775|3365875|P5|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1033385|NCT00151775|3365876|P4|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1033386|NCT00151775|3365877|P3|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1033387|NCT00151775|3365878|P2|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1033388|NCT00151775|3365879|P1|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1033389|NCT00151775|3365868|P12|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1033390|NCT00151775|3365869|P11|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1033391|NCT00151775|3365870|P10|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1033392|NCT00151775|3365871|P9|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1033393|NCT00151775|3365872|P8|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1033394|NCT00151775|3365873|P7|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1033395|NCT00151775|3365874|P6|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1033396|NCT00151775|3365875|P5|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1033397|NCT00151775|3365876|P4|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1033398|NCT00151775|3365877|P3|Period 3: Double-blind, Withdrawal|Protocol Violation|1
1033399|NCT00151775|3365878|P2|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1033400|NCT00151775|3365879|P1|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1033401|NCT00151775|3365868|P12|Period 3: Double-blind, Withdrawal|Adverse Event|0
1033402|NCT00151775|3365869|P11|Period 3: Double-blind, Withdrawal|Adverse Event|0
1033403|NCT00151775|3365870|P10|Period 3: Double-blind, Withdrawal|Adverse Event|0
1033404|NCT00151775|3365871|P9|Period 3: Double-blind, Withdrawal|Adverse Event|0
1033405|NCT00151775|3365872|P8|Period 3: Double-blind, Withdrawal|Adverse Event|0
1033406|NCT00151775|3365873|P7|Period 3: Double-blind, Withdrawal|Adverse Event|0
1033407|NCT00151775|3365874|P6|Period 3: Double-blind, Withdrawal|Adverse Event|0
1033408|NCT00151775|3365875|P5|Period 3: Double-blind, Withdrawal|Adverse Event|0
1033409|NCT00151775|3365876|P4|Period 3: Double-blind, Withdrawal|Adverse Event|0
1033410|NCT00151775|3365877|P3|Period 3: Double-blind, Withdrawal|Adverse Event|1
1033411|NCT00151775|3365878|P2|Period 3: Double-blind, Withdrawal|Adverse Event|0
1033412|NCT00151775|3365879|P1|Period 3: Double-blind, Withdrawal|Adverse Event|0
1033413|NCT00151775|3365868|P12|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1033414|NCT00151775|3365869|P11|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1033415|NCT00151775|3365870|P10|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1033416|NCT00151775|3365871|P9|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1033417|NCT00151775|3365872|P8|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1033418|NCT00151775|3365873|P7|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1
1033419|NCT00151775|3365874|P6|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1033420|NCT00151775|3365875|P5|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1033421|NCT00151775|3365876|P4|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1033422|NCT00151775|3365877|P3|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1033423|NCT00151775|3365878|P2|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1033424|NCT00151775|3365879|P1|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1033425|NCT00151775|3365868|P12|Period 3: Double-blind, Withdrawal|Other|0
1033426|NCT00151775|3365869|P11|Period 3: Double-blind, Withdrawal|Other|0
1033427|NCT00151775|3365870|P10|Period 3: Double-blind, Withdrawal|Other|0
1033428|NCT00151775|3365871|P9|Period 3: Double-blind, Withdrawal|Other|0
1033429|NCT00151775|3365872|P8|Period 3: Double-blind, Withdrawal|Other|1
1033430|NCT00151775|3365873|P7|Period 3: Double-blind, Withdrawal|Other|0
1033431|NCT00151775|3365874|P6|Period 3: Double-blind, Withdrawal|Other|0
1033432|NCT00151775|3365875|P5|Period 3: Double-blind, Withdrawal|Other|0
1033433|NCT00151775|3365876|P4|Period 3: Double-blind, Withdrawal|Other|0
1033434|NCT00151775|3365877|P3|Period 3: Double-blind, Withdrawal|Other|1
1033435|NCT00151775|3365878|P2|Period 3: Double-blind, Withdrawal|Other|0
1033436|NCT00151775|3365879|P1|Period 3: Double-blind, Withdrawal|Other|0
1033437|NCT00151775|3365868|P12|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1033438|NCT00151775|3365869|P11|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1033439|NCT00151775|3365870|P10|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1033440|NCT00151775|3365871|P9|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1033441|NCT00151775|3365872|P8|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1033442|NCT00151775|3365873|P7|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1033443|NCT00151775|3365874|P6|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1
1033444|NCT00151775|3365875|P5|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1033445|NCT00151775|3365876|P4|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1033446|NCT00151775|3365877|P3|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1033447|NCT00151775|3365878|P2|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1033448|NCT00151775|3365879|P1|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1033449|NCT00151775|3365868|P12|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1033450|NCT00151775|3365869|P11|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1033451|NCT00151775|3365870|P10|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1033452|NCT00151775|3365871|P9|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1033453|NCT00151775|3365872|P8|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1033454|NCT00151775|3365873|P7|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1
1033455|NCT00151775|3365874|P6|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1033456|NCT00151775|3365875|P5|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1033457|NCT00151775|3365876|P4|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1033458|NCT00151775|3365877|P3|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1033459|NCT00151775|3365878|P2|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1033460|NCT00151775|3365879|P1|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1033461|NCT00151775|3365868|P12|Period 2 - Double-Blind Dose Response|Physician Decision|0
1033462|NCT00151775|3365869|P11|Period 2 - Double-Blind Dose Response|Physician Decision|0
1033463|NCT00151775|3365870|P10|Period 2 - Double-Blind Dose Response|Physician Decision|0
1033464|NCT00151775|3365871|P9|Period 2 - Double-Blind Dose Response|Physician Decision|0
1033465|NCT00151775|3365872|P8|Period 2 - Double-Blind Dose Response|Physician Decision|0
1033466|NCT00151775|3365873|P7|Period 2 - Double-Blind Dose Response|Physician Decision|0
1033467|NCT00151775|3365874|P6|Period 2 - Double-Blind Dose Response|Physician Decision|1
1033468|NCT00151775|3365875|P5|Period 2 - Double-Blind Dose Response|Physician Decision|0
1033469|NCT00151775|3365876|P4|Period 2 - Double-Blind Dose Response|Physician Decision|0
1033470|NCT00151775|3365877|P3|Period 2 - Double-Blind Dose Response|Physician Decision|0
1033471|NCT00151775|3365878|P2|Period 2 - Double-Blind Dose Response|Physician Decision|0
1033472|NCT00151775|3365879|P1|Period 2 - Double-Blind Dose Response|Physician Decision|0
1033473|NCT00151775|3365868|P12|Period 2 - Double-Blind Dose Response|non-compliance|0
1033474|NCT00151775|3365869|P11|Period 2 - Double-Blind Dose Response|non-compliance|0
1033475|NCT00151775|3365870|P10|Period 2 - Double-Blind Dose Response|non-compliance|0
1033476|NCT00151775|3365871|P9|Period 2 - Double-Blind Dose Response|non-compliance|0
1033477|NCT00151775|3365872|P8|Period 2 - Double-Blind Dose Response|non-compliance|0
1033478|NCT00151775|3365873|P7|Period 2 - Double-Blind Dose Response|non-compliance|0
1033479|NCT00151775|3365874|P6|Period 2 - Double-Blind Dose Response|non-compliance|1
1033480|NCT00151775|3365875|P5|Period 2 - Double-Blind Dose Response|non-compliance|0
1033481|NCT00151775|3365876|P4|Period 2 - Double-Blind Dose Response|non-compliance|0
1033482|NCT00151775|3365877|P3|Period 2 - Double-Blind Dose Response|non-compliance|0
1033483|NCT00151775|3365878|P2|Period 2 - Double-Blind Dose Response|non-compliance|0
1033484|NCT00151775|3365879|P1|Period 2 - Double-Blind Dose Response|non-compliance|0
1033485|NCT00151775|3365868|P12|Period 2 - Double-Blind Dose Response|Other|0
1033486|NCT00151775|3365869|P11|Period 2 - Double-Blind Dose Response|Other|0
1033487|NCT00151775|3365870|P10|Period 2 - Double-Blind Dose Response|Other|0
1033488|NCT00151775|3365871|P9|Period 2 - Double-Blind Dose Response|Other|0
1033489|NCT00151775|3365872|P8|Period 2 - Double-Blind Dose Response|Other|0
1033490|NCT00151775|3365873|P7|Period 2 - Double-Blind Dose Response|Other|1
1033491|NCT00151775|3365874|P6|Period 2 - Double-Blind Dose Response|Other|0
1033492|NCT00151775|3365875|P5|Period 2 - Double-Blind Dose Response|Other|0
1033493|NCT00151775|3365876|P4|Period 2 - Double-Blind Dose Response|Other|0
1033494|NCT00151775|3365877|P3|Period 2 - Double-Blind Dose Response|Other|0
1033495|NCT00151775|3365878|P2|Period 2 - Double-Blind Dose Response|Other|0
1033496|NCT00151775|3365879|P1|Period 2 - Double-Blind Dose Response|Other|0
1033497|NCT00151775|3365868|P12|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1033498|NCT00151775|3365869|P11|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1033499|NCT00151775|3365870|P10|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1033500|NCT00151775|3365871|P9|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1033501|NCT00151775|3365872|P8|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1033502|NCT00151775|3365873|P7|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1033503|NCT00151775|3365874|P6|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1033504|NCT00151775|3365875|P5|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1033505|NCT00151775|3365876|P4|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1033506|NCT00151775|3365877|P3|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1033507|NCT00151775|3365878|P2|Period 2 - Double-Blind Dose Response|Protocol Violation|4
1033508|NCT00151775|3365879|P1|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1033509|NCT00151775|3365868|P12|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1033510|NCT00151775|3365869|P11|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
1033511|NCT00151775|3365870|P10|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1033512|NCT00151775|3365871|P9|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1033513|NCT00151775|3365872|P8|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1033514|NCT00151775|3365873|P7|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
1033515|NCT00151775|3365874|P6|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1033516|NCT00151775|3365875|P5|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1033517|NCT00151775|3365876|P4|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1033518|NCT00151775|3365877|P3|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1033519|NCT00151775|3365878|P2|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1033520|NCT00151775|3365879|P1|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
1033521|NCT00151775|3365868|P12|Period 2 - Double-Blind Dose Response|Adverse Event|0
1033522|NCT00151775|3365869|P11|Period 2 - Double-Blind Dose Response|Adverse Event|0
1033523|NCT00151775|3365870|P10|Period 2 - Double-Blind Dose Response|Adverse Event|0
1033524|NCT00151775|3365871|P9|Period 2 - Double-Blind Dose Response|Adverse Event|0
1033525|NCT00151775|3365872|P8|Period 2 - Double-Blind Dose Response|Adverse Event|0
1033526|NCT00151775|3365873|P7|Period 2 - Double-Blind Dose Response|Adverse Event|0
1033527|NCT00151775|3365874|P6|Period 2 - Double-Blind Dose Response|Adverse Event|0
1033528|NCT00151775|3365875|P5|Period 2 - Double-Blind Dose Response|Adverse Event|0
1033529|NCT00151775|3365876|P4|Period 2 - Double-Blind Dose Response|Adverse Event|0
1033530|NCT00151775|3365877|P3|Period 2 - Double-Blind Dose Response|Adverse Event|0
1033531|NCT00151775|3365878|P2|Period 2 - Double-Blind Dose Response|Adverse Event|2
1033532|NCT00151775|3365879|P1|Period 2 - Double-Blind Dose Response|Adverse Event|1
1033533|NCT00151476|3365923|P2|FAP Analyzed Subjects|Other study participation|1
1033534|NCT00151476|3365924|P1|FAP Analyzed Subjects|Other study participation|0
1033535|NCT00151476|3365923|P2|FAP Analyzed Subjects|Lost to Follow-up|2
1033536|NCT00151476|3365924|P1|FAP Analyzed Subjects|Lost to Follow-up|0
1033537|NCT00151476|3365923|P2|FAP Identified Subjects|Protocol Violation|1
1033538|NCT00151476|3365924|P1|FAP Identified Subjects|Protocol Violation|0
1033539|NCT00151411|3365981|P2|Overall Study|Pregnancy|4
1033540|NCT00151411|3365982|P1|Overall Study|Pregnancy|0
1033541|NCT00151411|3365981|P2|Overall Study|Adverse Event|0
1033542|NCT00151411|3365982|P1|Overall Study|Adverse Event|6
1033543|NCT00151411|3365981|P2|Overall Study|Withdrawal by Subject|20
1033544|NCT00151411|3365982|P1|Overall Study|Withdrawal by Subject|12
1033545|NCT00151411|3365981|P2|Overall Study|Lost to Follow-up|19
1033546|NCT00151411|3365982|P1|Overall Study|Lost to Follow-up|15
1033547|NCT00151372|3365994|P2|Overall Study|Withdrawal by Subject|7
1033548|NCT00151372|3365995|P1|Overall Study|Withdrawal by Subject|7
1033549|NCT00151372|3365994|P2|Overall Study|Too sick medically to continue|6
1033550|NCT00151372|3365995|P1|Overall Study|Too sick medically to continue|5
1033551|NCT00151372|3365994|P2|Overall Study|Lost to Follow-up|5
1033552|NCT00151372|3365995|P1|Overall Study|Lost to Follow-up|5
1033553|NCT00151372|3365994|P2|Overall Study|Death|11
1033554|NCT00151372|3365995|P1|Overall Study|Death|12
1033555|NCT00151281|3366010|P1|Overall Study|Not evaluable|3
1033556|NCT00150969|3366019|P2|24-48 Month Extension|Other Reason|91
1033557|NCT00150969|3366020|P1|24-48 Month Extension|Other Reason|81
1033558|NCT00150969|3366019|P2|24-48 Month Extension|Adverse Event|3
1033559|NCT00150969|3366020|P1|24-48 Month Extension|Adverse Event|1
1033560|NCT00150969|3366019|P2|24-48 Month Extension|Lack of Efficacy|1
1033561|NCT00150969|3366020|P1|24-48 Month Extension|Lack of Efficacy|0
1033562|NCT00150969|3366019|P2|24-48 Month Extension|Withdrawal by Subject|5
1033563|NCT00150969|3366020|P1|24-48 Month Extension|Withdrawal by Subject|6
1033564|NCT00150969|3366019|P2|24 Month Main Study|Withdrawal by Subject|4
1033565|NCT00150969|3366020|P1|24 Month Main Study|Withdrawal by Subject|7
1033566|NCT00150969|3366019|P2|24 Month Main Study|Protocol Violation|2
1033567|NCT00150969|3366020|P1|24 Month Main Study|Protocol Violation|4
1033568|NCT00150969|3366019|P2|24 Month Main Study|Lost to Follow-up|2
1033569|NCT00150969|3366020|P1|24 Month Main Study|Lost to Follow-up|3
1033570|NCT00150969|3366019|P2|24 Month Main Study|Lack of Efficacy|8
1033571|NCT00150969|3366020|P1|24 Month Main Study|Lack of Efficacy|1
1033572|NCT00150969|3366019|P2|24 Month Main Study|Death|1
1033573|NCT00150969|3366020|P1|24 Month Main Study|Death|1
1033574|NCT00150969|3366019|P2|24 Month Main Study|Adverse Event|4
1033575|NCT00150969|3366020|P1|24 Month Main Study|Adverse Event|3
1033576|NCT00150813|3366052|P1|Overall Study|Switch to commercially available LEV|2
1033577|NCT00150813|3366052|P1|Overall Study|Planned pregancy|1
1033578|NCT00150813|3366052|P1|Overall Study|Remission|3
1033579|NCT00150813|3366052|P1|Overall Study|Withdrawal by Subject|5
1033580|NCT00150813|3366052|P1|Overall Study|Lost to Follow-up|5
1033581|NCT00150813|3366052|P1|Overall Study|Lack of Efficacy|1
1033582|NCT00150813|3366052|P1|Overall Study|Adverse Event|1
1033583|NCT00150618|3366061|P5|Overall Study|Sponsor's decision|0
1033584|NCT00150618|3366062|P4|Overall Study|Sponsor's decision|1
1033585|NCT00150618|3366063|P3|Overall Study|Sponsor's decision|0
1033586|NCT00150618|3366064|P2|Overall Study|Sponsor's decision|0
1033587|NCT00150618|3366065|P1|Overall Study|Sponsor's decision|0
1033588|NCT00150618|3366061|P5|Overall Study|Abnormal ECG|0
1033589|NCT00150618|3366062|P4|Overall Study|Abnormal ECG|0
1033590|NCT00150618|3366063|P3|Overall Study|Abnormal ECG|0
1033591|NCT00150618|3366064|P2|Overall Study|Abnormal ECG|0
1033592|NCT00150618|3366065|P1|Overall Study|Abnormal ECG|1
1033593|NCT00150618|3366061|P5|Overall Study|Lack of compliance|1
1033594|NCT00150618|3366062|P4|Overall Study|Lack of compliance|0
1033595|NCT00150618|3366063|P3|Overall Study|Lack of compliance|1
1033596|NCT00150618|3366064|P2|Overall Study|Lack of compliance|1
1033597|NCT00150618|3366065|P1|Overall Study|Lack of compliance|2
1033598|NCT00150618|3366061|P5|Overall Study|Physician Decision|1
1033599|NCT00150618|3366062|P4|Overall Study|Physician Decision|0
1033600|NCT00150618|3366063|P3|Overall Study|Physician Decision|0
1033601|NCT00150618|3366064|P2|Overall Study|Physician Decision|2
1033602|NCT00150618|3366065|P1|Overall Study|Physician Decision|0
1033603|NCT00150618|3366061|P5|Overall Study|No study meds|2
1033604|NCT00150618|3366062|P4|Overall Study|No study meds|0
1033605|NCT00150618|3366063|P3|Overall Study|No study meds|0
1033606|NCT00150618|3366064|P2|Overall Study|No study meds|0
1033607|NCT00150618|3366065|P1|Overall Study|No study meds|0
1033608|NCT00150618|3366061|P5|Overall Study|Lack of Efficacy|6
1033609|NCT00150618|3366062|P4|Overall Study|Lack of Efficacy|4
1033610|NCT00150618|3366063|P3|Overall Study|Lack of Efficacy|7
1033611|NCT00150618|3366064|P2|Overall Study|Lack of Efficacy|4
1033612|NCT00150618|3366065|P1|Overall Study|Lack of Efficacy|1
1033613|NCT00150618|3366061|P5|Overall Study|Protocol Violation|1
1033614|NCT00150618|3366062|P4|Overall Study|Protocol Violation|0
1033615|NCT00150618|3366063|P3|Overall Study|Protocol Violation|0
1033616|NCT00150618|3366064|P2|Overall Study|Protocol Violation|0
1033617|NCT00150618|3366065|P1|Overall Study|Protocol Violation|1
1033618|NCT00150618|3366061|P5|Overall Study|Lost to Follow-up|4
1033619|NCT00150618|3366062|P4|Overall Study|Lost to Follow-up|8
1033620|NCT00150618|3366063|P3|Overall Study|Lost to Follow-up|5
1033621|NCT00150618|3366064|P2|Overall Study|Lost to Follow-up|1
1033622|NCT00150618|3366065|P1|Overall Study|Lost to Follow-up|4
1033623|NCT00150618|3366061|P5|Overall Study|Withdrawal by Subject|5
1033624|NCT00150618|3366062|P4|Overall Study|Withdrawal by Subject|4
1033625|NCT00150618|3366063|P3|Overall Study|Withdrawal by Subject|8
1033626|NCT00150618|3366064|P2|Overall Study|Withdrawal by Subject|8
1033627|NCT00150618|3366065|P1|Overall Study|Withdrawal by Subject|6
1033628|NCT00150618|3366061|P5|Overall Study|Adverse Event|5
1033629|NCT00150618|3366062|P4|Overall Study|Adverse Event|9
1033630|NCT00150618|3366063|P3|Overall Study|Adverse Event|6
1033631|NCT00150618|3366064|P2|Overall Study|Adverse Event|2
1033632|NCT00150618|3366065|P1|Overall Study|Adverse Event|2
1033633|NCT00150592|3366099|P2|Overall Study|Non-compliance|0
1033634|NCT00150592|3366100|P1|Overall Study|Non-compliance|1
1033635|NCT00150592|3366099|P2|Overall Study|Withdrawal by Subject|2
1033636|NCT00150592|3366100|P1|Overall Study|Withdrawal by Subject|1
1033637|NCT00150592|3366099|P2|Overall Study|Protocol Violation|0
1033638|NCT00150592|3366100|P1|Overall Study|Protocol Violation|1
1033639|NCT00150592|3366099|P2|Overall Study|Adverse Event|1
1033640|NCT00150592|3366100|P1|Overall Study|Adverse Event|4
1033641|NCT00150462|3366131|P11|Overall Study|Other|1
1033642|NCT00150462|3366132|P10|Overall Study|Other|1
1033643|NCT00150462|3366133|P9|Overall Study|Other|0
1033644|NCT00150462|3366134|P8|Overall Study|Other|0
1033645|NCT00150462|3366135|P7|Overall Study|Other|0
1033646|NCT00150462|3366136|P6|Overall Study|Other|0
1033647|NCT00150462|3366137|P5|Overall Study|Other|0
1033648|NCT00150462|3366138|P4|Overall Study|Other|0
1033649|NCT00150462|3366139|P3|Overall Study|Other|0
1033650|NCT00150462|3366140|P2|Overall Study|Other|0
1033651|NCT00150462|3366141|P1|Overall Study|Other|0
1033652|NCT00150462|3366131|P11|Overall Study|Physician Decision|0
1033653|NCT00150462|3366132|P10|Overall Study|Physician Decision|0
1033654|NCT00150462|3366133|P9|Overall Study|Physician Decision|0
1033655|NCT00150462|3366134|P8|Overall Study|Physician Decision|0
1033656|NCT00150462|3366135|P7|Overall Study|Physician Decision|0
1033657|NCT00150462|3366136|P6|Overall Study|Physician Decision|0
1033658|NCT00150462|3366137|P5|Overall Study|Physician Decision|0
1033659|NCT00150462|3366138|P4|Overall Study|Physician Decision|1
1033660|NCT00150462|3366139|P3|Overall Study|Physician Decision|1
1033661|NCT00150462|3366140|P2|Overall Study|Physician Decision|0
1033662|NCT00150462|3366141|P1|Overall Study|Physician Decision|0
1033663|NCT00150462|3366131|P11|Overall Study|Adverse Event|0
1033664|NCT00150462|3366132|P10|Overall Study|Adverse Event|1
1033665|NCT00150462|3366133|P9|Overall Study|Adverse Event|0
1033666|NCT00150462|3366134|P8|Overall Study|Adverse Event|2
1033667|NCT00150462|3366135|P7|Overall Study|Adverse Event|0
1033668|NCT00150462|3366136|P6|Overall Study|Adverse Event|0
1033669|NCT00150462|3366137|P5|Overall Study|Adverse Event|0
1033670|NCT00150462|3366138|P4|Overall Study|Adverse Event|1
1033671|NCT00150462|3366139|P3|Overall Study|Adverse Event|0
1033672|NCT00150462|3366140|P2|Overall Study|Adverse Event|0
1033673|NCT00150462|3366141|P1|Overall Study|Adverse Event|0
1033674|NCT00150462|3366131|P11|Overall Study|Death|0
1033675|NCT00150462|3366132|P10|Overall Study|Death|0
1033676|NCT00150462|3366133|P9|Overall Study|Death|1
1033677|NCT00150462|3366134|P8|Overall Study|Death|0
1033678|NCT00150462|3366135|P7|Overall Study|Death|0
1033679|NCT00150462|3366136|P6|Overall Study|Death|0
1033680|NCT00150462|3366137|P5|Overall Study|Death|0
1033681|NCT00150462|3366138|P4|Overall Study|Death|0
1033682|NCT00150462|3366139|P3|Overall Study|Death|0
1033683|NCT00150462|3366140|P2|Overall Study|Death|1
1033684|NCT00150462|3366141|P1|Overall Study|Death|0
1033685|NCT00150462|3366131|P11|Overall Study|Withdrawal by Subject|0
1033686|NCT00150462|3366132|P10|Overall Study|Withdrawal by Subject|1
1033687|NCT00150462|3366133|P9|Overall Study|Withdrawal by Subject|0
1033688|NCT00150462|3366134|P8|Overall Study|Withdrawal by Subject|1
1033689|NCT00150462|3366135|P7|Overall Study|Withdrawal by Subject|0
1033690|NCT00150462|3366136|P6|Overall Study|Withdrawal by Subject|2
1033691|NCT00150462|3366137|P5|Overall Study|Withdrawal by Subject|1
1033692|NCT00150462|3366138|P4|Overall Study|Withdrawal by Subject|0
1033693|NCT00150462|3366139|P3|Overall Study|Withdrawal by Subject|1
1033694|NCT00150462|3366140|P2|Overall Study|Withdrawal by Subject|1
1033695|NCT00150462|3366141|P1|Overall Study|Withdrawal by Subject|0
1033696|NCT00150462|3366131|P11|Overall Study|Disease Progression or Relapse|2
1033697|NCT00150462|3366132|P10|Overall Study|Disease Progression or Relapse|3
1033698|NCT00150462|3366133|P9|Overall Study|Disease Progression or Relapse|5
1033699|NCT00150462|3366134|P8|Overall Study|Disease Progression or Relapse|5
1033700|NCT00150462|3366135|P7|Overall Study|Disease Progression or Relapse|3
1033701|NCT00150462|3366136|P6|Overall Study|Disease Progression or Relapse|2
1033702|NCT00150462|3366137|P5|Overall Study|Disease Progression or Relapse|2
1033703|NCT00150462|3366138|P4|Overall Study|Disease Progression or Relapse|1
1033704|NCT00150462|3366139|P3|Overall Study|Disease Progression or Relapse|2
1033705|NCT00150462|3366140|P2|Overall Study|Disease Progression or Relapse|1
1033706|NCT00150462|3366141|P1|Overall Study|Disease Progression or Relapse|3
1033707|NCT00150345|3366251|P2|Overall Study|Other|14
1033708|NCT00150345|3366252|P1|Overall Study|Other|12
1033709|NCT00150345|3366251|P2|Overall Study|Laboratory abnormality|2
1033710|NCT00150345|3366252|P1|Overall Study|Laboratory abnormality|1
1033711|NCT00150345|3366251|P2|Overall Study|Withdrawal by Subject|4
1033712|NCT00150345|3366252|P1|Overall Study|Withdrawal by Subject|3
1033713|NCT00150345|3366251|P2|Overall Study|Lack of Efficacy|4
1033714|NCT00150345|3366252|P1|Overall Study|Lack of Efficacy|5
1033715|NCT00150345|3366251|P2|Overall Study|Adverse Event|6
1033716|NCT00150345|3366252|P1|Overall Study|Adverse Event|8
1033717|NCT00150345|3366251|P2|Overall Study|Death|2
1033718|NCT00150345|3366252|P1|Overall Study|Death|5
1033719|NCT00150176|3366316|P2|Overall Study|OTHER|13
1033720|NCT00150176|3366317|P1|Overall Study|OTHER|11
1033721|NCT00150176|3366316|P2|Overall Study|Lost to Follow-up|3
1033722|NCT00150176|3366317|P1|Overall Study|Lost to Follow-up|3
1033723|NCT00150176|3366316|P2|Overall Study|Withdrawal by Subject|12
1033724|NCT00150176|3366317|P1|Overall Study|Withdrawal by Subject|19
1033725|NCT00150176|3366316|P2|Overall Study|Relapse/Impending relapse, non-AE|39
1033726|NCT00150176|3366317|P1|Overall Study|Relapse/Impending relapse, non-AE|10
1033727|NCT00150176|3366316|P2|Overall Study|Adverse Event|53
1033728|NCT00150176|3366317|P1|Overall Study|Adverse Event|16
1033729|NCT00149994|3366328|P2|Overall Study|Protocol Violation|1
1033730|NCT00149994|3366329|P1|Overall Study|Protocol Violation|0
1033731|NCT00149994|3366328|P2|Overall Study|Administrative problems:|0
1033732|NCT00149994|3366329|P1|Overall Study|Administrative problems:|1
1033733|NCT00149890|3366337|P2|Overall Study|Graft Loss|1
1033734|NCT00149890|3366338|P1|Overall Study|Graft Loss|2
1033735|NCT00149890|3366337|P2|Overall Study|Lost to Follow-up|0
1033736|NCT00149890|3366338|P1|Overall Study|Lost to Follow-up|1
1033737|NCT00149890|3366337|P2|Overall Study|Protocol Violation|0
1033738|NCT00149890|3366338|P1|Overall Study|Protocol Violation|1
1033739|NCT00149890|3366337|P2|Overall Study|Lack of Efficacy|9
1033740|NCT00149890|3366338|P1|Overall Study|Lack of Efficacy|8
1033741|NCT00149890|3366337|P2|Overall Study|Adverse Event|8
1033742|NCT00149890|3366338|P1|Overall Study|Adverse Event|1
1033743|NCT00149825|3366358|P2|Overall Study|Other|0
1033744|NCT00149825|3366359|P1|Overall Study|Other|1
1033745|NCT00149825|3366358|P2|Overall Study|Not liking insomnia therapy|0
1033746|NCT00149825|3366359|P1|Overall Study|Not liking insomnia therapy|1
1033747|NCT00149825|3366358|P2|Overall Study|Time commitments|1
1033748|NCT00149825|3366359|P1|Overall Study|Time commitments|2
1033749|NCT00149825|3366358|P2|Overall Study|Intolerance to medication side effects|2
1033750|NCT00149825|3366359|P1|Overall Study|Intolerance to medication side effects|1
1033751|NCT00149747|3366387|P2|Overall Study|Withdrawal by Subject|3
1033752|NCT00149747|3366388|P1|Overall Study|Withdrawal by Subject|3
1033753|NCT00149747|3366387|P2|Overall Study|Death|0
1033754|NCT00149747|3366388|P1|Overall Study|Death|1
1033755|NCT00149630|3366434|P2|Overall Study|Adverse Event|0
1033756|NCT00149630|3366435|P1|Overall Study|Adverse Event|2
1033757|NCT00149630|3366434|P2|Overall Study|Treatment Programs|5
1033758|NCT00149630|3366435|P1|Overall Study|Treatment Programs|4
1033759|NCT00149630|3366434|P2|Overall Study|Incarceration|0
1033760|NCT00149630|3366435|P1|Overall Study|Incarceration|2
1033761|NCT00149396|3366445|P1|Overall Study|other treatment|5
1033762|NCT00149396|3366445|P1|Overall Study|Subject noncompliance|2
1033763|NCT00149396|3366445|P1|Overall Study|Withdrawal by Subject|1
1033764|NCT00149396|3366445|P1|Overall Study|Death|15
1033765|NCT00149214|3366515|P2|Overall Study|Progressive Disease|3
1033766|NCT00149214|3366516|P1|Overall Study|Progressive Disease|7
1033767|NCT00149214|3366515|P2|Overall Study|Sponsor Decision|1
1033768|NCT00149214|3366516|P1|Overall Study|Sponsor Decision|0
1033769|NCT00149214|3366515|P2|Overall Study|Physician Decision|3
1033770|NCT00149214|3366516|P1|Overall Study|Physician Decision|3
1033771|NCT00149214|3366515|P2|Overall Study|Withdrawal by Subject|1
1033772|NCT00149214|3366516|P1|Overall Study|Withdrawal by Subject|4
1033773|NCT00149214|3366515|P2|Overall Study|Adverse Event|9
1033774|NCT00149214|3366516|P1|Overall Study|Adverse Event|12
1033775|NCT00148759|3366564|P2|Overall Study|Lost to Follow-up|0
1033776|NCT00148759|3366565|P1|Overall Study|Lost to Follow-up|1
1033777|NCT00148759|3366564|P2|Overall Study|Withdrawal by Subject|1
1033778|NCT00148759|3366565|P1|Overall Study|Withdrawal by Subject|1
1033779|NCT00148343|3366593|P2|Overall Study|Physician Decision|4
1033780|NCT00148343|3366594|P1|Overall Study|Physician Decision|3
1033781|NCT00148343|3366593|P2|Overall Study|Withdrawal by Subject|7
1033782|NCT00148343|3366594|P1|Overall Study|Withdrawal by Subject|12
1033783|NCT00148317|3366608|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1
1033784|NCT00148317|3366608|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2
1033785|NCT00148317|3366608|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8
1033786|NCT00148122|3366615|P1|Overall Study|Withdrawal by Subject|2
1033787|NCT00148109|3366623|P2|Overall Study|Withdrawal by Subject|0
1033788|NCT00148109|3366624|P1|Overall Study|Withdrawal by Subject|2
1033789|NCT00148109|3366623|P2|Overall Study|Adverse Event|2
1033790|NCT00148109|3366624|P1|Overall Study|Adverse Event|0
1033791|NCT00148109|3366623|P2|Overall Study|Lack of Efficacy|18
1033792|NCT00148109|3366624|P1|Overall Study|Lack of Efficacy|10
1033793|NCT00147823|3366640|P2|Overall Study|Did not receive vitoss due to infection|2
1033794|NCT00147823|3366641|P1|Overall Study|Did not receive vitoss due to infection|6
1033795|NCT00147823|3366640|P2|Overall Study|Withdrawal by Subject|1
1033796|NCT00147823|3366641|P1|Overall Study|Withdrawal by Subject|0
1033797|NCT00147823|3366640|P2|Overall Study|Physician Decision|0
1033798|NCT00147823|3366641|P1|Overall Study|Physician Decision|1
1033799|NCT00147823|3366640|P2|Overall Study|Lost to Follow-up|12
1033800|NCT00147823|3366641|P1|Overall Study|Lost to Follow-up|6
1033801|NCT00147745|3366672|P3|Overall Study|Withdrawal by Subject|0
1033802|NCT00147745|3366673|P2|Overall Study|Withdrawal by Subject|0
1033803|NCT00147745|3366674|P1|Overall Study|Withdrawal by Subject|1
1033804|NCT00147537|3366696|P11|Phase 2|Randomized but not treated|1
1033805|NCT00147537|3366697|P10|Phase 2|Randomized but not treated|1
1033806|NCT00147537|3366698|P9|Phase 2|Randomized but not treated|0
1033807|NCT00147537|3366699|P8|Phase 2|Randomized but not treated|0
1033808|NCT00147537|3366700|P7|Phase 2|Randomized but not treated|0
1033809|NCT00147537|3366701|P6|Phase 2|Randomized but not treated|0
1033810|NCT00147537|3366702|P5|Phase 2|Randomized but not treated|0
1033811|NCT00147537|3366703|P4|Phase 2|Randomized but not treated|0
1033812|NCT00147537|3366704|P3|Phase 2|Randomized but not treated|0
1033813|NCT00147537|3366705|P2|Phase 2|Randomized but not treated|0
1033814|NCT00147537|3366706|P1|Phase 2|Randomized but not treated|0
1033815|NCT00147537|3366696|P11|Phase 2|Withdrawal by Subject|4
1033816|NCT00147537|3366697|P10|Phase 2|Withdrawal by Subject|16
1033817|NCT00147537|3366698|P9|Phase 2|Withdrawal by Subject|0
1033818|NCT00147537|3366699|P8|Phase 2|Withdrawal by Subject|0
1033819|NCT00147537|3366700|P7|Phase 2|Withdrawal by Subject|0
1033820|NCT00147537|3366701|P6|Phase 2|Withdrawal by Subject|0
1033821|NCT00147537|3366702|P5|Phase 2|Withdrawal by Subject|0
1033822|NCT00147537|3366703|P4|Phase 2|Withdrawal by Subject|0
1033823|NCT00147537|3366704|P3|Phase 2|Withdrawal by Subject|0
1033824|NCT00147537|3366705|P2|Phase 2|Withdrawal by Subject|0
1033825|NCT00147537|3366706|P1|Phase 2|Withdrawal by Subject|0
1033826|NCT00147537|3366696|P11|Phase 2|Other|12
1033827|NCT00147537|3366697|P10|Phase 2|Other|47
1033828|NCT00147537|3366698|P9|Phase 2|Other|0
1033829|NCT00147537|3366699|P8|Phase 2|Other|0
1033830|NCT00147537|3366700|P7|Phase 2|Other|0
1033831|NCT00147537|3366701|P6|Phase 2|Other|0
1033832|NCT00147537|3366702|P5|Phase 2|Other|0
1033833|NCT00147537|3366703|P4|Phase 2|Other|0
1033834|NCT00147537|3366704|P3|Phase 2|Other|0
1033835|NCT00147537|3366705|P2|Phase 2|Other|0
1033836|NCT00147537|3366706|P1|Phase 2|Other|0
1033837|NCT00147537|3366696|P11|Phase 2|Lost to Follow-up|4
1033838|NCT00147537|3366697|P10|Phase 2|Lost to Follow-up|12
1033839|NCT00147537|3366698|P9|Phase 2|Lost to Follow-up|0
1033840|NCT00147537|3366699|P8|Phase 2|Lost to Follow-up|0
1033841|NCT00147537|3366700|P7|Phase 2|Lost to Follow-up|0
1033842|NCT00147537|3366701|P6|Phase 2|Lost to Follow-up|0
1033843|NCT00147537|3366702|P5|Phase 2|Lost to Follow-up|0
1033844|NCT00147537|3366703|P4|Phase 2|Lost to Follow-up|0
1033845|NCT00147537|3366704|P3|Phase 2|Lost to Follow-up|0
1033846|NCT00147537|3366705|P2|Phase 2|Lost to Follow-up|0
1033847|NCT00147537|3366706|P1|Phase 2|Lost to Follow-up|0
1033848|NCT00147537|3366696|P11|Phase 2|Death|31
1033849|NCT00147537|3366697|P10|Phase 2|Death|85
1033850|NCT00147537|3366698|P9|Phase 2|Death|0
1033851|NCT00147537|3366699|P8|Phase 2|Death|0
1033852|NCT00147537|3366700|P7|Phase 2|Death|0
1033853|NCT00147537|3366701|P6|Phase 2|Death|0
1033854|NCT00147537|3366702|P5|Phase 2|Death|0
1033855|NCT00147537|3366703|P4|Phase 2|Death|0
1033856|NCT00147537|3366704|P3|Phase 2|Death|0
1033857|NCT00147537|3366705|P2|Phase 2|Death|0
1033858|NCT00147537|3366706|P1|Phase 2|Death|0
1033859|NCT00147537|3366696|P11|Phase 1b|Randomized but not treated|0
1033860|NCT00147537|3366697|P10|Phase 1b|Randomized but not treated|0
1033861|NCT00147537|3366698|P9|Phase 1b|Randomized but not treated|1
1033862|NCT00147537|3366699|P8|Phase 1b|Randomized but not treated|0
1033863|NCT00147537|3366700|P7|Phase 1b|Randomized but not treated|1
1033864|NCT00147537|3366701|P6|Phase 1b|Randomized but not treated|0
1033865|NCT00147537|3366702|P5|Phase 1b|Randomized but not treated|0
1033866|NCT00147537|3366703|P4|Phase 1b|Randomized but not treated|0
1033867|NCT00147537|3366704|P3|Phase 1b|Randomized but not treated|0
1033868|NCT00147537|3366705|P2|Phase 1b|Randomized but not treated|0
1033869|NCT00147537|3366706|P1|Phase 1b|Randomized but not treated|0
1033870|NCT00147537|3366696|P11|Phase 1b|Withdrawal by Subject|0
1033871|NCT00147537|3366697|P10|Phase 1b|Withdrawal by Subject|0
1033872|NCT00147537|3366698|P9|Phase 1b|Withdrawal by Subject|2
1033873|NCT00147537|3366699|P8|Phase 1b|Withdrawal by Subject|0
1033874|NCT00147537|3366700|P7|Phase 1b|Withdrawal by Subject|0
1033875|NCT00147537|3366701|P6|Phase 1b|Withdrawal by Subject|0
1033876|NCT00147537|3366702|P5|Phase 1b|Withdrawal by Subject|0
1033877|NCT00147537|3366703|P4|Phase 1b|Withdrawal by Subject|0
1033878|NCT00147537|3366704|P3|Phase 1b|Withdrawal by Subject|0
1033879|NCT00147537|3366705|P2|Phase 1b|Withdrawal by Subject|0
1033880|NCT00147537|3366706|P1|Phase 1b|Withdrawal by Subject|0
1033881|NCT00147537|3366696|P11|Phase 1b|Other|0
1033882|NCT00147537|3366697|P10|Phase 1b|Other|0
1033883|NCT00147537|3366698|P9|Phase 1b|Other|4
1033884|NCT00147537|3366699|P8|Phase 1b|Other|4
1033885|NCT00147537|3366700|P7|Phase 1b|Other|14
1033886|NCT00147537|3366701|P6|Phase 1b|Other|1
1033887|NCT00147537|3366702|P5|Phase 1b|Other|1
1033888|NCT00147537|3366703|P4|Phase 1b|Other|1
1033889|NCT00147537|3366704|P3|Phase 1b|Other|2
1033890|NCT00147537|3366705|P2|Phase 1b|Other|0
1033891|NCT00147537|3366706|P1|Phase 1b|Other|0
1033892|NCT00147537|3366696|P11|Phase 1b|Lost to Follow-up|0
1033893|NCT00147537|3366697|P10|Phase 1b|Lost to Follow-up|0
1033894|NCT00147537|3366698|P9|Phase 1b|Lost to Follow-up|1
1033895|NCT00147537|3366699|P8|Phase 1b|Lost to Follow-up|0
1033896|NCT00147537|3366700|P7|Phase 1b|Lost to Follow-up|2
1033897|NCT00147537|3366701|P6|Phase 1b|Lost to Follow-up|0
1033898|NCT00147537|3366702|P5|Phase 1b|Lost to Follow-up|0
1033899|NCT00147537|3366703|P4|Phase 1b|Lost to Follow-up|0
1033900|NCT00147537|3366704|P3|Phase 1b|Lost to Follow-up|0
1033901|NCT00147537|3366705|P2|Phase 1b|Lost to Follow-up|1
1033902|NCT00147537|3366706|P1|Phase 1b|Lost to Follow-up|2
1033903|NCT00147537|3366696|P11|Phase 1b|Death|0
1033904|NCT00147537|3366697|P10|Phase 1b|Death|0
1033905|NCT00147537|3366698|P9|Phase 1b|Death|9
1033906|NCT00147537|3366699|P8|Phase 1b|Death|3
1033907|NCT00147537|3366700|P7|Phase 1b|Death|1
1033908|NCT00147537|3366701|P6|Phase 1b|Death|2
1033909|NCT00147537|3366702|P5|Phase 1b|Death|2
1033910|NCT00147537|3366703|P4|Phase 1b|Death|1
1033911|NCT00147537|3366704|P3|Phase 1b|Death|2
1033912|NCT00147537|3366705|P2|Phase 1b|Death|1
1033913|NCT00147537|3366706|P1|Phase 1b|Death|0
1033914|NCT00147498|3366889|P4|Overall Study|Other|3
1033915|NCT00147498|3366890|P3|Overall Study|Other|3
1033916|NCT00147498|3366891|P2|Overall Study|Other|1
1033917|NCT00147498|3366892|P1|Overall Study|Other|1
1033918|NCT00147498|3366889|P4|Overall Study|Participant defaulted|3
1033919|NCT00147498|3366890|P3|Overall Study|Participant defaulted|4
1033920|NCT00147498|3366891|P2|Overall Study|Participant defaulted|1
1033921|NCT00147498|3366892|P1|Overall Study|Participant defaulted|0
1033922|NCT00147498|3366889|P4|Overall Study|Laboratory abnormality|0
1033923|NCT00147498|3366890|P3|Overall Study|Laboratory abnormality|2
1033924|NCT00147498|3366891|P2|Overall Study|Laboratory abnormality|0
1033925|NCT00147498|3366892|P1|Overall Study|Laboratory abnormality|0
1033926|NCT00147498|3366889|P4|Overall Study|Lack of Efficacy|8
1033927|NCT00147498|3366890|P3|Overall Study|Lack of Efficacy|1
1033928|NCT00147498|3366891|P2|Overall Study|Lack of Efficacy|1
1033929|NCT00147498|3366892|P1|Overall Study|Lack of Efficacy|1
1033930|NCT00147498|3366889|P4|Overall Study|Adverse Event|3
1033931|NCT00147498|3366890|P3|Overall Study|Adverse Event|7
1033932|NCT00147498|3366891|P2|Overall Study|Adverse Event|6
1033933|NCT00147498|3366892|P1|Overall Study|Adverse Event|1
1033934|NCT00147238|3367016|P1|Overall Study|Inevaluable|8
1033935|NCT00147225|3367026|P6|Overall Study|Chemotherapy Changed|1
1033936|NCT00147225|3367027|P5|Overall Study|Chemotherapy Changed|0
1033937|NCT00147225|3367028|P4|Overall Study|Chemotherapy Changed|0
1033938|NCT00147225|3367029|P3|Overall Study|Chemotherapy Changed|0
1033939|NCT00147225|3367030|P2|Overall Study|Chemotherapy Changed|0
1033940|NCT00147225|3367031|P1|Overall Study|Chemotherapy Changed|0
1033941|NCT00147225|3367026|P6|Overall Study|Screen Failure|0
1033942|NCT00147225|3367027|P5|Overall Study|Screen Failure|1
1033943|NCT00147225|3367028|P4|Overall Study|Screen Failure|0
1033944|NCT00147225|3367029|P3|Overall Study|Screen Failure|0
1033945|NCT00147225|3367030|P2|Overall Study|Screen Failure|0
1033946|NCT00147225|3367031|P1|Overall Study|Screen Failure|0
1033947|NCT00147225|3367026|P6|Overall Study|Adverse Event|0
1033948|NCT00147225|3367027|P5|Overall Study|Adverse Event|0
1033949|NCT00147225|3367028|P4|Overall Study|Adverse Event|1
1033950|NCT00147225|3367029|P3|Overall Study|Adverse Event|1
1033951|NCT00147225|3367030|P2|Overall Study|Adverse Event|0
1033952|NCT00147225|3367031|P1|Overall Study|Adverse Event|0
1033953|NCT00147225|3367026|P6|Overall Study|Withdrawal by Subject|1
1033954|NCT00147225|3367027|P5|Overall Study|Withdrawal by Subject|0
1033955|NCT00147225|3367028|P4|Overall Study|Withdrawal by Subject|0
1033956|NCT00147225|3367029|P3|Overall Study|Withdrawal by Subject|1
1033957|NCT00147225|3367030|P2|Overall Study|Withdrawal by Subject|0
1033958|NCT00147225|3367031|P1|Overall Study|Withdrawal by Subject|1
1033959|NCT00146848|3367134|P3|Post-randomization|Withdrawn|27
1033960|NCT00146848|3367135|P2|Post-randomization|Withdrawn|32
1033961|NCT00146848|3367136|P1|Post-randomization|Withdrawn|26
1033962|NCT00146848|3367134|P3|Post-randomization|Lost to Follow-up|12
1033963|NCT00146848|3367135|P2|Post-randomization|Lost to Follow-up|15
1033964|NCT00146848|3367136|P1|Post-randomization|Lost to Follow-up|12
1033965|NCT00146848|3367134|P3|Pre-randomization|Withdrawal by Subject|0
1033966|NCT00146848|3367135|P2|Pre-randomization|Withdrawal by Subject|0
1033967|NCT00146848|3367136|P1|Pre-randomization|Withdrawal by Subject|40
1033968|NCT00146848|3367134|P3|Pre-randomization|Protocol Violation|0
1033969|NCT00146848|3367135|P2|Pre-randomization|Protocol Violation|0
1033970|NCT00146848|3367136|P1|Pre-randomization|Protocol Violation|172
1033971|NCT00146848|3367134|P3|Pre-randomization|Physician Decision|0
1033972|NCT00146848|3367135|P2|Pre-randomization|Physician Decision|0
1033973|NCT00146848|3367136|P1|Pre-randomization|Physician Decision|8
1033974|NCT00146848|3367134|P3|Pre-randomization|Lost to Follow-up|0
1033975|NCT00146848|3367135|P2|Pre-randomization|Lost to Follow-up|0
1033976|NCT00146848|3367136|P1|Pre-randomization|Lost to Follow-up|70
1033977|NCT00146848|3367134|P3|Pre-randomization|Death|0
1033978|NCT00146848|3367135|P2|Pre-randomization|Death|0
1033979|NCT00146848|3367136|P1|Pre-randomization|Death|19
1033980|NCT00146770|3367152|P2|Overall Study|Withdrawal by Subject|0
1033981|NCT00146770|3367153|P1|Overall Study|Withdrawal by Subject|2
1033982|NCT00146770|3367152|P2|Overall Study|Pregnancy|0
1033983|NCT00146770|3367153|P1|Overall Study|Pregnancy|1
1033984|NCT00146770|3367152|P2|Overall Study|Adverse Event|0
1033985|NCT00146770|3367153|P1|Overall Study|Adverse Event|2
1033986|NCT00146757|3367171|P2|Overall Study|Adverse Event|0
1033987|NCT00146757|3367172|P1|Overall Study|Adverse Event|1
1033988|NCT00146757|3367171|P2|Overall Study|Death|0
1033989|NCT00146757|3367172|P1|Overall Study|Death|1
1033990|NCT00146640|3367191|P2|Overall Study|Non-Medical Reasons|4
1033991|NCT00146640|3367192|P1|Overall Study|Non-Medical Reasons|8
1033992|NCT00146640|3367191|P2|Overall Study|Medical Reasons|0
1033993|NCT00146640|3367192|P1|Overall Study|Medical Reasons|3
1033994|NCT00146640|3367191|P2|Overall Study|Adverse Event|10
1033995|NCT00146640|3367192|P1|Overall Study|Adverse Event|12
1033996|NCT00146328|3367215|P3|Overall Study|Interaction with other medication|1
1033997|NCT00146328|3367216|P2|Overall Study|Interaction with other medication|0
1033998|NCT00146328|3367217|P1|Overall Study|Interaction with other medication|2
1033999|NCT00146328|3367215|P3|Overall Study|Moved|0
1034000|NCT00146328|3367216|P2|Overall Study|Moved|0
1034001|NCT00146328|3367217|P1|Overall Study|Moved|2
1034002|NCT00146328|3367215|P3|Overall Study|Death|1
1034003|NCT00146328|3367216|P2|Overall Study|Death|1
1034004|NCT00146328|3367217|P1|Overall Study|Death|0
1034005|NCT00146328|3367215|P3|Overall Study|Enroll into other trial|2
1034006|NCT00146328|3367216|P2|Overall Study|Enroll into other trial|4
1034007|NCT00146328|3367217|P1|Overall Study|Enroll into other trial|2
1034008|NCT00146328|3367215|P3|Overall Study|Patient decision to end|6
1034009|NCT00146328|3367216|P2|Overall Study|Patient decision to end|1
1034010|NCT00146328|3367217|P1|Overall Study|Patient decision to end|0
1034011|NCT00146328|3367215|P3|Overall Study|Trial ended/site closed|19
1034012|NCT00146328|3367216|P2|Overall Study|Trial ended/site closed|2
1034013|NCT00146328|3367217|P1|Overall Study|Trial ended/site closed|8
1034014|NCT00146328|3367215|P3|Overall Study|Virologic Failure/lack of efficacy|142
1034015|NCT00146328|3367216|P2|Overall Study|Virologic Failure/lack of efficacy|72
1034016|NCT00146328|3367217|P1|Overall Study|Virologic Failure/lack of efficacy|54
1034017|NCT00146328|3367215|P3|Overall Study|Withdrawal by Subject|22
1034018|NCT00146328|3367216|P2|Overall Study|Withdrawal by Subject|16
1034019|NCT00146328|3367217|P1|Overall Study|Withdrawal by Subject|16
1034020|NCT00146328|3367215|P3|Overall Study|Lost to Follow-up|7
1034021|NCT00146328|3367216|P2|Overall Study|Lost to Follow-up|4
1034022|NCT00146328|3367217|P1|Overall Study|Lost to Follow-up|7
1034023|NCT00146328|3367215|P3|Overall Study|Protocol Violation|12
1034024|NCT00146328|3367216|P2|Overall Study|Protocol Violation|6
1034025|NCT00146328|3367217|P1|Overall Study|Protocol Violation|11
1034026|NCT00146328|3367215|P3|Overall Study|Adverse Event|79
1034027|NCT00146328|3367216|P2|Overall Study|Adverse Event|48
1034028|NCT00146328|3367217|P1|Overall Study|Adverse Event|39
1034029|NCT00146172|3367308|P8|Overall Study|Symptomatic Deterioration|2
1034030|NCT00146172|3367309|P7|Overall Study|Symptomatic Deterioration|0
1034031|NCT00146172|3367310|P6|Overall Study|Symptomatic Deterioration|2
1034032|NCT00146172|3367311|P5|Overall Study|Symptomatic Deterioration|1
1034033|NCT00146172|3367312|P4|Overall Study|Symptomatic Deterioration|0
1034034|NCT00146172|3367313|P3|Overall Study|Symptomatic Deterioration|1
1034035|NCT00146172|3367314|P2|Overall Study|Symptomatic Deterioration|0
1034036|NCT00146172|3367315|P1|Overall Study|Symptomatic Deterioration|1
1034037|NCT00146172|3367308|P8|Overall Study|Withdrawal by Subject|4
1034038|NCT00146172|3367309|P7|Overall Study|Withdrawal by Subject|1
1034039|NCT00146172|3367310|P6|Overall Study|Withdrawal by Subject|1
1034040|NCT00146172|3367311|P5|Overall Study|Withdrawal by Subject|0
1034041|NCT00146172|3367312|P4|Overall Study|Withdrawal by Subject|0
1034042|NCT00146172|3367313|P3|Overall Study|Withdrawal by Subject|0
1034043|NCT00146172|3367314|P2|Overall Study|Withdrawal by Subject|0
1034044|NCT00146172|3367315|P1|Overall Study|Withdrawal by Subject|0
1034045|NCT00146172|3367308|P8|Overall Study|Physician Decision|1
1034046|NCT00146172|3367309|P7|Overall Study|Physician Decision|0
1034047|NCT00146172|3367310|P6|Overall Study|Physician Decision|0
1034048|NCT00146172|3367311|P5|Overall Study|Physician Decision|0
1034049|NCT00146172|3367312|P4|Overall Study|Physician Decision|0
1034050|NCT00146172|3367313|P3|Overall Study|Physician Decision|0
1034051|NCT00146172|3367314|P2|Overall Study|Physician Decision|0
1034052|NCT00146172|3367315|P1|Overall Study|Physician Decision|0
1034053|NCT00146172|3367308|P8|Overall Study|Death|0
1034054|NCT00146172|3367309|P7|Overall Study|Death|1
1034055|NCT00146172|3367310|P6|Overall Study|Death|0
1034056|NCT00146172|3367311|P5|Overall Study|Death|0
1034057|NCT00146172|3367312|P4|Overall Study|Death|0
1034058|NCT00146172|3367313|P3|Overall Study|Death|0
1034059|NCT00146172|3367314|P2|Overall Study|Death|0
1034060|NCT00146172|3367315|P1|Overall Study|Death|0
1034061|NCT00146172|3367308|P8|Overall Study|Disease Progression|22
1034062|NCT00146172|3367309|P7|Overall Study|Disease Progression|1
1034063|NCT00146172|3367310|P6|Overall Study|Disease Progression|2
1034064|NCT00146172|3367311|P5|Overall Study|Disease Progression|2
1034065|NCT00146172|3367312|P4|Overall Study|Disease Progression|5
1034066|NCT00146172|3367313|P3|Overall Study|Disease Progression|2
1034067|NCT00146172|3367314|P2|Overall Study|Disease Progression|4
1034068|NCT00146172|3367315|P1|Overall Study|Disease Progression|2
1034069|NCT00146172|3367308|P8|Overall Study|Lost to Follow-up|1
1034070|NCT00146172|3367309|P7|Overall Study|Lost to Follow-up|0
1034071|NCT00146172|3367310|P6|Overall Study|Lost to Follow-up|0
1034072|NCT00146172|3367311|P5|Overall Study|Lost to Follow-up|0
1034073|NCT00146172|3367312|P4|Overall Study|Lost to Follow-up|0
1034074|NCT00146172|3367313|P3|Overall Study|Lost to Follow-up|0
1034075|NCT00146172|3367314|P2|Overall Study|Lost to Follow-up|0
1034076|NCT00146172|3367315|P1|Overall Study|Lost to Follow-up|0
1034077|NCT00146172|3367308|P8|Overall Study|Adverse Event|10
1034078|NCT00146172|3367309|P7|Overall Study|Adverse Event|3
1034079|NCT00146172|3367310|P6|Overall Study|Adverse Event|2
1034080|NCT00146172|3367311|P5|Overall Study|Adverse Event|0
1034081|NCT00146172|3367312|P4|Overall Study|Adverse Event|1
1034082|NCT00146172|3367313|P3|Overall Study|Adverse Event|1
1034083|NCT00146172|3367314|P2|Overall Study|Adverse Event|0
1034084|NCT00146172|3367315|P1|Overall Study|Adverse Event|0
1034085|NCT00145977|3367350|P2|Overall Study|Withdrawal by Subject|0
1034086|NCT00145977|3367351|P1|Overall Study|Withdrawal by Subject|1
1034087|NCT00145977|3367350|P2|Overall Study|Lost to Follow-up|0
1034088|NCT00145977|3367351|P1|Overall Study|Lost to Follow-up|1
1034089|NCT00145977|3367350|P2|Overall Study|Lack of Efficacy|4
1034090|NCT00145977|3367351|P1|Overall Study|Lack of Efficacy|0
1034091|NCT00145795|3367377|P2|Overall Study|Adverse Event|0
1034092|NCT00145795|3367378|P1|Overall Study|Adverse Event|1
1034093|NCT00145626|3367413|P1|Overall Study|Withdrawal by Subject|1
1034094|NCT00145626|3367413|P1|Overall Study|Death|1
1034095|NCT00145626|3367413|P1|Overall Study|Turned 2 years old before treatment|1
1034096|NCT00145626|3367413|P1|Overall Study|Did not have NK infusions|2
1034097|NCT00145600|3367459|P4|Overall Study|Withdrawal by Subject|1
1034098|NCT00145600|3367460|P3|Overall Study|Withdrawal by Subject|0
1034099|NCT00145600|3367461|P2|Overall Study|Withdrawal by Subject|2
1034100|NCT00145600|3367462|P1|Overall Study|Withdrawal by Subject|1
1034101|NCT00145600|3367459|P4|Overall Study|Noncompliance|0
1034102|NCT00145600|3367460|P3|Overall Study|Noncompliance|0
1034103|NCT00145600|3367461|P2|Overall Study|Noncompliance|0
1034104|NCT00145600|3367462|P1|Overall Study|Noncompliance|1
1034105|NCT00145600|3367459|P4|Overall Study|Lost to Follow-up|4
1034106|NCT00145600|3367460|P3|Overall Study|Lost to Follow-up|2
1034107|NCT00145600|3367461|P2|Overall Study|Lost to Follow-up|6
1034108|NCT00145600|3367462|P1|Overall Study|Lost to Follow-up|2
1034109|NCT00145600|3367459|P4|Overall Study|Ineligible|5
1034110|NCT00145600|3367460|P3|Overall Study|Ineligible|1
1034111|NCT00145600|3367461|P2|Overall Study|Ineligible|0
1034112|NCT00145600|3367462|P1|Overall Study|Ineligible|3
1034113|NCT00145600|3367459|P4|Overall Study|Death|6
1034114|NCT00145600|3367460|P3|Overall Study|Death|2
1034115|NCT00145600|3367461|P2|Overall Study|Death|2
1034116|NCT00145600|3367462|P1|Overall Study|Death|1
1034117|NCT00145574|3367586|P3|Open Label Long-term Extension|required restricted medicine|1
1034118|NCT00145574|3367587|P2|Open Label Long-term Extension|required restricted medicine|0
1034119|NCT00145574|3367588|P1|Open Label Long-term Extension|required restricted medicine|0
1034120|NCT00145574|3367586|P3|Open Label Long-term Extension|Withdrawal by Subject|4
1034121|NCT00145574|3367587|P2|Open Label Long-term Extension|Withdrawal by Subject|0
1034122|NCT00145574|3367588|P1|Open Label Long-term Extension|Withdrawal by Subject|0
1034123|NCT00145574|3367586|P3|Open Label Long-term Extension|Lost to Follow-up|1
1034124|NCT00145574|3367587|P2|Open Label Long-term Extension|Lost to Follow-up|0
1034125|NCT00145574|3367588|P1|Open Label Long-term Extension|Lost to Follow-up|0
1034126|NCT00145574|3367586|P3|Open Label Long-term Extension|Adverse Event|5
1034127|NCT00145574|3367587|P2|Open Label Long-term Extension|Adverse Event|0
1034128|NCT00145574|3367588|P1|Open Label Long-term Extension|Adverse Event|0
1034129|NCT00145574|3367586|P3|Double Blind|required restricted medicine|0
1034130|NCT00145574|3367587|P2|Double Blind|required restricted medicine|1
1034131|NCT00145574|3367588|P1|Double Blind|required restricted medicine|0
1034132|NCT00145574|3367586|P3|Double Blind|Withdrawal by Subject|1
1034133|NCT00145574|3367587|P2|Double Blind|Withdrawal by Subject|1
1034134|NCT00145574|3367588|P1|Double Blind|Withdrawal by Subject|1
1034135|NCT00145574|3367586|P3|Double Blind|Adverse Event|1
1034136|NCT00145574|3367587|P2|Double Blind|Adverse Event|3
1034137|NCT00145574|3367588|P1|Double Blind|Adverse Event|0
1034138|NCT00145509|3367645|P2|Overall Study|Reason not provided|1
1034139|NCT00145509|3367646|P1|Overall Study|Reason not provided|2
1034140|NCT00145509|3367645|P2|Overall Study|Withdrew Consent|7
1034141|NCT00145509|3367646|P1|Overall Study|Withdrew Consent|2
1034142|NCT00145509|3367645|P2|Overall Study|Lost to Follow-up|9
1034143|NCT00145509|3367646|P1|Overall Study|Lost to Follow-up|5
1034144|NCT00145509|3367645|P2|Overall Study|Lack of Efficacy|1
1034145|NCT00145509|3367646|P1|Overall Study|Lack of Efficacy|3
1034146|NCT00145509|3367645|P2|Overall Study|Adverse Event|3
1034147|NCT00145509|3367646|P1|Overall Study|Adverse Event|10
1034148|NCT00145496|3367660|P2|Overall Study|Other|13
1034149|NCT00145496|3367661|P1|Overall Study|Other|25
1034150|NCT00145496|3367660|P2|Overall Study|Lost to Follow-up|5
1034151|NCT00145496|3367661|P1|Overall Study|Lost to Follow-up|12
1034152|NCT00145496|3367660|P2|Overall Study|Withdrawal by Subject|26
1034153|NCT00145496|3367661|P1|Overall Study|Withdrawal by Subject|32
1034154|NCT00145496|3367660|P2|Overall Study|Lack of Efficacy|7
1034155|NCT00145496|3367661|P1|Overall Study|Lack of Efficacy|12
1034156|NCT00145496|3367660|P2|Overall Study|Adverse Event|30
1034157|NCT00145496|3367661|P1|Overall Study|Adverse Event|42
1034158|NCT00145327|3367681|P3|Overall Study|Missing – not stated|1
1034159|NCT00145327|3367682|P2|Overall Study|Missing – not stated|0
1034160|NCT00145327|3367683|P1|Overall Study|Missing – not stated|1
1034161|NCT00145327|3367681|P3|Overall Study|Abnormal laboratory value(s)|2
1034162|NCT00145327|3367682|P2|Overall Study|Abnormal laboratory value(s)|0
1034163|NCT00145327|3367683|P1|Overall Study|Abnormal laboratory value(s)|1
1034164|NCT00145327|3367681|P3|Overall Study|Protocol Violation|2
1034165|NCT00145327|3367682|P2|Overall Study|Protocol Violation|0
1034166|NCT00145327|3367683|P1|Overall Study|Protocol Violation|2
1034167|NCT00145327|3367681|P3|Overall Study|Administrative problems|13
1034168|NCT00145327|3367682|P2|Overall Study|Administrative problems|9
1034169|NCT00145327|3367683|P1|Overall Study|Administrative problems|12
1034170|NCT00145327|3367681|P3|Overall Study|Lost to Follow-up|14
1034171|NCT00145327|3367682|P2|Overall Study|Lost to Follow-up|14
1034172|NCT00145327|3367683|P1|Overall Study|Lost to Follow-up|9
1034173|NCT00145327|3367681|P3|Overall Study|Adverse Event|22
1034174|NCT00145327|3367682|P2|Overall Study|Adverse Event|11
1034175|NCT00145327|3367683|P1|Overall Study|Adverse Event|14
1034176|NCT00145327|3367681|P3|Overall Study|Death|30
1034177|NCT00145327|3367682|P2|Overall Study|Death|18
1034178|NCT00145327|3367683|P1|Overall Study|Death|26
1034179|NCT00145327|3367681|P3|Overall Study|Withdrawal by Subject|164
1034180|NCT00145327|3367682|P2|Overall Study|Withdrawal by Subject|72
1034181|NCT00145327|3367683|P1|Overall Study|Withdrawal by Subject|77
1034182|NCT00145119|3367782|P1|Overall Study|Death|45
1034183|NCT00144781|3367800|P4|Overall Study|Non-compliant|0
1034184|NCT00144781|3367801|P3|Overall Study|Non-compliant|0
1034185|NCT00144781|3367802|P2|Overall Study|Non-compliant|1
1034186|NCT00144781|3367803|P1|Overall Study|Non-compliant|0
1034187|NCT00144781|3367800|P4|Overall Study|Adverse Event|0
1034188|NCT00144781|3367801|P3|Overall Study|Adverse Event|0
1034189|NCT00144781|3367802|P2|Overall Study|Adverse Event|1
1034190|NCT00144781|3367803|P1|Overall Study|Adverse Event|0
1034191|NCT00144339|3367832|P2|Overall Study|Other|60
1034192|NCT00144339|3367833|P1|Overall Study|Other|58
1034193|NCT00144339|3367832|P2|Overall Study|Lost to Follow-up|64
1034194|NCT00144339|3367833|P1|Overall Study|Lost to Follow-up|76
1034195|NCT00144339|3367832|P2|Overall Study|Withdrawal by Subject|300
1034196|NCT00144339|3367833|P1|Overall Study|Withdrawal by Subject|403
1034197|NCT00144339|3367832|P2|Overall Study|Protocol Violation|48
1034198|NCT00144339|3367833|P1|Overall Study|Protocol Violation|75
1034199|NCT00144339|3367832|P2|Overall Study|Adverse Event|627
1034200|NCT00144339|3367833|P1|Overall Study|Adverse Event|746
1034201|NCT00144300|3368041|P2|Overall Study|Other reason (not specified)|3
1034202|NCT00144300|3368042|P1|Overall Study|Other reason (not specified)|1
1034203|NCT00144300|3368041|P2|Overall Study|Withdrawal by Subject|6
1034204|NCT00144300|3368042|P1|Overall Study|Withdrawal by Subject|6
1034205|NCT00144300|3368041|P2|Overall Study|Lost to Follow-up|0
1034206|NCT00144300|3368042|P1|Overall Study|Lost to Follow-up|3
1034207|NCT00144300|3368041|P2|Overall Study|Protocol Violation|3
1034208|NCT00144300|3368042|P1|Overall Study|Protocol Violation|1
1034209|NCT00144300|3368041|P2|Overall Study|Adverse Event|16
1034210|NCT00144300|3368042|P1|Overall Study|Adverse Event|18
1034211|NCT00144170|3368090|P2|Overall Study|Other reason not defined above|316
1034212|NCT00144170|3368091|P1|Overall Study|Other reason not defined above|211
1034213|NCT00144170|3368090|P2|Overall Study|Withdrawal by Subject|13
1034214|NCT00144170|3368091|P1|Overall Study|Withdrawal by Subject|29
1034215|NCT00144170|3368090|P2|Overall Study|Lost to Follow-up|10
1034216|NCT00144170|3368091|P1|Overall Study|Lost to Follow-up|5
1034217|NCT00144170|3368090|P2|Overall Study|Protocol Violation|16
1034218|NCT00144170|3368091|P1|Overall Study|Protocol Violation|23
1034219|NCT00144170|3368090|P2|Overall Study|Adverse Event|41
1034220|NCT00144170|3368091|P1|Overall Study|Adverse Event|84
1034221|NCT00144027|3368281|P2|Overall Study|did not complete baseline assessment|6
1034222|NCT00144027|3368282|P1|Overall Study|did not complete baseline assessment|0
1034223|NCT00144027|3368281|P2|Overall Study|Withdrawal by Subject|2
1034224|NCT00144027|3368282|P1|Overall Study|Withdrawal by Subject|2
1034225|NCT00144027|3368281|P2|Overall Study|Lost to Follow-up|3
1034226|NCT00144027|3368282|P1|Overall Study|Lost to Follow-up|1
1034227|NCT00143598|3368312|P2|Overall Study|Death|36
1034228|NCT00143598|3368313|P1|Overall Study|Death|36
1034229|NCT00143598|3368312|P2|Overall Study|Withdrawal by Subject|37
1034230|NCT00143598|3368313|P1|Overall Study|Withdrawal by Subject|33
1034231|NCT00143598|3368312|P2|Overall Study|Lost to Follow-up|21
1034232|NCT00143598|3368313|P1|Overall Study|Lost to Follow-up|23
1034233|NCT00143507|3368327|P2|Overall Study|Withdrawn by sponsor's decision|3
1034234|NCT00143507|3368328|P1|Overall Study|Withdrawn by sponsor's decision|0
1034235|NCT00143507|3368327|P2|Overall Study|Lost to Follow-up|0
1034236|NCT00143507|3368328|P1|Overall Study|Lost to Follow-up|1
1034237|NCT00143507|3368327|P2|Overall Study|Withdrawal by Subject|102
1034238|NCT00143507|3368328|P1|Overall Study|Withdrawal by Subject|114
1034239|NCT00143507|3368327|P2|Overall Study|Death|547
1034240|NCT00143507|3368328|P1|Overall Study|Death|572
1034241|NCT00143455|3368362|P4|Cohort 2|Randomized But Not Treated|1
1034242|NCT00143455|3368363|P3|Cohort 2|Randomized But Not Treated|1
1034243|NCT00143455|3368364|P2|Cohort 2|Randomized But Not Treated|0
1034244|NCT00143455|3368365|P1|Cohort 2|Randomized But Not Treated|0
1034245|NCT00143455|3368362|P4|Cohort 2|Other|6
1034246|NCT00143455|3368363|P3|Cohort 2|Other|7
1034247|NCT00143455|3368364|P2|Cohort 2|Other|0
1034248|NCT00143455|3368365|P1|Cohort 2|Other|0
1034249|NCT00143455|3368362|P4|Cohort 2|Withdrawal by Subject|12
1034250|NCT00143455|3368363|P3|Cohort 2|Withdrawal by Subject|13
1034251|NCT00143455|3368364|P2|Cohort 2|Withdrawal by Subject|0
1034252|NCT00143455|3368365|P1|Cohort 2|Withdrawal by Subject|0
1034253|NCT00143455|3368362|P4|Cohort 2|Progressive Disease|27
1034254|NCT00143455|3368363|P3|Cohort 2|Progressive Disease|20
1034255|NCT00143455|3368364|P2|Cohort 2|Progressive Disease|0
1034256|NCT00143455|3368365|P1|Cohort 2|Progressive Disease|0
1034257|NCT00143455|3368362|P4|Cohort 2|Death|12
1034258|NCT00143455|3368363|P3|Cohort 2|Death|20
1034259|NCT00143455|3368364|P2|Cohort 2|Death|0
1034260|NCT00143455|3368365|P1|Cohort 2|Death|0
1034261|NCT00143455|3368362|P4|Cohort 2|Lost to Follow-up|4
1034262|NCT00143455|3368363|P3|Cohort 2|Lost to Follow-up|1
1034263|NCT00143455|3368364|P2|Cohort 2|Lost to Follow-up|0
1034264|NCT00143455|3368365|P1|Cohort 2|Lost to Follow-up|0
1034265|NCT00143455|3368362|P4|Cohort 2|Protocol Violation|1
1034266|NCT00143455|3368363|P3|Cohort 2|Protocol Violation|1
1034267|NCT00143455|3368364|P2|Cohort 2|Protocol Violation|0
1034268|NCT00143455|3368365|P1|Cohort 2|Protocol Violation|0
1034269|NCT00143455|3368362|P4|Cohort 2|No Longer Required Study Treatment|0
1034270|NCT00143455|3368363|P3|Cohort 2|No Longer Required Study Treatment|1
1034271|NCT00143455|3368364|P2|Cohort 2|No Longer Required Study Treatment|0
1034272|NCT00143455|3368365|P1|Cohort 2|No Longer Required Study Treatment|0
1034273|NCT00143455|3368362|P4|Cohort 2|Adverse Event|30
1034274|NCT00143455|3368363|P3|Cohort 2|Adverse Event|42
1034275|NCT00143455|3368364|P2|Cohort 2|Adverse Event|0
1034276|NCT00143455|3368365|P1|Cohort 2|Adverse Event|0
1034277|NCT00143455|3368362|P4|Cohort 1|Randomized But Not Treated|0
1034278|NCT00143455|3368363|P3|Cohort 1|Randomized But Not Treated|0
1034279|NCT00143455|3368364|P2|Cohort 1|Randomized But Not Treated|1
1034280|NCT00143455|3368365|P1|Cohort 1|Randomized But Not Treated|0
1034281|NCT00143455|3368362|P4|Cohort 1|Withdrawal by Subject|0
1034282|NCT00143455|3368363|P3|Cohort 1|Withdrawal by Subject|0
1034283|NCT00143455|3368364|P2|Cohort 1|Withdrawal by Subject|4
1034284|NCT00143455|3368365|P1|Cohort 1|Withdrawal by Subject|1
1034285|NCT00143455|3368362|P4|Cohort 1|Progressive Disease|0
1034286|NCT00143455|3368363|P3|Cohort 1|Progressive Disease|0
1034287|NCT00143455|3368364|P2|Cohort 1|Progressive Disease|6
1034288|NCT00143455|3368365|P1|Cohort 1|Progressive Disease|0
1034289|NCT00143455|3368362|P4|Cohort 1|Death|0
1034290|NCT00143455|3368363|P3|Cohort 1|Death|0
1034291|NCT00143455|3368364|P2|Cohort 1|Death|2
1034292|NCT00143455|3368365|P1|Cohort 1|Death|5
1034293|NCT00143455|3368362|P4|Cohort 1|Adverse Event|0
1034294|NCT00143455|3368363|P3|Cohort 1|Adverse Event|0
1034295|NCT00143455|3368364|P2|Cohort 1|Adverse Event|4
1034296|NCT00143455|3368365|P1|Cohort 1|Adverse Event|8
1034297|NCT00143403|3368399|P2|Overall Study|Randomized Not Treated|8
1034298|NCT00143403|3368400|P1|Overall Study|Randomized Not Treated|7
1034299|NCT00143403|3368399|P2|Overall Study|specified by site|9
1034300|NCT00143403|3368400|P1|Overall Study|specified by site|4
1034301|NCT00143403|3368399|P2|Overall Study|Protocol Violation|2
1034302|NCT00143403|3368400|P1|Overall Study|Protocol Violation|2
1034303|NCT00143403|3368399|P2|Overall Study|Relapse|7
1034304|NCT00143403|3368400|P1|Overall Study|Relapse|15
1034305|NCT00143403|3368399|P2|Overall Study|Withdrawal by Subject|12
1034306|NCT00143403|3368400|P1|Overall Study|Withdrawal by Subject|3
1034307|NCT00143403|3368399|P2|Overall Study|Death|0
1034308|NCT00143403|3368400|P1|Overall Study|Death|1
1034309|NCT00143403|3368399|P2|Overall Study|Adverse Event|8
1034310|NCT00143403|3368400|P1|Overall Study|Adverse Event|3
1034311|NCT00143390|3368410|P2|Overall Study|Other|2
1034312|NCT00143390|3368411|P1|Overall Study|Other|1
1034313|NCT00143390|3368410|P2|Overall Study|Adverse Event|8
1034314|NCT00143390|3368411|P1|Overall Study|Adverse Event|9
1034315|NCT00143390|3368410|P2|Overall Study|Study termination|15
1034316|NCT00143390|3368411|P1|Overall Study|Study termination|10
1034317|NCT00143390|3368410|P2|Overall Study|Protocol Violation|0
1034318|NCT00143390|3368411|P1|Overall Study|Protocol Violation|2
1034319|NCT00143390|3368410|P2|Overall Study|Progressive disease|115
1034320|NCT00143390|3368411|P1|Overall Study|Progressive disease|119
1034321|NCT00143390|3368410|P2|Overall Study|Withdrawal by Subject|4
1034322|NCT00143390|3368411|P1|Overall Study|Withdrawal by Subject|4
1034323|NCT00143390|3368410|P2|Overall Study|Not meeting entry criteria|5
1034324|NCT00143390|3368411|P1|Overall Study|Not meeting entry criteria|2
1034325|NCT00143390|3368410|P2|Overall Study|Death|0
1034326|NCT00143390|3368411|P1|Overall Study|Death|2
1034327|NCT00143312|3368427|P1|Overall Study|Withdrawal by Subject|1
1034328|NCT00143312|3368427|P1|Overall Study|Other|1
1034329|NCT00143312|3368427|P1|Overall Study|Lost to Follow-up|1
1034330|NCT00143312|3368427|P1|Overall Study|Adverse Event|2
1034331|NCT00143312|3368427|P1|Overall Study|Death|11
1034332|NCT00143247|3368437|P1|Overall Study|Other|12
1034333|NCT00143247|3368437|P1|Overall Study|following inaccurate lab adverse event|1
1034334|NCT00143247|3368437|P1|Overall Study|Lost to Follow-up|12
1034335|NCT00143247|3368437|P1|Overall Study|Protocol Violation|15
1034336|NCT00143247|3368437|P1|Overall Study|Study terminated by sponsor|31
1034337|NCT00143247|3368437|P1|Overall Study|Withdrawal by Subject|55
1034338|NCT00143247|3368437|P1|Overall Study|Lack of Efficacy|3
1034339|NCT00143247|3368437|P1|Overall Study|Adverse Event|19
1034340|NCT00143247|3368437|P1|Overall Study|Death|8
1034341|NCT00142935|3368454|P3|Overall Study|Death|1
1034342|NCT00142935|3368455|P2|Overall Study|Death|2
1034343|NCT00142935|3368456|P1|Overall Study|Death|0
1034344|NCT00142935|3368454|P3|Overall Study|Lost to Follow-up|5
1034345|NCT00142935|3368455|P2|Overall Study|Lost to Follow-up|5
1034346|NCT00142935|3368456|P1|Overall Study|Lost to Follow-up|2
1034347|NCT00142935|3368454|P3|Overall Study|Other reason|1
1034348|NCT00142935|3368455|P2|Overall Study|Other reason|1
1034349|NCT00142935|3368456|P1|Overall Study|Other reason|1
1034350|NCT00142909|3368481|P2|Medications Begin|Withdrawal by Subject|0
1034351|NCT00142909|3368482|P1|Medications Begin|Withdrawal by Subject|2
1034352|NCT00142909|3368481|P2|Medications Begin|Withdrawal by Subject|3
1034353|NCT00142909|3368482|P1|Medications Begin|Withdrawal by Subject|5
1034354|NCT00142909|3368481|P2|Medications Begin|Protocol Violation|0
1034355|NCT00142909|3368482|P1|Medications Begin|Protocol Violation|2
1034356|NCT00142909|3368481|P2|Randomization|Various Reasons|10
1034357|NCT00142909|3368482|P1|Randomization|Various Reasons|7
1034358|NCT00142792|3368518|P3|Overall Study|No category|1
1034359|NCT00142792|3368519|P2|Overall Study|No category|2
1034360|NCT00142792|3368520|P1|Overall Study|No category|1
1034361|NCT00142792|3368518|P3|Overall Study|Lost to Follow-up|7
1034362|NCT00142792|3368519|P2|Overall Study|Lost to Follow-up|11
1034363|NCT00142792|3368520|P1|Overall Study|Lost to Follow-up|8
1034364|NCT00142792|3368518|P3|Overall Study|Withdrawal by Subject|3
1034365|NCT00142792|3368519|P2|Overall Study|Withdrawal by Subject|2
1034366|NCT00142792|3368520|P1|Overall Study|Withdrawal by Subject|3
1034367|NCT00142792|3368518|P3|Overall Study|Death|1
1034368|NCT00142792|3368519|P2|Overall Study|Death|0
1034369|NCT00142792|3368520|P1|Overall Study|Death|0
1034370|NCT00142415|3368555|P6|Overall Study|Physician Decision|2
1034371|NCT00142415|3368556|P5|Overall Study|Physician Decision|1
1034372|NCT00142415|3368557|P4|Overall Study|Physician Decision|0
1034373|NCT00142415|3368558|P3|Overall Study|Physician Decision|0
1034374|NCT00142415|3368559|P2|Overall Study|Physician Decision|0
1034375|NCT00142415|3368560|P1|Overall Study|Physician Decision|0
1034376|NCT00142298|3368598|P10|Overall Study|Treatment Failure|0
1034377|NCT00142298|3368599|P9|Overall Study|Treatment Failure|0
1034378|NCT00142298|3368600|P8|Overall Study|Treatment Failure|0
1034379|NCT00142298|3368601|P7|Overall Study|Treatment Failure|2
1034380|NCT00142298|3368602|P6|Overall Study|Treatment Failure|2
1034381|NCT00142298|3368603|P5|Overall Study|Treatment Failure|0
1034382|NCT00142298|3368604|P4|Overall Study|Treatment Failure|0
1034383|NCT00142298|3368605|P3|Overall Study|Treatment Failure|0
1034384|NCT00142298|3368606|P2|Overall Study|Treatment Failure|0
1034385|NCT00142298|3368607|P1|Overall Study|Treatment Failure|0
1034386|NCT00142298|3368598|P10|Overall Study|Lost to Follow-up|0
1034387|NCT00142298|3368599|P9|Overall Study|Lost to Follow-up|0
1034388|NCT00142298|3368600|P8|Overall Study|Lost to Follow-up|0
1034389|NCT00142298|3368601|P7|Overall Study|Lost to Follow-up|2
1034390|NCT00142298|3368602|P6|Overall Study|Lost to Follow-up|0
1034391|NCT00142298|3368603|P5|Overall Study|Lost to Follow-up|0
1034392|NCT00142298|3368604|P4|Overall Study|Lost to Follow-up|0
1034393|NCT00142298|3368605|P3|Overall Study|Lost to Follow-up|0
1034394|NCT00142298|3368606|P2|Overall Study|Lost to Follow-up|0
1034395|NCT00142298|3368607|P1|Overall Study|Lost to Follow-up|0
1034396|NCT00142298|3368598|P10|Overall Study|Other- not specified|0
1034397|NCT00142298|3368599|P9|Overall Study|Other- not specified|0
1034398|NCT00142298|3368600|P8|Overall Study|Other- not specified|0
1034399|NCT00142298|3368601|P7|Overall Study|Other- not specified|0
1034400|NCT00142298|3368602|P6|Overall Study|Other- not specified|0
1034401|NCT00142298|3368603|P5|Overall Study|Other- not specified|0
1034402|NCT00142298|3368604|P4|Overall Study|Other- not specified|1
1034403|NCT00142298|3368605|P3|Overall Study|Other- not specified|0
1034404|NCT00142298|3368606|P2|Overall Study|Other- not specified|3
1034405|NCT00142298|3368607|P1|Overall Study|Other- not specified|0
1034406|NCT00142298|3368598|P10|Overall Study|Virologic breakthrough|0
1034407|NCT00142298|3368599|P9|Overall Study|Virologic breakthrough|0
1034408|NCT00142298|3368600|P8|Overall Study|Virologic breakthrough|0
1034409|NCT00142298|3368601|P7|Overall Study|Virologic breakthrough|3
1034410|NCT00142298|3368602|P6|Overall Study|Virologic breakthrough|3
1034411|NCT00142298|3368603|P5|Overall Study|Virologic breakthrough|2
1034412|NCT00142298|3368604|P4|Overall Study|Virologic breakthrough|7
1034413|NCT00142298|3368605|P3|Overall Study|Virologic breakthrough|9
1034414|NCT00142298|3368606|P2|Overall Study|Virologic breakthrough|23
1034415|NCT00142298|3368607|P1|Overall Study|Virologic breakthrough|19
1034416|NCT00142298|3368598|P10|Overall Study|Pregnancy|0
1034417|NCT00142298|3368599|P9|Overall Study|Pregnancy|1
1034418|NCT00142298|3368600|P8|Overall Study|Pregnancy|0
1034419|NCT00142298|3368601|P7|Overall Study|Pregnancy|0
1034420|NCT00142298|3368602|P6|Overall Study|Pregnancy|0
1034421|NCT00142298|3368603|P5|Overall Study|Pregnancy|0
1034422|NCT00142298|3368604|P4|Overall Study|Pregnancy|3
1034423|NCT00142298|3368605|P3|Overall Study|Pregnancy|2
1034424|NCT00142298|3368606|P2|Overall Study|Pregnancy|4
1034425|NCT00142298|3368607|P1|Overall Study|Pregnancy|4
1034426|NCT00142298|3368598|P10|Overall Study|Patient, Investigator,or Sponsor request|0
1034427|NCT00142298|3368599|P9|Overall Study|Patient, Investigator,or Sponsor request|1
1034428|NCT00142298|3368600|P8|Overall Study|Patient, Investigator,or Sponsor request|4
1034429|NCT00142298|3368601|P7|Overall Study|Patient, Investigator,or Sponsor request|1
1034430|NCT00142298|3368602|P6|Overall Study|Patient, Investigator,or Sponsor request|3
1034431|NCT00142298|3368603|P5|Overall Study|Patient, Investigator,or Sponsor request|4
1034432|NCT00142298|3368604|P4|Overall Study|Patient, Investigator,or Sponsor request|51
1034433|NCT00142298|3368605|P3|Overall Study|Patient, Investigator,or Sponsor request|11
1034434|NCT00142298|3368606|P2|Overall Study|Patient, Investigator,or Sponsor request|60
1034435|NCT00142298|3368607|P1|Overall Study|Patient, Investigator,or Sponsor request|66
1034436|NCT00142298|3368598|P10|Overall Study|Non-compliance|0
1034437|NCT00142298|3368599|P9|Overall Study|Non-compliance|3
1034438|NCT00142298|3368600|P8|Overall Study|Non-compliance|3
1034439|NCT00142298|3368601|P7|Overall Study|Non-compliance|0
1034440|NCT00142298|3368602|P6|Overall Study|Non-compliance|0
1034441|NCT00142298|3368603|P5|Overall Study|Non-compliance|1
1034442|NCT00142298|3368604|P4|Overall Study|Non-compliance|6
1034443|NCT00142298|3368605|P3|Overall Study|Non-compliance|0
1034444|NCT00142298|3368606|P2|Overall Study|Non-compliance|13
1034445|NCT00142298|3368607|P1|Overall Study|Non-compliance|15
1034446|NCT00142298|3368598|P10|Overall Study|Lack of Efficacy|0
1034447|NCT00142298|3368599|P9|Overall Study|Lack of Efficacy|0
1034448|NCT00142298|3368600|P8|Overall Study|Lack of Efficacy|1
1034449|NCT00142298|3368601|P7|Overall Study|Lack of Efficacy|0
1034450|NCT00142298|3368602|P6|Overall Study|Lack of Efficacy|0
1034451|NCT00142298|3368603|P5|Overall Study|Lack of Efficacy|1
1034452|NCT00142298|3368604|P4|Overall Study|Lack of Efficacy|12
1034453|NCT00142298|3368605|P3|Overall Study|Lack of Efficacy|9
1034454|NCT00142298|3368606|P2|Overall Study|Lack of Efficacy|62
1034455|NCT00142298|3368607|P1|Overall Study|Lack of Efficacy|44
1034456|NCT00142298|3368598|P10|Overall Study|Death|0
1034457|NCT00142298|3368599|P9|Overall Study|Death|0
1034458|NCT00142298|3368600|P8|Overall Study|Death|0
1034459|NCT00142298|3368601|P7|Overall Study|Death|0
1034460|NCT00142298|3368602|P6|Overall Study|Death|6
1034461|NCT00142298|3368603|P5|Overall Study|Death|0
1034462|NCT00142298|3368604|P4|Overall Study|Death|0
1034463|NCT00142298|3368605|P3|Overall Study|Death|1
1034464|NCT00142298|3368606|P2|Overall Study|Death|1
1034465|NCT00142298|3368607|P1|Overall Study|Death|1
1034466|NCT00142298|3368598|P10|Overall Study|Clinical disease progression|0
1034467|NCT00142298|3368599|P9|Overall Study|Clinical disease progression|0
1034468|NCT00142298|3368600|P8|Overall Study|Clinical disease progression|0
1034469|NCT00142298|3368601|P7|Overall Study|Clinical disease progression|0
1034470|NCT00142298|3368602|P6|Overall Study|Clinical disease progression|0
1034471|NCT00142298|3368603|P5|Overall Study|Clinical disease progression|0
1034472|NCT00142298|3368604|P4|Overall Study|Clinical disease progression|0
1034473|NCT00142298|3368605|P3|Overall Study|Clinical disease progression|0
1034474|NCT00142298|3368606|P2|Overall Study|Clinical disease progression|0
1034475|NCT00142298|3368607|P1|Overall Study|Clinical disease progression|1
1034476|NCT00142298|3368598|P10|Overall Study|Adverse Event|0
1034477|NCT00142298|3368599|P9|Overall Study|Adverse Event|0
1034478|NCT00142298|3368600|P8|Overall Study|Adverse Event|0
1034479|NCT00142298|3368601|P7|Overall Study|Adverse Event|0
1034480|NCT00142298|3368602|P6|Overall Study|Adverse Event|2
1034481|NCT00142298|3368603|P5|Overall Study|Adverse Event|2
1034482|NCT00142298|3368604|P4|Overall Study|Adverse Event|5
1034483|NCT00142298|3368605|P3|Overall Study|Adverse Event|1
1034484|NCT00142298|3368606|P2|Overall Study|Adverse Event|10
1034485|NCT00142298|3368607|P1|Overall Study|Adverse Event|10
1034486|NCT00141921|3368641|P1|Overall Study|Other|8
1034487|NCT00141921|3368641|P1|Overall Study|Ineligibility Determined|2
1034488|NCT00141921|3368641|P1|Overall Study|Pregnancy|4
1034489|NCT00141921|3368641|P1|Overall Study|Administrative Decision|2
1034490|NCT00141921|3368641|P1|Overall Study|Adverse Event|5
1034491|NCT00141921|3368641|P1|Overall Study|Protocol Deviation|7
1034492|NCT00141921|3368641|P1|Overall Study|Disease Progression|7
1034493|NCT00141921|3368641|P1|Overall Study|Noncompliance|17
1034494|NCT00141921|3368641|P1|Overall Study|Lost to Follow-up|19
1034495|NCT00141921|3368641|P1|Overall Study|Withdrawal by Subject|42
1034496|NCT00141921|3368641|P1|Overall Study|Remain on Study|28
1034497|NCT00141817|3368667|P4|Overall Study|Parent request|0
1034498|NCT00141817|3368668|P3|Overall Study|Parent request|0
1034499|NCT00141817|3368669|P2|Overall Study|Parent request|0
1034500|NCT00141817|3368670|P1|Overall Study|Parent request|1
1034501|NCT00141817|3368667|P4|Overall Study|Protocol Violation|0
1034502|NCT00141817|3368668|P3|Overall Study|Protocol Violation|1
1034503|NCT00141817|3368669|P2|Overall Study|Protocol Violation|0
1034504|NCT00141817|3368670|P1|Overall Study|Protocol Violation|0
1034505|NCT00141778|3368711|P3|Started Study Medication|Chest Discomfort|1
1034506|NCT00141778|3368712|P2|Started Study Medication|Chest Discomfort|0
1034507|NCT00141778|3368713|P1|Started Study Medication|Chest Discomfort|0
1034508|NCT00141778|3368711|P3|Started Study Medication|Difficulty Swallowing|0
1034509|NCT00141778|3368712|P2|Started Study Medication|Difficulty Swallowing|1
1034510|NCT00141778|3368713|P1|Started Study Medication|Difficulty Swallowing|0
1034511|NCT00141778|3368711|P3|Started Study Medication|Withdrawal by Subject|0
1034512|NCT00141778|3368712|P2|Started Study Medication|Withdrawal by Subject|2
1034513|NCT00141778|3368713|P1|Started Study Medication|Withdrawal by Subject|0
1034514|NCT00141778|3368711|P3|Started Study Medication|Met safety criteria for discontinuation|3
1034515|NCT00141778|3368712|P2|Started Study Medication|Met safety criteria for discontinuation|4
1034516|NCT00141778|3368713|P1|Started Study Medication|Met safety criteria for discontinuation|2
1034517|NCT00141778|3368711|P3|Randomization Prior to Study Med|Withdrawal by Subject|6
1034518|NCT00141778|3368712|P2|Randomization Prior to Study Med|Withdrawal by Subject|2
1034519|NCT00141778|3368713|P1|Randomization Prior to Study Med|Withdrawal by Subject|5
1034520|NCT00141726|3368766|P1|Overall Study|Completed <50% Scheduled Dosing|3
1034521|NCT00141518|3368774|P3|Overall Study|Lack of Efficacy|0
1034522|NCT00141518|3368775|P2|Overall Study|Lack of Efficacy|0
1034523|NCT00141518|3368776|P1|Overall Study|Lack of Efficacy|5
1034524|NCT00141518|3368774|P3|Overall Study|Protocol Violation|2
1034525|NCT00141518|3368775|P2|Overall Study|Protocol Violation|1
1034526|NCT00141518|3368776|P1|Overall Study|Protocol Violation|1
1034527|NCT00141518|3368774|P3|Overall Study|Withdrawal by Subject|2
1034528|NCT00141518|3368775|P2|Overall Study|Withdrawal by Subject|0
1034529|NCT00141518|3368776|P1|Overall Study|Withdrawal by Subject|2
1034530|NCT00141518|3368774|P3|Overall Study|Adverse Event|2
1034531|NCT00141518|3368775|P2|Overall Study|Adverse Event|5
1034532|NCT00141518|3368776|P1|Overall Study|Adverse Event|7
1034533|NCT00141518|3368774|P3|Overall Study|Withdrew Consent Prior to Treatment|0
1034534|NCT00141518|3368775|P2|Overall Study|Withdrew Consent Prior to Treatment|0
1034535|NCT00141518|3368776|P1|Overall Study|Withdrew Consent Prior to Treatment|1
1034536|NCT00141453|3368965|P2|Overall Study|Protocol Violation|5
1034537|NCT00141453|3368966|P1|Overall Study|Protocol Violation|6
1034538|NCT00141297|3368980|P10|Overall Study|Transitioned|0
1034539|NCT00141297|3368981|P9|Overall Study|Transitioned|0
1034540|NCT00141297|3368982|P8|Overall Study|Transitioned|0
1034541|NCT00141297|3368983|P7|Overall Study|Transitioned|0
1034542|NCT00141297|3368984|P6|Overall Study|Transitioned|0
1034543|NCT00141297|3368985|P5|Overall Study|Transitioned|1
1034544|NCT00141297|3368986|P4|Overall Study|Transitioned|0
1034545|NCT00141297|3368987|P3|Overall Study|Transitioned|0
1034546|NCT00141297|3368988|P2|Overall Study|Transitioned|0
1034547|NCT00141297|3368989|P1|Overall Study|Transitioned|0
1034548|NCT00141297|3368980|P10|Overall Study|Progressive Disease|6
1034549|NCT00141297|3368981|P9|Overall Study|Progressive Disease|15
1034550|NCT00141297|3368982|P8|Overall Study|Progressive Disease|3
1034551|NCT00141297|3368983|P7|Overall Study|Progressive Disease|3
1034552|NCT00141297|3368984|P6|Overall Study|Progressive Disease|2
1034553|NCT00141297|3368985|P5|Overall Study|Progressive Disease|15
1034554|NCT00141297|3368986|P4|Overall Study|Progressive Disease|2
1034555|NCT00141297|3368987|P3|Overall Study|Progressive Disease|6
1034556|NCT00141297|3368988|P2|Overall Study|Progressive Disease|3
1034557|NCT00141297|3368989|P1|Overall Study|Progressive Disease|2
1034558|NCT00141297|3368980|P10|Overall Study|Other|0
1034559|NCT00141297|3368981|P9|Overall Study|Other|2
1034560|NCT00141297|3368982|P8|Overall Study|Other|0
1034561|NCT00141297|3368983|P7|Overall Study|Other|0
1034562|NCT00141297|3368984|P6|Overall Study|Other|0
1034563|NCT00141297|3368985|P5|Overall Study|Other|5
1034564|NCT00141297|3368986|P4|Overall Study|Other|1
1034565|NCT00141297|3368987|P3|Overall Study|Other|0
1034566|NCT00141297|3368988|P2|Overall Study|Other|0
1034567|NCT00141297|3368989|P1|Overall Study|Other|0
1034568|NCT00141297|3368980|P10|Overall Study|Withdrawal by Subject|0
1034569|NCT00141297|3368981|P9|Overall Study|Withdrawal by Subject|1
1034570|NCT00141297|3368982|P8|Overall Study|Withdrawal by Subject|0
1034571|NCT00141297|3368983|P7|Overall Study|Withdrawal by Subject|0
1034572|NCT00141297|3368984|P6|Overall Study|Withdrawal by Subject|0
1034573|NCT00141297|3368985|P5|Overall Study|Withdrawal by Subject|0
1034574|NCT00141297|3368986|P4|Overall Study|Withdrawal by Subject|0
1034575|NCT00141297|3368987|P3|Overall Study|Withdrawal by Subject|0
1034576|NCT00141297|3368988|P2|Overall Study|Withdrawal by Subject|0
1034577|NCT00141297|3368989|P1|Overall Study|Withdrawal by Subject|0
1034578|NCT00141297|3368980|P10|Overall Study|Death|0
1034579|NCT00141297|3368981|P9|Overall Study|Death|1
1034580|NCT00141297|3368982|P8|Overall Study|Death|0
1034581|NCT00141297|3368983|P7|Overall Study|Death|0
1034582|NCT00141297|3368984|P6|Overall Study|Death|0
1034583|NCT00141297|3368985|P5|Overall Study|Death|0
1034584|NCT00141297|3368986|P4|Overall Study|Death|0
1034585|NCT00141297|3368987|P3|Overall Study|Death|0
1034586|NCT00141297|3368988|P2|Overall Study|Death|0
1034587|NCT00141297|3368989|P1|Overall Study|Death|1
1034588|NCT00141297|3368980|P10|Overall Study|Adverse Event|0
1034589|NCT00141297|3368981|P9|Overall Study|Adverse Event|1
1034590|NCT00141297|3368982|P8|Overall Study|Adverse Event|1
1034591|NCT00141297|3368983|P7|Overall Study|Adverse Event|0
1034592|NCT00141297|3368984|P6|Overall Study|Adverse Event|1
1034593|NCT00141297|3368985|P5|Overall Study|Adverse Event|1
1034594|NCT00141297|3368986|P4|Overall Study|Adverse Event|0
1034595|NCT00141297|3368987|P3|Overall Study|Adverse Event|1
1034596|NCT00141297|3368988|P2|Overall Study|Adverse Event|0
1034597|NCT00141297|3368989|P1|Overall Study|Adverse Event|0
1034598|NCT00141271|3369267|P3|Overall Study|Other|5
1034599|NCT00141271|3369268|P2|Overall Study|Other|12
1034600|NCT00141271|3369269|P1|Overall Study|Other|11
1034601|NCT00141271|3369267|P3|Overall Study|Withdrawal by Subject|10
1034602|NCT00141271|3369268|P2|Overall Study|Withdrawal by Subject|9
1034603|NCT00141271|3369269|P1|Overall Study|Withdrawal by Subject|14
1034604|NCT00141271|3369267|P3|Overall Study|Lost to Follow-up|21
1034605|NCT00141271|3369268|P2|Overall Study|Lost to Follow-up|15
1034606|NCT00141271|3369269|P1|Overall Study|Lost to Follow-up|15
1034607|NCT00141271|3369267|P3|Overall Study|Lack of Efficacy|3
1034608|NCT00141271|3369268|P2|Overall Study|Lack of Efficacy|7
1034609|NCT00141271|3369269|P1|Overall Study|Lack of Efficacy|7
1034610|NCT00141271|3369267|P3|Overall Study|Laboratory Abnormality|1
1034611|NCT00141271|3369268|P2|Overall Study|Laboratory Abnormality|1
1034612|NCT00141271|3369269|P1|Overall Study|Laboratory Abnormality|2
1034613|NCT00141271|3369267|P3|Overall Study|Adverse Event|17
1034614|NCT00141271|3369268|P2|Overall Study|Adverse Event|19
1034615|NCT00141271|3369269|P1|Overall Study|Adverse Event|31
1034616|NCT00141219|3369390|P2|Overall Study|Withdrawal by Subject|2
1034617|NCT00141219|3369391|P1|Overall Study|Withdrawal by Subject|6
1034618|NCT00141219|3369390|P2|Overall Study|Lack of Efficacy|4
1034619|NCT00141219|3369391|P1|Overall Study|Lack of Efficacy|5
1034620|NCT00141219|3369390|P2|Overall Study|Adverse Event|6
1034621|NCT00141219|3369391|P1|Overall Study|Adverse Event|8
1034622|NCT00141219|3369390|P2|Overall Study|Protocol violations|4
1034623|NCT00141219|3369391|P1|Overall Study|Protocol violations|5
1034624|NCT00141102|3369448|P2|Overall Study|Death|2
1034625|NCT00141102|3369449|P1|Overall Study|Death|2
1034626|NCT00141102|3369448|P2|Overall Study|Randomized But Did Not Receive Treatment|9
1034627|NCT00141102|3369449|P1|Overall Study|Randomized But Did Not Receive Treatment|15
1034628|NCT00141102|3369448|P2|Overall Study|Withdrawal by Subject|142
1034629|NCT00141102|3369449|P1|Overall Study|Withdrawal by Subject|112
1034630|NCT00141102|3369448|P2|Overall Study|Other|76
1034631|NCT00141102|3369449|P1|Overall Study|Other|87
1034632|NCT00141102|3369448|P2|Overall Study|Lost to Follow-up|32
1034633|NCT00141102|3369449|P1|Overall Study|Lost to Follow-up|29
1034634|NCT00141102|3369448|P2|Overall Study|Lack of Efficacy|26
1034635|NCT00141102|3369449|P1|Overall Study|Lack of Efficacy|21
1034636|NCT00141102|3369448|P2|Overall Study|Laboratory Abnormality|33
1034637|NCT00141102|3369449|P1|Overall Study|Laboratory Abnormality|9
1034638|NCT00141102|3369448|P2|Overall Study|Adverse Event|305
1034639|NCT00141102|3369449|P1|Overall Study|Adverse Event|233
1034640|NCT00141037|3369489|P2|Overall Study|Graft Failure|4
1034641|NCT00141037|3369490|P1|Overall Study|Graft Failure|3
1034642|NCT00141037|3369489|P2|Overall Study|Moved from area|7
1034643|NCT00141037|3369490|P1|Overall Study|Moved from area|1
1034644|NCT00141037|3369489|P2|Overall Study|Other|1
1034645|NCT00141037|3369490|P1|Overall Study|Other|0
1034646|NCT00141037|3369489|P2|Overall Study|Withdrawal by Subject|1
1034647|NCT00141037|3369490|P1|Overall Study|Withdrawal by Subject|2
1034648|NCT00141037|3369489|P2|Overall Study|Protocol Violation|2
1034649|NCT00141037|3369490|P1|Overall Study|Protocol Violation|0
1034650|NCT00141037|3369489|P2|Overall Study|Lost to Follow-up|1
1034651|NCT00141037|3369490|P1|Overall Study|Lost to Follow-up|3
1034652|NCT00141037|3369489|P2|Overall Study|Physician Decision|2
1034653|NCT00141037|3369490|P1|Overall Study|Physician Decision|1
1034654|NCT00140426|3369525|P2|Overall Study|Withdrawal by Subject|3
1034655|NCT00140426|3369526|P1|Overall Study|Withdrawal by Subject|0
1034656|NCT00140413|3369559|P2|Overall Study|Withdrawal by Subject|0
1034657|NCT00140413|3369560|P1|Overall Study|Withdrawal by Subject|2
1034658|NCT00140413|3369559|P2|Overall Study|Lost to Follow-up|0
1034659|NCT00140413|3369560|P1|Overall Study|Lost to Follow-up|1
1034660|NCT00140140|3369691|P3|Overall Study|Physician Decision|0
1034661|NCT00140140|3369692|P2|Overall Study|Physician Decision|1
1034662|NCT00140140|3369693|P1|Overall Study|Physician Decision|1
1034663|NCT00140140|3369691|P3|Overall Study|Unacceptable toxicity|2
1034664|NCT00140140|3369692|P2|Overall Study|Unacceptable toxicity|1
1034665|NCT00140140|3369693|P1|Overall Study|Unacceptable toxicity|1
1034666|NCT00139776|3369743|P4|Period III|Withdrawal by Subject|21
1034667|NCT00139776|3369744|P3|Period III|Withdrawal by Subject|16
1034668|NCT00139776|3369745|P2|Period III|Withdrawal by Subject|0
1034669|NCT00139776|3369746|P1|Period III|Withdrawal by Subject|0
1034670|NCT00139776|3369743|P4|Period III|Lost to Follow-up|4
1034671|NCT00139776|3369744|P3|Period III|Lost to Follow-up|5
1034672|NCT00139776|3369745|P2|Period III|Lost to Follow-up|0
1034673|NCT00139776|3369746|P1|Period III|Lost to Follow-up|0
1034674|NCT00139776|3369743|P4|Period III|Lack of Efficacy|24
1034675|NCT00139776|3369744|P3|Period III|Lack of Efficacy|10
1034676|NCT00139776|3369745|P2|Period III|Lack of Efficacy|0
1034677|NCT00139776|3369746|P1|Period III|Lack of Efficacy|0
1034678|NCT00139776|3369743|P4|Period III|Other|34
1034679|NCT00139776|3369744|P3|Period III|Other|23
1034680|NCT00139776|3369745|P2|Period III|Other|0
1034681|NCT00139776|3369746|P1|Period III|Other|0
1034682|NCT00139776|3369743|P4|Period III|Adverse Event|23
1034683|NCT00139776|3369744|P3|Period III|Adverse Event|22
1034684|NCT00139776|3369745|P2|Period III|Adverse Event|0
1034685|NCT00139776|3369746|P1|Period III|Adverse Event|0
1034686|NCT00139776|3369743|P4|Period II|Not Randomized into Period III|0
1034687|NCT00139776|3369744|P3|Period II|Not Randomized into Period III|0
1034688|NCT00139776|3369745|P2|Period II|Not Randomized into Period III|322
1034689|NCT00139776|3369746|P1|Period II|Not Randomized into Period III|0
1034690|NCT00139776|3369743|P4|Period I|Did not enter Period II|0
1034691|NCT00139776|3369744|P3|Period I|Did not enter Period II|0
1034692|NCT00139776|3369745|P2|Period I|Did not enter Period II|0
1034693|NCT00139776|3369746|P1|Period I|Did not enter Period II|575
1034694|NCT00139737|3369781|P1|Overall Study|Screened, Not Treated|13
1034695|NCT00139737|3369781|P1|Overall Study|Did Not Meet Entrance Criteria|1
1034696|NCT00139737|3369781|P1|Overall Study|Withdrew During Screening Phase|8
1034697|NCT00139737|3369781|P1|Overall Study|Protocol Violation|18
1034698|NCT00139737|3369781|P1|Overall Study|Laboratory Abnormality|2
1034699|NCT00139737|3369781|P1|Overall Study|Death|3
1034700|NCT00139737|3369781|P1|Overall Study|Lost to Follow-up|8
1034701|NCT00139737|3369781|P1|Overall Study|Lack of Efficacy|40
1034702|NCT00139737|3369781|P1|Overall Study|Adverse Event|58
1034703|NCT00139737|3369781|P1|Overall Study|Withdrawal by Subject|190
1034704|NCT00139659|3369787|P2|Overall Study|Withdrawal by Subject|10
1034705|NCT00139659|3369788|P1|Overall Study|Withdrawal by Subject|14
1034706|NCT00139659|3369787|P2|Overall Study|Reason not Specified|3
1034707|NCT00139659|3369788|P1|Overall Study|Reason not Specified|6
1034708|NCT00139659|3369787|P2|Overall Study|Lost to Follow-up|3
1034709|NCT00139659|3369788|P1|Overall Study|Lost to Follow-up|7
1034710|NCT00139659|3369787|P2|Overall Study|Lack of Efficacy|1
1034711|NCT00139659|3369788|P1|Overall Study|Lack of Efficacy|1
1034712|NCT00139659|3369787|P2|Overall Study|Adverse Event|1
1034713|NCT00139659|3369788|P1|Overall Study|Adverse Event|12
1034714|NCT00139477|3369866|P2|Second Intervention -6Months to 12Months|Lost to Follow-up|3
1034715|NCT00139477|3369867|P1|Second Intervention -6Months to 12Months|Lost to Follow-up|4
1034716|NCT00139477|3369866|P2|Second Intervention -6Months to 12Months|Relocation|0
1034717|NCT00139477|3369867|P1|Second Intervention -6Months to 12Months|Relocation|1
1034718|NCT00139477|3369866|P2|Second Intervention -6Months to 12Months|No Longer Interested|2
1034719|NCT00139477|3369867|P1|Second Intervention -6Months to 12Months|No Longer Interested|0
1034720|NCT00139477|3369866|P2|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0
1034721|NCT00139477|3369867|P1|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2
1034722|NCT00139477|3369866|P2|First Intervention -Baseline to 6Months|Lost to Follow-up|3
1034723|NCT00139477|3369867|P1|First Intervention -Baseline to 6Months|Lost to Follow-up|3
1034724|NCT00139477|3369866|P2|First Intervention -Baseline to 6Months|Relocation|2
1034725|NCT00139477|3369867|P1|First Intervention -Baseline to 6Months|Relocation|1
1034726|NCT00139477|3369866|P2|First Intervention -Baseline to 6Months|No Longer Interested|7
1034727|NCT00139477|3369867|P1|First Intervention -Baseline to 6Months|No Longer Interested|6
1034728|NCT00138671|3369889|P2|Overall Study|Other|3
1034729|NCT00138671|3369890|P1|Overall Study|Other|3
1034730|NCT00138671|3369889|P2|Overall Study|Withdrawal by Subject|5
1034731|NCT00138671|3369890|P1|Overall Study|Withdrawal by Subject|3
1034732|NCT00138671|3369889|P2|Overall Study|Lost to Follow-up|2
1034733|NCT00138671|3369890|P1|Overall Study|Lost to Follow-up|1
1034734|NCT00138671|3369889|P2|Overall Study|Adverse Event|3
1034735|NCT00138671|3369890|P1|Overall Study|Adverse Event|6
1034736|NCT00138671|3369889|P2|Overall Study|Death|3
1034737|NCT00138671|3369890|P1|Overall Study|Death|0
1034738|NCT00138658|3369940|P1|Overall Study|Withdrawal by Subject|5
1034739|NCT00138658|3369940|P1|Overall Study|Physician Decision|11
1034740|NCT00138658|3369940|P1|Overall Study|Disease Progression|21
1034741|NCT00138658|3369940|P1|Overall Study|Death|1
1034742|NCT00138658|3369940|P1|Overall Study|Adverse Event|23
1034743|NCT00138424|3369963|P4|Overall Study|Physician Decision|0
1034744|NCT00138424|3369964|P3|Overall Study|Physician Decision|0
1034745|NCT00138424|3369965|P2|Overall Study|Physician Decision|1
1034746|NCT00138424|3369966|P1|Overall Study|Physician Decision|0
1034747|NCT00138151|3370049|P1|Overall Study|Physician Decision|1
1034748|NCT00138151|3370049|P1|Overall Study|Withdrawal by Subject|3
1034749|NCT00138073|3370059|P1|Overall Study|lack of resources|55
1034750|NCT00137631|3370100|P2|Overall Study|Lost to Follow-up|41
1034751|NCT00137631|3370101|P1|Overall Study|Lost to Follow-up|37
1034752|NCT00137449|3370117|P2|Overall Study|Withdrawal by Subject|1
1034753|NCT00137449|3370118|P1|Overall Study|Withdrawal by Subject|1
1034754|NCT00137449|3370117|P2|Overall Study|Adverse Event|1
1034755|NCT00137449|3370118|P1|Overall Study|Adverse Event|3
1034756|NCT00137449|3370117|P2|Overall Study|Death|3
1034757|NCT00137449|3370118|P1|Overall Study|Death|4
1034758|NCT00137449|3370117|P2|Overall Study|Disease Progression|13
1034759|NCT00137449|3370118|P1|Overall Study|Disease Progression|8
1034760|NCT00137436|3370155|P1|Overall Study|Other|5
1034761|NCT00137436|3370155|P1|Overall Study|Withdrawal by Subject|6
1034762|NCT00137436|3370155|P1|Overall Study|Lack of Efficacy|17
1034763|NCT00137436|3370155|P1|Overall Study|Death|2
1034764|NCT00137436|3370155|P1|Overall Study|Adverse Event|13
1034765|NCT00137423|3370174|P2|Overall Study|Death|1
1034766|NCT00137423|3370175|P1|Overall Study|Death|0
1034767|NCT00137423|3370174|P2|Overall Study|Lack of Efficacy|33
1034768|NCT00137423|3370175|P1|Overall Study|Lack of Efficacy|31
1034769|NCT00137423|3370174|P2|Overall Study|consent withdrawn|1
1034770|NCT00137423|3370175|P1|Overall Study|consent withdrawn|1
1034771|NCT00137423|3370174|P2|Overall Study|Adverse Event|9
1034772|NCT00137423|3370175|P1|Overall Study|Adverse Event|7
1034773|NCT00137267|3370212|P2|Overall Study|Lost to Follow-up|21
1034774|NCT00137267|3370213|P1|Overall Study|Lost to Follow-up|15
1034775|NCT00137111|3370225|P4|Total Therapy|Non Compliance|0
1034776|NCT00137111|3370226|P3|Total Therapy|Non Compliance|0
1034777|NCT00137111|3370227|P2|Total Therapy|Non Compliance|0
1034778|NCT00137111|3370228|P1|Total Therapy|Non Compliance|5
1034779|NCT00137111|3370225|P4|Total Therapy|Death|0
1034780|NCT00137111|3370226|P3|Total Therapy|Death|0
1034781|NCT00137111|3370227|P2|Total Therapy|Death|0
1034782|NCT00137111|3370228|P1|Total Therapy|Death|35
1034783|NCT00137046|3370242|P2|Overall Study|Withdrew prior to study treatment|1
1034784|NCT00137046|3370243|P1|Overall Study|Withdrew prior to study treatment|1
1034785|NCT00137046|3370242|P2|Overall Study|Adverse Event 4 Days after Last Dose|0
1034786|NCT00137046|3370243|P1|Overall Study|Adverse Event 4 Days after Last Dose|1
1034787|NCT00137046|3370242|P2|Overall Study|Withdrawal by Subject|42
1034788|NCT00137046|3370243|P1|Overall Study|Withdrawal by Subject|33
1034789|NCT00137046|3370242|P2|Overall Study|Other|19
1034790|NCT00137046|3370243|P1|Overall Study|Other|23
1034791|NCT00137046|3370242|P2|Overall Study|Lost to Follow-up|24
1034792|NCT00137046|3370243|P1|Overall Study|Lost to Follow-up|8
1034793|NCT00137046|3370242|P2|Overall Study|Lack of Efficacy|1
1034794|NCT00137046|3370243|P1|Overall Study|Lack of Efficacy|13
1034795|NCT00137046|3370242|P2|Overall Study|Laboratory Abnormality|0
1034796|NCT00137046|3370243|P1|Overall Study|Laboratory Abnormality|2
1034797|NCT00137046|3370242|P2|Overall Study|Adverse Event|5
1034798|NCT00137046|3370243|P1|Overall Study|Adverse Event|16
1034799|NCT00137046|3370242|P2|Overall Study|Death|1
1034800|NCT00137046|3370243|P1|Overall Study|Death|2
1034801|NCT00136955|3370291|P1|Overall Study|Incl. prog. disease, protocol violation|12
1034802|NCT00136955|3370291|P1|Overall Study|Withdrawal by Subject|2
1034803|NCT00136955|3370291|P1|Overall Study|Lost to Follow-up|1
1034804|NCT00136955|3370291|P1|Overall Study|Adverse Event|8
1034805|NCT00136916|3370300|P2|Overall Study|Discontinued in follow up period|0
1034806|NCT00136916|3370301|P1|Overall Study|Discontinued in follow up period|3
1034807|NCT00136916|3370300|P2|Overall Study|Other|24
1034808|NCT00136916|3370301|P1|Overall Study|Other|22
1034809|NCT00136916|3370300|P2|Overall Study|Withdrawal by Subject|46
1034810|NCT00136916|3370301|P1|Overall Study|Withdrawal by Subject|44
1034811|NCT00136916|3370300|P2|Overall Study|Lost to Follow-up|14
1034812|NCT00136916|3370301|P1|Overall Study|Lost to Follow-up|12
1034813|NCT00136916|3370300|P2|Overall Study|Lack of Efficacy|3
1034814|NCT00136916|3370301|P1|Overall Study|Lack of Efficacy|13
1034815|NCT00136916|3370300|P2|Overall Study|Laboratory abnormality|1
1034816|NCT00136916|3370301|P1|Overall Study|Laboratory abnormality|0
1034817|NCT00136916|3370300|P2|Overall Study|Adverse Event|8
1034818|NCT00136916|3370301|P1|Overall Study|Adverse Event|27
1034819|NCT00136916|3370300|P2|Overall Study|Death|3
1034820|NCT00136916|3370301|P1|Overall Study|Death|1
1034821|NCT00136916|3370300|P2|Overall Study|Never received study treatment|5
1034822|NCT00136916|3370301|P1|Overall Study|Never received study treatment|3
1034823|NCT00136604|3370408|P5|Overall Study|Migrated/moved from study area|0
1034824|NCT00136604|3370409|P4|Overall Study|Migrated/moved from study area|0
1034825|NCT00136604|3370410|P3|Overall Study|Migrated/moved from study area|0
1034826|NCT00136604|3370411|P2|Overall Study|Migrated/moved from study area|1
1034827|NCT00136604|3370412|P1|Overall Study|Migrated/moved from study area|0
1034828|NCT00136604|3370408|P5|Overall Study|Lost to Follow-up|1
1034829|NCT00136604|3370409|P4|Overall Study|Lost to Follow-up|0
1034830|NCT00136604|3370410|P3|Overall Study|Lost to Follow-up|0
1034831|NCT00136604|3370411|P2|Overall Study|Lost to Follow-up|0
1034832|NCT00136604|3370412|P1|Overall Study|Lost to Follow-up|1
1034833|NCT00136357|3370520|P2|Overall Study|Withdrawal by Subject|2
1034834|NCT00136357|3370521|P1|Overall Study|Withdrawal by Subject|3
1034835|NCT00136318|3370529|P2|Overall Study|Withdrawal by Subject|2
1034836|NCT00136318|3370530|P1|Overall Study|Withdrawal by Subject|2
1034837|NCT00136318|3370529|P2|Overall Study|Adverse Event|5
1034838|NCT00136318|3370530|P1|Overall Study|Adverse Event|5
1034839|NCT00136084|3370557|P2|Overall Study|Withdrawal by Subject|1
1034840|NCT00136084|3370558|P1|Overall Study|Withdrawal by Subject|5
1034841|NCT00136084|3370557|P2|Overall Study|No Response|2
1034842|NCT00136084|3370558|P1|Overall Study|No Response|1
1034843|NCT00136084|3370557|P2|Overall Study|Lost to Follow-up|0
1034844|NCT00136084|3370558|P1|Overall Study|Lost to Follow-up|2
1034845|NCT00136084|3370557|P2|Overall Study|Relapse|23
1034846|NCT00136084|3370558|P1|Overall Study|Relapse|20
1034847|NCT00136084|3370557|P2|Overall Study|Unacceptable toxicity|11
1034848|NCT00136084|3370558|P1|Overall Study|Unacceptable toxicity|8
1034849|NCT00136084|3370557|P2|Overall Study|Death|5
1034850|NCT00136084|3370558|P1|Overall Study|Death|12
1034851|NCT00135707|3370594|P2|Overall Study|Institutional review board request|0
1034852|NCT00135707|3370595|P1|Overall Study|Institutional review board request|1
1034853|NCT00135707|3370594|P2|Overall Study|Withdrawal by Subject|1
1034854|NCT00135707|3370595|P1|Overall Study|Withdrawal by Subject|0
1034855|NCT00135707|3370594|P2|Overall Study|Lost to Follow-up|89
1034856|NCT00135707|3370595|P1|Overall Study|Lost to Follow-up|94
1034857|NCT00135694|3370678|P3|Overall Study|Ineligible for Random assignment|0
1034858|NCT00135694|3370679|P2|Overall Study|Ineligible for Random assignment|0
1034944|NCT00134563|3371004|P3|Overall Study|progressive disease|2
1034859|NCT00135694|3370680|P1|Overall Study|Ineligible for Random assignment|42
1034860|NCT00135694|3370678|P3|Overall Study|Hepatitis C related reasons|0
1034861|NCT00135694|3370679|P2|Overall Study|Hepatitis C related reasons|1
1034862|NCT00135694|3370680|P1|Overall Study|Hepatitis C related reasons|39
1034863|NCT00135694|3370678|P3|Overall Study|Protocol Violation|0
1034864|NCT00135694|3370679|P2|Overall Study|Protocol Violation|1
1034865|NCT00135694|3370680|P1|Overall Study|Protocol Violation|19
1034866|NCT00135694|3370678|P3|Overall Study|Withdrawal by Subject|4
1034867|NCT00135694|3370679|P2|Overall Study|Withdrawal by Subject|7
1034868|NCT00135694|3370680|P1|Overall Study|Withdrawal by Subject|41
1034869|NCT00135694|3370678|P3|Overall Study|Lost to Follow-up|1
1034870|NCT00135694|3370679|P2|Overall Study|Lost to Follow-up|7
1034871|NCT00135694|3370680|P1|Overall Study|Lost to Follow-up|8
1034872|NCT00135694|3370678|P3|Overall Study|Death|2
1034873|NCT00135694|3370679|P2|Overall Study|Death|1
1034874|NCT00135694|3370680|P1|Overall Study|Death|14
1034875|NCT00135694|3370678|P3|Overall Study|Adverse Event|0
1034876|NCT00135694|3370679|P2|Overall Study|Adverse Event|4
1034877|NCT00135694|3370680|P1|Overall Study|Adverse Event|17
1034878|NCT00135356|3370700|P2|Overall Study|Withdrawal by Subject|4
1034879|NCT00135356|3370701|P1|Overall Study|Withdrawal by Subject|2
1034880|NCT00135356|3370700|P2|Overall Study|No longer meets study criteria|0
1034881|NCT00135356|3370701|P1|Overall Study|No longer meets study criteria|2
1034882|NCT00135356|3370700|P2|Overall Study|Poor/noncompliance|1
1034883|NCT00135356|3370701|P1|Overall Study|Poor/noncompliance|1
1034884|NCT00135356|3370700|P2|Overall Study|Change in antiviral regimen|1
1034885|NCT00135356|3370701|P1|Overall Study|Change in antiviral regimen|0
1034886|NCT00135356|3370700|P2|Overall Study|Surgery for abdominal fat|0
1034887|NCT00135356|3370701|P1|Overall Study|Surgery for abdominal fat|1
1034888|NCT00135356|3370700|P2|Overall Study|Lost to Follow-up|1
1034889|NCT00135356|3370701|P1|Overall Study|Lost to Follow-up|3
1034890|NCT00135356|3370700|P2|Overall Study|Lack of Efficacy|0
1034891|NCT00135356|3370701|P1|Overall Study|Lack of Efficacy|2
1034892|NCT00135356|3370700|P2|Overall Study|Adverse Event|2
1034893|NCT00135356|3370701|P1|Overall Study|Adverse Event|6
1034894|NCT00135330|3370744|P3|Overall Study|Sponsor Decision|0
1034895|NCT00135330|3370745|P2|Overall Study|Sponsor Decision|1
1034896|NCT00135330|3370746|P1|Overall Study|Sponsor Decision|0
1034897|NCT00135330|3370744|P3|Overall Study|Patient Decision|4
1034898|NCT00135330|3370745|P2|Overall Study|Patient Decision|1
1034899|NCT00135330|3370746|P1|Overall Study|Patient Decision|5
1034900|NCT00135330|3370744|P3|Overall Study|Protocol Violation|3
1034901|NCT00135330|3370745|P2|Overall Study|Protocol Violation|3
1034902|NCT00135330|3370746|P1|Overall Study|Protocol Violation|4
1034903|NCT00135330|3370744|P3|Overall Study|Physician Decision|0
1034904|NCT00135330|3370745|P2|Overall Study|Physician Decision|1
1034905|NCT00135330|3370746|P1|Overall Study|Physician Decision|1
1034906|NCT00135330|3370744|P3|Overall Study|Lost to Follow-up|3
1034907|NCT00135330|3370745|P2|Overall Study|Lost to Follow-up|2
1034908|NCT00135330|3370746|P1|Overall Study|Lost to Follow-up|0
1034909|NCT00135330|3370744|P3|Overall Study|Adverse Event|1
1034910|NCT00135330|3370745|P2|Overall Study|Adverse Event|5
1034911|NCT00135330|3370746|P1|Overall Study|Adverse Event|2
1034912|NCT00134901|3370845|P2|Overall Study|discontinued intervention|10
1034913|NCT00134901|3370846|P1|Overall Study|discontinued intervention|12
1034914|NCT00134901|3370845|P2|Overall Study|Lost to Follow-up|5
1034915|NCT00134901|3370846|P1|Overall Study|Lost to Follow-up|5
1034916|NCT00134784|3370858|P4|Overall Study|Withdrawal by Subject|1
1034917|NCT00134784|3370859|P3|Overall Study|Withdrawal by Subject|2
1034918|NCT00134784|3370860|P2|Overall Study|Withdrawal by Subject|2
1034919|NCT00134784|3370861|P1|Overall Study|Withdrawal by Subject|2
1034920|NCT00134719|3370871|P3|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
1034921|NCT00134719|3370872|P2|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
1034922|NCT00134719|3370873|P1|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1
1034923|NCT00134719|3370871|P3|Fourth Dose Vaccination Phase|Lost to Follow-up|1
1034924|NCT00134719|3370872|P2|Fourth Dose Vaccination Phase|Lost to Follow-up|3
1034925|NCT00134719|3370873|P1|Fourth Dose Vaccination Phase|Lost to Follow-up|1
1034926|NCT00134719|3370871|P3|Primary Vaccination Phase|Lost to Follow-up|3
1034927|NCT00134719|3370872|P2|Primary Vaccination Phase|Lost to Follow-up|3
1034928|NCT00134719|3370873|P1|Primary Vaccination Phase|Lost to Follow-up|7
1034929|NCT00134719|3370871|P3|Primary Vaccination Phase|Withdrawal by Subject|2
1034930|NCT00134719|3370872|P2|Primary Vaccination Phase|Withdrawal by Subject|3
1034931|NCT00134719|3370873|P1|Primary Vaccination Phase|Withdrawal by Subject|2
1034932|NCT00134719|3370871|P3|Primary Vaccination Phase|Protocol Violation|0
1034933|NCT00134719|3370872|P2|Primary Vaccination Phase|Protocol Violation|0
1034934|NCT00134719|3370873|P1|Primary Vaccination Phase|Protocol Violation|1
1034935|NCT00134719|3370871|P3|Primary Vaccination Phase|Adverse Event|0
1034936|NCT00134719|3370872|P2|Primary Vaccination Phase|Adverse Event|0
1034937|NCT00134719|3370873|P1|Primary Vaccination Phase|Adverse Event|4
1034938|NCT00134563|3371004|P3|Overall Study|Reason other than above|5
1034939|NCT00134563|3371005|P2|Overall Study|Reason other than above|2
1034940|NCT00134563|3371006|P1|Overall Study|Reason other than above|0
1034941|NCT00134563|3371004|P3|Overall Study|did not wish to continue|26
1034942|NCT00134563|3371005|P2|Overall Study|did not wish to continue|32
1034943|NCT00134563|3371006|P1|Overall Study|did not wish to continue|33
1034945|NCT00134563|3371005|P2|Overall Study|progressive disease|4
1034946|NCT00134563|3371006|P1|Overall Study|progressive disease|11
1034947|NCT00134563|3371004|P3|Overall Study|Lost to Follow-up|2
1034948|NCT00134563|3371005|P2|Overall Study|Lost to Follow-up|0
1034949|NCT00134563|3371006|P1|Overall Study|Lost to Follow-up|4
1034950|NCT00134563|3371004|P3|Overall Study|Protocol Violation|5
1034951|NCT00134563|3371005|P2|Overall Study|Protocol Violation|2
1034952|NCT00134563|3371006|P1|Overall Study|Protocol Violation|3
1034953|NCT00134563|3371004|P3|Overall Study|Lack of Efficacy|17
1034954|NCT00134563|3371005|P2|Overall Study|Lack of Efficacy|14
1034955|NCT00134563|3371006|P1|Overall Study|Lack of Efficacy|24
1034956|NCT00134563|3371004|P3|Overall Study|Adverse Event|38
1034957|NCT00134563|3371005|P2|Overall Study|Adverse Event|37
1034958|NCT00134563|3371006|P1|Overall Study|Adverse Event|29
1034959|NCT00134563|3371004|P3|Overall Study|Not treated due to protocol violation|1
1034960|NCT00134563|3371005|P2|Overall Study|Not treated due to protocol violation|1
1034961|NCT00134563|3371006|P1|Overall Study|Not treated due to protocol violation|0
1034962|NCT00134056|3371069|P2|Eligible for Protocol Assigned Treatment|Not specified|56
1034963|NCT00134056|3371070|P1|Eligible for Protocol Assigned Treatment|Not specified|55
1034964|NCT00134056|3371069|P2|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21
1034965|NCT00134056|3371070|P1|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20
1034966|NCT00134056|3371069|P2|Eligible for Protocol Assigned Treatment|Adverse Event|67
1034967|NCT00134056|3371070|P1|Eligible for Protocol Assigned Treatment|Adverse Event|81
1034968|NCT00134056|3371069|P2|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
1034969|NCT00134056|3371070|P1|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
1034970|NCT00134056|3371069|P2|Randomization|Not eligible for assigned treatment|20
1034971|NCT00134056|3371070|P1|Randomization|Not eligible for assigned treatment|22
1034972|NCT00133991|3371114|P1|Overall Study|Death|4
1034973|NCT00133952|3371153|P2|Overall Study|Sponsor Decision|1
1034974|NCT00133952|3371154|P1|Overall Study|Sponsor Decision|0
1034975|NCT00133952|3371153|P2|Overall Study|Physician Decision|3
1034976|NCT00133952|3371154|P1|Overall Study|Physician Decision|4
1034977|NCT00133952|3371153|P2|Overall Study|Withdrawal by Subject|4
1034978|NCT00133952|3371154|P1|Overall Study|Withdrawal by Subject|20
1034979|NCT00133952|3371153|P2|Overall Study|Protocol Violation|1
1034980|NCT00133952|3371154|P1|Overall Study|Protocol Violation|1
1034981|NCT00133952|3371153|P2|Overall Study|Protocol Entry Criteria Exclusion|1
1034982|NCT00133952|3371154|P1|Overall Study|Protocol Entry Criteria Exclusion|4
1034983|NCT00133952|3371153|P2|Overall Study|Lost to Follow-up|14
1034984|NCT00133952|3371154|P1|Overall Study|Lost to Follow-up|9
1034985|NCT00133952|3371153|P2|Overall Study|Death|2
1034986|NCT00133952|3371154|P1|Overall Study|Death|3
1034987|NCT00133952|3371153|P2|Overall Study|Adverse Event|2
1034988|NCT00133952|3371154|P1|Overall Study|Adverse Event|1
1034989|NCT00133705|3371185|P2|Overall Study|Withdrawal by Subject|3
1034990|NCT00133705|3371186|P1|Overall Study|Withdrawal by Subject|2
1034991|NCT00132873|3371312|P1|Overall Study|Planned Pregnancy|1
1034992|NCT00132873|3371312|P1|Overall Study|Withdrawal by Subject|3
1034993|NCT00132873|3371312|P1|Overall Study|Lack of Efficacy|1
1034994|NCT00132873|3371312|P1|Overall Study|Lost to Follow-up|1
1034995|NCT00132873|3371312|P1|Overall Study|Adverse Event|3
1034996|NCT00132808|3371320|P3|Stratum II|Withdrawal by Subject|6
1034997|NCT00132808|3371321|P2|Stratum II|Withdrawal by Subject|9
1034998|NCT00132808|3371322|P1|Stratum II|Withdrawal by Subject|4
1034999|NCT00132808|3371320|P3|Stratum II|Protocol Violation|1
1035000|NCT00132808|3371321|P2|Stratum II|Protocol Violation|2
1035001|NCT00132808|3371322|P1|Stratum II|Protocol Violation|0
1035002|NCT00132808|3371320|P3|Stratum II|Lost to Follow-up|1
1035003|NCT00132808|3371321|P2|Stratum II|Lost to Follow-up|2
1035004|NCT00132808|3371322|P1|Stratum II|Lost to Follow-up|2
1035005|NCT00132808|3371320|P3|Stratum II|Death|0
1035006|NCT00132808|3371321|P2|Stratum II|Death|0
1035007|NCT00132808|3371322|P1|Stratum II|Death|1
1035008|NCT00132808|3371320|P3|Stratum II|Adverse Event|1
1035009|NCT00132808|3371321|P2|Stratum II|Adverse Event|2
1035010|NCT00132808|3371322|P1|Stratum II|Adverse Event|1
1035011|NCT00132808|3371320|P3|Stratum I|Abnormal test procedure result (s)|1
1035012|NCT00132808|3371321|P2|Stratum I|Abnormal test procedure result (s)|0
1035013|NCT00132808|3371322|P1|Stratum I|Abnormal test procedure result (s)|0
1035014|NCT00132808|3371320|P3|Stratum I|Withdrawal by Subject|3
1035015|NCT00132808|3371321|P2|Stratum I|Withdrawal by Subject|7
1035016|NCT00132808|3371322|P1|Stratum I|Withdrawal by Subject|4
1035017|NCT00132808|3371320|P3|Stratum I|Lost to Follow-up|1
1035018|NCT00132808|3371321|P2|Stratum I|Lost to Follow-up|4
1035019|NCT00132808|3371322|P1|Stratum I|Lost to Follow-up|3
1035020|NCT00132808|3371320|P3|Stratum I|Adverse Event|0
1035021|NCT00132808|3371321|P2|Stratum I|Adverse Event|1
1035022|NCT00132808|3371322|P1|Stratum I|Adverse Event|2
1035023|NCT00132769|3371347|P2|Overall Study|Protocol Violation|1
1035024|NCT00132769|3371348|P1|Overall Study|Protocol Violation|1
1035025|NCT00132769|3371347|P2|Overall Study|Adverse Event|1
1035026|NCT00132769|3371348|P1|Overall Study|Adverse Event|2
1035027|NCT00132769|3371347|P2|Overall Study|Lack of Efficacy|6
1035028|NCT00132769|3371348|P1|Overall Study|Lack of Efficacy|7
1035029|NCT00132769|3371347|P2|Overall Study|Withdrawal by Subject|3
1035030|NCT00132769|3371348|P1|Overall Study|Withdrawal by Subject|1
1035031|NCT00132730|3371374|P6|Period V - Open-label Extension (EXT2)|Site terminated|2
1035032|NCT00132730|3371375|P5|Period V - Open-label Extension (EXT2)|Site terminated|7
1035033|NCT00132730|3371376|P4|Period V - Open-label Extension (EXT2)|Site terminated|0
1035034|NCT00132730|3371377|P3|Period V - Open-label Extension (EXT2)|Site terminated|0
1035035|NCT00132730|3371378|P2|Period V - Open-label Extension (EXT2)|Site terminated|0
1035036|NCT00132730|3371379|P1|Period V - Open-label Extension (EXT2)|Site terminated|0
1035037|NCT00132730|3371374|P6|Period IV - Open-label Extension (EXT2)|Other reasons|0
1035038|NCT00132730|3371375|P5|Period IV - Open-label Extension (EXT2)|Other reasons|6
1035039|NCT00132730|3371376|P4|Period IV - Open-label Extension (EXT2)|Other reasons|0
1035040|NCT00132730|3371377|P3|Period IV - Open-label Extension (EXT2)|Other reasons|0
1035041|NCT00132730|3371378|P2|Period IV - Open-label Extension (EXT2)|Other reasons|0
1035042|NCT00132730|3371379|P1|Period IV - Open-label Extension (EXT2)|Other reasons|0
1035043|NCT00132730|3371374|P6|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
1035044|NCT00132730|3371375|P5|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1
1035045|NCT00132730|3371376|P4|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
1035046|NCT00132730|3371377|P3|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
1035047|NCT00132730|3371378|P2|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
1035048|NCT00132730|3371379|P1|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
1035049|NCT00132730|3371374|P6|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
1035050|NCT00132730|3371375|P5|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3
1035051|NCT00132730|3371376|P4|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
1035052|NCT00132730|3371377|P3|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
1035053|NCT00132730|3371378|P2|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
1035054|NCT00132730|3371379|P1|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
1035055|NCT00132730|3371374|P6|Period IV - Open-label Extension (EXT2)|Site terminated|68
1035056|NCT00132730|3371375|P5|Period IV - Open-label Extension (EXT2)|Site terminated|169
1035057|NCT00132730|3371376|P4|Period IV - Open-label Extension (EXT2)|Site terminated|0
1035058|NCT00132730|3371377|P3|Period IV - Open-label Extension (EXT2)|Site terminated|0
1035059|NCT00132730|3371378|P2|Period IV - Open-label Extension (EXT2)|Site terminated|0
1035060|NCT00132730|3371379|P1|Period IV - Open-label Extension (EXT2)|Site terminated|0
1035061|NCT00132730|3371374|P6|Period III - Blinded Extension (EXT1)|Other reasons|0
1035062|NCT00132730|3371375|P5|Period III - Blinded Extension (EXT1)|Other reasons|0
1035063|NCT00132730|3371376|P4|Period III - Blinded Extension (EXT1)|Other reasons|3
1035064|NCT00132730|3371377|P3|Period III - Blinded Extension (EXT1)|Other reasons|14
1035065|NCT00132730|3371378|P2|Period III - Blinded Extension (EXT1)|Other reasons|0
1035066|NCT00132730|3371379|P1|Period III - Blinded Extension (EXT1)|Other reasons|0
1035067|NCT00132730|3371374|P6|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
1035068|NCT00132730|3371375|P5|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
1035069|NCT00132730|3371376|P4|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1
1035070|NCT00132730|3371377|P3|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
1035071|NCT00132730|3371378|P2|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
1035072|NCT00132730|3371379|P1|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
1035073|NCT00132730|3371374|P6|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
1035074|NCT00132730|3371375|P5|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
1035075|NCT00132730|3371376|P4|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1
1035076|NCT00132730|3371377|P3|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11
1035077|NCT00132730|3371378|P2|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
1035078|NCT00132730|3371379|P1|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
1035079|NCT00132730|3371374|P6|Period III - Blinded Extension (EXT1)|Site terminated|0
1035080|NCT00132730|3371375|P5|Period III - Blinded Extension (EXT1)|Site terminated|0
1035081|NCT00132730|3371376|P4|Period III - Blinded Extension (EXT1)|Site terminated|20
1035082|NCT00132730|3371377|P3|Period III - Blinded Extension (EXT1)|Site terminated|57
1035083|NCT00132730|3371378|P2|Period III - Blinded Extension (EXT1)|Site terminated|0
1035084|NCT00132730|3371379|P1|Period III - Blinded Extension (EXT1)|Site terminated|0
1035085|NCT00132730|3371374|P6|Period II - 12-week Treatment (Base)|Other reasons|0
1035086|NCT00132730|3371375|P5|Period II - 12-week Treatment (Base)|Other reasons|0
1035087|NCT00132730|3371376|P4|Period II - 12-week Treatment (Base)|Other reasons|13
1035088|NCT00132730|3371377|P3|Period II - 12-week Treatment (Base)|Other reasons|9
1035089|NCT00132730|3371378|P2|Period II - 12-week Treatment (Base)|Other reasons|10
1035090|NCT00132730|3371379|P1|Period II - 12-week Treatment (Base)|Other reasons|11
1035091|NCT00132730|3371374|P6|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
1035092|NCT00132730|3371375|P5|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
1035093|NCT00132730|3371376|P4|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
1035094|NCT00132730|3371377|P3|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
1035095|NCT00132730|3371378|P2|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
1035096|NCT00132730|3371379|P1|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
1035097|NCT00132730|3371374|P6|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
1035098|NCT00132730|3371375|P5|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
1035099|NCT00132730|3371376|P4|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
1035100|NCT00132730|3371377|P3|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
1035101|NCT00132730|3371378|P2|Period II - 12-week Treatment (Base)|Clinical adverse experience|4
1035102|NCT00132730|3371379|P1|Period II - 12-week Treatment (Base)|Clinical adverse experience|11
1035103|NCT00132691|3371423|P2|Overall Study|Death|0
1035104|NCT00132691|3371424|P1|Overall Study|Death|2
1035105|NCT00132691|3371423|P2|Overall Study|Missed 2-year visit|4
1035106|NCT00132691|3371424|P1|Overall Study|Missed 2-year visit|4
1035107|NCT00132691|3371423|P2|Overall Study|Lost to Follow-up|8
1035108|NCT00132691|3371424|P1|Overall Study|Lost to Follow-up|5
1035109|NCT00132678|3371464|P3|Period IV (Double-Blind Treatment)|Pregnancy|0
1035110|NCT00132678|3371465|P2|Period IV (Double-Blind Treatment)|Pregnancy|2
1035111|NCT00132678|3371466|P1|Period IV (Double-Blind Treatment)|Pregnancy|0
1035112|NCT00132678|3371464|P3|Period IV (Double-Blind Treatment)|Subject Non-compliant|0
1035113|NCT00132678|3371465|P2|Period IV (Double-Blind Treatment)|Subject Non-compliant|1
1035114|NCT00132678|3371466|P1|Period IV (Double-Blind Treatment)|Subject Non-compliant|2
1035115|NCT00132678|3371464|P3|Period IV (Double-Blind Treatment)|Physician Decision|0
1035116|NCT00132678|3371465|P2|Period IV (Double-Blind Treatment)|Physician Decision|14
1035117|NCT00132678|3371466|P1|Period IV (Double-Blind Treatment)|Physician Decision|10
1035118|NCT00132678|3371464|P3|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0
1035119|NCT00132678|3371465|P2|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15
1035120|NCT00132678|3371466|P1|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14
1035121|NCT00132678|3371464|P3|Period IV (Double-Blind Treatment)|Lost to Follow-up|0
1035122|NCT00132678|3371465|P2|Period IV (Double-Blind Treatment)|Lost to Follow-up|3
1035123|NCT00132678|3371466|P1|Period IV (Double-Blind Treatment)|Lost to Follow-up|6
1035124|NCT00132678|3371464|P3|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0
1035125|NCT00132678|3371465|P2|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
1035126|NCT00132678|3371466|P1|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
1035127|NCT00132678|3371464|P3|Period IV (Double-Blind Treatment)|Adverse Event|0
1035128|NCT00132678|3371465|P2|Period IV (Double-Blind Treatment)|Adverse Event|1
1035129|NCT00132678|3371466|P1|Period IV (Double-Blind Treatment)|Adverse Event|1
1035130|NCT00132678|3371464|P3|Period III (Open-Label Stabilization)|Pregnancy|0
1035131|NCT00132678|3371465|P2|Period III (Open-Label Stabilization)|Pregnancy|0
1035132|NCT00132678|3371466|P1|Period III (Open-Label Stabilization)|Pregnancy|2
1035133|NCT00132678|3371464|P3|Period III (Open-Label Stabilization)|Physician Decision|0
1035134|NCT00132678|3371465|P2|Period III (Open-Label Stabilization)|Physician Decision|0
1035135|NCT00132678|3371466|P1|Period III (Open-Label Stabilization)|Physician Decision|1
1035136|NCT00132678|3371464|P3|Period III (Open-Label Stabilization)|Subject non-compliant|0
1035137|NCT00132678|3371465|P2|Period III (Open-Label Stabilization)|Subject non-compliant|0
1035138|NCT00132678|3371466|P1|Period III (Open-Label Stabilization)|Subject non-compliant|1
1035139|NCT00132678|3371464|P3|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
1035140|NCT00132678|3371465|P2|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
1035141|NCT00132678|3371466|P1|Period III (Open-Label Stabilization)|Withdrawal by Subject|49
1035142|NCT00132678|3371464|P3|Period III (Open-Label Stabilization)|Lost to Follow-up|0
1035143|NCT00132678|3371465|P2|Period III (Open-Label Stabilization)|Lost to Follow-up|0
1035144|NCT00132678|3371466|P1|Period III (Open-Label Stabilization)|Lost to Follow-up|19
1035145|NCT00132678|3371464|P3|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
1035146|NCT00132678|3371465|P2|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
1035147|NCT00132678|3371466|P1|Period III (Open-Label Stabilization)|Ineligible to continue trial|5
1035148|NCT00132678|3371464|P3|Period III (Open-Label Stabilization)|Non responder|0
1035149|NCT00132678|3371465|P2|Period III (Open-Label Stabilization)|Non responder|0
1035150|NCT00132678|3371466|P1|Period III (Open-Label Stabilization)|Non responder|107
1035151|NCT00132678|3371464|P3|Period III (Open-Label Stabilization)|Adverse Event|0
1035152|NCT00132678|3371465|P2|Period III (Open-Label Stabilization)|Adverse Event|0
1035153|NCT00132678|3371466|P1|Period III (Open-Label Stabilization)|Adverse Event|12
1035154|NCT00132678|3371464|P3|Period III (Open-Label Stabilization)|Death|0
1035155|NCT00132678|3371465|P2|Period III (Open-Label Stabilization)|Death|0
1035156|NCT00132678|3371466|P1|Period III (Open-Label Stabilization)|Death|2
1035157|NCT00132678|3371464|P3|Period II (Open-Label Oral Risperidone)|Physician Decision|1
1035158|NCT00132678|3371465|P2|Period II (Open-Label Oral Risperidone)|Physician Decision|0
1035159|NCT00132678|3371466|P1|Period II (Open-Label Oral Risperidone)|Physician Decision|0
1035160|NCT00132678|3371464|P3|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16
1035161|NCT00132678|3371465|P2|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
1035162|NCT00132678|3371466|P1|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
1035163|NCT00132678|3371464|P3|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14
1035164|NCT00132678|3371465|P2|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
1035165|NCT00132678|3371466|P1|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
1035166|NCT00132678|3371464|P3|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7
1035167|NCT00132678|3371465|P2|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
1035168|NCT00132678|3371466|P1|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
1035169|NCT00132678|3371464|P3|Period II (Open-Label Oral Risperidone)|Non responder|6
1035170|NCT00132678|3371465|P2|Period II (Open-Label Oral Risperidone)|Non responder|0
1035171|NCT00132678|3371466|P1|Period II (Open-Label Oral Risperidone)|Non responder|0
1035172|NCT00132678|3371464|P3|Period II (Open-Label Oral Risperidone)|Adverse Event|13
1035173|NCT00132678|3371465|P2|Period II (Open-Label Oral Risperidone)|Adverse Event|0
1035174|NCT00132678|3371466|P1|Period II (Open-Label Oral Risperidone)|Adverse Event|0
1035175|NCT00132678|3371464|P3|Period II (Open-Label Oral Risperidone)|Death|1
1035176|NCT00132678|3371465|P2|Period II (Open-Label Oral Risperidone)|Death|0
1035177|NCT00132678|3371466|P1|Period II (Open-Label Oral Risperidone)|Death|0
1035178|NCT00132496|3371480|P2|Overall Study|Physician Decision|0
1035179|NCT00132496|3371481|P1|Overall Study|Physician Decision|1
1035180|NCT00132496|3371480|P2|Overall Study|Withdrawal by Subject|2
1035181|NCT00132496|3371481|P1|Overall Study|Withdrawal by Subject|1
1035182|NCT00132314|3371489|P2|Overall Study|Refused intervention at baseline|7
1035183|NCT00132314|3371490|P1|Overall Study|Refused intervention at baseline|2
1035184|NCT00132314|3371489|P2|Overall Study|Lacked SSN|3
1035185|NCT00132314|3371490|P1|Overall Study|Lacked SSN|1
1035186|NCT00132314|3371489|P2|Overall Study|Lost to Follow-up|62
1035187|NCT00132314|3371490|P1|Overall Study|Lost to Follow-up|70
1035188|NCT00132301|3371500|P2|Overall Study|Excluded by Data Monitoring Committee|0
1035189|NCT00132301|3371501|P1|Overall Study|Excluded by Data Monitoring Committee|1
1035190|NCT00132301|3371500|P2|Overall Study|Other|1
1035191|NCT00132301|3371501|P1|Overall Study|Other|1
1035192|NCT00132301|3371500|P2|Overall Study|Lost to Follow-up|3
1035193|NCT00132301|3371501|P1|Overall Study|Lost to Follow-up|5
1035194|NCT00132301|3371500|P2|Overall Study|Physician Decision|1
1035195|NCT00132301|3371501|P1|Overall Study|Physician Decision|1
1035196|NCT00132301|3371500|P2|Overall Study|Withdrawal by Subject|2
1035197|NCT00132301|3371501|P1|Overall Study|Withdrawal by Subject|5
1035198|NCT00132301|3371500|P2|Overall Study|Death|6
1035199|NCT00132301|3371501|P1|Overall Study|Death|7
1035200|NCT00132132|3371509|P2|Overall Study|Lost to Follow-up|2
1035201|NCT00132132|3371510|P1|Overall Study|Lost to Follow-up|7
1035202|NCT00132028|3371518|P1|Overall Study|Physician Decision|3
1035203|NCT00132028|3371518|P1|Overall Study|not eligible|2
1035204|NCT00132028|3371518|P1|Overall Study|Withdrawal by Subject|2
1035205|NCT00132028|3371518|P1|Overall Study|Lack of Efficacy|11
1035206|NCT00132028|3371518|P1|Overall Study|Death|2
1035207|NCT00132028|3371518|P1|Overall Study|Adverse Event|7
1035208|NCT00131937|3371530|P1|Overall Study|Alternative therapy|1
1035209|NCT00131937|3371530|P1|Overall Study|Disease Progression|7
1035210|NCT00131937|3371530|P1|Overall Study|Physician Decision|1
1035211|NCT00131937|3371530|P1|Overall Study|Withdrawal by Subject|2
1035212|NCT00131937|3371530|P1|Overall Study|Adverse Event|3
1035213|NCT00131911|3371538|P2|Overall Study|Withdrawal by Subject|0
1035214|NCT00131911|3371539|P1|Overall Study|Withdrawal by Subject|1
1035215|NCT00131664|3371609|P6|Second Period (Additional Drug Added)|Administrative reasons|0
1035216|NCT00131664|3371610|P5|Second Period (Additional Drug Added)|Administrative reasons|1
1035217|NCT00131664|3371611|P4|Second Period (Additional Drug Added)|Administrative reasons|0
1035218|NCT00131664|3371612|P3|Second Period (Additional Drug Added)|Administrative reasons|0
1035219|NCT00131664|3371613|P2|Second Period (Additional Drug Added)|Administrative reasons|2
1035220|NCT00131664|3371614|P1|Second Period (Additional Drug Added)|Administrative reasons|4
1035221|NCT00131664|3371609|P6|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
1035222|NCT00131664|3371610|P5|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
1035223|NCT00131664|3371611|P4|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1
1035224|NCT00131664|3371612|P3|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
1035225|NCT00131664|3371613|P2|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
1035226|NCT00131664|3371614|P1|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
1035227|NCT00131664|3371609|P6|Second Period (Additional Drug Added)|Adverse Event|1
1035228|NCT00131664|3371610|P5|Second Period (Additional Drug Added)|Adverse Event|0
1035229|NCT00131664|3371611|P4|Second Period (Additional Drug Added)|Adverse Event|0
1035230|NCT00131664|3371612|P3|Second Period (Additional Drug Added)|Adverse Event|0
1035231|NCT00131664|3371613|P2|Second Period (Additional Drug Added)|Adverse Event|1
1035232|NCT00131664|3371614|P1|Second Period (Additional Drug Added)|Adverse Event|0
1035233|NCT00131664|3371609|P6|Second Period (Additional Drug Added)|Withdrawal by Subject|0
1035234|NCT00131664|3371610|P5|Second Period (Additional Drug Added)|Withdrawal by Subject|0
1035235|NCT00131664|3371611|P4|Second Period (Additional Drug Added)|Withdrawal by Subject|0
1035236|NCT00131664|3371612|P3|Second Period (Additional Drug Added)|Withdrawal by Subject|0
1035237|NCT00131664|3371613|P2|Second Period (Additional Drug Added)|Withdrawal by Subject|0
1035238|NCT00131664|3371614|P1|Second Period (Additional Drug Added)|Withdrawal by Subject|2
1035239|NCT00131664|3371609|P6|Second Period (Additional Drug Added)|Protocol Violation|0
1035240|NCT00131664|3371610|P5|Second Period (Additional Drug Added)|Protocol Violation|0
1035241|NCT00131664|3371611|P4|Second Period (Additional Drug Added)|Protocol Violation|0
1035242|NCT00131664|3371612|P3|Second Period (Additional Drug Added)|Protocol Violation|1
1035243|NCT00131664|3371613|P2|Second Period (Additional Drug Added)|Protocol Violation|1
1035244|NCT00131664|3371614|P1|Second Period (Additional Drug Added)|Protocol Violation|0
1035245|NCT00131664|3371609|P6|Second Period (Additional Drug Added)|Lost to Follow-up|2
1035246|NCT00131664|3371610|P5|Second Period (Additional Drug Added)|Lost to Follow-up|0
1035247|NCT00131664|3371611|P4|Second Period (Additional Drug Added)|Lost to Follow-up|1
1035248|NCT00131664|3371612|P3|Second Period (Additional Drug Added)|Lost to Follow-up|2
1035329|NCT00130793|3371803|P2|Overall Study|Lost to Follow-up|4
1035249|NCT00131664|3371613|P2|Second Period (Additional Drug Added)|Lost to Follow-up|0
1035250|NCT00131664|3371614|P1|Second Period (Additional Drug Added)|Lost to Follow-up|3
1035251|NCT00131664|3371609|P6|First Period (First 6 Months)|Administrative reasons|0
1035252|NCT00131664|3371610|P5|First Period (First 6 Months)|Administrative reasons|0
1035253|NCT00131664|3371611|P4|First Period (First 6 Months)|Administrative reasons|0
1035254|NCT00131664|3371612|P3|First Period (First 6 Months)|Administrative reasons|5
1035255|NCT00131664|3371613|P2|First Period (First 6 Months)|Administrative reasons|0
1035256|NCT00131664|3371614|P1|First Period (First 6 Months)|Administrative reasons|2
1035257|NCT00131664|3371609|P6|First Period (First 6 Months)|Clinically significant lab abnormalities|0
1035258|NCT00131664|3371610|P5|First Period (First 6 Months)|Clinically significant lab abnormalities|0
1035259|NCT00131664|3371611|P4|First Period (First 6 Months)|Clinically significant lab abnormalities|0
1035260|NCT00131664|3371612|P3|First Period (First 6 Months)|Clinically significant lab abnormalities|0
1035261|NCT00131664|3371613|P2|First Period (First 6 Months)|Clinically significant lab abnormalities|2
1035262|NCT00131664|3371614|P1|First Period (First 6 Months)|Clinically significant lab abnormalities|1
1035263|NCT00131664|3371609|P6|First Period (First 6 Months)|Adverse Event|0
1035264|NCT00131664|3371610|P5|First Period (First 6 Months)|Adverse Event|0
1035265|NCT00131664|3371611|P4|First Period (First 6 Months)|Adverse Event|0
1035266|NCT00131664|3371612|P3|First Period (First 6 Months)|Adverse Event|5
1035267|NCT00131664|3371613|P2|First Period (First 6 Months)|Adverse Event|4
1035268|NCT00131664|3371614|P1|First Period (First 6 Months)|Adverse Event|9
1035269|NCT00131664|3371609|P6|First Period (First 6 Months)|Withdrawal by Subject|0
1035270|NCT00131664|3371610|P5|First Period (First 6 Months)|Withdrawal by Subject|0
1035271|NCT00131664|3371611|P4|First Period (First 6 Months)|Withdrawal by Subject|0
1035272|NCT00131664|3371612|P3|First Period (First 6 Months)|Withdrawal by Subject|2
1035273|NCT00131664|3371613|P2|First Period (First 6 Months)|Withdrawal by Subject|6
1035274|NCT00131664|3371614|P1|First Period (First 6 Months)|Withdrawal by Subject|4
1035275|NCT00131664|3371609|P6|First Period (First 6 Months)|Protocol Violation|0
1035276|NCT00131664|3371610|P5|First Period (First 6 Months)|Protocol Violation|0
1035277|NCT00131664|3371611|P4|First Period (First 6 Months)|Protocol Violation|0
1035278|NCT00131664|3371612|P3|First Period (First 6 Months)|Protocol Violation|1
1035279|NCT00131664|3371613|P2|First Period (First 6 Months)|Protocol Violation|2
1035280|NCT00131664|3371614|P1|First Period (First 6 Months)|Protocol Violation|2
1035281|NCT00131664|3371609|P6|First Period (First 6 Months)|Death|0
1035282|NCT00131664|3371610|P5|First Period (First 6 Months)|Death|0
1035283|NCT00131664|3371611|P4|First Period (First 6 Months)|Death|0
1035284|NCT00131664|3371612|P3|First Period (First 6 Months)|Death|0
1035285|NCT00131664|3371613|P2|First Period (First 6 Months)|Death|1
1035286|NCT00131664|3371614|P1|First Period (First 6 Months)|Death|0
1035287|NCT00131664|3371609|P6|First Period (First 6 Months)|Lost to Follow-up|0
1035288|NCT00131664|3371610|P5|First Period (First 6 Months)|Lost to Follow-up|0
1035289|NCT00131664|3371611|P4|First Period (First 6 Months)|Lost to Follow-up|0
1035290|NCT00131664|3371612|P3|First Period (First 6 Months)|Lost to Follow-up|3
1035291|NCT00131664|3371613|P2|First Period (First 6 Months)|Lost to Follow-up|3
1035292|NCT00131664|3371614|P1|First Period (First 6 Months)|Lost to Follow-up|7
1035293|NCT00131508|3371686|P2|Overall Study|Withdrawal by Subject|2
1035294|NCT00131508|3371687|P1|Overall Study|Withdrawal by Subject|1
1035295|NCT00131508|3371686|P2|Overall Study|Non-Compliance|4
1035296|NCT00131508|3371687|P1|Overall Study|Non-Compliance|2
1035297|NCT00131508|3371686|P2|Overall Study|Disease progression|2
1035298|NCT00131508|3371687|P1|Overall Study|Disease progression|0
1035299|NCT00131352|3371749|P2|Repeat Treatment Period|Other|0
1035300|NCT00131352|3371750|P1|Repeat Treatment Period|Other|1
1035301|NCT00131352|3371749|P2|Repeat Treatment Period|Adverse Event|0
1035302|NCT00131352|3371750|P1|Repeat Treatment Period|Adverse Event|1
1035303|NCT00131352|3371749|P2|Initial Treatment Period|Other|2
1035304|NCT00131352|3371750|P1|Initial Treatment Period|Other|0
1035305|NCT00131352|3371749|P2|Initial Treatment Period|Lack of Efficacy|4
1035306|NCT00131352|3371750|P1|Initial Treatment Period|Lack of Efficacy|6
1035307|NCT00131352|3371749|P2|Initial Treatment Period|Withdrawal by Subject|1
1035308|NCT00131352|3371750|P1|Initial Treatment Period|Withdrawal by Subject|1
1035309|NCT00131352|3371749|P2|Initial Treatment Period|Non-compliant|2
1035310|NCT00131352|3371750|P1|Initial Treatment Period|Non-compliant|1
1035311|NCT00131352|3371749|P2|Initial Treatment Period|Adverse Event|3
1035312|NCT00131352|3371750|P1|Initial Treatment Period|Adverse Event|1
1035313|NCT00131248|3371772|P2|Intervention 1 (3-day Course)|Withdrawal by Subject|0
1035314|NCT00131248|3371773|P1|Intervention 1 (3-day Course)|Withdrawal by Subject|1
1035315|NCT00130832|3371790|P2|Overall Study|Other|3
1035316|NCT00130832|3371791|P1|Overall Study|Other|0
1035317|NCT00130832|3371790|P2|Overall Study|Moved|2
1035318|NCT00130832|3371791|P1|Overall Study|Moved|2
1035319|NCT00130832|3371790|P2|Overall Study|Withdrawal by Subject|1
1035320|NCT00130832|3371791|P1|Overall Study|Withdrawal by Subject|6
1035321|NCT00130832|3371790|P2|Overall Study|Protocol Violation|8
1035322|NCT00130832|3371791|P1|Overall Study|Protocol Violation|6
1035323|NCT00130832|3371790|P2|Overall Study|Lost to Follow-up|2
1035324|NCT00130832|3371791|P1|Overall Study|Lost to Follow-up|1
1035325|NCT00130832|3371790|P2|Overall Study|Adverse Event|1
1035326|NCT00130832|3371791|P1|Overall Study|Adverse Event|1
1035327|NCT00130793|3371803|P2|Overall Study|Withdrew consent|0
1035328|NCT00130793|3371804|P1|Overall Study|Withdrew consent|2
1035330|NCT00130793|3371804|P1|Overall Study|Lost to Follow-up|1
1035331|NCT00130728|3371825|P2|Overall Study|Withdrawal by Subject|2
1035332|NCT00130728|3371826|P1|Overall Study|Withdrawal by Subject|0
1035333|NCT00130728|3371825|P2|Overall Study|Lost to Follow-up|0
1035334|NCT00130728|3371826|P1|Overall Study|Lost to Follow-up|4
1035335|NCT00130728|3371825|P2|Overall Study|Death|211
1035336|NCT00130728|3371826|P1|Overall Study|Death|207
1035337|NCT00130689|3371838|P1|Overall Study|Ineligible|6
1035338|NCT00130689|3371838|P1|Overall Study|Withdrawal by Subject|3
1035339|NCT00130689|3371838|P1|Overall Study|Clinical Deterioration|4
1035340|NCT00130689|3371838|P1|Overall Study|Death|1
1035341|NCT00130689|3371838|P1|Overall Study|Progressive Disease|29
1035342|NCT00130637|3371842|P1|Overall Study|Withdrawal by Subject|1
1035343|NCT00130637|3371842|P1|Overall Study|Adverse Event|2
1035344|NCT00130520|3371847|P1|Overall Study|Did not meet re-treatment criteria|1
1035345|NCT00130520|3371847|P1|Overall Study|Protocol non-compliance|1
1035346|NCT00130520|3371847|P1|Overall Study|Disease Progression|23
1035347|NCT00130520|3371847|P1|Overall Study|Withdrawal by Subject|1
1035348|NCT00130520|3371847|P1|Overall Study|Physician Decision|1
1035349|NCT00130520|3371847|P1|Overall Study|Death|1
1035350|NCT00130520|3371847|P1|Overall Study|Adverse Event|11
1035351|NCT00130286|3371857|P4|Overall Study|Missing lab specimens|0
1035352|NCT00130286|3371858|P3|Overall Study|Missing lab specimens|0
1035353|NCT00130286|3371859|P2|Overall Study|Missing lab specimens|2
1035354|NCT00130286|3371860|P1|Overall Study|Missing lab specimens|0
1035355|NCT00130286|3371857|P4|Overall Study|Adverse Event|0
1035356|NCT00130286|3371858|P3|Overall Study|Adverse Event|2
1035357|NCT00130286|3371859|P2|Overall Study|Adverse Event|0
1035358|NCT00130286|3371860|P1|Overall Study|Adverse Event|0
1035359|NCT00130286|3371857|P4|Overall Study|Withdrawal by Subject|2
1035360|NCT00130286|3371858|P3|Overall Study|Withdrawal by Subject|2
1035361|NCT00130286|3371859|P2|Overall Study|Withdrawal by Subject|1
1035362|NCT00130286|3371860|P1|Overall Study|Withdrawal by Subject|0
1035363|NCT00130247|3371880|P2|Overall Study|Not compliant with DOT|2
1035364|NCT00130247|3371881|P1|Overall Study|Not compliant with DOT|0
1035365|NCT00130247|3371880|P2|Overall Study|Post-randomization exclusion|2
1035366|NCT00130247|3371881|P1|Overall Study|Post-randomization exclusion|1
1035367|NCT00130247|3371880|P2|Overall Study|Pregnancy|0
1035368|NCT00130247|3371881|P1|Overall Study|Pregnancy|1
1035369|NCT00130208|3371899|P2|Washout Period (8 Weeks)|Other|1
1035370|NCT00130208|3371900|P1|Washout Period (8 Weeks)|Other|1
1035371|NCT00130208|3371899|P2|Washout Period (8 Weeks)|Lost to Follow-up|1
1035372|NCT00130208|3371900|P1|Washout Period (8 Weeks)|Lost to Follow-up|0
1035373|NCT00130208|3371899|P2|Washout Period (8 Weeks)|Withdrawal by Subject|4
1035374|NCT00130208|3371900|P1|Washout Period (8 Weeks)|Withdrawal by Subject|2
1035375|NCT00130208|3371899|P2|Washout Period (8 Weeks)|Adverse Event|6
1035376|NCT00130208|3371900|P1|Washout Period (8 Weeks)|Adverse Event|3
1035377|NCT00130208|3371899|P2|Maintenance Period (26 Weeks)|Other|1
1035378|NCT00130208|3371900|P1|Maintenance Period (26 Weeks)|Other|1
1035379|NCT00130208|3371899|P2|Maintenance Period (26 Weeks)|Lost to Follow-up|4
1035380|NCT00130208|3371900|P1|Maintenance Period (26 Weeks)|Lost to Follow-up|5
1035381|NCT00130208|3371899|P2|Maintenance Period (26 Weeks)|Withdrawal by Subject|11
1035382|NCT00130208|3371900|P1|Maintenance Period (26 Weeks)|Withdrawal by Subject|8
1035383|NCT00130208|3371899|P2|Maintenance Period (26 Weeks)|Physician Decision|2
1035384|NCT00130208|3371900|P1|Maintenance Period (26 Weeks)|Physician Decision|0
1035385|NCT00130208|3371899|P2|Maintenance Period (26 Weeks)|Adverse Event|12
1035386|NCT00130208|3371900|P1|Maintenance Period (26 Weeks)|Adverse Event|10
1035387|NCT00130039|3371936|P2|Overall Study|clinical events without follow up MRI|4
1035388|NCT00130039|3371937|P1|Overall Study|clinical events without follow up MRI|5
1035389|NCT00130039|3371936|P2|Overall Study|Physician Decision|0
1035390|NCT00130039|3371937|P1|Overall Study|Physician Decision|3
1035391|NCT00130039|3371936|P2|Overall Study|Adverse Event|2
1035392|NCT00130039|3371937|P1|Overall Study|Adverse Event|4
1035393|NCT00130039|3371936|P2|Overall Study|Lost to Follow-up|1
1035394|NCT00130039|3371937|P1|Overall Study|Lost to Follow-up|3
1035395|NCT00130039|3371936|P2|Overall Study|Withdrawal by Subject|11
1035396|NCT00130039|3371937|P1|Overall Study|Withdrawal by Subject|15
1035397|NCT00129974|3371953|P1|Overall Study|Other|1
1035398|NCT00129961|3371960|P2|Overall Study|Missing Record|1
1035399|NCT00129961|3371961|P1|Overall Study|Missing Record|0
1035400|NCT00129961|3371960|P2|Overall Study|Withdrawal by Subject|1
1035401|NCT00129961|3371961|P1|Overall Study|Withdrawal by Subject|2
1035402|NCT00129961|3371960|P2|Overall Study|Physician Decision|0
1035403|NCT00129961|3371961|P1|Overall Study|Physician Decision|1
1035404|NCT00129961|3371960|P2|Overall Study|Withdrawal by Sponsor|20
1035405|NCT00129961|3371961|P1|Overall Study|Withdrawal by Sponsor|14
1035406|NCT00129961|3371960|P2|Overall Study|Death|1
1035407|NCT00129961|3371961|P1|Overall Study|Death|1
1035408|NCT00129961|3371960|P2|Overall Study|Adverse Event|0
1035409|NCT00129961|3371961|P1|Overall Study|Adverse Event|1
1035410|NCT00129766|3371997|P2|Overall Study|Lost to Follow-up|21
1035411|NCT00129766|3371998|P1|Overall Study|Lost to Follow-up|26
1035412|NCT00129766|3371997|P2|Overall Study|Withdrawal of consent|30
1035413|NCT00129766|3371998|P1|Overall Study|Withdrawal of consent|31
1035414|NCT00129766|3371997|P2|Overall Study|Death|8
1035415|NCT00129766|3371998|P1|Overall Study|Death|3
1035416|NCT00129623|3372044|P2|Overall Study|Uncertainty to return|1
1035417|NCT00129623|3372045|P1|Overall Study|Uncertainty to return|0
1035418|NCT00129623|3372044|P2|Overall Study|Relocated job out of state|0
1035419|NCT00129623|3372045|P1|Overall Study|Relocated job out of state|1
1035420|NCT00129623|3372044|P2|Overall Study|Failure to Return|1
1035421|NCT00129623|3372045|P1|Overall Study|Failure to Return|1
1035422|NCT00129623|3372044|P2|Overall Study|Refused Treatment|3
1035423|NCT00129623|3372045|P1|Overall Study|Refused Treatment|5
1035424|NCT00129623|3372044|P2|Overall Study|Adverse Event|7
1035425|NCT00129623|3372045|P1|Overall Study|Adverse Event|3
1035426|NCT00129545|3372070|P3|Overall Study|Device not implanted|0
1035427|NCT00129545|3372071|P2|Overall Study|Device not implanted|61
1035428|NCT00129545|3372072|P1|Overall Study|Device not implanted|16
1035429|NCT00129545|3372070|P3|Overall Study|Physician Decision|10
1035430|NCT00129545|3372071|P2|Overall Study|Physician Decision|3
1035431|NCT00129545|3372072|P1|Overall Study|Physician Decision|0
1035432|NCT00129545|3372070|P3|Overall Study|Lost to Follow-up|13
1035433|NCT00129545|3372071|P2|Overall Study|Lost to Follow-up|22
1035434|NCT00129545|3372072|P1|Overall Study|Lost to Follow-up|2
1035435|NCT00129545|3372070|P3|Overall Study|Withdrawal by Subject|44
1035436|NCT00129545|3372071|P2|Overall Study|Withdrawal by Subject|18
1035437|NCT00129545|3372072|P1|Overall Study|Withdrawal by Subject|3
1035438|NCT00129545|3372070|P3|Overall Study|Death|44
1035439|NCT00129545|3372071|P2|Overall Study|Death|60
1035440|NCT00129545|3372072|P1|Overall Study|Death|5
1035441|NCT00129467|3372093|P2|Open Label for SSRI+Methylphenidate Arm|Delirium|0
1035442|NCT00129467|3372094|P1|Open Label for SSRI+Methylphenidate Arm|Delirium|1
1035443|NCT00129467|3372093|P2|Open Label for SSRI+Methylphenidate Arm|Death|0
1035444|NCT00129467|3372094|P1|Open Label for SSRI+Methylphenidate Arm|Death|1
1035445|NCT00129467|3372093|P2|Received Intervention|Dizzyness, fatigue|1
1035446|NCT00129467|3372094|P1|Received Intervention|Dizzyness, fatigue|0
1035447|NCT00129467|3372093|P2|Received Intervention|Intolerance to citalopram|1
1035448|NCT00129467|3372094|P1|Received Intervention|Intolerance to citalopram|0
1035449|NCT00129467|3372093|P2|Received Intervention|Nausea|0
1035450|NCT00129467|3372094|P1|Received Intervention|Nausea|1
1035451|NCT00129467|3372093|P2|Received Intervention|Withdrawal by Subject|0
1035452|NCT00129467|3372094|P1|Received Intervention|Withdrawal by Subject|1
1035453|NCT00129467|3372093|P2|Received Intervention|Delirium|0
1035454|NCT00129467|3372094|P1|Received Intervention|Delirium|2
1035455|NCT00129467|3372093|P2|Received Intervention|Cardiac SAE (hypertension)|1
1035456|NCT00129467|3372094|P1|Received Intervention|Cardiac SAE (hypertension)|1
1035457|NCT00129467|3372093|P2|Received Intervention|Death|1
1035458|NCT00129467|3372094|P1|Received Intervention|Death|1
1035459|NCT00129402|3372125|P7|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1
1035460|NCT00129402|3372126|P6|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
1035461|NCT00129402|3372127|P5|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
1035462|NCT00129402|3372128|P4|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
1035463|NCT00129402|3372129|P3|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
1035464|NCT00129402|3372130|P2|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
1035465|NCT00129402|3372131|P1|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
1035466|NCT00129402|3372125|P7|Start Period3 to End Period3(Week 34-53)|Subject moved|1
1035467|NCT00129402|3372126|P6|Start Period3 to End Period3(Week 34-53)|Subject moved|0
1035468|NCT00129402|3372127|P5|Start Period3 to End Period3(Week 34-53)|Subject moved|0
1035469|NCT00129402|3372128|P4|Start Period3 to End Period3(Week 34-53)|Subject moved|0
1035470|NCT00129402|3372129|P3|Start Period3 to End Period3(Week 34-53)|Subject moved|0
1035471|NCT00129402|3372130|P2|Start Period3 to End Period3(Week 34-53)|Subject moved|0
1035472|NCT00129402|3372131|P1|Start Period3 to End Period3(Week 34-53)|Subject moved|0
1035473|NCT00129402|3372125|P7|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3
1035474|NCT00129402|3372126|P6|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
1035475|NCT00129402|3372127|P5|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
1035476|NCT00129402|3372128|P4|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
1035477|NCT00129402|3372129|P3|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
1035478|NCT00129402|3372130|P2|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
1035479|NCT00129402|3372131|P1|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
1035480|NCT00129402|3372125|P7|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1
1035481|NCT00129402|3372126|P6|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
1035482|NCT00129402|3372127|P5|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
1035483|NCT00129402|3372128|P4|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
1035484|NCT00129402|3372129|P3|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
1035485|NCT00129402|3372130|P2|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
1035486|NCT00129402|3372131|P1|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
1035487|NCT00129402|3372125|P7|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
1035488|NCT00129402|3372126|P6|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
1035489|NCT00129402|3372127|P5|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
1035490|NCT00129402|3372128|P4|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
1035491|NCT00129402|3372129|P3|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
1035492|NCT00129402|3372130|P2|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
1035493|NCT00129402|3372131|P1|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
1035494|NCT00129402|3372125|P7|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
1035495|NCT00129402|3372126|P6|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3
1035496|NCT00129402|3372127|P5|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
1035497|NCT00129402|3372128|P4|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
1035498|NCT00129402|3372129|P3|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1
1035499|NCT00129402|3372130|P2|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
1035500|NCT00129402|3372131|P1|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
1035501|NCT00129402|3372125|P7|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
1035502|NCT00129402|3372126|P6|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
1035503|NCT00129402|3372127|P5|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
1035504|NCT00129402|3372128|P4|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
1035505|NCT00129402|3372129|P3|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1
1035506|NCT00129402|3372130|P2|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
1035507|NCT00129402|3372131|P1|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
1035508|NCT00129402|3372125|P7|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
1035509|NCT00129402|3372126|P6|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1
1035510|NCT00129402|3372127|P5|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
1035511|NCT00129402|3372128|P4|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
1035512|NCT00129402|3372129|P3|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3
1035513|NCT00129402|3372130|P2|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
1035514|NCT00129402|3372131|P1|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
1035515|NCT00129402|3372125|P7|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
1035516|NCT00129402|3372126|P6|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
1035517|NCT00129402|3372127|P5|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
1035518|NCT00129402|3372128|P4|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
1035519|NCT00129402|3372129|P3|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2
1035520|NCT00129402|3372130|P2|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
1035521|NCT00129402|3372131|P1|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
1035522|NCT00129402|3372125|P7|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
1035523|NCT00129402|3372126|P6|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
1035524|NCT00129402|3372127|P5|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
1035525|NCT00129402|3372128|P4|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
1035526|NCT00129402|3372129|P3|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
1035527|NCT00129402|3372130|P2|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
1035528|NCT00129402|3372131|P1|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
1035529|NCT00129402|3372125|P7|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
1035530|NCT00129402|3372126|P6|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
1035531|NCT00129402|3372127|P5|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
1035532|NCT00129402|3372128|P4|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1
1035533|NCT00129402|3372129|P3|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
1035534|NCT00129402|3372130|P2|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
1035535|NCT00129402|3372131|P1|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
1035536|NCT00129402|3372125|P7|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
1035537|NCT00129402|3372126|P6|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1
1035538|NCT00129402|3372127|P5|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
1035539|NCT00129402|3372128|P4|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
1035540|NCT00129402|3372129|P3|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
1035541|NCT00129402|3372130|P2|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
1035542|NCT00129402|3372131|P1|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
1035543|NCT00129402|3372125|P7|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
1035544|NCT00129402|3372126|P6|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
1035545|NCT00129402|3372127|P5|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
1035546|NCT00129402|3372128|P4|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
1035547|NCT00129402|3372129|P3|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
1035548|NCT00129402|3372130|P2|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
1035549|NCT00129402|3372131|P1|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
1035550|NCT00129311|3372150|P2|Overall Study|Withdrawal by Subject|19
1035551|NCT00129311|3372151|P1|Overall Study|Withdrawal by Subject|12
1035552|NCT00129272|3372180|P2|Overall Study|Withdrawal by Subject|11
1035553|NCT00129272|3372181|P1|Overall Study|Withdrawal by Subject|5
1035554|NCT00129272|3372180|P2|Overall Study|Lost to Follow-up|11
1035555|NCT00129272|3372181|P1|Overall Study|Lost to Follow-up|12
1035556|NCT00129259|3372191|P2|Overall Study|Only available minimal phone assessments|1
1035557|NCT00129259|3372192|P1|Overall Study|Only available minimal phone assessments|0
1035558|NCT00129259|3372191|P2|Overall Study|Withdrawal by Subject|1
1035559|NCT00129259|3372192|P1|Overall Study|Withdrawal by Subject|2
1035560|NCT00129259|3372191|P2|Overall Study|Lost to Follow-up|1
1035561|NCT00129259|3372192|P1|Overall Study|Lost to Follow-up|1
1035562|NCT00129220|3372220|P3|Study Period III|Reason Not Specified|2
1035563|NCT00129220|3372221|P2|Study Period III|Reason Not Specified|0
1035564|NCT00129220|3372222|P1|Study Period III|Reason Not Specified|9
1035565|NCT00129220|3372220|P3|Study Period III|Sponsor Decision|0
1035566|NCT00129220|3372221|P2|Study Period III|Sponsor Decision|0
1035567|NCT00129220|3372222|P1|Study Period III|Sponsor Decision|1
1035568|NCT00129220|3372220|P3|Study Period III|Withdrawal by Subject|3
1035569|NCT00129220|3372221|P2|Study Period III|Withdrawal by Subject|0
1035570|NCT00129220|3372222|P1|Study Period III|Withdrawal by Subject|1
1035571|NCT00129220|3372220|P3|Study Period III|Protocol Violation|2
1035572|NCT00129220|3372221|P2|Study Period III|Protocol Violation|1
1035573|NCT00129220|3372222|P1|Study Period III|Protocol Violation|1
1035574|NCT00129220|3372220|P3|Study Period III|Adverse Event|3
1035575|NCT00129220|3372221|P2|Study Period III|Adverse Event|0
1035576|NCT00129220|3372222|P1|Study Period III|Adverse Event|1
1035577|NCT00129220|3372220|P3|Study Period II|Reason Not Specified|5
1035578|NCT00129220|3372221|P2|Study Period II|Reason Not Specified|0
1035579|NCT00129220|3372222|P1|Study Period II|Reason Not Specified|2
1035580|NCT00129220|3372220|P3|Study Period II|Withdrawal by Subject|4
1035581|NCT00129220|3372221|P2|Study Period II|Withdrawal by Subject|3
1035582|NCT00129220|3372222|P1|Study Period II|Withdrawal by Subject|1
1035583|NCT00129220|3372220|P3|Study Period II|Physician Decision|0
1035584|NCT00129220|3372221|P2|Study Period II|Physician Decision|1
1035585|NCT00129220|3372222|P1|Study Period II|Physician Decision|0
1035586|NCT00129220|3372220|P3|Study Period II|Protocol Violation|1
1035587|NCT00129220|3372221|P2|Study Period II|Protocol Violation|2
1035588|NCT00129220|3372222|P1|Study Period II|Protocol Violation|4
1035589|NCT00129220|3372220|P3|Study Period II|Entry Criteria Not Met|2
1035590|NCT00129220|3372221|P2|Study Period II|Entry Criteria Not Met|0
1035591|NCT00129220|3372222|P1|Study Period II|Entry Criteria Not Met|2
1035592|NCT00129220|3372220|P3|Study Period II|Lack of Efficacy|28
1035593|NCT00129220|3372221|P2|Study Period II|Lack of Efficacy|1
1035594|NCT00129220|3372222|P1|Study Period II|Lack of Efficacy|15
1035595|NCT00129220|3372220|P3|Study Period II|Adverse Event|7
1035596|NCT00129220|3372221|P2|Study Period II|Adverse Event|5
1035597|NCT00129220|3372222|P1|Study Period II|Adverse Event|9
1035598|NCT00129129|3372262|P5|Fourth Dose Phase|Protocol Violation|0
1035599|NCT00129129|3372263|P4|Fourth Dose Phase|Protocol Violation|1
1035600|NCT00129129|3372264|P3|Fourth Dose Phase|Protocol Violation|0
1035601|NCT00129129|3372265|P2|Fourth Dose Phase|Protocol Violation|0
1035602|NCT00129129|3372266|P1|Fourth Dose Phase|Protocol Violation|0
1035603|NCT00129129|3372262|P5|Fourth Dose Phase|Other|1
1035604|NCT00129129|3372263|P4|Fourth Dose Phase|Other|1
1035605|NCT00129129|3372264|P3|Fourth Dose Phase|Other|0
1035606|NCT00129129|3372265|P2|Fourth Dose Phase|Other|0
1035607|NCT00129129|3372266|P1|Fourth Dose Phase|Other|0
1035608|NCT00129129|3372262|P5|Fourth Dose Phase|Migration from study area|2
1035609|NCT00129129|3372263|P4|Fourth Dose Phase|Migration from study area|0
1035610|NCT00129129|3372264|P3|Fourth Dose Phase|Migration from study area|0
1035611|NCT00129129|3372265|P2|Fourth Dose Phase|Migration from study area|0
1035612|NCT00129129|3372266|P1|Fourth Dose Phase|Migration from study area|0
1035613|NCT00129129|3372262|P5|Fourth Dose Phase|Withdrawal by Subject|1
1035614|NCT00129129|3372263|P4|Fourth Dose Phase|Withdrawal by Subject|0
1035615|NCT00129129|3372264|P3|Fourth Dose Phase|Withdrawal by Subject|0
1035616|NCT00129129|3372265|P2|Fourth Dose Phase|Withdrawal by Subject|0
1035617|NCT00129129|3372266|P1|Fourth Dose Phase|Withdrawal by Subject|0
1035618|NCT00129129|3372262|P5|Fourth Dose Phase|Lost to Follow-up|2
1035619|NCT00129129|3372263|P4|Fourth Dose Phase|Lost to Follow-up|2
1035620|NCT00129129|3372264|P3|Fourth Dose Phase|Lost to Follow-up|0
1035621|NCT00129129|3372265|P2|Fourth Dose Phase|Lost to Follow-up|0
1035622|NCT00129129|3372266|P1|Fourth Dose Phase|Lost to Follow-up|4
1035623|NCT00129129|3372262|P5|Primary Phase|Other|0
1035624|NCT00129129|3372263|P4|Primary Phase|Other|0
1035625|NCT00129129|3372264|P3|Primary Phase|Other|0
1035626|NCT00129129|3372265|P2|Primary Phase|Other|5
1035627|NCT00129129|3372266|P1|Primary Phase|Other|2
1035628|NCT00129129|3372262|P5|Primary Phase|Lost to Follow-up|0
1035629|NCT00129129|3372263|P4|Primary Phase|Lost to Follow-up|0
1035630|NCT00129129|3372264|P3|Primary Phase|Lost to Follow-up|0
1035631|NCT00129129|3372265|P2|Primary Phase|Lost to Follow-up|6
1035632|NCT00129129|3372266|P1|Primary Phase|Lost to Follow-up|8
1035633|NCT00129129|3372262|P5|Primary Phase|Migration from study area|0
1035634|NCT00129129|3372263|P4|Primary Phase|Migration from study area|0
1035635|NCT00129129|3372264|P3|Primary Phase|Migration from study area|0
1035636|NCT00129129|3372265|P2|Primary Phase|Migration from study area|3
1035637|NCT00129129|3372266|P1|Primary Phase|Migration from study area|1
1035638|NCT00129129|3372262|P5|Primary Phase|Withdrawal by Subject|0
1035639|NCT00129129|3372263|P4|Primary Phase|Withdrawal by Subject|0
1035640|NCT00129129|3372264|P3|Primary Phase|Withdrawal by Subject|0
1035641|NCT00129129|3372265|P2|Primary Phase|Withdrawal by Subject|10
1035642|NCT00129129|3372266|P1|Primary Phase|Withdrawal by Subject|12
1035643|NCT00129129|3372262|P5|Primary Phase|Adverse Event|0
1035644|NCT00129129|3372263|P4|Primary Phase|Adverse Event|0
1035645|NCT00129129|3372264|P3|Primary Phase|Adverse Event|0
1035646|NCT00129129|3372265|P2|Primary Phase|Adverse Event|1
1035647|NCT00129129|3372266|P1|Primary Phase|Adverse Event|2
1035648|NCT00129116|3372473|P5|Booster Phase|Lost to Follow-up|1
1035649|NCT00129116|3372474|P4|Booster Phase|Lost to Follow-up|0
1035650|NCT00129116|3372475|P3|Booster Phase|Lost to Follow-up|0
1035651|NCT00129116|3372476|P2|Booster Phase|Lost to Follow-up|0
1035652|NCT00129116|3372477|P1|Booster Phase|Lost to Follow-up|2
1035653|NCT00129116|3372473|P5|Primary Phase|Other|0
1035654|NCT00129116|3372474|P4|Primary Phase|Other|0
1035655|NCT00129116|3372475|P3|Primary Phase|Other|1
1035656|NCT00129116|3372476|P2|Primary Phase|Other|0
1035657|NCT00129116|3372477|P1|Primary Phase|Other|0
1035658|NCT00129116|3372473|P5|Primary Phase|Withdrawal by Subject|0
1035659|NCT00129116|3372474|P4|Primary Phase|Withdrawal by Subject|0
1035660|NCT00129116|3372475|P3|Primary Phase|Withdrawal by Subject|0
1035661|NCT00129116|3372476|P2|Primary Phase|Withdrawal by Subject|1
1035662|NCT00129116|3372477|P1|Primary Phase|Withdrawal by Subject|0
1035663|NCT00129116|3372473|P5|Primary Phase|Adverse Event|0
1035664|NCT00129116|3372474|P4|Primary Phase|Adverse Event|0
1035665|NCT00129116|3372475|P3|Primary Phase|Adverse Event|0
1035666|NCT00129116|3372476|P2|Primary Phase|Adverse Event|1
1035667|NCT00129116|3372477|P1|Primary Phase|Adverse Event|1
1035668|NCT00129116|3372473|P5|Primary Phase|Protocol Violation|0
1035669|NCT00129116|3372474|P4|Primary Phase|Protocol Violation|0
1035670|NCT00129116|3372475|P3|Primary Phase|Protocol Violation|0
1035671|NCT00129116|3372476|P2|Primary Phase|Protocol Violation|1
1035672|NCT00129116|3372477|P1|Primary Phase|Protocol Violation|0
1035673|NCT00129116|3372473|P5|Primary Phase|Lost to Follow-up|1
1035674|NCT00129116|3372474|P4|Primary Phase|Lost to Follow-up|1
1035675|NCT00129116|3372475|P3|Primary Phase|Lost to Follow-up|0
1035676|NCT00129116|3372476|P2|Primary Phase|Lost to Follow-up|1
1035677|NCT00129116|3372477|P1|Primary Phase|Lost to Follow-up|1
1035678|NCT00128830|3372761|P1|Overall Study|Other|9
1035679|NCT00128830|3372761|P1|Overall Study|Discontinued or ineligible for study|2
1035680|NCT00128830|3372761|P1|Overall Study|Non-compliant|4
1035681|NCT00128830|3372761|P1|Overall Study|Reached a virologic endpoint|29
1035682|NCT00128830|3372761|P1|Overall Study|Lost to Follow-up|4
1035683|NCT00128830|3372761|P1|Overall Study|Withdrawal by Subject|14
1035684|NCT00128830|3372761|P1|Overall Study|Adverse Event|10
1035685|NCT00128661|3372803|P2|Overall Study|Other|8
1035686|NCT00128661|3372804|P1|Overall Study|Other|7
1035687|NCT00128661|3372803|P2|Overall Study|Withdrawal by Subject|232
1035688|NCT00128661|3372804|P1|Overall Study|Withdrawal by Subject|243
1035689|NCT00128661|3372803|P2|Overall Study|Lost to Follow-up|7
1035690|NCT00128661|3372804|P1|Overall Study|Lost to Follow-up|10
1035691|NCT00128661|3372803|P2|Overall Study|Adverse Event|11
1035692|NCT00128661|3372804|P1|Overall Study|Adverse Event|14
1035693|NCT00128492|3372850|P2|Overall Study|Pregnancy|1
1035694|NCT00128492|3372851|P1|Overall Study|Pregnancy|0
1035695|NCT00128492|3372850|P2|Overall Study|Withdrawal by Subject|5
1035696|NCT00128492|3372851|P1|Overall Study|Withdrawal by Subject|3
1035697|NCT00128492|3372850|P2|Overall Study|Personal or administrative|22
1035698|NCT00128492|3372851|P1|Overall Study|Personal or administrative|10
1035699|NCT00128492|3372850|P2|Overall Study|Noncompliance|5
1035700|NCT00128492|3372851|P1|Overall Study|Noncompliance|0
1035701|NCT00128492|3372850|P2|Overall Study|Lost to Follow-up|5
1035702|NCT00128492|3372851|P1|Overall Study|Lost to Follow-up|1
1035703|NCT00128492|3372850|P2|Overall Study|Death|0
1035704|NCT00128492|3372851|P1|Overall Study|Death|1
1035705|NCT00128492|3372850|P2|Overall Study|AE related to study|4
1035706|NCT00128492|3372851|P1|Overall Study|AE related to study|1
1035707|NCT00128492|3372850|P2|Overall Study|Study drug intolerance (AE)|8
1035708|NCT00128492|3372851|P1|Overall Study|Study drug intolerance (AE)|2
1035709|NCT00128492|3372850|P2|Overall Study|AE unrelated to study|9
1035710|NCT00128492|3372851|P1|Overall Study|AE unrelated to study|2
1035711|NCT00128206|3373008|P2|Overall Study|Adverse Event|2
1035712|NCT00128206|3373009|P1|Overall Study|Adverse Event|0
1035713|NCT00128206|3373008|P2|Overall Study|Lost to Follow-up|118
1035714|NCT00128206|3373009|P1|Overall Study|Lost to Follow-up|137
1035715|NCT00127933|3373301|P2|Overall Study|Randomized but not dosed|0
1035716|NCT00127933|3373302|P1|Overall Study|Randomized but not dosed|1
1035717|NCT00127855|3373323|P5|Primary Vaccination Course|Other|1
1035718|NCT00127855|3373324|P4|Primary Vaccination Course|Other|0
1035719|NCT00127855|3373325|P3|Primary Vaccination Course|Other|0
1035720|NCT00127855|3373326|P2|Primary Vaccination Course|Other|0
1035721|NCT00127855|3373327|P1|Primary Vaccination Course|Other|0
1035722|NCT00127855|3373323|P5|Primary Vaccination Course|Lost to Follow-up|2
1035723|NCT00127855|3373324|P4|Primary Vaccination Course|Lost to Follow-up|0
1035724|NCT00127855|3373325|P3|Primary Vaccination Course|Lost to Follow-up|1
1035725|NCT00127855|3373326|P2|Primary Vaccination Course|Lost to Follow-up|1
1035726|NCT00127855|3373327|P1|Primary Vaccination Course|Lost to Follow-up|1
1035727|NCT00127855|3373323|P5|Primary Vaccination Course|Withdrawal by Subject|1
1035728|NCT00127855|3373324|P4|Primary Vaccination Course|Withdrawal by Subject|0
1035729|NCT00127855|3373325|P3|Primary Vaccination Course|Withdrawal by Subject|0
1035730|NCT00127855|3373326|P2|Primary Vaccination Course|Withdrawal by Subject|0
1035731|NCT00127855|3373327|P1|Primary Vaccination Course|Withdrawal by Subject|1
1035732|NCT00127855|3373323|P5|Primary Vaccination Course|Adverse Event|0
1035733|NCT00127855|3373324|P4|Primary Vaccination Course|Adverse Event|0
1035734|NCT00127855|3373325|P3|Primary Vaccination Course|Adverse Event|1
1035735|NCT00127855|3373326|P2|Primary Vaccination Course|Adverse Event|0
1035736|NCT00127855|3373327|P1|Primary Vaccination Course|Adverse Event|0
1035737|NCT00127842|3373509|P1|Overall Study|Other|5
1035738|NCT00127842|3373509|P1|Overall Study|Protocol Violation|1
1035739|NCT00127842|3373509|P1|Overall Study|Noncompliance|2
1035740|NCT00127842|3373509|P1|Overall Study|Lack of Efficacy|12
1035741|NCT00127842|3373509|P1|Overall Study|Lost to Follow-up|1
1035742|NCT00127842|3373509|P1|Overall Study|Withdrawal by Subject|3
1035743|NCT00127842|3373509|P1|Overall Study|Adverse Event|15
1035744|NCT00127803|3373527|P4|Overall Study|Lost to Follow-up|1
1035745|NCT00127803|3373528|P3|Overall Study|Lost to Follow-up|0
1035746|NCT00127803|3373529|P2|Overall Study|Lost to Follow-up|0
1035747|NCT00127803|3373530|P1|Overall Study|Lost to Follow-up|0
1035748|NCT00127803|3373527|P4|Overall Study|Withdrawal by Subject|0
1035749|NCT00127803|3373528|P3|Overall Study|Withdrawal by Subject|0
1035750|NCT00127803|3373529|P2|Overall Study|Withdrawal by Subject|0
1035751|NCT00127803|3373530|P1|Overall Study|Withdrawal by Subject|1
1035752|NCT00127803|3373527|P4|Overall Study|Adverse Event|0
1035753|NCT00127803|3373528|P3|Overall Study|Adverse Event|0
1035754|NCT00127803|3373529|P2|Overall Study|Adverse Event|0
1035755|NCT00127803|3373530|P1|Overall Study|Adverse Event|2
1035756|NCT00127712|3373579|P2|Overall Study|Lack of GI access to continue|0
1035757|NCT00127712|3373580|P1|Overall Study|Lack of GI access to continue|2
1035758|NCT00127712|3373579|P2|Overall Study|Adverse Event|0
1035759|NCT00127712|3373580|P1|Overall Study|Adverse Event|3
1035760|NCT00127660|3373596|P4|Overall Study|Protocol Violation|0
1035761|NCT00127660|3373597|P3|Overall Study|Protocol Violation|5
1035762|NCT00127660|3373598|P2|Overall Study|Protocol Violation|3
1035763|NCT00127660|3373599|P1|Overall Study|Protocol Violation|3
1035764|NCT00127413|3373647|P4|Overall Study|Lost to Follow-up|2
1035765|NCT00127413|3373648|P3|Overall Study|Lost to Follow-up|8
1035766|NCT00127413|3373649|P2|Overall Study|Lost to Follow-up|4
1035767|NCT00127413|3373650|P1|Overall Study|Lost to Follow-up|6
1035768|NCT00127192|3373693|P5|Overall Study|Adverse event in pre-treatment period|0
1035769|NCT00127192|3373694|P4|Overall Study|Adverse event in pre-treatment period|0
1035770|NCT00127192|3373695|P3|Overall Study|Adverse event in pre-treatment period|0
1035771|NCT00127192|3373696|P2|Overall Study|Adverse event in pre-treatment period|0
1035772|NCT00127192|3373697|P1|Overall Study|Adverse event in pre-treatment period|1
1035773|NCT00127192|3373693|P5|Overall Study|Withdrawal by Subject|3
1035774|NCT00127192|3373694|P4|Overall Study|Withdrawal by Subject|0
1035775|NCT00127192|3373695|P3|Overall Study|Withdrawal by Subject|1
1035776|NCT00127192|3373696|P2|Overall Study|Withdrawal by Subject|0
1035777|NCT00127192|3373697|P1|Overall Study|Withdrawal by Subject|0
1035778|NCT00127192|3373693|P5|Overall Study|Lack of Efficacy|2
1035779|NCT00127192|3373694|P4|Overall Study|Lack of Efficacy|0
1035780|NCT00127192|3373695|P3|Overall Study|Lack of Efficacy|0
1035781|NCT00127192|3373696|P2|Overall Study|Lack of Efficacy|0
1035782|NCT00127192|3373697|P1|Overall Study|Lack of Efficacy|2
1035783|NCT00127192|3373693|P5|Overall Study|Adverse Event|0
1035784|NCT00127192|3373694|P4|Overall Study|Adverse Event|1
1035785|NCT00127192|3373695|P3|Overall Study|Adverse Event|1
1035786|NCT00127192|3373696|P2|Overall Study|Adverse Event|1
1035787|NCT00127192|3373697|P1|Overall Study|Adverse Event|0
1035788|NCT00127166|3373721|P2|Period II|Patient did not perform Visit 6 exercise|0
1035789|NCT00127166|3373722|P1|Period II|Patient did not perform Visit 6 exercise|1
1035790|NCT00127166|3373721|P2|Period II|Withdrawal by Subject|0
1035791|NCT00127166|3373722|P1|Period II|Withdrawal by Subject|2
1035792|NCT00127166|3373721|P2|Washout Period|Patient did not meet inclusion criteria|1
1035793|NCT00127166|3373722|P1|Washout Period|Patient did not meet inclusion criteria|0
1035794|NCT00127166|3373721|P2|Period I|Patient did not meet inclusion criteria|0
1035795|NCT00127166|3373722|P1|Period I|Patient did not meet inclusion criteria|1
1035796|NCT00127166|3373721|P2|Period I|Withdrawal by Subject|0
1035797|NCT00127166|3373722|P1|Period I|Withdrawal by Subject|2
1035798|NCT00127166|3373721|P2|Period I|Protocol Violation|2
1035799|NCT00127166|3373722|P1|Period I|Protocol Violation|0
1035800|NCT00127101|3373742|P6|Continuation Phase|Withdrawal by Subject|1
1035801|NCT00127101|3373743|P5|Continuation Phase|Withdrawal by Subject|2
1035802|NCT00127101|3373744|P4|Continuation Phase|Withdrawal by Subject|0
1035803|NCT00127101|3373745|P3|Continuation Phase|Withdrawal by Subject|1
1035804|NCT00127101|3373746|P2|Continuation Phase|Withdrawal by Subject|0
1035805|NCT00127101|3373747|P1|Continuation Phase|Withdrawal by Subject|0
1035806|NCT00127101|3373742|P6|Continuation Phase|Lack of Efficacy|1
1035807|NCT00127101|3373743|P5|Continuation Phase|Lack of Efficacy|0
1035808|NCT00127101|3373744|P4|Continuation Phase|Lack of Efficacy|0
1035809|NCT00127101|3373745|P3|Continuation Phase|Lack of Efficacy|0
1035810|NCT00127101|3373746|P2|Continuation Phase|Lack of Efficacy|0
1035811|NCT00127101|3373747|P1|Continuation Phase|Lack of Efficacy|0
1035812|NCT00127101|3373742|P6|Continuation Phase|Adverse Event|1
1035813|NCT00127101|3373743|P5|Continuation Phase|Adverse Event|1
1035814|NCT00127101|3373744|P4|Continuation Phase|Adverse Event|0
1035815|NCT00127101|3373745|P3|Continuation Phase|Adverse Event|0
1035816|NCT00127101|3373746|P2|Continuation Phase|Adverse Event|0
1035817|NCT00127101|3373747|P1|Continuation Phase|Adverse Event|0
1035818|NCT00127101|3373742|P6|Base Protocol|Withdrawal by Subject|1
1035819|NCT00127101|3373743|P5|Base Protocol|Withdrawal by Subject|0
1035820|NCT00127101|3373744|P4|Base Protocol|Withdrawal by Subject|0
1035821|NCT00127101|3373745|P3|Base Protocol|Withdrawal by Subject|1
1035822|NCT00127101|3373746|P2|Base Protocol|Withdrawal by Subject|2
1035823|NCT00127101|3373747|P1|Base Protocol|Withdrawal by Subject|1
1035824|NCT00127101|3373742|P6|Base Protocol|Lack of Efficacy|0
1035825|NCT00127101|3373743|P5|Base Protocol|Lack of Efficacy|2
1035826|NCT00127101|3373744|P4|Base Protocol|Lack of Efficacy|0
1035827|NCT00127101|3373745|P3|Base Protocol|Lack of Efficacy|0
1035828|NCT00127101|3373746|P2|Base Protocol|Lack of Efficacy|0
1035829|NCT00127101|3373747|P1|Base Protocol|Lack of Efficacy|1
1035830|NCT00127101|3373742|P6|Base Protocol|Adverse Event|0
1035831|NCT00127101|3373743|P5|Base Protocol|Adverse Event|0
1035832|NCT00127101|3373744|P4|Base Protocol|Adverse Event|0
1035833|NCT00127101|3373745|P3|Base Protocol|Adverse Event|1
1035834|NCT00127101|3373746|P2|Base Protocol|Adverse Event|2
1035835|NCT00127101|3373747|P1|Base Protocol|Adverse Event|0
1035836|NCT00127036|3373769|P2|Overall Study|Screen Failure|0
1035837|NCT00127036|3373770|P1|Overall Study|Screen Failure|2
1035838|NCT00127036|3373769|P2|Overall Study|Insufficient Data for Analysis|11
1035839|NCT00127036|3373770|P1|Overall Study|Insufficient Data for Analysis|6
1035840|NCT00126776|3373782|P2|Overall Study|follow up complete on all patients|0
1035841|NCT00126776|3373783|P1|Overall Study|follow up complete on all patients|0
1035842|NCT00126659|3373832|P3|Overall Study|Adverse Event|2
1035843|NCT00126659|3373833|P2|Overall Study|Adverse Event|0
1035844|NCT00126659|3373834|P1|Overall Study|Adverse Event|0
1035845|NCT00126594|3373842|P2|Overall Study|Disease Progression|24
1035846|NCT00126594|3373843|P1|Overall Study|Disease Progression|29
1035847|NCT00126594|3373842|P2|Overall Study|Non-compliance|1
1035848|NCT00126594|3373843|P1|Overall Study|Non-compliance|0
1035849|NCT00126594|3373842|P2|Overall Study|Adverse Event|5
1035850|NCT00126594|3373843|P1|Overall Study|Adverse Event|7
1035851|NCT00126594|3373842|P2|Overall Study|Physician Decision|3
1035852|NCT00126594|3373843|P1|Overall Study|Physician Decision|1
1035853|NCT00126594|3373842|P2|Overall Study|Withdrawal by Subject|4
1035854|NCT00126594|3373843|P1|Overall Study|Withdrawal by Subject|0
1035855|NCT00126594|3373842|P2|Overall Study|Ineligible|0
1035856|NCT00126594|3373843|P1|Overall Study|Ineligible|2
1035857|NCT00126581|3373860|P2|Overall Study|Other illness/MD discretion|4
1035858|NCT00126581|3373861|P1|Overall Study|Other illness/MD discretion|3
1035859|NCT00126581|3373860|P2|Overall Study|Alternative therapy|3
1035860|NCT00126581|3373861|P1|Overall Study|Alternative therapy|3
1035861|NCT00126581|3373860|P2|Overall Study|Withdrawal by Subject|4
1035862|NCT00126581|3373861|P1|Overall Study|Withdrawal by Subject|1
1035863|NCT00126581|3373860|P2|Overall Study|Death|2
1035864|NCT00126581|3373861|P1|Overall Study|Death|3
1035865|NCT00126581|3373860|P2|Overall Study|Adverse Event|7
1035866|NCT00126581|3373861|P1|Overall Study|Adverse Event|3
1035867|NCT00126568|3373881|P1|Overall Study|Death|2
1035868|NCT00126555|3373888|P1|Overall Study|Progressive Disease|3
1035869|NCT00126555|3373888|P1|Overall Study|Adverse Event|2
1035870|NCT00126555|3373888|P1|Overall Study|Withdrawal by Subject|1
1035871|NCT00126503|3373904|P2|Overall Study|Physician Decision|1
1035872|NCT00126503|3373905|P1|Overall Study|Physician Decision|2
1035873|NCT00126503|3373904|P2|Overall Study|non-compliant|0
1035874|NCT00126503|3373905|P1|Overall Study|non-compliant|1
1035875|NCT00126503|3373904|P2|Overall Study|Adverse Event|3
1035876|NCT00126503|3373905|P1|Overall Study|Adverse Event|13
1035877|NCT00126503|3373904|P2|Overall Study|Death|0
1035878|NCT00126503|3373905|P1|Overall Study|Death|3
1035879|NCT00126503|3373904|P2|Overall Study|other complicating disease|1
1035880|NCT00126503|3373905|P1|Overall Study|other complicating disease|4
1035881|NCT00126503|3373904|P2|Overall Study|alternative therapy|1
1035882|NCT00126503|3373905|P1|Overall Study|alternative therapy|1
1035883|NCT00126503|3373904|P2|Overall Study|Withdrawal by Subject|1
1035884|NCT00126503|3373905|P1|Overall Study|Withdrawal by Subject|0
1035885|NCT00126503|3373904|P2|Overall Study|disease progression|14
1035886|NCT00126503|3373905|P1|Overall Study|disease progression|23
1035887|NCT00126490|3373917|P1|Overall Study|Stopped after 1 infusion (fall/injury)|1
1035888|NCT00126438|3373927|P2|Overall Study|Withdrawal by Subject|2
1035889|NCT00126438|3373928|P1|Overall Study|Withdrawal by Subject|3
1035890|NCT00126438|3373927|P2|Overall Study|Protocol Violation|8
1035891|NCT00126438|3373928|P1|Overall Study|Protocol Violation|8
1035892|NCT00126438|3373927|P2|Overall Study|Lost to Follow-up|0
1035893|NCT00126438|3373928|P1|Overall Study|Lost to Follow-up|22
1035894|NCT00126438|3373927|P2|Overall Study|Withdrawal due to adverse event|0
1035895|NCT00126438|3373928|P1|Overall Study|Withdrawal due to adverse event|1
1035896|NCT00126425|3373936|P2|Overall Study|Other|0
1035897|NCT00126425|3373937|P1|Overall Study|Other|5
1035898|NCT00126425|3373936|P2|Overall Study|Failed Inclusion Exclusion Criteria|0
1035899|NCT00126425|3373937|P1|Overall Study|Failed Inclusion Exclusion Criteria|1
1035900|NCT00126425|3373936|P2|Overall Study|Adverse Event|0
1035901|NCT00126425|3373937|P1|Overall Study|Adverse Event|1
1035902|NCT00126425|3373936|P2|Overall Study|Protocol Violation|6
1035903|NCT00126425|3373937|P1|Overall Study|Protocol Violation|9
1035904|NCT00126425|3373936|P2|Overall Study|Lost to Follow-up|4
1035905|NCT00126425|3373937|P1|Overall Study|Lost to Follow-up|8
1035906|NCT00126425|3373936|P2|Overall Study|Withdrawal by Subject|1
1035907|NCT00126425|3373937|P1|Overall Study|Withdrawal by Subject|17
1035908|NCT00126191|3373945|P2|Overall Study|Death|1
1035909|NCT00126191|3373946|P1|Overall Study|Death|0
1035910|NCT00126191|3373945|P2|Overall Study|Physician Decision|1
1035911|NCT00126191|3373946|P1|Overall Study|Physician Decision|0
1035912|NCT00126126|3373956|P2|Overall Study|Lost to Follow-up|2
1035913|NCT00126126|3373957|P1|Overall Study|Lost to Follow-up|0
1035914|NCT00125359|3374096|P1|Overall Study|Physician Decision|14
1035915|NCT00125359|3374096|P1|Overall Study|Adverse Event|5
1035916|NCT00125359|3374096|P1|Overall Study|Death|4
1035917|NCT00125268|3374105|P2|Overall Study|Withdrawal by Subject|1
1035918|NCT00125268|3374106|P1|Overall Study|Withdrawal by Subject|1
1035919|NCT00125242|3374118|P2|Overall Study|did not qualify|2
1035920|NCT00125242|3374119|P1|Overall Study|did not qualify|7
1035921|NCT00125190|3374124|P1|Overall Study|Non-compliance|2
1035922|NCT00125190|3374124|P1|Overall Study|other|1
1035923|NCT00125190|3374124|P1|Overall Study|Patient/Parent Decision|7
1035924|NCT00125190|3374124|P1|Overall Study|Lost to Follow-up|4
1035925|NCT00125190|3374124|P1|Overall Study|Adverse Event|1
1035926|NCT00125164|3374142|P4|Overall Study|Withdrawal by Subject|1
1035927|NCT00125164|3374143|P3|Overall Study|Withdrawal by Subject|1
1035928|NCT00125164|3374144|P2|Overall Study|Withdrawal by Subject|0
1035929|NCT00125164|3374145|P1|Overall Study|Withdrawal by Subject|2
1035930|NCT00125164|3374142|P4|Overall Study|Lost to Follow-up|1
1035931|NCT00125164|3374143|P3|Overall Study|Lost to Follow-up|1
1035932|NCT00125164|3374144|P2|Overall Study|Lost to Follow-up|0
1035933|NCT00125164|3374145|P1|Overall Study|Lost to Follow-up|0
1035934|NCT00125164|3374142|P4|Overall Study|Adverse Event|4
1035935|NCT00125164|3374143|P3|Overall Study|Adverse Event|2
1035936|NCT00125164|3374144|P2|Overall Study|Adverse Event|0
1035937|NCT00125164|3374145|P1|Overall Study|Adverse Event|0
1035938|NCT00125138|3374199|P4|Overall Study|Sponsor decision-pt moved to assist care|1
1035939|NCT00125138|3374200|P3|Overall Study|Sponsor decision-pt moved to assist care|0
1035940|NCT00125138|3374201|P2|Overall Study|Sponsor decision-pt moved to assist care|0
1035941|NCT00125138|3374202|P1|Overall Study|Sponsor decision-pt moved to assist care|0
1035942|NCT00125138|3374199|P4|Overall Study|Lack of Efficacy|1
1035943|NCT00125138|3374200|P3|Overall Study|Lack of Efficacy|0
1035944|NCT00125138|3374201|P2|Overall Study|Lack of Efficacy|0
1035945|NCT00125138|3374202|P1|Overall Study|Lack of Efficacy|0
1035946|NCT00125138|3374199|P4|Overall Study|Withdrawal by Subject|1
1035947|NCT00125138|3374200|P3|Overall Study|Withdrawal by Subject|1
1035948|NCT00125138|3374201|P2|Overall Study|Withdrawal by Subject|3
1035949|NCT00125138|3374202|P1|Overall Study|Withdrawal by Subject|2
1035950|NCT00125138|3374199|P4|Overall Study|Adverse Event|2
1035951|NCT00125138|3374200|P3|Overall Study|Adverse Event|3
1035952|NCT00125138|3374201|P2|Overall Study|Adverse Event|0
1035953|NCT00125138|3374202|P1|Overall Study|Adverse Event|1
1035954|NCT00124982|3374251|P3|Long-term Period|Neurologist Recommendation|1
1035955|NCT00124982|3374252|P2|Long-term Period|Neurologist Recommendation|0
1035956|NCT00124982|3374253|P1|Long-term Period|Neurologist Recommendation|0
1035957|NCT00124982|3374251|P3|Long-term Period|Administrative Reason by Sponsor|1
1035958|NCT00124982|3374252|P2|Long-term Period|Administrative Reason by Sponsor|0
1035959|NCT00124982|3374253|P1|Long-term Period|Administrative Reason by Sponsor|0
1035960|NCT00124982|3374251|P3|Long-term Period|Poor/Non-compliance|2
1035961|NCT00124982|3374252|P2|Long-term Period|Poor/Non-compliance|0
1035962|NCT00124982|3374253|P1|Long-term Period|Poor/Non-compliance|0
1035963|NCT00124982|3374251|P3|Long-term Period|Pregnancy|1
1035964|NCT00124982|3374252|P2|Long-term Period|Pregnancy|0
1035965|NCT00124982|3374253|P1|Long-term Period|Pregnancy|0
1035966|NCT00124982|3374251|P3|Long-term Period|Withdrawal by Subject|16
1035967|NCT00124982|3374252|P2|Long-term Period|Withdrawal by Subject|0
1035968|NCT00124982|3374253|P1|Long-term Period|Withdrawal by Subject|0
1035969|NCT00124982|3374251|P3|Long-term Period|Lost to Follow-up|4
1035970|NCT00124982|3374252|P2|Long-term Period|Lost to Follow-up|0
1035971|NCT00124982|3374253|P1|Long-term Period|Lost to Follow-up|0
1035972|NCT00124982|3374251|P3|Long-term Period|Lack of Efficacy|46
1035973|NCT00124982|3374252|P2|Long-term Period|Lack of Efficacy|0
1035974|NCT00124982|3374253|P1|Long-term Period|Lack of Efficacy|0
1035975|NCT00124982|3374251|P3|Long-term Period|Adverse Event|17
1035976|NCT00124982|3374252|P2|Long-term Period|Adverse Event|0
1035977|NCT00124982|3374253|P1|Long-term Period|Adverse Event|0
1035978|NCT00124982|3374251|P3|Long-term Period|Death|1
1035979|NCT00124982|3374252|P2|Long-term Period|Death|0
1035980|NCT00124982|3374253|P1|Long-term Period|Death|0
1035981|NCT00124982|3374251|P3|Short-term Period|Participant Had Lymphopenia|0
1035982|NCT00124982|3374252|P2|Short-term Period|Participant Had Lymphopenia|0
1035983|NCT00124982|3374253|P1|Short-term Period|Participant Had Lymphopenia|1
1035984|NCT00124982|3374251|P3|Short-term Period|Investigator Decision-No Specific AE|0
1035985|NCT00124982|3374252|P2|Short-term Period|Investigator Decision-No Specific AE|0
1035986|NCT00124982|3374253|P1|Short-term Period|Investigator Decision-No Specific AE|1
1035987|NCT00124982|3374251|P3|Short-term Period|Participant Chose Own Doctor|0
1035988|NCT00124982|3374252|P2|Short-term Period|Participant Chose Own Doctor|1
1035989|NCT00124982|3374253|P1|Short-term Period|Participant Chose Own Doctor|0
1035990|NCT00124982|3374251|P3|Short-term Period|Participant Decision|0
1035991|NCT00124982|3374252|P2|Short-term Period|Participant Decision|0
1035992|NCT00124982|3374253|P1|Short-term Period|Participant Decision|1
1035993|NCT00124982|3374251|P3|Short-term Period|No Longer Meets Study Criteria|0
1035994|NCT00124982|3374252|P2|Short-term Period|No Longer Meets Study Criteria|2
1035995|NCT00124982|3374253|P1|Short-term Period|No Longer Meets Study Criteria|1
1035996|NCT00124982|3374251|P3|Short-term Period|Poor/Non-compliance|0
1035997|NCT00124982|3374252|P2|Short-term Period|Poor/Non-compliance|1
1035998|NCT00124982|3374253|P1|Short-term Period|Poor/Non-compliance|3
1035999|NCT00124982|3374251|P3|Short-term Period|Withdrawal of Consent|0
1036000|NCT00124982|3374252|P2|Short-term Period|Withdrawal of Consent|9
1036001|NCT00124982|3374253|P1|Short-term Period|Withdrawal of Consent|7
1036002|NCT00124982|3374251|P3|Short-term Period|Lost to Follow-up|0
1036003|NCT00124982|3374252|P2|Short-term Period|Lost to Follow-up|5
1036004|NCT00124982|3374253|P1|Short-term Period|Lost to Follow-up|8
1036005|NCT00124982|3374251|P3|Short-term Period|Lack of Efficacy|0
1036006|NCT00124982|3374252|P2|Short-term Period|Lack of Efficacy|73
1036007|NCT00124982|3374253|P1|Short-term Period|Lack of Efficacy|32
1036008|NCT00124982|3374251|P3|Short-term Period|Adverse Event|0
1036009|NCT00124982|3374252|P2|Short-term Period|Adverse Event|22
1036010|NCT00124982|3374253|P1|Short-term Period|Adverse Event|17
1036011|NCT00124982|3374251|P3|Short-term Period|Death|0
1036012|NCT00124982|3374252|P2|Short-term Period|Death|1
1036013|NCT00124982|3374253|P1|Short-term Period|Death|1
1036014|NCT00124943|3374335|P4|Phase II|Withdrawal by Subject|2
1036015|NCT00124943|3374336|P3|Phase II|Withdrawal by Subject|0
1036016|NCT00124943|3374337|P2|Phase II|Withdrawal by Subject|0
1036017|NCT00124943|3374338|P1|Phase II|Withdrawal by Subject|0
1036018|NCT00124943|3374335|P4|Phase II|Lost to Follow-up|1
1036019|NCT00124943|3374336|P3|Phase II|Lost to Follow-up|0
1036020|NCT00124943|3374337|P2|Phase II|Lost to Follow-up|0
1036021|NCT00124943|3374338|P1|Phase II|Lost to Follow-up|0
1036022|NCT00124943|3374335|P4|Phase II|Protocol Violation|1
1036023|NCT00124943|3374336|P3|Phase II|Protocol Violation|0
1036024|NCT00124943|3374337|P2|Phase II|Protocol Violation|0
1036025|NCT00124943|3374338|P1|Phase II|Protocol Violation|0
1036026|NCT00124943|3374335|P4|Phase II|Adverse Event|1
1036027|NCT00124943|3374336|P3|Phase II|Adverse Event|0
1036028|NCT00124943|3374337|P2|Phase II|Adverse Event|2
1036029|NCT00124943|3374338|P1|Phase II|Adverse Event|0
1036030|NCT00124748|3374378|P2|Overall Study|Death|3
1036031|NCT00124748|3374379|P1|Overall Study|Death|1
1036032|NCT00124748|3374378|P2|Overall Study|Administrative Problem(Study Terminated)|174
1036033|NCT00124748|3374379|P1|Overall Study|Administrative Problem(Study Terminated)|101
1036034|NCT00124748|3374378|P2|Overall Study|Lost to Follow-up|7
1036035|NCT00124748|3374379|P1|Overall Study|Lost to Follow-up|2
1036036|NCT00124748|3374378|P2|Overall Study|Withdrawal by Subject|15
1036037|NCT00124748|3374379|P1|Overall Study|Withdrawal by Subject|5
1036038|NCT00124748|3374378|P2|Overall Study|Protocol Violation|1
1036039|NCT00124748|3374379|P1|Overall Study|Protocol Violation|3
1036040|NCT00124748|3374378|P2|Overall Study|No longer requires study drug|1
1036041|NCT00124748|3374379|P1|Overall Study|No longer requires study drug|1
1036042|NCT00124748|3374378|P2|Overall Study|Lack of Efficacy|41
1036043|NCT00124748|3374379|P1|Overall Study|Lack of Efficacy|20
1036044|NCT00124748|3374378|P2|Overall Study|Abnormal Procedure|1
1036045|NCT00124748|3374379|P1|Overall Study|Abnormal Procedure|0
1036046|NCT00124748|3374378|P2|Overall Study|Abnormal laboratory Value|2
1036047|NCT00124748|3374379|P1|Overall Study|Abnormal laboratory Value|2
1036048|NCT00124748|3374378|P2|Overall Study|Adverse Event|39
1036049|NCT00124748|3374379|P1|Overall Study|Adverse Event|8
1036050|NCT00124709|3374486|P2|Overall Study|Lost to Follow-up|120
1036051|NCT00124709|3374487|P1|Overall Study|Lost to Follow-up|114
1036052|NCT00124709|3374486|P2|Overall Study|Withdrawal by Subject|136
1036053|NCT00124709|3374487|P1|Overall Study|Withdrawal by Subject|127
1036054|NCT00124709|3374486|P2|Overall Study|Protocol Violation|5
1036055|NCT00124709|3374487|P1|Overall Study|Protocol Violation|3
1036056|NCT00124709|3374486|P2|Overall Study|Lack of Efficacy|10
1036057|NCT00124709|3374487|P1|Overall Study|Lack of Efficacy|5
1036058|NCT00124709|3374486|P2|Overall Study|Adverse Event|0
1036059|NCT00124709|3374487|P1|Overall Study|Adverse Event|3
1036060|NCT00124709|3374486|P2|Overall Study|Randomized but did not take medication|1
1036061|NCT00124709|3374487|P1|Overall Study|Randomized but did not take medication|3
1036062|NCT00124657|3374504|P3|Overall Study|Intercurrent illness|0
1036063|NCT00124657|3374505|P2|Overall Study|Intercurrent illness|0
1036064|NCT00124657|3374506|P1|Overall Study|Intercurrent illness|1
1036065|NCT00124657|3374504|P3|Overall Study|Progressive disease|27
1036066|NCT00124657|3374505|P2|Overall Study|Progressive disease|5
1036067|NCT00124657|3374506|P1|Overall Study|Progressive disease|14
1036068|NCT00124657|3374504|P3|Overall Study|Non-compliance|4
1036069|NCT00124657|3374505|P2|Overall Study|Non-compliance|0
1036070|NCT00124657|3374506|P1|Overall Study|Non-compliance|1
1036071|NCT00124657|3374504|P3|Overall Study|Toxicity|1
1036072|NCT00124657|3374505|P2|Overall Study|Toxicity|0
1036073|NCT00124657|3374506|P1|Overall Study|Toxicity|0
1036074|NCT00124618|3374541|P1|Overall Study|Ineligible|1
1036075|NCT00124462|3374556|P2|Overall Study|Device fitting, n=2, other hlth issues|1
1036076|NCT00124462|3374557|P1|Overall Study|Device fitting, n=2, other hlth issues|1
1036077|NCT00124462|3374556|P2|Overall Study|Withdrawal by Subject|5
1036078|NCT00124462|3374557|P1|Overall Study|Withdrawal by Subject|4
1036079|NCT00124462|3374556|P2|Overall Study|Physician Decision|4
1036080|NCT00124462|3374557|P1|Overall Study|Physician Decision|3
1036081|NCT00124462|3374556|P2|Overall Study|Lost to Follow-up|3
1036082|NCT00124462|3374557|P1|Overall Study|Lost to Follow-up|3
1036083|NCT00124449|3374567|P2|18-Month Untreated Observation Period|Relocated|0
1036084|NCT00124449|3374568|P1|18-Month Untreated Observation Period|Relocated|1
1036085|NCT00124449|3374567|P2|18-Month Untreated Observation Period|Poor/Noncompliance|0
1036086|NCT00124449|3374568|P1|18-Month Untreated Observation Period|Poor/Noncompliance|1
1036087|NCT00124449|3374567|P2|18-Month Untreated Observation Period|Pregnancy|0
1036088|NCT00124449|3374568|P1|18-Month Untreated Observation Period|Pregnancy|1
1036089|NCT00124449|3374567|P2|18-Month Untreated Observation Period|Lost to Follow-up|0
1036090|NCT00124449|3374568|P1|18-Month Untreated Observation Period|Lost to Follow-up|1
1036091|NCT00124449|3374567|P2|18-Month Untreated Observation Period|Lack of Efficacy|12
1036092|NCT00124449|3374568|P1|18-Month Untreated Observation Period|Lack of Efficacy|11
1036093|NCT00124449|3374567|P2|18-Month Untreated Observation Period|Adverse Event|1
1036094|NCT00124449|3374568|P1|18-Month Untreated Observation Period|Adverse Event|0
1036095|NCT00124449|3374567|P2|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1
1036096|NCT00124449|3374568|P1|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0
1036097|NCT00124449|3374567|P2|6-month Double-Blind Treatment Period|Sponsor request|1
1036098|NCT00124449|3374568|P1|6-month Double-Blind Treatment Period|Sponsor request|0
1036099|NCT00124449|3374567|P2|6-month Double-Blind Treatment Period|Poor/Noncompliance|0
1036100|NCT00124449|3374568|P1|6-month Double-Blind Treatment Period|Poor/Noncompliance|1
1036101|NCT00124449|3374567|P2|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
1036102|NCT00124449|3374568|P1|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
1036103|NCT00124449|3374567|P2|6-month Double-Blind Treatment Period|Lack of Efficacy|8
1036104|NCT00124449|3374568|P1|6-month Double-Blind Treatment Period|Lack of Efficacy|3
1036105|NCT00124449|3374567|P2|6-month Double-Blind Treatment Period|Adverse Event|0
1036106|NCT00124449|3374568|P1|6-month Double-Blind Treatment Period|Adverse Event|1
1036107|NCT00124072|3374622|P4|Overall Study|Death|480
1036108|NCT00124072|3374623|P3|Overall Study|Death|471
1036109|NCT00124072|3374624|P2|Overall Study|Death|484
1036110|NCT00124072|3374625|P1|Overall Study|Death|499
1036111|NCT00124072|3374622|P4|Overall Study|Lost to Follow-up for Morbidity|18
1036112|NCT00124072|3374623|P3|Overall Study|Lost to Follow-up for Morbidity|19
1036113|NCT00124072|3374624|P2|Overall Study|Lost to Follow-up for Morbidity|25
1036114|NCT00124072|3374625|P1|Overall Study|Lost to Follow-up for Morbidity|15
1036115|NCT00124072|3374622|P4|Overall Study|Lost to Follow-up for Mortality|2
1036116|NCT00124072|3374623|P3|Overall Study|Lost to Follow-up for Mortality|2
1036117|NCT00124072|3374624|P2|Overall Study|Lost to Follow-up for Mortality|3
1036118|NCT00124072|3374625|P1|Overall Study|Lost to Follow-up for Mortality|0
1036119|NCT00124020|3374637|P2|Overall Study|Transfer to another hospital|0
1036120|NCT00124020|3374638|P1|Overall Study|Transfer to another hospital|2
1036121|NCT00124020|3374637|P2|Overall Study|Other|1
1036122|NCT00124020|3374638|P1|Overall Study|Other|1
1036123|NCT00124020|3374637|P2|Overall Study|Lost to Follow-up|8
1036124|NCT00124020|3374638|P1|Overall Study|Lost to Follow-up|5
1036125|NCT00124020|3374637|P2|Overall Study|Withdrawal by Subject|11
1036126|NCT00124020|3374638|P1|Overall Study|Withdrawal by Subject|13
1036127|NCT00124020|3374637|P2|Overall Study|Death|71
1036128|NCT00124020|3374638|P1|Overall Study|Death|67
1036129|NCT00123955|3374646|P2|Overall Study|Death|1
1036130|NCT00123955|3374647|P1|Overall Study|Death|0
1036131|NCT00123955|3374646|P2|Overall Study|Withdrawal by Subject|3
1036132|NCT00123955|3374647|P1|Overall Study|Withdrawal by Subject|4
1036133|NCT00123955|3374646|P2|Overall Study|Adverse Event|0
1036134|NCT00123955|3374647|P1|Overall Study|Adverse Event|1
1036135|NCT00123734|3374659|P1|Overall Study|Withdrawal by Subject|1
1036136|NCT00123734|3374659|P1|Overall Study|Dropout|1
1036137|NCT00123734|3374659|P1|Overall Study|Lost to Follow-up|3
1036138|NCT00123734|3374659|P1|Overall Study|Death|3
1036139|NCT00123487|3374744|P2|Treated With Study Drug|Unknown (case report form lost)|1
1036140|NCT00123487|3374745|P1|Treated With Study Drug|Unknown (case report form lost)|0
1036141|NCT00123487|3374744|P2|Treated With Study Drug|Withdrawal by Subject|13
1036142|NCT00123487|3374745|P1|Treated With Study Drug|Withdrawal by Subject|11
1036143|NCT00123487|3374744|P2|Treated With Study Drug|Study Drug Toxicity|80
1036144|NCT00123487|3374745|P1|Treated With Study Drug|Study Drug Toxicity|62
1036145|NCT00123487|3374744|P2|Treated With Study Drug|Not Specified|58
1036146|NCT00123487|3374745|P1|Treated With Study Drug|Not Specified|59
1036147|NCT00123487|3374744|P2|Treated With Study Drug|Physician Decision|9
1036148|NCT00123487|3374745|P1|Treated With Study Drug|Physician Decision|8
1036149|NCT00123487|3374744|P2|Treated With Study Drug|Disease Progression|122
1036150|NCT00123487|3374745|P1|Treated With Study Drug|Disease Progression|141
1036151|NCT00123487|3374744|P2|Treated With Study Drug|Adverse Event|22
1036152|NCT00123487|3374745|P1|Treated With Study Drug|Adverse Event|23
1036153|NCT00123487|3374744|P2|Randomized|SAE prior to starting treatment|0
1036154|NCT00123487|3374745|P1|Randomized|SAE prior to starting treatment|1
1036155|NCT00123487|3374744|P2|Randomized|Death prior to starting treatment|1
1036156|NCT00123487|3374745|P1|Randomized|Death prior to starting treatment|0
1036157|NCT00123474|3374789|P4|As Treated at Study Closure|Withdrawal by Subject|16
1036158|NCT00123474|3374790|P3|As Treated at Study Closure|Withdrawal by Subject|18
1036159|NCT00123474|3374791|P2|As Treated at Study Closure|Withdrawal by Subject|19
1036160|NCT00123474|3374792|P1|As Treated at Study Closure|Withdrawal by Subject|14
1036161|NCT00123474|3374789|P4|As Treated at Study Closure|Study Drug Toxicity|51
1036162|NCT00123474|3374790|P3|As Treated at Study Closure|Study Drug Toxicity|45
1036163|NCT00123474|3374791|P2|As Treated at Study Closure|Study Drug Toxicity|45
1036164|NCT00123474|3374792|P1|As Treated at Study Closure|Study Drug Toxicity|39
1036165|NCT00123474|3374789|P4|As Treated at Study Closure|non-specified|60
1036166|NCT00123474|3374790|P3|As Treated at Study Closure|non-specified|57
1036167|NCT00123474|3374791|P2|As Treated at Study Closure|non-specified|47
1036168|NCT00123474|3374792|P1|As Treated at Study Closure|non-specified|54
1036169|NCT00123474|3374789|P4|As Treated at Study Closure|Investigator Request|5
1036170|NCT00123474|3374790|P3|As Treated at Study Closure|Investigator Request|7
1036171|NCT00123474|3374791|P2|As Treated at Study Closure|Investigator Request|6
1036172|NCT00123474|3374792|P1|As Treated at Study Closure|Investigator Request|12
1036173|NCT00123474|3374789|P4|As Treated at Study Closure|Disease Progression|27
1036174|NCT00123474|3374790|P3|As Treated at Study Closure|Disease Progression|29
1036175|NCT00123474|3374791|P2|As Treated at Study Closure|Disease Progression|42
1036176|NCT00123474|3374792|P1|As Treated at Study Closure|Disease Progression|35
1036177|NCT00123474|3374789|P4|As Treated at Study Closure|Adverse Event|8
1036178|NCT00123474|3374790|P3|As Treated at Study Closure|Adverse Event|10
1036179|NCT00123474|3374791|P2|As Treated at Study Closure|Adverse Event|4
1036180|NCT00123474|3374792|P1|As Treated at Study Closure|Adverse Event|10
1036181|NCT00123474|3374789|P4|As Treated at Study Closure|not reported when site closed|0
1036182|NCT00123474|3374790|P3|As Treated at Study Closure|not reported when site closed|1
1036183|NCT00123474|3374791|P2|As Treated at Study Closure|not reported when site closed|0
1036184|NCT00123474|3374792|P1|As Treated at Study Closure|not reported when site closed|1
1036185|NCT00123474|3374789|P4|Randomized to Treatment|Randomized, never treated|1
1036186|NCT00123474|3374790|P3|Randomized to Treatment|Randomized, never treated|2
1036187|NCT00123474|3374791|P2|Randomized to Treatment|Randomized, never treated|4
1036188|NCT00123474|3374792|P1|Randomized to Treatment|Randomized, never treated|1
1036189|NCT00123422|3374886|P3|Overall Study|Lost to Follow-up|2
1036190|NCT00123422|3374887|P2|Overall Study|Lost to Follow-up|2
1036191|NCT00123422|3374888|P1|Overall Study|Lost to Follow-up|1
1036192|NCT00123422|3374886|P3|Overall Study|Withdrawal by Subject|2
1036193|NCT00123422|3374887|P2|Overall Study|Withdrawal by Subject|2
1036194|NCT00123422|3374888|P1|Overall Study|Withdrawal by Subject|1
1036195|NCT00123422|3374886|P3|Overall Study|Physician Decision|6
1036196|NCT00123422|3374887|P2|Overall Study|Physician Decision|2
1036197|NCT00123422|3374888|P1|Overall Study|Physician Decision|2
1036198|NCT00122980|3374939|P2|Overall Study|Study termination|35
1036199|NCT00122980|3374940|P1|Overall Study|Study termination|27
1036200|NCT00122980|3374939|P2|Overall Study|Adjudicated stroke (study endpoint)|0
1036201|NCT00122980|3374940|P1|Overall Study|Adjudicated stroke (study endpoint)|7
1036202|NCT00122980|3374939|P2|Overall Study|Withdrawal by Subject|3
1036203|NCT00122980|3374940|P1|Overall Study|Withdrawal by Subject|2
1036204|NCT00122980|3374939|P2|Overall Study|Protocol Violation|1
1036205|NCT00122980|3374940|P1|Overall Study|Protocol Violation|5
1036206|NCT00122980|3374939|P2|Overall Study|Physician Decision|0
1036207|NCT00122980|3374940|P1|Overall Study|Physician Decision|2
1036208|NCT00122980|3374939|P2|Overall Study|Death|1
1036209|NCT00122980|3374940|P1|Overall Study|Death|0
1036210|NCT00122954|3374964|P2|Overall Study|Protocol Violation|1
1036211|NCT00122954|3374965|P1|Overall Study|Protocol Violation|0
1036212|NCT00122954|3374964|P2|Overall Study|Withdrawal by Subject|2
1036213|NCT00122954|3374965|P1|Overall Study|Withdrawal by Subject|2
1036214|NCT00122681|3374975|P2|Overall Study|Personal reasons|147
1036215|NCT00122681|3374976|P1|Overall Study|Personal reasons|150
1036216|NCT00122681|3374975|P2|Overall Study|Withdrawal by Subject|251
1036217|NCT00122681|3374976|P1|Overall Study|Withdrawal by Subject|257
1036218|NCT00122681|3374975|P2|Overall Study|Protocol Violation|10
1036219|NCT00122681|3374976|P1|Overall Study|Protocol Violation|7
1036220|NCT00122681|3374975|P2|Overall Study|Lost to Follow-up|1097
1036221|NCT00122681|3374976|P1|Overall Study|Lost to Follow-up|1080
1036222|NCT00122681|3374975|P2|Overall Study|Adverse Event|16
1036223|NCT00122681|3374976|P1|Overall Study|Adverse Event|20
1036224|NCT00122460|3375050|P2|Overall Study|investigational study phase ongoing|1
1036225|NCT00122460|3375051|P1|Overall Study|investigational study phase ongoing|7
1036226|NCT00122382|3375100|P3|Open-Label Study|Withdrawal of Consent|4
1036227|NCT00122382|3375101|P2|Open-Label Study|Withdrawal of Consent|0
1036228|NCT00122382|3375102|P1|Open-Label Study|Withdrawal of Consent|0
1036229|NCT00122382|3375100|P3|Open-Label Study|Poor/Non-Compliance|1
1036230|NCT00122382|3375101|P2|Open-Label Study|Poor/Non-Compliance|0
1036231|NCT00122382|3375102|P1|Open-Label Study|Poor/Non-Compliance|0
1036232|NCT00122382|3375100|P3|Open-Label Study|Pregnancy|2
1036233|NCT00122382|3375101|P2|Open-Label Study|Pregnancy|0
1036234|NCT00122382|3375102|P1|Open-Label Study|Pregnancy|0
1036235|NCT00122382|3375100|P3|Open-Label Study|Lost to Follow-up|3
1036236|NCT00122382|3375101|P2|Open-Label Study|Lost to Follow-up|0
1036237|NCT00122382|3375102|P1|Open-Label Study|Lost to Follow-up|0
1036238|NCT00122382|3375100|P3|Open-Label Study|Lack of Efficacy|3
1036239|NCT00122382|3375101|P2|Open-Label Study|Lack of Efficacy|0
1036240|NCT00122382|3375102|P1|Open-Label Study|Lack of Efficacy|0
1036241|NCT00122382|3375100|P3|Open-Label Study|Death|2
1036242|NCT00122382|3375101|P2|Open-Label Study|Death|0
1036243|NCT00122382|3375102|P1|Open-Label Study|Death|0
1036244|NCT00122382|3375100|P3|Open-Label Study|Adverse Event|11
1036245|NCT00122382|3375101|P2|Open-Label Study|Adverse Event|0
1036246|NCT00122382|3375102|P1|Open-Label Study|Adverse Event|0
1036247|NCT00122382|3375100|P3|Double-Blind Study|Randomized but not treated|0
1036248|NCT00122382|3375101|P2|Double-Blind Study|Randomized but not treated|2
1036249|NCT00122382|3375102|P1|Double-Blind Study|Randomized but not treated|0
1036250|NCT00122382|3375100|P3|Double-Blind Study|Methotrexate Discontinued|0
1036251|NCT00122382|3375101|P2|Double-Blind Study|Methotrexate Discontinued|1
1036252|NCT00122382|3375102|P1|Double-Blind Study|Methotrexate Discontinued|0
1036253|NCT00122382|3375100|P3|Double-Blind Study|Protocol Violation|0
1036254|NCT00122382|3375101|P2|Double-Blind Study|Protocol Violation|0
1036255|NCT00122382|3375102|P1|Double-Blind Study|Protocol Violation|1
1036256|NCT00122382|3375100|P3|Double-Blind Study|Withdrawal of Consent|0
1036257|NCT00122382|3375101|P2|Double-Blind Study|Withdrawal of Consent|3
1036258|NCT00122382|3375102|P1|Double-Blind Study|Withdrawal of Consent|7
1036259|NCT00122382|3375100|P3|Double-Blind Study|Subject No Longer Meets Study Criteria|0
1036260|NCT00122382|3375101|P2|Double-Blind Study|Subject No Longer Meets Study Criteria|0
1036261|NCT00122382|3375102|P1|Double-Blind Study|Subject No Longer Meets Study Criteria|1
1036262|NCT00122382|3375100|P3|Double-Blind Study|Pregnancy|0
1036263|NCT00122382|3375101|P2|Double-Blind Study|Pregnancy|0
1036264|NCT00122382|3375102|P1|Double-Blind Study|Pregnancy|2
1036265|NCT00122382|3375100|P3|Double-Blind Study|Lost to Follow-up|0
1036266|NCT00122382|3375101|P2|Double-Blind Study|Lost to Follow-up|1
1036267|NCT00122382|3375102|P1|Double-Blind Study|Lost to Follow-up|2
1036268|NCT00122382|3375100|P3|Double-Blind Study|Lack of Efficacy|0
1036269|NCT00122382|3375101|P2|Double-Blind Study|Lack of Efficacy|8
1036270|NCT00122382|3375102|P1|Double-Blind Study|Lack of Efficacy|0
1036271|NCT00122382|3375100|P3|Double-Blind Study|Death|0
1036272|NCT00122382|3375101|P2|Double-Blind Study|Death|2
1036273|NCT00122382|3375102|P1|Double-Blind Study|Death|2
1036274|NCT00122382|3375100|P3|Double-Blind Study|Adverse Event|0
1036275|NCT00122382|3375101|P2|Double-Blind Study|Adverse Event|11
1036276|NCT00122382|3375102|P1|Double-Blind Study|Adverse Event|9
1036277|NCT00122317|3375246|P1|Overall Study|Withdrawal by Subject|1
1036278|NCT00122317|3375246|P1|Overall Study|patient non-compliance|1
1036279|NCT00122317|3375246|P1|Overall Study|Physician Decision|2
1036280|NCT00122317|3375246|P1|Overall Study|Adverse Event|4
1036281|NCT00122317|3375246|P1|Overall Study|Death|3
1036282|NCT00122278|3375255|P2|Overall Study|Lost to Follow-up|0
1036283|NCT00122278|3375256|P1|Overall Study|Lost to Follow-up|2
1036284|NCT00122187|3375266|P2|Overall Study|Withdrew because of resource limitations|2
1036285|NCT00122187|3375267|P1|Overall Study|Withdrew because of resource limitations|2
1036286|NCT00122135|3375281|P2|Overall Study|Withdrawal by Subject|0
1036287|NCT00122135|3375282|P1|Overall Study|Withdrawal by Subject|3
1036288|NCT00122109|3375290|P2|Overall Study|Did not meet criteria|7
1036289|NCT00122109|3375291|P1|Overall Study|Did not meet criteria|6
1036290|NCT00121719|3375355|P14|Overall Study|Continuing/ongoing patients|0
1036291|NCT00121719|3375356|P13|Overall Study|Continuing/ongoing patients|3
1036292|NCT00121719|3375357|P12|Overall Study|Continuing/ongoing patients|1
1036293|NCT00121719|3375358|P11|Overall Study|Continuing/ongoing patients|1
1036294|NCT00121719|3375359|P10|Overall Study|Continuing/ongoing patients|0
1036295|NCT00121719|3375360|P9|Overall Study|Continuing/ongoing patients|0
1036296|NCT00121719|3375361|P8|Overall Study|Continuing/ongoing patients|1
1036297|NCT00121719|3375362|P7|Overall Study|Continuing/ongoing patients|0
1036298|NCT00121719|3375363|P6|Overall Study|Continuing/ongoing patients|0
1036299|NCT00121719|3375364|P5|Overall Study|Continuing/ongoing patients|0
1036300|NCT00121719|3375365|P4|Overall Study|Continuing/ongoing patients|0
1036301|NCT00121719|3375366|P3|Overall Study|Continuing/ongoing patients|0
1036302|NCT00121719|3375367|P2|Overall Study|Continuing/ongoing patients|0
1036303|NCT00121719|3375368|P1|Overall Study|Continuing/ongoing patients|0
1036304|NCT00121719|3375355|P14|Overall Study|Not specified|1
1036305|NCT00121719|3375356|P13|Overall Study|Not specified|1
1036306|NCT00121719|3375357|P12|Overall Study|Not specified|0
1036307|NCT00121719|3375358|P11|Overall Study|Not specified|0
1036308|NCT00121719|3375359|P10|Overall Study|Not specified|0
1036309|NCT00121719|3375360|P9|Overall Study|Not specified|1
1036310|NCT00121719|3375361|P8|Overall Study|Not specified|0
1036311|NCT00121719|3375362|P7|Overall Study|Not specified|1
1036312|NCT00121719|3375363|P6|Overall Study|Not specified|0
1036313|NCT00121719|3375364|P5|Overall Study|Not specified|0
1036314|NCT00121719|3375365|P4|Overall Study|Not specified|1
1036315|NCT00121719|3375366|P3|Overall Study|Not specified|1
1036316|NCT00121719|3375367|P2|Overall Study|Not specified|0
1036317|NCT00121719|3375368|P1|Overall Study|Not specified|0
1036318|NCT00121719|3375355|P14|Overall Study|Physician Decision|0
1036319|NCT00121719|3375356|P13|Overall Study|Physician Decision|1
1036320|NCT00121719|3375357|P12|Overall Study|Physician Decision|0
1036321|NCT00121719|3375358|P11|Overall Study|Physician Decision|0
1036322|NCT00121719|3375359|P10|Overall Study|Physician Decision|0
1036323|NCT00121719|3375360|P9|Overall Study|Physician Decision|0
1036324|NCT00121719|3375361|P8|Overall Study|Physician Decision|0
1036325|NCT00121719|3375362|P7|Overall Study|Physician Decision|0
1036326|NCT00121719|3375363|P6|Overall Study|Physician Decision|0
1036327|NCT00121719|3375364|P5|Overall Study|Physician Decision|0
1036328|NCT00121719|3375365|P4|Overall Study|Physician Decision|0
1036329|NCT00121719|3375366|P3|Overall Study|Physician Decision|0
1036330|NCT00121719|3375367|P2|Overall Study|Physician Decision|1
1036331|NCT00121719|3375368|P1|Overall Study|Physician Decision|0
1036332|NCT00121719|3375355|P14|Overall Study|Clinical deterioration|2
1036333|NCT00121719|3375356|P13|Overall Study|Clinical deterioration|2
1036334|NCT00121719|3375357|P12|Overall Study|Clinical deterioration|1
1036335|NCT00121719|3375358|P11|Overall Study|Clinical deterioration|0
1036336|NCT00121719|3375359|P10|Overall Study|Clinical deterioration|2
1036337|NCT00121719|3375360|P9|Overall Study|Clinical deterioration|2
1036338|NCT00121719|3375361|P8|Overall Study|Clinical deterioration|1
1036339|NCT00121719|3375362|P7|Overall Study|Clinical deterioration|2
1036340|NCT00121719|3375363|P6|Overall Study|Clinical deterioration|0
1036341|NCT00121719|3375364|P5|Overall Study|Clinical deterioration|1
1036342|NCT00121719|3375365|P4|Overall Study|Clinical deterioration|0
1036343|NCT00121719|3375366|P3|Overall Study|Clinical deterioration|1
1036344|NCT00121719|3375367|P2|Overall Study|Clinical deterioration|1
1036345|NCT00121719|3375368|P1|Overall Study|Clinical deterioration|0
1036346|NCT00121719|3375355|P14|Overall Study|Progressive disease|4
1036347|NCT00121719|3375356|P13|Overall Study|Progressive disease|13
1036348|NCT00121719|3375357|P12|Overall Study|Progressive disease|3
1036349|NCT00121719|3375358|P11|Overall Study|Progressive disease|4
1036350|NCT00121719|3375359|P10|Overall Study|Progressive disease|1
1036351|NCT00121719|3375360|P9|Overall Study|Progressive disease|3
1036352|NCT00121719|3375361|P8|Overall Study|Progressive disease|5
1036353|NCT00121719|3375362|P7|Overall Study|Progressive disease|7
1036354|NCT00121719|3375363|P6|Overall Study|Progressive disease|1
1036355|NCT00121719|3375364|P5|Overall Study|Progressive disease|2
1036356|NCT00121719|3375365|P4|Overall Study|Progressive disease|2
1036357|NCT00121719|3375366|P3|Overall Study|Progressive disease|0
1036358|NCT00121719|3375367|P2|Overall Study|Progressive disease|1
1036359|NCT00121719|3375368|P1|Overall Study|Progressive disease|2
1036360|NCT00121719|3375355|P14|Overall Study|Withdrawal by Subject|0
1036361|NCT00121719|3375356|P13|Overall Study|Withdrawal by Subject|0
1036362|NCT00121719|3375357|P12|Overall Study|Withdrawal by Subject|0
1036363|NCT00121719|3375358|P11|Overall Study|Withdrawal by Subject|0
1036364|NCT00121719|3375359|P10|Overall Study|Withdrawal by Subject|0
1036365|NCT00121719|3375360|P9|Overall Study|Withdrawal by Subject|0
1036366|NCT00121719|3375361|P8|Overall Study|Withdrawal by Subject|0
1036367|NCT00121719|3375362|P7|Overall Study|Withdrawal by Subject|0
1036368|NCT00121719|3375363|P6|Overall Study|Withdrawal by Subject|0
1036369|NCT00121719|3375364|P5|Overall Study|Withdrawal by Subject|0
1036370|NCT00121719|3375365|P4|Overall Study|Withdrawal by Subject|0
1036371|NCT00121719|3375366|P3|Overall Study|Withdrawal by Subject|0
1036372|NCT00121719|3375367|P2|Overall Study|Withdrawal by Subject|0
1036373|NCT00121719|3375368|P1|Overall Study|Withdrawal by Subject|1
1036374|NCT00121719|3375355|P14|Overall Study|Protocol deviation|0
1036375|NCT00121719|3375356|P13|Overall Study|Protocol deviation|0
1036376|NCT00121719|3375357|P12|Overall Study|Protocol deviation|0
1036377|NCT00121719|3375358|P11|Overall Study|Protocol deviation|0
1036378|NCT00121719|3375359|P10|Overall Study|Protocol deviation|0
1036379|NCT00121719|3375360|P9|Overall Study|Protocol deviation|0
1036380|NCT00121719|3375361|P8|Overall Study|Protocol deviation|0
1036381|NCT00121719|3375362|P7|Overall Study|Protocol deviation|0
1036382|NCT00121719|3375363|P6|Overall Study|Protocol deviation|0
1036383|NCT00121719|3375364|P5|Overall Study|Protocol deviation|0
1036384|NCT00121719|3375365|P4|Overall Study|Protocol deviation|0
1036385|NCT00121719|3375366|P3|Overall Study|Protocol deviation|1
1036386|NCT00121719|3375367|P2|Overall Study|Protocol deviation|0
1036387|NCT00121719|3375368|P1|Overall Study|Protocol deviation|0
1036388|NCT00121719|3375355|P14|Overall Study|Abnormal laboratory value|0
1036389|NCT00121719|3375356|P13|Overall Study|Abnormal laboratory value|1
1036390|NCT00121719|3375357|P12|Overall Study|Abnormal laboratory value|0
1036391|NCT00121719|3375358|P11|Overall Study|Abnormal laboratory value|0
1036392|NCT00121719|3375359|P10|Overall Study|Abnormal laboratory value|0
1036393|NCT00121719|3375360|P9|Overall Study|Abnormal laboratory value|0
1036394|NCT00121719|3375361|P8|Overall Study|Abnormal laboratory value|1
1036395|NCT00121719|3375362|P7|Overall Study|Abnormal laboratory value|0
1036396|NCT00121719|3375363|P6|Overall Study|Abnormal laboratory value|0
1036397|NCT00121719|3375364|P5|Overall Study|Abnormal laboratory value|0
1036398|NCT00121719|3375365|P4|Overall Study|Abnormal laboratory value|0
1036399|NCT00121719|3375366|P3|Overall Study|Abnormal laboratory value|0
1036400|NCT00121719|3375367|P2|Overall Study|Abnormal laboratory value|1
1036401|NCT00121719|3375368|P1|Overall Study|Abnormal laboratory value|1
1036402|NCT00121719|3375355|P14|Overall Study|Adverse Event|0
1036403|NCT00121719|3375356|P13|Overall Study|Adverse Event|3
1036404|NCT00121719|3375357|P12|Overall Study|Adverse Event|0
1036405|NCT00121719|3375358|P11|Overall Study|Adverse Event|1
1036406|NCT00121719|3375359|P10|Overall Study|Adverse Event|0
1036407|NCT00121719|3375360|P9|Overall Study|Adverse Event|0
1036408|NCT00121719|3375361|P8|Overall Study|Adverse Event|1
1036409|NCT00121719|3375362|P7|Overall Study|Adverse Event|2
1036410|NCT00121719|3375363|P6|Overall Study|Adverse Event|2
1036411|NCT00121719|3375364|P5|Overall Study|Adverse Event|0
1036412|NCT00121719|3375365|P4|Overall Study|Adverse Event|0
1036413|NCT00121719|3375366|P3|Overall Study|Adverse Event|1
1036414|NCT00121719|3375367|P2|Overall Study|Adverse Event|0
1036415|NCT00121719|3375368|P1|Overall Study|Adverse Event|0
1036416|NCT00121667|3375545|P4|Short Term (ST) + Long Term (LT) Period|Death|2
1036417|NCT00121667|3375546|P3|Short Term (ST) + Long Term (LT) Period|Death|0
1036418|NCT00121667|3375547|P2|Short Term (ST) + Long Term (LT) Period|Death|0
1036419|NCT00121667|3375548|P1|Short Term (ST) + Long Term (LT) Period|Death|1
1036420|NCT00121667|3375545|P4|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
1036421|NCT00121667|3375546|P3|Short Term (ST) + Long Term (LT) Period|Pregnancy|0
1036422|NCT00121667|3375547|P2|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
1036423|NCT00121667|3375548|P1|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
1036424|NCT00121667|3375545|P4|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4
1036425|NCT00121667|3375546|P3|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8
1036426|NCT00121667|3375547|P2|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5
1036427|NCT00121667|3375548|P1|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3
1036428|NCT00121667|3375545|P4|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9
1036505|NCT00121641|3375648|P3|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
1036429|NCT00121667|3375546|P3|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5
1036430|NCT00121667|3375547|P2|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6
1036431|NCT00121667|3375548|P1|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3
1036432|NCT00121667|3375545|P4|Short Term (ST) + Long Term (LT) Period|Other Reason|3
1036433|NCT00121667|3375546|P3|Short Term (ST) + Long Term (LT) Period|Other Reason|6
1036434|NCT00121667|3375547|P2|Short Term (ST) + Long Term (LT) Period|Other Reason|7
1036435|NCT00121667|3375548|P1|Short Term (ST) + Long Term (LT) Period|Other Reason|5
1036436|NCT00121667|3375545|P4|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16
1036437|NCT00121667|3375546|P3|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13
1036438|NCT00121667|3375547|P2|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
1036439|NCT00121667|3375548|P1|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
1036440|NCT00121667|3375545|P4|Short Term (ST) + Long Term (LT) Period|Adverse Event|10
1036441|NCT00121667|3375546|P3|Short Term (ST) + Long Term (LT) Period|Adverse Event|13
1036442|NCT00121667|3375547|P2|Short Term (ST) + Long Term (LT) Period|Adverse Event|18
1036443|NCT00121667|3375548|P1|Short Term (ST) + Long Term (LT) Period|Adverse Event|12
1036444|NCT00121667|3375545|P4|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30
1036445|NCT00121667|3375546|P3|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26
1036446|NCT00121667|3375547|P2|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34
1036447|NCT00121667|3375548|P1|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38
1036448|NCT00121667|3375545|P4|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65
1036449|NCT00121667|3375546|P3|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42
1036450|NCT00121667|3375547|P2|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51
1036451|NCT00121667|3375548|P1|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54
1036452|NCT00121667|3375545|P4|Short Term (ST) Period|Pregnancy|1
1036453|NCT00121667|3375546|P3|Short Term (ST) Period|Pregnancy|0
1036454|NCT00121667|3375547|P2|Short Term (ST) Period|Pregnancy|0
1036455|NCT00121667|3375548|P1|Short Term (ST) Period|Pregnancy|0
1036456|NCT00121667|3375545|P4|Short Term (ST) Period|Death|1
1036457|NCT00121667|3375546|P3|Short Term (ST) Period|Death|0
1036458|NCT00121667|3375547|P2|Short Term (ST) Period|Death|0
1036459|NCT00121667|3375548|P1|Short Term (ST) Period|Death|0
1036460|NCT00121667|3375545|P4|Short Term (ST) Period|Other Reason|0
1036461|NCT00121667|3375546|P3|Short Term (ST) Period|Other Reason|0
1036462|NCT00121667|3375547|P2|Short Term (ST) Period|Other Reason|0
1036463|NCT00121667|3375548|P1|Short Term (ST) Period|Other Reason|3
1036464|NCT00121667|3375545|P4|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
1036465|NCT00121667|3375546|P3|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
1036466|NCT00121667|3375547|P2|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
1036467|NCT00121667|3375548|P1|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
1036468|NCT00121667|3375545|P4|Short Term (ST) Period|Poor / Non-compliance|2
1036469|NCT00121667|3375546|P3|Short Term (ST) Period|Poor / Non-compliance|1
1036470|NCT00121667|3375547|P2|Short Term (ST) Period|Poor / Non-compliance|1
1036471|NCT00121667|3375548|P1|Short Term (ST) Period|Poor / Non-compliance|0
1036472|NCT00121667|3375545|P4|Short Term (ST) Period|Lost to Follow-up|3
1036473|NCT00121667|3375546|P3|Short Term (ST) Period|Lost to Follow-up|4
1036474|NCT00121667|3375547|P2|Short Term (ST) Period|Lost to Follow-up|4
1036475|NCT00121667|3375548|P1|Short Term (ST) Period|Lost to Follow-up|3
1036476|NCT00121667|3375545|P4|Short Term (ST) Period|Adverse Event|3
1036477|NCT00121667|3375546|P3|Short Term (ST) Period|Adverse Event|5
1036478|NCT00121667|3375547|P2|Short Term (ST) Period|Adverse Event|6
1036479|NCT00121667|3375548|P1|Short Term (ST) Period|Adverse Event|5
1036480|NCT00121667|3375545|P4|Short Term (ST) Period|Subject Withdrew Consent|11
1036481|NCT00121667|3375546|P3|Short Term (ST) Period|Subject Withdrew Consent|4
1036482|NCT00121667|3375547|P2|Short Term (ST) Period|Subject Withdrew Consent|13
1036483|NCT00121667|3375548|P1|Short Term (ST) Period|Subject Withdrew Consent|8
1036484|NCT00121667|3375545|P4|Short Term (ST) Period|Lack of Efficacy|44
1036485|NCT00121667|3375546|P3|Short Term (ST) Period|Lack of Efficacy|27
1036486|NCT00121667|3375547|P2|Short Term (ST) Period|Lack of Efficacy|22
1036487|NCT00121667|3375548|P1|Short Term (ST) Period|Lack of Efficacy|25
1036488|NCT00121641|3375646|P5|48-month Short Term + Long Term Period|Other Reason|1
1036489|NCT00121641|3375647|P4|48-month Short Term + Long Term Period|Other Reason|0
1036490|NCT00121641|3375648|P3|48-month Short Term + Long Term Period|Other Reason|2
1036491|NCT00121641|3375649|P2|48-month Short Term + Long Term Period|Other Reason|3
1036492|NCT00121641|3375650|P1|48-month Short Term + Long Term Period|Other Reason|5
1036493|NCT00121641|3375646|P5|48-month Short Term + Long Term Period|Missing|0
1036494|NCT00121641|3375647|P4|48-month Short Term + Long Term Period|Missing|0
1036495|NCT00121641|3375648|P3|48-month Short Term + Long Term Period|Missing|1
1036496|NCT00121641|3375649|P2|48-month Short Term + Long Term Period|Missing|0
1036497|NCT00121641|3375650|P1|48-month Short Term + Long Term Period|Missing|0
1036498|NCT00121641|3375646|P5|48-month Short Term + Long Term Period|Death|0
1036499|NCT00121641|3375647|P4|48-month Short Term + Long Term Period|Death|1
1036500|NCT00121641|3375648|P3|48-month Short Term + Long Term Period|Death|0
1036501|NCT00121641|3375649|P2|48-month Short Term + Long Term Period|Death|0
1036502|NCT00121641|3375650|P1|48-month Short Term + Long Term Period|Death|0
1036503|NCT00121641|3375646|P5|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
1036504|NCT00121641|3375647|P4|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
1036506|NCT00121641|3375649|P2|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2
1036507|NCT00121641|3375650|P1|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
1036508|NCT00121641|3375646|P5|48-month Short Term + Long Term Period|Pregnancy|0
1036509|NCT00121641|3375647|P4|48-month Short Term + Long Term Period|Pregnancy|1
1036510|NCT00121641|3375648|P3|48-month Short Term + Long Term Period|Pregnancy|0
1036511|NCT00121641|3375649|P2|48-month Short Term + Long Term Period|Pregnancy|1
1036512|NCT00121641|3375650|P1|48-month Short Term + Long Term Period|Pregnancy|0
1036513|NCT00121641|3375646|P5|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
1036514|NCT00121641|3375647|P4|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
1036515|NCT00121641|3375648|P3|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
1036516|NCT00121641|3375649|P2|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3
1036517|NCT00121641|3375650|P1|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
1036518|NCT00121641|3375646|P5|48-month Short Term + Long Term Period|Poor / Non-compliance|2
1036519|NCT00121641|3375647|P4|48-month Short Term + Long Term Period|Poor / Non-compliance|2
1036520|NCT00121641|3375648|P3|48-month Short Term + Long Term Period|Poor / Non-compliance|4
1036521|NCT00121641|3375649|P2|48-month Short Term + Long Term Period|Poor / Non-compliance|1
1036522|NCT00121641|3375650|P1|48-month Short Term + Long Term Period|Poor / Non-compliance|4
1036523|NCT00121641|3375646|P5|48-month Short Term + Long Term Period|Lost to Follow-up|12
1036524|NCT00121641|3375647|P4|48-month Short Term + Long Term Period|Lost to Follow-up|11
1036525|NCT00121641|3375648|P3|48-month Short Term + Long Term Period|Lost to Follow-up|12
1036526|NCT00121641|3375649|P2|48-month Short Term + Long Term Period|Lost to Follow-up|7
1036527|NCT00121641|3375650|P1|48-month Short Term + Long Term Period|Lost to Follow-up|9
1036528|NCT00121641|3375646|P5|48-month Short Term + Long Term Period|Adverse Event|5
1036529|NCT00121641|3375647|P4|48-month Short Term + Long Term Period|Adverse Event|5
1036530|NCT00121641|3375648|P3|48-month Short Term + Long Term Period|Adverse Event|10
1036531|NCT00121641|3375649|P2|48-month Short Term + Long Term Period|Adverse Event|10
1036532|NCT00121641|3375650|P1|48-month Short Term + Long Term Period|Adverse Event|9
1036533|NCT00121641|3375646|P5|48-month Short Term + Long Term Period|Subject Withdrew Consent|10
1036534|NCT00121641|3375647|P4|48-month Short Term + Long Term Period|Subject Withdrew Consent|24
1036535|NCT00121641|3375648|P3|48-month Short Term + Long Term Period|Subject Withdrew Consent|17
1036536|NCT00121641|3375649|P2|48-month Short Term + Long Term Period|Subject Withdrew Consent|28
1036537|NCT00121641|3375650|P1|48-month Short Term + Long Term Period|Subject Withdrew Consent|25
1036538|NCT00121641|3375646|P5|48-month Short Term + Long Term Period|Lack of Efficacy|25
1036539|NCT00121641|3375647|P4|48-month Short Term + Long Term Period|Lack of Efficacy|26
1036540|NCT00121641|3375648|P3|48-month Short Term + Long Term Period|Lack of Efficacy|21
1036541|NCT00121641|3375649|P2|48-month Short Term + Long Term Period|Lack of Efficacy|27
1036542|NCT00121641|3375650|P1|48-month Short Term + Long Term Period|Lack of Efficacy|26
1036543|NCT00121641|3375646|P5|24-week Short-term Treatment Period|Other Reason|0
1036544|NCT00121641|3375647|P4|24-week Short-term Treatment Period|Other Reason|0
1036545|NCT00121641|3375648|P3|24-week Short-term Treatment Period|Other Reason|0
1036546|NCT00121641|3375649|P2|24-week Short-term Treatment Period|Other Reason|0
1036547|NCT00121641|3375650|P1|24-week Short-term Treatment Period|Other Reason|1
1036548|NCT00121641|3375646|P5|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
1036549|NCT00121641|3375647|P4|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
1036550|NCT00121641|3375648|P3|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
1036551|NCT00121641|3375649|P2|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
1036552|NCT00121641|3375650|P1|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
1036553|NCT00121641|3375646|P5|24-week Short-term Treatment Period|Poor / Non-compliance|1
1036554|NCT00121641|3375647|P4|24-week Short-term Treatment Period|Poor / Non-compliance|1
1036555|NCT00121641|3375648|P3|24-week Short-term Treatment Period|Poor / Non-compliance|3
1036556|NCT00121641|3375649|P2|24-week Short-term Treatment Period|Poor / Non-compliance|0
1036557|NCT00121641|3375650|P1|24-week Short-term Treatment Period|Poor / Non-compliance|0
1036558|NCT00121641|3375646|P5|24-week Short-term Treatment Period|Lost to Follow-up|4
1036559|NCT00121641|3375647|P4|24-week Short-term Treatment Period|Lost to Follow-up|4
1036560|NCT00121641|3375648|P3|24-week Short-term Treatment Period|Lost to Follow-up|3
1036561|NCT00121641|3375649|P2|24-week Short-term Treatment Period|Lost to Follow-up|2
1036562|NCT00121641|3375650|P1|24-week Short-term Treatment Period|Lost to Follow-up|0
1036563|NCT00121641|3375646|P5|24-week Short-term Treatment Period|Adverse Event|2
1036564|NCT00121641|3375647|P4|24-week Short-term Treatment Period|Adverse Event|0
1036565|NCT00121641|3375648|P3|24-week Short-term Treatment Period|Adverse Event|4
1036566|NCT00121641|3375649|P2|24-week Short-term Treatment Period|Adverse Event|3
1036567|NCT00121641|3375650|P1|24-week Short-term Treatment Period|Adverse Event|3
1036568|NCT00121641|3375646|P5|24-week Short-term Treatment Period|Subject Withdrew Consent|3
1036569|NCT00121641|3375647|P4|24-week Short-term Treatment Period|Subject Withdrew Consent|10
1036570|NCT00121641|3375648|P3|24-week Short-term Treatment Period|Subject Withdrew Consent|5
1036571|NCT00121641|3375649|P2|24-week Short-term Treatment Period|Subject Withdrew Consent|11
1036572|NCT00121641|3375650|P1|24-week Short-term Treatment Period|Subject Withdrew Consent|9
1036573|NCT00121641|3375646|P5|24-week Short-term Treatment Period|Lack of Efficacy|30
1036574|NCT00121641|3375647|P4|24-week Short-term Treatment Period|Lack of Efficacy|25
1036575|NCT00121641|3375648|P3|24-week Short-term Treatment Period|Lack of Efficacy|14
1036576|NCT00121641|3375649|P2|24-week Short-term Treatment Period|Lack of Efficacy|21
1036577|NCT00121641|3375650|P1|24-week Short-term Treatment Period|Lack of Efficacy|15
1036578|NCT00121485|3375763|P2|Overall Study|Crossover|2
1036579|NCT00121485|3375764|P1|Overall Study|Crossover|0
1036580|NCT00121485|3375763|P2|Overall Study|Not implanted|5
1036581|NCT00121485|3375764|P1|Overall Study|Not implanted|1
1036582|NCT00121238|3375809|P1|Overall Study|Protocol Violation|2
1036583|NCT00121238|3375809|P1|Overall Study|disease progression before intervention|1
1036584|NCT00121199|3375821|P1|Overall Study|Ineligible|9
1036585|NCT00121199|3375821|P1|Overall Study|Other - Not Protocol Specified|3
1036586|NCT00121199|3375821|P1|Overall Study|Death|3
1036587|NCT00121199|3375821|P1|Overall Study|Progression/Relapse|1
1036588|NCT00121199|3375821|P1|Overall Study|Refusal Unrelated to Adverse Event|1
1036589|NCT00121199|3375821|P1|Overall Study|Adverse Event|11
1036590|NCT00121134|3375865|P4|Overall Study|Patient Personal Reasons|0
1036591|NCT00121134|3375866|P3|Overall Study|Patient Personal Reasons|0
1036592|NCT00121134|3375867|P2|Overall Study|Patient Personal Reasons|1
1036593|NCT00121134|3375868|P1|Overall Study|Patient Personal Reasons|0
1036594|NCT00121134|3375865|P4|Overall Study|Intercurrent Illness|1
1036595|NCT00121134|3375866|P3|Overall Study|Intercurrent Illness|0
1036596|NCT00121134|3375867|P2|Overall Study|Intercurrent Illness|0
1036597|NCT00121134|3375868|P1|Overall Study|Intercurrent Illness|0
1036598|NCT00121134|3375865|P4|Overall Study|Treatment Delay|0
1036599|NCT00121134|3375866|P3|Overall Study|Treatment Delay|0
1036600|NCT00121134|3375867|P2|Overall Study|Treatment Delay|0
1036601|NCT00121134|3375868|P1|Overall Study|Treatment Delay|1
1036602|NCT00121134|3375865|P4|Overall Study|Physician Decision|1
1036603|NCT00121134|3375866|P3|Overall Study|Physician Decision|4
1036604|NCT00121134|3375867|P2|Overall Study|Physician Decision|4
1036605|NCT00121134|3375868|P1|Overall Study|Physician Decision|6
1036606|NCT00121134|3375865|P4|Overall Study|Toxicity|5
1036607|NCT00121134|3375866|P3|Overall Study|Toxicity|13
1036608|NCT00121134|3375867|P2|Overall Study|Toxicity|7
1036609|NCT00121134|3375868|P1|Overall Study|Toxicity|4
1036610|NCT00121134|3375865|P4|Overall Study|Progression of Disease|2
1036611|NCT00121134|3375866|P3|Overall Study|Progression of Disease|4
1036612|NCT00121134|3375867|P2|Overall Study|Progression of Disease|3
1036613|NCT00121134|3375868|P1|Overall Study|Progression of Disease|5
1036614|NCT00120874|3375880|P2|Overall Study|Death|1
1036615|NCT00120874|3375881|P1|Overall Study|Death|0
1036616|NCT00120627|3375919|P2|Overall Study|Withdrawal by Subject|5
1036617|NCT00120627|3375920|P1|Overall Study|Withdrawal by Subject|5
1036618|NCT00120406|3375971|P2|Overall Study|patient moved but has not withdrawn|1
1036619|NCT00120406|3375972|P1|Overall Study|patient moved but has not withdrawn|0
1036620|NCT00120406|3375971|P2|Overall Study|received non-study stent|2
1036621|NCT00120406|3375972|P1|Overall Study|received non-study stent|0
1036622|NCT00120406|3375971|P2|Overall Study|Lost to Follow-up|2
1036623|NCT00120406|3375972|P1|Overall Study|Lost to Follow-up|5
1036624|NCT00120406|3375971|P2|Overall Study|Withdrawal by Subject|7
1036625|NCT00120406|3375972|P1|Overall Study|Withdrawal by Subject|5
1036626|NCT00120406|3375971|P2|Overall Study|Death|4
1036627|NCT00120406|3375972|P1|Overall Study|Death|9
1036628|NCT00120289|3375982|P2|Overall Study|Withdrawal by Subject|13
1036629|NCT00120289|3375983|P1|Overall Study|Withdrawal by Subject|14
1036630|NCT00120289|3375982|P2|Overall Study|Lost to Follow-up|14
1036631|NCT00120289|3375983|P1|Overall Study|Lost to Follow-up|11
1036632|NCT00120289|3375982|P2|Overall Study|Death|82
1036633|NCT00120289|3375983|P1|Overall Study|Death|96
1036634|NCT00120250|3375995|P2|Overall Study|Protocol Violation|1
1036635|NCT00120250|3375996|P1|Overall Study|Protocol Violation|0
1036636|NCT00120250|3375995|P2|Overall Study|Lost to Follow-up|1
1036637|NCT00120250|3375996|P1|Overall Study|Lost to Follow-up|1
1036638|NCT00120042|3376012|P3|Overall Study|all completed protocl|0
1036639|NCT00120042|3376013|P2|Overall Study|all completed protocl|0
1036640|NCT00120042|3376014|P1|Overall Study|all completed protocl|0
1036641|NCT00119678|3376037|P2|Open-label Treatment Period|Administrative reasons by sponsor|0
1036642|NCT00119678|3376038|P1|Open-label Treatment Period|Administrative reasons by sponsor|87
1036643|NCT00119678|3376037|P2|Open-label Treatment Period|Pregnancy|0
1036644|NCT00119678|3376038|P1|Open-label Treatment Period|Pregnancy|1
1036645|NCT00119678|3376037|P2|Open-label Treatment Period|Participants not meeting study criteria|0
1036646|NCT00119678|3376038|P1|Open-label Treatment Period|Participants not meeting study criteria|2
1036647|NCT00119678|3376037|P2|Open-label Treatment Period|Participant withdrew consent|0
1036648|NCT00119678|3376038|P1|Open-label Treatment Period|Participant withdrew consent|4
1036649|NCT00119678|3376037|P2|Open-label Treatment Period|Lost to Follow-up|0
1036650|NCT00119678|3376038|P1|Open-label Treatment Period|Lost to Follow-up|3
1036651|NCT00119678|3376037|P2|Open-label Treatment Period|Lack of Efficacy|0
1036652|NCT00119678|3376038|P1|Open-label Treatment Period|Lack of Efficacy|9
1036653|NCT00119678|3376037|P2|Open-label Treatment Period|Adverse Event|0
1036654|NCT00119678|3376038|P1|Open-label Treatment Period|Adverse Event|3
1036655|NCT00119678|3376037|P2|Open-label Treatment Period|Death|0
1036656|NCT00119678|3376038|P1|Open-label Treatment Period|Death|1
1036657|NCT00119678|3376037|P2|Double-blind Treatment Period|Site closed due to non-compliance|2
1036658|NCT00119678|3376038|P1|Double-blind Treatment Period|Site closed due to non-compliance|3
1036659|NCT00119678|3376037|P2|Double-blind Treatment Period|Not treated|2
1036660|NCT00119678|3376038|P1|Double-blind Treatment Period|Not treated|1
1036661|NCT00119678|3376037|P2|Double-blind Treatment Period|Pregnancy|2
1036662|NCT00119678|3376038|P1|Double-blind Treatment Period|Pregnancy|0
1036663|NCT00119678|3376037|P2|Double-blind Treatment Period|Poor/Non-compliance|0
1036664|NCT00119678|3376038|P1|Double-blind Treatment Period|Poor/Non-compliance|3
1036665|NCT00119678|3376037|P2|Double-blind Treatment Period|Participants not meeting study criteria|1
1036666|NCT00119678|3376038|P1|Double-blind Treatment Period|Participants not meeting study criteria|0
1036667|NCT00119678|3376037|P2|Double-blind Treatment Period|Participant withdrew consent|4
1036668|NCT00119678|3376038|P1|Double-blind Treatment Period|Participant withdrew consent|4
1036669|NCT00119678|3376037|P2|Double-blind Treatment Period|Lost to Follow-up|2
1036670|NCT00119678|3376038|P1|Double-blind Treatment Period|Lost to Follow-up|1
1036671|NCT00119678|3376037|P2|Double-blind Treatment Period|Lack of Efficacy|12
1036672|NCT00119678|3376038|P1|Double-blind Treatment Period|Lack of Efficacy|21
1036673|NCT00119678|3376037|P2|Double-blind Treatment Period|Adverse Event|1
1036674|NCT00119678|3376038|P1|Double-blind Treatment Period|Adverse Event|7
1036675|NCT00119678|3376037|P2|Double-blind Treatment Period|Death|0
1036676|NCT00119678|3376038|P1|Double-blind Treatment Period|Death|1
1036677|NCT00119405|3376084|P1|Overall Study|Withdrawal by Subject|1
1036678|NCT00119379|3376098|P2|Overall Study|Adverse Event|1
1036679|NCT00119379|3376099|P1|Overall Study|Adverse Event|4
1036680|NCT00119262|3376117|P2|Overall Study|others|5
1036681|NCT00119262|3376118|P1|Overall Study|others|0
1036682|NCT00119262|3376117|P2|Overall Study|ineligble|2
1036683|NCT00119262|3376118|P1|Overall Study|ineligble|1
1036684|NCT00119262|3376117|P2|Overall Study|other disease|2
1036685|NCT00119262|3376118|P1|Overall Study|other disease|0
1036686|NCT00119262|3376117|P2|Overall Study|Adverse Event|35
1036687|NCT00119262|3376118|P1|Overall Study|Adverse Event|33
1036688|NCT00119262|3376117|P2|Overall Study|Withdrawal by Subject|11
1036689|NCT00119262|3376118|P1|Overall Study|Withdrawal by Subject|12
1036690|NCT00119262|3376117|P2|Overall Study|Lack of Efficacy|3
1036691|NCT00119262|3376118|P1|Overall Study|Lack of Efficacy|0
1036692|NCT00119015|3376155|P3|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
1036693|NCT00119015|3376156|P2|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
1036694|NCT00119015|3376157|P1|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48
1036695|NCT00118911|3376173|P2|Overall Study|Withdrawal by Subject|5
1036696|NCT00118911|3376174|P1|Overall Study|Withdrawal by Subject|2
1036697|NCT00118898|3376186|P4|Overall Study|Not able to get to clinic|40
1036698|NCT00118898|3376187|P3|Overall Study|Not able to get to clinic|31
1036699|NCT00118898|3376188|P2|Overall Study|Not able to get to clinic|43
1036700|NCT00118898|3376189|P1|Overall Study|Not able to get to clinic|34
1036701|NCT00118898|3376186|P4|Overall Study|Not compliant with requirements|11
1036702|NCT00118898|3376187|P3|Overall Study|Not compliant with requirements|11
1036703|NCT00118898|3376188|P2|Overall Study|Not compliant with requirements|13
1036704|NCT00118898|3376189|P1|Overall Study|Not compliant with requirements|11
1036705|NCT00118898|3376186|P4|Overall Study|Severe debilitation|4
1036706|NCT00118898|3376187|P3|Overall Study|Severe debilitation|6
1036707|NCT00118898|3376188|P2|Overall Study|Severe debilitation|4
1036708|NCT00118898|3376189|P1|Overall Study|Severe debilitation|1
1036709|NCT00118898|3376186|P4|Overall Study|Site Closure|37
1036710|NCT00118898|3376187|P3|Overall Study|Site Closure|28
1036711|NCT00118898|3376188|P2|Overall Study|Site Closure|31
1036712|NCT00118898|3376189|P1|Overall Study|Site Closure|33
1036713|NCT00118898|3376186|P4|Overall Study|Withdrawal by Subject|8
1036714|NCT00118898|3376187|P3|Overall Study|Withdrawal by Subject|8
1036715|NCT00118898|3376188|P2|Overall Study|Withdrawal by Subject|5
1036716|NCT00118898|3376189|P1|Overall Study|Withdrawal by Subject|10
1036717|NCT00118898|3376186|P4|Overall Study|Lost to Follow-up|33
1036718|NCT00118898|3376187|P3|Overall Study|Lost to Follow-up|33
1036719|NCT00118898|3376188|P2|Overall Study|Lost to Follow-up|34
1036720|NCT00118898|3376189|P1|Overall Study|Lost to Follow-up|26
1036721|NCT00118898|3376186|P4|Overall Study|Death|8
1036722|NCT00118898|3376187|P3|Overall Study|Death|6
1036723|NCT00118898|3376188|P2|Overall Study|Death|11
1036724|NCT00118898|3376189|P1|Overall Study|Death|6
1036725|NCT00118703|3376315|P2|Overall Study|Lost to Follow-up|2
1036726|NCT00118703|3376316|P1|Overall Study|Lost to Follow-up|1
1036727|NCT00118703|3376315|P2|Overall Study|Withdrawal by Subject|5
1036728|NCT00118703|3376316|P1|Overall Study|Withdrawal by Subject|2
1036729|NCT00118703|3376315|P2|Overall Study|Participant took two different treatment|1
1036730|NCT00118703|3376316|P1|Overall Study|Participant took two different treatment|0
1036731|NCT00118703|3376315|P2|Overall Study|Adverse Event|1
1036732|NCT00118703|3376316|P1|Overall Study|Adverse Event|1
1036733|NCT00118703|3376315|P2|Overall Study|Protocol Violation|0
1036734|NCT00118703|3376316|P1|Overall Study|Protocol Violation|1
1036735|NCT00118482|3376413|P2|Overall Study|Withdrawal by Subject|22
1036736|NCT00118482|3376414|P1|Overall Study|Withdrawal by Subject|23
1036737|NCT00118482|3376413|P2|Overall Study|Lost to Follow-up|7
1036738|NCT00118482|3376414|P1|Overall Study|Lost to Follow-up|7
1036739|NCT00118430|3376425|P3|Overall Study|Lost to Follow-up|28
1036740|NCT00118430|3376426|P2|Overall Study|Lost to Follow-up|22
1036741|NCT00118430|3376427|P1|Overall Study|Lost to Follow-up|15
1036742|NCT00118430|3376425|P3|Overall Study|Withdrawal by Subject|0
1036743|NCT00118430|3376426|P2|Overall Study|Withdrawal by Subject|2
1036744|NCT00118430|3376427|P1|Overall Study|Withdrawal by Subject|6
1036745|NCT00118417|3376442|P2|Phase II (Weeks 6 to 12)|Remission|2
1036746|NCT00118417|3376443|P1|Phase II (Weeks 6 to 12)|Remission|1
1036747|NCT00118417|3376442|P2|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
1036748|NCT00118417|3376443|P1|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
1036749|NCT00118417|3376442|P2|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0
1036750|NCT00118417|3376443|P1|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4
1036751|NCT00118417|3376442|P2|Phase I (Weeks 0 to 6)|Lost to Follow-up|0
1036752|NCT00118417|3376443|P1|Phase I (Weeks 0 to 6)|Lost to Follow-up|6
1036753|NCT00118417|3376442|P2|Phase I (Weeks 0 to 6)|Remission|0
1036754|NCT00118417|3376443|P1|Phase I (Weeks 0 to 6)|Remission|8
1036755|NCT00118287|3376587|P1|Overall Study|Muscle pain|1
1036756|NCT00118287|3376587|P1|Overall Study|Intracranial haemorrhage|1
1036757|NCT00118157|3376607|P1|Overall Study|Withdrawal by Subject|2
1036758|NCT00118157|3376607|P1|Overall Study|Death|8
1036759|NCT00118157|3376607|P1|Overall Study|Adverse Event|2
1036760|NCT00118092|3376625|P1|Overall Study|Protocol Violation|1
1036761|NCT00118092|3376625|P1|Overall Study|Withdrawal by Subject|1
1036762|NCT00118040|3376643|P3|Overall Study|Other|1
1036763|NCT00118040|3376644|P2|Overall Study|Other|0
1036764|NCT00118040|3376645|P1|Overall Study|Other|0
1036765|NCT00118040|3376643|P3|Overall Study|Non-Compliant Participant|2
1036766|NCT00118040|3376644|P2|Overall Study|Non-Compliant Participant|1
1036767|NCT00118040|3376645|P1|Overall Study|Non-Compliant Participant|1
1036768|NCT00118040|3376643|P3|Overall Study|Medical Contraindication|1
1036769|NCT00118040|3376644|P2|Overall Study|Medical Contraindication|0
1036770|NCT00118040|3376645|P1|Overall Study|Medical Contraindication|0
1036771|NCT00118040|3376643|P3|Overall Study|Withdrawal by Subject|2
1036772|NCT00118040|3376644|P2|Overall Study|Withdrawal by Subject|0
1036773|NCT00118040|3376645|P1|Overall Study|Withdrawal by Subject|0
1036774|NCT00118040|3376643|P3|Overall Study|Adverse Event|0
1036775|NCT00118040|3376644|P2|Overall Study|Adverse Event|1
1036776|NCT00118040|3376645|P1|Overall Study|Adverse Event|0
1036777|NCT00117988|3376706|P1|Overall Study|Adverse Event|1
1036778|NCT00117988|3376706|P1|Overall Study|Death|3
1036779|NCT00117949|3376729|P4|Overall Study|Hepatic abnormalities|1
1036780|NCT00117949|3376730|P3|Overall Study|Hepatic abnormalities|0
1036781|NCT00117949|3376731|P2|Overall Study|Hepatic abnormalities|1
1036782|NCT00117949|3376732|P1|Overall Study|Hepatic abnormalities|0
1036783|NCT00117949|3376729|P4|Overall Study|PSA reduction <=50%|4
1036784|NCT00117949|3376730|P3|Overall Study|PSA reduction <=50%|2
1036785|NCT00117949|3376731|P2|Overall Study|PSA reduction <=50%|2
1036786|NCT00117949|3376732|P1|Overall Study|PSA reduction <=50%|0
1036787|NCT00117949|3376729|P4|Overall Study|PSA increase >=10ng/mL|0
1036788|NCT00117949|3376730|P3|Overall Study|PSA increase >=10ng/mL|1
1036789|NCT00117949|3376731|P2|Overall Study|PSA increase >=10ng/mL|1
1036790|NCT00117949|3376732|P1|Overall Study|PSA increase >=10ng/mL|0
1036791|NCT00117949|3376729|P4|Overall Study|Prostate-specific antigen increase >=25%|2
1036792|NCT00117949|3376730|P3|Overall Study|Prostate-specific antigen increase >=25%|1
1036793|NCT00117949|3376731|P2|Overall Study|Prostate-specific antigen increase >=25%|1
1036794|NCT00117949|3376732|P1|Overall Study|Prostate-specific antigen increase >=25%|0
1036795|NCT00117949|3376729|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
1036796|NCT00117949|3376730|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
1036797|NCT00117949|3376731|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
1036798|NCT00117949|3376732|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
1036799|NCT00117949|3376729|P4|Overall Study|Testosterone >1.0 ng/mL|15
1036800|NCT00117949|3376730|P3|Overall Study|Testosterone >1.0 ng/mL|17
1036801|NCT00117949|3376731|P2|Overall Study|Testosterone >1.0 ng/mL|18
1036802|NCT00117949|3376732|P1|Overall Study|Testosterone >1.0 ng/mL|10
1036803|NCT00117845|3376766|P1|Overall Study|stopped treatment/drug supplyinterrupted|1
1036804|NCT00117793|3376784|P1|Overall Study|Withdrawal by Subject|12
1036805|NCT00117676|3376807|P2|Open-label Period: Weeks 433 - 480|Withdrew Consent|1
1036806|NCT00117676|3376808|P1|Open-label Period: Weeks 433 - 480|Withdrew Consent|0
1036807|NCT00117676|3376807|P2|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
1036808|NCT00117676|3376808|P1|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
1036809|NCT00117676|3376807|P2|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0
1036810|NCT00117676|3376808|P1|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1
1036811|NCT00117676|3376807|P2|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1
1036812|NCT00117676|3376808|P1|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0
1036813|NCT00117676|3376807|P2|Open-label Period: Weeks 385 - 432|Investigator’s Discretion|1
1036814|NCT00117676|3376808|P1|Open-label Period: Weeks 385 - 432|Investigator’s Discretion|0
1036815|NCT00117676|3376807|P2|Open-label Period: Weeks 337 - 384|Withdrew Consent|1
1036816|NCT00117676|3376808|P1|Open-label Period: Weeks 337 - 384|Withdrew Consent|2
1036817|NCT00117676|3376807|P2|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0
1036818|NCT00117676|3376808|P1|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1
1036819|NCT00117676|3376807|P2|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1
1036820|NCT00117676|3376808|P1|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3
1036821|NCT00117676|3376807|P2|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
1036822|NCT00117676|3376808|P1|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
1036823|NCT00117676|3376807|P2|Open-label Period: Weeks 289 - 336|Withdrew Consent|1
1036824|NCT00117676|3376808|P1|Open-label Period: Weeks 289 - 336|Withdrew Consent|0
1036825|NCT00117676|3376807|P2|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
1036826|NCT00117676|3376808|P1|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
1036827|NCT00117676|3376807|P2|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4
1036828|NCT00117676|3376808|P1|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7
1036829|NCT00117676|3376807|P2|Open-label Period: Weeks 241 - 288|Withdrew Consent|1
1036830|NCT00117676|3376808|P1|Open-label Period: Weeks 241 - 288|Withdrew Consent|5
1036831|NCT00117676|3376807|P2|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
1036832|NCT00117676|3376808|P1|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1
1036833|NCT00117676|3376807|P2|Open-label Period: Weeks 241 - 288|Protocol Violation|0
1036834|NCT00117676|3376808|P1|Open-label Period: Weeks 241 - 288|Protocol Violation|2
1036835|NCT00117676|3376807|P2|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1
1036836|NCT00117676|3376808|P1|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2
1036837|NCT00117676|3376807|P2|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1
1036838|NCT00117676|3376808|P1|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0
1036839|NCT00117676|3376807|P2|Open-label Period: Weeks 193 - 240|Withdrew Consent|1
1036840|NCT00117676|3376808|P1|Open-label Period: Weeks 193 - 240|Withdrew Consent|4
1036841|NCT00117676|3376807|P2|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0
1036842|NCT00117676|3376808|P1|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
1036843|NCT00117676|3376807|P2|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1
1036844|NCT00117676|3376808|P1|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0
1036845|NCT00117676|3376807|P2|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
1036846|NCT00117676|3376808|P1|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
1036847|NCT00117676|3376807|P2|Open-label Period: Weeks 145 - 192|Withdrew Consent|2
1036848|NCT00117676|3376808|P1|Open-label Period: Weeks 145 - 192|Withdrew Consent|5
1036849|NCT00117676|3376807|P2|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1
1036850|NCT00117676|3376808|P1|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3
1036851|NCT00117676|3376807|P2|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0
1036852|NCT00117676|3376808|P1|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2
1036853|NCT00117676|3376807|P2|Open-label Period: Weeks 97 - 144|Withdrew Consent|0
1036854|NCT00117676|3376808|P1|Open-label Period: Weeks 97 - 144|Withdrew Consent|1
1036855|NCT00117676|3376807|P2|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0
1036856|NCT00117676|3376808|P1|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1
1036857|NCT00117676|3376807|P2|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1
1036858|NCT00117676|3376808|P1|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4
1036859|NCT00117676|3376807|P2|Open-label Period: Weeks 49 - 96|Withdrew Consent|1
1036860|NCT00117676|3376808|P1|Open-label Period: Weeks 49 - 96|Withdrew Consent|5
1036861|NCT00117676|3376807|P2|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
1036862|NCT00117676|3376808|P1|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3
1036863|NCT00117676|3376807|P2|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0
1036864|NCT00117676|3376808|P1|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2
1036865|NCT00117676|3376807|P2|Double-blind Period Through Week 48|Withdrew Consent|1
1036866|NCT00117676|3376808|P1|Double-blind Period Through Week 48|Withdrew Consent|0
1036867|NCT00117676|3376807|P2|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2
1036868|NCT00117676|3376808|P1|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5
1036869|NCT00117676|3376807|P2|Double-blind Period Through Week 48|Protocol Violation|1
1036870|NCT00117676|3376808|P1|Double-blind Period Through Week 48|Protocol Violation|0
1036871|NCT00117676|3376807|P2|Double-blind Period Through Week 48|Lost to Follow-up|0
1036872|NCT00117676|3376808|P1|Double-blind Period Through Week 48|Lost to Follow-up|1
1036873|NCT00117676|3376807|P2|Double-blind Period Through Week 48|Randomized but Not Treated|3
1036874|NCT00117676|3376808|P1|Double-blind Period Through Week 48|Randomized but Not Treated|4
1036875|NCT00117637|3376897|P2|Second Intervention (Period 2)|reason not reported|0
1036876|NCT00117637|3376898|P1|Second Intervention (Period 2)|reason not reported|1
1036877|NCT00117637|3376897|P2|Second Intervention (Period 2)|non compliant with study medication|1
1036878|NCT00117637|3376898|P1|Second Intervention (Period 2)|non compliant with study medication|1
1036879|NCT00117637|3376897|P2|Second Intervention (Period 2)|study terminated by the sponsor|9
1036880|NCT00117637|3376898|P1|Second Intervention (Period 2)|study terminated by the sponsor|2
1036881|NCT00117637|3376897|P2|Second Intervention (Period 2)|Withdrawal by Subject|3
1036882|NCT00117637|3376898|P1|Second Intervention (Period 2)|Withdrawal by Subject|4
1036883|NCT00117637|3376897|P2|Second Intervention (Period 2)|Protocol Violation|0
1036884|NCT00117637|3376898|P1|Second Intervention (Period 2)|Protocol Violation|1
1036885|NCT00117637|3376897|P2|Second Intervention (Period 2)|Lost to Follow-up|0
1036886|NCT00117637|3376898|P1|Second Intervention (Period 2)|Lost to Follow-up|1
1036887|NCT00117637|3376897|P2|Second Intervention (Period 2)|Adverse Event|9
1036888|NCT00117637|3376898|P1|Second Intervention (Period 2)|Adverse Event|0
1036889|NCT00117637|3376897|P2|First Intervention (Period 1)|reason not reported|1
1036890|NCT00117637|3376898|P1|First Intervention (Period 1)|reason not reported|0
1036891|NCT00117637|3376897|P2|First Intervention (Period 1)|investig. decision, not protocol driven|1
1036892|NCT00117637|3376898|P1|First Intervention (Period 1)|investig. decision, not protocol driven|0
1036893|NCT00117637|3376897|P2|First Intervention (Period 1)|protocol driven decision point|0
1036894|NCT00117637|3376898|P1|First Intervention (Period 1)|protocol driven decision point|1
1036895|NCT00117637|3376897|P2|First Intervention (Period 1)|study terminated by the sponsor|1
1036896|NCT00117637|3376898|P1|First Intervention (Period 1)|study terminated by the sponsor|3
1036897|NCT00117637|3376897|P2|First Intervention (Period 1)|Withdrawal by Subject|4
1036898|NCT00117637|3376898|P1|First Intervention (Period 1)|Withdrawal by Subject|2
1036899|NCT00117637|3376897|P2|First Intervention (Period 1)|Protocol Violation|0
1036900|NCT00117637|3376898|P1|First Intervention (Period 1)|Protocol Violation|1
1036901|NCT00117637|3376897|P2|First Intervention (Period 1)|Lost to Follow-up|2
1036902|NCT00117637|3376898|P1|First Intervention (Period 1)|Lost to Follow-up|0
1036903|NCT00117637|3376897|P2|First Intervention (Period 1)|Adverse Event|16
1036904|NCT00117637|3376898|P1|First Intervention (Period 1)|Adverse Event|11
1036905|NCT00117598|3376973|P5|After Treament Cross Over|Other|2
1036906|NCT00117598|3376974|P4|After Treament Cross Over|Other|1
1036907|NCT00117598|3376975|P3|After Treament Cross Over|Other|0
1036908|NCT00117598|3376976|P2|After Treament Cross Over|Other|0
1036909|NCT00117598|3376977|P1|After Treament Cross Over|Other|0
1036910|NCT00117598|3376973|P5|After Treament Cross Over|Withdrawal by Subject|0
1036911|NCT00117598|3376974|P4|After Treament Cross Over|Withdrawal by Subject|1
1036912|NCT00117598|3376975|P3|After Treament Cross Over|Withdrawal by Subject|0
1036913|NCT00117598|3376976|P2|After Treament Cross Over|Withdrawal by Subject|0
1036914|NCT00117598|3376977|P1|After Treament Cross Over|Withdrawal by Subject|0
1036915|NCT00117598|3376973|P5|After Treament Cross Over|Death|2
1036916|NCT00117598|3376974|P4|After Treament Cross Over|Death|1
1036917|NCT00117598|3376975|P3|After Treament Cross Over|Death|0
1036918|NCT00117598|3376976|P2|After Treament Cross Over|Death|0
1036919|NCT00117598|3376977|P1|After Treament Cross Over|Death|0
1036920|NCT00117598|3376973|P5|Prior to Treatment Cross Over|Other|0
1036921|NCT00117598|3376974|P4|Prior to Treatment Cross Over|Other|0
1036922|NCT00117598|3376975|P3|Prior to Treatment Cross Over|Other|9
1036923|NCT00117598|3376976|P2|Prior to Treatment Cross Over|Other|9
1036924|NCT00117598|3376977|P1|Prior to Treatment Cross Over|Other|15
1036925|NCT00117598|3376973|P5|Prior to Treatment Cross Over|Withdrawal by Subject|0
1036926|NCT00117598|3376974|P4|Prior to Treatment Cross Over|Withdrawal by Subject|0
1036927|NCT00117598|3376975|P3|Prior to Treatment Cross Over|Withdrawal by Subject|4
1036928|NCT00117598|3376976|P2|Prior to Treatment Cross Over|Withdrawal by Subject|1
1036929|NCT00117598|3376977|P1|Prior to Treatment Cross Over|Withdrawal by Subject|2
1036930|NCT00117598|3376973|P5|Prior to Treatment Cross Over|Lost to Follow-up|0
1036931|NCT00117598|3376974|P4|Prior to Treatment Cross Over|Lost to Follow-up|0
1036932|NCT00117598|3376975|P3|Prior to Treatment Cross Over|Lost to Follow-up|2
1036933|NCT00117598|3376976|P2|Prior to Treatment Cross Over|Lost to Follow-up|2
1036934|NCT00117598|3376977|P1|Prior to Treatment Cross Over|Lost to Follow-up|0
1036935|NCT00117598|3376973|P5|Prior to Treatment Cross Over|Death|0
1036936|NCT00117598|3376974|P4|Prior to Treatment Cross Over|Death|0
1036937|NCT00117598|3376975|P3|Prior to Treatment Cross Over|Death|37
1036938|NCT00117598|3376976|P2|Prior to Treatment Cross Over|Death|41
1036939|NCT00117598|3376977|P1|Prior to Treatment Cross Over|Death|40
1036940|NCT00117572|3377011|P2|Overall Study|Protocol Violation|0
1036941|NCT00117572|3377012|P1|Overall Study|Protocol Violation|1
1036942|NCT00117572|3377011|P2|Overall Study|Withdrawal by Subject|3
1036943|NCT00117572|3377012|P1|Overall Study|Withdrawal by Subject|3
1036944|NCT00117572|3377011|P2|Overall Study|Site withdrew before starting treatment|3
1036945|NCT00117572|3377012|P1|Overall Study|Site withdrew before starting treatment|2
1036946|NCT00117338|3377053|P2|Overall Study|Lack of Efficacy|1
1036947|NCT00117338|3377054|P1|Overall Study|Lack of Efficacy|0
1036948|NCT00117338|3377053|P2|Overall Study|Did not meet Inclusion Criteria|0
1036949|NCT00117338|3377054|P1|Overall Study|Did not meet Inclusion Criteria|1
1036950|NCT00117338|3377053|P2|Overall Study|Withdrawal by Subject|0
1036951|NCT00117338|3377054|P1|Overall Study|Withdrawal by Subject|1
1036952|NCT00117338|3377053|P2|Overall Study|Protocol Violation|2
1036953|NCT00117338|3377054|P1|Overall Study|Protocol Violation|3
1036954|NCT00117338|3377053|P2|Overall Study|Adverse Event|1
1036955|NCT00117338|3377054|P1|Overall Study|Adverse Event|0
1036956|NCT00117325|3377074|P2|Overall Study|Admisnitrative|0
1036957|NCT00117325|3377075|P1|Overall Study|Admisnitrative|1
1036958|NCT00117325|3377074|P2|Overall Study|Early termination|1
1036959|NCT00117325|3377075|P1|Overall Study|Early termination|1
1036960|NCT00117325|3377074|P2|Overall Study|Use of prohibited medicine|2
1036961|NCT00117325|3377075|P1|Overall Study|Use of prohibited medicine|1
1036962|NCT00117325|3377074|P2|Overall Study|Lack of Efficacy|0
1036963|NCT00117325|3377075|P1|Overall Study|Lack of Efficacy|1
1036964|NCT00117325|3377074|P2|Overall Study|Withdrawal by Subject|2
1036965|NCT00117325|3377075|P1|Overall Study|Withdrawal by Subject|3
1036966|NCT00117325|3377074|P2|Overall Study|Protocol Violation|3
1036967|NCT00117325|3377075|P1|Overall Study|Protocol Violation|2
1036968|NCT00117325|3377074|P2|Overall Study|Lost to Follow-up|1
1036969|NCT00117325|3377075|P1|Overall Study|Lost to Follow-up|1
1036970|NCT00117325|3377074|P2|Overall Study|Adverse Event|3
1036971|NCT00117325|3377075|P1|Overall Study|Adverse Event|3
1036972|NCT00117312|3377107|P4|Overall Study|Withdrawal by Subject|0
1036973|NCT00117312|3377108|P3|Overall Study|Withdrawal by Subject|0
1036974|NCT00117312|3377109|P2|Overall Study|Withdrawal by Subject|2
1036975|NCT00117312|3377110|P1|Overall Study|Withdrawal by Subject|0
1036976|NCT00117312|3377107|P4|Overall Study|Hepatic abnormality|1
1036977|NCT00117312|3377108|P3|Overall Study|Hepatic abnormality|0
1036978|NCT00117312|3377109|P2|Overall Study|Hepatic abnormality|1
1036979|NCT00117312|3377110|P1|Overall Study|Hepatic abnormality|0
1036980|NCT00117312|3377107|P4|Overall Study|PSA increase >= 10ng/mL|0
1036981|NCT00117312|3377108|P3|Overall Study|PSA increase >= 10ng/mL|1
1036982|NCT00117312|3377109|P2|Overall Study|PSA increase >= 10ng/mL|1
1036983|NCT00117312|3377110|P1|Overall Study|PSA increase >= 10ng/mL|0
1036984|NCT00117312|3377107|P4|Overall Study|PSA decrease <=50%|4
1036985|NCT00117312|3377108|P3|Overall Study|PSA decrease <=50%|2
1036986|NCT00117312|3377109|P2|Overall Study|PSA decrease <=50%|2
1036987|NCT00117312|3377110|P1|Overall Study|PSA decrease <=50%|0
1036988|NCT00117312|3377107|P4|Overall Study|Protocol Violation|0
1036989|NCT00117312|3377108|P3|Overall Study|Protocol Violation|3
1036990|NCT00117312|3377109|P2|Overall Study|Protocol Violation|1
1036991|NCT00117312|3377110|P1|Overall Study|Protocol Violation|0
1036992|NCT00117312|3377107|P4|Overall Study|Adverse Event|0
1036993|NCT00117312|3377108|P3|Overall Study|Adverse Event|0
1036994|NCT00117312|3377109|P2|Overall Study|Adverse Event|2
1036995|NCT00117312|3377110|P1|Overall Study|Adverse Event|0
1036996|NCT00117312|3377107|P4|Overall Study|Patient choice|1
1036997|NCT00117312|3377108|P3|Overall Study|Patient choice|2
1036998|NCT00117312|3377109|P2|Overall Study|Patient choice|0
1036999|NCT00117312|3377110|P1|Overall Study|Patient choice|0
1037000|NCT00117312|3377107|P4|Overall Study|Not specified|1
1037001|NCT00117312|3377108|P3|Overall Study|Not specified|3
1037002|NCT00117312|3377109|P2|Overall Study|Not specified|1
1037003|NCT00117312|3377110|P1|Overall Study|Not specified|0
1037004|NCT00117312|3377107|P4|Overall Study|Prostate-specific antigen increase >=25%|3
1037005|NCT00117312|3377108|P3|Overall Study|Prostate-specific antigen increase >=25%|5
1037006|NCT00117312|3377109|P2|Overall Study|Prostate-specific antigen increase >=25%|1
1037007|NCT00117312|3377110|P1|Overall Study|Prostate-specific antigen increase >=25%|0
1037008|NCT00117312|3377107|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
1037009|NCT00117312|3377108|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
1037010|NCT00117312|3377109|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
1037011|NCT00117312|3377110|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
1037012|NCT00117312|3377107|P4|Overall Study|Testosterone >1.0 ng/mL|9
1037013|NCT00117312|3377108|P3|Overall Study|Testosterone >1.0 ng/mL|5
1037014|NCT00117312|3377109|P2|Overall Study|Testosterone >1.0 ng/mL|9
1037015|NCT00117312|3377110|P1|Overall Study|Testosterone >1.0 ng/mL|9
1037016|NCT00117286|3377126|P2|Overall Study|Research site closing|2
1037017|NCT00117286|3377127|P1|Overall Study|Research site closing|0
1037018|NCT00117286|3377126|P2|Overall Study|Lack of Efficacy|1
1037019|NCT00117286|3377127|P1|Overall Study|Lack of Efficacy|2
1037020|NCT00117286|3377126|P2|Overall Study|Physician Decision|7
1037021|NCT00117286|3377127|P1|Overall Study|Physician Decision|3
1037022|NCT00117286|3377126|P2|Overall Study|Withdrawal by Subject|2
1037023|NCT00117286|3377127|P1|Overall Study|Withdrawal by Subject|6
1037024|NCT00117286|3377126|P2|Overall Study|Protocol Violation|3
1037025|NCT00117286|3377127|P1|Overall Study|Protocol Violation|3
1037026|NCT00117286|3377126|P2|Overall Study|Lost to Follow-up|0
1037027|NCT00117286|3377127|P1|Overall Study|Lost to Follow-up|2
1037028|NCT00117286|3377126|P2|Overall Study|Adverse Event|6
1037029|NCT00117286|3377127|P1|Overall Study|Adverse Event|12
1037030|NCT00117156|3377135|P1|Overall Study|Trt for Pre-Exist Second Primary|1
1037031|NCT00117156|3377135|P1|Overall Study|Physician Decision|1
1037032|NCT00117156|3377135|P1|Overall Study|Adverse Event|9
1037033|NCT00116844|3377154|P2|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
1037034|NCT00116844|3377155|P1|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
1037035|NCT00116844|3377154|P2|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1
1037036|NCT00116844|3377155|P1|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0
1037037|NCT00116844|3377154|P2|Period 1: Treatment Period 2 (60 Days)|Other|2
1037038|NCT00116844|3377155|P1|Period 1: Treatment Period 2 (60 Days)|Other|0
1037039|NCT00116844|3377154|P2|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1
1037040|NCT00116844|3377155|P1|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2
1037041|NCT00116844|3377154|P2|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0
1037042|NCT00116844|3377155|P1|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1
1037043|NCT00116844|3377154|P2|Period 1: Treatment Period 1 (60 Days)|Other|1
1037044|NCT00116844|3377155|P1|Period 1: Treatment Period 1 (60 Days)|Other|1
1037045|NCT00116844|3377154|P2|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0
1037046|NCT00116844|3377155|P1|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5
1037047|NCT00116844|3377154|P2|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1
1037048|NCT00116844|3377155|P1|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0
1037049|NCT00116844|3377154|P2|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
1037050|NCT00116844|3377155|P1|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
1037051|NCT00116831|3377173|P2|Overall Study|Missing data for participant|0
1037052|NCT00116831|3377174|P1|Overall Study|Missing data for participant|1
1037053|NCT00116831|3377173|P2|Overall Study|Insufficient therapeutic effect|1
1037054|NCT00116831|3377174|P1|Overall Study|Insufficient therapeutic effect|0
1037055|NCT00116831|3377173|P2|Overall Study|Withdrawal by Subject|32
1037056|NCT00116831|3377174|P1|Overall Study|Withdrawal by Subject|32
1037057|NCT00116831|3377173|P2|Overall Study|Withdrawn investigational product|0
1037058|NCT00116831|3377174|P1|Overall Study|Withdrawn investigational product|1
1037059|NCT00116831|3377173|P2|Overall Study|Low haemoglobin on screening|0
1037060|NCT00116831|3377174|P1|Overall Study|Low haemoglobin on screening|1
1037061|NCT00116831|3377173|P2|Overall Study|Hypoglycaemic events|0
1037062|NCT00116831|3377174|P1|Overall Study|Hypoglycaemic events|1
1037063|NCT00116831|3377173|P2|Overall Study|Protocol Violation|6
1037064|NCT00116831|3377174|P1|Overall Study|Protocol Violation|3
1037065|NCT00116831|3377173|P2|Overall Study|Lost to Follow-up|6
1037066|NCT00116831|3377174|P1|Overall Study|Lost to Follow-up|8
1037067|NCT00116831|3377173|P2|Overall Study|Baseline IVUS determined unevaluable|11
1037068|NCT00116831|3377174|P1|Overall Study|Baseline IVUS determined unevaluable|12
1037069|NCT00116831|3377173|P2|Overall Study|Adverse Event|16
1037070|NCT00116831|3377174|P1|Overall Study|Adverse Event|14
1037071|NCT00116805|3377252|P2|Open-label Period Weeks 433 - 480|Withdrew Consent|0
1037072|NCT00116805|3377253|P1|Open-label Period Weeks 433 - 480|Withdrew Consent|3
1037073|NCT00116805|3377252|P2|Open-label Period Weeks 433 - 480|Investigator’s Discretion|0
1037074|NCT00116805|3377253|P1|Open-label Period Weeks 433 - 480|Investigator’s Discretion|1
1037075|NCT00116805|3377252|P2|Open-label Period Weeks 385 - 432|Withdrew Consent|0
1037076|NCT00116805|3377253|P1|Open-label Period Weeks 385 - 432|Withdrew Consent|1
1037077|NCT00116805|3377252|P2|Open-label Period Weeks 385 - 432|Investigator’s Discretion|0
1037078|NCT00116805|3377253|P1|Open-label Period Weeks 385 - 432|Investigator’s Discretion|1
1037079|NCT00116805|3377252|P2|Open-label Period Weeks 337 - 384|Withdrew Consent|1
1037080|NCT00116805|3377253|P1|Open-label Period Weeks 337 - 384|Withdrew Consent|3
1037081|NCT00116805|3377252|P2|Open-label Period Weeks 337 - 384|Protocol Violation|0
1037082|NCT00116805|3377253|P1|Open-label Period Weeks 337 - 384|Protocol Violation|1
1037083|NCT00116805|3377252|P2|Open-label Period Weeks 337 - 384|Lost to Follow-up|0
1037084|NCT00116805|3377253|P1|Open-label Period Weeks 337 - 384|Lost to Follow-up|2
1037085|NCT00116805|3377252|P2|Open-label Period Weeks 337 - 384|Investigator's Discretion|0
1037086|NCT00116805|3377253|P1|Open-label Period Weeks 337 - 384|Investigator's Discretion|1
1037087|NCT00116805|3377252|P2|Open-label Period Weeks 337 - 384|Completed Study|0
1037088|NCT00116805|3377253|P1|Open-label Period Weeks 337 - 384|Completed Study|1
1037089|NCT00116805|3377252|P2|Open-label Period Weeks 289 - 336|Withdrew Consent|0
1037090|NCT00116805|3377253|P1|Open-label Period Weeks 289 - 336|Withdrew Consent|2
1037091|NCT00116805|3377252|P2|Open-label Period Weeks 289 - 336|Study Site Discontinued|1
1037092|NCT00116805|3377253|P1|Open-label Period Weeks 289 - 336|Study Site Discontinued|0
1037093|NCT00116805|3377252|P2|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1
1037094|NCT00116805|3377253|P1|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0
1037095|NCT00116805|3377252|P2|Open-label Period Weeks 289 - 336|Protocol Violation|1
1037096|NCT00116805|3377253|P1|Open-label Period Weeks 289 - 336|Protocol Violation|0
1037097|NCT00116805|3377252|P2|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
1037098|NCT00116805|3377253|P1|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
1037099|NCT00116805|3377252|P2|Open-label Period Weeks 289 - 336|Investigator's Discretion|2
1037100|NCT00116805|3377253|P1|Open-label Period Weeks 289 - 336|Investigator's Discretion|3
1037101|NCT00116805|3377252|P2|Open-label Period Weeks 289 - 336|Completed Study|1
1037102|NCT00116805|3377253|P1|Open-label Period Weeks 289 - 336|Completed Study|0
1037103|NCT00116805|3377252|P2|Open-label Period Weeks 241 - 288|Withdrew Consent|0
1037104|NCT00116805|3377253|P1|Open-label Period Weeks 241 - 288|Withdrew Consent|4
1037105|NCT00116805|3377252|P2|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
1037106|NCT00116805|3377253|P1|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2
1037107|NCT00116805|3377252|P2|Open-label Period Weeks 193 - 240|Withdrew Consent|1
1037108|NCT00116805|3377253|P1|Open-label Period Weeks 193 - 240|Withdrew Consent|7
1037109|NCT00116805|3377252|P2|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
1037110|NCT00116805|3377253|P1|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
1037111|NCT00116805|3377252|P2|Open-label Period Weeks 193 - 240|Lost to Follow-up|0
1037112|NCT00116805|3377253|P1|Open-label Period Weeks 193 - 240|Lost to Follow-up|3
1037113|NCT00116805|3377252|P2|Open-label Period Weeks 193 - 240|Investigator's Discretion|0
1037114|NCT00116805|3377253|P1|Open-label Period Weeks 193 - 240|Investigator's Discretion|1
1037115|NCT00116805|3377252|P2|Open-label Period Weeks 193 - 240|Completed Study|1
1037116|NCT00116805|3377253|P1|Open-label Period Weeks 193 - 240|Completed Study|0
1037117|NCT00116805|3377252|P2|Open-label Period Weeks 145 - 192|Withdrew Consent|2
1037118|NCT00116805|3377253|P1|Open-label Period Weeks 145 - 192|Withdrew Consent|3
1037119|NCT00116805|3377252|P2|Open-label Period Weeks 145 - 192|Seroconversion|1
1037120|NCT00116805|3377253|P1|Open-label Period Weeks 145 - 192|Seroconversion|0
1037121|NCT00116805|3377252|P2|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1
1037122|NCT00116805|3377253|P1|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0
1037123|NCT00116805|3377252|P2|Open-label Period Weeks 145 - 192|Protocol Violation|0
1037124|NCT00116805|3377253|P1|Open-label Period Weeks 145 - 192|Protocol Violation|1
1037125|NCT00116805|3377252|P2|Open-label Period Weeks 145 - 192|Lost to Follow-up|1
1037126|NCT00116805|3377253|P1|Open-label Period Weeks 145 - 192|Lost to Follow-up|3
1037127|NCT00116805|3377252|P2|Open-label Period Weeks 145 - 192|Investigator's Discretion|0
1037128|NCT00116805|3377253|P1|Open-label Period Weeks 145 - 192|Investigator's Discretion|2
1037129|NCT00116805|3377252|P2|Open-label Period Weeks 145 - 192|Completed Study|1
1037130|NCT00116805|3377253|P1|Open-label Period Weeks 145 - 192|Completed Study|1
1037131|NCT00116805|3377252|P2|Open-label Period Weeks 97 - 144|Withdrew Consent|3
1037132|NCT00116805|3377253|P1|Open-label Period Weeks 97 - 144|Withdrew Consent|1
1037133|NCT00116805|3377252|P2|Open-label Period Weeks 97 - 144|Seroconversion|3
1037134|NCT00116805|3377253|P1|Open-label Period Weeks 97 - 144|Seroconversion|2
1037135|NCT00116805|3377252|P2|Open-label Period Weeks 97 - 144|Protocol Violation|1
1037136|NCT00116805|3377253|P1|Open-label Period Weeks 97 - 144|Protocol Violation|0
1037137|NCT00116805|3377252|P2|Open-label Period Weeks 97 - 144|Lost to Follow-up|2
1037138|NCT00116805|3377253|P1|Open-label Period Weeks 97 - 144|Lost to Follow-up|5
1037139|NCT00116805|3377252|P2|Open-label Period Weeks 97 - 144|Investigator's Discretion|0
1037140|NCT00116805|3377253|P1|Open-label Period Weeks 97 - 144|Investigator's Discretion|2
1037141|NCT00116805|3377252|P2|Open-label Period Weeks 97 - 144|Completed Study|0
1037142|NCT00116805|3377253|P1|Open-label Period Weeks 97 - 144|Completed Study|1
1037143|NCT00116805|3377252|P2|Open-label Period Weeks 49 - 96|Withdrew Consent|1
1037144|NCT00116805|3377253|P1|Open-label Period Weeks 49 - 96|Withdrew Consent|2
1037145|NCT00116805|3377252|P2|Open-label Period Weeks 49 - 96|Seroconversion|0
1037146|NCT00116805|3377253|P1|Open-label Period Weeks 49 - 96|Seroconversion|2
1037147|NCT00116805|3377252|P2|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0
1037148|NCT00116805|3377253|P1|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
1037149|NCT00116805|3377252|P2|Open-label Period Weeks 49 - 96|Protocol Violation|0
1037150|NCT00116805|3377253|P1|Open-label Period Weeks 49 - 96|Protocol Violation|2
1037151|NCT00116805|3377252|P2|Open-label Period Weeks 49 - 96|Lost to Follow-up|0
1037152|NCT00116805|3377253|P1|Open-label Period Weeks 49 - 96|Lost to Follow-up|2
1037153|NCT00116805|3377252|P2|Open-label Period Weeks 49 - 96|Investigator's Discretion|0
1037154|NCT00116805|3377253|P1|Open-label Period Weeks 49 - 96|Investigator's Discretion|1
1037155|NCT00116805|3377252|P2|Double-blind Period Through Week 48|Withdrew Consent|2
1037156|NCT00116805|3377253|P1|Double-blind Period Through Week 48|Withdrew Consent|4
1037157|NCT00116805|3377252|P2|Double-blind Period Through Week 48|Protocol Violation|1
1037158|NCT00116805|3377253|P1|Double-blind Period Through Week 48|Protocol Violation|1
1037159|NCT00116805|3377252|P2|Double-blind Period Through Week 48|Lost to Follow-up|2
1037160|NCT00116805|3377253|P1|Double-blind Period Through Week 48|Lost to Follow-up|6
1037161|NCT00116779|3377346|P2|Overall Study|Elevated PSA levels|2
1037162|NCT00116779|3377347|P1|Overall Study|Elevated PSA levels|2
1037163|NCT00116779|3377346|P2|Overall Study|Physician Decision|1
1037164|NCT00116779|3377347|P1|Overall Study|Physician Decision|3
1037165|NCT00116779|3377346|P2|Overall Study|Inadequate testosterone suppression|9
1037166|NCT00116779|3377347|P1|Overall Study|Inadequate testosterone suppression|7
1037167|NCT00116779|3377346|P2|Overall Study|Withdrawal by Subject|1
1037168|NCT00116779|3377347|P1|Overall Study|Withdrawal by Subject|4
1037169|NCT00116779|3377346|P2|Overall Study|Protocol Violation|4
1037170|NCT00116779|3377347|P1|Overall Study|Protocol Violation|1
1037171|NCT00116779|3377346|P2|Overall Study|Adverse Event|2
1037172|NCT00116779|3377347|P1|Overall Study|Adverse Event|4
1037173|NCT00116753|3377380|P3|Overall Study|Dosing Error|0
1037174|NCT00116753|3377381|P2|Overall Study|Dosing Error|1
1037175|NCT00116753|3377382|P1|Overall Study|Dosing Error|0
1037176|NCT00116753|3377380|P3|Overall Study|Progressive Parkinson's Disease|0
1037177|NCT00116753|3377381|P2|Overall Study|Progressive Parkinson's Disease|0
1037178|NCT00116753|3377382|P1|Overall Study|Progressive Parkinson's Disease|1
1037179|NCT00116753|3377380|P3|Overall Study|Abnormal Echocardiogram|1
1037180|NCT00116753|3377381|P2|Overall Study|Abnormal Echocardiogram|0
1037181|NCT00116753|3377382|P1|Overall Study|Abnormal Echocardiogram|0
1037182|NCT00116753|3377380|P3|Overall Study|Disease Progression|3
1037183|NCT00116753|3377381|P2|Overall Study|Disease Progression|4
1037184|NCT00116753|3377382|P1|Overall Study|Disease Progression|3
1037185|NCT00116753|3377380|P3|Overall Study|Did not Fulfil Eligibility Criteria|3
1037186|NCT00116753|3377381|P2|Overall Study|Did not Fulfil Eligibility Criteria|1
1037187|NCT00116753|3377382|P1|Overall Study|Did not Fulfil Eligibility Criteria|1
1037188|NCT00116753|3377380|P3|Overall Study|Protocol Violation|1
1037189|NCT00116753|3377381|P2|Overall Study|Protocol Violation|0
1037190|NCT00116753|3377382|P1|Overall Study|Protocol Violation|0
1037191|NCT00116753|3377380|P3|Overall Study|Lost to Follow-up|1
1037192|NCT00116753|3377381|P2|Overall Study|Lost to Follow-up|2
1037193|NCT00116753|3377382|P1|Overall Study|Lost to Follow-up|0
1037194|NCT00116753|3377380|P3|Overall Study|Withdrawal by Subject|8
1037195|NCT00116753|3377381|P2|Overall Study|Withdrawal by Subject|12
1037196|NCT00116753|3377382|P1|Overall Study|Withdrawal by Subject|11
1037197|NCT00116753|3377380|P3|Overall Study|Adverse Event|7
1037198|NCT00116753|3377381|P2|Overall Study|Adverse Event|10
1037199|NCT00116753|3377382|P1|Overall Study|Adverse Event|16
1037200|NCT00116688|3377404|P2|Overall Study|Other|0
1037201|NCT00116688|3377405|P1|Overall Study|Other|11
1037202|NCT00116688|3377404|P2|Overall Study|Pregnancy|0
1037203|NCT00116688|3377405|P1|Overall Study|Pregnancy|1
1037204|NCT00116688|3377404|P2|Overall Study|Protocol-specified criteria|0
1037205|NCT00116688|3377405|P1|Overall Study|Protocol-specified criteria|3
1037206|NCT00116688|3377404|P2|Overall Study|Death|0
1037207|NCT00116688|3377405|P1|Overall Study|Death|15
1037208|NCT00116688|3377404|P2|Overall Study|Lost to Follow-up|0
1037209|NCT00116688|3377405|P1|Overall Study|Lost to Follow-up|3
1037210|NCT00116688|3377404|P2|Overall Study|Physician Decision|0
1037211|NCT00116688|3377405|P1|Overall Study|Physician Decision|7
1037212|NCT00116688|3377404|P2|Overall Study|Requirement for alternative therapy|1
1037213|NCT00116688|3377405|P1|Overall Study|Requirement for alternative therapy|11
1037214|NCT00116688|3377404|P2|Overall Study|Withdrawal by Subject|2
1037215|NCT00116688|3377405|P1|Overall Study|Withdrawal by Subject|26
1037216|NCT00116688|3377404|P2|Overall Study|Adverse Event|0
1037217|NCT00116688|3377405|P1|Overall Study|Adverse Event|11
1037218|NCT00116688|3377404|P2|Overall Study|Noncompliance|1
1037219|NCT00116688|3377405|P1|Overall Study|Noncompliance|3
1037220|NCT00116688|3377404|P2|Overall Study|Protocol deviation|0
1037221|NCT00116688|3377405|P1|Overall Study|Protocol deviation|1
1037222|NCT00116649|3377420|P1|Overall Study|Protocol Specified|7
1037223|NCT00116649|3377420|P1|Overall Study|Various Reasons|18
1037224|NCT00116649|3377420|P1|Overall Study|Local Skin Reaction|9
1037225|NCT00116649|3377420|P1|Overall Study|Withdrawal by Subject|68
1037226|NCT00116649|3377420|P1|Overall Study|Lost to Follow-up|32
1037227|NCT00116649|3377420|P1|Overall Study|Lack of Efficacy|1
1037228|NCT00116649|3377420|P1|Overall Study|Adverse Event|20
1037229|NCT00116428|3377427|P2|Overall Study|Did not meet inclusion criteria|0
1037230|NCT00116428|3377428|P1|Overall Study|Did not meet inclusion criteria|1
1037231|NCT00116428|3377427|P2|Overall Study|Withdrawal by Subject|5
1037232|NCT00116428|3377428|P1|Overall Study|Withdrawal by Subject|2
1037233|NCT00116272|3377446|P2|Overall Study|Lost to Follow-up|6
1037234|NCT00116272|3377447|P1|Overall Study|Lost to Follow-up|11
1037235|NCT00116168|3377516|P4|Overall Study|Lost to Follow-up|0
1037236|NCT00116168|3377517|P3|Overall Study|Lost to Follow-up|0
1037237|NCT00116168|3377518|P2|Overall Study|Lost to Follow-up|5
1037238|NCT00116168|3377519|P1|Overall Study|Lost to Follow-up|6
1037239|NCT00115934|3377583|P2|Overall Study|Did not receive intervention|2
1037240|NCT00115934|3377584|P1|Overall Study|Did not receive intervention|3
1037241|NCT00115934|3377583|P2|Overall Study|Lost to Follow-up|0
1037242|NCT00115934|3377584|P1|Overall Study|Lost to Follow-up|1
1037243|NCT00115804|3377633|P1|Overall Study|Adverse Event|2
1037244|NCT00115765|3377648|P4|Overall Study|Not specified|2
1037245|NCT00115765|3377649|P3|Overall Study|Not specified|9
1037246|NCT00115765|3377650|P2|Overall Study|Not specified|12
1037247|NCT00115765|3377651|P1|Overall Study|Not specified|6
1037248|NCT00115765|3377648|P4|Overall Study|Lost to Follow-up|1
1037249|NCT00115765|3377649|P3|Overall Study|Lost to Follow-up|18
1037250|NCT00115765|3377650|P2|Overall Study|Lost to Follow-up|20
1037251|NCT00115765|3377651|P1|Overall Study|Lost to Follow-up|3
1037252|NCT00115765|3377648|P4|Overall Study|Physician Decision|13
1037253|NCT00115765|3377649|P3|Overall Study|Physician Decision|18
1037254|NCT00115765|3377650|P2|Overall Study|Physician Decision|15
1037255|NCT00115765|3377651|P1|Overall Study|Physician Decision|4
1037256|NCT00115765|3377648|P4|Overall Study|Withdrawal by Subject|15
1037257|NCT00115765|3377649|P3|Overall Study|Withdrawal by Subject|76
1037258|NCT00115765|3377650|P2|Overall Study|Withdrawal by Subject|53
1037259|NCT00115765|3377651|P1|Overall Study|Withdrawal by Subject|22
1037260|NCT00115739|3377689|P1|Overall Study|Lost to Follow-up|3
1037261|NCT00115349|3377698|P2|Overall Study|Study closed due to low enrollment.|9
1037262|NCT00115349|3377699|P1|Overall Study|Study closed due to low enrollment.|11
1037263|NCT00115063|3377720|P2|Overall Study|Death|0
1037264|NCT00115063|3377721|P1|Overall Study|Death|1
1037265|NCT00115063|3377720|P2|Overall Study|Lost to Follow-up|104
1037266|NCT00115063|3377721|P1|Overall Study|Lost to Follow-up|98
1037267|NCT00114972|3377739|P2|Overall Study|Lost to Follow-up|5
1037268|NCT00114972|3377740|P1|Overall Study|Lost to Follow-up|8
1037269|NCT00114972|3377739|P2|Overall Study|Withdrawal by Subject|7
1037270|NCT00114972|3377740|P1|Overall Study|Withdrawal by Subject|40
1037271|NCT00114959|3377760|P1|Overall Study|Death|1
1037272|NCT00114959|3377760|P1|Overall Study|Physician Decision|1
1037273|NCT00114959|3377760|P1|Overall Study|Lack of Efficacy|6
1037274|NCT00114777|3377770|P3|Long-Term Extension to Month 84|Not Specified|2
1037275|NCT00114777|3377771|P2|Long-Term Extension to Month 84|Not Specified|0
1037276|NCT00114777|3377772|P1|Long-Term Extension to Month 84|Not Specified|2
1037277|NCT00114777|3377770|P3|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1
1037278|NCT00114777|3377771|P2|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
1037279|NCT00114777|3377772|P1|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
1037280|NCT00114777|3377770|P3|Long-Term Extension to Month 84|Lost to Follow-up|2
1037281|NCT00114777|3377771|P2|Long-Term Extension to Month 84|Lost to Follow-up|0
1037282|NCT00114777|3377772|P1|Long-Term Extension to Month 84|Lost to Follow-up|0
1037283|NCT00114777|3377770|P3|Long-Term Extension to Month 84|Withdrawal by Subject|6
1037284|NCT00114777|3377771|P2|Long-Term Extension to Month 84|Withdrawal by Subject|1
1037285|NCT00114777|3377772|P1|Long-Term Extension to Month 84|Withdrawal by Subject|2
1037286|NCT00114777|3377770|P3|Long-Term Extension to Month 84|Adverse Event|7
1037287|NCT00114777|3377771|P2|Long-Term Extension to Month 84|Adverse Event|14
1037288|NCT00114777|3377772|P1|Long-Term Extension to Month 84|Adverse Event|15
1037289|NCT00114777|3377770|P3|Long-Term Extension to Month 84|Poor or Non-Compliance|3
1037290|NCT00114777|3377771|P2|Long-Term Extension to Month 84|Poor or Non-Compliance|1
1037291|NCT00114777|3377772|P1|Long-Term Extension to Month 84|Poor or Non-Compliance|1
1037292|NCT00114777|3377770|P3|Long-Term Extension to Month 84|Lack of Efficacy|1
1037293|NCT00114777|3377771|P2|Long-Term Extension to Month 84|Lack of Efficacy|0
1037294|NCT00114777|3377772|P1|Long-Term Extension to Month 84|Lack of Efficacy|1
1037295|NCT00114777|3377770|P3|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
1037296|NCT00114777|3377771|P2|Long-Term Extension to Month 84|No Longer Met Study Criteria|0
1037297|NCT00114777|3377772|P1|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
1037298|NCT00114777|3377770|P3|Long-Term Extension to Month 84|Death|7
1037299|NCT00114777|3377771|P2|Long-Term Extension to Month 84|Death|13
1037300|NCT00114777|3377772|P1|Long-Term Extension to Month 84|Death|8
1037301|NCT00114777|3377770|P3|Randomization to Month 36|Not Specified|12
1037302|NCT00114777|3377771|P2|Randomization to Month 36|Not Specified|3
1037303|NCT00114777|3377772|P1|Randomization to Month 36|Not Specified|9
1037304|NCT00114777|3377770|P3|Randomization to Month 36|Withdrawal by Subject|5
1037305|NCT00114777|3377771|P2|Randomization to Month 36|Withdrawal by Subject|4
1037306|NCT00114777|3377772|P1|Randomization to Month 36|Withdrawal by Subject|3
1037307|NCT00114777|3377770|P3|Randomization to Month 36|Adverse Event|44
1037308|NCT00114777|3377771|P2|Randomization to Month 36|Adverse Event|35
1037309|NCT00114777|3377772|P1|Randomization to Month 36|Adverse Event|34
1037310|NCT00114777|3377770|P3|Randomization to Month 36|Poor or Non-Compliance|1
1037311|NCT00114777|3377771|P2|Randomization to Month 36|Poor or Non-Compliance|0
1037312|NCT00114777|3377772|P1|Randomization to Month 36|Poor or Non-Compliance|0
1037313|NCT00114777|3377770|P3|Randomization to Month 36|Lack of Efficacy|17
1037314|NCT00114777|3377771|P2|Randomization to Month 36|Lack of Efficacy|15
1037315|NCT00114777|3377772|P1|Randomization to Month 36|Lack of Efficacy|19
1037316|NCT00114777|3377770|P3|Randomization to Month 36|No Longer Met Study Criteria|2
1037317|NCT00114777|3377771|P2|Randomization to Month 36|No Longer Met Study Criteria|0
1037318|NCT00114777|3377772|P1|Randomization to Month 36|No Longer Met Study Criteria|0
1037319|NCT00114777|3377770|P3|Randomization to Month 36|Death|3
1037320|NCT00114777|3377771|P2|Randomization to Month 36|Death|4
1037321|NCT00114777|3377772|P1|Randomization to Month 36|Death|10
1037322|NCT00114738|3377846|P3|Screening for Randomization|Other|0
1037323|NCT00114738|3377847|P2|Screening for Randomization|Other|0
1037324|NCT00114738|3377848|P1|Screening for Randomization|Other|1
1037325|NCT00114738|3377846|P3|Screening for Randomization|CNS Hemorrhage|0
1037326|NCT00114738|3377847|P2|Screening for Randomization|CNS Hemorrhage|0
1037327|NCT00114738|3377848|P1|Screening for Randomization|CNS Hemorrhage|1
1037328|NCT00114738|3377846|P3|Screening for Randomization|Progressive disease|0
1037329|NCT00114738|3377847|P2|Screening for Randomization|Progressive disease|0
1037330|NCT00114738|3377848|P1|Screening for Randomization|Progressive disease|2
1037331|NCT00114738|3377846|P3|Screening for Randomization|Neuropathy|0
1037332|NCT00114738|3377847|P2|Screening for Randomization|Neuropathy|0
1037333|NCT00114738|3377848|P1|Screening for Randomization|Neuropathy|17
1037334|NCT00114738|3377846|P3|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
1037335|NCT00114738|3377847|P2|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
1037336|NCT00114738|3377848|P1|Bortezomib Then Bortezomib + Induction|Progressive Disease|1
1037337|NCT00114738|3377846|P3|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
1037338|NCT00114738|3377847|P2|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
1037339|NCT00114738|3377848|P1|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1
1037340|NCT00114634|3377861|P1|Overall Study|failure to return forms|3
1037341|NCT00114530|3377877|P2|Overall Study|Ineligible|0
1037342|NCT00114530|3377878|P1|Overall Study|Ineligible|1
1037343|NCT00114530|3377877|P2|Overall Study|Subject decision after endpoint failure|1
1037344|NCT00114530|3377878|P1|Overall Study|Subject decision after endpoint failure|0
1037345|NCT00114530|3377877|P2|Overall Study|Breast Cancer|0
1037346|NCT00114530|3377878|P1|Overall Study|Breast Cancer|1
1037347|NCT00114530|3377877|P2|Overall Study|Withdrawal by Subject|6
1037348|NCT00114530|3377878|P1|Overall Study|Withdrawal by Subject|2
1037349|NCT00114530|3377877|P2|Overall Study|Physician Decision|1
1037350|NCT00114530|3377878|P1|Overall Study|Physician Decision|1
1037351|NCT00114530|3377877|P2|Overall Study|Lost to Follow-up|1
1037352|NCT00114530|3377878|P1|Overall Study|Lost to Follow-up|1
1037353|NCT00114530|3377877|P2|Overall Study|Death|11
1037354|NCT00114530|3377878|P1|Overall Study|Death|3
1037355|NCT00114244|3378015|P2|Overall Study|Withdrawal by Subject|2
1037356|NCT00114244|3378016|P1|Overall Study|Withdrawal by Subject|0
1037357|NCT00114244|3378015|P2|Overall Study|Adverse Event|5
1037358|NCT00114244|3378016|P1|Overall Study|Adverse Event|2
1037359|NCT00114231|3378028|P2|Overall Study|Biopsy done after registration|0
1037360|NCT00114231|3378029|P1|Overall Study|Biopsy done after registration|1
1037361|NCT00114231|3378028|P2|Overall Study|No Absolute Neutrophil Count|0
1037362|NCT00114231|3378029|P1|Overall Study|No Absolute Neutrophil Count|2
1037363|NCT00114231|3378028|P2|Overall Study|Tumor fixed on digital exam|1
1037364|NCT00114231|3378029|P1|Overall Study|Tumor fixed on digital exam|0
1037365|NCT00114231|3378028|P2|Overall Study|Tumor size > 4cm|0
1037366|NCT00114231|3378029|P1|Overall Study|Tumor size > 4cm|1
1037367|NCT00114231|3378028|P2|Overall Study|Low creatinine clearance|1
1037368|NCT00114231|3378029|P1|Overall Study|Low creatinine clearance|0
1037369|NCT00114231|3378028|P2|Overall Study|No adenocarcinoma|0
1037370|NCT00114231|3378029|P1|Overall Study|No adenocarcinoma|1
1037371|NCT00114231|3378028|P2|Overall Study|Suspected metastatic disease|0
1037372|NCT00114231|3378029|P1|Overall Study|Suspected metastatic disease|1
1037373|NCT00114231|3378028|P2|Overall Study|QARC requirement not met|0
1037374|NCT00114231|3378029|P1|Overall Study|QARC requirement not met|1
1037375|NCT00114231|3378028|P2|Overall Study|No consent|0
1037376|NCT00114231|3378029|P1|Overall Study|No consent|2
1037377|NCT00114218|3378038|P1|Overall Study|Never Treated|1
1037378|NCT00114218|3378038|P1|Overall Study|Wrong Primary|1
1037379|NCT00114218|3378038|P1|Overall Study|Wrong Cell Type|2
1037380|NCT00114166|3378045|P2|Overall Study|Wrong primary|1
1037381|NCT00114166|3378046|P1|Overall Study|Wrong primary|0
1037382|NCT00114140|3378056|P1|Overall Study|Protocol Violation|7
1037383|NCT00114127|3378070|P2|Overall Study|Withdrawal by Subject|3
1037384|NCT00114127|3378071|P1|Overall Study|Withdrawal by Subject|1
1037385|NCT00114127|3378070|P2|Overall Study|Lost to Follow-up|0
1037386|NCT00114127|3378071|P1|Overall Study|Lost to Follow-up|1
1037387|NCT00114127|3378070|P2|Overall Study|Adverse Event|1
1037388|NCT00114127|3378071|P1|Overall Study|Adverse Event|2
1037389|NCT00113919|3378094|P1|Overall Study|Death|6
1037390|NCT00113919|3378094|P1|Overall Study|Physician Decision|8
1037391|NCT00113841|3378162|P2|Overall Study|Non-compliant|0
1037392|NCT00113841|3378163|P1|Overall Study|Non-compliant|1
1037393|NCT00113841|3378162|P2|Overall Study|Disease progression|2
1037394|NCT00113841|3378163|P1|Overall Study|Disease progression|0
1037395|NCT00113763|3378171|P2|Overall Study|Ongoing|0
1037396|NCT00113763|3378172|P1|Overall Study|Ongoing|1
1037397|NCT00113763|3378171|P2|Overall Study|Non-compliance|0
1037398|NCT00113763|3378172|P1|Overall Study|Non-compliance|1
1037399|NCT00113763|3378171|P2|Overall Study|Not specified|6
1037400|NCT00113763|3378172|P1|Overall Study|Not specified|27
1037401|NCT00113763|3378171|P2|Overall Study|Withdrawal by Subject|4
1037402|NCT00113763|3378172|P1|Overall Study|Withdrawal by Subject|1
1037403|NCT00113763|3378171|P2|Overall Study|Lost to Follow-up|0
1037404|NCT00113763|3378172|P1|Overall Study|Lost to Follow-up|10
1037405|NCT00113763|3378171|P2|Overall Study|Disease Progression|14
1037406|NCT00113763|3378172|P1|Overall Study|Disease Progression|28
1037407|NCT00113763|3378171|P2|Overall Study|Adverse Event|2
1037408|NCT00113763|3378172|P1|Overall Study|Adverse Event|5
1037409|NCT00113607|3378198|P2|Overall Study|Other|32
1037410|NCT00113607|3378199|P1|Overall Study|Other|43
1037411|NCT00113607|3378198|P2|Overall Study|Complete Response (Confirmed)|24
1037412|NCT00113607|3378199|P1|Overall Study|Complete Response (Confirmed)|14
1037413|NCT00113607|3378198|P2|Overall Study|Disease Progression|142
1037414|NCT00113607|3378199|P1|Overall Study|Disease Progression|180
1037415|NCT00113607|3378198|P2|Overall Study|Lost to Follow-up|2
1037416|NCT00113607|3378199|P1|Overall Study|Lost to Follow-up|0
1037417|NCT00113607|3378198|P2|Overall Study|Withdrawal by Subject|58
1037418|NCT00113607|3378199|P1|Overall Study|Withdrawal by Subject|50
1037419|NCT00113607|3378198|P2|Overall Study|Death|8
1037420|NCT00113607|3378199|P1|Overall Study|Death|8
1037421|NCT00113607|3378198|P2|Overall Study|Adverse Event|71
1037422|NCT00113607|3378199|P1|Overall Study|Adverse Event|40
1037423|NCT00113568|3378213|P1|Overall Study|Other|112
1037424|NCT00113568|3378213|P1|Overall Study|Withdrawal by Subject|117
1037425|NCT00113568|3378213|P1|Overall Study|Protocol Violation|32
1037426|NCT00113568|3378213|P1|Overall Study|Lost to Follow-up|156
1037427|NCT00113568|3378213|P1|Overall Study|Lack of Efficacy|30
1037428|NCT00113568|3378213|P1|Overall Study|Death|1
1037429|NCT00113568|3378213|P1|Overall Study|Adverse Event|97
1037430|NCT00113555|3378225|P1|Overall Study|Lost to Follow-up|8
1037431|NCT00113555|3378225|P1|Overall Study|Missed Followup|4
1037432|NCT00113555|3378225|P1|Overall Study|Death|1
1037433|NCT00113555|3378225|P1|Overall Study|Permanently Explanted|7
1037434|NCT00113555|3378225|P1|Overall Study|Baseline Failure|59
1037435|NCT00113529|3378235|P1|Overall Study|Withdrawal by Subject|4
1037436|NCT00113529|3378235|P1|Overall Study|Decision of sponsor|6
1037437|NCT00113529|3378235|P1|Overall Study|Lack of Efficacy|20
1037438|NCT00113529|3378235|P1|Overall Study|Adverse Event|4
1037439|NCT00113516|3378268|P2|Part 2|Ongoing|1
1037440|NCT00113516|3378269|P1|Part 2|Ongoing|0
1037441|NCT00113516|3378268|P2|Part 2|Laboratory Abnormality|1
1037442|NCT00113516|3378269|P1|Part 2|Laboratory Abnormality|0
1037443|NCT00113516|3378268|P2|Part 2|Other|3
1037444|NCT00113516|3378269|P1|Part 2|Other|0
1037445|NCT00113516|3378268|P2|Part 2|Withdrawal by Subject|3
1037446|NCT00113516|3378269|P1|Part 2|Withdrawal by Subject|0
1037447|NCT00113516|3378268|P2|Part 2|Lack of Efficacy|37
1037448|NCT00113516|3378269|P1|Part 2|Lack of Efficacy|0
1037449|NCT00113516|3378268|P2|Part 2|Death|5
1037450|NCT00113516|3378269|P1|Part 2|Death|0
1037451|NCT00113516|3378268|P2|Part 2|Adverse Event|16
1037452|NCT00113516|3378269|P1|Part 2|Adverse Event|0
1037453|NCT00113516|3378268|P2|Part 1|Missing|0
1037454|NCT00113516|3378269|P1|Part 1|Missing|65
1037455|NCT00113516|3378268|P2|Part 1|Ongoing|0
1037456|NCT00113516|3378269|P1|Part 1|Ongoing|1
1037457|NCT00113516|3378268|P2|Part 1|Laboratory Abnormality|0
1037458|NCT00113516|3378269|P1|Part 1|Laboratory Abnormality|1
1037459|NCT00113516|3378268|P2|Part 1|Did Not Meet Entrance Criteria|0
1037460|NCT00113516|3378269|P1|Part 1|Did Not Meet Entrance Criteria|1
1037461|NCT00113516|3378268|P2|Part 1|Lack of Efficacy|0
1037462|NCT00113516|3378269|P1|Part 1|Lack of Efficacy|2
1037463|NCT00113516|3378268|P2|Part 1|Withdrawal by Subject|0
1037464|NCT00113516|3378269|P1|Part 1|Withdrawal by Subject|2
1037465|NCT00113516|3378268|P2|Part 1|Other|0
1037466|NCT00113516|3378269|P1|Part 1|Other|3
1037467|NCT00113516|3378268|P2|Part 1|Death|0
1037468|NCT00113516|3378269|P1|Part 1|Death|3
1037469|NCT00113516|3378268|P2|Part 1|Adverse Event|0
1037470|NCT00113516|3378269|P1|Part 1|Adverse Event|6
1037471|NCT00113490|3378312|P2|Overall Study|Lost to Follow-up|0
1037472|NCT00113490|3378313|P1|Overall Study|Lost to Follow-up|1
1037473|NCT00113490|3378312|P2|Overall Study|Withdrawal by Subject|3
1037474|NCT00113490|3378313|P1|Overall Study|Withdrawal by Subject|1
1037475|NCT00113399|3378346|P2|Overall Study|Other|1
1037476|NCT00113399|3378347|P1|Overall Study|Other|0
1037477|NCT00113399|3378346|P2|Overall Study|Complete Response|1
1037478|NCT00113399|3378347|P1|Overall Study|Complete Response|0
1037479|NCT00113399|3378346|P2|Overall Study|Withdrawal by Subject|2
1037480|NCT00113399|3378347|P1|Overall Study|Withdrawal by Subject|1
1037481|NCT00113399|3378346|P2|Overall Study|Death|1
1037482|NCT00113399|3378347|P1|Overall Study|Death|1
1037483|NCT00113386|3378355|P2|Overall Study|Unknown - Lost to Follow-Up|1
1037484|NCT00113386|3378356|P1|Overall Study|Unknown - Lost to Follow-Up|2
1037485|NCT00113386|3378355|P2|Overall Study|Ineligible|2
1037486|NCT00113386|3378356|P1|Overall Study|Ineligible|1
1037487|NCT00113386|3378355|P2|Overall Study|Toxicity|0
1037488|NCT00113386|3378356|P1|Overall Study|Toxicity|3
1037489|NCT00113386|3378355|P2|Overall Study|Physician Decision|1
1037490|NCT00113386|3378356|P1|Overall Study|Physician Decision|0
1037491|NCT00113386|3378355|P2|Overall Study|Withdrawal by Subject|0
1037492|NCT00113386|3378356|P1|Overall Study|Withdrawal by Subject|1
1037493|NCT00113373|3378362|P1|Overall Study|Never Treated|1
1037494|NCT00113373|3378362|P1|Overall Study|Ineligible: second primary|1
1037495|NCT00113373|3378362|P1|Overall Study|Ineligible: wrong primary|1
1037496|NCT00113360|3378377|P1|Overall Study|Did not meet eligibility criteria|3
1037497|NCT00113360|3378377|P1|Overall Study|Subject required surgery|1
1037498|NCT00113360|3378377|P1|Overall Study|Adverse Event|3
1037499|NCT00113295|3378391|P2|Overall Study|Unrelated Medical Illness|0
1037500|NCT00113295|3378392|P1|Overall Study|Unrelated Medical Illness|1
1037501|NCT00113295|3378391|P2|Overall Study|Adverse Event|1
1037502|NCT00113295|3378392|P1|Overall Study|Adverse Event|4
1037503|NCT00113269|3378411|P4|Overall Study|Unable to return for follow up|0
1037504|NCT00113269|3378412|P3|Overall Study|Unable to return for follow up|0
1037505|NCT00113269|3378413|P2|Overall Study|Unable to return for follow up|1
1037506|NCT00113269|3378414|P1|Overall Study|Unable to return for follow up|2
1037507|NCT00113269|3378411|P4|Overall Study|Did not meet eligibility criteria|1
1037508|NCT00113269|3378412|P3|Overall Study|Did not meet eligibility criteria|0
1037509|NCT00113269|3378413|P2|Overall Study|Did not meet eligibility criteria|0
1037510|NCT00113269|3378414|P1|Overall Study|Did not meet eligibility criteria|1
1037511|NCT00113269|3378411|P4|Overall Study|Withdrew consent, Prednisone initiated|1
1037512|NCT00113269|3378412|P3|Overall Study|Withdrew consent, Prednisone initiated|0
1037513|NCT00113269|3378413|P2|Overall Study|Withdrew consent, Prednisone initiated|0
1037514|NCT00113269|3378414|P1|Overall Study|Withdrew consent, Prednisone initiated|0
1037515|NCT00113269|3378411|P4|Overall Study|Received pancreas transplant|2
1037516|NCT00113269|3378412|P3|Overall Study|Received pancreas transplant|0
1037517|NCT00113269|3378413|P2|Overall Study|Received pancreas transplant|0
1037518|NCT00113269|3378414|P1|Overall Study|Received pancreas transplant|0
1037519|NCT00113269|3378411|P4|Overall Study|Moved|3
1037520|NCT00113269|3378412|P3|Overall Study|Moved|0
1037521|NCT00113269|3378413|P2|Overall Study|Moved|1
1037522|NCT00113269|3378414|P1|Overall Study|Moved|0
1037523|NCT00113269|3378411|P4|Overall Study|Discontinued due to rejection|0
1037524|NCT00113269|3378412|P3|Overall Study|Discontinued due to rejection|1
1037525|NCT00113269|3378413|P2|Overall Study|Discontinued due to rejection|0
1037526|NCT00113269|3378414|P1|Overall Study|Discontinued due to rejection|0
1037527|NCT00113269|3378411|P4|Overall Study|Sponsor elected to discontinue patient|1
1037528|NCT00113269|3378412|P3|Overall Study|Sponsor elected to discontinue patient|0
1037529|NCT00113269|3378413|P2|Overall Study|Sponsor elected to discontinue patient|0
1037530|NCT00113269|3378414|P1|Overall Study|Sponsor elected to discontinue patient|1
1037531|NCT00113269|3378411|P4|Overall Study|Lost to Follow-up|3
1037532|NCT00113269|3378412|P3|Overall Study|Lost to Follow-up|6
1037533|NCT00113269|3378413|P2|Overall Study|Lost to Follow-up|3
1037534|NCT00113269|3378414|P1|Overall Study|Lost to Follow-up|2
1037535|NCT00113269|3378411|P4|Overall Study|Protocol Violation|2
1037536|NCT00113269|3378412|P3|Overall Study|Protocol Violation|4
1037537|NCT00113269|3378413|P2|Overall Study|Protocol Violation|0
1037538|NCT00113269|3378414|P1|Overall Study|Protocol Violation|1
1037539|NCT00113269|3378411|P4|Overall Study|Graft loss|9
1037540|NCT00113269|3378412|P3|Overall Study|Graft loss|4
1037541|NCT00113269|3378413|P2|Overall Study|Graft loss|6
1037542|NCT00113269|3378414|P1|Overall Study|Graft loss|6
1037543|NCT00113269|3378411|P4|Overall Study|Withdrawal by Subject|2
1037544|NCT00113269|3378412|P3|Overall Study|Withdrawal by Subject|4
1037545|NCT00113269|3378413|P2|Overall Study|Withdrawal by Subject|3
1037546|NCT00113269|3378414|P1|Overall Study|Withdrawal by Subject|4
1037547|NCT00113269|3378411|P4|Overall Study|Adverse Event|7
1037548|NCT00113269|3378412|P3|Overall Study|Adverse Event|11
1037549|NCT00113269|3378413|P2|Overall Study|Adverse Event|7
1037550|NCT00113269|3378414|P1|Overall Study|Adverse Event|2
1037551|NCT00113269|3378411|P4|Overall Study|Did not meet eligibility – pre-treatment|2
1037552|NCT00113269|3378412|P3|Overall Study|Did not meet eligibility – pre-treatment|0
1037553|NCT00113269|3378413|P2|Overall Study|Did not meet eligibility – pre-treatment|0
1037554|NCT00113269|3378414|P1|Overall Study|Did not meet eligibility – pre-treatment|0
1037555|NCT00113269|3378411|P4|Overall Study|Death in operating room|1
1037556|NCT00113269|3378412|P3|Overall Study|Death in operating room|0
1037557|NCT00113269|3378413|P2|Overall Study|Death in operating room|0
1037558|NCT00113269|3378414|P1|Overall Study|Death in operating room|0
1037559|NCT00113269|3378411|P4|Overall Study|Early graft loss, technical|0
1037560|NCT00113269|3378412|P3|Overall Study|Early graft loss, technical|2
1037561|NCT00113269|3378413|P2|Overall Study|Early graft loss, technical|0
1037562|NCT00113269|3378414|P1|Overall Study|Early graft loss, technical|0
1037563|NCT00113269|3378411|P4|Overall Study|Not transplanted, recipient issues|4
1037564|NCT00113269|3378412|P3|Overall Study|Not transplanted, recipient issues|7
1037565|NCT00113269|3378413|P2|Overall Study|Not transplanted, recipient issues|1
1037566|NCT00113269|3378414|P1|Overall Study|Not transplanted, recipient issues|2
1037567|NCT00113269|3378411|P4|Overall Study|Not transplanted, donor issues|2
1037568|NCT00113269|3378412|P3|Overall Study|Not transplanted, donor issues|2
1037569|NCT00113269|3378413|P2|Overall Study|Not transplanted, donor issues|0
1037570|NCT00113269|3378414|P1|Overall Study|Not transplanted, donor issues|4
1037571|NCT00113087|3378474|P2|Overall Study|Family or MD withdrew subject|5
1037572|NCT00113087|3378475|P1|Overall Study|Family or MD withdrew subject|10
1037573|NCT00113087|3378474|P2|Overall Study|Death or Transplant|16
1037574|NCT00113087|3378475|P1|Overall Study|Death or Transplant|14
1037575|NCT00112957|3378546|P1|Overall Study|Physician Decision|1
1037576|NCT00112957|3378546|P1|Overall Study|Progressive disease|18
1037577|NCT00112905|3378586|P1|Overall Study|performance status was deteiorating|1
1037578|NCT00112905|3378586|P1|Overall Study|Alternative treatment|1
1037579|NCT00112905|3378586|P1|Overall Study|Ineligibility|5
1037580|NCT00112905|3378586|P1|Overall Study|Death|1
1037581|NCT00112905|3378586|P1|Overall Study|Adverse Event|4
1037582|NCT00112866|3378595|P2|Overall Study|did not start treatment post-op|2
1037583|NCT00112866|3378596|P1|Overall Study|did not start treatment post-op|1
1037584|NCT00112866|3378595|P2|Overall Study|Protocol Violation|0
1037585|NCT00112866|3378596|P1|Overall Study|Protocol Violation|1
1037586|NCT00112840|3378618|P3|Overall Study|Protocol Violation|5
1037587|NCT00112840|3378619|P2|Overall Study|Protocol Violation|0
1037588|NCT00112840|3378620|P1|Overall Study|Protocol Violation|0
1037589|NCT00112840|3378618|P3|Overall Study|Withdrawal by Subject|1
1037590|NCT00112840|3378619|P2|Overall Study|Withdrawal by Subject|0
1037591|NCT00112840|3378620|P1|Overall Study|Withdrawal by Subject|1
1037592|NCT00112840|3378618|P3|Overall Study|Physician Decision|0
1037593|NCT00112840|3378619|P2|Overall Study|Physician Decision|0
1037594|NCT00112840|3378620|P1|Overall Study|Physician Decision|1
1037595|NCT00112736|3378639|P2|Overall Study|1 pt never had had RX due rapid decline|0
1037596|NCT00112736|3378640|P1|Overall Study|1 pt never had had RX due rapid decline|1
1037597|NCT00112489|3378697|P1|Overall Study|Ineligible|7
1037598|NCT00112489|3378697|P1|Overall Study|Patient never treated|2
1037599|NCT00112489|3378697|P1|Overall Study|Other, Not Specified|9
1037600|NCT00112489|3378697|P1|Overall Study|Death|2
1037601|NCT00112489|3378697|P1|Overall Study|Adverse Event|12
1037602|NCT00112489|3378697|P1|Overall Study|Refused further treatment|8
1037603|NCT00112463|3378707|P1|Overall Study|Never started treatment|2
1037604|NCT00112463|3378707|P1|Overall Study|Withdrawal by Subject|2
1037605|NCT00112463|3378707|P1|Overall Study|Toxicity|3
1037606|NCT00112463|3378707|P1|Overall Study|Second Primary|1
1037607|NCT00112463|3378707|P1|Overall Study|Progression|30
1037608|NCT00112463|3378707|P1|Overall Study|Physician Decision|1
1037609|NCT00112437|3378719|P26|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3
1037610|NCT00112437|3378720|P25|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1037611|NCT00112437|3378721|P24|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6
1037612|NCT00112437|3378722|P23|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4
1037613|NCT00112437|3378723|P22|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1037614|NCT00112437|3378724|P21|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1037615|NCT00112437|3378725|P20|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1037616|NCT00112437|3378726|P19|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1037617|NCT00112437|3378727|P18|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1037618|NCT00112437|3378728|P17|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1037619|NCT00112437|3378729|P16|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1037620|NCT00112437|3378730|P15|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1037621|NCT00112437|3378731|P14|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1037622|NCT00112437|3378732|P13|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1037623|NCT00112437|3378733|P12|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1037624|NCT00112437|3378734|P11|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1037625|NCT00112437|3378735|P10|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1037626|NCT00112437|3378736|P9|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1037627|NCT00112437|3378737|P8|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1037628|NCT00112437|3378738|P7|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1037629|NCT00112437|3378739|P6|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1037630|NCT00112437|3378740|P5|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1037631|NCT00112437|3378741|P4|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1037632|NCT00112437|3378742|P3|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1037633|NCT00112437|3378743|P2|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1037634|NCT00112437|3378744|P1|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1037635|NCT00112437|3378719|P26|Years 6-10 (60-Month Extension)|Physician Decision|0
1037636|NCT00112437|3378720|P25|Years 6-10 (60-Month Extension)|Physician Decision|0
1037637|NCT00112437|3378721|P24|Years 6-10 (60-Month Extension)|Physician Decision|2
1037638|NCT00112437|3378722|P23|Years 6-10 (60-Month Extension)|Physician Decision|0
1037639|NCT00112437|3378723|P22|Years 6-10 (60-Month Extension)|Physician Decision|0
1037640|NCT00112437|3378724|P21|Years 6-10 (60-Month Extension)|Physician Decision|0
1037641|NCT00112437|3378725|P20|Years 6-10 (60-Month Extension)|Physician Decision|0
1037642|NCT00112437|3378726|P19|Years 6-10 (60-Month Extension)|Physician Decision|0
1037643|NCT00112437|3378727|P18|Years 6-10 (60-Month Extension)|Physician Decision|0
1037644|NCT00112437|3378728|P17|Years 6-10 (60-Month Extension)|Physician Decision|0
1037645|NCT00112437|3378729|P16|Years 6-10 (60-Month Extension)|Physician Decision|0
1037646|NCT00112437|3378730|P15|Years 6-10 (60-Month Extension)|Physician Decision|0
1037647|NCT00112437|3378731|P14|Years 6-10 (60-Month Extension)|Physician Decision|0
1037648|NCT00112437|3378732|P13|Years 6-10 (60-Month Extension)|Physician Decision|0
1037649|NCT00112437|3378733|P12|Years 6-10 (60-Month Extension)|Physician Decision|0
1037650|NCT00112437|3378734|P11|Years 6-10 (60-Month Extension)|Physician Decision|0
1037651|NCT00112437|3378735|P10|Years 6-10 (60-Month Extension)|Physician Decision|0
1037652|NCT00112437|3378736|P9|Years 6-10 (60-Month Extension)|Physician Decision|0
1037653|NCT00112437|3378737|P8|Years 6-10 (60-Month Extension)|Physician Decision|0
1037654|NCT00112437|3378738|P7|Years 6-10 (60-Month Extension)|Physician Decision|0
1037655|NCT00112437|3378739|P6|Years 6-10 (60-Month Extension)|Physician Decision|0
1037656|NCT00112437|3378740|P5|Years 6-10 (60-Month Extension)|Physician Decision|0
1037657|NCT00112437|3378741|P4|Years 6-10 (60-Month Extension)|Physician Decision|0
1037658|NCT00112437|3378742|P3|Years 6-10 (60-Month Extension)|Physician Decision|0
1037659|NCT00112437|3378743|P2|Years 6-10 (60-Month Extension)|Physician Decision|0
1037660|NCT00112437|3378744|P1|Years 6-10 (60-Month Extension)|Physician Decision|0
1037661|NCT00112437|3378719|P26|Years 6-10 (60-Month Extension)|Other|0
1037662|NCT00112437|3378720|P25|Years 6-10 (60-Month Extension)|Other|1
1037663|NCT00112437|3378721|P24|Years 6-10 (60-Month Extension)|Other|0
1037664|NCT00112437|3378722|P23|Years 6-10 (60-Month Extension)|Other|0
1037665|NCT00112437|3378723|P22|Years 6-10 (60-Month Extension)|Other|0
1037666|NCT00112437|3378724|P21|Years 6-10 (60-Month Extension)|Other|0
1037667|NCT00112437|3378725|P20|Years 6-10 (60-Month Extension)|Other|0
1037668|NCT00112437|3378726|P19|Years 6-10 (60-Month Extension)|Other|0
1037669|NCT00112437|3378727|P18|Years 6-10 (60-Month Extension)|Other|0
1037670|NCT00112437|3378728|P17|Years 6-10 (60-Month Extension)|Other|0
1037671|NCT00112437|3378729|P16|Years 6-10 (60-Month Extension)|Other|0
1037672|NCT00112437|3378730|P15|Years 6-10 (60-Month Extension)|Other|0
1037673|NCT00112437|3378731|P14|Years 6-10 (60-Month Extension)|Other|0
1037674|NCT00112437|3378732|P13|Years 6-10 (60-Month Extension)|Other|0
1037675|NCT00112437|3378733|P12|Years 6-10 (60-Month Extension)|Other|0
1037676|NCT00112437|3378734|P11|Years 6-10 (60-Month Extension)|Other|0
1037677|NCT00112437|3378735|P10|Years 6-10 (60-Month Extension)|Other|0
1037678|NCT00112437|3378736|P9|Years 6-10 (60-Month Extension)|Other|0
1037679|NCT00112437|3378737|P8|Years 6-10 (60-Month Extension)|Other|0
1037680|NCT00112437|3378738|P7|Years 6-10 (60-Month Extension)|Other|0
1037681|NCT00112437|3378739|P6|Years 6-10 (60-Month Extension)|Other|0
1037682|NCT00112437|3378740|P5|Years 6-10 (60-Month Extension)|Other|0
1037683|NCT00112437|3378741|P4|Years 6-10 (60-Month Extension)|Other|0
1037684|NCT00112437|3378742|P3|Years 6-10 (60-Month Extension)|Other|0
1037685|NCT00112437|3378743|P2|Years 6-10 (60-Month Extension)|Other|0
1037686|NCT00112437|3378744|P1|Years 6-10 (60-Month Extension)|Other|0
1037687|NCT00112437|3378719|P26|Years 6-10 (60-Month Extension)|Lost to Follow-up|1
1037688|NCT00112437|3378720|P25|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1037689|NCT00112437|3378721|P24|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1037690|NCT00112437|3378722|P23|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1037691|NCT00112437|3378723|P22|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1037692|NCT00112437|3378724|P21|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1037693|NCT00112437|3378725|P20|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1037694|NCT00112437|3378726|P19|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1037695|NCT00112437|3378727|P18|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1037696|NCT00112437|3378728|P17|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1037697|NCT00112437|3378729|P16|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1037698|NCT00112437|3378730|P15|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1037699|NCT00112437|3378731|P14|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1037700|NCT00112437|3378732|P13|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1037701|NCT00112437|3378733|P12|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1037702|NCT00112437|3378734|P11|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1037703|NCT00112437|3378735|P10|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1037704|NCT00112437|3378736|P9|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1037705|NCT00112437|3378737|P8|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1037706|NCT00112437|3378738|P7|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1037707|NCT00112437|3378739|P6|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1037708|NCT00112437|3378740|P5|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1037709|NCT00112437|3378741|P4|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1037710|NCT00112437|3378742|P3|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1037711|NCT00112437|3378743|P2|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1037712|NCT00112437|3378744|P1|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1037713|NCT00112437|3378719|P26|Years 6-10 (60-Month Extension)|Death|0
1037714|NCT00112437|3378720|P25|Years 6-10 (60-Month Extension)|Death|0
1037715|NCT00112437|3378721|P24|Years 6-10 (60-Month Extension)|Death|2
1037716|NCT00112437|3378722|P23|Years 6-10 (60-Month Extension)|Death|0
1037717|NCT00112437|3378723|P22|Years 6-10 (60-Month Extension)|Death|0
1037718|NCT00112437|3378724|P21|Years 6-10 (60-Month Extension)|Death|0
1037719|NCT00112437|3378725|P20|Years 6-10 (60-Month Extension)|Death|0
1037720|NCT00112437|3378726|P19|Years 6-10 (60-Month Extension)|Death|0
1037721|NCT00112437|3378727|P18|Years 6-10 (60-Month Extension)|Death|0
1037722|NCT00112437|3378728|P17|Years 6-10 (60-Month Extension)|Death|0
1037723|NCT00112437|3378729|P16|Years 6-10 (60-Month Extension)|Death|0
1037724|NCT00112437|3378730|P15|Years 6-10 (60-Month Extension)|Death|0
1037725|NCT00112437|3378731|P14|Years 6-10 (60-Month Extension)|Death|0
1037726|NCT00112437|3378732|P13|Years 6-10 (60-Month Extension)|Death|0
1037727|NCT00112437|3378733|P12|Years 6-10 (60-Month Extension)|Death|0
1037728|NCT00112437|3378734|P11|Years 6-10 (60-Month Extension)|Death|0
1037729|NCT00112437|3378735|P10|Years 6-10 (60-Month Extension)|Death|0
1037730|NCT00112437|3378736|P9|Years 6-10 (60-Month Extension)|Death|0
1037731|NCT00112437|3378737|P8|Years 6-10 (60-Month Extension)|Death|0
1037732|NCT00112437|3378738|P7|Years 6-10 (60-Month Extension)|Death|0
1037733|NCT00112437|3378739|P6|Years 6-10 (60-Month Extension)|Death|0
1037734|NCT00112437|3378740|P5|Years 6-10 (60-Month Extension)|Death|0
1037735|NCT00112437|3378741|P4|Years 6-10 (60-Month Extension)|Death|0
1037736|NCT00112437|3378742|P3|Years 6-10 (60-Month Extension)|Death|0
1037737|NCT00112437|3378743|P2|Years 6-10 (60-Month Extension)|Death|0
1037738|NCT00112437|3378744|P1|Years 6-10 (60-Month Extension)|Death|0
1037739|NCT00112437|3378719|P26|Years 6-10 (60-Month Extension)|Adverse Event|1
1037740|NCT00112437|3378720|P25|Years 6-10 (60-Month Extension)|Adverse Event|0
1037741|NCT00112437|3378721|P24|Years 6-10 (60-Month Extension)|Adverse Event|2
1037742|NCT00112437|3378722|P23|Years 6-10 (60-Month Extension)|Adverse Event|1
1037743|NCT00112437|3378723|P22|Years 6-10 (60-Month Extension)|Adverse Event|0
1037744|NCT00112437|3378724|P21|Years 6-10 (60-Month Extension)|Adverse Event|0
1037745|NCT00112437|3378725|P20|Years 6-10 (60-Month Extension)|Adverse Event|0
1037746|NCT00112437|3378726|P19|Years 6-10 (60-Month Extension)|Adverse Event|0
1037747|NCT00112437|3378727|P18|Years 6-10 (60-Month Extension)|Adverse Event|0
1037748|NCT00112437|3378728|P17|Years 6-10 (60-Month Extension)|Adverse Event|0
1037749|NCT00112437|3378729|P16|Years 6-10 (60-Month Extension)|Adverse Event|0
1037750|NCT00112437|3378730|P15|Years 6-10 (60-Month Extension)|Adverse Event|0
1037751|NCT00112437|3378731|P14|Years 6-10 (60-Month Extension)|Adverse Event|0
1037752|NCT00112437|3378732|P13|Years 6-10 (60-Month Extension)|Adverse Event|0
1037753|NCT00112437|3378733|P12|Years 6-10 (60-Month Extension)|Adverse Event|0
1037754|NCT00112437|3378734|P11|Years 6-10 (60-Month Extension)|Adverse Event|0
1037755|NCT00112437|3378735|P10|Years 6-10 (60-Month Extension)|Adverse Event|0
1037756|NCT00112437|3378736|P9|Years 6-10 (60-Month Extension)|Adverse Event|0
1037757|NCT00112437|3378737|P8|Years 6-10 (60-Month Extension)|Adverse Event|0
1037758|NCT00112437|3378738|P7|Years 6-10 (60-Month Extension)|Adverse Event|0
1037759|NCT00112437|3378739|P6|Years 6-10 (60-Month Extension)|Adverse Event|0
1037760|NCT00112437|3378740|P5|Years 6-10 (60-Month Extension)|Adverse Event|0
1037761|NCT00112437|3378741|P4|Years 6-10 (60-Month Extension)|Adverse Event|0
1037762|NCT00112437|3378742|P3|Years 6-10 (60-Month Extension)|Adverse Event|0
1037763|NCT00112437|3378743|P2|Years 6-10 (60-Month Extension)|Adverse Event|0
1037764|NCT00112437|3378744|P1|Years 6-10 (60-Month Extension)|Adverse Event|0
1037765|NCT00112437|3378719|P26|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1037766|NCT00112437|3378720|P25|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1037767|NCT00112437|3378721|P24|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1037768|NCT00112437|3378722|P23|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1037769|NCT00112437|3378723|P22|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2
1037770|NCT00112437|3378724|P21|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1
1037771|NCT00112437|3378725|P20|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1037772|NCT00112437|3378726|P19|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1037773|NCT00112437|3378727|P18|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1037774|NCT00112437|3378728|P17|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1037775|NCT00112437|3378729|P16|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1037776|NCT00112437|3378730|P15|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1037777|NCT00112437|3378731|P14|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1037778|NCT00112437|3378732|P13|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1037779|NCT00112437|3378733|P12|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1037780|NCT00112437|3378734|P11|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1037781|NCT00112437|3378735|P10|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1037782|NCT00112437|3378736|P9|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1037783|NCT00112437|3378737|P8|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1037784|NCT00112437|3378738|P7|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1037785|NCT00112437|3378739|P6|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1037786|NCT00112437|3378740|P5|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1037787|NCT00112437|3378741|P4|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1037788|NCT00112437|3378742|P3|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1037789|NCT00112437|3378743|P2|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1037790|NCT00112437|3378744|P1|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1037791|NCT00112437|3378719|P26|Years 4-5 (24-Month Extension)|Participant moved|0
1037792|NCT00112437|3378720|P25|Years 4-5 (24-Month Extension)|Participant moved|0
1037793|NCT00112437|3378721|P24|Years 4-5 (24-Month Extension)|Participant moved|0
1037794|NCT00112437|3378722|P23|Years 4-5 (24-Month Extension)|Participant moved|0
1037795|NCT00112437|3378723|P22|Years 4-5 (24-Month Extension)|Participant moved|1
1037796|NCT00112437|3378724|P21|Years 4-5 (24-Month Extension)|Participant moved|0
1037797|NCT00112437|3378725|P20|Years 4-5 (24-Month Extension)|Participant moved|0
1037798|NCT00112437|3378726|P19|Years 4-5 (24-Month Extension)|Participant moved|0
1037799|NCT00112437|3378727|P18|Years 4-5 (24-Month Extension)|Participant moved|0
1037800|NCT00112437|3378728|P17|Years 4-5 (24-Month Extension)|Participant moved|0
1037801|NCT00112437|3378729|P16|Years 4-5 (24-Month Extension)|Participant moved|0
1037802|NCT00112437|3378730|P15|Years 4-5 (24-Month Extension)|Participant moved|0
1037803|NCT00112437|3378731|P14|Years 4-5 (24-Month Extension)|Participant moved|0
1037804|NCT00112437|3378732|P13|Years 4-5 (24-Month Extension)|Participant moved|0
1037805|NCT00112437|3378733|P12|Years 4-5 (24-Month Extension)|Participant moved|0
1037806|NCT00112437|3378734|P11|Years 4-5 (24-Month Extension)|Participant moved|0
1037807|NCT00112437|3378735|P10|Years 4-5 (24-Month Extension)|Participant moved|0
1037808|NCT00112437|3378736|P9|Years 4-5 (24-Month Extension)|Participant moved|0
1037809|NCT00112437|3378737|P8|Years 4-5 (24-Month Extension)|Participant moved|0
1037810|NCT00112437|3378738|P7|Years 4-5 (24-Month Extension)|Participant moved|0
1037811|NCT00112437|3378739|P6|Years 4-5 (24-Month Extension)|Participant moved|0
1037812|NCT00112437|3378740|P5|Years 4-5 (24-Month Extension)|Participant moved|0
1037813|NCT00112437|3378741|P4|Years 4-5 (24-Month Extension)|Participant moved|0
1037814|NCT00112437|3378742|P3|Years 4-5 (24-Month Extension)|Participant moved|0
1037815|NCT00112437|3378743|P2|Years 4-5 (24-Month Extension)|Participant moved|0
1037816|NCT00112437|3378744|P1|Years 4-5 (24-Month Extension)|Participant moved|0
1037817|NCT00112437|3378719|P26|Years 4-5 (24-Month Extension)|Adverse Event|0
1037818|NCT00112437|3378720|P25|Years 4-5 (24-Month Extension)|Adverse Event|0
1037819|NCT00112437|3378721|P24|Years 4-5 (24-Month Extension)|Adverse Event|0
1037820|NCT00112437|3378722|P23|Years 4-5 (24-Month Extension)|Adverse Event|0
1037821|NCT00112437|3378723|P22|Years 4-5 (24-Month Extension)|Adverse Event|4
1037822|NCT00112437|3378724|P21|Years 4-5 (24-Month Extension)|Adverse Event|0
1037823|NCT00112437|3378725|P20|Years 4-5 (24-Month Extension)|Adverse Event|0
1037824|NCT00112437|3378726|P19|Years 4-5 (24-Month Extension)|Adverse Event|0
1037825|NCT00112437|3378727|P18|Years 4-5 (24-Month Extension)|Adverse Event|0
1037826|NCT00112437|3378728|P17|Years 4-5 (24-Month Extension)|Adverse Event|0
1037827|NCT00112437|3378729|P16|Years 4-5 (24-Month Extension)|Adverse Event|0
1037828|NCT00112437|3378730|P15|Years 4-5 (24-Month Extension)|Adverse Event|0
1037829|NCT00112437|3378731|P14|Years 4-5 (24-Month Extension)|Adverse Event|0
1037830|NCT00112437|3378732|P13|Years 4-5 (24-Month Extension)|Adverse Event|0
1037831|NCT00112437|3378733|P12|Years 4-5 (24-Month Extension)|Adverse Event|0
1037832|NCT00112437|3378734|P11|Years 4-5 (24-Month Extension)|Adverse Event|0
1037833|NCT00112437|3378735|P10|Years 4-5 (24-Month Extension)|Adverse Event|0
1037834|NCT00112437|3378736|P9|Years 4-5 (24-Month Extension)|Adverse Event|0
1037835|NCT00112437|3378737|P8|Years 4-5 (24-Month Extension)|Adverse Event|0
1037836|NCT00112437|3378738|P7|Years 4-5 (24-Month Extension)|Adverse Event|0
1037837|NCT00112437|3378739|P6|Years 4-5 (24-Month Extension)|Adverse Event|0
1037838|NCT00112437|3378740|P5|Years 4-5 (24-Month Extension)|Adverse Event|0
1037839|NCT00112437|3378741|P4|Years 4-5 (24-Month Extension)|Adverse Event|0
1037840|NCT00112437|3378742|P3|Years 4-5 (24-Month Extension)|Adverse Event|0
1037841|NCT00112437|3378743|P2|Years 4-5 (24-Month Extension)|Adverse Event|0
1037842|NCT00112437|3378744|P1|Years 4-5 (24-Month Extension)|Adverse Event|0
1037843|NCT00112437|3378719|P26|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1037844|NCT00112437|3378720|P25|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1037845|NCT00112437|3378721|P24|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1037846|NCT00112437|3378722|P23|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1037847|NCT00112437|3378723|P22|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1037848|NCT00112437|3378724|P21|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1
1037849|NCT00112437|3378725|P20|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1037850|NCT00112437|3378726|P19|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1037851|NCT00112437|3378727|P18|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1037852|NCT00112437|3378728|P17|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1037853|NCT00112437|3378729|P16|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1037854|NCT00112437|3378730|P15|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1037855|NCT00112437|3378731|P14|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1037856|NCT00112437|3378732|P13|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1037857|NCT00112437|3378733|P12|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1037858|NCT00112437|3378734|P11|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1037859|NCT00112437|3378735|P10|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1037860|NCT00112437|3378736|P9|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1037861|NCT00112437|3378737|P8|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1037862|NCT00112437|3378738|P7|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1037863|NCT00112437|3378739|P6|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1037864|NCT00112437|3378740|P5|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1037865|NCT00112437|3378741|P4|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1037866|NCT00112437|3378742|P3|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1037867|NCT00112437|3378743|P2|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1037868|NCT00112437|3378744|P1|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1037869|NCT00112437|3378719|P26|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1037870|NCT00112437|3378720|P25|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1037871|NCT00112437|3378721|P24|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1037872|NCT00112437|3378722|P23|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1037873|NCT00112437|3378723|P22|Years 4-5 (24-Month Extension)|Lack of Efficacy|1
1037874|NCT00112437|3378724|P21|Years 4-5 (24-Month Extension)|Lack of Efficacy|2
1037875|NCT00112437|3378725|P20|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1037876|NCT00112437|3378726|P19|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1037877|NCT00112437|3378727|P18|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1037878|NCT00112437|3378728|P17|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1037879|NCT00112437|3378729|P16|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1037880|NCT00112437|3378730|P15|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1037881|NCT00112437|3378731|P14|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1037882|NCT00112437|3378732|P13|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1037883|NCT00112437|3378733|P12|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1037884|NCT00112437|3378734|P11|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1037885|NCT00112437|3378735|P10|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1037886|NCT00112437|3378736|P9|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1037887|NCT00112437|3378737|P8|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1037888|NCT00112437|3378738|P7|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1037889|NCT00112437|3378739|P6|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1037890|NCT00112437|3378740|P5|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1037891|NCT00112437|3378741|P4|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1037892|NCT00112437|3378742|P3|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1037893|NCT00112437|3378743|P2|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1037894|NCT00112437|3378744|P1|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1037895|NCT00112437|3378719|P26|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1037896|NCT00112437|3378720|P25|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1037897|NCT00112437|3378721|P24|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1037898|NCT00112437|3378722|P23|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1037899|NCT00112437|3378723|P22|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1037900|NCT00112437|3378724|P21|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1037901|NCT00112437|3378725|P20|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1037902|NCT00112437|3378726|P19|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1037903|NCT00112437|3378727|P18|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1037904|NCT00112437|3378728|P17|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1037905|NCT00112437|3378729|P16|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1037906|NCT00112437|3378730|P15|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1037907|NCT00112437|3378731|P14|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1037908|NCT00112437|3378732|P13|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1037909|NCT00112437|3378733|P12|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
1037910|NCT00112437|3378734|P11|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
1037911|NCT00112437|3378735|P10|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1037912|NCT00112437|3378736|P9|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1037913|NCT00112437|3378737|P8|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1037914|NCT00112437|3378738|P7|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1037915|NCT00112437|3378739|P6|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1037916|NCT00112437|3378740|P5|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1037917|NCT00112437|3378741|P4|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1037918|NCT00112437|3378742|P3|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1037919|NCT00112437|3378743|P2|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1037920|NCT00112437|3378744|P1|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1037921|NCT00112437|3378719|P26|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1037922|NCT00112437|3378720|P25|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1037923|NCT00112437|3378721|P24|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1037924|NCT00112437|3378722|P23|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1037925|NCT00112437|3378723|P22|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1037926|NCT00112437|3378724|P21|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1037927|NCT00112437|3378725|P20|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1037928|NCT00112437|3378726|P19|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1037929|NCT00112437|3378727|P18|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1037930|NCT00112437|3378728|P17|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1037931|NCT00112437|3378729|P16|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1037932|NCT00112437|3378730|P15|Year 3 (12-Month Extension)|Withdrawal by Subject|1
1037933|NCT00112437|3378731|P14|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1037934|NCT00112437|3378732|P13|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1037935|NCT00112437|3378733|P12|Year 3 (12-Month Extension)|Withdrawal by Subject|3
1037936|NCT00112437|3378734|P11|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1037937|NCT00112437|3378735|P10|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1037938|NCT00112437|3378736|P9|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1037939|NCT00112437|3378737|P8|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1037940|NCT00112437|3378738|P7|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1037941|NCT00112437|3378739|P6|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1037942|NCT00112437|3378740|P5|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1037943|NCT00112437|3378741|P4|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1037944|NCT00112437|3378742|P3|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1037945|NCT00112437|3378743|P2|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1037946|NCT00112437|3378744|P1|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1037947|NCT00112437|3378719|P26|Year 3 (12-Month Extension)|Protocol Violation|0
1037948|NCT00112437|3378720|P25|Year 3 (12-Month Extension)|Protocol Violation|0
1037949|NCT00112437|3378721|P24|Year 3 (12-Month Extension)|Protocol Violation|0
1037950|NCT00112437|3378722|P23|Year 3 (12-Month Extension)|Protocol Violation|0
1037951|NCT00112437|3378723|P22|Year 3 (12-Month Extension)|Protocol Violation|0
1037952|NCT00112437|3378724|P21|Year 3 (12-Month Extension)|Protocol Violation|0
1037953|NCT00112437|3378725|P20|Year 3 (12-Month Extension)|Protocol Violation|0
1037954|NCT00112437|3378726|P19|Year 3 (12-Month Extension)|Protocol Violation|0
1037955|NCT00112437|3378727|P18|Year 3 (12-Month Extension)|Protocol Violation|0
1037956|NCT00112437|3378728|P17|Year 3 (12-Month Extension)|Protocol Violation|0
1037957|NCT00112437|3378729|P16|Year 3 (12-Month Extension)|Protocol Violation|1
1037958|NCT00112437|3378730|P15|Year 3 (12-Month Extension)|Protocol Violation|0
1037959|NCT00112437|3378731|P14|Year 3 (12-Month Extension)|Protocol Violation|0
1037960|NCT00112437|3378732|P13|Year 3 (12-Month Extension)|Protocol Violation|0
1037961|NCT00112437|3378733|P12|Year 3 (12-Month Extension)|Protocol Violation|0
1037962|NCT00112437|3378734|P11|Year 3 (12-Month Extension)|Protocol Violation|0
1037963|NCT00112437|3378735|P10|Year 3 (12-Month Extension)|Protocol Violation|0
1037964|NCT00112437|3378736|P9|Year 3 (12-Month Extension)|Protocol Violation|0
1037965|NCT00112437|3378737|P8|Year 3 (12-Month Extension)|Protocol Violation|0
1037966|NCT00112437|3378738|P7|Year 3 (12-Month Extension)|Protocol Violation|0
1037967|NCT00112437|3378739|P6|Year 3 (12-Month Extension)|Protocol Violation|0
1037968|NCT00112437|3378740|P5|Year 3 (12-Month Extension)|Protocol Violation|0
1037969|NCT00112437|3378741|P4|Year 3 (12-Month Extension)|Protocol Violation|0
1037970|NCT00112437|3378742|P3|Year 3 (12-Month Extension)|Protocol Violation|0
1037971|NCT00112437|3378743|P2|Year 3 (12-Month Extension)|Protocol Violation|0
1037972|NCT00112437|3378744|P1|Year 3 (12-Month Extension)|Protocol Violation|0
1037973|NCT00112437|3378719|P26|Year 3 (12-Month Extension)|Lost to Follow-up|0
1037974|NCT00112437|3378720|P25|Year 3 (12-Month Extension)|Lost to Follow-up|0
1037975|NCT00112437|3378721|P24|Year 3 (12-Month Extension)|Lost to Follow-up|0
1037976|NCT00112437|3378722|P23|Year 3 (12-Month Extension)|Lost to Follow-up|0
1037977|NCT00112437|3378723|P22|Year 3 (12-Month Extension)|Lost to Follow-up|0
1037978|NCT00112437|3378724|P21|Year 3 (12-Month Extension)|Lost to Follow-up|0
1037979|NCT00112437|3378725|P20|Year 3 (12-Month Extension)|Lost to Follow-up|0
1037980|NCT00112437|3378726|P19|Year 3 (12-Month Extension)|Lost to Follow-up|0
1037981|NCT00112437|3378727|P18|Year 3 (12-Month Extension)|Lost to Follow-up|0
1037982|NCT00112437|3378728|P17|Year 3 (12-Month Extension)|Lost to Follow-up|0
1037983|NCT00112437|3378729|P16|Year 3 (12-Month Extension)|Lost to Follow-up|1
1037984|NCT00112437|3378730|P15|Year 3 (12-Month Extension)|Lost to Follow-up|0
1037985|NCT00112437|3378731|P14|Year 3 (12-Month Extension)|Lost to Follow-up|0
1037986|NCT00112437|3378732|P13|Year 3 (12-Month Extension)|Lost to Follow-up|0
1037987|NCT00112437|3378733|P12|Year 3 (12-Month Extension)|Lost to Follow-up|0
1037988|NCT00112437|3378734|P11|Year 3 (12-Month Extension)|Lost to Follow-up|0
1037989|NCT00112437|3378735|P10|Year 3 (12-Month Extension)|Lost to Follow-up|0
1037990|NCT00112437|3378736|P9|Year 3 (12-Month Extension)|Lost to Follow-up|0
1037991|NCT00112437|3378737|P8|Year 3 (12-Month Extension)|Lost to Follow-up|0
1037992|NCT00112437|3378738|P7|Year 3 (12-Month Extension)|Lost to Follow-up|0
1037993|NCT00112437|3378739|P6|Year 3 (12-Month Extension)|Lost to Follow-up|0
1037994|NCT00112437|3378740|P5|Year 3 (12-Month Extension)|Lost to Follow-up|0
1037995|NCT00112437|3378741|P4|Year 3 (12-Month Extension)|Lost to Follow-up|0
1037996|NCT00112437|3378742|P3|Year 3 (12-Month Extension)|Lost to Follow-up|0
1037997|NCT00112437|3378743|P2|Year 3 (12-Month Extension)|Lost to Follow-up|0
1037998|NCT00112437|3378744|P1|Year 3 (12-Month Extension)|Lost to Follow-up|0
1037999|NCT00112437|3378719|P26|Year 3 (12-Month Extension)|Lack of Efficacy|0
1038000|NCT00112437|3378720|P25|Year 3 (12-Month Extension)|Lack of Efficacy|0
1038001|NCT00112437|3378721|P24|Year 3 (12-Month Extension)|Lack of Efficacy|0
1038002|NCT00112437|3378722|P23|Year 3 (12-Month Extension)|Lack of Efficacy|0
1038003|NCT00112437|3378723|P22|Year 3 (12-Month Extension)|Lack of Efficacy|0
1038004|NCT00112437|3378724|P21|Year 3 (12-Month Extension)|Lack of Efficacy|0
1038005|NCT00112437|3378725|P20|Year 3 (12-Month Extension)|Lack of Efficacy|0
1038006|NCT00112437|3378726|P19|Year 3 (12-Month Extension)|Lack of Efficacy|2
1038007|NCT00112437|3378727|P18|Year 3 (12-Month Extension)|Lack of Efficacy|0
1038008|NCT00112437|3378728|P17|Year 3 (12-Month Extension)|Lack of Efficacy|0
1038009|NCT00112437|3378729|P16|Year 3 (12-Month Extension)|Lack of Efficacy|1
1038010|NCT00112437|3378730|P15|Year 3 (12-Month Extension)|Lack of Efficacy|0
1038011|NCT00112437|3378731|P14|Year 3 (12-Month Extension)|Lack of Efficacy|1
1038012|NCT00112437|3378732|P13|Year 3 (12-Month Extension)|Lack of Efficacy|0
1038013|NCT00112437|3378733|P12|Year 3 (12-Month Extension)|Lack of Efficacy|1
1038014|NCT00112437|3378734|P11|Year 3 (12-Month Extension)|Lack of Efficacy|0
1038015|NCT00112437|3378735|P10|Year 3 (12-Month Extension)|Lack of Efficacy|0
1038016|NCT00112437|3378736|P9|Year 3 (12-Month Extension)|Lack of Efficacy|0
1038017|NCT00112437|3378737|P8|Year 3 (12-Month Extension)|Lack of Efficacy|0
1038018|NCT00112437|3378738|P7|Year 3 (12-Month Extension)|Lack of Efficacy|0
1038019|NCT00112437|3378739|P6|Year 3 (12-Month Extension)|Lack of Efficacy|0
1038020|NCT00112437|3378740|P5|Year 3 (12-Month Extension)|Lack of Efficacy|0
1038021|NCT00112437|3378741|P4|Year 3 (12-Month Extension)|Lack of Efficacy|0
1038022|NCT00112437|3378742|P3|Year 3 (12-Month Extension)|Lack of Efficacy|0
1038023|NCT00112437|3378743|P2|Year 3 (12-Month Extension)|Lack of Efficacy|0
1038024|NCT00112437|3378744|P1|Year 3 (12-Month Extension)|Lack of Efficacy|0
1038025|NCT00112437|3378719|P26|Year 3 (12-Month Extension)|Adverse Event|0
1038026|NCT00112437|3378720|P25|Year 3 (12-Month Extension)|Adverse Event|0
1038027|NCT00112437|3378721|P24|Year 3 (12-Month Extension)|Adverse Event|0
1038028|NCT00112437|3378722|P23|Year 3 (12-Month Extension)|Adverse Event|0
1038029|NCT00112437|3378723|P22|Year 3 (12-Month Extension)|Adverse Event|0
1038030|NCT00112437|3378724|P21|Year 3 (12-Month Extension)|Adverse Event|0
1038031|NCT00112437|3378725|P20|Year 3 (12-Month Extension)|Adverse Event|1
1038032|NCT00112437|3378726|P19|Year 3 (12-Month Extension)|Adverse Event|0
1038033|NCT00112437|3378727|P18|Year 3 (12-Month Extension)|Adverse Event|1
1038034|NCT00112437|3378728|P17|Year 3 (12-Month Extension)|Adverse Event|3
1038035|NCT00112437|3378729|P16|Year 3 (12-Month Extension)|Adverse Event|1
1038036|NCT00112437|3378730|P15|Year 3 (12-Month Extension)|Adverse Event|0
1038037|NCT00112437|3378731|P14|Year 3 (12-Month Extension)|Adverse Event|0
1038038|NCT00112437|3378732|P13|Year 3 (12-Month Extension)|Adverse Event|0
1038039|NCT00112437|3378733|P12|Year 3 (12-Month Extension)|Adverse Event|0
1038040|NCT00112437|3378734|P11|Year 3 (12-Month Extension)|Adverse Event|1
1038041|NCT00112437|3378735|P10|Year 3 (12-Month Extension)|Adverse Event|0
1038042|NCT00112437|3378736|P9|Year 3 (12-Month Extension)|Adverse Event|0
1038043|NCT00112437|3378737|P8|Year 3 (12-Month Extension)|Adverse Event|0
1038044|NCT00112437|3378738|P7|Year 3 (12-Month Extension)|Adverse Event|0
1038045|NCT00112437|3378739|P6|Year 3 (12-Month Extension)|Adverse Event|0
1038046|NCT00112437|3378740|P5|Year 3 (12-Month Extension)|Adverse Event|0
1038047|NCT00112437|3378741|P4|Year 3 (12-Month Extension)|Adverse Event|0
1038048|NCT00112437|3378742|P3|Year 3 (12-Month Extension)|Adverse Event|0
1038049|NCT00112437|3378743|P2|Year 3 (12-Month Extension)|Adverse Event|0
1038050|NCT00112437|3378744|P1|Year 3 (12-Month Extension)|Adverse Event|0
1038051|NCT00112437|3378719|P26|Year 2 (12-Month Extension)|Moved|0
1038052|NCT00112437|3378720|P25|Year 2 (12-Month Extension)|Moved|0
1038053|NCT00112437|3378721|P24|Year 2 (12-Month Extension)|Moved|0
1038054|NCT00112437|3378722|P23|Year 2 (12-Month Extension)|Moved|0
1038055|NCT00112437|3378723|P22|Year 2 (12-Month Extension)|Moved|0
1038056|NCT00112437|3378724|P21|Year 2 (12-Month Extension)|Moved|0
1038057|NCT00112437|3378725|P20|Year 2 (12-Month Extension)|Moved|0
1038058|NCT00112437|3378726|P19|Year 2 (12-Month Extension)|Moved|0
1038059|NCT00112437|3378727|P18|Year 2 (12-Month Extension)|Moved|0
1038060|NCT00112437|3378728|P17|Year 2 (12-Month Extension)|Moved|0
1038061|NCT00112437|3378729|P16|Year 2 (12-Month Extension)|Moved|0
1038062|NCT00112437|3378730|P15|Year 2 (12-Month Extension)|Moved|0
1038063|NCT00112437|3378731|P14|Year 2 (12-Month Extension)|Moved|0
1038064|NCT00112437|3378732|P13|Year 2 (12-Month Extension)|Moved|0
1038065|NCT00112437|3378733|P12|Year 2 (12-Month Extension)|Moved|0
1038066|NCT00112437|3378734|P11|Year 2 (12-Month Extension)|Moved|0
1038067|NCT00112437|3378735|P10|Year 2 (12-Month Extension)|Moved|1
1038068|NCT00112437|3378736|P9|Year 2 (12-Month Extension)|Moved|0
1038069|NCT00112437|3378737|P8|Year 2 (12-Month Extension)|Moved|0
1038070|NCT00112437|3378738|P7|Year 2 (12-Month Extension)|Moved|0
1038071|NCT00112437|3378739|P6|Year 2 (12-Month Extension)|Moved|0
1038072|NCT00112437|3378740|P5|Year 2 (12-Month Extension)|Moved|0
1038073|NCT00112437|3378741|P4|Year 2 (12-Month Extension)|Moved|0
1038074|NCT00112437|3378742|P3|Year 2 (12-Month Extension)|Moved|0
1038075|NCT00112437|3378743|P2|Year 2 (12-Month Extension)|Moved|0
1038076|NCT00112437|3378744|P1|Year 2 (12-Month Extension)|Moved|0
1038077|NCT00112437|3378719|P26|Year 2 (12-Month Extension)|patient was out of windows|0
1038078|NCT00112437|3378720|P25|Year 2 (12-Month Extension)|patient was out of windows|0
1038079|NCT00112437|3378721|P24|Year 2 (12-Month Extension)|patient was out of windows|0
1038080|NCT00112437|3378722|P23|Year 2 (12-Month Extension)|patient was out of windows|0
1038081|NCT00112437|3378723|P22|Year 2 (12-Month Extension)|patient was out of windows|0
1038082|NCT00112437|3378724|P21|Year 2 (12-Month Extension)|patient was out of windows|0
1038083|NCT00112437|3378725|P20|Year 2 (12-Month Extension)|patient was out of windows|0
1038084|NCT00112437|3378726|P19|Year 2 (12-Month Extension)|patient was out of windows|0
1038085|NCT00112437|3378727|P18|Year 2 (12-Month Extension)|patient was out of windows|0
1038086|NCT00112437|3378728|P17|Year 2 (12-Month Extension)|patient was out of windows|0
1038087|NCT00112437|3378729|P16|Year 2 (12-Month Extension)|patient was out of windows|0
1038088|NCT00112437|3378730|P15|Year 2 (12-Month Extension)|patient was out of windows|0
1038089|NCT00112437|3378731|P14|Year 2 (12-Month Extension)|patient was out of windows|0
1038090|NCT00112437|3378732|P13|Year 2 (12-Month Extension)|patient was out of windows|0
1038091|NCT00112437|3378733|P12|Year 2 (12-Month Extension)|patient was out of windows|0
1038092|NCT00112437|3378734|P11|Year 2 (12-Month Extension)|patient was out of windows|0
1038093|NCT00112437|3378735|P10|Year 2 (12-Month Extension)|patient was out of windows|1
1038094|NCT00112437|3378736|P9|Year 2 (12-Month Extension)|patient was out of windows|0
1038095|NCT00112437|3378737|P8|Year 2 (12-Month Extension)|patient was out of windows|0
1038096|NCT00112437|3378738|P7|Year 2 (12-Month Extension)|patient was out of windows|0
1038097|NCT00112437|3378739|P6|Year 2 (12-Month Extension)|patient was out of windows|0
1038098|NCT00112437|3378740|P5|Year 2 (12-Month Extension)|patient was out of windows|0
1038099|NCT00112437|3378741|P4|Year 2 (12-Month Extension)|patient was out of windows|0
1038100|NCT00112437|3378742|P3|Year 2 (12-Month Extension)|patient was out of windows|0
1038101|NCT00112437|3378743|P2|Year 2 (12-Month Extension)|patient was out of windows|0
1038102|NCT00112437|3378744|P1|Year 2 (12-Month Extension)|patient was out of windows|0
1038103|NCT00112437|3378719|P26|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1038104|NCT00112437|3378720|P25|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1038105|NCT00112437|3378721|P24|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1038106|NCT00112437|3378722|P23|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1038107|NCT00112437|3378723|P22|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1038108|NCT00112437|3378724|P21|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1038109|NCT00112437|3378725|P20|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1038110|NCT00112437|3378726|P19|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1038111|NCT00112437|3378727|P18|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1038112|NCT00112437|3378728|P17|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1038113|NCT00112437|3378729|P16|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1038114|NCT00112437|3378730|P15|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1038115|NCT00112437|3378731|P14|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1038116|NCT00112437|3378732|P13|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1038117|NCT00112437|3378733|P12|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1038118|NCT00112437|3378734|P11|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1038119|NCT00112437|3378735|P10|Year 2 (12-Month Extension)|Patient stopped taking medication|1
1038120|NCT00112437|3378736|P9|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1038121|NCT00112437|3378737|P8|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1038122|NCT00112437|3378738|P7|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1038123|NCT00112437|3378739|P6|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1038124|NCT00112437|3378740|P5|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1038125|NCT00112437|3378741|P4|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1038126|NCT00112437|3378742|P3|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1038127|NCT00112437|3378743|P2|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1038128|NCT00112437|3378744|P1|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1038129|NCT00112437|3378719|P26|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1038130|NCT00112437|3378720|P25|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1038131|NCT00112437|3378721|P24|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1038132|NCT00112437|3378722|P23|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1038133|NCT00112437|3378723|P22|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1038134|NCT00112437|3378724|P21|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1038135|NCT00112437|3378725|P20|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1038136|NCT00112437|3378726|P19|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1038137|NCT00112437|3378727|P18|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1038138|NCT00112437|3378728|P17|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1038139|NCT00112437|3378729|P16|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1038140|NCT00112437|3378730|P15|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1038141|NCT00112437|3378731|P14|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1038142|NCT00112437|3378732|P13|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1038143|NCT00112437|3378733|P12|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1038144|NCT00112437|3378734|P11|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1038145|NCT00112437|3378735|P10|Year 2 (12-Month Extension)|Withdrawal by Subject|1
1038146|NCT00112437|3378736|P9|Year 2 (12-Month Extension)|Withdrawal by Subject|4
1038147|NCT00112437|3378737|P8|Year 2 (12-Month Extension)|Withdrawal by Subject|2
1038148|NCT00112437|3378738|P7|Year 2 (12-Month Extension)|Withdrawal by Subject|1
1038149|NCT00112437|3378739|P6|Year 2 (12-Month Extension)|Withdrawal by Subject|1
1038150|NCT00112437|3378740|P5|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1038151|NCT00112437|3378741|P4|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1038152|NCT00112437|3378742|P3|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1038153|NCT00112437|3378743|P2|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1038154|NCT00112437|3378744|P1|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1038155|NCT00112437|3378719|P26|Year 2 (12-Month Extension)|Protocol Violation|0
1038156|NCT00112437|3378720|P25|Year 2 (12-Month Extension)|Protocol Violation|0
1038157|NCT00112437|3378721|P24|Year 2 (12-Month Extension)|Protocol Violation|0
1038158|NCT00112437|3378722|P23|Year 2 (12-Month Extension)|Protocol Violation|0
1038159|NCT00112437|3378723|P22|Year 2 (12-Month Extension)|Protocol Violation|0
1038160|NCT00112437|3378724|P21|Year 2 (12-Month Extension)|Protocol Violation|0
1038161|NCT00112437|3378725|P20|Year 2 (12-Month Extension)|Protocol Violation|0
1038162|NCT00112437|3378726|P19|Year 2 (12-Month Extension)|Protocol Violation|0
1038163|NCT00112437|3378727|P18|Year 2 (12-Month Extension)|Protocol Violation|0
1038164|NCT00112437|3378728|P17|Year 2 (12-Month Extension)|Protocol Violation|0
1038165|NCT00112437|3378729|P16|Year 2 (12-Month Extension)|Protocol Violation|0
1038166|NCT00112437|3378730|P15|Year 2 (12-Month Extension)|Protocol Violation|0
1038167|NCT00112437|3378731|P14|Year 2 (12-Month Extension)|Protocol Violation|0
1038168|NCT00112437|3378732|P13|Year 2 (12-Month Extension)|Protocol Violation|0
1038169|NCT00112437|3378733|P12|Year 2 (12-Month Extension)|Protocol Violation|0
1038170|NCT00112437|3378734|P11|Year 2 (12-Month Extension)|Protocol Violation|0
1038171|NCT00112437|3378735|P10|Year 2 (12-Month Extension)|Protocol Violation|0
1038172|NCT00112437|3378736|P9|Year 2 (12-Month Extension)|Protocol Violation|1
1038173|NCT00112437|3378737|P8|Year 2 (12-Month Extension)|Protocol Violation|0
1038174|NCT00112437|3378738|P7|Year 2 (12-Month Extension)|Protocol Violation|0
1038175|NCT00112437|3378739|P6|Year 2 (12-Month Extension)|Protocol Violation|0
1038176|NCT00112437|3378740|P5|Year 2 (12-Month Extension)|Protocol Violation|0
1038177|NCT00112437|3378741|P4|Year 2 (12-Month Extension)|Protocol Violation|0
1038178|NCT00112437|3378742|P3|Year 2 (12-Month Extension)|Protocol Violation|0
1038179|NCT00112437|3378743|P2|Year 2 (12-Month Extension)|Protocol Violation|0
1038180|NCT00112437|3378744|P1|Year 2 (12-Month Extension)|Protocol Violation|0
1038181|NCT00112437|3378719|P26|Year 2 (12-Month Extension)|Lost to Follow-up|0
1038182|NCT00112437|3378720|P25|Year 2 (12-Month Extension)|Lost to Follow-up|0
1038183|NCT00112437|3378721|P24|Year 2 (12-Month Extension)|Lost to Follow-up|0
1038184|NCT00112437|3378722|P23|Year 2 (12-Month Extension)|Lost to Follow-up|0
1038185|NCT00112437|3378723|P22|Year 2 (12-Month Extension)|Lost to Follow-up|0
1038186|NCT00112437|3378724|P21|Year 2 (12-Month Extension)|Lost to Follow-up|0
1038187|NCT00112437|3378725|P20|Year 2 (12-Month Extension)|Lost to Follow-up|0
1038188|NCT00112437|3378726|P19|Year 2 (12-Month Extension)|Lost to Follow-up|0
1038189|NCT00112437|3378727|P18|Year 2 (12-Month Extension)|Lost to Follow-up|0
1038190|NCT00112437|3378728|P17|Year 2 (12-Month Extension)|Lost to Follow-up|0
1038191|NCT00112437|3378729|P16|Year 2 (12-Month Extension)|Lost to Follow-up|0
1038192|NCT00112437|3378730|P15|Year 2 (12-Month Extension)|Lost to Follow-up|0
1038193|NCT00112437|3378731|P14|Year 2 (12-Month Extension)|Lost to Follow-up|0
1038194|NCT00112437|3378732|P13|Year 2 (12-Month Extension)|Lost to Follow-up|0
1038195|NCT00112437|3378733|P12|Year 2 (12-Month Extension)|Lost to Follow-up|0
1038196|NCT00112437|3378734|P11|Year 2 (12-Month Extension)|Lost to Follow-up|0
1038197|NCT00112437|3378735|P10|Year 2 (12-Month Extension)|Lost to Follow-up|0
1038198|NCT00112437|3378736|P9|Year 2 (12-Month Extension)|Lost to Follow-up|1
1038199|NCT00112437|3378737|P8|Year 2 (12-Month Extension)|Lost to Follow-up|0
1038200|NCT00112437|3378738|P7|Year 2 (12-Month Extension)|Lost to Follow-up|0
1038201|NCT00112437|3378739|P6|Year 2 (12-Month Extension)|Lost to Follow-up|0
1038202|NCT00112437|3378740|P5|Year 2 (12-Month Extension)|Lost to Follow-up|0
1038203|NCT00112437|3378741|P4|Year 2 (12-Month Extension)|Lost to Follow-up|0
1038204|NCT00112437|3378742|P3|Year 2 (12-Month Extension)|Lost to Follow-up|0
1038205|NCT00112437|3378743|P2|Year 2 (12-Month Extension)|Lost to Follow-up|0
1038206|NCT00112437|3378744|P1|Year 2 (12-Month Extension)|Lost to Follow-up|0
1038207|NCT00112437|3378719|P26|Year 2 (12-Month Extension)|Lack of Efficacy|0
1038208|NCT00112437|3378720|P25|Year 2 (12-Month Extension)|Lack of Efficacy|0
1038209|NCT00112437|3378721|P24|Year 2 (12-Month Extension)|Lack of Efficacy|0
1038210|NCT00112437|3378722|P23|Year 2 (12-Month Extension)|Lack of Efficacy|0
1038211|NCT00112437|3378723|P22|Year 2 (12-Month Extension)|Lack of Efficacy|0
1038212|NCT00112437|3378724|P21|Year 2 (12-Month Extension)|Lack of Efficacy|0
1038213|NCT00112437|3378725|P20|Year 2 (12-Month Extension)|Lack of Efficacy|0
1038214|NCT00112437|3378726|P19|Year 2 (12-Month Extension)|Lack of Efficacy|0
1038215|NCT00112437|3378727|P18|Year 2 (12-Month Extension)|Lack of Efficacy|0
1038216|NCT00112437|3378728|P17|Year 2 (12-Month Extension)|Lack of Efficacy|0
1038217|NCT00112437|3378729|P16|Year 2 (12-Month Extension)|Lack of Efficacy|0
1038218|NCT00112437|3378730|P15|Year 2 (12-Month Extension)|Lack of Efficacy|0
1038219|NCT00112437|3378731|P14|Year 2 (12-Month Extension)|Lack of Efficacy|0
1038220|NCT00112437|3378732|P13|Year 2 (12-Month Extension)|Lack of Efficacy|0
1038221|NCT00112437|3378733|P12|Year 2 (12-Month Extension)|Lack of Efficacy|0
1038222|NCT00112437|3378734|P11|Year 2 (12-Month Extension)|Lack of Efficacy|0
1038223|NCT00112437|3378735|P10|Year 2 (12-Month Extension)|Lack of Efficacy|2
1038224|NCT00112437|3378736|P9|Year 2 (12-Month Extension)|Lack of Efficacy|0
1038225|NCT00112437|3378737|P8|Year 2 (12-Month Extension)|Lack of Efficacy|0
1038226|NCT00112437|3378738|P7|Year 2 (12-Month Extension)|Lack of Efficacy|6
1038227|NCT00112437|3378739|P6|Year 2 (12-Month Extension)|Lack of Efficacy|1
1038228|NCT00112437|3378740|P5|Year 2 (12-Month Extension)|Lack of Efficacy|0
1038229|NCT00112437|3378741|P4|Year 2 (12-Month Extension)|Lack of Efficacy|0
1038230|NCT00112437|3378742|P3|Year 2 (12-Month Extension)|Lack of Efficacy|0
1038231|NCT00112437|3378743|P2|Year 2 (12-Month Extension)|Lack of Efficacy|0
1038232|NCT00112437|3378744|P1|Year 2 (12-Month Extension)|Lack of Efficacy|0
1038233|NCT00112437|3378719|P26|Year 2 (12-Month Extension)|Adverse Event|0
1038234|NCT00112437|3378720|P25|Year 2 (12-Month Extension)|Adverse Event|0
1038235|NCT00112437|3378721|P24|Year 2 (12-Month Extension)|Adverse Event|0
1038236|NCT00112437|3378722|P23|Year 2 (12-Month Extension)|Adverse Event|0
1038237|NCT00112437|3378723|P22|Year 2 (12-Month Extension)|Adverse Event|0
1038238|NCT00112437|3378724|P21|Year 2 (12-Month Extension)|Adverse Event|0
1038239|NCT00112437|3378725|P20|Year 2 (12-Month Extension)|Adverse Event|0
1038240|NCT00112437|3378726|P19|Year 2 (12-Month Extension)|Adverse Event|0
1038241|NCT00112437|3378727|P18|Year 2 (12-Month Extension)|Adverse Event|0
1038242|NCT00112437|3378728|P17|Year 2 (12-Month Extension)|Adverse Event|0
1038243|NCT00112437|3378729|P16|Year 2 (12-Month Extension)|Adverse Event|0
1038244|NCT00112437|3378730|P15|Year 2 (12-Month Extension)|Adverse Event|0
1038245|NCT00112437|3378731|P14|Year 2 (12-Month Extension)|Adverse Event|0
1038246|NCT00112437|3378732|P13|Year 2 (12-Month Extension)|Adverse Event|0
1038247|NCT00112437|3378733|P12|Year 2 (12-Month Extension)|Adverse Event|0
1038248|NCT00112437|3378734|P11|Year 2 (12-Month Extension)|Adverse Event|0
1038249|NCT00112437|3378735|P10|Year 2 (12-Month Extension)|Adverse Event|7
1038250|NCT00112437|3378736|P9|Year 2 (12-Month Extension)|Adverse Event|1
1038251|NCT00112437|3378737|P8|Year 2 (12-Month Extension)|Adverse Event|6
1038252|NCT00112437|3378738|P7|Year 2 (12-Month Extension)|Adverse Event|2
1038253|NCT00112437|3378739|P6|Year 2 (12-Month Extension)|Adverse Event|1
1038254|NCT00112437|3378740|P5|Year 2 (12-Month Extension)|Adverse Event|0
1038255|NCT00112437|3378741|P4|Year 2 (12-Month Extension)|Adverse Event|0
1038256|NCT00112437|3378742|P3|Year 2 (12-Month Extension)|Adverse Event|0
1038257|NCT00112437|3378743|P2|Year 2 (12-Month Extension)|Adverse Event|0
1038258|NCT00112437|3378744|P1|Year 2 (12-Month Extension)|Adverse Event|0
1038259|NCT00112437|3378719|P26|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1038260|NCT00112437|3378720|P25|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1038261|NCT00112437|3378721|P24|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1038262|NCT00112437|3378722|P23|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1038263|NCT00112437|3378723|P22|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1038264|NCT00112437|3378724|P21|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1038265|NCT00112437|3378725|P20|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1038266|NCT00112437|3378726|P19|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1038267|NCT00112437|3378727|P18|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1038268|NCT00112437|3378728|P17|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1038269|NCT00112437|3378729|P16|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1038270|NCT00112437|3378730|P15|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1038271|NCT00112437|3378731|P14|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1038272|NCT00112437|3378732|P13|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1038273|NCT00112437|3378733|P12|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1038274|NCT00112437|3378734|P11|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1038275|NCT00112437|3378735|P10|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1038276|NCT00112437|3378736|P9|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1038277|NCT00112437|3378737|P8|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1038278|NCT00112437|3378738|P7|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1038279|NCT00112437|3378739|P6|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1038280|NCT00112437|3378740|P5|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1
1038281|NCT00112437|3378741|P4|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1038282|NCT00112437|3378742|P3|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1038283|NCT00112437|3378743|P2|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1038284|NCT00112437|3378744|P1|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1038285|NCT00112437|3378719|P26|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1038286|NCT00112437|3378720|P25|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1038287|NCT00112437|3378721|P24|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1038288|NCT00112437|3378722|P23|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1038289|NCT00112437|3378723|P22|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1038290|NCT00112437|3378724|P21|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1038291|NCT00112437|3378725|P20|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1038292|NCT00112437|3378726|P19|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1038293|NCT00112437|3378727|P18|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1038294|NCT00112437|3378728|P17|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1038295|NCT00112437|3378729|P16|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1038296|NCT00112437|3378730|P15|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1038297|NCT00112437|3378731|P14|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1038298|NCT00112437|3378732|P13|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1038299|NCT00112437|3378733|P12|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1038300|NCT00112437|3378734|P11|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1038301|NCT00112437|3378735|P10|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1038302|NCT00112437|3378736|P9|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1038303|NCT00112437|3378737|P8|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1038304|NCT00112437|3378738|P7|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1038305|NCT00112437|3378739|P6|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1038306|NCT00112437|3378740|P5|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1038307|NCT00112437|3378741|P4|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2
1038308|NCT00112437|3378742|P3|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1038309|NCT00112437|3378743|P2|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1038310|NCT00112437|3378744|P1|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1038311|NCT00112437|3378719|P26|Year 1 (12-Month Base Study)|moved|0
1038312|NCT00112437|3378720|P25|Year 1 (12-Month Base Study)|moved|0
1038313|NCT00112437|3378721|P24|Year 1 (12-Month Base Study)|moved|0
1038314|NCT00112437|3378722|P23|Year 1 (12-Month Base Study)|moved|0
1038315|NCT00112437|3378723|P22|Year 1 (12-Month Base Study)|moved|0
1038316|NCT00112437|3378724|P21|Year 1 (12-Month Base Study)|moved|0
1038317|NCT00112437|3378725|P20|Year 1 (12-Month Base Study)|moved|0
1038318|NCT00112437|3378726|P19|Year 1 (12-Month Base Study)|moved|0
1038319|NCT00112437|3378727|P18|Year 1 (12-Month Base Study)|moved|0
1038320|NCT00112437|3378728|P17|Year 1 (12-Month Base Study)|moved|0
1038321|NCT00112437|3378729|P16|Year 1 (12-Month Base Study)|moved|0
1038322|NCT00112437|3378730|P15|Year 1 (12-Month Base Study)|moved|0
1038323|NCT00112437|3378731|P14|Year 1 (12-Month Base Study)|moved|0
1038324|NCT00112437|3378732|P13|Year 1 (12-Month Base Study)|moved|0
1038325|NCT00112437|3378733|P12|Year 1 (12-Month Base Study)|moved|0
1038326|NCT00112437|3378734|P11|Year 1 (12-Month Base Study)|moved|0
1038327|NCT00112437|3378735|P10|Year 1 (12-Month Base Study)|moved|0
1038328|NCT00112437|3378736|P9|Year 1 (12-Month Base Study)|moved|0
1038329|NCT00112437|3378737|P8|Year 1 (12-Month Base Study)|moved|0
1038330|NCT00112437|3378738|P7|Year 1 (12-Month Base Study)|moved|0
1038331|NCT00112437|3378739|P6|Year 1 (12-Month Base Study)|moved|0
1038332|NCT00112437|3378740|P5|Year 1 (12-Month Base Study)|moved|0
1038333|NCT00112437|3378741|P4|Year 1 (12-Month Base Study)|moved|0
1038334|NCT00112437|3378742|P3|Year 1 (12-Month Base Study)|moved|1
1038335|NCT00112437|3378743|P2|Year 1 (12-Month Base Study)|moved|1
1038336|NCT00112437|3378744|P1|Year 1 (12-Month Base Study)|moved|0
1038337|NCT00112437|3378719|P26|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1038338|NCT00112437|3378720|P25|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1038339|NCT00112437|3378721|P24|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1038340|NCT00112437|3378722|P23|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1038341|NCT00112437|3378723|P22|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1038342|NCT00112437|3378724|P21|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1038343|NCT00112437|3378725|P20|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1038344|NCT00112437|3378726|P19|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1038345|NCT00112437|3378727|P18|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1038346|NCT00112437|3378728|P17|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1038347|NCT00112437|3378729|P16|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1038348|NCT00112437|3378730|P15|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1038349|NCT00112437|3378731|P14|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1038350|NCT00112437|3378732|P13|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1038351|NCT00112437|3378733|P12|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1038352|NCT00112437|3378734|P11|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1038353|NCT00112437|3378735|P10|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1038354|NCT00112437|3378736|P9|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1038355|NCT00112437|3378737|P8|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1038356|NCT00112437|3378738|P7|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1038357|NCT00112437|3378739|P6|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1038358|NCT00112437|3378740|P5|Year 1 (12-Month Base Study)|Withdrawal by Subject|7
1038359|NCT00112437|3378741|P4|Year 1 (12-Month Base Study)|Withdrawal by Subject|1
1038360|NCT00112437|3378742|P3|Year 1 (12-Month Base Study)|Withdrawal by Subject|2
1038361|NCT00112437|3378743|P2|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
1038362|NCT00112437|3378744|P1|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
1038363|NCT00112437|3378719|P26|Year 1 (12-Month Base Study)|Protocol Violation|0
1038364|NCT00112437|3378720|P25|Year 1 (12-Month Base Study)|Protocol Violation|0
1038365|NCT00112437|3378721|P24|Year 1 (12-Month Base Study)|Protocol Violation|0
1038366|NCT00112437|3378722|P23|Year 1 (12-Month Base Study)|Protocol Violation|0
1038367|NCT00112437|3378723|P22|Year 1 (12-Month Base Study)|Protocol Violation|0
1038368|NCT00112437|3378724|P21|Year 1 (12-Month Base Study)|Protocol Violation|0
1038369|NCT00112437|3378725|P20|Year 1 (12-Month Base Study)|Protocol Violation|0
1038370|NCT00112437|3378726|P19|Year 1 (12-Month Base Study)|Protocol Violation|0
1038371|NCT00112437|3378727|P18|Year 1 (12-Month Base Study)|Protocol Violation|0
1038372|NCT00112437|3378728|P17|Year 1 (12-Month Base Study)|Protocol Violation|0
1038373|NCT00112437|3378729|P16|Year 1 (12-Month Base Study)|Protocol Violation|0
1038374|NCT00112437|3378730|P15|Year 1 (12-Month Base Study)|Protocol Violation|0
1038375|NCT00112437|3378731|P14|Year 1 (12-Month Base Study)|Protocol Violation|0
1038376|NCT00112437|3378732|P13|Year 1 (12-Month Base Study)|Protocol Violation|0
1038377|NCT00112437|3378733|P12|Year 1 (12-Month Base Study)|Protocol Violation|0
1038378|NCT00112437|3378734|P11|Year 1 (12-Month Base Study)|Protocol Violation|0
1038379|NCT00112437|3378735|P10|Year 1 (12-Month Base Study)|Protocol Violation|0
1038380|NCT00112437|3378736|P9|Year 1 (12-Month Base Study)|Protocol Violation|0
1038381|NCT00112437|3378737|P8|Year 1 (12-Month Base Study)|Protocol Violation|0
1038382|NCT00112437|3378738|P7|Year 1 (12-Month Base Study)|Protocol Violation|0
1038383|NCT00112437|3378739|P6|Year 1 (12-Month Base Study)|Protocol Violation|0
1038384|NCT00112437|3378740|P5|Year 1 (12-Month Base Study)|Protocol Violation|1
1038385|NCT00112437|3378741|P4|Year 1 (12-Month Base Study)|Protocol Violation|1
1038386|NCT00112437|3378742|P3|Year 1 (12-Month Base Study)|Protocol Violation|3
1038387|NCT00112437|3378743|P2|Year 1 (12-Month Base Study)|Protocol Violation|0
1038388|NCT00112437|3378744|P1|Year 1 (12-Month Base Study)|Protocol Violation|1
1038389|NCT00112437|3378719|P26|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1038390|NCT00112437|3378720|P25|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1038391|NCT00112437|3378721|P24|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1038392|NCT00112437|3378722|P23|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1038393|NCT00112437|3378723|P22|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1038394|NCT00112437|3378724|P21|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1038395|NCT00112437|3378725|P20|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1038396|NCT00112437|3378726|P19|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1038397|NCT00112437|3378727|P18|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1038398|NCT00112437|3378728|P17|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1038399|NCT00112437|3378729|P16|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1038400|NCT00112437|3378730|P15|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1038401|NCT00112437|3378731|P14|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1038402|NCT00112437|3378732|P13|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1038403|NCT00112437|3378733|P12|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1038404|NCT00112437|3378734|P11|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1038405|NCT00112437|3378735|P10|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1038406|NCT00112437|3378736|P9|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1038407|NCT00112437|3378737|P8|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1038408|NCT00112437|3378738|P7|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1038409|NCT00112437|3378739|P6|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1038410|NCT00112437|3378740|P5|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1038411|NCT00112437|3378741|P4|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1038412|NCT00112437|3378742|P3|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1038413|NCT00112437|3378743|P2|Year 1 (12-Month Base Study)|Lost to Follow-up|1
1038414|NCT00112437|3378744|P1|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1038415|NCT00112437|3378719|P26|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1038416|NCT00112437|3378720|P25|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1038417|NCT00112437|3378721|P24|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1038418|NCT00112437|3378722|P23|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1038419|NCT00112437|3378723|P22|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1038420|NCT00112437|3378724|P21|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1038421|NCT00112437|3378725|P20|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1038422|NCT00112437|3378726|P19|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1038423|NCT00112437|3378727|P18|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1038424|NCT00112437|3378728|P17|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1038425|NCT00112437|3378729|P16|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1038426|NCT00112437|3378730|P15|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1038427|NCT00112437|3378731|P14|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1038428|NCT00112437|3378732|P13|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1038429|NCT00112437|3378733|P12|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1038430|NCT00112437|3378734|P11|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1038431|NCT00112437|3378735|P10|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1038432|NCT00112437|3378736|P9|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1038433|NCT00112437|3378737|P8|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1038434|NCT00112437|3378738|P7|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1038435|NCT00112437|3378739|P6|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1038436|NCT00112437|3378740|P5|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1038437|NCT00112437|3378741|P4|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1038438|NCT00112437|3378742|P3|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1038439|NCT00112437|3378743|P2|Year 1 (12-Month Base Study)|Lack of Efficacy|1
1038440|NCT00112437|3378744|P1|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1038441|NCT00112437|3378719|P26|Year 1 (12-Month Base Study)|Adverse Event|0
1038442|NCT00112437|3378720|P25|Year 1 (12-Month Base Study)|Adverse Event|0
1038443|NCT00112437|3378721|P24|Year 1 (12-Month Base Study)|Adverse Event|0
1038444|NCT00112437|3378722|P23|Year 1 (12-Month Base Study)|Adverse Event|0
1038445|NCT00112437|3378723|P22|Year 1 (12-Month Base Study)|Adverse Event|0
1038446|NCT00112437|3378724|P21|Year 1 (12-Month Base Study)|Adverse Event|0
1038447|NCT00112437|3378725|P20|Year 1 (12-Month Base Study)|Adverse Event|0
1038448|NCT00112437|3378726|P19|Year 1 (12-Month Base Study)|Adverse Event|0
1038449|NCT00112437|3378727|P18|Year 1 (12-Month Base Study)|Adverse Event|0
1038450|NCT00112437|3378728|P17|Year 1 (12-Month Base Study)|Adverse Event|0
1038451|NCT00112437|3378729|P16|Year 1 (12-Month Base Study)|Adverse Event|0
1038452|NCT00112437|3378730|P15|Year 1 (12-Month Base Study)|Adverse Event|0
1038453|NCT00112437|3378731|P14|Year 1 (12-Month Base Study)|Adverse Event|0
1038454|NCT00112437|3378732|P13|Year 1 (12-Month Base Study)|Adverse Event|0
1038455|NCT00112437|3378733|P12|Year 1 (12-Month Base Study)|Adverse Event|0
1038456|NCT00112437|3378734|P11|Year 1 (12-Month Base Study)|Adverse Event|0
1038457|NCT00112437|3378735|P10|Year 1 (12-Month Base Study)|Adverse Event|0
1038458|NCT00112437|3378736|P9|Year 1 (12-Month Base Study)|Adverse Event|0
1038459|NCT00112437|3378737|P8|Year 1 (12-Month Base Study)|Adverse Event|0
1038460|NCT00112437|3378738|P7|Year 1 (12-Month Base Study)|Adverse Event|0
1038461|NCT00112437|3378739|P6|Year 1 (12-Month Base Study)|Adverse Event|0
1038462|NCT00112437|3378740|P5|Year 1 (12-Month Base Study)|Adverse Event|3
1038463|NCT00112437|3378741|P4|Year 1 (12-Month Base Study)|Adverse Event|4
1038464|NCT00112437|3378742|P3|Year 1 (12-Month Base Study)|Adverse Event|6
1038465|NCT00112437|3378743|P2|Year 1 (12-Month Base Study)|Adverse Event|10
1038466|NCT00112437|3378744|P1|Year 1 (12-Month Base Study)|Adverse Event|9
1038467|NCT00112385|3379024|P2|Overall Study|Withdrawal by Subject|1
1038468|NCT00112385|3379025|P1|Overall Study|Withdrawal by Subject|0
1038469|NCT00112385|3379024|P2|Overall Study|Lost to Follow-up|0
1038470|NCT00112385|3379025|P1|Overall Study|Lost to Follow-up|1
1038471|NCT00112359|3379115|P2|Overall Study|Other|0
1038472|NCT00112359|3379116|P1|Overall Study|Other|3
1038473|NCT00112359|3379115|P2|Overall Study|Personal/administrative|1
1038474|NCT00112359|3379116|P1|Overall Study|Personal/administrative|1
1038475|NCT00112359|3379115|P2|Overall Study|Lost to Follow-up|1
1038476|NCT00112359|3379116|P1|Overall Study|Lost to Follow-up|0
1038477|NCT00112359|3379115|P2|Overall Study|Related adverse event|3
1038478|NCT00112359|3379116|P1|Overall Study|Related adverse event|5
1038479|NCT00112359|3379115|P2|Overall Study|Trial drug intolerance (adverse event)|0
1038480|NCT00112359|3379116|P1|Overall Study|Trial drug intolerance (adverse event)|2
1038481|NCT00112359|3379115|P2|Overall Study|Unrelated adverse event|8
1038482|NCT00112359|3379116|P1|Overall Study|Unrelated adverse event|16
1038483|NCT00112294|3379142|P2|Overall Study|Still on study|0
1038484|NCT00112294|3379143|P1|Overall Study|Still on study|5
1038485|NCT00112047|3379366|P2|Atripla Phase|Not specified|1
1038486|NCT00112047|3379367|P1|Atripla Phase|Not specified|3
1038487|NCT00112047|3379366|P2|Atripla Phase|Non-compliance|0
1038488|NCT00112047|3379367|P1|Atripla Phase|Non-compliance|1
1038489|NCT00112047|3379366|P2|Atripla Phase|Sub-optimal virological response|1
1038490|NCT00112047|3379367|P1|Atripla Phase|Sub-optimal virological response|0
1038491|NCT00112047|3379366|P2|Atripla Phase|Withdrew consent|7
1038492|NCT00112047|3379367|P1|Atripla Phase|Withdrew consent|7
1038493|NCT00112047|3379366|P2|Atripla Phase|Death|2
1038494|NCT00112047|3379367|P1|Atripla Phase|Death|0
1038495|NCT00112047|3379366|P2|Atripla Phase|Pregnancy|1
1038496|NCT00112047|3379367|P1|Atripla Phase|Pregnancy|0
1038497|NCT00112047|3379366|P2|Atripla Phase|Lost to Follow-up|7
1038498|NCT00112047|3379367|P1|Atripla Phase|Lost to Follow-up|5
1038499|NCT00112047|3379366|P2|Atripla Phase|Adverse Event|1
1038500|NCT00112047|3379367|P1|Atripla Phase|Adverse Event|2
1038501|NCT00112047|3379366|P2|Randomized Phase|High Hepatitis B DNA|1
1038502|NCT00112047|3379367|P1|Randomized Phase|High Hepatitis B DNA|0
1038503|NCT00112047|3379366|P2|Randomized Phase|Baseline NNRTI resistance mutations|0
1038504|NCT00112047|3379367|P1|Randomized Phase|Baseline NNRTI resistance mutations|4
1038505|NCT00112047|3379366|P2|Randomized Phase|Moved out of State|1
1038506|NCT00112047|3379367|P1|Randomized Phase|Moved out of State|0
1038507|NCT00112047|3379366|P2|Randomized Phase|Incarceration|2
1038508|NCT00112047|3379367|P1|Randomized Phase|Incarceration|3
1038509|NCT00112047|3379366|P2|Randomized Phase|Inability to swallow pills|1
1038510|NCT00112047|3379367|P1|Randomized Phase|Inability to swallow pills|0
1038511|NCT00112047|3379366|P2|Randomized Phase|Hepatitis C treatment contraindicated|1
1038512|NCT00112047|3379367|P1|Randomized Phase|Hepatitis C treatment contraindicated|0
1038513|NCT00112047|3379366|P2|Randomized Phase|Death|3
1038514|NCT00112047|3379367|P1|Randomized Phase|Death|1
1038515|NCT00112047|3379366|P2|Randomized Phase|Pregnancy|1
1038516|NCT00112047|3379367|P1|Randomized Phase|Pregnancy|3
1038517|NCT00112047|3379366|P2|Randomized Phase|Protocol Violation|0
1038518|NCT00112047|3379367|P1|Randomized Phase|Protocol Violation|2
1038519|NCT00112047|3379366|P2|Randomized Phase|Noncompliance|4
1038520|NCT00112047|3379367|P1|Randomized Phase|Noncompliance|8
1038521|NCT00112047|3379366|P2|Randomized Phase|Sub-optimal virological response|13
1038522|NCT00112047|3379367|P1|Randomized Phase|Sub-optimal virological response|3
1038523|NCT00112047|3379366|P2|Randomized Phase|Withrawal of consent|18
1038524|NCT00112047|3379367|P1|Randomized Phase|Withrawal of consent|10
1038525|NCT00112047|3379366|P2|Randomized Phase|Adverse Event|10
1038526|NCT00112047|3379367|P1|Randomized Phase|Adverse Event|10
1038527|NCT00112047|3379366|P2|Randomized Phase|Lost to Follow-up|33
1038528|NCT00112047|3379367|P1|Randomized Phase|Lost to Follow-up|26
1038529|NCT00111917|3379467|P2|Overall Study|Withdrawal by Subject|1
1038530|NCT00111917|3379468|P1|Overall Study|Withdrawal by Subject|1
1038531|NCT00111839|3379483|P3|Overall Study|Randomized but Not Treated|2
1038532|NCT00111839|3379484|P2|Overall Study|Randomized but Not Treated|0
1038533|NCT00111839|3379485|P1|Overall Study|Randomized but Not Treated|0
1038534|NCT00111839|3379483|P3|Overall Study|Other|3
1038535|NCT00111839|3379484|P2|Overall Study|Other|3
1038536|NCT00111839|3379485|P1|Overall Study|Other|6
1038537|NCT00111839|3379483|P3|Overall Study|Logistical Constraint|0
1038538|NCT00111839|3379484|P2|Overall Study|Logistical Constraint|0
1038539|NCT00111839|3379485|P1|Overall Study|Logistical Constraint|1
1038540|NCT00111839|3379483|P3|Overall Study|Lost to Follow-up|0
1038541|NCT00111839|3379484|P2|Overall Study|Lost to Follow-up|0
1038542|NCT00111839|3379485|P1|Overall Study|Lost to Follow-up|1
1038543|NCT00111839|3379483|P3|Overall Study|Withdrawal by Subject|2
1038544|NCT00111839|3379484|P2|Overall Study|Withdrawal by Subject|2
1038545|NCT00111839|3379485|P1|Overall Study|Withdrawal by Subject|2
1038546|NCT00111839|3379483|P3|Overall Study|Death|6
1038547|NCT00111839|3379484|P2|Overall Study|Death|1
1038548|NCT00111839|3379485|P1|Overall Study|Death|1
1038549|NCT00111839|3379483|P3|Overall Study|Protocol Violation|2
1038550|NCT00111839|3379484|P2|Overall Study|Protocol Violation|4
1038551|NCT00111839|3379485|P1|Overall Study|Protocol Violation|2
1038552|NCT00111839|3379483|P3|Overall Study|Adverse Event|1
1038553|NCT00111839|3379484|P2|Overall Study|Adverse Event|3
1038554|NCT00111839|3379485|P1|Overall Study|Adverse Event|5
1038555|NCT00111839|3379483|P3|Overall Study|Disease Progression|33
1038556|NCT00111839|3379484|P2|Overall Study|Disease Progression|33
1038557|NCT00111839|3379485|P1|Overall Study|Disease Progression|30
1038558|NCT00111813|3379505|P6|Overall Study|Not specified|0
1038559|NCT00111813|3379506|P5|Overall Study|Not specified|0
1038560|NCT00111813|3379507|P4|Overall Study|Not specified|0
1038561|NCT00111813|3379508|P3|Overall Study|Not specified|1
1038562|NCT00111813|3379509|P2|Overall Study|Not specified|0
1038563|NCT00111813|3379510|P1|Overall Study|Not specified|0
1038564|NCT00111813|3379505|P6|Overall Study|Lack of Efficacy|1
1038565|NCT00111813|3379506|P5|Overall Study|Lack of Efficacy|0
1038566|NCT00111813|3379507|P4|Overall Study|Lack of Efficacy|0
1038567|NCT00111813|3379508|P3|Overall Study|Lack of Efficacy|0
1038568|NCT00111813|3379509|P2|Overall Study|Lack of Efficacy|0
1038569|NCT00111813|3379510|P1|Overall Study|Lack of Efficacy|0
1038570|NCT00111813|3379505|P6|Overall Study|Progressive disease|3
1038571|NCT00111813|3379506|P5|Overall Study|Progressive disease|4
1038572|NCT00111813|3379507|P4|Overall Study|Progressive disease|3
1038573|NCT00111813|3379508|P3|Overall Study|Progressive disease|5
1038574|NCT00111813|3379509|P2|Overall Study|Progressive disease|1
1038575|NCT00111813|3379510|P1|Overall Study|Progressive disease|2
1038576|NCT00111813|3379505|P6|Overall Study|Adverse Event|2
1038577|NCT00111813|3379506|P5|Overall Study|Adverse Event|2
1038578|NCT00111813|3379507|P4|Overall Study|Adverse Event|2
1038579|NCT00111813|3379508|P3|Overall Study|Adverse Event|4
1038580|NCT00111813|3379509|P2|Overall Study|Adverse Event|2
1038581|NCT00111813|3379510|P1|Overall Study|Adverse Event|1
1038582|NCT00111800|3379549|P6|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
1038583|NCT00111800|3379550|P5|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
1038584|NCT00111800|3379551|P4|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
1038585|NCT00111800|3379552|P3|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1
1038586|NCT00111800|3379553|P2|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
1038587|NCT00111800|3379554|P1|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
1038588|NCT00111800|3379549|P6|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
1038589|NCT00111800|3379550|P5|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
1038590|NCT00111800|3379551|P4|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
1038591|NCT00111800|3379552|P3|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1
1038592|NCT00111800|3379553|P2|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
1038593|NCT00111800|3379554|P1|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
1038594|NCT00111800|3379549|P6|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
1038595|NCT00111800|3379550|P5|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
1038596|NCT00111800|3379551|P4|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
1038597|NCT00111800|3379552|P3|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
1038598|NCT00111800|3379553|P2|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1
1038599|NCT00111800|3379554|P1|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
1038600|NCT00111800|3379549|P6|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
1038601|NCT00111800|3379550|P5|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
1038602|NCT00111800|3379551|P4|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
1038603|NCT00111800|3379552|P3|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0
1038604|NCT00111800|3379553|P2|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
1038605|NCT00111800|3379554|P1|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
1038606|NCT00111800|3379549|P6|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
1038607|NCT00111800|3379550|P5|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
1038608|NCT00111800|3379551|P4|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
1038609|NCT00111800|3379552|P3|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
1038610|NCT00111800|3379553|P2|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
1038611|NCT00111800|3379554|P1|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
1038612|NCT00111800|3379549|P6|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
1038613|NCT00111800|3379550|P5|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3
1038614|NCT00111800|3379551|P4|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
1038615|NCT00111800|3379552|P3|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
1038616|NCT00111800|3379553|P2|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
1038617|NCT00111800|3379554|P1|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
1038618|NCT00111800|3379549|P6|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
1038619|NCT00111800|3379550|P5|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
1038620|NCT00111800|3379551|P4|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
1038621|NCT00111800|3379552|P3|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
1038622|NCT00111800|3379553|P2|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
1038623|NCT00111800|3379554|P1|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
1038624|NCT00111800|3379549|P6|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
1038625|NCT00111800|3379550|P5|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
1038626|NCT00111800|3379551|P4|Period 2: Extension Phase (12 Weeks)|Adverse Event|3
1038627|NCT00111800|3379552|P3|Period 2: Extension Phase (12 Weeks)|Adverse Event|1
1038628|NCT00111800|3379553|P2|Period 2: Extension Phase (12 Weeks)|Adverse Event|2
1038629|NCT00111800|3379554|P1|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
1038630|NCT00111800|3379549|P6|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1
1038631|NCT00111800|3379550|P5|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
1038632|NCT00111800|3379551|P4|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
1038633|NCT00111800|3379552|P3|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
1038634|NCT00111800|3379553|P2|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
1038635|NCT00111800|3379554|P1|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
1038636|NCT00111800|3379549|P6|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
1038637|NCT00111800|3379550|P5|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1
1038638|NCT00111800|3379551|P4|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
1038639|NCT00111800|3379552|P3|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
1038640|NCT00111800|3379553|P2|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
1038641|NCT00111800|3379554|P1|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
1038642|NCT00111800|3379549|P6|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
1038643|NCT00111800|3379550|P5|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1
1038644|NCT00111800|3379551|P4|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
1038645|NCT00111800|3379552|P3|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
1038646|NCT00111800|3379553|P2|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
1038647|NCT00111800|3379554|P1|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
1038648|NCT00111800|3379549|P6|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
1038649|NCT00111800|3379550|P5|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
1038650|NCT00111800|3379551|P4|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1
1038651|NCT00111800|3379552|P3|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
1038652|NCT00111800|3379553|P2|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
1038653|NCT00111800|3379554|P1|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
1038654|NCT00111800|3379549|P6|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
1038655|NCT00111800|3379550|P5|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
1038656|NCT00111800|3379551|P4|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1
1038657|NCT00111800|3379552|P3|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
1038658|NCT00111800|3379553|P2|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
1038659|NCT00111800|3379554|P1|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
1038660|NCT00111800|3379549|P6|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
1038661|NCT00111800|3379550|P5|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
1038662|NCT00111800|3379551|P4|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
1038663|NCT00111800|3379552|P3|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
1038664|NCT00111800|3379553|P2|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1
1038665|NCT00111800|3379554|P1|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
1038666|NCT00111800|3379549|P6|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
1038667|NCT00111800|3379550|P5|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
1038668|NCT00111800|3379551|P4|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
1038669|NCT00111800|3379552|P3|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
1038670|NCT00111800|3379553|P2|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1
1038671|NCT00111800|3379554|P1|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
1038672|NCT00111800|3379549|P6|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
1038673|NCT00111800|3379550|P5|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
1038674|NCT00111800|3379551|P4|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
1038675|NCT00111800|3379552|P3|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
1038676|NCT00111800|3379553|P2|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1
1038677|NCT00111800|3379554|P1|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
1038678|NCT00111800|3379549|P6|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
1038679|NCT00111800|3379550|P5|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
1038680|NCT00111800|3379551|P4|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
1038681|NCT00111800|3379552|P3|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
1038682|NCT00111800|3379553|P2|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1
1038683|NCT00111800|3379554|P1|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
1038684|NCT00111800|3379549|P6|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
1038685|NCT00111800|3379550|P5|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
1038686|NCT00111800|3379551|P4|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
1038687|NCT00111800|3379552|P3|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
1038688|NCT00111800|3379553|P2|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
1038689|NCT00111800|3379554|P1|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1
1038690|NCT00111800|3379549|P6|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
1038691|NCT00111800|3379550|P5|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
1038692|NCT00111800|3379551|P4|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
1038693|NCT00111800|3379552|P3|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
1038694|NCT00111800|3379553|P2|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
1038695|NCT00111800|3379554|P1|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
1038696|NCT00111800|3379549|P6|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
1038697|NCT00111800|3379550|P5|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
1038698|NCT00111800|3379551|P4|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
1038699|NCT00111800|3379552|P3|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
1038700|NCT00111800|3379553|P2|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
1038701|NCT00111800|3379554|P1|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
1038702|NCT00111800|3379549|P6|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
1038703|NCT00111800|3379550|P5|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
1038704|NCT00111800|3379551|P4|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
1038705|NCT00111800|3379552|P3|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
1038706|NCT00111800|3379553|P2|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
1038707|NCT00111800|3379554|P1|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
1038708|NCT00111800|3379549|P6|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
1038709|NCT00111800|3379550|P5|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
1038710|NCT00111800|3379551|P4|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1
1038711|NCT00111800|3379552|P3|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
1038712|NCT00111800|3379553|P2|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
1038713|NCT00111800|3379554|P1|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3
1038714|NCT00111800|3379549|P6|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1
1038715|NCT00111800|3379550|P5|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
1038716|NCT00111800|3379551|P4|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
1038717|NCT00111800|3379552|P3|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3
1038718|NCT00111800|3379553|P2|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
1038719|NCT00111800|3379554|P1|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
1038720|NCT00111800|3379549|P6|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
1038721|NCT00111800|3379550|P5|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
1038722|NCT00111800|3379551|P4|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
1038723|NCT00111800|3379552|P3|Period 1: Main Phase (12 Weeks)|Protocol Violation|4
1038724|NCT00111800|3379553|P2|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
1038725|NCT00111800|3379554|P1|Period 1: Main Phase (12 Weeks)|Protocol Violation|0
1038726|NCT00111800|3379549|P6|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
1038727|NCT00111800|3379550|P5|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
1038728|NCT00111800|3379551|P4|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
1038729|NCT00111800|3379552|P3|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
1038730|NCT00111800|3379553|P2|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
1038731|NCT00111800|3379554|P1|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1
1038732|NCT00111800|3379549|P6|Period 1: Main Phase (12 Weeks)|Adverse Event|0
1038733|NCT00111800|3379550|P5|Period 1: Main Phase (12 Weeks)|Adverse Event|1
1038734|NCT00111800|3379551|P4|Period 1: Main Phase (12 Weeks)|Adverse Event|0
1038735|NCT00111800|3379552|P3|Period 1: Main Phase (12 Weeks)|Adverse Event|0
1038736|NCT00111800|3379553|P2|Period 1: Main Phase (12 Weeks)|Adverse Event|4
1038737|NCT00111800|3379554|P1|Period 1: Main Phase (12 Weeks)|Adverse Event|5
1038738|NCT00111761|3379724|P2|Part 2|Other|0
1038739|NCT00111761|3379725|P1|Part 2|Other|1
1038740|NCT00111761|3379724|P2|Part 2|Protocol-specified criteria|0
1038741|NCT00111761|3379725|P1|Part 2|Protocol-specified criteria|1
1038742|NCT00111761|3379724|P2|Part 2|Disease progression|0
1038743|NCT00111761|3379725|P1|Part 2|Disease progression|3
1038744|NCT00111761|3379724|P2|Part 2|Death|0
1038745|NCT00111761|3379725|P1|Part 2|Death|1
1038746|NCT00111761|3379724|P2|Part 2|Physician Decision|0
1038747|NCT00111761|3379725|P1|Part 2|Physician Decision|1
1038748|NCT00111761|3379724|P2|Part 2|Adverse Event|0
1038749|NCT00111761|3379725|P1|Part 2|Adverse Event|1
1038750|NCT00111761|3379724|P2|Part 1|Withdrawal by Subject|1
1038751|NCT00111761|3379725|P1|Part 1|Withdrawal by Subject|0
1038752|NCT00111761|3379724|P2|Part 1|Other|1
1038753|NCT00111761|3379725|P1|Part 1|Other|0
1038754|NCT00111761|3379724|P2|Part 1|Death|2
1038755|NCT00111761|3379725|P1|Part 1|Death|0
1038756|NCT00111761|3379724|P2|Part 1|Physician Decision|1
1038757|NCT00111761|3379725|P1|Part 1|Physician Decision|0
1038758|NCT00111241|3379754|P2|Overall Study|Adverse Event|0
1038759|NCT00111241|3379755|P1|Overall Study|Adverse Event|1
1038760|NCT00111241|3379754|P2|Overall Study|Protocol Violation|8
1038761|NCT00111241|3379755|P1|Overall Study|Protocol Violation|9
1038762|NCT00111241|3379754|P2|Overall Study|Withdrawal by Subject|0
1038763|NCT00111241|3379755|P1|Overall Study|Withdrawal by Subject|4
1038764|NCT00111241|3379754|P2|Overall Study|Lost to Follow-up|0
1038765|NCT00111241|3379755|P1|Overall Study|Lost to Follow-up|1
1038766|NCT00111007|3379765|P2|Long Term Follow-up|Missing|3
1038767|NCT00111007|3379766|P1|Long Term Follow-up|Missing|10
1038768|NCT00111007|3379765|P2|Long Term Follow-up|Disease progression/recurrence/relapse|1
1038769|NCT00111007|3379766|P1|Long Term Follow-up|Disease progression/recurrence/relapse|2
1038770|NCT00111007|3379765|P2|Long Term Follow-up|Withdrawal by Subject|1
1038771|NCT00111007|3379766|P1|Long Term Follow-up|Withdrawal by Subject|0
1038772|NCT00111007|3379765|P2|Long Term Follow-up|Lost to Follow-up|1
1038773|NCT00111007|3379766|P1|Long Term Follow-up|Lost to Follow-up|1
1038774|NCT00111007|3379765|P2|Long Term Follow-up|Death|39
1038775|NCT00111007|3379766|P1|Long Term Follow-up|Death|34
1038776|NCT00111007|3379765|P2|Active Follow-up|Disease progression/recurrence/relapse|2
1038777|NCT00111007|3379766|P1|Active Follow-up|Disease progression/recurrence/relapse|3
1038778|NCT00111007|3379765|P2|Active Follow-up|Death|0
1038779|NCT00111007|3379766|P1|Active Follow-up|Death|2
1038780|NCT00111007|3379765|P2|Active Follow-up|Adverse Event|0
1038781|NCT00111007|3379766|P1|Active Follow-up|Adverse Event|1
1038782|NCT00111007|3379765|P2|Double-blind (DB) Treatment|Primary reason with other category|1
1038783|NCT00111007|3379766|P1|Double-blind (DB) Treatment|Primary reason with other category|0
1038784|NCT00111007|3379765|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|93
1038785|NCT00111007|3379766|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|83
1038786|NCT00111007|3379765|P2|Double-blind (DB) Treatment|Progression by clinical judgement|2
1038787|NCT00111007|3379766|P1|Double-blind (DB) Treatment|Progression by clinical judgement|0
1038788|NCT00111007|3379765|P2|Double-blind (DB) Treatment|Relapse|0
1038789|NCT00111007|3379766|P1|Double-blind (DB) Treatment|Relapse|1
1038790|NCT00111007|3379765|P2|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0
1038791|NCT00111007|3379766|P1|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1
1038792|NCT00111007|3379765|P2|Double-blind (DB) Treatment|Withdrawal by Subject|8
1038793|NCT00111007|3379766|P1|Double-blind (DB) Treatment|Withdrawal by Subject|6
1038794|NCT00111007|3379765|P2|Double-blind (DB) Treatment|Protocol Violation|1
1038795|NCT00111007|3379766|P1|Double-blind (DB) Treatment|Protocol Violation|0
1038796|NCT00111007|3379765|P2|Double-blind (DB) Treatment|Death|2
1038797|NCT00111007|3379766|P1|Double-blind (DB) Treatment|Death|5
1038798|NCT00111007|3379765|P2|Double-blind (DB) Treatment|Adverse Event|4
1038799|NCT00111007|3379766|P1|Double-blind (DB) Treatment|Adverse Event|12
1038800|NCT00110994|3379782|P2|Long Term Follow-up|Death|17
1038801|NCT00110994|3379783|P1|Long Term Follow-up|Death|19
1038802|NCT00110994|3379782|P2|Active Follow-up|Other reasons|2
1038803|NCT00110994|3379783|P1|Active Follow-up|Other reasons|0
1038804|NCT00110994|3379782|P2|Active Follow-up|Disease progression/recurrence/replace|0
1038805|NCT00110994|3379783|P1|Active Follow-up|Disease progression/recurrence/replace|1
1038806|NCT00110994|3379782|P2|Double-blind (DB) Treatment|other reasons|3
1038807|NCT00110994|3379783|P1|Double-blind (DB) Treatment|other reasons|2
1038808|NCT00110994|3379782|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|41
1038809|NCT00110994|3379783|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|34
1038810|NCT00110994|3379782|P2|Double-blind (DB) Treatment|Progression by clinical judgement|1
1038811|NCT00110994|3379783|P1|Double-blind (DB) Treatment|Progression by clinical judgement|2
1038812|NCT00110994|3379782|P2|Double-blind (DB) Treatment|Withdrawal by Subject|2
1038813|NCT00110994|3379783|P1|Double-blind (DB) Treatment|Withdrawal by Subject|0
1038814|NCT00110994|3379782|P2|Double-blind (DB) Treatment|Death|0
1038815|NCT00110994|3379783|P1|Double-blind (DB) Treatment|Death|1
1038816|NCT00110994|3379782|P2|Double-blind (DB) Treatment|Adverse Event|0
1038817|NCT00110994|3379783|P1|Double-blind (DB) Treatment|Adverse Event|3
1038818|NCT00110890|3379809|P2|Overall Study|Did not enter follow-up phase|4
1038819|NCT00110890|3379810|P1|Overall Study|Did not enter follow-up phase|10
1038820|NCT00110890|3379809|P2|Overall Study|Parathyroidectomy|1
1038821|NCT00110890|3379810|P1|Overall Study|Parathyroidectomy|0
1038822|NCT00110890|3379809|P2|Overall Study|Disease progression|1
1038823|NCT00110890|3379810|P1|Overall Study|Disease progression|0
1038824|NCT00110890|3379809|P2|Overall Study|Requirement for alternative therapy|1
1038825|NCT00110890|3379810|P1|Overall Study|Requirement for alternative therapy|0
1038826|NCT00110890|3379809|P2|Overall Study|Ineligibility determined|0
1038827|NCT00110890|3379810|P1|Overall Study|Ineligibility determined|3
1038828|NCT00110890|3379809|P2|Overall Study|Other|23
1038829|NCT00110890|3379810|P1|Overall Study|Other|34
1038830|NCT00110890|3379809|P2|Overall Study|Invest. Product Commercially Available|110
1038831|NCT00110890|3379810|P1|Overall Study|Invest. Product Commercially Available|217
1038832|NCT00110890|3379809|P2|Overall Study|Kidney Transplant|12
1038833|NCT00110890|3379810|P1|Overall Study|Kidney Transplant|16
1038834|NCT00110890|3379809|P2|Overall Study|Noncompliance|0
1038835|NCT00110890|3379810|P1|Overall Study|Noncompliance|10
1038836|NCT00110890|3379809|P2|Overall Study|Protocol Deviation|0
1038837|NCT00110890|3379810|P1|Overall Study|Protocol Deviation|1
1038838|NCT00110890|3379809|P2|Overall Study|Withdrawal by Subject|5
1038839|NCT00110890|3379810|P1|Overall Study|Withdrawal by Subject|17
1038840|NCT00110890|3379809|P2|Overall Study|Physician Decision|5
1038841|NCT00110890|3379810|P1|Overall Study|Physician Decision|4
1038842|NCT00110890|3379809|P2|Overall Study|Lost to Follow-up|1
1038843|NCT00110890|3379810|P1|Overall Study|Lost to Follow-up|3
1038844|NCT00110890|3379809|P2|Overall Study|Death|9
1038845|NCT00110890|3379810|P1|Overall Study|Death|16
1038846|NCT00110890|3379809|P2|Overall Study|Adverse Event|7
1038847|NCT00110890|3379810|P1|Overall Study|Adverse Event|30
1038848|NCT00110812|3379827|P3|Extended Follow-up|Lost to Follow-up|1
1038849|NCT00110812|3379828|P2|Extended Follow-up|Lost to Follow-up|3
1038850|NCT00110812|3379829|P1|Extended Follow-up|Lost to Follow-up|1
1038851|NCT00110812|3379827|P3|Extended Follow-up|Withdrawal by Subject|0
1038852|NCT00110812|3379828|P2|Extended Follow-up|Withdrawal by Subject|1
1038853|NCT00110812|3379829|P1|Extended Follow-up|Withdrawal by Subject|0
1038854|NCT00110812|3379827|P3|Extended Follow-up|Death|3
1038855|NCT00110812|3379828|P2|Extended Follow-up|Death|0
1038856|NCT00110812|3379829|P1|Extended Follow-up|Death|1
1038857|NCT00110812|3379827|P3|Main Study|Lost to Follow-up|10
1038858|NCT00110812|3379828|P2|Main Study|Lost to Follow-up|11
1038859|NCT00110812|3379829|P1|Main Study|Lost to Follow-up|8
1038860|NCT00110812|3379827|P3|Main Study|Withdrawal by Subject|1
1038861|NCT00110812|3379828|P2|Main Study|Withdrawal by Subject|0
1038862|NCT00110812|3379829|P1|Main Study|Withdrawal by Subject|0
1038863|NCT00110812|3379827|P3|Main Study|Death|2
1038864|NCT00110812|3379828|P2|Main Study|Death|0
1038865|NCT00110812|3379829|P1|Main Study|Death|0
1038866|NCT00110617|3379874|P2|Overall Study|Did not receive study drug|12
1038867|NCT00110617|3379875|P1|Overall Study|Did not receive study drug|0
1038868|NCT00110617|3379874|P2|Overall Study|Death|1
1038869|NCT00110617|3379875|P1|Overall Study|Death|1
1038870|NCT00110617|3379874|P2|Overall Study|Administrative problems|5
1038871|NCT00110617|3379875|P1|Overall Study|Administrative problems|6
1038872|NCT00110617|3379874|P2|Overall Study|Lost to Follow-up|1
1038873|NCT00110617|3379875|P1|Overall Study|Lost to Follow-up|9
1038874|NCT00110617|3379874|P2|Overall Study|Withdrawal by Subject|4
1038875|NCT00110617|3379875|P1|Overall Study|Withdrawal by Subject|10
1038876|NCT00110617|3379874|P2|Overall Study|Protocol Violation|0
1038877|NCT00110617|3379875|P1|Overall Study|Protocol Violation|5
1038878|NCT00110617|3379874|P2|Overall Study|Patient no longer requires study drug|0
1038879|NCT00110617|3379875|P1|Overall Study|Patient no longer requires study drug|1
1038880|NCT00110617|3379874|P2|Overall Study|Lack of Efficacy|0
1038881|NCT00110617|3379875|P1|Overall Study|Lack of Efficacy|1
1038882|NCT00110617|3379874|P2|Overall Study|Abnormal Laboratory Value|2
1038883|NCT00110617|3379875|P1|Overall Study|Abnormal Laboratory Value|4
1038884|NCT00110617|3379874|P2|Overall Study|Adverse Event|4
1038885|NCT00110617|3379875|P1|Overall Study|Adverse Event|2
1038886|NCT00110396|3379992|P1|Overall Study|Patient is to be administered copaxone|1
1038887|NCT00110396|3379992|P1|Overall Study|The patient has refused to visit site|1
1038888|NCT00110396|3379992|P1|Overall Study|The patient has refused|2
1038889|NCT00110396|3379992|P1|Overall Study|Patient refused to come back|1
1038890|NCT00110396|3379992|P1|Overall Study|Protocol Violation|2
1038891|NCT00110396|3379992|P1|Overall Study|Pregnancy (Protocol violation)|2
1038892|NCT00110396|3379992|P1|Overall Study|Pregnancy|1
1038893|NCT00110396|3379992|P1|Overall Study|Participation in MS vaccine study|1
1038894|NCT00110396|3379992|P1|Overall Study|Patient's decision|1
1038895|NCT00110396|3379992|P1|Overall Study|Patient will|1
1038896|NCT00110396|3379992|P1|Overall Study|Patient refused to participate|1
1038897|NCT00110396|3379992|P1|Overall Study|Patient refused to continue|1
1038898|NCT00110396|3379992|P1|Overall Study|Patient non-compliance|1
1038899|NCT00110396|3379992|P1|Overall Study|Decided not to continue treatment|1
1038900|NCT00110396|3379992|P1|Overall Study|Lack of Efficacy|1
1038901|NCT00110396|3379992|P1|Overall Study|Initiated mitoxantrone therapy|1
1038902|NCT00110396|3379992|P1|Overall Study|Administration of plasmapheresis|1
1038903|NCT00110396|3379992|P1|Overall Study|Lost to Follow-up|1
1038904|NCT00110396|3379992|P1|Overall Study|Adverse Event|15
1038905|NCT00110357|3380000|P2|Overall Study|Withdrawal by Subject|1
1038906|NCT00110357|3380001|P1|Overall Study|Withdrawal by Subject|3
1038907|NCT00110357|3380000|P2|Overall Study|Study Drug Toxicity|3
1038908|NCT00110357|3380001|P1|Overall Study|Study Drug Toxicity|1
1038909|NCT00110357|3380000|P2|Overall Study|Study Closure|0
1038910|NCT00110357|3380001|P1|Overall Study|Study Closure|1
1038911|NCT00110357|3380000|P2|Overall Study|Disease progression/relapse|15
1038912|NCT00110357|3380001|P1|Overall Study|Disease progression/relapse|20
1038913|NCT00110357|3380000|P2|Overall Study|Deterioration without progression|0
1038914|NCT00110357|3380001|P1|Overall Study|Deterioration without progression|2
1038915|NCT00110305|3380089|P2|Overall Study|Other|2
1038916|NCT00110305|3380090|P1|Overall Study|Other|8
1038917|NCT00110305|3380089|P2|Overall Study|Lost to Follow-up|3
1038918|NCT00110305|3380090|P1|Overall Study|Lost to Follow-up|20
1038919|NCT00110305|3380089|P2|Overall Study|Withdrawal by Subject|7
1038920|NCT00110305|3380090|P1|Overall Study|Withdrawal by Subject|7
1038921|NCT00110305|3380089|P2|Overall Study|Protocol Violation|1
1038922|NCT00110305|3380090|P1|Overall Study|Protocol Violation|0
1038923|NCT00110305|3380089|P2|Overall Study|Subject Reached A Virologic Endpoint|3
1038924|NCT00110305|3380090|P1|Overall Study|Subject Reached A Virologic Endpoint|21
1038925|NCT00110305|3380089|P2|Overall Study|Subject Ineligible To Continue The Trial|1
1038926|NCT00110305|3380090|P1|Overall Study|Subject Ineligible To Continue The Trial|2
1038927|NCT00110305|3380089|P2|Overall Study|Subject Non-Compliant|2
1038928|NCT00110305|3380090|P1|Overall Study|Subject Non-Compliant|9
1038929|NCT00110305|3380089|P2|Overall Study|Sponsors Decision|0
1038930|NCT00110305|3380090|P1|Overall Study|Sponsors Decision|1
1038931|NCT00110305|3380089|P2|Overall Study|Adverse Event|13
1038932|NCT00110305|3380090|P1|Overall Study|Adverse Event|46
1038933|NCT00110214|3380143|P2|Overall Study|Other (not specified)|75
1038934|NCT00110214|3380144|P1|Overall Study|Other (not specified)|61
1038935|NCT00110214|3380143|P2|Overall Study|Refused further treatment|65
1038936|NCT00110214|3380144|P1|Overall Study|Refused further treatment|52
1038937|NCT00110214|3380143|P2|Overall Study|Adverse Event|192
1038938|NCT00110214|3380144|P1|Overall Study|Adverse Event|115
1038939|NCT00110214|3380143|P2|Overall Study|Disease progression or death|151
1038940|NCT00110214|3380144|P1|Overall Study|Disease progression or death|260
1038941|NCT00110214|3380143|P2|Overall Study|Never started treatment|20
1038942|NCT00110214|3380144|P1|Overall Study|Never started treatment|21
1038943|NCT00110149|3380156|P1|Overall Study|Physician Decision|3
1038944|NCT00110084|3380170|P1|Overall Study|Other|2
1038945|NCT00110084|3380170|P1|Overall Study|Intercurrent Illness|1
1038946|NCT00110084|3380170|P1|Overall Study|Alternate Therapy|5
1038947|NCT00110084|3380170|P1|Overall Study|Patient Refusal|10
1038948|NCT00110084|3380170|P1|Overall Study|Death|1
1038949|NCT00110084|3380170|P1|Overall Study|Adverse Event|9
1038950|NCT00110019|3380179|P2|Overall Study|other reasons|30
1038951|NCT00110019|3380180|P1|Overall Study|other reasons|22
1038952|NCT00110019|3380179|P2|Overall Study|Not start protocol therapy|16
1038953|NCT00110019|3380180|P1|Overall Study|Not start protocol therapy|17
1038954|NCT00110019|3380179|P2|Overall Study|symptom deterioration|16
1038955|NCT00110019|3380180|P1|Overall Study|symptom deterioration|13
1038956|NCT00110019|3380179|P2|Overall Study|complicating disease|1
1038957|NCT00110019|3380180|P1|Overall Study|complicating disease|1
1038958|NCT00110019|3380179|P2|Overall Study|alternative therapy|1
1038959|NCT00110019|3380180|P1|Overall Study|alternative therapy|5
1038960|NCT00110019|3380179|P2|Overall Study|Withdrawal by Subject|9
1038961|NCT00110019|3380180|P1|Overall Study|Withdrawal by Subject|21
1038962|NCT00110019|3380179|P2|Overall Study|Death|15
1038963|NCT00110019|3380180|P1|Overall Study|Death|13
1038964|NCT00110019|3380179|P2|Overall Study|Adverse Event|40
1038965|NCT00110019|3380180|P1|Overall Study|Adverse Event|61
1038966|NCT00110019|3380179|P2|Overall Study|Lack of Efficacy|285
1038967|NCT00110019|3380180|P1|Overall Study|Lack of Efficacy|253
1038968|NCT00109967|3380192|P2|Overall Study|Death|2
1038969|NCT00109967|3380193|P1|Overall Study|Death|0
1038970|NCT00109967|3380192|P2|Overall Study|Physician Decision|3
1038971|NCT00109967|3380193|P1|Overall Study|Physician Decision|1
1038972|NCT00109967|3380192|P2|Overall Study|Withdrawal by Subject|0
1038973|NCT00109967|3380193|P1|Overall Study|Withdrawal by Subject|5
1038974|NCT00109967|3380192|P2|Overall Study|Adverse Event|1
1038975|NCT00109967|3380193|P1|Overall Study|Adverse Event|12
1038976|NCT00109967|3380192|P2|Overall Study|Cancel Prior to Treatment|0
1038977|NCT00109967|3380193|P1|Overall Study|Cancel Prior to Treatment|2
1038978|NCT00109928|3380207|P1|Overall Study|not eligible|1
1038979|NCT00109928|3380207|P1|Overall Study|not protocol specified|2
1038980|NCT00109928|3380207|P1|Overall Study|Death|2
1038981|NCT00109928|3380207|P1|Overall Study|Progression|6
1038982|NCT00109928|3380207|P1|Overall Study|Adverse Event|2
1038983|NCT00109850|3380224|P1|Overall Study|Ineligible|1
1038984|NCT00109850|3380224|P1|Overall Study|Death|2
1038985|NCT00109850|3380224|P1|Overall Study|Adverse Event|1
1038986|NCT00109837|3380231|P1|Overall Study|Ineligible|1
1038987|NCT00109837|3380231|P1|Overall Study|Not treated|1
1038988|NCT00109837|3380231|P1|Overall Study|BCR/ABL+ or Ph+|17
1038989|NCT00109837|3380231|P1|Overall Study|Death|1
1038990|NCT00109837|3380231|P1|Overall Study|Refusal unrelated to adverse effects|1
1038991|NCT00109837|3380231|P1|Overall Study|Adverse Event|2
1038992|NCT00109772|3380241|P2|Open-label Extension|not specified|10
1038993|NCT00109772|3380242|P1|Open-label Extension|not specified|4
1038994|NCT00109772|3380241|P2|Open-label Extension|Protocol Violation|2
1038995|NCT00109772|3380242|P1|Open-label Extension|Protocol Violation|2
1038996|NCT00109772|3380241|P2|Open-label Extension|Death|1
1038997|NCT00109772|3380242|P1|Open-label Extension|Death|0
1038998|NCT00109772|3380241|P2|Open-label Extension|Lost to Follow-up|0
1038999|NCT00109772|3380242|P1|Open-label Extension|Lost to Follow-up|1
1039000|NCT00109772|3380241|P2|Open-label Extension|Withdrawal by Subject|6
1039001|NCT00109772|3380242|P1|Open-label Extension|Withdrawal by Subject|9
1039002|NCT00109772|3380241|P2|Open-label Extension|Lack of Efficacy|11
1039003|NCT00109772|3380242|P1|Open-label Extension|Lack of Efficacy|19
1039004|NCT00109772|3380241|P2|Open-label Extension|Adverse Event|19
1039005|NCT00109772|3380242|P1|Open-label Extension|Adverse Event|10
1039006|NCT00109772|3380241|P2|Double-blind Treatment|Withdrew prior to treatment|1
1039007|NCT00109772|3380242|P1|Double-blind Treatment|Withdrew prior to treatment|3
1039008|NCT00109772|3380241|P2|Double-blind Treatment|not specified|4
1039009|NCT00109772|3380242|P1|Double-blind Treatment|not specified|0
1039010|NCT00109772|3380241|P2|Double-blind Treatment|Protocol Violation|1
1039011|NCT00109772|3380242|P1|Double-blind Treatment|Protocol Violation|0
1039012|NCT00109772|3380241|P2|Double-blind Treatment|Lost to Follow-up|3
1039013|NCT00109772|3380242|P1|Double-blind Treatment|Lost to Follow-up|2
1039014|NCT00109772|3380241|P2|Double-blind Treatment|Withdrawal by Subject|1
1039015|NCT00109772|3380242|P1|Double-blind Treatment|Withdrawal by Subject|2
1039016|NCT00109772|3380241|P2|Double-blind Treatment|Lack of Efficacy|0
1039017|NCT00109772|3380242|P1|Double-blind Treatment|Lack of Efficacy|1
1039018|NCT00109772|3380241|P2|Double-blind Treatment|Adverse Event|5
1039019|NCT00109772|3380242|P1|Double-blind Treatment|Adverse Event|14
1039020|NCT00109733|3380282|P2|Overall Study|Could not commit time for study|1
1039021|NCT00109733|3380283|P1|Overall Study|Could not commit time for study|1
1039022|NCT00109733|3380282|P2|Overall Study|Non-compliant|1
1039023|NCT00109733|3380283|P1|Overall Study|Non-compliant|0
1039024|NCT00109733|3380282|P2|Overall Study|Stopped taking study drug|1
1039025|NCT00109733|3380283|P1|Overall Study|Stopped taking study drug|1
1039026|NCT00109733|3380282|P2|Overall Study|Protocol Violation|1
1039027|NCT00109733|3380283|P1|Overall Study|Protocol Violation|0
1039028|NCT00109590|3380300|P3|Overall Study|Never Started Treatment|3
1039029|NCT00109590|3380301|P2|Overall Study|Never Started Treatment|2
1039030|NCT00109590|3380302|P1|Overall Study|Never Started Treatment|1
1039031|NCT00109590|3380300|P3|Overall Study|Lost to Follow-up|1
1039032|NCT00109590|3380301|P2|Overall Study|Lost to Follow-up|0
1039033|NCT00109590|3380302|P1|Overall Study|Lost to Follow-up|1
1039034|NCT00109577|3380344|P2|Overall Study|Withdrawal by Subject|3
1039035|NCT00109577|3380345|P1|Overall Study|Withdrawal by Subject|3
1039036|NCT00109343|3380376|P3|Overall Study|Other|1
1039037|NCT00109343|3380377|P2|Overall Study|Other|2
1039038|NCT00109343|3380378|P1|Overall Study|Other|5
1039039|NCT00109343|3380376|P3|Overall Study|Subject Moved|1
1039040|NCT00109343|3380377|P2|Overall Study|Subject Moved|2
1039041|NCT00109343|3380378|P1|Overall Study|Subject Moved|6
1039042|NCT00109343|3380376|P3|Overall Study|Withdrawal by Subject|10
1039043|NCT00109343|3380377|P2|Overall Study|Withdrawal by Subject|11
1039044|NCT00109343|3380378|P1|Overall Study|Withdrawal by Subject|15
1039045|NCT00109343|3380376|P3|Overall Study|Protocol Violation|2
1039046|NCT00109343|3380377|P2|Overall Study|Protocol Violation|2
1039047|NCT00109343|3380378|P1|Overall Study|Protocol Violation|1
1039048|NCT00109343|3380376|P3|Overall Study|Lost to Follow-up|14
1039049|NCT00109343|3380377|P2|Overall Study|Lost to Follow-up|20
1039050|NCT00109343|3380378|P1|Overall Study|Lost to Follow-up|35
1039051|NCT00109343|3380376|P3|Overall Study|Lack of Efficacy|0
1039052|NCT00109343|3380377|P2|Overall Study|Lack of Efficacy|0
1039053|NCT00109343|3380378|P1|Overall Study|Lack of Efficacy|1
1039054|NCT00109343|3380376|P3|Overall Study|Adverse Event|2
1039055|NCT00109343|3380377|P2|Overall Study|Adverse Event|0
1039056|NCT00109343|3380378|P1|Overall Study|Adverse Event|1
1039057|NCT00109031|3380423|P4|Overall Study|Protocol Violation|0
1039058|NCT00109031|3380424|P3|Overall Study|Protocol Violation|1
1039059|NCT00109031|3380425|P2|Overall Study|Protocol Violation|0
1039060|NCT00109031|3380426|P1|Overall Study|Protocol Violation|0
1039061|NCT00109031|3380423|P4|Overall Study|Physician Decision|0
1039062|NCT00109031|3380424|P3|Overall Study|Physician Decision|0
1039063|NCT00109031|3380425|P2|Overall Study|Physician Decision|1
1039064|NCT00109031|3380426|P1|Overall Study|Physician Decision|0
1039065|NCT00109031|3380423|P4|Overall Study|Withdrawal by Subject|0
1039066|NCT00109031|3380424|P3|Overall Study|Withdrawal by Subject|0
1039067|NCT00109031|3380425|P2|Overall Study|Withdrawal by Subject|1
1039068|NCT00109031|3380426|P1|Overall Study|Withdrawal by Subject|0
1039069|NCT00109031|3380423|P4|Overall Study|Adverse Event|0
1039070|NCT00109031|3380424|P3|Overall Study|Adverse Event|1
1039071|NCT00109031|3380425|P2|Overall Study|Adverse Event|0
1039072|NCT00109031|3380426|P1|Overall Study|Adverse Event|0
1039073|NCT00108953|3380477|P2|Follow-up|Study terminated by sponsor|6
1039074|NCT00108953|3380478|P1|Follow-up|Study terminated by sponsor|10
1039075|NCT00108953|3380477|P2|Follow-up|Lost to Follow-up|1
1039076|NCT00108953|3380478|P1|Follow-up|Lost to Follow-up|1
1039077|NCT00108953|3380477|P2|Follow-up|Death|26
1039078|NCT00108953|3380478|P1|Follow-up|Death|18
1039079|NCT00108862|3380500|P2|Overall Study|Lost to Follow-up|19
1039080|NCT00108862|3380501|P1|Overall Study|Lost to Follow-up|27
1039081|NCT00108862|3380500|P2|Overall Study|Withdrawal by Subject|6
1039082|NCT00108862|3380501|P1|Overall Study|Withdrawal by Subject|10
1039083|NCT00108862|3380500|P2|Overall Study|Death|37
1039084|NCT00108862|3380501|P1|Overall Study|Death|31
1039085|NCT00108732|3380529|P1|Step 2 (Androgen Ablation and Vaccine)|Other|1
1039086|NCT00108732|3380529|P1|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1
1039087|NCT00108732|3380529|P1|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3
1039088|NCT00108732|3380529|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1
1039089|NCT00108732|3380529|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10
1039090|NCT00108732|3380529|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2
1039091|NCT00108732|3380529|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1
1039092|NCT00108628|3380538|P2|Overall Study|Death|0
1039093|NCT00108628|3380539|P1|Overall Study|Death|1
1039094|NCT00108628|3380538|P2|Overall Study|Lack of Efficacy|1
1039095|NCT00108628|3380539|P1|Overall Study|Lack of Efficacy|2
1039096|NCT00108628|3380538|P2|Overall Study|Withdrawal by Subject|9
1039097|NCT00108628|3380539|P1|Overall Study|Withdrawal by Subject|17
1039098|NCT00108485|3380589|P2|Overall Study|Lost to Follow-up|2
1039099|NCT00108485|3380590|P1|Overall Study|Lost to Follow-up|0
1039100|NCT00108485|3380589|P2|Overall Study|Withdrawal by Subject|0
1039101|NCT00108485|3380590|P1|Overall Study|Withdrawal by Subject|3
1039102|NCT00108433|3380598|P2|Overall Study|Other|14
1039103|NCT00108433|3380599|P1|Overall Study|Other|14
1039104|NCT00108433|3380598|P2|Overall Study|Adverse Event|1
1039105|NCT00108433|3380599|P1|Overall Study|Adverse Event|3
1039106|NCT00108433|3380598|P2|Overall Study|Death|0
1039107|NCT00108433|3380599|P1|Overall Study|Death|3
1039108|NCT00108433|3380598|P2|Overall Study|Lack of Efficacy|2
1039109|NCT00108433|3380599|P1|Overall Study|Lack of Efficacy|1
1039110|NCT00108355|3380615|P2|Overall Study|Loculated ascites, limiting paracentesis|1
1039111|NCT00108355|3380616|P1|Overall Study|Loculated ascites, limiting paracentesis|1
1039112|NCT00108355|3380615|P2|Overall Study|Peritonitis at index paracentesis|1
1039113|NCT00108355|3380616|P1|Overall Study|Peritonitis at index paracentesis|1
1039114|NCT00108160|3380665|P2|Overall Study|Protocol Violation|5
1039115|NCT00108160|3380666|P1|Overall Study|Protocol Violation|9
1039116|NCT00108160|3380665|P2|Overall Study|Withdrawal by Subject|2
1039117|NCT00108160|3380666|P1|Overall Study|Withdrawal by Subject|4
1039118|NCT00108160|3380665|P2|Overall Study|Death|2
1039119|NCT00108160|3380666|P1|Overall Study|Death|1
1039120|NCT00108160|3380665|P2|Overall Study|Lost to Follow-up|12
1039121|NCT00108160|3380666|P1|Overall Study|Lost to Follow-up|25
1039122|NCT00108082|3380679|P3|Overall Study|Blood Pressure Not Controlled|0
1039123|NCT00108082|3380680|P2|Overall Study|Blood Pressure Not Controlled|0
1039124|NCT00108082|3380681|P1|Overall Study|Blood Pressure Not Controlled|1
1039125|NCT00108082|3380679|P3|Overall Study|Investigator Not at Site|0
1039126|NCT00108082|3380680|P2|Overall Study|Investigator Not at Site|0
1039127|NCT00108082|3380681|P1|Overall Study|Investigator Not at Site|1
1039128|NCT00108082|3380679|P3|Overall Study|Subject Left Site Location|0
1039129|NCT00108082|3380680|P2|Overall Study|Subject Left Site Location|0
1039130|NCT00108082|3380681|P1|Overall Study|Subject Left Site Location|1
1039131|NCT00108082|3380679|P3|Overall Study|Study Medication Not Tapered|0
1039132|NCT00108082|3380680|P2|Overall Study|Study Medication Not Tapered|1
1039133|NCT00108082|3380681|P1|Overall Study|Study Medication Not Tapered|0
1039134|NCT00108082|3380679|P3|Overall Study|Protocol Amendment|0
1039135|NCT00108082|3380680|P2|Overall Study|Protocol Amendment|1
1039136|NCT00108082|3380681|P1|Overall Study|Protocol Amendment|0
1039137|NCT00108082|3380679|P3|Overall Study|Site Closed Study|0
1039138|NCT00108082|3380680|P2|Overall Study|Site Closed Study|2
1039139|NCT00108082|3380681|P1|Overall Study|Site Closed Study|0
1039140|NCT00108082|3380679|P3|Overall Study|Stopped Study Medication|1
1039141|NCT00108082|3380680|P2|Overall Study|Stopped Study Medication|0
1039142|NCT00108082|3380681|P1|Overall Study|Stopped Study Medication|0
1039143|NCT00108082|3380679|P3|Overall Study|Non-compliance|2
1039144|NCT00108082|3380680|P2|Overall Study|Non-compliance|0
1039145|NCT00108082|3380681|P1|Overall Study|Non-compliance|1
1039146|NCT00108082|3380679|P3|Overall Study|Incorrectly Randomized|2
1039147|NCT00108082|3380680|P2|Overall Study|Incorrectly Randomized|0
1039148|NCT00108082|3380681|P1|Overall Study|Incorrectly Randomized|0
1039149|NCT00108082|3380679|P3|Overall Study|Woman of Child-bearing Potential|2
1039150|NCT00108082|3380680|P2|Overall Study|Woman of Child-bearing Potential|0
1039151|NCT00108082|3380681|P1|Overall Study|Woman of Child-bearing Potential|2
1039152|NCT00108082|3380679|P3|Overall Study|Amendment 4: > Month 12|5
1039153|NCT00108082|3380680|P2|Overall Study|Amendment 4: > Month 12|7
1039154|NCT00108082|3380681|P1|Overall Study|Amendment 4: > Month 12|5
1039155|NCT00108082|3380679|P3|Overall Study|Lack of Efficacy|2
1039156|NCT00108082|3380680|P2|Overall Study|Lack of Efficacy|1
1039157|NCT00108082|3380681|P1|Overall Study|Lack of Efficacy|3
1039158|NCT00108082|3380679|P3|Overall Study|Protocol Violation|0
1039159|NCT00108082|3380680|P2|Overall Study|Protocol Violation|2
1039160|NCT00108082|3380681|P1|Overall Study|Protocol Violation|1
1039161|NCT00108082|3380679|P3|Overall Study|Consent Withdrawn|5
1039162|NCT00108082|3380680|P2|Overall Study|Consent Withdrawn|3
1039163|NCT00108082|3380681|P1|Overall Study|Consent Withdrawn|3
1039164|NCT00108082|3380679|P3|Overall Study|Lost to Follow-up|7
1039165|NCT00108082|3380680|P2|Overall Study|Lost to Follow-up|3
1039166|NCT00108082|3380681|P1|Overall Study|Lost to Follow-up|6
1039167|NCT00108082|3380679|P3|Overall Study|Adverse Event|17
1039168|NCT00108082|3380680|P2|Overall Study|Adverse Event|12
1039169|NCT00108082|3380681|P1|Overall Study|Adverse Event|14
1039170|NCT00108069|3380730|P2|Overall Study|Progessive disease|11
1039171|NCT00108069|3380731|P1|Overall Study|Progessive disease|27
1039172|NCT00108069|3380730|P2|Overall Study|Death|0
1039173|NCT00108069|3380731|P1|Overall Study|Death|1
1039174|NCT00108069|3380730|P2|Overall Study|Withdrawal by Subject|0
1039175|NCT00108069|3380731|P1|Overall Study|Withdrawal by Subject|1
1039176|NCT00108069|3380730|P2|Overall Study|Adverse Event|1
1039177|NCT00108069|3380731|P1|Overall Study|Adverse Event|1
1039178|NCT00108069|3380730|P2|Overall Study|Never rec'd study drug|1
1039179|NCT00108069|3380731|P1|Overall Study|Never rec'd study drug|0
1039180|NCT00107991|3380745|P1|18-Week Post Treatment Assessment|Adverse Event|2
1039181|NCT00107991|3380745|P1|12 Week Treatment Period|Incarcerated|1
1039182|NCT00107991|3380745|P1|12 Week Treatment Period|Protocol Violation|1
1039183|NCT00107991|3380745|P1|12 Week Treatment Period|Adverse Event|1
1039184|NCT00107991|3380745|P1|12 Week Treatment Period|Lack of Efficacy|2
1039185|NCT00107991|3380745|P1|Eligibility Assessment|hx of alcohol abuse in past 12 months|1
1039186|NCT00107991|3380745|P1|Eligibility Assessment|chronic uncontrolled asthma|1
1039187|NCT00107991|3380745|P1|Eligibility Assessment|Ongoing treatment with antibiotics|1
1039188|NCT00107991|3380745|P1|Eligibility Assessment|Abnormal labs|2
1039189|NCT00107991|3380745|P1|Eligibility Assessment|Positive purified protein derivative|4
1039190|NCT00107991|3380745|P1|Eligibility Assessment|Unwilling to participate|7
1039191|NCT00107991|3380745|P1|Eligibility Assessment|Disease not severe enough|7
1039192|NCT00107978|3380755|P2|Overall Study|Other|4
1039193|NCT00107978|3380756|P1|Overall Study|Other|5
1039194|NCT00107978|3380755|P2|Overall Study|Protocol Violation|1
1039195|NCT00107978|3380756|P1|Overall Study|Protocol Violation|0
1039196|NCT00107978|3380755|P2|Overall Study|Withdrawal by Subject|9
1039197|NCT00107978|3380756|P1|Overall Study|Withdrawal by Subject|4
1039198|NCT00107978|3380755|P2|Overall Study|Lost to Follow-up|28
1039199|NCT00107978|3380756|P1|Overall Study|Lost to Follow-up|20
1039200|NCT00107978|3380755|P2|Overall Study|Death|3
1039201|NCT00107978|3380756|P1|Overall Study|Death|3
1039202|NCT00107978|3380755|P2|Overall Study|Adverse Event|5
1039203|NCT00107978|3380756|P1|Overall Study|Adverse Event|1
1039204|NCT00107952|3380764|P2|Overall Study|Never received study treatment|6
1039205|NCT00107952|3380765|P1|Overall Study|Never received study treatment|9
1039206|NCT00107952|3380764|P2|Overall Study|Other|5
1039207|NCT00107952|3380765|P1|Overall Study|Other|2
1039208|NCT00107952|3380764|P2|Overall Study|Withdrawal by Subject|6
1039209|NCT00107952|3380765|P1|Overall Study|Withdrawal by Subject|9
1039210|NCT00107952|3380764|P2|Overall Study|Lost to Follow-up|3
1039211|NCT00107952|3380765|P1|Overall Study|Lost to Follow-up|0
1039212|NCT00107952|3380764|P2|Overall Study|Death|61
1039213|NCT00107952|3380765|P1|Overall Study|Death|75
1039214|NCT00107900|3380777|P6|Overall Study|Administrative Reasons|0
1039215|NCT00107900|3380778|P5|Overall Study|Administrative Reasons|2
1039216|NCT00107900|3380779|P4|Overall Study|Administrative Reasons|2
1039217|NCT00107900|3380780|P3|Overall Study|Administrative Reasons|2
1039218|NCT00107900|3380781|P2|Overall Study|Administrative Reasons|0
1039219|NCT00107900|3380782|P1|Overall Study|Administrative Reasons|1
1039220|NCT00107900|3380777|P6|Overall Study|Withdrawal by Subject|1
1039221|NCT00107900|3380778|P5|Overall Study|Withdrawal by Subject|1
1039222|NCT00107900|3380779|P4|Overall Study|Withdrawal by Subject|0
1039223|NCT00107900|3380780|P3|Overall Study|Withdrawal by Subject|5
1039224|NCT00107900|3380781|P2|Overall Study|Withdrawal by Subject|0
1039225|NCT00107900|3380782|P1|Overall Study|Withdrawal by Subject|1
1039226|NCT00107900|3380777|P6|Overall Study|Protocol Violation|0
1039227|NCT00107900|3380778|P5|Overall Study|Protocol Violation|7
1039228|NCT00107900|3380779|P4|Overall Study|Protocol Violation|5
1039229|NCT00107900|3380780|P3|Overall Study|Protocol Violation|5
1039230|NCT00107900|3380781|P2|Overall Study|Protocol Violation|0
1039231|NCT00107900|3380782|P1|Overall Study|Protocol Violation|1
1039232|NCT00107900|3380777|P6|Overall Study|Lost to Follow-up|5
1039233|NCT00107900|3380778|P5|Overall Study|Lost to Follow-up|5
1039234|NCT00107900|3380779|P4|Overall Study|Lost to Follow-up|2
1039235|NCT00107900|3380780|P3|Overall Study|Lost to Follow-up|3
1039236|NCT00107900|3380781|P2|Overall Study|Lost to Follow-up|1
1039237|NCT00107900|3380782|P1|Overall Study|Lost to Follow-up|4
1039238|NCT00107900|3380777|P6|Overall Study|Death|0
1039239|NCT00107900|3380778|P5|Overall Study|Death|1
1039240|NCT00107900|3380779|P4|Overall Study|Death|0
1039241|NCT00107900|3380780|P3|Overall Study|Death|0
1039242|NCT00107900|3380781|P2|Overall Study|Death|0
1039243|NCT00107900|3380782|P1|Overall Study|Death|0
1039244|NCT00107900|3380777|P6|Overall Study|Adverse Event|3
1039245|NCT00107900|3380778|P5|Overall Study|Adverse Event|5
1039246|NCT00107900|3380779|P4|Overall Study|Adverse Event|3
1039247|NCT00107900|3380780|P3|Overall Study|Adverse Event|10
1039248|NCT00107900|3380781|P2|Overall Study|Adverse Event|2
1039249|NCT00107900|3380782|P1|Overall Study|Adverse Event|3
1039250|NCT00107783|3380816|P2|Overall Study|Second hip replacement|1
1039251|NCT00107783|3380817|P1|Overall Study|Second hip replacement|1
1039252|NCT00107783|3380816|P2|Overall Study|Withdrawal by Subject|0
1039253|NCT00107783|3380817|P1|Overall Study|Withdrawal by Subject|2
1039254|NCT00107783|3380816|P2|Overall Study|Death|1
1039255|NCT00107783|3380817|P1|Overall Study|Death|0
1039256|NCT00107783|3380816|P2|Overall Study|Adverse Event|2
1039257|NCT00107783|3380817|P1|Overall Study|Adverse Event|0
1039258|NCT00107653|3380852|P2|Overall Study|Administrative Reasons|3
1039259|NCT00107653|3380853|P1|Overall Study|Administrative Reasons|3
1039260|NCT00107653|3380852|P2|Overall Study|Lost to Follow-up|5
1039261|NCT00107653|3380853|P1|Overall Study|Lost to Follow-up|13
1039262|NCT00107653|3380852|P2|Overall Study|Withdrawal by Subject|13
1039263|NCT00107653|3380853|P1|Overall Study|Withdrawal by Subject|12
1039264|NCT00107653|3380852|P2|Overall Study|Protocol Violation|0
1039265|NCT00107653|3380853|P1|Overall Study|Protocol Violation|1
1039266|NCT00107653|3380852|P2|Overall Study|Violation of Selection Criteria at Entry|1
1039267|NCT00107653|3380853|P1|Overall Study|Violation of Selection Criteria at Entry|1
1039268|NCT00107653|3380852|P2|Overall Study|Insufficient Therapeutic Response|11
1039269|NCT00107653|3380853|P1|Overall Study|Insufficient Therapeutic Response|25
1039270|NCT00107653|3380852|P2|Overall Study|Adverse Event|43
1039271|NCT00107653|3380853|P1|Overall Study|Adverse Event|24
1039272|NCT00107614|3380899|P1|Overall Study|Death|2
1039273|NCT00107614|3380899|P1|Overall Study|Physician Decision|10
1039274|NCT00107380|3380930|P1|Overall Study|Ineligible|2
1039275|NCT00107380|3380930|P1|Overall Study|Other - not protocol specified|7
1039276|NCT00107380|3380930|P1|Overall Study|Death|3
1039277|NCT00107380|3380930|P1|Overall Study|Progression/relapse|4
1039278|NCT00107380|3380930|P1|Overall Study|Refusal Unrelated to Adverse Event|7
1039279|NCT00107380|3380930|P1|Overall Study|Adverse Event|7
1039280|NCT00107315|3380936|P1|Overall Study|Withdrawal by Subject|2
1039281|NCT00107315|3380936|P1|Overall Study|Adverse Event|4
1039282|NCT00107315|3380936|P1|Overall Study|Disease Progression|9
1039283|NCT00107276|3380943|P1|Overall Study|Ineligible|16
1039284|NCT00107276|3380943|P1|Overall Study|Death|1
1039285|NCT00107276|3380943|P1|Overall Study|Patient refusal|1
1039286|NCT00107276|3380943|P1|Overall Study|M.D. decision|2
1039287|NCT00107276|3380943|P1|Overall Study|Adverse Event|6
1039288|NCT00107276|3380943|P1|Overall Study|Progression|46
1039289|NCT00107198|3380949|P1|Overall Study|Ineligible|5
1039290|NCT00107198|3380949|P1|Overall Study|Withdrawal by Subject|6
1039291|NCT00107198|3380949|P1|Overall Study|Protocol Violation|1
1039292|NCT00107198|3380949|P1|Overall Study|Lost to Follow-up|12
1039293|NCT00107198|3380949|P1|Overall Study|Lack of Efficacy|28
1039294|NCT00107172|3380959|P2|Overall Study|Other Reason|3
1039295|NCT00107172|3380960|P1|Overall Study|Other Reason|4
1039296|NCT00107172|3380959|P2|Overall Study|Death|2
1039297|NCT00107172|3380960|P1|Overall Study|Death|0
1039298|NCT00107172|3380959|P2|Overall Study|Withdrawal by Subject|0
1039299|NCT00107172|3380960|P1|Overall Study|Withdrawal by Subject|1
1039300|NCT00107120|3380990|P2|Overall Study|death of parent|1
1039301|NCT00107120|3380991|P1|Overall Study|death of parent|0
1039302|NCT00107120|3380990|P2|Overall Study|moving away from site|1
1039303|NCT00107120|3380991|P1|Overall Study|moving away from site|1
1039304|NCT00107120|3380990|P2|Overall Study|Pregnancy|1
1039305|NCT00107120|3380991|P1|Overall Study|Pregnancy|0
1039306|NCT00107120|3380990|P2|Overall Study|Lost to Follow-up|6
1039307|NCT00107120|3380991|P1|Overall Study|Lost to Follow-up|8
1039308|NCT00107120|3380990|P2|Overall Study|Withdrawal by Subject|9
1039309|NCT00107120|3380991|P1|Overall Study|Withdrawal by Subject|8
1039310|NCT00107120|3380990|P2|Overall Study|Protocol Violation|0
1039311|NCT00107120|3380991|P1|Overall Study|Protocol Violation|3
1039312|NCT00107120|3380990|P2|Overall Study|Lack of Efficacy|5
1039313|NCT00107120|3380991|P1|Overall Study|Lack of Efficacy|5
1039314|NCT00107120|3380990|P2|Overall Study|Adverse Event|1
1039315|NCT00107120|3380991|P1|Overall Study|Adverse Event|4
1039316|NCT00107042|3381003|P2|Overall Study|Disallowed medications|2
1039317|NCT00107042|3381004|P1|Overall Study|Disallowed medications|0
1039318|NCT00107042|3381003|P2|Overall Study|vaccinated outside window|1
1039319|NCT00107042|3381004|P1|Overall Study|vaccinated outside window|1
1039320|NCT00107042|3381003|P2|Overall Study|Inadvertent enrollment|1
1039321|NCT00107042|3381004|P1|Overall Study|Inadvertent enrollment|0
1039322|NCT00107042|3381003|P2|Overall Study|Pregnancy|1
1039323|NCT00107042|3381004|P1|Overall Study|Pregnancy|1
1039324|NCT00107042|3381003|P2|Overall Study|Moved out of area|3
1039325|NCT00107042|3381004|P1|Overall Study|Moved out of area|5
1039326|NCT00107042|3381003|P2|Overall Study|Withdrawal by Subject|1
1039327|NCT00107042|3381004|P1|Overall Study|Withdrawal by Subject|6
1039328|NCT00107042|3381003|P2|Overall Study|Lost to Follow-up|7
1039329|NCT00107042|3381004|P1|Overall Study|Lost to Follow-up|9
1039330|NCT00106964|3381070|P3|Overall Study|Required disallowed medication|0
1039331|NCT00106964|3381071|P2|Overall Study|Required disallowed medication|1
1039332|NCT00106964|3381072|P1|Overall Study|Required disallowed medication|0
1039333|NCT00106964|3381070|P3|Overall Study|Did not meet eligibility criteria|2
1039334|NCT00106964|3381071|P2|Overall Study|Did not meet eligibility criteria|2
1039335|NCT00106964|3381072|P1|Overall Study|Did not meet eligibility criteria|0
1039336|NCT00106964|3381070|P3|Overall Study|Failure to adhere|0
1039337|NCT00106964|3381071|P2|Overall Study|Failure to adhere|0
1039338|NCT00106964|3381072|P1|Overall Study|Failure to adhere|2
1039339|NCT00106964|3381070|P3|Overall Study|Site Funding Terminated|1
1039340|NCT00106964|3381071|P2|Overall Study|Site Funding Terminated|1
1039341|NCT00106964|3381072|P1|Overall Study|Site Funding Terminated|0
1039342|NCT00106964|3381070|P3|Overall Study|Incarceration|0
1039343|NCT00106964|3381071|P2|Overall Study|Incarceration|1
1039344|NCT00106964|3381072|P1|Overall Study|Incarceration|0
1039345|NCT00106964|3381070|P3|Overall Study|Death|0
1039346|NCT00106964|3381071|P2|Overall Study|Death|1
1039347|NCT00106964|3381072|P1|Overall Study|Death|1
1039348|NCT00106964|3381070|P3|Overall Study|Pregnancy|2
1039349|NCT00106964|3381071|P2|Overall Study|Pregnancy|3
1039350|NCT00106964|3381072|P1|Overall Study|Pregnancy|2
1039351|NCT00106964|3381070|P3|Overall Study|Lost to Follow-up|2
1039352|NCT00106964|3381071|P2|Overall Study|Lost to Follow-up|6
1039353|NCT00106964|3381072|P1|Overall Study|Lost to Follow-up|8
1039354|NCT00106704|3381167|P2|Overall Study|Laboratory test|1
1039355|NCT00106704|3381168|P1|Overall Study|Laboratory test|1
1039356|NCT00106704|3381167|P2|Overall Study|Unable to re-enter US|0
1039357|NCT00106704|3381168|P1|Overall Study|Unable to re-enter US|1
1039358|NCT00106704|3381167|P2|Overall Study|Patient Received Glycemic Medication|41
1039359|NCT00106704|3381168|P1|Overall Study|Patient Received Glycemic Medication|22
1039360|NCT00106704|3381167|P2|Overall Study|Planned major surgery|0
1039361|NCT00106704|3381168|P1|Overall Study|Planned major surgery|1
1039362|NCT00106704|3381167|P2|Overall Study|Site terminated|1
1039363|NCT00106704|3381168|P1|Overall Study|Site terminated|0
1039364|NCT00106704|3381167|P2|Overall Study|Patient moved|0
1039365|NCT00106704|3381168|P1|Overall Study|Patient moved|1
1039366|NCT00106704|3381167|P2|Overall Study|Withdrawal by Subject|21
1039367|NCT00106704|3381168|P1|Overall Study|Withdrawal by Subject|14
1039368|NCT00106704|3381167|P2|Overall Study|Protocol Violation|7
1039369|NCT00106704|3381168|P1|Overall Study|Protocol Violation|4
1039370|NCT00106704|3381167|P2|Overall Study|Pregnancy|0
1039371|NCT00106704|3381168|P1|Overall Study|Pregnancy|1
1039372|NCT00106704|3381167|P2|Overall Study|Lost to Follow-up|3
1039373|NCT00106704|3381168|P1|Overall Study|Lost to Follow-up|7
1039374|NCT00106704|3381167|P2|Overall Study|Lack of Efficacy|69
1039375|NCT00106704|3381168|P1|Overall Study|Lack of Efficacy|67
1039376|NCT00106704|3381167|P2|Overall Study|Death|1
1039377|NCT00106704|3381168|P1|Overall Study|Death|2
1039378|NCT00106704|3381167|P2|Overall Study|Adverse Event|7
1039379|NCT00106704|3381168|P1|Overall Study|Adverse Event|10
1039380|NCT00106639|3381179|P3|Overall Study|Participant defaulted|1
1039381|NCT00106639|3381180|P2|Overall Study|Participant defaulted|1
1039382|NCT00106639|3381181|P1|Overall Study|Participant defaulted|0
1039383|NCT00106639|3381179|P3|Overall Study|Withdrawal by Subject|0
1039384|NCT00106639|3381180|P2|Overall Study|Withdrawal by Subject|1
1039385|NCT00106639|3381181|P1|Overall Study|Withdrawal by Subject|0
1039386|NCT00106639|3381179|P3|Overall Study|Protocol Violation|0
1039387|NCT00106639|3381180|P2|Overall Study|Protocol Violation|1
1039388|NCT00106639|3381181|P1|Overall Study|Protocol Violation|0
1039389|NCT00106639|3381179|P3|Overall Study|Adverse Event|1
1039390|NCT00106639|3381180|P2|Overall Study|Adverse Event|4
1039391|NCT00106639|3381181|P1|Overall Study|Adverse Event|3
1039392|NCT00106626|3381308|P4|Overall Study|> 14 day delay in therapy start|0
1039393|NCT00106626|3381309|P3|Overall Study|> 14 day delay in therapy start|0
1039394|NCT00106626|3381310|P2|Overall Study|> 14 day delay in therapy start|1
1039395|NCT00106626|3381311|P1|Overall Study|> 14 day delay in therapy start|0
1039396|NCT00106626|3381308|P4|Overall Study|Received radiation on new therapy|0
1039397|NCT00106626|3381309|P3|Overall Study|Received radiation on new therapy|0
1039398|NCT00106626|3381310|P2|Overall Study|Received radiation on new therapy|0
1039399|NCT00106626|3381311|P1|Overall Study|Received radiation on new therapy|1
1039400|NCT00106626|3381308|P4|Overall Study|Progressive Disease|10
1039401|NCT00106626|3381309|P3|Overall Study|Progressive Disease|9
1039402|NCT00106626|3381310|P2|Overall Study|Progressive Disease|1
1039403|NCT00106626|3381311|P1|Overall Study|Progressive Disease|4
1039404|NCT00106626|3381308|P4|Overall Study|Adverse Event|3
1039405|NCT00106626|3381309|P3|Overall Study|Adverse Event|3
1039406|NCT00106626|3381310|P2|Overall Study|Adverse Event|4
1039407|NCT00106626|3381311|P1|Overall Study|Adverse Event|5
1039408|NCT00106353|3381656|P7|Part 2|Physician Decision|0
1039409|NCT00106353|3381657|P6|Part 2|Physician Decision|1
1039410|NCT00106353|3381658|P5|Part 2|Physician Decision|0
1039411|NCT00106353|3381659|P4|Part 2|Physician Decision|0
1039412|NCT00106353|3381660|P3|Part 2|Physician Decision|0
1039413|NCT00106353|3381661|P2|Part 2|Physician Decision|0
1039414|NCT00106353|3381662|P1|Part 2|Physician Decision|0
1039415|NCT00106353|3381656|P7|Part 2|Withdrawal by Subject|0
1039416|NCT00106353|3381657|P6|Part 2|Withdrawal by Subject|0
1039417|NCT00106353|3381658|P5|Part 2|Withdrawal by Subject|1
1039418|NCT00106353|3381659|P4|Part 2|Withdrawal by Subject|0
1039419|NCT00106353|3381660|P3|Part 2|Withdrawal by Subject|0
1039420|NCT00106353|3381661|P2|Part 2|Withdrawal by Subject|0
1039421|NCT00106353|3381662|P1|Part 2|Withdrawal by Subject|0
1039422|NCT00106353|3381656|P7|Part 2|Other|1
1039423|NCT00106353|3381657|P6|Part 2|Other|1
1039424|NCT00106353|3381658|P5|Part 2|Other|1
1039425|NCT00106353|3381659|P4|Part 2|Other|0
1039426|NCT00106353|3381660|P3|Part 2|Other|0
1039427|NCT00106353|3381661|P2|Part 2|Other|0
1039428|NCT00106353|3381662|P1|Part 2|Other|0
1039429|NCT00106353|3381656|P7|Part 2|Adverse Event|1
1039430|NCT00106353|3381657|P6|Part 2|Adverse Event|2
1039431|NCT00106353|3381658|P5|Part 2|Adverse Event|0
1039432|NCT00106353|3381659|P4|Part 2|Adverse Event|0
1039433|NCT00106353|3381660|P3|Part 2|Adverse Event|0
1039434|NCT00106353|3381661|P2|Part 2|Adverse Event|0
1039435|NCT00106353|3381662|P1|Part 2|Adverse Event|0
1039436|NCT00106353|3381656|P7|Part 2|Symptomatic deterioration|0
1039437|NCT00106353|3381657|P6|Part 2|Symptomatic deterioration|0
1039438|NCT00106353|3381658|P5|Part 2|Symptomatic deterioration|3
1039439|NCT00106353|3381659|P4|Part 2|Symptomatic deterioration|0
1039440|NCT00106353|3381660|P3|Part 2|Symptomatic deterioration|0
1039441|NCT00106353|3381661|P2|Part 2|Symptomatic deterioration|0
1039442|NCT00106353|3381662|P1|Part 2|Symptomatic deterioration|0
1039443|NCT00106353|3381656|P7|Part 2|Death|1
1039444|NCT00106353|3381657|P6|Part 2|Death|0
1039445|NCT00106353|3381658|P5|Part 2|Death|3
1039446|NCT00106353|3381659|P4|Part 2|Death|0
1039447|NCT00106353|3381660|P3|Part 2|Death|0
1039448|NCT00106353|3381661|P2|Part 2|Death|0
1039449|NCT00106353|3381662|P1|Part 2|Death|0
1039450|NCT00106353|3381656|P7|Part 2|Disease progression|13
1039451|NCT00106353|3381657|P6|Part 2|Disease progression|14
1039452|NCT00106353|3381658|P5|Part 2|Disease progression|8
1039453|NCT00106353|3381659|P4|Part 2|Disease progression|0
1039454|NCT00106353|3381660|P3|Part 2|Disease progression|0
1039455|NCT00106353|3381661|P2|Part 2|Disease progression|0
1039456|NCT00106353|3381662|P1|Part 2|Disease progression|0
1039457|NCT00106353|3381656|P7|Part 1|Adverse Event|0
1039458|NCT00106353|3381657|P6|Part 1|Adverse Event|0
1039459|NCT00106353|3381658|P5|Part 1|Adverse Event|0
1039460|NCT00106353|3381659|P4|Part 1|Adverse Event|1
1039461|NCT00106353|3381660|P3|Part 1|Adverse Event|0
1039462|NCT00106353|3381661|P2|Part 1|Adverse Event|0
1039463|NCT00106353|3381662|P1|Part 1|Adverse Event|0
1039464|NCT00106353|3381656|P7|Part 1|Entered follow-up phase|0
1039465|NCT00106353|3381657|P6|Part 1|Entered follow-up phase|0
1039466|NCT00106353|3381658|P5|Part 1|Entered follow-up phase|0
1039467|NCT00106353|3381659|P4|Part 1|Entered follow-up phase|1
1039468|NCT00106353|3381660|P3|Part 1|Entered follow-up phase|0
1039469|NCT00106353|3381661|P2|Part 1|Entered follow-up phase|1
1039470|NCT00106353|3381662|P1|Part 1|Entered follow-up phase|1
1039471|NCT00106353|3381656|P7|Part 1|Symptomatic deterioration|0
1039472|NCT00106353|3381657|P6|Part 1|Symptomatic deterioration|0
1039473|NCT00106353|3381658|P5|Part 1|Symptomatic deterioration|0
1039474|NCT00106353|3381659|P4|Part 1|Symptomatic deterioration|0
1039475|NCT00106353|3381660|P3|Part 1|Symptomatic deterioration|1
1039476|NCT00106353|3381661|P2|Part 1|Symptomatic deterioration|0
1039477|NCT00106353|3381662|P1|Part 1|Symptomatic deterioration|0
1039478|NCT00106353|3381656|P7|Part 1|Withdrawal by Subject|0
1039479|NCT00106353|3381657|P6|Part 1|Withdrawal by Subject|0
1039480|NCT00106353|3381658|P5|Part 1|Withdrawal by Subject|0
1039481|NCT00106353|3381659|P4|Part 1|Withdrawal by Subject|2
1039482|NCT00106353|3381660|P3|Part 1|Withdrawal by Subject|1
1039483|NCT00106353|3381661|P2|Part 1|Withdrawal by Subject|0
1039484|NCT00106353|3381662|P1|Part 1|Withdrawal by Subject|0
1039485|NCT00106353|3381656|P7|Part 1|Disease progression|0
1039486|NCT00106353|3381657|P6|Part 1|Disease progression|0
1039487|NCT00106353|3381658|P5|Part 1|Disease progression|0
1039488|NCT00106353|3381659|P4|Part 1|Disease progression|3
1039489|NCT00106353|3381660|P3|Part 1|Disease progression|1
1039490|NCT00106353|3381661|P2|Part 1|Disease progression|4
1039491|NCT00106353|3381662|P1|Part 1|Disease progression|3
1039492|NCT00106249|3381789|P2|Overall Study|Lost to Follow-up|2
1039493|NCT00106249|3381790|P1|Overall Study|Lost to Follow-up|3
1039494|NCT00106184|3381802|P2|Overall Study|Withdrawal by Subject|2
1039495|NCT00106184|3381803|P1|Overall Study|Withdrawal by Subject|3
1039496|NCT00106080|3381845|P2|Overall Study|Withdrew/Loss to follow-up|27
1039497|NCT00106080|3381846|P1|Overall Study|Withdrew/Loss to follow-up|43
1039498|NCT00106028|3381856|P2|Overall Study|Lost to Follow-up|1
1039499|NCT00106028|3381857|P1|Overall Study|Lost to Follow-up|0
1039500|NCT00106028|3381856|P2|Overall Study|Withdrawal by Subject|8
1039501|NCT00106028|3381857|P1|Overall Study|Withdrawal by Subject|2
1039502|NCT00106028|3381856|P2|Overall Study|Protocol Violation|1
1039503|NCT00106028|3381857|P1|Overall Study|Protocol Violation|1
1039504|NCT00106028|3381856|P2|Overall Study|Adverse Event|2
1039505|NCT00106028|3381857|P1|Overall Study|Adverse Event|3
1039506|NCT00106002|3381951|P1|Overall Study|Ineligible after Registration|1
1039507|NCT00106002|3381951|P1|Overall Study|Did not take any study drug|1
1039508|NCT00105989|3381959|P2|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
1039509|NCT00105989|3381960|P1|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
1039510|NCT00105989|3381959|P2|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43
1039511|NCT00105989|3381960|P1|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14
1039512|NCT00105989|3381959|P2|Maintenance - Double-Blind:Week 34-86|Death|0
1039513|NCT00105989|3381960|P1|Maintenance - Double-Blind:Week 34-86|Death|0
1039514|NCT00105989|3381959|P2|Maintenance - Double-Blind:Week 34-86|Physician Decision|1
1039515|NCT00105989|3381960|P1|Maintenance - Double-Blind:Week 34-86|Physician Decision|4
1039516|NCT00105989|3381959|P2|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0
1039517|NCT00105989|3381960|P1|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4
1039518|NCT00105989|3381959|P2|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4
1039519|NCT00105989|3381960|P1|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5
1039520|NCT00105989|3381959|P2|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
1039521|NCT00105989|3381960|P1|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
1039522|NCT00105989|3381959|P2|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
1039523|NCT00105989|3381960|P1|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
1039524|NCT00105989|3381959|P2|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18
1039525|NCT00105989|3381960|P1|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17
1039526|NCT00105989|3381959|P2|Maintenance - Double-Blind:Week 34-86|Adverse Event|3
1039527|NCT00105989|3381960|P1|Maintenance - Double-Blind:Week 34-86|Adverse Event|6
1039528|NCT00105989|3381959|P2|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
1039529|NCT00105989|3381960|P1|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
1039530|NCT00105989|3381959|P2|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0
1039531|NCT00105989|3381960|P1|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2
1039532|NCT00105989|3381959|P2|Continuation - Open Label:Week 10-34|Death|0
1039533|NCT00105989|3381960|P1|Continuation - Open Label:Week 10-34|Death|0
1039534|NCT00105989|3381959|P2|Continuation - Open Label:Week 10-34|Physician Decision|0
1039535|NCT00105989|3381960|P1|Continuation - Open Label:Week 10-34|Physician Decision|3
1039536|NCT00105989|3381959|P2|Continuation - Open Label:Week 10-34|Lost to Follow-up|0
1039537|NCT00105989|3381960|P1|Continuation - Open Label:Week 10-34|Lost to Follow-up|9
1039538|NCT00105989|3381959|P2|Continuation - Open Label:Week 10-34|Protocol Violation|0
1039539|NCT00105989|3381960|P1|Continuation - Open Label:Week 10-34|Protocol Violation|5
1039540|NCT00105989|3381959|P2|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0
1039541|NCT00105989|3381960|P1|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16
1039542|NCT00105989|3381959|P2|Continuation - Open Label:Week 10-34|Lack of Efficacy|0
1039543|NCT00105989|3381960|P1|Continuation - Open Label:Week 10-34|Lack of Efficacy|15
1039544|NCT00105989|3381959|P2|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0
1039545|NCT00105989|3381960|P1|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50
1039546|NCT00105989|3381959|P2|Continuation - Open Label:Week 10-34|Adverse Event|0
1039547|NCT00105989|3381960|P1|Continuation - Open Label:Week 10-34|Adverse Event|25
1039548|NCT00105989|3381959|P2|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
1039549|NCT00105989|3381960|P1|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
1039550|NCT00105989|3381959|P2|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
1039551|NCT00105989|3381960|P1|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
1039552|NCT00105989|3381959|P2|Acute - Open Label: Week 0-10|Death|0
1039553|NCT00105989|3381960|P1|Acute - Open Label: Week 0-10|Death|1
1039554|NCT00105989|3381959|P2|Acute - Open Label: Week 0-10|Physician Decision|0
1039555|NCT00105989|3381960|P1|Acute - Open Label: Week 0-10|Physician Decision|0
1039556|NCT00105989|3381959|P2|Acute - Open Label: Week 0-10|Lost to Follow-up|0
1039557|NCT00105989|3381960|P1|Acute - Open Label: Week 0-10|Lost to Follow-up|4
1039558|NCT00105989|3381959|P2|Acute - Open Label: Week 0-10|Protocol Violation|0
1039559|NCT00105989|3381960|P1|Acute - Open Label: Week 0-10|Protocol Violation|8
1039560|NCT00105989|3381959|P2|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0
1039561|NCT00105989|3381960|P1|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14
1039562|NCT00105989|3381959|P2|Acute - Open Label: Week 0-10|Lack of Efficacy|0
1039563|NCT00105989|3381960|P1|Acute - Open Label: Week 0-10|Lack of Efficacy|17
1039564|NCT00105989|3381959|P2|Acute - Open Label: Week 0-10|Withdrawal by Subject|0
1039565|NCT00105989|3381960|P1|Acute - Open Label: Week 0-10|Withdrawal by Subject|24
1039566|NCT00105989|3381959|P2|Acute - Open Label: Week 0-10|Adverse Event|0
1039567|NCT00105989|3381960|P1|Acute - Open Label: Week 0-10|Adverse Event|33
1039568|NCT00105586|3382076|P2|Overall Study|Physician Decision|13
1039569|NCT00105586|3382077|P1|Overall Study|Physician Decision|13
1039570|NCT00105586|3382076|P2|Overall Study|Adverse Event|3
1039571|NCT00105586|3382077|P1|Overall Study|Adverse Event|4
1039572|NCT00105560|3382085|P1|Overall Study|Lost to Follow-up|1
1039573|NCT00105534|3382107|P2|Overall Study|Other Reason|2
1039574|NCT00105534|3382108|P1|Overall Study|Other Reason|0
1039575|NCT00105534|3382107|P2|Overall Study|Treatment unmasked|0
1039576|NCT00105534|3382108|P1|Overall Study|Treatment unmasked|1
1039577|NCT00105534|3382107|P2|Overall Study|Lack of Efficacy|15
1039578|NCT00105534|3382108|P1|Overall Study|Lack of Efficacy|7
1039579|NCT00105534|3382107|P2|Overall Study|Lost to Follow-up|1
1039580|NCT00105534|3382108|P1|Overall Study|Lost to Follow-up|5
1039581|NCT00105534|3382107|P2|Overall Study|Withdrawal by Subject|6
1039582|NCT00105534|3382108|P1|Overall Study|Withdrawal by Subject|6
1039583|NCT00105534|3382107|P2|Overall Study|Protocol Violation|4
1039584|NCT00105534|3382108|P1|Overall Study|Protocol Violation|1
1039585|NCT00105534|3382107|P2|Overall Study|Adverse Event|5
1039586|NCT00105534|3382108|P1|Overall Study|Adverse Event|2
1039587|NCT00105521|3382120|P4|Overall Study|Lost to Follow-up|0
1039588|NCT00105521|3382121|P3|Overall Study|Lost to Follow-up|0
1039589|NCT00105521|3382122|P2|Overall Study|Lost to Follow-up|1
1039590|NCT00105521|3382123|P1|Overall Study|Lost to Follow-up|0
1039591|NCT00105521|3382120|P4|Overall Study|Protocol Violation|4
1039592|NCT00105521|3382121|P3|Overall Study|Protocol Violation|4
1039593|NCT00105521|3382122|P2|Overall Study|Protocol Violation|5
1039594|NCT00105521|3382123|P1|Overall Study|Protocol Violation|3
1039595|NCT00105521|3382120|P4|Overall Study|Lack of Efficacy|1
1039596|NCT00105521|3382121|P3|Overall Study|Lack of Efficacy|0
1039597|NCT00105521|3382122|P2|Overall Study|Lack of Efficacy|0
1039598|NCT00105521|3382123|P1|Overall Study|Lack of Efficacy|0
1039599|NCT00105521|3382120|P4|Overall Study|Withdrawal by Subject|4
1039600|NCT00105521|3382121|P3|Overall Study|Withdrawal by Subject|1
1039601|NCT00105521|3382122|P2|Overall Study|Withdrawal by Subject|0
1039602|NCT00105521|3382123|P1|Overall Study|Withdrawal by Subject|1
1039603|NCT00105521|3382120|P4|Overall Study|Adverse Event|8
1039604|NCT00105521|3382121|P3|Overall Study|Adverse Event|10
1039605|NCT00105521|3382122|P2|Overall Study|Adverse Event|4
1039606|NCT00105521|3382123|P1|Overall Study|Adverse Event|10
1039607|NCT00105521|3382120|P4|Overall Study|Other|0
1039608|NCT00105521|3382121|P3|Overall Study|Other|2
1039609|NCT00105521|3382122|P2|Overall Study|Other|1
1039610|NCT00105521|3382123|P1|Overall Study|Other|1
1039611|NCT00105508|3382147|P2|Overall Study|Other|9
1039612|NCT00105508|3382148|P1|Overall Study|Other|8
1039613|NCT00105508|3382147|P2|Overall Study|Protocol Violation|2
1039614|NCT00105508|3382148|P1|Overall Study|Protocol Violation|1
1039615|NCT00105508|3382147|P2|Overall Study|Lost to Follow-up|0
1039616|NCT00105508|3382148|P1|Overall Study|Lost to Follow-up|3
1039617|NCT00105508|3382147|P2|Overall Study|Withdrawal by Subject|6
1039618|NCT00105508|3382148|P1|Overall Study|Withdrawal by Subject|10
1039619|NCT00105508|3382147|P2|Overall Study|Insufficient Efficacy|0
1039620|NCT00105508|3382148|P1|Overall Study|Insufficient Efficacy|1
1039621|NCT00105508|3382147|P2|Overall Study|Adverse Event|19
1039622|NCT00105508|3382148|P1|Overall Study|Adverse Event|16
1039623|NCT00105508|3382147|P2|Overall Study|Prephase Dropout|0
1039624|NCT00105508|3382148|P1|Overall Study|Prephase Dropout|1
1039625|NCT00105482|3382162|P2|Overall Study|Withdrawn by PI|1
1039626|NCT00105482|3382163|P1|Overall Study|Withdrawn by PI|1
1039627|NCT00105482|3382162|P2|Overall Study|Scheduling Conflict|3
1039628|NCT00105482|3382163|P1|Overall Study|Scheduling Conflict|2
1039629|NCT00105482|3382162|P2|Overall Study|Lost Interest|32
1039630|NCT00105482|3382163|P1|Overall Study|Lost Interest|29
1039631|NCT00105482|3382162|P2|Overall Study|Withdrawal by Subject|1
1039632|NCT00105482|3382163|P1|Overall Study|Withdrawal by Subject|0
1039633|NCT00105482|3382162|P2|Overall Study|Lost to Follow-up|17
1039634|NCT00105482|3382163|P1|Overall Study|Lost to Follow-up|26
1039635|NCT00105482|3382162|P2|Overall Study|Adverse Event|1
1039636|NCT00105482|3382163|P1|Overall Study|Adverse Event|1
1039637|NCT00105469|3382179|P2|Overall Study|Other Reason|0
1039638|NCT00105469|3382180|P1|Overall Study|Other Reason|4
1039639|NCT00105469|3382179|P2|Overall Study|Lack of Efficacy|0
1039640|NCT00105469|3382180|P1|Overall Study|Lack of Efficacy|2
1039641|NCT00105469|3382179|P2|Overall Study|Lost to Follow-up|0
1039642|NCT00105469|3382180|P1|Overall Study|Lost to Follow-up|1
1039643|NCT00105469|3382179|P2|Overall Study|Withdrawal by Subject|3
1039644|NCT00105469|3382180|P1|Overall Study|Withdrawal by Subject|2
1039645|NCT00105469|3382179|P2|Overall Study|Protocol Violation|0
1039646|NCT00105469|3382180|P1|Overall Study|Protocol Violation|4
1039647|NCT00105469|3382179|P2|Overall Study|Adverse Event|8
1039648|NCT00105469|3382180|P1|Overall Study|Adverse Event|9
1039649|NCT00105443|3382190|P4|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11
1039650|NCT00105443|3382191|P3|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
1039651|NCT00105443|3382192|P2|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23
1039652|NCT00105443|3382193|P1|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
1039653|NCT00105443|3382190|P4|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
1039654|NCT00105443|3382191|P3|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
1039655|NCT00105443|3382192|P2|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
1039656|NCT00105443|3382193|P1|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
1039657|NCT00105443|3382190|P4|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1
1039658|NCT00105443|3382191|P3|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
1039659|NCT00105443|3382192|P2|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
1039660|NCT00105443|3382193|P1|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
1039661|NCT00105443|3382190|P4|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
1039662|NCT00105443|3382191|P3|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
1039663|NCT00105443|3382192|P2|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
1039664|NCT00105443|3382193|P1|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1
1039665|NCT00105443|3382190|P4|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
1039666|NCT00105443|3382191|P3|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1
1039667|NCT00105443|3382192|P2|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
1039668|NCT00105443|3382193|P1|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
1039669|NCT00105443|3382190|P4|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
1039670|NCT00105443|3382191|P3|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1
1039671|NCT00105443|3382192|P2|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
1039672|NCT00105443|3382193|P1|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6
1039673|NCT00105443|3382190|P4|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
1039674|NCT00105443|3382191|P3|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
1039675|NCT00105443|3382192|P2|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
1039676|NCT00105443|3382193|P1|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
1039677|NCT00105443|3382190|P4|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5
1039678|NCT00105443|3382191|P3|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
1039679|NCT00105443|3382192|P2|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2
1039680|NCT00105443|3382193|P1|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
1039681|NCT00105443|3382190|P4|Follow-up and/or Open Label Nexavar|Protocol Violation|0
1039682|NCT00105443|3382191|P3|Follow-up and/or Open Label Nexavar|Protocol Violation|0
1039683|NCT00105443|3382192|P2|Follow-up and/or Open Label Nexavar|Protocol Violation|2
1039684|NCT00105443|3382193|P1|Follow-up and/or Open Label Nexavar|Protocol Violation|0
1039685|NCT00105443|3382190|P4|Follow-up and/or Open Label Nexavar|Physician Decision|0
1039686|NCT00105443|3382191|P3|Follow-up and/or Open Label Nexavar|Physician Decision|1
1039687|NCT00105443|3382192|P2|Follow-up and/or Open Label Nexavar|Physician Decision|0
1039688|NCT00105443|3382193|P1|Follow-up and/or Open Label Nexavar|Physician Decision|1
1039689|NCT00105443|3382190|P4|Follow-up and/or Open Label Nexavar|Adverse Event|16
1039690|NCT00105443|3382191|P3|Follow-up and/or Open Label Nexavar|Adverse Event|0
1039691|NCT00105443|3382192|P2|Follow-up and/or Open Label Nexavar|Adverse Event|14
1039692|NCT00105443|3382193|P1|Follow-up and/or Open Label Nexavar|Adverse Event|0
1039693|NCT00105443|3382190|P4|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4
1039694|NCT00105443|3382191|P3|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13
1039695|NCT00105443|3382192|P2|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3
1039696|NCT00105443|3382193|P1|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24
1039697|NCT00105443|3382190|P4|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
1039698|NCT00105443|3382191|P3|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10
1039699|NCT00105443|3382192|P2|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
1039700|NCT00105443|3382193|P1|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14
1039701|NCT00105443|3382190|P4|Follow-up and/or Open Label Nexavar|Death|4
1039702|NCT00105443|3382191|P3|Follow-up and/or Open Label Nexavar|Death|219
1039703|NCT00105443|3382192|P2|Follow-up and/or Open Label Nexavar|Death|7
1039704|NCT00105443|3382193|P1|Follow-up and/or Open Label Nexavar|Death|180
1039705|NCT00105443|3382190|P4|Double-Blind Treatment|Radiological and symptomatic progression|0
1039706|NCT00105443|3382191|P3|Double-Blind Treatment|Radiological and symptomatic progression|1
1039707|NCT00105443|3382192|P2|Double-Blind Treatment|Radiological and symptomatic progression|0
1039708|NCT00105443|3382193|P1|Double-Blind Treatment|Radiological and symptomatic progression|4
1039709|NCT00105443|3382190|P4|Double-Blind Treatment|Physician Decision|0
1039710|NCT00105443|3382191|P3|Double-Blind Treatment|Physician Decision|2
1039711|NCT00105443|3382192|P2|Double-Blind Treatment|Physician Decision|0
1039712|NCT00105443|3382193|P1|Double-Blind Treatment|Physician Decision|1
1039713|NCT00105443|3382190|P4|Double-Blind Treatment|Withdrawal by Subject|0
1039714|NCT00105443|3382191|P3|Double-Blind Treatment|Withdrawal by Subject|7
1039715|NCT00105443|3382192|P2|Double-Blind Treatment|Withdrawal by Subject|0
1039716|NCT00105443|3382193|P1|Double-Blind Treatment|Withdrawal by Subject|8
1039717|NCT00105443|3382190|P4|Double-Blind Treatment|Lost to Follow-up|0
1039718|NCT00105443|3382191|P3|Double-Blind Treatment|Lost to Follow-up|1
1039719|NCT00105443|3382192|P2|Double-Blind Treatment|Lost to Follow-up|0
1039720|NCT00105443|3382193|P1|Double-Blind Treatment|Lost to Follow-up|0
1039721|NCT00105443|3382190|P4|Double-Blind Treatment|Adverse Event|0
1039722|NCT00105443|3382191|P3|Double-Blind Treatment|Adverse Event|0
1039723|NCT00105443|3382192|P2|Double-Blind Treatment|Adverse Event|0
1039724|NCT00105443|3382193|P1|Double-Blind Treatment|Adverse Event|1
1039725|NCT00105235|3382220|P1|Overall Study|Withdrawal by Subject|2
1039726|NCT00105235|3382220|P1|Overall Study|Physician Decision|1
1039727|NCT00105235|3382220|P1|Overall Study|Death|4
1039728|NCT00105196|3382233|P2|Overall Study|Subject became unblinded|1
1039729|NCT00105196|3382234|P1|Overall Study|Subject became unblinded|0
1039730|NCT00105196|3382233|P2|Overall Study|marijuana use|1
1039731|NCT00105196|3382234|P1|Overall Study|marijuana use|0
1039732|NCT00105196|3382233|P2|Overall Study|pending surgery|1
1039733|NCT00105196|3382234|P1|Overall Study|pending surgery|0
1039734|NCT00105196|3382233|P2|Overall Study|Protocol Violation|2
1039735|NCT00105196|3382234|P1|Overall Study|Protocol Violation|5
1039736|NCT00105196|3382233|P2|Overall Study|Poor/noncompliance|4
1039737|NCT00105196|3382234|P1|Overall Study|Poor/noncompliance|3
1039738|NCT00105196|3382233|P2|Overall Study|Lost to Follow-up|2
1039739|NCT00105196|3382234|P1|Overall Study|Lost to Follow-up|3
1039740|NCT00105196|3382233|P2|Overall Study|Withdrawal by Subject|6
1039741|NCT00105196|3382234|P1|Overall Study|Withdrawal by Subject|6
1039742|NCT00105196|3382233|P2|Overall Study|Adverse Event|3
1039743|NCT00105196|3382234|P1|Overall Study|Adverse Event|11
1039744|NCT00105196|3382233|P2|Overall Study|Lack of Efficacy|3
1039745|NCT00105196|3382234|P1|Overall Study|Lack of Efficacy|2
1039746|NCT00105183|3382257|P3|Overall Study|Other reason|0
1039747|NCT00105183|3382258|P2|Overall Study|Other reason|2
1039748|NCT00105183|3382259|P1|Overall Study|Other reason|1
1039749|NCT00105183|3382257|P3|Overall Study|Lost to Follow-up|1
1039750|NCT00105183|3382258|P2|Overall Study|Lost to Follow-up|1
1039751|NCT00105183|3382259|P1|Overall Study|Lost to Follow-up|0
1039752|NCT00105183|3382257|P3|Overall Study|Physician Decision|3
1039753|NCT00105183|3382258|P2|Overall Study|Physician Decision|2
1039754|NCT00105183|3382259|P1|Overall Study|Physician Decision|1
1039755|NCT00105183|3382257|P3|Overall Study|Withdrawal by Subject|4
1039756|NCT00105183|3382258|P2|Overall Study|Withdrawal by Subject|1
1039757|NCT00105183|3382259|P1|Overall Study|Withdrawal by Subject|1
1039758|NCT00105183|3382257|P3|Overall Study|Death|15
1039759|NCT00105183|3382258|P2|Overall Study|Death|13
1039760|NCT00105183|3382259|P1|Overall Study|Death|19
1039761|NCT00105157|3382295|P4|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
1039762|NCT00105157|3382296|P3|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
1039763|NCT00105157|3382297|P2|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0
1039764|NCT00105157|3382298|P1|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
1039765|NCT00105157|3382295|P4|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5
1039766|NCT00105157|3382296|P3|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
1039767|NCT00105157|3382297|P2|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
1039768|NCT00105157|3382298|P1|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
1039769|NCT00105157|3382295|P4|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
1039770|NCT00105157|3382296|P3|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
1039771|NCT00105157|3382297|P2|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
1039772|NCT00105157|3382298|P1|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
1039773|NCT00105157|3382295|P4|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10
1039774|NCT00105157|3382296|P3|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5
1039775|NCT00105157|3382297|P2|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6
1039776|NCT00105157|3382298|P1|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7
1039777|NCT00105157|3382295|P4|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1
1039778|NCT00105157|3382296|P3|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
1039779|NCT00105157|3382297|P2|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
1039780|NCT00105157|3382298|P1|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
1039781|NCT00105157|3382295|P4|Open-Label Continuation of DB|Patient moved/site stopped trial|0
1039782|NCT00105157|3382296|P3|Open-Label Continuation of DB|Patient moved/site stopped trial|2
1039783|NCT00105157|3382297|P2|Open-Label Continuation of DB|Patient moved/site stopped trial|3
1039784|NCT00105157|3382298|P1|Open-Label Continuation of DB|Patient moved/site stopped trial|1
1039785|NCT00105157|3382295|P4|Open-Label Continuation of DB|Patient did not continue in extension|0
1039786|NCT00105157|3382296|P3|Open-Label Continuation of DB|Patient did not continue in extension|0
1039787|NCT00105157|3382297|P2|Open-Label Continuation of DB|Patient did not continue in extension|0
1039788|NCT00105157|3382298|P1|Open-Label Continuation of DB|Patient did not continue in extension|1
1039789|NCT00105157|3382295|P4|Open-Label Continuation of DB|Withdrawal by Subject|0
1039790|NCT00105157|3382296|P3|Open-Label Continuation of DB|Withdrawal by Subject|3
1039791|NCT00105157|3382297|P2|Open-Label Continuation of DB|Withdrawal by Subject|1
1039792|NCT00105157|3382298|P1|Open-Label Continuation of DB|Withdrawal by Subject|0
1039793|NCT00105157|3382295|P4|Open-Label Continuation of DB|Lost to Follow-up|0
1039794|NCT00105157|3382296|P3|Open-Label Continuation of DB|Lost to Follow-up|1
1039795|NCT00105157|3382297|P2|Open-Label Continuation of DB|Lost to Follow-up|1
1039796|NCT00105157|3382298|P1|Open-Label Continuation of DB|Lost to Follow-up|1
1039797|NCT00105157|3382295|P4|Open-Label Continuation of DB|Lack of Efficacy|1
1039798|NCT00105157|3382296|P3|Open-Label Continuation of DB|Lack of Efficacy|3
1039799|NCT00105157|3382297|P2|Open-Label Continuation of DB|Lack of Efficacy|4
1039800|NCT00105157|3382298|P1|Open-Label Continuation of DB|Lack of Efficacy|1
1039801|NCT00105157|3382295|P4|Open-Label Continuation of DB|Adverse Event|0
1039802|NCT00105157|3382296|P3|Open-Label Continuation of DB|Adverse Event|0
1039803|NCT00105157|3382297|P2|Open-Label Continuation of DB|Adverse Event|1
1039804|NCT00105157|3382298|P1|Open-Label Continuation of DB|Adverse Event|3
1039805|NCT00105157|3382295|P4|Double-Blind (DB)|Lack of Efficacy|38
1039806|NCT00105157|3382296|P3|Double-Blind (DB)|Lack of Efficacy|11
1039807|NCT00105157|3382297|P2|Double-Blind (DB)|Lack of Efficacy|14
1039808|NCT00105157|3382298|P1|Double-Blind (DB)|Lack of Efficacy|11
1039809|NCT00105157|3382295|P4|Double-Blind (DB)|Adverse Event|1
1039810|NCT00105157|3382296|P3|Double-Blind (DB)|Adverse Event|1
1039811|NCT00105157|3382297|P2|Double-Blind (DB)|Adverse Event|0
1039812|NCT00105157|3382298|P1|Double-Blind (DB)|Adverse Event|2
1039813|NCT00105157|3382295|P4|Double-Blind (DB)|Never Treated|0
1039814|NCT00105157|3382296|P3|Double-Blind (DB)|Never Treated|0
1039815|NCT00105157|3382297|P2|Double-Blind (DB)|Never Treated|0
1039816|NCT00105157|3382298|P1|Double-Blind (DB)|Never Treated|1
1039817|NCT00105079|3382492|P2|Overall Study|not specified|1
1039818|NCT00105079|3382493|P1|Overall Study|not specified|3
1039819|NCT00105079|3382492|P2|Overall Study|Protocol Violation|0
1039820|NCT00105079|3382493|P1|Overall Study|Protocol Violation|1
1039821|NCT00105079|3382492|P2|Overall Study|Violation of selection criteria at entry|2
1039822|NCT00105079|3382493|P1|Overall Study|Violation of selection criteria at entry|0
1039823|NCT00105079|3382492|P2|Overall Study|Refused treatment|4
1039824|NCT00105079|3382493|P1|Overall Study|Refused treatment|6
1039825|NCT00105079|3382492|P2|Overall Study|Lack of Efficacy|3
1039826|NCT00105079|3382493|P1|Overall Study|Lack of Efficacy|9
1039827|NCT00105079|3382492|P2|Overall Study|Lost to Follow-up|12
1039828|NCT00105079|3382493|P1|Overall Study|Lost to Follow-up|12
1039829|NCT00105079|3382492|P2|Overall Study|Death|1
1039830|NCT00105079|3382493|P1|Overall Study|Death|3
1039831|NCT00105079|3382492|P2|Overall Study|Adverse Event|12
1039832|NCT00105079|3382493|P1|Overall Study|Adverse Event|5
1039833|NCT00105066|3382511|P2|Overall Study|Adverse Event|5
1039834|NCT00105066|3382512|P1|Overall Study|Adverse Event|2
1039835|NCT00104884|3382590|P1|Overall Study|Disease progression|4
1039836|NCT00104871|3382594|P1|Overall Study|Not evaluable|1
1039837|NCT00104728|3382599|P1|Overall Study|screen failures|19
1039838|NCT00104650|3382607|P3|Follow-up Period|Other|0
1039839|NCT00104650|3382608|P2|Follow-up Period|Other|1
1039840|NCT00104650|3382609|P1|Follow-up Period|Other|0
1039841|NCT00104650|3382607|P3|Follow-up Period|Lost to Follow-up|2
1039842|NCT00104650|3382608|P2|Follow-up Period|Lost to Follow-up|1
1039843|NCT00104650|3382609|P1|Follow-up Period|Lost to Follow-up|0
1039844|NCT00104650|3382607|P3|Follow-up Period|Disease progression|0
1039845|NCT00104650|3382608|P2|Follow-up Period|Disease progression|1
1039846|NCT00104650|3382609|P1|Follow-up Period|Disease progression|3
1039847|NCT00104650|3382607|P3|Follow-up Period|Death|4
1039848|NCT00104650|3382608|P2|Follow-up Period|Death|6
1039849|NCT00104650|3382609|P1|Follow-up Period|Death|6
1039850|NCT00104650|3382607|P3|Follow-up Period|Withdrawal by Subject|3
1039851|NCT00104650|3382608|P2|Follow-up Period|Withdrawal by Subject|3
1039852|NCT00104650|3382609|P1|Follow-up Period|Withdrawal by Subject|0
1039853|NCT00104650|3382607|P3|Follow-up Period|Adverse Event|1
1039854|NCT00104650|3382608|P2|Follow-up Period|Adverse Event|0
1039855|NCT00104650|3382609|P1|Follow-up Period|Adverse Event|1
1039856|NCT00104650|3382607|P3|Follow-up Period|Physician Decision|0
1039857|NCT00104650|3382608|P2|Follow-up Period|Physician Decision|1
1039858|NCT00104650|3382609|P1|Follow-up Period|Physician Decision|1
1039859|NCT00104650|3382607|P3|Treatment Period (25 Weeks)|Protocol deviation|0
1039860|NCT00104650|3382608|P2|Treatment Period (25 Weeks)|Protocol deviation|1
1039861|NCT00104650|3382609|P1|Treatment Period (25 Weeks)|Protocol deviation|0
1039862|NCT00104650|3382607|P3|Treatment Period (25 Weeks)|Other|0
1039863|NCT00104650|3382608|P2|Treatment Period (25 Weeks)|Other|0
1039864|NCT00104650|3382609|P1|Treatment Period (25 Weeks)|Other|1
1039865|NCT00104650|3382607|P3|Treatment Period (25 Weeks)|Ineligibility determined|0
1039866|NCT00104650|3382608|P2|Treatment Period (25 Weeks)|Ineligibility determined|1
1039867|NCT00104650|3382609|P1|Treatment Period (25 Weeks)|Ineligibility determined|0
1039868|NCT00104650|3382607|P3|Treatment Period (25 Weeks)|Disease progression|2
1039869|NCT00104650|3382608|P2|Treatment Period (25 Weeks)|Disease progression|3
1039870|NCT00104650|3382609|P1|Treatment Period (25 Weeks)|Disease progression|2
1039871|NCT00104650|3382607|P3|Treatment Period (25 Weeks)|Death|6
1039872|NCT00104650|3382608|P2|Treatment Period (25 Weeks)|Death|5
1039873|NCT00104650|3382609|P1|Treatment Period (25 Weeks)|Death|7
1039874|NCT00104650|3382607|P3|Treatment Period (25 Weeks)|Withdrawal by Subject|1
1039875|NCT00104650|3382608|P2|Treatment Period (25 Weeks)|Withdrawal by Subject|1
1039876|NCT00104650|3382609|P1|Treatment Period (25 Weeks)|Withdrawal by Subject|2
1039877|NCT00104650|3382607|P3|Treatment Period (25 Weeks)|Physician Decision|1
1039878|NCT00104650|3382608|P2|Treatment Period (25 Weeks)|Physician Decision|0
1039879|NCT00104650|3382609|P1|Treatment Period (25 Weeks)|Physician Decision|0
1039880|NCT00104637|3382641|P2|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0
1039881|NCT00104637|3382642|P1|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1
1039882|NCT00104572|3382671|P3|Overall Study|Withdrawal by Subject|0
1039883|NCT00104572|3382672|P2|Overall Study|Withdrawal by Subject|3
1039884|NCT00104572|3382673|P1|Overall Study|Withdrawal by Subject|3
1039885|NCT00104520|3382692|P2|Overall Study|Other|5
1039886|NCT00104520|3382693|P1|Overall Study|Other|1
1039887|NCT00104520|3382692|P2|Overall Study|Personal/administrative|1
1039888|NCT00104520|3382693|P1|Overall Study|Personal/administrative|1
1039889|NCT00104520|3382692|P2|Overall Study|Noncompliance|2
1039890|NCT00104520|3382693|P1|Overall Study|Noncompliance|0
1039891|NCT00104520|3382692|P2|Overall Study|Lost to Follow-up|0
1039892|NCT00104520|3382693|P1|Overall Study|Lost to Follow-up|1
1039893|NCT00104520|3382692|P2|Overall Study|Related adverse event|15
1039894|NCT00104520|3382693|P1|Overall Study|Related adverse event|13
1039895|NCT00104520|3382692|P2|Overall Study|Study drug intolerance|1
1039896|NCT00104520|3382693|P1|Overall Study|Study drug intolerance|0
1039897|NCT00104520|3382692|P2|Overall Study|Unrelated adverse event|47
1039898|NCT00104520|3382693|P1|Overall Study|Unrelated adverse event|34
1039899|NCT00104416|3382713|P5|Continuation Phase|Non-compliance|1
1039900|NCT00104416|3382714|P4|Continuation Phase|Non-compliance|0
1039901|NCT00104416|3382715|P3|Continuation Phase|Non-compliance|0
1039902|NCT00104416|3382716|P2|Continuation Phase|Non-compliance|0
1039903|NCT00104416|3382717|P1|Continuation Phase|Non-compliance|0
1039904|NCT00104416|3382713|P5|Continuation Phase|Pregnancy|0
1039905|NCT00104416|3382714|P4|Continuation Phase|Pregnancy|1
1039906|NCT00104416|3382715|P3|Continuation Phase|Pregnancy|1
1039907|NCT00104416|3382716|P2|Continuation Phase|Pregnancy|0
1039908|NCT00104416|3382717|P1|Continuation Phase|Pregnancy|0
1039909|NCT00104416|3382713|P5|Continuation Phase|Withdrawal by Subject|1
1039910|NCT00104416|3382714|P4|Continuation Phase|Withdrawal by Subject|1
1039911|NCT00104416|3382715|P3|Continuation Phase|Withdrawal by Subject|2
1039912|NCT00104416|3382716|P2|Continuation Phase|Withdrawal by Subject|0
1039913|NCT00104416|3382717|P1|Continuation Phase|Withdrawal by Subject|0
1039914|NCT00104416|3382713|P5|Continuation Phase|Lost to Follow-up|1
1039915|NCT00104416|3382714|P4|Continuation Phase|Lost to Follow-up|0
1039916|NCT00104416|3382715|P3|Continuation Phase|Lost to Follow-up|1
1039917|NCT00104416|3382716|P2|Continuation Phase|Lost to Follow-up|0
1039918|NCT00104416|3382717|P1|Continuation Phase|Lost to Follow-up|0
1039919|NCT00104416|3382713|P5|Continuation Phase|Adverse Event|2
1039920|NCT00104416|3382714|P4|Continuation Phase|Adverse Event|0
1039921|NCT00104416|3382715|P3|Continuation Phase|Adverse Event|2
1039922|NCT00104416|3382716|P2|Continuation Phase|Adverse Event|0
1039923|NCT00104416|3382717|P1|Continuation Phase|Adverse Event|0
1039924|NCT00104416|3382713|P5|Double-Blind Phase|Participant Did Not Take Drug|0
1039925|NCT00104416|3382714|P4|Double-Blind Phase|Participant Did Not Take Drug|0
1039926|NCT00104416|3382715|P3|Double-Blind Phase|Participant Did Not Take Drug|0
1039927|NCT00104416|3382716|P2|Double-Blind Phase|Participant Did Not Take Drug|4
1039928|NCT00104416|3382717|P1|Double-Blind Phase|Participant Did Not Take Drug|3
1039929|NCT00104416|3382713|P5|Double-Blind Phase|Pregnancy|0
1039930|NCT00104416|3382714|P4|Double-Blind Phase|Pregnancy|0
1039931|NCT00104416|3382715|P3|Double-Blind Phase|Pregnancy|0
1039932|NCT00104416|3382716|P2|Double-Blind Phase|Pregnancy|0
1039933|NCT00104416|3382717|P1|Double-Blind Phase|Pregnancy|1
1039934|NCT00104416|3382713|P5|Double-Blind Phase|Withdrawal by Subject|0
1039935|NCT00104416|3382714|P4|Double-Blind Phase|Withdrawal by Subject|0
1039936|NCT00104416|3382715|P3|Double-Blind Phase|Withdrawal by Subject|0
1039937|NCT00104416|3382716|P2|Double-Blind Phase|Withdrawal by Subject|3
1039938|NCT00104416|3382717|P1|Double-Blind Phase|Withdrawal by Subject|2
1039939|NCT00104416|3382713|P5|Double-Blind Phase|Protocol Violation|0
1039940|NCT00104416|3382714|P4|Double-Blind Phase|Protocol Violation|0
1039941|NCT00104416|3382715|P3|Double-Blind Phase|Protocol Violation|0
1039942|NCT00104416|3382716|P2|Double-Blind Phase|Protocol Violation|1
1039943|NCT00104416|3382717|P1|Double-Blind Phase|Protocol Violation|0
1039944|NCT00104416|3382713|P5|Double-Blind Phase|Lost to Follow-up|0
1039945|NCT00104416|3382714|P4|Double-Blind Phase|Lost to Follow-up|0
1039946|NCT00104416|3382715|P3|Double-Blind Phase|Lost to Follow-up|0
1039947|NCT00104416|3382716|P2|Double-Blind Phase|Lost to Follow-up|1
1039948|NCT00104416|3382717|P1|Double-Blind Phase|Lost to Follow-up|0
1039949|NCT00104416|3382713|P5|Double-Blind Phase|Adverse Event|0
1039950|NCT00104416|3382714|P4|Double-Blind Phase|Adverse Event|0
1039951|NCT00104416|3382715|P3|Double-Blind Phase|Adverse Event|0
1039952|NCT00104416|3382716|P2|Double-Blind Phase|Adverse Event|1
1039953|NCT00104416|3382717|P1|Double-Blind Phase|Adverse Event|2
1039954|NCT00104299|3382762|P2|Overall Study|To have renal transplant|0
1039955|NCT00104299|3382763|P1|Overall Study|To have renal transplant|1
1039956|NCT00104299|3382762|P2|Overall Study|Physician Decision|1
1039957|NCT00104299|3382763|P1|Overall Study|Physician Decision|1
1039958|NCT00104299|3382762|P2|Overall Study|Withdrawal by Subject|6
1039959|NCT00104299|3382763|P1|Overall Study|Withdrawal by Subject|2
1039960|NCT00104299|3382762|P2|Overall Study|Death|2
1039961|NCT00104299|3382763|P1|Overall Study|Death|2
1039962|NCT00104299|3382762|P2|Overall Study|Adverse Event|1
1039963|NCT00104299|3382763|P1|Overall Study|Adverse Event|3
1039964|NCT00104247|3382785|P2|Overall Study|Noncompliant with dosing|1
1039965|NCT00104247|3382786|P1|Overall Study|Noncompliant with dosing|0
1039966|NCT00104247|3382785|P2|Overall Study|Withdrawal by Subject|0
1039967|NCT00104247|3382786|P1|Overall Study|Withdrawal by Subject|1
1039968|NCT00104104|3382805|P2|Overall Study|Death|6
1039969|NCT00104104|3382806|P1|Overall Study|Death|9
1039970|NCT00104104|3382805|P2|Overall Study|Administrative problems|13
1039971|NCT00104104|3382806|P1|Overall Study|Administrative problems|12
1039972|NCT00104104|3382805|P2|Overall Study|Lost to Follow-up|7
1039973|NCT00104104|3382806|P1|Overall Study|Lost to Follow-up|3
1039974|NCT00104104|3382805|P2|Overall Study|Withdrawal by Subject|15
1039975|NCT00104104|3382806|P1|Overall Study|Withdrawal by Subject|11
1039976|NCT00104104|3382805|P2|Overall Study|Protocol Violation|2
1039977|NCT00104104|3382806|P1|Overall Study|Protocol Violation|5
1039978|NCT00104104|3382805|P2|Overall Study|Condition no longer requires study drug|4
1039979|NCT00104104|3382806|P1|Overall Study|Condition no longer requires study drug|7
1039980|NCT00104104|3382805|P2|Overall Study|Lack of Efficacy|3
1039981|NCT00104104|3382806|P1|Overall Study|Lack of Efficacy|0
1039982|NCT00104104|3382805|P2|Overall Study|Abnormal laboratory value(s)|14
1039983|NCT00104104|3382806|P1|Overall Study|Abnormal laboratory value(s)|20
1039984|NCT00104104|3382805|P2|Overall Study|Adverse Event|8
1039985|NCT00104104|3382806|P1|Overall Study|Adverse Event|8
1039986|NCT00104052|3382820|P1|Overall Study|Discontinuation unrelated to treatment|2
1039987|NCT00104052|3382820|P1|Overall Study|Lack of Efficacy|26
1039988|NCT00104052|3382820|P1|Overall Study|Adverse Event|1
1039989|NCT00103857|3382831|P7|50-Week Extension Study|reason unspecified|0
1039990|NCT00103857|3382832|P6|50-Week Extension Study|reason unspecified|0
1039991|NCT00103857|3382833|P5|50-Week Extension Study|reason unspecified|1
1039992|NCT00103857|3382834|P4|50-Week Extension Study|reason unspecified|0
1039993|NCT00103857|3382835|P3|50-Week Extension Study|reason unspecified|0
1039994|NCT00103857|3382836|P2|50-Week Extension Study|reason unspecified|0
1039995|NCT00103857|3382837|P1|50-Week Extension Study|reason unspecified|0
1039996|NCT00103857|3382831|P7|50-Week Extension Study|patient scheduled for elective surgery|0
1039997|NCT00103857|3382832|P6|50-Week Extension Study|patient scheduled for elective surgery|0
1039998|NCT00103857|3382833|P5|50-Week Extension Study|patient scheduled for elective surgery|0
1039999|NCT00103857|3382834|P4|50-Week Extension Study|patient scheduled for elective surgery|0
1040000|NCT00103857|3382835|P3|50-Week Extension Study|patient scheduled for elective surgery|1
1040001|NCT00103857|3382836|P2|50-Week Extension Study|patient scheduled for elective surgery|0
1040002|NCT00103857|3382837|P1|50-Week Extension Study|patient scheduled for elective surgery|0
1040003|NCT00103857|3382831|P7|50-Week Extension Study|patient moved|0
1040004|NCT00103857|3382832|P6|50-Week Extension Study|patient moved|0
1040005|NCT00103857|3382833|P5|50-Week Extension Study|patient moved|0
1040006|NCT00103857|3382834|P4|50-Week Extension Study|patient moved|2
1040007|NCT00103857|3382835|P3|50-Week Extension Study|patient moved|1
1040008|NCT00103857|3382836|P2|50-Week Extension Study|patient moved|0
1040009|NCT00103857|3382837|P1|50-Week Extension Study|patient moved|0
1040010|NCT00103857|3382831|P7|50-Week Extension Study|non-compliance with study procedures|0
1040011|NCT00103857|3382832|P6|50-Week Extension Study|non-compliance with study procedures|0
1040012|NCT00103857|3382833|P5|50-Week Extension Study|non-compliance with study procedures|1
1040013|NCT00103857|3382834|P4|50-Week Extension Study|non-compliance with study procedures|1
1040014|NCT00103857|3382835|P3|50-Week Extension Study|non-compliance with study procedures|0
1040015|NCT00103857|3382836|P2|50-Week Extension Study|non-compliance with study procedures|0
1040016|NCT00103857|3382837|P1|50-Week Extension Study|non-compliance with study procedures|1
1040017|NCT00103857|3382831|P7|50-Week Extension Study|protocol discontinuation criteria|0
1040018|NCT00103857|3382832|P6|50-Week Extension Study|protocol discontinuation criteria|3
1040019|NCT00103857|3382833|P5|50-Week Extension Study|protocol discontinuation criteria|3
1040020|NCT00103857|3382834|P4|50-Week Extension Study|protocol discontinuation criteria|2
1040021|NCT00103857|3382835|P3|50-Week Extension Study|protocol discontinuation criteria|3
1040022|NCT00103857|3382836|P2|50-Week Extension Study|protocol discontinuation criteria|2
1040023|NCT00103857|3382837|P1|50-Week Extension Study|protocol discontinuation criteria|2
1040024|NCT00103857|3382831|P7|50-Week Extension Study|Withdrawal by Subject|0
1040025|NCT00103857|3382832|P6|50-Week Extension Study|Withdrawal by Subject|3
1040026|NCT00103857|3382833|P5|50-Week Extension Study|Withdrawal by Subject|3
1040027|NCT00103857|3382834|P4|50-Week Extension Study|Withdrawal by Subject|8
1040028|NCT00103857|3382835|P3|50-Week Extension Study|Withdrawal by Subject|2
1040029|NCT00103857|3382836|P2|50-Week Extension Study|Withdrawal by Subject|5
1040030|NCT00103857|3382837|P1|50-Week Extension Study|Withdrawal by Subject|2
1040031|NCT00103857|3382831|P7|50-Week Extension Study|Protocol Violation|0
1040032|NCT00103857|3382832|P6|50-Week Extension Study|Protocol Violation|1
1040033|NCT00103857|3382833|P5|50-Week Extension Study|Protocol Violation|0
1040034|NCT00103857|3382834|P4|50-Week Extension Study|Protocol Violation|2
1040035|NCT00103857|3382835|P3|50-Week Extension Study|Protocol Violation|1
1040036|NCT00103857|3382836|P2|50-Week Extension Study|Protocol Violation|1
1040037|NCT00103857|3382837|P1|50-Week Extension Study|Protocol Violation|1
1040038|NCT00103857|3382831|P7|50-Week Extension Study|Pregnancy|0
1040039|NCT00103857|3382832|P6|50-Week Extension Study|Pregnancy|0
1040040|NCT00103857|3382833|P5|50-Week Extension Study|Pregnancy|1
1040041|NCT00103857|3382834|P4|50-Week Extension Study|Pregnancy|0
1040042|NCT00103857|3382835|P3|50-Week Extension Study|Pregnancy|1
1040043|NCT00103857|3382836|P2|50-Week Extension Study|Pregnancy|0
1040044|NCT00103857|3382837|P1|50-Week Extension Study|Pregnancy|0
1040045|NCT00103857|3382831|P7|50-Week Extension Study|Physician Decision|0
1040046|NCT00103857|3382832|P6|50-Week Extension Study|Physician Decision|0
1040047|NCT00103857|3382833|P5|50-Week Extension Study|Physician Decision|0
1040048|NCT00103857|3382834|P4|50-Week Extension Study|Physician Decision|0
1040049|NCT00103857|3382835|P3|50-Week Extension Study|Physician Decision|1
1040050|NCT00103857|3382836|P2|50-Week Extension Study|Physician Decision|1
1040051|NCT00103857|3382837|P1|50-Week Extension Study|Physician Decision|0
1040052|NCT00103857|3382831|P7|50-Week Extension Study|Lost to Follow-up|0
1040053|NCT00103857|3382832|P6|50-Week Extension Study|Lost to Follow-up|3
1040054|NCT00103857|3382833|P5|50-Week Extension Study|Lost to Follow-up|3
1040055|NCT00103857|3382834|P4|50-Week Extension Study|Lost to Follow-up|4
1040056|NCT00103857|3382835|P3|50-Week Extension Study|Lost to Follow-up|1
1040057|NCT00103857|3382836|P2|50-Week Extension Study|Lost to Follow-up|0
1040058|NCT00103857|3382837|P1|50-Week Extension Study|Lost to Follow-up|4
1040059|NCT00103857|3382831|P7|50-Week Extension Study|Lack of Efficacy|0
1040060|NCT00103857|3382832|P6|50-Week Extension Study|Lack of Efficacy|8
1040061|NCT00103857|3382833|P5|50-Week Extension Study|Lack of Efficacy|8
1040062|NCT00103857|3382834|P4|50-Week Extension Study|Lack of Efficacy|16
1040063|NCT00103857|3382835|P3|50-Week Extension Study|Lack of Efficacy|13
1040064|NCT00103857|3382836|P2|50-Week Extension Study|Lack of Efficacy|15
1040065|NCT00103857|3382837|P1|50-Week Extension Study|Lack of Efficacy|26
1040066|NCT00103857|3382831|P7|50-Week Extension Study|Death|0
1040067|NCT00103857|3382832|P6|50-Week Extension Study|Death|1
1040068|NCT00103857|3382833|P5|50-Week Extension Study|Death|0
1040069|NCT00103857|3382834|P4|50-Week Extension Study|Death|1
1040070|NCT00103857|3382835|P3|50-Week Extension Study|Death|0
1040071|NCT00103857|3382836|P2|50-Week Extension Study|Death|0
1040072|NCT00103857|3382837|P1|50-Week Extension Study|Death|0
1040073|NCT00103857|3382831|P7|50-Week Extension Study|Adverse Event|0
1040074|NCT00103857|3382832|P6|50-Week Extension Study|Adverse Event|1
1040075|NCT00103857|3382833|P5|50-Week Extension Study|Adverse Event|1
1040076|NCT00103857|3382834|P4|50-Week Extension Study|Adverse Event|0
1040077|NCT00103857|3382835|P3|50-Week Extension Study|Adverse Event|2
1040078|NCT00103857|3382836|P2|50-Week Extension Study|Adverse Event|3
1040079|NCT00103857|3382837|P1|50-Week Extension Study|Adverse Event|2
1040080|NCT00103857|3382831|P7|54-Week Base Study|patient intolerance to rescue therapy|0
1040081|NCT00103857|3382832|P6|54-Week Base Study|patient intolerance to rescue therapy|0
1040082|NCT00103857|3382833|P5|54-Week Base Study|patient intolerance to rescue therapy|0
1040083|NCT00103857|3382834|P4|54-Week Base Study|patient intolerance to rescue therapy|0
1040084|NCT00103857|3382835|P3|54-Week Base Study|patient intolerance to rescue therapy|0
1040085|NCT00103857|3382836|P2|54-Week Base Study|patient intolerance to rescue therapy|0
1040086|NCT00103857|3382837|P1|54-Week Base Study|patient intolerance to rescue therapy|1
1040087|NCT00103857|3382831|P7|54-Week Base Study|site error|0
1040088|NCT00103857|3382832|P6|54-Week Base Study|site error|1
1040089|NCT00103857|3382833|P5|54-Week Base Study|site error|0
1040090|NCT00103857|3382834|P4|54-Week Base Study|site error|0
1040091|NCT00103857|3382835|P3|54-Week Base Study|site error|0
1040092|NCT00103857|3382836|P2|54-Week Base Study|site error|0
1040093|NCT00103857|3382837|P1|54-Week Base Study|site error|0
1040094|NCT00103857|3382831|P7|54-Week Base Study|laboratory reporting error|0
1040095|NCT00103857|3382832|P6|54-Week Base Study|laboratory reporting error|0
1040096|NCT00103857|3382833|P5|54-Week Base Study|laboratory reporting error|1
1040097|NCT00103857|3382834|P4|54-Week Base Study|laboratory reporting error|0
1040098|NCT00103857|3382835|P3|54-Week Base Study|laboratory reporting error|0
1040099|NCT00103857|3382836|P2|54-Week Base Study|laboratory reporting error|0
1040100|NCT00103857|3382837|P1|54-Week Base Study|laboratory reporting error|0
1040101|NCT00103857|3382831|P7|54-Week Base Study|patient incarcerated|0
1040102|NCT00103857|3382832|P6|54-Week Base Study|patient incarcerated|1
1040103|NCT00103857|3382833|P5|54-Week Base Study|patient incarcerated|1
1040104|NCT00103857|3382834|P4|54-Week Base Study|patient incarcerated|0
1040105|NCT00103857|3382835|P3|54-Week Base Study|patient incarcerated|0
1040106|NCT00103857|3382836|P2|54-Week Base Study|patient incarcerated|0
1040107|NCT00103857|3382837|P1|54-Week Base Study|patient incarcerated|0
1040108|NCT00103857|3382831|P7|54-Week Base Study|non-compliance with study procedures|0
1040109|NCT00103857|3382832|P6|54-Week Base Study|non-compliance with study procedures|2
1040110|NCT00103857|3382833|P5|54-Week Base Study|non-compliance with study procedures|0
1040111|NCT00103857|3382834|P4|54-Week Base Study|non-compliance with study procedures|0
1040112|NCT00103857|3382835|P3|54-Week Base Study|non-compliance with study procedures|0
1040113|NCT00103857|3382836|P2|54-Week Base Study|non-compliance with study procedures|2
1040114|NCT00103857|3382837|P1|54-Week Base Study|non-compliance with study procedures|1
1040115|NCT00103857|3382831|P7|54-Week Base Study|patient moved|0
1040116|NCT00103857|3382832|P6|54-Week Base Study|patient moved|1
1040117|NCT00103857|3382833|P5|54-Week Base Study|patient moved|3
1040118|NCT00103857|3382834|P4|54-Week Base Study|patient moved|2
1040119|NCT00103857|3382835|P3|54-Week Base Study|patient moved|1
1040120|NCT00103857|3382836|P2|54-Week Base Study|patient moved|1
1040121|NCT00103857|3382837|P1|54-Week Base Study|patient moved|0
1040122|NCT00103857|3382831|P7|54-Week Base Study|protocol discontinuation criteria|5
1040123|NCT00103857|3382832|P6|54-Week Base Study|protocol discontinuation criteria|3
1040124|NCT00103857|3382833|P5|54-Week Base Study|protocol discontinuation criteria|5
1040125|NCT00103857|3382834|P4|54-Week Base Study|protocol discontinuation criteria|6
1040126|NCT00103857|3382835|P3|54-Week Base Study|protocol discontinuation criteria|2
1040127|NCT00103857|3382836|P2|54-Week Base Study|protocol discontinuation criteria|5
1040128|NCT00103857|3382837|P1|54-Week Base Study|protocol discontinuation criteria|2
1040129|NCT00103857|3382831|P7|54-Week Base Study|Withdrawal by Subject|4
1040130|NCT00103857|3382832|P6|54-Week Base Study|Withdrawal by Subject|15
1040131|NCT00103857|3382833|P5|54-Week Base Study|Withdrawal by Subject|10
1040132|NCT00103857|3382834|P4|54-Week Base Study|Withdrawal by Subject|15
1040133|NCT00103857|3382835|P3|54-Week Base Study|Withdrawal by Subject|16
1040134|NCT00103857|3382836|P2|54-Week Base Study|Withdrawal by Subject|16
1040135|NCT00103857|3382837|P1|54-Week Base Study|Withdrawal by Subject|17
1040136|NCT00103857|3382831|P7|54-Week Base Study|Protocol Violation|3
1040137|NCT00103857|3382832|P6|54-Week Base Study|Protocol Violation|3
1040138|NCT00103857|3382833|P5|54-Week Base Study|Protocol Violation|0
1040139|NCT00103857|3382834|P4|54-Week Base Study|Protocol Violation|4
1040140|NCT00103857|3382835|P3|54-Week Base Study|Protocol Violation|2
1040141|NCT00103857|3382836|P2|54-Week Base Study|Protocol Violation|4
1040142|NCT00103857|3382837|P1|54-Week Base Study|Protocol Violation|6
1040143|NCT00103857|3382831|P7|54-Week Base Study|Pregnancy|1
1040144|NCT00103857|3382832|P6|54-Week Base Study|Pregnancy|0
1040145|NCT00103857|3382833|P5|54-Week Base Study|Pregnancy|1
1040146|NCT00103857|3382834|P4|54-Week Base Study|Pregnancy|0
1040147|NCT00103857|3382835|P3|54-Week Base Study|Pregnancy|0
1040148|NCT00103857|3382836|P2|54-Week Base Study|Pregnancy|0
1040149|NCT00103857|3382837|P1|54-Week Base Study|Pregnancy|1
1040150|NCT00103857|3382831|P7|54-Week Base Study|Physician Decision|0
1040151|NCT00103857|3382832|P6|54-Week Base Study|Physician Decision|0
1040152|NCT00103857|3382833|P5|54-Week Base Study|Physician Decision|1
1040153|NCT00103857|3382834|P4|54-Week Base Study|Physician Decision|0
1040154|NCT00103857|3382835|P3|54-Week Base Study|Physician Decision|0
1040155|NCT00103857|3382836|P2|54-Week Base Study|Physician Decision|1
1040156|NCT00103857|3382837|P1|54-Week Base Study|Physician Decision|1
1040157|NCT00103857|3382831|P7|54-Week Base Study|Lost to Follow-up|3
1040158|NCT00103857|3382832|P6|54-Week Base Study|Lost to Follow-up|9
1040159|NCT00103857|3382833|P5|54-Week Base Study|Lost to Follow-up|10
1040160|NCT00103857|3382834|P4|54-Week Base Study|Lost to Follow-up|5
1040161|NCT00103857|3382835|P3|54-Week Base Study|Lost to Follow-up|7
1040162|NCT00103857|3382836|P2|54-Week Base Study|Lost to Follow-up|4
1040163|NCT00103857|3382837|P1|54-Week Base Study|Lost to Follow-up|5
1040164|NCT00103857|3382831|P7|54-Week Base Study|Lack of Efficacy|19
1040165|NCT00103857|3382832|P6|54-Week Base Study|Lack of Efficacy|14
1040166|NCT00103857|3382833|P5|54-Week Base Study|Lack of Efficacy|3
1040167|NCT00103857|3382834|P4|54-Week Base Study|Lack of Efficacy|4
1040168|NCT00103857|3382835|P3|54-Week Base Study|Lack of Efficacy|8
1040169|NCT00103857|3382836|P2|54-Week Base Study|Lack of Efficacy|14
1040170|NCT00103857|3382837|P1|54-Week Base Study|Lack of Efficacy|11
1040171|NCT00103857|3382831|P7|54-Week Base Study|Death|0
1040172|NCT00103857|3382832|P6|54-Week Base Study|Death|1
1040173|NCT00103857|3382833|P5|54-Week Base Study|Death|1
1040174|NCT00103857|3382834|P4|54-Week Base Study|Death|0
1040175|NCT00103857|3382835|P3|54-Week Base Study|Death|0
1040176|NCT00103857|3382836|P2|54-Week Base Study|Death|0
1040177|NCT00103857|3382837|P1|54-Week Base Study|Death|0
1040178|NCT00103857|3382831|P7|54-Week Base Study|Adverse Event|3
1040179|NCT00103857|3382832|P6|54-Week Base Study|Adverse Event|11
1040180|NCT00103857|3382833|P5|54-Week Base Study|Adverse Event|5
1040181|NCT00103857|3382834|P4|54-Week Base Study|Adverse Event|6
1040182|NCT00103857|3382835|P3|54-Week Base Study|Adverse Event|11
1040183|NCT00103857|3382836|P2|54-Week Base Study|Adverse Event|9
1040184|NCT00103857|3382837|P1|54-Week Base Study|Adverse Event|12
1040185|NCT00103740|3382936|P2|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9
1040186|NCT00103740|3382937|P1|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30
1040187|NCT00103740|3382936|P2|Period 2 - Extended Observation Period|Death|2
1040188|NCT00103740|3382937|P1|Period 2 - Extended Observation Period|Death|6
1040189|NCT00103740|3382936|P2|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6
1040190|NCT00103740|3382937|P1|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5
1040191|NCT00103740|3382936|P2|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13
1040192|NCT00103740|3382937|P1|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21
1040193|NCT00103740|3382936|P2|Period 2 - Extended Observation Period|Lost to Follow-up|6
1040194|NCT00103740|3382937|P1|Period 2 - Extended Observation Period|Lost to Follow-up|7
1040195|NCT00103740|3382936|P2|Period 1 - Core|Patient withdrew consent|2
1040196|NCT00103740|3382937|P1|Period 1 - Core|Patient withdrew consent|3
1040197|NCT00103740|3382936|P2|Period 1 - Core|Protocol Violation|2
1040198|NCT00103740|3382937|P1|Period 1 - Core|Protocol Violation|3
1040199|NCT00103740|3382936|P2|Period 1 - Core|Adverse Event|0
1040200|NCT00103740|3382937|P1|Period 1 - Core|Adverse Event|1
1040201|NCT00103662|3382965|P2|Overall Study|Intercurrent illness|0
1040202|NCT00103662|3382966|P1|Overall Study|Intercurrent illness|1
1040203|NCT00103662|3382965|P2|Overall Study|Failed mobilization|4
1040204|NCT00103662|3382966|P1|Overall Study|Failed mobilization|0
1040205|NCT00103662|3382965|P2|Overall Study|Other|9
1040206|NCT00103662|3382966|P1|Overall Study|Other|6
1040207|NCT00103662|3382965|P2|Overall Study|Lost to Follow-up|1
1040208|NCT00103662|3382966|P1|Overall Study|Lost to Follow-up|0
1040209|NCT00103662|3382965|P2|Overall Study|Elective Withdrawal|5
1040210|NCT00103662|3382966|P1|Overall Study|Elective Withdrawal|5
1040211|NCT00103662|3382965|P2|Overall Study|Death|7
1040212|NCT00103662|3382966|P1|Overall Study|Death|7
1040213|NCT00103662|3382965|P2|Overall Study|Entered Rescue Procedure|7
1040214|NCT00103662|3382966|P1|Overall Study|Entered Rescue Procedure|0
1040215|NCT00103610|3382992|P2|Overall Study|Noncompliance|1
1040216|NCT00103610|3382993|P1|Overall Study|Noncompliance|0
1040217|NCT00103610|3382992|P2|Overall Study|Failed mobilization|5
1040218|NCT00103610|3382993|P1|Overall Study|Failed mobilization|1
1040219|NCT00103610|3382992|P2|Overall Study|Other|7
1040220|NCT00103610|3382993|P1|Overall Study|Other|2
1040221|NCT00103610|3382992|P2|Overall Study|Adverse Event|2
1040222|NCT00103610|3382993|P1|Overall Study|Adverse Event|2
1040223|NCT00103610|3382992|P2|Overall Study|Lost to Follow-up|1
1040224|NCT00103610|3382993|P1|Overall Study|Lost to Follow-up|3
1040225|NCT00103610|3382992|P2|Overall Study|Elective Withdrawal|0
1040226|NCT00103610|3382993|P1|Overall Study|Elective Withdrawal|4
1040227|NCT00103610|3382992|P2|Overall Study|Death|12
1040228|NCT00103610|3382993|P1|Overall Study|Death|16
1040229|NCT00103610|3382992|P2|Overall Study|Entered Rescue Procedure|52
1040230|NCT00103610|3382993|P1|Overall Study|Entered Rescue Procedure|10
1040231|NCT00103506|3383017|P2|Overall Study|Withdrawal by Subject|21
1040232|NCT00103506|3383018|P1|Overall Study|Withdrawal by Subject|18
1040233|NCT00103506|3383017|P2|Overall Study|Lost to Follow-up|13
1040234|NCT00103506|3383018|P1|Overall Study|Lost to Follow-up|13
1040235|NCT00103506|3383017|P2|Overall Study|Death|253
1040236|NCT00103506|3383018|P1|Overall Study|Death|257
1040237|NCT00103506|3383017|P2|Overall Study|Study closed by sponsor|37
1040238|NCT00103506|3383018|P1|Overall Study|Study closed by sponsor|34
1040239|NCT00103311|3383049|P2|Overall Study|Adverse Event|0
1040240|NCT00103311|3383050|P1|Overall Study|Adverse Event|1
1040241|NCT00103311|3383049|P2|Overall Study|Withdrawal by Subject|1
1040242|NCT00103311|3383050|P1|Overall Study|Withdrawal by Subject|2
1040243|NCT00103311|3383049|P2|Overall Study|Lost to Follow-up|0
1040244|NCT00103311|3383050|P1|Overall Study|Lost to Follow-up|1
1040245|NCT00103285|3383060|P8|Response Assignment|Other|53
1040246|NCT00103285|3383061|P7|Response Assignment|Other|11
1040247|NCT00103285|3383062|P6|Response Assignment|Other|17
1040248|NCT00103285|3383063|P5|Response Assignment|Other|37
1040249|NCT00103285|3383064|P4|Response Assignment|Other|38
1040250|NCT00103285|3383065|P3|Response Assignment|Other|48
1040251|NCT00103285|3383066|P2|Response Assignment|Other|30
1040252|NCT00103285|3383067|P1|Response Assignment|Other|0
1040253|NCT00103285|3383060|P8|Response Assignment|Refusal|10
1040254|NCT00103285|3383061|P7|Response Assignment|Refusal|30
1040255|NCT00103285|3383062|P6|Response Assignment|Refusal|15
1040256|NCT00103285|3383063|P5|Response Assignment|Refusal|25
1040257|NCT00103285|3383064|P4|Response Assignment|Refusal|3
1040258|NCT00103285|3383065|P3|Response Assignment|Refusal|5
1040259|NCT00103285|3383066|P2|Response Assignment|Refusal|53
1040260|NCT00103285|3383067|P1|Response Assignment|Refusal|0
1040261|NCT00103285|3383060|P8|Response Assignment|Ineligible|5
1040262|NCT00103285|3383061|P7|Response Assignment|Ineligible|1
1040263|NCT00103285|3383062|P6|Response Assignment|Ineligible|3
1040264|NCT00103285|3383063|P5|Response Assignment|Ineligible|0
1040265|NCT00103285|3383064|P4|Response Assignment|Ineligible|2
1040266|NCT00103285|3383065|P3|Response Assignment|Ineligible|6
1040267|NCT00103285|3383066|P2|Response Assignment|Ineligible|8
1040268|NCT00103285|3383067|P1|Response Assignment|Ineligible|0
1040269|NCT00103285|3383060|P8|Response Assignment|Withdrawal by Subject|2
1040270|NCT00103285|3383061|P7|Response Assignment|Withdrawal by Subject|0
1040271|NCT00103285|3383062|P6|Response Assignment|Withdrawal by Subject|2
1040272|NCT00103285|3383063|P5|Response Assignment|Withdrawal by Subject|2
1040273|NCT00103285|3383064|P4|Response Assignment|Withdrawal by Subject|1
1040274|NCT00103285|3383065|P3|Response Assignment|Withdrawal by Subject|1
1040275|NCT00103285|3383066|P2|Response Assignment|Withdrawal by Subject|4
1040276|NCT00103285|3383067|P1|Response Assignment|Withdrawal by Subject|0
1040277|NCT00103285|3383060|P8|Response Assignment|Protocol Violation|0
1040278|NCT00103285|3383061|P7|Response Assignment|Protocol Violation|0
1040279|NCT00103285|3383062|P6|Response Assignment|Protocol Violation|0
1040280|NCT00103285|3383063|P5|Response Assignment|Protocol Violation|0
1040281|NCT00103285|3383064|P4|Response Assignment|Protocol Violation|0
1040282|NCT00103285|3383065|P3|Response Assignment|Protocol Violation|0
1040283|NCT00103285|3383066|P2|Response Assignment|Protocol Violation|2
1040284|NCT00103285|3383067|P1|Response Assignment|Protocol Violation|0
1040285|NCT00103285|3383060|P8|Response Assignment|Physician Decision|35
1040286|NCT00103285|3383061|P7|Response Assignment|Physician Decision|4
1040287|NCT00103285|3383062|P6|Response Assignment|Physician Decision|7
1040288|NCT00103285|3383063|P5|Response Assignment|Physician Decision|13
1040289|NCT00103285|3383064|P4|Response Assignment|Physician Decision|9
1040290|NCT00103285|3383065|P3|Response Assignment|Physician Decision|14
1040291|NCT00103285|3383066|P2|Response Assignment|Physician Decision|13
1040292|NCT00103285|3383067|P1|Response Assignment|Physician Decision|0
1040293|NCT00103285|3383060|P8|Response Assignment|Lost to Follow-up|5
1040294|NCT00103285|3383061|P7|Response Assignment|Lost to Follow-up|2
1040295|NCT00103285|3383062|P6|Response Assignment|Lost to Follow-up|2
1040296|NCT00103285|3383063|P5|Response Assignment|Lost to Follow-up|1
1040297|NCT00103285|3383064|P4|Response Assignment|Lost to Follow-up|5
1040298|NCT00103285|3383065|P3|Response Assignment|Lost to Follow-up|5
1040299|NCT00103285|3383066|P2|Response Assignment|Lost to Follow-up|9
1040300|NCT00103285|3383067|P1|Response Assignment|Lost to Follow-up|0
1040301|NCT00103285|3383060|P8|Response Assignment|Death|8
1040302|NCT00103285|3383061|P7|Response Assignment|Death|0
1040303|NCT00103285|3383062|P6|Response Assignment|Death|1
1040304|NCT00103285|3383063|P5|Response Assignment|Death|3
1040305|NCT00103285|3383064|P4|Response Assignment|Death|2
1040306|NCT00103285|3383065|P3|Response Assignment|Death|2
1040307|NCT00103285|3383066|P2|Response Assignment|Death|5
1040308|NCT00103285|3383067|P1|Response Assignment|Death|0
1040309|NCT00103285|3383060|P8|Response Assignment|Adverse Event|2
1040310|NCT00103285|3383061|P7|Response Assignment|Adverse Event|1
1040311|NCT00103285|3383062|P6|Response Assignment|Adverse Event|1
1040312|NCT00103285|3383063|P5|Response Assignment|Adverse Event|3
1040313|NCT00103285|3383064|P4|Response Assignment|Adverse Event|2
1040314|NCT00103285|3383065|P3|Response Assignment|Adverse Event|3
1040315|NCT00103285|3383066|P2|Response Assignment|Adverse Event|8
1040316|NCT00103285|3383067|P1|Response Assignment|Adverse Event|0
1040317|NCT00103285|3383060|P8|Induction|Other|0
1040318|NCT00103285|3383061|P7|Induction|Other|0
1040319|NCT00103285|3383062|P6|Induction|Other|0
1040320|NCT00103285|3383063|P5|Induction|Other|0
1040321|NCT00103285|3383064|P4|Induction|Other|0
1040322|NCT00103285|3383065|P3|Induction|Other|0
1040323|NCT00103285|3383066|P2|Induction|Other|0
1040324|NCT00103285|3383067|P1|Induction|Other|258
1040325|NCT00103285|3383060|P8|Induction|Refusal|0
1040326|NCT00103285|3383061|P7|Induction|Refusal|0
1040327|NCT00103285|3383062|P6|Induction|Refusal|0
1040328|NCT00103285|3383063|P5|Induction|Refusal|0
1040329|NCT00103285|3383064|P4|Induction|Refusal|0
1040330|NCT00103285|3383065|P3|Induction|Refusal|0
1040331|NCT00103285|3383066|P2|Induction|Refusal|0
1040332|NCT00103285|3383067|P1|Induction|Refusal|906
1040333|NCT00103285|3383060|P8|Induction|Ineligible|0
1040334|NCT00103285|3383061|P7|Induction|Ineligible|0
1040335|NCT00103285|3383062|P6|Induction|Ineligible|0
1040336|NCT00103285|3383063|P5|Induction|Ineligible|0
1040337|NCT00103285|3383064|P4|Induction|Ineligible|0
1040338|NCT00103285|3383065|P3|Induction|Ineligible|0
1040339|NCT00103285|3383066|P2|Induction|Ineligible|0
1040340|NCT00103285|3383067|P1|Induction|Ineligible|43
1040341|NCT00103285|3383060|P8|Induction|Withdrawal by Subject|0
1040342|NCT00103285|3383061|P7|Induction|Withdrawal by Subject|0
1040343|NCT00103285|3383062|P6|Induction|Withdrawal by Subject|0
1040344|NCT00103285|3383063|P5|Induction|Withdrawal by Subject|0
1040345|NCT00103285|3383064|P4|Induction|Withdrawal by Subject|0
1040346|NCT00103285|3383065|P3|Induction|Withdrawal by Subject|0
1040347|NCT00103285|3383066|P2|Induction|Withdrawal by Subject|0
1040348|NCT00103285|3383067|P1|Induction|Withdrawal by Subject|1
1040349|NCT00103285|3383060|P8|Induction|Physician Decision|0
1040350|NCT00103285|3383061|P7|Induction|Physician Decision|0
1040351|NCT00103285|3383062|P6|Induction|Physician Decision|0
1040352|NCT00103285|3383063|P5|Induction|Physician Decision|0
1040353|NCT00103285|3383064|P4|Induction|Physician Decision|0
1040354|NCT00103285|3383065|P3|Induction|Physician Decision|0
1040355|NCT00103285|3383066|P2|Induction|Physician Decision|0
1040356|NCT00103285|3383067|P1|Induction|Physician Decision|103
1040357|NCT00103285|3383060|P8|Induction|Death|0
1040358|NCT00103285|3383061|P7|Induction|Death|0
1040359|NCT00103285|3383062|P6|Induction|Death|0
1040360|NCT00103285|3383063|P5|Induction|Death|0
1040361|NCT00103285|3383064|P4|Induction|Death|0
1040362|NCT00103285|3383065|P3|Induction|Death|0
1040363|NCT00103285|3383066|P2|Induction|Death|0
1040364|NCT00103285|3383067|P1|Induction|Death|24
1040365|NCT00103285|3383060|P8|Induction|Adverse Event|0
1040366|NCT00103285|3383061|P7|Induction|Adverse Event|0
1040367|NCT00103285|3383062|P6|Induction|Adverse Event|0
1040368|NCT00103285|3383063|P5|Induction|Adverse Event|0
1040369|NCT00103285|3383064|P4|Induction|Adverse Event|0
1040370|NCT00103285|3383065|P3|Induction|Adverse Event|0
1040371|NCT00103285|3383066|P2|Induction|Adverse Event|0
1040372|NCT00103285|3383067|P1|Induction|Adverse Event|14
1040373|NCT00103259|3383096|P2|Overall Study|ineligible/no protocol therapy|6
1040374|NCT00103259|3383097|P1|Overall Study|ineligible/no protocol therapy|4
1040375|NCT00103259|3383096|P2|Overall Study|other (reasons were not specified)|1
1040376|NCT00103259|3383097|P1|Overall Study|other (reasons were not specified)|2
1040377|NCT00103259|3383096|P2|Overall Study|alternative therapy|0
1040378|NCT00103259|3383097|P1|Overall Study|alternative therapy|1
1040379|NCT00103259|3383096|P2|Overall Study|Withdrawal by Subject|3
1040380|NCT00103259|3383097|P1|Overall Study|Withdrawal by Subject|2
1040381|NCT00103259|3383096|P2|Overall Study|Death|2
1040382|NCT00103259|3383097|P1|Overall Study|Death|3
1040383|NCT00103207|3383109|P1|Overall Study|Diagnosis of BAC not confirmed|27
1040384|NCT00103207|3383109|P1|Overall Study|Ineligible|4
1040385|NCT00103207|3383109|P1|Overall Study|Other complicating disease|1
1040386|NCT00103207|3383109|P1|Overall Study|Withdrawal by Subject|2
1040387|NCT00103207|3383109|P1|Overall Study|Death|1
1040388|NCT00103207|3383109|P1|Overall Study|Adverse Event|3
1040389|NCT00103142|3383128|P2|Overall Study|Progression of disease|1
1040390|NCT00103142|3383129|P1|Overall Study|Progression of disease|2
1040391|NCT00103142|3383128|P2|Overall Study|Adverse Event|0
1040392|NCT00103142|3383129|P1|Overall Study|Adverse Event|1
1040393|NCT00103012|3383145|P3|Overall Study|Subject non-compliant with medications|1
1040394|NCT00103012|3383146|P2|Overall Study|Subject non-compliant with medications|0
1040395|NCT00103012|3383147|P1|Overall Study|Subject non-compliant with medications|0
1040396|NCT00103012|3383145|P3|Overall Study|Adverse Event|1
1040397|NCT00103012|3383146|P2|Overall Study|Adverse Event|0
1040398|NCT00103012|3383147|P1|Overall Study|Adverse Event|0
1040399|NCT00103012|3383145|P3|Overall Study|Pregnancy|0
1040400|NCT00103012|3383146|P2|Overall Study|Pregnancy|0
1040401|NCT00103012|3383147|P1|Overall Study|Pregnancy|1
1040402|NCT00103012|3383145|P3|Overall Study|Withdrawal by Subject|2
1040403|NCT00103012|3383146|P2|Overall Study|Withdrawal by Subject|1
1040404|NCT00103012|3383147|P1|Overall Study|Withdrawal by Subject|2
1040405|NCT00102960|3383158|P3|Overall Study|Withdrawal by Subject|1
1040406|NCT00102960|3383159|P2|Overall Study|Withdrawal by Subject|0
1040407|NCT00102960|3383160|P1|Overall Study|Withdrawal by Subject|1
1040408|NCT00102960|3383158|P3|Overall Study|Lost to Follow-up|16
1040409|NCT00102960|3383159|P2|Overall Study|Lost to Follow-up|12
1040410|NCT00102960|3383160|P1|Overall Study|Lost to Follow-up|6
1040411|NCT00102960|3383158|P3|Overall Study|Death|11
1040412|NCT00102960|3383159|P2|Overall Study|Death|11
1040413|NCT00102960|3383160|P1|Overall Study|Death|23
1040414|NCT00102804|3383209|P2|Overall Study|Alive, Receiving Treatment|2
1040415|NCT00102804|3383210|P1|Overall Study|Alive, Receiving Treatment|7
1040416|NCT00102804|3383209|P2|Overall Study|Sponsor Decision|0
1040417|NCT00102804|3383210|P1|Overall Study|Sponsor Decision|1
1040418|NCT00102804|3383209|P2|Overall Study|Satisfactory Response|0
1040419|NCT00102804|3383210|P1|Overall Study|Satisfactory Response|2
1040420|NCT00102804|3383209|P2|Overall Study|Protocol Violation|1
1040421|NCT00102804|3383210|P1|Overall Study|Protocol Violation|2
1040422|NCT00102804|3383209|P2|Overall Study|Lost to Follow-up|1
1040423|NCT00102804|3383210|P1|Overall Study|Lost to Follow-up|4
1040424|NCT00102804|3383209|P2|Overall Study|Enrollment Criteria Not Met|0
1040425|NCT00102804|3383210|P1|Overall Study|Enrollment Criteria Not Met|6
1040426|NCT00102804|3383209|P2|Overall Study|Death|6
1040427|NCT00102804|3383210|P1|Overall Study|Death|5
1040428|NCT00102804|3383209|P2|Overall Study|Physician Decision|6
1040429|NCT00102804|3383210|P1|Overall Study|Physician Decision|24
1040430|NCT00102804|3383209|P2|Overall Study|Adverse Event|3
1040431|NCT00102804|3383210|P1|Overall Study|Adverse Event|37
1040432|NCT00102804|3383209|P2|Overall Study|Withdrawal by Subject|7
1040433|NCT00102804|3383210|P1|Overall Study|Withdrawal by Subject|46
1040434|NCT00102804|3383209|P2|Overall Study|Progressive Disease (PD)|196
1040435|NCT00102804|3383210|P1|Overall Study|Progressive Disease (PD)|307
1040436|NCT00102687|3383231|P5|Maintenance Period|Death|1
1040437|NCT00102687|3383232|P4|Maintenance Period|Death|1
1040438|NCT00102687|3383233|P3|Maintenance Period|Death|0
1040439|NCT00102687|3383234|P2|Maintenance Period|Death|0
1040440|NCT00102687|3383235|P1|Maintenance Period|Death|0
1040441|NCT00102687|3383231|P5|Maintenance Period|Failed Treatment (relapse,disease prog)|4
1040442|NCT00102687|3383232|P4|Maintenance Period|Failed Treatment (relapse,disease prog)|3
1040443|NCT00102687|3383233|P3|Maintenance Period|Failed Treatment (relapse,disease prog)|1
1040444|NCT00102687|3383234|P2|Maintenance Period|Failed Treatment (relapse,disease prog)|1
1040445|NCT00102687|3383235|P1|Maintenance Period|Failed Treatment (relapse,disease prog)|1
1040446|NCT00102687|3383231|P5|Maintenance Period|Sponsor decision|0
1040447|NCT00102687|3383232|P4|Maintenance Period|Sponsor decision|0
1040448|NCT00102687|3383233|P3|Maintenance Period|Sponsor decision|0
1040449|NCT00102687|3383234|P2|Maintenance Period|Sponsor decision|0
1040450|NCT00102687|3383235|P1|Maintenance Period|Sponsor decision|0
1040451|NCT00102687|3383231|P5|Maintenance Period|Physician Decision|4
1040452|NCT00102687|3383232|P4|Maintenance Period|Physician Decision|0
1040453|NCT00102687|3383233|P3|Maintenance Period|Physician Decision|3
1040454|NCT00102687|3383234|P2|Maintenance Period|Physician Decision|2
1040455|NCT00102687|3383235|P1|Maintenance Period|Physician Decision|1
1040456|NCT00102687|3383231|P5|Maintenance Period|Protocol Violation|0
1040457|NCT00102687|3383232|P4|Maintenance Period|Protocol Violation|0
1040458|NCT00102687|3383233|P3|Maintenance Period|Protocol Violation|0
1040459|NCT00102687|3383234|P2|Maintenance Period|Protocol Violation|0
1040460|NCT00102687|3383235|P1|Maintenance Period|Protocol Violation|0
1040461|NCT00102687|3383231|P5|Maintenance Period|Transformation to AML (blast > 30%)|0
1040462|NCT00102687|3383232|P4|Maintenance Period|Transformation to AML (blast > 30%)|2
1040463|NCT00102687|3383233|P3|Maintenance Period|Transformation to AML (blast > 30%)|0
1040464|NCT00102687|3383234|P2|Maintenance Period|Transformation to AML (blast > 30%)|1
1040465|NCT00102687|3383235|P1|Maintenance Period|Transformation to AML (blast > 30%)|0
1040466|NCT00102687|3383231|P5|Maintenance Period|Adverse Event|3
1040467|NCT00102687|3383232|P4|Maintenance Period|Adverse Event|1
1040468|NCT00102687|3383233|P3|Maintenance Period|Adverse Event|0
1040469|NCT00102687|3383234|P2|Maintenance Period|Adverse Event|0
1040470|NCT00102687|3383235|P1|Maintenance Period|Adverse Event|1
1040471|NCT00102687|3383231|P5|Maintenance Period|Withdrawal by Subject|1
1040472|NCT00102687|3383232|P4|Maintenance Period|Withdrawal by Subject|3
1040473|NCT00102687|3383233|P3|Maintenance Period|Withdrawal by Subject|2
1040474|NCT00102687|3383234|P2|Maintenance Period|Withdrawal by Subject|0
1040475|NCT00102687|3383235|P1|Maintenance Period|Withdrawal by Subject|4
1040476|NCT00102687|3383231|P5|Initial Period|Death|0
1040477|NCT00102687|3383232|P4|Initial Period|Death|0
1040478|NCT00102687|3383233|P3|Initial Period|Death|1
1040479|NCT00102687|3383234|P2|Initial Period|Death|1
1040480|NCT00102687|3383235|P1|Initial Period|Death|1
1040481|NCT00102687|3383231|P5|Initial Period|Failed Treatments (relapse,disease prog)|0
1040482|NCT00102687|3383232|P4|Initial Period|Failed Treatments (relapse,disease prog)|0
1040483|NCT00102687|3383233|P3|Initial Period|Failed Treatments (relapse,disease prog)|2
1040484|NCT00102687|3383234|P2|Initial Period|Failed Treatments (relapse,disease prog)|4
1040485|NCT00102687|3383235|P1|Initial Period|Failed Treatments (relapse,disease prog)|4
1040486|NCT00102687|3383231|P5|Initial Period|Sponsor's decision|0
1040487|NCT00102687|3383232|P4|Initial Period|Sponsor's decision|0
1040488|NCT00102687|3383233|P3|Initial Period|Sponsor's decision|1
1040489|NCT00102687|3383234|P2|Initial Period|Sponsor's decision|1
1040490|NCT00102687|3383235|P1|Initial Period|Sponsor's decision|0
1040491|NCT00102687|3383231|P5|Initial Period|Physician Decision|0
1040492|NCT00102687|3383232|P4|Initial Period|Physician Decision|0
1040493|NCT00102687|3383233|P3|Initial Period|Physician Decision|6
1040494|NCT00102687|3383234|P2|Initial Period|Physician Decision|9
1040495|NCT00102687|3383235|P1|Initial Period|Physician Decision|2
1040496|NCT00102687|3383231|P5|Initial Period|Protocol Violation|0
1040497|NCT00102687|3383232|P4|Initial Period|Protocol Violation|0
1040498|NCT00102687|3383233|P3|Initial Period|Protocol Violation|2
1040499|NCT00102687|3383234|P2|Initial Period|Protocol Violation|0
1040500|NCT00102687|3383235|P1|Initial Period|Protocol Violation|0
1040501|NCT00102687|3383231|P5|Initial Period|Transformation to AML (blast > 30%)|0
1040502|NCT00102687|3383232|P4|Initial Period|Transformation to AML (blast > 30%)|0
1040503|NCT00102687|3383233|P3|Initial Period|Transformation to AML (blast > 30%)|0
1040504|NCT00102687|3383234|P2|Initial Period|Transformation to AML (blast > 30%)|3
1040505|NCT00102687|3383235|P1|Initial Period|Transformation to AML (blast > 30%)|1
1040506|NCT00102687|3383231|P5|Initial Period|Adverse Event|0
1040507|NCT00102687|3383232|P4|Initial Period|Adverse Event|0
1040508|NCT00102687|3383233|P3|Initial Period|Adverse Event|9
1040509|NCT00102687|3383234|P2|Initial Period|Adverse Event|7
1040510|NCT00102687|3383235|P1|Initial Period|Adverse Event|4
1040511|NCT00102687|3383231|P5|Initial Period|Withdrawal by Subject|0
1040512|NCT00102687|3383232|P4|Initial Period|Withdrawal by Subject|0
1040513|NCT00102687|3383233|P3|Initial Period|Withdrawal by Subject|5
1040514|NCT00102687|3383234|P2|Initial Period|Withdrawal by Subject|3
1040515|NCT00102687|3383235|P1|Initial Period|Withdrawal by Subject|6
1040516|NCT00102596|3383299|P2|Part A|Adverse Event|0
1040517|NCT00102596|3383300|P1|Part A|Adverse Event|1
1040518|NCT00102596|3383299|P2|Part A|Screen failures|0
1040519|NCT00102596|3383300|P1|Part A|Screen failures|6
1040520|NCT00102531|3383311|P2|Overall Study|Physician Decision|1
1040521|NCT00102531|3383312|P1|Overall Study|Physician Decision|0
1040522|NCT00102531|3383311|P2|Overall Study|Disease Progression|9
1040523|NCT00102531|3383312|P1|Overall Study|Disease Progression|5
1040524|NCT00102531|3383311|P2|Overall Study|Adverse Event|1
1040525|NCT00102531|3383312|P1|Overall Study|Adverse Event|0
1040526|NCT00102440|3383327|P3|Overall Study|Protocol Violation|1
1040527|NCT00102440|3383328|P2|Overall Study|Protocol Violation|2
1040528|NCT00102440|3383329|P1|Overall Study|Protocol Violation|7
1040529|NCT00102440|3383327|P3|Overall Study|Other|14
1040530|NCT00102440|3383328|P2|Overall Study|Other|14
1040531|NCT00102440|3383329|P1|Overall Study|Other|11
1040532|NCT00102440|3383327|P3|Overall Study|Personal Reason(s)|13
1040533|NCT00102440|3383328|P2|Overall Study|Personal Reason(s)|13
1040534|NCT00102440|3383329|P1|Overall Study|Personal Reason(s)|19
1040535|NCT00102440|3383327|P3|Overall Study|Gout Flare|9
1040536|NCT00102440|3383328|P2|Overall Study|Gout Flare|28
1040537|NCT00102440|3383329|P1|Overall Study|Gout Flare|10
1040538|NCT00102440|3383327|P3|Overall Study|Adverse Event|8
1040539|NCT00102440|3383328|P2|Overall Study|Adverse Event|23
1040540|NCT00102440|3383329|P1|Overall Study|Adverse Event|16
1040541|NCT00102440|3383327|P3|Overall Study|Lost to Follow-up|21
1040542|NCT00102440|3383328|P2|Overall Study|Lost to Follow-up|18
1040543|NCT00102440|3383329|P1|Overall Study|Lost to Follow-up|25
1040544|NCT00102063|3383379|P3|Overall Study|Protocol Violation|1
1040545|NCT00102063|3383380|P2|Overall Study|Protocol Violation|1
1040546|NCT00102063|3383381|P1|Overall Study|Protocol Violation|0
1040547|NCT00102063|3383379|P3|Overall Study|Lost to Follow-up|1
1040548|NCT00102063|3383380|P2|Overall Study|Lost to Follow-up|0
1040549|NCT00102063|3383381|P1|Overall Study|Lost to Follow-up|0
1040550|NCT00102063|3383379|P3|Overall Study|Withdrawal by Subject|5
1040551|NCT00102063|3383380|P2|Overall Study|Withdrawal by Subject|12
1040552|NCT00102063|3383381|P1|Overall Study|Withdrawal by Subject|4
1040553|NCT00102063|3383379|P3|Overall Study|Adverse Event|2
1040554|NCT00102063|3383380|P2|Overall Study|Adverse Event|4
1040555|NCT00102063|3383381|P1|Overall Study|Adverse Event|7
1040556|NCT00102063|3383379|P3|Overall Study|Lack of Efficacy|1
1040557|NCT00102063|3383380|P2|Overall Study|Lack of Efficacy|1
1040558|NCT00102063|3383381|P1|Overall Study|Lack of Efficacy|5
1040559|NCT00101907|3383439|P6|Overall Study|Withdrawal by Subject|0
1040560|NCT00101907|3383440|P5|Overall Study|Withdrawal by Subject|1
1040561|NCT00101907|3383441|P4|Overall Study|Withdrawal by Subject|0
1040562|NCT00101907|3383442|P3|Overall Study|Withdrawal by Subject|1
1040563|NCT00101907|3383443|P2|Overall Study|Withdrawal by Subject|0
1040564|NCT00101907|3383444|P1|Overall Study|Withdrawal by Subject|1
1040565|NCT00101907|3383439|P6|Overall Study|Physician Decision|0
1040566|NCT00101907|3383440|P5|Overall Study|Physician Decision|1
1040567|NCT00101907|3383441|P4|Overall Study|Physician Decision|1
1040568|NCT00101907|3383442|P3|Overall Study|Physician Decision|0
1040569|NCT00101907|3383443|P2|Overall Study|Physician Decision|0
1040570|NCT00101907|3383444|P1|Overall Study|Physician Decision|0
1040571|NCT00101907|3383439|P6|Overall Study|Death|0
1040572|NCT00101907|3383440|P5|Overall Study|Death|3
1040573|NCT00101907|3383441|P4|Overall Study|Death|0
1040574|NCT00101907|3383442|P3|Overall Study|Death|0
1040575|NCT00101907|3383443|P2|Overall Study|Death|1
1040576|NCT00101907|3383444|P1|Overall Study|Death|0
1040577|NCT00101907|3383439|P6|Overall Study|Adverse Event|0
1040578|NCT00101907|3383440|P5|Overall Study|Adverse Event|0
1040579|NCT00101907|3383441|P4|Overall Study|Adverse Event|0
1040580|NCT00101907|3383442|P3|Overall Study|Adverse Event|0
1040581|NCT00101907|3383443|P2|Overall Study|Adverse Event|0
1040582|NCT00101907|3383444|P1|Overall Study|Adverse Event|1
1040583|NCT00101868|3383486|P2|Overall Study|Lost to Follow-up|13
1040584|NCT00101868|3383487|P1|Overall Study|Lost to Follow-up|8
1040585|NCT00101868|3383486|P2|Overall Study|Protocol Violation|0
1040586|NCT00101868|3383487|P1|Overall Study|Protocol Violation|3
1040587|NCT00101868|3383486|P2|Overall Study|Withdrawal by Subject|9
1040588|NCT00101868|3383487|P1|Overall Study|Withdrawal by Subject|8
1040589|NCT00101868|3383486|P2|Overall Study|Death|10
1040590|NCT00101868|3383487|P1|Overall Study|Death|10
1040591|NCT00101686|3383557|P10|Overall Study|Withdrawal by Subject|9
1040592|NCT00101686|3383558|P9|Overall Study|Withdrawal by Subject|8
1040593|NCT00101686|3383559|P8|Overall Study|Withdrawal by Subject|7
1040594|NCT00101686|3383560|P7|Overall Study|Withdrawal by Subject|7
1040595|NCT00101686|3383561|P6|Overall Study|Withdrawal by Subject|7
1040596|NCT00101686|3383562|P5|Overall Study|Withdrawal by Subject|8
1040597|NCT00101686|3383563|P4|Overall Study|Withdrawal by Subject|8
1040598|NCT00101686|3383564|P3|Overall Study|Withdrawal by Subject|6
1040599|NCT00101686|3383565|P2|Overall Study|Withdrawal by Subject|8
1040600|NCT00101686|3383566|P1|Overall Study|Withdrawal by Subject|9
1040601|NCT00101686|3383557|P10|Overall Study|Other|3
1040602|NCT00101686|3383558|P9|Overall Study|Other|3
1040603|NCT00101686|3383559|P8|Overall Study|Other|5
1040604|NCT00101686|3383560|P7|Overall Study|Other|1
1040605|NCT00101686|3383561|P6|Overall Study|Other|12
1040606|NCT00101686|3383562|P5|Overall Study|Other|2
1040607|NCT00101686|3383563|P4|Overall Study|Other|6
1040608|NCT00101686|3383564|P3|Overall Study|Other|1
1040609|NCT00101686|3383565|P2|Overall Study|Other|4
1040610|NCT00101686|3383566|P1|Overall Study|Other|1
1040611|NCT00101686|3383557|P10|Overall Study|Physician Decision|1
1040612|NCT00101686|3383558|P9|Overall Study|Physician Decision|1
1040613|NCT00101686|3383559|P8|Overall Study|Physician Decision|5
1040614|NCT00101686|3383560|P7|Overall Study|Physician Decision|5
1040615|NCT00101686|3383561|P6|Overall Study|Physician Decision|9
1040616|NCT00101686|3383562|P5|Overall Study|Physician Decision|8
1040617|NCT00101686|3383563|P4|Overall Study|Physician Decision|7
1040618|NCT00101686|3383564|P3|Overall Study|Physician Decision|6
1040619|NCT00101686|3383565|P2|Overall Study|Physician Decision|13
1040620|NCT00101686|3383566|P1|Overall Study|Physician Decision|10
1040621|NCT00101686|3383557|P10|Overall Study|intercurrent non-cancer related illness|1
1040622|NCT00101686|3383558|P9|Overall Study|intercurrent non-cancer related illness|1
1040623|NCT00101686|3383559|P8|Overall Study|intercurrent non-cancer related illness|0
1040624|NCT00101686|3383560|P7|Overall Study|intercurrent non-cancer related illness|1
1040625|NCT00101686|3383561|P6|Overall Study|intercurrent non-cancer related illness|3
1040626|NCT00101686|3383562|P5|Overall Study|intercurrent non-cancer related illness|1
1040627|NCT00101686|3383563|P4|Overall Study|intercurrent non-cancer related illness|0
1040628|NCT00101686|3383564|P3|Overall Study|intercurrent non-cancer related illness|2
1040629|NCT00101686|3383565|P2|Overall Study|intercurrent non-cancer related illness|0
1040630|NCT00101686|3383566|P1|Overall Study|intercurrent non-cancer related illness|0
1040631|NCT00101686|3383557|P10|Overall Study|Randomized but did not receive treament|1
1040632|NCT00101686|3383558|P9|Overall Study|Randomized but did not receive treament|0
1040633|NCT00101686|3383559|P8|Overall Study|Randomized but did not receive treament|1
1040634|NCT00101686|3383560|P7|Overall Study|Randomized but did not receive treament|0
1040635|NCT00101686|3383561|P6|Overall Study|Randomized but did not receive treament|2
1040636|NCT00101686|3383562|P5|Overall Study|Randomized but did not receive treament|2
1040637|NCT00101686|3383563|P4|Overall Study|Randomized but did not receive treament|2
1040638|NCT00101686|3383564|P3|Overall Study|Randomized but did not receive treament|2
1040639|NCT00101686|3383565|P2|Overall Study|Randomized but did not receive treament|6
1040640|NCT00101686|3383566|P1|Overall Study|Randomized but did not receive treament|1
1040641|NCT00101686|3383557|P10|Overall Study|unacceptable toxicity|4
1040642|NCT00101686|3383558|P9|Overall Study|unacceptable toxicity|1
1040643|NCT00101686|3383559|P8|Overall Study|unacceptable toxicity|2
1040644|NCT00101686|3383560|P7|Overall Study|unacceptable toxicity|4
1040645|NCT00101686|3383561|P6|Overall Study|unacceptable toxicity|10
1040646|NCT00101686|3383562|P5|Overall Study|unacceptable toxicity|16
1040647|NCT00101686|3383563|P4|Overall Study|unacceptable toxicity|6
1040648|NCT00101686|3383564|P3|Overall Study|unacceptable toxicity|10
1040649|NCT00101686|3383565|P2|Overall Study|unacceptable toxicity|9
1040650|NCT00101686|3383566|P1|Overall Study|unacceptable toxicity|3
1040651|NCT00101686|3383557|P10|Overall Study|>3 week delay treatment due toxicity|0
1040652|NCT00101686|3383558|P9|Overall Study|>3 week delay treatment due toxicity|3
1040653|NCT00101686|3383559|P8|Overall Study|>3 week delay treatment due toxicity|1
1040654|NCT00101686|3383560|P7|Overall Study|>3 week delay treatment due toxicity|2
1040655|NCT00101686|3383561|P6|Overall Study|>3 week delay treatment due toxicity|3
1040656|NCT00101686|3383562|P5|Overall Study|>3 week delay treatment due toxicity|7
1040657|NCT00101686|3383563|P4|Overall Study|>3 week delay treatment due toxicity|2
1040658|NCT00101686|3383564|P3|Overall Study|>3 week delay treatment due toxicity|1
1040659|NCT00101686|3383565|P2|Overall Study|>3 week delay treatment due toxicity|2
1040660|NCT00101686|3383566|P1|Overall Study|>3 week delay treatment due toxicity|6
1040661|NCT00101686|3383557|P10|Overall Study|initiation other anti-cancer treatment|3
1040662|NCT00101686|3383558|P9|Overall Study|initiation other anti-cancer treatment|3
1040663|NCT00101686|3383559|P8|Overall Study|initiation other anti-cancer treatment|2
1040664|NCT00101686|3383560|P7|Overall Study|initiation other anti-cancer treatment|2
1040665|NCT00101686|3383561|P6|Overall Study|initiation other anti-cancer treatment|1
1040666|NCT00101686|3383562|P5|Overall Study|initiation other anti-cancer treatment|1
1040667|NCT00101686|3383563|P4|Overall Study|initiation other anti-cancer treatment|3
1040668|NCT00101686|3383564|P3|Overall Study|initiation other anti-cancer treatment|4
1040669|NCT00101686|3383565|P2|Overall Study|initiation other anti-cancer treatment|3
1040670|NCT00101686|3383566|P1|Overall Study|initiation other anti-cancer treatment|4
1040671|NCT00101686|3383557|P10|Overall Study|Progressive Disease|8
1040672|NCT00101686|3383558|P9|Overall Study|Progressive Disease|10
1040673|NCT00101686|3383559|P8|Overall Study|Progressive Disease|7
1040674|NCT00101686|3383560|P7|Overall Study|Progressive Disease|5
1040675|NCT00101686|3383561|P6|Overall Study|Progressive Disease|25
1040676|NCT00101686|3383562|P5|Overall Study|Progressive Disease|28
1040677|NCT00101686|3383563|P4|Overall Study|Progressive Disease|38
1040678|NCT00101686|3383564|P3|Overall Study|Progressive Disease|37
1040679|NCT00101686|3383565|P2|Overall Study|Progressive Disease|28
1040680|NCT00101686|3383566|P1|Overall Study|Progressive Disease|37
1040681|NCT00101582|3383683|P2|Overall Study|Other|1
1040682|NCT00101582|3383684|P1|Overall Study|Other|0
1040683|NCT00101582|3383683|P2|Overall Study|Death|5
1040684|NCT00101582|3383684|P1|Overall Study|Death|3
1040685|NCT00101582|3383683|P2|Overall Study|Physician Decision|0
1040686|NCT00101582|3383684|P1|Overall Study|Physician Decision|1
1040687|NCT00101582|3383683|P2|Overall Study|Withdrawal by Subject|4
1040688|NCT00101582|3383684|P1|Overall Study|Withdrawal by Subject|6
1040689|NCT00101582|3383683|P2|Overall Study|Adverse Event|4
1040690|NCT00101582|3383684|P1|Overall Study|Adverse Event|1
1040691|NCT00101582|3383683|P2|Overall Study|Ineligibility determined|1
1040692|NCT00101582|3383684|P1|Overall Study|Ineligibility determined|0
1040693|NCT00101452|3383707|P3|Overall Study|Other|12
1040694|NCT00101452|3383708|P2|Overall Study|Other|16
1040695|NCT00101452|3383709|P1|Overall Study|Other|15
1040696|NCT00101452|3383707|P3|Overall Study|Protocol Violation|3
1040697|NCT00101452|3383708|P2|Overall Study|Protocol Violation|1
1040698|NCT00101452|3383709|P1|Overall Study|Protocol Violation|2
1040699|NCT00101452|3383707|P3|Overall Study|Physician Decision|2
1040700|NCT00101452|3383708|P2|Overall Study|Physician Decision|3
1040701|NCT00101452|3383709|P1|Overall Study|Physician Decision|0
1040702|NCT00101452|3383707|P3|Overall Study|Baseline Fail|2
1040703|NCT00101452|3383708|P2|Overall Study|Baseline Fail|1
1040704|NCT00101452|3383709|P1|Overall Study|Baseline Fail|2
1040705|NCT00101452|3383707|P3|Overall Study|Withdrawal by Subject|9
1040706|NCT00101452|3383708|P2|Overall Study|Withdrawal by Subject|14
1040707|NCT00101452|3383709|P1|Overall Study|Withdrawal by Subject|10
1040708|NCT00101452|3383707|P3|Overall Study|Lost to Follow-up|14
1040709|NCT00101452|3383708|P2|Overall Study|Lost to Follow-up|8
1040710|NCT00101452|3383709|P1|Overall Study|Lost to Follow-up|13
1040711|NCT00101452|3383707|P3|Overall Study|Adverse Event|1
1040712|NCT00101452|3383708|P2|Overall Study|Adverse Event|0
1040713|NCT00101452|3383709|P1|Overall Study|Adverse Event|2
1040714|NCT00101439|3383723|P2|Period 2|Withdrawal by Subject|2
1040715|NCT00101439|3383724|P1|Period 2|Withdrawal by Subject|0
1040716|NCT00101400|3383740|P1|Survival Follow-Up|Alive|7
1040717|NCT00101283|3383760|P2|Overall Study|Prostate Cancer Recurrence|1
1040718|NCT00101283|3383761|P1|Overall Study|Prostate Cancer Recurrence|0
1040719|NCT00101283|3383760|P2|Overall Study|Insurance Refusal|1
1040720|NCT00101283|3383761|P1|Overall Study|Insurance Refusal|0
1040721|NCT00101283|3383760|P2|Overall Study|Withdrawal by Subject|1
1040722|NCT00101283|3383761|P1|Overall Study|Withdrawal by Subject|0
1040723|NCT00101192|3383771|P1|Overall Study|Inevaluable|1
1040724|NCT00101192|3383771|P1|Overall Study|Ineligible|6
1040725|NCT00101166|3383775|P1|Overall Study|progressive disease|10
1040726|NCT00101101|3383783|P1|Overall Study|never received vaccine|20
1040727|NCT00100932|3383806|P2|Overall Study|Not specified|2
1040728|NCT00100932|3383807|P1|Overall Study|Not specified|5
1040729|NCT00100932|3383806|P2|Overall Study|Physician Decision|5
1040730|NCT00100932|3383807|P1|Overall Study|Physician Decision|7
1040731|NCT00100932|3383806|P2|Overall Study|Progressive Disease|18
1040732|NCT00100932|3383807|P1|Overall Study|Progressive Disease|44
1040733|NCT00100932|3383806|P2|Overall Study|Withdrawal by Subject|0
1040734|NCT00100932|3383807|P1|Overall Study|Withdrawal by Subject|6
1040735|NCT00100932|3383806|P2|Overall Study|Adverse Event|2
1040736|NCT00100932|3383807|P1|Overall Study|Adverse Event|11
1040737|NCT00100815|3383822|P1|Overall Study|not specified|3
1040738|NCT00100815|3383822|P1|Overall Study|Death|4
1040739|NCT00100815|3383822|P1|Overall Study|Adverse Event|18
1040740|NCT00100815|3383822|P1|Overall Study|Progression|24
1040741|NCT00100802|3383830|P1|Overall Study|Ineligible|12
1040742|NCT00100802|3383830|P1|Overall Study|Withdrawal by Subject|5
1040743|NCT00100802|3383830|P1|Overall Study|Protocol Violation|1
1040744|NCT00100802|3383830|P1|Overall Study|Physician Decision|5
1040745|NCT00100802|3383830|P1|Overall Study|Lack of Efficacy|47
1040746|NCT00100802|3383830|P1|Overall Study|Death|1
1040747|NCT00100802|3383830|P1|Overall Study|Adverse Event|9
1040748|NCT00100789|3383835|P1|Overall Study|Never received treatment|1
1040749|NCT00100789|3383835|P1|Overall Study|Ineligible|3
1040750|NCT00100789|3383835|P1|Overall Study|Not protocol specified|5
1040751|NCT00100789|3383835|P1|Overall Study|Death|2
1040752|NCT00100789|3383835|P1|Overall Study|Progression/relapse|42
1040753|NCT00100789|3383835|P1|Overall Study|Withdrawal by Subject|1
1040754|NCT00100789|3383835|P1|Overall Study|Adverse Event|10
1040755|NCT00100178|3383912|P3|Overall Study|Physician Decision|3
1040756|NCT00100178|3383913|P2|Overall Study|Physician Decision|1
1040757|NCT00100178|3383914|P1|Overall Study|Physician Decision|6
1040758|NCT00100178|3383912|P3|Overall Study|Withdrawal by Subject|1
1040759|NCT00100178|3383913|P2|Overall Study|Withdrawal by Subject|1
1040760|NCT00100178|3383914|P1|Overall Study|Withdrawal by Subject|1
1040761|NCT00100178|3383912|P3|Overall Study|Adverse Event|1
1040762|NCT00100178|3383913|P2|Overall Study|Adverse Event|2
1040763|NCT00100178|3383914|P1|Overall Study|Adverse Event|2
1040764|NCT00100178|3383912|P3|Overall Study|Lost to Follow-up|5
1040765|NCT00100178|3383913|P2|Overall Study|Lost to Follow-up|6
1040766|NCT00100178|3383914|P1|Overall Study|Lost to Follow-up|0
1040767|NCT00100048|3383927|P6|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
1040768|NCT00100048|3383928|P5|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
1040769|NCT00100048|3383929|P4|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1
1040770|NCT00100048|3383930|P3|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
1040771|NCT00100048|3383931|P2|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
1040772|NCT00100048|3383932|P1|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
1040773|NCT00100048|3383927|P6|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
1040774|NCT00100048|3383928|P5|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
1040775|NCT00100048|3383929|P4|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
1040776|NCT00100048|3383930|P3|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
1040777|NCT00100048|3383931|P2|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
1040778|NCT00100048|3383932|P1|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
1040779|NCT00100048|3383927|P6|Cohort I & II-Combination Therapy Phase|Other Reason|0
1040780|NCT00100048|3383928|P5|Cohort I & II-Combination Therapy Phase|Other Reason|0
1040781|NCT00100048|3383929|P4|Cohort I & II-Combination Therapy Phase|Other Reason|2
1040782|NCT00100048|3383930|P3|Cohort I & II-Combination Therapy Phase|Other Reason|4
1040783|NCT00100048|3383931|P2|Cohort I & II-Combination Therapy Phase|Other Reason|1
1040784|NCT00100048|3383932|P1|Cohort I & II-Combination Therapy Phase|Other Reason|7
1040785|NCT00100048|3383927|P6|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4
1040786|NCT00100048|3383928|P5|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0
1040787|NCT00100048|3383929|P4|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5
1040788|NCT00100048|3383930|P3|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
1040789|NCT00100048|3383931|P2|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
1040790|NCT00100048|3383932|P1|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1
1040791|NCT00100048|3383927|P6|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
1040792|NCT00100048|3383928|P5|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0
1040793|NCT00100048|3383929|P4|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
1040794|NCT00100048|3383930|P3|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
1040795|NCT00100048|3383931|P2|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1
1040796|NCT00100048|3383932|P1|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
1040797|NCT00100048|3383927|P6|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2
1040798|NCT00100048|3383928|P5|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
1040799|NCT00100048|3383929|P4|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
1040800|NCT00100048|3383930|P3|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
1040801|NCT00100048|3383931|P2|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3
1040802|NCT00100048|3383932|P1|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1
1040803|NCT00100048|3383927|P6|Cohort I & II-Combination Therapy Phase|Adverse Event|1
1040804|NCT00100048|3383928|P5|Cohort I & II-Combination Therapy Phase|Adverse Event|0
1040805|NCT00100048|3383929|P4|Cohort I & II-Combination Therapy Phase|Adverse Event|0
1040806|NCT00100048|3383930|P3|Cohort I & II-Combination Therapy Phase|Adverse Event|2
1040807|NCT00100048|3383931|P2|Cohort I & II-Combination Therapy Phase|Adverse Event|1
1040808|NCT00100048|3383932|P1|Cohort I & II-Combination Therapy Phase|Adverse Event|0
1040809|NCT00100048|3383927|P6|Cohort I & II-Combination Therapy Phase|Never Treated|1
1040810|NCT00100048|3383928|P5|Cohort I & II-Combination Therapy Phase|Never Treated|0
1040811|NCT00100048|3383929|P4|Cohort I & II-Combination Therapy Phase|Never Treated|0
1040812|NCT00100048|3383930|P3|Cohort I & II-Combination Therapy Phase|Never Treated|0
1040813|NCT00100048|3383931|P2|Cohort I & II-Combination Therapy Phase|Never Treated|0
1040814|NCT00100048|3383932|P1|Cohort I & II-Combination Therapy Phase|Never Treated|2
1040815|NCT00099983|3384041|P2|Overall Study|Other issue|0
1040816|NCT00099983|3384042|P1|Overall Study|Other issue|1
1040817|NCT00099983|3384041|P2|Overall Study|Intolerant of burden of visits|1
1040818|NCT00099983|3384042|P1|Overall Study|Intolerant of burden of visits|0
1040819|NCT00099983|3384041|P2|Overall Study|Incarcerated|1
1040820|NCT00099983|3384042|P1|Overall Study|Incarcerated|0
1040821|NCT00099983|3384041|P2|Overall Study|Other psychiatric problem|0
1040822|NCT00099983|3384042|P1|Overall Study|Other psychiatric problem|1
1040823|NCT00099983|3384041|P2|Overall Study|Moved|0
1040824|NCT00099983|3384042|P1|Overall Study|Moved|1
1040825|NCT00099983|3384041|P2|Overall Study|Unable to return for appointments|1
1040826|NCT00099983|3384042|P1|Overall Study|Unable to return for appointments|1
1040827|NCT00099983|3384041|P2|Overall Study|Lack of Efficacy|1
1040828|NCT00099983|3384042|P1|Overall Study|Lack of Efficacy|0
1040829|NCT00099983|3384041|P2|Overall Study|Adverse Event|1
1040830|NCT00099983|3384042|P1|Overall Study|Adverse Event|1
1040831|NCT00099983|3384041|P2|Overall Study|Withdrawal by Subject|2
1040832|NCT00099983|3384042|P1|Overall Study|Withdrawal by Subject|3
1040833|NCT00099983|3384041|P2|Overall Study|Missing Source Documents|15
1040834|NCT00099983|3384042|P1|Overall Study|Missing Source Documents|14
1040835|NCT00099983|3384041|P2|Overall Study|Lost to Follow-up|3
1040836|NCT00099983|3384042|P1|Overall Study|Lost to Follow-up|2
1040837|NCT00099632|3384054|P6|Overall Study|Protocol Violation|1
1040838|NCT00099632|3384055|P5|Overall Study|Protocol Violation|0
1040839|NCT00099632|3384056|P4|Overall Study|Protocol Violation|0
1040840|NCT00099632|3384057|P3|Overall Study|Protocol Violation|0
1040841|NCT00099632|3384058|P2|Overall Study|Protocol Violation|0
1040842|NCT00099632|3384059|P1|Overall Study|Protocol Violation|0
1040843|NCT00099632|3384054|P6|Overall Study|Withdrawal by Subject|1
1040844|NCT00099632|3384055|P5|Overall Study|Withdrawal by Subject|0
1040845|NCT00099632|3384056|P4|Overall Study|Withdrawal by Subject|0
1040846|NCT00099632|3384057|P3|Overall Study|Withdrawal by Subject|0
1040847|NCT00099632|3384058|P2|Overall Study|Withdrawal by Subject|1
1040848|NCT00099632|3384059|P1|Overall Study|Withdrawal by Subject|0
1040849|NCT00099632|3384054|P6|Overall Study|Lost to Follow-up|0
1040850|NCT00099632|3384055|P5|Overall Study|Lost to Follow-up|1
1040851|NCT00099632|3384056|P4|Overall Study|Lost to Follow-up|1
1040852|NCT00099632|3384057|P3|Overall Study|Lost to Follow-up|3
1040853|NCT00099632|3384058|P2|Overall Study|Lost to Follow-up|0
1040854|NCT00099632|3384059|P1|Overall Study|Lost to Follow-up|1
1040855|NCT00099437|3384099|P2|Overall Study|Ongoing in FU but not on treatment|45
1040856|NCT00099437|3384100|P1|Overall Study|Ongoing in FU but not on treatment|37
1040857|NCT00099437|3384099|P2|Overall Study|Withdrawal by Subject|10
1040858|NCT00099437|3384100|P1|Overall Study|Withdrawal by Subject|6
1040859|NCT00099437|3384099|P2|Overall Study|Death|261
1040860|NCT00099437|3384100|P1|Overall Study|Death|293
1040861|NCT00099437|3384099|P2|Overall Study|Lost to Follow-up|33
1040862|NCT00099437|3384100|P1|Overall Study|Lost to Follow-up|30
1040863|NCT00099359|3384123|P3|Overall Study|moved out of area|4
1040864|NCT00099359|3384124|P2|Overall Study|moved out of area|7
1040865|NCT00099359|3384125|P1|Overall Study|moved out of area|9
1040866|NCT00099359|3384123|P3|Overall Study|Lost to Follow-up|24
1040867|NCT00099359|3384124|P2|Overall Study|Lost to Follow-up|24
1040868|NCT00099359|3384125|P1|Overall Study|Lost to Follow-up|15
1040869|NCT00099359|3384123|P3|Overall Study|Withdrawal by Subject|23
1040870|NCT00099359|3384124|P2|Overall Study|Withdrawal by Subject|19
1040871|NCT00099359|3384125|P1|Overall Study|Withdrawal by Subject|19
1040872|NCT00099359|3384123|P3|Overall Study|Death|17
1040873|NCT00099359|3384124|P2|Overall Study|Death|15
1040874|NCT00099359|3384125|P1|Overall Study|Death|11
1040875|NCT00099268|3384148|P2|Overall Study|Death|1
1040876|NCT00099268|3384149|P1|Overall Study|Death|3
1040877|NCT00099268|3384148|P2|Overall Study|Administrative problems|4
1040878|NCT00099268|3384149|P1|Overall Study|Administrative problems|4
1040879|NCT00099268|3384148|P2|Overall Study|Lack of Efficacy|18
1040880|NCT00099268|3384149|P1|Overall Study|Lack of Efficacy|5
1040881|NCT00099268|3384148|P2|Overall Study|Lost to Follow-up|4
1040882|NCT00099268|3384149|P1|Overall Study|Lost to Follow-up|6
1040883|NCT00099268|3384148|P2|Overall Study|Protocol Violation|8
1040884|NCT00099268|3384149|P1|Overall Study|Protocol Violation|9
1040885|NCT00099268|3384148|P2|Overall Study|Adverse Event|19
1040886|NCT00099268|3384149|P1|Overall Study|Adverse Event|19
1040887|NCT00099268|3384148|P2|Overall Study|Withdrawal by Subject|28
1040888|NCT00099268|3384149|P1|Overall Study|Withdrawal by Subject|46
1040889|NCT00098865|3384189|P1|Overall Study|Alternative Therapy|1
1040890|NCT00098865|3384189|P1|Overall Study|Adverse Event|2
1040891|NCT00098865|3384189|P1|Overall Study|Progressive Disease|6
1040892|NCT00098839|3384197|P2|Overall Study|Ineligible|0
1040893|NCT00098839|3384198|P1|Overall Study|Ineligible|2
1040894|NCT00098839|3384197|P2|Overall Study|M2/M3 marrow on Day 15 of Block 2|11
1040895|NCT00098839|3384198|P1|Overall Study|M2/M3 marrow on Day 15 of Block 2|10
1040896|NCT00098839|3384197|P2|Overall Study|Relapse|3
1040897|NCT00098839|3384198|P1|Overall Study|Relapse|6
1040898|NCT00098839|3384197|P2|Overall Study|Refusal of further protocol therapy|1
1040899|NCT00098839|3384198|P1|Overall Study|Refusal of further protocol therapy|3
1040900|NCT00098839|3384197|P2|Overall Study|Withdrawal by Subject|0
1040901|NCT00098839|3384198|P1|Overall Study|Withdrawal by Subject|1
1040902|NCT00098839|3384197|P2|Overall Study|Physician Decision|14
1040903|NCT00098839|3384198|P1|Overall Study|Physician Decision|4
1040904|NCT00098839|3384197|P2|Overall Study|Death|2
1040905|NCT00098839|3384198|P1|Overall Study|Death|1
1040906|NCT00098839|3384197|P2|Overall Study|Adverse Event|2
1040907|NCT00098839|3384198|P1|Overall Study|Adverse Event|5
1040908|NCT00098813|3384209|P1|Overall Study|Reversal of RAI resistance|1
1040909|NCT00098813|3384209|P1|Overall Study|Other complicating disease|1
1040910|NCT00098813|3384209|P1|Overall Study|Progression of Disease|1
1040911|NCT00098813|3384209|P1|Overall Study|Withdrawal by Subject|7
1040912|NCT00098813|3384209|P1|Overall Study|Protocol Violation|1
1040913|NCT00098813|3384209|P1|Overall Study|Death|8
1040914|NCT00098787|3384216|P3|Overall Study|Other|9
1040915|NCT00098787|3384217|P2|Overall Study|Other|6
1040916|NCT00098787|3384218|P1|Overall Study|Other|7
1040917|NCT00098787|3384216|P3|Overall Study|Alternative therapy|13
1040918|NCT00098787|3384217|P2|Overall Study|Alternative therapy|13
1040919|NCT00098787|3384218|P1|Overall Study|Alternative therapy|8
1040920|NCT00098787|3384216|P3|Overall Study|Withdrawal by Subject|6
1040921|NCT00098787|3384217|P2|Overall Study|Withdrawal by Subject|12
1040922|NCT00098787|3384218|P1|Overall Study|Withdrawal by Subject|4
1040923|NCT00098787|3384216|P3|Overall Study|Death|0
1040924|NCT00098787|3384217|P2|Overall Study|Death|1
1040925|NCT00098787|3384218|P1|Overall Study|Death|6
1040926|NCT00098787|3384216|P3|Overall Study|Adverse Event|8
1040927|NCT00098787|3384217|P2|Overall Study|Adverse Event|17
1040928|NCT00098787|3384218|P1|Overall Study|Adverse Event|8
1040929|NCT00098787|3384216|P3|Overall Study|Disease progression|23
1040930|NCT00098787|3384217|P2|Overall Study|Disease progression|17
1040931|NCT00098787|3384218|P1|Overall Study|Disease progression|28
1040932|NCT00098787|3384216|P3|Overall Study|Ineligible|3
1040933|NCT00098787|3384217|P2|Overall Study|Ineligible|7
1040934|NCT00098787|3384218|P1|Overall Study|Ineligible|9
1040935|NCT00098787|3384216|P3|Overall Study|Never started treatment|1
1040936|NCT00098787|3384217|P2|Overall Study|Never started treatment|2
1040937|NCT00098787|3384218|P1|Overall Study|Never started treatment|3
1040938|NCT00098774|3384232|P1|Overall Study|Physician Decision|2
1040939|NCT00098774|3384232|P1|Overall Study|Failed (to respond) during induction|4
1040940|NCT00098774|3384232|P1|Overall Study|Withdrawal by Subject|1
1040941|NCT00098774|3384232|P1|Overall Study|Disease Progression|9
1040942|NCT00098774|3384232|P1|Overall Study|Adverse Event|2
1040943|NCT00098748|3384242|P3|Continued on Open-Label Treatment|Withdrawal by Subject|0
1040944|NCT00098748|3384243|P2|Continued on Open-Label Treatment|Withdrawal by Subject|4
1040945|NCT00098748|3384244|P1|Continued on Open-Label Treatment|Withdrawal by Subject|0
1040946|NCT00098748|3384242|P3|Continued on Open-Label Treatment|Lost to Follow-up|0
1040947|NCT00098748|3384243|P2|Continued on Open-Label Treatment|Lost to Follow-up|1
1040948|NCT00098748|3384244|P1|Continued on Open-Label Treatment|Lost to Follow-up|1
1040949|NCT00098748|3384242|P3|Continued on Open-Label Treatment|Other reason includes protocol violation|0
1040950|NCT00098748|3384243|P2|Continued on Open-Label Treatment|Other reason includes protocol violation|7
1040951|NCT00098748|3384244|P1|Continued on Open-Label Treatment|Other reason includes protocol violation|6
1040952|NCT00098748|3384242|P3|Continued on Open-Label Treatment|Lack of Efficacy|0
1040953|NCT00098748|3384243|P2|Continued on Open-Label Treatment|Lack of Efficacy|2
1040954|NCT00098748|3384244|P1|Continued on Open-Label Treatment|Lack of Efficacy|1
1040955|NCT00098748|3384242|P3|Continued on Open-Label Treatment|Adverse Event|0
1040956|NCT00098748|3384243|P2|Continued on Open-Label Treatment|Adverse Event|1
1040957|NCT00098748|3384244|P1|Continued on Open-Label Treatment|Adverse Event|0
1040958|NCT00098748|3384242|P3|Received Study Treatment|Subject defaulted|4
1040959|NCT00098748|3384243|P2|Received Study Treatment|Subject defaulted|4
1040960|NCT00098748|3384244|P1|Received Study Treatment|Subject defaulted|3
1040961|NCT00098748|3384242|P3|Received Study Treatment|Other|6
1040962|NCT00098748|3384243|P2|Received Study Treatment|Other|2
1040963|NCT00098748|3384244|P1|Received Study Treatment|Other|2
1040964|NCT00098748|3384242|P3|Received Study Treatment|Lack of Efficacy|27
1040965|NCT00098748|3384243|P2|Received Study Treatment|Lack of Efficacy|27
1040966|NCT00098748|3384244|P1|Received Study Treatment|Lack of Efficacy|40
1040967|NCT00098748|3384242|P3|Received Study Treatment|Adverse Event|5
1040968|NCT00098748|3384243|P2|Received Study Treatment|Adverse Event|2
1040969|NCT00098748|3384244|P1|Received Study Treatment|Adverse Event|1
1040970|NCT00098748|3384242|P3|Received Study Treatment|Death|2
1040971|NCT00098748|3384243|P2|Received Study Treatment|Death|1
1040972|NCT00098748|3384244|P1|Received Study Treatment|Death|2
1040973|NCT00098748|3384242|P3|Assigned to Study Treatment|Randomized, but not treated|2
1040974|NCT00098748|3384243|P2|Assigned to Study Treatment|Randomized, but not treated|2
1040975|NCT00098748|3384244|P1|Assigned to Study Treatment|Randomized, but not treated|0
1040976|NCT00098722|3384300|P7|Observation Phase|Other|10
1040977|NCT00098722|3384301|P6|Observation Phase|Other|21
1040978|NCT00098722|3384302|P5|Observation Phase|Other|0
1040979|NCT00098722|3384303|P4|Observation Phase|Other|0
1040980|NCT00098722|3384304|P3|Observation Phase|Other|0
1040981|NCT00098722|3384305|P2|Observation Phase|Other|0
1040982|NCT00098722|3384306|P1|Observation Phase|Other|0
1040983|NCT00098722|3384300|P7|Observation Phase|Participant defaulted|4
1040984|NCT00098722|3384301|P6|Observation Phase|Participant defaulted|17
1040985|NCT00098722|3384302|P5|Observation Phase|Participant defaulted|0
1040986|NCT00098722|3384303|P4|Observation Phase|Participant defaulted|0
1040987|NCT00098722|3384304|P3|Observation Phase|Participant defaulted|0
1040988|NCT00098722|3384305|P2|Observation Phase|Participant defaulted|0
1040989|NCT00098722|3384306|P1|Observation Phase|Participant defaulted|0
1040990|NCT00098722|3384300|P7|Observation Phase|Lack of Efficacy|0
1040991|NCT00098722|3384301|P6|Observation Phase|Lack of Efficacy|2
1040992|NCT00098722|3384302|P5|Observation Phase|Lack of Efficacy|0
1040993|NCT00098722|3384303|P4|Observation Phase|Lack of Efficacy|0
1040994|NCT00098722|3384304|P3|Observation Phase|Lack of Efficacy|0
1040995|NCT00098722|3384305|P2|Observation Phase|Lack of Efficacy|0
1040996|NCT00098722|3384306|P1|Observation Phase|Lack of Efficacy|0
1040997|NCT00098722|3384300|P7|Observation Phase|Death|3
1040998|NCT00098722|3384301|P6|Observation Phase|Death|5
1040999|NCT00098722|3384302|P5|Observation Phase|Death|0
1041000|NCT00098722|3384303|P4|Observation Phase|Death|0
1041001|NCT00098722|3384304|P3|Observation Phase|Death|0
1041002|NCT00098722|3384305|P2|Observation Phase|Death|0
1041003|NCT00098722|3384306|P1|Observation Phase|Death|0
1041004|NCT00098722|3384300|P7|Open Label Phase|Other|0
1041005|NCT00098722|3384301|P6|Open Label Phase|Other|0
1041006|NCT00098722|3384302|P5|Open Label Phase|Other|0
1041007|NCT00098722|3384303|P4|Open Label Phase|Other|18
1041008|NCT00098722|3384304|P3|Open Label Phase|Other|0
1041009|NCT00098722|3384305|P2|Open Label Phase|Other|0
1041010|NCT00098722|3384306|P1|Open Label Phase|Other|0
1041011|NCT00098722|3384300|P7|Open Label Phase|Ongoing at cut-off date|0
1041012|NCT00098722|3384301|P6|Open Label Phase|Ongoing at cut-off date|0
1041013|NCT00098722|3384302|P5|Open Label Phase|Ongoing at cut-off date|50
1041014|NCT00098722|3384303|P4|Open Label Phase|Ongoing at cut-off date|220
1041015|NCT00098722|3384304|P3|Open Label Phase|Ongoing at cut-off date|0
1041016|NCT00098722|3384305|P2|Open Label Phase|Ongoing at cut-off date|0
1041017|NCT00098722|3384306|P1|Open Label Phase|Ongoing at cut-off date|0
1041018|NCT00098722|3384300|P7|Open Label Phase|Participant defaulted|0
1041019|NCT00098722|3384301|P6|Open Label Phase|Participant defaulted|0
1041020|NCT00098722|3384302|P5|Open Label Phase|Participant defaulted|0
1041021|NCT00098722|3384303|P4|Open Label Phase|Participant defaulted|18
1041022|NCT00098722|3384304|P3|Open Label Phase|Participant defaulted|0
1041023|NCT00098722|3384305|P2|Open Label Phase|Participant defaulted|0
1041024|NCT00098722|3384306|P1|Open Label Phase|Participant defaulted|0
1041025|NCT00098722|3384300|P7|Open Label Phase|Pregnancy|0
1041026|NCT00098722|3384301|P6|Open Label Phase|Pregnancy|0
1041027|NCT00098722|3384302|P5|Open Label Phase|Pregnancy|0
1041028|NCT00098722|3384303|P4|Open Label Phase|Pregnancy|1
1041029|NCT00098722|3384304|P3|Open Label Phase|Pregnancy|0
1041030|NCT00098722|3384305|P2|Open Label Phase|Pregnancy|0
1041031|NCT00098722|3384306|P1|Open Label Phase|Pregnancy|0
1041032|NCT00098722|3384300|P7|Open Label Phase|Lack of Efficacy|0
1041033|NCT00098722|3384301|P6|Open Label Phase|Lack of Efficacy|0
1041034|NCT00098722|3384302|P5|Open Label Phase|Lack of Efficacy|0
1041035|NCT00098722|3384303|P4|Open Label Phase|Lack of Efficacy|8
1041036|NCT00098722|3384304|P3|Open Label Phase|Lack of Efficacy|0
1041037|NCT00098722|3384305|P2|Open Label Phase|Lack of Efficacy|0
1041038|NCT00098722|3384306|P1|Open Label Phase|Lack of Efficacy|0
1041039|NCT00098722|3384300|P7|Open Label Phase|Death|0
1041040|NCT00098722|3384301|P6|Open Label Phase|Death|0
1041041|NCT00098722|3384302|P5|Open Label Phase|Death|0
1041042|NCT00098722|3384303|P4|Open Label Phase|Death|2
1041043|NCT00098722|3384304|P3|Open Label Phase|Death|0
1041044|NCT00098722|3384305|P2|Open Label Phase|Death|0
1041045|NCT00098722|3384306|P1|Open Label Phase|Death|0
1041046|NCT00098722|3384300|P7|Open Label Phase|Adverse Event|0
1041047|NCT00098722|3384301|P6|Open Label Phase|Adverse Event|0
1041048|NCT00098722|3384302|P5|Open Label Phase|Adverse Event|0
1041049|NCT00098722|3384303|P4|Open Label Phase|Adverse Event|5
1041050|NCT00098722|3384304|P3|Open Label Phase|Adverse Event|0
1041051|NCT00098722|3384305|P2|Open Label Phase|Adverse Event|0
1041052|NCT00098722|3384306|P1|Open Label Phase|Adverse Event|0
1041053|NCT00098722|3384300|P7|Double Blind Phase|Other|0
1041054|NCT00098722|3384301|P6|Double Blind Phase|Other|0
1041055|NCT00098722|3384302|P5|Double Blind Phase|Other|0
1041056|NCT00098722|3384303|P4|Double Blind Phase|Other|0
1041057|NCT00098722|3384304|P3|Double Blind Phase|Other|7
1041058|NCT00098722|3384305|P2|Double Blind Phase|Other|8
1041059|NCT00098722|3384306|P1|Double Blind Phase|Other|7
1041060|NCT00098722|3384300|P7|Double Blind Phase|Ongoing at cut-off date|0
1041061|NCT00098722|3384301|P6|Double Blind Phase|Ongoing at cut-off date|0
1041062|NCT00098722|3384302|P5|Double Blind Phase|Ongoing at cut-off date|0
1041063|NCT00098722|3384303|P4|Double Blind Phase|Ongoing at cut-off date|0
1041064|NCT00098722|3384304|P3|Double Blind Phase|Ongoing at cut-off date|57
1041065|NCT00098722|3384305|P2|Double Blind Phase|Ongoing at cut-off date|137
1041066|NCT00098722|3384306|P1|Double Blind Phase|Ongoing at cut-off date|128
1041067|NCT00098722|3384300|P7|Double Blind Phase|Randomized, not treated|0
1041068|NCT00098722|3384301|P6|Double Blind Phase|Randomized, not treated|0
1041069|NCT00098722|3384302|P5|Double Blind Phase|Randomized, not treated|0
1041070|NCT00098722|3384303|P4|Double Blind Phase|Randomized, not treated|0
1041071|NCT00098722|3384304|P3|Double Blind Phase|Randomized, not treated|3
1041072|NCT00098722|3384305|P2|Double Blind Phase|Randomized, not treated|3
1041073|NCT00098722|3384306|P1|Double Blind Phase|Randomized, not treated|4
1041074|NCT00098722|3384300|P7|Double Blind Phase|Pregnancy|0
1041075|NCT00098722|3384301|P6|Double Blind Phase|Pregnancy|0
1041076|NCT00098722|3384302|P5|Double Blind Phase|Pregnancy|0
1041077|NCT00098722|3384303|P4|Double Blind Phase|Pregnancy|0
1041078|NCT00098722|3384304|P3|Double Blind Phase|Pregnancy|0
1041079|NCT00098722|3384305|P2|Double Blind Phase|Pregnancy|0
1041080|NCT00098722|3384306|P1|Double Blind Phase|Pregnancy|1
1041081|NCT00098722|3384300|P7|Double Blind Phase|Participant defaulted|0
1041082|NCT00098722|3384301|P6|Double Blind Phase|Participant defaulted|0
1041083|NCT00098722|3384302|P5|Double Blind Phase|Participant defaulted|0
1041084|NCT00098722|3384303|P4|Double Blind Phase|Participant defaulted|0
1041085|NCT00098722|3384304|P3|Double Blind Phase|Participant defaulted|9
1041086|NCT00098722|3384305|P2|Double Blind Phase|Participant defaulted|11
1041087|NCT00098722|3384306|P1|Double Blind Phase|Participant defaulted|16
1041088|NCT00098722|3384300|P7|Double Blind Phase|Lack of Efficacy|0
1041089|NCT00098722|3384301|P6|Double Blind Phase|Lack of Efficacy|0
1041090|NCT00098722|3384302|P5|Double Blind Phase|Lack of Efficacy|0
1041091|NCT00098722|3384303|P4|Double Blind Phase|Lack of Efficacy|0
1041092|NCT00098722|3384304|P3|Double Blind Phase|Lack of Efficacy|15
1041093|NCT00098722|3384305|P2|Double Blind Phase|Lack of Efficacy|23
1041094|NCT00098722|3384306|P1|Double Blind Phase|Lack of Efficacy|21
1041095|NCT00098722|3384300|P7|Double Blind Phase|Death|0
1041096|NCT00098722|3384301|P6|Double Blind Phase|Death|0
1041097|NCT00098722|3384302|P5|Double Blind Phase|Death|0
1041098|NCT00098722|3384303|P4|Double Blind Phase|Death|0
1041099|NCT00098722|3384304|P3|Double Blind Phase|Death|0
1041100|NCT00098722|3384305|P2|Double Blind Phase|Death|5
1041101|NCT00098722|3384306|P1|Double Blind Phase|Death|2
1041102|NCT00098722|3384300|P7|Double Blind Phase|Adverse Event|0
1041103|NCT00098722|3384301|P6|Double Blind Phase|Adverse Event|0
1041104|NCT00098722|3384302|P5|Double Blind Phase|Adverse Event|0
1041105|NCT00098722|3384303|P4|Double Blind Phase|Adverse Event|0
1041106|NCT00098722|3384304|P3|Double Blind Phase|Adverse Event|3
1041107|NCT00098722|3384305|P2|Double Blind Phase|Adverse Event|7
1041108|NCT00098722|3384306|P1|Double Blind Phase|Adverse Event|7
1041109|NCT00098475|3384380|P4|Step 2|Never started treatment|0
1041110|NCT00098475|3384381|P3|Step 2|Never started treatment|0
1041111|NCT00098475|3384382|P2|Step 2|Never started treatment|1
1041112|NCT00098475|3384383|P1|Step 2|Never started treatment|1
1041113|NCT00098475|3384380|P4|Step 2|Alternative therapy|0
1041114|NCT00098475|3384381|P3|Step 2|Alternative therapy|0
1041115|NCT00098475|3384382|P2|Step 2|Alternative therapy|2
1041116|NCT00098475|3384383|P1|Step 2|Alternative therapy|1
1041117|NCT00098475|3384380|P4|Step 2|Physician Decision|0
1041118|NCT00098475|3384381|P3|Step 2|Physician Decision|0
1041119|NCT00098475|3384382|P2|Step 2|Physician Decision|1
1041120|NCT00098475|3384383|P1|Step 2|Physician Decision|0
1041121|NCT00098475|3384380|P4|Step 2|Withdrawal by Subject|0
1041122|NCT00098475|3384381|P3|Step 2|Withdrawal by Subject|0
1041123|NCT00098475|3384382|P2|Step 2|Withdrawal by Subject|2
1041124|NCT00098475|3384383|P1|Step 2|Withdrawal by Subject|0
1041125|NCT00098475|3384380|P4|Step 2|Adverse Event|0
1041126|NCT00098475|3384381|P3|Step 2|Adverse Event|0
1041127|NCT00098475|3384382|P2|Step 2|Adverse Event|0
1041128|NCT00098475|3384383|P1|Step 2|Adverse Event|2
1041129|NCT00098475|3384380|P4|Step 2|Disease progression|0
1041130|NCT00098475|3384381|P3|Step 2|Disease progression|0
1041131|NCT00098475|3384382|P2|Step 2|Disease progression|4
1041132|NCT00098475|3384383|P1|Step 2|Disease progression|1
1041133|NCT00098475|3384380|P4|Step 1|Not documented|0
1041134|NCT00098475|3384381|P3|Step 1|Not documented|0
1041135|NCT00098475|3384382|P2|Step 1|Not documented|1
1041136|NCT00098475|3384383|P1|Step 1|Not documented|0
1041137|NCT00098475|3384380|P4|Step 1|Patient fell with fracture|0
1041138|NCT00098475|3384381|P3|Step 1|Patient fell with fracture|0
1041139|NCT00098475|3384382|P2|Step 1|Patient fell with fracture|0
1041140|NCT00098475|3384383|P1|Step 1|Patient fell with fracture|1
1041141|NCT00098475|3384380|P4|Step 1|Misinterpretation of lab data|0
1041142|NCT00098475|3384381|P3|Step 1|Misinterpretation of lab data|0
1041143|NCT00098475|3384382|P2|Step 1|Misinterpretation of lab data|1
1041144|NCT00098475|3384383|P1|Step 1|Misinterpretation of lab data|0
1041145|NCT00098475|3384380|P4|Step 1|Criteria to continue treatment not met|0
1041146|NCT00098475|3384381|P3|Step 1|Criteria to continue treatment not met|0
1041147|NCT00098475|3384382|P2|Step 1|Criteria to continue treatment not met|1
1041148|NCT00098475|3384383|P1|Step 1|Criteria to continue treatment not met|0
1041149|NCT00098475|3384380|P4|Step 1|Referred to other physicians|0
1041150|NCT00098475|3384381|P3|Step 1|Referred to other physicians|0
1041151|NCT00098475|3384382|P2|Step 1|Referred to other physicians|1
1041152|NCT00098475|3384383|P1|Step 1|Referred to other physicians|0
1041153|NCT00098475|3384380|P4|Step 1|Rising paraprotein|0
1041154|NCT00098475|3384381|P3|Step 1|Rising paraprotein|0
1041155|NCT00098475|3384382|P2|Step 1|Rising paraprotein|1
1041156|NCT00098475|3384383|P1|Step 1|Rising paraprotein|0
1041157|NCT00098475|3384380|P4|Step 1|Insurance issue|0
1041158|NCT00098475|3384381|P3|Step 1|Insurance issue|0
1041159|NCT00098475|3384382|P2|Step 1|Insurance issue|1
1041160|NCT00098475|3384383|P1|Step 1|Insurance issue|0
1041161|NCT00098475|3384380|P4|Step 1|Declining performance status|0
1041162|NCT00098475|3384381|P3|Step 1|Declining performance status|0
1041163|NCT00098475|3384382|P2|Step 1|Declining performance status|1
1041164|NCT00098475|3384383|P1|Step 1|Declining performance status|0
1041165|NCT00098475|3384380|P4|Step 1|Off treatment for > specified timeframe|0
1041166|NCT00098475|3384381|P3|Step 1|Off treatment for > specified timeframe|0
1041167|NCT00098475|3384382|P2|Step 1|Off treatment for > specified timeframe|1
1041168|NCT00098475|3384383|P1|Step 1|Off treatment for > specified timeframe|1
1041169|NCT00098475|3384380|P4|Step 1|Incorrect disease assessment|0
1041170|NCT00098475|3384381|P3|Step 1|Incorrect disease assessment|0
1041171|NCT00098475|3384382|P2|Step 1|Incorrect disease assessment|0
1041172|NCT00098475|3384383|P1|Step 1|Incorrect disease assessment|2
1041173|NCT00098475|3384380|P4|Step 1|Both patient and physician's decision|0
1041174|NCT00098475|3384381|P3|Step 1|Both patient and physician's decision|0
1041175|NCT00098475|3384382|P2|Step 1|Both patient and physician's decision|1
1041176|NCT00098475|3384383|P1|Step 1|Both patient and physician's decision|2
1041177|NCT00098475|3384380|P4|Step 1|Cannot comply due to other tx|0
1041178|NCT00098475|3384381|P3|Step 1|Cannot comply due to other tx|0
1041179|NCT00098475|3384382|P2|Step 1|Cannot comply due to other tx|1
1041180|NCT00098475|3384383|P1|Step 1|Cannot comply due to other tx|0
1041181|NCT00098475|3384380|P4|Step 1|Complications|0
1041182|NCT00098475|3384381|P3|Step 1|Complications|0
1041183|NCT00098475|3384382|P2|Step 1|Complications|0
1041184|NCT00098475|3384383|P1|Step 1|Complications|1
1041185|NCT00098475|3384380|P4|Step 1|Knee surgery|0
1041186|NCT00098475|3384381|P3|Step 1|Knee surgery|0
1041187|NCT00098475|3384382|P2|Step 1|Knee surgery|0
1041188|NCT00098475|3384383|P1|Step 1|Knee surgery|1
1041189|NCT00098475|3384380|P4|Step 1|Still on treatment as of this analysis|0
1041190|NCT00098475|3384381|P3|Step 1|Still on treatment as of this analysis|0
1041191|NCT00098475|3384382|P2|Step 1|Still on treatment as of this analysis|27
1041192|NCT00098475|3384383|P1|Step 1|Still on treatment as of this analysis|14
1041193|NCT00098475|3384380|P4|Step 1|Never started treatment|0
1041194|NCT00098475|3384381|P3|Step 1|Never started treatment|0
1041195|NCT00098475|3384382|P2|Step 1|Never started treatment|2
1041196|NCT00098475|3384383|P1|Step 1|Never started treatment|0
1041197|NCT00098475|3384380|P4|Step 1|Other disease|0
1041198|NCT00098475|3384381|P3|Step 1|Other disease|1
1041199|NCT00098475|3384382|P2|Step 1|Other disease|1
1041200|NCT00098475|3384383|P1|Step 1|Other disease|2
1041201|NCT00098475|3384380|P4|Step 1|Alternative therapy|0
1041202|NCT00098475|3384381|P3|Step 1|Alternative therapy|1
1041203|NCT00098475|3384382|P2|Step 1|Alternative therapy|43
1041204|NCT00098475|3384383|P1|Step 1|Alternative therapy|31
1041205|NCT00098475|3384380|P4|Step 1|Physician Decision|0
1041206|NCT00098475|3384381|P3|Step 1|Physician Decision|0
1041207|NCT00098475|3384382|P2|Step 1|Physician Decision|2
1041208|NCT00098475|3384383|P1|Step 1|Physician Decision|5
1041209|NCT00098475|3384380|P4|Step 1|Withdrawal by Subject|0
1041210|NCT00098475|3384381|P3|Step 1|Withdrawal by Subject|0
1041211|NCT00098475|3384382|P2|Step 1|Withdrawal by Subject|11
1041212|NCT00098475|3384383|P1|Step 1|Withdrawal by Subject|14
1041213|NCT00098475|3384380|P4|Step 1|Death|1
1041214|NCT00098475|3384381|P3|Step 1|Death|0
1041215|NCT00098475|3384382|P2|Step 1|Death|5
1041216|NCT00098475|3384383|P1|Step 1|Death|8
1041217|NCT00098475|3384380|P4|Step 1|Adverse Event|1
1041218|NCT00098475|3384381|P3|Step 1|Adverse Event|0
1041219|NCT00098475|3384382|P2|Step 1|Adverse Event|37
1041220|NCT00098475|3384383|P1|Step 1|Adverse Event|56
1041221|NCT00098475|3384380|P4|Step 1|Progressive disease|1
1041222|NCT00098475|3384381|P3|Step 1|Progressive disease|2
1041223|NCT00098475|3384382|P2|Step 1|Progressive disease|35
1041224|NCT00098475|3384383|P1|Step 1|Progressive disease|33
1041225|NCT00098345|3384420|P1|Overall Study|progression|4
1041226|NCT00098345|3384420|P1|Overall Study|Withdrawal by Subject|2
1041227|NCT00098345|3384420|P1|Overall Study|Adverse Event|7
1041228|NCT00098306|3384433|P7|Observational Phase|Un-specified|4
1041229|NCT00098306|3384434|P6|Observational Phase|Un-specified|7
1041230|NCT00098306|3384435|P5|Observational Phase|Un-specified|0
1041231|NCT00098306|3384436|P4|Observational Phase|Un-specified|0
1041232|NCT00098306|3384437|P3|Observational Phase|Un-specified|0
1041233|NCT00098306|3384438|P2|Observational Phase|Un-specified|0
1041234|NCT00098306|3384439|P1|Observational Phase|Un-specified|0
1041235|NCT00098306|3384433|P7|Observational Phase|Participant defaulted|18
1041236|NCT00098306|3384434|P6|Observational Phase|Participant defaulted|34
1041237|NCT00098306|3384435|P5|Observational Phase|Participant defaulted|0
1041238|NCT00098306|3384436|P4|Observational Phase|Participant defaulted|0
1041239|NCT00098306|3384437|P3|Observational Phase|Participant defaulted|0
1041240|NCT00098306|3384438|P2|Observational Phase|Participant defaulted|0
1041241|NCT00098306|3384439|P1|Observational Phase|Participant defaulted|0
1041242|NCT00098306|3384433|P7|Observational Phase|Death|4
1041243|NCT00098306|3384434|P6|Observational Phase|Death|5
1041244|NCT00098306|3384435|P5|Observational Phase|Death|0
1041245|NCT00098306|3384436|P4|Observational Phase|Death|0
1041246|NCT00098306|3384437|P3|Observational Phase|Death|0
1041247|NCT00098306|3384438|P2|Observational Phase|Death|0
1041248|NCT00098306|3384439|P1|Observational Phase|Death|0
1041249|NCT00098306|3384433|P7|Open Label|Ongoing at cut-off date|0
1041250|NCT00098306|3384434|P6|Open Label|Ongoing at cut-off date|0
1041251|NCT00098306|3384435|P5|Open Label|Ongoing at cut-off date|62
1041252|NCT00098306|3384436|P4|Open Label|Ongoing at cut-off date|269
1041253|NCT00098306|3384437|P3|Open Label|Ongoing at cut-off date|0
1041254|NCT00098306|3384438|P2|Open Label|Ongoing at cut-off date|0
1041255|NCT00098306|3384439|P1|Open Label|Ongoing at cut-off date|0
1041256|NCT00098306|3384433|P7|Open Label|Un-specified|0
1041257|NCT00098306|3384434|P6|Open Label|Un-specified|0
1041258|NCT00098306|3384435|P5|Open Label|Un-specified|0
1041259|NCT00098306|3384436|P4|Open Label|Un-specified|15
1041260|NCT00098306|3384437|P3|Open Label|Un-specified|0
1041261|NCT00098306|3384438|P2|Open Label|Un-specified|0
1041262|NCT00098306|3384439|P1|Open Label|Un-specified|0
1041263|NCT00098306|3384433|P7|Open Label|Participant defaulted|0
1041264|NCT00098306|3384434|P6|Open Label|Participant defaulted|0
1041265|NCT00098306|3384435|P5|Open Label|Participant defaulted|0
1041266|NCT00098306|3384436|P4|Open Label|Participant defaulted|24
1041267|NCT00098306|3384437|P3|Open Label|Participant defaulted|0
1041268|NCT00098306|3384438|P2|Open Label|Participant defaulted|0
1041269|NCT00098306|3384439|P1|Open Label|Participant defaulted|0
1041270|NCT00098306|3384433|P7|Open Label|Death|0
1041271|NCT00098306|3384434|P6|Open Label|Death|0
1041272|NCT00098306|3384435|P5|Open Label|Death|0
1041273|NCT00098306|3384436|P4|Open Label|Death|4
1041274|NCT00098306|3384437|P3|Open Label|Death|0
1041275|NCT00098306|3384438|P2|Open Label|Death|0
1041276|NCT00098306|3384439|P1|Open Label|Death|0
1041277|NCT00098306|3384433|P7|Open Label|Adverse Event|0
1041278|NCT00098306|3384434|P6|Open Label|Adverse Event|0
1041279|NCT00098306|3384435|P5|Open Label|Adverse Event|0
1041280|NCT00098306|3384436|P4|Open Label|Adverse Event|2
1041281|NCT00098306|3384437|P3|Open Label|Adverse Event|0
1041282|NCT00098306|3384438|P2|Open Label|Adverse Event|0
1041283|NCT00098306|3384439|P1|Open Label|Adverse Event|0
1041284|NCT00098306|3384433|P7|Open Label|Lack of Efficacy|0
1041285|NCT00098306|3384434|P6|Open Label|Lack of Efficacy|0
1041286|NCT00098306|3384435|P5|Open Label|Lack of Efficacy|0
1041287|NCT00098306|3384436|P4|Open Label|Lack of Efficacy|13
1041288|NCT00098306|3384437|P3|Open Label|Lack of Efficacy|0
1041289|NCT00098306|3384438|P2|Open Label|Lack of Efficacy|0
1041290|NCT00098306|3384439|P1|Open Label|Lack of Efficacy|0
1041291|NCT00098306|3384433|P7|Double Blind|Un-specified|0
1041292|NCT00098306|3384434|P6|Double Blind|Un-specified|0
1041293|NCT00098306|3384435|P5|Double Blind|Un-specified|0
1041294|NCT00098306|3384436|P4|Double Blind|Un-specified|0
1041295|NCT00098306|3384437|P3|Double Blind|Un-specified|11
1041296|NCT00098306|3384438|P2|Double Blind|Un-specified|3
1041297|NCT00098306|3384439|P1|Double Blind|Un-specified|7
1041298|NCT00098306|3384433|P7|Double Blind|Participant defaulted|0
1041299|NCT00098306|3384434|P6|Double Blind|Participant defaulted|0
1041300|NCT00098306|3384435|P5|Double Blind|Participant defaulted|0
1041301|NCT00098306|3384436|P4|Double Blind|Participant defaulted|0
1041302|NCT00098306|3384437|P3|Double Blind|Participant defaulted|11
1041303|NCT00098306|3384438|P2|Double Blind|Participant defaulted|18
1041304|NCT00098306|3384439|P1|Double Blind|Participant defaulted|19
1041305|NCT00098306|3384433|P7|Double Blind|Death|0
1041306|NCT00098306|3384434|P6|Double Blind|Death|0
1041307|NCT00098306|3384435|P5|Double Blind|Death|0
1041308|NCT00098306|3384436|P4|Double Blind|Death|0
1041309|NCT00098306|3384437|P3|Double Blind|Death|1
1041310|NCT00098306|3384438|P2|Double Blind|Death|4
1041311|NCT00098306|3384439|P1|Double Blind|Death|1
1041312|NCT00098306|3384433|P7|Double Blind|Lack of Efficacy|0
1041313|NCT00098306|3384434|P6|Double Blind|Lack of Efficacy|0
1041314|NCT00098306|3384435|P5|Double Blind|Lack of Efficacy|0
1041315|NCT00098306|3384436|P4|Double Blind|Lack of Efficacy|0
1041316|NCT00098306|3384437|P3|Double Blind|Lack of Efficacy|17
1041317|NCT00098306|3384438|P2|Double Blind|Lack of Efficacy|34
1041318|NCT00098306|3384439|P1|Double Blind|Lack of Efficacy|43
1041319|NCT00098306|3384433|P7|Double Blind|Adverse Event|0
1041320|NCT00098306|3384434|P6|Double Blind|Adverse Event|0
1041321|NCT00098306|3384435|P5|Double Blind|Adverse Event|0
1041322|NCT00098306|3384436|P4|Double Blind|Adverse Event|0
1041323|NCT00098306|3384437|P3|Double Blind|Adverse Event|6
1041324|NCT00098306|3384438|P2|Double Blind|Adverse Event|10
1041325|NCT00098306|3384439|P1|Double Blind|Adverse Event|11
1041326|NCT00098306|3384433|P7|Double Blind|Ongoing at cut-off date|0
1041327|NCT00098306|3384434|P6|Double Blind|Ongoing at cut-off date|0
1041328|NCT00098306|3384435|P5|Double Blind|Ongoing at cut-off date|0
1041329|NCT00098306|3384436|P4|Double Blind|Ongoing at cut-off date|0
1041330|NCT00098306|3384437|P3|Double Blind|Ongoing at cut-off date|72
1041331|NCT00098306|3384438|P2|Double Blind|Ongoing at cut-off date|166
1041332|NCT00098306|3384439|P1|Double Blind|Ongoing at cut-off date|151
1041333|NCT00098306|3384433|P7|Double Blind|Randomized, not treated|0
1041334|NCT00098306|3384434|P6|Double Blind|Randomized, not treated|0
1041335|NCT00098306|3384435|P5|Double Blind|Randomized, not treated|0
1041336|NCT00098306|3384436|P4|Double Blind|Randomized, not treated|0
1041337|NCT00098306|3384437|P3|Double Blind|Randomized, not treated|2
1041338|NCT00098306|3384438|P2|Double Blind|Randomized, not treated|5
1041339|NCT00098306|3384439|P1|Double Blind|Randomized, not treated|9
1041340|NCT00098293|3384505|P5|Supplemental Phase (SP)|Other|22
1041341|NCT00098293|3384506|P4|Supplemental Phase (SP)|Other|0
1041342|NCT00098293|3384507|P3|Supplemental Phase (SP)|Other|0
1041343|NCT00098293|3384508|P2|Supplemental Phase (SP)|Other|0
1041344|NCT00098293|3384509|P1|Supplemental Phase (SP)|Other|0
1041345|NCT00098293|3384505|P5|Supplemental Phase (SP)|Withdrawal by Subject|8
1041346|NCT00098293|3384506|P4|Supplemental Phase (SP)|Withdrawal by Subject|0
1041347|NCT00098293|3384507|P3|Supplemental Phase (SP)|Withdrawal by Subject|0
1041348|NCT00098293|3384508|P2|Supplemental Phase (SP)|Withdrawal by Subject|0
1041349|NCT00098293|3384509|P1|Supplemental Phase (SP)|Withdrawal by Subject|0
1041350|NCT00098293|3384505|P5|Supplemental Phase (SP)|Lost to Follow-up|2
1041351|NCT00098293|3384506|P4|Supplemental Phase (SP)|Lost to Follow-up|0
1041352|NCT00098293|3384507|P3|Supplemental Phase (SP)|Lost to Follow-up|0
1041353|NCT00098293|3384508|P2|Supplemental Phase (SP)|Lost to Follow-up|0
1041354|NCT00098293|3384509|P1|Supplemental Phase (SP)|Lost to Follow-up|0
1041355|NCT00098293|3384505|P5|Supplemental Phase (SP)|Death|1
1041356|NCT00098293|3384506|P4|Supplemental Phase (SP)|Death|0
1041357|NCT00098293|3384507|P3|Supplemental Phase (SP)|Death|0
1041358|NCT00098293|3384508|P2|Supplemental Phase (SP)|Death|0
1041359|NCT00098293|3384509|P1|Supplemental Phase (SP)|Death|0
1041360|NCT00098293|3384505|P5|Open-label (OL) Phase|Death|0
1041361|NCT00098293|3384506|P4|Open-label (OL) Phase|Death|0
1041362|NCT00098293|3384507|P3|Open-label (OL) Phase|Death|3
1041363|NCT00098293|3384508|P2|Open-label (OL) Phase|Death|2
1041364|NCT00098293|3384509|P1|Open-label (OL) Phase|Death|0
1041365|NCT00098293|3384505|P5|Open-label (OL) Phase|Participant Defaulted|0
1041366|NCT00098293|3384506|P4|Open-label (OL) Phase|Participant Defaulted|20
1041367|NCT00098293|3384507|P3|Open-label (OL) Phase|Participant Defaulted|16
1041368|NCT00098293|3384508|P2|Open-label (OL) Phase|Participant Defaulted|6
1041369|NCT00098293|3384509|P1|Open-label (OL) Phase|Participant Defaulted|0
1041370|NCT00098293|3384505|P5|Open-label (OL) Phase|Protocol Violation|0
1041371|NCT00098293|3384506|P4|Open-label (OL) Phase|Protocol Violation|16
1041372|NCT00098293|3384507|P3|Open-label (OL) Phase|Protocol Violation|13
1041373|NCT00098293|3384508|P2|Open-label (OL) Phase|Protocol Violation|6
1041374|NCT00098293|3384509|P1|Open-label (OL) Phase|Protocol Violation|0
1041375|NCT00098293|3384505|P5|Open-label (OL) Phase|Pregnancy|0
1041376|NCT00098293|3384506|P4|Open-label (OL) Phase|Pregnancy|3
1041377|NCT00098293|3384507|P3|Open-label (OL) Phase|Pregnancy|0
1041378|NCT00098293|3384508|P2|Open-label (OL) Phase|Pregnancy|1
1041379|NCT00098293|3384509|P1|Open-label (OL) Phase|Pregnancy|0
1041380|NCT00098293|3384505|P5|Open-label (OL) Phase|Lack of Efficacy|0
1041381|NCT00098293|3384506|P4|Open-label (OL) Phase|Lack of Efficacy|20
1041382|NCT00098293|3384507|P3|Open-label (OL) Phase|Lack of Efficacy|2
1041383|NCT00098293|3384508|P2|Open-label (OL) Phase|Lack of Efficacy|7
1041384|NCT00098293|3384509|P1|Open-label (OL) Phase|Lack of Efficacy|0
1041385|NCT00098293|3384505|P5|Open-label (OL) Phase|Adverse Event|0
1041386|NCT00098293|3384506|P4|Open-label (OL) Phase|Adverse Event|6
1041387|NCT00098293|3384507|P3|Open-label (OL) Phase|Adverse Event|7
1041388|NCT00098293|3384508|P2|Open-label (OL) Phase|Adverse Event|3
1041389|NCT00098293|3384509|P1|Open-label (OL) Phase|Adverse Event|0
1041390|NCT00098293|3384505|P5|Between DB and OL Phase|Did Not Enter Open-label Phase|0
1041391|NCT00098293|3384506|P4|Between DB and OL Phase|Did Not Enter Open-label Phase|0
1041392|NCT00098293|3384507|P3|Between DB and OL Phase|Did Not Enter Open-label Phase|3
1041393|NCT00098293|3384508|P2|Between DB and OL Phase|Did Not Enter Open-label Phase|0
1041394|NCT00098293|3384509|P1|Between DB and OL Phase|Did Not Enter Open-label Phase|0
1041395|NCT00098293|3384505|P5|Double-blind (DB) Phase|Terminated by sponsor|0
1041396|NCT00098293|3384506|P4|Double-blind (DB) Phase|Terminated by sponsor|0
1041397|NCT00098293|3384507|P3|Double-blind (DB) Phase|Terminated by sponsor|0
1041398|NCT00098293|3384508|P2|Double-blind (DB) Phase|Terminated by sponsor|0
1041399|NCT00098293|3384509|P1|Double-blind (DB) Phase|Terminated by sponsor|135
1041400|NCT00098293|3384505|P5|Double-blind (DB) Phase|Protocol Violation|0
1041401|NCT00098293|3384506|P4|Double-blind (DB) Phase|Protocol Violation|0
1041402|NCT00098293|3384507|P3|Double-blind (DB) Phase|Protocol Violation|22
1041403|NCT00098293|3384508|P2|Double-blind (DB) Phase|Protocol Violation|18
1041404|NCT00098293|3384509|P1|Double-blind (DB) Phase|Protocol Violation|2
1041405|NCT00098293|3384505|P5|Double-blind (DB) Phase|Randomized, Not Treated|0
1041406|NCT00098293|3384506|P4|Double-blind (DB) Phase|Randomized, Not Treated|0
1041407|NCT00098293|3384507|P3|Double-blind (DB) Phase|Randomized, Not Treated|11
1041408|NCT00098293|3384508|P2|Double-blind (DB) Phase|Randomized, Not Treated|8
1041409|NCT00098293|3384509|P1|Double-blind (DB) Phase|Randomized, Not Treated|3
1041410|NCT00098293|3384505|P5|Double-blind (DB) Phase|Death|0
1041411|NCT00098293|3384506|P4|Double-blind (DB) Phase|Death|0
1041412|NCT00098293|3384507|P3|Double-blind (DB) Phase|Death|2
1041413|NCT00098293|3384508|P2|Double-blind (DB) Phase|Death|2
1041414|NCT00098293|3384509|P1|Double-blind (DB) Phase|Death|1
1041415|NCT00098293|3384505|P5|Double-blind (DB) Phase|Lack of Efficacy|0
1041416|NCT00098293|3384506|P4|Double-blind (DB) Phase|Lack of Efficacy|0
1041417|NCT00098293|3384507|P3|Double-blind (DB) Phase|Lack of Efficacy|30
1041418|NCT00098293|3384508|P2|Double-blind (DB) Phase|Lack of Efficacy|64
1041419|NCT00098293|3384509|P1|Double-blind (DB) Phase|Lack of Efficacy|11
1041420|NCT00098293|3384505|P5|Double-blind (DB) Phase|Participant Defaulted|0
1041421|NCT00098293|3384506|P4|Double-blind (DB) Phase|Participant Defaulted|0
1041422|NCT00098293|3384507|P3|Double-blind (DB) Phase|Participant Defaulted|36
1041423|NCT00098293|3384508|P2|Double-blind (DB) Phase|Participant Defaulted|40
1041424|NCT00098293|3384509|P1|Double-blind (DB) Phase|Participant Defaulted|11
1041425|NCT00098293|3384505|P5|Double-blind (DB) Phase|Pregnancy|0
1041426|NCT00098293|3384506|P4|Double-blind (DB) Phase|Pregnancy|0
1041427|NCT00098293|3384507|P3|Double-blind (DB) Phase|Pregnancy|9
1041428|NCT00098293|3384508|P2|Double-blind (DB) Phase|Pregnancy|7
1041429|NCT00098293|3384509|P1|Double-blind (DB) Phase|Pregnancy|0
1041430|NCT00098293|3384505|P5|Double-blind (DB) Phase|Adverse Event|0
1041431|NCT00098293|3384506|P4|Double-blind (DB) Phase|Adverse Event|0
1041432|NCT00098293|3384507|P3|Double-blind (DB) Phase|Adverse Event|60
1041433|NCT00098293|3384508|P2|Double-blind (DB) Phase|Adverse Event|27
1041434|NCT00098293|3384509|P1|Double-blind (DB) Phase|Adverse Event|14
1041435|NCT00098254|3384562|P1|Overall Study|Death|1
1041436|NCT00098254|3384562|P1|Overall Study|Adverse Event|2
1041437|NCT00098020|3384628|P1|Overall Study|Low epidermal growth factor receptor|1
1041438|NCT00098020|3384628|P1|Overall Study|Low urine PCR|1
1041439|NCT00098020|3384628|P1|Overall Study|elevated liver enzymes|1
1041440|NCT00098020|3384628|P1|Overall Study|Lost to Follow-up|1
1041441|NCT00098020|3384628|P1|Overall Study|Adverse Event|2
1041442|NCT00097981|3384635|P2|Overall Study|Other|13
1041443|NCT00097981|3384636|P1|Overall Study|Other|19
1041444|NCT00097981|3384635|P2|Overall Study|Transplant planned|27
1041445|NCT00097981|3384636|P1|Overall Study|Transplant planned|28
1041446|NCT00097981|3384635|P2|Overall Study|Disease Progression|2
1041447|NCT00097981|3384636|P1|Overall Study|Disease Progression|8
1041448|NCT00097981|3384635|P2|Overall Study|Physician Decision|1
1041449|NCT00097981|3384636|P1|Overall Study|Physician Decision|7
1041450|NCT00097981|3384635|P2|Overall Study|Death|4
1041451|NCT00097981|3384636|P1|Overall Study|Death|2
1041452|NCT00097981|3384635|P2|Overall Study|Protocol Violation|1
1041453|NCT00097981|3384636|P1|Overall Study|Protocol Violation|1
1041454|NCT00097981|3384635|P2|Overall Study|Withdrawal by Subject|8
1041455|NCT00097981|3384636|P1|Overall Study|Withdrawal by Subject|10
1041456|NCT00097981|3384635|P2|Overall Study|Adverse Event|44
1041457|NCT00097981|3384636|P1|Overall Study|Adverse Event|31
1041458|NCT00097786|3384658|P4|Overall Study|lost to follow-up for all-cause death|310
1041459|NCT00097786|3384659|P3|Overall Study|lost to follow-up for all-cause death|313
1041460|NCT00097786|3384660|P2|Overall Study|lost to follow-up for all-cause death|292
1041461|NCT00097786|3384661|P1|Overall Study|lost to follow-up for all-cause death|296
1041462|NCT00097773|3384683|P4|Overall Study|Other|0
1041463|NCT00097773|3384684|P3|Overall Study|Other|2
1041464|NCT00097773|3384685|P2|Overall Study|Other|0
1041465|NCT00097773|3384686|P1|Overall Study|Other|1
1041466|NCT00097773|3384683|P4|Overall Study|Adverse Event|0
1041467|NCT00097773|3384684|P3|Overall Study|Adverse Event|0
1041468|NCT00097773|3384685|P2|Overall Study|Adverse Event|1
1041469|NCT00097773|3384686|P1|Overall Study|Adverse Event|0
1041470|NCT00097773|3384683|P4|Overall Study|Withdrawal by Subject|1
1041471|NCT00097773|3384684|P3|Overall Study|Withdrawal by Subject|3
1041472|NCT00097773|3384685|P2|Overall Study|Withdrawal by Subject|3
1041473|NCT00097773|3384686|P1|Overall Study|Withdrawal by Subject|3
1041474|NCT00097773|3384683|P4|Overall Study|Physician Decision|1
1041475|NCT00097773|3384684|P3|Overall Study|Physician Decision|3
1041476|NCT00097773|3384685|P2|Overall Study|Physician Decision|2
1041477|NCT00097773|3384686|P1|Overall Study|Physician Decision|2
1041478|NCT00097773|3384683|P4|Overall Study|Lost to Follow-up|1
1041479|NCT00097773|3384684|P3|Overall Study|Lost to Follow-up|0
1041480|NCT00097773|3384685|P2|Overall Study|Lost to Follow-up|2
1041481|NCT00097773|3384686|P1|Overall Study|Lost to Follow-up|2
1041482|NCT00097721|3384706|P2|Overall Study|Reason not given|1
1041483|NCT00097721|3384707|P1|Overall Study|Reason not given|1
1041484|NCT00097721|3384706|P2|Overall Study|Physician Decision|3
1041485|NCT00097721|3384707|P1|Overall Study|Physician Decision|1
1041486|NCT00097721|3384706|P2|Overall Study|Progressive Disease|27
1041487|NCT00097721|3384707|P1|Overall Study|Progressive Disease|55
1041488|NCT00097721|3384706|P2|Overall Study|Withdrawal by Subject|1
1041489|NCT00097721|3384707|P1|Overall Study|Withdrawal by Subject|6
1041490|NCT00097721|3384706|P2|Overall Study|Adverse Event|1
1041491|NCT00097721|3384707|P1|Overall Study|Adverse Event|8
1041492|NCT00097591|3384757|P2|Overall Study|Other|3
1041493|NCT00097591|3384758|P1|Overall Study|Other|0
1041494|NCT00097591|3384757|P2|Overall Study|Lost to follow up|10
1041495|NCT00097591|3384758|P1|Overall Study|Lost to follow up|6
1041496|NCT00097591|3384757|P2|Overall Study|Unable to attend termination visit|51
1041497|NCT00097591|3384758|P1|Overall Study|Unable to attend termination visit|53
1041498|NCT00097591|3384757|P2|Overall Study|Less than 6 months on study drug|7
1041499|NCT00097591|3384758|P1|Overall Study|Less than 6 months on study drug|9
1041500|NCT00097591|3384757|P2|Overall Study|Withdrawal of consent|323
1041501|NCT00097591|3384758|P1|Overall Study|Withdrawal of consent|342
1041502|NCT00097539|3384781|P7|Overall Study|Reason not Specified|2
1041503|NCT00097539|3384782|P6|Overall Study|Reason not Specified|40
1041504|NCT00097539|3384783|P5|Overall Study|Reason not Specified|11
1041505|NCT00097539|3384784|P4|Overall Study|Reason not Specified|21
1041506|NCT00097539|3384785|P3|Overall Study|Reason not Specified|53
1041507|NCT00097539|3384786|P2|Overall Study|Reason not Specified|49
1041508|NCT00097539|3384787|P1|Overall Study|Reason not Specified|111
1041509|NCT00097539|3384781|P7|Overall Study|Reasons Other Than Above|34
1041510|NCT00097539|3384782|P6|Overall Study|Reasons Other Than Above|1244
1041511|NCT00097539|3384783|P5|Overall Study|Reasons Other Than Above|361
1041512|NCT00097539|3384784|P4|Overall Study|Reasons Other Than Above|692
1041513|NCT00097539|3384785|P3|Overall Study|Reasons Other Than Above|1757
1041514|NCT00097539|3384786|P2|Overall Study|Reasons Other Than Above|1382
1041515|NCT00097539|3384787|P1|Overall Study|Reasons Other Than Above|3602
1041516|NCT00097539|3384781|P7|Overall Study|Death|0
1041517|NCT00097539|3384782|P6|Overall Study|Death|3
1041518|NCT00097539|3384783|P5|Overall Study|Death|1
1041519|NCT00097539|3384784|P4|Overall Study|Death|0
1041520|NCT00097539|3384785|P3|Overall Study|Death|0
1041521|NCT00097539|3384786|P2|Overall Study|Death|7
1041522|NCT00097539|3384787|P1|Overall Study|Death|2
1041523|NCT00097539|3384781|P7|Overall Study|Adverse Event|1
1041524|NCT00097539|3384782|P6|Overall Study|Adverse Event|59
1041525|NCT00097539|3384783|P5|Overall Study|Adverse Event|30
1041526|NCT00097539|3384784|P4|Overall Study|Adverse Event|27
1041527|NCT00097539|3384785|P3|Overall Study|Adverse Event|37
1041528|NCT00097539|3384786|P2|Overall Study|Adverse Event|133
1041529|NCT00097539|3384787|P1|Overall Study|Adverse Event|78
1041530|NCT00097539|3384781|P7|Overall Study|Lack of Efficacy|5
1041531|NCT00097539|3384782|P6|Overall Study|Lack of Efficacy|228
1041532|NCT00097539|3384783|P5|Overall Study|Lack of Efficacy|45
1041533|NCT00097539|3384784|P4|Overall Study|Lack of Efficacy|105
1041534|NCT00097539|3384785|P3|Overall Study|Lack of Efficacy|202
1041535|NCT00097539|3384786|P2|Overall Study|Lack of Efficacy|122
1041536|NCT00097539|3384787|P1|Overall Study|Lack of Efficacy|249
1041537|NCT00097539|3384781|P7|Overall Study|Participant Non-compliant|18
1041538|NCT00097539|3384782|P6|Overall Study|Participant Non-compliant|543
1041539|NCT00097539|3384783|P5|Overall Study|Participant Non-compliant|136
1041540|NCT00097539|3384784|P4|Overall Study|Participant Non-compliant|353
1041541|NCT00097539|3384785|P3|Overall Study|Participant Non-compliant|1067
1041542|NCT00097539|3384786|P2|Overall Study|Participant Non-compliant|567
1041543|NCT00097539|3384787|P1|Overall Study|Participant Non-compliant|2140
1041544|NCT00097539|3384781|P7|Overall Study|Withdrawal by Subject|3
1041545|NCT00097539|3384782|P6|Overall Study|Withdrawal by Subject|229
1041546|NCT00097539|3384783|P5|Overall Study|Withdrawal by Subject|68
1041547|NCT00097539|3384784|P4|Overall Study|Withdrawal by Subject|217
1041548|NCT00097539|3384785|P3|Overall Study|Withdrawal by Subject|346
1041549|NCT00097539|3384786|P2|Overall Study|Withdrawal by Subject|323
1041550|NCT00097539|3384787|P1|Overall Study|Withdrawal by Subject|925
1041551|NCT00097539|3384781|P7|Overall Study|Status Unknown (Or no final evaluation)|108
1041552|NCT00097539|3384782|P6|Overall Study|Status Unknown (Or no final evaluation)|3546
1041553|NCT00097539|3384783|P5|Overall Study|Status Unknown (Or no final evaluation)|1106
1041554|NCT00097539|3384784|P4|Overall Study|Status Unknown (Or no final evaluation)|2170
1041555|NCT00097539|3384785|P3|Overall Study|Status Unknown (Or no final evaluation)|5646
1041556|NCT00097539|3384786|P2|Overall Study|Status Unknown (Or no final evaluation)|3948
1041557|NCT00097539|3384787|P1|Overall Study|Status Unknown (Or no final evaluation)|11959
1041558|NCT00097500|3384833|P2|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2
1041559|NCT00097500|3384834|P1|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3
1041560|NCT00097500|3384833|P2|Off-drug Period (Week 52 to Week 64)|Physician Decision|1
1041561|NCT00097500|3384834|P1|Off-drug Period (Week 52 to Week 64)|Physician Decision|0
1041562|NCT00097500|3384833|P2|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1
1041563|NCT00097500|3384834|P1|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2
1041564|NCT00097500|3384833|P2|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1
1041565|NCT00097500|3384834|P1|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0
1041566|NCT00097500|3384833|P2|On-drug Period (Week 0 to Week 52)|Physician Decision|1
1041567|NCT00097500|3384834|P1|On-drug Period (Week 0 to Week 52)|Physician Decision|0
1041568|NCT00097500|3384833|P2|On-drug Period (Week 0 to Week 52)|Adverse Event|0
1041569|NCT00097500|3384834|P1|On-drug Period (Week 0 to Week 52)|Adverse Event|5
1041570|NCT00097500|3384833|P2|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
1041571|NCT00097500|3384834|P1|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
1041572|NCT00097370|3384865|P1|Stage 3|Lost to Follow-up|1
1041573|NCT00097370|3384865|P1|Stage 3|Sponsor Terminated Study|52
1041574|NCT00097370|3384865|P1|Stage 3|Lack of Efficacy|1
1041575|NCT00097370|3384865|P1|Stage 3|Withdrawal by Subject|3
1041576|NCT00097370|3384865|P1|Stage 3|Adverse Event|2
1041577|NCT00097370|3384865|P1|Stage 2|Lost to Follow-up|1
1041578|NCT00097370|3384865|P1|Stage 2|Sponsor Terminated Study|2
1041579|NCT00097370|3384865|P1|Stage 2|Pregnancy|1
1041580|NCT00097370|3384865|P1|Stage 2|Lack of Efficacy|3
1041581|NCT00097370|3384865|P1|Stage 2|Withdrawal by Subject|1
1041582|NCT00097370|3384865|P1|Stage 2|Adverse Event|5
1041583|NCT00097370|3384865|P1|Stage 1|Lack of Efficacy|2
1041584|NCT00097370|3384865|P1|Stage 1|Withdrawal by Subject|1
1041585|NCT00097370|3384865|P1|Stage 1|Adverse Event|3
1041586|NCT00096993|3384899|P2|Overall Study|Other unspecified|1
1041587|NCT00096993|3384900|P1|Overall Study|Other unspecified|1
1041588|NCT00096993|3384899|P2|Overall Study|Non-compliance|1
1041589|NCT00096993|3384900|P1|Overall Study|Non-compliance|0
1041590|NCT00096993|3384899|P2|Overall Study|Physician Decision|1
1041591|NCT00096993|3384900|P1|Overall Study|Physician Decision|2
1041592|NCT00096993|3384899|P2|Overall Study|Subject's decision|1
1041593|NCT00096993|3384900|P1|Overall Study|Subject's decision|3
1041594|NCT00096993|3384899|P2|Overall Study|Adverse Event|8
1041595|NCT00096993|3384900|P1|Overall Study|Adverse Event|2
1041596|NCT00096993|3384899|P2|Overall Study|Disease progression|53
1041597|NCT00096993|3384900|P1|Overall Study|Disease progression|56
1041598|NCT00096993|3384899|P2|Overall Study|Death|0
1041599|NCT00096993|3384900|P1|Overall Study|Death|1
1041600|NCT00096954|3384916|P2|Overall Study|Lost to Follow-up|5
1041601|NCT00096954|3384917|P1|Overall Study|Lost to Follow-up|8
1041602|NCT00096954|3384916|P2|Overall Study|Non-compliance|3
1041603|NCT00096954|3384917|P1|Overall Study|Non-compliance|0
1041604|NCT00096954|3384916|P2|Overall Study|Initiation of immunotherapy|0
1041605|NCT00096954|3384917|P1|Overall Study|Initiation of immunotherapy|1
1041606|NCT00096954|3384916|P2|Overall Study|Pregnancy|1
1041607|NCT00096954|3384917|P1|Overall Study|Pregnancy|1
1041608|NCT00096954|3384916|P2|Overall Study|Sponsors Decision|1
1041609|NCT00096954|3384917|P1|Overall Study|Sponsors Decision|1
1041610|NCT00096954|3384916|P2|Overall Study|Physician Decision|1
1041611|NCT00096954|3384917|P1|Overall Study|Physician Decision|1
1041612|NCT00096954|3384916|P2|Overall Study|Withdrawal by Subject|8
1041613|NCT00096954|3384917|P1|Overall Study|Withdrawal by Subject|9
1041614|NCT00096954|3384916|P2|Overall Study|Adverse Event|1
1041615|NCT00096954|3384917|P1|Overall Study|Adverse Event|3
1041616|NCT00096941|3384929|P1|Overall Study|disease progression|3
1041617|NCT00096785|3384936|P2|Overall Study|Relocated|0
1041618|NCT00096785|3384937|P1|Overall Study|Relocated|1
1041619|NCT00096785|3384936|P2|Overall Study|Withdrawal by Subject|1
1041620|NCT00096785|3384937|P1|Overall Study|Withdrawal by Subject|0
1041621|NCT00096785|3384936|P2|Overall Study|Lost to Follow-up|0
1041622|NCT00096785|3384937|P1|Overall Study|Lost to Follow-up|1
1041623|NCT00096538|3384966|P1|Overall Study|Withdrawal by Subject|1
1041624|NCT00096486|3384974|P4|Overall Study|Not Treated|1
1041625|NCT00096486|3384975|P3|Overall Study|Not Treated|1
1041626|NCT00096486|3384976|P2|Overall Study|Not Treated|0
1041627|NCT00096486|3384977|P1|Overall Study|Not Treated|0
1041628|NCT00096486|3384974|P4|Overall Study|Withdrawal by Subject|1
1041629|NCT00096486|3384975|P3|Overall Study|Withdrawal by Subject|1
1041630|NCT00096486|3384976|P2|Overall Study|Withdrawal by Subject|0
1041631|NCT00096486|3384977|P1|Overall Study|Withdrawal by Subject|0
1041632|NCT00096447|3384996|P1|Overall Study|Never treated|1
1041633|NCT00096382|3385012|P2|Overall Study|Death during treatment|0
1041634|NCT00096382|3385013|P1|Overall Study|Death during treatment|1
1041635|NCT00096382|3385012|P2|Overall Study|Not treated|0
1041636|NCT00096382|3385013|P1|Overall Study|Not treated|1
1041637|NCT00096356|3385023|P2|Overall Study|multiple reasons|18
1041638|NCT00096356|3385024|P1|Overall Study|multiple reasons|10
1041639|NCT00096356|3385023|P2|Overall Study|Lack of Efficacy|0
1041640|NCT00096356|3385024|P1|Overall Study|Lack of Efficacy|1
1041641|NCT00096356|3385023|P2|Overall Study|Withdrawal by Subject|23
1041642|NCT00096356|3385024|P1|Overall Study|Withdrawal by Subject|17
1041643|NCT00096356|3385023|P2|Overall Study|Physician Decision|3
1041644|NCT00096356|3385024|P1|Overall Study|Physician Decision|5
1041645|NCT00096356|3385023|P2|Overall Study|Adverse Event|9
1041646|NCT00096356|3385024|P1|Overall Study|Adverse Event|11
1041647|NCT00096278|3385036|P2|Overall Study|Patient not at risk for primary endpoint|2
1041648|NCT00096278|3385037|P1|Overall Study|Patient not at risk for primary endpoint|3
1041649|NCT00096278|3385036|P2|Overall Study|No follow-up data|18
1041650|NCT00096278|3385037|P1|Overall Study|No follow-up data|15
1041651|NCT00096265|3385046|P3|Overall Study|Ineligible|0
1041652|NCT00096265|3385047|P2|Overall Study|Ineligible|0
1041653|NCT00096265|3385048|P1|Overall Study|Ineligible|1
1041654|NCT00096226|3385074|P1|Overall Study|Surgery but inadequate nodal sampling|1
1041655|NCT00096226|3385074|P1|Overall Study|Surgical restaging not performed|13
1041656|NCT00096226|3385074|P1|Overall Study|Protocol treatment not started|1
1041657|NCT00096226|3385074|P1|Overall Study|Ineligible|2
1041658|NCT00096200|3385081|P3|Overall Study|Ineligible pathology|0
1041659|NCT00096200|3385082|P2|Overall Study|Ineligible pathology|1
1041660|NCT00096200|3385083|P1|Overall Study|Ineligible pathology|0
1041661|NCT00096200|3385081|P3|Overall Study|Withdrawal by Subject|0
1041662|NCT00096200|3385082|P2|Overall Study|Withdrawal by Subject|2
1041663|NCT00096200|3385083|P1|Overall Study|Withdrawal by Subject|1
1041664|NCT00096200|3385081|P3|Overall Study|Adverse Event|0
1041665|NCT00096200|3385082|P2|Overall Study|Adverse Event|4
1041666|NCT00096200|3385083|P1|Overall Study|Adverse Event|0
1041667|NCT00096174|3385097|P1|Overall Study|other reason|8
1041668|NCT00096174|3385097|P1|Overall Study|Ineligible|6
1041669|NCT00096174|3385097|P1|Overall Study|Not started protocol therapy|3
1041670|NCT00096174|3385097|P1|Overall Study|Withdrawal by Subject|15
1041671|NCT00096174|3385097|P1|Overall Study|Death|6
1041672|NCT00096174|3385097|P1|Overall Study|Adverse Event|15
1041673|NCT00096174|3385097|P1|Overall Study|Lack of Efficacy|9
1041674|NCT00096135|3385142|P2|Overall Study|Ineligible|0
1041675|NCT00096135|3385143|P1|Overall Study|Ineligible|2
1041676|NCT00096135|3385142|P2|Overall Study|Other, specify|3
1041677|NCT00096135|3385143|P1|Overall Study|Other, specify|15
1041678|NCT00096135|3385142|P2|Overall Study|Progressive disease, Marrow,CNS, Relapse|7
1041679|NCT00096135|3385143|P1|Overall Study|Progressive disease, Marrow,CNS, Relapse|22
1041680|NCT00096135|3385142|P2|Overall Study|Refusal of further protocol therapy|1
1041681|NCT00096135|3385143|P1|Overall Study|Refusal of further protocol therapy|4
1041682|NCT00096135|3385142|P2|Overall Study|Physician Decision|4
1041683|NCT00096135|3385143|P1|Overall Study|Physician Decision|20
1041684|NCT00096044|3385159|P1|Overall Study|Disease Progression|4
1041685|NCT00096044|3385159|P1|Overall Study|Adverse Event|21
1041686|NCT00096044|3385159|P1|Overall Study|Withdrawal by Subject|9
1041687|NCT00096031|3385168|P1|Overall Study|Not protocol specified|5
1041688|NCT00096031|3385168|P1|Overall Study|Ineligible|8
1041689|NCT00096031|3385168|P1|Overall Study|Withdrawal by Subject|1
1041690|NCT00096031|3385168|P1|Overall Study|Death|4
1041691|NCT00096031|3385168|P1|Overall Study|Lack of Efficacy|42
1041692|NCT00096031|3385168|P1|Overall Study|Adverse Event|3
1041693|NCT00096018|3385176|P2|Overall Study|Miscellaneous|1
1041694|NCT00096018|3385177|P1|Overall Study|Miscellaneous|2
1041695|NCT00096018|3385176|P2|Overall Study|Withdrawal by Subject|2
1041696|NCT00096018|3385177|P1|Overall Study|Withdrawal by Subject|0
1041697|NCT00096018|3385176|P2|Overall Study|Death|1
1041698|NCT00096018|3385177|P1|Overall Study|Death|0
1041699|NCT00096018|3385176|P2|Overall Study|Adverse Event|5
1041700|NCT00096018|3385177|P1|Overall Study|Adverse Event|0
1041701|NCT00096018|3385176|P2|Overall Study|Miscellaneous (not treated)|2
1041702|NCT00096018|3385177|P1|Overall Study|Miscellaneous (not treated)|0
1041703|NCT00096018|3385176|P2|Overall Study|Became Ineligible (not treated)|3
1041704|NCT00096018|3385177|P1|Overall Study|Became Ineligible (not treated)|0
1041705|NCT00095979|3385185|P1|Overall Study|Ineligible: Second primary cancer site|2
1041706|NCT00095940|3385203|P9|Lapatinib Continuation/Phase II|Adverse Event|0
1041707|NCT00095940|3385204|P8|Lapatinib Continuation/Phase II|Adverse Event|1
1041708|NCT00095940|3385205|P7|Lapatinib Continuation/Phase II|Adverse Event|0
1041709|NCT00095940|3385206|P6|Lapatinib Continuation/Phase II|Adverse Event|0
1041710|NCT00095940|3385207|P5|Lapatinib Continuation/Phase II|Adverse Event|0
1041711|NCT00095940|3385208|P4|Lapatinib Continuation/Phase II|Adverse Event|0
1041712|NCT00095940|3385209|P3|Lapatinib Continuation/Phase II|Adverse Event|0
1041713|NCT00095940|3385210|P2|Lapatinib Continuation/Phase II|Adverse Event|0
1041714|NCT00095940|3385211|P1|Lapatinib Continuation/Phase II|Adverse Event|0
1041715|NCT00095940|3385203|P9|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
1041716|NCT00095940|3385204|P8|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
1041717|NCT00095940|3385205|P7|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
1041718|NCT00095940|3385206|P6|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
1041719|NCT00095940|3385207|P5|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
1041720|NCT00095940|3385208|P4|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
1041721|NCT00095940|3385209|P3|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
1041722|NCT00095940|3385210|P2|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
1041723|NCT00095940|3385211|P1|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
1041724|NCT00095940|3385203|P9|Lapatinib Continuation/Phase II|Disease Progression|12
1041725|NCT00095940|3385204|P8|Lapatinib Continuation/Phase II|Disease Progression|1
1041726|NCT00095940|3385205|P7|Lapatinib Continuation/Phase II|Disease Progression|2
1041727|NCT00095940|3385206|P6|Lapatinib Continuation/Phase II|Disease Progression|13
1041728|NCT00095940|3385207|P5|Lapatinib Continuation/Phase II|Disease Progression|0
1041729|NCT00095940|3385208|P4|Lapatinib Continuation/Phase II|Disease Progression|0
1041730|NCT00095940|3385209|P3|Lapatinib Continuation/Phase II|Disease Progression|15
1041731|NCT00095940|3385210|P2|Lapatinib Continuation/Phase II|Disease Progression|1
1041732|NCT00095940|3385211|P1|Lapatinib Continuation/Phase II|Disease Progression|1
1041733|NCT00095836|3385244|P1|Overall Study|Death|2
1041734|NCT00095836|3385244|P1|Overall Study|Adverse Event|1
1041735|NCT00095836|3385244|P1|Overall Study|Lost to Follow-up|1
1041736|NCT00095628|3385274|P1|Overall Study|Disease progression prior to treatment|1
1041737|NCT00095576|3385285|P2|Overall Study|Subject moved|36
1041738|NCT00095576|3385286|P1|Overall Study|Subject moved|30
1041739|NCT00095576|3385285|P2|Overall Study|Site terminated|67
1041740|NCT00095576|3385286|P1|Overall Study|Site terminated|75
1041741|NCT00095576|3385285|P2|Overall Study|Option to switch to a rollover study|1099
1041742|NCT00095576|3385286|P1|Overall Study|Option to switch to a rollover study|1097
1041743|NCT00095576|3385285|P2|Overall Study|Withdrawal by Subject|47
1041744|NCT00095576|3385286|P1|Overall Study|Withdrawal by Subject|34
1041745|NCT00095576|3385285|P2|Overall Study|Protocol Violation|0
1041746|NCT00095576|3385286|P1|Overall Study|Protocol Violation|1
1041747|NCT00095576|3385285|P2|Overall Study|Lost to Follow-up|229
1041748|NCT00095576|3385286|P1|Overall Study|Lost to Follow-up|233
1041749|NCT00095576|3385285|P2|Overall Study|Adverse Event|3
1041750|NCT00095576|3385286|P1|Overall Study|Adverse Event|5
1041751|NCT00095498|3385310|P3|Overall Study|Requirement for alternative therapy|2
1041752|NCT00095498|3385311|P2|Overall Study|Requirement for alternative therapy|0
1041753|NCT00095498|3385312|P1|Overall Study|Requirement for alternative therapy|1
1041754|NCT00095498|3385310|P3|Overall Study|Protocol Violation|1
1041755|NCT00095498|3385311|P2|Overall Study|Protocol Violation|0
1041756|NCT00095498|3385312|P1|Overall Study|Protocol Violation|0
1041757|NCT00095498|3385310|P3|Overall Study|Other|6
1041758|NCT00095498|3385311|P2|Overall Study|Other|7
1041759|NCT00095498|3385312|P1|Overall Study|Other|6
1041760|NCT00095498|3385310|P3|Overall Study|Noncompliance|1
1041761|NCT00095498|3385311|P2|Overall Study|Noncompliance|0
1041762|NCT00095498|3385312|P1|Overall Study|Noncompliance|1
1041763|NCT00095498|3385310|P3|Overall Study|Lost to Follow-up|2
1041764|NCT00095498|3385311|P2|Overall Study|Lost to Follow-up|1
1041765|NCT00095498|3385312|P1|Overall Study|Lost to Follow-up|1
1041766|NCT00095498|3385310|P3|Overall Study|Ineligibility determined|2
1041767|NCT00095498|3385311|P2|Overall Study|Ineligibility determined|0
1041768|NCT00095498|3385312|P1|Overall Study|Ineligibility determined|3
1041769|NCT00095498|3385310|P3|Overall Study|Disease progression|1
1041770|NCT00095498|3385311|P2|Overall Study|Disease progression|1
1041771|NCT00095498|3385312|P1|Overall Study|Disease progression|0
1041772|NCT00095498|3385310|P3|Overall Study|Withdrawal by Subject|15
1041773|NCT00095498|3385311|P2|Overall Study|Withdrawal by Subject|16
1041774|NCT00095498|3385312|P1|Overall Study|Withdrawal by Subject|15
1041775|NCT00095498|3385310|P3|Overall Study|Adverse Event|1
1041776|NCT00095498|3385311|P2|Overall Study|Adverse Event|0
1041777|NCT00095498|3385312|P1|Overall Study|Adverse Event|1
1041778|NCT00095498|3385310|P3|Overall Study|Physician Decision|8
1041779|NCT00095498|3385311|P2|Overall Study|Physician Decision|10
1041780|NCT00095498|3385312|P1|Overall Study|Physician Decision|9
1041781|NCT00095303|3385739|P2|Follow Up Study|Lost to Follow-up|58
1041782|NCT00095303|3385740|P1|Follow Up Study|Lost to Follow-up|59
1041783|NCT00095303|3385739|P2|Main Study|Lost to Follow-up|87
1041784|NCT00095303|3385740|P1|Main Study|Lost to Follow-up|91
1041785|NCT00095238|3385808|P2|Overall Study|Other Reasons|88
1041786|NCT00095238|3385809|P1|Overall Study|Other Reasons|87
1041787|NCT00095238|3385808|P2|Overall Study|Missing|0
1041788|NCT00095238|3385809|P1|Overall Study|Missing|1
1041789|NCT00095238|3385808|P2|Overall Study|Study terminated by sponsor|1
1041790|NCT00095238|3385809|P1|Overall Study|Study terminated by sponsor|0
1041791|NCT00095238|3385808|P2|Overall Study|No longer met study criteria|5
1041792|NCT00095238|3385809|P1|Overall Study|No longer met study criteria|4
1041793|NCT00095238|3385808|P2|Overall Study|Noncompliance|45
1041794|NCT00095238|3385809|P1|Overall Study|Noncompliance|44
1041795|NCT00095238|3385808|P2|Overall Study|Lost to Follow-up|24
1041796|NCT00095238|3385809|P1|Overall Study|Lost to Follow-up|19
1041797|NCT00095238|3385808|P2|Overall Study|Death|170
1041798|NCT00095238|3385809|P1|Overall Study|Death|154
1041799|NCT00095238|3385808|P2|Overall Study|Subject Withdrew Consent|223
1041800|NCT00095238|3385809|P1|Overall Study|Subject Withdrew Consent|208
1041801|NCT00095238|3385808|P2|Overall Study|Adverse Event|287
1041802|NCT00095238|3385809|P1|Overall Study|Adverse Event|331
1041803|NCT00095238|3385808|P2|Overall Study|Lack of Efficacy|9
1041804|NCT00095238|3385809|P1|Overall Study|Lack of Efficacy|9
1041805|NCT00095212|3385871|P2|Overall Study|Withdrawal by Subject|3
1041806|NCT00095212|3385872|P1|Overall Study|Withdrawal by Subject|1
1041807|NCT00095199|3385902|P4|Overall Study|Data inadvertently lost by site|0
1041808|NCT00095199|3385903|P3|Overall Study|Data inadvertently lost by site|0
1041809|NCT00095199|3385904|P2|Overall Study|Data inadvertently lost by site|0
1041810|NCT00095199|3385905|P1|Overall Study|Data inadvertently lost by site|1
1041811|NCT00095199|3385902|P4|Overall Study|Primary tumor removed in other surgery|0
1041812|NCT00095199|3385903|P3|Overall Study|Primary tumor removed in other surgery|0
1041813|NCT00095199|3385904|P2|Overall Study|Primary tumor removed in other surgery|1
1041814|NCT00095199|3385905|P1|Overall Study|Primary tumor removed in other surgery|0
1041815|NCT00095199|3385902|P4|Overall Study|Started radiotherapy regimen|0
1041816|NCT00095199|3385903|P3|Overall Study|Started radiotherapy regimen|0
1041817|NCT00095199|3385904|P2|Overall Study|Started radiotherapy regimen|1
1041818|NCT00095199|3385905|P1|Overall Study|Started radiotherapy regimen|0
1041819|NCT00095199|3385902|P4|Overall Study|Started Palliative Radiotherapy|0
1041820|NCT00095199|3385903|P3|Overall Study|Started Palliative Radiotherapy|0
1041821|NCT00095199|3385904|P2|Overall Study|Started Palliative Radiotherapy|0
1041822|NCT00095199|3385905|P1|Overall Study|Started Palliative Radiotherapy|1
1041823|NCT00095199|3385902|P4|Overall Study|Not eligible|1
1041824|NCT00095199|3385903|P3|Overall Study|Not eligible|0
1041825|NCT00095199|3385904|P2|Overall Study|Not eligible|7
1041826|NCT00095199|3385905|P1|Overall Study|Not eligible|1
1041827|NCT00095199|3385902|P4|Overall Study|Physician Decision|1
1041828|NCT00095199|3385903|P3|Overall Study|Physician Decision|1
1041829|NCT00095199|3385904|P2|Overall Study|Physician Decision|6
1041830|NCT00095199|3385905|P1|Overall Study|Physician Decision|5
1041831|NCT00095199|3385902|P4|Overall Study|Surgery needed could not start in 7 days|0
1041832|NCT00095199|3385903|P3|Overall Study|Surgery needed could not start in 7 days|1
1041833|NCT00095199|3385904|P2|Overall Study|Surgery needed could not start in 7 days|0
1041834|NCT00095199|3385905|P1|Overall Study|Surgery needed could not start in 7 days|0
1041835|NCT00095199|3385902|P4|Overall Study|Liver function test results elevated|1
1041836|NCT00095199|3385903|P3|Overall Study|Liver function test results elevated|1
1041837|NCT00095199|3385904|P2|Overall Study|Liver function test results elevated|0
1041838|NCT00095199|3385905|P1|Overall Study|Liver function test results elevated|0
1041839|NCT00095199|3385902|P4|Overall Study|Protocol Violation|0
1041840|NCT00095199|3385903|P3|Overall Study|Protocol Violation|2
1041841|NCT00095199|3385904|P2|Overall Study|Protocol Violation|4
1041842|NCT00095199|3385905|P1|Overall Study|Protocol Violation|4
1041843|NCT00095199|3385902|P4|Overall Study|Withdrawal by Subject|22
1041844|NCT00095199|3385903|P3|Overall Study|Withdrawal by Subject|13
1041845|NCT00095199|3385904|P2|Overall Study|Withdrawal by Subject|16
1041846|NCT00095199|3385905|P1|Overall Study|Withdrawal by Subject|21
1041847|NCT00095199|3385902|P4|Overall Study|Death|9
1041848|NCT00095199|3385903|P3|Overall Study|Death|11
1041849|NCT00095199|3385904|P2|Overall Study|Death|6
1041850|NCT00095199|3385905|P1|Overall Study|Death|10
1041851|NCT00095199|3385902|P4|Overall Study|Progressive disease|98
1041852|NCT00095199|3385903|P3|Overall Study|Progressive disease|105
1041853|NCT00095199|3385904|P2|Overall Study|Progressive disease|179
1041854|NCT00095199|3385905|P1|Overall Study|Progressive disease|213
1041855|NCT00095199|3385902|P4|Overall Study|Adverse Event|11
1041856|NCT00095199|3385903|P3|Overall Study|Adverse Event|26
1041857|NCT00095199|3385904|P2|Overall Study|Adverse Event|22
1041858|NCT00095199|3385905|P1|Overall Study|Adverse Event|40
1041859|NCT00095173|3385943|P6|Open-Label Extension Phase (Period C)|Not Specified|8
1041860|NCT00095173|3385944|P5|Open-Label Extension Phase (Period C)|Not Specified|6
1041861|NCT00095173|3385945|P4|Open-Label Extension Phase (Period C)|Not Specified|4
1041862|NCT00095173|3385946|P3|Open-Label Extension Phase (Period C)|Not Specified|0
1041863|NCT00095173|3385947|P2|Open-Label Extension Phase (Period C)|Not Specified|0
1041864|NCT00095173|3385948|P1|Open-Label Extension Phase (Period C)|Not Specified|0
1041865|NCT00095173|3385943|P6|Open-Label Extension Phase (Period C)|Pregnancy|3
1041866|NCT00095173|3385944|P5|Open-Label Extension Phase (Period C)|Pregnancy|2
1041867|NCT00095173|3385945|P4|Open-Label Extension Phase (Period C)|Pregnancy|1
1041868|NCT00095173|3385946|P3|Open-Label Extension Phase (Period C)|Pregnancy|0
1041869|NCT00095173|3385947|P2|Open-Label Extension Phase (Period C)|Pregnancy|0
1041870|NCT00095173|3385948|P1|Open-Label Extension Phase (Period C)|Pregnancy|0
1041871|NCT00095173|3385943|P6|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
1041872|NCT00095173|3385944|P5|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
1041873|NCT00095173|3385945|P4|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
1041874|NCT00095173|3385946|P3|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
1041875|NCT00095173|3385947|P2|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
1041876|NCT00095173|3385948|P1|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
1041877|NCT00095173|3385943|P6|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
1041878|NCT00095173|3385944|P5|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
1041879|NCT00095173|3385945|P4|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
1041880|NCT00095173|3385946|P3|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
1041881|NCT00095173|3385947|P2|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
1041882|NCT00095173|3385948|P1|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
1041883|NCT00095173|3385943|P6|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
1041884|NCT00095173|3385944|P5|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6
1041885|NCT00095173|3385945|P4|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4
1041886|NCT00095173|3385946|P3|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
1041887|NCT00095173|3385947|P2|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
1041888|NCT00095173|3385948|P1|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
1041889|NCT00095173|3385943|P6|Open-Label Extension Phase (Period C)|Lost to Follow-up|6
1041890|NCT00095173|3385944|P5|Open-Label Extension Phase (Period C)|Lost to Follow-up|5
1041891|NCT00095173|3385945|P4|Open-Label Extension Phase (Period C)|Lost to Follow-up|2
1041892|NCT00095173|3385946|P3|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
1041893|NCT00095173|3385947|P2|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
1041894|NCT00095173|3385948|P1|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
1041895|NCT00095173|3385943|P6|Open-Label Extension Phase (Period C)|Lack of Efficacy|8
1041896|NCT00095173|3385944|P5|Open-Label Extension Phase (Period C)|Lack of Efficacy|5
1041897|NCT00095173|3385945|P4|Open-Label Extension Phase (Period C)|Lack of Efficacy|11
1041898|NCT00095173|3385946|P3|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
1041899|NCT00095173|3385947|P2|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
1041900|NCT00095173|3385948|P1|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
1041901|NCT00095173|3385943|P6|Open-Label Extension Phase (Period C)|Adverse Event|3
1041902|NCT00095173|3385944|P5|Open-Label Extension Phase (Period C)|Adverse Event|2
1041903|NCT00095173|3385945|P4|Open-Label Extension Phase (Period C)|Adverse Event|1
1041904|NCT00095173|3385946|P3|Open-Label Extension Phase (Period C)|Adverse Event|0
1041905|NCT00095173|3385947|P2|Open-Label Extension Phase (Period C)|Adverse Event|0
1041906|NCT00095173|3385948|P1|Open-Label Extension Phase (Period C)|Adverse Event|0
1041907|NCT00095173|3385943|P6|Open-Label Extension Phase (Period C)|Death|1
1041908|NCT00095173|3385944|P5|Open-Label Extension Phase (Period C)|Death|0
1041909|NCT00095173|3385945|P4|Open-Label Extension Phase (Period C)|Death|0
1041910|NCT00095173|3385946|P3|Open-Label Extension Phase (Period C)|Death|0
1041911|NCT00095173|3385947|P2|Open-Label Extension Phase (Period C)|Death|0
1041912|NCT00095173|3385948|P1|Open-Label Extension Phase (Period C)|Death|0
1041913|NCT00095173|3385943|P6|Double-Blind Phase (Period B)|Withdrawal by Subject|0
1041914|NCT00095173|3385944|P5|Double-Blind Phase (Period B)|Withdrawal by Subject|0
1041915|NCT00095173|3385945|P4|Double-Blind Phase (Period B)|Withdrawal by Subject|0
1041916|NCT00095173|3385946|P3|Double-Blind Phase (Period B)|Withdrawal by Subject|0
1041917|NCT00095173|3385947|P2|Double-Blind Phase (Period B)|Withdrawal by Subject|1
1041918|NCT00095173|3385948|P1|Double-Blind Phase (Period B)|Withdrawal by Subject|0
1041919|NCT00095173|3385943|P6|Double-Blind Phase (Period B)|Lack of Efficacy|0
1041920|NCT00095173|3385944|P5|Double-Blind Phase (Period B)|Lack of Efficacy|0
1041921|NCT00095173|3385945|P4|Double-Blind Phase (Period B)|Lack of Efficacy|0
1041922|NCT00095173|3385946|P3|Double-Blind Phase (Period B)|Lack of Efficacy|31
1041923|NCT00095173|3385947|P2|Double-Blind Phase (Period B)|Lack of Efficacy|10
1041924|NCT00095173|3385948|P1|Double-Blind Phase (Period B)|Lack of Efficacy|0
1041925|NCT00095173|3385943|P6|Open-Label Lead-In Phase (Period A)|Not specified|0
1041926|NCT00095173|3385944|P5|Open-Label Lead-In Phase (Period A)|Not specified|0
1041927|NCT00095173|3385945|P4|Open-Label Lead-In Phase (Period A)|Not specified|0
1041928|NCT00095173|3385946|P3|Open-Label Lead-In Phase (Period A)|Not specified|0
1041929|NCT00095173|3385947|P2|Open-Label Lead-In Phase (Period A)|Not specified|0
1041930|NCT00095173|3385948|P1|Open-Label Lead-In Phase (Period A)|Not specified|1
1041931|NCT00095173|3385943|P6|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
1041932|NCT00095173|3385944|P5|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
1041933|NCT00095173|3385945|P4|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
1041934|NCT00095173|3385946|P3|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
1041935|NCT00095173|3385947|P2|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
1041936|NCT00095173|3385948|P1|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1
1041937|NCT00095173|3385943|P6|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
1041938|NCT00095173|3385944|P5|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
1041939|NCT00095173|3385945|P4|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
1041940|NCT00095173|3385946|P3|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
1041941|NCT00095173|3385947|P2|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
1042019|NCT00095147|3385986|P5|Double-blind Period 1 (Days 1-197)|Pregnancy|0
1041942|NCT00095173|3385948|P1|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17
1041943|NCT00095173|3385943|P6|Open-Label Lead-In Phase (Period A)|Adverse Event|0
1041944|NCT00095173|3385944|P5|Open-Label Lead-In Phase (Period A)|Adverse Event|0
1041945|NCT00095173|3385945|P4|Open-Label Lead-In Phase (Period A)|Adverse Event|0
1041946|NCT00095173|3385946|P3|Open-Label Lead-In Phase (Period A)|Adverse Event|0
1041947|NCT00095173|3385947|P2|Open-Label Lead-In Phase (Period A)|Adverse Event|0
1041948|NCT00095173|3385948|P1|Open-Label Lead-In Phase (Period A)|Adverse Event|1
1041949|NCT00095147|3385986|P5|Long-term Extension Period|Leaving country|1
1041950|NCT00095147|3385987|P4|Long-term Extension Period|Leaving country|0
1041951|NCT00095147|3385988|P3|Long-term Extension Period|Leaving country|0
1041952|NCT00095147|3385989|P2|Long-term Extension Period|Leaving country|0
1041953|NCT00095147|3385990|P1|Long-term Extension Period|Leaving country|0
1041954|NCT00095147|3385986|P5|Long-term Extension Period|Participant chose to use Revellex|1
1041955|NCT00095147|3385987|P4|Long-term Extension Period|Participant chose to use Revellex|0
1041956|NCT00095147|3385988|P3|Long-term Extension Period|Participant chose to use Revellex|0
1041957|NCT00095147|3385989|P2|Long-term Extension Period|Participant chose to use Revellex|0
1041958|NCT00095147|3385990|P1|Long-term Extension Period|Participant chose to use Revellex|0
1041959|NCT00095147|3385986|P5|Long-term Extension Period|No longer meets study criteria|1
1041960|NCT00095147|3385987|P4|Long-term Extension Period|No longer meets study criteria|0
1041961|NCT00095147|3385988|P3|Long-term Extension Period|No longer meets study criteria|0
1041962|NCT00095147|3385989|P2|Long-term Extension Period|No longer meets study criteria|0
1041963|NCT00095147|3385990|P1|Long-term Extension Period|No longer meets study criteria|0
1041964|NCT00095147|3385986|P5|Long-term Extension Period|Pregnancy|1
1041965|NCT00095147|3385987|P4|Long-term Extension Period|Pregnancy|0
1041966|NCT00095147|3385988|P3|Long-term Extension Period|Pregnancy|0
1041967|NCT00095147|3385989|P2|Long-term Extension Period|Pregnancy|0
1041968|NCT00095147|3385990|P1|Long-term Extension Period|Pregnancy|0
1041969|NCT00095147|3385986|P5|Long-term Extension Period|Withdrawal of consent|12
1041970|NCT00095147|3385987|P4|Long-term Extension Period|Withdrawal of consent|0
1041971|NCT00095147|3385988|P3|Long-term Extension Period|Withdrawal of consent|0
1041972|NCT00095147|3385989|P2|Long-term Extension Period|Withdrawal of consent|0
1041973|NCT00095147|3385990|P1|Long-term Extension Period|Withdrawal of consent|0
1041974|NCT00095147|3385986|P5|Long-term Extension Period|Lost to Follow-up|6
1041975|NCT00095147|3385987|P4|Long-term Extension Period|Lost to Follow-up|0
1041976|NCT00095147|3385988|P3|Long-term Extension Period|Lost to Follow-up|0
1041977|NCT00095147|3385989|P2|Long-term Extension Period|Lost to Follow-up|0
1041978|NCT00095147|3385990|P1|Long-term Extension Period|Lost to Follow-up|0
1041979|NCT00095147|3385986|P5|Long-term Extension Period|Lack of Efficacy|9
1041980|NCT00095147|3385987|P4|Long-term Extension Period|Lack of Efficacy|0
1041981|NCT00095147|3385988|P3|Long-term Extension Period|Lack of Efficacy|0
1041982|NCT00095147|3385989|P2|Long-term Extension Period|Lack of Efficacy|0
1041983|NCT00095147|3385990|P1|Long-term Extension Period|Lack of Efficacy|0
1041984|NCT00095147|3385986|P5|Long-term Extension Period|Adverse Event|11
1041985|NCT00095147|3385987|P4|Long-term Extension Period|Adverse Event|0
1041986|NCT00095147|3385988|P3|Long-term Extension Period|Adverse Event|0
1041987|NCT00095147|3385989|P2|Long-term Extension Period|Adverse Event|0
1041988|NCT00095147|3385990|P1|Long-term Extension Period|Adverse Event|0
1041989|NCT00095147|3385986|P5|Long-term Extension Period|Death|3
1041990|NCT00095147|3385987|P4|Long-term Extension Period|Death|0
1041991|NCT00095147|3385988|P3|Long-term Extension Period|Death|0
1041992|NCT00095147|3385989|P2|Long-term Extension Period|Death|0
1041993|NCT00095147|3385990|P1|Long-term Extension Period|Death|0
1041994|NCT00095147|3385986|P5|Double-blind Period 2 (Days 198-365)|Participant relocation|0
1041995|NCT00095147|3385987|P4|Double-blind Period 2 (Days 198-365)|Participant relocation|1
1041996|NCT00095147|3385988|P3|Double-blind Period 2 (Days 198-365)|Participant relocation|0
1041997|NCT00095147|3385989|P2|Double-blind Period 2 (Days 198-365)|Participant relocation|0
1041998|NCT00095147|3385990|P1|Double-blind Period 2 (Days 198-365)|Participant relocation|1
1041999|NCT00095147|3385986|P5|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
1042000|NCT00095147|3385987|P4|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
1042001|NCT00095147|3385988|P3|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
1042002|NCT00095147|3385989|P2|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2
1042003|NCT00095147|3385990|P1|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3
1042004|NCT00095147|3385986|P5|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
1042005|NCT00095147|3385987|P4|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1
1042006|NCT00095147|3385988|P3|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
1042007|NCT00095147|3385989|P2|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4
1042008|NCT00095147|3385990|P1|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2
1042009|NCT00095147|3385986|P5|Double-blind Period 2 (Days 198-365)|Adverse Event|0
1042010|NCT00095147|3385987|P4|Double-blind Period 2 (Days 198-365)|Adverse Event|0
1042011|NCT00095147|3385988|P3|Double-blind Period 2 (Days 198-365)|Adverse Event|0
1042012|NCT00095147|3385989|P2|Double-blind Period 2 (Days 198-365)|Adverse Event|4
1042013|NCT00095147|3385990|P1|Double-blind Period 2 (Days 198-365)|Adverse Event|2
1042014|NCT00095147|3385986|P5|Double-blind Period 2 (Days 198-365)|Death|0
1042015|NCT00095147|3385987|P4|Double-blind Period 2 (Days 198-365)|Death|1
1042016|NCT00095147|3385988|P3|Double-blind Period 2 (Days 198-365)|Death|0
1042017|NCT00095147|3385989|P2|Double-blind Period 2 (Days 198-365)|Death|1
1042018|NCT00095147|3385990|P1|Double-blind Period 2 (Days 198-365)|Death|0
1042020|NCT00095147|3385987|P4|Double-blind Period 1 (Days 1-197)|Pregnancy|0
1042021|NCT00095147|3385988|P3|Double-blind Period 1 (Days 1-197)|Pregnancy|0
1042022|NCT00095147|3385989|P2|Double-blind Period 1 (Days 1-197)|Pregnancy|1
1042023|NCT00095147|3385990|P1|Double-blind Period 1 (Days 1-197)|Pregnancy|1
1042024|NCT00095147|3385986|P5|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
1042025|NCT00095147|3385987|P4|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
1042026|NCT00095147|3385988|P3|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
1042027|NCT00095147|3385989|P2|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
1042028|NCT00095147|3385990|P1|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
1042029|NCT00095147|3385986|P5|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
1042030|NCT00095147|3385987|P4|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
1042031|NCT00095147|3385988|P3|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
1042032|NCT00095147|3385989|P2|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
1042033|NCT00095147|3385990|P1|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
1042034|NCT00095147|3385986|P5|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
1042035|NCT00095147|3385987|P4|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
1042036|NCT00095147|3385988|P3|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1
1042037|NCT00095147|3385989|P2|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
1042038|NCT00095147|3385990|P1|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
1042039|NCT00095147|3385986|P5|Double-blind Period 1 (Days 1-197)|Adverse Event|0
1042040|NCT00095147|3385987|P4|Double-blind Period 1 (Days 1-197)|Adverse Event|0
1042041|NCT00095147|3385988|P3|Double-blind Period 1 (Days 1-197)|Adverse Event|1
1042042|NCT00095147|3385989|P2|Double-blind Period 1 (Days 1-197)|Adverse Event|8
1042043|NCT00095147|3385990|P1|Double-blind Period 1 (Days 1-197)|Adverse Event|2
1042044|NCT00095147|3385986|P5|Double-blind Period 1 (Days 1-197)|Death|0
1042045|NCT00095147|3385987|P4|Double-blind Period 1 (Days 1-197)|Death|0
1042046|NCT00095147|3385988|P3|Double-blind Period 1 (Days 1-197)|Death|0
1042047|NCT00095147|3385989|P2|Double-blind Period 1 (Days 1-197)|Death|0
1042048|NCT00095147|3385990|P1|Double-blind Period 1 (Days 1-197)|Death|1
1042049|NCT00095121|3386185|P2|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0
1042050|NCT00095121|3386186|P1|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2
1042051|NCT00095121|3386185|P2|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0
1042052|NCT00095121|3386186|P1|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1
1042053|NCT00095056|3386232|P2|Phase B (Weeks 12-54)|Protocol Violation|1
1042054|NCT00095056|3386233|P1|Phase B (Weeks 12-54)|Protocol Violation|0
1042055|NCT00095056|3386232|P2|Phase B (Weeks 12-54)|Protocol specific criteria|0
1042056|NCT00095056|3386233|P1|Phase B (Weeks 12-54)|Protocol specific criteria|1
1042057|NCT00095056|3386232|P2|Phase B (Weeks 12-54)|Death|1
1042058|NCT00095056|3386233|P1|Phase B (Weeks 12-54)|Death|3
1042059|NCT00095056|3386232|P2|Phase B (Weeks 12-54)|Patient Moved|0
1042060|NCT00095056|3386233|P1|Phase B (Weeks 12-54)|Patient Moved|1
1042061|NCT00095056|3386232|P2|Phase B (Weeks 12-54)|Withdrawal by Subject|1
1042062|NCT00095056|3386233|P1|Phase B (Weeks 12-54)|Withdrawal by Subject|2
1042063|NCT00095056|3386232|P2|Phase B (Weeks 12-54)|Lost to Follow-up|0
1042064|NCT00095056|3386233|P1|Phase B (Weeks 12-54)|Lost to Follow-up|1
1042065|NCT00095056|3386232|P2|Phase B (Weeks 12-54)|Adverse Event|2
1042066|NCT00095056|3386233|P1|Phase B (Weeks 12-54)|Adverse Event|2
1042067|NCT00095056|3386232|P2|Phase A (Weeks 0-12)|Protocol specific criteria|0
1042068|NCT00095056|3386233|P1|Phase A (Weeks 0-12)|Protocol specific criteria|2
1042069|NCT00095056|3386232|P2|Phase A (Weeks 0-12)|Death|0
1042070|NCT00095056|3386233|P1|Phase A (Weeks 0-12)|Death|1
1042071|NCT00095056|3386232|P2|Phase A (Weeks 0-12)|Withdrawal by Subject|0
1042072|NCT00095056|3386233|P1|Phase A (Weeks 0-12)|Withdrawal by Subject|3
1042073|NCT00095056|3386232|P2|Phase A (Weeks 0-12)|Adverse Event|1
1042074|NCT00095056|3386233|P1|Phase A (Weeks 0-12)|Adverse Event|1
1042075|NCT00094887|3386343|P2|Overall Study|Physician Decision|2
1042076|NCT00094887|3386344|P1|Overall Study|Physician Decision|2
1042077|NCT00094887|3386343|P2|Overall Study|Family emergency, Subject noncompliance|4
1042078|NCT00094887|3386344|P1|Overall Study|Family emergency, Subject noncompliance|3
1042079|NCT00094861|3386352|P2|Overall Study|Other|0
1042080|NCT00094861|3386353|P1|Overall Study|Other|3
1042081|NCT00094861|3386352|P2|Overall Study|Death|2
1042082|NCT00094861|3386353|P1|Overall Study|Death|4
1042083|NCT00094861|3386352|P2|Overall Study|Lost to Follow-up|1
1042084|NCT00094861|3386353|P1|Overall Study|Lost to Follow-up|0
1042085|NCT00094861|3386352|P2|Overall Study|Physician Decision|1
1042086|NCT00094861|3386353|P1|Overall Study|Physician Decision|1
1042087|NCT00094861|3386352|P2|Overall Study|Withdrawal by Subject|3
1042088|NCT00094861|3386353|P1|Overall Study|Withdrawal by Subject|5
1042089|NCT00094861|3386352|P2|Overall Study|Adverse Event|2
1042090|NCT00094861|3386353|P1|Overall Study|Adverse Event|5
1042091|NCT00094835|3386380|P7|Overall Study|Other|0
1042092|NCT00094835|3386381|P6|Overall Study|Other|0
1042093|NCT00094835|3386382|P5|Overall Study|Other|0
1042094|NCT00094835|3386383|P4|Overall Study|Other|1
1042095|NCT00094835|3386384|P3|Overall Study|Other|1
1042096|NCT00094835|3386385|P2|Overall Study|Other|1
1042097|NCT00094835|3386386|P1|Overall Study|Other|1
1042098|NCT00094835|3386380|P7|Overall Study|Non-compliance|1
1042099|NCT00094835|3386381|P6|Overall Study|Non-compliance|2
1042100|NCT00094835|3386382|P5|Overall Study|Non-compliance|2
1042101|NCT00094835|3386383|P4|Overall Study|Non-compliance|0
1042102|NCT00094835|3386384|P3|Overall Study|Non-compliance|2
1042103|NCT00094835|3386385|P2|Overall Study|Non-compliance|2
1042104|NCT00094835|3386386|P1|Overall Study|Non-compliance|1
1042105|NCT00094835|3386380|P7|Overall Study|Death|0
1042106|NCT00094835|3386381|P6|Overall Study|Death|0
1042107|NCT00094835|3386382|P5|Overall Study|Death|1
1042108|NCT00094835|3386383|P4|Overall Study|Death|0
1042109|NCT00094835|3386384|P3|Overall Study|Death|0
1042110|NCT00094835|3386385|P2|Overall Study|Death|0
1042111|NCT00094835|3386386|P1|Overall Study|Death|1
1042112|NCT00094835|3386380|P7|Overall Study|Lost to Follow-up|0
1042113|NCT00094835|3386381|P6|Overall Study|Lost to Follow-up|0
1042114|NCT00094835|3386382|P5|Overall Study|Lost to Follow-up|1
1042115|NCT00094835|3386383|P4|Overall Study|Lost to Follow-up|0
1042116|NCT00094835|3386384|P3|Overall Study|Lost to Follow-up|0
1042117|NCT00094835|3386385|P2|Overall Study|Lost to Follow-up|0
1042118|NCT00094835|3386386|P1|Overall Study|Lost to Follow-up|0
1042119|NCT00094835|3386380|P7|Overall Study|Withdrawal by Subject|1
1042120|NCT00094835|3386381|P6|Overall Study|Withdrawal by Subject|0
1042121|NCT00094835|3386382|P5|Overall Study|Withdrawal by Subject|0
1042122|NCT00094835|3386383|P4|Overall Study|Withdrawal by Subject|0
1042123|NCT00094835|3386384|P3|Overall Study|Withdrawal by Subject|0
1042124|NCT00094835|3386385|P2|Overall Study|Withdrawal by Subject|0
1042125|NCT00094835|3386386|P1|Overall Study|Withdrawal by Subject|0
1042126|NCT00094835|3386380|P7|Overall Study|Physician Decision|0
1042127|NCT00094835|3386381|P6|Overall Study|Physician Decision|1
1042128|NCT00094835|3386382|P5|Overall Study|Physician Decision|0
1042129|NCT00094835|3386383|P4|Overall Study|Physician Decision|0
1042130|NCT00094835|3386384|P3|Overall Study|Physician Decision|0
1042131|NCT00094835|3386385|P2|Overall Study|Physician Decision|0
1042132|NCT00094835|3386386|P1|Overall Study|Physician Decision|1
1042133|NCT00094809|3386464|P2|Overall Study|Other|1
1042134|NCT00094809|3386465|P1|Overall Study|Other|1
1042135|NCT00094809|3386464|P2|Overall Study|Study drug not received|8
1042136|NCT00094809|3386465|P1|Overall Study|Study drug not received|2
1042137|NCT00094809|3386464|P2|Overall Study|Informed consent signed after treatment|0
1042138|NCT00094809|3386465|P1|Overall Study|Informed consent signed after treatment|1
1042139|NCT00094809|3386464|P2|Overall Study|Other|4
1042140|NCT00094809|3386465|P1|Overall Study|Other|2
1042141|NCT00094809|3386464|P2|Overall Study|Protocol-specified criteria|1
1042142|NCT00094809|3386465|P1|Overall Study|Protocol-specified criteria|1
1042143|NCT00094809|3386464|P2|Overall Study|Death|25
1042144|NCT00094809|3386465|P1|Overall Study|Death|19
1042145|NCT00094809|3386464|P2|Overall Study|Lost to Follow-up|6
1042146|NCT00094809|3386465|P1|Overall Study|Lost to Follow-up|6
1042147|NCT00094809|3386464|P2|Overall Study|Physician Decision|5
1042148|NCT00094809|3386465|P1|Overall Study|Physician Decision|3
1042149|NCT00094809|3386464|P2|Overall Study|Disease progression|3
1042150|NCT00094809|3386465|P1|Overall Study|Disease progression|3
1042151|NCT00094809|3386464|P2|Overall Study|Withdrawal by Subject|9
1042152|NCT00094809|3386465|P1|Overall Study|Withdrawal by Subject|8
1042153|NCT00094809|3386464|P2|Overall Study|Adverse Event|1
1042154|NCT00094809|3386465|P1|Overall Study|Adverse Event|3
1042155|NCT00094809|3386464|P2|Overall Study|Noncompliance|0
1042156|NCT00094809|3386465|P1|Overall Study|Noncompliance|1
1042157|NCT00094809|3386464|P2|Overall Study|Protocol deviation|2
1042158|NCT00094809|3386465|P1|Overall Study|Protocol deviation|2
1042159|NCT00094770|3386491|P2|Year 2 (Week 0 to Week 104)|Other|23
1042160|NCT00094770|3386492|P1|Year 2 (Week 0 to Week 104)|Other|15
1042161|NCT00094770|3386491|P2|Year 2 (Week 0 to Week 104)|Site Terminated|2
1042162|NCT00094770|3386492|P1|Year 2 (Week 0 to Week 104)|Site Terminated|2
1042163|NCT00094770|3386491|P2|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38
1042164|NCT00094770|3386492|P1|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28
1042165|NCT00094770|3386491|P2|Year 2 (Week 0 to Week 104)|Patient Moved|2
1042166|NCT00094770|3386492|P1|Year 2 (Week 0 to Week 104)|Patient Moved|6
1042167|NCT00094770|3386491|P2|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30
1042168|NCT00094770|3386492|P1|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29
1042169|NCT00094770|3386491|P2|Year 2 (Week 0 to Week 104)|Protocol Violation|12
1042170|NCT00094770|3386492|P1|Year 2 (Week 0 to Week 104)|Protocol Violation|13
1042171|NCT00094770|3386491|P2|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15
1042172|NCT00094770|3386492|P1|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25
1042173|NCT00094770|3386491|P2|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162
1042174|NCT00094770|3386492|P1|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180
1042175|NCT00094770|3386491|P2|Year 2 (Week 0 to Week 104)|Adverse Event|36
1042176|NCT00094770|3386492|P1|Year 2 (Week 0 to Week 104)|Adverse Event|35
1042177|NCT00094770|3386491|P2|Year 1 ( Week 0 to Week 52)|Other|11
1042178|NCT00094770|3386492|P1|Year 1 ( Week 0 to Week 52)|Other|10
1042179|NCT00094770|3386491|P2|Year 1 ( Week 0 to Week 52)|Site Terminated|2
1042180|NCT00094770|3386492|P1|Year 1 ( Week 0 to Week 52)|Site Terminated|2
1042181|NCT00094770|3386491|P2|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28
1042182|NCT00094770|3386492|P1|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25
1042183|NCT00094770|3386491|P2|Year 1 ( Week 0 to Week 52)|Patient Moved|2
1042184|NCT00094770|3386492|P1|Year 1 ( Week 0 to Week 52)|Patient Moved|6
1042185|NCT00094770|3386491|P2|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25
1042186|NCT00094770|3386492|P1|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19
1042187|NCT00094770|3386491|P2|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
1042188|NCT00094770|3386492|P1|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
1042189|NCT00094770|3386491|P2|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10
1042190|NCT00094770|3386492|P1|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19
1042191|NCT00094770|3386491|P2|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58
1042192|NCT00094770|3386492|P1|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86
1042193|NCT00094770|3386491|P2|Year 1 ( Week 0 to Week 52)|Adverse Event|26
1042194|NCT00094770|3386492|P1|Year 1 ( Week 0 to Week 52)|Adverse Event|25
1042195|NCT00094757|3386523|P3|Overall Study|Protocol specified discontinuation|0
1042196|NCT00094757|3386524|P2|Overall Study|Protocol specified discontinuation|3
1042197|NCT00094757|3386525|P1|Overall Study|Protocol specified discontinuation|1
1042198|NCT00094757|3386523|P3|Overall Study|Other|1
1042199|NCT00094757|3386524|P2|Overall Study|Other|3
1042200|NCT00094757|3386525|P1|Overall Study|Other|3
1042201|NCT00094757|3386523|P3|Overall Study|Withdrawal by Subject|5
1042202|NCT00094757|3386524|P2|Overall Study|Withdrawal by Subject|21
1042203|NCT00094757|3386525|P1|Overall Study|Withdrawal by Subject|14
1042204|NCT00094757|3386523|P3|Overall Study|Protocol Violation|3
1042205|NCT00094757|3386524|P2|Overall Study|Protocol Violation|5
1042206|NCT00094757|3386525|P1|Overall Study|Protocol Violation|8
1042207|NCT00094757|3386523|P3|Overall Study|Patient Moved|1
1042208|NCT00094757|3386524|P2|Overall Study|Patient Moved|1
1042209|NCT00094757|3386525|P1|Overall Study|Patient Moved|2
1042210|NCT00094757|3386523|P3|Overall Study|Lost to Follow-up|6
1042211|NCT00094757|3386524|P2|Overall Study|Lost to Follow-up|5
1042212|NCT00094757|3386525|P1|Overall Study|Lost to Follow-up|3
1042213|NCT00094757|3386523|P3|Overall Study|Lack of Efficacy|8
1042214|NCT00094757|3386524|P2|Overall Study|Lack of Efficacy|15
1042215|NCT00094757|3386525|P1|Overall Study|Lack of Efficacy|11
1042216|NCT00094757|3386523|P3|Overall Study|Adverse Event|6
1042217|NCT00094757|3386524|P2|Overall Study|Adverse Event|9
1042218|NCT00094757|3386525|P1|Overall Study|Adverse Event|11
1042219|NCT00094653|3386545|P3|Overall Study|Protocol Violation|1
1042220|NCT00094653|3386546|P2|Overall Study|Protocol Violation|0
1042221|NCT00094653|3386547|P1|Overall Study|Protocol Violation|0
1042222|NCT00094653|3386545|P3|Overall Study|Lost to Follow-up|1
1042223|NCT00094653|3386546|P2|Overall Study|Lost to Follow-up|2
1042224|NCT00094653|3386547|P1|Overall Study|Lost to Follow-up|3
1042225|NCT00094653|3386545|P3|Overall Study|Not specified|2
1042226|NCT00094653|3386546|P2|Overall Study|Not specified|2
1042227|NCT00094653|3386547|P1|Overall Study|Not specified|2
1042228|NCT00094653|3386545|P3|Overall Study|Subject Withdrew Consent|3
1042229|NCT00094653|3386546|P2|Overall Study|Subject Withdrew Consent|2
1042230|NCT00094653|3386547|P1|Overall Study|Subject Withdrew Consent|10
1042231|NCT00094653|3386545|P3|Overall Study|Death|119
1042232|NCT00094653|3386546|P2|Overall Study|Death|100
1042233|NCT00094653|3386547|P1|Overall Study|Death|306
1042234|NCT00094575|3386610|P2|Overall Study|Death|146
1042235|NCT00094575|3386611|P1|Overall Study|Death|146
1042236|NCT00094536|3386631|P1|Treatment and Follow-up|Unable to attend visits|1
1042237|NCT00094536|3386631|P1|Treatment and Follow-up|Subject non-compliance|9
1042238|NCT00094536|3386631|P1|Treatment and Follow-up|Withdrawal by Subject|1
1042239|NCT00094536|3386631|P1|Treatment and Follow-up|Lost to Follow-up|7
1042240|NCT00094536|3386631|P1|Treatment and Follow-up|Lack of Efficacy|9
1042241|NCT00094536|3386631|P1|Treatment and Follow-up|Adverse Event|4
1042242|NCT00094536|3386631|P1|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24
1042243|NCT00094458|3386655|P6|OLE: Open-Label Extension|Patient decision|0
1042244|NCT00094458|3386656|P5|OLE: Open-Label Extension|Patient decision|1
1042245|NCT00094458|3386657|P4|OLE: Open-Label Extension|Patient decision|0
1042246|NCT00094458|3386658|P3|OLE: Open-Label Extension|Patient decision|0
1042247|NCT00094458|3386659|P2|OLE: Open-Label Extension|Patient decision|0
1042248|NCT00094458|3386660|P1|OLE: Open-Label Extension|Patient decision|0
1042249|NCT00094458|3386655|P6|OLE: Open-Label Extension|Inadequate therapeutic effect|0
1042250|NCT00094458|3386656|P5|OLE: Open-Label Extension|Inadequate therapeutic effect|1
1042251|NCT00094458|3386657|P4|OLE: Open-Label Extension|Inadequate therapeutic effect|1
1042252|NCT00094458|3386658|P3|OLE: Open-Label Extension|Inadequate therapeutic effect|0
1042253|NCT00094458|3386659|P2|OLE: Open-Label Extension|Inadequate therapeutic effect|0
1042254|NCT00094458|3386660|P1|OLE: Open-Label Extension|Inadequate therapeutic effect|0
1042255|NCT00094458|3386655|P6|OLE: Open-Label Extension|Adverse Event|4
1042256|NCT00094458|3386656|P5|OLE: Open-Label Extension|Adverse Event|3
1042257|NCT00094458|3386657|P4|OLE: Open-Label Extension|Adverse Event|0
1042258|NCT00094458|3386658|P3|OLE: Open-Label Extension|Adverse Event|0
1042259|NCT00094458|3386659|P2|OLE: Open-Label Extension|Adverse Event|0
1042260|NCT00094458|3386660|P1|OLE: Open-Label Extension|Adverse Event|0
1042261|NCT00094458|3386655|P6|Study Extension: Week 30 Through Week 50|Other|0
1042262|NCT00094458|3386656|P5|Study Extension: Week 30 Through Week 50|Other|0
1042263|NCT00094458|3386657|P4|Study Extension: Week 30 Through Week 50|Other|0
1042264|NCT00094458|3386658|P3|Study Extension: Week 30 Through Week 50|Other|3
1042265|NCT00094458|3386659|P2|Study Extension: Week 30 Through Week 50|Other|2
1042266|NCT00094458|3386660|P1|Study Extension: Week 30 Through Week 50|Other|1
1042267|NCT00094458|3386655|P6|Study Extension: Week 30 Through Week 50|Adverse Event|0
1042268|NCT00094458|3386656|P5|Study Extension: Week 30 Through Week 50|Adverse Event|0
1042269|NCT00094458|3386657|P4|Study Extension: Week 30 Through Week 50|Adverse Event|0
1042270|NCT00094458|3386658|P3|Study Extension: Week 30 Through Week 50|Adverse Event|7
1042271|NCT00094458|3386659|P2|Study Extension: Week 30 Through Week 50|Adverse Event|9
1042272|NCT00094458|3386660|P1|Study Extension: Week 30 Through Week 50|Adverse Event|3
1042273|NCT00094458|3386655|P6|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
1042274|NCT00094458|3386656|P5|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
1042275|NCT00094458|3386657|P4|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
1042276|NCT00094458|3386658|P3|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4
1042277|NCT00094458|3386659|P2|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
1042278|NCT00094458|3386660|P1|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2
1042279|NCT00094458|3386655|P6|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
1042280|NCT00094458|3386656|P5|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
1042281|NCT00094458|3386657|P4|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
1042282|NCT00094458|3386658|P3|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4
1042283|NCT00094458|3386659|P2|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1
1042284|NCT00094458|3386660|P1|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2
1042285|NCT00094458|3386655|P6|Main Study: Through Week 30|Other|0
1042286|NCT00094458|3386656|P5|Main Study: Through Week 30|Other|0
1042287|NCT00094458|3386657|P4|Main Study: Through Week 30|Other|0
1042288|NCT00094458|3386658|P3|Main Study: Through Week 30|Other|9
1042289|NCT00094458|3386659|P2|Main Study: Through Week 30|Other|16
1042290|NCT00094458|3386660|P1|Main Study: Through Week 30|Other|19
1042291|NCT00094458|3386655|P6|Main Study: Through Week 30|Death|0
1042292|NCT00094458|3386656|P5|Main Study: Through Week 30|Death|0
1042293|NCT00094458|3386657|P4|Main Study: Through Week 30|Death|0
1042294|NCT00094458|3386658|P3|Main Study: Through Week 30|Death|0
1042295|NCT00094458|3386659|P2|Main Study: Through Week 30|Death|0
1042296|NCT00094458|3386660|P1|Main Study: Through Week 30|Death|1
1042297|NCT00094458|3386655|P6|Main Study: Through Week 30|Adverse Event|0
1042298|NCT00094458|3386656|P5|Main Study: Through Week 30|Adverse Event|0
1042299|NCT00094458|3386657|P4|Main Study: Through Week 30|Adverse Event|0
1042300|NCT00094458|3386658|P3|Main Study: Through Week 30|Adverse Event|28
1042301|NCT00094458|3386659|P2|Main Study: Through Week 30|Adverse Event|20
1042302|NCT00094458|3386660|P1|Main Study: Through Week 30|Adverse Event|38
1042303|NCT00094458|3386655|P6|Main Study: Through Week 30|Withdrawal by Subject|0
1042304|NCT00094458|3386656|P5|Main Study: Through Week 30|Withdrawal by Subject|0
1042305|NCT00094458|3386657|P4|Main Study: Through Week 30|Withdrawal by Subject|0
1042306|NCT00094458|3386658|P3|Main Study: Through Week 30|Withdrawal by Subject|7
1042307|NCT00094458|3386659|P2|Main Study: Through Week 30|Withdrawal by Subject|9
1042308|NCT00094458|3386660|P1|Main Study: Through Week 30|Withdrawal by Subject|18
1042309|NCT00094458|3386655|P6|Main Study: Through Week 30|Lost to Follow-up|0
1042310|NCT00094458|3386656|P5|Main Study: Through Week 30|Lost to Follow-up|0
1042311|NCT00094458|3386657|P4|Main Study: Through Week 30|Lost to Follow-up|0
1042312|NCT00094458|3386658|P3|Main Study: Through Week 30|Lost to Follow-up|2
1042313|NCT00094458|3386659|P2|Main Study: Through Week 30|Lost to Follow-up|5
1042314|NCT00094458|3386660|P1|Main Study: Through Week 30|Lost to Follow-up|5
1042315|NCT00094458|3386655|P6|Main Study: Through Week 30|Eligibility criteria not met|0
1042316|NCT00094458|3386656|P5|Main Study: Through Week 30|Eligibility criteria not met|0
1042317|NCT00094458|3386657|P4|Main Study: Through Week 30|Eligibility criteria not met|0
1042318|NCT00094458|3386658|P3|Main Study: Through Week 30|Eligibility criteria not met|2
1042319|NCT00094458|3386659|P2|Main Study: Through Week 30|Eligibility criteria not met|8
1042320|NCT00094458|3386660|P1|Main Study: Through Week 30|Eligibility criteria not met|3
1042321|NCT00094328|3386698|P1|Overall Study|Lost to Follow-up|1
1042322|NCT00094302|3386712|P2|Overall Study|Death|246
1042323|NCT00094302|3386713|P1|Overall Study|Death|266
1042324|NCT00094302|3386712|P2|Overall Study|Withdrawal by Subject|111
1042325|NCT00094302|3386713|P1|Overall Study|Withdrawal by Subject|103
1042326|NCT00094302|3386712|P2|Overall Study|Physician Decision|8
1042327|NCT00094302|3386713|P1|Overall Study|Physician Decision|5
1042328|NCT00094302|3386712|P2|Overall Study|Lost to Follow-up|41
1042329|NCT00094302|3386713|P1|Overall Study|Lost to Follow-up|43
1042330|NCT00094172|3386769|P2|Overall Study|Started other MS therapy due to disease|0
1042331|NCT00094172|3386770|P1|Overall Study|Started other MS therapy due to disease|1
1042332|NCT00094172|3386769|P2|Overall Study|Primary endpoint met.|0
1042333|NCT00094172|3386770|P1|Overall Study|Primary endpoint met.|1
1042334|NCT00094172|3386769|P2|Overall Study|Withdrawal by Subject|5
1042335|NCT00094172|3386770|P1|Overall Study|Withdrawal by Subject|10
1042336|NCT00094172|3386769|P2|Overall Study|Protocol Violation|1
1042337|NCT00094172|3386770|P1|Overall Study|Protocol Violation|0
1042338|NCT00094172|3386769|P2|Overall Study|Lost to Follow-up|0
1042339|NCT00094172|3386770|P1|Overall Study|Lost to Follow-up|2
1042340|NCT00094172|3386769|P2|Overall Study|Adverse Event|1
1042341|NCT00094172|3386770|P1|Overall Study|Adverse Event|0
1042342|NCT00094107|3386780|P1|Overall Study|Withdrawal due to Disease Progression|1
1042343|NCT00094107|3386780|P1|Overall Study|Adverse Event|3
1042344|NCT00094107|3386780|P1|Overall Study|Death|5
1042345|NCT00094107|3386780|P1|Overall Study|Lack of Efficacy|23
1042346|NCT00094094|3386789|P1|Overall Study|Adverse Event|7
1042347|NCT00094094|3386789|P1|Overall Study|Lack of Efficacy|23
1042348|NCT00094094|3386789|P1|Overall Study|Death|2
1042349|NCT00094055|3386798|P1|Overall Study|Withdrawal by Subject|9
1042350|NCT00094055|3386798|P1|Overall Study|roll-over to another study|14
1042351|NCT00094055|3386798|P1|Overall Study|clinical progression|1
1042352|NCT00094055|3386798|P1|Overall Study|progressive disease|2
1042353|NCT00094055|3386798|P1|Overall Study|Lost to Follow-up|2
1042354|NCT00094055|3386798|P1|Overall Study|Lack of Efficacy|17
1042355|NCT00094055|3386798|P1|Overall Study|Death|4
1042356|NCT00094055|3386798|P1|Overall Study|Adverse Event|11
1042357|NCT00093808|3386818|P1|Overall Study|Protocol Violation|1
1042358|NCT00093808|3386818|P1|Overall Study|Cancel participation before receiving tx|1
1042359|NCT00093795|3386828|P3|Overall Study|No follow up data|17
1042360|NCT00093795|3386829|P2|Overall Study|No follow up data|16
1042361|NCT00093795|3386830|P1|Overall Study|No follow up data|20
1042362|NCT00093496|3386875|P2|Overall Study|Protocol Violation|3
1042363|NCT00093496|3386876|P1|Overall Study|Protocol Violation|1
1042364|NCT00093470|3386889|P2|Overall Study|ANC < 1000 on day 1 of cycle 1|0
1042365|NCT00093470|3386890|P1|Overall Study|ANC < 1000 on day 1 of cycle 1|1
1042366|NCT00093470|3386889|P2|Overall Study|Never started treatment|0
1042367|NCT00093470|3386890|P1|Overall Study|Never started treatment|1
1042368|NCT00093470|3386889|P2|Overall Study|Physician Decision|0
1042369|NCT00093470|3386890|P1|Overall Study|Physician Decision|2
1042370|NCT00093470|3386889|P2|Overall Study|Other complicating disease|0
1042371|NCT00093470|3386890|P1|Overall Study|Other complicating disease|3
1042372|NCT00093470|3386889|P2|Overall Study|Alternative therapy|0
1042373|NCT00093470|3386890|P1|Overall Study|Alternative therapy|2
1042374|NCT00093470|3386889|P2|Overall Study|Withdrawal by Subject|0
1042375|NCT00093470|3386890|P1|Overall Study|Withdrawal by Subject|8
1042376|NCT00093470|3386889|P2|Overall Study|Death|0
1042377|NCT00093470|3386890|P1|Overall Study|Death|2
1042378|NCT00093470|3386889|P2|Overall Study|Adverse Event|0
1042379|NCT00093470|3386890|P1|Overall Study|Adverse Event|15
1042380|NCT00093470|3386889|P2|Overall Study|Disease progression|0
1042381|NCT00093470|3386890|P1|Overall Study|Disease progression|39
1042382|NCT00093145|3386904|P1|Overall Study|Other|1
1042383|NCT00093145|3386904|P1|Overall Study|Withdrawal by Subject|9
1042384|NCT00093145|3386904|P1|Overall Study|Physician Decision|5
1042385|NCT00093145|3386904|P1|Overall Study|Unacceptable Toxicity Only|2
1042386|NCT00093015|3386946|P2|Overall Study|Death|385
1042387|NCT00093015|3386947|P1|Overall Study|Death|375
1042388|NCT00093015|3386946|P2|Overall Study|Lost to Follow-up|108
1042389|NCT00093015|3386947|P1|Overall Study|Lost to Follow-up|96
1042390|NCT00093015|3386946|P2|Overall Study|Withdrawal by Subject|171
1042391|NCT00093015|3386947|P1|Overall Study|Withdrawal by Subject|194
1042392|NCT00092677|3386975|P2|Overall Study|Adminstrative|9
1042393|NCT00092677|3386976|P1|Overall Study|Adminstrative|5
1042394|NCT00092677|3386975|P2|Overall Study|Lost to Follow-up|2
1042395|NCT00092677|3386976|P1|Overall Study|Lost to Follow-up|0
1042396|NCT00092547|3387020|P3|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
1042397|NCT00092547|3387021|P2|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
1042398|NCT00092547|3387022|P1|Long-term Follow-up (Month 42 Visit)|Adverse Event|1
1042399|NCT00092547|3387020|P3|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7
1042400|NCT00092547|3387021|P2|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0
1042401|NCT00092547|3387022|P1|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14
1042402|NCT00092547|3387020|P3|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9
1042403|NCT00092547|3387021|P2|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0
1042404|NCT00092547|3387022|P1|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6
1042405|NCT00092547|3387020|P3|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
1042406|NCT00092547|3387021|P2|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
1042407|NCT00092547|3387022|P1|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3
1042408|NCT00092547|3387020|P3|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
1042409|NCT00092547|3387021|P2|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
1042410|NCT00092547|3387022|P1|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1
1042411|NCT00092547|3387020|P3|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
1042412|NCT00092547|3387021|P2|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
1042413|NCT00092547|3387022|P1|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2
1042414|NCT00092547|3387020|P3|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0
1042415|NCT00092547|3387021|P2|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3
1042416|NCT00092547|3387022|P1|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1
1042417|NCT00092547|3387020|P3|Base Follow-up Phase (Month 18 to 30)|Subject moved|0
1042418|NCT00092547|3387021|P2|Base Follow-up Phase (Month 18 to 30)|Subject moved|2
1042419|NCT00092547|3387022|P1|Base Follow-up Phase (Month 18 to 30)|Subject moved|4
1042420|NCT00092547|3387020|P3|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
1042421|NCT00092547|3387021|P2|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
1042422|NCT00092547|3387022|P1|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1
1042423|NCT00092547|3387020|P3|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
1042424|NCT00092547|3387021|P2|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
1042425|NCT00092547|3387022|P1|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1
1042426|NCT00092547|3387020|P3|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0
1042427|NCT00092547|3387021|P2|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7
1042428|NCT00092547|3387022|P1|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13
1042429|NCT00092547|3387020|P3|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0
1042430|NCT00092547|3387021|P2|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2
1042431|NCT00092547|3387022|P1|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4
1042432|NCT00092547|3387020|P3|Base Follow-up Phase (Month 7 to 18)|Subject moved|0
1042513|NCT00092534|3387066|P3|Base Study Follow Up Period|Death|0
1042433|NCT00092547|3387021|P2|Base Follow-up Phase (Month 7 to 18)|Subject moved|5
1042434|NCT00092547|3387022|P1|Base Follow-up Phase (Month 7 to 18)|Subject moved|1
1042435|NCT00092547|3387020|P3|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0
1042436|NCT00092547|3387021|P2|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3
1042437|NCT00092547|3387022|P1|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5
1042438|NCT00092547|3387020|P3|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
1042439|NCT00092547|3387021|P2|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1
1042440|NCT00092547|3387022|P1|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
1042441|NCT00092547|3387020|P3|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
1042442|NCT00092547|3387021|P2|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1
1042443|NCT00092547|3387022|P1|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
1042444|NCT00092547|3387020|P3|Base Vaccine Phase (Day 1 to Month 7)|Moved|0
1042445|NCT00092547|3387021|P2|Base Vaccine Phase (Day 1 to Month 7)|Moved|1
1042446|NCT00092547|3387022|P1|Base Vaccine Phase (Day 1 to Month 7)|Moved|3
1042447|NCT00092547|3387020|P3|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0
1042448|NCT00092547|3387021|P2|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21
1042449|NCT00092547|3387022|P1|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28
1042450|NCT00092547|3387020|P3|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0
1042451|NCT00092547|3387021|P2|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7
1042452|NCT00092547|3387022|P1|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18
1042453|NCT00092547|3387020|P3|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0
1042454|NCT00092547|3387021|P2|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1
1042455|NCT00092547|3387022|P1|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4
1042456|NCT00092547|3387020|P3|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0
1042457|NCT00092547|3387021|P2|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1
1042458|NCT00092547|3387022|P1|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5
1042459|NCT00092534|3387066|P3|Extension Study|Protocol Deviation|15
1042460|NCT00092534|3387067|P2|Extension Study|Protocol Deviation|0
1042461|NCT00092534|3387068|P1|Extension Study|Protocol Deviation|0
1042462|NCT00092534|3387066|P3|Extension Study|Study Ended|29
1042463|NCT00092534|3387067|P2|Extension Study|Study Ended|0
1042464|NCT00092534|3387068|P1|Extension Study|Study Ended|0
1042465|NCT00092534|3387066|P3|Extension Study|Site Closed|21
1042466|NCT00092534|3387067|P2|Extension Study|Site Closed|0
1042467|NCT00092534|3387068|P1|Extension Study|Site Closed|0
1042468|NCT00092534|3387066|P3|Extension Study|Travel|2
1042469|NCT00092534|3387067|P2|Extension Study|Travel|0
1042470|NCT00092534|3387068|P1|Extension Study|Travel|0
1042471|NCT00092534|3387066|P3|Extension Study|Moved|6
1042472|NCT00092534|3387067|P2|Extension Study|Moved|0
1042473|NCT00092534|3387068|P1|Extension Study|Moved|0
1042474|NCT00092534|3387066|P3|Extension Study|Withdrawal by Subject|18
1042475|NCT00092534|3387067|P2|Extension Study|Withdrawal by Subject|0
1042476|NCT00092534|3387068|P1|Extension Study|Withdrawal by Subject|0
1042477|NCT00092534|3387066|P3|Extension Study|Pregnancy|12
1042478|NCT00092534|3387067|P2|Extension Study|Pregnancy|0
1042479|NCT00092534|3387068|P1|Extension Study|Pregnancy|0
1042480|NCT00092534|3387066|P3|Extension Study|Physician Decision|1
1042481|NCT00092534|3387067|P2|Extension Study|Physician Decision|0
1042482|NCT00092534|3387068|P1|Extension Study|Physician Decision|0
1042483|NCT00092534|3387066|P3|Extension Study|Lost to Follow-up|41
1042484|NCT00092534|3387067|P2|Extension Study|Lost to Follow-up|0
1042485|NCT00092534|3387068|P1|Extension Study|Lost to Follow-up|0
1042486|NCT00092534|3387066|P3|Base Study Follow Up Period|Subjects in extension|0
1042487|NCT00092534|3387067|P2|Base Study Follow Up Period|Subjects in extension|371
1042488|NCT00092534|3387068|P1|Base Study Follow Up Period|Subjects in extension|15
1042489|NCT00092534|3387066|P3|Base Study Follow Up Period|Subjects continuing|0
1042490|NCT00092534|3387067|P2|Base Study Follow Up Period|Subjects continuing|31
1042491|NCT00092534|3387068|P1|Base Study Follow Up Period|Subjects continuing|27
1042492|NCT00092534|3387066|P3|Base Study Follow Up Period|Site Closed|0
1042493|NCT00092534|3387067|P2|Base Study Follow Up Period|Site Closed|2
1042494|NCT00092534|3387068|P1|Base Study Follow Up Period|Site Closed|0
1042495|NCT00092534|3387066|P3|Base Study Follow Up Period|Travel|0
1042496|NCT00092534|3387067|P2|Base Study Follow Up Period|Travel|7
1042497|NCT00092534|3387068|P1|Base Study Follow Up Period|Travel|10
1042498|NCT00092534|3387066|P3|Base Study Follow Up Period|Moved|0
1042499|NCT00092534|3387067|P2|Base Study Follow Up Period|Moved|58
1042500|NCT00092534|3387068|P1|Base Study Follow Up Period|Moved|62
1042501|NCT00092534|3387066|P3|Base Study Follow Up Period|Withdrawal by Subject|0
1042502|NCT00092534|3387067|P2|Base Study Follow Up Period|Withdrawal by Subject|62
1042503|NCT00092534|3387068|P1|Base Study Follow Up Period|Withdrawal by Subject|71
1042504|NCT00092534|3387066|P3|Base Study Follow Up Period|Protocol Violation|0
1042505|NCT00092534|3387067|P2|Base Study Follow Up Period|Protocol Violation|2
1042506|NCT00092534|3387068|P1|Base Study Follow Up Period|Protocol Violation|1
1042507|NCT00092534|3387066|P3|Base Study Follow Up Period|Pregnancy|0
1042508|NCT00092534|3387067|P2|Base Study Follow Up Period|Pregnancy|10
1042509|NCT00092534|3387068|P1|Base Study Follow Up Period|Pregnancy|6
1042510|NCT00092534|3387066|P3|Base Study Follow Up Period|Lost to Follow-up|0
1042511|NCT00092534|3387067|P2|Base Study Follow Up Period|Lost to Follow-up|146
1042512|NCT00092534|3387068|P1|Base Study Follow Up Period|Lost to Follow-up|120
1042514|NCT00092534|3387067|P2|Base Study Follow Up Period|Death|1
1042515|NCT00092534|3387068|P1|Base Study Follow Up Period|Death|2
1042516|NCT00092534|3387066|P3|Base Study Follow Up Period|Adverse Event|0
1042517|NCT00092534|3387067|P2|Base Study Follow Up Period|Adverse Event|4
1042518|NCT00092534|3387068|P1|Base Study Follow Up Period|Adverse Event|2
1042519|NCT00092534|3387066|P3|Base Study Vaccination Period|Site Closed|0
1042520|NCT00092534|3387067|P2|Base Study Vaccination Period|Site Closed|1
1042521|NCT00092534|3387068|P1|Base Study Vaccination Period|Site Closed|0
1042522|NCT00092534|3387066|P3|Base Study Vaccination Period|Travel|0
1042523|NCT00092534|3387067|P2|Base Study Vaccination Period|Travel|0
1042524|NCT00092534|3387068|P1|Base Study Vaccination Period|Travel|1
1042525|NCT00092534|3387066|P3|Base Study Vaccination Period|New Medical History (Not AEs)|0
1042526|NCT00092534|3387067|P2|Base Study Vaccination Period|New Medical History (Not AEs)|0
1042527|NCT00092534|3387068|P1|Base Study Vaccination Period|New Medical History (Not AEs)|5
1042528|NCT00092534|3387066|P3|Base Study Vaccination Period|Moved|0
1042529|NCT00092534|3387067|P2|Base Study Vaccination Period|Moved|12
1042530|NCT00092534|3387068|P1|Base Study Vaccination Period|Moved|14
1042531|NCT00092534|3387066|P3|Base Study Vaccination Period|Withdrawal by Subject|0
1042532|NCT00092534|3387067|P2|Base Study Vaccination Period|Withdrawal by Subject|58
1042533|NCT00092534|3387068|P1|Base Study Vaccination Period|Withdrawal by Subject|85
1042534|NCT00092534|3387066|P3|Base Study Vaccination Period|Protocol Violation|0
1042535|NCT00092534|3387067|P2|Base Study Vaccination Period|Protocol Violation|1
1042536|NCT00092534|3387068|P1|Base Study Vaccination Period|Protocol Violation|2
1042537|NCT00092534|3387066|P3|Base Study Vaccination Period|Pregnancy|0
1042538|NCT00092534|3387067|P2|Base Study Vaccination Period|Pregnancy|7
1042539|NCT00092534|3387068|P1|Base Study Vaccination Period|Pregnancy|9
1042540|NCT00092534|3387066|P3|Base Study Vaccination Period|Physician Decision|0
1042541|NCT00092534|3387067|P2|Base Study Vaccination Period|Physician Decision|0
1042542|NCT00092534|3387068|P1|Base Study Vaccination Period|Physician Decision|1
1042543|NCT00092534|3387066|P3|Base Study Vaccination Period|Lost to Follow-up|0
1042544|NCT00092534|3387067|P2|Base Study Vaccination Period|Lost to Follow-up|37
1042545|NCT00092534|3387068|P1|Base Study Vaccination Period|Lost to Follow-up|41
1042546|NCT00092534|3387066|P3|Base Study Vaccination Period|Death|0
1042547|NCT00092534|3387067|P2|Base Study Vaccination Period|Death|4
1042548|NCT00092534|3387068|P1|Base Study Vaccination Period|Death|5
1042549|NCT00092534|3387066|P3|Base Study Vaccination Period|Adverse Event|0
1042550|NCT00092534|3387067|P2|Base Study Vaccination Period|Adverse Event|1
1042551|NCT00092534|3387068|P1|Base Study Vaccination Period|Adverse Event|3
1042552|NCT00092534|3387066|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
1042553|NCT00092534|3387067|P2|Base Study Vaccination Period|Randomized not Vaccinated|5
1042554|NCT00092534|3387068|P1|Base Study Vaccination Period|Randomized not Vaccinated|5
1042555|NCT00092521|3387086|P4|Extension Study (Group 4)|Unable/unwilling to return|25
1042556|NCT00092521|3387087|P3|Extension Study (Group 4)|Unable/unwilling to return|0
1042557|NCT00092521|3387088|P2|Extension Study (Group 4)|Unable/unwilling to return|0
1042558|NCT00092521|3387089|P1|Extension Study (Group 4)|Unable/unwilling to return|0
1042559|NCT00092521|3387086|P4|Extension Study (Group 4)|Site Terminated|4
1042560|NCT00092521|3387087|P3|Extension Study (Group 4)|Site Terminated|0
1042561|NCT00092521|3387088|P2|Extension Study (Group 4)|Site Terminated|0
1042562|NCT00092521|3387089|P1|Extension Study (Group 4)|Site Terminated|0
1042563|NCT00092521|3387086|P4|Extension Study (Group 4)|Moved|16
1042564|NCT00092521|3387087|P3|Extension Study (Group 4)|Moved|0
1042565|NCT00092521|3387088|P2|Extension Study (Group 4)|Moved|0
1042566|NCT00092521|3387089|P1|Extension Study (Group 4)|Moved|0
1042567|NCT00092521|3387086|P4|Extension Study (Group 4)|Withdrawal by Subject|46
1042568|NCT00092521|3387087|P3|Extension Study (Group 4)|Withdrawal by Subject|0
1042569|NCT00092521|3387088|P2|Extension Study (Group 4)|Withdrawal by Subject|0
1042570|NCT00092521|3387089|P1|Extension Study (Group 4)|Withdrawal by Subject|0
1042571|NCT00092521|3387086|P4|Extension Study (Group 4)|Protocol Violation|2
1042572|NCT00092521|3387087|P3|Extension Study (Group 4)|Protocol Violation|0
1042573|NCT00092521|3387088|P2|Extension Study (Group 4)|Protocol Violation|0
1042574|NCT00092521|3387089|P1|Extension Study (Group 4)|Protocol Violation|0
1042575|NCT00092521|3387086|P4|Extension Study (Group 4)|Pregnancy|4
1042576|NCT00092521|3387087|P3|Extension Study (Group 4)|Pregnancy|0
1042577|NCT00092521|3387088|P2|Extension Study (Group 4)|Pregnancy|0
1042578|NCT00092521|3387089|P1|Extension Study (Group 4)|Pregnancy|0
1042579|NCT00092521|3387086|P4|Extension Study (Group 4)|Lost to Follow-up|87
1042580|NCT00092521|3387087|P3|Extension Study (Group 4)|Lost to Follow-up|0
1042581|NCT00092521|3387088|P2|Extension Study (Group 4)|Lost to Follow-up|0
1042582|NCT00092521|3387089|P1|Extension Study (Group 4)|Lost to Follow-up|0
1042583|NCT00092521|3387086|P4|Extension Study (Group 4)|Adverse Event|2
1042584|NCT00092521|3387087|P3|Extension Study (Group 4)|Adverse Event|0
1042585|NCT00092521|3387088|P2|Extension Study (Group 4)|Adverse Event|0
1042586|NCT00092521|3387089|P1|Extension Study (Group 4)|Adverse Event|0
1042587|NCT00092521|3387086|P4|Extension Study (Group 4)|Excluded ineligible for extension|23
1042588|NCT00092521|3387087|P3|Extension Study (Group 4)|Excluded ineligible for extension|0
1042589|NCT00092521|3387088|P2|Extension Study (Group 4)|Excluded ineligible for extension|0
1042590|NCT00092521|3387089|P1|Extension Study (Group 4)|Excluded ineligible for extension|0
1042591|NCT00092521|3387086|P4|Follow-Up (After Month 7)|Visits Compressed|0
1042592|NCT00092521|3387087|P3|Follow-Up (After Month 7)|Visits Compressed|5
1042593|NCT00092521|3387088|P2|Follow-Up (After Month 7)|Visits Compressed|0
1042594|NCT00092521|3387089|P1|Follow-Up (After Month 7)|Visits Compressed|5
1042595|NCT00092521|3387086|P4|Follow-Up (After Month 7)|Travel|0
1042596|NCT00092521|3387087|P3|Follow-Up (After Month 7)|Travel|0
1042597|NCT00092521|3387088|P2|Follow-Up (After Month 7)|Travel|0
1042598|NCT00092521|3387089|P1|Follow-Up (After Month 7)|Travel|2
1042599|NCT00092521|3387086|P4|Follow-Up (After Month 7)|Site Terminated|0
1042600|NCT00092521|3387087|P3|Follow-Up (After Month 7)|Site Terminated|3
1042601|NCT00092521|3387088|P2|Follow-Up (After Month 7)|Site Terminated|0
1042602|NCT00092521|3387089|P1|Follow-Up (After Month 7)|Site Terminated|3
1042603|NCT00092521|3387086|P4|Follow-Up (After Month 7)|Moved|0
1042604|NCT00092521|3387087|P3|Follow-Up (After Month 7)|Moved|28
1042605|NCT00092521|3387088|P2|Follow-Up (After Month 7)|Moved|2
1042606|NCT00092521|3387089|P1|Follow-Up (After Month 7)|Moved|32
1042607|NCT00092521|3387086|P4|Follow-Up (After Month 7)|Withdrawal by Subject|0
1042608|NCT00092521|3387087|P3|Follow-Up (After Month 7)|Withdrawal by Subject|51
1042609|NCT00092521|3387088|P2|Follow-Up (After Month 7)|Withdrawal by Subject|6
1042610|NCT00092521|3387089|P1|Follow-Up (After Month 7)|Withdrawal by Subject|40
1042611|NCT00092521|3387086|P4|Follow-Up (After Month 7)|Protocol Violation|0
1042612|NCT00092521|3387087|P3|Follow-Up (After Month 7)|Protocol Violation|5
1042613|NCT00092521|3387088|P2|Follow-Up (After Month 7)|Protocol Violation|1
1042614|NCT00092521|3387089|P1|Follow-Up (After Month 7)|Protocol Violation|1
1042615|NCT00092521|3387086|P4|Follow-Up (After Month 7)|Lost to Follow-up|0
1042616|NCT00092521|3387087|P3|Follow-Up (After Month 7)|Lost to Follow-up|108
1042617|NCT00092521|3387088|P2|Follow-Up (After Month 7)|Lost to Follow-up|14
1042618|NCT00092521|3387089|P1|Follow-Up (After Month 7)|Lost to Follow-up|113
1042619|NCT00092521|3387086|P4|Follow-Up (After Month 7)|Death|0
1042620|NCT00092521|3387087|P3|Follow-Up (After Month 7)|Death|1
1042621|NCT00092521|3387088|P2|Follow-Up (After Month 7)|Death|0
1042622|NCT00092521|3387089|P1|Follow-Up (After Month 7)|Death|2
1042623|NCT00092521|3387086|P4|Follow-Up (After Month 7)|Adverse Event|0
1042624|NCT00092521|3387087|P3|Follow-Up (After Month 7)|Adverse Event|0
1042625|NCT00092521|3387088|P2|Follow-Up (After Month 7)|Adverse Event|0
1042626|NCT00092521|3387089|P1|Follow-Up (After Month 7)|Adverse Event|1
1042627|NCT00092521|3387086|P4|Follow-Up (After Month 7)|Subjects in Extension|0
1042628|NCT00092521|3387087|P3|Follow-Up (After Month 7)|Subjects in Extension|412
1042629|NCT00092521|3387088|P2|Follow-Up (After Month 7)|Subjects in Extension|109
1042630|NCT00092521|3387089|P1|Follow-Up (After Month 7)|Subjects in Extension|13
1042631|NCT00092521|3387086|P4|Follow-Up (After Month 7)|Subjects Continuing|0
1042632|NCT00092521|3387087|P3|Follow-Up (After Month 7)|Subjects Continuing|35
1042633|NCT00092521|3387088|P2|Follow-Up (After Month 7)|Subjects Continuing|4
1042634|NCT00092521|3387089|P1|Follow-Up (After Month 7)|Subjects Continuing|34
1042635|NCT00092521|3387086|P4|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
1042636|NCT00092521|3387087|P3|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
1042637|NCT00092521|3387088|P2|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
1042638|NCT00092521|3387089|P1|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2
1042639|NCT00092521|3387086|P4|Vaccination (Day 1 Through Month 7)|Unblinded|0
1042640|NCT00092521|3387087|P3|Vaccination (Day 1 Through Month 7)|Unblinded|0
1042641|NCT00092521|3387088|P2|Vaccination (Day 1 Through Month 7)|Unblinded|0
1042642|NCT00092521|3387089|P1|Vaccination (Day 1 Through Month 7)|Unblinded|2
1042643|NCT00092521|3387086|P4|Vaccination (Day 1 Through Month 7)|Moved|0
1042644|NCT00092521|3387087|P3|Vaccination (Day 1 Through Month 7)|Moved|18
1042645|NCT00092521|3387088|P2|Vaccination (Day 1 Through Month 7)|Moved|1
1042646|NCT00092521|3387089|P1|Vaccination (Day 1 Through Month 7)|Moved|14
1042647|NCT00092521|3387086|P4|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0
1042648|NCT00092521|3387087|P3|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62
1042649|NCT00092521|3387088|P2|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7
1042650|NCT00092521|3387089|P1|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59
1042651|NCT00092521|3387086|P4|Vaccination (Day 1 Through Month 7)|Pregnancy|0
1042652|NCT00092521|3387087|P3|Vaccination (Day 1 Through Month 7)|Pregnancy|7
1042653|NCT00092521|3387088|P2|Vaccination (Day 1 Through Month 7)|Pregnancy|0
1042654|NCT00092521|3387089|P1|Vaccination (Day 1 Through Month 7)|Pregnancy|5
1042655|NCT00092521|3387086|P4|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0
1042656|NCT00092521|3387087|P3|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44
1042657|NCT00092521|3387088|P2|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6
1042658|NCT00092521|3387089|P1|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51
1042659|NCT00092521|3387086|P4|Vaccination (Day 1 Through Month 7)|Death|0
1042660|NCT00092521|3387087|P3|Vaccination (Day 1 Through Month 7)|Death|1
1042661|NCT00092521|3387088|P2|Vaccination (Day 1 Through Month 7)|Death|0
1042662|NCT00092521|3387089|P1|Vaccination (Day 1 Through Month 7)|Death|0
1042663|NCT00092521|3387086|P4|Vaccination (Day 1 Through Month 7)|Adverse Event|0
1042664|NCT00092521|3387087|P3|Vaccination (Day 1 Through Month 7)|Adverse Event|7
1042665|NCT00092521|3387088|P2|Vaccination (Day 1 Through Month 7)|Adverse Event|0
1042666|NCT00092521|3387089|P1|Vaccination (Day 1 Through Month 7)|Adverse Event|1
1042667|NCT00092521|3387086|P4|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
1042668|NCT00092521|3387087|P3|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7
1042669|NCT00092521|3387088|P2|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
1042670|NCT00092521|3387089|P1|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6
1042671|NCT00092495|3387103|P5|Base Study Follow-up Period|Withdrawal by Subject|0
1042672|NCT00092495|3387104|P4|Base Study Follow-up Period|Withdrawal by Subject|0
1042673|NCT00092495|3387105|P3|Base Study Follow-up Period|Withdrawal by Subject|0
1042674|NCT00092495|3387106|P2|Base Study Follow-up Period|Withdrawal by Subject|0
1042675|NCT00092495|3387107|P1|Base Study Follow-up Period|Withdrawal by Subject|2
1042676|NCT00092495|3387103|P5|Base Study Follow-up Period|Lost to Follow-up|0
1042677|NCT00092495|3387104|P4|Base Study Follow-up Period|Lost to Follow-up|12
1042678|NCT00092495|3387105|P3|Base Study Follow-up Period|Lost to Follow-up|3
1042679|NCT00092495|3387106|P2|Base Study Follow-up Period|Lost to Follow-up|3
1042680|NCT00092495|3387107|P1|Base Study Follow-up Period|Lost to Follow-up|1
1042681|NCT00092495|3387103|P5|Base Study Follow-up Period|Extended|0
1042682|NCT00092495|3387104|P4|Base Study Follow-up Period|Extended|2
1042683|NCT00092495|3387105|P3|Base Study Follow-up Period|Extended|1
1042684|NCT00092495|3387106|P2|Base Study Follow-up Period|Extended|0
1042685|NCT00092495|3387107|P1|Base Study Follow-up Period|Extended|0
1042686|NCT00092495|3387103|P5|Base Study Vaccination Period|Withdrawal by Subject|0
1042687|NCT00092495|3387104|P4|Base Study Vaccination Period|Withdrawal by Subject|25
1042688|NCT00092495|3387105|P3|Base Study Vaccination Period|Withdrawal by Subject|14
1042689|NCT00092495|3387106|P2|Base Study Vaccination Period|Withdrawal by Subject|10
1042690|NCT00092495|3387107|P1|Base Study Vaccination Period|Withdrawal by Subject|9
1042691|NCT00092495|3387103|P5|Base Study Vaccination Period|Protocol Violation|0
1042692|NCT00092495|3387104|P4|Base Study Vaccination Period|Protocol Violation|0
1042693|NCT00092495|3387105|P3|Base Study Vaccination Period|Protocol Violation|0
1042694|NCT00092495|3387106|P2|Base Study Vaccination Period|Protocol Violation|0
1042695|NCT00092495|3387107|P1|Base Study Vaccination Period|Protocol Violation|1
1042696|NCT00092495|3387103|P5|Base Study Vaccination Period|Parent Withdrew Consent|0
1042697|NCT00092495|3387104|P4|Base Study Vaccination Period|Parent Withdrew Consent|5
1042698|NCT00092495|3387105|P3|Base Study Vaccination Period|Parent Withdrew Consent|1
1042699|NCT00092495|3387106|P2|Base Study Vaccination Period|Parent Withdrew Consent|1
1042700|NCT00092495|3387107|P1|Base Study Vaccination Period|Parent Withdrew Consent|1
1042701|NCT00092495|3387103|P5|Base Study Vaccination Period|Pregnancy|0
1042702|NCT00092495|3387104|P4|Base Study Vaccination Period|Pregnancy|0
1042703|NCT00092495|3387105|P3|Base Study Vaccination Period|Pregnancy|0
1042704|NCT00092495|3387106|P2|Base Study Vaccination Period|Pregnancy|0
1042705|NCT00092495|3387107|P1|Base Study Vaccination Period|Pregnancy|2
1042706|NCT00092495|3387103|P5|Base Study Vaccination Period|Other|0
1042707|NCT00092495|3387104|P4|Base Study Vaccination Period|Other|2
1042708|NCT00092495|3387105|P3|Base Study Vaccination Period|Other|0
1042709|NCT00092495|3387106|P2|Base Study Vaccination Period|Other|1
1042710|NCT00092495|3387107|P1|Base Study Vaccination Period|Other|1
1042711|NCT00092495|3387103|P5|Base Study Vaccination Period|Moved|0
1042712|NCT00092495|3387104|P4|Base Study Vaccination Period|Moved|2
1042713|NCT00092495|3387105|P3|Base Study Vaccination Period|Moved|2
1042714|NCT00092495|3387106|P2|Base Study Vaccination Period|Moved|1
1042715|NCT00092495|3387107|P1|Base Study Vaccination Period|Moved|3
1042716|NCT00092495|3387103|P5|Base Study Vaccination Period|Lost to Follow-up|0
1042717|NCT00092495|3387104|P4|Base Study Vaccination Period|Lost to Follow-up|36
1042718|NCT00092495|3387105|P3|Base Study Vaccination Period|Lost to Follow-up|11
1042719|NCT00092495|3387106|P2|Base Study Vaccination Period|Lost to Follow-up|6
1042720|NCT00092495|3387107|P1|Base Study Vaccination Period|Lost to Follow-up|16
1042721|NCT00092495|3387103|P5|Base Study Vaccination Period|Adverse Event|0
1042722|NCT00092495|3387104|P4|Base Study Vaccination Period|Adverse Event|3
1042723|NCT00092495|3387105|P3|Base Study Vaccination Period|Adverse Event|0
1042724|NCT00092495|3387106|P2|Base Study Vaccination Period|Adverse Event|0
1042725|NCT00092495|3387107|P1|Base Study Vaccination Period|Adverse Event|1
1042726|NCT00092495|3387103|P5|Base Study Vaccination Period|*Pregnancy|0
1042727|NCT00092495|3387104|P4|Base Study Vaccination Period|*Pregnancy|7
1042728|NCT00092495|3387105|P3|Base Study Vaccination Period|*Pregnancy|5
1042729|NCT00092495|3387106|P2|Base Study Vaccination Period|*Pregnancy|2
1042730|NCT00092495|3387107|P1|Base Study Vaccination Period|*Pregnancy|0
1042731|NCT00092495|3387103|P5|Base Study Vaccination Period|*Other reasons|0
1042732|NCT00092495|3387104|P4|Base Study Vaccination Period|*Other reasons|1
1042733|NCT00092495|3387105|P3|Base Study Vaccination Period|*Other reasons|0
1042734|NCT00092495|3387106|P2|Base Study Vaccination Period|*Other reasons|0
1042735|NCT00092495|3387107|P1|Base Study Vaccination Period|*Other reasons|1
1042736|NCT00092495|3387103|P5|Base Study Vaccination Period|*Clinical AE|0
1042737|NCT00092495|3387104|P4|Base Study Vaccination Period|*Clinical AE|2
1042738|NCT00092495|3387105|P3|Base Study Vaccination Period|*Clinical AE|1
1042739|NCT00092495|3387106|P2|Base Study Vaccination Period|*Clinical AE|0
1042740|NCT00092495|3387107|P1|Base Study Vaccination Period|*Clinical AE|1
1042741|NCT00092495|3387103|P5|Base Study Vaccination Period|Extended|0
1042742|NCT00092495|3387104|P4|Base Study Vaccination Period|Extended|1
1042743|NCT00092495|3387105|P3|Base Study Vaccination Period|Extended|0
1042744|NCT00092495|3387106|P2|Base Study Vaccination Period|Extended|0
1042745|NCT00092495|3387107|P1|Base Study Vaccination Period|Extended|0
1042746|NCT00092495|3387103|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
1042747|NCT00092495|3387104|P4|Base Study Vaccination Period|Randomized Not Vaccinated|4
1042748|NCT00092495|3387105|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
1042749|NCT00092495|3387106|P2|Base Study Vaccination Period|Randomized Not Vaccinated|1
1042750|NCT00092495|3387107|P1|Base Study Vaccination Period|Randomized Not Vaccinated|1
1042751|NCT00092456|3387173|P4|Overall Study|Not Specified|0
1042752|NCT00092456|3387174|P3|Overall Study|Not Specified|3
1042753|NCT00092456|3387175|P2|Overall Study|Not Specified|2
1042754|NCT00092456|3387176|P1|Overall Study|Not Specified|4
1042755|NCT00092456|3387173|P4|Overall Study|Moved|1
1042756|NCT00092456|3387174|P3|Overall Study|Moved|0
1042757|NCT00092456|3387175|P2|Overall Study|Moved|1
1042758|NCT00092456|3387176|P1|Overall Study|Moved|1
1042759|NCT00092456|3387173|P4|Overall Study|Withdrawal by Subject|6
1042760|NCT00092456|3387174|P3|Overall Study|Withdrawal by Subject|16
1042761|NCT00092456|3387175|P2|Overall Study|Withdrawal by Subject|5
1042762|NCT00092456|3387176|P1|Overall Study|Withdrawal by Subject|13
1042763|NCT00092456|3387173|P4|Overall Study|Protocol Violation|6
1042764|NCT00092456|3387174|P3|Overall Study|Protocol Violation|8
1042765|NCT00092456|3387175|P2|Overall Study|Protocol Violation|7
1042766|NCT00092456|3387176|P1|Overall Study|Protocol Violation|5
1042767|NCT00092456|3387173|P4|Overall Study|Lost to Follow-up|2
1042768|NCT00092456|3387174|P3|Overall Study|Lost to Follow-up|1
1042769|NCT00092456|3387175|P2|Overall Study|Lost to Follow-up|2
1042770|NCT00092456|3387176|P1|Overall Study|Lost to Follow-up|2
1042771|NCT00092456|3387173|P4|Overall Study|Adverse Event|1
1042772|NCT00092456|3387174|P3|Overall Study|Adverse Event|1
1042773|NCT00092456|3387175|P2|Overall Study|Adverse Event|0
1042774|NCT00092456|3387176|P1|Overall Study|Adverse Event|0
1042775|NCT00092443|3387224|P2|Overall Study|Not Specified|13
1042776|NCT00092443|3387225|P1|Overall Study|Not Specified|17
1042777|NCT00092443|3387224|P2|Overall Study|Moved|5
1042778|NCT00092443|3387225|P1|Overall Study|Moved|5
1042779|NCT00092443|3387224|P2|Overall Study|Withdrawal by Subject|11
1042780|NCT00092443|3387225|P1|Overall Study|Withdrawal by Subject|9
1042781|NCT00092443|3387224|P2|Overall Study|Protocol Violation|9
1042782|NCT00092443|3387225|P1|Overall Study|Protocol Violation|11
1042783|NCT00092443|3387224|P2|Overall Study|Lost to Follow-up|3
1042784|NCT00092443|3387225|P1|Overall Study|Lost to Follow-up|7
1042785|NCT00092443|3387224|P2|Overall Study|Adverse Event|13
1042786|NCT00092443|3387225|P1|Overall Study|Adverse Event|9
1042787|NCT00092417|3387243|P2|Overall Study|Not Specified|0
1042788|NCT00092417|3387244|P1|Overall Study|Not Specified|1
1042789|NCT00092417|3387243|P2|Overall Study|Withdrawal by Subject|1
1042790|NCT00092417|3387244|P1|Overall Study|Withdrawal by Subject|2
1042791|NCT00092417|3387243|P2|Overall Study|Lost to Follow-up|0
1042792|NCT00092417|3387244|P1|Overall Study|Lost to Follow-up|2
1042793|NCT00092131|3387258|P2|Treatment Period II|Adverse Event|1
1042794|NCT00092131|3387259|P1|Treatment Period II|Adverse Event|0
1042795|NCT00092131|3387258|P2|Treatment Period I|Adverse Event|0
1042796|NCT00092131|3387259|P1|Treatment Period I|Adverse Event|1
1042797|NCT00092118|3387289|P2|Overall Study|Not Specified|5
1042798|NCT00092118|3387290|P1|Overall Study|Not Specified|6
1042799|NCT00092118|3387289|P2|Overall Study|Withdrawal by Subject|10
1042800|NCT00092118|3387290|P1|Overall Study|Withdrawal by Subject|4
1042801|NCT00092118|3387289|P2|Overall Study|Protocol Violation|25
1042802|NCT00092118|3387290|P1|Overall Study|Protocol Violation|23
1042803|NCT00092118|3387289|P2|Overall Study|Lost to Follow-up|3
1042804|NCT00092118|3387290|P1|Overall Study|Lost to Follow-up|4
1042805|NCT00092118|3387289|P2|Overall Study|Lack of Efficacy|14
1042806|NCT00092118|3387290|P1|Overall Study|Lack of Efficacy|12
1042807|NCT00092118|3387289|P2|Overall Study|Adverse Event|32
1042808|NCT00092118|3387290|P1|Overall Study|Adverse Event|35
1042809|NCT00091949|3387324|P2|Overall Study|Lost to Follow-up|41
1042810|NCT00091949|3387325|P1|Overall Study|Lost to Follow-up|58
1042811|NCT00091949|3387324|P2|Overall Study|Withdrawal by Subject|110
1042812|NCT00091949|3387325|P1|Overall Study|Withdrawal by Subject|117
1042813|NCT00091832|3387349|P6|Overall Study|Protocol Violation|1
1042814|NCT00091832|3387350|P5|Overall Study|Protocol Violation|0
1042815|NCT00091832|3387351|P4|Overall Study|Protocol Violation|0
1042816|NCT00091832|3387352|P3|Overall Study|Protocol Violation|1
1042817|NCT00091832|3387353|P2|Overall Study|Protocol Violation|0
1042818|NCT00091832|3387354|P1|Overall Study|Protocol Violation|0
1042819|NCT00091832|3387349|P6|Overall Study|Other|0
1042820|NCT00091832|3387350|P5|Overall Study|Other|0
1042821|NCT00091832|3387351|P4|Overall Study|Other|0
1042822|NCT00091832|3387352|P3|Overall Study|Other|2
1042823|NCT00091832|3387353|P2|Overall Study|Other|1
1042824|NCT00091832|3387354|P1|Overall Study|Other|0
1042825|NCT00091832|3387349|P6|Overall Study|Noncompliance|0
1042826|NCT00091832|3387350|P5|Overall Study|Noncompliance|0
1042827|NCT00091832|3387351|P4|Overall Study|Noncompliance|0
1042828|NCT00091832|3387352|P3|Overall Study|Noncompliance|0
1042829|NCT00091832|3387353|P2|Overall Study|Noncompliance|1
1042830|NCT00091832|3387354|P1|Overall Study|Noncompliance|0
1042831|NCT00091832|3387349|P6|Overall Study|Lost to Follow-up|1
1042832|NCT00091832|3387350|P5|Overall Study|Lost to Follow-up|2
1042833|NCT00091832|3387351|P4|Overall Study|Lost to Follow-up|3
1042834|NCT00091832|3387352|P3|Overall Study|Lost to Follow-up|3
1042835|NCT00091832|3387353|P2|Overall Study|Lost to Follow-up|0
1042836|NCT00091832|3387354|P1|Overall Study|Lost to Follow-up|1
1042837|NCT00091832|3387349|P6|Overall Study|Ineligibility Determined|0
1042838|NCT00091832|3387350|P5|Overall Study|Ineligibility Determined|1
1042839|NCT00091832|3387351|P4|Overall Study|Ineligibility Determined|0
1042840|NCT00091832|3387352|P3|Overall Study|Ineligibility Determined|1
1042841|NCT00091832|3387353|P2|Overall Study|Ineligibility Determined|0
1042842|NCT00091832|3387354|P1|Overall Study|Ineligibility Determined|0
1042843|NCT00091832|3387349|P6|Overall Study|Disease Progression|2
1042844|NCT00091832|3387350|P5|Overall Study|Disease Progression|1
1042845|NCT00091832|3387351|P4|Overall Study|Disease Progression|1
1042846|NCT00091832|3387352|P3|Overall Study|Disease Progression|0
1042847|NCT00091832|3387353|P2|Overall Study|Disease Progression|0
1042848|NCT00091832|3387354|P1|Overall Study|Disease Progression|2
1042849|NCT00091832|3387349|P6|Overall Study|Death|6
1042850|NCT00091832|3387350|P5|Overall Study|Death|5
1042851|NCT00091832|3387351|P4|Overall Study|Death|8
1042852|NCT00091832|3387352|P3|Overall Study|Death|5
1042853|NCT00091832|3387353|P2|Overall Study|Death|4
1042854|NCT00091832|3387354|P1|Overall Study|Death|6
1042855|NCT00091832|3387349|P6|Overall Study|Withdrawal by Subject|1
1042856|NCT00091832|3387350|P5|Overall Study|Withdrawal by Subject|3
1042857|NCT00091832|3387351|P4|Overall Study|Withdrawal by Subject|1
1042858|NCT00091832|3387352|P3|Overall Study|Withdrawal by Subject|0
1042859|NCT00091832|3387353|P2|Overall Study|Withdrawal by Subject|5
1042860|NCT00091832|3387354|P1|Overall Study|Withdrawal by Subject|4
1042861|NCT00091832|3387349|P6|Overall Study|Adverse Event|0
1042862|NCT00091832|3387350|P5|Overall Study|Adverse Event|3
1042863|NCT00091832|3387351|P4|Overall Study|Adverse Event|1
1042864|NCT00091832|3387352|P3|Overall Study|Adverse Event|0
1042865|NCT00091832|3387353|P2|Overall Study|Adverse Event|0
1042866|NCT00091832|3387354|P1|Overall Study|Adverse Event|0
1042867|NCT00091832|3387349|P6|Overall Study|Physician Decision|0
1042868|NCT00091832|3387350|P5|Overall Study|Physician Decision|0
1042869|NCT00091832|3387351|P4|Overall Study|Physician Decision|0
1042870|NCT00091832|3387352|P3|Overall Study|Physician Decision|0
1042871|NCT00091832|3387353|P2|Overall Study|Physician Decision|0
1042872|NCT00091832|3387354|P1|Overall Study|Physician Decision|1
1042873|NCT00091819|3387472|P2|Overall Study|Never received study treatment|4
1042874|NCT00091819|3387473|P1|Overall Study|Never received study treatment|3
1042875|NCT00091819|3387472|P2|Overall Study|Other|3
1042876|NCT00091819|3387473|P1|Overall Study|Other|2
1042877|NCT00091819|3387472|P2|Overall Study|Protocol Violation|2
1042878|NCT00091819|3387473|P1|Overall Study|Protocol Violation|1
1042879|NCT00091819|3387472|P2|Overall Study|Withdrawal by Subject|8
1042880|NCT00091819|3387473|P1|Overall Study|Withdrawal by Subject|5
1042881|NCT00091819|3387472|P2|Overall Study|Lost to Follow-up|23
1042882|NCT00091819|3387473|P1|Overall Study|Lost to Follow-up|26
1042883|NCT00091819|3387472|P2|Overall Study|Death|5
1042884|NCT00091819|3387473|P1|Overall Study|Death|4
1042885|NCT00091819|3387472|P2|Overall Study|Adverse Event|1
1042886|NCT00091819|3387473|P1|Overall Study|Adverse Event|1
1042887|NCT00091793|3387481|P2|Overall Study|Other|0
1042888|NCT00091793|3387482|P1|Overall Study|Other|2
1042889|NCT00091793|3387481|P2|Overall Study|Noncompliance|0
1042890|NCT00091793|3387482|P1|Overall Study|Noncompliance|2
1042891|NCT00091793|3387481|P2|Overall Study|Lost to Follow-up|5
1042892|NCT00091793|3387482|P1|Overall Study|Lost to Follow-up|7
1042893|NCT00091793|3387481|P2|Overall Study|Ineligibility determined|0
1042894|NCT00091793|3387482|P1|Overall Study|Ineligibility determined|2
1042895|NCT00091793|3387481|P2|Overall Study|Withdrawal by Subject|15
1042896|NCT00091793|3387482|P1|Overall Study|Withdrawal by Subject|10
1042897|NCT00091793|3387481|P2|Overall Study|Adverse Event|2
1042898|NCT00091793|3387482|P1|Overall Study|Adverse Event|1
1042899|NCT00091572|3387506|P2|Overall Study|Toxicity (Related AE)|9
1042900|NCT00091572|3387507|P1|Overall Study|Toxicity (Related AE)|53
1042901|NCT00091572|3387506|P2|Overall Study|Major Protocol Violation|0
1042902|NCT00091572|3387507|P1|Overall Study|Major Protocol Violation|2
1042903|NCT00091572|3387506|P2|Overall Study|Ongoing (still on treatment)|12
1042904|NCT00091572|3387507|P1|Overall Study|Ongoing (still on treatment)|8
1042905|NCT00091572|3387506|P2|Overall Study|Other Reason|13
1042906|NCT00091572|3387507|P1|Overall Study|Other Reason|6
1042907|NCT00091572|3387506|P2|Overall Study|Medical Decision unrelated toxicity/PD|22
1042908|NCT00091572|3387507|P1|Overall Study|Medical Decision unrelated toxicity/PD|10
1042909|NCT00091572|3387506|P2|Overall Study|Death not due to malignancy/toxicity|3
1042910|NCT00091572|3387507|P1|Overall Study|Death not due to malignancy/toxicity|1
1042911|NCT00091572|3387506|P2|Overall Study|Subject's Refusal unrelated to toxicity|22
1042912|NCT00091572|3387507|P1|Overall Study|Subject's Refusal unrelated to toxicity|14
1042913|NCT00091572|3387506|P2|Overall Study|Lost to Follow-up|1
1042914|NCT00091572|3387507|P1|Overall Study|Lost to Follow-up|1
1042915|NCT00091442|3387538|P2|Overall Study|Not Specified|6
1042916|NCT00091442|3387539|P1|Overall Study|Not Specified|2
1042917|NCT00091442|3387538|P2|Overall Study|Lost to Follow-up|3
1042918|NCT00091442|3387539|P1|Overall Study|Lost to Follow-up|1
1042919|NCT00091442|3387538|P2|Overall Study|Death|7
1042920|NCT00091442|3387539|P1|Overall Study|Death|9
1042921|NCT00091442|3387538|P2|Overall Study|2cycles therapy beyond Complete response|16
1042922|NCT00091442|3387539|P1|Overall Study|2cycles therapy beyond Complete response|9
1042923|NCT00091442|3387538|P2|Overall Study|Adverse Event|48
1042924|NCT00091442|3387539|P1|Overall Study|Adverse Event|29
1042925|NCT00091442|3387538|P2|Overall Study|Withdrawal by Subject|46
1042926|NCT00091442|3387539|P1|Overall Study|Withdrawal by Subject|38
1042927|NCT00091442|3387538|P2|Overall Study|Physician Decision|58
1042928|NCT00091442|3387539|P1|Overall Study|Physician Decision|61
1042929|NCT00091442|3387538|P2|Overall Study|Progressive Disease|189
1042930|NCT00091442|3387539|P1|Overall Study|Progressive Disease|220
1042931|NCT00091390|3387549|P1|Overall Study|Protocol Violation|2
1042932|NCT00091390|3387549|P1|Overall Study|Withdrawal by Subject|2
1042933|NCT00091169|3387567|P2|Overall Study|Not start protocol therapy|17
1042934|NCT00091169|3387568|P1|Overall Study|Not start protocol therapy|26
1042935|NCT00091169|3387567|P2|Overall Study|Other|4
1042936|NCT00091169|3387568|P1|Overall Study|Other|3
1042937|NCT00091169|3387567|P2|Overall Study|Withdrawal by Subject|13
1042938|NCT00091169|3387568|P1|Overall Study|Withdrawal by Subject|10
1042939|NCT00091169|3387567|P2|Overall Study|Death|1
1042940|NCT00091169|3387568|P1|Overall Study|Death|4
1042941|NCT00091169|3387567|P2|Overall Study|Adverse Event|17
1042942|NCT00091169|3387568|P1|Overall Study|Adverse Event|11
1042943|NCT00091169|3387567|P2|Overall Study|Disease progression|1
1042944|NCT00091169|3387568|P1|Overall Study|Disease progression|3
1042945|NCT00091026|3387586|P2|Overall Study|Unknown-never received treatment|1
1042946|NCT00091026|3387587|P1|Overall Study|Unknown-never received treatment|0
1042947|NCT00091026|3387586|P2|Overall Study|Patient withdrew and never received trea|2
1042948|NCT00091026|3387587|P1|Overall Study|Patient withdrew and never received trea|0
1042949|NCT00091026|3387586|P2|Overall Study|Patient deemed non eligible-never receiv|0
1042950|NCT00091026|3387587|P1|Overall Study|Patient deemed non eligible-never receiv|1
1042951|NCT00090987|3387597|P1|Overall Study|Incarcerated|1
1042952|NCT00090987|3387597|P1|Overall Study|Non-compliance|4
1042953|NCT00090987|3387597|P1|Overall Study|alternative therapy|1
1042954|NCT00090987|3387597|P1|Overall Study|Withdrawal by Subject|3
1042955|NCT00090987|3387597|P1|Overall Study|Lack of Efficacy|7
1042956|NCT00090987|3387597|P1|Overall Study|Adverse Event|5
1042957|NCT00090857|3387610|P2|Overall Study|Adverse Event|2
1042958|NCT00090857|3387611|P1|Overall Study|Adverse Event|2
1042959|NCT00090857|3387610|P2|Overall Study|Withdrawal by Subject|0
1042960|NCT00090857|3387611|P1|Overall Study|Withdrawal by Subject|2
1042961|NCT00090857|3387610|P2|Overall Study|Lost to Follow-up|1
1042962|NCT00090857|3387611|P1|Overall Study|Lost to Follow-up|0
1042963|NCT00090779|3387650|P2|Step 3|Off extended study due to study closure|3
1042964|NCT00090779|3387651|P1|Step 3|Off extended study due to study closure|4
1042965|NCT00090779|3387650|P2|Step 3|Initiation of ART and off extended study|2
1042966|NCT00090779|3387651|P1|Step 3|Initiation of ART and off extended study|3
1042967|NCT00090779|3387650|P2|Step 2|Non-compliance to study requirements|1
1042968|NCT00090779|3387651|P1|Step 2|Non-compliance to study requirements|0
1042969|NCT00090779|3387650|P2|Step 2|Subject relocated|1
1042970|NCT00090779|3387651|P1|Step 2|Subject relocated|0
1042971|NCT00090779|3387650|P2|Step 2|Off study per study closure|16
1042972|NCT00090779|3387651|P1|Step 2|Off study per study closure|6
1042973|NCT00090779|3387650|P2|Step 1|Subject relocated|8
1042974|NCT00090779|3387651|P1|Step 1|Subject relocated|2
1042975|NCT00090779|3387650|P2|Step 1|Non-compliance to study requirements|1
1042976|NCT00090779|3387651|P1|Step 1|Non-compliance to study requirements|0
1042977|NCT00090779|3387650|P2|Step 1|Pregnancy|0
1042978|NCT00090779|3387651|P1|Step 1|Pregnancy|1
1042979|NCT00090779|3387650|P2|Step 1|Physician Decision|0
1042980|NCT00090779|3387651|P1|Step 1|Physician Decision|1
1042981|NCT00090779|3387650|P2|Step 1|Death|2
1042982|NCT00090779|3387651|P1|Step 1|Death|0
1042983|NCT00090779|3387650|P2|Step 1|Lost to Follow-up|2
1042984|NCT00090779|3387651|P1|Step 1|Lost to Follow-up|3
1042985|NCT00090779|3387650|P2|Step 1|Withdrawal by Subject|2
1042986|NCT00090779|3387651|P1|Step 1|Withdrawal by Subject|4
1042987|NCT00090766|3387675|P3|Overall Study|Lost to Follow-up|2
1042988|NCT00090766|3387676|P2|Overall Study|Lost to Follow-up|0
1042989|NCT00090766|3387677|P1|Overall Study|Lost to Follow-up|2
1042990|NCT00090766|3387675|P3|Overall Study|Admin|0
1042991|NCT00090766|3387676|P2|Overall Study|Admin|2
1042992|NCT00090766|3387677|P1|Overall Study|Admin|0
1042993|NCT00090766|3387675|P3|Overall Study|Death|0
1042994|NCT00090766|3387676|P2|Overall Study|Death|0
1042995|NCT00090766|3387677|P1|Overall Study|Death|1
1042996|NCT00090766|3387675|P3|Overall Study|Nephrectomy Planned|1
1042997|NCT00090766|3387676|P2|Overall Study|Nephrectomy Planned|0
1042998|NCT00090766|3387677|P1|Overall Study|Nephrectomy Planned|0
1042999|NCT00090753|3387719|P2|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43
1043000|NCT00090753|3387720|P1|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65
1043001|NCT00090753|3387719|P2|Extended Treatment Period|Mircera Commercialization|93
1043002|NCT00090753|3387720|P1|Extended Treatment Period|Mircera Commercialization|188
1043003|NCT00090753|3387719|P2|Extended Treatment Period|Renal Transplant|12
1043004|NCT00090753|3387720|P1|Extended Treatment Period|Renal Transplant|15
1043005|NCT00090753|3387719|P2|Extended Treatment Period|Lost to Follow-up|1
1043006|NCT00090753|3387720|P1|Extended Treatment Period|Lost to Follow-up|3
1043007|NCT00090753|3387719|P2|Extended Treatment Period|Refused Treatment|12
1043008|NCT00090753|3387720|P1|Extended Treatment Period|Refused Treatment|18
1043009|NCT00090753|3387719|P2|Extended Treatment Period|Lack of Efficacy|0
1043010|NCT00090753|3387720|P1|Extended Treatment Period|Lack of Efficacy|1
1043011|NCT00090753|3387719|P2|Extended Treatment Period|Death|30
1043012|NCT00090753|3387720|P1|Extended Treatment Period|Death|58
1043013|NCT00090753|3387719|P2|Extended Treatment Period|Adverse Event|0
1043014|NCT00090753|3387720|P1|Extended Treatment Period|Adverse Event|11
1043015|NCT00090753|3387719|P2|First Treatment Period|Other Unrelated to Safety and Efficacy|28
1043016|NCT00090753|3387720|P1|First Treatment Period|Other Unrelated to Safety and Efficacy|39
1043017|NCT00090753|3387719|P2|First Treatment Period|Mircera Commercialization|0
1043018|NCT00090753|3387720|P1|First Treatment Period|Mircera Commercialization|1
1043019|NCT00090753|3387719|P2|First Treatment Period|Renal Transplant|50
1043020|NCT00090753|3387720|P1|First Treatment Period|Renal Transplant|70
1043021|NCT00090753|3387719|P2|First Treatment Period|Lost to Follow-up|4
1043022|NCT00090753|3387720|P1|First Treatment Period|Lost to Follow-up|4
1043023|NCT00090753|3387719|P2|First Treatment Period|Refused Treatment|25
1043024|NCT00090753|3387720|P1|First Treatment Period|Refused Treatment|32
1043025|NCT00090753|3387719|P2|First Treatment Period|Lack of Efficacy|1
1043026|NCT00090753|3387720|P1|First Treatment Period|Lack of Efficacy|2
1043027|NCT00090753|3387719|P2|First Treatment Period|Death|62
1043028|NCT00090753|3387720|P1|First Treatment Period|Death|88
1043029|NCT00090753|3387719|P2|First Treatment Period|Adverse Event|8
1043030|NCT00090753|3387720|P1|First Treatment Period|Adverse Event|20
1043031|NCT00090610|3387730|P2|Overall Study|Withdrawal by Subject|1
1043032|NCT00090610|3387731|P1|Overall Study|Withdrawal by Subject|1
1043033|NCT00090584|3387747|P2|Baseline to 8 Months|Lost to Follow-up|41
1043034|NCT00090584|3387748|P1|Baseline to 8 Months|Lost to Follow-up|44
1043035|NCT00090584|3387747|P2|Baseline to 10 Weeks|Lost to Follow-up|12
1043036|NCT00090584|3387748|P1|Baseline to 10 Weeks|Lost to Follow-up|15
1043037|NCT00090519|3387780|P2|Overall Study|Sponsor Decision|1
1043038|NCT00090519|3387781|P1|Overall Study|Sponsor Decision|3
1043039|NCT00090519|3387780|P2|Overall Study|Physician Decision|3
1043040|NCT00090519|3387781|P1|Overall Study|Physician Decision|2
1043041|NCT00090519|3387780|P2|Overall Study|Withdrawal by Subject|29
1043042|NCT00090519|3387781|P1|Overall Study|Withdrawal by Subject|28
1043043|NCT00090519|3387780|P2|Overall Study|Lost to Follow-up|29
1043044|NCT00090519|3387781|P1|Overall Study|Lost to Follow-up|26
1043045|NCT00090519|3387780|P2|Overall Study|Death|9
1043046|NCT00090519|3387781|P1|Overall Study|Death|9
1043047|NCT00090519|3387780|P2|Overall Study|Adverse Event|4
1043048|NCT00090519|3387781|P1|Overall Study|Adverse Event|5
1043049|NCT00090493|3387805|P1|Overall Study|Physician Decision|2
1043050|NCT00090363|3387812|P3|Overall Study|Continuing on study off treatment|16
1043051|NCT00090363|3387813|P2|Overall Study|Continuing on study off treatment|13
1043052|NCT00090363|3387814|P1|Overall Study|Continuing on study off treatment|14
1043053|NCT00090363|3387812|P3|Overall Study|Reasons not specified|1
1043054|NCT00090363|3387813|P2|Overall Study|Reasons not specified|1
1043055|NCT00090363|3387814|P1|Overall Study|Reasons not specified|2
1043056|NCT00090363|3387812|P3|Overall Study|Consent expired|9
1043057|NCT00090363|3387813|P2|Overall Study|Consent expired|10
1043058|NCT00090363|3387814|P1|Overall Study|Consent expired|7
1043059|NCT00090363|3387812|P3|Overall Study|Eligibility criteria not fulfilled|1
1043060|NCT00090363|3387813|P2|Overall Study|Eligibility criteria not fulfilled|0
1043061|NCT00090363|3387814|P1|Overall Study|Eligibility criteria not fulfilled|0
1043062|NCT00090363|3387812|P3|Overall Study|Study-specific discontinuation criteria|62
1043063|NCT00090363|3387813|P2|Overall Study|Study-specific discontinuation criteria|74
1043064|NCT00090363|3387814|P1|Overall Study|Study-specific discontinuation criteria|75
1043065|NCT00090363|3387812|P3|Overall Study|Withdrawal by Subject|6
1043066|NCT00090363|3387813|P2|Overall Study|Withdrawal by Subject|7
1043067|NCT00090363|3387814|P1|Overall Study|Withdrawal by Subject|7
1043068|NCT00090363|3387812|P3|Overall Study|Lost to Follow-up|1
1043069|NCT00090363|3387813|P2|Overall Study|Lost to Follow-up|2
1043070|NCT00090363|3387814|P1|Overall Study|Lost to Follow-up|1
1043071|NCT00090545|3387836|P2|Overall Study|Adverse Event|2
1043072|NCT00090545|3387837|P1|Overall Study|Adverse Event|0
1043073|NCT00090545|3387836|P2|Overall Study|Death|1
1043074|NCT00090545|3387837|P1|Overall Study|Death|0
1043075|NCT00090545|3387836|P2|Overall Study|Refused further treatment|4
1043076|NCT00090545|3387837|P1|Overall Study|Refused further treatment|1
1043077|NCT00090545|3387836|P2|Overall Study|Disease progression on study|17
1043078|NCT00090545|3387837|P1|Overall Study|Disease progression on study|21
1043079|NCT00090285|3387857|P6|Long-term Follow-up (EXT2)|Physician Decision|5
1043080|NCT00090285|3387858|P5|Long-term Follow-up (EXT2)|Physician Decision|6
1043081|NCT00090285|3387859|P4|Long-term Follow-up (EXT2)|Physician Decision|0
1043082|NCT00090285|3387860|P3|Long-term Follow-up (EXT2)|Physician Decision|0
1043083|NCT00090285|3387861|P2|Long-term Follow-up (EXT2)|Physician Decision|0
1043084|NCT00090285|3387862|P1|Long-term Follow-up (EXT2)|Physician Decision|0
1043085|NCT00090285|3387857|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|53
1043086|NCT00090285|3387858|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|60
1043087|NCT00090285|3387859|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1043088|NCT00090285|3387860|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1043089|NCT00090285|3387861|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1043090|NCT00090285|3387862|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1043091|NCT00090285|3387857|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|143
1043092|NCT00090285|3387858|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|156
1043093|NCT00090285|3387859|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1043094|NCT00090285|3387860|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1043095|NCT00090285|3387861|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1043096|NCT00090285|3387862|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1043097|NCT00090285|3387857|P6|Long-term Follow-up (EXT2)|Adverse Event|2
1043098|NCT00090285|3387858|P5|Long-term Follow-up (EXT2)|Adverse Event|5
1043099|NCT00090285|3387859|P4|Long-term Follow-up (EXT2)|Adverse Event|0
1043100|NCT00090285|3387860|P3|Long-term Follow-up (EXT2)|Adverse Event|0
1043101|NCT00090285|3387861|P2|Long-term Follow-up (EXT2)|Adverse Event|0
1043102|NCT00090285|3387862|P1|Long-term Follow-up (EXT2)|Adverse Event|0
1043103|NCT00090285|3387857|P6|Extension 1|Moved|0
1043104|NCT00090285|3387858|P5|Extension 1|Moved|0
1043105|NCT00090285|3387859|P4|Extension 1|Moved|0
1043106|NCT00090285|3387860|P3|Extension 1|Moved|3
1043107|NCT00090285|3387861|P2|Extension 1|Moved|0
1043108|NCT00090285|3387862|P1|Extension 1|Moved|0
1043109|NCT00090285|3387857|P6|Extension 1|Other|0
1043110|NCT00090285|3387858|P5|Extension 1|Other|0
1043111|NCT00090285|3387859|P4|Extension 1|Other|0
1043112|NCT00090285|3387860|P3|Extension 1|Other|4
1043113|NCT00090285|3387861|P2|Extension 1|Other|0
1043114|NCT00090285|3387862|P1|Extension 1|Other|0
1043115|NCT00090285|3387857|P6|Extension 1|Withdrawal by Subject|0
1043116|NCT00090285|3387858|P5|Extension 1|Withdrawal by Subject|0
1043117|NCT00090285|3387859|P4|Extension 1|Withdrawal by Subject|1
1043118|NCT00090285|3387860|P3|Extension 1|Withdrawal by Subject|13
1043119|NCT00090285|3387861|P2|Extension 1|Withdrawal by Subject|0
1043120|NCT00090285|3387862|P1|Extension 1|Withdrawal by Subject|0
1043121|NCT00090285|3387857|P6|Extension 1|Lost to Follow-up|0
1043122|NCT00090285|3387858|P5|Extension 1|Lost to Follow-up|0
1043123|NCT00090285|3387859|P4|Extension 1|Lost to Follow-up|0
1043124|NCT00090285|3387860|P3|Extension 1|Lost to Follow-up|35
1043125|NCT00090285|3387861|P2|Extension 1|Lost to Follow-up|0
1043126|NCT00090285|3387862|P1|Extension 1|Lost to Follow-up|0
1043127|NCT00090285|3387857|P6|Extension 1|Adverse Event|0
1043128|NCT00090285|3387858|P5|Extension 1|Adverse Event|0
1043129|NCT00090285|3387859|P4|Extension 1|Adverse Event|0
1043130|NCT00090285|3387860|P3|Extension 1|Adverse Event|2
1043131|NCT00090285|3387861|P2|Extension 1|Adverse Event|0
1043132|NCT00090285|3387862|P1|Extension 1|Adverse Event|0
1043133|NCT00090285|3387857|P6|Base Study Follow-up Period|Subject Incarcerated|0
1043134|NCT00090285|3387858|P5|Base Study Follow-up Period|Subject Incarcerated|0
1043135|NCT00090285|3387859|P4|Base Study Follow-up Period|Subject Incarcerated|0
1043136|NCT00090285|3387860|P3|Base Study Follow-up Period|Subject Incarcerated|0
1043137|NCT00090285|3387861|P2|Base Study Follow-up Period|Subject Incarcerated|2
1043138|NCT00090285|3387862|P1|Base Study Follow-up Period|Subject Incarcerated|0
1043139|NCT00090285|3387857|P6|Base Study Follow-up Period|Uncooperative|0
1043140|NCT00090285|3387858|P5|Base Study Follow-up Period|Uncooperative|0
1043141|NCT00090285|3387859|P4|Base Study Follow-up Period|Uncooperative|0
1043142|NCT00090285|3387860|P3|Base Study Follow-up Period|Uncooperative|0
1043143|NCT00090285|3387861|P2|Base Study Follow-up Period|Uncooperative|4
1043144|NCT00090285|3387862|P1|Base Study Follow-up Period|Uncooperative|3
1043145|NCT00090285|3387857|P6|Base Study Follow-up Period|Protocol Violation|0
1043146|NCT00090285|3387858|P5|Base Study Follow-up Period|Protocol Violation|0
1043147|NCT00090285|3387859|P4|Base Study Follow-up Period|Protocol Violation|0
1043148|NCT00090285|3387860|P3|Base Study Follow-up Period|Protocol Violation|0
1043149|NCT00090285|3387861|P2|Base Study Follow-up Period|Protocol Violation|0
1043150|NCT00090285|3387862|P1|Base Study Follow-up Period|Protocol Violation|1
1043151|NCT00090285|3387857|P6|Base Study Follow-up Period|Other|0
1043152|NCT00090285|3387858|P5|Base Study Follow-up Period|Other|0
1043153|NCT00090285|3387859|P4|Base Study Follow-up Period|Other|0
1043154|NCT00090285|3387860|P3|Base Study Follow-up Period|Other|0
1043155|NCT00090285|3387861|P2|Base Study Follow-up Period|Other|0
1043156|NCT00090285|3387862|P1|Base Study Follow-up Period|Other|2
1043157|NCT00090285|3387857|P6|Base Study Follow-up Period|Moved|0
1043158|NCT00090285|3387858|P5|Base Study Follow-up Period|Moved|0
1043159|NCT00090285|3387859|P4|Base Study Follow-up Period|Moved|0
1043160|NCT00090285|3387860|P3|Base Study Follow-up Period|Moved|0
1043161|NCT00090285|3387861|P2|Base Study Follow-up Period|Moved|36
1043162|NCT00090285|3387862|P1|Base Study Follow-up Period|Moved|41
1043163|NCT00090285|3387857|P6|Base Study Follow-up Period|Withdrawal by Subject|0
1043164|NCT00090285|3387858|P5|Base Study Follow-up Period|Withdrawal by Subject|0
1043165|NCT00090285|3387859|P4|Base Study Follow-up Period|Withdrawal by Subject|0
1043166|NCT00090285|3387860|P3|Base Study Follow-up Period|Withdrawal by Subject|0
1043167|NCT00090285|3387861|P2|Base Study Follow-up Period|Withdrawal by Subject|64
1043168|NCT00090285|3387862|P1|Base Study Follow-up Period|Withdrawal by Subject|53
1043169|NCT00090285|3387857|P6|Base Study Follow-up Period|Lost to Follow-up|0
1043170|NCT00090285|3387858|P5|Base Study Follow-up Period|Lost to Follow-up|0
1043171|NCT00090285|3387859|P4|Base Study Follow-up Period|Lost to Follow-up|0
1043172|NCT00090285|3387860|P3|Base Study Follow-up Period|Lost to Follow-up|0
1043173|NCT00090285|3387861|P2|Base Study Follow-up Period|Lost to Follow-up|226
1043174|NCT00090285|3387862|P1|Base Study Follow-up Period|Lost to Follow-up|232
1043175|NCT00090285|3387857|P6|Base Study Follow-up Period|Adverse Event|0
1043176|NCT00090285|3387858|P5|Base Study Follow-up Period|Adverse Event|0
1043177|NCT00090285|3387859|P4|Base Study Follow-up Period|Adverse Event|0
1043178|NCT00090285|3387860|P3|Base Study Follow-up Period|Adverse Event|0
1043179|NCT00090285|3387861|P2|Base Study Follow-up Period|Adverse Event|10
1043180|NCT00090285|3387862|P1|Base Study Follow-up Period|Adverse Event|3
1043181|NCT00090285|3387857|P6|Base Study Vaccination Period|HIV positive|0
1043182|NCT00090285|3387858|P5|Base Study Vaccination Period|HIV positive|0
1043183|NCT00090285|3387859|P4|Base Study Vaccination Period|HIV positive|0
1043184|NCT00090285|3387860|P3|Base Study Vaccination Period|HIV positive|0
1043185|NCT00090285|3387861|P2|Base Study Vaccination Period|HIV positive|1
1043186|NCT00090285|3387862|P1|Base Study Vaccination Period|HIV positive|1
1043187|NCT00090285|3387857|P6|Base Study Vaccination Period|Subject Incarcerated|0
1043188|NCT00090285|3387858|P5|Base Study Vaccination Period|Subject Incarcerated|0
1043189|NCT00090285|3387859|P4|Base Study Vaccination Period|Subject Incarcerated|0
1043190|NCT00090285|3387860|P3|Base Study Vaccination Period|Subject Incarcerated|0
1043191|NCT00090285|3387861|P2|Base Study Vaccination Period|Subject Incarcerated|2
1043192|NCT00090285|3387862|P1|Base Study Vaccination Period|Subject Incarcerated|2
1043193|NCT00090285|3387857|P6|Base Study Vaccination Period|Other|0
1043194|NCT00090285|3387858|P5|Base Study Vaccination Period|Other|0
1043195|NCT00090285|3387859|P4|Base Study Vaccination Period|Other|0
1043196|NCT00090285|3387860|P3|Base Study Vaccination Period|Other|0
1043197|NCT00090285|3387861|P2|Base Study Vaccination Period|Other|2
1043198|NCT00090285|3387862|P1|Base Study Vaccination Period|Other|2
1043199|NCT00090285|3387857|P6|Base Study Vaccination Period|Site Terminated|0
1043200|NCT00090285|3387858|P5|Base Study Vaccination Period|Site Terminated|0
1043201|NCT00090285|3387859|P4|Base Study Vaccination Period|Site Terminated|0
1043202|NCT00090285|3387860|P3|Base Study Vaccination Period|Site Terminated|0
1043203|NCT00090285|3387861|P2|Base Study Vaccination Period|Site Terminated|0
1043204|NCT00090285|3387862|P1|Base Study Vaccination Period|Site Terminated|1
1043205|NCT00090285|3387857|P6|Base Study Vaccination Period|Moved|0
1043206|NCT00090285|3387858|P5|Base Study Vaccination Period|Moved|0
1043207|NCT00090285|3387859|P4|Base Study Vaccination Period|Moved|0
1043208|NCT00090285|3387860|P3|Base Study Vaccination Period|Moved|0
1043209|NCT00090285|3387861|P2|Base Study Vaccination Period|Moved|21
1043210|NCT00090285|3387862|P1|Base Study Vaccination Period|Moved|20
1043211|NCT00090285|3387857|P6|Base Study Vaccination Period|Uncooperative|0
1043212|NCT00090285|3387858|P5|Base Study Vaccination Period|Uncooperative|0
1043213|NCT00090285|3387859|P4|Base Study Vaccination Period|Uncooperative|0
1043214|NCT00090285|3387860|P3|Base Study Vaccination Period|Uncooperative|0
1043215|NCT00090285|3387861|P2|Base Study Vaccination Period|Uncooperative|2
1043216|NCT00090285|3387862|P1|Base Study Vaccination Period|Uncooperative|2
1043217|NCT00090285|3387857|P6|Base Study Vaccination Period|Withdrawal by Subject|0
1043218|NCT00090285|3387858|P5|Base Study Vaccination Period|Withdrawal by Subject|0
1043219|NCT00090285|3387859|P4|Base Study Vaccination Period|Withdrawal by Subject|0
1043220|NCT00090285|3387860|P3|Base Study Vaccination Period|Withdrawal by Subject|0
1043221|NCT00090285|3387861|P2|Base Study Vaccination Period|Withdrawal by Subject|69
1043222|NCT00090285|3387862|P1|Base Study Vaccination Period|Withdrawal by Subject|64
1043223|NCT00090285|3387857|P6|Base Study Vaccination Period|Protocol Violation|0
1043224|NCT00090285|3387858|P5|Base Study Vaccination Period|Protocol Violation|0
1043225|NCT00090285|3387859|P4|Base Study Vaccination Period|Protocol Violation|0
1043226|NCT00090285|3387860|P3|Base Study Vaccination Period|Protocol Violation|0
1043227|NCT00090285|3387861|P2|Base Study Vaccination Period|Protocol Violation|3
1043228|NCT00090285|3387862|P1|Base Study Vaccination Period|Protocol Violation|2
1043229|NCT00090285|3387857|P6|Base Study Vaccination Period|Lost to Follow-up|0
1043230|NCT00090285|3387858|P5|Base Study Vaccination Period|Lost to Follow-up|0
1043231|NCT00090285|3387859|P4|Base Study Vaccination Period|Lost to Follow-up|0
1043232|NCT00090285|3387860|P3|Base Study Vaccination Period|Lost to Follow-up|0
1043233|NCT00090285|3387861|P2|Base Study Vaccination Period|Lost to Follow-up|112
1043234|NCT00090285|3387862|P1|Base Study Vaccination Period|Lost to Follow-up|111
1043235|NCT00090285|3387857|P6|Base Study Vaccination Period|Adverse Event|0
1043236|NCT00090285|3387858|P5|Base Study Vaccination Period|Adverse Event|0
1043237|NCT00090285|3387859|P4|Base Study Vaccination Period|Adverse Event|0
1043238|NCT00090285|3387860|P3|Base Study Vaccination Period|Adverse Event|0
1043239|NCT00090285|3387861|P2|Base Study Vaccination Period|Adverse Event|4
1043240|NCT00090285|3387862|P1|Base Study Vaccination Period|Adverse Event|2
1043241|NCT00090285|3387857|P6|Base Study Vaccination Period|Randomized Not Vaccinated|0
1043242|NCT00090285|3387858|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
1043243|NCT00090285|3387859|P4|Base Study Vaccination Period|Randomized Not Vaccinated|0
1043244|NCT00090285|3387860|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
1043245|NCT00090285|3387861|P2|Base Study Vaccination Period|Randomized Not Vaccinated|3
1043246|NCT00090285|3387862|P1|Base Study Vaccination Period|Randomized Not Vaccinated|7
1043247|NCT00090259|3387899|P2|Overall Study|Investigator site closed|7
1043248|NCT00090259|3387900|P1|Overall Study|Investigator site closed|11
1043249|NCT00090259|3387899|P2|Overall Study|Withdrawal by Subject|15
1043250|NCT00090259|3387900|P1|Overall Study|Withdrawal by Subject|21
1043251|NCT00090259|3387899|P2|Overall Study|Lost to Follow-up|26
1043252|NCT00090259|3387900|P1|Overall Study|Lost to Follow-up|30
1043253|NCT00090233|3387916|P2|Overall Study|Data not available at data cut-off point|1563
1043254|NCT00090233|3387917|P1|Overall Study|Data not available at data cut-off point|1552
1043255|NCT00090233|3387916|P2|Overall Study|Not Specified|1160
1043256|NCT00090233|3387917|P1|Overall Study|Not Specified|1211
1043257|NCT00090233|3387916|P2|Overall Study|Moved|189
1043258|NCT00090233|3387917|P1|Overall Study|Moved|203
1043259|NCT00090233|3387916|P2|Overall Study|Withdrawal by Subject|211
1043260|NCT00090233|3387917|P1|Overall Study|Withdrawal by Subject|182
1043261|NCT00090233|3387916|P2|Overall Study|Protocol Violation|1022
1043262|NCT00090233|3387917|P1|Overall Study|Protocol Violation|960
1043263|NCT00090233|3387916|P2|Overall Study|Lost to Follow-up|95
1043264|NCT00090233|3387917|P1|Overall Study|Lost to Follow-up|68
1043265|NCT00090233|3387916|P2|Overall Study|Adverse Event|198
1043266|NCT00090233|3387917|P1|Overall Study|Adverse Event|214
1043267|NCT00090233|3387916|P2|Overall Study|Randomized Not Vaccinated (Visit 1)|627
1043268|NCT00090233|3387917|P1|Overall Study|Randomized Not Vaccinated (Visit 1)|609
1043269|NCT00090220|3387941|P6|Long-term Follow-up (EXT2)|Other|0
1043270|NCT00090220|3387942|P5|Long-term Follow-up (EXT2)|Other|1
1043271|NCT00090220|3387943|P4|Long-term Follow-up (EXT2)|Other|0
1043272|NCT00090220|3387944|P3|Long-term Follow-up (EXT2)|Other|0
1043273|NCT00090220|3387945|P2|Long-term Follow-up (EXT2)|Other|0
1043274|NCT00090220|3387946|P1|Long-term Follow-up (EXT2)|Other|0
1043275|NCT00090220|3387941|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
1043276|NCT00090220|3387942|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
1043277|NCT00090220|3387943|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1043278|NCT00090220|3387944|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1043279|NCT00090220|3387945|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1043280|NCT00090220|3387946|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1043281|NCT00090220|3387941|P6|Long-term Follow-up (EXT2)|Death|1
1043282|NCT00090220|3387942|P5|Long-term Follow-up (EXT2)|Death|1
1043283|NCT00090220|3387943|P4|Long-term Follow-up (EXT2)|Death|0
1043284|NCT00090220|3387944|P3|Long-term Follow-up (EXT2)|Death|0
1043285|NCT00090220|3387945|P2|Long-term Follow-up (EXT2)|Death|0
1043286|NCT00090220|3387946|P1|Long-term Follow-up (EXT2)|Death|0
1043287|NCT00090220|3387941|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|23
1043288|NCT00090220|3387942|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|38
1043289|NCT00090220|3387943|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1043290|NCT00090220|3387944|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1043291|NCT00090220|3387945|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1043292|NCT00090220|3387946|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1043293|NCT00090220|3387941|P6|Extension 1 (EXT1)|Other reason|0
1043294|NCT00090220|3387942|P5|Extension 1 (EXT1)|Other reason|0
1043295|NCT00090220|3387943|P4|Extension 1 (EXT1)|Other reason|0
1043296|NCT00090220|3387944|P3|Extension 1 (EXT1)|Other reason|2
1043297|NCT00090220|3387945|P2|Extension 1 (EXT1)|Other reason|0
1043298|NCT00090220|3387946|P1|Extension 1 (EXT1)|Other reason|0
1043299|NCT00090220|3387941|P6|Extension 1 (EXT1)|Protocol Violation|0
1043300|NCT00090220|3387942|P5|Extension 1 (EXT1)|Protocol Violation|0
1043301|NCT00090220|3387943|P4|Extension 1 (EXT1)|Protocol Violation|1
1043302|NCT00090220|3387944|P3|Extension 1 (EXT1)|Protocol Violation|0
1043303|NCT00090220|3387945|P2|Extension 1 (EXT1)|Protocol Violation|0
1043304|NCT00090220|3387946|P1|Extension 1 (EXT1)|Protocol Violation|0
1043305|NCT00090220|3387941|P6|Extension 1 (EXT1)|Withdrawal by Subject|0
1043306|NCT00090220|3387942|P5|Extension 1 (EXT1)|Withdrawal by Subject|0
1043307|NCT00090220|3387943|P4|Extension 1 (EXT1)|Withdrawal by Subject|0
1043308|NCT00090220|3387944|P3|Extension 1 (EXT1)|Withdrawal by Subject|25
1043309|NCT00090220|3387945|P2|Extension 1 (EXT1)|Withdrawal by Subject|0
1043310|NCT00090220|3387946|P1|Extension 1 (EXT1)|Withdrawal by Subject|0
1043311|NCT00090220|3387941|P6|Extension 1 (EXT1)|Moved|0
1043312|NCT00090220|3387942|P5|Extension 1 (EXT1)|Moved|0
1043313|NCT00090220|3387943|P4|Extension 1 (EXT1)|Moved|1
1043314|NCT00090220|3387944|P3|Extension 1 (EXT1)|Moved|2
1043315|NCT00090220|3387945|P2|Extension 1 (EXT1)|Moved|0
1043316|NCT00090220|3387946|P1|Extension 1 (EXT1)|Moved|0
1043317|NCT00090220|3387941|P6|Extension 1 (EXT1)|Lost to Follow-up|0
1043318|NCT00090220|3387942|P5|Extension 1 (EXT1)|Lost to Follow-up|0
1043319|NCT00090220|3387943|P4|Extension 1 (EXT1)|Lost to Follow-up|0
1043320|NCT00090220|3387944|P3|Extension 1 (EXT1)|Lost to Follow-up|22
1043321|NCT00090220|3387945|P2|Extension 1 (EXT1)|Lost to Follow-up|0
1043322|NCT00090220|3387946|P1|Extension 1 (EXT1)|Lost to Follow-up|0
1043323|NCT00090220|3387941|P6|Extension 1 (EXT1)|Adverse Event|0
1043324|NCT00090220|3387942|P5|Extension 1 (EXT1)|Adverse Event|0
1043325|NCT00090220|3387943|P4|Extension 1 (EXT1)|Adverse Event|0
1043326|NCT00090220|3387944|P3|Extension 1 (EXT1)|Adverse Event|4
1043327|NCT00090220|3387945|P2|Extension 1 (EXT1)|Adverse Event|0
1043328|NCT00090220|3387946|P1|Extension 1 (EXT1)|Adverse Event|0
1043329|NCT00090220|3387941|P6|Base Study Follow-up Period|Other|0
1043330|NCT00090220|3387942|P5|Base Study Follow-up Period|Other|0
1043331|NCT00090220|3387943|P4|Base Study Follow-up Period|Other|0
1043332|NCT00090220|3387944|P3|Base Study Follow-up Period|Other|0
1043333|NCT00090220|3387945|P2|Base Study Follow-up Period|Other|21
1043334|NCT00090220|3387946|P1|Base Study Follow-up Period|Other|19
1043335|NCT00090220|3387941|P6|Base Study Follow-up Period|Patient Moved|0
1043336|NCT00090220|3387942|P5|Base Study Follow-up Period|Patient Moved|0
1043337|NCT00090220|3387943|P4|Base Study Follow-up Period|Patient Moved|0
1043338|NCT00090220|3387944|P3|Base Study Follow-up Period|Patient Moved|0
1043339|NCT00090220|3387945|P2|Base Study Follow-up Period|Patient Moved|28
1043340|NCT00090220|3387946|P1|Base Study Follow-up Period|Patient Moved|20
1043341|NCT00090220|3387941|P6|Base Study Follow-up Period|Withdrawal by Subject|0
1043342|NCT00090220|3387942|P5|Base Study Follow-up Period|Withdrawal by Subject|0
1043343|NCT00090220|3387943|P4|Base Study Follow-up Period|Withdrawal by Subject|0
1043344|NCT00090220|3387944|P3|Base Study Follow-up Period|Withdrawal by Subject|0
1043345|NCT00090220|3387945|P2|Base Study Follow-up Period|Withdrawal by Subject|36
1043346|NCT00090220|3387946|P1|Base Study Follow-up Period|Withdrawal by Subject|27
1043347|NCT00090220|3387941|P6|Base Study Follow-up Period|Lost to Follow-up|0
1043348|NCT00090220|3387942|P5|Base Study Follow-up Period|Lost to Follow-up|0
1043349|NCT00090220|3387943|P4|Base Study Follow-up Period|Lost to Follow-up|0
1043350|NCT00090220|3387944|P3|Base Study Follow-up Period|Lost to Follow-up|0
1043351|NCT00090220|3387945|P2|Base Study Follow-up Period|Lost to Follow-up|78
1043352|NCT00090220|3387946|P1|Base Study Follow-up Period|Lost to Follow-up|88
1043353|NCT00090220|3387941|P6|Base Study Follow-up Period|Adverse Event|0
1043354|NCT00090220|3387942|P5|Base Study Follow-up Period|Adverse Event|0
1043355|NCT00090220|3387943|P4|Base Study Follow-up Period|Adverse Event|0
1043356|NCT00090220|3387944|P3|Base Study Follow-up Period|Adverse Event|0
1043357|NCT00090220|3387945|P2|Base Study Follow-up Period|Adverse Event|1
1043358|NCT00090220|3387946|P1|Base Study Follow-up Period|Adverse Event|6
1043359|NCT00090220|3387941|P6|Base Study Vaccination Period|Other|0
1043360|NCT00090220|3387942|P5|Base Study Vaccination Period|Other|0
1043361|NCT00090220|3387943|P4|Base Study Vaccination Period|Other|0
1043362|NCT00090220|3387944|P3|Base Study Vaccination Period|Other|0
1043363|NCT00090220|3387945|P2|Base Study Vaccination Period|Other|4
1043364|NCT00090220|3387946|P1|Base Study Vaccination Period|Other|4
1043365|NCT00090220|3387941|P6|Base Study Vaccination Period|Patient Moved|0
1043366|NCT00090220|3387942|P5|Base Study Vaccination Period|Patient Moved|0
1043367|NCT00090220|3387943|P4|Base Study Vaccination Period|Patient Moved|0
1043368|NCT00090220|3387944|P3|Base Study Vaccination Period|Patient Moved|0
1043369|NCT00090220|3387945|P2|Base Study Vaccination Period|Patient Moved|2
1043370|NCT00090220|3387946|P1|Base Study Vaccination Period|Patient Moved|6
1043371|NCT00090220|3387941|P6|Base Study Vaccination Period|Withdrawal by Subject|0
1043372|NCT00090220|3387942|P5|Base Study Vaccination Period|Withdrawal by Subject|0
1043373|NCT00090220|3387943|P4|Base Study Vaccination Period|Withdrawal by Subject|0
1043374|NCT00090220|3387944|P3|Base Study Vaccination Period|Withdrawal by Subject|0
1043375|NCT00090220|3387945|P2|Base Study Vaccination Period|Withdrawal by Subject|27
1043376|NCT00090220|3387946|P1|Base Study Vaccination Period|Withdrawal by Subject|23
1043377|NCT00090220|3387941|P6|Base Study Vaccination Period|Lost to Follow-up|0
1043378|NCT00090220|3387942|P5|Base Study Vaccination Period|Lost to Follow-up|0
1043379|NCT00090220|3387943|P4|Base Study Vaccination Period|Lost to Follow-up|0
1043380|NCT00090220|3387944|P3|Base Study Vaccination Period|Lost to Follow-up|0
1043381|NCT00090220|3387945|P2|Base Study Vaccination Period|Lost to Follow-up|28
1043382|NCT00090220|3387946|P1|Base Study Vaccination Period|Lost to Follow-up|24
1043383|NCT00090220|3387941|P6|Base Study Vaccination Period|Adverse Event|0
1043384|NCT00090220|3387942|P5|Base Study Vaccination Period|Adverse Event|0
1043385|NCT00090220|3387943|P4|Base Study Vaccination Period|Adverse Event|0
1043386|NCT00090220|3387944|P3|Base Study Vaccination Period|Adverse Event|0
1043387|NCT00090220|3387945|P2|Base Study Vaccination Period|Adverse Event|1
1043388|NCT00090220|3387946|P1|Base Study Vaccination Period|Adverse Event|6
1043389|NCT00090220|3387941|P6|Base Study Vaccination Period|Randomized not Vaccinated|0
1043390|NCT00090220|3387942|P5|Base Study Vaccination Period|Randomized not Vaccinated|0
1043391|NCT00090220|3387943|P4|Base Study Vaccination Period|Randomized not Vaccinated|0
1043392|NCT00090220|3387944|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
1043393|NCT00090220|3387945|P2|Base Study Vaccination Period|Randomized not Vaccinated|1
1043394|NCT00090220|3387946|P1|Base Study Vaccination Period|Randomized not Vaccinated|1
1043395|NCT00090402|3388041|P3|Overall Study|stopped taking study medication|1
1043396|NCT00090402|3388042|P2|Overall Study|stopped taking study medication|0
1043397|NCT00090402|3388043|P1|Overall Study|stopped taking study medication|1
1043398|NCT00090402|3388041|P3|Overall Study|subject moved|0
1043399|NCT00090402|3388042|P2|Overall Study|subject moved|1
1043400|NCT00090402|3388043|P1|Overall Study|subject moved|0
1043401|NCT00090402|3388041|P3|Overall Study|Death|0
1043402|NCT00090402|3388042|P2|Overall Study|Death|1
1043403|NCT00090402|3388043|P1|Overall Study|Death|1
1043404|NCT00090142|3388057|P2|Treatment Period II|Not Specified|0
1043405|NCT00090142|3388058|P1|Treatment Period II|Not Specified|1
1043406|NCT00090142|3388057|P2|Treatment Period I|Not Specified|1
1043407|NCT00090142|3388058|P1|Treatment Period I|Not Specified|0
1043408|NCT00090142|3388057|P2|Treatment Period I|Withdrawal by Subject|0
1043409|NCT00090142|3388058|P1|Treatment Period I|Withdrawal by Subject|2
1043410|NCT00090142|3388057|P2|Treatment Period I|Protocol Violation|0
1043411|NCT00090142|3388058|P1|Treatment Period I|Protocol Violation|2
1043412|NCT00090142|3388057|P2|Treatment Period I|Lost to Follow-up|2
1043413|NCT00090142|3388058|P1|Treatment Period I|Lost to Follow-up|1
1043414|NCT00090103|3388089|P3|16-Week Safety Follow-up Period|Other|0
1043415|NCT00090103|3388090|P2|16-Week Safety Follow-up Period|Other|1
1043416|NCT00090103|3388091|P1|16-Week Safety Follow-up Period|Other|0
1043417|NCT00090103|3388089|P3|16-Week Safety Follow-up Period|Jailed|0
1043418|NCT00090103|3388090|P2|16-Week Safety Follow-up Period|Jailed|1
1043419|NCT00090103|3388091|P1|16-Week Safety Follow-up Period|Jailed|0
1043420|NCT00090103|3388089|P3|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
1043421|NCT00090103|3388090|P2|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1
1043422|NCT00090103|3388091|P1|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
1043423|NCT00090103|3388089|P3|16-Week Safety Follow-up Period|Depression|0
1043424|NCT00090103|3388090|P2|16-Week Safety Follow-up Period|Depression|1
1043425|NCT00090103|3388091|P1|16-Week Safety Follow-up Period|Depression|0
1043426|NCT00090103|3388089|P3|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3
1043427|NCT00090103|3388090|P2|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2
1043428|NCT00090103|3388091|P1|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0
1043429|NCT00090103|3388089|P3|16-Week Safety Follow-up Period|Scheduling Issues|4
1043430|NCT00090103|3388090|P2|16-Week Safety Follow-up Period|Scheduling Issues|2
1043431|NCT00090103|3388091|P1|16-Week Safety Follow-up Period|Scheduling Issues|0
1043432|NCT00090103|3388089|P3|16-Week Safety Follow-up Period|Back Pain|0
1043433|NCT00090103|3388090|P2|16-Week Safety Follow-up Period|Back Pain|1
1043434|NCT00090103|3388091|P1|16-Week Safety Follow-up Period|Back Pain|0
1043435|NCT00090103|3388089|P3|16-Week Safety Follow-up Period|Angina Pectoris|0
1043436|NCT00090103|3388090|P2|16-Week Safety Follow-up Period|Angina Pectoris|1
1043437|NCT00090103|3388091|P1|16-Week Safety Follow-up Period|Angina Pectoris|0
1043438|NCT00090103|3388089|P3|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3
1043439|NCT00090103|3388090|P2|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2
1043440|NCT00090103|3388091|P1|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0
1043441|NCT00090103|3388089|P3|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4
1043442|NCT00090103|3388090|P2|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5
1043443|NCT00090103|3388091|P1|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0
1043444|NCT00090103|3388089|P3|16-Week Safety Follow-up Period|Gyneomastia|0
1043445|NCT00090103|3388090|P2|16-Week Safety Follow-up Period|Gyneomastia|0
1043446|NCT00090103|3388091|P1|16-Week Safety Follow-up Period|Gyneomastia|1
1043447|NCT00090103|3388089|P3|16-Week Safety Follow-up Period|Death|1
1043448|NCT00090103|3388090|P2|16-Week Safety Follow-up Period|Death|0
1043449|NCT00090103|3388091|P1|16-Week Safety Follow-up Period|Death|1
1043450|NCT00090103|3388089|P3|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6
1043451|NCT00090103|3388090|P2|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3
1043452|NCT00090103|3388091|P1|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1
1043453|NCT00090103|3388089|P3|16-Week Safety Follow-up Period|Enrollment Error|2
1043454|NCT00090103|3388090|P2|16-Week Safety Follow-up Period|Enrollment Error|0
1043455|NCT00090103|3388091|P1|16-Week Safety Follow-up Period|Enrollment Error|1
1043456|NCT00090103|3388089|P3|16-Week Safety Follow-up Period|Loss of Libido|0
1043457|NCT00090103|3388090|P2|16-Week Safety Follow-up Period|Loss of Libido|0
1043458|NCT00090103|3388091|P1|16-Week Safety Follow-up Period|Loss of Libido|1
1043459|NCT00090103|3388089|P3|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13
1043460|NCT00090103|3388090|P2|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5
1043461|NCT00090103|3388091|P1|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1
1043462|NCT00090103|3388089|P3|16-Week Safety Follow-up Period|Alcohol Dependent|1
1043463|NCT00090103|3388090|P2|16-Week Safety Follow-up Period|Alcohol Dependent|0
1043464|NCT00090103|3388091|P1|16-Week Safety Follow-up Period|Alcohol Dependent|1
1043465|NCT00090103|3388089|P3|16-Week Safety Follow-up Period|Prohibited Medication|5
1043466|NCT00090103|3388090|P2|16-Week Safety Follow-up Period|Prohibited Medication|3
1043467|NCT00090103|3388091|P1|16-Week Safety Follow-up Period|Prohibited Medication|2
1043468|NCT00090103|3388089|P3|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
1043469|NCT00090103|3388090|P2|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1
1043470|NCT00090103|3388091|P1|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
1043471|NCT00090103|3388089|P3|16-Week Safety Follow-up Period|Participant relocated|1
1043472|NCT00090103|3388090|P2|16-Week Safety Follow-up Period|Participant relocated|3
1043473|NCT00090103|3388091|P1|16-Week Safety Follow-up Period|Participant relocated|2
1043474|NCT00090103|3388089|P3|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
1043475|NCT00090103|3388090|P2|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
1043476|NCT00090103|3388091|P1|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3
1043477|NCT00090103|3388089|P3|16-Week Safety Follow-up Period|Loss of Contact|2
1043478|NCT00090103|3388090|P2|16-Week Safety Follow-up Period|Loss of Contact|0
1043479|NCT00090103|3388091|P1|16-Week Safety Follow-up Period|Loss of Contact|4
1043480|NCT00090103|3388089|P3|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4
1043481|NCT00090103|3388090|P2|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6
1043482|NCT00090103|3388091|P1|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8
1043483|NCT00090103|3388089|P3|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4
1043484|NCT00090103|3388090|P2|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5
1043485|NCT00090103|3388091|P1|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8
1043486|NCT00090103|3388089|P3|16-Week Safety Follow-up Period|Protocol Violation|17
1043487|NCT00090103|3388090|P2|16-Week Safety Follow-up Period|Protocol Violation|18
1043488|NCT00090103|3388091|P1|16-Week Safety Follow-up Period|Protocol Violation|18
1043489|NCT00090103|3388089|P3|16-Week Safety Follow-up Period|Lost to Follow-up|111
1043490|NCT00090103|3388090|P2|16-Week Safety Follow-up Period|Lost to Follow-up|97
1043491|NCT00090103|3388091|P1|16-Week Safety Follow-up Period|Lost to Follow-up|101
1043492|NCT00090103|3388089|P3|16-Week Safety Follow-up Period|Withdrawal by Subject|229
1043493|NCT00090103|3388090|P2|16-Week Safety Follow-up Period|Withdrawal by Subject|212
1043494|NCT00090103|3388091|P1|16-Week Safety Follow-up Period|Withdrawal by Subject|185
1043495|NCT00090103|3388089|P3|16-Week Safety Follow-up Period|Adverse Event|44
1043496|NCT00090103|3388090|P2|16-Week Safety Follow-up Period|Adverse Event|39
1043497|NCT00090103|3388091|P1|16-Week Safety Follow-up Period|Adverse Event|34
1043498|NCT00090103|3388089|P3|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
1043499|NCT00090103|3388090|P2|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1
1043500|NCT00090103|3388091|P1|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
1043501|NCT00090103|3388089|P3|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1
1043502|NCT00090103|3388090|P2|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
1043503|NCT00090103|3388091|P1|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
1043504|NCT00090103|3388089|P3|Four-Year Double-Blind Treatment Period|Enrollment Error|2
1043505|NCT00090103|3388090|P2|Four-Year Double-Blind Treatment Period|Enrollment Error|0
1043506|NCT00090103|3388091|P1|Four-Year Double-Blind Treatment Period|Enrollment Error|0
1043507|NCT00090103|3388089|P3|Four-Year Double-Blind Treatment Period|Investigator Decision|3
1043508|NCT00090103|3388090|P2|Four-Year Double-Blind Treatment Period|Investigator Decision|1
1043509|NCT00090103|3388091|P1|Four-Year Double-Blind Treatment Period|Investigator Decision|0
1043510|NCT00090103|3388089|P3|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
1043511|NCT00090103|3388090|P2|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1
1043512|NCT00090103|3388091|P1|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
1043513|NCT00090103|3388089|P3|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
1043514|NCT00090103|3388090|P2|Four-Year Double-Blind Treatment Period|Scheduling Issues|1
1043515|NCT00090103|3388091|P1|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
1043516|NCT00090103|3388089|P3|Four-Year Double-Blind Treatment Period|Back Pain|0
1043517|NCT00090103|3388090|P2|Four-Year Double-Blind Treatment Period|Back Pain|1
1043518|NCT00090103|3388091|P1|Four-Year Double-Blind Treatment Period|Back Pain|0
1043519|NCT00090103|3388089|P3|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
1043520|NCT00090103|3388090|P2|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1
1043521|NCT00090103|3388091|P1|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
1043522|NCT00090103|3388089|P3|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
1043523|NCT00090103|3388090|P2|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2
1043524|NCT00090103|3388091|P1|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
1043525|NCT00090103|3388089|P3|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
1043526|NCT00090103|3388090|P2|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
1043527|NCT00090103|3388091|P1|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0
1043528|NCT00090103|3388089|P3|Four-Year Double-Blind Treatment Period|Loss of Contact|0
1043529|NCT00090103|3388090|P2|Four-Year Double-Blind Treatment Period|Loss of Contact|1
1043530|NCT00090103|3388091|P1|Four-Year Double-Blind Treatment Period|Loss of Contact|0
1043531|NCT00090103|3388089|P3|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
1043532|NCT00090103|3388090|P2|Four-Year Double-Blind Treatment Period|Angina Pectoris|2
1043533|NCT00090103|3388091|P1|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
1043534|NCT00090103|3388089|P3|Four-Year Double-Blind Treatment Period|Loss of Libido|0
1043535|NCT00090103|3388090|P2|Four-Year Double-Blind Treatment Period|Loss of Libido|0
1043536|NCT00090103|3388091|P1|Four-Year Double-Blind Treatment Period|Loss of Libido|1
1043537|NCT00090103|3388089|P3|Four-Year Double-Blind Treatment Period|Financial Problems|0
1043538|NCT00090103|3388090|P2|Four-Year Double-Blind Treatment Period|Financial Problems|0
1043539|NCT00090103|3388091|P1|Four-Year Double-Blind Treatment Period|Financial Problems|1
1043540|NCT00090103|3388089|P3|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5
1043541|NCT00090103|3388090|P2|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0
1043542|NCT00090103|3388091|P1|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1
1043543|NCT00090103|3388089|P3|Four-Year Double-Blind Treatment Period|No Improvement|0
1043544|NCT00090103|3388090|P2|Four-Year Double-Blind Treatment Period|No Improvement|0
1043545|NCT00090103|3388091|P1|Four-Year Double-Blind Treatment Period|No Improvement|1
1043546|NCT00090103|3388089|P3|Four-Year Double-Blind Treatment Period|Screen Failure|0
1043547|NCT00090103|3388090|P2|Four-Year Double-Blind Treatment Period|Screen Failure|0
1043548|NCT00090103|3388091|P1|Four-Year Double-Blind Treatment Period|Screen Failure|1
1043549|NCT00090103|3388089|P3|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
1043550|NCT00090103|3388090|P2|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
1043551|NCT00090103|3388091|P1|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1
1043552|NCT00090103|3388089|P3|Four-Year Double-Blind Treatment Period|Investigator Departure|0
1043553|NCT00090103|3388090|P2|Four-Year Double-Blind Treatment Period|Investigator Departure|0
1043554|NCT00090103|3388091|P1|Four-Year Double-Blind Treatment Period|Investigator Departure|2
1043555|NCT00090103|3388089|P3|Four-Year Double-Blind Treatment Period|Prohibited Medication|8
1043556|NCT00090103|3388090|P2|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
1043557|NCT00090103|3388091|P1|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
1043558|NCT00090103|3388089|P3|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6
1043559|NCT00090103|3388090|P2|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3
1043560|NCT00090103|3388091|P1|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2
1043561|NCT00090103|3388089|P3|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4
1043562|NCT00090103|3388090|P2|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0
1043563|NCT00090103|3388091|P1|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2
1043564|NCT00090103|3388089|P3|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19
1043565|NCT00090103|3388090|P2|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7
1043566|NCT00090103|3388091|P1|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3
1043644|NCT00089986|3388282|P2|Overall Study|Adverse Event|9
1043567|NCT00090103|3388089|P3|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7
1043568|NCT00090103|3388090|P2|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4
1043569|NCT00090103|3388091|P1|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6
1043570|NCT00090103|3388089|P3|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4
1043571|NCT00090103|3388090|P2|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
1043572|NCT00090103|3388091|P1|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
1043573|NCT00090103|3388089|P3|Four-Year Double-Blind Treatment Period|Participant Relocated|8
1043574|NCT00090103|3388090|P2|Four-Year Double-Blind Treatment Period|Participant Relocated|2
1043575|NCT00090103|3388091|P1|Four-Year Double-Blind Treatment Period|Participant Relocated|7
1043576|NCT00090103|3388089|P3|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104
1043577|NCT00090103|3388090|P2|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71
1043578|NCT00090103|3388091|P1|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53
1043579|NCT00090103|3388089|P3|Four-Year Double-Blind Treatment Period|Protocol Violation|34
1043580|NCT00090103|3388090|P2|Four-Year Double-Blind Treatment Period|Protocol Violation|29
1043581|NCT00090103|3388091|P1|Four-Year Double-Blind Treatment Period|Protocol Violation|29
1043582|NCT00090103|3388089|P3|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58
1043583|NCT00090103|3388090|P2|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48
1043584|NCT00090103|3388091|P1|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53
1043585|NCT00090103|3388089|P3|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148
1043586|NCT00090103|3388090|P2|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160
1043587|NCT00090103|3388091|P1|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114
1043588|NCT00090103|3388089|P3|Four-Year Double-Blind Treatment Period|Adverse Event|210
1043589|NCT00090103|3388090|P2|Four-Year Double-Blind Treatment Period|Adverse Event|185
1043590|NCT00090103|3388091|P1|Four-Year Double-Blind Treatment Period|Adverse Event|211
1043591|NCT00089999|3388257|P2|Overall Study|Skin Nodule Over Right Mastectomy|1
1043592|NCT00089999|3388258|P1|Overall Study|Skin Nodule Over Right Mastectomy|0
1043593|NCT00089999|3388257|P2|Overall Study|Patient Underwent Surgery|0
1043594|NCT00089999|3388258|P1|Overall Study|Patient Underwent Surgery|2
1043595|NCT00089999|3388257|P2|Overall Study|Physician Decision|2
1043596|NCT00089999|3388258|P1|Overall Study|Physician Decision|2
1043597|NCT00089999|3388257|P2|Overall Study|Clinical Progression|2
1043598|NCT00089999|3388258|P1|Overall Study|Clinical Progression|1
1043599|NCT00089999|3388257|P2|Overall Study|Poor General Condition|0
1043600|NCT00089999|3388258|P1|Overall Study|Poor General Condition|1
1043601|NCT00089999|3388257|P2|Overall Study|Death|3
1043602|NCT00089999|3388258|P1|Overall Study|Death|3
1043603|NCT00089999|3388257|P2|Overall Study|Symptomatic Progression of Cancer|5
1043604|NCT00089999|3388258|P1|Overall Study|Symptomatic Progression of Cancer|2
1043605|NCT00089999|3388257|P2|Overall Study|Radiological Progression of Cancer|44
1043606|NCT00089999|3388258|P1|Overall Study|Radiological Progression of Cancer|52
1043607|NCT00089999|3388257|P2|Overall Study|Lost to Follow-up|1
1043608|NCT00089999|3388258|P1|Overall Study|Lost to Follow-up|2
1043609|NCT00089999|3388257|P2|Overall Study|Withdrawal by Subject|4
1043610|NCT00089999|3388258|P1|Overall Study|Withdrawal by Subject|0
1043611|NCT00089999|3388257|P2|Overall Study|Adverse Event|7
1043612|NCT00089999|3388258|P1|Overall Study|Adverse Event|4
1043613|NCT00089986|3388281|P3|Overall Study|Withdrawal by Subject|2
1043614|NCT00089986|3388282|P2|Overall Study|Withdrawal by Subject|6
1043615|NCT00089986|3388283|P1|Overall Study|Withdrawal by Subject|3
1043616|NCT00089986|3388281|P3|Overall Study|Do not resuscitate (DNR)|1
1043617|NCT00089986|3388282|P2|Overall Study|Do not resuscitate (DNR)|0
1043618|NCT00089986|3388283|P1|Overall Study|Do not resuscitate (DNR)|0
1043619|NCT00089986|3388281|P3|Overall Study|Family decision|0
1043620|NCT00089986|3388282|P2|Overall Study|Family decision|1
1043621|NCT00089986|3388283|P1|Overall Study|Family decision|0
1043622|NCT00089986|3388281|P3|Overall Study|Enrollment in another study|0
1043623|NCT00089986|3388282|P2|Overall Study|Enrollment in another study|1
1043624|NCT00089986|3388283|P1|Overall Study|Enrollment in another study|0
1043625|NCT00089986|3388281|P3|Overall Study|Investigator decision to withdrew|0
1043626|NCT00089986|3388282|P2|Overall Study|Investigator decision to withdrew|1
1043627|NCT00089986|3388283|P1|Overall Study|Investigator decision to withdrew|0
1043628|NCT00089986|3388281|P3|Overall Study|Hemohlobin stopping rule|0
1043629|NCT00089986|3388282|P2|Overall Study|Hemohlobin stopping rule|1
1043630|NCT00089986|3388283|P1|Overall Study|Hemohlobin stopping rule|0
1043631|NCT00089986|3388281|P3|Overall Study|Subject withdrew but agreed follow up|0
1043632|NCT00089986|3388282|P2|Overall Study|Subject withdrew but agreed follow up|2
1043633|NCT00089986|3388283|P1|Overall Study|Subject withdrew but agreed follow up|1
1043634|NCT00089986|3388281|P3|Overall Study|Patient transferred to another hospital|0
1043635|NCT00089986|3388282|P2|Overall Study|Patient transferred to another hospital|1
1043636|NCT00089986|3388283|P1|Overall Study|Patient transferred to another hospital|2
1043637|NCT00089986|3388281|P3|Overall Study|Protocol Violation|0
1043638|NCT00089986|3388282|P2|Overall Study|Protocol Violation|1
1043639|NCT00089986|3388283|P1|Overall Study|Protocol Violation|0
1043640|NCT00089986|3388281|P3|Overall Study|Lost to Follow-up|1
1043641|NCT00089986|3388282|P2|Overall Study|Lost to Follow-up|1
1043642|NCT00089986|3388283|P1|Overall Study|Lost to Follow-up|3
1043643|NCT00089986|3388281|P3|Overall Study|Adverse Event|6
1043645|NCT00089986|3388283|P1|Overall Study|Adverse Event|6
1043646|NCT00089973|3388300|P1|Overall Study|Death|1
1043647|NCT00089973|3388300|P1|Overall Study|Disease progression|45
1043648|NCT00089973|3388300|P1|Overall Study|Withdrawal by Subject|1
1043649|NCT00089973|3388300|P1|Overall Study|Adverse Event|3
1043650|NCT00089895|3388315|P2|Overall Study|Missing|2
1043651|NCT00089895|3388316|P1|Overall Study|Missing|4
1043652|NCT00089895|3388315|P2|Overall Study|Not otherwise specified|8
1043653|NCT00089895|3388316|P1|Overall Study|Not otherwise specified|4
1043654|NCT00089895|3388315|P2|Overall Study|Exclusion criteria met|6
1043655|NCT00089895|3388316|P1|Overall Study|Exclusion criteria met|6
1043656|NCT00089895|3388315|P2|Overall Study|Physician Decision|7
1043657|NCT00089895|3388316|P1|Overall Study|Physician Decision|3
1043658|NCT00089895|3388315|P2|Overall Study|Bleeding|2
1043659|NCT00089895|3388316|P1|Overall Study|Bleeding|0
1043660|NCT00089895|3388315|P2|Overall Study|Surgery|1
1043661|NCT00089895|3388316|P1|Overall Study|Surgery|0
1043662|NCT00089895|3388315|P2|Overall Study|Technical reason|2
1043663|NCT00089895|3388316|P1|Overall Study|Technical reason|7
1043664|NCT00089895|3388315|P2|Overall Study|Consent Withdrawn|14
1043665|NCT00089895|3388316|P1|Overall Study|Consent Withdrawn|11
1043666|NCT00089843|3388328|P4|Overall Study|Physician Decision|1
1043667|NCT00089843|3388329|P3|Overall Study|Physician Decision|0
1043668|NCT00089843|3388330|P2|Overall Study|Physician Decision|0
1043669|NCT00089843|3388331|P1|Overall Study|Physician Decision|1
1043670|NCT00089843|3388328|P4|Overall Study|Withdrawal by Subject|6
1043671|NCT00089843|3388329|P3|Overall Study|Withdrawal by Subject|5
1043672|NCT00089843|3388330|P2|Overall Study|Withdrawal by Subject|4
1043673|NCT00089843|3388331|P1|Overall Study|Withdrawal by Subject|1
1043674|NCT00089791|3388343|P2|Overall Study|Requirement for alternative therapy|4
1043675|NCT00089791|3388344|P1|Overall Study|Requirement for alternative therapy|7
1043676|NCT00089791|3388343|P2|Overall Study|Protocol deviation|10
1043677|NCT00089791|3388344|P1|Overall Study|Protocol deviation|12
1043678|NCT00089791|3388343|P2|Overall Study|Other|32
1043679|NCT00089791|3388344|P1|Overall Study|Other|20
1043680|NCT00089791|3388343|P2|Overall Study|Noncompliance|13
1043681|NCT00089791|3388344|P1|Overall Study|Noncompliance|17
1043682|NCT00089791|3388343|P2|Overall Study|Lost to Follow-up|57
1043683|NCT00089791|3388344|P1|Overall Study|Lost to Follow-up|57
1043684|NCT00089791|3388343|P2|Overall Study|Ineligibility determined|9
1043685|NCT00089791|3388344|P1|Overall Study|Ineligibility determined|12
1043686|NCT00089791|3388343|P2|Overall Study|Disease progression|3
1043687|NCT00089791|3388344|P1|Overall Study|Disease progression|7
1043688|NCT00089791|3388343|P2|Overall Study|Death|62
1043689|NCT00089791|3388344|P1|Overall Study|Death|78
1043690|NCT00089791|3388343|P2|Overall Study|Withdrawal by Subject|344
1043691|NCT00089791|3388344|P1|Overall Study|Withdrawal by Subject|403
1043692|NCT00089791|3388343|P2|Overall Study|Adverse Event|93
1043693|NCT00089791|3388344|P1|Overall Study|Adverse Event|81
1043694|NCT00089791|3388343|P2|Overall Study|Physician Decision|3
1043695|NCT00089791|3388344|P1|Overall Study|Physician Decision|6
1043696|NCT00089778|3388378|P3|Overall Study|Protocol Violation|1
1043697|NCT00089778|3388379|P2|Overall Study|Protocol Violation|0
1043698|NCT00089778|3388380|P1|Overall Study|Protocol Violation|0
1043699|NCT00089674|3388393|P2|Overall Study|Requirement for alternative therapy|4
1043700|NCT00089674|3388394|P1|Overall Study|Requirement for alternative therapy|14
1043701|NCT00089674|3388393|P2|Overall Study|Other|9
1043702|NCT00089674|3388394|P1|Overall Study|Other|5
1043703|NCT00089674|3388393|P2|Overall Study|Noncompliance|3
1043704|NCT00089674|3388394|P1|Overall Study|Noncompliance|7
1043705|NCT00089674|3388393|P2|Overall Study|Lost to Follow-up|17
1043706|NCT00089674|3388394|P1|Overall Study|Lost to Follow-up|21
1043707|NCT00089674|3388393|P2|Overall Study|Ineligibility determined|10
1043708|NCT00089674|3388394|P1|Overall Study|Ineligibility determined|8
1043709|NCT00089674|3388393|P2|Overall Study|Disease progression|23
1043710|NCT00089674|3388394|P1|Overall Study|Disease progression|21
1043711|NCT00089674|3388393|P2|Overall Study|Death|43
1043712|NCT00089674|3388394|P1|Overall Study|Death|43
1043713|NCT00089674|3388393|P2|Overall Study|Withdrawal by Subject|127
1043714|NCT00089674|3388394|P1|Overall Study|Withdrawal by Subject|143
1043715|NCT00089674|3388393|P2|Overall Study|Adverse Event|29
1043716|NCT00089674|3388394|P1|Overall Study|Adverse Event|23
1043717|NCT00089674|3388393|P2|Overall Study|Physician Decision|2
1043718|NCT00089674|3388394|P1|Overall Study|Physician Decision|4
1043719|NCT00089661|3388420|P2|Overall Study|Other|1
1043720|NCT00089661|3388421|P1|Overall Study|Other|2
1043721|NCT00089661|3388420|P2|Overall Study|Noncompliance|4
1043722|NCT00089661|3388421|P1|Overall Study|Noncompliance|2
1043723|NCT00089661|3388420|P2|Overall Study|Ineligibility determined|4
1043724|NCT00089661|3388421|P1|Overall Study|Ineligibility determined|4
1043725|NCT00089661|3388420|P2|Overall Study|Disease progression|3
1043726|NCT00089661|3388421|P1|Overall Study|Disease progression|1
1043727|NCT00089661|3388420|P2|Overall Study|Withdrawal by Subject|9
1043728|NCT00089661|3388421|P1|Overall Study|Withdrawal by Subject|11
1043729|NCT00089661|3388420|P2|Overall Study|Lost to Follow-up|3
1043730|NCT00089661|3388421|P1|Overall Study|Lost to Follow-up|0
1043731|NCT00089661|3388420|P2|Overall Study|Death|0
1043732|NCT00089661|3388421|P1|Overall Study|Death|1
1043733|NCT00089661|3388420|P2|Overall Study|Adverse Event|2
1043734|NCT00089661|3388421|P1|Overall Study|Adverse Event|0
1043735|NCT00089648|3388437|P1|Overall Study|Lack of Efficacy|33
1043736|NCT00089648|3388437|P1|Overall Study|Withdrawal by Subject|1
1043737|NCT00089648|3388437|P1|Overall Study|Adverse Event|7
1043738|NCT00089635|3388453|P1|Overall Study|Not specified|2
1043739|NCT00089635|3388453|P1|Overall Study|Ineligibility determined|1
1043740|NCT00089635|3388453|P1|Overall Study|Withdrawal by Subject|6
1043741|NCT00089635|3388453|P1|Overall Study|Lost to Follow-up|3
1043742|NCT00089635|3388453|P1|Overall Study|Disease Progression|12
1043743|NCT00089635|3388453|P1|Overall Study|Death|17
1043744|NCT00089635|3388453|P1|Overall Study|Adverse Event|2
1043745|NCT00089583|3388467|P2|Overall Study|Participant Incarcerated|1
1043746|NCT00089583|3388468|P1|Overall Study|Participant Incarcerated|0
1043747|NCT00089583|3388467|P2|Overall Study|Necessity to Use Prohibited Drug|0
1043748|NCT00089583|3388468|P1|Overall Study|Necessity to Use Prohibited Drug|1
1043749|NCT00089583|3388467|P2|Overall Study|Start of Disallowed Medication|1
1043750|NCT00089583|3388468|P1|Overall Study|Start of Disallowed Medication|0
1043751|NCT00089583|3388467|P2|Overall Study|Principal Investigator Decision|10
1043752|NCT00089583|3388468|P1|Overall Study|Principal Investigator Decision|0
1043753|NCT00089583|3388467|P2|Overall Study|Protocol Violation|3
1043754|NCT00089583|3388468|P1|Overall Study|Protocol Violation|0
1043755|NCT00089583|3388467|P2|Overall Study|Reason Not Provided|1
1043756|NCT00089583|3388468|P1|Overall Study|Reason Not Provided|0
1043757|NCT00089583|3388467|P2|Overall Study|Participant Management Criteria Met|1
1043758|NCT00089583|3388468|P1|Overall Study|Participant Management Criteria Met|0
1043759|NCT00089583|3388467|P2|Overall Study|Poor Medical Compliance/Adherence Issues|3
1043760|NCT00089583|3388468|P1|Overall Study|Poor Medical Compliance/Adherence Issues|0
1043761|NCT00089583|3388467|P2|Overall Study|Non-Compliance|4
1043762|NCT00089583|3388468|P1|Overall Study|Non-Compliance|0
1043763|NCT00089583|3388467|P2|Overall Study|Participant Refused Study Medication|2
1043764|NCT00089583|3388468|P1|Overall Study|Participant Refused Study Medication|0
1043765|NCT00089583|3388467|P2|Overall Study|Participant (Par) Didn't Take Medication|0
1043766|NCT00089583|3388468|P1|Overall Study|Participant (Par) Didn't Take Medication|1
1043767|NCT00089583|3388467|P2|Overall Study|Withdrawal by Subject|4
1043768|NCT00089583|3388468|P1|Overall Study|Withdrawal by Subject|0
1043769|NCT00089583|3388467|P2|Overall Study|Insufficient Viral Load Response|5
1043770|NCT00089583|3388468|P1|Overall Study|Insufficient Viral Load Response|5
1043771|NCT00089583|3388467|P2|Overall Study|Adverse Event|3
1043772|NCT00089583|3388468|P1|Overall Study|Adverse Event|0
1043773|NCT00089609|3388562|P2|Overall Study|Withdrawal by Subject|1
1043774|NCT00089609|3388563|P1|Overall Study|Withdrawal by Subject|3
1043775|NCT00089544|3388582|P2|Overall Study|Ineligible|0
1043776|NCT00089544|3388583|P1|Overall Study|Ineligible|1
1043777|NCT00089505|3388597|P4|Overall Study|Protocol Violation|0
1043778|NCT00089505|3388598|P3|Overall Study|Protocol Violation|1
1043779|NCT00089505|3388599|P2|Overall Study|Protocol Violation|0
1043780|NCT00089505|3388600|P1|Overall Study|Protocol Violation|0
1043781|NCT00089505|3388597|P4|Overall Study|Physician Decision|0
1043782|NCT00089505|3388598|P3|Overall Study|Physician Decision|0
1043783|NCT00089505|3388599|P2|Overall Study|Physician Decision|0
1043784|NCT00089505|3388600|P1|Overall Study|Physician Decision|1
1043785|NCT00089505|3388597|P4|Overall Study|Lost to Follow-up|7
1043786|NCT00089505|3388598|P3|Overall Study|Lost to Follow-up|9
1043787|NCT00089505|3388599|P2|Overall Study|Lost to Follow-up|1
1043788|NCT00089505|3388600|P1|Overall Study|Lost to Follow-up|1
1043789|NCT00089505|3388597|P4|Overall Study|Withdrawal by Subject|6
1043790|NCT00089505|3388598|P3|Overall Study|Withdrawal by Subject|6
1043791|NCT00089505|3388599|P2|Overall Study|Withdrawal by Subject|0
1043792|NCT00089505|3388600|P1|Overall Study|Withdrawal by Subject|3
1043793|NCT00089505|3388597|P4|Overall Study|Death|8
1043794|NCT00089505|3388598|P3|Overall Study|Death|5
1043795|NCT00089505|3388599|P2|Overall Study|Death|1
1043796|NCT00089505|3388600|P1|Overall Study|Death|4
1043797|NCT00089479|3388644|P2|Overall Study|Lost to Follow-up|107
1043798|NCT00089479|3388645|P1|Overall Study|Lost to Follow-up|137
1043799|NCT00089479|3388644|P2|Overall Study|Withdrawal by Subject|107
1043800|NCT00089479|3388645|P1|Overall Study|Withdrawal by Subject|86
1043801|NCT00089479|3388644|P2|Overall Study|Death|75
1043802|NCT00089479|3388645|P1|Overall Study|Death|108
1043803|NCT00089297|3388688|P1|Overall Study|Non-compliance|1
1043804|NCT00089297|3388688|P1|Overall Study|IRB approval not ready|1
1043805|NCT00089297|3388688|P1|Overall Study|Secondary malignancy|1
1043806|NCT00089297|3388688|P1|Overall Study|Ineligible|11
1043807|NCT00089297|3388688|P1|Overall Study|Disease progression|2
1043808|NCT00089297|3388688|P1|Overall Study|Withdrawal by Subject|12
1043809|NCT00089297|3388688|P1|Overall Study|Death|1
1043810|NCT00089297|3388688|P1|Overall Study|Adverse Event|9
1043811|NCT00089141|3388697|P2|Overall Study|Termination of trial|24
1043812|NCT00089141|3388698|P1|Overall Study|Termination of trial|18
1043813|NCT00089076|3388734|P1|Overall Study|Progression|7
1043814|NCT00089076|3388734|P1|Overall Study|Withdrawal by Subject|2
1043815|NCT00089076|3388734|P1|Overall Study|Alternate Therapy|1
1043816|NCT00088907|3388786|P2|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0
1043817|NCT00088907|3388787|P1|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5
1043818|NCT00088907|3388786|P2|Single Gefitinib Treatment (Step 2)|unknown/not specify|0
1043819|NCT00088907|3388787|P1|Single Gefitinib Treatment (Step 2)|unknown/not specify|2
1043820|NCT00088907|3388786|P2|Single Gefitinib Treatment (Step 2)|Death|0
1043821|NCT00088907|3388787|P1|Single Gefitinib Treatment (Step 2)|Death|1
1043822|NCT00088907|3388786|P2|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0
1043823|NCT00088907|3388787|P1|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16
1043824|NCT00088907|3388786|P2|Randomized Study (Step 1)|ineligible or not start protocol therapy|12
1043825|NCT00088907|3388787|P1|Randomized Study (Step 1)|ineligible or not start protocol therapy|19
1043826|NCT00088907|3388786|P2|Randomized Study (Step 1)|unknown/not specify|13
1043827|NCT00088907|3388787|P1|Randomized Study (Step 1)|unknown/not specify|24
1043828|NCT00088907|3388786|P2|Randomized Study (Step 1)|complicating disease|1
1043829|NCT00088907|3388787|P1|Randomized Study (Step 1)|complicating disease|3
1043830|NCT00088907|3388786|P2|Randomized Study (Step 1)|Withdrawal by Subject|15
1043831|NCT00088907|3388787|P1|Randomized Study (Step 1)|Withdrawal by Subject|10
1043832|NCT00088907|3388786|P2|Randomized Study (Step 1)|Death|12
1043833|NCT00088907|3388787|P1|Randomized Study (Step 1)|Death|11
1043834|NCT00088907|3388786|P2|Randomized Study (Step 1)|Adverse Event|19
1043835|NCT00088907|3388787|P1|Randomized Study (Step 1)|Adverse Event|14
1043836|NCT00088907|3388786|P2|Randomized Study (Step 1)|Lack of Efficacy|62
1043837|NCT00088907|3388787|P1|Randomized Study (Step 1)|Lack of Efficacy|55
1043838|NCT00088881|3388798|P1|Step 2 - Zevalin™ Radioimmunotherapy|Other|3
1043839|NCT00088881|3388798|P1|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8
1043840|NCT00088881|3388798|P1|Step 1 - R-CHOP|Insurance company refused to cover|1
1043841|NCT00088881|3388798|P1|Step 1 - R-CHOP|Physician Decision|1
1043842|NCT00088881|3388798|P1|Step 1 - R-CHOP|Withdrawal by Subject|2
1043843|NCT00088881|3388798|P1|Step 1 - R-CHOP|Adverse Event|1
1043844|NCT00088881|3388798|P1|Step 1 - R-CHOP|Patient ineligible|9
1043845|NCT00088829|3388807|P1|Overall Study|PI left institution and study was close|22
1043846|NCT00088595|3388849|P1|Overall Study|New Cancer Therapy|2
1043847|NCT00088595|3388849|P1|Overall Study|Ongoing (After Core)|7
1043848|NCT00088595|3388849|P1|Overall Study|Withdrawal by Subject|8
1043849|NCT00088595|3388849|P1|Overall Study|Adverse Event|11
1043850|NCT00088530|3388867|P2|Overall Study|Patient never treated|0
1043851|NCT00088530|3388868|P1|Overall Study|Patient never treated|1
1043852|NCT00088530|3388867|P2|Overall Study|Sponsor decision|1
1043853|NCT00088530|3388868|P1|Overall Study|Sponsor decision|0
1043854|NCT00088530|3388867|P2|Overall Study|Physician Decision|0
1043855|NCT00088530|3388868|P1|Overall Study|Physician Decision|2
1043856|NCT00088530|3388867|P2|Overall Study|Lost to Follow-up|0
1043857|NCT00088530|3388868|P1|Overall Study|Lost to Follow-up|2
1043858|NCT00088530|3388867|P2|Overall Study|Withdrawal by Subject|5
1043859|NCT00088530|3388868|P1|Overall Study|Withdrawal by Subject|2
1043860|NCT00088530|3388867|P2|Overall Study|Adverse Event|9
1043861|NCT00088530|3388868|P1|Overall Study|Adverse Event|15
1043862|NCT00088530|3388867|P2|Overall Study|Progressive/Relapsed Disease|39
1043863|NCT00088530|3388868|P1|Overall Study|Progressive/Relapsed Disease|28
1043864|NCT00088465|3388880|P1|Overall Study|Death|11
1043865|NCT00088465|3388880|P1|Overall Study|Protocol Violation|17
1043866|NCT00088465|3388880|P1|Overall Study|Lack of Efficacy|27
1043867|NCT00088465|3388880|P1|Overall Study|Sponsor Decision|37
1043868|NCT00088465|3388880|P1|Overall Study|Physician Decision|45
1043869|NCT00088465|3388880|P1|Overall Study|Lost to Follow-up|57
1043870|NCT00088465|3388880|P1|Overall Study|Adverse Event|77
1043871|NCT00088465|3388880|P1|Overall Study|Withdrawal by Subject|290
1043872|NCT00088374|3388903|P1|Overall Study|patient received <1 cycle only of 17AAG|1
1043873|NCT00088374|3388903|P1|Overall Study|patient did not receive any 17AAG|1
1043874|NCT00088166|3388923|P2|Overall Study|Withdrawal by Subject|5
1043875|NCT00088166|3388924|P1|Overall Study|Withdrawal by Subject|5
1043876|NCT00088166|3388923|P2|Overall Study|Patient deterioration|39
1043877|NCT00088166|3388924|P1|Overall Study|Patient deterioration|29
1043878|NCT00088166|3388923|P2|Overall Study|Protocol Violation|5
1043879|NCT00088166|3388924|P1|Overall Study|Protocol Violation|1
1043880|NCT00088166|3388923|P2|Overall Study|Physician Decision|1
1043881|NCT00088166|3388924|P1|Overall Study|Physician Decision|4
1043882|NCT00088166|3388923|P2|Overall Study|Lost to Follow-up|1
1043883|NCT00088166|3388924|P1|Overall Study|Lost to Follow-up|0
1043884|NCT00088166|3388923|P2|Overall Study|Death|1
1043885|NCT00088166|3388924|P1|Overall Study|Death|3
1043886|NCT00088166|3388923|P2|Overall Study|Adverse Event|9
1043887|NCT00088166|3388924|P1|Overall Study|Adverse Event|11
1043888|NCT00088153|3388948|P2|Overall Study|Lost to Follow-up|12
1043889|NCT00088153|3388949|P1|Overall Study|Lost to Follow-up|11
1043890|NCT00088153|3388948|P2|Overall Study|Withdrawal by Subject|10
1043891|NCT00088153|3388949|P1|Overall Study|Withdrawal by Subject|10
1043892|NCT00088153|3388948|P2|Overall Study|Physician Decision|3
1043893|NCT00088153|3388949|P1|Overall Study|Physician Decision|3
1043894|NCT00087698|3388959|P1|Overall Study|Protocol Violation|1
1043895|NCT00087698|3388959|P1|Overall Study|Death from Study Drug Toxicity|2
1043896|NCT00087698|3388959|P1|Overall Study|Death from Study Disease|2
1043897|NCT00087698|3388959|P1|Overall Study|Clinical Relapse|1
1043898|NCT00087698|3388959|P1|Overall Study|Protocol Entry Criteria Not Met|2
1043899|NCT00087698|3388959|P1|Overall Study|Lack of Efficacy, Physician Perception|3
1043900|NCT00087698|3388959|P1|Overall Study|Withdrawal by Subject|4
1043901|NCT00087698|3388959|P1|Overall Study|Adverse Event|4
1043902|NCT00087698|3388959|P1|Overall Study|Death from Other Causes|3
1043903|NCT00087698|3388959|P1|Overall Study|Lack of Efficacy, Progressive Disease|14
1043904|NCT00087685|3388968|P1|Overall Study|Withdrawal by Subject|3
1043905|NCT00087685|3388968|P1|Overall Study|Progressive Disease|5
1043906|NCT00087685|3388968|P1|Overall Study|Non-Compliance|1
1043907|NCT00087685|3388968|P1|Overall Study|Adverse Event|5
1043908|NCT00087646|3388981|P4|Overall Study|Violation of Selection Criteria at Entry|1
1043909|NCT00087646|3388982|P3|Overall Study|Violation of Selection Criteria at Entry|0
1043910|NCT00087646|3388983|P2|Overall Study|Violation of Selection Criteria at Entry|0
1043911|NCT00087646|3388984|P1|Overall Study|Violation of Selection Criteria at Entry|1
1043912|NCT00087646|3388981|P4|Overall Study|Other Protocol Violation|0
1043913|NCT00087646|3388982|P3|Overall Study|Other Protocol Violation|0
1043914|NCT00087646|3388983|P2|Overall Study|Other Protocol Violation|1
1043915|NCT00087646|3388984|P1|Overall Study|Other Protocol Violation|3
1043916|NCT00087646|3388981|P4|Overall Study|Administrative/Other|2
1043917|NCT00087646|3388982|P3|Overall Study|Administrative/Other|1
1043918|NCT00087646|3388983|P2|Overall Study|Administrative/Other|1
1043919|NCT00087646|3388984|P1|Overall Study|Administrative/Other|6
1043920|NCT00087646|3388981|P4|Overall Study|Failure to Return|3
1043921|NCT00087646|3388982|P3|Overall Study|Failure to Return|2
1043922|NCT00087646|3388983|P2|Overall Study|Failure to Return|2
1043923|NCT00087646|3388984|P1|Overall Study|Failure to Return|5
1043924|NCT00087646|3388981|P4|Overall Study|Refused Treatment/Did Not Cooperate|5
1043925|NCT00087646|3388982|P3|Overall Study|Refused Treatment/Did Not Cooperate|4
1043926|NCT00087646|3388983|P2|Overall Study|Refused Treatment/Did Not Cooperate|6
1043927|NCT00087646|3388984|P1|Overall Study|Refused Treatment/Did Not Cooperate|13
1043928|NCT00087646|3388981|P4|Overall Study|Insufficient therapeutic response|51
1043929|NCT00087646|3388982|P3|Overall Study|Insufficient therapeutic response|38
1043930|NCT00087646|3388983|P2|Overall Study|Insufficient therapeutic response|24
1043931|NCT00087646|3388984|P1|Overall Study|Insufficient therapeutic response|64
1043932|NCT00087646|3388981|P4|Overall Study|Withdrawal by Subject|2
1043933|NCT00087646|3388982|P3|Overall Study|Withdrawal by Subject|2
1043934|NCT00087646|3388983|P2|Overall Study|Withdrawal by Subject|1
1043935|NCT00087646|3388984|P1|Overall Study|Withdrawal by Subject|6
1043936|NCT00087646|3388981|P4|Overall Study|Death|0
1043937|NCT00087646|3388982|P3|Overall Study|Death|0
1043938|NCT00087646|3388983|P2|Overall Study|Death|1
1043939|NCT00087646|3388984|P1|Overall Study|Death|0
1043940|NCT00087646|3388981|P4|Overall Study|Adverse Event|20
1043941|NCT00087646|3388982|P3|Overall Study|Adverse Event|18
1043942|NCT00087646|3388983|P2|Overall Study|Adverse Event|6
1043943|NCT00087646|3388984|P1|Overall Study|Adverse Event|37
1043944|NCT00087607|3389023|P2|Overall Study|Violation of Selection Criteria at Entry|1
1043945|NCT00087607|3389024|P1|Overall Study|Violation of Selection Criteria at Entry|0
1043946|NCT00087607|3389023|P2|Overall Study|Other Protocol Violation|2
1043947|NCT00087607|3389024|P1|Overall Study|Other Protocol Violation|5
1043948|NCT00087607|3389023|P2|Overall Study|Refused Treatment|7
1043949|NCT00087607|3389024|P1|Overall Study|Refused Treatment|5
1043950|NCT00087607|3389023|P2|Overall Study|Administrative|12
1043951|NCT00087607|3389024|P1|Overall Study|Administrative|12
1043952|NCT00087607|3389023|P2|Overall Study|Withdrew Consent|16
1043953|NCT00087607|3389024|P1|Overall Study|Withdrew Consent|12
1043954|NCT00087607|3389023|P2|Overall Study|Failure to return|17
1043955|NCT00087607|3389024|P1|Overall Study|Failure to return|21
1043956|NCT00087607|3389023|P2|Overall Study|Insufficient Therapeutic Response|42
1043957|NCT00087607|3389024|P1|Overall Study|Insufficient Therapeutic Response|53
1043958|NCT00087607|3389023|P2|Overall Study|Death|1
1043959|NCT00087607|3389024|P1|Overall Study|Death|0
1043960|NCT00087607|3389023|P2|Overall Study|Adverse Event|24
1043961|NCT00087607|3389024|P1|Overall Study|Adverse Event|14
1043962|NCT00087594|3389064|P2|Overall Study|Lack of Efficacy|5
1043963|NCT00087594|3389065|P1|Overall Study|Lack of Efficacy|2
1043964|NCT00087594|3389064|P2|Overall Study|Withdrawal by Subject|2
1043965|NCT00087594|3389065|P1|Overall Study|Withdrawal by Subject|4
1043966|NCT00087594|3389064|P2|Overall Study|Lost to Follow-up|2
1043967|NCT00087594|3389065|P1|Overall Study|Lost to Follow-up|0
1043968|NCT00087594|3389064|P2|Overall Study|Adverse Event|3
1043969|NCT00087594|3389065|P1|Overall Study|Adverse Event|2
1043970|NCT00087568|3389099|P2|Overall Study|Lack of Efficacy|1
1043971|NCT00087568|3389100|P1|Overall Study|Lack of Efficacy|24
1043972|NCT00087568|3389099|P2|Overall Study|Lost to Follow-up|0
1043973|NCT00087568|3389100|P1|Overall Study|Lost to Follow-up|1
1043974|NCT00087568|3389099|P2|Overall Study|Withdrawal by Subject|1
1043975|NCT00087568|3389100|P1|Overall Study|Withdrawal by Subject|1
1043976|NCT00087568|3389099|P2|Overall Study|Adverse Event|0
1043977|NCT00087568|3389100|P1|Overall Study|Adverse Event|4
1043978|NCT00087555|3389127|P3|Overall Study|Patient wanted to go back on Med|0
1043979|NCT00087555|3389128|P2|Overall Study|Patient wanted to go back on Med|0
1043980|NCT00087555|3389129|P1|Overall Study|Patient wanted to go back on Med|1
1043981|NCT00087555|3389127|P3|Overall Study|Chronic Migraine Headaches (Med History)|0
1043982|NCT00087555|3389128|P2|Overall Study|Chronic Migraine Headaches (Med History)|0
1043983|NCT00087555|3389129|P1|Overall Study|Chronic Migraine Headaches (Med History)|1
1043984|NCT00087555|3389127|P3|Overall Study|Non Compliance|1
1043985|NCT00087555|3389128|P2|Overall Study|Non Compliance|0
1043986|NCT00087555|3389129|P1|Overall Study|Non Compliance|0
1043987|NCT00087555|3389127|P3|Overall Study|Lack of Efficacy|1
1043988|NCT00087555|3389128|P2|Overall Study|Lack of Efficacy|0
1043989|NCT00087555|3389129|P1|Overall Study|Lack of Efficacy|2
1043990|NCT00087555|3389127|P3|Overall Study|Withdrawal by Subject|1
1043991|NCT00087555|3389128|P2|Overall Study|Withdrawal by Subject|2
1043992|NCT00087555|3389129|P1|Overall Study|Withdrawal by Subject|3
1043993|NCT00087555|3389127|P3|Overall Study|Pregnancy|1
1043994|NCT00087555|3389128|P2|Overall Study|Pregnancy|1
1043995|NCT00087555|3389129|P1|Overall Study|Pregnancy|0
1043996|NCT00087555|3389127|P3|Overall Study|Screen Failure|0
1043997|NCT00087555|3389128|P2|Overall Study|Screen Failure|1
1043998|NCT00087555|3389129|P1|Overall Study|Screen Failure|1
1043999|NCT00087555|3389127|P3|Overall Study|Protocol Violation|2
1044000|NCT00087555|3389128|P2|Overall Study|Protocol Violation|0
1044001|NCT00087555|3389129|P1|Overall Study|Protocol Violation|0
1044002|NCT00087555|3389127|P3|Overall Study|Non - Compliance|0
1044003|NCT00087555|3389128|P2|Overall Study|Non - Compliance|0
1044004|NCT00087555|3389129|P1|Overall Study|Non - Compliance|1
1044005|NCT00087555|3389127|P3|Overall Study|Lost to Follow-up|1
1044006|NCT00087555|3389128|P2|Overall Study|Lost to Follow-up|1
1044007|NCT00087555|3389129|P1|Overall Study|Lost to Follow-up|0
1044008|NCT00087555|3389127|P3|Overall Study|Adverse Event|14
1044009|NCT00087555|3389128|P2|Overall Study|Adverse Event|6
1044010|NCT00087555|3389129|P1|Overall Study|Adverse Event|3
1044011|NCT00087529|3389139|P2|Overall Study|Did Not Continue to Safety Follow-Up|5
1044012|NCT00087529|3389140|P1|Overall Study|Did Not Continue to Safety Follow-Up|5
1044013|NCT00087529|3389139|P2|Overall Study|Disease Progression|4
1044014|NCT00087529|3389140|P1|Overall Study|Disease Progression|5
1044015|NCT00087529|3389139|P2|Overall Study|Participant Noncompliance|1
1044016|NCT00087529|3389140|P1|Overall Study|Participant Noncompliance|0
1044017|NCT00087529|3389139|P2|Overall Study|Initiation of Excluded Therapy|1
1044018|NCT00087529|3389140|P1|Overall Study|Initiation of Excluded Therapy|0
1044019|NCT00087529|3389139|P2|Overall Study|Physician Decision|8
1044020|NCT00087529|3389140|P1|Overall Study|Physician Decision|4
1044021|NCT00087529|3389139|P2|Overall Study|Participant Decision|37
1044022|NCT00087529|3389140|P1|Overall Study|Participant Decision|14
1044023|NCT00087529|3389139|P2|Overall Study|Lost to Follow-up|3
1044024|NCT00087529|3389140|P1|Overall Study|Lost to Follow-up|2
1044025|NCT00087529|3389139|P2|Overall Study|Pregnancy|1
1044026|NCT00087529|3389140|P1|Overall Study|Pregnancy|0
1044027|NCT00087529|3389139|P2|Overall Study|Adverse Event|8
1044028|NCT00087529|3389140|P1|Overall Study|Adverse Event|0
1044029|NCT00087529|3389139|P2|Overall Study|Death|0
1044030|NCT00087529|3389140|P1|Overall Study|Death|1
1044031|NCT00087516|3389155|P4|Overall Study|Other|0
1044032|NCT00087516|3389156|P3|Overall Study|Other|1
1044033|NCT00087516|3389157|P2|Overall Study|Other|0
1044034|NCT00087516|3389158|P1|Overall Study|Other|0
1044035|NCT00087516|3389155|P4|Overall Study|Recommendation of Primary Care Physician|1
1044036|NCT00087516|3389156|P3|Overall Study|Recommendation of Primary Care Physician|0
1044037|NCT00087516|3389157|P2|Overall Study|Recommendation of Primary Care Physician|0
1044038|NCT00087516|3389158|P1|Overall Study|Recommendation of Primary Care Physician|0
1044039|NCT00087516|3389155|P4|Overall Study|Patient was non-compliant|0
1044040|NCT00087516|3389156|P3|Overall Study|Patient was non-compliant|0
1044041|NCT00087516|3389157|P2|Overall Study|Patient was non-compliant|1
1044042|NCT00087516|3389158|P1|Overall Study|Patient was non-compliant|3
1044043|NCT00087516|3389155|P4|Overall Study|Patient moved|0
1044044|NCT00087516|3389156|P3|Overall Study|Patient moved|1
1044045|NCT00087516|3389157|P2|Overall Study|Patient moved|2
1044046|NCT00087516|3389158|P1|Overall Study|Patient moved|3
1044047|NCT00087516|3389155|P4|Overall Study|Protocol specified discontinuation|26
1044048|NCT00087516|3389156|P3|Overall Study|Protocol specified discontinuation|33
1044049|NCT00087516|3389157|P2|Overall Study|Protocol specified discontinuation|33
1044050|NCT00087516|3389158|P1|Overall Study|Protocol specified discontinuation|35
1044051|NCT00087516|3389155|P4|Overall Study|Site terminated|0
1044052|NCT00087516|3389156|P3|Overall Study|Site terminated|1
1044053|NCT00087516|3389157|P2|Overall Study|Site terminated|2
1044054|NCT00087516|3389158|P1|Overall Study|Site terminated|0
1044055|NCT00087516|3389155|P4|Overall Study|Withdrawal by Subject|12
1044056|NCT00087516|3389156|P3|Overall Study|Withdrawal by Subject|11
1044057|NCT00087516|3389157|P2|Overall Study|Withdrawal by Subject|27
1044058|NCT00087516|3389158|P1|Overall Study|Withdrawal by Subject|16
1044059|NCT00087516|3389155|P4|Overall Study|Protocol Violation|6
1044060|NCT00087516|3389156|P3|Overall Study|Protocol Violation|3
1044061|NCT00087516|3389157|P2|Overall Study|Protocol Violation|8
1044062|NCT00087516|3389158|P1|Overall Study|Protocol Violation|4
1044063|NCT00087516|3389155|P4|Overall Study|Lost to Follow-up|5
1044064|NCT00087516|3389156|P3|Overall Study|Lost to Follow-up|5
1044065|NCT00087516|3389157|P2|Overall Study|Lost to Follow-up|6
1044066|NCT00087516|3389158|P1|Overall Study|Lost to Follow-up|8
1044067|NCT00087516|3389155|P4|Overall Study|Lack of Efficacy|29
1044068|NCT00087516|3389156|P3|Overall Study|Lack of Efficacy|39
1044069|NCT00087516|3389157|P2|Overall Study|Lack of Efficacy|80
1044070|NCT00087516|3389158|P1|Overall Study|Lack of Efficacy|82
1044071|NCT00087516|3389155|P4|Overall Study|Adverse Event|6
1044072|NCT00087516|3389156|P3|Overall Study|Adverse Event|3
1044073|NCT00087516|3389157|P2|Overall Study|Adverse Event|10
1044074|NCT00087516|3389158|P1|Overall Study|Adverse Event|10
1044075|NCT00087490|3389187|P2|Overall Study|Randomized but not treated|18
1044076|NCT00087490|3389188|P1|Overall Study|Randomized but not treated|7
1044077|NCT00087490|3389187|P2|Overall Study|Lost to Follow-Up/participant withdrawal|36
1044078|NCT00087490|3389188|P1|Overall Study|Lost to Follow-Up/participant withdrawal|28
1044079|NCT00087490|3389187|P2|Overall Study|Protocol Violation or (/) Unspecified|201
1044080|NCT00087490|3389188|P1|Overall Study|Protocol Violation or (/) Unspecified|214
1044081|NCT00087490|3389187|P2|Overall Study|Lack of Efficacy|2
1044082|NCT00087490|3389188|P1|Overall Study|Lack of Efficacy|0
1044083|NCT00087490|3389187|P2|Overall Study|Adverse Event|8
1044084|NCT00087490|3389188|P1|Overall Study|Adverse Event|3
1044085|NCT00087490|3389187|P2|Overall Study|Death|4
1044086|NCT00087490|3389188|P1|Overall Study|Death|6
1044087|NCT00087438|3389222|P1|Overall Study|Ineligible / No protocol treatment|4
1044088|NCT00087152|3389226|P1|Overall Study|Ineligible|6
1044089|NCT00087139|3389235|P3|Overall Study|Extradural disease|1
1044090|NCT00087139|3389236|P2|Overall Study|Extradural disease|0
1044091|NCT00087139|3389237|P1|Overall Study|Extradural disease|0
1044092|NCT00087139|3389235|P3|Overall Study|Response achieved|0
1044093|NCT00087139|3389236|P2|Overall Study|Response achieved|1
1044094|NCT00087139|3389237|P1|Overall Study|Response achieved|0
1044095|NCT00087139|3389235|P3|Overall Study|Use of coumadin|0
1044096|NCT00087139|3389236|P2|Overall Study|Use of coumadin|0
1044097|NCT00087139|3389237|P1|Overall Study|Use of coumadin|1
1044098|NCT00087139|3389235|P3|Overall Study|Symptomatic deterioration|3
1044099|NCT00087139|3389236|P2|Overall Study|Symptomatic deterioration|1
1044100|NCT00087139|3389237|P1|Overall Study|Symptomatic deterioration|1
1044101|NCT00087139|3389235|P3|Overall Study|Ineligible|4
1044102|NCT00087139|3389236|P2|Overall Study|Ineligible|7
1044103|NCT00087139|3389237|P1|Overall Study|Ineligible|4
1044104|NCT00087139|3389235|P3|Overall Study|Disease progression|12
1044105|NCT00087139|3389236|P2|Overall Study|Disease progression|19
1044106|NCT00087139|3389237|P1|Overall Study|Disease progression|9
1044107|NCT00087139|3389235|P3|Overall Study|Physician Decision|1
1044108|NCT00087139|3389236|P2|Overall Study|Physician Decision|1
1044109|NCT00087139|3389237|P1|Overall Study|Physician Decision|1
1044110|NCT00087139|3389235|P3|Overall Study|Withdrawal by Subject|2
1044111|NCT00087139|3389236|P2|Overall Study|Withdrawal by Subject|2
1044112|NCT00087139|3389237|P1|Overall Study|Withdrawal by Subject|3
1044113|NCT00087139|3389235|P3|Overall Study|Death|0
1044114|NCT00087139|3389236|P2|Overall Study|Death|1
1044115|NCT00087139|3389237|P1|Overall Study|Death|2
1044116|NCT00087139|3389235|P3|Overall Study|Adverse Event|13
1044117|NCT00087139|3389236|P2|Overall Study|Adverse Event|17
1044118|NCT00087139|3389237|P1|Overall Study|Adverse Event|18
1044119|NCT00086996|3389268|P1|Overall Study|not eligible|5
1044120|NCT00086996|3389268|P1|Overall Study|not specified|6
1044121|NCT00086996|3389268|P1|Overall Study|Withdrawal by Subject|13
1044122|NCT00086996|3389268|P1|Overall Study|progression/relapse|7
1044123|NCT00086996|3389268|P1|Overall Study|Death|4
1044124|NCT00086996|3389268|P1|Overall Study|Adverse Event|29
1044125|NCT00086684|3389290|P3|Overall Study|Not specified|3
1044126|NCT00086684|3389291|P2|Overall Study|Not specified|2
1044127|NCT00086684|3389292|P1|Overall Study|Not specified|4
1044128|NCT00086684|3389290|P3|Overall Study|WITHDRAWAL OF CONSENT|5
1044129|NCT00086684|3389291|P2|Overall Study|WITHDRAWAL OF CONSENT|7
1044130|NCT00086684|3389292|P1|Overall Study|WITHDRAWAL OF CONSENT|5
1044131|NCT00086684|3389290|P3|Overall Study|STUDY TERMINATED BY SPONSOR|0
1044132|NCT00086684|3389291|P2|Overall Study|STUDY TERMINATED BY SPONSOR|1
1044133|NCT00086684|3389292|P1|Overall Study|STUDY TERMINATED BY SPONSOR|0
1044134|NCT00086684|3389290|P3|Overall Study|NONCOMPLIANCE|6
1044135|NCT00086684|3389291|P2|Overall Study|NONCOMPLIANCE|7
1044136|NCT00086684|3389292|P1|Overall Study|NONCOMPLIANCE|5
1044137|NCT00086684|3389290|P3|Overall Study|Withdrawal by Subject|10
1044138|NCT00086684|3389291|P2|Overall Study|Withdrawal by Subject|4
1044139|NCT00086684|3389292|P1|Overall Study|Withdrawal by Subject|0
1044140|NCT00086684|3389290|P3|Overall Study|Protocol Violation|0
1044141|NCT00086684|3389291|P2|Overall Study|Protocol Violation|3
1044142|NCT00086684|3389292|P1|Overall Study|Protocol Violation|8
1044143|NCT00086684|3389290|P3|Overall Study|Lost to Follow-up|10
1044144|NCT00086684|3389291|P2|Overall Study|Lost to Follow-up|8
1044145|NCT00086684|3389292|P1|Overall Study|Lost to Follow-up|15
1044146|NCT00086684|3389290|P3|Overall Study|Lack of Efficacy|5
1044147|NCT00086684|3389291|P2|Overall Study|Lack of Efficacy|6
1044148|NCT00086684|3389292|P1|Overall Study|Lack of Efficacy|6
1044149|NCT00086684|3389290|P3|Overall Study|Adverse Event|14
1044150|NCT00086684|3389291|P2|Overall Study|Adverse Event|17
1044151|NCT00086684|3389292|P1|Overall Study|Adverse Event|12
1044152|NCT00086619|3389305|P2|Overall Study|Protocol Violation|1
1044153|NCT00086619|3389306|P1|Overall Study|Protocol Violation|1
1044154|NCT00086619|3389305|P2|Overall Study|Adverse Event|10
1044155|NCT00086619|3389306|P1|Overall Study|Adverse Event|8
1044156|NCT00086619|3389305|P2|Overall Study|Withdrawal by Subject|6
1044157|NCT00086619|3389306|P1|Overall Study|Withdrawal by Subject|6
1044158|NCT00086580|3389316|P2|Observation Period|Not specified|7
1044159|NCT00086580|3389317|P1|Observation Period|Not specified|8
1044160|NCT00086580|3389316|P2|Observation Period|Death|55
1044161|NCT00086580|3389317|P1|Observation Period|Death|33
1044162|NCT00086580|3389316|P2|Observation Period|Withdrawal by Subject|2
1044163|NCT00086580|3389317|P1|Observation Period|Withdrawal by Subject|4
1044164|NCT00086580|3389316|P2|Observation Period|Unable to comply with protocol|1
1044165|NCT00086580|3389317|P1|Observation Period|Unable to comply with protocol|1
1044166|NCT00086580|3389316|P2|Follow-up Period|Not specified|6
1044167|NCT00086580|3389317|P1|Follow-up Period|Not specified|7
1044168|NCT00086580|3389316|P2|Follow-up Period|Death|7
1044169|NCT00086580|3389317|P1|Follow-up Period|Death|13
1044170|NCT00086580|3389316|P2|Follow-up Period|AE - not related|0
1044171|NCT00086580|3389317|P1|Follow-up Period|AE - not related|1
1044172|NCT00086580|3389316|P2|Follow-up Period|Physician Decision|1
1044173|NCT00086580|3389317|P1|Follow-up Period|Physician Decision|0
1044174|NCT00086580|3389316|P2|Follow-up Period|Withdrawal by Subject|6
1044175|NCT00086580|3389317|P1|Follow-up Period|Withdrawal by Subject|6
1044176|NCT00086580|3389316|P2|Follow-up Period|Unable to comply with protocol|0
1044177|NCT00086580|3389317|P1|Follow-up Period|Unable to comply with protocol|5
1044178|NCT00086580|3389316|P2|Follow-up Period|Disease progression|99
1044179|NCT00086580|3389317|P1|Follow-up Period|Disease progression|72
1044180|NCT00086580|3389316|P2|Treatment Period|Not specified|3
1044181|NCT00086580|3389317|P1|Treatment Period|Not specified|5
1044182|NCT00086580|3389316|P2|Treatment Period|Death|7
1044183|NCT00086580|3389317|P1|Treatment Period|Death|5
1044184|NCT00086580|3389316|P2|Treatment Period|Anemia or thrombocytopenia|4
1044185|NCT00086580|3389317|P1|Treatment Period|Anemia or thrombocytopenia|1
1044186|NCT00086580|3389316|P2|Treatment Period|Toxicity - treatment related|15
1044187|NCT00086580|3389317|P1|Treatment Period|Toxicity - treatment related|15
1044188|NCT00086580|3389316|P2|Treatment Period|AE - not treatment related|7
1044189|NCT00086580|3389317|P1|Treatment Period|AE - not treatment related|7
1044190|NCT00086580|3389316|P2|Treatment Period|Physician Decision|7
1044191|NCT00086580|3389317|P1|Treatment Period|Physician Decision|13
1044192|NCT00086580|3389316|P2|Treatment Period|Withdrawal by Subject|8
1044193|NCT00086580|3389317|P1|Treatment Period|Withdrawal by Subject|7
1044194|NCT00086580|3389316|P2|Treatment Period|Unable to comply with protocol|1
1044195|NCT00086580|3389317|P1|Treatment Period|Unable to comply with protocol|3
1044196|NCT00086580|3389316|P2|Treatment Period|Disease progression|8
1044197|NCT00086580|3389317|P1|Treatment Period|Disease progression|9
1044198|NCT00086411|3389365|P4|Overall Study|Lost to Follow-up|12
1044199|NCT00086411|3389366|P3|Overall Study|Lost to Follow-up|13
1044200|NCT00086411|3389367|P2|Overall Study|Lost to Follow-up|11
1044201|NCT00086411|3389368|P1|Overall Study|Lost to Follow-up|11
1044202|NCT00086385|3389382|P4|Overall Study|Death|1
1044203|NCT00086385|3389383|P3|Overall Study|Death|1
1044204|NCT00086385|3389384|P2|Overall Study|Death|2
1044205|NCT00086385|3389385|P1|Overall Study|Death|2
1044206|NCT00086515|3389397|P2|Phase B (Weeks 24-104)|Discontinued in error|0
1044207|NCT00086515|3389398|P1|Phase B (Weeks 24-104)|Discontinued in error|1
1044208|NCT00086515|3389397|P2|Phase B (Weeks 24-104)|Personal Circumstance|0
1044209|NCT00086515|3389398|P1|Phase B (Weeks 24-104)|Personal Circumstance|1
1044210|NCT00086515|3389397|P2|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1
1044211|NCT00086515|3389398|P1|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0
1044212|NCT00086515|3389397|P2|Phase B (Weeks 24-104)|Patient Died|1
1044213|NCT00086515|3389398|P1|Phase B (Weeks 24-104)|Patient Died|3
1044214|NCT00086515|3389397|P2|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10
1044215|NCT00086515|3389398|P1|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36
1044216|NCT00086515|3389397|P2|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3
1044217|NCT00086515|3389398|P1|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5
1044218|NCT00086515|3389397|P2|Phase B (Weeks 24-104)|Patient Moved|2
1044219|NCT00086515|3389398|P1|Phase B (Weeks 24-104)|Patient Moved|2
1044220|NCT00086515|3389397|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|5
1044221|NCT00086515|3389398|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|15
1044222|NCT00086515|3389397|P2|Phase B (Weeks 24-104)|Protocol Violation|0
1044223|NCT00086515|3389398|P1|Phase B (Weeks 24-104)|Protocol Violation|1
1044224|NCT00086515|3389397|P2|Phase B (Weeks 24-104)|Physician Decision|0
1044225|NCT00086515|3389398|P1|Phase B (Weeks 24-104)|Physician Decision|3
1044226|NCT00086515|3389397|P2|Phase B (Weeks 24-104)|Lost to Follow-up|4
1044227|NCT00086515|3389398|P1|Phase B (Weeks 24-104)|Lost to Follow-up|13
1044228|NCT00086515|3389397|P2|Phase B (Weeks 24-104)|Lack of Efficacy|19
1044229|NCT00086515|3389398|P1|Phase B (Weeks 24-104)|Lack of Efficacy|94
1044230|NCT00086515|3389397|P2|Phase B (Weeks 24-104)|Adverse Event|10
1044231|NCT00086515|3389398|P1|Phase B (Weeks 24-104)|Adverse Event|16
1044232|NCT00086515|3389397|P2|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0
1044233|NCT00086515|3389398|P1|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1
1044234|NCT00086515|3389397|P2|Phase A to Phase B Transition Period|Poor compliance|0
1044235|NCT00086515|3389398|P1|Phase A to Phase B Transition Period|Poor compliance|1
1044236|NCT00086515|3389397|P2|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
1044237|NCT00086515|3389398|P1|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
1044238|NCT00086515|3389397|P2|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23
1044239|NCT00086515|3389398|P1|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16
1044240|NCT00086515|3389397|P2|Phase A to Phase B Transition Period|Protocol Violation|1
1044241|NCT00086515|3389398|P1|Phase A to Phase B Transition Period|Protocol Violation|0
1044242|NCT00086515|3389397|P2|Phase A to Phase B Transition Period|Withdrawal by Subject|0
1044243|NCT00086515|3389398|P1|Phase A to Phase B Transition Period|Withdrawal by Subject|1
1044244|NCT00086515|3389397|P2|Phase A to Phase B Transition Period|Lack of Efficacy|2
1044245|NCT00086515|3389398|P1|Phase A to Phase B Transition Period|Lack of Efficacy|2
1044246|NCT00086515|3389397|P2|Phase A to Phase B Transition Period|Adverse Event|1
1044247|NCT00086515|3389398|P1|Phase A to Phase B Transition Period|Adverse Event|2
1044248|NCT00086515|3389397|P2|Phase A (Weeks 0-24)|Personal Circumstance|0
1044249|NCT00086515|3389398|P1|Phase A (Weeks 0-24)|Personal Circumstance|1
1044250|NCT00086515|3389397|P2|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1
1044251|NCT00086515|3389398|P1|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0
1044252|NCT00086515|3389397|P2|Phase A (Weeks 0-24)|Poor compliance|0
1044253|NCT00086515|3389398|P1|Phase A (Weeks 0-24)|Poor compliance|1
1044254|NCT00086515|3389397|P2|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3
1044255|NCT00086515|3389398|P1|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4
1044256|NCT00086515|3389397|P2|Phase A (Weeks 0-24)|Patient Moved|3
1044257|NCT00086515|3389398|P1|Phase A (Weeks 0-24)|Patient Moved|2
1044258|NCT00086515|3389397|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|10
1044259|NCT00086515|3389398|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|10
1044260|NCT00086515|3389397|P2|Phase A (Weeks 0-24)|Protocol Violation|1
1044261|NCT00086515|3389398|P1|Phase A (Weeks 0-24)|Protocol Violation|3
1044262|NCT00086515|3389397|P2|Phase A (Weeks 0-24)|Lost to Follow-up|5
1044263|NCT00086515|3389398|P1|Phase A (Weeks 0-24)|Lost to Follow-up|4
1044264|NCT00086515|3389397|P2|Phase A (Weeks 0-24)|Lack of Efficacy|13
1044265|NCT00086515|3389398|P1|Phase A (Weeks 0-24)|Lack of Efficacy|7
1044266|NCT00086515|3389397|P2|Phase A (Weeks 0-24)|Adverse Event|9
1044267|NCT00086515|3389398|P1|Phase A (Weeks 0-24)|Adverse Event|17
1044268|NCT00086502|3389410|P2|Overall Study|Patient Accidentally Unblinded|0
1044269|NCT00086502|3389411|P1|Overall Study|Patient Accidentally Unblinded|1
1044270|NCT00086502|3389410|P2|Overall Study|Protocol Discontinuation Criteria|3
1044271|NCT00086502|3389411|P1|Overall Study|Protocol Discontinuation Criteria|1
1044272|NCT00086502|3389410|P2|Overall Study|Patient Moved|1
1044273|NCT00086502|3389411|P1|Overall Study|Patient Moved|1
1044274|NCT00086502|3389410|P2|Overall Study|Withdrawal by Subject|6
1044275|NCT00086502|3389411|P1|Overall Study|Withdrawal by Subject|5
1044276|NCT00086502|3389410|P2|Overall Study|Protocol Violation|3
1044277|NCT00086502|3389411|P1|Overall Study|Protocol Violation|3
1044278|NCT00086502|3389410|P2|Overall Study|Pregnancy|1
1044279|NCT00086502|3389411|P1|Overall Study|Pregnancy|0
1044280|NCT00086502|3389410|P2|Overall Study|Physician Decision|1
1044281|NCT00086502|3389411|P1|Overall Study|Physician Decision|1
1044282|NCT00086502|3389410|P2|Overall Study|Lost to Follow-up|1
1044283|NCT00086502|3389411|P1|Overall Study|Lost to Follow-up|3
1044284|NCT00086502|3389410|P2|Overall Study|Lack of Efficacy|2
1044285|NCT00086502|3389411|P1|Overall Study|Lack of Efficacy|0
1044286|NCT00086502|3389410|P2|Overall Study|Adverse Event|2
1044287|NCT00086502|3389411|P1|Overall Study|Adverse Event|11
1044288|NCT00086346|3389436|P2|Patients Dosed With Test Article|Lack of Efficacy|0
1044289|NCT00086346|3389437|P1|Patients Dosed With Test Article|Lack of Efficacy|11
1044290|NCT00086346|3389436|P2|Patients Dosed With Test Article|Protocol Violation|3
1044291|NCT00086346|3389437|P1|Patients Dosed With Test Article|Protocol Violation|11
1044292|NCT00086346|3389436|P2|Patients Dosed With Test Article|Withdrawal by Subject|3
1044293|NCT00086346|3389437|P1|Patients Dosed With Test Article|Withdrawal by Subject|16
1044294|NCT00086346|3389436|P2|Patients Dosed With Test Article|Nonmedical event|3
1044295|NCT00086346|3389437|P1|Patients Dosed With Test Article|Nonmedical event|7
1044296|NCT00086346|3389436|P2|Patients Dosed With Test Article|Lost to Follow-up|3
1044297|NCT00086346|3389437|P1|Patients Dosed With Test Article|Lost to Follow-up|1
1044298|NCT00086346|3389436|P2|Patients Dosed With Test Article|Adverse Event|11
1044299|NCT00086346|3389437|P1|Patients Dosed With Test Article|Adverse Event|94
1044300|NCT00086346|3389436|P2|Randomization|Did not receive test article|4
1044301|NCT00086346|3389437|P1|Randomization|Did not receive test article|4
1044302|NCT00086281|3389464|P15|Phase 2|Adverse Event|0
1044303|NCT00086281|3389465|P14|Phase 2|Adverse Event|1
1044304|NCT00086281|3389466|P13|Phase 2|Adverse Event|1
1044305|NCT00086281|3389467|P12|Phase 2|Adverse Event|0
1044306|NCT00086281|3389468|P11|Phase 2|Adverse Event|0
1044307|NCT00086281|3389469|P10|Phase 2|Adverse Event|0
1044308|NCT00086281|3389470|P9|Phase 2|Adverse Event|0
1044309|NCT00086281|3389471|P8|Phase 2|Adverse Event|0
1044310|NCT00086281|3389472|P7|Phase 2|Adverse Event|0
1044311|NCT00086281|3389473|P6|Phase 2|Adverse Event|0
1044312|NCT00086281|3389474|P5|Phase 2|Adverse Event|0
1044313|NCT00086281|3389475|P4|Phase 2|Adverse Event|0
1044314|NCT00086281|3389476|P3|Phase 2|Adverse Event|0
1044315|NCT00086281|3389477|P2|Phase 2|Adverse Event|0
1044316|NCT00086281|3389478|P1|Phase 2|Adverse Event|0
1044317|NCT00086281|3389464|P15|Phase 1|Serious Adverse Event|1
1044318|NCT00086281|3389465|P14|Phase 1|Serious Adverse Event|0
1044319|NCT00086281|3389466|P13|Phase 1|Serious Adverse Event|0
1044320|NCT00086281|3389467|P12|Phase 1|Serious Adverse Event|0
1044321|NCT00086281|3389468|P11|Phase 1|Serious Adverse Event|0
1044322|NCT00086281|3389469|P10|Phase 1|Serious Adverse Event|0
1044323|NCT00086281|3389470|P9|Phase 1|Serious Adverse Event|0
1044324|NCT00086281|3389471|P8|Phase 1|Serious Adverse Event|0
1044325|NCT00086281|3389472|P7|Phase 1|Serious Adverse Event|0
1044326|NCT00086281|3389473|P6|Phase 1|Serious Adverse Event|0
1044327|NCT00086281|3389474|P5|Phase 1|Serious Adverse Event|0
1044328|NCT00086281|3389475|P4|Phase 1|Serious Adverse Event|0
1044329|NCT00086281|3389476|P3|Phase 1|Serious Adverse Event|0
1044330|NCT00086281|3389477|P2|Phase 1|Serious Adverse Event|0
1044331|NCT00086281|3389478|P1|Phase 1|Serious Adverse Event|0
1044332|NCT00086281|3389464|P15|Phase 1|Protocol Violation|0
1044333|NCT00086281|3389465|P14|Phase 1|Protocol Violation|0
1044334|NCT00086281|3389466|P13|Phase 1|Protocol Violation|0
1044335|NCT00086281|3389467|P12|Phase 1|Protocol Violation|0
1044336|NCT00086281|3389468|P11|Phase 1|Protocol Violation|1
1044337|NCT00086281|3389469|P10|Phase 1|Protocol Violation|0
1044338|NCT00086281|3389470|P9|Phase 1|Protocol Violation|0
1044339|NCT00086281|3389471|P8|Phase 1|Protocol Violation|0
1044340|NCT00086281|3389472|P7|Phase 1|Protocol Violation|0
1044341|NCT00086281|3389473|P6|Phase 1|Protocol Violation|0
1044342|NCT00086281|3389474|P5|Phase 1|Protocol Violation|0
1044343|NCT00086281|3389475|P4|Phase 1|Protocol Violation|0
1044344|NCT00086281|3389476|P3|Phase 1|Protocol Violation|0
1044345|NCT00086281|3389477|P2|Phase 1|Protocol Violation|0
1044346|NCT00086281|3389478|P1|Phase 1|Protocol Violation|0
1044347|NCT00086281|3389464|P15|Phase 1|Adverse Event|2
1044348|NCT00086281|3389465|P14|Phase 1|Adverse Event|1
1044349|NCT00086281|3389466|P13|Phase 1|Adverse Event|1
1044350|NCT00086281|3389467|P12|Phase 1|Adverse Event|1
1044351|NCT00086281|3389468|P11|Phase 1|Adverse Event|2
1044352|NCT00086281|3389469|P10|Phase 1|Adverse Event|1
1044353|NCT00086281|3389470|P9|Phase 1|Adverse Event|0
1044354|NCT00086281|3389471|P8|Phase 1|Adverse Event|0
1044355|NCT00086281|3389472|P7|Phase 1|Adverse Event|0
1044356|NCT00086281|3389473|P6|Phase 1|Adverse Event|0
1044357|NCT00086281|3389474|P5|Phase 1|Adverse Event|0
1044358|NCT00086281|3389475|P4|Phase 1|Adverse Event|0
1044359|NCT00086281|3389476|P3|Phase 1|Adverse Event|0
1044360|NCT00086281|3389477|P2|Phase 1|Adverse Event|0
1044361|NCT00086281|3389478|P1|Phase 1|Adverse Event|0
1044362|NCT00086307|3389491|P3|Overall Study|Withdrawal by Subject|2
1044363|NCT00086307|3389492|P2|Overall Study|Withdrawal by Subject|0
1044364|NCT00086307|3389493|P1|Overall Study|Withdrawal by Subject|0
1044365|NCT00086307|3389491|P3|Overall Study|Fatigue and difficulty falling asleep|1
1044366|NCT00086307|3389492|P2|Overall Study|Fatigue and difficulty falling asleep|0
1044367|NCT00086307|3389493|P1|Overall Study|Fatigue and difficulty falling asleep|0
1044368|NCT00086307|3389491|P3|Overall Study|Suicidal ideation|1
1044369|NCT00086307|3389492|P2|Overall Study|Suicidal ideation|0
1044370|NCT00086307|3389493|P1|Overall Study|Suicidal ideation|0
1044371|NCT00086307|3389491|P3|Overall Study|Constipation and sleepiness|1
1044372|NCT00086307|3389492|P2|Overall Study|Constipation and sleepiness|0
1044373|NCT00086307|3389493|P1|Overall Study|Constipation and sleepiness|0
1044374|NCT00086307|3389491|P3|Overall Study|Nausea and headaches|1
1044375|NCT00086307|3389492|P2|Overall Study|Nausea and headaches|0
1044376|NCT00086307|3389493|P1|Overall Study|Nausea and headaches|0
1044377|NCT00086307|3389491|P3|Overall Study|Shortness of breath and muscle spasms|0
1044378|NCT00086307|3389492|P2|Overall Study|Shortness of breath and muscle spasms|0
1044379|NCT00086307|3389493|P1|Overall Study|Shortness of breath and muscle spasms|1
1044380|NCT00086307|3389491|P3|Overall Study|Lack of Efficacy|2
1044381|NCT00086307|3389492|P2|Overall Study|Lack of Efficacy|1
1044382|NCT00086307|3389493|P1|Overall Study|Lack of Efficacy|1
1044383|NCT00086190|3389504|P3|Overall Study|Worsening depression|2
1044384|NCT00086190|3389505|P2|Overall Study|Worsening depression|0
1044385|NCT00086190|3389506|P1|Overall Study|Worsening depression|0
1044386|NCT00086190|3389504|P3|Overall Study|Moved|0
1044387|NCT00086190|3389505|P2|Overall Study|Moved|0
1044388|NCT00086190|3389506|P1|Overall Study|Moved|1
1044389|NCT00086190|3389504|P3|Overall Study|Protocol Violation|0
1044390|NCT00086190|3389505|P2|Overall Study|Protocol Violation|0
1044391|NCT00086190|3389506|P1|Overall Study|Protocol Violation|1
1044392|NCT00086190|3389504|P3|Overall Study|Withdrawal by Subject|2
1044393|NCT00086190|3389505|P2|Overall Study|Withdrawal by Subject|2
1044394|NCT00086190|3389506|P1|Overall Study|Withdrawal by Subject|0
1044395|NCT00086190|3389504|P3|Overall Study|Adverse Event|2
1044396|NCT00086190|3389505|P2|Overall Study|Adverse Event|2
1044397|NCT00086190|3389506|P1|Overall Study|Adverse Event|6
1044398|NCT00086047|3389575|P2|Overall Study|Physician Decision|1
1044399|NCT00086047|3389576|P1|Overall Study|Physician Decision|0
1044400|NCT00086047|3389575|P2|Overall Study|Lost to Follow-up|6
1044401|NCT00086047|3389576|P1|Overall Study|Lost to Follow-up|7
1044402|NCT00085917|3389584|P2|Overall Study|Adverse Event|3
1044403|NCT00085917|3389585|P1|Overall Study|Adverse Event|4
1044404|NCT00085735|3389614|P6|Overall Study|Pt transferred to inst w/out study open|0
1044405|NCT00085735|3389615|P5|Overall Study|Pt transferred to inst w/out study open|0
1044406|NCT00085735|3389616|P4|Overall Study|Pt transferred to inst w/out study open|0
1044407|NCT00085735|3389617|P3|Overall Study|Pt transferred to inst w/out study open|0
1044408|NCT00085735|3389618|P2|Overall Study|Pt transferred to inst w/out study open|0
1044409|NCT00085735|3389619|P1|Overall Study|Pt transferred to inst w/out study open|1
1044410|NCT00085735|3389614|P6|Overall Study|Reason not documented|0
1044411|NCT00085735|3389615|P5|Overall Study|Reason not documented|1
1044412|NCT00085735|3389616|P4|Overall Study|Reason not documented|0
1044413|NCT00085735|3389617|P3|Overall Study|Reason not documented|1
1044414|NCT00085735|3389618|P2|Overall Study|Reason not documented|0
1044415|NCT00085735|3389619|P1|Overall Study|Reason not documented|1
1044416|NCT00085735|3389614|P6|Overall Study|Excess residual disease|4
1044417|NCT00085735|3389615|P5|Overall Study|Excess residual disease|1
1044418|NCT00085735|3389616|P4|Overall Study|Excess residual disease|1
1044419|NCT00085735|3389617|P3|Overall Study|Excess residual disease|1
1044420|NCT00085735|3389618|P2|Overall Study|Excess residual disease|2
1044421|NCT00085735|3389619|P1|Overall Study|Excess residual disease|2
1044422|NCT00085735|3389614|P6|Overall Study|Patient ineligible|8
1044423|NCT00085735|3389615|P5|Overall Study|Patient ineligible|17
1044424|NCT00085735|3389616|P4|Overall Study|Patient ineligible|7
1044425|NCT00085735|3389617|P3|Overall Study|Patient ineligible|3
1044426|NCT00085735|3389618|P2|Overall Study|Patient ineligible|0
1044427|NCT00085735|3389619|P1|Overall Study|Patient ineligible|1
1044428|NCT00085735|3389614|P6|Overall Study|Withdrawal by Subject|8
1044429|NCT00085735|3389615|P5|Overall Study|Withdrawal by Subject|7
1044430|NCT00085735|3389616|P4|Overall Study|Withdrawal by Subject|5
1044431|NCT00085735|3389617|P3|Overall Study|Withdrawal by Subject|4
1044432|NCT00085735|3389618|P2|Overall Study|Withdrawal by Subject|0
1044433|NCT00085735|3389619|P1|Overall Study|Withdrawal by Subject|1
1044434|NCT00085735|3389614|P6|Overall Study|Protocol Violation|0
1044435|NCT00085735|3389615|P5|Overall Study|Protocol Violation|0
1044436|NCT00085735|3389616|P4|Overall Study|Protocol Violation|0
1044437|NCT00085735|3389617|P3|Overall Study|Protocol Violation|0
1044438|NCT00085735|3389618|P2|Overall Study|Protocol Violation|0
1044439|NCT00085735|3389619|P1|Overall Study|Protocol Violation|1
1044440|NCT00085735|3389614|P6|Overall Study|Physician Decision|8
1044441|NCT00085735|3389615|P5|Overall Study|Physician Decision|11
1044442|NCT00085735|3389616|P4|Overall Study|Physician Decision|3
1044443|NCT00085735|3389617|P3|Overall Study|Physician Decision|2
1044444|NCT00085735|3389618|P2|Overall Study|Physician Decision|3
1044445|NCT00085735|3389619|P1|Overall Study|Physician Decision|2
1044446|NCT00085735|3389614|P6|Overall Study|Lost to Follow-up|0
1044447|NCT00085735|3389615|P5|Overall Study|Lost to Follow-up|1
1044448|NCT00085735|3389616|P4|Overall Study|Lost to Follow-up|0
1044449|NCT00085735|3389617|P3|Overall Study|Lost to Follow-up|0
1044450|NCT00085735|3389618|P2|Overall Study|Lost to Follow-up|1
1044451|NCT00085735|3389619|P1|Overall Study|Lost to Follow-up|0
1044452|NCT00085735|3389614|P6|Overall Study|Lack of Efficacy|3
1044453|NCT00085735|3389615|P5|Overall Study|Lack of Efficacy|4
1044454|NCT00085735|3389616|P4|Overall Study|Lack of Efficacy|3
1044455|NCT00085735|3389617|P3|Overall Study|Lack of Efficacy|6
1044456|NCT00085735|3389618|P2|Overall Study|Lack of Efficacy|4
1044457|NCT00085735|3389619|P1|Overall Study|Lack of Efficacy|2
1044458|NCT00085735|3389614|P6|Overall Study|Adverse Event|0
1044459|NCT00085735|3389615|P5|Overall Study|Adverse Event|0
1044460|NCT00085735|3389616|P4|Overall Study|Adverse Event|0
1044461|NCT00085735|3389617|P3|Overall Study|Adverse Event|0
1044462|NCT00085735|3389618|P2|Overall Study|Adverse Event|0
1044463|NCT00085735|3389619|P1|Overall Study|Adverse Event|1
1044464|NCT00085709|3389647|P2|Overall Study|Withdrawal by Subject|1
1044465|NCT00085709|3389648|P1|Overall Study|Withdrawal by Subject|2
1044466|NCT00085709|3389647|P2|Overall Study|Not eligible|19
1044467|NCT00085709|3389648|P1|Overall Study|Not eligible|19
1044468|NCT00085709|3389647|P2|Overall Study|Not protocol specified|22
1044469|NCT00085709|3389648|P1|Overall Study|Not protocol specified|12
1044470|NCT00085709|3389647|P2|Overall Study|Progression|4
1044471|NCT00085709|3389648|P1|Overall Study|Progression|3
1044472|NCT00085709|3389647|P2|Overall Study|Refusal unrelated to adverse events|2
1044473|NCT00085709|3389648|P1|Overall Study|Refusal unrelated to adverse events|1
1044474|NCT00085709|3389647|P2|Overall Study|Death|2
1044475|NCT00085709|3389648|P1|Overall Study|Death|8
1044476|NCT00085709|3389647|P2|Overall Study|Adverse Event|0
1044477|NCT00085709|3389648|P1|Overall Study|Adverse Event|8
1044478|NCT00085644|3389664|P3|Open-Label Period|Personal reason|4
1044479|NCT00085644|3389665|P2|Open-Label Period|Personal reason|0
1044480|NCT00085644|3389666|P1|Open-Label Period|Personal reason|0
1044481|NCT00085644|3389664|P3|Open-Label Period|Protocol Violation|4
1044482|NCT00085644|3389665|P2|Open-Label Period|Protocol Violation|0
1044483|NCT00085644|3389666|P1|Open-Label Period|Protocol Violation|0
1044484|NCT00085644|3389664|P3|Open-Label Period|Contemplating pregnancy|3
1044485|NCT00085644|3389665|P2|Open-Label Period|Contemplating pregnancy|0
1044486|NCT00085644|3389666|P1|Open-Label Period|Contemplating pregnancy|0
1044487|NCT00085644|3389664|P3|Open-Label Period|Pregnancy|3
1044488|NCT00085644|3389665|P2|Open-Label Period|Pregnancy|0
1044489|NCT00085644|3389666|P1|Open-Label Period|Pregnancy|0
1044490|NCT00085644|3389664|P3|Open-Label Period|Lack of Efficacy|15
1044491|NCT00085644|3389665|P2|Open-Label Period|Lack of Efficacy|0
1044492|NCT00085644|3389666|P1|Open-Label Period|Lack of Efficacy|0
1044493|NCT00085644|3389664|P3|Open-Label Period|Lost to Follow-up|13
1044494|NCT00085644|3389665|P2|Open-Label Period|Lost to Follow-up|0
1044495|NCT00085644|3389666|P1|Open-Label Period|Lost to Follow-up|0
1044496|NCT00085644|3389664|P3|Open-Label Period|Withdrawal by Subject|29
1044497|NCT00085644|3389665|P2|Open-Label Period|Withdrawal by Subject|0
1044498|NCT00085644|3389666|P1|Open-Label Period|Withdrawal by Subject|0
1044499|NCT00085644|3389664|P3|Open-Label Period|Adverse Event|38
1044500|NCT00085644|3389665|P2|Open-Label Period|Adverse Event|0
1044501|NCT00085644|3389666|P1|Open-Label Period|Adverse Event|0
1044502|NCT00085644|3389664|P3|Double-Blind Period|Undiagnosed pre-existing condition|0
1044503|NCT00085644|3389665|P2|Double-Blind Period|Undiagnosed pre-existing condition|1
1044504|NCT00085644|3389666|P1|Double-Blind Period|Undiagnosed pre-existing condition|0
1044505|NCT00085644|3389664|P3|Double-Blind Period|Contemplating pregnancy|0
1044506|NCT00085644|3389665|P2|Double-Blind Period|Contemplating pregnancy|0
1044507|NCT00085644|3389666|P1|Double-Blind Period|Contemplating pregnancy|1
1044508|NCT00085644|3389664|P3|Double-Blind Period|Lack/loss of efficacy|0
1044509|NCT00085644|3389665|P2|Double-Blind Period|Lack/loss of efficacy|2
1044510|NCT00085644|3389666|P1|Double-Blind Period|Lack/loss of efficacy|2
1044511|NCT00085644|3389664|P3|Double-Blind Period|Lost to Follow-up|0
1044512|NCT00085644|3389665|P2|Double-Blind Period|Lost to Follow-up|1
1044513|NCT00085644|3389666|P1|Double-Blind Period|Lost to Follow-up|2
1044514|NCT00085644|3389664|P3|Double-Blind Period|Withdrawal by Subject|0
1044515|NCT00085644|3389665|P2|Double-Blind Period|Withdrawal by Subject|0
1044516|NCT00085644|3389666|P1|Double-Blind Period|Withdrawal by Subject|3
1044517|NCT00085644|3389664|P3|Double-Blind Period|Adverse Event|0
1044518|NCT00085644|3389665|P2|Double-Blind Period|Adverse Event|2
1044519|NCT00085644|3389666|P1|Double-Blind Period|Adverse Event|5
1044520|NCT00085631|3389707|P3|Overall Study|Missing Data|7
1044521|NCT00085631|3389708|P2|Overall Study|Missing Data|11
1044522|NCT00085631|3389709|P1|Overall Study|Missing Data|4
1044523|NCT00085566|3389719|P3|Overall Study|Clinical progression|1
1044524|NCT00085566|3389720|P2|Overall Study|Clinical progression|0
1044525|NCT00085566|3389721|P1|Overall Study|Clinical progression|0
1044526|NCT00085566|3389719|P3|Overall Study|Patient Not treated|3
1044527|NCT00085566|3389720|P2|Overall Study|Patient Not treated|0
1044528|NCT00085566|3389721|P1|Overall Study|Patient Not treated|0
1044529|NCT00085566|3389719|P3|Overall Study|Adverse Event|10
1044530|NCT00085566|3389720|P2|Overall Study|Adverse Event|0
1044531|NCT00085566|3389721|P1|Overall Study|Adverse Event|0
1044532|NCT00085540|3389731|P2|Overall Study|Protocol Violation|1
1044533|NCT00085540|3389732|P1|Overall Study|Protocol Violation|0
1044534|NCT00085540|3389731|P2|Overall Study|Withdrawal by Subject|1
1044535|NCT00085540|3389732|P1|Overall Study|Withdrawal by Subject|0
1044536|NCT00085423|3389744|P1|Overall Study|screen failure|1
1044537|NCT00085423|3389744|P1|Overall Study|Withdrawal by Subject|1
1044538|NCT00085202|3389795|P2|Overall Study|Progressive disease|11
1044539|NCT00085202|3389796|P1|Overall Study|Progressive disease|1
1044540|NCT00085202|3389795|P2|Overall Study|Physician Decision|1
1044541|NCT00085202|3389796|P1|Overall Study|Physician Decision|4
1044542|NCT00085202|3389795|P2|Overall Study|Withdrawal by Subject|1
1044543|NCT00085202|3389796|P1|Overall Study|Withdrawal by Subject|2
1044544|NCT00085202|3389795|P2|Overall Study|Non-specified|5
1044545|NCT00085202|3389796|P1|Overall Study|Non-specified|3
1044546|NCT00085202|3389795|P2|Overall Study|Excessive toxicity|5
1044547|NCT00085202|3389796|P1|Overall Study|Excessive toxicity|6
1044548|NCT00085202|3389795|P2|Overall Study|Bone involvement confirmed by bone scan|1
1044549|NCT00085202|3389796|P1|Overall Study|Bone involvement confirmed by bone scan|0
1044550|NCT00085202|3389795|P2|Overall Study|Still on therapy|0
1044551|NCT00085202|3389796|P1|Overall Study|Still on therapy|2
1044552|NCT00085098|3389817|P2|Overall Study|Ineligible|1
1044553|NCT00085098|3389818|P1|Overall Study|Ineligible|1
1044554|NCT00085098|3389817|P2|Overall Study|Withdrawal by Subject|1
1044555|NCT00085098|3389818|P1|Overall Study|Withdrawal by Subject|0
1044556|NCT00084864|3389832|P4|Overall Study|Adverse Event|0
1044557|NCT00084864|3389833|P3|Overall Study|Adverse Event|0
1044558|NCT00084864|3389834|P2|Overall Study|Adverse Event|0
1044559|NCT00084864|3389835|P1|Overall Study|Adverse Event|1
1044560|NCT00084838|3389861|P1|Overall Study|Ineligible|4
1044561|NCT00084838|3389861|P1|Overall Study|Pt Non-Compliance|1
1044562|NCT00084838|3389861|P1|Overall Study|Progressive Disease|4
1044563|NCT00084838|3389861|P1|Overall Study|Withdrawal by Subject|1
1044564|NCT00084838|3389861|P1|Overall Study|Adverse Event|2
1044565|NCT00084838|3389861|P1|Overall Study|Death|1
1044566|NCT00084747|3389883|P1|Overall Study|Withdrawal by Subject|2
1044567|NCT00084747|3389883|P1|Overall Study|Death|3
1044568|NCT00084747|3389883|P1|Overall Study|Relapsed|8
1044569|NCT00084682|3389888|P1|Overall Study|Withdrawal by Subject|1
1044570|NCT00084617|3389892|P1|Overall Study|Protocol Violation|1
1044571|NCT00084617|3389892|P1|Overall Study|Lack of Efficacy|1
1044572|NCT00084617|3389892|P1|Overall Study|Withdrawal by Subject|7
1044573|NCT00084487|3389898|P1|Overall Study|Death|1
1044574|NCT00084318|3389942|P2|Overall Study|No protocol treatment|0
1044575|NCT00084318|3389943|P1|Overall Study|No protocol treatment|2
1044576|NCT00084318|3389942|P2|Overall Study|Protocol Violation|11
1044577|NCT00084318|3389943|P1|Overall Study|Protocol Violation|15
1044578|NCT00084318|3389942|P2|Overall Study|Withdrawal by Subject|2
1044579|NCT00084318|3389943|P1|Overall Study|Withdrawal by Subject|5
1044580|NCT00084266|3389961|P2|Overall Study|Randomized not treated|20
1044581|NCT00084266|3389962|P1|Overall Study|Randomized not treated|21
1044582|NCT00084266|3389961|P2|Overall Study|Other|344
1044583|NCT00084266|3389962|P1|Overall Study|Other|360
1044584|NCT00084266|3389961|P2|Overall Study|Participant not willing to participate|8
1044585|NCT00084266|3389962|P1|Overall Study|Participant not willing to participate|3
1044586|NCT00084266|3389961|P2|Overall Study|Lost to Follow-up|3
1044587|NCT00084266|3389962|P1|Overall Study|Lost to Follow-up|5
1044588|NCT00084266|3389961|P2|Overall Study|Lack of Efficacy|4
1044589|NCT00084266|3389962|P1|Overall Study|Lack of Efficacy|2
1044590|NCT00084266|3389961|P2|Overall Study|Adverse Event|5
1044591|NCT00084266|3389962|P1|Overall Study|Adverse Event|8
1044592|NCT00084266|3389961|P2|Overall Study|Death|39
1044593|NCT00084266|3389962|P1|Overall Study|Death|42
1044594|NCT00084136|3390020|P3|NRTI Comparison|Not reason above|0
1044595|NCT00084136|3390021|P2|NRTI Comparison|Not reason above|0
1044596|NCT00084136|3390022|P1|NRTI Comparison|Not reason above|1
1044597|NCT00084136|3390020|P3|NRTI Comparison|Clinic site closed|14
1044598|NCT00084136|3390021|P2|NRTI Comparison|Clinic site closed|0
1044599|NCT00084136|3390022|P1|NRTI Comparison|Clinic site closed|12
1044600|NCT00084136|3390020|P3|NRTI Comparison|Withdrawal by Subject|38
1044601|NCT00084136|3390021|P2|NRTI Comparison|Withdrawal by Subject|0
1044602|NCT00084136|3390022|P1|NRTI Comparison|Withdrawal by Subject|54
1044603|NCT00084136|3390020|P3|NRTI Comparison|Lost to Follow-up|12
1044604|NCT00084136|3390021|P2|NRTI Comparison|Lost to Follow-up|0
1044605|NCT00084136|3390022|P1|NRTI Comparison|Lost to Follow-up|14
1044606|NCT00084136|3390020|P3|NRTI Comparison|Death|18
1044607|NCT00084136|3390021|P2|NRTI Comparison|Death|0
1044608|NCT00084136|3390022|P1|NRTI Comparison|Death|20
1044609|NCT00084136|3390020|P3|PI Comparison|Clinic site closed|0
1044610|NCT00084136|3390021|P2|PI Comparison|Clinic site closed|0
1044611|NCT00084136|3390022|P1|PI Comparison|Clinic site closed|1
1044612|NCT00084136|3390020|P3|PI Comparison|Withdrawal by Subject|0
1044613|NCT00084136|3390021|P2|PI Comparison|Withdrawal by Subject|30
1044614|NCT00084136|3390022|P1|PI Comparison|Withdrawal by Subject|33
1044615|NCT00084136|3390020|P3|PI Comparison|Lost to Follow-up|0
1044616|NCT00084136|3390021|P2|PI Comparison|Lost to Follow-up|8
1044617|NCT00084136|3390022|P1|PI Comparison|Lost to Follow-up|11
1044618|NCT00084136|3390020|P3|PI Comparison|Death|0
1044619|NCT00084136|3390021|P2|PI Comparison|Death|9
1044620|NCT00084136|3390022|P1|PI Comparison|Death|10
1044621|NCT00084084|3390081|P1|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1
1044622|NCT00084084|3390081|P1|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1
1044623|NCT00083915|3390091|P2|Overall Study|Insurance issues|1
1044624|NCT00083915|3390092|P1|Overall Study|Insurance issues|1
1044625|NCT00083915|3390091|P2|Overall Study|No response|1
1044626|NCT00083915|3390092|P1|Overall Study|No response|3
1044627|NCT00083915|3390091|P2|Overall Study|Failure to collect|0
1044628|NCT00083915|3390092|P1|Overall Study|Failure to collect|3
1044629|NCT00083915|3390091|P2|Overall Study|disease progression|23
1044630|NCT00083915|3390092|P1|Overall Study|disease progression|18
1044631|NCT00083915|3390091|P2|Overall Study|Withdrawal by Subject|3
1044632|NCT00083915|3390092|P1|Overall Study|Withdrawal by Subject|8
1044633|NCT00083915|3390091|P2|Overall Study|Physician Decision|6
1044634|NCT00083915|3390092|P1|Overall Study|Physician Decision|11
1044635|NCT00083915|3390091|P2|Overall Study|Death|3
1044636|NCT00083915|3390092|P1|Overall Study|Death|6
1044637|NCT00083889|3390100|P2|Overall Study|Crossover to SU011248|25
1044638|NCT00083889|3390101|P1|Overall Study|Crossover to SU011248|0
1044639|NCT00083889|3390100|P2|Overall Study|Completed on marketed sunitinub|0
1044640|NCT00083889|3390101|P1|Overall Study|Completed on marketed sunitinub|3
1044641|NCT00083889|3390100|P2|Overall Study|Randomized: did not take study drug|15
1044642|NCT00083889|3390101|P1|Overall Study|Randomized: did not take study drug|0
1044643|NCT00083889|3390100|P2|Overall Study|Decision of sponsor|4
1044644|NCT00083889|3390101|P1|Overall Study|Decision of sponsor|32
1044645|NCT00083889|3390100|P2|Overall Study|Lack of Efficacy|219
1044646|NCT00083889|3390101|P1|Overall Study|Lack of Efficacy|240
1044647|NCT00083889|3390100|P2|Overall Study|Withdrawal by Subject|24
1044648|NCT00083889|3390101|P1|Overall Study|Withdrawal by Subject|22
1044649|NCT00083889|3390100|P2|Overall Study|Protocol Violation|2
1044650|NCT00083889|3390101|P1|Overall Study|Protocol Violation|2
1044651|NCT00083889|3390100|P2|Overall Study|Adverse Event|86
1044652|NCT00083889|3390101|P1|Overall Study|Adverse Event|76
1044653|NCT00083759|3390159|P2|Overall Study|Other|13
1044654|NCT00083759|3390160|P1|Overall Study|Other|14
1044655|NCT00083759|3390159|P2|Overall Study|Sponsor's Discretion|29
1044656|NCT00083759|3390160|P1|Overall Study|Sponsor's Discretion|28
1044657|NCT00083759|3390159|P2|Overall Study|Non-Compliance|0
1044658|NCT00083759|3390160|P1|Overall Study|Non-Compliance|1
1044659|NCT00083759|3390159|P2|Overall Study|Subject Withdrew Consent|2
1044660|NCT00083759|3390160|P1|Overall Study|Subject Withdrew Consent|2
1044661|NCT00083759|3390159|P2|Overall Study|Inadequate Therapeutic Response|35
1044662|NCT00083759|3390160|P1|Overall Study|Inadequate Therapeutic Response|32
1044663|NCT00083759|3390159|P2|Overall Study|Death|1
1044664|NCT00083759|3390160|P1|Overall Study|Death|1
1044665|NCT00083759|3390159|P2|Overall Study|Lost to Follow-up|0
1044666|NCT00083759|3390160|P1|Overall Study|Lost to Follow-up|1
1044667|NCT00083759|3390159|P2|Overall Study|Adverse Event|3
1044668|NCT00083759|3390160|P1|Overall Study|Adverse Event|5
1044669|NCT00083616|3390178|P1|Overall Study|Other|6
1044670|NCT00083616|3390178|P1|Overall Study|Non-compliance|1
1044671|NCT00083616|3390178|P1|Overall Study|Ineligibility determined|2
1044672|NCT00083616|3390178|P1|Overall Study|Withdrawal by Subject|3
1044673|NCT00083616|3390178|P1|Overall Study|Physician Decision|2
1044674|NCT00083616|3390178|P1|Overall Study|Lost to Follow-up|1
1044675|NCT00083616|3390178|P1|Overall Study|Disease Progression|16
1044676|NCT00082888|3390203|P1|Overall Study|Still receiving treatment|4
1044677|NCT00082888|3390203|P1|Overall Study|Other Medical Problems|2
1044678|NCT00082888|3390203|P1|Overall Study|Alternate Treatment|1
1044679|NCT00082888|3390203|P1|Overall Study|Withdrawal by Subject|9
1044680|NCT00082888|3390203|P1|Overall Study|Adverse Event|4
1044681|NCT00082888|3390203|P1|Overall Study|Death|2
1044682|NCT00082810|3390207|P1|Overall Study|Withdrawal by Subject|4
1044683|NCT00082810|3390207|P1|Overall Study|Progressive disease|24
1044684|NCT00082810|3390207|P1|Overall Study|Adverse Event|3
1044685|NCT00082758|3390218|P3|Overall Study|Protocol Violation|0
1044686|NCT00082758|3390219|P2|Overall Study|Protocol Violation|1
1044687|NCT00082758|3390220|P1|Overall Study|Protocol Violation|0
1044688|NCT00082758|3390218|P3|Overall Study|Withdrawal by Subject|0
1044689|NCT00082758|3390219|P2|Overall Study|Withdrawal by Subject|0
1044690|NCT00082758|3390220|P1|Overall Study|Withdrawal by Subject|3
1044691|NCT00082758|3390218|P3|Overall Study|Physician Decision|0
1044692|NCT00082758|3390219|P2|Overall Study|Physician Decision|1
1044693|NCT00082758|3390220|P1|Overall Study|Physician Decision|0
1044694|NCT00082758|3390218|P3|Overall Study|Lack of Efficacy|0
1044695|NCT00082758|3390219|P2|Overall Study|Lack of Efficacy|13
1044696|NCT00082758|3390220|P1|Overall Study|Lack of Efficacy|12
1044697|NCT00082758|3390218|P3|Overall Study|Adverse Event|0
1044698|NCT00082758|3390219|P2|Overall Study|Adverse Event|2
1044699|NCT00082758|3390220|P1|Overall Study|Adverse Event|0
1044700|NCT00083226|3390228|P1|Overall Study|ineligible or not receiving treatment|4
1044701|NCT00083226|3390228|P1|Overall Study|Other|2
1044702|NCT00083226|3390228|P1|Overall Study|Withdrawal by Subject|4
1044703|NCT00083226|3390228|P1|Overall Study|Death|4
1044704|NCT00083226|3390228|P1|Overall Study|Adverse Event|9
1044705|NCT00083226|3390228|P1|Overall Study|Lack of Efficacy|19
1044706|NCT00082628|3390272|P5|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17
1044707|NCT00082628|3390273|P4|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
1044708|NCT00082628|3390274|P3|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
1044709|NCT00082628|3390275|P2|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
1044710|NCT00082628|3390276|P1|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
1044711|NCT00082628|3390272|P5|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
1044712|NCT00082628|3390273|P4|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1
1044713|NCT00082628|3390274|P3|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
1044714|NCT00082628|3390275|P2|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
1044715|NCT00082628|3390276|P1|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
1044716|NCT00082628|3390272|P5|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1
1044717|NCT00082628|3390273|P4|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
1044718|NCT00082628|3390274|P3|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
1044719|NCT00082628|3390275|P2|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
1044720|NCT00082628|3390276|P1|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
1044721|NCT00082628|3390272|P5|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
1044722|NCT00082628|3390273|P4|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
1044723|NCT00082628|3390274|P3|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
1044724|NCT00082628|3390275|P2|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15
1044725|NCT00082628|3390276|P1|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1
1044726|NCT00082628|3390272|P5|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
1044727|NCT00082628|3390273|P4|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
1044728|NCT00082628|3390274|P3|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
1044729|NCT00082628|3390275|P2|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43
1044730|NCT00082628|3390276|P1|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5
1044731|NCT00082628|3390272|P5|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
1044732|NCT00082628|3390273|P4|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
1044733|NCT00082628|3390274|P3|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
1044734|NCT00082628|3390275|P2|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1
1044735|NCT00082628|3390276|P1|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2
1044736|NCT00082628|3390272|P5|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
1044737|NCT00082628|3390273|P4|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
1044738|NCT00082628|3390274|P3|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
1044739|NCT00082628|3390275|P2|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1
1044740|NCT00082628|3390276|P1|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
1044741|NCT00082433|3390296|P2|Overall Study|Impending surgery|1
1044742|NCT00082433|3390297|P1|Overall Study|Impending surgery|0
1044743|NCT00082433|3390296|P2|Overall Study|New primary cancer|0
1044744|NCT00082433|3390297|P1|Overall Study|New primary cancer|1
1044745|NCT00082433|3390296|P2|Overall Study|Noncompliance|1
1044746|NCT00082433|3390297|P1|Overall Study|Noncompliance|2
1044747|NCT00082433|3390296|P2|Overall Study|Ineligible|1
1044748|NCT00082433|3390297|P1|Overall Study|Ineligible|2
1044749|NCT00082433|3390296|P2|Overall Study|Not Treated|11
1044750|NCT00082433|3390297|P1|Overall Study|Not Treated|12
1044751|NCT00082433|3390296|P2|Overall Study|Still On Treatment|1
1044752|NCT00082433|3390297|P1|Overall Study|Still On Treatment|2
1044753|NCT00082433|3390296|P2|Overall Study|Withdrawal by Subject|30
1044754|NCT00082433|3390297|P1|Overall Study|Withdrawal by Subject|55
1044755|NCT00082433|3390296|P2|Overall Study|Study Drug Toxicity|66
1044756|NCT00082433|3390297|P1|Overall Study|Study Drug Toxicity|179
1044757|NCT00082433|3390296|P2|Overall Study|Lost to Follow-up|2
1044758|NCT00082433|3390297|P1|Overall Study|Lost to Follow-up|1
1044759|NCT00082433|3390296|P2|Overall Study|Physician Decision|61
1044760|NCT00082433|3390297|P1|Overall Study|Physician Decision|50
1044761|NCT00082433|3390296|P2|Overall Study|Disease Progression/Relapse|388
1044762|NCT00082433|3390297|P1|Overall Study|Disease Progression/Relapse|270
1044763|NCT00082433|3390296|P2|Overall Study|Death|18
1044764|NCT00082433|3390297|P1|Overall Study|Death|8
1044765|NCT00082433|3390296|P2|Overall Study|Adverse Event|17
1044766|NCT00082433|3390297|P1|Overall Study|Adverse Event|12
1044767|NCT00082381|3390317|P2|Overall Study|Loss of Glucose Control|0
1044768|NCT00082381|3390318|P1|Overall Study|Loss of Glucose Control|4
1044769|NCT00082381|3390317|P2|Overall Study|Protocol Violation|11
1044770|NCT00082381|3390318|P1|Overall Study|Protocol Violation|10
1044771|NCT00082381|3390317|P2|Overall Study|Physician Decision|2
1044772|NCT00082381|3390318|P1|Overall Study|Physician Decision|1
1044773|NCT00082381|3390317|P2|Overall Study|Patient Decision|4
1044774|NCT00082381|3390318|P1|Overall Study|Patient Decision|8
1044775|NCT00082381|3390317|P2|Overall Study|Lost to Follow-up|7
1044776|NCT00082381|3390318|P1|Overall Study|Lost to Follow-up|5
1044777|NCT00082381|3390317|P2|Overall Study|Adverse Event|2
1044778|NCT00082381|3390318|P1|Overall Study|Adverse Event|27
1044779|NCT00082407|3390338|P2|Overall Study|Lost to Follow-up|3
1044780|NCT00082407|3390339|P1|Overall Study|Lost to Follow-up|0
1044781|NCT00082407|3390338|P2|Overall Study|Death|1
1044782|NCT00082407|3390339|P1|Overall Study|Death|2
1044783|NCT00082407|3390338|P2|Overall Study|Loss of Glucose Control|2
1044784|NCT00082407|3390339|P1|Overall Study|Loss of Glucose Control|2
1044785|NCT00082407|3390338|P2|Overall Study|Physician Decision|3
1044786|NCT00082407|3390339|P1|Overall Study|Physician Decision|5
1044787|NCT00082407|3390338|P2|Overall Study|Patient Decision|6
1044788|NCT00082407|3390339|P1|Overall Study|Patient Decision|13
1044789|NCT00082407|3390338|P2|Overall Study|Protocol Violation|12
1044790|NCT00082407|3390339|P1|Overall Study|Protocol Violation|14
1044791|NCT00082407|3390338|P2|Overall Study|Adverse Event|0
1044792|NCT00082407|3390339|P1|Overall Study|Adverse Event|20
1044793|NCT00082368|3390357|P1|Overall Study|Not treated-pt had poor IV access|1
1044794|NCT00082355|3390362|P1|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28
1044795|NCT00082355|3390362|P1|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1
1044796|NCT00082355|3390362|P1|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1
1044797|NCT00082173|3390396|P2|Overall Study|Culture negative or resistant at baselin|6
1044798|NCT00082173|3390397|P1|Overall Study|Culture negative or resistant at baselin|5
1044799|NCT00082173|3390396|P2|Overall Study|Adverse Event|0
1044800|NCT00082173|3390397|P1|Overall Study|Adverse Event|1
1044801|NCT00082173|3390396|P2|Overall Study|Lost to Follow-up|0
1044802|NCT00082173|3390397|P1|Overall Study|Lost to Follow-up|1
1044803|NCT00082173|3390396|P2|Overall Study|Withdrawal by Subject|5
1044804|NCT00082173|3390397|P1|Overall Study|Withdrawal by Subject|3
1044805|NCT00081770|3390437|P3|Overall Study|Not Specified|8
1044806|NCT00081770|3390438|P2|Overall Study|Not Specified|7
1044807|NCT00081770|3390439|P1|Overall Study|Not Specified|2
1044808|NCT00081770|3390437|P3|Overall Study|Administrative|1
1044809|NCT00081770|3390438|P2|Overall Study|Administrative|0
1044810|NCT00081770|3390439|P1|Overall Study|Administrative|1
1044811|NCT00081770|3390437|P3|Overall Study|Did not meet protocol eligibility|3
1044812|NCT00081770|3390438|P2|Overall Study|Did not meet protocol eligibility|0
1044813|NCT00081770|3390439|P1|Overall Study|Did not meet protocol eligibility|2
1044814|NCT00081770|3390437|P3|Overall Study|Withdrawal by Subject|42
1044815|NCT00081770|3390438|P2|Overall Study|Withdrawal by Subject|40
1044816|NCT00081770|3390439|P1|Overall Study|Withdrawal by Subject|45
1044817|NCT00081770|3390437|P3|Overall Study|Protocol Violation|10
1044818|NCT00081770|3390438|P2|Overall Study|Protocol Violation|10
1044819|NCT00081770|3390439|P1|Overall Study|Protocol Violation|15
1044820|NCT00081770|3390437|P3|Overall Study|Lost to Follow-up|45
1044821|NCT00081770|3390438|P2|Overall Study|Lost to Follow-up|34
1044822|NCT00081770|3390439|P1|Overall Study|Lost to Follow-up|45
1044823|NCT00081770|3390437|P3|Overall Study|Lack of Efficacy|211
1044824|NCT00081770|3390438|P2|Overall Study|Lack of Efficacy|357
1044825|NCT00081770|3390439|P1|Overall Study|Lack of Efficacy|262
1044826|NCT00081770|3390437|P3|Overall Study|Adverse Event|136
1044827|NCT00081770|3390438|P2|Overall Study|Adverse Event|98
1044828|NCT00081770|3390439|P1|Overall Study|Adverse Event|130
1044829|NCT00081731|3390458|P2|Overall Study|scientific integrity issue|8
1044830|NCT00081731|3390459|P1|Overall Study|scientific integrity issue|8
1044831|NCT00081653|3390479|P2|Overall Study|Loss of bone mass|2
1044832|NCT00081653|3390480|P1|Overall Study|Loss of bone mass|0
1044833|NCT00081653|3390479|P2|Overall Study|Participant leaving country|0
1044834|NCT00081653|3390480|P1|Overall Study|Participant leaving country|1
1044835|NCT00081653|3390479|P2|Overall Study|Bone loss|0
1044836|NCT00081653|3390480|P1|Overall Study|Bone loss|2
1044837|NCT00081653|3390479|P2|Overall Study|Low bone mineral density|0
1044838|NCT00081653|3390480|P1|Overall Study|Low bone mineral density|1
1044839|NCT00081653|3390479|P2|Overall Study|Refused Treatment|14
1044840|NCT00081653|3390480|P1|Overall Study|Refused Treatment|18
1044841|NCT00081653|3390479|P2|Overall Study|Lost to Follow-up|4
1044842|NCT00081653|3390480|P1|Overall Study|Lost to Follow-up|2
1044843|NCT00081653|3390479|P2|Overall Study|Adverse Event|17
1044844|NCT00081653|3390480|P1|Overall Study|Adverse Event|23
1044845|NCT00081497|3390498|P2|Overall Study|Non-compliance|1
1044846|NCT00081497|3390499|P1|Overall Study|Non-compliance|0
1044847|NCT00081497|3390498|P2|Overall Study|Withdrawal by Subject|0
1044848|NCT00081497|3390499|P1|Overall Study|Withdrawal by Subject|1
1044849|NCT00081497|3390498|P2|Overall Study|Death|1
1044850|NCT00081497|3390499|P1|Overall Study|Death|0
1044851|NCT00081497|3390498|P2|Overall Study|Adverse Event|0
1044852|NCT00081497|3390499|P1|Overall Study|Adverse Event|2
1044853|NCT00081458|3390517|P3|Overall Study|Randomized but not dosed|1
1044854|NCT00081458|3390518|P2|Overall Study|Randomized but not dosed|0
1044855|NCT00081458|3390519|P1|Overall Study|Randomized but not dosed|0
1044856|NCT00081458|3390517|P3|Overall Study|Withdrawal by Subject|1
1044857|NCT00081458|3390518|P2|Overall Study|Withdrawal by Subject|3
1044858|NCT00081458|3390519|P1|Overall Study|Withdrawal by Subject|0
1044859|NCT00081458|3390517|P3|Overall Study|Adverse Event|2
1044860|NCT00081458|3390518|P2|Overall Study|Adverse Event|5
1044861|NCT00081458|3390519|P1|Overall Study|Adverse Event|1
1044862|NCT00081289|3390575|P2|Overall Study|Ineligible / no protocol treatment|4
1044863|NCT00081289|3390576|P1|Overall Study|Ineligible / no protocol treatment|3
1044864|NCT00081289|3390575|P2|Overall Study|Accrued prior to chemotherapy amendment|17
1044865|NCT00081289|3390576|P1|Overall Study|Accrued prior to chemotherapy amendment|18
1044866|NCT00081263|3390584|P2|Overall Study|Inadequate data|10
1044867|NCT00081263|3390585|P1|Overall Study|Inadequate data|5
1044868|NCT00081263|3390584|P2|Overall Study|Never treated|5
1044869|NCT00081263|3390585|P1|Overall Study|Never treated|4
1044870|NCT00081263|3390584|P2|Overall Study|Inadequate pathology|1
1044871|NCT00081263|3390585|P1|Overall Study|Inadequate pathology|0
1044872|NCT00081263|3390584|P2|Overall Study|improper pre-protocol therapy|1
1044873|NCT00081263|3390585|P1|Overall Study|improper pre-protocol therapy|0
1044874|NCT00081263|3390584|P2|Overall Study|wrong cell type|5
1044875|NCT00081263|3390585|P1|Overall Study|wrong cell type|7
1044876|NCT00081263|3390584|P2|Overall Study|clerical error|0
1044877|NCT00081263|3390585|P1|Overall Study|clerical error|1
1044878|NCT00081159|3390595|P2|Overall Study|Lost to Follow-up|1
1044879|NCT00081159|3390596|P1|Overall Study|Lost to Follow-up|2
1044880|NCT00081159|3390595|P2|Overall Study|Myelosuppression prior to treatment|1
1044881|NCT00081159|3390596|P1|Overall Study|Myelosuppression prior to treatment|0
1044882|NCT00081159|3390595|P2|Overall Study|Withdrawal by Subject|3
1044883|NCT00081159|3390596|P1|Overall Study|Withdrawal by Subject|0
1044884|NCT00080938|3390606|P1|Overall Study|Ineligible|4
1044885|NCT00080938|3390606|P1|Overall Study|Not started protocol therapy|1
1044886|NCT00080938|3390606|P1|Overall Study|other disease|1
1044887|NCT00080938|3390606|P1|Overall Study|Lack of Efficacy|7
1044888|NCT00080938|3390606|P1|Overall Study|Death|2
1044889|NCT00080938|3390606|P1|Overall Study|Withdrawal by Subject|6
1044890|NCT00080938|3390606|P1|Overall Study|Adverse Event|3
1044891|NCT00080899|3390622|P1|Overall Study|Adverse Event|1
1044892|NCT00080483|3390634|P2|Overall Study|Physician Decision|1
1044893|NCT00080483|3390635|P1|Overall Study|Physician Decision|1
1044894|NCT00080483|3390634|P2|Overall Study|Lost to Follow-up|1
1044895|NCT00080483|3390635|P1|Overall Study|Lost to Follow-up|1
1044896|NCT00002525|3390643|P2|Overall Study|Never start protocol therapy|0
1044897|NCT00002525|3390644|P1|Overall Study|Never start protocol therapy|8
1044898|NCT00002525|3390643|P2|Overall Study|Other|0
1044899|NCT00002525|3390644|P1|Overall Study|Other|26
1044900|NCT00002525|3390643|P2|Overall Study|Error|0
1044901|NCT00002525|3390644|P1|Overall Study|Error|6
1044902|NCT00002525|3390643|P2|Overall Study|Duke's A, B1, D disease|0
1044903|NCT00002525|3390644|P1|Overall Study|Duke's A, B1, D disease|92
1044904|NCT00002525|3390643|P2|Overall Study|Other complicating disease|0
1044905|NCT00002525|3390644|P1|Overall Study|Other complicating disease|1
1044906|NCT00002525|3390643|P2|Overall Study|Start non-protocol therapy|0
1044907|NCT00002525|3390644|P1|Overall Study|Start non-protocol therapy|1
1044908|NCT00002525|3390643|P2|Overall Study|Withdrawal by Subject|0
1044909|NCT00002525|3390644|P1|Overall Study|Withdrawal by Subject|11
1044910|NCT00002525|3390643|P2|Overall Study|Death|0
1044911|NCT00002525|3390644|P1|Overall Study|Death|5
1044912|NCT00002525|3390643|P2|Overall Study|Adverse Event|0
1044913|NCT00002525|3390644|P1|Overall Study|Adverse Event|36
1044914|NCT00080301|3390671|P2|Overall Study|Still on Treatment as of CSR date|1
1044915|NCT00080301|3390672|P1|Overall Study|Still on Treatment as of CSR date|0
1044916|NCT00080301|3390671|P2|Overall Study|Randomized but Never Treated|10
1044917|NCT00080301|3390672|P1|Overall Study|Randomized but Never Treated|5
1044918|NCT00080288|3390692|P2|Overall Study|Miscellaneous|11
1044919|NCT00080288|3390693|P1|Overall Study|Miscellaneous|11
1044920|NCT00080288|3390692|P2|Overall Study|Withdrawal by Subject|16
1044921|NCT00080288|3390693|P1|Overall Study|Withdrawal by Subject|3
1044922|NCT00080288|3390692|P2|Overall Study|Physician Decision|2
1044923|NCT00080288|3390693|P1|Overall Study|Physician Decision|6
1044924|NCT00080288|3390692|P2|Overall Study|Lost to Follow-up|5
1044925|NCT00080288|3390693|P1|Overall Study|Lost to Follow-up|3
1044926|NCT00080288|3390692|P2|Overall Study|Adverse Event|4
1044927|NCT00080288|3390693|P1|Overall Study|Adverse Event|7
1044928|NCT00080223|3390701|P1|Overall Study|Physician Decision|1
1044929|NCT00080223|3390701|P1|Overall Study|Participant unwilling to continue|2
1044930|NCT00080223|3390701|P1|Overall Study|Non-compliance With Study Treatment|7
1044931|NCT00080223|3390701|P1|Overall Study|Lung Transplantation|9
1044932|NCT00080223|3390701|P1|Overall Study|Withdrawal by Subject|13
1044933|NCT00080223|3390701|P1|Overall Study|Death|21
1044934|NCT00080223|3390701|P1|Overall Study|Adverse Event|23
1044935|NCT00002540|3390711|P2|Overall Study|Refused Screen (Prostate Screening)|2433
1044936|NCT00002540|3390712|P1|Overall Study|Refused Screen (Prostate Screening)|0
1044937|NCT00002540|3390711|P2|Overall Study|Refused ASU (Control)|0
1044938|NCT00002540|3390712|P1|Overall Study|Refused ASU (Control)|597
1044939|NCT00002540|3390711|P2|Overall Study|Died Before ASU (Control)|0
1044940|NCT00002540|3390712|P1|Overall Study|Died Before ASU (Control)|202
1044941|NCT00002540|3390711|P2|Overall Study|Died Before Randomization|6
1044942|NCT00002540|3390712|P1|Overall Study|Died Before Randomization|2
1044943|NCT00002540|3390711|P2|Overall Study|Cancer Before Rand. (Prostate Screening)|25
1044944|NCT00002540|3390712|P1|Overall Study|Cancer Before Rand. (Prostate Screening)|0
1044945|NCT00080119|3390742|P4|Overall Study|Lost to Follow-up|14
1044946|NCT00080119|3390743|P3|Overall Study|Lost to Follow-up|19
1044947|NCT00080119|3390744|P2|Overall Study|Lost to Follow-up|19
1044948|NCT00080119|3390745|P1|Overall Study|Lost to Follow-up|16
1044949|NCT00080119|3390742|P4|Overall Study|Unwilling to adhere to study requirement|1
1044950|NCT00080119|3390743|P3|Overall Study|Unwilling to adhere to study requirement|5
1044951|NCT00080119|3390744|P2|Overall Study|Unwilling to adhere to study requirement|2
1044952|NCT00080119|3390745|P1|Overall Study|Unwilling to adhere to study requirement|3
1044953|NCT00080119|3390742|P4|Overall Study|Consent withdrawn|6
1044954|NCT00080119|3390743|P3|Overall Study|Consent withdrawn|4
1044955|NCT00080119|3390744|P2|Overall Study|Consent withdrawn|17
1044956|NCT00080119|3390745|P1|Overall Study|Consent withdrawn|13
1044957|NCT00080119|3390742|P4|Overall Study|Unable to get to clinic|1
1044958|NCT00080119|3390743|P3|Overall Study|Unable to get to clinic|7
1044959|NCT00080119|3390744|P2|Overall Study|Unable to get to clinic|24
1044960|NCT00080119|3390745|P1|Overall Study|Unable to get to clinic|24
1044961|NCT00080119|3390742|P4|Overall Study|Discontinued because of study closure|141
1044962|NCT00080119|3390743|P3|Overall Study|Discontinued because of study closure|130
1044963|NCT00080119|3390744|P2|Overall Study|Discontinued because of study closure|0
1044964|NCT00080119|3390745|P1|Overall Study|Discontinued because of study closure|0
1044965|NCT00079937|3390779|P2|Overall Study|Administrative problems|11
1044966|NCT00079937|3390780|P1|Overall Study|Administrative problems|22
1044967|NCT00079937|3390779|P2|Overall Study|Lost to Follow-up|5
1044968|NCT00079937|3390780|P1|Overall Study|Lost to Follow-up|12
1044969|NCT00079937|3390779|P2|Overall Study|Withdrawal by Subject|7
1044970|NCT00079937|3390780|P1|Overall Study|Withdrawal by Subject|21
1044971|NCT00079937|3390779|P2|Overall Study|Protocol Violation|6
1044972|NCT00079937|3390780|P1|Overall Study|Protocol Violation|8
1044973|NCT00079937|3390779|P2|Overall Study|Subject no longer requires study drug|0
1044974|NCT00079937|3390780|P1|Overall Study|Subject no longer requires study drug|3
1044975|NCT00079937|3390779|P2|Overall Study|Unsatisfactory therapeutic effect|2
1044976|NCT00079937|3390780|P1|Overall Study|Unsatisfactory therapeutic effect|1
1044977|NCT00079937|3390779|P2|Overall Study|Adverse Event|1
1044978|NCT00079937|3390780|P1|Overall Study|Adverse Event|2
1044979|NCT00009737|3390798|P2|Overall Study|Administrative/Other Reasons|1
1044980|NCT00009737|3390799|P1|Overall Study|Administrative/Other Reasons|7
1044981|NCT00009737|3390798|P2|Overall Study|Lost to Follow-up|1
1044982|NCT00009737|3390799|P1|Overall Study|Lost to Follow-up|1
1044983|NCT00009737|3390798|P2|Overall Study|Refused Treatment|16
1044984|NCT00009737|3390799|P1|Overall Study|Refused Treatment|15
1044985|NCT00009737|3390798|P2|Overall Study|Other Protocol Violation|0
1044986|NCT00009737|3390799|P1|Overall Study|Other Protocol Violation|1
1044987|NCT00009737|3390798|P2|Overall Study|Violation of Selection Criteria at Entry|9
1044988|NCT00009737|3390799|P1|Overall Study|Violation of Selection Criteria at Entry|13
1044989|NCT00009737|3390798|P2|Overall Study|Lack of Efficacy|15
1044990|NCT00009737|3390799|P1|Overall Study|Lack of Efficacy|17
1044991|NCT00009737|3390798|P2|Overall Study|Death|6
1044992|NCT00009737|3390799|P1|Overall Study|Death|4
1044993|NCT00009737|3390798|P2|Overall Study|Adverse Event|75
1044994|NCT00009737|3390799|P1|Overall Study|Adverse Event|112
1044995|NCT00079781|3390818|P3|Follow-up Period|Death|1
1044996|NCT00079781|3390819|P2|Follow-up Period|Death|0
1044997|NCT00079781|3390820|P1|Follow-up Period|Death|0
1044998|NCT00079781|3390818|P3|Follow-up Period|Lost to Follow-up|0
1044999|NCT00079781|3390819|P2|Follow-up Period|Lost to Follow-up|0
1045000|NCT00079781|3390820|P1|Follow-up Period|Lost to Follow-up|1
1045001|NCT00079781|3390818|P3|Follow-up Period|Withdrawal by Subject|1
1045002|NCT00079781|3390819|P2|Follow-up Period|Withdrawal by Subject|0
1045003|NCT00079781|3390820|P1|Follow-up Period|Withdrawal by Subject|3
1045004|NCT00079781|3390818|P3|Pre-implant Period|Did not meet I/E criteria|1
1045005|NCT00079781|3390819|P2|Pre-implant Period|Did not meet I/E criteria|1
1045006|NCT00079781|3390820|P1|Pre-implant Period|Did not meet I/E criteria|1
1045007|NCT00079781|3390818|P3|Pre-implant Period|Withdrawal by Subject|0
1045008|NCT00079781|3390819|P2|Pre-implant Period|Withdrawal by Subject|0
1045009|NCT00079781|3390820|P1|Pre-implant Period|Withdrawal by Subject|2
1045010|NCT00079677|3390829|P2|Overall Study|Miscellaneous|0
1045011|NCT00079677|3390830|P1|Overall Study|Miscellaneous|2
1045012|NCT00079677|3390829|P2|Overall Study|Withdrawal by Subject|3
1045013|NCT00079677|3390830|P1|Overall Study|Withdrawal by Subject|5
1045014|NCT00079677|3390829|P2|Overall Study|Protocol Violation|3
1045015|NCT00079677|3390830|P1|Overall Study|Protocol Violation|2
1045016|NCT00079677|3390829|P2|Overall Study|Physician Decision|0
1045017|NCT00079677|3390830|P1|Overall Study|Physician Decision|3
1045018|NCT00079677|3390829|P2|Overall Study|Lost to Follow-up|2
1045019|NCT00079677|3390830|P1|Overall Study|Lost to Follow-up|2
1045020|NCT00079677|3390829|P2|Overall Study|Lack of Efficacy|0
1045021|NCT00079677|3390830|P1|Overall Study|Lack of Efficacy|1
1045022|NCT00079677|3390829|P2|Overall Study|Adverse Event|6
1045023|NCT00079677|3390830|P1|Overall Study|Adverse Event|5
1045024|NCT00079417|3390846|P1|Overall Study|Ineligible|7
1045025|NCT00079417|3390846|P1|Overall Study|Physician Decision|2
1045026|NCT00079391|3390854|P1|Overall Study|Withdrawal by Subject|1
1045027|NCT00079339|3390866|P3|Overall Study|Disease progression|2
1045028|NCT00079339|3390867|P2|Overall Study|Disease progression|28
1045029|NCT00079339|3390868|P1|Overall Study|Disease progression|3
1045030|NCT00079339|3390866|P3|Overall Study|Withdrawal by Subject|1
1045031|NCT00079339|3390867|P2|Overall Study|Withdrawal by Subject|4
1045032|NCT00079339|3390868|P1|Overall Study|Withdrawal by Subject|0
1045033|NCT00079339|3390866|P3|Overall Study|Non-compliance|1
1045034|NCT00079339|3390867|P2|Overall Study|Non-compliance|0
1045035|NCT00079339|3390868|P1|Overall Study|Non-compliance|0
1045036|NCT00079339|3390866|P3|Overall Study|Death|0
1045037|NCT00079339|3390867|P2|Overall Study|Death|0
1045038|NCT00079339|3390868|P1|Overall Study|Death|1
1045039|NCT00079339|3390866|P3|Overall Study|Adverse Event|2
1045040|NCT00079339|3390867|P2|Overall Study|Adverse Event|7
1045041|NCT00079339|3390868|P1|Overall Study|Adverse Event|1
1045042|NCT00079274|3390899|P7|Overall Study|Not Specified|0
1045043|NCT00079274|3390900|P6|Overall Study|Not Specified|2
1045044|NCT00079274|3390901|P5|Overall Study|Not Specified|1
1045045|NCT00079274|3390902|P4|Overall Study|Not Specified|55
1045046|NCT00079274|3390903|P3|Overall Study|Not Specified|5
1045047|NCT00079274|3390904|P2|Overall Study|Not Specified|7
1045048|NCT00079274|3390905|P1|Overall Study|Not Specified|43
1045049|NCT00079274|3390899|P7|Overall Study|Cytogenetic resistance|0
1045050|NCT00079274|3390900|P6|Overall Study|Cytogenetic resistance|0
1045051|NCT00079274|3390901|P5|Overall Study|Cytogenetic resistance|0
1045052|NCT00079274|3390902|P4|Overall Study|Cytogenetic resistance|2
1045053|NCT00079274|3390903|P3|Overall Study|Cytogenetic resistance|0
1045054|NCT00079274|3390904|P2|Overall Study|Cytogenetic resistance|0
1045055|NCT00079274|3390905|P1|Overall Study|Cytogenetic resistance|0
1045056|NCT00079274|3390899|P7|Overall Study|Death|0
1045057|NCT00079274|3390900|P6|Overall Study|Death|0
1045058|NCT00079274|3390901|P5|Overall Study|Death|0
1045059|NCT00079274|3390902|P4|Overall Study|Death|15
1045060|NCT00079274|3390903|P3|Overall Study|Death|1
1045061|NCT00079274|3390904|P2|Overall Study|Death|0
1045062|NCT00079274|3390905|P1|Overall Study|Death|4
1045063|NCT00079274|3390899|P7|Overall Study|Other Medical Problems|0
1045064|NCT00079274|3390900|P6|Overall Study|Other Medical Problems|0
1045065|NCT00079274|3390901|P5|Overall Study|Other Medical Problems|0
1045066|NCT00079274|3390902|P4|Overall Study|Other Medical Problems|7
1045067|NCT00079274|3390903|P3|Overall Study|Other Medical Problems|0
1045068|NCT00079274|3390904|P2|Overall Study|Other Medical Problems|1
1045069|NCT00079274|3390905|P1|Overall Study|Other Medical Problems|6
1045070|NCT00079274|3390899|P7|Overall Study|Alternate Treatment|0
1045071|NCT00079274|3390900|P6|Overall Study|Alternate Treatment|0
1045072|NCT00079274|3390901|P5|Overall Study|Alternate Treatment|0
1045073|NCT00079274|3390902|P4|Overall Study|Alternate Treatment|3
1045074|NCT00079274|3390903|P3|Overall Study|Alternate Treatment|0
1045075|NCT00079274|3390904|P2|Overall Study|Alternate Treatment|1
1045076|NCT00079274|3390905|P1|Overall Study|Alternate Treatment|6
1045077|NCT00079274|3390899|P7|Overall Study|Recurrence|0
1045078|NCT00079274|3390900|P6|Overall Study|Recurrence|2
1045079|NCT00079274|3390901|P5|Overall Study|Recurrence|0
1045080|NCT00079274|3390902|P4|Overall Study|Recurrence|15
1045081|NCT00079274|3390903|P3|Overall Study|Recurrence|1
1045082|NCT00079274|3390904|P2|Overall Study|Recurrence|0
1045083|NCT00079274|3390905|P1|Overall Study|Recurrence|21
1045084|NCT00079274|3390899|P7|Overall Study|Adverse Event|0
1045085|NCT00079274|3390900|P6|Overall Study|Adverse Event|8
1045086|NCT00079274|3390901|P5|Overall Study|Adverse Event|7
1045087|NCT00079274|3390902|P4|Overall Study|Adverse Event|184
1045088|NCT00079274|3390903|P3|Overall Study|Adverse Event|8
1045089|NCT00079274|3390904|P2|Overall Study|Adverse Event|8
1045090|NCT00079274|3390905|P1|Overall Study|Adverse Event|130
1045091|NCT00079274|3390899|P7|Overall Study|Withdrawal by Subject|0
1045092|NCT00079274|3390900|P6|Overall Study|Withdrawal by Subject|8
1045093|NCT00079274|3390901|P5|Overall Study|Withdrawal by Subject|7
1045094|NCT00079274|3390902|P4|Overall Study|Withdrawal by Subject|163
1045095|NCT00079274|3390903|P3|Overall Study|Withdrawal by Subject|12
1045096|NCT00079274|3390904|P2|Overall Study|Withdrawal by Subject|10
1045097|NCT00079274|3390905|P1|Overall Study|Withdrawal by Subject|111
1045098|NCT00079183|3390918|P1|Overall Study|Specimen collection non-compliance|1
1045099|NCT00079183|3390918|P1|Overall Study|Study medication non-compliance|2
1045100|NCT00079183|3390918|P1|Overall Study|Withdrawal by Subject|4
1045101|NCT00079040|3390933|P1|Overall Study|Ineligible|1
1045102|NCT00079040|3390933|P1|Overall Study|Withdrew before treatment|1
1045103|NCT00078949|3390956|P4|Maintenance|No treated|3
1045104|NCT00078949|3390957|P3|Maintenance|No treated|3
1045105|NCT00078949|3390958|P2|Maintenance|No treated|0
1045106|NCT00078949|3390959|P1|Maintenance|No treated|0
1045107|NCT00078949|3390956|P4|Salvage|No treated|0
1045108|NCT00078949|3390957|P3|Salvage|No treated|0
1045109|NCT00078949|3390958|P2|Salvage|No treated|5
1045110|NCT00078949|3390959|P1|Salvage|No treated|4
1045111|NCT00078767|3390973|P2|Overall Study|Withdrawal by Subject|1
1045112|NCT00078767|3390974|P1|Overall Study|Withdrawal by Subject|1
1045113|NCT00005947|3391021|P2|Overall Study|Site Closure|0
1045114|NCT00005947|3391022|P1|Overall Study|Site Closure|1
1045115|NCT00005947|3391021|P2|Overall Study|Patient Refused to Continue|1
1045116|NCT00005947|3391022|P1|Overall Study|Patient Refused to Continue|2
1045117|NCT00005947|3391021|P2|Overall Study|Death|40
1045118|NCT00005947|3391022|P1|Overall Study|Death|54
1045119|NCT00002597|3391058|P2|Overall Study|Withdrawal by Subject|6
1045120|NCT00002597|3391059|P1|Overall Study|Withdrawal by Subject|7
1045121|NCT00002597|3391058|P2|Overall Study|Protocol Violation|17
1045122|NCT00002597|3391059|P1|Overall Study|Protocol Violation|19
1045123|NCT00078377|3391084|P3|Overall Study|Miscellaneous|1
1045124|NCT00078377|3391085|P2|Overall Study|Miscellaneous|6
1045125|NCT00078377|3391086|P1|Overall Study|Miscellaneous|2
1045126|NCT00078377|3391084|P3|Overall Study|Withdrawal by Subject|4
1045127|NCT00078377|3391085|P2|Overall Study|Withdrawal by Subject|4
1045128|NCT00078377|3391086|P1|Overall Study|Withdrawal by Subject|3
1045129|NCT00078377|3391084|P3|Overall Study|Physician Decision|0
1045130|NCT00078377|3391085|P2|Overall Study|Physician Decision|0
1045131|NCT00078377|3391086|P1|Overall Study|Physician Decision|2
1045132|NCT00078377|3391084|P3|Overall Study|Lost to Follow-up|1
1045133|NCT00078377|3391085|P2|Overall Study|Lost to Follow-up|1
1045134|NCT00078377|3391086|P1|Overall Study|Lost to Follow-up|0
1045135|NCT00078377|3391084|P3|Overall Study|Lack of Efficacy|2
1045136|NCT00078377|3391085|P2|Overall Study|Lack of Efficacy|0
1045137|NCT00078377|3391086|P1|Overall Study|Lack of Efficacy|2
1045138|NCT00078377|3391084|P3|Overall Study|Adverse Event|1
1045139|NCT00078377|3391085|P2|Overall Study|Adverse Event|5
1045140|NCT00078377|3391086|P1|Overall Study|Adverse Event|2
1045141|NCT00078338|3391101|P2|Overall Study|Subjects randomized, but not treated|3
1045142|NCT00078338|3391102|P1|Overall Study|Subjects randomized, but not treated|3
1045143|NCT00078338|3391101|P2|Overall Study|Other|16
1045144|NCT00078338|3391102|P1|Overall Study|Other|28
1045145|NCT00078338|3391101|P2|Overall Study|Disease Progression|7
1045146|NCT00078338|3391102|P1|Overall Study|Disease Progression|4
1045147|NCT00078338|3391101|P2|Overall Study|Protocol Violation|2
1045148|NCT00078338|3391102|P1|Overall Study|Protocol Violation|2
1045149|NCT00078338|3391101|P2|Overall Study|Lost to Follow-up|2
1045150|NCT00078338|3391102|P1|Overall Study|Lost to Follow-up|17
1045151|NCT00078338|3391101|P2|Overall Study|Adverse Event|24
1045152|NCT00078338|3391102|P1|Overall Study|Adverse Event|31
1045153|NCT00078325|3391195|P3|Overall Study|Miscellaneous|1
1045154|NCT00078325|3391196|P2|Overall Study|Miscellaneous|1
1045155|NCT00078325|3391197|P1|Overall Study|Miscellaneous|1
1045156|NCT00078325|3391195|P3|Overall Study|Physician Decision|1
1045157|NCT00078325|3391196|P2|Overall Study|Physician Decision|0
1045158|NCT00078325|3391197|P1|Overall Study|Physician Decision|2
1045159|NCT00078325|3391195|P3|Overall Study|Lost to Follow-up|1
1045160|NCT00078325|3391196|P2|Overall Study|Lost to Follow-up|1
1045161|NCT00078325|3391197|P1|Overall Study|Lost to Follow-up|0
1045162|NCT00078325|3391195|P3|Overall Study|Withdrawal by Subject|3
1045163|NCT00078325|3391196|P2|Overall Study|Withdrawal by Subject|5
1045164|NCT00078325|3391197|P1|Overall Study|Withdrawal by Subject|1
1045165|NCT00078325|3391195|P3|Overall Study|Protocol Violation|0
1045166|NCT00078325|3391196|P2|Overall Study|Protocol Violation|2
1045167|NCT00078325|3391197|P1|Overall Study|Protocol Violation|2
1045168|NCT00078325|3391195|P3|Overall Study|Adverse Event|5
1045169|NCT00078325|3391196|P2|Overall Study|Adverse Event|10
1045170|NCT00078325|3391197|P1|Overall Study|Adverse Event|15
1045171|NCT00078312|3391208|P1|Overall Study|Miscellaneous|33
1045172|NCT00078312|3391208|P1|Overall Study|Withdrawal by Subject|33
1045173|NCT00078312|3391208|P1|Overall Study|Protocol Violation|3
1045174|NCT00078312|3391208|P1|Overall Study|Physician Decision|9
1045175|NCT00078312|3391208|P1|Overall Study|Lost to Follow-up|41
1045176|NCT00078312|3391208|P1|Overall Study|Lack of Efficacy|15
1045177|NCT00078312|3391208|P1|Overall Study|Adverse Event|43
1045178|NCT00077974|3391223|P1|Overall Study|Decision of Sponsor|2
1045179|NCT00077974|3391223|P1|Overall Study|Lack of Efficacy|76
1045180|NCT00077974|3391223|P1|Overall Study|Withdrawal by Subject|3
1045181|NCT00077974|3391223|P1|Overall Study|Protocol Violation|1
1045182|NCT00077974|3391223|P1|Overall Study|Adverse Event|22
1045183|NCT00077857|3391240|P2|Overall Study|Other|13
1045184|NCT00077857|3391241|P1|Overall Study|Other|15
1045185|NCT00077857|3391240|P2|Overall Study|Failure to return|5
1045186|NCT00077857|3391241|P1|Overall Study|Failure to return|5
1045187|NCT00077857|3391240|P2|Overall Study|Refused treatment|21
1045188|NCT00077857|3391241|P1|Overall Study|Refused treatment|29
1045189|NCT00077857|3391240|P2|Overall Study|Other protocol violation|1
1045190|NCT00077857|3391241|P1|Overall Study|Other protocol violation|0
1045191|NCT00077857|3391240|P2|Overall Study|Violation of selection criteria at entry|1
1045192|NCT00077857|3391241|P1|Overall Study|Violation of selection criteria at entry|3
1045193|NCT00077857|3391240|P2|Overall Study|Insufficient therapeutic response|128
1045194|NCT00077857|3391241|P1|Overall Study|Insufficient therapeutic response|112
1045195|NCT00077857|3391240|P2|Overall Study|Death|3
1045196|NCT00077857|3391241|P1|Overall Study|Death|7
1045197|NCT00077857|3391240|P2|Overall Study|Adverse Event|32
1045198|NCT00077857|3391241|P1|Overall Study|Adverse Event|30
1045199|NCT00077766|3391261|P2|Overall Study|Participants Vacation|1
1045200|NCT00077766|3391262|P1|Overall Study|Participants Vacation|2
1045201|NCT00077766|3391261|P2|Overall Study|Stop Dialysis|1
1045202|NCT00077766|3391262|P1|Overall Study|Stop Dialysis|0
1045203|NCT00077766|3391261|P2|Overall Study|Started Nocturnal Dialysis|1
1045204|NCT00077766|3391262|P1|Overall Study|Started Nocturnal Dialysis|0
1045205|NCT00077766|3391261|P2|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1
1045206|NCT00077766|3391262|P1|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0
1045207|NCT00077766|3391261|P2|Overall Study|Dialysis|1
1045208|NCT00077766|3391262|P1|Overall Study|Dialysis|0
1045209|NCT00077766|3391261|P2|Overall Study|Dialysis Discontinued|0
1045210|NCT00077766|3391262|P1|Overall Study|Dialysis Discontinued|1
1045211|NCT00077766|3391261|P2|Overall Study|Participant's decision|0
1045212|NCT00077766|3391262|P1|Overall Study|Participant's decision|1
1045213|NCT00077766|3391261|P2|Overall Study|Investigators Discretion|0
1045214|NCT00077766|3391262|P1|Overall Study|Investigators Discretion|1
1045215|NCT00077766|3391261|P2|Overall Study|Transplantation|1
1045216|NCT00077766|3391262|P1|Overall Study|Transplantation|5
1045217|NCT00077766|3391261|P2|Overall Study|Kidney Transplantation|5
1045218|NCT00077766|3391262|P1|Overall Study|Kidney Transplantation|9
1045219|NCT00077766|3391261|P2|Overall Study|Protocol Violation|0
1045220|NCT00077766|3391262|P1|Overall Study|Protocol Violation|1
1045221|NCT00077766|3391261|P2|Overall Study|Lost to Follow-up|0
1045222|NCT00077766|3391262|P1|Overall Study|Lost to Follow-up|2
1045223|NCT00077766|3391261|P2|Overall Study|Death|10
1045224|NCT00077766|3391262|P1|Overall Study|Death|12
1045225|NCT00077766|3391261|P2|Overall Study|Withdrawal by Subject|3
1045226|NCT00077766|3391262|P1|Overall Study|Withdrawal by Subject|4
1045227|NCT00077766|3391261|P2|Overall Study|Adverse Event|1
1045228|NCT00077766|3391262|P1|Overall Study|Adverse Event|1
1045229|NCT00077675|3391287|P2|Overall Study|Never received study treatment|3
1045230|NCT00077675|3391288|P1|Overall Study|Never received study treatment|3
1045231|NCT00077675|3391287|P2|Overall Study|Other|1
1045232|NCT00077675|3391288|P1|Overall Study|Other|0
1045233|NCT00077675|3391287|P2|Overall Study|Withdrawal by Subject|0
1045234|NCT00077675|3391288|P1|Overall Study|Withdrawal by Subject|1
1045235|NCT00077675|3391287|P2|Overall Study|Lost to Follow-up|3
1045236|NCT00077675|3391288|P1|Overall Study|Lost to Follow-up|6
1045237|NCT00077675|3391287|P2|Overall Study|Adverse Event|2
1045238|NCT00077675|3391288|P1|Overall Study|Adverse Event|1
1045239|NCT00077649|3391298|P4|Overall Study|Randomized but never dosed|0
1045240|NCT00077649|3391299|P3|Overall Study|Randomized but never dosed|0
1045241|NCT00077649|3391300|P2|Overall Study|Randomized but never dosed|0
1045242|NCT00077649|3391301|P1|Overall Study|Randomized but never dosed|1
1045243|NCT00077649|3391298|P4|Overall Study|Abnormality of Laboratory Test|2
1045244|NCT00077649|3391299|P3|Overall Study|Abnormality of Laboratory Test|1
1045245|NCT00077649|3391300|P2|Overall Study|Abnormality of Laboratory Test|2
1045246|NCT00077649|3391301|P1|Overall Study|Abnormality of Laboratory Test|1
1045247|NCT00077649|3391298|P4|Overall Study|Lost to Follow-up|2
1045248|NCT00077649|3391299|P3|Overall Study|Lost to Follow-up|3
1045249|NCT00077649|3391300|P2|Overall Study|Lost to Follow-up|2
1045250|NCT00077649|3391301|P1|Overall Study|Lost to Follow-up|2
1045251|NCT00077649|3391298|P4|Overall Study|Withdrawal by Subject|2
1045252|NCT00077649|3391299|P3|Overall Study|Withdrawal by Subject|1
1045253|NCT00077649|3391300|P2|Overall Study|Withdrawal by Subject|1
1045254|NCT00077649|3391301|P1|Overall Study|Withdrawal by Subject|0
1045255|NCT00077649|3391298|P4|Overall Study|Lack of Efficacy|2
1045256|NCT00077649|3391299|P3|Overall Study|Lack of Efficacy|3
1045257|NCT00077649|3391300|P2|Overall Study|Lack of Efficacy|3
1045258|NCT00077649|3391301|P1|Overall Study|Lack of Efficacy|5
1045259|NCT00077649|3391298|P4|Overall Study|Adverse Event|9
1045260|NCT00077649|3391299|P3|Overall Study|Adverse Event|7
1045261|NCT00077649|3391300|P2|Overall Study|Adverse Event|1
1045262|NCT00077649|3391301|P1|Overall Study|Adverse Event|5
1045263|NCT00077636|3391349|P2|Overall Study|Abnormality Of Laboratory Test|2
1045264|NCT00077636|3391350|P1|Overall Study|Abnormality Of Laboratory Test|3
1045265|NCT00077636|3391349|P2|Overall Study|Lost to Follow-up|18
1045266|NCT00077636|3391350|P1|Overall Study|Lost to Follow-up|10
1045267|NCT00077636|3391349|P2|Overall Study|Protocol Violation|2
1045268|NCT00077636|3391350|P1|Overall Study|Protocol Violation|0
1045269|NCT00077636|3391349|P2|Overall Study|Adverse Event|34
1045270|NCT00077636|3391350|P1|Overall Study|Adverse Event|17
1045271|NCT00077636|3391349|P2|Overall Study|Withdrawal by Subject|2
1045272|NCT00077636|3391350|P1|Overall Study|Withdrawal by Subject|2
1045273|NCT00077636|3391349|P2|Overall Study|Admin|3
1045274|NCT00077636|3391350|P1|Overall Study|Admin|3
1045275|NCT00077636|3391349|P2|Overall Study|Refused Treatment|31
1045276|NCT00077636|3391350|P1|Overall Study|Refused Treatment|9
1045277|NCT00077623|3391371|P3|Overall Study|Failure to return|0
1045278|NCT00077623|3391372|P2|Overall Study|Failure to return|0
1045279|NCT00077623|3391373|P1|Overall Study|Failure to return|1
1045280|NCT00077623|3391371|P3|Overall Study|Death|11
1045281|NCT00077623|3391372|P2|Overall Study|Death|18
1045282|NCT00077623|3391373|P1|Overall Study|Death|12
1045283|NCT00077623|3391371|P3|Overall Study|Insufficient therapeutic response|0
1045284|NCT00077623|3391372|P2|Overall Study|Insufficient therapeutic response|0
1045285|NCT00077623|3391373|P1|Overall Study|Insufficient therapeutic response|2
1045286|NCT00077623|3391371|P3|Overall Study|Other-Non safety reason|19
1045287|NCT00077623|3391372|P2|Overall Study|Other-Non safety reason|15
1045288|NCT00077623|3391373|P1|Overall Study|Other-Non safety reason|18
1045289|NCT00077623|3391371|P3|Overall Study|Withdrawal by Subject|1
1045290|NCT00077623|3391372|P2|Overall Study|Withdrawal by Subject|10
1045291|NCT00077623|3391373|P1|Overall Study|Withdrawal by Subject|2
1045292|NCT00077623|3391371|P3|Overall Study|Adverse Event|1
1045293|NCT00077623|3391372|P2|Overall Study|Adverse Event|0
1045294|NCT00077623|3391373|P1|Overall Study|Adverse Event|1
1045295|NCT00077610|3391408|P3|Overall Study|Sponsors decision to withdraw|1
1045296|NCT00077610|3391409|P2|Overall Study|Sponsors decision to withdraw|0
1045297|NCT00077610|3391410|P1|Overall Study|Sponsors decision to withdraw|0
1045298|NCT00077610|3391408|P3|Overall Study|Financial issues|0
1045299|NCT00077610|3391409|P2|Overall Study|Financial issues|1
1045300|NCT00077610|3391410|P1|Overall Study|Financial issues|0
1045301|NCT00077610|3391408|P3|Overall Study|Relocation|5
1045302|NCT00077610|3391409|P2|Overall Study|Relocation|8
1045303|NCT00077610|3391410|P1|Overall Study|Relocation|0
1045304|NCT00077610|3391408|P3|Overall Study|Change in dialysis modality|0
1045305|NCT00077610|3391409|P2|Overall Study|Change in dialysis modality|0
1045306|NCT00077610|3391410|P1|Overall Study|Change in dialysis modality|1
1045307|NCT00077610|3391408|P3|Overall Study|Transfer to other center for surgery|0
1045308|NCT00077610|3391409|P2|Overall Study|Transfer to other center for surgery|0
1045309|NCT00077610|3391410|P1|Overall Study|Transfer to other center for surgery|1
1045310|NCT00077610|3391408|P3|Overall Study|Transfer to satellite unit|0
1045311|NCT00077610|3391409|P2|Overall Study|Transfer to satellite unit|0
1045312|NCT00077610|3391410|P1|Overall Study|Transfer to satellite unit|1
1045313|NCT00077610|3391408|P3|Overall Study|Transferred to nursing home|1
1045314|NCT00077610|3391409|P2|Overall Study|Transferred to nursing home|0
1045315|NCT00077610|3391410|P1|Overall Study|Transferred to nursing home|0
1045316|NCT00077610|3391408|P3|Overall Study|Transferred to other unit|1
1045317|NCT00077610|3391409|P2|Overall Study|Transferred to other unit|0
1045318|NCT00077610|3391410|P1|Overall Study|Transferred to other unit|0
1045319|NCT00077610|3391408|P3|Overall Study|Given Epogen in hospital|0
1045320|NCT00077610|3391409|P2|Overall Study|Given Epogen in hospital|0
1045321|NCT00077610|3391410|P1|Overall Study|Given Epogen in hospital|1
1045322|NCT00077610|3391408|P3|Overall Study|Worsening of health condition|0
1045323|NCT00077610|3391409|P2|Overall Study|Worsening of health condition|1
1045324|NCT00077610|3391410|P1|Overall Study|Worsening of health condition|1
1045325|NCT00077610|3391408|P3|Overall Study|Principal Investigator's decision|1
1045326|NCT00077610|3391409|P2|Overall Study|Principal Investigator's decision|0
1045327|NCT00077610|3391410|P1|Overall Study|Principal Investigator's decision|1
1045328|NCT00077610|3391408|P3|Overall Study|Multiple blood transfusions|1
1045329|NCT00077610|3391409|P2|Overall Study|Multiple blood transfusions|0
1045330|NCT00077610|3391410|P1|Overall Study|Multiple blood transfusions|0
1045331|NCT00077610|3391408|P3|Overall Study|Insufficient Therapeutic Response|0
1045332|NCT00077610|3391409|P2|Overall Study|Insufficient Therapeutic Response|0
1045333|NCT00077610|3391410|P1|Overall Study|Insufficient Therapeutic Response|1
1045334|NCT00077610|3391408|P3|Overall Study|Withdrew from dialysis care|3
1045335|NCT00077610|3391409|P2|Overall Study|Withdrew from dialysis care|0
1045336|NCT00077610|3391410|P1|Overall Study|Withdrew from dialysis care|5
1045337|NCT00077610|3391408|P3|Overall Study|Renal transplant|11
1045338|NCT00077610|3391409|P2|Overall Study|Renal transplant|15
1045339|NCT00077610|3391410|P1|Overall Study|Renal transplant|12
1045340|NCT00077610|3391408|P3|Overall Study|Death|13
1045341|NCT00077610|3391409|P2|Overall Study|Death|13
1045342|NCT00077610|3391410|P1|Overall Study|Death|17
1045343|NCT00077610|3391408|P3|Overall Study|Withdrawal by Subject|6
1045344|NCT00077610|3391409|P2|Overall Study|Withdrawal by Subject|10
1045345|NCT00077610|3391410|P1|Overall Study|Withdrawal by Subject|4
1045346|NCT00077610|3391408|P3|Overall Study|Lost to Follow-up|2
1045347|NCT00077610|3391409|P2|Overall Study|Lost to Follow-up|1
1045348|NCT00077610|3391410|P1|Overall Study|Lost to Follow-up|0
1045349|NCT00077610|3391408|P3|Overall Study|Adverse Event|1
1045350|NCT00077610|3391409|P2|Overall Study|Adverse Event|7
1045351|NCT00077610|3391410|P1|Overall Study|Adverse Event|9
1045352|NCT00077376|3391439|P1|Overall Study|Insurance ran out|1
1045353|NCT00077376|3391439|P1|Overall Study|Surgery|1
1045354|NCT00077376|3391439|P1|Overall Study|Symptomatic deterioration|1
1045355|NCT00077376|3391439|P1|Overall Study|Still on treatment|1
1045356|NCT00077376|3391439|P1|Overall Study|Complicating disease|1
1045357|NCT00077376|3391439|P1|Overall Study|Alternative therapy|5
1045358|NCT00077376|3391439|P1|Overall Study|Physician Decision|1
1045359|NCT00077376|3391439|P1|Overall Study|Death|1
1045360|NCT00077376|3391439|P1|Overall Study|Withdrawal by Subject|2
1045361|NCT00077376|3391439|P1|Overall Study|Adverse Event|8
1045362|NCT00077207|3391450|P1|Overall Study|Ineligible|1
1045363|NCT00077207|3391450|P1|Overall Study|Withdrawal by Subject|6
1045364|NCT00077207|3391450|P1|Overall Study|Physician Decision|6
1045365|NCT00077207|3391450|P1|Overall Study|Lack of Efficacy|12
1045366|NCT00077207|3391450|P1|Overall Study|Adverse Event|5
1045367|NCT00077064|3391462|P2|Overall Study|Patient refusal|2
1045368|NCT00077064|3391463|P1|Overall Study|Patient refusal|0
1045369|NCT00077064|3391462|P2|Overall Study|Adverse Event|4
1045370|NCT00077064|3391463|P1|Overall Study|Adverse Event|0
1045371|NCT00076999|3391479|P5|Overall Study|Other reason (not specified)|13
1045372|NCT00076999|3391480|P4|Overall Study|Other reason (not specified)|1
1045373|NCT00076999|3391481|P3|Overall Study|Other reason (not specified)|4
1045374|NCT00076999|3391482|P2|Overall Study|Other reason (not specified)|8
1045375|NCT00076999|3391483|P1|Overall Study|Other reason (not specified)|8
1045376|NCT00076999|3391479|P5|Overall Study|Withdrawal by Subject|1
1045377|NCT00076999|3391480|P4|Overall Study|Withdrawal by Subject|0
1045378|NCT00076999|3391481|P3|Overall Study|Withdrawal by Subject|3
1045379|NCT00076999|3391482|P2|Overall Study|Withdrawal by Subject|4
1045380|NCT00076999|3391483|P1|Overall Study|Withdrawal by Subject|0
1045381|NCT00076999|3391479|P5|Overall Study|Lost to Follow-up|0
1045382|NCT00076999|3391480|P4|Overall Study|Lost to Follow-up|0
1045383|NCT00076999|3391481|P3|Overall Study|Lost to Follow-up|0
1045384|NCT00076999|3391482|P2|Overall Study|Lost to Follow-up|1
1045385|NCT00076999|3391483|P1|Overall Study|Lost to Follow-up|2
1045386|NCT00076999|3391479|P5|Overall Study|Protocol Violation|9
1045387|NCT00076999|3391480|P4|Overall Study|Protocol Violation|0
1045388|NCT00076999|3391481|P3|Overall Study|Protocol Violation|4
1045389|NCT00076999|3391482|P2|Overall Study|Protocol Violation|3
1045390|NCT00076999|3391483|P1|Overall Study|Protocol Violation|0
1045391|NCT00076999|3391479|P5|Overall Study|Adverse Event|2
1045392|NCT00076999|3391480|P4|Overall Study|Adverse Event|0
1045393|NCT00076999|3391481|P3|Overall Study|Adverse Event|6
1045394|NCT00076999|3391482|P2|Overall Study|Adverse Event|8
1045395|NCT00076999|3391483|P1|Overall Study|Adverse Event|2
1045396|NCT00003222|3391602|P2|Overall Study|Physician Decision|1
1045397|NCT00003222|3391603|P1|Overall Study|Physician Decision|0
1045398|NCT00076804|3391615|P2|Overall Study|Early study Closure|32
1045399|NCT00076804|3391616|P1|Overall Study|Early study Closure|32
1045400|NCT00076804|3391615|P2|Overall Study|Withdrawal by Subject|8
1045401|NCT00076804|3391616|P1|Overall Study|Withdrawal by Subject|10
1045402|NCT00076804|3391615|P2|Overall Study|Lost to Follow-up|9
1045403|NCT00076804|3391616|P1|Overall Study|Lost to Follow-up|9
1045404|NCT00076804|3391615|P2|Overall Study|Death|20
1045405|NCT00076804|3391616|P1|Overall Study|Death|9
1045406|NCT00076752|3391628|P1|Overall Study|Withdrawal per PI, PI put study on hold|1
1045407|NCT00076752|3391628|P1|Overall Study|Death|2
1045408|NCT00076570|3391674|P2|Overall Study|Drug intolerance|8
1045409|NCT00076570|3391675|P1|Overall Study|Drug intolerance|8
1045410|NCT00003298|3391683|P1|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2
1045411|NCT00003298|3391683|P1|Step 2 (Adjuvant Therapy)|Excessive complication|1
1045412|NCT00003298|3391683|P1|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1
1045413|NCT00003298|3391683|P1|Step 2 (Adjuvant Therapy)|Death|1
1045414|NCT00003298|3391683|P1|Step 2 (Adjuvant Therapy)|Ineligible|1
1045415|NCT00003298|3391683|P1|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3
1045416|NCT00003298|3391683|P1|Re-register to Step 2 After Surgery|Reason unknown|1
1045417|NCT00003298|3391683|P1|Re-register to Step 2 After Surgery|Other complications|2
1045418|NCT00003298|3391683|P1|Re-register to Step 2 After Surgery|Positive margins|5
1045419|NCT00003298|3391683|P1|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7
1045420|NCT00003298|3391683|P1|Surgery|Unevaluable and off study|2
1045421|NCT00003298|3391683|P1|Surgery|Progression before surgery|2
1045422|NCT00003298|3391683|P1|Surgery|Unresectable at surgery|3
1045423|NCT00003298|3391683|P1|Step 1 (Neoadjuvant Therapy)|Adverse Event|3
1045424|NCT00003298|3391683|P1|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1
1045425|NCT00076336|3391693|P2|Overall Study|Treatment failure|5
1045426|NCT00076336|3391694|P1|Overall Study|Treatment failure|4
1045427|NCT00076336|3391693|P2|Overall Study|Virologic Breakthrough|16
1045428|NCT00076336|3391694|P1|Overall Study|Virologic Breakthrough|14
1045429|NCT00076336|3391693|P2|Overall Study|Liver Transplantation|3
1045430|NCT00076336|3391694|P1|Overall Study|Liver Transplantation|3
1045431|NCT00076336|3391693|P2|Overall Study|Patient, Investigator, Sponsor request|6
1045432|NCT00076336|3391694|P1|Overall Study|Patient, Investigator, Sponsor request|8
1045433|NCT00076336|3391693|P2|Overall Study|Creatinine Clearance < 30 or Dialysis|1
1045434|NCT00076336|3391694|P1|Overall Study|Creatinine Clearance < 30 or Dialysis|0
1045435|NCT00076336|3391693|P2|Overall Study|Non-Compliance|0
1045436|NCT00076336|3391694|P1|Overall Study|Non-Compliance|2
1045437|NCT00076336|3391693|P2|Overall Study|Lost to Follow-up|4
1045438|NCT00076336|3391694|P1|Overall Study|Lost to Follow-up|4
1045439|NCT00076336|3391693|P2|Overall Study|Adverse Event|4
1045440|NCT00076336|3391694|P1|Overall Study|Adverse Event|4
1045441|NCT00076336|3391693|P2|Overall Study|Death|17
1045442|NCT00076336|3391694|P1|Overall Study|Death|13
1045443|NCT00076102|3391747|P1|Overall Study|refusal of further therapy|2
1045444|NCT00076102|3391747|P1|Overall Study|plexiform neurofibroma surgery|1
1045445|NCT00076102|3391747|P1|Overall Study|Progression in pre-existing brain tumor|1
1045446|NCT00076102|3391747|P1|Overall Study|Clinical progression|1
1045447|NCT00076024|3391775|P4|Phase 2, Open-label|Other|2
1045448|NCT00076024|3391776|P3|Phase 2, Open-label|Other|0
1045449|NCT00076024|3391777|P2|Phase 2, Open-label|Other|0
1045450|NCT00076024|3391778|P1|Phase 2, Open-label|Other|0
1045451|NCT00076024|3391775|P4|Phase 2, Open-label|Withdrawal by Subject|1
1045452|NCT00076024|3391776|P3|Phase 2, Open-label|Withdrawal by Subject|0
1045453|NCT00076024|3391777|P2|Phase 2, Open-label|Withdrawal by Subject|0
1045454|NCT00076024|3391778|P1|Phase 2, Open-label|Withdrawal by Subject|0
1045455|NCT00076024|3391775|P4|Phase 2, Open-label|Lack of Efficacy|11
1045456|NCT00076024|3391776|P3|Phase 2, Open-label|Lack of Efficacy|0
1045457|NCT00076024|3391777|P2|Phase 2, Open-label|Lack of Efficacy|0
1045458|NCT00076024|3391778|P1|Phase 2, Open-label|Lack of Efficacy|0
1045459|NCT00076024|3391775|P4|Phase 2, Open-label|Adverse Event|2
1045460|NCT00076024|3391776|P3|Phase 2, Open-label|Adverse Event|0
1045461|NCT00076024|3391777|P2|Phase 2, Open-label|Adverse Event|0
1045462|NCT00076024|3391778|P1|Phase 2, Open-label|Adverse Event|0
1045463|NCT00076024|3391775|P4|Phase 2, Double-blind|Randomized but not treated|0
1045464|NCT00076024|3391776|P3|Phase 2, Double-blind|Randomized but not treated|0
1045465|NCT00076024|3391777|P2|Phase 2, Double-blind|Randomized but not treated|1
1045466|NCT00076024|3391778|P1|Phase 2, Double-blind|Randomized but not treated|0
1045467|NCT00076024|3391775|P4|Phase 2, Double-blind|Un-specified|0
1045468|NCT00076024|3391776|P3|Phase 2, Double-blind|Un-specified|6
1045469|NCT00076024|3391777|P2|Phase 2, Double-blind|Un-specified|14
1045470|NCT00076024|3391778|P1|Phase 2, Double-blind|Un-specified|0
1045471|NCT00076024|3391775|P4|Phase 2, Double-blind|Adverse Event|0
1045472|NCT00076024|3391776|P3|Phase 2, Double-blind|Adverse Event|6
1045473|NCT00076024|3391777|P2|Phase 2, Double-blind|Adverse Event|25
1045474|NCT00076024|3391778|P1|Phase 2, Double-blind|Adverse Event|0
1045475|NCT00076024|3391775|P4|Phase 2, Double-blind|Withdrawal by Subject|0
1045476|NCT00076024|3391776|P3|Phase 2, Double-blind|Withdrawal by Subject|4
1045477|NCT00076024|3391777|P2|Phase 2, Double-blind|Withdrawal by Subject|13
1045478|NCT00076024|3391778|P1|Phase 2, Double-blind|Withdrawal by Subject|0
1045479|NCT00076024|3391775|P4|Phase 2, Double-blind|Lack of Efficacy|0
1045480|NCT00076024|3391776|P3|Phase 2, Double-blind|Lack of Efficacy|40
1045481|NCT00076024|3391777|P2|Phase 2, Double-blind|Lack of Efficacy|59
1045482|NCT00076024|3391778|P1|Phase 2, Double-blind|Lack of Efficacy|0
1045483|NCT00076024|3391775|P4|Phase 1, Lead-in|Clinical progression|0
1045484|NCT00076024|3391776|P3|Phase 1, Lead-in|Clinical progression|0
1045485|NCT00076024|3391777|P2|Phase 1, Lead-in|Clinical progression|0
1045486|NCT00076024|3391778|P1|Phase 1, Lead-in|Clinical progression|1
1045487|NCT00076024|3391775|P4|Phase 1, Lead-in|Adverse Event|0
1045488|NCT00076024|3391776|P3|Phase 1, Lead-in|Adverse Event|0
1045489|NCT00076024|3391777|P2|Phase 1, Lead-in|Adverse Event|0
1045490|NCT00076024|3391778|P1|Phase 1, Lead-in|Adverse Event|1
1045491|NCT00076024|3391775|P4|Phase 1, Lead-in|Lack of Efficacy|0
1045492|NCT00076024|3391776|P3|Phase 1, Lead-in|Lack of Efficacy|0
1045493|NCT00076024|3391777|P2|Phase 1, Lead-in|Lack of Efficacy|0
1045494|NCT00076024|3391778|P1|Phase 1, Lead-in|Lack of Efficacy|4
1045495|NCT00076011|3391792|P1|Overall Study|Ongoing|1
1045496|NCT00076011|3391792|P1|Overall Study|Other|11
1045497|NCT00076011|3391792|P1|Overall Study|Study terminated by sponsor|3
1045498|NCT00076011|3391792|P1|Overall Study|Withdrawal by Subject|1
1045499|NCT00076011|3391792|P1|Overall Study|Lack of Efficacy|25
1045500|NCT00076011|3391792|P1|Overall Study|Adverse Event|10
1045501|NCT00076011|3391792|P1|Overall Study|Death|1
1045502|NCT00075946|3391804|P5|Overall Study|Other|0
1045503|NCT00075946|3391805|P4|Overall Study|Other|2
1045504|NCT00075946|3391806|P3|Overall Study|Other|0
1045505|NCT00075946|3391807|P2|Overall Study|Other|13
1045506|NCT00075946|3391808|P1|Overall Study|Other|5
1045507|NCT00075946|3391804|P5|Overall Study|Time to progression less than 6 months|0
1045508|NCT00075946|3391805|P4|Overall Study|Time to progression less than 6 months|3
1045509|NCT00075946|3391806|P3|Overall Study|Time to progression less than 6 months|8
1045510|NCT00075946|3391807|P2|Overall Study|Time to progression less than 6 months|30
1045511|NCT00075946|3391808|P1|Overall Study|Time to progression less than 6 months|15
1045512|NCT00075946|3391804|P5|Overall Study|No response to retreatment|0
1045513|NCT00075946|3391805|P4|Overall Study|No response to retreatment|0
1045514|NCT00075946|3391806|P3|Overall Study|No response to retreatment|2
1045515|NCT00075946|3391807|P2|Overall Study|No response to retreatment|0
1045516|NCT00075946|3391808|P1|Overall Study|No response to retreatment|23
1045517|NCT00075946|3391804|P5|Overall Study|Other complicating disease|0
1045518|NCT00075946|3391805|P4|Overall Study|Other complicating disease|4
1045519|NCT00075946|3391806|P3|Overall Study|Other complicating disease|1
1045520|NCT00075946|3391807|P2|Overall Study|Other complicating disease|13
1045521|NCT00075946|3391808|P1|Overall Study|Other complicating disease|7
1045522|NCT00075946|3391804|P5|Overall Study|Alternative therapy|0
1045523|NCT00075946|3391805|P4|Overall Study|Alternative therapy|0
1045524|NCT00075946|3391806|P3|Overall Study|Alternative therapy|5
1045525|NCT00075946|3391807|P2|Overall Study|Alternative therapy|2
1045526|NCT00075946|3391808|P1|Overall Study|Alternative therapy|16
1045527|NCT00075946|3391804|P5|Overall Study|Withdrawal by Subject|0
1045528|NCT00075946|3391805|P4|Overall Study|Withdrawal by Subject|9
1045529|NCT00075946|3391806|P3|Overall Study|Withdrawal by Subject|4
1045530|NCT00075946|3391807|P2|Overall Study|Withdrawal by Subject|58
1045531|NCT00075946|3391808|P1|Overall Study|Withdrawal by Subject|23
1045532|NCT00075946|3391804|P5|Overall Study|Death|0
1045533|NCT00075946|3391805|P4|Overall Study|Death|0
1045534|NCT00075946|3391806|P3|Overall Study|Death|0
1045535|NCT00075946|3391807|P2|Overall Study|Death|1
1045536|NCT00075946|3391808|P1|Overall Study|Death|0
1045537|NCT00075946|3391804|P5|Overall Study|Adverse Event|0
1045538|NCT00075946|3391805|P4|Overall Study|Adverse Event|2
1045539|NCT00075946|3391806|P3|Overall Study|Adverse Event|0
1045540|NCT00075946|3391807|P2|Overall Study|Adverse Event|10
1045541|NCT00075946|3391808|P1|Overall Study|Adverse Event|2
1045542|NCT00075946|3391804|P5|Overall Study|Still on treatment at time of analysis|0
1045543|NCT00075946|3391805|P4|Overall Study|Still on treatment at time of analysis|9
1045544|NCT00075946|3391806|P3|Overall Study|Still on treatment at time of analysis|3
1045545|NCT00075946|3391807|P2|Overall Study|Still on treatment at time of analysis|19
1045546|NCT00075946|3391808|P1|Overall Study|Still on treatment at time of analysis|52
1045547|NCT00075946|3391804|P5|Overall Study|Incorrectly randomized (no response)|0
1045548|NCT00075946|3391805|P4|Overall Study|Incorrectly randomized (no response)|1
1045549|NCT00075946|3391806|P3|Overall Study|Incorrectly randomized (no response)|5
1045550|NCT00075946|3391807|P2|Overall Study|Incorrectly randomized (no response)|5
1045551|NCT00075946|3391808|P1|Overall Study|Incorrectly randomized (no response)|5
1045552|NCT00075946|3391804|P5|Overall Study|Did not achieve response after induction|182
1045553|NCT00075946|3391805|P4|Overall Study|Did not achieve response after induction|0
1045554|NCT00075946|3391806|P3|Overall Study|Did not achieve response after induction|0
1045555|NCT00075946|3391807|P2|Overall Study|Did not achieve response after induction|0
1045556|NCT00075946|3391808|P1|Overall Study|Did not achieve response after induction|0
1045557|NCT00075946|3391804|P5|Overall Study|Path ineligible: undetermined histology|6
1045558|NCT00075946|3391805|P4|Overall Study|Path ineligible: undetermined histology|0
1045559|NCT00075946|3391806|P3|Overall Study|Path ineligible: undetermined histology|0
1045560|NCT00075946|3391807|P2|Overall Study|Path ineligible: undetermined histology|0
1045561|NCT00075946|3391808|P1|Overall Study|Path ineligible: undetermined histology|0
1045562|NCT00075881|3391823|P1|Overall Study|never start protocol therapy|1
1045563|NCT00075881|3391823|P1|Overall Study|Ineligible|1
1045564|NCT00075881|3391823|P1|Overall Study|missing data|2
1045565|NCT00075881|3391823|P1|Overall Study|other|4
1045566|NCT00075881|3391823|P1|Overall Study|other complicating disease|3
1045567|NCT00075881|3391823|P1|Overall Study|Protocol Violation|4
1045568|NCT00075881|3391823|P1|Overall Study|Withdrawal by Subject|2
1045569|NCT00075881|3391823|P1|Overall Study|Death|1
1045570|NCT00075881|3391823|P1|Overall Study|Adverse Event|7
1045571|NCT00075881|3391823|P1|Overall Study|Lack of Efficacy|18
1045572|NCT00075816|3391867|P2|Overall Study|Did not undergo transplantation|11
1045573|NCT00075816|3391868|P1|Overall Study|Did not undergo transplantation|14
1045574|NCT00075764|3391937|P2|Overall Study|Under review|1
1045575|NCT00075764|3391938|P1|Overall Study|Under review|0
1045576|NCT00075764|3391937|P2|Overall Study|Not protocol specified|19
1045577|NCT00075764|3391938|P1|Overall Study|Not protocol specified|27
1045578|NCT00075764|3391937|P2|Overall Study|Delinquent|2
1045579|NCT00075764|3391938|P1|Overall Study|Delinquent|4
1045580|NCT00075764|3391937|P2|Overall Study|Still on treatment|15
1045581|NCT00075764|3391938|P1|Overall Study|Still on treatment|8
1045582|NCT00075764|3391937|P2|Overall Study|Progression|274
1045583|NCT00075764|3391938|P1|Overall Study|Progression|269
1045584|NCT00075764|3391937|P2|Overall Study|Withdrawal by Subject|18
1045585|NCT00075764|3391938|P1|Overall Study|Withdrawal by Subject|28
1045586|NCT00075764|3391937|P2|Overall Study|Death|8
1045587|NCT00075764|3391938|P1|Overall Study|Death|4
1045588|NCT00075764|3391937|P2|Overall Study|Adverse Event|12
1045589|NCT00075764|3391938|P1|Overall Study|Adverse Event|5
1045590|NCT00075725|3391962|P12|Overall Study|Pt incarcerated|0
1045591|NCT00075725|3391963|P11|Overall Study|Pt incarcerated|0
1045592|NCT00075725|3391964|P10|Overall Study|Pt incarcerated|0
1045593|NCT00075725|3391965|P9|Overall Study|Pt incarcerated|0
1045594|NCT00075725|3391966|P8|Overall Study|Pt incarcerated|1
1045595|NCT00075725|3391967|P7|Overall Study|Pt incarcerated|0
1045596|NCT00075725|3391968|P6|Overall Study|Pt incarcerated|0
1045597|NCT00075725|3391969|P5|Overall Study|Pt incarcerated|0
1045598|NCT00075725|3391970|P4|Overall Study|Pt incarcerated|0
1045599|NCT00075725|3391971|P3|Overall Study|Pt incarcerated|0
1045600|NCT00075725|3391972|P2|Overall Study|Pt incarcerated|0
1045601|NCT00075725|3391973|P1|Overall Study|Pt incarcerated|0
1045602|NCT00075725|3391962|P12|Overall Study|Pt care terminated due to pt behavior|0
1045603|NCT00075725|3391963|P11|Overall Study|Pt care terminated due to pt behavior|0
1045604|NCT00075725|3391964|P10|Overall Study|Pt care terminated due to pt behavior|0
1045605|NCT00075725|3391965|P9|Overall Study|Pt care terminated due to pt behavior|0
1045606|NCT00075725|3391966|P8|Overall Study|Pt care terminated due to pt behavior|1
1045607|NCT00075725|3391967|P7|Overall Study|Pt care terminated due to pt behavior|0
1045608|NCT00075725|3391968|P6|Overall Study|Pt care terminated due to pt behavior|0
1045609|NCT00075725|3391969|P5|Overall Study|Pt care terminated due to pt behavior|0
1045610|NCT00075725|3391970|P4|Overall Study|Pt care terminated due to pt behavior|0
1045611|NCT00075725|3391971|P3|Overall Study|Pt care terminated due to pt behavior|0
1045612|NCT00075725|3391972|P2|Overall Study|Pt care terminated due to pt behavior|0
1045613|NCT00075725|3391973|P1|Overall Study|Pt care terminated due to pt behavior|0
1045614|NCT00075725|3391962|P12|Overall Study|Other complications|0
1045615|NCT00075725|3391963|P11|Overall Study|Other complications|0
1045616|NCT00075725|3391964|P10|Overall Study|Other complications|0
1045617|NCT00075725|3391965|P9|Overall Study|Other complications|0
1045618|NCT00075725|3391966|P8|Overall Study|Other complications|0
1045619|NCT00075725|3391967|P7|Overall Study|Other complications|0
1045620|NCT00075725|3391968|P6|Overall Study|Other complications|1
1045621|NCT00075725|3391969|P5|Overall Study|Other complications|0
1045622|NCT00075725|3391970|P4|Overall Study|Other complications|0
1045623|NCT00075725|3391971|P3|Overall Study|Other complications|0
1045624|NCT00075725|3391972|P2|Overall Study|Other complications|0
1045625|NCT00075725|3391973|P1|Overall Study|Other complications|0
1045626|NCT00075725|3391962|P12|Overall Study|Study Closure|0
1045627|NCT00075725|3391963|P11|Overall Study|Study Closure|0
1045628|NCT00075725|3391964|P10|Overall Study|Study Closure|0
1045629|NCT00075725|3391965|P9|Overall Study|Study Closure|0
1045630|NCT00075725|3391966|P8|Overall Study|Study Closure|1
1045631|NCT00075725|3391967|P7|Overall Study|Study Closure|0
1045632|NCT00075725|3391968|P6|Overall Study|Study Closure|3
1045633|NCT00075725|3391969|P5|Overall Study|Study Closure|1
1045634|NCT00075725|3391970|P4|Overall Study|Study Closure|0
1045635|NCT00075725|3391971|P3|Overall Study|Study Closure|0
1045636|NCT00075725|3391972|P2|Overall Study|Study Closure|0
1045637|NCT00075725|3391973|P1|Overall Study|Study Closure|1
1045638|NCT00075725|3391962|P12|Overall Study|Institution Terminated|0
1045639|NCT00075725|3391963|P11|Overall Study|Institution Terminated|0
1045640|NCT00075725|3391964|P10|Overall Study|Institution Terminated|0
1045641|NCT00075725|3391965|P9|Overall Study|Institution Terminated|0
1045642|NCT00075725|3391966|P8|Overall Study|Institution Terminated|3
1045643|NCT00075725|3391967|P7|Overall Study|Institution Terminated|0
1045644|NCT00075725|3391968|P6|Overall Study|Institution Terminated|0
1045645|NCT00075725|3391969|P5|Overall Study|Institution Terminated|1
1045646|NCT00075725|3391970|P4|Overall Study|Institution Terminated|0
1045647|NCT00075725|3391971|P3|Overall Study|Institution Terminated|0
1045648|NCT00075725|3391972|P2|Overall Study|Institution Terminated|0
1045649|NCT00075725|3391973|P1|Overall Study|Institution Terminated|0
1045650|NCT00075725|3391962|P12|Overall Study|Pt relocated|0
1045651|NCT00075725|3391963|P11|Overall Study|Pt relocated|0
1045652|NCT00075725|3391964|P10|Overall Study|Pt relocated|0
1045653|NCT00075725|3391965|P9|Overall Study|Pt relocated|1
1045654|NCT00075725|3391966|P8|Overall Study|Pt relocated|2
1045655|NCT00075725|3391967|P7|Overall Study|Pt relocated|1
1045656|NCT00075725|3391968|P6|Overall Study|Pt relocated|1
1045657|NCT00075725|3391969|P5|Overall Study|Pt relocated|0
1045658|NCT00075725|3391970|P4|Overall Study|Pt relocated|2
1045659|NCT00075725|3391971|P3|Overall Study|Pt relocated|0
1045660|NCT00075725|3391972|P2|Overall Study|Pt relocated|0
1045661|NCT00075725|3391973|P1|Overall Study|Pt relocated|0
1045662|NCT00075725|3391962|P12|Overall Study|Pt received additional steroids|0
1045663|NCT00075725|3391963|P11|Overall Study|Pt received additional steroids|0
1045664|NCT00075725|3391964|P10|Overall Study|Pt received additional steroids|0
1045665|NCT00075725|3391965|P9|Overall Study|Pt received additional steroids|0
1045666|NCT00075725|3391966|P8|Overall Study|Pt received additional steroids|0
1045667|NCT00075725|3391967|P7|Overall Study|Pt received additional steroids|0
1045668|NCT00075725|3391968|P6|Overall Study|Pt received additional steroids|0
1045669|NCT00075725|3391969|P5|Overall Study|Pt received additional steroids|0
1045670|NCT00075725|3391970|P4|Overall Study|Pt received additional steroids|1
1045671|NCT00075725|3391971|P3|Overall Study|Pt received additional steroids|0
1045672|NCT00075725|3391972|P2|Overall Study|Pt received additional steroids|0
1045673|NCT00075725|3391973|P1|Overall Study|Pt received additional steroids|0
1045674|NCT00075725|3391962|P12|Overall Study|Pt went to transplant|0
1045675|NCT00075725|3391963|P11|Overall Study|Pt went to transplant|0
1045676|NCT00075725|3391964|P10|Overall Study|Pt went to transplant|0
1045677|NCT00075725|3391965|P9|Overall Study|Pt went to transplant|0
1045678|NCT00075725|3391966|P8|Overall Study|Pt went to transplant|0
1045679|NCT00075725|3391967|P7|Overall Study|Pt went to transplant|0
1045680|NCT00075725|3391968|P6|Overall Study|Pt went to transplant|1
1045681|NCT00075725|3391969|P5|Overall Study|Pt went to transplant|0
1045682|NCT00075725|3391970|P4|Overall Study|Pt went to transplant|1
1045683|NCT00075725|3391971|P3|Overall Study|Pt went to transplant|0
1045684|NCT00075725|3391972|P2|Overall Study|Pt went to transplant|0
1045685|NCT00075725|3391973|P1|Overall Study|Pt went to transplant|0
1045686|NCT00075725|3391962|P12|Overall Study|specimen(s) not submitted|0
1045687|NCT00075725|3391963|P11|Overall Study|specimen(s) not submitted|0
1045688|NCT00075725|3391964|P10|Overall Study|specimen(s) not submitted|0
1045689|NCT00075725|3391965|P9|Overall Study|specimen(s) not submitted|0
1045690|NCT00075725|3391966|P8|Overall Study|specimen(s) not submitted|0
1045691|NCT00075725|3391967|P7|Overall Study|specimen(s) not submitted|0
1045692|NCT00075725|3391968|P6|Overall Study|specimen(s) not submitted|0
1045693|NCT00075725|3391969|P5|Overall Study|specimen(s) not submitted|0
1045694|NCT00075725|3391970|P4|Overall Study|specimen(s) not submitted|0
1045695|NCT00075725|3391971|P3|Overall Study|specimen(s) not submitted|2
1045696|NCT00075725|3391972|P2|Overall Study|specimen(s) not submitted|0
1045697|NCT00075725|3391973|P1|Overall Study|specimen(s) not submitted|0
1045698|NCT00075725|3391962|P12|Overall Study|Unsuccessful institutional transfer|0
1045699|NCT00075725|3391963|P11|Overall Study|Unsuccessful institutional transfer|0
1045700|NCT00075725|3391964|P10|Overall Study|Unsuccessful institutional transfer|1
1045701|NCT00075725|3391965|P9|Overall Study|Unsuccessful institutional transfer|0
1045702|NCT00075725|3391966|P8|Overall Study|Unsuccessful institutional transfer|0
1045703|NCT00075725|3391967|P7|Overall Study|Unsuccessful institutional transfer|0
1045704|NCT00075725|3391968|P6|Overall Study|Unsuccessful institutional transfer|0
1045705|NCT00075725|3391969|P5|Overall Study|Unsuccessful institutional transfer|0
1045706|NCT00075725|3391970|P4|Overall Study|Unsuccessful institutional transfer|0
1045707|NCT00075725|3391971|P3|Overall Study|Unsuccessful institutional transfer|2
1045708|NCT00075725|3391972|P2|Overall Study|Unsuccessful institutional transfer|0
1045709|NCT00075725|3391973|P1|Overall Study|Unsuccessful institutional transfer|0
1045710|NCT00075725|3391962|P12|Overall Study|Clinic chart lost unable to recreate|0
1045711|NCT00075725|3391963|P11|Overall Study|Clinic chart lost unable to recreate|0
1045712|NCT00075725|3391964|P10|Overall Study|Clinic chart lost unable to recreate|0
1045713|NCT00075725|3391965|P9|Overall Study|Clinic chart lost unable to recreate|0
1045714|NCT00075725|3391966|P8|Overall Study|Clinic chart lost unable to recreate|0
1045715|NCT00075725|3391967|P7|Overall Study|Clinic chart lost unable to recreate|0
1045716|NCT00075725|3391968|P6|Overall Study|Clinic chart lost unable to recreate|0
1045717|NCT00075725|3391969|P5|Overall Study|Clinic chart lost unable to recreate|0
1045718|NCT00075725|3391970|P4|Overall Study|Clinic chart lost unable to recreate|0
1045719|NCT00075725|3391971|P3|Overall Study|Clinic chart lost unable to recreate|1
1045720|NCT00075725|3391972|P2|Overall Study|Clinic chart lost unable to recreate|0
1045721|NCT00075725|3391973|P1|Overall Study|Clinic chart lost unable to recreate|0
1045722|NCT00075725|3391962|P12|Overall Study|Pt trying to find a BM donor|0
1045723|NCT00075725|3391963|P11|Overall Study|Pt trying to find a BM donor|0
1045724|NCT00075725|3391964|P10|Overall Study|Pt trying to find a BM donor|0
1045725|NCT00075725|3391965|P9|Overall Study|Pt trying to find a BM donor|0
1045726|NCT00075725|3391966|P8|Overall Study|Pt trying to find a BM donor|0
1045727|NCT00075725|3391967|P7|Overall Study|Pt trying to find a BM donor|0
1045728|NCT00075725|3391968|P6|Overall Study|Pt trying to find a BM donor|0
1045729|NCT00075725|3391969|P5|Overall Study|Pt trying to find a BM donor|0
1045730|NCT00075725|3391970|P4|Overall Study|Pt trying to find a BM donor|0
1045731|NCT00075725|3391971|P3|Overall Study|Pt trying to find a BM donor|0
1045732|NCT00075725|3391972|P2|Overall Study|Pt trying to find a BM donor|1
1045733|NCT00075725|3391973|P1|Overall Study|Pt trying to find a BM donor|0
1045734|NCT00075725|3391962|P12|Overall Study|Other|3
1045735|NCT00075725|3391963|P11|Overall Study|Other|0
1045736|NCT00075725|3391964|P10|Overall Study|Other|1
1045737|NCT00075725|3391965|P9|Overall Study|Other|2
1045738|NCT00075725|3391966|P8|Overall Study|Other|9
1045739|NCT00075725|3391967|P7|Overall Study|Other|2
1045740|NCT00075725|3391968|P6|Overall Study|Other|4
1045741|NCT00075725|3391969|P5|Overall Study|Other|1
1045742|NCT00075725|3391970|P4|Overall Study|Other|1
1045743|NCT00075725|3391971|P3|Overall Study|Other|1
1045744|NCT00075725|3391972|P2|Overall Study|Other|2
1045745|NCT00075725|3391973|P1|Overall Study|Other|4
1045746|NCT00075725|3391962|P12|Overall Study|Inevaluable|0
1045747|NCT00075725|3391963|P11|Overall Study|Inevaluable|1
1045748|NCT00075725|3391964|P10|Overall Study|Inevaluable|0
1045749|NCT00075725|3391965|P9|Overall Study|Inevaluable|2
1045750|NCT00075725|3391966|P8|Overall Study|Inevaluable|11
1045751|NCT00075725|3391967|P7|Overall Study|Inevaluable|1
1045752|NCT00075725|3391968|P6|Overall Study|Inevaluable|9
1045753|NCT00075725|3391969|P5|Overall Study|Inevaluable|2
1045754|NCT00075725|3391970|P4|Overall Study|Inevaluable|2
1045755|NCT00075725|3391971|P3|Overall Study|Inevaluable|4
1045756|NCT00075725|3391972|P2|Overall Study|Inevaluable|1
1045757|NCT00075725|3391973|P1|Overall Study|Inevaluable|1
1045758|NCT00075725|3391962|P12|Overall Study|Pt has very high risk ALL characteristic|3
1045759|NCT00075725|3391963|P11|Overall Study|Pt has very high risk ALL characteristic|0
1045760|NCT00075725|3391964|P10|Overall Study|Pt has very high risk ALL characteristic|1
1045761|NCT00075725|3391965|P9|Overall Study|Pt has very high risk ALL characteristic|29
1045762|NCT00075725|3391966|P8|Overall Study|Pt has very high risk ALL characteristic|74
1045763|NCT00075725|3391967|P7|Overall Study|Pt has very high risk ALL characteristic|23
1045764|NCT00075725|3391968|P6|Overall Study|Pt has very high risk ALL characteristic|75
1045765|NCT00075725|3391969|P5|Overall Study|Pt has very high risk ALL characteristic|11
1045766|NCT00075725|3391970|P4|Overall Study|Pt has very high risk ALL characteristic|18
1045767|NCT00075725|3391971|P3|Overall Study|Pt has very high risk ALL characteristic|26
1045768|NCT00075725|3391972|P2|Overall Study|Pt has very high risk ALL characteristic|11
1045769|NCT00075725|3391973|P1|Overall Study|Pt has very high risk ALL characteristic|15
1045770|NCT00075725|3391962|P12|Overall Study|MRD positive after extended ind|0
1045771|NCT00075725|3391963|P11|Overall Study|MRD positive after extended ind|0
1045772|NCT00075725|3391964|P10|Overall Study|MRD positive after extended ind|0
1045773|NCT00075725|3391965|P9|Overall Study|MRD positive after extended ind|0
1045774|NCT00075725|3391966|P8|Overall Study|MRD positive after extended ind|1
1045775|NCT00075725|3391967|P7|Overall Study|MRD positive after extended ind|0
1045776|NCT00075725|3391968|P6|Overall Study|MRD positive after extended ind|2
1045777|NCT00075725|3391969|P5|Overall Study|MRD positive after extended ind|1
1045778|NCT00075725|3391970|P4|Overall Study|MRD positive after extended ind|0
1045779|NCT00075725|3391971|P3|Overall Study|MRD positive after extended ind|1
1045780|NCT00075725|3391972|P2|Overall Study|MRD positive after extended ind|1
1045781|NCT00075725|3391973|P1|Overall Study|MRD positive after extended ind|0
1045782|NCT00075725|3391962|P12|Overall Study|Insurance issues|0
1045783|NCT00075725|3391963|P11|Overall Study|Insurance issues|0
1045784|NCT00075725|3391964|P10|Overall Study|Insurance issues|0
1045785|NCT00075725|3391965|P9|Overall Study|Insurance issues|0
1045786|NCT00075725|3391966|P8|Overall Study|Insurance issues|1
1045787|NCT00075725|3391967|P7|Overall Study|Insurance issues|0
1045788|NCT00075725|3391968|P6|Overall Study|Insurance issues|1
1045789|NCT00075725|3391969|P5|Overall Study|Insurance issues|1
1045790|NCT00075725|3391970|P4|Overall Study|Insurance issues|1
1045791|NCT00075725|3391971|P3|Overall Study|Insurance issues|0
1045792|NCT00075725|3391972|P2|Overall Study|Insurance issues|1
1045793|NCT00075725|3391973|P1|Overall Study|Insurance issues|0
1045794|NCT00075725|3391962|P12|Overall Study|Pt age out of range for treatment|0
1045795|NCT00075725|3391963|P11|Overall Study|Pt age out of range for treatment|0
1045796|NCT00075725|3391964|P10|Overall Study|Pt age out of range for treatment|0
1045797|NCT00075725|3391965|P9|Overall Study|Pt age out of range for treatment|0
1045798|NCT00075725|3391966|P8|Overall Study|Pt age out of range for treatment|1
1045799|NCT00075725|3391967|P7|Overall Study|Pt age out of range for treatment|0
1045800|NCT00075725|3391968|P6|Overall Study|Pt age out of range for treatment|1
1045801|NCT00075725|3391969|P5|Overall Study|Pt age out of range for treatment|0
1045802|NCT00075725|3391970|P4|Overall Study|Pt age out of range for treatment|0
1045803|NCT00075725|3391971|P3|Overall Study|Pt age out of range for treatment|0
1045804|NCT00075725|3391972|P2|Overall Study|Pt age out of range for treatment|1
1045805|NCT00075725|3391973|P1|Overall Study|Pt age out of range for treatment|0
1045806|NCT00075725|3391962|P12|Overall Study|Pt non compliant with therapy|0
1045807|NCT00075725|3391963|P11|Overall Study|Pt non compliant with therapy|0
1045808|NCT00075725|3391964|P10|Overall Study|Pt non compliant with therapy|0
1045809|NCT00075725|3391965|P9|Overall Study|Pt non compliant with therapy|3
1045810|NCT00075725|3391966|P8|Overall Study|Pt non compliant with therapy|5
1045811|NCT00075725|3391967|P7|Overall Study|Pt non compliant with therapy|2
1045812|NCT00075725|3391968|P6|Overall Study|Pt non compliant with therapy|14
1045813|NCT00075725|3391969|P5|Overall Study|Pt non compliant with therapy|2
1045814|NCT00075725|3391970|P4|Overall Study|Pt non compliant with therapy|0
1045815|NCT00075725|3391971|P3|Overall Study|Pt non compliant with therapy|1
1045816|NCT00075725|3391972|P2|Overall Study|Pt non compliant with therapy|1
1045817|NCT00075725|3391973|P1|Overall Study|Pt non compliant with therapy|2
1045818|NCT00075725|3391962|P12|Overall Study|Pt/Guardian refused RT therapy|0
1045819|NCT00075725|3391963|P11|Overall Study|Pt/Guardian refused RT therapy|0
1045820|NCT00075725|3391964|P10|Overall Study|Pt/Guardian refused RT therapy|0
1045821|NCT00075725|3391965|P9|Overall Study|Pt/Guardian refused RT therapy|0
1045822|NCT00075725|3391966|P8|Overall Study|Pt/Guardian refused RT therapy|0
1045823|NCT00075725|3391967|P7|Overall Study|Pt/Guardian refused RT therapy|0
1045824|NCT00075725|3391968|P6|Overall Study|Pt/Guardian refused RT therapy|0
1045825|NCT00075725|3391969|P5|Overall Study|Pt/Guardian refused RT therapy|1
1045826|NCT00075725|3391970|P4|Overall Study|Pt/Guardian refused RT therapy|2
1045827|NCT00075725|3391971|P3|Overall Study|Pt/Guardian refused RT therapy|1
1045828|NCT00075725|3391972|P2|Overall Study|Pt/Guardian refused RT therapy|0
1045829|NCT00075725|3391973|P1|Overall Study|Pt/Guardian refused RT therapy|1
1045830|NCT00075725|3391962|P12|Overall Study|Ineligible or wrong diagnosis|4
1045831|NCT00075725|3391963|P11|Overall Study|Ineligible or wrong diagnosis|2
1045832|NCT00075725|3391964|P10|Overall Study|Ineligible or wrong diagnosis|1
1045833|NCT00075725|3391965|P9|Overall Study|Ineligible or wrong diagnosis|10
1045834|NCT00075725|3391966|P8|Overall Study|Ineligible or wrong diagnosis|9
1045835|NCT00075725|3391967|P7|Overall Study|Ineligible or wrong diagnosis|6
1045836|NCT00075725|3391968|P6|Overall Study|Ineligible or wrong diagnosis|17
1045837|NCT00075725|3391969|P5|Overall Study|Ineligible or wrong diagnosis|3
1045838|NCT00075725|3391970|P4|Overall Study|Ineligible or wrong diagnosis|10
1045839|NCT00075725|3391971|P3|Overall Study|Ineligible or wrong diagnosis|3
1045840|NCT00075725|3391972|P2|Overall Study|Ineligible or wrong diagnosis|3
1045841|NCT00075725|3391973|P1|Overall Study|Ineligible or wrong diagnosis|8
1045842|NCT00075725|3391962|P12|Overall Study|Patient off treatment|0
1045843|NCT00075725|3391963|P11|Overall Study|Patient off treatment|0
1045844|NCT00075725|3391964|P10|Overall Study|Patient off treatment|0
1045845|NCT00075725|3391965|P9|Overall Study|Patient off treatment|1
1045846|NCT00075725|3391966|P8|Overall Study|Patient off treatment|2
1045847|NCT00075725|3391967|P7|Overall Study|Patient off treatment|0
1045848|NCT00075725|3391968|P6|Overall Study|Patient off treatment|0
1045849|NCT00075725|3391969|P5|Overall Study|Patient off treatment|1
1045850|NCT00075725|3391970|P4|Overall Study|Patient off treatment|2
1045851|NCT00075725|3391971|P3|Overall Study|Patient off treatment|1
1045852|NCT00075725|3391972|P2|Overall Study|Patient off treatment|0
1045853|NCT00075725|3391973|P1|Overall Study|Patient off treatment|0
1045854|NCT00075725|3391962|P12|Overall Study|Disease Progression, all other reasons|5
1045855|NCT00075725|3391963|P11|Overall Study|Disease Progression, all other reasons|0
1045856|NCT00075725|3391964|P10|Overall Study|Disease Progression, all other reasons|4
1045857|NCT00075725|3391965|P9|Overall Study|Disease Progression, all other reasons|21
1045858|NCT00075725|3391966|P8|Overall Study|Disease Progression, all other reasons|46
1045859|NCT00075725|3391967|P7|Overall Study|Disease Progression, all other reasons|20
1045860|NCT00075725|3391968|P6|Overall Study|Disease Progression, all other reasons|59
1045861|NCT00075725|3391969|P5|Overall Study|Disease Progression, all other reasons|21
1045862|NCT00075725|3391970|P4|Overall Study|Disease Progression, all other reasons|6
1045863|NCT00075725|3391971|P3|Overall Study|Disease Progression, all other reasons|33
1045864|NCT00075725|3391972|P2|Overall Study|Disease Progression, all other reasons|5
1045865|NCT00075725|3391973|P1|Overall Study|Disease Progression, all other reasons|17
1045866|NCT00075725|3391962|P12|Overall Study|Withdrawal by Subject|0
1045867|NCT00075725|3391963|P11|Overall Study|Withdrawal by Subject|0
1045868|NCT00075725|3391964|P10|Overall Study|Withdrawal by Subject|2
1045869|NCT00075725|3391965|P9|Overall Study|Withdrawal by Subject|10
1045870|NCT00075725|3391966|P8|Overall Study|Withdrawal by Subject|31
1045871|NCT00075725|3391967|P7|Overall Study|Withdrawal by Subject|7
1045872|NCT00075725|3391968|P6|Overall Study|Withdrawal by Subject|27
1045873|NCT00075725|3391969|P5|Overall Study|Withdrawal by Subject|6
1045874|NCT00075725|3391970|P4|Overall Study|Withdrawal by Subject|10
1045875|NCT00075725|3391971|P3|Overall Study|Withdrawal by Subject|6
1045876|NCT00075725|3391972|P2|Overall Study|Withdrawal by Subject|3
1045877|NCT00075725|3391973|P1|Overall Study|Withdrawal by Subject|12
1045878|NCT00075725|3391962|P12|Overall Study|Protocol Violation|1
1045879|NCT00075725|3391963|P11|Overall Study|Protocol Violation|0
1045880|NCT00075725|3391964|P10|Overall Study|Protocol Violation|0
1045881|NCT00075725|3391965|P9|Overall Study|Protocol Violation|3
1045882|NCT00075725|3391966|P8|Overall Study|Protocol Violation|2
1045883|NCT00075725|3391967|P7|Overall Study|Protocol Violation|1
1045884|NCT00075725|3391968|P6|Overall Study|Protocol Violation|2
1045885|NCT00075725|3391969|P5|Overall Study|Protocol Violation|3
1045886|NCT00075725|3391970|P4|Overall Study|Protocol Violation|3
1045887|NCT00075725|3391971|P3|Overall Study|Protocol Violation|0
1045888|NCT00075725|3391972|P2|Overall Study|Protocol Violation|1
1045889|NCT00075725|3391973|P1|Overall Study|Protocol Violation|1
1045890|NCT00075725|3391962|P12|Overall Study|Pregnancy|0
1045891|NCT00075725|3391963|P11|Overall Study|Pregnancy|0
1045892|NCT00075725|3391964|P10|Overall Study|Pregnancy|0
1045893|NCT00075725|3391965|P9|Overall Study|Pregnancy|0
1045894|NCT00075725|3391966|P8|Overall Study|Pregnancy|1
1045895|NCT00075725|3391967|P7|Overall Study|Pregnancy|0
1045896|NCT00075725|3391968|P6|Overall Study|Pregnancy|1
1045897|NCT00075725|3391969|P5|Overall Study|Pregnancy|0
1045898|NCT00075725|3391970|P4|Overall Study|Pregnancy|0
1045899|NCT00075725|3391971|P3|Overall Study|Pregnancy|0
1045900|NCT00075725|3391972|P2|Overall Study|Pregnancy|0
1045901|NCT00075725|3391973|P1|Overall Study|Pregnancy|0
1045902|NCT00075725|3391962|P12|Overall Study|Physician Decision|0
1045903|NCT00075725|3391963|P11|Overall Study|Physician Decision|1
1045904|NCT00075725|3391964|P10|Overall Study|Physician Decision|0
1045905|NCT00075725|3391965|P9|Overall Study|Physician Decision|5
1045906|NCT00075725|3391966|P8|Overall Study|Physician Decision|17
1045907|NCT00075725|3391967|P7|Overall Study|Physician Decision|3
1045908|NCT00075725|3391968|P6|Overall Study|Physician Decision|19
1045909|NCT00075725|3391969|P5|Overall Study|Physician Decision|4
1045910|NCT00075725|3391970|P4|Overall Study|Physician Decision|8
1045911|NCT00075725|3391971|P3|Overall Study|Physician Decision|5
1045912|NCT00075725|3391972|P2|Overall Study|Physician Decision|6
1045913|NCT00075725|3391973|P1|Overall Study|Physician Decision|2
1045914|NCT00075725|3391962|P12|Overall Study|Lost to Follow-up|0
1045915|NCT00075725|3391963|P11|Overall Study|Lost to Follow-up|0
1045916|NCT00075725|3391964|P10|Overall Study|Lost to Follow-up|0
1045917|NCT00075725|3391965|P9|Overall Study|Lost to Follow-up|1
1045918|NCT00075725|3391966|P8|Overall Study|Lost to Follow-up|4
1045919|NCT00075725|3391967|P7|Overall Study|Lost to Follow-up|2
1045920|NCT00075725|3391968|P6|Overall Study|Lost to Follow-up|13
1045921|NCT00075725|3391969|P5|Overall Study|Lost to Follow-up|0
1045922|NCT00075725|3391970|P4|Overall Study|Lost to Follow-up|1
1045923|NCT00075725|3391971|P3|Overall Study|Lost to Follow-up|4
1045924|NCT00075725|3391972|P2|Overall Study|Lost to Follow-up|1
1045925|NCT00075725|3391973|P1|Overall Study|Lost to Follow-up|1
1045926|NCT00075725|3391962|P12|Overall Study|Death|0
1045927|NCT00075725|3391963|P11|Overall Study|Death|3
1045928|NCT00075725|3391964|P10|Overall Study|Death|4
1045929|NCT00075725|3391965|P9|Overall Study|Death|14
1045930|NCT00075725|3391966|P8|Overall Study|Death|22
1045931|NCT00075725|3391967|P7|Overall Study|Death|4
1045932|NCT00075725|3391968|P6|Overall Study|Death|25
1045933|NCT00075725|3391969|P5|Overall Study|Death|3
1045934|NCT00075725|3391970|P4|Overall Study|Death|2
1045935|NCT00075725|3391971|P3|Overall Study|Death|10
1045936|NCT00075725|3391972|P2|Overall Study|Death|5
1045937|NCT00075725|3391973|P1|Overall Study|Death|3
1045938|NCT00075725|3391962|P12|Overall Study|Adverse Event|2
1045939|NCT00075725|3391963|P11|Overall Study|Adverse Event|2
1045940|NCT00075725|3391964|P10|Overall Study|Adverse Event|4
1045941|NCT00075725|3391965|P9|Overall Study|Adverse Event|15
1045942|NCT00075725|3391966|P8|Overall Study|Adverse Event|51
1045943|NCT00075725|3391967|P7|Overall Study|Adverse Event|3
1045944|NCT00075725|3391968|P6|Overall Study|Adverse Event|38
1045945|NCT00075725|3391969|P5|Overall Study|Adverse Event|4
1045946|NCT00075725|3391970|P4|Overall Study|Adverse Event|8
1045947|NCT00075725|3391971|P3|Overall Study|Adverse Event|20
1045948|NCT00075725|3391972|P2|Overall Study|Adverse Event|6
1045949|NCT00075725|3391973|P1|Overall Study|Adverse Event|6
1045950|NCT00075582|3392070|P2|Overall Study|Ineligible for study|16
1045951|NCT00075582|3392071|P1|Overall Study|Ineligible for study|36
1045952|NCT00075582|3392070|P2|Overall Study|Withdrawal by Subject|2
1045953|NCT00075582|3392071|P1|Overall Study|Withdrawal by Subject|2
1045954|NCT00075582|3392070|P2|Overall Study|Physician Decision|8
1045955|NCT00075582|3392071|P1|Overall Study|Physician Decision|5
1045956|NCT00075582|3392070|P2|Overall Study|Lack of Efficacy|8
1045957|NCT00075582|3392071|P1|Overall Study|Lack of Efficacy|4
1045958|NCT00075582|3392070|P2|Overall Study|Adverse Event|1
1045959|NCT00075582|3392071|P1|Overall Study|Adverse Event|3
1045960|NCT00075504|3392081|P2|Overall Study|Withdrawal by Subject|7
1045961|NCT00075504|3392082|P1|Overall Study|Withdrawal by Subject|9
1045962|NCT00075478|3392094|P2|Overall Study|Physician Decision|1
1045963|NCT00075478|3392095|P1|Overall Study|Physician Decision|0
1045964|NCT00075478|3392094|P2|Overall Study|not eligible|0
1045965|NCT00075478|3392095|P1|Overall Study|not eligible|1
1045966|NCT00075400|3392115|P1|Overall Study|Never treated|2
1045967|NCT00075400|3392115|P1|Overall Study|Ineligible: wrong primary|1
1045968|NCT00075270|3392136|P2|Overall Study|Missing|13
1045969|NCT00075270|3392137|P1|Overall Study|Missing|26
1045970|NCT00075270|3392136|P2|Overall Study|Other/Unknown|5
1045971|NCT00075270|3392137|P1|Overall Study|Other/Unknown|9
1045972|NCT00075270|3392136|P2|Overall Study|Death|215
1045973|NCT00075270|3392137|P1|Overall Study|Death|198
1045974|NCT00075270|3392136|P2|Overall Study|Protocol Violation|2
1045975|NCT00075270|3392137|P1|Overall Study|Protocol Violation|0
1045976|NCT00075270|3392136|P2|Overall Study|Lost to Follow-up|28
1045977|NCT00075270|3392137|P1|Overall Study|Lost to Follow-up|25
1045978|NCT00075270|3392136|P2|Overall Study|Withdrawal by Subject|21
1045979|NCT00075270|3392137|P1|Overall Study|Withdrawal by Subject|28
1045980|NCT00075218|3392183|P3|Open-Label Treatment|enrolled in a separate continuation|9
1045981|NCT00075218|3392184|P2|Open-Label Treatment|enrolled in a separate continuation|0
1045982|NCT00075218|3392185|P1|Open-Label Treatment|enrolled in a separate continuation|0
1045983|NCT00075218|3392183|P3|Open-Label Treatment|Protocol Violation|1
1045984|NCT00075218|3392184|P2|Open-Label Treatment|Protocol Violation|0
1045985|NCT00075218|3392185|P1|Open-Label Treatment|Protocol Violation|0
1045986|NCT00075218|3392183|P3|Open-Label Treatment|Decision of Sponsor|8
1045987|NCT00075218|3392184|P2|Open-Label Treatment|Decision of Sponsor|0
1045988|NCT00075218|3392185|P1|Open-Label Treatment|Decision of Sponsor|0
1045989|NCT00075218|3392183|P3|Open-Label Treatment|Withdrawal by Subject|12
1045990|NCT00075218|3392184|P2|Open-Label Treatment|Withdrawal by Subject|0
1045991|NCT00075218|3392185|P1|Open-Label Treatment|Withdrawal by Subject|0
1045992|NCT00075218|3392183|P3|Open-Label Treatment|Adverse Event|51
1045993|NCT00075218|3392184|P2|Open-Label Treatment|Adverse Event|0
1045994|NCT00075218|3392185|P1|Open-Label Treatment|Adverse Event|0
1045995|NCT00075218|3392183|P3|Open-Label Treatment|Lack of Efficacy|174
1045996|NCT00075218|3392184|P2|Open-Label Treatment|Lack of Efficacy|0
1045997|NCT00075218|3392185|P1|Open-Label Treatment|Lack of Efficacy|0
1045998|NCT00075218|3392183|P3|Double-Blind Treatment|No study medication taken|0
1045999|NCT00075218|3392184|P2|Double-Blind Treatment|No study medication taken|0
1046000|NCT00075218|3392185|P1|Double-Blind Treatment|No study medication taken|2
1046001|NCT00075218|3392183|P3|Double-Blind Treatment|Decision of Sponsor|0
1046002|NCT00075218|3392184|P2|Double-Blind Treatment|Decision of Sponsor|1
1046003|NCT00075218|3392185|P1|Double-Blind Treatment|Decision of Sponsor|0
1046004|NCT00075218|3392183|P3|Double-Blind Treatment|Lack of Efficacy|0
1046005|NCT00075218|3392184|P2|Double-Blind Treatment|Lack of Efficacy|6
1046006|NCT00075218|3392185|P1|Double-Blind Treatment|Lack of Efficacy|58
1046007|NCT00075218|3392183|P3|Double-Blind Treatment|Lost to Follow-up|0
1046008|NCT00075218|3392184|P2|Double-Blind Treatment|Lost to Follow-up|0
1046009|NCT00075218|3392185|P1|Double-Blind Treatment|Lost to Follow-up|1
1046010|NCT00075218|3392183|P3|Double-Blind Treatment|Withdrawal by Subject|0
1046011|NCT00075218|3392184|P2|Double-Blind Treatment|Withdrawal by Subject|4
1046012|NCT00075218|3392185|P1|Double-Blind Treatment|Withdrawal by Subject|7
1046013|NCT00075218|3392183|P3|Double-Blind Treatment|Adverse Event|0
1046014|NCT00075218|3392184|P2|Double-Blind Treatment|Adverse Event|4
1046015|NCT00075218|3392185|P1|Double-Blind Treatment|Adverse Event|23
1046016|NCT00075023|3392234|P2|Pilot Study|Withdrawal by Subject|0
1046017|NCT00075023|3392235|P1|Pilot Study|Withdrawal by Subject|1
1046018|NCT00075023|3392234|P2|Pilot Study|Physician Decision|2
1046019|NCT00075023|3392235|P1|Pilot Study|Physician Decision|1
1046020|NCT00074984|3392244|P2|Overall Study|Patient Withdrawn Per Protocol|3
1046021|NCT00074984|3392245|P1|Overall Study|Patient Withdrawn Per Protocol|0
1046022|NCT00074984|3392244|P2|Overall Study|Withdrawal by Subject|3
1046023|NCT00074984|3392245|P1|Overall Study|Withdrawal by Subject|2
1046024|NCT00074984|3392244|P2|Overall Study|Death|2
1046025|NCT00074984|3392245|P1|Overall Study|Death|1
1046026|NCT00074958|3392260|P1|Overall Study|Adverse Event|1
1046027|NCT00074711|3392301|P2|Overall Study|Participant stopped study drug|6
1046028|NCT00074711|3392302|P1|Overall Study|Participant stopped study drug|4
1046029|NCT00074711|3392301|P2|Overall Study|Lost to Follow-up|8
1046030|NCT00074711|3392302|P1|Overall Study|Lost to Follow-up|10
1046031|NCT00074711|3392301|P2|Overall Study|Withdrawal by Subject|1
1046032|NCT00074711|3392302|P1|Overall Study|Withdrawal by Subject|1
1046033|NCT00074581|3392320|P2|Overall Study|Other|19
1046034|NCT00074581|3392321|P1|Overall Study|Other|14
1046035|NCT00074581|3392320|P2|Overall Study|Ended relationship w. index participant|106
1046036|NCT00074581|3392321|P1|Overall Study|Ended relationship w. index participant|117
1046037|NCT00074581|3392320|P2|Overall Study|Lost to Follow-up|11
1046038|NCT00074581|3392321|P1|Overall Study|Lost to Follow-up|16
1046039|NCT00074581|3392320|P2|Overall Study|Were withdrawn by investigator|2
1046040|NCT00074581|3392321|P1|Overall Study|Were withdrawn by investigator|5
1046041|NCT00074581|3392320|P2|Overall Study|Relocated|9
1046042|NCT00074581|3392321|P1|Overall Study|Relocated|14
1046043|NCT00074581|3392320|P2|Overall Study|Unable to adhere to visit schedule|14
1046044|NCT00074581|3392321|P1|Overall Study|Unable to adhere to visit schedule|13
1046045|NCT00074581|3392320|P2|Overall Study|Withdrawal by Subject|49
1046046|NCT00074581|3392321|P1|Overall Study|Withdrawal by Subject|50
1046047|NCT00074581|3392320|P2|Overall Study|Death|16
1046048|NCT00074581|3392321|P1|Overall Study|Death|15
1046049|NCT00074412|3392331|P2|Overall Study|Lost to Follow-up|58
1046050|NCT00074412|3392332|P1|Overall Study|Lost to Follow-up|52
1046051|NCT00074412|3392331|P2|Overall Study|Death|26
1046052|NCT00074412|3392332|P1|Overall Study|Death|30
1046053|NCT00074152|3392380|P2|Overall Study|Lack of Efficacy|24
1046054|NCT00074152|3392381|P1|Overall Study|Lack of Efficacy|34
1046055|NCT00074152|3392380|P2|Overall Study|Death|9
1046056|NCT00074152|3392381|P1|Overall Study|Death|21
1046057|NCT00073983|3392398|P1|Overall Study|not evaluable|1
1046058|NCT00073918|3392419|P1|Overall Study|Eligibility requirement not met-low CD20|1
1046059|NCT00073918|3392419|P1|Overall Study|Rapid disease progression|2
1046060|NCT00073918|3392419|P1|Overall Study|Eligibility requirement not met - HAMA+|1
1046061|NCT00073749|3392433|P7|Overall Study|Other|0
1046062|NCT00073749|3392434|P6|Overall Study|Other|2
1046063|NCT00073749|3392435|P5|Overall Study|Other|0
1046064|NCT00073749|3392436|P4|Overall Study|Other|0
1046065|NCT00073749|3392437|P3|Overall Study|Other|0
1046066|NCT00073749|3392438|P2|Overall Study|Other|0
1046067|NCT00073749|3392439|P1|Overall Study|Other|0
1046068|NCT00073749|3392433|P7|Overall Study|Lost to Follow-up|2
1046069|NCT00073749|3392434|P6|Overall Study|Lost to Follow-up|0
1046070|NCT00073749|3392435|P5|Overall Study|Lost to Follow-up|0
1046071|NCT00073749|3392436|P4|Overall Study|Lost to Follow-up|0
1046072|NCT00073749|3392437|P3|Overall Study|Lost to Follow-up|0
1046073|NCT00073749|3392438|P2|Overall Study|Lost to Follow-up|0
1046074|NCT00073749|3392439|P1|Overall Study|Lost to Follow-up|0
1046075|NCT00073749|3392433|P7|Overall Study|Discontinuation of Study by Sponsor|4
1046076|NCT00073749|3392434|P6|Overall Study|Discontinuation of Study by Sponsor|0
1046077|NCT00073749|3392435|P5|Overall Study|Discontinuation of Study by Sponsor|0
1046078|NCT00073749|3392436|P4|Overall Study|Discontinuation of Study by Sponsor|0
1046079|NCT00073749|3392437|P3|Overall Study|Discontinuation of Study by Sponsor|0
1046080|NCT00073749|3392438|P2|Overall Study|Discontinuation of Study by Sponsor|0
1046081|NCT00073749|3392439|P1|Overall Study|Discontinuation of Study by Sponsor|0
1046082|NCT00073749|3392433|P7|Overall Study|Withdrawal by Subject|2
1046083|NCT00073749|3392434|P6|Overall Study|Withdrawal by Subject|0
1046084|NCT00073749|3392435|P5|Overall Study|Withdrawal by Subject|1
1046085|NCT00073749|3392436|P4|Overall Study|Withdrawal by Subject|0
1046086|NCT00073749|3392437|P3|Overall Study|Withdrawal by Subject|0
1046087|NCT00073749|3392438|P2|Overall Study|Withdrawal by Subject|1
1046088|NCT00073749|3392439|P1|Overall Study|Withdrawal by Subject|0
1046089|NCT00073749|3392433|P7|Overall Study|Physician Decision|0
1046090|NCT00073749|3392434|P6|Overall Study|Physician Decision|2
1046091|NCT00073749|3392435|P5|Overall Study|Physician Decision|0
1046092|NCT00073749|3392436|P4|Overall Study|Physician Decision|0
1046093|NCT00073749|3392437|P3|Overall Study|Physician Decision|1
1046094|NCT00073749|3392438|P2|Overall Study|Physician Decision|0
1046095|NCT00073749|3392439|P1|Overall Study|Physician Decision|0
1046096|NCT00073749|3392433|P7|Overall Study|Adverse Event|0
1046097|NCT00073749|3392434|P6|Overall Study|Adverse Event|1
1046098|NCT00073749|3392435|P5|Overall Study|Adverse Event|2
1046099|NCT00073749|3392436|P4|Overall Study|Adverse Event|4
1046100|NCT00073749|3392437|P3|Overall Study|Adverse Event|6
1046101|NCT00073749|3392438|P2|Overall Study|Adverse Event|3
1046102|NCT00073749|3392439|P1|Overall Study|Adverse Event|0
1046103|NCT00073749|3392433|P7|Overall Study|Death|29
1046104|NCT00073749|3392434|P6|Overall Study|Death|0
1046105|NCT00073749|3392435|P5|Overall Study|Death|0
1046106|NCT00073749|3392436|P4|Overall Study|Death|0
1046107|NCT00073749|3392437|P3|Overall Study|Death|1
1046108|NCT00073749|3392438|P2|Overall Study|Death|1
1046109|NCT00073749|3392439|P1|Overall Study|Death|0
1046110|NCT00073749|3392433|P7|Overall Study|Disease Progression|3
1046111|NCT00073749|3392434|P6|Overall Study|Disease Progression|1
1046112|NCT00073749|3392435|P5|Overall Study|Disease Progression|3
1046113|NCT00073749|3392436|P4|Overall Study|Disease Progression|2
1046114|NCT00073749|3392437|P3|Overall Study|Disease Progression|3
1046115|NCT00073749|3392438|P2|Overall Study|Disease Progression|0
1046116|NCT00073749|3392439|P1|Overall Study|Disease Progression|2
1046117|NCT00073528|3392470|P2|Overall Study|Ongoing|344
1046118|NCT00073528|3392471|P1|Overall Study|Ongoing|349
1046119|NCT00073528|3392470|P2|Overall Study|Non-compliance|1
1046120|NCT00073528|3392471|P1|Overall Study|Non-compliance|0
1046121|NCT00073528|3392470|P2|Overall Study|Enrolled in Error|1
1046122|NCT00073528|3392471|P1|Overall Study|Enrolled in Error|0
1046123|NCT00073528|3392470|P2|Overall Study|Participant Was Unblinded|1
1046124|NCT00073528|3392471|P1|Overall Study|Participant Was Unblinded|0
1046125|NCT00073528|3392470|P2|Overall Study|Progressive Disease|1
1046126|NCT00073528|3392471|P1|Overall Study|Progressive Disease|0
1046127|NCT00073528|3392470|P2|Overall Study|Randomized in Error; Not Treated|0
1046128|NCT00073528|3392471|P1|Overall Study|Randomized in Error; Not Treated|2
1046129|NCT00073528|3392470|P2|Overall Study|Mastectomy Intervention|0
1046130|NCT00073528|3392471|P1|Overall Study|Mastectomy Intervention|1
1046131|NCT00073528|3392470|P2|Overall Study|Death|238
1046132|NCT00073528|3392471|P1|Overall Study|Death|229
1046133|NCT00073528|3392470|P2|Overall Study|Protocol Violation|5
1046134|NCT00073528|3392471|P1|Overall Study|Protocol Violation|3
1046135|NCT00073528|3392470|P2|Overall Study|Lost to Follow-up|22
1046136|NCT00073528|3392471|P1|Overall Study|Lost to Follow-up|26
1046137|NCT00073528|3392470|P2|Overall Study|Withdrawal by Subject|29
1046138|NCT00073528|3392471|P1|Overall Study|Withdrawal by Subject|34
1046139|NCT00073307|3392560|P3|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83
1046140|NCT00073307|3392561|P2|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0
1046141|NCT00073307|3392562|P1|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35
1046142|NCT00073307|3392560|P3|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9
1046143|NCT00073307|3392561|P2|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0
1046144|NCT00073307|3392562|P1|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19
1046145|NCT00073307|3392560|P3|Open Label-Sorafenib Only [30Jun2008]|Missing|1
1046146|NCT00073307|3392561|P2|Open Label-Sorafenib Only [30Jun2008]|Missing|0
1046147|NCT00073307|3392562|P1|Open Label-Sorafenib Only [30Jun2008]|Missing|3
1046148|NCT00073307|3392560|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3
1046149|NCT00073307|3392561|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
1046150|NCT00073307|3392562|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
1046151|NCT00073307|3392560|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
1046152|NCT00073307|3392561|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0
1046153|NCT00073307|3392562|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
1046154|NCT00073307|3392560|P3|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
1046155|NCT00073307|3392561|P2|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0
1046156|NCT00073307|3392562|P1|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
1046157|NCT00073307|3392560|P3|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28
1046158|NCT00073307|3392561|P2|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0
1046159|NCT00073307|3392562|P1|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37
1046160|NCT00073307|3392560|P3|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9
1046161|NCT00073307|3392561|P2|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0
1046162|NCT00073307|3392562|P1|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19
1046163|NCT00073307|3392560|P3|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
1046164|NCT00073307|3392561|P2|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0
1046165|NCT00073307|3392562|P1|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
1046166|NCT00073307|3392560|P3|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19
1046167|NCT00073307|3392561|P2|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0
1046168|NCT00073307|3392562|P1|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17
1046169|NCT00073307|3392560|P3|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
1046170|NCT00073307|3392561|P2|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1
1046171|NCT00073307|3392562|P1|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
1046172|NCT00073307|3392560|P3|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0
1046173|NCT00073307|3392561|P2|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114
1046174|NCT00073307|3392562|P1|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165
1046175|NCT00073307|3392560|P3|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
1046176|NCT00073307|3392561|P2|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1
1046177|NCT00073307|3392562|P1|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
1046178|NCT00073307|3392560|P3|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
1046179|NCT00073307|3392561|P2|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
1046180|NCT00073307|3392562|P1|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1
1046181|NCT00073307|3392560|P3|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0
1046182|NCT00073307|3392561|P2|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2
1046183|NCT00073307|3392562|P1|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1
1046184|NCT00073307|3392560|P3|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0
1046185|NCT00073307|3392561|P2|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
1046186|NCT00073307|3392562|P1|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
1046187|NCT00073307|3392560|P3|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0
1046188|NCT00073307|3392561|P2|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11
1046189|NCT00073307|3392562|P1|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6
1046190|NCT00073307|3392560|P3|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0
1046191|NCT00073307|3392561|P2|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6
1046192|NCT00073307|3392562|P1|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1
1046193|NCT00073307|3392560|P3|Double-Blind (DB, as of ~31May2005)|Adverse Event|0
1046194|NCT00073307|3392561|P2|Double-Blind (DB, as of ~31May2005)|Adverse Event|17
1046195|NCT00073307|3392562|P1|Double-Blind (DB, as of ~31May2005)|Adverse Event|22
1046196|NCT00073021|3392593|P2|Overall Study|Lack of Efficacy|5
1046197|NCT00073021|3392594|P1|Overall Study|Lack of Efficacy|11
1046198|NCT00073021|3392593|P2|Overall Study|Physician Decision|1
1046199|NCT00073021|3392594|P1|Overall Study|Physician Decision|3
1046200|NCT00073021|3392593|P2|Overall Study|Withdrawal by Subject|5
1046201|NCT00073021|3392594|P1|Overall Study|Withdrawal by Subject|6
1046202|NCT00073021|3392593|P2|Overall Study|Adverse Event|4
1046203|NCT00073021|3392594|P1|Overall Study|Adverse Event|4
1046204|NCT00073021|3392593|P2|Overall Study|Protocol Violation|1
1046205|NCT00073021|3392594|P1|Overall Study|Protocol Violation|2
1046206|NCT00073008|3392624|P2|Overall Study|"Other selected on Case Report Form"|5
1046207|NCT00073008|3392625|P1|Overall Study|"Other selected on Case Report Form"|7
1046208|NCT00073008|3392624|P2|Overall Study|Death|47
1046209|NCT00073008|3392625|P1|Overall Study|Death|46
1046210|NCT00073008|3392624|P2|Overall Study|Lost to Follow-up|3
1046211|NCT00073008|3392625|P1|Overall Study|Lost to Follow-up|1
1046212|NCT00073008|3392624|P2|Overall Study|Withdrawal by Subject|2
1046213|NCT00073008|3392625|P1|Overall Study|Withdrawal by Subject|2
1046214|NCT00073008|3392624|P2|Overall Study|Missing|6
1046215|NCT00073008|3392625|P1|Overall Study|Missing|6
1046216|NCT00072475|3392664|P1|Overall Study|Patient/Investigator Decision|4
1046217|NCT00072475|3392664|P1|Overall Study|Withdrawal by Subject|46
1046218|NCT00072475|3392664|P1|Overall Study|Death|3
1046219|NCT00072475|3392664|P1|Overall Study|Adverse Event|44
1046220|NCT00072384|3392679|P1|Overall Study|Ineligible|8
1046221|NCT00072384|3392679|P1|Overall Study|Physician Decision|1
1046222|NCT00072293|3392692|P2|Overall Study|Withdrawal by Subject|1
1046223|NCT00072293|3392693|P1|Overall Study|Withdrawal by Subject|0
1046224|NCT00072293|3392692|P2|Overall Study|Lost to Follow-up|1
1046225|NCT00072293|3392693|P1|Overall Study|Lost to Follow-up|1
1046226|NCT00072280|3392705|P2|Follow-up|Early termination of study|2
1046227|NCT00072280|3392706|P1|Follow-up|Early termination of study|2
1046228|NCT00072280|3392705|P2|Treatment|Found ineligible|2
1046229|NCT00072280|3392706|P1|Treatment|Found ineligible|1
1046230|NCT00072189|3392711|P1|Overall Study|Withdrawal by Subject|1
1046231|NCT00072176|3392719|P2|Overall Study|Protocol Violation|1
1046232|NCT00072176|3392720|P1|Overall Study|Protocol Violation|0
1046233|NCT00072176|3392719|P2|Overall Study|Withdrawal by Subject|0
1046234|NCT00072176|3392720|P1|Overall Study|Withdrawal by Subject|1
1046235|NCT00071981|3392732|P4|Overall Study|others (not specified in the study)|0
1046236|NCT00071981|3392733|P3|Overall Study|others (not specified in the study)|2
1046237|NCT00071981|3392734|P2|Overall Study|others (not specified in the study)|2
1046238|NCT00071981|3392735|P1|Overall Study|others (not specified in the study)|0
1046239|NCT00071981|3392732|P4|Overall Study|No protocol therapy|0
1046240|NCT00071981|3392733|P3|Overall Study|No protocol therapy|1
1046241|NCT00071981|3392734|P2|Overall Study|No protocol therapy|5
1046242|NCT00071981|3392735|P1|Overall Study|No protocol therapy|2
1046243|NCT00071981|3392732|P4|Overall Study|Withdrawal by Subject|0
1046244|NCT00071981|3392733|P3|Overall Study|Withdrawal by Subject|0
1046245|NCT00071981|3392734|P2|Overall Study|Withdrawal by Subject|1
1046246|NCT00071981|3392735|P1|Overall Study|Withdrawal by Subject|3
1046247|NCT00071981|3392732|P4|Overall Study|Death|1
1046248|NCT00071981|3392733|P3|Overall Study|Death|1
1046249|NCT00071981|3392734|P2|Overall Study|Death|0
1046250|NCT00071981|3392735|P1|Overall Study|Death|0
1046251|NCT00071981|3392732|P4|Overall Study|Adverse Event|1
1046252|NCT00071981|3392733|P3|Overall Study|Adverse Event|3
1046253|NCT00071981|3392734|P2|Overall Study|Adverse Event|4
1046254|NCT00071981|3392735|P1|Overall Study|Adverse Event|4
1046255|NCT00071981|3392732|P4|Overall Study|Lack of Efficacy|43
1046256|NCT00071981|3392733|P3|Overall Study|Lack of Efficacy|30
1046257|NCT00071981|3392734|P2|Overall Study|Lack of Efficacy|29
1046258|NCT00071981|3392735|P1|Overall Study|Lack of Efficacy|37
1046259|NCT00071812|3392778|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
1046260|NCT00071812|3392779|P3|24-Week Open-Label Extension Period|Lack of Compliance|1
1046261|NCT00071812|3392780|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
1046262|NCT00071812|3392781|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
1046263|NCT00071812|3392778|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|12
1046264|NCT00071812|3392779|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
1046265|NCT00071812|3392780|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
1046266|NCT00071812|3392781|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
1046267|NCT00071812|3392778|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
1046268|NCT00071812|3392779|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
1046269|NCT00071812|3392780|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
1046270|NCT00071812|3392781|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
1046271|NCT00071812|3392778|P4|24-Week Open-Label Extension Period|Lack of Efficacy|17
1046272|NCT00071812|3392779|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
1046273|NCT00071812|3392780|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
1046274|NCT00071812|3392781|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
1046275|NCT00071812|3392778|P4|24-Week Open-Label Extension Period|Adverse Event|7
1046276|NCT00071812|3392779|P3|24-Week Open-Label Extension Period|Adverse Event|0
1046277|NCT00071812|3392780|P2|24-Week Open-Label Extension Period|Adverse Event|0
1046278|NCT00071812|3392781|P1|24-Week Open-Label Extension Period|Adverse Event|0
1046279|NCT00071812|3392778|P4|24-Week Double-Blind Period|Protocol Violation|1
1046280|NCT00071812|3392779|P3|24-Week Double-Blind Period|Protocol Violation|0
1046281|NCT00071812|3392780|P2|24-Week Double-Blind Period|Protocol Violation|0
1046282|NCT00071812|3392781|P1|24-Week Double-Blind Period|Protocol Violation|0
1046283|NCT00071812|3392778|P4|24-Week Double-Blind Period|Withdrawal by Subject|5
1046284|NCT00071812|3392779|P3|24-Week Double-Blind Period|Withdrawal by Subject|1
1046285|NCT00071812|3392780|P2|24-Week Double-Blind Period|Withdrawal by Subject|1
1046286|NCT00071812|3392781|P1|24-Week Double-Blind Period|Withdrawal by Subject|5
1046287|NCT00071812|3392778|P4|24-Week Double-Blind Period|Lost to Follow-up|0
1046288|NCT00071812|3392779|P3|24-Week Double-Blind Period|Lost to Follow-up|1
1046289|NCT00071812|3392780|P2|24-Week Double-Blind Period|Lost to Follow-up|1
1046290|NCT00071812|3392781|P1|24-Week Double-Blind Period|Lost to Follow-up|0
1046291|NCT00071812|3392778|P4|24-Week Double-Blind Period|Lack of Efficacy|1
1046292|NCT00071812|3392779|P3|24-Week Double-Blind Period|Lack of Efficacy|2
1046293|NCT00071812|3392780|P2|24-Week Double-Blind Period|Lack of Efficacy|1
1046294|NCT00071812|3392781|P1|24-Week Double-Blind Period|Lack of Efficacy|3
1046295|NCT00071812|3392778|P4|24-Week Double-Blind Period|Adverse Event|4
1046296|NCT00071812|3392779|P3|24-Week Double-Blind Period|Adverse Event|4
1046297|NCT00071812|3392780|P2|24-Week Double-Blind Period|Adverse Event|3
1046298|NCT00071812|3392781|P1|24-Week Double-Blind Period|Adverse Event|2
1046299|NCT00071799|3392823|P2|Overall Study|Not Documented|2
1046300|NCT00071799|3392824|P1|Overall Study|Not Documented|0
1046301|NCT00071799|3392823|P2|Overall Study|Different Central+Local Pathology Review|1
1046302|NCT00071799|3392824|P1|Overall Study|Different Central+Local Pathology Review|0
1046303|NCT00071799|3392823|P2|Overall Study|Disease Progression|20
1046304|NCT00071799|3392824|P1|Overall Study|Disease Progression|23
1046305|NCT00071799|3392823|P2|Overall Study|Lack of Efficacy|18
1046306|NCT00071799|3392824|P1|Overall Study|Lack of Efficacy|11
1046307|NCT00071799|3392823|P2|Overall Study|Physician Decision|2
1046308|NCT00071799|3392824|P1|Overall Study|Physician Decision|0
1046309|NCT00071799|3392823|P2|Overall Study|Withdrawal by Subject|37
1046310|NCT00071799|3392824|P1|Overall Study|Withdrawal by Subject|15
1046311|NCT00071799|3392823|P2|Overall Study|Lost to Follow-up|1
1046312|NCT00071799|3392824|P1|Overall Study|Lost to Follow-up|1
1046313|NCT00071799|3392823|P2|Overall Study|Protocol Violation|7
1046314|NCT00071799|3392824|P1|Overall Study|Protocol Violation|1
1046315|NCT00071799|3392823|P2|Overall Study|Adverse Event|10
1046316|NCT00071799|3392824|P1|Overall Study|Adverse Event|19
1046317|NCT00071760|3392877|P1|Overall Study|Ongoing|25
1046318|NCT00071760|3392877|P1|Overall Study|Study Team Rec./Resistance|1
1046319|NCT00071760|3392877|P1|Overall Study|Investigator's Recommendation (Rec.)|4
1046320|NCT00071760|3392877|P1|Overall Study|Relocation|1
1046321|NCT00071760|3392877|P1|Overall Study|Unavailability of RTV|8
1046322|NCT00071760|3392877|P1|Overall Study|Pulmonary Tuberculosis|1
1046323|NCT00071760|3392877|P1|Overall Study|Insufficient Viral Load Response|3
1046324|NCT00071760|3392877|P1|Overall Study|Withdrawal by Subject|3
1046325|NCT00071760|3392877|P1|Overall Study|Protocol Violation|1
1046326|NCT00071760|3392877|P1|Overall Study|Lost to Follow-up|4
1046327|NCT00071760|3392877|P1|Overall Study|Adverse Event|3
1046328|NCT00071513|3392957|P2|Follow-up Assessment|Withdrawal by Subject|6
1046329|NCT00071513|3392958|P1|Follow-up Assessment|Withdrawal by Subject|6
1046330|NCT00071513|3392957|P2|Intervention Component|Withdrawal by Subject|3
1046331|NCT00071513|3392958|P1|Intervention Component|Withdrawal by Subject|2
1046332|NCT00071487|3392970|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
1046333|NCT00071487|3392971|P3|24-Week Open-Label Extension Period|Lack of Compliance|0
1046334|NCT00071487|3392972|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
1046335|NCT00071487|3392973|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
1046336|NCT00071487|3392970|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
1046337|NCT00071487|3392971|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
1046338|NCT00071487|3392972|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
1046339|NCT00071487|3392973|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
1046340|NCT00071487|3392970|P4|24-Week Open-Label Extension Period|Pregnancy|1
1046341|NCT00071487|3392971|P3|24-Week Open-Label Extension Period|Pregnancy|0
1046342|NCT00071487|3392972|P2|24-Week Open-Label Extension Period|Pregnancy|0
1046343|NCT00071487|3392973|P1|24-Week Open-Label Extension Period|Pregnancy|0
1046344|NCT00071487|3392970|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|9
1046345|NCT00071487|3392971|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
1046346|NCT00071487|3392972|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
1046347|NCT00071487|3392973|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
1046348|NCT00071487|3392970|P4|24-Week Open-Label Extension Period|Lack of Efficacy|3
1046349|NCT00071487|3392971|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
1046350|NCT00071487|3392972|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
1046351|NCT00071487|3392973|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
1046352|NCT00071487|3392970|P4|24-Week Open-Label Extension Period|Adverse Event|6
1046353|NCT00071487|3392971|P3|24-Week Open-Label Extension Period|Adverse Event|1
1046354|NCT00071487|3392972|P2|24-Week Open-Label Extension Period|Adverse Event|0
1046355|NCT00071487|3392973|P1|24-Week Open-Label Extension Period|Adverse Event|0
1046356|NCT00071487|3392970|P4|52-Week Double-Blind Period|Lack of Compliance|3
1046357|NCT00071487|3392971|P3|52-Week Double-Blind Period|Lack of Compliance|3
1046358|NCT00071487|3392972|P2|52-Week Double-Blind Period|Lack of Compliance|3
1046359|NCT00071487|3392973|P1|52-Week Double-Blind Period|Lack of Compliance|6
1046360|NCT00071487|3392970|P4|52-Week Double-Blind Period|Death|0
1046361|NCT00071487|3392971|P3|52-Week Double-Blind Period|Death|0
1046362|NCT00071487|3392972|P2|52-Week Double-Blind Period|Death|1
1046363|NCT00071487|3392973|P1|52-Week Double-Blind Period|Death|0
1046364|NCT00071487|3392970|P4|52-Week Double-Blind Period|Protocol Violation|0
1046365|NCT00071487|3392971|P3|52-Week Double-Blind Period|Protocol Violation|1
1046366|NCT00071487|3392972|P2|52-Week Double-Blind Period|Protocol Violation|1
1046367|NCT00071487|3392973|P1|52-Week Double-Blind Period|Protocol Violation|0
1046368|NCT00071487|3392970|P4|52-Week Double-Blind Period|Pregnancy|0
1046369|NCT00071487|3392971|P3|52-Week Double-Blind Period|Pregnancy|0
1046370|NCT00071487|3392972|P2|52-Week Double-Blind Period|Pregnancy|1
1046371|NCT00071487|3392973|P1|52-Week Double-Blind Period|Pregnancy|0
1046372|NCT00071487|3392970|P4|52-Week Double-Blind Period|Lost to Follow-up|2
1046373|NCT00071487|3392971|P3|52-Week Double-Blind Period|Lost to Follow-up|2
1046374|NCT00071487|3392972|P2|52-Week Double-Blind Period|Lost to Follow-up|0
1046375|NCT00071487|3392973|P1|52-Week Double-Blind Period|Lost to Follow-up|0
1046376|NCT00071487|3392970|P4|52-Week Double-Blind Period|Physician Decision|0
1046377|NCT00071487|3392971|P3|52-Week Double-Blind Period|Physician Decision|0
1046378|NCT00071487|3392972|P2|52-Week Double-Blind Period|Physician Decision|0
1046379|NCT00071487|3392973|P1|52-Week Double-Blind Period|Physician Decision|1
1046380|NCT00071487|3392970|P4|52-Week Double-Blind Period|Withdrawal by Subject|7
1046381|NCT00071487|3392971|P3|52-Week Double-Blind Period|Withdrawal by Subject|7
1046382|NCT00071487|3392972|P2|52-Week Double-Blind Period|Withdrawal by Subject|11
1046383|NCT00071487|3392973|P1|52-Week Double-Blind Period|Withdrawal by Subject|7
1046384|NCT00071487|3392970|P4|52-Week Double-Blind Period|Lack of Efficacy|1
1046385|NCT00071487|3392971|P3|52-Week Double-Blind Period|Lack of Efficacy|0
1046386|NCT00071487|3392972|P2|52-Week Double-Blind Period|Lack of Efficacy|2
1046387|NCT00071487|3392973|P1|52-Week Double-Blind Period|Lack of Efficacy|1
1046388|NCT00071487|3392970|P4|52-Week Double-Blind Period|Adverse Event|8
1046389|NCT00071487|3392971|P3|52-Week Double-Blind Period|Adverse Event|4
1046390|NCT00071487|3392972|P2|52-Week Double-Blind Period|Adverse Event|8
1046391|NCT00071487|3392973|P1|52-Week Double-Blind Period|Adverse Event|5
1046392|NCT00071396|3393017|P1|Overall Study|Physician Decision|2
1046393|NCT00071396|3393017|P1|Overall Study|Withdrawal by Subject|1
1046394|NCT00071110|3393023|P2|Overall Study|Protocol Violation|4
1046395|NCT00071110|3393024|P1|Overall Study|Protocol Violation|0
1046396|NCT00071032|3393038|P2|Overall Study|Missing Primary Outcome|1
1046397|NCT00071032|3393039|P1|Overall Study|Missing Primary Outcome|0
1046398|NCT00071032|3393038|P2|Overall Study|Withdrawal by Subject|6
1046399|NCT00071032|3393039|P1|Overall Study|Withdrawal by Subject|8
1046400|NCT00071032|3393038|P2|Overall Study|Lost to Follow-up|1
1046401|NCT00071032|3393039|P1|Overall Study|Lost to Follow-up|1
1046402|NCT00071006|3393047|P1|Overall Study|Other|3
1046403|NCT00071006|3393047|P1|Overall Study|Withdrawal by Subject|1
1046404|NCT00071006|3393047|P1|Overall Study|Adverse Event|1
1046405|NCT00071006|3393047|P1|Overall Study|Lack of Efficacy|7
1046406|NCT00070941|3393060|P3|Overall Study|Adverse Event|4
1046407|NCT00070941|3393061|P2|Overall Study|Adverse Event|8
1046408|NCT00070941|3393062|P1|Overall Study|Adverse Event|10
1046409|NCT00071058|3393070|P1|Overall Study|brain tumor-removed from study|1
1046410|NCT00003907|3393077|P2|Overall Study|ineligible or not treated|2
1046411|NCT00003907|3393078|P1|Overall Study|ineligible or not treated|2
1046412|NCT00003907|3393077|P2|Overall Study|Not specified|3
1046413|NCT00003907|3393078|P1|Overall Study|Not specified|1
1046414|NCT00003907|3393077|P2|Overall Study|Complicating disease|0
1046415|NCT00003907|3393078|P1|Overall Study|Complicating disease|1
1046416|NCT00003907|3393077|P2|Overall Study|Progressive disease|4
1046417|NCT00003907|3393078|P1|Overall Study|Progressive disease|4
1046418|NCT00003907|3393077|P2|Overall Study|Withdrawal by Subject|3
1046419|NCT00003907|3393078|P1|Overall Study|Withdrawal by Subject|1
1046420|NCT00003907|3393077|P2|Overall Study|Death|0
1046421|NCT00003907|3393078|P1|Overall Study|Death|2
1046422|NCT00003907|3393077|P2|Overall Study|Adverse Event|11
1046423|NCT00003907|3393078|P1|Overall Study|Adverse Event|2
1046424|NCT00070564|3393094|P6|Overall Study|Not reported|0
1046425|NCT00070564|3393095|P5|Overall Study|Not reported|1
1046426|NCT00070564|3393096|P4|Overall Study|Not reported|0
1046427|NCT00070564|3393097|P3|Overall Study|Not reported|0
1046428|NCT00070564|3393098|P2|Overall Study|Not reported|0
1046429|NCT00070564|3393099|P1|Overall Study|Not reported|0
1046430|NCT00070564|3393094|P6|Overall Study|Withdrawal by Subject|8
1046431|NCT00070564|3393095|P5|Overall Study|Withdrawal by Subject|8
1046432|NCT00070564|3393096|P4|Overall Study|Withdrawal by Subject|30
1046433|NCT00070564|3393097|P3|Overall Study|Withdrawal by Subject|23
1046434|NCT00070564|3393098|P2|Overall Study|Withdrawal by Subject|37
1046435|NCT00070564|3393099|P1|Overall Study|Withdrawal by Subject|26
1046436|NCT00070564|3393094|P6|Overall Study|Other, not protocol specified|7
1046437|NCT00070564|3393095|P5|Overall Study|Other, not protocol specified|6
1046438|NCT00070564|3393096|P4|Overall Study|Other, not protocol specified|19
1046439|NCT00070564|3393097|P3|Overall Study|Other, not protocol specified|14
1046440|NCT00070564|3393098|P2|Overall Study|Other, not protocol specified|15
1046441|NCT00070564|3393099|P1|Overall Study|Other, not protocol specified|17
1046442|NCT00070564|3393094|P6|Overall Study|Death|1
1046443|NCT00070564|3393095|P5|Overall Study|Death|0
1046444|NCT00070564|3393096|P4|Overall Study|Death|3
1046445|NCT00070564|3393097|P3|Overall Study|Death|5
1046446|NCT00070564|3393098|P2|Overall Study|Death|1
1046447|NCT00070564|3393099|P1|Overall Study|Death|4
1046448|NCT00070564|3393094|P6|Overall Study|Adverse Event|36
1046449|NCT00070564|3393095|P5|Overall Study|Adverse Event|63
1046450|NCT00070564|3393096|P4|Overall Study|Adverse Event|108
1046451|NCT00070564|3393097|P3|Overall Study|Adverse Event|120
1046452|NCT00070564|3393098|P2|Overall Study|Adverse Event|142
1046453|NCT00070564|3393099|P1|Overall Study|Adverse Event|150
1046454|NCT00070564|3393094|P6|Overall Study|Delinquent|0
1046455|NCT00070564|3393095|P5|Overall Study|Delinquent|0
1046456|NCT00070564|3393096|P4|Overall Study|Delinquent|0
1046457|NCT00070564|3393097|P3|Overall Study|Delinquent|2
1046458|NCT00070564|3393098|P2|Overall Study|Delinquent|4
1046459|NCT00070564|3393099|P1|Overall Study|Delinquent|1
1046460|NCT00070564|3393094|P6|Overall Study|Progression|0
1046461|NCT00070564|3393095|P5|Overall Study|Progression|1
1046462|NCT00070564|3393096|P4|Overall Study|Progression|7
1046463|NCT00070564|3393097|P3|Overall Study|Progression|7
1046464|NCT00070564|3393098|P2|Overall Study|Progression|4
1046465|NCT00070564|3393099|P1|Overall Study|Progression|2
1046466|NCT00070499|3393153|P4|Overall Study|Not eligible|2
1046467|NCT00070499|3393154|P3|Overall Study|Not eligible|3
1046468|NCT00070499|3393155|P2|Overall Study|Not eligible|5
1046469|NCT00070499|3393156|P1|Overall Study|Not eligible|2
1046470|NCT00070499|3393153|P4|Overall Study|Did not start treatment|2
1046471|NCT00070499|3393154|P3|Overall Study|Did not start treatment|0
1046472|NCT00070499|3393155|P2|Overall Study|Did not start treatment|0
1046473|NCT00070499|3393156|P1|Overall Study|Did not start treatment|1
1046474|NCT00070499|3393153|P4|Overall Study|Still on protocol treatment|57
1046475|NCT00070499|3393154|P3|Overall Study|Still on protocol treatment|79
1046476|NCT00070499|3393155|P2|Overall Study|Still on protocol treatment|4
1046477|NCT00070499|3393156|P1|Overall Study|Still on protocol treatment|10
1046478|NCT00070499|3393153|P4|Overall Study|Other - not protocol specified|20
1046479|NCT00070499|3393154|P3|Overall Study|Other - not protocol specified|12
1046480|NCT00070499|3393155|P2|Overall Study|Other - not protocol specified|3
1046481|NCT00070499|3393156|P1|Overall Study|Other - not protocol specified|7
1046482|NCT00070499|3393153|P4|Overall Study|Death|2
1046483|NCT00070499|3393154|P3|Overall Study|Death|1
1046484|NCT00070499|3393155|P2|Overall Study|Death|1
1046485|NCT00070499|3393156|P1|Overall Study|Death|1
1046486|NCT00070499|3393153|P4|Overall Study|Progression/relapse|4
1046487|NCT00070499|3393154|P3|Overall Study|Progression/relapse|1
1046488|NCT00070499|3393155|P2|Overall Study|Progression/relapse|2
1046489|NCT00070499|3393156|P1|Overall Study|Progression/relapse|4
1046490|NCT00070499|3393153|P4|Overall Study|Refusal unrelated to adverse effects|8
1046491|NCT00070499|3393154|P3|Overall Study|Refusal unrelated to adverse effects|5
1046492|NCT00070499|3393155|P2|Overall Study|Refusal unrelated to adverse effects|5
1046493|NCT00070499|3393156|P1|Overall Study|Refusal unrelated to adverse effects|7
1046494|NCT00070499|3393153|P4|Overall Study|Adverse Event|15
1046495|NCT00070499|3393154|P3|Overall Study|Adverse Event|19
1046496|NCT00070499|3393155|P2|Overall Study|Adverse Event|6
1046497|NCT00070499|3393156|P1|Overall Study|Adverse Event|6
1046498|NCT00070317|3393182|P1|Overall Study|Ineligible-Inadequate pathology|6
1046499|NCT00070317|3393182|P1|Overall Study|Ineligible-Improper prior treatment|2
1046500|NCT00070317|3393182|P1|Overall Study|Ineligible required test not done|1
1046501|NCT00070317|3393182|P1|Overall Study|Ineligible Wrong Cell type/primary/stage|3
1046502|NCT00070317|3393182|P1|Overall Study|Inevaluable (Never Treated)|1
1046503|NCT00070291|3393187|P1|Step 2|Adverse Event|1
1046504|NCT00070291|3393187|P1|Step 1|Adverse Event|1
1046505|NCT00070291|3393187|P1|Step 1|Withdrawal by Subject|1
1046506|NCT00070109|3393203|P5|Overall Study|removed from prot thpy prior to chemo|0
1046507|NCT00070109|3393204|P4|Overall Study|removed from prot thpy prior to chemo|1
1046508|NCT00070109|3393205|P3|Overall Study|removed from prot thpy prior to chemo|0
1046509|NCT00070109|3393206|P2|Overall Study|removed from prot thpy prior to chemo|0
1046510|NCT00070109|3393207|P1|Overall Study|removed from prot thpy prior to chemo|0
1046511|NCT00070109|3393203|P5|Overall Study|Adverse Event|2
1046512|NCT00070109|3393204|P4|Overall Study|Adverse Event|4
1046513|NCT00070109|3393205|P3|Overall Study|Adverse Event|2
1046514|NCT00070109|3393206|P2|Overall Study|Adverse Event|0
1046515|NCT00070109|3393207|P1|Overall Study|Adverse Event|0
1046516|NCT00070109|3393203|P5|Overall Study|Withdrawal by Subject|0
1046517|NCT00070109|3393204|P4|Overall Study|Withdrawal by Subject|0
1046518|NCT00070109|3393205|P3|Overall Study|Withdrawal by Subject|1
1046519|NCT00070109|3393206|P2|Overall Study|Withdrawal by Subject|1
1046520|NCT00070109|3393207|P1|Overall Study|Withdrawal by Subject|0
1046521|NCT00070109|3393203|P5|Overall Study|Physician Decision|0
1046522|NCT00070109|3393204|P4|Overall Study|Physician Decision|0
1046523|NCT00070109|3393205|P3|Overall Study|Physician Decision|0
1046524|NCT00070109|3393206|P2|Overall Study|Physician Decision|0
1046525|NCT00070109|3393207|P1|Overall Study|Physician Decision|1
1046526|NCT00070109|3393203|P5|Overall Study|Lack of Efficacy|5
1046527|NCT00070109|3393204|P4|Overall Study|Lack of Efficacy|15
1046528|NCT00070109|3393205|P3|Overall Study|Lack of Efficacy|5
1046529|NCT00070109|3393206|P2|Overall Study|Lack of Efficacy|4
1046530|NCT00070109|3393207|P1|Overall Study|Lack of Efficacy|6
1046531|NCT00070109|3393203|P5|Overall Study|Death|1
1046532|NCT00070109|3393204|P4|Overall Study|Death|0
1046533|NCT00070109|3393205|P3|Overall Study|Death|0
1046534|NCT00070109|3393206|P2|Overall Study|Death|1
1046535|NCT00070109|3393207|P1|Overall Study|Death|1
1046536|NCT00070018|3393235|P1|Overall Study|Withdrawal by Subject|1
1046537|NCT00070018|3393235|P1|Overall Study|Lack of Efficacy|1
1046538|NCT00070018|3393235|P1|Overall Study|Adverse Event|2
1046539|NCT00069953|3393239|P1|Overall Study|Protocol Violation|2
1046540|NCT00069784|3393245|P2|Overall Study|Other|0
1046541|NCT00069784|3393246|P1|Overall Study|Other|17
1046542|NCT00069784|3393245|P2|Overall Study|Withdrawal by Subject|0
1046543|NCT00069784|3393246|P1|Overall Study|Withdrawal by Subject|1090
1046544|NCT00069784|3393245|P2|Overall Study|Adverse Event|0
1046545|NCT00069784|3393246|P1|Overall Study|Adverse Event|105
1046546|NCT00069823|3393266|P2|Overall Study|Did not have follow-up diary cards|3
1046547|NCT00069823|3393267|P1|Overall Study|Did not have follow-up diary cards|6
1046548|NCT00069641|3393310|P3|Overall Study|Death|1
1046549|NCT00069641|3393311|P2|Overall Study|Death|0
1046550|NCT00069641|3393312|P1|Overall Study|Death|1
1046551|NCT00069277|3393337|P1|Overall Study|Physician Decision|2
1046552|NCT00069277|3393337|P1|Overall Study|Progressive Disease|15
1046553|NCT00069277|3393337|P1|Overall Study|Withdrawal by Subject|1
1046554|NCT00069277|3393337|P1|Overall Study|Adverse Event|3
1046555|NCT00069264|3393341|P1|Overall Study|Discon Therapy|3
1046556|NCT00069264|3393341|P1|Overall Study|Withdrawal by Subject|3
1046557|NCT00069264|3393341|P1|Overall Study|Progressive Disease|23
1046558|NCT00069264|3393341|P1|Overall Study|Adverse Event|3
1046559|NCT00069238|3393369|P3|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2
1046560|NCT00069238|3393370|P2|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
1046561|NCT00069238|3393371|P1|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
1046562|NCT00069238|3393369|P3|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
1046563|NCT00069238|3393370|P2|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2
1046564|NCT00069238|3393371|P1|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
1046565|NCT00069238|3393369|P3|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
1046566|NCT00069238|3393370|P2|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
1046567|NCT00069238|3393371|P1|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9
1046568|NCT00069121|3393379|P2|Overall Study|Lost to Follow-up|57
1046569|NCT00069121|3393380|P1|Overall Study|Lost to Follow-up|57
1046570|NCT00069121|3393379|P2|Overall Study|Withdrawal by Subject|22
1046571|NCT00069121|3393380|P1|Overall Study|Withdrawal by Subject|20
1046572|NCT00069121|3393379|P2|Overall Study|Death|197
1046573|NCT00069121|3393380|P1|Overall Study|Death|225
1046574|NCT00069108|3393402|P2|Overall Study|Refused treatment|10
1046575|NCT00069108|3393403|P1|Overall Study|Refused treatment|5
1046576|NCT00069108|3393402|P2|Overall Study|Violation criteria|4
1046577|NCT00069108|3393403|P1|Overall Study|Violation criteria|1
1046578|NCT00069108|3393402|P2|Overall Study|Insufficient therapy|144
1046579|NCT00069108|3393403|P1|Overall Study|Insufficient therapy|117
1046580|NCT00069108|3393402|P2|Overall Study|Administration|4
1046581|NCT00069108|3393403|P1|Overall Study|Administration|15
1046582|NCT00069108|3393402|P2|Overall Study|Death|6
1046583|NCT00069108|3393403|P1|Overall Study|Death|6
1046584|NCT00069108|3393402|P2|Overall Study|Adverse Event|42
1046585|NCT00069108|3393403|P1|Overall Study|Adverse Event|64
1046586|NCT00069108|3393402|P2|Overall Study|Withdrawal by Subject|9
1046587|NCT00069108|3393403|P1|Overall Study|Withdrawal by Subject|5
1046588|NCT00069095|3393435|P6|Follow-up Phase|Death|101
1046589|NCT00069095|3393436|P5|Follow-up Phase|Death|92
1046590|NCT00069095|3393437|P4|Follow-up Phase|Death|112
1046591|NCT00069095|3393438|P3|Follow-up Phase|Death|120
1046592|NCT00069095|3393439|P2|Follow-up Phase|Death|206
1046593|NCT00069095|3393440|P1|Follow-up Phase|Death|174
1046594|NCT00069095|3393435|P6|Post-study Treatment Phase|Investigator decision|1
1046595|NCT00069095|3393436|P5|Post-study Treatment Phase|Investigator decision|0
1046596|NCT00069095|3393437|P4|Post-study Treatment Phase|Investigator decision|0
1046597|NCT00069095|3393438|P3|Post-study Treatment Phase|Investigator decision|0
1046598|NCT00069095|3393439|P2|Post-study Treatment Phase|Investigator decision|0
1046599|NCT00069095|3393440|P1|Post-study Treatment Phase|Investigator decision|0
1046600|NCT00069095|3393435|P6|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
1046601|NCT00069095|3393436|P5|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1
1046602|NCT00069095|3393437|P4|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
1046603|NCT00069095|3393438|P3|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
1046604|NCT00069095|3393439|P2|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
1046605|NCT00069095|3393440|P1|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
1046606|NCT00069095|3393435|P6|Post-study Treatment Phase|Participant/Physician decision to stop|0
1046607|NCT00069095|3393436|P5|Post-study Treatment Phase|Participant/Physician decision to stop|1
1046608|NCT00069095|3393437|P4|Post-study Treatment Phase|Participant/Physician decision to stop|0
1046609|NCT00069095|3393438|P3|Post-study Treatment Phase|Participant/Physician decision to stop|0
1046610|NCT00069095|3393439|P2|Post-study Treatment Phase|Participant/Physician decision to stop|0
1046611|NCT00069095|3393440|P1|Post-study Treatment Phase|Participant/Physician decision to stop|0
1046612|NCT00069095|3393435|P6|Post-study Treatment Phase|Participant had progressive disease|0
1046613|NCT00069095|3393436|P5|Post-study Treatment Phase|Participant had progressive disease|1
1046614|NCT00069095|3393437|P4|Post-study Treatment Phase|Participant had progressive disease|0
1046615|NCT00069095|3393438|P3|Post-study Treatment Phase|Participant had progressive disease|0
1046616|NCT00069095|3393439|P2|Post-study Treatment Phase|Participant had progressive disease|0
1046617|NCT00069095|3393440|P1|Post-study Treatment Phase|Participant had progressive disease|0
1046618|NCT00069095|3393435|P6|Post-study Treatment Phase|Death|0
1046619|NCT00069095|3393436|P5|Post-study Treatment Phase|Death|1
1046620|NCT00069095|3393437|P4|Post-study Treatment Phase|Death|0
1046621|NCT00069095|3393438|P3|Post-study Treatment Phase|Death|0
1046622|NCT00069095|3393439|P2|Post-study Treatment Phase|Death|0
1046623|NCT00069095|3393440|P1|Post-study Treatment Phase|Death|0
1046624|NCT00069095|3393435|P6|Post-study Treatment Phase|Surgery|0
1046625|NCT00069095|3393436|P5|Post-study Treatment Phase|Surgery|1
1046626|NCT00069095|3393437|P4|Post-study Treatment Phase|Surgery|1
1046627|NCT00069095|3393438|P3|Post-study Treatment Phase|Surgery|0
1046628|NCT00069095|3393439|P2|Post-study Treatment Phase|Surgery|0
1046629|NCT00069095|3393440|P1|Post-study Treatment Phase|Surgery|0
1046630|NCT00069095|3393435|P6|Post-study Treatment Phase|Participant completed treatment|0
1046631|NCT00069095|3393436|P5|Post-study Treatment Phase|Participant completed treatment|0
1046632|NCT00069095|3393437|P4|Post-study Treatment Phase|Participant completed treatment|1
1046633|NCT00069095|3393438|P3|Post-study Treatment Phase|Participant completed treatment|0
1046634|NCT00069095|3393439|P2|Post-study Treatment Phase|Participant completed treatment|0
1046635|NCT00069095|3393440|P1|Post-study Treatment Phase|Participant completed treatment|0
1046636|NCT00069095|3393435|P6|Post-study Treatment Phase|Participant wanted break from treatment|0
1046637|NCT00069095|3393436|P5|Post-study Treatment Phase|Participant wanted break from treatment|0
1046638|NCT00069095|3393437|P4|Post-study Treatment Phase|Participant wanted break from treatment|1
1046639|NCT00069095|3393438|P3|Post-study Treatment Phase|Participant wanted break from treatment|0
1046640|NCT00069095|3393439|P2|Post-study Treatment Phase|Participant wanted break from treatment|0
1046641|NCT00069095|3393440|P1|Post-study Treatment Phase|Participant wanted break from treatment|0
1046642|NCT00069095|3393435|P6|Post-study Treatment Phase|Participant will start new treatment|0
1046643|NCT00069095|3393436|P5|Post-study Treatment Phase|Participant will start new treatment|0
1046644|NCT00069095|3393437|P4|Post-study Treatment Phase|Participant will start new treatment|0
1046645|NCT00069095|3393438|P3|Post-study Treatment Phase|Participant will start new treatment|1
1046646|NCT00069095|3393439|P2|Post-study Treatment Phase|Participant will start new treatment|0
1046647|NCT00069095|3393440|P1|Post-study Treatment Phase|Participant will start new treatment|0
1046648|NCT00069095|3393435|P6|Post-study Treatment Phase|Participant withdrew consent|0
1046649|NCT00069095|3393436|P5|Post-study Treatment Phase|Participant withdrew consent|0
1046650|NCT00069095|3393437|P4|Post-study Treatment Phase|Participant withdrew consent|0
1046651|NCT00069095|3393438|P3|Post-study Treatment Phase|Participant withdrew consent|1
1046652|NCT00069095|3393439|P2|Post-study Treatment Phase|Participant withdrew consent|0
1046653|NCT00069095|3393440|P1|Post-study Treatment Phase|Participant withdrew consent|0
1046654|NCT00069095|3393435|P6|Post-study Treatment Phase|Investigator decision (enough treatment)|0
1046655|NCT00069095|3393436|P5|Post-study Treatment Phase|Investigator decision (enough treatment)|1
1046656|NCT00069095|3393437|P4|Post-study Treatment Phase|Investigator decision (enough treatment)|0
1046657|NCT00069095|3393438|P3|Post-study Treatment Phase|Investigator decision (enough treatment)|1
1046658|NCT00069095|3393439|P2|Post-study Treatment Phase|Investigator decision (enough treatment)|1
1046659|NCT00069095|3393440|P1|Post-study Treatment Phase|Investigator decision (enough treatment)|0
1046660|NCT00069095|3393435|P6|Post-study Treatment Phase|More than 21 days delay between cycles|0
1046661|NCT00069095|3393436|P5|Post-study Treatment Phase|More than 21 days delay between cycles|0
1046662|NCT00069095|3393437|P4|Post-study Treatment Phase|More than 21 days delay between cycles|0
1046663|NCT00069095|3393438|P3|Post-study Treatment Phase|More than 21 days delay between cycles|0
1046664|NCT00069095|3393439|P2|Post-study Treatment Phase|More than 21 days delay between cycles|1
1046665|NCT00069095|3393440|P1|Post-study Treatment Phase|More than 21 days delay between cycles|0
1046666|NCT00069095|3393435|P6|Post-study Treatment Phase|Participant had complete response|0
1046667|NCT00069095|3393436|P5|Post-study Treatment Phase|Participant had complete response|0
1046668|NCT00069095|3393437|P4|Post-study Treatment Phase|Participant had complete response|0
1046669|NCT00069095|3393438|P3|Post-study Treatment Phase|Participant had complete response|0
1046670|NCT00069095|3393439|P2|Post-study Treatment Phase|Participant had complete response|1
1046671|NCT00069095|3393440|P1|Post-study Treatment Phase|Participant had complete response|1
1046672|NCT00069095|3393435|P6|Post-study Treatment Phase|Participant refusal/Admin reasons|1
1046673|NCT00069095|3393436|P5|Post-study Treatment Phase|Participant refusal/Admin reasons|0
1046674|NCT00069095|3393437|P4|Post-study Treatment Phase|Participant refusal/Admin reasons|0
1046675|NCT00069095|3393438|P3|Post-study Treatment Phase|Participant refusal/Admin reasons|0
1046676|NCT00069095|3393439|P2|Post-study Treatment Phase|Participant refusal/Admin reasons|0
1046677|NCT00069095|3393440|P1|Post-study Treatment Phase|Participant refusal/Admin reasons|1
1046678|NCT00069095|3393435|P6|Post-study Treatment Phase|Insufficient therapeutic response|9
1046679|NCT00069095|3393436|P5|Post-study Treatment Phase|Insufficient therapeutic response|7
1046680|NCT00069095|3393437|P4|Post-study Treatment Phase|Insufficient therapeutic response|6
1046681|NCT00069095|3393438|P3|Post-study Treatment Phase|Insufficient therapeutic response|5
1046682|NCT00069095|3393439|P2|Post-study Treatment Phase|Insufficient therapeutic response|4
1046683|NCT00069095|3393440|P1|Post-study Treatment Phase|Insufficient therapeutic response|1
1046684|NCT00069095|3393435|P6|Post-study Treatment Phase|Eligible for surgery|0
1046685|NCT00069095|3393436|P5|Post-study Treatment Phase|Eligible for surgery|0
1046686|NCT00069095|3393437|P4|Post-study Treatment Phase|Eligible for surgery|0
1046687|NCT00069095|3393438|P3|Post-study Treatment Phase|Eligible for surgery|0
1046688|NCT00069095|3393439|P2|Post-study Treatment Phase|Eligible for surgery|0
1046689|NCT00069095|3393440|P1|Post-study Treatment Phase|Eligible for surgery|2
1046690|NCT00069095|3393435|P6|Post-study Treatment Phase|Adverse Event|1
1046691|NCT00069095|3393436|P5|Post-study Treatment Phase|Adverse Event|5
1046692|NCT00069095|3393437|P4|Post-study Treatment Phase|Adverse Event|0
1046693|NCT00069095|3393438|P3|Post-study Treatment Phase|Adverse Event|1
1046694|NCT00069095|3393439|P2|Post-study Treatment Phase|Adverse Event|3
1046695|NCT00069095|3393440|P1|Post-study Treatment Phase|Adverse Event|2
1046696|NCT00069095|3393435|P6|Post-study Treatment Phase|Missing reason|17
1046697|NCT00069095|3393436|P5|Post-study Treatment Phase|Missing reason|18
1046698|NCT00069095|3393437|P4|Post-study Treatment Phase|Missing reason|8
1046699|NCT00069095|3393438|P3|Post-study Treatment Phase|Missing reason|12
1046700|NCT00069095|3393439|P2|Post-study Treatment Phase|Missing reason|3
1046701|NCT00069095|3393440|P1|Post-study Treatment Phase|Missing reason|1
1046702|NCT00069095|3393435|P6|Primary Treatment Phase|Violation criteria|5
1046703|NCT00069095|3393436|P5|Primary Treatment Phase|Violation criteria|1
1046704|NCT00069095|3393437|P4|Primary Treatment Phase|Violation criteria|3
1046705|NCT00069095|3393438|P3|Primary Treatment Phase|Violation criteria|4
1046706|NCT00069095|3393439|P2|Primary Treatment Phase|Violation criteria|2
1046707|NCT00069095|3393440|P1|Primary Treatment Phase|Violation criteria|0
1046708|NCT00069095|3393435|P6|Primary Treatment Phase|Other Violation|1
1046709|NCT00069095|3393436|P5|Primary Treatment Phase|Other Violation|0
1046710|NCT00069095|3393437|P4|Primary Treatment Phase|Other Violation|1
1046711|NCT00069095|3393438|P3|Primary Treatment Phase|Other Violation|1
1046712|NCT00069095|3393439|P2|Primary Treatment Phase|Other Violation|1
1046713|NCT00069095|3393440|P1|Primary Treatment Phase|Other Violation|0
1046714|NCT00069095|3393435|P6|Primary Treatment Phase|Withdrew|9
1046715|NCT00069095|3393436|P5|Primary Treatment Phase|Withdrew|4
1046716|NCT00069095|3393437|P4|Primary Treatment Phase|Withdrew|2
1046717|NCT00069095|3393438|P3|Primary Treatment Phase|Withdrew|8
1046718|NCT00069095|3393439|P2|Primary Treatment Phase|Withdrew|3
1046719|NCT00069095|3393440|P1|Primary Treatment Phase|Withdrew|2
1046720|NCT00069095|3393435|P6|Primary Treatment Phase|Refused treatment|27
1046721|NCT00069095|3393436|P5|Primary Treatment Phase|Refused treatment|24
1046722|NCT00069095|3393437|P4|Primary Treatment Phase|Refused treatment|31
1046723|NCT00069095|3393438|P3|Primary Treatment Phase|Refused treatment|17
1046724|NCT00069095|3393439|P2|Primary Treatment Phase|Refused treatment|26
1046725|NCT00069095|3393440|P1|Primary Treatment Phase|Refused treatment|15
1046726|NCT00069095|3393435|P6|Primary Treatment Phase|Insufficient Therapeutic Response|102
1046727|NCT00069095|3393436|P5|Primary Treatment Phase|Insufficient Therapeutic Response|101
1046728|NCT00069095|3393437|P4|Primary Treatment Phase|Insufficient Therapeutic Response|154
1046729|NCT00069095|3393438|P3|Primary Treatment Phase|Insufficient Therapeutic Response|175
1046730|NCT00069095|3393439|P2|Primary Treatment Phase|Insufficient Therapeutic Response|127
1046731|NCT00069095|3393440|P1|Primary Treatment Phase|Insufficient Therapeutic Response|131
1046732|NCT00069095|3393435|P6|Primary Treatment Phase|Failure to return|2
1046733|NCT00069095|3393436|P5|Primary Treatment Phase|Failure to return|0
1046734|NCT00069095|3393437|P4|Primary Treatment Phase|Failure to return|0
1046735|NCT00069095|3393438|P3|Primary Treatment Phase|Failure to return|0
1046736|NCT00069095|3393439|P2|Primary Treatment Phase|Failure to return|5
1046737|NCT00069095|3393440|P1|Primary Treatment Phase|Failure to return|5
1046738|NCT00069095|3393435|P6|Primary Treatment Phase|Death|8
1046739|NCT00069095|3393436|P5|Primary Treatment Phase|Death|8
1046740|NCT00069095|3393437|P4|Primary Treatment Phase|Death|5
1046741|NCT00069095|3393438|P3|Primary Treatment Phase|Death|2
1046742|NCT00069095|3393439|P2|Primary Treatment Phase|Death|8
1046743|NCT00069095|3393440|P1|Primary Treatment Phase|Death|14
1046744|NCT00069095|3393435|P6|Primary Treatment Phase|Adverse Event|101
1046745|NCT00069095|3393436|P5|Primary Treatment Phase|Adverse Event|109
1046746|NCT00069095|3393437|P4|Primary Treatment Phase|Adverse Event|72
1046747|NCT00069095|3393438|P3|Primary Treatment Phase|Adverse Event|71
1046748|NCT00069095|3393439|P2|Primary Treatment Phase|Adverse Event|92
1046749|NCT00069095|3393440|P1|Primary Treatment Phase|Adverse Event|99
1046750|NCT00069095|3393435|P6|Primary Treatment Phase|Admin/Other|42
1046751|NCT00069095|3393436|P5|Primary Treatment Phase|Admin/Other|48
1046752|NCT00069095|3393437|P4|Primary Treatment Phase|Admin/Other|45
1046753|NCT00069095|3393438|P3|Primary Treatment Phase|Admin/Other|31
1046754|NCT00069095|3393439|P2|Primary Treatment Phase|Admin/Other|38
1046755|NCT00069095|3393440|P1|Primary Treatment Phase|Admin/Other|29
1046756|NCT00069095|3393435|P6|Primary Treatment Phase|Ongoing|4
1046757|NCT00069095|3393436|P5|Primary Treatment Phase|Ongoing|7
1046758|NCT00069095|3393437|P4|Primary Treatment Phase|Ongoing|7
1046759|NCT00069095|3393438|P3|Primary Treatment Phase|Ongoing|5
1046760|NCT00069095|3393439|P2|Primary Treatment Phase|Ongoing|0
1046761|NCT00069095|3393440|P1|Primary Treatment Phase|Ongoing|0
1046762|NCT00068822|3393510|P2|First Randomized Intervention|Lost to Follow-up|2
1046763|NCT00068822|3393511|P1|First Randomized Intervention|Lost to Follow-up|1
1046764|NCT00068601|3393544|P2|Overall Study|Missing primary outcome data|34
1046765|NCT00068601|3393545|P1|Overall Study|Missing primary outcome data|30
1046766|NCT00068601|3393544|P2|Overall Study|Lost to Follow-up|2
1046767|NCT00068601|3393545|P1|Overall Study|Lost to Follow-up|3
1046768|NCT00068601|3393544|P2|Overall Study|Death|3
1046769|NCT00068601|3393545|P1|Overall Study|Death|11
1046770|NCT00068601|3393544|P2|Overall Study|Not evaluable: hysterectomy/oophorectomy|4
1046771|NCT00068601|3393545|P1|Overall Study|Not evaluable: hysterectomy/oophorectomy|2
1046772|NCT00068601|3393544|P2|Overall Study|Not evaluable: withdrew consent|4
1046773|NCT00068601|3393545|P1|Overall Study|Not evaluable: withdrew consent|5
1046774|NCT00068601|3393544|P2|Overall Study|Ineligible|13
1046775|NCT00068601|3393545|P1|Overall Study|Ineligible|11
1046776|NCT00068588|3393558|P3|Overall Study|Poor KPS|1
1046777|NCT00068588|3393559|P2|Overall Study|Poor KPS|0
1046778|NCT00068588|3393560|P1|Overall Study|Poor KPS|0
1046779|NCT00068588|3393558|P3|Overall Study|Withdrawal by Subject|1
1046780|NCT00068588|3393559|P2|Overall Study|Withdrawal by Subject|0
1046781|NCT00068588|3393560|P1|Overall Study|Withdrawal by Subject|0
1046782|NCT00068588|3393558|P3|Overall Study|Adverse Event|2
1046783|NCT00068588|3393559|P2|Overall Study|Adverse Event|0
1046784|NCT00068588|3393560|P1|Overall Study|Adverse Event|0
1046785|NCT00068445|3393576|P2|Treatment|Other (Specifics not available)|5
1046786|NCT00068445|3393577|P1|Treatment|Other (Specifics not available)|9
1046787|NCT00068445|3393576|P2|Treatment|Adverse Event|1
1046788|NCT00068445|3393577|P1|Treatment|Adverse Event|7
1046789|NCT00068445|3393576|P2|Treatment|Refused Further Treatment|10
1046790|NCT00068445|3393577|P1|Treatment|Refused Further Treatment|13
1046791|NCT00068445|3393576|P2|Randomization|Ineligible|1
1046792|NCT00068445|3393577|P1|Randomization|Ineligible|1
1046793|NCT00068445|3393576|P2|Randomization|Cancel|3
1046794|NCT00068445|3393577|P1|Randomization|Cancel|1
1046795|NCT00068419|3393601|P1|Overall Study|Ineligible|11
1046796|NCT00068419|3393601|P1|Overall Study|Withdrawal by Subject|14
1046797|NCT00068419|3393601|P1|Overall Study|Physician Decision|7
1046798|NCT00068419|3393601|P1|Overall Study|Lost to Follow-up|1
1046799|NCT00068419|3393601|P1|Overall Study|Lack of Efficacy|24
1046800|NCT00068419|3393601|P1|Overall Study|Adverse Event|3
1046801|NCT00068406|3393605|P1|Overall Study|Ineligible-Inadequate Pathology|2
1046802|NCT00068406|3393605|P1|Overall Study|Ineligible-improper pre-protocol treatm|1
1046803|NCT00068393|3393610|P1|Overall Study|Quality of life worsening|1
1046804|NCT00068393|3393610|P1|Overall Study|Alternative treatment|1
1046805|NCT00068393|3393610|P1|Overall Study|Withdrawal by Subject|3
1046806|NCT00068393|3393610|P1|Overall Study|Death|3
1046807|NCT00068393|3393610|P1|Overall Study|Adverse Event|2
1046808|NCT00068380|3393616|P1|Overall Study|Adverse Event|2
1046809|NCT00068380|3393616|P1|Overall Study|Withdrawal by Subject|3
1046810|NCT00068250|3393660|P4|Phase I: Dose Level 2|Protocol Violation|0
1046811|NCT00068250|3393661|P3|Phase I: Dose Level 2|Protocol Violation|0
1046812|NCT00068250|3393662|P2|Phase I: Dose Level 2|Protocol Violation|1
1046813|NCT00068250|3393663|P1|Phase I: Dose Level 2|Protocol Violation|0
1046814|NCT00068237|3393673|P1|Overall Study|No protocol treatment received|2
1046815|NCT00068237|3393673|P1|Overall Study|Ineligible|3
1046816|NCT00068107|3393677|P1|Overall Study|Withdrawal by Subject|1
1046817|NCT00068107|3393677|P1|Overall Study|Death|2
1046818|NCT00068107|3393677|P1|Overall Study|end-stage renal disease|6
1046819|NCT00067990|3393690|P2|Overall Study|Withdrawal by Subject|12
1046820|NCT00067990|3393691|P1|Overall Study|Withdrawal by Subject|4
1046821|NCT00067990|3393690|P2|Overall Study|ESRD, Non IF/TA|3
1046822|NCT00067990|3393691|P1|Overall Study|ESRD, Non IF/TA|1
1046823|NCT00067990|3393690|P2|Overall Study|Death|7
1046824|NCT00067990|3393691|P1|Overall Study|Death|5
1046825|NCT00067470|3393714|P2|Overall Study|Withdrawal by Subject|1
1046826|NCT00067470|3393715|P1|Overall Study|Withdrawal by Subject|0
1046827|NCT00066807|3393778|P2|Overall Study|Study was terminated early|15
1046828|NCT00066807|3393779|P1|Overall Study|Study was terminated early|14
1046829|NCT00066742|3393804|P1|Consolidation Chemotherapy|Ineligible|2
1046830|NCT00066742|3393804|P1|Consolidation Chemotherapy|not protocol specified|1
1046831|NCT00066742|3393804|P1|Induction Chemoradiotherapy|Ineligible|3
1046832|NCT00066742|3393804|P1|Induction Chemoradiotherapy|not protocol specified|2
1046833|NCT00066742|3393804|P1|Induction Chemoradiotherapy|Withdrawal by Subject|2
1046834|NCT00066742|3393804|P1|Induction Chemoradiotherapy|Adverse Event|21
1046835|NCT00066742|3393804|P1|Induction Chemoradiotherapy|Did not receive any protocol treatment|1
1046836|NCT00066703|3393813|P2|Overall Study|Treatment ongoing|311
1046837|NCT00066703|3393814|P1|Overall Study|Treatment ongoing|346
1046838|NCT00066703|3393813|P2|Overall Study|Withdrawal by Subject|63
1046839|NCT00066703|3393814|P1|Overall Study|Withdrawal by Subject|38
1046840|NCT00066703|3393813|P2|Overall Study|Lost to Follow-up|28
1046841|NCT00066703|3393814|P1|Overall Study|Lost to Follow-up|31
1046842|NCT00066703|3393813|P2|Overall Study|Lack of Efficacy|69
1046843|NCT00066703|3393814|P1|Overall Study|Lack of Efficacy|114
1046844|NCT00066703|3393813|P2|Overall Study|Death|0
1046845|NCT00066703|3393814|P1|Overall Study|Death|3
1046846|NCT00066703|3393813|P2|Overall Study|Adverse Event|111
1046847|NCT00066703|3393814|P1|Overall Study|Adverse Event|80
1046848|NCT00066690|3393827|P3|Overall Study|Treatment Ongoing|282
1046849|NCT00066690|3393828|P2|Overall Study|Treatment Ongoing|278
1046850|NCT00066690|3393829|P1|Overall Study|Treatment Ongoing|246
1046851|NCT00066690|3393827|P3|Overall Study|Withdrawal by Subject|49
1046852|NCT00066690|3393828|P2|Overall Study|Withdrawal by Subject|55
1046853|NCT00066690|3393829|P1|Overall Study|Withdrawal by Subject|50
1046854|NCT00066690|3393827|P3|Overall Study|Lost to Follow-up|29
1046855|NCT00066690|3393828|P2|Overall Study|Lost to Follow-up|21
1046856|NCT00066690|3393829|P1|Overall Study|Lost to Follow-up|40
1046857|NCT00066690|3393827|P3|Overall Study|Lack of Efficacy|76
1046858|NCT00066690|3393828|P2|Overall Study|Lack of Efficacy|110
1046859|NCT00066690|3393829|P1|Overall Study|Lack of Efficacy|114
1046860|NCT00066690|3393827|P3|Overall Study|Death|2
1046861|NCT00066690|3393828|P2|Overall Study|Death|0
1046862|NCT00066690|3393829|P1|Overall Study|Death|3
1046863|NCT00066690|3393827|P3|Overall Study|Adverse Event|126
1046864|NCT00066690|3393828|P2|Overall Study|Adverse Event|58
1046865|NCT00066690|3393829|P1|Overall Study|Adverse Event|145
1046866|NCT00066573|3393845|P2|Overall Study|Did not received protocol treatment|28
1046867|NCT00066573|3393846|P1|Overall Study|Did not received protocol treatment|28
1046868|NCT00066469|3393858|P1|Overall Study|ineligible|1
1046869|NCT00066469|3393858|P1|Overall Study|Withdrawal by Subject|1
1046870|NCT00066469|3393858|P1|Overall Study|Physician Decision|1
1046871|NCT00066469|3393858|P1|Overall Study|Lost to Follow-up|1
1046872|NCT00066469|3393858|P1|Overall Study|Lack of Efficacy|9
1046873|NCT00066469|3393858|P1|Overall Study|Death|3
1046874|NCT00066365|3393864|P2|Overall Study|Ineligible|2
1046875|NCT00066365|3393865|P1|Overall Study|Ineligible|4
1046876|NCT00066365|3393864|P2|Overall Study|No viable tumor after 1 cycle of therapy|0
1046877|NCT00066365|3393865|P1|Overall Study|No viable tumor after 1 cycle of therapy|2
1046878|NCT00066365|3393864|P2|Overall Study|Physician Decision|0
1046879|NCT00066365|3393865|P1|Overall Study|Physician Decision|1
1046880|NCT00066365|3393864|P2|Overall Study|Lack of Efficacy|12
1046881|NCT00066365|3393865|P1|Overall Study|Lack of Efficacy|15
1046882|NCT00066365|3393864|P2|Overall Study|Adverse Event|0
1046883|NCT00066365|3393865|P1|Overall Study|Adverse Event|1
1046884|NCT00066222|3393893|P1|Overall Study|No protocol treatment received|1
1046885|NCT00066170|3393906|P4|Overall Study|Other|0
1046886|NCT00066170|3393907|P3|Overall Study|Other|2
1046887|NCT00066170|3393908|P2|Overall Study|Other|5
1046888|NCT00066170|3393909|P1|Overall Study|Other|1
1046889|NCT00066170|3393906|P4|Overall Study|Protocol Violation|0
1046890|NCT00066170|3393907|P3|Overall Study|Protocol Violation|0
1046891|NCT00066170|3393908|P2|Overall Study|Protocol Violation|0
1046892|NCT00066170|3393909|P1|Overall Study|Protocol Violation|3
1046893|NCT00066170|3393906|P4|Overall Study|Non-Compliance with Trial Medicine|1
1046894|NCT00066170|3393907|P3|Overall Study|Non-Compliance with Trial Medicine|0
1046895|NCT00066170|3393908|P2|Overall Study|Non-Compliance with Trial Medicine|0
1046896|NCT00066170|3393909|P1|Overall Study|Non-Compliance with Trial Medicine|1
1046897|NCT00066170|3393906|P4|Overall Study|Lost to Follow-up|0
1046898|NCT00066170|3393907|P3|Overall Study|Lost to Follow-up|0
1046899|NCT00066170|3393908|P2|Overall Study|Lost to Follow-up|1
1046900|NCT00066170|3393909|P1|Overall Study|Lost to Follow-up|0
1046901|NCT00066170|3393906|P4|Overall Study|Serious Adverse Event|1
1046902|NCT00066170|3393907|P3|Overall Study|Serious Adverse Event|1
1046903|NCT00066170|3393908|P2|Overall Study|Serious Adverse Event|0
1046904|NCT00066170|3393909|P1|Overall Study|Serious Adverse Event|0
1046905|NCT00066170|3393906|P4|Overall Study|Adverse Event|7
1046906|NCT00066170|3393907|P3|Overall Study|Adverse Event|1
1046907|NCT00066170|3393908|P2|Overall Study|Adverse Event|4
1046908|NCT00066170|3393909|P1|Overall Study|Adverse Event|2
1046909|NCT00066066|3393922|P6|Overall Study|Lost to Follow-up|5
1046910|NCT00066066|3393923|P5|Overall Study|Lost to Follow-up|3
1046911|NCT00066066|3393924|P4|Overall Study|Lost to Follow-up|4
1046912|NCT00066066|3393925|P3|Overall Study|Lost to Follow-up|7
1046913|NCT00066066|3393926|P2|Overall Study|Lost to Follow-up|4
1046914|NCT00066066|3393927|P1|Overall Study|Lost to Follow-up|6
1046915|NCT00065507|3394005|P2|Overall Study|Subject No Longer Meets Study Criteria|0
1046916|NCT00065507|3394006|P1|Overall Study|Subject No Longer Meets Study Criteria|1
1046917|NCT00065507|3394005|P2|Overall Study|Subject Withdrew Consent|1
1046918|NCT00065507|3394006|P1|Overall Study|Subject Withdrew Consent|2
1046919|NCT00065507|3394005|P2|Overall Study|Lost to Follow-up|0
1046920|NCT00065507|3394006|P1|Overall Study|Lost to Follow-up|3
1046921|NCT00065507|3394005|P2|Overall Study|Poor/Non-compliance|2
1046922|NCT00065507|3394006|P1|Overall Study|Poor/Non-compliance|3
1046923|NCT00065507|3394005|P2|Overall Study|Lack of Efficacy|6
1046924|NCT00065507|3394006|P1|Overall Study|Lack of Efficacy|0
1046925|NCT00065507|3394005|P2|Overall Study|Adverse Event|3
1046926|NCT00065507|3394006|P1|Overall Study|Adverse Event|4
1046927|NCT00065507|3394005|P2|Overall Study|Death|17
1046928|NCT00065507|3394006|P1|Overall Study|Death|16
1046929|NCT00065468|3394071|P3|Overall Study|Other|18
1046930|NCT00065468|3394072|P2|Overall Study|Other|24
1046931|NCT00065468|3394073|P1|Overall Study|Other|14
1046932|NCT00065468|3394071|P3|Overall Study|Disease progression|1
1046933|NCT00065468|3394072|P2|Overall Study|Disease progression|0
1046934|NCT00065468|3394073|P1|Overall Study|Disease progression|0
1046935|NCT00065468|3394071|P3|Overall Study|Discontinuation of study by Sponsor|13
1046936|NCT00065468|3394072|P2|Overall Study|Discontinuation of study by Sponsor|9
1046937|NCT00065468|3394073|P1|Overall Study|Discontinuation of study by Sponsor|13
1046938|NCT00065468|3394071|P3|Overall Study|Lost to Follow-up|2
1046939|NCT00065468|3394072|P2|Overall Study|Lost to Follow-up|3
1046940|NCT00065468|3394073|P1|Overall Study|Lost to Follow-up|5
1046941|NCT00065468|3394071|P3|Overall Study|Withdrawal by Subject|5
1046942|NCT00065468|3394072|P2|Overall Study|Withdrawal by Subject|4
1046943|NCT00065468|3394073|P1|Overall Study|Withdrawal by Subject|3
1046944|NCT00065468|3394071|P3|Overall Study|Death|171
1046945|NCT00065468|3394072|P2|Overall Study|Death|169
1046946|NCT00065468|3394073|P1|Overall Study|Death|172
1046947|NCT00065442|3394104|P2|Overall Study|Withdrawal by Subject|9
1046948|NCT00065442|3394105|P1|Overall Study|Withdrawal by Subject|3
1046949|NCT00065442|3394104|P2|Overall Study|Death|210
1046950|NCT00065442|3394105|P1|Overall Study|Death|121
1046951|NCT00065442|3394104|P2|Overall Study|Lost to Follow-up|1
1046952|NCT00065442|3394105|P1|Overall Study|Lost to Follow-up|1
1046953|NCT00065429|3394120|P7|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
1046954|NCT00065429|3394121|P6|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
1046955|NCT00065429|3394122|P5|Phase II - Apr 2003 - Aug 2008|Adverse Event|2
1046956|NCT00065429|3394123|P4|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
1046957|NCT00065429|3394124|P3|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
1046958|NCT00065429|3394125|P2|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
1046959|NCT00065429|3394126|P1|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
1046960|NCT00065429|3394120|P7|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
1046961|NCT00065429|3394121|P6|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
1046962|NCT00065429|3394122|P5|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4
1046963|NCT00065429|3394123|P4|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
1046964|NCT00065429|3394124|P3|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
1046965|NCT00065429|3394125|P2|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
1046966|NCT00065429|3394126|P1|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
1046967|NCT00065429|3394120|P7|Phase I - May 2001 - Oct 2002|Adverse Event|2
1046968|NCT00065429|3394121|P6|Phase I - May 2001 - Oct 2002|Adverse Event|1
1046969|NCT00065429|3394122|P5|Phase I - May 2001 - Oct 2002|Adverse Event|0
1046970|NCT00065429|3394123|P4|Phase I - May 2001 - Oct 2002|Adverse Event|1
1046971|NCT00065429|3394124|P3|Phase I - May 2001 - Oct 2002|Adverse Event|0
1046972|NCT00065429|3394125|P2|Phase I - May 2001 - Oct 2002|Adverse Event|0
1046973|NCT00065429|3394126|P1|Phase I - May 2001 - Oct 2002|Adverse Event|0
1046974|NCT00065429|3394120|P7|Phase I - May 2001 - Oct 2002|Death|0
1046975|NCT00065429|3394121|P6|Phase I - May 2001 - Oct 2002|Death|0
1046976|NCT00065429|3394122|P5|Phase I - May 2001 - Oct 2002|Death|1
1046977|NCT00065429|3394123|P4|Phase I - May 2001 - Oct 2002|Death|0
1046978|NCT00065429|3394124|P3|Phase I - May 2001 - Oct 2002|Death|0
1046979|NCT00065429|3394125|P2|Phase I - May 2001 - Oct 2002|Death|0
1046980|NCT00065429|3394126|P1|Phase I - May 2001 - Oct 2002|Death|0
1046981|NCT00065429|3394120|P7|Phase I - May 2001 - Oct 2002|Physician Decision|0
1046982|NCT00065429|3394121|P6|Phase I - May 2001 - Oct 2002|Physician Decision|0
1046983|NCT00065429|3394122|P5|Phase I - May 2001 - Oct 2002|Physician Decision|0
1046984|NCT00065429|3394123|P4|Phase I - May 2001 - Oct 2002|Physician Decision|0
1046985|NCT00065429|3394124|P3|Phase I - May 2001 - Oct 2002|Physician Decision|0
1046986|NCT00065429|3394125|P2|Phase I - May 2001 - Oct 2002|Physician Decision|0
1046987|NCT00065429|3394126|P1|Phase I - May 2001 - Oct 2002|Physician Decision|1
1046988|NCT00065429|3394120|P7|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
1046989|NCT00065429|3394121|P6|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
1046990|NCT00065429|3394122|P5|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
1046991|NCT00065429|3394123|P4|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
1046992|NCT00065429|3394124|P3|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1
1046993|NCT00065429|3394125|P2|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
1046994|NCT00065429|3394126|P1|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
1046995|NCT00065429|3394120|P7|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
1046996|NCT00065429|3394121|P6|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1
1046997|NCT00065429|3394122|P5|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
1046998|NCT00065429|3394123|P4|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
1046999|NCT00065429|3394124|P3|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
1047000|NCT00065429|3394125|P2|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
1047001|NCT00065429|3394126|P1|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
1047002|NCT00065260|3394140|P2|Overall Study|Death|1
1047003|NCT00065260|3394141|P1|Overall Study|Death|0
1047004|NCT00065156|3394147|P1|Overall Study|Secondary Malign Disease|1
1047005|NCT00065156|3394147|P1|Overall Study|Loss of Response|1
1047006|NCT00065156|3394147|P1|Overall Study|Non-Compliance|2
1047007|NCT00065156|3394147|P1|Overall Study|Investigator Decision|2
1047008|NCT00065156|3394147|P1|Overall Study|Disease Progression|7
1047009|NCT00065156|3394147|P1|Overall Study|Study Closed by Sponsor|2
1047010|NCT00065156|3394147|P1|Overall Study|Death|11
1047011|NCT00065156|3394147|P1|Overall Study|Lost to Follow-up|1
1047012|NCT00065156|3394147|P1|Overall Study|Withdrawal by Subject|8
1047013|NCT00065156|3394147|P1|Overall Study|Lack of Efficacy|52
1047014|NCT00065156|3394147|P1|Overall Study|Adverse Event|37
1047015|NCT00065065|3394164|P2|Overall Study|Other|2
1047016|NCT00065065|3394165|P1|Overall Study|Other|2
1047017|NCT00065065|3394164|P2|Overall Study|Lack of Efficacy|11
1047018|NCT00065065|3394165|P1|Overall Study|Lack of Efficacy|4
1047019|NCT00065065|3394164|P2|Overall Study|Withdrawal by Subject|5
1047020|NCT00065065|3394165|P1|Overall Study|Withdrawal by Subject|1
1047021|NCT00065065|3394164|P2|Overall Study|Adverse Event|2
1047022|NCT00065065|3394165|P1|Overall Study|Adverse Event|3
1047023|NCT00003895|3394177|P2|Overall Study|Withdrawal by Subject|3
1047024|NCT00003895|3394178|P1|Overall Study|Withdrawal by Subject|0
1047025|NCT00003895|3394177|P2|Overall Study|Patient Vacation|0
1047026|NCT00003895|3394178|P1|Overall Study|Patient Vacation|2
1047027|NCT00003895|3394177|P2|Overall Study|Lack of Efficacy|1
1047028|NCT00003895|3394178|P1|Overall Study|Lack of Efficacy|1
1047029|NCT00003895|3394177|P2|Overall Study|Adverse Event|0
1047030|NCT00003895|3394178|P1|Overall Study|Adverse Event|4
1047031|NCT00064987|3394186|P2|Overall Study|Physician Decision|0
1047032|NCT00064987|3394187|P1|Overall Study|Physician Decision|3
1047033|NCT00064753|3394218|P2|Overall Study|Lost to Follow-up|235
1047034|NCT00064753|3394219|P1|Overall Study|Lost to Follow-up|225
1047035|NCT00064753|3394218|P2|Overall Study|Withdrawal by Subject|171
1047036|NCT00064753|3394219|P1|Overall Study|Withdrawal by Subject|198
1047037|NCT00064753|3394218|P2|Overall Study|Death|242
1047038|NCT00064753|3394219|P1|Overall Study|Death|251
1047039|NCT00064792|3394249|P2|Overall Study|Adverse Event|0
1047040|NCT00064792|3394250|P1|Overall Study|Adverse Event|3
1047041|NCT00064792|3394249|P2|Overall Study|Withdrawal by Subject|0
1047042|NCT00064792|3394250|P1|Overall Study|Withdrawal by Subject|2
1047043|NCT00064701|3394261|P3|Clinical Continuation Phase|Patient opted out|1
1047044|NCT00064701|3394262|P2|Clinical Continuation Phase|Patient opted out|0
1047045|NCT00064701|3394263|P1|Clinical Continuation Phase|Patient opted out|0
1047046|NCT00064701|3394261|P3|Clinical Continuation Phase|Incorrect study drug dispensed|0
1047047|NCT00064701|3394262|P2|Clinical Continuation Phase|Incorrect study drug dispensed|1
1047048|NCT00064701|3394263|P1|Clinical Continuation Phase|Incorrect study drug dispensed|0
1047049|NCT00064701|3394261|P3|Clinical Continuation Phase|Discharged to nursing home|0
1047050|NCT00064701|3394262|P2|Clinical Continuation Phase|Discharged to nursing home|1
1047051|NCT00064701|3394263|P1|Clinical Continuation Phase|Discharged to nursing home|0
1047052|NCT00064701|3394261|P3|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
1047053|NCT00064701|3394262|P2|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1
1047054|NCT00064701|3394263|P1|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
1047055|NCT00064701|3394261|P3|Clinical Continuation Phase|Pancreas transplant|0
1047056|NCT00064701|3394262|P2|Clinical Continuation Phase|Pancreas transplant|0
1047057|NCT00064701|3394263|P1|Clinical Continuation Phase|Pancreas transplant|1
1047058|NCT00064701|3394261|P3|Clinical Continuation Phase|Unable to return to site for study visit|1
1047059|NCT00064701|3394262|P2|Clinical Continuation Phase|Unable to return to site for study visit|0
1047060|NCT00064701|3394263|P1|Clinical Continuation Phase|Unable to return to site for study visit|1
1047061|NCT00064701|3394261|P3|Clinical Continuation Phase|Physician Decision|0
1047062|NCT00064701|3394262|P2|Clinical Continuation Phase|Physician Decision|3
1047063|NCT00064701|3394263|P1|Clinical Continuation Phase|Physician Decision|1
1047064|NCT00064701|3394261|P3|Clinical Continuation Phase|Immunosuppressive treatment crossover|6
1047065|NCT00064701|3394262|P2|Clinical Continuation Phase|Immunosuppressive treatment crossover|3
1047066|NCT00064701|3394263|P1|Clinical Continuation Phase|Immunosuppressive treatment crossover|0
1047067|NCT00064701|3394261|P3|Clinical Continuation Phase|Sponsor discontinued study|79
1047068|NCT00064701|3394262|P2|Clinical Continuation Phase|Sponsor discontinued study|129
1047069|NCT00064701|3394263|P1|Clinical Continuation Phase|Sponsor discontinued study|113
1047070|NCT00064701|3394261|P3|Clinical Continuation Phase|Rejection|2
1047071|NCT00064701|3394262|P2|Clinical Continuation Phase|Rejection|2
1047072|NCT00064701|3394263|P1|Clinical Continuation Phase|Rejection|1
1047073|NCT00064701|3394261|P3|Clinical Continuation Phase|Graft Failure|2
1047074|NCT00064701|3394262|P2|Clinical Continuation Phase|Graft Failure|5
1047075|NCT00064701|3394263|P1|Clinical Continuation Phase|Graft Failure|5
1047076|NCT00064701|3394261|P3|Clinical Continuation Phase|Lost to Follow-up|6
1047077|NCT00064701|3394262|P2|Clinical Continuation Phase|Lost to Follow-up|3
1047078|NCT00064701|3394263|P1|Clinical Continuation Phase|Lost to Follow-up|6
1047079|NCT00064701|3394261|P3|Clinical Continuation Phase|Withdrawal by Subject|22
1047080|NCT00064701|3394262|P2|Clinical Continuation Phase|Withdrawal by Subject|3
1047081|NCT00064701|3394263|P1|Clinical Continuation Phase|Withdrawal by Subject|22
1047082|NCT00064701|3394261|P3|Clinical Continuation Phase|Non-compliance|7
1047083|NCT00064701|3394262|P2|Clinical Continuation Phase|Non-compliance|6
1047084|NCT00064701|3394263|P1|Clinical Continuation Phase|Non-compliance|8
1047085|NCT00064701|3394261|P3|Clinical Continuation Phase|Adverse Event|14
1047086|NCT00064701|3394262|P2|Clinical Continuation Phase|Adverse Event|21
1047087|NCT00064701|3394263|P1|Clinical Continuation Phase|Adverse Event|12
1047088|NCT00064701|3394261|P3|One Year Post-transplant|Pancreas transplant|1
1047089|NCT00064701|3394262|P2|One Year Post-transplant|Pancreas transplant|0
1047090|NCT00064701|3394263|P1|One Year Post-transplant|Pancreas transplant|0
1047091|NCT00064701|3394261|P3|One Year Post-transplant|Poor absorption|0
1047092|NCT00064701|3394262|P2|One Year Post-transplant|Poor absorption|1
1047093|NCT00064701|3394263|P1|One Year Post-transplant|Poor absorption|0
1047094|NCT00064701|3394261|P3|One Year Post-transplant|Crossover secondary to possible toxicity|0
1047095|NCT00064701|3394262|P2|One Year Post-transplant|Crossover secondary to possible toxicity|1
1047096|NCT00064701|3394263|P1|One Year Post-transplant|Crossover secondary to possible toxicity|0
1047097|NCT00064701|3394261|P3|One Year Post-transplant|Incorrect study drug dispensed|0
1047098|NCT00064701|3394262|P2|One Year Post-transplant|Incorrect study drug dispensed|1
1047099|NCT00064701|3394263|P1|One Year Post-transplant|Incorrect study drug dispensed|0
1047100|NCT00064701|3394261|P3|One Year Post-transplant|Acute tubular necrosis|0
1047101|NCT00064701|3394262|P2|One Year Post-transplant|Acute tubular necrosis|0
1047102|NCT00064701|3394263|P1|One Year Post-transplant|Acute tubular necrosis|1
1047103|NCT00064701|3394261|P3|One Year Post-transplant|Converted to rapamycin|0
1047104|NCT00064701|3394262|P2|One Year Post-transplant|Converted to rapamycin|0
1047105|NCT00064701|3394263|P1|One Year Post-transplant|Converted to rapamycin|1
1047106|NCT00064701|3394261|P3|One Year Post-transplant|Lost to Follow-up|0
1047107|NCT00064701|3394262|P2|One Year Post-transplant|Lost to Follow-up|0
1047108|NCT00064701|3394263|P1|One Year Post-transplant|Lost to Follow-up|1
1047109|NCT00064701|3394261|P3|One Year Post-transplant|Withdrawal by Subject|1
1047110|NCT00064701|3394262|P2|One Year Post-transplant|Withdrawal by Subject|4
1047111|NCT00064701|3394263|P1|One Year Post-transplant|Withdrawal by Subject|0
1047112|NCT00064701|3394261|P3|One Year Post-transplant|Graft Failure|1
1047113|NCT00064701|3394262|P2|One Year Post-transplant|Graft Failure|2
1047114|NCT00064701|3394263|P1|One Year Post-transplant|Graft Failure|3
1047115|NCT00064701|3394261|P3|One Year Post-transplant|Non-compliance|5
1047116|NCT00064701|3394262|P2|One Year Post-transplant|Non-compliance|2
1047117|NCT00064701|3394263|P1|One Year Post-transplant|Non-compliance|4
1047118|NCT00064701|3394261|P3|One Year Post-transplant|Rejection|16
1047119|NCT00064701|3394262|P2|One Year Post-transplant|Rejection|1
1047120|NCT00064701|3394263|P1|One Year Post-transplant|Rejection|0
1047121|NCT00064701|3394261|P3|One Year Post-transplant|Adverse Event|37
1047122|NCT00064701|3394262|P2|One Year Post-transplant|Adverse Event|19
1047123|NCT00064701|3394263|P1|One Year Post-transplant|Adverse Event|23
1047124|NCT00064701|3394261|P3|One Year Post-transplant|Did not receive study drug|11
1047125|NCT00064701|3394262|P2|One Year Post-transplant|Did not receive study drug|12
1047126|NCT00064701|3394263|P1|One Year Post-transplant|Did not receive study drug|7
1047127|NCT00064662|3394315|P2|Overall Study|Administratively withdrawn|2
1047128|NCT00064662|3394316|P1|Overall Study|Administratively withdrawn|2
1047129|NCT00064662|3394315|P2|Overall Study|Withdrawal by Subject|14
1047130|NCT00064662|3394316|P1|Overall Study|Withdrawal by Subject|14
1047131|NCT00064662|3394315|P2|Overall Study|Lost to Follow-up|44
1047132|NCT00064662|3394316|P1|Overall Study|Lost to Follow-up|57
1047133|NCT00064662|3394315|P2|Overall Study|Death|1
1047134|NCT00064662|3394316|P1|Overall Study|Death|1
1047135|NCT00064350|3394327|P3|Cross-Over|Other|0
1047136|NCT00064350|3394328|P2|Cross-Over|Other|2
1047137|NCT00064350|3394329|P1|Cross-Over|Other|0
1047138|NCT00064350|3394327|P3|Cross-Over|Ineligible or never started treatment|0
1047139|NCT00064350|3394328|P2|Cross-Over|Ineligible or never started treatment|6
1047140|NCT00064350|3394329|P1|Cross-Over|Ineligible or never started treatment|3
1047141|NCT00064350|3394327|P3|Cross-Over|Withdrawal by Subject|0
1047142|NCT00064350|3394328|P2|Cross-Over|Withdrawal by Subject|2
1047143|NCT00064350|3394329|P1|Cross-Over|Withdrawal by Subject|2
1047144|NCT00064350|3394327|P3|Cross-Over|Death|0
1047145|NCT00064350|3394328|P2|Cross-Over|Death|3
1047146|NCT00064350|3394329|P1|Cross-Over|Death|1
1047147|NCT00064350|3394327|P3|Cross-Over|Adverse Event|0
1047148|NCT00064350|3394328|P2|Cross-Over|Adverse Event|1
1047149|NCT00064350|3394329|P1|Cross-Over|Adverse Event|0
1047150|NCT00064350|3394327|P3|Randomization|Other|0
1047151|NCT00064350|3394328|P2|Randomization|Other|0
1047152|NCT00064350|3394329|P1|Randomization|Other|5
1047153|NCT00064350|3394327|P3|Randomization|Ineligible or never started treatment|0
1047154|NCT00064350|3394328|P2|Randomization|Ineligible or never started treatment|15
1047155|NCT00064350|3394329|P1|Randomization|Ineligible or never started treatment|9
1047156|NCT00064350|3394327|P3|Randomization|Withdrawal by Subject|0
1047157|NCT00064350|3394328|P2|Randomization|Withdrawal by Subject|0
1047158|NCT00064350|3394329|P1|Randomization|Withdrawal by Subject|1
1047159|NCT00064350|3394327|P3|Randomization|Death|0
1047160|NCT00064350|3394328|P2|Randomization|Death|0
1047161|NCT00064350|3394329|P1|Randomization|Death|3
1047162|NCT00064350|3394327|P3|Randomization|Adverse Event|0
1047163|NCT00064350|3394328|P2|Randomization|Adverse Event|3
1047164|NCT00064350|3394329|P1|Randomization|Adverse Event|8
1047165|NCT00064350|3394327|P3|Induction Treatment|Other|13
1047166|NCT00064350|3394328|P2|Induction Treatment|Other|0
1047167|NCT00064350|3394329|P1|Induction Treatment|Other|0
1047168|NCT00064350|3394327|P3|Induction Treatment|Ineligible or never started treatment|34
1047169|NCT00064350|3394328|P2|Induction Treatment|Ineligible or never started treatment|6
1047170|NCT00064350|3394329|P1|Induction Treatment|Ineligible or never started treatment|3
1047171|NCT00064350|3394327|P3|Induction Treatment|Withdrawal by Subject|21
1047172|NCT00064350|3394328|P2|Induction Treatment|Withdrawal by Subject|0
1047173|NCT00064350|3394329|P1|Induction Treatment|Withdrawal by Subject|0
1047174|NCT00064350|3394327|P3|Induction Treatment|Death|9
1047175|NCT00064350|3394328|P2|Induction Treatment|Death|0
1047176|NCT00064350|3394329|P1|Induction Treatment|Death|0
1047177|NCT00064350|3394327|P3|Induction Treatment|Adverse Event|49
1047178|NCT00064350|3394328|P2|Induction Treatment|Adverse Event|2
1047179|NCT00064350|3394329|P1|Induction Treatment|Adverse Event|0
1047180|NCT00064350|3394327|P3|Induction Treatment|Disease Progression|110
1047181|NCT00064350|3394328|P2|Induction Treatment|Disease Progression|1
1047182|NCT00064350|3394329|P1|Induction Treatment|Disease Progression|5
1047183|NCT00064337|3394344|P1|Maintenance|Death|1
1047184|NCT00064337|3394344|P1|Maintenance|Not protocol-specified|2
1047185|NCT00064337|3394344|P1|Maintenance|On treatment at time of analysis|2
1047186|NCT00064337|3394344|P1|Maintenance|Progression|2
1047187|NCT00064337|3394344|P1|Maintenance|Adverse Event|3
1047188|NCT00064337|3394344|P1|Transplant|Progression|2
1047189|NCT00064337|3394344|P1|Transplant|Patient Refusal|2
1047190|NCT00064337|3394344|P1|Transplant|Death|3
1047191|NCT00064337|3394344|P1|Transplant|Not protocol-specified|5
1047192|NCT00064337|3394344|P1|Transplant|Adverse Event|9
1047193|NCT00064337|3394344|P1|PBSCC or Induction/PBSCC|Death|2
1047194|NCT00064337|3394344|P1|PBSCC or Induction/PBSCC|Patient Refusal|2
1047195|NCT00064337|3394344|P1|PBSCC or Induction/PBSCC|Progression|3
1047196|NCT00064337|3394344|P1|PBSCC or Induction/PBSCC|Adverse Event|6
1047197|NCT00064337|3394344|P1|PBSCC or Induction/PBSCC|Not protocol-specified|7
1047198|NCT00064298|3394353|P2|Overall Study|Disease Progression|1
1047199|NCT00064298|3394354|P1|Overall Study|Disease Progression|2
1047200|NCT00064298|3394353|P2|Overall Study|Death|1
1047201|NCT00064298|3394354|P1|Overall Study|Death|0
1047202|NCT00064298|3394353|P2|Overall Study|Lost to Follow-up|2
1047203|NCT00064298|3394354|P1|Overall Study|Lost to Follow-up|2
1047204|NCT00064298|3394353|P2|Overall Study|Withdrawal by Subject|1
1047205|NCT00064298|3394354|P1|Overall Study|Withdrawal by Subject|2
1047206|NCT00064259|3394362|P4|Overall Study|Adverse Event|1
1047207|NCT00064259|3394363|P3|Overall Study|Adverse Event|0
1047208|NCT00064259|3394364|P2|Overall Study|Adverse Event|0
1047209|NCT00064259|3394365|P1|Overall Study|Adverse Event|1
1047210|NCT00064077|3394373|P4|Overall Study|Other reasons|2
1047211|NCT00064077|3394374|P3|Overall Study|Other reasons|1
1047212|NCT00064077|3394375|P2|Overall Study|Other reasons|2
1047213|NCT00064077|3394376|P1|Overall Study|Other reasons|2
1047214|NCT00064077|3394373|P4|Overall Study|No tumor|0
1047215|NCT00064077|3394374|P3|Overall Study|No tumor|1
1047216|NCT00064077|3394375|P2|Overall Study|No tumor|0
1047217|NCT00064077|3394376|P1|Overall Study|No tumor|0
1047218|NCT00064077|3394373|P4|Overall Study|No surgery|0
1047219|NCT00064077|3394374|P3|Overall Study|No surgery|1
1047220|NCT00064077|3394375|P2|Overall Study|No surgery|0
1047221|NCT00064077|3394376|P1|Overall Study|No surgery|0
1047222|NCT00064077|3394373|P4|Overall Study|Pathology|4
1047223|NCT00064077|3394374|P3|Overall Study|Pathology|3
1047224|NCT00064077|3394375|P2|Overall Study|Pathology|7
1047225|NCT00064077|3394376|P1|Overall Study|Pathology|10
1047226|NCT00064077|3394373|P4|Overall Study|Poor risk|1
1047227|NCT00064077|3394374|P3|Overall Study|Poor risk|1
1047228|NCT00064077|3394375|P2|Overall Study|Poor risk|0
1047229|NCT00064077|3394376|P1|Overall Study|Poor risk|2
1047230|NCT00064077|3394373|P4|Overall Study|Improper prior treatment|0
1047231|NCT00064077|3394374|P3|Overall Study|Improper prior treatment|0
1047232|NCT00064077|3394375|P2|Overall Study|Improper prior treatment|0
1047233|NCT00064077|3394376|P1|Overall Study|Improper prior treatment|1
1047234|NCT00064025|3394420|P1|Overall Study|Inevaluable|3
1047235|NCT00064025|3394420|P1|Overall Study|Ineligible|4
1047236|NCT00063999|3394429|P2|Overall Study|Ineligible|24
1047237|NCT00063999|3394430|P1|Overall Study|Ineligible|44
1047238|NCT00063999|3394429|P2|Overall Study|Withdrawal by Subject|0
1047239|NCT00063999|3394430|P1|Overall Study|Withdrawal by Subject|1
1047240|NCT00063986|3394446|P1|Overall Study|Intra-operatively ineligible|4
1047241|NCT00063986|3394446|P1|Overall Study|Ineligible|1
1047242|NCT00063986|3394446|P1|Overall Study|Withdrawal by Subject|1
1047243|NCT00063934|3394458|P1|Overall Study|Ineligible|1
1047244|NCT00063258|3394563|P2|Overall Study|Lack of Efficacy|0
1047245|NCT00063258|3394564|P1|Overall Study|Lack of Efficacy|2
1047246|NCT00063258|3394563|P2|Overall Study|Physician Decision|0
1047247|NCT00063258|3394564|P1|Overall Study|Physician Decision|2
1047248|NCT00063154|3394570|P1|Overall Study|Did not receive treatment|8
1047249|NCT00063154|3394570|P1|Overall Study|Reason unspecified|1
1047250|NCT00063154|3394570|P1|Overall Study|Death|3
1047251|NCT00063154|3394570|P1|Overall Study|Physician Decision|10
1047252|NCT00063154|3394570|P1|Overall Study|Adverse Event|2
1047253|NCT00063154|3394570|P1|Overall Study|Disease progression|27
1047254|NCT00062751|3394596|P5|Overall Study|Death|0
1047255|NCT00062751|3394597|P4|Overall Study|Death|0
1047256|NCT00062751|3394598|P3|Overall Study|Death|1
1047257|NCT00062751|3394599|P2|Overall Study|Death|0
1047258|NCT00062751|3394600|P1|Overall Study|Death|1
1047259|NCT00062751|3394596|P5|Overall Study|Symptomatic deterioration|1
1047260|NCT00062751|3394597|P4|Overall Study|Symptomatic deterioration|0
1047261|NCT00062751|3394598|P3|Overall Study|Symptomatic deterioration|0
1047262|NCT00062751|3394599|P2|Overall Study|Symptomatic deterioration|1
1047263|NCT00062751|3394600|P1|Overall Study|Symptomatic deterioration|1
1047264|NCT00062751|3394596|P5|Overall Study|Withdrawal by Subject|0
1047265|NCT00062751|3394597|P4|Overall Study|Withdrawal by Subject|1
1047266|NCT00062751|3394598|P3|Overall Study|Withdrawal by Subject|2
1047267|NCT00062751|3394599|P2|Overall Study|Withdrawal by Subject|2
1047268|NCT00062751|3394600|P1|Overall Study|Withdrawal by Subject|1
1047269|NCT00062751|3394596|P5|Overall Study|Other|1
1047270|NCT00062751|3394597|P4|Overall Study|Other|0
1047271|NCT00062751|3394598|P3|Overall Study|Other|1
1047272|NCT00062751|3394599|P2|Overall Study|Other|3
1047273|NCT00062751|3394600|P1|Overall Study|Other|2
1047274|NCT00062751|3394596|P5|Overall Study|Adverse Event|2
1047275|NCT00062751|3394597|P4|Overall Study|Adverse Event|2
1047276|NCT00062751|3394598|P3|Overall Study|Adverse Event|2
1047277|NCT00062751|3394599|P2|Overall Study|Adverse Event|7
1047278|NCT00062751|3394600|P1|Overall Study|Adverse Event|4
1047279|NCT00062751|3394596|P5|Overall Study|Disease progression|2
1047280|NCT00062751|3394597|P4|Overall Study|Disease progression|2
1047281|NCT00062751|3394598|P3|Overall Study|Disease progression|24
1047282|NCT00062751|3394599|P2|Overall Study|Disease progression|17
1047283|NCT00062751|3394600|P1|Overall Study|Disease progression|24
1047284|NCT00062647|3394686|P2|Overall Study|Never received study treatment|1
1047285|NCT00062647|3394687|P1|Overall Study|Never received study treatment|1
1047286|NCT00062647|3394686|P2|Overall Study|Other|4
1047287|NCT00062647|3394687|P1|Overall Study|Other|4
1047288|NCT00062647|3394686|P2|Overall Study|Failed continuation criteria|2
1047289|NCT00062647|3394687|P1|Overall Study|Failed continuation criteria|4
1047290|NCT00062647|3394686|P2|Overall Study|Lost to Follow-up|2
1047291|NCT00062647|3394687|P1|Overall Study|Lost to Follow-up|1
1047292|NCT00062647|3394686|P2|Overall Study|Protocol Violation|0
1047293|NCT00062647|3394687|P1|Overall Study|Protocol Violation|1
1047294|NCT00062647|3394686|P2|Overall Study|Withdrawal by Subject|1
1047295|NCT00062647|3394687|P1|Overall Study|Withdrawal by Subject|2
1047296|NCT00062647|3394686|P2|Overall Study|Adverse Event|1
1047297|NCT00062647|3394687|P1|Overall Study|Adverse Event|1
1047298|NCT00062647|3394686|P2|Overall Study|Death|2
1047299|NCT00062647|3394687|P1|Overall Study|Death|2
1047300|NCT00062439|3394693|P1|Consolidation Chemotherapy|Adverse Event|2
1047301|NCT00062439|3394693|P1|Surgery|Adverse Event|2
1047302|NCT00062439|3394693|P1|Surgery|Death|1
1047303|NCT00062439|3394693|P1|Surgery|Physician Decision|4
1047304|NCT00062439|3394693|P1|Post Chemoradiation Assessment|Not eligible to continue to surgery|4
1047305|NCT00062439|3394693|P1|Post Chemoradiation Assessment|Physician Decision|1
1047306|NCT00062439|3394693|P1|Post Chemoradiation Assessment|Withdrawal by Subject|1
1047307|NCT00062439|3394693|P1|Post Chemoradiation Assessment|Disease progression|2
1047308|NCT00062439|3394693|P1|Post Chemoradiation Assessment|Death|1
1047309|NCT00062439|3394693|P1|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3
1047310|NCT00062439|3394693|P1|Induction Chemotherapy + Radiotherapy|Adverse Event|3
1047311|NCT00062439|3394693|P1|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1
1047312|NCT00062439|3394693|P1|Induction Chemotherapy + Radiotherapy|Ineligible|1
1047313|NCT00062374|3394705|P1|Overall Study|Not treated|12
1047314|NCT00062166|3394710|P1|Overall Study|Withdrawal by Subject|6
1047315|NCT00062010|3394718|P1|Overall Study|Ineligible|3
1047316|NCT00061945|3394726|P2|Course IV: Alemtuzumab|Early exits|15
1047317|NCT00061945|3394727|P1|Course IV: Alemtuzumab|Early exits|6
1047318|NCT00061945|3394726|P2|Course IV: Alemtuzumab|Declined Alemtuzumab|1
1047319|NCT00061945|3394727|P1|Course IV: Alemtuzumab|Declined Alemtuzumab|1
1047320|NCT00061945|3394726|P2|Registration Through Course 3|Early discontinuation during course I-IV|90
1047321|NCT00061945|3394727|P1|Registration Through Course 3|Early discontinuation during course I-IV|76
1047322|NCT00061945|3394726|P2|Registration Through Course 3|Not Alemtuzumab Eligible|25
1047323|NCT00061945|3394727|P1|Registration Through Course 3|Not Alemtuzumab Eligible|18
1047324|NCT00061932|3394737|P2|Overall Study|Withdrawal by Subject|4
1047325|NCT00061932|3394738|P1|Overall Study|Withdrawal by Subject|13
1047326|NCT00061633|3394751|P2|Overall Study|Never received study treatment|2
1047327|NCT00061633|3394752|P1|Overall Study|Never received study treatment|0
1047328|NCT00061633|3394751|P2|Overall Study|Other|1
1047329|NCT00061633|3394752|P1|Overall Study|Other|1
1047330|NCT00061633|3394751|P2|Overall Study|Lost to Follow-up|4
1047331|NCT00061633|3394752|P1|Overall Study|Lost to Follow-up|1
1047332|NCT00061633|3394751|P2|Overall Study|Withdrawal by Subject|2
1047333|NCT00061633|3394752|P1|Overall Study|Withdrawal by Subject|2
1047334|NCT00061633|3394751|P2|Overall Study|Adverse Event|2
1047335|NCT00061633|3394752|P1|Overall Study|Adverse Event|1
1047336|NCT00061048|3394777|P1|Overall Study|disease progression|20
1047337|NCT00061048|3394777|P1|Overall Study|Adverse Event|2
1047338|NCT00060944|3394787|P2|Overall Study|randomized but not treated|4
1047339|NCT00060944|3394788|P1|Overall Study|randomized but not treated|6
1047340|NCT00060944|3394787|P2|Overall Study|Not specified|4
1047341|NCT00060944|3394788|P1|Overall Study|Not specified|2
1047342|NCT00060944|3394787|P2|Overall Study|Treatment Switch|13
1047343|NCT00060944|3394788|P1|Overall Study|Treatment Switch|0
1047344|NCT00060944|3394787|P2|Overall Study|Subject Ineligible To Continue|1
1047345|NCT00060944|3394788|P1|Overall Study|Subject Ineligible To Continue|2
1047346|NCT00060944|3394787|P2|Overall Study|Lost to Follow-up|0
1047347|NCT00060944|3394788|P1|Overall Study|Lost to Follow-up|1
1047348|NCT00060944|3394787|P2|Overall Study|Disease Progression|94
1047349|NCT00060944|3394788|P1|Overall Study|Disease Progression|93
1047350|NCT00060944|3394787|P2|Overall Study|Withdrawal by Subject|5
1047351|NCT00060944|3394788|P1|Overall Study|Withdrawal by Subject|18
1047352|NCT00060944|3394787|P2|Overall Study|Death|3
1047353|NCT00060944|3394788|P1|Overall Study|Death|2
1047354|NCT00060944|3394787|P2|Overall Study|Adverse Event|10
1047355|NCT00060944|3394788|P1|Overall Study|Adverse Event|12
1047356|NCT00060840|3394804|P2|Overall Study|Other|0
1047357|NCT00060840|3394805|P1|Overall Study|Other|1
1047358|NCT00060840|3394804|P2|Overall Study|Physician Decision|0
1047359|NCT00060840|3394805|P1|Overall Study|Physician Decision|1
1047360|NCT00060840|3394804|P2|Overall Study|Subinvestigator unavailable|1
1047361|NCT00060840|3394805|P1|Overall Study|Subinvestigator unavailable|0
1047362|NCT00060840|3394804|P2|Overall Study|Withdrawal by Subject|1
1047363|NCT00060840|3394805|P1|Overall Study|Withdrawal by Subject|0
1047364|NCT00060840|3394804|P2|Overall Study|Death|1
1047365|NCT00060840|3394805|P1|Overall Study|Death|0
1047366|NCT00060840|3394804|P2|Overall Study|Change in surgical plan|6
1047367|NCT00060840|3394805|P1|Overall Study|Change in surgical plan|2
1047368|NCT00059839|3394858|P2|Overall Study|Ineligible|3
1047369|NCT00059839|3394859|P1|Overall Study|Ineligible|1
1047370|NCT00059839|3394858|P2|Overall Study|Withdrawal by Subject|6
1047371|NCT00059839|3394859|P1|Overall Study|Withdrawal by Subject|1
1047372|NCT00059839|3394858|P2|Overall Study|Physician Decision|2
1047373|NCT00059839|3394859|P1|Overall Study|Physician Decision|1
1047374|NCT00059839|3394858|P2|Overall Study|Lost to Follow-up|0
1047375|NCT00059839|3394859|P1|Overall Study|Lost to Follow-up|2
1047376|NCT00059839|3394858|P2|Overall Study|Lack of Efficacy|5
1047377|NCT00059839|3394859|P1|Overall Study|Lack of Efficacy|6
1047378|NCT00059839|3394858|P2|Overall Study|Death|1
1047379|NCT00059839|3394859|P1|Overall Study|Death|1
1047380|NCT00059787|3394865|P1|Overall Study|Other|4
1047381|NCT00059787|3394865|P1|Overall Study|ineligible|1
1047382|NCT00059787|3394865|P1|Overall Study|disease progression|2
1047383|NCT00059787|3394865|P1|Overall Study|Adverse Event|13
1047384|NCT00059332|3394916|P2|Overall Study|Lost to Follow-up|1
1047385|NCT00059332|3394917|P1|Overall Study|Lost to Follow-up|1
1047386|NCT00059332|3394916|P2|Overall Study|Withdrawal by Subject|1
1047387|NCT00059332|3394917|P1|Overall Study|Withdrawal by Subject|2
1047388|NCT00059215|3394943|P4|Overall Study|Physician Decision|1
1047389|NCT00059215|3394944|P3|Overall Study|Physician Decision|1
1047390|NCT00059215|3394945|P2|Overall Study|Physician Decision|2
1047391|NCT00059215|3394946|P1|Overall Study|Physician Decision|1
1047392|NCT00059215|3394943|P4|Overall Study|Protocol entry criteria not met|2
1047393|NCT00059215|3394944|P3|Overall Study|Protocol entry criteria not met|0
1047394|NCT00059215|3394945|P2|Overall Study|Protocol entry criteria not met|1
1047395|NCT00059215|3394946|P1|Overall Study|Protocol entry criteria not met|1
1047396|NCT00059215|3394943|P4|Overall Study|Protocol Violation|0
1047397|NCT00059215|3394944|P3|Overall Study|Protocol Violation|1
1047398|NCT00059215|3394945|P2|Overall Study|Protocol Violation|0
1047399|NCT00059215|3394946|P1|Overall Study|Protocol Violation|1
1047400|NCT00059215|3394943|P4|Overall Study|Withdrawal by Subject|3
1047401|NCT00059215|3394944|P3|Overall Study|Withdrawal by Subject|1
1047402|NCT00059215|3394945|P2|Overall Study|Withdrawal by Subject|4
1047403|NCT00059215|3394946|P1|Overall Study|Withdrawal by Subject|4
1047404|NCT00059215|3394943|P4|Overall Study|Lost to Follow-up|0
1047405|NCT00059215|3394944|P3|Overall Study|Lost to Follow-up|0
1047406|NCT00059215|3394945|P2|Overall Study|Lost to Follow-up|2
1047407|NCT00059215|3394946|P1|Overall Study|Lost to Follow-up|1
1047408|NCT00059215|3394943|P4|Overall Study|Death|0
1047409|NCT00059215|3394944|P3|Overall Study|Death|3
1047410|NCT00059215|3394945|P2|Overall Study|Death|0
1047411|NCT00059215|3394946|P1|Overall Study|Death|0
1047412|NCT00059215|3394943|P4|Overall Study|Adverse Event|9
1047413|NCT00059215|3394944|P3|Overall Study|Adverse Event|9
1047414|NCT00059215|3394945|P2|Overall Study|Adverse Event|5
1047415|NCT00059215|3394946|P1|Overall Study|Adverse Event|5
1047416|NCT00058825|3394983|P1|Overall Study|Death|3
1047417|NCT00058825|3394983|P1|Overall Study|Graft Failure|5
1047418|NCT00058825|3394983|P1|Overall Study|Progressive Disease|5
1047419|NCT00058825|3394983|P1|Overall Study|Relapse|9
1047420|NCT00058552|3394999|P2|Overall Study|Clinical disease progression|4
1047421|NCT00058552|3395000|P1|Overall Study|Clinical disease progression|0
1047422|NCT00058552|3394999|P2|Overall Study|Physician Decision|5
1047423|NCT00058552|3395000|P1|Overall Study|Physician Decision|2
1047424|NCT00058552|3394999|P2|Overall Study|Withdrawal by Subject|5
1047425|NCT00058552|3395000|P1|Overall Study|Withdrawal by Subject|3
1047426|NCT00058552|3394999|P2|Overall Study|Adverse Event|2
1047427|NCT00058552|3395000|P1|Overall Study|Adverse Event|4
1047428|NCT00058552|3394999|P2|Overall Study|Disease progression|44
1047429|NCT00058552|3395000|P1|Overall Study|Disease progression|52
1047430|NCT00058552|3394999|P2|Overall Study|Died prior to receiving treatment|2
1047431|NCT00058552|3395000|P1|Overall Study|Died prior to receiving treatment|4
1047432|NCT00058539|3395018|P1|Overall Study|Death|1
1047433|NCT00058539|3395018|P1|Overall Study|Physician Decision|9
1047434|NCT00058539|3395018|P1|Overall Study|Withdrawal by Subject|5
1047435|NCT00058539|3395018|P1|Overall Study|Adverse Event|3
1047436|NCT00058539|3395018|P1|Overall Study|Disease progression|24
1047437|NCT00058214|3395045|P1|Overall Study|Adverse Event|1
1047438|NCT00058123|3395050|P1|Overall Study|Received >3 prior treatments|1
1047439|NCT00058123|3395050|P1|Overall Study|Wrong histology|9
1047440|NCT00058058|3395057|P1|Overall Study|Poor positioning, illness,pain|3
1047441|NCT00058058|3395057|P1|Overall Study|technical issues|6
1047442|NCT00058058|3395057|P1|Overall Study|Claustrophobic|5
1047443|NCT00058058|3395057|P1|Overall Study|Ineligible|20
1047444|NCT00058058|3395057|P1|Overall Study|Withdrawal by Subject|4
1047445|NCT00057954|3395082|P1|Overall Study|Disease progression|1
1047446|NCT00057954|3395082|P1|Overall Study|Death|1
1047447|NCT00057941|3395090|P2|Overall Study|Ineligible|5
1047448|NCT00057941|3395091|P1|Overall Study|Ineligible|2
1047449|NCT00057941|3395090|P2|Overall Study|insurance, symptomatic deterioration|3
1047450|NCT00057941|3395091|P1|Overall Study|insurance, symptomatic deterioration|1
1047451|NCT00057941|3395090|P2|Overall Study|still on treatment|1
1047452|NCT00057941|3395091|P1|Overall Study|still on treatment|3
1047453|NCT00057941|3395090|P2|Overall Study|Withdrawal by Subject|1
1047454|NCT00057941|3395091|P1|Overall Study|Withdrawal by Subject|6
1047455|NCT00057941|3395090|P2|Overall Study|Lack of Efficacy|53
1047456|NCT00057941|3395091|P1|Overall Study|Lack of Efficacy|54
1047457|NCT00057941|3395090|P2|Overall Study|Adverse Event|9
1047458|NCT00057941|3395091|P1|Overall Study|Adverse Event|7
1047459|NCT00057941|3395090|P2|Overall Study|Death|2
1047460|NCT00057941|3395091|P1|Overall Study|Death|1
1047461|NCT00057876|3395099|P2|Overall Study|other complicating disease|0
1047462|NCT00057876|3395100|P1|Overall Study|other complicating disease|1
1047463|NCT00057876|3395099|P2|Overall Study|other reason|2
1047464|NCT00057876|3395100|P1|Overall Study|other reason|2
1047465|NCT00057876|3395099|P2|Overall Study|Ineligible|2
1047466|NCT00057876|3395100|P1|Overall Study|Ineligible|1
1047467|NCT00057876|3395099|P2|Overall Study|Lack of Efficacy|8
1047468|NCT00057876|3395100|P1|Overall Study|Lack of Efficacy|10
1047469|NCT00057876|3395099|P2|Overall Study|Withdrawal by Subject|6
1047470|NCT00057876|3395100|P1|Overall Study|Withdrawal by Subject|5
1047471|NCT00057876|3395099|P2|Overall Study|Death|1
1047472|NCT00057876|3395100|P1|Overall Study|Death|2
1047473|NCT00057876|3395099|P2|Overall Study|Adverse Event|8
1047474|NCT00057876|3395100|P1|Overall Study|Adverse Event|8
1047475|NCT00057863|3395110|P1|Overall Study|Withdrawal by Subject|2
1047476|NCT00057863|3395110|P1|Overall Study|Death|1
1047477|NCT00057837|3395119|P2|Overall Study|Never started treatment|1
1047478|NCT00057837|3395120|P1|Overall Study|Never started treatment|1
1047479|NCT00057837|3395119|P2|Overall Study|Ineligible|3
1047480|NCT00057837|3395120|P1|Overall Study|Ineligible|3
1047481|NCT00057837|3395119|P2|Overall Study|Physician Decision|0
1047482|NCT00057837|3395120|P1|Overall Study|Physician Decision|1
1047483|NCT00057837|3395119|P2|Overall Study|Other complicating disease|1
1047484|NCT00057837|3395120|P1|Overall Study|Other complicating disease|2
1047485|NCT00057837|3395119|P2|Overall Study|Alternative therapy|1
1047486|NCT00057837|3395120|P1|Overall Study|Alternative therapy|0
1047487|NCT00057837|3395119|P2|Overall Study|Withdrawal by Subject|3
1047488|NCT00057837|3395120|P1|Overall Study|Withdrawal by Subject|5
1047489|NCT00057837|3395119|P2|Overall Study|Death|4
1047490|NCT00057837|3395120|P1|Overall Study|Death|5
1047491|NCT00057837|3395119|P2|Overall Study|Adverse Event|12
1047492|NCT00057837|3395120|P1|Overall Study|Adverse Event|2
1047493|NCT00057837|3395119|P2|Overall Study|Progression/relapse|14
1047494|NCT00057837|3395120|P1|Overall Study|Progression/relapse|12
1047495|NCT00057811|3395132|P2|Overall Study|Inevaluable|2
1047496|NCT00057811|3395133|P1|Overall Study|Inevaluable|1
1047497|NCT00057811|3395132|P2|Overall Study|Ineligible|2
1047498|NCT00057811|3395133|P1|Overall Study|Ineligible|4
1047499|NCT00057811|3395132|P2|Overall Study|Withdrawal by Subject|4
1047500|NCT00057811|3395133|P1|Overall Study|Withdrawal by Subject|3
1047501|NCT00057811|3395132|P2|Overall Study|Physician Decision|0
1047502|NCT00057811|3395133|P1|Overall Study|Physician Decision|1
1047503|NCT00057811|3395132|P2|Overall Study|Lack of Efficacy|4
1047504|NCT00057811|3395133|P1|Overall Study|Lack of Efficacy|1
1047505|NCT00057746|3395152|P3|Overall Study|Withdrawal by Subject|1
1047506|NCT00057746|3395153|P2|Overall Study|Withdrawal by Subject|0
1047507|NCT00057746|3395154|P1|Overall Study|Withdrawal by Subject|0
1047508|NCT00023673|3395165|P4|Overall Study|Patient withdrew consent|1
1047509|NCT00023673|3395166|P3|Overall Study|Patient withdrew consent|0
1047510|NCT00023673|3395167|P2|Overall Study|Patient withdrew consent|0
1047511|NCT00023673|3395168|P1|Overall Study|Patient withdrew consent|0
1047512|NCT00023673|3395165|P4|Overall Study|Ineligible / no protocol treatment|1
1047513|NCT00023673|3395166|P3|Overall Study|Ineligible / no protocol treatment|0
1047514|NCT00023673|3395167|P2|Overall Study|Ineligible / no protocol treatment|0
1047515|NCT00023673|3395168|P1|Overall Study|Ineligible / no protocol treatment|0
1047516|NCT00057330|3395232|P2|Overall Study|Other|206
1047517|NCT00057330|3395233|P1|Overall Study|Other|260
1047518|NCT00057330|3395232|P2|Overall Study|Physician Decision|0
1047519|NCT00057330|3395233|P1|Overall Study|Physician Decision|1
1047520|NCT00057330|3395232|P2|Overall Study|Lost to Follow-up|617
1047521|NCT00057330|3395233|P1|Overall Study|Lost to Follow-up|745
1047522|NCT00057330|3395232|P2|Overall Study|Withdrawal by Subject|84
1047523|NCT00057330|3395233|P1|Overall Study|Withdrawal by Subject|115
1047524|NCT00057330|3395232|P2|Overall Study|Protocol Violation|1
1047525|NCT00057330|3395233|P1|Overall Study|Protocol Violation|1
1047526|NCT00057330|3395232|P2|Overall Study|Death|0
1047527|NCT00057330|3395233|P1|Overall Study|Death|1
1047528|NCT00057330|3395232|P2|Overall Study|Adverse Event|12
1047529|NCT00057330|3395233|P1|Overall Study|Adverse Event|9
1047530|NCT00056862|3395263|P2|Overall Study|Protocol Violation|0
1047531|NCT00056862|3395264|P1|Overall Study|Protocol Violation|1
1047532|NCT00056407|3395322|P2|Overall Study|Missing|34
1047533|NCT00056407|3395323|P1|Overall Study|Missing|25
1047534|NCT00056407|3395322|P2|Overall Study|"Listed as Other on Case Report Form"|60
1047535|NCT00056407|3395323|P1|Overall Study|"Listed as Other on Case Report Form"|98
1047536|NCT00056407|3395322|P2|Overall Study|Diagnosed with Prostate Cancer|166
1047537|NCT00056407|3395323|P1|Overall Study|Diagnosed with Prostate Cancer|202
1047538|NCT00056407|3395322|P2|Overall Study|Protocol Violation|95
1047539|NCT00056407|3395323|P1|Overall Study|Protocol Violation|104
1047540|NCT00056407|3395322|P2|Overall Study|Lost to Follow-up|113
1047541|NCT00056407|3395323|P1|Overall Study|Lost to Follow-up|123
1047542|NCT00056407|3395322|P2|Overall Study|Withdrawal by Subject|361
1047543|NCT00056407|3395323|P1|Overall Study|Withdrawal by Subject|377
1047544|NCT00056407|3395322|P2|Overall Study|Adverse Event|364
1047545|NCT00056407|3395323|P1|Overall Study|Adverse Event|282
1047546|NCT00056316|3395381|P2|Overall Study|Death/NH placement of pt|1
1047547|NCT00056316|3395382|P1|Overall Study|Death/NH placement of pt|1
1047548|NCT00056316|3395381|P2|Overall Study|Withdrawal by Subject|2
1047549|NCT00056316|3395382|P1|Overall Study|Withdrawal by Subject|2
1047550|NCT00056160|3395396|P2|Final Follow-up|Adverse Event|0
1047551|NCT00056160|3395397|P1|Final Follow-up|Adverse Event|1
1047552|NCT00056160|3395396|P2|Final Follow-up|Transferred into RevAssist Program|0
1047553|NCT00056160|3395397|P1|Final Follow-up|Transferred into RevAssist Program|2
1047554|NCT00056160|3395396|P2|Final Follow-up|Transferred into expanded access study.|0
1047555|NCT00056160|3395397|P1|Final Follow-up|Transferred into expanded access study.|3
1047556|NCT00056160|3395396|P2|Extended Follow-up Cutoff (23 Jul 2008)|Not specified|0
1047557|NCT00056160|3395397|P1|Extended Follow-up Cutoff (23 Jul 2008)|Not specified|21
1047558|NCT00056160|3395396|P2|Extended Follow-up Cutoff (23 Jul 2008)|Death|0
1047559|NCT00056160|3395397|P1|Extended Follow-up Cutoff (23 Jul 2008)|Death|5
1047560|NCT00056160|3395396|P2|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0
1047561|NCT00056160|3395397|P1|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11
1047562|NCT00056160|3395396|P2|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0
1047563|NCT00056160|3395397|P1|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3
1047564|NCT00056160|3395396|P2|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0
1047565|NCT00056160|3395397|P1|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87
1047566|NCT00056160|3395396|P2|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0
1047567|NCT00056160|3395397|P1|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44
1047568|NCT00056160|3395396|P2|Up to Unblinding (07 Jun 2005)|Not specified|7
1047569|NCT00056160|3395397|P1|Up to Unblinding (07 Jun 2005)|Not specified|8
1047570|NCT00056160|3395396|P2|Up to Unblinding (07 Jun 2005)|Death|1
1047571|NCT00056160|3395397|P1|Up to Unblinding (07 Jun 2005)|Death|2
1047572|NCT00056160|3395396|P2|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
1047573|NCT00056160|3395397|P1|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
1047574|NCT00056160|3395396|P2|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5
1047575|NCT00056160|3395397|P1|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3
1047576|NCT00056160|3395396|P2|Up to Unblinding (07 Jun 2005)|Progression of disease|124
1047577|NCT00056160|3395397|P1|Up to Unblinding (07 Jun 2005)|Progression of disease|57
1047578|NCT00056160|3395396|P2|Up to Unblinding (07 Jun 2005)|Adverse Event|18
1047579|NCT00056160|3395397|P1|Up to Unblinding (07 Jun 2005)|Adverse Event|35
1047580|NCT00055601|3395420|P2|Overall Study|No protocol treatment received|1
1047581|NCT00055601|3395421|P1|Overall Study|No protocol treatment received|1
1047582|NCT00055601|3395420|P2|Overall Study|Protocol Violation|1
1047583|NCT00055601|3395421|P1|Overall Study|Protocol Violation|1
1047584|NCT00055497|3395435|P4|Overall Study|Other|11
1047585|NCT00055497|3395436|P3|Overall Study|Other|0
1047586|NCT00055497|3395437|P2|Overall Study|Other|0
1047587|NCT00055497|3395438|P1|Overall Study|Other|0
1047588|NCT00055497|3395435|P4|Overall Study|Administrative Reasons|1
1047589|NCT00055497|3395436|P3|Overall Study|Administrative Reasons|0
1047590|NCT00055497|3395437|P2|Overall Study|Administrative Reasons|0
1047591|NCT00055497|3395438|P1|Overall Study|Administrative Reasons|0
1047592|NCT00055497|3395435|P4|Overall Study|Lack of Efficacy|27
1047593|NCT00055497|3395436|P3|Overall Study|Lack of Efficacy|0
1047594|NCT00055497|3395437|P2|Overall Study|Lack of Efficacy|0
1047595|NCT00055497|3395438|P1|Overall Study|Lack of Efficacy|1
1047596|NCT00055497|3395435|P4|Overall Study|Protocol Violation|3
1047597|NCT00055497|3395436|P3|Overall Study|Protocol Violation|0
1047598|NCT00055497|3395437|P2|Overall Study|Protocol Violation|0
1047599|NCT00055497|3395438|P1|Overall Study|Protocol Violation|0
1047600|NCT00055497|3395435|P4|Overall Study|Lost to Follow-up|5
1047601|NCT00055497|3395436|P3|Overall Study|Lost to Follow-up|0
1047602|NCT00055497|3395437|P2|Overall Study|Lost to Follow-up|1
1047603|NCT00055497|3395438|P1|Overall Study|Lost to Follow-up|0
1047604|NCT00055497|3395435|P4|Overall Study|Withdrawal by Subject|15
1047605|NCT00055497|3395436|P3|Overall Study|Withdrawal by Subject|1
1047606|NCT00055497|3395437|P2|Overall Study|Withdrawal by Subject|1
1047607|NCT00055497|3395438|P1|Overall Study|Withdrawal by Subject|3
1047608|NCT00055497|3395435|P4|Overall Study|Adverse Event|28
1047609|NCT00055497|3395436|P3|Overall Study|Adverse Event|1
1047610|NCT00055497|3395437|P2|Overall Study|Adverse Event|1
1047611|NCT00055497|3395438|P1|Overall Study|Adverse Event|1
1047612|NCT00055471|3395483|P3|Period 1: Dose Escalation Period|Disease progression|0
1047613|NCT00055471|3395484|P2|Period 1: Dose Escalation Period|Disease progression|1
1047614|NCT00055471|3395485|P1|Period 1: Dose Escalation Period|Disease progression|0
1047615|NCT00055471|3395483|P3|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1
1047616|NCT00055471|3395484|P2|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
1047617|NCT00055471|3395485|P1|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
1047618|NCT00055471|3395483|P3|Period 1: Dose Escalation Period|Adverse Event|2
1047619|NCT00055471|3395484|P2|Period 1: Dose Escalation Period|Adverse Event|1
1047620|NCT00055471|3395485|P1|Period 1: Dose Escalation Period|Adverse Event|0
1047621|NCT00054717|3395540|P2|Overall Study|Other reason not defined above|217
1047622|NCT00054717|3395541|P1|Overall Study|Other reason not defined above|117
1047623|NCT00054717|3395540|P2|Overall Study|Withdrawal by Subject|20
1047624|NCT00054717|3395541|P1|Overall Study|Withdrawal by Subject|32
1047625|NCT00054717|3395540|P2|Overall Study|Lost to Follow-up|13
1047626|NCT00054717|3395541|P1|Overall Study|Lost to Follow-up|23
1047627|NCT00054717|3395540|P2|Overall Study|Protocol Violation|19
1047628|NCT00054717|3395541|P1|Overall Study|Protocol Violation|18
1047629|NCT00054717|3395540|P2|Overall Study|Adverse Event|22
1047630|NCT00054717|3395541|P1|Overall Study|Adverse Event|70
1047631|NCT00054717|3395540|P2|Overall Study|Randomized but not treated|8
1047632|NCT00054717|3395541|P1|Overall Study|Randomized but not treated|2
1047633|NCT00054704|3395729|P2|Overall Study|Lost to Follow-up|0
1047634|NCT00054704|3395730|P1|Overall Study|Lost to Follow-up|1
1047635|NCT00054704|3395729|P2|Overall Study|Adverse Event|2
1047636|NCT00054704|3395730|P1|Overall Study|Adverse Event|3
1047637|NCT00054704|3395729|P2|Overall Study|Lack of Efficacy|3
1047638|NCT00054704|3395730|P1|Overall Study|Lack of Efficacy|1
1047639|NCT00054691|3395736|P1|Overall Study|Noncompliant|1
1047640|NCT00054691|3395736|P1|Overall Study|Unmeasurable Disease|2
1047641|NCT00054639|3395750|P1|Overall Study|Physician Decision|1
1047642|NCT00054639|3395750|P1|Overall Study|Lack of Efficacy|1
1047643|NCT00054327|3395783|P6|Overall Study|Engraftment failure|0
1047644|NCT00054327|3395784|P5|Overall Study|Engraftment failure|0
1047645|NCT00054327|3395785|P4|Overall Study|Engraftment failure|0
1047646|NCT00054327|3395786|P3|Overall Study|Engraftment failure|0
1047647|NCT00054327|3395787|P2|Overall Study|Engraftment failure|0
1047648|NCT00054327|3395788|P1|Overall Study|Engraftment failure|1
1047649|NCT00054275|3395826|P1|Overall Study|Physician Decision|1
1047650|NCT00054275|3395826|P1|Overall Study|Progressive disease in cycle 1|1
1047651|NCT00054275|3395826|P1|Overall Study|Adverse Event|5
1047652|NCT00054275|3395826|P1|Overall Study|Withdrawal by Subject|4
1047653|NCT00054132|3395832|P1|Overall Study|Not Treated|1
1047654|NCT00053898|3395851|P2|Overall Study|Follow-up from telephone contact only|1
1047655|NCT00053898|3395852|P1|Overall Study|Follow-up from telephone contact only|5
1047656|NCT00053898|3395851|P2|Overall Study|No follow-up data from any source|12
1047657|NCT00053898|3395852|P1|Overall Study|No follow-up data from any source|9
1047658|NCT00053846|3395878|P2|Overall Study|Pills too large|1
1047659|NCT00053846|3395879|P1|Overall Study|Pills too large|0
1047660|NCT00053846|3395878|P2|Overall Study|Quit due to side effects|3
1047661|NCT00053846|3395879|P1|Overall Study|Quit due to side effects|1
1047662|NCT00053846|3395878|P2|Overall Study|Did not return data|2
1047663|NCT00053846|3395879|P1|Overall Study|Did not return data|1
1047664|NCT00053846|3395878|P2|Overall Study|Became ineligible|1
1047665|NCT00053846|3395879|P1|Overall Study|Became ineligible|3
1047666|NCT00053846|3395878|P2|Overall Study|Expired|0
1047667|NCT00053846|3395879|P1|Overall Study|Expired|5
1047668|NCT00053846|3395878|P2|Overall Study|Became too ill|7
1047669|NCT00053846|3395879|P1|Overall Study|Became too ill|8
1047670|NCT00053846|3395878|P2|Overall Study|Changed mind|13
1047671|NCT00053846|3395879|P1|Overall Study|Changed mind|8
1047672|NCT00053417|3396038|P4|Overall Study|Lost to Follow-up|0
1047673|NCT00053417|3396039|P3|Overall Study|Lost to Follow-up|0
1047674|NCT00053417|3396040|P2|Overall Study|Lost to Follow-up|1
1047675|NCT00053417|3396041|P1|Overall Study|Lost to Follow-up|1
1047676|NCT00053417|3396038|P4|Overall Study|Withdrawal by Subject|0
1047677|NCT00053417|3396039|P3|Overall Study|Withdrawal by Subject|0
1047678|NCT00053417|3396040|P2|Overall Study|Withdrawal by Subject|1
1047679|NCT00053417|3396041|P1|Overall Study|Withdrawal by Subject|0
1047680|NCT00053417|3396038|P4|Overall Study|Non-Compliance|1
1047681|NCT00053417|3396039|P3|Overall Study|Non-Compliance|0
1047682|NCT00053417|3396040|P2|Overall Study|Non-Compliance|0
1047683|NCT00053417|3396041|P1|Overall Study|Non-Compliance|0
1047684|NCT00053417|3396038|P4|Overall Study|Adverse Event|5
1047685|NCT00053417|3396039|P3|Overall Study|Adverse Event|1
1047686|NCT00053417|3396040|P2|Overall Study|Adverse Event|0
1047687|NCT00053417|3396041|P1|Overall Study|Adverse Event|1
1047688|NCT00053365|3396051|P1|Overall Study|Never treated|4
1047689|NCT00053365|3396051|P1|Overall Study|Platinum-sensitive interval >12 months|1
1047690|NCT00053365|3396051|P1|Overall Study|Incorrect cell type|1
1047691|NCT00053352|3396060|P2|Overall Study|Disease at new site|0
1047692|NCT00053352|3396061|P1|Overall Study|Disease at new site|1
1047693|NCT00053352|3396060|P2|Overall Study|Ineligible|8
1047694|NCT00053352|3396061|P1|Overall Study|Ineligible|8
1047695|NCT00053352|3396060|P2|Overall Study|Withdrawal by Subject|0
1047696|NCT00053352|3396061|P1|Overall Study|Withdrawal by Subject|1
1047697|NCT00053352|3396060|P2|Overall Study|Physician Decision|1
1047698|NCT00053352|3396061|P1|Overall Study|Physician Decision|11
1047699|NCT00053352|3396060|P2|Overall Study|Lost to Follow-up|1
1047700|NCT00053352|3396061|P1|Overall Study|Lost to Follow-up|0
1047701|NCT00003830|3396077|P2|Overall Study|Sentinel node positive patients|793
1047702|NCT00003830|3396078|P1|Overall Study|Sentinel node positive patients|829
1047703|NCT00003830|3396077|P2|Overall Study|No follow up data|0
1047704|NCT00003830|3396078|P1|Overall Study|No follow up data|3
1047705|NCT00052962|3396104|P2|Overall Study|Not randomized/not evaluable|0
1047706|NCT00052962|3396105|P1|Overall Study|Not randomized/not evaluable|1
1047707|NCT00052962|3396104|P2|Overall Study|Not evaluable|2
1047708|NCT00052962|3396105|P1|Overall Study|Not evaluable|0
1047709|NCT00052715|3396124|P1|Overall Study|wrong histology|1
1047710|NCT00049543|3396140|P2|Overall Study|still on treatment|9
1047711|NCT00049543|3396141|P1|Overall Study|still on treatment|2
1047712|NCT00049530|3396151|P1|Overall Study|ineligible|3
1047713|NCT00049530|3396151|P1|Overall Study|symptomatic deterioration|1
1047714|NCT00049530|3396151|P1|Overall Study|Death|1
1047715|NCT00049530|3396151|P1|Overall Study|Adverse Event|2
1047716|NCT00049530|3396151|P1|Overall Study|Lack of Efficacy|25
1047717|NCT00049517|3396160|P6|Conditioning/Transplant|Reasons not reported|5
1047718|NCT00049517|3396161|P5|Conditioning/Transplant|Reasons not reported|5
1047719|NCT00049517|3396162|P4|Conditioning/Transplant|Reasons not reported|15
1047720|NCT00049517|3396163|P3|Conditioning/Transplant|Reasons not reported|18
1047721|NCT00049517|3396164|P2|Conditioning/Transplant|Reasons not reported|31
1047722|NCT00049517|3396165|P1|Conditioning/Transplant|Reasons not reported|25
1047723|NCT00049517|3396160|P6|Conditioning/Transplant|Other complicating disease|1
1047724|NCT00049517|3396161|P5|Conditioning/Transplant|Other complicating disease|0
1047725|NCT00049517|3396162|P4|Conditioning/Transplant|Other complicating disease|4
1047726|NCT00049517|3396163|P3|Conditioning/Transplant|Other complicating disease|0
1047727|NCT00049517|3396164|P2|Conditioning/Transplant|Other complicating disease|0
1047728|NCT00049517|3396165|P1|Conditioning/Transplant|Other complicating disease|2
1047729|NCT00049517|3396160|P6|Conditioning/Transplant|Alternative therapy|0
1047730|NCT00049517|3396161|P5|Conditioning/Transplant|Alternative therapy|1
1047731|NCT00049517|3396162|P4|Conditioning/Transplant|Alternative therapy|1
1047732|NCT00049517|3396163|P3|Conditioning/Transplant|Alternative therapy|2
1047733|NCT00049517|3396164|P2|Conditioning/Transplant|Alternative therapy|4
1047734|NCT00049517|3396165|P1|Conditioning/Transplant|Alternative therapy|4
1047735|NCT00049517|3396160|P6|Conditioning/Transplant|Withdrawal by Subject|0
1047736|NCT00049517|3396161|P5|Conditioning/Transplant|Withdrawal by Subject|0
1047737|NCT00049517|3396162|P4|Conditioning/Transplant|Withdrawal by Subject|7
1047738|NCT00049517|3396163|P3|Conditioning/Transplant|Withdrawal by Subject|4
1047739|NCT00049517|3396164|P2|Conditioning/Transplant|Withdrawal by Subject|8
1047740|NCT00049517|3396165|P1|Conditioning/Transplant|Withdrawal by Subject|4
1047741|NCT00049517|3396160|P6|Conditioning/Transplant|Death|0
1047742|NCT00049517|3396161|P5|Conditioning/Transplant|Death|0
1047743|NCT00049517|3396162|P4|Conditioning/Transplant|Death|2
1047744|NCT00049517|3396163|P3|Conditioning/Transplant|Death|0
1047745|NCT00049517|3396164|P2|Conditioning/Transplant|Death|0
1047746|NCT00049517|3396165|P1|Conditioning/Transplant|Death|1
1047747|NCT00049517|3396160|P6|Conditioning/Transplant|Adverse Event|0
1047748|NCT00049517|3396161|P5|Conditioning/Transplant|Adverse Event|0
1047749|NCT00049517|3396162|P4|Conditioning/Transplant|Adverse Event|8
1047750|NCT00049517|3396163|P3|Conditioning/Transplant|Adverse Event|4
1047751|NCT00049517|3396164|P2|Conditioning/Transplant|Adverse Event|1
1047752|NCT00049517|3396165|P1|Conditioning/Transplant|Adverse Event|2
1047753|NCT00049517|3396160|P6|Conditioning/Transplant|Disease progression|0
1047754|NCT00049517|3396161|P5|Conditioning/Transplant|Disease progression|0
1047755|NCT00049517|3396162|P4|Conditioning/Transplant|Disease progression|6
1047756|NCT00049517|3396163|P3|Conditioning/Transplant|Disease progression|10
1047757|NCT00049517|3396164|P2|Conditioning/Transplant|Disease progression|6
1047758|NCT00049517|3396165|P1|Conditioning/Transplant|Disease progression|14
1047759|NCT00049517|3396160|P6|Induction|Reasons not reported|25
1047760|NCT00049517|3396161|P5|Induction|Reasons not reported|22
1047761|NCT00049517|3396162|P4|Induction|Reasons not reported|0
1047762|NCT00049517|3396163|P3|Induction|Reasons not reported|0
1047763|NCT00049517|3396164|P2|Induction|Reasons not reported|0
1047764|NCT00049517|3396165|P1|Induction|Reasons not reported|0
1047765|NCT00049517|3396160|P6|Induction|Other complicating disease|0
1047766|NCT00049517|3396161|P5|Induction|Other complicating disease|3
1047767|NCT00049517|3396162|P4|Induction|Other complicating disease|0
1047768|NCT00049517|3396163|P3|Induction|Other complicating disease|0
1047769|NCT00049517|3396164|P2|Induction|Other complicating disease|0
1047770|NCT00049517|3396165|P1|Induction|Other complicating disease|0
1047771|NCT00049517|3396160|P6|Induction|Alternative therapy|2
1047772|NCT00049517|3396161|P5|Induction|Alternative therapy|2
1047773|NCT00049517|3396162|P4|Induction|Alternative therapy|0
1047774|NCT00049517|3396163|P3|Induction|Alternative therapy|0
1047775|NCT00049517|3396164|P2|Induction|Alternative therapy|0
1047776|NCT00049517|3396165|P1|Induction|Alternative therapy|0
1047777|NCT00049517|3396160|P6|Induction|Withdrawal by Subject|3
1047778|NCT00049517|3396161|P5|Induction|Withdrawal by Subject|1
1047779|NCT00049517|3396162|P4|Induction|Withdrawal by Subject|0
1047780|NCT00049517|3396163|P3|Induction|Withdrawal by Subject|0
1047781|NCT00049517|3396164|P2|Induction|Withdrawal by Subject|0
1047782|NCT00049517|3396165|P1|Induction|Withdrawal by Subject|0
1047783|NCT00049517|3396160|P6|Induction|Death|6
1047784|NCT00049517|3396161|P5|Induction|Death|9
1047785|NCT00049517|3396162|P4|Induction|Death|0
1047786|NCT00049517|3396163|P3|Induction|Death|0
1047787|NCT00049517|3396164|P2|Induction|Death|0
1047788|NCT00049517|3396165|P1|Induction|Death|0
1047789|NCT00049517|3396160|P6|Induction|Adverse Event|7
1047790|NCT00049517|3396161|P5|Induction|Adverse Event|5
1047791|NCT00049517|3396162|P4|Induction|Adverse Event|0
1047792|NCT00049517|3396163|P3|Induction|Adverse Event|0
1047793|NCT00049517|3396164|P2|Induction|Adverse Event|0
1047794|NCT00049517|3396165|P1|Induction|Adverse Event|0
1047795|NCT00049517|3396160|P6|Induction|Disease progression|11
1047796|NCT00049517|3396161|P5|Induction|Disease progression|18
1047797|NCT00049517|3396162|P4|Induction|Disease progression|0
1047798|NCT00049517|3396163|P3|Induction|Disease progression|0
1047799|NCT00049517|3396164|P2|Induction|Disease progression|0
1047800|NCT00049517|3396165|P1|Induction|Disease progression|0
1047801|NCT00049322|3396183|P2|Overall Study|refused angio|3
1047802|NCT00049322|3396184|P1|Overall Study|refused angio|0
1047803|NCT00049322|3396183|P2|Overall Study|Adverse Event|0
1047804|NCT00049322|3396184|P1|Overall Study|Adverse Event|1
1047805|NCT00049322|3396183|P2|Overall Study|disease burden|3
1047806|NCT00049322|3396184|P1|Overall Study|disease burden|0
1047807|NCT00049257|3396196|P1|Follow-up Period for Survival Status|Lost to Follow-up|4
1047808|NCT00049257|3396196|P1|Carboplatin, Paclitaxel|Death|2
1047809|NCT00049257|3396196|P1|Carboplatin, Paclitaxel|Lost to Follow-up|1
1047810|NCT00049257|3396196|P1|Carboplatin, Paclitaxel|Withdrawal by Subject|10
1047811|NCT00049127|3396208|P5|Overall Study|Withdrawal by Subject|0
1047812|NCT00049127|3396209|P4|Overall Study|Withdrawal by Subject|0
1047813|NCT00049127|3396210|P3|Overall Study|Withdrawal by Subject|1
1047814|NCT00049127|3396211|P2|Overall Study|Withdrawal by Subject|0
1047815|NCT00049127|3396212|P1|Overall Study|Withdrawal by Subject|0
1047816|NCT00048997|3396250|P2|Overall Study|Withdrawal by Subject|1
1047817|NCT00048997|3396251|P1|Overall Study|Withdrawal by Subject|6
1047818|NCT00048997|3396250|P2|Overall Study|Protocol Violation|2
1047819|NCT00048997|3396251|P1|Overall Study|Protocol Violation|7
1047820|NCT00047385|3396274|P2|Overall Study|Eligible for screening but had no screen|492
1047821|NCT00047385|3396275|P1|Overall Study|Eligible for screening but had no screen|260
1047822|NCT00047385|3396274|P2|Overall Study|Lung Cancer diagnosed before screening|3
1047823|NCT00047385|3396275|P1|Overall Study|Lung Cancer diagnosed before screening|5
1047824|NCT00047385|3396274|P2|Overall Study|Death before any screening|5
1047825|NCT00047385|3396275|P1|Overall Study|Death before any screening|2
1047826|NCT00047320|3396293|P1|Overall Study|Ineligible|2
1047827|NCT00047320|3396293|P1|Overall Study|Withdrawal by Subject|9
1047828|NCT00047320|3396293|P1|Overall Study|Physician Decision|8
1047829|NCT00047320|3396293|P1|Overall Study|Lost to Follow-up|1
1047830|NCT00047320|3396293|P1|Overall Study|Lack of Efficacy|8
1047831|NCT00047008|3396304|P2|Overall Study|Ineligible|8
1047832|NCT00047008|3396305|P1|Overall Study|Ineligible|9
1047833|NCT00047008|3396304|P2|Overall Study|Withdrawn consent|3
1047834|NCT00047008|3396305|P1|Overall Study|Withdrawn consent|2
1047835|NCT00046930|3396313|P2|Overall Study|Ineligible|4
1047836|NCT00046930|3396314|P1|Overall Study|Ineligible|12
1047837|NCT00046891|3396329|P2|Overall Study|Adverse Event|5
1047838|NCT00046891|3396330|P1|Overall Study|Adverse Event|5
1047839|NCT00046891|3396329|P2|Overall Study|Withdrawal by Subject|15
1047840|NCT00046891|3396330|P1|Overall Study|Withdrawal by Subject|18
1047841|NCT00046891|3396329|P2|Overall Study|Ineligible|1
1047842|NCT00046891|3396330|P1|Overall Study|Ineligible|1
1047843|NCT00046891|3396329|P2|Overall Study|Cancels|9
1047844|NCT00046891|3396330|P1|Overall Study|Cancels|5
1047845|NCT00046839|3396350|P2|Overall Study|Withdrawal of consent|0
1047846|NCT00046839|3396351|P1|Overall Study|Withdrawal of consent|1
1047847|NCT00046839|3396350|P2|Overall Study|Ineligible / No protocol treatment|2
1047848|NCT00046839|3396351|P1|Overall Study|Ineligible / No protocol treatment|0
1047849|NCT00045734|3396358|P1|Overall Study|Protocol Violation|1
1047850|NCT00045708|3396373|P3|Phase 1|early progressive disease|0
1047851|NCT00045708|3396374|P2|Phase 1|early progressive disease|1
1047852|NCT00045708|3396375|P1|Phase 1|early progressive disease|0
1047853|NCT00045630|3396400|P1|Overall Study|Ineligible|2
1047854|NCT00045630|3396400|P1|Overall Study|Death|1
1047855|NCT00045630|3396400|P1|Overall Study|Progression/relapse|1
1047856|NCT00045630|3396400|P1|Overall Study|Refusal unrelated to adverse event|1
1047857|NCT00045630|3396400|P1|Overall Study|Adverse Event|1
1047858|NCT00045305|3396419|P1|Overall Study|site error|2
1047859|NCT00045305|3396419|P1|Overall Study|Death|3
1047860|NCT00045305|3396419|P1|Overall Study|Adverse Event|3
1047861|NCT00045305|3396419|P1|Overall Study|Lack of Efficacy|6
1047862|NCT00045162|3396430|P2|Overall Study|Not specified|16
1047863|NCT00045162|3396431|P1|Overall Study|Not specified|21
1047864|NCT00045162|3396430|P2|Overall Study|Withdrawal by Subject|3
1047865|NCT00045162|3396431|P1|Overall Study|Withdrawal by Subject|5
1047866|NCT00045162|3396430|P2|Overall Study|Death|10
1047867|NCT00045162|3396431|P1|Overall Study|Death|10
1047868|NCT00045162|3396430|P2|Overall Study|Lack of Efficacy|29
1047869|NCT00045162|3396431|P1|Overall Study|Lack of Efficacy|32
1047870|NCT00045162|3396430|P2|Overall Study|Adverse Event|50
1047871|NCT00045162|3396431|P1|Overall Study|Adverse Event|55
1047872|NCT00045162|3396430|P2|Overall Study|Not treated|2
1047873|NCT00045162|3396431|P1|Overall Study|Not treated|7
1047874|NCT00045162|3396430|P2|Overall Study|Ineligible|8
1047875|NCT00045162|3396431|P1|Overall Study|Ineligible|12
1047876|NCT00045110|3396446|P3|100mg Phase 1 Dose Escalalation|ineligible histology|1
1047877|NCT00045110|3396447|P2|100mg Phase 1 Dose Escalalation|ineligible histology|0
1047878|NCT00045110|3396448|P1|100mg Phase 1 Dose Escalalation|ineligible histology|0
1047879|NCT00045110|3396446|P3|100mg Phase 1 Dose Escalalation|prior treatment history|0
1047880|NCT00045110|3396447|P2|100mg Phase 1 Dose Escalalation|prior treatment history|4
1047881|NCT00045110|3396448|P1|100mg Phase 1 Dose Escalalation|prior treatment history|0
1047882|NCT00045110|3396446|P3|100mg Phase 1 Dose Escalalation|did not initiate treatment|1
1047883|NCT00045110|3396447|P2|100mg Phase 1 Dose Escalalation|did not initiate treatment|2
1047884|NCT00045110|3396448|P1|100mg Phase 1 Dose Escalalation|did not initiate treatment|0
1047885|NCT00045032|3396497|P3|Overall Study|Not Specified|105
1047886|NCT00045032|3396498|P2|Overall Study|Not Specified|84
1047887|NCT00045032|3396499|P1|Overall Study|Not Specified|93
1047888|NCT00045032|3396497|P3|Overall Study|Failure to Return|61
1047889|NCT00045032|3396498|P2|Overall Study|Failure to Return|62
1047890|NCT00045032|3396499|P1|Overall Study|Failure to Return|57
1047891|NCT00045032|3396497|P3|Overall Study|Refused/Did Not Cooperate/Withdrew|84
1047892|NCT00045032|3396498|P2|Overall Study|Refused/Did Not Cooperate/Withdrew|93
1047893|NCT00045032|3396499|P1|Overall Study|Refused/Did Not Cooperate/Withdrew|142
1047894|NCT00045032|3396497|P3|Overall Study|Other Protocol Violation|1
1047895|NCT00045032|3396498|P2|Overall Study|Other Protocol Violation|0
1047896|NCT00045032|3396499|P1|Overall Study|Other Protocol Violation|2
1047897|NCT00045032|3396497|P3|Overall Study|Violation of Selection Criteria at Entry|6
1047898|NCT00045032|3396498|P2|Overall Study|Violation of Selection Criteria at Entry|6
1047899|NCT00045032|3396499|P1|Overall Study|Violation of Selection Criteria at Entry|3
1047900|NCT00045032|3396497|P3|Overall Study|Insufficient Therapeutic Response|445
1047901|NCT00045032|3396498|P2|Overall Study|Insufficient Therapeutic Response|437
1047902|NCT00045032|3396499|P1|Overall Study|Insufficient Therapeutic Response|542
1047903|NCT00045032|3396497|P3|Overall Study|Death|17
1047904|NCT00045032|3396498|P2|Overall Study|Death|24
1047905|NCT00045032|3396499|P1|Overall Study|Death|22
1047906|NCT00045032|3396497|P3|Overall Study|Adverse Event/Intercurrent Illness|7
1047907|NCT00045032|3396498|P2|Overall Study|Adverse Event/Intercurrent Illness|2
1047908|NCT00045032|3396499|P1|Overall Study|Adverse Event/Intercurrent Illness|2
1047909|NCT00042991|3396633|P7|Overall Study|Alternative Therapy|0
1047910|NCT00042991|3396634|P6|Overall Study|Alternative Therapy|0
1047911|NCT00042991|3396635|P5|Overall Study|Alternative Therapy|1
1047912|NCT00042991|3396636|P4|Overall Study|Alternative Therapy|0
1047913|NCT00042991|3396637|P3|Overall Study|Alternative Therapy|0
1047914|NCT00042991|3396638|P2|Overall Study|Alternative Therapy|0
1047915|NCT00042991|3396639|P1|Overall Study|Alternative Therapy|0
1047916|NCT00042991|3396633|P7|Overall Study|Disease Progression|2
1047917|NCT00042991|3396634|P6|Overall Study|Disease Progression|4
1047918|NCT00042991|3396635|P5|Overall Study|Disease Progression|1
1047919|NCT00042991|3396636|P4|Overall Study|Disease Progression|2
1047920|NCT00042991|3396637|P3|Overall Study|Disease Progression|2
1047921|NCT00042991|3396638|P2|Overall Study|Disease Progression|29
1047922|NCT00042991|3396639|P1|Overall Study|Disease Progression|5
1047923|NCT00042991|3396633|P7|Overall Study|Withdrawal by Subject|0
1047924|NCT00042991|3396634|P6|Overall Study|Withdrawal by Subject|0
1047925|NCT00042991|3396635|P5|Overall Study|Withdrawal by Subject|1
1047926|NCT00042991|3396636|P4|Overall Study|Withdrawal by Subject|0
1047927|NCT00042991|3396637|P3|Overall Study|Withdrawal by Subject|2
1047928|NCT00042991|3396638|P2|Overall Study|Withdrawal by Subject|7
1047929|NCT00042991|3396639|P1|Overall Study|Withdrawal by Subject|0
1047930|NCT00042991|3396633|P7|Overall Study|Adverse Event|0
1047931|NCT00042991|3396634|P6|Overall Study|Adverse Event|1
1047932|NCT00042991|3396635|P5|Overall Study|Adverse Event|0
1047933|NCT00042991|3396636|P4|Overall Study|Adverse Event|0
1047934|NCT00042991|3396637|P3|Overall Study|Adverse Event|2
1047935|NCT00042991|3396638|P2|Overall Study|Adverse Event|4
1047936|NCT00042991|3396639|P1|Overall Study|Adverse Event|1
1047937|NCT00042939|3396682|P2|Overall Study|Did not start treatment|1
1047938|NCT00042939|3396683|P1|Overall Study|Did not start treatment|2
1047939|NCT00042939|3396682|P2|Overall Study|Treatment break > 4 weeks|1
1047940|NCT00042939|3396683|P1|Overall Study|Treatment break > 4 weeks|0
1047941|NCT00042939|3396682|P2|Overall Study|Still on treatment|0
1047942|NCT00042939|3396683|P1|Overall Study|Still on treatment|1
1047943|NCT00042939|3396682|P2|Overall Study|Patient non-compliance|0
1047944|NCT00042939|3396683|P1|Overall Study|Patient non-compliance|1
1047945|NCT00042939|3396682|P2|Overall Study|Rising ca 19-9|0
1047946|NCT00042939|3396683|P1|Overall Study|Rising ca 19-9|1
1047947|NCT00042939|3396682|P2|Overall Study|QOL diminished|0
1047948|NCT00042939|3396683|P1|Overall Study|QOL diminished|1
1047949|NCT00042939|3396682|P2|Overall Study|Deterioration of health|4
1047950|NCT00042939|3396683|P1|Overall Study|Deterioration of health|3
1047951|NCT00042939|3396682|P2|Overall Study|Ineligible|2
1047952|NCT00042939|3396683|P1|Overall Study|Ineligible|2
1047953|NCT00042939|3396682|P2|Overall Study|Other disease|0
1047954|NCT00042939|3396683|P1|Overall Study|Other disease|1
1047955|NCT00042939|3396682|P2|Overall Study|Withdrawal by Subject|4
1047956|NCT00042939|3396683|P1|Overall Study|Withdrawal by Subject|3
1047957|NCT00042939|3396682|P2|Overall Study|Death|2
1047958|NCT00042939|3396683|P1|Overall Study|Death|3
1047959|NCT00042939|3396682|P2|Overall Study|Adverse Event|7
1047960|NCT00042939|3396683|P1|Overall Study|Adverse Event|6
1047961|NCT00041132|3396697|P1|Overall Study|Physician Decision|2
1047962|NCT00041132|3396697|P1|Overall Study|Withdrawal by Subject|1
1047963|NCT00041132|3396697|P1|Overall Study|Not Eligible|7
1047964|NCT00041132|3396697|P1|Overall Study|Death|1
1047965|NCT00041132|3396697|P1|Overall Study|Adverse Event|19
1047966|NCT00041080|3396732|P2|Overall Study|Ineligible|0
1047967|NCT00041080|3396733|P1|Overall Study|Ineligible|1
1047968|NCT00041080|3396732|P2|Overall Study|Did not start therapy|1
1047969|NCT00041080|3396733|P1|Overall Study|Did not start therapy|1
1047970|NCT00041080|3396732|P2|Overall Study|Concommitant Illness/Other|2
1047971|NCT00041080|3396733|P1|Overall Study|Concommitant Illness/Other|1
1047972|NCT00041080|3396732|P2|Overall Study|Withdrawal by Subject|6
1047973|NCT00041080|3396733|P1|Overall Study|Withdrawal by Subject|6
1047974|NCT00041080|3396732|P2|Overall Study|Adverse Event|1
1047975|NCT00041080|3396733|P1|Overall Study|Adverse Event|21
1047976|NCT00041067|3396739|P1|Overall Study|Ineligible|2
1047977|NCT00041067|3396739|P1|Overall Study|Other reasons|23
1047978|NCT00041067|3396739|P1|Overall Study|Patient refusal|12
1047979|NCT00041067|3396739|P1|Overall Study|Progression|19
1047980|NCT00041067|3396739|P1|Overall Study|Adverse Event|20
1047981|NCT00040742|3396806|P4|Overall Study|Other medical|5
1047982|NCT00040742|3396807|P3|Overall Study|Other medical|5
1047983|NCT00040742|3396808|P2|Overall Study|Other medical|5
1047984|NCT00040742|3396809|P1|Overall Study|Other medical|7
1047985|NCT00040742|3396806|P4|Overall Study|Incomplete Forms|5
1047986|NCT00040742|3396807|P3|Overall Study|Incomplete Forms|4
1047987|NCT00040742|3396808|P2|Overall Study|Incomplete Forms|10
1047988|NCT00040742|3396809|P1|Overall Study|Incomplete Forms|6
1047989|NCT00040742|3396806|P4|Overall Study|Chemotoxicity|2
1047990|NCT00040742|3396807|P3|Overall Study|Chemotoxicity|5
1047991|NCT00040742|3396808|P2|Overall Study|Chemotoxicity|3
1047992|NCT00040742|3396809|P1|Overall Study|Chemotoxicity|4
1047993|NCT00040742|3396806|P4|Overall Study|Withdrawal by Subject|13
1047994|NCT00040742|3396807|P3|Overall Study|Withdrawal by Subject|10
1047995|NCT00040742|3396808|P2|Overall Study|Withdrawal by Subject|15
1047996|NCT00040742|3396809|P1|Overall Study|Withdrawal by Subject|7
1047997|NCT00040742|3396806|P4|Overall Study|Adverse Event|9
1047998|NCT00040742|3396807|P3|Overall Study|Adverse Event|21
1047999|NCT00040742|3396808|P2|Overall Study|Adverse Event|16
1048000|NCT00040742|3396809|P1|Overall Study|Adverse Event|15
1048001|NCT00040742|3396806|P4|Overall Study|Death|0
1048002|NCT00040742|3396807|P3|Overall Study|Death|1
1048003|NCT00040742|3396808|P2|Overall Study|Death|0
1048004|NCT00040742|3396809|P1|Overall Study|Death|0
1048005|NCT00039377|3396823|P4|Initial Registration|Withdrawal by Subject|0
1048006|NCT00039377|3396824|P3|Initial Registration|Withdrawal by Subject|0
1048007|NCT00039377|3396825|P2|Initial Registration|Withdrawal by Subject|0
1048008|NCT00039377|3396826|P1|Initial Registration|Withdrawal by Subject|3
1048009|NCT00039377|3396823|P4|Initial Registration|Received non-protocol therapy|0
1048010|NCT00039377|3396824|P3|Initial Registration|Received non-protocol therapy|0
1048011|NCT00039377|3396825|P2|Initial Registration|Received non-protocol therapy|0
1048012|NCT00039377|3396826|P1|Initial Registration|Received non-protocol therapy|11
1048013|NCT00039377|3396823|P4|Initial Registration|Relapsed|0
1048014|NCT00039377|3396824|P3|Initial Registration|Relapsed|0
1048015|NCT00039377|3396825|P2|Initial Registration|Relapsed|0
1048016|NCT00039377|3396826|P1|Initial Registration|Relapsed|6
1048017|NCT00039377|3396823|P4|Initial Registration|Adverse Event|0
1048018|NCT00039377|3396824|P3|Initial Registration|Adverse Event|0
1048019|NCT00039377|3396825|P2|Initial Registration|Adverse Event|0
1048020|NCT00039377|3396826|P1|Initial Registration|Adverse Event|2
1048021|NCT00039130|3396842|P1|Overall Study|Physician Decision|3
1048022|NCT00039130|3396842|P1|Overall Study|Subsequent treatment|2
1048023|NCT00039130|3396842|P1|Overall Study|Progression|2
1048024|NCT00039130|3396842|P1|Overall Study|Withdrawal by Subject|3
1048025|NCT00039130|3396842|P1|Overall Study|Death|9
1048026|NCT00039130|3396842|P1|Overall Study|Adverse Event|11
1048027|NCT00033657|3396856|P2|Adjuvant Chemotherapy|Other|2
1048028|NCT00033657|3396857|P1|Adjuvant Chemotherapy|Other|0
1048029|NCT00033657|3396856|P2|Adjuvant Chemotherapy|alternative therapy|0
1048030|NCT00033657|3396857|P1|Adjuvant Chemotherapy|alternative therapy|1
1048031|NCT00033657|3396856|P2|Adjuvant Chemotherapy|Withdrawal by Subject|3
1048032|NCT00033657|3396857|P1|Adjuvant Chemotherapy|Withdrawal by Subject|5
1048033|NCT00033657|3396856|P2|Adjuvant Chemotherapy|Death|1
1048034|NCT00033657|3396857|P1|Adjuvant Chemotherapy|Death|2
1048035|NCT00033657|3396856|P2|Adjuvant Chemotherapy|Adverse Event|10
1048036|NCT00033657|3396857|P1|Adjuvant Chemotherapy|Adverse Event|7
1048037|NCT00033657|3396856|P2|Adjuvant Chemotherapy|Lack of Efficacy|1
1048038|NCT00033657|3396857|P1|Adjuvant Chemotherapy|Lack of Efficacy|3
1048039|NCT00033657|3396856|P2|Surgical Resection|not complete resection|3
1048040|NCT00033657|3396857|P1|Surgical Resection|not complete resection|0
1048041|NCT00033657|3396856|P2|Neoadjuvant Chemotherapy|Not started protocol therapy|1
1048042|NCT00033657|3396857|P1|Neoadjuvant Chemotherapy|Not started protocol therapy|3
1048043|NCT00033657|3396856|P2|Neoadjuvant Chemotherapy|Ineligible|4
1048044|NCT00033657|3396857|P1|Neoadjuvant Chemotherapy|Ineligible|8
1048045|NCT00033657|3396856|P2|Neoadjuvant Chemotherapy|other complicating disease|1
1048046|NCT00033657|3396857|P1|Neoadjuvant Chemotherapy|other complicating disease|0
1048047|NCT00033657|3396856|P2|Neoadjuvant Chemotherapy|Withdrawal by Subject|0
1048048|NCT00033657|3396857|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
1048049|NCT00033657|3396856|P2|Neoadjuvant Chemotherapy|Death|1
1048050|NCT00033657|3396857|P1|Neoadjuvant Chemotherapy|Death|1
1048051|NCT00033657|3396856|P2|Neoadjuvant Chemotherapy|Adverse Event|2
1048052|NCT00033657|3396857|P1|Neoadjuvant Chemotherapy|Adverse Event|0
1048053|NCT00033657|3396856|P2|Neoadjuvant Chemotherapy|Lack of Efficacy|2
1048054|NCT00033657|3396857|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|1
1048055|NCT00033631|3396871|P2|Overall Study|Withdrawal by Subject|4
1048056|NCT00033631|3396872|P1|Overall Study|Withdrawal by Subject|4
1048057|NCT00033631|3396871|P2|Overall Study|Protocol Violation|11
1048058|NCT00033631|3396872|P1|Overall Study|Protocol Violation|14
1048059|NCT00033540|3396890|P1|Overall Study|Never received treatment|2
1048060|NCT00033540|3396890|P1|Overall Study|Ineligible|3
1048061|NCT00033540|3396890|P1|Overall Study|Not specified|5
1048062|NCT00033540|3396890|P1|Overall Study|Withdrawal by Subject|6
1048063|NCT00033540|3396890|P1|Overall Study|Progression|26
1048064|NCT00033540|3396890|P1|Overall Study|Death|1
1048065|NCT00033540|3396890|P1|Overall Study|Adverse Event|14
1048066|NCT00033514|3396900|P2|Overall Study|Withdrawal by Subject|3
1048067|NCT00033514|3396901|P1|Overall Study|Withdrawal by Subject|0
1048068|NCT00033514|3396900|P2|Overall Study|Lost to Follow-up|1
1048069|NCT00033514|3396901|P1|Overall Study|Lost to Follow-up|1
1048070|NCT00033371|3396911|P2|Overall Study|Disease Progression|1
1048071|NCT00033371|3396912|P1|Overall Study|Disease Progression|0
1048072|NCT00033371|3396911|P2|Overall Study|Withdrawal by Subject|3
1048073|NCT00033371|3396912|P1|Overall Study|Withdrawal by Subject|3
1048074|NCT00033371|3396911|P2|Overall Study|Lost to Follow-up|1
1048075|NCT00033371|3396912|P1|Overall Study|Lost to Follow-up|2
1048076|NCT00033371|3396911|P2|Overall Study|Adverse Event|5
1048077|NCT00033371|3396912|P1|Overall Study|Adverse Event|1
1048078|NCT00033293|3396920|P2|Overall Study|Treatment refused|6
1048079|NCT00033293|3396921|P1|Overall Study|Treatment refused|0
1048080|NCT00033293|3396920|P2|Overall Study|Could not be weaned from steroid therapy|1
1048081|NCT00033293|3396921|P1|Overall Study|Could not be weaned from steroid therapy|1
1048082|NCT00033293|3396920|P2|Overall Study|Withdrawal by Subject|0
1048083|NCT00033293|3396921|P1|Overall Study|Withdrawal by Subject|1
1048084|NCT00033293|3396920|P2|Overall Study|Physician Decision|1
1048085|NCT00033293|3396921|P1|Overall Study|Physician Decision|3
1048086|NCT00033293|3396920|P2|Overall Study|Lost to Follow-up|1
1048087|NCT00033293|3396921|P1|Overall Study|Lost to Follow-up|0
1048088|NCT00033293|3396920|P2|Overall Study|Lack of Efficacy|8
1048089|NCT00033293|3396921|P1|Overall Study|Lack of Efficacy|5
1048090|NCT00033293|3396920|P2|Overall Study|Death|1
1048091|NCT00033293|3396921|P1|Overall Study|Death|0
1048092|NCT00031694|3396939|P1|Overall Study|Withdrawal by Subject|5
1048093|NCT00031694|3396939|P1|Overall Study|Death|2
1048094|NCT00031694|3396939|P1|Overall Study|Adverse Event|12
1048095|NCT00030901|3396945|P3|Randomization|Ineligible|14
1048096|NCT00030901|3396946|P2|Randomization|Ineligible|15
1048097|NCT00030901|3396947|P1|Randomization|Ineligible|0
1048098|NCT00030901|3396945|P3|Randomization|Other|33
1048099|NCT00030901|3396946|P2|Randomization|Other|36
1048100|NCT00030901|3396947|P1|Randomization|Other|0
1048101|NCT00030901|3396945|P3|Randomization|Death|3
1048102|NCT00030901|3396946|P2|Randomization|Death|1
1048103|NCT00030901|3396947|P1|Randomization|Death|0
1048104|NCT00030901|3396945|P3|Randomization|Progression/Relapse|21
1048105|NCT00030901|3396946|P2|Randomization|Progression/Relapse|22
1048106|NCT00030901|3396947|P1|Randomization|Progression/Relapse|0
1048107|NCT00030901|3396945|P3|Randomization|Refusal Unrelated to Adverse Event|10
1048108|NCT00030901|3396946|P2|Randomization|Refusal Unrelated to Adverse Event|16
1048109|NCT00030901|3396947|P1|Randomization|Refusal Unrelated to Adverse Event|0
1048110|NCT00030901|3396945|P3|Randomization|Adverse Event|7
1048111|NCT00030901|3396946|P2|Randomization|Adverse Event|11
1048112|NCT00030901|3396947|P1|Randomization|Adverse Event|0
1048113|NCT00030901|3396945|P3|Initial Registration|Ineligible|0
1048114|NCT00030901|3396946|P2|Initial Registration|Ineligible|0
1048115|NCT00030901|3396947|P1|Initial Registration|Ineligible|167
1048116|NCT00030823|3396955|P1|Overall Study|Withdrawal by Subject|1
1048117|NCT00028769|3396963|P1|Overall Study|Not Analyzable|1
1048118|NCT00028769|3396963|P1|Overall Study|Ineligible|5
1048119|NCT00028769|3396963|P1|Overall Study|Other - Not Protocol Specified|1
1048120|NCT00028769|3396963|P1|Overall Study|Progression or Death|31
1048121|NCT00028769|3396963|P1|Overall Study|Refusal Unrelated to Adverse Events|1
1048122|NCT00028769|3396963|P1|Overall Study|Adverse Event|2
1048123|NCT00028002|3396969|P1|Overall Study|Ineligible|8
1048124|NCT00028002|3396969|P1|Overall Study|Withdrawal by Subject|3
1048125|NCT00027846|3396979|P3|Overall Study|Neuraxis dissemination during/after ther|5
1048126|NCT00027846|3396980|P2|Overall Study|Neuraxis dissemination during/after ther|2
1048127|NCT00027846|3396981|P1|Overall Study|Neuraxis dissemination during/after ther|0
1048128|NCT00027846|3396979|P3|Overall Study|Entry into another COG therapeutic study|2
1048129|NCT00027846|3396980|P2|Overall Study|Entry into another COG therapeutic study|5
1048130|NCT00027846|3396981|P1|Overall Study|Entry into another COG therapeutic study|0
1048131|NCT00027846|3396979|P3|Overall Study|Ineligible for study|14
1048132|NCT00027846|3396980|P2|Overall Study|Ineligible for study|6
1048133|NCT00027846|3396981|P1|Overall Study|Ineligible for study|2
1048134|NCT00027846|3396979|P3|Overall Study|Withdrawal by Subject|7
1048135|NCT00027846|3396980|P2|Overall Study|Withdrawal by Subject|14
1048136|NCT00027846|3396981|P1|Overall Study|Withdrawal by Subject|0
1048137|NCT00027846|3396979|P3|Overall Study|Lost to Follow-up|9
1048138|NCT00027846|3396980|P2|Overall Study|Lost to Follow-up|41
1048139|NCT00027846|3396981|P1|Overall Study|Lost to Follow-up|0
1048140|NCT00027560|3396999|P1|Overall Study|Withdrawal by Subject|1
1048141|NCT00026494|3397012|P4|Overall Study|Clinical progression|0
1048142|NCT00026494|3397013|P3|Overall Study|Clinical progression|3
1048143|NCT00026494|3397014|P2|Overall Study|Clinical progression|0
1048144|NCT00026494|3397015|P1|Overall Study|Clinical progression|0
1048145|NCT00026494|3397012|P4|Overall Study|Patient not treated|0
1048146|NCT00026494|3397013|P3|Overall Study|Patient not treated|2
1048147|NCT00026494|3397014|P2|Overall Study|Patient not treated|0
1048148|NCT00026494|3397015|P1|Overall Study|Patient not treated|0
1048149|NCT00026494|3397012|P4|Overall Study|Patient non-compliance|0
1048150|NCT00026494|3397013|P3|Overall Study|Patient non-compliance|0
1048151|NCT00026494|3397014|P2|Overall Study|Patient non-compliance|0
1048152|NCT00026494|3397015|P1|Overall Study|Patient non-compliance|1
1048153|NCT00026494|3397012|P4|Overall Study|Withdrawal by Subject|0
1048154|NCT00026494|3397013|P3|Overall Study|Withdrawal by Subject|1
1048155|NCT00026494|3397014|P2|Overall Study|Withdrawal by Subject|0
1048156|NCT00026494|3397015|P1|Overall Study|Withdrawal by Subject|1
1048157|NCT00026312|3397027|P2|Overall Study|Refusal by patient/parent/guardian|59
1048158|NCT00026312|3397028|P1|Overall Study|Refusal by patient/parent/guardian|8
1048159|NCT00026312|3397027|P2|Overall Study|Entry onto another COG study|1
1048160|NCT00026312|3397028|P1|Overall Study|Entry onto another COG study|0
1048161|NCT00026312|3397027|P2|Overall Study|Ineligible|5
1048162|NCT00026312|3397028|P1|Overall Study|Ineligible|4
1048163|NCT00026312|3397027|P2|Overall Study|Withdrawal by Subject|6
1048164|NCT00026312|3397028|P1|Overall Study|Withdrawal by Subject|1
1048165|NCT00026312|3397027|P2|Overall Study|Protocol Violation|3
1048166|NCT00026312|3397028|P1|Overall Study|Protocol Violation|0
1048167|NCT00026312|3397027|P2|Overall Study|Physician Decision|37
1048168|NCT00026312|3397028|P1|Overall Study|Physician Decision|1
1048169|NCT00026312|3397027|P2|Overall Study|Lost to Follow-up|5
1048170|NCT00026312|3397028|P1|Overall Study|Lost to Follow-up|0
1048171|NCT00026312|3397027|P2|Overall Study|Lack of Efficacy|114
1048172|NCT00026312|3397028|P1|Overall Study|Lack of Efficacy|19
1048173|NCT00026312|3397027|P2|Overall Study|Death|7
1048174|NCT00026312|3397028|P1|Overall Study|Death|1
1048175|NCT00026312|3397027|P2|Overall Study|Adverse Event|32
1048176|NCT00026312|3397028|P1|Overall Study|Adverse Event|0
1048177|NCT00026208|3397067|P2|Overall Study|Complications of auto accident|0
1048178|NCT00026208|3397068|P1|Overall Study|Complications of auto accident|1
1048179|NCT00025662|3397086|P1|Overall Study|Technical failure of manipulation|1
1048180|NCT00025662|3397086|P1|Overall Study|Withdrawal by Subject|2
1048181|NCT00025506|3397094|P1|Overall Study|Never Treated|2
1048182|NCT00025506|3397094|P1|Overall Study|Ineligible: inadequate pathology|2
1048183|NCT00025506|3397094|P1|Overall Study|Ineligible: wrong cell type|5
1048184|NCT00025506|3397094|P1|Overall Study|Ineligible: clerical error|1
1048185|NCT00025259|3397115|P7|Overall Study|Adverse Event|0
1048186|NCT00025259|3397116|P6|Overall Study|Adverse Event|0
1048187|NCT00025259|3397117|P5|Overall Study|Adverse Event|0
1048188|NCT00025259|3397118|P4|Overall Study|Adverse Event|0
1048189|NCT00025259|3397119|P3|Overall Study|Adverse Event|0
1048190|NCT00025259|3397120|P2|Overall Study|Adverse Event|0
1048191|NCT00025259|3397121|P1|Overall Study|Adverse Event|1
1048192|NCT00025259|3397115|P7|Overall Study|Randomization error|2
1048193|NCT00025259|3397116|P6|Overall Study|Randomization error|7
1048194|NCT00025259|3397117|P5|Overall Study|Randomization error|1
1048195|NCT00025259|3397118|P4|Overall Study|Randomization error|0
1048196|NCT00025259|3397119|P3|Overall Study|Randomization error|0
1048197|NCT00025259|3397120|P2|Overall Study|Randomization error|0
1048198|NCT00025259|3397121|P1|Overall Study|Randomization error|1
1048199|NCT00025259|3397115|P7|Overall Study|Ineligible|1
1048200|NCT00025259|3397116|P6|Overall Study|Ineligible|0
1048201|NCT00025259|3397117|P5|Overall Study|Ineligible|6
1048202|NCT00025259|3397118|P4|Overall Study|Ineligible|0
1048203|NCT00025259|3397119|P3|Overall Study|Ineligible|0
1048204|NCT00025259|3397120|P2|Overall Study|Ineligible|1
1048205|NCT00025259|3397121|P1|Overall Study|Ineligible|14
1048206|NCT00025259|3397115|P7|Overall Study|Withdrawal by Subject|3
1048207|NCT00025259|3397116|P6|Overall Study|Withdrawal by Subject|8
1048208|NCT00025259|3397117|P5|Overall Study|Withdrawal by Subject|11
1048209|NCT00025259|3397118|P4|Overall Study|Withdrawal by Subject|14
1048210|NCT00025259|3397119|P3|Overall Study|Withdrawal by Subject|6
1048211|NCT00025259|3397120|P2|Overall Study|Withdrawal by Subject|27
1048212|NCT00025259|3397121|P1|Overall Study|Withdrawal by Subject|9
1048213|NCT00025259|3397115|P7|Overall Study|Protocol Violation|3
1048214|NCT00025259|3397116|P6|Overall Study|Protocol Violation|1
1048215|NCT00025259|3397117|P5|Overall Study|Protocol Violation|2
1048216|NCT00025259|3397118|P4|Overall Study|Protocol Violation|1
1048217|NCT00025259|3397119|P3|Overall Study|Protocol Violation|2
1048218|NCT00025259|3397120|P2|Overall Study|Protocol Violation|2
1048219|NCT00025259|3397121|P1|Overall Study|Protocol Violation|3
1048220|NCT00025259|3397115|P7|Overall Study|Physician Decision|1
1048221|NCT00025259|3397116|P6|Overall Study|Physician Decision|2
1048222|NCT00025259|3397117|P5|Overall Study|Physician Decision|4
1048223|NCT00025259|3397118|P4|Overall Study|Physician Decision|5
1048224|NCT00025259|3397119|P3|Overall Study|Physician Decision|0
1048225|NCT00025259|3397120|P2|Overall Study|Physician Decision|1
1048226|NCT00025259|3397121|P1|Overall Study|Physician Decision|12
1048227|NCT00025259|3397115|P7|Overall Study|Lost to Follow-up|1
1048228|NCT00025259|3397116|P6|Overall Study|Lost to Follow-up|3
1048229|NCT00025259|3397117|P5|Overall Study|Lost to Follow-up|1
1048230|NCT00025259|3397118|P4|Overall Study|Lost to Follow-up|13
1048231|NCT00025259|3397119|P3|Overall Study|Lost to Follow-up|13
1048232|NCT00025259|3397120|P2|Overall Study|Lost to Follow-up|9
1048233|NCT00025259|3397121|P1|Overall Study|Lost to Follow-up|2
1048234|NCT00025259|3397115|P7|Overall Study|Lack of Efficacy|38
1048235|NCT00025259|3397116|P6|Overall Study|Lack of Efficacy|30
1048236|NCT00025259|3397117|P5|Overall Study|Lack of Efficacy|11
1048237|NCT00025259|3397118|P4|Overall Study|Lack of Efficacy|78
1048238|NCT00025259|3397119|P3|Overall Study|Lack of Efficacy|60
1048239|NCT00025259|3397120|P2|Overall Study|Lack of Efficacy|46
1048240|NCT00025259|3397121|P1|Overall Study|Lack of Efficacy|2
1048241|NCT00025259|3397115|P7|Overall Study|Death|2
1048242|NCT00025259|3397116|P6|Overall Study|Death|1
1048243|NCT00025259|3397117|P5|Overall Study|Death|0
1048244|NCT00025259|3397118|P4|Overall Study|Death|3
1048245|NCT00025259|3397119|P3|Overall Study|Death|0
1048246|NCT00025259|3397120|P2|Overall Study|Death|3
1048247|NCT00025259|3397121|P1|Overall Study|Death|1
1048248|NCT00025233|3397157|P1|Overall Study|Never treated|1
1048249|NCT00025233|3397157|P1|Overall Study|Ineligible: improper prior treatment|1
1048250|NCT00025233|3397157|P1|Overall Study|Ineligible: wrong primary|1
1048251|NCT00025233|3397157|P1|Overall Study|Ineligible: wrong cell type|1
1048252|NCT00025155|3397172|P1|Overall Study|Ineligible: Second primary cancer site|1
1048253|NCT00025155|3397172|P1|Overall Study|Ineligible: Wrong primary cancer site|1
1048254|NCT00024258|3397183|P1|Overall Study|Disease Progression|8
1048255|NCT00024258|3397183|P1|Overall Study|Withdrawal by Subject|1
1048256|NCT00024167|3397190|P2|Overall Study|Death|47
1048257|NCT00024167|3397191|P1|Overall Study|Death|53
1048258|NCT00023764|3397215|P1|Overall Study|delay in obtaining staging images|1
1048259|NCT00023764|3397215|P1|Overall Study|patient received other treatment|1
1048260|NCT00023764|3397215|P1|Overall Study|Progression of disease|6
1048261|NCT00023764|3397215|P1|Overall Study|Withdrawal by Subject|1
1048262|NCT00023764|3397215|P1|Overall Study|Adverse Event|4
1048263|NCT00023764|3397215|P1|Overall Study|Other|1
1048264|NCT00023712|3397222|P2|Overall Study|Never treated|1
1048265|NCT00023712|3397223|P1|Overall Study|Never treated|1
1048266|NCT00023712|3397222|P2|Overall Study|Not platinum sensitive|0
1048267|NCT00023712|3397223|P1|Overall Study|Not platinum sensitive|1
1048268|NCT00022698|3397247|P2|Overall Study|Administrative /other|7
1048269|NCT00022698|3397248|P1|Overall Study|Administrative /other|1
1048270|NCT00022698|3397247|P2|Overall Study|Insufficient therapeutic response|14
1048271|NCT00022698|3397248|P1|Overall Study|Insufficient therapeutic response|2
1048272|NCT00022698|3397247|P2|Overall Study|Refused treatment|2
1048273|NCT00022698|3397248|P1|Overall Study|Refused treatment|0
1048274|NCT00022698|3397247|P2|Overall Study|Failure to return|1
1048275|NCT00022698|3397248|P1|Overall Study|Failure to return|0
1048276|NCT00022698|3397247|P2|Overall Study|Death|2
1048277|NCT00022698|3397248|P1|Overall Study|Death|0
1048278|NCT00022698|3397247|P2|Overall Study|Adverse Event|9
1048279|NCT00022698|3397248|P1|Overall Study|Adverse Event|5
1048280|NCT00022672|3397273|P2|Extension Phase|Other|1
1048281|NCT00022672|3397274|P1|Extension Phase|Other|1
1048282|NCT00022672|3397273|P2|Extension Phase|Refused Treatment|2
1048283|NCT00022672|3397274|P1|Extension Phase|Refused Treatment|0
1048284|NCT00022672|3397273|P2|Extension Phase|Insufficient Therapeutic Response|44
1048285|NCT00022672|3397274|P1|Extension Phase|Insufficient Therapeutic Response|1
1048286|NCT00022672|3397273|P2|Extension Phase|Death|1
1048287|NCT00022672|3397274|P1|Extension Phase|Death|0
1048288|NCT00022672|3397273|P2|Extension Phase|Adverse Event|3
1048289|NCT00022672|3397274|P1|Extension Phase|Adverse Event|1
1048290|NCT00022672|3397273|P2|Main Phase: 24 Months|Other|0
1048291|NCT00022672|3397274|P1|Main Phase: 24 Months|Other|1
1048292|NCT00022672|3397273|P2|Main Phase: 24 Months|Failure to Return|1
1048293|NCT00022672|3397274|P1|Main Phase: 24 Months|Failure to Return|1
1048294|NCT00022672|3397273|P2|Main Phase: 24 Months|Refused Treatment|4
1048295|NCT00022672|3397274|P1|Main Phase: 24 Months|Refused Treatment|3
1048296|NCT00022672|3397273|P2|Main Phase: 24 Months|Other Protocol Violation|0
1048297|NCT00022672|3397274|P1|Main Phase: 24 Months|Other Protocol Violation|1
1048298|NCT00022672|3397273|P2|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1
1048299|NCT00022672|3397274|P1|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0
1048300|NCT00022672|3397273|P2|Main Phase: 24 Months|Insufficient Therapeutic Response|91
1048301|NCT00022672|3397274|P1|Main Phase: 24 Months|Insufficient Therapeutic Response|75
1048302|NCT00022672|3397273|P2|Main Phase: 24 Months|Death|3
1048303|NCT00022672|3397274|P1|Main Phase: 24 Months|Death|0
1048304|NCT00022672|3397273|P2|Main Phase: 24 Months|Adverse Event|0
1048305|NCT00022672|3397274|P1|Main Phase: 24 Months|Adverse Event|6
1048306|NCT00022659|3397307|P1|Overall Study|Never treated|1
1048307|NCT00022659|3397307|P1|Overall Study|Ineligible: wrong primary|1
1048308|NCT00022633|3397320|P2|Overall Study|Ineligible|0
1048309|NCT00022633|3397321|P1|Overall Study|Ineligible|4
1048310|NCT00022633|3397320|P2|Overall Study|Other - not protocol specified|2
1048311|NCT00022633|3397321|P1|Overall Study|Other - not protocol specified|3
1048312|NCT00022633|3397320|P2|Overall Study|Death|0
1048313|NCT00022633|3397321|P1|Overall Study|Death|4
1048314|NCT00022633|3397320|P2|Overall Study|Progression/relapse|2
1048315|NCT00022633|3397321|P1|Overall Study|Progression/relapse|9
1048316|NCT00022633|3397320|P2|Overall Study|Refusal unrelated to adverse event|0
1048317|NCT00022633|3397321|P1|Overall Study|Refusal unrelated to adverse event|1
1048318|NCT00022633|3397320|P2|Overall Study|Adverse Event|1
1048319|NCT00022633|3397321|P1|Overall Study|Adverse Event|11
1048320|NCT00022516|3397334|P2|Overall Study|Incomplete documentation|27
1048321|NCT00022516|3397335|P1|Overall Study|Incomplete documentation|0
1048322|NCT00022516|3397334|P2|Overall Study|Withdrawal by Subject|113
1048323|NCT00022516|3397335|P1|Overall Study|Withdrawal by Subject|2
1048324|NCT00022516|3397334|P2|Overall Study|Protocol Violation|3
1048325|NCT00022516|3397335|P1|Overall Study|Protocol Violation|1
1048326|NCT00022516|3397334|P2|Overall Study|Physician Decision|1
1048327|NCT00022516|3397335|P1|Overall Study|Physician Decision|0
1048328|NCT00022516|3397334|P2|Overall Study|Lack of Efficacy|27
1048329|NCT00022516|3397335|P1|Overall Study|Lack of Efficacy|0
1048330|NCT00022516|3397334|P2|Overall Study|Adverse Event|59
1048331|NCT00022516|3397335|P1|Overall Study|Adverse Event|0
1048332|NCT00021255|3397354|P3|Overall Study|Randomized but not treated|18
1048333|NCT00021255|3397355|P2|Overall Study|Randomized but not treated|2
1048334|NCT00021255|3397356|P1|Overall Study|Randomized but not treated|28
1048335|NCT00021255|3397354|P3|Overall Study|Missing|13
1048336|NCT00021255|3397355|P2|Overall Study|Missing|27
1048337|NCT00021255|3397356|P1|Overall Study|Missing|0
1048338|NCT00021255|3397354|P3|Overall Study|Other than specified above|19
1048339|NCT00021255|3397355|P2|Overall Study|Other than specified above|38
1048340|NCT00021255|3397356|P1|Overall Study|Other than specified above|0
1048341|NCT00021255|3397354|P3|Overall Study|Protocol Violation|0
1048342|NCT00021255|3397355|P2|Overall Study|Protocol Violation|2
1048343|NCT00021255|3397356|P1|Overall Study|Protocol Violation|0
1048344|NCT00021255|3397354|P3|Overall Study|Adverse Event|18
1048345|NCT00021255|3397355|P2|Overall Study|Adverse Event|30
1048346|NCT00021255|3397356|P1|Overall Study|Adverse Event|46
1048347|NCT00021255|3397354|P3|Overall Study|Herceptin toxicity|6
1048348|NCT00021255|3397355|P2|Overall Study|Herceptin toxicity|22
1048349|NCT00021255|3397356|P1|Overall Study|Herceptin toxicity|0
1048350|NCT00021255|3397354|P3|Overall Study|Cardiac toxicity|32
1048351|NCT00021255|3397355|P2|Overall Study|Cardiac toxicity|61
1048352|NCT00021255|3397356|P1|Overall Study|Cardiac toxicity|0
1048353|NCT00021255|3397354|P3|Overall Study|Lost to Follow-up|3
1048354|NCT00021255|3397355|P2|Overall Study|Lost to Follow-up|2
1048355|NCT00021255|3397356|P1|Overall Study|Lost to Follow-up|0
1048356|NCT00021255|3397354|P3|Overall Study|Withdrawal by Subject|26
1048357|NCT00021255|3397355|P2|Overall Study|Withdrawal by Subject|64
1048358|NCT00021255|3397356|P1|Overall Study|Withdrawal by Subject|41
1048359|NCT00021255|3397354|P3|Overall Study|Second primary malignancy|1
1048360|NCT00021255|3397355|P2|Overall Study|Second primary malignancy|4
1048361|NCT00021255|3397356|P1|Overall Study|Second primary malignancy|0
1048362|NCT00021255|3397354|P3|Overall Study|Breast cancer relapse|11
1048363|NCT00021255|3397355|P2|Overall Study|Breast cancer relapse|18
1048364|NCT00021255|3397356|P1|Overall Study|Breast cancer relapse|5
1048365|NCT00021255|3397354|P3|Overall Study|Death|2
1048366|NCT00021255|3397355|P2|Overall Study|Death|0
1048367|NCT00021255|3397356|P1|Overall Study|Death|1
1048368|NCT00021229|3397373|P3|Overall Study|Punctate hemmorrhage post RT|0
1048369|NCT00021229|3397374|P2|Overall Study|Punctate hemmorrhage post RT|0
1048370|NCT00021229|3397375|P1|Overall Study|Punctate hemmorrhage post RT|2
1048371|NCT00021229|3397373|P3|Overall Study|Physician Decision|1
1048372|NCT00021229|3397374|P2|Overall Study|Physician Decision|0
1048373|NCT00021229|3397375|P1|Overall Study|Physician Decision|0
1048374|NCT00021229|3397373|P3|Overall Study|Protocol Violation|0
1048375|NCT00021229|3397374|P2|Overall Study|Protocol Violation|1
1048376|NCT00021229|3397375|P1|Overall Study|Protocol Violation|1
1048377|NCT00021229|3397373|P3|Overall Study|Progressive Disease|12
1048378|NCT00021229|3397374|P2|Overall Study|Progressive Disease|19
1048379|NCT00021229|3397375|P1|Overall Study|Progressive Disease|15
1048380|NCT00021229|3397373|P3|Overall Study|Withdrawal by Subject|1
1048381|NCT00021229|3397374|P2|Overall Study|Withdrawal by Subject|7
1048382|NCT00021229|3397375|P1|Overall Study|Withdrawal by Subject|7
1048383|NCT00021229|3397373|P3|Overall Study|Death|0
1048384|NCT00021229|3397374|P2|Overall Study|Death|1
1048385|NCT00021229|3397375|P1|Overall Study|Death|0
1048386|NCT00021229|3397373|P3|Overall Study|Adverse Event|2
1048387|NCT00021229|3397374|P2|Overall Study|Adverse Event|5
1048388|NCT00021229|3397375|P1|Overall Study|Adverse Event|10
1048389|NCT00019604|3397430|P1|Overall Study|Details for other not available|4
1048390|NCT00019604|3397430|P1|Overall Study|Unable to evaluate|1
1048391|NCT00019604|3397430|P1|Overall Study|Too much disease|1
1048392|NCT00019604|3397430|P1|Overall Study|Pt going to immunotherapy study|1
1048393|NCT00019604|3397430|P1|Overall Study|Started new chemo regimen|1
1048394|NCT00019604|3397430|P1|Overall Study|Resectable disease|1
1048395|NCT00019604|3397430|P1|Overall Study|Non compliant|1
1048396|NCT00019604|3397430|P1|Overall Study|Non compliant on systemic CH|1
1048397|NCT00019604|3397430|P1|Overall Study|Move to a different study|1
1048398|NCT00019604|3397430|P1|Overall Study|Going to have liver transplant|1
1048399|NCT00019604|3397430|P1|Overall Study|Carcinoid tumor, not treatable|1
1048400|NCT00019604|3397430|P1|Overall Study|Refused treatment|1
1048401|NCT00019604|3397430|P1|Overall Study|Progressive disease|23
1048402|NCT00019604|3397430|P1|Overall Study|Death|1
1048403|NCT00016354|3397453|P8|Overall Study|Lack of Efficacy|1
1048404|NCT00016354|3397454|P7|Overall Study|Lack of Efficacy|0
1048405|NCT00016354|3397455|P6|Overall Study|Lack of Efficacy|0
1048406|NCT00016354|3397456|P5|Overall Study|Lack of Efficacy|0
1048407|NCT00016354|3397457|P4|Overall Study|Lack of Efficacy|0
1048408|NCT00016354|3397458|P3|Overall Study|Lack of Efficacy|0
1048409|NCT00016354|3397459|P2|Overall Study|Lack of Efficacy|0
1048410|NCT00016354|3397460|P1|Overall Study|Lack of Efficacy|0
1048411|NCT00014495|3397474|P4|Overall Study|Clinical deterioration|1
1048412|NCT00014495|3397475|P3|Overall Study|Clinical deterioration|0
1048413|NCT00014495|3397476|P2|Overall Study|Clinical deterioration|0
1048414|NCT00014495|3397477|P1|Overall Study|Clinical deterioration|0
1048415|NCT00014495|3397474|P4|Overall Study|Death|0
1048416|NCT00014495|3397475|P3|Overall Study|Death|1
1048417|NCT00014495|3397476|P2|Overall Study|Death|0
1048418|NCT00014495|3397477|P1|Overall Study|Death|0
1048419|NCT00012012|3397527|P2|Overall Study|Withdrawal by Subject|2
1048420|NCT00012012|3397528|P1|Overall Study|Withdrawal by Subject|0
1048421|NCT00012012|3397527|P2|Overall Study|Protocol Violation|1
1048422|NCT00012012|3397528|P1|Overall Study|Protocol Violation|1
1048423|NCT00010257|3397557|P2|Overall Study|Withdrawal by Subject|0
1048424|NCT00010257|3397558|P1|Overall Study|Withdrawal by Subject|1
1048425|NCT00009945|3397568|P2|Overall Study|no follow up data|5
1048426|NCT00009945|3397569|P1|Overall Study|no follow up data|7
1048427|NCT00008385|3397585|P2|Overall Study|Not start protocol therapy|175
1048428|NCT00008385|3397586|P1|Overall Study|Not start protocol therapy|44
1048429|NCT00008385|3397585|P2|Overall Study|Not specified|212
1048430|NCT00008385|3397586|P1|Overall Study|Not specified|105
1048431|NCT00008385|3397585|P2|Overall Study|Maximum dose reached|2
1048432|NCT00008385|3397586|P1|Overall Study|Maximum dose reached|0
1048433|NCT00008385|3397585|P2|Overall Study|Other complicating disease|30
1048434|NCT00008385|3397586|P1|Overall Study|Other complicating disease|17
1048435|NCT00008385|3397585|P2|Overall Study|Start non-protocol therapy|1
1048436|NCT00008385|3397586|P1|Overall Study|Start non-protocol therapy|3
1048437|NCT00008385|3397585|P2|Overall Study|Withdrawal by Subject|157
1048438|NCT00008385|3397586|P1|Overall Study|Withdrawal by Subject|67
1048439|NCT00008385|3397585|P2|Overall Study|Death|18
1048440|NCT00008385|3397586|P1|Overall Study|Death|12
1048441|NCT00008385|3397585|P2|Overall Study|Adverse Event|20
1048442|NCT00008385|3397586|P1|Overall Study|Adverse Event|8
1048443|NCT00008385|3397585|P2|Overall Study|Progressive disease|117
1048444|NCT00008385|3397586|P1|Overall Study|Progressive disease|52
1048445|NCT00008385|3397585|P2|Overall Study|Off treatment reasons not reported|70
1048446|NCT00008385|3397586|P1|Overall Study|Off treatment reasons not reported|79
1048447|NCT00008138|3397596|P1|Post-Cytoreduction Chemotherapy|not protocol specified|1
1048448|NCT00008138|3397596|P1|Post-Cytoreduction Chemotherapy|Progression|1
1048449|NCT00008138|3397596|P1|Post-Cytoreduction Chemotherapy|Adverse Event|6
1048450|NCT00008138|3397596|P1|Interval Debulking|Withdrawal by Subject|2
1048451|NCT00008138|3397596|P1|Neoadjuvant Chemotherapy|not protocol specified|8
1048452|NCT00008138|3397596|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|6
1048453|NCT00008138|3397596|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|3
1048454|NCT00008138|3397596|P1|Neoadjuvant Chemotherapy|Adverse Event|3
1048455|NCT00006916|3397602|P1|Overall Study|Complication of device insertion|1
1048456|NCT00006916|3397602|P1|Overall Study|Device not inserted|4
1048457|NCT00006903|3397608|P3|Overall Study|Ineligible|2
1048458|NCT00006903|3397609|P2|Overall Study|Ineligible|1
1048459|NCT00006903|3397610|P1|Overall Study|Ineligible|10
1048460|NCT00006903|3397608|P3|Overall Study|Patient never treated|1
1048461|NCT00006903|3397609|P2|Overall Study|Patient never treated|0
1048462|NCT00006903|3397610|P1|Overall Study|Patient never treated|0
1048463|NCT00006903|3397608|P3|Overall Study|Death|0
1048464|NCT00006903|3397609|P2|Overall Study|Death|1
1048465|NCT00006903|3397610|P1|Overall Study|Death|0
1048466|NCT00006903|3397608|P3|Overall Study|Adverse Event|1
1048467|NCT00006903|3397609|P2|Overall Study|Adverse Event|0
1048468|NCT00006903|3397610|P1|Overall Study|Adverse Event|0
1048469|NCT00006903|3397608|P3|Overall Study|Refused further treatment|1
1048470|NCT00006903|3397609|P2|Overall Study|Refused further treatment|2
1048471|NCT00006903|3397610|P1|Overall Study|Refused further treatment|0
1048472|NCT00006903|3397608|P3|Overall Study|Still receiving treatment|1
1048473|NCT00006903|3397609|P2|Overall Study|Still receiving treatment|0
1048474|NCT00006903|3397610|P1|Overall Study|Still receiving treatment|0
1048475|NCT00006721|3397623|P3|Overall Study|Eligible but no Treatment Received|0
1048476|NCT00006721|3397624|P2|Overall Study|Eligible but no Treatment Received|0
1048477|NCT00006721|3397625|P1|Overall Study|Eligible but no Treatment Received|1
1048478|NCT00006721|3397623|P3|Overall Study|Ineligible|10
1048479|NCT00006721|3397624|P2|Overall Study|Ineligible|12
1048480|NCT00006721|3397625|P1|Overall Study|Ineligible|2
1048481|NCT00006721|3397623|P3|Overall Study|Other - Not Protocol Specified|7
1048482|NCT00006721|3397624|P2|Overall Study|Other - Not Protocol Specified|7
1048483|NCT00006721|3397625|P1|Overall Study|Other - Not Protocol Specified|0
1048484|NCT00006721|3397623|P3|Overall Study|Death|2
1048485|NCT00006721|3397624|P2|Overall Study|Death|1
1048486|NCT00006721|3397625|P1|Overall Study|Death|0
1048487|NCT00006721|3397623|P3|Overall Study|Progression/Relapse|2
1048488|NCT00006721|3397624|P2|Overall Study|Progression/Relapse|1
1048489|NCT00006721|3397625|P1|Overall Study|Progression/Relapse|0
1048490|NCT00006721|3397623|P3|Overall Study|Refusal Unrelated to Adverse Event|8
1048491|NCT00006721|3397624|P2|Overall Study|Refusal Unrelated to Adverse Event|0
1048492|NCT00006721|3397625|P1|Overall Study|Refusal Unrelated to Adverse Event|1
1048493|NCT00006721|3397623|P3|Overall Study|Adverse Event|4
1048494|NCT00006721|3397624|P2|Overall Study|Adverse Event|4
1048495|NCT00006721|3397625|P1|Overall Study|Adverse Event|0
1048496|NCT00006478|3397643|P1|Overall Study|Physician Decision|6
1048497|NCT00006478|3397643|P1|Overall Study|Vaccine could not be produced|1
1048498|NCT00006392|3397654|P4|Overall Study|Poor data/ppt mgmt, regulatory problems|155
1048499|NCT00006392|3397655|P3|Overall Study|Poor data/ppt mgmt, regulatory problems|155
1048500|NCT00006392|3397656|P2|Overall Study|Poor data/ppt mgmt, regulatory problems|155
1048501|NCT00006392|3397657|P1|Overall Study|Poor data/ppt mgmt, regulatory problems|156
1048502|NCT00006392|3397654|P4|Overall Study|Ineligible|5
1048503|NCT00006392|3397655|P3|Overall Study|Ineligible|5
1048504|NCT00006392|3397656|P2|Overall Study|Ineligible|3
1048505|NCT00006392|3397657|P1|Overall Study|Ineligible|11
1048506|NCT00006389|3397687|P1|Overall Study|Adverse Event|1
1048507|NCT00006237|3397704|P2|Overall Study|Not protocol specified|5
1048508|NCT00006237|3397705|P1|Overall Study|Not protocol specified|14
1048509|NCT00006237|3397704|P2|Overall Study|Withdrawal by Subject|1
1048510|NCT00006237|3397705|P1|Overall Study|Withdrawal by Subject|0
1048511|NCT00006237|3397704|P2|Overall Study|Not eligible|20
1048512|NCT00006237|3397705|P1|Overall Study|Not eligible|9
1048513|NCT00006237|3397704|P2|Overall Study|Progression/relapse|2
1048514|NCT00006237|3397705|P1|Overall Study|Progression/relapse|54
1048515|NCT00006237|3397704|P2|Overall Study|Refusal unrelated to adverse effects|4
1048516|NCT00006237|3397705|P1|Overall Study|Refusal unrelated to adverse effects|8
1048517|NCT00006237|3397704|P2|Overall Study|Death|0
1048518|NCT00006237|3397705|P1|Overall Study|Death|1
1048519|NCT00006237|3397704|P2|Overall Study|Adverse Event|29
1048520|NCT00006237|3397705|P1|Overall Study|Adverse Event|39
1048521|NCT00006011|3397742|P3|Overall Study|Ineligible|9
1048522|NCT00006011|3397743|P2|Overall Study|Ineligible|16
1048523|NCT00006011|3397744|P1|Overall Study|Ineligible|18
1048524|NCT00006011|3397742|P3|Overall Study|Not specified|5
1048525|NCT00006011|3397743|P2|Overall Study|Not specified|2
1048526|NCT00006011|3397744|P1|Overall Study|Not specified|4
1048527|NCT00006011|3397742|P3|Overall Study|Death|2
1048528|NCT00006011|3397743|P2|Overall Study|Death|1
1048529|NCT00006011|3397744|P1|Overall Study|Death|0
1048530|NCT00006011|3397742|P3|Overall Study|Adverse Event|5
1048531|NCT00006011|3397743|P2|Overall Study|Adverse Event|39
1048532|NCT00006011|3397744|P1|Overall Study|Adverse Event|15
1048533|NCT00006011|3397742|P3|Overall Study|Refused further treatment|26
1048534|NCT00006011|3397743|P2|Overall Study|Refused further treatment|13
1048535|NCT00006011|3397744|P1|Overall Study|Refused further treatment|15
1048536|NCT00006011|3397742|P3|Overall Study|Disease progression|26
1048537|NCT00006011|3397743|P2|Overall Study|Disease progression|6
1048538|NCT00006011|3397744|P1|Overall Study|Disease progression|13
1048539|NCT00005957|3397752|P2|Overall Study|Crossover to the other arm|19
1048540|NCT00005957|3397753|P1|Overall Study|Crossover to the other arm|5
1048541|NCT00005957|3397752|P2|Overall Study|No treated|9
1048542|NCT00005957|3397753|P1|Overall Study|No treated|3
1048543|NCT00005879|3397763|P2|Overall Study|Withdrawal by Subject|10
1048544|NCT00005879|3397764|P1|Overall Study|Withdrawal by Subject|8
1048545|NCT00005047|3397787|P4|Overall Study|Lack of Efficacy|0
1048546|NCT00005047|3397788|P3|Overall Study|Lack of Efficacy|0
1048547|NCT00005047|3397789|P2|Overall Study|Lack of Efficacy|0
1048548|NCT00005047|3397790|P1|Overall Study|Lack of Efficacy|1
1048549|NCT00005047|3397787|P4|Overall Study|Lost to Follow-up|0
1048550|NCT00005047|3397788|P3|Overall Study|Lost to Follow-up|0
1048551|NCT00005047|3397789|P2|Overall Study|Lost to Follow-up|0
1048552|NCT00005047|3397790|P1|Overall Study|Lost to Follow-up|1
1048553|NCT00005047|3397787|P4|Overall Study|Adverse Event|0
1048554|NCT00005047|3397788|P3|Overall Study|Adverse Event|0
1048555|NCT00005047|3397789|P2|Overall Study|Adverse Event|0
1048556|NCT00005047|3397790|P1|Overall Study|Adverse Event|5
1048557|NCT00005047|3397787|P4|Overall Study|Withdrawal by Subject|0
1048558|NCT00005047|3397788|P3|Overall Study|Withdrawal by Subject|0
1048559|NCT00005047|3397789|P2|Overall Study|Withdrawal by Subject|0
1048560|NCT00005047|3397790|P1|Overall Study|Withdrawal by Subject|12
1048561|NCT00005044|3397806|P2|Overall Study|No protocol treatment|1
1048562|NCT00005044|3397807|P1|Overall Study|No protocol treatment|0
1048563|NCT00005044|3397806|P2|Overall Study|Withdrawal by Subject|5
1048564|NCT00005044|3397807|P1|Overall Study|Withdrawal by Subject|1
1048565|NCT00005044|3397806|P2|Overall Study|Protocol Violation|46
1048566|NCT00005044|3397807|P1|Overall Study|Protocol Violation|37
1048567|NCT00004888|3397827|P2|Overall Study|Toxic death|0
1048568|NCT00004888|3397828|P1|Overall Study|Toxic death|1
1048569|NCT00004888|3397827|P2|Overall Study|Death without progressive disease|1
1048570|NCT00004888|3397828|P1|Overall Study|Death without progressive disease|0
1048571|NCT00004888|3397827|P2|Overall Study|Progressive Disease|9
1048572|NCT00004888|3397828|P1|Overall Study|Progressive Disease|4
1048573|NCT00004888|3397827|P2|Overall Study|Physician Decision|1
1048574|NCT00004888|3397828|P1|Overall Study|Physician Decision|1
1048575|NCT00004888|3397827|P2|Overall Study|Withdrawal by Subject|3
1048576|NCT00004888|3397828|P1|Overall Study|Withdrawal by Subject|0
1048577|NCT00004888|3397827|P2|Overall Study|Adverse Event|10
1048578|NCT00004888|3397828|P1|Overall Study|Adverse Event|5
1048579|NCT00004859|3397846|P2|Overall Study|Not specified|21
1048580|NCT00004859|3397847|P1|Overall Study|Not specified|13
1048581|NCT00004859|3397846|P2|Overall Study|missing data|11
1048582|NCT00004859|3397847|P1|Overall Study|missing data|14
1048583|NCT00004859|3397846|P2|Overall Study|error|1
1048584|NCT00004859|3397847|P1|Overall Study|error|3
1048585|NCT00004859|3397846|P2|Overall Study|other disease|3
1048586|NCT00004859|3397847|P1|Overall Study|other disease|0
1048587|NCT00004859|3397846|P2|Overall Study|Protocol Violation|2
1048588|NCT00004859|3397847|P1|Overall Study|Protocol Violation|2
1048589|NCT00004859|3397846|P2|Overall Study|Withdrawal by Subject|33
1048590|NCT00004859|3397847|P1|Overall Study|Withdrawal by Subject|7
1048591|NCT00004859|3397846|P2|Overall Study|Death|5
1048592|NCT00004859|3397847|P1|Overall Study|Death|5
1048593|NCT00004859|3397846|P2|Overall Study|Adverse Event|93
1048594|NCT00004859|3397847|P1|Overall Study|Adverse Event|31
1048595|NCT00004859|3397846|P2|Overall Study|Lack of Efficacy|113
1048596|NCT00004859|3397847|P1|Overall Study|Lack of Efficacy|43
1048597|NCT00004259|3397861|P4|Overall Study|Withdrawal by Subject|0
1048598|NCT00004259|3397862|P3|Overall Study|Withdrawal by Subject|0
1048599|NCT00004259|3397863|P2|Overall Study|Withdrawal by Subject|2
1048600|NCT00004259|3397864|P1|Overall Study|Withdrawal by Subject|0
1048601|NCT00004259|3397861|P4|Overall Study|Protocol Violation|0
1048602|NCT00004259|3397862|P3|Overall Study|Protocol Violation|0
1048603|NCT00004259|3397863|P2|Overall Study|Protocol Violation|2
1048604|NCT00004259|3397864|P1|Overall Study|Protocol Violation|1
1048605|NCT00004228|3397885|P7|Overall Study|ineligible|5
1048606|NCT00004228|3397886|P6|Overall Study|ineligible|2
1048607|NCT00004228|3397887|P5|Overall Study|ineligible|1
1048608|NCT00004228|3397888|P4|Overall Study|ineligible|1
1048609|NCT00004228|3397889|P3|Overall Study|ineligible|4
1048610|NCT00004228|3397890|P2|Overall Study|ineligible|2
1048611|NCT00004228|3397891|P1|Overall Study|ineligible|4
1048612|NCT00004228|3397885|P7|Overall Study|Other|0
1048613|NCT00004228|3397886|P6|Overall Study|Other|0
1048614|NCT00004228|3397887|P5|Overall Study|Other|0
1048615|NCT00004228|3397888|P4|Overall Study|Other|0
1048616|NCT00004228|3397889|P3|Overall Study|Other|1
1048617|NCT00004228|3397890|P2|Overall Study|Other|0
1048618|NCT00004228|3397891|P1|Overall Study|Other|0
1048619|NCT00004228|3397885|P7|Overall Study|Withdrawal by Subject|2
1048620|NCT00004228|3397886|P6|Overall Study|Withdrawal by Subject|1
1048621|NCT00004228|3397887|P5|Overall Study|Withdrawal by Subject|2
1048622|NCT00004228|3397888|P4|Overall Study|Withdrawal by Subject|0
1048623|NCT00004228|3397889|P3|Overall Study|Withdrawal by Subject|1
1048624|NCT00004228|3397890|P2|Overall Study|Withdrawal by Subject|0
1048625|NCT00004228|3397891|P1|Overall Study|Withdrawal by Subject|3
1048626|NCT00004228|3397885|P7|Overall Study|Protocol Violation|0
1048627|NCT00004228|3397886|P6|Overall Study|Protocol Violation|2
1048628|NCT00004228|3397887|P5|Overall Study|Protocol Violation|1
1048629|NCT00004228|3397888|P4|Overall Study|Protocol Violation|1
1048630|NCT00004228|3397889|P3|Overall Study|Protocol Violation|2
1048631|NCT00004228|3397890|P2|Overall Study|Protocol Violation|5
1048632|NCT00004228|3397891|P1|Overall Study|Protocol Violation|0
1048633|NCT00004228|3397885|P7|Overall Study|Physician Decision|1
1048634|NCT00004228|3397886|P6|Overall Study|Physician Decision|1
1048635|NCT00004228|3397887|P5|Overall Study|Physician Decision|1
1048636|NCT00004228|3397888|P4|Overall Study|Physician Decision|2
1048637|NCT00004228|3397889|P3|Overall Study|Physician Decision|3
1048638|NCT00004228|3397890|P2|Overall Study|Physician Decision|0
1048639|NCT00004228|3397891|P1|Overall Study|Physician Decision|1
1048640|NCT00004228|3397885|P7|Overall Study|Lost to Follow-up|0
1048641|NCT00004228|3397886|P6|Overall Study|Lost to Follow-up|0
1048642|NCT00004228|3397887|P5|Overall Study|Lost to Follow-up|0
1048643|NCT00004228|3397888|P4|Overall Study|Lost to Follow-up|0
1048644|NCT00004228|3397889|P3|Overall Study|Lost to Follow-up|1
1048645|NCT00004228|3397890|P2|Overall Study|Lost to Follow-up|0
1048646|NCT00004228|3397891|P1|Overall Study|Lost to Follow-up|0
1048647|NCT00004228|3397885|P7|Overall Study|Lack of Efficacy|4
1048648|NCT00004228|3397886|P6|Overall Study|Lack of Efficacy|8
1048649|NCT00004228|3397887|P5|Overall Study|Lack of Efficacy|9
1048650|NCT00004228|3397888|P4|Overall Study|Lack of Efficacy|3
1048651|NCT00004228|3397889|P3|Overall Study|Lack of Efficacy|5
1048652|NCT00004228|3397890|P2|Overall Study|Lack of Efficacy|6
1048653|NCT00004228|3397891|P1|Overall Study|Lack of Efficacy|1
1048654|NCT00004228|3397885|P7|Overall Study|Death|0
1048655|NCT00004228|3397886|P6|Overall Study|Death|0
1048656|NCT00004228|3397887|P5|Overall Study|Death|1
1048657|NCT00004228|3397888|P4|Overall Study|Death|0
1048658|NCT00004228|3397889|P3|Overall Study|Death|2
1048659|NCT00004228|3397890|P2|Overall Study|Death|1
1048660|NCT00004228|3397891|P1|Overall Study|Death|0
1048661|NCT00004228|3397885|P7|Overall Study|Adverse Event|0
1048662|NCT00004228|3397886|P6|Overall Study|Adverse Event|0
1048663|NCT00004228|3397887|P5|Overall Study|Adverse Event|1
1048664|NCT00004228|3397888|P4|Overall Study|Adverse Event|0
1048665|NCT00004228|3397889|P3|Overall Study|Adverse Event|0
1048666|NCT00004228|3397890|P2|Overall Study|Adverse Event|1
1048667|NCT00004228|3397891|P1|Overall Study|Adverse Event|0
1048668|NCT00004124|3397925|P2|Overall Study|Received no protocol therapy|20
1048669|NCT00004124|3397926|P1|Overall Study|Received no protocol therapy|12
1048670|NCT00003901|3397974|P1|Overall Study|Medical problems|6
1048671|NCT00003901|3397974|P1|Overall Study|Chest X-Ray not done prior registration|1
1048672|NCT00003901|3397974|P1|Overall Study|CT Scan not within protocol requirement|2
1048673|NCT00003901|3397974|P1|Overall Study|Ineligible|6
1048674|NCT00003901|3397974|P1|Overall Study|Withdrawal by Subject|1
1048675|NCT00003901|3397974|P1|Overall Study|Adverse Event|1
1048676|NCT00003896|3397985|P1|Overall Study|ineligible|5
1048677|NCT00003896|3397985|P1|Overall Study|not protocol specified|3
1048678|NCT00003896|3397985|P1|Overall Study|Death|3
1048679|NCT00003896|3397985|P1|Overall Study|Lack of Efficacy|1
1048680|NCT00003896|3397985|P1|Overall Study|Withdrawal by Subject|1
1048681|NCT00003896|3397985|P1|Overall Study|Adverse Event|16
1048682|NCT00003875|3397991|P1|Overall Study|Screen Failed|1
1048683|NCT00003869|3398000|P2|Overall Study|Alternative treatmnt, medical problems|4
1048684|NCT00003869|3398001|P1|Overall Study|Alternative treatmnt, medical problems|5
1048685|NCT00003869|3398000|P2|Overall Study|Death|2
1048686|NCT00003869|3398001|P1|Overall Study|Death|1
1048687|NCT00003869|3398000|P2|Overall Study|Withdrawal by Subject|3
1048688|NCT00003869|3398001|P1|Overall Study|Withdrawal by Subject|21
1048689|NCT00003869|3398000|P2|Overall Study|Adverse Event|3
1048690|NCT00003869|3398001|P1|Overall Study|Adverse Event|14
1048691|NCT00003782|3398027|P3|Overall Study|No follow up data|26
1048692|NCT00003782|3398028|P2|Overall Study|No follow up data|31
1048693|NCT00003782|3398029|P1|Overall Study|No follow up data|30
1048694|NCT00003702|3398039|P2|Overall Study|Inadequate documentation of disease|3
1048695|NCT00003702|3398040|P1|Overall Study|Inadequate documentation of disease|1
1048696|NCT00003702|3398039|P2|Overall Study|WHO score > 6|1
1048697|NCT00003702|3398040|P1|Overall Study|WHO score > 6|2
1048698|NCT00003702|3398039|P2|Overall Study|Did not meet criteria for persistence|5
1048699|NCT00003702|3398040|P1|Overall Study|Did not meet criteria for persistence|8
1048700|NCT00003702|3398039|P2|Overall Study|Ineligible cell types|2
1048701|NCT00003702|3398040|P1|Overall Study|Ineligible cell types|2
1048702|NCT00003659|3398049|P1|Overall Study|Withdrawal by Subject|3
1048703|NCT00003641|3398057|P2|Overall Study|Never started interferon|12
1048704|NCT00003641|3398058|P1|Overall Study|Never started interferon|567
1048705|NCT00003641|3398057|P2|Overall Study|Should not receive interferon therapy|0
1048706|NCT00003641|3398058|P1|Overall Study|Should not receive interferon therapy|2
1048707|NCT00003641|3398057|P2|Overall Study|Unknown/missing|22
1048708|NCT00003641|3398058|P1|Overall Study|Unknown/missing|0
1048709|NCT00003641|3398057|P2|Overall Study|Disease progression|2
1048710|NCT00003641|3398058|P1|Overall Study|Disease progression|0
1048711|NCT00003641|3398057|P2|Overall Study|Adverse Event|38
1048712|NCT00003641|3398058|P1|Overall Study|Adverse Event|0
1048713|NCT00003641|3398057|P2|Overall Study|Withdrawal by Subject|100
1048714|NCT00003641|3398058|P1|Overall Study|Withdrawal by Subject|0
1048715|NCT00003631|3398069|P3|Overall Study|Evaluable for toxicity only|2
1048716|NCT00003631|3398070|P2|Overall Study|Evaluable for toxicity only|0
1048717|NCT00003631|3398071|P1|Overall Study|Evaluable for toxicity only|0
1048718|NCT00003631|3398069|P3|Overall Study|Death|1
1048719|NCT00003631|3398070|P2|Overall Study|Death|0
1048720|NCT00003631|3398071|P1|Overall Study|Death|0
1048721|NCT00003631|3398069|P3|Overall Study|Adverse Event|5
1048722|NCT00003631|3398070|P2|Overall Study|Adverse Event|1
1048723|NCT00003631|3398071|P1|Overall Study|Adverse Event|1
1048724|NCT00003631|3398069|P3|Overall Study|Protocol Violation|0
1048725|NCT00003631|3398070|P2|Overall Study|Protocol Violation|0
1048726|NCT00003631|3398071|P1|Overall Study|Protocol Violation|1
1048727|NCT00003631|3398069|P3|Overall Study|Patient not treated|1
1048728|NCT00003631|3398070|P2|Overall Study|Patient not treated|0
1048729|NCT00003631|3398071|P1|Overall Study|Patient not treated|1
1048730|NCT00003590|3398079|P1|Overall Study|Physician Decision|1
1048731|NCT00003590|3398079|P1|Overall Study|Death|1
1048732|NCT00003590|3398079|P1|Overall Study|Lack of Efficacy|11
1048733|NCT00003590|3398079|P1|Overall Study|Withdrawal by Subject|1
1048734|NCT00003590|3398079|P1|Overall Study|Adverse Event|7
1048735|NCT00003590|3398079|P1|Overall Study|Ineligible Patient|1
1048736|NCT00003537|3398084|P1|Overall Study|Not evalauable|1
1048737|NCT00003535|3398089|P1|Overall Study|Not evaluable|5
1048738|NCT00003483|3398094|P1|Overall Study|Not evaluable|1
1048739|NCT00003479|3398099|P1|Overall Study|Not evaluable|3
1048740|NCT00003477|3398104|P1|Overall Study|Not evalauable|4
1048741|NCT00003476|3398109|P1|Overall Study|Not evaluable|1
1048742|NCT00003475|3398114|P1|Overall Study|Not evaluable|13
1048743|NCT00003474|3398119|P1|Overall Study|Not Evaluable|14
1048744|NCT00003473|3398124|P1|Overall Study|Three patients were not evaluable.|3
1048745|NCT00003472|3398129|P1|Overall Study|Not evaluable|3
1048746|NCT00003471|3398134|P1|Overall Study|Not evaluable|4
1048747|NCT00003470|3398139|P1|Overall Study|Not evaluable|6
1048748|NCT00003458|3398164|P1|Overall Study|Not evaluable|4
1048749|NCT00003457|3398169|P1|Overall Study|Not evaluable|9
1048750|NCT00003456|3398174|P1|Overall Study|Not evaluable|8
1048751|NCT00003389|3398186|P2|Overall Study|Ineligible|27
1048752|NCT00003389|3398187|P1|Overall Study|Ineligible|33
1048753|NCT00003389|3398186|P2|Overall Study|Off-treatment reason missing|21
1048754|NCT00003389|3398187|P1|Overall Study|Off-treatment reason missing|31
1048755|NCT00003389|3398186|P2|Overall Study|Complicating disease|0
1048756|NCT00003389|3398187|P1|Overall Study|Complicating disease|1
1048757|NCT00003389|3398186|P2|Overall Study|Alternative therapy|1
1048758|NCT00003389|3398187|P1|Overall Study|Alternative therapy|2
1048759|NCT00003389|3398186|P2|Overall Study|Withdrawal by Subject|5
1048760|NCT00003389|3398187|P1|Overall Study|Withdrawal by Subject|12
1048761|NCT00003389|3398186|P2|Overall Study|Death|3
1048762|NCT00003389|3398187|P1|Overall Study|Death|0
1048763|NCT00003389|3398186|P2|Overall Study|Adverse Event|2
1048764|NCT00003389|3398187|P1|Overall Study|Adverse Event|13
1048765|NCT00003389|3398186|P2|Overall Study|Disease progression|1
1048766|NCT00003389|3398187|P1|Overall Study|Disease progression|6
1048767|NCT00003377|3398202|P5|Period II|Ureteral stent complications|1
1048768|NCT00003377|3398203|P4|Period II|Ureteral stent complications|0
1048769|NCT00003377|3398204|P3|Period II|Ureteral stent complications|0
1048770|NCT00003377|3398205|P2|Period II|Ureteral stent complications|0
1048771|NCT00003377|3398206|P1|Period II|Ureteral stent complications|0
1048772|NCT00003377|3398202|P5|Period I|Dose Limiting Toxicity(DLT)|0
1048773|NCT00003377|3398203|P4|Period I|Dose Limiting Toxicity(DLT)|1
1048774|NCT00003377|3398204|P3|Period I|Dose Limiting Toxicity(DLT)|1
1048775|NCT00003377|3398205|P2|Period I|Dose Limiting Toxicity(DLT)|0
1048776|NCT00003377|3398206|P1|Period I|Dose Limiting Toxicity(DLT)|0
1048777|NCT00003199|3398220|P1|Overall Study|Screen fail|15
1048778|NCT00003199|3398220|P1|Overall Study|Lack of insurance clearance|2
1048779|NCT00003199|3398220|P1|Overall Study|Refused Post-Transplant Immunotherapy|5
1048780|NCT00003138|3398228|P2|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7
1048781|NCT00003138|3398229|P1|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6
1048782|NCT00003138|3398228|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1
1048783|NCT00003138|3398229|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0
1048784|NCT00003138|3398228|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19
1048785|NCT00003138|3398229|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12
1048786|NCT00003138|3398228|P2|Step 2 (Cross Over)|Reasons off treatment not documented|0
1048787|NCT00003138|3398229|P1|Step 2 (Cross Over)|Reasons off treatment not documented|26
1048788|NCT00003138|3398228|P2|Step 1|Never started treatment|0
1048789|NCT00003138|3398229|P1|Step 1|Never started treatment|1
1048790|NCT00003138|3398228|P2|Step 1|Reasons off treatment not documented|57
1048791|NCT00003138|3398229|P1|Step 1|Reasons off treatment not documented|60
1048792|NCT00002931|3398246|P1|Overall Study|rapidly progressing disease during|2
1048793|NCT00002874|3398254|P2|Overall Study|Protocol Violation|34
1048794|NCT00002874|3398255|P1|Overall Study|Protocol Violation|44
1048795|NCT00002874|3398254|P2|Overall Study|Withdrawal by Subject|1
1048796|NCT00002874|3398255|P1|Overall Study|Withdrawal by Subject|1
1048797|NCT00002850|3398280|P3|Overall Study|Withdrawal by Subject|0
1048798|NCT00002850|3398281|P2|Overall Study|Withdrawal by Subject|1
1048799|NCT00002850|3398282|P1|Overall Study|Withdrawal by Subject|0
1048800|NCT00002850|3398280|P3|Overall Study|Protocol Violation|1
1048801|NCT00002850|3398281|P2|Overall Study|Protocol Violation|0
1048802|NCT00002850|3398282|P1|Overall Study|Protocol Violation|1
1048803|NCT00002850|3398280|P3|Overall Study|Death|3
1048804|NCT00002850|3398281|P2|Overall Study|Death|1
1048805|NCT00002850|3398282|P1|Overall Study|Death|4
1048806|NCT00002842|3398290|P1|Overall Study|ineligible for surgical resection|27
1048807|NCT00002766|3398296|P2|Overall Study|Protocol Violation|0
1048808|NCT00002766|3398297|P1|Overall Study|Protocol Violation|1
1048809|NCT00002766|3398296|P2|Overall Study|Adverse Event|1
1048810|NCT00002766|3398297|P1|Overall Study|Adverse Event|1
1048811|NCT00002766|3398296|P2|Overall Study|Patient Not Treated|2
1048812|NCT00002766|3398297|P1|Overall Study|Patient Not Treated|1
1048813|NCT00002766|3398296|P2|Overall Study|Withdrawal by Subject|1
1048814|NCT00002766|3398297|P1|Overall Study|Withdrawal by Subject|0
1048815|NCT00002651|3398305|P3|Consolidation and Randomization|not eligible|112
1048816|NCT00002651|3398306|P2|Consolidation and Randomization|not eligible|102
1048817|NCT00002651|3398307|P1|Consolidation and Randomization|not eligible|0
1048818|NCT00002651|3398305|P3|Consolidation and Randomization|not specified|313
1048819|NCT00002651|3398306|P2|Consolidation and Randomization|not specified|314
1048820|NCT00002651|3398307|P1|Consolidation and Randomization|not specified|0
1048821|NCT00002651|3398305|P3|Consolidation and Randomization|Death|48
1048822|NCT00002651|3398306|P2|Consolidation and Randomization|Death|38
1048823|NCT00002651|3398307|P1|Consolidation and Randomization|Death|0
1048824|NCT00002651|3398305|P3|Consolidation and Randomization|Progression/relapse|298
1048825|NCT00002651|3398306|P2|Consolidation and Randomization|Progression/relapse|295
1048826|NCT00002651|3398307|P1|Consolidation and Randomization|Progression/relapse|0
1048827|NCT00002651|3398305|P3|Consolidation and Randomization|Refusal unrelated to adverse event|75
1048828|NCT00002651|3398306|P2|Consolidation and Randomization|Refusal unrelated to adverse event|53
1048829|NCT00002651|3398307|P1|Consolidation and Randomization|Refusal unrelated to adverse event|0
1048830|NCT00002651|3398305|P3|Consolidation and Randomization|Adverse Event|14
1048831|NCT00002651|3398306|P2|Consolidation and Randomization|Adverse Event|36
1048832|NCT00002651|3398307|P1|Consolidation and Randomization|Adverse Event|0
1048833|NCT00002651|3398305|P3|Induction|not eligible|0
1048834|NCT00002651|3398306|P2|Induction|not eligible|0
1048835|NCT00002651|3398307|P1|Induction|not eligible|90
1048836|NCT00002651|3398305|P3|Induction|not specified|0
1048837|NCT00002651|3398306|P2|Induction|not specified|0
1048838|NCT00002651|3398307|P1|Induction|not specified|823
1048839|NCT00002651|3398305|P3|Induction|Death|0
1048840|NCT00002651|3398306|P2|Induction|Death|0
1048841|NCT00002651|3398307|P1|Induction|Death|62
1048842|NCT00002651|3398305|P3|Induction|Progression/relapse|0
1048843|NCT00002651|3398306|P2|Induction|Progression/relapse|0
1048844|NCT00002651|3398307|P1|Induction|Progression/relapse|274
1048845|NCT00002651|3398305|P3|Induction|Refusal unrelated to adverse event|0
1048846|NCT00002651|3398306|P2|Induction|Refusal unrelated to adverse event|0
1048847|NCT00002651|3398307|P1|Induction|Refusal unrelated to adverse event|50
1048848|NCT00002651|3398305|P3|Induction|Adverse Event|0
1048849|NCT00002651|3398306|P2|Induction|Adverse Event|0
1048850|NCT00002651|3398307|P1|Induction|Adverse Event|44
1048851|NCT00002558|3398325|P2|Overall Study|Withdrawal by Subject|1
1048852|NCT00002558|3398326|P1|Overall Study|Withdrawal by Subject|0
1048853|NCT00051636|3398351|P2|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12
1048854|NCT00051636|3398352|P1|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40
1048855|NCT00051636|3398351|P2|Period 2- Extended Observation Period|Death|5
1048856|NCT00051636|3398352|P1|Period 2- Extended Observation Period|Death|4
1048857|NCT00051636|3398351|P2|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2
1048858|NCT00051636|3398352|P1|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9
1048859|NCT00051636|3398351|P2|Period 2- Extended Observation Period|withdrew for nonclinical reason|7
1048860|NCT00051636|3398352|P1|Period 2- Extended Observation Period|withdrew for nonclinical reason|12
1048861|NCT00051636|3398351|P2|Period 2- Extended Observation Period|Lost to Follow-up|4
1048862|NCT00051636|3398352|P1|Period 2- Extended Observation Period|Lost to Follow-up|5
1048863|NCT00051636|3398351|P2|Period 1 - Core|Lost to Follow-up|2
1048864|NCT00051636|3398352|P1|Period 1 - Core|Lost to Follow-up|0
1048865|NCT00051636|3398351|P2|Period 1 - Core|Withdrawal by Subject|2
1048866|NCT00051636|3398352|P1|Period 1 - Core|Withdrawal by Subject|1
1048867|NCT00051636|3398351|P2|Period 1 - Core|Protocol Violation|0
1048868|NCT00051636|3398352|P1|Period 1 - Core|Protocol Violation|1
1048869|NCT00051636|3398351|P2|Period 1 - Core|Adverse Event|2
1048870|NCT00051636|3398352|P1|Period 1 - Core|Adverse Event|2
1048871|NCT00051558|3398380|P2|Overall Study|Physician Decision|0
1048872|NCT00051558|3398381|P1|Overall Study|Physician Decision|5
1048873|NCT00051558|3398380|P2|Overall Study|Significant Lab Value|0
1048874|NCT00051558|3398381|P1|Overall Study|Significant Lab Value|2
1048875|NCT00051558|3398380|P2|Overall Study|Other|1
1048876|NCT00051558|3398381|P1|Overall Study|Other|2
1048877|NCT00051558|3398380|P2|Overall Study|Sponsor Decision|1
1048878|NCT00051558|3398381|P1|Overall Study|Sponsor Decision|6
1048879|NCT00051558|3398380|P2|Overall Study|Protocol Entry Criteria Unmet|2
1048880|NCT00051558|3398381|P1|Overall Study|Protocol Entry Criteria Unmet|1
1048881|NCT00051558|3398380|P2|Overall Study|Protocol Violation|4
1048882|NCT00051558|3398381|P1|Overall Study|Protocol Violation|3
1048883|NCT00051558|3398380|P2|Overall Study|Lost to Follow-up|13
1048884|NCT00051558|3398381|P1|Overall Study|Lost to Follow-up|4
1048885|NCT00051558|3398380|P2|Overall Study|Death|15
1048886|NCT00051558|3398381|P1|Overall Study|Death|9
1048887|NCT00051558|3398380|P2|Overall Study|Withdrawal by Subject|42
1048888|NCT00051558|3398381|P1|Overall Study|Withdrawal by Subject|29
1048889|NCT00051558|3398380|P2|Overall Study|Adverse Event|18
1048890|NCT00051558|3398381|P1|Overall Study|Adverse Event|30
1048891|NCT00051363|3398417|P2|Overall Study|Excluded Pre-Randomization|5
1048892|NCT00051363|3398418|P1|Overall Study|Excluded Pre-Randomization|2
1048893|NCT00051363|3398417|P2|Overall Study|Death|2
1048894|NCT00051363|3398418|P1|Overall Study|Death|2
1048895|NCT00051363|3398417|P2|Overall Study|Disqualified Post-Rand for Any Reason|11
1048896|NCT00051363|3398418|P1|Overall Study|Disqualified Post-Rand for Any Reason|9
1048897|NCT00051363|3398417|P2|Overall Study|Dropped Post-Rand for Any Reason|126
1048898|NCT00051363|3398418|P1|Overall Study|Dropped Post-Rand for Any Reason|102
1048899|NCT00051025|3398458|P2|Overall Study|Death|1
1048900|NCT00051025|3398459|P1|Overall Study|Death|0
1048901|NCT00051025|3398458|P2|Overall Study|Withdrawal by Subject|1
1048902|NCT00051025|3398459|P1|Overall Study|Withdrawal by Subject|0
1048903|NCT00051025|3398458|P2|Overall Study|Adverse Event|1
1048904|NCT00051025|3398459|P1|Overall Study|Adverse Event|1
1048905|NCT00051025|3398458|P2|Overall Study|Progressive Disease|1
1048906|NCT00051025|3398459|P1|Overall Study|Progressive Disease|1
1048907|NCT00050960|3398473|P2|Overall Study|Death|15
1048908|NCT00050960|3398474|P1|Overall Study|Death|13
1048909|NCT00050960|3398473|P2|Overall Study|Non-compliance|1
1048910|NCT00050960|3398474|P1|Overall Study|Non-compliance|3
1048911|NCT00050960|3398473|P2|Overall Study|Administrative|46
1048912|NCT00050960|3398474|P1|Overall Study|Administrative|31
1048913|NCT00050960|3398473|P2|Overall Study|Withdrawal by Subject|18
1048914|NCT00050960|3398474|P1|Overall Study|Withdrawal by Subject|23
1048915|NCT00050960|3398473|P2|Overall Study|Lost to Follow-up|1
1048916|NCT00050960|3398474|P1|Overall Study|Lost to Follow-up|0
1048917|NCT00050960|3398473|P2|Overall Study|Adverse Event|61
1048918|NCT00050960|3398474|P1|Overall Study|Adverse Event|62
1048919|NCT00050960|3398473|P2|Overall Study|Complete Response|2
1048920|NCT00050960|3398474|P1|Overall Study|Complete Response|0
1048921|NCT00050960|3398473|P2|Overall Study|Partial Response|19
1048922|NCT00050960|3398474|P1|Overall Study|Partial Response|14
1048923|NCT00050960|3398473|P2|Overall Study|Stable Disease|48
1048924|NCT00050960|3398474|P1|Overall Study|Stable Disease|19
1048925|NCT00050960|3398473|P2|Overall Study|Progressive Disease|93
1048926|NCT00050960|3398474|P1|Overall Study|Progressive Disease|137
1048927|NCT00050778|3398483|P3|Overall Study|Familial and personal reasons|0
1048928|NCT00050778|3398484|P2|Overall Study|Familial and personal reasons|0
1048929|NCT00050778|3398485|P1|Overall Study|Familial and personal reasons|1
1048930|NCT00050778|3398483|P3|Overall Study|Randomized but not treated|2
1048931|NCT00050778|3398484|P2|Overall Study|Randomized but not treated|5
1048932|NCT00050778|3398485|P1|Overall Study|Randomized but not treated|4
1048933|NCT00050778|3398483|P3|Overall Study|Withdrawal by Subject|4
1048934|NCT00050778|3398484|P2|Overall Study|Withdrawal by Subject|8
1048935|NCT00050778|3398485|P1|Overall Study|Withdrawal by Subject|6
1048936|NCT00050778|3398483|P3|Overall Study|Protocol Violation|1
1048937|NCT00050778|3398484|P2|Overall Study|Protocol Violation|0
1048938|NCT00050778|3398485|P1|Overall Study|Protocol Violation|2
1048939|NCT00050778|3398483|P3|Overall Study|Physician Decision|2
1048940|NCT00050778|3398484|P2|Overall Study|Physician Decision|0
1048941|NCT00050778|3398485|P1|Overall Study|Physician Decision|3
1048942|NCT00050778|3398483|P3|Overall Study|Lost to Follow-up|4
1048943|NCT00050778|3398484|P2|Overall Study|Lost to Follow-up|2
1048944|NCT00050778|3398485|P1|Overall Study|Lost to Follow-up|0
1048945|NCT00050778|3398483|P3|Overall Study|Lack of Efficacy|2
1048946|NCT00050778|3398484|P2|Overall Study|Lack of Efficacy|2
1048947|NCT00050778|3398485|P1|Overall Study|Lack of Efficacy|16
1048948|NCT00050778|3398483|P3|Overall Study|Death|1
1048949|NCT00050778|3398484|P2|Overall Study|Death|1
1048950|NCT00050778|3398485|P1|Overall Study|Death|0
1048951|NCT00050778|3398483|P3|Overall Study|Adverse Event|2
1048952|NCT00050778|3398484|P2|Overall Study|Adverse Event|3
1048953|NCT00050778|3398485|P1|Overall Study|Adverse Event|13
1048954|NCT00050622|3398511|P1|Overall Study|Adverse Event|1
1048955|NCT00050167|3398549|P2|Overall Study|not eligible not invasive|1
1048956|NCT00050167|3398550|P1|Overall Study|not eligible not invasive|1
1048957|NCT00050011|3398583|P2|Overall Study|Unknown - Reason is missing|2
1048958|NCT00050011|3398584|P1|Overall Study|Unknown - Reason is missing|0
1048959|NCT00050011|3398583|P2|Overall Study|Death|4
1048960|NCT00050011|3398584|P1|Overall Study|Death|7
1048961|NCT00050011|3398583|P2|Overall Study|Administrative problems|6
1048962|NCT00050011|3398584|P1|Overall Study|Administrative problems|10
1048963|NCT00050011|3398583|P2|Overall Study|Lost to Follow-up|9
1048964|NCT00050011|3398584|P1|Overall Study|Lost to Follow-up|7
1048965|NCT00050011|3398583|P2|Overall Study|Withdrawal by Subject|26
1048966|NCT00050011|3398584|P1|Overall Study|Withdrawal by Subject|34
1048967|NCT00050011|3398583|P2|Overall Study|Protocol Violation|10
1048968|NCT00050011|3398584|P1|Overall Study|Protocol Violation|4
1048969|NCT00050011|3398583|P2|Overall Study|Participant condition no longer required|0
1048970|NCT00050011|3398584|P1|Overall Study|Participant condition no longer required|1
1048971|NCT00050011|3398583|P2|Overall Study|Lack of Efficacy|21
1048972|NCT00050011|3398584|P1|Overall Study|Lack of Efficacy|16
1048973|NCT00050011|3398583|P2|Overall Study|Abnormal test procedure results|1
1048974|NCT00050011|3398584|P1|Overall Study|Abnormal test procedure results|0
1048975|NCT00050011|3398583|P2|Overall Study|Abnormal laboratory value(s)|1
1048976|NCT00050011|3398584|P1|Overall Study|Abnormal laboratory value(s)|1
1048977|NCT00050011|3398583|P2|Overall Study|Adverse Event|46
1048978|NCT00050011|3398584|P1|Overall Study|Adverse Event|41
1048979|NCT00049842|3398606|P2|Follow-up Phase|Not specified|4
1048980|NCT00049842|3398607|P1|Follow-up Phase|Not specified|1
1048981|NCT00049842|3398606|P2|Follow-up Phase|Adverse Event|1
1048982|NCT00049842|3398607|P1|Follow-up Phase|Adverse Event|6
1048983|NCT00049842|3398606|P2|Treatment Phase|Did not meet protocol eligibility|1
1048984|NCT00049842|3398607|P1|Treatment Phase|Did not meet protocol eligibility|0
1048985|NCT00049842|3398606|P2|Treatment Phase|Administrative|3
1048986|NCT00049842|3398607|P1|Treatment Phase|Administrative|0
1048987|NCT00049842|3398606|P2|Treatment Phase|Lost to Follow-up|8
1048988|NCT00049842|3398607|P1|Treatment Phase|Lost to Follow-up|4
1048989|NCT00049842|3398606|P2|Treatment Phase|Non-compliance with protocol|8
1048990|NCT00049842|3398607|P1|Treatment Phase|Non-compliance with protocol|7
1048991|NCT00049842|3398606|P2|Treatment Phase|Withdrawal by Subject|46
1048992|NCT00049842|3398607|P1|Treatment Phase|Withdrawal by Subject|35
1048993|NCT00049842|3398606|P2|Treatment Phase|Adverse Event|12
1048994|NCT00049842|3398607|P1|Treatment Phase|Adverse Event|47
1048995|NCT00048932|3398625|P3|Open Label Period (OL)|Participant Surgery|1
1048996|NCT00048932|3398626|P2|Open Label Period (OL)|Participant Surgery|0
1048997|NCT00048932|3398627|P1|Open Label Period (OL)|Participant Surgery|0
1048998|NCT00048932|3398625|P3|Open Label Period (OL)|Site Not Participating in Open Label|9
1048999|NCT00048932|3398626|P2|Open Label Period (OL)|Site Not Participating in Open Label|0
1049000|NCT00048932|3398627|P1|Open Label Period (OL)|Site Not Participating in Open Label|0
1049001|NCT00048932|3398625|P3|Open Label Period (OL)|Site Staff Issues|2
1049002|NCT00048932|3398626|P2|Open Label Period (OL)|Site Staff Issues|0
1049003|NCT00048932|3398627|P1|Open Label Period (OL)|Site Staff Issues|0
1049004|NCT00048932|3398625|P3|Open Label Period (OL)|Investigator Decision|4
1049005|NCT00048932|3398626|P2|Open Label Period (OL)|Investigator Decision|0
1049006|NCT00048932|3398627|P1|Open Label Period (OL)|Investigator Decision|0
1049007|NCT00048932|3398625|P3|Open Label Period (OL)|Medication Lost Efficacy|1
1049008|NCT00048932|3398626|P2|Open Label Period (OL)|Medication Lost Efficacy|0
1049009|NCT00048932|3398627|P1|Open Label Period (OL)|Medication Lost Efficacy|0
1049010|NCT00048932|3398625|P3|Open Label Period (OL)|Participant Missed Consecutive Doses|5
1049011|NCT00048932|3398626|P2|Open Label Period (OL)|Participant Missed Consecutive Doses|0
1049012|NCT00048932|3398627|P1|Open Label Period (OL)|Participant Missed Consecutive Doses|0
1049013|NCT00048932|3398625|P3|Open Label Period (OL)|Participant Desires Pregnancy|2
1049014|NCT00048932|3398626|P2|Open Label Period (OL)|Participant Desires Pregnancy|0
1049015|NCT00048932|3398627|P1|Open Label Period (OL)|Participant Desires Pregnancy|0
1049016|NCT00048932|3398625|P3|Open Label Period (OL)|Participant Received Wrong Medication|1
1049017|NCT00048932|3398626|P2|Open Label Period (OL)|Participant Received Wrong Medication|0
1049018|NCT00048932|3398627|P1|Open Label Period (OL)|Participant Received Wrong Medication|0
1049019|NCT00048932|3398625|P3|Open Label Period (OL)|Patient Decision|4
1049020|NCT00048932|3398626|P2|Open Label Period (OL)|Patient Decision|0
1049021|NCT00048932|3398627|P1|Open Label Period (OL)|Patient Decision|0
1049022|NCT00048932|3398625|P3|Open Label Period (OL)|Difficult IV Access with Participant|1
1049023|NCT00048932|3398626|P2|Open Label Period (OL)|Difficult IV Access with Participant|0
1049024|NCT00048932|3398627|P1|Open Label Period (OL)|Difficult IV Access with Participant|0
1049025|NCT00048932|3398625|P3|Open Label Period (OL)|Trial Terminated|1
1049026|NCT00048932|3398626|P2|Open Label Period (OL)|Trial Terminated|0
1049027|NCT00048932|3398627|P1|Open Label Period (OL)|Trial Terminated|0
1049028|NCT00048932|3398625|P3|Open Label Period (OL)|Site Closure|3
1049029|NCT00048932|3398626|P2|Open Label Period (OL)|Site Closure|0
1049030|NCT00048932|3398627|P1|Open Label Period (OL)|Site Closure|0
1049031|NCT00048932|3398625|P3|Open Label Period (OL)|Investigator Dosing the Trial|1
1049032|NCT00048932|3398626|P2|Open Label Period (OL)|Investigator Dosing the Trial|0
1049033|NCT00048932|3398627|P1|Open Label Period (OL)|Investigator Dosing the Trial|0
1049034|NCT00048932|3398625|P3|Open Label Period (OL)|Participant Relocated|6
1049035|NCT00048932|3398626|P2|Open Label Period (OL)|Participant Relocated|0
1049036|NCT00048932|3398627|P1|Open Label Period (OL)|Participant Relocated|0
1049037|NCT00048932|3398625|P3|Open Label Period (OL)|Participant Transportation Issues|1
1049038|NCT00048932|3398626|P2|Open Label Period (OL)|Participant Transportation Issues|0
1049039|NCT00048932|3398627|P1|Open Label Period (OL)|Participant Transportation Issues|0
1049040|NCT00048932|3398625|P3|Open Label Period (OL)|Investigator Retiring|2
1049041|NCT00048932|3398626|P2|Open Label Period (OL)|Investigator Retiring|0
1049042|NCT00048932|3398627|P1|Open Label Period (OL)|Investigator Retiring|0
1049043|NCT00048932|3398625|P3|Open Label Period (OL)|Administrative Reason By Sponsor|20
1049044|NCT00048932|3398626|P2|Open Label Period (OL)|Administrative Reason By Sponsor|0
1049045|NCT00048932|3398627|P1|Open Label Period (OL)|Administrative Reason By Sponsor|0
1049046|NCT00048932|3398625|P3|Open Label Period (OL)|Pregnancy|6
1049047|NCT00048932|3398626|P2|Open Label Period (OL)|Pregnancy|0
1049048|NCT00048932|3398627|P1|Open Label Period (OL)|Pregnancy|0
1049049|NCT00048932|3398625|P3|Open Label Period (OL)|Poor/Non-Compliance|13
1049050|NCT00048932|3398626|P2|Open Label Period (OL)|Poor/Non-Compliance|0
1049051|NCT00048932|3398627|P1|Open Label Period (OL)|Poor/Non-Compliance|0
1049052|NCT00048932|3398625|P3|Open Label Period (OL)|No Longer Meets Study Criteria|5
1049053|NCT00048932|3398626|P2|Open Label Period (OL)|No Longer Meets Study Criteria|0
1049054|NCT00048932|3398627|P1|Open Label Period (OL)|No Longer Meets Study Criteria|0
1049055|NCT00048932|3398625|P3|Open Label Period (OL)|Withdrawal by Subject|117
1049056|NCT00048932|3398626|P2|Open Label Period (OL)|Withdrawal by Subject|0
1049057|NCT00048932|3398627|P1|Open Label Period (OL)|Withdrawal by Subject|0
1049058|NCT00048932|3398625|P3|Open Label Period (OL)|Lost to Follow-up|27
1049059|NCT00048932|3398626|P2|Open Label Period (OL)|Lost to Follow-up|0
1049060|NCT00048932|3398627|P1|Open Label Period (OL)|Lost to Follow-up|0
1049061|NCT00048932|3398625|P3|Open Label Period (OL)|Lack of Efficacy|81
1049062|NCT00048932|3398626|P2|Open Label Period (OL)|Lack of Efficacy|0
1049063|NCT00048932|3398627|P1|Open Label Period (OL)|Lack of Efficacy|0
1049064|NCT00048932|3398625|P3|Open Label Period (OL)|Adverse Event|103
1049065|NCT00048932|3398626|P2|Open Label Period (OL)|Adverse Event|0
1049066|NCT00048932|3398627|P1|Open Label Period (OL)|Adverse Event|0
1049067|NCT00048932|3398625|P3|Open Label Period (OL)|Death|25
1049068|NCT00048932|3398626|P2|Open Label Period (OL)|Death|0
1049069|NCT00048932|3398627|P1|Open Label Period (OL)|Death|0
1049070|NCT00048932|3398625|P3|Double Blind Period (DB)|Poor/Non-Compliance|0
1049071|NCT00048932|3398626|P2|Double Blind Period (DB)|Poor/Non-Compliance|4
1049072|NCT00048932|3398627|P1|Double Blind Period (DB)|Poor/Non-Compliance|2
1049073|NCT00048932|3398625|P3|Double Blind Period (DB)|Withdrawal by Subject|0
1049074|NCT00048932|3398626|P2|Double Blind Period (DB)|Withdrawal by Subject|10
1049075|NCT00048932|3398627|P1|Double Blind Period (DB)|Withdrawal by Subject|24
1049076|NCT00048932|3398625|P3|Double Blind Period (DB)|No Longer Meets Study Criteria|0
1049077|NCT00048932|3398626|P2|Double Blind Period (DB)|No Longer Meets Study Criteria|2
1049078|NCT00048932|3398627|P1|Double Blind Period (DB)|No Longer Meets Study Criteria|8
1049079|NCT00048932|3398625|P3|Double Blind Period (DB)|Pregnancy|0
1049080|NCT00048932|3398626|P2|Double Blind Period (DB)|Pregnancy|0
1049081|NCT00048932|3398627|P1|Double Blind Period (DB)|Pregnancy|1
1049082|NCT00048932|3398625|P3|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
1049083|NCT00048932|3398626|P2|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
1049084|NCT00048932|3398627|P1|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1
1049085|NCT00048932|3398625|P3|Double Blind Period (DB)|Uncontrolled hypertension|0
1049086|NCT00048932|3398626|P2|Double Blind Period (DB)|Uncontrolled hypertension|1
1049087|NCT00048932|3398627|P1|Double Blind Period (DB)|Uncontrolled hypertension|0
1049088|NCT00048932|3398625|P3|Double Blind Period (DB)|Relocation|0
1049089|NCT00048932|3398626|P2|Double Blind Period (DB)|Relocation|0
1049090|NCT00048932|3398627|P1|Double Blind Period (DB)|Relocation|1
1049091|NCT00048932|3398625|P3|Double Blind Period (DB)|Lost to Follow-up|0
1049092|NCT00048932|3398626|P2|Double Blind Period (DB)|Lost to Follow-up|4
1049093|NCT00048932|3398627|P1|Double Blind Period (DB)|Lost to Follow-up|3
1049094|NCT00048932|3398625|P3|Double Blind Period (DB)|Lack of Efficacy|0
1049095|NCT00048932|3398626|P2|Double Blind Period (DB)|Lack of Efficacy|44
1049096|NCT00048932|3398627|P1|Double Blind Period (DB)|Lack of Efficacy|26
1049097|NCT00048932|3398625|P3|Double Blind Period (DB)|Death|0
1049098|NCT00048932|3398626|P2|Double Blind Period (DB)|Death|3
1049099|NCT00048932|3398627|P1|Double Blind Period (DB)|Death|5
1049100|NCT00048932|3398625|P3|Double Blind Period (DB)|Adverse Event|0
1049101|NCT00048932|3398626|P2|Double Blind Period (DB)|Adverse Event|19
1049102|NCT00048932|3398627|P1|Double Blind Period (DB)|Adverse Event|51
1049103|NCT00048932|3398625|P3|Double Blind Period (DB)|Administrative Reason By Sponsor|0
1049104|NCT00048932|3398626|P2|Double Blind Period (DB)|Administrative Reason By Sponsor|0
1049105|NCT00048932|3398627|P1|Double Blind Period (DB)|Administrative Reason By Sponsor|1
1049106|NCT00048581|3398669|P3|Open-Label Period|Study Ended By Sponsor|1
1049107|NCT00048581|3398670|P2|Open-Label Period|Study Ended By Sponsor|0
1049108|NCT00048581|3398671|P1|Open-Label Period|Study Ended By Sponsor|0
1049109|NCT00048581|3398669|P3|Open-Label Period|Primary Investigator Retired|2
1049110|NCT00048581|3398670|P2|Open-Label Period|Primary Investigator Retired|0
1049111|NCT00048581|3398671|P1|Open-Label Period|Primary Investigator Retired|0
1049112|NCT00048581|3398669|P3|Open-Label Period|Problem With Transportation To Site|1
1049113|NCT00048581|3398670|P2|Open-Label Period|Problem With Transportation To Site|0
1049114|NCT00048581|3398671|P1|Open-Label Period|Problem With Transportation To Site|0
1049115|NCT00048581|3398669|P3|Open-Label Period|Continue ABA With Primary Rheumatologist|3
1049116|NCT00048581|3398670|P2|Open-Label Period|Continue ABA With Primary Rheumatologist|0
1049117|NCT00048581|3398671|P1|Open-Label Period|Continue ABA With Primary Rheumatologist|0
1049118|NCT00048581|3398669|P3|Open-Label Period|Study Site Closure|2
1049119|NCT00048581|3398670|P2|Open-Label Period|Study Site Closure|0
1049120|NCT00048581|3398671|P1|Open-Label Period|Study Site Closure|0
1049121|NCT00048581|3398669|P3|Open-Label Period|Pregnancy|7
1049122|NCT00048581|3398670|P2|Open-Label Period|Pregnancy|0
1049123|NCT00048581|3398671|P1|Open-Label Period|Pregnancy|0
1049124|NCT00048581|3398669|P3|Open-Label Period|Poor/Non-compliance|5
1049125|NCT00048581|3398670|P2|Open-Label Period|Poor/Non-compliance|0
1049126|NCT00048581|3398671|P1|Open-Label Period|Poor/Non-compliance|0
1049127|NCT00048581|3398669|P3|Open-Label Period|No Longer Meets Study Criteria|2
1049128|NCT00048581|3398670|P2|Open-Label Period|No Longer Meets Study Criteria|0
1049129|NCT00048581|3398671|P1|Open-Label Period|No Longer Meets Study Criteria|0
1049130|NCT00048581|3398669|P3|Open-Label Period|Withdrawal by Subject|20
1049131|NCT00048581|3398670|P2|Open-Label Period|Withdrawal by Subject|0
1049132|NCT00048581|3398671|P1|Open-Label Period|Withdrawal by Subject|0
1049133|NCT00048581|3398669|P3|Open-Label Period|Lost to Follow-up|14
1049134|NCT00048581|3398670|P2|Open-Label Period|Lost to Follow-up|0
1049135|NCT00048581|3398671|P1|Open-Label Period|Lost to Follow-up|0
1049136|NCT00048581|3398669|P3|Open-Label Period|Lack of Efficacy|69
1049137|NCT00048581|3398670|P2|Open-Label Period|Lack of Efficacy|0
1049138|NCT00048581|3398671|P1|Open-Label Period|Lack of Efficacy|0
1049139|NCT00048581|3398669|P3|Open-Label Period|Adverse Event|37
1049140|NCT00048581|3398670|P2|Open-Label Period|Adverse Event|0
1049141|NCT00048581|3398671|P1|Open-Label Period|Adverse Event|0
1049142|NCT00048581|3398669|P3|Open-Label Period|Death|4
1049143|NCT00048581|3398670|P2|Open-Label Period|Death|0
1049144|NCT00048581|3398671|P1|Open-Label Period|Death|0
1049145|NCT00048581|3398669|P3|Double-Blind Period|Investigator Decision|0
1049146|NCT00048581|3398670|P2|Double-Blind Period|Investigator Decision|0
1049147|NCT00048581|3398671|P1|Double-Blind Period|Investigator Decision|1
1049148|NCT00048581|3398669|P3|Double-Blind Period|Participant Has History of Lymphopenia|0
1049149|NCT00048581|3398670|P2|Double-Blind Period|Participant Has History of Lymphopenia|0
1049150|NCT00048581|3398671|P1|Double-Blind Period|Participant Has History of Lymphopenia|1
1049151|NCT00048581|3398669|P3|Double-Blind Period|Withdrawal by Subject|0
1049152|NCT00048581|3398670|P2|Double-Blind Period|Withdrawal by Subject|2
1049153|NCT00048581|3398671|P1|Double-Blind Period|Withdrawal by Subject|5
1049154|NCT00048581|3398669|P3|Double-Blind Period|Lost to Follow-up|0
1049155|NCT00048581|3398670|P2|Double-Blind Period|Lost to Follow-up|0
1049156|NCT00048581|3398671|P1|Double-Blind Period|Lost to Follow-up|5
1049157|NCT00048581|3398669|P3|Double-Blind Period|Lack of Efficacy|0
1049158|NCT00048581|3398670|P2|Double-Blind Period|Lack of Efficacy|27
1049159|NCT00048581|3398671|P1|Double-Blind Period|Lack of Efficacy|14
1049160|NCT00048581|3398669|P3|Double-Blind Period|Adverse Event|0
1049161|NCT00048581|3398670|P2|Double-Blind Period|Adverse Event|5
1049162|NCT00048581|3398671|P1|Double-Blind Period|Adverse Event|9
1049163|NCT00048568|3398838|P3|Open-Label Period|Lost to Follow-up|7
1049164|NCT00048568|3398839|P2|Open-Label Period|Lost to Follow-up|0
1049165|NCT00048568|3398840|P1|Open-Label Period|Lost to Follow-up|0
1049166|NCT00048568|3398838|P3|Open-Label Period|Unknown Reasons|25
1049167|NCT00048568|3398839|P2|Open-Label Period|Unknown Reasons|0
1049168|NCT00048568|3398840|P1|Open-Label Period|Unknown Reasons|0
1049169|NCT00048568|3398838|P3|Open-Label Period|Administrative Decision By Sponsor|1
1049170|NCT00048568|3398839|P2|Open-Label Period|Administrative Decision By Sponsor|0
1049171|NCT00048568|3398840|P1|Open-Label Period|Administrative Decision By Sponsor|0
1049172|NCT00048568|3398838|P3|Open-Label Period|No Longer Met Study Criteria|2
1049173|NCT00048568|3398839|P2|Open-Label Period|No Longer Met Study Criteria|0
1049174|NCT00048568|3398840|P1|Open-Label Period|No Longer Met Study Criteria|0
1049175|NCT00048568|3398838|P3|Open-Label Period|Pregnancy|5
1049176|NCT00048568|3398839|P2|Open-Label Period|Pregnancy|0
1049177|NCT00048568|3398840|P1|Open-Label Period|Pregnancy|0
1049178|NCT00048568|3398838|P3|Open-Label Period|Withdrawal by Subject|26
1049179|NCT00048568|3398839|P2|Open-Label Period|Withdrawal by Subject|0
1049180|NCT00048568|3398840|P1|Open-Label Period|Withdrawal by Subject|0
1049181|NCT00048568|3398838|P3|Open-Label Period|Lack of Efficacy|32
1049182|NCT00048568|3398839|P2|Open-Label Period|Lack of Efficacy|0
1049183|NCT00048568|3398840|P1|Open-Label Period|Lack of Efficacy|0
1049184|NCT00048568|3398838|P3|Open-Label Period|Adverse Event|49
1049185|NCT00048568|3398839|P2|Open-Label Period|Adverse Event|0
1049186|NCT00048568|3398840|P1|Open-Label Period|Adverse Event|0
1049187|NCT00048568|3398838|P3|Open-Label Period|Death|13
1049188|NCT00048568|3398839|P2|Open-Label Period|Death|0
1049189|NCT00048568|3398840|P1|Open-Label Period|Death|0
1049190|NCT00048568|3398838|P3|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0
1049191|NCT00048568|3398839|P2|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
1049192|NCT00048568|3398840|P1|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
1049193|NCT00048568|3398838|P3|Double-Blind Period Days 170 to 365|Pregnancy|0
1049194|NCT00048568|3398839|P2|Double-Blind Period Days 170 to 365|Pregnancy|0
1049195|NCT00048568|3398840|P1|Double-Blind Period Days 170 to 365|Pregnancy|2
1049196|NCT00048568|3398838|P3|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
1049197|NCT00048568|3398839|P2|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1
1049198|NCT00048568|3398840|P1|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
1049199|NCT00048568|3398838|P3|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0
1049200|NCT00048568|3398839|P2|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1
1049201|NCT00048568|3398840|P1|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3
1049202|NCT00048568|3398838|P3|Double-Blind Period Days 170 to 365|Lack of Efficacy|0
1049203|NCT00048568|3398839|P2|Double-Blind Period Days 170 to 365|Lack of Efficacy|7
1049204|NCT00048568|3398840|P1|Double-Blind Period Days 170 to 365|Lack of Efficacy|2
1049205|NCT00048568|3398838|P3|Double-Blind Period Days 170 to 365|Adverse Event|0
1049206|NCT00048568|3398839|P2|Double-Blind Period Days 170 to 365|Adverse Event|1
1049207|NCT00048568|3398840|P1|Double-Blind Period Days 170 to 365|Adverse Event|7
1049208|NCT00048568|3398838|P3|Double-Blind Period Days 170 to 365|Death|0
1049209|NCT00048568|3398839|P2|Double-Blind Period Days 170 to 365|Death|1
1049210|NCT00048568|3398840|P1|Double-Blind Period Days 170 to 365|Death|1
1049211|NCT00048568|3398838|P3|Double-Blind Period Days 1 to 169|Unknown Reasons|0
1049212|NCT00048568|3398839|P2|Double-Blind Period Days 1 to 169|Unknown Reasons|4
1049213|NCT00048568|3398840|P1|Double-Blind Period Days 1 to 169|Unknown Reasons|2
1049214|NCT00048568|3398838|P3|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0
1049215|NCT00048568|3398839|P2|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4
1049216|NCT00048568|3398840|P1|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7
1049217|NCT00048568|3398838|P3|Double-Blind Period Days 1 to 169|Lost to Follow-up|0
1049218|NCT00048568|3398839|P2|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
1049219|NCT00048568|3398840|P1|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
1049220|NCT00048568|3398838|P3|Double-Blind Period Days 1 to 169|Lack of Efficacy|0
1049221|NCT00048568|3398839|P2|Double-Blind Period Days 1 to 169|Lack of Efficacy|33
1049222|NCT00048568|3398840|P1|Double-Blind Period Days 1 to 169|Lack of Efficacy|11
1049223|NCT00048568|3398838|P3|Double-Blind Period Days 1 to 169|Adverse Event|0
1049224|NCT00048568|3398839|P2|Double-Blind Period Days 1 to 169|Adverse Event|3
1049225|NCT00048568|3398840|P1|Double-Blind Period Days 1 to 169|Adverse Event|11
1049226|NCT00048724|3399145|P2|Overall Study|Administrative|1
1049227|NCT00048724|3399146|P1|Overall Study|Administrative|1
1049228|NCT00048724|3399145|P2|Overall Study|Did Not Meet Protocol Eligibility|2
1049229|NCT00048724|3399146|P1|Overall Study|Did Not Meet Protocol Eligibility|2
1049230|NCT00048724|3399145|P2|Overall Study|Noncompliance With Protocol|12
1049231|NCT00048724|3399146|P1|Overall Study|Noncompliance With Protocol|4
1049232|NCT00048724|3399145|P2|Overall Study|Protocol-defined Clinical Event|32
1049233|NCT00048724|3399146|P1|Overall Study|Protocol-defined Clinical Event|17
1049234|NCT00048724|3399145|P2|Overall Study|Lost to Follow-up|5
1049235|NCT00048724|3399146|P1|Overall Study|Lost to Follow-up|5
1049236|NCT00048724|3399145|P2|Overall Study|Withdrawal by Subject|54
1049237|NCT00048724|3399146|P1|Overall Study|Withdrawal by Subject|34
1049238|NCT00048724|3399145|P2|Overall Study|Adverse Event|12
1049239|NCT00048724|3399146|P1|Overall Study|Adverse Event|53
1049240|NCT00048542|3399158|P8|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8
1049241|NCT00048542|3399159|P7|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5
1049242|NCT00048542|3399160|P6|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
1049243|NCT00048542|3399161|P5|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
1049244|NCT00048542|3399162|P4|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
1049245|NCT00048542|3399163|P3|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
1049246|NCT00048542|3399164|P2|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
1049247|NCT00048542|3399165|P1|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
1049248|NCT00048542|3399158|P8|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1
1049249|NCT00048542|3399159|P7|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2
1049250|NCT00048542|3399160|P6|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
1049251|NCT00048542|3399161|P5|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
1049252|NCT00048542|3399162|P4|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
1049253|NCT00048542|3399163|P3|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
1049254|NCT00048542|3399164|P2|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
1049255|NCT00048542|3399165|P1|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
1049256|NCT00048542|3399158|P8|Open-Label Extension Fixed Dose Phase|Adverse Event|2
1049257|NCT00048542|3399159|P7|Open-Label Extension Fixed Dose Phase|Adverse Event|2
1049258|NCT00048542|3399160|P6|Open-Label Extension Fixed Dose Phase|Adverse Event|0
1049259|NCT00048542|3399161|P5|Open-Label Extension Fixed Dose Phase|Adverse Event|0
1049260|NCT00048542|3399162|P4|Open-Label Extension Fixed Dose Phase|Adverse Event|0
1049261|NCT00048542|3399163|P3|Open-Label Extension Fixed Dose Phase|Adverse Event|0
1049262|NCT00048542|3399164|P2|Open-Label Extension Fixed Dose Phase|Adverse Event|0
1049263|NCT00048542|3399165|P1|Open-Label Extension Fixed Dose Phase|Adverse Event|0
1049264|NCT00048542|3399158|P8|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7
1049265|NCT00048542|3399159|P7|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6
1049266|NCT00048542|3399160|P6|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
1049267|NCT00048542|3399161|P5|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
1049268|NCT00048542|3399162|P4|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
1049269|NCT00048542|3399163|P3|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
1049270|NCT00048542|3399164|P2|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
1049271|NCT00048542|3399165|P1|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
1049272|NCT00048542|3399158|P8|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
1049273|NCT00048542|3399159|P7|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
1049274|NCT00048542|3399160|P6|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
1049275|NCT00048542|3399161|P5|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
1049276|NCT00048542|3399162|P4|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
1049277|NCT00048542|3399163|P3|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
1049278|NCT00048542|3399164|P2|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
1049279|NCT00048542|3399165|P1|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
1049280|NCT00048542|3399158|P8|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3
1049281|NCT00048542|3399159|P7|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6
1049282|NCT00048542|3399160|P6|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
1049283|NCT00048542|3399161|P5|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
1049284|NCT00048542|3399162|P4|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
1049285|NCT00048542|3399163|P3|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
1049286|NCT00048542|3399164|P2|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
1049287|NCT00048542|3399165|P1|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
1049288|NCT00048542|3399158|P8|Open-Label Extension BSA Phase|Lack of Efficacy|0
1049289|NCT00048542|3399159|P7|Open-Label Extension BSA Phase|Lack of Efficacy|0
1049290|NCT00048542|3399160|P6|Open-Label Extension BSA Phase|Lack of Efficacy|1
1049291|NCT00048542|3399161|P5|Open-Label Extension BSA Phase|Lack of Efficacy|3
1049292|NCT00048542|3399162|P4|Open-Label Extension BSA Phase|Lack of Efficacy|0
1049293|NCT00048542|3399163|P3|Open-Label Extension BSA Phase|Lack of Efficacy|0
1049294|NCT00048542|3399164|P2|Open-Label Extension BSA Phase|Lack of Efficacy|0
1049295|NCT00048542|3399165|P1|Open-Label Extension BSA Phase|Lack of Efficacy|0
1049296|NCT00048542|3399158|P8|Open-Label Extension BSA Phase|Adverse Event|0
1049297|NCT00048542|3399159|P7|Open-Label Extension BSA Phase|Adverse Event|0
1049298|NCT00048542|3399160|P6|Open-Label Extension BSA Phase|Adverse Event|1
1049299|NCT00048542|3399161|P5|Open-Label Extension BSA Phase|Adverse Event|1
1049300|NCT00048542|3399162|P4|Open-Label Extension BSA Phase|Adverse Event|0
1049301|NCT00048542|3399163|P3|Open-Label Extension BSA Phase|Adverse Event|0
1049302|NCT00048542|3399164|P2|Open-Label Extension BSA Phase|Adverse Event|0
1049303|NCT00048542|3399165|P1|Open-Label Extension BSA Phase|Adverse Event|0
1049304|NCT00048542|3399158|P8|Open-Label Extension BSA Phase|Sponsor request or decision|0
1049305|NCT00048542|3399159|P7|Open-Label Extension BSA Phase|Sponsor request or decision|0
1049306|NCT00048542|3399160|P6|Open-Label Extension BSA Phase|Sponsor request or decision|1
1049307|NCT00048542|3399161|P5|Open-Label Extension BSA Phase|Sponsor request or decision|5
1049308|NCT00048542|3399162|P4|Open-Label Extension BSA Phase|Sponsor request or decision|0
1049309|NCT00048542|3399163|P3|Open-Label Extension BSA Phase|Sponsor request or decision|0
1049310|NCT00048542|3399164|P2|Open-Label Extension BSA Phase|Sponsor request or decision|0
1049311|NCT00048542|3399165|P1|Open-Label Extension BSA Phase|Sponsor request or decision|0
1049312|NCT00048542|3399158|P8|Open-Label Extension BSA Phase|Protocol Violation|0
1049313|NCT00048542|3399159|P7|Open-Label Extension BSA Phase|Protocol Violation|0
1049314|NCT00048542|3399160|P6|Open-Label Extension BSA Phase|Protocol Violation|1
1049315|NCT00048542|3399161|P5|Open-Label Extension BSA Phase|Protocol Violation|0
1049316|NCT00048542|3399162|P4|Open-Label Extension BSA Phase|Protocol Violation|0
1049317|NCT00048542|3399163|P3|Open-Label Extension BSA Phase|Protocol Violation|0
1049318|NCT00048542|3399164|P2|Open-Label Extension BSA Phase|Protocol Violation|0
1049319|NCT00048542|3399165|P1|Open-Label Extension BSA Phase|Protocol Violation|0
1049320|NCT00048542|3399158|P8|Open-Label Extension BSA Phase|Withdrawal by Subject|0
1049321|NCT00048542|3399159|P7|Open-Label Extension BSA Phase|Withdrawal by Subject|0
1049322|NCT00048542|3399160|P6|Open-Label Extension BSA Phase|Withdrawal by Subject|6
1049323|NCT00048542|3399161|P5|Open-Label Extension BSA Phase|Withdrawal by Subject|3
1049324|NCT00048542|3399162|P4|Open-Label Extension BSA Phase|Withdrawal by Subject|0
1049325|NCT00048542|3399163|P3|Open-Label Extension BSA Phase|Withdrawal by Subject|0
1049326|NCT00048542|3399164|P2|Open-Label Extension BSA Phase|Withdrawal by Subject|0
1049327|NCT00048542|3399165|P1|Open-Label Extension BSA Phase|Withdrawal by Subject|0
1049328|NCT00048542|3399158|P8|Double-Blind Phase|Randomized in error|0
1049329|NCT00048542|3399159|P7|Double-Blind Phase|Randomized in error|0
1049330|NCT00048542|3399160|P6|Double-Blind Phase|Randomized in error|0
1049331|NCT00048542|3399161|P5|Double-Blind Phase|Randomized in error|0
1049332|NCT00048542|3399162|P4|Double-Blind Phase|Randomized in error|0
1049333|NCT00048542|3399163|P3|Double-Blind Phase|Randomized in error|0
1049334|NCT00048542|3399164|P2|Double-Blind Phase|Randomized in error|0
1049335|NCT00048542|3399165|P1|Double-Blind Phase|Randomized in error|1
1049336|NCT00048542|3399158|P8|Double-Blind Phase|Sponsor request or decision|0
1049337|NCT00048542|3399159|P7|Double-Blind Phase|Sponsor request or decision|0
1049338|NCT00048542|3399160|P6|Double-Blind Phase|Sponsor request or decision|0
1049339|NCT00048542|3399161|P5|Double-Blind Phase|Sponsor request or decision|0
1049340|NCT00048542|3399162|P4|Double-Blind Phase|Sponsor request or decision|0
1049341|NCT00048542|3399163|P3|Double-Blind Phase|Sponsor request or decision|0
1049342|NCT00048542|3399164|P2|Double-Blind Phase|Sponsor request or decision|0
1049343|NCT00048542|3399165|P1|Double-Blind Phase|Sponsor request or decision|2
1049344|NCT00048542|3399158|P8|Double-Blind Phase|Protocol Violation|0
1049345|NCT00048542|3399159|P7|Double-Blind Phase|Protocol Violation|0
1049346|NCT00048542|3399160|P6|Double-Blind Phase|Protocol Violation|0
1049347|NCT00048542|3399161|P5|Double-Blind Phase|Protocol Violation|0
1049348|NCT00048542|3399162|P4|Double-Blind Phase|Protocol Violation|0
1049349|NCT00048542|3399163|P3|Double-Blind Phase|Protocol Violation|1
1049350|NCT00048542|3399164|P2|Double-Blind Phase|Protocol Violation|0
1049351|NCT00048542|3399165|P1|Double-Blind Phase|Protocol Violation|0
1049352|NCT00048542|3399158|P8|Double-Blind Phase|Withdrawal by Subject|0
1049353|NCT00048542|3399159|P7|Double-Blind Phase|Withdrawal by Subject|0
1049354|NCT00048542|3399160|P6|Double-Blind Phase|Withdrawal by Subject|0
1049355|NCT00048542|3399161|P5|Double-Blind Phase|Withdrawal by Subject|0
1049356|NCT00048542|3399162|P4|Double-Blind Phase|Withdrawal by Subject|0
1049357|NCT00048542|3399163|P3|Double-Blind Phase|Withdrawal by Subject|0
1049358|NCT00048542|3399164|P2|Double-Blind Phase|Withdrawal by Subject|1
1049359|NCT00048542|3399165|P1|Double-Blind Phase|Withdrawal by Subject|0
1049360|NCT00048347|3399231|P1|Overall Study|Screen failure|2
1049361|NCT00048165|3399237|P2|Completed 12 Months Study|Did not co-operate/Withdrew|0
1049362|NCT00048165|3399238|P1|Completed 12 Months Study|Did not co-operate/Withdrew|1
1049363|NCT00048165|3399237|P2|Completed 12 Months Study|Death|1
1049364|NCT00048165|3399238|P1|Completed 12 Months Study|Death|2
1049365|NCT00048165|3399237|P2|Completed 12 Months Study|Administration/Other|2
1049366|NCT00048165|3399238|P1|Completed 12 Months Study|Administration/Other|0
1049367|NCT00048165|3399237|P2|Completed 6 Months Study|Did not receive study drug|6
1049368|NCT00048165|3399238|P1|Completed 6 Months Study|Did not receive study drug|6
1049369|NCT00048165|3399237|P2|Completed 6 Months Study|Violation criteria|2
1049370|NCT00048165|3399238|P1|Completed 6 Months Study|Violation criteria|0
1049371|NCT00048165|3399237|P2|Completed 6 Months Study|Refused treatment|5
1049372|NCT00048165|3399238|P1|Completed 6 Months Study|Refused treatment|5
1049373|NCT00048165|3399237|P2|Completed 6 Months Study|Other violation|6
1049374|NCT00048165|3399238|P1|Completed 6 Months Study|Other violation|4
1049375|NCT00048165|3399237|P2|Completed 6 Months Study|Insufficient therapy|4
1049376|NCT00048165|3399238|P1|Completed 6 Months Study|Insufficient therapy|1
1049377|NCT00048165|3399237|P2|Completed 6 Months Study|Death|6
1049378|NCT00048165|3399238|P1|Completed 6 Months Study|Death|12
1049379|NCT00048165|3399237|P2|Completed 6 Months Study|Adverse event/intermittent illness|11
1049380|NCT00048165|3399238|P1|Completed 6 Months Study|Adverse event/intermittent illness|14
1049381|NCT00048165|3399237|P2|Completed 6 Months Study|Abnormality of laboratory test|0
1049382|NCT00048165|3399238|P1|Completed 6 Months Study|Abnormality of laboratory test|1
1049383|NCT00048165|3399237|P2|Completed 6 Months Study|Administration/Other|8
1049384|NCT00048165|3399238|P1|Completed 6 Months Study|Administration/Other|8
1049385|NCT00048074|3399273|P3|Overall Study|Social reasons|0
1049386|NCT00048074|3399274|P2|Overall Study|Social reasons|0
1049387|NCT00048074|3399275|P1|Overall Study|Social reasons|1
1049388|NCT00048074|3399273|P3|Overall Study|Out of station|1
1049389|NCT00048074|3399274|P2|Overall Study|Out of station|1
1049390|NCT00048074|3399275|P1|Overall Study|Out of station|0
1049391|NCT00048074|3399273|P3|Overall Study|Poor compliance|0
1049392|NCT00048074|3399274|P2|Overall Study|Poor compliance|1
1049393|NCT00048074|3399275|P1|Overall Study|Poor compliance|0
1049394|NCT00048074|3399273|P3|Overall Study|Husband ill|0
1049395|NCT00048074|3399274|P2|Overall Study|Husband ill|1
1049396|NCT00048074|3399275|P1|Overall Study|Husband ill|0
1049397|NCT00048074|3399273|P3|Overall Study|Study participation was terminated|0
1049398|NCT00048074|3399274|P2|Overall Study|Study participation was terminated|1
1049399|NCT00048074|3399275|P1|Overall Study|Study participation was terminated|0
1049400|NCT00048074|3399273|P3|Overall Study|Protocol Violation|0
1049401|NCT00048074|3399274|P2|Overall Study|Protocol Violation|3
1049402|NCT00048074|3399275|P1|Overall Study|Protocol Violation|1
1049403|NCT00048074|3399273|P3|Overall Study|Withdrawal by Subject|35
1049404|NCT00048074|3399274|P2|Overall Study|Withdrawal by Subject|30
1049405|NCT00048074|3399275|P1|Overall Study|Withdrawal by Subject|28
1049406|NCT00048074|3399273|P3|Overall Study|Lost to Follow-up|6
1049407|NCT00048074|3399274|P2|Overall Study|Lost to Follow-up|6
1049408|NCT00048074|3399275|P1|Overall Study|Lost to Follow-up|2
1049409|NCT00048074|3399273|P3|Overall Study|Death|2
1049410|NCT00048074|3399274|P2|Overall Study|Death|3
1049411|NCT00048074|3399275|P1|Overall Study|Death|3
1049412|NCT00048074|3399273|P3|Overall Study|Adverse Event|53
1049413|NCT00048074|3399274|P2|Overall Study|Adverse Event|41
1049414|NCT00048074|3399275|P1|Overall Study|Adverse Event|46
1049415|NCT00048061|3399332|P4|Overall Study|Early improvement|0
1049416|NCT00048061|3399333|P3|Overall Study|Early improvement|3
1049417|NCT00048061|3399334|P2|Overall Study|Early improvement|5
1049418|NCT00048061|3399335|P1|Overall Study|Early improvement|6
1049419|NCT00048061|3399332|P4|Overall Study|Did not follow-up|5
1049420|NCT00048061|3399333|P3|Overall Study|Did not follow-up|4
1049421|NCT00048061|3399334|P2|Overall Study|Did not follow-up|5
1049422|NCT00048061|3399335|P1|Overall Study|Did not follow-up|5
1049423|NCT00048061|3399332|P4|Overall Study|Withdrawal by Subject|32
1049424|NCT00048061|3399333|P3|Overall Study|Withdrawal by Subject|29
1049425|NCT00048061|3399334|P2|Overall Study|Withdrawal by Subject|29
1049426|NCT00048061|3399335|P1|Overall Study|Withdrawal by Subject|20
1049427|NCT00048061|3399332|P4|Overall Study|Lost to Follow-up|5
1049428|NCT00048061|3399333|P3|Overall Study|Lost to Follow-up|4
1049429|NCT00048061|3399334|P2|Overall Study|Lost to Follow-up|2
1049430|NCT00048061|3399335|P1|Overall Study|Lost to Follow-up|3
1049431|NCT00048061|3399332|P4|Overall Study|Adverse Event|37
1049432|NCT00048061|3399333|P3|Overall Study|Adverse Event|44
1049433|NCT00048061|3399334|P2|Overall Study|Adverse Event|32
1049434|NCT00048061|3399335|P1|Overall Study|Adverse Event|41
1049435|NCT00048048|3399414|P12|Extension Year 2|Early withdrawals|2
1049436|NCT00048048|3399415|P11|Extension Year 2|Early withdrawals|4
1049437|NCT00048048|3399416|P10|Extension Year 2|Early withdrawals|0
1049438|NCT00048048|3399417|P9|Extension Year 2|Early withdrawals|0
1049439|NCT00048048|3399418|P8|Extension Year 2|Early withdrawals|0
1049440|NCT00048048|3399419|P7|Extension Year 2|Early withdrawals|0
1049441|NCT00048048|3399420|P6|Extension Year 2|Early withdrawals|0
1049442|NCT00048048|3399421|P5|Extension Year 2|Early withdrawals|0
1049443|NCT00048048|3399422|P4|Extension Year 2|Early withdrawals|0
1049444|NCT00048048|3399423|P3|Extension Year 2|Early withdrawals|0
1049445|NCT00048048|3399424|P2|Extension Year 2|Early withdrawals|0
1049446|NCT00048048|3399425|P1|Extension Year 2|Early withdrawals|0
1049447|NCT00048048|3399414|P12|Extension Year 1|Early withdrawals|4
1049448|NCT00048048|3399415|P11|Extension Year 1|Early withdrawals|2
1049449|NCT00048048|3399416|P10|Extension Year 1|Early withdrawals|2
1049450|NCT00048048|3399417|P9|Extension Year 1|Early withdrawals|0
1049451|NCT00048048|3399418|P8|Extension Year 1|Early withdrawals|0
1049452|NCT00048048|3399419|P7|Extension Year 1|Early withdrawals|0
1049453|NCT00048048|3399420|P6|Extension Year 1|Early withdrawals|0
1049454|NCT00048048|3399421|P5|Extension Year 1|Early withdrawals|0
1049455|NCT00048048|3399422|P4|Extension Year 1|Early withdrawals|0
1049456|NCT00048048|3399423|P3|Extension Year 1|Early withdrawals|0
1049457|NCT00048048|3399424|P2|Extension Year 1|Early withdrawals|0
1049458|NCT00048048|3399425|P1|Extension Year 1|Early withdrawals|0
1049459|NCT00048048|3399414|P12|Core Treatment|Adverse Event|0
1049460|NCT00048048|3399415|P11|Core Treatment|Adverse Event|0
1049461|NCT00048048|3399416|P10|Core Treatment|Adverse Event|0
1049462|NCT00048048|3399417|P9|Core Treatment|Adverse Event|0
1049463|NCT00048048|3399418|P8|Core Treatment|Adverse Event|1
1049464|NCT00048048|3399419|P7|Core Treatment|Adverse Event|0
1049465|NCT00048048|3399420|P6|Core Treatment|Adverse Event|0
1049466|NCT00048048|3399421|P5|Core Treatment|Adverse Event|0
1049467|NCT00048048|3399422|P4|Core Treatment|Adverse Event|0
1049468|NCT00048048|3399423|P3|Core Treatment|Adverse Event|0
1049469|NCT00048048|3399424|P2|Core Treatment|Adverse Event|0
1049470|NCT00048048|3399425|P1|Core Treatment|Adverse Event|0
1049471|NCT00048048|3399414|P12|Core Treatment|Withdrawal by Subject|0
1049472|NCT00048048|3399415|P11|Core Treatment|Withdrawal by Subject|0
1049473|NCT00048048|3399416|P10|Core Treatment|Withdrawal by Subject|0
1049474|NCT00048048|3399417|P9|Core Treatment|Withdrawal by Subject|0
1049475|NCT00048048|3399418|P8|Core Treatment|Withdrawal by Subject|0
1049476|NCT00048048|3399419|P7|Core Treatment|Withdrawal by Subject|0
1049477|NCT00048048|3399420|P6|Core Treatment|Withdrawal by Subject|0
1049478|NCT00048048|3399421|P5|Core Treatment|Withdrawal by Subject|0
1049479|NCT00048048|3399422|P4|Core Treatment|Withdrawal by Subject|0
1049480|NCT00048048|3399423|P3|Core Treatment|Withdrawal by Subject|1
1049481|NCT00048048|3399424|P2|Core Treatment|Withdrawal by Subject|0
1049482|NCT00048048|3399425|P1|Core Treatment|Withdrawal by Subject|0
1049483|NCT00048035|3399481|P8|Extension Year 2|Early Withdrawals|3
1049484|NCT00048035|3399482|P7|Extension Year 2|Early Withdrawals|3
1049485|NCT00048035|3399483|P6|Extension Year 2|Early Withdrawals|0
1049486|NCT00048035|3399484|P5|Extension Year 2|Early Withdrawals|0
1049487|NCT00048035|3399485|P4|Extension Year 2|Early Withdrawals|0
1049488|NCT00048035|3399486|P3|Extension Year 2|Early Withdrawals|0
1049489|NCT00048035|3399487|P2|Extension Year 2|Early Withdrawals|0
1049490|NCT00048035|3399488|P1|Extension Year 2|Early Withdrawals|0
1049491|NCT00048035|3399481|P8|Extension Year 1|Early Withdrawals|11
1049492|NCT00048035|3399482|P7|Extension Year 1|Early Withdrawals|11
1049493|NCT00048035|3399483|P6|Extension Year 1|Early Withdrawals|0
1049494|NCT00048035|3399484|P5|Extension Year 1|Early Withdrawals|0
1049495|NCT00048035|3399485|P4|Extension Year 1|Early Withdrawals|0
1049496|NCT00048035|3399486|P3|Extension Year 1|Early Withdrawals|0
1049497|NCT00048035|3399487|P2|Extension Year 1|Early Withdrawals|0
1049498|NCT00048035|3399488|P1|Extension Year 1|Early Withdrawals|0
1049499|NCT00048035|3399481|P8|Core Period|Early Withdrawals|0
1049500|NCT00048035|3399482|P7|Core Period|Early Withdrawals|0
1049501|NCT00048035|3399483|P6|Core Period|Early Withdrawals|1
1049502|NCT00048035|3399484|P5|Core Period|Early Withdrawals|1
1049503|NCT00048035|3399485|P4|Core Period|Early Withdrawals|1
1049504|NCT00048035|3399486|P3|Core Period|Early Withdrawals|1
1049505|NCT00048035|3399487|P2|Core Period|Early Withdrawals|2
1049506|NCT00048035|3399488|P1|Core Period|Early Withdrawals|4
1049507|NCT00047879|3399526|P2|Overall Study|Progressive disease|3
1049508|NCT00047879|3399527|P1|Overall Study|Progressive disease|4
1049509|NCT00047463|3399563|P2|Overall Study|Withdrawal by Subject|3
1049510|NCT00047463|3399564|P1|Overall Study|Withdrawal by Subject|0
1049511|NCT00045942|3399681|P9|PKC412A2104E2|Death|0
1049512|NCT00045942|3399682|P8|PKC412A2104E2|Death|0
1049513|NCT00045942|3399683|P7|PKC412A2104E2|Death|2
1049514|NCT00045942|3399684|P6|PKC412A2104E2|Death|1
1049515|NCT00045942|3399685|P5|PKC412A2104E2|Death|0
1049516|NCT00045942|3399686|P4|PKC412A2104E2|Death|0
1049517|NCT00045942|3399687|P3|PKC412A2104E2|Death|0
1049518|NCT00045942|3399688|P2|PKC412A2104E2|Death|0
1049519|NCT00045942|3399689|P1|PKC412A2104E2|Death|0
1049520|NCT00045942|3399681|P9|PKC412A2104E2|Adverse Event|0
1049521|NCT00045942|3399682|P8|PKC412A2104E2|Adverse Event|1
1049522|NCT00045942|3399683|P7|PKC412A2104E2|Adverse Event|3
1049523|NCT00045942|3399684|P6|PKC412A2104E2|Adverse Event|4
1049524|NCT00045942|3399685|P5|PKC412A2104E2|Adverse Event|0
1049525|NCT00045942|3399686|P4|PKC412A2104E2|Adverse Event|0
1049526|NCT00045942|3399687|P3|PKC412A2104E2|Adverse Event|0
1049527|NCT00045942|3399688|P2|PKC412A2104E2|Adverse Event|0
1049528|NCT00045942|3399689|P1|PKC412A2104E2|Adverse Event|0
1049529|NCT00045942|3399681|P9|PKC412A2104E2|Lack of Efficacy|6
1049530|NCT00045942|3399682|P8|PKC412A2104E2|Lack of Efficacy|2
1049531|NCT00045942|3399683|P7|PKC412A2104E2|Lack of Efficacy|2
1049532|NCT00045942|3399684|P6|PKC412A2104E2|Lack of Efficacy|3
1049533|NCT00045942|3399685|P5|PKC412A2104E2|Lack of Efficacy|0
1049534|NCT00045942|3399686|P4|PKC412A2104E2|Lack of Efficacy|0
1049535|NCT00045942|3399687|P3|PKC412A2104E2|Lack of Efficacy|0
1049536|NCT00045942|3399688|P2|PKC412A2104E2|Lack of Efficacy|0
1049537|NCT00045942|3399689|P1|PKC412A2104E2|Lack of Efficacy|0
1049538|NCT00045942|3399681|P9|PKC412A2104E2|Withdrawal by Subject|0
1049539|NCT00045942|3399682|P8|PKC412A2104E2|Withdrawal by Subject|1
1049540|NCT00045942|3399683|P7|PKC412A2104E2|Withdrawal by Subject|0
1049541|NCT00045942|3399684|P6|PKC412A2104E2|Withdrawal by Subject|1
1049542|NCT00045942|3399685|P5|PKC412A2104E2|Withdrawal by Subject|0
1049543|NCT00045942|3399686|P4|PKC412A2104E2|Withdrawal by Subject|0
1049544|NCT00045942|3399687|P3|PKC412A2104E2|Withdrawal by Subject|0
1049545|NCT00045942|3399688|P2|PKC412A2104E2|Withdrawal by Subject|0
1049546|NCT00045942|3399689|P1|PKC412A2104E2|Withdrawal by Subject|0
1049547|NCT00045942|3399681|P9|PKC412A2104E2|Lost to Follow-up|0
1049548|NCT00045942|3399682|P8|PKC412A2104E2|Lost to Follow-up|3
1049549|NCT00045942|3399683|P7|PKC412A2104E2|Lost to Follow-up|0
1049550|NCT00045942|3399684|P6|PKC412A2104E2|Lost to Follow-up|0
1049551|NCT00045942|3399685|P5|PKC412A2104E2|Lost to Follow-up|0
1049552|NCT00045942|3399686|P4|PKC412A2104E2|Lost to Follow-up|0
1049553|NCT00045942|3399687|P3|PKC412A2104E2|Lost to Follow-up|0
1049554|NCT00045942|3399688|P2|PKC412A2104E2|Lost to Follow-up|0
1049555|NCT00045942|3399689|P1|PKC412A2104E2|Lost to Follow-up|0
1049556|NCT00045942|3399681|P9|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1049557|NCT00045942|3399682|P8|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1049558|NCT00045942|3399683|P7|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1049559|NCT00045942|3399684|P6|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1049560|NCT00045942|3399685|P5|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1049561|NCT00045942|3399686|P4|PKC412A2104E1|Enrolled into PKC412A2104E2|1
1049562|NCT00045942|3399687|P3|PKC412A2104E1|Enrolled into PKC412A2104E2|1
1049563|NCT00045942|3399688|P2|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1049564|NCT00045942|3399689|P1|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1049565|NCT00045942|3399681|P9|PKC412A2104E1|Death|0
1049566|NCT00045942|3399682|P8|PKC412A2104E1|Death|0
1049567|NCT00045942|3399683|P7|PKC412A2104E1|Death|0
1049568|NCT00045942|3399684|P6|PKC412A2104E1|Death|0
1049569|NCT00045942|3399685|P5|PKC412A2104E1|Death|1
1049570|NCT00045942|3399686|P4|PKC412A2104E1|Death|1
1049571|NCT00045942|3399687|P3|PKC412A2104E1|Death|1
1049572|NCT00045942|3399688|P2|PKC412A2104E1|Death|4
1049573|NCT00045942|3399689|P1|PKC412A2104E1|Death|0
1049574|NCT00045942|3399681|P9|PKC412A2104E1|Adverse Event|0
1049575|NCT00045942|3399682|P8|PKC412A2104E1|Adverse Event|0
1049576|NCT00045942|3399683|P7|PKC412A2104E1|Adverse Event|0
1049577|NCT00045942|3399684|P6|PKC412A2104E1|Adverse Event|0
1049578|NCT00045942|3399685|P5|PKC412A2104E1|Adverse Event|6
1049579|NCT00045942|3399686|P4|PKC412A2104E1|Adverse Event|3
1049580|NCT00045942|3399687|P3|PKC412A2104E1|Adverse Event|1
1049581|NCT00045942|3399688|P2|PKC412A2104E1|Adverse Event|1
1049582|NCT00045942|3399689|P1|PKC412A2104E1|Adverse Event|0
1049583|NCT00045942|3399681|P9|PKC412A2104E1|Abnormal laboratory value|0
1049584|NCT00045942|3399682|P8|PKC412A2104E1|Abnormal laboratory value|0
1049585|NCT00045942|3399683|P7|PKC412A2104E1|Abnormal laboratory value|0
1049586|NCT00045942|3399684|P6|PKC412A2104E1|Abnormal laboratory value|0
1049587|NCT00045942|3399685|P5|PKC412A2104E1|Abnormal laboratory value|0
1049588|NCT00045942|3399686|P4|PKC412A2104E1|Abnormal laboratory value|0
1049589|NCT00045942|3399687|P3|PKC412A2104E1|Abnormal laboratory value|0
1049590|NCT00045942|3399688|P2|PKC412A2104E1|Abnormal laboratory value|1
1049591|NCT00045942|3399689|P1|PKC412A2104E1|Abnormal laboratory value|0
1049592|NCT00045942|3399681|P9|PKC412A2104E1|Lack of Efficacy|0
1049593|NCT00045942|3399682|P8|PKC412A2104E1|Lack of Efficacy|0
1049594|NCT00045942|3399683|P7|PKC412A2104E1|Lack of Efficacy|0
1049595|NCT00045942|3399684|P6|PKC412A2104E1|Lack of Efficacy|0
1049596|NCT00045942|3399685|P5|PKC412A2104E1|Lack of Efficacy|17
1049597|NCT00045942|3399686|P4|PKC412A2104E1|Lack of Efficacy|23
1049598|NCT00045942|3399687|P3|PKC412A2104E1|Lack of Efficacy|11
1049599|NCT00045942|3399688|P2|PKC412A2104E1|Lack of Efficacy|11
1049600|NCT00045942|3399689|P1|PKC412A2104E1|Lack of Efficacy|0
1049601|NCT00045942|3399681|P9|PKC412A2104E1|Condition no longer requires study drug|0
1049602|NCT00045942|3399682|P8|PKC412A2104E1|Condition no longer requires study drug|0
1049603|NCT00045942|3399683|P7|PKC412A2104E1|Condition no longer requires study drug|0
1049604|NCT00045942|3399684|P6|PKC412A2104E1|Condition no longer requires study drug|0
1049605|NCT00045942|3399685|P5|PKC412A2104E1|Condition no longer requires study drug|1
1049606|NCT00045942|3399686|P4|PKC412A2104E1|Condition no longer requires study drug|0
1049607|NCT00045942|3399687|P3|PKC412A2104E1|Condition no longer requires study drug|1
1049608|NCT00045942|3399688|P2|PKC412A2104E1|Condition no longer requires study drug|1
1049609|NCT00045942|3399689|P1|PKC412A2104E1|Condition no longer requires study drug|0
1049610|NCT00045942|3399681|P9|PKC412A2104E1|Withdrawal by Subject|0
1049611|NCT00045942|3399682|P8|PKC412A2104E1|Withdrawal by Subject|0
1049612|NCT00045942|3399683|P7|PKC412A2104E1|Withdrawal by Subject|0
1049613|NCT00045942|3399684|P6|PKC412A2104E1|Withdrawal by Subject|0
1049614|NCT00045942|3399685|P5|PKC412A2104E1|Withdrawal by Subject|2
1049615|NCT00045942|3399686|P4|PKC412A2104E1|Withdrawal by Subject|5
1049616|NCT00045942|3399687|P3|PKC412A2104E1|Withdrawal by Subject|2
1049617|NCT00045942|3399688|P2|PKC412A2104E1|Withdrawal by Subject|0
1049618|NCT00045942|3399689|P1|PKC412A2104E1|Withdrawal by Subject|0
1049619|NCT00045942|3399681|P9|PKC412A2104 (Core)|Death|0
1049620|NCT00045942|3399682|P8|PKC412A2104 (Core)|Death|0
1049621|NCT00045942|3399683|P7|PKC412A2104 (Core)|Death|0
1049622|NCT00045942|3399684|P6|PKC412A2104 (Core)|Death|0
1049623|NCT00045942|3399685|P5|PKC412A2104 (Core)|Death|0
1049624|NCT00045942|3399686|P4|PKC412A2104 (Core)|Death|0
1049625|NCT00045942|3399687|P3|PKC412A2104 (Core)|Death|0
1049626|NCT00045942|3399688|P2|PKC412A2104 (Core)|Death|0
1049627|NCT00045942|3399689|P1|PKC412A2104 (Core)|Death|1
1049628|NCT00045942|3399681|P9|PKC412A2104 (Core)|Lack of Efficacy|0
1049629|NCT00045942|3399682|P8|PKC412A2104 (Core)|Lack of Efficacy|0
1049630|NCT00045942|3399683|P7|PKC412A2104 (Core)|Lack of Efficacy|0
1049631|NCT00045942|3399684|P6|PKC412A2104 (Core)|Lack of Efficacy|0
1049632|NCT00045942|3399685|P5|PKC412A2104 (Core)|Lack of Efficacy|0
1049633|NCT00045942|3399686|P4|PKC412A2104 (Core)|Lack of Efficacy|0
1049634|NCT00045942|3399687|P3|PKC412A2104 (Core)|Lack of Efficacy|0
1049635|NCT00045942|3399688|P2|PKC412A2104 (Core)|Lack of Efficacy|0
1049636|NCT00045942|3399689|P1|PKC412A2104 (Core)|Lack of Efficacy|13
1049637|NCT00045942|3399681|P9|PKC412A2104 (Core)|Adverse Event|0
1049638|NCT00045942|3399682|P8|PKC412A2104 (Core)|Adverse Event|0
1049639|NCT00045942|3399683|P7|PKC412A2104 (Core)|Adverse Event|0
1049640|NCT00045942|3399684|P6|PKC412A2104 (Core)|Adverse Event|0
1049641|NCT00045942|3399685|P5|PKC412A2104 (Core)|Adverse Event|0
1049642|NCT00045942|3399686|P4|PKC412A2104 (Core)|Adverse Event|0
1049643|NCT00045942|3399687|P3|PKC412A2104 (Core)|Adverse Event|0
1049644|NCT00045942|3399688|P2|PKC412A2104 (Core)|Adverse Event|0
1049645|NCT00045942|3399689|P1|PKC412A2104 (Core)|Adverse Event|5
1049646|NCT00045942|3399681|P9|PKC412A2104 (Core)|Withdrawal by Subject|0
1049647|NCT00045942|3399682|P8|PKC412A2104 (Core)|Withdrawal by Subject|0
1049648|NCT00045942|3399683|P7|PKC412A2104 (Core)|Withdrawal by Subject|0
1049649|NCT00045942|3399684|P6|PKC412A2104 (Core)|Withdrawal by Subject|0
1049650|NCT00045942|3399685|P5|PKC412A2104 (Core)|Withdrawal by Subject|0
1049651|NCT00045942|3399686|P4|PKC412A2104 (Core)|Withdrawal by Subject|0
1049652|NCT00045942|3399687|P3|PKC412A2104 (Core)|Withdrawal by Subject|0
1049653|NCT00045942|3399688|P2|PKC412A2104 (Core)|Withdrawal by Subject|0
1049654|NCT00045942|3399689|P1|PKC412A2104 (Core)|Withdrawal by Subject|1
1049655|NCT00044512|3399778|P1|Follow Up|Lost to Follow-up|2
1049656|NCT00044213|3399793|P4|Overall Study|Lost to Follow-up|4
1049657|NCT00044213|3399794|P3|Overall Study|Lost to Follow-up|5
1049658|NCT00044213|3399795|P2|Overall Study|Lost to Follow-up|5
1049659|NCT00044213|3399796|P1|Overall Study|Lost to Follow-up|8
1049660|NCT00044213|3399793|P4|Overall Study|Death|49
1049661|NCT00044213|3399794|P3|Overall Study|Death|42
1049662|NCT00044213|3399795|P2|Overall Study|Death|42
1049663|NCT00044213|3399796|P1|Overall Study|Death|42
1049664|NCT00044213|3399793|P4|Overall Study|Withdrawal by Subject|83
1049665|NCT00044213|3399794|P3|Overall Study|Withdrawal by Subject|91
1049666|NCT00044213|3399795|P2|Overall Study|Withdrawal by Subject|65
1049667|NCT00044213|3399796|P1|Overall Study|Withdrawal by Subject|50
1049668|NCT00044083|3399861|P2|Second Intervention (One Week) Patients|Withdrawal by Subject|1
1049669|NCT00044083|3399862|P1|Second Intervention (One Week) Patients|Withdrawal by Subject|0
1049670|NCT00044083|3399861|P2|First Intervention (One Week) Patients|Used illegal drug|0
1049671|NCT00044083|3399862|P1|First Intervention (One Week) Patients|Used illegal drug|1
1049672|NCT00044083|3399861|P2|First Intervention (One Week) Patients|Not follow directions|2
1049673|NCT00044083|3399862|P1|First Intervention (One Week) Patients|Not follow directions|0
1049674|NCT00044083|3399861|P2|First Intervention (One Week)- HV's|Drank while on protocol|1
1049675|NCT00044083|3399862|P1|First Intervention (One Week)- HV's|Drank while on protocol|0
1049676|NCT00044083|3399861|P2|First Intervention (One Week)- HV's|Abnormal MRI|1
1049677|NCT00044083|3399862|P1|First Intervention (One Week)- HV's|Abnormal MRI|0
1049678|NCT00044083|3399861|P2|First Intervention (One Week)- HV's|Used illegal drugs|0
1049679|NCT00044083|3399862|P1|First Intervention (One Week)- HV's|Used illegal drugs|1
1049680|NCT00044083|3399861|P2|First Intervention (One Week)- HV's|Pregnancy|0
1049681|NCT00044083|3399862|P1|First Intervention (One Week)- HV's|Pregnancy|1
1049682|NCT00044083|3399861|P2|First Intervention (One Week)- HV's|Withdrawal by Subject|3
1049683|NCT00044083|3399862|P1|First Intervention (One Week)- HV's|Withdrawal by Subject|5
1049684|NCT00044083|3399861|P2|First Intervention (One Week)- HV's|Not follow directions|2
1049685|NCT00044083|3399862|P1|First Intervention (One Week)- HV's|Not follow directions|2
1049686|NCT00044083|3399861|P2|First Intervention (One Week)- HV's|Adverse Event|0
1049687|NCT00044083|3399862|P1|First Intervention (One Week)- HV's|Adverse Event|1
1049688|NCT00043979|3399900|P3|Period 1|recipient with progressive disease|3
1049689|NCT00043979|3399901|P2|Period 1|recipient with progressive disease|4
1049690|NCT00043979|3399902|P1|Period 1|recipient with progressive disease|7
1049691|NCT00043550|3399923|P3|Overall Study|Withdrawal by Subject|20
1049692|NCT00043550|3399924|P2|Overall Study|Withdrawal by Subject|12
1049693|NCT00043550|3399925|P1|Overall Study|Withdrawal by Subject|22
1049694|NCT00043186|3399942|P9|Overall Study|Other|0
1049695|NCT00043186|3399943|P8|Overall Study|Other|0
1049696|NCT00043186|3399944|P7|Overall Study|Other|0
1049697|NCT00043186|3399945|P6|Overall Study|Other|0
1049698|NCT00043186|3399946|P5|Overall Study|Other|0
1049699|NCT00043186|3399947|P4|Overall Study|Other|1
1049700|NCT00043186|3399948|P3|Overall Study|Other|1
1049701|NCT00043186|3399949|P2|Overall Study|Other|0
1049702|NCT00043186|3399950|P1|Overall Study|Other|0
1049703|NCT00043186|3399942|P9|Overall Study|Noncompliance|0
1049704|NCT00043186|3399943|P8|Overall Study|Noncompliance|0
1049705|NCT00043186|3399944|P7|Overall Study|Noncompliance|0
1049706|NCT00043186|3399945|P6|Overall Study|Noncompliance|0
1049707|NCT00043186|3399946|P5|Overall Study|Noncompliance|0
1049708|NCT00043186|3399947|P4|Overall Study|Noncompliance|1
1049709|NCT00043186|3399948|P3|Overall Study|Noncompliance|1
1049710|NCT00043186|3399949|P2|Overall Study|Noncompliance|0
1049711|NCT00043186|3399950|P1|Overall Study|Noncompliance|0
1049712|NCT00043186|3399942|P9|Overall Study|Lost to Follow-up|2
1049713|NCT00043186|3399943|P8|Overall Study|Lost to Follow-up|1
1049714|NCT00043186|3399944|P7|Overall Study|Lost to Follow-up|1
1049715|NCT00043186|3399945|P6|Overall Study|Lost to Follow-up|1
1049716|NCT00043186|3399946|P5|Overall Study|Lost to Follow-up|1
1049717|NCT00043186|3399947|P4|Overall Study|Lost to Follow-up|1
1049718|NCT00043186|3399948|P3|Overall Study|Lost to Follow-up|1
1049719|NCT00043186|3399949|P2|Overall Study|Lost to Follow-up|5
1049720|NCT00043186|3399950|P1|Overall Study|Lost to Follow-up|3
1049721|NCT00043186|3399942|P9|Overall Study|Ineligibility determined|1
1049722|NCT00043186|3399943|P8|Overall Study|Ineligibility determined|0
1049723|NCT00043186|3399944|P7|Overall Study|Ineligibility determined|0
1049724|NCT00043186|3399945|P6|Overall Study|Ineligibility determined|0
1049725|NCT00043186|3399946|P5|Overall Study|Ineligibility determined|0
1049726|NCT00043186|3399947|P4|Overall Study|Ineligibility determined|0
1049727|NCT00043186|3399948|P3|Overall Study|Ineligibility determined|0
1049728|NCT00043186|3399949|P2|Overall Study|Ineligibility determined|0
1049729|NCT00043186|3399950|P1|Overall Study|Ineligibility determined|0
1049730|NCT00043186|3399942|P9|Overall Study|Disease progression|0
1049731|NCT00043186|3399943|P8|Overall Study|Disease progression|4
1049732|NCT00043186|3399944|P7|Overall Study|Disease progression|0
1049733|NCT00043186|3399945|P6|Overall Study|Disease progression|0
1049734|NCT00043186|3399946|P5|Overall Study|Disease progression|0
1049735|NCT00043186|3399947|P4|Overall Study|Disease progression|3
1049736|NCT00043186|3399948|P3|Overall Study|Disease progression|0
1049737|NCT00043186|3399949|P2|Overall Study|Disease progression|0
1049738|NCT00043186|3399950|P1|Overall Study|Disease progression|1
1049739|NCT00043186|3399942|P9|Overall Study|Death|0
1049740|NCT00043186|3399943|P8|Overall Study|Death|0
1049741|NCT00043186|3399944|P7|Overall Study|Death|2
1049742|NCT00043186|3399945|P6|Overall Study|Death|0
1049743|NCT00043186|3399946|P5|Overall Study|Death|0
1049744|NCT00043186|3399947|P4|Overall Study|Death|0
1049745|NCT00043186|3399948|P3|Overall Study|Death|1
1049746|NCT00043186|3399949|P2|Overall Study|Death|0
1049747|NCT00043186|3399950|P1|Overall Study|Death|0
1049748|NCT00043186|3399942|P9|Overall Study|Withdrawal by Subject|10
1049749|NCT00043186|3399943|P8|Overall Study|Withdrawal by Subject|9
1049750|NCT00043186|3399944|P7|Overall Study|Withdrawal by Subject|12
1049751|NCT00043186|3399945|P6|Overall Study|Withdrawal by Subject|6
1049752|NCT00043186|3399946|P5|Overall Study|Withdrawal by Subject|14
1049753|NCT00043186|3399947|P4|Overall Study|Withdrawal by Subject|13
1049754|NCT00043186|3399948|P3|Overall Study|Withdrawal by Subject|11
1049755|NCT00043186|3399949|P2|Overall Study|Withdrawal by Subject|8
1049756|NCT00043186|3399950|P1|Overall Study|Withdrawal by Subject|11
1049757|NCT00043186|3399942|P9|Overall Study|Adverse Event|3
1049758|NCT00043186|3399943|P8|Overall Study|Adverse Event|1
1049759|NCT00043186|3399944|P7|Overall Study|Adverse Event|2
1049760|NCT00043186|3399945|P6|Overall Study|Adverse Event|1
1049761|NCT00043186|3399946|P5|Overall Study|Adverse Event|2
1049762|NCT00043186|3399947|P4|Overall Study|Adverse Event|3
1049763|NCT00043186|3399948|P3|Overall Study|Adverse Event|2
1049764|NCT00043186|3399949|P2|Overall Study|Adverse Event|2
1049765|NCT00043186|3399950|P1|Overall Study|Adverse Event|2
1049766|NCT00043186|3399942|P9|Overall Study|Physician Decision|1
1049767|NCT00043186|3399943|P8|Overall Study|Physician Decision|1
1049768|NCT00043186|3399944|P7|Overall Study|Physician Decision|0
1049769|NCT00043186|3399945|P6|Overall Study|Physician Decision|0
1049770|NCT00043186|3399946|P5|Overall Study|Physician Decision|1
1049771|NCT00043186|3399947|P4|Overall Study|Physician Decision|0
1049772|NCT00043186|3399948|P3|Overall Study|Physician Decision|3
1049773|NCT00043186|3399949|P2|Overall Study|Physician Decision|0
1049774|NCT00043186|3399950|P1|Overall Study|Physician Decision|0
1049775|NCT00042432|3400278|P2|Overall Study|Other|0
1049776|NCT00042432|3400279|P1|Overall Study|Other|2
1049777|NCT00042432|3400278|P2|Overall Study|Initiation of maintenance dialysis|1
1049778|NCT00042432|3400279|P1|Overall Study|Initiation of maintenance dialysis|1
1049779|NCT00042432|3400278|P2|Overall Study|Ineligibility determined|0
1049780|NCT00042432|3400279|P1|Overall Study|Ineligibility determined|1
1049781|NCT00042432|3400278|P2|Overall Study|Death|2
1049782|NCT00042432|3400279|P1|Overall Study|Death|0
1049783|NCT00042432|3400278|P2|Overall Study|Withdrawal by Subject|3
1049784|NCT00042432|3400279|P1|Overall Study|Withdrawal by Subject|1
1049785|NCT00042432|3400278|P2|Overall Study|Adverse Event|1
1049786|NCT00042432|3400279|P1|Overall Study|Adverse Event|4
1049787|NCT00041756|3400332|P5|Overall Study|Data Monitoring Committee Recommendation|21
1049788|NCT00041756|3400333|P4|Overall Study|Data Monitoring Committee Recommendation|0
1049789|NCT00041756|3400334|P3|Overall Study|Data Monitoring Committee Recommendation|0
1049790|NCT00041756|3400335|P2|Overall Study|Data Monitoring Committee Recommendation|0
1049791|NCT00041756|3400336|P1|Overall Study|Data Monitoring Committee Recommendation|0
1049792|NCT00041756|3400332|P5|Overall Study|Unable to meet protocol criteria|1
1049793|NCT00041756|3400333|P4|Overall Study|Unable to meet protocol criteria|0
1049794|NCT00041756|3400334|P3|Overall Study|Unable to meet protocol criteria|1
1049795|NCT00041756|3400335|P2|Overall Study|Unable to meet protocol criteria|0
1049796|NCT00041756|3400336|P1|Overall Study|Unable to meet protocol criteria|0
1049797|NCT00041756|3400332|P5|Overall Study|Lost to Follow-up|0
1049798|NCT00041756|3400333|P4|Overall Study|Lost to Follow-up|1
1049799|NCT00041756|3400334|P3|Overall Study|Lost to Follow-up|0
1049800|NCT00041756|3400335|P2|Overall Study|Lost to Follow-up|1
1049801|NCT00041756|3400336|P1|Overall Study|Lost to Follow-up|0
1049802|NCT00041756|3400332|P5|Overall Study|Withdrawal by Subject|3
1049803|NCT00041756|3400333|P4|Overall Study|Withdrawal by Subject|2
1049804|NCT00041756|3400334|P3|Overall Study|Withdrawal by Subject|4
1049805|NCT00041756|3400335|P2|Overall Study|Withdrawal by Subject|3
1049806|NCT00041756|3400336|P1|Overall Study|Withdrawal by Subject|3
1049807|NCT00041756|3400332|P5|Overall Study|Protocol Violation|1
1049808|NCT00041756|3400333|P4|Overall Study|Protocol Violation|2
1049809|NCT00041756|3400334|P3|Overall Study|Protocol Violation|2
1049810|NCT00041756|3400335|P2|Overall Study|Protocol Violation|1
1049811|NCT00041756|3400336|P1|Overall Study|Protocol Violation|1
1049812|NCT00041756|3400332|P5|Overall Study|Adverse Event|34
1049813|NCT00041756|3400333|P4|Overall Study|Adverse Event|11
1049814|NCT00041756|3400334|P3|Overall Study|Adverse Event|6
1049815|NCT00041756|3400335|P2|Overall Study|Adverse Event|10
1049816|NCT00041756|3400336|P1|Overall Study|Adverse Event|4
1049817|NCT00041470|3400364|P1|Overall Study|Loss of Funding|38
1049818|NCT00040664|3400369|P4|Overall Study|Non-viability of oral suspension|0
1049819|NCT00040664|3400370|P3|Overall Study|Non-viability of oral suspension|1
1049820|NCT00040664|3400371|P2|Overall Study|Non-viability of oral suspension|0
1049821|NCT00040664|3400372|P1|Overall Study|Non-viability of oral suspension|1
1049822|NCT00040664|3400369|P4|Overall Study|Change of formulation|0
1049823|NCT00040664|3400370|P3|Overall Study|Change of formulation|0
1049824|NCT00040664|3400371|P2|Overall Study|Change of formulation|2
1049825|NCT00040664|3400372|P1|Overall Study|Change of formulation|2
1049826|NCT00040664|3400369|P4|Overall Study|Pharmacokinetic target not achieved|1
1049827|NCT00040664|3400370|P3|Overall Study|Pharmacokinetic target not achieved|0
1049828|NCT00040664|3400371|P2|Overall Study|Pharmacokinetic target not achieved|1
1049829|NCT00040664|3400372|P1|Overall Study|Pharmacokinetic target not achieved|2
1049830|NCT00040664|3400369|P4|Overall Study|Poor taste|0
1049831|NCT00040664|3400370|P3|Overall Study|Poor taste|2
1049832|NCT00040664|3400371|P2|Overall Study|Poor taste|0
1049833|NCT00040664|3400372|P1|Overall Study|Poor taste|2
1049834|NCT00040664|3400369|P4|Overall Study|Medication adherence/compliance problems|5
1049835|NCT00040664|3400370|P3|Overall Study|Medication adherence/compliance problems|1
1049836|NCT00040664|3400371|P2|Overall Study|Medication adherence/compliance problems|2
1049837|NCT00040664|3400372|P1|Overall Study|Medication adherence/compliance problems|8
1049838|NCT00040664|3400369|P4|Overall Study|Pregnancy|3
1049839|NCT00040664|3400370|P3|Overall Study|Pregnancy|0
1049840|NCT00040664|3400371|P2|Overall Study|Pregnancy|0
1049841|NCT00040664|3400372|P1|Overall Study|Pregnancy|3
1049842|NCT00040664|3400369|P4|Overall Study|Withdrawal by Subject|4
1049843|NCT00040664|3400370|P3|Overall Study|Withdrawal by Subject|3
1049844|NCT00040664|3400371|P2|Overall Study|Withdrawal by Subject|0
1049845|NCT00040664|3400372|P1|Overall Study|Withdrawal by Subject|7
1049846|NCT00040664|3400369|P4|Overall Study|Protocol Violation|1
1049847|NCT00040664|3400370|P3|Overall Study|Protocol Violation|0
1049848|NCT00040664|3400371|P2|Overall Study|Protocol Violation|1
1049849|NCT00040664|3400372|P1|Overall Study|Protocol Violation|2
1049850|NCT00040664|3400369|P4|Overall Study|Lost to Follow-up|2
1049851|NCT00040664|3400370|P3|Overall Study|Lost to Follow-up|0
1049852|NCT00040664|3400371|P2|Overall Study|Lost to Follow-up|2
1049853|NCT00040664|3400372|P1|Overall Study|Lost to Follow-up|4
1049854|NCT00040664|3400369|P4|Overall Study|Insufficient CD4 response|0
1049855|NCT00040664|3400370|P3|Overall Study|Insufficient CD4 response|1
1049856|NCT00040664|3400371|P2|Overall Study|Insufficient CD4 response|0
1049857|NCT00040664|3400372|P1|Overall Study|Insufficient CD4 response|1
1049858|NCT00040664|3400369|P4|Overall Study|Lack of Efficacy|4
1049859|NCT00040664|3400370|P3|Overall Study|Lack of Efficacy|3
1049860|NCT00040664|3400371|P2|Overall Study|Lack of Efficacy|2
1049861|NCT00040664|3400372|P1|Overall Study|Lack of Efficacy|9
1049862|NCT00040664|3400369|P4|Overall Study|Adverse Event|7
1049863|NCT00040664|3400370|P3|Overall Study|Adverse Event|2
1049864|NCT00040664|3400371|P2|Overall Study|Adverse Event|3
1049865|NCT00040664|3400372|P1|Overall Study|Adverse Event|12
1049866|NCT00040365|3400438|P1|Overall Study|Lost to Follow-up|3
1049867|NCT00040365|3400438|P1|Overall Study|Progressive disease|7
1049868|NCT00040365|3400438|P1|Overall Study|Death|1
1049869|NCT00039871|3400447|P1|Overall Study|Never entered follow-up|7
1049870|NCT00039871|3400447|P1|Overall Study|Discontinued at Week 12 per protocol|1061
1049871|NCT00039871|3400447|P1|Overall Study|Administrative|1
1049872|NCT00039871|3400447|P1|Overall Study|Did not meet eligibility criteria|11
1049873|NCT00039871|3400447|P1|Overall Study|Withdrawal by Subject|97
1049874|NCT00039871|3400447|P1|Overall Study|Protocol Violation|24
1049875|NCT00039871|3400447|P1|Overall Study|Lost to Follow-up|18
1049876|NCT00039871|3400447|P1|Overall Study|Adverse Event|165
1049877|NCT00039741|3400457|P4|Overall Study|Missed final visit|2
1049878|NCT00039741|3400458|P3|Overall Study|Missed final visit|2
1049879|NCT00039741|3400459|P2|Overall Study|Missed final visit|1
1049880|NCT00039741|3400460|P1|Overall Study|Missed final visit|2
1049881|NCT00039741|3400457|P4|Overall Study|Withdrew consent|1
1049882|NCT00039741|3400458|P3|Overall Study|Withdrew consent|0
1049883|NCT00039741|3400459|P2|Overall Study|Withdrew consent|5
1049884|NCT00039741|3400460|P1|Overall Study|Withdrew consent|0
1049885|NCT00039741|3400457|P4|Overall Study|Non-compliance with protocol|0
1049886|NCT00039741|3400458|P3|Overall Study|Non-compliance with protocol|1
1049887|NCT00039741|3400459|P2|Overall Study|Non-compliance with protocol|0
1049888|NCT00039741|3400460|P1|Overall Study|Non-compliance with protocol|1
1049889|NCT00039741|3400457|P4|Overall Study|Moved|6
1049890|NCT00039741|3400458|P3|Overall Study|Moved|3
1049891|NCT00039741|3400459|P2|Overall Study|Moved|2
1049892|NCT00039741|3400460|P1|Overall Study|Moved|3
1049893|NCT00039741|3400457|P4|Overall Study|Not able to get to clinic|3
1049894|NCT00039741|3400458|P3|Overall Study|Not able to get to clinic|0
1049895|NCT00039741|3400459|P2|Overall Study|Not able to get to clinic|2
1049896|NCT00039741|3400460|P1|Overall Study|Not able to get to clinic|5
1049897|NCT00039741|3400457|P4|Overall Study|Confounding medical condition|0
1049898|NCT00039741|3400458|P3|Overall Study|Confounding medical condition|0
1049899|NCT00039741|3400459|P2|Overall Study|Confounding medical condition|0
1049900|NCT00039741|3400460|P1|Overall Study|Confounding medical condition|1
1049901|NCT00039741|3400457|P4|Overall Study|Lost to Follow-up|2
1049902|NCT00039741|3400458|P3|Overall Study|Lost to Follow-up|5
1049903|NCT00039741|3400459|P2|Overall Study|Lost to Follow-up|1
1049904|NCT00039741|3400460|P1|Overall Study|Lost to Follow-up|3
1049905|NCT00039741|3400457|P4|Overall Study|Death|0
1049906|NCT00039741|3400458|P3|Overall Study|Death|0
1049907|NCT00039741|3400459|P2|Overall Study|Death|1
1049908|NCT00039741|3400460|P1|Overall Study|Death|0
1049909|NCT00038948|3400504|P2|Overall Study|Lack of Efficacy|6
1049910|NCT00038948|3400505|P1|Overall Study|Lack of Efficacy|3
1049911|NCT00038948|3400504|P2|Overall Study|Protocol Violation|7
1049912|NCT00038948|3400505|P1|Overall Study|Protocol Violation|3
1049913|NCT00038948|3400504|P2|Overall Study|Withdrawal by Subject|10
1049914|NCT00038948|3400505|P1|Overall Study|Withdrawal by Subject|23
1049915|NCT00038948|3400504|P2|Overall Study|Nonmedical event|7
1049916|NCT00038948|3400505|P1|Overall Study|Nonmedical event|5
1049917|NCT00038948|3400504|P2|Overall Study|Lost to Follow-up|4
1049918|NCT00038948|3400505|P1|Overall Study|Lost to Follow-up|4
1049919|NCT00038948|3400504|P2|Overall Study|Adverse Event|43
1049920|NCT00038948|3400505|P1|Overall Study|Adverse Event|131
1049921|NCT00038649|3400537|P1|Overall Study|Adverse Event|9
1049922|NCT00038467|3400550|P2|Overall Study|Other|28
1049923|NCT00038467|3400551|P1|Overall Study|Other|26
1049924|NCT00038467|3400550|P2|Overall Study|Randomized, but not treated|35
1049925|NCT00038467|3400551|P1|Overall Study|Randomized, but not treated|31
1049926|NCT00038467|3400550|P2|Overall Study|Recurrence|179
1049927|NCT00038467|3400551|P1|Overall Study|Recurrence|109
1049928|NCT00038467|3400550|P2|Overall Study|Lost to Follow-up|10
1049929|NCT00038467|3400551|P1|Overall Study|Lost to Follow-up|15
1049930|NCT00038467|3400550|P2|Overall Study|Death|16
1049931|NCT00038467|3400551|P1|Overall Study|Death|22
1049932|NCT00038467|3400550|P2|Overall Study|Protocol Violation|22
1049933|NCT00038467|3400551|P1|Overall Study|Protocol Violation|19
1049934|NCT00038467|3400550|P2|Overall Study|Withdrawal by Subject|107
1049935|NCT00038467|3400551|P1|Overall Study|Withdrawal by Subject|150
1049936|NCT00038467|3400550|P2|Overall Study|Adverse Event|145
1049937|NCT00038467|3400551|P1|Overall Study|Adverse Event|170
1049938|NCT00038103|3400613|P2|Overall Study|Randomized/never treated|0
1049939|NCT00038103|3400614|P1|Overall Study|Randomized/never treated|2
1049940|NCT00038103|3400613|P2|Overall Study|Sponsor Decision|1
1049941|NCT00038103|3400614|P1|Overall Study|Sponsor Decision|0
1049942|NCT00038103|3400613|P2|Overall Study|Protocol Violation|2
1049943|NCT00038103|3400614|P1|Overall Study|Protocol Violation|0
1049944|NCT00038103|3400613|P2|Overall Study|Lost to Follow-up|3
1049945|NCT00038103|3400614|P1|Overall Study|Lost to Follow-up|0
1049946|NCT00038103|3400613|P2|Overall Study|Withdrawal by Subject|3
1049947|NCT00038103|3400614|P1|Overall Study|Withdrawal by Subject|0
1049948|NCT00038103|3400613|P2|Overall Study|Lack of Efficacy|41
1049949|NCT00038103|3400614|P1|Overall Study|Lack of Efficacy|48
1049950|NCT00038103|3400613|P2|Overall Study|Adverse Event|6
1049951|NCT00038103|3400614|P1|Overall Study|Adverse Event|5
1049952|NCT00037830|3400637|P3|Overall Study|Unrelated Medical Problem|0
1049953|NCT00037830|3400638|P2|Overall Study|Unrelated Medical Problem|0
1049954|NCT00037830|3400639|P1|Overall Study|Unrelated Medical Problem|2
1049955|NCT00037830|3400637|P3|Overall Study|Protocol Violation|0
1049956|NCT00037830|3400638|P2|Overall Study|Protocol Violation|2
1049957|NCT00037830|3400639|P1|Overall Study|Protocol Violation|2
1049958|NCT00037830|3400637|P3|Overall Study|Withdrawal by Subject|1
1049959|NCT00037830|3400638|P2|Overall Study|Withdrawal by Subject|5
1049960|NCT00037830|3400639|P1|Overall Study|Withdrawal by Subject|4
1049961|NCT00037830|3400637|P3|Overall Study|Adverse Event|0
1049962|NCT00037830|3400638|P2|Overall Study|Adverse Event|0
1049963|NCT00037830|3400639|P1|Overall Study|Adverse Event|2
1049964|NCT00036270|3400671|P2|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750
1049965|NCT00036270|3400672|P1|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0
1049966|NCT00036270|3400671|P2|Study Treatment to 5 Year Report|Too early switch|103
1049967|NCT00036270|3400672|P1|Study Treatment to 5 Year Report|Too early switch|0
1049968|NCT00036270|3400671|P2|Study Treatment to 5 Year Report|Intercurrent illness|29
1049969|NCT00036270|3400672|P1|Study Treatment to 5 Year Report|Intercurrent illness|17
1049970|NCT00036270|3400671|P2|Study Treatment to 5 Year Report|Protocol Violation|91
1049971|NCT00036270|3400672|P1|Study Treatment to 5 Year Report|Protocol Violation|23
1049972|NCT00036270|3400671|P2|Study Treatment to 5 Year Report|Randomized but not treated|54
1049973|NCT00036270|3400672|P1|Study Treatment to 5 Year Report|Randomized but not treated|46
1049974|NCT00036270|3400671|P2|Study Treatment to 5 Year Report|Treatment refusal|208
1049975|NCT00036270|3400672|P1|Study Treatment to 5 Year Report|Treatment refusal|113
1049976|NCT00036270|3400671|P2|Study Treatment to 5 Year Report|Other|288
1049977|NCT00036270|3400672|P1|Study Treatment to 5 Year Report|Other|277
1049978|NCT00036270|3400671|P2|Study Treatment to 5 Year Report|Adverse Event|782
1049979|NCT00036270|3400672|P1|Study Treatment to 5 Year Report|Adverse Event|501
1049980|NCT00036270|3400671|P2|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447
1049981|NCT00036270|3400672|P1|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507
1049982|NCT00036270|3400671|P2|Study Treatment to 5 Year Report|Ongoing|736
1049983|NCT00036270|3400672|P1|Study Treatment to 5 Year Report|Ongoing|1081
1049984|NCT00036270|3400671|P2|Randomized to Study Treatment|Withdrawal by Subject|7
1049985|NCT00036270|3400672|P1|Randomized to Study Treatment|Withdrawal by Subject|6
1049986|NCT00035932|3400691|P3|Overall Study|Lack of Efficacy|28
1049987|NCT00035932|3400692|P2|Overall Study|Lack of Efficacy|33
1049988|NCT00035932|3400693|P1|Overall Study|Lack of Efficacy|33
1049989|NCT00035932|3400691|P3|Overall Study|Study Termination by Sponsor|0
1049990|NCT00035932|3400692|P2|Overall Study|Study Termination by Sponsor|0
1049991|NCT00035932|3400693|P1|Overall Study|Study Termination by Sponsor|1
1049992|NCT00035932|3400691|P3|Overall Study|Withdrawal by Subject|0
1049993|NCT00035932|3400692|P2|Overall Study|Withdrawal by Subject|5
1049994|NCT00035932|3400693|P1|Overall Study|Withdrawal by Subject|1
1049995|NCT00035932|3400691|P3|Overall Study|Protocol Violation While on Study|2
1049996|NCT00035932|3400692|P2|Overall Study|Protocol Violation While on Study|1
1049997|NCT00035932|3400693|P1|Overall Study|Protocol Violation While on Study|0
1049998|NCT00035932|3400691|P3|Overall Study|Noncompliance|6
1049999|NCT00035932|3400692|P2|Overall Study|Noncompliance|7
1050000|NCT00035932|3400693|P1|Overall Study|Noncompliance|6
1050001|NCT00035932|3400691|P3|Overall Study|Lost to Follow-up|3
1050002|NCT00035932|3400692|P2|Overall Study|Lost to Follow-up|4
1050003|NCT00035932|3400693|P1|Overall Study|Lost to Follow-up|4
1050004|NCT00035932|3400691|P3|Overall Study|Disease Progression / Relapse|0
1050005|NCT00035932|3400692|P2|Overall Study|Disease Progression / Relapse|1
1050006|NCT00035932|3400693|P1|Overall Study|Disease Progression / Relapse|1
1050007|NCT00035932|3400691|P3|Overall Study|Death|1
1050008|NCT00035932|3400692|P2|Overall Study|Death|0
1050009|NCT00035932|3400693|P1|Overall Study|Death|0
1050010|NCT00035932|3400691|P3|Overall Study|Adverse Event|9
1050011|NCT00035932|3400692|P2|Overall Study|Adverse Event|9
1050012|NCT00035932|3400693|P1|Overall Study|Adverse Event|10
1050013|NCT00035815|3400819|P2|Overall Study|Withdrawal by Subject|11
1050014|NCT00035815|3400820|P1|Overall Study|Withdrawal by Subject|17
1050015|NCT00035555|3400833|P3|Overall Study|Received cyclosporin in error|1
1050016|NCT00035555|3400834|P2|Overall Study|Received cyclosporin in error|0
1050017|NCT00035555|3400835|P1|Overall Study|Received cyclosporin in error|0
1050018|NCT00035555|3400833|P3|Overall Study|Investigator deemed not a good candidate|1
1050019|NCT00035555|3400834|P2|Overall Study|Investigator deemed not a good candidate|0
1050020|NCT00035555|3400835|P1|Overall Study|Investigator deemed not a good candidate|0
1050021|NCT00035555|3400833|P3|Overall Study|Withdrawal by Subject|2
1050022|NCT00035555|3400834|P2|Overall Study|Withdrawal by Subject|0
1050023|NCT00035555|3400835|P1|Overall Study|Withdrawal by Subject|2
1050024|NCT00035555|3400833|P3|Overall Study|Treatment failure/lack of efficacy|3
1050025|NCT00035555|3400834|P2|Overall Study|Treatment failure/lack of efficacy|5
1050026|NCT00035555|3400835|P1|Overall Study|Treatment failure/lack of efficacy|7
1050027|NCT00035555|3400833|P3|Overall Study|Prohibited medication|0
1050028|NCT00035555|3400834|P2|Overall Study|Prohibited medication|1
1050029|NCT00035555|3400835|P1|Overall Study|Prohibited medication|1
1050030|NCT00035555|3400833|P3|Overall Study|Noncompliance|1
1050031|NCT00035555|3400834|P2|Overall Study|Noncompliance|1
1050032|NCT00035555|3400835|P1|Overall Study|Noncompliance|0
1050033|NCT00035555|3400833|P3|Overall Study|Lost to Follow-up|1
1050034|NCT00035555|3400834|P2|Overall Study|Lost to Follow-up|0
1050035|NCT00035555|3400835|P1|Overall Study|Lost to Follow-up|0
1050036|NCT00035555|3400833|P3|Overall Study|Death|2
1050037|NCT00035555|3400834|P2|Overall Study|Death|0
1050038|NCT00035555|3400835|P1|Overall Study|Death|0
1050039|NCT00035555|3400833|P3|Overall Study|Allograft loss|2
1050040|NCT00035555|3400834|P2|Overall Study|Allograft loss|1
1050041|NCT00035555|3400835|P1|Overall Study|Allograft loss|1
1050042|NCT00035555|3400833|P3|Overall Study|Adverse Event|9
1050043|NCT00035555|3400834|P2|Overall Study|Adverse Event|8
1050044|NCT00035555|3400835|P1|Overall Study|Adverse Event|5
1050045|NCT00032487|3400919|P2|Overall Study|Had other reason|12
1050046|NCT00032487|3400920|P1|Overall Study|Had other reason|12
1050047|NCT00032487|3400919|P2|Overall Study|Lost to Follow-up|58
1050048|NCT00032487|3400920|P1|Overall Study|Lost to Follow-up|57
1050049|NCT00032487|3400919|P2|Overall Study|Adverse Event|7
1050050|NCT00032487|3400920|P1|Overall Study|Adverse Event|3
1050051|NCT00032487|3400919|P2|Overall Study|Withdrawal by Subject|43
1050052|NCT00032487|3400920|P1|Overall Study|Withdrawal by Subject|67
1050053|NCT00031551|3400930|P2|Overall Study|Withdrew due to chemotherapy effects|0
1050054|NCT00031551|3400931|P1|Overall Study|Withdrew due to chemotherapy effects|2
1050055|NCT00031486|3400943|P2|Overall Study|Other|1
1050056|NCT00031486|3400944|P1|Overall Study|Other|1
1050057|NCT00031486|3400943|P2|Overall Study|Did not meet eligibility requirement|1
1050058|NCT00031486|3400944|P1|Overall Study|Did not meet eligibility requirement|2
1050059|NCT00031486|3400943|P2|Overall Study|Non-compliant|4
1050060|NCT00031486|3400944|P1|Overall Study|Non-compliant|0
1050061|NCT00031486|3400943|P2|Overall Study|Death|3
1050062|NCT00031486|3400944|P1|Overall Study|Death|0
1050063|NCT00031486|3400943|P2|Overall Study|Withdrawal by Subject|2
1050064|NCT00031486|3400944|P1|Overall Study|Withdrawal by Subject|3
1050065|NCT00031486|3400943|P2|Overall Study|Lost to Follow-up|1
1050066|NCT00031486|3400944|P1|Overall Study|Lost to Follow-up|0
1050067|NCT00031486|3400943|P2|Overall Study|Adverse Event|0
1050068|NCT00031486|3400944|P1|Overall Study|Adverse Event|1
1050069|NCT00031460|3400970|P2|Overall Study|Confirmed unevaluable|1
1050070|NCT00031460|3400971|P1|Overall Study|Confirmed unevaluable|0
1050071|NCT00031460|3400970|P2|Overall Study|Disruption of blinded drug supply|0
1050072|NCT00031460|3400971|P1|Overall Study|Disruption of blinded drug supply|2
1050073|NCT00031460|3400970|P2|Overall Study|Reactivation of Disease|9
1050074|NCT00031460|3400971|P1|Overall Study|Reactivation of Disease|5
1050075|NCT00031460|3400970|P2|Overall Study|Death|1
1050076|NCT00031460|3400971|P1|Overall Study|Death|0
1050077|NCT00031460|3400970|P2|Overall Study|Non-Compliant|1
1050078|NCT00031460|3400971|P1|Overall Study|Non-Compliant|1
1050079|NCT00031460|3400970|P2|Overall Study|Withdrawal by Subject|1
1050080|NCT00031460|3400971|P1|Overall Study|Withdrawal by Subject|1
1050081|NCT00031460|3400970|P2|Overall Study|Lost to Follow-up|1
1050082|NCT00031460|3400971|P1|Overall Study|Lost to Follow-up|0
1050083|NCT00031447|3400985|P2|Overall Study|Disruption of blinded study drug supply|4
1050084|NCT00031447|3400986|P1|Overall Study|Disruption of blinded study drug supply|7
1050085|NCT00031447|3400985|P2|Overall Study|Re-activation of Disease|1
1050086|NCT00031447|3400986|P1|Overall Study|Re-activation of Disease|2
1050087|NCT00031447|3400985|P2|Overall Study|Non-compliant|1
1050088|NCT00031447|3400986|P1|Overall Study|Non-compliant|1
1050089|NCT00031447|3400985|P2|Overall Study|Lost to Follow-up|1
1050090|NCT00031447|3400986|P1|Overall Study|Lost to Follow-up|0
1050091|NCT00029146|3401061|P2|Overall Study|Lost to Follow-up|1
1050092|NCT00029146|3401062|P1|Overall Study|Lost to Follow-up|2
1050093|NCT00027378|3401113|P2|Overall Study|Physician Decision|3
1050094|NCT00027378|3401114|P1|Overall Study|Physician Decision|0
1050095|NCT00027027|3401127|P5|Overall Study|Withdrawal by Subject|1
1050096|NCT00027027|3401128|P4|Overall Study|Withdrawal by Subject|0
1050097|NCT00027027|3401129|P3|Overall Study|Withdrawal by Subject|0
1050098|NCT00027027|3401130|P2|Overall Study|Withdrawal by Subject|0
1050099|NCT00027027|3401131|P1|Overall Study|Withdrawal by Subject|0
1050100|NCT00027027|3401127|P5|Overall Study|Physician Decision Due To PD|5
1050101|NCT00027027|3401128|P4|Overall Study|Physician Decision Due To PD|3
1050102|NCT00027027|3401129|P3|Overall Study|Physician Decision Due To PD|2
1050103|NCT00027027|3401130|P2|Overall Study|Physician Decision Due To PD|3
1050104|NCT00027027|3401131|P1|Overall Study|Physician Decision Due To PD|2
1050105|NCT00027027|3401127|P5|Overall Study|PD Requiring Surgery|0
1050106|NCT00027027|3401128|P4|Overall Study|PD Requiring Surgery|0
1050107|NCT00027027|3401129|P3|Overall Study|PD Requiring Surgery|1
1050108|NCT00027027|3401130|P2|Overall Study|PD Requiring Surgery|0
1050109|NCT00027027|3401131|P1|Overall Study|PD Requiring Surgery|0
1050110|NCT00027027|3401127|P5|Overall Study|Clinical Symptoms Progression not PD|0
1050111|NCT00027027|3401128|P4|Overall Study|Clinical Symptoms Progression not PD|0
1050112|NCT00027027|3401129|P3|Overall Study|Clinical Symptoms Progression not PD|0
1050113|NCT00027027|3401130|P2|Overall Study|Clinical Symptoms Progression not PD|0
1050114|NCT00027027|3401131|P1|Overall Study|Clinical Symptoms Progression not PD|1
1050115|NCT00027027|3401127|P5|Overall Study|Admitted for Signs of PD|1
1050116|NCT00027027|3401128|P4|Overall Study|Admitted for Signs of PD|0
1050117|NCT00027027|3401129|P3|Overall Study|Admitted for Signs of PD|0
1050118|NCT00027027|3401130|P2|Overall Study|Admitted for Signs of PD|0
1050119|NCT00027027|3401131|P1|Overall Study|Admitted for Signs of PD|0
1050120|NCT00027027|3401127|P5|Overall Study|Adverse Event|1
1050121|NCT00027027|3401128|P4|Overall Study|Adverse Event|0
1050122|NCT00027027|3401129|P3|Overall Study|Adverse Event|1
1050123|NCT00027027|3401130|P2|Overall Study|Adverse Event|0
1050124|NCT00027027|3401131|P1|Overall Study|Adverse Event|0
1050125|NCT00025883|3401178|P1|Overall Study|didn't reach 6 months of Metreleptin|10
1050126|NCT00025883|3401178|P1|Overall Study|Adverse Event|1
1050127|NCT00025883|3401178|P1|Overall Study|Death|1
1050128|NCT00025883|3401178|P1|Overall Study|no baseline data|1
1050129|NCT00025883|3401178|P1|Overall Study|had atypical progeriod lipodystrophy|4
1050130|NCT00023595|3401190|P5|10 Year Follow up|Lost to Follow-up|0
1050131|NCT00023595|3401191|P4|10 Year Follow up|Lost to Follow-up|0
1050132|NCT00023595|3401192|P3|10 Year Follow up|Lost to Follow-up|3
1050133|NCT00023595|3401193|P2|10 Year Follow up|Lost to Follow-up|10
1050134|NCT00023595|3401194|P1|10 Year Follow up|Lost to Follow-up|12
1050135|NCT00023595|3401190|P5|5 Year Follow up|Lost to Follow-up|3
1050136|NCT00023595|3401191|P4|5 Year Follow up|Lost to Follow-up|7
1050137|NCT00023595|3401192|P3|5 Year Follow up|Lost to Follow-up|1
1050138|NCT00023595|3401193|P2|5 Year Follow up|Lost to Follow-up|2
1050139|NCT00023595|3401194|P1|5 Year Follow up|Lost to Follow-up|2
1050140|NCT00023452|3401405|P2|Overall Study|Other|69
1050141|NCT00023452|3401406|P1|Overall Study|Other|204
1050142|NCT00023452|3401405|P2|Overall Study|Pregnant|20
1050143|NCT00023452|3401406|P1|Overall Study|Pregnant|53
1050144|NCT00023452|3401405|P2|Overall Study|Refused Treatment (continued follow-up)|224
1050145|NCT00023452|3401406|P1|Overall Study|Refused Treatment (continued follow-up)|225
1050146|NCT00023452|3401405|P2|Overall Study|Physician Decision|21
1050147|NCT00023452|3401406|P1|Overall Study|Physician Decision|49
1050148|NCT00023452|3401405|P2|Overall Study|Lost to Follow-up|60
1050149|NCT00023452|3401406|P1|Overall Study|Lost to Follow-up|293
1050150|NCT00023452|3401405|P2|Overall Study|Adverse Event|196
1050151|NCT00023452|3401406|P1|Overall Study|Adverse Event|139
1050152|NCT00023452|3401405|P2|Overall Study|Withdrawal by Subject|54
1050153|NCT00023452|3401406|P1|Overall Study|Withdrawal by Subject|66
1050154|NCT00023452|3401405|P2|Overall Study|Death|0
1050155|NCT00023452|3401406|P1|Overall Study|Death|2
1050156|NCT00023452|3401405|P2|Overall Study|Out of Window|69
1050157|NCT00023452|3401406|P1|Overall Study|Out of Window|129
1050158|NCT00023452|3401405|P2|Overall Study|Ineligible for Study|159
1050159|NCT00023452|3401406|P1|Overall Study|Ineligible for Study|163
1050160|NCT00023322|3401430|P1|Overall Study|Lost to Follow-up|1
1050161|NCT00022763|3401454|P2|Overall Study|Admin|2
1050162|NCT00022763|3401455|P1|Overall Study|Admin|3
1050163|NCT00022763|3401454|P2|Overall Study|Insufficient Therapy|0
1050164|NCT00022763|3401455|P1|Overall Study|Insufficient Therapy|1
1050165|NCT00022763|3401454|P2|Overall Study|Withdrawal by Subject|7
1050166|NCT00022763|3401455|P1|Overall Study|Withdrawal by Subject|4
1050167|NCT00022763|3401454|P2|Overall Study|Lost to Follow-up|3
1050168|NCT00022763|3401455|P1|Overall Study|Lost to Follow-up|0
1050169|NCT00022763|3401454|P2|Overall Study|Death|1
1050170|NCT00022763|3401455|P1|Overall Study|Death|0
1050171|NCT00022763|3401454|P2|Overall Study|Injection Site Reactions|2
1050172|NCT00022763|3401455|P1|Overall Study|Injection Site Reactions|0
1050173|NCT00022763|3401454|P2|Overall Study|Adverse Event|2
1050174|NCT00022763|3401455|P1|Overall Study|Adverse Event|1
1050175|NCT00014911|3401497|P1|Overall Study|Immunosuppression-related Side Effects|1
1050176|NCT00014911|3401497|P1|Overall Study|Unknown Reasons|2
1050177|NCT00014911|3401497|P1|Overall Study|Withdrawal by Subject|6
1050178|NCT00014911|3401497|P1|Overall Study|Lost to Follow-up|1
1050179|NCT00014911|3401497|P1|Overall Study|Adverse Event|1
1050180|NCT00006604|3401513|P17|Overall Study|Other Reason|0
1050181|NCT00006604|3401514|P16|Overall Study|Other Reason|0
1050182|NCT00006604|3401515|P15|Overall Study|Other Reason|0
1050183|NCT00006604|3401516|P14|Overall Study|Other Reason|0
1050184|NCT00006604|3401517|P13|Overall Study|Other Reason|0
1050185|NCT00006604|3401518|P12|Overall Study|Other Reason|0
1050186|NCT00006604|3401519|P11|Overall Study|Other Reason|0
1050187|NCT00006604|3401520|P10|Overall Study|Other Reason|1
1050188|NCT00006604|3401521|P9|Overall Study|Other Reason|0
1050189|NCT00006604|3401522|P8|Overall Study|Other Reason|0
1050190|NCT00006604|3401523|P7|Overall Study|Other Reason|0
1050191|NCT00006604|3401524|P6|Overall Study|Other Reason|1
1050192|NCT00006604|3401525|P5|Overall Study|Other Reason|0
1050193|NCT00006604|3401526|P4|Overall Study|Other Reason|0
1050194|NCT00006604|3401527|P3|Overall Study|Other Reason|0
1050195|NCT00006604|3401528|P2|Overall Study|Other Reason|0
1050196|NCT00006604|3401529|P1|Overall Study|Other Reason|0
1050197|NCT00006604|3401513|P17|Overall Study|Lost to Follow-up|3
1050198|NCT00006604|3401514|P16|Overall Study|Lost to Follow-up|1
1050199|NCT00006604|3401515|P15|Overall Study|Lost to Follow-up|0
1050200|NCT00006604|3401516|P14|Overall Study|Lost to Follow-up|0
1050201|NCT00006604|3401517|P13|Overall Study|Lost to Follow-up|0
1050202|NCT00006604|3401518|P12|Overall Study|Lost to Follow-up|0
1050203|NCT00006604|3401519|P11|Overall Study|Lost to Follow-up|0
1050204|NCT00006604|3401520|P10|Overall Study|Lost to Follow-up|2
1050205|NCT00006604|3401521|P9|Overall Study|Lost to Follow-up|0
1050206|NCT00006604|3401522|P8|Overall Study|Lost to Follow-up|1
1050207|NCT00006604|3401523|P7|Overall Study|Lost to Follow-up|0
1050208|NCT00006604|3401524|P6|Overall Study|Lost to Follow-up|0
1050209|NCT00006604|3401525|P5|Overall Study|Lost to Follow-up|0
1050210|NCT00006604|3401526|P4|Overall Study|Lost to Follow-up|0
1050211|NCT00006604|3401527|P3|Overall Study|Lost to Follow-up|0
1050212|NCT00006604|3401528|P2|Overall Study|Lost to Follow-up|0
1050213|NCT00006604|3401529|P1|Overall Study|Lost to Follow-up|0
1050214|NCT00006604|3401513|P17|Overall Study|Subj/parent not willing to adhere to req|4
1050215|NCT00006604|3401514|P16|Overall Study|Subj/parent not willing to adhere to req|3
1050216|NCT00006604|3401515|P15|Overall Study|Subj/parent not willing to adhere to req|3
1050217|NCT00006604|3401516|P14|Overall Study|Subj/parent not willing to adhere to req|2
1050218|NCT00006604|3401517|P13|Overall Study|Subj/parent not willing to adhere to req|0
1050219|NCT00006604|3401518|P12|Overall Study|Subj/parent not willing to adhere to req|0
1050220|NCT00006604|3401519|P11|Overall Study|Subj/parent not willing to adhere to req|3
1050221|NCT00006604|3401520|P10|Overall Study|Subj/parent not willing to adhere to req|6
1050222|NCT00006604|3401521|P9|Overall Study|Subj/parent not willing to adhere to req|0
1050223|NCT00006604|3401522|P8|Overall Study|Subj/parent not willing to adhere to req|1
1050224|NCT00006604|3401523|P7|Overall Study|Subj/parent not willing to adhere to req|3
1050225|NCT00006604|3401524|P6|Overall Study|Subj/parent not willing to adhere to req|0
1050226|NCT00006604|3401525|P5|Overall Study|Subj/parent not willing to adhere to req|0
1050227|NCT00006604|3401526|P4|Overall Study|Subj/parent not willing to adhere to req|3
1050228|NCT00006604|3401527|P3|Overall Study|Subj/parent not willing to adhere to req|1
1050229|NCT00006604|3401528|P2|Overall Study|Subj/parent not willing to adhere to req|0
1050230|NCT00006604|3401529|P1|Overall Study|Subj/parent not willing to adhere to req|0
1050231|NCT00006604|3401513|P17|Overall Study|Withdrawal by Subject|1
1050232|NCT00006604|3401514|P16|Overall Study|Withdrawal by Subject|0
1050233|NCT00006604|3401515|P15|Overall Study|Withdrawal by Subject|1
1050234|NCT00006604|3401516|P14|Overall Study|Withdrawal by Subject|2
1050235|NCT00006604|3401517|P13|Overall Study|Withdrawal by Subject|1
1050236|NCT00006604|3401518|P12|Overall Study|Withdrawal by Subject|0
1050237|NCT00006604|3401519|P11|Overall Study|Withdrawal by Subject|2
1050238|NCT00006604|3401520|P10|Overall Study|Withdrawal by Subject|3
1050239|NCT00006604|3401521|P9|Overall Study|Withdrawal by Subject|1
1050240|NCT00006604|3401522|P8|Overall Study|Withdrawal by Subject|0
1050241|NCT00006604|3401523|P7|Overall Study|Withdrawal by Subject|2
1050242|NCT00006604|3401524|P6|Overall Study|Withdrawal by Subject|2
1050243|NCT00006604|3401525|P5|Overall Study|Withdrawal by Subject|1
1050244|NCT00006604|3401526|P4|Overall Study|Withdrawal by Subject|0
1050245|NCT00006604|3401527|P3|Overall Study|Withdrawal by Subject|2
1050246|NCT00006604|3401528|P2|Overall Study|Withdrawal by Subject|0
1050247|NCT00006604|3401529|P1|Overall Study|Withdrawal by Subject|1
1050248|NCT00006604|3401513|P17|Overall Study|Site closing|1
1050249|NCT00006604|3401514|P16|Overall Study|Site closing|0
1050250|NCT00006604|3401515|P15|Overall Study|Site closing|0
1050251|NCT00006604|3401516|P14|Overall Study|Site closing|1
1050252|NCT00006604|3401517|P13|Overall Study|Site closing|1
1050253|NCT00006604|3401518|P12|Overall Study|Site closing|1
1050254|NCT00006604|3401519|P11|Overall Study|Site closing|0
1050255|NCT00006604|3401520|P10|Overall Study|Site closing|0
1050256|NCT00006604|3401521|P9|Overall Study|Site closing|0
1050257|NCT00006604|3401522|P8|Overall Study|Site closing|1
1050258|NCT00006604|3401523|P7|Overall Study|Site closing|0
1050259|NCT00006604|3401524|P6|Overall Study|Site closing|0
1050260|NCT00006604|3401525|P5|Overall Study|Site closing|0
1050261|NCT00006604|3401526|P4|Overall Study|Site closing|1
1050262|NCT00006604|3401527|P3|Overall Study|Site closing|1
1050263|NCT00006604|3401528|P2|Overall Study|Site closing|0
1050264|NCT00006604|3401529|P1|Overall Study|Site closing|0
1050265|NCT00006604|3401513|P17|Overall Study|Subj/Parent not able to get to clinic|0
1050266|NCT00006604|3401514|P16|Overall Study|Subj/Parent not able to get to clinic|0
1050267|NCT00006604|3401515|P15|Overall Study|Subj/Parent not able to get to clinic|3
1050268|NCT00006604|3401516|P14|Overall Study|Subj/Parent not able to get to clinic|1
1050269|NCT00006604|3401517|P13|Overall Study|Subj/Parent not able to get to clinic|1
1050270|NCT00006604|3401518|P12|Overall Study|Subj/Parent not able to get to clinic|1
1050271|NCT00006604|3401519|P11|Overall Study|Subj/Parent not able to get to clinic|2
1050272|NCT00006604|3401520|P10|Overall Study|Subj/Parent not able to get to clinic|1
1050273|NCT00006604|3401521|P9|Overall Study|Subj/Parent not able to get to clinic|0
1050274|NCT00006604|3401522|P8|Overall Study|Subj/Parent not able to get to clinic|0
1050275|NCT00006604|3401523|P7|Overall Study|Subj/Parent not able to get to clinic|1
1050276|NCT00006604|3401524|P6|Overall Study|Subj/Parent not able to get to clinic|0
1050277|NCT00006604|3401525|P5|Overall Study|Subj/Parent not able to get to clinic|1
1050278|NCT00006604|3401526|P4|Overall Study|Subj/Parent not able to get to clinic|1
1050279|NCT00006604|3401527|P3|Overall Study|Subj/Parent not able to get to clinic|0
1050280|NCT00006604|3401528|P2|Overall Study|Subj/Parent not able to get to clinic|0
1050281|NCT00006604|3401529|P1|Overall Study|Subj/Parent not able to get to clinic|0
1050282|NCT00006604|3401513|P17|Overall Study|Severe debilitation, unable to continue|0
1050283|NCT00006604|3401514|P16|Overall Study|Severe debilitation, unable to continue|0
1050284|NCT00006604|3401515|P15|Overall Study|Severe debilitation, unable to continue|2
1050285|NCT00006604|3401516|P14|Overall Study|Severe debilitation, unable to continue|0
1050286|NCT00006604|3401517|P13|Overall Study|Severe debilitation, unable to continue|1
1050287|NCT00006604|3401518|P12|Overall Study|Severe debilitation, unable to continue|2
1050288|NCT00006604|3401519|P11|Overall Study|Severe debilitation, unable to continue|0
1050289|NCT00006604|3401520|P10|Overall Study|Severe debilitation, unable to continue|5
1050290|NCT00006604|3401521|P9|Overall Study|Severe debilitation, unable to continue|0
1050291|NCT00006604|3401522|P8|Overall Study|Severe debilitation, unable to continue|0
1050292|NCT00006604|3401523|P7|Overall Study|Severe debilitation, unable to continue|3
1050293|NCT00006604|3401524|P6|Overall Study|Severe debilitation, unable to continue|0
1050294|NCT00006604|3401525|P5|Overall Study|Severe debilitation, unable to continue|0
1050295|NCT00006604|3401526|P4|Overall Study|Severe debilitation, unable to continue|0
1050296|NCT00006604|3401527|P3|Overall Study|Severe debilitation, unable to continue|0
1050297|NCT00006604|3401528|P2|Overall Study|Severe debilitation, unable to continue|0
1050298|NCT00006604|3401529|P1|Overall Study|Severe debilitation, unable to continue|0
1050299|NCT00006604|3401513|P17|Overall Study|Death|0
1050300|NCT00006604|3401514|P16|Overall Study|Death|0
1050301|NCT00006604|3401515|P15|Overall Study|Death|0
1050302|NCT00006604|3401516|P14|Overall Study|Death|0
1050303|NCT00006604|3401517|P13|Overall Study|Death|0
1050304|NCT00006604|3401518|P12|Overall Study|Death|1
1050305|NCT00006604|3401519|P11|Overall Study|Death|1
1050306|NCT00006604|3401520|P10|Overall Study|Death|1
1050307|NCT00006604|3401521|P9|Overall Study|Death|0
1050308|NCT00006604|3401522|P8|Overall Study|Death|0
1050309|NCT00006604|3401523|P7|Overall Study|Death|0
1050310|NCT00006604|3401524|P6|Overall Study|Death|0
1050311|NCT00006604|3401525|P5|Overall Study|Death|0
1050312|NCT00006604|3401526|P4|Overall Study|Death|0
1050313|NCT00006604|3401527|P3|Overall Study|Death|0
1050314|NCT00006604|3401528|P2|Overall Study|Death|0
1050315|NCT00006604|3401529|P1|Overall Study|Death|0
1050316|NCT00006604|3401513|P17|Overall Study|Randomization entry error-no RX, no FU|0
1050317|NCT00006604|3401514|P16|Overall Study|Randomization entry error-no RX, no FU|0
1050318|NCT00006604|3401515|P15|Overall Study|Randomization entry error-no RX, no FU|0
1050319|NCT00006604|3401516|P14|Overall Study|Randomization entry error-no RX, no FU|0
1050320|NCT00006604|3401517|P13|Overall Study|Randomization entry error-no RX, no FU|0
1050321|NCT00006604|3401518|P12|Overall Study|Randomization entry error-no RX, no FU|1
1050322|NCT00006604|3401519|P11|Overall Study|Randomization entry error-no RX, no FU|0
1050323|NCT00006604|3401520|P10|Overall Study|Randomization entry error-no RX, no FU|0
1050324|NCT00006604|3401521|P9|Overall Study|Randomization entry error-no RX, no FU|0
1050325|NCT00006604|3401522|P8|Overall Study|Randomization entry error-no RX, no FU|0
1050326|NCT00006604|3401523|P7|Overall Study|Randomization entry error-no RX, no FU|0
1050327|NCT00006604|3401524|P6|Overall Study|Randomization entry error-no RX, no FU|0
1050328|NCT00006604|3401525|P5|Overall Study|Randomization entry error-no RX, no FU|0
1050329|NCT00006604|3401526|P4|Overall Study|Randomization entry error-no RX, no FU|0
1050330|NCT00006604|3401527|P3|Overall Study|Randomization entry error-no RX, no FU|0
1050331|NCT00006604|3401528|P2|Overall Study|Randomization entry error-no RX, no FU|0
1050332|NCT00006604|3401529|P1|Overall Study|Randomization entry error-no RX, no FU|0
1050333|NCT00006604|3401513|P17|Overall Study|Met study objective - no further FU|0
1050334|NCT00006604|3401514|P16|Overall Study|Met study objective - no further FU|1
1050335|NCT00006604|3401515|P15|Overall Study|Met study objective - no further FU|1
1050336|NCT00006604|3401516|P14|Overall Study|Met study objective - no further FU|0
1050337|NCT00006604|3401517|P13|Overall Study|Met study objective - no further FU|0
1050338|NCT00006604|3401518|P12|Overall Study|Met study objective - no further FU|0
1050339|NCT00006604|3401519|P11|Overall Study|Met study objective - no further FU|0
1050340|NCT00006604|3401520|P10|Overall Study|Met study objective - no further FU|0
1050341|NCT00006604|3401521|P9|Overall Study|Met study objective - no further FU|0
1050342|NCT00006604|3401522|P8|Overall Study|Met study objective - no further FU|0
1050343|NCT00006604|3401523|P7|Overall Study|Met study objective - no further FU|0
1050344|NCT00006604|3401524|P6|Overall Study|Met study objective - no further FU|0
1050345|NCT00006604|3401525|P5|Overall Study|Met study objective - no further FU|0
1050346|NCT00006604|3401526|P4|Overall Study|Met study objective - no further FU|0
1050347|NCT00006604|3401527|P3|Overall Study|Met study objective - no further FU|0
1050348|NCT00006604|3401528|P2|Overall Study|Met study objective - no further FU|0
1050349|NCT00006604|3401529|P1|Overall Study|Met study objective - no further FU|1
1050350|NCT00004978|3401645|P2|Overall Study|site closure - not in analysis cohort|20
1050351|NCT00004978|3401646|P1|Overall Study|site closure - not in analysis cohort|19
1050352|NCT00004978|3401645|P2|Overall Study|Withdrawal by Subject|26
1050353|NCT00004978|3401646|P1|Overall Study|Withdrawal by Subject|17
1050354|NCT00004978|3401645|P2|Overall Study|Lost to Follow-up|108
1050355|NCT00004978|3401646|P1|Overall Study|Lost to Follow-up|101
1050356|NCT00004978|3401645|P2|Overall Study|Death|116
1050357|NCT00004978|3401646|P1|Overall Study|Death|107
1050358|NCT00021541|3401672|P2|Period 2-crossover|Pts that did not progress|3
1050359|NCT00021541|3401673|P1|Period 2-crossover|Pts that did not progress|2
1050360|NCT00021541|3401672|P2|Period 2-crossover|non-adherence|0
1050361|NCT00021541|3401673|P1|Period 2-crossover|non-adherence|1
1050362|NCT00021541|3401672|P2|Period 2-crossover|Adverse Event|2
1050363|NCT00021541|3401673|P1|Period 2-crossover|Adverse Event|2
1050364|NCT00021541|3401672|P2|Period 2-crossover|Withdrawal by Subject|4
1050365|NCT00021541|3401673|P1|Period 2-crossover|Withdrawal by Subject|3
1050366|NCT00021541|3401672|P2|Period 2-crossover|refused phase B|2
1050367|NCT00021541|3401673|P1|Period 2-crossover|refused phase B|2
1050368|NCT00021541|3401672|P2|Period 1-First Treatment|Ineligible|2
1050369|NCT00021541|3401673|P1|Period 1-First Treatment|Ineligible|0
1050370|NCT00021541|3401672|P2|Period 1-First Treatment|Pts that did not progress|2
1050371|NCT00021541|3401673|P1|Period 1-First Treatment|Pts that did not progress|2
1050372|NCT00021541|3401672|P2|Period 1-First Treatment|Death|0
1050373|NCT00021541|3401673|P1|Period 1-First Treatment|Death|1
1050374|NCT00021541|3401672|P2|Period 1-First Treatment|non-adherence|0
1050375|NCT00021541|3401673|P1|Period 1-First Treatment|non-adherence|3
1050376|NCT00021541|3401672|P2|Period 1-First Treatment|Adverse Event|1
1050377|NCT00021541|3401673|P1|Period 1-First Treatment|Adverse Event|2
1050378|NCT00021541|3401672|P2|Period 1-First Treatment|Withdrawal by Subject|3
1050379|NCT00021541|3401673|P1|Period 1-First Treatment|Withdrawal by Subject|3
1050380|NCT00015457|3401687|P2|Second Intervention|Withdrawal by Subject|0
1050381|NCT00015457|3401688|P1|Second Intervention|Withdrawal by Subject|1
1050382|NCT00015457|3401687|P2|First Intervention|Lack of Efficacy|1
1050383|NCT00015457|3401688|P1|First Intervention|Lack of Efficacy|0
1050384|NCT00015457|3401687|P2|First Intervention|Adverse Event|2
1050385|NCT00015457|3401688|P1|First Intervention|Adverse Event|0
1050386|NCT00013611|3401698|P2|Overall Study|Lost to Follow-up|100
1050387|NCT00013611|3401699|P1|Overall Study|Lost to Follow-up|91
1050388|NCT00010803|3401717|P2|Overall Study|Withdrawal by Subject|98
1050389|NCT00010803|3401718|P1|Overall Study|Withdrawal by Subject|97
1050390|NCT00007475|3401745|P4|Overall Study|Adverse Event|0
1050391|NCT00007475|3401746|P3|Overall Study|Adverse Event|0
1050392|NCT00007475|3401747|P2|Overall Study|Adverse Event|0
1050393|NCT00007475|3401748|P1|Overall Study|Adverse Event|3
1050394|NCT00007475|3401745|P4|Overall Study|Withdrawal by Subject|0
1050395|NCT00007475|3401746|P3|Overall Study|Withdrawal by Subject|0
1050396|NCT00007475|3401747|P2|Overall Study|Withdrawal by Subject|0
1050397|NCT00007475|3401748|P1|Overall Study|Withdrawal by Subject|1
1050398|NCT00007345|3401770|P2|Overall Study|Death on study|1
1050399|NCT00007345|3401771|P1|Overall Study|Death on study|1
1050400|NCT00007345|3401770|P2|Overall Study|Intercurrent illness|0
1050401|NCT00007345|3401771|P1|Overall Study|Intercurrent illness|1
1050402|NCT00007345|3401770|P2|Overall Study|Switched to alternative treatment|3
1050403|NCT00007345|3401771|P1|Overall Study|Switched to alternative treatment|0
1050404|NCT00007345|3401770|P2|Overall Study|Refused further treatment|7
1050405|NCT00007345|3401771|P1|Overall Study|Refused further treatment|0
1050406|NCT00006489|3401793|P4|Overall Study|Death|1
1050407|NCT00006489|3401794|P3|Overall Study|Death|0
1050408|NCT00006489|3401795|P2|Overall Study|Death|0
1050409|NCT00006489|3401796|P1|Overall Study|Death|0
1050410|NCT00006489|3401793|P4|Overall Study|Scheduling Conflict|1
1050411|NCT00006489|3401794|P3|Overall Study|Scheduling Conflict|2
1050412|NCT00006489|3401795|P2|Overall Study|Scheduling Conflict|3
1050413|NCT00006489|3401796|P1|Overall Study|Scheduling Conflict|0
1050414|NCT00006489|3401793|P4|Overall Study|Withdrawal by Subject|6
1050415|NCT00006489|3401794|P3|Overall Study|Withdrawal by Subject|9
1050416|NCT00006489|3401795|P2|Overall Study|Withdrawal by Subject|9
1050417|NCT00006489|3401796|P1|Overall Study|Withdrawal by Subject|10
1050418|NCT00006489|3401793|P4|Overall Study|Adverse Event|3
1050419|NCT00006489|3401794|P3|Overall Study|Adverse Event|4
1050420|NCT00006489|3401795|P2|Overall Study|Adverse Event|2
1050421|NCT00006489|3401796|P1|Overall Study|Adverse Event|3
1050422|NCT00006409|3401820|P6|Post-3 Year Intervention|Protocol Violation|62
1050423|NCT00006409|3401821|P5|Post-3 Year Intervention|Protocol Violation|62
1050424|NCT00006409|3401822|P4|Post-3 Year Intervention|Protocol Violation|0
1050425|NCT00006409|3401823|P3|Post-3 Year Intervention|Protocol Violation|0
1050426|NCT00006409|3401824|P2|Post-3 Year Intervention|Protocol Violation|0
1050427|NCT00006409|3401825|P1|Post-3 Year Intervention|Protocol Violation|0
1050428|NCT00006409|3401820|P6|Post-2 Year Intervention|Protocol Violation|0
1050429|NCT00006409|3401821|P5|Post-2 Year Intervention|Protocol Violation|0
1050430|NCT00006409|3401822|P4|Post-2 Year Intervention|Protocol Violation|168
1050431|NCT00006409|3401823|P3|Post-2 Year Intervention|Protocol Violation|251
1050432|NCT00006409|3401824|P2|Post-2 Year Intervention|Protocol Violation|0
1050433|NCT00006409|3401825|P1|Post-2 Year Intervention|Protocol Violation|0
1050434|NCT00006409|3401820|P6|Baseline|Protocol Violation|0
1050435|NCT00006409|3401821|P5|Baseline|Protocol Violation|0
1050436|NCT00006409|3401822|P4|Baseline|Protocol Violation|0
1050437|NCT00006409|3401823|P3|Baseline|Protocol Violation|0
1050438|NCT00006409|3401824|P2|Baseline|Protocol Violation|70
1050439|NCT00006409|3401825|P1|Baseline|Protocol Violation|48
1050440|NCT00006305|3401849|P4|Overall Study|Withdrawal by Subject|14
1050441|NCT00006305|3401850|P3|Overall Study|Withdrawal by Subject|15
1050442|NCT00006305|3401851|P2|Overall Study|Withdrawal by Subject|10
1050443|NCT00006305|3401852|P1|Overall Study|Withdrawal by Subject|17
1050444|NCT00006289|3401868|P2|Second Intervention (5 Weeks)|Protocol Violation|1
1050445|NCT00006289|3401869|P1|Second Intervention (5 Weeks)|Protocol Violation|1
1050446|NCT00006289|3401868|P2|First Intervention (5 Weeks)|Adverse Event|0
1050447|NCT00006289|3401869|P1|First Intervention (5 Weeks)|Adverse Event|1
1050448|NCT00006184|3401887|P2|Overall Study|Death|0
1050449|NCT00006184|3401888|P1|Overall Study|Death|1
1050450|NCT00006164|3401939|P2|Overall Study|Withdrew or lost to follow-up|81
1050451|NCT00006164|3401940|P1|Overall Study|Withdrew or lost to follow-up|70
1050452|NCT00005937|3401983|P1|Overall Study|Lack of Efficacy|5
1050453|NCT00005908|3401987|P2|Overall Study|Withdrawal by Subject|0
1050454|NCT00005908|3401988|P1|Overall Study|Withdrawal by Subject|1
1050455|NCT00005906|3401997|P1|Overall Study|Lack of Efficacy|3
1050456|NCT00004980|3402041|P2|Overall Study|Physician Decision|1
1050457|NCT00004980|3402042|P1|Overall Study|Physician Decision|0
1050458|NCT00004980|3402041|P2|Overall Study|memory difficulties|1
1050459|NCT00004980|3402042|P1|Overall Study|memory difficulties|1
1050460|NCT00004980|3402041|P2|Overall Study|Withdrawal by Subject|0
1050461|NCT00004980|3402042|P1|Overall Study|Withdrawal by Subject|1
1050462|NCT00004732|3402056|P2|Overall Study|Lost to Follow-up|47
1050463|NCT00004732|3402057|P1|Overall Study|Lost to Follow-up|33
1050464|NCT00004732|3402056|P2|Overall Study|Withdrawal by Subject|64
1050465|NCT00004732|3402057|P1|Overall Study|Withdrawal by Subject|36
1050466|NCT00004635|3402067|P2|Period Two|discrepancy in data entry|1
1050467|NCT00004635|3402068|P1|Period Two|discrepancy in data entry|0
1050468|NCT00004635|3402067|P2|Period Two|Lost to Follow-up|0
1050469|NCT00004635|3402068|P1|Period Two|Lost to Follow-up|1
1050470|NCT00004635|3402067|P2|Period Two|secondary malignancy|1
1050471|NCT00004635|3402068|P1|Period Two|secondary malignancy|1
1050472|NCT00004635|3402067|P2|Period Two|travel issues|1
1050473|NCT00004635|3402068|P1|Period Two|travel issues|0
1050474|NCT00004635|3402067|P2|Period Two|health problem|1
1050475|NCT00004635|3402068|P1|Period Two|health problem|1
1050476|NCT00004635|3402067|P2|Period Two|refused|2
1050477|NCT00004635|3402068|P1|Period Two|refused|0
1050478|NCT00004635|3402067|P2|Period Two|Adverse Event|0
1050479|NCT00004635|3402068|P1|Period Two|Adverse Event|1
1050480|NCT00004635|3402067|P2|Period Two|progression|3
1050481|NCT00004635|3402068|P1|Period Two|progression|2
1050482|NCT00004635|3402067|P2|Period One|discrepancy in data entry|1
1050483|NCT00004635|3402068|P1|Period One|discrepancy in data entry|0
1050484|NCT00004635|3402067|P2|Period One|health problem|1
1050485|NCT00004635|3402068|P1|Period One|health problem|0
1050486|NCT00004635|3402067|P2|Period One|progressed|2
1050487|NCT00004635|3402068|P1|Period One|progressed|0
1050488|NCT00004635|3402067|P2|Period One|second malignancy|0
1050489|NCT00004635|3402068|P1|Period One|second malignancy|1
1050490|NCT00004635|3402067|P2|Period One|PSA did not go <5 ng/mL|0
1050491|NCT00004635|3402068|P1|Period One|PSA did not go <5 ng/mL|1
1050492|NCT00004635|3402067|P2|Period One|Protocol Violation|0
1050493|NCT00004635|3402068|P1|Period One|Protocol Violation|1
1050494|NCT00004635|3402067|P2|Period One|Withdrawal by Subject|1
1050495|NCT00004635|3402068|P1|Period One|Withdrawal by Subject|1
1050496|NCT00004635|3402067|P2|Period One|refused|1
1050497|NCT00004635|3402068|P1|Period One|refused|2
1050498|NCT00004563|3402080|P2|Overall Study|Death|3
1050499|NCT00004563|3402081|P1|Overall Study|Death|2
1050500|NCT00004563|3402080|P2|Overall Study|Lack of Efficacy|5
1050501|NCT00004563|3402081|P1|Overall Study|Lack of Efficacy|3
1050502|NCT00004563|3402080|P2|Overall Study|Withdrawal by Subject|16
1050503|NCT00004563|3402081|P1|Overall Study|Withdrawal by Subject|20
1050504|NCT00004562|3402093|P2|Overall Study|Lost to Follow-up|91
1050505|NCT00004562|3402094|P1|Overall Study|Lost to Follow-up|102
1050506|NCT00001962|3402135|P1|Overall Study|Adverse Event|1
1050507|NCT00001962|3402135|P1|Overall Study|Lost to Follow-up|2
1050508|NCT00001962|3402135|P1|Overall Study|Death|1
1050509|NCT00001962|3402135|P1|Overall Study|Lack of Accrual|6
1050510|NCT00001962|3402135|P1|Overall Study|Lack of Efficacy|18
1050511|NCT00001959|3402139|P1|Overall Study|non-compliance|1
1050512|NCT00001959|3402139|P1|Overall Study|disabling sedation|1
1050513|NCT00001959|3402139|P1|Overall Study|newly diagnosed colon cancer|1
1050514|NCT00001941|3402145|P5|Overall Study|not treated- rapidly progressing disease|1
1050515|NCT00001941|3402146|P4|Overall Study|not treated- rapidly progressing disease|0
1050516|NCT00001941|3402147|P3|Overall Study|not treated- rapidly progressing disease|0
1050517|NCT00001941|3402148|P2|Overall Study|not treated- rapidly progressing disease|0
1050518|NCT00001941|3402149|P1|Overall Study|not treated- rapidly progressing disease|0
1050519|NCT00001832|3402181|P15|Treatment Period|Not treated|0
1050520|NCT00001832|3402182|P14|Treatment Period|Not treated|0
1050521|NCT00001832|3402183|P13|Treatment Period|Not treated|0
1050522|NCT00001832|3402184|P12|Treatment Period|Not treated|0
1050523|NCT00001832|3402185|P11|Treatment Period|Not treated|0
1050524|NCT00001832|3402186|P10|Treatment Period|Not treated|0
1050525|NCT00001832|3402187|P9|Treatment Period|Not treated|0
1050526|NCT00001832|3402188|P8|Treatment Period|Not treated|1
1050527|NCT00001832|3402189|P7|Treatment Period|Not treated|0
1050528|NCT00001832|3402190|P6|Treatment Period|Not treated|0
1050529|NCT00001832|3402191|P5|Treatment Period|Not treated|0
1050530|NCT00001832|3402192|P4|Treatment Period|Not treated|0
1050531|NCT00001832|3402193|P3|Treatment Period|Not treated|0
1050532|NCT00001832|3402194|P2|Treatment Period|Not treated|0
1050533|NCT00001832|3402195|P1|Treatment Period|Not treated|0
1050534|NCT00001832|3402181|P15|Treatment Period|Death during treatment|0
1050535|NCT00001832|3402182|P14|Treatment Period|Death during treatment|0
1050536|NCT00001832|3402183|P13|Treatment Period|Death during treatment|0
1050537|NCT00001832|3402184|P12|Treatment Period|Death during treatment|0
1050538|NCT00001832|3402185|P11|Treatment Period|Death during treatment|0
1050539|NCT00001832|3402186|P10|Treatment Period|Death during treatment|0
1050540|NCT00001832|3402187|P9|Treatment Period|Death during treatment|0
1050541|NCT00001832|3402188|P8|Treatment Period|Death during treatment|0
1050542|NCT00001832|3402189|P7|Treatment Period|Death during treatment|0
1050543|NCT00001832|3402190|P6|Treatment Period|Death during treatment|1
1050544|NCT00001832|3402191|P5|Treatment Period|Death during treatment|0
1050545|NCT00001832|3402192|P4|Treatment Period|Death during treatment|0
1050546|NCT00001832|3402193|P3|Treatment Period|Death during treatment|0
1050547|NCT00001832|3402194|P2|Treatment Period|Death during treatment|0
1050548|NCT00001832|3402195|P1|Treatment Period|Death during treatment|0
1050549|NCT00001832|3402181|P15|Apheresis Period|not able to manufacture treatment cells|0
1050550|NCT00001832|3402182|P14|Apheresis Period|not able to manufacture treatment cells|0
1050551|NCT00001832|3402183|P13|Apheresis Period|not able to manufacture treatment cells|0
1050552|NCT00001832|3402184|P12|Apheresis Period|not able to manufacture treatment cells|0
1050553|NCT00001832|3402185|P11|Apheresis Period|not able to manufacture treatment cells|0
1050554|NCT00001832|3402186|P10|Apheresis Period|not able to manufacture treatment cells|0
1050555|NCT00001832|3402187|P9|Apheresis Period|not able to manufacture treatment cells|0
1050556|NCT00001832|3402188|P8|Apheresis Period|not able to manufacture treatment cells|0
1050557|NCT00001832|3402189|P7|Apheresis Period|not able to manufacture treatment cells|0
1050558|NCT00001832|3402190|P6|Apheresis Period|not able to manufacture treatment cells|0
1050559|NCT00001832|3402191|P5|Apheresis Period|not able to manufacture treatment cells|0
1050560|NCT00001832|3402192|P4|Apheresis Period|not able to manufacture treatment cells|0
1050561|NCT00001832|3402193|P3|Apheresis Period|not able to manufacture treatment cells|0
1050562|NCT00001832|3402194|P2|Apheresis Period|not able to manufacture treatment cells|0
1050563|NCT00001832|3402195|P1|Apheresis Period|not able to manufacture treatment cells|60
1050564|NCT00001723|3402241|P2|Overall Study|medication intolerance|2
1050565|NCT00001723|3402242|P1|Overall Study|medication intolerance|1
1050566|NCT00001723|3402241|P2|Overall Study|Lost to Follow-up|2
1050567|NCT00001723|3402242|P1|Overall Study|Lost to Follow-up|2
1050568|NCT00001723|3402241|P2|Overall Study|Lack of family interest|5
1050569|NCT00001723|3402242|P1|Overall Study|Lack of family interest|4
1050570|NCT00001723|3402241|P2|Overall Study|Lack of Efficacy|7
1050571|NCT00001723|3402242|P1|Overall Study|Lack of Efficacy|6
1050572|NCT00001703|3402258|P1|Overall Study|recurrent disease|2
1050573|NCT00001703|3402258|P1|Overall Study|No evidence of disease|1
1050574|NCT00001703|3402258|P1|Overall Study|progressed disease|2
1050575|NCT00001596|3402296|P2|Overall Study|Adverse Event|0
1050576|NCT00001596|3402297|P1|Overall Study|Adverse Event|1
1050577|NCT00001596|3402296|P2|Overall Study|Study Termination|9
1050578|NCT00001596|3402297|P1|Overall Study|Study Termination|12
1050579|NCT00001596|3402296|P2|Overall Study|Withdrawal by Subject|1
1050580|NCT00001596|3402297|P1|Overall Study|Withdrawal by Subject|3
1050581|NCT00001596|3402296|P2|Overall Study|Death|0
1050582|NCT00001596|3402297|P1|Overall Study|Death|1
1050583|NCT00001575|3402328|P1|Overall Study|Withdrawn/deaths|23
1050584|NCT00001575|3402328|P1|Overall Study|Screening failures-Ph I portion|22
1050585|NCT00001566|3402334|P1|Overall Study|unable to complete initial apheresis|1
1050586|NCT00001566|3402334|P1|Overall Study|Lost to Follow-up|1
1050587|NCT00001566|3402334|P1|Overall Study|Death|13
1050588|NCT00001566|3402334|P1|Overall Study|stopped after C3 due to symptomatic PD|1
1050589|NCT00001566|3402334|P1|Overall Study|patients' choice to discontinue protocol|3
1050590|NCT00001262|3402370|P3|Overall Study|Withdrawal by Subject|0
1050591|NCT00001262|3402371|P2|Overall Study|Withdrawal by Subject|3
1050592|NCT00001262|3402372|P1|Overall Study|Withdrawal by Subject|0
1050593|NCT00001262|3402370|P3|Overall Study|Death|0
1050594|NCT00001262|3402371|P2|Overall Study|Death|11
1050595|NCT00001262|3402372|P1|Overall Study|Death|10
1050596|NCT00001213|3402398|P1|Overall Study|Death|18
1050597|NCT00000378|3402409|P2|Overall Study|Lack of Efficacy|14
1050598|NCT00000378|3402410|P1|Overall Study|Lack of Efficacy|16
1050599|NCT00000620|3402427|P8|Overall Study|missed closeout visit|16
1050600|NCT00000620|3402428|P7|Overall Study|missed closeout visit|13
1050601|NCT00000620|3402429|P6|Overall Study|missed closeout visit|28
1050602|NCT00000620|3402430|P5|Overall Study|missed closeout visit|26
1050603|NCT00000620|3402431|P4|Overall Study|missed closeout visit|11
1050604|NCT00000620|3402432|P3|Overall Study|missed closeout visit|16
1050605|NCT00000620|3402433|P2|Overall Study|missed closeout visit|28
1050606|NCT00000620|3402434|P1|Overall Study|missed closeout visit|22
1050607|NCT00000620|3402427|P8|Overall Study|Withdrawal by Subject|21
1050608|NCT00000620|3402428|P7|Overall Study|Withdrawal by Subject|32
1050609|NCT00000620|3402429|P6|Overall Study|Withdrawal by Subject|32
1050610|NCT00000620|3402430|P5|Overall Study|Withdrawal by Subject|30
1050611|NCT00000620|3402431|P4|Overall Study|Withdrawal by Subject|27
1050612|NCT00000620|3402432|P3|Overall Study|Withdrawal by Subject|28
1050613|NCT00000620|3402433|P2|Overall Study|Withdrawal by Subject|27
1050614|NCT00000620|3402434|P1|Overall Study|Withdrawal by Subject|40
1050615|NCT00000620|3402427|P8|Overall Study|Lost to Follow-up|14
1050616|NCT00000620|3402428|P7|Overall Study|Lost to Follow-up|13
1050617|NCT00000620|3402429|P6|Overall Study|Lost to Follow-up|15
1050618|NCT00000620|3402430|P5|Overall Study|Lost to Follow-up|15
1050619|NCT00000620|3402431|P4|Overall Study|Lost to Follow-up|14
1050620|NCT00000620|3402432|P3|Overall Study|Lost to Follow-up|14
1050621|NCT00000620|3402433|P2|Overall Study|Lost to Follow-up|14
1050622|NCT00000620|3402434|P1|Overall Study|Lost to Follow-up|14
1050623|NCT00000620|3402427|P8|Overall Study|Death|95
1050624|NCT00000620|3402428|P7|Overall Study|Death|91
1050625|NCT00000620|3402429|P6|Overall Study|Death|77
1050626|NCT00000620|3402430|P5|Overall Study|Death|64
1050627|NCT00000620|3402431|P4|Overall Study|Death|126
1050628|NCT00000620|3402432|P3|Overall Study|Death|112
1050629|NCT00000620|3402433|P2|Overall Study|Death|67
1050630|NCT00000620|3402434|P1|Overall Study|Death|86
1050631|NCT00004412|3402518|P3|Randomized Period|Moved to Crossover Period|0
1050632|NCT00004412|3402519|P2|Randomized Period|Moved to Crossover Period|0
1050633|NCT00004412|3402520|P1|Randomized Period|Moved to Crossover Period|3
1050634|NCT00000135|3402561|P2|Overall Study|Death|14
1050635|NCT00000135|3402562|P1|Overall Study|Death|27
